{"meta":{"query_hash":"a398f4a60e3c","filters":{"topic":"Renal cell carcinoma treatment"},"cohort_total":2551,"direct_labels_cover":11,"predictions_cover":2551,"exported":2551,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/a398f4a60e3c","api":"https://metacan.xera.ac/api/v1/cohort?topic=Renal+cell+carcinoma+treatment"},"results":[{"id":"W1024746013","doi":"10.1007/s00345-015-1606-4","title":"Comparison of renal function detriments after local tumor ablation or partial nephrectomy for renal cell carcinoma","year":2015,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Renal function; Dialysis; Urology; Kidney disease; Nephrology; Renal cell carcinoma; Hemodialysis; Nephrectomy; Propensity score matching; Acute kidney injury; Internal medicine; Kidney cancer; Nephropathy; Surgery; Gastroenterology; Kidney; Endocrinology; Diabetes mellitus","score_opus":0.04780092173897033,"score_gpt":0.30983604654339475,"score_spread":0.2620351248044244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1024746013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97717553,0.0023466446,0.018403994,0.00036617913,0.00061899755,0.00047627275,0.0000053408826,0.000008971505,0.00059808156],"genre_scores_gemma":[0.99645257,0.000003441752,0.002132469,0.00026361088,0.000590133,0.00002988811,0.000013488599,0.000025350282,0.0004890517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801373,0.00014828859,0.0009229154,0.00019330252,0.00042290252,0.00029882812],"domain_scores_gemma":[0.99810636,0.00016796283,0.0007478082,0.00018428438,0.00049059844,0.00030297102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047241358,0.00019215631,0.00067420065,0.0004582393,0.00003272976,0.000008259825,0.00008864292,0.00008648049,0.00016579452],"category_scores_gemma":[0.00007103637,0.00013842879,0.00022300922,0.00024657618,0.00010815205,0.00010227905,0.000029437688,0.00028876442,0.000012799479],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25465024,0.0028682654,0.6473923,0.00023107258,0.00070607883,0.0013161801,0.0008952396,0.0048207617,0.043712888,0.00008484545,0.023998866,0.019323308],"study_design_scores_gemma":[0.050913237,0.07150184,0.38175556,0.00014596316,0.0050760726,0.0025258649,0.00036486125,0.009461406,0.2927194,0.00052820396,0.18443362,0.00057398994],"about_ca_topic_score_codex":0.000016105865,"about_ca_topic_score_gemma":0.000052198102,"teacher_disagreement_score":0.2656367,"about_ca_system_score_codex":0.00022132015,"about_ca_system_score_gemma":0.0004075498,"threshold_uncertainty_score":0.5644962},"labels":[],"label_agreement":null},{"id":"W1172870045","doi":"10.1148/radiol.2015132798","title":"Case 221: Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome","year":2015,"lang":"en","type":"article","venue":"Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Abdomen; Pelvis; Radiology; Physical examination; Magnetic resonance imaging; Nuclear medicine","score_opus":0.04114823574892032,"score_gpt":0.2709645659892641,"score_spread":0.22981633024034379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1172870045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98607844,0.00941583,0.000012755521,0.00064843433,0.00026903037,0.00022407362,0.000015175682,0.00004456554,0.0032916986],"genre_scores_gemma":[0.99759823,0.00014535713,0.0006674668,0.00030386544,0.0002041595,0.000048864935,0.000020783646,0.000020427584,0.0009908688],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99912566,0.0000735356,0.00017015023,0.0002779203,0.00009724699,0.0002554894],"domain_scores_gemma":[0.9992779,0.000057023193,0.00004614305,0.00023240286,0.000046403624,0.00034016356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011358411,0.0001505518,0.0003637645,0.00008375437,0.000036045672,0.0000045651946,0.00003765276,0.00012497081,0.00011795336],"category_scores_gemma":[0.000017115117,0.00011634909,0.00004957372,0.00008035076,0.00011669847,0.000035869147,0.000038094735,0.00012848295,0.000050792274],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076439464,0.00038462604,0.29372957,0.00031674295,0.00060806546,0.61413735,0.0013907447,0.000040904924,0.013873417,0.00015826662,0.06874604,0.0058498923],"study_design_scores_gemma":[0.0047439667,0.0025215026,0.07810641,0.00004567777,0.0004731539,0.89963067,0.00029171785,0.00016566747,0.005808239,0.00014057501,0.007795713,0.00027670537],"about_ca_topic_score_codex":0.00052572053,"about_ca_topic_score_gemma":0.00002294893,"teacher_disagreement_score":0.28549334,"about_ca_system_score_codex":0.00016645835,"about_ca_system_score_gemma":0.0001326514,"threshold_uncertainty_score":0.47445783},"labels":[],"label_agreement":null},{"id":"W117357840","doi":"10.1016/s1695-3290(08)35026-5","title":"10.1016/s1695-3290(08)35026-5","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology; Carcinoma; Internal medicine","score_opus":0.014340793626945169,"score_gpt":0.19028956513946213,"score_spread":0.17594877151251695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W117357840","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009363271,0.0013587195,1.9304765e-7,0.00032568435,0.000004980193,0.0010572652,0.00008314759,0.00021870763,0.9969419],"genre_scores_gemma":[0.000008982415,0.0000068757636,0.0001340661,0.00012026548,0.0007157243,0.000042867123,0.00041877144,0.00023492395,0.99831754],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976948,0.00001805511,0.00048233685,0.00071083894,0.0006389029,0.00045508295],"domain_scores_gemma":[0.998065,0.000068010435,0.00013281524,0.001061693,0.00012293362,0.00054953014],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00010062668,0.0006796511,0.00095210253,0.00035102628,0.00006580351,0.000031716303,0.00021872962,0.0004702718,0.9986552],"category_scores_gemma":[0.000018224631,0.00060058216,0.00042517134,0.000053988886,0.00008165993,0.00003868787,0.000098487304,0.0005146231,0.99855655],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006390354,0.000085151594,4.5379387e-8,0.00008498712,0.0003731254,0.00097111025,0.000015669219,0.0000030618094,0.000030838302,0.000033293858,0.52270716,0.4750565],"study_design_scores_gemma":[0.0009023908,0.0011708677,0.000013727199,0.0004213425,0.0007168928,0.0002715717,2.2931802e-7,0.000004490603,0.00013176227,0.00010111752,0.9957616,0.00050400855],"about_ca_topic_score_codex":0.000023201259,"about_ca_topic_score_gemma":2.6163445e-7,"teacher_disagreement_score":0.47455248,"about_ca_system_score_codex":0.00041625326,"about_ca_system_score_gemma":0.00018973944,"threshold_uncertainty_score":0.9996446},"labels":[],"label_agreement":null},{"id":"W1178170136","doi":"10.1016/j.urology.2015.04.062","title":"Contrast-enhanced Ultrasonography for Surveillance of Radiofrequency-ablated Renal Tumors: A Prospective, Radiologist-blinded Pilot Study","year":2015,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Radiology; Contrast-enhanced ultrasound; Radiofrequency ablation; Concordance; Percutaneous; Prospective cohort study; Biopsy; Ultrasonography; Ablation; Ultrasound; Surgery; Internal medicine","score_opus":0.05875414044013089,"score_gpt":0.2985661493404071,"score_spread":0.2398120089002762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1178170136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903625,0.0013496628,0.0021996333,0.0002366559,0.00018397384,0.0037387367,0.000037830312,0.00011766114,0.0017732956],"genre_scores_gemma":[0.99828815,0.00002048203,0.0007730673,0.00011612851,0.00013290964,0.0004771848,0.000056217596,0.000036458117,0.000099412326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978226,0.00027158004,0.0005855834,0.0005864213,0.0002452395,0.0004886003],"domain_scores_gemma":[0.99806094,0.0003515609,0.00028959845,0.0005087491,0.0005516734,0.00023748323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006472043,0.0002948351,0.0009667028,0.00019916658,0.00004612094,0.0000074575714,0.00016858857,0.00010536448,0.000025775575],"category_scores_gemma":[0.0006400351,0.00023388799,0.00013866628,0.00039473482,0.00032356387,0.000046917274,0.000023064258,0.00021661661,0.000008596919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045971956,0.006219454,0.7433258,0.00010824547,0.0013426833,0.00033019733,0.0014077378,0.0003278775,0.19840978,0.00040013233,0.0011194272,0.0010366685],"study_design_scores_gemma":[0.056237333,0.17728744,0.7061777,0.000027273773,0.00053491024,0.00053468853,0.00044859305,0.0002771049,0.05581007,0.0018527689,0.00031323338,0.0004988784],"about_ca_topic_score_codex":0.00013425876,"about_ca_topic_score_gemma":0.00006775213,"teacher_disagreement_score":0.171068,"about_ca_system_score_codex":0.00013120723,"about_ca_system_score_gemma":0.00025839242,"threshold_uncertainty_score":0.9537675},"labels":[],"label_agreement":null},{"id":"W123023646","doi":"","title":"Ambulatory laparoscopic renal cyst decortication.","year":2010,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Medicine; Decortication; Ambulatory; Sclerotherapy; Surgery; Cyst; Laparoscopy; Percutaneous; Anesthesia","score_opus":0.02038405623670324,"score_gpt":0.23853738759828538,"score_spread":0.21815333136158213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W123023646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97275597,0.00015037844,0.000012907732,0.0007053855,0.0003386698,0.00068949326,0.0000029223716,0.00007283421,0.02527146],"genre_scores_gemma":[0.993463,0.0000070343485,0.0005341143,0.00031924297,0.00028560078,0.001072988,0.000022139644,0.000017192671,0.004278735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909854,0.000013066486,0.00017836023,0.00021608936,0.00021041681,0.0002835019],"domain_scores_gemma":[0.99915165,0.000031390508,0.000048770366,0.00042998738,0.000058097547,0.00028010682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012849158,0.00010487019,0.00016771174,0.000070226844,0.000044124943,0.000016584512,0.00006823253,0.000072225055,0.00016733124],"category_scores_gemma":[0.00010374597,0.000084717445,0.00006615692,0.00010207052,0.0000649719,0.000048744834,0.000023083256,0.00019087917,0.00020272053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034098292,0.00083245826,0.6935741,0.00013295746,0.00032126767,0.00046863058,0.00019018872,0.0000027741885,0.08700587,0.002683453,0.010293017,0.20415433],"study_design_scores_gemma":[0.00094527,0.000030388404,0.9492038,0.0000037370091,0.00008808269,0.00011688401,0.0000043879772,0.000009622735,0.034180008,0.00009504675,0.015248849,0.00007395173],"about_ca_topic_score_codex":0.000019099376,"about_ca_topic_score_gemma":0.000025139563,"teacher_disagreement_score":0.2556297,"about_ca_system_score_codex":0.00006846979,"about_ca_system_score_gemma":0.000052307398,"threshold_uncertainty_score":0.34546772},"labels":[],"label_agreement":null},{"id":"W1241485355","doi":"10.1016/j.ejca.2015.08.017","title":"Efficacy of targeted therapies after PD-1/PD-L1 blockade in metastatic renal cell carcinoma","year":2015,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; Unicancer; Fondation de France; Dana-Farber/Harvard Cancer Center","keywords":"Renal cell carcinoma; Blockade; PD-L1; Medicine; Oncology; Cancer research; Internal medicine; Immunotherapy; Receptor; Cancer","score_opus":0.03496179729988725,"score_gpt":0.27880808328509454,"score_spread":0.2438462859852073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1241485355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9633051,0.03192097,0.00003613791,0.0005843304,0.0002178097,0.00019938288,0.000008047325,0.0000065534314,0.0037216563],"genre_scores_gemma":[0.9967526,0.00016532298,0.0015939509,0.00016716919,0.00032961223,0.000003871515,0.000002390439,0.000055197317,0.0009298449],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976955,0.0004644905,0.00079692266,0.00017134495,0.00060975226,0.0002619822],"domain_scores_gemma":[0.99849796,0.000063409585,0.0004974381,0.00025975434,0.00037218985,0.00030925896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007892896,0.0002200077,0.00055955845,0.00028859315,0.00001380809,0.0000139427075,0.00016803994,0.00001992182,0.00028198148],"category_scores_gemma":[0.00007230017,0.00015249552,0.00022632476,0.00024165542,0.00009047356,0.00009186753,0.000039938706,0.00032317982,0.000025331847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048078403,0.0037044082,0.5329585,0.000747815,0.0021070603,0.043690924,0.03880989,0.0031069824,0.2668995,0.000014519463,0.014299774,0.045582194],"study_design_scores_gemma":[0.014145291,0.0025386263,0.8815739,0.00036632214,0.0005421798,0.00028233236,0.00046997872,0.000024889481,0.09072217,0.000015966063,0.0091233635,0.0001949636],"about_ca_topic_score_codex":0.000052019215,"about_ca_topic_score_gemma":0.000012571634,"teacher_disagreement_score":0.34861538,"about_ca_system_score_codex":0.00022678546,"about_ca_system_score_gemma":0.0003595847,"threshold_uncertainty_score":0.62185866},"labels":[],"label_agreement":null},{"id":"W1249263666","doi":"10.1503/cmaj.150191","title":"Hereditary leiomyomatosis and renal cell cancer syndrome","year":2015,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Leiomyomatosis; Abdomen; Surgery; Gynecology; General surgery; Leiomyoma","score_opus":0.015910646487322967,"score_gpt":0.23903844187335355,"score_spread":0.2231277953860306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1249263666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9588534,0.0027177103,0.000009373306,0.031434134,0.0006166138,0.00012062754,0.000019767052,0.000016800803,0.006211561],"genre_scores_gemma":[0.99138474,0.00023260326,0.00020713918,0.00506632,0.0010792665,0.000011186371,0.000011718657,0.00002098662,0.0019860456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764466,0.00009789354,0.0003139849,0.00016102723,0.001358939,0.00042349237],"domain_scores_gemma":[0.9950266,0.000060996754,0.00013307347,0.00009146917,0.00033683344,0.0043510413],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00084599486,0.000133388,0.00028171352,0.0001801844,0.00012185882,0.000049771912,0.000081934835,0.00028458916,0.0016098712],"category_scores_gemma":[0.00035447135,0.0001106871,0.00007655007,0.0001668713,0.00003792853,0.00009843396,0.000015318476,0.0006195318,0.00011333123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000428045,0.0000844492,0.48264965,0.00003740275,0.0003497012,0.0207942,0.00055936,0.000005013545,0.000088275134,0.000024285262,0.47813886,0.017225979],"study_design_scores_gemma":[0.008259785,0.00095225585,0.5350901,0.00042341143,0.0004807028,0.037868995,0.0011460113,0.00032003797,0.00056468474,0.00025463616,0.41416112,0.00047826584],"about_ca_topic_score_codex":0.0073405793,"about_ca_topic_score_gemma":0.008925136,"teacher_disagreement_score":0.06397775,"about_ca_system_score_codex":0.002229471,"about_ca_system_score_gemma":0.0048148083,"threshold_uncertainty_score":0.9993028},"labels":[],"label_agreement":null},{"id":"W128623453","doi":"","title":"Microarray gene expression profiling using core biopsies of renal neoplasia.","year":2009,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pathology; Biopsy; Oncocytoma; Histology; Renal cell carcinoma; Gene expression profiling; Microarray; Nephrectomy; Gene expression; Medicine; Kidney; Biology; Gene; Internal medicine","score_opus":0.05872591524265178,"score_gpt":0.264302275372019,"score_spread":0.20557636012936722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W128623453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99579877,0.00095725036,0.00013595371,0.00013049113,0.000085815765,0.00083192333,0.0000059213758,0.00004191498,0.0020119497],"genre_scores_gemma":[0.98698676,0.000022778131,0.012232789,0.00007968266,0.0001420932,0.00007110465,0.000025762427,0.000015270072,0.00042375503],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989113,0.000021192145,0.00027541775,0.00023740261,0.00024378276,0.00031090673],"domain_scores_gemma":[0.9993392,0.000023201315,0.00012757942,0.00028254505,0.00007776805,0.00014970856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013926871,0.00014682644,0.00029140385,0.00012313557,0.00004312711,0.000008316475,0.00006217576,0.00007723751,0.000012959465],"category_scores_gemma":[0.000055881526,0.00011115319,0.00010138438,0.00015820937,0.00004646181,0.00005446115,0.00002178318,0.000095153424,0.000003064731],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031502696,0.00013836075,0.017812349,0.00004802995,0.000031634612,0.00009190234,0.00011313416,0.00004215045,0.965042,0.000007749277,0.00011259461,0.016245086],"study_design_scores_gemma":[0.0008467931,0.000090263165,0.18738614,0.00005584516,0.00008672578,0.00015307959,0.00003653694,0.00005952532,0.81108475,0.000032103693,0.000090635265,0.000077582015],"about_ca_topic_score_codex":0.000010988455,"about_ca_topic_score_gemma":4.4854292e-7,"teacher_disagreement_score":0.1695738,"about_ca_system_score_codex":0.00011437574,"about_ca_system_score_gemma":0.000045422486,"threshold_uncertainty_score":0.45326954},"labels":[],"label_agreement":null},{"id":"W1457625536","doi":"10.1097/pas.0000000000000292","title":"Succinate Dehydrogenase (SDH)-deficient Renal Carcinoma","year":2014,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":343,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institutes of Health; Cancer Institute NSW","keywords":"SDHB; Pathology; Eosinophilic; Carcinoma; Paraganglioma; Renal cell carcinoma; Medicine; Coagulative necrosis; SDHD; Germline mutation; Biology; Mutation","score_opus":0.014184358980686023,"score_gpt":0.2585349821378682,"score_spread":0.24435062315718217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1457625536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99239254,0.00070775906,0.00025276715,0.00391519,0.00015199007,0.0001328883,0.0000024657033,0.000016504027,0.0024278716],"genre_scores_gemma":[0.997989,0.0001164486,0.00055947015,0.0007424674,0.0004031614,0.000004214111,0.00000253555,0.00002782308,0.00015488638],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975582,0.0006607493,0.0006500754,0.00023100725,0.00045797444,0.0004420461],"domain_scores_gemma":[0.997814,0.00043585242,0.0007006565,0.0004651343,0.00022886365,0.0003554929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012062547,0.00022886587,0.0008903563,0.00018612923,0.00009855443,0.000012728584,0.00026287613,0.00004835237,0.0000995916],"category_scores_gemma":[0.00009301226,0.00012327603,0.00042545283,0.00033717044,0.0007530001,0.0000360842,0.00007611613,0.00050649286,0.000072849114],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030709743,0.0037551152,0.2951005,0.0001422338,0.0012636352,0.16094823,0.0036713742,0.0014823403,0.17104971,0.0061786473,0.0034499394,0.32224852],"study_design_scores_gemma":[0.012935303,0.035933018,0.5468693,0.00016340504,0.0014741295,0.30505782,0.0008412199,0.00070481806,0.041186947,0.0014935796,0.05263625,0.00070425984],"about_ca_topic_score_codex":0.000018859519,"about_ca_topic_score_gemma":8.720845e-7,"teacher_disagreement_score":0.32154426,"about_ca_system_score_codex":0.00012503528,"about_ca_system_score_gemma":0.0001071071,"threshold_uncertainty_score":0.50270504},"labels":[],"label_agreement":null},{"id":"W1480175705","doi":"10.4161/cbt.29187","title":"Dual VEGF/VEGFR inhibition in advanced solid malignancies","year":2014,"lang":"en","type":"article","venue":"Cancer Biology & Therapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"Sunitinib; Medicine; Bevacizumab; Renal cell carcinoma; Thrombotic microangiopathy; Melanoma; Vascular endothelial growth factor; Internal medicine; Cancer; Oncology; Response Evaluation Criteria in Solid Tumors; Kidney cancer; Axitinib; Cancer research; Gastroenterology; Phases of clinical research; Chemotherapy; VEGF receptors","score_opus":0.02708406765607009,"score_gpt":0.3146572954899642,"score_spread":0.2875732278338941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1480175705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906455,0.006002792,0.000059259986,0.0014738244,0.0002779204,0.00035932782,0.00000827497,0.000051191037,0.0011218601],"genre_scores_gemma":[0.9942817,0.002567147,0.00019647628,0.00206408,0.00028479748,0.0002328548,0.00005681729,0.00002181528,0.00029430728],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899733,0.00008857883,0.00021803677,0.00031880138,0.00007242728,0.00030482732],"domain_scores_gemma":[0.99950916,0.000045109842,0.00007231618,0.00023940498,0.00006114479,0.00007283896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013210355,0.00017415981,0.00034643803,0.000102543694,0.000036951787,0.0000045990773,0.000034200497,0.00013608659,0.00017720315],"category_scores_gemma":[0.000014530598,0.00013068784,0.00007459351,0.0001333042,0.00012923568,0.000039018978,0.000015247828,0.00013166807,0.00003809623],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008485233,0.00015389427,0.07474737,0.000021767055,0.00006623477,0.000047391808,0.000489444,0.000027932652,0.8482788,0.00045628232,0.00023949702,0.074622855],"study_design_scores_gemma":[0.009150375,0.0028782072,0.32626677,0.00021196165,0.000032853233,0.000081128295,0.00011222731,0.000049495768,0.6230075,0.0018224091,0.03607343,0.00031368708],"about_ca_topic_score_codex":0.00009610977,"about_ca_topic_score_gemma":0.00007068048,"teacher_disagreement_score":0.25151938,"about_ca_system_score_codex":0.00018987973,"about_ca_system_score_gemma":0.00008189886,"threshold_uncertainty_score":0.53292954},"labels":[],"label_agreement":null},{"id":"W1480615770","doi":"10.5489/cuaj.979","title":"Determining the best treatment for renal cell carcinoma in young patients","year":2008,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Cryotherapy; Kidney cancer; Renal function; Cancer; Surgery; Adjuvant therapy; Disease; Oncology; Internal medicine; Urology; Kidney","score_opus":0.03058397040966338,"score_gpt":0.2313372099511332,"score_spread":0.2007532395414698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1480615770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941537,0.0001049788,0.000006167664,0.0023538629,0.00019020616,0.00052156294,0.000031254356,0.0000065031954,0.0026318105],"genre_scores_gemma":[0.9978393,0.00003384863,0.00013922207,0.00072861975,0.00029652592,0.000051259503,0.000048279657,0.000015061781,0.0008478956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985014,0.00011931329,0.000359369,0.00019573607,0.00028871253,0.0005354742],"domain_scores_gemma":[0.9987536,0.00019518858,0.00021441888,0.00011426507,0.0002479713,0.00047452314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024020122,0.00016960248,0.0002720292,0.00015513944,0.0004080702,0.00003404822,0.000094892326,0.00016425387,0.000061366896],"category_scores_gemma":[0.00026763923,0.000104940445,0.00019215161,0.00013380789,0.000030413792,0.000058091773,0.000008280297,0.00027682923,0.000027682818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057187906,0.00018153427,0.99705756,0.0000016724969,0.00002519115,0.00013661767,0.00029232437,0.000023659717,0.000018816529,0.0000031814122,0.0010320632,0.0011701914],"study_design_scores_gemma":[0.004334384,0.0021441742,0.9883328,0.0000052506343,0.00008882382,0.0001306713,0.00005398312,0.000106037274,0.00013819296,0.000029012337,0.0045440905,0.00009258712],"about_ca_topic_score_codex":0.0016088284,"about_ca_topic_score_gemma":0.0027950716,"teacher_disagreement_score":0.008724768,"about_ca_system_score_codex":0.0038628394,"about_ca_system_score_gemma":0.0005273305,"threshold_uncertainty_score":0.99996114},"labels":[],"label_agreement":null},{"id":"W1483755438","doi":"","title":"Efficacy and safety of temsirolimus in renal cell carcinoma","year":2015,"lang":"en","type":"article","venue":"Journal of symptoms and signs","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Temsirolimus; Renal cell carcinoma; Medicine; Oncology; Cancer research; PI3K/AKT/mTOR pathway; Internal medicine; Cancer; Kinase; Pharmacology; Discovery and development of mTOR inhibitors; Biology; Signal transduction","score_opus":0.025357491342728664,"score_gpt":0.253109595627089,"score_spread":0.22775210428436035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1483755438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934591,0.0036451719,0.000020277874,0.00021205388,0.00005298442,0.0001430637,0.000002182567,0.0000020298341,0.0024631368],"genre_scores_gemma":[0.9991204,0.00015322825,0.00034985947,0.000039254024,0.00011256182,6.821391e-7,0.0000010397106,0.000010289545,0.00021268315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897647,0.00004267994,0.00047415897,0.00010208195,0.00026544594,0.00013915365],"domain_scores_gemma":[0.99916935,0.0000802362,0.0002301782,0.000102599304,0.0001293146,0.00028835144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035747216,0.000113614864,0.0004301039,0.0001813045,0.000014629241,0.000008407342,0.00004132698,0.000064030275,0.000011667428],"category_scores_gemma":[0.000037872418,0.00007747839,0.000060282924,0.00009573654,0.00006893339,0.000065725595,0.00002714582,0.0001705282,8.927063e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068375967,0.0009946763,0.83261794,0.00024149688,0.00016206696,0.0017651787,0.0042899936,0.00009569299,0.14071582,0.00013897674,0.00085291517,0.011287648],"study_design_scores_gemma":[0.018303283,0.0076846657,0.95015377,0.00024778352,0.0002315757,0.0014795072,0.00045089214,0.00007780544,0.020047484,0.00010325798,0.0010898423,0.00013013797],"about_ca_topic_score_codex":0.000043582102,"about_ca_topic_score_gemma":0.000002979116,"teacher_disagreement_score":0.12066834,"about_ca_system_score_codex":0.00007435,"about_ca_system_score_gemma":0.00013759929,"threshold_uncertainty_score":0.3159477},"labels":[],"label_agreement":null},{"id":"W1488122804","doi":"10.5489/cuaj.853","title":"Interferon-alfa in the treatment of patients with inoperable locally advanced or metastatic renal cell carcinoma: a systematic review","year":2013,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; McMaster University; Cancer Care Ontario; Juravinski Cancer Centre; Ottawa Regional Cancer Foundation; Ottawa Hospital","funders":"","keywords":"Renal cell carcinoma; Medicine; Oncology; Interferon alfa; Internal medicine; Interferon; Cancer research; Alpha interferon; Immunology","score_opus":0.031397444687079924,"score_gpt":0.26263969305033613,"score_spread":0.23124224836325621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1488122804","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039314283,0.9883942,0.0000047771405,0.0003769533,0.000072357754,0.006843121,0.000099707315,0.0000060589714,0.00027137817],"genre_scores_gemma":[0.010854373,0.9863561,0.0001784454,0.0007186884,0.00005773145,0.00086877076,0.0002325735,0.00004254361,0.00069082185],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950879,0.0014919381,0.0016952835,0.0003591349,0.0007460552,0.00061969366],"domain_scores_gemma":[0.9962334,0.0006425318,0.0017094437,0.00042883458,0.00046557965,0.0005202231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077410793,0.0005778576,0.003680513,0.00034816278,0.00010765501,0.00006424321,0.00032786748,0.00023934488,0.00040365514],"category_scores_gemma":[0.00039199882,0.00023351939,0.0005916872,0.0005719755,0.000041235,0.000088052235,0.000011851885,0.00066108647,0.0000655549],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054900866,0.004156247,0.012949416,0.8699634,0.0029596477,0.0033902817,0.000935328,0.000018871156,3.3938315e-7,0.000017887822,0.0039591445,0.10110039],"study_design_scores_gemma":[0.014009935,0.049479805,0.009005491,0.37217802,0.04829634,0.0019471446,0.00030957506,0.000016396645,0.0000025545348,0.000027851202,0.5032036,0.0015233294],"about_ca_topic_score_codex":0.0005952343,"about_ca_topic_score_gemma":0.00069558044,"teacher_disagreement_score":0.49924442,"about_ca_system_score_codex":0.0050772466,"about_ca_system_score_gemma":0.001981058,"threshold_uncertainty_score":0.9987421},"labels":[],"label_agreement":null},{"id":"W1498916804","doi":"10.1111/j.1464-410x.2010.09990.x","title":"Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with severe renal impairment or on haemodialysis","year":2011,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital; Royal Ottawa Mental Health Centre","funders":"","keywords":"Sunitinib; Medicine; Renal cell carcinoma; Renal function; Dialysis; Internal medicine; Kidney disease; Adverse effect; Urology; Oncology","score_opus":0.022152479056336192,"score_gpt":0.22545710698693133,"score_spread":0.20330462793059514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1498916804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99857366,0.00028796514,0.000033799268,0.00005382726,0.000021804772,0.00039161538,0.000020022919,0.0000039003894,0.0006133844],"genre_scores_gemma":[0.9975934,0.000042076288,0.002110101,0.00014323951,0.000027254082,0.000005430223,0.000010849257,0.000024189852,0.000043449367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828285,0.00022509233,0.000579902,0.00022563226,0.00040278447,0.00028372428],"domain_scores_gemma":[0.9987201,0.00013146042,0.0004951813,0.0001664416,0.00026593398,0.00022089387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027974177,0.00019313436,0.00073523197,0.00028682096,0.000034602806,0.000008793235,0.000095555486,0.000065909,0.00016736402],"category_scores_gemma":[0.0000507468,0.0001351474,0.00007781327,0.00019788556,0.00017436504,0.00007899732,0.000029515832,0.00033836285,0.0000012387763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.107625596,0.008906492,0.8344177,0.00021733524,0.0008868266,0.028331911,0.0015865016,0.00021669765,0.0007837947,0.000008024252,0.00025292952,0.01676616],"study_design_scores_gemma":[0.0235564,0.042835914,0.91991043,0.00019330058,0.0007432681,0.0077502276,0.00006095444,0.0000074169475,0.004786578,0.000014065479,0.000014180634,0.00012724812],"about_ca_topic_score_codex":0.00020863672,"about_ca_topic_score_gemma":0.00019571345,"teacher_disagreement_score":0.085492715,"about_ca_system_score_codex":0.00008270418,"about_ca_system_score_gemma":0.00020351945,"threshold_uncertainty_score":0.5511151},"labels":[],"label_agreement":null},{"id":"W1504653398","doi":"10.1111/j.1464-410x.2011.10701.x","title":"Node‐positive renal cell carcinoma in the absence of distant metastases: predictors of cancer‐specific mortality in a population‐based cohort","year":2011,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Nephrectomy; Cohort; Renal cell carcinoma; Cancer; Internal medicine; Population; Oncology; Retrospective cohort study; Epidemiology; Prospective cohort study; Kidney","score_opus":0.027092301296689592,"score_gpt":0.2619648676922394,"score_spread":0.23487256639554982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1504653398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938139,0.0050401455,0.000059619702,0.000056501605,0.00011399041,0.00037218755,0.00011180802,0.0000019882555,0.0004298569],"genre_scores_gemma":[0.99930876,0.00026571477,0.00025291505,0.000074042146,0.000045391913,0.000014103845,0.000023322624,0.000012158043,0.000003613721],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977838,0.0003991093,0.0009899773,0.00018686384,0.00042347517,0.00021680053],"domain_scores_gemma":[0.99867666,0.00014441638,0.0006641511,0.00021555423,0.00021832793,0.000080868085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007995102,0.00013181395,0.00063015544,0.00022576969,0.000019574514,0.0000045600673,0.00019161595,0.00008271981,0.00010937858],"category_scores_gemma":[0.000058809317,0.00010898226,0.0001733104,0.00028897863,0.0001764587,0.000068207344,0.000021115959,0.00033831203,3.918671e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008789866,0.0007118088,0.9919493,0.000055838533,0.00008380514,0.0036671131,0.00057873246,0.0002376362,0.0015125634,0.000019406476,0.000060531205,0.00024427177],"study_design_scores_gemma":[0.0023629125,0.0011347558,0.98949414,0.0001376347,0.0002470421,0.0008767576,0.00014405901,0.00005885437,0.005380672,0.00008227451,0.00001275932,0.00006811836],"about_ca_topic_score_codex":0.012623862,"about_ca_topic_score_gemma":0.0021950083,"teacher_disagreement_score":0.010428854,"about_ca_system_score_codex":0.00014592896,"about_ca_system_score_gemma":0.00021378603,"threshold_uncertainty_score":0.99395114},"labels":[],"label_agreement":null},{"id":"W1508431346","doi":"10.5772/27165","title":"Laparoscopic Partial Nephrectomy – Current State of the Art","year":2012,"lang":"en","type":"book-chapter","venue":"InTech eBooks","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Current (fluid); Nephrectomy; Medicine; State (computer science); Urology; General surgery; Computer science; Internal medicine; Engineering; Kidney; Electrical engineering; Algorithm","score_opus":0.037668445648388414,"score_gpt":0.27508825660348646,"score_spread":0.23741981095509804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1508431346","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02875494,0.0056598857,0.000068376234,0.00011190134,0.0017489078,0.0024320977,0.00008289556,0.00010699208,0.961034],"genre_scores_gemma":[0.43570596,0.00009475575,0.00006649711,0.000095879564,0.00037850215,0.00010290018,0.00002460338,0.000088712586,0.5634422],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99837625,0.000023229231,0.0004909386,0.0002953717,0.000509296,0.0003049243],"domain_scores_gemma":[0.99850184,0.000045413544,0.0003272141,0.0008371259,0.00012909688,0.00015930695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001120431,0.00038917,0.0006474374,0.000110660585,0.000037237314,0.00000974303,0.00019455346,0.0001431603,0.0003034656],"category_scores_gemma":[0.000014962369,0.00024490446,0.0004145437,0.000012174031,0.0002597077,0.000014596278,0.0001708561,0.0006573198,0.0003987461],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009404069,0.00033024477,0.0018615726,0.0015914199,0.0015883158,0.00016932207,0.00091491523,3.9059574e-7,0.06858692,0.00606018,0.008212134,0.9097442],"study_design_scores_gemma":[0.0006031794,0.00019367198,0.0002596611,0.0009869869,0.0004401914,0.00004438142,0.0000011296933,5.331422e-7,0.35731444,0.0019493003,0.63804644,0.00016004698],"about_ca_topic_score_codex":0.0000098430055,"about_ca_topic_score_gemma":0.00001620308,"teacher_disagreement_score":0.9095841,"about_ca_system_score_codex":0.00020418657,"about_ca_system_score_gemma":0.00023904299,"threshold_uncertainty_score":0.9986914},"labels":[],"label_agreement":null},{"id":"W1514281697","doi":"10.1111/bju.12111","title":"Sociodemographic disparities in the treatment of small renal masses","year":2013,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Nephrectomy; Logistic regression; Renal cell carcinoma; Odds ratio; Poverty; Internal medicine; Surgery; Demography; Kidney","score_opus":0.024077631612258926,"score_gpt":0.2421671715239568,"score_spread":0.21808953991169788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1514281697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781713,0.017984917,0.000028552524,0.0028833514,0.00007981954,0.0002519116,0.0000036752563,0.0000034856168,0.00059297023],"genre_scores_gemma":[0.9927042,0.0060285167,0.00064394536,0.000356726,0.00013569898,0.000020877125,0.000003876412,0.000010580413,0.00009554755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987999,0.00019589555,0.00049233064,0.00010184974,0.00019170681,0.00021829491],"domain_scores_gemma":[0.9992065,0.0002143143,0.00023511553,0.000127864,0.00014332346,0.00007291214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020922578,0.00010828308,0.00043851658,0.00015690047,0.000031971882,0.000020039814,0.00011834973,0.00008816508,0.00012634454],"category_scores_gemma":[0.000040760944,0.00007562922,0.00024185606,0.00011805861,0.00019214198,0.00005487718,0.000008587289,0.00018829918,0.0000049723194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005352192,0.0033996888,0.8958112,0.00007853289,0.0006078158,0.008612691,0.001109904,0.000056040546,0.0022590419,0.00020483244,0.002988829,0.08433623],"study_design_scores_gemma":[0.0028738969,0.005807435,0.96743673,0.000057130495,0.00024442383,0.018798687,0.00020697738,0.000021650476,0.00032705834,0.0012778036,0.0028858245,0.000062394756],"about_ca_topic_score_codex":0.0010610933,"about_ca_topic_score_gemma":0.00028634144,"teacher_disagreement_score":0.08427384,"about_ca_system_score_codex":0.000052198713,"about_ca_system_score_gemma":0.000075840944,"threshold_uncertainty_score":0.308407},"labels":[],"label_agreement":null},{"id":"W1515585666","doi":"10.1111/j.1464-410x.2011.10115.x","title":"What is the best treatment strategy for incidentally detected small renal masses? A decision analysis","year":2011,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Nephrectomy; Life expectancy; Hazard ratio; Quality of life (healthcare); Kidney disease; Surgery; Intensive care medicine; Internal medicine; Kidney; Population; Confidence interval","score_opus":0.05452710127869493,"score_gpt":0.28753836650506065,"score_spread":0.23301126522636573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1515585666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841625,0.011520186,0.0030210784,0.00035398605,0.00020986017,0.00043955425,0.000015028446,0.0000087073,0.00026908837],"genre_scores_gemma":[0.9912724,0.004075293,0.0036868637,0.00032471164,0.00017288416,0.000027848484,0.000012814161,0.000025011228,0.0004021703],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982978,0.00013381899,0.00069318514,0.00025691415,0.0002654511,0.00035279698],"domain_scores_gemma":[0.99835163,0.0002805967,0.00045816475,0.00026631978,0.00042704825,0.00021621099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039548386,0.00019354321,0.000621643,0.00028943646,0.00012768654,0.00009285423,0.0002044532,0.00014947607,0.00045941252],"category_scores_gemma":[0.000084292406,0.00013855872,0.0007129548,0.00030330714,0.00010571455,0.00016169404,0.00003728403,0.0002130999,0.000012293005],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012469034,0.0034194884,0.08759567,0.00003850052,0.015122269,0.018624485,0.0018490748,0.0003350351,0.0041243704,0.00004081424,0.001151068,0.8552302],"study_design_scores_gemma":[0.014572417,0.03943551,0.8181511,0.00024463466,0.024089709,0.082022436,0.0018652834,0.00065531663,0.010527273,0.0021944297,0.0058372254,0.00040466437],"about_ca_topic_score_codex":0.0004889144,"about_ca_topic_score_gemma":0.0018296405,"teacher_disagreement_score":0.85482556,"about_ca_system_score_codex":0.00018981672,"about_ca_system_score_gemma":0.00019857624,"threshold_uncertainty_score":0.5650261},"labels":[],"label_agreement":null},{"id":"W1517663239","doi":"10.1002/cncr.26201","title":"The impact of kidney function on the outcome of metastatic renal cell carcinoma patients treated with vascular endothelial growth factor‐targeted therapy","year":2011,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary; BC Cancer Agency","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Renal function; Hazard ratio; Internal medicine; Nephrectomy; Kidney disease; Urology; Odds ratio; Gastroenterology; Univariate analysis; Kidney cancer; Vascular endothelial growth factor; Bevacizumab; Thrombocytosis; Confidence interval; Kidney; Multivariate analysis; Chemotherapy; Platelet","score_opus":0.04613606773144768,"score_gpt":0.2632855850588473,"score_spread":0.21714951732739962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1517663239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971807,0.00051078724,0.000011184944,0.000036878504,0.000071488575,0.0008714661,0.00014218678,0.000013226222,0.001162089],"genre_scores_gemma":[0.99938524,0.00009922013,0.000017892233,0.00011808538,0.000031979016,0.00009444473,0.000027971713,0.00003521211,0.0001899694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987144,0.00013436154,0.00031575334,0.00020669578,0.00039683512,0.0002319886],"domain_scores_gemma":[0.9987141,0.00011387924,0.00027283953,0.00045607888,0.00028667794,0.00015640762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102613514,0.0002425037,0.00036958873,0.00006845096,0.00007143925,0.00000551568,0.000118306,0.000039846233,0.00046429964],"category_scores_gemma":[0.000053781412,0.00009242343,0.00029480012,0.00019264,0.00012964084,0.00003882477,0.000011673098,0.00013138364,0.000005591261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040713735,0.00042698518,0.97840136,0.00003859269,0.0008660357,0.000006621868,0.0007246484,0.0000064518626,0.01440013,0.000019517982,0.00035459115,0.00068369304],"study_design_scores_gemma":[0.0035061205,0.004091385,0.749068,0.000030292873,0.00028301575,9.3868897e-7,0.000039382416,0.000012930637,0.2428293,0.000014657783,0.00004824583,0.000075719276],"about_ca_topic_score_codex":0.003276726,"about_ca_topic_score_gemma":0.000013747793,"teacher_disagreement_score":0.22933334,"about_ca_system_score_codex":0.00021125803,"about_ca_system_score_gemma":0.00022681202,"threshold_uncertainty_score":0.5083755},"labels":[],"label_agreement":null},{"id":"W1517953570","doi":"10.1111/j.1464-410x.2011.10569.x","title":"Cytoreductive nephrectomy in the elderly: a population‐based cohort from the USA","year":2011,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Perioperative; Renal cell carcinoma; Nephrectomy; Context (archaeology); Cohort; Comorbidity; Mortality rate; Population; Adverse effect; Surgery; Internal medicine; Kidney","score_opus":0.03198979362469201,"score_gpt":0.25748174551423897,"score_spread":0.22549195188954696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1517953570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99506193,0.001875437,0.00006935969,0.001376877,0.0001823755,0.0002792906,0.0000067952387,0.0000037729874,0.0011441836],"genre_scores_gemma":[0.99737465,0.000078187215,0.0007020388,0.0014998658,0.0002911189,0.000012086696,0.0000108837885,0.000011235591,0.000019947209],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987196,0.0003614401,0.00036348257,0.00012577281,0.00025393174,0.0001758015],"domain_scores_gemma":[0.99917513,0.00025830526,0.00021669599,0.00017967544,0.00011036808,0.000059824863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046481704,0.00009336233,0.0002797138,0.00006669848,0.00005900121,0.00001722683,0.00020132853,0.00007841326,0.00037608034],"category_scores_gemma":[0.00015120202,0.00005940629,0.00013396147,0.00013524863,0.000090012094,0.000062280305,0.000014544424,0.00043938754,0.000011753492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051805796,0.00024134202,0.9838223,0.000002023531,0.00013058697,0.003518111,0.00047727514,0.000011924785,0.00008785401,0.000030458596,0.0010718122,0.010088255],"study_design_scores_gemma":[0.0016540235,0.0011005984,0.986638,0.000030214009,0.00024731297,0.008371578,0.0001160016,0.000013336792,0.0000835732,0.00074621063,0.00095027854,0.00004888679],"about_ca_topic_score_codex":0.00747937,"about_ca_topic_score_gemma":0.00164871,"teacher_disagreement_score":0.010039369,"about_ca_system_score_codex":0.00006972241,"about_ca_system_score_gemma":0.000112615686,"threshold_uncertainty_score":0.9991299},"labels":[],"label_agreement":null},{"id":"W1522152077","doi":"10.1111/j.1464-410x.2011.10186.x","title":"Sequential use of sorafenib and sunitinib in advanced renal‐cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases","year":2011,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Sunitinib; Medicine; Sorafenib; Renal cell carcinoma; Internal medicine; Hazard ratio; Retrospective cohort study; Oncology; Kidney cancer; Tyrosine-kinase inhibitor; Cancer; Confidence interval; Surgery; Hepatocellular carcinoma","score_opus":0.038645624174556234,"score_gpt":0.2554995308243465,"score_spread":0.21685390664979026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1522152077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99749947,0.0018628231,0.000021733927,0.00002685474,0.00006846965,0.00024205675,0.00012208865,0.0000040137793,0.0001525143],"genre_scores_gemma":[0.998003,0.00026254889,0.0015635913,0.00006482961,0.000026457703,0.0000027170117,0.00003573241,0.00002009327,0.000021014279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795264,0.00029288945,0.00094888237,0.0002554735,0.00028474795,0.00026538863],"domain_scores_gemma":[0.9980425,0.00012119277,0.00084877067,0.00021549014,0.0005535203,0.00021851873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020317335,0.00016808382,0.000975647,0.000625148,0.000027676606,0.000009102674,0.00008888412,0.00012405952,0.000161347],"category_scores_gemma":[0.00021537444,0.00017455258,0.000247962,0.00040214942,0.00022078858,0.00021986158,0.00004648447,0.00028234645,3.7880912e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004700493,0.0020623247,0.93655413,0.0000725724,0.0010150378,0.025751848,0.0030726225,0.0002890891,0.01745322,0.000017434246,0.000047602076,0.008963636],"study_design_scores_gemma":[0.004135737,0.007019395,0.9636878,0.00006669959,0.0023480877,0.005103667,0.0005238083,0.00017270827,0.01676817,0.000024966457,0.00002765142,0.00012130791],"about_ca_topic_score_codex":0.0033170867,"about_ca_topic_score_gemma":0.0024766312,"teacher_disagreement_score":0.02713368,"about_ca_system_score_codex":0.000104171086,"about_ca_system_score_gemma":0.00010764872,"threshold_uncertainty_score":0.7118048},"labels":[],"label_agreement":null},{"id":"W152907739","doi":"","title":"The significance of florid giant cell component in renal cell carcinoma: a case report and review of the literature.","year":2010,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Giant cell; Pathology; Medicine; Vimentin; CD68; Renal cell carcinoma; Clear cell; Immunohistochemistry; Giant-cell tumor of bone; Clear cell renal cell carcinoma","score_opus":0.015232266477319725,"score_gpt":0.22099565525430875,"score_spread":0.20576338877698902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W152907739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95607734,0.037918914,6.651708e-7,0.0010633343,0.00024219714,0.0021545726,0.000014241325,0.0000050257413,0.0025236888],"genre_scores_gemma":[0.99709666,0.0013346847,0.00009480871,0.00009740096,0.000066503715,0.00056373444,0.000007484944,0.000013563643,0.0007251888],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99851424,0.000105357096,0.0005722052,0.0002511073,0.00030502432,0.00025210055],"domain_scores_gemma":[0.99846226,0.00015355555,0.00034413638,0.00077640644,0.0001405482,0.00012306857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093205145,0.0001527386,0.00037470658,0.000045156157,0.000048864447,0.00001001953,0.00011945976,0.000058920756,0.00000507961],"category_scores_gemma":[0.00015597619,0.00007667874,0.00012861461,0.00026274135,0.0001767111,0.000027435748,0.0000773248,0.0003467226,4.7124826e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002131061,0.003814952,0.25909346,0.06330426,0.00028355728,0.23427418,0.005037227,0.0000062451495,0.35907474,0.0003602623,0.011717945,0.0609021],"study_design_scores_gemma":[0.001498688,0.00009319731,0.7092834,0.0007863775,0.00022528677,0.017215312,0.00006653111,0.000011613413,0.26736125,0.00002434974,0.003303539,0.0001304498],"about_ca_topic_score_codex":0.00018889543,"about_ca_topic_score_gemma":0.000107043816,"teacher_disagreement_score":0.45018995,"about_ca_system_score_codex":0.000054926757,"about_ca_system_score_gemma":0.0000933069,"threshold_uncertainty_score":0.31268683},"labels":[],"label_agreement":null},{"id":"W1529626565","doi":"10.1111/iju.12110","title":"Rates of open versus laparoscopic and partial versus radical nephrectomy for <scp>T</scp>1a renal cell carcinoma: A population‐based evaluation","year":2013,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nephrectomy; Medicine; Renal cell carcinoma; Logistic regression; Population; Urology; Surgery; Internal medicine; Kidney","score_opus":0.05805166873412829,"score_gpt":0.3666992673675146,"score_spread":0.3086475986333863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1529626565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950508,0.0006222044,0.00034451197,0.0014929648,0.0011883404,0.00071353134,0.000012457692,0.0000042738307,0.0005709121],"genre_scores_gemma":[0.99617344,0.000014976328,0.003022391,0.0001656085,0.00040874133,0.000060703613,0.00008167299,0.000016475075,0.000056003322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983238,0.00015310018,0.00058968924,0.0001917559,0.00055904733,0.00018259561],"domain_scores_gemma":[0.99713486,0.0010768675,0.0005334836,0.00012811815,0.00097373116,0.00015295828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004557628,0.00014609855,0.00039959306,0.00027009624,0.00003649948,0.000048263522,0.00027269393,0.000110873145,0.00017668767],"category_scores_gemma":[0.0007506572,0.0001208687,0.00013705374,0.00007425283,0.00008668556,0.00021762992,0.00007314114,0.00016308167,0.0000069392822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07376987,0.0034983067,0.7763582,0.0002511915,0.0036779325,0.00041862056,0.0012953548,0.004333038,0.09261011,0.0022637802,0.020543871,0.020979742],"study_design_scores_gemma":[0.13807833,0.019165004,0.7232519,0.00007822514,0.001951981,0.00034520644,0.00020116435,0.02631769,0.08006415,0.0012370866,0.009131392,0.00017791393],"about_ca_topic_score_codex":0.00020882653,"about_ca_topic_score_gemma":0.000015561396,"teacher_disagreement_score":0.064308465,"about_ca_system_score_codex":0.00019392454,"about_ca_system_score_gemma":0.00036720457,"threshold_uncertainty_score":0.49288827},"labels":[],"label_agreement":null},{"id":"W1530100936","doi":"10.1111/j.1464-410x.2010.09818.x","title":"Altered transcription factor E3 expression in unclassified adult renal cell carcinoma indicates adverse pathological features and poor outcome","year":2010,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"TFE3; Medicine; Renal cell carcinoma; Pathology; Immunohistochemistry; Lymph node; Carcinoma; Fusion gene; Internal medicine; Gene expression; Gene; Biology","score_opus":0.02080073536851236,"score_gpt":0.251017754336344,"score_spread":0.23021701896783164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1530100936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99656034,0.0016171398,0.000039099563,0.0009429466,0.00033699058,0.00023084479,0.000020233956,0.000012507483,0.0002398741],"genre_scores_gemma":[0.9976353,0.00020234354,0.0013460763,0.0004414481,0.00023397038,0.0000071179925,0.000014723282,0.00002005429,0.0000989434],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99829805,0.00019361872,0.0006441402,0.00027711617,0.00027326893,0.0003137985],"domain_scores_gemma":[0.9990515,0.000096258285,0.0003170093,0.00011907561,0.00014158995,0.00027456493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002417931,0.00018971706,0.0005467065,0.00024471738,0.00006457125,0.00002128351,0.00012154286,0.00036176207,0.00014727387],"category_scores_gemma":[0.00019164171,0.00015899102,0.00016522889,0.00008388221,0.00017435449,0.00012181465,0.00003312071,0.0012275398,0.000004159484],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012662895,0.00035829216,0.24281232,0.000040020233,0.00001527486,0.008129535,0.0002347793,0.0000019760985,0.74105924,0.000006312817,0.000321602,0.00575436],"study_design_scores_gemma":[0.005806193,0.0016194888,0.92786866,0.000040512867,0.00009563305,0.026988234,0.000082086764,0.000010786098,0.037053637,0.000072775525,0.0002424646,0.00011951439],"about_ca_topic_score_codex":0.000060060593,"about_ca_topic_score_gemma":0.0001532553,"teacher_disagreement_score":0.7040056,"about_ca_system_score_codex":0.000046024365,"about_ca_system_score_gemma":0.00005857151,"threshold_uncertainty_score":0.6483466},"labels":[],"label_agreement":null},{"id":"W1531376870","doi":"10.1111/bju.12084","title":"An analysis of patients with <scp>T</scp> 2 renal cell carcinoma ( <scp>RCC</scp> ) according to tumour size: a population‐based analysis","year":2013,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Renal cell carcinoma; Proportional hazards model; Medicine; Linear discriminant analysis; Nephrectomy; Oncology; Survival analysis; Kidney cancer; Population; Internal medicine; Carcinoma; Regression; Urology; Statistics; Kidney; Mathematics","score_opus":0.008221130131400335,"score_gpt":0.22626404867125063,"score_spread":0.2180429185398503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1531376870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970801,0.00051193964,0.0013123747,0.00009476358,0.000076397315,0.0004951444,0.00007389068,0.000020599768,0.00033480022],"genre_scores_gemma":[0.99514806,0.000013320211,0.0037019178,0.0005563447,0.00013592227,0.000021117974,0.0002297479,0.00005419436,0.00013938028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961689,0.000397666,0.0013060353,0.0005316385,0.00096134184,0.0006343851],"domain_scores_gemma":[0.99517477,0.0008133831,0.0012695389,0.00050252717,0.0014673542,0.0007724056],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047042168,0.0003605423,0.0017503111,0.0020588578,0.0001228448,0.00009090036,0.0003679116,0.0002070094,0.00016063215],"category_scores_gemma":[0.00078899326,0.0003369098,0.00082368497,0.0028585433,0.000082865576,0.00031060656,0.000059168386,0.00045229166,0.000012752585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010856636,0.000899192,0.97529155,0.000031786112,0.0029012335,0.0007477234,0.00019289827,0.016003821,0.0023608045,0.0000017257878,0.00054301106,0.0009177155],"study_design_scores_gemma":[0.0034894757,0.0040537817,0.9711272,0.000029888755,0.016679801,0.0002403382,0.00037410346,0.0024527072,0.0014009305,0.000015537118,0.00006357617,0.000072645315],"about_ca_topic_score_codex":0.002152356,"about_ca_topic_score_gemma":0.0003702965,"teacher_disagreement_score":0.013778567,"about_ca_system_score_codex":0.00023404373,"about_ca_system_score_gemma":0.00019621108,"threshold_uncertainty_score":0.99990827},"labels":[],"label_agreement":null},{"id":"W1534913041","doi":"10.1002/cjp2.23","title":"Biphasic components of sarcomatoid clear cell renal cell carcinomas are molecularly similar to each other, but distinct from, non‐sarcomatoid renal carcinomas","year":2015,"lang":"en","type":"article","venue":"The Journal of Pathology Clinical Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center","keywords":"Pathology; Cell; Sarcomatoid carcinoma; Clear cell; Biology; Renal cell carcinoma; Medicine; Cancer research; Immunohistochemistry; Genetics","score_opus":0.19138024845460685,"score_gpt":0.40615613266245987,"score_spread":0.214775884207853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1534913041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894321,0.0038396756,0.00069030054,0.002314195,0.0003650775,0.0010387754,0.00014348759,0.000022347556,0.00215406],"genre_scores_gemma":[0.9945725,0.00020454024,0.003476863,0.0004629343,0.00061495084,0.000016143667,0.000032489384,0.00010622968,0.0005133339],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9869336,0.005382732,0.002811412,0.00072592666,0.0029228872,0.0012234353],"domain_scores_gemma":[0.98944324,0.0035076635,0.0013146054,0.0017518662,0.0021896912,0.0017929109],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.013181638,0.00054623384,0.0020399021,0.0007245995,0.00024836703,0.00004508067,0.0015659067,0.000525588,0.00011287789],"category_scores_gemma":[0.0023297532,0.00035913612,0.00081569445,0.00076403766,0.0013431866,0.0001237184,0.00082106056,0.003279952,0.0003575886],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016881373,0.0029702627,0.45238632,0.0001495035,0.00036053377,0.016276114,0.0017889532,0.00007468297,0.50066906,0.00000788137,0.0077917823,0.0006435247],"study_design_scores_gemma":[0.020271448,0.024479922,0.6946479,0.00068224553,0.0009545211,0.003478378,0.002550236,0.00040953624,0.2477711,0.0006751353,0.003435834,0.0006437084],"about_ca_topic_score_codex":0.00056331395,"about_ca_topic_score_gemma":0.000039112263,"teacher_disagreement_score":0.25289795,"about_ca_system_score_codex":0.00041829312,"about_ca_system_score_gemma":0.0011045069,"threshold_uncertainty_score":0.99988604},"labels":[],"label_agreement":null},{"id":"W1536286673","doi":"10.1016/j.eururo.2015.07.006","title":"Long-term Safety of Sunitinib in Metastatic Renal Cell Carcinoma","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"National Cancer Institute; Pfizer","keywords":"Medicine; Sunitinib; Dysgeusia; Internal medicine; Cumulative incidence; Population; Adverse effect; Incidence (geometry); Renal cell carcinoma; Nausea; Oncology; Gastroenterology; Cohort","score_opus":0.05135493585488278,"score_gpt":0.27188920483757223,"score_spread":0.22053426898268946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1536286673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8987664,0.00082166743,0.0000752929,0.0002704193,0.000095079784,0.00026775725,0.0000075941907,0.000022394845,0.09967341],"genre_scores_gemma":[0.9979784,0.0000132070145,0.0004096132,0.00034588666,0.000077116616,0.0000037518143,0.00006890935,0.000043708886,0.0010594225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980849,0.00066246674,0.0004657302,0.00028577764,0.00019642214,0.00030471888],"domain_scores_gemma":[0.9990149,0.00010679028,0.00013801848,0.000422283,0.00009590735,0.00022205767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005744533,0.00017701773,0.00041527618,0.00021289334,0.00001410569,0.0000035539913,0.00013517412,0.000032722113,0.00015310045],"category_scores_gemma":[0.00009913437,0.00014906639,0.000086458036,0.00017417017,0.00013060862,0.000031908196,0.000099507466,0.00021811263,0.00028483057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036614342,0.0010488199,0.9518221,0.00019450212,0.00010193742,0.020803077,0.0020811076,0.00013561104,0.014952813,0.00020022705,0.001236497,0.0037618696],"study_design_scores_gemma":[0.00582733,0.0025696154,0.9820806,0.000013259606,0.0001821528,0.0005490148,0.000055635188,0.000026122403,0.007183031,0.000019848732,0.0013729769,0.00012042837],"about_ca_topic_score_codex":0.00004177801,"about_ca_topic_score_gemma":0.000024107805,"teacher_disagreement_score":0.099212006,"about_ca_system_score_codex":0.000073610216,"about_ca_system_score_gemma":0.00012276946,"threshold_uncertainty_score":0.6078751},"labels":[],"label_agreement":null},{"id":"W1537867181","doi":"10.1111/j.1464-410x.2012.11125.x","title":"Predictors of early mortality after radical nephrectomy with renal vein or inferior vena cava thrombectomy – a population‐based study","year":2012,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Nephrectomy; Inferior vena cava; Surgery; Mortality rate; Population; Renal vein; Internal medicine; Kidney","score_opus":0.02243122898882965,"score_gpt":0.2784555057948474,"score_spread":0.25602427680601775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1537867181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762464,0.0013551384,0.000086511434,0.000098325865,0.0002053214,0.0005274073,0.00001546612,0.000015727914,0.00007147793],"genre_scores_gemma":[0.99855524,0.000013347171,0.0007576648,0.00015433396,0.00041982782,0.000024280653,0.0000098280625,0.000033590644,0.000031877003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977039,0.00034815102,0.0007621226,0.00018324862,0.0006237802,0.00037878065],"domain_scores_gemma":[0.99857914,0.0001197924,0.0004658236,0.00023480215,0.00023217613,0.00036824937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053558557,0.00019270423,0.00076996686,0.00020014377,0.00004308099,0.000018009549,0.00011579376,0.00013179917,0.00040819356],"category_scores_gemma":[0.00015032037,0.00014855155,0.0001711034,0.00022944227,0.00014300268,0.00020272002,0.000031882624,0.0004448735,0.0000037116984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005284391,0.0018893984,0.9859951,0.00003766549,0.0006781625,0.0046814005,0.00031333973,0.000020946363,0.00017645395,0.0000010266308,0.000107140164,0.0008149576],"study_design_scores_gemma":[0.007118589,0.010080575,0.9731247,0.00011447171,0.0011418889,0.0077282204,0.0000352501,0.000007308981,0.00016780019,0.0000045117,0.0003593501,0.00011736044],"about_ca_topic_score_codex":0.00078982,"about_ca_topic_score_gemma":0.0003941143,"teacher_disagreement_score":0.012870445,"about_ca_system_score_codex":0.00012407632,"about_ca_system_score_gemma":0.00033171536,"threshold_uncertainty_score":0.60577565},"labels":[],"label_agreement":null},{"id":"W1544119899","doi":"10.1002/cncr.28151","title":"Metastatic non–clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteria","year":2013,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":232,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Queen Elizabeth II Health Sciences Centre; BC Cancer Agency; Princess Margaret Cancer Centre; London Health Sciences Centre; University of Toronto; Alberta Cancer Foundation; Sunnybrook Health Science Centre; Baker Hughes (Canada)","funders":"National Cancer Institute","keywords":"Medicine; Renal cell carcinoma; Oncology; Internal medicine; Database","score_opus":0.030064740661853533,"score_gpt":0.2822121193137213,"score_spread":0.25214737865186776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1544119899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99769694,0.0001511624,0.00033088203,0.00022735713,0.000081582126,0.00094905455,0.00019075307,0.000009191854,0.0003630536],"genre_scores_gemma":[0.99832684,0.000083277584,0.00024194935,0.00013942854,0.000036274403,0.00016060086,0.00033542194,0.000023724182,0.00065250957],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99902534,0.000050172333,0.00032022205,0.00022495855,0.0002620972,0.00011718552],"domain_scores_gemma":[0.999034,0.000024634832,0.00029864468,0.0003209003,0.0002552603,0.000066574255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007174418,0.00014820154,0.00028077062,0.00006369937,0.000027646953,0.000011552635,0.00010372463,0.00003008985,0.00047007034],"category_scores_gemma":[0.000005861562,0.00008982608,0.000048285885,0.00013870456,0.0001036652,0.00010352129,0.000033497578,0.00006842317,0.000004591406],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026982676,0.00012409569,0.32940134,0.00009198425,0.000052374064,0.000002131884,0.00013687763,0.0000031227494,0.6694698,0.000002532063,0.000049517606,0.00039639778],"study_design_scores_gemma":[0.0017630442,0.00015751254,0.5708939,0.000022781118,0.00010139203,0.0000024371882,0.0000528537,0.001089318,0.42574272,8.939133e-7,0.00011712813,0.000056075147],"about_ca_topic_score_codex":0.00081177946,"about_ca_topic_score_gemma":0.000012476124,"teacher_disagreement_score":0.24372709,"about_ca_system_score_codex":0.000076143944,"about_ca_system_score_gemma":0.00006999698,"threshold_uncertainty_score":0.51469404},"labels":[],"label_agreement":null},{"id":"W1545207088","doi":"10.1002/cncr.25750","title":"Progression‐free survival as a predictor of overall survival in metastatic renal cell carcinoma treated with contemporary targeted therapy","year":2010,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; Dalhousie University; University of Toronto; Sunnybrook Health Science Centre; University of Calgary; Alberta Health Services","funders":"National Cancer Institute","keywords":"Medicine; Renal cell carcinoma; Oncology; Internal medicine; Targeted therapy; Overall survival; Progression-free survival; Carcinoma; Cancer","score_opus":0.03343678659187718,"score_gpt":0.28822689664206336,"score_spread":0.25479011005018615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1545207088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98886186,0.0032761337,0.0000050572835,0.00025232774,0.00022283012,0.0013050495,0.00011287916,0.000050890114,0.0059129964],"genre_scores_gemma":[0.997748,0.00006459895,0.0005463528,0.00007768239,0.00012813702,0.00028181757,0.00011233236,0.00006613761,0.00097491813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792665,0.00014082123,0.00044446756,0.0004511238,0.0006783559,0.00035859252],"domain_scores_gemma":[0.9985107,0.00011533609,0.0002397623,0.00065921136,0.0002218061,0.00025313976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024367888,0.00034212097,0.00073167175,0.000175395,0.00003336117,0.000012887849,0.0001862473,0.0001105987,0.000568448],"category_scores_gemma":[0.00003917646,0.00021927347,0.00012545892,0.00030945204,0.00018813064,0.00010116724,0.000041099862,0.0003803168,0.0000061532946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005814728,0.00070692605,0.8084757,0.00014183778,0.00019651702,0.0006903569,0.0004810244,0.0000070381266,0.18219055,0.000039195977,0.00055281405,0.00070332905],"study_design_scores_gemma":[0.01695862,0.0023730262,0.68925625,0.00015875416,0.00011765178,0.000025477168,0.00009554321,0.0000720066,0.29003772,0.00004900803,0.00062707753,0.00022886439],"about_ca_topic_score_codex":0.0028205907,"about_ca_topic_score_gemma":0.00049258827,"teacher_disagreement_score":0.11921944,"about_ca_system_score_codex":0.0001339605,"about_ca_system_score_gemma":0.0009647782,"threshold_uncertainty_score":0.89417124},"labels":[],"label_agreement":null},{"id":"W1548185254","doi":"10.5489/cuaj.1042","title":"Laparoscopic partial nephrectomy: a challenging operation with a steep learning curve","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Nephrectomy; Learning curve; Medicine; Computer science; Internal medicine; Kidney; Operating system","score_opus":0.014494146483955722,"score_gpt":0.21738638418587417,"score_spread":0.20289223770191844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1548185254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832452,0.00022268406,0.00014170563,0.012662041,0.000113438036,0.00041587974,0.0000014973807,0.000039070674,0.0031584837],"genre_scores_gemma":[0.9968428,0.000036732854,0.0002943033,0.0013619842,0.00042102218,0.00006739341,0.000018753892,0.000016288952,0.0009406987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984912,0.00020348947,0.00025605303,0.00019464406,0.00034676338,0.00050781935],"domain_scores_gemma":[0.9986677,0.000080766025,0.00017422346,0.00008138995,0.0002538922,0.0007419961],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032451708,0.0001518901,0.00027578112,0.00014682868,0.00035541612,0.0001805107,0.00005994498,0.00016575282,0.0015758241],"category_scores_gemma":[0.00024433568,0.00010661533,0.00007906727,0.0001414105,0.000019902554,0.00017967392,0.000008411879,0.000684956,0.00027096953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049483024,0.000044249082,0.9946272,0.000005172355,0.00015917043,0.00018153558,0.0002801801,0.0008864094,0.00032523746,0.000092736555,0.001051729,0.0022968971],"study_design_scores_gemma":[0.0028363012,0.0017667433,0.96110517,0.000035677705,0.00012602775,0.0005261642,0.00027340619,0.003476251,0.00023678844,0.00009577755,0.029305799,0.00021590828],"about_ca_topic_score_codex":0.0016077973,"about_ca_topic_score_gemma":0.00050118193,"teacher_disagreement_score":0.033522047,"about_ca_system_score_codex":0.001399653,"about_ca_system_score_gemma":0.00041666307,"threshold_uncertainty_score":0.9993369},"labels":[],"label_agreement":null},{"id":"W1551477984","doi":"10.1023/a:1026310323882","title":"Diet and vitamin or mineral supplements and risk of renal cell carcinoma in Canada","year":2003,"lang":"en","type":"article","venue":"Cancer Causes & Control","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Statistics Canada; Health Canada","funders":"","keywords":"Medicine; Cruciferous vegetables; Odds ratio; Quartile; Vitamin; Renal cell carcinoma; Confidence interval; Population; Internal medicine; Environmental health; Cancer","score_opus":0.013407198355354361,"score_gpt":0.23960172753320222,"score_spread":0.22619452917784785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1551477984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289757,0.005824436,0.000005840239,0.00010397359,0.000081287624,0.00053656125,0.00027076114,0.0000036018728,0.00027596072],"genre_scores_gemma":[0.9985945,0.0006493106,0.00006900104,0.00018325487,0.000036124788,0.00009396365,0.000009820715,0.000018465078,0.00034551165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988608,0.00008486981,0.00029108717,0.0002713128,0.00020216937,0.00028977622],"domain_scores_gemma":[0.9993401,0.000117567535,0.00011321644,0.00018972054,0.000057372978,0.00018200107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000091156886,0.00018461542,0.00044627886,0.00006856174,0.000027688333,0.0000066370944,0.000033943285,0.000038259794,0.00017244689],"category_scores_gemma":[0.000043425607,0.00013677972,0.000031148906,0.000093371,0.00005309104,0.000036613495,0.0000141180435,0.000111423265,3.5197715e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011675161,0.000045982844,0.9899124,0.00011623541,0.00010076129,0.00029535985,0.0001396516,0.000023529588,0.006618723,0.000005905954,0.0010659897,0.00050792925],"study_design_scores_gemma":[0.014957987,0.00089604314,0.95793015,0.000063935055,0.0005392964,0.000033574714,0.00026949562,0.00017131274,0.022601178,0.000006043415,0.0023640606,0.00016691383],"about_ca_topic_score_codex":0.7120225,"about_ca_topic_score_gemma":0.88167256,"teacher_disagreement_score":0.1696501,"about_ca_system_score_codex":0.00047607394,"about_ca_system_score_gemma":0.0010708139,"threshold_uncertainty_score":0.5577715},"labels":[],"label_agreement":null},{"id":"W1552202656","doi":"10.5489/cuaj.936","title":"Use of a novel parenchymal clamp for laparoscopic and open partial nephrectomy","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; St Joseph's Health Centre; University of Toronto","funders":"","keywords":"Nephrectomy; Medicine; Clamp; Dissection (medical); Blood loss; Surgery; Parenchyma; Kidney; Internal medicine; Computer science; Pathology","score_opus":0.0641834694545716,"score_gpt":0.27113704633354496,"score_spread":0.20695357687897337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1552202656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99068004,0.000084774336,0.00009773645,0.007735438,0.00011064837,0.00090073765,0.000040700386,0.0000059822887,0.00034394895],"genre_scores_gemma":[0.9939473,0.000018256967,0.0032591296,0.0018961026,0.00016967466,0.00010350901,0.000020045907,0.00000872212,0.00057726156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989741,0.000057352758,0.00030625783,0.00015393615,0.00016921484,0.00033916318],"domain_scores_gemma":[0.9985514,0.0002195107,0.00022807246,0.00008417098,0.00028568596,0.00063112087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026527696,0.00010591109,0.00033883497,0.000086899396,0.0001256109,0.00016929112,0.0000916082,0.00015773751,0.0003155778],"category_scores_gemma":[0.00065114966,0.000079145095,0.000080780075,0.00008357394,0.00003113682,0.0001976998,0.00002584163,0.00019970714,0.000008038284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101139965,0.000107468055,0.983072,0.000009148593,0.00016332755,0.000014008588,0.000078207144,0.0000148353165,0.0016350152,0.00031959813,0.012027564,0.0024576806],"study_design_scores_gemma":[0.0032512073,0.0009371719,0.9407126,0.000016989712,0.00012685615,0.00012151836,0.000028536833,0.00064380415,0.00040033055,0.00030799236,0.053352755,0.0001002643],"about_ca_topic_score_codex":0.0048753987,"about_ca_topic_score_gemma":0.00071225205,"teacher_disagreement_score":0.04235943,"about_ca_system_score_codex":0.0004180911,"about_ca_system_score_gemma":0.00039916535,"threshold_uncertainty_score":0.7370177},"labels":[],"label_agreement":null},{"id":"W1556956178","doi":"10.1111/bju.12711","title":"Association of type of renal surgery and access to robotic technology for kidney cancer: results from a population‐based cohort","year":2014,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Kidney cancer; Cohort; Odds ratio; Logistic regression; Population; Cancer; Odds; Internal medicine; Cancer registry; Cohort study; Surgery; Kidney; Environmental health","score_opus":0.026321839471072448,"score_gpt":0.28918902882472686,"score_spread":0.2628671893536544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1556956178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99152136,0.00074166746,0.00094929634,0.0062123584,0.00023591639,0.00022897813,0.00007686693,0.000005573282,0.000027959679],"genre_scores_gemma":[0.9978406,0.00018110474,0.0013113284,0.00043095218,0.00012515856,0.0000067936558,0.00005790375,0.000011442034,0.000034754525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988115,0.0000865524,0.000641793,0.00013692537,0.00018392687,0.00013932964],"domain_scores_gemma":[0.99784195,0.0005615488,0.0007880473,0.00010329168,0.00059027073,0.000114871335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005764114,0.00007160241,0.0005961656,0.0002805756,0.000021444324,0.000007516169,0.00007549874,0.00015267373,0.000019142764],"category_scores_gemma":[0.0035121841,0.000074949814,0.00008475653,0.00018733602,0.000029834026,0.000046314584,0.000021655804,0.0001186327,2.9006733e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018443381,0.00009878388,0.9774731,0.000045653145,0.00028996263,0.000043192333,0.000011622171,0.00091295695,0.0025379125,0.0000068259683,0.006808581,0.009927107],"study_design_scores_gemma":[0.0027106006,0.0010166033,0.9912246,0.00022725854,0.00053430686,0.000232675,0.0000023152445,0.0004502667,0.0024563444,0.000395495,0.0006928638,0.000056664685],"about_ca_topic_score_codex":0.0010015988,"about_ca_topic_score_gemma":0.0002276504,"teacher_disagreement_score":0.013751541,"about_ca_system_score_codex":0.00010225558,"about_ca_system_score_gemma":0.00020149974,"threshold_uncertainty_score":0.4204666},"labels":[],"label_agreement":null},{"id":"W1562209564","doi":"10.1111/j.1464-410x.2012.10946.x","title":"Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian survey","year":2012,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Sunitinib; Medicine; Sorafenib; Internal medicine; Retrospective cohort study; Renal cell carcinoma; Tyrosine-kinase inhibitor; Oncology; Population; Cancer; Urology; Pharmacology; Hepatocellular carcinoma","score_opus":0.029095895979656394,"score_gpt":0.25863288608515916,"score_spread":0.22953699010550277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1562209564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99602586,0.0031596695,0.000022253818,0.00017386026,0.000238581,0.0002504517,0.000096797965,0.0000038886246,0.000028641152],"genre_scores_gemma":[0.9987211,0.00022809362,0.0006284428,0.00022479943,0.0000960721,0.0000072546413,0.000031287313,0.000028685543,0.000034238365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804914,0.00041395208,0.00064814906,0.00015769093,0.00039221012,0.00033885404],"domain_scores_gemma":[0.99820715,0.00013024418,0.0005943435,0.00014110006,0.0005991628,0.00032796813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006759209,0.00015245807,0.00075412454,0.00029206596,0.000026619213,0.000015462107,0.00006763514,0.000070295115,0.00008819799],"category_scores_gemma":[0.0010812868,0.0001356822,0.00011421236,0.00038552214,0.000119730634,0.0003187521,0.000028118202,0.00033148722,0.0000015042516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001498372,0.00091119664,0.99162525,0.000035410118,0.0003803396,0.0005143846,0.000213906,0.00004172015,0.00018486033,0.0000014440911,0.0009237409,0.003669398],"study_design_scores_gemma":[0.004239511,0.0017393959,0.991636,0.0003647254,0.0005119637,0.000682404,0.000017745046,0.0000062114236,0.0006019892,0.0000069508737,0.00009088042,0.00010227389],"about_ca_topic_score_codex":0.0034308478,"about_ca_topic_score_gemma":0.0011952675,"teacher_disagreement_score":0.003567124,"about_ca_system_score_codex":0.0002933748,"about_ca_system_score_gemma":0.0002026772,"threshold_uncertainty_score":0.55329597},"labels":[],"label_agreement":null},{"id":"W1562420879","doi":"10.1111/j.1464-410x.2012.11254.x","title":"Comparison of partial vs radical nephrectomy with regard to other‐cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbidities","year":2012,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Context (archaeology); Hazard ratio; Propensity score matching; Proportional hazards model; Epidemiology; Internal medicine; Comorbidity; Surgery; Urology; Confidence interval; Kidney","score_opus":0.02964688743060168,"score_gpt":0.27314258842025413,"score_spread":0.24349570098965245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1562420879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984609,0.00065919134,0.00008155305,0.000052355183,0.00012816527,0.00041836765,0.000022261935,0.000008994404,0.00016825066],"genre_scores_gemma":[0.9984987,0.000014359493,0.0010358546,0.00016848103,0.00018920781,0.000013146975,0.000015199143,0.000037884132,0.000027208243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99769604,0.00032588255,0.00074318785,0.00020409218,0.0005561101,0.00047467902],"domain_scores_gemma":[0.99856484,0.00013306108,0.0004988359,0.00021542121,0.00016914055,0.00041872734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038714978,0.00019641985,0.0008748904,0.00019941217,0.00003722434,0.000015460993,0.0001440833,0.00013311142,0.00007750362],"category_scores_gemma":[0.00007904774,0.00017277831,0.00010976101,0.00017935093,0.00030975454,0.00014756872,0.000041582167,0.00054352806,0.0000038222215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004746382,0.0014907424,0.9890132,0.00004104564,0.00017552628,0.001733675,0.0009132622,0.00018682115,0.00036193468,0.0000014340902,0.0008126207,0.00052336405],"study_design_scores_gemma":[0.009432934,0.0062391222,0.9764799,0.00013409808,0.000381126,0.0012780472,0.00013058308,0.00003400938,0.0051000477,0.0000017742562,0.00063660886,0.00015178601],"about_ca_topic_score_codex":0.001431563,"about_ca_topic_score_gemma":0.001307448,"teacher_disagreement_score":0.012533329,"about_ca_system_score_codex":0.00012213975,"about_ca_system_score_gemma":0.0001169179,"threshold_uncertainty_score":0.70456946},"labels":[],"label_agreement":null},{"id":"W1563150810","doi":"10.1038/mt.2015.129","title":"miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma","year":2015,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Sunitinib; Renal cell carcinoma; Cancer research; Oncology; Medicine; Internal medicine","score_opus":0.06766515216444068,"score_gpt":0.3005715847734472,"score_spread":0.2329064326090065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1563150810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923101,0.0033303157,0.00004862573,0.0018328533,0.00005419722,0.0016700132,0.000013201569,0.00003533933,0.00070537056],"genre_scores_gemma":[0.9960196,0.00003299227,0.0015465077,0.001157349,0.000023760538,0.0003712158,0.000054658805,0.00007027336,0.000723621],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974205,0.00068893103,0.00043030496,0.00051187014,0.00045424703,0.0004941813],"domain_scores_gemma":[0.9985768,0.00009870797,0.00009163649,0.00068225764,0.00010220301,0.00044836727],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005447289,0.00037789228,0.00061776506,0.0005754625,0.000022678458,0.000024388897,0.00013703079,0.000084086954,0.00005303877],"category_scores_gemma":[0.000067136825,0.0003061776,0.00016017878,0.0005945221,0.00003969257,0.000044322907,0.000032783017,0.00016392101,0.000122655],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03146433,0.00380228,0.15334713,0.000048688376,0.00017061946,0.032808613,0.008838696,0.00047604018,0.7644079,0.000020748588,0.00038647326,0.0042285216],"study_design_scores_gemma":[0.026082639,0.0067166663,0.29220316,0.00010878319,0.000075395954,0.00007625168,0.0016381771,0.0000860514,0.6655564,0.0001330363,0.00689607,0.00042739394],"about_ca_topic_score_codex":0.0010604509,"about_ca_topic_score_gemma":0.0004014028,"teacher_disagreement_score":0.13885602,"about_ca_system_score_codex":0.0010843696,"about_ca_system_score_gemma":0.00040273194,"threshold_uncertainty_score":0.999939},"labels":[],"label_agreement":null},{"id":"W1564728191","doi":"10.1038/bjc.2015.196","title":"Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University Hospital Foundation","funders":"Astellas Pharma; GlaxoSmithKline; Exelixis; Genentech; AstraZeneca; Royal Marsden NHS Foundation Trust; Pfizer; Bristol-Myers Squibb","keywords":"Sunitinib; Medicine; Renal cell carcinoma; Neutropenia; Expanded access; Internal medicine; Adverse effect; Clear cell renal cell carcinoma; Tyrosine-kinase inhibitor; Oncology; Confidence interval; Surgery; Cancer; Chemotherapy","score_opus":0.1058398097867058,"score_gpt":0.3561710599735537,"score_spread":0.2503312501868479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1564728191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767106,0.018035572,0.000033363416,0.00093994447,0.0006858675,0.00045124145,0.00055279373,0.000007127797,0.0025834574],"genre_scores_gemma":[0.9971575,0.0004641761,0.00030853268,0.00046547566,0.001235347,0.00002265373,0.000043580316,0.000019639478,0.00028308164],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99732,0.00029201203,0.00092383754,0.00023089598,0.0008605194,0.00037272947],"domain_scores_gemma":[0.9983149,0.00017899972,0.00053198927,0.00022140732,0.00041226295,0.00034043143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009360113,0.00018482859,0.00057177444,0.00005934451,0.000059160993,0.00013907709,0.000322898,0.0000668848,0.00017073308],"category_scores_gemma":[0.00035424306,0.0001430708,0.00022470017,0.00028807178,0.00006964013,0.00024173564,0.00007646362,0.0004488051,0.0000068613153],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42211875,0.003729633,0.23599043,0.00011572573,0.0008685568,0.078101,0.0026050603,0.0005265893,0.0004999231,0.000032397675,0.14836244,0.10704947],"study_design_scores_gemma":[0.35032764,0.0023530705,0.6188308,0.0009538095,0.0008309233,0.0046533397,0.00095503224,0.000056649184,0.0027868773,0.0005374584,0.01740368,0.000310701],"about_ca_topic_score_codex":0.011651068,"about_ca_topic_score_gemma":0.008353048,"teacher_disagreement_score":0.3828404,"about_ca_system_score_codex":0.00059381954,"about_ca_system_score_gemma":0.0013501431,"threshold_uncertainty_score":0.99493045},"labels":[],"label_agreement":null},{"id":"W1567663671","doi":"10.5489/cuaj.2597","title":"Efficacy of percutaneous cryoablation of renal cell carcinoma in older patients with medical comorbidities: Outcome study in 70 patients","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cryoablation; Renal cell carcinoma; Percutaneous; Internal medicine; Outcome (game theory); Cryosurgery; Oncology; Surgery","score_opus":0.020586031524439472,"score_gpt":0.24094249202212745,"score_spread":0.22035646049768798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1567663671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980671,0.00003354053,0.0000031121047,0.00046563003,0.00010295533,0.00067513826,0.000021991158,0.000004411671,0.0006261233],"genre_scores_gemma":[0.9995934,0.0000019330348,0.000040559997,0.00019604925,0.000047997844,0.0000062731383,0.000058000365,0.000014110433,0.000041727417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968548,0.00037302636,0.00089523045,0.00020963141,0.0012870567,0.00038027033],"domain_scores_gemma":[0.99777174,0.00027212658,0.00050197926,0.00013799385,0.0005890526,0.0007271145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079485984,0.00017366625,0.0005550119,0.0004423483,0.000035670204,0.000012455181,0.00013282005,0.00022755888,0.00020335832],"category_scores_gemma":[0.0014255524,0.00012742936,0.00007998902,0.0003379194,0.000046368896,0.00007411826,0.000020612186,0.0005464342,0.000005383788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004929625,0.0017538498,0.9953008,0.000008797759,0.000031789354,0.0004181861,0.0013031986,0.00023950181,0.0000025890065,0.0000019454876,0.00015680167,0.00028955995],"study_design_scores_gemma":[0.012542402,0.0036322465,0.983067,0.00003500641,0.000070309456,0.000030975945,0.00036170054,0.000090969246,0.000016401047,0.000014257149,0.000033688364,0.00010508515],"about_ca_topic_score_codex":0.0040502534,"about_ca_topic_score_gemma":0.004123336,"teacher_disagreement_score":0.01223386,"about_ca_system_score_codex":0.0021667816,"about_ca_system_score_gemma":0.00084269146,"threshold_uncertainty_score":0.61227983},"labels":[],"label_agreement":null},{"id":"W1568494625","doi":"10.1002/14651858.cd006017.pub2","title":"Targeted therapy for advanced renal cell carcinoma","year":2008,"lang":"en","type":"review","venue":"Cochrane Database of Systematic Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Internal medicine; Targeted therapy; MEDLINE; Randomized controlled trial; Data extraction; Meta-analysis; Cancer; Clinical trial; Placebo; Performance status; Intensive care medicine; Pathology; Alternative medicine","score_opus":0.12065848680417789,"score_gpt":0.36923559522057225,"score_spread":0.24857710841639435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1568494625","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000027754537,0.9565264,0.0002594262,0.0000070998403,0.00028846064,0.041150235,0.0011940661,0.00004471362,0.00050187384],"genre_scores_gemma":[0.0000149639745,0.9733833,0.006622377,0.000041505264,0.00024329801,0.009747273,0.008696857,0.00020536075,0.0010450478],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9909927,0.0011324427,0.005333975,0.0010822378,0.00086656125,0.00059207703],"domain_scores_gemma":[0.9899494,0.0012962427,0.004244938,0.0036817952,0.000448004,0.00037963066],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0015343716,0.0013854197,0.015875516,0.00044641187,0.00010567752,0.00001887247,0.0006498303,0.00033590337,0.00014370134],"category_scores_gemma":[0.0010385958,0.0008102149,0.0037250041,0.00060203235,0.0001233641,0.00012347796,0.00009902016,0.00038073343,0.0003133968],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079845864,0.00033161207,8.3832833e-7,0.94862276,0.0002919766,0.00015565385,0.000058307876,7.61675e-8,0.00012595956,0.000009539222,0.006586572,0.043736875],"study_design_scores_gemma":[0.001966586,0.00066541124,8.2851057e-7,0.6139758,0.004049922,0.0009017263,0.0000135990795,0.0000033784581,0.00036971326,8.1249016e-7,0.37759757,0.00045464738],"about_ca_topic_score_codex":0.000013144129,"about_ca_topic_score_gemma":9.912229e-7,"teacher_disagreement_score":0.371011,"about_ca_system_score_codex":0.0003265938,"about_ca_system_score_gemma":0.0007168612,"threshold_uncertainty_score":0.9998896},"labels":[],"label_agreement":null},{"id":"W1568762723","doi":"10.1111/iju.12204","title":"Partial and radical nephrectomy provide comparable long‐term cancer control for <scp>T</scp>1b renal cell carcinoma","year":2013,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Cytodiagnostics (Canada); Institute for Research in Immunology and Cancer","funders":"","keywords":"Nephrectomy; Medicine; Renal cell carcinoma; Cohort; Cancer; Hazard ratio; Urology; Kidney cancer; Proportional hazards model; Surgery; Internal medicine; Kidney; Confidence interval","score_opus":0.01838231190895707,"score_gpt":0.27942623968686564,"score_spread":0.2610439277779086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1568762723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879578,0.0029882283,0.0026462553,0.0046938634,0.0007141852,0.000575349,0.00002039656,0.000010090102,0.0003938616],"genre_scores_gemma":[0.99602485,0.000088416775,0.00073292747,0.0013605276,0.0011290946,0.00008839626,0.000013139964,0.000023626244,0.00053900515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983833,0.00008425728,0.00058106735,0.00022140967,0.00040765246,0.0003223136],"domain_scores_gemma":[0.9979686,0.000540614,0.0004207044,0.00011321544,0.0006523064,0.0003045632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020533109,0.0001907816,0.00047607237,0.0002109083,0.00004363461,0.000049837854,0.00021354856,0.00012298039,0.00017792605],"category_scores_gemma":[0.00014948419,0.00014555079,0.00019800165,0.000040119277,0.000163689,0.00016633428,0.000038963004,0.00030187354,0.00001885517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026188274,0.0010046134,0.8974785,0.00009936336,0.0013357115,0.0014450299,0.00046561827,0.00028034492,0.06162261,0.00020927614,0.025532033,0.007908045],"study_design_scores_gemma":[0.03835289,0.005801395,0.8527961,0.000079395475,0.001050207,0.0069577014,0.00005494573,0.004222264,0.03734255,0.0006358998,0.052538242,0.00016842705],"about_ca_topic_score_codex":0.00010965975,"about_ca_topic_score_gemma":0.000013033722,"teacher_disagreement_score":0.044682447,"about_ca_system_score_codex":0.00016458126,"about_ca_system_score_gemma":0.00028024585,"threshold_uncertainty_score":0.5935389},"labels":[],"label_agreement":null},{"id":"W1572411832","doi":"10.1046/j.1464-410x.2000.00880.x","title":"Placebo‐associated remissions in a multicentre, randomized, double‐blind trial of interferon γ‐1b for the treatment of metastatic renal cell carcinoma","year":2000,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta Hospital; Sunnybrook Health Science Centre; Hôpital Notre-Dame; Juravinski Hospital; Hôtel-Dieu de Québec; Health Sciences Centre; Vancouver General Hospital; Royal Victoria Hospital","funders":"Genentech; Canadian Urological Oncology Group","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Placebo; Internal medicine; Randomized controlled trial; Clinical endpoint; Surgery; Performance status; Carcinoma; Oncology; Gastroenterology; Urology; Chemotherapy; Kidney; Pathology","score_opus":0.03841418931568062,"score_gpt":0.2950314361719036,"score_spread":0.25661724685622295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1572411832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865641,0.009486318,0.0000628997,0.00045286774,0.000177317,0.0027503285,0.000029604329,0.0000034875006,0.00047307232],"genre_scores_gemma":[0.99565494,0.0030025474,0.00038918908,0.00003517396,0.0001080878,0.000091072434,0.000016309954,0.000023336435,0.0006793467],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99725705,0.00052983256,0.0014412063,0.00018445868,0.0002872157,0.0003002348],"domain_scores_gemma":[0.9967223,0.0018692915,0.00082905137,0.00018724035,0.00025432187,0.00013783302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010109751,0.00019203608,0.0014946685,0.00019752848,0.00004492413,0.0000095898595,0.00014307923,0.000117118456,0.00029582265],"category_scores_gemma":[0.0002886958,0.00013276923,0.0006968801,0.00015569362,0.00019788725,0.000044658234,0.000011464631,0.00021930366,0.0000015234295],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97606647,0.0044678664,0.00023736122,0.000040779574,0.00071322557,0.0007468034,0.00064772536,0.00034702718,0.0009767395,0.00000278512,0.00022319783,0.015530016],"study_design_scores_gemma":[0.97326195,0.014939497,0.0012360056,0.00012810619,0.0027643952,0.0013366608,0.00013969178,0.0007383236,0.0048221434,0.00005128976,0.0004956524,0.000086268505],"about_ca_topic_score_codex":0.0005452908,"about_ca_topic_score_gemma":0.00021731104,"teacher_disagreement_score":0.015443748,"about_ca_system_score_codex":0.00019149706,"about_ca_system_score_gemma":0.00026044872,"threshold_uncertainty_score":0.5414172},"labels":[],"label_agreement":null},{"id":"W1572876072","doi":"10.1002/cncr.27582","title":"Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor–associated tumors","year":2012,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Neutropenia; Internal medicine; Oncology; Adverse effect; Gastroenterology; Clinical endpoint; Microphthalmia-associated transcription factor; Surgery; Clinical trial; Chemotherapy","score_opus":0.018205742385234397,"score_gpt":0.2572227953645037,"score_spread":0.2390170529792693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1572876072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979672,0.00058204075,0.0000024096692,0.000019124007,0.00012372904,0.0006014244,0.000057541936,0.000015981326,0.0006305914],"genre_scores_gemma":[0.99948096,0.000009190487,0.00007333312,0.000031343432,0.00006277562,0.000055909702,0.00004384153,0.000027083095,0.00021554675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990358,0.00004970165,0.00021471274,0.00016913954,0.0002445637,0.0002861175],"domain_scores_gemma":[0.99947906,0.00002082234,0.00012424281,0.00011524674,0.00015390952,0.00010672036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005421161,0.00015528416,0.00033530153,0.00011054971,0.000017708971,0.0000027496285,0.000031982545,0.00006999159,0.0001188882],"category_scores_gemma":[0.000021588909,0.00011300541,0.00006145769,0.00029740037,0.00004157727,0.00009891133,0.0000064393057,0.00013846764,0.000006374248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007522347,0.000568584,0.94566894,0.000051597046,0.00011778151,0.0000056576387,0.0016451231,0.0000019339402,0.05039995,0.0000019507538,0.00008012049,0.0007061017],"study_design_scores_gemma":[0.003611586,0.0006475356,0.84088403,0.0002496169,0.000097287775,0.0000019256534,0.00006341777,0.0000011787705,0.15428771,0.0000011954319,0.000059639293,0.00009489153],"about_ca_topic_score_codex":0.0003130422,"about_ca_topic_score_gemma":0.00003996346,"teacher_disagreement_score":0.10478495,"about_ca_system_score_codex":0.0005784869,"about_ca_system_score_gemma":0.000111177505,"threshold_uncertainty_score":0.46082267},"labels":[],"label_agreement":null},{"id":"W1574553070","doi":"10.1111/j.1464-410x.2012.11693.x","title":"Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data","year":2013,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Missing data; Lymphadenectomy; Renal cell carcinoma; Hazard ratio; Lymph node; Proportional hazards model; Population; Dissection (medical); Imputation (statistics); Urology; Oncology; Internal medicine; Nomogram; Surgery; Kidney; Confidence interval; Statistics","score_opus":0.0225352250246864,"score_gpt":0.23256224438094397,"score_spread":0.21002701935625756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1574553070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99602497,0.0027690337,0.00009013091,0.00042416737,0.000060093647,0.00035441245,0.00024072506,0.0000022346844,0.00003421344],"genre_scores_gemma":[0.999356,0.00007088777,0.00036701965,0.00007712332,0.000047472557,0.0000031153963,0.000039501952,0.000020290028,0.000018626535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981287,0.00033436358,0.00060911226,0.00019527935,0.0005131395,0.00021937281],"domain_scores_gemma":[0.9967127,0.00092132966,0.0011926279,0.00033060694,0.00074602605,0.000096751515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006367994,0.00015560939,0.0006704422,0.00008109191,0.000071807335,0.000022753691,0.00027515664,0.000059864084,0.000032120843],"category_scores_gemma":[0.00040509694,0.000074355856,0.00008078952,0.000114990486,0.00046130482,0.00013940268,0.000116658804,0.00020044384,1.3374466e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006612428,0.002644935,0.8821413,0.00031897702,0.0027709352,0.0013763265,0.0009189082,0.00015327925,0.068862654,0.000006074357,0.00042967254,0.033764508],"study_design_scores_gemma":[0.0076977694,0.004498888,0.9510137,0.00028988192,0.0016028294,0.0010054692,0.00036427693,0.00017223282,0.033227533,0.000012008941,0.000018036963,0.000097401826],"about_ca_topic_score_codex":0.0010059434,"about_ca_topic_score_gemma":0.00016429336,"teacher_disagreement_score":0.06887237,"about_ca_system_score_codex":0.000030003941,"about_ca_system_score_gemma":0.00021254567,"threshold_uncertainty_score":0.30321437},"labels":[],"label_agreement":null},{"id":"W1577157491","doi":"10.1016/j.eururo.2015.07.003","title":"Prediction of Complications Following Partial Nephrectomy: Implications for Ablative Techniques Candidates","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Perioperative; Logistic regression; Kidney cancer; Complication; Kidney disease; Renal cell carcinoma; Surgery; Odds ratio; Internal medicine; Comorbidity; Cancer; Urology; Kidney","score_opus":0.07984670587099317,"score_gpt":0.3096110459365195,"score_spread":0.22976434006552632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1577157491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8621789,0.0005810206,0.035286475,0.0063462025,0.00023331016,0.0028499463,0.00025823514,0.0004279706,0.09183793],"genre_scores_gemma":[0.99342847,0.0000056791932,0.0055199196,0.00027819528,0.00012284129,0.00020754652,0.00025792775,0.000026889345,0.00015251288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921066,0.00011416908,0.00025531763,0.00020847018,0.00006178166,0.00014959526],"domain_scores_gemma":[0.99921674,0.000106368396,0.000105772124,0.00030129327,0.00015708353,0.00011271938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023275314,0.00009636931,0.00019398652,0.00009142411,0.00005385283,0.0000044708427,0.00007326177,0.00003392268,0.0000049717287],"category_scores_gemma":[0.00014274509,0.00008457039,0.00009641027,0.000107500884,0.00007118476,0.00003850388,0.00003401022,0.000066639775,0.000021367647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014922485,0.0011557842,0.71181947,0.00008231059,0.0011084353,0.000043772172,0.0027374998,0.00007986967,0.20612128,0.013427295,0.036947764,0.024984267],"study_design_scores_gemma":[0.0029268337,0.0037712145,0.7683722,0.000022473814,0.0007142665,0.00013593871,0.000073408606,0.0004280844,0.032602917,0.0015736643,0.18922034,0.00015865212],"about_ca_topic_score_codex":0.000019336916,"about_ca_topic_score_gemma":0.0000033645235,"teacher_disagreement_score":0.17351837,"about_ca_system_score_codex":0.000060472,"about_ca_system_score_gemma":0.00007564847,"threshold_uncertainty_score":0.34486803},"labels":[],"label_agreement":null},{"id":"W158379672","doi":"10.1016/s1695-3290(08)35054-x","title":"10.1016/s1695-3290(08)35054-x","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.014356474626791698,"score_gpt":0.19032066926425642,"score_spread":0.1759641946374647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W158379672","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007993354,0.0013285216,1.9270851e-7,0.00043723683,0.000004988003,0.0010682147,0.00008050078,0.00021749243,0.99685484],"genre_scores_gemma":[0.0000071674026,0.0000068616646,0.00013342577,0.0001548163,0.00073395565,0.000044721404,0.00041709957,0.00023165453,0.9982703],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976748,0.000018191664,0.00049678044,0.00071283686,0.00064113614,0.00045623546],"domain_scores_gemma":[0.9980592,0.00006816359,0.00013643822,0.0010560501,0.00012675927,0.0005533782],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00010258783,0.0006807505,0.0009631067,0.00035515858,0.00006541948,0.00003220851,0.00022115411,0.00046988254,0.9986748],"category_scores_gemma":[0.000019301364,0.0006017883,0.0004260106,0.000055049426,0.00008112669,0.00003922457,0.00009937262,0.0005159789,0.99848866],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069770793,0.00009118296,5.3661427e-8,0.000093475,0.0004086541,0.0010786515,0.000014930669,0.0000034254376,0.000033075816,0.000036339996,0.5606641,0.43687838],"study_design_scores_gemma":[0.0009076759,0.0011524125,0.000016854707,0.00042196806,0.00071728666,0.0002727043,2.2883323e-7,0.000004554193,0.00012141899,0.00013765726,0.9957424,0.0005048537],"about_ca_topic_score_codex":0.000021644793,"about_ca_topic_score_gemma":2.1913706e-7,"teacher_disagreement_score":0.43637353,"about_ca_system_score_codex":0.00041364654,"about_ca_system_score_gemma":0.0001947059,"threshold_uncertainty_score":0.9996433},"labels":[],"label_agreement":null},{"id":"W1587591612","doi":"10.1111/j.1464-410x.2012.11418.x","title":"THE CASE FOR PARTIAL NEPHRECTOMY: ACTION IS REQUIRED","year":2012,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Prognostics; Medicine; Unit (ring theory); Gerontology; Family medicine; Psychology; Engineering","score_opus":0.049817314955968285,"score_gpt":0.30938371923109315,"score_spread":0.25956640427512484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1587591612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830694,0.012124632,0.00046305184,0.0026182237,0.0012255779,0.00026444136,0.0000056567496,0.000007548577,0.00022146865],"genre_scores_gemma":[0.9962159,0.000565409,0.00044936704,0.00072674314,0.0017273,0.000019855093,0.0000019130155,0.00001493485,0.0002786025],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99911743,0.00008994958,0.0003198133,0.00007183456,0.00010717164,0.0002937908],"domain_scores_gemma":[0.9990704,0.00020477509,0.00022005943,0.0000998098,0.00023036232,0.0001745887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005064176,0.00007153217,0.00021383501,0.000038870337,0.0001549809,0.000022058846,0.00005007262,0.00008195778,0.00006530555],"category_scores_gemma":[0.00026884358,0.0000559473,0.00017639664,0.000046713558,0.00006951315,0.00011543771,0.000013409295,0.00018518188,0.000009506655],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059023513,0.0006918975,0.013017867,0.00006232797,0.0008837276,0.02717731,0.00048085712,0.000007642873,0.0053101145,0.0001971384,0.13891917,0.80734956],"study_design_scores_gemma":[0.0034975323,0.0019736618,0.015128044,0.000017818254,0.0005454072,0.601031,0.00013712626,0.00006619927,0.0043884087,0.00021974235,0.37291995,0.00007508721],"about_ca_topic_score_codex":0.00005093493,"about_ca_topic_score_gemma":0.000034990808,"teacher_disagreement_score":0.8072745,"about_ca_system_score_codex":0.00006971103,"about_ca_system_score_gemma":0.000071968054,"threshold_uncertainty_score":0.22814646},"labels":[],"label_agreement":null},{"id":"W1587851761","doi":"10.1111/bju.12115","title":"Conditional survival after nephrectomy for renal cell carcinoma ( <scp>RCC</scp> ): changes in future survival probability over time","year":2013,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Renal cell carcinoma; Nephrectomy; Medicine; Proportional hazards model; Stage (stratigraphy); Survival analysis; Internal medicine; Kidney cancer; Epidemiology; Urology; Surgery; Cancer; Oncology; Kidney; Biology","score_opus":0.011985043918070416,"score_gpt":0.22434888868125683,"score_spread":0.2123638447631864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1587851761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99227303,0.0034642667,0.00006446094,0.0014742521,0.0005790937,0.0009710942,0.000117758544,0.000015511998,0.0010405281],"genre_scores_gemma":[0.99540937,0.00009379076,0.0010664272,0.0006410406,0.0017660839,0.00015098856,0.00009717405,0.000047160218,0.00072793826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974975,0.00033534144,0.0006932828,0.00038530614,0.00047974862,0.0006088492],"domain_scores_gemma":[0.99800426,0.0005370053,0.00036362864,0.00021009729,0.00055303174,0.00033200506],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00067783165,0.00027927174,0.0008360969,0.00023731694,0.000059473674,0.00005147714,0.00017905617,0.00031267366,0.0010237074],"category_scores_gemma":[0.0002050609,0.00027440127,0.00031757652,0.00016697282,0.00017725436,0.00018967404,0.000060551378,0.000604402,0.000051712454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003968308,0.0037167121,0.88751316,0.000687765,0.0006471515,0.012961807,0.0007193404,0.00008127948,0.023786979,0.00017371334,0.053899508,0.011844305],"study_design_scores_gemma":[0.0072281878,0.0029448268,0.9692816,0.00004111978,0.00019956184,0.0054391217,0.000058981404,0.000061765895,0.0011435837,0.0015699336,0.011915979,0.00011530232],"about_ca_topic_score_codex":0.0001707919,"about_ca_topic_score_gemma":0.0003407113,"teacher_disagreement_score":0.081768505,"about_ca_system_score_codex":0.00020797238,"about_ca_system_score_gemma":0.00027085634,"threshold_uncertainty_score":0.9999708},"labels":[],"label_agreement":null},{"id":"W1591039646","doi":"10.1016/j.ctrv.2015.05.006","title":"New molecular targets in non clear renal cell carcinoma: An overview of ongoing clinical trials","year":2015,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Associazione Italiana per la Ricerca sul Cancro","keywords":"Medicine; PI3K/AKT/mTOR pathway; Renal cell carcinoma; Cancer research; Discovery and development of mTOR inhibitors; Targeted therapy; Immunotherapy; Clinical trial; Immunohistochemistry; Pathology; Oncology; Internal medicine; Bioinformatics; Cancer; Signal transduction; Biology","score_opus":0.4860007036524934,"score_gpt":0.528739808086189,"score_spread":0.04273910443369561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1591039646","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039226696,0.98687387,0.000018280376,0.00003460109,0.00043831152,0.010385772,0.000096510244,0.000028354143,0.0017320518],"genre_scores_gemma":[0.00004837738,0.9928331,0.002378312,0.000084987565,0.00078081625,0.0014507476,0.00065247493,0.00019430093,0.0015769121],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98700607,0.004191214,0.0059830816,0.0015103056,0.0006213905,0.0006879568],"domain_scores_gemma":[0.9930764,0.00036925424,0.00325146,0.0020442826,0.00014798854,0.0011106057],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.004655639,0.0014803676,0.016723655,0.00043706657,0.000032645195,0.000029623092,0.0003975372,0.0007179903,0.00046177633],"category_scores_gemma":[0.00023447291,0.00091125455,0.0043988274,0.0007414402,0.00007801649,0.00011428284,0.000108591536,0.00060715195,0.00022222108],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016886939,0.0009422082,0.00030792246,0.026218541,0.000441809,0.0006022964,0.000081098675,0.0000012618484,0.0000108339345,0.000006905777,0.002487056,0.9687312],"study_design_scores_gemma":[0.00529744,0.0040844684,0.00012716542,0.03443948,0.014591288,0.000040772695,0.000007282238,0.0000031308252,0.00016258123,0.000008890213,0.94066966,0.0005678395],"about_ca_topic_score_codex":0.0013222613,"about_ca_topic_score_gemma":0.00013773362,"teacher_disagreement_score":0.9681634,"about_ca_system_score_codex":0.0030433163,"about_ca_system_score_gemma":0.0039372444,"threshold_uncertainty_score":0.99979454},"labels":[],"label_agreement":null},{"id":"W1593849496","doi":"10.1111/bju.13212","title":"Oncological control associated with surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma","year":2015,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Interquartile range; Surgery; Proportional hazards model; Lymph node; Internal medicine; Kidney","score_opus":0.024814949593429975,"score_gpt":0.2528038190814686,"score_spread":0.22798886948803862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1593849496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938815,0.003366956,0.0001955875,0.00028688952,0.00018690714,0.00020014211,0.000025547666,0.000009505085,0.0018469375],"genre_scores_gemma":[0.9992717,0.00013223957,0.00024687138,0.00006155293,0.00015756748,0.0000035672542,0.000015346968,0.000019345553,0.00009181956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728197,0.0006357381,0.00094294536,0.00022064583,0.0006001268,0.00031859835],"domain_scores_gemma":[0.99682724,0.00026557027,0.0009890002,0.00015375875,0.0014401997,0.00032423766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095353584,0.00016646016,0.0010080064,0.00016583296,0.000034597713,0.0000089640625,0.00015283233,0.0003041206,0.000065712855],"category_scores_gemma":[0.00053247175,0.00013730375,0.00019920015,0.00028363752,0.0003412196,0.000080011196,0.00003225983,0.0005382145,0.000002024666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.089776814,0.0057746717,0.79458284,0.00016109443,0.0011036976,0.06980129,0.0003863322,0.0014597125,0.027290823,0.000032310767,0.0032229277,0.0064074914],"study_design_scores_gemma":[0.04550031,0.06471186,0.78968585,0.00040302685,0.0011712124,0.08884168,0.00012429187,0.0012065127,0.0075817467,0.00006299062,0.00044996638,0.00026053906],"about_ca_topic_score_codex":0.00024798585,"about_ca_topic_score_gemma":0.00003467098,"teacher_disagreement_score":0.05893719,"about_ca_system_score_codex":0.00028105825,"about_ca_system_score_gemma":0.0006038199,"threshold_uncertainty_score":0.55990845},"labels":[],"label_agreement":null},{"id":"W1595374633","doi":"10.1016/j.eururo.2015.05.011","title":"Management of Small Renal Mass: An Opportunity to Address a Growing Problem in Early Stage Kidney Cancer","year":2015,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Renal mass; Kidney cancer; Stage (stratigraphy); Intervention (counseling); Kidney; General surgery; Surgery; Intensive care medicine; Cancer; Urology; Internal medicine; Nephrectomy; Nursing","score_opus":0.07646830547592356,"score_gpt":0.28584453888636896,"score_spread":0.2093762334104454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1595374633","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38234046,0.000768702,0.00012512966,0.36812913,0.00083142944,0.004770084,0.00057953486,0.0002394097,0.24221613],"genre_scores_gemma":[0.064192936,0.00016666105,0.007053812,0.88459724,0.0025768527,0.00033067673,0.0018140355,0.00054250285,0.03872527],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996225,0.0010415504,0.0007167027,0.0008617312,0.0004640231,0.0006909855],"domain_scores_gemma":[0.9977408,0.00003527799,0.0003025413,0.0009771099,0.00016395941,0.0007803125],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008211025,0.0004852424,0.00083285436,0.0005287404,0.00002619047,0.000018172594,0.00046456055,0.0002660537,0.00035906874],"category_scores_gemma":[0.00005453211,0.00043791273,0.00013296683,0.00023965884,0.000094622075,0.00006885114,0.00030511478,0.0013241514,0.00010692484],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018122141,0.0004705191,0.010478401,0.0022460488,0.0012171544,0.19695361,0.0020709923,0.00029695267,0.0014308298,0.00006898951,0.77621984,0.0067344643],"study_design_scores_gemma":[0.0029024845,0.003231862,0.023031894,0.0005897697,0.0006179397,0.000087760134,0.000046532565,0.000014453257,0.00015939286,0.000025246101,0.96882945,0.0004632143],"about_ca_topic_score_codex":0.00076618145,"about_ca_topic_score_gemma":0.000041580457,"teacher_disagreement_score":0.5164681,"about_ca_system_score_codex":0.00031488345,"about_ca_system_score_gemma":0.00036881547,"threshold_uncertainty_score":0.99980724},"labels":[],"label_agreement":null},{"id":"W1597498414","doi":"10.5489/cuaj.2900","title":"Stereotactic body radiotherapy for the treatment of medically inoperable primary renal cell carcinoma: Current evidence and future directions","year":2015,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Radiation therapy; Ablative case; Population; Kidney cancer; Dosing; Radiosurgery; Radiology; Surgery; Oncology; Internal medicine","score_opus":0.05444240438734118,"score_gpt":0.31038910140179055,"score_spread":0.2559466970144494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1597498414","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012809146,0.992343,0.00001224344,0.0035434114,0.000819186,0.0017282699,0.000115364295,0.000010938074,0.00014664413],"genre_scores_gemma":[0.00070181565,0.99561214,0.00015128519,0.00020938202,0.002463792,0.0002124156,0.00007368676,0.000035365843,0.0005401413],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99728876,0.00048352953,0.0007980177,0.00036143998,0.00055714545,0.00051108474],"domain_scores_gemma":[0.9962314,0.0011700789,0.00084772747,0.0002720938,0.00047275322,0.0010059421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009202965,0.000417389,0.0015823531,0.0002512602,0.00032998624,0.00008251395,0.0001802024,0.00045045387,0.00012341162],"category_scores_gemma":[0.00020936699,0.00021992243,0.00063698314,0.00025788497,0.00007515327,0.00007710695,0.000011514906,0.00068252493,0.0000046047976],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096948526,0.00034267677,0.0049208114,0.0009448847,0.0008125514,0.00008553573,0.0002482491,5.633957e-7,0.0000015367677,0.0000098354,0.0063270964,0.98620933],"study_design_scores_gemma":[0.0012995582,0.0027570527,0.009709159,0.00042551346,0.003496163,0.0005876737,0.000015342473,0.000011179584,6.94301e-7,0.000012905693,0.9815108,0.00017394878],"about_ca_topic_score_codex":0.00043637017,"about_ca_topic_score_gemma":0.00013478074,"teacher_disagreement_score":0.98603535,"about_ca_system_score_codex":0.007150298,"about_ca_system_score_gemma":0.004173032,"threshold_uncertainty_score":0.99666107},"labels":[],"label_agreement":null},{"id":"W1598230406","doi":"10.5489/cuaj.1037","title":"Laparoscopic partial nephrectomy: the University of Saskatchewan (Regina division) experience","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Saskatchewan; McMaster University; Hamilton Health Sciences","funders":"","keywords":"Nephrectomy; Division (mathematics); General surgery; Medicine; Urology; Internal medicine; Mathematics; Kidney","score_opus":0.012425955771933164,"score_gpt":0.20588526273382463,"score_spread":0.19345930696189145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1598230406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775279,0.00012707399,0.00004852956,0.021050006,0.00013029181,0.00023093927,0.000003960104,0.000010239472,0.0008710523],"genre_scores_gemma":[0.9975028,0.000020736785,0.00014153142,0.0010029441,0.00010382467,0.00000327204,0.0000036491597,0.000004620285,0.0012166408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989975,0.00014799154,0.00014239307,0.0001221866,0.0002801726,0.00030974412],"domain_scores_gemma":[0.99890196,0.00011185972,0.000179605,0.00012798302,0.00019608875,0.00048247498],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020929192,0.00008959763,0.00020136191,0.00005503311,0.00026981876,0.000031614258,0.00014030989,0.00011436717,0.0019163924],"category_scores_gemma":[0.0001729052,0.000058385565,0.00011412091,0.0001461572,0.00007839508,0.00008868015,0.000017796936,0.00030636057,0.0001402662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022244812,0.00003543603,0.9857003,0.0000023707578,0.00006556395,0.00007285506,0.001570266,0.000019439967,0.0004705666,0.000034982615,0.008849241,0.003156713],"study_design_scores_gemma":[0.0007161821,0.00025579764,0.9514514,0.000008698825,0.00004962508,0.00004958064,0.0016162948,0.00010077403,0.00024852145,0.00013586262,0.045306087,0.000061161045],"about_ca_topic_score_codex":0.0066481363,"about_ca_topic_score_gemma":0.0012564746,"teacher_disagreement_score":0.036456846,"about_ca_system_score_codex":0.00070339657,"about_ca_system_score_gemma":0.00045737354,"threshold_uncertainty_score":0.9999667},"labels":[],"label_agreement":null},{"id":"W1606568926","doi":"10.1111/j.1464-410x.2012.10936.x","title":"Higher perioperative morbidity and in‐hospital mortality in patients with end‐stage renal disease undergoing nephrectomy for non‐metastatic kidney cancer: a population‐based analysis","year":2012,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Perioperative; Population; End stage renal disease; Kidney disease; Cohort; Renal replacement therapy; Disease; Surgery; Renal function; Internal medicine; Kidney","score_opus":0.017592882471247694,"score_gpt":0.2789257010233057,"score_spread":0.26133281855205803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1606568926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978773,0.00084272784,0.00021719081,0.00036053086,0.00008850319,0.0004785562,0.00011953899,0.0000033566828,0.000012312154],"genre_scores_gemma":[0.9983727,0.000057607296,0.0009799441,0.00032248104,0.000072848816,0.000041244988,0.00011314655,0.000016382242,0.000023642515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986883,0.00014565044,0.0004394514,0.00018613253,0.000247908,0.0002925615],"domain_scores_gemma":[0.999031,0.000103155435,0.00027467078,0.00010123636,0.00015179628,0.00033815156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025133006,0.00014496381,0.0005491304,0.0003015384,0.000046931687,0.000022587057,0.00004616984,0.000043821048,0.000112701775],"category_scores_gemma":[0.00012574137,0.00013078019,0.000121534766,0.00030079336,0.000062713225,0.00022726112,0.000015212283,0.0002005377,2.3400142e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014243744,0.00079954346,0.9948816,0.00006551524,0.0005079657,0.0004249855,0.000102562044,0.0013543174,0.000009305024,0.0000048617103,0.000023468669,0.00040155902],"study_design_scores_gemma":[0.008452284,0.0009992662,0.9881717,0.00010042145,0.001488605,0.000025995483,0.000017690278,0.0005421836,0.000012854205,0.000010383036,0.00006202438,0.00011657121],"about_ca_topic_score_codex":0.0013312501,"about_ca_topic_score_gemma":0.0019778651,"teacher_disagreement_score":0.0070279096,"about_ca_system_score_codex":0.0002442699,"about_ca_system_score_gemma":0.0002890712,"threshold_uncertainty_score":0.5333061},"labels":[],"label_agreement":null},{"id":"W162776451","doi":"10.1016/s1695-3290(08)35046-0","title":"10.1016/s1695-3290(08)35046-0","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Philosophy; Physics; Medicine; Gynecology","score_opus":0.014351129799664011,"score_gpt":0.1905619845174873,"score_spread":0.17621085471782327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W162776451","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009397747,0.0013332007,1.8770218e-7,0.00032925984,0.000004924614,0.0010638111,0.00008226073,0.00021730414,0.9969596],"genre_scores_gemma":[0.000009013671,0.000006857272,0.00013351704,0.0001200914,0.00072040403,0.00004460517,0.00043534776,0.00022881675,0.9983013],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99768853,0.00001815217,0.00048394216,0.00071293704,0.0006398958,0.00045656963],"domain_scores_gemma":[0.99806577,0.00006829998,0.00013295481,0.0010580609,0.00012477546,0.00055015605],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000101306505,0.00068114285,0.00095418916,0.0003450364,0.00006562332,0.00003166724,0.00021827337,0.0004701961,0.99859923],"category_scores_gemma":[0.0000187305,0.00060176203,0.00042565868,0.000054757547,0.00008172435,0.000038604183,0.000097595286,0.00051561056,0.99858385],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070039916,0.000093351526,5.2199546e-8,0.00009367112,0.00040917908,0.0010820099,0.000016838761,0.0000033292533,0.000033450626,0.000035276327,0.58412284,0.4134096],"study_design_scores_gemma":[0.00090916536,0.0011719327,0.000011990448,0.0004241596,0.0007163259,0.0002754781,2.606891e-7,0.000004340394,0.00012963214,0.00011402534,0.9957383,0.0005043406],"about_ca_topic_score_codex":0.000023783408,"about_ca_topic_score_gemma":2.612513e-7,"teacher_disagreement_score":0.41290525,"about_ca_system_score_codex":0.00041079483,"about_ca_system_score_gemma":0.0001928998,"threshold_uncertainty_score":0.9996434},"labels":[],"label_agreement":null},{"id":"W1634590582","doi":"10.1016/j.urolonc.2015.08.003","title":"The use of prognostic factors in metastatic renal cell carcinoma","year":2015,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Temsirolimus; Medicine; Renal cell carcinoma; Intensive care medicine; Oncology; Systemic therapy; Disease; Internal medicine; Risk stratification; Targeted therapy; Clinical trial; Nephrectomy; Cancer; Discovery and development of mTOR inhibitors; Kidney; Breast cancer","score_opus":0.1859153957915972,"score_gpt":0.3636804763907399,"score_spread":0.17776508059914273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1634590582","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08006108,0.91708577,0.0000021405715,0.00021814388,0.00013149476,0.001652212,0.00006971957,0.000020099807,0.00075934984],"genre_scores_gemma":[0.0015742972,0.98631805,0.01011637,0.00008688411,0.000053399563,0.00033641743,0.0003173749,0.000039637245,0.0011575654],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972509,0.0006447168,0.000925508,0.0004893959,0.00027404912,0.00041541617],"domain_scores_gemma":[0.9960053,0.0024511188,0.0006376891,0.00043392286,0.00012202739,0.0003499622],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005444156,0.00047720168,0.0018978751,0.00032751038,0.00013792855,0.000028296121,0.00017600127,0.00036732692,0.00001501164],"category_scores_gemma":[0.00057839905,0.00026476503,0.00024674047,0.0005258426,0.0010247446,0.000075284865,0.00009723376,0.00070001424,0.000012555816],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004345304,0.0030611388,0.5435447,0.021636594,0.0013372189,0.0061522317,0.0022928368,0.00014080551,0.000024006502,0.004102455,0.029258717,0.38801473],"study_design_scores_gemma":[0.00046202925,0.0027970762,0.00047974312,0.00081166223,0.0033659642,0.00041304698,0.0000732911,0.00003309915,0.000012210221,0.00027446385,0.9910831,0.00019432626],"about_ca_topic_score_codex":0.00014159863,"about_ca_topic_score_gemma":0.00006027288,"teacher_disagreement_score":0.96182436,"about_ca_system_score_codex":0.00040253293,"about_ca_system_score_gemma":0.002131244,"threshold_uncertainty_score":0.99998045},"labels":[],"label_agreement":null},{"id":"W1638591339","doi":"10.1111/j.1464-410x.2012.11776.x","title":"Comparative effectiveness, costs and trends in treatment of small renal masses from 2005 to 2007","year":2013,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"U.S. Department of Defense","keywords":"Nephrectomy; Medicine; Population; Retrospective cohort study; Modalities; Surgery; Urology; Kidney; Internal medicine","score_opus":0.027209957871410166,"score_gpt":0.2836443743146914,"score_spread":0.25643441644328124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1638591339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871608,0.011259303,0.000059007354,0.00039199952,0.00008980023,0.00026644472,0.000019503035,0.000003364658,0.0007497734],"genre_scores_gemma":[0.9974292,0.000610589,0.0016027107,0.000096014126,0.0001141461,0.000018781695,0.000012812859,0.000010695056,0.00010505946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988333,0.0002289777,0.0004185295,0.00017376963,0.0001279658,0.00021746775],"domain_scores_gemma":[0.99907684,0.00028285073,0.0001885592,0.00009298024,0.00014182042,0.00021693383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014074538,0.00013658665,0.0007809781,0.00027120268,0.000017292783,0.000013753864,0.0000527425,0.00008431322,0.00036358967],"category_scores_gemma":[0.000028719154,0.00012228683,0.000094798976,0.00011368651,0.00008335665,0.00005893016,0.000018852574,0.00012546613,0.000011112236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005564841,0.0032392482,0.5655991,0.000040885174,0.0012860497,0.010566096,0.0008995345,0.00024921205,0.032831825,0.00001645937,0.0051094303,0.37459734],"study_design_scores_gemma":[0.0053675715,0.0062434594,0.9763107,0.0001327195,0.00017437356,0.004482289,0.000055875014,0.00003294019,0.005390973,0.00006191573,0.0016687128,0.000078511286],"about_ca_topic_score_codex":0.0033070832,"about_ca_topic_score_gemma":0.0012480798,"teacher_disagreement_score":0.4107116,"about_ca_system_score_codex":0.00021601435,"about_ca_system_score_gemma":0.00005643621,"threshold_uncertainty_score":0.49993426},"labels":[],"label_agreement":null},{"id":"W1694356739","doi":"10.1111/his.12797","title":"Cystic clear cell papillary renal cell carcinoma: is it related to multilocular clear cell cystic neoplasm of low malignant potential?","year":2015,"lang":"en","type":"article","venue":"Histopathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Trillium Health Centre; McGill University Health Centre","funders":"","keywords":"Pathology; Medicine; Neoplasm; Cell; Clear cell; Papillary renal cell carcinomas; Carcinoma; Renal cell carcinoma; Clear cell renal cell carcinoma; Biology","score_opus":0.01598781176205157,"score_gpt":0.2344049316766537,"score_spread":0.2184171199146021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1694356739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98191315,0.0033739367,0.0003707293,0.00058086,0.0007964167,0.0010506604,0.000054509634,0.00008419409,0.011775553],"genre_scores_gemma":[0.9782824,0.000046619807,0.0045864945,0.00087808655,0.000107106054,0.000041030497,0.00010037308,0.00014658051,0.015811322],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953671,0.0005551546,0.0012788589,0.001131843,0.000782658,0.00088436354],"domain_scores_gemma":[0.9965534,0.00011543577,0.0004968737,0.001467577,0.0004843145,0.0008823795],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007721836,0.0006132594,0.0012745179,0.00048694658,0.0001159932,0.000014796442,0.0003624173,0.0005261977,0.00040574122],"category_scores_gemma":[0.0001454792,0.00055286975,0.00043304078,0.00042209076,0.0002785249,0.00006906711,0.00025782475,0.0005444813,0.0026026922],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036892155,0.001973248,0.006379182,0.001220647,0.000031342075,0.034624346,0.00835303,0.0017011532,0.9121427,0.000024370422,0.029588316,0.00027247256],"study_design_scores_gemma":[0.028478416,0.028017472,0.10517164,0.00048574567,0.003490601,0.00972605,0.0033120809,0.0048769424,0.77600443,0.00027585617,0.03764908,0.002511691],"about_ca_topic_score_codex":0.00023795897,"about_ca_topic_score_gemma":0.000006530194,"teacher_disagreement_score":0.13613826,"about_ca_system_score_codex":0.0006574994,"about_ca_system_score_gemma":0.0004911308,"threshold_uncertainty_score":0.99969226},"labels":[],"label_agreement":null},{"id":"W1738783343","doi":"10.1089/end.2014.0878","title":"Selective Versus Hilar Clamping During Minimally Invasive Partial Nephrectomy: A Systematic Review and Meta-Analysis","year":2015,"lang":"en","type":"review","venue":"Journal of Endourology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Renal function; Urology; Surgery; Meta-analysis; Blood transfusion; Body mass index; Internal medicine; Kidney","score_opus":0.15233587955871747,"score_gpt":0.3708591252414362,"score_spread":0.21852324568271875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1738783343","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021876104,0.99669975,0.0000037372617,0.00025693496,0.00011615779,0.0025048412,0.000017095103,0.000012222789,0.00017051176],"genre_scores_gemma":[0.0003681922,0.99831235,0.00038110907,0.00024234605,0.00020555778,0.0002683852,0.000017490682,0.000059360184,0.00014521947],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9943239,0.0017365905,0.0024795048,0.00046027533,0.0005789842,0.00042073178],"domain_scores_gemma":[0.9932686,0.001136368,0.0038804591,0.000524041,0.0007542777,0.00043624127],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0016045857,0.0006845526,0.018015383,0.0009773816,0.0000567515,0.000028640865,0.00025403473,0.00035114115,0.00012719593],"category_scores_gemma":[0.0015134666,0.0004045761,0.004937858,0.00078979315,0.00008512742,0.00009721235,0.00011239403,0.001016728,0.000021729507],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035306075,0.000077273566,0.0000048327074,0.5302018,0.4665001,0.0024975603,0.000060427716,0.0000013793183,0.0000019583429,0.00000503642,0.00014345032,0.00015314316],"study_design_scores_gemma":[0.0015327444,0.00172185,0.0000040353116,0.015140717,0.9608803,0.00784486,0.000014090478,5.0705654e-7,0.000008381748,0.0000053489703,0.0126174735,0.00022970153],"about_ca_topic_score_codex":0.0000062252275,"about_ca_topic_score_gemma":0.000015988355,"teacher_disagreement_score":0.5150611,"about_ca_system_score_codex":0.00055627374,"about_ca_system_score_gemma":0.0011613757,"threshold_uncertainty_score":0.9998406},"labels":[],"label_agreement":null},{"id":"W1742027290","doi":"10.5489/cuaj.1122","title":"Impact of tyrosine kinase inhibitors and cytoreductive nephrectomy in patients with metastatic renal cell carcinoma","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Renal cell carcinoma; Tyrosine kinase; Medicine; Tyrosine-kinase inhibitor; Nephrectomy; Cancer research; Internal medicine; Oncology; Urology; Kidney; Cancer; Receptor","score_opus":0.007857779829934698,"score_gpt":0.2072261582654986,"score_spread":0.1993683784355639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1742027290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99834144,0.0001810962,0.0000022592485,0.00069673266,0.00003685687,0.0004226163,0.000025572364,0.0000041067055,0.00028929627],"genre_scores_gemma":[0.9993701,0.0000047311905,0.0003225623,0.00013504973,0.00006265702,0.000011767392,0.000024825176,0.000012313086,0.000055988763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865234,0.00014456322,0.0003301294,0.00017425542,0.000315915,0.00038277806],"domain_scores_gemma":[0.9984816,0.00008012346,0.00029209687,0.00008434199,0.00038191857,0.00067996193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018885285,0.0001664349,0.00035687687,0.00030292445,0.00006319575,0.00003617632,0.00004631196,0.00009496238,0.00027535873],"category_scores_gemma":[0.00014866286,0.00010599353,0.00009654311,0.00025431038,0.00004963327,0.00014277095,0.000009994682,0.00035450936,0.000008768091],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016091662,0.0001659283,0.9976233,0.0000054345237,0.00007722053,0.0000672465,0.00013709132,0.000029329174,0.00033471495,0.0000023755842,0.00072309934,0.0006733126],"study_design_scores_gemma":[0.0037238414,0.0028496573,0.99272823,0.000014137839,0.000100174955,0.000039010916,0.000042463704,0.000024775392,0.00027269596,0.00006777502,0.000039062066,0.00009816679],"about_ca_topic_score_codex":0.008547566,"about_ca_topic_score_gemma":0.00033089824,"teacher_disagreement_score":0.008216667,"about_ca_system_score_codex":0.001820369,"about_ca_system_score_gemma":0.0004917776,"threshold_uncertainty_score":0.9980546},"labels":[],"label_agreement":null},{"id":"W1748266548","doi":"10.5489/cuaj.2863","title":"Sorafenib treatement for recurrent stage T1 bilateral renal cell carcinoma in patients with Von Hippel- Lindau disease: A case report and literature review","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Sorafenib; Medicine; Renal cell carcinoma; Von Hippel–Lindau disease; Disease; Radiofrequency ablation; Stage (stratigraphy); Renal function; Progressive disease; Clear cell; Internal medicine; Oncology; Radiology; Urology; Ablation; Hepatocellular carcinoma","score_opus":0.019602400104628017,"score_gpt":0.2458027781729068,"score_spread":0.22620037806827878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1748266548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815488,0.010984748,0.0000052985556,0.005756656,0.00012991943,0.0012288176,0.00020671923,0.000010219577,0.00012884213],"genre_scores_gemma":[0.99688375,0.00030366838,0.00018366244,0.0011469282,0.00017243857,0.00006812641,0.00043283857,0.000020208328,0.00078837987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788827,0.0002009355,0.0005716104,0.0003657138,0.00045761137,0.0005158791],"domain_scores_gemma":[0.99697196,0.000053662236,0.00043253475,0.0001797742,0.0006008726,0.0017611695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007926461,0.00025189933,0.0004543519,0.00020931405,0.0001244734,0.00009390533,0.000056890614,0.00015369678,0.000045772773],"category_scores_gemma":[0.00037669786,0.00016716968,0.00011922074,0.00022670897,0.000022946293,0.00012288427,0.00001578888,0.00045071295,0.00000328893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089930254,0.00019108372,0.9016958,0.00017292822,0.000046446257,0.09190237,0.00019379352,0.000008525398,9.544581e-7,0.000005194481,0.003982027,0.0009016058],"study_design_scores_gemma":[0.008106147,0.004042274,0.96422327,0.00062825397,0.00042096703,0.008247193,0.00003867394,0.00008604476,0.000010232783,0.00005672669,0.013854876,0.00028535767],"about_ca_topic_score_codex":0.00028491492,"about_ca_topic_score_gemma":0.00068625435,"teacher_disagreement_score":0.08365517,"about_ca_system_score_codex":0.0023740928,"about_ca_system_score_gemma":0.0008076908,"threshold_uncertainty_score":0.6816982},"labels":[],"label_agreement":null},{"id":"W1749328926","doi":"10.5489/cuaj.288","title":"Laparoscopic partial nephrectomy: The McMaster University","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McMaster University; Queen's University","funders":"","keywords":"Nephrectomy; Medicine; Blood loss; Surgery; Laparoscopy; Renal function; Pathological; Retrospective cohort study; Urology; Kidney; Internal medicine","score_opus":0.015040995213010147,"score_gpt":0.20044508747221637,"score_spread":0.18540409225920623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1749328926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9417654,0.00008795839,0.00001173357,0.04682899,0.00017954946,0.0002789645,0.0000045143875,0.000016294165,0.010826548],"genre_scores_gemma":[0.9876895,0.000018467726,0.00007476117,0.0048668156,0.00034313492,0.0000044452336,0.0000043688046,0.0000057083607,0.0069927783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989674,0.00017434442,0.00014276286,0.00011701328,0.00022696682,0.00037149023],"domain_scores_gemma":[0.9989546,0.000099395664,0.00011150534,0.00008732222,0.00016102096,0.0005861748],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002255452,0.000092575356,0.0001609548,0.00006810805,0.00029370218,0.000078595585,0.000103002014,0.00013187442,0.005709282],"category_scores_gemma":[0.00015570348,0.00005658489,0.0001122417,0.00013804538,0.000033394153,0.000089619156,0.000012939529,0.00042159818,0.0005997537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032597643,0.000030266363,0.9517214,0.0000014748676,0.00012445348,0.00013626026,0.00009891643,0.000012348185,0.00016605888,0.00017264004,0.04340604,0.0040975725],"study_design_scores_gemma":[0.00074764225,0.00016620882,0.72345054,0.0000029808837,0.00006791295,0.0001169588,0.00007671726,0.000073196425,0.00005401242,0.00015774759,0.27503377,0.00005228403],"about_ca_topic_score_codex":0.0026029563,"about_ca_topic_score_gemma":0.00044324918,"teacher_disagreement_score":0.23162775,"about_ca_system_score_codex":0.0012751744,"about_ca_system_score_gemma":0.00030884755,"threshold_uncertainty_score":0.9951996},"labels":[],"label_agreement":null},{"id":"W1755166933","doi":"10.5489/cuaj.2479","title":"Accuracy capabilities comparisons between Karakiewicz, Kattan and Cindolo nomograms in predicting outcomes for renal cancer carcinoma: A systematic review and meta-analysis","year":2015,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Nomogram; Meta-analysis; Medicine; Receiver operating characteristic; Renal cell carcinoma; Oncology; Urology; Internal medicine; Statistics; Mathematics","score_opus":0.16138853891060334,"score_gpt":0.36919833721438344,"score_spread":0.2078097983037801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1755166933","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007735275,0.9897195,0.000013118375,0.004176026,0.00004605854,0.004250928,0.0009582253,0.000016815557,0.00004581339],"genre_scores_gemma":[0.03129197,0.96528274,0.00017908345,0.00093377696,0.00013751135,0.0014001491,0.0003425192,0.000048353937,0.0003838909],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9945467,0.0013193839,0.0022013073,0.00060087367,0.00057284074,0.0007588568],"domain_scores_gemma":[0.99316156,0.00254454,0.002185887,0.00033063098,0.00051339925,0.001264],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037108555,0.000668056,0.011488318,0.00075124705,0.0002304298,0.00016602066,0.00021456034,0.00057246495,0.000090645925],"category_scores_gemma":[0.0032388659,0.00040455195,0.0021210865,0.00068643637,0.00007477356,0.0001115716,0.000047566056,0.0011057454,0.0000025385968],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010594847,0.000064600725,0.59790677,0.25149846,0.14643493,0.00013130208,0.00021265457,0.000004852107,1.1198871e-8,0.000016185999,0.0019448746,0.0017747318],"study_design_scores_gemma":[0.00070057495,0.00027029117,0.023735413,0.0044723134,0.9343199,0.00022410523,0.00007166897,0.000017395538,1.8935394e-8,0.00003273502,0.035764992,0.00039060094],"about_ca_topic_score_codex":0.0041441564,"about_ca_topic_score_gemma":0.005957794,"teacher_disagreement_score":0.78788495,"about_ca_system_score_codex":0.0033746671,"about_ca_system_score_gemma":0.0014593346,"threshold_uncertainty_score":0.9998406},"labels":[],"label_agreement":null},{"id":"W1768901225","doi":"10.2214/ajr.14.13245","title":"Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non–Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma","year":2015,"lang":"en","type":"article","venue":"American Journal of Roentgenology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Women's College Hospital; Mount Sinai Hospital","funders":"","keywords":"Medicine; Renal cell carcinoma; Clear cell; Clear cell renal cell carcinoma; Angiomyolipoma; Pathology; Cell; Urology; Kidney; Internal medicine","score_opus":0.012033301667887434,"score_gpt":0.22961977091576125,"score_spread":0.2175864692478738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1768901225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99252367,0.0026465554,0.000271535,0.00048011387,0.00025277652,0.00046576542,0.00008837174,0.000020624686,0.0032505966],"genre_scores_gemma":[0.99017096,0.00010749445,0.008694547,0.0001710505,0.0005516152,0.000010017045,0.000043532003,0.00011354465,0.000137239],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99524343,0.00048964,0.001630194,0.0008098376,0.00085310877,0.0009737913],"domain_scores_gemma":[0.9954985,0.0003766395,0.0019843094,0.0006688681,0.00047161093,0.0010001088],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005209947,0.0006435328,0.0018802049,0.00066343485,0.0000640556,0.00003213844,0.00053541525,0.00026074715,0.00005110231],"category_scores_gemma":[0.00012277284,0.0005757098,0.0004201897,0.0005790389,0.000910421,0.00018030434,0.000331819,0.0010896587,0.000019711306],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010224474,0.0018133987,0.5406572,0.00023002732,0.00021499083,0.0043870187,0.010801698,0.00035045025,0.42823204,0.0000055955356,0.0021723814,0.00091068126],"study_design_scores_gemma":[0.013836984,0.02561625,0.28773057,0.0002105977,0.001230193,0.0006469035,0.0072269225,0.0012449604,0.66115546,0.00009979815,0.0003707233,0.0006306038],"about_ca_topic_score_codex":0.0026827937,"about_ca_topic_score_gemma":0.000026769154,"teacher_disagreement_score":0.25292665,"about_ca_system_score_codex":0.00065035035,"about_ca_system_score_gemma":0.00058109284,"threshold_uncertainty_score":0.99966943},"labels":[],"label_agreement":null},{"id":"W1768998713","doi":"10.5489/cuaj.962","title":"Can tumour location predict degree of malignancy in small renal masses?","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Malignancy; Degree (music); Medicine; Pathology; Physics","score_opus":0.02660673783514953,"score_gpt":0.2145512864830259,"score_spread":0.18794454864787638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1768998713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816813,0.0002726657,0.000044302276,0.014466471,0.000105877625,0.0003547221,0.000012242743,0.000011468953,0.0030509864],"genre_scores_gemma":[0.9977694,0.000035617246,0.0005993884,0.0008492041,0.00018421302,0.000026101947,0.000026150257,0.00001199632,0.0004979014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983858,0.00017412247,0.0005157723,0.00017869723,0.00029054034,0.00045505664],"domain_scores_gemma":[0.9983343,0.0000979302,0.00034827532,0.00011513021,0.00046192843,0.000642429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046940538,0.00014054839,0.0003145463,0.0003082225,0.00006870855,0.000038218233,0.00010994601,0.00021913768,0.0006418628],"category_scores_gemma":[0.0006238821,0.00011215615,0.00010363811,0.0003258641,0.000026753198,0.00007570241,0.000011214349,0.00044680352,0.000050376744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002374545,0.000064314125,0.9940917,0.00001051342,0.000052315707,0.0001622365,0.00008299614,0.00007870762,0.001150747,0.00010312595,0.0018917909,0.0022878423],"study_design_scores_gemma":[0.0010692128,0.00045915472,0.9954788,0.000051105733,0.000055653112,0.00021952139,0.000060880553,0.00020352616,0.0004344219,0.0011412835,0.0007354653,0.0000909859],"about_ca_topic_score_codex":0.012888194,"about_ca_topic_score_gemma":0.010561171,"teacher_disagreement_score":0.016088165,"about_ca_system_score_codex":0.001980527,"about_ca_system_score_gemma":0.00087452587,"threshold_uncertainty_score":0.99368507},"labels":[],"label_agreement":null},{"id":"W1773664942","doi":"10.5489/cuaj.68","title":"Locally advanced renal cell carcinoma","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Renal cell carcinoma; Cancer research; Medicine; Oncology","score_opus":0.013735638427452236,"score_gpt":0.2177710684729466,"score_spread":0.20403543004549438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1773664942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96896136,0.0011579315,0.000067376655,0.00674799,0.00039922076,0.00019483257,0.000012703788,0.000024213341,0.022434356],"genre_scores_gemma":[0.99233776,0.000022580187,0.0007247207,0.003697712,0.00088691554,0.000009254524,0.000026132297,0.000018034758,0.002276914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980428,0.00014394018,0.00033141443,0.00016172368,0.00043746945,0.00088265905],"domain_scores_gemma":[0.99735385,0.00009432107,0.00021964654,0.00013718905,0.00023139168,0.0019636238],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005611437,0.00017418225,0.00028143483,0.00016767728,0.00022599679,0.000043924247,0.000098027,0.00024437075,0.0010664349],"category_scores_gemma":[0.0002676812,0.00013531272,0.0001929907,0.00018001044,0.000024160905,0.00015152007,0.000014074123,0.0006216747,0.00036221446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008339971,0.00010514763,0.98292446,0.000004570432,0.000044540633,0.00023374059,0.00011428087,0.000021708918,0.0013270604,0.00007622045,0.011566421,0.003498419],"study_design_scores_gemma":[0.0014742328,0.00054554397,0.9179426,0.0000055830083,0.000107544605,0.00059425517,0.000050095543,0.000020567642,0.00116669,0.00008179349,0.07786937,0.00014173663],"about_ca_topic_score_codex":0.00035962483,"about_ca_topic_score_gemma":0.00011429153,"teacher_disagreement_score":0.06630295,"about_ca_system_score_codex":0.0025183223,"about_ca_system_score_gemma":0.00056132855,"threshold_uncertainty_score":0.9998467},"labels":[],"label_agreement":null},{"id":"W1791548917","doi":"10.5489/cuaj.954","title":"Surgical cryoablation as an option for small renal masses in patients who are not ideal partial nephrectomy candidates: intermediate-term outcomes","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cryoablation; Nephrectomy; Medicine; Ideal (ethics); Renal mass; Term (time); Surgery; General surgery; Urology; Kidney; Internal medicine; Philosophy; Ablation; Physics","score_opus":0.02349306307178642,"score_gpt":0.25566043394583804,"score_spread":0.23216737087405162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1791548917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99444336,0.000027426378,0.00003117927,0.0039453045,0.00030365196,0.0009793342,0.000049812355,0.000024890616,0.00019505568],"genre_scores_gemma":[0.9969503,0.000020282054,0.00024151678,0.0015676805,0.00046137985,0.000173559,0.0002882743,0.000022923914,0.0002740748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976166,0.00027064246,0.0006563584,0.00033612683,0.00043233123,0.00068797515],"domain_scores_gemma":[0.99768746,0.00025766474,0.00046303868,0.000136361,0.00044114853,0.0010143078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000503405,0.0002487057,0.00053248205,0.00032779571,0.00018915732,0.00019741566,0.00013037588,0.00036272014,0.000569117],"category_scores_gemma":[0.0007200325,0.0001927553,0.00020113491,0.00015032162,0.000032891894,0.000319257,0.000017583821,0.00048706346,0.000077560006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000369051,0.00015996184,0.99496996,0.000007002922,0.00007681566,0.00009968135,0.00009624593,0.000039417584,0.000024558134,0.00004825527,0.000698772,0.0034102516],"study_design_scores_gemma":[0.0050048335,0.0012938952,0.9878921,0.00003381733,0.000080709695,0.000040745985,0.00004252161,0.000692185,0.000084795705,0.00036778802,0.004276975,0.00018966998],"about_ca_topic_score_codex":0.0030912517,"about_ca_topic_score_gemma":0.0029085292,"teacher_disagreement_score":0.007077924,"about_ca_system_score_codex":0.0023157068,"about_ca_system_score_gemma":0.00036231027,"threshold_uncertainty_score":0.7860333},"labels":[],"label_agreement":null},{"id":"W1819753364","doi":"10.1111/j.1442-2042.2012.03006.x","title":"Overall mortality after radical nephrectomy in patients aged over 80 years with renal cancer: A retrospective study on preoperative prognostic factors","year":2012,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Nephrectomy; Comorbidity; Charlson comorbidity index; Renal cell carcinoma; Retrospective cohort study; Cancer; Internal medicine; Stage (stratigraphy); Kidney cancer; Body mass index; Perioperative; Multivariate analysis; Etiology; Nephrology; Surgery; Kidney","score_opus":0.018340057660703197,"score_gpt":0.3006257681445619,"score_spread":0.2822857104838587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1819753364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99863493,0.00010808009,0.0000090226395,0.00017034818,0.0004268195,0.00051118154,0.000017776776,0.0000057139787,0.00011614982],"genre_scores_gemma":[0.9992172,0.000007728057,0.000047267302,0.00034657566,0.0002938823,0.000035588422,0.000009387073,0.000017729088,0.000024650044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998186,0.00019236848,0.00039621763,0.00018153888,0.0008123483,0.00023151223],"domain_scores_gemma":[0.99912435,0.00008369375,0.00026184798,0.000109124005,0.0002642508,0.00015674805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020127313,0.00017290894,0.00036497615,0.0002649199,0.000013488444,0.0000144356045,0.00012146185,0.00007010905,0.00023876528],"category_scores_gemma":[0.00012417875,0.0001157782,0.00009306882,0.000082604805,0.00007620782,0.0001793874,0.00003723133,0.00048127552,0.0000045692555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071455687,0.0028108677,0.9855433,0.000002074202,0.0009484426,0.00082050444,0.002454757,0.000048261074,0.000056283006,0.0000133404665,0.00007058281,0.00008600002],"study_design_scores_gemma":[0.0074716723,0.006341845,0.9855168,0.0000480886,0.00020688634,0.000064386215,0.000052511645,0.0000062627314,0.00010484073,0.000019151687,0.000076818505,0.00009072251],"about_ca_topic_score_codex":0.00013261885,"about_ca_topic_score_gemma":0.00011259604,"teacher_disagreement_score":0.003530977,"about_ca_system_score_codex":0.00069017016,"about_ca_system_score_gemma":0.00012831004,"threshold_uncertainty_score":0.47212982},"labels":[],"label_agreement":null},{"id":"W1821339412","doi":"10.1186/s40064-015-1385-9","title":"The growth rate of “clinically significant” renal cancer","year":2015,"lang":"en","type":"article","venue":"SpringerPlus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Kidney cancer; Cancer; Urology; Kidney; Renal tumor; Renal cell carcinoma; Internal medicine; Radiology; Nephrectomy","score_opus":0.05528714593328261,"score_gpt":0.31833708260753224,"score_spread":0.26304993667424964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1821339412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98200136,0.00099525,0.00005718639,0.0022583273,0.00031846386,0.00031154268,0.000004314475,0.000037101487,0.014016449],"genre_scores_gemma":[0.9966233,0.00021853583,0.00037932856,0.0001359324,0.00022352429,0.000036583704,0.000002237644,0.000020420053,0.0023601803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881464,0.00007069262,0.00041324753,0.00020354977,0.00026457087,0.00023331576],"domain_scores_gemma":[0.99877286,0.00017944639,0.00016501457,0.0003779218,0.00027733445,0.00022739543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007082192,0.0001235139,0.0002642849,0.00003588358,0.00004612068,0.0000125301,0.00013341504,0.000054620843,0.000034034765],"category_scores_gemma":[0.00037387176,0.00007219734,0.000116421514,0.00013536653,0.00014989966,0.00002572026,0.00006053576,0.00015215733,0.000059830465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012517707,0.0010222483,0.72267246,0.00037679952,0.001734512,0.0011685167,0.0024276015,0.00026781386,0.17645591,0.00899924,0.029070864,0.043286342],"study_design_scores_gemma":[0.016253276,0.0046006176,0.5169289,0.0005372194,0.0010556648,0.00008678914,0.00053599704,0.0007518298,0.41325128,0.0038396171,0.041465487,0.0006933388],"about_ca_topic_score_codex":0.0004734433,"about_ca_topic_score_gemma":0.000024700938,"teacher_disagreement_score":0.23679537,"about_ca_system_score_codex":0.00014446156,"about_ca_system_score_gemma":0.00042651573,"threshold_uncertainty_score":0.2944122},"labels":[],"label_agreement":null},{"id":"W1831040360","doi":"10.1111/j.1464-410x.2011.10254.x","title":"How often are patients with diabetes or hypertension being treated with partial nephrectomy for renal cell carcinoma? A population‐based analysis","year":2011,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Nephrectomy; Renal cell carcinoma; Medicine; Diabetes mellitus; Urology; Internal medicine; Kidney; Endocrinology","score_opus":0.01993616744501494,"score_gpt":0.2016420076012177,"score_spread":0.18170584015620275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1831040360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982916,0.0003233404,0.0005588129,0.00019850167,0.000034237906,0.00051542977,0.00002667344,0.000016450878,0.000034937224],"genre_scores_gemma":[0.9936601,0.0000048938264,0.0055838944,0.00037006426,0.00010129386,0.000036775185,0.00012956014,0.000041347725,0.000072082556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984698,0.00012223361,0.00040871324,0.0002885546,0.00033809687,0.0003725937],"domain_scores_gemma":[0.99812454,0.00010726216,0.0006267505,0.00018840312,0.00071181497,0.00024120597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013307027,0.00022070525,0.000831261,0.0003936881,0.00010557187,0.000036303692,0.00009454768,0.00011964218,0.000052301173],"category_scores_gemma":[0.0000734978,0.00015159177,0.00025064862,0.00041406625,0.000066935216,0.0001424041,0.000013897767,0.00019919824,5.785313e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070615336,0.000615534,0.98671293,0.000040438023,0.0008078052,0.0021951064,0.000032323394,0.000083481784,0.00019122889,4.102613e-7,0.00011056739,0.0021486345],"study_design_scores_gemma":[0.011396092,0.009613617,0.9683731,0.00008089941,0.0064833118,0.00053288037,0.000023378292,0.00046029073,0.0027308224,0.000006094107,0.00012994555,0.0001695609],"about_ca_topic_score_codex":0.00018429772,"about_ca_topic_score_gemma":0.00020945923,"teacher_disagreement_score":0.01833983,"about_ca_system_score_codex":0.000086694425,"about_ca_system_score_gemma":0.00010490034,"threshold_uncertainty_score":0.6181733},"labels":[],"label_agreement":null},{"id":"W1832040166","doi":"","title":"Novelizovaná klasifikace nádorů ledvin 2013 (International Society of Urological Pathology Vancouver Classification of Renal Neoplasia)","year":2014,"lang":"cs","type":"article","venue":"Česká urologie","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.043944162687887985,"score_gpt":0.279249184587283,"score_spread":0.235305021899395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1832040166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9603115,0.0014048158,0.007279073,0.006839641,0.0028668868,0.0009398879,0.00014048631,0.00011568806,0.02010202],"genre_scores_gemma":[0.99030215,0.0010418757,0.00460928,0.00092743826,0.00064256275,0.00005316421,0.00015615737,0.000054792465,0.0022126099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953727,0.0004447618,0.0014346674,0.0010518649,0.0009390637,0.0007569081],"domain_scores_gemma":[0.99584264,0.00095587847,0.0011747614,0.0011187633,0.00066077727,0.00024719123],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012253559,0.00057789613,0.0012162895,0.00019917282,0.00008797881,0.000016518234,0.00068048516,0.0009817193,0.00068615313],"category_scores_gemma":[0.00075377425,0.00048123853,0.00074359926,0.00032451798,0.0009879847,0.00013334608,0.0003372594,0.0007602123,0.0002061868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057859663,0.0052755526,0.3754248,0.00075435016,0.0021244348,0.0002544476,0.0012557696,0.0025551436,0.2697605,0.0038047517,0.29936928,0.03363502],"study_design_scores_gemma":[0.010428796,0.0106799975,0.78514796,0.00016888553,0.0015188301,0.00021223031,0.0005648936,0.036018554,0.025445882,0.0013866303,0.12760638,0.00082094735],"about_ca_topic_score_codex":0.00009843517,"about_ca_topic_score_gemma":0.00006993383,"teacher_disagreement_score":0.40972316,"about_ca_system_score_codex":0.0002946628,"about_ca_system_score_gemma":0.00035901877,"threshold_uncertainty_score":0.9997639},"labels":[],"label_agreement":null},{"id":"W1836606401","doi":"10.1016/j.eururo.2015.06.037","title":"Personalized Medicine in Kidney Cancer: Learning How to Walk Before We Run","year":2015,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Renal cell carcinoma; Radiogenomics; Clear cell renal cell carcinoma; Kidney cancer; Metastasis; Oncology; Internal medicine; Personalized medicine; Cancer; Gene signature; Pathology; Bioinformatics; Gene expression; Gene; Radiology","score_opus":0.035113287264943366,"score_gpt":0.2735569426563131,"score_spread":0.23844365539136972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1836606401","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012126414,0.004133543,0.000010382066,0.94018996,0.0008799201,0.0007929839,0.000026389109,0.00015080694,0.04168958],"genre_scores_gemma":[0.037554134,0.00038079088,0.00015591757,0.8451104,0.010689282,0.000054313598,0.0010620859,0.0003483484,0.10464471],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99561864,0.0012884671,0.0004934431,0.0010375014,0.00067123346,0.0008906969],"domain_scores_gemma":[0.99812907,0.00012741097,0.00026181067,0.0006825861,0.00020001915,0.00059907744],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007364559,0.0006666152,0.0013384955,0.00070278073,0.000058609756,0.000017732538,0.00037525847,0.00044688082,0.0011201894],"category_scores_gemma":[0.0008805361,0.0005130278,0.00017755313,0.00034818792,0.00027630248,0.00003340623,0.00022563984,0.003193257,0.0008241763],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036427137,0.000029706918,0.0039222827,0.00024177818,0.00018162046,0.02578303,0.0031053792,0.000010254505,0.00026329976,0.000005804312,0.9624601,0.0036324433],"study_design_scores_gemma":[0.0041547217,0.0035516645,0.0052148737,0.0004257391,0.00044481098,0.00067201164,0.00008746409,0.000021218422,0.000009824591,0.000017357454,0.98507303,0.00032727723],"about_ca_topic_score_codex":0.00029148645,"about_ca_topic_score_gemma":0.00004508755,"teacher_disagreement_score":0.09507956,"about_ca_system_score_codex":0.00056985265,"about_ca_system_score_gemma":0.00037406266,"threshold_uncertainty_score":0.9999538},"labels":[],"label_agreement":null},{"id":"W1838178069","doi":"10.3978/j.issn.2223-4683.2012.05.07","title":"Modifying sunitinib schedule in advanced kidney cancer patients: Reflections from the results of the renal EFFECT trial.","year":2012,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Sunitinib; Kidney cancer; Medicine; Schedule; Cancer; Kidney; Urology; Intensive care medicine; Internal medicine; Oncology; Computer science","score_opus":0.06335206257916084,"score_gpt":0.30671014862928997,"score_spread":0.24335808605012912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1838178069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98991644,0.00058022665,0.0000016733978,0.0012677007,0.0007511234,0.0029115672,0.000103130085,0.000019248902,0.004448908],"genre_scores_gemma":[0.99573,0.000032425778,0.000060427607,0.0003100945,0.0003233681,0.0031365405,0.000052107356,0.000018596844,0.0003364742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846417,0.0003058843,0.00035576167,0.00018525287,0.00031582557,0.0003730905],"domain_scores_gemma":[0.9986954,0.0004274283,0.00018408854,0.00045487762,0.00007039796,0.00016783367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056287996,0.00014042745,0.00026180065,0.00005413871,0.000085687076,0.000008247863,0.00012676472,0.00006505303,0.00001575078],"category_scores_gemma":[0.001712857,0.00007089855,0.00012678686,0.0003585898,0.00006484489,0.000096178774,0.000058914367,0.00024528973,0.0000034382685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.089043744,0.0023527874,0.7663057,0.00012338923,0.000572257,0.000006257325,0.0029723903,0.00012129129,0.0050768144,0.00006326172,0.004014647,0.12934746],"study_design_scores_gemma":[0.045008283,0.00017218641,0.9058636,0.00011457781,0.00018155895,9.618707e-7,0.000046095218,0.0000056591,0.0442773,0.000016742715,0.004236776,0.000076281314],"about_ca_topic_score_codex":0.0012193276,"about_ca_topic_score_gemma":0.00023914191,"teacher_disagreement_score":0.13955787,"about_ca_system_score_codex":0.00030251805,"about_ca_system_score_gemma":0.0000737352,"threshold_uncertainty_score":0.28911594},"labels":[],"label_agreement":null},{"id":"W1841658160","doi":"10.5489/cuaj.362","title":"Importance of patient compliance in small renal mass active","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Compliance (psychology); Renal mass; Medicine; Intensive care medicine; Psychology; Internal medicine; Kidney; Social psychology","score_opus":0.026528057963377455,"score_gpt":0.2265098669126814,"score_spread":0.19998180894930395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1841658160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888339,0.00013748721,0.000013335802,0.006965119,0.000078010344,0.0002804687,0.000011667177,0.0000058078926,0.0036742156],"genre_scores_gemma":[0.99741614,0.00001952118,0.0007187444,0.0015607662,0.00007194606,0.000018267647,0.00001055262,0.000007357503,0.00017673102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987361,0.00010684416,0.0004084298,0.00015200996,0.00021972778,0.00037688788],"domain_scores_gemma":[0.99865526,0.00009354454,0.00035708488,0.00009876397,0.00029430457,0.0005010459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019092891,0.00011052775,0.00028712518,0.00014681966,0.00005280186,0.000019653931,0.00007597696,0.00012777603,0.0007033102],"category_scores_gemma":[0.00031736758,0.000086354645,0.00010115089,0.00018094368,0.000026439522,0.000065953325,0.000007818902,0.00042880853,0.000055103348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004752237,0.00005755058,0.9919659,0.000004452937,0.000055075612,0.00018896187,0.000119473894,0.0000464739,0.0010637345,0.000040342846,0.0011422177,0.0052683153],"study_design_scores_gemma":[0.00074062374,0.00045156231,0.995468,0.00002650572,0.000022131293,0.000093379866,0.00008361855,0.00013865111,0.0005557974,0.0012412264,0.0011014596,0.00007703464],"about_ca_topic_score_codex":0.0026099957,"about_ca_topic_score_gemma":0.0020981038,"teacher_disagreement_score":0.008582225,"about_ca_system_score_codex":0.0018839268,"about_ca_system_score_gemma":0.00032445468,"threshold_uncertainty_score":0.7700753},"labels":[],"label_agreement":null},{"id":"W1843618509","doi":"10.5489/cuaj.62","title":"Summary of the first annual Genitourinary Medical Oncology Conference Renal Cell Carcinoma Forum","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Ottawa Regional Cancer Foundation; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Genitourinary system; Renal cell carcinoma; Medicine; Oncology; Internal medicine; General surgery; Urology; Medical physics","score_opus":0.018122255456315694,"score_gpt":0.23555906114117925,"score_spread":0.21743680568486357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1843618509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92912686,0.0009296054,0.000011053799,0.05599381,0.0006345355,0.00022088573,0.00004811517,0.000009826853,0.013025305],"genre_scores_gemma":[0.99356455,0.000045151555,0.00009470272,0.004541621,0.0008038703,0.000009407312,0.000012426308,0.000012877959,0.0009153838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749815,0.0002722066,0.00049308117,0.00015948658,0.0007893229,0.00078774476],"domain_scores_gemma":[0.99738777,0.00023281689,0.00041237008,0.00018553213,0.00034859113,0.0014329256],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00090128375,0.000174774,0.000386772,0.00012658416,0.0002924357,0.000015351381,0.00027775878,0.00050183624,0.0012774527],"category_scores_gemma":[0.0004986323,0.000110671404,0.0002655321,0.00019028716,0.00011597829,0.00010579888,0.00007379106,0.00097393285,0.000041851436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000852326,0.00019778976,0.94620925,0.000008571794,0.000057794896,0.00024100074,0.00026338222,0.0000027903154,0.00008856109,0.00010616377,0.05174058,0.0009989083],"study_design_scores_gemma":[0.0011380479,0.000796615,0.8588027,0.000015159418,0.00012554006,0.0012315325,0.00022204216,0.000027528127,0.00044931768,0.00008675225,0.13700582,0.0000989386],"about_ca_topic_score_codex":0.0011191478,"about_ca_topic_score_gemma":0.0014520079,"teacher_disagreement_score":0.08740652,"about_ca_system_score_codex":0.001946054,"about_ca_system_score_gemma":0.00206107,"threshold_uncertainty_score":0.9996355},"labels":[],"label_agreement":null},{"id":"W1855090231","doi":"10.5489/cuaj.65","title":"Current status of cytokine therapy in management of patients with metastatic renal cell carcinoma","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Renal cell carcinoma; Medicine; Cytokine; Angiogenesis; Population; Oncology; Toxicity; Immunotherapy; Internal medicine; Immunology; Cancer","score_opus":0.02041494601833634,"score_gpt":0.23583732655008818,"score_spread":0.21542238053175183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1855090231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968739,0.0015689877,0.0000176053,0.00020769825,0.000091430826,0.00035284075,0.0000524772,0.0000028675718,0.00083220174],"genre_scores_gemma":[0.9989899,0.00027461964,0.000509362,0.00008228148,0.00003934298,0.000009443521,0.000044382865,0.000010716066,0.00003997867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981962,0.00015013249,0.000439893,0.00011708245,0.0005060713,0.0005906161],"domain_scores_gemma":[0.9985427,0.00005688364,0.00042373166,0.000110920686,0.00023409806,0.0006316401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037727118,0.00013859375,0.00034606722,0.00025520657,0.000035898058,0.000007208327,0.00006755071,0.000055197397,0.00025749666],"category_scores_gemma":[0.00003255455,0.00009290868,0.00009252105,0.0002646818,0.00002729805,0.00007553123,0.000010477655,0.00027472552,0.0000054096677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028032702,0.000539848,0.99389535,0.000033936612,0.00010683033,0.000034219458,0.00017749192,0.000026043112,0.000045397675,0.000038186485,0.00017901194,0.0046433476],"study_design_scores_gemma":[0.0042791753,0.001172915,0.9905873,0.000026944137,0.0001275828,0.000006764054,0.00005954004,0.000005738106,0.00046337987,0.000030797888,0.0031607572,0.00007912303],"about_ca_topic_score_codex":0.0006215948,"about_ca_topic_score_gemma":0.00009111549,"teacher_disagreement_score":0.0045642243,"about_ca_system_score_codex":0.0012336051,"about_ca_system_score_gemma":0.0002285609,"threshold_uncertainty_score":0.3788706},"labels":[],"label_agreement":null},{"id":"W1855839624","doi":"10.5858/2003-127-0593-iaivut","title":"Interobserver and Intraobserver Variability Using the Fuhrman Grading System for Renal Cell Carcinoma","year":2003,"lang":"en","type":"article","venue":"Archives of Pathology & Laboratory Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Grading (engineering); Renal cell carcinoma; Carcinoma; Nuclear medicine; Tumor grade; Radiology; Predictive value; Pathology; Internal medicine; Immunohistochemistry","score_opus":0.030344685171302024,"score_gpt":0.26552032527854463,"score_spread":0.23517564010724262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1855839624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929348,0.0017606653,0.0022540789,0.0002836434,0.0002860851,0.00085200305,0.000038551985,0.000029896108,0.0015602458],"genre_scores_gemma":[0.9925357,0.000021685391,0.0069382605,0.00020270057,0.00015079335,0.00004229384,0.00002390566,0.00003436725,0.000050275445],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977433,0.000674855,0.0005757378,0.0004718699,0.00018558525,0.00034865324],"domain_scores_gemma":[0.99794513,0.00083697215,0.0002569259,0.00062965235,0.00014342062,0.00018790568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011413269,0.0002768658,0.00068092794,0.00014327212,0.00014375435,0.000004670651,0.00013888068,0.000099789635,0.000015983745],"category_scores_gemma":[0.00033709442,0.000172849,0.00010303417,0.00020202146,0.0010012102,0.000055599467,0.000057148238,0.0002506497,6.244363e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055519375,0.00017092282,0.21424718,0.0016522441,0.0001362981,0.00045379714,0.004703537,0.000012010554,0.77116483,0.0063716313,0.00011111544,0.00042125955],"study_design_scores_gemma":[0.01570512,0.006021697,0.4448907,0.00120911,0.0028747888,0.0020082425,0.006868791,0.0013424497,0.5141891,0.0016484866,0.0026024054,0.0006390805],"about_ca_topic_score_codex":0.000028062379,"about_ca_topic_score_gemma":0.000006321302,"teacher_disagreement_score":0.2569757,"about_ca_system_score_codex":0.000086028645,"about_ca_system_score_gemma":0.0001842516,"threshold_uncertainty_score":0.70485777},"labels":[],"label_agreement":null},{"id":"W1858153778","doi":"","title":"A retrospective analysis of two different sequences of therapy lines for advanced kidney cancer.","year":2013,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Sorafenib; Sunitinib; Medicine; Internal medicine; Oncology; Kidney cancer; Cancer; Urology; Hepatocellular carcinoma","score_opus":0.036507690509741376,"score_gpt":0.29556113105664045,"score_spread":0.25905344054689905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1858153778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528766,0.0013876321,0.00006551151,0.0007045316,0.00007737961,0.0020744172,0.00008119663,0.00001656041,0.00030511926],"genre_scores_gemma":[0.99243855,0.0004287022,0.00038029594,0.00010917629,0.000056533252,0.0060955225,0.0000366036,0.000012747653,0.00044188835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990094,0.000022563372,0.00029813967,0.00022386537,0.0002262283,0.0002198542],"domain_scores_gemma":[0.998971,0.000059987036,0.00022291957,0.00025272457,0.0003328224,0.00016056764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007559036,0.00013647618,0.000642292,0.00018998662,0.00001754597,0.000004955112,0.00007316409,0.000034221663,0.00010734255],"category_scores_gemma":[0.000087219036,0.0000870607,0.00029496104,0.00038071547,0.00007481086,0.00004948468,0.000012603603,0.000041924774,4.3952824e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043363843,0.00035538047,0.8541518,0.00011259011,0.0035824892,0.0000016990298,0.00030534115,0.00007388986,0.057462007,0.000088356835,0.00018931531,0.0832435],"study_design_scores_gemma":[0.0018558899,0.00018807688,0.77438736,0.000016771937,0.00087000284,4.1028662e-7,0.000034577046,0.00017710001,0.22218627,0.0001877766,0.000036263602,0.000059522612],"about_ca_topic_score_codex":0.000704239,"about_ca_topic_score_gemma":0.000071569026,"teacher_disagreement_score":0.16472426,"about_ca_system_score_codex":0.00016871936,"about_ca_system_score_gemma":0.00004586102,"threshold_uncertainty_score":0.3550232},"labels":[],"label_agreement":null},{"id":"W1859889471","doi":"10.5489/cuaj.2846","title":"Renal vein leiomyosarcoma and renal cell carcinoma presenting together: A case report and discussion on the follow up.","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Renal vein; Leiomyosarcoma; Confusion; Radiological weapon; Radiology; Perioperative; Surgery; General surgery; Kidney; Internal medicine","score_opus":0.03311510583726541,"score_gpt":0.24224240784555337,"score_spread":0.20912730200828797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1859889471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9587416,0.00036493482,0.000010748917,0.037197717,0.00016804619,0.00028770708,0.000010623303,0.00001393859,0.0032046894],"genre_scores_gemma":[0.99499524,0.000009615303,0.0001270663,0.0010929032,0.0003939223,0.000012324109,0.000013140552,0.000016658705,0.0033391367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796826,0.0003759321,0.00038658292,0.0003003987,0.0004953613,0.00047346725],"domain_scores_gemma":[0.9977916,0.00021918045,0.00032841662,0.00018887725,0.00021390527,0.0012580552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014764821,0.00019664325,0.00028412548,0.00014001098,0.00044224988,0.00015311163,0.00007225158,0.00020145897,0.00007602364],"category_scores_gemma":[0.0010576104,0.00009922508,0.00010717055,0.0001418111,0.00005999188,0.00008389508,0.00004168487,0.0006613663,0.000009726834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021855236,0.00006757261,0.8625482,0.000006726142,0.000092641654,0.114542015,0.001046381,0.000009643878,0.00059401715,0.00006779342,0.01891547,0.001891045],"study_design_scores_gemma":[0.005473896,0.0023633747,0.70849335,0.000045961056,0.0004169693,0.24513994,0.0014027245,0.0006499239,0.0012801724,0.0015317486,0.032793596,0.00040832104],"about_ca_topic_score_codex":0.0018306277,"about_ca_topic_score_gemma":0.00097154226,"teacher_disagreement_score":0.15405478,"about_ca_system_score_codex":0.0008051898,"about_ca_system_score_gemma":0.00046072932,"threshold_uncertainty_score":0.40462813},"labels":[],"label_agreement":null},{"id":"W1863330379","doi":"10.5489/cuaj.984","title":"Renal mucinous tubular and spindle cell carcinoma","year":2008,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cytokeratin; Pathology; Stroma; Cuboidal Cell; Metastasis; Spindle cell carcinoma; Carcinoma; Mucinous carcinoma; Papillary renal cell carcinomas; Epithelium; Biology; Anatomy; Immunohistochemistry; Medicine; Adenocarcinoma; Cancer; Internal medicine","score_opus":0.01666472354326441,"score_gpt":0.20095114890217275,"score_spread":0.18428642535890835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1863330379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98496544,0.0011742387,0.000014099651,0.006397762,0.00013068874,0.00016957354,0.00001027872,0.000018679562,0.007119218],"genre_scores_gemma":[0.99476075,0.0001114222,0.00036390295,0.0024065431,0.00042052774,0.0000051332963,0.000014093101,0.00001489607,0.001902739],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844897,0.000115352836,0.00029737622,0.00022959124,0.0003765593,0.0005321534],"domain_scores_gemma":[0.99819344,0.00006702797,0.00016806583,0.00012217494,0.00019574583,0.0012535723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030225792,0.0001663997,0.00030224922,0.00018608684,0.00041379177,0.0000385691,0.00007245337,0.00023846734,0.00045382432],"category_scores_gemma":[0.00019003896,0.000132185,0.0001297309,0.00014332919,0.00005191627,0.00006834947,0.00001527099,0.00055912806,0.000090040565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044654575,0.00005803951,0.9869123,0.000004452415,0.00004054212,0.003269239,0.00017174608,0.000007252685,0.00085458584,0.000020943176,0.008199892,0.00041637127],"study_design_scores_gemma":[0.0015146111,0.0008552574,0.96917665,0.00000421183,0.00008778496,0.005688413,0.000029773968,0.000050064715,0.00072579616,0.00010374236,0.021632329,0.00013136066],"about_ca_topic_score_codex":0.001423836,"about_ca_topic_score_gemma":0.00017950108,"teacher_disagreement_score":0.017735625,"about_ca_system_score_codex":0.001229194,"about_ca_system_score_gemma":0.00062058034,"threshold_uncertainty_score":0.5390348},"labels":[],"label_agreement":null},{"id":"W1863626987","doi":"10.5114/pg.2015.49000","title":"Renal cell carcinoma metastases to the pancreas and the thyroid gland 19 years after the primary tumour","year":2015,"lang":"en","type":"article","venue":"Gastroenterology Review","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Thyroid; Pancreas; Renal cell carcinoma; Pathology; Internal medicine; Carcinoma; Gastroenterology","score_opus":0.01974453096290362,"score_gpt":0.2448954130454148,"score_spread":0.22515088208251116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1863626987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7076317,0.26116502,0.000022785087,0.029003754,0.00008148734,0.001526829,0.000021653463,0.0000139651565,0.00053278735],"genre_scores_gemma":[0.9394387,0.012100708,0.00024010298,0.04704228,0.00020959409,0.0004936324,0.000030626186,0.000025101239,0.00041928014],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99766916,0.0009481965,0.0003635779,0.0003303699,0.00029549378,0.00039322232],"domain_scores_gemma":[0.998647,0.00014236104,0.00013077781,0.0007352543,0.00007357626,0.00027104383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014604,0.00024960955,0.0006594284,0.000034024717,0.000075917254,0.000023903272,0.00026000047,0.000033627457,0.00004507416],"category_scores_gemma":[0.00010526415,0.000096822514,0.0002045544,0.000112073016,0.00031447582,0.000032756565,0.00024274248,0.0002734372,0.000116242525],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020363964,0.00041533817,0.46902648,0.0020861807,0.00070914737,0.0018404988,0.0017424794,0.00000763399,0.0005718641,0.00006705361,0.49594414,0.007225215],"study_design_scores_gemma":[0.008559857,0.0028287382,0.7732886,0.00057662977,0.0034018226,0.006462735,0.00011844779,0.0000046472205,0.000087696964,0.00004985696,0.204461,0.00015995659],"about_ca_topic_score_codex":0.000106457665,"about_ca_topic_score_gemma":0.000065475564,"teacher_disagreement_score":0.30426213,"about_ca_system_score_codex":0.00006811628,"about_ca_system_score_gemma":0.000075201795,"threshold_uncertainty_score":0.39483073},"labels":[],"label_agreement":null},{"id":"W1864023954","doi":"10.5489/cuaj.34","title":"Interleukin-2 in the treatment of unresectable or metastatic renal cell cancer: a systematic review and practice guideline","year":2012,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Ottawa Regional Cancer Foundation; Cancer Care Ontario; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Renal cell carcinoma; Nausea; Alpha interferon; Randomized controlled trial; Progression-free survival; Gastroenterology; Chemotherapy; Interferon; Immunology","score_opus":0.09133601096097894,"score_gpt":0.36113603202997163,"score_spread":0.2698000210689927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1864023954","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023866773,0.9909514,0.0000031832822,0.0053402884,0.000087203705,0.002914999,0.00008841343,0.000004411622,0.00058624096],"genre_scores_gemma":[0.0002073681,0.99538136,0.00027673497,0.0028193563,0.00015654073,0.00039939553,0.000061061124,0.000024442008,0.0006737704],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99435854,0.0026213662,0.0017633835,0.00024307317,0.0004952616,0.00051839475],"domain_scores_gemma":[0.994561,0.0022431335,0.0020806538,0.00028046363,0.00033370903,0.0005009982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032048714,0.00039787893,0.0032088251,0.00029241788,0.00009078452,0.000054325526,0.00019570957,0.00022273368,0.00037848245],"category_scores_gemma":[0.0020542364,0.00017589581,0.00045472404,0.00048268624,0.00003104626,0.00009114205,0.0000121817675,0.0005607752,0.000019233807],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023582268,0.001970139,0.00082012056,0.8410682,0.00620085,0.0038494912,0.0013478477,0.0000034912023,8.9785317e-7,0.000040726256,0.019128727,0.1253337],"study_design_scores_gemma":[0.0007200151,0.00146038,0.000046228222,0.044493042,0.0370161,0.003546163,0.0001016627,0.0000019877345,2.6782723e-7,0.0000063371226,0.9124442,0.00016362297],"about_ca_topic_score_codex":0.002802708,"about_ca_topic_score_gemma":0.001866701,"teacher_disagreement_score":0.8933155,"about_ca_system_score_codex":0.0043961285,"about_ca_system_score_gemma":0.0018069409,"threshold_uncertainty_score":0.9994258},"labels":[],"label_agreement":null},{"id":"W1864597007","doi":"10.5489/cuaj.36","title":"Interleukin-2 in the treatment of unresectable or metastatic renal cell cancer: Time to write the obituary?","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Oncology; Immunotherapy; Placebo; Cancer; Alpha interferon; Toxicity; Renal cell carcinoma; Interferon; Gastroenterology; Immunology; Pathology","score_opus":0.030385093465788417,"score_gpt":0.2659303846803989,"score_spread":0.2355452912146105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1864597007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96769357,0.0015954534,0.0000070465235,0.026977073,0.000113321155,0.0005587902,0.000038286376,0.0000051145294,0.0030113582],"genre_scores_gemma":[0.9923326,0.00016214038,0.00011109646,0.0032935643,0.00028142481,0.0000638673,0.000009691167,0.000009842076,0.003735789],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981651,0.0004190345,0.00036520878,0.00011938089,0.0003721264,0.00055920775],"domain_scores_gemma":[0.99858475,0.00046848954,0.00020027815,0.00016155883,0.0001092565,0.00047566352],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008595975,0.00015051631,0.00031910778,0.0001566348,0.00013913168,0.000039649407,0.00016154104,0.0000744957,0.001999415],"category_scores_gemma":[0.00017609174,0.00006501772,0.00014747992,0.000357078,0.00002646652,0.00007813105,0.000008222243,0.00026471957,0.00014784743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012152625,0.0017684957,0.9045019,0.000020706711,0.0007545785,0.00073354726,0.011087071,0.00050574844,0.0026485433,0.00008382097,0.057113715,0.0195666],"study_design_scores_gemma":[0.0025374303,0.0044375476,0.7083208,0.000032587857,0.00046927924,0.00034357418,0.0005947857,0.00009767706,0.0012074241,0.000078806544,0.28171712,0.00016300328],"about_ca_topic_score_codex":0.004792861,"about_ca_topic_score_gemma":0.0038552308,"teacher_disagreement_score":0.2246034,"about_ca_system_score_codex":0.002510379,"about_ca_system_score_gemma":0.0004777217,"threshold_uncertainty_score":0.9989129},"labels":[],"label_agreement":null},{"id":"W1868867340","doi":"10.5489/cuaj.778","title":"Nephrectomy is necessary in the treatment of metastatic renal cell carcinoma","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Nephrectomy; Renal cell carcinoma; Medicine; Urology; Oncology; Internal medicine; General surgery; Kidney","score_opus":0.021808542931673735,"score_gpt":0.23204848491461955,"score_spread":0.21023994198294582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1868867340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97546566,0.00090293924,0.000004484906,0.018802177,0.00006816611,0.00047031912,0.000015252644,0.000004592028,0.0042664176],"genre_scores_gemma":[0.9958309,0.00010289911,0.00027110477,0.0030203387,0.00013884965,0.00004458975,0.000015191893,0.000009270497,0.00056684174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829227,0.00030070054,0.000421712,0.00016166446,0.00039232048,0.0004313597],"domain_scores_gemma":[0.9987583,0.0002515551,0.000256407,0.00016156478,0.00017002078,0.0004021383],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033068887,0.0001626684,0.00035430602,0.00021645107,0.000101265214,0.000051663363,0.00012442775,0.00010937359,0.0013997759],"category_scores_gemma":[0.00007024249,0.000091974325,0.00020887978,0.00027712452,0.000030609957,0.000079198864,0.0000043528603,0.00026920318,0.00009560705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003928595,0.0003864925,0.98190165,0.0000070231135,0.0000910003,0.00040550393,0.001281192,0.000015800098,0.0004216627,0.000017789303,0.012192417,0.0032401977],"study_design_scores_gemma":[0.0020390416,0.001915468,0.97803545,0.0000052259375,0.00017101012,0.00022564505,0.00038918282,0.00009696652,0.00080253306,0.0004527203,0.015780041,0.000086723914],"about_ca_topic_score_codex":0.009646586,"about_ca_topic_score_gemma":0.00077208766,"teacher_disagreement_score":0.020365262,"about_ca_system_score_codex":0.0014460913,"about_ca_system_score_gemma":0.00042334793,"threshold_uncertainty_score":0.9995131},"labels":[],"label_agreement":null},{"id":"W1870620365","doi":"10.5489/cuaj.892","title":"Antegrade balloon occlusion of inferior vena cava during thrombectomy for renal cell carcinoma","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia Hospital","funders":"","keywords":"Medicine; Inferior vena cava; Renal cell carcinoma; Balloon; Surgery; Nephrectomy; Thrombus; Occlusion; Radiology; Embolectomy; Dissection (medical); Pulmonary embolism; Kidney; Internal medicine","score_opus":0.01204056584645451,"score_gpt":0.21556984224471526,"score_spread":0.20352927639826074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1870620365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925228,0.00035831117,0.00003244956,0.0049418923,0.00017008797,0.00058866094,0.00003190176,0.000015614534,0.0013383232],"genre_scores_gemma":[0.99783385,0.000026262189,0.00056200806,0.0005374778,0.00032940038,0.000023767545,0.00002936752,0.00002040579,0.0006374353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998228,0.00010704925,0.00048477686,0.00021905042,0.00037419522,0.0005869359],"domain_scores_gemma":[0.9980857,0.00013996879,0.000392103,0.00014345815,0.00044978154,0.0007890016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032022348,0.00018931723,0.00042421254,0.00022744603,0.00024887754,0.000049747323,0.00012196536,0.00026586012,0.00070228265],"category_scores_gemma":[0.0003248123,0.00014396096,0.0002726326,0.00016393377,0.0000337861,0.0001162536,0.00002136319,0.00041870476,0.000042075455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010183094,0.000107210224,0.9270929,0.000041454867,0.00008417762,0.00020639159,0.00020524344,0.000021193768,0.067923695,0.000023968436,0.0037742574,0.00041765036],"study_design_scores_gemma":[0.0023730672,0.0009160391,0.9804567,0.000021792397,0.00013092237,0.00035656753,0.00006626532,0.0001313838,0.013743008,0.00022385128,0.0014456889,0.00013471414],"about_ca_topic_score_codex":0.0032948332,"about_ca_topic_score_gemma":0.00038526443,"teacher_disagreement_score":0.054180685,"about_ca_system_score_codex":0.0016970204,"about_ca_system_score_gemma":0.00055371644,"threshold_uncertainty_score":0.7689502},"labels":[],"label_agreement":null},{"id":"W1874157619","doi":"10.5489/cuaj.12018","title":"Review of the efficacy and safety of cryoablation for the treatment of small renal masses.","year":2013,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Cryoablation; Medicine; Cryosurgery; Radiofrequency ablation; Cochrane Library; Kidney cancer; MEDLINE; Surgery; Hematoma; Radiology; Randomized controlled trial; Ablation; Cancer; Internal medicine","score_opus":0.04752673247284397,"score_gpt":0.2520330326132673,"score_spread":0.20450630014042334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1874157619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8974334,0.08578328,0.00009696269,0.0039044756,0.00007839029,0.011112888,0.000020874113,0.000007377627,0.0015623248],"genre_scores_gemma":[0.9801964,0.017335735,0.00038638964,0.00009794733,0.000038272825,0.0014414082,0.000008560401,0.000009210311,0.0004860563],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99934065,0.00003749088,0.00030209273,0.00009717856,0.000115180956,0.00010739448],"domain_scores_gemma":[0.99899846,0.00032617408,0.0002057612,0.0003126223,0.000117274925,0.00003967695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018121848,0.00008123005,0.00027807517,0.000019226682,0.000021318347,0.0000018680896,0.000050732047,0.000024928553,0.000019993224],"category_scores_gemma":[0.00011622287,0.000035028985,0.0001275948,0.0000834251,0.00007600388,0.000015562626,0.000013103703,0.000020566256,4.0329138e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006449079,0.0008531032,0.034065213,0.0055648745,0.0006771169,6.9805213e-7,0.00033674715,0.000012390242,0.0014756137,0.00023146102,0.001188123,0.95494974],"study_design_scores_gemma":[0.0020952076,0.00031303414,0.96932316,0.0005240548,0.0006332909,0.0000051775633,0.00001330552,0.000029963989,0.016867824,0.000038448772,0.010125363,0.00003115283],"about_ca_topic_score_codex":0.00010470987,"about_ca_topic_score_gemma":0.0000062134714,"teacher_disagreement_score":0.9549186,"about_ca_system_score_codex":0.000056971312,"about_ca_system_score_gemma":0.000025977371,"threshold_uncertainty_score":0.14284407},"labels":[],"label_agreement":null},{"id":"W1880937717","doi":"10.1111/j.1542-4758.2011.00540.x","title":"Complete remission of renal cell carcinoma with lung metastases in two hemodialysis patients after low-dose interferon therapy","year":2011,"lang":"en","type":"article","venue":"Hemodialysis International","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Hemodialysis; Immunotherapy; Lung; Dialysis; Internal medicine; Oncology; Interferon; Carcinoma; Gastroenterology; Urology; Cancer; Immunology","score_opus":0.026615956934026713,"score_gpt":0.26149506159957586,"score_spread":0.23487910466554915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1880937717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931629,0.00023199807,0.00035990414,0.000052850162,0.00012045501,0.00047097122,0.00009731433,0.000021476975,0.0054821465],"genre_scores_gemma":[0.99577266,0.000036103076,0.0030618857,0.00012831518,0.00008618615,0.000104611114,0.00050294364,0.000043578264,0.00026373263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974499,0.00015110282,0.0007170343,0.0005563973,0.00082645944,0.00029914337],"domain_scores_gemma":[0.998473,0.000078697085,0.00033487275,0.00051674736,0.00042242047,0.00017429581],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022946254,0.00035082217,0.00066338526,0.00067090325,0.000031395375,0.000018189658,0.00025301153,0.00006583803,0.0016199378],"category_scores_gemma":[0.00002915052,0.000259487,0.00033621397,0.00036133514,0.000114986484,0.00017705766,0.00010395995,0.00019901645,0.00002440404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01122929,0.0023153964,0.9617359,0.00006260638,0.00053029077,0.0002333684,0.0015972543,0.00007495815,0.018080354,0.000015735412,0.00013607508,0.0039887815],"study_design_scores_gemma":[0.013116096,0.0009844436,0.74614346,0.00021563463,0.0005047287,0.000016551388,0.0000921638,0.0019575837,0.23639967,0.00004273234,0.00019072606,0.00033624575],"about_ca_topic_score_codex":0.00059903454,"about_ca_topic_score_gemma":0.00010398598,"teacher_disagreement_score":0.21831931,"about_ca_system_score_codex":0.00037932905,"about_ca_system_score_gemma":0.00010073896,"threshold_uncertainty_score":0.99998575},"labels":[],"label_agreement":null},{"id":"W1882437780","doi":"10.5489/cuaj.3040","title":"Canadian guidelines for SRMs: How Canadian are they?","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Psychology; Medicine","score_opus":0.091551915678874,"score_gpt":0.2846828608205379,"score_spread":0.1931309451416639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1882437780","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33079627,0.0011190153,0.00004601945,0.6564147,0.001236448,0.0009094605,0.0005067168,0.000041960087,0.00892943],"genre_scores_gemma":[0.96556497,0.000030793475,0.0011875547,0.026713992,0.0015178066,0.00003809485,0.00011887351,0.00003372823,0.0047941986],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974559,0.00012839946,0.00039336816,0.00029543298,0.00045842046,0.0012684695],"domain_scores_gemma":[0.98845696,0.00008610742,0.0002724776,0.00020301364,0.0024374244,0.008544025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012173159,0.00025517726,0.0004327524,0.0006216394,0.00045004982,0.00022337594,0.00020910217,0.00045058606,0.00022075119],"category_scores_gemma":[0.005011665,0.00020226557,0.0002411744,0.0002134648,0.00002279853,0.00012293199,0.000007657058,0.0004991822,0.00011161359],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000029777606,0.000012090377,0.528871,0.000003941339,0.00014642839,0.00061841734,0.00013383153,0.000065903965,0.0000073218926,0.00015344213,0.4686734,0.0012844193],"study_design_scores_gemma":[0.0015777971,0.00046694858,0.2463728,0.000021231832,0.00016019194,0.0006041689,0.0005634044,0.00031739072,0.00001578162,0.0012425126,0.7484082,0.0002495668],"about_ca_topic_score_codex":0.91520524,"about_ca_topic_score_gemma":0.9948881,"teacher_disagreement_score":0.63476866,"about_ca_system_score_codex":0.017190384,"about_ca_system_score_gemma":0.01233017,"threshold_uncertainty_score":0.993269},"labels":[],"label_agreement":null},{"id":"W188739255","doi":"10.1007/978-1-62703-062-5_14","title":"Prognostic Factors in Advanced Renal Cell Carcinoma","year":2012,"lang":"en","type":"book-chapter","venue":"Humana Press eBooks","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Renal cell carcinoma; Medicine; Immunotherapy; Oncology; Proinflammatory cytokine; Risk stratification; Disease; Internal medicine; PI3K/AKT/mTOR pathway; Intensive care medicine; Cancer; Signal transduction; Biology; Inflammation","score_opus":0.07110795909099912,"score_gpt":0.26153107648190393,"score_spread":0.1904231173909048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W188739255","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1102398,0.019901322,0.0000027117594,0.000004525999,0.00020407654,0.001968558,0.00004079969,0.00010278375,0.8675354],"genre_scores_gemma":[0.5735888,0.00009381373,0.000088384426,0.000028980752,0.00022824478,0.000090494286,0.0001856602,0.00014728218,0.42554837],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997357,0.000033896973,0.000634232,0.00072364917,0.00059336406,0.0006578189],"domain_scores_gemma":[0.9981768,0.00010484496,0.0003199499,0.00092530204,0.00009689487,0.0003762069],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009602456,0.0007900724,0.0009842365,0.00034020212,0.00006911338,0.000026645614,0.00022001227,0.00048276546,0.00032898455],"category_scores_gemma":[0.000012702932,0.0006761549,0.00034736557,0.000007789336,0.00014656267,0.000053305917,0.00016344344,0.0008141693,0.000082756844],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008883711,0.004218301,0.05860559,0.026665663,0.0042412747,0.037786126,0.032222368,0.00010203956,0.020531533,0.26388255,0.016604684,0.52625614],"study_design_scores_gemma":[0.011252326,0.003377365,0.09278669,0.0030975484,0.0042943447,0.00022583928,0.000082416474,0.00001781103,0.071707316,0.0020777201,0.80764395,0.0034366443],"about_ca_topic_score_codex":0.00019253194,"about_ca_topic_score_gemma":0.000079382095,"teacher_disagreement_score":0.7910393,"about_ca_system_score_codex":0.0004218863,"about_ca_system_score_gemma":0.00013148876,"threshold_uncertainty_score":0.99956894},"labels":[],"label_agreement":null},{"id":"W1891708259","doi":"","title":"Long-term oncologic outcomes of laparoscopic versus open partial nephrectomy.","year":2013,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Odds ratio; Cochrane Library; Confidence interval; Meta-analysis; Internal medicine; MEDLINE; Surgery; Urology; Kidney","score_opus":0.08106242816764635,"score_gpt":0.3113987872751144,"score_spread":0.23033635910746802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1891708259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747956,0.00019066375,0.0000020175453,0.0007619438,0.00046758755,0.0037580107,0.0000030399879,0.00004072205,0.019980425],"genre_scores_gemma":[0.99000525,0.000018244426,0.00021015017,0.00021309414,0.000081695645,0.005834735,0.00001871899,0.000017419301,0.0036006682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987747,0.00005172514,0.00029454523,0.00025445104,0.00023891487,0.0003856785],"domain_scores_gemma":[0.99902946,0.00012970158,0.00012085743,0.00041498616,0.00007082945,0.00023415264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013773606,0.00016301005,0.00052955654,0.00006488159,0.000031477302,0.000039906474,0.00023525742,0.0000817231,0.00057999714],"category_scores_gemma":[0.00012580867,0.00011292396,0.00011238639,0.00012014317,0.00007732303,0.00013649525,0.00018069013,0.00009841291,0.00015462005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004678526,0.00036895985,0.94423914,0.000046522095,0.000257261,0.00005973627,0.000037421698,7.2726453e-7,0.00017048007,0.00004317551,0.0011034975,0.05320522],"study_design_scores_gemma":[0.0071221073,0.000369177,0.97912997,0.000009193044,0.00019406933,0.000007735281,0.000014515961,0.000002329823,0.0124819,0.000023061726,0.0005506374,0.00009528585],"about_ca_topic_score_codex":0.00032356958,"about_ca_topic_score_gemma":0.000037794583,"teacher_disagreement_score":0.053109933,"about_ca_system_score_codex":0.00018428803,"about_ca_system_score_gemma":0.000061487146,"threshold_uncertainty_score":0.6350562},"labels":[],"label_agreement":null},{"id":"W1891958064","doi":"10.5489/cuaj.2749","title":"Minimal fat renal angiomyolipoma with lymph node involvement: A case report and literature review","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lymph; Lymph node; Angiomyolipoma; Adipose capsule of kidney; Kidney; Pathology; Internal medicine","score_opus":0.024131596163716903,"score_gpt":0.24191142031207521,"score_spread":0.2177798241483583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1891958064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92969537,0.036624994,0.000022220753,0.030678678,0.00011307516,0.00038503142,0.00003451981,0.000025473293,0.0024206215],"genre_scores_gemma":[0.9850446,0.0013438294,0.0012170449,0.010370453,0.0005656215,0.00002146399,0.00010462431,0.000019359266,0.0013130073],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99824935,0.00016361394,0.00040204887,0.00027037982,0.00047834046,0.000436245],"domain_scores_gemma":[0.9971208,0.00005075354,0.00033786448,0.00016434578,0.0005828029,0.0017434151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079002016,0.0001982855,0.00039114253,0.00015763787,0.00015954691,0.000110342524,0.00005524427,0.00018809726,0.000086063],"category_scores_gemma":[0.00058208825,0.00012950176,0.000103937644,0.00030169936,0.000037914448,0.00011959586,0.000016627153,0.00039655756,0.000013386324],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011337964,0.000045391786,0.40631616,0.00006421032,0.0001994614,0.5680083,0.0002048504,0.000002236013,0.000021056969,0.000029769466,0.024260068,0.0007350976],"study_design_scores_gemma":[0.002486672,0.0008556394,0.13287169,0.000712794,0.0004924419,0.8302529,0.00009800281,0.000033051052,0.00002056122,0.00008531137,0.03187778,0.00021317093],"about_ca_topic_score_codex":0.0006241653,"about_ca_topic_score_gemma":0.00046569016,"teacher_disagreement_score":0.27344444,"about_ca_system_score_codex":0.0015080136,"about_ca_system_score_gemma":0.00068813266,"threshold_uncertainty_score":0.52809286},"labels":[],"label_agreement":null},{"id":"W1894980595","doi":"10.5489/cuaj.978","title":"Age at diagnosis is a determinant factor of renal cell carcinoma– specific survival in patients treated with nephrectomy","year":2008,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Nephrectomy; Renal cell carcinoma; Medicine; Carcinoma; Oncology; Internal medicine; Urology; Kidney","score_opus":0.023224212258945703,"score_gpt":0.20311034995175126,"score_spread":0.17988613769280556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1894980595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977642,0.00017714877,0.0000011579339,0.0004917829,0.000071127404,0.00033470188,0.00009117343,0.0000087934795,0.001059905],"genre_scores_gemma":[0.9987955,0.00007545336,0.00008045913,0.0003166148,0.000090894304,0.000016961476,0.0000472884,0.00002079792,0.00055601133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787897,0.00019485738,0.000497305,0.00027738203,0.00058838824,0.00056311133],"domain_scores_gemma":[0.99834204,0.00015265607,0.00038306476,0.00015948147,0.00023655388,0.00072622276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015832107,0.00023202132,0.0005388253,0.0003251109,0.00016198096,0.000017758086,0.00010798156,0.00022460415,0.0007588323],"category_scores_gemma":[0.00007380387,0.00016415615,0.00017137715,0.00033447484,0.00006149368,0.000060453352,0.00001670008,0.0004047693,0.000030035373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003656949,0.00022882738,0.9946135,0.000005560947,0.000044152588,0.00192531,0.00035472048,0.0000040973296,0.0001620799,5.371908e-7,0.001999462,0.00029604507],"study_design_scores_gemma":[0.004238855,0.0018654915,0.98663557,0.000016834721,0.00005965214,0.00011961737,0.000017077586,0.000006663202,0.0026024375,0.0000032094958,0.0042781564,0.00015644955],"about_ca_topic_score_codex":0.0024867908,"about_ca_topic_score_gemma":0.002212974,"teacher_disagreement_score":0.007977957,"about_ca_system_score_codex":0.003136694,"about_ca_system_score_gemma":0.00032910312,"threshold_uncertainty_score":0.8308682},"labels":[],"label_agreement":null},{"id":"W1896238037","doi":"10.5489/cuaj.2677","title":"Submitted as a letter to the editor; Papillary renal cell carcinoma within a renal oncocytoma; case report of a very rare coexistence.","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Oncocytoma; Renal oncocytoma; Papillary renal cell carcinomas; Renal cell carcinoma; Medicine; General surgery; Urology; Pathology","score_opus":0.025892599563543957,"score_gpt":0.24023061955753525,"score_spread":0.2143380199939913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1896238037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96325725,0.00030670626,0.000015488602,0.030865932,0.0015248958,0.00046522415,0.00004234185,0.000021521471,0.0035006544],"genre_scores_gemma":[0.9825226,0.0000032207352,0.00034495778,0.009152123,0.0062433435,0.00002676296,0.00004174611,0.000024371846,0.0016408416],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.996658,0.00046752926,0.00083163264,0.000355186,0.0010576776,0.0006299301],"domain_scores_gemma":[0.9958065,0.00021240972,0.00073500135,0.00037833367,0.000959986,0.0019077271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018832744,0.00026611527,0.0005098324,0.00025408875,0.00026780696,0.000083064144,0.00020870048,0.0003602883,0.00017680418],"category_scores_gemma":[0.00187525,0.00017305928,0.00026726685,0.00044073915,0.000069900205,0.00009696742,0.000048018268,0.00095240097,0.000097247175],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005058729,0.00010581845,0.14238124,0.000010893996,0.0001631005,0.2798248,0.0016003276,0.00015921467,0.0006894331,0.000009596636,0.57437146,0.00017825472],"study_design_scores_gemma":[0.005994297,0.007115793,0.2199847,0.00009043828,0.0008644195,0.41598794,0.0016257813,0.00020322877,0.0043225824,0.00029629125,0.34280658,0.00070794823],"about_ca_topic_score_codex":0.0061827614,"about_ca_topic_score_gemma":0.0025949934,"teacher_disagreement_score":0.23156488,"about_ca_system_score_codex":0.002695461,"about_ca_system_score_gemma":0.002574445,"threshold_uncertainty_score":0.93465275},"labels":[],"label_agreement":null},{"id":"W1903302369","doi":"10.1111/bju.12883","title":"Partial nephrectomy for the treatment of renal cell carcinoma ( <scp>RCC</scp> ) and the risk of end‐stage renal disease ( <scp>ESRD</scp> )","year":2014,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Hazard ratio; Renal cell carcinoma; Nephrectomy; End stage renal disease; Cohort; Proportional hazards model; Kidney disease; Internal medicine; Renal replacement therapy; Retrospective cohort study; Population; Urology; Propensity score matching; Cohort study; Lower risk; Confidence interval; Surgery; Oncology; Disease; Kidney","score_opus":0.012507724496762192,"score_gpt":0.2298367205837282,"score_spread":0.21732899608696601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1903302369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9685984,0.027939476,0.0010840005,0.00037088429,0.0002558809,0.0010546332,0.00015625107,0.00000932652,0.0005311168],"genre_scores_gemma":[0.9935393,0.0042605638,0.0004208012,0.00019588968,0.0007522778,0.0000890009,0.00001817277,0.000045416367,0.0006786052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969144,0.0007150071,0.0010309998,0.00033292564,0.00048954005,0.00051714835],"domain_scores_gemma":[0.9931237,0.0044048633,0.0012491716,0.00045011277,0.00036576999,0.0004063446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011232017,0.0003199224,0.0010586019,0.00014752436,0.00021219911,0.000035599827,0.0002746877,0.00015206877,0.000028507326],"category_scores_gemma":[0.0010899995,0.0001990843,0.00073831744,0.0001378106,0.0008745254,0.00007616969,0.00005726277,0.00035890183,0.0000023558496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022019045,0.011762806,0.629804,0.0014116869,0.0098808855,0.009177149,0.010110545,0.0053544636,0.028492382,0.0026030464,0.033621285,0.23576267],"study_design_scores_gemma":[0.0562993,0.022448273,0.72150004,0.00014540703,0.010467228,0.006282518,0.0007113012,0.0037851653,0.036585785,0.0013728708,0.140271,0.00013111514],"about_ca_topic_score_codex":0.00044711685,"about_ca_topic_score_gemma":0.00007840658,"teacher_disagreement_score":0.23563156,"about_ca_system_score_codex":0.00007954532,"about_ca_system_score_gemma":0.00027577288,"threshold_uncertainty_score":0.8118422},"labels":[],"label_agreement":null},{"id":"W1903591232","doi":"10.1111/j.1464-410x.2012.11675.x","title":"Prevalence and impact on survival of positive surgical margins in partial nephrectomy for renal cell carcinoma: a population‐based study","year":2013,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Surgical margin; Proportional hazards model; Population; Stage (stratigraphy); Logistic regression; Log-rank test; Survival analysis; Internal medicine; Kidney cancer; Surgery; Urology; Oncology; Cancer; Kidney","score_opus":0.01686274669148288,"score_gpt":0.2762460804511391,"score_spread":0.2593833337596562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1903591232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975792,0.0009502844,0.000023725635,0.0001692694,0.00007349895,0.0010872526,0.000031055137,0.0000030134495,0.00008270453],"genre_scores_gemma":[0.99954194,0.000022212784,0.00018811879,0.000039451326,0.00011994794,0.000035343477,0.000009805939,0.00001621927,0.000026937612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841475,0.00031571998,0.0005619283,0.00019619979,0.00026029206,0.00025110802],"domain_scores_gemma":[0.9987799,0.00042119573,0.00029596512,0.000104357816,0.00022873493,0.0001698305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041110645,0.00014253511,0.00057478313,0.00020393051,0.000030809242,0.000015989885,0.000071383685,0.00008722315,0.00010551098],"category_scores_gemma":[0.000081688006,0.0001246413,0.00016996246,0.00010249428,0.000050002935,0.000079163285,0.000019974012,0.00025060147,0.0000012245614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035206408,0.0014325103,0.99045926,0.000058455287,0.00006350174,0.0020895957,0.00008492035,0.0001918701,0.0005007962,0.000003622022,0.00006136799,0.0015334751],"study_design_scores_gemma":[0.011217927,0.013309853,0.97213185,0.000063960164,0.00020079868,0.002121129,0.000036547888,0.0002803837,0.00051709655,0.000030274306,0.0000085335205,0.00008163539],"about_ca_topic_score_codex":0.0010776452,"about_ca_topic_score_gemma":0.00007106748,"teacher_disagreement_score":0.018327383,"about_ca_system_score_codex":0.00010687499,"about_ca_system_score_gemma":0.00012919567,"threshold_uncertainty_score":0.50827247},"labels":[],"label_agreement":null},{"id":"W1905767239","doi":"10.1111/hdi.12329","title":"Sequential molecularly targeted drug therapy including axitinib for a patient with end‐stage renal failure and metastatic renal cell carcinoma","year":2015,"lang":"en","type":"article","venue":"Hemodialysis International","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Axitinib; Medicine; Sunitinib; Sorafenib; Renal cell carcinoma; Everolimus; Targeted therapy; Hemodialysis; Internal medicine; Adverse effect; Oncology; End stage renal disease; Stage (stratigraphy); Urology; Cancer","score_opus":0.03988296201278138,"score_gpt":0.2770670589675848,"score_spread":0.23718409695480344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1905767239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881298,0.0004930753,0.007836655,0.00091458776,0.000118590266,0.0008423111,0.0001581836,0.000045408866,0.0014613952],"genre_scores_gemma":[0.97087634,0.00001074414,0.02666213,0.00031913616,0.00020869989,0.0002422045,0.00081641786,0.00005241638,0.00081189635],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976558,0.000113659305,0.0004385399,0.00055311195,0.00091666495,0.0003222005],"domain_scores_gemma":[0.9984729,0.00010314958,0.0002590714,0.0002865634,0.0005560032,0.00032228706],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030877415,0.00032973522,0.0004513634,0.00032191348,0.000098838515,0.0000985646,0.00014405932,0.000059302718,0.00019847185],"category_scores_gemma":[0.000063318,0.0002523205,0.0002210973,0.0001808729,0.00009963017,0.0001728988,0.00008599074,0.00017379031,0.000009282343],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02459206,0.0038492386,0.07325583,0.00040227652,0.008529681,0.0068539125,0.023016777,0.0030230714,0.8200682,0.0019817362,0.013293612,0.021133604],"study_design_scores_gemma":[0.029836897,0.0037208349,0.004821992,0.00012428367,0.0013489329,0.00080793083,0.0017878847,0.01532309,0.91722906,0.0004556174,0.023630155,0.0009133509],"about_ca_topic_score_codex":0.00018037195,"about_ca_topic_score_gemma":0.000046031564,"teacher_disagreement_score":0.09716083,"about_ca_system_score_codex":0.00035569622,"about_ca_system_score_gemma":0.00031048997,"threshold_uncertainty_score":0.9999929},"labels":[],"label_agreement":null},{"id":"W1906073601","doi":"10.5489/cuaj.2377","title":"Bone metastases affect prognosis but not effectiveness of third-line targeted therapies in patients with metastatic renal cell carcinoma","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Sorafenib; Renal cell carcinoma; Hazard ratio; Internal medicine; Everolimus; Oncology; Confidence interval; Bone metastasis; Retrospective cohort study; Targeted therapy; Urology; Metastasis; Cancer; Hepatocellular carcinoma","score_opus":0.021428813309500857,"score_gpt":0.22946024818739108,"score_spread":0.20803143487789022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1906073601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973596,0.00064604246,0.000029111809,0.0008038745,0.000080992126,0.00077835436,0.000110479414,0.000013490692,0.00017807675],"genre_scores_gemma":[0.99872667,0.0000066440675,0.0006868017,0.0003104342,0.0000518853,0.000040386596,0.0001070985,0.000022167911,0.00004793946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969157,0.0010890499,0.0004779543,0.0002606081,0.00075085444,0.0005058186],"domain_scores_gemma":[0.99753976,0.00042756432,0.00045451973,0.00013785098,0.00069230766,0.0007479884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016799875,0.00025264843,0.0007185047,0.0003957394,0.00007776385,0.000036085083,0.00010038728,0.00012884714,0.00005905978],"category_scores_gemma":[0.00052996963,0.00016518876,0.00015671155,0.00040997608,0.000057895388,0.00012176794,0.000015444739,0.0004539687,0.000009684482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018302669,0.00046579906,0.9955081,0.000040693372,0.00026278093,0.00033020813,0.00015759548,0.00018574735,0.00074342446,0.000008931588,0.00020093573,0.0002655284],"study_design_scores_gemma":[0.008113585,0.0051762657,0.9761151,0.000043826545,0.0004264428,0.000045268145,0.000085889806,0.00003346174,0.009622126,0.000070616145,0.000109138084,0.00015830171],"about_ca_topic_score_codex":0.0021510394,"about_ca_topic_score_gemma":0.000591176,"teacher_disagreement_score":0.01939301,"about_ca_system_score_codex":0.0016132216,"about_ca_system_score_gemma":0.00081719115,"threshold_uncertainty_score":0.67362016},"labels":[],"label_agreement":null},{"id":"W1907991309","doi":"10.1158/1078-0432.ccr-15-0215","title":"Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Sunitinib; Renal cell carcinoma; Medicine; Adjuvant; Sorafenib; Internal medicine; Renal function; Oncology; Urology; Hepatocellular carcinoma","score_opus":0.1551892286076148,"score_gpt":0.42482418811199524,"score_spread":0.26963495950438043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1907991309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99140555,0.0033557243,0.0000020727664,0.00018794036,0.00045305924,0.0015623485,0.0004803368,0.000018236975,0.0025347238],"genre_scores_gemma":[0.99794656,0.00041528553,0.000104683924,0.00011583672,0.00038877985,0.00014864984,0.0003531836,0.000047545956,0.00047948526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943026,0.0017271797,0.0010225589,0.000862212,0.0015236349,0.00056186423],"domain_scores_gemma":[0.9945727,0.0031079038,0.00022370424,0.00064275286,0.0007600784,0.0006928859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003259675,0.00027060907,0.0010538377,0.00031509897,0.00005610761,0.00002500126,0.00015269556,0.00025013922,0.000030316573],"category_scores_gemma":[0.002496862,0.0002081395,0.00019894078,0.0004366757,0.00033249546,0.00009340957,0.00018801902,0.001052301,0.000045646208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040750287,0.002362115,0.92293435,0.00030401698,0.0002403363,0.00023108239,0.00041438593,0.000017454346,0.002163413,0.0000116404735,0.011394571,0.019176349],"study_design_scores_gemma":[0.023579542,0.00819529,0.93270487,0.0003865589,0.0002872603,5.986064e-7,0.000118565804,0.000055956833,0.031314187,0.00011389937,0.003060457,0.00018282169],"about_ca_topic_score_codex":0.00724269,"about_ca_topic_score_gemma":0.0003511726,"teacher_disagreement_score":0.029150775,"about_ca_system_score_codex":0.00044048144,"about_ca_system_score_gemma":0.0007517341,"threshold_uncertainty_score":0.9993682},"labels":[],"label_agreement":null},{"id":"W1910911704","doi":"10.1007/s00292-014-2030-z","title":"Vancouver-Klassifikation von Nierentumoren","year":2014,"lang":"de","type":"article","venue":"Der Pathologe","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Gynecology; Medicine","score_opus":0.019548408829744974,"score_gpt":0.24508569761378818,"score_spread":0.2255372887840432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1910911704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94567007,0.013130697,0.0029385793,0.0005867339,0.007417778,0.0009962899,0.000052052557,0.00020713253,0.029000686],"genre_scores_gemma":[0.990972,0.00028440496,0.0008723251,0.00073299033,0.0018675257,0.000065346736,0.00028508162,0.000079533034,0.0048408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971544,0.00035823492,0.0005466352,0.00074248743,0.0005363489,0.00066190405],"domain_scores_gemma":[0.9981641,0.00015162995,0.0002702382,0.0009244618,0.0001524896,0.0003370377],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005013008,0.00046012108,0.0006264676,0.0002004961,0.00014710396,0.00004751751,0.00018675301,0.0003036797,0.0004399572],"category_scores_gemma":[0.00023860215,0.00039044855,0.00024357619,0.00022829368,0.00016324242,0.0000988439,0.00010715897,0.00037835925,0.0045520025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008962178,0.0025998247,0.51676583,0.0010682703,0.0013273732,0.004322433,0.00425295,0.000068343055,0.028174175,0.0019644997,0.17548174,0.26307833],"study_design_scores_gemma":[0.0079016695,0.0037373765,0.72334415,0.0005493241,0.004077997,0.00012921754,0.00036398388,0.0031781255,0.042128075,0.001475037,0.21196973,0.0011452952],"about_ca_topic_score_codex":0.000046776673,"about_ca_topic_score_gemma":0.000047970414,"teacher_disagreement_score":0.26193303,"about_ca_system_score_codex":0.0003405309,"about_ca_system_score_gemma":0.00009019549,"threshold_uncertainty_score":0.99985474},"labels":[],"label_agreement":null},{"id":"W1913451886","doi":"10.1002/dc.23154","title":"Fluorescence in situ hybridization as an adjunct tool in the diagnosis of primary and metastatic renal cell carcinoma in fine needle aspiration specimens","year":2014,"lang":"en","type":"article","venue":"Diagnostic Cytopathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Chromophobe cell; Medicine; Pathology; Renal cell carcinoma; Clear cell; CD117; Fluorescence in situ hybridization; Immunohistochemistry; Fine-needle aspiration; Papillary renal cell carcinomas; PAX8; Oncocytoma; Subtyping; Clear cell renal cell carcinoma; Clear cell carcinoma; Carcinoma; Biopsy; Biology","score_opus":0.020162216863439667,"score_gpt":0.2464219503938945,"score_spread":0.22625973353045484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1913451886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971452,0.0006110002,0.0000784629,0.0003696782,0.000049514958,0.0009267656,0.0000075081107,0.00000779475,0.0008041041],"genre_scores_gemma":[0.99846375,0.000110795554,0.0005890398,0.00036815813,0.000048046437,0.00023173653,0.00016064865,0.000017998875,0.000009849434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997961,0.00057127426,0.00055124465,0.00039995968,0.00023776572,0.00027877462],"domain_scores_gemma":[0.9976255,0.0017440477,0.00014243013,0.00038403823,0.000053277196,0.000050700208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008104658,0.00020187389,0.0005084867,0.00036400766,0.00002272474,0.000011327956,0.00010915296,0.000075538046,0.000030212304],"category_scores_gemma":[0.0014908846,0.00015780222,0.000040562783,0.00039238925,0.00011947268,0.00011480621,0.000048712875,0.00021273826,0.0000110892115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016673648,0.0009585492,0.94529206,0.00015530437,0.0000029998973,0.0015719635,0.001957252,0.00017399716,0.042965166,0.000372993,0.000032915457,0.0063500614],"study_design_scores_gemma":[0.0028026435,0.002264386,0.95290333,0.00011169779,0.00007968194,0.00022517101,0.00017515004,0.0003375098,0.040602777,0.00035256176,0.00001981234,0.00012528326],"about_ca_topic_score_codex":0.00041848226,"about_ca_topic_score_gemma":0.0011413089,"teacher_disagreement_score":0.007611264,"about_ca_system_score_codex":0.00014207943,"about_ca_system_score_gemma":0.00009345528,"threshold_uncertainty_score":0.6434988},"labels":[],"label_agreement":null},{"id":"W191783398","doi":"10.1016/j.urology.2014.02.004","title":"Advances in Renal Neoplasia","year":2014,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Renal sinus; Pathology; Clear cell; Nuclear atypia; Renal cell carcinoma; Chromophobe cell; Anaplastic lymphoma kinase; Nephrectomy; Immunohistochemistry; Internal medicine; Kidney; Lung cancer","score_opus":0.008643851622170481,"score_gpt":0.2507776014585391,"score_spread":0.24213374983636862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W191783398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89404625,0.0013219457,0.00055599166,0.0016928446,0.00011729171,0.00012003611,3.2862923e-7,0.000029245286,0.10211609],"genre_scores_gemma":[0.9983806,0.00006973201,0.00026563092,0.00083372626,0.00009497468,0.000012592918,0.000006124451,0.000007158824,0.00032944258],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99947435,0.000044940025,0.00010568671,0.00014959717,0.0000630985,0.00016235693],"domain_scores_gemma":[0.9996955,0.000067250345,0.000022401797,0.00015005196,0.000011933532,0.000052881453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007303884,0.00006498092,0.00015760672,0.00007479827,0.000009922816,0.0000014139441,0.000032582393,0.00005511724,0.0001297027],"category_scores_gemma":[0.000052088228,0.00005076036,0.00002787712,0.00006143269,0.000039559523,0.000024380497,0.0000139251315,0.0000950032,0.00017394584],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021275736,0.0005083435,0.6261368,0.00009018603,0.000044750235,0.0012436913,0.00048807598,0.00081158883,0.0133654745,0.010528701,0.0018008301,0.342854],"study_design_scores_gemma":[0.0054058633,0.0044634906,0.38987842,0.00001685717,0.00008743363,0.0009621951,0.000019978945,0.0018192271,0.0074964077,0.004023646,0.5856433,0.00018319032],"about_ca_topic_score_codex":0.000010551511,"about_ca_topic_score_gemma":0.0000676382,"teacher_disagreement_score":0.58384246,"about_ca_system_score_codex":0.000024045778,"about_ca_system_score_gemma":0.000017502893,"threshold_uncertainty_score":0.22357798},"labels":[],"label_agreement":null},{"id":"W1919038197","doi":"10.5489/cuaj.1163","title":"Renal cell carcinoma with caval thrombus extending to the right atrium in a horseshoe kidney: a unique surgical challenge","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Horseshoe kidney; Medicine; Right atrium; Renal cell carcinoma; Thrombus; Horseshoe (symbol); Kidney; Cardiology; Internal medicine; Anatomy; Computer science","score_opus":0.011567107848471096,"score_gpt":0.21478691774354833,"score_spread":0.20321980989507724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1919038197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90066683,0.00036003557,0.0000181612,0.08795401,0.00015036821,0.00075865764,0.00001762731,0.000020420784,0.010053872],"genre_scores_gemma":[0.9938153,0.00004825394,0.0002320716,0.004099974,0.0005848385,0.00006255445,0.00001983368,0.00002604966,0.0011111324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972358,0.00042054532,0.00045339903,0.00035859586,0.0005995177,0.00093217293],"domain_scores_gemma":[0.9970487,0.00020353706,0.00021608993,0.00023005003,0.0003003751,0.0020012693],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007860668,0.0002743352,0.0004521253,0.00032593467,0.0002977428,0.00014677408,0.00022278278,0.0002876014,0.0014330056],"category_scores_gemma":[0.00024840425,0.000155134,0.0001686957,0.0004708208,0.000046147074,0.00013344908,0.000031957665,0.0011020465,0.00021614262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000407082,0.0003656743,0.92115515,0.000021407799,0.00018904163,0.011300943,0.0014477739,0.00022358881,0.00055262184,0.000567634,0.06210692,0.0016621867],"study_design_scores_gemma":[0.0026173953,0.0019297957,0.90725553,0.00003682897,0.000115711526,0.0019555592,0.00016267195,0.00016037069,0.00022012352,0.00022106129,0.085051455,0.0002735075],"about_ca_topic_score_codex":0.008120403,"about_ca_topic_score_gemma":0.0048301923,"teacher_disagreement_score":0.09314845,"about_ca_system_score_codex":0.002854525,"about_ca_system_score_gemma":0.0011123779,"threshold_uncertainty_score":0.99947983},"labels":[],"label_agreement":null},{"id":"W1923457240","doi":"10.5489/cuaj.1039","title":"L’amélioration de l’imagerie pour les tumeurs : la clé de la chirurgie du futur en urologie","year":2013,"lang":"fr","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Humanities; Art","score_opus":0.012175772005749725,"score_gpt":0.23456546997219718,"score_spread":0.22238969796644745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1923457240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.802353,0.0040334216,0.00047650517,0.16924691,0.00091316446,0.00039138374,0.000031180112,0.00005740278,0.022497019],"genre_scores_gemma":[0.98379016,0.0016972491,0.001206031,0.005564297,0.0042022076,0.00004914888,0.000030475116,0.000046911093,0.0034135394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99355525,0.0034658958,0.0006234287,0.00036229365,0.00048927584,0.0015038592],"domain_scores_gemma":[0.9950046,0.0018837941,0.00049371494,0.00019625461,0.0004176804,0.0020039806],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003301255,0.0003918897,0.00050214643,0.00029902565,0.0005275568,0.0004894076,0.0002934122,0.0013047209,0.0052002347],"category_scores_gemma":[0.00455749,0.00034619443,0.0003368612,0.0002880333,0.00015481353,0.00039980735,0.000039803774,0.0020058209,0.00076726504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060517734,0.0002321588,0.86645126,0.000021170816,0.000320704,0.0028872404,0.0005336714,0.00035478774,0.0016167915,0.0014464187,0.08736282,0.038712457],"study_design_scores_gemma":[0.0014460512,0.00062798604,0.87948364,0.000037582176,0.00035021422,0.0025851487,0.0004499278,0.0015820395,0.00015110889,0.0052863774,0.107718,0.00028190986],"about_ca_topic_score_codex":0.008874159,"about_ca_topic_score_gemma":0.0005037088,"teacher_disagreement_score":0.18143712,"about_ca_system_score_codex":0.00782422,"about_ca_system_score_gemma":0.0032368605,"threshold_uncertainty_score":0.9999918},"labels":[],"label_agreement":null},{"id":"W1928749685","doi":"10.1111/j.1442-2042.2012.03170.x","title":"Nodal involvement at nephrectomy is associated with worse survival: A stage‐for‐stage and grade‐for‐grade analysis","year":2012,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Stage (stratigraphy); Nephrectomy; NODAL; Survival analysis; Urology; Oncology; Internal medicine; Kidney","score_opus":0.04596952805082602,"score_gpt":0.3149286028727507,"score_spread":0.2689590748219247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1928749685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992035,0.0008110126,0.0021149195,0.0040457416,0.00043754381,0.0003081841,0.000110004614,0.0000108048935,0.00012684417],"genre_scores_gemma":[0.9952924,0.000088611174,0.001317675,0.0011987743,0.00036021584,0.000024102419,0.00011069261,0.000024983176,0.0015825075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836063,0.00008522476,0.0004926192,0.00018581942,0.00055359385,0.00032209433],"domain_scores_gemma":[0.99801654,0.00042736798,0.0005913267,0.00013012718,0.0005902541,0.0002443725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061787554,0.0001921984,0.000536223,0.0005150736,0.00005315075,0.00002204688,0.00014939836,0.00010495672,0.00018188078],"category_scores_gemma":[0.00013816809,0.00014022113,0.00030387228,0.00017814292,0.00009331152,0.00012918831,0.00005537052,0.0001765503,0.0000024064323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003171055,0.0007144257,0.9792199,0.000018564366,0.012170861,0.00020273123,0.00090115116,0.00018180136,0.0018833796,0.0004216275,0.00074260717,0.00037187655],"study_design_scores_gemma":[0.017554624,0.00426391,0.9030755,0.00004578951,0.006260047,0.0006010655,0.00034581858,0.0014951203,0.0046691494,0.00018689812,0.06116257,0.00033949447],"about_ca_topic_score_codex":0.0000509869,"about_ca_topic_score_gemma":0.0001657704,"teacher_disagreement_score":0.076144405,"about_ca_system_score_codex":0.00040304,"about_ca_system_score_gemma":0.0000856766,"threshold_uncertainty_score":0.5718052},"labels":[],"label_agreement":null},{"id":"W1934966215","doi":"10.5489/cuaj.1190","title":"Dose escalation of second-line sunitinib results in rapid partial remission of multiple hepatic metastases","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Sunitinib; Medicine; Sorafenib; Dosing; Toxicity; Renal cell carcinoma; Oncology; Urology; Internal medicine; Hepatocellular carcinoma","score_opus":0.030451873577808364,"score_gpt":0.24806884032733767,"score_spread":0.2176169667495293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1934966215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943819,0.00016581533,0.000011059702,0.004053948,0.00008171944,0.00032983843,0.00007471432,0.0000063115494,0.00089471776],"genre_scores_gemma":[0.9988781,0.0000390681,0.00042133953,0.00025842327,0.00010451157,0.00000916165,0.00010452087,0.000008123922,0.00017675284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980331,0.00033949173,0.0008334839,0.0001494845,0.00034309243,0.0003013657],"domain_scores_gemma":[0.9979674,0.00044616516,0.0006105038,0.0001228589,0.0003908978,0.0004621786],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008813284,0.00011988278,0.0004003674,0.00027961418,0.00005257109,0.000015044655,0.00006745044,0.00017667044,0.0013421319],"category_scores_gemma":[0.0026337828,0.00009044935,0.00013272275,0.0002437129,0.00003264524,0.00010383906,0.000010707681,0.00032306026,0.000015771477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063508755,0.00031508834,0.9680065,0.00003403708,0.0001340388,0.000104578234,0.0003487602,0.00027533335,0.017659683,0.000024154368,0.0027695002,0.009693224],"study_design_scores_gemma":[0.0036299182,0.00094335986,0.983738,0.00004335531,0.00008043452,0.000046394656,0.0000815266,0.0014080098,0.008170569,0.00018578877,0.0015924589,0.00008018776],"about_ca_topic_score_codex":0.003848861,"about_ca_topic_score_gemma":0.0019504857,"teacher_disagreement_score":0.01573148,"about_ca_system_score_codex":0.00066851627,"about_ca_system_score_gemma":0.00037759703,"threshold_uncertainty_score":0.9995708},"labels":[],"label_agreement":null},{"id":"W1937841852","doi":"10.5489/cuaj.829","title":"Recurrent renal cell cancer: 10 years or more after nephrectomy","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Northeast Cancer Centre; York Central Hospital; McMaster University","funders":"","keywords":"Nephrectomy; Medicine; Renal cell carcinoma; Disease; Kidney cancer; Cancer; Optimism; Surgery; Internal medicine; General surgery; Intensive care medicine; Kidney; Psychology","score_opus":0.014917430790203863,"score_gpt":0.2372917689969813,"score_spread":0.22237433820677743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1937841852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770963,0.0010994684,0.0000032992298,0.018851286,0.00030658158,0.0003407019,0.000029456594,0.000024235447,0.0022486548],"genre_scores_gemma":[0.98485774,0.00021178064,0.00033417714,0.0048200632,0.00072233635,0.0001050028,0.000019557077,0.000019760839,0.008909566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982664,0.000118773874,0.00033874545,0.00022788846,0.0004387353,0.0006094642],"domain_scores_gemma":[0.9980392,0.000081622165,0.00021125896,0.00013125366,0.00030278432,0.0012338693],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022259736,0.00017796225,0.00029703355,0.00017631373,0.00011603429,0.00011090711,0.000107404936,0.00023819624,0.024356147],"category_scores_gemma":[0.00017686194,0.00012313876,0.00017770851,0.0002103349,0.000030084404,0.00010702435,0.000016422076,0.0005901586,0.00077508565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044800033,0.0001448993,0.7136282,0.000013051719,0.00021719448,0.0014391076,0.0003068663,0.000025530431,0.0003528158,0.0000044826215,0.24790561,0.035514247],"study_design_scores_gemma":[0.001043818,0.00052843004,0.7881856,0.00001852709,0.00010803175,0.00016565868,0.00003472075,0.000052808387,0.00008278855,0.000059264607,0.20958658,0.00013374847],"about_ca_topic_score_codex":0.0031424463,"about_ca_topic_score_gemma":0.0013895347,"teacher_disagreement_score":0.07455744,"about_ca_system_score_codex":0.0025116503,"about_ca_system_score_gemma":0.00085637596,"threshold_uncertainty_score":0.9962416},"labels":[],"label_agreement":null},{"id":"W1940809367","doi":"10.5489/cuaj.1038","title":"Improved tumour imaging: the key to urological surgery of the future","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Key (lock); Medicine; Medical physics; General surgery; Surgery; Computer science; Computer security","score_opus":0.0111402676722591,"score_gpt":0.2023218862633579,"score_spread":0.1911816185910988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1940809367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7710465,0.0003107392,0.000008831552,0.2268441,0.00045656064,0.00037544503,0.00000827142,0.000010967237,0.0009385615],"genre_scores_gemma":[0.9801845,0.000019879164,0.000068938745,0.018339615,0.000823821,0.000025733181,0.0000036217339,0.000010997392,0.00052291097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981215,0.0003324868,0.00041749686,0.0001815144,0.00041942432,0.0005275808],"domain_scores_gemma":[0.9979848,0.00035612122,0.0003133924,0.0002174722,0.00041757344,0.0007105957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007778459,0.00015944762,0.0003210983,0.000100708006,0.00028891,0.000080789665,0.000247043,0.00016168533,0.0008380472],"category_scores_gemma":[0.0010947925,0.00007204707,0.0003424481,0.00030107886,0.00005615418,0.000059643135,0.000038635964,0.00069455977,0.000080631755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003285899,0.000041450883,0.93829674,0.0000023757839,0.00007165184,0.000039927174,0.0001130761,0.000010690424,0.0017101645,0.00006705784,0.056578085,0.0030359507],"study_design_scores_gemma":[0.00026409217,0.00013343773,0.96337825,0.0000056130443,0.000070478185,0.0003068574,0.00010701149,0.000089573565,0.00018594154,0.00034529663,0.03503666,0.000076796634],"about_ca_topic_score_codex":0.0010795512,"about_ca_topic_score_gemma":0.00028463046,"teacher_disagreement_score":0.20913796,"about_ca_system_score_codex":0.00074939104,"about_ca_system_score_gemma":0.0005293149,"threshold_uncertainty_score":0.9176029},"labels":[],"label_agreement":null},{"id":"W1943008665","doi":"10.1093/annonc/mdu337.25","title":"Pancreatic Metastases from Renal Cell Carcinoma: Incidence and Prognostic Impact","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Renal cell carcinoma; Incidence (geometry); Oncology; Internal medicine; Carcinoma","score_opus":0.05595619436937144,"score_gpt":0.34725560715614423,"score_spread":0.2912994127867728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1943008665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906605,0.0032378465,0.00005752656,0.0007174026,0.000039348597,0.00033240783,0.00003311577,0.000018139306,0.0049037305],"genre_scores_gemma":[0.99757314,0.00013591418,0.001567818,0.0004227292,0.00010470439,0.000025442267,0.00005549164,0.000017339104,0.0000974279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986601,0.00022021848,0.0003373647,0.00029744417,0.00019622211,0.00028865054],"domain_scores_gemma":[0.9982141,0.0008610099,0.00020160711,0.00031606873,0.00016265083,0.00024452017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003173879,0.00019029807,0.0006862157,0.000112286034,0.0000346874,0.000007006119,0.000079454556,0.00010501825,0.00014913433],"category_scores_gemma":[0.00035749207,0.00013714677,0.00013443085,0.000106826934,0.0001724883,0.000059665752,0.000065166874,0.00012944886,0.000028871633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001135345,0.00097211293,0.89463353,0.00019944337,0.00032162806,0.0005744826,0.0005600187,0.000014435271,0.0625459,0.00009056256,0.004360576,0.034591958],"study_design_scores_gemma":[0.0017982128,0.012164191,0.89529175,0.000059071575,0.00055444863,0.0001520935,0.00005632916,0.00014298112,0.08769806,0.0005716064,0.0013857426,0.00012552121],"about_ca_topic_score_codex":0.0013939788,"about_ca_topic_score_gemma":0.00004381586,"teacher_disagreement_score":0.034466434,"about_ca_system_score_codex":0.000048012742,"about_ca_system_score_gemma":0.00021547635,"threshold_uncertainty_score":0.5592683},"labels":[],"label_agreement":null},{"id":"W1943352558","doi":"10.5489/cuaj.2842","title":"Comparative effectiveness of adrenal sparing radical nephrectomy and non-adrenal sparing radical nephrectomy in clear cell renal cell carcinoma: Observational study of survival outcomes","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Nephrectomy; Medicine; Renal cell carcinoma; Urology; Observational study; Adrenocortical carcinoma; Internal medicine; Kidney","score_opus":0.06810314614668196,"score_gpt":0.28036744551736525,"score_spread":0.2122642993706833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1943352558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969076,0.00026409279,0.000062576706,0.0003805468,0.00023895457,0.0008382259,0.000025264415,0.000013512549,0.0012692389],"genre_scores_gemma":[0.9987484,0.000007251014,0.0007881253,0.00011109575,0.00019899041,0.000026888281,0.000038290924,0.000026317126,0.00005460783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951345,0.0012793799,0.0011333146,0.0005009649,0.0012190376,0.00073284534],"domain_scores_gemma":[0.9960944,0.0011684824,0.0007094613,0.00021032449,0.00050568226,0.0013116595],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026702299,0.00040427447,0.0015866172,0.00056880055,0.00015947016,0.0000577844,0.00023858617,0.00035731168,0.000075464326],"category_scores_gemma":[0.00052253884,0.0003352553,0.00022923587,0.0005462583,0.0001685985,0.00019205498,0.00009089624,0.0012183853,0.000007303802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014909875,0.0009843373,0.99349666,0.000054126263,0.0001968738,0.00040851824,0.0010310068,0.0008519626,0.0012218149,0.000025108278,0.00017693682,0.000061682156],"study_design_scores_gemma":[0.01391417,0.002907728,0.978782,0.000056883702,0.00025652495,0.00011296938,0.0006992483,0.0008025352,0.001882795,0.00010007723,0.00022331097,0.00026174454],"about_ca_topic_score_codex":0.0067913276,"about_ca_topic_score_gemma":0.002232177,"teacher_disagreement_score":0.014714632,"about_ca_system_score_codex":0.0018732981,"about_ca_system_score_gemma":0.0014654907,"threshold_uncertainty_score":0.99990994},"labels":[],"label_agreement":null},{"id":"W1950005495","doi":"10.1111/bju.13326","title":"Population‐based assessment of cancer‐specific mortality after local tumour ablation or observation for kidney cancer: a competing risks analysis","year":2015,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Propensity score matching; Kidney cancer; Poisson regression; Cancer; Hazard ratio; Confidence interval; Internal medicine; Population; Epidemiology; Cancer registry; Surgery","score_opus":0.10390568676595884,"score_gpt":0.37739854918970817,"score_spread":0.2734928624237493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1950005495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96189874,0.0019415908,0.034613315,0.000859608,0.0002218425,0.0003197314,0.000110344394,0.00000807524,0.000026764572],"genre_scores_gemma":[0.9910156,0.00019549487,0.007906952,0.0003874186,0.00025550424,0.000057895853,0.00014502989,0.000017208273,0.00001890583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812996,0.00018436763,0.00086120487,0.00019238384,0.00043643132,0.00019563663],"domain_scores_gemma":[0.9976311,0.000117053445,0.0008777679,0.00012913077,0.0009902315,0.00025475078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007379895,0.00012521251,0.0006831186,0.00024599492,0.000043353768,0.000019478657,0.00007603591,0.00010164598,0.00017640328],"category_scores_gemma":[0.0001635085,0.00011864621,0.0002718032,0.00038726453,0.000052058876,0.0001073656,0.000014046934,0.00018770057,2.6650284e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001177267,0.00020076738,0.9528282,0.0000776186,0.0007615925,0.00024178458,0.000036980182,0.03569213,0.00027875672,0.000006901872,0.0002652733,0.008432682],"study_design_scores_gemma":[0.0035666192,0.0008078112,0.9549528,0.00012111901,0.0025358591,0.00016985669,0.000043436135,0.037203036,0.00020270907,0.000047945978,0.00026102638,0.000087831766],"about_ca_topic_score_codex":0.0055469703,"about_ca_topic_score_gemma":0.0028102968,"teacher_disagreement_score":0.029116865,"about_ca_system_score_codex":0.00054220256,"about_ca_system_score_gemma":0.0007672917,"threshold_uncertainty_score":0.8385397},"labels":[],"label_agreement":null},{"id":"W1950163147","doi":"10.5489/cuaj.779","title":"Cytoreductive nephrectomy: a treatment of the past","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Nephrectomy; Medicine; General surgery; Internal medicine; Kidney","score_opus":0.015295996649878137,"score_gpt":0.21574687833578052,"score_spread":0.2004508816859024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1950163147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9668978,0.00020681717,0.0000026044127,0.02850084,0.00020739749,0.00035728773,0.000009191362,0.0000071523,0.0038109324],"genre_scores_gemma":[0.99705297,0.000028524839,0.00012632266,0.000851606,0.00038524123,0.000024435325,0.0000036619551,0.0000074161458,0.0015198314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989721,0.00012983684,0.00023162882,0.00011238737,0.0002530219,0.0003010035],"domain_scores_gemma":[0.998847,0.00007615377,0.00022153603,0.00012574454,0.00027535475,0.00045417776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010093541,0.0001110408,0.00023421235,0.00008138698,0.00014264161,0.00003088986,0.00007360842,0.000121240526,0.0008297747],"category_scores_gemma":[0.0001408058,0.000058199217,0.00022088052,0.00016542996,0.000039773244,0.000049080496,0.0000065867775,0.00016980694,0.00008328054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019980855,0.00009746871,0.9894106,0.000001329604,0.00018002541,0.000024471952,0.00019644976,0.000008380653,0.0005624992,0.000047119887,0.0057284334,0.0037232388],"study_design_scores_gemma":[0.00085403176,0.0007277014,0.9758302,0.000005031959,0.00011436482,0.00021636982,0.00008690923,0.000016339154,0.0004234521,0.00043902398,0.021235129,0.000051422216],"about_ca_topic_score_codex":0.0037157554,"about_ca_topic_score_gemma":0.0002880323,"teacher_disagreement_score":0.030155182,"about_ca_system_score_codex":0.0027997408,"about_ca_system_score_gemma":0.0004692369,"threshold_uncertainty_score":0.9085451},"labels":[],"label_agreement":null},{"id":"W1959748419","doi":"10.1111/j.1365-2559.2010.03726.x","title":"Renal oncocytoma revisited: a clinicopathological study of 109 cases with emphasis on problematic diagnostic features","year":2010,"lang":"en","type":"article","venue":"Histopathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Oncocytoma; Renal oncocytoma; Nuclear atypia; Pathology; Medicine; Coagulative necrosis; Clear cell; Chromophobe cell; Histopathology; Adipose capsule of kidney; Atypia; Kidney; Carcinoma; Renal cell carcinoma; Immunohistochemistry; Internal medicine","score_opus":0.03294721836465377,"score_gpt":0.30999771538018944,"score_spread":0.2770504970155357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1959748419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955711,0.00033328412,0.000009639512,0.00022535652,0.00014750322,0.001592176,0.0000125134,0.00008780523,0.0020206661],"genre_scores_gemma":[0.99698216,0.000021256474,0.0018822221,0.00027066385,0.00012295041,0.00022908211,0.00002629339,0.000038480783,0.00042691635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997638,0.00036647465,0.0006501268,0.0006262519,0.00038951548,0.00032961718],"domain_scores_gemma":[0.997053,0.0013701357,0.00035202003,0.0008991113,0.000145176,0.00018054606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051728217,0.0003259819,0.0010699295,0.00027079525,0.00009059304,0.000008390486,0.00015302148,0.00021069005,0.0001600939],"category_scores_gemma":[0.0016774929,0.00020701892,0.00014633205,0.0002446463,0.00031203293,0.000031211457,0.00006045889,0.00061057997,0.000055669007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006151041,0.015866308,0.77026486,0.0005267479,0.00006524746,0.13043304,0.0036382151,0.000019669016,0.06229644,0.00055366335,0.0023679577,0.007816823],"study_design_scores_gemma":[0.003882474,0.037309982,0.93669045,0.00021956653,0.00064570096,0.019010274,0.00022011437,0.000002227546,0.0014588712,0.000058474896,0.00030567707,0.00019619941],"about_ca_topic_score_codex":0.000044565975,"about_ca_topic_score_gemma":0.00019857846,"teacher_disagreement_score":0.16642559,"about_ca_system_score_codex":0.00009978621,"about_ca_system_score_gemma":0.00011271214,"threshold_uncertainty_score":0.84419864},"labels":[],"label_agreement":null},{"id":"W1962536232","doi":"10.5489/cuaj.2817","title":"Imaging hallmark of Xp11.2 translocation renal cell carcinoma","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chromosomal translocation; Renal cell carcinoma; Cancer research; Pathology; Medicine; Internal medicine; Biology; Oncology; Genetics; Gene","score_opus":0.021409007335286948,"score_gpt":0.22298596039813595,"score_spread":0.201576953062849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1962536232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734262,0.0012846712,0.00020733023,0.012040586,0.00021292038,0.00017523638,0.000014224764,0.000015413238,0.012623365],"genre_scores_gemma":[0.99761075,0.000021691301,0.0005004109,0.0010223364,0.00029153694,0.0000047206936,0.0000268167,0.000013583,0.0005081482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832,0.00017668106,0.000427379,0.00017091529,0.00050599617,0.00039903622],"domain_scores_gemma":[0.99781156,0.0000699135,0.00030636907,0.00012648293,0.0005686102,0.0011170608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008235322,0.00013829775,0.0002967147,0.00022351612,0.00009351091,0.00003353726,0.00010051205,0.0001430828,0.00019283875],"category_scores_gemma":[0.0003083641,0.00011339143,0.00016081371,0.00020174161,0.000031415424,0.000092853006,0.0000070939072,0.00038386663,0.000043277494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000118926764,0.00008840605,0.9811662,0.000008121393,0.00004652276,0.00030213257,0.0003888941,0.00009901751,0.0020546534,0.000052331583,0.01166214,0.00401269],"study_design_scores_gemma":[0.0031968409,0.0006673827,0.97495663,0.000016829063,0.00018357813,0.00060955127,0.00024532064,0.000502236,0.0039967704,0.00055061455,0.014906939,0.00016728876],"about_ca_topic_score_codex":0.0019762826,"about_ca_topic_score_gemma":0.00031101963,"teacher_disagreement_score":0.024184505,"about_ca_system_score_codex":0.0018845587,"about_ca_system_score_gemma":0.0012443044,"threshold_uncertainty_score":0.49280554},"labels":[],"label_agreement":null},{"id":"W1964736947","doi":"10.1136/jmg.2010.085068","title":"Novel <i>FH</i> mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma","year":2011,"lang":"en","type":"article","venue":"Journal of Medical Genetics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Victoria General Hospital; BC Cancer Agency","funders":"National Cancer Institute; Institut National Du Cancer","keywords":"Leiomyomatosis; Missense mutation; Germline mutation; Germline; Penetrance; Medicine; Cancer research; Cancer syndrome; Proband; Mutation; Pathology; Genetics; Internal medicine; Biology; Gene; Leiomyoma; Phenotype","score_opus":0.01745354804820557,"score_gpt":0.22532044669794446,"score_spread":0.2078668986497389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964736947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99256474,0.0062703835,0.00016289916,0.0002654878,0.000096959324,0.00024155942,0.0000133409,0.000006465701,0.00037816612],"genre_scores_gemma":[0.9916078,0.0018277874,0.0061023375,0.00024090549,0.000119135795,0.000005231561,0.000013156819,0.00003565965,0.00004800528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979085,0.00005232952,0.00052940025,0.00022773149,0.0010074227,0.00027463926],"domain_scores_gemma":[0.99859697,0.00007326158,0.0002815755,0.00015878674,0.00034303064,0.0005463989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018892172,0.00024148206,0.00045005683,0.00021086115,0.000052031064,0.000014135058,0.00011207768,0.0001697728,0.00008691954],"category_scores_gemma":[0.000023477203,0.00015181613,0.00004067175,0.00028010274,0.00024756172,0.000070703056,0.00005716333,0.00045168778,0.0000011609403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016994387,0.0010059825,0.98443955,0.00022779721,0.0001666599,0.0014998242,0.002023108,0.0000335207,0.0037948082,0.0000011474565,0.0005300993,0.0045780432],"study_design_scores_gemma":[0.010335904,0.007079514,0.9683546,0.00055787276,0.00061114866,0.0009545015,0.0005932244,0.0002938475,0.010695162,0.000009739471,0.00027882433,0.00023569433],"about_ca_topic_score_codex":0.0002309877,"about_ca_topic_score_gemma":0.00015432565,"teacher_disagreement_score":0.016085003,"about_ca_system_score_codex":0.00008029418,"about_ca_system_score_gemma":0.00054220756,"threshold_uncertainty_score":0.61908823},"labels":[],"label_agreement":null},{"id":"W1964762710","doi":"10.1097/spc.0b013e32832e9c6d","title":"The current management of small renal masses","year":2009,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc; Université de Montréal","funders":"","keywords":"Medicine; Cryoablation; Natural history; Radiology; Microwave ablation; Ablative case; Ablation; Kidney cancer; Biopsy; Cryosurgery; Intensive care medicine; Nephrectomy; General surgery; Kidney disease; Kidney; Surgery; Internal medicine; Radiation therapy","score_opus":0.2014019312872931,"score_gpt":0.43450235978053026,"score_spread":0.23310042849323714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964762710","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007289323,0.99509335,0.00003930568,0.000026783644,0.0014027782,0.0024478112,0.0001795324,0.000015751832,0.00072177296],"genre_scores_gemma":[0.00012473023,0.9977582,0.00012468193,0.0000029580979,0.00023487945,0.00036594263,0.0012830321,0.00003384747,0.000071735034],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971739,0.00023507894,0.0011098414,0.0006537523,0.00042034363,0.00040707493],"domain_scores_gemma":[0.99812096,0.00022682271,0.00074352894,0.00045441004,0.00028072382,0.000173528],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020313458,0.0006072882,0.001599587,0.00022954664,0.00009156891,0.0000289322,0.00020035301,0.00012551573,0.000019396799],"category_scores_gemma":[0.000029120687,0.00036767608,0.0005550822,0.00039396458,0.00017811423,0.000033340697,0.00015187937,0.0006595799,0.000013761489],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050209474,0.0001453458,0.0020075412,0.056865443,0.00023964304,0.000018897697,0.000346267,1.5536045e-7,2.2599128e-8,0.00057259615,0.00051574124,0.93923813],"study_design_scores_gemma":[0.00071187894,0.00039784188,0.009555816,0.07990364,0.00082596706,0.0000049813393,0.0003615283,9.583495e-7,0.0000024284263,0.000079802754,0.9078733,0.00028189592],"about_ca_topic_score_codex":0.0000023954087,"about_ca_topic_score_gemma":0.0000025840554,"teacher_disagreement_score":0.93895626,"about_ca_system_score_codex":0.00039417052,"about_ca_system_score_gemma":0.0003226328,"threshold_uncertainty_score":0.9998775},"labels":[],"label_agreement":null},{"id":"W1964947356","doi":"10.1016/j.juro.2010.08.045","title":"Re: Fuhrman Grade Provides Higher Prognostic Accuracy Than Nucleolar Grade for Papillary Renal Cell Carcinoma","year":2010,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Papillary renal cell carcinomas; Renal cell carcinoma; Oncology; Internal medicine; Urology; Pathology; Radiology","score_opus":0.02808995403386303,"score_gpt":0.2701003948512889,"score_spread":0.24201044081742587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964947356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97907805,0.0022706222,0.000049135127,0.016449517,0.0007330306,0.00085961714,0.000006374943,0.000023038132,0.00053059374],"genre_scores_gemma":[0.9958285,0.000093516326,0.0011876547,0.0010917372,0.00125131,0.00001954129,0.000008649706,0.000058062822,0.0004610397],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980854,0.000248816,0.0006225539,0.00020200181,0.0003626529,0.00047857777],"domain_scores_gemma":[0.99729365,0.0010809842,0.0006266954,0.0004946361,0.00023888037,0.0002651246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008205597,0.00027417854,0.00051748985,0.00016632027,0.00015863769,0.00002066706,0.00038893978,0.00020332824,0.00012299564],"category_scores_gemma":[0.00028571486,0.00015731844,0.00029972102,0.00012943907,0.00023187534,0.0001259682,0.00007287626,0.00095497986,0.00002177019],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065976786,0.0015547698,0.17962565,0.00038706255,0.00057864655,0.0016994793,0.0021570972,0.00004261597,0.7814916,0.00048698144,0.02293054,0.0024479078],"study_design_scores_gemma":[0.009881714,0.017776975,0.77105635,0.00005255213,0.0038463399,0.0075977794,0.00027944782,0.00019377288,0.12128823,0.004008639,0.063561454,0.00045671826],"about_ca_topic_score_codex":0.000027552182,"about_ca_topic_score_gemma":0.000026704784,"teacher_disagreement_score":0.66020334,"about_ca_system_score_codex":0.00005154529,"about_ca_system_score_gemma":0.00022031997,"threshold_uncertainty_score":0.641526},"labels":[],"label_agreement":null},{"id":"W1964986931","doi":"10.1007/s11934-014-0396-3","title":"Update on Cryoablation for Treatment of Small Renal Mass: Oncologic Control, Renal Function Preservation, and Rate of Complications","year":2014,"lang":"en","type":"review","venue":"Current Urology Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Cryoablation; Nephrology; Renal function; Renal mass; Urology; Internal medicine; Kidney; Nephrectomy","score_opus":0.11577430627167982,"score_gpt":0.35763534931319907,"score_spread":0.24186104304151923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964986931","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022304363,0.9805492,0.010811551,0.00027314143,0.00050866045,0.005212238,0.000101079015,0.000042467833,0.00027123673],"genre_scores_gemma":[0.011605316,0.9815494,0.00056323205,0.00006069194,0.0002941352,0.001820607,0.0038673768,0.000056514502,0.00018275042],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99696606,0.0003454203,0.0016091806,0.0006898157,0.00014868224,0.00024082235],"domain_scores_gemma":[0.9955351,0.000614546,0.002578525,0.00073510455,0.0004150357,0.000121726225],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00054408837,0.00043762077,0.0022737691,0.00031810295,0.00007036187,0.000006840864,0.00005890489,0.00033529478,0.000019715773],"category_scores_gemma":[0.0002122146,0.0003103079,0.0004918025,0.00015078227,0.00016240387,0.000040393403,0.00001863664,0.00012890597,0.0000037829066],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017019479,0.0020587225,0.0045345123,0.012952422,0.0022088687,0.00006818231,0.000040516672,0.00021722853,0.0001828922,0.0014576544,0.0015311748,0.9730459],"study_design_scores_gemma":[0.0022445298,0.007711514,0.0056305556,0.0012373978,0.008982834,0.00031934326,9.2146064e-7,0.00021583823,0.000038563667,0.0012085789,0.9722077,0.00020221517],"about_ca_topic_score_codex":0.0000081412145,"about_ca_topic_score_gemma":0.000004816679,"teacher_disagreement_score":0.97284365,"about_ca_system_score_codex":0.00020889906,"about_ca_system_score_gemma":0.00033136047,"threshold_uncertainty_score":0.9999349},"labels":[],"label_agreement":null},{"id":"W1965014839","doi":"10.1002/cncr.24682","title":"Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma","year":2009,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Lymphadenectomy; Lymph node; Renal cell carcinoma; Stage (stratigraphy); Nephrectomy; Proportional hazards model; Lymph; Oncology; Cancer; Internal medicine; Urology; Pathology; Kidney","score_opus":0.020045850705944987,"score_gpt":0.24405398161628658,"score_spread":0.2240081309103416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965014839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970034,0.0008914287,0.00003273345,0.00011876527,0.00003250461,0.00077288836,0.00001562847,0.000012179348,0.0011204752],"genre_scores_gemma":[0.9984726,0.000014888384,0.0009897377,0.00018997387,0.00002354648,0.000072059695,0.000030095589,0.00001721695,0.00018993726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988712,0.000036507212,0.00025635023,0.00027212815,0.00033212028,0.00023165908],"domain_scores_gemma":[0.9993409,0.00003901744,0.00012556197,0.00026045082,0.00012740026,0.00010667913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057383775,0.00016366997,0.0003339417,0.000110018635,0.000016780117,0.000004476426,0.0000641764,0.000032468066,0.00007004742],"category_scores_gemma":[0.000019815243,0.000115119205,0.000046923953,0.000267516,0.000047278845,0.000053769578,0.000010259512,0.000083280895,0.0000073346887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081418594,0.00056305825,0.98609525,0.00017515571,0.000018015082,0.0000760781,0.00019049205,0.00017204096,0.008856428,0.000004934104,0.00008707399,0.00294731],"study_design_scores_gemma":[0.0047537987,0.0009967538,0.93235147,0.00024976578,0.00016516041,0.0000022717104,0.00002202424,0.000040274612,0.061268013,0.000018004155,0.000024122011,0.0001083596],"about_ca_topic_score_codex":0.00017742492,"about_ca_topic_score_gemma":0.000015499043,"teacher_disagreement_score":0.053743776,"about_ca_system_score_codex":0.00031293958,"about_ca_system_score_gemma":0.00026214574,"threshold_uncertainty_score":0.4694425},"labels":[],"label_agreement":null},{"id":"W1965216076","doi":"10.1016/j.urology.2006.04.022","title":"Intraoperative laparoscopic renal ultrasonography: Use in advanced laparoscopic renal surgery","year":2006,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Nephrectomy; Adipose capsule of kidney; Cryoablation; Laparoscopy; Laparoscopic surgery; Renal artery; Surgery; Renal vein; Cryotherapy; Radiology; Kidney; Internal medicine; Ablation","score_opus":0.01939167313628231,"score_gpt":0.25271128261704096,"score_spread":0.23331960948075864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965216076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99546385,0.0009446288,0.000056141093,0.00061147736,0.00024111306,0.00047200985,0.000013081122,0.000065822016,0.0021319077],"genre_scores_gemma":[0.99721855,0.00008465141,0.0005406777,0.0007689393,0.00018169652,0.00011036676,0.00017366777,0.000029841665,0.00089163653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790996,0.00020074294,0.0005219842,0.0005526549,0.00020999521,0.0006046855],"domain_scores_gemma":[0.9987838,0.00048631866,0.00011334288,0.0004042191,0.00007631193,0.00013596214],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016204393,0.0003006436,0.00074292236,0.00043931266,0.00006030398,0.000022120681,0.00008263315,0.00020788233,0.00026544803],"category_scores_gemma":[0.00012040486,0.00025959464,0.00016056135,0.00042621733,0.0002115463,0.00015245036,0.000029022285,0.0003737953,0.00009924017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001321529,0.0005586593,0.91389316,0.000038170932,0.00009880637,0.0013308421,0.0001390259,0.00083843153,0.07834341,0.00038796564,0.0023390066,0.00071102416],"study_design_scores_gemma":[0.0045680283,0.0012048105,0.9134143,0.00006785196,0.00012931695,0.0002453721,0.000023479972,0.000100302466,0.07382822,0.00028425356,0.0058440245,0.00029005652],"about_ca_topic_score_codex":0.0005401881,"about_ca_topic_score_gemma":0.0011142571,"teacher_disagreement_score":0.004515186,"about_ca_system_score_codex":0.00012737123,"about_ca_system_score_gemma":0.00015774753,"threshold_uncertainty_score":0.99998564},"labels":[],"label_agreement":null},{"id":"W1965427512","doi":"10.1089/lap.2008.0050","title":"Habib Laparoscopic Bipolar Radiofrequency Device: A Novel Way of Creating an Avascular Resection Margin in Laparoscopic Partial Nephrectomy","year":2008,"lang":"en","type":"article","venue":"Journal of Laparoendoscopic & Advanced Surgical Techniques","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McGill University","keywords":"Medicine; Nephrectomy; Renal hilum; Surgery; Blood loss; Laparoscopy; Resection margin; Renal cell carcinoma; Lesion; Resection; Radiology; Kidney; Internal medicine","score_opus":0.031165041093821063,"score_gpt":0.31035116304967536,"score_spread":0.2791861219558543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965427512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883346,0.008832126,0.00045504872,0.00013257918,0.00023704082,0.0010810845,0.000008220505,0.000115071845,0.0008042316],"genre_scores_gemma":[0.9444586,0.004448705,0.050326746,0.00006120765,0.00036105965,0.00011962621,0.000015796664,0.00006750472,0.00014072891],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9954492,0.00035439097,0.0019406347,0.0005322111,0.0010497922,0.0006737895],"domain_scores_gemma":[0.997184,0.00029046566,0.00095308165,0.0006514803,0.00047485277,0.00044612013],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007609253,0.0004990994,0.0018840666,0.0008300382,0.00014394852,0.00002313505,0.0003338782,0.00026940627,0.00011849911],"category_scores_gemma":[0.00032430913,0.00040831568,0.00047718623,0.0008963658,0.00029539224,0.0006935552,0.00006825772,0.0009700533,0.000003198048],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004576515,0.0033490981,0.37551948,0.0007941785,0.0004112119,0.0057673897,0.00076999154,0.00017239207,0.5916767,0.00037899322,0.00007709717,0.01650695],"study_design_scores_gemma":[0.0125591,0.006588327,0.03378426,0.0021421704,0.00023826706,0.0044588223,0.00010718496,0.000092690716,0.92228156,0.00018660215,0.017162153,0.00039884966],"about_ca_topic_score_codex":0.00020311482,"about_ca_topic_score_gemma":0.000032300904,"teacher_disagreement_score":0.34173524,"about_ca_system_score_codex":0.00062197103,"about_ca_system_score_gemma":0.00040613688,"threshold_uncertainty_score":0.99983686},"labels":[],"label_agreement":null},{"id":"W1965487954","doi":"10.5489/cuaj.2264","title":"Sequential treatments in Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC). Case report and review of the literature.","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Internal medicine; Gemcitabine; Carcinoma; Tyrosine kinase; Tyrosine-kinase inhibitor; Cancer research; Cancer; Pathology; Receptor","score_opus":0.022517881867890277,"score_gpt":0.24069320217387308,"score_spread":0.2181753203059828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965487954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96426624,0.027209766,5.48788e-7,0.0070896954,0.00013985539,0.0002966056,0.000031577187,0.000003716694,0.0009619931],"genre_scores_gemma":[0.99735796,0.00083930313,0.00010617019,0.0011993308,0.00013641545,0.000008467464,0.000019272278,0.000008204937,0.00032484182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849796,0.00027656427,0.00045297726,0.0001921327,0.0003190571,0.0002612958],"domain_scores_gemma":[0.99855965,0.00006801527,0.00032802753,0.0001441837,0.00023967269,0.000660443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007582393,0.00014361167,0.00034745852,0.000120623525,0.00008894562,0.000031629796,0.000049504233,0.0001599571,0.000038672108],"category_scores_gemma":[0.00050870737,0.00008878778,0.000099501245,0.00023251426,0.000043930653,0.000076021635,0.000026528794,0.0003556998,0.0000014281866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003712295,0.0000561472,0.9015374,0.00013072508,0.000060126567,0.0923337,0.00023656852,0.0000010264944,0.00007217184,0.0000055790074,0.0050883316,0.0004410861],"study_design_scores_gemma":[0.0018372262,0.0005112549,0.75959295,0.00060949195,0.00034698623,0.23472618,0.00008570809,0.000014770106,0.00025560337,0.00013586054,0.001770807,0.000113146256],"about_ca_topic_score_codex":0.0024819702,"about_ca_topic_score_gemma":0.0007924837,"teacher_disagreement_score":0.14239247,"about_ca_system_score_codex":0.001045193,"about_ca_system_score_gemma":0.00060366694,"threshold_uncertainty_score":0.3752013},"labels":[],"label_agreement":null},{"id":"W1965989268","doi":"10.1007/s11255-011-0056-1","title":"The effect of insurance status on outcomes after partial nephrectomy","year":2011,"lang":"en","type":"article","venue":"International Urology and Nephrology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Medicaid; Confounding; Logistic regression; Emergency medicine; Nephrectomy; Internal medicine; Proportional hazards model; Health care; Kidney","score_opus":0.012746891725243861,"score_gpt":0.2596752809614879,"score_spread":0.24692838923624405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965989268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99334544,0.00047385923,0.000008323161,0.001251736,0.0004037093,0.00023430506,0.000008977675,0.000013790484,0.004259875],"genre_scores_gemma":[0.9978728,0.00008859579,0.00003667571,0.001660125,0.00006036505,0.0001347554,0.000004866841,0.000007915407,0.00013384226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992027,0.00012795154,0.0001875008,0.00018017458,0.0001068384,0.00019477775],"domain_scores_gemma":[0.9991706,0.0004995424,0.00007417642,0.00015950334,0.000039544015,0.000056649595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013447119,0.000119218115,0.00023392426,0.000067959874,0.000036807167,0.0000024713374,0.00007494043,0.0001025491,0.00016239677],"category_scores_gemma":[0.00007993966,0.00006657592,0.00007354724,0.000027592056,0.000317321,0.000023526094,0.000041158324,0.00015234477,0.000034584908],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013963875,0.00006066614,0.97958446,0.000004618126,0.00033677596,0.00013298463,0.00010116543,8.657467e-7,0.0003802943,0.0017179683,0.00009153623,0.0036248066],"study_design_scores_gemma":[0.0020573207,0.0035347326,0.9762038,0.0000023983002,0.0000715429,0.00012473812,0.000002653132,0.00001824798,0.005275307,0.00037122174,0.012293931,0.00004412253],"about_ca_topic_score_codex":0.000047964157,"about_ca_topic_score_gemma":0.000027776321,"teacher_disagreement_score":0.012202394,"about_ca_system_score_codex":0.0000159829,"about_ca_system_score_gemma":0.000013989298,"threshold_uncertainty_score":0.27148873},"labels":[],"label_agreement":null},{"id":"W1966413475","doi":"10.14740/jmc.v6i4.1844","title":"Contralateral Adrenal Metastasis After Renal Cell Carcinoma Treatment","year":2015,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Metastasis; Primary tumor; Primary treatment; Adrenal gland; Carcinoma; Oncology; Internal medicine; Cancer","score_opus":0.05429012885028065,"score_gpt":0.30265064352945864,"score_spread":0.248360514679178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966413475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864657,0.008432163,0.00006172926,0.0035310076,0.0004097754,0.00020254368,0.000019773912,0.000014479858,0.0008628432],"genre_scores_gemma":[0.996312,0.00015459218,0.0009887448,0.00061385834,0.0011937423,0.00001428197,0.000012193338,0.000030011075,0.00068055355],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9961422,0.00018382909,0.0008470488,0.00021824978,0.002195663,0.00041299142],"domain_scores_gemma":[0.9968391,0.00020761754,0.0003181073,0.00026420245,0.00037961415,0.0019913574],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006937903,0.00030783948,0.00084656,0.00023277673,0.00003343487,0.00003544093,0.00016107498,0.0001794732,0.0014235849],"category_scores_gemma":[0.00035101306,0.00018055312,0.0005314736,0.00014494569,0.00014310912,0.00013510355,0.00004653035,0.00037253453,0.000058286627],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022718724,0.006391046,0.22326972,0.0002514409,0.0016536973,0.63585705,0.0023482828,0.000027250053,0.0023008974,0.000045620494,0.05324112,0.051895186],"study_design_scores_gemma":[0.08404304,0.078662656,0.25599533,0.0010743302,0.008498757,0.28792566,0.0019838468,0.000302173,0.18107802,0.00021319703,0.09903078,0.0011922246],"about_ca_topic_score_codex":0.00018404039,"about_ca_topic_score_gemma":0.000024636334,"teacher_disagreement_score":0.34793139,"about_ca_system_score_codex":0.00059263327,"about_ca_system_score_gemma":0.0013223172,"threshold_uncertainty_score":0.99948925},"labels":[],"label_agreement":null},{"id":"W1966629200","doi":"10.1016/j.eururo.2008.07.026","title":"Re: Bevacizumab plus Interferon alfa-2a for Treatment of Metastatic Renal Cell Carcinoma: A Randomised, Double-Blind Phase III Trial","year":2008,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Bevacizumab; Oncology; Internal medicine; Interferon alfa; Interferon; Urology; Chemotherapy; Immunotherapy; Cancer; Immunology","score_opus":0.09391503087787555,"score_gpt":0.31515652726630383,"score_spread":0.22124149638842827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966629200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.830867,0.01117923,0.0011032259,0.08741695,0.0030283227,0.030585127,0.00080667454,0.00024112569,0.03477234],"genre_scores_gemma":[0.90756387,0.00052098726,0.0010619002,0.046426587,0.009422376,0.0016561341,0.00861852,0.00071384205,0.024015766],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99389315,0.0012043059,0.0019131996,0.0014158941,0.0005563797,0.0010170446],"domain_scores_gemma":[0.9959234,0.000867647,0.0011709592,0.0014951364,0.00025581833,0.00028704078],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046573297,0.0011837578,0.0032739027,0.00069960416,0.00013622908,0.000024147404,0.00041471823,0.00047051394,0.0003699315],"category_scores_gemma":[0.000064635,0.00091102504,0.0015492635,0.00019178443,0.00037844025,0.000052450476,0.00011682186,0.00077066786,0.00015659038],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7320153,0.0015039723,0.000002202929,0.00030318185,0.0011284649,0.015100556,0.0009229161,0.000013618058,0.00046258257,0.0000014113708,0.24758615,0.0009596523],"study_design_scores_gemma":[0.6400213,0.05081619,0.0000034045058,0.00002444565,0.00495456,0.00067236996,0.00002046627,0.000043156928,0.0035872972,0.00000428931,0.29947546,0.00037705255],"about_ca_topic_score_codex":0.00010758728,"about_ca_topic_score_gemma":0.0000113686465,"teacher_disagreement_score":0.09199399,"about_ca_system_score_codex":0.00071652664,"about_ca_system_score_gemma":0.0006179479,"threshold_uncertainty_score":0.99933404},"labels":[],"label_agreement":null},{"id":"W1966925928","doi":"10.1016/j.eururo.2013.08.051","title":"Slow and Steady Wins the Race: Practical (and Philosophical) Considerations of Treatment Activity Evaluation When Novel Anticancer Agents Just Slow Neoplastic Progression","year":2013,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Race (biology); Oncology; Pharmacology; Internal medicine","score_opus":0.1197997273907254,"score_gpt":0.3496696631711289,"score_spread":0.2298699357804035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966925928","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33987272,0.00059839897,0.00009890554,0.65374047,0.0003033993,0.0026165238,0.000048182173,0.000033809873,0.0026875725],"genre_scores_gemma":[0.9531147,0.00019382701,0.0008594585,0.043528955,0.0013270167,0.00014923971,0.00016428788,0.000087253895,0.00057529507],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9966204,0.0014022533,0.0004262273,0.0006950744,0.0005085254,0.00034750137],"domain_scores_gemma":[0.9972325,0.0013527998,0.00042294632,0.00061238586,0.00024307141,0.00013627198],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004818601,0.00043459338,0.0006723435,0.00013344927,0.00017966358,0.000049533384,0.00006637944,0.00039202638,0.00026356967],"category_scores_gemma":[0.0005515137,0.0002640818,0.00010051778,0.000054916683,0.0005911842,0.00008973439,0.00013576877,0.001163911,0.00005938336],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029995919,0.004384679,0.011877628,0.0013008835,0.005621787,0.00662506,0.005728722,0.00012434261,0.019049013,0.0008401984,0.9008994,0.04054867],"study_design_scores_gemma":[0.035008416,0.03280372,0.53248054,0.0007598335,0.031180445,0.01642949,0.00013686862,0.023102833,0.0014883489,0.0021042814,0.32250658,0.0019986196],"about_ca_topic_score_codex":0.00003584165,"about_ca_topic_score_gemma":0.0000064948053,"teacher_disagreement_score":0.6132419,"about_ca_system_score_codex":0.00020989825,"about_ca_system_score_gemma":0.00039962528,"threshold_uncertainty_score":0.99998116},"labels":[],"label_agreement":null},{"id":"W1967195539","doi":"10.5489/cuaj.1642","title":"The association between the anatomical features of renal tumours and the functional outcomes of robot-assisted partial nephrectomy","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Nephrectomy; Medicine; Renal function; Odds ratio; Urology; Magnetic resonance imaging; Renal cell carcinoma; Multivariate analysis; Surgery; Internal medicine; Kidney; Radiology","score_opus":0.014624885213317245,"score_gpt":0.22629785916896225,"score_spread":0.211672973955645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967195539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9252641,0.00033332463,0.0000648803,0.072874315,0.00020904031,0.000302557,0.000019234687,0.000007896625,0.00092463207],"genre_scores_gemma":[0.9980952,0.000038324164,0.00004005211,0.0009938548,0.00043688377,0.000015693859,0.00001378116,0.000008122555,0.00035806707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737656,0.00090375554,0.00051596493,0.00013812636,0.00071435317,0.00035124153],"domain_scores_gemma":[0.9951381,0.00329077,0.00078974996,0.00014880596,0.00036338012,0.00026918825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002936307,0.00014199557,0.00044007014,0.00007208298,0.00051139825,0.000073502306,0.00015587821,0.00020491605,0.00004036439],"category_scores_gemma":[0.0032357012,0.000059848626,0.00027032764,0.00017608763,0.00018773024,0.000042451942,0.000024402825,0.0006618503,0.0000031693808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020575924,0.000017877439,0.99099845,0.000001766332,0.00050615944,0.0000024877736,0.000060311515,0.000028964778,0.000043225707,0.001420845,0.003438765,0.0032754138],"study_design_scores_gemma":[0.0023461473,0.0001614916,0.98873776,0.000006027035,0.00048999983,0.000046254157,0.000047354024,0.00009146011,0.00010747976,0.0010195839,0.006889222,0.000057243564],"about_ca_topic_score_codex":0.0009164437,"about_ca_topic_score_gemma":0.00084870326,"teacher_disagreement_score":0.0728311,"about_ca_system_score_codex":0.00072043977,"about_ca_system_score_gemma":0.00029792494,"threshold_uncertainty_score":0.39333135},"labels":[],"label_agreement":null},{"id":"W1967279872","doi":"10.5489/cuaj.10023","title":"Guidelines on the management of renal cyst disease","year":2010,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; IIf; Radiology; Cyst; Randomized controlled trial; Magnetic resonance imaging; Lesion; Conservative management; Disease; Surgery; Internal medicine","score_opus":0.03033837043950635,"score_gpt":0.2599258282126401,"score_spread":0.22958745777313375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967279872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8901167,0.00008244466,0.000011448551,0.099489756,0.00026641405,0.00020273555,0.000025029683,0.000009016695,0.009796478],"genre_scores_gemma":[0.9925943,0.000038347483,0.000369306,0.0049415603,0.00036689802,0.00000924423,0.000010919,0.0000073865294,0.0016620482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883157,0.00006161722,0.00030576592,0.00011990549,0.0004215901,0.00025954595],"domain_scores_gemma":[0.9986073,0.00008265703,0.00019794122,0.00017153336,0.00029395687,0.0006466064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006282987,0.00009936195,0.00014981494,0.000083110106,0.00015535796,0.000028939392,0.000120164805,0.00008411239,0.00091086264],"category_scores_gemma":[0.00038588388,0.000054959895,0.00014803561,0.00011654395,0.000031496194,0.00002223296,0.000011867189,0.0004590722,0.00006221852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072823337,0.0004114982,0.7701486,0.000040459447,0.0014820588,0.0043066745,0.000113143455,0.00026399738,0.0028824515,0.032760713,0.16673611,0.020126052],"study_design_scores_gemma":[0.00065614405,0.00024009078,0.8848155,0.000029084533,0.00021153767,0.000107093554,0.000029951032,0.00010357504,0.00011141856,0.001507765,0.11211377,0.00007403303],"about_ca_topic_score_codex":0.00014801667,"about_ca_topic_score_gemma":0.00014886563,"teacher_disagreement_score":0.11466694,"about_ca_system_score_codex":0.00032565705,"about_ca_system_score_gemma":0.00021315223,"threshold_uncertainty_score":0.9973307},"labels":[],"label_agreement":null},{"id":"W1967291345","doi":"10.1038/ng849","title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","year":2002,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1634,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hatch (Canada)","funders":"U.S. Public Health Service","keywords":"Biology; Cancer research; Genetics; Germline mutation; Compound heterozygosity; Mutation; Pathogenesis; Germline; Fumarase; Gene; Immunology","score_opus":0.014137535375178496,"score_gpt":0.28032798266857306,"score_spread":0.2661904472933946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967291345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701792,0.026573671,0.000018371895,0.0016236579,0.00014871708,0.00070420624,0.00011387239,0.00003300465,0.00060528115],"genre_scores_gemma":[0.9855493,0.0024916176,0.008351369,0.0006008812,0.00027719926,0.0000628823,0.000101752245,0.000044138706,0.0025208844],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998611,0.0000375549,0.00032702246,0.0004144688,0.0002921815,0.00031781543],"domain_scores_gemma":[0.9991522,0.000040883708,0.00006600018,0.00039124323,0.000100616744,0.00024910158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006824889,0.00024744438,0.00031916925,0.00022029185,0.00004696999,0.000023361774,0.00009767453,0.00028516338,0.00020590366],"category_scores_gemma":[0.000029382865,0.00021337018,0.00005501207,0.00044118377,0.000048769754,0.000035063185,0.00009676485,0.00039973686,0.000019981695],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013231981,0.0019033463,0.2051431,0.0014959123,0.00031616585,0.0039700437,0.0051347655,0.001336553,0.61157733,0.00001496376,0.046744745,0.12103986],"study_design_scores_gemma":[0.004483012,0.0010524701,0.7963399,0.0002794849,0.0002058444,0.00026713772,0.00006410411,0.0026029479,0.14841488,0.00003316543,0.045841273,0.0004157456],"about_ca_topic_score_codex":0.00005723394,"about_ca_topic_score_gemma":0.00014486551,"teacher_disagreement_score":0.59119684,"about_ca_system_score_codex":0.00012957786,"about_ca_system_score_gemma":0.00004400512,"threshold_uncertainty_score":0.87009835},"labels":[],"label_agreement":null},{"id":"W1967432305","doi":"10.1038/nrurol.2010.40","title":"Functional imaging of renal cell carcinoma","year":2010,"lang":"en","type":"review","venue":"Nature Reviews Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"European Association of Urology","keywords":"Medicine; Renal cell carcinoma; Functional imaging; Stage (stratigraphy); Clinical Practice; Radiology; Medical physics; Oncology","score_opus":0.035017747214333046,"score_gpt":0.31672804333264115,"score_spread":0.2817102961183081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967432305","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023978226,0.98750067,0.000023426419,0.00014529131,0.0010271862,0.0021476077,0.000035251916,0.00003113349,0.009065453],"genre_scores_gemma":[0.00030037833,0.99551004,0.00066257414,0.00045985327,0.000989337,0.00021793346,0.000636011,0.000104455175,0.0011194454],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963207,0.00047893098,0.001468603,0.00085856416,0.00039106238,0.00048212922],"domain_scores_gemma":[0.99685365,0.00029203796,0.0012028815,0.0012061158,0.00020206923,0.00024323708],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00065286015,0.0007959584,0.0048414404,0.0004889623,0.00005005199,0.0000075874937,0.0002998894,0.0017926382,0.00073776563],"category_scores_gemma":[0.00022649989,0.0005186339,0.0020126721,0.00044863063,0.00018562503,0.000036921083,0.00013342565,0.0043846387,0.0004326204],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004079161,0.0001626737,0.00015241661,0.02701433,0.00008749509,0.0002912923,0.000006405149,4.5379167e-8,0.000051468793,0.00010223986,0.011283063,0.9608078],"study_design_scores_gemma":[0.00051174127,0.00026830265,0.00018738644,0.0020550082,0.0057293805,0.0033459202,4.846953e-7,9.721116e-7,0.00004055957,0.000016492417,0.9875558,0.00028796733],"about_ca_topic_score_codex":0.000005250242,"about_ca_topic_score_gemma":0.0000027022857,"teacher_disagreement_score":0.9762727,"about_ca_system_score_codex":0.00015763765,"about_ca_system_score_gemma":0.0006684344,"threshold_uncertainty_score":0.99972653},"labels":[],"label_agreement":null},{"id":"W1967490085","doi":"10.5489/cuaj.2321","title":"A rare cause of childhood renal cysts: Xp11.2 translocation renal cell carcinoma","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Renal cell carcinoma; Chromosomal translocation; Asymptomatic; Medicine; Cyst; Kidney; Pathology; Internal medicine; Biology; Genetics; Gene","score_opus":0.022194005711586293,"score_gpt":0.2215556136364821,"score_spread":0.19936160792489582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967490085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872008,0.0011448564,0.000074094474,0.006911253,0.00025142144,0.00031003827,0.00007003302,0.000023115024,0.004014403],"genre_scores_gemma":[0.9973529,0.000038668735,0.0003217736,0.0009874393,0.0004886312,0.000011304612,0.00009485096,0.000022070506,0.0006823883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975717,0.00027507465,0.0006210147,0.00025952226,0.00072846556,0.00054421276],"domain_scores_gemma":[0.9969787,0.00008872833,0.00045989713,0.00020094043,0.00068341393,0.0015883263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078047236,0.00021881876,0.0004546046,0.00030759446,0.00013938517,0.000045805667,0.00015069018,0.0003253452,0.0002631329],"category_scores_gemma":[0.00045865172,0.00017653684,0.00023633977,0.00032470823,0.000041677853,0.00012075628,0.0000114088025,0.00062792294,0.000059083057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033886865,0.0004015947,0.96858716,0.000018285502,0.00024513772,0.0012757014,0.0016466399,0.000259775,0.0031888443,0.00008224869,0.0216214,0.0023343184],"study_design_scores_gemma":[0.004871074,0.0018770376,0.97750854,0.000033095723,0.0003388857,0.0012986384,0.00021066294,0.00008323139,0.0041357465,0.00035074112,0.009066224,0.00022609478],"about_ca_topic_score_codex":0.0012559537,"about_ca_topic_score_gemma":0.0007341182,"teacher_disagreement_score":0.012555176,"about_ca_system_score_codex":0.0023508945,"about_ca_system_score_gemma":0.0020589577,"threshold_uncertainty_score":0.7198963},"labels":[],"label_agreement":null},{"id":"W1967706628","doi":"10.1097/01.ju.0000102409.69570.f5","title":"Natural History of Renal Masses Followed Expectantly","year":2004,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Asymptomatic; Natural history; Abdominal ultrasonography; Renal mass; Nothing; Magnetic resonance imaging; Retrospective cohort study; Radiology; Ultrasonography; Kidney; Nuclear medicine; Surgery; Internal medicine; Nephrectomy","score_opus":0.02003269599874703,"score_gpt":0.24727284786770276,"score_spread":0.22724015186895574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967706628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735543,0.020583533,0.00011137456,0.0026939448,0.0005911946,0.000080295606,3.9521558e-7,0.000005247615,0.0023796856],"genre_scores_gemma":[0.99800825,0.0001823669,0.00052742957,0.00043330927,0.00018133169,6.3161656e-7,5.6412773e-7,0.000010927155,0.00065517664],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990731,0.00010148111,0.00037210246,0.00005949804,0.00024569876,0.00014815644],"domain_scores_gemma":[0.9991157,0.00012288925,0.000370066,0.00018659864,0.00013736259,0.00006737493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030123245,0.00009613514,0.0003417481,0.00012213751,0.000015764894,9.1212274e-7,0.00013876309,0.000054703964,0.000088464],"category_scores_gemma":[0.000086894834,0.000052554613,0.00017264222,0.000057635127,0.00016249235,0.000038242422,0.000022311318,0.00030209895,0.0000073966494],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011294592,0.0006283106,0.005390083,0.0000497601,0.0010974429,0.0027107692,0.004786796,0.0005572636,0.9637453,0.00057235017,0.007747237,0.0014200801],"study_design_scores_gemma":[0.05429291,0.055547353,0.31605694,0.0003798435,0.009155219,0.112252295,0.0018910863,0.000118851516,0.28550398,0.008533578,0.15545313,0.0008148039],"about_ca_topic_score_codex":0.000024301802,"about_ca_topic_score_gemma":0.000007787288,"teacher_disagreement_score":0.6782413,"about_ca_system_score_codex":0.00038141472,"about_ca_system_score_gemma":0.00039749825,"threshold_uncertainty_score":0.21431148},"labels":[],"label_agreement":null},{"id":"W1967975968","doi":"10.5489/cuaj.1811","title":"Renal collision tumour of papillary cell carcinoma and chromophobe cell carcinoma with sarcomatoid transformation: A case report and review of the literature","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Papillary renal cell carcinomas; Chromophobe cell; Clear cell carcinoma; Renal cell carcinoma; Pathology; Clear cell; Carcinoma; Lymphadenectomy; Kidney; Internal medicine","score_opus":0.006706671909849542,"score_gpt":0.1943224250677238,"score_spread":0.18761575315787424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967975968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97567594,0.017684834,0.0000136039735,0.0044438005,0.000048081492,0.0004371418,0.000040241346,0.0000042748597,0.0016520817],"genre_scores_gemma":[0.997549,0.0010515918,0.00020507403,0.0009769563,0.00008418989,0.000006349472,0.000020626778,0.000011787956,0.00009445488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982304,0.00027002292,0.0006062606,0.00019822971,0.0004327691,0.00026234429],"domain_scores_gemma":[0.9980506,0.00013852722,0.00067126134,0.00019520766,0.0004630808,0.00048138076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008599724,0.00018597524,0.0004863728,0.00011288155,0.00019689165,0.00003107019,0.0000732713,0.00017499401,0.00003828452],"category_scores_gemma":[0.00020423182,0.000107037515,0.0001290044,0.00028802257,0.000072901275,0.00008809751,0.000017012215,0.0004315487,5.8264374e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027038873,0.00017427056,0.95525163,0.0037869893,0.00008854561,0.02910906,0.0019951728,0.000013650914,0.0045781545,0.000085331376,0.0038277477,0.0008190276],"study_design_scores_gemma":[0.002524838,0.001875716,0.79403424,0.001326547,0.0004913736,0.18747589,0.00015072926,0.00010172035,0.0087704025,0.00007062504,0.0029721523,0.00020575609],"about_ca_topic_score_codex":0.00051045534,"about_ca_topic_score_gemma":0.00018988836,"teacher_disagreement_score":0.1612174,"about_ca_system_score_codex":0.0003224958,"about_ca_system_score_gemma":0.00045342324,"threshold_uncertainty_score":0.43648633},"labels":[],"label_agreement":null},{"id":"W1968199404","doi":"10.1007/s00261-014-0162-5","title":"Inter-rater agreement in the characterization of cystic renal lesions on contrast-enhanced MRI","year":2014,"lang":"en","type":"article","venue":"Abdominal Imaging","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Hepatology; Contrast (vision); Radiology; Magnetic resonance imaging; Internal medicine; Nuclear medicine; Pathology; Artificial intelligence","score_opus":0.013821486470097665,"score_gpt":0.2606756009138136,"score_spread":0.2468541144437159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968199404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784782,0.0000229215,0.015887793,0.0019827473,0.0000732644,0.00039561407,0.0000028053291,0.0000092522805,0.0031474202],"genre_scores_gemma":[0.9985063,0.000006978677,0.00034824928,0.0008001739,0.000091418224,0.000039245315,0.000038192968,0.000011354035,0.00015810733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989726,0.00013555253,0.00029495303,0.00018961636,0.00022384062,0.00018343305],"domain_scores_gemma":[0.9993744,0.00013314642,0.00011050792,0.00027935806,0.00005924217,0.000043381486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035618036,0.00012902787,0.00022533003,0.00011860632,0.000030554802,0.000016540123,0.00008555543,0.000019269552,0.00007362194],"category_scores_gemma":[0.00005971227,0.00008121975,0.00006508736,0.000105359315,0.000055683966,0.00005572785,0.000020967209,0.00012513065,0.000053749558],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004971696,0.00022667643,0.005109336,0.000042840726,0.000021389098,0.00005822318,0.0010815983,0.000009824576,0.9523802,0.00013739368,0.00005148096,0.040383894],"study_design_scores_gemma":[0.0038269598,0.0008633197,0.39582863,0.0009170587,0.00020282588,0.00010681029,0.00042904034,0.0051636207,0.59149885,0.00011817635,0.00086696167,0.00017772587],"about_ca_topic_score_codex":0.000037826303,"about_ca_topic_score_gemma":0.00000791771,"teacher_disagreement_score":0.3907193,"about_ca_system_score_codex":0.00007686633,"about_ca_system_score_gemma":0.000021493326,"threshold_uncertainty_score":0.3312045},"labels":[],"label_agreement":null},{"id":"W1969279841","doi":"10.1089/end.2006.20.569","title":"Radiofrequency Ablation of Renal Tumors: Intermediate-Term Results","year":2006,"lang":"en","type":"article","venue":"Journal of Endourology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Radiofrequency ablation; Percutaneous; Surgery; Kidney cancer; Ablation; Renal cell carcinoma; Population; Nephrology; Radiology; Urology; Internal medicine","score_opus":0.015947471186422264,"score_gpt":0.25905593051157394,"score_spread":0.24310845932515168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969279841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912497,0.0012393749,0.00019129956,0.0006593208,0.00025373977,0.00011930875,0.0000071714967,0.000007940322,0.0062721665],"genre_scores_gemma":[0.998026,0.00006878962,0.00083418365,0.00007597284,0.00073085335,0.0000015050285,0.000017218974,0.000014081914,0.00023140291],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982976,0.00010071095,0.0009986156,0.00012535379,0.00028018662,0.00019757026],"domain_scores_gemma":[0.9983713,0.00015332154,0.00091869175,0.00019088504,0.00026920642,0.000096620344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037996285,0.00012667841,0.0004941643,0.00031873182,0.000017321243,0.000004589987,0.00010156104,0.0000943876,0.00007341093],"category_scores_gemma":[0.00017578645,0.00009293913,0.00020652238,0.000109965295,0.0001041394,0.000084889616,0.00001747118,0.00026904445,0.000008316012],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018763566,0.0016490874,0.20838124,0.00019376237,0.000681673,0.013057206,0.00069897197,0.0012126294,0.7245159,0.0010624807,0.013089375,0.016694093],"study_design_scores_gemma":[0.014287085,0.009783979,0.8321588,0.00022445813,0.00051975856,0.012560713,0.000029879164,0.00011717867,0.12541954,0.0017418835,0.002997884,0.0001588333],"about_ca_topic_score_codex":0.000039213905,"about_ca_topic_score_gemma":0.0000055485566,"teacher_disagreement_score":0.62377757,"about_ca_system_score_codex":0.00011762692,"about_ca_system_score_gemma":0.00014862578,"threshold_uncertainty_score":0.37899476},"labels":[],"label_agreement":null},{"id":"W1969344095","doi":"10.1007/s11255-009-9545-x","title":"Prolonged use of the tyrosine kinase inhibitor in a peritoneal dialysis patient with metastatic renal cell carcinoma: possible beneficial effects on peritoneal membrane and peritonitis rates","year":2009,"lang":"en","type":"article","venue":"International Urology and Nephrology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Peritoneal dialysis; Peritoneum; Peritonitis; Vascular endothelial growth factor; Tyrosine-kinase inhibitor; Metastasis; Sunitinib; Angiogenesis; Tyrosine kinase; Cancer research; Renal cell carcinoma; Internal medicine; Pathology; Cancer","score_opus":0.010367346061489393,"score_gpt":0.22916313321531961,"score_spread":0.21879578715383022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969344095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99353534,0.0005925917,0.0000030607614,0.0050020493,0.00013443621,0.00057464343,0.000029358014,0.000010776702,0.00011772787],"genre_scores_gemma":[0.9975866,0.00003957394,0.00029822625,0.0018157505,0.0001137974,0.00006245596,0.00003324787,0.000014409404,0.000035955716],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99854237,0.00023048911,0.00032865413,0.00040528626,0.00023219244,0.00026100178],"domain_scores_gemma":[0.9991746,0.00029767884,0.00014791789,0.0001837559,0.00010638179,0.00008964572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009385867,0.0002400864,0.0004716416,0.00025456908,0.00008159588,0.000017448227,0.00008016217,0.0001341742,0.000021971553],"category_scores_gemma":[0.00006122113,0.00015877289,0.00007370608,0.0001461407,0.00030551114,0.00007940512,0.00005685021,0.00029694082,0.0000012288931],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038220417,0.0028368297,0.45475185,0.00019038639,0.00053246337,0.004519386,0.0034180784,0.00049156096,0.4833989,0.0010142248,0.000119844015,0.010506065],"study_design_scores_gemma":[0.0048953095,0.010716849,0.8236277,0.0000324418,0.00033363048,0.0011262696,0.000033313736,0.00069736753,0.15808594,0.00010312133,0.00019923915,0.00014878673],"about_ca_topic_score_codex":0.00021778373,"about_ca_topic_score_gemma":0.00021739342,"teacher_disagreement_score":0.3688759,"about_ca_system_score_codex":0.00005471883,"about_ca_system_score_gemma":0.000087362845,"threshold_uncertainty_score":0.64745706},"labels":[],"label_agreement":null},{"id":"W1970912779","doi":"10.5489/cuaj.1679","title":"Comparison of robotic and open partial nephrectomy: Single-surgeon matched cohort study","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Perioperative; Body mass index; Renal function; Cohort; Surgery; American society of anesthesiologists; Prospective cohort study; Internal medicine; Kidney","score_opus":0.042695476211499835,"score_gpt":0.2880650289957445,"score_spread":0.24536955278424466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970912779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99358153,0.000085603286,0.000058476242,0.0032675245,0.00016366264,0.0007132811,0.00000252894,0.0000103285165,0.002117071],"genre_scores_gemma":[0.99887997,0.000004407111,0.0002192472,0.0005201298,0.00014808161,0.00001908982,0.000009897087,0.000010736094,0.0001884303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982325,0.00039307724,0.0004777592,0.000205881,0.00035506417,0.00033570803],"domain_scores_gemma":[0.9984114,0.00021010873,0.00038105724,0.00013237887,0.00019588662,0.0006691694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012113586,0.00013454532,0.00067898835,0.00011616914,0.00015384586,0.00010866834,0.00012998637,0.00014018772,0.00024063324],"category_scores_gemma":[0.0006596295,0.00010448343,0.00007385392,0.0001381655,0.000030643798,0.000072553776,0.000038825114,0.00033340885,0.000014275276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008429322,0.0003171763,0.99632055,0.0000034128334,0.00018497372,0.00003409597,0.00017241751,0.00007899073,0.00018045184,0.000028566827,0.0010328215,0.0015622247],"study_design_scores_gemma":[0.0016256341,0.0020185988,0.99147964,0.000009765667,0.00029866592,0.00006530565,0.0001465037,0.0005890957,0.00014307033,0.00011638635,0.0034142318,0.0000930941],"about_ca_topic_score_codex":0.0027053119,"about_ca_topic_score_gemma":0.0017430632,"teacher_disagreement_score":0.0052984576,"about_ca_system_score_codex":0.00074879767,"about_ca_system_score_gemma":0.00021480616,"threshold_uncertainty_score":0.42607105},"labels":[],"label_agreement":null},{"id":"W1970960761","doi":"10.1111/j.1440-1827.2007.02205.x","title":"Oncocytic papillary renal cell carcinoma with solid architecture: Mimic of renal oncocytoma","year":2008,"lang":"en","type":"article","venue":"Pathology International","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Oncocytoma; CD117; Pathology; Immunophenotyping; Cytokeratin; Vimentin; Papillary renal cell carcinomas; Renal cell carcinoma; Renal oncocytoma; Immunohistochemistry; Clear cell; Biology; Medicine; Antigen; Immunology","score_opus":0.01852997284425784,"score_gpt":0.25349524647734306,"score_spread":0.23496527363308523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970960761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782402,0.00039621,0.0009599194,0.0007013195,0.00021441639,0.00028913803,0.000039255003,0.000047319085,0.019112237],"genre_scores_gemma":[0.99236745,0.00004916518,0.0050531854,0.00033664214,0.00029595013,0.00004008406,0.0001683681,0.00003891918,0.001650227],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981129,0.000090289715,0.00045404217,0.00045134005,0.00056842517,0.00032300726],"domain_scores_gemma":[0.9988264,0.00010690476,0.00024610906,0.00040012633,0.00025604392,0.00016442275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011893839,0.00027648488,0.00047579402,0.00031393353,0.000072238036,0.000004821853,0.00022569131,0.00014785951,0.00033050656],"category_scores_gemma":[0.0000373914,0.00020971936,0.0001850941,0.00014104154,0.00041503515,0.000050347182,0.00008487841,0.00034490388,0.000073252224],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052572,0.0015727434,0.35970867,0.00015777812,0.00057789794,0.04716535,0.002619989,0.000893147,0.5770343,0.0002568684,0.002581273,0.0021747623],"study_design_scores_gemma":[0.0065888967,0.0040682307,0.5162669,0.00010460783,0.00026266105,0.04251165,0.00006303768,0.00030121097,0.42802185,0.00016670585,0.0013222769,0.00032197434],"about_ca_topic_score_codex":0.000036795947,"about_ca_topic_score_gemma":0.00001520957,"teacher_disagreement_score":0.15655822,"about_ca_system_score_codex":0.00027840544,"about_ca_system_score_gemma":0.00039398708,"threshold_uncertainty_score":0.8552108},"labels":[],"label_agreement":null},{"id":"W1971026009","doi":"10.1016/j.urology.2013.09.060","title":"Laparoscopic Management of Advanced Renal Cell Carcinoma With Renal Vein and Inferior Vena Cava Thrombus","year":2014,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Joseph’s Healthcare Hamilton; McMaster University","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Inferior vena cava; Thrombus; Renal vein; Surgery; Kidney disease; Vein; Radiology; Kidney; Internal medicine","score_opus":0.008559401437194842,"score_gpt":0.22618693993262565,"score_spread":0.21762753849543082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971026009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98649234,0.0007484261,0.00019710495,0.00030887616,0.000060176022,0.00037400698,0.0000034779328,0.000025007968,0.011790597],"genre_scores_gemma":[0.9971573,0.000036592934,0.0018016252,0.00021475911,0.000044578395,0.00002668026,0.00002256448,0.000024365974,0.00067155046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890035,0.00006454465,0.00022915583,0.00034278864,0.00017543582,0.0002876968],"domain_scores_gemma":[0.9992728,0.000048116413,0.00011254394,0.00039171628,0.000048764283,0.00012604031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009401495,0.00018681619,0.00042769048,0.000094534655,0.000037194084,0.0000045187744,0.000071902396,0.00008132002,0.000058938753],"category_scores_gemma":[0.000006550817,0.00014066274,0.00004021702,0.00009727546,0.00017681728,0.000031568798,0.00006802152,0.0001334785,0.000017242033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012651083,0.001952457,0.61161476,0.0031967754,0.0011530998,0.0037454325,0.0023568633,0.0014430395,0.31512642,0.0046187565,0.0015283775,0.04061292],"study_design_scores_gemma":[0.012103163,0.013810601,0.8587304,0.00007966061,0.0007472204,0.00030620475,0.000085908665,0.00023984576,0.105956085,0.00017637212,0.007506528,0.00025800787],"about_ca_topic_score_codex":0.000038906423,"about_ca_topic_score_gemma":0.000019849034,"teacher_disagreement_score":0.24711563,"about_ca_system_score_codex":0.000039753846,"about_ca_system_score_gemma":0.000035887482,"threshold_uncertainty_score":0.573606},"labels":[],"label_agreement":null},{"id":"W1971365073","doi":"10.2147/btt.s6748","title":"Everolimus: the first approved product for patients with advanced renal cell cancer after sunitinib and/or sorafenib","year":2010,"lang":"en","type":"article","venue":"Biologics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Sunitinib; Sorafenib; Everolimus; Medicine; Internal medicine; Oncology; Renal cell carcinoma; Urology","score_opus":0.01719074779736497,"score_gpt":0.24529601222092892,"score_spread":0.22810526442356396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971365073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99634206,0.00036337815,0.0000113226315,0.0009898831,0.00015837718,0.0018103401,0.00008375453,0.000034212215,0.0002066587],"genre_scores_gemma":[0.9953498,0.00007596783,0.0023089023,0.00057620264,0.00019549722,0.0007690833,0.00008370572,0.000020772733,0.00062001985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991475,0.000016248643,0.0001460607,0.00032595743,0.00011010598,0.0002541466],"domain_scores_gemma":[0.9992304,0.000106806205,0.000092590526,0.00032341553,0.00017086937,0.000075923715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009101049,0.00018706785,0.00020886144,0.000023845774,0.000102885824,0.000013499856,0.000080736136,0.00007777848,0.000046379497],"category_scores_gemma":[0.000078481855,0.00007778979,0.00004627358,0.00007465057,0.00014501548,0.000035274366,0.000039414528,0.00016320613,0.0000037000113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026015945,0.0014495377,0.908598,0.00047658055,0.00022045492,0.000043315766,0.0008526618,0.000009778032,0.01760475,0.000042348325,0.0027100022,0.041976612],"study_design_scores_gemma":[0.006593572,0.004921584,0.86805785,0.000064259555,0.00023830635,0.00001370925,0.00007951398,0.000024664048,0.023750506,0.000040786013,0.09592127,0.0002939589],"about_ca_topic_score_codex":0.000021571383,"about_ca_topic_score_gemma":0.00024332081,"teacher_disagreement_score":0.09321127,"about_ca_system_score_codex":0.000031347736,"about_ca_system_score_gemma":0.00007082254,"threshold_uncertainty_score":0.31721753},"labels":[],"label_agreement":null},{"id":"W1971549450","doi":"10.1038/bjc.2014.25","title":"First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; London Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Dalhousie University; University of Toronto; University Health Network; University of Calgary","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Clinical trial; Population; Proportional hazards model; Progression-free survival; Hazard ratio; Renal cell carcinoma; Oncology; Overall survival; Surgery; Confidence interval","score_opus":0.04437082598213789,"score_gpt":0.30390294821716096,"score_spread":0.2595321222350231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971549450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90207005,0.053755518,0.02935068,0.0075972117,0.002358748,0.004071269,0.00027179503,0.00001753999,0.00050721667],"genre_scores_gemma":[0.97127336,0.0050551007,0.010634276,0.003033039,0.00857516,0.00043897174,0.00004364048,0.0000655072,0.00088092155],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99859375,0.00009143267,0.00055050594,0.00018478998,0.00031938276,0.00026015786],"domain_scores_gemma":[0.9977028,0.0011453967,0.00040768954,0.00018054809,0.00041788095,0.00014568651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085918995,0.00015944536,0.0005112095,0.00003505558,0.00015868315,0.00007829497,0.00019338491,0.000102329606,0.00077067164],"category_scores_gemma":[0.00026026342,0.000112298774,0.00045951852,0.000057514215,0.00005450798,0.000092258255,0.000011249737,0.00022002078,0.0000012618102],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18063566,0.0006356485,0.0010990001,0.00010557863,0.0017543806,0.00013238228,0.00044537146,0.00038620282,0.0019996571,0.000053688098,0.3435559,0.46919653],"study_design_scores_gemma":[0.24115272,0.015359322,0.026068062,0.0011618874,0.0009947378,0.0007797233,0.000104282764,0.0010793578,0.021816092,0.004460059,0.6866505,0.00037322548],"about_ca_topic_score_codex":0.00026933305,"about_ca_topic_score_gemma":0.0005785093,"teacher_disagreement_score":0.4688233,"about_ca_system_score_codex":0.00015006358,"about_ca_system_score_gemma":0.0002889016,"threshold_uncertainty_score":0.8438314},"labels":[],"label_agreement":null},{"id":"W1971705000","doi":"10.1016/j.critrevonc.2011.06.001","title":"Combination or sequencing strategies to improve the outcome of metastatic renal cell carcinoma patients: A critical review","year":2011,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Temsirolimus; Medicine; Tolerability; Everolimus; Oncology; Bevacizumab; Renal cell carcinoma; Clinical trial; Internal medicine; Combination therapy; Targeted therapy; Discovery and development of mTOR inhibitors; Intensive care medicine; Cancer; Adverse effect; Chemotherapy; PI3K/AKT/mTOR pathway","score_opus":0.2091943021318495,"score_gpt":0.4524947061415655,"score_spread":0.243300404009716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971705000","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006748292,0.9846438,0.00021485426,0.0011074691,0.0006208883,0.008570834,0.000056352466,0.000031369444,0.0046869586],"genre_scores_gemma":[0.0019599884,0.9879485,0.004363766,0.0019187629,0.00006662239,0.0033971276,0.000109627275,0.00010638522,0.0001292287],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.98835844,0.003563731,0.0053067934,0.0012175263,0.00047910478,0.00107442],"domain_scores_gemma":[0.989105,0.0071719433,0.00092670816,0.0015599,0.0007247502,0.0005117174],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002862613,0.0010965653,0.010657558,0.0004844859,0.00009955136,0.000022909806,0.00078125176,0.00070034387,0.0006164569],"category_scores_gemma":[0.019332895,0.00059863675,0.0013375999,0.0009782359,0.0010006251,0.00015066596,0.0003958202,0.0016204607,0.0004234724],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015745968,0.002292479,0.00018060597,0.5067128,0.00015339168,0.0015995946,0.0002343246,2.192701e-8,0.000003700972,0.0659196,0.0029732971,0.4197727],"study_design_scores_gemma":[0.0015540185,0.0070154816,0.000059594462,0.13046706,0.011150926,0.0022964594,0.00016755208,0.0000029999712,0.000039693405,0.0012862132,0.84516305,0.0007969788],"about_ca_topic_score_codex":0.000050310016,"about_ca_topic_score_gemma":0.000043086722,"teacher_disagreement_score":0.8421897,"about_ca_system_score_codex":0.0015061167,"about_ca_system_score_gemma":0.0022004095,"threshold_uncertainty_score":0.9996465},"labels":[],"label_agreement":null},{"id":"W1971872052","doi":"10.1016/j.urology.2006.09.061","title":"Intact Specimen Extraction in Laparoscopic Nephrectomy Procedures: Pfannenstiel Versus Expanded Port Site Incisions","year":2007,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Nephrectomy; Surgery; Laparoscopy; Port (circuit theory); Urology; Kidney; Internal medicine","score_opus":0.027628067722236836,"score_gpt":0.32141792242057804,"score_spread":0.2937898546983412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971872052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98274684,0.0003276548,0.0001422918,0.00043833753,0.0004954055,0.00049359904,0.0000020555067,0.00007065072,0.015283193],"genre_scores_gemma":[0.9982485,0.000044842942,0.00041164996,0.0004313698,0.00023269805,0.000029207451,0.00005737756,0.000023429697,0.00052089035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985978,0.000039563358,0.0003634842,0.00036570866,0.00020786341,0.00042555216],"domain_scores_gemma":[0.99912316,0.00025708516,0.00009355085,0.00030449763,0.000053229498,0.00016846207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002178496,0.00018565031,0.0003359067,0.00035706713,0.00004467718,0.0000068551894,0.00006437725,0.00020713102,0.00030801582],"category_scores_gemma":[0.00021994069,0.00016257458,0.00006975641,0.00026857402,0.000060735114,0.00007435582,0.000039562718,0.00033136705,0.00022200168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02453106,0.0016035357,0.8275317,0.000105889594,0.00024458516,0.00657599,0.0020410838,0.00013763794,0.12408002,0.00031915275,0.0029714098,0.009857941],"study_design_scores_gemma":[0.013298299,0.003610227,0.9335807,0.0000362698,0.00021106355,0.0008232965,0.0003562527,0.00011205226,0.026617479,0.00014821324,0.020944018,0.0002621119],"about_ca_topic_score_codex":0.0001872752,"about_ca_topic_score_gemma":0.0011857233,"teacher_disagreement_score":0.106049016,"about_ca_system_score_codex":0.00027384315,"about_ca_system_score_gemma":0.00018171346,"threshold_uncertainty_score":0.6629599},"labels":[],"label_agreement":null},{"id":"W1972642455","doi":"10.1016/j.eururo.2007.01.072","title":"Editorial Comment on: Collecting Duct Renal Cell Carcinoma: A Matched Analysis of 41 Cases","year":2007,"lang":"en","type":"editorial","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Renal cell carcinoma; Carcinoma; General surgery; Urology; Pathology","score_opus":0.023795537560253696,"score_gpt":0.27817511336439327,"score_spread":0.25437957580413956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972642455","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06003325,0.00048565035,0.000014378723,0.00028528957,0.90973586,0.00061974704,0.00027579657,0.00008688172,0.028463127],"genre_scores_gemma":[0.22286275,0.000036027974,0.000105599014,0.0003964203,0.773745,0.000012987914,0.0013945976,0.0001556343,0.0012910085],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99400145,0.0010866846,0.0012988198,0.001148628,0.001675067,0.00078935735],"domain_scores_gemma":[0.99310714,0.0035484112,0.0009907373,0.0012593713,0.00073276705,0.00036155735],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016708312,0.00078406534,0.0023082802,0.0015654651,0.00014996322,0.000027680693,0.0004148999,0.0007505301,0.00027486496],"category_scores_gemma":[0.0013716349,0.00069493137,0.0009318661,0.0011692296,0.00022928164,0.000024301107,0.00026991384,0.001908031,0.00015204826],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039944514,0.00071271276,0.00043531272,0.0001523099,0.002139448,0.005725476,0.0003951685,0.000092518094,0.0006885762,0.0000024257572,0.9855776,0.00008402444],"study_design_scores_gemma":[0.0044008014,0.007871851,0.0024720954,0.000036313344,0.013250658,0.000052864736,0.00007369574,0.000020276222,0.0012334362,0.0000014577788,0.97013766,0.000448919],"about_ca_topic_score_codex":0.0005481275,"about_ca_topic_score_gemma":0.00004728726,"teacher_disagreement_score":0.16282949,"about_ca_system_score_codex":0.0005760273,"about_ca_system_score_gemma":0.0005377516,"threshold_uncertainty_score":0.99955016},"labels":[],"label_agreement":null},{"id":"W1973061977","doi":"10.3747/co.v16i0.430","title":"Sorafenib in the Management of Metastatic Renal Cell Carcinoma","year":2009,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc","funders":"","keywords":"Sorafenib; Medicine; Renal cell carcinoma; Internal medicine; Oncology; Cancer research; Pathology; Hepatocellular carcinoma","score_opus":0.1117335116971616,"score_gpt":0.38070498993360213,"score_spread":0.2689714782364405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973061977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96750635,0.0039949245,0.00007399346,0.0012248855,0.0001828023,0.00075417594,0.0000031515551,0.000010871573,0.026248846],"genre_scores_gemma":[0.9982787,0.00016080978,0.001109729,0.0001617268,0.000049467075,0.000045708042,0.000027118234,0.0000070541796,0.00015971252],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987174,0.00015710291,0.00036926684,0.00022824464,0.00026379936,0.00026414488],"domain_scores_gemma":[0.9993436,0.00007013037,0.0001222436,0.0003549088,0.000043902848,0.000065238724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000319957,0.00014934341,0.00037087372,0.00013742819,0.00002285621,0.000003915642,0.00014560464,0.000037957252,0.00006712267],"category_scores_gemma":[0.0000053320005,0.00009510142,0.0001178214,0.0002551528,0.0000621595,0.00002419298,0.000028981072,0.00020681354,0.000034534216],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023837734,0.022456836,0.06742057,0.0024465902,0.00033527994,0.0088948645,0.008051577,0.00008601605,0.009995215,0.0104028545,0.01470754,0.8528189],"study_design_scores_gemma":[0.009894483,0.006370883,0.9261697,0.00017926836,0.0011144732,0.00027807927,0.0016294732,0.00014904431,0.010092522,0.0014673762,0.04242426,0.0002304502],"about_ca_topic_score_codex":0.000008799917,"about_ca_topic_score_gemma":0.0000047297426,"teacher_disagreement_score":0.8587491,"about_ca_system_score_codex":0.0002101602,"about_ca_system_score_gemma":0.0000789183,"threshold_uncertainty_score":0.38781235},"labels":[],"label_agreement":null},{"id":"W1973263699","doi":"10.1016/j.urolonc.2013.06.010","title":"A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma","year":2013,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Stage (stratigraphy); Poisson regression; Population; Kidney cancer; Cancer; Relative survival; Internal medicine; Urology; Surgery; Oncology; Cancer registry; Kidney","score_opus":0.040194092652696946,"score_gpt":0.30852075393608525,"score_spread":0.2683266612833883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973263699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946906,0.00050511473,0.0002543829,0.0017194974,0.00007340057,0.00081386353,0.00006228347,0.000033003093,0.0018478609],"genre_scores_gemma":[0.93340135,0.0000106748075,0.064656384,0.0007547372,0.000061350765,0.000439796,0.00039361988,0.000014184567,0.00026792136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854064,0.00014340697,0.00045608176,0.00039095423,0.00017399821,0.0002949118],"domain_scores_gemma":[0.99826974,0.00075298914,0.0002578808,0.0002655221,0.00019229934,0.0002615841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002628404,0.00022001567,0.0007281054,0.0004288873,0.00012734094,0.000016530379,0.00007463262,0.0002095824,0.00029786807],"category_scores_gemma":[0.00010616549,0.00017682055,0.00022856666,0.0005544651,0.00030128256,0.000059944417,0.000025747106,0.00016583403,0.000008714707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021775323,0.00023763775,0.99646604,0.000059905204,0.0002277989,0.00002646289,0.00014400776,0.0007179043,0.0010780798,0.00026422387,0.00027874604,0.000281428],"study_design_scores_gemma":[0.0018417834,0.0030175315,0.9471088,0.000020278943,0.004798974,0.000016510507,0.00012979086,0.013594639,0.0019721393,0.0005975882,0.026692424,0.00020952056],"about_ca_topic_score_codex":0.0011178093,"about_ca_topic_score_gemma":0.00013963935,"teacher_disagreement_score":0.064402,"about_ca_system_score_codex":0.00013424172,"about_ca_system_score_gemma":0.00024246705,"threshold_uncertainty_score":0.7210533},"labels":[],"label_agreement":null},{"id":"W1973367645","doi":"10.1111/j.1365-2559.2007.02931.x","title":"Progesterone receptor reactivity in renal oncocytoma and chromophobe renal cell carcinoma","year":2007,"lang":"en","type":"article","venue":"Histopathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Oncocytoma; Chromophobe cell; CD117; Clear cell; Renal cell carcinoma; Eosinophilic; Pathology; Biology; Medicine","score_opus":0.018169273278202606,"score_gpt":0.253082966183561,"score_spread":0.2349136929053584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973367645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838738,0.0017863337,0.00005990527,0.00031476028,0.00019285208,0.0005213079,0.000006718909,0.00005635079,0.013187958],"genre_scores_gemma":[0.9947696,0.00003918148,0.002672518,0.00018502289,0.000178439,0.0000369188,0.00003889091,0.000038376325,0.0020410754],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980818,0.00012687828,0.00042505443,0.0006051541,0.00022609952,0.0005350016],"domain_scores_gemma":[0.99901116,0.000095447795,0.00014526244,0.0004356715,0.000058735703,0.0002537114],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00064985565,0.0002695575,0.00054344186,0.00032178237,0.000062481704,0.000006742519,0.000076279386,0.00024796414,0.000095024065],"category_scores_gemma":[0.000047509315,0.00024640854,0.00007594476,0.00020747974,0.00024244956,0.00008679377,0.000077786375,0.00040751908,0.00007315613],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011720272,0.00048780002,0.18176754,0.000086125016,0.0000024252718,0.008347398,0.0007732714,2.4954767e-7,0.80215144,0.000035684036,0.0004578348,0.0047181924],"study_design_scores_gemma":[0.0028083264,0.0018169442,0.79803455,0.000035981386,0.000053273652,0.0028772335,0.000051801806,0.0000047050075,0.18473005,0.000018724788,0.0093864845,0.00018191949],"about_ca_topic_score_codex":0.00021351488,"about_ca_topic_score_gemma":0.00027574148,"teacher_disagreement_score":0.6174214,"about_ca_system_score_codex":0.0008266252,"about_ca_system_score_gemma":0.00014794173,"threshold_uncertainty_score":0.9999988},"labels":[],"label_agreement":null},{"id":"W1973736405","doi":"10.1245/s10434-014-3821-4","title":"Long-term Survival After Pancreatic Resection for Renal Cell Carcinoma Metastasis","year":2014,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Surgical oncology; Renal cell carcinoma; Surgery; Carcinoma; Lymph node; Metastasis; Retrospective cohort study; Survival rate; Internal medicine; Cancer","score_opus":0.07882516864678499,"score_gpt":0.35421122672351235,"score_spread":0.27538605807672734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973736405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97915286,0.0010408515,0.00021482742,0.0030703107,0.00020905327,0.00059116894,0.00002218939,0.000025196045,0.015673544],"genre_scores_gemma":[0.99674433,0.00044390734,0.0005632044,0.00024312503,0.00039784136,0.00018236945,0.00007134457,0.000031948253,0.001321924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979648,0.0003231165,0.0005460163,0.00040296515,0.00030981973,0.00045326535],"domain_scores_gemma":[0.9979316,0.00085704186,0.0002058679,0.00037581223,0.00034643503,0.00028322457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078761735,0.00022853682,0.00092570175,0.00016927515,0.000048277594,0.00000774302,0.000094217015,0.00022510032,0.000357351],"category_scores_gemma":[0.000051149887,0.00017465623,0.0004560446,0.00016223533,0.00015736946,0.000057702295,0.000053239586,0.0001692827,0.000038228824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.109936565,0.008353707,0.63453746,0.0036433968,0.0019316317,0.005275507,0.0006799646,0.000043332453,0.02301595,0.0017864596,0.0095088845,0.20128712],"study_design_scores_gemma":[0.011155815,0.032548334,0.5997481,0.00011813434,0.001277453,0.00049214857,0.000043200296,0.00007657564,0.20775828,0.0003905879,0.1459671,0.0004243126],"about_ca_topic_score_codex":0.000060897866,"about_ca_topic_score_gemma":0.000050447827,"teacher_disagreement_score":0.20086281,"about_ca_system_score_codex":0.00008267929,"about_ca_system_score_gemma":0.00012162039,"threshold_uncertainty_score":0.7122274},"labels":[],"label_agreement":null},{"id":"W1974008015","doi":"10.1038/ncpuro0254","title":"The natural history of small renal masses","year":2005,"lang":"en","type":"review","venue":"Nature Clinical Practice Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Asymptomatic; Natural history; Radiology; Incidence (geometry); Biopsy; Conservative management; Disease; Renal mass; Watchful waiting; Kidney; Oncology; Internal medicine; Surgery; Cancer","score_opus":0.11679834599571662,"score_gpt":0.4463477571599145,"score_spread":0.3295494111641979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974008015","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000056436584,0.96820116,0.0000034485586,0.0043470208,0.005072288,0.0010345989,0.00000769734,0.000048807793,0.021279335],"genre_scores_gemma":[0.000065328466,0.9811688,0.0033207538,0.0038863725,0.0027088027,0.00005699326,0.00009899348,0.000086220556,0.008607704],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928192,0.0030373554,0.0022628487,0.00086003373,0.0005189919,0.00050155405],"domain_scores_gemma":[0.95291257,0.042609096,0.0024170307,0.0013284282,0.00049416657,0.00023872305],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.003806305,0.00058350596,0.0029834707,0.00015732492,0.0000618207,0.000011021464,0.0005801906,0.0031560624,0.00010495629],"category_scores_gemma":[0.03702879,0.00032072287,0.0017266087,0.000196276,0.0007616239,0.00008439799,0.00021884147,0.010274536,0.0001922697],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013611655,0.0005305583,0.000012006694,0.001319893,0.0014795403,0.0007595535,0.000010388684,1.3536774e-7,2.8809316e-7,0.0005182769,0.046646148,0.94736207],"study_design_scores_gemma":[0.00075779506,0.0013760878,0.00009091897,0.0004971021,0.010785589,0.0024905743,0.0000055325277,0.0000039755405,1.5995421e-7,0.000018920571,0.9837543,0.00021908217],"about_ca_topic_score_codex":0.000010292646,"about_ca_topic_score_gemma":0.000026835214,"teacher_disagreement_score":0.94714296,"about_ca_system_score_codex":0.0007804531,"about_ca_system_score_gemma":0.0030165885,"threshold_uncertainty_score":0.9999245},"labels":[],"label_agreement":null},{"id":"W1974840001","doi":"10.1177/1066896909333750","title":"Metastatic Clear Cell Renal Cell Carcinoma Presenting as Multiple Colonic Polyps","year":2009,"lang":"en","type":"article","venue":"International Journal of Surgical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Regional Health Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Lamina propria; Cytokeratin; Pathology; Immunohistochemistry; Nephrectomy; Vimentin; Renal cell carcinoma; Clear cell; Carcinoma; Ascending colon; Signet ring cell carcinoma; Adenocarcinoma; Kidney; Internal medicine; Cancer; Epithelium","score_opus":0.024016204461182508,"score_gpt":0.2959754290004682,"score_spread":0.27195922453928567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974840001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98397774,0.0011998012,0.00008800327,0.0034308515,0.00050961156,0.00017371798,0.000008391196,0.000016173939,0.010595741],"genre_scores_gemma":[0.99556756,0.00014559677,0.0019616333,0.00048023174,0.00053846877,0.0000026562923,0.000017710994,0.000020674008,0.0012654501],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9975664,0.0002032232,0.00082981295,0.00026185994,0.0007986423,0.00034005122],"domain_scores_gemma":[0.99808306,0.00033828415,0.0005488562,0.00018588711,0.0005535096,0.00029040815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043006995,0.00021733034,0.0005289419,0.00034307715,0.000048280588,0.000034589255,0.00032050122,0.0001091257,0.00041220384],"category_scores_gemma":[0.00012561821,0.00016930253,0.00042715715,0.00011828304,0.000098127704,0.00013591965,0.00006941484,0.000522017,0.00012741897],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014212289,0.006207773,0.1147878,0.00008795768,0.0005626059,0.50855905,0.0015406462,0.0005470043,0.33941904,0.0007466271,0.004353895,0.008975333],"study_design_scores_gemma":[0.037160147,0.015608151,0.43369108,0.00020060259,0.0010006146,0.1619626,0.0004998855,0.0011251831,0.3131811,0.0025029723,0.032329626,0.0007380569],"about_ca_topic_score_codex":0.000022295788,"about_ca_topic_score_gemma":0.0000015822363,"teacher_disagreement_score":0.34659642,"about_ca_system_score_codex":0.00022250466,"about_ca_system_score_gemma":0.00020864444,"threshold_uncertainty_score":0.69039565},"labels":[],"label_agreement":null},{"id":"W1974968339","doi":"10.1007/bf03016676","title":"Echocardiography images of inferior vena cava tumour thrombus in patient with renal cell carcinoma","year":2008,"lang":"en","type":"article","venue":"Canadian Journal of Anesthesia/Journal canadien d anesthésie","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Inferior vena cava; Renal cell carcinoma; Medicine; Thrombus; Vena cava; Radiology; Cardiology; Internal medicine","score_opus":0.01053128954824143,"score_gpt":0.1950418462595265,"score_spread":0.18451055671128508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974968339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934434,0.0038047587,0.0000063802045,0.00087270665,0.00012109054,0.0003582897,0.000011110689,0.0000066464536,0.001375581],"genre_scores_gemma":[0.99832743,0.00016544628,0.00096246897,0.000073198076,0.00026680445,0.000004684008,0.000007343447,0.00009025442,0.000102381164],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99599195,0.00021565934,0.0013907804,0.00033902566,0.0009566389,0.001105933],"domain_scores_gemma":[0.99448717,0.00007625377,0.0010776761,0.00041972156,0.0010507865,0.0028883833],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006131823,0.00054482307,0.0013814272,0.0023579572,0.0002948297,0.000060412203,0.00042303168,0.0002115385,0.00010588759],"category_scores_gemma":[0.000066241315,0.00042864124,0.0006106147,0.0010982895,0.00052410463,0.00036013752,0.000010662708,0.0011292784,0.0000063321236],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043237497,0.00010245417,0.30065975,0.00006503559,0.0001069846,0.6944759,0.0017478609,0.00034004028,0.00074777135,0.000005519892,0.00093204237,0.00038428203],"study_design_scores_gemma":[0.0019385325,0.004467139,0.37312004,0.00031766552,0.00020844971,0.6119748,0.00057890813,0.0000032969854,0.0066765477,0.000016425909,0.00044102588,0.00025716377],"about_ca_topic_score_codex":0.020725673,"about_ca_topic_score_gemma":0.0064404323,"teacher_disagreement_score":0.08250108,"about_ca_system_score_codex":0.0013554596,"about_ca_system_score_gemma":0.00874055,"threshold_uncertainty_score":0.99981654},"labels":[],"label_agreement":null},{"id":"W1974969547","doi":"10.5489/cuaj.10044","title":"Multivariate analysis of the factors involved in loss of renal differential function after laparoscopic partial nephrectomy; a role for warm ischemia time","year":2011,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Nephrectomy; Renal function; Surgery; Urology; Multivariate analysis; Kidney; Internal medicine","score_opus":0.018209934786960435,"score_gpt":0.21871997929196846,"score_spread":0.20051004450500803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974969547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99902374,0.000048271515,0.00008149942,0.00023333379,0.00011522048,0.0003149365,0.00007092355,0.0000047855165,0.00010728115],"genre_scores_gemma":[0.9995576,0.0000027553342,0.00007266468,0.00011171448,0.000070175025,0.000032189313,0.000033883614,0.000008350549,0.00011067327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860394,0.00016156111,0.00048249203,0.00016537376,0.00027370884,0.00031292206],"domain_scores_gemma":[0.9988733,0.00011269756,0.00043250914,0.00013103664,0.00019826839,0.0002522109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027065774,0.00013706171,0.00048594826,0.00029270406,0.000059433805,0.000010735674,0.000096813594,0.00021806805,0.0008154959],"category_scores_gemma":[0.00027515827,0.00008572958,0.0004040941,0.0004227977,0.00004240792,0.000050901886,0.000015999069,0.00027149546,0.0000024195149],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071905856,0.000118543976,0.9891262,0.000005182082,0.0009171618,0.0000068852046,0.00041876934,0.000033647237,0.008519032,0.000010769448,0.000045705507,0.0000790316],"study_design_scores_gemma":[0.0016731876,0.00036728694,0.9837748,0.000014027575,0.0016047406,0.0000018718492,0.00003949637,0.00092723325,0.011199182,0.00012470882,0.0002021158,0.000071375856],"about_ca_topic_score_codex":0.0028326856,"about_ca_topic_score_gemma":0.0028396533,"teacher_disagreement_score":0.0053514405,"about_ca_system_score_codex":0.0006029093,"about_ca_system_score_gemma":0.00025443005,"threshold_uncertainty_score":0.89291084},"labels":[],"label_agreement":null},{"id":"W1975035423","doi":"10.1016/j.urology.2014.01.050","title":"Laparoscopic Radical Nephrectomy vs Laparoscopic or Open Partial Nephrectomy for T1 Renal Cell Carcinoma: Comparison of Complication Rates in Elderly Patients During the Initial Phase of Adoption","year":2014,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Odds ratio; Confidence interval; Complication; Surgery; Urology; Genitourinary system; Kidney cancer; Internal medicine; Kidney","score_opus":0.0493491876877971,"score_gpt":0.3517032484178083,"score_spread":0.3023540607300112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975035423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996247,0.00010363241,0.0004517318,0.0002444086,0.00018313252,0.002439292,0.000026066382,0.000015107322,0.00028963567],"genre_scores_gemma":[0.99832964,0.0000044108288,0.00064927636,0.00012633522,0.00012483579,0.00047197856,0.00020630898,0.00002564828,0.000061564446],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99793994,0.00031878144,0.0007936903,0.00038138207,0.00021717299,0.00034902472],"domain_scores_gemma":[0.9984982,0.0004161617,0.00042111255,0.0004197682,0.00014266824,0.00010209671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002618743,0.00021955348,0.0008313463,0.00015786524,0.00008553261,0.000017990484,0.00028743222,0.0001703892,0.00007139368],"category_scores_gemma":[0.00012508001,0.00015575366,0.00009436599,0.00020838503,0.00023162809,0.00010701245,0.00010689886,0.00022256804,0.0000056362337],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03015505,0.0046167383,0.90231246,0.0006092352,0.00008920115,0.000009736482,0.00091144606,0.0002704847,0.057267997,0.00028912877,0.00050582964,0.0029627096],"study_design_scores_gemma":[0.06476454,0.021383177,0.38629836,0.000068867055,0.00040122875,0.000017160311,0.00007580824,0.005308758,0.51556474,0.00010551927,0.0057763015,0.00023551978],"about_ca_topic_score_codex":0.00022146766,"about_ca_topic_score_gemma":0.00015052326,"teacher_disagreement_score":0.5160141,"about_ca_system_score_codex":0.00008591943,"about_ca_system_score_gemma":0.00013643787,"threshold_uncertainty_score":0.63514495},"labels":[],"label_agreement":null},{"id":"W1975060545","doi":"10.5489/cuaj.2303","title":"The association between renal tumour scoring system components and complications of partial nephrectomy","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Ottawa Public Health; University of Ottawa","funders":"","keywords":"Medicine; Nephrectomy; Perioperative; Cohort; Complication; Surgery; Medical record; Surgical complication; Confounding; Renal cell carcinoma; Radiology; Internal medicine; Kidney","score_opus":0.047317424350946574,"score_gpt":0.24867427472397527,"score_spread":0.2013568503730287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975060545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98802936,0.0002867217,0.000066272805,0.00888482,0.00017830942,0.00028277285,0.000028573651,0.000020298954,0.0022228458],"genre_scores_gemma":[0.99907297,0.000017611703,0.00015185226,0.00016624604,0.00040601703,0.00001646769,0.00002429503,0.000008634698,0.0001358872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982002,0.000298321,0.00045060556,0.0001403194,0.00054260995,0.0003679875],"domain_scores_gemma":[0.9976228,0.0003977603,0.0005636176,0.00010339503,0.00050688745,0.00080558035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014151847,0.00011207639,0.00029285968,0.00009892239,0.00036561294,0.00008621378,0.00009833777,0.00015118456,0.000005478707],"category_scores_gemma":[0.00074632216,0.00007776377,0.000091500755,0.00015763061,0.00003103988,0.00006516554,0.000020207577,0.00038036177,0.000020284586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003136714,0.000015069784,0.99736965,0.000004450771,0.0001965237,0.00001598738,0.00006885713,0.000017909204,0.00034271865,0.00033591493,0.0010871091,0.00051443285],"study_design_scores_gemma":[0.0011168802,0.00020955218,0.9800103,0.00002645818,0.00020494757,0.0001061712,0.00010166175,0.0002119699,0.00016807488,0.00014561857,0.017630486,0.00006788132],"about_ca_topic_score_codex":0.0010907876,"about_ca_topic_score_gemma":0.00020354064,"teacher_disagreement_score":0.017359361,"about_ca_system_score_codex":0.002733417,"about_ca_system_score_gemma":0.00040251785,"threshold_uncertainty_score":0.7147791},"labels":[],"label_agreement":null},{"id":"W1975530820","doi":"10.1002/pbc.21243","title":"Vascular endothelial growth factor (VEGF) receptor antibody bevacizumab (avastin) induces regression of renal cell carcinoma in an adolescent resulting in residual tumorectomy","year":2007,"lang":"en","type":"article","venue":"Pediatric Blood & Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; McGill University","keywords":"Medicine; Bevacizumab; Renal cell carcinoma; Vascular endothelial growth factor; Malignancy; Oncology; Internal medicine; Pathology; Chemotherapy; VEGF receptors","score_opus":0.02261072345351448,"score_gpt":0.2935829114766582,"score_spread":0.2709721880231437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975530820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992586,0.0056508146,0.0000060462853,0.00006917992,0.00031177845,0.0009341941,0.00009841224,0.000048793685,0.00029475172],"genre_scores_gemma":[0.99625623,0.0010788129,0.00062880083,0.000040514,0.0017155037,0.000048976948,0.00009595465,0.000081348364,0.000053856445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99581635,0.00023546179,0.0011910247,0.0008833233,0.0009986152,0.00087522436],"domain_scores_gemma":[0.99812025,0.00021958728,0.0005210145,0.00051748217,0.0002617834,0.000359901],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007422885,0.0005061863,0.000897016,0.0009816961,0.000066348424,0.000020610982,0.00026089704,0.00027512558,0.0001369993],"category_scores_gemma":[0.0001908053,0.00037639236,0.00020365478,0.0009905868,0.00007402655,0.00020628597,0.000111194924,0.0007557059,0.000009395092],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015013351,0.0012368382,0.8019536,0.00066895306,0.00002784754,0.00047964748,0.001288823,0.000015800004,0.19143236,0.000001607964,0.000048976603,0.0013441697],"study_design_scores_gemma":[0.007283915,0.00067678426,0.6241345,0.00029471394,0.0002610405,0.000015181868,0.00019091267,0.000011165442,0.3668463,0.0000028883794,0.000023670818,0.00025894618],"about_ca_topic_score_codex":0.0032516997,"about_ca_topic_score_gemma":0.00053849653,"teacher_disagreement_score":0.17781913,"about_ca_system_score_codex":0.0004619732,"about_ca_system_score_gemma":0.0006311416,"threshold_uncertainty_score":0.9998688},"labels":[],"label_agreement":null},{"id":"W1976171988","doi":"10.5539/cco.v1n1p1","title":"Practical Insights and Challenges in the Rational Use of Targeted Agents in Metastatic Clear Cell Renal Carcinoma","year":2012,"lang":"en","type":"article","venue":"Cancer and Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Renal cell carcinoma; Medicine; Targeted therapy; Immunotherapy; Oncology; Internal medicine; Carcinoma; Disease; Cancer research; Cancer","score_opus":0.412730657777344,"score_gpt":0.46213159391900527,"score_spread":0.049400936141661245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976171988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823116,0.011799377,0.0000029966404,0.004784148,0.00010314059,0.000317233,0.0000035492355,0.0000023663615,0.0006755736],"genre_scores_gemma":[0.9882198,0.010150482,0.00070138683,0.0007249031,0.000114161405,0.000040842795,0.000007450231,0.000006757853,0.000034230867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985314,0.00048497532,0.00047378152,0.00019189996,0.00014096346,0.00017697414],"domain_scores_gemma":[0.9978918,0.0016940348,0.00012000439,0.00012339972,0.000037933405,0.00013281772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005911637,0.00009542736,0.00042821723,0.000058546953,0.000016663718,0.0000036684426,0.000030475114,0.00011587398,0.000046452566],"category_scores_gemma":[0.00026456284,0.000058390175,0.00004809858,0.00007408005,0.00019594695,0.0000960314,0.000034017547,0.00029274955,0.0000024293445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024563633,0.0029962142,0.9681658,0.00016347512,0.000114381925,0.0003829197,0.0027479746,0.0000027574686,0.00023665196,0.0011274177,0.0008097853,0.020796271],"study_design_scores_gemma":[0.0034836428,0.001762014,0.98133594,0.000021164042,0.0001773029,0.000051962725,0.00046177226,0.00015016322,0.00014298511,0.00006487982,0.012292967,0.000055230397],"about_ca_topic_score_codex":0.00012648739,"about_ca_topic_score_gemma":0.00036879352,"teacher_disagreement_score":0.02074104,"about_ca_system_score_codex":0.00008101721,"about_ca_system_score_gemma":0.00022594932,"threshold_uncertainty_score":0.23810823},"labels":[],"label_agreement":null},{"id":"W1976250121","doi":"10.1111/j.1464-410x.2009.08745.x","title":"A comparative population‐based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma","year":2009,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Logistic regression; Epidemiology; Cohort; Surveillance, Epidemiology, and End Results; Population; Internal medicine; Stage (stratigraphy); Urology; Prospective cohort study; Surgery; Kidney cancer; Oncology; Demography; Kidney; Cancer registry","score_opus":0.0312921322195131,"score_gpt":0.3092419026134626,"score_spread":0.2779497703939495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976250121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942141,0.00087775104,0.0031041321,0.001192049,0.000096646596,0.00036855091,0.000035359648,0.0000038926028,0.000107488915],"genre_scores_gemma":[0.99552435,0.000020799229,0.003374786,0.00089102145,0.000117762465,0.000004450776,0.00003033752,0.000008877795,0.000027615832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973473,0.00053718395,0.001409881,0.00018687273,0.0002932579,0.00022552659],"domain_scores_gemma":[0.9974004,0.00055270764,0.0012073877,0.0002191446,0.00046104667,0.00015929373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007602982,0.00013907439,0.0013357538,0.00024405982,0.000052124517,0.00000844539,0.0001901817,0.00014445462,0.00009654392],"category_scores_gemma":[0.0002677554,0.000109708904,0.0009827892,0.00047778513,0.00019809407,0.000038233906,0.000017180395,0.00029542917,4.869204e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051629737,0.0044496967,0.8832921,0.00013640443,0.004105231,0.0012597439,0.00044072213,0.021363042,0.021381931,0.00015284913,0.00392459,0.007863988],"study_design_scores_gemma":[0.010437869,0.0064016213,0.9587557,0.00004667744,0.0057489416,0.0005044072,0.000014973316,0.0074779964,0.009553832,0.00018027618,0.0007848774,0.00009285767],"about_ca_topic_score_codex":0.00012990969,"about_ca_topic_score_gemma":0.000041501644,"teacher_disagreement_score":0.07546361,"about_ca_system_score_codex":0.000057729456,"about_ca_system_score_gemma":0.00030066317,"threshold_uncertainty_score":0.44737992},"labels":[],"label_agreement":null},{"id":"W1976328931","doi":"10.1016/j.annpat.2014.10.003","title":"Les tumeurs rénales : recommandations de la conférence de consensus de l’International Society of Urologic Pathology (ISUP) 2012","year":2014,"lang":"fr","type":"article","venue":"Annales de Pathologie","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Calgary Laboratory Services; McMaster University","funders":"","keywords":"Medicine; Consensus conference; Anatomical pathology; Pathology; Internal medicine; Immunohistochemistry","score_opus":0.06464627308860527,"score_gpt":0.33844993114286764,"score_spread":0.2738036580542624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976328931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94716936,0.014559259,0.012273013,0.011928584,0.00047833862,0.00027646447,0.00015561613,0.00010129579,0.013058063],"genre_scores_gemma":[0.94737744,0.005991079,0.040889814,0.0018293548,0.00042382788,0.000068501744,0.00012362198,0.000038783874,0.0032575657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961036,0.001575732,0.00057694747,0.00050855376,0.0002325487,0.0010026495],"domain_scores_gemma":[0.9960752,0.0024865905,0.0003639915,0.0004943222,0.00027409336,0.00030577264],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027184433,0.00037546104,0.00056918804,0.00012539918,0.00016807049,0.00003597888,0.00041762216,0.0006620948,0.00048844964],"category_scores_gemma":[0.0015039736,0.00036023877,0.00042231797,0.0001402632,0.001777235,0.00006986899,0.00017648103,0.0006819769,0.000109684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041402475,0.0013468006,0.77311534,0.00046474437,0.00047816656,0.0031463585,0.0030702322,0.0014209419,0.107131146,0.009556897,0.033158023,0.066697344],"study_design_scores_gemma":[0.0029690086,0.0016291551,0.8309792,0.00042531008,0.0008925984,0.01171742,0.0013859984,0.008744561,0.029587857,0.00957583,0.10150638,0.000586652],"about_ca_topic_score_codex":0.00027575306,"about_ca_topic_score_gemma":0.000042305997,"teacher_disagreement_score":0.07754329,"about_ca_system_score_codex":0.00047217077,"about_ca_system_score_gemma":0.0007530573,"threshold_uncertainty_score":0.99988496},"labels":[],"label_agreement":null},{"id":"W1976558206","doi":"10.1200/jco.2003.03.057","title":"Phase II Study of Troxacitabine (BCH-4556) in Patients With Advanced and/or Metastatic Renal Cell Carcinoma: A Trial of the National Cancer Institute of Canada-Clinical Trials Group","year":2003,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Occupational Cancer Research Centre; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Rash; Premedication; Nausea; Surgery; Internal medicine; Cancer; Renal cell carcinoma; Gastroenterology","score_opus":0.20779063918195953,"score_gpt":0.48354613626140286,"score_spread":0.27575549707944336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976558206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962584,0.00020307423,0.00001096646,0.00038304433,0.0011431602,0.0017107615,0.00003946673,9.921865e-7,0.00025017603],"genre_scores_gemma":[0.998184,0.00005882086,0.0012853756,0.00015754093,0.00019077428,0.00002499092,0.0000027235612,0.000013943104,0.000081816324],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9888869,0.00282994,0.006613928,0.00026157274,0.0011909525,0.00021672479],"domain_scores_gemma":[0.98776317,0.004555367,0.0061463937,0.00021850255,0.0010343089,0.000282288],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009449479,0.00020988923,0.0035765176,0.00016848398,0.000037671933,0.0000018249292,0.00017746199,0.00015242236,0.00006144257],"category_scores_gemma":[0.01515494,0.00010492249,0.00041171678,0.000328259,0.00035299576,0.00009703711,0.000051512303,0.00068944274,5.880986e-8],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.571874,0.086767316,0.32001773,0.0001392876,0.0013690129,0.00025008095,0.00029738495,0.00024087551,0.00024830864,0.000046096724,0.00052060455,0.018229295],"study_design_scores_gemma":[0.45410514,0.19963287,0.34326616,0.00011953824,0.001427433,0.000018759869,0.00017121878,0.000016218866,0.00034190374,0.00003262584,0.0007865866,0.00008152667],"about_ca_topic_score_codex":0.0027574424,"about_ca_topic_score_gemma":0.029981008,"teacher_disagreement_score":0.11776886,"about_ca_system_score_codex":0.00032665743,"about_ca_system_score_gemma":0.009369384,"threshold_uncertainty_score":0.9962466},"labels":[],"label_agreement":null},{"id":"W1976575396","doi":"10.1016/j.clgc.2014.06.015","title":"Dosing Patterns, Toxicity, and Outcomes in Patients Treated With First-Line Sunitinib for Advanced Renal Cell Carcinoma in Community-Based Practices","year":2014,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Astellas Pharma; Canadian Centre for Applied Research in Cancer Control","keywords":"Sunitinib; Medicine; Dosing; Renal cell carcinoma; Toxicity; Oncology; Internal medicine; Carcinoma; Pharmacology","score_opus":0.06840083324777685,"score_gpt":0.36831609110235947,"score_spread":0.2999152578545826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976575396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99722373,0.0001663947,0.000031825122,0.0008222478,0.000091936985,0.001348856,0.00006777902,0.000030618303,0.00021658053],"genre_scores_gemma":[0.99718237,0.00009392474,0.0009614562,0.00094061374,0.0001282518,0.00028749337,0.0002371964,0.000054774457,0.00011394919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975629,0.0005335121,0.0007866637,0.00045557608,0.00025016986,0.0004111956],"domain_scores_gemma":[0.9960611,0.00254672,0.0005095881,0.0004943248,0.00015520214,0.00023307683],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006407933,0.00033285972,0.0008134721,0.00018724789,0.00012704541,0.000023648558,0.00014235928,0.00017098838,0.00001751392],"category_scores_gemma":[0.00037529616,0.000252324,0.00012451618,0.00018302856,0.00012559294,0.00013099099,0.000085236126,0.00064382283,0.0000018661694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061687166,0.003508485,0.9831811,0.0005469907,0.000035695004,0.00007748909,0.00009834709,0.00020389735,0.00009159283,4.2262778e-7,0.00003238909,0.0060548354],"study_design_scores_gemma":[0.030009078,0.010869211,0.9539433,0.00045306145,0.00017084822,0.000003590068,0.00007243836,0.00044991382,0.0033437547,0.000007925401,0.00041010338,0.0002667773],"about_ca_topic_score_codex":0.0009931329,"about_ca_topic_score_gemma":0.00288482,"teacher_disagreement_score":0.02923784,"about_ca_system_score_codex":0.00022228189,"about_ca_system_score_gemma":0.0001516826,"threshold_uncertainty_score":0.9999929},"labels":[],"label_agreement":null},{"id":"W1977431296","doi":"10.1016/j.eururo.2008.09.039","title":"Rebuttal from Authors re: Christian Bolenz, Yair Lotan. Decision Making in the Management of Renal Cell Carcinoma: Can Nomograms Assist? Eur Urol 2009;55:296–8","year":2008,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nomogram; Rebuttal; Renal cell carcinoma; Clear cell renal cell carcinoma; General surgery; Oncology; Internal medicine; Archaeology","score_opus":0.024488285206212382,"score_gpt":0.24674092197198688,"score_spread":0.2222526367657745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977431296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96581787,0.0022783047,0.00050024013,0.00080738874,0.00031655235,0.0007010647,0.000043799737,0.00006170995,0.029473044],"genre_scores_gemma":[0.9959274,0.000085451284,0.0021544169,0.0009640297,0.00026040705,0.000019267585,0.00010048864,0.000095651296,0.00039287776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961325,0.0009095868,0.0008731306,0.0008216181,0.0006218051,0.0006413672],"domain_scores_gemma":[0.9979916,0.00023275513,0.00033641106,0.001179905,0.00007536008,0.00018396649],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000786745,0.00042364208,0.00058496423,0.00027123635,0.0001550453,0.00001771948,0.0005602252,0.00012499734,0.00017478848],"category_scores_gemma":[0.000047106372,0.00031864046,0.00024325363,0.00046039338,0.00025798808,0.0000433988,0.00027021684,0.00061459444,0.00022839212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010662591,0.0056437063,0.5570669,0.000501711,0.0010210776,0.25912973,0.03124576,0.0012593075,0.008181468,0.00043472488,0.057385553,0.06746747],"study_design_scores_gemma":[0.0037044534,0.0013366141,0.98388594,0.00008904058,0.00040605981,0.00059959345,0.0005325082,0.00017590846,0.00060524006,0.00007614357,0.008307985,0.00028048598],"about_ca_topic_score_codex":0.00037531357,"about_ca_topic_score_gemma":0.00012716753,"teacher_disagreement_score":0.42681906,"about_ca_system_score_codex":0.00014232172,"about_ca_system_score_gemma":0.00006551848,"threshold_uncertainty_score":0.99992657},"labels":[],"label_agreement":null},{"id":"W1977715013","doi":"10.1016/j.purol.2010.11.010","title":"Traitement du carcinome rénal métastatique","year":2011,"lang":"fr","type":"review","venue":"Progrès en Urologie","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Temsirolimus; Sunitinib; Sorafenib; Medicine; Bevacizumab; Everolimus; Oncology; Renal cell carcinoma; Internal medicine; Population; Targeted therapy; Discovery and development of mTOR inhibitors; Cancer; Chemotherapy; PI3K/AKT/mTOR pathway; Hepatocellular carcinoma","score_opus":0.10623491293538208,"score_gpt":0.3317235450283949,"score_spread":0.22548863209301284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977715013","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002265508,0.9728718,0.00021911494,0.0011364997,0.002243451,0.006024732,0.00018064214,0.00028759355,0.0147707],"genre_scores_gemma":[0.016284984,0.96940225,0.0046673613,0.0005752118,0.0025488834,0.0025545321,0.0007378973,0.00027449898,0.0029543552],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99196655,0.0015280886,0.0019127337,0.0017564724,0.00073563686,0.0021005473],"domain_scores_gemma":[0.9956521,0.0008432736,0.00082336226,0.0014409926,0.00031397204,0.00092634466],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0016921803,0.0017491236,0.0035561055,0.0004350815,0.00017718045,0.00008822311,0.0009523497,0.0012014583,0.0048113433],"category_scores_gemma":[0.0005156959,0.0013357784,0.001503608,0.00050918735,0.0005468549,0.0001612087,0.000539299,0.0018071785,0.0059345593],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020838766,0.0014579348,0.009299657,0.018873813,0.001758725,0.0038995617,0.00084484706,0.0000043153773,0.000007576145,0.0024297484,0.001368263,0.95984715],"study_design_scores_gemma":[0.0016540941,0.005603763,0.011611163,0.0033889373,0.007101947,0.0015770886,0.000071257826,0.000039037157,0.000060342045,0.0002688566,0.96762824,0.0009952717],"about_ca_topic_score_codex":0.0002631484,"about_ca_topic_score_gemma":0.000021085802,"teacher_disagreement_score":0.96625996,"about_ca_system_score_codex":0.0018559321,"about_ca_system_score_gemma":0.0017434094,"threshold_uncertainty_score":0.9995255},"labels":[],"label_agreement":null},{"id":"W1977760251","doi":"10.1016/j.ejso.2008.07.008","title":"The use of partial nephrectomy in European tertiary care centers","year":2008,"lang":"en","type":"article","venue":"European Journal of Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Logistic regression; Generalizability theory; Renal cell carcinoma; Tertiary care; Demography; Internal medicine; Descriptive statistics; Surgery; Statistics; Mathematics; Kidney","score_opus":0.060822841444286,"score_gpt":0.2804512878234614,"score_spread":0.2196284463791754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977760251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780049,0.0014090494,0.000013986983,0.0012837711,0.00031756837,0.00018048953,0.000002006153,0.000008541476,0.018779704],"genre_scores_gemma":[0.99679077,0.0018751648,0.0005464388,0.00020726353,0.000345713,8.7179575e-7,0.0000032753599,0.000033638524,0.00019685748],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961444,0.0021473253,0.0009663148,0.00014829013,0.0003105415,0.00028312008],"domain_scores_gemma":[0.9984478,0.00044213107,0.0004484905,0.00022540636,0.00019430515,0.00024187741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007802117,0.00015631282,0.00047094037,0.00013773153,0.00007098813,0.000009084929,0.00019363454,0.000029597402,0.000046071007],"category_scores_gemma":[0.000082227794,0.00009107006,0.0002927883,0.00014143586,0.00031921206,0.000081840175,0.000089312976,0.00047474806,0.000039682007],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007744313,0.0012614772,0.40946254,0.00005780854,0.00038144554,0.38017344,0.0036366927,0.00034225386,0.0029201624,0.000041288768,0.007605775,0.18637279],"study_design_scores_gemma":[0.0049735876,0.0020951594,0.30664268,0.00009317521,0.00006787217,0.008536022,0.00015542096,0.000008538018,0.0006472502,5.1477645e-7,0.67671067,0.00006914295],"about_ca_topic_score_codex":0.000009399778,"about_ca_topic_score_gemma":0.0000032227604,"teacher_disagreement_score":0.6691049,"about_ca_system_score_codex":0.00020716613,"about_ca_system_score_gemma":0.00016106236,"threshold_uncertainty_score":0.37137294},"labels":[],"label_agreement":null},{"id":"W1978070750","doi":"10.1089/end.2011.0088","title":"Prospective Study Comparing Two Techniques of Renal Clamping in Laparoscopic Partial Nephrectomy: Impact on Perioperative Parameters","year":2011,"lang":"en","type":"article","venue":"Journal of Endourology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Nephrectomy; Renal function; Urology; Perioperative; Renal artery; Kidney; Renal hilum; Creatinine; Surgery; Nephrology; Internal medicine","score_opus":0.062476324950897374,"score_gpt":0.3441503939599842,"score_spread":0.2816740690090868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978070750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966906,0.00011082931,0.00005065105,0.000037494305,0.000100391764,0.000823503,0.0000010334413,0.000012041757,0.0021734885],"genre_scores_gemma":[0.99798065,0.000009618469,0.0018020667,0.00005584243,0.0000869807,0.000036795132,6.601396e-7,0.000018321576,0.000009067659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982703,0.0003038822,0.0007057393,0.00019921272,0.00024596212,0.0002749068],"domain_scores_gemma":[0.9989242,0.00012533016,0.00048852107,0.00017249817,0.00017036159,0.00011907336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047420984,0.00021091488,0.0009707401,0.00044446188,0.000028385286,0.000007364726,0.00010885232,0.00006827821,0.000050040395],"category_scores_gemma":[0.00010111445,0.00014069122,0.00019440029,0.0001763563,0.00011184998,0.00009166002,0.000036966063,0.0005681165,0.0000022601341],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010238806,0.0016080759,0.9624879,0.000010625644,0.0004597105,0.0011971698,0.004619442,0.00019993441,0.018645942,0.000043984404,0.00001291756,0.00047553898],"study_design_scores_gemma":[0.008231828,0.032500703,0.733394,0.00013110405,0.00024343212,0.0006082519,0.0005769214,0.00009032631,0.22400892,0.0001008487,0.000007561533,0.00010608074],"about_ca_topic_score_codex":0.00029296346,"about_ca_topic_score_gemma":0.00009352974,"teacher_disagreement_score":0.22909383,"about_ca_system_score_codex":0.0002960047,"about_ca_system_score_gemma":0.00018338408,"threshold_uncertainty_score":0.5737222},"labels":[],"label_agreement":null},{"id":"W1978281887","doi":"10.1016/j.urology.2012.04.043","title":"Assessment of Cancer Control Outcomes in Patients With High-risk Renal Cell Carcinoma Treated With Partial Nephrectomy","year":2012,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Urology; Kidney cancer; Cancer; Oncology; Internal medicine; Carcinoma; Surgery; Kidney","score_opus":0.007690153504118573,"score_gpt":0.24445192031722165,"score_spread":0.23676176681310307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978281887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980143,0.00019406342,0.00006973852,0.00011343224,0.000065657805,0.000948509,0.000046800058,0.000020000403,0.0005275073],"genre_scores_gemma":[0.99903727,0.000004431296,0.0003075357,0.0001803351,0.000056271663,0.00024468222,0.00004951783,0.00003197027,0.00008796282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984937,0.00016421157,0.00030694302,0.00026943246,0.0002879959,0.00047773425],"domain_scores_gemma":[0.99907094,0.000104473205,0.00023299141,0.0003170286,0.000101915284,0.00017263205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010175888,0.00024628392,0.00067272916,0.00015564404,0.000026480364,0.0000030064232,0.000061532126,0.00010831527,0.00017032637],"category_scores_gemma":[0.00000791183,0.00014600405,0.000056770976,0.00014710338,0.00010710794,0.000058642803,0.000018502202,0.00021968714,0.000005739754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027436223,0.0011980488,0.9947752,0.000021179114,0.0002355245,0.000046426136,0.00007971624,0.00029044366,0.00028117464,0.000022217748,0.000018935318,0.00028752608],"study_design_scores_gemma":[0.023295859,0.0060375114,0.9662567,0.000007643871,0.00083665387,0.0000049357673,0.0000091061165,0.00009275812,0.0031713587,0.0000013797189,0.00015464294,0.00013148633],"about_ca_topic_score_codex":0.00273968,"about_ca_topic_score_gemma":0.00034489296,"teacher_disagreement_score":0.028518522,"about_ca_system_score_codex":0.0001724765,"about_ca_system_score_gemma":0.00013271735,"threshold_uncertainty_score":0.5953872},"labels":[],"label_agreement":null},{"id":"W1978573390","doi":"10.1016/j.prp.2008.05.008","title":"Oncocytic renal cell carcinoma with immunohistochemical properties of renal oncocytoma","year":2008,"lang":"en","type":"article","venue":"Pathology - Research and Practice","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Pathology; Oncocytoma; Cytokeratin; Renal oncocytoma; Renal cell carcinoma; Vimentin; Immunohistochemistry; Biology; Basophilic; Immunostaining; CD117; Lymph node; Medicine; CD34","score_opus":0.12502609409821294,"score_gpt":0.3533111820404996,"score_spread":0.22828508794228666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978573390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96764374,0.0057866448,0.000021796508,0.0013930317,0.000024639661,0.0005748257,0.0000052417113,0.000023694773,0.024526365],"genre_scores_gemma":[0.9939225,0.000516875,0.0026521436,0.00009637658,0.0001007357,0.00008704338,0.000013902488,0.000030984513,0.0025794767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971015,0.00072416215,0.00033882138,0.0004897555,0.00078085886,0.0005649046],"domain_scores_gemma":[0.9973244,0.0009169285,0.00014405062,0.0005449207,0.0007736279,0.00029608607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012202746,0.00020730653,0.00045711666,0.00024144234,0.00025617567,0.000012458176,0.0001375071,0.00017077755,0.00005486943],"category_scores_gemma":[0.0010576448,0.00012699966,0.00005891743,0.00031000946,0.0016066438,0.00019552113,0.00014701758,0.0008885719,0.00004240267],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018660355,0.0009668562,0.0058439,0.00025437493,0.000082956496,0.014692506,0.0018573551,8.0973086e-7,0.9565052,0.00004115987,0.0006735513,0.00042098586],"study_design_scores_gemma":[0.0049828915,0.013758728,0.02159285,0.000142341,0.00020752585,0.049232483,0.0010127921,0.000024902953,0.90526915,0.00004364283,0.0035113955,0.00022129258],"about_ca_topic_score_codex":0.0002737605,"about_ca_topic_score_gemma":0.000007786321,"teacher_disagreement_score":0.051236037,"about_ca_system_score_codex":0.00023144713,"about_ca_system_score_gemma":0.0008513754,"threshold_uncertainty_score":0.59197456},"labels":[],"label_agreement":null},{"id":"W1979571949","doi":"10.1007/s12032-009-9303-z","title":"Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGET","year":2009,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Hospital Foundation","funders":"","keywords":"Sorafenib; Medicine; Renal cell carcinoma; Internal medicine; Hazard ratio; Placebo; Oncology; Cytokine; Kidney cancer; Confidence interval; Gastroenterology; Hepatocellular carcinoma; Pathology","score_opus":0.008199493033392145,"score_gpt":0.2573436654551726,"score_spread":0.24914417242178047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979571949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99722224,0.0007069175,0.000080328995,0.0006722117,0.000009181435,0.00069170265,0.0000066114285,0.000008387448,0.0006023901],"genre_scores_gemma":[0.99593306,0.00010101836,0.003622668,0.0002371863,0.00001845036,0.000011883978,0.000032939795,0.000014715082,0.000028108436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982777,0.00012307739,0.00047697112,0.00034018786,0.0005325063,0.00024954366],"domain_scores_gemma":[0.9989787,0.00014568288,0.00024154136,0.00023258835,0.00012662212,0.0002749067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025503206,0.00020385561,0.0009805027,0.00018021354,0.000022203745,0.0000016787318,0.000071505994,0.00015602172,0.000073738134],"category_scores_gemma":[0.000068813315,0.000119830365,0.00003902376,0.00027568018,0.0003671698,0.000035203993,0.000026758977,0.00022967467,3.5521185e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029212726,0.0020853018,0.9111589,0.00006697012,0.0001104667,0.00015850652,0.0005284431,0.000011324647,0.0015258599,0.000009457965,0.000008897225,0.05512314],"study_design_scores_gemma":[0.04171393,0.0246365,0.92690367,0.00011174024,0.00019922263,0.0000356441,0.00004360376,0.00006219115,0.0058846194,0.00000887415,0.00029275086,0.0001072294],"about_ca_topic_score_codex":0.000060079263,"about_ca_topic_score_gemma":0.00006238736,"teacher_disagreement_score":0.05501591,"about_ca_system_score_codex":0.000105952,"about_ca_system_score_gemma":0.0003277461,"threshold_uncertainty_score":0.48865405},"labels":[],"label_agreement":null},{"id":"W1980115097","doi":"10.1016/s0140-6736(08)61040-5","title":"Progression-free survival as endpoint in metastatic RCC?","year":2008,"lang":"en","type":"letter","venue":"The Lancet","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Progression-free survival; Clinical endpoint; Oncology; Internal medicine; Overall survival; Clinical trial","score_opus":0.07401527550882557,"score_gpt":0.3206946640413414,"score_spread":0.2466793885325158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980115097","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031877242,0.0032652982,0.0000045213164,0.9286784,0.00046234994,0.0013529093,0.000088899105,0.0001029473,0.03416742],"genre_scores_gemma":[0.029259088,0.0016702912,0.0032964172,0.9275035,0.018081995,0.0006379343,0.0013456519,0.00025505258,0.017950054],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99738365,0.0003159501,0.00037230048,0.00040646203,0.00093267596,0.0005889657],"domain_scores_gemma":[0.9974857,0.0003443701,0.0001731065,0.0018831876,0.00004741918,0.00006624239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040169223,0.00038275475,0.0012514433,0.00013024145,0.000054735523,0.000023266055,0.0005691218,0.0002216127,0.0003464598],"category_scores_gemma":[0.00020051055,0.00020715069,0.00019960922,0.00018599356,0.00014965057,0.000027075494,0.0001724835,0.0017941542,0.00043976816],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032343535,0.00007267795,0.001726344,0.0003107216,0.00018448288,0.014443861,0.0002574434,0.0000010546346,0.000029911445,0.000024215617,0.98174864,0.00087722985],"study_design_scores_gemma":[0.0049174093,0.0004940444,0.019218618,0.0006200483,0.00036794817,0.0011484617,0.0000364999,0.000011767275,0.00065484975,0.0014424919,0.9707596,0.00032829947],"about_ca_topic_score_codex":0.00021222161,"about_ca_topic_score_gemma":0.00003152344,"teacher_disagreement_score":0.017619645,"about_ca_system_score_codex":0.0002321075,"about_ca_system_score_gemma":0.000213995,"threshold_uncertainty_score":0.84473604},"labels":[],"label_agreement":null},{"id":"W1980488633","doi":"10.5489/cuaj.10061","title":"Subclavian vein thrombosis: an unusual presentation of renal cell carcinoma","year":2011,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Subclavian vein; Presentation (obstetrics); Thrombosis; Radiology; Malignancy; Renal cell carcinoma; Pelvis; Etiology; Abdomen; Renal vein; Differential diagnosis; Venous thrombosis; Renal vein thrombosis; Surgery; Pathology; Internal medicine; Kidney; Catheter","score_opus":0.042383640062943345,"score_gpt":0.2549618128910839,"score_spread":0.21257817282814054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980488633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861344,0.00013621416,0.000042640997,0.0010295297,0.00016250474,0.00021365345,0.000022816641,0.0000167004,0.012241551],"genre_scores_gemma":[0.9981382,0.00001463081,0.00054995454,0.0005824221,0.00026171972,0.000007852645,0.00004618457,0.000017192147,0.00038188393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981267,0.000271907,0.00046297078,0.00022148705,0.00045551476,0.00046140575],"domain_scores_gemma":[0.99801934,0.00005333011,0.00039480565,0.00017389335,0.00037469814,0.0009839573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049392227,0.00016395803,0.0003263869,0.00025610442,0.0001477272,0.000029899229,0.00014320784,0.00025591615,0.00085352274],"category_scores_gemma":[0.00014569968,0.00013408829,0.00017123659,0.00021619318,0.00004778832,0.00017634663,0.00001227705,0.00042540336,0.000039807997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011930667,0.00024387367,0.9922947,0.00000885863,0.000077374214,0.00018344217,0.00094851915,0.0000082312545,0.003817727,0.00011750491,0.001575665,0.00060476345],"study_design_scores_gemma":[0.0012122693,0.0020339251,0.9848079,0.000007108351,0.00019719079,0.0001224781,0.00025571647,0.00006565448,0.010154221,0.00043352554,0.0005906451,0.00011932771],"about_ca_topic_score_codex":0.004741457,"about_ca_topic_score_gemma":0.0010434085,"teacher_disagreement_score":0.01200377,"about_ca_system_score_codex":0.000977526,"about_ca_system_score_gemma":0.0005979683,"threshold_uncertainty_score":0.93454754},"labels":[],"label_agreement":null},{"id":"W1980536878","doi":"10.1016/j.eururo.2012.08.069","title":"In-hospital Mortality and Failure to Rescue After Cytoreductive Nephrectomy","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Logistic regression; Emergency medicine; Respiratory failure; Internal medicine; Complication; Mortality rate; Surgery; Kidney","score_opus":0.016346348922537283,"score_gpt":0.2649701342892702,"score_spread":0.2486237853667329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980536878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98551184,0.0005439439,0.000008894114,0.0029788383,0.0002482075,0.00035284203,0.000003564228,0.00002778021,0.010324104],"genre_scores_gemma":[0.99682033,0.0000063780853,0.0005257669,0.0017257921,0.0005410714,0.000023168726,0.000005299333,0.000033245295,0.0003189384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887425,0.00021979268,0.00016848417,0.0002805908,0.00009835334,0.0003585431],"domain_scores_gemma":[0.99936885,0.000028894297,0.000023362241,0.00028293396,0.000027351796,0.00026863554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022566905,0.00015123382,0.00021692975,0.000105291656,0.000018145398,0.000006463944,0.000049283695,0.00004234408,0.00013941329],"category_scores_gemma":[0.000069337446,0.00012452014,0.000040941148,0.000104914434,0.00008155744,0.00009002352,0.00011258266,0.00018026293,0.0004366243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049804844,0.0003496794,0.9885836,0.000017713575,0.00008087946,0.0015285109,0.00350949,0.000002008048,0.0019668234,0.00014141525,0.002772586,0.0005491971],"study_design_scores_gemma":[0.0007367182,0.00087693805,0.9561329,0.000004888896,0.000066933746,0.0001813765,0.00006113527,0.0000010407202,0.0005048659,0.000013083403,0.041314494,0.000105630024],"about_ca_topic_score_codex":0.00004841885,"about_ca_topic_score_gemma":0.000028269966,"teacher_disagreement_score":0.038541906,"about_ca_system_score_codex":0.00005883625,"about_ca_system_score_gemma":0.000015703801,"threshold_uncertainty_score":0.56120676},"labels":[],"label_agreement":null},{"id":"W1980623011","doi":"10.1089/end.2011.0050","title":"Preliminary Assessment of a Renal Tumor Materials Model","year":2011,"lang":"en","type":"article","venue":"Journal of Endourology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Cryotherapy; Ablative case; Radiofrequency ablation; Likert scale; Renal tumor; Ablation; Radiology; Medical physics; Surgery; General surgery; Kidney; Nephrectomy; Radiation therapy; Internal medicine","score_opus":0.05915292609481069,"score_gpt":0.3061184352113477,"score_spread":0.246965509116537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980623011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99243844,0.00022658202,0.0011388389,0.00020565536,0.00018702657,0.00014958954,0.0000048223847,0.0000055960886,0.0056434344],"genre_scores_gemma":[0.9800626,0.000028554807,0.019425334,0.00021005388,0.00012854591,0.0000049454497,0.000001807088,0.000016861613,0.00012130342],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99865514,0.00010176927,0.0006922703,0.00010952892,0.00024976282,0.00019154127],"domain_scores_gemma":[0.998708,0.000053877433,0.0006786167,0.0002011645,0.00022478712,0.00013351574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004076383,0.00012598698,0.0005883117,0.0002075675,0.00001517105,0.0000024509263,0.00011583044,0.00006634333,0.0005083224],"category_scores_gemma":[0.00004994972,0.000087826484,0.00016349764,0.00005051237,0.00007541185,0.000059496135,0.000045198747,0.00018962147,0.0000042298016],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008754117,0.0014986517,0.016952509,0.00013938788,0.0006611281,0.005616998,0.0006445205,0.0004007427,0.9621303,0.0011811065,0.0015557467,0.00046479973],"study_design_scores_gemma":[0.0066924216,0.026338954,0.24857558,0.00013502559,0.0012142843,0.019151654,0.00007486038,0.0012766011,0.6941805,0.0020457946,0.00015597953,0.00015837204],"about_ca_topic_score_codex":0.000010900328,"about_ca_topic_score_gemma":6.721862e-7,"teacher_disagreement_score":0.26794982,"about_ca_system_score_codex":0.00006153168,"about_ca_system_score_gemma":0.0002884937,"threshold_uncertainty_score":0.5565774},"labels":[],"label_agreement":null},{"id":"W1980697018","doi":"10.1159/000167629","title":"Myeloma-Like Cast Nephropathy Associated with Acinar Cell Carcinoma of the Pancreas","year":2008,"lang":"en","type":"article","venue":"American Journal of Nephrology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Pancreas; Nephropathy; Multiple myeloma; Carcinoma; Pathology; Internal medicine; Cancer research; Endocrinology; Diabetes mellitus","score_opus":0.01315017509128577,"score_gpt":0.21429578393896065,"score_spread":0.20114560884767488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980697018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969964,0.0007081101,0.000030242969,0.001080381,0.00010852594,0.00020842963,0.000006846112,0.000009132046,0.00085192476],"genre_scores_gemma":[0.99712896,0.00008705662,0.0006008598,0.0017104441,0.00014557775,0.00000395321,0.0000028926727,0.000038561528,0.0002816993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794686,0.00035422662,0.0005940739,0.00020022248,0.00051240704,0.00039220985],"domain_scores_gemma":[0.99735606,0.0002032694,0.0013116918,0.00043528096,0.00046322047,0.00023046647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021434488,0.0002522424,0.0009613791,0.00017649923,0.000105235464,0.0000033612912,0.0002539912,0.00007581948,0.00005661014],"category_scores_gemma":[0.000057482295,0.00014437179,0.00030570631,0.00055649463,0.0012318564,0.000061812665,0.00005701247,0.00045391245,0.0000069633643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039860504,0.000929626,0.92542493,0.000024391093,0.0006575655,0.0061489306,0.0020587335,0.000055301123,0.0539573,0.00000815414,0.0038787604,0.0028702384],"study_design_scores_gemma":[0.0030567725,0.012814931,0.9551725,0.000044475015,0.000554919,0.017806562,0.00046198288,0.000012389261,0.008083217,0.0000070321084,0.0018604437,0.00012480997],"about_ca_topic_score_codex":0.00024721885,"about_ca_topic_score_gemma":0.000028421928,"teacher_disagreement_score":0.04587408,"about_ca_system_score_codex":0.00020340733,"about_ca_system_score_gemma":0.00058105617,"threshold_uncertainty_score":0.5887311},"labels":[],"label_agreement":null},{"id":"W1981409214","doi":"10.1053/j.semdp.2015.02.002","title":"The evolving classification of renal cell neoplasia","year":2015,"lang":"en","type":"review","venue":"Seminars in Diagnostic Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Renal cell carcinoma; Clear cell; Pathology; Tuberous sclerosis; Medicine; Malignancy; TFE3; Angiomyolipoma; Biology; Kidney; Internal medicine","score_opus":0.05232049614276608,"score_gpt":0.3351865346327138,"score_spread":0.28286603848994774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981409214","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014633022,0.99018073,0.000012903271,0.000060318383,0.00038039795,0.0013336927,0.000026750995,0.00002023452,0.006521642],"genre_scores_gemma":[0.0019690187,0.9961218,0.0004374845,0.000013456155,0.00012226148,0.00042012084,0.00020010331,0.000057905374,0.00065781316],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971129,0.00052909495,0.0011062603,0.00050265045,0.00033462376,0.00041450505],"domain_scores_gemma":[0.991502,0.006557843,0.0007116539,0.0009317302,0.00016079844,0.0001359629],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011031613,0.00040068186,0.0017522369,0.00027738968,0.00004854641,0.000009916936,0.00030925008,0.00051187753,0.00002100771],"category_scores_gemma":[0.004862347,0.00025629264,0.00031313434,0.00040347042,0.00030001832,0.000024986168,0.00013036598,0.0006102919,0.00010400604],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026285517,0.00026097565,0.0009814859,0.0047832313,0.000051593386,0.0026645986,0.00021734125,0.0000012663071,0.000034431996,0.000077078694,0.005713436,0.98518825],"study_design_scores_gemma":[0.0009130659,0.0010521231,0.00259319,0.024986502,0.002305606,0.0029073732,0.00016769138,0.000019090698,0.00008454432,0.00025554863,0.964362,0.0003532192],"about_ca_topic_score_codex":0.000010437572,"about_ca_topic_score_gemma":0.0000123626605,"teacher_disagreement_score":0.984835,"about_ca_system_score_codex":0.0005497154,"about_ca_system_score_gemma":0.00078961934,"threshold_uncertainty_score":0.9999889},"labels":[],"label_agreement":null},{"id":"W1981994655","doi":"10.1016/j.ajpath.2014.11.017","title":"Low Expression of miR-126 Is a Prognostic Marker for Metastatic Clear Cell Renal Cell Carcinoma","year":2015,"lang":"en","type":"article","venue":"American Journal Of Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; York University; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Kidney Foundation of Canada; Prostate Cancer Canada; Movember Foundation","keywords":"Renal cell carcinoma; Clear cell renal cell carcinoma; Cell; Oncology; Medicine; Cancer research; Internal medicine; Pathology; Biology; Biochemistry","score_opus":0.02754722524586759,"score_gpt":0.2788558122039164,"score_spread":0.2513085869580488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981994655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99537915,0.0009734589,0.0020545388,0.00033355047,0.00013180598,0.0004322662,0.000023114913,0.0000067726555,0.0006653687],"genre_scores_gemma":[0.9619568,0.000026136591,0.03725677,0.0002914456,0.00011208881,0.000017996515,0.000007830795,0.000042305677,0.0002886351],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979709,0.00028834812,0.0007491669,0.00024588616,0.00039544015,0.0003502731],"domain_scores_gemma":[0.9973198,0.0002789463,0.0011143085,0.00031336822,0.00057400117,0.0003995348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005651458,0.00022697012,0.0009215581,0.00026538968,0.000027351138,0.0000063311804,0.00016272314,0.000053442353,0.00005984254],"category_scores_gemma":[0.0001828442,0.00016353077,0.00032569768,0.00020354196,0.0003194933,0.00006467459,0.000047567075,0.0002397595,0.000014378024],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011104795,0.0026437952,0.079283185,0.0005802411,0.00016404092,0.007960215,0.005531856,0.000043793927,0.8705351,0.0000068297386,0.010493006,0.011653179],"study_design_scores_gemma":[0.011846352,0.053680655,0.0544646,0.00028036846,0.0015558321,0.0075048245,0.0044192155,0.00016992887,0.8639645,0.00021813359,0.0015554556,0.00034013164],"about_ca_topic_score_codex":0.000015171002,"about_ca_topic_score_gemma":6.158196e-7,"teacher_disagreement_score":0.05103686,"about_ca_system_score_codex":0.00011705827,"about_ca_system_score_gemma":0.00041168308,"threshold_uncertainty_score":0.6668591},"labels":[],"label_agreement":null},{"id":"W1982498137","doi":"10.1159/000356175","title":"Delay in Nephrectomy and Cancer Control Outcomes in Elderly Patients with Small Renal Masses","year":2014,"lang":"en","type":"article","venue":"Urologia Internationalis","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cytodiagnostics (Canada); Université de Montréal; McGill University Health Centre","funders":"National Cancer Institute","keywords":"Nephrectomy; Medicine; Renal cell carcinoma; Hazard ratio; Urology; Confidence interval; Internal medicine; Proportional hazards model; Surgery; Kidney","score_opus":0.013415653401154049,"score_gpt":0.2439247696374509,"score_spread":0.23050911623629686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982498137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968982,0.000120587254,0.00019146019,0.0015078984,0.00005656504,0.00035358907,0.000018075283,0.000017456148,0.00083617796],"genre_scores_gemma":[0.9977963,0.000011694518,0.00071849814,0.0011131465,0.000027672826,0.0001240175,0.000035406054,0.0000124260005,0.00016084212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911433,0.000058533267,0.00021465024,0.00024032909,0.00020702418,0.00016510475],"domain_scores_gemma":[0.9994695,0.00019544429,0.00007473277,0.00011361442,0.00009071681,0.000055962584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011628741,0.00013883464,0.00025822895,0.00019197179,0.000011718922,0.000015398935,0.00006795827,0.00006037846,0.00008105968],"category_scores_gemma":[0.00010773616,0.00009322126,0.000029471039,0.000075939904,0.000044621404,0.00005504312,0.000020805803,0.00013650337,0.000004759983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000468076,0.00016591193,0.9951517,0.0000086272485,0.000077409626,0.000045107,0.00006496189,0.00011700076,0.00004232776,0.00016489107,0.00003860041,0.0036553992],"study_design_scores_gemma":[0.0074134604,0.00078182266,0.9883556,0.00003977293,0.00003883551,0.000008242,0.000004797457,0.0004310562,0.000108015265,0.00010509493,0.002623835,0.00008950489],"about_ca_topic_score_codex":0.001565855,"about_ca_topic_score_gemma":0.0032691516,"teacher_disagreement_score":0.006945384,"about_ca_system_score_codex":0.00012595077,"about_ca_system_score_gemma":0.000032428772,"threshold_uncertainty_score":0.38014525},"labels":[],"label_agreement":null},{"id":"W1982863037","doi":"10.5489/cuaj.1721","title":"Clinico-pathological analysis of renal cell carcinoma demonstrates decreasing tumour grade over a 17-year period","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Incidence (geometry); Pathological; Stage (stratigraphy); Cohort; T-stage; Kidney cancer; Retrospective cohort study; Carcinoma; Demographics; Cancer registry; Internal medicine; Cancer; Urology","score_opus":0.019321507549658293,"score_gpt":0.2472772550561411,"score_spread":0.2279557475064828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982863037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922829,0.00021532529,0.00015224594,0.0026270654,0.00009484955,0.00015858647,0.000037909198,0.000021170566,0.004409946],"genre_scores_gemma":[0.9970569,0.00002032604,0.001154657,0.0011306095,0.00030317926,0.00000571331,0.000057356607,0.000016393282,0.00025488745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99699837,0.0005699666,0.000789071,0.00036888322,0.0006079137,0.00066579244],"domain_scores_gemma":[0.99722236,0.00038911728,0.0006356829,0.00021048247,0.0003303635,0.0012119957],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013570888,0.00025452755,0.0008518257,0.00061313744,0.00024329063,0.00008329234,0.0001750745,0.00041339308,0.0010662603],"category_scores_gemma":[0.0010573405,0.00019295534,0.00071502937,0.00073027035,0.000094477495,0.00007512328,0.000023997203,0.00075001287,0.000024517476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010430266,0.00014584496,0.9948391,0.0000050483873,0.00036104445,0.00031374747,0.00009405524,0.00013798685,0.0027049344,0.00011870027,0.00082304544,0.00035223656],"study_design_scores_gemma":[0.001451847,0.0010156056,0.99141973,0.000009260455,0.0021098005,0.00024943886,0.000093879746,0.0014639483,0.0005905696,0.0002717815,0.0011463985,0.00017773769],"about_ca_topic_score_codex":0.000710607,"about_ca_topic_score_gemma":0.00056896696,"teacher_disagreement_score":0.004773976,"about_ca_system_score_codex":0.0009902401,"about_ca_system_score_gemma":0.00054447976,"threshold_uncertainty_score":0.9998469},"labels":[],"label_agreement":null},{"id":"W1982933533","doi":"10.1586/era.12.81","title":"Primary resistance to tyrosine kinase inhibitors in patients with advanced renal cell carcinoma: state-of-the-science","year":2012,"lang":"en","type":"review","venue":"Expert Review of Anticancer Therapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Renal cell carcinoma; Tyrosine kinase; Cancer research; Tyrosine-kinase inhibitor; Internal medicine; Oncology; Cancer; Receptor","score_opus":0.021122600647472598,"score_gpt":0.30439440707003024,"score_spread":0.2832718064225576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982933533","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008811914,0.9851776,0.0000039747765,0.00009683148,0.00025642023,0.0050885533,0.00004193047,0.000010545013,0.00051226636],"genre_scores_gemma":[0.005125734,0.99162835,0.0020420281,0.0004689485,0.0000884552,0.00034237065,0.000043259948,0.000088421955,0.00017245159],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958633,0.00019100588,0.0013571415,0.0007094328,0.0013044229,0.0005746935],"domain_scores_gemma":[0.99678034,0.00008336658,0.0009892189,0.0014662248,0.00041934865,0.00026150089],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005168575,0.0006502125,0.0030575765,0.00027523615,0.000056178666,0.0000080510945,0.00057036255,0.000081254075,0.000039174196],"category_scores_gemma":[0.00003910779,0.00034862256,0.00049953297,0.0019018225,0.00042746784,0.00013818701,0.00012861985,0.00031550517,0.0000060644807],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046212913,0.0008013438,0.0013838515,0.064704426,0.000049299462,0.00001054734,0.00018069417,1.9304979e-7,0.00029474954,0.0000031218092,0.00031556105,0.9317941],"study_design_scores_gemma":[0.0022063272,0.0011332429,0.012468069,0.20698258,0.0003341461,0.000004104265,0.0000034005413,3.6473676e-8,0.008841703,0.0000011424056,0.7675454,0.00047981157],"about_ca_topic_score_codex":0.000031453263,"about_ca_topic_score_gemma":0.00000585727,"teacher_disagreement_score":0.9313143,"about_ca_system_score_codex":0.0008972522,"about_ca_system_score_gemma":0.0013226726,"threshold_uncertainty_score":0.9998966},"labels":[],"label_agreement":null},{"id":"W1983294325","doi":"10.1038/bjc.2014.28","title":"Anti-VEGF therapy in mRCC: differences between Asian and non-Asian patients","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Alberta Cancer Foundation; University of Calgary","funders":"BC Cancer Agency; Yonsei University; Alberta Health Services","keywords":"Medicine; Internal medicine; Cohort; Retrospective cohort study; Renal cell carcinoma; Toxicity; Cohort study; Asian americans; Targeted therapy; Ethnic group; Oncology; Cancer","score_opus":0.015125402951028693,"score_gpt":0.2651320945689757,"score_spread":0.250006691617947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983294325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938802,0.003599283,0.0000141474275,0.0006297024,0.00014183288,0.00016434089,0.0000070982173,0.0000037594664,0.0015596233],"genre_scores_gemma":[0.9953225,0.0039096815,0.00013897807,0.0001503232,0.00037370078,0.0000053170797,0.0000031690765,0.000016893853,0.000079405734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998899,0.000059244372,0.00036937327,0.00013888387,0.00033705993,0.00019645283],"domain_scores_gemma":[0.9993713,0.000027413686,0.00020538762,0.00007873037,0.00013354392,0.0001836553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015953004,0.000117669406,0.00047910053,0.00010909227,0.000038239094,0.00004647705,0.000079195066,0.00006441243,0.00006121866],"category_scores_gemma":[0.000027455913,0.00010126743,0.00007924134,0.000096070136,0.00005856584,0.000104897306,0.000014773173,0.00023087708,0.0000014290416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042004107,0.00006770009,0.6229457,0.00001655166,0.000047131423,0.000094683506,0.00012508291,2.2048852e-7,0.000079890415,5.2279205e-7,0.000111852,0.37646866],"study_design_scores_gemma":[0.004434995,0.0009673734,0.9913249,0.00078191294,0.000054625794,0.0001630138,0.00004867443,0.0000035213368,0.0006612458,0.00006235036,0.0014036783,0.00009370647],"about_ca_topic_score_codex":0.00045579302,"about_ca_topic_score_gemma":0.0003359085,"teacher_disagreement_score":0.37637493,"about_ca_system_score_codex":0.00009183787,"about_ca_system_score_gemma":0.00007463907,"threshold_uncertainty_score":0.4129566},"labels":[],"label_agreement":null},{"id":"W1983746526","doi":"10.1007/s10552-014-0427-x","title":"Trends in incidence, mortality, and survival for kidney cancer in Canada, 1986–2007","year":2014,"lang":"en","type":"article","venue":"Cancer Causes & Control","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; Public Health Agency of Canada; Statistics Canada; Public Health Ontario; BC Centre for Disease Control; University of Toronto; Canadian Cancer Society","funders":"Public Health Agency; Public Health Agency of Canada","keywords":"Medicine; Incidence (geometry); Epidemiology; Kidney cancer; Public health; Cancer incidence; Hematology; Cancer; Environmental health; Cancer survival; Demography; Internal medicine; Oncology; Pathology","score_opus":0.03532880274741605,"score_gpt":0.3203108410345482,"score_spread":0.28498203828713214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983746526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910533,0.003735268,0.000053537722,0.0022611413,0.0006556582,0.00061456556,0.00029165897,0.000015581147,0.0013193145],"genre_scores_gemma":[0.9954639,0.00024954003,0.000015606382,0.002558019,0.00037201002,0.0007314594,0.00002330411,0.000031399377,0.0005547798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983703,0.00006905702,0.00037255976,0.00041283143,0.00029996096,0.00047529937],"domain_scores_gemma":[0.9990128,0.00018572347,0.000097750926,0.0002733256,0.00008881335,0.00034158237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024861147,0.00023698926,0.00064846274,0.00020333125,0.00003185364,0.000014133867,0.000084183244,0.00007319702,0.00024186679],"category_scores_gemma":[0.00011566713,0.00020503403,0.00006540131,0.00023597527,0.000054559907,0.00006785605,0.000022495662,0.00015638961,9.547817e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033216708,0.000040285264,0.9857431,0.00009976292,0.00010768502,0.00007689057,0.000072472234,0.00014829569,0.0006406514,0.00007694448,0.0024697725,0.010191989],"study_design_scores_gemma":[0.008588849,0.0001363517,0.9799936,0.00020542523,0.00022493028,0.000006004027,0.0000398126,0.0019558507,0.0005439178,0.000038140308,0.008061677,0.00020543573],"about_ca_topic_score_codex":0.9416209,"about_ca_topic_score_gemma":0.9910304,"teacher_disagreement_score":0.049409453,"about_ca_system_score_codex":0.001836775,"about_ca_system_score_gemma":0.0019375155,"threshold_uncertainty_score":0.83610445},"labels":[],"label_agreement":null},{"id":"W1984772825","doi":"10.1016/j.urology.2009.04.098","title":"Nephron-sparing Surgery Is Equally Effective to Radical Nephrectomy for T1BN0M0 Renal Cell Carcinoma: A Population-based Assessment","year":2009,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Kidney cancer; Cohort; Population; Urology; Surgery; Internal medicine; Oncology; Kidney","score_opus":0.019547583461994363,"score_gpt":0.28946383680818194,"score_spread":0.2699162533461876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984772825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97129256,0.00031273346,0.019178394,0.0057223896,0.00020944982,0.0020312099,0.0000144441965,0.00009545642,0.0011433801],"genre_scores_gemma":[0.9841695,0.0000016612436,0.005566655,0.009256001,0.00033248911,0.0003372806,0.00017204322,0.000040669747,0.00012374611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977637,0.00017134598,0.0004525028,0.0006494472,0.00031917423,0.00064382405],"domain_scores_gemma":[0.99784285,0.0010856964,0.00013505839,0.0004484032,0.0001146,0.0003733683],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038304544,0.00032542917,0.0007157511,0.00036420271,0.00012113865,0.0000210459,0.00010311668,0.00022234285,0.00013667978],"category_scores_gemma":[0.00011108114,0.000292099,0.0003310319,0.00024253526,0.00003739815,0.000045907018,0.000029240511,0.000255057,0.00004653086],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009369892,0.0022352731,0.8829242,0.00038016698,0.0002923743,0.00105962,0.0005228612,0.003927987,0.034713116,0.00061217905,0.02217388,0.041788463],"study_design_scores_gemma":[0.0045458255,0.00543657,0.96127474,0.00002429338,0.00039564096,0.00006979832,0.00000796888,0.0061126826,0.013809963,0.00026221687,0.0077335676,0.00032671713],"about_ca_topic_score_codex":0.00019161009,"about_ca_topic_score_gemma":0.000020578289,"teacher_disagreement_score":0.07835057,"about_ca_system_score_codex":0.00047961005,"about_ca_system_score_gemma":0.00035758596,"threshold_uncertainty_score":0.9999531},"labels":[],"label_agreement":null},{"id":"W1985462868","doi":"10.5489/cuaj.2415","title":"Knowledge of genetic testing for hereditary kidney cancer in Canada is lacking: The results of the Canadian national hereditary kidney cancer needs assessment survey","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital; University of Ottawa; Alberta Kidney Disease Network; University Health Network; University of Toronto; Children's Hospital of Eastern Ontario; Western University","funders":"Astellas Pharma; Teva Pharmaceutical Industries; Kidney Foundation of Canada; Sanofi; GlaxoSmithKline; Pfizer","keywords":"Genetic testing; Genetic counseling; Family medicine; Medicine; Exploratory research; Cancer; Test (biology); Kidney cancer; Medical education; Internal medicine; Genetics","score_opus":0.04182388351997903,"score_gpt":0.2808860845860425,"score_spread":0.23906220106606343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985462868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8901004,0.00068596937,0.0000060384937,0.09721168,0.0016717516,0.0008692361,0.0053706965,0.0000054023526,0.004078782],"genre_scores_gemma":[0.98907644,0.000019184978,0.000116550895,0.009711492,0.00066103734,0.00005443775,0.00007006463,0.000019520552,0.0002712856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997145,0.0005543083,0.00078252953,0.00022482571,0.0006784068,0.00061490375],"domain_scores_gemma":[0.99532866,0.0010934916,0.0006247249,0.00019381155,0.0015529018,0.0012064292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020504412,0.00020424236,0.00041370429,0.00023348207,0.00034210208,0.000027818036,0.00032412895,0.00019153421,0.00018717964],"category_scores_gemma":[0.0057612583,0.0001310384,0.00013307198,0.00069349876,0.00006839474,0.00004475324,0.000025515095,0.0006000166,8.227705e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00004250019,0.000024082281,0.8802619,0.000021282001,0.00014501742,0.000010347267,0.00017618736,0.00089098647,0.000027997137,0.000016513231,0.11725553,0.001127632],"study_design_scores_gemma":[0.0015424999,0.0001612209,0.9746177,0.0001110999,0.00009737588,0.000034972913,0.00006765323,0.0032190427,0.000054654643,0.00015029177,0.019821318,0.00012212462],"about_ca_topic_score_codex":0.9971691,"about_ca_topic_score_gemma":0.99943686,"teacher_disagreement_score":0.098975986,"about_ca_system_score_codex":0.013959692,"about_ca_system_score_gemma":0.06264909,"threshold_uncertainty_score":0.98982555},"labels":[],"label_agreement":null},{"id":"W1985598595","doi":"10.1016/j.clgc.2013.07.004","title":"Considerations for the Design of Future Clinical Trials in Metastatic Renal Cell Carcinoma","year":2013,"lang":"en","type":"review","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"Bayer HealthCare","keywords":"Medicine; Clinical trial; Renal cell carcinoma; Intensive care medicine; Clinical study design; Disease; Targeted therapy; Identification (biology); Medical physics; Oncology; Cancer; Internal medicine","score_opus":0.5976262395296403,"score_gpt":0.5387439501577905,"score_spread":0.058882289371849805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985598595","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00062591565,0.9833547,0.00038253152,0.00066116673,0.0022097218,0.012369147,0.00027293508,0.00002073375,0.000103151164],"genre_scores_gemma":[0.00064143934,0.97767156,0.010096688,0.0003172476,0.0052496376,0.0045841685,0.0000895505,0.000119265365,0.0012304117],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98286444,0.007585465,0.007653122,0.00096244033,0.0004261326,0.00050842954],"domain_scores_gemma":[0.931533,0.06378943,0.0026969044,0.0012264707,0.00037805014,0.00037615333],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.012238835,0.0007216516,0.008228475,0.00022233727,0.00010648099,0.00003396967,0.00034926838,0.0007653204,0.0007093378],"category_scores_gemma":[0.0054476727,0.00038798564,0.0043852325,0.00031655686,0.00041138695,0.000057192334,0.00013130924,0.0014993205,0.000059484275],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079724885,0.0016073083,0.00047472445,0.011835312,0.0018827105,0.00042179582,0.00004427861,0.000053047876,0.0000035765293,0.000021932845,0.065595195,0.91726285],"study_design_scores_gemma":[0.0076958407,0.0045908997,0.001305038,0.0045683365,0.025834754,0.00017421167,0.00009591006,0.00022819215,0.000029375129,0.00022033822,0.9546264,0.0006307127],"about_ca_topic_score_codex":0.000056193778,"about_ca_topic_score_gemma":0.0000134562,"teacher_disagreement_score":0.9166322,"about_ca_system_score_codex":0.00024276151,"about_ca_system_score_gemma":0.004225829,"threshold_uncertainty_score":0.9998572},"labels":[],"label_agreement":null},{"id":"W1986760015","doi":"10.5489/cuaj.1685","title":"Evaluation and screening for hereditary renal cell cancers","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Internal medicine; Oncology","score_opus":0.03310593133450392,"score_gpt":0.2559004433137228,"score_spread":0.22279451197921887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986760015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800297,0.0009641412,0.0002773279,0.014930355,0.0001807272,0.00072845456,0.000016731816,0.000012278534,0.0028602562],"genre_scores_gemma":[0.9949334,0.000027732605,0.001874645,0.0020443462,0.0005454069,0.00007191154,0.000032787295,0.000010176856,0.00045954747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987293,0.000120995035,0.00021748822,0.00015731165,0.0004245967,0.000350306],"domain_scores_gemma":[0.9983266,0.00013006845,0.00015681898,0.000059866197,0.0006479547,0.0006786991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095400255,0.00010264515,0.00017238171,0.00011168122,0.00021948156,0.000070273156,0.00004086489,0.00014972164,0.0007827651],"category_scores_gemma":[0.00047957205,0.000080967075,0.00008377907,0.00007524377,0.000017945205,0.0001079157,0.0000059596564,0.0002470899,0.000019713227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015617529,0.000068553534,0.68315893,0.000025367985,0.0005489728,0.00012731767,0.00035149904,0.000781004,0.0025705553,0.00004665678,0.15852344,0.15364155],"study_design_scores_gemma":[0.0026088408,0.0008266681,0.9752046,0.000015180078,0.00038683487,0.00024015522,0.00013045681,0.006499253,0.00020712249,0.001269467,0.01247645,0.00013499442],"about_ca_topic_score_codex":0.0034040352,"about_ca_topic_score_gemma":0.00072732114,"teacher_disagreement_score":0.29204565,"about_ca_system_score_codex":0.0022381698,"about_ca_system_score_gemma":0.0007091102,"threshold_uncertainty_score":0.8570729},"labels":[],"label_agreement":null},{"id":"W1987151740","doi":"10.1148/radiol.2015142215","title":"Can Quantitative CT Texture Analysis be Used to Differentiate Fat-poor Renal Angiomyolipoma from Renal Cell Carcinoma on Unenhanced CT Images?","year":2015,"lang":"en","type":"article","venue":"Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":257,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Renal cell carcinoma; Lesion; Radiology; Receiver operating characteristic; Carcinoma; Reproducibility; Nuclear medicine; Angiomyolipoma; Pathology; Kidney; Internal medicine","score_opus":0.0457650568388394,"score_gpt":0.29328717364563833,"score_spread":0.24752211680679892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987151740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99218357,0.0010036959,0.0009100829,0.0028368419,0.00027521508,0.000733827,0.00045239003,0.00009755403,0.0015068195],"genre_scores_gemma":[0.99344075,0.000012145905,0.0019626592,0.0009611292,0.00034070588,0.00009656432,0.0014322258,0.00006621599,0.0016875942],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99649096,0.0005109203,0.00058367546,0.0011080316,0.0005261372,0.00078027457],"domain_scores_gemma":[0.9973792,0.00035859496,0.00027040523,0.0009295781,0.00020551309,0.00085673673],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020806643,0.000593106,0.0014792727,0.00073733926,0.00010051978,0.000031759657,0.00029517672,0.00013308352,0.00030245582],"category_scores_gemma":[0.0001508123,0.00045820916,0.00056020345,0.0009549482,0.00016941065,0.000054098902,0.00009900021,0.000418552,0.00019390612],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00631814,0.0012347896,0.26601166,0.00006471293,0.006509259,0.012035291,0.0052126762,0.0010706292,0.6544867,0.00045863035,0.044974454,0.0016230103],"study_design_scores_gemma":[0.007615751,0.005749971,0.6033162,0.000051536597,0.0043792524,0.00023875512,0.00055935857,0.0009847302,0.37472755,0.00020000889,0.0014453081,0.00073160103],"about_ca_topic_score_codex":0.002881776,"about_ca_topic_score_gemma":0.0008337399,"teacher_disagreement_score":0.33730453,"about_ca_system_score_codex":0.0006491445,"about_ca_system_score_gemma":0.00020615611,"threshold_uncertainty_score":0.999787},"labels":[],"label_agreement":null},{"id":"W1987342480","doi":"10.1097/pas.0b013e31818fbdff","title":"Melanotic Xp11 Translocation Renal Cancers","year":2009,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"TFE3; Pathology; Perivascular Epithelioid Cell; Biology; Microphthalmia-associated transcription factor; S100 protein; Angiomyolipoma; HMB-45; Renal cell carcinoma; Immunohistochemistry; PAX8; Fusion gene; Epithelioid cell; Kidney; Medicine; Gene; Gene expression","score_opus":0.01820778548453677,"score_gpt":0.2801696209901375,"score_spread":0.2619618355056007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987342480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832227,0.0011823616,0.0003197584,0.013657886,0.00008029097,0.0000975191,0.0000010040567,0.000010177113,0.00142829],"genre_scores_gemma":[0.9973721,0.00069847173,0.00060412555,0.0009427246,0.00027247073,0.0000014609525,0.0000016393019,0.000008829981,0.00009818125],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987208,0.00024178598,0.000416769,0.00011863099,0.00027714897,0.00022483898],"domain_scores_gemma":[0.99897414,0.00014490413,0.00039092475,0.00020228665,0.0001251524,0.00016258689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045762394,0.00012430275,0.0005407596,0.0001049779,0.000046379733,0.0000058239934,0.00013326458,0.00003062987,0.00006532769],"category_scores_gemma":[0.000023173789,0.00006751212,0.00021699152,0.00025336846,0.00036730585,0.000035757577,0.000006030972,0.00032746457,0.00001616987],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013439586,0.0006698421,0.0061244587,0.000015650172,0.00041435548,0.03306509,0.0027024369,0.0012702554,0.074869856,0.0008891419,0.0012394069,0.86529994],"study_design_scores_gemma":[0.014136312,0.053933106,0.6618722,0.00036741712,0.001646314,0.22092184,0.001783634,0.00026397425,0.025816074,0.0033046058,0.015326044,0.00062847784],"about_ca_topic_score_codex":0.000017868117,"about_ca_topic_score_gemma":0.0000014509532,"teacher_disagreement_score":0.86467147,"about_ca_system_score_codex":0.00017216126,"about_ca_system_score_gemma":0.00016990864,"threshold_uncertainty_score":0.2753064},"labels":[],"label_agreement":null},{"id":"W1988200223","doi":"10.1007/s00330-015-3610-x","title":"Intracellular lipid in papillary renal cell carcinoma (pRCC): T2 weighted (T2W) MRI and pathologic correlation","year":2015,"lang":"en","type":"article","venue":"European Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Neuroradiology; Intraclass correlation; Pathology; Histopathology; Nuclear medicine; Magnetic resonance imaging; Radiology; Papillary renal cell carcinomas; Renal cell carcinoma; Neurology","score_opus":0.02109074917778481,"score_gpt":0.21900437286419094,"score_spread":0.19791362368640614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988200223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95078784,0.0052290787,0.00026372494,0.00043213862,0.00030758817,0.00042995915,0.000003733502,0.00007169036,0.04247425],"genre_scores_gemma":[0.99616903,0.00021270975,0.0015627588,0.0002751671,0.0003933582,0.000008602851,0.00014462392,0.000048425863,0.0011853436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754447,0.00096152857,0.00043332297,0.0005251103,0.00015548665,0.00038011043],"domain_scores_gemma":[0.9990086,0.0000949806,0.00013729537,0.0003981611,0.00006829316,0.00029270165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072563643,0.00026508048,0.0004517204,0.00021587247,0.0000435583,0.000011467903,0.00010504081,0.00013692932,0.000061565515],"category_scores_gemma":[0.00007711865,0.00021368866,0.000064215375,0.00017877655,0.00017304179,0.000057475445,0.00010040188,0.0003851184,0.0002947487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012654801,0.00047241303,0.88169307,0.00011249225,0.00005769364,0.031238537,0.0029136634,0.00016406397,0.06414646,0.00034455827,0.011972498,0.005619072],"study_design_scores_gemma":[0.006545428,0.0037728907,0.9657919,0.000043102773,0.000140875,0.00540789,0.00022898051,0.001550983,0.0056180633,0.00013829823,0.010390643,0.00037097753],"about_ca_topic_score_codex":0.000017834585,"about_ca_topic_score_gemma":0.0000029019784,"teacher_disagreement_score":0.0840988,"about_ca_system_score_codex":0.00017786777,"about_ca_system_score_gemma":0.00007248265,"threshold_uncertainty_score":0.8713971},"labels":[],"label_agreement":null},{"id":"W1988927211","doi":"10.1016/j.juro.2010.02.1721","title":"1797 TUMOR SIZE IS ASSOCIATED WITH THE RATE OF SYNCHRONOUS METASTASES IN PATIENTS WITH SMALL RENAL CELL TUMORS","year":2010,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Art history; Classics; History; Internal medicine","score_opus":0.008521466898825663,"score_gpt":0.20287965999471405,"score_spread":0.1943581930958884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988927211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997573,0.00018310215,0.0000132003715,0.0016160911,0.000050724964,0.0002982481,0.000010638219,0.000003871678,0.0002511174],"genre_scores_gemma":[0.99881035,0.000008036413,0.0001792791,0.0008482133,0.000041280953,0.0000028626202,0.0000026621897,0.000022217442,0.00008507391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985433,0.00041506512,0.00041380644,0.000107272266,0.00026172338,0.00025879793],"domain_scores_gemma":[0.997635,0.00084061676,0.000828901,0.0002929206,0.0003152318,0.000087315384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009999789,0.00017526929,0.0005187996,0.00009493171,0.000047126396,0.0000053007648,0.00022577085,0.000048702765,0.00011770145],"category_scores_gemma":[0.00018738849,0.000069527705,0.00007939566,0.0001931081,0.00028365603,0.000036619596,0.000033515804,0.00067703705,0.0000036187696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050523084,0.005149773,0.8573376,0.00009766724,0.0027795066,0.003435741,0.005358804,0.0012821174,0.07053828,0.000039554092,0.0022650836,0.0011927668],"study_design_scores_gemma":[0.008742836,0.01415813,0.9527579,0.00005132912,0.0013165463,0.0007280611,0.00014906222,0.000022399561,0.021749595,0.000049387632,0.00016996886,0.00010479269],"about_ca_topic_score_codex":0.000082617684,"about_ca_topic_score_gemma":0.00023089173,"teacher_disagreement_score":0.09542027,"about_ca_system_score_codex":0.00005125045,"about_ca_system_score_gemma":0.00023897909,"threshold_uncertainty_score":0.29414266},"labels":[],"label_agreement":null},{"id":"W1990378122","doi":"10.1038/bjc.2014.214","title":"Sunitinib re-challenge in advanced renal-cell carcinoma","year":2014,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Pfizer","keywords":"Sunitinib; Renal cell carcinoma; Medicine; Carcinoma; Kidney cancer; Pathology; Oncology; Internal medicine; Cancer research","score_opus":0.05057340882865962,"score_gpt":0.34380958598262956,"score_spread":0.29323617715396993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990378122","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004516562,0.98523575,0.0000041704907,0.00008653452,0.0005129328,0.00075614685,0.000049397277,0.000011692778,0.008826818],"genre_scores_gemma":[0.0067336806,0.9897132,0.00030396073,0.00009292313,0.0011410939,0.000089606074,0.00004422489,0.00014233388,0.0017390017],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961956,0.00031983855,0.0018270817,0.00041702995,0.0007246775,0.00051576406],"domain_scores_gemma":[0.9970666,0.00019912324,0.0015643121,0.00038140023,0.00038584796,0.00040271104],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058496563,0.0005097528,0.0036192986,0.00047201721,0.000046337074,0.000049787355,0.00031826715,0.00038708164,0.00054005627],"category_scores_gemma":[0.00010453796,0.00047894282,0.001147522,0.0003369312,0.00007598896,0.00011662207,0.00006321236,0.0015016784,0.000027823455],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009708418,0.00021328442,0.0000644097,0.012398199,0.0001480562,0.011422478,0.000038021983,0.000004382699,0.0000023937755,0.000002460157,0.0017733969,0.9738358],"study_design_scores_gemma":[0.003207479,0.00083816267,0.0006264962,0.07032347,0.0016675203,0.007650082,0.000025899028,7.240488e-7,0.000024968007,0.000015138708,0.9152628,0.000357261],"about_ca_topic_score_codex":0.0003722156,"about_ca_topic_score_gemma":0.00086008303,"teacher_disagreement_score":0.97347856,"about_ca_system_score_codex":0.0010392887,"about_ca_system_score_gemma":0.001276738,"threshold_uncertainty_score":0.99976623},"labels":[],"label_agreement":null},{"id":"W1990888148","doi":"10.1053/j.ackd.2013.09.003","title":"Chronic Kidney Disease in Patients With Renal Cell Carcinoma","year":2013,"lang":"en","type":"review","venue":"Advances in Chronic Kidney Disease","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Nephrology; Kidney disease; Internal medicine; Renal cell carcinoma; Referral; Disease; Demographics; Kidney cancer; Intensive care medicine; General surgery; Family medicine","score_opus":0.015116256585639856,"score_gpt":0.28471205214358947,"score_spread":0.2695957955579496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990888148","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023334736,0.98804843,0.0000067637325,0.00012689998,0.00039388187,0.006589907,0.001160554,0.00009215544,0.0012479131],"genre_scores_gemma":[0.017315554,0.9697696,0.00013231038,0.00031522417,0.00078682456,0.002657395,0.007342421,0.0003271146,0.0013535504],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932574,0.00035867654,0.0015306757,0.0020428163,0.0012240886,0.0015863155],"domain_scores_gemma":[0.9911658,0.0001507962,0.0007407357,0.0021666894,0.00015872034,0.0056172516],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00016521817,0.0016694004,0.0029735898,0.0008405927,0.00010247728,0.0000650211,0.0006827426,0.00030860075,0.001110724],"category_scores_gemma":[0.0003412938,0.0012262398,0.00081057614,0.0010510508,0.00037461027,0.0006801689,0.000290343,0.0011556738,0.00053450686],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0017969395,0.0034874205,0.15030275,0.23802744,0.00030277972,0.0054649212,0.000060417027,0.00022462531,0.000001166994,0.000056102657,0.005855944,0.5944195],"study_design_scores_gemma":[0.01202944,0.0012315285,0.019651625,0.045050286,0.0029581054,0.000006276675,0.000003575401,0.00006725158,0.00000419277,0.000046288853,0.9175774,0.0013740228],"about_ca_topic_score_codex":0.00010541805,"about_ca_topic_score_gemma":0.00003531046,"teacher_disagreement_score":0.91172147,"about_ca_system_score_codex":0.011399445,"about_ca_system_score_gemma":0.022367803,"threshold_uncertainty_score":0.9998024},"labels":[],"label_agreement":null},{"id":"W1991311119","doi":"10.1007/s00330-014-3310-y","title":"Diagnostic accuracy of segmental enhancement inversion for the diagnosis of renal oncocytoma using biphasic computed tomography (CT) and multiphase contrast-enhanced magnetic resonance imaging (MRI)","year":2014,"lang":"en","type":"article","venue":"European Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Neuroradiology; Magnetic resonance imaging; Medicine; Radiology; Computed tomography; Interventional radiology; Contrast enhancement; Oncocytoma; Ultrasound; Tomography; Renal oncocytoma; Diagnostic accuracy; Contrast (vision); Nuclear medicine; Kidney; Neurology; Physics","score_opus":0.020236555985430994,"score_gpt":0.26305993873309635,"score_spread":0.24282338274766535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991311119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713782,0.01123278,0.015629524,0.00015152514,0.00017112192,0.0012228433,0.000028811215,0.000022238144,0.00016295427],"genre_scores_gemma":[0.9945169,0.00053759286,0.0044462774,0.00024852165,0.00012546056,0.000045546603,0.000033412438,0.000034621826,0.000011648753],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99823713,0.0003968718,0.0005140249,0.0003932732,0.00015773653,0.00030098273],"domain_scores_gemma":[0.99661607,0.0024812773,0.00031996702,0.0003614097,0.00011095594,0.00011030815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042705226,0.0002328081,0.0005052649,0.00015187987,0.00010707083,0.000008365189,0.00015225678,0.00001949395,0.000027390888],"category_scores_gemma":[0.00046961982,0.00016945203,0.00014968916,0.00017090216,0.00044547598,0.000050678358,0.00009909904,0.00011212799,0.0000023457876],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017003566,0.00063148927,0.20351231,0.00038846154,0.00025898367,0.0003084088,0.0008387202,0.00033475689,0.526067,0.00008356813,0.0010383688,0.26483756],"study_design_scores_gemma":[0.015452765,0.0044634817,0.45765877,0.00076811796,0.00077642425,0.00048509956,0.00018869282,0.03174487,0.48674294,0.00002049986,0.0013933226,0.00030502354],"about_ca_topic_score_codex":0.000040108025,"about_ca_topic_score_gemma":0.0000028807153,"teacher_disagreement_score":0.26453254,"about_ca_system_score_codex":0.00007059126,"about_ca_system_score_gemma":0.00003201401,"threshold_uncertainty_score":0.6910053},"labels":[],"label_agreement":null},{"id":"W1991406747","doi":"10.3747/co.2007.113","title":"Radiofrequency Ablation and Cryoablation of Renal Tumours","year":2007,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Cryoablation; Radiofrequency ablation; Ablation; Cryosurgery; Radiology; Pathology; Internal medicine","score_opus":0.08718582997815937,"score_gpt":0.38584973254681965,"score_spread":0.29866390256866027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991406747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843079,0.0053773653,0.0021737677,0.00020740408,0.00030668892,0.00028367303,0.0000018501729,0.000019957834,0.0073214285],"genre_scores_gemma":[0.99837947,0.00027263467,0.0010488528,0.000016696553,0.00016694015,0.0000052500636,0.000038849063,0.000007795495,0.00006348551],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992302,0.000036087793,0.00028139542,0.00015768477,0.00014005961,0.00015457353],"domain_scores_gemma":[0.9994386,0.00010280668,0.00013607774,0.000116467185,0.000103560065,0.00010253009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033143815,0.00008607726,0.00022777125,0.00014571832,0.000024838262,0.000001988079,0.000024121213,0.00007425409,0.00005216235],"category_scores_gemma":[0.000064589156,0.000073244526,0.000043032476,0.00011478742,0.0000903323,0.000042804862,0.000013622072,0.00011278892,0.000007275506],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004379579,0.00043674558,0.37504146,0.00012702812,0.000037730708,0.00006554957,0.0005116975,0.000007918719,0.035721302,0.0013796287,0.00044932414,0.58578366],"study_design_scores_gemma":[0.0024315123,0.0015965371,0.94985497,0.000081006525,0.00020267468,0.0002476218,0.00007567914,0.00023530182,0.023158705,0.00056942576,0.021452043,0.0000945333],"about_ca_topic_score_codex":0.000012152859,"about_ca_topic_score_gemma":0.0000063618504,"teacher_disagreement_score":0.5856891,"about_ca_system_score_codex":0.00023397365,"about_ca_system_score_gemma":0.00009240962,"threshold_uncertainty_score":0.2986825},"labels":[],"label_agreement":null},{"id":"W1991870034","doi":"10.1007/s00345-014-1292-7","title":"Are warm ischemia and ischemia time still predictive factors of poor renal function after partial nephrectomy in the setting of elective indication?","year":2014,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Nephrectomy; Warm ischemia; Nephrology; Renal function; Ischemia; Renal ischemia; Internal medicine; Urology; Kidney; Reperfusion injury","score_opus":0.007299066200310945,"score_gpt":0.22958654709044166,"score_spread":0.2222874808901307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991870034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99771625,0.0005382755,0.00017765145,0.00085881987,0.000048118833,0.0002194289,0.0000045777547,0.0000033811712,0.00043352682],"genre_scores_gemma":[0.9993851,0.000011987606,0.00013529492,0.00024447666,0.0001572125,0.000012670593,0.00000442247,0.000010844581,0.00003798683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870515,0.0002237448,0.00050250645,0.0001433675,0.0002601265,0.00016513457],"domain_scores_gemma":[0.9983215,0.00037014837,0.0009237766,0.0001290429,0.00018549233,0.000070057984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053320295,0.00013257876,0.00042961605,0.00030296136,0.000019186466,0.0000037162529,0.0000763972,0.0000843842,0.00006860395],"category_scores_gemma":[0.00022337986,0.00008387579,0.000095163465,0.0002450566,0.00012459322,0.00007107846,0.000025513576,0.00041482697,0.0000014336238],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004841499,0.00020963536,0.9268534,0.000041071464,0.00029639492,0.00002691184,0.0017918872,0.000052066094,0.06432522,0.00001590707,0.000415426,0.0011305813],"study_design_scores_gemma":[0.002064172,0.0018868258,0.9259621,0.00006921678,0.00050816714,0.00014854097,0.0001616255,0.00019057769,0.06749461,0.00014050644,0.0013103837,0.00006328318],"about_ca_topic_score_codex":0.000011142948,"about_ca_topic_score_gemma":0.000024868554,"teacher_disagreement_score":0.0031693901,"about_ca_system_score_codex":0.00006047371,"about_ca_system_score_gemma":0.000063917214,"threshold_uncertainty_score":0.34203556},"labels":[],"label_agreement":null},{"id":"W1991943110","doi":"10.5489/cuaj.1111","title":"Moderated Poster Session 8: Kidney Cancer","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Session (web analytics); Kidney cancer; Cancer; Medicine; Psychology; Computer science; Internal medicine; World Wide Web","score_opus":0.018342654606068636,"score_gpt":0.24049669489462255,"score_spread":0.22215404028855393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991943110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9024104,0.0002177036,0.000013507285,0.08979989,0.00029636172,0.00025643373,0.00001685787,0.0000247344,0.006964118],"genre_scores_gemma":[0.9732534,0.00005354662,0.000104112354,0.022230538,0.00038582587,0.000028071374,0.00002816162,0.00001296528,0.0039033648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868274,0.00011723387,0.0002580391,0.00016264076,0.0003164092,0.00046296243],"domain_scores_gemma":[0.99759126,0.00003886544,0.00015513937,0.00008940862,0.00044820644,0.0016771297],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018494185,0.00013242479,0.00022303336,0.0001337957,0.00020753553,0.00011796917,0.00006621708,0.00022954981,0.0076857647],"category_scores_gemma":[0.00032465204,0.0000905653,0.00011091407,0.00014260644,0.000014819247,0.0001331983,0.000009947639,0.00046568472,0.0004659642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029667213,0.00004083545,0.8566159,0.0000037201446,0.00011879794,0.00010947858,0.00007027676,0.000025650172,0.0019494864,0.000014163221,0.1377724,0.0032496173],"study_design_scores_gemma":[0.0010801946,0.00024411903,0.9690897,0.000024614277,0.0000842626,0.0002613315,0.000021338494,0.00043399286,0.00040693788,0.00037531424,0.027855156,0.00012304288],"about_ca_topic_score_codex":0.006038151,"about_ca_topic_score_gemma":0.00028314663,"teacher_disagreement_score":0.112473786,"about_ca_system_score_codex":0.0021300523,"about_ca_system_score_gemma":0.00085950014,"threshold_uncertainty_score":0.99322134},"labels":[],"label_agreement":null},{"id":"W1992164131","doi":"10.1007/s00261-009-9546-3","title":"Small (≤4 cm) cortical renal tumors: characterization with multidetector CT","year":2009,"lang":"en","type":"article","venue":"Abdominal Imaging","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Chromophobe cell; Medicine; Clear cell; Papillary renal cell carcinomas; Renal cell carcinoma; Pathology; Oncocytoma; Clear cell renal cell carcinoma; Nephrology; Kidney; Internal medicine","score_opus":0.018190620627960414,"score_gpt":0.24358610284612872,"score_spread":0.2253954822181683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992164131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99312556,0.00007545715,0.003744827,0.001313911,0.00003470152,0.00038048308,0.0000031228176,0.000101350466,0.0012205766],"genre_scores_gemma":[0.9924529,0.00000521911,0.0060683372,0.0007942053,0.00021154173,0.000015660004,0.00006791181,0.000027740996,0.00035646246],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987227,0.000043172542,0.00027248522,0.0003488139,0.0002631956,0.0003496414],"domain_scores_gemma":[0.9992621,0.00004471595,0.00009723388,0.00028109027,0.00009964299,0.00021520443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000116800344,0.00022225619,0.00030885055,0.000112185226,0.00008760694,0.000045463596,0.00006542859,0.000016759515,0.0000889459],"category_scores_gemma":[0.00005053951,0.00016468448,0.000083219966,0.00015732323,0.00007084808,0.00012224528,0.00001632494,0.00022174821,0.000087795495],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012148182,0.0002325073,0.03947435,0.000030431082,0.00004038899,0.004149536,0.00014369031,0.0000029350842,0.87605405,0.00003098307,0.000030598047,0.07859568],"study_design_scores_gemma":[0.0029578006,0.0008510964,0.73818153,0.00037466738,0.0002697483,0.0037688143,0.000070647344,0.0037416462,0.24914983,0.000016403415,0.00035961848,0.0002582218],"about_ca_topic_score_codex":0.000032390137,"about_ca_topic_score_gemma":0.0000029431055,"teacher_disagreement_score":0.69870716,"about_ca_system_score_codex":0.00014391668,"about_ca_system_score_gemma":0.0000774701,"threshold_uncertainty_score":0.6715638},"labels":[],"label_agreement":null},{"id":"W1992242899","doi":"10.1016/j.eururo.2014.07.023","title":"Reply to Marc Bjurlin, Elena Elkin, and William Huang's Letter to the Editor re: Maxine Sun, Andreas Becker, Zhe Tian, et al. Management of Localized Kidney Cancer: Calculating Cancer-specific Mortality and Competing Risks of Death for Surgery and Nonsurgical Management. Eur Urol 2014;65:235–41","year":2014,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Cancer; Tian; Kidney cancer; Gerontology; Internal medicine; Literature","score_opus":0.07250835637253691,"score_gpt":0.32316587763048393,"score_spread":0.25065752125794705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992242899","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18462087,0.00949356,0.001423647,0.79235315,0.002608942,0.006028223,0.0007322638,0.00011628632,0.0026230505],"genre_scores_gemma":[0.086308345,0.00740232,0.0027605558,0.89276856,0.00796189,0.0005095903,0.00068852794,0.00038016122,0.0012200765],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99446946,0.001239842,0.0012970817,0.0015230502,0.0006468959,0.00082365616],"domain_scores_gemma":[0.99663246,0.0008341182,0.00074386405,0.0011451951,0.00024820433,0.00039617255],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002524346,0.00075284304,0.0015993043,0.0003441473,0.00016266065,0.00005290002,0.00030720906,0.00021945908,0.00008146401],"category_scores_gemma":[0.00012235671,0.0005740232,0.00024689973,0.00021802884,0.00032479689,0.00004682293,0.00061746745,0.0008459835,0.000009415842],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010745178,0.00006933988,0.035366043,0.001537388,0.0010887677,0.001297456,0.00013678243,0.000041956417,0.000094656985,0.000020553387,0.95506346,0.004209057],"study_design_scores_gemma":[0.0024290981,0.0005217594,0.09472212,0.00054083247,0.0012500231,0.00009267549,0.000019565618,0.000097607735,0.000054248045,0.0000057463517,0.89984655,0.0004197441],"about_ca_topic_score_codex":0.0007878706,"about_ca_topic_score_gemma":0.000054092936,"teacher_disagreement_score":0.10041537,"about_ca_system_score_codex":0.0001064086,"about_ca_system_score_gemma":0.000050133327,"threshold_uncertainty_score":0.9996711},"labels":[],"label_agreement":null},{"id":"W1992385125","doi":"10.1111/jth.12459","title":"Increased risk of preoperative venous thromboembolism in patients with renal cell carcinoma and tumor thrombus","year":2013,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Thrombus; Inferior vena cava; Radiology; Renal vein; Thrombosis; Incidence (geometry); Surgery; Kidney; Internal medicine","score_opus":0.016006112547816902,"score_gpt":0.23702569376820645,"score_spread":0.22101958122038956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992385125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976377,0.0011199116,0.0000057625352,0.00019892809,0.000036222384,0.0006448459,0.00003471629,0.0000041176263,0.00031778647],"genre_scores_gemma":[0.9972304,0.0003867989,0.0021888765,0.00010492477,0.00003908399,0.0000071919058,0.0000067523456,0.000028630106,0.00000730572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982812,0.00013160803,0.00063908193,0.00023691764,0.0004564226,0.0002548027],"domain_scores_gemma":[0.99827594,0.00011453554,0.0006507684,0.00022145061,0.0004714783,0.00026580496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023127053,0.00026715358,0.0011020021,0.00024657891,0.00007760844,0.0000378052,0.000081876366,0.00007503144,0.0001126381],"category_scores_gemma":[0.0000460394,0.00016917461,0.000108304834,0.00019423562,0.00019579438,0.0002791005,0.000056562465,0.0003044534,0.0000024814335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053149567,0.001299136,0.9916805,0.00014416434,0.00035579762,0.000036728004,0.0021522583,0.000006480026,0.0020064071,0.0000050628746,0.0002845865,0.0014973585],"study_design_scores_gemma":[0.007551431,0.0059255087,0.9632359,0.0002634173,0.00086595194,0.000059672995,0.00053284055,0.000022703687,0.021324417,0.00004859339,0.000013743474,0.00015578361],"about_ca_topic_score_codex":0.0011657402,"about_ca_topic_score_gemma":0.000024266723,"teacher_disagreement_score":0.028444588,"about_ca_system_score_codex":0.00011191699,"about_ca_system_score_gemma":0.00013873314,"threshold_uncertainty_score":0.68987405},"labels":[],"label_agreement":null},{"id":"W1993420299","doi":"10.1016/j.urology.2014.11.016","title":"Clinical Outcomes of Patients With Nondiagnostic Biopsy During Cryoablation of Small Renal Masses","year":2015,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Biopsy; Cryoablation; Renal cell carcinoma; Oncocytoma; Angiomyolipoma; Radiology; Histopathology; Renal biopsy; Nephrology; Surgery; Kidney; Internal medicine; Pathology","score_opus":0.04078476677642723,"score_gpt":0.2938854435661256,"score_spread":0.2531006767896984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993420299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988007,0.00006547324,0.00013012909,0.00012203127,0.00008872141,0.00023008155,0.000006858638,0.0000120505365,0.0005439435],"genre_scores_gemma":[0.9980628,0.000003998548,0.0017255698,0.000047812973,0.000029653223,0.0000066208095,0.00003477679,0.000011536945,0.000077227596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999103,0.00006934449,0.00037352103,0.00016350769,0.00016183635,0.00012880168],"domain_scores_gemma":[0.99901986,0.0002639455,0.00020300348,0.0002240926,0.00018927224,0.00009981335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012154941,0.00009316592,0.00038270943,0.000097667384,0.000008355566,9.736292e-7,0.000045817713,0.000087520784,0.000029303992],"category_scores_gemma":[0.0003812696,0.00006276999,0.00006331874,0.00007561514,0.00011761075,0.000020042902,0.000030569317,0.00008256746,0.000010635674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011637097,0.00041329622,0.9977422,0.000029563866,0.00013088781,0.00004962994,0.000067877154,0.00008869717,0.00010277615,0.00002161784,0.000016360536,0.00017340048],"study_design_scores_gemma":[0.0042975815,0.0030593069,0.991327,0.000010361257,0.00024214825,0.000016782302,0.000010881565,0.000026081245,0.0008591548,0.00003926513,0.00006495199,0.00004650899],"about_ca_topic_score_codex":0.00003812951,"about_ca_topic_score_gemma":0.0000147432,"teacher_disagreement_score":0.006415207,"about_ca_system_score_codex":0.000024415607,"about_ca_system_score_gemma":0.000072898714,"threshold_uncertainty_score":0.2559686},"labels":[],"label_agreement":null},{"id":"W1993497587","doi":"10.1111/j.1464-410x.2008.08259.x","title":"A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population‐based study","year":2008,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Cytodiagnostics (Canada)","funders":"","keywords":"Chromophobe cell; Clear cell; Papillary renal cell carcinomas; Clear cell renal cell carcinoma; Pathology; Medicine; Population; Renal cell carcinoma; Oncology","score_opus":0.019908780217359753,"score_gpt":0.2685986635940184,"score_spread":0.24868988337665865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993497587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99390274,0.0050616246,0.000020895859,0.00031019244,0.000088148525,0.0004110039,0.0000056016743,0.000003375646,0.00019642395],"genre_scores_gemma":[0.9987388,0.000077401586,0.0010011734,0.00010199704,0.000045556837,0.0000063363104,0.0000024308324,0.00001434586,0.000011961725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782205,0.00056218466,0.00078376563,0.00019669408,0.00042323055,0.00021207007],"domain_scores_gemma":[0.99874073,0.00039034922,0.00035544546,0.0001649296,0.0002332315,0.00011533944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041002213,0.0001316989,0.0006425548,0.00014931234,0.000062047395,0.0000049378627,0.0001256365,0.000119064025,0.000043574433],"category_scores_gemma":[0.00031791072,0.00010440306,0.0001509894,0.0001700361,0.00025345958,0.000043425807,0.000061380255,0.0004416497,3.087397e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004496451,0.002594166,0.9865888,0.00011182088,0.000026072885,0.0069267247,0.00012146299,0.00013209852,0.0028233426,0.000014703025,0.00006280577,0.00014840066],"study_design_scores_gemma":[0.003840073,0.0077138594,0.9781097,0.000062757485,0.00030430526,0.008859405,0.00007035699,0.0002356852,0.0006714277,0.00005354352,0.000008707561,0.00007017878],"about_ca_topic_score_codex":0.0003331066,"about_ca_topic_score_gemma":0.000041452593,"teacher_disagreement_score":0.008479057,"about_ca_system_score_codex":0.00010913726,"about_ca_system_score_gemma":0.00030620693,"threshold_uncertainty_score":0.4257433},"labels":[],"label_agreement":null},{"id":"W1994295819","doi":"10.1002/cam4.302","title":"Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first‐line sunitinib: a medical chart review across ten centers in five European countries","year":2014,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"GlaxoSmithKline","keywords":"Sunitinib; Medicine; Renal cell carcinoma; Discontinuation; Adverse effect; Proportional hazards model; Common Terminology Criteria for Adverse Events; Internal medicine; Hazard ratio; Oncology","score_opus":0.019327725567929496,"score_gpt":0.28979992850502745,"score_spread":0.27047220293709795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994295819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99490917,0.0018999382,0.000010788903,0.0009206744,0.00004657335,0.0015140031,0.00015126729,0.000030356789,0.00051720464],"genre_scores_gemma":[0.99256295,0.00608383,0.000024236255,0.00030817997,0.000087772845,0.00011761739,0.0005835971,0.000054154327,0.00017765754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749684,0.00019816853,0.00058978284,0.00055748987,0.0007386555,0.00041903922],"domain_scores_gemma":[0.99798375,0.0001753598,0.00037592775,0.00054421026,0.0004334083,0.0004873389],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035395488,0.00046630925,0.0011315101,0.00014229995,0.00008133727,0.000002093117,0.00011667412,0.00006636514,0.00010618333],"category_scores_gemma":[0.00014480442,0.0002507983,0.00008936764,0.00032782074,0.0005033322,0.00008168053,0.000036766007,0.00021675622,0.0000037294667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005438112,0.00071933685,0.98846513,0.0006690894,0.00019378106,0.00017284446,0.0009668851,0.0000659731,0.000040856914,0.0000016730118,0.00012099971,0.003145319],"study_design_scores_gemma":[0.023041021,0.013300496,0.953122,0.009127629,0.00046862583,0.000018353161,0.00017427697,0.00008694823,0.00027757837,4.029181e-7,0.00017894342,0.00020368584],"about_ca_topic_score_codex":0.0035206445,"about_ca_topic_score_gemma":0.0011581762,"teacher_disagreement_score":0.035343092,"about_ca_system_score_codex":0.00072032295,"about_ca_system_score_gemma":0.00021131532,"threshold_uncertainty_score":0.9999944},"labels":[],"label_agreement":null},{"id":"W1994922466","doi":"10.1016/s0242-6498(06)78414-0","title":"Le grade nucléaire de Fuhrman : détermination du meilleur système pronostique de grading sur une étude européenne multicentrique incluant 5 453 carcinomes à cellules rénales (CCR)","year":2006,"lang":"fr","type":"article","venue":"Annales de Pathologie","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cytodiagnostics (Canada)","funders":"","keywords":"Medicine; Multicenter study; Randomized controlled trial; Surgery","score_opus":0.025528050423487703,"score_gpt":0.2625421768923655,"score_spread":0.23701412646887776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994922466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9267932,0.05367279,0.0022677407,0.013330577,0.000510139,0.0013948068,0.00009214405,0.00035929,0.0015792686],"genre_scores_gemma":[0.98424566,0.006547855,0.0047450145,0.00045378215,0.0013531114,0.00020651391,0.0003307146,0.0001968069,0.0019205397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936329,0.0015046643,0.0011079413,0.0010749968,0.0005266838,0.0021527829],"domain_scores_gemma":[0.9968641,0.0008236175,0.00056811003,0.00078364165,0.00037379045,0.0005867453],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016171411,0.0009241724,0.0010573844,0.000452206,0.0005044825,0.00014867414,0.0005432878,0.0006341024,0.00003509268],"category_scores_gemma":[0.0008632069,0.0009178606,0.00049960194,0.00055566296,0.000590482,0.000374929,0.00032639402,0.00082064647,0.00016665665],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042780183,0.003522868,0.7266694,0.002972568,0.00032495978,0.045994096,0.0076473854,0.0029625355,0.18509226,0.008610554,0.002698648,0.0130769545],"study_design_scores_gemma":[0.0028836695,0.000902382,0.8325745,0.00124486,0.0007426865,0.003960248,0.0015178872,0.009203058,0.14113735,0.0022961136,0.0026468409,0.00089041603],"about_ca_topic_score_codex":0.0055269934,"about_ca_topic_score_gemma":0.0020043375,"teacher_disagreement_score":0.10590512,"about_ca_system_score_codex":0.002635542,"about_ca_system_score_gemma":0.0015966481,"threshold_uncertainty_score":0.9993272},"labels":[],"label_agreement":null},{"id":"W1994973140","doi":"10.1016/j.prp.2006.08.007","title":"Cytohistopathologic hybrid renal cell carcinoma with papillary and clear cell features","year":2006,"lang":"en","type":"article","venue":"Pathology - Research and Practice","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Papillary renal cell carcinomas; Clear cell; Cytokeratin; Medicine; Pathology; Renal cell carcinoma; Lymph node metastasis; Lymph node; Metastasis; Immunohistochemistry; Internal medicine; Cancer","score_opus":0.037742105831659566,"score_gpt":0.3153673825015702,"score_spread":0.27762527666991066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994973140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8888793,0.012923641,0.00002111325,0.0028084829,0.000033829205,0.0005458389,0.000016008376,0.000040022438,0.094731785],"genre_scores_gemma":[0.9861583,0.001113478,0.0046608164,0.00035256485,0.0001912049,0.000053929907,0.000052204672,0.000038536058,0.00737898],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99677676,0.0010324413,0.0002276013,0.00073268893,0.000535188,0.0006953029],"domain_scores_gemma":[0.99734396,0.0014196674,0.000114010356,0.0004767377,0.0003440412,0.00030157133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017043557,0.00025714134,0.00036824078,0.00025175454,0.00038100375,0.00006905679,0.000098046694,0.00016113238,0.000051804695],"category_scores_gemma":[0.00035599273,0.00016621964,0.000039725313,0.00021287614,0.0007986327,0.00019867183,0.00017009531,0.001008563,0.000048788505],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031841382,0.0034498253,0.17080525,0.0011418525,0.000076164964,0.25525984,0.0014639854,0.0000057481216,0.5019685,0.0008170581,0.027475199,0.005695212],"study_design_scores_gemma":[0.007843451,0.025807885,0.6733464,0.000066261666,0.00047086115,0.09587158,0.0020370472,0.000017322698,0.15075001,0.0013453163,0.04181115,0.00063268346],"about_ca_topic_score_codex":0.00035784504,"about_ca_topic_score_gemma":0.000027447213,"teacher_disagreement_score":0.5025412,"about_ca_system_score_codex":0.00009459522,"about_ca_system_score_gemma":0.00016778398,"threshold_uncertainty_score":0.6778241},"labels":[],"label_agreement":null},{"id":"W1995304774","doi":"10.5489/cuaj.11015","title":"Determining the best warm ischemic time for patients undergoing partial nephrectomy for renal cancer","year":2011,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Nephrectomy; Medicine; Urology; Cancer; Internal medicine; Kidney","score_opus":0.03454865888788897,"score_gpt":0.24814136236966444,"score_spread":0.21359270348177548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995304774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99442405,0.00009360116,0.000130801,0.0027508251,0.00030082787,0.0008676271,0.000074389856,0.000014527637,0.0013433391],"genre_scores_gemma":[0.9954386,0.000019762969,0.0007724992,0.0020540005,0.0007095388,0.00022501251,0.00004876801,0.000021755495,0.0007101165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986516,0.00006392826,0.00032098926,0.00019020544,0.0002256496,0.0005476142],"domain_scores_gemma":[0.998363,0.00037829633,0.00029817375,0.00009060992,0.00040087133,0.00046905587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036552196,0.00015157158,0.00023929875,0.0000756493,0.0004115193,0.000048872433,0.00011766865,0.00017371647,0.0002787708],"category_scores_gemma":[0.0008307876,0.00009900932,0.00021484312,0.00007918965,0.000026477905,0.00007586544,0.000011428354,0.00026022707,0.000026482448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027624035,0.00010890272,0.97717845,0.000008190718,0.00023603151,0.000010554235,0.00022915807,0.000010008466,0.00015679702,0.00001858058,0.015135889,0.0066311904],"study_design_scores_gemma":[0.011688071,0.004851337,0.77008307,0.00008382876,0.0012176724,0.000062700696,0.00009396489,0.0014138442,0.0019325787,0.000591313,0.20752949,0.0004521337],"about_ca_topic_score_codex":0.00027329728,"about_ca_topic_score_gemma":0.0005182555,"teacher_disagreement_score":0.20709538,"about_ca_system_score_codex":0.001370191,"about_ca_system_score_gemma":0.0006146306,"threshold_uncertainty_score":0.4037483},"labels":[],"label_agreement":null},{"id":"W1996277527","doi":"10.1016/j.urology.2009.08.028","title":"A Population-based Comparison of Cancer-control Rates Between Radical and Partial Nephrectomy for T1A Renal Cell Carcinoma","year":2010,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Kidney cancer; Population; Urology; Surveillance, Epidemiology, and End Results; Cohort; Cancer; Oncology; Epidemiology; Internal medicine; Surgery; Kidney; Cancer registry","score_opus":0.021850530970378597,"score_gpt":0.31091273504124656,"score_spread":0.28906220407086797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996277527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961905,0.00053645653,0.0010009521,0.0012270311,0.00013379048,0.0007799471,0.000050990882,0.000019908719,0.00006045711],"genre_scores_gemma":[0.99838734,8.6378685e-7,0.0007003471,0.00021036799,0.0003654466,0.00018097565,0.00011203968,0.000019423345,0.000023191416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989548,0.00005995333,0.0003381755,0.00026527344,0.00012221177,0.00025962916],"domain_scores_gemma":[0.9989647,0.00046290556,0.00014798393,0.00019540737,0.00006760138,0.00016138966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001197375,0.00014918715,0.0005600408,0.00009667711,0.00005299324,0.000005066716,0.000056707482,0.00018488706,0.00009010292],"category_scores_gemma":[0.00005754965,0.00012282553,0.00009515078,0.000058631013,0.00012742693,0.000017574523,0.000011600876,0.00021413316,0.0000022782674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010669725,0.000117717136,0.96594703,0.000060612347,0.000047660826,0.000007324136,0.00005302164,0.00007869804,0.030479321,0.00005371258,0.0001406184,0.0019473144],"study_design_scores_gemma":[0.008779117,0.0020098456,0.8843412,0.0000040748214,0.0006717737,0.0000070492647,0.00000520879,0.013486015,0.08759966,0.000062710584,0.0029236916,0.000109695284],"about_ca_topic_score_codex":0.00076609297,"about_ca_topic_score_gemma":0.0002453402,"teacher_disagreement_score":0.08160587,"about_ca_system_score_codex":0.000025781505,"about_ca_system_score_gemma":0.0001324526,"threshold_uncertainty_score":0.50086796},"labels":[],"label_agreement":null},{"id":"W1998628385","doi":"10.1016/j.eururo.2011.06.041","title":"Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review","year":2011,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":331,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Disease; Oncology; Internal medicine; MEDLINE; Stage (stratigraphy); Natural history; Clinical significance; Carcinoma; Pathology","score_opus":0.1062311787085082,"score_gpt":0.28351132202892954,"score_spread":0.17728014332042133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998628385","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008103734,0.926802,0.0000161178,0.000027246095,0.000099518744,0.003172329,0.00006561873,0.00005375797,0.068953075],"genre_scores_gemma":[0.050057728,0.9483456,0.000043251122,0.00026846363,0.00010486918,0.000115220995,0.00047507786,0.00016905453,0.00042071976],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99565154,0.001689289,0.0010517288,0.0009741777,0.00017481837,0.00045847055],"domain_scores_gemma":[0.99813426,0.00029760852,0.0004984582,0.0006863822,0.00006766413,0.00031563902],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050998473,0.0007815042,0.0029128324,0.00036689872,0.000034869445,0.000008677639,0.00023595031,0.00022507262,0.00005987006],"category_scores_gemma":[0.00012662454,0.0005317378,0.00041724028,0.00024768343,0.00019705914,0.000069925256,0.0002638202,0.00092410675,0.00013814589],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009823815,0.0030262978,0.030745976,0.4949351,0.0017999732,0.055851158,0.0028779479,0.000003222911,0.000004357358,0.00025631062,0.021015676,0.3885016],"study_design_scores_gemma":[0.0014994494,0.0036688717,0.008525795,0.021074222,0.005203209,0.0014151937,0.000010426789,0.000013425761,0.0000012348579,0.000027538521,0.9579399,0.0006207109],"about_ca_topic_score_codex":0.000034335582,"about_ca_topic_score_gemma":0.000002006994,"teacher_disagreement_score":0.9369242,"about_ca_system_score_codex":0.000121518045,"about_ca_system_score_gemma":0.00039108717,"threshold_uncertainty_score":0.9997134},"labels":[],"label_agreement":null},{"id":"W1998668334","doi":"10.1002/cncr.22463","title":"Prognostic ability of simplified nuclear grading of renal cell carcinoma","year":2007,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Grading (engineering); Renal cell carcinoma; Kidney cancer; Internal medicine; Predictive value of tests; Radiology; Oncology","score_opus":0.02826512084853723,"score_gpt":0.2832360557944165,"score_spread":0.2549709349458793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998668334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912393,0.00093552493,0.000044939712,0.000058355145,0.0000858783,0.0003953114,0.000011549464,0.000017172413,0.0072119744],"genre_scores_gemma":[0.99931884,0.000013100989,0.00036786936,0.00004357752,0.00008605367,0.000008543926,0.000005286215,0.000021811236,0.0001349484],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99897516,0.000018081808,0.00034273646,0.00020683552,0.00023609566,0.00022110496],"domain_scores_gemma":[0.9991896,0.000098639655,0.0001479456,0.0003063258,0.00012852193,0.00012893787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020158321,0.00011748741,0.00031921183,0.00007560414,0.000021108266,0.0000019053737,0.00006602581,0.000064117536,0.00023932518],"category_scores_gemma":[0.00004085649,0.00009619895,0.00012296217,0.00014293501,0.000116340394,0.000024913208,0.000026518243,0.00010116349,0.0000058800447],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057094236,0.00025726552,0.42958695,0.0007045763,0.00004798765,0.000061402716,0.0005743528,0.000014464398,0.56312084,0.00009202586,0.0003399055,0.0046293153],"study_design_scores_gemma":[0.00078902923,0.00034509742,0.5692363,0.00006206708,0.00014097504,0.000007423096,0.00008344365,0.000027187949,0.42889765,0.000033594053,0.00032110553,0.000056130302],"about_ca_topic_score_codex":0.00025367705,"about_ca_topic_score_gemma":0.0000134330785,"teacher_disagreement_score":0.13964935,"about_ca_system_score_codex":0.00020497064,"about_ca_system_score_gemma":0.000108544285,"threshold_uncertainty_score":0.39228794},"labels":[],"label_agreement":null},{"id":"W1999130942","doi":"10.1089/end.2008.9724","title":"Number of Needle Passes Does Not Correlate with the Diagnostic Yield of Renal Fine Needle Aspiration Cytology","year":2008,"lang":"en","type":"article","venue":"Journal of Endourology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McGill University","keywords":"Medicine; Fine needle aspiration cytology; Fine-needle aspiration; Cytology; Diagnostic accuracy; Renal mass; Radiology; Biopsy; Kidney; Pathology; Nephrectomy; Internal medicine","score_opus":0.026567631751904967,"score_gpt":0.25473809268210507,"score_spread":0.2281704609302001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999130942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937449,0.000373963,0.000398816,0.0037493757,0.00023010012,0.00017458075,0.0000050676986,0.0000051485517,0.0013180125],"genre_scores_gemma":[0.9984392,0.00012226742,0.0005105258,0.00039019185,0.00023019421,0.0000056733534,0.0000029652092,0.000016397813,0.00028257945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986048,0.0001299298,0.000634993,0.000117942276,0.00030632905,0.00020600551],"domain_scores_gemma":[0.9967605,0.0016614144,0.0008809744,0.00022832549,0.00038259258,0.00008621877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002397994,0.0001538645,0.00063600345,0.00013824763,0.000047881073,0.0000023157527,0.00012546734,0.00012499468,0.00029243474],"category_scores_gemma":[0.0005916876,0.00007383525,0.00016469152,0.0001506429,0.00032402293,0.00006663814,0.000029388302,0.0003796591,0.0000080805075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009116613,0.0011951667,0.8393033,0.00011960656,0.001326454,0.0048710816,0.0018489988,0.002100165,0.1324706,0.00055238267,0.0055034924,0.001592141],"study_design_scores_gemma":[0.0076819845,0.01882368,0.73789823,0.00017645612,0.0014875105,0.04182539,0.00031479658,0.00009293445,0.18969798,0.00022332696,0.0015866011,0.0001910877],"about_ca_topic_score_codex":0.00008300917,"about_ca_topic_score_gemma":0.00006686245,"teacher_disagreement_score":0.101405054,"about_ca_system_score_codex":0.000031324802,"about_ca_system_score_gemma":0.00019733704,"threshold_uncertainty_score":0.32019556},"labels":[],"label_agreement":null},{"id":"W2000020851","doi":"10.1089/jpm.2008.9846","title":"Rapid Improvement in Pain and Functional Level in a Patient with Metastatic Renal Cell Carcinoma: A Case Report and Review of the Literature","year":2008,"lang":"en","type":"article","venue":"Journal of Palliative Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Cancer Care Ontario","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Zoledronic acid; Bone pain; Palliative care; Performance status; Radiology; Internal medicine; Oncology; Cancer","score_opus":0.051864518296167464,"score_gpt":0.27273571956065656,"score_spread":0.22087120126448911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000020851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91092867,0.08596085,0.0000711773,0.002291065,0.000043061405,0.000596746,0.000006147329,9.4317016e-7,0.000101341924],"genre_scores_gemma":[0.9931347,0.005066895,0.00087432016,0.0007302573,0.0000578276,0.000015648244,0.000006312206,0.000010670001,0.000103405604],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99783677,0.00025170983,0.0009695911,0.00018517942,0.00060953054,0.00014721052],"domain_scores_gemma":[0.9982282,0.00023079794,0.0008401481,0.00017409486,0.00038903524,0.00013775741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012981449,0.00019458358,0.0007296991,0.00022866644,0.000033002514,0.0000022335398,0.000032787473,0.000031510812,0.00003081298],"category_scores_gemma":[0.0004363087,0.000090148875,0.00006973765,0.0004196908,0.00020424009,0.000055972596,0.00002774452,0.00039619955,6.0345116e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018017796,0.00092491636,0.34693745,0.007947948,0.0002693233,0.6133866,0.012323223,0.000008987469,0.0071712914,0.000010249938,0.0014248663,0.00779342],"study_design_scores_gemma":[0.011884029,0.012986014,0.73997885,0.028184619,0.0005398912,0.20077126,0.0018387111,0.000043412456,0.0033234663,0.000038676528,0.00026281938,0.00014823348],"about_ca_topic_score_codex":0.00011303028,"about_ca_topic_score_gemma":0.00006050348,"teacher_disagreement_score":0.4126153,"about_ca_system_score_codex":0.00021295968,"about_ca_system_score_gemma":0.00027022162,"threshold_uncertainty_score":0.36761644},"labels":[],"label_agreement":null},{"id":"W2000274235","doi":"10.1097/mou.0b013e32833c7b19","title":"Factors affecting outcome in renal cell carcinoma","year":2010,"lang":"en","type":"review","venue":"Current Opinion in Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"University of California, Los Angeles","keywords":"Medicine; Renal cell carcinoma; Disease; Pathological; Natural history; Oncology; Predictive value; Prognostic model; Internal medicine; Overall survival; Intensive care medicine","score_opus":0.19597768159003726,"score_gpt":0.41063077665739617,"score_spread":0.2146530950673589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000274235","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032180086,0.95694166,0.000005066404,0.000029387384,0.008566642,0.0016786852,0.000023147906,0.00004229904,0.00053302955],"genre_scores_gemma":[0.027461654,0.97061974,0.000032634747,0.000010737273,0.00078443607,0.00017639024,0.0007495384,0.00010528933,0.000059587805],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99616104,0.00047271443,0.0013980877,0.0009422827,0.00028687093,0.0007390184],"domain_scores_gemma":[0.9978998,0.0005915909,0.0005243998,0.0007135667,0.000039455124,0.00023122919],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00043735476,0.00078796805,0.0028869025,0.0012064277,0.000037080215,0.000014683786,0.00028841087,0.0009110029,0.0001260069],"category_scores_gemma":[0.00018394721,0.00058715825,0.00066307286,0.0005248018,0.00010339801,0.000044085868,0.00018950528,0.0029798667,0.00012110234],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058812995,0.00094115094,0.31091133,0.04371265,0.00003904374,0.00013035061,0.00035164188,0.000002530653,0.0000043069954,0.000046535082,0.00036420338,0.64343745],"study_design_scores_gemma":[0.0015103657,0.000560959,0.044130046,0.002741952,0.00031833164,0.00014350672,0.000016479731,0.0000065494405,0.000006740642,0.000010365669,0.9500874,0.00046725292],"about_ca_topic_score_codex":0.000045262597,"about_ca_topic_score_gemma":0.000016364607,"teacher_disagreement_score":0.94972324,"about_ca_system_score_codex":0.00049700454,"about_ca_system_score_gemma":0.00039208407,"threshold_uncertainty_score":0.999658},"labels":[],"label_agreement":null},{"id":"W2000473823","doi":"10.1016/s1359-6349(07)70017-4","title":"Staging of cancer","year":2007,"lang":"en","type":"article","venue":"European Journal of Cancer Supplements","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Renal sinus; Grading (engineering); Kidney cancer; Renal cell carcinoma; Cancer staging; Clinical significance; Cancer; Pathology; Kidney; Internal medicine; Nephrectomy; Biology","score_opus":0.03181044075866164,"score_gpt":0.34173368587723457,"score_spread":0.30992324511857294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000473823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857246,0.0056457627,0.0004996853,0.000522108,0.00053263665,0.00015433223,0.000032009528,0.0000060631723,0.006882793],"genre_scores_gemma":[0.996072,0.0008581972,0.0015848951,0.0002584423,0.00051632157,0.0000010472202,0.0000045204833,0.000038031532,0.00066654803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981727,0.000080081154,0.00077006326,0.00011866885,0.0005855603,0.0002729258],"domain_scores_gemma":[0.9986751,0.000026743837,0.0005858311,0.00017431352,0.00032042558,0.00021758898],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000911779,0.0001402139,0.00032648075,0.00019794048,0.000030483896,0.000008705923,0.00014623853,0.00001122195,0.0016272017],"category_scores_gemma":[0.000017358585,0.000106512016,0.00015998114,0.00015307257,0.000041853575,0.000079259175,0.000044182547,0.00018047684,0.000008376604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010680297,0.0002005054,0.8493806,0.00013616173,0.0007832339,0.0019455461,0.000905348,0.000048592803,0.037917048,0.000014295695,0.009375963,0.09822469],"study_design_scores_gemma":[0.0056863995,0.0010647789,0.7029282,0.00061193126,0.0004975006,0.00007688458,0.00031611568,0.0000039082242,0.18612023,0.0000062644845,0.10255784,0.00012998426],"about_ca_topic_score_codex":0.00014289959,"about_ca_topic_score_gemma":0.000051882616,"teacher_disagreement_score":0.14820318,"about_ca_system_score_codex":0.00026433868,"about_ca_system_score_gemma":0.00016497147,"threshold_uncertainty_score":0.99928546},"labels":[],"label_agreement":null},{"id":"W2001043667","doi":"10.5489/cuaj.1639","title":"Prise en charge du cancer du rein de stade avancé : Mise à jour 2013 des lignes directrices consensuelles du Forum canadien sur le cancer du rein","year":2013,"lang":"fr","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Humanities; Political science; Art","score_opus":0.015920747937203304,"score_gpt":0.22109920038078562,"score_spread":0.20517845244358232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001043667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7092105,0.047220014,0.000017867775,0.23975489,0.0017080993,0.0007146464,0.0003079189,0.00003939847,0.0010266348],"genre_scores_gemma":[0.93532,0.04122683,0.00018324915,0.004790475,0.004813217,0.00022715528,0.000034823664,0.000086575346,0.013317663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99351263,0.0014088737,0.0010758019,0.0006378042,0.00070756197,0.0026573245],"domain_scores_gemma":[0.99241745,0.0011277137,0.001040011,0.00027293945,0.001390441,0.0037514505],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017383568,0.00067079393,0.0010326706,0.00044315212,0.001282593,0.00045377912,0.0004439021,0.00084565196,0.007094704],"category_scores_gemma":[0.0029708066,0.000583157,0.00042173485,0.00046072854,0.00024672077,0.00049540075,0.00006230995,0.0012513838,0.00030575725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00009487989,0.00015487934,0.7190825,0.000046933626,0.00063644396,0.0016094418,0.0016030578,0.00041280806,0.00050156674,0.00013804919,0.26855624,0.007163206],"study_design_scores_gemma":[0.0032776226,0.00059549493,0.6836897,0.00029293756,0.0006420522,0.0009675766,0.0007781173,0.004052162,0.0005309369,0.0005140431,0.30399796,0.0006613942],"about_ca_topic_score_codex":0.78096676,"about_ca_topic_score_gemma":0.55144256,"teacher_disagreement_score":0.23496442,"about_ca_system_score_codex":0.018327724,"about_ca_system_score_gemma":0.0075380187,"threshold_uncertainty_score":0.999662},"labels":[],"label_agreement":null},{"id":"W2001477340","doi":"10.1016/j.clinimag.2012.01.010","title":"Spectrum of malignant renal and urinary bladder tumors on 18F-FDG PET/CT: a pictorial essay","year":2012,"lang":"en","type":"review","venue":"Clinical Imaging","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Royal Victoria Hospital; Brandon University; Royal Victoria Regional Health Centre; McGill University Health Centre; Brandon Regional Health Authority","funders":"","keywords":"Medicine; Malignancy; Urinary system; Urinary bladder; Broad spectrum; PET-CT; Radiology; Renal tumor; Positron emission tomography; Kidney; Pathology; Urology; Internal medicine; Nephrectomy","score_opus":0.1053973431641786,"score_gpt":0.39812561918445555,"score_spread":0.29272827602027696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001477340","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004335695,0.98803085,0.0000062774684,0.00021551512,0.0015600256,0.0011037086,0.00003966973,0.00005467837,0.0046536014],"genre_scores_gemma":[0.020555155,0.97375405,0.00041023723,0.00012565982,0.0038296073,0.000058086338,0.0001410331,0.00014597863,0.0009802037],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99561375,0.00043818762,0.0019501298,0.0008742733,0.00051351835,0.0006101445],"domain_scores_gemma":[0.9964359,0.0011942228,0.0008401928,0.0009146329,0.00006004129,0.00055504264],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011651932,0.0006752612,0.0034006226,0.0002411084,0.0000631774,0.000029053172,0.00021452016,0.000057190944,0.00027651383],"category_scores_gemma":[0.00032873868,0.0004610877,0.0011668277,0.00019221079,0.00042596247,0.00007610295,0.00026719065,0.0011201698,0.00015959934],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004938878,0.0027243742,0.009251445,0.018118352,0.0014678222,0.030516453,0.0000593826,9.842497e-8,0.0000050399276,0.00038647998,0.0014162475,0.9355604],"study_design_scores_gemma":[0.0026988026,0.0016000018,0.003954645,0.028535435,0.0086654285,0.016595112,0.000019298277,0.000009653487,0.000026040472,0.00014755709,0.9370471,0.0007008817],"about_ca_topic_score_codex":0.000022234753,"about_ca_topic_score_gemma":8.6962604e-7,"teacher_disagreement_score":0.9356309,"about_ca_system_score_codex":0.00022810037,"about_ca_system_score_gemma":0.00056796335,"threshold_uncertainty_score":0.9997841},"labels":[],"label_agreement":null},{"id":"W2001567963","doi":"10.1016/s0140-6736(01)06113-x","title":"Back to nephrectomy for patients with metastatic renal cancer","year":2001,"lang":"en","type":"letter","venue":"The Lancet","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Nephrectomy; Internal medicine; Cancer; Kidney cancer; Renal cell carcinoma; Alpha interferon; Oncology; Clinical trial; Nephrology; Interferon; Surgery; Urology; Kidney; Immunology","score_opus":0.050857019558507875,"score_gpt":0.29490566470972024,"score_spread":0.24404864515121236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001567963","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07986336,0.00032509747,0.00015838227,0.9082203,0.0003633353,0.0043474464,0.0006607581,0.000048581802,0.0060127284],"genre_scores_gemma":[0.0016968845,0.000059385726,0.009418028,0.9461566,0.012750019,0.0013727305,0.0014317442,0.00016511524,0.026949484],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99847263,0.000046863894,0.00020065096,0.00035584785,0.00040841824,0.0005156085],"domain_scores_gemma":[0.9986679,0.00015365805,0.00012711805,0.0008166882,0.00014910016,0.00008553864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008810966,0.000329051,0.0008480748,0.000070892944,0.000056244615,0.00003051742,0.00024915618,0.00013829382,0.0007752018],"category_scores_gemma":[0.000021849804,0.00016395222,0.00012321574,0.00015999931,0.000048745187,0.000021605778,0.00003407589,0.0007681278,0.0002067209],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010684863,0.000045392746,0.00493739,0.0002543117,0.00042896086,0.00009397281,0.00007255811,0.00000769411,0.000021489555,0.000001468332,0.99190456,0.001163728],"study_design_scores_gemma":[0.004520832,0.0007823927,0.006437653,0.00028209505,0.0008638013,0.000024165949,0.0000025415375,0.000005354228,0.0001549072,0.000031099393,0.98668826,0.00020690534],"about_ca_topic_score_codex":0.00015629511,"about_ca_topic_score_gemma":0.00009020271,"teacher_disagreement_score":0.07816648,"about_ca_system_score_codex":0.00016723418,"about_ca_system_score_gemma":0.00011634405,"threshold_uncertainty_score":0.84879166},"labels":[],"label_agreement":null},{"id":"W2001772470","doi":"10.1111/j.1464-410x.2008.08252.x","title":"Cancer‐specific and non‐cancer‐related mortality rates in European patients with T1a and T1b renal cell carcinoma","year":2008,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Renal cell carcinoma; Nephrectomy; Medicine; Renal function; Cancer; Kidney cancer; Univariate analysis; Urology; Internal medicine; Stage (stratigraphy); Mortality rate; Kidney disease; Oncology; Multivariate analysis; Kidney","score_opus":0.015377117852510086,"score_gpt":0.22950470651396343,"score_spread":0.21412758866145334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001772470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769213,0.021767437,0.000003356191,0.00016489474,0.00009646684,0.00021374783,0.0000142505,0.000006963043,0.0008115906],"genre_scores_gemma":[0.99147016,0.008064931,0.00013361065,0.00013817806,0.00009353679,0.000004518982,0.000007452851,0.0000284752,0.000059159956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985953,0.00017667489,0.0004876211,0.0002528742,0.00022268361,0.00026482448],"domain_scores_gemma":[0.9991486,0.00004223093,0.0002959871,0.00010592879,0.00019117199,0.00021609366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002049101,0.00016270256,0.00046986877,0.00013637032,0.00007443345,0.000015769856,0.000068353635,0.00007408854,0.00006159829],"category_scores_gemma":[0.000012067593,0.00014646948,0.000047773952,0.00013461549,0.00021614807,0.00009877177,0.00003784585,0.00041515636,0.0000016983985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005165678,0.00030075898,0.98073584,0.000032625827,0.0000873091,0.012590008,0.0003000076,0.000027340735,0.00054612866,6.888995e-7,0.00038433803,0.004478407],"study_design_scores_gemma":[0.0084652845,0.001964297,0.98090017,0.0000959668,0.00015447017,0.0075202896,0.000020215488,0.000020937929,0.0004063604,0.000009235402,0.0003228248,0.00011996016],"about_ca_topic_score_codex":0.00050468097,"about_ca_topic_score_gemma":0.0001631476,"teacher_disagreement_score":0.014548843,"about_ca_system_score_codex":0.00009049193,"about_ca_system_score_gemma":0.00012532827,"threshold_uncertainty_score":0.5972852},"labels":[],"label_agreement":null},{"id":"W2002036713","doi":"10.1016/j.ctrv.2004.06.006","title":"Autologous tumour cell vaccine may reduce risk of tumour progression in people with primary renal cell carcinoma","year":2004,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Oncology; Cell; Carcinoma; Kidney; Internal medicine","score_opus":0.021932125755524574,"score_gpt":0.2912317810521755,"score_spread":0.26929965529665095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002036713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8636377,0.12868729,0.000015740565,0.00039352255,0.00007903604,0.0034709387,0.000033044686,0.000043300784,0.0036394699],"genre_scores_gemma":[0.96158713,0.03128266,0.0043379264,0.00007087314,0.00013058042,0.0013266325,0.00012758255,0.00007277924,0.001063816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970377,0.00022564078,0.0009489926,0.0008151769,0.00039803362,0.00057445146],"domain_scores_gemma":[0.9979933,0.000047503814,0.0007830085,0.00076927623,0.00010397014,0.00030296427],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025553527,0.00065471703,0.0017517251,0.00022799415,0.000076947894,0.000013248957,0.00016216614,0.00012888275,0.00012365846],"category_scores_gemma":[0.000012188495,0.0003832695,0.00034916683,0.0005951976,0.00005733376,0.00009746983,0.000050841805,0.0002665024,0.000056455934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026857005,0.005326623,0.8285605,0.0030798044,0.00017335934,0.0016135785,0.0016921542,0.0003561441,0.09225886,0.0000069881403,0.00077069446,0.06347561],"study_design_scores_gemma":[0.013058953,0.0056327404,0.6023057,0.0017162974,0.001414411,0.00017825513,0.00005796542,0.000006728793,0.3710277,0.00001042155,0.0042411005,0.00034968165],"about_ca_topic_score_codex":0.002647854,"about_ca_topic_score_gemma":0.00069344905,"teacher_disagreement_score":0.27876884,"about_ca_system_score_codex":0.0027168274,"about_ca_system_score_gemma":0.00094018865,"threshold_uncertainty_score":0.9998619},"labels":[],"label_agreement":null},{"id":"W2002055535","doi":"10.5489/cuaj.1350","title":"The trend towards nephron-sparing procedures for renal masses: Surprisingly slow or reassuringly rapid?","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Renal mass; Nephron; Urology; Medicine; Kidney; Internal medicine; Nephrectomy","score_opus":0.02445742874116305,"score_gpt":0.24264261144344898,"score_spread":0.21818518270228593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002055535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9280037,0.0012758297,0.00016582359,0.06153119,0.0005497204,0.0012970396,0.000031980107,0.00007115059,0.0070735347],"genre_scores_gemma":[0.98993856,0.00016757334,0.0012619926,0.0021018093,0.0009806664,0.000137136,0.000024619274,0.000029880617,0.0053577498],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99765444,0.00015861235,0.0005198834,0.00028164795,0.00049755006,0.0008878761],"domain_scores_gemma":[0.9975269,0.0005128677,0.00037772604,0.00018766898,0.00041715248,0.0009776909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000952477,0.00023689934,0.00036032757,0.00015686112,0.00084676535,0.00043387298,0.00021318343,0.0002613442,0.00046965008],"category_scores_gemma":[0.0023161566,0.0001320841,0.00025503174,0.00021580621,0.00005328299,0.00016400665,0.00002097286,0.0005152884,0.000044908826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014733969,0.00026111348,0.51363826,0.00008369179,0.0014072721,0.0005173679,0.00070922764,0.00013725754,0.0013212082,0.00042785733,0.33880603,0.14121732],"study_design_scores_gemma":[0.0020984772,0.0013013395,0.733632,0.00003532407,0.00021235191,0.00065013755,0.00019376326,0.0003014414,0.00022976889,0.00092672394,0.26019317,0.0002254829],"about_ca_topic_score_codex":0.0016388954,"about_ca_topic_score_gemma":0.004786338,"teacher_disagreement_score":0.21999374,"about_ca_system_score_codex":0.0020387333,"about_ca_system_score_gemma":0.0015271804,"threshold_uncertainty_score":0.651272},"labels":[],"label_agreement":null},{"id":"W2002161733","doi":"10.5489/cuaj.1372","title":"Association between R.E.N.A.L nephrometry score and perioperative outcomes following open partial nephrectomy under cold ischemia","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Perioperative; Renal cell carcinoma; Blood loss; Ischemia; Surgery; Complication; Renal function; Urology; Kidney; Internal medicine","score_opus":0.027359384839486852,"score_gpt":0.2672937223634834,"score_spread":0.23993433752399657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002161733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732938,0.00014556573,0.0000860795,0.021868158,0.0002249989,0.00049452,0.000019098356,0.00002501192,0.0038428004],"genre_scores_gemma":[0.99078095,0.000014227675,0.00049215206,0.005279083,0.0004905087,0.000023267425,0.00003663666,0.000022398053,0.002860801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99765587,0.00037398946,0.0004514528,0.00032123507,0.00057209696,0.00062534993],"domain_scores_gemma":[0.99767923,0.00055546855,0.00038583524,0.00013589895,0.00022376553,0.0010198179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014660803,0.00024196797,0.0006531175,0.0001839194,0.00052089576,0.00046675184,0.0001779301,0.00040900332,0.0003043825],"category_scores_gemma":[0.0015609019,0.00018966247,0.0002648767,0.00025543422,0.000024021443,0.00028056768,0.00006401658,0.0007231981,0.00005216215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016531874,0.000019394702,0.99586797,0.000002854212,0.0008357132,0.000035616944,0.000089754874,0.000010821616,0.0002764192,0.0001958604,0.0019041453,0.00074490975],"study_design_scores_gemma":[0.0024265153,0.00038094964,0.9545316,0.00001730195,0.0005724279,0.000022417174,0.00007120404,0.000047895363,0.00026409808,0.00018856487,0.041282896,0.00019413276],"about_ca_topic_score_codex":0.0012342643,"about_ca_topic_score_gemma":0.0005839356,"teacher_disagreement_score":0.041336384,"about_ca_system_score_codex":0.0032795435,"about_ca_system_score_gemma":0.00047464273,"threshold_uncertainty_score":0.8575892},"labels":[],"label_agreement":null},{"id":"W2003041485","doi":"10.1016/j.urology.2008.08.127","title":"POD-6.11: Computerized Tomography Measurement of Visceral Adiposity Predicts Plasma Adiponectin Levels and Presence of Metastatic Disease in Patients with Clear Cell Renal Cell Carcinoma","year":2008,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Adiponectin; Renal cell carcinoma; Obesity; Body mass index; Internal medicine; Disease; Oncology; Hormone; Kidney disease; Endocrinology; Insulin resistance","score_opus":0.02090996813122978,"score_gpt":0.20413879342701086,"score_spread":0.18322882529578108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003041485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99817806,0.00041211667,0.00011946635,0.000058378067,0.00004487846,0.0009195726,0.0000592988,0.0000149908965,0.0001932072],"genre_scores_gemma":[0.9985482,0.0000054100196,0.0012905794,0.000050409133,0.000012069056,0.000021908954,0.000026573149,0.000022669281,0.000022182592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799645,0.000247232,0.00045261133,0.00041779026,0.00056253496,0.00032338648],"domain_scores_gemma":[0.9988026,0.00009689976,0.00024383677,0.00035437642,0.00022855207,0.00027376218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016503937,0.00024152517,0.0006102888,0.00028414145,0.000040508436,0.0000026601808,0.0001067151,0.000053937692,0.000027255339],"category_scores_gemma":[0.000031237327,0.00019233828,0.00009034815,0.00022383251,0.00029998293,0.000056155863,0.00007834639,0.00015537352,0.0000015845021],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009237779,0.0016600629,0.9804533,0.00034435312,0.00011058827,0.00036160136,0.00050543103,0.00018446764,0.006990938,0.0000035451599,0.000056670684,0.00009124706],"study_design_scores_gemma":[0.011706464,0.0065760505,0.9644783,0.00003861753,0.00045851106,0.000028668748,0.000006745476,0.0011766274,0.0153757725,0.000005802152,0.000019643823,0.00012880802],"about_ca_topic_score_codex":0.00026035303,"about_ca_topic_score_gemma":0.00003545762,"teacher_disagreement_score":0.015975026,"about_ca_system_score_codex":0.0000583289,"about_ca_system_score_gemma":0.00016542927,"threshold_uncertainty_score":0.78433275},"labels":[],"label_agreement":null},{"id":"W2003161920","doi":"10.1016/j.urolonc.2014.09.003","title":"Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal masses","year":2014,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cryoablation; Medicine; Renal cell carcinoma; Cancer; Survival rate; Kidney cancer; Cryosurgery; Progression-free survival; Surgery; Retrospective cohort study; Internal medicine; Overall survival","score_opus":0.0518119510930411,"score_gpt":0.32842191378544,"score_spread":0.2766099626923989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003161920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886179,0.00068841176,0.0008194675,0.0032807197,0.0001617823,0.0011041148,0.000023412382,0.000061885665,0.0052423277],"genre_scores_gemma":[0.8199181,0.00056461216,0.17159595,0.0024910648,0.00026541026,0.00066502445,0.00053900294,0.000034169134,0.0039266683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983133,0.00014988956,0.00052498165,0.00048539785,0.00017056454,0.00035586438],"domain_scores_gemma":[0.9979952,0.0009540338,0.00035191796,0.00030327027,0.00011932395,0.00027624783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034650194,0.0003168125,0.0008404839,0.00019766817,0.00020318993,0.000016811862,0.0000986237,0.00031506072,0.000075566975],"category_scores_gemma":[0.00026746953,0.00022598713,0.0001701026,0.0001557822,0.00057551585,0.000073498275,0.000040999577,0.00016061157,0.000016263115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005001696,0.00071863114,0.9774668,0.00010474219,0.00024064447,0.00007256552,0.00018288549,0.00006622088,0.006907957,0.0061230864,0.00038453372,0.0072317384],"study_design_scores_gemma":[0.00885321,0.044856824,0.63208276,0.00013780697,0.0023077251,0.0005868442,0.000056303423,0.00037925,0.018211575,0.013191039,0.2789171,0.00041954117],"about_ca_topic_score_codex":0.00006288218,"about_ca_topic_score_gemma":0.000078151636,"teacher_disagreement_score":0.34538403,"about_ca_system_score_codex":0.00044504774,"about_ca_system_score_gemma":0.0005080568,"threshold_uncertainty_score":0.9215488},"labels":[],"label_agreement":null},{"id":"W2003470917","doi":"10.2174/156800908786733450","title":"Anti-Angiogenic Targets in the Treatment of Advanced Renal Cell Carcinoma","year":2008,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Health Canada; Memorial Sloan-Kettering Cancer Center","keywords":"Pazopanib; Temsirolimus; Sunitinib; Axitinib; Sorafenib; Everolimus; Medicine; Vascular endothelial growth factor; Cancer research; Renal cell carcinoma; Bevacizumab; Platelet-derived growth factor receptor; Angiogenesis; PI3K/AKT/mTOR pathway; Tyrosine-kinase inhibitor; Growth factor; Pharmacology; Internal medicine; Cancer; Biology; Signal transduction; VEGF receptors; Discovery and development of mTOR inhibitors; Receptor; Chemotherapy; Hepatocellular carcinoma","score_opus":0.05341450169617008,"score_gpt":0.340254233950875,"score_spread":0.28683973225470494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003470917","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011006768,0.9824006,0.000002097555,0.00006092109,0.001256636,0.0042279386,0.0004013098,0.00003854488,0.00060515857],"genre_scores_gemma":[0.012328872,0.98341054,0.00010274906,0.00001965634,0.0006575613,0.0018325581,0.0011024439,0.0001383447,0.0004072752],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952867,0.00039135257,0.0014540686,0.0011079094,0.0008595969,0.00090036774],"domain_scores_gemma":[0.9971185,0.00023119163,0.00089382165,0.0013299538,0.00015378465,0.0002727821],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014757799,0.0012383773,0.003919643,0.00055822544,0.00011334994,0.00001515725,0.00050976593,0.00024149036,0.00016255763],"category_scores_gemma":[0.000014920724,0.0007401014,0.0022165051,0.0008315026,0.0001912822,0.0000772718,0.000064617816,0.00051191787,0.00007767308],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095437164,0.0029596607,0.0013690231,0.012572362,0.0003774599,0.00070178695,0.0020992027,0.000019730673,0.000016310443,0.0000050761723,0.0055215163,0.9742624],"study_design_scores_gemma":[0.0027859986,0.000663529,0.0017929977,0.005236323,0.0024160526,0.00015649715,0.000051283318,0.0000042739025,0.00082960364,0.0000043262075,0.98548025,0.00057887635],"about_ca_topic_score_codex":0.00025563434,"about_ca_topic_score_gemma":0.00005874352,"teacher_disagreement_score":0.9799587,"about_ca_system_score_codex":0.0018877174,"about_ca_system_score_gemma":0.0014412228,"threshold_uncertainty_score":0.999505},"labels":[],"label_agreement":null},{"id":"W2003599127","doi":"10.1016/j.urology.2005.12.050","title":"Cryotherapy: Clinical end points and their experimental foundations","year":2006,"lang":"en","type":"review","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cryotherapy; Cryoablation; Medicine; Nephrectomy; Ablation; Cryosurgery; Radiology; Stage (stratigraphy); Surgery; Renal cell carcinoma; Kidney; Pathology; Internal medicine","score_opus":0.11689778653298706,"score_gpt":0.4171653376316722,"score_spread":0.30026755109868514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003599127","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008155069,0.99208397,0.000033664495,0.00017557459,0.00027908004,0.0007634197,0.000021317306,0.00004083736,0.005786657],"genre_scores_gemma":[0.0010871993,0.9963988,0.00020997589,0.00046274092,0.0004820749,0.00012127585,0.00034477518,0.00006025299,0.00083287567],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99832517,0.00028056788,0.0005957032,0.00048050203,0.00008174261,0.00023630624],"domain_scores_gemma":[0.99886864,0.0003902215,0.00019061765,0.0004008229,0.00002227822,0.00012743917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001740906,0.00034179926,0.0015409057,0.0001341897,0.000051138668,0.000012212937,0.00007898699,0.0004125317,0.00047864605],"category_scores_gemma":[0.000025266487,0.00022223014,0.0004316879,0.00007127237,0.0002606766,0.000017676057,0.00005763205,0.0003457136,0.00016593588],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056180877,0.0005197319,0.00019963374,0.000744632,0.00054039125,0.00018081751,0.000053697375,2.863501e-8,0.0000026517644,0.00036176405,0.002114998,0.9952255],"study_design_scores_gemma":[0.0008130333,0.0011494173,0.00017146583,0.00015062954,0.00061472214,0.00097358774,0.0000060371976,0.000003060155,0.0000039918264,0.000071608745,0.9959026,0.00013987614],"about_ca_topic_score_codex":0.000018767665,"about_ca_topic_score_gemma":0.0000063850016,"teacher_disagreement_score":0.9950856,"about_ca_system_score_codex":0.00008535287,"about_ca_system_score_gemma":0.00018242488,"threshold_uncertainty_score":0.90622824},"labels":[],"label_agreement":null},{"id":"W2003723816","doi":"10.5489/cuaj.1760","title":"Contemporary incidence and mortality rates of kidney cancer in the United States","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University Health Network; Université de Montréal","funders":"","keywords":"Incidence (geometry); Medicine; Demography; Renal cell carcinoma; Epidemiology; Cancer; Kidney cancer; Stage (stratigraphy); Mortality rate; Internal medicine; Biology","score_opus":0.03611586700239609,"score_gpt":0.2843583091501365,"score_spread":0.24824244214774038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003723816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9672205,0.00031854436,0.0000067235046,0.031563103,0.00004614625,0.00012139324,0.000024838135,0.0000029517735,0.00069579924],"genre_scores_gemma":[0.9891643,0.000143841,0.00001773323,0.010528434,0.000071622475,0.0000065114236,0.000024824887,0.0000033470155,0.000039414117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890935,0.00034817337,0.00024911,0.000091265465,0.00022277946,0.00017929277],"domain_scores_gemma":[0.99888974,0.0002648125,0.00019035429,0.00007050045,0.00015255675,0.00043203286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010638756,0.00007402277,0.00019213372,0.0001222092,0.000067083485,0.00002521587,0.00006739671,0.00008380324,0.000086069784],"category_scores_gemma":[0.0012894891,0.00004405041,0.000038269754,0.00019769826,0.000045932044,0.000043098047,0.000006575199,0.0002833731,0.0000016169939],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020602864,0.000017651042,0.9934778,0.0000058182704,0.000036986665,0.00004437353,0.00025668475,0.000034812143,0.000051227893,0.000054707452,0.005828016,0.00017131562],"study_design_scores_gemma":[0.00059040065,0.00020411063,0.9904913,0.000020962876,0.000034206365,0.00003826398,0.00012588411,0.0005383946,0.000058163645,0.0006469491,0.0072091026,0.000042299773],"about_ca_topic_score_codex":0.025201144,"about_ca_topic_score_gemma":0.0024450505,"teacher_disagreement_score":0.022756092,"about_ca_system_score_codex":0.00033322303,"about_ca_system_score_gemma":0.0004971491,"threshold_uncertainty_score":0.9812901},"labels":[],"label_agreement":null},{"id":"W2003964500","doi":"10.5489/cuaj.2547","title":"Assessment of healthcare quality metrics: length-of-stay, 30-day readmission, and 30-day mortality for radical nephrectomy with inferior vena cava thrombectomy","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Comorbidity; Renal cell carcinoma; Logistic regression; Cohort; Surgery; Odds; Internal medicine; Emergency medicine; Kidney","score_opus":0.07077496851502814,"score_gpt":0.3494703646636197,"score_spread":0.27869539614859157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003964500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885955,0.0009535496,0.00073407183,0.007963922,0.000162914,0.0007348514,0.00014992397,0.00001843926,0.0006868171],"genre_scores_gemma":[0.9973845,0.000077064506,0.0013976432,0.000787229,0.00020162239,0.000027349102,0.000051936095,0.000019909761,0.000052766747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965451,0.0008260254,0.0008687553,0.00032328055,0.0009124609,0.00052442995],"domain_scores_gemma":[0.99511796,0.000710559,0.0008732374,0.00023259762,0.0011414969,0.0019241433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040133046,0.00023736682,0.0008823121,0.00026417818,0.00016880705,0.00003876272,0.00012218919,0.00033254968,0.00016682746],"category_scores_gemma":[0.0029392182,0.00016529989,0.00016720477,0.00035561764,0.00012080404,0.00009928777,0.000024712996,0.0005758227,0.0000018123342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006586112,0.00013509723,0.99541336,0.00006114252,0.0003698378,0.00006746985,0.0003040696,0.0000146856,0.0000612571,0.0003263047,0.0011108816,0.0020700349],"study_design_scores_gemma":[0.0032519258,0.0022866516,0.97961116,0.000045770437,0.0003042477,0.00004445028,0.0002213027,0.00026253078,0.00014264915,0.0004934901,0.013172792,0.0001630555],"about_ca_topic_score_codex":0.005472376,"about_ca_topic_score_gemma":0.0014714667,"teacher_disagreement_score":0.015802225,"about_ca_system_score_codex":0.0022629933,"about_ca_system_score_gemma":0.0033023811,"threshold_uncertainty_score":0.8272632},"labels":[],"label_agreement":null},{"id":"W2004112616","doi":"10.1111/j.1464-410x.2008.08258.x","title":"Baseline renal function, ischaemia time and blood loss predict the rate of renal failure after partial nephrectomy","year":2008,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal function; Nephrectomy; Perioperative; Urology; Renal cell carcinoma; Kidney disease; Internal medicine; Surgery; Kidney","score_opus":0.007546280257395041,"score_gpt":0.2004241983614766,"score_spread":0.19287791810408156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004112616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890053,0.008154648,0.00032305345,0.0020524936,0.00010626861,0.00022103019,0.000026086405,0.000010373353,0.00010074355],"genre_scores_gemma":[0.99678963,0.00087839464,0.00035323596,0.000748215,0.00083454384,0.00001225028,0.000012496421,0.000022385426,0.00034885752],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9982557,0.0003477988,0.0006612717,0.00019722494,0.00027211328,0.0002658461],"domain_scores_gemma":[0.9987429,0.00017544405,0.00036375705,0.00017479483,0.00034510577,0.00019804198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066233234,0.00016151587,0.00050688634,0.000105126615,0.0000934584,0.000012314157,0.000098036704,0.00014313933,0.000588933],"category_scores_gemma":[0.00017763967,0.00012248744,0.00018533497,0.00012928831,0.00042283995,0.00010488724,0.00004762329,0.00050189695,0.000010659535],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06022342,0.00370358,0.30351815,0.00029261762,0.008682794,0.2757241,0.0012895237,0.0010555523,0.15917625,0.000055957127,0.15200509,0.034272946],"study_design_scores_gemma":[0.012899245,0.0076510874,0.4129837,0.00021896837,0.002756361,0.51137537,0.000019499339,0.00029567096,0.008999841,0.00014799085,0.04242809,0.00022419776],"about_ca_topic_score_codex":0.000047842703,"about_ca_topic_score_gemma":0.000033354787,"teacher_disagreement_score":0.23565122,"about_ca_system_score_codex":0.000019451825,"about_ca_system_score_gemma":0.00017683141,"threshold_uncertainty_score":0.64484036},"labels":[],"label_agreement":null},{"id":"W2004322330","doi":"10.1111/j.1464-410x.2007.07148.x","title":"Unclassified renal cell carcinoma: an analysis of 85 cases","year":2007,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Nephrectomy; Medicine; Renal cell carcinoma; Stage (stratigraphy); Proportional hazards model; Multivariate analysis; Internal medicine; Oncology; Clear cell; Distant metastasis; T-stage; Urology; Clear cell renal cell carcinoma; Cancer; Metastasis; Gastroenterology; Kidney; Biology","score_opus":0.02720499847460421,"score_gpt":0.2722185305201372,"score_spread":0.245013532045533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004322330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99225634,0.0046412116,0.0005832196,0.00015094347,0.00013430884,0.00009367093,0.000016325528,0.000007413447,0.002116558],"genre_scores_gemma":[0.9982847,0.00012099454,0.0009054694,0.00023047924,0.00021442522,7.570879e-7,0.00002440992,0.000019038836,0.00019971376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805796,0.00014107996,0.000874469,0.00020454732,0.00039208538,0.0003298745],"domain_scores_gemma":[0.9981588,0.00021545288,0.0005855646,0.00023183583,0.00046606013,0.00034226358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007725692,0.00014271583,0.00083371194,0.00070528797,0.000046311812,0.000011885468,0.00014556883,0.00015560843,0.00027896426],"category_scores_gemma":[0.00012912408,0.00014199785,0.0004510412,0.00050956645,0.00019251379,0.00008638527,0.000028255785,0.00034119835,0.0000031534032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064098835,0.0035927917,0.63061976,0.00012022011,0.0035483323,0.21980573,0.00056241977,0.00088560936,0.09199539,0.00010661795,0.0019999107,0.040353324],"study_design_scores_gemma":[0.002644035,0.0048977006,0.93529034,0.000016078706,0.0052179904,0.037492987,0.00017604414,0.00012407333,0.013391952,0.000031016792,0.0006087829,0.00010900955],"about_ca_topic_score_codex":0.0005305394,"about_ca_topic_score_gemma":0.00063914026,"teacher_disagreement_score":0.30467057,"about_ca_system_score_codex":0.00010946959,"about_ca_system_score_gemma":0.00017566483,"threshold_uncertainty_score":0.5790504},"labels":[],"label_agreement":null},{"id":"W2004674373","doi":"10.1002/dc.21274","title":"Fine needle aspiration of renal cortical lesions in adults","year":2009,"lang":"en","type":"article","venue":"Diagnostic Cytopathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital","funders":"","keywords":"Medicine; Chromophobe cell; Fine-needle aspiration; Renal cell carcinoma; Cytology; Papillary renal cell carcinomas; Biopsy; Papanicolaou stain; Radiology; Pathology; Clear cell; Internal medicine; Cancer","score_opus":0.019350583673172245,"score_gpt":0.27395473826911654,"score_spread":0.2546041545959443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004674373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99565655,0.00045599786,0.00024839616,0.0011058146,0.00006698502,0.0003714007,0.0000071228615,0.000023881186,0.0020638513],"genre_scores_gemma":[0.9988985,0.000038641636,0.00054315216,0.000289174,0.000071393464,0.000025771938,0.00007009783,0.00000833148,0.0000549587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892133,0.000082777304,0.00038857115,0.00023515856,0.00014776931,0.00022441457],"domain_scores_gemma":[0.99891645,0.00058945775,0.00007249035,0.0002556697,0.00006973864,0.000096178206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014199487,0.00012235025,0.00035528402,0.00016982676,0.000021311573,0.000002277659,0.000050595758,0.00011408532,0.00011556514],"category_scores_gemma":[0.001868,0.000104291896,0.000070198985,0.00019751389,0.00007835295,0.000028758126,0.000018770717,0.00018273106,0.000046314137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016557514,0.0050606774,0.7578985,0.00015190867,0.000026506725,0.011997198,0.0016206007,0.00025423185,0.1022236,0.0058904067,0.000842416,0.112378165],"study_design_scores_gemma":[0.002185232,0.003424382,0.9797451,0.00022559188,0.00006365411,0.00041066096,0.000035032645,0.00013406132,0.013329206,0.0003247305,0.000044450044,0.00007788302],"about_ca_topic_score_codex":0.000031958265,"about_ca_topic_score_gemma":0.000072268725,"teacher_disagreement_score":0.22184658,"about_ca_system_score_codex":0.00006647541,"about_ca_system_score_gemma":0.00006992891,"threshold_uncertainty_score":0.42529},"labels":[],"label_agreement":null},{"id":"W2004769831","doi":"10.1007/s11934-008-0006-3","title":"Watchful waiting for small renal masses","year":2008,"lang":"en","type":"review","venue":"Current Urology Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Watchful waiting; Renal cell carcinoma; Nephrology; Percutaneous; Radiology; Internal medicine; Surgery; Oncology; Cancer; Prostate cancer","score_opus":0.1550534405542903,"score_gpt":0.3725689156456889,"score_spread":0.2175154750913986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004769831","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000493215,0.99293894,0.00011800615,0.000077000164,0.0020814291,0.0029674456,0.000022245094,0.00015086455,0.0011508603],"genre_scores_gemma":[0.00013502837,0.99420714,0.0006166193,0.000043163276,0.0013205679,0.0010843076,0.0016565764,0.00014360664,0.0007929608],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959703,0.0001390511,0.0016507326,0.0012142154,0.0002812125,0.00074445445],"domain_scores_gemma":[0.99675155,0.0003753775,0.0013427006,0.0010140641,0.00019761667,0.00031871986],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002889112,0.0007899953,0.0030917486,0.00031677922,0.00014249906,0.000015754546,0.00013428325,0.00057514483,0.000066222914],"category_scores_gemma":[0.00038461192,0.00058369903,0.001579801,0.00019345751,0.0001591176,0.000030122394,0.00012520928,0.00075907935,0.00005226773],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003671538,0.00027207725,0.00075186184,0.013324057,0.000539294,0.008969777,0.000025754523,5.331924e-7,8.2371713e-7,0.00001908091,0.007974674,0.96808535],"study_design_scores_gemma":[0.00035348447,0.00044058153,0.00003928501,0.0028187372,0.003927161,0.06261306,0.0000014788998,0.00000526281,0.000007201628,0.000054418153,0.9293693,0.00037007648],"about_ca_topic_score_codex":0.0000050963026,"about_ca_topic_score_gemma":0.0000021767082,"teacher_disagreement_score":0.96771526,"about_ca_system_score_codex":0.00020322077,"about_ca_system_score_gemma":0.0010482024,"threshold_uncertainty_score":0.99966145},"labels":[],"label_agreement":null},{"id":"W2004805159","doi":"10.1038/ncponc0773","title":"Hereditary leiomyomatosis and renal cell cancer: an unusual and aggressive form of hereditary renal carcinoma","year":2007,"lang":"en","type":"article","venue":"Nature Clinical Practice Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Debulking; Leiomyomatosis; Pathology; Radiology; Cancer; Internal medicine; Kidney","score_opus":0.03708986281287093,"score_gpt":0.4181664397243733,"score_spread":0.3810765769115024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004805159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9557685,0.029294463,0.000024207644,0.0046008066,0.0009711667,0.00062350795,0.000041228344,0.000041368432,0.008634752],"genre_scores_gemma":[0.98025256,0.0017160391,0.012861745,0.0028910753,0.001970621,0.00002098208,0.00006782416,0.000047330497,0.00017179272],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9964257,0.0004615702,0.0012314846,0.00081918924,0.00053451717,0.0005275269],"domain_scores_gemma":[0.991051,0.005949037,0.0012135078,0.00048459857,0.0005499044,0.0007519415],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0023845462,0.00036084664,0.0010997339,0.00019594606,0.00012656667,0.000013019904,0.0001577431,0.0015707399,0.000057725752],"category_scores_gemma":[0.002548156,0.00028887528,0.00017874305,0.00025179528,0.0007114502,0.00043831576,0.00018810015,0.0024329938,0.0000049880164],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0402336,0.008343963,0.2387253,0.00079751783,0.0015685146,0.063739344,0.0017803684,0.000002616624,0.011288409,0.0005545829,0.030868283,0.6020975],"study_design_scores_gemma":[0.015855398,0.031822193,0.8499345,0.0003107447,0.00369857,0.01666166,0.0028850767,0.00014387735,0.017324224,0.00054293935,0.060155265,0.00066555344],"about_ca_topic_score_codex":0.00045937134,"about_ca_topic_score_gemma":0.00040871135,"teacher_disagreement_score":0.6112092,"about_ca_system_score_codex":0.00027426425,"about_ca_system_score_gemma":0.0007961857,"threshold_uncertainty_score":0.9999563},"labels":[],"label_agreement":null},{"id":"W2004950211","doi":"10.1097/01.pas.0000180443.94645.50","title":"Immunohistochemical Analysis of Mucinous Tubular and Spindle Cell Carcinoma and Papillary Renal Cell Carcinoma of the Kidney","year":2006,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; Credit Valley Hospital","funders":"","keywords":"Pathology; Cytokeratin; Clear cell; Clear cell carcinoma; Papillary renal cell carcinomas; Renal cell carcinoma; Mucinous carcinoma; Carcinoma; Immunohistochemistry; Spindle cell carcinoma; Tissue microarray; Medicine; Adenocarcinoma; Cancer; Internal medicine","score_opus":0.0065161604230488945,"score_gpt":0.2192912215067942,"score_spread":0.2127750610837453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004950211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916733,0.006282181,0.000013879375,0.0008457554,0.000048515954,0.00017142599,0.000022027241,0.000003483403,0.00093943626],"genre_scores_gemma":[0.9990815,0.00022096281,0.00034658675,0.00014433627,0.00007720186,0.000002459736,0.000007017097,0.000020599104,0.00009931915],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976535,0.00044164082,0.0009128535,0.00025869295,0.00042755544,0.0003057523],"domain_scores_gemma":[0.9975348,0.0003108856,0.0011847562,0.00052368484,0.00022675027,0.00021909592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055535615,0.0002506537,0.0013642145,0.00027953734,0.000075812924,0.0000062498584,0.00024821662,0.00008646831,0.00003691402],"category_scores_gemma":[0.000037135294,0.00013539648,0.0005231958,0.00068078394,0.001791492,0.00003056478,0.00015534513,0.00043562887,6.6521545e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017488165,0.0005406042,0.4904086,0.00009191476,0.00031833,0.0023036776,0.00056318165,0.00005602842,0.5028194,0.000041650434,0.00023799762,0.00086981023],"study_design_scores_gemma":[0.0025044316,0.0031806042,0.8587844,0.00003283006,0.0034155985,0.0054743392,0.0003310441,0.00007132131,0.12576999,0.000082882056,0.00020335439,0.00014920994],"about_ca_topic_score_codex":0.00037251654,"about_ca_topic_score_gemma":0.000001932467,"teacher_disagreement_score":0.37704942,"about_ca_system_score_codex":0.000078254554,"about_ca_system_score_gemma":0.00017066005,"threshold_uncertainty_score":0.6600827},"labels":[],"label_agreement":null},{"id":"W2005375324","doi":"10.1016/j.eururo.2014.11.054","title":"Characterizing the Impact of Lymph Node Metastases on the Survival Outcome for Metastatic Renal Cell Carcinoma Patients Treated with Targeted Therapies","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Queen Elizabeth II Health Sciences Centre; University of British Columbia; BC Cancer Agency; Princess Margaret Cancer Centre; Dalhousie University; University Health Network; University of Toronto; Sunnybrook Health Science Centre; University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Lymph node; Oncology; Overall survival; Internal medicine","score_opus":0.034714979863734695,"score_gpt":0.2609921918801777,"score_spread":0.226277212016443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005375324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950898,0.00010539506,0.0001081587,0.00059703516,0.000055713113,0.00080730347,0.00011784987,0.000031954456,0.0030867597],"genre_scores_gemma":[0.9986115,0.0000034231875,0.00013780514,0.00072127575,0.00007315421,0.00003547893,0.00018023973,0.00007968396,0.0001574134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973045,0.0013454754,0.0004105919,0.00032527978,0.00023705052,0.00037713212],"domain_scores_gemma":[0.9978307,0.00096932607,0.00033493296,0.00063227786,0.00014212617,0.00009063071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070554885,0.000330625,0.0005435435,0.000100620135,0.0001330194,0.00001709431,0.00022616373,0.000024431403,0.0000747602],"category_scores_gemma":[0.00017038877,0.00013333463,0.00027926543,0.00014032594,0.00019439249,0.00003195048,0.000045485223,0.00014551687,0.000034722805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057175187,0.0009231237,0.9565841,0.00006797512,0.0011363296,0.00008273976,0.0011386573,0.00013865117,0.03268721,0.00015686716,0.0002855615,0.0010812914],"study_design_scores_gemma":[0.004189498,0.006459085,0.97879404,0.000008503651,0.0006047645,0.000021203388,0.00006010792,0.00018030727,0.00914383,0.000007823028,0.0003983972,0.0001324532],"about_ca_topic_score_codex":0.00010136798,"about_ca_topic_score_gemma":0.000002552447,"teacher_disagreement_score":0.023543378,"about_ca_system_score_codex":0.00005472817,"about_ca_system_score_gemma":0.000034909597,"threshold_uncertainty_score":0.54372287},"labels":[],"label_agreement":null},{"id":"W2005460119","doi":"10.1016/j.urology.2007.01.034","title":"Cytoreductive Nephrectomy for T4NxM1 Renal Cell Carcinoma: The M.D. Anderson Cancer Center Experience","year":2007,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Surgery; Stage (stratigraphy); Cancer; Carcinoma; Wound dehiscence; Systemic therapy; Internal medicine; Kidney; Breast cancer","score_opus":0.027617798005556218,"score_gpt":0.2997442290259295,"score_spread":0.2721264310203733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005460119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889996,0.0013521783,0.0015568942,0.0019478134,0.00043937573,0.0007865933,0.000011811087,0.000031121992,0.0048746276],"genre_scores_gemma":[0.99608076,0.000014531056,0.00030294614,0.001744374,0.0005553059,0.0002100286,0.000016390504,0.000025819938,0.0010498563],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875367,0.000038732975,0.00019898443,0.00036489716,0.00015269272,0.0004910399],"domain_scores_gemma":[0.9992346,0.00014678355,0.00008238261,0.0003080125,0.00009783918,0.00013035505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001567218,0.00018018323,0.00023951913,0.000075843345,0.000116120806,0.0000076316965,0.00011629604,0.00011194002,0.00015841005],"category_scores_gemma":[0.000022615275,0.00011442379,0.00012365034,0.00010950843,0.00020801745,0.000038062357,0.000036513014,0.00017329553,0.000015493808],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01858462,0.0014084859,0.71809363,0.00019342481,0.000423068,0.0011467391,0.038513843,0.00009205507,0.17479748,0.0007114666,0.031877745,0.014157423],"study_design_scores_gemma":[0.011612035,0.004607335,0.3935174,0.000013628718,0.0005370007,0.00076923793,0.0029669781,0.00032950612,0.4264199,0.00017945054,0.15859602,0.0004514636],"about_ca_topic_score_codex":0.00016610406,"about_ca_topic_score_gemma":0.000080307094,"teacher_disagreement_score":0.32457623,"about_ca_system_score_codex":0.00017195543,"about_ca_system_score_gemma":0.0000899986,"threshold_uncertainty_score":0.46660668},"labels":[],"label_agreement":null},{"id":"W2005699818","doi":"10.1159/000319498","title":"The Effect of Sunitinib on Immune Subsets in Metastatic Clear Cell Renal Cancer","year":2010,"lang":"en","type":"article","venue":"Urologia Internationalis","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Sunitinib; Medicine; Immune system; CD8; Lymphocyte; Immunology; T cell; Natural killer cell; Cancer; Internal medicine; Oncology; Cytotoxic T cell; Biology","score_opus":0.013869399592151334,"score_gpt":0.292978999789225,"score_spread":0.27910960019707365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005699818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99204665,0.00025111024,0.0000033859772,0.001224274,0.00028940002,0.000351278,0.00002410255,0.000013961122,0.0057958052],"genre_scores_gemma":[0.9988766,0.000039792245,0.00006005457,0.00013861808,0.000056658533,0.00009588163,0.000039671544,0.0000144867745,0.00067824277],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989521,0.00011880215,0.00028245465,0.00016649147,0.000320176,0.00015998354],"domain_scores_gemma":[0.99867773,0.00080508296,0.00013548262,0.00025607937,0.00008294629,0.0000427027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047117486,0.00012796954,0.00021957899,0.00011443043,0.000032092987,0.000011111069,0.00016953933,0.00004958659,0.0004010376],"category_scores_gemma":[0.00027390558,0.00007330166,0.00010814836,0.00010276528,0.00010834674,0.000026549082,0.000035859928,0.00034534154,0.00004573963],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012612202,0.00081374095,0.489554,0.00018628582,0.00074161054,0.0007209726,0.0005633648,0.00064645277,0.47228283,0.004550474,0.0026014203,0.014726683],"study_design_scores_gemma":[0.0035615917,0.0028888858,0.39997387,0.00004958795,0.000132661,0.000043490043,0.000015768404,0.0006174767,0.5886038,0.00014161275,0.003865517,0.00010575793],"about_ca_topic_score_codex":0.00071259117,"about_ca_topic_score_gemma":0.00032502838,"teacher_disagreement_score":0.11632095,"about_ca_system_score_codex":0.000060203114,"about_ca_system_score_gemma":0.00004093407,"threshold_uncertainty_score":0.43910804},"labels":[],"label_agreement":null},{"id":"W2005821882","doi":"10.1002/cncr.24051","title":"A population‐based study evaluating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancer","year":2009,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Sunitinib; Medicine; Renal cell carcinoma; Hazard ratio; Internal medicine; Population; Cancer; Gastroenterology; Confidence interval; Oncology; Kidney cancer; Surgery; Urology","score_opus":0.09123519207814039,"score_gpt":0.39746999588759885,"score_spread":0.30623480380945844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005821882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741894,0.0003199981,0.0000013451016,0.00011479277,0.000025783884,0.0018046339,0.00006482677,0.0000042968213,0.00024540522],"genre_scores_gemma":[0.9995502,0.0000142898525,0.000040520044,0.00006902763,0.00003233452,0.00018357422,0.00004469185,0.00001248756,0.00005284389],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854916,0.00026600933,0.00028745955,0.00017445351,0.0005544782,0.00016842318],"domain_scores_gemma":[0.99905604,0.00019364178,0.0002253573,0.00034946195,0.00013749585,0.000038018516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019955431,0.00017914832,0.00037116787,0.00007840949,0.000038047834,0.0000062352783,0.000074787364,0.000016167325,0.00013626687],"category_scores_gemma":[0.000014630497,0.00007289357,0.00011604433,0.00023207013,0.000020936355,0.000024706826,0.0000030347644,0.00006976679,5.2745713e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027977813,0.004101547,0.9662271,0.000019203131,0.00019012355,0.000010673589,0.0028287114,0.017667294,0.0003333046,0.000002990773,0.000014495991,0.005806731],"study_design_scores_gemma":[0.008562448,0.024133375,0.96514446,0.00009314053,0.00044347683,2.1095313e-7,0.00022547621,0.00039710858,0.00092248234,0.000010969419,0.0000020692316,0.0000647806],"about_ca_topic_score_codex":0.007740243,"about_ca_topic_score_gemma":0.000672016,"teacher_disagreement_score":0.020031828,"about_ca_system_score_codex":0.00063789054,"about_ca_system_score_gemma":0.00025805974,"threshold_uncertainty_score":0.9988673},"labels":[],"label_agreement":null},{"id":"W2005853612","doi":"10.5489/cuaj.182","title":"A population based study of surgeon characteristics associated with the uptake of contemporary techniques in renal surgery","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Toronto Rehabilitation Institute; University of Toronto","funders":"","keywords":"Medicine; Laparoscopy; Nephrectomy; Logistic regression; Renal cell carcinoma; Odds ratio; Population; Cohort; Confidence interval; General surgery; Surgery; Urology; Internal medicine; Kidney","score_opus":0.02819475555155419,"score_gpt":0.22529724130657103,"score_spread":0.19710248575501685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005853612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962227,0.000032856424,0.000006038042,0.0029007182,0.000032734522,0.0005978638,0.00001661545,0.000010691837,0.00017982378],"genre_scores_gemma":[0.99941725,0.0000025955187,0.000027011634,0.0003670822,0.000040738658,0.000030255973,0.00006349643,0.000010468618,0.000041078885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981102,0.00040037482,0.00068305264,0.00012285369,0.0004415457,0.00024202689],"domain_scores_gemma":[0.99779445,0.0005339104,0.00087702187,0.00011753718,0.0004767477,0.00020035078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013497835,0.00012367324,0.00051067414,0.00029214687,0.00006811021,0.000022589062,0.000068203764,0.00015097385,0.00012649284],"category_scores_gemma":[0.0009795565,0.00007429194,0.00009910754,0.00033819824,0.000019733023,0.0000723135,0.000005966472,0.0003494569,0.0000012772283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009160757,0.00028772393,0.99740106,0.0000040297714,0.00009657435,0.000072131275,0.000089369816,0.000008541318,0.0001362135,0.0000022372965,0.000801485,0.0010090356],"study_design_scores_gemma":[0.00069817994,0.0008477529,0.9978283,0.00005354967,0.00006078764,0.000011118654,0.00013223392,0.0000852753,0.000083635256,0.000020574527,0.00011418874,0.00006442283],"about_ca_topic_score_codex":0.009300981,"about_ca_topic_score_gemma":0.0035110712,"teacher_disagreement_score":0.0057899095,"about_ca_system_score_codex":0.0008230064,"about_ca_system_score_gemma":0.00061403465,"threshold_uncertainty_score":0.99729615},"labels":[],"label_agreement":null},{"id":"W2005878196","doi":"10.1016/j.eururo.2011.11.048","title":"Re: Hendrik Van Poppel, Luigi Da Pozzo, Walter Albrecht, et al. A Prospective, Randomized EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma. Eur Urol 2011;59:543–52","year":2011,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Surgery; Urology; Randomized controlled trial; Prospective cohort study; Kidney; Internal medicine","score_opus":0.058095455503794156,"score_gpt":0.30386802831206233,"score_spread":0.24577257280826817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005878196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9338085,0.0020432153,0.0010209545,0.03482165,0.0010800861,0.012535834,0.00010098997,0.00023303262,0.014355763],"genre_scores_gemma":[0.8797685,0.00008017894,0.0003429882,0.115761526,0.0009197709,0.0006175154,0.0003577497,0.00036993914,0.0017818304],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98694295,0.006386957,0.0024425236,0.002122452,0.00068928086,0.0014158491],"domain_scores_gemma":[0.9912509,0.004793819,0.0017456561,0.0015632274,0.0003181831,0.0003282136],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.004496596,0.0014528247,0.004684621,0.00080822164,0.00026295634,0.000093918716,0.0007507281,0.00046876963,0.000259158],"category_scores_gemma":[0.0006277126,0.0010002032,0.0011475432,0.00026740646,0.0010894669,0.00015452162,0.00076187536,0.0037407796,0.00007697459],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20423746,0.0046926625,0.22360495,0.00088120624,0.004004319,0.014525233,0.004525881,0.000020222,0.0012068584,0.00004835156,0.54162467,0.00062819244],"study_design_scores_gemma":[0.5237964,0.025317509,0.08957338,0.00027875783,0.010762545,0.0017819706,0.00048176578,0.0008775515,0.0019077396,0.00018317158,0.34200627,0.003032984],"about_ca_topic_score_codex":0.00035522121,"about_ca_topic_score_gemma":0.000069607646,"teacher_disagreement_score":0.31955892,"about_ca_system_score_codex":0.00039804488,"about_ca_system_score_gemma":0.00027229195,"threshold_uncertainty_score":0.99982214},"labels":[],"label_agreement":null},{"id":"W2006394714","doi":"10.1007/s00345-014-1256-y","title":"Benefit in regionalization of care for patients treated with nephrectomy: a Nationwide Inpatient Sample","year":2014,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Logistic regression; Nephrology; Complication; Adverse effect; Emergency medicine; Blood transfusion; Internal medicine; Surgery; Intensive care medicine; Kidney","score_opus":0.011157082565602784,"score_gpt":0.23895586621220818,"score_spread":0.2277987836466054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006394714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99760777,0.00036632307,0.0008347807,0.00041137318,0.000054353113,0.00035643368,0.000007072424,0.0000037550249,0.00035813355],"genre_scores_gemma":[0.99672896,0.00001991979,0.0028313783,0.00022581022,0.000049083475,0.000013002024,0.00007035128,0.000014293314,0.000047228674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910533,0.00005117496,0.00041816896,0.00010266442,0.00019897002,0.00012366539],"domain_scores_gemma":[0.9985306,0.0002630858,0.00042509384,0.00010326556,0.00061607244,0.000061861596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010400682,0.00009556597,0.00035528338,0.0004802401,0.000019496567,0.0000024558497,0.00004985652,0.00004087953,0.000016266908],"category_scores_gemma":[0.0001423287,0.00006837935,0.000073328876,0.00024668776,0.00003499498,0.000037382048,0.000007948295,0.0000817104,4.300208e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037725945,0.00031419366,0.98769265,0.000067742796,0.00007162046,0.00000686774,0.00048453466,0.00075634825,0.00008175895,0.0006571623,0.00009900748,0.0059954985],"study_design_scores_gemma":[0.012529957,0.013947029,0.94858265,0.00014411334,0.00029556555,0.000050074017,0.000051538915,0.0003143918,0.0010281045,0.0006165135,0.022340247,0.000099834804],"about_ca_topic_score_codex":0.000057189252,"about_ca_topic_score_gemma":0.0007324479,"teacher_disagreement_score":0.039110042,"about_ca_system_score_codex":0.0001215021,"about_ca_system_score_gemma":0.000066969376,"threshold_uncertainty_score":0.27884287},"labels":[],"label_agreement":null},{"id":"W2007156823","doi":"10.1111/j.1464-410x.2008.08119.x","title":"Race affects access to nephrectomy but not survival in renal cell carcinoma","year":2008,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Nephrectomy; Medicine; Renal cell carcinoma; Proportional hazards model; Race (biology); Logistic regression; Internal medicine; Surgery; Kidney","score_opus":0.02969270896625164,"score_gpt":0.266232028736814,"score_spread":0.23653931977056236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007156823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935156,0.0018016901,0.00009443698,0.0017114115,0.0005271414,0.0003284996,0.000006945968,0.000012483274,0.0020017955],"genre_scores_gemma":[0.9964609,0.00026221812,0.0009263001,0.001403888,0.0005045603,0.000009275439,0.0000044988515,0.00003627755,0.00039208352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802244,0.00024219033,0.0005427571,0.0002823474,0.00043587023,0.00047441898],"domain_scores_gemma":[0.9986744,0.00022638771,0.0002519779,0.00020553728,0.00020971338,0.00043197346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000436624,0.00019496692,0.00073114864,0.00038162727,0.000070502734,0.000032373384,0.00029781729,0.00019976751,0.0001650902],"category_scores_gemma":[0.00021500544,0.0002078242,0.00020101792,0.00030296293,0.000103219565,0.00016458356,0.00010812879,0.0009076014,0.000029884353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005044073,0.0011757564,0.60329115,0.00008571666,0.0001056294,0.25080812,0.00037884506,0.0004941225,0.11285353,0.000007498195,0.011450004,0.014305578],"study_design_scores_gemma":[0.0053022103,0.0021822613,0.8829853,0.00003944872,0.000086708926,0.0683873,0.000015292417,0.00001607121,0.03681232,0.000010752645,0.0040084478,0.00015386808],"about_ca_topic_score_codex":0.0004893004,"about_ca_topic_score_gemma":0.0004645868,"teacher_disagreement_score":0.2796942,"about_ca_system_score_codex":0.00013340097,"about_ca_system_score_gemma":0.00035455747,"threshold_uncertainty_score":0.84748244},"labels":[],"label_agreement":null},{"id":"W2007418983","doi":"10.1038/modpathol.2009.70","title":"Uncommon and recently described renal carcinomas","year":2009,"lang":"en","type":"review","venue":"Modern Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":213,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Credit Valley Hospital","funders":"","keywords":"Pathology; Medicine; Clear cell carcinoma; Carcinoma; Chromophobe cell; Renal cell carcinoma; Papillary renal cell carcinomas; Clear cell; Adenocarcinoma; Cancer; Internal medicine","score_opus":0.08556332779309314,"score_gpt":0.3245847600628006,"score_spread":0.23902143226970748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007418983","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016283393,0.99216706,0.00011886762,0.00012511176,0.0001478506,0.0011595862,0.000031175277,0.000098104625,0.004523929],"genre_scores_gemma":[0.0011535622,0.99484843,0.0012608368,0.00020211568,0.00022360128,0.00010909571,0.00042188124,0.00009889253,0.0016816051],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971903,0.00036710413,0.00069561985,0.0009478216,0.00024818716,0.00055094203],"domain_scores_gemma":[0.99833816,0.00010320064,0.00028208192,0.0009053262,0.00006911403,0.00030211368],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025080386,0.00068248744,0.002872202,0.000330135,0.000075231175,0.000021812255,0.00015692381,0.00071559346,0.000040473627],"category_scores_gemma":[0.000048949198,0.0005088649,0.00046649366,0.00017235974,0.00014701564,0.000034994366,0.00012725727,0.0006975374,0.00009259577],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005164176,0.00012236628,0.0001053001,0.0031351093,0.00011999317,0.0059395265,0.00009993599,2.0883597e-7,0.000023741124,0.00003609105,0.0004186636,0.98994744],"study_design_scores_gemma":[0.0014008641,0.0014373527,0.0009124079,0.0052312477,0.0043778787,0.01878934,0.0000057258862,0.00002550334,0.000022681577,0.0005872988,0.96661633,0.0005933728],"about_ca_topic_score_codex":0.000017616603,"about_ca_topic_score_gemma":0.0000146176735,"teacher_disagreement_score":0.9893541,"about_ca_system_score_codex":0.00037358995,"about_ca_system_score_gemma":0.00028892743,"threshold_uncertainty_score":0.9997363},"labels":[],"label_agreement":null},{"id":"W2008346867","doi":"10.1111/j.1464-410x.2008.08247.x","title":"A population‐based comparison of survival after nephrectomy vs nonsurgical management for small renal masses","year":2009,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nephrectomy; Medicine; Renal cell carcinoma; Population; Incidence (geometry); Epidemiology; Kidney cancer; Internal medicine; Urology; Surgery; Kidney","score_opus":0.029783660337080204,"score_gpt":0.29298471601370196,"score_spread":0.2632010556766218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008346867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916499,0.0022357358,0.0037098252,0.0012472967,0.00017121465,0.00035387292,0.000011924931,0.000009886329,0.0006103165],"genre_scores_gemma":[0.9804511,0.000059066522,0.018760087,0.00041585826,0.00017339575,0.000010632542,0.000024323945,0.000013845631,0.00009165883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848217,0.000117325006,0.00071874354,0.00016217245,0.00027604052,0.00024357671],"domain_scores_gemma":[0.99900025,0.00015269114,0.00035752158,0.00012771435,0.00021855594,0.00014327183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032396335,0.00012858692,0.00070178224,0.0001957311,0.000033744644,0.000015876585,0.0000991123,0.00010141545,0.000110376684],"category_scores_gemma":[0.000054742603,0.00012705097,0.00029823332,0.00010959647,0.00004110043,0.000037874655,0.000015038653,0.00019783856,0.0000019496645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028635431,0.0036236485,0.8268926,0.00031198267,0.00083719747,0.010888933,0.00008917274,0.0011652262,0.0008011824,0.00029827576,0.0023918261,0.124064505],"study_design_scores_gemma":[0.0069484315,0.004425125,0.9755616,0.00013644734,0.0006001887,0.002801789,0.000015967664,0.00031077533,0.000361695,0.0002765168,0.008456688,0.000104735685],"about_ca_topic_score_codex":0.000031438383,"about_ca_topic_score_gemma":0.000047994094,"teacher_disagreement_score":0.14866902,"about_ca_system_score_codex":0.00006697622,"about_ca_system_score_gemma":0.000054606473,"threshold_uncertainty_score":0.5180988},"labels":[],"label_agreement":null},{"id":"W2008516116","doi":"10.1002/gcc.20771","title":"Combined classical cytogenetics and microarray‐based genomic copy number analysis reveal frequent 3;5 rearrangements in clear cell renal cell carcinoma","year":2010,"lang":"en","type":"article","venue":"Genes Chromosomes and Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Hospital for Sick Children","keywords":"Biology; Comparative genomic hybridization; Uniparental disomy; SNP array; Genetics; Copy number analysis; Cytogenetics; Copy-number variation; Karyotype; Locus (genetics); Loss of heterozygosity; Gene duplication; Chromosome; Cancer research; Single-nucleotide polymorphism; Genome; Gene; Genotype","score_opus":0.013905205526711357,"score_gpt":0.2563333272269326,"score_spread":0.24242812170022124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008516116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937779,0.0042904112,0.000009490657,0.0004146878,0.00015057597,0.00048504514,0.00007350091,0.000019841355,0.00077858096],"genre_scores_gemma":[0.99547935,0.0011196212,0.0015720007,0.00032972268,0.00018575275,0.00008296755,0.000093178634,0.000046272216,0.0010911281],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981869,0.00006140137,0.00039449762,0.0006378569,0.0002821295,0.00043723048],"domain_scores_gemma":[0.9989943,0.000035044024,0.00012790105,0.00043562148,0.00007351691,0.00033363656],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012414085,0.00033063596,0.00061195943,0.00017827674,0.00009284077,0.00004595916,0.00010047304,0.00019124571,0.00060086424],"category_scores_gemma":[0.0000029048335,0.00028507703,0.00016368617,0.0003277285,0.00017457217,0.000035890218,0.00007867854,0.00028657136,0.000016848873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028775126,0.00016644661,0.5812645,0.00012222612,0.00010702366,0.000099914396,0.00013013755,0.000021133808,0.4160999,0.0000021753242,0.00027573208,0.0014230468],"study_design_scores_gemma":[0.0052962857,0.00047746583,0.6807359,0.00002746606,0.0011633089,0.000018917539,0.0000717263,0.00045827034,0.30806485,0.000011298878,0.0033607474,0.00031376834],"about_ca_topic_score_codex":0.00071669614,"about_ca_topic_score_gemma":0.0005793187,"teacher_disagreement_score":0.10803504,"about_ca_system_score_codex":0.00018278418,"about_ca_system_score_gemma":0.0001814196,"threshold_uncertainty_score":0.9999601},"labels":[],"label_agreement":null},{"id":"W2008791033","doi":"10.1016/j.urology.2008.08.117","title":"POD-6.01: A Retrospective Review of Renal Ablative Therapies for Renal Masses: Clinical Outcomes","year":2008,"lang":"en","type":"review","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; St Joseph's Health Centre; Western University","funders":"","keywords":"Medicine; Ablative case; Cryoablation; Retrospective cohort study; Radiofrequency ablation; Population; Incidence (geometry); Tertiary referral centre; Surgery; Ablation; Internal medicine; Radiation therapy","score_opus":0.11670584752904074,"score_gpt":0.4232759379267353,"score_spread":0.30657009039769456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008791033","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000160023,0.9910067,0.00017033263,0.0005934191,0.00031442998,0.004099442,0.00019187134,0.000051001683,0.0035568506],"genre_scores_gemma":[0.00003256924,0.9943426,0.0016676554,0.0011905052,0.00043198338,0.00063820323,0.0004015868,0.0001096143,0.0011852415],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951706,0.00077167933,0.002205689,0.0009457132,0.0004056693,0.0005006568],"domain_scores_gemma":[0.99480146,0.0020885859,0.001563667,0.00097138144,0.0003804465,0.00019443287],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007195913,0.00074729504,0.0073277033,0.00027406006,0.00006483236,0.0000043892774,0.0002972393,0.00074908906,0.00031343388],"category_scores_gemma":[0.0013807676,0.00047251018,0.0032014383,0.00031073342,0.0005272218,0.000037770533,0.00010762731,0.0008434211,0.000062031264],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010383048,0.0013761483,0.0053703906,0.12129734,0.017526636,0.0010349515,0.00022720103,2.1582304e-7,0.0000012546235,0.0015240812,0.035682198,0.81492126],"study_design_scores_gemma":[0.0014841921,0.0045584864,0.0018737696,0.017270353,0.006214984,0.00088477466,0.000004050265,9.710066e-7,0.0000012078357,0.0001935893,0.96721065,0.00030298255],"about_ca_topic_score_codex":0.000013028461,"about_ca_topic_score_gemma":0.00000620189,"teacher_disagreement_score":0.93152845,"about_ca_system_score_codex":0.00027665636,"about_ca_system_score_gemma":0.00091953605,"threshold_uncertainty_score":0.99977267},"labels":[],"label_agreement":null},{"id":"W2008966005","doi":"10.1016/j.urology.2008.09.022","title":"Population-based Assessment of Survival After Cytoreductive Nephrectomy Versus No Surgery in Patients With Metastatic Renal Cell Carcinoma","year":2008,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Urology; Cytoreductive surgery; Carcinoma; Population; Surgery; Oncology; Internal medicine; Kidney; Cancer","score_opus":0.021373105093094275,"score_gpt":0.25099141391454705,"score_spread":0.22961830882145276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008966005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983325,0.00006213377,0.000054498625,0.000056926543,0.00024297563,0.00045571825,0.000019356294,0.000013027445,0.00076288724],"genre_scores_gemma":[0.998254,0.0000013077232,0.0012542435,0.00006885929,0.000039752736,0.0000726255,0.00024350488,0.00002724055,0.000038455313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844587,0.00021579688,0.00036197226,0.00032259684,0.0003633532,0.00029039968],"domain_scores_gemma":[0.9988269,0.00042426944,0.00016586285,0.00029583444,0.00018582436,0.00010125882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117318385,0.00020293306,0.00059670606,0.00029811,0.000025777106,0.000001961864,0.000045458113,0.00006593123,0.00017583152],"category_scores_gemma":[0.00004128567,0.00015917196,0.000103648956,0.00021788519,0.000102336904,0.000046800888,0.000017864659,0.00016057814,0.000011119185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008842175,0.0007446175,0.98931944,0.000046600835,0.000072691815,0.0003759865,0.000069871516,0.00038536597,0.00006852806,0.0000039879533,0.000028513357,0.00004223557],"study_design_scores_gemma":[0.007929896,0.002625984,0.9883861,0.000008268251,0.00019231641,0.000007362588,0.000009081716,0.00019233314,0.00049218023,0.0000029008972,0.000033009324,0.00012056418],"about_ca_topic_score_codex":0.00049451983,"about_ca_topic_score_gemma":0.00007186328,"teacher_disagreement_score":0.0018813664,"about_ca_system_score_codex":0.0002373563,"about_ca_system_score_gemma":0.0003765748,"threshold_uncertainty_score":0.6490844},"labels":[],"label_agreement":null},{"id":"W2009512913","doi":"10.1111/j.1464-410x.2008.07942.x","title":"Aetiology of non‐diagnostic renal fine‐needle aspiration cytologies in a contemporary series","year":2008,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McGill University","keywords":"Etiology; Medicine; Pathology; Series (stratigraphy); Fine-needle aspiration; Radiology; Geology; Biopsy","score_opus":0.0405298897376897,"score_gpt":0.2607308951573331,"score_spread":0.2202010054196434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009512913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872307,0.010016867,0.0001190354,0.00097581896,0.00015764186,0.00018864787,0.000006600434,0.0000076077536,0.0012970606],"genre_scores_gemma":[0.9977608,0.0009446868,0.00081700063,0.00022565741,0.00012059625,0.000008321349,0.000014691627,0.000012172994,0.0000960807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855393,0.00017628385,0.00076889916,0.00014018986,0.00016473819,0.00019597435],"domain_scores_gemma":[0.9987856,0.00035816955,0.00042335835,0.00011054963,0.0002451196,0.000077184326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002721528,0.00011459908,0.00065299065,0.000260509,0.00003415515,0.000003864545,0.00009481587,0.00016377652,0.00006575088],"category_scores_gemma":[0.0010156169,0.000114041395,0.00013110248,0.00014614429,0.00033191513,0.00013140563,0.000031537176,0.00033597273,0.0000056365993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004527847,0.001266675,0.8247561,0.00014565075,0.00035797255,0.10965656,0.0008559009,0.0007471715,0.032235824,0.000086770255,0.010677742,0.014685781],"study_design_scores_gemma":[0.0034785902,0.00749242,0.86309624,0.00011650902,0.00006119301,0.1213927,0.00007050232,0.000018817656,0.003173291,0.0002492573,0.0007714147,0.00007906509],"about_ca_topic_score_codex":0.00020316339,"about_ca_topic_score_gemma":0.00013865736,"teacher_disagreement_score":0.038340136,"about_ca_system_score_codex":0.00005010409,"about_ca_system_score_gemma":0.00030992262,"threshold_uncertainty_score":0.4650473},"labels":[],"label_agreement":null},{"id":"W2010225305","doi":"10.1002/ijc.23496","title":"Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma","year":2008,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Renal cell carcinoma; Cancer research; Mutation; Clear cell renal cell carcinoma; Biology; Medicine; Internal medicine; Oncology; Pathology; Gene; Genetics","score_opus":0.015511989677865198,"score_gpt":0.2586839577317716,"score_spread":0.2431719680539064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010225305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963938,0.002929846,0.00012175815,0.00013045146,0.00016580187,0.000105907806,0.000047172853,0.000002695352,0.000102591075],"genre_scores_gemma":[0.9989295,0.00042317234,0.0003553019,0.000034634984,0.00012450226,0.0000033274116,0.000008307245,0.000016057787,0.00010517178],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853903,0.00005612045,0.00041862152,0.00013802633,0.00074503734,0.000103182516],"domain_scores_gemma":[0.997473,0.000098454046,0.0011553835,0.00007068235,0.0010963083,0.000106158564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012598385,0.00012799114,0.00035063302,0.00015510705,0.00002859565,0.0000075181442,0.00009245977,0.00004519747,0.000038422593],"category_scores_gemma":[0.000044242755,0.00009222669,0.000066230845,0.00007248319,0.00013192209,0.00012172305,0.000031011736,0.00013482447,2.4617034e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003272846,0.00033047353,0.4613251,0.00011739536,0.00019685083,0.002251167,0.0006312139,0.00049285125,0.53071064,0.0000016929641,0.0000897889,0.0005800134],"study_design_scores_gemma":[0.0030049302,0.0005076673,0.47053888,0.00068516564,0.00007566092,0.0004060112,0.00011116411,0.00007115531,0.52452636,0.000007374645,0.0000109185885,0.00005472938],"about_ca_topic_score_codex":0.00013385122,"about_ca_topic_score_gemma":0.000027421685,"teacher_disagreement_score":0.009213789,"about_ca_system_score_codex":0.0001557884,"about_ca_system_score_gemma":0.0002428992,"threshold_uncertainty_score":0.37608954},"labels":[],"label_agreement":null},{"id":"W2010554092","doi":"10.1016/j.urology.2004.04.028","title":"Laparoscopic versus open partial nephrectomy","year":2004,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; McMaster University; Western University","funders":"","keywords":"Medicine; Nephrectomy; Convalescence; Demographics; Blood loss; Narcotic; Cohort; Urology; Surgery; Internal medicine; Kidney","score_opus":0.046515424519563545,"score_gpt":0.3175047066322983,"score_spread":0.27098928211273476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010554092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.953189,0.00026882382,0.00006050073,0.0029910633,0.00050384196,0.0005216869,0.0000015398375,0.000047370337,0.04241615],"genre_scores_gemma":[0.9973485,0.000011077079,0.0005518247,0.0012326748,0.00017512936,0.00009516852,0.000019771678,0.0000146733655,0.0005511946],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992707,0.00002876759,0.00012722163,0.00023436145,0.00009065644,0.0002483434],"domain_scores_gemma":[0.9994993,0.00003727018,0.000031731855,0.00028822906,0.000022437285,0.00012103352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053080872,0.00010384752,0.0002397927,0.000043206397,0.00004004004,0.000013065699,0.00012897552,0.00008529428,0.0004925203],"category_scores_gemma":[0.000036900492,0.000085471154,0.000047290167,0.00007865228,0.00006491044,0.00004009766,0.00010437519,0.00011675382,0.0006465371],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17408343,0.012702321,0.29088002,0.00048142765,0.0063391756,0.035066698,0.0060908855,0.006956186,0.15203969,0.19079812,0.050919443,0.07364261],"study_design_scores_gemma":[0.11340394,0.022375928,0.07415166,0.000027662465,0.0011043347,0.00091859826,0.000076448145,0.00009224914,0.1261114,0.0034343987,0.6577452,0.00055819494],"about_ca_topic_score_codex":0.00018210249,"about_ca_topic_score_gemma":0.000053399133,"teacher_disagreement_score":0.6068257,"about_ca_system_score_codex":0.000093940616,"about_ca_system_score_gemma":0.00014288611,"threshold_uncertainty_score":0.8310142},"labels":[],"label_agreement":null},{"id":"W2010762033","doi":"10.1038/nrurol.2010.63","title":"Imaging renal cell carcinoma with ultrasonography, CT and MRI","year":2010,"lang":"en","type":"review","venue":"Nature Reviews Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"Vedecká Grantová Agentúra MŠVVaŠ SR a SAV","keywords":"Medicine; Radiology; Malignancy; Renal cell carcinoma; Magnetic resonance imaging; Ultrasonography; Pathology","score_opus":0.01643289354850051,"score_gpt":0.2926938936029402,"score_spread":0.27626100005443965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010762033","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013685296,0.98929965,0.000008548178,0.00023812098,0.00030661366,0.0033189747,0.00002686608,0.000060154518,0.0066042063],"genre_scores_gemma":[0.00046446378,0.99541485,0.0017081046,0.00073388225,0.0005115076,0.00034146584,0.00032115786,0.00015224805,0.00035231584],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99636924,0.00038134147,0.0009611675,0.0012761088,0.00031381552,0.00069832354],"domain_scores_gemma":[0.9971362,0.0002898816,0.00078000064,0.001255765,0.00010879239,0.00042936837],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005690631,0.0011412965,0.004756577,0.0005500897,0.00010296682,0.00003470802,0.00030108553,0.0007682737,0.00013204246],"category_scores_gemma":[0.000077510675,0.0006547703,0.0010092326,0.00058423495,0.00031995203,0.00005906021,0.00009808204,0.005073609,0.00010161368],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043691005,0.00010188622,0.0012212977,0.021807333,0.00012431695,0.0020837276,0.000013029092,9.695612e-9,0.000008789193,0.00003668922,0.0028321005,0.97172713],"study_design_scores_gemma":[0.00073346216,0.00057179807,0.0002476659,0.003159017,0.007328628,0.02475587,0.0000014590662,5.1448404e-7,0.000011416231,0.000006674311,0.9626966,0.0004868717],"about_ca_topic_score_codex":0.000011863895,"about_ca_topic_score_gemma":0.000013817971,"teacher_disagreement_score":0.9712403,"about_ca_system_score_codex":0.00009125954,"about_ca_system_score_gemma":0.00035692044,"threshold_uncertainty_score":0.99959034},"labels":[],"label_agreement":null},{"id":"W2010850866","doi":"10.1016/j.urology.2009.07.1221","title":"Limited Prognostic Value of Tumor Necrosis in Patients With Renal Cell Carcinoma","year":2009,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Proportional hazards model; Internal medicine; Hazard ratio; Oncology; Stage (stratigraphy); Multivariate analysis; T-stage; Population; Histology; Clear cell renal cell carcinoma; Cancer; Kidney; Confidence interval","score_opus":0.008336760449513102,"score_gpt":0.20565634192819854,"score_spread":0.19731958147868545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010850866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968764,0.00011833281,0.000012834878,0.00032806,0.000027973036,0.0005744445,0.000004568959,0.000018138642,0.0020392165],"genre_scores_gemma":[0.9988367,0.0000010531976,0.00040320857,0.0005903658,0.000019837733,0.000015060521,0.00004434599,0.000014858655,0.0000745784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989339,0.00006456437,0.00026204577,0.00026495237,0.00018815103,0.0002863494],"domain_scores_gemma":[0.99936926,0.00006636343,0.000105228064,0.0002715297,0.00009023862,0.00009735316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056870147,0.0001534786,0.00034804142,0.00019151504,0.000014870061,0.0000024904396,0.000066978726,0.00007117988,0.000037412156],"category_scores_gemma":[0.000043404998,0.000113284215,0.00005007456,0.0002258056,0.000066341505,0.000024817271,0.000017083723,0.00014935303,0.000015292655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018521652,0.0010721354,0.99360186,0.00002788564,0.00001440819,0.00024337723,0.0001509979,0.00007884185,0.0023897784,0.000042483494,0.00008178425,0.00044425705],"study_design_scores_gemma":[0.0051857852,0.013035899,0.9717607,0.000014575227,0.00014829011,0.00002486742,0.0000055284713,0.00016355666,0.009481149,0.00004920227,0.000044813278,0.00008562014],"about_ca_topic_score_codex":0.000057838428,"about_ca_topic_score_gemma":0.0000074689474,"teacher_disagreement_score":0.021841172,"about_ca_system_score_codex":0.000059561018,"about_ca_system_score_gemma":0.00007654271,"threshold_uncertainty_score":0.46195963},"labels":[],"label_agreement":null},{"id":"W2011175331","doi":"10.5489/cuaj.1003","title":"Laparoscopic partial nephrectomy for &gt;4 cm renal masses","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Nephrectomy; Renal function; Surgery; Renal cell carcinoma; Pathological; Blood loss; Laparoscopy; Surgical margin; Resection margin; Kidney; Urology; Resection; Internal medicine","score_opus":0.019610453272851536,"score_gpt":0.23949486147087504,"score_spread":0.2198844081980235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011175331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9665444,0.00026842364,0.00013695771,0.028902886,0.00038888145,0.0007878992,0.000022378017,0.0000349409,0.002913235],"genre_scores_gemma":[0.9902113,0.000027012895,0.001765818,0.00436125,0.0010826468,0.0001837924,0.000038545662,0.000017783374,0.0023118253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983385,0.00010745787,0.00035989995,0.00021309624,0.0003226927,0.0006583304],"domain_scores_gemma":[0.9980485,0.0002035669,0.00021394489,0.00011999434,0.0003525284,0.0010614957],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034777183,0.00016514413,0.00033491908,0.00014722312,0.0002664633,0.00014959103,0.00010332866,0.0002438919,0.0021310616],"category_scores_gemma":[0.0006824645,0.00012439773,0.00021204387,0.00013577157,0.000027655633,0.00012579706,0.0000101141995,0.0003646778,0.00028227983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009980733,0.00009099537,0.8645818,0.000010898004,0.00027860157,0.00011472594,0.00006477008,0.000028902365,0.0021594826,0.00032661413,0.1278305,0.004412844],"study_design_scores_gemma":[0.002415342,0.000871811,0.53463686,0.000013266545,0.00015938457,0.00021704585,0.000026317046,0.00023636919,0.0008685363,0.001380551,0.45901752,0.00015703656],"about_ca_topic_score_codex":0.000892819,"about_ca_topic_score_gemma":0.00035570568,"teacher_disagreement_score":0.331187,"about_ca_system_score_codex":0.0013891322,"about_ca_system_score_gemma":0.00058725284,"threshold_uncertainty_score":0.99878114},"labels":[],"label_agreement":null},{"id":"W2011365044","doi":"10.15586/jkcvhl.2014.13","title":"Tubulocystic Renal Cell Carcinoma: A Rare Renal Tumor","year":2014,"lang":"en","type":"article","venue":"Journal of Kidney Cancer and VHL","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Renal cell carcinoma; Pathology; Medicine; Kidney; Carcinoma; Internal medicine","score_opus":0.013302921964472348,"score_gpt":0.251944156258019,"score_spread":0.23864123429354667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011365044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856867,0.004519194,0.00018837713,0.003183791,0.00039185386,0.00016232743,0.00001824298,0.000010905729,0.005838573],"genre_scores_gemma":[0.9941808,0.00016050936,0.0007543614,0.0022109149,0.0012440546,0.000007548163,0.0000048580196,0.00002698599,0.0014099779],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99855125,0.00005952416,0.00048278537,0.00019722556,0.0004283339,0.00028088436],"domain_scores_gemma":[0.9979856,0.00006720482,0.000319544,0.0001956355,0.0002414397,0.0011905681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002835792,0.00021196004,0.0005344966,0.00017165988,0.000074895994,0.000030525982,0.00009637682,0.000061769,0.00025216382],"category_scores_gemma":[0.0002163385,0.00014521889,0.00019867337,0.00012689039,0.00007036826,0.000097526136,0.0000339743,0.00034676195,0.000009887221],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006675657,0.0010128841,0.23177256,0.0019100815,0.0006745094,0.005373818,0.0018681687,0.00009243172,0.30226058,0.00013616,0.42639527,0.021827897],"study_design_scores_gemma":[0.03301643,0.010674305,0.3516781,0.002141746,0.003489253,0.013570145,0.00030752117,0.0008712408,0.30631828,0.00050086423,0.2765077,0.0009244017],"about_ca_topic_score_codex":0.00009189837,"about_ca_topic_score_gemma":0.0000042223605,"teacher_disagreement_score":0.14988756,"about_ca_system_score_codex":0.00020595611,"about_ca_system_score_gemma":0.000849538,"threshold_uncertainty_score":0.59218544},"labels":[],"label_agreement":null},{"id":"W2011612190","doi":"10.1002/cncr.23054","title":"Cytoreductive nephron‐sparing surgery does not appear to undermine disease‐specific survival in patients with metastatic renal cell carcinoma","year":2007,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fonds de Recherche du Québec - Santé; Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephron; Disease; Carcinoma; Surgery; Urology; Kidney; Oncology; Internal medicine","score_opus":0.032792540252378655,"score_gpt":0.25836505127002757,"score_spread":0.2255725110176489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011612190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970057,0.00073665625,0.00015098928,0.0002645621,0.0003507725,0.00085164997,0.00005186234,0.000031086027,0.000556716],"genre_scores_gemma":[0.998104,0.000020540658,0.00034185607,0.00020637846,0.00026194894,0.000087707784,0.00007052172,0.00006230987,0.00084474945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978486,0.000052283096,0.00037604105,0.0005573217,0.00058650837,0.0005792569],"domain_scores_gemma":[0.99865526,0.00014840375,0.00010866188,0.00041290344,0.00015541252,0.0005193709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021812618,0.00030626493,0.0005248178,0.00031296682,0.000056051962,0.000020672232,0.0000839311,0.000037889997,0.00016894966],"category_scores_gemma":[0.000022796943,0.00020777642,0.00010535404,0.00042633896,0.00008353195,0.000101992846,0.00004979109,0.00017480108,0.000029721323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005148191,0.0004440794,0.9875836,0.00016735117,0.00007853696,0.00058917736,0.00044438304,0.0001704337,0.0018135326,0.000015176135,0.0003467049,0.0031988488],"study_design_scores_gemma":[0.00243186,0.00023374031,0.97646075,0.00016633187,0.0001568568,0.000001928074,0.00025677454,0.0000070729757,0.019280907,0.000007522035,0.00073266454,0.00026360952],"about_ca_topic_score_codex":0.00034566416,"about_ca_topic_score_gemma":0.0002911435,"teacher_disagreement_score":0.017467374,"about_ca_system_score_codex":0.0011104393,"about_ca_system_score_gemma":0.00029848033,"threshold_uncertainty_score":0.84728765},"labels":[],"label_agreement":null},{"id":"W2012358190","doi":"10.1159/000366287","title":"Tubulocystic Carcinoma of the Kidney with Fatal Outcome in an Adolescent Male","year":2014,"lang":"en","type":"article","venue":"Urologia Internationalis","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Kidney; Kidney cancer; Renal cell carcinoma; Pathology; Carcinoma; Internal medicine","score_opus":0.02457834530584598,"score_gpt":0.26481824831077977,"score_spread":0.24023990300493378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012358190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99503547,0.000023536762,0.00015872357,0.00155209,0.0001243736,0.00029454584,0.000021017491,0.000014001657,0.0027762393],"genre_scores_gemma":[0.99769866,5.7790214e-7,0.00029710075,0.0013922544,0.00006497734,0.00002426616,0.000046795154,0.00001385642,0.00046147997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989229,0.000079494115,0.0002713874,0.00022079055,0.00035732024,0.00014814532],"domain_scores_gemma":[0.99926066,0.000050920404,0.00010844532,0.0003675686,0.00011453217,0.000097884666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015207338,0.00012779901,0.00020687451,0.00010117344,0.000017975019,0.000008246816,0.00020919884,0.00005333863,0.00017248256],"category_scores_gemma":[0.00018891644,0.00007316805,0.00006977017,0.000107660155,0.00010060285,0.00004901687,0.00006233455,0.00016032351,0.000015767497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027196697,0.0002270202,0.9968179,0.000037759575,0.000022634014,0.00004465791,0.00007954753,0.00009404619,0.0012544446,0.0008286046,0.00015589912,0.00016550811],"study_design_scores_gemma":[0.0016163731,0.00069573655,0.98959714,0.000053757187,0.0000514908,0.0001774091,0.000017980432,0.0013577613,0.005908744,0.000047528003,0.0004041323,0.00007194882],"about_ca_topic_score_codex":0.00027058428,"about_ca_topic_score_gemma":0.00008354972,"teacher_disagreement_score":0.0072207726,"about_ca_system_score_codex":0.00012629671,"about_ca_system_score_gemma":0.00006277097,"threshold_uncertainty_score":0.29837066},"labels":[],"label_agreement":null},{"id":"W2012647532","doi":"10.1097/01.ju.0000132126.85812.7d","title":"GUIDELINES FOR THE SURVEILLANCE OF LOCALIZED RENAL CELL CARCINOMA BASED ON THE PATTERNS OF RELAPSE AFTER NEPHRECTOMY","year":2004,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; McGill University; University of British Columbia; Western University","funders":"National Cancer Institute","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Cancer; General surgery; Urology; Internal medicine; Oncology; Gynecology; Kidney","score_opus":0.03630957825261644,"score_gpt":0.2811218576856907,"score_spread":0.24481227943307426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012647532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96449775,0.0024430736,0.0043679485,0.027940953,0.00016250124,0.00045407622,0.000018028131,0.0000030183687,0.00011265135],"genre_scores_gemma":[0.9961551,0.00012461215,0.00047658503,0.002929956,0.0002096682,0.000013616498,0.0000016847798,0.000020757258,0.00006804485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831516,0.00031235468,0.00073024386,0.00009793411,0.00034095006,0.0002033764],"domain_scores_gemma":[0.9965622,0.0016096509,0.0006588315,0.00050689623,0.0006066999,0.000055730354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015400532,0.00016075658,0.00045432182,0.00008394574,0.000048612706,0.0000030866245,0.0002991727,0.00007546366,0.000084430845],"category_scores_gemma":[0.00031658926,0.00006154689,0.000306308,0.00010400352,0.00017936822,0.000016601294,0.000030790106,0.0002745808,0.0000023229973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20338395,0.0032967313,0.5292538,0.0009207377,0.0021886413,0.0010666453,0.004772254,0.10561854,0.12559319,0.0007008288,0.017479302,0.005725412],"study_design_scores_gemma":[0.04047027,0.030149618,0.6501117,0.0003466825,0.0031825285,0.0020153713,0.00070396834,0.0049013454,0.24708654,0.0016871587,0.018941697,0.0004031573],"about_ca_topic_score_codex":0.00012886385,"about_ca_topic_score_gemma":0.00004496332,"teacher_disagreement_score":0.16291368,"about_ca_system_score_codex":0.000051244526,"about_ca_system_score_gemma":0.00020520514,"threshold_uncertainty_score":0.2509809},"labels":[],"label_agreement":null},{"id":"W2013105338","doi":"10.1007/s11934-005-0065-7","title":"Chemotherapies and immunotherapies for metastatic kidney cancer","year":2005,"lang":"en","type":"review","venue":"Current Urology Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Nephrology; Kidney cancer; Internal medicine; Oncology; Cancer; Immunotherapy","score_opus":0.0971910181274414,"score_gpt":0.4062064042412347,"score_spread":0.3090153861137933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013105338","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010678291,0.99552727,0.000037143258,0.00039142475,0.0010671065,0.002645507,0.000059163674,0.000067943525,0.00009764918],"genre_scores_gemma":[0.000050935014,0.99562746,0.00039400542,0.00026223186,0.00048421152,0.0018818626,0.00037501872,0.00011773911,0.00080652675],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976318,0.000081898164,0.00094114075,0.00075307983,0.0001782594,0.00041384797],"domain_scores_gemma":[0.9981174,0.00015744925,0.00078530493,0.0006027384,0.00010047776,0.00023664732],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026620095,0.00061188696,0.0024611657,0.00023696359,0.00007708793,0.00002077502,0.000069473856,0.00021653823,0.00022369144],"category_scores_gemma":[0.00010619281,0.00042808152,0.0006193366,0.00011246003,0.00020329635,0.00003984591,0.00004573832,0.0003431338,0.000008210206],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040645853,0.00015586284,0.000113425376,0.014563263,0.0014296335,0.00019719143,0.000099242825,9.5778226e-8,0.0000016645494,0.000013796123,0.0028878183,0.98049736],"study_design_scores_gemma":[0.0006151653,0.0002667791,0.000045129276,0.0027115617,0.006688992,0.004906723,0.0000034404259,0.0000020058292,0.0000044383546,0.00008006855,0.98438305,0.00029263197],"about_ca_topic_score_codex":0.000009729748,"about_ca_topic_score_gemma":0.000002594942,"teacher_disagreement_score":0.98149526,"about_ca_system_score_codex":0.00015875662,"about_ca_system_score_gemma":0.0007538563,"threshold_uncertainty_score":0.9998171},"labels":[],"label_agreement":null},{"id":"W2013172820","doi":"10.5858/arpa.2011-0498-ed","title":"Genitourinary Tumor Pathology: Introductory Comments","year":2012,"lang":"en","type":"article","venue":"Archives of Pathology & Laboratory Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Molecular pathology; Pathology; Genitourinary system; Surgical pathology; Anatomical pathology; Renal cell carcinoma; Immunohistochemistry; Internal medicine; Biology","score_opus":0.019851246808004815,"score_gpt":0.28033311953538986,"score_spread":0.26048187272738504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013172820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97685015,0.01085977,0.00007629677,0.002740631,0.00090893666,0.00049531314,0.000043189506,0.00008496558,0.007940766],"genre_scores_gemma":[0.99227595,0.0002566665,0.0030752537,0.0024027233,0.0013922885,0.000055576995,0.00010857132,0.000055826767,0.0003771639],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973707,0.0005235922,0.0006574542,0.00044220607,0.00033496463,0.0006710427],"domain_scores_gemma":[0.99780333,0.00038265082,0.00030776026,0.00091098464,0.00012088771,0.0004743815],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006013215,0.00036604572,0.00094533083,0.00043174098,0.0000903314,0.0000014566737,0.00021049751,0.00011127844,0.00033508104],"category_scores_gemma":[0.00038736884,0.0002786921,0.00012213558,0.00028452382,0.0016691779,0.00010383229,0.00016146284,0.000458623,0.00007647379],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007006475,0.001118115,0.3466309,0.00026034738,0.0002004753,0.0048317155,0.004201638,6.4177954e-7,0.6332035,0.00056699815,0.005168478,0.003116565],"study_design_scores_gemma":[0.005285658,0.0037181668,0.8873555,0.00024492247,0.0007015035,0.003888114,0.0011772828,0.0000051817715,0.07829406,0.00027026772,0.018748231,0.0003111065],"about_ca_topic_score_codex":0.000009204272,"about_ca_topic_score_gemma":0.0000014912662,"teacher_disagreement_score":0.5549094,"about_ca_system_score_codex":0.00006973846,"about_ca_system_score_gemma":0.00016693234,"threshold_uncertainty_score":0.9999665},"labels":[],"label_agreement":null},{"id":"W2013347392","doi":"10.5489/cuaj.1674","title":"Does gender influence morbidity or mortality in the surgical treatment of renal masses?","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Renal mass; Intensive care medicine; Surgery; Internal medicine; Kidney; Nephrectomy","score_opus":0.04547395142555752,"score_gpt":0.28644492251053494,"score_spread":0.24097097108497742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013347392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99249476,0.00006365715,0.000010165989,0.005276742,0.00009753872,0.00023026249,0.000017211474,0.000007245118,0.0018024384],"genre_scores_gemma":[0.9986539,0.000101014004,0.000085684274,0.00066881225,0.00030076355,0.000016150758,0.000011343051,0.000006127692,0.00015622436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792457,0.000561085,0.00043957744,0.0001877017,0.0004941897,0.0003928542],"domain_scores_gemma":[0.99855673,0.00043965364,0.0002584682,0.00019299366,0.0001534798,0.00039865533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010382326,0.0001504175,0.00036687835,0.00011485588,0.00012244482,0.000039367187,0.00012569217,0.00018260091,0.00039417137],"category_scores_gemma":[0.00051251054,0.00006011996,0.00016953006,0.00021163303,0.000053745232,0.00006162036,0.0000071472496,0.00029184675,0.000013035285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102846105,0.00016403433,0.9976792,0.000004299525,0.00008734725,0.00063878694,0.00018364543,0.00010329539,0.000053683158,0.00013119954,0.00019873642,0.0006529286],"study_design_scores_gemma":[0.0014463803,0.00077854446,0.9722219,0.000006476747,0.00011531039,0.0003121145,0.00006210225,0.0001032354,0.00010716628,0.0006034153,0.024169302,0.00007401475],"about_ca_topic_score_codex":0.003939501,"about_ca_topic_score_gemma":0.0057173334,"teacher_disagreement_score":0.02545726,"about_ca_system_score_codex":0.0013541816,"about_ca_system_score_gemma":0.0004434619,"threshold_uncertainty_score":0.5955373},"labels":[],"label_agreement":null},{"id":"W2013898299","doi":"10.1007/s00330-014-3147-4","title":"Diagnostic accuracy of segmental enhancement inversion for diagnosis of renal oncocytoma at biphasic contrast enhanced CT: systematic review","year":2014,"lang":"en","type":"review","venue":"European Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Center for Clinical and Translational Research","keywords":"Medicine; Neuroradiology; Radiology; Diagnostic accuracy; Forest plot; Renal oncocytoma; Clinical Practice; Interventional radiology; Contrast (vision); Oncocytoma; Meta-analysis; Medical physics; Nuclear medicine; Pathology; Neurology; Artificial intelligence; Renal cell carcinoma; Computer science","score_opus":0.040329084744022595,"score_gpt":0.3195538898834769,"score_spread":0.2792248051394543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013898299","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002020388,0.98520267,0.000215351,0.000029855995,0.00031604548,0.011097865,0.00015319645,0.000031595242,0.0009330366],"genre_scores_gemma":[0.008007408,0.9883501,0.00020639719,0.00022435922,0.00020178361,0.0014596953,0.0010474877,0.00013569319,0.00036708036],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99344367,0.002091155,0.0028451332,0.0007768902,0.00036600028,0.00047715078],"domain_scores_gemma":[0.98911726,0.0061768414,0.0031668996,0.001119255,0.00018554376,0.00023422315],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012635294,0.0007670615,0.0076363636,0.0002684502,0.00006361359,0.0000048481807,0.00044842588,0.000117866344,0.00021218711],"category_scores_gemma":[0.0035611168,0.0005318618,0.0015271929,0.00023934165,0.00024157262,0.000035345547,0.00022051971,0.00024605257,0.00023785511],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000785265,0.00023012012,0.000033846045,0.9570494,0.0013871584,0.0002507807,0.00004147524,2.7370558e-7,0.00020733167,0.000014897636,0.0041515236,0.03655462],"study_design_scores_gemma":[0.0027298266,0.0040033287,0.00003877909,0.88532555,0.022465628,0.0012814937,0.0000085969195,0.0000023900257,0.0045330413,0.0000014978818,0.07913211,0.0004777606],"about_ca_topic_score_codex":0.00000467178,"about_ca_topic_score_gemma":0.0000013482667,"teacher_disagreement_score":0.07498059,"about_ca_system_score_codex":0.0007796506,"about_ca_system_score_gemma":0.00019625627,"threshold_uncertainty_score":0.9997133},"labels":[],"label_agreement":null},{"id":"W2014201331","doi":"10.1111/j.1399-0004.2009.01159.x","title":"Early onset of renal cancer in a family with Birt–Hogg–Dubé syndrome","year":2009,"lang":"en","type":"article","venue":"Clinical Genetics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Birt–Hogg–Dubé syndrome; Folliculin; Medicine; Pathology; Cancer; Mutation; Connective Tissue Disorder; Internal medicine; Gene; Genetics; Biology; Anatomy; Pneumothorax","score_opus":0.06350243042076693,"score_gpt":0.3629538067281497,"score_spread":0.2994513763073828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014201331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960115,0.001996768,0.000045117242,0.00037982065,0.00007658274,0.0003758296,0.0000190038,0.000018780085,0.001076632],"genre_scores_gemma":[0.9957864,0.00078448094,0.0022940307,0.00057097146,0.00005904405,0.000012096353,0.000007136196,0.000020087411,0.00046570715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831927,0.00007597748,0.0006911604,0.0003297358,0.000321473,0.00026236108],"domain_scores_gemma":[0.998943,0.00014274848,0.00014369261,0.0004513078,0.00010003884,0.00021923504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023127752,0.00016823727,0.0005738108,0.00009142413,0.000013347277,0.0000062989425,0.00011044569,0.00015596724,0.000047211724],"category_scores_gemma":[0.000056595592,0.00012179391,0.0001308165,0.00026737098,0.0001632165,0.00001526115,0.000025017753,0.0002847058,0.000023767774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00117947,0.001018725,0.96621805,0.000044341323,0.00013194823,0.001307744,0.000112204565,0.00025570704,0.0019064676,0.000012431648,0.00027782103,0.027535113],"study_design_scores_gemma":[0.002992263,0.007078167,0.9872075,0.000265415,0.00017115707,0.00011026044,0.000016962596,0.00012847746,0.0015247057,0.00008916099,0.00029175708,0.0001241982],"about_ca_topic_score_codex":0.00006794937,"about_ca_topic_score_gemma":0.000043338132,"teacher_disagreement_score":0.027410915,"about_ca_system_score_codex":0.00006293327,"about_ca_system_score_gemma":0.00026970325,"threshold_uncertainty_score":0.49666116},"labels":[],"label_agreement":null},{"id":"W2014842121","doi":"10.5489/cuaj.1604","title":"Clinical outcomes in patients with metastatic renal cell carcinoma receiving everolimus or temsirolimus after sunitinib.","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Temsirolimus; Medicine; Sunitinib; Hazard ratio; Renal cell carcinoma; Internal medicine; Everolimus; Proportional hazards model; Confidence interval; Overall survival; Urology; Oncology; Surgery; Gastroenterology; Discovery and development of mTOR inhibitors","score_opus":0.02195669717371967,"score_gpt":0.25129420481138703,"score_spread":0.22933750763766736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014842121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954986,0.000040866962,0.000022214192,0.002338574,0.00021728418,0.00039469046,0.000023662795,0.000017983692,0.0014461536],"genre_scores_gemma":[0.99407864,0.000008246819,0.0007010498,0.0040467046,0.00022705368,0.000025106738,0.00003000874,0.00003134117,0.00085183955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996538,0.0007798777,0.00086253666,0.0003612812,0.0006604911,0.00079785596],"domain_scores_gemma":[0.99700147,0.00078270707,0.0004553354,0.00022789491,0.00034601835,0.0011865572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013929937,0.00028927592,0.00075673213,0.00034709604,0.0001440464,0.00007986232,0.0001445211,0.0002453454,0.0007061791],"category_scores_gemma":[0.0013653677,0.00017781444,0.00022532174,0.00027608091,0.000053269858,0.0001276409,0.00002259587,0.0009903022,0.00008310461],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008550206,0.00028479006,0.9960784,0.000008048772,0.0000986444,0.0004885741,0.00007316753,0.000017454397,0.0000014482519,0.0000033062295,0.00045861184,0.0016325852],"study_design_scores_gemma":[0.0071883923,0.0029700184,0.9866166,0.000023227052,0.00022655287,0.000058845388,0.000028051236,0.000042238928,0.00000513706,0.00005258543,0.002582665,0.00020566751],"about_ca_topic_score_codex":0.00085214357,"about_ca_topic_score_gemma":0.0033857147,"teacher_disagreement_score":0.00946173,"about_ca_system_score_codex":0.0014704897,"about_ca_system_score_gemma":0.0006208573,"threshold_uncertainty_score":0.7732166},"labels":[],"label_agreement":null},{"id":"W2015489672","doi":"10.5489/cuaj.2096","title":"Prognostic factors for overall survival with targeted therapy in Chinese patients with metastatic renal cell carcinoma","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Sunitinib; Sorafenib; Medicine; Internal medicine; Renal cell carcinoma; Oncology; Proportional hazards model; Multivariate analysis; Hepatocellular carcinoma; Metastasis; Bone metastasis; Univariate analysis; Targeted therapy; Gastroenterology; Urology; Cancer","score_opus":0.012634729146594092,"score_gpt":0.2102765554595179,"score_spread":0.19764182631292382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015489672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973694,0.00006278761,0.00014293962,0.0011013987,0.000089717934,0.00085207995,0.00004349384,0.000013817942,0.00032433975],"genre_scores_gemma":[0.9983138,0.0000038109897,0.00057787634,0.0006159736,0.00011486264,0.000039439947,0.00017846316,0.000029656247,0.00012615565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980561,0.00024644518,0.0003320497,0.00026783752,0.0004972273,0.0006003415],"domain_scores_gemma":[0.9980546,0.0004616402,0.00030427935,0.00012007315,0.00038663112,0.00067275635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042332054,0.0002640191,0.00046524723,0.00022966503,0.00015083878,0.000061113096,0.00009710296,0.00011589968,0.00010918541],"category_scores_gemma":[0.00048077916,0.00014470993,0.0001094213,0.00022751298,0.000028201963,0.00009547175,0.000005382616,0.00039515662,0.0000045694856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006290989,0.00020175171,0.9983039,0.000007979415,0.00009144849,0.0000506789,0.00016839622,0.00012182754,0.000036272195,0.000011206344,0.00013924867,0.00023819991],"study_design_scores_gemma":[0.008868964,0.0056386143,0.98426604,0.000010629074,0.0000962102,0.000015374992,0.000027175924,0.00015702947,0.00004619119,0.0001322107,0.0005655696,0.00017598906],"about_ca_topic_score_codex":0.0010188648,"about_ca_topic_score_gemma":0.0021648535,"teacher_disagreement_score":0.01403785,"about_ca_system_score_codex":0.0010490915,"about_ca_system_score_gemma":0.00045305077,"threshold_uncertainty_score":0.59011},"labels":[],"label_agreement":null},{"id":"W2015870827","doi":"10.5489/cuaj.2740","title":"Renal tumour scoring systems: How useful are they?","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Computer science; Medicine","score_opus":0.04643436781076438,"score_gpt":0.23128333850508995,"score_spread":0.18484897069432557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015870827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9687717,0.00091345736,0.000050750252,0.025233904,0.0006661782,0.00024670427,0.000019676483,0.00004301214,0.0040546465],"genre_scores_gemma":[0.9955056,0.00002247494,0.000121256475,0.0011665251,0.0012692177,0.000011494149,0.000012623125,0.00001852783,0.0018723153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797916,0.0002605844,0.00028999426,0.0002193193,0.0006579003,0.0005930294],"domain_scores_gemma":[0.9969199,0.000076352306,0.0003852995,0.000140575,0.00055720477,0.0019206816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009840267,0.00017968667,0.00037631879,0.00021204182,0.00018866868,0.00022798244,0.00010473155,0.00023378446,0.000060890998],"category_scores_gemma":[0.0012385466,0.00013209492,0.00015230208,0.00015410232,0.000018475823,0.0001315206,0.000016629481,0.0006382727,0.00013364882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062349645,0.000037977414,0.9670338,0.0000067578285,0.0001489067,0.0021718848,0.00013954953,0.00024282912,0.00018086495,0.000117065436,0.029708648,0.00014933848],"study_design_scores_gemma":[0.0018600165,0.000623038,0.93869644,0.00006317723,0.000170628,0.002876268,0.00056625117,0.0002683143,0.00007523439,0.00028146588,0.054321747,0.00019742738],"about_ca_topic_score_codex":0.0012789469,"about_ca_topic_score_gemma":0.00075641327,"teacher_disagreement_score":0.028337395,"about_ca_system_score_codex":0.0042948104,"about_ca_system_score_gemma":0.00087147625,"threshold_uncertainty_score":0.9995275},"labels":[],"label_agreement":null},{"id":"W2015923016","doi":"10.5489/cuaj.2448","title":"Zero Ischemia Robotic-Assisted Partial Nephrectomy in Alberta: Initial Results of a Novel Approach","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Nephrectomy; Medicine; Ischemia; Clamping; Surgery; Creatinine; Blood loss; Renal artery; Kidney; Internal medicine","score_opus":0.05711669439227946,"score_gpt":0.26707414688279163,"score_spread":0.20995745249051218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015923016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9674573,0.000102849735,0.00030920783,0.008136369,0.00025906513,0.0003866633,0.000026712085,0.000012754515,0.023309082],"genre_scores_gemma":[0.99624884,0.0000040145305,0.002089077,0.0007676745,0.00029912966,0.000018474084,0.000071290866,0.00001325512,0.00048822805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979027,0.00017303582,0.000673439,0.00023814582,0.0005051277,0.00050756376],"domain_scores_gemma":[0.9978395,0.00019639751,0.0003970371,0.00014468803,0.00034191518,0.0010804535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009077072,0.00017019063,0.00047616157,0.00024926057,0.000057190347,0.00003652114,0.00011567521,0.0003367186,0.000035431258],"category_scores_gemma":[0.0024355804,0.00013610306,0.00014939628,0.00036435618,0.000042562,0.00009054871,0.000018508967,0.00061918545,0.000015765121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034546517,0.0017669613,0.9525713,0.000026990701,0.00054772117,0.00089093077,0.001626358,0.004175968,0.0017405333,0.00048590376,0.02983799,0.0028747085],"study_design_scores_gemma":[0.035426278,0.0022264747,0.916432,0.00007035954,0.00041515048,0.0019227812,0.00028204845,0.0058794813,0.0014341671,0.000301614,0.03511172,0.000497891],"about_ca_topic_score_codex":0.011081765,"about_ca_topic_score_gemma":0.003022839,"teacher_disagreement_score":0.03613925,"about_ca_system_score_codex":0.0020111743,"about_ca_system_score_gemma":0.0013232179,"threshold_uncertainty_score":0.99550354},"labels":[],"label_agreement":null},{"id":"W2016079491","doi":"10.3747/co.20.1230","title":"Management of Renal Collecting Duct Carcinoma: A Systematic Review and the McMaster Experience","year":2013,"lang":"en","type":"review","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Gemcitabine; Regimen; Internal medicine; Cochrane Library; Carboplatin; MEDLINE; Oncology; Vinblastine; Nephrectomy; Systematic review; Cisplatin; Surgery; Chemotherapy; Randomized controlled trial; Kidney","score_opus":0.20007451370670512,"score_gpt":0.42944135665545774,"score_spread":0.22936684294875262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016079491","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000056053184,0.9842192,0.000008448262,0.000091670285,0.00031585438,0.012341806,0.000005748665,0.000016922393,0.00294428],"genre_scores_gemma":[0.00015722928,0.9926886,0.00013435142,0.000046368663,0.00007830543,0.0052812095,0.000023176592,0.00003826155,0.001552516],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99635667,0.00088488456,0.001563104,0.00053259643,0.00032786606,0.00033488416],"domain_scores_gemma":[0.99727744,0.0005102436,0.0012234861,0.0007003574,0.00014990204,0.00013857191],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007373652,0.00050988956,0.0055508944,0.00014267585,0.00008061408,0.000015436,0.00028012774,0.00015304655,0.00017082873],"category_scores_gemma":[0.00013120109,0.0002504677,0.0005998011,0.00039038263,0.00035784926,0.00003297982,0.00030355723,0.00042473857,0.00005522936],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015806047,0.000118607655,0.0000055203955,0.87494737,0.00046580753,0.00007551191,0.00024517573,7.292264e-9,6.814778e-8,0.000104573126,0.00058618473,0.12343535],"study_design_scores_gemma":[0.0017458912,0.0003424165,0.000007285729,0.64222294,0.04004987,0.0016818307,0.00021950359,0.000004625696,0.0000010573249,0.000007716186,0.31348416,0.00023267478],"about_ca_topic_score_codex":0.00001125685,"about_ca_topic_score_gemma":6.8967535e-7,"teacher_disagreement_score":0.31289798,"about_ca_system_score_codex":0.00051560864,"about_ca_system_score_gemma":0.0002031599,"threshold_uncertainty_score":0.99999475},"labels":[],"label_agreement":null},{"id":"W2017074680","doi":"10.1016/j.purol.2009.10.020","title":"Valeur pronostique des polyamines érythrocytaires dans le cancer du rein. Étude chez 418 patients","year":2010,"lang":"fr","type":"article","venue":"Progrès en Urologie","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Renal cell carcinoma; SPMD; Stage (stratigraphy); Internal medicine; Nephrectomy; Gastroenterology; Medicine; Urology; Population; Oncology; Biology; Kidney","score_opus":0.019171170269207876,"score_gpt":0.27049036315475294,"score_spread":0.25131919288554505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017074680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96687174,0.01860468,0.00011236488,0.0068166913,0.0028013275,0.002144699,0.000079782454,0.0002895438,0.0022791817],"genre_scores_gemma":[0.9881903,0.002227909,0.003240813,0.00040746474,0.0018724088,0.00091378234,0.00011805042,0.00012668264,0.0029025853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963316,0.00034444066,0.000603459,0.0009314732,0.00048150858,0.0013075318],"domain_scores_gemma":[0.9977464,0.00033794294,0.00025660326,0.0007932151,0.00039324988,0.00047259268],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051872444,0.0006675823,0.0006679349,0.00013383717,0.00030276962,0.00008396152,0.0005036858,0.00058357086,0.0003514245],"category_scores_gemma":[0.0011493383,0.00055899256,0.0002445264,0.00029951037,0.001240102,0.00033236734,0.0003620954,0.0009153218,0.00023872594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038186193,0.001759381,0.8559311,0.0004791448,0.00032038643,0.00041657724,0.0019115303,0.000026175689,0.01401565,0.00035347955,0.00080046547,0.12360426],"study_design_scores_gemma":[0.002924525,0.0028322039,0.89927983,0.00017520407,0.0006293875,0.000105062216,0.00017711218,0.00027934034,0.077077776,0.00036090068,0.01565089,0.00050777517],"about_ca_topic_score_codex":0.004119524,"about_ca_topic_score_gemma":0.002178922,"teacher_disagreement_score":0.12309649,"about_ca_system_score_codex":0.0005238783,"about_ca_system_score_gemma":0.0008178608,"threshold_uncertainty_score":0.9996862},"labels":[],"label_agreement":null},{"id":"W2017091267","doi":"10.1016/j.urology.2006.12.031","title":"Malignant Hypertension Due to Renal Artery Stenosis After Open Partial Nephrectomy in a Solitary Kidney","year":2007,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Nephrectomy; Renal artery; Renal artery stenosis; Kidney; Stenosis; Dissection (medical); Nephron; Surgery; Radiology; Urology; Internal medicine","score_opus":0.02576218789991322,"score_gpt":0.2668576171265321,"score_spread":0.2410954292266189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017091267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898492,0.00019282052,0.00022946605,0.005699017,0.0002358321,0.0010782598,0.00000720173,0.000030118093,0.0026780844],"genre_scores_gemma":[0.9786175,0.0000063163634,0.0011144532,0.019462515,0.00022310075,0.00021318311,0.00003085407,0.000030005256,0.0003021029],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982249,0.00010141909,0.00039671024,0.0004936494,0.00018071051,0.0006026015],"domain_scores_gemma":[0.9988862,0.00009090842,0.000043130094,0.0004288916,0.000053559255,0.00049729965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004100195,0.00020686116,0.0005032947,0.0002819472,0.000031407908,0.000013397939,0.00014887431,0.00016698685,0.00031427352],"category_scores_gemma":[0.0000817441,0.00016232124,0.00008475647,0.0002084986,0.000051412575,0.00005344379,0.0002293337,0.00020061687,0.00030751823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057244953,0.0030929812,0.5157516,0.00012798977,0.0005291885,0.19588305,0.0023592482,0.0000847629,0.16997278,0.00023722088,0.024800643,0.029915594],"study_design_scores_gemma":[0.0066418834,0.0043761474,0.9029847,0.00009498924,0.00026512225,0.00391535,0.000072804585,0.00018339674,0.021615596,0.00018481698,0.05931158,0.0003536086],"about_ca_topic_score_codex":0.00036570773,"about_ca_topic_score_gemma":0.0002789875,"teacher_disagreement_score":0.3872331,"about_ca_system_score_codex":0.00012742514,"about_ca_system_score_gemma":0.00012683924,"threshold_uncertainty_score":0.66192687},"labels":[],"label_agreement":null},{"id":"W2017356092","doi":"10.1007/s10689-012-9576-9","title":"Birt–Hogg–Dubé: tumour suppressor function and signalling dynamics central to folliculin","year":2012,"lang":"en","type":"article","venue":"Familial Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Myrovlytis Trust","keywords":"Folliculin; Birt–Hogg–Dubé syndrome; Biology; Cell biology; Cancer research; Genetics","score_opus":0.021453803682859235,"score_gpt":0.2658013077727783,"score_spread":0.24434750408991904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017356092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940392,0.0018118224,0.00085189095,0.0006458658,0.0010139837,0.00055636134,0.0000557285,0.000065272274,0.00095986965],"genre_scores_gemma":[0.99607664,0.00010940484,0.0004884624,0.0006364267,0.0013135124,0.00009920685,0.000058598467,0.00003817347,0.0011795955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986562,0.00003108179,0.00020637069,0.00027399926,0.0002920875,0.0005402364],"domain_scores_gemma":[0.9992175,0.00003234037,0.000048031066,0.00015729811,0.00006789686,0.000476914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009858198,0.00020458255,0.00027497584,0.000080718295,0.000076471,0.000019281599,0.000046444038,0.000091846865,0.00020675278],"category_scores_gemma":[0.000024751138,0.00016907872,0.00008782604,0.00014584762,0.000030234012,0.00011460917,0.000044141965,0.0001483735,0.0000609068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026257066,0.00037504194,0.75688547,0.00025583286,0.0002915435,0.000040971107,0.0011387576,0.00058492925,0.21772693,0.00055885734,0.0048000715,0.014715919],"study_design_scores_gemma":[0.0020089597,0.00056842074,0.9673987,0.000111099835,0.00043064903,0.000027872817,0.00021525791,0.0018293422,0.02229413,0.000042141706,0.0047943797,0.0002790474],"about_ca_topic_score_codex":0.001243832,"about_ca_topic_score_gemma":0.00036468785,"teacher_disagreement_score":0.21051326,"about_ca_system_score_codex":0.00053974666,"about_ca_system_score_gemma":0.00007091674,"threshold_uncertainty_score":0.68948305},"labels":[],"label_agreement":null},{"id":"W2017801374","doi":"10.1016/j.urology.2012.01.015","title":"Bilateral Renal Cell Carcinoma in a Child","year":2012,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Medicine; Renal cell carcinoma; Carcinoma; Oncology; Pathology","score_opus":0.014858091686409815,"score_gpt":0.23519568668872107,"score_spread":0.22033759500231126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017801374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9409796,0.0014266905,0.00000878236,0.0010352645,0.00015759062,0.00019489617,0.0000014446977,0.000022470858,0.056173258],"genre_scores_gemma":[0.9980586,0.0000059983745,0.00010223362,0.000946884,0.0002702348,0.00002279428,0.00001846641,0.000017627388,0.0005571251],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990644,0.000057411315,0.00017110136,0.0001748397,0.00009309569,0.0004391407],"domain_scores_gemma":[0.9995308,0.00002800037,0.000033343105,0.00023535354,0.000013393054,0.00015911977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010136097,0.00012307226,0.00022201566,0.00015300747,0.000020920885,0.0000024568517,0.000048029367,0.00011160791,0.00032218083],"category_scores_gemma":[0.000010855248,0.00009700616,0.00006357183,0.000102938895,0.000043474043,0.00004057987,0.00003710771,0.00020827881,0.00031998707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043038334,0.00048686107,0.9906609,0.000025920346,0.000015051741,0.00073868927,0.00068701874,0.00001886253,0.0054782326,0.0001551197,0.00055389956,0.000749029],"study_design_scores_gemma":[0.0025567885,0.0009888133,0.9682146,0.0000038607536,0.00007257092,0.0015013192,0.000015399091,0.000097592456,0.014305083,0.000036103942,0.012095763,0.00011215708],"about_ca_topic_score_codex":0.0000893547,"about_ca_topic_score_gemma":0.000013103379,"teacher_disagreement_score":0.057079036,"about_ca_system_score_codex":0.00007083763,"about_ca_system_score_gemma":0.000025757954,"threshold_uncertainty_score":0.4112893},"labels":[],"label_agreement":null},{"id":"W2017806482","doi":"10.1159/000338001","title":"A Pooled Analysis of Sequential Therapies with Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma","year":2012,"lang":"en","type":"article","venue":"Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Pfizer","keywords":"Sorafenib; Sunitinib; Medicine; Internal medicine; Renal cell carcinoma; Oncology; Tyrosine-kinase inhibitor; Progression-free survival; Pharmacology; Cancer; Overall survival; Hepatocellular carcinoma","score_opus":0.039049768998341734,"score_gpt":0.306605251106678,"score_spread":0.2675554821083363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017806482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99362826,0.0017040076,0.000050525545,0.00022340564,0.000024382976,0.00026669743,0.000011268511,0.000008251729,0.0040832],"genre_scores_gemma":[0.99733126,0.000024769643,0.0021871699,0.000103622246,0.000030911724,0.000029547378,0.00005428852,0.000013659977,0.00022475145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894345,0.00019575519,0.00026966503,0.00016840924,0.00014920117,0.0002735326],"domain_scores_gemma":[0.99933773,0.00015003081,0.0001389523,0.00018815378,0.000059303708,0.00012583965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026568185,0.00013897853,0.0006854164,0.00045277545,0.000019418412,0.00000341405,0.00003927787,0.00006192821,0.00023673034],"category_scores_gemma":[0.000011728793,0.00009661632,0.00008467913,0.00048075963,0.00014849674,0.000051032785,0.000025960824,0.0001158234,0.0000037988348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021637548,0.0021049182,0.8759594,0.00013182574,0.0034094055,0.0006820917,0.0074584456,0.00004052034,0.10380073,0.00030457717,0.00005747064,0.0038868657],"study_design_scores_gemma":[0.0054414156,0.0037199974,0.9406303,0.000015689418,0.010228739,0.00017594239,0.0013744184,0.00013647595,0.03757951,0.00002116787,0.000535328,0.00014099194],"about_ca_topic_score_codex":0.0005279084,"about_ca_topic_score_gemma":0.000551357,"teacher_disagreement_score":0.066221215,"about_ca_system_score_codex":0.00013479823,"about_ca_system_score_gemma":0.0001505153,"threshold_uncertainty_score":0.39398992},"labels":[],"label_agreement":null},{"id":"W2018560904","doi":"10.1016/j.urology.2006.03.031","title":"Laparoscopic management of advanced renal cell carcinoma with level I renal vein thrombus","year":2006,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McMaster University","funders":"","keywords":"Medicine; Renal vein; Renal cell carcinoma; Thrombus; Urology; Radiology; Surgery; Kidney; Internal medicine","score_opus":0.016562703199316,"score_gpt":0.23550846301466705,"score_spread":0.21894575981535105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018560904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96151316,0.0009513501,0.00042180304,0.00032989352,0.000075487376,0.00044072644,0.000012596483,0.00003491519,0.036220092],"genre_scores_gemma":[0.9901644,0.000012604033,0.004308409,0.00013868498,0.00006843642,0.000033927077,0.00008288324,0.00003050477,0.0051601348],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986323,0.00004582461,0.00030688662,0.0003833463,0.00026224766,0.00036938614],"domain_scores_gemma":[0.9992198,0.000032252927,0.00013830113,0.00045780785,0.00006877739,0.00008309711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006734199,0.00021645552,0.00043155445,0.00011774374,0.000038529863,0.000003828597,0.00010562543,0.00009307293,0.00014340183],"category_scores_gemma":[0.0000019180034,0.00016482435,0.000075736665,0.00016517231,0.0001513945,0.00003356985,0.000054229637,0.00014444184,0.000044066324],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015656505,0.005693968,0.35837117,0.0021779542,0.0011835917,0.016261188,0.00072566833,0.01060636,0.55692166,0.008964753,0.0128157,0.010621474],"study_design_scores_gemma":[0.010717548,0.0066830893,0.71624273,0.000045960944,0.00063483266,0.00027371917,0.00006479419,0.00007668104,0.26013428,0.00028932226,0.004600607,0.00023645288],"about_ca_topic_score_codex":0.00013848236,"about_ca_topic_score_gemma":0.00005450346,"teacher_disagreement_score":0.35787156,"about_ca_system_score_codex":0.000082082675,"about_ca_system_score_gemma":0.000059262384,"threshold_uncertainty_score":0.67213416},"labels":[],"label_agreement":null},{"id":"W2018900307","doi":"10.1016/j.juro.2009.10.002","title":"Unintended Consequences of Laparoscopic Surgery on Partial Nephrectomy for Kidney Cancer","year":2009,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Nephrectomy; Medicine; Renal cell carcinoma; Kidney cancer; Surgery; Cancer; Cryotherapy; General surgery; Kidney; Urology; Internal medicine","score_opus":0.04587543208569548,"score_gpt":0.3146241710560841,"score_spread":0.2687487389703886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018900307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96375424,0.0012022317,0.0000497647,0.03411174,0.00035374472,0.00020773185,0.000005914398,0.0000044682556,0.00031015277],"genre_scores_gemma":[0.99519426,0.00034496665,0.000085401196,0.0040438594,0.00023152903,0.000005254841,0.0000014668899,0.000006059804,0.00008723436],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990893,0.00013950163,0.00037984582,0.000064219836,0.00015351843,0.00017362698],"domain_scores_gemma":[0.9987629,0.00044302363,0.00037244707,0.00013489946,0.00017348376,0.00011323467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044746214,0.00009312082,0.00045068882,0.00010594453,0.000029262086,0.0000021636577,0.000088237175,0.000055958884,0.00008175082],"category_scores_gemma":[0.00027511903,0.000050263916,0.00015280336,0.00007225477,0.00027863862,0.000022087666,0.000005260058,0.00015685653,0.0000020128687],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07641096,0.0017282334,0.06977995,0.0002303603,0.002245573,0.0008178115,0.0016470844,0.00091949897,0.7206231,0.0053251423,0.09559589,0.024676451],"study_design_scores_gemma":[0.008831826,0.022848431,0.081308536,0.00030783494,0.002370607,0.002887783,0.00014700106,0.000114050956,0.8406273,0.008434273,0.031908102,0.00021426677],"about_ca_topic_score_codex":0.00003188979,"about_ca_topic_score_gemma":0.0000035866933,"teacher_disagreement_score":0.12000422,"about_ca_system_score_codex":0.00004434015,"about_ca_system_score_gemma":0.00043566013,"threshold_uncertainty_score":0.2049703},"labels":[],"label_agreement":null},{"id":"W2019733630","doi":"10.15586/jkcvhl.2014.11","title":"The ISUP system of staging, grading and classification of renal cell neoplasia","year":2014,"lang":"en","type":"article","venue":"Journal of Kidney Cancer and VHL","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Grading (engineering); Pathology; Medicine; Biology","score_opus":0.01640787844556433,"score_gpt":0.26364390864861387,"score_spread":0.24723603020304954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019733630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99258137,0.003225177,0.00020904189,0.0012308602,0.00015856967,0.000093596995,0.000005805598,0.0000023948628,0.0024932],"genre_scores_gemma":[0.9984882,0.0009127208,0.00016309827,0.00005459231,0.00014815365,0.0000018138074,7.7368946e-7,0.000007187453,0.00022347037],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992197,0.000043196775,0.00036309395,0.00007072424,0.0002154492,0.00008779547],"domain_scores_gemma":[0.99895585,0.00008339233,0.0004630226,0.00010277466,0.00015920715,0.00023575166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037038198,0.00007411765,0.0002650328,0.00006591637,0.000046559086,0.000010595768,0.00004339334,0.000031435135,0.000004424511],"category_scores_gemma":[0.000069534406,0.000042032752,0.000058469504,0.000058572114,0.000067594476,0.000044658736,0.000011070897,0.00010389113,1.9490396e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001320819,0.00014415779,0.43723089,0.002631847,0.00045733515,0.000028017088,0.0021379266,0.000017237615,0.50755996,0.0014978115,0.020171389,0.026802594],"study_design_scores_gemma":[0.0088979425,0.003035325,0.6430912,0.003472949,0.0015792538,0.00078951876,0.0024116903,0.0028622684,0.2977923,0.00016587786,0.035680566,0.00022115048],"about_ca_topic_score_codex":0.00004065273,"about_ca_topic_score_gemma":0.0000028543368,"teacher_disagreement_score":0.20976771,"about_ca_system_score_codex":0.00007334501,"about_ca_system_score_gemma":0.00020553726,"threshold_uncertainty_score":0.17140459},"labels":[],"label_agreement":null},{"id":"W2020103830","doi":"10.1078/0344-0338-00144","title":"A Comparative Study of Metastatic Renal Cell Carcinoma with Correlation to Subtype and Primary Tumor","year":2001,"lang":"en","type":"article","venue":"Pathology - Research and Practice","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Papillary renal cell carcinomas; Medicine; Renal cell carcinoma; Lymph node; Metastasis; Primary tumor; Pathology; Clear cell; Radiology; Internal medicine; Cancer","score_opus":0.13260972419455308,"score_gpt":0.40260808614805493,"score_spread":0.26999836195350185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020103830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985169,0.0007857372,0.00009060399,0.0006667344,0.000013744009,0.0013064495,0.00000419923,0.000007595036,0.011955937],"genre_scores_gemma":[0.9960782,0.000054387732,0.0030182782,0.000101192665,0.00002009682,0.000077836135,0.00001178575,0.0000109814055,0.0006272609],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772686,0.0010370961,0.00019759955,0.00034601172,0.00042547446,0.00026696536],"domain_scores_gemma":[0.9971114,0.00185507,0.00010568742,0.00024099759,0.00046566708,0.00022118242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013741181,0.00012070605,0.00035733083,0.00023192592,0.000117084375,0.000016931712,0.000043616692,0.000028034918,0.000023078765],"category_scores_gemma":[0.00042618535,0.0000780844,0.000011413407,0.00035577652,0.00019870828,0.00014695192,0.00007936013,0.0003552988,0.000015926744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060919054,0.0077634105,0.80259246,0.00036591807,0.00032670223,0.026971474,0.031417143,0.000023444549,0.067112215,0.0001185755,0.00057015073,0.0018194644],"study_design_scores_gemma":[0.0053146007,0.041910294,0.9242845,0.000033209802,0.0003760245,0.0071076127,0.016582752,0.00006384679,0.0035315468,0.000057635047,0.0006139128,0.00012404902],"about_ca_topic_score_codex":0.00029232056,"about_ca_topic_score_gemma":0.00010540789,"teacher_disagreement_score":0.12169207,"about_ca_system_score_codex":0.000055498447,"about_ca_system_score_gemma":0.00015697614,"threshold_uncertainty_score":0.31841895},"labels":[],"label_agreement":null},{"id":"W2020269123","doi":"10.1002/dc.10242","title":"Distribution of subtypes of metastatic renal‐cell carcinoma: Correlating findings of fine‐needle aspiration biopsy and surgical pathology","year":2003,"lang":"en","type":"article","venue":"Diagnostic Cytopathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Pathology; Medicine; Cytopathology; Fine-needle aspiration; Chromophobe cell; Clear cell; Surgical pathology; Cytokeratin; Biopsy; Vimentin; Papillary renal cell carcinomas; Renal cell carcinoma; Metastasis; Immunohistochemistry; Cancer; Cytology; Internal medicine","score_opus":0.017571961059970352,"score_gpt":0.24905115995418964,"score_spread":0.23147919889421928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020269123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99546105,0.0026463857,0.00071301556,0.0000407265,0.00009287222,0.0003783126,0.00008509004,0.000009882809,0.00057264866],"genre_scores_gemma":[0.9982716,0.000061613275,0.0013561256,0.000007868975,0.000013754793,0.000019852745,0.00021093835,0.000015647804,0.000042602154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983307,0.0002609919,0.00069526234,0.00030198926,0.00017859275,0.00023244337],"domain_scores_gemma":[0.99745977,0.0016295636,0.0003628565,0.00026517393,0.00020118104,0.00008147991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046344113,0.00018646668,0.00073126995,0.00015017974,0.000029782199,0.0000021578235,0.000049381888,0.00013699771,0.00006150414],"category_scores_gemma":[0.002028903,0.00016157873,0.00011330208,0.00024421737,0.0003392953,0.000036896963,0.00003732064,0.00014407761,0.000004453764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017743467,0.0005096087,0.9159628,0.0004606172,0.00002538096,0.0015169552,0.00042370366,0.00003644512,0.07713844,0.002979832,0.000025003388,0.00074378663],"study_design_scores_gemma":[0.0025708547,0.0023296904,0.7424746,0.00009513373,0.00047025917,0.002653783,0.00012939576,0.000060346334,0.24883166,0.00024380098,0.000028456916,0.00011201651],"about_ca_topic_score_codex":0.000049229995,"about_ca_topic_score_gemma":0.00000511858,"teacher_disagreement_score":0.1734882,"about_ca_system_score_codex":0.000044063712,"about_ca_system_score_gemma":0.00009474123,"threshold_uncertainty_score":0.65889895},"labels":[],"label_agreement":null},{"id":"W2020496374","doi":"10.1016/j.clgc.2014.02.009","title":"Efficacy of Targeted Therapy for Metastatic Renal Cell Carcinoma in the Elderly Patient Population","year":2014,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Sunnybrook Health Science Centre; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; BC Cancer Agency; University of Calgary","funders":"National Cancer Institute","keywords":"Medicine; Renal cell carcinoma; Oncology; Targeted therapy; Internal medicine; Population; Kidney cancer; Cancer; Environmental health","score_opus":0.0668936906804395,"score_gpt":0.36309174508875747,"score_spread":0.296198054408318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020496374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951216,0.0020915398,0.00006278725,0.0005218263,0.00025786925,0.0015796177,0.000016893127,0.000013043967,0.00033484152],"genre_scores_gemma":[0.99734145,0.00014489373,0.0011990049,0.00046215503,0.00038175864,0.0002742259,0.00008437673,0.00002780244,0.00008433789],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978686,0.0003797392,0.0008585436,0.0003407202,0.0002992272,0.00025316654],"domain_scores_gemma":[0.99800754,0.0010459649,0.00028294767,0.00045290834,0.000109268054,0.000101369376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057918014,0.0001861059,0.0005002774,0.000080516475,0.000046554695,0.0000073681754,0.00013743923,0.00008433568,0.000056923396],"category_scores_gemma":[0.00015130099,0.00011518638,0.00035733814,0.00017834736,0.00006968618,0.00003553245,0.00002135513,0.00021421965,0.000004784599],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0136796385,0.006500014,0.49511096,0.000384199,0.0002921411,0.00013414447,0.0013083763,0.0009330408,0.006087905,0.00004693384,0.004153071,0.4713696],"study_design_scores_gemma":[0.0092471,0.012836659,0.9679394,0.00005421415,0.00019658914,0.000009080855,0.000085325526,0.0005344488,0.006288897,0.00016220359,0.0025052344,0.00014088862],"about_ca_topic_score_codex":0.00022100398,"about_ca_topic_score_gemma":0.000018505674,"teacher_disagreement_score":0.47282842,"about_ca_system_score_codex":0.00007587193,"about_ca_system_score_gemma":0.000104193794,"threshold_uncertainty_score":0.46971646},"labels":[],"label_agreement":null},{"id":"W2020552064","doi":"10.1159/000320223","title":"Safety and Efficacy of Sorafenib in Elderly Patients Treated in the North American Advanced Renal Cell Carcinoma Sorafenib Expanded Access Program","year":2010,"lang":"en","type":"article","venue":"Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McMaster University; Jewish General Hospital; University of Toronto","funders":"Onyx Pharmaceuticals; Canadian Centre for Applied Research in Cancer Control; Bayer","keywords":"Sorafenib; Medicine; Renal cell carcinoma; Rash; Internal medicine; Adverse effect; Expanded access; Hepatocellular carcinoma; Carcinoma; Surgery; Oncology; Gastroenterology; Urology","score_opus":0.01695252499369459,"score_gpt":0.3116484416200446,"score_spread":0.29469591662635003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020552064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950458,0.000055603843,0.000001000981,0.00030209176,0.000066082044,0.0019303842,0.0000116710025,0.000024335171,0.0025630277],"genre_scores_gemma":[0.9989107,0.00003382339,0.0005185581,0.00009914671,0.000033801156,0.00018346998,0.00014589872,0.000023331713,0.000051240415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819946,0.0002273029,0.00053352903,0.00041019134,0.00022761915,0.00040189916],"domain_scores_gemma":[0.9987709,0.00030704177,0.0002853504,0.00041037166,0.00010022551,0.0001261281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018807419,0.00023948637,0.000679364,0.00022804306,0.000041080435,0.000012178857,0.00022340255,0.00011718815,0.000021999778],"category_scores_gemma":[0.00007826737,0.00016208108,0.0000746869,0.0006260304,0.00033816605,0.000078175275,0.00007402343,0.0004797142,0.0000034404538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002553512,0.003117077,0.7820324,0.000031509026,0.000013931307,0.00018001632,0.00081721594,0.00000617703,0.002001968,0.00000416891,0.000019445542,0.20922263],"study_design_scores_gemma":[0.01363767,0.010154375,0.9713308,0.000014082858,0.000077352764,0.00002741293,0.00016180139,0.0000296563,0.0033543706,0.0000049424634,0.0010755557,0.00013198762],"about_ca_topic_score_codex":0.0011813716,"about_ca_topic_score_gemma":0.011859702,"teacher_disagreement_score":0.20909064,"about_ca_system_score_codex":0.00016356813,"about_ca_system_score_gemma":0.00017328837,"threshold_uncertainty_score":0.6617992},"labels":[],"label_agreement":null},{"id":"W2020873066","doi":"10.1016/j.carj.2012.12.005","title":"The Value of “Liver Windows” Settings in the Detection of Small Renal Cell Carcinomas on Unenhanced Computed Tomography","year":2013,"lang":"en","type":"article","venue":"Canadian Association of Radiologists Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Coronal plane; Hounsfield scale; Radiology; Receiver operating characteristic; Soft tissue; Nephrectomy; Sagittal plane; Kappa; Nuclear medicine; Kidney; Computed tomography","score_opus":0.01109902179554025,"score_gpt":0.20578406611776037,"score_spread":0.1946850443222201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020873066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99590284,0.00065880053,0.00009346966,0.0014815175,0.00013210696,0.00048420703,0.0000120640225,0.0000038795133,0.0012310934],"genre_scores_gemma":[0.9992514,0.00008670804,0.0002284166,0.00020522108,0.00008937858,0.000010773542,0.000007844519,0.000009213901,0.00011099358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818754,0.00046871795,0.0005661301,0.00012896155,0.00034230654,0.00030633277],"domain_scores_gemma":[0.99772143,0.0005769366,0.0009379447,0.0002068491,0.0004044743,0.00015238511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012250148,0.0001323812,0.0003341247,0.00032588246,0.00012643712,0.000018592824,0.0002049288,0.00014389002,0.0000138271],"category_scores_gemma":[0.00031032067,0.0000805426,0.00021099193,0.00037411135,0.00011348235,0.000041106985,0.000007684168,0.00040582716,0.0000028742581],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005055151,0.00037092675,0.82390356,0.00018988486,0.0007998467,0.0001909907,0.0047885324,0.0023929777,0.13693355,0.00049904466,0.008468938,0.020956248],"study_design_scores_gemma":[0.0012741669,0.000819837,0.9702822,0.00007528269,0.0000775275,0.00007956092,0.00028653158,0.00047001874,0.026082741,0.00012788111,0.00035540515,0.000068822104],"about_ca_topic_score_codex":0.015924508,"about_ca_topic_score_gemma":0.014377662,"teacher_disagreement_score":0.14637868,"about_ca_system_score_codex":0.00095237745,"about_ca_system_score_gemma":0.00035824144,"threshold_uncertainty_score":0.99062854},"labels":[],"label_agreement":null},{"id":"W2020955454","doi":"10.5489/cuaj.2349","title":"Strain elastography in the characterization of renal cell carcinoma and angiomyolipoma","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Angiomyolipoma; Elastography; Renal cell carcinoma; Lesion; Medicine; Strain (injury); Radiology; Clear cell; Nuclear medicine; Pathology; Ultrasound; Internal medicine; Kidney","score_opus":0.018071208263178425,"score_gpt":0.20957157966762266,"score_spread":0.19150037140444423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020955454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99255943,0.00017437253,0.000027059556,0.005724766,0.000056891353,0.00016654875,0.000031662676,0.0000034344414,0.0012558579],"genre_scores_gemma":[0.9986968,0.000013761149,0.000070214264,0.0009619262,0.00013676012,0.0000047904873,0.000039707193,0.0000053425865,0.00007072243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988552,0.00022071002,0.00026302872,0.00010838201,0.0003079092,0.00024481388],"domain_scores_gemma":[0.9991179,0.000060097842,0.00019747655,0.00007586578,0.00015584237,0.00039281618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007601276,0.00009103939,0.00018339642,0.00024071064,0.000054126696,0.00003098252,0.00006953675,0.00012406176,0.00003475826],"category_scores_gemma":[0.00012982753,0.000059881026,0.00007223216,0.0002711833,0.00003168625,0.000059981678,0.0000063881425,0.00027697743,0.0000034763082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051568713,0.000053319945,0.99188524,0.000003997236,0.000017769033,0.00016189339,0.00065883744,0.000004653315,0.005718463,0.000059250506,0.00039821016,0.0009867655],"study_design_scores_gemma":[0.0010711444,0.00059883227,0.9951536,0.0000050722015,0.000047980455,0.0002645151,0.00018964909,0.000047957816,0.00022814836,0.00014917237,0.002191118,0.000052785108],"about_ca_topic_score_codex":0.00051757344,"about_ca_topic_score_gemma":0.0002957991,"teacher_disagreement_score":0.0061373683,"about_ca_system_score_codex":0.00034711816,"about_ca_system_score_gemma":0.00030878466,"threshold_uncertainty_score":0.24418773},"labels":[],"label_agreement":null},{"id":"W2021217464","doi":"10.1097/00042307-200305000-00003","title":"Cryotherapy and radiofrequency ablation: pathophysiologic basis and laboratory studies","year":2003,"lang":"en","type":"review","venue":"Current Opinion in Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Calgary; University of Toronto","funders":"","keywords":"Cryoablation; Medicine; Cryosurgery; Radiofrequency ablation; Cryotherapy; Coagulative necrosis; Ablation; Pathology; Radiology; Surgery; Internal medicine","score_opus":0.16567279593706533,"score_gpt":0.4185457201359341,"score_spread":0.25287292419886875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021217464","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00051348645,0.9963246,0.0000036070655,0.000079701436,0.002018219,0.00095059886,0.00002649964,0.00002512051,0.000058173504],"genre_scores_gemma":[0.0000738547,0.9990001,0.00011518796,0.000063891646,0.00031029677,0.0002876793,0.000100313126,0.000033156688,0.000015541493],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99790037,0.0005325729,0.0005627107,0.0006252972,0.000115694995,0.00026337622],"domain_scores_gemma":[0.99897593,0.00028480092,0.00024725072,0.00030856143,0.000078068435,0.00010537523],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024096933,0.00043036087,0.0017629075,0.00031374773,0.00004948935,0.000008520104,0.000057053003,0.00029783873,0.000032547367],"category_scores_gemma":[0.000085446714,0.0003093495,0.00012125236,0.0002857948,0.000252422,0.00003772567,0.000043293858,0.0004272332,0.000012104486],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029393648,0.00012892527,0.0014745774,0.01910485,0.00020235246,0.00002363467,0.00011528979,2.3841412e-7,0.0000016035372,0.00033481442,0.0008055946,0.97777873],"study_design_scores_gemma":[0.00087006047,0.0006757753,0.001306787,0.0024568248,0.00032076667,0.00016051975,0.000013921849,0.0000018401804,2.8692875e-7,0.00028495266,0.99367654,0.0002317168],"about_ca_topic_score_codex":0.0000012591164,"about_ca_topic_score_gemma":1.7399414e-7,"teacher_disagreement_score":0.9928709,"about_ca_system_score_codex":0.00015214666,"about_ca_system_score_gemma":0.00016462764,"threshold_uncertainty_score":0.99993587},"labels":[],"label_agreement":null},{"id":"W2021770899","doi":"10.1016/j.clgc.2014.11.001","title":"First-Line and Sequential Use of Pazopanib Followed by Mammalian Target of Rapamycin Inhibitor Therapy Among Patients With Advanced Renal Cell Carcinoma in a US Community Oncology Setting","year":2014,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Centre for Applied Research in Cancer Control; GlaxoSmithKline","keywords":"Pazopanib; Medicine; Temsirolimus; Everolimus; Internal medicine; Oncology; Adverse effect; Renal cell carcinoma; Cohort; Nausea; Clinical trial; Sunitinib; PI3K/AKT/mTOR pathway; Discovery and development of mTOR inhibitors","score_opus":0.04026818035067124,"score_gpt":0.31459013582231826,"score_spread":0.274321955471647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021770899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977513,0.00059770315,0.000024813357,0.00014860244,0.00019570818,0.0010235849,0.000118029144,0.000016868651,0.00012339753],"genre_scores_gemma":[0.9970628,0.0002308227,0.0019668438,0.0001959315,0.00016645098,0.00008402896,0.0001548288,0.00005225822,0.00008601279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968322,0.0008953365,0.0011401821,0.0004275694,0.00033226304,0.00037244274],"domain_scores_gemma":[0.9974535,0.0008385017,0.0006438521,0.000551782,0.00023985049,0.0002725199],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00064781756,0.0003237322,0.0010420923,0.00011919474,0.00008423901,0.00000761958,0.00014830244,0.0002581188,0.000049219005],"category_scores_gemma":[0.00014208797,0.0002511272,0.00018552344,0.00020661831,0.00044227435,0.00013114035,0.00013870747,0.0007032632,8.057058e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071376585,0.002542272,0.9775511,0.00021022564,0.00008695455,0.00006971582,0.00029161214,0.0003145976,0.005080335,2.3673279e-7,0.00035604864,0.006359227],"study_design_scores_gemma":[0.019328747,0.015326403,0.9329115,0.0002217022,0.00013508454,0.0000049283854,0.000059433412,0.00022109025,0.030243311,0.000007189405,0.001316435,0.00022418323],"about_ca_topic_score_codex":0.0012635781,"about_ca_topic_score_gemma":0.00043399577,"teacher_disagreement_score":0.044639625,"about_ca_system_score_codex":0.00019519163,"about_ca_system_score_gemma":0.0002141083,"threshold_uncertainty_score":0.9999941},"labels":[],"label_agreement":null},{"id":"W2022076442","doi":"10.3747/co.v16i0.415","title":"Adjuvant and Neoadjuvant Small-Molecule Targeted Therapy in High-Risk Renal Cell Carcinoma","year":2009,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Temsirolimus; Medicine; Sorafenib; Oncology; Sunitinib; Adjuvant; Internal medicine; Renal cell carcinoma; Bevacizumab; Neoadjuvant therapy; Adjuvant therapy; Targeted therapy; Pazopanib; Cancer; Chemotherapy; Hepatocellular carcinoma; Breast cancer; PI3K/AKT/mTOR pathway","score_opus":0.049225750089526704,"score_gpt":0.3159595353086008,"score_spread":0.2667337852190741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022076442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726093,0.023634192,0.00004671879,0.0008775688,0.00040132564,0.0008212976,0.000013340919,0.000053682637,0.0015426103],"genre_scores_gemma":[0.9961479,0.002454155,0.00060248486,0.00029198494,0.00021135532,0.00005048585,0.00009749616,0.000026480093,0.00011768954],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979254,0.0002477435,0.00047801447,0.00058968435,0.00021095591,0.00054820045],"domain_scores_gemma":[0.9989313,0.00009812347,0.00018806671,0.00038555046,0.00009288272,0.0003040845],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024484313,0.0003392747,0.0007258547,0.00027061196,0.000066582346,0.0000134737265,0.00010899633,0.0001945116,0.000088718065],"category_scores_gemma":[0.000040732342,0.00026824986,0.00011810357,0.00024299233,0.000104605446,0.000042073738,0.00004831992,0.0005537119,0.00003727705],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018878843,0.0034062774,0.37134445,0.00006667825,0.000046781504,0.0017523655,0.0012966223,0.000013033152,0.048793036,0.00011737344,0.0017265924,0.5695489],"study_design_scores_gemma":[0.012173867,0.010179005,0.9253872,0.000052408264,0.00012635264,0.00015338219,0.00009320031,0.00024850934,0.044227667,0.00024793623,0.006823651,0.00028679482],"about_ca_topic_score_codex":0.00018996788,"about_ca_topic_score_gemma":0.00006780952,"teacher_disagreement_score":0.5692621,"about_ca_system_score_codex":0.00040705042,"about_ca_system_score_gemma":0.00025575867,"threshold_uncertainty_score":0.999977},"labels":[],"label_agreement":null},{"id":"W2022110376","doi":"10.1097/mou.0b013e32802b7070","title":"Expanding the indications for laparoscopic radical nephrectomy","year":2007,"lang":"en","type":"review","venue":"Current Opinion in Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Renal vein; Surgery; Laparoscopic surgery; Laparoscopy; Kidney cancer; General surgery; Kidney; Internal medicine","score_opus":0.20276142006379397,"score_gpt":0.45919060231870756,"score_spread":0.2564291822549136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022110376","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034904573,0.99090356,0.0005249943,0.0003404428,0.0048669023,0.00305938,0.000028401908,0.00003112041,0.0002102738],"genre_scores_gemma":[0.00007766328,0.995731,0.00016551756,0.000056978915,0.001309626,0.0016661354,0.00089625537,0.000047980924,0.000048841015],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978426,0.00021148344,0.0007771725,0.0005023063,0.00019845083,0.00046800636],"domain_scores_gemma":[0.9979705,0.0010345137,0.00030646546,0.00051545014,0.000035952413,0.00013709145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046905765,0.00035775598,0.0013118681,0.00051974534,0.000097574244,0.0000131630995,0.00025715725,0.00038954368,0.000064688335],"category_scores_gemma":[0.0001872893,0.000223903,0.0004366235,0.00042658116,0.00020743998,0.000021291331,0.000078666206,0.00080088095,0.00008025075],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062922416,0.00034327034,0.0007308949,0.014198696,0.00014756771,0.0000048455877,0.000106735504,3.963912e-7,3.4668096e-7,0.0015389073,0.0067652212,0.9761002],"study_design_scores_gemma":[0.0011682583,0.0002886837,0.00026727407,0.002830413,0.00049847894,0.00016008358,0.000005711204,0.0000034796524,0.0000010880377,0.00010952039,0.99451554,0.0001514803],"about_ca_topic_score_codex":0.000003308405,"about_ca_topic_score_gemma":0.0000012687377,"teacher_disagreement_score":0.9877503,"about_ca_system_score_codex":0.0003024396,"about_ca_system_score_gemma":0.0004514142,"threshold_uncertainty_score":0.91304994},"labels":[],"label_agreement":null},{"id":"W2022566441","doi":"10.1097/pas.0000000000000254","title":"Best Practices Recommendations in the Application of Immunohistochemistry in Urologic Pathology","year":2014,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":315,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Medicine; Anatomical pathology; Pathology; Consensus conference; MEDLINE; Surgical pathology; Best practice; Immunohistochemistry; Internal medicine; Biology","score_opus":0.03329303173240811,"score_gpt":0.3419610742267629,"score_spread":0.3086680424943548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022566441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98051214,0.00051088346,0.00018322708,0.01658144,0.000036898648,0.00015475429,0.0000013369676,0.000002577246,0.002016737],"genre_scores_gemma":[0.9982465,0.00043382167,0.00073257333,0.00045652594,0.000078097706,0.000020963445,0.000004897704,0.0000070435717,0.000019568166],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978451,0.0010636732,0.0006185971,0.00013586525,0.0001640889,0.00017268075],"domain_scores_gemma":[0.99658376,0.0013596152,0.0015764225,0.000347047,0.00009481194,0.000038364407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021467514,0.00010522987,0.00050714076,0.00012447068,0.000030046467,0.00000355603,0.0002729946,0.000053185242,0.000019134013],"category_scores_gemma":[0.00035165876,0.000054867345,0.00010862312,0.0003441832,0.00059153326,0.000035061617,0.00003487905,0.0005467873,0.0000072963603],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008378528,0.005109782,0.3531857,0.00009691024,0.00016345398,0.0076061375,0.0057657235,0.00038265425,0.2588609,0.0022712853,0.00030563667,0.35787326],"study_design_scores_gemma":[0.00963006,0.01995581,0.81235814,0.00018295225,0.0006866764,0.11037538,0.010195531,0.0004082408,0.004661781,0.004720649,0.026395012,0.0004297495],"about_ca_topic_score_codex":0.00007664588,"about_ca_topic_score_gemma":0.000005753818,"teacher_disagreement_score":0.45917243,"about_ca_system_score_codex":0.0000625509,"about_ca_system_score_gemma":0.000055671724,"threshold_uncertainty_score":0.23755491},"labels":[],"label_agreement":null},{"id":"W2022859954","doi":"10.2147/btt.s1834","title":"Sunitinib for advanced renal cell cancer","year":2008,"lang":"en","type":"article","venue":"Biologics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Sunitinib; Medicine; Oncology; Tyrosine-kinase inhibitor; Internal medicine; Cancer; Kidney cancer; Pharmacology","score_opus":0.09144051966007616,"score_gpt":0.31365842360725577,"score_spread":0.2222179039471796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022859954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903958,0.0016818823,0.00014025375,0.00030129112,0.00012601005,0.0004868327,0.00004590062,0.00005724592,0.006764823],"genre_scores_gemma":[0.9880205,0.00070045964,0.005396563,0.00046666,0.00019237303,0.00014506093,0.000121207624,0.000011998818,0.0049451753],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99940294,0.000013680544,0.00012643445,0.00018438794,0.00006956817,0.0002030063],"domain_scores_gemma":[0.99955726,0.000066946675,0.000051126357,0.00015831603,0.00008516949,0.00008118035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004398618,0.00010894802,0.00018621412,0.000027846501,0.00007332934,0.0000017887771,0.000047151843,0.00007868212,0.00008883451],"category_scores_gemma":[0.000036565605,0.00007187821,0.00009353843,0.00006109065,0.00006100651,0.000014790566,0.00001627853,0.00006155318,0.000024358997],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027557006,0.00084939855,0.13008656,0.00023918123,0.00016541965,0.00057990634,0.00044794998,0.00009861587,0.7998873,0.00040664434,0.028120706,0.03636262],"study_design_scores_gemma":[0.0050334013,0.0034142446,0.09570865,0.00004523252,0.00012163673,0.0001527811,0.00009107694,0.00005118363,0.68369406,0.00015865473,0.2112356,0.000293501],"about_ca_topic_score_codex":0.000019437324,"about_ca_topic_score_gemma":0.000004538389,"teacher_disagreement_score":0.18311489,"about_ca_system_score_codex":0.00007755626,"about_ca_system_score_gemma":0.00008593849,"threshold_uncertainty_score":0.29311082},"labels":[],"label_agreement":null},{"id":"W2023159598","doi":"10.1007/s00428-014-1600-z","title":"Foamy cell (hibernoma-like) change is a rare histopathological feature in renal cell carcinoma","year":2014,"lang":"en","type":"article","venue":"Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"European Regional Development Fund; Univerzita Karlova v Praze","keywords":"Pathology; Clear cell; Cytoplasm; Renal cell carcinoma; Grading (engineering); Immunohistochemistry; Carcinoma; Mitochondrion; Cell; Biology; Medicine; Cell biology","score_opus":0.04095318169952945,"score_gpt":0.3157862605229527,"score_spread":0.2748330788234233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023159598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9438706,0.0101295905,0.0003491411,0.0036438464,0.0005812104,0.0020568434,0.00009897849,0.0003575228,0.03891225],"genre_scores_gemma":[0.9775078,0.00083376566,0.008453495,0.0087213805,0.001072144,0.0004081665,0.00061956566,0.00016087544,0.0022227797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9916233,0.0014118359,0.0013491022,0.002516281,0.0010472435,0.0020522343],"domain_scores_gemma":[0.9946894,0.0012092121,0.00066112546,0.0023051414,0.00019550236,0.0009396333],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0016010632,0.0014563131,0.0023845905,0.00077784783,0.0003246025,0.000054505592,0.0010959823,0.0010952861,0.00023392485],"category_scores_gemma":[0.00053414475,0.001048269,0.0008476686,0.0009287436,0.0012957482,0.0002393174,0.0007797655,0.0028333901,0.00044063802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007735139,0.008574527,0.4324667,0.0024698153,0.00046388284,0.025289044,0.013802847,0.000092919654,0.41029462,0.002122997,0.050361842,0.046325658],"study_design_scores_gemma":[0.016957277,0.010366575,0.83866745,0.0005204501,0.0014403226,0.00047533098,0.0012110954,0.0015714337,0.06831348,0.0030684466,0.055176117,0.002232025],"about_ca_topic_score_codex":0.00038929092,"about_ca_topic_score_gemma":0.00005195619,"teacher_disagreement_score":0.40620077,"about_ca_system_score_codex":0.00030438247,"about_ca_system_score_gemma":0.00037752127,"threshold_uncertainty_score":0.9998186},"labels":[],"label_agreement":null},{"id":"W2024227467","doi":"10.5489/cuaj.414","title":"Papillary renal cell carcinoma embedded in an oncocytoma: Case report of a rare combined tumour of the kidney","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Oncocytoma; Pathology; Cytokeratin; Renal oncocytoma; Nephrectomy; Papillary renal cell carcinomas; Renal cell carcinoma; Medicine; CD117; Kidney; Vimentin; Immunohistochemistry; Biology; Internal medicine","score_opus":0.014740171510229183,"score_gpt":0.22447670661711064,"score_spread":0.20973653510688145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024227467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99172926,0.00010652475,0.0000014715691,0.0056962213,0.00013952446,0.00045016178,0.000028926605,0.00000670189,0.0018412127],"genre_scores_gemma":[0.99829924,0.0000037459888,0.00015325152,0.0010141539,0.000111272995,0.00001421733,0.000025717978,0.000013970001,0.00036440097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977346,0.00040312103,0.0007963266,0.00020731176,0.00045251442,0.00040610504],"domain_scores_gemma":[0.99732536,0.00010808489,0.0007771929,0.00027871242,0.00054705824,0.0009635722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006287491,0.0001660874,0.00046425225,0.00020458625,0.00011330609,0.000025243984,0.00015646688,0.00024091378,0.00051191763],"category_scores_gemma":[0.0008121759,0.00010916262,0.00021658312,0.0003237027,0.000057348017,0.0001069283,0.000027723798,0.00055786123,0.000007933479],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072805065,0.00019217048,0.953914,0.000019731686,0.000039795923,0.033550084,0.00034199003,0.000024092884,0.0060039754,0.000011826762,0.005671755,0.00015780312],"study_design_scores_gemma":[0.0021203232,0.0010505958,0.9672109,0.000026197953,0.000102530415,0.024048094,0.00028806462,0.00017050619,0.004477251,0.00020633961,0.00019404272,0.00010517453],"about_ca_topic_score_codex":0.008458763,"about_ca_topic_score_gemma":0.001999329,"teacher_disagreement_score":0.013296909,"about_ca_system_score_codex":0.0012097298,"about_ca_system_score_gemma":0.0015303977,"threshold_uncertainty_score":0.998144},"labels":[],"label_agreement":null},{"id":"W2024489667","doi":"10.1038/labinvest.2011.153","title":"Microvascular density as an independent predictor of clinical outcome in renal cell carcinoma: an automated image analysis study","year":2011,"lang":"en","type":"article","venue":"Laboratory Investigation","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Renal cell carcinoma; Clear cell renal cell carcinoma; Pathology; CD34; Stage (stratigraphy); Univariate analysis; Proportional hazards model; Vascularity; Carcinoma; Clinical significance; Vascular endothelial growth factor; Oncology; Multivariate analysis; Internal medicine; Biology; VEGF receptors; Stem cell","score_opus":0.0601889916748445,"score_gpt":0.336251678588791,"score_spread":0.27606268691394653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024489667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985271,0.00004961892,0.000018315051,0.000012936031,0.000097193995,0.0009747048,0.000024881416,0.00016795131,0.00012729433],"genre_scores_gemma":[0.9962271,0.0000018016837,0.0032620265,0.00012824126,0.000064436324,0.000037105456,0.00022454928,0.000033721564,0.00002100351],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99595356,0.0010679628,0.0013802213,0.0006984953,0.00063865894,0.00026111316],"domain_scores_gemma":[0.99733055,0.00004188595,0.00048760753,0.0010358567,0.00058361545,0.00052050885],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001743568,0.00028427134,0.0009252451,0.0005218957,0.000050573566,0.000018694658,0.00018236754,0.00023832939,0.000087535554],"category_scores_gemma":[0.00018852313,0.0002545903,0.00020584793,0.0013228613,0.00020937301,0.00038341296,0.000055950564,0.00034837803,0.00002560455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023268031,0.0023383775,0.9489564,0.000057604724,0.00032804126,0.00044600083,0.0033232637,0.000012743458,0.04426053,0.000011287062,0.000012357984,0.000020769956],"study_design_scores_gemma":[0.0032214758,0.0021875438,0.85296464,0.000011386058,0.001906657,0.0000044757135,0.00092620193,0.001270027,0.13729985,0.00003776297,0.0000015340587,0.00016842101],"about_ca_topic_score_codex":0.0023346453,"about_ca_topic_score_gemma":0.0009514491,"teacher_disagreement_score":0.09599168,"about_ca_system_score_codex":0.00018185012,"about_ca_system_score_gemma":0.0004974688,"threshold_uncertainty_score":0.99999064},"labels":[],"label_agreement":null},{"id":"W2025071626","doi":"10.1016/j.eururo.2008.03.037","title":"Preservation of Renal Function Following Partial or Radical Nephrectomy Using 24-Hour Creatinine Clearance","year":2008,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Nephrectomy; Renal function; Urology; Creatinine; Renal cell carcinoma; Kidney disease; Kidney; Surgery; Internal medicine","score_opus":0.07664359660321447,"score_gpt":0.2792353980431245,"score_spread":0.20259180143991007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025071626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99082565,0.0002906664,0.0030514777,0.00024019778,0.00027355485,0.00024982152,0.000001437348,0.000071381284,0.004995792],"genre_scores_gemma":[0.9951873,0.00002125788,0.00293871,0.00042159148,0.0004712532,0.0000040914856,0.0000236389,0.00004530895,0.0008868502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984239,0.0003844954,0.0003967054,0.00030000551,0.00024374183,0.00025119656],"domain_scores_gemma":[0.9993043,0.00009290644,0.0001521104,0.00028715978,0.000053154625,0.000110398825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002627694,0.00015392368,0.000330857,0.00010078312,0.00009450396,0.000003898246,0.00007564012,0.00006081967,0.00022166192],"category_scores_gemma":[0.00021791045,0.00012107213,0.00013865942,0.00019495125,0.000120317694,0.00009717026,0.000050847797,0.00019595838,0.000058733058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04731348,0.0015442251,0.5702542,0.00018089586,0.0013556564,0.013361209,0.0021257591,0.004751713,0.34163067,0.00028258012,0.0072382097,0.0099613825],"study_design_scores_gemma":[0.010237603,0.007651558,0.8627211,0.00008234397,0.0008930261,0.0019932638,0.000027919285,0.008460967,0.015380614,0.000016420907,0.09223219,0.00030302998],"about_ca_topic_score_codex":0.000039694536,"about_ca_topic_score_gemma":0.0000031225786,"teacher_disagreement_score":0.32625005,"about_ca_system_score_codex":0.000041221523,"about_ca_system_score_gemma":0.00008708957,"threshold_uncertainty_score":0.49371782},"labels":[],"label_agreement":null},{"id":"W2025140275","doi":"10.4021/wjon232w","title":"Unusual Metastases in Renal Cell Carcinoma: A Single Institution Experience and Review of Literature","year":2010,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Institution; Radiology; General surgery; Oncology","score_opus":0.02530931937444784,"score_gpt":0.31231569876285237,"score_spread":0.2870063793884045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025140275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94554794,0.049148932,0.000008888307,0.00082205987,0.0002378279,0.00017132118,0.0000032660275,0.000002132303,0.0040576416],"genre_scores_gemma":[0.9935552,0.0022278128,0.003577147,0.0003546182,0.00012958795,0.000004550676,0.0000038674716,0.000006362759,0.00014087856],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988362,0.00011164382,0.00058755634,0.00012409104,0.000198415,0.00014207095],"domain_scores_gemma":[0.9989888,0.00009436703,0.000421692,0.00013726036,0.00022497393,0.0001328839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043476792,0.00011719238,0.0005802838,0.00035628365,0.000019223824,0.0000058214428,0.000072470335,0.000066120396,0.00007190451],"category_scores_gemma":[0.00016074754,0.0000825102,0.00010052853,0.00037685505,0.00016699416,0.00011467325,0.000031031464,0.00048638796,9.502553e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018907677,0.003127262,0.08813051,0.0043058875,0.00009138014,0.010418615,0.0035181062,0.0000043447744,0.8223318,0.00072984415,0.002803425,0.06264807],"study_design_scores_gemma":[0.014428409,0.015615078,0.29906094,0.013653204,0.0010898886,0.025779514,0.00041024268,0.000013828313,0.42850015,0.00018307775,0.20084389,0.00042177024],"about_ca_topic_score_codex":0.000016438946,"about_ca_topic_score_gemma":0.00010067945,"teacher_disagreement_score":0.39383164,"about_ca_system_score_codex":0.00014944153,"about_ca_system_score_gemma":0.00033562587,"threshold_uncertainty_score":0.33646685},"labels":[],"label_agreement":null},{"id":"W2026333081","doi":"10.1056/nejmcp0910041","title":"Small Renal Mass","year":2010,"lang":"en","type":"review","venue":"New England Journal of Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":404,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Renal hilum; Kidney; Computed tomographic; Nephrectomy; Renal mass; Creatinine; Physical examination; Renal artery; Abdominal mass; Radiology; Abdominal pain; Ureter; Urology; Surgery; Computed tomography; Internal medicine","score_opus":0.08920882891124954,"score_gpt":0.32885488696764076,"score_spread":0.23964605805639122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026333081","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000118930686,0.9894754,0.00019681985,0.0012926774,0.0016468345,0.00047262953,0.0000041258995,0.000016908592,0.0067756413],"genre_scores_gemma":[0.000030751336,0.9709221,0.0027899721,0.00016677132,0.020821817,0.000004019886,0.000047077676,0.000085777545,0.005131723],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99660444,0.00020042407,0.0016799254,0.00028185555,0.00087105023,0.0003622754],"domain_scores_gemma":[0.9961471,0.00050176575,0.0014875715,0.0005232086,0.0003161072,0.0010242567],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012952739,0.0005922097,0.0040261364,0.00067572604,0.000039640778,0.000013530204,0.00032260086,0.00045905696,0.0006915977],"category_scores_gemma":[0.0005885832,0.0003034159,0.00078769104,0.000299821,0.00014885359,0.00004102704,0.00003175593,0.0024260662,0.000052090545],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020551174,0.00005647959,0.000019371568,0.0031251148,0.0005238823,0.0047793426,0.00008149696,1.6748561e-7,0.00008307761,0.000025207779,0.0055212257,0.98557913],"study_design_scores_gemma":[0.02161095,0.0028917298,0.000018790393,0.031560075,0.007692413,0.033789705,0.00000894735,4.339757e-7,0.000020513455,0.00011635198,0.9020989,0.00019116687],"about_ca_topic_score_codex":0.000034743218,"about_ca_topic_score_gemma":0.000012766192,"teacher_disagreement_score":0.985388,"about_ca_system_score_codex":0.00022086632,"about_ca_system_score_gemma":0.0014569953,"threshold_uncertainty_score":0.99994177},"labels":[],"label_agreement":null},{"id":"W2026710260","doi":"10.5489/cuaj.2209","title":"Metastatic renal cell carcinoma to the testis: A case report and review of the literature","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Renal cell carcinoma; Medicine; Nephrectomy; Metastasis; Lesion; Metastatic lesion; Renal mass; Radiology; Computed tomography; Carcinoma; Kidney; Urology; Pathology; Internal medicine; Cancer","score_opus":0.014983102288227985,"score_gpt":0.23251868742704118,"score_spread":0.2175355851388132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026710260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90120083,0.013392785,0.000022409175,0.082906924,0.00015423626,0.0005268426,0.000029906994,0.000005427839,0.001760627],"genre_scores_gemma":[0.98613226,0.00019163225,0.0002711638,0.012500356,0.00018422089,0.000012163452,0.000005749091,0.0000074541745,0.0006950004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984549,0.00040836586,0.00039205118,0.00015643983,0.00033419702,0.00025401634],"domain_scores_gemma":[0.9982704,0.00026734135,0.00035672484,0.00023988145,0.0003481059,0.00051753724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014239535,0.00011981383,0.00028460266,0.000064066524,0.0002155341,0.000043460906,0.00009900428,0.00007033627,0.0000840168],"category_scores_gemma":[0.003271758,0.000055736647,0.00014148571,0.00030880177,0.000028236864,0.00002951466,0.000023658442,0.00045025276,0.0000065096538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007376614,0.00013836897,0.7575134,0.0009191228,0.0002854169,0.08212803,0.0012351854,0.00003410162,0.00041916867,0.00021006502,0.14894693,0.008096422],"study_design_scores_gemma":[0.000608858,0.0007319304,0.6832498,0.00083437585,0.0006740198,0.24894933,0.00004898806,0.000042625215,0.00015586564,0.0002128168,0.064361,0.0001304477],"about_ca_topic_score_codex":0.0006139201,"about_ca_topic_score_gemma":0.00052639394,"teacher_disagreement_score":0.1668213,"about_ca_system_score_codex":0.00039977694,"about_ca_system_score_gemma":0.00034211346,"threshold_uncertainty_score":0.39168364},"labels":[],"label_agreement":null},{"id":"W2026835557","doi":"10.1016/s0003-4401(02)00117-1","title":"La place de la néphrectomie partielle dans le traitement des cancers du rein","year":2002,"lang":"fr","type":"review","venue":"Annales d Urologie","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Gynecology; Urology; Kidney; Internal medicine","score_opus":0.08654540894529683,"score_gpt":0.3168364431498403,"score_spread":0.23029103420454344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026835557","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04414774,0.9039355,0.00017743235,0.000864694,0.00037176677,0.0011193034,0.000077090415,0.00014430785,0.049162194],"genre_scores_gemma":[0.10660945,0.8831932,0.00061912194,0.00038828177,0.0006490199,0.0005199542,0.00011531478,0.00013455618,0.007771124],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935534,0.0026807736,0.0009422199,0.00097485876,0.000453868,0.001394855],"domain_scores_gemma":[0.99577683,0.002303023,0.00042370267,0.00082111836,0.00009816857,0.0005771826],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0016403837,0.0009966446,0.0018898273,0.00019884293,0.0003207438,0.000079502985,0.0005311346,0.0009491139,0.0011462846],"category_scores_gemma":[0.0005782898,0.00082971365,0.00091917603,0.0004074719,0.0015110099,0.00009879751,0.00018156899,0.0011320974,0.0007841032],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030166795,0.0010577049,0.008044035,0.011432627,0.0019812684,0.00891686,0.0027064956,0.0012616934,0.00008343859,0.0007816212,0.030937612,0.932495],"study_design_scores_gemma":[0.001561789,0.0014613868,0.0039197165,0.004236419,0.0027658003,0.0013865832,0.00045843978,0.00047083097,0.00033073148,0.00013841903,0.98262596,0.0006439212],"about_ca_topic_score_codex":0.0014223793,"about_ca_topic_score_gemma":0.00034678666,"teacher_disagreement_score":0.95168835,"about_ca_system_score_codex":0.003174466,"about_ca_system_score_gemma":0.002180904,"threshold_uncertainty_score":0.9999939},"labels":[],"label_agreement":null},{"id":"W2026889359","doi":"10.2147/cbf.s39103","title":"Predicting efficacy of sunitinib in metastatic renal cell carcinoma","year":2014,"lang":"en","type":"article","venue":"Current Biomarker Findings","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Pfizer","keywords":"Sunitinib; Renal cell carcinoma; Medicine; Oncology; Internal medicine; Cancer research","score_opus":0.05056953875250192,"score_gpt":0.29979913699251226,"score_spread":0.24922959824001034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026889359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99302995,0.0008145487,0.00009213949,0.000084037325,0.00026087678,0.0005827175,0.000016110833,0.00004015819,0.005079437],"genre_scores_gemma":[0.999105,0.000022779132,0.00047391272,0.000020325977,0.00006673741,0.000029634679,0.00011023943,0.000036987505,0.00013438979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787754,0.00014232945,0.00066343043,0.0004313739,0.00043960332,0.0004457221],"domain_scores_gemma":[0.99873567,0.00034940432,0.00020775947,0.00040539957,0.0000926314,0.0002091414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006077224,0.00028423264,0.00055100105,0.00048161115,0.000047983034,0.000015709706,0.00015159449,0.00006572762,0.00010468816],"category_scores_gemma":[0.00025283478,0.0002417873,0.00021402334,0.0005158227,0.0001169474,0.00007682847,0.00008711649,0.00024743078,0.000038478425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005746514,0.0011299719,0.9009152,0.0009305735,0.0000635275,0.00006893363,0.00087835395,0.0000032930823,0.064190276,0.00010010166,0.00058939337,0.030555723],"study_design_scores_gemma":[0.005891179,0.000491454,0.8875559,0.00043717888,0.0002662274,0.000047645914,0.00007935432,0.0008342554,0.102527864,0.00003167443,0.0016323898,0.00020489871],"about_ca_topic_score_codex":0.00008654574,"about_ca_topic_score_gemma":0.0000073395026,"teacher_disagreement_score":0.038337592,"about_ca_system_score_codex":0.00015440432,"about_ca_system_score_gemma":0.00010000407,"threshold_uncertainty_score":0.98598},"labels":[],"label_agreement":null},{"id":"W2027008978","doi":"10.1089/end.2004.18.657","title":"Comparison of Laparoscopic Radical Renal Surgery in Morbidly Obese and Non-obese Patients","year":2004,"lang":"en","type":"article","venue":"Journal of Endourology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Surgery; Nephrectomy; Perioperative; Contraindication; Morbidly obese; Body mass index; Laparoscopy; Laparoscopic surgery; Obesity; Weight loss; Kidney; Internal medicine","score_opus":0.028948702815030643,"score_gpt":0.31120367361506773,"score_spread":0.2822549708000371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027008978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99736625,0.0014885016,0.000023221748,0.0005660542,0.00020872419,0.00013561737,0.000001630829,0.0000028228956,0.00020718265],"genre_scores_gemma":[0.99899215,0.00014370131,0.0005871375,0.00014401667,0.0001040283,0.0000021376136,0.0000036791844,0.000012488015,0.000010655123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841213,0.00008964996,0.0008252318,0.00013316315,0.00030247125,0.00023732347],"domain_scores_gemma":[0.99887097,0.00023140805,0.0004413661,0.00013455583,0.00012916804,0.00019251167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030621883,0.00013432212,0.0009025015,0.00038905788,0.00001633111,0.0000041114376,0.00006753266,0.00012227592,0.00003606728],"category_scores_gemma":[0.00024356344,0.00010138765,0.00013453275,0.00013738411,0.00014822268,0.00006197012,0.000032811153,0.0003896305,0.000003727956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014899046,0.0011586653,0.9890002,0.00006702223,0.000079567435,0.0010955741,0.00030388663,0.00011913141,0.005457594,0.00001335832,0.00034058656,0.0008745223],"study_design_scores_gemma":[0.008317333,0.00289707,0.9726233,0.00019571882,0.00011428522,0.00052385824,0.000034119374,0.000019523555,0.014876502,0.00020516805,0.00012883476,0.00006428653],"about_ca_topic_score_codex":0.000057208363,"about_ca_topic_score_gemma":0.0000388853,"teacher_disagreement_score":0.016376887,"about_ca_system_score_codex":0.00011055433,"about_ca_system_score_gemma":0.0002131044,"threshold_uncertainty_score":0.41344684},"labels":[],"label_agreement":null},{"id":"W2027335142","doi":"10.1038/nrurol.2010.57","title":"Treatment of metastatic renal cell carcinoma","year":2010,"lang":"en","type":"review","venue":"Nature Reviews Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Temsirolimus; Medicine; Sunitinib; Sorafenib; Everolimus; Bevacizumab; Renal cell carcinoma; Oncology; Internal medicine; Targeted therapy; Population; Discovery and development of mTOR inhibitors; Cancer; Chemotherapy; PI3K/AKT/mTOR pathway; Hepatocellular carcinoma","score_opus":0.05622754629677669,"score_gpt":0.3562315944305629,"score_spread":0.3000040481337862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027335142","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007491339,0.9891812,0.000005089724,0.00008587395,0.00055551465,0.0048277755,0.00007872534,0.000030186897,0.005160729],"genre_scores_gemma":[0.00018734919,0.99425256,0.0019868084,0.00012363768,0.0004472781,0.00064438384,0.0006425025,0.00012910519,0.001586385],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955341,0.0007919966,0.0017945266,0.0009623539,0.00034491843,0.0005720663],"domain_scores_gemma":[0.99595445,0.000415276,0.0014461939,0.0017185559,0.00013844481,0.0003270549],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000329908,0.0011352091,0.008487806,0.000511513,0.000043596414,0.0000076190922,0.00031026124,0.0018061887,0.0003787747],"category_scores_gemma":[0.0001417946,0.00064699544,0.0029059793,0.0005016265,0.00017602115,0.00002688224,0.00006443635,0.0019093284,0.0004229828],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000486368,0.0006432503,0.000024188857,0.0270469,0.0002874906,0.00080193137,0.000024839908,2.2871925e-8,0.000024684374,0.00006858906,0.0006887946,0.97034067],"study_design_scores_gemma":[0.0010821415,0.0035574047,0.000021903235,0.0011949517,0.01953378,0.0035804124,7.9410734e-7,5.917587e-7,0.000087790184,0.000011988214,0.9705998,0.00032845908],"about_ca_topic_score_codex":0.000014541586,"about_ca_topic_score_gemma":0.000008625415,"teacher_disagreement_score":0.9700122,"about_ca_system_score_codex":0.00032828626,"about_ca_system_score_gemma":0.00073901925,"threshold_uncertainty_score":0.99959815},"labels":[],"label_agreement":null},{"id":"W2027358625","doi":"10.1097/mou.0b013e3283362624","title":"Laparoscopic partial nephrectomy: advances since 2005","year":2010,"lang":"en","type":"review","venue":"Current Opinion in Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton","funders":"","keywords":"Medicine; Nephrectomy; Perioperative; Gold standard (test); Laparoscopy; Surgery; General surgery; Urology; Kidney; Radiology; Internal medicine","score_opus":0.09133254325586329,"score_gpt":0.40819682040175004,"score_spread":0.3168642771458867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027358625","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000052706062,0.9819616,0.000012764122,0.00015955567,0.015614727,0.0016889741,0.000031543637,0.00006719288,0.0004109409],"genre_scores_gemma":[0.000028210385,0.99609303,0.000109996094,0.000031041585,0.0020916092,0.0008920738,0.00060936925,0.000061755185,0.00008291139],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970931,0.00028381665,0.0008886762,0.00080852816,0.00025611566,0.0006697781],"domain_scores_gemma":[0.99838394,0.0002539739,0.0003915568,0.0006820496,0.000043247845,0.00024522864],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021223006,0.00058473303,0.0022889397,0.0004103189,0.00004405758,0.000015248703,0.0002561761,0.0006107242,0.00023158529],"category_scores_gemma":[0.000112920665,0.00045384205,0.00041041293,0.0002823195,0.00020068341,0.0000685437,0.00012147857,0.0015743817,0.000499943],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057878846,0.0003124639,0.00055475166,0.0125896605,0.000042069278,0.000021067175,0.000015064572,7.90141e-7,5.179908e-7,0.00029030934,0.0012504581,0.98486495],"study_design_scores_gemma":[0.0010853866,0.00035698595,0.00009605728,0.004112966,0.0003711968,0.00021800322,0.0000011116496,0.000007377038,0.0000023551524,0.000042169726,0.99341875,0.00028763476],"about_ca_topic_score_codex":0.0000052081723,"about_ca_topic_score_gemma":0.00000959265,"teacher_disagreement_score":0.9921683,"about_ca_system_score_codex":0.0002178268,"about_ca_system_score_gemma":0.0006717565,"threshold_uncertainty_score":0.9997913},"labels":[],"label_agreement":null},{"id":"W2027519217","doi":"10.4021//jmc.v1i1.18","title":"Mucinous Tubular and Spindle Cell Carcinoma of the Kidney: Four New Cases","year":2010,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Clear cell carcinoma; Asymptomatic; Renal cell carcinoma; Clear cell; Pathology; Kidney; Renal capsule; Carcinoma; Radiology; Internal medicine","score_opus":0.028759069574829172,"score_gpt":0.2704091543262337,"score_spread":0.2416500847514045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027519217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873199,0.0026122506,0.000012391584,0.008736811,0.0006526696,0.00017450412,0.0000069516404,0.000005348906,0.00047920507],"genre_scores_gemma":[0.99693376,0.00013741147,0.00055438187,0.0009372706,0.00094986585,0.0000010917051,0.0000011860361,0.000020747635,0.0004642855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746805,0.000076053664,0.00060454,0.00015284964,0.0014639056,0.00023458381],"domain_scores_gemma":[0.9974563,0.00038980195,0.00039283448,0.00033924752,0.00019493865,0.0012268856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052998064,0.00018317535,0.00052551675,0.00011712337,0.000062752566,0.00001554453,0.00023708549,0.00019451298,0.0007501315],"category_scores_gemma":[0.0028849782,0.00009902978,0.0002707884,0.00014202273,0.00023856452,0.00006212332,0.000104114806,0.0007964863,0.000004745018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015530053,0.0020276539,0.6575383,0.0011063238,0.00036422614,0.1097645,0.0011844586,0.0000022124868,0.085663505,0.00018454687,0.11377331,0.026837979],"study_design_scores_gemma":[0.010401605,0.006722682,0.42753237,0.0008169864,0.0014276096,0.2768584,0.0005781116,0.000064903856,0.24753825,0.00016606167,0.027596278,0.00029673698],"about_ca_topic_score_codex":0.00055239606,"about_ca_topic_score_gemma":0.00005849131,"teacher_disagreement_score":0.2300059,"about_ca_system_score_codex":0.000045579785,"about_ca_system_score_gemma":0.0015281793,"threshold_uncertainty_score":0.8213414},"labels":[],"label_agreement":null},{"id":"W2027533421","doi":"10.1016/j.jvir.2007.12.386","title":"Abstract No. 335: CT Imaging of Ablation Zones after Radiofrequency Ablation (RFA) of Kidney Tumors","year":2008,"lang":"en","type":"article","venue":"Journal of Vascular and Interventional Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Mount Sinai Hospital","funders":"","keywords":"Medicine; Ablation; Hounsfield scale; Ablation zone; Radiofrequency ablation; Radiology; Nuclear medicine; Adipose capsule of kidney; Kidney; Computed tomography; Internal medicine","score_opus":0.015558070615610226,"score_gpt":0.25897683040569225,"score_spread":0.243418759790082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027533421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886783,0.009186134,0.0009832842,0.00021250996,0.00019549557,0.00012410019,0.000009406685,0.0000034232426,0.00060734194],"genre_scores_gemma":[0.9971411,0.0009982635,0.001523086,0.00005627284,0.00018497817,0.0000031269153,0.000025834666,0.000011793865,0.000055502485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843115,0.00009312252,0.00091440266,0.00012987384,0.00030665068,0.00012483142],"domain_scores_gemma":[0.9985766,0.00006558394,0.0006376022,0.00012273477,0.00044380847,0.00015367915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004637236,0.00013049034,0.000525249,0.00031043828,0.000028722712,0.000003051629,0.000058840036,0.000043577336,0.0003611688],"category_scores_gemma":[0.0003038217,0.00010181001,0.0006434668,0.0000850665,0.00017542191,0.0001864901,0.000014717436,0.00016423193,0.000003957266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015580709,0.0010181974,0.9403486,0.0009933637,0.0017646921,0.0012509066,0.00031528686,0.00015603013,0.046291452,0.00042261672,0.0020139597,0.0038668048],"study_design_scores_gemma":[0.002237679,0.001042562,0.9827822,0.0006371148,0.00022584779,0.007546108,0.000023257224,0.00012682556,0.0044664294,0.00030759588,0.0005257494,0.00007863803],"about_ca_topic_score_codex":0.00004880494,"about_ca_topic_score_gemma":5.6817515e-7,"teacher_disagreement_score":0.04243357,"about_ca_system_score_codex":0.00008424317,"about_ca_system_score_gemma":0.00016036887,"threshold_uncertainty_score":0.41516918},"labels":[],"label_agreement":null},{"id":"W2027807531","doi":"10.1007/s12032-009-9388-4","title":"Experience with sorafenib and the elderly patient","year":2009,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Centre for Applied Research in Cancer Control","keywords":"Sorafenib; Medicine; Renal cell carcinoma; Regimen; Adverse effect; Internal medicine; Population; Hematology; Oncology; Quality of life (healthcare); Intensive care medicine; Hepatocellular carcinoma; Nursing","score_opus":0.014705071514812845,"score_gpt":0.2911583709533907,"score_spread":0.2764532994385779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027807531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94924206,0.00074916694,0.00013049487,0.03538517,0.000062215695,0.0003292484,2.545834e-7,0.000024671523,0.014076738],"genre_scores_gemma":[0.9925605,0.000088956476,0.00045697548,0.006574186,0.00008263807,0.00003893623,0.000002480605,0.0000048606257,0.00019047257],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989402,0.00009681983,0.00018245488,0.00018533402,0.00040100448,0.0001941708],"domain_scores_gemma":[0.99925834,0.0002097185,0.000047451307,0.00018433126,0.000035281413,0.00026486037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001843531,0.0000971697,0.0003055894,0.00002310331,0.00005980408,0.0000049738173,0.00006310594,0.000101709935,0.00025905983],"category_scores_gemma":[0.00017702309,0.000042388103,0.000032626293,0.000075695556,0.0006097287,0.000017486977,0.00002208425,0.00020839309,0.000016613089],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031193532,0.0005390389,0.0030101107,0.000009428441,0.00005257957,0.00315166,0.0053607156,4.6455818e-7,0.00019323415,0.0021468245,0.0015438516,0.98087275],"study_design_scores_gemma":[0.08533328,0.1646535,0.2818452,0.00042765652,0.0008549847,0.02219319,0.005655773,0.00090871804,0.0072275195,0.0029752788,0.4271564,0.00076849054],"about_ca_topic_score_codex":0.000035368434,"about_ca_topic_score_gemma":0.000017418439,"teacher_disagreement_score":0.98010427,"about_ca_system_score_codex":0.00007520737,"about_ca_system_score_gemma":0.0001966088,"threshold_uncertainty_score":0.28365234},"labels":[],"label_agreement":null},{"id":"W2028266898","doi":"10.1007/s00345-011-0759-z","title":"Does partial nephrectomy at an academic institution result in better outcomes?","year":2011,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"American Hospital Association; Agency for Healthcare Research and Quality; American Heart Association","keywords":"Medicine; Nephrectomy; Academic institution; Logistic regression; Comorbidity; Charlson comorbidity index; Nephrology; Family medicine; Internal medicine; Kidney","score_opus":0.04533090579034142,"score_gpt":0.2964730784042787,"score_spread":0.2511421726139373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028266898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928979,0.00034474922,0.000023396844,0.00389113,0.00062759884,0.00016908546,0.0000011837113,0.000010447098,0.0020344767],"genre_scores_gemma":[0.99594694,0.00008077078,0.00074254256,0.0024017792,0.00032785354,0.00000754115,0.0000029210255,0.000012859221,0.000476788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985579,0.00016336971,0.0006345714,0.00016523211,0.00020705743,0.0002718608],"domain_scores_gemma":[0.99918336,0.000057362748,0.0003058791,0.00019822914,0.000067270674,0.00018789699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040359626,0.00014309585,0.000425889,0.0004625736,0.000032862332,0.0000030507974,0.0001234873,0.00012698528,0.00034396225],"category_scores_gemma":[0.00006884131,0.00007816042,0.00011877535,0.00015594704,0.00011729678,0.0001595971,0.000041594583,0.00065344584,0.000041814095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029528341,0.00019306954,0.9862549,0.0000075344287,0.00007701678,0.0016900796,0.00052926876,0.000010028466,0.0036178476,0.00017690027,0.00031594513,0.004174618],"study_design_scores_gemma":[0.0038809455,0.0010887885,0.9570941,0.000021159642,0.00017545241,0.0007857581,0.00001565449,0.000016593614,0.004157305,0.0004909402,0.0321843,0.000089032816],"about_ca_topic_score_codex":0.000048021975,"about_ca_topic_score_gemma":0.00036683388,"teacher_disagreement_score":0.031868353,"about_ca_system_score_codex":0.00019815132,"about_ca_system_score_gemma":0.00008105991,"threshold_uncertainty_score":0.37661457},"labels":[],"label_agreement":null},{"id":"W2028525468","doi":"10.1016/j.eururo.2007.11.037","title":"Toxicities Associated with the Administration of Sorafenib, Sunitinib, and Temsirolimus and Their Management in Patients with Metastatic Renal Cell Carcinoma","year":2007,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":240,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Sorafenib; Sunitinib; Temsirolimus; Medicine; Renal cell carcinoma; Oncology; Side effect (computer science); Internal medicine; Pharmacology; Dosing; Hepatocellular carcinoma; Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway","score_opus":0.03891092092891279,"score_gpt":0.25909736985387083,"score_spread":0.22018644892495803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028525468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50520766,0.48466724,0.000010686916,0.000036140304,0.000018680492,0.0015923963,0.000047030953,0.000015876652,0.008404314],"genre_scores_gemma":[0.85386074,0.14519419,0.000071167844,0.00010978688,0.00002341296,0.000026673883,0.00031086867,0.00008252364,0.00032061918],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978228,0.0007794419,0.0004971102,0.00040208604,0.00020542245,0.0002930978],"domain_scores_gemma":[0.9986958,0.00034092445,0.00047342817,0.00033164662,0.000071553215,0.00008665732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005025783,0.0004228744,0.0010764446,0.00027839662,0.00004933191,0.000015255647,0.00010542665,0.00006596239,0.000008737891],"category_scores_gemma":[0.000016997414,0.00021140103,0.00006874591,0.00022011489,0.00030977905,0.000027296159,0.00008030848,0.0003265822,0.000002618021],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008861819,0.0035698456,0.02009339,0.025838511,0.0049902205,0.010453703,0.0040405933,0.000008285382,0.0000070609876,0.00030729306,0.00034148243,0.9214878],"study_design_scores_gemma":[0.020016432,0.038221702,0.7340764,0.0046296273,0.013306881,0.000917322,0.0010461739,0.000010441038,0.00005902573,0.00001703948,0.18641195,0.0012870071],"about_ca_topic_score_codex":0.000007324032,"about_ca_topic_score_gemma":0.000039004135,"teacher_disagreement_score":0.92020077,"about_ca_system_score_codex":0.000059683698,"about_ca_system_score_gemma":0.00007376834,"threshold_uncertainty_score":0.86206836},"labels":[],"label_agreement":null},{"id":"W2028690273","doi":"10.1002/cncr.25931","title":"A phase 1 study of everolimus and sorafenib for metastatic clear cell renal cell carcinoma","year":2011,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Sorafenib; Everolimus; Renal cell carcinoma; Common Terminology Criteria for Adverse Events; Sunitinib; Adverse effect; Rash; Internal medicine; Response Evaluation Criteria in Solid Tumors; Toxicity; Urology; Pharmacology; Oncology; Gastroenterology; Phases of clinical research; Hepatocellular carcinoma","score_opus":0.08551078911157818,"score_gpt":0.32090491421332806,"score_spread":0.2353941251017499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028690273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943079,0.0024747164,0.00004934969,0.000018489693,0.00007374994,0.0014097232,0.00004006281,0.000014399702,0.001611657],"genre_scores_gemma":[0.99749684,0.000032805852,0.0010603048,0.000065760534,0.000054193977,0.00025313208,0.000006739163,0.00003381991,0.0009964126],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903035,0.000035696426,0.00025887782,0.00028930965,0.00016807968,0.00021770223],"domain_scores_gemma":[0.9992822,0.00004150123,0.00012533028,0.00028301287,0.00011115834,0.00015684533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000096507196,0.00016651992,0.0003843867,0.00008314941,0.000038199894,0.0000043502464,0.00005887162,0.00003193031,0.0002011866],"category_scores_gemma":[0.000007652446,0.0001305,0.00008091865,0.00008890233,0.000050770595,0.000041152496,0.000028694241,0.00007502553,0.000005483102],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05423244,0.06493623,0.18954045,0.007261539,0.0019872664,0.002030443,0.103302136,0.000035354886,0.52095693,0.000082243656,0.011421072,0.044213932],"study_design_scores_gemma":[0.080802195,0.04469795,0.067500785,0.000083131614,0.0039635818,0.000041121697,0.0051791114,0.00041869472,0.79532206,0.00010100236,0.0014649786,0.00042540705],"about_ca_topic_score_codex":0.000499351,"about_ca_topic_score_gemma":0.000040427927,"teacher_disagreement_score":0.27436513,"about_ca_system_score_codex":0.00007749617,"about_ca_system_score_gemma":0.00010808416,"threshold_uncertainty_score":0.5321636},"labels":[],"label_agreement":null},{"id":"W2029003257","doi":"10.1016/j.canep.2009.10.004","title":"Total fluid and specific beverage intake and risk of renal cell carcinoma in Canada","year":2009,"lang":"en","type":"article","venue":"Cancer Epidemiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Partnership Against Cancer; Alberta Health Services; Public Health Agency of Canada","funders":"","keywords":"Medicine; Quartile; Renal cell carcinoma; Odds ratio; Confidence interval; Alcohol intake; Population; Fluid intake; Risk factor; Kidney cancer; Internal medicine; Environmental health; Alcohol","score_opus":0.030600450163948363,"score_gpt":0.2687335143905644,"score_spread":0.23813306422661606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029003257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9647565,0.03323401,0.00001491805,0.0010208667,0.000115333976,0.00022773512,0.00003458413,0.0000046429554,0.00059143495],"genre_scores_gemma":[0.99568063,0.0032901345,0.00034841022,0.00044155418,0.000102369995,0.000012646507,0.000013408683,0.000009069178,0.000101748956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859864,0.00020669874,0.00045431047,0.0003543161,0.000072938754,0.0003130727],"domain_scores_gemma":[0.9990147,0.0003920287,0.00015387475,0.0002223789,0.000032341366,0.00018472967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031288038,0.00016649553,0.00069562945,0.000076838485,0.000023256076,0.0000010369178,0.00003993124,0.00008452888,0.00007146771],"category_scores_gemma":[0.00008904608,0.00013553929,0.000039712744,0.00007934875,0.000097059914,0.000022562794,0.000025811521,0.0002163478,8.854994e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002697906,0.000026535208,0.9836388,0.000049789043,0.000022272407,0.00015606961,0.00011508249,0.0001166503,0.0042583086,0.00005422198,0.0023261367,0.008966295],"study_design_scores_gemma":[0.001478402,0.00046946673,0.9899784,0.0000366579,0.000055076463,0.00008781153,0.000061785206,0.00026377733,0.0064480463,0.0002099981,0.0008086776,0.00010194788],"about_ca_topic_score_codex":0.6059759,"about_ca_topic_score_gemma":0.26703647,"teacher_disagreement_score":0.3389395,"about_ca_system_score_codex":0.00051137444,"about_ca_system_score_gemma":0.0004193633,"threshold_uncertainty_score":0.7463382},"labels":[],"label_agreement":null},{"id":"W2029246938","doi":"10.1007/s00270-013-0743-7","title":"Thermal Versus Impedance-Based Ablation of Renal Cell Carcinoma: A Meta-analysis","year":2013,"lang":"en","type":"review","venue":"CardioVascular and Interventional Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University","funders":"","keywords":"Medicine; Radiofrequency ablation; Percutaneous; Confidence interval; Renal cell carcinoma; Meta-analysis; Relative risk; Renal function; Radiology; Ablation; Complication; Surgery; Urology; Internal medicine","score_opus":0.1277627161499409,"score_gpt":0.3270859031954021,"score_spread":0.1993231870454612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029246938","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017806842,0.994472,0.0012088518,0.000009269452,0.00015965178,0.0009917109,0.00011091852,0.00001651164,0.0012503854],"genre_scores_gemma":[0.09789254,0.89772373,0.00074086804,0.0000147185,0.00026988817,0.0006732923,0.0019586845,0.0000726826,0.00065356895],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9966267,0.000846524,0.0010463931,0.0007307766,0.00045564031,0.00029397442],"domain_scores_gemma":[0.997931,0.00029145685,0.00048316558,0.00087326166,0.0002560369,0.00016510142],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.000689796,0.0005489235,0.0065402775,0.0006317141,0.000047918824,0.000014126288,0.00016133291,0.00042407724,0.00086763874],"category_scores_gemma":[0.000049333255,0.0003729303,0.029992852,0.0004112225,0.00021597826,0.000050808572,0.00007040734,0.0003311795,0.000032009644],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002093837,0.00025857246,0.00005327775,0.012461219,0.89282167,0.00016682492,0.00001621541,0.00046381867,0.000011030298,0.00012972936,0.00022837604,0.09317986],"study_design_scores_gemma":[0.0020799811,0.0010297745,0.00062539673,0.0001859927,0.89398843,0.00015864526,0.0000053366903,0.00011312828,0.0000646083,0.000005922606,0.10145096,0.00029184986],"about_ca_topic_score_codex":0.000074604795,"about_ca_topic_score_gemma":0.0000013431498,"teacher_disagreement_score":0.101222575,"about_ca_system_score_codex":0.00021285893,"about_ca_system_score_gemma":0.00023773656,"threshold_uncertainty_score":0.99987227},"labels":[],"label_agreement":null},{"id":"W2029690180","doi":"10.1016/j.urolonc.2005.05.020","title":"Renal radiofrequency ablation: Technique and results","year":2005,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Percutaneous; Radiofrequency ablation; Medicine; Ablation; Radiology; Surgery; Internal medicine","score_opus":0.03225267443313697,"score_gpt":0.302567953491929,"score_spread":0.27031527905879205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029690180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9266941,0.0041960385,0.0002796503,0.036618493,0.00006189202,0.0007699288,0.000021180243,0.0001269045,0.031231817],"genre_scores_gemma":[0.58160996,0.001533516,0.41075832,0.0027322278,0.00038276595,0.00021691032,0.00011085341,0.000018002038,0.0026374455],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987802,0.00009159685,0.00038005982,0.0003849086,0.00012506913,0.00023819247],"domain_scores_gemma":[0.999105,0.00019198131,0.00014130671,0.00020793681,0.000058015146,0.00029578691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039870487,0.00018152004,0.00029165143,0.00014755875,0.00020603657,0.000016889104,0.00005020492,0.00024059204,0.000055291322],"category_scores_gemma":[0.00017068873,0.00014488919,0.000039104783,0.00018248295,0.0006144126,0.00011410515,0.00003339653,0.00029811295,0.000020607706],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021598148,0.0013889081,0.6224515,0.00019403236,0.0004515158,0.0027403,0.0031573845,0.00030227314,0.07232331,0.07474832,0.061511826,0.15857084],"study_design_scores_gemma":[0.0013592038,0.002615734,0.0074991686,0.000042362968,0.00021558053,0.0034276198,0.000038710674,0.00036086448,0.005471557,0.004328302,0.9744887,0.00015223774],"about_ca_topic_score_codex":0.000032762935,"about_ca_topic_score_gemma":0.000014205372,"teacher_disagreement_score":0.91297686,"about_ca_system_score_codex":0.00017082962,"about_ca_system_score_gemma":0.0002229403,"threshold_uncertainty_score":0.59084094},"labels":[],"label_agreement":null},{"id":"W2030524144","doi":"10.1097/spc.0b013e32832e4681","title":"Management of sorafenib, sunitinib, and temsirolimus toxicity in metastatic renal cell carcinoma","year":2009,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Sunitinib; Medicine; Sorafenib; Temsirolimus; Mucositis; Hypophosphatemia; Pazopanib; Renal cell carcinoma; Internal medicine; Toxicity; Neutropenia; Side effect (computer science); Oncology; Hepatocellular carcinoma; Pharmacology; Gastroenterology; PI3K/AKT/mTOR pathway; Discovery and development of mTOR inhibitors","score_opus":0.16071553977600705,"score_gpt":0.4071184294412977,"score_spread":0.24640288966529067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030524144","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02725508,0.9688958,0.000011226336,0.000012105573,0.000281133,0.0025399302,0.00034753905,0.000010316274,0.0006468771],"genre_scores_gemma":[0.05646311,0.9416593,0.00016928438,0.000006729813,0.00006999317,0.00022442629,0.0013210333,0.000037714242,0.00004846679],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968088,0.00034071624,0.0012372175,0.0007951602,0.00038775406,0.00043034184],"domain_scores_gemma":[0.99844587,0.00017877345,0.0006482065,0.00033033921,0.00017538329,0.00022142609],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022742606,0.00067759684,0.0023600215,0.000614408,0.000036913338,0.000017272689,0.00011653098,0.0001691586,0.00003743341],"category_scores_gemma":[0.000020430976,0.0005454228,0.00030885296,0.00051083876,0.0001606077,0.00006712512,0.00013488632,0.00057220826,0.0000045639695],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016414502,0.00068092835,0.023424858,0.169734,0.00019995873,0.0003918464,0.002565748,7.162686e-7,0.0000014449614,0.00022818595,0.000115066585,0.8024931],"study_design_scores_gemma":[0.011920547,0.0042957743,0.25395438,0.17722592,0.0040600495,0.00007975443,0.008060578,0.000014944514,0.00022782145,0.00022509405,0.53791106,0.0020240787],"about_ca_topic_score_codex":0.000023218334,"about_ca_topic_score_gemma":0.0000073183005,"teacher_disagreement_score":0.80046904,"about_ca_system_score_codex":0.00037504395,"about_ca_system_score_gemma":0.00025319948,"threshold_uncertainty_score":0.9996997},"labels":[],"label_agreement":null},{"id":"W2030779837","doi":"10.1038/nrurol.2014.216","title":"Routine small renal mass needle biopsy should be adopted","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Renal mass; Biopsy; Renal cell carcinoma; Renal biopsy; Radiology; Kidney; Urology; General surgery; Surgery; Nephrectomy; Pathology; Internal medicine","score_opus":0.10147979333566329,"score_gpt":0.36386488589102856,"score_spread":0.26238509255536524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030779837","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004505145,0.9837512,0.00013359745,0.001260967,0.00092497305,0.0042821206,0.000052507603,0.00015677867,0.009433354],"genre_scores_gemma":[0.000018116765,0.9855794,0.0033587883,0.004204353,0.0017201238,0.00055257016,0.0017991659,0.00022600463,0.0025415353],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99341804,0.0014370393,0.002155439,0.0015049614,0.00047977827,0.0010047515],"domain_scores_gemma":[0.99524945,0.0004697117,0.0014026802,0.0021324502,0.00020698315,0.000538743],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0014714121,0.0015383163,0.009023599,0.0006216137,0.000090530666,0.00002805165,0.0006611277,0.00432851,0.00061324134],"category_scores_gemma":[0.00086946075,0.00096522865,0.0026731577,0.00095572625,0.00017953465,0.000032258693,0.00019425395,0.005154453,0.0010256759],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008651562,0.00016532374,0.000030116193,0.03592396,0.00068959844,0.00083850056,0.000012853562,1.9364217e-7,0.0000089515715,0.0003316291,0.014193996,0.9477184],"study_design_scores_gemma":[0.00083348196,0.0008130093,0.00001640215,0.0071075615,0.01035642,0.0050751804,7.595899e-7,0.0000042003367,0.0000033827764,0.000018774279,0.97515035,0.00062050583],"about_ca_topic_score_codex":0.000013636018,"about_ca_topic_score_gemma":0.000008215114,"teacher_disagreement_score":0.96095634,"about_ca_system_score_codex":0.00039937423,"about_ca_system_score_gemma":0.00044028412,"threshold_uncertainty_score":0.99975216},"labels":[],"label_agreement":null},{"id":"W2031087535","doi":"10.1016/j.juro.2009.07.004","title":"Guideline for Management of the Clinical T1 Renal Mass","year":2009,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1841,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Guideline; Renal mass; Intensive care medicine; Medical physics; Internal medicine; Kidney; Pathology; Nephrectomy","score_opus":0.05742976895901188,"score_gpt":0.3650603437856339,"score_spread":0.30763057482662204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031087535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8919216,0.002445168,0.008337732,0.09185776,0.0006132591,0.00067980477,0.0000032912444,0.0000062321133,0.004135169],"genre_scores_gemma":[0.9892513,0.0003333562,0.0059232786,0.0036153088,0.00035708208,0.0000010836607,8.1540065e-7,0.000007293203,0.00051045214],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9985043,0.00018181127,0.0008810322,0.00006744881,0.0002173892,0.0001480606],"domain_scores_gemma":[0.99869716,0.0002010968,0.0005382314,0.00031177298,0.00019240844,0.00005935548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001764765,0.0000837961,0.0003280572,0.000040492516,0.00003445064,0.0000016779994,0.0002451168,0.00006040177,0.000037740047],"category_scores_gemma":[0.00007525021,0.000036033052,0.0002949836,0.00006928994,0.00010043334,0.000014595335,0.000028799015,0.00022370544,0.0000030992994],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07073067,0.0045656604,0.032113075,0.00028850537,0.007937362,0.0016981461,0.0009649612,0.0045664078,0.07854851,0.011986418,0.46027002,0.32633024],"study_design_scores_gemma":[0.026279628,0.042365316,0.585688,0.00021660607,0.010327993,0.006331136,0.00034380186,0.0011938415,0.015795356,0.03413854,0.2770431,0.0002766669],"about_ca_topic_score_codex":0.000001241815,"about_ca_topic_score_gemma":6.328351e-7,"teacher_disagreement_score":0.5535749,"about_ca_system_score_codex":0.000028552731,"about_ca_system_score_gemma":0.000056647048,"threshold_uncertainty_score":0.14693852},"labels":[],"label_agreement":null},{"id":"W2031152150","doi":"10.1016/j.urology.2009.12.031","title":"Clinical Outcome in Metastatic Renal Cell Carcinoma Patients After Failure of Initial Vascular Endothelial Growth Factor-Targeted Therapy","year":2010,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta; BC Cancer Agency","funders":"","keywords":"Medicine; Sorafenib; Temsirolimus; Sunitinib; Everolimus; Bevacizumab; Internal medicine; Targeted therapy; Oncology; Axitinib; Vascular endothelial growth factor; Renal cell carcinoma; Cancer; Second-line therapy; Chemotherapy; PI3K/AKT/mTOR pathway; Discovery and development of mTOR inhibitors; VEGF receptors; Hepatocellular carcinoma","score_opus":0.027889895584937246,"score_gpt":0.3073046206455494,"score_spread":0.27941472506061216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031152150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99819607,0.00016106458,0.000028966384,0.0001619547,0.00044375288,0.00064995774,0.000065468026,0.00001982,0.00027295537],"genre_scores_gemma":[0.9983729,0.000012328873,0.00067525444,0.000578588,0.00016224419,0.000058159298,0.00006914564,0.00004045366,0.000030922536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976388,0.00033018197,0.0008733523,0.0004382566,0.0003223015,0.00039709307],"domain_scores_gemma":[0.99869066,0.00030404306,0.00019907682,0.00046407912,0.00015863164,0.00018349302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025374684,0.00027217602,0.00078257243,0.00024476086,0.000018577084,0.0000049082028,0.00014960358,0.0002630758,0.00078173366],"category_scores_gemma":[0.00020706675,0.0002041772,0.00035295726,0.00013394903,0.00020573132,0.0000523671,0.000057002813,0.0006977472,0.000054004973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016656689,0.0010152083,0.9871146,0.000035532634,0.00009636024,0.00033227433,0.0002589625,0.0000010166046,0.008729532,0.000014117662,0.00002727591,0.00070941343],"study_design_scores_gemma":[0.011072459,0.003119717,0.96761507,0.000002530493,0.0001420222,0.000014659317,0.000009993972,0.00002330618,0.017124914,0.00007778279,0.0006516343,0.00014588448],"about_ca_topic_score_codex":0.00015194966,"about_ca_topic_score_gemma":0.000115710674,"teacher_disagreement_score":0.01949954,"about_ca_system_score_codex":0.00003005926,"about_ca_system_score_gemma":0.00012004769,"threshold_uncertainty_score":0.85594356},"labels":[],"label_agreement":null},{"id":"W2032021171","doi":"10.1053/j.semdp.2015.02.009","title":"Issues and challenges associated with classifying neoplasms in percutaneous needle biopsies of incidentally found small renal masses","year":2015,"lang":"en","type":"article","venue":"Seminars in Diagnostic Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Trillium Health Centre; University Health Network","funders":"","keywords":"Medicine; Radiology; Percutaneous; Pathology; Renal mass; Kidney; Nephrectomy; Internal medicine","score_opus":0.06133143289859967,"score_gpt":0.27855581714718985,"score_spread":0.2172243842485902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032021171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9656522,0.031956628,0.0000029437842,0.00071170257,0.00007837605,0.000400174,0.000009077667,0.000028712044,0.0011601314],"genre_scores_gemma":[0.9894559,0.007800289,0.0024329263,0.000059937487,0.000027482523,0.00004852319,0.000030800802,0.00003103888,0.000113098344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983387,0.00021264522,0.00043084053,0.00040176077,0.00024068588,0.00037534206],"domain_scores_gemma":[0.99710506,0.0022400683,0.00016830662,0.0002481398,0.00009791738,0.00014053239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005211573,0.0002511756,0.0006715048,0.00035182305,0.000020599526,0.000009723443,0.00009579182,0.00022451216,0.000007872324],"category_scores_gemma":[0.004256073,0.0002084635,0.00003455708,0.00022788646,0.00034539556,0.00005574974,0.00010516441,0.00024410628,0.0000041122867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041343243,0.0005322154,0.9451528,0.00014538215,0.000055542645,0.0380271,0.008155237,0.00009811612,0.0037299835,0.000057173693,0.000037794416,0.003595198],"study_design_scores_gemma":[0.0040519075,0.0057435795,0.95283526,0.0029077062,0.00021541634,0.015342814,0.012892885,0.00014839561,0.004541538,0.0008182349,0.00013713953,0.00036514917],"about_ca_topic_score_codex":0.0003961992,"about_ca_topic_score_gemma":0.0033848046,"teacher_disagreement_score":0.024156338,"about_ca_system_score_codex":0.00028877606,"about_ca_system_score_gemma":0.00015376172,"threshold_uncertainty_score":0.85008955},"labels":[],"label_agreement":null},{"id":"W2032051122","doi":"10.1186/1471-2407-9-34","title":"Metastatic renal cell cancer treatments: An indirect comparison meta-analysis","year":2009,"lang":"en","type":"review","venue":"BMC Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; St. Joseph’s Healthcare Hamilton; Simon Fraser University","funders":"Pfizer","keywords":"Sorafenib; Medicine; Bevacizumab; Sunitinib; Temsirolimus; Internal medicine; Oncology; Meta-analysis; Progression-free survival; Placebo; Renal cell carcinoma; Overall survival; Pathology; Hepatocellular carcinoma; Chemotherapy; Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway","score_opus":0.35759145300525197,"score_gpt":0.45667306492104864,"score_spread":0.09908161191579667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032051122","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013912017,0.99461883,0.000054554224,0.000033168308,0.00013685961,0.002460211,0.00079215,0.00010453774,0.0016605502],"genre_scores_gemma":[0.00017749326,0.97563636,0.0028636768,0.00015414075,0.00031432073,0.0034401899,0.0014736969,0.00014692164,0.015793188],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9946111,0.0007283227,0.0015095518,0.0014527797,0.0009873619,0.00071088376],"domain_scores_gemma":[0.99627304,0.0002095608,0.0012366732,0.0015322213,0.00017306913,0.00057542836],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00032589995,0.0013474129,0.012415338,0.0009681789,0.00011697222,0.00007948972,0.0003428373,0.0003033943,0.0060698004],"category_scores_gemma":[0.000014543536,0.00083550496,0.0076023084,0.0018121985,0.00007443515,0.00011776452,0.000051766576,0.000526414,0.0001445512],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010152374,0.0013316105,0.00030472607,0.007736735,0.48716775,0.00023561608,0.00014624688,0.00036756153,0.0000025803329,0.0000027428298,0.00215299,0.5004499],"study_design_scores_gemma":[0.00057344534,0.0003543724,0.00015226565,0.00044232758,0.6224548,0.000017693003,0.000009534174,0.000030454446,0.00006419806,0.000002386296,0.37546852,0.00042997807],"about_ca_topic_score_codex":0.0032814695,"about_ca_topic_score_gemma":0.0040296125,"teacher_disagreement_score":0.50001997,"about_ca_system_score_codex":0.0022352757,"about_ca_system_score_gemma":0.0017586924,"threshold_uncertainty_score":0.9999277},"labels":[],"label_agreement":null},{"id":"W2033496873","doi":"10.3747/co.v16i0.405","title":"First-Line Therapy with Sunitinib in Advanced Renal Cell Carcinoma: Interpretation of the Overall Survival Data from asco 2008","year":2009,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"American Society of Clinical Oncology","keywords":"Sunitinib; Medicine; Renal cell carcinoma; Interpretation (philosophy); Oncology; Internal medicine; Cancer research","score_opus":0.10655134607788129,"score_gpt":0.36540635907603114,"score_spread":0.25885501299814984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033496873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917644,0.0040175486,0.00022761323,0.0010095381,0.0004347117,0.00070278643,0.000095701034,0.00001591084,0.0017317879],"genre_scores_gemma":[0.9981205,0.00042836583,0.0004407886,0.00012840943,0.00013643483,0.000018635848,0.0006509487,0.000015796611,0.000060114184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846774,0.00019803047,0.00040450637,0.00040851257,0.00027565306,0.00024557277],"domain_scores_gemma":[0.9984923,0.00023121663,0.00024554445,0.00084042124,0.00011073414,0.00007978399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017589441,0.00020867176,0.0004923417,0.00009013073,0.000034864606,0.000005293114,0.00033371735,0.00008914498,0.000094204435],"category_scores_gemma":[0.000050199604,0.00012892728,0.00006895989,0.00019031495,0.00010137652,0.000097335316,0.000087300825,0.0003321538,0.000007339841],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022139437,0.01031788,0.6585659,0.00018425731,0.00017223894,0.0003529369,0.0043289503,0.0011777413,0.017163465,0.000112479065,0.0028363834,0.28264838],"study_design_scores_gemma":[0.013853977,0.0047520166,0.9610853,0.00022151232,0.00012558667,0.000022723889,0.0001240321,0.0027109114,0.009002128,0.00019432436,0.00773198,0.00017547654],"about_ca_topic_score_codex":0.00015745703,"about_ca_topic_score_gemma":0.00062377274,"teacher_disagreement_score":0.30251947,"about_ca_system_score_codex":0.00024407984,"about_ca_system_score_gemma":0.0002896085,"threshold_uncertainty_score":0.5257502},"labels":[],"label_agreement":null},{"id":"W2034058863","doi":"10.1186/1471-2407-11-105","title":"Safety and treatment patterns of multikinase inhibitors in patients with metastatic renal cell carcinoma at a tertiary oncology center in Italy","year":2011,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"GlaxoSmithKline","keywords":"Sunitinib; Medicine; Sorafenib; Renal cell carcinoma; Mucositis; Internal medicine; Discontinuation; Adverse effect; Oncology; Retrospective cohort study; Surgery; Radiation therapy; Hepatocellular carcinoma","score_opus":0.02689998125627282,"score_gpt":0.252759402937624,"score_spread":0.22585942168135117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034058863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99790007,0.0003890525,0.0000046047157,0.000022725531,0.00004842802,0.0009709995,0.00009307649,0.000005939742,0.00056509534],"genre_scores_gemma":[0.9989239,0.000052673295,0.0005058736,0.00005045603,0.000016231425,0.00014300109,0.000054566182,0.000025420177,0.00022786658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874324,0.00009042231,0.00039324738,0.0003346574,0.00017398573,0.00026442186],"domain_scores_gemma":[0.9994226,0.000043714183,0.00014358583,0.00022124377,0.000041966974,0.00012685546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060603346,0.00022101904,0.0004675228,0.00019163989,0.00001527841,0.0000019054648,0.000036481077,0.000053801974,0.0001464339],"category_scores_gemma":[0.000004289928,0.00014897081,0.000060665105,0.00009798863,0.0000580031,0.000052156356,0.000048480688,0.00007615454,0.0000031226364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056407177,0.0018374746,0.98543584,0.00013671939,0.00004525491,0.00026836336,0.0027010366,0.00000742348,0.00029619352,6.225635e-7,0.000010230208,0.0036201288],"study_design_scores_gemma":[0.020735247,0.0027554433,0.9579315,0.00017552052,0.00014833656,0.0000104077,0.00014418965,0.000024429832,0.017849911,8.202532e-7,0.00010074878,0.00012340838],"about_ca_topic_score_codex":0.009003569,"about_ca_topic_score_gemma":0.023230093,"teacher_disagreement_score":0.027504299,"about_ca_system_score_codex":0.0014351186,"about_ca_system_score_gemma":0.00016196698,"threshold_uncertainty_score":0.99759555},"labels":[],"label_agreement":null},{"id":"W2034141668","doi":"10.1159/000020188","title":"Impact of Noninvasive Imaging on Increased Incidental Detection of Renal Cell Carcinoma","year":2000,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northeast Cancer Centre","funders":"Health Canada","keywords":"Medicine; Renal cell carcinoma; Radiology; Ultrasound; Stage (stratigraphy); Presentation (obstetrics); Carcinoma; Proportional hazards model; Nuclear medicine; Pathology; Surgery","score_opus":0.009684491040837039,"score_gpt":0.2335699977020117,"score_spread":0.22388550666117465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034141668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93446845,0.00019252182,0.000014625362,0.000022137323,0.000035035046,0.00019836238,0.0000118879325,0.000022426631,0.06503454],"genre_scores_gemma":[0.9994813,0.000009614095,0.000038677725,0.00011553499,0.00009602059,0.0000021615815,0.000026045982,0.000039763385,0.00019088683],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986675,0.0003360759,0.00033556705,0.00026392628,0.00017423027,0.00022270215],"domain_scores_gemma":[0.99921334,0.00008910234,0.00016134854,0.00034452477,0.00006941191,0.00012225968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017028759,0.00017550735,0.00031477975,0.00018957055,0.000029071685,0.0000027967826,0.00008934966,0.000033195236,0.0005711151],"category_scores_gemma":[0.00003566664,0.00014278905,0.0002252941,0.0001291038,0.00012251461,0.000031371175,0.000030607964,0.00017274347,0.00019021393],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033538716,0.00050867157,0.20158523,0.000033507582,0.00008669137,0.0019356372,0.00037679606,0.00016975806,0.7785482,0.0000022206539,0.00012135931,0.013278081],"study_design_scores_gemma":[0.0021111579,0.004600543,0.7586407,0.000009734893,0.00012943996,0.00054890424,0.000012226149,0.000091732705,0.2337207,0.0000031818104,0.00006031778,0.000071327355],"about_ca_topic_score_codex":0.00049349066,"about_ca_topic_score_gemma":0.0000061257474,"teacher_disagreement_score":0.55705553,"about_ca_system_score_codex":0.00011591783,"about_ca_system_score_gemma":0.0000678965,"threshold_uncertainty_score":0.625331},"labels":[],"label_agreement":null},{"id":"W2034579655","doi":"10.1002/cncr.26369","title":"Small renal masses progressing to metastases under active surveillance","year":2011,"lang":"en","type":"review","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":405,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Metastasis; Renal mass; Internal medicine; Radiology; Cancer; Kidney; Nephrectomy","score_opus":0.2275931807736509,"score_gpt":0.3961249699976015,"score_spread":0.1685317892239506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034579655","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019158742,0.99401665,0.00004159052,0.000053859698,0.00033635553,0.0016311933,0.00022557852,0.00007253259,0.0034306692],"genre_scores_gemma":[0.00009170097,0.99372655,0.0016154491,0.00014834318,0.0005079125,0.0010946421,0.00021726401,0.000119082564,0.0024790836],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980765,0.0001606664,0.00042297694,0.0006695202,0.00022783349,0.0004424945],"domain_scores_gemma":[0.99852943,0.00011528942,0.00030221074,0.00057192426,0.00015941884,0.0003217206],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013186895,0.00055728946,0.0019324606,0.00019529728,0.000058817117,0.00003410187,0.00016738214,0.00019021539,0.0005512288],"category_scores_gemma":[0.000040192906,0.0003727849,0.00043324,0.00033664453,0.00007453416,0.000039678507,0.00009282594,0.00032244402,0.0001797299],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075470234,0.00007282819,0.000073298135,0.0063786386,0.00088157767,0.00016695204,0.000043282806,7.541103e-7,0.0000032007065,0.00003371707,0.0011704725,0.99109983],"study_design_scores_gemma":[0.00028156527,0.00020486867,0.00031544853,0.013630855,0.002084031,0.00012321345,0.000013289439,1.4518021e-7,0.00015167453,0.000008195307,0.98283786,0.00034887088],"about_ca_topic_score_codex":0.00018813292,"about_ca_topic_score_gemma":0.00015571617,"teacher_disagreement_score":0.9907509,"about_ca_system_score_codex":0.00096032664,"about_ca_system_score_gemma":0.0010435153,"threshold_uncertainty_score":0.9998724},"labels":[],"label_agreement":null},{"id":"W2034585097","doi":"10.1016/j.juro.2008.03.124","title":"Who Will Fail Local Therapy for Renal Cell Carcinoma","year":2008,"lang":"en","type":"letter","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Nephrectomy; Nomogram; Renal cell carcinoma; Kidney cancer; Clear cell renal cell carcinoma; Urology; Natural history; Internal medicine; Surgery; Oncology; Kidney","score_opus":0.024887163161459183,"score_gpt":0.24541921987823315,"score_spread":0.22053205671677395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034585097","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24150379,0.0225904,0.0030394946,0.7294371,0.0008622931,0.0010287433,0.00002858659,0.000016963442,0.0014925984],"genre_scores_gemma":[0.5117513,0.0028149753,0.00024563313,0.47119573,0.008934713,0.000017236258,0.00004820044,0.00013393721,0.004858269],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99739254,0.00041514906,0.0008053452,0.00024342758,0.00056243053,0.0005811171],"domain_scores_gemma":[0.9972532,0.0006824122,0.0009206271,0.0005788467,0.00042828926,0.00013664002],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00049335294,0.000452297,0.0011754397,0.00029135813,0.00011792908,0.000009219555,0.00047980252,0.0008122577,0.00014504536],"category_scores_gemma":[0.000031695192,0.00024764426,0.0006987522,0.000099337914,0.0004231016,0.000055880224,0.00004577185,0.002558871,0.00002462447],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004121884,0.00009223044,0.00031727384,0.000071425544,0.00038470756,0.004821827,0.00048162809,0.000044942604,0.00096316135,0.0000018367957,0.9867594,0.0019396294],"study_design_scores_gemma":[0.0061231423,0.013685726,0.0022521676,0.000028691138,0.0011088041,0.023015546,0.000028274759,0.000053443164,0.003873742,0.00017824827,0.94942784,0.00022435733],"about_ca_topic_score_codex":0.000030254047,"about_ca_topic_score_gemma":0.0000020015013,"teacher_disagreement_score":0.27024752,"about_ca_system_score_codex":0.00023239148,"about_ca_system_score_gemma":0.0005214135,"threshold_uncertainty_score":0.99999756},"labels":[],"label_agreement":null},{"id":"W2034711615","doi":"10.1002/cncr.22871","title":"Active surveillance for selected patients with renal masses","year":2007,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Asymptomatic; Comorbidity; Medical record; Surgery; Kidney disease; Renal function; Internal medicine","score_opus":0.01447488582927784,"score_gpt":0.276453383847873,"score_spread":0.26197849801859513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034711615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966204,0.00024168035,0.00058030174,0.00010764252,0.0000775458,0.0006289371,0.000042808133,0.00003401804,0.0016666303],"genre_scores_gemma":[0.9974698,0.000011713846,0.0011371208,0.00013379722,0.00014450471,0.00008844431,0.000087363376,0.000021932683,0.00090534514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932486,0.000007081458,0.00009579657,0.00018537663,0.00016119335,0.00022571703],"domain_scores_gemma":[0.9992926,0.00006780769,0.000054874658,0.0001234807,0.00036906538,0.00009214417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048141243,0.000102998485,0.00016287307,0.000039318,0.000035119505,0.0000045354273,0.000027816946,0.00003694963,0.00007755275],"category_scores_gemma":[0.000029801171,0.00006972282,0.00003071196,0.00017536758,0.000027953602,0.000030552786,0.000005764498,0.000056647033,0.000004412642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037773107,0.00011958775,0.9761415,0.00004788591,0.00016713023,0.000016092807,0.00009784956,0.00000540856,0.0022271138,0.000008859234,0.0019063898,0.01548488],"study_design_scores_gemma":[0.0029886374,0.00061779364,0.9354907,0.00004153969,0.000050154984,0.000002468096,0.000013576444,0.0000052694695,0.048414685,0.0000050530657,0.0122848535,0.00008522112],"about_ca_topic_score_codex":0.00004695059,"about_ca_topic_score_gemma":0.00022150911,"teacher_disagreement_score":0.04618757,"about_ca_system_score_codex":0.000306353,"about_ca_system_score_gemma":0.00013164114,"threshold_uncertainty_score":0.2843214},"labels":[],"label_agreement":null},{"id":"W2035166360","doi":"10.1245/s10434-013-3028-0","title":"Active Surveillance, Radiofrequency Ablation, or Cryoablation for the Nonsurgical Management of a Small Renal Mass: A Cost-Utility Analysis","year":2013,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Programs for Assessment of Technology in Health Research Institute; St. Joseph’s Healthcare Hamilton; Western University; McMaster University","funders":"","keywords":"Medicine; Cryoablation; Surgical oncology; Renal mass; Radiofrequency ablation; Ablation; Radiology; Cryosurgery; Surgery; General surgery; Internal medicine; Kidney; Nephrectomy","score_opus":0.10780406717542686,"score_gpt":0.36637273735219555,"score_spread":0.2585686701767687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035166360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92479897,0.0016719099,0.010709193,0.020908657,0.00015718727,0.0066902004,0.00016732697,0.000056752066,0.034839824],"genre_scores_gemma":[0.99304163,0.0026673223,0.0027517744,0.00011160513,0.0000648751,0.0004890416,0.000122060825,0.000013154218,0.00073852],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99788386,0.0002712269,0.00081238564,0.00036402812,0.00032882718,0.00033965835],"domain_scores_gemma":[0.9960304,0.0020703583,0.00044914105,0.0004433244,0.00084512203,0.00016165501],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00091481063,0.00019745584,0.00095252617,0.00020016525,0.00006849315,0.000007769483,0.00015109834,0.00018524425,0.0012100002],"category_scores_gemma":[0.000056444525,0.00011404006,0.00055917626,0.0008128796,0.00028000702,0.00006840005,0.00004221009,0.00014015619,0.000011170157],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03417256,0.0045946375,0.09746786,0.00087444746,0.025525229,0.00078807975,0.00065941166,0.0022855767,0.0011417414,0.0056119966,0.0066755526,0.8202029],"study_design_scores_gemma":[0.007073256,0.0035930749,0.81710964,0.00007264126,0.0025639625,0.00007772764,0.00031280445,0.011018437,0.0035697068,0.0012542376,0.15308799,0.00026654216],"about_ca_topic_score_codex":0.00026225563,"about_ca_topic_score_gemma":0.000050484978,"teacher_disagreement_score":0.81993634,"about_ca_system_score_codex":0.000096812066,"about_ca_system_score_gemma":0.00014270902,"threshold_uncertainty_score":0.99970305},"labels":[],"label_agreement":null},{"id":"W2035220174","doi":"10.5489/cuaj.2876","title":"Partial versus radical nephrectomy for renal tumours ≤7 cm: The debate continues","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Nephrectomy; Urology; Medicine; Kidney; Internal medicine","score_opus":0.04376843198912543,"score_gpt":0.2645352036564719,"score_spread":0.22076677166734643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035220174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9078032,0.00059630076,0.0001872068,0.08555404,0.0011345939,0.000542644,0.000032502852,0.000037158297,0.0041124],"genre_scores_gemma":[0.99370074,0.000017085613,0.0005098563,0.0030010608,0.0017778372,0.000039877687,0.000034261644,0.000016449347,0.0009028039],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99811107,0.0002432899,0.00034040122,0.00019276049,0.00048282082,0.00062965107],"domain_scores_gemma":[0.9974437,0.00043817246,0.0002324649,0.00012718597,0.00037616902,0.0013823421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001204948,0.00016185484,0.00030235676,0.00009095488,0.00029831554,0.00011778093,0.00015169427,0.0002091449,0.00015800462],"category_scores_gemma":[0.0022725016,0.000099046185,0.0002332557,0.00014068939,0.000073773226,0.00007043653,0.00001353691,0.0005196029,0.00006435363],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042094146,0.00015450592,0.5172087,0.0000054087586,0.0007133061,0.0008951644,0.00058198423,0.00013229666,0.00020537409,0.0011735361,0.46789703,0.0068232603],"study_design_scores_gemma":[0.00926735,0.0021028805,0.14900169,0.000010656703,0.00044127414,0.0005950872,0.00016009908,0.0004463486,0.0002884537,0.0009437568,0.8365554,0.00018696483],"about_ca_topic_score_codex":0.0005797676,"about_ca_topic_score_gemma":0.00071023544,"teacher_disagreement_score":0.3686584,"about_ca_system_score_codex":0.0017909613,"about_ca_system_score_gemma":0.0011333504,"threshold_uncertainty_score":0.46833014},"labels":[],"label_agreement":null},{"id":"W2035240798","doi":"10.1002/cncr.26429","title":"Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma","year":2011,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Sunitinib; Everolimus; Medicine; Renal cell carcinoma; Tyrosine-kinase inhibitor; Internal medicine; Urology; Oncology; Pharmacology; Gastroenterology; Cancer","score_opus":0.06176865617352181,"score_gpt":0.29208911188215153,"score_spread":0.23032045570862972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035240798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99366874,0.00029875062,0.000009628821,0.00001187,0.000112449205,0.0010127518,0.000043190877,0.000009742041,0.0048328945],"genre_scores_gemma":[0.99896646,0.000009149589,0.00037725925,0.000059591242,0.000050038907,0.00013007116,0.000038491977,0.000025740997,0.00034320736],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989147,0.000050743154,0.00029982306,0.00021586531,0.00029115228,0.00022767614],"domain_scores_gemma":[0.9992935,0.000027106244,0.00014632722,0.0002802587,0.00012603843,0.00012678781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007721812,0.00016031148,0.000406401,0.00013165687,0.000014495928,0.0000023871169,0.000065580774,0.000035607216,0.0005334605],"category_scores_gemma":[0.000011788141,0.000113571434,0.00006820898,0.00018163961,0.000068439156,0.000052106545,0.000017706037,0.000112036345,0.000009064267],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63878167,0.012970874,0.3251626,0.00066363765,0.0003806468,0.00083446235,0.006680931,0.000029597957,0.002088818,0.000039979615,0.0007665276,0.011600266],"study_design_scores_gemma":[0.58137053,0.017708974,0.32544106,0.00014920178,0.0006788462,0.000004629493,0.00014519623,0.00003023207,0.07404181,0.000018399307,0.00018717833,0.00022396728],"about_ca_topic_score_codex":0.0007603574,"about_ca_topic_score_gemma":0.000071949195,"teacher_disagreement_score":0.071953,"about_ca_system_score_codex":0.00025362748,"about_ca_system_score_gemma":0.00032113,"threshold_uncertainty_score":0.58410186},"labels":[],"label_agreement":null},{"id":"W2035762106","doi":"10.1111/j.1464-410x.2008.07917.x","title":"Nephrectomy improves the survival of patients with locally advanced renal cell carcinoma","year":2008,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Association Française d'Urologie; Fondation de France","keywords":"Nephrectomy; Medicine; Renal cell carcinoma; Internal medicine; Oncology; Urology; General surgery; Kidney","score_opus":0.008724637439666375,"score_gpt":0.20321636873275525,"score_spread":0.1944917312930889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035762106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528587,0.002957293,0.00013495825,0.0002140706,0.00016544684,0.00026559143,0.000010264808,0.0000056052327,0.0009609301],"genre_scores_gemma":[0.99846584,0.0001854862,0.00081983395,0.00022218867,0.00012674525,0.0000038676767,0.000008984729,0.000024997307,0.00014203957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984697,0.00013989584,0.0005206437,0.00015814717,0.00044443677,0.00026718795],"domain_scores_gemma":[0.9984702,0.00013086243,0.0004895848,0.00018989091,0.0005710337,0.00014845881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018009884,0.00014622963,0.0005024,0.00008531254,0.00007933698,0.000006253925,0.00017122261,0.00007939747,0.00004892202],"category_scores_gemma":[0.00006172563,0.00010121515,0.00016136428,0.00013507107,0.00030116556,0.00008234522,0.000036257745,0.0003851321,0.0000029260254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012053923,0.0018040098,0.9182009,0.000097230506,0.00039800254,0.011539588,0.00041154996,0.00022232416,0.0094194235,0.000011745585,0.0017434814,0.04409782],"study_design_scores_gemma":[0.008477263,0.0074039316,0.97033525,0.00003154849,0.00020996254,0.008559818,0.0000359877,0.000008534995,0.0033342987,0.000016737413,0.0014974406,0.00008924453],"about_ca_topic_score_codex":0.000068957925,"about_ca_topic_score_gemma":0.00003188101,"teacher_disagreement_score":0.05213433,"about_ca_system_score_codex":0.00004930434,"about_ca_system_score_gemma":0.00028621967,"threshold_uncertainty_score":0.4127434},"labels":[],"label_agreement":null},{"id":"W2036674153","doi":"10.5489/cuaj.1775","title":"Ex-vivo nephron-sparing surgery and autotransplantation for renal tumours: Revisited","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Autotransplantation; Medicine; Nephrectomy; Surgery; Laparoscopy; Ex vivo; Urology; Renal cell carcinoma; Kidney; Nephron; In vivo; Transplantation; Internal medicine","score_opus":0.019368833795254285,"score_gpt":0.22573488653387708,"score_spread":0.2063660527386228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036674153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98576134,0.00032907352,0.0013628295,0.010854128,0.00015838875,0.00028179504,0.000027609098,0.000030339037,0.0011945115],"genre_scores_gemma":[0.9959797,0.00011052714,0.00069817563,0.0023036224,0.00052143174,0.000011401894,0.00006358446,0.0000139375625,0.00029757735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986625,0.00014972332,0.00033668443,0.00019608381,0.00023844863,0.00041659083],"domain_scores_gemma":[0.99825585,0.0005805483,0.00022820654,0.000075960816,0.00019695832,0.000662461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010450688,0.00013500924,0.0003272809,0.0002035802,0.0002319559,0.0000908483,0.000042908316,0.00017522406,0.00012696105],"category_scores_gemma":[0.0007394732,0.00011035986,0.00014233371,0.00011087569,0.0000208476,0.000091357266,0.0000042621136,0.0002673258,0.000011474754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016745292,0.000025485726,0.9808441,0.000032523578,0.00011575005,0.00007931069,0.00009480252,0.000031330383,0.0009596848,0.000315143,0.011683336,0.0056511215],"study_design_scores_gemma":[0.0011298544,0.00033839679,0.9659432,0.000057014244,0.00022539412,0.0005230631,0.0000143056495,0.00092004676,0.00027955664,0.0005851019,0.029845117,0.00013894432],"about_ca_topic_score_codex":0.0003501555,"about_ca_topic_score_gemma":0.0002901364,"teacher_disagreement_score":0.018161781,"about_ca_system_score_codex":0.0007133144,"about_ca_system_score_gemma":0.00024401447,"threshold_uncertainty_score":0.45003447},"labels":[],"label_agreement":null},{"id":"W2037096531","doi":"10.1007/s11523-012-0252-7","title":"The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients","year":2013,"lang":"en","type":"article","venue":"Targeted Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; BC Cancer Agency; Princess Margaret Cancer Centre; University of Toronto; London Health Sciences Centre; University of Alberta; Queen Elizabeth II Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Renal cell carcinoma; Oncology; Targeted therapy; VEGF receptors; Internal medicine; Second-line therapy; Cancer; Chemotherapy","score_opus":0.07733604392423403,"score_gpt":0.3777414729966405,"score_spread":0.30040542907240647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037096531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98669416,0.0007377807,0.00009575522,0.0051325294,0.0011189322,0.0055363756,0.00009421642,0.000096347954,0.00049393176],"genre_scores_gemma":[0.9853859,0.0001914958,0.006204708,0.0050386093,0.00037979448,0.0007024171,0.0003185972,0.00014282313,0.0016356355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9898507,0.0018472738,0.004654021,0.0012119934,0.0011109897,0.0013249998],"domain_scores_gemma":[0.9909801,0.0038506042,0.0017207409,0.0012423572,0.001293641,0.00091259176],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003631328,0.00080264604,0.0030027498,0.00048081102,0.00019053495,0.00004135615,0.00063222024,0.00067702436,0.0010734583],"category_scores_gemma":[0.0017778099,0.0005048224,0.00070091477,0.001065492,0.0002154967,0.0001648682,0.00017824545,0.0013356074,0.00040388602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073235813,0.004158712,0.9573284,0.000053343414,0.000604303,0.000112345246,0.0009024803,0.00008788848,0.0012213181,0.0000075682174,0.0030270596,0.025173001],"study_design_scores_gemma":[0.026070582,0.033232477,0.9230247,0.000033464847,0.00022227202,0.0000083304185,0.00016824514,0.00026146253,0.003604141,0.00009105735,0.012799418,0.00048383023],"about_ca_topic_score_codex":0.0008826692,"about_ca_topic_score_gemma":0.0018046224,"teacher_disagreement_score":0.03430368,"about_ca_system_score_codex":0.0011148299,"about_ca_system_score_gemma":0.00070444547,"threshold_uncertainty_score":0.9998397},"labels":[],"label_agreement":null},{"id":"W2037806061","doi":"10.5489/cuaj.2969","title":"Canadian guidelines for the management of the small renal mass (SRM)","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Alberta; University of Manitoba; University of Toronto; Western University; McMaster University; Queen's University; McGill University; University of Ottawa; McGill University Health Centre; Université de Montréal; Université Laval; University Health Network; Dalhousie University; Kingston General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Renal mass; Medicine; Internal medicine; Nephrectomy; Kidney","score_opus":0.0903927729883645,"score_gpt":0.27771591852607536,"score_spread":0.18732314553771084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037806061","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43414536,0.00226873,0.0006391982,0.5460513,0.0015991785,0.0017965721,0.0001453714,0.000020083578,0.01333419],"genre_scores_gemma":[0.9834446,0.00006261131,0.0022997793,0.008818433,0.0005395701,0.00003323585,0.00001166368,0.000014725428,0.004775415],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99853307,0.00009802972,0.00039078525,0.00013553876,0.00037999416,0.00046258807],"domain_scores_gemma":[0.9974999,0.000108559005,0.00025038893,0.00020406436,0.0009800298,0.00095708563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012631288,0.00012447356,0.00020004936,0.00009513731,0.00027679562,0.000045993394,0.00026205005,0.00013794517,0.000092333285],"category_scores_gemma":[0.00059835886,0.00006286344,0.00021554153,0.00019288229,0.00003134288,0.000024865838,0.000015751077,0.00027513417,0.000013644071],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002261492,0.000059654358,0.6335758,0.000031819545,0.0018156646,0.00034209745,0.0003888134,0.0017363909,0.00011188232,0.0023804603,0.34304398,0.01628729],"study_design_scores_gemma":[0.0019415978,0.0003610364,0.48112047,0.000040280145,0.00060601725,0.0002009163,0.0003726173,0.0006150635,0.000111141555,0.0025046389,0.5119956,0.00013058913],"about_ca_topic_score_codex":0.06429633,"about_ca_topic_score_gemma":0.14854835,"teacher_disagreement_score":0.5492992,"about_ca_system_score_codex":0.002929872,"about_ca_system_score_gemma":0.0015202328,"threshold_uncertainty_score":0.9419346},"labels":[],"label_agreement":null},{"id":"W2037859645","doi":"10.1089/end.2000.14.407","title":"Metastatic Renal Cell Cancer after Laparoscopic Radical Nephrectomy: Long-Term Follow-Up","year":2000,"lang":"en","type":"article","venue":"Journal of Endourology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Surgery; Stage (stratigraphy); Metastasis; Asymptomatic; Kidney cancer; Cancer; Kidney; Internal medicine","score_opus":0.020994673430711562,"score_gpt":0.28860768503073997,"score_spread":0.2676130116000284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037859645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882385,0.007984537,0.000040133375,0.0015667457,0.0005615375,0.00021874088,0.0000065251443,0.000014210418,0.0013690297],"genre_scores_gemma":[0.9918808,0.00074634206,0.0010194627,0.0016463613,0.0006097098,0.000025788097,0.0000047361277,0.000036577916,0.004030272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980584,0.00019307603,0.0006651313,0.00022811523,0.00040469883,0.0004505852],"domain_scores_gemma":[0.99883515,0.00013416806,0.0002745492,0.00025453596,0.00011538446,0.0003862276],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022781536,0.00024796414,0.0008095227,0.00022034856,0.000040187897,0.000017058446,0.00015047306,0.00011541601,0.010722315],"category_scores_gemma":[0.000030476542,0.00017577823,0.00037394345,0.00014584317,0.00013529288,0.00009770082,0.00002220235,0.00056306424,0.0001304566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033056084,0.0020833765,0.79281795,0.0003753577,0.0026138485,0.056031246,0.0010804344,0.00020901923,0.050096482,0.000018337969,0.0142116705,0.047406208],"study_design_scores_gemma":[0.047087517,0.011945005,0.78925216,0.0003412805,0.005267231,0.019051582,0.000024246123,0.000051669016,0.074748464,0.00022408378,0.051451527,0.0005552049],"about_ca_topic_score_codex":0.00002843235,"about_ca_topic_score_gemma":0.00004688836,"teacher_disagreement_score":0.046851,"about_ca_system_score_codex":0.00017344386,"about_ca_system_score_gemma":0.00035067837,"threshold_uncertainty_score":0.99018204},"labels":[],"label_agreement":null},{"id":"W2038349091","doi":"10.1016/j.ejca.2011.09.002","title":"Phase 2 trial of linifanib (ABT-869) in patients with advanced renal cell cancer after sunitinib failure","year":2011,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute","keywords":"Sunitinib; Medicine; Internal medicine; Cancer research; Oncology; Cancer; Urology","score_opus":0.02376342824592086,"score_gpt":0.2733685222410839,"score_spread":0.249605093995163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038349091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99278283,0.0014378958,0.00001538284,0.00009905177,0.00029961302,0.00047977577,0.000036791524,0.000006425735,0.004842225],"genre_scores_gemma":[0.99737585,0.00021780016,0.0014376242,0.00012483113,0.00037414752,0.0000149817815,0.0000058206747,0.00006392613,0.00038504187],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99795914,0.00022543895,0.0008025636,0.0001949645,0.0005555794,0.00026233634],"domain_scores_gemma":[0.99819267,0.000024982664,0.00075853936,0.00024772523,0.00054596894,0.00023014516],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033510025,0.0002321933,0.0005362901,0.00022256956,0.000018223885,0.000007702946,0.00014979311,0.00003145287,0.0009303806],"category_scores_gemma":[0.0000263651,0.00015532042,0.00016287625,0.00020676632,0.00008436363,0.0001602621,0.000028671335,0.00036805216,0.000008527017],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7411074,0.007764436,0.12885062,0.00024441103,0.00060165767,0.0039570555,0.005057563,0.000114722156,0.0049107736,0.0000037142338,0.0011866207,0.10620101],"study_design_scores_gemma":[0.44949484,0.037083015,0.45841384,0.0017148029,0.0007327851,0.000027484637,0.00017616608,0.0000026847179,0.04063709,0.0000044289445,0.011355965,0.00035688523],"about_ca_topic_score_codex":0.000043276894,"about_ca_topic_score_gemma":0.000062786916,"teacher_disagreement_score":0.3295632,"about_ca_system_score_codex":0.00016104594,"about_ca_system_score_gemma":0.00028961187,"threshold_uncertainty_score":0.9999829},"labels":[],"label_agreement":null},{"id":"W2038387455","doi":"10.5539/gjhs.v6n7p38","title":"Comparison of DMSA scan 99 m and EC scan 99 m in diagnosis of cortical defect and differential renal function","year":2014,"lang":"en","type":"article","venue":"Global Journal of Health Science","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Predictive value; Renal function; Gold standard (test); Nuclear medicine; Differential diagnosis; Radiology; Pathology; Internal medicine","score_opus":0.033716531069193,"score_gpt":0.34931795963914275,"score_spread":0.31560142856994977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038387455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99664325,0.0020645293,0.00040901377,0.0004099278,0.00016720338,0.00016188982,0.0000036516087,0.000002539415,0.00013800974],"genre_scores_gemma":[0.9991716,0.00022006105,0.0004947802,0.00006212707,0.000045367302,0.000001325474,6.758279e-7,0.000002980812,0.0000010740135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792194,0.00011516917,0.0007842832,0.00019092382,0.0007030684,0.0002846122],"domain_scores_gemma":[0.9986728,0.000092550836,0.0005493768,0.00012468142,0.00018557442,0.00037505393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011329727,0.00010942873,0.0006045522,0.00017993822,0.00008668176,0.000015439691,0.00009739306,0.00003945703,0.000011079087],"category_scores_gemma":[0.00017888204,0.00007902553,0.000066031054,0.00038481673,0.00055721466,0.00010430377,0.00005330164,0.00017156875,3.6969482e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040422895,0.00023730789,0.9662158,0.000121859004,0.000013279996,0.000005468196,0.00007392371,0.000017276758,0.002231308,0.00016062336,0.00008406664,0.03043487],"study_design_scores_gemma":[0.0016075136,0.004101655,0.9895996,0.00040783116,0.0000751837,0.00028170564,0.00010024719,0.0006542556,0.0029787486,0.00012182447,0.000021756117,0.000049717346],"about_ca_topic_score_codex":0.00038783925,"about_ca_topic_score_gemma":0.00011852237,"teacher_disagreement_score":0.030385152,"about_ca_system_score_codex":0.0002868309,"about_ca_system_score_gemma":0.00046224764,"threshold_uncertainty_score":0.32225677},"labels":[],"label_agreement":null},{"id":"W2038640546","doi":"10.5489/cuaj.11256","title":"Laparoscopic partial nephrectomy: The McMaster University experience","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McMaster University; Kingston General Hospital; Queen's University","funders":"","keywords":"Nephrectomy; Medicine; Blood loss; Surgery; Laparoscopy; Renal function; Pathological; Retrospective cohort study; Grading (engineering); Kidney; Internal medicine","score_opus":0.02340966897573748,"score_gpt":0.22856960661091627,"score_spread":0.20515993763517879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038640546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820329,0.0002262976,0.000017598873,0.010703133,0.00032036187,0.00014716735,0.0000045581087,0.000013598873,0.006534367],"genre_scores_gemma":[0.99342966,0.00002056528,0.00006946107,0.0030867597,0.0005935433,0.0000029928435,0.0000029405965,0.000005022835,0.0027890394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886924,0.00017692527,0.00013098733,0.00009341393,0.00024244624,0.0004869938],"domain_scores_gemma":[0.9988802,0.0000904658,0.00010834532,0.00008509232,0.000082191385,0.0007537129],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003321556,0.000089729976,0.00014642793,0.00005651939,0.0003229207,0.000037509297,0.00009715347,0.00011732439,0.0019525113],"category_scores_gemma":[0.00018219996,0.0000564472,0.00009736486,0.00014260337,0.000040182185,0.00012359238,0.000014211264,0.0003610229,0.00014847971],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037965463,0.000028285716,0.99389344,7.099822e-7,0.00004379963,0.000049631362,0.00048118902,0.0000031074412,0.00009413652,0.00015699583,0.004139552,0.0010711557],"study_design_scores_gemma":[0.00048136467,0.00008713254,0.64964736,0.0000023047214,0.000052605028,0.0001444154,0.000207071,0.000013509901,0.00013184198,0.000015940985,0.34916973,0.00004670402],"about_ca_topic_score_codex":0.0005979368,"about_ca_topic_score_gemma":0.0001591529,"teacher_disagreement_score":0.3450302,"about_ca_system_score_codex":0.0013471649,"about_ca_system_score_gemma":0.00020876537,"threshold_uncertainty_score":0.99895984},"labels":[],"label_agreement":null},{"id":"W2038663112","doi":"10.1016/j.juro.2014.02.1793","title":"MP57-18 SHORT-TERM OUTCOME OF METASTASECTOMY IN RENAL CELL CARCINOMA: THE CANADIAN KIDNEY CANCER INFORMATION SYSTEM INITIAL EXPERIENCE.","year":2014,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metastasectomy; Medicine; Renal cell carcinoma; Cancer; Kidney cancer; Metastasis; General surgery; Oncology; Internal medicine","score_opus":0.037959023834439436,"score_gpt":0.29465620683287563,"score_spread":0.2566971829984362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038663112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939093,0.00035085675,0.000073014795,0.0018402855,0.00035308572,0.00026265203,0.000016337703,0.0000034032028,0.0031910557],"genre_scores_gemma":[0.9986333,0.0000126476225,0.000033145814,0.0010917161,0.00018517797,0.000012208905,0.0000055095743,0.000009666287,0.000016618424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814045,0.0003770924,0.00080072676,0.000068285124,0.0003302644,0.00028316307],"domain_scores_gemma":[0.9987065,0.00013718654,0.00041075883,0.00028727629,0.00020425252,0.00025398537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010669611,0.00014525058,0.00043997937,0.00030371296,0.00008429335,0.000010885884,0.00027227416,0.00009050765,0.00011385349],"category_scores_gemma":[0.00009505654,0.000073892115,0.00011558072,0.00016708215,0.00016108899,0.00012561212,0.000032558164,0.0004017235,0.000007042466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025352938,0.000114248505,0.96938556,0.00031716388,0.00023533225,0.00041404922,0.015953863,0.0010347723,0.00546555,0.00031902845,0.0021781032,0.0020470542],"study_design_scores_gemma":[0.0054517584,0.0026937881,0.9572239,0.00008892769,0.0011055398,0.003633957,0.0021028295,0.0010358295,0.020225255,0.000028332073,0.006199916,0.00020995288],"about_ca_topic_score_codex":0.025407584,"about_ca_topic_score_gemma":0.0153172035,"teacher_disagreement_score":0.014759705,"about_ca_system_score_codex":0.00037685165,"about_ca_system_score_gemma":0.00059069955,"threshold_uncertainty_score":0.9810823},"labels":[],"label_agreement":null},{"id":"W2038781838","doi":"10.1038/sj.bjc.6605298","title":"Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Centre Hospitalier Universitaire de Rennes; Institut National Du Cancer; Ligue Contre le Cancer","keywords":"Clear cell renal cell carcinoma; Cancer research; Vascular endothelial growth factor; Angiogenesis; Multiplex ligation-dependent probe amplification; Biology; Renal cell carcinoma; DNA methylation; Pathology; Medicine; Gene expression; Gene; VEGF receptors; Genetics","score_opus":0.012262583784001049,"score_gpt":0.24258670978154637,"score_spread":0.23032412599754531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038781838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977164,0.022334736,0.00006248332,0.00014778058,0.00006341834,0.00014324278,0.00003689409,0.0000030933966,0.00004440787],"genre_scores_gemma":[0.99745524,0.0020228927,0.00028568011,0.000035794463,0.00011045501,0.0000025540407,0.000007494972,0.000012965993,0.00006692601],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987768,0.00008098924,0.00041720358,0.00014890006,0.00043848262,0.00013760854],"domain_scores_gemma":[0.9982751,0.000047722362,0.000923774,0.00007477373,0.0005473137,0.00013134404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018105922,0.0001227325,0.0005047156,0.00007859042,0.000042006715,0.000019539282,0.00004984845,0.0000621478,0.000017996797],"category_scores_gemma":[0.00004685972,0.00010366817,0.00005367714,0.000100529076,0.00007223646,0.00012634395,0.000014092657,0.00014669925,5.3721905e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013916419,0.00033488072,0.17476343,0.00018890171,0.000103348364,0.002833793,0.00018961678,0.00015930705,0.80545145,0.0000020802709,0.00016747943,0.014414042],"study_design_scores_gemma":[0.0027854065,0.00078388286,0.6188662,0.002576846,0.0001254363,0.00081091357,0.00004251924,0.000021119551,0.37390253,0.000016666125,0.000005644746,0.00006284235],"about_ca_topic_score_codex":0.00026782736,"about_ca_topic_score_gemma":0.000112699476,"teacher_disagreement_score":0.44410276,"about_ca_system_score_codex":0.00008649284,"about_ca_system_score_gemma":0.00015389669,"threshold_uncertainty_score":0.42274654},"labels":[],"label_agreement":null},{"id":"W2039565698","doi":"10.5489/cuaj.10035","title":"How long can patients with renal cell carcinoma wait for surgery without compromising pathological outcomes?","year":2011,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Pathological; Renal cell carcinoma; Stage (stratigraphy); Pathological staging; Surgery; Kidney cancer; Multivariate analysis; Cancer; Internal medicine","score_opus":0.03380214109597567,"score_gpt":0.2078119694068255,"score_spread":0.17400982831084982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039565698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99301684,0.00006242732,0.00028343956,0.0050466787,0.00021552587,0.00064406585,0.000073666655,0.000032348777,0.0006249882],"genre_scores_gemma":[0.99562293,0.000003306802,0.0013590911,0.0017948014,0.00020122416,0.000034401917,0.00011536133,0.000034840057,0.0008340397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753386,0.00020471882,0.00043558498,0.00038379236,0.00054707937,0.0008949721],"domain_scores_gemma":[0.9971246,0.0002696945,0.00052524946,0.00019455593,0.00062876486,0.0012571351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059057097,0.00031918782,0.00069698604,0.00025335432,0.0004016966,0.00012954381,0.00013609891,0.00032813786,0.00014742666],"category_scores_gemma":[0.0005095051,0.00020551558,0.00033633076,0.0001665161,0.00006573491,0.00011965294,0.000017850405,0.0005768507,0.000008536057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030428832,0.00019603637,0.99698424,0.000011150502,0.0000943997,0.00045873725,0.00014038412,0.0000016617964,0.000020166275,0.000010640663,0.0011636681,0.0006146312],"study_design_scores_gemma":[0.0027627249,0.0012672867,0.9942209,0.000015553716,0.00025755307,0.00014847967,0.000047666577,0.000017124687,0.00019115159,0.00008686926,0.00073820236,0.00024646142],"about_ca_topic_score_codex":0.00059802964,"about_ca_topic_score_gemma":0.0007965229,"teacher_disagreement_score":0.0032518771,"about_ca_system_score_codex":0.0017052139,"about_ca_system_score_gemma":0.0006220984,"threshold_uncertainty_score":0.8380682},"labels":[],"label_agreement":null},{"id":"W2039973990","doi":"10.5489/cuaj.1496","title":"Canadian guideline on genetic screening for hereditary renal cell cancers","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; McMaster University; Sunnybrook Health Science Centre; Western University; Université de Moncton; University of Toronto; Ottawa Hospital; University Health Network; Princess Margaret Cancer Centre; University of Calgary; Centre Hospitalier de l’Université de Montréal; Queen Elizabeth II Health Sciences Centre; Children's Hospital of Eastern Ontario; University of Manitoba; McGill University; University of Ottawa","funders":"Kidney Foundation of Canada","keywords":"Guideline; Medicine; Referral; Genetic testing; Medical diagnosis; Family medicine; Genetic counseling; Genetic diagnosis; Intensive care medicine; Internal medicine; Pathology; Genetics","score_opus":0.02090251724341387,"score_gpt":0.2345682767094855,"score_spread":0.2136657594660716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039973990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9049228,0.0006260946,0.00043033948,0.08221185,0.00063039135,0.0011270309,0.00015819025,0.000033062217,0.009860254],"genre_scores_gemma":[0.9720361,0.000024574594,0.0055588945,0.018508216,0.001392027,0.00006442762,0.00010837744,0.000029471323,0.0022779033],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9978862,0.00009212505,0.00048404443,0.00026861174,0.0003703345,0.0008986941],"domain_scores_gemma":[0.9964606,0.00013367458,0.00021838698,0.00014902712,0.0005332166,0.0025050587],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039076907,0.00020749029,0.00030203577,0.00032912687,0.00038226845,0.000095067706,0.00013722756,0.00027917547,0.0021941897],"category_scores_gemma":[0.00034745177,0.00016878695,0.00020946178,0.00015857875,0.000019622663,0.00007080244,0.000006656736,0.00050004834,0.00017172213],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009678428,0.0000406462,0.23098941,0.000009295762,0.00024797162,0.00072571315,0.000084065934,0.002670682,0.00036788805,0.000026025227,0.745853,0.018888509],"study_design_scores_gemma":[0.0026906955,0.0019564945,0.7499735,0.000030616302,0.00020454262,0.00042937617,0.000114767005,0.0026633642,0.00021902742,0.0005791468,0.2408012,0.00033731305],"about_ca_topic_score_codex":0.4014156,"about_ca_topic_score_gemma":0.21734597,"teacher_disagreement_score":0.518984,"about_ca_system_score_codex":0.0076698684,"about_ca_system_score_gemma":0.0025383395,"threshold_uncertainty_score":0.99871796},"labels":[],"label_agreement":null},{"id":"W2040188695","doi":"10.1016/j.ejca.2007.01.020","title":"ECOG performance status 0 or 1 and symptom classification do not improve the ability to predict renal cell carcinoma-specific survival","year":2007,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Renal cell carcinoma; Medicine; Performance status; Oncology; Internal medicine; Carcinoma; Overall survival; Urology","score_opus":0.03682240408196857,"score_gpt":0.2735863110909505,"score_spread":0.23676390700898192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040188695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988802,0.0022178795,0.00024151827,0.00083603256,0.0005985111,0.0003669771,0.000019271058,0.000011898072,0.006905902],"genre_scores_gemma":[0.99658644,0.0008280601,0.00042859153,0.00020004918,0.0010214669,0.0000034439242,0.000002154923,0.00004028839,0.0008894802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978852,0.00021378491,0.00066949386,0.00026645523,0.00059772085,0.0003673235],"domain_scores_gemma":[0.9982519,0.00015533465,0.00037658843,0.00038719046,0.0004045885,0.00042439857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020523337,0.00020271973,0.00029513845,0.00011471528,0.000116339084,0.000053850177,0.00017109614,0.000027894846,0.00013661647],"category_scores_gemma":[0.000056386496,0.000112631795,0.00010225632,0.00017864635,0.00011719627,0.000113638016,0.000055274035,0.00039081843,0.000022140075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0119714895,0.00027769592,0.42432928,0.00021194802,0.00012938373,0.00067553326,0.0033608114,0.000101007725,0.27606544,0.00001701846,0.00311486,0.27974555],"study_design_scores_gemma":[0.0021022763,0.0019546128,0.93913555,0.000079266436,0.00012692154,0.0001128304,0.00031961553,0.000034591503,0.025561206,8.6541155e-7,0.030456807,0.00011546986],"about_ca_topic_score_codex":0.0000137247325,"about_ca_topic_score_gemma":0.000011608141,"teacher_disagreement_score":0.5148063,"about_ca_system_score_codex":0.00042324295,"about_ca_system_score_gemma":0.0002325211,"threshold_uncertainty_score":0.45929912},"labels":[],"label_agreement":null},{"id":"W2040257289","doi":"10.1016/j.juro.2012.02.1828","title":"1797 THE RISK OF IN-HOSPITAL MORTALITY AFTER CYTOREDUCTIVE NEPHRECTOMY: AN ASSESSMENT BASED ON PATIENT CHARACTERISTICS AND POSTOPERATIVE OUTCOMES DURING HOSPITALIZATION","year":2012,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Cohort; Population; General surgery; Internal medicine; Kidney","score_opus":0.00974673528742207,"score_gpt":0.2823258789355101,"score_spread":0.272579143648088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040257289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980044,0.00018872834,0.000058149606,0.0011473645,0.00021476478,0.00033269738,0.000012543714,0.0000024224923,0.00003893292],"genre_scores_gemma":[0.99946815,0.00006173791,0.00011915522,0.00024944489,0.00007566295,0.000008571629,0.0000033927051,0.000011327075,0.0000025727136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862844,0.00052143657,0.00037831624,0.00007823302,0.00023379816,0.00015975941],"domain_scores_gemma":[0.99893874,0.00017392528,0.00045474884,0.00020969317,0.00014548765,0.000077383585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005238016,0.00013110874,0.0003270582,0.00008522968,0.000048181573,0.0000055480086,0.00006204724,0.000049875845,0.000020037953],"category_scores_gemma":[0.000096067684,0.00006184453,0.000066673565,0.00006421088,0.00013606706,0.000106794265,0.000027084621,0.00027795986,5.2538655e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011162853,0.00068227935,0.9924539,0.000008295903,0.00015963572,0.000029452362,0.0045268885,0.00013081316,0.0005901969,0.000021820815,0.0000025426893,0.0002778956],"study_design_scores_gemma":[0.001118115,0.004813737,0.99161357,0.000014446686,0.00041391197,0.000060341583,0.00049520057,0.00023872142,0.0011396819,0.000029476092,0.000008851211,0.000053947737],"about_ca_topic_score_codex":0.000036058816,"about_ca_topic_score_gemma":0.0000060471802,"teacher_disagreement_score":0.0041314573,"about_ca_system_score_codex":0.00012120637,"about_ca_system_score_gemma":0.00006107891,"threshold_uncertainty_score":0.25219464},"labels":[],"label_agreement":null},{"id":"W2040644141","doi":"10.5489/cuaj.1509","title":"Concerns about renal mass biopsy","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Renal mass; Renal biopsy; Biopsy; Medicine; Urology; Radiology; Internal medicine; Kidney; Nephrectomy","score_opus":0.01876573847332553,"score_gpt":0.23757404669641285,"score_spread":0.21880830822308733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040644141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93036145,0.00028299072,0.0006168571,0.029934706,0.000484886,0.00019313105,0.000021421745,0.000047347818,0.038057223],"genre_scores_gemma":[0.9909096,0.000026481926,0.00068802777,0.00499713,0.0011690318,0.000006036757,0.00002202608,0.000013799922,0.00216786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983601,0.00019109432,0.00031465403,0.00019353763,0.00040306879,0.000537542],"domain_scores_gemma":[0.9980918,0.00013309786,0.00022352318,0.00013156203,0.00024528927,0.0011746832],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00065907056,0.00014679563,0.0002882947,0.00014838975,0.00022413475,0.00008332428,0.00010469678,0.00024491726,0.001266783],"category_scores_gemma":[0.0006903418,0.000110728644,0.0001771447,0.00014921864,0.000035408524,0.000056664936,0.00000779956,0.00053680013,0.00030973123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006684376,0.00003753128,0.97000915,0.000004221154,0.00017856396,0.00044598532,0.00006709507,0.00004311909,0.0019466829,0.0009003021,0.021157492,0.0051430166],"study_design_scores_gemma":[0.0012932043,0.00049758237,0.80326205,0.000013342088,0.000111194575,0.00067916024,0.000017519724,0.00023406885,0.00019108022,0.0010995115,0.1924668,0.00013447397],"about_ca_topic_score_codex":0.00064189074,"about_ca_topic_score_gemma":0.00019788496,"teacher_disagreement_score":0.1713093,"about_ca_system_score_codex":0.0017396384,"about_ca_system_score_gemma":0.0003950889,"threshold_uncertainty_score":0.9996462},"labels":[],"label_agreement":null},{"id":"W2040925101","doi":"10.1016/j.cancergen.2014.05.004","title":"Predictive chromosomal clusters of synchronous and metachronous brain metastases in clear cell renal cell carcinoma","year":2014,"lang":"en","type":"article","venue":"Cancer Genetics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Renal cell carcinoma; Clear cell renal cell carcinoma; Brain Cell; Oncology; Cell; Medicine; Cancer research; Internal medicine; Pathology; Biology; Neuroscience; Genetics","score_opus":0.011925546726517225,"score_gpt":0.2431893514931746,"score_spread":0.2312638047666574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040925101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98338777,0.013274536,0.00053071463,0.0001476192,0.000107479944,0.00059680594,0.00007532252,0.000018360606,0.0018614184],"genre_scores_gemma":[0.9968456,0.00044316283,0.001994462,0.0001964017,0.00016065952,0.000057803478,0.00003660815,0.00005049849,0.00021479111],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983198,0.00015024662,0.00040616057,0.00045850803,0.00029440108,0.0003709028],"domain_scores_gemma":[0.998966,0.000129059,0.00017210096,0.0004147581,0.00009144045,0.00022668889],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017930531,0.00027975356,0.000575014,0.00016002348,0.0000382748,0.000011742489,0.000109183806,0.0001099177,0.00006998648],"category_scores_gemma":[0.000020594274,0.0002509445,0.0001061071,0.00017588619,0.00020121475,0.000037696173,0.00009434552,0.00018201482,0.00000495459],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003718229,0.002127968,0.44444814,0.0041002617,0.00061413477,0.00063443324,0.0077456306,0.017777795,0.47438353,0.000033835575,0.0034441745,0.04097184],"study_design_scores_gemma":[0.0065727774,0.005853395,0.2881556,0.00012583104,0.0007786385,0.0000650375,0.0003175942,0.010377816,0.68547493,0.00002273498,0.0019060951,0.00034957612],"about_ca_topic_score_codex":0.0004455516,"about_ca_topic_score_gemma":0.00014656414,"teacher_disagreement_score":0.21109137,"about_ca_system_score_codex":0.00034560388,"about_ca_system_score_gemma":0.00026741138,"threshold_uncertainty_score":0.9999943},"labels":[],"label_agreement":null},{"id":"W2040947621","doi":"10.1053/j.semdp.2005.11.004","title":"An immunohistochemical approach to the differential diagnosis of renal tumors","year":2005,"lang":"en","type":"review","venue":"Seminars in Diagnostic Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Pathology; Differential diagnosis; Immunohistochemistry; Chromophobe cell; Renal cell carcinoma; Cytokeratin; Clear cell; Surgical pathology; Medicine; H&E stain; Metastatic carcinoma; Anatomical pathology; Oncocytoma; Carcinoma","score_opus":0.03480548219853811,"score_gpt":0.3290436473320621,"score_spread":0.29423816513352397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040947621","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018802768,0.9769053,0.00007806336,0.00008247931,0.00023789312,0.0027617323,0.0001181029,0.000034461937,0.0009792103],"genre_scores_gemma":[0.013147467,0.9804649,0.0016262239,0.00009746911,0.00045679894,0.0033123754,0.0006853141,0.00010785217,0.000101653306],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99589354,0.00060653454,0.0014338702,0.0009763425,0.000436088,0.0006536471],"domain_scores_gemma":[0.9946825,0.0029485608,0.0004567052,0.0015689743,0.000070373,0.00027290956],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049210555,0.0007186902,0.0030663423,0.00050119543,0.00005222073,0.000011717178,0.0007443063,0.0006270845,0.000096787015],"category_scores_gemma":[0.0024068889,0.00046827135,0.0006343621,0.0005581107,0.00036314738,0.000030678413,0.00026344875,0.00095815095,0.00007201379],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000853158,0.0025721353,0.00084105483,0.0034029074,0.0001518779,0.001766596,0.00062553084,0.000017165512,0.000057993944,0.00007741492,0.0020970064,0.988305],"study_design_scores_gemma":[0.0032702389,0.005552908,0.0067382664,0.07183092,0.010521989,0.014614907,0.00025443177,0.000050434217,0.0009229029,0.00008074364,0.88403213,0.0021301168],"about_ca_topic_score_codex":0.00003389198,"about_ca_topic_score_gemma":0.0000062573854,"teacher_disagreement_score":0.9861749,"about_ca_system_score_codex":0.00057774445,"about_ca_system_score_gemma":0.00032088085,"threshold_uncertainty_score":0.9997769},"labels":[],"label_agreement":null},{"id":"W2041067061","doi":"10.1016/j.juro.2015.02.1975","title":"MP84-08 PATHOLOGICAL UPSTAGING OF CLINICAL T1 RENAL CELL CARCINOMA: A MULTI-INSTITUTIONAL ANALYSIS OF OUTCOMES","year":2015,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Pathological; Kidney cancer; Oncology; Kidney; Pathology; Internal medicine","score_opus":0.1312038733288711,"score_gpt":0.37014298125976863,"score_spread":0.23893910793089754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041067061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99422747,0.0013933893,0.002217822,0.0011610256,0.00021786355,0.00012442296,0.000011547156,0.0000049131804,0.0006415262],"genre_scores_gemma":[0.9967423,0.000058466707,0.002674151,0.00030219022,0.000112230446,0.0000011170002,0.0000056617655,0.000008804101,0.00009506461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99691445,0.0006979783,0.0014929185,0.00015026102,0.00052116025,0.000223262],"domain_scores_gemma":[0.9969466,0.00074682,0.0011680046,0.00036140994,0.00054398767,0.00023323341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029587022,0.0001766089,0.0014237311,0.00039062457,0.000035075725,0.0000024042859,0.00026722427,0.00016003316,0.00007082114],"category_scores_gemma":[0.0006972165,0.00008687152,0.0007912286,0.00034964707,0.0005489148,0.000043954402,0.00009707431,0.0005028736,0.0000069399603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002719508,0.0011175177,0.98573947,0.000018043907,0.0014082836,0.00074907445,0.00064030284,0.002869153,0.003941529,0.00008750558,0.00017357443,0.0005360373],"study_design_scores_gemma":[0.005471187,0.0033494306,0.9795145,0.0000072775797,0.0069764545,0.0008427181,0.0002138578,0.0014025501,0.0018782044,0.00008394395,0.00018743679,0.00007244898],"about_ca_topic_score_codex":0.00004655739,"about_ca_topic_score_gemma":0.00001070279,"teacher_disagreement_score":0.00622498,"about_ca_system_score_codex":0.00006273094,"about_ca_system_score_gemma":0.0004136618,"threshold_uncertainty_score":0.35425177},"labels":[],"label_agreement":null},{"id":"W2041210462","doi":"10.5489/cuaj.1979","title":"Association between visceral and subcutaneous adiposity and clinicopathological outcomes in non-metastatic clear cell renal cell carcinoma","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Sidney Kimmel Center for Prostate and Urologic Cancers","keywords":"Renal cell carcinoma; Medicine; Clear cell renal cell carcinoma; Internal medicine; Oncology; Clear cell; Cell; Pathology; Biology","score_opus":0.013000498269606824,"score_gpt":0.23188766272840236,"score_spread":0.21888716445879552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041210462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919539,0.00017507601,0.000030526953,0.005817038,0.000107669795,0.0003070667,0.000032819342,0.000016806052,0.0015591062],"genre_scores_gemma":[0.9968178,0.000053316347,0.0004914422,0.0015479277,0.00022692591,0.00000694286,0.000025924246,0.000018544162,0.00081114843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971925,0.00062049594,0.0006431603,0.0003885878,0.00045964424,0.00069558364],"domain_scores_gemma":[0.99736077,0.00087037595,0.00048287993,0.00012752069,0.00015531949,0.001003151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017296307,0.0002615529,0.00073015224,0.00025330772,0.000240275,0.00012299871,0.00009626795,0.00040084368,0.000094511684],"category_scores_gemma":[0.0008351765,0.0002065828,0.00014684233,0.00015460255,0.000045553596,0.00009223123,0.00003829233,0.0010272715,0.0000348208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008798953,0.00008776414,0.9973466,0.000013684417,0.000036741647,0.00051540503,0.00012477461,0.000007178233,0.00024622853,0.000005108753,0.0004137405,0.0011147968],"study_design_scores_gemma":[0.0025825861,0.0024250147,0.99272555,0.000008920603,0.00035203795,0.00027778142,0.00003453917,0.00025671598,0.00008273229,0.00030670172,0.00075349613,0.00019393087],"about_ca_topic_score_codex":0.0010665258,"about_ca_topic_score_gemma":0.0007239991,"teacher_disagreement_score":0.0048639374,"about_ca_system_score_codex":0.0017235142,"about_ca_system_score_gemma":0.00018177435,"threshold_uncertainty_score":0.8424202},"labels":[],"label_agreement":null},{"id":"W2041302820","doi":"10.5489/cuaj.1483","title":"Growth kinetics of small renal masses: A prospective analysis from the Renal Cell Carcinoma Consortium of Canada","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Manitoba; Vancouver General Hospital; University of British Columbia; McGill University; Queen's University; Western University; Dalhousie University; University of Toronto; University Health Network; University of Ottawa","funders":"","keywords":"Medicine; Renal cell carcinoma; Prospective cohort study; Population; Cohort; Internal medicine; Disease; Carcinoma; Oncology","score_opus":0.010081773272539056,"score_gpt":0.18840173116492462,"score_spread":0.17831995789238556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041302820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98973626,0.0002178117,0.0003311503,0.0051758965,0.00009494331,0.000216356,0.00016287513,0.0000047634253,0.004059965],"genre_scores_gemma":[0.9978713,0.000009618662,0.00062087586,0.0009537204,0.00023640161,0.000006389494,0.00004385901,0.000011323038,0.0002465089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770963,0.0003703818,0.00064310513,0.00023490321,0.00060882355,0.00043317245],"domain_scores_gemma":[0.9969349,0.00064754166,0.00079669186,0.00022711128,0.00079605036,0.0005977128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054120395,0.00018406229,0.00059727626,0.00017092269,0.00011807044,0.000025365107,0.00021013091,0.00017304052,0.00032280592],"category_scores_gemma":[0.0009869993,0.00012094893,0.00029651052,0.0005433788,0.00007562901,0.000025359497,0.000021788566,0.00047281056,0.0000017526272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009453054,0.00006251413,0.9944269,0.0000055237692,0.00065116776,0.00006600348,0.00014156078,0.00018557327,0.0018020418,0.00010226876,0.0023900708,0.00007184964],"study_design_scores_gemma":[0.0010731457,0.0006416139,0.9857744,0.00000839089,0.001513437,0.00002480008,0.000102823426,0.00028840385,0.008410795,0.0004324594,0.0016225438,0.00010721463],"about_ca_topic_score_codex":0.48548195,"about_ca_topic_score_gemma":0.6122308,"teacher_disagreement_score":0.12674884,"about_ca_system_score_codex":0.0016626191,"about_ca_system_score_gemma":0.001503099,"threshold_uncertainty_score":0.5179443},"labels":[],"label_agreement":null},{"id":"W2041310270","doi":"10.1517/14656566.2012.689130","title":"Sunitinib malate for the treatment of renal cell carcinoma","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Sunitinib; Sunitinib malate; Medicine; Renal cell carcinoma; Tolerability; Tyrosine-kinase inhibitor; Vascular endothelial growth factor; Pazopanib; Oncology; Clinical trial; Dosing; Internal medicine; Pharmacology; Adverse effect; Cancer; VEGF receptors","score_opus":0.19213255162905601,"score_gpt":0.4298720621045542,"score_spread":0.23773951047549818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041310270","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000115068215,0.9915311,0.000042734773,0.00021256259,0.0015085767,0.0053410064,0.00018154827,0.000049493654,0.0010179235],"genre_scores_gemma":[0.00032368582,0.99122405,0.000267175,0.00031021767,0.0026805066,0.0024285177,0.00044931527,0.00021744685,0.0020990653],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974847,0.00020614399,0.00082198915,0.00053296186,0.00041178643,0.0005424501],"domain_scores_gemma":[0.9975115,0.00072288234,0.0005506192,0.0008457459,0.0001001941,0.0002690438],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018226859,0.00084515044,0.0019508054,0.0002464503,0.00013246534,0.000017445753,0.00025874848,0.00025472272,0.0008117197],"category_scores_gemma":[0.000002830485,0.000443755,0.0016932344,0.00020357357,0.00009888057,0.00004008565,0.000013694998,0.00019931581,0.00007416357],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070917956,0.0018511626,0.0000063595367,0.0021117358,0.00080127164,0.000011808677,0.00062540313,6.770964e-7,0.00034805236,0.000037833266,0.0036005746,0.98989594],"study_design_scores_gemma":[0.0049516647,0.0038265313,0.000010160679,0.001205841,0.00064977753,0.00006474386,0.000024061354,0.000011741939,0.015855417,0.000001762401,0.9730538,0.00034448833],"about_ca_topic_score_codex":0.000042537366,"about_ca_topic_score_gemma":2.9625332e-7,"teacher_disagreement_score":0.9895514,"about_ca_system_score_codex":0.0005024309,"about_ca_system_score_gemma":0.00028067417,"threshold_uncertainty_score":0.9998014},"labels":[],"label_agreement":null},{"id":"W2041834416","doi":"10.1016/j.ctrv.2012.12.006","title":"A contemporary update on rates and management of toxicities of targeted therapies for metastatic renal cell carcinoma","year":2013,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"National Cancer Institute; National Comprehensive Cancer Network","keywords":"Medicine; Renal cell carcinoma; Oncology; Carcinoma; Targeted therapy; Internal medicine; Intensive care medicine; Cancer research; Cancer","score_opus":0.07822416874921215,"score_gpt":0.3204338860142576,"score_spread":0.24220971726504545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041834416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6839263,0.3097175,0.000019837871,0.00032722947,0.000036672234,0.0042964346,0.00006995652,0.000009347203,0.0015967564],"genre_scores_gemma":[0.9323597,0.05947238,0.003557404,0.0001440846,0.000022597202,0.0030256205,0.00008562737,0.000026072226,0.0013065427],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874455,0.00008039072,0.00056250364,0.000291416,0.00013844558,0.000182717],"domain_scores_gemma":[0.9990692,0.00006749174,0.00034143167,0.00034675162,0.00008100459,0.00009410974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104509745,0.0002995634,0.0009712125,0.00009318649,0.00003198512,0.000008858041,0.000055365097,0.000027764037,0.00017652984],"category_scores_gemma":[0.000002921072,0.00017612179,0.00024248486,0.0000977294,0.00009422394,0.000061348,0.000016967208,0.000029646268,0.000010168802],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004706029,0.006614145,0.09105865,0.042981822,0.009839639,0.00023366627,0.0063196626,0.000032301035,0.11197524,0.001451172,0.048981898,0.67580575],"study_design_scores_gemma":[0.015387207,0.011287712,0.0634809,0.0026322522,0.002739946,0.0000099937815,0.0010685588,0.00008325696,0.8098977,0.00028188614,0.092639714,0.00049085624],"about_ca_topic_score_codex":0.00030341817,"about_ca_topic_score_gemma":0.000005508385,"teacher_disagreement_score":0.69792247,"about_ca_system_score_codex":0.00014987776,"about_ca_system_score_gemma":0.000061437786,"threshold_uncertainty_score":0.7182038},"labels":[],"label_agreement":null},{"id":"W2041881011","doi":"10.1136/jcp.2006.044438","title":"Renal oncocytoma, yet another tumour that does not fit in the dualistic benign/malignant paradigm?","year":2007,"lang":"en","type":"review","venue":"Journal of Clinical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Renal oncocytoma; Oncocytoma; Pathology; Medicine; Kidney; Internal medicine; Immunohistochemistry","score_opus":0.32975591460870607,"score_gpt":0.4805298815653235,"score_spread":0.15077396695661743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041881011","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013821818,0.98040426,0.000069144146,0.0012968761,0.0018174307,0.0010444422,0.000048774957,0.000014218878,0.0014830302],"genre_scores_gemma":[0.018259753,0.9758359,0.00072778354,0.0022067595,0.002228264,0.000023345767,0.00002182545,0.00009261643,0.00060372124],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9901031,0.0027213208,0.004965436,0.0005745353,0.0009899621,0.00064559595],"domain_scores_gemma":[0.9878419,0.0073744226,0.0034864214,0.0008251767,0.00015872811,0.00031336976],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009217836,0.00065386604,0.0059188535,0.00052573776,0.00005393816,0.000035056783,0.0006992435,0.0010895769,0.00017559469],"category_scores_gemma":[0.0019151059,0.00028052158,0.002552649,0.00030456352,0.0004365235,0.00006454438,0.00009656132,0.0030669512,0.00009016068],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019498661,0.002752591,0.0024833265,0.0047664954,0.0010377592,0.23918264,0.0004249213,0.0000023390398,0.000014558614,0.000421765,0.004024502,0.74293923],"study_design_scores_gemma":[0.0037462066,0.004506043,0.009838562,0.011565011,0.004260318,0.04400327,0.00008319604,0.0000021226215,0.000020646394,0.0005530924,0.92100143,0.0004200853],"about_ca_topic_score_codex":0.000009923993,"about_ca_topic_score_gemma":0.000032729222,"teacher_disagreement_score":0.9169769,"about_ca_system_score_codex":0.00026000998,"about_ca_system_score_gemma":0.0010409356,"threshold_uncertainty_score":0.9999647},"labels":[],"label_agreement":null},{"id":"W2042809345","doi":"10.1016/j.urology.2009.02.013","title":"Does Histologic Subtype Affect Oncologic Outcomes After Nephron-sparing Surgery?","year":2009,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Chromophobe cell; Renal cell carcinoma; Nephrectomy; Proportional hazards model; Univariate analysis; Kidney cancer; Stage (stratigraphy); Surveillance, Epidemiology, and End Results; Clear cell; Urology; Internal medicine; Clear cell carcinoma; Clear cell renal cell carcinoma; Oncology; Cancer; Multivariate analysis; Kidney; Cancer registry","score_opus":0.02422148815307906,"score_gpt":0.27140155132669774,"score_spread":0.24718006317361868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042809345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825903,0.0013724186,0.000045524146,0.008765928,0.00057098456,0.0003479479,0.0000015251233,0.00016449453,0.0061408808],"genre_scores_gemma":[0.9907333,0.0000689261,0.00021551733,0.007290115,0.00013684946,0.00004736335,0.000013651317,0.00001601381,0.0014782512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985077,0.00013691082,0.0002854847,0.00042145516,0.00015611903,0.00049235194],"domain_scores_gemma":[0.99875355,0.00052972813,0.000102044556,0.0004295459,0.000041010553,0.00014414144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002057194,0.00025279875,0.00070399523,0.00018252863,0.000050736875,0.000008469388,0.00008584755,0.0002336749,0.00059600035],"category_scores_gemma":[0.00022570873,0.00013286668,0.0002486647,0.00011773283,0.000105248866,0.000041610037,0.000038460043,0.00023267166,0.00031635782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009990578,0.00031414806,0.98302364,0.000021742715,0.000085348365,0.0030586177,0.00007388538,0.000012518849,0.0007192918,0.00010479859,0.0017703738,0.009816558],"study_design_scores_gemma":[0.0006445193,0.0015309416,0.98363537,0.0000069130556,0.00020605003,0.00025825904,0.000007458392,0.000024679235,0.00049776514,0.0004469741,0.012580208,0.00016086546],"about_ca_topic_score_codex":0.00003248013,"about_ca_topic_score_gemma":0.000050903986,"teacher_disagreement_score":0.010809833,"about_ca_system_score_codex":0.00021506342,"about_ca_system_score_gemma":0.00008189519,"threshold_uncertainty_score":0.6525786},"labels":[],"label_agreement":null},{"id":"W2042890035","doi":"10.1136/bcr-2014-206015","title":"Durable control of locally recurrent renal cell carcinoma using stereotactic body radiotherapy","year":2014,"lang":"en","type":"article","venue":"BMJ Case Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Renal cell carcinoma; Asymptomatic; Radiation therapy; Nephrectomy; Radiology; Disease; Oncology; Surgery; Internal medicine; Kidney","score_opus":0.02409683374818756,"score_gpt":0.2903344854832791,"score_spread":0.26623765173509156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042890035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907254,0.001474562,0.0036432806,0.00010775929,0.0003210826,0.0013499089,0.000003572149,0.00003934308,0.002335106],"genre_scores_gemma":[0.99763674,0.000014100078,0.0014757456,0.0001133732,0.0002831859,0.000038983464,0.000013149921,0.000056084817,0.0003686519],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.997422,0.00017662228,0.0010037071,0.0004913414,0.00051735085,0.00038901734],"domain_scores_gemma":[0.9975795,0.00012517227,0.0007681474,0.00095797493,0.000256297,0.00031287613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007096959,0.00030028206,0.0007604462,0.00016380241,0.00007646709,0.000020094922,0.000034863962,0.0001179932,0.00016352726],"category_scores_gemma":[0.000112610214,0.00024472765,0.00027440937,0.00015871236,0.000077624994,0.00007719672,0.00002197679,0.00018470592,0.0000063354173],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013111504,0.00082920707,0.07261387,0.00070318946,0.00028818747,0.72189695,0.00026805137,0.00021002803,0.19773981,0.000015324164,0.00043269017,0.0036915296],"study_design_scores_gemma":[0.0052304133,0.002385507,0.017366253,0.00027830747,0.0008725343,0.86765385,0.000056495417,0.0101150265,0.09401662,0.000026530866,0.0016235665,0.00037487506],"about_ca_topic_score_codex":0.00052832486,"about_ca_topic_score_gemma":0.00001123534,"teacher_disagreement_score":0.14575692,"about_ca_system_score_codex":0.0003457079,"about_ca_system_score_gemma":0.00035961904,"threshold_uncertainty_score":0.99797034},"labels":[],"label_agreement":null},{"id":"W2043167674","doi":"10.1097/pas.0000000000000403","title":"A Novel SDHA-deficient Renal Cell Carcinoma Revealed by Comprehensive Genomic Profiling","year":2015,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"SDHB; SDHA; SDHD; Biology; Renal cell carcinoma; Paraganglioma; Pathology; Cancer research; Medicine; Genetics; Germline mutation; Mutation; Gene; Gene expression","score_opus":0.039300330832214715,"score_gpt":0.2754095520374911,"score_spread":0.23610922120527641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043167674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928234,0.002928765,0.00043779414,0.002051094,0.00017160604,0.0002884261,0.000015638669,0.000014373787,0.0012688625],"genre_scores_gemma":[0.9948103,0.00009349559,0.003929985,0.0005998268,0.00027705397,0.0000070398046,0.000009516673,0.00003472203,0.00023810372],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9976057,0.00040928723,0.0007498428,0.0002740472,0.00050710427,0.00045406062],"domain_scores_gemma":[0.9974143,0.00030483303,0.00091904483,0.0003941981,0.0004803719,0.0004872657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007240796,0.0002647056,0.0010174289,0.00015167169,0.00007084973,0.0000140188995,0.0002760577,0.000057604688,0.000021691894],"category_scores_gemma":[0.000042198222,0.00015494232,0.0003150799,0.00030017275,0.0007374528,0.00003822812,0.00011087301,0.0006055772,0.00004403073],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009317481,0.0012971762,0.02802325,0.000042847536,0.00015587026,0.017280022,0.0015703544,0.000416166,0.9328944,0.00007007159,0.003954508,0.00497783],"study_design_scores_gemma":[0.05275447,0.066197395,0.2618763,0.00026314336,0.0027984714,0.42556733,0.013998277,0.0006741998,0.1307053,0.00041366956,0.04307471,0.0016767378],"about_ca_topic_score_codex":0.00004151982,"about_ca_topic_score_gemma":3.4092542e-7,"teacher_disagreement_score":0.8021891,"about_ca_system_score_codex":0.00030640335,"about_ca_system_score_gemma":0.0003194028,"threshold_uncertainty_score":0.6318364},"labels":[],"label_agreement":null},{"id":"W2043202290","doi":"10.1016/j.humpath.2011.08.012","title":"Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis","year":2011,"lang":"en","type":"article","venue":"Human Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; London Health Sciences Centre; University of Toronto","funders":"","keywords":"Endoglin; CD31; Hazard ratio; Medicine; Angiogenesis; Renal cell carcinoma; Proportional hazards model; Oncology; Internal medicine; Receiver operating characteristic; Stage (stratigraphy); Immunohistochemistry; Pathology; Confidence interval; Biology; CD34; Stem cell","score_opus":0.05057907476539494,"score_gpt":0.3020641489869086,"score_spread":0.25148507422151367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043202290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99215484,0.00014233099,0.00014728673,0.0000059282834,0.0000390021,0.0006907326,0.000017488577,0.00003376818,0.006768613],"genre_scores_gemma":[0.99232584,0.0000029629182,0.007459726,0.000019228453,0.000015832982,0.000029979115,0.000018473176,0.000026433974,0.0001015342],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99796903,0.0003978926,0.00066685025,0.000393986,0.00025589135,0.000316354],"domain_scores_gemma":[0.9985749,0.000071800765,0.000458764,0.0006797216,0.00014361004,0.00007121145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000347244,0.00020685064,0.0006914588,0.00038572637,0.000047869904,0.0000034714074,0.00020338538,0.00012179774,0.00021738985],"category_scores_gemma":[0.000024096504,0.00015288965,0.00026930228,0.00062214705,0.00030772842,0.000034276887,0.00010744868,0.00023107015,0.0000037594734],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038494774,0.00051522686,0.47735524,0.00012149911,0.00004015282,0.00042481854,0.00060687994,0.000055447592,0.52080095,0.000025907788,0.0000050010663,0.000010370727],"study_design_scores_gemma":[0.0010636575,0.0006733905,0.7303459,0.00002488725,0.00089843944,0.000025369398,0.00014004964,0.002093238,0.26462305,0.000027781169,9.512633e-7,0.00008330043],"about_ca_topic_score_codex":0.00041155244,"about_ca_topic_score_gemma":0.000067834575,"teacher_disagreement_score":0.2561779,"about_ca_system_score_codex":0.00015310402,"about_ca_system_score_gemma":0.00017238806,"threshold_uncertainty_score":0.6234659},"labels":[],"label_agreement":null},{"id":"W2043287555","doi":"10.4161/auto.29640","title":"FLCN, a novel autophagy component, interacts with GABARAP and is regulated by ULK1 phosphorylation","year":2014,"lang":"en","type":"article","venue":"Autophagy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"National Institute of General Medical Sciences; Cancer Research UK","keywords":"Folliculin; Autophagy; ULK1; Biology; Cell biology; BAG3; Phosphorylation; Cancer research; Protein kinase A; AMPK; Biochemistry; Apoptosis; Gene","score_opus":0.010817544242011737,"score_gpt":0.22975164202312987,"score_spread":0.21893409778111814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043287555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928508,0.0009568436,0.0012513535,0.00071056385,0.00010447451,0.00047295747,0.000012642415,0.00014473514,0.0034956597],"genre_scores_gemma":[0.9924825,0.0000273056,0.0018627774,0.0010752255,0.00006522675,0.000027090024,0.00013452688,0.00005050575,0.00427488],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985209,0.000039448576,0.00030040942,0.0004859874,0.0003313708,0.00032186322],"domain_scores_gemma":[0.9989822,0.00008674157,0.0001468426,0.0004309355,0.000107506996,0.0002458112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013497192,0.0002920421,0.00042254393,0.00010785306,0.00008645095,0.000042007196,0.000073741234,0.0001174918,0.00019939983],"category_scores_gemma":[0.000028284987,0.00022416812,0.00006579339,0.00017874996,0.0000865542,0.00012846848,0.00004517151,0.00017760113,0.00008042408],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015210239,0.001058136,0.0053643147,0.00023662005,0.0005813432,0.00018325061,0.001934657,0.000023053233,0.9514,0.0010121368,0.013617148,0.023068352],"study_design_scores_gemma":[0.0067739254,0.0015675823,0.26185554,0.0002044107,0.000265647,0.0005416631,0.000033471664,0.008713519,0.7068737,0.00007438951,0.012762114,0.00033402658],"about_ca_topic_score_codex":0.00019643817,"about_ca_topic_score_gemma":0.000006666871,"teacher_disagreement_score":0.25649124,"about_ca_system_score_codex":0.00012731412,"about_ca_system_score_gemma":0.00004645961,"threshold_uncertainty_score":0.91413105},"labels":[],"label_agreement":null},{"id":"W2044071612","doi":"10.1016/j.juro.2013.02.2536","title":"1182 GROWTH KINETICS OF SMALL RENAL MASSES: A PROSPECTIVE ANALYSIS FROM THE RENAL CELL CARCINOMA CONSORTIUM OF CANADA","year":2013,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Library science; History; Art history; Classics","score_opus":0.011738961093357677,"score_gpt":0.2054414569420112,"score_spread":0.19370249584865354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044071612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929019,0.001710874,0.00035517506,0.0032433525,0.00008769496,0.00032697228,0.00002626944,0.000002286664,0.0013454731],"genre_scores_gemma":[0.9986279,0.00006021122,0.00061925943,0.00036563087,0.00014648782,0.000004791836,0.0000050703406,0.000015779424,0.00015487197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978926,0.0003916627,0.0008445114,0.00014025232,0.00045757106,0.00027341003],"domain_scores_gemma":[0.9965869,0.00087493093,0.001116436,0.00044608687,0.0008317419,0.00014385801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039073653,0.00019004283,0.0007690191,0.00014728057,0.000041378873,0.0000054646052,0.00036697675,0.00008406217,0.00030216642],"category_scores_gemma":[0.00015834036,0.00009461442,0.0002708562,0.00039068444,0.0002992797,0.000029809695,0.00007264065,0.0004135254,0.0000019509148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026986704,0.0005139701,0.7891547,0.000048622493,0.0042817933,0.00033267547,0.0021592844,0.0010825993,0.19492622,0.0000910487,0.004585506,0.0001248869],"study_design_scores_gemma":[0.0017031726,0.002551748,0.86135906,0.000012084169,0.0057184966,0.0002766364,0.0004744437,0.00021179793,0.12697493,0.0005167139,0.00012258888,0.000078308476],"about_ca_topic_score_codex":0.15625466,"about_ca_topic_score_gemma":0.049884576,"teacher_disagreement_score":0.106370084,"about_ca_system_score_codex":0.00015080128,"about_ca_system_score_gemma":0.0005992992,"threshold_uncertainty_score":0.9674525},"labels":[],"label_agreement":null},{"id":"W2044165483","doi":"10.1097/pas.0000000000000203","title":"t(6;11) Renal Cell Carcinoma (RCC)","year":2014,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"PAX8; Tissue microarray; Renal cell carcinoma; TFE3; Immunohistochemistry; Pathology; CD117; Cytokeratin; Fluorescence in situ hybridization; Clear cell; Chromophobe cell; Clear cell renal cell carcinoma; Vimentin; Surgical pathology; Oncocytoma; Medicine; Biology; CD34","score_opus":0.015334309772536681,"score_gpt":0.25278105045427146,"score_spread":0.23744674068173477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044165483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880907,0.0004458444,0.00026261227,0.0045605474,0.0001523822,0.000100230274,0.0000015492365,0.000012540639,0.00637358],"genre_scores_gemma":[0.99707276,0.00008806303,0.0010071378,0.00074945204,0.0006261533,0.0000029126045,0.0000018721188,0.000025586478,0.0004260804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997896,0.000604983,0.00056034815,0.00019083523,0.0003821254,0.0003656651],"domain_scores_gemma":[0.99794966,0.0004898949,0.00066237804,0.00041216603,0.00018538498,0.00030053145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009381176,0.00019869748,0.0008259563,0.00014324598,0.0000722898,0.000010091141,0.00025324363,0.000048897913,0.00012671063],"category_scores_gemma":[0.000054947795,0.00010651209,0.00037016472,0.0002494427,0.0007418213,0.00003612398,0.00006369905,0.00046132496,0.000069692454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018701082,0.0029393747,0.481564,0.0001445145,0.00047736306,0.08674243,0.0028847978,0.00035013582,0.15394837,0.0025612235,0.011535117,0.23815161],"study_design_scores_gemma":[0.010685304,0.029503198,0.7086112,0.00008265224,0.0010297184,0.13369954,0.00077969534,0.00013729409,0.028199485,0.0009874955,0.085778326,0.0005061093],"about_ca_topic_score_codex":0.0000254792,"about_ca_topic_score_gemma":0.0000012361099,"teacher_disagreement_score":0.23764549,"about_ca_system_score_codex":0.00008252252,"about_ca_system_score_gemma":0.00009612164,"threshold_uncertainty_score":0.4343437},"labels":[],"label_agreement":null},{"id":"W2044697402","doi":"10.1016/j.urolonc.2015.03.003","title":"Reprint of: Outcomes in patients with metastatic renal cell cancer treated with individualized sunitinib therapy: Correlation with dynamic microbubble ultrasound data and review of the literature","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Sunitinib; Medicine; Toxicity; Internal medicine; Renal cell carcinoma; Oncology; Cancer; Urology","score_opus":0.03841444750015224,"score_gpt":0.30938739513532354,"score_spread":0.2709729476351713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044697402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988547,0.009098018,0.000010237555,0.0010045198,0.000013148203,0.0009990637,0.00015623707,0.000007831088,0.00016392316],"genre_scores_gemma":[0.97255266,0.0038051077,0.022091702,0.0006345731,0.000004142545,0.00007544014,0.0006643982,0.000014817463,0.00015715048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988259,0.00022705966,0.00030669046,0.0003026034,0.0002029398,0.00013481309],"domain_scores_gemma":[0.9987107,0.00021470591,0.000387104,0.0003896294,0.00019471889,0.000103131286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032161488,0.00018259905,0.0004997833,0.000091384085,0.000046996443,0.000008243763,0.000104787185,0.000070390146,0.000010703564],"category_scores_gemma":[0.000086566186,0.000085064145,0.000017505417,0.00039998404,0.0005439704,0.00009455185,0.00004144428,0.0002201943,2.0502691e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000658983,0.00032113213,0.99729156,0.00027744137,0.00013474286,0.000023128023,0.000665962,0.000052247655,0.00012541118,0.00002876348,0.00009687605,0.00032376376],"study_design_scores_gemma":[0.012035304,0.009391418,0.9632108,0.0044594384,0.001679082,0.00027943176,0.00030978088,0.00012224195,0.0011110457,0.00019585324,0.006966316,0.00023926877],"about_ca_topic_score_codex":0.0001596847,"about_ca_topic_score_gemma":0.0001600446,"teacher_disagreement_score":0.03408073,"about_ca_system_score_codex":0.00008483696,"about_ca_system_score_gemma":0.00044386945,"threshold_uncertainty_score":0.3468815},"labels":[],"label_agreement":null},{"id":"W2045055834","doi":"10.1016/s1569-9056(07)60439-4","title":"441 TECHNIQUES, SAFETY AND ACCURACY OF NEEDLE BIOPSY OF RENAL TUMOURS: REVIEW OF THE TORONTO UHN EXPERIENCE","year":2007,"lang":"en","type":"article","venue":"European Urology Supplements","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Biopsy; General surgery; Pathology","score_opus":0.01812019034360049,"score_gpt":0.29861437741980695,"score_spread":0.28049418707620644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045055834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9312448,0.028334482,0.00030941272,0.0008308558,0.00014502696,0.0016771941,0.00011017315,0.0000327684,0.037315294],"genre_scores_gemma":[0.9943917,0.0034567497,0.0013571715,0.0005330703,0.000036145408,0.000004899138,0.000033680124,0.000021624659,0.00016496975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826014,0.00023147727,0.00076875504,0.00023228613,0.00028009358,0.00022722878],"domain_scores_gemma":[0.99867386,0.00009936545,0.00046230506,0.00056183955,0.00012200426,0.00008060546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092109205,0.00015687657,0.00041128666,0.000043120133,0.000031738564,0.0000011990913,0.00022652559,0.000032585136,0.0005204171],"category_scores_gemma":[0.00019222623,0.000104662344,0.00010288493,0.00012202959,0.00028135293,0.000054004122,0.00022925058,0.00009972973,0.0000024866742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035301498,0.0015052471,0.5544611,0.0055864747,0.0005669078,0.00049705507,0.0059746616,7.738539e-7,0.36668956,0.0007576523,0.0100380285,0.050392352],"study_design_scores_gemma":[0.002312399,0.0022635646,0.61698055,0.0018654498,0.00045612414,0.000437304,0.0003910576,0.000002089629,0.30010632,0.000011124408,0.074983306,0.00019070694],"about_ca_topic_score_codex":0.00017706289,"about_ca_topic_score_gemma":0.000021243417,"teacher_disagreement_score":0.06658324,"about_ca_system_score_codex":0.000051889365,"about_ca_system_score_gemma":0.000039138362,"threshold_uncertainty_score":0.5698202},"labels":[],"label_agreement":null},{"id":"W2045276739","doi":"10.2214/ajr.04.1475","title":"Birt-Hogg-Dubé Syndrome: A Rare Cause of Pulmonary Cysts","year":2005,"lang":"en","type":"article","venue":"American Journal of Roentgenology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Birt–Hogg–Dubé syndrome; Dermatology; Radiology; Pneumothorax","score_opus":0.014069649671095443,"score_gpt":0.2619072501737958,"score_spread":0.24783760050270034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045276739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930437,0.002869073,0.0000916268,0.002768936,0.00014347311,0.00016467377,0.000007433043,0.000015074879,0.00089600176],"genre_scores_gemma":[0.99571866,0.0005503447,0.002779279,0.00041406677,0.00016340251,0.000004181692,0.000005576887,0.000036055877,0.00032840998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980842,0.00014441552,0.0008030177,0.00020177699,0.0003833575,0.00038327204],"domain_scores_gemma":[0.9980106,0.00009008901,0.00094073906,0.0003737578,0.00029119587,0.00029364723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017752565,0.00021577539,0.0009847083,0.00046582308,0.00003200479,0.0000041310627,0.00020956347,0.00006570561,0.00023743077],"category_scores_gemma":[0.00006347962,0.00016701702,0.00029733373,0.00036900997,0.0004502218,0.00009049991,0.00005778642,0.00033432708,0.000050003375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005623814,0.0032931785,0.471242,0.00021983146,0.0041071908,0.04232679,0.0017486413,0.00044453485,0.10161291,0.00015407761,0.0024151416,0.3668119],"study_design_scores_gemma":[0.0050933263,0.024066603,0.6369722,0.00038837953,0.001610325,0.28883323,0.0022506046,0.00009932422,0.030466452,0.00008112557,0.009727529,0.00041090258],"about_ca_topic_score_codex":0.00006425104,"about_ca_topic_score_gemma":0.000007635325,"teacher_disagreement_score":0.366401,"about_ca_system_score_codex":0.00025616714,"about_ca_system_score_gemma":0.00021965394,"threshold_uncertainty_score":0.68107563},"labels":[],"label_agreement":null},{"id":"W2045902424","doi":"10.1080/01635581.2011.594207","title":"Prognostic Significance of Body Mass Index in Asian Patients With Localized Renal Cell Carcinoma","year":2011,"lang":"en","type":"article","venue":"Nutrition and Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"American Cancer Society","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Body mass index; Proportional hazards model; Pathological; Gastroenterology; Stage (stratigraphy); Multivariate analysis; Carcinoma; Cancer; Adjuvant therapy; Oncology","score_opus":0.01699512318507227,"score_gpt":0.22893316526565027,"score_spread":0.211938042080578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045902424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99554634,0.00069885654,0.000062479405,0.0000623605,0.00002403328,0.0008347749,0.00001995859,0.000010331584,0.002740836],"genre_scores_gemma":[0.9988692,0.0000829762,0.00056598015,0.000053857595,0.000023006076,0.00025257297,0.000026567739,0.000013738097,0.00011213776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992488,0.000029802504,0.000179326,0.00019942751,0.00019374602,0.00014888468],"domain_scores_gemma":[0.99960244,0.0000098747105,0.00007717121,0.00011682424,0.00009770406,0.00009600027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000033106317,0.00011327724,0.00021842688,0.000094447,0.000015781037,0.000003528759,0.000028843875,0.000056677214,0.00016477208],"category_scores_gemma":[0.0000037561656,0.00007831656,0.00002775092,0.00014820056,0.00007203198,0.000042989523,0.0000066316,0.000087662236,0.0000017498741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015254418,0.00080703245,0.9932699,0.0003864214,0.000013697563,0.000042631716,0.0001988666,4.4489863e-7,0.0019470208,0.000009675938,0.00007352169,0.0017253092],"study_design_scores_gemma":[0.008871266,0.0008934816,0.9554187,0.0002845663,0.00007302648,0.0000025433737,0.00011709001,0.000025000267,0.03371271,0.000051241856,0.00045719478,0.000093192],"about_ca_topic_score_codex":0.0004019676,"about_ca_topic_score_gemma":0.000058386177,"teacher_disagreement_score":0.03785125,"about_ca_system_score_codex":0.000091427275,"about_ca_system_score_gemma":0.00006832582,"threshold_uncertainty_score":0.31936568},"labels":[],"label_agreement":null},{"id":"W2045992174","doi":"10.1002/cncr.25583","title":"Sunitinib rechallenge in metastatic renal cell carcinoma patients","year":2010,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of Calgary","funders":"","keywords":"Sunitinib; Medicine; Renal cell carcinoma; Toxicity; Internal medicine; Oncology; Response Evaluation Criteria in Solid Tumors; Refractory (planetary science); Retrospective cohort study; Surgery; Urology; Phases of clinical research","score_opus":0.039965425767444177,"score_gpt":0.29353590918002026,"score_spread":0.2535704834125761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045992174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862211,0.0006815154,0.0000024144013,0.0002754223,0.0003385662,0.00042782372,0.00001959354,0.000021033533,0.012012568],"genre_scores_gemma":[0.9978674,0.00005714743,0.0005710157,0.00020916387,0.000120224475,0.00014353434,0.000040829153,0.000029764202,0.0009608899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898607,0.000035604666,0.00021983225,0.00025996426,0.00022610466,0.00027245298],"domain_scores_gemma":[0.99933034,0.000044292956,0.00006415738,0.00030910881,0.00008927925,0.00016282541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009853375,0.00015538045,0.00025283356,0.00012105045,0.00002625723,0.000007470294,0.00007245331,0.000054253214,0.0008920175],"category_scores_gemma":[0.000030246432,0.00012649952,0.00007040276,0.0001474496,0.00004377617,0.0000500003,0.000027977336,0.0003282145,0.00007463458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043614354,0.0009987141,0.8711305,0.0002892193,0.00005007121,0.0005625919,0.0013247081,0.000008230093,0.10041237,0.00009304055,0.0021481658,0.022546245],"study_design_scores_gemma":[0.0045956518,0.00034534058,0.90181786,0.00005278991,0.00011969841,0.000011639907,0.00007243095,0.000025908057,0.08751107,0.00004770639,0.005221558,0.00017833541],"about_ca_topic_score_codex":0.00031880598,"about_ca_topic_score_gemma":0.0006067281,"teacher_disagreement_score":0.030687366,"about_ca_system_score_codex":0.00016687775,"about_ca_system_score_gemma":0.00014467085,"threshold_uncertainty_score":0.9766966},"labels":[],"label_agreement":null},{"id":"W2046474914","doi":"10.1016/j.clgc.2014.03.003","title":"First-Line Mammalian Target of Rapamycin Inhibition in Metastatic Renal Cell Carcinoma: An Analysis of Practice Patterns From the International Metastatic Renal Cell Carcinoma Database Consortium","year":2014,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre","funders":"National Cancer Institute; Genentech; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Renal cell carcinoma; Oncology; Cancer research; Cell culture; Internal medicine; Biology","score_opus":0.059614904111763366,"score_gpt":0.3511681714682748,"score_spread":0.29155326735651144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046474914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921418,0.0012496697,0.0014937081,0.0015650173,0.00039340183,0.0007759619,0.001974742,0.000018012282,0.00038770348],"genre_scores_gemma":[0.9893421,0.0002648239,0.0062560043,0.0008407349,0.0005473983,0.00012728108,0.0023590932,0.000056212637,0.0002063638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99397796,0.0013291956,0.002293771,0.0009587431,0.0009895645,0.00045077334],"domain_scores_gemma":[0.9936332,0.0027890436,0.0014037876,0.0012740525,0.00052192586,0.00037798582],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019468947,0.00046163172,0.001434738,0.00044365507,0.000077133416,0.000026802652,0.0003975271,0.00013060652,0.0011233939],"category_scores_gemma":[0.0005922998,0.00034763664,0.00067001506,0.0006605319,0.00030519467,0.00032970548,0.00024628377,0.0006839843,0.000014012222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055954377,0.006018207,0.95861095,0.00040178912,0.0017445865,0.0017965824,0.0009725753,0.007242524,0.015531153,0.000015055289,0.0011102872,0.00096087344],"study_design_scores_gemma":[0.00979065,0.0031834207,0.88141793,0.00018032655,0.011307569,0.00004146884,0.0008967756,0.015966477,0.07553651,0.00007592275,0.0011610736,0.0004418946],"about_ca_topic_score_codex":0.007024009,"about_ca_topic_score_gemma":0.0018506948,"teacher_disagreement_score":0.07719302,"about_ca_system_score_codex":0.0002690036,"about_ca_system_score_gemma":0.0004472887,"threshold_uncertainty_score":0.99989754},"labels":[],"label_agreement":null},{"id":"W2046580969","doi":"10.1007/s13277-013-1245-6","title":"Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma","year":2013,"lang":"en","type":"article","venue":"Tumor Biology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Cancer research; Metastasis; Glycolysis; Pentose phosphate pathway; Biology; Renal cell carcinoma; Signal transduction; Metabolic pathway; Cell cycle; Cancer; Medicine; Bioinformatics; Gene; Oncology; Metabolism; Endocrinology; Biochemistry; Genetics","score_opus":0.024081693617727155,"score_gpt":0.25082652860121685,"score_spread":0.22674483498348968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046580969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99781185,0.0011142364,0.00004549883,0.00011875163,0.000039495117,0.00055164366,0.000008974632,0.000014043281,0.00029551188],"genre_scores_gemma":[0.9991763,0.000019379087,0.00044444788,0.000032785043,0.000016114102,0.000067459434,0.00012016376,0.000010727995,0.00011257663],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990353,0.00012864893,0.00037530257,0.0002283442,0.000071795344,0.00016059785],"domain_scores_gemma":[0.99942523,0.000050885035,0.00015817801,0.00021515446,0.00008764982,0.00006292535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017298975,0.00011368002,0.00032893778,0.00020339276,0.000015356785,0.0000056256636,0.000043853866,0.0000375374,0.00011526769],"category_scores_gemma":[0.00003652257,0.00008809921,0.00003908628,0.00017092313,0.00008668965,0.000051506617,0.000024704083,0.00006680121,0.00004311473],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039558792,0.000107466156,0.08111684,0.000057406698,0.000018050194,0.000015783697,0.00017975885,0.0000032583598,0.9169576,0.00033348694,0.000022908878,0.0011478752],"study_design_scores_gemma":[0.00076800183,0.00018871961,0.4815463,0.0000063032144,0.00006682308,0.000040595376,0.000050540395,0.00017482942,0.5165344,0.000563224,0.000016002406,0.000044246135],"about_ca_topic_score_codex":0.00044974335,"about_ca_topic_score_gemma":0.00000641621,"teacher_disagreement_score":0.4004295,"about_ca_system_score_codex":0.00003140374,"about_ca_system_score_gemma":0.00004247915,"threshold_uncertainty_score":0.35925815},"labels":[],"label_agreement":null},{"id":"W2046768854","doi":"10.5489/cuaj.1884","title":"Surgeon-specific factors affecting treatment decisions among Canadian urologists in the management of pT1a renal tumours","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Nephrectomy; General surgery; Comorbidity; Affect (linguistics); Family history; Family medicine; Surgery; Internal medicine; Kidney","score_opus":0.03027992660422985,"score_gpt":0.23910893870044903,"score_spread":0.20882901209621918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046768854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893597,0.00020078204,0.000020516438,0.0050551454,0.00021808354,0.00044527373,0.000019922061,0.000010996742,0.0046695787],"genre_scores_gemma":[0.998759,0.00018923433,0.00020643063,0.00050047477,0.00014331564,0.000014674781,0.00003894697,0.000015114732,0.00013283803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99732965,0.0005210417,0.0005304651,0.00028420502,0.0005395553,0.00079509994],"domain_scores_gemma":[0.99741083,0.0008281599,0.00032207015,0.00032771268,0.00014149447,0.000969728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015921994,0.00024167693,0.00043463855,0.00050062826,0.00033148084,0.000075602475,0.00028190677,0.00022547864,0.00018446318],"category_scores_gemma":[0.00046956693,0.00014893287,0.00026251923,0.0004350073,0.00006204938,0.000061146035,0.000016750746,0.0005017841,0.000020881529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002990242,0.00007432191,0.99294937,0.0000021759754,0.00012446458,0.0006161321,0.00040325013,0.00017791345,0.000010911574,0.00017384303,0.0010137017,0.004423993],"study_design_scores_gemma":[0.0010254899,0.00067145994,0.98654306,0.000033956276,0.00012258619,0.0001185815,0.00052272144,0.000037625814,0.000045361543,0.0002460137,0.010512483,0.00012066992],"about_ca_topic_score_codex":0.10598652,"about_ca_topic_score_gemma":0.2895946,"teacher_disagreement_score":0.18360807,"about_ca_system_score_codex":0.0039109406,"about_ca_system_score_gemma":0.00036830342,"threshold_uncertainty_score":0.99991286},"labels":[],"label_agreement":null},{"id":"W2048321372","doi":"10.5489/cuaj.11202","title":"The association between renal tumour scoring systems and ischemia time during open partial nephrectomy","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Nephrectomy; Medicine; Ischemia; Urology; Internal medicine; Kidney","score_opus":0.021080431819459268,"score_gpt":0.23904803646934722,"score_spread":0.21796760464988796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048321372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98989344,0.0008557418,0.0000045756474,0.00491024,0.00028141224,0.00044873345,0.000014883452,0.000020584064,0.0035703771],"genre_scores_gemma":[0.9944772,0.000053821488,0.00005091356,0.00022948827,0.0021394351,0.000036050173,0.000015395437,0.000016765325,0.0029809007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977307,0.00033591728,0.00042498732,0.00017575931,0.0004978103,0.00083485007],"domain_scores_gemma":[0.99770147,0.00041002067,0.00048509345,0.00011155979,0.00018837019,0.0011035043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00225801,0.00016696169,0.00035027092,0.00008570299,0.00085335143,0.00048603382,0.00014558513,0.00024693206,0.00007987606],"category_scores_gemma":[0.0009372182,0.00011371032,0.000095463176,0.00015351149,0.00001971836,0.00029302653,0.000064279826,0.00065301516,0.00010712113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043300017,0.0000141411865,0.9946439,0.00000412343,0.00027164762,0.000035614437,0.00007219694,0.0000069313905,0.0016558412,0.000040920047,0.0028897354,0.00032162332],"study_design_scores_gemma":[0.001147886,0.00011430976,0.95568067,0.000025291693,0.00024122598,0.0002745398,0.000039250644,0.00004602425,0.00086404453,0.000027269798,0.041411296,0.00012816883],"about_ca_topic_score_codex":0.0009855339,"about_ca_topic_score_gemma":0.00007800469,"teacher_disagreement_score":0.038963232,"about_ca_system_score_codex":0.0038641512,"about_ca_system_score_gemma":0.00030172543,"threshold_uncertainty_score":0.9999598},"labels":[],"label_agreement":null},{"id":"W2048595273","doi":"10.1109/mecbme.2014.6783230","title":"Towards multi-modal image-guided tumour identification in robot-assisted partial nephrectomy","year":2014,"lang":"en","type":"article","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Simon Fraser University","funders":"Qatar National Research Fund; Qatar Foundation","keywords":"Nephrectomy; Augmented reality; Computer science; Visualization; Computer vision; Artificial intelligence; Identification (biology); Robot; Modalities; Segmentation; Surgical robot; Resection; Modality (human–computer interaction); Radiology; Medicine; Surgery; Kidney","score_opus":0.04766795400165029,"score_gpt":0.31574398887595956,"score_spread":0.26807603487430925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048595273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9723908,0.00005373498,0.01506431,0.0013959504,0.00020661397,0.0008476392,0.0000020316538,0.00015964563,0.009879328],"genre_scores_gemma":[0.97849065,0.0000056985505,0.018195001,0.00021579918,0.00014816734,0.00016314638,0.00007126491,0.00003069247,0.0026795648],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99827296,0.00012462217,0.00051745767,0.00042090728,0.00034013376,0.00032395104],"domain_scores_gemma":[0.9991044,0.0000399434,0.00010308833,0.0004310692,0.00013513885,0.00018638941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003920518,0.00020945256,0.00036074704,0.0001858111,0.00004399539,0.000048577404,0.000102793914,0.000096424024,0.0002894585],"category_scores_gemma":[0.00019206245,0.00016721476,0.00013229111,0.00025830822,0.000053846758,0.0001276328,0.000043821932,0.0001556348,0.00040721652],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031148206,0.0010772905,0.047280867,0.00011877393,0.000079334284,0.00017527587,0.0002591035,0.000061565755,0.9124995,0.00040084546,0.0018310306,0.03590494],"study_design_scores_gemma":[0.0038385445,0.00013226611,0.74748504,0.000030861956,0.000077681645,0.00007667832,0.00004459622,0.010084699,0.23729438,0.000031248746,0.0007591013,0.00014488232],"about_ca_topic_score_codex":0.0009390934,"about_ca_topic_score_gemma":0.00018243893,"teacher_disagreement_score":0.7002042,"about_ca_system_score_codex":0.00026533456,"about_ca_system_score_gemma":0.00010636735,"threshold_uncertainty_score":0.681882},"labels":[],"label_agreement":null},{"id":"W2048638532","doi":"10.1097/pas.0b013e318299f14a","title":"International Society of Urological Pathology (ISUP) Consensus Conference on Renal Neoplasia","year":2013,"lang":"en","type":"editorial","venue":"The American Journal of Surgical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Consensus conference; Medicine; Pathology; Anatomical pathology; Renal pathology; Kidney; Internal medicine; Immunohistochemistry","score_opus":0.025074509064308532,"score_gpt":0.29332220573635254,"score_spread":0.268247696672044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048638532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83324635,0.00044085825,0.000050380284,0.012161907,0.14861694,0.00039333734,0.00013707978,0.000024837742,0.0049283295],"genre_scores_gemma":[0.6752721,0.005669333,0.0030916252,0.00082801125,0.31372657,0.000032953696,0.00015742479,0.00009834468,0.0011236191],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951574,0.0011612377,0.0014444853,0.00048856356,0.0012366613,0.0005116569],"domain_scores_gemma":[0.9909248,0.0040185256,0.002828918,0.0005702822,0.0013572753,0.00030024405],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014405904,0.0005190451,0.0023505269,0.00021150241,0.000076989185,0.00001982529,0.0007179926,0.0006237399,0.0004368422],"category_scores_gemma":[0.0005980528,0.0002902422,0.001054585,0.00020940708,0.003304151,0.000026943533,0.00020420461,0.003315538,0.000065500695],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010526326,0.00082437956,0.0006210937,0.000045831806,0.0010345874,0.01861296,0.00040001055,0.000034421835,0.0043710414,0.00020651703,0.95379764,0.009525169],"study_design_scores_gemma":[0.010702529,0.041708067,0.007898522,0.00046224502,0.0015771801,0.059679747,0.0007999557,0.000121728335,0.0007555892,0.0010366137,0.87453747,0.0007203375],"about_ca_topic_score_codex":0.00002234923,"about_ca_topic_score_gemma":4.7756e-7,"teacher_disagreement_score":0.16510963,"about_ca_system_score_codex":0.00023273076,"about_ca_system_score_gemma":0.0007251548,"threshold_uncertainty_score":0.999955},"labels":[],"label_agreement":null},{"id":"W2048800818","doi":"10.1016/s0140-6736(08)60697-2","title":"An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial","year":2008,"lang":"en","type":"article","venue":"The Lancet","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":330,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Clinical endpoint; Population; Surgery; Intention-to-treat analysis; Internal medicine; Adjuvant therapy; Kidney cancer; Placebo; Randomized controlled trial; Cancer; Kidney","score_opus":0.0778533306348733,"score_gpt":0.32379723638333724,"score_spread":0.24594390574846392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048800818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860251,0.0009452254,0.00027340298,0.0002913947,0.00054514885,0.0113485595,0.00048104808,0.00004192795,0.000048196078],"genre_scores_gemma":[0.99109334,0.00019260756,0.0050030057,0.00022637416,0.000543043,0.001804393,0.0008349777,0.000051773623,0.000250516],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997626,0.00029615345,0.0006999714,0.000522472,0.0003364442,0.0005189762],"domain_scores_gemma":[0.99694765,0.0010055493,0.00060803175,0.00093574007,0.00034507024,0.00015795369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053215685,0.0003580789,0.001316427,0.00007127184,0.00024354176,0.000023848523,0.00043937372,0.00011973063,0.0000643811],"category_scores_gemma":[0.00021397969,0.0002296755,0.00017030591,0.000186684,0.00007619049,0.00018229481,0.000088224624,0.00017090312,0.000008371529],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96882874,0.0037349202,0.013678164,0.00011868789,0.00026311,0.000021245218,0.0008506742,0.000013758101,0.00505321,0.0000052848786,0.0017785025,0.0056537176],"study_design_scores_gemma":[0.89965814,0.016609833,0.05323138,0.000050858376,0.0015426486,0.000006787297,0.000022119038,0.0028341713,0.024435613,0.000040141156,0.0013206394,0.0002476383],"about_ca_topic_score_codex":0.00030543,"about_ca_topic_score_gemma":0.00008844842,"teacher_disagreement_score":0.06917056,"about_ca_system_score_codex":0.0002344484,"about_ca_system_score_gemma":0.00014120684,"threshold_uncertainty_score":0.93658954},"labels":[],"label_agreement":null},{"id":"W2049195732","doi":"10.1016/j.urolonc.2005.07.003","title":"Expectant management for the treatment of small renal masses","year":2006,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Dalhousie University; University of Toronto; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Natural history; Medicine; Life expectancy; Intensive care medicine; Incidence (geometry); Expectant management; Clinical trial; Pathology; Internal medicine; Pregnancy; Population","score_opus":0.10407458280995156,"score_gpt":0.3619331480926299,"score_spread":0.2578585652826783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049195732","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010823079,0.99172395,0.00014378274,0.00063019164,0.00017313127,0.0032801658,0.0000936261,0.00003577253,0.002837074],"genre_scores_gemma":[0.000008492021,0.92651594,0.06709948,0.00009615397,0.00022088645,0.0021537628,0.00034843732,0.00003163727,0.0035252369],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981856,0.0001290341,0.0006895804,0.0005177415,0.00014094662,0.00033713866],"domain_scores_gemma":[0.99781656,0.0010457415,0.0004834045,0.00044394075,0.000057813802,0.00015252622],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018649141,0.00047481322,0.0015802894,0.00022130224,0.00021306025,0.000015917498,0.00014337382,0.000350342,0.000027366745],"category_scores_gemma":[0.000023606564,0.00025356028,0.00050685933,0.00024219646,0.0006188852,0.000018232704,0.000035364297,0.00016630035,0.0000074117006],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014250618,0.0013300824,0.0014122038,0.005177094,0.0018633294,0.00055945397,0.00018043531,0.000015746506,0.00000306753,0.007816531,0.00541047,0.97608906],"study_design_scores_gemma":[0.00084689376,0.0068149143,0.000035783425,0.00083653466,0.011345546,0.00051696337,0.00006160959,0.000035185207,0.000016908518,0.0006717297,0.9786352,0.00018273102],"about_ca_topic_score_codex":0.00005344253,"about_ca_topic_score_gemma":0.000031173753,"teacher_disagreement_score":0.9759064,"about_ca_system_score_codex":0.00045898795,"about_ca_system_score_gemma":0.0004185485,"threshold_uncertainty_score":0.99999166},"labels":[],"label_agreement":null},{"id":"W2049482772","doi":"10.1111/his.12502","title":"Tubulocystic carcinoma of kidney: a challenging diagnostic entity mimicking multicystic kidney and presenting with bone metastasis","year":2014,"lang":"en","type":"article","venue":"Histopathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; St. Michael's Hospital; Markham Stouffville Hospital","funders":"","keywords":"Medicine; Library science; Medical laboratory; General surgery; Pathology","score_opus":0.01443603421375634,"score_gpt":0.23076648624566937,"score_spread":0.21633045203191303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049482772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99299204,0.0015266127,0.0028177253,0.00063957344,0.00016622062,0.00049555633,0.00001624211,0.00005854675,0.001287451],"genre_scores_gemma":[0.99467516,0.000045980963,0.00453514,0.00032612658,0.000092389775,0.000059462498,0.00003732715,0.000049569542,0.00017886737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981176,0.00020888951,0.00043075182,0.000538821,0.0002646772,0.0004392409],"domain_scores_gemma":[0.998018,0.0005399051,0.00023695809,0.00050264155,0.00013514256,0.0005673369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038402583,0.00028859908,0.0007773206,0.0002997345,0.00012063029,0.0000102296435,0.00008257678,0.000103210405,0.00004120649],"category_scores_gemma":[0.0035855682,0.00024119679,0.00009857483,0.00015590024,0.00031226204,0.00006151239,0.00010565335,0.00021596736,0.000012646194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004067472,0.00053905183,0.92955244,0.0028033142,0.00008934453,0.0035823307,0.002569654,0.000036654652,0.05762515,0.0005800817,0.00034686306,0.0018683478],"study_design_scores_gemma":[0.0057219574,0.00163662,0.9680598,0.0005994619,0.0022098578,0.0057679913,0.00017810741,0.0039480226,0.009401185,0.00012230153,0.0019110262,0.0004436786],"about_ca_topic_score_codex":0.00019345689,"about_ca_topic_score_gemma":0.000017329372,"teacher_disagreement_score":0.048223965,"about_ca_system_score_codex":0.00011220206,"about_ca_system_score_gemma":0.0001565165,"threshold_uncertainty_score":0.983572},"labels":[],"label_agreement":null},{"id":"W2049583363","doi":"10.1245/s10434-011-1715-2","title":"Mortality and Morbidity After Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Population-Based Study","year":2011,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Surgical oncology; Renal cell carcinoma; Nephrectomy; Oncology; Carcinoma; General surgery; Internal medicine; Kidney","score_opus":0.19727612798383531,"score_gpt":0.39094402004838946,"score_spread":0.19366789206455415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049583363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960328,0.00037965085,0.000025667438,0.00037559314,0.00007152628,0.00143648,0.000048856386,0.000017549595,0.0016119003],"genre_scores_gemma":[0.9978521,0.000018955103,0.001454605,0.00013834375,0.00007562894,0.00033248847,0.000039851897,0.000019240708,0.00006882676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983618,0.00024163189,0.00048371858,0.00039568404,0.00022648342,0.00029067925],"domain_scores_gemma":[0.9986417,0.00037141776,0.00020542115,0.00027913105,0.00026765818,0.00023461624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047331033,0.00020886614,0.0007700022,0.00012416602,0.000041335254,0.0000039009824,0.000058846577,0.00009482744,0.00019759743],"category_scores_gemma":[0.000028136234,0.00015922687,0.00021372635,0.00012649361,0.000120798104,0.00006036129,0.000036794594,0.000127563,0.0000034920574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006945267,0.0056514265,0.98283726,0.000179376,0.00031882594,0.0014064228,0.0008445633,0.0000051136017,0.0002148981,0.00006078071,0.00020530302,0.0013307662],"study_design_scores_gemma":[0.005158741,0.008138005,0.9759793,0.000011309424,0.0006416539,0.000037774098,0.00021416058,0.000053456588,0.00805267,0.00032693415,0.0012464796,0.00013949348],"about_ca_topic_score_codex":0.0018228106,"about_ca_topic_score_gemma":0.00014940588,"teacher_disagreement_score":0.007837772,"about_ca_system_score_codex":0.00007169508,"about_ca_system_score_gemma":0.00019168353,"threshold_uncertainty_score":0.6493083},"labels":[],"label_agreement":null},{"id":"W2049831707","doi":"10.1016/j.eururo.2011.02.023","title":"Growth Kinetics of Renal Masses: Analysis of a Prospective Cohort of Patients Undergoing Active Surveillance","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Cohort; Renal cell carcinoma; Prospective cohort study; Kidney disease; Urology; Surgery; Internal medicine; Radiology","score_opus":0.017046274446073952,"score_gpt":0.22625285601337922,"score_spread":0.20920658156730526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049831707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9495366,0.00005960926,0.0003072146,0.000010270327,0.00003315279,0.00029356306,0.000038976646,0.000010835239,0.049709786],"genre_scores_gemma":[0.99914825,0.00003064869,0.0006534211,0.000026007976,0.000013038967,0.000003266387,0.000052211817,0.000023356084,0.00004982092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985904,0.00031207886,0.00045929506,0.0002698495,0.00020896655,0.00015941018],"domain_scores_gemma":[0.9985551,0.00015406868,0.00047017378,0.00033168998,0.0004289194,0.00005999925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017442623,0.00013736245,0.0006191777,0.0003127597,0.000009218045,7.400777e-7,0.00010702827,0.000038570586,0.000105993284],"category_scores_gemma":[0.00023535428,0.000114838185,0.00017496162,0.0005025124,0.0002028334,0.000021694052,0.00007713425,0.00009299227,0.000004986135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011508967,0.00062211993,0.99016917,0.0000495829,0.0026410497,0.000043415002,0.0008819438,0.000019442,0.00413129,0.00016056329,0.000014300504,0.000116223106],"study_design_scores_gemma":[0.0012498607,0.003564874,0.9579157,0.000009543774,0.0016227557,0.0000032526887,0.00003725493,0.000024604493,0.035456378,0.00003736105,0.000012537901,0.00006584343],"about_ca_topic_score_codex":0.00006013435,"about_ca_topic_score_gemma":0.000040836574,"teacher_disagreement_score":0.049659964,"about_ca_system_score_codex":0.000046168403,"about_ca_system_score_gemma":0.00003202597,"threshold_uncertainty_score":0.46829653},"labels":[],"label_agreement":null},{"id":"W2049868634","doi":"10.1097/mou.0b013e32832a0814","title":"Predicting cancer-control outcomes in patients with renal cell carcinoma","year":2009,"lang":"en","type":"review","venue":"Current Opinion in Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Natural history; Kidney cancer; Life expectancy; Cancer; Gold standard (test); Internal medicine; Oncology; Radiology; Surgery; Kidney; Population","score_opus":0.05099246995650587,"score_gpt":0.342384439039919,"score_spread":0.29139196908341314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049868634","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018690052,0.97592187,0.0000060941725,0.00008263916,0.0021473188,0.002840301,0.0000985752,0.000036528854,0.0001766407],"genre_scores_gemma":[0.048794087,0.94920266,0.00002220195,0.000045520814,0.00043458104,0.00068284257,0.0007017132,0.000081613114,0.00003477133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99646187,0.0003717315,0.0011555833,0.0008885123,0.00041459856,0.00070768973],"domain_scores_gemma":[0.9983568,0.00022393932,0.0005804832,0.0005578595,0.000085539985,0.00019536531],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019762701,0.0007254995,0.0028638423,0.000810787,0.000034357185,0.000011778972,0.00023556393,0.00042063362,0.00004787678],"category_scores_gemma":[0.000047885424,0.0005031094,0.00033641414,0.00042254766,0.000075455035,0.000055074208,0.000061829815,0.0012016724,0.000026411382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019427034,0.0007665285,0.695789,0.0059073605,0.000052818006,0.000022313548,0.000040569506,0.0000137578445,2.148577e-8,0.000004345835,0.00011690116,0.2970921],"study_design_scores_gemma":[0.012192854,0.0029157598,0.64437026,0.007416192,0.00094660727,0.00002680024,0.0000032171922,0.000031508655,2.7150196e-7,0.000007023346,0.33155334,0.0005361858],"about_ca_topic_score_codex":0.0000855858,"about_ca_topic_score_gemma":0.00002495945,"teacher_disagreement_score":0.33143646,"about_ca_system_score_codex":0.00076202716,"about_ca_system_score_gemma":0.0006013199,"threshold_uncertainty_score":0.99974203},"labels":[],"label_agreement":null},{"id":"W2050877010","doi":"10.1016/j.eururo.2014.05.027","title":"International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia","year":2014,"lang":"en","type":"editorial","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Grading (engineering); Consensus conference; Malignancy; Renal pathology; Pathology; Nephrology; Anatomical pathology; General surgery; Internal medicine; Kidney; Immunohistochemistry","score_opus":0.02407704273938394,"score_gpt":0.26686912081388026,"score_spread":0.24279207807449632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050877010","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4231481,0.0008502787,0.0022157836,0.0012276602,0.55323774,0.001800754,0.0005260893,0.00018462859,0.016808987],"genre_scores_gemma":[0.4265448,0.00016909812,0.0032101804,0.00090131164,0.5659148,0.00006182381,0.0015046688,0.00024077794,0.0014525857],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99795216,0.0003012004,0.0004810499,0.00064720714,0.00027552713,0.00034284842],"domain_scores_gemma":[0.99707884,0.0019730537,0.00036478828,0.00028088762,0.0001741946,0.000128237],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005303019,0.0003577804,0.0007271993,0.00011390615,0.00005006711,0.000012295675,0.00021127611,0.00051536405,0.00005394007],"category_scores_gemma":[0.001351001,0.00027018684,0.0003114378,0.00004243381,0.00034707575,0.000016190777,0.00016086687,0.00060057995,0.000015470667],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089573103,0.00017203426,0.023419108,0.00019426298,0.0005431475,0.00018634406,0.0003984228,0.00000442709,0.0015784038,0.00009780308,0.9717381,0.00077221025],"study_design_scores_gemma":[0.0023038464,0.0038742505,0.0145346625,0.000027064825,0.0005298537,0.00016065761,0.000012307964,0.00009023492,0.00007640315,0.000062388324,0.9781439,0.00018446258],"about_ca_topic_score_codex":0.0000042801785,"about_ca_topic_score_gemma":8.8314283e-7,"teacher_disagreement_score":0.0153564,"about_ca_system_score_codex":0.000052057443,"about_ca_system_score_gemma":0.00008223749,"threshold_uncertainty_score":0.999975},"labels":[],"label_agreement":null},{"id":"W2050935911","doi":"10.1016/j.ejso.2007.09.009","title":"Sorafenib and surgical complications: a case report of adverse reaction to sorafenib during treatment for renal cell carcinoma","year":2008,"lang":"en","type":"article","venue":"European Journal of Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Sorafenib; Renal cell carcinoma; Medicine; Adverse effect; Internal medicine; Urology; Surgery; Oncology; Intensive care medicine; Hepatocellular carcinoma","score_opus":0.06380735743708227,"score_gpt":0.31074438931694387,"score_spread":0.2469370318798616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050935911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880837,0.0005167983,0.00007228914,0.00121712,0.000119740864,0.00058981346,0.000014660992,0.000014767063,0.009371096],"genre_scores_gemma":[0.9939155,0.0003461807,0.004340153,0.000027968155,0.00037653305,0.000013111638,0.000016967391,0.000038292852,0.00092531677],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9975192,0.0003656404,0.0012459919,0.00032631165,0.00025741564,0.0002854512],"domain_scores_gemma":[0.99761796,0.00032781626,0.0007771626,0.00029675182,0.00042244644,0.00055786106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065864227,0.00023731627,0.00084768,0.00027676745,0.00014701133,0.0000034812529,0.000075909,0.00007035276,0.000030612508],"category_scores_gemma":[0.000047489713,0.00017615479,0.00037505978,0.00016805305,0.00017336642,0.00007517394,0.000050521827,0.00021152993,0.000012954253],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006969187,0.0014855481,0.004027168,0.000061616316,0.00015568378,0.96181494,0.0006582424,0.000047037778,0.019623179,0.000021194806,0.00026139346,0.0048748315],"study_design_scores_gemma":[0.0139475195,0.009982232,0.04210867,0.00005066549,0.0003335517,0.8086193,0.00015664278,0.000011437832,0.011248629,0.0000036124368,0.11339919,0.00013851524],"about_ca_topic_score_codex":0.000029328894,"about_ca_topic_score_gemma":0.0000036684548,"teacher_disagreement_score":0.15319557,"about_ca_system_score_codex":0.0004899987,"about_ca_system_score_gemma":0.00026482774,"threshold_uncertainty_score":0.71833843},"labels":[],"label_agreement":null},{"id":"W2051463287","doi":"10.1007/s00330-013-2802-5","title":"Percutaneous radiofrequency ablation of small renal tumours in patients with a single functioning kidney: long-term results","year":2013,"lang":"en","type":"article","venue":"European Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Percutaneous; Neuroradiology; Radiofrequency ablation; Interventional radiology; Radiology; Ablation; Kidney; Ultrasound; Catheter ablation; Internal medicine; Neurology","score_opus":0.016231582549685097,"score_gpt":0.20273020090054558,"score_spread":0.18649861835086048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051463287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831044,0.00014001213,0.000114154755,0.00014014558,0.00010819271,0.00058083487,0.000007872648,0.00004217689,0.015762199],"genre_scores_gemma":[0.997119,0.000009210534,0.0017964059,0.00014377537,0.00010231226,0.0000053715803,0.00030163955,0.000043561893,0.0004787314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983988,0.0003299977,0.0004646941,0.00036962493,0.00014667696,0.0002902545],"domain_scores_gemma":[0.99905455,0.000068241694,0.00021508135,0.0003436609,0.00014395243,0.00017451328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018343,0.00019135374,0.00034961678,0.00020772152,0.000035839686,0.000010199615,0.00008677212,0.000052846637,0.000094573596],"category_scores_gemma":[0.00017681328,0.00014584383,0.000056694626,0.00016777024,0.00012445409,0.00006619649,0.000025046,0.00018914368,0.000075484684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013949216,0.0003626613,0.9775522,0.000046342266,0.00007433427,0.001020065,0.00056355057,0.00017414574,0.013904138,0.000010079404,0.00029428318,0.004603297],"study_design_scores_gemma":[0.0038408616,0.0038464004,0.99031,0.000174311,0.00007282283,0.0010211976,0.000014920094,0.000044099157,0.0005043884,0.000004225673,0.000035933095,0.00013085348],"about_ca_topic_score_codex":0.00007434836,"about_ca_topic_score_gemma":0.0000062532467,"teacher_disagreement_score":0.015283467,"about_ca_system_score_codex":0.00024118116,"about_ca_system_score_gemma":0.00006321517,"threshold_uncertainty_score":0.5947339},"labels":[],"label_agreement":null},{"id":"W2051494228","doi":"10.1002/gcc.10209","title":"Patterns of aneuploidy in stage IV clear cell renal cell carcinoma revealed by comparative genomic hybridization and spectral karyotyping","year":2003,"lang":"en","type":"article","venue":"Genes Chromosomes and Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Comparative genomic hybridization; Karyotype; Biology; Chromosomal translocation; Renal cell carcinoma; Chromosome; Aneuploidy; Carcinogenesis; Clear cell renal cell carcinoma; Chromosome 7 (human); Genetics; Chromosome 3; Cancer research; Molecular biology; Pathology; Cancer; Gene; Medicine","score_opus":0.01921366886242087,"score_gpt":0.25044107582136904,"score_spread":0.23122740695894817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051494228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9691219,0.029729722,0.000017100892,0.000033763794,0.000046173118,0.00041251222,0.000085584936,0.000008658492,0.00054459303],"genre_scores_gemma":[0.99427986,0.0044061737,0.00014524336,0.00005314628,0.000047419333,0.000026698279,0.00004385255,0.000022884205,0.0009746994],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989271,0.0000660859,0.00028615684,0.00034224795,0.0001365076,0.00024191325],"domain_scores_gemma":[0.9995385,0.00002293288,0.0001291839,0.00015780602,0.000036764406,0.00011480981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007086924,0.00019582918,0.00040732368,0.000079921236,0.000044352313,0.000012648379,0.00003614297,0.000054722303,0.00016151692],"category_scores_gemma":[0.0000015102663,0.00017381056,0.000043091095,0.000100637844,0.00004594157,0.00005759345,0.000023594968,0.00009770922,0.0000016750887],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015375866,0.00011983372,0.62115514,0.00043814525,0.000022591637,0.000050094688,0.000974305,0.00006579517,0.37652838,0.000010910987,0.00010302089,0.00037802893],"study_design_scores_gemma":[0.002772172,0.000588974,0.46013334,0.000073989584,0.00008374064,0.000027851152,0.0005704997,0.00017088943,0.5344683,0.000006410686,0.0009240091,0.00017980149],"about_ca_topic_score_codex":0.00053777295,"about_ca_topic_score_gemma":0.00010802455,"teacher_disagreement_score":0.16102178,"about_ca_system_score_codex":0.00014738055,"about_ca_system_score_gemma":0.000090198264,"threshold_uncertainty_score":0.7087789},"labels":[],"label_agreement":null},{"id":"W2052076354","doi":"10.1007/s10637-013-9931-1","title":"A phase II study of cediranib (AZD 2171) in treatment naive patients with progressive unresectable recurrent or metastatic renal cell carcinoma. A trial of the PMH phase 2 consortium","year":2013,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Juravinski Cancer Centre; Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Tolerability; Internal medicine; Sunitinib; Clinical endpoint; Renal cell carcinoma; Progressive disease; Phases of clinical research; Pazopanib; Oncology; Adverse effect; Gastroenterology; Clinical trial; Surgery; Disease","score_opus":0.03995789522017983,"score_gpt":0.3047918596194014,"score_spread":0.2648339643992216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052076354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897096,0.00018012134,0.000001980197,0.00041392923,0.000104627456,0.009234152,0.00011191206,0.000013969527,0.00022969279],"genre_scores_gemma":[0.99723285,0.000002678239,0.00082594814,0.00007261264,0.00008016168,0.0009115597,0.00014705525,0.000033619785,0.0006935256],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967691,0.0003011908,0.0009703829,0.0004897315,0.0011269973,0.00034259728],"domain_scores_gemma":[0.9977503,0.00027740025,0.0007539676,0.0004532428,0.00042309263,0.00034203773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015078273,0.00038938937,0.0007656681,0.00023667746,0.000101990045,0.000016967084,0.00017999201,0.000057424324,0.00026249883],"category_scores_gemma":[0.00014834017,0.0002092597,0.00014606443,0.0006484302,0.00031112536,0.00016272366,0.00007719239,0.00019147045,0.0000069236544],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34138772,0.36454576,0.17913643,0.0009325231,0.0027623768,0.00044311307,0.06931653,0.00047084285,0.018022146,0.00024031359,0.0046107643,0.018131493],"study_design_scores_gemma":[0.72542536,0.15058485,0.036963757,0.00048241758,0.0014228899,0.000021000747,0.0022992657,0.0003139247,0.08168406,0.00031992237,0.00011449626,0.0003680738],"about_ca_topic_score_codex":0.0014884821,"about_ca_topic_score_gemma":0.0000867904,"teacher_disagreement_score":0.3840376,"about_ca_system_score_codex":0.00037471068,"about_ca_system_score_gemma":0.0016868633,"threshold_uncertainty_score":0.85333633},"labels":[],"label_agreement":null},{"id":"W2052299340","doi":"10.1016/j.urolonc.2013.08.030","title":"Local tumor destruction in renal cell carcinoma—An inpatient population-based study","year":2013,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Logistic regression; Cohort; Complication; Population; Comorbidity; Retrospective cohort study; Cohort study; Surgery; Internal medicine; Emergency medicine","score_opus":0.025147298548234005,"score_gpt":0.28133930730913903,"score_spread":0.25619200876090503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052299340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967602,0.00013913172,0.00007454642,0.00095762894,0.00010750056,0.0013048584,0.00000365091,0.000051932235,0.00060059037],"genre_scores_gemma":[0.980603,0.0000028635677,0.017814094,0.0008967905,0.000057302732,0.0003840025,0.00012592349,0.000016937836,0.00009912149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982652,0.00026735,0.0004486772,0.00048562014,0.00021165096,0.0003214874],"domain_scores_gemma":[0.9989783,0.00014228768,0.00016170167,0.0002741397,0.000086383494,0.0003571541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021858363,0.00023930449,0.00037814068,0.00030319416,0.00017102897,0.000025428822,0.000078280675,0.00015280145,0.00016973312],"category_scores_gemma":[0.00004773188,0.0001973288,0.000046661637,0.0003122655,0.00023744038,0.00016863283,0.00002992024,0.00034534704,0.000036305784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010097572,0.0011352521,0.99515,0.000019611518,0.000009179749,0.0002372356,0.00034286553,0.0010046605,0.0005417845,0.00019041084,0.00011810202,0.0011499079],"study_design_scores_gemma":[0.0024251181,0.011405869,0.97390926,0.000018174622,0.00018233282,0.00016362114,0.00089893595,0.0057008713,0.0011600382,0.0015780368,0.0023552394,0.00020250387],"about_ca_topic_score_codex":0.0025167132,"about_ca_topic_score_gemma":0.00043125404,"teacher_disagreement_score":0.021240756,"about_ca_system_score_codex":0.0004825981,"about_ca_system_score_gemma":0.00033243033,"threshold_uncertainty_score":0.8046835},"labels":[],"label_agreement":null},{"id":"W2052762622","doi":"10.1097/coc.0b013e3181574084","title":"Sorafenib for Metastatic Renal Cancer","year":2008,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Sorafenib; Rash; Internal medicine; Adverse effect; Population; Placebo; Common Terminology Criteria for Adverse Events; Oncology; Surgery; Cancer; Cohort; Gastroenterology; Hepatocellular carcinoma; Pathology","score_opus":0.22788009951966287,"score_gpt":0.5035995736530775,"score_spread":0.27571947413341463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052762622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98658866,0.0007265958,0.0018349864,0.008673614,0.000605118,0.00027702135,0.000007018611,0.0000092078935,0.0012777827],"genre_scores_gemma":[0.9561794,0.001243676,0.03762687,0.0031240704,0.0011296968,0.000023087425,0.0000026595367,0.000024670733,0.00064586004],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972223,0.00031241972,0.0016876064,0.00019243638,0.0003050206,0.00028023287],"domain_scores_gemma":[0.9948056,0.0023225513,0.0016855665,0.0001824713,0.00051869324,0.00048516324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011291326,0.00014796112,0.001776852,0.00011701792,0.000052078518,0.0000025807096,0.00013468633,0.000065417385,0.00015018527],"category_scores_gemma":[0.0011401607,0.00009857511,0.00076880533,0.00017745263,0.00079880713,0.000052458792,0.000021371872,0.0004588771,0.000015635358],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01640881,0.0027633402,0.093388826,0.000036687838,0.0024579389,0.005261813,0.000349957,0.00010507351,0.0010347686,0.00009059479,0.021819722,0.8562825],"study_design_scores_gemma":[0.02781839,0.13408658,0.35066557,0.00016618008,0.003513582,0.013552295,0.0005135775,0.00022727277,0.0019075122,0.000486715,0.46669462,0.00036769797],"about_ca_topic_score_codex":0.0000526346,"about_ca_topic_score_gemma":0.000014691241,"teacher_disagreement_score":0.8559148,"about_ca_system_score_codex":0.0001988367,"about_ca_system_score_gemma":0.0021968253,"threshold_uncertainty_score":0.40197766},"labels":[],"label_agreement":null},{"id":"W2053203696","doi":"10.1016/j.eururo.2007.04.014","title":"Re: Sorafenib in Advanced Clear-Cell Renal Cell Carcinoma","year":2007,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Sorafenib; Renal cell carcinoma; Oncology; Internal medicine; Urology; Carcinoma; Clear cell renal cell carcinoma; Cancer research; Hepatocellular carcinoma","score_opus":0.015568587513944986,"score_gpt":0.24088874921630618,"score_spread":0.2253201617023612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053203696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7108092,0.0008102051,0.000099738645,0.00041877315,0.00014872556,0.000270282,0.0000016143496,0.00006095506,0.28738052],"genre_scores_gemma":[0.99189764,0.000023984841,0.0010446482,0.0017049026,0.00023415552,0.0000037399734,0.000030394016,0.000089241796,0.0049712686],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977794,0.00029666422,0.00048991863,0.00055999204,0.00021224447,0.0006617319],"domain_scores_gemma":[0.998829,0.0001451281,0.00012703675,0.0005876815,0.00005433537,0.00025679392],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007245407,0.00026268692,0.0003630513,0.0002642575,0.000047768408,0.000007943544,0.00017607039,0.000092713344,0.00026449407],"category_scores_gemma":[0.000054990396,0.00023907554,0.000119418764,0.00025776777,0.00010564431,0.000045188695,0.00011543228,0.0004848999,0.0013254936],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015397714,0.002923394,0.30020043,0.000279622,0.00006694791,0.08854046,0.0034236184,0.0004693836,0.55268186,0.0002034385,0.010893206,0.02491989],"study_design_scores_gemma":[0.00891783,0.004792042,0.85402054,0.000011898609,0.00010348063,0.0002705172,0.00023016654,0.0000443251,0.072367325,0.000028127983,0.05887725,0.00033652593],"about_ca_topic_score_codex":0.000027840053,"about_ca_topic_score_gemma":0.000052012398,"teacher_disagreement_score":0.5538201,"about_ca_system_score_codex":0.00013140056,"about_ca_system_score_gemma":0.000053708543,"threshold_uncertainty_score":0.9994521},"labels":[],"label_agreement":null},{"id":"W2053690300","doi":"10.5489/cuaj.11196","title":"Intrahepatic extension of renal cell carcinoma tumor thrombus causing Budd-Chiari syndrome","year":2011,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Budd–Chiari syndrome; Medicine; Renal cell carcinoma; Pathology; Thrombus; Radiology; Internal medicine; Inferior vena cava","score_opus":0.02609098127684872,"score_gpt":0.21017542572685086,"score_spread":0.18408444445000213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053690300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936397,0.0003660116,0.00004852111,0.00092909636,0.00027520928,0.00023589726,0.000015332762,0.000018402503,0.0044718264],"genre_scores_gemma":[0.9977085,0.000017474931,0.0009657001,0.0009316263,0.00013372963,0.000003702244,0.000013986862,0.000022428652,0.00020287505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783367,0.00020694437,0.000605464,0.00026786016,0.00049178366,0.0005942727],"domain_scores_gemma":[0.9978242,0.00009774897,0.0005372669,0.00021320296,0.00039548552,0.00093210913],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00059525453,0.00021640066,0.00052230037,0.00030094665,0.0002032916,0.000027279131,0.00010638387,0.00021997347,0.0013730791],"category_scores_gemma":[0.00033174577,0.00016960484,0.00023029947,0.00025305088,0.0000614088,0.000097611395,0.000023169388,0.000614948,0.000052720487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014888248,0.00024512626,0.98125285,0.0000308953,0.00013911397,0.00737072,0.0005455611,0.000020663672,0.008239449,0.00006841136,0.0014730688,0.00046526061],"study_design_scores_gemma":[0.0010870293,0.0014554168,0.98846906,0.00003288512,0.0003005239,0.004504171,0.000078207435,0.00013845444,0.0031152396,0.00040354035,0.0002581993,0.00015729484],"about_ca_topic_score_codex":0.0042819087,"about_ca_topic_score_gemma":0.0004258382,"teacher_disagreement_score":0.007216191,"about_ca_system_score_codex":0.0014530742,"about_ca_system_score_gemma":0.0007436625,"threshold_uncertainty_score":0.9995398},"labels":[],"label_agreement":null},{"id":"W2053981520","doi":"10.1016/j.jpurol.2014.02.006","title":"Feasibility of using CT volume as a predictor of specimen weight in a subgroup of patients with low risk Wilms tumors registered on COG Study AREN03B2: Implications for central venous catheter placement","year":2014,"lang":"en","type":"article","venue":"Journal of Pediatric Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre","funders":"National Cancer Institute","keywords":"Medicine; Cog; Subgroup analysis; Central venous catheter; Wilms tumour; Wilms' tumor; Radiology; Internal medicine; Oncology; Catheter; Confidence interval","score_opus":0.02373793167074208,"score_gpt":0.2712050131134829,"score_spread":0.2474670814427408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053981520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978413,0.00017112897,0.00023205511,0.000056349996,0.00010223758,0.0014793021,0.000090137066,0.0000028166558,0.000024646355],"genre_scores_gemma":[0.9992414,0.000020690835,0.00047721557,0.000015685911,0.000190582,0.000014238945,0.000011696619,0.0000213385,0.000007140886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977402,0.00023613809,0.0011279255,0.00024368173,0.00037498432,0.00027705255],"domain_scores_gemma":[0.9968206,0.0002415614,0.0019847513,0.00040697554,0.00040167628,0.00014440491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005331438,0.00018296327,0.00081083865,0.00037274839,0.000025374338,0.0000025335278,0.00014751211,0.000056121364,0.000017121645],"category_scores_gemma":[0.0002571278,0.00013161142,0.00018007212,0.00021601509,0.00008451924,0.000044674307,0.00003158755,0.00020763291,4.3536616e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077495133,0.0106064975,0.9799156,0.00009434974,0.00032046085,0.000017134433,0.00072195067,0.00032351303,0.000115380324,0.000003837698,0.00004968442,0.00008207839],"study_design_scores_gemma":[0.013285636,0.03706595,0.9470948,0.00001877958,0.0019988602,0.00004094574,0.00006272766,0.00014104818,0.0001496581,0.000056492918,0.0000086542395,0.000076442644],"about_ca_topic_score_codex":0.00012781553,"about_ca_topic_score_gemma":0.00003645603,"teacher_disagreement_score":0.03282079,"about_ca_system_score_codex":0.00023518206,"about_ca_system_score_gemma":0.00027396728,"threshold_uncertainty_score":0.5366958},"labels":[],"label_agreement":null},{"id":"W2054068761","doi":"10.1007/s00428-009-0871-2","title":"Renal cell carcinoma with mixed features of papillary and clear cell cytomorphology: a fluorescent in situ hybridization study","year":2009,"lang":"en","type":"article","venue":"Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Pathology; Fluorescence in situ hybridization; Cytokeratin; Clear cell; Papillary renal cell carcinomas; Biology; Renal cell carcinoma; Chromosome; Immunohistochemistry; Medicine; Genetics","score_opus":0.01844039474070859,"score_gpt":0.2956734243140486,"score_spread":0.27723302957334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054068761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98664224,0.0051014773,0.00010507771,0.00056835,0.000091380556,0.0020513586,0.000027362155,0.00011069989,0.0053020804],"genre_scores_gemma":[0.99409294,0.00075609924,0.0038727908,0.0006607138,0.00013586093,0.000050557297,0.00025884208,0.000060963514,0.000111244015],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9953016,0.00087545346,0.0010093735,0.0012846701,0.00065626105,0.00087264716],"domain_scores_gemma":[0.99729526,0.00055301195,0.0005177423,0.0010827959,0.00016431508,0.00038688653],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00088740425,0.00075560785,0.0015384189,0.0005632044,0.00014842354,0.000022654664,0.0003907342,0.00030314035,0.000017116916],"category_scores_gemma":[0.00023121345,0.0005140725,0.0001924045,0.0006477125,0.00084831467,0.00011740303,0.00023613278,0.0011172282,0.000012827457],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008716946,0.006031029,0.16994214,0.00037133656,0.00025170503,0.008013883,0.003459883,0.00019926537,0.7933039,0.00019180676,0.0009979468,0.00852014],"study_design_scores_gemma":[0.008918855,0.01748448,0.7574536,0.00015020257,0.0006681062,0.00014531787,0.002027561,0.00007314839,0.21226445,0.00032090273,0.00006542403,0.00042792468],"about_ca_topic_score_codex":0.00020669887,"about_ca_topic_score_gemma":0.00007318438,"teacher_disagreement_score":0.5875115,"about_ca_system_score_codex":0.00010919565,"about_ca_system_score_gemma":0.00034186884,"threshold_uncertainty_score":0.99973106},"labels":[],"label_agreement":null},{"id":"W2054151954","doi":"10.1016/j.prp.2011.11.001","title":"Needle core biopsies provide ample material for genomic and proteomic studies of kidney cancer: Observations on DNA, RNA, protein extractions and VHL mutation detection","year":2011,"lang":"en","type":"article","venue":"Pathology - Research and Practice","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Hospital for Sick Children; Kingston General Hospital; Toronto Western Hospital; Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Kidney cancer; RNA; Cancer; DNA; genomic DNA; Cancer research; Mutation; Biology; Computational biology; Molecular biology; Gene; Genetics","score_opus":0.35323748680617295,"score_gpt":0.43098404451862254,"score_spread":0.0777465577124496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054151954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937608,0.0006112926,0.00005830271,0.0022660168,0.00008297187,0.0028904402,0.00011466781,0.000017959037,0.000197536],"genre_scores_gemma":[0.9898234,0.001064415,0.0065357136,0.00007185594,0.00009233326,0.0019817736,0.000033094075,0.000017916425,0.00037951156],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988302,0.0002559872,0.00022468719,0.000309956,0.00014750384,0.0002316909],"domain_scores_gemma":[0.9983656,0.00069365144,0.00015948863,0.00015354385,0.00047474226,0.00015300208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009518894,0.000118369775,0.00022651028,0.0001951535,0.00032272752,0.000022129489,0.000030048132,0.00009305954,0.00001290074],"category_scores_gemma":[0.004138857,0.000089465364,0.000019160316,0.00011677139,0.00040061685,0.00024570405,0.00004984753,0.00020277199,0.000001521704],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005489596,0.00023250007,0.0024873319,0.0005079501,0.00013323044,0.00005754206,0.0025037874,2.452248e-7,0.98325115,0.0002223307,0.00009470786,0.005019601],"study_design_scores_gemma":[0.003517587,0.0116861705,0.22575481,0.00023579778,0.00041780272,0.0011089402,0.007580877,0.000093140006,0.74291193,0.0042706425,0.0022093798,0.00021290508],"about_ca_topic_score_codex":0.000912712,"about_ca_topic_score_gemma":0.00013652736,"teacher_disagreement_score":0.24033922,"about_ca_system_score_codex":0.00009220763,"about_ca_system_score_gemma":0.00018992758,"threshold_uncertainty_score":0.49548975},"labels":[],"label_agreement":null},{"id":"W2054367364","doi":"10.1016/j.eururo.2012.04.049","title":"A Review of Integrated Staging Systems for Renal Cell Carcinoma","year":2012,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Carcinoma; Kidney cancer; Urology; Oncology; Internal medicine","score_opus":0.08266134731898771,"score_gpt":0.3110269158727544,"score_spread":0.22836556855376666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054367364","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021796342,0.97925663,0.00012631522,0.000030749965,0.00048022266,0.0032400936,0.00016175522,0.00005354569,0.016628869],"genre_scores_gemma":[0.00036918346,0.99538076,0.00018730642,0.00032670467,0.0005165923,0.00015880079,0.001167293,0.00021645642,0.0016769171],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959523,0.0013740712,0.0013753896,0.0005642152,0.00019097503,0.0005430494],"domain_scores_gemma":[0.9972784,0.00030582258,0.0010057526,0.00091980153,0.00024335326,0.00024688296],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012215702,0.00060902303,0.0032823812,0.00028841142,0.00003616685,0.0000078346375,0.00029855772,0.0001691733,0.0001085385],"category_scores_gemma":[0.0001332597,0.00041822044,0.00091823074,0.00026829893,0.0000963552,0.000025836924,0.00012519986,0.00049361144,0.0002740735],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006822658,0.00020118366,0.000044248438,0.67432016,0.0003574468,0.00036419995,0.000037628688,2.4613388e-7,0.000010387192,0.00005293134,0.010932871,0.3136105],"study_design_scores_gemma":[0.0005671472,0.00097535824,0.00002331766,0.03978251,0.008471948,0.00070079,0.000004297366,0.000002755977,0.0000048943452,3.050885e-7,0.9492225,0.00024416202],"about_ca_topic_score_codex":0.000021218091,"about_ca_topic_score_gemma":1.9957272e-7,"teacher_disagreement_score":0.93828964,"about_ca_system_score_codex":0.00020145992,"about_ca_system_score_gemma":0.0003721865,"threshold_uncertainty_score":0.99982697},"labels":[],"label_agreement":null},{"id":"W2054420426","doi":"10.1038/bjc.2012.548","title":"Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institut National Du Cancer; Institute of Cancer Research; Vlaamse regering; Hellenic Society of Medical Oncology; Vlaamse Liga Tegen Kanker","keywords":"Sunitinib; Medicine; Single-nucleotide polymorphism; Internal medicine; Oncology; Renal cell carcinoma; Clear cell renal cell carcinoma; Proportional hazards model; Progression-free survival; Kidney cancer; Genotype; Biology; Chemotherapy; Gene","score_opus":0.029628351071134377,"score_gpt":0.2537770313473713,"score_spread":0.2241486802762369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054420426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929138,0.0041669696,0.000011623387,0.00038100424,0.0000559822,0.00049246417,0.000024820152,0.00001794136,0.001935394],"genre_scores_gemma":[0.99706334,0.00009051199,0.0006481014,0.00030966013,0.00010821606,0.000037963375,0.00001783517,0.000071999624,0.0016523518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770516,0.00014257281,0.00076142896,0.00023333888,0.0006910582,0.00046643818],"domain_scores_gemma":[0.9981507,0.00010635483,0.00063360814,0.00016345686,0.0005987822,0.00034708087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021952942,0.0002716516,0.0008263568,0.00026600313,0.00005606639,0.00009373603,0.00012684526,0.00006520427,0.0006230744],"category_scores_gemma":[0.000050246443,0.0002089002,0.00014598857,0.0004476849,0.00012727638,0.00028428633,0.000016856713,0.0004696837,0.000010036736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008381755,0.000916578,0.95351017,0.000059395086,0.00041051762,0.020097312,0.000153146,0.0000787826,0.010389755,9.890309e-7,0.00061925786,0.01292594],"study_design_scores_gemma":[0.011272837,0.0029371916,0.9592383,0.0013212186,0.0007501843,0.005272863,0.00018855032,0.000023623883,0.018541269,0.00000922791,0.00018586741,0.00025890427],"about_ca_topic_score_codex":0.007992973,"about_ca_topic_score_gemma":0.0036022856,"teacher_disagreement_score":0.014824449,"about_ca_system_score_codex":0.0007090886,"about_ca_system_score_gemma":0.00034682505,"threshold_uncertainty_score":0.9986129},"labels":[],"label_agreement":null},{"id":"W2055197266","doi":"10.1136/jmg.2009.072009","title":"Renal tumour suppressor function of the Birt–Hogg–Dubé syndrome gene product folliculin","year":2009,"lang":"en","type":"article","venue":"Journal of Medical Genetics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Medicine; Folliculin; Pathology; Pulmonary function testing; Hypoxemia; Pulmonary alveolar proteinosis; Lung; Gastroenterology; Internal medicine; Biology; Gene; Genetics","score_opus":0.020433403227727007,"score_gpt":0.26427626394284975,"score_spread":0.24384286071512273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055197266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98364305,0.004830714,0.00037489133,0.009988785,0.0006383939,0.0002830257,0.000003431109,0.000008303825,0.00022937666],"genre_scores_gemma":[0.9961459,0.00063407735,0.0014588523,0.0005674045,0.0008454892,0.0000017025267,0.0000028212537,0.000018355802,0.00032541313],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9960917,0.00013833583,0.0009078609,0.0001826904,0.0024159625,0.00026345663],"domain_scores_gemma":[0.99824107,0.00006390763,0.00053820584,0.00038780025,0.00033958248,0.0004294486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000853951,0.00018869054,0.00053734164,0.00012815758,0.00004878396,0.00001208494,0.00035142255,0.00015995883,0.0002513666],"category_scores_gemma":[0.00046073072,0.00010425517,0.00036805688,0.00028393997,0.00012397573,0.00003542813,0.000056227505,0.0005749464,0.000009568901],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002141754,0.0029379108,0.020370057,0.00029147015,0.0010712539,0.0035566515,0.00047077498,0.0005524902,0.8829329,0.000100444755,0.017866805,0.06770749],"study_design_scores_gemma":[0.00352354,0.0045188894,0.59716845,0.00047953698,0.0008602731,0.010401504,0.000036511145,0.00015514033,0.37905335,0.00028852047,0.003382605,0.00013169812],"about_ca_topic_score_codex":0.000004887861,"about_ca_topic_score_gemma":0.0000017316208,"teacher_disagreement_score":0.5767984,"about_ca_system_score_codex":0.00010012138,"about_ca_system_score_gemma":0.00052922644,"threshold_uncertainty_score":0.42514023},"labels":[],"label_agreement":null},{"id":"W2055453759","doi":"10.1016/j.eururo.2011.08.045","title":"Reply from Authors re: Simon P. Kim, R. Houston Thompson. Competing-Risks Analysis for Renal Cell Carcinoma: How Do We Accurately Communicate the Risks and Benefits of Treatment to Patients? Eur Urol 2011;60:1160–2","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Urology; Intensive care medicine; General surgery; Oncology","score_opus":0.1506185232062442,"score_gpt":0.2915797787935549,"score_spread":0.1409612555873107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055453759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863234,0.005202157,0.0001518527,0.0029652887,0.00014634998,0.0015073019,0.00029288683,0.000069845235,0.0033409123],"genre_scores_gemma":[0.9961242,0.00069511496,0.0016198044,0.00064288295,0.00013057781,0.00006744099,0.00023965398,0.00011580308,0.0003645197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960433,0.0014282204,0.0007423125,0.00091973017,0.00027597861,0.00059040694],"domain_scores_gemma":[0.9961074,0.0006759306,0.0006834511,0.0018718049,0.0002834021,0.0003779965],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007129586,0.0005521113,0.0010587022,0.0003346972,0.00025962628,0.000040095798,0.0005498211,0.00013264592,0.00013285334],"category_scores_gemma":[0.00013687389,0.00037322965,0.0004204049,0.0003461876,0.0002544522,0.00006449037,0.00040370552,0.0003657463,0.00006228657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007740884,0.001711634,0.9521262,0.000067303175,0.0020434954,0.00027165705,0.012203233,0.0010250598,0.001995493,0.000039599865,0.0033857522,0.017389676],"study_design_scores_gemma":[0.004450331,0.0100587215,0.96328807,0.000018893743,0.0048521245,0.000009722728,0.0003400035,0.0003521737,0.0063183024,0.000021155418,0.0099653695,0.00032512465],"about_ca_topic_score_codex":0.0025045662,"about_ca_topic_score_gemma":0.00029505364,"teacher_disagreement_score":0.01706455,"about_ca_system_score_codex":0.00012880085,"about_ca_system_score_gemma":0.00005094045,"threshold_uncertainty_score":0.99987197},"labels":[],"label_agreement":null},{"id":"W2055827929","doi":"10.1016/s1470-2045(12)70391-1","title":"Conditional survival of patients with metastatic renal-cell carcinoma","year":2012,"lang":"en","type":"letter","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Oncology; Sorafenib; Internal medicine; Context (archaeology); Population; Clear cell renal cell carcinoma; Carcinoma; Kidney cancer; Targeted therapy; Cancer","score_opus":0.056122131624055105,"score_gpt":0.2929632004744176,"score_spread":0.2368410688503625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055827929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69173217,0.0009368859,0.00005455555,0.27254885,0.0006929016,0.0018403758,0.00094343646,0.00004814158,0.031202655],"genre_scores_gemma":[0.8329477,0.000019389887,0.00093968114,0.15313433,0.0040969234,0.0001545546,0.005393022,0.000090931,0.0032234597],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975433,0.0005253302,0.00040749702,0.00031000466,0.0006428334,0.00057107554],"domain_scores_gemma":[0.99776495,0.00063348253,0.0005252527,0.0007392465,0.0002524272,0.00008465685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035561292,0.00035787126,0.0014465029,0.00011366419,0.000051965104,0.000005105746,0.00025764597,0.00031840528,0.0007059579],"category_scores_gemma":[0.000024593905,0.00019349651,0.00017123435,0.00012089834,0.00036591463,0.00003247337,0.00007614762,0.0011948001,0.0001253332],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015627955,0.00064089877,0.07786378,0.0008080829,0.000694846,0.0008948686,0.0002267704,0.0000037318741,0.000097279844,0.00007817129,0.91688067,0.00024811339],"study_design_scores_gemma":[0.008668612,0.0032164468,0.31463754,0.000049952985,0.002330668,0.000129285,0.000021468082,0.0000019149306,0.000593843,0.0001425675,0.6699572,0.000250486],"about_ca_topic_score_codex":0.000058862493,"about_ca_topic_score_gemma":0.000012291162,"teacher_disagreement_score":0.24692345,"about_ca_system_score_codex":0.00036000155,"about_ca_system_score_gemma":0.00039269336,"threshold_uncertainty_score":0.7890559},"labels":[],"label_agreement":null},{"id":"W2056649589","doi":"10.5489/cuaj.1682","title":"Oncological outcomes of partial nephrectomy for tumours larger than 4 cm: A systematic review","year":2014,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Nephrectomy; Medicine; Kidney cancer; Urology; Renal cell carcinoma; Cancer; Surgery; Internal medicine; Kidney","score_opus":0.04841056698757397,"score_gpt":0.3214295549948149,"score_spread":0.27301898800724095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056649589","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008245828,0.9907811,0.00003410132,0.0029699346,0.00038624677,0.005194841,0.00013783155,0.00002496974,0.00038849044],"genre_scores_gemma":[0.0008669532,0.99354535,0.0002454515,0.0028943708,0.00051714835,0.000947371,0.0001737699,0.000049566137,0.000760042],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946353,0.0013027112,0.0021629808,0.0004020128,0.00070041046,0.00079661433],"domain_scores_gemma":[0.99350995,0.0017338732,0.0027705806,0.0003436244,0.000514117,0.001127886],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031148568,0.00055111345,0.006791297,0.00030926272,0.00017015221,0.000055848886,0.00033549205,0.0008395582,0.00030721514],"category_scores_gemma":[0.0070061465,0.00031191052,0.002662271,0.00029753408,0.00004586262,0.000043021602,0.000027083064,0.00096937356,0.00009461442],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054972537,0.0003834416,0.024985923,0.9208665,0.004622148,0.0005109131,0.00002983175,8.8287214e-7,1.9331642e-7,0.0004220314,0.03056688,0.017556269],"study_design_scores_gemma":[0.000952901,0.0011910765,0.0025924565,0.10955765,0.019570667,0.0009539037,0.000005886397,0.000005259668,2.502467e-7,0.00007528259,0.86472183,0.0003728333],"about_ca_topic_score_codex":0.000109244625,"about_ca_topic_score_gemma":0.00009118245,"teacher_disagreement_score":0.83415496,"about_ca_system_score_codex":0.003004469,"about_ca_system_score_gemma":0.001856814,"threshold_uncertainty_score":0.9999333},"labels":[],"label_agreement":null},{"id":"W2057414744","doi":"10.3747/co.v16i0.407","title":"State-of-the-Art Treatment of Metastatic Renal Cell Carcinoma","year":2009,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Renal cell carcinoma; Immunotherapy; Angiogenesis; Targeted therapy; Clinical trial; Cancer research; Standard of care; Metastasis; Vascular endothelial growth factor; Oncology; Internal medicine; Cancer; VEGF receptors","score_opus":0.09352376409159908,"score_gpt":0.3643288788722119,"score_spread":0.2708051147806128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057414744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877983,0.004994745,0.00006368296,0.00054290774,0.00042089124,0.00075787626,0.000022535394,0.000013746708,0.005385315],"genre_scores_gemma":[0.99791527,0.00018411006,0.00064857653,0.000036740446,0.000054850047,0.000028673925,0.000031472126,0.000012335477,0.0010879876],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985599,0.00014345362,0.00050570106,0.00025339352,0.0002620205,0.00027553865],"domain_scores_gemma":[0.99886394,0.00010254207,0.0002973137,0.00046571728,0.00013334498,0.0001371399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009346028,0.00021039872,0.000671603,0.00011664713,0.000030653428,0.0000021372205,0.000098690725,0.000042364733,0.00009159159],"category_scores_gemma":[0.000020360178,0.00013001608,0.00030685728,0.00020195381,0.0001350256,0.0000239666,0.000024026562,0.00010263125,0.000033444332],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019243732,0.019497424,0.12998348,0.00053269893,0.0003128378,0.00038107662,0.0031575263,0.0000798552,0.09149669,0.00023758107,0.008030036,0.7443664],"study_design_scores_gemma":[0.009071416,0.024106493,0.38678238,0.00008861628,0.0012891832,0.00018294358,0.000080666876,0.0001256276,0.4949636,0.00051136356,0.08259634,0.00020137685],"about_ca_topic_score_codex":0.000016417336,"about_ca_topic_score_gemma":0.000011002057,"teacher_disagreement_score":0.74416506,"about_ca_system_score_codex":0.0004948776,"about_ca_system_score_gemma":0.00039372937,"threshold_uncertainty_score":0.53019017},"labels":[],"label_agreement":null},{"id":"W2057636560","doi":"10.1016/j.urology.2006.03.067","title":"Cryoablation of small peripheral renal masses: A retrospective analysis","year":2006,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Cryoablation; Peripheral; Retrospective cohort study; Radiology; Surgery; Internal medicine","score_opus":0.011988225125621487,"score_gpt":0.23789451674366704,"score_spread":0.22590629161804557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057636560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777736,0.00022496922,0.005368014,0.00034384817,0.000031259322,0.00014588608,0.000005270135,0.000025156005,0.01608197],"genre_scores_gemma":[0.99672955,0.000003889276,0.0018851944,0.00008975896,0.00010042379,0.0000113309925,0.00007403608,0.000009203391,0.0010965822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923027,0.00005137471,0.00022182224,0.00021815473,0.00012267132,0.00015573949],"domain_scores_gemma":[0.9995007,0.000030940573,0.00010472519,0.00022231042,0.00010376078,0.000037564845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007970154,0.000095086,0.0003433852,0.00021406813,0.00002081835,0.0000031432328,0.00003591366,0.00009006169,0.00039404893],"category_scores_gemma":[0.000023049592,0.00007974408,0.00017477681,0.00037894197,0.00006930024,0.000017667684,0.0000152038365,0.00008576567,0.000009654292],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003353238,0.00017351472,0.9821673,0.000009963784,0.000586207,0.00010332336,0.0000869756,0.0021626214,0.012884095,0.0011670248,0.00016057403,0.00016306748],"study_design_scores_gemma":[0.0009009741,0.000998339,0.98844016,0.0000015586953,0.0015004551,0.000039124996,0.000011325104,0.003395754,0.0031327596,0.00072884007,0.0007924643,0.000058225665],"about_ca_topic_score_codex":0.00041440755,"about_ca_topic_score_gemma":0.00034252403,"teacher_disagreement_score":0.018955953,"about_ca_system_score_codex":0.00011867542,"about_ca_system_score_gemma":0.000038280574,"threshold_uncertainty_score":0.43145594},"labels":[],"label_agreement":null},{"id":"W2058565844","doi":"10.5489/cuaj.2067","title":"Peritoneal metastases from renal cell carcinoma: Images in urology","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Urology; Renal cell carcinoma; Medicine; Pathology","score_opus":0.012061593303747127,"score_gpt":0.21595716255975142,"score_spread":0.2038955692560043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058565844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97982776,0.00072737026,0.000060316637,0.012900967,0.00023168117,0.00014860397,0.00006442197,0.000017403903,0.0060214647],"genre_scores_gemma":[0.9947544,0.00002205231,0.00057126733,0.003535861,0.00064793014,0.000010649361,0.000081272265,0.000017158221,0.00035943076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99769795,0.00053809583,0.00044185342,0.00030716351,0.0003576215,0.0006573357],"domain_scores_gemma":[0.9982146,0.00035079577,0.0002322552,0.00016279328,0.00015735089,0.0008822155],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007162358,0.00020318643,0.00045874857,0.00029549774,0.00015395688,0.00006546367,0.00013627145,0.0002839296,0.0010420575],"category_scores_gemma":[0.00059863337,0.00016393035,0.00018136218,0.00018232629,0.00004729737,0.000082151455,0.00002045761,0.00079231104,0.00013185314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121465244,0.000108837536,0.98708755,0.0000030083436,0.000045128156,0.00092677027,0.00009829655,0.00007336377,0.0026216707,0.000045471268,0.00743612,0.0014323074],"study_design_scores_gemma":[0.0021544055,0.00080171385,0.9672493,0.0000032408059,0.00015458591,0.00023682187,0.000041908577,0.00015950586,0.0012529342,0.00063300657,0.027161239,0.00015134123],"about_ca_topic_score_codex":0.007493266,"about_ca_topic_score_gemma":0.0026732343,"teacher_disagreement_score":0.019838264,"about_ca_system_score_codex":0.0013591276,"about_ca_system_score_gemma":0.00043263318,"threshold_uncertainty_score":0.99987113},"labels":[],"label_agreement":null},{"id":"W2058736678","doi":"10.1038/bjc.2012.543","title":"Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Cilag; Genentech; Bayer HealthCare; Exelixis; Sanofi; Pfizer","keywords":"Sorafenib; Tolerability; Medicine; Renal cell carcinoma; Internal medicine; Adverse effect; Cumulative incidence; Incidence (geometry); Dosing; Population; Oncology; Confidence interval; Cohort; Hepatocellular carcinoma","score_opus":0.0068845273697906014,"score_gpt":0.23108474868871218,"score_spread":0.2242002213189216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058736678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935412,0.0048000575,0.000050863146,0.0002535341,0.00008762002,0.00050304946,0.00026695768,0.000008841705,0.00048791044],"genre_scores_gemma":[0.9980107,0.0001394875,0.0012253751,0.00013797439,0.00012322621,0.00003447035,0.00010798607,0.000026005513,0.00019477542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974565,0.00012288094,0.0009537776,0.00036804983,0.00070643664,0.0003923868],"domain_scores_gemma":[0.9978805,0.000088091765,0.00060194335,0.000295074,0.0008257071,0.00030868113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023523197,0.000213841,0.00085094984,0.0002436292,0.000052149713,0.00006340477,0.00014289437,0.000094821655,0.0005784591],"category_scores_gemma":[0.00007787148,0.00018381866,0.00029146488,0.0005967914,0.00004950186,0.00031352282,0.000029038387,0.00043560003,0.000007916407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032146112,0.0012867013,0.9441307,0.00003338086,0.00075356866,0.0011320768,0.0003344604,0.00047220895,0.0008068913,2.3762146e-7,0.0006232851,0.047211863],"study_design_scores_gemma":[0.020705072,0.0011097566,0.97332186,0.00029569355,0.0014992415,0.000035579207,0.000102242855,0.00007122975,0.0023376574,0.000025277774,0.00031587863,0.00018054564],"about_ca_topic_score_codex":0.009340326,"about_ca_topic_score_gemma":0.006255962,"teacher_disagreement_score":0.047031317,"about_ca_system_score_codex":0.00050045206,"about_ca_system_score_gemma":0.00028742626,"threshold_uncertainty_score":0.9972566},"labels":[],"label_agreement":null},{"id":"W2059052363","doi":"10.5489/cuaj.252","title":"Extensive renal infarction following percutaneous biopsy of a small renal mass: A case report","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Biopsy; Nephrectomy; Renal mass; Renal cell carcinoma; Percutaneous; Renal biopsy; Complication; Surgery; Kidney; Radiology; Urology; Internal medicine","score_opus":0.017583135782236563,"score_gpt":0.22603220179105868,"score_spread":0.20844906600882213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059052363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898479,0.00018191876,0.00017137885,0.0069153174,0.00026734092,0.00038021512,0.000011308927,0.000024724075,0.002199914],"genre_scores_gemma":[0.9951157,0.000012513892,0.002445678,0.0010314522,0.0003352462,0.00001679502,0.000028885222,0.000018941675,0.0009948026],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9978208,0.0001915651,0.00070498657,0.0002801213,0.00045573208,0.00054681196],"domain_scores_gemma":[0.9972887,0.00016644291,0.00057942944,0.00019745289,0.0007788634,0.0009890923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059648283,0.0002034305,0.00044842504,0.0003122045,0.00023738993,0.00007533194,0.00007653916,0.00031611172,0.0007332599],"category_scores_gemma":[0.0014181983,0.00016010548,0.00038928704,0.0002553174,0.000037820853,0.000107611995,0.000011089173,0.0006094176,0.00006553879],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012846423,0.00011317463,0.275813,0.000013650141,0.0009287429,0.6739281,0.00040277155,0.000193123,0.0411923,0.00003071856,0.0039356016,0.0033203522],"study_design_scores_gemma":[0.00096599635,0.00087030366,0.22201736,0.00004271245,0.0004113777,0.7717269,0.00028740274,0.00029429226,0.0003403717,0.0006120808,0.0022298116,0.00020135652],"about_ca_topic_score_codex":0.009824025,"about_ca_topic_score_gemma":0.0007388814,"teacher_disagreement_score":0.097798854,"about_ca_system_score_codex":0.0018834912,"about_ca_system_score_gemma":0.0006699867,"threshold_uncertainty_score":0.99676967},"labels":[],"label_agreement":null},{"id":"W2059209072","doi":"10.5489/cuaj.10039","title":"Preferred management option for small renal masses: laparoscopic partial nephrectomy","year":2010,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Nephrectomy; Medicine; Renal mass; Urology; General surgery; Kidney; Internal medicine","score_opus":0.02491616026664164,"score_gpt":0.24675817086851906,"score_spread":0.22184201060187742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059209072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857512,0.00005729582,0.00057171937,0.007962347,0.0008163862,0.000905247,0.000025513824,0.000040101924,0.0038701613],"genre_scores_gemma":[0.9874655,0.00002625567,0.007593826,0.0016434555,0.0009955973,0.00016858027,0.00007709253,0.00001909691,0.0020106002],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99842495,0.000080070415,0.00036212502,0.00025729885,0.0002950379,0.00058052567],"domain_scores_gemma":[0.9984817,0.00009637531,0.00022732848,0.00015368736,0.00020965327,0.0008312426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057724694,0.00017148281,0.00028331915,0.00018803442,0.00026721807,0.00012062504,0.000119535034,0.0002813191,0.00041937063],"category_scores_gemma":[0.0002621085,0.0001383781,0.00019840915,0.00013220335,0.000024433042,0.000072850344,0.000014297732,0.0005836674,0.000059461287],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008627343,0.00037916706,0.9390265,0.00006088416,0.0010250052,0.0006054697,0.00016817077,0.00012020935,0.007412844,0.0049777064,0.022818726,0.022542613],"study_design_scores_gemma":[0.003974743,0.0007478497,0.49210578,0.000016363761,0.0003569646,0.00023437063,0.000033148688,0.0003549347,0.0009240613,0.0015428878,0.49952158,0.00018733167],"about_ca_topic_score_codex":0.00022487642,"about_ca_topic_score_gemma":0.001303555,"teacher_disagreement_score":0.47670284,"about_ca_system_score_codex":0.00092865294,"about_ca_system_score_gemma":0.00030523635,"threshold_uncertainty_score":0.5642895},"labels":[],"label_agreement":null},{"id":"W2060125881","doi":"10.1016/j.jbspin.2006.01.028","title":"Endoneural metastasis of the sciatic nerve disclosing the relapse of a renal carcinoma, four years after its surgical treatment","year":2006,"lang":"en","type":"article","venue":"Joint Bone Spine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Sciatica; Sciatic nerve; Palpation; Metastasis; Thigh; Renal cell carcinoma; Carcinoma; Renal carcinoma; Cancer; Surgery; Pathology; Internal medicine","score_opus":0.030701615496904054,"score_gpt":0.2448445401529517,"score_spread":0.21414292465604765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060125881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933382,0.0029902766,0.0000068224554,0.0019790241,0.00010395136,0.00081303646,0.000039482027,0.000016274853,0.0007129089],"genre_scores_gemma":[0.9974311,0.000026085943,0.0003701712,0.000032319782,0.00017147978,0.000074609416,0.000015041314,0.000032385793,0.0018468157],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99794084,0.00016476736,0.00070396386,0.00028811287,0.0005893819,0.00031296498],"domain_scores_gemma":[0.9987545,0.00006079125,0.00033813345,0.0006683124,0.00009918185,0.00007910684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021638333,0.00026365623,0.0006808931,0.00011165927,0.000057801484,0.000012258569,0.00009433666,0.0000613314,0.00008974374],"category_scores_gemma":[0.000043803997,0.00012630728,0.00064907107,0.00033965157,0.00017912316,0.00004965315,0.00010057116,0.00015739459,0.000010358561],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004060551,0.0057901265,0.26276147,0.00096289703,0.002108865,0.0109709725,0.002208856,0.0006552415,0.69344556,0.0018321674,0.0017840501,0.013419234],"study_design_scores_gemma":[0.0035917927,0.0010585393,0.7560671,0.00018704128,0.0011289743,0.0006785194,0.00005273236,0.00024997783,0.23635666,0.000050056857,0.00045084214,0.0001277754],"about_ca_topic_score_codex":0.00094694743,"about_ca_topic_score_gemma":0.00008663927,"teacher_disagreement_score":0.4933056,"about_ca_system_score_codex":0.00025628577,"about_ca_system_score_gemma":0.00011643302,"threshold_uncertainty_score":0.5150661},"labels":[],"label_agreement":null},{"id":"W2060130851","doi":"10.3747/co.v17i2.470","title":"Sunitinib Causes Macrocytosis in Patients with Advanced Renal Cell Carcinoma","year":2010,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Dalhousie University","funders":"","keywords":"Macrocytosis; Medicine; Sunitinib; Internal medicine; Renal cell carcinoma; Gastroenterology; Concomitant; Anemia; Mean corpuscular volume; Hematology; Oncology; Hematocrit","score_opus":0.041426291443110524,"score_gpt":0.32674993376847594,"score_spread":0.28532364232536545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060130851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936541,0.00025292026,0.00000451168,0.00014169567,0.00064449094,0.0007428393,0.000021951839,0.00003827502,0.0044992715],"genre_scores_gemma":[0.9986191,0.000018418941,0.0006987385,0.000074633004,0.00012534289,0.00011294182,0.00020299423,0.00003325482,0.00011460483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985078,0.00006832872,0.00031681007,0.00040539893,0.00026130857,0.00044038447],"domain_scores_gemma":[0.99895936,0.000100951955,0.00013722335,0.00037626247,0.00018910714,0.00023709873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009055641,0.00024844418,0.000460328,0.00021411545,0.000049263337,0.000007844292,0.00010131586,0.00013726103,0.00024098362],"category_scores_gemma":[0.00004105478,0.00018737734,0.000070009744,0.00022356844,0.00013515184,0.00006816299,0.00006172977,0.0006188839,0.00007112735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001256004,0.0021293566,0.9571834,0.00008425273,0.000014859002,0.00015438368,0.00030303848,0.0000022215806,0.0043580574,0.00002271285,0.00036074047,0.034130946],"study_design_scores_gemma":[0.011166263,0.0037554137,0.9386507,0.000043351472,0.00011451612,0.00002818774,0.000075774995,0.0000070322685,0.022248574,0.000010707916,0.023703214,0.00019622818],"about_ca_topic_score_codex":0.000032627922,"about_ca_topic_score_gemma":0.00031386357,"teacher_disagreement_score":0.033934716,"about_ca_system_score_codex":0.00030675938,"about_ca_system_score_gemma":0.00029088455,"threshold_uncertainty_score":0.76410264},"labels":[],"label_agreement":null},{"id":"W2060260809","doi":"10.1186/s40425-015-0055-3","title":"Survival with AGS-003, an autologous dendritic cell–based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results","year":2015,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":214,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Immunotherapy; Internal medicine; Clinical endpoint; Oncology; Progression-free survival; Phases of clinical research; Surgery; Urology; Gastroenterology; Overall survival; Clinical trial; Cancer","score_opus":0.023501342217022044,"score_gpt":0.31248380080424937,"score_spread":0.2889824585872273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060260809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99395704,0.0019807452,0.0003435468,0.00009852002,0.0001737055,0.0030567402,0.00011828791,0.00002483103,0.00024659667],"genre_scores_gemma":[0.99643165,0.00013788087,0.0025989315,0.000068279085,0.00004144094,0.00026668404,0.00012556795,0.00013299185,0.00019658654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964183,0.00044841532,0.0010016819,0.000499777,0.0010308381,0.00060097035],"domain_scores_gemma":[0.9970244,0.00018140805,0.001047076,0.0005706594,0.00093908753,0.00023736137],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010236352,0.00049886754,0.0009981671,0.00059281057,0.0001483569,0.000056504192,0.00025161894,0.00011572941,0.000026331443],"category_scores_gemma":[0.000022531241,0.0003371842,0.000105563835,0.0006250427,0.00014731941,0.0003955691,0.000010295264,0.0005983323,6.455901e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26589757,0.01912354,0.6802716,0.000111141824,0.00034257528,0.00037564524,0.0049099876,0.00914975,0.004592494,0.0000022947434,0.000035389185,0.015187989],"study_design_scores_gemma":[0.37442118,0.11669935,0.47929186,0.00050859276,0.00026753455,0.00003914521,0.0030525038,0.0004827555,0.024280826,0.000027094016,0.0003882447,0.0005408934],"about_ca_topic_score_codex":0.0020401364,"about_ca_topic_score_gemma":0.002243092,"teacher_disagreement_score":0.20097977,"about_ca_system_score_codex":0.0010253044,"about_ca_system_score_gemma":0.0012886266,"threshold_uncertainty_score":0.99990803},"labels":[],"label_agreement":null},{"id":"W2060327264","doi":"10.1111/j.1464-410x.2009.08575.x","title":"Renal cell carcinoma with inferior vena caval extention: impact of tumour extent on surgical outcome","year":2009,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Inferior vena cava; Thrombus; Surgery; Radiology; Carcinoma; Kidney; Internal medicine","score_opus":0.019127441034358546,"score_gpt":0.2779671119771298,"score_spread":0.25883967094277127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060327264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941682,0.003157418,0.000040934476,0.00046449708,0.00010815498,0.000205832,0.000011246565,0.000009575036,0.0018340938],"genre_scores_gemma":[0.9988849,0.00012263708,0.0002875474,0.00015301458,0.0003174289,0.000001956348,0.00000802435,0.000022586228,0.0002019163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787724,0.00016614201,0.0008376204,0.0002274592,0.0005171364,0.00037438516],"domain_scores_gemma":[0.9984665,0.000078674,0.00056050834,0.00020168764,0.0003427812,0.0003498319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003462642,0.00022236438,0.00084361766,0.00022843259,0.000049008075,0.00001951563,0.00013853487,0.00012983123,0.00028982532],"category_scores_gemma":[0.000047236837,0.00017369514,0.0005490325,0.0001492451,0.000117061936,0.0000800026,0.000019022647,0.0005602178,0.000010734975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021555472,0.0050476515,0.65445584,0.000109445056,0.0005111962,0.25219855,0.00017271539,0.0013388741,0.02960149,0.000069098955,0.0020769967,0.032862686],"study_design_scores_gemma":[0.006822651,0.029066253,0.84468967,0.00008874703,0.00030926015,0.116666265,0.000011743671,0.000017304355,0.001999694,0.000035890036,0.00017621262,0.00011631428],"about_ca_topic_score_codex":0.00011035475,"about_ca_topic_score_gemma":0.000007885637,"teacher_disagreement_score":0.19023384,"about_ca_system_score_codex":0.00020231346,"about_ca_system_score_gemma":0.00028716098,"threshold_uncertainty_score":0.7083082},"labels":[],"label_agreement":null},{"id":"W2060481687","doi":"10.1016/j.critrevonc.2014.08.001","title":"Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis","year":2014,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"Associazione Italiana per la Ricerca sul Cancro; Ministero dell’Istruzione, dell’Università e della Ricerca","keywords":"Benchmarking; Renal cell carcinoma; Medicine; Oncology; Clinical endpoint; Internal medicine; Progression-free survival; Clinical trial; Overall survival; Randomized controlled trial","score_opus":0.12207618892468768,"score_gpt":0.48118485976249337,"score_spread":0.3591086708378057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060481687","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016201149,0.9798839,0.0027880569,0.00026626792,0.00072954857,0.012713915,0.000065961365,0.000021789638,0.00191044],"genre_scores_gemma":[0.0050162324,0.9722683,0.017914267,0.00019336397,0.00013995165,0.0030742504,0.0012382253,0.00009530963,0.000060143575],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.96511,0.022185469,0.009621447,0.001610198,0.0006172626,0.00085564447],"domain_scores_gemma":[0.9295937,0.064803116,0.0035300604,0.0012471784,0.0003620601,0.00046391497],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03774944,0.0010302338,0.032538787,0.0011335706,0.00006079966,0.0000169084,0.00040669978,0.0016126619,0.00023484493],"category_scores_gemma":[0.061016627,0.0006476629,0.0033335618,0.0008532969,0.0010686982,0.00008373969,0.0002976317,0.0013387924,0.000010366229],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09120545,0.0048580733,0.012032521,0.10346564,0.0034020147,0.0016487018,0.00021036997,0.00000549534,0.000007428289,0.012930294,0.0008594007,0.7693746],"study_design_scores_gemma":[0.35199076,0.0120364465,0.003167781,0.0764266,0.07527365,0.0007794591,0.00007228989,0.0006010493,0.000027859716,0.0024178969,0.47500122,0.0022049833],"about_ca_topic_score_codex":0.000020970667,"about_ca_topic_score_gemma":0.00006577256,"teacher_disagreement_score":0.76716965,"about_ca_system_score_codex":0.000630237,"about_ca_system_score_gemma":0.0012854823,"threshold_uncertainty_score":0.99968344},"labels":[],"label_agreement":null},{"id":"W2060788031","doi":"10.1159/000068763","title":"A Right-Sided Renal Carcinoma Uniquely Presenting as a Mass in the Spermatic Cord","year":2003,"lang":"en","type":"review","venue":"Urologia Internationalis","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre","funders":"","keywords":"Spermatic cord; Medicine; Renal cell carcinoma; Cord; Carcinoma; Renal artery; Lesion; Anatomy; Urology; Kidney; Surgery; Pathology; Internal medicine","score_opus":0.07426593765582092,"score_gpt":0.3503304634440525,"score_spread":0.2760645257882316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060788031","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009539949,0.9328596,0.000025856569,0.00059346826,0.00029585304,0.0026351933,0.00005014659,0.000057687525,0.053942252],"genre_scores_gemma":[0.023159042,0.9645045,0.001073567,0.001900081,0.00033359727,0.0012635798,0.0012565592,0.00013075533,0.0063783224],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962159,0.00084757037,0.0010559484,0.0006045192,0.00084758026,0.00042848306],"domain_scores_gemma":[0.9975014,0.00094304717,0.00056195236,0.0007328005,0.00015591616,0.000104896644],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007043182,0.0005710475,0.0013518552,0.0005233342,0.00006284829,0.000089880436,0.0006474139,0.00034436208,0.0008340198],"category_scores_gemma":[0.00056883885,0.00033594194,0.0006788356,0.0004528801,0.00011178886,0.000079360274,0.00009414641,0.00091099244,0.0003505881],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018384985,0.006303951,0.04827402,0.06992202,0.01290128,0.15463822,0.0044522625,0.000053619922,0.000101884456,0.11684854,0.08846613,0.49619955],"study_design_scores_gemma":[0.0010301424,0.0005515818,0.0016134948,0.0036703595,0.0016448536,0.005378151,0.000033347074,0.000075043914,0.000025673262,0.0020830717,0.98346823,0.00042606756],"about_ca_topic_score_codex":0.0002954232,"about_ca_topic_score_gemma":0.000028735043,"teacher_disagreement_score":0.89500207,"about_ca_system_score_codex":0.00054799457,"about_ca_system_score_gemma":0.0004349391,"threshold_uncertainty_score":0.9999093},"labels":[],"label_agreement":null},{"id":"W2061414864","doi":"10.1016/j.eururo.2008.11.023","title":"Thirty-Day Mortality After Nephrectomy: Clinical Implications for Informed Consent","year":2008,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Informed consent; Nephrectomy; Surgery; General surgery; Intensive care medicine; Internal medicine; Family medicine; Kidney; Alternative medicine; Pathology","score_opus":0.14654189914218513,"score_gpt":0.37632787221128716,"score_spread":0.22978597306910203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061414864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9593588,0.00038106597,0.0005879511,0.004949448,0.00026869684,0.0007894476,0.000030885567,0.00011618452,0.0335175],"genre_scores_gemma":[0.9896295,0.00019001818,0.0009114304,0.0071807397,0.0004051074,0.00009164596,0.0000895935,0.000039830655,0.0014621188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834543,0.00032707947,0.00055651343,0.0003606795,0.00008827942,0.00032203709],"domain_scores_gemma":[0.998024,0.0008775593,0.00012204185,0.0006239134,0.00011424763,0.00023827855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045963275,0.00017152428,0.000349572,0.00006761499,0.000093182396,0.0000055147143,0.00010856437,0.00007585878,0.00010216667],"category_scores_gemma":[0.00072468026,0.0001363737,0.00025108238,0.00008031784,0.00032474674,0.0000321248,0.000074580326,0.0001963823,0.0005018429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060822297,0.0003154494,0.97365963,0.000032145686,0.00023088577,0.00045283444,0.00023196886,0.000001941449,0.0001606368,0.00032519412,0.02153659,0.0024444705],"study_design_scores_gemma":[0.0018642587,0.0008942588,0.8537991,0.0000042719766,0.00018231022,0.00035881804,0.0000034441669,0.000012007272,0.000046475052,0.00007059636,0.14266741,0.0000970631],"about_ca_topic_score_codex":0.000007537663,"about_ca_topic_score_gemma":0.000029081899,"teacher_disagreement_score":0.121130824,"about_ca_system_score_codex":0.00004886003,"about_ca_system_score_gemma":0.00033772987,"threshold_uncertainty_score":0.6450342},"labels":[],"label_agreement":null},{"id":"W2061564534","doi":"10.5489/cuaj.2439","title":"Concurrent RCC with tuberculous para aortic lymphadenopathy: A pleasant surprise","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Lymph; Lymph node; Renal cell carcinoma; Radiology; Dissection (medical); Biopsy; Lymph node biopsy; Magnetic resonance imaging; Pathology; Kidney; Internal medicine","score_opus":0.03174630212004069,"score_gpt":0.24612285020228664,"score_spread":0.21437654808224593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061564534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844955,0.000893614,0.00007265417,0.011418405,0.00028344893,0.00029131921,0.000014105829,0.000036866946,0.0024940707],"genre_scores_gemma":[0.9967196,0.000039878185,0.00012511887,0.0021360063,0.00040462601,0.000017588009,0.000028314396,0.000020591651,0.00050828676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781954,0.00021232401,0.00037597594,0.00025115916,0.0006216149,0.0007193575],"domain_scores_gemma":[0.9963786,0.000092665905,0.00026392943,0.00015218908,0.0005242736,0.0025883457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006865159,0.00021315861,0.00039811103,0.0001665327,0.00015629748,0.00009739136,0.00010957321,0.00019427486,0.00026383033],"category_scores_gemma":[0.0006224657,0.00014342665,0.00012226724,0.00022785024,0.00004639633,0.00008919695,0.000013310927,0.0004432877,0.00019924334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012941056,0.0001223206,0.9863079,0.000004696411,0.00020982152,0.0022380676,0.00041145348,0.00006830606,0.00004527863,0.000056081597,0.0049182237,0.0054884255],"study_design_scores_gemma":[0.0042640916,0.002169145,0.9629286,0.000027600183,0.00035390104,0.0033901131,0.00022924428,0.00032006702,0.00006255174,0.00019730299,0.025812402,0.00024501252],"about_ca_topic_score_codex":0.0017939901,"about_ca_topic_score_gemma":0.00085677986,"teacher_disagreement_score":0.023379346,"about_ca_system_score_codex":0.004310415,"about_ca_system_score_gemma":0.001990454,"threshold_uncertainty_score":0.99951184},"labels":[],"label_agreement":null},{"id":"W2061623831","doi":"10.1016/j.eururo.2011.01.004","title":"Accurate Molecular Classification of Kidney Cancer Subtypes Using MicroRNA Signature","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":220,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; St. Michael's Hospital; York University; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Chromophobe cell; Oncocytoma; Medicine; Papillary renal cell carcinomas; Clear cell renal cell carcinoma; Clear cell; Pathology; Carcinogenesis; microRNA; Renal cell carcinoma; Computational biology; Biology; Cancer; Gene; Internal medicine; Genetics","score_opus":0.06107287388755651,"score_gpt":0.28105026548148543,"score_spread":0.21997739159392893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061623831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96912473,0.0012873181,0.00038279092,0.0005302019,0.00015138731,0.00018839267,0.000009159135,0.000031827887,0.028294193],"genre_scores_gemma":[0.99698025,0.000038651462,0.0009535791,0.0017160107,0.00006487564,0.000002746533,0.00002043511,0.000038437283,0.00018502152],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990694,0.00020801186,0.00021707847,0.00024210429,0.000088553934,0.00017484163],"domain_scores_gemma":[0.99926835,0.000014140418,0.00015554401,0.000302892,0.00010318028,0.00015590234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000120538236,0.00012645389,0.00019855145,0.000087504595,0.00002227798,0.000002469798,0.00009831513,0.00006037816,0.00026778193],"category_scores_gemma":[0.00008437477,0.00010463562,0.00007216819,0.0001089512,0.00009358557,0.00002627202,0.000039944644,0.00015529401,0.00006491067],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034288436,0.00010506316,0.015002937,0.000038748534,0.000117093354,0.0004788734,0.0003937714,0.000013879132,0.98192304,0.00028195078,0.00070018246,0.00060156826],"study_design_scores_gemma":[0.0017626303,0.0009031653,0.6194259,0.0000487003,0.0006909289,0.00024995787,0.0000368737,0.0004937224,0.3656815,0.00007287515,0.010404465,0.0002292655],"about_ca_topic_score_codex":0.000050551094,"about_ca_topic_score_gemma":0.0000016337499,"teacher_disagreement_score":0.6162416,"about_ca_system_score_codex":0.00003744883,"about_ca_system_score_gemma":0.000108821834,"threshold_uncertainty_score":0.42669168},"labels":[],"label_agreement":null},{"id":"W2061663237","doi":"10.1007/s11523-010-0143-8","title":"Prognostic and predictive biomarkers in renal cell carcinoma","year":2010,"lang":"en","type":"review","venue":"Targeted Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Biomarker; Biomarker discovery; Kidney cancer; Vascular endothelial growth factor; Clear cell renal cell carcinoma; Oncology; Targeted therapy; Cancer; Pathology; Cancer research; Bioinformatics; Internal medicine; VEGF receptors; Proteomics; Biology; Gene","score_opus":0.03238352251163952,"score_gpt":0.3148014887375521,"score_spread":0.2824179662259126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061663237","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009020171,0.97845834,0.000004670914,0.00006474476,0.00035596194,0.0032926293,0.000081616876,0.000051143164,0.008670705],"genre_scores_gemma":[0.007945543,0.9885826,0.0012234877,0.000053035234,0.0002620796,0.00068461185,0.0007593221,0.0001051221,0.00038417295],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99710387,0.00039941203,0.00081467925,0.00084651116,0.00023652396,0.0005990082],"domain_scores_gemma":[0.99805194,0.00060489913,0.00040327437,0.00048191837,0.00008477179,0.00037321495],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00034135158,0.0006287226,0.0026684264,0.0006857522,0.000048066275,0.000011245269,0.00015908487,0.0013120897,0.00014614726],"category_scores_gemma":[0.00018060963,0.00047511232,0.00032422252,0.0004439319,0.0002925647,0.00003865307,0.000139871,0.001394173,0.000088483815],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037883825,0.0007691244,0.0043255785,0.012304928,0.00044393033,0.005939407,0.00024375595,1.7472051e-7,0.00012828033,0.000010856151,0.001123952,0.9743312],"study_design_scores_gemma":[0.0024523982,0.0041578664,0.008332286,0.0023839641,0.00415254,0.0018077388,0.000036910413,0.000020616537,0.000057563007,0.000027711547,0.97613674,0.0004336565],"about_ca_topic_score_codex":0.00007662957,"about_ca_topic_score_gemma":0.000055025772,"teacher_disagreement_score":0.9750128,"about_ca_system_score_codex":0.00087671983,"about_ca_system_score_gemma":0.0016299031,"threshold_uncertainty_score":0.99998444},"labels":[],"label_agreement":null},{"id":"W2061768235","doi":"10.1016/j.urology.2009.04.019","title":"A Population-based Analysis of the Rate of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the United States","year":2009,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Quartile; Epidemiology; Logistic regression; Nephrectomy; Internal medicine; Surveillance, Epidemiology, and End Results; Multivariate analysis; Population; Surgery; Oncology; Urology; Kidney; Cancer registry; Confidence interval","score_opus":0.022020988029893065,"score_gpt":0.2753574838774432,"score_spread":0.25333649584755014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061768235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99673796,0.0001227794,0.00031240346,0.0020653743,0.000018424878,0.00062104437,0.000039277318,0.0000039838337,0.00007875962],"genre_scores_gemma":[0.998507,0.0000015674937,0.0002935437,0.00082735205,0.000010387433,0.0000327614,0.00030327367,0.0000061188225,0.000017974524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890274,0.00035102307,0.00031626917,0.0001583913,0.00011560336,0.00015594721],"domain_scores_gemma":[0.9987287,0.00058896304,0.00021098537,0.00032845567,0.00011803931,0.000024877345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002884079,0.00010870486,0.00040553862,0.0004505338,0.000028470726,0.0000021581131,0.000111679496,0.00003766738,0.00002025943],"category_scores_gemma":[0.000083397405,0.000058176272,0.00021058915,0.0011746906,0.000066570305,0.000012608155,0.0000069644834,0.000087023574,3.1976302e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004994329,0.001576773,0.71058744,0.0001284414,0.0013768341,0.000057520047,0.004584629,0.25035664,0.024602942,0.0010507428,0.00023989847,0.00044377826],"study_design_scores_gemma":[0.0020166286,0.0014097828,0.9410804,0.0000035544442,0.0032922854,0.000003849847,0.00023537004,0.03454867,0.016538674,0.00074195035,0.00007940361,0.00004945039],"about_ca_topic_score_codex":0.0011625795,"about_ca_topic_score_gemma":0.00015872065,"teacher_disagreement_score":0.23049292,"about_ca_system_score_codex":0.0000461694,"about_ca_system_score_gemma":0.00007387409,"threshold_uncertainty_score":0.23723595},"labels":[],"label_agreement":null},{"id":"W2061870732","doi":"10.1097/spc.0b013e3283490418","title":"Current systemic management of metastatic renal cell carcinoma – first line and second line therapy","year":2011,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; Juravinski Cancer Centre; St. Joseph's Hospital","funders":"","keywords":"Temsirolimus; Medicine; Sunitinib; Sorafenib; Pazopanib; Everolimus; Renal cell carcinoma; Bevacizumab; Targeted therapy; Oncology; Systemic therapy; Clinical trial; Internal medicine; Intensive care medicine; Discovery and development of mTOR inhibitors; Cancer; PI3K/AKT/mTOR pathway; Chemotherapy; Hepatocellular carcinoma","score_opus":0.2023019775837762,"score_gpt":0.4001937180149413,"score_spread":0.19789174043116511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061870732","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0071526812,0.9868687,0.000057221845,0.0000053027547,0.001093619,0.0037502714,0.0008553501,0.000016362419,0.00020053772],"genre_scores_gemma":[0.026683874,0.9700777,0.00008454348,0.0000034746176,0.00018394191,0.0005877773,0.002235089,0.000070393995,0.000073214134],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99650145,0.00026921582,0.0014642559,0.0009722299,0.00036145948,0.0004314162],"domain_scores_gemma":[0.99765545,0.000168197,0.0010637094,0.00048166237,0.00034314065,0.00028786607],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002245727,0.00088598265,0.0026317288,0.00047728707,0.00006498564,0.000019585343,0.00016282026,0.00016475453,0.00017238357],"category_scores_gemma":[0.0000115834355,0.000643928,0.00046750339,0.0003727927,0.0001852865,0.00006933541,0.00018789673,0.00060441374,0.000012831508],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017537037,0.0004699656,0.00838965,0.3187969,0.00045108667,0.00005671557,0.0027117627,2.341529e-7,5.326665e-7,0.000106023464,0.00020378883,0.66863793],"study_design_scores_gemma":[0.0052619483,0.0024847877,0.013800076,0.1221645,0.00221685,0.000056668738,0.0011630477,0.0000056471426,0.000095277,0.00003782735,0.851825,0.00088836125],"about_ca_topic_score_codex":0.000009566426,"about_ca_topic_score_gemma":0.000003920936,"teacher_disagreement_score":0.8516212,"about_ca_system_score_codex":0.00031119245,"about_ca_system_score_gemma":0.00025958492,"threshold_uncertainty_score":0.9996012},"labels":[],"label_agreement":null},{"id":"W2062264163","doi":"10.1007/s00345-012-0896-z","title":"External validation of the preoperative Karakiewicz nomogram in a large multicentre series of patients with renal cell carcinoma","year":2012,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nomogram; Renal cell carcinoma; Nephrectomy; Kidney cancer; Nephrology; Population; Proportional hazards model; Internal medicine; Cohort; Surgery; Kidney disease; Urology; Oncology; Kidney","score_opus":0.010071078375541637,"score_gpt":0.22958580155665576,"score_spread":0.21951472318111412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062264163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99753964,0.0013235677,0.00004556892,0.00019923729,0.0001418438,0.00034391577,0.00000951173,0.0000015357808,0.00039515903],"genre_scores_gemma":[0.9988807,0.0000143194675,0.0007807112,0.000056774465,0.00007578457,0.000003902331,0.0000042287907,0.0000128712345,0.0001707063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985422,0.00023737726,0.0005552774,0.000091932656,0.00032229995,0.0002509228],"domain_scores_gemma":[0.99864656,0.000075867254,0.0006899303,0.00018248124,0.000311021,0.000094127434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027303235,0.00013595713,0.00040878888,0.00021477901,0.000024691028,0.0000030196777,0.000110417765,0.000047871075,0.00010193818],"category_scores_gemma":[0.000040678544,0.000076455726,0.00011508451,0.00023620382,0.000105100866,0.00015896167,0.000043853397,0.00027133425,0.0000015743245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027027915,0.0012032437,0.9897082,0.000048327656,0.00005847961,0.000021761987,0.0019337843,0.000093969145,0.003934318,0.00003754475,0.000024086437,0.00023348744],"study_design_scores_gemma":[0.0050406815,0.0015005696,0.9420852,0.000061120634,0.0002612026,0.00008110117,0.000109137625,0.000010668639,0.050571356,0.000009968587,0.00021467124,0.000054293312],"about_ca_topic_score_codex":0.000018627643,"about_ca_topic_score_gemma":0.000078470875,"teacher_disagreement_score":0.04762298,"about_ca_system_score_codex":0.000077149896,"about_ca_system_score_gemma":0.000102991056,"threshold_uncertainty_score":0.31177738},"labels":[],"label_agreement":null},{"id":"W2062358462","doi":"10.1179/joc.2000.12.4.360","title":"A Pilot Study of Low Dose Hydroxyurea as a Novel Resistance Modulator in Metastatic Renal Cell Cancer","year":2000,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Vinblastine; Neutropenia; Medicine; Chemotherapy; Renal cell carcinoma; Internal medicine; Gastroenterology; Toxicity; Febrile neutropenia; Cancer; Pharmacology; Urology; Oncology","score_opus":0.026772745466838936,"score_gpt":0.29582095655836016,"score_spread":0.2690482110915212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062358462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507,0.0023366406,0.000013045709,0.0004823677,0.000049332215,0.0005218326,0.0000040190166,0.0000054643247,0.0015173341],"genre_scores_gemma":[0.9949047,0.0004961461,0.0013064379,0.00033940753,0.00011094479,0.0000142362605,6.5340777e-7,0.00003874269,0.0027887174],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806064,0.000059881382,0.00080833206,0.00018527616,0.00066399644,0.000221894],"domain_scores_gemma":[0.9988703,0.00006638223,0.00046025266,0.00028841276,0.00015450943,0.00016015286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031482917,0.00021288102,0.00072847854,0.0002225782,0.000019438769,0.000010720704,0.00014490528,0.000025704208,0.0007359953],"category_scores_gemma":[0.000014380413,0.00015507644,0.00014177726,0.00032787918,0.000040578896,0.00009724941,0.000005841606,0.0002687674,0.0000055230994],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039573107,0.033342082,0.022052111,0.0004590951,0.0012999272,0.0016643093,0.0070838183,0.0021881375,0.88084024,0.0000069515904,0.0012376794,0.01025251],"study_design_scores_gemma":[0.11782602,0.043088548,0.37894413,0.0023178281,0.0008653537,0.0005699068,0.0008047906,0.0004115027,0.45183527,0.0004649972,0.0022370527,0.00063457084],"about_ca_topic_score_codex":0.0002539551,"about_ca_topic_score_gemma":0.00020139167,"teacher_disagreement_score":0.429005,"about_ca_system_score_codex":0.00027164328,"about_ca_system_score_gemma":0.00030422147,"threshold_uncertainty_score":0.80586326},"labels":[],"label_agreement":null},{"id":"W2063648710","doi":"10.1038/bjc.2012.367","title":"Association between treatment effects on disease progression end points and overall survival in clinical studies of patients with metastatic renal cell carcinoma","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of Calgary","funders":"Novartis Pharmaceuticals Corporation","keywords":"Renal cell carcinoma; Hazard ratio; Medicine; Internal medicine; Confidence interval; Oncology; Progression-free survival; Proportional hazards model; Chemotherapy","score_opus":0.035887020276444595,"score_gpt":0.34489422547890264,"score_spread":0.30900720520245806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063648710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819298,0.017226275,0.0000012010266,0.00013208324,0.00016536866,0.00046033756,0.000045018136,0.0000024127023,0.000037522128],"genre_scores_gemma":[0.99783707,0.0014765322,0.00027223985,0.000032945638,0.0002677708,0.000018798957,0.000013305109,0.000017515345,0.0000637977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981228,0.000310788,0.0005748731,0.000138543,0.00062556035,0.00022740195],"domain_scores_gemma":[0.99826777,0.00046316293,0.00065574574,0.00007931867,0.00024261657,0.0002913767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052273035,0.00014914697,0.0006899343,0.00008817709,0.000029308809,0.000010719579,0.000031662064,0.000040030594,0.000011809695],"category_scores_gemma":[0.00017742481,0.00010672466,0.00012167914,0.00006791299,0.00004511924,0.00012930795,0.000017528451,0.00016777648,5.67645e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018841184,0.001024206,0.9337707,0.0002093354,0.00055038655,0.0002847175,0.00014490752,0.0000018218332,0.000014831862,5.941543e-7,0.00007414011,0.062040232],"study_design_scores_gemma":[0.012511127,0.0039334116,0.97868717,0.0013460757,0.0014392224,0.000009748429,0.000022249673,8.884926e-7,0.0018655183,0.00001355021,0.000085703934,0.00008534724],"about_ca_topic_score_codex":0.00009414426,"about_ca_topic_score_gemma":0.00006221689,"teacher_disagreement_score":0.061954886,"about_ca_system_score_codex":0.0006837166,"about_ca_system_score_gemma":0.00013964128,"threshold_uncertainty_score":0.43521056},"labels":[],"label_agreement":null},{"id":"W2063698832","doi":"10.1016/j.eururo.2014.05.010","title":"Systemic Therapy for Non–clear Cell Renal Cell Carcinomas: A Systematic Review and Meta-analysis","year":2014,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Clear cell renal cell carcinoma; Oncology; Internal medicine; Clear cell; Renal cell carcinoma; Targeted therapy; Odds ratio; Meta-analysis; Confidence interval; Cancer","score_opus":0.07410049256108052,"score_gpt":0.30740602801999656,"score_spread":0.23330553545891602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063698832","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000122408865,0.9843452,0.00021042817,0.00010433658,0.000057288296,0.010629559,0.00008830804,0.00007194544,0.0044807205],"genre_scores_gemma":[0.0010836913,0.98749584,0.00021923169,0.0017480252,0.0001449777,0.0010906511,0.0003270802,0.0002884002,0.0076021007],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.991666,0.003817003,0.0022341441,0.001355333,0.00032677164,0.00060075754],"domain_scores_gemma":[0.994783,0.00083903223,0.001770768,0.002054658,0.0002034474,0.00034912812],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.002307382,0.0011458019,0.01664718,0.00058297167,0.00009902854,0.000040997216,0.0004910637,0.0002616204,0.0001711813],"category_scores_gemma":[0.00011523015,0.00067556027,0.005871534,0.00052035006,0.00010377667,0.00002711334,0.00014770318,0.00051281706,0.00057201524],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032204545,0.00009543096,0.0000012058061,0.919176,0.078924984,0.00028423322,0.00003925955,6.307542e-7,0.000003948675,0.000004688742,0.001006928,0.00043050502],"study_design_scores_gemma":[0.00065796834,0.0015460956,0.0000022294505,0.0072917473,0.8341841,0.0007144141,0.0000036083738,0.000008282751,0.0000020022817,6.122353e-7,0.15518358,0.00040534706],"about_ca_topic_score_codex":0.000007793803,"about_ca_topic_score_gemma":0.0000010734929,"teacher_disagreement_score":0.91188425,"about_ca_system_score_codex":0.00011470794,"about_ca_system_score_gemma":0.00013307045,"threshold_uncertainty_score":0.99956954},"labels":[],"label_agreement":null},{"id":"W2063798988","doi":"10.1158/1538-7445.am2014-3119","title":"Abstract 3119: Predicting drug resistance in metastatic renal cell carcinoma: Personalized medicine by xenografting patient tumors into chicken embryos","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Sunitinib; Medicine; Chorioallantoic membrane; Renal cell carcinoma; Angiogenesis; In vivo; Cancer research; Cell culture; Internal medicine; Pathology; Oncology; Biology","score_opus":0.04032324083987818,"score_gpt":0.3402777968596722,"score_spread":0.29995455601979404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063798988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96877825,0.014655713,0.000026724672,0.0030520072,0.00010822866,0.001333972,0.000019354185,0.000060241233,0.01196553],"genre_scores_gemma":[0.9943396,0.00017394856,0.0006526668,0.00018205405,0.00029773774,0.0005786361,0.00009327845,0.00009520703,0.003586859],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9942268,0.00064626726,0.0009000043,0.00095959805,0.002095626,0.0011716967],"domain_scores_gemma":[0.99705714,0.0009575286,0.00024200472,0.0006923831,0.0004484284,0.0006025286],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028804224,0.0004056527,0.0008267419,0.0005861957,0.0003310326,0.00004695046,0.0003357962,0.00009008776,0.00051432155],"category_scores_gemma":[0.0008346387,0.00032257685,0.00014049215,0.0010111214,0.00057845475,0.00013986498,0.00015713433,0.0012947915,0.000040630905],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006216026,0.0015352045,0.14585276,0.0069865542,0.00034136057,0.0023103126,0.0648546,0.000094992836,0.6772047,0.00023454295,0.07607116,0.01829778],"study_design_scores_gemma":[0.046796955,0.0048570572,0.20850752,0.012375648,0.000691179,0.00012831703,0.024623394,0.0017024102,0.61838305,0.0017314474,0.07780776,0.0023952497],"about_ca_topic_score_codex":0.007469581,"about_ca_topic_score_gemma":0.0013109801,"teacher_disagreement_score":0.062654756,"about_ca_system_score_codex":0.0014881352,"about_ca_system_score_gemma":0.0005707538,"threshold_uncertainty_score":0.99992263},"labels":[],"label_agreement":null},{"id":"W2064059015","doi":"10.1007/s00428-014-1702-7","title":"Molecular-genetic analysis is essential for accurate classification of renal carcinoma resembling Xp11.2 translocation carcinoma","year":2014,"lang":"en","type":"article","venue":"Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"European Regional Development Fund; Univerzita Karlova v Praze","keywords":"Polysomy; Pathology; TFE3; Eosinophilic; Renal cell carcinoma; Biology; Chromosomal translocation; Vimentin; Epithelioid cell; Carcinoma; Fluorescence in situ hybridization; Immunohistochemistry; Medicine; Chromosome","score_opus":0.04723595685673905,"score_gpt":0.36331854927634916,"score_spread":0.3160825924196101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064059015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89528716,0.0026589844,0.09733248,0.0013783886,0.00017757437,0.0014953364,0.00010530283,0.00012310038,0.001441679],"genre_scores_gemma":[0.98598325,0.00035287827,0.011168904,0.0005998786,0.0003692814,0.0002568064,0.0010876532,0.00008994159,0.0000914032],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9942767,0.0008049609,0.0016236793,0.0015220608,0.00081122963,0.00096139143],"domain_scores_gemma":[0.9951607,0.0012080445,0.0009016046,0.0017636009,0.0005278664,0.00043819574],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013651357,0.0007421905,0.0017580425,0.0009949752,0.0002560927,0.000037318507,0.0006509642,0.0004609701,0.00005094186],"category_scores_gemma":[0.00094201684,0.0005881348,0.0011036231,0.001419087,0.00084714516,0.0001303316,0.00014921512,0.0006576284,0.000023785944],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024289223,0.00078139687,0.04524733,0.0005363211,0.0026230556,0.00013473611,0.0014748451,0.002759879,0.92246157,0.0020752614,0.0003457779,0.019130891],"study_design_scores_gemma":[0.005497008,0.0028469241,0.48441005,0.00014102497,0.007763487,0.000024342971,0.00045912788,0.077345915,0.4177032,0.0027550133,0.00041028633,0.0006435949],"about_ca_topic_score_codex":0.00029224323,"about_ca_topic_score_gemma":0.000038787715,"teacher_disagreement_score":0.50475836,"about_ca_system_score_codex":0.00010228984,"about_ca_system_score_gemma":0.0004475577,"threshold_uncertainty_score":0.99965703},"labels":[],"label_agreement":null},{"id":"W2064275611","doi":"10.1002/cncr.24035","title":"Radical versus partial nephrectomy","year":2009,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":322,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Kidney cancer; Cancer; Proportional hazards model; Cohort; Relative survival; Epidemiology; Surgery; Urology; Mortality rate; Internal medicine; Oncology; Kidney; Cancer registry","score_opus":0.0439013797900479,"score_gpt":0.32694293600029906,"score_spread":0.2830415562102512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064275611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720375,0.002614435,0.000022706003,0.0039062863,0.00046276415,0.00024182482,0.0000022029149,0.00006457851,0.020647708],"genre_scores_gemma":[0.9968858,0.00009294555,0.0002797781,0.00091887685,0.00068342884,0.000044127697,0.0000069672733,0.000007876574,0.0010802508],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994149,0.0000103835255,0.000088333036,0.00015191884,0.00015675687,0.00017770498],"domain_scores_gemma":[0.99962705,0.000016126403,0.00001833141,0.00016346,0.000021894566,0.0001531302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000025002844,0.00008361021,0.00014426227,0.00002483097,0.000024274379,0.000006377393,0.000032879412,0.00004503506,0.0009054983],"category_scores_gemma":[0.000014231144,0.000064287226,0.00007009062,0.000078404686,0.000051244708,0.000023919742,0.000005613643,0.00008787746,0.000119717086],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013121078,0.0007396813,0.029472077,0.00006494681,0.00046457286,0.0017960544,0.00051057176,0.00006573675,0.034728367,0.0031979633,0.10649569,0.8093433],"study_design_scores_gemma":[0.013026558,0.0018583366,0.11324148,0.00007801277,0.0003862269,0.00005414664,0.000033551754,0.00019648913,0.09789563,0.00009145889,0.7729004,0.0002376951],"about_ca_topic_score_codex":0.000051477182,"about_ca_topic_score_gemma":0.000006794599,"teacher_disagreement_score":0.8091056,"about_ca_system_score_codex":0.00019845043,"about_ca_system_score_gemma":0.00010789092,"threshold_uncertainty_score":0.9914571},"labels":[],"label_agreement":null},{"id":"W2064533535","doi":"10.1055/s-0030-1252720","title":"Nierenzellkarzinom in der Perfusions-CT: erste klinische Erfahrungen","year":2010,"lang":"de","type":"article","venue":"RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Nuclear medicine; Medicine; Chemistry; Physics","score_opus":0.02231058759149797,"score_gpt":0.2844978815236574,"score_spread":0.26218729393215945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064533535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.829598,0.13887508,0.00013623327,0.002390988,0.0074146925,0.004821107,0.00052715203,0.00052395917,0.015712745],"genre_scores_gemma":[0.97698444,0.004627153,0.0045713577,0.0017330411,0.004548355,0.00038507185,0.0014893103,0.00086358073,0.004797665],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9817613,0.00079810736,0.0043434976,0.0046559186,0.003392251,0.0050489362],"domain_scores_gemma":[0.9888827,0.0009760576,0.0013635319,0.0049645007,0.0007121635,0.0031010213],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0023682988,0.003532868,0.0037903227,0.0018793548,0.0011080643,0.0008054054,0.0021401905,0.0022009574,0.0059978594],"category_scores_gemma":[0.00043906778,0.0033813172,0.0017873206,0.0021553773,0.0013339918,0.0011798292,0.0013773135,0.006314734,0.008687646],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046981936,0.009993881,0.6743588,0.0028647168,0.030266007,0.03389881,0.007646486,0.00063921115,0.056655373,0.0032126645,0.054240193,0.12152567],"study_design_scores_gemma":[0.03596688,0.0036521293,0.28142118,0.0023533101,0.04224391,0.003730041,0.0018295557,0.004892675,0.08603003,0.002309544,0.5254993,0.01007145],"about_ca_topic_score_codex":0.0034325677,"about_ca_topic_score_gemma":0.002984164,"teacher_disagreement_score":0.4712591,"about_ca_system_score_codex":0.0008850795,"about_ca_system_score_gemma":0.0031119417,"threshold_uncertainty_score":0.99909437},"labels":[],"label_agreement":null},{"id":"W2064572991","doi":"10.1002/ijc.11427","title":"Physical activity and risk of renal cell carcinoma","year":2003,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Confidence interval; Odds ratio; Body mass index; Quartile; Population; Case-control study; Demography; Renal cell carcinoma; Internal medicine; Logistic regression; Environmental health","score_opus":0.016092089017765744,"score_gpt":0.3046274875336222,"score_spread":0.2885353985158564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064572991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952886,0.0013987097,0.00022670977,0.0002276522,0.0002604778,0.000054570537,0.000013622548,0.0000017057844,0.0025279454],"genre_scores_gemma":[0.99868387,0.0004236666,0.00033669325,0.00002523945,0.00028150567,0.0000019615018,4.4576902e-7,0.000008456336,0.00023816421],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991499,0.00004775126,0.00017403862,0.00008353827,0.00046715492,0.00007759845],"domain_scores_gemma":[0.9990071,0.000067545065,0.0003529997,0.000070056085,0.00040989372,0.00009239236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001126595,0.00008383734,0.00022260672,0.00009971087,0.000012089199,0.000007798542,0.00006675858,0.000027295788,0.00008728167],"category_scores_gemma":[0.00004603551,0.000060762857,0.0001381991,0.00004284573,0.000053036507,0.00007870291,0.000014342369,0.00016970534,0.0000013932813],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021956447,0.0010908239,0.6834819,0.00005696685,0.0013332184,0.0004954106,0.00062076957,0.00028326942,0.26818612,0.00033946786,0.0006845881,0.04123185],"study_design_scores_gemma":[0.0026357807,0.00045836178,0.41889,0.00006109211,0.00037196,0.00026124716,0.000029623301,0.0000604682,0.57537085,0.00025617922,0.0015480844,0.000056332676],"about_ca_topic_score_codex":0.00013792829,"about_ca_topic_score_gemma":0.000011158647,"teacher_disagreement_score":0.30718476,"about_ca_system_score_codex":0.00015307464,"about_ca_system_score_gemma":0.00018649276,"threshold_uncertainty_score":0.24778374},"labels":[],"label_agreement":null},{"id":"W2064859743","doi":"10.1016/j.urology.2007.03.044","title":"Consolidative Renal Cell Carcinoma Metastatectomy for Partial Response After Multitargeted Tyrosine Kinase Inhibitor Therapy","year":2007,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Tyrosine-kinase inhibitor; Tyrosine kinase; Oncology; Cancer research; Internal medicine; Cancer; Receptor","score_opus":0.02235441099191004,"score_gpt":0.28132258075763006,"score_spread":0.25896816976572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064859743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992239,0.0022032305,0.0026045,0.00090592843,0.00026688888,0.0013829061,0.00008207506,0.00006625952,0.00024920335],"genre_scores_gemma":[0.9947525,0.0000123684595,0.0023478973,0.0013386854,0.00031838592,0.0002609985,0.00009981831,0.00005569941,0.0008136311],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99795663,0.00021724196,0.00044042637,0.0005233036,0.0002124226,0.0006499783],"domain_scores_gemma":[0.9981197,0.0008263829,0.00012698398,0.00040481277,0.00024570606,0.00027642568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077186053,0.00030692364,0.00047442407,0.00025404876,0.00007621744,0.000010579453,0.000081238584,0.00020982073,0.00030903512],"category_scores_gemma":[0.00016876606,0.00024100635,0.00021389528,0.00016679532,0.000215625,0.00005180433,0.00004012846,0.0002433798,0.00007772714],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2175827,0.0008715509,0.010885877,0.000042196672,0.00018793494,0.0027072616,0.0011190056,0.00001543616,0.76391155,0.00003446719,0.0013016233,0.0013403936],"study_design_scores_gemma":[0.013605275,0.008183839,0.076792896,0.000005199867,0.00021952088,0.00013493106,0.00006750251,0.00013672283,0.8697595,0.000042824777,0.030829268,0.00022251699],"about_ca_topic_score_codex":0.00004043253,"about_ca_topic_score_gemma":0.000025314052,"teacher_disagreement_score":0.20397744,"about_ca_system_score_codex":0.00012779143,"about_ca_system_score_gemma":0.0001765873,"threshold_uncertainty_score":0.98279536},"labels":[],"label_agreement":null},{"id":"W2064915842","doi":"10.5489/cuaj.2598","title":"Surgical Management of Stage T1 Renal Tumors in Canadian Academic Centers","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; University of British Columbia; University of Toronto; Western University; Centre Hospitalier de l’Université de Montréal; Université Laval; University of Alberta; McMaster University; Dalhousie University; University of Calgary; University of Ottawa; McGill University; University of Manitoba; Ottawa Hospital","funders":"","keywords":"Nephrectomy; Medicine; Stage (stratigraphy); Renal function; Internal medicine; Kidney; Surgery; Urology","score_opus":0.03033145057092715,"score_gpt":0.2589717376500573,"score_spread":0.22864028707913017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064915842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9733832,0.00041885278,0.0000023340774,0.009287532,0.00017553537,0.00026120406,0.000039914226,0.000009271393,0.016422147],"genre_scores_gemma":[0.9971025,0.00009339343,0.00009870938,0.0008425618,0.00014183736,0.000007713984,0.000033488664,0.000013059753,0.0016667311],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976383,0.0001735132,0.0005586582,0.00021486044,0.00056822505,0.00084643794],"domain_scores_gemma":[0.9964548,0.000050724717,0.00024361888,0.00012335613,0.00018085299,0.0029466532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001316803,0.00016312476,0.00037051563,0.000517655,0.00006999505,0.000022740032,0.00016012549,0.00026938564,0.00035028646],"category_scores_gemma":[0.00017025915,0.00013670635,0.0001308537,0.00035697152,0.00003940321,0.00007657358,0.00001781441,0.00082827266,0.000049298593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010994736,0.000032762284,0.9891307,0.000008696322,0.00009809251,0.005837716,0.00010729468,0.00017890081,0.000012041067,0.0003929752,0.003459845,0.0006310641],"study_design_scores_gemma":[0.002739402,0.00037025506,0.9370455,0.00006181312,0.00006447124,0.00041814186,0.0002584415,0.0000933945,0.000039081384,0.00019364532,0.058583215,0.00013262272],"about_ca_topic_score_codex":0.20412815,"about_ca_topic_score_gemma":0.15237832,"teacher_disagreement_score":0.05512337,"about_ca_system_score_codex":0.007622293,"about_ca_system_score_gemma":0.0017639722,"threshold_uncertainty_score":0.99618727},"labels":[],"label_agreement":null},{"id":"W2065414041","doi":"10.1136/jcp.2006.041129","title":"Papillary renal cell carcinoma within a renal oncocytoma: case report of an incidental finding of a tumour within a tumour","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; Toronto General Hospital; University Health Network","funders":"","keywords":"Oncocytoma; Chromophobe cell; Renal oncocytoma; Pathology; Clear cell; Nephrectomy; Papillary renal cell carcinomas; Kidney; Renal cell carcinoma; Medicine; Biology; Internal medicine","score_opus":0.0678907838739218,"score_gpt":0.38032278534980263,"score_spread":0.3124320014758808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065414041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969983,0.00051018817,0.0002533586,0.00013837,0.0007706741,0.000343749,0.000013531293,0.000014397561,0.000957432],"genre_scores_gemma":[0.98053277,0.0000141608525,0.018174158,0.00016159781,0.000899714,0.000002261677,0.000013112515,0.00005267718,0.0001495768],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9906489,0.0007470141,0.0066401777,0.0005072127,0.00097549945,0.00048114156],"domain_scores_gemma":[0.990133,0.0010038747,0.0066260267,0.0006057311,0.00084028416,0.00079111743],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.011081199,0.00037428996,0.00228351,0.0005780898,0.000069897884,0.000009293971,0.0002768263,0.00050498993,0.0000534946],"category_scores_gemma":[0.0024272748,0.0002829375,0.0009458683,0.00035503772,0.00053205073,0.0001912446,0.00015083286,0.0015206229,0.000005162258],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005254887,0.001548551,0.12360935,0.00012642762,0.00012117209,0.7114775,0.0009187593,0.000040182807,0.156257,0.000015733458,0.00010945309,0.0005209512],"study_design_scores_gemma":[0.00543104,0.012374455,0.29323998,0.00020693084,0.00058965135,0.538842,0.0008844389,0.00006225592,0.14807293,0.00012975537,0.000011093546,0.00015546654],"about_ca_topic_score_codex":0.000121250116,"about_ca_topic_score_gemma":0.00015847907,"teacher_disagreement_score":0.17263551,"about_ca_system_score_codex":0.00020936802,"about_ca_system_score_gemma":0.0012388952,"threshold_uncertainty_score":0.9999623},"labels":[],"label_agreement":null},{"id":"W2065749477","doi":"10.5489/cuaj.11046","title":"Determining optimal surgical care for patients with renal masses","year":2011,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; General surgery","score_opus":0.020781794729103614,"score_gpt":0.21956876987806048,"score_spread":0.19878697514895688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065749477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938243,0.00009906521,0.000055828485,0.00049436104,0.00011672201,0.00034084343,0.00003915033,0.000019360778,0.005010385],"genre_scores_gemma":[0.99339366,0.0000068644854,0.0056689754,0.00037669425,0.00025731281,0.000024456642,0.00006287111,0.000017820847,0.00019136864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864316,0.000068202644,0.0002621309,0.00020162662,0.0003207471,0.0005041496],"domain_scores_gemma":[0.9982944,0.00010776391,0.00020239581,0.00008944423,0.00051273376,0.000793267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018054977,0.00015509714,0.0002779779,0.00013101759,0.00025016782,0.00004329385,0.000082245606,0.00018445506,0.00037476272],"category_scores_gemma":[0.000189004,0.000105107654,0.0001439207,0.000095294396,0.00002772796,0.00008173464,0.0000089301,0.00029818356,0.000015534892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034767823,0.000061661245,0.99571043,0.0000056616345,0.00010502034,0.00039033714,0.00030356558,0.000006254661,0.0000026462646,0.000046660818,0.00047293268,0.0025471437],"study_design_scores_gemma":[0.0035123385,0.0032915492,0.94452536,0.000019157123,0.0001926836,0.0002536205,0.00016896307,0.000020489615,0.00006723347,0.000033905264,0.047766365,0.00014834676],"about_ca_topic_score_codex":0.00014772678,"about_ca_topic_score_gemma":0.0002688092,"teacher_disagreement_score":0.05118509,"about_ca_system_score_codex":0.0011650908,"about_ca_system_score_gemma":0.00044942484,"threshold_uncertainty_score":0.42861658},"labels":[],"label_agreement":null},{"id":"W2066355838","doi":"10.1016/j.clgc.2013.12.003","title":"A Population-Based Overview of Sequences of Targeted Therapy in Metastatic Renal Cell Carcinoma","year":2014,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; London Health Sciences Centre; BC Cancer Agency; Princess Margaret Cancer Centre; Baker Hughes (Canada); Western University; Alberta Cancer Foundation; Sunnybrook Health Science Centre","funders":"","keywords":"Sunitinib; Medicine; Temsirolimus; Hazard ratio; Everolimus; Renal cell carcinoma; Internal medicine; Oncology; Confidence interval; Population; Clear cell renal cell carcinoma; Urology; Gastroenterology; PI3K/AKT/mTOR pathway; Discovery and development of mTOR inhibitors","score_opus":0.124437901460307,"score_gpt":0.39399840166557637,"score_spread":0.26956050020526934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066355838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880512,0.010747535,0.000021701015,0.00021108553,0.00015496307,0.00046349133,0.0000230317,0.000012127337,0.00031490406],"genre_scores_gemma":[0.9965908,0.00063752354,0.0020976365,0.00029512675,0.00014669108,0.00006161928,0.000043076703,0.000023976278,0.00010353843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763787,0.00039833502,0.0010735141,0.00033281292,0.00034238986,0.0002150877],"domain_scores_gemma":[0.9983401,0.0005388475,0.0004154172,0.00041907487,0.00014562624,0.00014095461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054716325,0.00019208423,0.00085748936,0.00013580188,0.000017894161,0.0000026845821,0.000127416,0.000092454,0.00036339505],"category_scores_gemma":[0.000093618604,0.00014553884,0.00033452173,0.00028324092,0.0001131994,0.000038504775,0.00002411019,0.00019915626,0.0000053038066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011363816,0.0009800387,0.9727981,0.0004674624,0.000057731242,0.00007315067,0.000060996026,0.00066747324,0.012309739,0.000007750924,0.000105725114,0.011335456],"study_design_scores_gemma":[0.0043365248,0.0032118428,0.937866,0.00020072787,0.00013675011,0.0000037527952,0.000021400232,0.00086524914,0.052934334,0.00011751359,0.00017628519,0.0001296712],"about_ca_topic_score_codex":0.0011559974,"about_ca_topic_score_gemma":0.000064255124,"teacher_disagreement_score":0.040624596,"about_ca_system_score_codex":0.00009571388,"about_ca_system_score_gemma":0.0003728432,"threshold_uncertainty_score":0.5934902},"labels":[],"label_agreement":null},{"id":"W2067736210","doi":"10.1038/modpathol.2012.230","title":"FG has no added value in prediction of mortality after partial and radical nephrectomy for chromophobe renal cell carcinoma patients","year":2013,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nephrectomy; Chromophobe cell; Medicine; Renal cell carcinoma; Context (archaeology); Proportional hazards model; Urology; Confidence interval; Kidney cancer; Stage (stratigraphy); Cancer; Internal medicine; Surgery; Clear cell; Kidney; Biology","score_opus":0.024559840618051016,"score_gpt":0.23489104208576297,"score_spread":0.21033120146771195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067736210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99714595,0.00028606848,0.0005450657,0.00008238888,0.00015049418,0.0014088174,0.00009508707,0.000020259353,0.0002658617],"genre_scores_gemma":[0.99751234,0.000009583224,0.0014281808,0.00011027643,0.0001128065,0.0005650552,0.00016079805,0.00002670788,0.00007423975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844223,0.00012979849,0.0004477113,0.00044739546,0.00020092475,0.0003319561],"domain_scores_gemma":[0.99922556,0.00006817343,0.00010972558,0.00031670698,0.00012783722,0.00015202291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015432347,0.00019788955,0.00045517203,0.00011392247,0.000032624528,0.000008784263,0.000051501123,0.00021551247,0.00010057011],"category_scores_gemma":[0.00006264217,0.00016695117,0.00010106954,0.00006117861,0.0002144181,0.00008948594,0.00005412168,0.00015185172,0.000015621064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093170133,0.00075949606,0.94384074,0.0001776292,0.000028355858,0.00015532183,0.00079807214,0.0000144451515,0.05196193,0.0000057125603,0.00029826953,0.001028331],"study_design_scores_gemma":[0.006459102,0.0019254535,0.95002604,0.000033099343,0.00015025258,0.00004245295,0.000008906171,0.007817783,0.033046447,0.00026858758,0.00011425539,0.00010763183],"about_ca_topic_score_codex":0.00029632603,"about_ca_topic_score_gemma":0.000018034385,"teacher_disagreement_score":0.018915484,"about_ca_system_score_codex":0.000103631406,"about_ca_system_score_gemma":0.00007027072,"threshold_uncertainty_score":0.6808071},"labels":[],"label_agreement":null},{"id":"W2068016036","doi":"10.1016/j.critrevonc.2013.12.003","title":"A critical appraisal of systemic treatment options for metastatic non-clear cell renal cell carcinoma","year":2013,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Temsirolimus; Sunitinib; Sorafenib; Medicine; Oncology; Renal cell carcinoma; Internal medicine; Discovery and development of mTOR inhibitors; Biology","score_opus":0.13347212915148227,"score_gpt":0.4518256693344538,"score_spread":0.3183535401829715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068016036","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029863333,0.98373216,0.0010774303,0.00035774734,0.00097035355,0.0102405185,0.00018008696,0.00004318684,0.0030998948],"genre_scores_gemma":[0.0037351097,0.95585304,0.026405148,0.000095358526,0.00023785622,0.012723894,0.00030832467,0.0001965687,0.00044467344],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9896294,0.0021771442,0.0046977242,0.0016223387,0.00037593264,0.0014974735],"domain_scores_gemma":[0.97835904,0.017968113,0.0008275241,0.001532083,0.0005011109,0.0008121239],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0012127695,0.0014412745,0.013712392,0.00079241226,0.00011400605,0.000026928317,0.000540187,0.0013778908,0.00045412278],"category_scores_gemma":[0.005729985,0.0010168647,0.002744404,0.0005693101,0.0011402449,0.00010384432,0.00020722793,0.0010431561,0.000985092],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004105157,0.011816721,0.00007831189,0.54616416,0.00054771267,0.004101444,0.0004235048,5.583258e-7,0.0002430621,0.027229382,0.008736408,0.40024823],"study_design_scores_gemma":[0.0047728526,0.013360227,0.000006521866,0.044161323,0.017781712,0.0104863085,0.00027022508,0.00009025896,0.0004025956,0.00026853336,0.9073331,0.0010663669],"about_ca_topic_score_codex":0.000044850327,"about_ca_topic_score_gemma":0.000010539791,"teacher_disagreement_score":0.89859664,"about_ca_system_score_codex":0.0018063034,"about_ca_system_score_gemma":0.0022925888,"threshold_uncertainty_score":0.9999185},"labels":[],"label_agreement":null},{"id":"W2068287946","doi":"10.1016/j.eururo.2007.01.070","title":"Collecting Duct Renal Cell Carcinoma: A Matched Analysis of 41 Cases","year":2007,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Stage (stratigraphy); Internal medicine; Cohort; Clear cell; Clear cell renal cell carcinoma; Kidney cancer; Kidney disease; Surgery; Urology; Oncology; Kidney","score_opus":0.03327093450918067,"score_gpt":0.26999642904469967,"score_spread":0.236725494535519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068287946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91890424,0.00064413546,0.00019292042,0.00012601857,0.00007870998,0.00018017723,0.000006953493,0.000044043976,0.07982277],"genre_scores_gemma":[0.99697816,0.000006468667,0.00062414154,0.0003264165,0.00013669104,0.0000016882265,0.00004243667,0.000041112427,0.0018428544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824774,0.0002683378,0.00050806,0.00038190908,0.00020337147,0.0003905728],"domain_scores_gemma":[0.9986475,0.00037323838,0.00022269397,0.0004621416,0.00012199684,0.0001724446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073895365,0.00019294553,0.00060917187,0.00066001376,0.00006390405,0.000005599781,0.00011032729,0.000055091834,0.00028304875],"category_scores_gemma":[0.00015773327,0.00016609622,0.0002830714,0.0010405824,0.00010995496,0.000019529847,0.00008048803,0.00019093438,0.000078320314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027987831,0.00095687684,0.6212446,0.00012663187,0.00219136,0.035624262,0.0026735626,0.00035877022,0.33008358,0.000069139445,0.002077923,0.0017945197],"study_design_scores_gemma":[0.0016812808,0.0018394231,0.94900197,0.000003899005,0.00403033,0.00071297644,0.00018975098,0.00013976176,0.040816467,0.0000032294724,0.0014341186,0.00014678133],"about_ca_topic_score_codex":0.00016550878,"about_ca_topic_score_gemma":0.00006845118,"teacher_disagreement_score":0.3277574,"about_ca_system_score_codex":0.00008086179,"about_ca_system_score_gemma":0.000056530967,"threshold_uncertainty_score":0.6773207},"labels":[],"label_agreement":null},{"id":"W2068918729","doi":"10.1016/j.prp.2005.03.008","title":"Hybrid chromophobe renal cell neoplasm","year":2005,"lang":"en","type":"article","venue":"Pathology - Research and Practice","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Chromophobe cell; Oncocytoma; Pathology; Renal oncocytoma; Cytokeratin; Immunostaining; Renal cell carcinoma; Staining; Medicine; Clear cell; Vimentin; Immunohistochemistry","score_opus":0.08382263902423412,"score_gpt":0.391206356752534,"score_spread":0.30738371772829987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068918729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81972504,0.003425262,0.000033692217,0.015078663,0.000057480625,0.0003800464,0.000008321649,0.000034823744,0.16125667],"genre_scores_gemma":[0.98002374,0.0025494772,0.0067213085,0.00076074945,0.00042591162,0.000054655222,0.000025207577,0.000024324565,0.009414621],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99752736,0.00072790385,0.00020409064,0.00045287696,0.00049539027,0.0005923612],"domain_scores_gemma":[0.996838,0.0019755422,0.00006271709,0.00042065277,0.00032775674,0.0003753483],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022322312,0.00014528193,0.00023757077,0.00019712557,0.0002182804,0.000040152358,0.00009121719,0.000101117286,0.000342644],"category_scores_gemma":[0.0015245326,0.00010423101,0.00004440917,0.00015513686,0.00032252996,0.00029537693,0.00013643262,0.0008315276,0.00090667664],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011476772,0.0049226442,0.006768,0.0004277161,0.00029519838,0.07235261,0.0026186318,0.0000068807453,0.72788745,0.0012159573,0.048808187,0.12321994],"study_design_scores_gemma":[0.004337715,0.0053108865,0.01452504,0.00004607921,0.0001808172,0.041051574,0.0005554865,0.00009528214,0.24633746,0.0005628963,0.6867286,0.00026813732],"about_ca_topic_score_codex":0.000058858182,"about_ca_topic_score_gemma":0.000011518398,"teacher_disagreement_score":0.63792044,"about_ca_system_score_codex":0.00012051488,"about_ca_system_score_gemma":0.00020703918,"threshold_uncertainty_score":0.99987125},"labels":[],"label_agreement":null},{"id":"W2069672800","doi":"10.1016/j.eururo.2010.10.029","title":"Age-Adjusted Incidence, Mortality, and Survival Rates of Stage-Specific Renal Cell Carcinoma in North America: A Trend Analysis","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":311,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Incidence (geometry); Renal cell carcinoma; Stage (stratigraphy); Epidemiology; Mortality rate; Survival rate; Demography; Internal medicine","score_opus":0.04569799973891559,"score_gpt":0.27548371824312046,"score_spread":0.22978571850420487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069672800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856921,0.00045977984,0.000024393488,0.00008129072,0.000102693964,0.00020815966,0.00003543882,0.000025181469,0.013370978],"genre_scores_gemma":[0.998841,0.00007406368,0.0002547004,0.00010188786,0.00009245292,0.0000052873656,0.00017609914,0.000035491157,0.00041901646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779356,0.00051741296,0.0005516543,0.000544345,0.0002472988,0.00034570447],"domain_scores_gemma":[0.99869996,0.00017797099,0.00023440065,0.00062685943,0.00006505662,0.00019574008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003661923,0.00025255635,0.00072199723,0.0006157793,0.000035422094,0.000013359326,0.00016723934,0.00006469923,0.00025625963],"category_scores_gemma":[0.000054741085,0.00021478566,0.00015291339,0.0010634623,0.00040593883,0.0000445542,0.00015545767,0.00044350236,0.000028620783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026889087,0.00022360464,0.9779467,0.000030226149,0.00017838698,0.003710892,0.0005776136,0.0001291317,0.016127883,0.00002007435,0.000064401596,0.00072222244],"study_design_scores_gemma":[0.0015555611,0.00078776316,0.9937273,0.0000018743547,0.000601067,0.00003326379,0.00009067946,0.00021255019,0.0012725756,0.0000028947973,0.0015659712,0.00014845349],"about_ca_topic_score_codex":0.0006257818,"about_ca_topic_score_gemma":0.007596382,"teacher_disagreement_score":0.015780672,"about_ca_system_score_codex":0.00002561409,"about_ca_system_score_gemma":0.000041343803,"threshold_uncertainty_score":0.8758705},"labels":[],"label_agreement":null},{"id":"W2069701490","doi":"10.1016/j.eururo.2013.08.012","title":"Impact of Bone and Liver Metastases on Patients with Renal Cell Carcinoma Treated with Targeted Therapy","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":253,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of Toronto; Western University; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Calgary","funders":"National Cancer Institute; Bayer Korea; Genentech; GlaxoSmithKline; Pfizer","keywords":"Medicine; Renal cell carcinoma; Targeted therapy; Oncology; Carcinoma; Internal medicine; Cancer","score_opus":0.0117646008524895,"score_gpt":0.20782902668480147,"score_spread":0.19606442583231196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069701490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99403757,0.0006603418,0.0000045260576,0.00003617843,0.0000071632817,0.0006178232,0.00002304541,0.000028196122,0.0045851576],"genre_scores_gemma":[0.9991627,0.000026727177,0.00021682674,0.0001731126,0.000024116767,0.000009385546,0.00011014237,0.00005632565,0.00022069919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987527,0.0002930047,0.00020301495,0.00032114994,0.00017315609,0.00025696895],"domain_scores_gemma":[0.9991317,0.000065668675,0.00015110592,0.0003282661,0.00015433443,0.00016896939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068631125,0.00025400534,0.0003957396,0.00015201027,0.000032759668,0.000008085859,0.00004411832,0.000030769625,0.00034239207],"category_scores_gemma":[0.000009699707,0.00013188603,0.000067527384,0.000118869284,0.00015954391,0.000046247256,0.00002302018,0.0001271135,0.00007249201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057995077,0.0009814675,0.9781978,0.000017198225,0.00029531086,0.00071620115,0.00023507483,0.000025316516,0.010582219,0.000002580095,0.0007115335,0.0024357808],"study_design_scores_gemma":[0.007431738,0.03850069,0.9461411,0.00000844933,0.00016414153,0.00007182547,0.0000067043684,0.000016154509,0.0074405186,6.8053566e-7,0.00010154223,0.00011642114],"about_ca_topic_score_codex":0.00031596638,"about_ca_topic_score_gemma":0.0000028513093,"teacher_disagreement_score":0.03751922,"about_ca_system_score_codex":0.000032735214,"about_ca_system_score_gemma":0.00003282798,"threshold_uncertainty_score":0.53781563},"labels":[],"label_agreement":null},{"id":"W2069717010","doi":"10.1016/j.eururo.2007.04.015","title":"Re: Cytoreductive Nephrectomy in the Elderly Patient: The M.D. Anderson Cancer Center Experience","year":2007,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Cancer; Center (category theory); General surgery; Urology; Surgery; Internal medicine; Kidney","score_opus":0.026934407015303093,"score_gpt":0.2824254768634989,"score_spread":0.2554910698481958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069717010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94376785,0.0009871746,0.00003070537,0.0044183214,0.00024782628,0.00041599546,0.0000018676777,0.000021382413,0.05010888],"genre_scores_gemma":[0.9939394,0.000045650908,0.00003439846,0.0055360575,0.00024267897,0.000024541583,0.000005703791,0.000022610604,0.00014898804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856955,0.00040920614,0.0002113676,0.000276456,0.00018790008,0.00034554125],"domain_scores_gemma":[0.9992991,0.00015457199,0.000072403396,0.00038139045,0.00003521143,0.00005731574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037900277,0.00014318677,0.00014132868,0.00006239482,0.00008227987,0.000012095889,0.00018437848,0.000031546286,0.00011794549],"category_scores_gemma":[0.000046919202,0.000072902236,0.000059085363,0.00018847386,0.00019814867,0.000036808593,0.000047544694,0.00028856474,0.00006470112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00470457,0.001312571,0.5241331,0.00003324129,0.00023987527,0.010141774,0.26228634,0.00004510021,0.006411244,0.00041933826,0.018668467,0.17160441],"study_design_scores_gemma":[0.002185463,0.0026379733,0.8164768,0.000017236796,0.00006775819,0.00043282346,0.010494788,0.000011481154,0.0023370825,0.000025547848,0.16515666,0.00015633133],"about_ca_topic_score_codex":0.00011283773,"about_ca_topic_score_gemma":0.00014804384,"teacher_disagreement_score":0.29234377,"about_ca_system_score_codex":0.00007589618,"about_ca_system_score_gemma":0.000022945656,"threshold_uncertainty_score":0.2972867},"labels":[],"label_agreement":null},{"id":"W2070286579","doi":"10.1038/nrurol.2010.65","title":"Pazopanib trial data cannot support first-line use","year":2010,"lang":"en","type":"review","venue":"Nature Reviews Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Pazopanib; Medicine; Sunitinib; Tolerability; Everolimus; Oncology; Renal cell carcinoma; Internal medicine; Randomized controlled trial; Clinical trial; Urology; Adverse effect","score_opus":0.20871114336935243,"score_gpt":0.42391346243045797,"score_spread":0.21520231906110554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070286579","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000054635616,0.9841985,0.000007582106,0.00068855146,0.0033826814,0.00975406,0.00063039234,0.000097852826,0.0012348895],"genre_scores_gemma":[0.000005267993,0.97506666,0.0006778259,0.0017748872,0.003850197,0.000632426,0.014993433,0.00020884015,0.0027904387],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932526,0.00086306396,0.00238581,0.0020590578,0.0005563917,0.00088307215],"domain_scores_gemma":[0.9908402,0.0008521225,0.0014388391,0.00615847,0.00017623615,0.000534109],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0018379623,0.0013670401,0.008460196,0.00043137654,0.000106619555,0.00005064787,0.0014816932,0.0046821604,0.0011469973],"category_scores_gemma":[0.003260045,0.0008502681,0.0015565859,0.0006139984,0.00018607988,0.00015452527,0.00075305335,0.0074309083,0.0014918916],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012390559,0.00030823448,0.000008395106,0.013873554,0.00035148129,0.001174693,0.0000051746883,1.3069866e-8,2.574707e-7,0.00005132764,0.05297479,0.930013],"study_design_scores_gemma":[0.007945645,0.0017067463,0.000005889406,0.002536426,0.013222089,0.004204293,1.5441178e-7,0.0000013777563,3.4186868e-7,0.0000067213455,0.96983737,0.000532947],"about_ca_topic_score_codex":0.00003784118,"about_ca_topic_score_gemma":0.0002821161,"teacher_disagreement_score":0.9294801,"about_ca_system_score_codex":0.00024112492,"about_ca_system_score_gemma":0.0013656442,"threshold_uncertainty_score":0.99990803},"labels":[],"label_agreement":null},{"id":"W2070640824","doi":"10.1097/pas.0b013e318299f2d1","title":"The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia","year":2013,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1052,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Renal cell carcinoma; Clear cell; Oncocytoma; Chromophobe cell; Pathology","score_opus":0.02149023160245386,"score_gpt":0.2671929664527862,"score_spread":0.2457027348503323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070640824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98708427,0.0003090379,0.0002904446,0.010502103,0.00026751426,0.00017668083,0.000004074074,0.0000061554747,0.001359738],"genre_scores_gemma":[0.99727243,0.0007277036,0.0012365847,0.0003568342,0.00020266339,0.0000111438,0.000002982176,0.000011517723,0.00017811751],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99781525,0.00046501262,0.00087196496,0.00016565672,0.00043760487,0.00024448877],"domain_scores_gemma":[0.9964653,0.0011723067,0.001380453,0.00033007062,0.0005418927,0.00010996871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011172154,0.00015169154,0.00065465056,0.00006565769,0.00007456546,0.0000072935586,0.00040353034,0.00008220152,0.0001365094],"category_scores_gemma":[0.00013504134,0.00006976212,0.00046345868,0.00020050163,0.0019736323,0.000052497933,0.00009467681,0.0005445486,0.000012885912],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011988419,0.0022471861,0.19134347,0.00005454379,0.0018401049,0.0027339114,0.0027224764,0.00028049454,0.5450505,0.002773313,0.054492876,0.18447268],"study_design_scores_gemma":[0.0041630575,0.009363258,0.9382656,0.000052256222,0.00041652133,0.018553238,0.0031623896,0.0007066158,0.0067726723,0.0025581091,0.015793735,0.00019254247],"about_ca_topic_score_codex":0.000015678921,"about_ca_topic_score_gemma":0.0000022161412,"teacher_disagreement_score":0.74692214,"about_ca_system_score_codex":0.0000775032,"about_ca_system_score_gemma":0.00012899979,"threshold_uncertainty_score":0.72719306},"labels":[],"label_agreement":null},{"id":"W2071061528","doi":"10.1002/cncr.20025","title":"The natural history of incidentally detected small renal masses","year":2004,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":525,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre; University of Toronto; University Health Network","funders":"Kidney Foundation of Canada","keywords":"Medicine; Asymptomatic; Natural history; Confidence interval; Incidence (geometry); Renal cell carcinoma; Surgery; Radiology; Nuclear medicine; Internal medicine","score_opus":0.023604050835138755,"score_gpt":0.2518879537539988,"score_spread":0.22828390291886005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071061528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9646579,0.030645402,0.0000098330665,0.00035751838,0.0004827052,0.00018027762,0.0000018687981,0.000024032757,0.0036404352],"genre_scores_gemma":[0.99041826,0.00023757422,0.00028661595,0.00012245607,0.000112812086,0.000037040707,0.000004044218,0.0000131796505,0.008768028],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994203,0.000013521605,0.00014377106,0.00011919079,0.00016573144,0.00013749144],"domain_scores_gemma":[0.9995504,0.000031688538,0.00007217182,0.00020101153,0.000088539055,0.00005618812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004572561,0.00008640189,0.00012943473,0.000029930223,0.000027257878,0.0000031266202,0.0000731451,0.000033483047,0.00009835121],"category_scores_gemma":[0.00003172817,0.0000524998,0.00007719403,0.000056805828,0.00011142308,0.00002018732,0.000022461685,0.00011328546,0.0000095433525],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00198524,0.00023712499,0.04729315,0.0002456856,0.0006531942,0.00039283774,0.0021548346,0.00017622515,0.9029814,0.0005321997,0.010532193,0.032815915],"study_design_scores_gemma":[0.0043165963,0.00055225816,0.53323346,0.00032166234,0.0003232355,0.00015395819,0.00014837315,0.00002240311,0.34760368,0.00021622807,0.11289991,0.00020824009],"about_ca_topic_score_codex":0.00063966145,"about_ca_topic_score_gemma":0.00094522047,"teacher_disagreement_score":0.5553777,"about_ca_system_score_codex":0.0019803857,"about_ca_system_score_gemma":0.00062392344,"threshold_uncertainty_score":0.517864},"labels":[],"label_agreement":null},{"id":"W2071155427","doi":"10.1155/2014/354104","title":"Laparoscopic Nephrectomy,<i>Ex Vivo</i>Partial Nephrectomy, and Autotransplantation for the Treatment of Complex Renal Masses","year":2014,"lang":"en","type":"article","venue":"Case Reports in Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Canadian Urological Association","keywords":"Medicine; Nephrectomy; Autotransplantation; Renal cell carcinoma; Surgery; Renal function; Kidney; Ex vivo; Urology; Transplantation; In vivo; Internal medicine","score_opus":0.033709087685854774,"score_gpt":0.29731006814045613,"score_spread":0.26360098045460134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071155427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958197,0.00097060745,0.0007819167,0.00043897485,0.00021253037,0.0012383681,0.000012238905,0.000027764141,0.00049791695],"genre_scores_gemma":[0.99767387,0.00021886991,0.0013480822,0.00016568475,0.00013070875,0.0002924244,0.000048272374,0.000019935302,0.00010216889],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986704,0.000098785684,0.0005103144,0.00034883304,0.00011566602,0.00025597643],"domain_scores_gemma":[0.99867094,0.00060838053,0.00021181365,0.00036828718,0.000054675595,0.000085892636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023550617,0.00018936364,0.00048709504,0.00010874291,0.00006732154,0.0000084214835,0.000021605782,0.00010923339,0.000055528777],"category_scores_gemma":[0.000056288307,0.00012484298,0.00009854383,0.00008951744,0.0001895379,0.000028831255,0.000009261052,0.0000656464,9.880154e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00833823,0.0028546692,0.7011043,0.0009521351,0.0014108418,0.11631457,0.004930624,0.0015571816,0.104073144,0.0014560018,0.00095846923,0.056049824],"study_design_scores_gemma":[0.016966105,0.01725835,0.14465088,0.00007678641,0.003243666,0.26741064,0.00016526887,0.015180961,0.11952428,0.00093644694,0.4140786,0.0005080294],"about_ca_topic_score_codex":0.00041296895,"about_ca_topic_score_gemma":0.0003714535,"teacher_disagreement_score":0.5564534,"about_ca_system_score_codex":0.00007222039,"about_ca_system_score_gemma":0.00007578573,"threshold_uncertainty_score":0.5090949},"labels":[],"label_agreement":null},{"id":"W2071275751","doi":"10.1016/j.eururo.2011.07.064","title":"A Stage-for-Stage and Grade-for-Grade Analysis of Cancer-Specific Mortality Rates in Renal Cell Carcinoma According to Age: A Competing-Risks Regression Analysis","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Stage (stratigraphy); Kidney cancer; Internal medicine; Cancer; Epidemiology; Population; Cohort; Cancer stage; Carcinoma; Oncology","score_opus":0.138070243098142,"score_gpt":0.3530760132821776,"score_spread":0.21500577018403558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071275751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99493444,0.0015191701,0.0010245845,0.00011759718,0.000060224746,0.0008038435,0.00016534417,0.000031867537,0.0013429511],"genre_scores_gemma":[0.99699706,0.00010613021,0.0020144952,0.0001563139,0.000064209074,0.00006754177,0.00019480984,0.000051462448,0.0003479597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971678,0.00052696874,0.0007688338,0.0008286652,0.00021403124,0.00049367524],"domain_scores_gemma":[0.99826133,0.00027597143,0.00041378854,0.00066249643,0.00013256008,0.0002538792],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009250846,0.00033893227,0.001215232,0.0011667322,0.000088459856,0.00001725538,0.00020951692,0.00008728875,0.00009606382],"category_scores_gemma":[0.00007917587,0.00028021517,0.0004484342,0.0016500632,0.00015175276,0.000043828637,0.0001463352,0.00021960611,0.0000028163797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010964606,0.00024248683,0.97158337,0.00011327476,0.0016218661,0.00051228906,0.0021610763,0.0009630591,0.02099427,0.00006380823,0.000041707553,0.0006063304],"study_design_scores_gemma":[0.002188633,0.0010262373,0.97383064,0.000017136283,0.006436138,0.0000029491107,0.00055366097,0.0021272372,0.012970962,0.000008241633,0.00061262475,0.00022555653],"about_ca_topic_score_codex":0.0020852303,"about_ca_topic_score_gemma":0.0012010512,"teacher_disagreement_score":0.008023308,"about_ca_system_score_codex":0.0001032129,"about_ca_system_score_gemma":0.000043394026,"threshold_uncertainty_score":0.999965},"labels":[],"label_agreement":null},{"id":"W2071876402","doi":"10.1038/sj.bjc.6603629","title":"A cohort study of reproductive and hormonal factors and renal cell cancer risk in women","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Hazard ratio; Cohort study; Obstetrics; Gynecology; Cohort; Confidence interval; Pregnancy; Parity (physics); Relative risk; Cancer; Internal medicine; Biology","score_opus":0.011923008972024597,"score_gpt":0.2728643878861293,"score_spread":0.26094137891410474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071876402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9674553,0.031834118,0.0000029023254,0.000029900533,0.000084512816,0.00038155052,0.000018982191,0.0000024051271,0.0001902767],"genre_scores_gemma":[0.99039704,0.009191076,0.00006482809,0.000019603762,0.00018008397,0.000014328911,4.5967747e-7,0.000015039811,0.000117531774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998587,0.000056203568,0.00050135504,0.00022904268,0.00041054742,0.0002158322],"domain_scores_gemma":[0.9990202,0.000057839716,0.0004090377,0.00009675949,0.00022956013,0.0001865602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007706646,0.00012101173,0.00050355226,0.00015396978,0.000034076606,0.000014155579,0.000042508575,0.00004657226,0.000059297992],"category_scores_gemma":[0.000058028112,0.00010651861,0.000043169475,0.00015218278,0.00008320758,0.0000947723,0.000027373177,0.00031851386,7.109833e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010922864,0.0004101706,0.95937186,0.000035708297,0.0002755141,0.00093509763,0.002653174,0.000015201799,0.0023379477,1.3170632e-7,0.00010208583,0.032770813],"study_design_scores_gemma":[0.003884879,0.0014683042,0.9844105,0.00026556573,0.00024878222,0.000491929,0.0023314883,0.0000013549744,0.0066300156,0.00001733272,0.00016297308,0.000086867054],"about_ca_topic_score_codex":0.010169218,"about_ca_topic_score_gemma":0.0038255006,"teacher_disagreement_score":0.032683946,"about_ca_system_score_codex":0.00039015213,"about_ca_system_score_gemma":0.00015066718,"threshold_uncertainty_score":0.9964222},"labels":[],"label_agreement":null},{"id":"W2072300037","doi":"10.1016/j.eururo.2011.06.048","title":"Basic Research in Kidney Cancer","year":2011,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute","keywords":"Medicine; Kidney cancer; Cancer; Kidney; Internal medicine","score_opus":0.286109948887339,"score_gpt":0.4244793886500025,"score_spread":0.13836943976266353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072300037","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038458395,0.80363524,3.4308837e-7,0.0001817805,0.00028210308,0.0007823372,0.000018255274,0.000034646437,0.19502686],"genre_scores_gemma":[0.00019164951,0.9924236,0.00003119735,0.0005210903,0.0005838876,0.00012651652,0.00011999257,0.00017081689,0.0058312365],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949604,0.0028434994,0.00056776754,0.000736603,0.00022327583,0.0006684335],"domain_scores_gemma":[0.9983521,0.00020844882,0.00013424626,0.00085319043,0.00008200158,0.00037000384],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001334405,0.00036818619,0.0014527935,0.00080046634,0.000039391576,0.0000087775825,0.00034268678,0.00020503947,0.0011807879],"category_scores_gemma":[0.00018294917,0.00026906046,0.00029172105,0.0005277017,0.00020605627,0.000017761302,0.00027692664,0.0015048764,0.005658676],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069725975,0.00016618881,0.00020388693,0.0073877005,0.00016557676,0.007011269,0.00010492458,4.55849e-8,7.6921214e-7,0.00017377794,0.014153929,0.9705622],"study_design_scores_gemma":[0.0005135117,0.00057464873,0.00058425806,0.0037335749,0.00048600178,0.00048222518,0.0000019592428,2.6237228e-7,6.5679023e-7,0.000014375075,0.99344385,0.00016465361],"about_ca_topic_score_codex":0.00015127238,"about_ca_topic_score_gemma":0.000018267514,"teacher_disagreement_score":0.97928995,"about_ca_system_score_codex":0.0003246823,"about_ca_system_score_gemma":0.0007565385,"threshold_uncertainty_score":0.99997616},"labels":[],"label_agreement":null},{"id":"W2072478300","doi":"10.1016/j.eururo.2014.05.034","title":"Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":474,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; BC Cancer Agency; Sunnybrook Health Science Centre; Alberta Cancer Foundation; University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Carcinoma; Kidney; Urology; Internal medicine; Oncology; Database","score_opus":0.014312277349316473,"score_gpt":0.21491309446702786,"score_spread":0.20060081711771138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072478300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850228,0.0004889218,0.00026970572,0.0006725984,0.00037749155,0.0007824811,0.0020783055,0.000051598377,0.010256126],"genre_scores_gemma":[0.98936266,0.0000062437025,0.0029938167,0.0011474452,0.0004942547,0.00002856522,0.0056785233,0.00010197791,0.00018650625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951842,0.0016425558,0.00081520405,0.0011594204,0.0006172173,0.0005813986],"domain_scores_gemma":[0.99664265,0.0011802573,0.00048150937,0.0012087771,0.00021236899,0.00027444193],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006215674,0.0005324767,0.00066788844,0.00021397015,0.000117901785,0.00005090553,0.0005739932,0.000058334666,0.00028092155],"category_scores_gemma":[0.00030944197,0.00035498128,0.00014474454,0.00021720142,0.0003642251,0.00015461321,0.00033277972,0.00062664907,0.00030679486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03463608,0.0044509214,0.90497375,0.000051466373,0.0010225556,0.0066202004,0.0045849625,0.0007623097,0.021028962,0.00007088562,0.019119427,0.0026784965],"study_design_scores_gemma":[0.021910615,0.0028380698,0.950881,0.000026987373,0.0010400994,0.00004096611,0.00018255455,0.00029066828,0.014074959,0.0000255569,0.008297089,0.0003914439],"about_ca_topic_score_codex":0.0025630386,"about_ca_topic_score_gemma":0.00024306997,"teacher_disagreement_score":0.045907255,"about_ca_system_score_codex":0.00022502548,"about_ca_system_score_gemma":0.00020278606,"threshold_uncertainty_score":0.9998902},"labels":[],"label_agreement":null},{"id":"W2072638902","doi":"10.1158/1078-0432.ccr-10-3309","title":"Sequential FDG-PET/CT as a Biomarker of Response to Sunitinib in Metastatic Clear Cell Renal Cancer","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Sunitinib; Nuclear medicine; Positron emission tomography; Cancer; Clinical endpoint; Biomarker; Stage (stratigraphy); Internal medicine; Oncology; Clinical trial","score_opus":0.5055549876519253,"score_gpt":0.5522083451222032,"score_spread":0.04665335747027788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072638902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878932,0.0010499407,0.0000050852223,0.0014880059,0.00020747764,0.0013439853,0.00006653373,0.000023203396,0.007922535],"genre_scores_gemma":[0.99317616,0.00058766536,0.00066830934,0.0003706093,0.00012589867,0.00046787327,0.000009467938,0.000064630774,0.0045293616],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99364746,0.002332555,0.0011662989,0.00075529615,0.0012497542,0.0008486521],"domain_scores_gemma":[0.99605876,0.0015938206,0.00014991702,0.00080948416,0.0006331108,0.0007549031],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006914149,0.00024133478,0.0008054965,0.0006621156,0.0000686873,0.00001827882,0.00036983806,0.00004672865,0.0069896406],"category_scores_gemma":[0.001668401,0.00019519511,0.00029674722,0.001212086,0.0005969725,0.00007395042,0.00030160486,0.00096321537,0.000379713],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44795662,0.008444152,0.19456966,0.0014289053,0.0013899823,0.048217785,0.0033578202,0.000032133637,0.22852328,0.00016911786,0.027254,0.03865655],"study_design_scores_gemma":[0.018206453,0.015179549,0.64443827,0.0015366371,0.00045981724,0.00033227078,0.001217698,0.00023055992,0.2950809,0.0005144882,0.022150675,0.0006527055],"about_ca_topic_score_codex":0.016974613,"about_ca_topic_score_gemma":0.0015666112,"teacher_disagreement_score":0.4498686,"about_ca_system_score_codex":0.0005749398,"about_ca_system_score_gemma":0.002453441,"threshold_uncertainty_score":0.9939181},"labels":[],"label_agreement":null},{"id":"W2072842129","doi":"10.2147/dhps.s6467","title":"Safety and clinical efficacy of everolimus in the treatment of advanced renal cell carcinoma (RCC)","year":2010,"lang":"en","type":"article","venue":"Drug Healthcare and Patient Safety","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Everolimus; Temsirolimus; Medicine; Renal cell carcinoma; Mucositis; Oncology; Sirolimus; Internal medicine; Sunitinib; PI3K/AKT/mTOR pathway; Discovery and development of mTOR inhibitors; Population; Radiation therapy","score_opus":0.025653674268328562,"score_gpt":0.3129594576774066,"score_spread":0.2873057834090781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072842129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931698,0.002746081,0.0000015309482,0.0018791677,0.00016066455,0.0012715043,0.00007726374,0.000007805251,0.0006861705],"genre_scores_gemma":[0.99662673,0.0025964123,0.00034867448,0.00022952382,0.000056841516,0.000013607533,0.000074950956,0.000015175893,0.00003806563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978938,0.00025660236,0.0009430745,0.0003598295,0.00028495456,0.00026175726],"domain_scores_gemma":[0.9982609,0.00066489883,0.00027879822,0.00048289844,0.000101423015,0.00021105933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031981617,0.00021615211,0.0006394031,0.000088814304,0.00007352358,0.0000028331217,0.00006412437,0.00012316197,0.000012975743],"category_scores_gemma":[0.000033435746,0.0001336785,0.00014753999,0.00015064921,0.0001784381,0.00003284892,0.000026928825,0.00026711123,0.0000013978156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069634235,0.0020227623,0.7080023,0.0003268168,0.00004324516,0.00007416844,0.010596155,0.000006757741,0.0004829316,0.00014542285,0.00003160568,0.27130437],"study_design_scores_gemma":[0.007616559,0.0068351724,0.9760784,0.00007688657,0.00010411241,0.00003311157,0.00087684294,0.000029669569,0.0028145208,0.000021340778,0.0054080025,0.000105401814],"about_ca_topic_score_codex":0.0012160939,"about_ca_topic_score_gemma":0.00079376885,"teacher_disagreement_score":0.27119896,"about_ca_system_score_codex":0.00007091593,"about_ca_system_score_gemma":0.00015372426,"threshold_uncertainty_score":0.5451251},"labels":[],"label_agreement":null},{"id":"W2073021016","doi":"10.1007/s10637-005-0793-z","title":"Phase II study of the efficacy and safety of oral GD0039 in patients with locally advanced or metastatic renal cell carcinoma","year":2005,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Renal cell carcinoma; Medicine; Carcinoma; Internal medicine; Oncology; Phases of clinical research; Chemotherapy","score_opus":0.019725545834419628,"score_gpt":0.2647082686783908,"score_spread":0.24498272284397118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073021016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99771047,0.00008036974,0.000009070829,0.000489586,0.000017319904,0.0014844955,0.000019244206,0.0000065196587,0.00018294215],"genre_scores_gemma":[0.9943382,0.0000012524032,0.0050080647,0.00015841705,0.00001844383,0.0000175488,0.000033927907,0.0000172102,0.0004069482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839747,0.00008941016,0.000502183,0.0002481966,0.0006109291,0.00015179932],"domain_scores_gemma":[0.99904406,0.00013294176,0.00023964088,0.00026360535,0.0001526937,0.00016707974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001237202,0.00017851268,0.00035884124,0.00010286408,0.00005200939,0.0000037641335,0.00009525618,0.00002728156,0.000040932173],"category_scores_gemma":[0.00007645502,0.000102446436,0.000035714766,0.00034380495,0.00018728609,0.000094032985,0.00006260504,0.00012985898,0.0000013682793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029161897,0.029962763,0.86508137,0.0003339326,0.000405919,0.000054832046,0.019910362,0.008009199,0.008451198,0.00024061161,0.00053138006,0.037856527],"study_design_scores_gemma":[0.0782453,0.012235528,0.8903963,0.00018116864,0.00028205846,0.0000070536266,0.0003563184,0.00020908662,0.01775473,0.00006159016,0.00013513982,0.00013574013],"about_ca_topic_score_codex":0.00017727469,"about_ca_topic_score_gemma":0.0001330577,"teacher_disagreement_score":0.049083404,"about_ca_system_score_codex":0.00010049733,"about_ca_system_score_gemma":0.00053249934,"threshold_uncertainty_score":0.41776443},"labels":[],"label_agreement":null},{"id":"W2073037511","doi":"10.5489/cuaj.1552","title":"Feasibility of nephron sparing surgery in giant oncocytoma","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Nephrectomy; Oncocytoma; Medicine; Kidney; Biopsy; Renal oncocytoma; Nephron; Renal mass; Radiology; Surgery; Urology; Internal medicine","score_opus":0.03753679891682674,"score_gpt":0.2506203780160117,"score_spread":0.213083579099185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073037511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908043,0.00011088928,0.000029522935,0.005614205,0.00014355434,0.00012951675,0.0000038021954,0.000008633358,0.0031555677],"genre_scores_gemma":[0.9986026,0.000019227646,0.00017283706,0.00090390403,0.00018549703,0.0000028236896,0.0000071708528,0.000007275305,0.00009864577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840945,0.00027041975,0.00046702323,0.00015870163,0.00030844644,0.00038597363],"domain_scores_gemma":[0.9985337,0.00038158652,0.00027537762,0.00012576321,0.00015346556,0.0005300687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015982097,0.000104597384,0.0004112176,0.00024794758,0.000060856113,0.000019653655,0.00006146397,0.00017989369,0.00022970402],"category_scores_gemma":[0.0016695395,0.00008356316,0.00016791499,0.00020196495,0.000025419653,0.000053566266,0.000009925247,0.00039705785,0.000020549563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006853364,0.000057491812,0.9952909,0.000007744199,0.000024798119,0.000116493284,0.000037002814,0.000034230477,0.0002885498,0.000055281882,0.0008965215,0.0031224526],"study_design_scores_gemma":[0.00073896017,0.00021253679,0.99576443,0.000023466442,0.000031681026,0.00014491916,0.000017311413,0.00023764705,0.0001799469,0.00042083737,0.0021594956,0.000068756985],"about_ca_topic_score_codex":0.002634026,"about_ca_topic_score_gemma":0.0037355945,"teacher_disagreement_score":0.00779831,"about_ca_system_score_codex":0.0025921406,"about_ca_system_score_gemma":0.000552015,"threshold_uncertainty_score":0.67783576},"labels":[],"label_agreement":null},{"id":"W2073428880","doi":"10.1016/j.eururo.2015.04.004","title":"Renal Tumor Biopsy for Small Renal Masses: A Single-center 13-year Experience","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":310,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Toronto General Hospital; University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Concordance; Biopsy; Single Center; Radiology; Retrospective cohort study; Renal biopsy; Surgery; Internal medicine","score_opus":0.0789498930544846,"score_gpt":0.27202023566142497,"score_spread":0.19307034260694036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073428880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94454116,0.00020775569,0.001437297,0.0008378185,0.00034097524,0.0005774623,0.000015907905,0.00012004718,0.05192159],"genre_scores_gemma":[0.98719543,0.00000226225,0.008085317,0.0017810477,0.00057378475,0.000051701238,0.00006283359,0.00007992401,0.0021676982],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99821955,0.00023840099,0.00034647394,0.0005261802,0.00018610981,0.00048329352],"domain_scores_gemma":[0.9987868,0.00007879138,0.0001238227,0.0004833435,0.00015123215,0.0003760239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003297781,0.00024049454,0.0003224391,0.00012352047,0.0000525394,0.000025259355,0.00019880808,0.000047054546,0.00010743208],"category_scores_gemma":[0.00027692525,0.00019540857,0.00013682162,0.00011544701,0.00016949224,0.000046163063,0.00012726204,0.00016492911,0.0005037892],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03107578,0.0067937775,0.34120235,0.00033274756,0.0010366644,0.041404612,0.017553005,0.00014447384,0.45779032,0.0017975057,0.09103233,0.00983646],"study_design_scores_gemma":[0.02157895,0.01719539,0.039866634,0.00008438977,0.00039240677,0.010506588,0.0007206711,0.0002998187,0.016171489,0.00015488602,0.8922688,0.0007599889],"about_ca_topic_score_codex":0.000010829952,"about_ca_topic_score_gemma":0.0000064512537,"teacher_disagreement_score":0.80123645,"about_ca_system_score_codex":0.00010743018,"about_ca_system_score_gemma":0.00008506154,"threshold_uncertainty_score":0.79685307},"labels":[],"label_agreement":null},{"id":"W2073649992","doi":"10.5489/cuaj.2272","title":"A rare case of spontaneous necrosis of primary renal cell carcinoma","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Nephrectomy; Chromophobe cell; Asymptomatic; Medicine; Renal cell carcinoma; Gross hematuria; Pathology; Immunohistochemistry; Necrosis; Kidney; Clear cell carcinoma; Carcinoma; Clear cell; Radiology; Internal medicine","score_opus":0.02292226876115738,"score_gpt":0.21675040775646204,"score_spread":0.19382813899530466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073649992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884291,0.0007597661,0.000008648311,0.0016622223,0.00012202809,0.00017925414,0.00006348913,0.0000074656155,0.008767979],"genre_scores_gemma":[0.99796873,0.000013276229,0.00054577226,0.00058461906,0.00015254559,0.0000033693436,0.000020851308,0.000012617564,0.0006982212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983731,0.00018458173,0.0005081229,0.00015822481,0.0004124328,0.00036352212],"domain_scores_gemma":[0.9974567,0.0001352999,0.00047683698,0.00015264866,0.00064106117,0.001137432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000581443,0.00014319282,0.00047162388,0.0002139317,0.00007026563,0.000016131547,0.000090177055,0.000224228,0.00023388721],"category_scores_gemma":[0.00041019166,0.00011338988,0.00020655768,0.00020580622,0.000045266243,0.000050412884,0.000017854041,0.00036733825,0.000013410663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005969492,0.0002587232,0.8930085,0.000046726946,0.00013624747,0.086173795,0.0007799688,0.000098095865,0.004971921,0.000028354241,0.011475006,0.0024257402],"study_design_scores_gemma":[0.00526184,0.004252678,0.86318153,0.000037013557,0.0005659754,0.11593806,0.00037021853,0.00009157622,0.0046951957,0.00040201773,0.004944512,0.0002593883],"about_ca_topic_score_codex":0.0051482897,"about_ca_topic_score_gemma":0.0010059918,"teacher_disagreement_score":0.029826945,"about_ca_system_score_codex":0.0022330186,"about_ca_system_score_gemma":0.0015422849,"threshold_uncertainty_score":0.77827084},"labels":[],"label_agreement":null},{"id":"W2073681230","doi":"10.1016/s1470-2045(11)70146-2","title":"Combination therapy in metastatic renal cell carcinoma","year":2011,"lang":"en","type":"letter","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Temsirolimus; Medicine; Bevacizumab; Sunitinib; Renal cell carcinoma; Oncology; Internal medicine; Toxicity; Combination therapy; Discovery and development of mTOR inhibitors; Chemotherapy; PI3K/AKT/mTOR pathway","score_opus":0.10222718322988199,"score_gpt":0.3187340458167887,"score_spread":0.2165068625869067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073681230","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36994952,0.0020545206,0.000010272292,0.55759716,0.00052129244,0.0016023887,0.000020851516,0.000056434335,0.06818754],"genre_scores_gemma":[0.4549526,0.00055808085,0.00059266825,0.53169596,0.0028351983,0.00037246992,0.00049736165,0.000091564376,0.00840411],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997506,0.00079936435,0.00041772722,0.00040492046,0.00030584176,0.00056612137],"domain_scores_gemma":[0.99837875,0.00037956543,0.00029676227,0.00081134593,0.00008405266,0.000049509028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005985164,0.00035327993,0.0012146626,0.000219342,0.0000455379,0.000010474741,0.00034844983,0.00048058855,0.00045562393],"category_scores_gemma":[0.000022578892,0.0002134231,0.00017197525,0.00018026223,0.00016794328,0.00002866236,0.000060925617,0.001958615,0.00024385721],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009132522,0.0004594413,0.0041094283,0.00023991702,0.00015158,0.00697094,0.0010992676,9.326063e-7,0.00069298176,0.00010216863,0.9804753,0.004784787],"study_design_scores_gemma":[0.010416984,0.0049101054,0.05177034,0.00005557718,0.00035343049,0.00052958465,0.00003664633,0.000017785715,0.0033809214,0.0015017249,0.92674553,0.00028137083],"about_ca_topic_score_codex":0.00046186743,"about_ca_topic_score_gemma":0.00005536808,"teacher_disagreement_score":0.08500308,"about_ca_system_score_codex":0.0006327025,"about_ca_system_score_gemma":0.0003768805,"threshold_uncertainty_score":0.8703141},"labels":[],"label_agreement":null},{"id":"W2074004618","doi":"10.1016/j.jvir.2009.11.005","title":"Percutaneous US-guided Renal Biopsy: A Retrospective Study Comparing the 16-gauge End-cut and 14-gauge Side-notch Needles","year":2010,"lang":"en","type":"article","venue":"Journal of Vascular and Interventional Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Gauge (firearms); Percutaneous; Percutaneous biopsy; Radiology","score_opus":0.023353639770460642,"score_gpt":0.28765979530844205,"score_spread":0.2643061555379814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074004618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480325,0.0029465337,0.00010557473,0.00049772125,0.00036807105,0.00033789634,0.000008201308,0.000009256101,0.000923503],"genre_scores_gemma":[0.9987391,0.000150536,0.000375528,0.00009719119,0.00045285674,0.000006238596,0.000010879367,0.000019426001,0.00014820346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812406,0.00026015696,0.0007070302,0.00027020104,0.0003995524,0.00023897328],"domain_scores_gemma":[0.99877244,0.00014410663,0.00034285538,0.00024568255,0.00030354297,0.00019139447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010629684,0.0002297292,0.0007149867,0.00020925011,0.000162357,0.000046756973,0.00015185324,0.00011884389,0.00022918724],"category_scores_gemma":[0.00026761746,0.00014016927,0.0005443961,0.000096835414,0.00031297232,0.000092767965,0.00009857248,0.0007746296,0.0000038315975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011199842,0.0014586489,0.92608887,0.00008592718,0.004482098,0.002741271,0.0014430982,0.0000108276145,0.05687061,0.0028974705,0.0016057468,0.0011954432],"study_design_scores_gemma":[0.0030984476,0.0037050338,0.885935,0.00010635512,0.0007734754,0.1029655,0.00065077987,0.00007655644,0.00054937234,0.0013436043,0.00066336716,0.00013252096],"about_ca_topic_score_codex":0.00019197173,"about_ca_topic_score_gemma":0.00013540694,"teacher_disagreement_score":0.10022423,"about_ca_system_score_codex":0.00014395687,"about_ca_system_score_gemma":0.000075021766,"threshold_uncertainty_score":0.5715937},"labels":[],"label_agreement":null},{"id":"W2074014907","doi":"10.1016/j.eururo.2011.06.040","title":"Treatment of Localised Renal Cell Carcinoma","year":2011,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":235,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Cryoablation; Watchful waiting; Laparoscopy; Surgery; Kidney cancer; Radiofrequency ablation; Cryotherapy; General surgery; Kidney; Ablation; Internal medicine; Cancer","score_opus":0.07577986124350544,"score_gpt":0.2886587940130707,"score_spread":0.21287893276956527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074014907","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005528571,0.8566267,0.000011648868,0.000012599391,0.00019206801,0.00096947304,0.000038396964,0.00004960046,0.14154668],"genre_scores_gemma":[0.0079328045,0.98600113,0.00019856707,0.000051101117,0.0003786513,0.000041947616,0.0003312906,0.00020332291,0.0048611853],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99677587,0.0009400157,0.0009463679,0.00071983656,0.0001605636,0.00045737784],"domain_scores_gemma":[0.9977575,0.00013842167,0.00057437865,0.0011734165,0.000076620025,0.0002796748],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013500554,0.0007051732,0.002702941,0.00034531488,0.000033340457,0.000004828518,0.00024286106,0.00023370085,0.000505799],"category_scores_gemma":[0.000018593573,0.0004743613,0.0010893544,0.00018843816,0.00020718807,0.000015032245,0.00009631239,0.00025058896,0.0015302823],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028126803,0.0012897777,0.00014262297,0.006756418,0.00055625814,0.007848795,0.00026093723,2.988101e-7,0.000021317634,0.00008352255,0.0010271443,0.98173165],"study_design_scores_gemma":[0.0017316646,0.008287822,0.00041255134,0.00028141084,0.005624805,0.001400772,0.0000028961829,8.0462326e-7,0.00009972921,0.0000024853928,0.98189145,0.00026361347],"about_ca_topic_score_codex":0.00004238603,"about_ca_topic_score_gemma":0.0000012947556,"teacher_disagreement_score":0.981468,"about_ca_system_score_codex":0.00022377528,"about_ca_system_score_gemma":0.00030635583,"threshold_uncertainty_score":0.9997708},"labels":[],"label_agreement":null},{"id":"W2074635429","doi":"10.1097/cad.0b013e32831fb500","title":"Sorafenib tosylate in advanced kidney cancer: past, present and future","year":2009,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Sorafenib; Medicine; Sunitinib; Kidney cancer; Oncology; Internal medicine; Cancer; Pharmacology; Clinical trial; Population; Hepatocellular carcinoma","score_opus":0.026817686603057903,"score_gpt":0.3380587351365086,"score_spread":0.3112410485334507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074635429","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014242496,0.98812157,4.8885835e-7,0.005221721,0.00058809895,0.0023893989,0.00016551098,0.000074172756,0.0020147695],"genre_scores_gemma":[0.00012994451,0.9898813,0.0001278851,0.0006902874,0.0041698306,0.0006996028,0.00023627881,0.00012155143,0.003943356],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967428,0.00013400464,0.00083356845,0.0010741183,0.00049723504,0.00071826414],"domain_scores_gemma":[0.9981697,0.000056412682,0.00043094167,0.0007416183,0.00009035208,0.0005109735],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015254485,0.00088491244,0.0030622203,0.00034977982,0.00007286075,0.000042698324,0.00022649438,0.0004594725,0.0002493788],"category_scores_gemma":[0.000005519193,0.0006568344,0.00048762572,0.0005879885,0.000087446504,0.00013079122,0.000108349894,0.00080156524,0.00003999771],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006218745,0.00014731193,0.0003049749,0.011669968,0.00029821348,0.00023121851,0.00022891515,0.0000022397207,0.000008216634,0.0000071585355,0.012029504,0.9750101],"study_design_scores_gemma":[0.0020629035,0.00016313988,0.0009472181,0.01835271,0.0014708911,0.000058087597,0.00003883758,0.000004461132,0.000079079604,0.000011088625,0.97625655,0.0005550299],"about_ca_topic_score_codex":0.00054043543,"about_ca_topic_score_gemma":0.000037097685,"teacher_disagreement_score":0.97445506,"about_ca_system_score_codex":0.0007660861,"about_ca_system_score_gemma":0.0010342925,"threshold_uncertainty_score":0.9995883},"labels":[],"label_agreement":null},{"id":"W2074905128","doi":"10.5489/cuaj.10038","title":"Active surveillance as the preferred management option for small renal masses","year":2010,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Renal mass; Computer science; Business; Medicine; Kidney; Internal medicine","score_opus":0.022922256216033395,"score_gpt":0.24334120514464355,"score_spread":0.22041894892861016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074905128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9570856,0.000058092737,0.00018365223,0.03281821,0.00048254558,0.0007019562,0.00003166857,0.000021975187,0.008616275],"genre_scores_gemma":[0.99360865,0.00004246973,0.0011785926,0.0022113263,0.00056574953,0.00006985137,0.000043170363,0.000012567729,0.0022676187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877185,0.0001109197,0.00023716093,0.00019197828,0.00027237658,0.00041573533],"domain_scores_gemma":[0.9986845,0.00023349417,0.00022390283,0.0001457426,0.00026872184,0.00044362538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007067239,0.00013252776,0.00018880723,0.00009921666,0.00033850656,0.00009248615,0.00013383025,0.00018068479,0.00025977436],"category_scores_gemma":[0.00049689214,0.00008315847,0.00016114893,0.0001174244,0.000030023391,0.000049511047,0.000013465858,0.00055619207,0.00004634762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019142068,0.00037075634,0.8664404,0.000042714953,0.0020260843,0.0006720397,0.0005887386,0.00019315425,0.005389167,0.010230286,0.029903624,0.082228795],"study_design_scores_gemma":[0.001148455,0.00039937565,0.8045372,0.000005154259,0.00010501624,0.0002488843,0.00006563492,0.000089356196,0.00027217626,0.0023615253,0.19067338,0.000093859606],"about_ca_topic_score_codex":0.00037982184,"about_ca_topic_score_gemma":0.0030442833,"teacher_disagreement_score":0.16076975,"about_ca_system_score_codex":0.00082113576,"about_ca_system_score_gemma":0.0002572285,"threshold_uncertainty_score":0.3391104},"labels":[],"label_agreement":null},{"id":"W2075623047","doi":"10.1586/era.11.122","title":"The expanding role of imaging in the management of renal cell carcinoma","year":2011,"lang":"en","type":"review","venue":"Expert Review of Anticancer Therapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Women's College Hospital; Mount Sinai Hospital","funders":"","keywords":"Medicine; Renal cell carcinoma; Radiology; Biomarker; Medical imaging; Biopsy; Magnetic resonance imaging; Pathology","score_opus":0.04571901235198827,"score_gpt":0.3622751798974922,"score_spread":0.3165561675455039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075623047","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018084046,0.9897436,0.00000596037,0.000096622854,0.00009569053,0.0026507645,0.0000068853396,0.000005205629,0.007214415],"genre_scores_gemma":[0.0027947894,0.99612,0.0003219255,0.00016089826,0.000090778434,0.000371406,0.00001619987,0.00005117639,0.000072859446],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99696153,0.0003721418,0.0014475805,0.0003569907,0.00054850266,0.00031322453],"domain_scores_gemma":[0.9973405,0.00020842401,0.0010368971,0.0012591494,0.00010571025,0.00004931058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010216811,0.0004418662,0.0023169206,0.00012390934,0.00004506376,0.000006697367,0.00066274963,0.000065279346,0.00011270809],"category_scores_gemma":[0.000007377631,0.00019834834,0.0009871976,0.00045360604,0.00022845683,0.000034856595,0.000076975484,0.00023318133,0.0000041359153],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055332104,0.00021424903,0.00008917791,0.0602644,0.00024596916,0.000029957548,0.0005623851,1.0951745e-8,0.00007185107,0.00023965942,0.0002880314,0.937939],"study_design_scores_gemma":[0.0006319387,0.0002534761,0.00022782934,0.14350508,0.0007757096,0.000039870934,0.00034010477,5.412831e-7,0.0017154334,0.000025464142,0.85230756,0.00017697131],"about_ca_topic_score_codex":0.00013632276,"about_ca_topic_score_gemma":0.0000012359575,"teacher_disagreement_score":0.937762,"about_ca_system_score_codex":0.00012158404,"about_ca_system_score_gemma":0.00017702884,"threshold_uncertainty_score":0.80884105},"labels":[],"label_agreement":null},{"id":"W2075627892","doi":"10.1016/j.eururo.2011.02.035","title":"Renal Cell Carcinoma (RCC) in Patients With End-Stage Renal Disease Exhibits Many Favourable Clinical, Pathologic, and Outcome Features Compared With RCC in the General Population","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Univariate analysis; Renal cell carcinoma; End stage renal disease; Population; Context (archaeology); Asymptomatic; Internal medicine; Stage (stratigraphy); Urology; Disease; Multivariate analysis","score_opus":0.047260411543950734,"score_gpt":0.26756811840260314,"score_spread":0.22030770685865242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075627892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939423,0.0002478753,0.000012172547,0.00017959968,0.00005282359,0.00080242136,0.000022706234,0.00002990196,0.004710159],"genre_scores_gemma":[0.9974541,0.000008408963,0.00064100506,0.0010903397,0.000072263065,0.0000185987,0.00022274005,0.000045960092,0.00044655125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99690104,0.0012371853,0.00055650546,0.0006062045,0.00027552116,0.00042354522],"domain_scores_gemma":[0.99887997,0.00009495866,0.00023005177,0.00053865905,0.00005302745,0.00020334448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059609953,0.00030667946,0.00048181185,0.00017003294,0.000073860625,0.000019281895,0.00017960869,0.00006927667,0.00006332466],"category_scores_gemma":[0.00004575532,0.00017210234,0.0000622405,0.0001592468,0.00020303934,0.00007415179,0.00008943597,0.0004949352,0.000019861172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052531743,0.00067132834,0.9864636,0.000024837462,0.00001627227,0.006485846,0.00056204566,0.000060165905,0.000035923687,0.000050524108,0.00012975866,0.00024653802],"study_design_scores_gemma":[0.007526892,0.003762225,0.9880027,0.000015246063,0.00013118285,0.00007695193,0.00004696366,0.000045372264,0.000026237629,0.000012969743,0.00016732278,0.00018590798],"about_ca_topic_score_codex":0.00024428352,"about_ca_topic_score_gemma":0.00019049467,"teacher_disagreement_score":0.006408894,"about_ca_system_score_codex":0.000049508988,"about_ca_system_score_gemma":0.000035779896,"threshold_uncertainty_score":0.701813},"labels":[],"label_agreement":null},{"id":"W2075644080","doi":"10.1097/spc.0b013e32832e466b","title":"Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy","year":2009,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Targeted therapy; Urology; Kidney; Internal medicine; Oncology; Cancer","score_opus":0.11370573468950408,"score_gpt":0.37610504053897065,"score_spread":0.2623993058494666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075644080","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09579899,0.9012316,0.000004168872,0.000029600244,0.00020448554,0.0024733744,0.00016249625,0.000003631412,0.00009164314],"genre_scores_gemma":[0.33749664,0.66149116,0.00003181298,0.000009363326,0.000050426373,0.00027932329,0.00061598356,0.000023969907,0.0000013186198],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9959195,0.0012955437,0.0013415046,0.000554875,0.00051287253,0.00037566852],"domain_scores_gemma":[0.9972546,0.00097233086,0.0009508759,0.00042970275,0.00032135297,0.00007115064],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059489434,0.0005699305,0.00223695,0.0004932289,0.00003206968,0.000013326557,0.00022325666,0.00014364555,0.000029083767],"category_scores_gemma":[0.00013422588,0.00031923578,0.00058996456,0.0010679978,0.0002097297,0.00007071621,0.000051882027,0.0009733523,0.0000010971177],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005005533,0.0016143008,0.20137534,0.03267538,0.00040935128,0.0001810568,0.04772592,0.000012352327,0.00010955508,0.00013186548,0.00028305672,0.71498126],"study_design_scores_gemma":[0.0066178893,0.0023025875,0.7772053,0.08043931,0.0015440639,0.0000463917,0.034466244,0.000032788274,0.0034403445,0.00052563776,0.091850184,0.0015292797],"about_ca_topic_score_codex":0.00013779695,"about_ca_topic_score_gemma":0.000009874928,"teacher_disagreement_score":0.713452,"about_ca_system_score_codex":0.00032659195,"about_ca_system_score_gemma":0.00088423333,"threshold_uncertainty_score":0.999926},"labels":[],"label_agreement":null},{"id":"W2075849635","doi":"10.1016/j.eururo.2009.03.048","title":"Positive Surgical Margin Appears to Have Negligible Impact on Survival of Renal Cell Carcinomas Treated by Nephron-Sparing Surgery","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":271,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Proportional hazards model; Surgery; Retrospective cohort study; Renal cell carcinoma; Natural history; Surgical margin; Cohort; Cancer; Kidney cancer; Internal medicine; Kidney","score_opus":0.018482975515621097,"score_gpt":0.2562083614132526,"score_spread":0.2377253858976315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075849635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92275494,0.00046156917,0.0000247897,0.0007777423,0.00007861953,0.0004257964,0.00004354668,0.00007206802,0.07536093],"genre_scores_gemma":[0.99746335,0.000029939414,0.00004021132,0.0006201604,0.0001892535,0.0000036568867,0.00019353603,0.00006980368,0.0013900725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99700695,0.00076321216,0.00054454734,0.0006428497,0.00034484937,0.0006975858],"domain_scores_gemma":[0.9982608,0.0004281299,0.00017129003,0.0005575683,0.00009983656,0.00048238967],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004905348,0.000421521,0.00086919445,0.0003619779,0.00006118394,0.000016497339,0.00015483286,0.00010454118,0.00012434386],"category_scores_gemma":[0.000051005816,0.00033355533,0.0003674039,0.000280241,0.00009334942,0.000040895186,0.00007043294,0.00033527764,0.00028900465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032607038,0.0037427999,0.605265,0.0000881349,0.0007992476,0.032991804,0.0012359243,0.0020804312,0.25704518,0.00013435583,0.051309377,0.012700667],"study_design_scores_gemma":[0.0029075334,0.009113169,0.9164045,0.000053151092,0.00022540282,0.0003860758,0.000031000633,0.00008487455,0.06697557,0.0000063084067,0.0034540915,0.00035834816],"about_ca_topic_score_codex":0.00018437425,"about_ca_topic_score_gemma":0.0000041604817,"teacher_disagreement_score":0.31113943,"about_ca_system_score_codex":0.00019324786,"about_ca_system_score_gemma":0.00008322762,"threshold_uncertainty_score":0.99991167},"labels":[],"label_agreement":null},{"id":"W2075865217","doi":"10.1016/j.ucl.2008.07.004","title":"Renal Tumor Natural History: the Rationale and Role for Active Surveillance","year":2008,"lang":"en","type":"review","venue":"Urologic Clinics of North America","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Natural history; Renal cell carcinoma; Malignancy; Incidence (geometry); Kidney; Kidney cancer; Watchful waiting; Internal medicine; Oncology; Intensive care medicine; Radiology; Cancer","score_opus":0.06026933895345225,"score_gpt":0.31416021965379876,"score_spread":0.2538908807003465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075865217","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016958012,0.9953738,0.000010140149,0.000157874,0.00020499394,0.0020075033,0.00022474957,0.000023870029,0.00030130352],"genre_scores_gemma":[0.00087922584,0.996056,0.0006922684,0.0005634737,0.0002239378,0.0003053126,0.0007645088,0.000033806187,0.0004814737],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981379,0.00017978503,0.00068568304,0.00049043616,0.00025907173,0.00024715703],"domain_scores_gemma":[0.99598813,0.0021815246,0.0010653113,0.0004803596,0.00018819026,0.00009650394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014032998,0.00036350274,0.0017923211,0.00008341322,0.00007763325,0.000003559041,0.00020280405,0.00011087654,0.000024839632],"category_scores_gemma":[0.0007006358,0.00020679874,0.00067047786,0.00013645229,0.0005105409,0.000023325361,0.00007696318,0.00047440606,0.000010481773],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003914891,0.00014404663,0.0009878883,0.0009735429,0.00043167017,0.00005389043,0.00007235815,0.0000031056775,1.3728797e-7,0.0000055065643,0.004824466,0.9921119],"study_design_scores_gemma":[0.000490437,0.0013028233,0.003181493,0.00015201968,0.0005334431,0.00025095462,0.000008248228,0.000050523584,1.4330426e-7,0.000012942437,0.99384993,0.00016700942],"about_ca_topic_score_codex":0.000020184973,"about_ca_topic_score_gemma":0.000019702085,"teacher_disagreement_score":0.9919449,"about_ca_system_score_codex":0.00019066765,"about_ca_system_score_gemma":0.0006638867,"threshold_uncertainty_score":0.84330076},"labels":[],"label_agreement":null},{"id":"W2076031717","doi":"10.5489/cuaj.1894","title":"Surgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of British Columbia; Queen's University; McMaster University; Credit Valley Hospital; University of Ottawa; Dalhousie University","funders":"","keywords":"Kidney cancer; Renal cell carcinoma; Medicine; Cancer; Consensus conference; Kidney; General surgery; Oncology; Internal medicine","score_opus":0.012506625685674627,"score_gpt":0.22346259840262045,"score_spread":0.21095597271694583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076031717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90385145,0.0005362204,0.000011118677,0.042121716,0.0004243455,0.00032824356,0.00012446007,0.000015823825,0.052586645],"genre_scores_gemma":[0.9932824,0.00006799432,0.0002717021,0.0033922128,0.00032504884,0.00001653295,0.00004126117,0.000021473188,0.0025814003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975038,0.00022554837,0.00052896363,0.00028537874,0.00052029017,0.00093600637],"domain_scores_gemma":[0.9956815,0.00011017098,0.0003231732,0.00020021424,0.00034966436,0.0033352727],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00065275934,0.00022646855,0.0004603844,0.00033764096,0.00026016633,0.000040448882,0.00015991494,0.00029962015,0.0012793648],"category_scores_gemma":[0.0001339601,0.00018568181,0.00025213536,0.0002629745,0.000060385602,0.00003213447,0.000019375986,0.000534885,0.00006137337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109201435,0.0000690085,0.93147504,0.000038031692,0.00023294604,0.0019057313,0.00005322426,0.00008940891,0.00009052113,0.00075259805,0.06291329,0.0022710122],"study_design_scores_gemma":[0.003757674,0.000662915,0.6997465,0.00004842403,0.00041265172,0.00058970635,0.00010549705,0.00026443467,0.00050983095,0.00032319542,0.29331923,0.00025993396],"about_ca_topic_score_codex":0.13431877,"about_ca_topic_score_gemma":0.06156665,"teacher_disagreement_score":0.23172851,"about_ca_system_score_codex":0.003356726,"about_ca_system_score_gemma":0.0017789168,"threshold_uncertainty_score":0.9996336},"labels":[],"label_agreement":null},{"id":"W2076589106","doi":"10.1038/ncpuro0674","title":"The role of surveillance for small renal masses","year":2007,"lang":"en","type":"review","venue":"Nature Clinical Practice Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Viewpoints; Renal mass; Intensive care medicine; Renal tumor; General surgery; Radiology; Surgery; Kidney; Internal medicine; Nephrectomy","score_opus":0.11502973534226305,"score_gpt":0.4834688014397693,"score_spread":0.3684390660975062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076589106","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001244239,0.9854358,0.00006186086,0.0017264553,0.0011823536,0.0019557949,0.0000404346,0.00003255907,0.009552296],"genre_scores_gemma":[0.00016846911,0.99069744,0.0053775636,0.0012765198,0.0016357885,0.00010893127,0.00015485476,0.000079263926,0.00050114846],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946473,0.0017086137,0.002025025,0.00074942503,0.00035201275,0.0005175969],"domain_scores_gemma":[0.89818,0.09809174,0.0019123907,0.0009787406,0.00064583204,0.00019126461],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.007883589,0.0004487099,0.0026921243,0.00011423931,0.000096930846,0.00001568409,0.0004337212,0.0030092087,0.000018514018],"category_scores_gemma":[0.055965208,0.0002500801,0.0014384928,0.00026316874,0.00038594852,0.00003892626,0.00012916398,0.004243086,0.000043140015],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027986574,0.00042757724,0.00018094189,0.0017862469,0.0012643397,0.00016456722,0.0000033271288,1.1394264e-7,4.6538298e-7,0.0011804566,0.00211368,0.99007964],"study_design_scores_gemma":[0.0008145776,0.0024447755,0.00020125926,0.00031228212,0.0042082933,0.0008347583,0.000010686975,0.0000030822748,0.0000024692213,0.00024676012,0.99074703,0.00017402184],"about_ca_topic_score_codex":0.000007934238,"about_ca_topic_score_gemma":0.000035308458,"teacher_disagreement_score":0.9899056,"about_ca_system_score_codex":0.00008859267,"about_ca_system_score_gemma":0.000868229,"threshold_uncertainty_score":0.9999952},"labels":[],"label_agreement":null},{"id":"W2076731419","doi":"10.3747/co.v16i0.417","title":"Role of Cytokine Therapy for Renal Cell Carcinoma in the Era of Targeted Agents","year":2009,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Renal cell carcinoma; Cytokine; Targeted therapy; Angiogenesis; Oncology; Internal medicine; Immunotherapy; Hormonal therapy; Chemotherapy; Immunology; Cancer","score_opus":0.0722931986125377,"score_gpt":0.35998050221625383,"score_spread":0.28768730360371614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076731419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98888475,0.007315636,0.000019717687,0.00064800313,0.00012859651,0.001113284,0.000024740397,0.000006840431,0.001858459],"genre_scores_gemma":[0.9990084,0.0002383795,0.0003076011,0.00015112915,0.000111889385,0.000066647786,0.00008617209,0.00000958586,0.000020163588],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988307,0.00012116107,0.00041538084,0.00020129816,0.00019590679,0.00023559267],"domain_scores_gemma":[0.99918956,0.0001398447,0.00020306605,0.00029214195,0.00012119111,0.000054215663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025649965,0.00014514028,0.00045839435,0.000103183964,0.000019650004,0.0000017492495,0.00015483507,0.00008848552,0.000053830925],"category_scores_gemma":[0.000028507697,0.00009257979,0.00016474913,0.00018270548,0.00006531357,0.000020505346,0.000013453415,0.00020287484,0.0000026125804],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049232626,0.010703527,0.13832328,0.00022763317,0.00007569104,0.00006515566,0.0059405463,0.00004103116,0.45375267,0.0003615809,0.005145414,0.3804402],"study_design_scores_gemma":[0.008383434,0.009522246,0.7374664,0.000044723805,0.000096226875,0.00002380475,0.00027611273,0.00024860573,0.2209696,0.00048628083,0.022388566,0.00009402564],"about_ca_topic_score_codex":0.000023112325,"about_ca_topic_score_gemma":0.0000074189365,"teacher_disagreement_score":0.5991431,"about_ca_system_score_codex":0.00012789831,"about_ca_system_score_gemma":0.00017283499,"threshold_uncertainty_score":0.3775294},"labels":[],"label_agreement":null},{"id":"W207684095","doi":"10.1016/s1695-3290(08)35048-4","title":"10.1016/s1695-3290(08)35048-4","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Philosophy; Molecular biology; Biology; Humanities; Physics","score_opus":0.0143370633808507,"score_gpt":0.19021577489642655,"score_spread":0.17587871151557585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W207684095","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009529356,0.0013486999,1.9213645e-7,0.0003285875,0.000005092125,0.0010635504,0.000082020175,0.00021746382,0.99694484],"genre_scores_gemma":[0.00000853436,0.0000068413988,0.00013263349,0.00012621407,0.00072264863,0.00004458786,0.00041793392,0.00022885045,0.99831176],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997688,0.000018149838,0.00048420014,0.00071278494,0.0006402253,0.00045666585],"domain_scores_gemma":[0.99806607,0.000067752495,0.00013303256,0.0010580103,0.00012482663,0.000550337],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00010132163,0.00068132655,0.00095455855,0.0003517189,0.00006561115,0.00003167191,0.00021847423,0.00047032008,0.9986067],"category_scores_gemma":[0.000018760154,0.0006019339,0.0004257002,0.000054852662,0.00008168868,0.00003931665,0.00010210255,0.0005156157,0.9985255],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006976044,0.00009303359,5.431421e-8,0.00009368508,0.00040768136,0.0010598748,0.000016935914,0.0000032318858,0.00003229152,0.000037702106,0.55850285,0.43905506],"study_design_scores_gemma":[0.0009099758,0.0011860713,0.000012189616,0.00042514427,0.0007164573,0.00027127,2.6748492e-7,0.000004427669,0.0001272971,0.00011860896,0.9957239,0.0005043793],"about_ca_topic_score_codex":0.0000239459,"about_ca_topic_score_gemma":2.6178463e-7,"teacher_disagreement_score":0.43855065,"about_ca_system_score_codex":0.00041157712,"about_ca_system_score_gemma":0.00019593882,"threshold_uncertainty_score":0.9996432},"labels":[],"label_agreement":null},{"id":"W2076872027","doi":"10.1016/j.eururo.2013.07.031","title":"Survival Outcome and Treatment Response of Patients with Late Relapse from Renal Cell Carcinoma in the Era of Targeted Therapy","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Alberta; Queen Elizabeth II Health Sciences Centre; London Health Sciences Centre; BC Cancer Agency; Princess Margaret Cancer Centre; University of Toronto; Western University; Sunnybrook Health Science Centre; University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Internal medicine; Proportional hazards model; Exact test; Retrospective cohort study; Carcinoma; Oncology; Surgery; Urology; Kidney","score_opus":0.018819540177126618,"score_gpt":0.21995767785616618,"score_spread":0.20113813767903957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076872027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731773,0.00049508,0.0000014653173,0.00046716587,0.000037524555,0.0006570303,0.00002834107,0.0000088422785,0.0009868185],"genre_scores_gemma":[0.99934095,0.000031623324,0.00015615491,0.00022620388,0.000020201258,0.000012615845,0.000054526972,0.000030624422,0.00012711776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770164,0.001296217,0.00037422337,0.00025996324,0.00017761353,0.00019036407],"domain_scores_gemma":[0.99886805,0.0003799654,0.00017354774,0.00043951644,0.00007335462,0.00006555343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029706015,0.00018792285,0.00038937473,0.000082073384,0.00002101796,0.0000044589856,0.00010159913,0.000040614505,0.000103794424],"category_scores_gemma":[0.000032008447,0.00009880594,0.00005734806,0.000103548264,0.00014642136,0.000029576551,0.000031310778,0.00015428229,0.000023303111],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0082010245,0.0005863197,0.976781,0.000005256615,0.000060539427,0.00019949212,0.0020095392,0.000011914774,0.0112370225,0.000002614718,0.000031567033,0.0008736731],"study_design_scores_gemma":[0.008361517,0.008286794,0.98003477,0.0000047013036,0.00007015764,0.00000441579,0.000058849117,0.000014299801,0.0028816129,0.000005304011,0.00020430109,0.00007329822],"about_ca_topic_score_codex":0.00054127554,"about_ca_topic_score_gemma":0.000020624422,"teacher_disagreement_score":0.00835541,"about_ca_system_score_codex":0.000032700962,"about_ca_system_score_gemma":0.00003183143,"threshold_uncertainty_score":0.40291893},"labels":[],"label_agreement":null},{"id":"W2076942018","doi":"10.1016/s1569-9056(05)81086-3","title":"V15Laparoscopic partial nephrectomy for renal tumours after renalartery clamping: The Quebec City experience","year":2005,"lang":"en","type":"article","venue":"European Urology Supplements","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Clamping; Urology; Kidney; Internal medicine","score_opus":0.02804871265701156,"score_gpt":0.28748033382575144,"score_spread":0.25943162116873986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076942018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99024177,0.00030644285,0.0006539317,0.005163974,0.0002966653,0.0013292395,0.00004095908,0.000080807484,0.0018862084],"genre_scores_gemma":[0.98908544,0.0000114340655,0.0014648492,0.0052284035,0.00097262673,0.00051986193,0.00015470637,0.00005816326,0.002504508],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975401,0.000358632,0.000515043,0.00058948697,0.00030121376,0.0006955328],"domain_scores_gemma":[0.99879843,0.0001105413,0.0001455045,0.0006626556,0.00007243308,0.00021042865],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042843624,0.00031543933,0.00032881473,0.0000901928,0.0002040793,0.000044770353,0.00027969546,0.000057188114,0.0012438474],"category_scores_gemma":[0.00006573012,0.00021972047,0.0001966692,0.0001090732,0.0002531429,0.00012065867,0.00015307302,0.00026237336,0.0002500745],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069897063,0.0011661215,0.8758889,0.00007014911,0.00062755845,0.0012688984,0.007675868,0.000054736254,0.016666602,0.00023748098,0.075940065,0.013413954],"study_design_scores_gemma":[0.004395245,0.0010893506,0.32946855,0.000021995029,0.00030630725,0.00015983342,0.00009787002,0.00012645373,0.016174937,0.000019628163,0.6478857,0.00025411622],"about_ca_topic_score_codex":0.00009626965,"about_ca_topic_score_gemma":0.0004453677,"teacher_disagreement_score":0.57194567,"about_ca_system_score_codex":0.00013343351,"about_ca_system_score_gemma":0.00008533174,"threshold_uncertainty_score":0.99966913},"labels":[],"label_agreement":null},{"id":"W2077111716","doi":"10.1245/aso.2003.02.003","title":"Pancreatic Resection for Metastatic Renal Cell Carcinoma: Presentation, Treatment, and Outcome","year":2003,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; University of Toronto; Mount Sinai Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Pancreas; Surgical oncology; Perioperative; Surgery; Internal medicine; Kidney","score_opus":0.15537053560371952,"score_gpt":0.40457055139473974,"score_spread":0.24920001579102022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077111716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764324,0.001915494,0.000074452386,0.0021240294,0.00007438134,0.0009489309,0.000019171488,0.00001566649,0.018395493],"genre_scores_gemma":[0.9938122,0.0010056976,0.0016748419,0.000110199915,0.000053819043,0.00017673206,0.00004640733,0.000019575471,0.003100527],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985247,0.0002329012,0.0005071464,0.00030280082,0.00013967739,0.00029276076],"domain_scores_gemma":[0.9983896,0.0008000604,0.00019181594,0.00020099626,0.00020959404,0.00020792775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034644466,0.00018338532,0.000698014,0.00013958162,0.00006132225,0.000006381106,0.000031746065,0.00009757672,0.00010836253],"category_scores_gemma":[0.0000657129,0.00013254638,0.00020640594,0.00013983298,0.00012477301,0.000057209945,0.000011169139,0.00007185459,0.000007680852],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033435695,0.01579362,0.8210169,0.0032463411,0.0028254902,0.0041692825,0.002718412,0.00014107904,0.033597935,0.017138144,0.0176835,0.04823361],"study_design_scores_gemma":[0.032327723,0.06136821,0.071085535,0.000050597097,0.0022293888,0.0018184566,0.000637363,0.0001576069,0.35859868,0.0028510827,0.46840352,0.00047183363],"about_ca_topic_score_codex":0.00010757715,"about_ca_topic_score_gemma":0.000023113978,"teacher_disagreement_score":0.74993134,"about_ca_system_score_codex":0.00009455117,"about_ca_system_score_gemma":0.00015170028,"threshold_uncertainty_score":0.54050845},"labels":[],"label_agreement":null},{"id":"W2077150094","doi":"10.1089/end.2009.0503","title":"Assessing Outcomes in Probe Ablative Therapies for Small Renal Masses","year":2010,"lang":"en","type":"review","venue":"Journal of Endourology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Renal cell carcinoma; Cryotherapy; Context (archaeology); Ablative case; Kidney cancer; Radiofrequency ablation; Ablation; Cryosurgery; Cryoablation; Surgery; Radiology; Internal medicine; Radiation therapy","score_opus":0.14673969667359893,"score_gpt":0.40816297807849805,"score_spread":0.2614232814048991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077150094","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004207299,0.9926867,0.0003582806,0.0005010571,0.0005813446,0.0011501999,0.000009044729,0.000009732719,0.0004963767],"genre_scores_gemma":[0.00078838255,0.97516674,0.022669354,0.00014975766,0.0006723344,0.000096833624,0.000018952107,0.0000863803,0.00035129537],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974075,0.000309378,0.0013851452,0.00027319707,0.00022974094,0.00039506436],"domain_scores_gemma":[0.9959564,0.0015812878,0.0017898484,0.00026399535,0.00026653422,0.00014193542],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00084437605,0.00045576677,0.0035330693,0.00077270484,0.00004014406,0.000044368127,0.0002272638,0.00055083574,0.000055183988],"category_scores_gemma":[0.00051715766,0.00026730774,0.0011191227,0.0001494495,0.00010284899,0.00011846953,0.00004232294,0.001486991,0.000004770674],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038627884,0.00063172524,0.006274684,0.005170947,0.002187117,0.0023601416,0.00025782504,0.0000017363016,0.00015004016,0.00018986526,0.00014793835,0.9822417],"study_design_scores_gemma":[0.0026964783,0.0023208333,0.0022332922,0.003354508,0.0028141022,0.005441405,0.000045638357,0.0000015698306,0.000041643812,0.00051263697,0.98030865,0.00022921806],"about_ca_topic_score_codex":0.0000063875746,"about_ca_topic_score_gemma":0.00003535648,"teacher_disagreement_score":0.9820125,"about_ca_system_score_codex":0.00021055453,"about_ca_system_score_gemma":0.00095164205,"threshold_uncertainty_score":0.9999779},"labels":[],"label_agreement":null},{"id":"W2077860755","doi":"10.3816/cgc.2009.n.035","title":"Tolerance of Sunitinib in Dialyzed Patients With Metastatic Renal Cell Carcinoma","year":2009,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Foothills Medical Centre","funders":"","keywords":"Sunitinib; Medicine; Renal cell carcinoma; Hemodialysis; Dialysis; Peritoneal dialysis; Internal medicine; Toxicity; Oncology; Urology","score_opus":0.042401785770641985,"score_gpt":0.3333178607955501,"score_spread":0.2909160750249081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077860755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945952,0.001195786,0.00000816119,0.0002697492,0.0001493298,0.00073653477,0.000030159756,0.000019312754,0.0029957648],"genre_scores_gemma":[0.99715257,0.0001251554,0.0013774175,0.00047935912,0.00022225399,0.0000470783,0.000045099612,0.000026253269,0.0005248092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775314,0.00017146266,0.0008818479,0.00043819417,0.00040305068,0.00035230396],"domain_scores_gemma":[0.99858534,0.00021697985,0.00027616715,0.0004596584,0.00021097345,0.00025086117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022242231,0.0002511693,0.00080170255,0.00012794229,0.000028105573,0.000005844226,0.00013273618,0.00008761568,0.00016751395],"category_scores_gemma":[0.000052388856,0.00018492632,0.00020680865,0.0003300763,0.0001343077,0.000073163494,0.000030521405,0.0003478689,0.0000136712315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053722155,0.0032092354,0.97255695,0.000118463315,0.0000557485,0.000708549,0.00012127357,0.00011394818,0.00081010384,0.000003554503,0.0004570878,0.016472846],"study_design_scores_gemma":[0.011552768,0.005508992,0.97608674,0.00015857724,0.00023762038,0.000007324202,0.000025512636,0.000041239055,0.0057931435,0.0000289564,0.00037162963,0.00018748439],"about_ca_topic_score_codex":0.00009242103,"about_ca_topic_score_gemma":0.000023396782,"teacher_disagreement_score":0.016285364,"about_ca_system_score_codex":0.00013004536,"about_ca_system_score_gemma":0.00030487223,"threshold_uncertainty_score":0.75410765},"labels":[],"label_agreement":null},{"id":"W2078829964","doi":"10.1100/tsw.2007.157","title":"The Role of Surveillance in the Management of Small Renal Masses","year":2007,"lang":"en","type":"review","venue":"The Scientific World JOURNAL","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Medicine; Natural history; Life expectancy; Slow growth; Surgery; Radiology; Internal medicine; Population","score_opus":0.06938087646217986,"score_gpt":0.3293047478143616,"score_spread":0.25992387135218176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078829964","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008495353,0.9827534,0.0000072178645,0.00024276931,0.0006143464,0.0009460054,0.000010076837,0.0000043635637,0.014572273],"genre_scores_gemma":[0.0031558964,0.9858747,0.00031990878,0.000012916395,0.0001969603,0.000022497561,0.000012187085,0.000025517757,0.010379411],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963281,0.00061890064,0.001199417,0.0002777002,0.0011370134,0.00043888277],"domain_scores_gemma":[0.9969511,0.0006704829,0.0010219992,0.0011158546,0.00016717863,0.000073406874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010026227,0.00028802422,0.00091953203,0.00042950228,0.00036692247,0.00015560845,0.001199855,0.000053519376,0.000057451816],"category_scores_gemma":[0.000031077587,0.00010499821,0.00065420044,0.0016961428,0.00058590004,0.000025839689,0.00014880834,0.0007894613,0.000020818965],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006596801,0.0001535212,0.00020663612,0.0021262928,0.00050205295,0.00019437567,0.0002264792,0.0000056622516,0.000008970492,0.0007843321,0.0012178968,0.9945078],"study_design_scores_gemma":[0.0002957491,0.00005951334,0.0010602735,0.007059119,0.00068914396,0.00062941073,0.00038607678,0.000003837227,0.000046393674,0.0004140699,0.98926127,0.000095124364],"about_ca_topic_score_codex":0.000015570962,"about_ca_topic_score_gemma":0.00020490227,"teacher_disagreement_score":0.99441266,"about_ca_system_score_codex":0.0001795442,"about_ca_system_score_gemma":0.00026837108,"threshold_uncertainty_score":0.42817026},"labels":[],"label_agreement":null},{"id":"W2078843021","doi":"10.1016/j.eururo.2006.02.034","title":"Tumor Size Improves the Accuracy of TNM Predictions in Patients with Renal Cancer","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Multivariate analysis; Univariate; Nephrectomy; Multivariate statistics; Renal cell carcinoma; Cancer; Internal medicine; Oncology; Renal tumor; Kidney cancer; Univariate analysis; Urology; Kidney; Statistics","score_opus":0.007029511871624475,"score_gpt":0.21556016880366738,"score_spread":0.2085306569320429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078843021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851997,0.00021429153,0.000010983537,0.0007610213,0.00006853718,0.0003641266,0.000014064529,0.000021479947,0.0133458115],"genre_scores_gemma":[0.9988539,0.000005659863,0.00006432471,0.0004184269,0.00012195176,0.000017679757,0.000015303396,0.000024296223,0.00047841735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911004,0.00015862778,0.00023119258,0.00018504042,0.00013427039,0.00018080465],"domain_scores_gemma":[0.99933684,0.00016712773,0.00012459958,0.00026885924,0.00006736158,0.000035233796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010206912,0.00010746899,0.00016682583,0.0000497804,0.000032608154,0.0000035786152,0.000085054526,0.000015816771,0.000078096666],"category_scores_gemma":[0.00009031379,0.000060181566,0.000037531205,0.00012851109,0.00013364661,0.000027772528,0.00003960472,0.00015116569,0.000017599094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014613481,0.00061208016,0.9890658,0.000023581722,0.00008810937,0.0001999068,0.00020070946,0.0005099957,0.00362444,0.000090061665,0.0022352054,0.0018887606],"study_design_scores_gemma":[0.0024218757,0.0012578403,0.9919931,0.000012859405,0.000097426375,0.000017018232,0.0000077144805,0.000033093984,0.0005226434,0.000011765726,0.0035765283,0.000048122944],"about_ca_topic_score_codex":0.0002841857,"about_ca_topic_score_gemma":0.000100700905,"teacher_disagreement_score":0.013654256,"about_ca_system_score_codex":0.000040811283,"about_ca_system_score_gemma":0.000053802352,"threshold_uncertainty_score":0.2454133},"labels":[],"label_agreement":null},{"id":"W2079168970","doi":"10.1016/j.clgc.2014.09.003","title":"Characteristics of Long-Term and Short-Term Survivors of Metastatic Renal Cell Carcinoma Treated With Targeted Therapies: Results From the International mRCC Database Consortium","year":2014,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia; Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; BC Cancer Agency; Princess Margaret Cancer Centre; London Health Sciences Centre; University of Toronto; Western University; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Dana-Farber/Harvard Cancer Center","keywords":"Medicine; Renal cell carcinoma; Term (time); Oncology; Internal medicine; Carcinoma; Database","score_opus":0.0563195451303097,"score_gpt":0.32547690014645964,"score_spread":0.26915735501614996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079168970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960192,0.001079442,0.000056335346,0.0003198315,0.00024899558,0.0005038489,0.0014895815,0.000017557115,0.00026524527],"genre_scores_gemma":[0.99657035,0.00095367443,0.000542596,0.00015387437,0.00041247308,0.000036381,0.0010268668,0.00003709571,0.00026669848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974187,0.00029387747,0.0011203204,0.00051330304,0.000430483,0.0002233242],"domain_scores_gemma":[0.99687296,0.0013786253,0.00052622706,0.0007253609,0.00029773655,0.0001990913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050047913,0.00028075578,0.00075773813,0.00006311188,0.00004700362,0.000014700508,0.0002487409,0.00008574922,0.00015374948],"category_scores_gemma":[0.00016415083,0.0001676447,0.00016325979,0.00011859477,0.0005254864,0.000065569475,0.00012282497,0.00028779428,0.0000028891507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072015324,0.0006510193,0.97147334,0.00010783208,0.00059433794,0.00031521416,0.00025984528,0.0000026140135,0.013359721,0.0000015279619,0.0002047632,0.0058282414],"study_design_scores_gemma":[0.004649748,0.001824995,0.9681935,0.00021893269,0.00088311825,0.000027099737,0.000073216936,0.00013520653,0.023704255,0.0000026218358,0.0001248015,0.00016254302],"about_ca_topic_score_codex":0.0007064999,"about_ca_topic_score_gemma":0.00016143227,"teacher_disagreement_score":0.010344533,"about_ca_system_score_codex":0.00005299162,"about_ca_system_score_gemma":0.00018955514,"threshold_uncertainty_score":0.68363523},"labels":[],"label_agreement":null},{"id":"W2079743297","doi":"10.5489/cuaj.2373","title":"Clinical outcome and prognostic factors in renal medullary carcinoma. A pooled analysis from 18 years of medical literature.","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Oncology; Proportional hazards model; Renal cell carcinoma; Nephrectomy; Stage (stratigraphy); Multivariate analysis; Lymph node; Disease; Gemcitabine; Chemotherapy; Kidney cancer; Surgery; Kidney","score_opus":0.04781600369439031,"score_gpt":0.30376142207909385,"score_spread":0.2559454183847035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079743297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99305457,0.0014612805,0.000016244012,0.0048843594,0.00017171793,0.00016735877,0.00005877777,0.000009151044,0.00017652813],"genre_scores_gemma":[0.99830914,0.00007452097,0.00030870788,0.00088897004,0.00024200081,0.0000037048073,0.00010673543,0.0000101978785,0.000056043238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99675274,0.0005670488,0.00095374486,0.00029349932,0.0010404708,0.00039250913],"domain_scores_gemma":[0.99635786,0.00083086663,0.0003721214,0.00015078844,0.00026448932,0.0020238918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020915228,0.000166091,0.00080914254,0.0005607211,0.000038101854,0.000057220168,0.0001541338,0.00059213943,0.0003760326],"category_scores_gemma":[0.0075480775,0.00012687023,0.00030014798,0.00070759567,0.00007401505,0.00006758342,0.00003614824,0.0010172857,0.0000067528526],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008605886,0.00009324823,0.99585325,0.0000030950612,0.0006435731,0.0015216515,0.00027715074,0.00000848279,0.0000058252745,0.0000119993465,0.0006260533,0.0008695874],"study_design_scores_gemma":[0.0018657042,0.00045487273,0.99509513,0.00003191827,0.0011093293,0.00007918653,0.00010208476,0.0003147158,0.00000385172,0.0001791274,0.0006590883,0.00010495867],"about_ca_topic_score_codex":0.0042152926,"about_ca_topic_score_gemma":0.0040038754,"teacher_disagreement_score":0.0054565547,"about_ca_system_score_codex":0.00079057727,"about_ca_system_score_gemma":0.000980424,"threshold_uncertainty_score":0.9036299},"labels":[],"label_agreement":null},{"id":"W2080322619","doi":"10.1002/cncr.24409","title":"Targeted inhibition of mammalian target of rapamycin for the treatment of advanced renal cell carcinoma","year":2009,"lang":"en","type":"review","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Temsirolimus; Medicine; Everolimus; Sunitinib; Sorafenib; Renal cell carcinoma; Sirolimus; Internal medicine; PI3K/AKT/mTOR pathway; Oncology; Tyrosine-kinase inhibitor; Kidney cancer; Discovery and development of mTOR inhibitors; Targeted therapy; Clinical trial; Cancer; Cancer research; Hepatocellular carcinoma; Signal transduction; Biology","score_opus":0.04590314406237158,"score_gpt":0.3232325820766255,"score_spread":0.2773294380142539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080322619","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009992358,0.9844898,0.000039611255,0.00004647789,0.00018068252,0.00398095,0.00089929265,0.000010847547,0.0003599808],"genre_scores_gemma":[0.022576502,0.97292775,0.001154425,0.000015998166,0.00023806121,0.000922771,0.0006938695,0.00006941961,0.0014011904],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978238,0.0000842762,0.0010542584,0.00041284636,0.00032486898,0.00029995685],"domain_scores_gemma":[0.9977486,0.00019163352,0.0009817438,0.0006858015,0.0002837324,0.00010850325],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011494641,0.0005005478,0.0024958206,0.0002007006,0.000034653633,0.00000270815,0.00012144989,0.00023692365,0.00016761693],"category_scores_gemma":[0.000015608515,0.00029013085,0.0012385102,0.00031414873,0.00013041173,0.000029245884,0.000013771532,0.00011372444,0.0000021791477],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000736841,0.00090274337,0.00009964097,0.028427571,0.00058359106,0.000030923526,0.00034414663,0.00007071546,0.0028052593,0.000018882743,0.00088269945,0.965097],"study_design_scores_gemma":[0.004973694,0.006466891,0.00073351787,0.0074311686,0.0073043606,0.00001734746,0.000063896245,0.00001120174,0.18860625,0.000024430914,0.78404635,0.00032087957],"about_ca_topic_score_codex":0.00013576302,"about_ca_topic_score_gemma":0.000018570132,"teacher_disagreement_score":0.9647761,"about_ca_system_score_codex":0.0006733378,"about_ca_system_score_gemma":0.0007183415,"threshold_uncertainty_score":0.99995506},"labels":[],"label_agreement":null},{"id":"W2080477888","doi":"10.1038/nrurol.2014.194","title":"Landmarks in the diagnosis and treatment of renal cell carcinoma","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":231,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Kidney cancer; Disease; Incidence (geometry); Cancer; Oncology; Targeted therapy; Localized disease; Internal medicine; Intensive care medicine; Prostate cancer","score_opus":0.0502894682707636,"score_gpt":0.3409109030450106,"score_spread":0.290621434774247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080477888","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005257099,0.992858,8.8767734e-7,0.00025873384,0.00011897221,0.0036842567,0.0000204469,0.0000071201403,0.0025258788],"genre_scores_gemma":[0.002633878,0.99506253,0.00009217564,0.0003497786,0.00029666713,0.0011974188,0.0001944767,0.00004361775,0.00012947716],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99641347,0.0013810587,0.0010422162,0.00060889067,0.00020755337,0.00034678742],"domain_scores_gemma":[0.99737597,0.00092558545,0.0006233616,0.00092919695,0.000038261343,0.00010761987],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00065821665,0.00063465297,0.0045871777,0.00029367366,0.000029168168,0.000007611254,0.00022181221,0.0011396691,0.000056442415],"category_scores_gemma":[0.00012223152,0.00029308978,0.00087341067,0.00033650774,0.00011496578,0.000014063956,0.000045174616,0.0009196529,0.000034162495],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034988392,0.00035465884,0.0016030448,0.015191603,0.00008364719,0.0002801471,0.000087836655,3.383282e-8,3.7034258e-7,0.000042518444,0.0014170059,0.98090416],"study_design_scores_gemma":[0.0008736515,0.002364774,0.0008368584,0.0018469393,0.0044196444,0.0008317675,0.000002053247,6.4207177e-7,0.000003932262,0.000008309274,0.98863584,0.00017559929],"about_ca_topic_score_codex":0.00003644322,"about_ca_topic_score_gemma":0.00004653014,"teacher_disagreement_score":0.9872188,"about_ca_system_score_codex":0.00016662944,"about_ca_system_score_gemma":0.00014474541,"threshold_uncertainty_score":0.99995214},"labels":[],"label_agreement":null},{"id":"W2081017683","doi":"10.1111/j.1464-410x.2009.08662.x","title":"Survival of patients with nonmetastatic pT3 renal tumours: a matched comparison of laparoscopic vs open radical nephrectomy","year":2009,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Urology; Laparoscopy; Surgery; Kidney; Internal medicine","score_opus":0.021613423120794745,"score_gpt":0.28701497172120316,"score_spread":0.26540154860040843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081017683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972307,0.0011945001,0.00020561188,0.00048802007,0.00009892841,0.0004013279,0.000019465244,0.0000044766666,0.00035693374],"genre_scores_gemma":[0.99449974,0.000056445602,0.005115897,0.00019412053,0.000061695835,0.0000025109816,0.000023317989,0.000017675055,0.000028589082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773103,0.00027509683,0.0009849967,0.00018233585,0.000550341,0.0002761872],"domain_scores_gemma":[0.99818546,0.00014381054,0.00091038493,0.00018106545,0.00036037096,0.00021889558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003982496,0.00016322844,0.0014057198,0.00015450438,0.00003149287,0.000019769323,0.00029757884,0.000090354755,0.00015529848],"category_scores_gemma":[0.00012897479,0.00014178787,0.00013873495,0.00018593902,0.00021128668,0.00011668903,0.000049877584,0.0003819514,0.00000263948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013990196,0.0046398607,0.95907694,0.0001034645,0.00057861715,0.0020912155,0.0003148429,0.0001313372,0.0019165006,0.000040132756,0.0018793568,0.015237538],"study_design_scores_gemma":[0.018301561,0.017688483,0.95767504,0.00028637543,0.00064044044,0.0021809733,0.00005480382,0.000031784322,0.0025661206,0.000108402804,0.00035872887,0.00010728417],"about_ca_topic_score_codex":0.00010152728,"about_ca_topic_score_gemma":0.000040644998,"teacher_disagreement_score":0.0151302535,"about_ca_system_score_codex":0.00005821218,"about_ca_system_score_gemma":0.00024407936,"threshold_uncertainty_score":0.57819414},"labels":[],"label_agreement":null},{"id":"W2081137211","doi":"10.5489/cuaj.1966","title":"Robot-assisted partial nephrectomy: Excellent results even in more complex renal tumours","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Nephrectomy; Urology; Medicine; Computer science; Kidney; Internal medicine","score_opus":0.03283454984185659,"score_gpt":0.25470377417022916,"score_spread":0.22186922432837258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081137211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94149894,0.00009536162,0.00006490433,0.0525811,0.00026415312,0.00036472589,0.00003072208,0.000035736382,0.0050643343],"genre_scores_gemma":[0.9945735,0.000017410153,0.00056696986,0.0033696753,0.0006783386,0.00002174257,0.0001088385,0.00001856109,0.00064498966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971788,0.0004841046,0.00067982904,0.00032752886,0.00056908524,0.0007606444],"domain_scores_gemma":[0.9978307,0.00023721099,0.0003734176,0.00018996162,0.00020967252,0.0011590238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012116869,0.00022340292,0.00048440226,0.00030711037,0.00020548794,0.000079980855,0.00015019067,0.000280362,0.0003780357],"category_scores_gemma":[0.0011493419,0.0001791994,0.00020542191,0.00030348066,0.000044364362,0.00006844241,0.000020786289,0.0007823323,0.00009574032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008986914,0.00026915557,0.9498191,0.000008066582,0.00015752485,0.0011834482,0.00034264982,0.0010636804,0.0019714416,0.00011371845,0.032018527,0.012154025],"study_design_scores_gemma":[0.0038119438,0.00058329967,0.92403585,0.000024911498,0.000078892226,0.00034087803,0.000041129133,0.0011436585,0.000108412496,0.00014926262,0.06952089,0.000160879],"about_ca_topic_score_codex":0.002552404,"about_ca_topic_score_gemma":0.0033049127,"teacher_disagreement_score":0.053074513,"about_ca_system_score_codex":0.002981507,"about_ca_system_score_gemma":0.00054833054,"threshold_uncertainty_score":0.7796537},"labels":[],"label_agreement":null},{"id":"W2081291322","doi":"10.1007/s00038-003-2046-2","title":"Overweight and obesity in adults and risk of renal cell carcinoma in Canada","year":2003,"lang":"en","type":"article","venue":"Sozial- und Präventivmedizin","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Statistics Canada; Institute of Population and Public Health; Health Canada","funders":"","keywords":"Overweight; Medicine; Obesity; Body mass index; Odds ratio; Confidence interval; Population; Logistic regression; Demography; Internal medicine; Renal cell carcinoma; Environmental health","score_opus":0.006760780961477458,"score_gpt":0.2056914189554468,"score_spread":0.19893063799396934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081291322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98918855,0.006427599,0.0000034217878,0.00004633646,0.000105144114,0.00053218805,0.000030144864,0.000004961997,0.0036616377],"genre_scores_gemma":[0.9988462,0.00059272844,0.00026451837,0.00002845254,0.00002822397,0.000016368738,0.000014436337,0.000018681374,0.0001904329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983289,0.00020685758,0.00042598412,0.00038379393,0.00031824148,0.00033619438],"domain_scores_gemma":[0.99921256,0.00014407632,0.00015000335,0.0002460427,0.00004304618,0.00020429403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032821827,0.00021499279,0.0004752929,0.00017379344,0.000032136697,0.00000649912,0.000050133607,0.00009069035,0.0000672866],"category_scores_gemma":[0.00009339692,0.00019014487,0.000047209145,0.0002572486,0.00008995539,0.000058773447,0.00004111446,0.0002668179,0.0000016216649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003107996,0.00020461087,0.996473,0.00030076975,0.00003278378,0.00043004387,0.0004897376,0.0000041219137,0.000639977,0.00006897325,0.0001380816,0.00090710964],"study_design_scores_gemma":[0.005227076,0.00033107263,0.95836174,0.00021488413,0.00012724641,0.000032364645,0.0003059973,0.000066092034,0.03440733,0.00023480995,0.00053266436,0.00015873325],"about_ca_topic_score_codex":0.64019006,"about_ca_topic_score_gemma":0.81808144,"teacher_disagreement_score":0.17789137,"about_ca_system_score_codex":0.00045546173,"about_ca_system_score_gemma":0.00081831974,"threshold_uncertainty_score":0.7753883},"labels":[],"label_agreement":null},{"id":"W2081371466","doi":"10.1016/j.urology.2012.09.019","title":"Safety of Everolimus by Treatment Duration in Patients With Advanced Renal Cell Cancer in an Expanded Access Program","year":2012,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Everolimus; Urology; Duration (music); Oncology; Internal medicine","score_opus":0.015297783100087737,"score_gpt":0.30025282345636073,"score_spread":0.284955040356273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081371466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978015,0.000503,0.000009582904,0.000072329225,0.00005684596,0.0011715319,0.000017509721,0.000015553944,0.00035213956],"genre_scores_gemma":[0.9990915,0.00004932766,0.00016044763,0.00006509699,0.000028098704,0.00033648984,0.00021324898,0.000016160939,0.000039623166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898916,0.00008895969,0.00026879413,0.00018627598,0.00013408554,0.0003326941],"domain_scores_gemma":[0.999508,0.000024756206,0.00012142383,0.00018885438,0.000043175187,0.00011376851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059735175,0.00014628658,0.00029850967,0.00010784593,0.000012320528,0.000002554682,0.000046913912,0.00008503465,0.000053098214],"category_scores_gemma":[0.0000055522823,0.000102272585,0.00002401592,0.00014229001,0.00003799424,0.00020521822,0.00001552283,0.000074578435,0.000001918095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005234298,0.0035875184,0.96505004,0.000016339814,0.000024190695,0.000005790343,0.0005799741,0.00019941294,0.0014907556,0.000002081463,0.000010542527,0.023799056],"study_design_scores_gemma":[0.010255721,0.0075246743,0.9664493,0.000011487959,0.000065695334,0.0000023353562,0.000020725933,0.00006066062,0.015246147,0.0000019691568,0.00027919482,0.00008204965],"about_ca_topic_score_codex":0.00024994617,"about_ca_topic_score_gemma":0.00046579586,"teacher_disagreement_score":0.023717007,"about_ca_system_score_codex":0.0003276077,"about_ca_system_score_gemma":0.000055315817,"threshold_uncertainty_score":0.41705552},"labels":[],"label_agreement":null},{"id":"W2082145860","doi":"10.5489/cuaj.1210","title":"Complete response to low-dose sorafenib in a patient with metastatic renal cell carcinoma: A case report","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Sorafenib; Medicine; Renal cell carcinoma; Toxicity; Adverse effect; Refractory (planetary science); Internal medicine; Oncology; Lymph; Carcinoma; Urology; Hepatocellular carcinoma; Pathology","score_opus":0.019065314030254805,"score_gpt":0.22351746317284665,"score_spread":0.20445214914259185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082145860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833139,0.000085171756,0.000028364211,0.01460611,0.000079008234,0.00092202687,0.000034288918,0.000015420715,0.00091567705],"genre_scores_gemma":[0.99465096,0.0000012006531,0.0012776285,0.0032581773,0.000076668206,0.00009941658,0.000025215095,0.000023978304,0.00058675127],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99708897,0.000562175,0.00067714805,0.00035886682,0.00055405305,0.00075877464],"domain_scores_gemma":[0.9968655,0.0002861135,0.00037736516,0.00024848376,0.00046423485,0.0017582773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009176555,0.0002481868,0.0004754536,0.0004962749,0.00018985386,0.00010687164,0.00008823256,0.00012532745,0.0006240061],"category_scores_gemma":[0.00074627344,0.00017737603,0.00013119442,0.00046044204,0.000031119165,0.00011037377,0.000018393624,0.00063052075,0.00019704916],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014923761,0.00028085115,0.21174599,0.000012252691,0.00009340724,0.77581096,0.0009068577,0.00034359744,0.002935193,0.000004609831,0.005594686,0.0007792241],"study_design_scores_gemma":[0.003962314,0.0037616114,0.7592336,0.0000309663,0.00015226814,0.22681364,0.00047815306,0.00019353036,0.0002760934,0.0000810721,0.0047267154,0.00029003015],"about_ca_topic_score_codex":0.011673122,"about_ca_topic_score_gemma":0.0048628896,"teacher_disagreement_score":0.54899734,"about_ca_system_score_codex":0.0033449864,"about_ca_system_score_gemma":0.0011555296,"threshold_uncertainty_score":0.9949082},"labels":[],"label_agreement":null},{"id":"W2082817448","doi":"10.5489/cuaj.10148","title":"Recent developments in kidney cancer","year":2011,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; University Health Network; Queen's University","funders":"","keywords":"Medicine; Nephrectomy; Gynecology; Lymphadenectomy; Kidney cancer; Renal cell carcinoma; General surgery; Cancer; Oncology; Internal medicine; Kidney","score_opus":0.04421111693032185,"score_gpt":0.2480731288527305,"score_spread":0.20386201192240866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082817448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94827557,0.00059484784,0.0000029095304,0.013597459,0.00043909406,0.00020151837,0.000012084407,0.000014415061,0.03686213],"genre_scores_gemma":[0.98869246,0.00076160696,0.00044212537,0.009016376,0.00013108771,0.00001788033,0.000010517392,0.000009088019,0.0009188761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987957,0.000090634174,0.00028214447,0.00014391376,0.00025077333,0.0004368458],"domain_scores_gemma":[0.998498,0.000021407011,0.00013237014,0.00006289848,0.00017643384,0.0011088862],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037559125,0.00010434996,0.0001942112,0.00020050762,0.000083222825,0.000018261466,0.00007233324,0.00016273212,0.0030581753],"category_scores_gemma":[0.00044347966,0.00008132096,0.00005660396,0.00021771168,0.0000121353205,0.000052459724,0.000008853275,0.00040160492,0.00010492721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048080376,0.0000515222,0.98115575,0.0000018138103,0.000058630107,0.00041922403,0.0002496526,0.0000010652531,0.000033971435,0.000034528435,0.0060680667,0.011877666],"study_design_scores_gemma":[0.000856863,0.000111756504,0.8783901,0.000019322992,0.000027858827,0.000103037375,0.000023067634,0.000004843561,0.00012586545,0.00017854458,0.12008479,0.00007395143],"about_ca_topic_score_codex":0.0033028251,"about_ca_topic_score_gemma":0.0030293053,"teacher_disagreement_score":0.11401672,"about_ca_system_score_codex":0.0039927703,"about_ca_system_score_gemma":0.001498713,"threshold_uncertainty_score":0.9998307},"labels":[],"label_agreement":null},{"id":"W2082992113","doi":"10.1002/cncr.25452","title":"Sunitinib in metastatic renal cell carcinoma patients with brain metastases","year":2010,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Discontinuation; Adverse effect; Neutropenia; Internal medicine; Population; Expanded access; Brain metastasis; Common Terminology Criteria for Adverse Events; Oncology; Surgery; Cancer; Metastasis; Chemotherapy","score_opus":0.01925466073497809,"score_gpt":0.2684098122825676,"score_spread":0.24915515154758952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082992113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954043,0.0003539816,0.000008839803,0.00039857544,0.00012418425,0.0005652498,0.00007942524,0.000021727386,0.0030437016],"genre_scores_gemma":[0.9967778,0.0000048287484,0.001218012,0.00053247216,0.000072025796,0.00015190052,0.00011974377,0.00003718799,0.0010860689],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881446,0.00005227824,0.00021644426,0.00029778574,0.0003069683,0.00031203966],"domain_scores_gemma":[0.99917626,0.000092838236,0.00008303182,0.00033698263,0.00012248215,0.00018837515],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011433559,0.00020325922,0.0003277091,0.00015079993,0.000033696037,0.000013931819,0.00007542503,0.000038888425,0.0009801454],"category_scores_gemma":[0.000037431597,0.0001401916,0.00006279012,0.0002433566,0.00008421212,0.00007674321,0.000024240073,0.00028873503,0.000032873126],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006961517,0.0006694532,0.97197425,0.00015903045,0.000084307525,0.00050001283,0.00040420296,0.000019592766,0.01681573,0.000060177405,0.002816112,0.0058009955],"study_design_scores_gemma":[0.007141541,0.00072856253,0.91428,0.00005670781,0.00026945907,0.000017656364,0.00007520792,0.000018366336,0.07081113,0.000020689133,0.006372716,0.00020795129],"about_ca_topic_score_codex":0.00060489884,"about_ca_topic_score_gemma":0.0010428595,"teacher_disagreement_score":0.057694223,"about_ca_system_score_codex":0.000120508026,"about_ca_system_score_gemma":0.00025112054,"threshold_uncertainty_score":0.9999331},"labels":[],"label_agreement":null},{"id":"W2083633182","doi":"10.1016/j.juro.2016.10.095","title":"The Results of Radical Nephrectomy for Renal Cell Carcinoma","year":2016,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Urology; Oncology; Kidney; Internal medicine","score_opus":0.020608433984285964,"score_gpt":0.25670701721255507,"score_spread":0.2360985832282691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083633182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720234,0.0024545016,0.0006120064,0.023138952,0.00022147829,0.00025107962,0.000008508194,0.0000033871588,0.0012866367],"genre_scores_gemma":[0.99782765,0.00023962258,0.00040062575,0.00024856676,0.000390715,0.000003245381,5.9872156e-7,0.00001330569,0.00087565347],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986307,0.00024184633,0.0005711562,0.00008082349,0.00023655189,0.00023891377],"domain_scores_gemma":[0.9967191,0.0021423122,0.00050376664,0.00031471383,0.00021544276,0.0001046368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013076409,0.000104697756,0.00030992078,0.0000647294,0.00007521202,0.0000027390479,0.00024312257,0.000075288,0.00001852017],"category_scores_gemma":[0.00033678583,0.000035726105,0.00020257884,0.00006186838,0.0003288156,0.000025103049,0.000034297595,0.00017572101,0.0000068369113],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12675145,0.00065932435,0.010825841,0.00007379875,0.0007106529,0.0004288611,0.0013125874,0.00003211705,0.7273567,0.0007868836,0.08791602,0.043145806],"study_design_scores_gemma":[0.038082995,0.027816342,0.093772374,0.000063984364,0.0019604322,0.0070279893,0.00015838115,0.00006906177,0.44667628,0.003216156,0.3809712,0.00018480793],"about_ca_topic_score_codex":0.000010518896,"about_ca_topic_score_gemma":0.000005374882,"teacher_disagreement_score":0.29305518,"about_ca_system_score_codex":0.000053127722,"about_ca_system_score_gemma":0.00018344873,"threshold_uncertainty_score":0.14568684},"labels":[],"label_agreement":null},{"id":"W2084310241","doi":"10.1016/s0022-5347(05)66015-6","title":"RE: PORT SITE TUMOR RECURRENCES OF RENAL CELL CARCINOMA AFTER VIDEOLAPAROSCOPIC RADICAL NEPHRECTOMY","year":2001,"lang":"en","type":"letter","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nephrectomy; Medicine; Renal cell carcinoma; Carcinoma; Urology; Metastasis; General surgery; Kidney; Cancer; Pathology; Internal medicine","score_opus":0.01685243051805111,"score_gpt":0.2474856345259517,"score_spread":0.2306332040079006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084310241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7912143,0.013277781,0.000033347646,0.19243667,0.0007934282,0.00038654683,0.000020564254,0.000009958848,0.0018274446],"genre_scores_gemma":[0.83973646,0.00055192143,0.0004308881,0.15292977,0.0049172547,0.000012181831,0.000036215275,0.0000708506,0.001314454],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958911,0.000787916,0.0014388108,0.00031638067,0.0009478593,0.0006179645],"domain_scores_gemma":[0.9963761,0.00063749525,0.0017245334,0.00073023775,0.00032957637,0.00020206686],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008994913,0.00050616194,0.0015892143,0.00048123964,0.00005429365,0.000011731867,0.00052593247,0.0006105495,0.0010666205],"category_scores_gemma":[0.00010320855,0.00029693096,0.00057473936,0.00026556183,0.00060367776,0.000068533634,0.00010946449,0.003539321,0.000054216587],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005793758,0.0002779226,0.06276284,0.00039907766,0.00047242225,0.038246848,0.000556544,0.0000110811025,0.0023175376,7.962057e-7,0.8887613,0.00039987083],"study_design_scores_gemma":[0.004727233,0.012184506,0.038477693,0.00030816984,0.005725905,0.027482359,0.00005115212,0.0000145003105,0.0064076143,0.0002282419,0.9039535,0.0004391441],"about_ca_topic_score_codex":0.00008665464,"about_ca_topic_score_gemma":0.00001528877,"teacher_disagreement_score":0.048522204,"about_ca_system_score_codex":0.00016494757,"about_ca_system_score_gemma":0.000662763,"threshold_uncertainty_score":0.99994826},"labels":[],"label_agreement":null},{"id":"W2085518532","doi":"10.1016/j.ejca.2011.05.017","title":"Health-related quality of life in patients with advanced renal cell carcinoma receiving pazopanib or placebo in a randomised phase III trial","year":2011,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Pazopanib; Placebo; Medicine; Renal cell carcinoma; Quality of life (healthcare); Oncology; Internal medicine; Clinical trial; Phases of clinical research; Alternative medicine; Sunitinib; Pathology; Nursing","score_opus":0.05298764010998183,"score_gpt":0.3047085310886384,"score_spread":0.2517208909786566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085518532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99472433,0.0015325008,0.0000244296,0.00010732837,0.00021332222,0.001322276,0.000008682044,0.000006606176,0.0020605442],"genre_scores_gemma":[0.99890655,0.00008819034,0.00059060875,0.00009364472,0.000090784626,0.0000109894245,0.0000055246014,0.00004791695,0.00016581555],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99533725,0.0013655504,0.0021948249,0.00023217346,0.0005548688,0.00031535668],"domain_scores_gemma":[0.9970943,0.0001452372,0.0019153974,0.0002429263,0.00026779002,0.00033434798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023120765,0.00023402806,0.0012264048,0.000307439,0.000026636893,0.0000060171205,0.00014779465,0.00003282905,0.00027709646],"category_scores_gemma":[0.0002824099,0.00015108167,0.00016000519,0.00033546003,0.00006444233,0.00013326644,0.000026195054,0.00044379014,0.000002414287],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8735913,0.0016109541,0.10889674,0.00012006987,0.00009735096,0.00047771068,0.0036484518,0.00006807856,0.00051748543,6.07439e-7,0.00009462857,0.010876592],"study_design_scores_gemma":[0.57200986,0.008641653,0.4173722,0.0005381989,0.00006186453,0.000007910699,0.00013099633,0.000005550896,0.0010966319,9.22474e-7,0.000028778319,0.0001054653],"about_ca_topic_score_codex":0.00038759154,"about_ca_topic_score_gemma":0.00021127699,"teacher_disagreement_score":0.30847546,"about_ca_system_score_codex":0.00039501116,"about_ca_system_score_gemma":0.0008315782,"threshold_uncertainty_score":0.61609316},"labels":[],"label_agreement":null},{"id":"W2086291342","doi":"10.1002/jcph.510","title":"Pharmacokinetic (PK) drug interaction studies of cabozantinib: Effect of CYP3A inducer rifampin and inhibitor ketoconazole on cabozantinib plasma PK and effect of cabozantinib on CYP2C8 probe substrate rosiglitazone plasma PK","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"Exelixis","keywords":"Cabozantinib; Pharmacology; Ketoconazole; CYP3A4; Pharmacokinetics; CYP3A; Drug interaction; Tyrosine-kinase inhibitor; Chemistry; Medicine; Cytochrome P450; Internal medicine; Cancer; Metabolism","score_opus":0.09779140068654354,"score_gpt":0.4436915727444264,"score_spread":0.3459001720578828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086291342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923281,0.0016982695,0.0000016402639,0.001016248,0.0024531027,0.0020332881,0.000030922944,0.000018007293,0.0004204096],"genre_scores_gemma":[0.99672335,0.0019329742,0.000053822423,0.0001988893,0.0009172202,0.000028509865,0.000005338361,0.000060248498,0.0000796681],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99205154,0.0032915405,0.0029380503,0.00044191998,0.0008117684,0.00046516187],"domain_scores_gemma":[0.98489815,0.011101005,0.0025124038,0.0003161011,0.0007056701,0.00046666156],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0072661135,0.00059521303,0.0029701602,0.0004087783,0.000075780146,0.000010712231,0.00027451757,0.00027005805,0.00004404892],"category_scores_gemma":[0.0015661201,0.00034418146,0.0004315442,0.0003015018,0.0010953497,0.00017027037,0.00017909081,0.0015906147,0.000009738132],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22024682,0.003142046,0.10370699,0.0025586984,0.0054805116,0.0005725791,0.003044272,0.00066741806,0.6411369,0.000020070238,0.0063648657,0.013058803],"study_design_scores_gemma":[0.045463927,0.038565323,0.035940442,0.0010834087,0.0037092413,0.0006069409,0.00035620312,0.00036176035,0.8732323,0.00001752911,0.0004257319,0.00023721065],"about_ca_topic_score_codex":0.000050198178,"about_ca_topic_score_gemma":0.0000076203573,"teacher_disagreement_score":0.23209536,"about_ca_system_score_codex":0.00007396884,"about_ca_system_score_gemma":0.00025671217,"threshold_uncertainty_score":0.999901},"labels":[],"label_agreement":null},{"id":"W2086621090","doi":"10.1097/spc.0b013e32832e469d","title":"Advanced renal cell carcinoma: what to do after first line antiangiogenic therapy?","year":2009,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Sunitinib; Everolimus; Bevacizumab; Renal cell carcinoma; Oncology; Internal medicine; Cabozantinib; Tyrosine-kinase inhibitor; First line; Cancer; Chemotherapy","score_opus":0.10104755510817409,"score_gpt":0.3912191576438094,"score_spread":0.2901716025356353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086621090","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0051361993,0.989037,0.000022223583,0.000071791124,0.0014868339,0.0037214975,0.00036937982,0.000026088324,0.00012902047],"genre_scores_gemma":[0.016561298,0.9788628,0.00009571297,0.00006318432,0.00061816024,0.0008789162,0.0027483664,0.00008693243,0.000084610045],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964247,0.00019455454,0.0010283967,0.0012525759,0.0004684221,0.0006313931],"domain_scores_gemma":[0.99796474,0.00014858918,0.0004442651,0.0005858325,0.00037651227,0.00048006963],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011944379,0.0010051595,0.0022802723,0.0005674123,0.00008036323,0.000094758725,0.00018184533,0.0003289395,0.00018720042],"category_scores_gemma":[0.00003069675,0.0007561832,0.00084308675,0.0006544433,0.00008476387,0.00019628351,0.00012704133,0.0006320858,0.0000923215],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035959046,0.00029851386,0.009837656,0.01836233,0.0000856094,0.00012220292,0.0028739416,0.0000010758141,6.053223e-7,0.0000054932166,0.00048940274,0.96756357],"study_design_scores_gemma":[0.0022233722,0.002008343,0.02629548,0.045216437,0.00039115365,0.000014635996,0.00055821985,4.6810882e-7,0.00004948831,0.000008524314,0.9225071,0.0007267967],"about_ca_topic_score_codex":0.0000043301293,"about_ca_topic_score_gemma":0.000007147284,"teacher_disagreement_score":0.9668368,"about_ca_system_score_codex":0.0006085829,"about_ca_system_score_gemma":0.00042569122,"threshold_uncertainty_score":0.9994889},"labels":[],"label_agreement":null},{"id":"W2086800912","doi":"10.1078/0065-1281-00543","title":"Chromophobe cell carcinoma and renal cell neoplasms with mucin-like changes","year":2000,"lang":"en","type":"article","venue":"Acta Histochemica","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Chromophobe cell; Staining; Pathology; Mucin; Renal oncocytoma; Clear cell; Renal cell carcinoma; Eosinophilic; Oncocytoma; Biology; Medicine","score_opus":0.008034507186815731,"score_gpt":0.19440355926367878,"score_spread":0.18636905207686305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086800912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.941058,0.002586226,0.000001462455,0.00067190774,0.000043656306,0.0004911484,0.00001138631,0.00007822092,0.055058025],"genre_scores_gemma":[0.97278637,0.00018178679,0.0014931775,0.00053246325,0.00014986472,0.00006804038,0.00008421587,0.00006688964,0.024637181],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983898,0.000021164622,0.00020344033,0.0005998704,0.00034057943,0.00044515263],"domain_scores_gemma":[0.99882734,0.000050439383,0.000089405155,0.0006076293,0.000059347793,0.00036585753],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000053593063,0.00036088208,0.000424805,0.00009719815,0.00010144039,0.000018949622,0.00012161141,0.0001457917,0.0010352014],"category_scores_gemma":[0.0000037702218,0.00028462394,0.00007171388,0.00016853436,0.00016618845,0.000057413723,0.000039753035,0.00025185593,0.00010588592],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086867023,0.00029243037,0.0021750077,0.00022177413,0.0000337592,0.0005654433,0.0009151611,5.927997e-7,0.9714453,9.813928e-7,0.021288672,0.0021921613],"study_design_scores_gemma":[0.003969505,0.0018876283,0.0055060573,0.000075945936,0.00037116665,0.0007655337,0.000078091325,0.000035314817,0.913086,0.000005460299,0.073814094,0.00040519115],"about_ca_topic_score_codex":0.00018743965,"about_ca_topic_score_gemma":0.000024026338,"teacher_disagreement_score":0.058359336,"about_ca_system_score_codex":0.00029042113,"about_ca_system_score_gemma":0.0001223248,"threshold_uncertainty_score":0.9999606},"labels":[],"label_agreement":null},{"id":"W2087154177","doi":"10.5489/cuaj.718","title":"Treating small renal masses: Costing it out","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Activity-based costing; Renal mass; Computer science; Medicine; Business; Internal medicine; Kidney; Accounting","score_opus":0.033597869027684704,"score_gpt":0.23814737023583268,"score_spread":0.20454950120814797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087154177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9372928,0.00009624512,0.000077821525,0.03495548,0.00024054413,0.00028737806,0.000007070336,0.000034373887,0.027008299],"genre_scores_gemma":[0.9867533,0.000015701487,0.0029438036,0.005839653,0.00075721083,0.000022717797,0.00002284347,0.000018197054,0.0036265585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998237,0.00013954147,0.0004292419,0.00021637592,0.00033549874,0.0006423448],"domain_scores_gemma":[0.99771976,0.00027043984,0.0003082638,0.00012281312,0.00037903857,0.0011996975],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005318627,0.00017588666,0.00029881418,0.00017295207,0.00033331366,0.00019702248,0.000108768465,0.00030289235,0.0026982734],"category_scores_gemma":[0.0015542958,0.00013393958,0.00017668563,0.00013507908,0.00002442167,0.00010343413,0.0000148938,0.000971986,0.00053532474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015706477,0.000042413027,0.9737935,0.0000041491808,0.00012796502,0.00034798068,0.00025446442,0.000018487799,0.0026310151,0.000030425146,0.013467103,0.009266768],"study_design_scores_gemma":[0.0013778523,0.0005253805,0.9133499,0.000033393724,0.00015712147,0.00083655125,0.00023369692,0.0004176025,0.00032850294,0.00051301625,0.082013905,0.0002130494],"about_ca_topic_score_codex":0.0031976558,"about_ca_topic_score_gemma":0.0027479024,"teacher_disagreement_score":0.0685468,"about_ca_system_score_codex":0.0017164254,"about_ca_system_score_gemma":0.00051826093,"threshold_uncertainty_score":0.9982134},"labels":[],"label_agreement":null},{"id":"W2087209023","doi":"10.1089/end.2008.0196","title":"Single Center Comparison of Laparoscopic Cryoablation and CT-Guided Percutaneous Cryoablation for Renal Tumors","year":2008,"lang":"en","type":"article","venue":"Journal of Endourology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Cryoablation; Percutaneous; Cryosurgery; Radiology; Renal tumor; Laparoscopy; Nephrology; Single Center; Surgery; Kidney; Internal medicine; Ablation; Nephrectomy","score_opus":0.06258687084216075,"score_gpt":0.31170709667408364,"score_spread":0.2491202258319229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087209023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973767,0.0007437895,0.00053591916,0.0004883324,0.00015406973,0.0002519449,0.0000044820763,0.000006777185,0.00043801573],"genre_scores_gemma":[0.99598765,0.000039683673,0.003537335,0.00011001959,0.00018595552,0.000002268309,0.000012066856,0.000015537073,0.00010948114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873626,0.000068345784,0.000680867,0.00012696467,0.00021095482,0.00017658489],"domain_scores_gemma":[0.9987326,0.00019696393,0.0005788744,0.00011050232,0.0002725799,0.00010847574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001534931,0.0001221448,0.0005708624,0.00020402722,0.000056195764,0.000004458094,0.000047494465,0.000058633785,0.00004263173],"category_scores_gemma":[0.00016027033,0.00009777794,0.00012665208,0.00006199689,0.00010432128,0.00006881238,0.000014556077,0.00015634073,0.0000014036199],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024504976,0.00096192287,0.5917063,0.00012812004,0.00027059863,0.0012012173,0.0012686312,0.0007014653,0.3966314,0.00007604499,0.0029557892,0.0016480113],"study_design_scores_gemma":[0.022744065,0.02766365,0.3908493,0.00029555615,0.0011256066,0.22613242,0.00025760822,0.0039942684,0.31602457,0.0007017261,0.009834902,0.00037633115],"about_ca_topic_score_codex":0.000009797234,"about_ca_topic_score_gemma":0.00000512506,"teacher_disagreement_score":0.22493121,"about_ca_system_score_codex":0.00008370361,"about_ca_system_score_gemma":0.00008231283,"threshold_uncertainty_score":0.39872688},"labels":[],"label_agreement":null},{"id":"W2087671902","doi":"10.1007/s12156-010-0039-y","title":"Sequencing or not sequencing multikinase inhibitors in kidney cancer: this is the dilemma","year":2010,"lang":"en","type":"article","venue":"Oncology Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Cancer; Kidney cancer; Dilemma; DNA sequencing; Computational biology; Bioinformatics; Internal medicine; Genetics; Gene; Biology","score_opus":0.09614602639710522,"score_gpt":0.3651717580876123,"score_spread":0.2690257316905071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087671902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96834964,0.0063482868,0.0000026166008,0.011571591,0.0011431116,0.0026796265,0.000017736305,0.00005352204,0.009833868],"genre_scores_gemma":[0.94609386,0.014296685,0.004231165,0.026481077,0.0011396545,0.00145659,0.000027118218,0.00007885911,0.006195006],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975847,0.00033977328,0.00083333626,0.0005161226,0.00023385788,0.0004921816],"domain_scores_gemma":[0.9981641,0.00028951475,0.00035049088,0.0007725864,0.000097970056,0.0003253252],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014222948,0.00033346258,0.0010213181,0.00013095439,0.00013745659,0.000018132227,0.00023021946,0.00028418284,0.0020590732],"category_scores_gemma":[0.0011389349,0.00017515598,0.00025235032,0.00042294967,0.00020295358,0.00009873453,0.00010104061,0.0010336954,0.00038505087],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084410736,0.00034479273,0.06864868,0.0013059346,0.00016805026,0.0033818395,0.008935815,0.0000047591966,0.48646912,0.0001616476,0.0754155,0.35431975],"study_design_scores_gemma":[0.0019297919,0.00053072796,0.0031519735,0.0010044546,0.00029433164,0.0006712988,0.00015441515,0.00016179553,0.04088424,0.000012568826,0.95096135,0.00024304481],"about_ca_topic_score_codex":0.0033289818,"about_ca_topic_score_gemma":0.0042913733,"teacher_disagreement_score":0.87554586,"about_ca_system_score_codex":0.0019174211,"about_ca_system_score_gemma":0.0019857595,"threshold_uncertainty_score":0.9988532},"labels":[],"label_agreement":null},{"id":"W2087922367","doi":"10.5489/cuaj.10011","title":"Associations between radiographic characteristics and change in renal function following partial nephrectomy using 24-hour creatinine clearance","year":2011,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Nephrectomy; Renal function; Medicine; Creatinine; Urology; Urine; Radiography; Magnetic resonance imaging; Kidney; Surgery; Internal medicine; Radiology","score_opus":0.0696931471462662,"score_gpt":0.25606820203954356,"score_spread":0.18637505489327735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087922367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975659,0.00028385926,0.00006859218,0.0010726968,0.00030739556,0.00033260748,0.000047288228,0.000024453893,0.00029716414],"genre_scores_gemma":[0.99755317,0.00006326956,0.00056443573,0.0008342452,0.00085301814,0.00001959137,0.000058290465,0.000019677445,0.000034303222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813265,0.0002507896,0.00051084463,0.00024112625,0.00032637906,0.00053822465],"domain_scores_gemma":[0.9986494,0.00011135102,0.0003954211,0.00009208443,0.00012494427,0.00062680995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008152972,0.00018299649,0.0004755204,0.00041987404,0.00028138488,0.000062948326,0.00006150073,0.0002985783,0.0001470059],"category_scores_gemma":[0.00039294717,0.00016606967,0.00017942325,0.000424734,0.000026657157,0.0001990665,0.0000133137355,0.0006387806,0.000008717909],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008000906,0.000040590196,0.99618953,0.000002216956,0.0001861386,0.00018775267,0.0004030557,0.0000010208839,0.000092319606,0.000019570265,0.000057588317,0.0027402258],"study_design_scores_gemma":[0.00137098,0.00044144838,0.9961571,0.000035437537,0.00037700337,0.000062063555,0.000023297856,0.00021330132,0.000024195575,0.0001353551,0.0010147319,0.00014509856],"about_ca_topic_score_codex":0.0051488504,"about_ca_topic_score_gemma":0.0010984574,"teacher_disagreement_score":0.004050393,"about_ca_system_score_codex":0.0011286968,"about_ca_system_score_gemma":0.0002104036,"threshold_uncertainty_score":0.7783556},"labels":[],"label_agreement":null},{"id":"W2088468324","doi":"10.5489/cuaj.10060","title":"Tumour location as a predictor of benign disease in the management of renal masses","year":2010,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Odds ratio; Renal cell carcinoma; Logistic regression; Univariate analysis; Surgical pathology; Renal sinus; Disease; Radiology; Pathology; Internal medicine; Nephrectomy; Surgery; Kidney; Multivariate analysis","score_opus":0.01151737567092377,"score_gpt":0.22770543387352413,"score_spread":0.21618805820260037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088468324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887654,0.0001242119,0.00002093591,0.008559753,0.00009426492,0.00026453543,0.000014530831,0.000003727952,0.002152602],"genre_scores_gemma":[0.9989988,0.000031244843,0.00025051984,0.00043857834,0.00011683726,0.000013546395,0.000015577774,0.000005136172,0.0001297182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876386,0.000120335,0.00034317945,0.00010961883,0.0004498139,0.00021316756],"domain_scores_gemma":[0.99898094,0.00008908191,0.00026635197,0.00012760074,0.00020165702,0.00033437967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006944983,0.00008394455,0.00017196378,0.00014712045,0.00005326,0.000016521935,0.00013019005,0.000086285116,0.0002325997],"category_scores_gemma":[0.0002744629,0.000054030046,0.00008970382,0.00023682872,0.000034348468,0.000043915807,0.000008855331,0.00036946792,0.0000084094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014935523,0.00016449473,0.9948461,0.000032368527,0.00011746767,0.0003810723,0.00017788648,0.00011321157,0.000866024,0.0017786683,0.00073690113,0.0006364282],"study_design_scores_gemma":[0.0007784632,0.00025765278,0.9946751,0.000031809224,0.00016217935,0.000052169347,0.00010648716,0.00008864257,0.00016791727,0.0014628812,0.002173578,0.000043129927],"about_ca_topic_score_codex":0.00070699456,"about_ca_topic_score_gemma":0.00061989494,"teacher_disagreement_score":0.010233403,"about_ca_system_score_codex":0.00030350132,"about_ca_system_score_gemma":0.00039666527,"threshold_uncertainty_score":0.25468037},"labels":[],"label_agreement":null},{"id":"W2088633031","doi":"10.1159/000342099","title":"Changes in Circulating Pro-Angiogenic Cytokines, other than VEGF, before Progression to Sunitinib Therapy in Advanced Renal Cell Carcinoma Patients","year":2012,"lang":"en","type":"article","venue":"Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Sunitinib; Medicine; Hepatocyte growth factor; Renal cell carcinoma; Internal medicine; Vascular endothelial growth factor; Angiogenesis; Kidney cancer; Proinflammatory cytokine; Cytokine; Tumor progression; Cancer; Oncology; Endocrinology; Inflammation; Receptor; VEGF receptors","score_opus":0.036557317919079464,"score_gpt":0.32160030542991674,"score_spread":0.2850429875108373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088633031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938973,0.0006390547,0.0000021085286,0.0004636183,0.00017824773,0.001909356,0.000007794431,0.000030767736,0.0028717131],"genre_scores_gemma":[0.9972121,0.000010541194,0.0012841766,0.00042866592,0.00023669546,0.00053566747,0.00009111116,0.00005566063,0.00014534003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982303,0.00018233802,0.0003325823,0.00034112323,0.00024608913,0.0006675822],"domain_scores_gemma":[0.9992171,0.00005680274,0.00014833073,0.00028735705,0.00007422335,0.00021620883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002716532,0.0002475442,0.00046030467,0.0003442639,0.00003847799,0.000005088008,0.00009938125,0.00019668869,0.00009026127],"category_scores_gemma":[0.00003623487,0.00019131444,0.00007638427,0.0003862479,0.0000371435,0.0000737555,0.00006644862,0.00020313133,0.00003640278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061526883,0.0016071538,0.8812776,0.000041073337,0.000011763847,0.00010030326,0.0033072967,0.0000038408607,0.03185959,0.000007391389,0.000031549,0.08113714],"study_design_scores_gemma":[0.00556795,0.0071238093,0.9369148,0.00012135905,0.000021631893,0.000031003005,0.00025051314,0.000010904363,0.0462667,0.000008544959,0.0035193006,0.0001634868],"about_ca_topic_score_codex":0.00015959918,"about_ca_topic_score_gemma":0.0011348291,"teacher_disagreement_score":0.080973655,"about_ca_system_score_codex":0.0007250792,"about_ca_system_score_gemma":0.000116608055,"threshold_uncertainty_score":0.7801576},"labels":[],"label_agreement":null},{"id":"W2088651921","doi":"10.1111/j.1464-410x.2004.04925.x","title":"Laparoscopic cytoreductive nephrectomy for metastatic renal cell carcinoma","year":2004,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Kidney cancer; Surgery; Urology; Cancer; Kidney; Internal medicine","score_opus":0.020040784250455367,"score_gpt":0.2627834896919647,"score_spread":0.24274270544150933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088651921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98788214,0.008115093,0.001631389,0.0009183241,0.00036207822,0.0004252252,0.000019751615,0.000010788083,0.00063523505],"genre_scores_gemma":[0.986944,0.000121869445,0.011742847,0.0004968993,0.00042086482,0.000021099484,0.000012330527,0.000033157787,0.00020693429],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.99858814,0.00007966161,0.0005284533,0.00021030781,0.0002390896,0.0003543301],"domain_scores_gemma":[0.9988291,0.000106396554,0.0003361637,0.00013602311,0.00034818743,0.00024410892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025138844,0.00016127805,0.000615174,0.00016781638,0.000074145486,0.000023175464,0.00012239051,0.00008310666,0.00006848534],"category_scores_gemma":[0.0001228351,0.00016070143,0.00029816618,0.00011766034,0.00012774381,0.000102193306,0.000021967353,0.00032634634,0.0000116920455],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035634544,0.017502096,0.05913545,0.0024963014,0.006597424,0.21647425,0.0059487745,0.00831599,0.47770402,0.002433667,0.047025546,0.12073193],"study_design_scores_gemma":[0.08771077,0.04015666,0.27107668,0.00033790432,0.0050835814,0.31851056,0.0005636816,0.00004351846,0.23887236,0.011662829,0.025220435,0.0007610189],"about_ca_topic_score_codex":0.00009703019,"about_ca_topic_score_gemma":0.000023229803,"teacher_disagreement_score":0.23883165,"about_ca_system_score_codex":0.00020900289,"about_ca_system_score_gemma":0.00046638696,"threshold_uncertainty_score":0.6553214},"labels":[],"label_agreement":null},{"id":"W2090422348","doi":"10.1038/sj.onc.1206686","title":"A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23)","year":2003,"lang":"en","type":"article","venue":"Oncogene","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":261,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"National Cancer Institute; Center for Long-Term Cybersecurity, University of California Berkeley; National Institutes of Health","keywords":"TFE3; Biology; Fusion gene; Cancer research; Gene; Genetics; Gene expression","score_opus":0.024306009518908395,"score_gpt":0.24517407704989413,"score_spread":0.22086806753098573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090422348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764102,0.004623399,0.00043536522,0.00026544827,0.00014808132,0.0007289731,0.000011567136,0.000065567234,0.017311417],"genre_scores_gemma":[0.9822077,0.00033227986,0.012729878,0.0003056714,0.00039962307,0.00008632844,0.000064036394,0.00007929338,0.00379519],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755496,0.00007574309,0.00045998726,0.0006703557,0.0006323115,0.0006066484],"domain_scores_gemma":[0.99865544,0.00006165506,0.00015144447,0.000642836,0.00012265667,0.00036597502],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029207885,0.00039012812,0.0005503107,0.00038760967,0.00008020163,0.000021857539,0.00012611233,0.00018373619,0.00042797797],"category_scores_gemma":[0.000053602536,0.000297085,0.00014064577,0.0008219032,0.000052833704,0.00007939768,0.00004985441,0.00029902373,0.00017688422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001415971,0.0019926983,0.60157675,0.00014111887,0.00014122257,0.0038838026,0.00046641764,0.00016819505,0.38535702,0.00014235654,0.0023883265,0.0023261057],"study_design_scores_gemma":[0.014957746,0.0031558988,0.8029181,0.000124561,0.00070949155,0.0035592993,0.00010006223,0.00008927313,0.16727355,0.0000388993,0.0063845553,0.00068859593],"about_ca_topic_score_codex":0.00015548342,"about_ca_topic_score_gemma":0.00017507435,"teacher_disagreement_score":0.21808347,"about_ca_system_score_codex":0.00047818603,"about_ca_system_score_gemma":0.00048099298,"threshold_uncertainty_score":0.99994814},"labels":[],"label_agreement":null},{"id":"W2090589928","doi":"10.1038/nrurol.2010.140","title":"Neuroendocrine carcinoma in a patient with Birt–Hogg–Dubé syndrome","year":2010,"lang":"en","type":"review","venue":"Nature Reviews Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Ontario Institute for Cancer Research; BC Cancer Agency","funders":"","keywords":"Medicine; Rectal examination; Biopsy; Prostate; Pathology; Prostate cancer; Cancer; Radiology; Urology; Internal medicine","score_opus":0.02445720756241315,"score_gpt":0.3081788234911382,"score_spread":0.283721615928725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090589928","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022995935,0.98773885,8.9046216e-7,0.00030219377,0.00064840075,0.006647526,0.000030452147,0.00006973459,0.0022623404],"genre_scores_gemma":[0.0025648125,0.9935389,0.0003539793,0.0012037539,0.00021234495,0.0012681306,0.00035775977,0.00021893196,0.00028136672],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944051,0.00088631024,0.0017238713,0.0015117103,0.0004905423,0.0009824506],"domain_scores_gemma":[0.9963145,0.000286431,0.00096567604,0.0019069971,0.00010942405,0.00041694517],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00031487548,0.0013666732,0.0072426093,0.0009527046,0.00005075322,0.000019343515,0.0004441654,0.0012892458,0.00024309462],"category_scores_gemma":[0.0003012397,0.0007976856,0.0011104343,0.0011713174,0.00017325244,0.000055967274,0.00019823013,0.007176456,0.0004969804],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010546275,0.00033569726,0.0004010808,0.021421207,0.00013598503,0.043741778,0.000014737217,1.4150999e-7,0.0000012105628,0.00007606721,0.00068207696,0.93308455],"study_design_scores_gemma":[0.00084443076,0.0027085312,0.00036779157,0.005016476,0.0027073459,0.13853939,8.297538e-7,7.832369e-7,0.0000018253529,0.0000056406566,0.8493513,0.00045568275],"about_ca_topic_score_codex":0.000026244823,"about_ca_topic_score_gemma":0.000062144856,"teacher_disagreement_score":0.93262887,"about_ca_system_score_codex":0.00033430735,"about_ca_system_score_gemma":0.0005979372,"threshold_uncertainty_score":0.9999084},"labels":[],"label_agreement":null},{"id":"W2090882471","doi":"10.1023/b:urol.0000020355.30870.3a","title":"Renal cell carcinoma in peritoneal dialysis patients","year":2003,"lang":"en","type":"article","venue":"International Urology and Nephrology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrology; Dialysis; Peritoneal dialysis; Incidence (geometry); Internal medicine; Complication; Population; Surgery; Carcinoma","score_opus":0.009558151060109906,"score_gpt":0.23194959887747596,"score_spread":0.22239144781736606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090882471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810441,0.0003324125,0.000017180146,0.0013807276,0.0002508052,0.00015099172,0.000005360593,0.000011031773,0.016807381],"genre_scores_gemma":[0.99682367,0.00003259232,0.00017871945,0.0024991424,0.000070727045,0.00003264586,0.000046698835,0.000010649966,0.00030513137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989812,0.00012400432,0.00023561911,0.0003111336,0.00012174863,0.0002263199],"domain_scores_gemma":[0.9995611,0.00009744762,0.000058600628,0.00012699066,0.00007084689,0.000085054606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000109531094,0.00013275185,0.00024502326,0.00024053699,0.000032657514,0.0000049791524,0.000064696615,0.00017115101,0.00041368243],"category_scores_gemma":[0.000056219298,0.00011878581,0.000060464576,0.000075415446,0.00013535704,0.000041060342,0.000035170262,0.00020229646,0.00004286154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078863796,0.00040637917,0.992619,0.000005335127,0.00006465162,0.0003469021,0.00017376912,0.000017418,0.0029781386,0.0017354641,0.0003262625,0.0005380515],"study_design_scores_gemma":[0.0039238785,0.0009901935,0.97687,0.0000011982203,0.00007637461,0.0002498176,0.000012368382,0.00013918604,0.0026317558,0.00064773514,0.01436411,0.00009340577],"about_ca_topic_score_codex":0.000057893056,"about_ca_topic_score_gemma":0.00005186155,"teacher_disagreement_score":0.01650225,"about_ca_system_score_codex":0.0000625188,"about_ca_system_score_gemma":0.000045779067,"threshold_uncertainty_score":0.48439446},"labels":[],"label_agreement":null},{"id":"W2091242168","doi":"10.3109/10408363.2013.869544","title":"Management of metastatic kidney cancer in the era of personalized medicine","year":2014,"lang":"en","type":"review","venue":"Critical Reviews in Clinical Laboratory Sciences","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Kidney cancer; Oncology; Immunotherapy; Targeted therapy; Cancer; Internal medicine; Radiation therapy; Disease; Renal cell carcinoma","score_opus":0.2757465780215628,"score_gpt":0.5443928992061732,"score_spread":0.26864632118461035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091242168","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000080079575,0.9936927,0.000011223563,0.0018871028,0.00037654972,0.0020970218,0.0000591068,0.0000049754617,0.0017912566],"genre_scores_gemma":[0.0003437164,0.99599904,0.0018299829,0.0012383405,0.00012812385,0.00039467344,0.000010836116,0.000017579516,0.00003769047],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9897186,0.0035871686,0.0044041877,0.00078398664,0.0010947647,0.00041129824],"domain_scores_gemma":[0.99114585,0.006685236,0.0008271422,0.0008236752,0.00021141773,0.0003066973],"candidate_categories":["metaresearch","sts"],"consensus_categories":[],"category_scores_codex":[0.01844929,0.00043992687,0.0058324467,0.00022036208,0.000040190916,0.0000112208845,0.0008561,0.00017990221,0.00048325484],"category_scores_gemma":[0.011687218,0.00020504676,0.0007181913,0.0024622276,0.004405021,0.00006394579,0.000102140235,0.0009532931,0.000026734468],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025099025,0.00061234145,0.000615515,0.13381964,0.000112353926,0.00021184822,0.00008688034,1.3479563e-7,3.254189e-7,0.014160509,0.0011643628,0.849191],"study_design_scores_gemma":[0.0006554309,0.00069838954,0.00039852282,0.17496929,0.002336154,0.0000083789,0.00011078582,0.000005572742,5.511945e-7,0.0003043841,0.8203507,0.00016182118],"about_ca_topic_score_codex":0.00003323201,"about_ca_topic_score_gemma":0.000011343565,"teacher_disagreement_score":0.8490292,"about_ca_system_score_codex":0.0001084845,"about_ca_system_score_gemma":0.001051372,"threshold_uncertainty_score":0.9983044},"labels":[],"label_agreement":null},{"id":"W2091658206","doi":"10.1186/1471-2407-14-707","title":"Physical activity and renal cell carcinoma among black and white Americans: a case-control study","year":2014,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; University of Illinois at Urbana-Champaign; National Institutes of Health; Wayne State University","keywords":"Surgical oncology; Medicine; Renal cell carcinoma; White (mutation); Carcinoma; Renal carcinoma; Oncology; Internal medicine; Gerontology; Biology","score_opus":0.021465132262205013,"score_gpt":0.2769921372285298,"score_spread":0.25552700496632474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091658206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997422,0.00017171088,0.00018516414,0.00008522435,0.00003203891,0.0009074695,0.000020648004,0.000029638575,0.0011461432],"genre_scores_gemma":[0.99864686,0.000008229286,0.00009523413,0.00007406353,0.00032091798,0.00013993836,9.181824e-7,0.000029692856,0.00068415893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988159,0.00014092645,0.00011543372,0.00045541377,0.00021340717,0.00025895325],"domain_scores_gemma":[0.9991852,0.00013171606,0.000088020235,0.00030520765,0.00004821537,0.00024166492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011204789,0.00022583819,0.00045805363,0.000057026675,0.00007111757,0.000027205224,0.000033296066,0.000041387186,0.00003275648],"category_scores_gemma":[0.000018041343,0.00017357917,0.00006770636,0.00010271029,0.00020565673,0.00006905456,0.000042388358,0.00016328362,0.0000051746256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047481066,0.00044403016,0.9846177,0.00009636117,0.000063077125,0.00040541386,0.0015101354,0.000026220445,0.00474438,0.0000011305887,0.00014538062,0.0074713766],"study_design_scores_gemma":[0.0050313366,0.001399623,0.983482,0.000022197186,0.0006033341,0.00014174203,0.00047585004,0.0060556536,0.0025818006,0.0000045036236,0.000033599634,0.00016834836],"about_ca_topic_score_codex":0.0034137964,"about_ca_topic_score_gemma":0.0016951804,"teacher_disagreement_score":0.007303028,"about_ca_system_score_codex":0.00011842582,"about_ca_system_score_gemma":0.00006870867,"threshold_uncertainty_score":0.7078353},"labels":[],"label_agreement":null},{"id":"W2091842565","doi":"10.3747/co.20.1596","title":"Prognostic Factors Associated with the Response to Sunitinib in Patients with Metastatic Renal Cell Carcinoma","year":2013,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Oncology; Internal medicine; Cancer research; Pathology","score_opus":0.07912047140470606,"score_gpt":0.31852293155718736,"score_spread":0.2394024601524813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091842565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99551004,0.00011136796,0.0000139316,0.00095205044,0.0001050461,0.0028937457,0.000019290532,0.000031369826,0.00036314866],"genre_scores_gemma":[0.99893844,8.265878e-7,0.00008428711,0.00013354,0.000020280144,0.00043140975,0.00015308225,0.00003599026,0.00020213521],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997821,0.00062221836,0.0002937094,0.00035751774,0.00040672123,0.000498854],"domain_scores_gemma":[0.99792176,0.0009809587,0.00017190728,0.00032793172,0.00033288097,0.00026453717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029124692,0.0002833618,0.00048201781,0.00022628614,0.00007196784,0.000020118086,0.00012877915,0.00006196162,0.00015370059],"category_scores_gemma":[0.00032515186,0.00014298604,0.000053033633,0.0004833814,0.00012918246,0.00006378897,0.00005596129,0.00036120572,0.000074682575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023622923,0.001874512,0.9912271,0.000029350054,0.000064363114,0.00007244065,0.001510814,0.000012402367,0.00020542262,0.0000023403963,0.0010745699,0.0015643765],"study_design_scores_gemma":[0.006658383,0.010536037,0.9799737,0.00009885942,0.0002897446,0.000004829227,0.0004892401,0.00001658426,0.0005374696,0.000004031222,0.0012233102,0.00016780892],"about_ca_topic_score_codex":0.00007014138,"about_ca_topic_score_gemma":0.00015555027,"teacher_disagreement_score":0.011253415,"about_ca_system_score_codex":0.00072547863,"about_ca_system_score_gemma":0.00040087916,"threshold_uncertainty_score":0.5830802},"labels":[],"label_agreement":null},{"id":"W2091856690","doi":"10.1016/s0090-4295(02)01742-9","title":"Multilocular cystic renal cell carcinoma: a series of 12 cases and review of the literature","year":2002,"lang":"en","type":"review","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Nephrectomy; Radiology; Magnetic resonance imaging; Renal cell carcinoma; Pathology; Kidney; Internal medicine","score_opus":0.03246134982603606,"score_gpt":0.2736387060888066,"score_spread":0.24117735626277054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091856690","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006371346,0.9970767,5.8321666e-7,0.00011340122,0.00009795294,0.001310733,0.00010401956,0.0000076094843,0.0006518601],"genre_scores_gemma":[0.0048663113,0.9936373,0.00008859998,0.00016082951,0.00007888445,0.000066216344,0.00008246139,0.000038230966,0.0009811411],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.998036,0.00043665682,0.0007302384,0.00036972752,0.00020829464,0.00021903483],"domain_scores_gemma":[0.99808013,0.00034869573,0.0005761367,0.0007832313,0.00012590627,0.00008589756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015608333,0.00039624792,0.0024173858,0.00012510113,0.000028374372,0.0000033690405,0.00015752851,0.0003366904,0.000104365856],"category_scores_gemma":[0.00029628433,0.00021354755,0.0005998888,0.00024735884,0.00027218423,0.00002036975,0.00012660983,0.00041776095,0.0000063863986],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010188785,0.0002804654,0.00022157363,0.8807362,0.00036971061,0.002699565,0.00024407236,2.6239937e-7,0.000033541048,0.00004622512,0.0019887097,0.113277815],"study_design_scores_gemma":[0.0005464636,0.0014387426,0.00014050142,0.060013957,0.008333847,0.012008686,0.0000035285718,0.0000011406876,0.00008111101,0.0000055690834,0.91725314,0.00017334033],"about_ca_topic_score_codex":0.00001700283,"about_ca_topic_score_gemma":0.000003279515,"teacher_disagreement_score":0.9152644,"about_ca_system_score_codex":0.000046888505,"about_ca_system_score_gemma":0.00016328465,"threshold_uncertainty_score":0.8708216},"labels":[],"label_agreement":null},{"id":"W2091891919","doi":"10.1245/s10434-012-2806-4","title":"Effect of Nodal Metastases on Cancer-specific Mortality After Cytoreductive Nephrectomy","year":2012,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Internal medicine; Disease; Cancer; Cohort; Oncology; Epidemiology; Surgery; Kidney","score_opus":0.09154576537311279,"score_gpt":0.41382624671013685,"score_spread":0.322280481337024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091891919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98279625,0.0059290957,0.000001048072,0.0010863363,0.0002723351,0.00045326393,0.00007286302,0.000014996772,0.009373796],"genre_scores_gemma":[0.9974132,0.0017521702,0.00006325376,0.00013657892,0.0003715129,0.00013559785,0.000022645649,0.000017403474,0.00008760427],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981131,0.00048323727,0.00042426828,0.00024249328,0.00034188075,0.00039500633],"domain_scores_gemma":[0.9982568,0.00080158486,0.0002092766,0.0003014933,0.00015898235,0.00027187806],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00071981206,0.00021800472,0.001029391,0.00011634515,0.00001779248,0.0000017498994,0.00006829034,0.00015004083,0.00092874875],"category_scores_gemma":[0.000025068512,0.00014342924,0.00036972226,0.00017744472,0.00030702725,0.00006977842,0.00004352366,0.00018528447,0.000034585642],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07578731,0.009631132,0.64993167,0.0009790291,0.0037582733,0.0028891102,0.0010676669,0.00003390734,0.015727952,0.0016884899,0.012947461,0.22555798],"study_design_scores_gemma":[0.0031226552,0.012112403,0.23855615,0.00009273081,0.00044768953,0.00012174641,0.000028513738,0.0000013075545,0.51564366,0.000023086057,0.22969946,0.00015061798],"about_ca_topic_score_codex":0.00018738698,"about_ca_topic_score_gemma":0.000005046915,"teacher_disagreement_score":0.4999157,"about_ca_system_score_codex":0.00010825841,"about_ca_system_score_gemma":0.000090015594,"threshold_uncertainty_score":0.99998456},"labels":[],"label_agreement":null},{"id":"W2092128102","doi":"10.1007/s13139-011-0090-z","title":"Incidental Bilateral Renal Oncocytoma in a Patient with Metastatic Carcinoma of Unknown Primary: a Pitfall on 18F-FDG PET/CT","year":2011,"lang":"en","type":"article","venue":"Nuclear Medicine and Molecular Imaging","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre; Brandon University; Brandon Regional Health Authority","funders":"","keywords":"Medicine; Renal oncocytoma; Oncocytoma; Malignancy; Radiology; Differential diagnosis; Renal cell carcinoma; Work-up; Kidney; Etiology; Renal mass; Pathology; Nephrectomy; Internal medicine","score_opus":0.017953793686424968,"score_gpt":0.23441309725127096,"score_spread":0.216459303564846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092128102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839087,0.00066266407,0.000014099988,0.0005657809,0.000036068424,0.0005143745,0.0000023585108,0.000027787511,0.014268168],"genre_scores_gemma":[0.9942687,0.000023602885,0.003258277,0.0023191425,0.000016755339,0.000014132783,0.000019559488,0.00006165792,0.000018181507],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9982334,0.000087763176,0.00042222283,0.00041861538,0.0005101076,0.0003279221],"domain_scores_gemma":[0.99916846,0.000029240246,0.00015595347,0.0003469868,0.00007640444,0.0002229383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001639672,0.00029263663,0.0006000847,0.00038949025,0.000037088506,0.0000075921666,0.00007990501,0.000007857451,0.00009137547],"category_scores_gemma":[0.000032917727,0.00019992146,0.00007750239,0.00022897856,0.0002518577,0.000075924385,0.000071755705,0.0002439456,0.0000071062964],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008458689,0.0023814118,0.18057305,0.0011574344,0.0006965604,0.55777067,0.017663527,0.0000092178525,0.20792738,0.0015269432,0.0010965536,0.020738572],"study_design_scores_gemma":[0.052067343,0.03826917,0.6596616,0.0083313715,0.00305811,0.121460974,0.008830784,0.0020499823,0.09963387,0.00060611195,0.0043157414,0.0017149764],"about_ca_topic_score_codex":0.001232031,"about_ca_topic_score_gemma":0.00002587899,"teacher_disagreement_score":0.47908852,"about_ca_system_score_codex":0.00017596636,"about_ca_system_score_gemma":0.00008920103,"threshold_uncertainty_score":0.81525606},"labels":[],"label_agreement":null},{"id":"W2092228974","doi":"10.1038/bjc.2014.244","title":"Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakeridge Health","funders":"Genentech; Eisai; GlaxoSmithKline; Pfizer; Astellas Pharma; Bristol-Myers Squibb","keywords":"Axitinib; Sorafenib; Medicine; Sunitinib; Internal medicine; Oncology; Renal cell carcinoma; Urology; Hepatocellular carcinoma","score_opus":0.025548564476173617,"score_gpt":0.3147698027311995,"score_spread":0.2892212382550259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092228974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95651513,0.04080908,0.0000942812,0.00021913314,0.0006595432,0.0008512248,0.00006377554,0.000012274905,0.00077554025],"genre_scores_gemma":[0.99454886,0.0033012882,0.00041688094,0.00018327318,0.0010614793,0.000078058096,0.000047284528,0.000047310245,0.0003155404],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99731296,0.00025449807,0.0010613675,0.000326187,0.00066361745,0.00038135692],"domain_scores_gemma":[0.9981148,0.0003666053,0.00071027345,0.00022013279,0.0002644842,0.0003237047],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000493714,0.00026616672,0.0011329302,0.00016096853,0.000070841816,0.000066194436,0.00018897817,0.00012402657,0.00066669035],"category_scores_gemma":[0.00015695863,0.00024853006,0.00048558018,0.00020849374,0.00007934106,0.00017723913,0.00001770816,0.0004607609,0.0000040630516],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.75942105,0.0011979146,0.0006453716,0.000018646595,0.00030033162,0.0012229953,0.00018413823,0.000037841008,0.043483607,5.4429677e-7,0.0027120274,0.19077553],"study_design_scores_gemma":[0.9012315,0.0039916383,0.0035698584,0.00027604194,0.0004757605,0.00013770242,0.00008460139,0.00005829041,0.08098451,0.000020392723,0.00893435,0.0002353434],"about_ca_topic_score_codex":0.0022264468,"about_ca_topic_score_gemma":0.0005957941,"teacher_disagreement_score":0.19054018,"about_ca_system_score_codex":0.00037009394,"about_ca_system_score_gemma":0.00045191302,"threshold_uncertainty_score":0.9999967},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2092298515","doi":"10.1016/j.ejso.2011.09.035","title":"Propensity-score matched comparison of complications, blood transfusions, length of stay, and in-hospital mortality between open and laparoscopic partial nephrectomy: A national series","year":2011,"lang":"en","type":"article","venue":"European Journal of Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Propensity score matching; Nephrectomy; Odds ratio; Blood transfusion; Retrospective cohort study; Surgery; Logistic regression; Complication; Cohort; Internal medicine; Kidney","score_opus":0.1476062227029171,"score_gpt":0.34706934464985123,"score_spread":0.19946312194693414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092298515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933948,0.00049326423,0.000008731461,0.00058828143,0.00004157904,0.0004863823,0.00001696119,0.0000039925753,0.0049660075],"genre_scores_gemma":[0.9975783,0.0003698783,0.0019436841,0.000016866728,0.000053067884,0.000004240097,0.000007954421,0.00001309268,0.000012922362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788517,0.000557996,0.0009877692,0.00017662688,0.00025605693,0.00013641312],"domain_scores_gemma":[0.9987359,0.00015247113,0.0005483153,0.00012251141,0.00026517757,0.00017563059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008967904,0.00013324631,0.0009646686,0.00011480332,0.000037597783,0.000008745231,0.00015361533,0.000049920534,0.000048851878],"category_scores_gemma":[0.00004079128,0.00009990395,0.00006988628,0.00011843279,0.00034471072,0.00013410143,0.00012868264,0.0002748191,0.0000010516285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014886777,0.0017962058,0.98981977,0.00007570381,0.00030211717,0.0005873308,0.0016645938,0.0000012144963,0.0012906966,0.00038573757,0.000033888602,0.0025540558],"study_design_scores_gemma":[0.0066376864,0.0062512965,0.9775194,0.0001342244,0.0003305964,0.00042080806,0.00027820808,0.0000031891261,0.005881181,0.0000899179,0.0023721883,0.00008131555],"about_ca_topic_score_codex":0.000060537743,"about_ca_topic_score_gemma":0.000023825567,"teacher_disagreement_score":0.01230039,"about_ca_system_score_codex":0.000055276134,"about_ca_system_score_gemma":0.00021052857,"threshold_uncertainty_score":0.40739647},"labels":[],"label_agreement":null},{"id":"W2092426625","doi":"10.5489/cuaj.1388","title":"Métastase pancréatique métachrone du cancer du rein : A propos d’un cas","year":2013,"lang":"fr","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.011914457348404215,"score_gpt":0.228047227884837,"score_spread":0.2161327705364328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092426625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72167397,0.014816024,0.0001240281,0.25718078,0.002709363,0.0010485289,0.0001879812,0.00003656551,0.002222753],"genre_scores_gemma":[0.9729828,0.0034850924,0.00039923177,0.0091283275,0.0059606903,0.00018662303,0.000058478363,0.000056120014,0.0077425847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99509263,0.0010615959,0.0008942753,0.00048886135,0.00076014677,0.0017025152],"domain_scores_gemma":[0.99443334,0.000356888,0.0007214873,0.00025985308,0.0010590494,0.0031693997],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012469833,0.00048452892,0.0007292448,0.00027135626,0.00068424636,0.00030977646,0.00026387765,0.0007848177,0.03347956],"category_scores_gemma":[0.0015639323,0.00039922443,0.00035203734,0.00041587747,0.00013990948,0.0003578499,0.000045143643,0.0016571969,0.0023750616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068911046,0.00030930378,0.78402805,0.000046190537,0.00082170864,0.0043540495,0.0007806903,0.0001751331,0.00047841578,0.0006367171,0.17041211,0.0378887],"study_design_scores_gemma":[0.0027351177,0.001195023,0.8738596,0.00015207194,0.0006410513,0.0022448865,0.00022745802,0.001311531,0.00026289257,0.0011755559,0.11574673,0.00044807946],"about_ca_topic_score_codex":0.08145905,"about_ca_topic_score_gemma":0.010453017,"teacher_disagreement_score":0.25130886,"about_ca_system_score_codex":0.014244885,"about_ca_system_score_gemma":0.0030398306,"threshold_uncertainty_score":0.999846},"labels":[],"label_agreement":null},{"id":"W2092616796","doi":"10.3747/co.v16i0.410","title":"The Contemporary Role of Surgery in Kidney Cancer","year":2009,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Kidney cancer; General surgery; Intensive care medicine; Nephrectomy; Surgery; Kidney; Pathology; Internal medicine","score_opus":0.16744780350066138,"score_gpt":0.4035377747072292,"score_spread":0.2360899712065678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092616796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94123363,0.041588515,0.0000011503466,0.00495292,0.0006046043,0.0003126216,0.000006295028,0.0000140393695,0.011286238],"genre_scores_gemma":[0.99804765,0.001394088,0.000009749568,0.00025557182,0.00012027618,0.000040131374,0.000017411796,0.000005461356,0.00010963461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991574,0.00009207065,0.00030976193,0.00013842949,0.00012141722,0.00018090084],"domain_scores_gemma":[0.99927586,0.00024641264,0.000114510585,0.00018714421,0.00006027972,0.0001158106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023620433,0.00008969827,0.0003456945,0.00008257422,0.000023003005,0.0000022991749,0.000058180347,0.000058356003,0.000037879745],"category_scores_gemma":[0.00012740864,0.00005641392,0.0000941421,0.00013425882,0.00007657166,0.000021243031,0.000015390975,0.00015466489,0.0000093050985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005045075,0.00076049473,0.6357829,0.000045063327,0.000030461366,0.00006499316,0.00026141462,9.247739e-7,0.0027255858,0.00024925655,0.023253316,0.33632106],"study_design_scores_gemma":[0.0013734286,0.0004697672,0.64196295,0.00022055401,0.00003874109,0.000023288028,0.00014183192,0.000049889273,0.0056219217,0.00047299554,0.34955013,0.000074534466],"about_ca_topic_score_codex":0.000077189994,"about_ca_topic_score_gemma":0.000023669925,"teacher_disagreement_score":0.33624652,"about_ca_system_score_codex":0.00024661442,"about_ca_system_score_gemma":0.0008815521,"threshold_uncertainty_score":0.23004928},"labels":[],"label_agreement":null},{"id":"W2093012990","doi":"10.1038/sj.bjc.6603025","title":"The place of VEGF inhibition in the current management of renal cell carcinoma","year":2006,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Autocrine signalling; Renal cell carcinoma; Vascular endothelial growth factor; Angiogenesis; Kidney cancer; Medicine; Cancer research; Carcinoma; Vascular endothelial growth factor A; Kidney; Oncology; VEGF receptors; Internal medicine; Pathology; Receptor","score_opus":0.033300005009721634,"score_gpt":0.32474219692272216,"score_spread":0.2914421919130005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093012990","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010221248,0.9863745,0.000006461727,0.000057490357,0.00028438953,0.00083683623,0.000054523593,0.0000015715178,0.0021629632],"genre_scores_gemma":[0.023056066,0.97620964,0.000044638942,0.000010300649,0.00032033198,0.00006184163,0.00002144644,0.000030040283,0.0002457157],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969232,0.00028748173,0.0014919263,0.00017295114,0.0008859115,0.00023853836],"domain_scores_gemma":[0.99759144,0.00014952266,0.0016931786,0.00026728204,0.00023726335,0.000061293766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008077665,0.00024646125,0.0012418489,0.0001585754,0.000048203972,0.000028533263,0.00023258489,0.00008865499,0.000022700826],"category_scores_gemma":[0.00001058608,0.00015115384,0.0007160619,0.000338639,0.000118084216,0.000046269608,0.000049305265,0.0007161462,0.000001413474],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007825916,0.0002670788,0.0000663216,0.01554802,0.00015801826,0.0017282735,0.00003919319,0.000014623989,0.0000020692269,0.000012989062,0.0051165964,0.9769686],"study_design_scores_gemma":[0.0018737031,0.00038428075,0.0060866307,0.078486994,0.0030231737,0.0025852874,0.00006555562,0.000001212824,0.0001152713,0.00003160318,0.9071928,0.00015347004],"about_ca_topic_score_codex":0.00029332223,"about_ca_topic_score_gemma":0.0002151754,"teacher_disagreement_score":0.9768151,"about_ca_system_score_codex":0.00048622242,"about_ca_system_score_gemma":0.0004954991,"threshold_uncertainty_score":0.6163875},"labels":[],"label_agreement":null},{"id":"W2093105875","doi":"10.1503/cmaj.092121","title":"Birt–Hogg–Dubé syndrome: an inherited cause of spontaneous pneumothorax","year":2011,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Canadian Institutes of Health Research","keywords":"Pneumothorax; Medicine; Birt–Hogg–Dubé syndrome; Body mass index; Pediatrics; Surgery; Internal medicine","score_opus":0.02542077692553561,"score_gpt":0.2443643539295834,"score_spread":0.2189435770040478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093105875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912976,0.00018207506,0.00001257183,0.0020829022,0.00042330116,0.00017893911,0.000024754723,0.00002427971,0.0057735913],"genre_scores_gemma":[0.99620026,0.00008244928,0.0004102008,0.0021685087,0.00027760965,0.0000048391485,0.00002451112,0.000033100016,0.0007985203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970946,0.00021734012,0.00060349505,0.00019637466,0.0013775419,0.00051066646],"domain_scores_gemma":[0.9958378,0.00007410889,0.0003067446,0.00022293888,0.0004924805,0.0030659318],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009875669,0.00017448788,0.0004331436,0.0003522585,0.00011945187,0.00002350033,0.00018485975,0.00041289852,0.0069643143],"category_scores_gemma":[0.0008118233,0.00015105821,0.00014742753,0.0003084201,0.000062002124,0.00011657811,0.000012827341,0.000756348,0.0001305176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003001368,0.0008170831,0.6825295,0.00008961308,0.0014288662,0.25357696,0.0037486355,0.0000018879061,0.0012011947,0.00036878875,0.0148025565,0.04113477],"study_design_scores_gemma":[0.0019978497,0.0014490155,0.8835474,0.00019706674,0.00027477837,0.09776256,0.0005850604,0.000083205734,0.0004525562,0.00012649475,0.013282069,0.00024191484],"about_ca_topic_score_codex":0.007459777,"about_ca_topic_score_gemma":0.021118192,"teacher_disagreement_score":0.2010179,"about_ca_system_score_codex":0.0015332055,"about_ca_system_score_gemma":0.0026522134,"threshold_uncertainty_score":0.9991496},"labels":[],"label_agreement":null},{"id":"W2093323595","doi":"10.1016/s1078-1439(03)00099-1","title":"Permanent flank bulge is a consequence of flank incision for radical nephrectomy in one half of patients","year":2004,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Flank; Medicine; Nephrectomy; Flank pain; Surgery; Incidence (geometry); Renal cell carcinoma; Kidney; Anatomy; Internal medicine","score_opus":0.043113166350554795,"score_gpt":0.3070740894506124,"score_spread":0.2639609231000576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093323595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99262285,0.00064492004,0.00007952966,0.0053432276,0.00005345716,0.00079763215,0.000046406403,0.00001280427,0.00039916448],"genre_scores_gemma":[0.9381872,0.00020804806,0.06048173,0.0008372826,0.000025323356,0.000096261814,0.00010589628,0.000008790223,0.00004950525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876463,0.000062809806,0.0004759312,0.00028728053,0.00018738395,0.00022198741],"domain_scores_gemma":[0.9990562,0.00027519738,0.00021542364,0.00017662659,0.000107361164,0.00016914491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002314982,0.00015388933,0.00049305486,0.00019779029,0.000055923723,0.000003098763,0.00007786089,0.00020779809,0.000034725363],"category_scores_gemma":[0.00021536245,0.00012667764,0.0000727009,0.00020947157,0.0008096234,0.000047695274,0.000036989793,0.00018292353,0.0000039975444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012204985,0.0020488237,0.97067773,0.00026802887,0.00009817799,0.00023793294,0.001349083,0.00010583115,0.012648345,0.009085492,0.00048933655,0.0017707173],"study_design_scores_gemma":[0.031922936,0.043714933,0.4121024,0.0009795581,0.0014328578,0.0009995026,0.00043367065,0.00072356,0.09689672,0.083007805,0.32707402,0.0007120425],"about_ca_topic_score_codex":0.0002805334,"about_ca_topic_score_gemma":0.000048538794,"teacher_disagreement_score":0.55857533,"about_ca_system_score_codex":0.00022147196,"about_ca_system_score_gemma":0.00043429746,"threshold_uncertainty_score":0.5165764},"labels":[],"label_agreement":null},{"id":"W2093356247","doi":"10.1016/j.clgc.2014.08.011","title":"Outcome of Patients With Metastatic Sarcomatoid Renal Cell Carcinoma: Results From the International Metastatic Renal Cell Carcinoma Database Consortium","year":2014,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta; Queen Elizabeth II Health Sciences Centre; Western University; Sunnybrook Health Science Centre; University of Toronto; Dalhousie University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Carcinoma; Internal medicine; Sarcomatoid carcinoma; Database; Pathology","score_opus":0.06455312898978038,"score_gpt":0.3293076878502526,"score_spread":0.2647545588604722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093356247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99127793,0.0009794733,0.00017126245,0.0009168462,0.00080293685,0.0010844873,0.0025813773,0.000039336966,0.0021463537],"genre_scores_gemma":[0.98995286,0.00006307546,0.005447974,0.0010180713,0.0006630015,0.000111283945,0.0015458252,0.000085006395,0.0011128816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99426264,0.00065499,0.0022165095,0.0010522689,0.0012547366,0.00055886334],"domain_scores_gemma":[0.99387234,0.0024378172,0.0010849955,0.0015710248,0.00053874915,0.00049507554],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010192245,0.00056132156,0.001191404,0.00013353415,0.00013775218,0.000037615217,0.0006928504,0.00010553155,0.0004197979],"category_scores_gemma":[0.00045787287,0.0003462357,0.0004898558,0.00026476354,0.0005111782,0.00016516977,0.00036877903,0.00074863475,0.000080202524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008447281,0.0024282672,0.97635764,0.0001613157,0.00042437474,0.0004948349,0.00019256951,0.00009893164,0.001365573,0.000007655027,0.008667351,0.0013541917],"study_design_scores_gemma":[0.02385223,0.002930057,0.9488514,0.00012080597,0.0019998965,0.00002138943,0.000147804,0.00053479814,0.015162383,0.000037239082,0.005891917,0.00045007016],"about_ca_topic_score_codex":0.0011544031,"about_ca_topic_score_gemma":0.00011730612,"teacher_disagreement_score":0.027506243,"about_ca_system_score_codex":0.00022934125,"about_ca_system_score_gemma":0.00047595365,"threshold_uncertainty_score":0.99989897},"labels":[],"label_agreement":null},{"id":"W2093944201","doi":"10.1053/j.seminoncol.2013.05.011","title":"Selected Toxicities of Targeted Therapies: Presentation and Management","year":2013,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Targeted therapy; Intensive care medicine; Dosing; Toxicity; Renal cell carcinoma; Disease; Radiation therapy; Intervention (counseling); Oncology; Cancer; Internal medicine; Psychiatry","score_opus":0.014273307442966442,"score_gpt":0.2872275127491344,"score_spread":0.27295420530616793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093944201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849231,0.0025009715,0.000011345756,0.00067813945,0.000046890622,0.0007197476,9.818633e-7,0.000015602518,0.011103181],"genre_scores_gemma":[0.99183285,0.0020990183,0.0043554194,0.00011824919,0.00001601074,0.00014250772,0.000017548124,0.000009068557,0.0014093171],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993666,0.000062382605,0.00019527465,0.00013936829,0.00009718056,0.00013923424],"domain_scores_gemma":[0.9996271,0.00009720542,0.000061135,0.00011212668,0.000063899155,0.000038525308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007443686,0.00008099146,0.00022469662,0.00014750128,0.00001256356,0.000003010338,0.000032847354,0.0000701648,0.00020250703],"category_scores_gemma":[0.000020471387,0.00006679927,0.00001839166,0.000171096,0.00008967054,0.00003801305,0.000029119568,0.00006352235,0.000008931899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091765966,0.0013860943,0.4182305,0.00081617263,0.00061574334,0.000481754,0.016072646,0.00002114474,0.2377288,0.0010466884,0.015710972,0.30697182],"study_design_scores_gemma":[0.0027568922,0.002483425,0.93936306,0.000152247,0.000068759284,0.00008273503,0.0048647355,0.00020744004,0.04639383,0.0008139606,0.0027088209,0.00010411448],"about_ca_topic_score_codex":0.00013942886,"about_ca_topic_score_gemma":0.00002604663,"teacher_disagreement_score":0.5211325,"about_ca_system_score_codex":0.00014434858,"about_ca_system_score_gemma":0.000030377265,"threshold_uncertainty_score":0.27239951},"labels":[],"label_agreement":null},{"id":"W2094220710","doi":"10.1007/s00428-014-1546-1","title":"Biomarkers in renal cancer","year":2014,"lang":"en","type":"article","venue":"Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Cancer; Incidence (geometry); Disease; Oncology; Internal medicine; Humanities; Philosophy","score_opus":0.03742267370185138,"score_gpt":0.3651997865154683,"score_spread":0.32777711281361693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094220710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95427155,0.0060688597,0.00083046366,0.0034394702,0.0004977365,0.0011295923,0.00003898001,0.00029294583,0.033430368],"genre_scores_gemma":[0.9887398,0.0018003212,0.004952335,0.002866552,0.00061006204,0.00023066082,0.00025212954,0.00009190984,0.00045625377],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99460834,0.0008518313,0.001106365,0.0014250566,0.0006873619,0.001321015],"domain_scores_gemma":[0.99631745,0.0012353754,0.00037754432,0.0013697145,0.00012130045,0.0005786434],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015713276,0.0007960332,0.0014739824,0.000619892,0.0001814162,0.000031266612,0.00061044545,0.00043781826,0.00024426694],"category_scores_gemma":[0.0012294688,0.0005647436,0.00043729847,0.00080785947,0.0011836751,0.00014025382,0.00035460168,0.0012644599,0.00021198169],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063433624,0.0029816052,0.22988164,0.0007878381,0.0034062094,0.0040291008,0.0023412148,0.0011830813,0.5113147,0.008202013,0.012830656,0.21669857],"study_design_scores_gemma":[0.01953263,0.0064835483,0.82466197,0.0015001904,0.0020793974,0.00020749557,0.000950779,0.007807904,0.078275695,0.0145840105,0.04179788,0.0021184986],"about_ca_topic_score_codex":0.00075971737,"about_ca_topic_score_gemma":0.00016353562,"teacher_disagreement_score":0.5947803,"about_ca_system_score_codex":0.0002345072,"about_ca_system_score_gemma":0.000446109,"threshold_uncertainty_score":0.9996804},"labels":[],"label_agreement":null},{"id":"W2094262560","doi":"10.1007/s00292-003-0657-2","title":"Muzin�ses, tubul�res und spindelzelliges Nierenkarzinom","year":2003,"lang":"de","type":"article","venue":"Der Pathologe","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital","funders":"","keywords":"Immunohistochemistry; Pathology; Renal cell carcinoma; Immunophenotyping; Fluorescence in situ hybridization; Biology; Clear cell; Papillary renal cell carcinomas; Chromosome; Cancer research; Medicine; Molecular biology; Gene; Genetics; Flow cytometry","score_opus":0.03327192700546701,"score_gpt":0.28651592591135466,"score_spread":0.25324399890588767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094262560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65336984,0.31778508,0.00024759842,0.00060089305,0.0023720518,0.0010517383,0.00010106183,0.00015440602,0.024317322],"genre_scores_gemma":[0.98416954,0.005343648,0.0019774553,0.0011612976,0.0008970615,0.00009316151,0.0001967451,0.00015466778,0.0060064094],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.995352,0.0005562102,0.0008579278,0.0012198276,0.00069952843,0.0013144847],"domain_scores_gemma":[0.9971652,0.00022389044,0.00028810895,0.0014902177,0.0001924226,0.0006401473],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00059494993,0.00086279615,0.001062689,0.00032581232,0.00026346682,0.000106283274,0.00030689305,0.0006106623,0.0012822949],"category_scores_gemma":[0.00032471874,0.00074418733,0.00044795344,0.00043469318,0.0004065795,0.00011716641,0.000118360564,0.000718689,0.0077706375],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009852033,0.007428214,0.7516521,0.0018935588,0.008010869,0.060113523,0.0077743856,0.00012819878,0.020909628,0.016424248,0.06455802,0.060122017],"study_design_scores_gemma":[0.007409038,0.0036730687,0.23860037,0.0006575927,0.008695534,0.0010356685,0.00084719865,0.000047702015,0.19032957,0.0023896443,0.54428965,0.0020249581],"about_ca_topic_score_codex":0.00012230662,"about_ca_topic_score_gemma":0.000027584583,"teacher_disagreement_score":0.51305175,"about_ca_system_score_codex":0.00040687333,"about_ca_system_score_gemma":0.00040822048,"threshold_uncertainty_score":0.9996307},"labels":[],"label_agreement":null},{"id":"W2094659848","doi":"10.1086/323744","title":"Birt-Hogg-Dubé Syndrome, a Genodermatosis Associated with Spontaneous Pneumothorax and Kidney Neoplasia, Maps to Chromosome 17p11.2","year":2001,"lang":"en","type":"article","venue":"The American Journal of Human Genetics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":376,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Center for Information Technology; National Cancer Institute; National Institutes of Health","keywords":"Genodermatosis; Birt–Hogg–Dubé syndrome; Medicine; Pneumothorax; Chromosome; Pathology; Dermatology; Genetics; Biology; Anatomy; Gene","score_opus":0.012818271129805667,"score_gpt":0.2439471146046773,"score_spread":0.23112884347487164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094659848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962892,0.0007888824,0.00005323949,0.0020003326,0.00004921125,0.0003418525,0.000016617307,0.000025622747,0.00043505567],"genre_scores_gemma":[0.9957649,0.00046090907,0.0011043233,0.0019798675,0.000107282416,0.000005894375,0.000009027572,0.00007773297,0.00049004005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979349,0.0001849054,0.00054731726,0.00023710003,0.00065120833,0.00044461028],"domain_scores_gemma":[0.9978085,0.00011384734,0.00065906404,0.00044177606,0.0002471547,0.0007296358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028931987,0.000317309,0.0008195619,0.00025967034,0.00018861597,0.000059666,0.00026608974,0.00004189315,0.000065408996],"category_scores_gemma":[0.00006214863,0.00019995985,0.00013651272,0.00049256964,0.00033615113,0.00003692327,0.00007459092,0.0003422719,0.000018468567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007483516,0.0026741044,0.4183212,0.00018488457,0.0076812296,0.17650765,0.01299527,0.0010061812,0.31348345,0.000048381982,0.00899391,0.050620243],"study_design_scores_gemma":[0.003975898,0.035311747,0.54238373,0.0007947255,0.002131244,0.40282586,0.0016162592,0.00008751342,0.0059443396,0.000119820215,0.0041311514,0.000677716],"about_ca_topic_score_codex":0.000046183948,"about_ca_topic_score_gemma":0.000030240719,"teacher_disagreement_score":0.3075391,"about_ca_system_score_codex":0.0002706048,"about_ca_system_score_gemma":0.0001875906,"threshold_uncertainty_score":0.8154126},"labels":[],"label_agreement":null},{"id":"W2094904152","doi":"10.1016/j.urology.2007.11.015","title":"The Hem-o-Lok Clip Is Safe for Laparoscopic Nephrectomy: A Multi-institutional Review","year":2008,"lang":"en","type":"review","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Nephrectomy; CLIPS; Renal artery; Renal vein; Surgery; Vein; Kidney; Urology; Internal medicine","score_opus":0.09940721734800255,"score_gpt":0.3752093835568668,"score_spread":0.2758021662088642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094904152","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000031222085,0.99116915,0.00011415341,0.0018161233,0.0006470427,0.004581614,0.000093978524,0.00005291784,0.0015218708],"genre_scores_gemma":[0.0000022085228,0.98682487,0.0007390802,0.0050641233,0.00050892157,0.0018675001,0.00046583795,0.000066311775,0.0044611273],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973854,0.00022874027,0.00089493964,0.00066860975,0.0002545924,0.00056776375],"domain_scores_gemma":[0.99761695,0.00077758695,0.00039435635,0.00088170625,0.00014087405,0.00018851244],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024285901,0.0006100509,0.0027785804,0.000112283946,0.00034632997,0.000010712612,0.00030784454,0.0004522686,0.00018267959],"category_scores_gemma":[0.00035442857,0.0003260456,0.0012745325,0.00021766279,0.00037601186,0.000023453133,0.000091672424,0.0005265788,0.00070649333],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101806116,0.0002143127,0.000019351339,0.037928127,0.000939347,0.00030067287,0.000019583935,3.6819483e-7,3.3966077e-7,0.00043592745,0.08813218,0.871908],"study_design_scores_gemma":[0.0013492019,0.000554463,0.000011234752,0.0060012043,0.0030071896,0.0021424007,4.9341355e-7,0.000011703409,0.0000015860008,0.000016278998,0.98668617,0.00021809927],"about_ca_topic_score_codex":0.000013512672,"about_ca_topic_score_gemma":0.0000129443615,"teacher_disagreement_score":0.89855397,"about_ca_system_score_codex":0.00031538337,"about_ca_system_score_gemma":0.0013956219,"threshold_uncertainty_score":0.9999192},"labels":[],"label_agreement":null},{"id":"W2094917401","doi":"10.4103/0970-1591.91443","title":"Appraisal and use of a prognostic study from the urological literature","year":2011,"lang":"en","type":"article","venue":"Indian Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Intensive care medicine; Medical physics","score_opus":0.04858872560069851,"score_gpt":0.2742243482268306,"score_spread":0.2256356226261321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094917401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967251,0.0020908487,0.000014681816,0.0007072273,0.0001394435,0.0002569499,0.000006652826,0.000003540374,0.00005556575],"genre_scores_gemma":[0.998924,0.000035627374,0.0005288465,0.0003464442,0.00014469364,0.0000032426094,0.000002005151,0.000008546202,0.000006560657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989648,0.00026785693,0.00034735387,0.000120019,0.00015950424,0.00014047806],"domain_scores_gemma":[0.99862677,0.0006830719,0.00025907412,0.00017433387,0.00013112437,0.00012562226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022531283,0.00010990648,0.00034117964,0.00008895673,0.000024811441,0.000010998638,0.0001030856,0.00010542649,0.000065923305],"category_scores_gemma":[0.0005025088,0.00005531393,0.000082422004,0.000092768765,0.00016572158,0.00006009449,0.00003781221,0.00041808755,0.0000026952926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015851378,0.00061948877,0.97804713,0.0000054295283,0.00030531592,0.0073684235,0.010569613,6.8629004e-7,0.00036054384,0.000019699313,0.000106934094,0.0010115971],"study_design_scores_gemma":[0.001631697,0.011186068,0.98130816,0.00001614691,0.00041668976,0.0046125785,0.00027385133,0.0000027631245,0.000058680012,0.00021307851,0.00024178761,0.000038498558],"about_ca_topic_score_codex":0.000024095834,"about_ca_topic_score_gemma":0.000007440313,"teacher_disagreement_score":0.010566579,"about_ca_system_score_codex":0.0000076117926,"about_ca_system_score_gemma":0.000057202233,"threshold_uncertainty_score":0.22556366},"labels":[],"label_agreement":null},{"id":"W2095316759","doi":"10.1002/cncr.22896","title":"C‐reactive protein is an informative predictor of renal cell carcinoma‐specific mortality","year":2007,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Internal medicine; Proportional hazards model; Cohort; C-reactive protein; Oncology; Stage (stratigraphy); Carcinoma; Kidney cancer; Gastroenterology; Urology; Kidney","score_opus":0.04510083821294978,"score_gpt":0.30147848711909764,"score_spread":0.25637764890614784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095316759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769328,0.00085383374,0.00017625168,0.000046388963,0.000091523,0.0009772396,0.00010783401,0.000031440977,0.02078268],"genre_scores_gemma":[0.9981824,0.000012105028,0.0003450628,0.00011998933,0.00022973148,0.00009042931,0.00004108935,0.000022628112,0.00095653685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985658,0.000025714502,0.00040253377,0.0002614706,0.00043974328,0.00030471775],"domain_scores_gemma":[0.9987714,0.000023256738,0.00022647678,0.00044972126,0.00027001702,0.00025910634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021653005,0.00019980351,0.00034359907,0.00010915884,0.00003957155,0.0000071142413,0.00009262768,0.000103340746,0.0005398174],"category_scores_gemma":[0.000008128785,0.00015847168,0.00011626819,0.00020066385,0.00013611547,0.0001950469,0.0000304049,0.00019739088,0.00002094688],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028307284,0.0010047407,0.47257426,0.00069062243,0.00036260247,0.00028266737,0.020747226,0.00001568275,0.4919956,0.0002160126,0.0030531469,0.0062266947],"study_design_scores_gemma":[0.0010789057,0.0005101521,0.42721817,0.00005209922,0.000073002986,0.000005197867,0.00044902854,0.000018868624,0.5692837,0.000025134246,0.0011960214,0.00008967572],"about_ca_topic_score_codex":0.00051690696,"about_ca_topic_score_gemma":0.000043254488,"teacher_disagreement_score":0.07728812,"about_ca_system_score_codex":0.00049726054,"about_ca_system_score_gemma":0.00025412164,"threshold_uncertainty_score":0.64622873},"labels":[],"label_agreement":null},{"id":"W2095557833","doi":"10.1016/j.carpath.2013.01.024","title":"The effects of waveform on the generation of flow dependent phospho-Smad2 and Akt species","year":2013,"lang":"en","type":"article","venue":"Cardiovascular Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Hyperplasia; Neointimal hyperplasia; Waveform; Chemistry; Medicine; Cardiology; Urology; Internal medicine; Surgery; Restenosis","score_opus":0.017314344339002936,"score_gpt":0.1991306906959753,"score_spread":0.18181634635697236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095557833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98298204,0.013890682,0.00019098172,0.00024622589,0.00024385772,0.0008998657,0.0000021580097,0.000008458227,0.001535746],"genre_scores_gemma":[0.9979767,0.0012123929,0.00019696481,0.00006695394,0.00011555665,0.00011706857,0.000007979988,0.0000142829895,0.00029208293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891174,0.00020537249,0.00020834005,0.00020011303,0.00030800203,0.00016643014],"domain_scores_gemma":[0.9987905,0.00022954687,0.0000674242,0.0007377214,0.00012970799,0.000045081306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043996228,0.00013309317,0.0004080094,0.00003648659,0.00008043393,0.000008841779,0.00007765677,0.00008126945,0.000016339616],"category_scores_gemma":[0.00020496889,0.000063577434,0.0003899392,0.00006367787,0.00022691698,0.000021214575,0.000052308973,0.000109204266,0.00001717103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019010446,0.00035486015,0.010196033,0.0007627385,0.0062235147,0.0010515193,0.0025095274,0.0003040342,0.6937201,0.0034603444,0.0023258429,0.2789014],"study_design_scores_gemma":[0.0014790298,0.0009865718,0.15714155,0.000047453203,0.000693658,0.0005143964,0.00019804502,0.0002592691,0.8375013,0.00014430826,0.00094251765,0.00009192085],"about_ca_topic_score_codex":0.000037558737,"about_ca_topic_score_gemma":0.0000033299848,"teacher_disagreement_score":0.27880946,"about_ca_system_score_codex":0.00004789303,"about_ca_system_score_gemma":0.000025197327,"threshold_uncertainty_score":0.25926125},"labels":[],"label_agreement":null},{"id":"W2096391284","doi":"10.1038/onc.2010.497","title":"Absence of the Birt–Hogg–Dubé gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility","year":2010,"lang":"en","type":"article","venue":"Oncogene","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Myrovlytis Trust; Wellcome Trust","keywords":"Biology; GLUT1; Hypoxia-inducible factors; Lactate dehydrogenase A; Warburg effect; Angiogenesis; Endocrinology; Cancer research; Gene knockdown; Internal medicine; Glucose transporter; Glycolysis; Cell culture; Biochemistry; Metabolism; Insulin; Gene; Medicine","score_opus":0.033139146945215886,"score_gpt":0.26439435250501314,"score_spread":0.23125520555979726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096391284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978269,0.00055396545,0.000011987309,0.00030011454,0.000082500956,0.00068111473,0.00027938897,0.00001785121,0.00024618112],"genre_scores_gemma":[0.99901915,0.00002951538,0.0005653327,0.00004974167,0.000059723752,0.00002336807,0.000013573463,0.000020732161,0.00021886326],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99845916,0.00010642217,0.00026451828,0.00042264024,0.00053660886,0.00021065562],"domain_scores_gemma":[0.99857193,0.00008497897,0.00023976665,0.0006842828,0.00028061683,0.00013840063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032995152,0.00020858579,0.0005260453,0.00006573587,0.00006148346,0.000006342755,0.00011902203,0.00009850893,0.00014851552],"category_scores_gemma":[0.00018392784,0.00012524065,0.00013991281,0.00034166386,0.00034451048,0.00007591652,0.00003457082,0.00024141955,0.0000019227073],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034431604,0.0005840619,0.19811884,0.000053270414,0.00022889169,0.0000062318377,0.00021092195,9.402535e-7,0.7993672,0.00002206272,0.0000058385613,0.0010574306],"study_design_scores_gemma":[0.0009853146,0.000148829,0.48662078,0.000023011287,0.00014757337,0.00003633458,0.0000055440278,0.0000135485525,0.51188684,0.000020702515,0.0000524096,0.00005911295],"about_ca_topic_score_codex":0.0008013358,"about_ca_topic_score_gemma":0.00025597762,"teacher_disagreement_score":0.28850195,"about_ca_system_score_codex":0.000048200585,"about_ca_system_score_gemma":0.00042151302,"threshold_uncertainty_score":0.51071656},"labels":[],"label_agreement":null},{"id":"W2097842049","doi":"10.1158/0008-5472.can-12-0656","title":"Multilevel Whole-Genome Analysis Reveals Candidate Biomarkers in Clear Cell Renal Cell Carcinoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Toronto; St. Michael's Hospital; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Biology; CDKN2A; Clear cell renal cell carcinoma; Comparative genomic hybridization; FHIT; DNA methylation; Cancer research; Gene; Copy-number variation; Methylation; microRNA; Genetics; Gene dosage; Cancer; Copy number analysis; Genome; Renal cell carcinoma; Gene expression; Carcinogenesis; Tumor suppressor gene; Oncology; Medicine","score_opus":0.08414714634864989,"score_gpt":0.37426265030623124,"score_spread":0.29011550395758134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097842049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815607,0.008690011,0.000019219562,0.00049041136,0.00008933693,0.000977343,0.00016483896,0.000028305518,0.007979805],"genre_scores_gemma":[0.98987025,0.0002771304,0.0003088747,0.00009622628,0.00030953618,0.0003062837,0.0001927491,0.00006920261,0.008569717],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9955764,0.0004794079,0.00051673333,0.000678824,0.0011666976,0.0015819388],"domain_scores_gemma":[0.9975972,0.00019332799,0.00010328566,0.00093292026,0.00030628796,0.0008669437],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018733448,0.00030771072,0.00066806015,0.0015932192,0.00016067634,0.00004602056,0.00030712274,0.00018906135,0.0011820359],"category_scores_gemma":[0.00005861377,0.00026242566,0.00028480875,0.0024095566,0.00022156557,0.00016510439,0.00020977788,0.0007278964,0.00042716434],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009286118,0.00043398095,0.40573093,0.00026042122,0.00036969988,0.0002885854,0.0012380591,0.000050633196,0.5878428,0.000003530852,0.0021319322,0.00072076806],"study_design_scores_gemma":[0.0032436121,0.00043828777,0.838083,0.00006251194,0.00053383375,0.000011677258,0.00053230615,0.00018483974,0.1492072,0.000009312049,0.0073685814,0.00032479054],"about_ca_topic_score_codex":0.0073743355,"about_ca_topic_score_gemma":0.0004006053,"teacher_disagreement_score":0.43863562,"about_ca_system_score_codex":0.0019013091,"about_ca_system_score_gemma":0.00045437773,"threshold_uncertainty_score":0.9999828},"labels":[],"label_agreement":null},{"id":"W2097975386","doi":"10.1111/j.1464-410x.2011.10597.x","title":"Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach","year":2011,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Propensity score matching; Hazard ratio; Urology; Cohort; Kidney cancer; Population; Stage (stratigraphy); Nephrology; Surgery; Internal medicine; Kidney; Confidence interval","score_opus":0.06834678287800576,"score_gpt":0.25433773060508347,"score_spread":0.1859909477270777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097975386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916633,0.006464025,0.0003523498,0.0001690866,0.00011762613,0.000814399,0.000011166565,0.0000022816319,0.00040580684],"genre_scores_gemma":[0.9978381,0.0005113458,0.0011553911,0.000101248916,0.00023970034,0.00006806738,0.000002208768,0.000016230684,0.000067709974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984667,0.00030076547,0.0004874412,0.00020149622,0.00024613025,0.00029750448],"domain_scores_gemma":[0.999127,0.0002390144,0.00023660217,0.00019109722,0.00009833696,0.00010795632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006849667,0.00015433847,0.00052233436,0.00007730433,0.00006709885,0.00001776851,0.00013834117,0.00009292903,0.0000419064],"category_scores_gemma":[0.00003872714,0.00009127086,0.00019586056,0.00008539796,0.00028309363,0.000057201803,0.000027738892,0.0002488276,7.1582605e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011202862,0.002879409,0.9551831,0.00011880844,0.00027878897,0.006834973,0.00336646,0.00001680558,0.0011799783,0.000053916367,0.00008233583,0.018802585],"study_design_scores_gemma":[0.006966353,0.0070662424,0.97203994,0.000021424352,0.0005191574,0.0077295676,0.00018234168,0.00009090395,0.0032143493,0.000025734927,0.0020575472,0.000086440035],"about_ca_topic_score_codex":0.0011036617,"about_ca_topic_score_gemma":0.00046547956,"teacher_disagreement_score":0.018716145,"about_ca_system_score_codex":0.00006211277,"about_ca_system_score_gemma":0.00011841254,"threshold_uncertainty_score":0.37219176},"labels":[],"label_agreement":null},{"id":"W2098121417","doi":"10.1016/j.rmed.2014.11.008","title":"Birt-Hogg-Dubé syndrome. State-of-the-art review with emphasis on pulmonary involvement","year":2014,"lang":"en","type":"review","venue":"Respiratory Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Birt–Hogg–Dubé syndrome; Folliculin; Medicine; Pneumothorax; Pathological; Pathology; Radiology; Gene; Genetics","score_opus":0.07610963758703387,"score_gpt":0.33756922272196493,"score_spread":0.26145958513493106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098121417","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001965911,0.98673904,0.000008300736,0.00057227595,0.00039653736,0.0053424556,0.00003251202,0.000082812505,0.0066294735],"genre_scores_gemma":[0.00019286697,0.99040616,0.000038367903,0.004541666,0.00035809426,0.0006528251,0.00018150518,0.00023844662,0.0033900489],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99316245,0.0008094377,0.0021744415,0.0011101685,0.0021005305,0.00064295804],"domain_scores_gemma":[0.9942595,0.00044081447,0.0015706725,0.0028578995,0.00030176158,0.0005693636],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015602602,0.0012498753,0.0061434424,0.0005590625,0.000113430455,0.000007228628,0.00061680615,0.00027862156,0.00043607745],"category_scores_gemma":[0.0002967274,0.0005986535,0.0009341318,0.0012900981,0.0005726326,0.00004668354,0.00016641917,0.00096672075,0.00041139303],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009446421,0.00034905394,0.00011741872,0.21437518,0.00072980864,0.001200982,0.000017317649,4.552456e-7,0.0000074509453,0.000021646214,0.017581588,0.76550466],"study_design_scores_gemma":[0.0008652488,0.004103042,0.00014924222,0.28734922,0.005716869,0.0008450965,0.0000042463334,3.0319674e-7,0.000027239417,0.000003490266,0.7005978,0.00033819178],"about_ca_topic_score_codex":0.000021637203,"about_ca_topic_score_gemma":0.000008274034,"teacher_disagreement_score":0.76516646,"about_ca_system_score_codex":0.0007982634,"about_ca_system_score_gemma":0.00097272976,"threshold_uncertainty_score":0.9996465},"labels":[],"label_agreement":null},{"id":"W2098563824","doi":"10.1016/j.urology.2007.06.034","title":"POD-03.06: Renal insufficiency is not a contraindication for renal cryoablation","year":2007,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Cryoablation; Contraindication; Renal function; Creatinine; Urology; Population; Cryosurgery; Kidney; Internal medicine; Surgery; Pathology; Ablation","score_opus":0.027787966536667742,"score_gpt":0.2922498539267026,"score_spread":0.26446188739003484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098563824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8939929,0.0003267582,0.08748267,0.0051146545,0.00014342934,0.0010072584,0.000021008076,0.00007769102,0.011833634],"genre_scores_gemma":[0.99320704,0.000008736953,0.0020509176,0.0034857779,0.0003040602,0.000046007044,0.0001533387,0.000019796005,0.00072430214],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99871445,0.00002618158,0.000343856,0.00033342492,0.0002054523,0.00037662295],"domain_scores_gemma":[0.99911034,0.00020652678,0.00014837476,0.00025951036,0.00014115564,0.00013409236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045773323,0.00014004573,0.00023747778,0.00021256754,0.000086326145,0.000006855202,0.00006943981,0.0001873997,0.00016441134],"category_scores_gemma":[0.00016716737,0.00012055645,0.000103743405,0.00014899793,0.000093922186,0.000041798914,0.000016340115,0.00013560733,0.00012678304],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01766222,0.004120091,0.03378957,0.00021544908,0.0007332399,0.00064804306,0.0060322867,0.00019475142,0.74766695,0.046939533,0.02382126,0.118176565],"study_design_scores_gemma":[0.013579802,0.012573356,0.621037,0.00002538731,0.0007546838,0.0008095493,0.00008380158,0.004732385,0.12946562,0.002295741,0.21418841,0.0004542521],"about_ca_topic_score_codex":0.000019148221,"about_ca_topic_score_gemma":0.00001657118,"teacher_disagreement_score":0.6182014,"about_ca_system_score_codex":0.00012070153,"about_ca_system_score_gemma":0.00010631839,"threshold_uncertainty_score":0.49161494},"labels":[],"label_agreement":null},{"id":"W2099088585","doi":"10.1200/jco.2008.20.1293","title":"Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2189,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Pfizer Canada; Genentech; GlaxoSmithKline; American Society of Clinical Oncology; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Internal medicine; Hazard ratio; Discontinuation; Alpha interferon; Adverse effect; Clinical endpoint; Gastroenterology; Log-rank test; Progression-free survival; Oncology; Urology; Proportional hazards model; Randomized controlled trial; Confidence interval; Interferon; Overall survival; Immunology","score_opus":0.10192842348918427,"score_gpt":0.387397130270231,"score_spread":0.28546870678104674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099088585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99478686,0.00009036394,0.000087343615,0.0022219243,0.00014221757,0.0005943442,0.000023705035,0.000005436068,0.0020478256],"genre_scores_gemma":[0.99158734,0.000017291608,0.0074549695,0.0005529053,0.00014251041,0.0000034243574,0.00007915462,0.000017163953,0.00014524852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99671507,0.00041149466,0.0019332273,0.00026922132,0.00037679635,0.00029416202],"domain_scores_gemma":[0.99624157,0.001256617,0.0013502339,0.00019196208,0.00057950825,0.0003801118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015287428,0.00021561373,0.0016420396,0.00018082921,0.0000273663,0.000012202513,0.00010695068,0.00013940304,0.000013939042],"category_scores_gemma":[0.00036791043,0.00012557046,0.00015326426,0.0001267949,0.00014086333,0.00011175522,0.000020543968,0.00061563606,0.000001386394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45899075,0.009434829,0.5069016,0.00007919635,0.0005341464,0.0023194288,0.00035916857,0.00011402666,0.00016084572,0.00006274344,0.0030816137,0.017961647],"study_design_scores_gemma":[0.07816819,0.12153137,0.79708445,0.00010586823,0.0005100859,0.000100508965,0.00009108274,0.00007528416,0.00019587428,0.00006147391,0.001961788,0.000114035254],"about_ca_topic_score_codex":0.000035090696,"about_ca_topic_score_gemma":0.00013249354,"teacher_disagreement_score":0.38082257,"about_ca_system_score_codex":0.0001880098,"about_ca_system_score_gemma":0.00062781706,"threshold_uncertainty_score":0.5120615},"labels":[],"label_agreement":null},{"id":"W2099265250","doi":"10.1016/j.urology.2006.04.004","title":"Radical nephrectomy with en bloc resection of liver, diaphragm, and lung for locally invasive sarcomatoid renal cell carcinoma","year":2006,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Health Sciences Centre","funders":"","keywords":"Medicine; Diaphragm (acoustics); Nephrectomy; Renal cell carcinoma; Lung; Carcinoma; Kidney; Sarcomatoid carcinoma; Surgery; Resection; Urology; Radiology; Pathology; Internal medicine","score_opus":0.00697812166298639,"score_gpt":0.21085768748622966,"score_spread":0.20387956582324326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099265250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924459,0.0032148026,0.0017109464,0.00039755466,0.000040089955,0.00078483106,0.000009411898,0.000026254067,0.0013702211],"genre_scores_gemma":[0.99682117,0.000054259603,0.0023608683,0.00015857336,0.00017156912,0.00007510246,0.000053389704,0.000028663422,0.0002763971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988406,0.000103047205,0.00025818666,0.00033872726,0.00016843165,0.00029105597],"domain_scores_gemma":[0.9990453,0.00040780203,0.00011233038,0.00022225281,0.00010211554,0.00011017882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013092642,0.00017865856,0.00037780392,0.0001675825,0.00005195961,0.000005363636,0.000059775295,0.00017185381,0.000030547035],"category_scores_gemma":[0.000036523215,0.0001379298,0.000073775984,0.00011234223,0.00023351992,0.000034869805,0.00003788063,0.00016360018,0.0000030355761],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021700617,0.0013347485,0.66536695,0.0013295283,0.00038526268,0.0023716632,0.000800822,0.00040451306,0.29540136,0.0010030163,0.00749434,0.0024072044],"study_design_scores_gemma":[0.019792892,0.022289159,0.4720471,0.000066457134,0.0012541917,0.0034606375,0.00006981466,0.003633886,0.46992895,0.0005245027,0.006519643,0.00041275867],"about_ca_topic_score_codex":0.00052839535,"about_ca_topic_score_gemma":0.00039543642,"teacher_disagreement_score":0.19331983,"about_ca_system_score_codex":0.00007607456,"about_ca_system_score_gemma":0.0001649121,"threshold_uncertainty_score":0.56246144},"labels":[],"label_agreement":null},{"id":"W2099752220","doi":"10.1200/jco.2008.21.4809","title":"Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2130,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Internal medicine; Bevacizumab; Sorafenib; Proportional hazards model; Cohort; Adverse effect; Oncology; Vascular endothelial growth factor; Cancer; Gastroenterology; Hepatocellular carcinoma; Chemotherapy; VEGF receptors","score_opus":0.07369899872305304,"score_gpt":0.3582692181119489,"score_spread":0.2845702193888959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099752220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99637306,0.000058373775,0.00011026461,0.00018266383,0.00024627356,0.002631238,0.00027997766,0.000015223856,0.000102902646],"genre_scores_gemma":[0.9968079,0.000012542322,0.00240161,0.00025228196,0.0002252831,0.000017904369,0.000186377,0.000047082947,0.000049033606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99409544,0.0010218208,0.0027867956,0.0005687625,0.0009617065,0.0005654492],"domain_scores_gemma":[0.99255526,0.0036719097,0.0019482488,0.00035121804,0.00091768027,0.00055569457],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011849839,0.00045598304,0.0024326663,0.00027943673,0.00005441655,0.000022173408,0.00021992726,0.0002224574,0.000043610828],"category_scores_gemma":[0.0027379391,0.00025334078,0.0005212167,0.00020939899,0.000079429636,0.00019044963,0.000030880914,0.00082084874,0.000003573975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.068777435,0.024179872,0.90303606,0.000019768928,0.0010702563,0.0014990382,0.00074395834,0.000025779236,0.000049848288,9.524935e-7,0.00006768166,0.00052932766],"study_design_scores_gemma":[0.13299467,0.0960781,0.7680778,0.00008645887,0.001839409,0.000004182816,0.000276701,0.00006554793,0.00024790794,0.0000108301865,0.00012787744,0.00019052096],"about_ca_topic_score_codex":0.00027085064,"about_ca_topic_score_gemma":0.00022179197,"teacher_disagreement_score":0.1349583,"about_ca_system_score_codex":0.00042965123,"about_ca_system_score_gemma":0.0007268643,"threshold_uncertainty_score":0.9999919},"labels":[],"label_agreement":null},{"id":"W2100061101","doi":"10.1093/jnci/djn386","title":"Fat, Protein, and Meat Consumption and Renal Cell Cancer Risk: A Pooled Analysis of 13 Prospective Studies","year":2008,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Consumption (sociology); Environmental health; Prospective cohort study; Medicine; Cancer; Internal medicine; Oncology; Food science; Biology; Sociology; Social science","score_opus":0.0720546138649675,"score_gpt":0.3411174918271203,"score_spread":0.2690628779621528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100061101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98053265,0.017990032,0.000023389744,0.00060232874,0.00017674855,0.00041124638,0.00007829207,0.0000037391724,0.00018158274],"genre_scores_gemma":[0.9921654,0.0066132774,0.00039427576,0.00009592956,0.0002494783,0.000037871636,0.0000017954255,0.0000072887588,0.00043471082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846196,0.00006149699,0.0004295951,0.00015887246,0.0007806284,0.00010743648],"domain_scores_gemma":[0.99777293,0.00005917455,0.0007098338,0.00008067757,0.0012942472,0.00008311197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022969753,0.00014331716,0.00049379445,0.0003006892,0.00017165815,0.000007911871,0.000070141636,0.00004829933,0.000023605391],"category_scores_gemma":[0.00017126136,0.00008536567,0.00018189702,0.00039609533,0.0003733266,0.00017462633,0.000046086174,0.00022813263,3.391024e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014862805,0.00020693176,0.92590165,0.00020746037,0.010980877,0.000056653327,0.0021354116,0.004668585,0.052408975,0.00013500391,0.000921607,0.0008905466],"study_design_scores_gemma":[0.0027313048,0.00023991731,0.9107009,0.00029316745,0.0056351414,0.00016056125,0.000057037298,0.0002060366,0.07935386,0.00021413188,0.00030952343,0.0000983697],"about_ca_topic_score_codex":0.00033374986,"about_ca_topic_score_gemma":0.00064261176,"teacher_disagreement_score":0.026944889,"about_ca_system_score_codex":0.00054751156,"about_ca_system_score_gemma":0.00041277314,"threshold_uncertainty_score":0.34811106},"labels":[],"label_agreement":null},{"id":"W2100321098","doi":"10.1515/bc.2009.013","title":"Exploring the pathogenesis of renal cell carcinoma: pathway and bioinformatics analysis of dysregulated genes and proteins","year":2008,"lang":"en","type":"article","venue":"Biological Chemistry","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Pathogenesis; Renal cell carcinoma; Gene; Bioinformatics; Pathway analysis; Computational biology; Biology; Cancer research; Medicine; Genetics; Pathology; Gene expression","score_opus":0.08229432465613351,"score_gpt":0.22343205358107313,"score_spread":0.14113772892493961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100321098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974117,0.001951531,0.000019682042,0.000025173362,0.0000049163023,0.00018399056,0.000034932385,0.000012890711,0.0003551626],"genre_scores_gemma":[0.9983281,0.0005467068,0.00096409983,0.000008357072,0.000020160627,0.0000280296,0.00004502181,0.0000051471893,0.000054391814],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99918085,0.000022590613,0.00033759684,0.00017599617,0.00014419024,0.00013875327],"domain_scores_gemma":[0.99935454,0.000076368204,0.00015302052,0.0002497624,0.0000749196,0.00009140341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010137129,0.00014490754,0.0004233672,0.000041884097,0.00005424804,0.0000026971745,0.000059920207,0.00008948287,0.000020434769],"category_scores_gemma":[0.000039260343,0.000077105826,0.00012474784,0.00029354505,0.000315148,0.0000227995,0.00007741829,0.0000689319,2.7119947e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000855256,0.00008253124,0.11647807,0.00018551252,0.00016257101,0.000030436247,0.00021246336,0.0000062158533,0.88109636,0.0000011997766,0.0000015800765,0.0016575545],"study_design_scores_gemma":[0.00027545803,0.00013342105,0.4009148,0.000009746957,0.00026742942,0.000039608924,0.00011988788,0.00018753385,0.5979848,0.0000013002829,0.000013602441,0.000052406824],"about_ca_topic_score_codex":0.000022289763,"about_ca_topic_score_gemma":4.1255262e-7,"teacher_disagreement_score":0.28443673,"about_ca_system_score_codex":0.000019493737,"about_ca_system_score_gemma":0.000032698066,"threshold_uncertainty_score":0.31442845},"labels":[],"label_agreement":null},{"id":"W2100366384","doi":"10.1186/s13046-015-0122-0","title":"Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?","year":2015,"lang":"en","type":"article","venue":"Journal of Experimental & Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Concomitant; Histology; Renal cell carcinoma; Nephrectomy; Internal medicine; Bone metastasis; Lymph node; Proportional hazards model; Oncology; Metastasis; Gastroenterology; Urology; Cancer; Kidney","score_opus":0.20343184541475529,"score_gpt":0.44810337258224836,"score_spread":0.24467152716749307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100366384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99258226,0.0050447905,0.0000019572312,0.0005613891,0.00010504174,0.0011607051,0.00003983278,0.000010367362,0.0004936651],"genre_scores_gemma":[0.9984516,0.000043906803,0.0007899282,0.0001454494,0.00017368267,0.00012072947,0.000026937572,0.00006747366,0.00018027218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932864,0.0011604453,0.0013163708,0.00046736977,0.0030492882,0.00072012586],"domain_scores_gemma":[0.9955831,0.0006024938,0.00081210176,0.0003054261,0.0017156324,0.0009812354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034997992,0.00033141635,0.0012273601,0.00044993663,0.00008627078,0.00006422234,0.00026806368,0.00010554686,0.00012374185],"category_scores_gemma":[0.0005682747,0.00019264141,0.00024942873,0.0006130716,0.0003821543,0.000280116,0.00013250098,0.0013257692,0.000012814795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021655612,0.011535293,0.9581675,0.00004570559,0.00052770396,0.0028110496,0.00055143,0.00003552148,0.0015650244,0.000003992351,0.0027582115,0.00034296955],"study_design_scores_gemma":[0.048281714,0.04600476,0.8269473,0.00097354734,0.0005024433,0.00008958147,0.003363228,0.000020404848,0.07322697,0.000022775834,0.00023637294,0.00033089917],"about_ca_topic_score_codex":0.0004866432,"about_ca_topic_score_gemma":0.00026599536,"teacher_disagreement_score":0.13122019,"about_ca_system_score_codex":0.0016246537,"about_ca_system_score_gemma":0.001488524,"threshold_uncertainty_score":0.7855689},"labels":[],"label_agreement":null},{"id":"W2100856745","doi":"10.5489/cuaj.1456","title":"Ovarian metastasis of clear cell renal cell carcinoma: A case report","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Univerzita Karlova v Praze","keywords":"Cytokeratin; Nephrectomy; Metastasis; Renal cell carcinoma; Medicine; Clear cell carcinoma; Pathology; Clear cell; Vimentin; Ovary; Clear cell renal cell carcinoma; Carcinoma; Kidney; Immunohistochemistry; Internal medicine; Cancer","score_opus":0.016277827365197454,"score_gpt":0.21950638314720008,"score_spread":0.20322855578200263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100856745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708831,0.00019890387,0.00015795353,0.003977415,0.00019395616,0.00020219016,0.000028749677,0.000016342978,0.024341423],"genre_scores_gemma":[0.99592894,0.0000072173816,0.0012529513,0.0009334363,0.00038016413,0.0000058517453,0.000027235652,0.000021935042,0.0014422666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975807,0.00036517513,0.0006976387,0.00029170918,0.0005061807,0.0005586006],"domain_scores_gemma":[0.9971807,0.00018526462,0.0006984595,0.0002784465,0.00044571972,0.001211419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001465427,0.00020419233,0.00050709693,0.00027582984,0.00022386802,0.000045895413,0.000108440996,0.00027267492,0.00072888285],"category_scores_gemma":[0.00061956974,0.00016261813,0.00032755753,0.00025379416,0.00004121494,0.000068935675,0.000016678856,0.0006155849,0.00005579493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036364546,0.00049111684,0.7640945,0.00006537622,0.00030881882,0.20338078,0.00044038796,0.00012628445,0.004925319,0.0001939684,0.022893053,0.002716793],"study_design_scores_gemma":[0.006242385,0.004441046,0.699282,0.000020026066,0.0015431291,0.19742219,0.00029873563,0.00048735426,0.013177103,0.00057915103,0.075969264,0.00053760654],"about_ca_topic_score_codex":0.004673041,"about_ca_topic_score_gemma":0.0006775571,"teacher_disagreement_score":0.064812444,"about_ca_system_score_codex":0.0011634561,"about_ca_system_score_gemma":0.0006601644,"threshold_uncertainty_score":0.7980756},"labels":[],"label_agreement":null},{"id":"W2101091806","doi":"10.3747/co.v16i0.438","title":"Review of Guidelines on the Treatment of Metastatic Renal Cell Carcinoma","year":2009,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université de Montréal; HEC Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Context (archaeology); Intensive care medicine; Relevance (law); Clinical trial; Oncology; Internal medicine","score_opus":0.2649829131212425,"score_gpt":0.4444864012609865,"score_spread":0.17950348813974398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101091806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6974266,0.287384,0.000017856337,0.006909086,0.00026387113,0.0012520701,0.000019728155,0.000012854032,0.006713927],"genre_scores_gemma":[0.9159524,0.08103969,0.0009661163,0.0013792756,0.00018099838,0.00008251427,0.0000632632,0.000015337988,0.00032040937],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99846494,0.0001695293,0.0007048747,0.00022507297,0.00024075367,0.0001948497],"domain_scores_gemma":[0.998522,0.00021413498,0.00034976675,0.0005031442,0.0003189537,0.00009202408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002444148,0.00020443379,0.00079438963,0.00008605386,0.00002398094,0.0000012409707,0.00009435652,0.00003744234,0.00021119944],"category_scores_gemma":[0.0001063715,0.00010595221,0.0003101016,0.00017559338,0.00008676752,0.000012142803,0.000010424342,0.00008511716,0.000026837022],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010779157,0.017440243,0.0047804583,0.0068304455,0.0002963122,0.0002279654,0.00080123125,0.000010801545,0.013655492,0.0013451742,0.09725972,0.85627425],"study_design_scores_gemma":[0.0067496644,0.06196034,0.025715426,0.0060548303,0.0031112176,0.00016843827,0.00013650753,0.00009824299,0.16665024,0.00036530843,0.728714,0.0002757783],"about_ca_topic_score_codex":0.000012923726,"about_ca_topic_score_gemma":0.0000017867171,"teacher_disagreement_score":0.85599846,"about_ca_system_score_codex":0.00027925053,"about_ca_system_score_gemma":0.00024062645,"threshold_uncertainty_score":0.43206057},"labels":[],"label_agreement":null},{"id":"W2101143367","doi":"10.5489/cuaj.1048","title":"Review of the efficacy and safety of radiofrequency ablation for the treatment of small renal masses","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Cryoablation; Medicine; Radiofrequency ablation; Nephrectomy; Radiology; Clinical trial; Cochrane Library; Surgery; Ablation; Randomized controlled trial; Retrospective cohort study; Kidney; Internal medicine","score_opus":0.027271517040037305,"score_gpt":0.24238767675141928,"score_spread":0.21511615971138198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101143367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91318977,0.053852465,0.00009740233,0.030046847,0.0001304555,0.0019820726,0.000053768355,0.0000035966848,0.0006436275],"genre_scores_gemma":[0.97708046,0.021486482,0.00046687562,0.0006660828,0.000100839825,0.0000279526,0.000008525823,0.0000059045765,0.00015686847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902767,0.00013276911,0.00044135915,0.00008190019,0.0001634875,0.00015278537],"domain_scores_gemma":[0.99823564,0.00059566955,0.00053869217,0.00012665034,0.00035860413,0.00014471877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003860891,0.00008571648,0.00030489793,0.00004208956,0.000093634095,0.0000068527006,0.00007079458,0.00007570518,0.00015655023],"category_scores_gemma":[0.0006265686,0.000039453458,0.00017954709,0.00011353081,0.000054361724,0.000025094707,0.000004056553,0.00008638064,8.357915e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024841714,0.00035546022,0.89039415,0.000583041,0.0010100672,0.000005406488,0.0004188496,0.00008580074,0.0024960858,0.0005562218,0.0050012367,0.09884525],"study_design_scores_gemma":[0.001520279,0.0012599481,0.96811116,0.00033039218,0.00047219434,0.000048722508,0.00001923903,0.00006691354,0.0005837958,0.00028728056,0.027258419,0.000041677427],"about_ca_topic_score_codex":0.0011468878,"about_ca_topic_score_gemma":0.00014837495,"teacher_disagreement_score":0.09880357,"about_ca_system_score_codex":0.00048557995,"about_ca_system_score_gemma":0.00027899977,"threshold_uncertainty_score":0.17337589},"labels":[],"label_agreement":null},{"id":"W2101882485","doi":"10.1016/s0242-6498(06)70680-0","title":"Au sujet d’un specimen de néphrectomie radicale : carcinome médullaire ou carcinome des tubes collecteurs","year":2006,"lang":"fr","type":"article","venue":"Annales de Pathologie","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-François d'Assise","funders":"","keywords":"Medicine; Gynecology","score_opus":0.043132404664119176,"score_gpt":0.2744970705801668,"score_spread":0.23136466591604765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101882485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8381555,0.133576,0.00030492246,0.0036358237,0.0009678599,0.00095183717,0.00018732494,0.00028576434,0.021934941],"genre_scores_gemma":[0.96574485,0.0054474236,0.0045037926,0.000612362,0.002708735,0.00018878441,0.000231257,0.00019183426,0.020370966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9926131,0.0010087028,0.0010859387,0.0013022879,0.00070195517,0.0032880234],"domain_scores_gemma":[0.9964839,0.0007559558,0.00021937018,0.0012136218,0.0003114978,0.0010156203],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013586828,0.0010654214,0.001390828,0.00047953293,0.00062836043,0.00013383526,0.0006391215,0.0008139387,0.0010743379],"category_scores_gemma":[0.000547049,0.0010249062,0.0007374639,0.00094701175,0.0018535858,0.0002271237,0.00030552267,0.00093811663,0.0012191638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005489331,0.0014062435,0.90727645,0.00061826466,0.00030242163,0.030689986,0.002277774,0.00018287807,0.017692126,0.0007524644,0.012377798,0.025874684],"study_design_scores_gemma":[0.0034516721,0.0019996287,0.92024416,0.00048634608,0.001043144,0.0050302944,0.0011217424,0.00028103127,0.047226135,0.0052960687,0.01290456,0.0009152048],"about_ca_topic_score_codex":0.0043504294,"about_ca_topic_score_gemma":0.0009206836,"teacher_disagreement_score":0.12812859,"about_ca_system_score_codex":0.00557731,"about_ca_system_score_gemma":0.0021344223,"threshold_uncertainty_score":0.9998388},"labels":[],"label_agreement":null},{"id":"W2102160395","doi":"10.1111/iju.12231","title":"Microvessel area of immature vessels is a prognostic factor in renal cell carcinoma","year":2013,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Microvessel; Medicine; Renal cell carcinoma; Nephrectomy; Pathology; Carcinoma; Metastasis; Stage (stratigraphy); Blood vessel; Immunohistochemistry; Kidney; Internal medicine; Cancer; Biology","score_opus":0.015034265644463172,"score_gpt":0.25292622588359776,"score_spread":0.2378919602391346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102160395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99368674,0.0012739507,0.000082106715,0.003398865,0.00036221422,0.00021878583,0.000016704118,0.0000035853761,0.0009570437],"genre_scores_gemma":[0.9981882,0.00004737032,0.00067287235,0.0006293031,0.0001819024,0.000007533625,0.000008763231,0.000016058228,0.00024802567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985218,0.000056469962,0.00066256244,0.00015387463,0.000415018,0.00019026209],"domain_scores_gemma":[0.99830127,0.00017002384,0.00049121527,0.00013501475,0.0007857229,0.00011672719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009601403,0.00015255564,0.00039489253,0.00044375163,0.000008091739,0.000012798995,0.00026668023,0.00013354974,0.00058517366],"category_scores_gemma":[0.000103876635,0.00011529313,0.00018159882,0.00009539828,0.00006902146,0.00012437637,0.000050402683,0.00036115362,0.00002499573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012939688,0.0008444676,0.5253287,0.000053262727,0.0002905549,0.001622714,0.0010502925,0.000033430595,0.46425924,0.000034252505,0.003300967,0.0018881449],"study_design_scores_gemma":[0.0030945546,0.0014573956,0.8848794,0.000061259445,0.000088985085,0.0020958083,0.00006687528,0.00009468639,0.1066217,0.00037579125,0.0010747164,0.000088831235],"about_ca_topic_score_codex":0.000091055954,"about_ca_topic_score_gemma":0.000004977055,"teacher_disagreement_score":0.35955068,"about_ca_system_score_codex":0.00012694582,"about_ca_system_score_gemma":0.0002042957,"threshold_uncertainty_score":0.6407241},"labels":[],"label_agreement":null},{"id":"W2102554065","doi":"10.3747/co.21.1914","title":"Metastatic Renal Cell Carcinoma without Evidence of a Primary Renal Tumour","year":2014,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Urological Association","keywords":"Medicine; Renal cell carcinoma; Sunitinib; Radiology; Biopsy; Magnetic resonance imaging; Kidney; Surgery; Pathology; Internal medicine","score_opus":0.12883963988522457,"score_gpt":0.3728412850216437,"score_spread":0.24400164513641914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102554065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98133016,0.007925432,0.0010173353,0.00047759723,0.00045915035,0.0006513447,0.0000059204685,0.000040859057,0.008092181],"genre_scores_gemma":[0.99527556,0.0001226586,0.0036637087,0.00012386874,0.00026961023,0.000078829355,0.00003547368,0.000031508633,0.000398762],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99759233,0.00040498935,0.0006327046,0.0004815644,0.00046358403,0.00042482224],"domain_scores_gemma":[0.99811214,0.0004542413,0.00038090724,0.0005156858,0.00024204857,0.00029499087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006210829,0.00028571443,0.0009662071,0.00021026652,0.000048575115,0.000007147707,0.00019695674,0.00008620818,0.00015226116],"category_scores_gemma":[0.00022444381,0.00022307807,0.00023442572,0.00021243909,0.0002231879,0.000082922044,0.00012244763,0.0003664618,0.00010505183],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041411105,0.004571268,0.28759444,0.0046296353,0.00023245755,0.00052313565,0.0014772667,0.000040641105,0.55935353,0.0004570481,0.009974534,0.12700494],"study_design_scores_gemma":[0.013970142,0.021757727,0.63267624,0.0016651546,0.0031105168,0.0012265954,0.00014804,0.0014033332,0.2663935,0.00041751756,0.056475237,0.00075600774],"about_ca_topic_score_codex":0.00003711359,"about_ca_topic_score_gemma":0.000011896559,"teacher_disagreement_score":0.3450818,"about_ca_system_score_codex":0.00053667044,"about_ca_system_score_gemma":0.00065515697,"threshold_uncertainty_score":0.9096859},"labels":[],"label_agreement":null},{"id":"W2104918865","doi":"10.1148/rg.266065010","title":"Common and Uncommon Histologic Subtypes of Renal Cell Carcinoma: Imaging Spectrum with Pathologic Correlation","year":2006,"lang":"en","type":"review","venue":"Radiographics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":335,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Chromophobe cell; Renal cell carcinoma; Pathology; Clear cell; Clear cell carcinoma; Carcinoma; Stage (stratigraphy)","score_opus":0.02236081857895064,"score_gpt":0.25885612422599347,"score_spread":0.23649530564704282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104918865","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018094366,0.97718984,0.00011622013,0.00003454626,0.000099948746,0.0010666928,0.000039791645,0.0000678941,0.0032906737],"genre_scores_gemma":[0.18934281,0.8091089,0.00065123773,0.000014027944,0.00007760988,0.000039176313,0.0005674421,0.000070836104,0.0001279123],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976444,0.00023763996,0.0007530545,0.0006120236,0.00038168093,0.00037116927],"domain_scores_gemma":[0.9980867,0.00023307063,0.0008144143,0.00065536477,0.000069164955,0.0001413108],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026440425,0.00063398795,0.0023149648,0.0009068985,0.00009525149,0.00001936247,0.00014322354,0.0003440743,0.000007915042],"category_scores_gemma":[0.000008770112,0.00042502047,0.0005471702,0.0009087346,0.00041777414,0.00005123022,0.000055147277,0.00068327214,0.000002808816],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031462507,0.00096442236,0.7432811,0.04177205,0.00042540918,0.0075231954,0.00013038647,0.00003140763,0.000016031716,0.0005037823,0.0012179858,0.20381957],"study_design_scores_gemma":[0.010089938,0.01102258,0.16775942,0.027692921,0.052163634,0.03590202,0.000132519,0.0005942084,0.00023384397,0.0010787972,0.68912053,0.004209593],"about_ca_topic_score_codex":0.00027047808,"about_ca_topic_score_gemma":0.000067920024,"teacher_disagreement_score":0.68790257,"about_ca_system_score_codex":0.00022291073,"about_ca_system_score_gemma":0.00017369198,"threshold_uncertainty_score":0.9998202},"labels":[],"label_agreement":null},{"id":"W2105562405","doi":"10.1186/2051-1426-2-2","title":"Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study","year":2014,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Pfizer; Bristol-Myers Squibb; Genentech; Amgen","keywords":"Sorafenib; Medicine; Renal cell carcinoma; Pharmacokinetics; Pharmacodynamics; Pharmacology; Internal medicine; Rash; Oncology; Immunotherapy; Toxicity; Gastroenterology; Hepatocellular carcinoma; Cancer","score_opus":0.04145423578145745,"score_gpt":0.3631940069784667,"score_spread":0.32173977119700925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105562405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800443,0.0068960204,0.008378622,0.00054217444,0.0012287911,0.0026971532,0.000036683923,0.000016457581,0.00015980586],"genre_scores_gemma":[0.99032956,0.0002530279,0.0045735934,0.00024058984,0.00035525643,0.00054727774,0.000013631356,0.00009563811,0.0035914124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978115,0.000113100396,0.00091824547,0.0003060644,0.00041086684,0.00044024616],"domain_scores_gemma":[0.9979981,0.00024341235,0.00069077266,0.0003990627,0.0004959599,0.00017270302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008886141,0.0003296704,0.0009670747,0.00025307795,0.00018905014,0.00004564543,0.00022135823,0.000059538732,0.00018796154],"category_scores_gemma":[0.00004509285,0.00023619148,0.0006592181,0.0001359467,0.000064970285,0.00011494414,0.000017327922,0.00024663168,0.0000024960884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09548707,0.0140248,0.0061722184,0.0014505133,0.0052085016,0.00015732142,0.01309434,0.00029553377,0.5437751,0.00013182842,0.013307175,0.30689558],"study_design_scores_gemma":[0.28826413,0.1012249,0.008427368,0.0006598341,0.0037452718,0.0005680901,0.0029940738,0.0021589715,0.44439736,0.0016941881,0.14491044,0.0009553862],"about_ca_topic_score_codex":0.00015597159,"about_ca_topic_score_gemma":0.00004219807,"teacher_disagreement_score":0.3059402,"about_ca_system_score_codex":0.00058700633,"about_ca_system_score_gemma":0.0004548087,"threshold_uncertainty_score":0.96316093},"labels":[],"label_agreement":null},{"id":"W2105641380","doi":"10.1200/jco.2010.34.4309","title":"Incidence and Risk of Congestive Heart Failure in Patients With Renal and Nonrenal Cell Carcinoma Treated With Sunitinib","year":2011,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary","funders":"","keywords":"Sunitinib; Medicine; Renal cell carcinoma; Internal medicine; Heart failure; Incidence (geometry); Tyrosine-kinase inhibitor; Placebo; Relative risk; Oncology; Adverse effect; Gastroenterology; Cancer; Confidence interval; Pathology","score_opus":0.09344358486587996,"score_gpt":0.38725832035002,"score_spread":0.29381473548414005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105641380","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68566245,0.31332985,0.000002123364,0.000032938788,0.000040138326,0.0006377356,0.000025865276,0.0000024123256,0.00026646373],"genre_scores_gemma":[0.33045536,0.66653097,0.0027117752,0.000039930394,0.00014152686,0.000011087103,0.000018700077,0.000042835065,0.00004782831],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948045,0.0013457112,0.0027691596,0.00041158704,0.00038452845,0.0002845176],"domain_scores_gemma":[0.99100035,0.0029064177,0.0045243516,0.0002666671,0.0007626515,0.0005395722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016863577,0.000454609,0.005920262,0.00036240174,0.000027940521,0.0000074142617,0.00013238477,0.0007093624,0.00003440392],"category_scores_gemma":[0.0006725266,0.00023783608,0.00035766358,0.00024272525,0.0007264791,0.00009941409,0.00007725716,0.0019708206,0.000002225942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068309754,0.0013442327,0.84721,0.0015235601,0.00065694103,0.0011050873,0.00007001702,2.7811532e-7,2.0186867e-7,0.0000032628557,0.00010041668,0.14115502],"study_design_scores_gemma":[0.015487269,0.07373837,0.8534077,0.007908697,0.007947365,0.0013796963,0.00004187448,9.860162e-7,0.000006944727,0.00000607066,0.039838195,0.0002368364],"about_ca_topic_score_codex":0.00020686466,"about_ca_topic_score_gemma":0.00027739178,"teacher_disagreement_score":0.35520712,"about_ca_system_score_codex":0.0001828966,"about_ca_system_score_gemma":0.0023609765,"threshold_uncertainty_score":0.96986735},"labels":[],"label_agreement":null},{"id":"W2106267463","doi":"10.3747/co.19.972","title":"Hypertension Management in Patients with Renal Cell Cancer Treated with Anti-Angiogenic Agents","year":2012,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Jewish General Hospital; BC Cancer Agency; Centre hospitalier universitaire de Québec; Robarts Clinical Trials; Health Sciences Centre; Montreal Clinical Research Institute","funders":"Daiichi Sankyo Europe; Daiichi-Sankyo; Servier; Pfizer Canada; GlaxoSmithKline; AstraZeneca","keywords":"Medicine; Renal cell carcinoma; Expert opinion; VEGF receptors; Clinical trial; Vascular endothelial growth factor; Intensive care medicine; Cancer; Bioinformatics; Internal medicine; Oncology","score_opus":0.07394685336227327,"score_gpt":0.32719437529576606,"score_spread":0.25324752193349276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106267463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994072,0.0018537047,0.0000089644955,0.00008254917,0.0002640526,0.0010898045,0.000007984805,0.00003368385,0.0025872083],"genre_scores_gemma":[0.9986458,0.00025032964,0.00028569243,0.00009958585,0.00009253934,0.00016005633,0.00015919867,0.000035150133,0.00027167052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847937,0.000077885124,0.00024250368,0.00033834897,0.0003240282,0.0005378474],"domain_scores_gemma":[0.99922985,0.000021157462,0.0001221453,0.00028839798,0.00010143032,0.00023699764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008137886,0.00025634683,0.00044550232,0.00022160578,0.00004055954,0.000004730362,0.00007000147,0.00008070335,0.0001578361],"category_scores_gemma":[0.0000024799317,0.0001595326,0.00006263743,0.0003015431,0.00006359421,0.00007594156,0.00005320616,0.00016643197,0.00006848888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010897461,0.0037800774,0.9701183,0.00008958911,0.00017437934,0.00017843726,0.0001277843,0.000015246034,0.00013551147,0.0000038667467,0.001308315,0.022978747],"study_design_scores_gemma":[0.011210582,0.001835426,0.9717859,0.00016858737,0.00069757475,0.000022593178,0.00003982324,0.000021602995,0.0012399519,6.6713807e-7,0.012795491,0.00018177734],"about_ca_topic_score_codex":0.000057412442,"about_ca_topic_score_gemma":0.000024332574,"teacher_disagreement_score":0.02279697,"about_ca_system_score_codex":0.0007605272,"about_ca_system_score_gemma":0.00006745851,"threshold_uncertainty_score":0.6505551},"labels":[],"label_agreement":null},{"id":"W2106290086","doi":"10.5489/cuaj.2074","title":"Solidifying prognosis after surgery for renal cell carcinoma","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Renal cell carcinoma; Medicine; General surgery; Oncology","score_opus":0.022650847376177976,"score_gpt":0.22081754570425677,"score_spread":0.1981666983280788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106290086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98486745,0.00031145048,0.00034335337,0.011892731,0.00030149115,0.00034140275,0.00002092311,0.000023139197,0.0018980388],"genre_scores_gemma":[0.993676,0.000012204684,0.0007165391,0.0037070748,0.0010276708,0.000090454596,0.00003085255,0.000023379942,0.0007158202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981394,0.00017384365,0.0004080351,0.00024456886,0.00033431718,0.000699835],"domain_scores_gemma":[0.99777806,0.0005105153,0.00025962142,0.000116599855,0.00033099647,0.0010041955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010297968,0.00017871003,0.00038863634,0.0002383933,0.00024603104,0.00009249332,0.00007408113,0.0002565264,0.00031417297],"category_scores_gemma":[0.0007821273,0.00014056472,0.00038305542,0.00013773955,0.000021673775,0.00007269889,0.000010303124,0.0003716229,0.0000551591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013364821,0.000055388155,0.98033005,0.000020260675,0.000049327362,0.00011505837,0.00005425878,0.000007128276,0.00021046975,0.000017311308,0.016112098,0.002895023],"study_design_scores_gemma":[0.000991618,0.00054904737,0.93338114,0.000014759033,0.0001928728,0.00019385573,0.00001685799,0.0002235968,0.00094066426,0.00029742386,0.06302845,0.00016969789],"about_ca_topic_score_codex":0.00031045088,"about_ca_topic_score_gemma":0.00023941117,"teacher_disagreement_score":0.046948873,"about_ca_system_score_codex":0.0013374425,"about_ca_system_score_gemma":0.0005278258,"threshold_uncertainty_score":0.57320625},"labels":[],"label_agreement":null},{"id":"W2107626284","doi":"10.1007/s11934-013-0383-0","title":"Trends in Surgical Management of T1 Renal Cell Carcinoma","year":2014,"lang":"en","type":"review","venue":"Current Urology Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Guideline; Nephrology; Incidence (geometry); Standard of care; Urology; Internal medicine; Surgery; General surgery; Intensive care medicine; Kidney; Pathology","score_opus":0.05755597114556986,"score_gpt":0.3500585167592189,"score_spread":0.292502545613649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107626284","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004307107,0.9725163,0.000004617271,0.000019971725,0.0010121044,0.0009000116,0.000008420626,0.000035881676,0.021195577],"genre_scores_gemma":[0.04061438,0.9561824,0.000059785863,0.0000065791032,0.0002458965,0.0002501438,0.00089071743,0.00008145897,0.0016686283],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99520683,0.00032774245,0.0022183973,0.0011449325,0.0004929884,0.0006090872],"domain_scores_gemma":[0.9968472,0.00010418015,0.0013463678,0.0013672452,0.00006754813,0.0002674233],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00062828424,0.0007197767,0.0037396366,0.0010734895,0.000025918407,0.0000062684435,0.0001753895,0.0005065456,0.0003117615],"category_scores_gemma":[0.0000107791275,0.00054772134,0.0012276195,0.0006198126,0.00017009229,0.00002288064,0.00022693597,0.00081347703,0.000041932708],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061842075,0.00073290884,0.003630064,0.024191217,0.00019881516,0.037212256,0.000016379823,0.000001354274,1.9642889e-7,0.000042345135,0.0011039628,0.93280864],"study_design_scores_gemma":[0.0009223147,0.0005769968,0.002946577,0.0029142024,0.004063608,0.0093332175,0.0000016332145,0.0000025129075,0.00000666494,0.000017581046,0.9788818,0.00033292331],"about_ca_topic_score_codex":0.000012340564,"about_ca_topic_score_gemma":0.000002161085,"teacher_disagreement_score":0.9777778,"about_ca_system_score_codex":0.00026168558,"about_ca_system_score_gemma":0.00019507426,"threshold_uncertainty_score":0.99969745},"labels":[],"label_agreement":null},{"id":"W2108950758","doi":"10.1371/journal.pone.0114264","title":"Comparative Effectiveness of Second-Line Targeted Therapies for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Real-World Observational Studies","year":2014,"lang":"en","type":"review","venue":"PLoS ONE","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Calgary; Alberta Health Services","funders":"Novartis Pharmaceuticals Corporation; Pfizer","keywords":"Medicine; Sorafenib; Oncology; Internal medicine; Axitinib; Sunitinib; Renal cell carcinoma; Everolimus; Observational study; Cabozantinib; Retrospective cohort study; Cohort study; Progression-free survival; Overall survival; Hepatocellular carcinoma","score_opus":0.4248402098844387,"score_gpt":0.4084291344750627,"score_spread":0.01641107540937603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108950758","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015440463,0.9851172,0.000029956427,0.000027482667,0.0000078938,0.012140603,0.0010576244,0.0000144458145,0.000060721024],"genre_scores_gemma":[0.011051945,0.9775912,0.0036915531,0.00004460639,0.000016440692,0.005345076,0.0013831177,0.000059063266,0.00081696705],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99409664,0.0019912715,0.002388142,0.00061051006,0.0006811676,0.00023228282],"domain_scores_gemma":[0.9883264,0.0067554084,0.00267776,0.00079120824,0.0013438661,0.000105378116],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0021264101,0.0007443423,0.0309418,0.0007143928,0.000049338014,0.000007959342,0.00017454854,0.00008424815,0.00010434216],"category_scores_gemma":[0.00034605636,0.0004341472,0.0030934184,0.0011900822,0.00017990645,0.000051471852,0.0000673644,0.00018918094,0.0000025309391],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039054812,0.00061004056,0.000010046559,0.5969486,0.40216458,0.0000029193707,0.00009447737,8.40252e-7,0.000058184025,0.000054596203,0.000011380512,0.000005257516],"study_design_scores_gemma":[0.0005937605,0.0007727472,0.00014061389,0.08121389,0.91566926,0.0000029553225,0.000028290648,0.000020731857,0.001214936,0.000028510884,0.000060336537,0.00025399143],"about_ca_topic_score_codex":0.00002766012,"about_ca_topic_score_gemma":0.00006561035,"teacher_disagreement_score":0.51573473,"about_ca_system_score_codex":0.00019526474,"about_ca_system_score_gemma":0.000217214,"threshold_uncertainty_score":0.99981105},"labels":[],"label_agreement":null},{"id":"W2108967575","doi":"10.5489/cuaj.11159","title":"Renal leiomyoma: Case report and literature review","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Differential diagnosis; Asymptomatic; Leiomyoma; Renal cell carcinoma; Flank pain; Radiology; Leiomyosarcoma; Abdominal pain; Abdominal mass; Gross hematuria; Pathology; Surgery","score_opus":0.018794086525869926,"score_gpt":0.2525808805923276,"score_spread":0.23378679406645766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108967575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8299151,0.12354305,0.000010839903,0.040318914,0.00031848226,0.00033324555,0.000019171735,0.00002328865,0.00551793],"genre_scores_gemma":[0.98593456,0.004062679,0.00036004803,0.007249798,0.0008519865,0.00000889828,0.000037539885,0.000010463066,0.0014840043],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99863696,0.00014947329,0.00033987648,0.00014345691,0.0002637768,0.00046645067],"domain_scores_gemma":[0.9978834,0.00007060962,0.00024074085,0.00012060261,0.00023536122,0.0014492921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001068579,0.00013386967,0.00029136625,0.00011025768,0.00019917342,0.00005676574,0.000033017826,0.00019308564,0.00034328442],"category_scores_gemma":[0.00089296914,0.00009346176,0.00011953549,0.00019604541,0.000019687,0.00013776687,0.000011262774,0.0005619614,0.000029706282],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018686214,0.00005103418,0.57716566,0.00007064939,0.00013678294,0.36471212,0.00012284919,1.9725815e-7,0.000046065474,0.0000836146,0.054921705,0.0026706082],"study_design_scores_gemma":[0.00035628877,0.00013202804,0.22996424,0.00017664698,0.00019711103,0.67841184,0.000011177889,0.000001874281,0.000010885083,0.000042824297,0.09061354,0.00008155198],"about_ca_topic_score_codex":0.00019332686,"about_ca_topic_score_gemma":0.000102668964,"teacher_disagreement_score":0.34720144,"about_ca_system_score_codex":0.00086108793,"about_ca_system_score_gemma":0.00021381893,"threshold_uncertainty_score":0.381126},"labels":[],"label_agreement":null},{"id":"W2109308320","doi":"10.1177/1078155214527145","title":"Does gastric acid suppression affect sunitinib efficacy in patients with advanced or metastatic renal cell cancer?","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Alberta","funders":"","keywords":"Sunitinib; Medicine; Internal medicine; Hazard ratio; Cancer; Progression-free survival; Proportional hazards model; Gastroenterology; Population; Univariate analysis; Retrospective cohort study; Tyrosine-kinase inhibitor; Oncology; Surgery; Chemotherapy; Multivariate analysis; Confidence interval","score_opus":0.03492748437011041,"score_gpt":0.38559231009288814,"score_spread":0.35066482572277774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109308320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99373484,0.00032682306,0.000101944184,0.0029724783,0.00052868406,0.0007241633,0.0000059260515,0.000012570572,0.0015925522],"genre_scores_gemma":[0.9856842,0.0005287091,0.012442801,0.0008713067,0.0002309786,0.000026637163,0.0000099856015,0.00003805992,0.000167285],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99687314,0.0011307481,0.00073163107,0.00025693348,0.00062188884,0.00038563632],"domain_scores_gemma":[0.9948831,0.002445426,0.001539307,0.0002139076,0.0005820199,0.00033621004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010875365,0.00027412619,0.0007776912,0.0003671021,0.00006915268,0.000019187286,0.00017168238,0.000053612883,0.00034380142],"category_scores_gemma":[0.001240805,0.00012983054,0.00011193752,0.00039008557,0.000073080635,0.00071629556,0.00004695703,0.00092299987,0.000013842518],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31330863,0.02759902,0.16243282,0.00061705936,0.0016079511,0.010287163,0.0016009265,0.001638624,0.10792949,0.000005726522,0.0040094014,0.36896318],"study_design_scores_gemma":[0.20386997,0.052727897,0.33055216,0.0010624775,0.006990631,0.0032558932,0.0006452219,0.00021068937,0.21834843,0.000008508068,0.18174604,0.00058207347],"about_ca_topic_score_codex":0.00003124159,"about_ca_topic_score_gemma":0.00001460338,"teacher_disagreement_score":0.3683811,"about_ca_system_score_codex":0.000641815,"about_ca_system_score_gemma":0.0008250404,"threshold_uncertainty_score":0.5294336},"labels":[],"label_agreement":null},{"id":"W2109634081","doi":"10.5152/dir.2013.13070","title":"Meta-analysis of cryoablation versus microwave ablation for small renal masses: is there a difference in outcome?","year":2013,"lang":"en","type":"review","venue":"Diagnostic and Interventional Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Cryoablation; Microwave ablation; Medicine; Chromophobe cell; Ablation; Oncocytoma; Catheter ablation; Urology; Univariate analysis; Multivariate analysis; Internal medicine; Renal cell carcinoma; Radiology; Clear cell","score_opus":0.27848247915146523,"score_gpt":0.39275703570943554,"score_spread":0.11427455655797031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109634081","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004894504,0.99027544,0.0025614402,0.00008122998,0.000106240215,0.0015754998,0.0003186432,0.0000070476367,0.00017997409],"genre_scores_gemma":[0.024963161,0.96708095,0.0021106575,0.000047362206,0.00007222643,0.0014594002,0.003061933,0.00003624438,0.0011680543],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9976388,0.0002489588,0.0012658648,0.0005000299,0.00013847048,0.00020787117],"domain_scores_gemma":[0.99414426,0.0046710838,0.0006870534,0.0002661413,0.00015457238,0.00007691154],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031423816,0.00036044174,0.00351432,0.00066385936,0.000023955035,0.000012982042,0.00010691459,0.00032544532,0.0007884596],"category_scores_gemma":[0.00067007175,0.00024578656,0.003070846,0.00029070207,0.00010289775,0.000032739317,0.00004617907,0.00018933356,0.000010339945],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065539,0.0014701433,0.03170003,0.02735779,0.62218404,0.00009721724,0.00024191661,0.000029616915,0.000014151166,0.008492941,0.0007900334,0.30696675],"study_design_scores_gemma":[0.002709968,0.002424112,0.07485588,0.0018954913,0.8762853,0.00008240759,0.000030502157,0.00035862537,0.000012694587,0.0009518022,0.039939724,0.00045347345],"about_ca_topic_score_codex":0.000094295865,"about_ca_topic_score_gemma":0.000076405966,"teacher_disagreement_score":0.30651328,"about_ca_system_score_codex":0.00016757217,"about_ca_system_score_gemma":0.00008502145,"threshold_uncertainty_score":0.99999946},"labels":[],"label_agreement":null},{"id":"W2110643529","doi":"10.1016/j.eururo.2007.11.006","title":"Neoadjuvant Sutent Induction Therapy May Effectively Down-Stage Renal Cell Carcinoma Atrial Thrombi","year":2007,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Thrombus; Sunitinib; Stage (stratigraphy); Renal cell carcinoma; Urology; Median sternotomy; Internal medicine; Surgery","score_opus":0.029572603943497824,"score_gpt":0.26359032866365856,"score_spread":0.23401772472016075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110643529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9553383,0.0014165359,0.0002626339,0.00056511717,0.00097107637,0.00085171,0.000007546075,0.00013876724,0.040448338],"genre_scores_gemma":[0.99475604,0.000060283874,0.00028143826,0.0008313081,0.0016249034,0.0000051266175,0.00004839312,0.000097726814,0.0022947842],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9971646,0.0006820732,0.00048986723,0.0006719595,0.0003354675,0.00065602746],"domain_scores_gemma":[0.998639,0.000184868,0.00021088982,0.00056913786,0.00010827735,0.00028783092],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011903081,0.0003713376,0.00047432954,0.0002530643,0.00012932105,0.000018447621,0.0001679895,0.00014100641,0.00028833057],"category_scores_gemma":[0.0000520897,0.00028929734,0.00033303647,0.00021494896,0.00017582689,0.000047458845,0.00009603334,0.00053080614,0.0007627186],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019911423,0.0015675467,0.13926227,0.000102662096,0.00060293864,0.020894693,0.0026737163,0.00025149723,0.7159943,0.00050379254,0.0046989378,0.093536235],"study_design_scores_gemma":[0.008099077,0.0076702693,0.88399017,0.000006288446,0.00017298841,0.00060635014,0.000058661368,0.000019605024,0.0642913,0.000012886211,0.034809794,0.00026260084],"about_ca_topic_score_codex":0.00012588178,"about_ca_topic_score_gemma":0.000010767199,"teacher_disagreement_score":0.7447279,"about_ca_system_score_codex":0.00019964745,"about_ca_system_score_gemma":0.00007373001,"threshold_uncertainty_score":0.9999559},"labels":[],"label_agreement":null},{"id":"W2110697333","doi":"10.1093/annonc/mdt130","title":"A prospective evaluation of VEGF-targeted treatment cessation in metastatic clear cell renal cancer","year":2013,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Oncology; Cancer; Targeted therapy; Nephrectomy; Clinical trial; Confidence interval; Surgery; Kidney","score_opus":0.15171743016833295,"score_gpt":0.4181931238162052,"score_spread":0.26647569364787227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110697333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885414,0.0015379501,0.0000058443816,0.0011915156,0.000045252862,0.0015744609,0.000009082912,0.000006829576,0.0070876344],"genre_scores_gemma":[0.99837273,0.00027526772,0.00044567487,0.00009186417,0.000026586276,0.00058230467,0.00002847438,0.000011810566,0.00016525613],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99862885,0.00025408133,0.0004074729,0.00020373966,0.00032972384,0.00017614127],"domain_scores_gemma":[0.99864525,0.000096714066,0.00029641265,0.00017287189,0.0007264072,0.0000623476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041058395,0.000121050834,0.00046692824,0.00019400452,0.00001248358,0.0000021094183,0.00003777374,0.00006840855,0.00058819],"category_scores_gemma":[0.00006689228,0.00009215296,0.00009072153,0.0002034769,0.00006471598,0.00007457021,0.000012083885,0.00006204633,0.000019488114],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039746524,0.011206005,0.2243059,0.0004601675,0.0015222388,0.00008886958,0.012870321,0.0030277318,0.3511792,0.00021953562,0.0024211255,0.38872424],"study_design_scores_gemma":[0.0070032915,0.012168796,0.5875474,0.00006429315,0.0004924467,0.0000074121967,0.0004362755,0.0026166386,0.38823575,0.0010882061,0.0002566009,0.000082885424],"about_ca_topic_score_codex":0.0030569064,"about_ca_topic_score_gemma":0.00040919994,"teacher_disagreement_score":0.38864136,"about_ca_system_score_codex":0.00049582747,"about_ca_system_score_gemma":0.000607834,"threshold_uncertainty_score":0.6440268},"labels":[],"label_agreement":null},{"id":"W2111169039","doi":"10.1016/j.urology.2011.07.700","title":"UP-01.148 E2EPF as an Ubiquitin Carrier Protein Plays a Role in the Cancer Genesis of Papillary Renal Cell Carcinoma","year":2011,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Papillary renal cell carcinomas; Cancer; Pathogenesis; Renal cell carcinoma; Kidney cancer; Cancer research; Pathology; Oncology; Internal medicine","score_opus":0.027883607289913803,"score_gpt":0.25138632663388355,"score_spread":0.22350271934396976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111169039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836907,0.002972436,0.000005971628,0.00032614122,0.00006671591,0.000898749,0.000024506908,0.000020085672,0.011994707],"genre_scores_gemma":[0.99800694,0.000032809934,0.0001392194,0.00082700624,0.00013815696,0.00035713374,0.000024187664,0.000037127105,0.00043741503],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981619,0.0003323191,0.0003757858,0.0004372903,0.0002587277,0.0004339577],"domain_scores_gemma":[0.9989066,0.00005132498,0.0001458725,0.0006773027,0.00007653587,0.00014238126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003031434,0.00023370954,0.0004222557,0.000160664,0.000046386773,0.000004355433,0.0002683889,0.0002125028,0.0008573357],"category_scores_gemma":[0.000027758171,0.00016082871,0.00011064899,0.00018667354,0.00015953749,0.000046742134,0.000069259586,0.00025750443,0.000031548112],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005835887,0.0013596069,0.47861493,0.0002897814,0.00017524687,0.0030015085,0.039425083,0.000044726607,0.4656055,0.00083814736,0.0007393242,0.004070269],"study_design_scores_gemma":[0.0032259207,0.0067106835,0.45068854,0.00002280356,0.00036027472,0.00038088704,0.0016947349,0.00015128529,0.5342132,0.0006726362,0.0016095132,0.0002695595],"about_ca_topic_score_codex":0.009480492,"about_ca_topic_score_gemma":0.0008854416,"teacher_disagreement_score":0.06860767,"about_ca_system_score_codex":0.00007835174,"about_ca_system_score_gemma":0.0002767895,"threshold_uncertainty_score":0.9971155},"labels":[],"label_agreement":null},{"id":"W2111338100","doi":"10.1016/j.urology.2007.06.262","title":"MP-05.14: Laparoscopic partial nephrectomy: what we have learned after 200 cases?","year":2007,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Nephrectomy; Urology; Surgery; General surgery; Internal medicine; Kidney","score_opus":0.03179315607680983,"score_gpt":0.29745327774315805,"score_spread":0.2656601216663482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111338100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985859,0.0062027317,0.00011245428,0.004366129,0.0008423795,0.00052242674,0.00000309092,0.00009084646,0.0020009507],"genre_scores_gemma":[0.991873,0.0003462105,0.0001838313,0.0035660455,0.0005513794,0.000085640444,0.000028929515,0.00004097707,0.0033239883],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99820006,0.00009310671,0.00033016296,0.0004710662,0.00022654486,0.00067907973],"domain_scores_gemma":[0.9988605,0.00021012827,0.00007858012,0.0004892743,0.000067184614,0.00029435288],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00022694211,0.00025472607,0.00045739912,0.00016799993,0.000054410408,0.000029497816,0.000082114355,0.00026903563,0.0015830685],"category_scores_gemma":[0.0000774715,0.00021161792,0.00013926665,0.00011170858,0.00015931102,0.000118286815,0.00006156468,0.00032463664,0.00090224796],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040467586,0.0026038813,0.6541486,0.000373569,0.0013628714,0.1304161,0.004809764,0.00016707813,0.024208423,0.0005520077,0.02487644,0.11601371],"study_design_scores_gemma":[0.015566681,0.011253387,0.12518187,0.000105476494,0.001311187,0.007302014,0.000650806,0.00033154731,0.06167357,0.00052876107,0.77527845,0.0008162829],"about_ca_topic_score_codex":0.00010403288,"about_ca_topic_score_gemma":0.00033763252,"teacher_disagreement_score":0.750402,"about_ca_system_score_codex":0.00012711233,"about_ca_system_score_gemma":0.0000930111,"threshold_uncertainty_score":0.99987566},"labels":[],"label_agreement":null},{"id":"W2111378135","doi":"10.1093/annonc/mdr362","title":"Distribution of metastatic sites in renal cell carcinoma: a population-based analysis","year":2011,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":658,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Lung; Bone metastasis; Internal medicine; Brain metastasis; Logistic regression; Oncology; Radiology; Cancer; Metastasis","score_opus":0.11916439843814368,"score_gpt":0.35111740990645196,"score_spread":0.23195301146830827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111378135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975846,0.0003285939,0.0002033388,0.00020740995,0.000014241322,0.00021133655,0.000040137587,0.000009397574,0.0014009343],"genre_scores_gemma":[0.9980221,0.000009298048,0.0013468867,0.00008091242,0.000008587885,0.000016571525,0.00047712686,0.000009117364,0.000029398303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988233,0.00014382014,0.00050935807,0.00018100732,0.00016498518,0.0001775495],"domain_scores_gemma":[0.99902743,0.00015025056,0.0003007315,0.0002427496,0.00020268025,0.00007616039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002924518,0.00010953324,0.00064323173,0.0003597495,0.000009641725,8.706048e-7,0.00005864241,0.000071559654,0.00013020958],"category_scores_gemma":[0.00007806699,0.000092195136,0.0002451697,0.00064658077,0.000060306687,0.00003092722,0.000015384734,0.00007544225,0.0000031796326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063029025,0.0014138281,0.991711,0.00011123462,0.00024733585,0.00012535456,0.00026588092,0.0001792057,0.0040480676,0.00009882306,0.00011668247,0.0010522688],"study_design_scores_gemma":[0.0012140938,0.0025227375,0.8941062,0.000010673152,0.000913935,0.0000037133734,0.000053207503,0.0004856572,0.100453116,0.00013719502,0.000043042055,0.000056404297],"about_ca_topic_score_codex":0.0028058544,"about_ca_topic_score_gemma":0.0004492739,"teacher_disagreement_score":0.097604804,"about_ca_system_score_codex":0.00008035327,"about_ca_system_score_gemma":0.00015592224,"threshold_uncertainty_score":0.42416313},"labels":[],"label_agreement":null},{"id":"W2112441848","doi":"10.1016/j.eururo.2014.03.028","title":"Next-generation Sequencing of Urologic Cancers: Next Is Now","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Medicine; Exome sequencing; DNA sequencing; Exome; Prostate cancer; Genome; Computational biology; Bioinformatics; Gene; Internal medicine; Mutation; Cancer; Genetics; Biology","score_opus":0.09248761131502344,"score_gpt":0.2618621397794102,"score_spread":0.16937452846438678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112441848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.940145,0.0006905222,0.0006832817,0.0014191319,0.00022463026,0.0001821067,0.000002203339,0.00005362608,0.056599505],"genre_scores_gemma":[0.99251544,0.00007242314,0.0007852856,0.005393611,0.00051182887,0.0000046499313,0.00002781978,0.00003504184,0.0006538869],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99858904,0.00038595908,0.00029852818,0.00033342256,0.0001428405,0.00025019472],"domain_scores_gemma":[0.99919116,0.00006463882,0.00014327599,0.0004145619,0.000082787585,0.0001035767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034848746,0.00015724507,0.00029073155,0.00009909354,0.00004414277,0.00001079781,0.0001063681,0.00005851607,0.00032219704],"category_scores_gemma":[0.000103261445,0.00012920861,0.000089539855,0.000103524646,0.00010421237,0.0000755841,0.00005271773,0.00015884051,0.00044370248],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003766541,0.000110122935,0.019604037,0.00008559163,0.00018334319,0.0004698527,0.0012758615,0.0008835847,0.9424809,0.0007059448,0.009531313,0.024292747],"study_design_scores_gemma":[0.012342457,0.030069338,0.21260256,0.00008746725,0.0018809222,0.002340577,0.0003048386,0.07113653,0.25804666,0.00059791387,0.4092246,0.0013661218],"about_ca_topic_score_codex":0.000062991356,"about_ca_topic_score_gemma":0.000021061362,"teacher_disagreement_score":0.6844343,"about_ca_system_score_codex":0.00011822099,"about_ca_system_score_gemma":0.000075359916,"threshold_uncertainty_score":0.5703046},"labels":[],"label_agreement":null},{"id":"W2113306582","doi":"10.1111/j.1464-410x.2008.08014.x","title":"Stage‐specific effect of nodal metastases on survival in patients with non‐metastatic renal cell carcinoma","year":2008,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"NODAL; Stage (stratigraphy); Renal cell carcinoma; Medicine; Oncology; Carcinoma; Internal medicine; Urology; Radiology; Biology","score_opus":0.014270575632223384,"score_gpt":0.22566585485731844,"score_spread":0.21139527922509505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113306582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99727064,0.0014606639,0.00004532255,0.000037954782,0.00015759164,0.00038686086,0.000047719914,0.000004304877,0.0005889628],"genre_scores_gemma":[0.999135,0.00012294254,0.0004603055,0.00005771651,0.00006962735,0.0000050969024,0.000027254518,0.00003503164,0.00008700763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975764,0.0004718909,0.0007215354,0.00024361457,0.0006388984,0.00034767462],"domain_scores_gemma":[0.99849474,0.0003550573,0.00050078245,0.00020713024,0.0002477258,0.00019453953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047138272,0.00023028492,0.0010218762,0.0002954044,0.00004566643,0.000007749026,0.00013660261,0.000068386245,0.00013467656],"category_scores_gemma":[0.0000772363,0.0001869868,0.000201395,0.00022721861,0.00020044905,0.000081844344,0.000027625321,0.0004869602,0.000008845918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013703072,0.0017916342,0.9448765,0.00013966709,0.00019734609,0.033166725,0.00012251364,0.00044749802,0.0009787336,0.0000030214774,0.00060081086,0.0039724642],"study_design_scores_gemma":[0.01995635,0.033046793,0.93360144,0.00009138252,0.00025521262,0.004389964,0.0000160448,0.0000075048597,0.008294321,0.0000024759795,0.00021370858,0.00012483062],"about_ca_topic_score_codex":0.00012976106,"about_ca_topic_score_gemma":0.000029124458,"teacher_disagreement_score":0.03125516,"about_ca_system_score_codex":0.000110961424,"about_ca_system_score_gemma":0.00015720897,"threshold_uncertainty_score":0.76251006},"labels":[],"label_agreement":null},{"id":"W2113322173","doi":"10.1016/s1470-2045(12)70559-4","title":"External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study","year":2013,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1029,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Health Sciences Centre; Western University; Sunnybrook Health Science Centre; University of Calgary","funders":"National Cancer Institute","keywords":"Renal cell carcinoma; Medicine; Prognostic model; Population; Oncology; Database; Internal medicine; Computer science; Overall survival; Environmental health","score_opus":0.08719604319912287,"score_gpt":0.3307886472917002,"score_spread":0.24359260409257733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113322173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913383,0.00009765066,0.004361558,0.0015579794,0.00005502073,0.001719255,0.000024050565,0.000016370377,0.0008297745],"genre_scores_gemma":[0.9946337,0.0000015452563,0.004535074,0.00034907783,0.000056525274,0.00022616546,0.000032225154,0.000018310202,0.00014737365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870086,0.00026228614,0.00031441802,0.00021530822,0.00034203322,0.00016507607],"domain_scores_gemma":[0.99883354,0.00025699296,0.00028083837,0.00043478428,0.00014179341,0.00005207891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033766386,0.00014094356,0.00041213582,0.000052889176,0.000059163747,0.000017665543,0.00018398277,0.000028119723,0.000063541265],"category_scores_gemma":[0.000033962464,0.000069300586,0.000038085367,0.000083829844,0.00009107333,0.00007715075,0.00006587522,0.00015842528,0.000005051768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006956387,0.0009995666,0.9602619,0.00006340569,0.00011689252,0.00000916437,0.00075165625,0.03161767,0.0048564756,0.00025136193,0.00013679716,0.00023948189],"study_design_scores_gemma":[0.0077984226,0.0015207804,0.5654354,0.00007328937,0.00081597874,0.000042112086,0.00043605483,0.4177311,0.005337233,0.0006617105,0.000023509872,0.00012437828],"about_ca_topic_score_codex":0.000826339,"about_ca_topic_score_gemma":0.00018434133,"teacher_disagreement_score":0.39482644,"about_ca_system_score_codex":0.00011820731,"about_ca_system_score_gemma":0.00015702083,"threshold_uncertainty_score":0.2825996},"labels":[],"label_agreement":null},{"id":"W2113518167","doi":"10.1016/j.eururo.2006.12.015","title":"Renal Cell Carcinoma with Nodal Metastases in the Absence of Distant Metastatic Disease: Prognostic Indicators of Disease-Specific Survival","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Clear cell; Oncology; Cohort; Carcinoma; Clear cell renal cell carcinoma; Disease; Kidney cancer; Stage (stratigraphy); Nephrectomy; Adjuvant therapy; Kidney; Cancer","score_opus":0.018816999113465294,"score_gpt":0.22500989613217784,"score_spread":0.20619289701871255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113518167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924125,0.003232692,0.00016301606,0.0002609883,0.00004722009,0.000694773,0.00012748035,0.000017127128,0.003044194],"genre_scores_gemma":[0.99932003,0.000019783862,0.00023423429,0.000060151877,0.000056287732,0.000023107625,0.00017161286,0.000045265304,0.00006952806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99717605,0.0009819033,0.00056005426,0.00042093592,0.00051395583,0.00034710998],"domain_scores_gemma":[0.9983995,0.00041581958,0.00030261517,0.0006405582,0.00006525202,0.00017624511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049301336,0.00026319304,0.00046865208,0.00026035687,0.00003887246,0.000008504673,0.00026342005,0.000013227869,0.000060908817],"category_scores_gemma":[0.000065294545,0.00015693906,0.00013232767,0.0004807616,0.0005138667,0.000037235048,0.00006269402,0.00019016926,0.00001757125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004219822,0.001990116,0.9763998,0.00035272026,0.00007952117,0.011279609,0.00034224827,0.00038189263,0.0028227186,0.0015722959,0.00033261953,0.00022664164],"study_design_scores_gemma":[0.0018826919,0.001400645,0.99395216,0.000030582254,0.00048569174,0.000040720228,0.00011079008,0.000022965007,0.00087073166,0.00006231256,0.0010065776,0.00013411256],"about_ca_topic_score_codex":0.000050030314,"about_ca_topic_score_gemma":0.000020027826,"teacher_disagreement_score":0.017552383,"about_ca_system_score_codex":0.000033686585,"about_ca_system_score_gemma":0.00014674784,"threshold_uncertainty_score":0.6399789},"labels":[],"label_agreement":null},{"id":"W2113562909","doi":"10.1177/1758834009352498","title":"Review: Targeted therapy for metastatic renal cell carcinoma: current treatment and future directions","year":2009,"lang":"en","type":"article","venue":"Therapeutic Advances in Medical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; BC Cancer Agency","funders":"","keywords":"Temsirolimus; Pazopanib; Medicine; Axitinib; Sorafenib; Sunitinib; Bevacizumab; Everolimus; Renal cell carcinoma; Targeted therapy; Oncology; PI3K/AKT/mTOR pathway; Adjuvant; Clinical trial; Vascular endothelial growth factor; Adjuvant therapy; Internal medicine; Pharmacology; Discovery and development of mTOR inhibitors; Cancer; VEGF receptors; Chemotherapy","score_opus":0.03495072061428077,"score_gpt":0.38143006076980135,"score_spread":0.34647934015552057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113562909","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.048249785,0.93272614,0.0004165066,0.014833281,0.00047603235,0.002073356,0.000009851354,0.000048591926,0.001166447],"genre_scores_gemma":[0.23545934,0.7554459,0.0020378649,0.0058571375,0.0005207596,0.0004963389,0.00006630509,0.000022734106,0.000093629365],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980205,0.00025240012,0.0005392663,0.00046802722,0.0002810715,0.00043869915],"domain_scores_gemma":[0.9987644,0.0003986682,0.00015240008,0.00028095688,0.00007590589,0.0003276781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039980907,0.00032137026,0.0009271504,0.00013323611,0.00008278635,0.0000044828616,0.0001051048,0.00012938406,0.0002158931],"category_scores_gemma":[0.00004022072,0.00020762667,0.00017043494,0.00025950762,0.00017574812,0.00007492522,0.000012068573,0.0002999002,0.000005924683],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075539644,0.0017648194,0.00048554176,0.0002227579,0.000047952937,0.00009312064,0.00025786672,6.9091624e-7,0.00026107492,0.00015980659,0.00024987274,0.9957011],"study_design_scores_gemma":[0.008948921,0.010303712,0.006513787,0.00022666957,0.000338051,0.00022961682,0.00008302756,0.00009129778,0.00084870344,0.0012235529,0.97100556,0.00018710464],"about_ca_topic_score_codex":0.000007846477,"about_ca_topic_score_gemma":0.000024421583,"teacher_disagreement_score":0.995514,"about_ca_system_score_codex":0.0004986499,"about_ca_system_score_gemma":0.00042599608,"threshold_uncertainty_score":0.846677},"labels":[],"label_agreement":null},{"id":"W2113833543","doi":"10.15537/1658-3175.2646","title":"Renal cell carcinoma in children. Prognostic factors","year":2004,"lang":"en","type":"article","venue":"Saudi Medical Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Radiation therapy; Surgery; Carcinoma; Kidney; Internal medicine","score_opus":0.013721649204126354,"score_gpt":0.24725612669711625,"score_spread":0.2335344774929899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113833543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99334306,0.0015865989,0.00016169462,0.0019611444,0.00023289684,0.00038305434,0.0000031122597,0.000032651904,0.0022957742],"genre_scores_gemma":[0.99816394,0.00012882125,0.00048761955,0.000412957,0.00062048266,0.000009162914,0.000024967978,0.000036194462,0.000115841896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968683,0.00008970287,0.0006121376,0.00031157103,0.0014909962,0.0006272992],"domain_scores_gemma":[0.9982227,0.00008213564,0.00014767142,0.0002336952,0.000084074156,0.0012297046],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004446618,0.00028058342,0.00046584892,0.00029296015,0.00010471904,0.00003157699,0.00021289126,0.00023096934,0.00092057505],"category_scores_gemma":[0.0004338796,0.0001916645,0.0002367536,0.0003100892,0.0001512855,0.00008754808,0.00006197148,0.0013349531,0.00010663152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001154478,0.0007254732,0.9899236,0.000031466658,0.00005372143,0.0049873157,0.0002756751,0.000028343391,0.0007577749,0.00002445385,0.00037787654,0.0026988836],"study_design_scores_gemma":[0.006772264,0.0009797085,0.97486836,0.0003128938,0.0001258837,0.008617958,0.000087676905,0.000010020804,0.0075721135,0.00034275677,0.00013360711,0.00017678067],"about_ca_topic_score_codex":0.00012279607,"about_ca_topic_score_gemma":0.00002052573,"teacher_disagreement_score":0.015055232,"about_ca_system_score_codex":0.00057423126,"about_ca_system_score_gemma":0.0011517123,"threshold_uncertainty_score":0.9999927},"labels":[],"label_agreement":null},{"id":"W2114719173","doi":"10.3747/co.v18i1.647","title":"Lymphangitic Metastasis of Recurrent Renal Cell Carcinoma to the Contralateral Lung Causing Lymphangitic Carcinomatosis and Respiratory Symptoms","year":2011,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Pleural effusion; Lung; Metastasis; Radiology; Respiratory failure; Biopsy; Kidney; Pathology; Internal medicine; Cancer","score_opus":0.10208008101297884,"score_gpt":0.3352576789714989,"score_spread":0.23317759795852006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114719173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778016,0.017913837,0.00012862246,0.00022760911,0.00091481686,0.0012544561,0.000055849825,0.00004458174,0.0016586027],"genre_scores_gemma":[0.9987708,0.00008336003,0.00032442476,0.00027295246,0.00022655074,0.00019307913,0.000027279224,0.000050282644,0.000051306637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971283,0.00037612117,0.00076468795,0.00062749814,0.00038627512,0.00071712106],"domain_scores_gemma":[0.9980936,0.00019888736,0.0002868484,0.00064797123,0.00027156976,0.0005011434],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047631568,0.00042818475,0.0009016265,0.00038778826,0.00015162754,0.000018894709,0.00018980747,0.00014838373,0.00014359866],"category_scores_gemma":[0.000070201895,0.00030293522,0.00026725102,0.00036913884,0.00029006827,0.000091814625,0.00021491865,0.00017909083,0.00002668633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023275611,0.0027683612,0.8274918,0.0017223294,0.00068761414,0.001033132,0.01620248,0.0000075295247,0.021877691,0.0006271638,0.0037373784,0.12151694],"study_design_scores_gemma":[0.009091193,0.006967023,0.8371852,0.0004980014,0.003982678,0.0010128908,0.0007791138,0.00046274893,0.12735285,0.00007614037,0.011834643,0.0007575246],"about_ca_topic_score_codex":0.00014789974,"about_ca_topic_score_gemma":0.00003942293,"teacher_disagreement_score":0.12075941,"about_ca_system_score_codex":0.0007504796,"about_ca_system_score_gemma":0.00041593332,"threshold_uncertainty_score":0.9999423},"labels":[],"label_agreement":null},{"id":"W2117924296","doi":"10.1093/annonc/mdr533","title":"Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapy","year":2011,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Queen Elizabeth II Health Sciences Centre; BC Cancer Agency; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Alberta Health Services; London Health Sciences Centre; University of Calgary","funders":"National Cancer Institute","keywords":"Medicine; Renal cell carcinoma; Vascular endothelial growth factor; Refractory (planetary science); VEGF receptors; Oncology; Internal medicine; Vascular endothelial growth factor A; Risk factor; Cancer research","score_opus":0.14149633116960145,"score_gpt":0.3444685042515667,"score_spread":0.20297217308196527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117924296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99377286,0.0027572801,0.000034878412,0.000116658,0.00036204647,0.0007338445,0.00027435142,0.000039479593,0.001908611],"genre_scores_gemma":[0.9873125,0.010722317,0.0009612306,0.0004917759,0.00022578325,0.000023789475,0.00012175316,0.00005948219,0.00008135204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99659866,0.0007297008,0.0011128997,0.00062478206,0.0003979236,0.00053605175],"domain_scores_gemma":[0.9971786,0.000618411,0.0007998865,0.0005675351,0.00037899072,0.0004565661],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007252177,0.00044914513,0.0016124167,0.00021454509,0.00007862296,0.000009651588,0.00019476602,0.00028775923,0.0003187763],"category_scores_gemma":[0.000252421,0.00032220068,0.00054610503,0.00010553749,0.00050459016,0.00012158022,0.000096877535,0.000538033,0.0000257502],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013290792,0.0033733577,0.96096134,0.00016624488,0.0007478051,0.0005871564,0.001274953,4.42806e-8,0.017812476,0.00003393293,0.0003414824,0.013372139],"study_design_scores_gemma":[0.0041196034,0.010871498,0.9007611,0.000020224494,0.00039546305,0.000048005055,0.00007405672,0.0000032905446,0.079238124,0.00007774219,0.004150982,0.00023988313],"about_ca_topic_score_codex":0.0007924158,"about_ca_topic_score_gemma":0.000009350459,"teacher_disagreement_score":0.061425645,"about_ca_system_score_codex":0.000096601696,"about_ca_system_score_gemma":0.0005000541,"threshold_uncertainty_score":0.999923},"labels":[],"label_agreement":null},{"id":"W2118036246","doi":"10.1586/era.09.51","title":"Obesity and renal cell carcinoma: epidemiology, underlying mechanisms and management considerations","year":2009,"lang":"en","type":"review","venue":"Expert Review of Anticancer Therapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Renal cell carcinoma; Obesity; Epidemiology; Incidence (geometry); Risk factor; Internal medicine; Kidney cancer; Oncology; Bioinformatics","score_opus":0.14287052290111021,"score_gpt":0.4102427606357801,"score_spread":0.2673722377346699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118036246","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004323462,0.9944577,0.00024114782,0.0008580542,0.00008464335,0.003172232,0.000012070118,0.000026244694,0.001104662],"genre_scores_gemma":[0.00019949875,0.9804296,0.015609167,0.003226464,0.000083285006,0.00022148965,0.00005451682,0.0000466509,0.00012935806],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997061,0.000484339,0.0011421449,0.0007239738,0.00024424752,0.0003442673],"domain_scores_gemma":[0.9980333,0.0004342444,0.00056654116,0.00067108736,0.000083772975,0.00021103956],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007381341,0.0005983559,0.003798499,0.00015511442,0.000114886745,0.00001219944,0.000098382996,0.00019500546,0.00014057614],"category_scores_gemma":[0.00004160262,0.00040112677,0.00049805804,0.0001656434,0.0002028601,0.000047203943,0.000065804845,0.00026871343,0.0000058475853],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017080716,0.00019733924,0.00002796182,0.093888566,0.0003796317,0.00012847714,0.000053048232,1.6918857e-8,0.000024222116,0.0028053583,0.002100415,0.90037787],"study_design_scores_gemma":[0.001355196,0.0010332201,0.0007373334,0.123891026,0.0022555161,0.0005965414,0.000022159205,0.0000018637563,0.00011579093,0.0011779607,0.8682572,0.0005561565],"about_ca_topic_score_codex":0.000045042685,"about_ca_topic_score_gemma":0.0000019333181,"teacher_disagreement_score":0.8998217,"about_ca_system_score_codex":0.00015265355,"about_ca_system_score_gemma":0.0001841077,"threshold_uncertainty_score":0.9998441},"labels":[],"label_agreement":null},{"id":"W2118365548","doi":"10.1126/scitranslmed.3010722","title":"Postsurgical adjuvant or metastatic renal cell carcinoma therapy models reveal potent antitumor activity of metronomic oral topotecan with pazopanib","year":2015,"lang":"en","type":"article","venue":"Science Translational Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Associazione Italiana per la Ricerca sul Cancro; Ontario Institute for Cancer Research; Canada Research Chairs; Israel Cancer Research Fund","keywords":"Pazopanib; Topotecan; Medicine; Renal cell carcinoma; Adjuvant; Oncology; Pharmacology; Internal medicine; Cancer research; Chemotherapy; Sunitinib","score_opus":0.11183404820332657,"score_gpt":0.3178089895061693,"score_spread":0.20597494130284275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118365548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893463,0.00084088,0.0033532574,0.0027960257,0.00014138663,0.0008734025,0.00002709563,0.000030841973,0.0025907687],"genre_scores_gemma":[0.9912821,0.000022394772,0.008080428,0.000118408134,0.00009988714,0.000025073954,0.00003050663,0.000024985986,0.00031618166],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9963422,0.00011392319,0.00050773367,0.0006137822,0.001944087,0.00047826883],"domain_scores_gemma":[0.9980677,0.00014487868,0.00021248002,0.00042355485,0.0005073338,0.0006440478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013435134,0.0003187714,0.0008235888,0.0004242257,0.00011236605,0.000013086932,0.00026150263,0.000038705108,0.00013920343],"category_scores_gemma":[0.00004745377,0.00017805125,0.00010208677,0.0009661854,0.0014351157,0.00039376624,0.000022796301,0.00023143593,0.000006157804],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051108584,0.0050987536,0.061304107,0.0005048262,0.0004942912,0.002379125,0.0075519164,0.013882196,0.7747588,0.0027097398,0.00041204787,0.07979562],"study_design_scores_gemma":[0.040567055,0.026452634,0.6194028,0.00046230824,0.0009505428,0.0016852489,0.0011708976,0.02571537,0.28096318,0.001594506,0.00021659907,0.0008188239],"about_ca_topic_score_codex":0.00063264824,"about_ca_topic_score_gemma":0.000058034657,"teacher_disagreement_score":0.55809873,"about_ca_system_score_codex":0.00028031808,"about_ca_system_score_gemma":0.002280035,"threshold_uncertainty_score":0.72607195},"labels":[],"label_agreement":null},{"id":"W2119144996","doi":"10.1016/j.eururo.2012.03.051","title":"Chronic Kidney Disease After Nephrectomy in Patients with Small Renal Masses: A Retrospective Observational Analysis","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Kidney disease; Nephrectomy; Renal cell carcinoma; Retrospective cohort study; Renal function; Internal medicine; Nephrology; Anemia; Proportional hazards model; Renal replacement therapy; Urology; Surgery; Kidney","score_opus":0.01872499190374968,"score_gpt":0.2239723813713477,"score_spread":0.20524738946759802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119144996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947085,0.00037056045,0.00015472871,0.00056869787,0.00006080792,0.00036866195,0.00003457595,0.000037154536,0.0036963073],"genre_scores_gemma":[0.99637157,0.0000039957304,0.0008484441,0.0015807254,0.00030284916,0.00004041792,0.00043273767,0.00004188427,0.00037737892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839085,0.00030726384,0.00025417196,0.00037474034,0.00024132158,0.00043162645],"domain_scores_gemma":[0.9988926,0.000038414964,0.00009827745,0.00039534213,0.00009697101,0.00047839983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020282662,0.00021087879,0.0003281351,0.0003000968,0.000030223575,0.000009981946,0.00008251883,0.000034727946,0.0005862672],"category_scores_gemma":[0.0001068182,0.00015957541,0.00012453992,0.00055753515,0.00008308162,0.000093372844,0.0000689212,0.00021433512,0.00017227771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019498394,0.00037688404,0.99632823,0.000014464222,0.00048407656,0.0003059978,0.00013830284,0.00004075053,0.000018215625,0.000035968347,0.00015669655,0.00015057491],"study_design_scores_gemma":[0.0032142915,0.00084688177,0.9847179,0.000012887645,0.0011799291,0.0000045360543,0.0000025050542,0.000039532842,0.000009987494,0.0000073026895,0.009821189,0.0001430322],"about_ca_topic_score_codex":0.00001786357,"about_ca_topic_score_gemma":0.000032488788,"teacher_disagreement_score":0.011610304,"about_ca_system_score_codex":0.00036654953,"about_ca_system_score_gemma":0.00013529845,"threshold_uncertainty_score":0.65072966},"labels":[],"label_agreement":null},{"id":"W2119729273","doi":"10.1158/1078-0432.ccr-14-3370","title":"A Phase I/II Trial of BNC105P with Everolimus in Metastatic Renal Cell Carcinoma","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Everolimus; Renal cell carcinoma; Medicine; Carcinoma; Oncology; Phases of clinical research; Internal medicine; Cancer research; Clinical trial","score_opus":0.442022090306782,"score_gpt":0.5456514551660511,"score_spread":0.10362936485926905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119729273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908056,0.0014184581,0.000009920062,0.0009548123,0.0001450447,0.0018351433,0.00002560208,0.000014180228,0.0047912076],"genre_scores_gemma":[0.99658334,0.000113125054,0.0005572197,0.00008115327,0.00036155278,0.00034504244,0.000018220357,0.000039403505,0.0019009328],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9953119,0.0008734429,0.000979932,0.0005802861,0.0016224529,0.0006319834],"domain_scores_gemma":[0.99681884,0.00084397243,0.00016140909,0.00070736976,0.00072852924,0.00073985854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00441684,0.00019889956,0.0008935294,0.00034454916,0.000050978026,0.000013018825,0.00024012748,0.00011915925,0.00018470874],"category_scores_gemma":[0.0008054581,0.00013558847,0.00018357104,0.0008379238,0.0005541145,0.00007309233,0.0001753363,0.0009859541,0.000037841346],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87397516,0.03101694,0.048496783,0.0004999949,0.00028953675,0.0036536,0.0013999336,0.000057935613,0.0029898528,0.000060699214,0.010104104,0.02745545],"study_design_scores_gemma":[0.7544896,0.19359988,0.01600685,0.00033147447,0.0003663736,0.000046529705,0.00062933087,0.00033771116,0.027754718,0.00032887096,0.0057940846,0.0003145778],"about_ca_topic_score_codex":0.0018580956,"about_ca_topic_score_gemma":0.00037512212,"teacher_disagreement_score":0.16258293,"about_ca_system_score_codex":0.00046991854,"about_ca_system_score_gemma":0.0030642657,"threshold_uncertainty_score":0.5529138},"labels":[],"label_agreement":null},{"id":"W2119967200","doi":"10.1007/s12032-011-0016-8","title":"Maximising the duration of disease control in metastatic renal cell carcinoma with targeted agents: an expert agreement","year":2011,"lang":"en","type":"review","venue":"Medical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Novartis Pharma; Sanofi; Bayer HealthCare; GlaxoSmithKline; Pfizer","keywords":"Sunitinib; Sorafenib; Temsirolimus; Everolimus; Medicine; Pazopanib; Renal cell carcinoma; Bevacizumab; Internal medicine; Oncology; Axitinib; Pharmacology; Hepatocellular carcinoma; Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway; Chemotherapy; Biology","score_opus":0.07924066159462474,"score_gpt":0.3525873089175282,"score_spread":0.2733466473229035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119967200","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041815955,0.990796,0.0003977262,0.0005891444,0.00017862054,0.0028115641,0.000025595504,0.000016571816,0.0010031523],"genre_scores_gemma":[0.08099221,0.9151758,0.00066837866,0.0011232306,0.0002799974,0.0008969482,0.0005515711,0.00008226806,0.00022957864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954949,0.0013794178,0.0013052293,0.0005456799,0.0008370303,0.0004377167],"domain_scores_gemma":[0.99740475,0.00041957013,0.0006960916,0.0006691113,0.00011311151,0.00069736945],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00093684037,0.00047404825,0.002367609,0.0002468238,0.000048119648,0.000006504695,0.00031488997,0.00028343836,0.0013849221],"category_scores_gemma":[0.00022144409,0.00023649193,0.00032498033,0.00027541415,0.0003598971,0.000048988793,0.000061018614,0.0006232242,0.000028545433],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022768502,0.004305096,0.0009006242,0.0097325565,0.0007308496,0.009713051,0.0012684991,0.0000020341624,0.000014044836,0.00007238181,0.0011924856,0.96979153],"study_design_scores_gemma":[0.011480353,0.010163708,0.0042287875,0.007249823,0.008092076,0.00053780014,0.0002687664,0.00028644828,0.000032147476,0.000030183886,0.95711195,0.00051794143],"about_ca_topic_score_codex":0.00035831245,"about_ca_topic_score_gemma":0.00027035788,"teacher_disagreement_score":0.96927357,"about_ca_system_score_codex":0.00076445873,"about_ca_system_score_gemma":0.0029152962,"threshold_uncertainty_score":0.99952793},"labels":[],"label_agreement":null},{"id":"W2120110014","doi":"10.1177/1756287212466128","title":"An evidence-based guide to the selection of sequential therapies in metastatic renal cell carcinoma","year":2012,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Temsirolimus; Medicine; Sorafenib; Sunitinib; Axitinib; Everolimus; Pazopanib; Renal cell carcinoma; Oncology; Bevacizumab; Internal medicine; Context (archaeology); Targeted therapy; Cancer; Hepatocellular carcinoma; Chemotherapy; PI3K/AKT/mTOR pathway; Discovery and development of mTOR inhibitors","score_opus":0.049168168976717844,"score_gpt":0.34903683080184256,"score_spread":0.2998686618251247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120110014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9628604,0.03027395,0.004535165,0.0011481637,0.00016460508,0.0007025966,0.0000019942552,0.00001780959,0.00029529468],"genre_scores_gemma":[0.99553365,0.00021795378,0.0025108398,0.0014312704,0.00011016596,0.00012532451,0.000005314739,0.0000233436,0.000042124964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806905,0.0005840481,0.0004246404,0.00025516524,0.00023375415,0.000433344],"domain_scores_gemma":[0.9989967,0.0003616419,0.00012902048,0.0003605739,0.00006304781,0.00008905964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072916097,0.00019128995,0.0003731456,0.0002552686,0.000033474982,0.0000044609906,0.00017040723,0.00006162214,0.00013726308],"category_scores_gemma":[0.000030865256,0.00012656706,0.000067218425,0.000419218,0.00013196954,0.00024154059,0.000018960178,0.00020519829,0.00001312518],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057562655,0.0013872919,0.693985,0.00015593282,0.000082785795,0.000051313746,0.0041276277,0.013991175,0.22733422,0.00051643763,0.000022974598,0.052588962],"study_design_scores_gemma":[0.0052186446,0.009242843,0.69799614,0.00008978654,0.0004878932,0.00016628175,0.0007707735,0.0036779754,0.26482198,0.00077313767,0.016343493,0.00041106774],"about_ca_topic_score_codex":0.00017056461,"about_ca_topic_score_gemma":0.00031057914,"teacher_disagreement_score":0.052177895,"about_ca_system_score_codex":0.00016585496,"about_ca_system_score_gemma":0.00013027566,"threshold_uncertainty_score":0.5161255},"labels":[],"label_agreement":null},{"id":"W2120346453","doi":"10.5489/cuaj.70","title":"Sunitinib, sorafenib and other systemic noncytotoxic kidney cancer therapies can and should be administered by urologists","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Sunitinib; Sorafenib; Medicine; Kidney cancer; Systemic therapy; Cancer; Internal medicine; Oncology; Pharmacology; Breast cancer; Hepatocellular carcinoma","score_opus":0.049503792148237726,"score_gpt":0.2799962458836048,"score_spread":0.23049245373536706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120346453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95162857,0.0059020454,0.0000040038403,0.040855028,0.00019689012,0.00028078133,0.00032536255,0.00002301504,0.00078430225],"genre_scores_gemma":[0.97263205,0.00049399456,0.000037876616,0.025648855,0.00038517718,0.000029671854,0.000025892832,0.000023229173,0.00072324247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826384,0.00025590486,0.00032031545,0.00020316527,0.00030809638,0.0006486814],"domain_scores_gemma":[0.99752074,0.00013176072,0.00025492758,0.000104909086,0.00011600354,0.0018716679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005904413,0.00021626927,0.0003816299,0.00012323188,0.00024655793,0.00008754981,0.0000694152,0.00032295345,0.0004097868],"category_scores_gemma":[0.000299034,0.00015870032,0.00007300924,0.000097824646,0.000085499036,0.00008111613,0.00001555695,0.00047783545,0.0000050066064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006735062,0.000039890023,0.98502845,0.000012274229,0.00020024354,0.000049310263,0.0006378177,3.0600347e-7,0.0011607389,0.00005427853,0.011790535,0.0009588027],"study_design_scores_gemma":[0.002241259,0.0006905228,0.85051185,0.000042336138,0.00029855908,0.0019149684,0.0003084625,0.000017677878,0.00033748866,0.000058158355,0.14329718,0.00028156256],"about_ca_topic_score_codex":0.0034050697,"about_ca_topic_score_gemma":0.0011338304,"teacher_disagreement_score":0.13451663,"about_ca_system_score_codex":0.00093798555,"about_ca_system_score_gemma":0.00041588614,"threshold_uncertainty_score":0.6471611},"labels":[],"label_agreement":null},{"id":"W2120679692","doi":"10.4021/wjon247w","title":"A Case of Metastatic Renal Cell Cancer Presenting as Jaundice","year":2010,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Malignancy; Jaundice; Ampulla of Vater; Renal cell carcinoma; Radiology; Ampulla; Metastasis; Cancer; Renal colic; Carcinoma; Surgery; Internal medicine; Pathology","score_opus":0.03882170348132642,"score_gpt":0.3599173379808504,"score_spread":0.321095634499524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120679692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97398853,0.00092495594,0.000019069836,0.0012821591,0.0005564189,0.00017635986,0.0000030409344,0.0000044278786,0.02304504],"genre_scores_gemma":[0.9889174,0.00005993122,0.006955756,0.00019879219,0.00037390096,0.0000063378884,8.97189e-7,0.000018008852,0.0034689596],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9986089,0.00011936887,0.0006653993,0.00012292752,0.00025229366,0.00023109544],"domain_scores_gemma":[0.9980298,0.0003482516,0.0008574501,0.00018440948,0.00033681656,0.00024322135],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005329103,0.00012932782,0.0005990568,0.00036876928,0.000042317024,0.000006324502,0.00010124081,0.00005346509,0.0011580208],"category_scores_gemma":[0.00013218155,0.00009424331,0.00021148058,0.00023823559,0.00012169057,0.000067186906,0.000040308532,0.0006549518,0.000013729861],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00204642,0.0023143196,0.032776866,0.00040228365,0.0011894965,0.23640408,0.0023382604,0.00011344987,0.6616467,0.0003735959,0.008441793,0.051952712],"study_design_scores_gemma":[0.01567759,0.008894711,0.019804038,0.00030927738,0.005099815,0.41562644,0.0009374296,0.00019524293,0.3890023,0.00085327803,0.1432368,0.00036307203],"about_ca_topic_score_codex":0.0003904969,"about_ca_topic_score_gemma":0.001250073,"teacher_disagreement_score":0.27264443,"about_ca_system_score_codex":0.00015885888,"about_ca_system_score_gemma":0.000776017,"threshold_uncertainty_score":0.9997551},"labels":[],"label_agreement":null},{"id":"W2121201545","doi":"10.1373/clinchem.2014.225854","title":"Integrative Bioinformatics Analysis Reveals New Prognostic Biomarkers of Clear Cell Renal Cell Carcinoma","year":2014,"lang":"en","type":"article","venue":"Clinical Chemistry","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Kidney Foundation of Canada; Prostate Cancer Canada","keywords":"Gene knockdown; Clear cell renal cell carcinoma; Biology; Hazard ratio; Gene silencing; Proportional hazards model; Cancer; Renal cell carcinoma; Cancer research; Internal medicine; Oncology; Disease; Small interfering RNA; Aryl hydrocarbon receptor; microRNA; Cell growth; Gene; Medicine; RNA; Transcription factor; Genetics","score_opus":0.02893993624048449,"score_gpt":0.30465262155017414,"score_spread":0.2757126853096897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121201545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9556962,0.0002291004,0.00085045636,0.00018089042,0.00005093362,0.00029532626,0.000017500091,0.00004112312,0.042638473],"genre_scores_gemma":[0.985706,0.000026834912,0.008426086,0.0001320975,0.00021277653,0.000008513741,0.00016129746,0.000027097598,0.0052993307],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99729663,0.00009350484,0.0014289902,0.00043865474,0.0004075817,0.00033464716],"domain_scores_gemma":[0.9968289,0.00086280174,0.0006249699,0.00084552314,0.0002261684,0.0006116107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006255011,0.0003184515,0.0010729698,0.000091051246,0.000037239028,0.000016715843,0.00023541335,0.00032625764,0.00031761386],"category_scores_gemma":[0.00095128827,0.00023781077,0.0008814876,0.0006221969,0.00027389452,0.000047279726,0.00010203149,0.0004281558,0.00007185992],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010016095,0.0011672768,0.93969285,0.0014914577,0.0013123335,0.00006635807,0.00032790657,0.000013834568,0.03890222,0.0000066802686,0.012502093,0.003515385],"study_design_scores_gemma":[0.006491215,0.0025237738,0.22045824,0.00028394713,0.00891921,0.00002998077,0.00062101515,0.0056563313,0.7528344,0.00016232254,0.0014151832,0.00060440414],"about_ca_topic_score_codex":0.00003079445,"about_ca_topic_score_gemma":0.0000014374904,"teacher_disagreement_score":0.7192346,"about_ca_system_score_codex":0.00009489517,"about_ca_system_score_gemma":0.00027088207,"threshold_uncertainty_score":0.96976423},"labels":[],"label_agreement":null},{"id":"W2122511717","doi":"10.5489/cuaj.409","title":"Double jeopardy? Renal sparing management of simultaneous ipsilateral renal cell carcinoma and urothelial carcinoma","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Nephrectomy; Medicine; Renal cell carcinoma; Renal pelvis; Malignancy; Urology; Kidney; Urothelial carcinoma; Kidney disease; Carcinoma; Surgery; Radiology; Internal medicine; Cancer; Bladder cancer","score_opus":0.01379231202746303,"score_gpt":0.20760910886174927,"score_spread":0.19381679683428624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122511717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880195,0.0004153623,0.000026435646,0.0024287866,0.00016665408,0.0005601257,0.000016528085,0.000019309517,0.008347249],"genre_scores_gemma":[0.99556553,0.000041660256,0.0009237782,0.0006059123,0.00029757633,0.00002370685,0.00001909789,0.000025363895,0.0024973804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766845,0.0001157493,0.00059728976,0.00034662482,0.00053900987,0.00073290034],"domain_scores_gemma":[0.9979253,0.00010854221,0.00036594315,0.00019772253,0.0003123284,0.0010901853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035410715,0.00027329195,0.00047781438,0.0002487851,0.00023116598,0.00011501048,0.00015058469,0.00024842747,0.0007243544],"category_scores_gemma":[0.000037077556,0.00022074919,0.00018621644,0.00017789903,0.00006273367,0.00012832232,0.00005324355,0.0005439399,0.00007732522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003994078,0.00012781456,0.98655987,0.00006610621,0.00022878886,0.0021196515,0.0002643051,0.0003220887,0.0043265386,0.00012394921,0.002495133,0.002966319],"study_design_scores_gemma":[0.005197321,0.0011129214,0.9835578,0.00003380689,0.00033721275,0.00082275225,0.00011579213,0.0010014469,0.00416995,0.00027253115,0.0031072188,0.0002712067],"about_ca_topic_score_codex":0.004744882,"about_ca_topic_score_gemma":0.00021678086,"teacher_disagreement_score":0.0075459746,"about_ca_system_score_codex":0.0011264526,"about_ca_system_score_gemma":0.00025069097,"threshold_uncertainty_score":0.9001891},"labels":[],"label_agreement":null},{"id":"W2123069120","doi":"10.1111/j.1464-410x.2012.11112.x","title":"Practice‐setting and surgeon characteristics heavily influence the decision to perform partial nephrectomy among <scp>A</scp> merican <scp>U</scp> rologic <scp>A</scp> ssociation surgeons","year":2012,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Nephrectomy; Medicine; Logistic regression; Odds; Odds ratio; Renal mass; Urology; Surgery; General surgery; Internal medicine; Kidney","score_opus":0.012700704639871423,"score_gpt":0.2569787121401246,"score_spread":0.24427800750025316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123069120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99129236,0.004954561,0.0002728983,0.0008885712,0.0008426035,0.0008202835,0.00003562108,0.000052840725,0.0008402858],"genre_scores_gemma":[0.9928295,0.0022574663,0.0009335597,0.0025701332,0.001052892,0.000064603504,0.000035086643,0.00007667657,0.00018009833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945788,0.0009150701,0.0015336924,0.00051358854,0.0010331067,0.0014257521],"domain_scores_gemma":[0.98343384,0.012269309,0.001949601,0.0004064621,0.0009718121,0.00096898054],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00414857,0.0004853063,0.0011806913,0.00035999843,0.00055496936,0.00023098044,0.00035234733,0.0004401551,0.000019333767],"category_scores_gemma":[0.0360062,0.000422161,0.00033504443,0.0005565786,0.00033919592,0.00088266283,0.00024085239,0.0014668971,0.000045578447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011456152,0.0005656212,0.9502556,0.00003878436,0.00041117187,0.0018590254,0.0024565298,0.00012555993,0.0014496894,0.000024065394,0.010331825,0.032367595],"study_design_scores_gemma":[0.001576653,0.0017531634,0.90470946,0.00012863374,0.00082669803,0.016733162,0.0017314488,0.00017479886,0.0005159918,0.000062467494,0.07172469,0.00006283042],"about_ca_topic_score_codex":0.00046468113,"about_ca_topic_score_gemma":0.000099342804,"teacher_disagreement_score":0.061392862,"about_ca_system_score_codex":0.00031624624,"about_ca_system_score_gemma":0.00031275948,"threshold_uncertainty_score":0.99982303},"labels":[],"label_agreement":null},{"id":"W2123190711","doi":"10.1002/ijc.23010","title":"Patients with renal cell carcinoma nodal metastases can be accurately identified: External validation of a new nomogram","year":2007,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nomogram; Medicine; Cohort; Renal cell carcinoma; Logistic regression; Stage (stratigraphy); Lymph node; Proportional hazards model; Internal medicine; Oncology; Pathological; Radiology","score_opus":0.03726559496094325,"score_gpt":0.3294319975345147,"score_spread":0.29216640257357146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123190711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954544,0.0007714686,0.001926234,0.0004726672,0.0006975566,0.00019990084,0.00007417229,0.000005949527,0.00039768903],"genre_scores_gemma":[0.99645185,0.00003714379,0.00214347,0.00018959792,0.00064904185,0.0000030749868,0.000044484663,0.000024982462,0.00045636576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99730414,0.000031004976,0.0007611882,0.00017374333,0.0015198229,0.0002100908],"domain_scores_gemma":[0.99688613,0.00007260278,0.0009725429,0.00014504655,0.0016611886,0.00026247866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027076987,0.00019303965,0.00035048128,0.00039234935,0.000024696867,0.000042765034,0.00025184432,0.000053717507,0.00040845782],"category_scores_gemma":[0.000040719846,0.00013928577,0.00021333338,0.00015387268,0.00006034787,0.00024146635,0.00003763317,0.00020945538,0.000002696583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0092121465,0.0009699714,0.9084553,0.000056699464,0.001174383,0.0010489788,0.0007962144,0.0004744227,0.044734057,0.000039932704,0.0018087187,0.031229166],"study_design_scores_gemma":[0.006114691,0.00092787517,0.533632,0.00020675502,0.00045295618,0.00016527464,0.000071016446,0.0000055986807,0.45717305,0.000043573065,0.0010982474,0.00010898046],"about_ca_topic_score_codex":0.0009490336,"about_ca_topic_score_gemma":0.0002146596,"teacher_disagreement_score":0.412439,"about_ca_system_score_codex":0.00046764428,"about_ca_system_score_gemma":0.0006001864,"threshold_uncertainty_score":0.56799084},"labels":[],"label_agreement":null},{"id":"W2123553756","doi":"10.1016/j.urolonc.2007.05.029","title":"The once and future role of cytoreductive nephrectomy","year":2008,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Nephrectomy; Renal cell carcinoma; Medicine; Randomized controlled trial; Urology; Internal medicine; Intensive care medicine; Oncology; General surgery; Kidney","score_opus":0.03543594296639664,"score_gpt":0.3268781618633462,"score_spread":0.29144221889694955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123553756","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0061118756,0.98776436,6.2070313e-7,0.0012953342,0.00016201694,0.0008404805,0.000027078608,0.000025452684,0.003772802],"genre_scores_gemma":[0.00003314704,0.9891739,0.009519915,0.000118311356,0.00046212322,0.00019410653,0.00006822156,0.000022234688,0.0004080309],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984023,0.000254453,0.00047968552,0.0004295726,0.00015866921,0.00027530218],"domain_scores_gemma":[0.9982422,0.00069826737,0.00043681203,0.000305042,0.000077452474,0.00024025147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016898302,0.00036778336,0.0012848662,0.00013208266,0.00039836412,0.000013226376,0.000121080004,0.0004885324,0.000012259779],"category_scores_gemma":[0.0000829391,0.00020956142,0.00018635995,0.00027735712,0.001749515,0.000045941313,0.00007878233,0.00061724323,0.000007208453],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006452666,0.00013305862,0.0026640182,0.00090005656,0.00043260862,0.00023375932,0.00043277582,3.459952e-7,0.000007033245,0.009460227,0.002676102,0.9829955],"study_design_scores_gemma":[0.00026715337,0.0015260023,0.000101240636,0.00051536696,0.001442409,0.0048537594,0.00029438603,0.0000050065537,0.000010987001,0.0012139332,0.98961735,0.00015240746],"about_ca_topic_score_codex":0.000026874264,"about_ca_topic_score_gemma":0.000006513424,"teacher_disagreement_score":0.9869412,"about_ca_system_score_codex":0.0001811547,"about_ca_system_score_gemma":0.0009541284,"threshold_uncertainty_score":0.8545667},"labels":[],"label_agreement":null},{"id":"W2123644514","doi":"10.1016/j.cdp.2008.02.001","title":"Alcohol drinking and renal cell carcinoma in Canadian men and women","year":2008,"lang":"en","type":"article","venue":"Cancer Detection and Prevention","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Public Health Agency of Canada","funders":"","keywords":"Medicine; Odds ratio; Confidence interval; Alcohol consumption; Logistic regression; Renal cell carcinoma; Alcohol intake; Alcohol; Demography; Postmenopausal women; Population; Obesity; Gynecology; Internal medicine; Environmental health","score_opus":0.024181255270082486,"score_gpt":0.2565578137938691,"score_spread":0.2323765585237866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123644514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947066,0.0021771698,0.000016870361,0.00008643511,0.0000453794,0.0002852051,0.0000012419524,0.0000108707945,0.0026702643],"genre_scores_gemma":[0.99759,0.000831076,0.000037798425,0.000052848816,0.000052568303,0.00008464843,0.0000032462028,0.000009257043,0.001338548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938536,0.00003481048,0.00011541601,0.00020203553,0.00007254382,0.00018984223],"domain_scores_gemma":[0.99964213,0.0000067436536,0.00003368922,0.00006650796,0.00001872233,0.00023219826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010976896,0.0000888398,0.00012832649,0.00016667559,0.00010654762,0.0000112416055,0.000010430506,0.000060369406,0.00004938611],"category_scores_gemma":[0.0000038773696,0.00008517278,0.000016131833,0.000093267605,0.000037028305,0.00006811352,0.00001063841,0.00009296433,0.0000010258746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002863287,0.00003307846,0.8190731,0.00015345923,0.000035906727,0.0001517297,0.004240965,0.0000077391505,0.05398977,0.0000061183805,0.00006526873,0.121956535],"study_design_scores_gemma":[0.0019156073,0.00032785392,0.97403705,0.000048670023,0.000032309348,0.00022307296,0.00020190938,0.0003102613,0.021339793,0.000092319875,0.0013783041,0.00009287033],"about_ca_topic_score_codex":0.05100293,"about_ca_topic_score_gemma":0.07385506,"teacher_disagreement_score":0.15496394,"about_ca_system_score_codex":0.00041043968,"about_ca_system_score_gemma":0.00010342621,"threshold_uncertainty_score":0.95531654},"labels":[],"label_agreement":null},{"id":"W2124285239","doi":"10.1016/j.carj.2010.09.008","title":"Effectiveness of Ultrasound-Guided Radiofrequency Ablation in the Treatment of 36 Renal Cell Carcinoma Tumours Compared with Published Results of Using Computed Tomography Guidance","year":2010,"lang":"en","type":"article","venue":"Canadian Association of Radiologists Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Computed tomography; Radiofrequency ablation; Radiology; Ultrasound; Renal cell carcinoma; Ablation; Pathology; Internal medicine","score_opus":0.01858229015496842,"score_gpt":0.2521943805475258,"score_spread":0.23361209039255737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124285239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976966,0.00045605996,0.00009736262,0.00013058903,0.00018690855,0.00066055014,0.000134076,0.000004259538,0.00063359214],"genre_scores_gemma":[0.99754614,0.000031224594,0.0021957357,0.000008922607,0.00007648662,0.000006976204,0.000107558335,0.000013872956,0.000013074984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997249,0.0007363943,0.0009989921,0.00021917837,0.0004792236,0.00031719744],"domain_scores_gemma":[0.99550617,0.0008947022,0.0018937781,0.000342357,0.0011630646,0.00019991092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020032506,0.00020989098,0.00080903614,0.00067067664,0.0000694339,0.000017642455,0.00020739385,0.00017407197,0.00001276588],"category_scores_gemma":[0.0005901717,0.00014334655,0.00022578235,0.00074376765,0.00021103787,0.000118521144,0.0000033452507,0.00027880017,1.6422524e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079390884,0.00031615605,0.91443413,0.00010372148,0.00017468278,0.000066057095,0.00091541425,0.001953996,0.080789834,0.000027764236,0.0003362237,0.000088099674],"study_design_scores_gemma":[0.0070217173,0.0014894168,0.9322263,0.00017325205,0.00021508159,0.00036628774,0.0001283119,0.00024064931,0.05795461,0.0000547575,0.000027811773,0.00010181038],"about_ca_topic_score_codex":0.019729152,"about_ca_topic_score_gemma":0.00848466,"teacher_disagreement_score":0.022835225,"about_ca_system_score_codex":0.0015543055,"about_ca_system_score_gemma":0.0012327464,"threshold_uncertainty_score":0.9867986},"labels":[],"label_agreement":null},{"id":"W2124745089","doi":"10.1016/j.eururo.2012.05.009","title":"Rationale for Percutaneous Biopsy and Histologic Characterisation of Renal Tumours","year":2012,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":246,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Biopsy; Renal cell carcinoma; Percutaneous; Radiology; Pathology","score_opus":0.08501986248181878,"score_gpt":0.29973086918757563,"score_spread":0.21471100670575685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124745089","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031228324,0.9927739,0.000060685215,0.00010035964,0.00018032297,0.0011455237,0.000052036718,0.000025771486,0.002538556],"genre_scores_gemma":[0.009063405,0.9874559,0.0007215446,0.00010656649,0.00046191068,0.00004652554,0.0009714841,0.0000785408,0.0010940947],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99857,0.00034188488,0.0004766096,0.000312936,0.00009161002,0.00020691162],"domain_scores_gemma":[0.99894947,0.00022536011,0.00041103878,0.0002513225,0.0000654983,0.00009733683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002846141,0.00025754998,0.0010280043,0.0001644445,0.000035910914,0.000004234935,0.0000756236,0.00012233233,0.000086620144],"category_scores_gemma":[0.00008785375,0.00019058364,0.00022930847,0.000053357347,0.0001249579,0.000020078003,0.000045010944,0.00016361142,0.00007623224],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002935831,0.00024023064,0.00015650541,0.010480552,0.0003616311,0.0009251169,0.00029567294,3.1837922e-7,0.0006288033,0.00033876474,0.0004554518,0.9858234],"study_design_scores_gemma":[0.00030904217,0.00094535283,0.0012886364,0.000247095,0.0027081145,0.016899262,0.0000035071782,0.00000254996,0.0000039124516,0.0000074291,0.9774412,0.00014388509],"about_ca_topic_score_codex":0.0000014116263,"about_ca_topic_score_gemma":3.101402e-7,"teacher_disagreement_score":0.9856795,"about_ca_system_score_codex":0.00007398731,"about_ca_system_score_gemma":0.00007883372,"threshold_uncertainty_score":0.7771776},"labels":[],"label_agreement":null},{"id":"W2125068022","doi":"10.5489/cuaj.69","title":"New surgical horizons: the role of cytoreductive nephrectomy for metastatic kidney cancer","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Malignancy; Kidney cancer; Cancer; Kidney; Disease; Kidney disease; Urology; Oncology; Internal medicine; Surgery","score_opus":0.020168188210462398,"score_gpt":0.2648379648464872,"score_spread":0.2446697766360248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125068022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9182019,0.012121508,0.00019405993,0.0609663,0.0010469195,0.001228986,0.00022957056,0.000024755116,0.0059859618],"genre_scores_gemma":[0.99568766,0.00012878631,0.0010375876,0.0009703586,0.001426375,0.00004664228,0.00001822012,0.000013741997,0.00067061384],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985526,0.00016774266,0.0003069888,0.00011519597,0.00032049487,0.00053697405],"domain_scores_gemma":[0.9976101,0.00033437947,0.00028418793,0.00009799295,0.00025422365,0.0014191284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006351926,0.00013287738,0.00031858016,0.000097677585,0.000186449,0.000025997586,0.00009974829,0.000112704736,0.0007308761],"category_scores_gemma":[0.0007049675,0.00007843375,0.00024200397,0.00017711101,0.000032649456,0.0000933379,0.000009169335,0.0003285117,0.000013575287],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040299236,0.00014974031,0.92083764,0.000012172191,0.0011215267,0.000035724115,0.0006893685,0.000020893396,0.00057296164,0.0032527049,0.045800757,0.027103534],"study_design_scores_gemma":[0.0023679216,0.0006602492,0.28590414,0.000020694642,0.0008039192,0.00048045735,0.00041517732,0.000046444173,0.0012803479,0.0026828435,0.70519257,0.00014522858],"about_ca_topic_score_codex":0.0029906386,"about_ca_topic_score_gemma":0.00020076684,"teacher_disagreement_score":0.6593918,"about_ca_system_score_codex":0.001310581,"about_ca_system_score_gemma":0.0014625948,"threshold_uncertainty_score":0.8002581},"labels":[],"label_agreement":null},{"id":"W2125178790","doi":"10.1016/j.urology.2011.07.709","title":"UP-01.157 Metastatic Renal Cancer in the Targeted Therapy Era: The Sherbrooke Experience","year":2011,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Vascular endothelial growth factor; Targeted therapy; PI3K/AKT/mTOR pathway; Oncology; VEGF receptors; Discovery and development of mTOR inhibitors; Internal medicine; Cancer; Cancer research; Signal transduction","score_opus":0.06642649430837673,"score_gpt":0.3011465049099115,"score_spread":0.2347200106015348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125178790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98342484,0.007898073,0.00008628296,0.0027914715,0.0002483843,0.00062141265,0.000002960278,0.000023130253,0.0049034283],"genre_scores_gemma":[0.99354917,0.00039590005,0.00010625955,0.00500464,0.00007814067,0.00044759092,0.0000044074263,0.0000164662,0.00039742887],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99873424,0.00027521208,0.00021833874,0.0002553001,0.00019108353,0.00032582073],"domain_scores_gemma":[0.99924177,0.00014246728,0.00006236861,0.00047047055,0.000032056618,0.000050855084],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023729456,0.00016225966,0.00023875966,0.000060026454,0.00006907793,0.000006933125,0.00024638278,0.000054981632,0.0015520684],"category_scores_gemma":[0.00003179614,0.00007331447,0.00007860233,0.00018954296,0.0002186166,0.00003533292,0.000027144451,0.0002801732,0.000049905677],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014230946,0.0031144354,0.2985742,0.00010380651,0.0019090008,0.0056019784,0.4569604,0.00050110935,0.08918807,0.008045012,0.012570852,0.10920017],"study_design_scores_gemma":[0.006734973,0.004249292,0.90230393,0.000022074151,0.0003308408,0.0007723925,0.0029487272,0.00092218054,0.032994162,0.002124425,0.04624191,0.000355061],"about_ca_topic_score_codex":0.0009244582,"about_ca_topic_score_gemma":0.00043271846,"teacher_disagreement_score":0.6037297,"about_ca_system_score_codex":0.000051190018,"about_ca_system_score_gemma":0.000082772836,"threshold_uncertainty_score":0.9993606},"labels":[],"label_agreement":null},{"id":"W2125200750","doi":"10.1016/j.urology.2008.08.492","title":"Partial Versus Radical Nephrectomy in Patients With Adverse Clinical or Pathologic Characteristics","year":2009,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Nephrectomy; Medicine; Stage (stratigraphy); Kidney cancer; Histology; Cancer; Urology; Surgery; Internal medicine; Kidney","score_opus":0.037334491080352056,"score_gpt":0.30919362086813706,"score_spread":0.27185912978778504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125200750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777716,0.000021036883,0.000029376828,0.00073910184,0.00030681788,0.00039094436,0.0000047891576,0.00004251111,0.00068825396],"genre_scores_gemma":[0.9973545,0.000014854843,0.000549303,0.0017325997,0.00018736951,0.000012370062,0.000076930555,0.00001163855,0.000060453083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858636,0.00015907061,0.00039420338,0.00034555784,0.00017186244,0.00034297348],"domain_scores_gemma":[0.9992292,0.00017386572,0.00009588164,0.0002827009,0.000041377156,0.00017697607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015359728,0.00016420856,0.000456042,0.00008072779,0.000022698601,0.0000029762775,0.00007000637,0.00021370997,0.00023116251],"category_scores_gemma":[0.00025889574,0.00010325431,0.00006903149,0.000119960336,0.00016018865,0.000028577466,0.000022499353,0.0003416622,0.000115026814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049093556,0.0014121784,0.93130857,0.0000046618825,0.00003905622,0.0039300197,0.000047102752,0.0000032062321,0.000011558899,0.000043654687,0.00018387962,0.013922557],"study_design_scores_gemma":[0.018383663,0.021789726,0.95310503,0.0000056764848,0.0001432389,0.000055750264,0.000004689957,0.00006782071,0.000015891357,0.000010105661,0.006316648,0.00010174841],"about_ca_topic_score_codex":0.000003259358,"about_ca_topic_score_gemma":0.000006380906,"teacher_disagreement_score":0.03070989,"about_ca_system_score_codex":0.00006576709,"about_ca_system_score_gemma":0.000105880004,"threshold_uncertainty_score":0.42105886},"labels":[],"label_agreement":null},{"id":"W2125216212","doi":"10.1186/1476-4598-8-20","title":"From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma","year":2009,"lang":"en","type":"review","venue":"Molecular Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Renal cell carcinoma; Profiling (computer programming); Biology; Computational biology; Gene expression profiling; Biomarker discovery; Molecular diagnostics; Bioinformatics; Proteomics; Pathology; Medicine; Gene; Gene expression; Computer science; Genetics","score_opus":0.023625005914932325,"score_gpt":0.3263705495610694,"score_spread":0.3027455436461371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125216212","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012636836,0.98276764,0.0003710006,0.00014540479,0.00009208709,0.0033721197,0.00017265628,0.000016911703,0.00042531602],"genre_scores_gemma":[0.0044973595,0.9900108,0.0026824486,0.00011764752,0.00039974743,0.0016365094,0.0005266301,0.00008719678,0.000041686526],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99754274,0.00010954954,0.00071947474,0.0008352222,0.00044177787,0.00035124895],"domain_scores_gemma":[0.9985323,0.000025892068,0.0002803629,0.00076705497,0.00011471881,0.0002797024],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009308695,0.0005383996,0.0016623173,0.00039373923,0.000024401326,0.000016224038,0.00019073927,0.0002774347,0.00005009647],"category_scores_gemma":[0.0000072011426,0.00045934875,0.00039212054,0.0006466152,0.000038241396,0.0000228749,0.00009830268,0.00050023396,0.000008742415],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022772343,0.00016982602,0.000118035154,0.0067732134,0.00009420303,0.0003238488,0.00009760474,0.000007747673,0.0025031264,0.000039273098,0.0001105193,0.98973984],"study_design_scores_gemma":[0.0010672119,0.0002806553,0.00041805572,0.0065906486,0.0028523533,0.00003312028,0.000028042332,0.0000057019097,0.023173515,0.00008551581,0.9648718,0.00059333595],"about_ca_topic_score_codex":0.000363659,"about_ca_topic_score_gemma":0.00002186243,"teacher_disagreement_score":0.9891465,"about_ca_system_score_codex":0.00051478064,"about_ca_system_score_gemma":0.0006404876,"threshold_uncertainty_score":0.99978584},"labels":[],"label_agreement":null},{"id":"W2125580575","doi":"10.3978/j.issn.2223-4683.2015.06.01","title":"Indications for biopsy and the current status of focal therapy for renal tumours.","year":2015,"lang":"en","type":"review","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Renal mass; Biopsy; Nephrectomy; Percutaneous; Percutaneous biopsy; Pathological; Radiology; Natural history; Intensive care medicine; Ablation; Liquid biopsy; Oncology; Kidney; Internal medicine; Cancer","score_opus":0.13876554620483314,"score_gpt":0.3638991700934076,"score_spread":0.22513362388857447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125580575","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005912968,0.9838047,0.00018629212,0.00020356198,0.00017842163,0.01485764,0.000414035,0.000016918637,0.00027932855],"genre_scores_gemma":[0.00037367866,0.96086895,0.00032835157,0.000015071138,0.00027517008,0.037338797,0.00052101404,0.000044514505,0.00023444058],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984637,0.000087473854,0.00050166226,0.00029549428,0.00023412432,0.0004175397],"domain_scores_gemma":[0.998242,0.0004983195,0.00043773165,0.000375284,0.00017925927,0.00026737843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006954691,0.00026693186,0.001338575,0.0001492393,0.000049854058,0.000015804926,0.00012019138,0.00009941585,0.0000019404488],"category_scores_gemma":[0.00024363297,0.00013334269,0.0004901,0.00014788231,0.00021773181,0.000019514406,0.000031418982,0.00016620602,0.0000010297106],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030563053,0.00012036221,0.00002662153,0.003818471,0.00028780606,6.642235e-7,0.00005139931,1.4327253e-8,3.1977248e-8,0.00046764314,0.0017273368,0.99319404],"study_design_scores_gemma":[0.0047392743,0.00017086108,0.0017927019,0.00062377163,0.002212494,0.000037794995,0.000006486084,0.0000019158856,0.00000445455,0.00043034952,0.9898629,0.00011699465],"about_ca_topic_score_codex":0.000010088337,"about_ca_topic_score_gemma":0.0000012907102,"teacher_disagreement_score":0.99307704,"about_ca_system_score_codex":0.00020336841,"about_ca_system_score_gemma":0.0005262615,"threshold_uncertainty_score":0.5437557},"labels":[],"label_agreement":null},{"id":"W2125660225","doi":"10.3747/co.v16i0.402","title":"Managing Toxicities and Optimal Dosing of Targeted Drugs in Advanced Kidney Cancer","year":2009,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Kidney cancer; Discontinuation; Dosing; Cancer; Cancer drugs; Intensive care medicine; Drug; Kidney; Urothelial cancer; Cancer treatment; Pharmacology; Oncology; Internal medicine","score_opus":0.04947010153457045,"score_gpt":0.3744965651794894,"score_spread":0.325026463644919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125660225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838944,0.011697979,0.000031121584,0.0018931055,0.00028319834,0.00028128742,0.000005687937,0.000019395944,0.001893804],"genre_scores_gemma":[0.99718726,0.0014001903,0.0010358584,0.00019363569,0.000065290806,0.000022005219,0.00001704414,0.000007921044,0.00007079393],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991703,0.000042092284,0.00024782305,0.00020696389,0.00010870304,0.0002241238],"domain_scores_gemma":[0.9995906,0.000040588035,0.000088207584,0.0001125557,0.000043953354,0.00012413399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008880363,0.00012184888,0.0003765153,0.00016501393,0.000021082327,0.0000032664655,0.000039161616,0.00005399903,0.000046724756],"category_scores_gemma":[0.000034052493,0.00010648948,0.000040641888,0.00012655446,0.000075204705,0.000051523977,0.000025380607,0.00015166125,0.0000013541713],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010843351,0.000810139,0.09002683,0.0004017898,0.00005636686,0.00010960342,0.0050179614,0.00019654301,0.044463538,0.0003105239,0.0007491927,0.8567732],"study_design_scores_gemma":[0.020371055,0.0057780845,0.821957,0.0023343074,0.00045228578,0.00014208096,0.0034309821,0.0042877933,0.11474823,0.001060251,0.024816308,0.0006216284],"about_ca_topic_score_codex":0.000030437035,"about_ca_topic_score_gemma":0.0000074219097,"teacher_disagreement_score":0.8561515,"about_ca_system_score_codex":0.00032671643,"about_ca_system_score_gemma":0.00015451874,"threshold_uncertainty_score":0.43425152},"labels":[],"label_agreement":null},{"id":"W2127385754","doi":"10.1016/s1470-2045(14)70030-0","title":"Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":263,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; BC Cancer Agency","funders":"National Cancer Institute; Novartis Pharmaceuticals Corporation","keywords":"Sorafenib; Open label; Renal cell carcinoma; Medicine; Oncology; Internal medicine; Second line treatment; Hepatocellular carcinoma; Clinical trial; Overall survival","score_opus":0.1290889388003442,"score_gpt":0.3833123518399601,"score_spread":0.25422341303961593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127385754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98845893,0.00015386623,0.00026119084,0.00066799764,0.000352197,0.0074238754,0.00019276173,0.00003553628,0.0024536643],"genre_scores_gemma":[0.9897204,0.000016851884,0.0070930105,0.00022128462,0.0005820067,0.0011182216,0.0008920076,0.00004688245,0.00030933385],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975691,0.000676231,0.0005713541,0.00043251915,0.00027082113,0.00047999044],"domain_scores_gemma":[0.9971031,0.0011968514,0.000494917,0.0007708613,0.0002389098,0.00019536287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007454352,0.0003335291,0.001647583,0.000079190395,0.00012302102,0.000018482888,0.00032287266,0.00009614835,0.00006720136],"category_scores_gemma":[0.00013518096,0.00017634057,0.00010796718,0.00014004226,0.00018449062,0.00007698567,0.000049019596,0.00011744198,0.000009518396],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9745477,0.013240558,0.00028974365,0.000075420765,0.00044767832,0.000034684712,0.0004979447,0.000020021545,0.0042451057,0.00011666976,0.0007065658,0.005777896],"study_design_scores_gemma":[0.78225845,0.19002637,0.00057855906,0.000009508261,0.0018237497,0.000005515016,0.000058018515,0.0005331376,0.017751705,0.00006580775,0.006740255,0.00014892421],"about_ca_topic_score_codex":0.00011683957,"about_ca_topic_score_gemma":0.00010873547,"teacher_disagreement_score":0.19228926,"about_ca_system_score_codex":0.0003284307,"about_ca_system_score_gemma":0.00037210155,"threshold_uncertainty_score":0.719096},"labels":[],"label_agreement":null},{"id":"W2127850839","doi":"10.1111/j.1464-410x.2009.08484.x","title":"Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma)","year":2009,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Renal cell carcinoma; Hazard ratio; Proportional hazards model; Internal medicine; Nephrectomy; Medicine; Oncology; Stage (stratigraphy); Urology; Cancer; Carcinoma; Kidney; Biology; Confidence interval","score_opus":0.010530827556974012,"score_gpt":0.2188518915112599,"score_spread":0.20832106395428587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127850839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961104,0.0032080745,0.000030080517,0.0001057661,0.00007100314,0.0002450493,0.00002606032,0.0000026612306,0.00020095272],"genre_scores_gemma":[0.998567,0.00023910818,0.0010194978,0.00008572374,0.000041221752,0.0000010290031,0.000010570136,0.000012602321,0.00002326553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983831,0.00015490304,0.0006504384,0.00019123057,0.00038768735,0.00023265117],"domain_scores_gemma":[0.9987577,0.000091957925,0.00057314377,0.00013679072,0.00029159663,0.00014881416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029982743,0.00015197544,0.00068296515,0.0002180163,0.000021553626,0.0000085299225,0.00009598005,0.00007754842,0.000031407744],"category_scores_gemma":[0.000066322165,0.0001311488,0.00009359145,0.00014086302,0.00014364287,0.0001086595,0.000032792865,0.000280238,3.1485223e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006594001,0.0019351214,0.9244989,0.00016852825,0.00010218825,0.0028114452,0.00020117262,0.000073531744,0.041254207,0.000013227356,0.00012732763,0.022220321],"study_design_scores_gemma":[0.008729372,0.010966882,0.9632685,0.00012495692,0.00014990167,0.0009074945,0.00004801543,0.0000133638,0.015603381,0.000021118987,0.00007641778,0.00009057184],"about_ca_topic_score_codex":0.00026933532,"about_ca_topic_score_gemma":0.0000840211,"teacher_disagreement_score":0.038769595,"about_ca_system_score_codex":0.000048630718,"about_ca_system_score_gemma":0.00015057843,"threshold_uncertainty_score":0.5348093},"labels":[],"label_agreement":null},{"id":"W2127868784","doi":"10.1590/s1677-55382011000300026","title":"Adverse renal outcomes in subjects undergoing nephrectomy for renal tumors: a population-based analysis","year":2011,"lang":"en","type":"article","venue":"International braz j urol","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Nephrectomy; Hazard ratio; Renal function; Kidney disease; Proteinuria; Population; Proportional hazards model; Internal medicine; Urology; Dialysis; Confidence interval; Adverse effect; Cohort; Surgery; Kidney","score_opus":0.03146051222223127,"score_gpt":0.28608695143349866,"score_spread":0.2546264392112674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127868784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919502,0.000026581674,0.0030471785,0.0005586961,0.00014521948,0.0005664693,0.000040527284,0.000062732965,0.0036023592],"genre_scores_gemma":[0.9907608,0.0000013288195,0.007266135,0.00057437614,0.00009925163,0.00015387897,0.00039650116,0.00002774195,0.000719993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983579,0.000042930977,0.00048584837,0.00039846552,0.000459912,0.00025495663],"domain_scores_gemma":[0.99892616,0.0003499616,0.00018016685,0.0002659224,0.00015495151,0.00012284852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018374687,0.00021435965,0.000402397,0.0009143575,0.00004274504,0.00001732897,0.00016210678,0.00007394824,0.00053016533],"category_scores_gemma":[0.00029059086,0.00018663655,0.0004276562,0.00040475896,0.000025442107,0.00013710685,0.000028143239,0.00012616298,0.000031821673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008612273,0.0004028644,0.9950712,0.000019617513,0.00096679927,0.0001785165,0.00014577409,0.0009720079,0.0006050592,0.00038437385,0.000050546485,0.00034206762],"study_design_scores_gemma":[0.004055392,0.00025603516,0.9839459,0.00007224368,0.0005172877,0.000014197895,0.000030939882,0.0066328105,0.0037261276,0.0004204623,0.00015727457,0.00017134532],"about_ca_topic_score_codex":0.001096263,"about_ca_topic_score_gemma":0.001460968,"teacher_disagreement_score":0.011125262,"about_ca_system_score_codex":0.00042026813,"about_ca_system_score_gemma":0.00017177738,"threshold_uncertainty_score":0.76108176},"labels":[],"label_agreement":null},{"id":"W2128156782","doi":"10.2214/ajr.11.7376","title":"Centrally Infiltrating Renal Masses on CT: Differentiating Intrarenal Transitional Cell Carcinoma From Centrally Located Renal Cell Carcinoma","year":2012,"lang":"en","type":"article","venue":"American Journal of Roentgenology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Receiver operating characteristic; Renal cell carcinoma; Radiology; Diagnostic accuracy; Transitional cell carcinoma; Kappa; Carcinoma; Clear cell renal cell carcinoma; Area under the curve; Clear cell carcinoma; Pathology; Nuclear medicine; Cancer; Internal medicine; Bladder cancer","score_opus":0.01364243694418061,"score_gpt":0.22870756501538503,"score_spread":0.21506512807120443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128156782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99397755,0.0015859532,0.001143963,0.000912045,0.0005607767,0.00035079077,0.00009296386,0.000042589563,0.0013333635],"genre_scores_gemma":[0.98992723,0.000075458614,0.007544647,0.00074534834,0.0012632818,0.000011262563,0.0002616704,0.00010021183,0.0000708662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948129,0.0005475889,0.0015751781,0.00054264476,0.0010128194,0.0015088446],"domain_scores_gemma":[0.9961116,0.00038489772,0.0015835731,0.00047780722,0.00037590394,0.0010662265],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003328871,0.0006934446,0.0013737527,0.00051994866,0.00021082205,0.00005159226,0.00040550335,0.0001292392,0.0006556045],"category_scores_gemma":[0.00006751369,0.0005804336,0.00060559827,0.0004492298,0.00045262507,0.0002909443,0.00006937397,0.0012116014,0.000044437544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028449576,0.0021507076,0.7237539,0.00008784335,0.00046792952,0.0023656627,0.0020389077,0.00038508142,0.2581907,0.000054481137,0.0007214709,0.006938378],"study_design_scores_gemma":[0.0056094383,0.0066687204,0.69447976,0.00014919281,0.00095338776,0.0027966183,0.00165263,0.000112215464,0.28655905,0.00003994978,0.00048346244,0.0004956193],"about_ca_topic_score_codex":0.0003494756,"about_ca_topic_score_gemma":0.000018578285,"teacher_disagreement_score":0.029274166,"about_ca_system_score_codex":0.0006580595,"about_ca_system_score_gemma":0.0006088382,"threshold_uncertainty_score":0.9996647},"labels":[],"label_agreement":null},{"id":"W2128337644","doi":"10.4021/wjon222w","title":"Renal Medullary Carcinoma is a Diagnosis Worth Considering: Case Report","year":2010,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Sickle cell trait; Medullary cavity; Lymph node; Biopsy; Kidney; Renal cell carcinoma; Radiology; Pathology; Internal medicine; Disease","score_opus":0.038458143743527844,"score_gpt":0.31978612609473794,"score_spread":0.2813279823512101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128337644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97471374,0.0010969456,0.000017814174,0.010123827,0.0012287918,0.00025410682,0.0000031484847,0.00001718615,0.01254441],"genre_scores_gemma":[0.98621845,0.000072803676,0.009335308,0.0014370598,0.00096832775,0.000020673493,0.0000035491555,0.000034902583,0.0019089297],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9977808,0.000101468046,0.0010705276,0.00026930613,0.00040639803,0.00037148458],"domain_scores_gemma":[0.9971832,0.00044076523,0.0008702111,0.00046603964,0.00045817049,0.00058159913],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007467043,0.00024070192,0.00084986875,0.00054290297,0.00009612747,0.00001813514,0.000118656855,0.00016744413,0.0016083347],"category_scores_gemma":[0.0003586703,0.00018536589,0.00037529774,0.0003068058,0.00021531234,0.00009264623,0.000072388684,0.0011440587,0.000028569611],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036227566,0.00040651887,0.24987954,0.000023047432,0.0002417885,0.7089984,0.0003209082,0.0000016122714,0.00337312,0.000041543408,0.022341635,0.014009622],"study_design_scores_gemma":[0.0023013323,0.0015873448,0.046753798,0.000047272053,0.0005159621,0.69885075,0.00009653333,0.000005519255,0.012602022,0.00009750112,0.23702154,0.00012040993],"about_ca_topic_score_codex":0.00012328858,"about_ca_topic_score_gemma":0.0011381117,"teacher_disagreement_score":0.2146799,"about_ca_system_score_codex":0.0003200199,"about_ca_system_score_gemma":0.0011443907,"threshold_uncertainty_score":0.99930435},"labels":[],"label_agreement":null},{"id":"W2128495482","doi":"10.1016/j.eururo.2008.07.037","title":"A Preoperative Prognostic Model for Patients Treated with Nephrectomy for Renal Cell Carcinoma","year":2008,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Nomogram; Medicine; Nephrectomy; Renal cell carcinoma; Proportional hazards model; Cohort; Kidney cancer; Urology; Internal medicine; Surgery; Oncology; Kidney","score_opus":0.026652199894483124,"score_gpt":0.22610928892225746,"score_spread":0.19945708902777434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128495482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832968,0.0001268882,0.0040352955,0.00012295805,0.00003609742,0.0030990245,0.000059462764,0.000081019454,0.009142464],"genre_scores_gemma":[0.988546,0.0000036744984,0.0061782263,0.00044059474,0.00011752949,0.00036266906,0.00033854146,0.00010574166,0.0039070314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852026,0.00012748147,0.00026882548,0.0005116785,0.00014172093,0.0004300173],"domain_scores_gemma":[0.9989572,0.00017312834,0.000109171895,0.0002979574,0.00028447498,0.0001780298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008424155,0.00028338569,0.00037449668,0.000103477316,0.00015529185,0.000007269475,0.00009788545,0.00005461543,0.000012559705],"category_scores_gemma":[0.000071436545,0.00020048223,0.00012168634,0.00009635343,0.00012535206,0.00004046832,0.000031314987,0.00011684345,0.000035762318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016825816,0.0024867803,0.962677,0.00020409147,0.00031051278,0.0007895891,0.0034517366,0.0013618324,0.0028539503,0.00007953578,0.008283657,0.000675515],"study_design_scores_gemma":[0.042993322,0.05806875,0.8286016,0.000030083904,0.0015695062,0.00041558998,0.000038282422,0.051977184,0.008546141,0.000022899023,0.0070203147,0.0007163114],"about_ca_topic_score_codex":0.000006219651,"about_ca_topic_score_gemma":0.0000041320923,"teacher_disagreement_score":0.13407537,"about_ca_system_score_codex":0.00006774095,"about_ca_system_score_gemma":0.00012663251,"threshold_uncertainty_score":0.8175428},"labels":[],"label_agreement":null},{"id":"W2128815088","doi":"10.5489/cuaj.57","title":"Progression to metastatic disease from a small renal cell carcinoma prospectively followed with an active surveillance protocol","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Internal medicine; Disease; Protocol (science); Kidney disease; Pathology","score_opus":0.022606744888257386,"score_gpt":0.26538146091633275,"score_spread":0.24277471602807535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128815088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768872,0.000048060705,0.00012926632,0.0028701301,0.000070931965,0.019180167,0.0001150036,0.0000327033,0.00066649844],"genre_scores_gemma":[0.9855185,4.7661987e-7,0.0040194457,0.0009903641,0.00045221514,0.008740235,0.00006254344,0.00003141872,0.00018480411],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974334,0.00043892115,0.00033075453,0.00035612736,0.0006137822,0.00082699885],"domain_scores_gemma":[0.9952779,0.00011982182,0.00036809588,0.00020672745,0.0003917427,0.003635712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005357104,0.00027720447,0.00040653456,0.0001742164,0.00027370147,0.000094616684,0.0001319927,0.000097274824,0.0002818716],"category_scores_gemma":[0.00032579486,0.00018164165,0.00012912843,0.00028292806,0.00002906684,0.00020591581,0.000020248312,0.0005027117,0.000051796964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026220917,0.00044306414,0.99361455,0.000009753674,0.00010600915,0.00059291883,0.0003719893,0.0000139129115,0.00055570714,0.000008303069,0.0003497894,0.0013119244],"study_design_scores_gemma":[0.0029463426,0.002717222,0.990415,0.000023730176,0.00016409518,0.000085323336,0.00008053945,0.000039448103,0.0013348351,0.000096482516,0.001873774,0.0002232246],"about_ca_topic_score_codex":0.001208705,"about_ca_topic_score_gemma":0.001695731,"teacher_disagreement_score":0.010439932,"about_ca_system_score_codex":0.0025847426,"about_ca_system_score_gemma":0.0010237823,"threshold_uncertainty_score":0.7407132},"labels":[],"label_agreement":null},{"id":"W2129671248","doi":"10.3747/co.v16i0.409","title":"Natural History and Management of Small Renal Masses","year":2009,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Natural history; Medicine; Popularity; Renal mass; Population; Nephron; Intensive care medicine; Urology; Nephrectomy; Kidney; Internal medicine","score_opus":0.10823160272659536,"score_gpt":0.3535932829486677,"score_spread":0.24536168022207233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129671248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93619496,0.043691386,0.000041766893,0.00069535663,0.00070213183,0.00035019786,0.0000011188564,0.00002834218,0.018294755],"genre_scores_gemma":[0.99338204,0.0019025506,0.0034418928,0.0001221915,0.00009198173,0.000013238071,0.000019563488,0.0000066080615,0.0010199135],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993066,0.00003410976,0.00019538375,0.00019652997,0.000109277185,0.00015807516],"domain_scores_gemma":[0.9995966,0.000026693448,0.00008317707,0.00016188135,0.000045677425,0.000085976055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000079080826,0.00010956644,0.00027488725,0.00008697506,0.000013192078,0.000001325138,0.000047738627,0.000046282767,0.00005551111],"category_scores_gemma":[0.0000069262924,0.00008770308,0.00006019609,0.000044613516,0.000081565784,0.000017692024,0.00003199602,0.00012845137,0.00000802848],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009029016,0.001847451,0.02352,0.000830211,0.00025080564,0.00086088566,0.0005258191,0.0000015444937,0.00781535,0.004583638,0.018604666,0.9402567],"study_design_scores_gemma":[0.002875267,0.0022359688,0.40614066,0.00019321073,0.00038623397,0.00019130556,0.00006817559,0.000059786402,0.0014688335,0.00019349002,0.5860663,0.00012075024],"about_ca_topic_score_codex":0.0000033783058,"about_ca_topic_score_gemma":0.000003379835,"teacher_disagreement_score":0.94013596,"about_ca_system_score_codex":0.00052216294,"about_ca_system_score_gemma":0.00006354461,"threshold_uncertainty_score":0.3576428},"labels":[],"label_agreement":null},{"id":"W2130847374","doi":"10.1517/14656566.2012.651461","title":"3rd Pavia international symposium on advanced kidney cancer","year":2012,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Kidney cancer; Cancer; Viewpoints; Kidney disease; Natural history; Disease; Intensive care medicine; Oncology; Internal medicine","score_opus":0.04326929366883678,"score_gpt":0.39209366209510604,"score_spread":0.3488243684262693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130847374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7216759,0.030882781,0.0002269812,0.112479866,0.043263752,0.0034328327,0.00018463588,0.00080662407,0.08704664],"genre_scores_gemma":[0.91355556,0.0287516,0.0005373324,0.048743922,0.0044834674,0.00051448523,0.00014677881,0.00010298016,0.003163863],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99853027,0.000054492008,0.0002309193,0.00032039886,0.000498548,0.00036540156],"domain_scores_gemma":[0.99904555,0.000044904158,0.00008902261,0.00027731946,0.00006279598,0.00048040596],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008989263,0.0002740337,0.00023909687,0.00010323904,0.000066553795,0.000015722942,0.00013244116,0.000068137066,0.003475167],"category_scores_gemma":[0.000008701299,0.00021042992,0.00014901777,0.00009835842,0.000032641572,0.00014588718,0.000014977825,0.00018268202,0.0002977834],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004464846,0.0020220028,0.008378751,0.000019769117,0.0004501942,0.000017931055,0.0019004429,0.00003974865,0.7345599,0.00043736122,0.14107744,0.10663164],"study_design_scores_gemma":[0.003956306,0.0003718733,0.0018379134,0.0001150636,0.0000042626516,0.000012799926,0.00002344498,0.00006232724,0.3765562,0.000003333543,0.61690736,0.00014913308],"about_ca_topic_score_codex":0.00003239699,"about_ca_topic_score_gemma":1.7318185e-7,"teacher_disagreement_score":0.4758299,"about_ca_system_score_codex":0.00044574638,"about_ca_system_score_gemma":0.00005913684,"threshold_uncertainty_score":0.9974358},"labels":[],"label_agreement":null},{"id":"W2131859250","doi":"10.1093/annonc/mdt492","title":"Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials","year":2013,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; University of Alberta; University of British Columbia; BC Cancer Agency; London Health Sciences Centre; University of Toronto; Western University; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Genentech; Pfizer","keywords":"Medicine; Renal cell carcinoma; Oncology; Clinical trial; Internal medicine; Carcinoma; Intensive care medicine","score_opus":0.3613297907484573,"score_gpt":0.5129254630778948,"score_spread":0.1515956723294375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131859250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99346256,0.00023881668,0.000059430833,0.0020199872,0.00019205894,0.002598965,0.0001866077,0.000011176813,0.0012304217],"genre_scores_gemma":[0.99295604,0.000043320422,0.005591433,0.00091454753,0.000054836753,0.00018638099,0.00007795591,0.000025660765,0.00014983506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99627393,0.0009412061,0.0016485092,0.00042598706,0.00036403968,0.0003463141],"domain_scores_gemma":[0.9936136,0.0035511446,0.0011074786,0.00059393374,0.0008969033,0.00023691161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031228915,0.00025235943,0.0024143732,0.00013054411,0.0000268903,0.0000073846195,0.00015264786,0.00016481313,0.0003382513],"category_scores_gemma":[0.0014832239,0.00015257805,0.0005868245,0.00008651894,0.00027295857,0.000092589486,0.00005981436,0.000114090886,0.000012060717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061094356,0.0036019858,0.9613601,0.00036892176,0.0006455758,0.000016422719,0.00022843463,9.544576e-7,0.0012899233,0.00004730068,0.014146877,0.012184063],"study_design_scores_gemma":[0.011082951,0.019807803,0.91852313,0.000025948568,0.00073475635,0.0000031777938,0.000094908784,0.000011641237,0.047876574,0.00039355532,0.0013191219,0.00012640597],"about_ca_topic_score_codex":0.00016311732,"about_ca_topic_score_gemma":0.000016324517,"teacher_disagreement_score":0.04658665,"about_ca_system_score_codex":0.000045474622,"about_ca_system_score_gemma":0.00029958258,"threshold_uncertainty_score":0.62219524},"labels":[],"label_agreement":null},{"id":"W2132463881","doi":"10.1016/s1535-6108(02)00104-6","title":"Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome","year":2002,"lang":"en","type":"article","venue":"Cancer Cell","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":937,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"U.S. Public Health Service","keywords":"Birt–Hogg–Dubé syndrome; Hair follicle; Lung; Kidney; Cancer research; Gene; Folliculin; Biology; Pathology; Medicine; Internal medicine; Cell biology; Endocrinology; Genetics; Anatomy","score_opus":0.012212003805296941,"score_gpt":0.21370499764920967,"score_spread":0.20149299384391273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132463881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596494,0.001112642,0.00001001972,0.000879572,0.000037864378,0.0011699677,0.00004121184,0.0000106070775,0.00077314966],"genre_scores_gemma":[0.99833363,0.000026392881,0.00015033866,0.00068165135,0.000012214148,0.00016271658,0.000009229001,0.000029818353,0.0005940002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892145,0.00004073451,0.00023523004,0.00027533123,0.00026754613,0.00025969127],"domain_scores_gemma":[0.9993223,0.0000479551,0.00009116703,0.0003434152,0.000056496305,0.00013864225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000075667915,0.00017028084,0.00027251866,0.00009018589,0.000049873735,0.000009841681,0.00012053885,0.000036645226,0.00005588536],"category_scores_gemma":[0.000021317264,0.00009720281,0.00005015825,0.00047836604,0.00007559083,0.000053390948,0.00004909453,0.00013782749,0.0000051755283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014592434,0.00053953595,0.9867567,0.0001676425,0.00003637265,0.000052696858,0.0040519643,0.00062701816,0.006764508,0.000014487051,0.00050256937,0.00034056942],"study_design_scores_gemma":[0.0041402923,0.0004604085,0.9726296,0.00035035145,0.0000911148,0.000017662616,0.00018284397,0.00044160002,0.0213912,0.000004197822,0.00015541991,0.00013527712],"about_ca_topic_score_codex":0.0019947495,"about_ca_topic_score_gemma":0.001317723,"teacher_disagreement_score":0.014626691,"about_ca_system_score_codex":0.0004735819,"about_ca_system_score_gemma":0.00013378896,"threshold_uncertainty_score":0.39638156},"labels":[],"label_agreement":null},{"id":"W2133635509","doi":"10.5489/cuaj.1121","title":"A population-based study examining the effect of tyrosine kinase inhibitors on survival in metastatic renal cell carcinoma in Alberta and the role of nephrectomy prior to treatment","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Population; Cohort; Nephrectomy; Proportional hazards model; Oncology; Tyrosine kinase; Cancer; Kidney cancer; Surgery; Kidney","score_opus":0.011513217541863224,"score_gpt":0.2240886749196432,"score_spread":0.21257545737778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133635509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953179,0.00016542703,4.1797722e-7,0.002711308,0.00004120686,0.0015887889,0.000005329245,0.0000018415379,0.00016780214],"genre_scores_gemma":[0.9996129,0.0000016204176,0.000024597713,0.00016353733,0.000039666586,0.000108071064,0.0000065685476,0.000009605729,0.000033408938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975949,0.001132291,0.0004969946,0.00017253091,0.00032897596,0.00027434411],"domain_scores_gemma":[0.99723744,0.002023172,0.0002837063,0.00014235242,0.00007327312,0.00024004205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011235143,0.00016775362,0.0005171418,0.0002749397,0.00007918313,0.000027520318,0.00007696911,0.00006153671,0.000048290298],"category_scores_gemma":[0.00070392544,0.00008149516,0.000084993466,0.00031593762,0.000025988697,0.000032367094,0.000010936596,0.00024178937,0.0000032454611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052176643,0.00016026807,0.99505585,0.0000048366455,0.0000427245,0.000031442512,0.00072345784,0.0006841331,0.00021092319,0.0000074456825,0.000007373918,0.002549774],"study_design_scores_gemma":[0.0077369004,0.005382907,0.9846319,0.000021403921,0.00014124707,0.000005831211,0.0003103807,0.0005110419,0.0011362716,0.000032758206,0.000027473983,0.000061896375],"about_ca_topic_score_codex":0.116268404,"about_ca_topic_score_gemma":0.036115892,"teacher_disagreement_score":0.08015251,"about_ca_system_score_codex":0.0010532158,"about_ca_system_score_gemma":0.00018298908,"threshold_uncertainty_score":0.9814725},"labels":[],"label_agreement":null},{"id":"W2135258573","doi":"10.1016/j.ctrv.2009.12.003","title":"Bevacizumab as a treatment option in advanced renal cell carcinoma: An analysis and interpretation of clinical trial data","year":2010,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Centre for Applied Research in Cancer Control","keywords":"Medicine; Bevacizumab; Renal cell carcinoma; Oncology; Targeted therapy; Combination therapy; Internal medicine; Kidney cancer; Context (archaeology); Alpha interferon; Cancer; Chemotherapy; Immunology; Interferon","score_opus":0.23586084353472192,"score_gpt":0.4972069989666378,"score_spread":0.26134615543191586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135258573","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.054773673,0.93476945,0.000021305415,0.000016858598,0.00032759283,0.009312991,0.00040610027,0.00002266256,0.0003493367],"genre_scores_gemma":[0.006522716,0.9799685,0.0015522925,0.000015005712,0.00040416772,0.00318437,0.007722929,0.000081173326,0.0005488389],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924528,0.0011708105,0.0036213791,0.0019749152,0.0003630835,0.00041699669],"domain_scores_gemma":[0.9937976,0.0003212179,0.0022861208,0.0030498747,0.000092203656,0.0004529583],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00088871573,0.001137278,0.009072165,0.00075140817,0.000051471674,0.000037496957,0.0003597004,0.0006043329,0.00013828713],"category_scores_gemma":[0.00010927522,0.0006992469,0.0019525052,0.0008816832,0.00013906354,0.0002444493,0.00011850742,0.00042191887,0.000032003867],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053319037,0.0022765382,0.0011042712,0.0038479709,0.0012066667,0.0001155169,0.00015627948,0.0000020144014,0.000004032651,0.0000026426237,0.0000071494014,0.985945],"study_design_scores_gemma":[0.049178172,0.0155394105,0.00080663187,0.006024896,0.08049524,0.00005376796,0.000026591217,0.00036323085,0.000048566504,0.0000043051145,0.8468575,0.0006017291],"about_ca_topic_score_codex":0.0016522385,"about_ca_topic_score_gemma":0.002201613,"teacher_disagreement_score":0.9853433,"about_ca_system_score_codex":0.0017574084,"about_ca_system_score_gemma":0.0014793351,"threshold_uncertainty_score":0.9995459},"labels":[],"label_agreement":null},{"id":"W2135564723","doi":"10.1016/j.eururo.2011.05.044","title":"Contemporary Management of Small Renal Masses","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Nephrectomy; Watchful waiting; Observational study; Randomized controlled trial; MEDLINE; Ablative case; Surgery; Renal mass; General surgery; Kidney; Radiation therapy; Internal medicine; Cancer","score_opus":0.09378567032500179,"score_gpt":0.243701965537001,"score_spread":0.1499162952119992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135564723","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4496325,0.0005363086,0.00016796205,0.000090591144,0.000060827682,0.00014907916,0.0000013911152,0.000033563792,0.5493278],"genre_scores_gemma":[0.9915188,0.000038018283,0.0051017473,0.0003983494,0.000044843975,0.0000041358476,0.000013045098,0.000029437644,0.0028516105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991272,0.00016356893,0.00024963354,0.00021787015,0.00008423077,0.00015747736],"domain_scores_gemma":[0.9994179,0.00001904693,0.00009239888,0.00035156688,0.0000337114,0.00008538671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018482775,0.00011517085,0.00020798668,0.00007905366,0.000015156205,0.0000015114874,0.00010547311,0.00002413175,0.00029442422],"category_scores_gemma":[0.000006839393,0.00009239469,0.000078360914,0.00006364363,0.00009493486,0.000015015206,0.000098453864,0.00008630475,0.00030973516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012226816,0.0048228814,0.70389515,0.0014690876,0.00509156,0.12089937,0.0050615766,0.000013650416,0.03238433,0.017466942,0.04684357,0.049825095],"study_design_scores_gemma":[0.002558282,0.002912386,0.9244605,0.00003753928,0.00028650137,0.00033090223,0.00009528848,0.000007808445,0.009454652,0.00011226494,0.059607215,0.00013666303],"about_ca_topic_score_codex":0.000016477054,"about_ca_topic_score_gemma":5.974318e-7,"teacher_disagreement_score":0.5464762,"about_ca_system_score_codex":0.000012539499,"about_ca_system_score_gemma":0.000016798893,"threshold_uncertainty_score":0.3981122},"labels":[],"label_agreement":null},{"id":"W2135647551","doi":"10.1158/1541-7786.mcr-12-0117","title":"State of the Science: An Update on Renal Cell Carcinoma","year":2012,"lang":"en","type":"review","venue":"Molecular Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Toronto","funders":"National Cancer Institute","keywords":"Proteostasis; Clear cell renal cell carcinoma; Context (archaeology); Epigenetics; Biology; Cancer research; Cancer; Renal cell carcinoma; Disease; Bioinformatics; Computational biology; Medicine; Oncology; Genetics; Internal medicine; Gene","score_opus":0.16039673251346964,"score_gpt":0.4400283415906798,"score_spread":0.27963160907721013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135647551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06289819,0.93039256,0.00000197291,0.00008817079,0.00017620884,0.0021480815,0.00007690418,0.000012505442,0.0042053834],"genre_scores_gemma":[0.13917181,0.8585076,0.0000532022,0.00004607965,0.00016507036,0.00043286625,0.00004129739,0.00012065431,0.0014614501],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99349463,0.0008371279,0.0005267421,0.00081199326,0.0032131039,0.001116419],"domain_scores_gemma":[0.99641144,0.00006882143,0.00023778918,0.0021345997,0.00060188473,0.00054549024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002108659,0.00042315782,0.001149901,0.0007615521,0.00024708486,0.000055521843,0.0010908118,0.00015478978,0.0001776251],"category_scores_gemma":[0.000052517098,0.00024142824,0.0005255985,0.002093762,0.0010721781,0.0000719682,0.0005132909,0.0013889379,0.00012330456],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013945236,0.00049284805,0.00006850301,0.012668879,0.00013477966,0.00040083862,0.00016643152,0.000008866894,0.008769526,0.00011802449,0.00030499784,0.97672683],"study_design_scores_gemma":[0.0008805473,0.0013009991,0.00065762317,0.006498435,0.0011890747,0.00008991994,0.000014436667,0.0000061107603,0.18713173,0.00005087982,0.8017479,0.0004323076],"about_ca_topic_score_codex":0.0004944345,"about_ca_topic_score_gemma":0.00001830653,"teacher_disagreement_score":0.9762945,"about_ca_system_score_codex":0.00157329,"about_ca_system_score_gemma":0.00496781,"threshold_uncertainty_score":0.9845158},"labels":[],"label_agreement":null},{"id":"W2137364132","doi":"10.1097/pas.0b013e31829a85d0","title":"Handling and Staging of Renal Cell Carcinoma","year":2013,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Adipose capsule of kidney; Medicine; Renal sinus; Nephrectomy; Renal vein; Renal cell carcinoma; Sinus (botany); Desmoplasia; Radiology; Kidney; Pathology; Cancer; Internal medicine; Biology","score_opus":0.014633930702974475,"score_gpt":0.24672257472481354,"score_spread":0.23208864402183907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137364132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958321,0.0012660895,0.000101060614,0.0016006742,0.0000419692,0.000107527245,0.0000010589982,0.00000371936,0.0010457912],"genre_scores_gemma":[0.9983892,0.0002131243,0.0010401536,0.00013564904,0.00011442267,0.0000021016454,5.3059085e-7,0.000012177223,0.000092635186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988247,0.00020770478,0.0004413849,0.00011209589,0.00020871876,0.00020538858],"domain_scores_gemma":[0.9986152,0.00031587356,0.0005509765,0.00017882595,0.00017743939,0.00016166097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004071698,0.00011637597,0.0006019343,0.00011345342,0.00003809751,0.000007240718,0.0000986934,0.000025156345,0.00007703964],"category_scores_gemma":[0.000023739294,0.00006282445,0.00013772116,0.00013928478,0.00063956046,0.000044206732,0.000050950362,0.00027634532,0.0000068778777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031982819,0.0006111691,0.47860113,0.00013165521,0.00025446375,0.012533964,0.003147306,0.000108530156,0.39595243,0.00015886742,0.0005085295,0.10479367],"study_design_scores_gemma":[0.005322829,0.010791993,0.8904346,0.00011911549,0.0005143732,0.031633966,0.0024998803,0.00015698362,0.057042554,0.00054116326,0.00072160776,0.00022093681],"about_ca_topic_score_codex":0.000059734495,"about_ca_topic_score_gemma":2.2956696e-7,"teacher_disagreement_score":0.41183347,"about_ca_system_score_codex":0.000031217896,"about_ca_system_score_gemma":0.000059612463,"threshold_uncertainty_score":0.2561907},"labels":[],"label_agreement":null},{"id":"W2138021907","doi":"10.1158/1055-9965.epi-06-0616","title":"Obesity, High Energy Intake, Lack of Physical Activity, and the Risk of Kidney Cancer","year":2006,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Agency of Canada","funders":"","keywords":"Medicine; Obesity; Kidney cancer; Body mass index; Internal medicine; Cancer; Odds ratio; Quartile; Confidence interval; Population; Endocrinology; Environmental health","score_opus":0.044483284394479065,"score_gpt":0.344083646245868,"score_spread":0.29960036185138894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138021907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867265,0.007165209,0.0008690429,0.004136203,0.00018830702,0.00042519812,0.0000538411,0.000017144612,0.00041854533],"genre_scores_gemma":[0.9958239,0.0025880202,0.00032878199,0.00020776868,0.00021131341,0.00016608366,0.00004496464,0.00001679489,0.0006123628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779165,0.00104084,0.0004344679,0.00035611546,0.00013476153,0.00024215919],"domain_scores_gemma":[0.9979531,0.0007822657,0.0007148017,0.0003279718,0.00010272314,0.000119113625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091147795,0.00020240973,0.0008850271,0.00008837501,0.00005465749,0.0000017833719,0.000090025664,0.00014984967,0.000058744343],"category_scores_gemma":[0.0003246325,0.00012830827,0.00032017496,0.00016653656,0.00081923336,0.00005370425,0.00008420061,0.0001351869,0.0000010520799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030591195,0.0005983012,0.9310293,0.00029442448,0.0017286451,0.000004122516,0.00006356691,0.000070687,0.012664192,0.009224266,0.0087380875,0.03252528],"study_design_scores_gemma":[0.004006136,0.0003201645,0.92562,0.00029717668,0.0014576191,0.0000082555025,0.000011978765,0.0007847279,0.035679314,0.031325113,0.00037450358,0.0001149647],"about_ca_topic_score_codex":0.0364363,"about_ca_topic_score_gemma":0.00093086355,"teacher_disagreement_score":0.035505436,"about_ca_system_score_codex":0.000163466,"about_ca_system_score_gemma":0.000194951,"threshold_uncertainty_score":0.9699802},"labels":[],"label_agreement":null},{"id":"W2138335151","doi":"10.5489/cuaj.66","title":"Systemic therapy for patients with advanced, unresectable or metastatic renal cell carcinoma: moving to guidelines","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St Joseph's Health Care; Juravinski Cancer Centre","funders":"","keywords":"Temsirolimus; Sorafenib; Sunitinib; Renal cell carcinoma; Medicine; Sunitinib malate; Bevacizumab; Context (archaeology); Angiogenesis; Oncology; Internal medicine; Cancer research; Targeted therapy; Kidney cancer; Clear cell; Cancer; Chemotherapy; PI3K/AKT/mTOR pathway; Hepatocellular carcinoma; Discovery and development of mTOR inhibitors; Biology; Signal transduction","score_opus":0.033599547660636955,"score_gpt":0.26829982547650477,"score_spread":0.23470027781586783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138335151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940592,0.0011233321,0.0004236352,0.0026297676,0.0002476014,0.0011192778,0.00006058177,0.000017974196,0.00031860825],"genre_scores_gemma":[0.98949647,0.00002762608,0.0060576145,0.002776517,0.00044849422,0.00010291402,0.00004339981,0.00003114803,0.0010157938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787164,0.00012846,0.00047056275,0.00021487894,0.00046972628,0.0008447103],"domain_scores_gemma":[0.99700975,0.00024332479,0.00031090106,0.00014496631,0.00096854905,0.0013225287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067224045,0.00021991042,0.00040651555,0.0002114763,0.00026530278,0.00005852215,0.000112148664,0.00010645832,0.00020763105],"category_scores_gemma":[0.0007948534,0.00012961045,0.0001251989,0.00025002495,0.00001140892,0.00016896668,0.000011084966,0.0002492388,0.00002933327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011669123,0.00017679915,0.98662686,0.000020650554,0.00011904814,0.000042624677,0.00016658829,0.00022554235,0.0003178565,0.000010555726,0.007831497,0.0032950433],"study_design_scores_gemma":[0.008623913,0.005981962,0.9497623,0.00005716437,0.0002700504,0.00023012099,0.00020377821,0.00007420562,0.000545655,0.00003106013,0.03389868,0.00032110905],"about_ca_topic_score_codex":0.0003939214,"about_ca_topic_score_gemma":0.00021802832,"teacher_disagreement_score":0.036864582,"about_ca_system_score_codex":0.001954105,"about_ca_system_score_gemma":0.0006218696,"threshold_uncertainty_score":0.528536},"labels":[],"label_agreement":null},{"id":"W2139015860","doi":"10.5489/cuaj.12056","title":"Partial Nephrectomy for T1b Renal Cell Carcinoma: A Safe and","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Nephrectomy; Renal cell carcinoma; Medicine; Urology; Carcinoma; General surgery; Oncology; Kidney; Internal medicine","score_opus":0.019835916871588203,"score_gpt":0.2291630284722346,"score_spread":0.2093271116006464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139015860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98728085,0.0012751778,0.00010763683,0.0069977976,0.00029101493,0.00040867578,0.000028725108,0.000013283553,0.003596865],"genre_scores_gemma":[0.99435157,0.000020666143,0.0010954249,0.002172909,0.0013561307,0.000043840766,0.000023660983,0.000014790531,0.0009210109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984864,0.00010603471,0.0002792749,0.00015858568,0.00024291429,0.0007268013],"domain_scores_gemma":[0.9979092,0.00017655984,0.000179149,0.00008573012,0.00015580494,0.0014935419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006307485,0.00015163465,0.0002758896,0.00012841819,0.00026266926,0.000054581433,0.000052974898,0.00021999305,0.00032181354],"category_scores_gemma":[0.00030548414,0.00011729366,0.00015002668,0.00009548908,0.000026666496,0.00010775495,0.000011501169,0.00034922184,0.000036666683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014138872,0.00007423136,0.9826124,0.000008823102,0.000056920184,0.00005318097,0.00014568983,0.000002495465,0.0006803567,0.00013914729,0.014244563,0.0018408331],"study_design_scores_gemma":[0.0021796797,0.0006063269,0.76851594,0.0000037810214,0.00021045493,0.000426669,0.000038373426,0.00006044098,0.00082247076,0.00014079848,0.2268676,0.00012746191],"about_ca_topic_score_codex":0.00042071944,"about_ca_topic_score_gemma":0.00012321307,"teacher_disagreement_score":0.21409643,"about_ca_system_score_codex":0.0010795004,"about_ca_system_score_gemma":0.00034542748,"threshold_uncertainty_score":0.47830966},"labels":[],"label_agreement":null},{"id":"W2139021651","doi":"10.14740/jmc.v6i10.2289","title":"Cerebrovascular Ischemic Events in Patients With Advanced Renal Cell Carcinoma Treated With Anti-Angiogenic Tyrosine Kinase Inhibitors: A Report on Two Cases With Different Outcomes","year":2015,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Axitinib; Pazopanib; Renal cell carcinoma; Vascular endothelial growth factor; Angiogenesis; Internal medicine; Aspirin; Dipyridamole; Stroke (engine); Oncology; Sunitinib; VEGF receptors","score_opus":0.01879062563561207,"score_gpt":0.2627120416394789,"score_spread":0.24392141600386685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139021651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979742,0.0007085995,0.000016780172,0.00043371518,0.000092306436,0.00066631334,0.000014054976,0.000022664768,0.000071330345],"genre_scores_gemma":[0.99907213,0.00001975291,0.00026400888,0.0001600809,0.00017996527,0.000021528827,0.000106141735,0.00007409361,0.00010227363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99421644,0.00016261754,0.0010046101,0.00047395387,0.0036389336,0.00050342403],"domain_scores_gemma":[0.99664396,0.00024656983,0.0007875002,0.000546088,0.00058269623,0.0011932048],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042914873,0.0005727514,0.0013260086,0.00043481792,0.00004875556,0.000017048254,0.0001849998,0.00014620094,0.0000590578],"category_scores_gemma":[0.00048745683,0.00027303907,0.00027895154,0.0004179984,0.00015840953,0.00017457639,0.000054682394,0.0006053154,0.000004089857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074830935,0.0031029314,0.90387535,0.000073777606,0.00033459804,0.08398534,0.0000802663,0.00007133281,0.0001396138,4.3932886e-7,0.00047968214,0.0003735767],"study_design_scores_gemma":[0.045294195,0.024486784,0.88058764,0.001858261,0.0010541991,0.021242112,0.00018653963,0.000010096858,0.024827518,9.56235e-7,0.00009515894,0.00035653403],"about_ca_topic_score_codex":0.00038028878,"about_ca_topic_score_gemma":0.00015718838,"teacher_disagreement_score":0.06274323,"about_ca_system_score_codex":0.000650625,"about_ca_system_score_gemma":0.0007372228,"threshold_uncertainty_score":0.99997216},"labels":[],"label_agreement":null},{"id":"W2139553763","doi":"10.4021//jmc.v4i3.1011","title":"Sunitinib Induced Diffuse Alveolar Hemorrhage: A Case Report","year":2013,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Sunitinib; Diffuse alveolar hemorrhage; Bloody; Papillary renal cell carcinomas; Respiratory distress; Bronchoalveolar lavage; Renal cell carcinoma; Adverse effect; Lung; Bronchoscopy; Nephrectomy; Radiology; Pathology; Kidney; Internal medicine; Surgery","score_opus":0.05447092138630914,"score_gpt":0.3209089631282108,"score_spread":0.26643804174190167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139553763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890514,0.0009535009,0.000042341166,0.008365573,0.00038216272,0.00026127783,0.0000018802414,0.000022360904,0.0009195073],"genre_scores_gemma":[0.99631035,0.000055429497,0.0008945117,0.0012261661,0.00097478053,0.000011132229,0.0000063811704,0.000029077753,0.0004921386],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99654865,0.00012425051,0.0010010535,0.00017934594,0.0018362197,0.00031045347],"domain_scores_gemma":[0.9968241,0.00048174916,0.00049746776,0.00035906152,0.00052279804,0.0013148081],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009026794,0.00020789477,0.000609319,0.00021255524,0.00007043059,0.000041765,0.00014737011,0.00021883489,0.0040396093],"category_scores_gemma":[0.004547355,0.00013311507,0.00032094546,0.00018663389,0.000103664635,0.00017783605,0.00006936788,0.0008082131,0.000091858295],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010857536,0.00070097786,0.0030691517,0.00007977612,0.00011848252,0.9722896,0.00011212071,1.1352359e-7,0.0012868849,0.0000074247196,0.0072187083,0.015008186],"study_design_scores_gemma":[0.003715958,0.001619537,0.0065203337,0.0002079738,0.0003439692,0.97998255,0.0007364565,0.000059514707,0.0052750073,0.000034130604,0.0013867742,0.000117762],"about_ca_topic_score_codex":0.0006139616,"about_ca_topic_score_gemma":0.000019602363,"teacher_disagreement_score":0.014890424,"about_ca_system_score_codex":0.00014890518,"about_ca_system_score_gemma":0.0006225347,"threshold_uncertainty_score":0.9968708},"labels":[],"label_agreement":null},{"id":"W2140116071","doi":"10.1016/s1470-2045(14)71222-7","title":"The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study","year":2015,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":375,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Queen Elizabeth II Health Sciences Centre; University of British Columbia; Sunnybrook Health Science Centre; Dalhousie University; University of Toronto; University Health Network; BC Cancer Agency; Princess Margaret Cancer Centre; University of Calgary","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Renal cell carcinoma; Medicine; Oncology; Internal medicine; Population based study; Epidemiology","score_opus":0.05650128386318062,"score_gpt":0.29932592221088883,"score_spread":0.2428246383477082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140116071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99175525,0.00044877658,0.00020354851,0.0012695967,0.00007156349,0.0056302734,0.00012621576,0.0000635416,0.0004312219],"genre_scores_gemma":[0.99429435,0.0000117697045,0.0024498585,0.00056886533,0.00009075303,0.0011418845,0.001036865,0.00007937759,0.00032630193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959715,0.0008381574,0.0007793487,0.00068764685,0.001000663,0.0007227064],"domain_scores_gemma":[0.99673146,0.00094053504,0.00054465205,0.0010484623,0.0005169315,0.00021793065],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011283325,0.0005364352,0.0010227298,0.00021157296,0.00019852242,0.000062446095,0.0005131071,0.00006454319,0.000046618716],"category_scores_gemma":[0.00022946589,0.00026352992,0.000093487484,0.00047223037,0.0001787278,0.00013427039,0.00010060985,0.00048387767,0.000022744383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023718925,0.004313419,0.9581407,0.00007312281,0.00032868463,0.00077512866,0.0014009448,0.01042247,0.000106808286,0.000017168808,0.0004179897,0.0002846534],"study_design_scores_gemma":[0.06825849,0.023449183,0.8764234,0.0000904744,0.0014676352,0.00007308549,0.00060317764,0.027545024,0.0013176407,0.00009234059,0.00021433999,0.00046521844],"about_ca_topic_score_codex":0.001662072,"about_ca_topic_score_gemma":0.0029213533,"teacher_disagreement_score":0.08171729,"about_ca_system_score_codex":0.0007664306,"about_ca_system_score_gemma":0.0015528074,"threshold_uncertainty_score":0.9999817},"labels":[],"label_agreement":null},{"id":"W2140531948","doi":"10.1016/j.ejca.2011.06.054","title":"An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy","year":2011,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Université de Montréal","funders":"","keywords":"Everolimus; Medicine; Renal cell carcinoma; Internal medicine; Adverse effect; Oncology; Sunitinib; Tyrosine-kinase inhibitor; Response Evaluation Criteria in Solid Tumors; Clinical trial; Cancer; Phases of clinical research","score_opus":0.04339297819874657,"score_gpt":0.29240780831487906,"score_spread":0.24901483011613249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140531948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99704933,0.0018504527,0.000048984726,0.000037081518,0.00019401645,0.0005692838,0.00006306134,0.00000879977,0.0001790146],"genre_scores_gemma":[0.9978461,0.00025045723,0.0014141306,0.00006128345,0.00031963288,0.000012303306,0.00001685936,0.000068877685,0.000010341801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976033,0.0004041991,0.0007323742,0.00027484162,0.00070552155,0.00027976517],"domain_scores_gemma":[0.9982745,0.000030161696,0.0006156609,0.00020484507,0.0006032809,0.0002715346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034548555,0.0002819119,0.00051465223,0.00027856106,0.000033946217,0.000057760215,0.00022622169,0.00002754497,0.00020860147],"category_scores_gemma":[0.000028181168,0.00018744078,0.00012572891,0.00015341006,0.00018422799,0.0005323801,0.000051928786,0.0002722,8.819467e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026825143,0.002013276,0.9025099,0.00010581003,0.0002989775,0.0006471411,0.00325526,0.000005020152,0.0023754686,0.000001150562,0.000008190166,0.06195461],"study_design_scores_gemma":[0.021561688,0.00496488,0.92144585,0.0006624583,0.00014996769,0.000020689402,0.000052260842,0.000005648563,0.050759513,0.0000010973823,0.00020176911,0.00017416036],"about_ca_topic_score_codex":0.00004817512,"about_ca_topic_score_gemma":0.0000068268,"teacher_disagreement_score":0.06178045,"about_ca_system_score_codex":0.00015953806,"about_ca_system_score_gemma":0.00016938671,"threshold_uncertainty_score":0.76436126},"labels":[],"label_agreement":null},{"id":"W2140885542","doi":"10.1093/annonc/mdq320","title":"Temsirolimus in VEGF-refractory metastatic renal cell carcinoma","year":2010,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Temsirolimus; Medicine; Renal cell carcinoma; Refractory (planetary science); VEGF receptors; Oncology; Internal medicine; Cancer research; Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway","score_opus":0.07894114752279004,"score_gpt":0.3604743647877649,"score_spread":0.2815332172649749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140885542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9509777,0.0006533638,0.0000028724162,0.0015268434,0.00022864885,0.00032622946,0.000007693547,0.000015653415,0.04626099],"genre_scores_gemma":[0.9972878,0.00006313039,0.0010015932,0.00076248223,0.00011920924,0.00003477346,0.000020736237,0.000024486062,0.00068578153],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985117,0.00011599415,0.00048138548,0.00028505037,0.00022685192,0.00037902157],"domain_scores_gemma":[0.9987767,0.00024268153,0.00020416058,0.0004165187,0.00015832011,0.00020165041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040711297,0.00018210645,0.0006264625,0.00029196346,0.00002115838,0.0000033584138,0.0001252373,0.00016564348,0.00032110285],"category_scores_gemma":[0.00010287424,0.00015091329,0.00015576484,0.00018656558,0.00016164292,0.00005705353,0.00004913405,0.00047767776,0.000087705535],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014721538,0.0046423655,0.10013524,0.000307386,0.00013854381,0.003890338,0.0012727365,0.000010761697,0.82665175,0.0003378983,0.0067331055,0.0544077],"study_design_scores_gemma":[0.0055740434,0.0109958695,0.5414557,0.000031632524,0.00017957356,0.00039185063,0.00020358864,0.00005371761,0.36930373,0.0004342349,0.071140446,0.00023561476],"about_ca_topic_score_codex":0.00039696437,"about_ca_topic_score_gemma":0.00030941312,"teacher_disagreement_score":0.45734805,"about_ca_system_score_codex":0.00005663882,"about_ca_system_score_gemma":0.0004375852,"threshold_uncertainty_score":0.6154066},"labels":[],"label_agreement":null},{"id":"W2140899580","doi":"10.5489/cuaj.909","title":"Residual renal function after partial or radical nephrectomy for renal cell carcinoma","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alberta Heritage Foundation for Medical Research; Fondation pour la Recherche Médicale; University of Alberta; Heart and Stroke Foundation of Canada","keywords":"Nephrectomy; Medicine; Renal cell carcinoma; Nephrology; Renal function; Urology; Kidney disease; Internal medicine; Surgery; Kidney","score_opus":0.017111105195165205,"score_gpt":0.2178648176865018,"score_spread":0.20075371249133658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140899580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821607,0.00028254863,0.00037907425,0.014648988,0.00043434819,0.00084927876,0.00004250324,0.000037437818,0.0011651387],"genre_scores_gemma":[0.9867383,0.000011504404,0.0017560599,0.004823452,0.0024506021,0.00024664582,0.00007461345,0.00003254508,0.0038662257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972623,0.00024163345,0.0005930158,0.0003792673,0.00057663413,0.00094717264],"domain_scores_gemma":[0.9972411,0.00027735307,0.00029313363,0.00018013624,0.00041546783,0.0015928173],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005797782,0.00027657248,0.00043102523,0.00025001864,0.00034102387,0.00017880987,0.00012291326,0.00046666648,0.005570303],"category_scores_gemma":[0.00048924296,0.00019236235,0.00030769108,0.00020932607,0.0000596177,0.00019410983,0.00001880021,0.00071911374,0.0002999782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036825358,0.00023643274,0.77034914,0.00002465793,0.00027495666,0.0007895038,0.00014750226,0.000028314878,0.0024621156,0.00007218795,0.21671171,0.005220933],"study_design_scores_gemma":[0.0040620393,0.002839893,0.766795,0.000012150192,0.00037326358,0.0004651693,0.00003856775,0.0001794417,0.0011417211,0.0003857293,0.22346321,0.0002438202],"about_ca_topic_score_codex":0.0015497961,"about_ca_topic_score_gemma":0.0008326195,"teacher_disagreement_score":0.009825536,"about_ca_system_score_codex":0.0018835193,"about_ca_system_score_gemma":0.0010029264,"threshold_uncertainty_score":0.99533874},"labels":[],"label_agreement":null},{"id":"W2141196289","doi":"10.1186/s13550-014-0027-5","title":"Detecting functional changes with [18F]FAZA in a renal cell carcinoma mouse model following sunitinib therapy","year":2014,"lang":"en","type":"article","venue":"EJNMMI Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Alberta","funders":"Alberta Innovates; Alberta Innovates - Health Solutions","keywords":"Sunitinib; Medicine; Renal cell carcinoma; Tyrosine-kinase inhibitor; Hypoxia (environmental); In vivo; Angiogenesis; Tumor hypoxia; Tumor microenvironment; Combination therapy; Ex vivo; Cancer research; Metastasis; Pharmacology; Pathology; Internal medicine; Cancer; Radiation therapy; Chemistry","score_opus":0.14231682968181558,"score_gpt":0.33885574967959753,"score_spread":0.19653891999778195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141196289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98541653,0.00040362158,0.00033589796,0.0010588173,0.000039296305,0.0007881046,0.0000035447736,0.000060538394,0.011893651],"genre_scores_gemma":[0.9907942,0.000028301436,0.0012822433,0.00014609023,0.00027149724,0.00023818351,0.000029636183,0.000080578226,0.0071292715],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965058,0.0003814664,0.00020436422,0.0005958822,0.0014109784,0.0009014932],"domain_scores_gemma":[0.9983667,0.00044626373,0.000053265343,0.0005642861,0.0002707633,0.00029872727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019058313,0.00026372215,0.00038602503,0.0007003598,0.00025884196,0.00006160401,0.00017191692,0.00011456406,0.000098495555],"category_scores_gemma":[0.00014165837,0.00019763796,0.000116971154,0.0006492427,0.00011349374,0.00009822948,0.000096681404,0.00089159334,0.00006305141],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057057897,0.001070045,0.13756849,0.00028020094,0.0001702502,0.0011542417,0.0029482143,0.0018361821,0.82827765,0.00017445139,0.0012935072,0.019520983],"study_design_scores_gemma":[0.014221766,0.0059028147,0.05132192,0.00023310196,0.000049908504,0.000125336,0.0014427621,0.024274943,0.9000886,0.00015982217,0.0016362405,0.00054276455],"about_ca_topic_score_codex":0.00040377022,"about_ca_topic_score_gemma":0.0005310365,"teacher_disagreement_score":0.08624658,"about_ca_system_score_codex":0.00038231735,"about_ca_system_score_gemma":0.0003330748,"threshold_uncertainty_score":0.8059442},"labels":[],"label_agreement":null},{"id":"W2141371761","doi":"10.1245/s10434-012-2247-0","title":"Treatment Management of Small Renal Masses in the 21st Century: A Paradigm Shift","year":2012,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé","keywords":"Surgical oncology; Paradigm shift; Medicine; General surgery; Intensive care medicine; Internal medicine; Epistemology","score_opus":0.1183504983016805,"score_gpt":0.3615889036307327,"score_spread":0.24323840532905222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141371761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8511384,0.006317111,0.0000024636179,0.016474662,0.00009256529,0.00069441955,0.000010223327,0.000010934786,0.12525919],"genre_scores_gemma":[0.9807843,0.018322084,0.00037038937,0.00020306565,0.00009741458,0.00008648206,0.000026021095,0.000010994707,0.00009926048],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99839944,0.00024252008,0.00049105973,0.00018849247,0.00024872235,0.00042977036],"domain_scores_gemma":[0.99895275,0.00035506545,0.00017787135,0.0003394726,0.000026399484,0.00014845411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004499866,0.00018118501,0.00062508055,0.00011396099,0.000020073687,0.0000028178977,0.00012476473,0.00011800915,0.00017196694],"category_scores_gemma":[0.0000035613987,0.00010239313,0.00024184621,0.0002176537,0.0001482177,0.000038042363,0.000046373338,0.00010786376,0.000022380169],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01020312,0.036331914,0.22392346,0.00093133777,0.003047857,0.011530837,0.0078067053,0.00004081347,0.00033896373,0.30769217,0.0014943001,0.3966585],"study_design_scores_gemma":[0.0040347204,0.0050615673,0.19531669,0.00009504805,0.0002940857,0.00030959467,0.00086617627,0.0000030625356,0.002769898,0.00041610372,0.79071474,0.00011830228],"about_ca_topic_score_codex":0.00014510407,"about_ca_topic_score_gemma":0.000019030502,"teacher_disagreement_score":0.78922045,"about_ca_system_score_codex":0.000104687315,"about_ca_system_score_gemma":0.000060705577,"threshold_uncertainty_score":0.41754708},"labels":[],"label_agreement":null},{"id":"W2141457695","doi":"10.1016/j.urology.2013.05.029","title":"In Vitro Comparison of a Novel Facilitated Ultrasound Targeting Technology vs Standard Technique for Percutaneous Renal Biopsy","year":2013,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Biopsy; Percutaneous; Ultrasound; Radiology; Gold standard (test); Imaging phantom; Surgery","score_opus":0.0183001007590461,"score_gpt":0.2835342566960109,"score_spread":0.2652341559369648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141457695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97723734,0.00038859536,0.018181326,0.0019158926,0.00005943047,0.0018366901,0.00007852746,0.000071560426,0.00023064303],"genre_scores_gemma":[0.9628117,0.000004931905,0.03649668,0.000117262025,0.000023682718,0.00036127795,0.000073707466,0.0000246632,0.00008606323],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985054,0.000040292194,0.00053743913,0.00035866583,0.00013582934,0.00042234134],"domain_scores_gemma":[0.99896264,0.00031506375,0.00014660506,0.00028320428,0.0002194471,0.00007302356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017879592,0.00019800941,0.0006969419,0.00042997886,0.000035312907,0.0000042851507,0.00011608523,0.00034494066,0.00012294496],"category_scores_gemma":[0.00042090917,0.00016915635,0.000093047005,0.0002788275,0.00025191455,0.00003435079,0.00003832525,0.00029117713,0.0000143859415],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019826975,0.00031822204,0.0051614526,0.00007054108,0.00005788536,0.000081789134,0.00028386482,0.000057838275,0.99116516,0.00007993074,0.00044268303,0.00029795498],"study_design_scores_gemma":[0.0029445344,0.005333299,0.0007577312,0.000020576434,0.000103770704,0.0036059446,0.00039165243,0.0012056712,0.98208666,0.0007197149,0.0026339989,0.0001964277],"about_ca_topic_score_codex":0.0001602726,"about_ca_topic_score_gemma":0.000010515072,"teacher_disagreement_score":0.018315352,"about_ca_system_score_codex":0.00015092293,"about_ca_system_score_gemma":0.00008603351,"threshold_uncertainty_score":0.6897996},"labels":[],"label_agreement":null},{"id":"W2141561215","doi":"10.1016/j.eururo.2011.11.047","title":"A Non–Cancer-Related Survival Benefit Is Associated With Partial Nephrectomy","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Propensity score matching; Nephrectomy; Hazard ratio; Renal cell carcinoma; Confidence interval; Internal medicine; Cancer; Proportional hazards model; Population; Epidemiology; Surgery; Urology; Kidney","score_opus":0.0351994027784501,"score_gpt":0.2380875145360995,"score_spread":0.2028881117576494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141561215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8798609,0.00022242374,0.000013767413,0.0003730381,0.00023117627,0.00036291085,0.000008268371,0.00019285847,0.11873466],"genre_scores_gemma":[0.9959658,0.00003182706,0.00015803578,0.0009897138,0.00012191919,0.000028158096,0.000033851422,0.00008556019,0.0025851405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844027,0.00018691525,0.00029193563,0.0004399675,0.00019242486,0.00044851602],"domain_scores_gemma":[0.99909604,0.00004938631,0.0001537032,0.00038954642,0.00010438051,0.00020696723],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024327717,0.00025075767,0.00040692274,0.00009544946,0.00006554272,0.00000765167,0.00013377683,0.000088174915,0.0016302993],"category_scores_gemma":[0.000028649798,0.00018907958,0.00010402854,0.0002228707,0.000110749825,0.000039007897,0.00006683575,0.0002892817,0.00074587215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036258008,0.0016065725,0.964976,0.000028964841,0.0028967299,0.009715027,0.006117153,0.000018460374,0.0025710731,0.00039958846,0.0027870105,0.0052576205],"study_design_scores_gemma":[0.0060299602,0.00395634,0.9707587,0.000028879238,0.0008810712,0.00020960796,0.000020197329,0.00013649534,0.0033049565,0.000036530408,0.0143635925,0.000273682],"about_ca_topic_score_codex":0.00010198485,"about_ca_topic_score_gemma":0.000031953714,"teacher_disagreement_score":0.11614952,"about_ca_system_score_codex":0.00007968921,"about_ca_system_score_gemma":0.000064202766,"threshold_uncertainty_score":0.99928236},"labels":[],"label_agreement":null},{"id":"W2142294849","doi":"10.1016/j.eururo.2013.03.034","title":"Management of Localized Kidney Cancer: Calculating Cancer-specific Mortality and Competing Risks of Death for Surgery and Nonsurgical Management","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Hazard ratio; Kidney cancer; Confidence interval; Confounding; Proportional hazards model; Cancer; Surgery; Cohort; Urology; Internal medicine; Kidney","score_opus":0.11561826740946685,"score_gpt":0.33747665171932817,"score_spread":0.22185838430986132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142294849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891506,0.0029336265,0.00043924808,0.0003745707,0.00009996502,0.0009051134,0.000024606088,0.000022040002,0.0060502365],"genre_scores_gemma":[0.9951972,0.0022556153,0.0020778154,0.00017016812,0.000053426927,0.000084458195,0.000022673783,0.00003193607,0.000106746695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998486,0.000202871,0.00051348575,0.00037345072,0.00015529782,0.00026889006],"domain_scores_gemma":[0.999055,0.00020030074,0.00023419053,0.00025622928,0.00007837568,0.00017584924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048766893,0.00017688108,0.0005291259,0.00009452164,0.000051326508,0.000007804769,0.00005769937,0.000034316363,0.00010778186],"category_scores_gemma":[0.000017236505,0.00014837255,0.00009119876,0.00008316488,0.00016132514,0.000024578076,0.00015126818,0.00008098859,0.0000027708509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005483566,0.00022228585,0.93000054,0.002295837,0.0011971411,0.00050156494,0.00023903024,0.00013062969,0.0010344791,0.0014734779,0.0007734764,0.06158315],"study_design_scores_gemma":[0.0024496128,0.00019795024,0.98948175,0.00020690598,0.00053685816,0.000027348342,0.0001103313,0.0010130971,0.00046169304,0.00003594218,0.00534786,0.00013065645],"about_ca_topic_score_codex":0.0006086184,"about_ca_topic_score_gemma":0.000005516502,"teacher_disagreement_score":0.061452493,"about_ca_system_score_codex":0.00004189284,"about_ca_system_score_gemma":0.000015769374,"threshold_uncertainty_score":0.6050457},"labels":[],"label_agreement":null},{"id":"W2142381505","doi":"10.1111/j.1464-410x.2007.07170.x","title":"Patients with distant metastases from renal cell carcinoma can be accurately identified: external validation of a new nomogram","year":2007,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nomogram; Medicine; Cohort; Nephrectomy; Renal cell carcinoma; Logistic regression; Oncology; Radiology; Distant metastasis; Internal medicine; Pathological; Kidney cancer; Cancer; Metastasis; Kidney","score_opus":0.026756054521536527,"score_gpt":0.2614495650453316,"score_spread":0.23469351052379508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142381505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99429333,0.0024848022,0.002341417,0.0001350374,0.00023442601,0.00024340847,0.00011632374,0.0000070707106,0.00014418695],"genre_scores_gemma":[0.99667126,0.00005431225,0.0026428094,0.00014916933,0.00023239828,0.0000014158461,0.0001261062,0.000028550958,0.00009399072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783975,0.00011273281,0.000869401,0.00023854866,0.000614074,0.0003255244],"domain_scores_gemma":[0.9979374,0.00013844622,0.00087888964,0.00019447856,0.0004881153,0.0003626653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003514381,0.00018779741,0.0005788652,0.00020190637,0.000047793073,0.00003699258,0.0001608892,0.00009805101,0.00021305094],"category_scores_gemma":[0.00008198695,0.000167264,0.00019118578,0.00016408911,0.00011075617,0.00013978903,0.00003696043,0.00031845627,0.0000024239218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01234156,0.0025796967,0.85608965,0.00009124242,0.0007479651,0.023182014,0.00076760247,0.00014050248,0.04379604,0.00001376686,0.002991052,0.057258923],"study_design_scores_gemma":[0.008019514,0.004243135,0.86849505,0.00010282687,0.0009396,0.0031452468,0.00008442984,0.0000032526823,0.11416052,0.00012908877,0.0005371478,0.00014015922],"about_ca_topic_score_codex":0.0024546091,"about_ca_topic_score_gemma":0.0005577593,"teacher_disagreement_score":0.07036448,"about_ca_system_score_codex":0.00011092476,"about_ca_system_score_gemma":0.00027673013,"threshold_uncertainty_score":0.68208283},"labels":[],"label_agreement":null},{"id":"W2142466627","doi":"10.5171/2012.441895","title":"Case Report of Long Term Complete Remission of Metastatic Renal Squamous Cell Carcinoma after Palliative Radiotherapy and Adjuvant Dichloroacetate","year":2013,"lang":"en","type":"article","venue":"Advances in Cancer Research & Treatment","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Oncology; Radiation therapy; Renal cell carcinoma; Internal medicine; Basal cell; Adjuvant radiotherapy; Adjuvant","score_opus":0.08120192339325605,"score_gpt":0.4000797236064999,"score_spread":0.31887780021324386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142466627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9122262,0.0849074,0.00004502752,0.00021412267,0.00004107148,0.002129902,0.000051064315,0.000009626596,0.00037561302],"genre_scores_gemma":[0.98453563,0.010728867,0.002698382,0.000014213468,0.000038329123,0.001287844,0.00003300434,0.000042647393,0.00062107685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970153,0.00028709587,0.00074688887,0.00063398294,0.0007581682,0.00055859616],"domain_scores_gemma":[0.99800205,0.00041903098,0.0002926054,0.0006249627,0.0003545883,0.00030674023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036729232,0.00033169868,0.0008670241,0.00035077514,0.000068209556,0.0000146483935,0.000090921094,0.00005546798,0.00030490596],"category_scores_gemma":[0.000039945604,0.00022380892,0.00013591642,0.0003653659,0.00046084693,0.0002250963,0.0000699109,0.00022161787,0.000003009165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030180216,0.0017274888,0.7408029,0.0012453104,0.0002521007,0.13074547,0.0034875232,0.00017071361,0.023631876,0.0000067656874,0.000029581443,0.094882265],"study_design_scores_gemma":[0.017490398,0.012265125,0.67066586,0.00097087387,0.00046183987,0.009581334,0.00093566754,0.000610434,0.285677,0.00025393817,0.00060208363,0.00048546385],"about_ca_topic_score_codex":0.0060852407,"about_ca_topic_score_gemma":0.0011149418,"teacher_disagreement_score":0.2620451,"about_ca_system_score_codex":0.0013398208,"about_ca_system_score_gemma":0.00031152027,"threshold_uncertainty_score":0.9199104},"labels":[],"label_agreement":null},{"id":"W2142583773","doi":"10.1016/j.urology.2008.06.059","title":"Cytoreductive Partial Nephrectomy Does Not Undermine Cancer Control in Metastatic Renal Cell Carcinoma: A Population-Based Study","year":2008,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Urology; Kidney cancer; Oncology; Cancer; Internal medicine; Surgery; Kidney","score_opus":0.029241471219055525,"score_gpt":0.2823683039330283,"score_spread":0.2531268327139728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142583773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963666,0.0003019751,0.00015617348,0.0011550175,0.00020125283,0.00163426,0.000029383858,0.00003766215,0.000117649535],"genre_scores_gemma":[0.9977456,0.0000025807888,0.00011701425,0.00094527286,0.00019738186,0.00068492955,0.00004282869,0.000032822853,0.00023157809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980676,0.00032210926,0.00042705922,0.0004906417,0.00027959477,0.00041299927],"domain_scores_gemma":[0.9990684,0.00023916781,0.00013766081,0.00032251593,0.00008289821,0.00014936167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013193121,0.0002611094,0.00063952204,0.00026486246,0.0000779591,0.000004742758,0.00007871935,0.000078194564,0.00024619236],"category_scores_gemma":[0.00004588409,0.00018609429,0.000108833476,0.0002108419,0.000087922075,0.000046031713,0.000018695524,0.0002448693,0.000020447509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002722041,0.0015536716,0.9834571,0.000022272872,0.00011658239,0.0024887945,0.00066592614,0.0029579785,0.0058498946,0.000008874243,0.000051439947,0.0001054436],"study_design_scores_gemma":[0.018874746,0.0028546022,0.96555924,0.000004252123,0.0006512067,0.00010126521,0.00013789683,0.003416049,0.008034829,0.00003024136,0.0001360426,0.00019962265],"about_ca_topic_score_codex":0.00476815,"about_ca_topic_score_gemma":0.0017412667,"teacher_disagreement_score":0.017897835,"about_ca_system_score_codex":0.00032456184,"about_ca_system_score_gemma":0.00035786838,"threshold_uncertainty_score":0.7588705},"labels":[],"label_agreement":null},{"id":"W2142856250","doi":"10.1016/j.juro.2012.01.019","title":"Will Radio Frequency Ablation Become “Routine First Line Answer” for Small Renal Masses?","year":2012,"lang":"en","type":"letter","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Cryoablation; Nephrectomy; Renal cell carcinoma; Kidney cancer; Malignancy; Radiofrequency ablation; Renal mass; Ablation; Radiology; Kidney; General surgery; Surgery; Oncology; Internal medicine","score_opus":0.03829860338900135,"score_gpt":0.26295811318614476,"score_spread":0.22465950979714341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142856250","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06831058,0.011029992,0.0063983635,0.9107076,0.0018112272,0.0010276552,0.000047265756,0.000025177616,0.0006421531],"genre_scores_gemma":[0.5828291,0.0022821387,0.0075026974,0.3490432,0.053123128,0.0000498457,0.0005601313,0.00028993536,0.004319801],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99741167,0.00032066926,0.0010402907,0.00021083665,0.00040626322,0.0006102587],"domain_scores_gemma":[0.99643415,0.0010293201,0.0014128244,0.0005390234,0.00042938394,0.00015529044],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012250022,0.00042265392,0.0010758318,0.000350033,0.00011501994,0.000013620517,0.00037871365,0.00078985014,0.0003529592],"category_scores_gemma":[0.0002103522,0.00025171577,0.00048768663,0.000120377445,0.000157973,0.00012403839,0.000045827295,0.0021625499,0.000029559596],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006013955,0.00055942626,0.020844456,0.00091474416,0.0036381911,0.003486734,0.0010336132,0.0002982216,0.0031201474,0.000101172096,0.9575732,0.0024161604],"study_design_scores_gemma":[0.0046438887,0.0076915557,0.010484836,0.00012744956,0.005240512,0.015201786,0.00000827042,0.00008161182,0.00029447896,0.0015562107,0.9543656,0.0003038163],"about_ca_topic_score_codex":0.0000424141,"about_ca_topic_score_gemma":0.00002688868,"teacher_disagreement_score":0.5616644,"about_ca_system_score_codex":0.0003013682,"about_ca_system_score_gemma":0.00021618359,"threshold_uncertainty_score":0.9999935},"labels":[],"label_agreement":null},{"id":"W2142904013","doi":"10.1016/j.juro.2008.08.014","title":"Contemporary Results of Percutaneous Biopsy of 100 Small Renal Masses: A Single Center Experience","year":2008,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":245,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Percutaneous; Percutaneous biopsy; Single Center; Biopsy; Center (category theory); Radiology; Renal biopsy; Renal mass; Urology; General surgery; Kidney; Surgery; Internal medicine; Nephrectomy","score_opus":0.07102314816233024,"score_gpt":0.27085025494124276,"score_spread":0.19982710677891252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142904013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925809,0.0017194962,0.00006934673,0.0010735447,0.000114852315,0.00013035559,0.000009298459,0.0000044173385,0.0042977887],"genre_scores_gemma":[0.99846786,0.00017282416,0.0008310185,0.00018814359,0.00008987906,6.36681e-7,0.0000023702996,0.000012612722,0.0002346286],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.99846727,0.00021405502,0.00078392494,0.00010066559,0.00026508616,0.00016897457],"domain_scores_gemma":[0.99833757,0.00027703348,0.00072895223,0.00030354757,0.00025543937,0.00009747367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032563353,0.00012535151,0.0004907956,0.00013950194,0.000032389344,0.0000013146855,0.00020207945,0.00007895246,0.000041159474],"category_scores_gemma":[0.00015588882,0.000072342526,0.00016019758,0.00010919362,0.00043345641,0.00003639911,0.00004472226,0.0002206868,0.0000033853898],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027977664,0.0014087533,0.027109008,0.00005287972,0.00037915132,0.009997857,0.013838496,0.00008155018,0.91676086,0.000009485856,0.0020142351,0.00037006053],"study_design_scores_gemma":[0.013195144,0.036562692,0.04556588,0.00025690286,0.00058925216,0.64983785,0.0027298278,0.00009598677,0.2405509,0.00011161083,0.010237066,0.00026686932],"about_ca_topic_score_codex":0.00007688805,"about_ca_topic_score_gemma":0.0000030968167,"teacher_disagreement_score":0.6762099,"about_ca_system_score_codex":0.00004426472,"about_ca_system_score_gemma":0.00018505487,"threshold_uncertainty_score":0.29500428},"labels":[],"label_agreement":null},{"id":"W2143006986","doi":"10.1634/theoncologist.2010-0263","title":"Sunitinib in Metastatic Renal Cell Carcinoma: Recommendations for Management of Noncardiovascular Toxicities","year":2011,"lang":"en","type":"review","venue":"The Oncologist","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; BC Cancer Agency","funders":"Genentech; GlaxoSmithKline; Pfizer","keywords":"Sunitinib; Medicine; Dosing; Renal cell carcinoma; Intensive care medicine; Tyrosine-kinase inhibitor; Toxicity; Oncology; Internal medicine; Cancer","score_opus":0.20589735659080372,"score_gpt":0.37857232910030164,"score_spread":0.17267497250949793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143006986","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002228863,0.9690383,0.00011607671,0.00011739892,0.00016650188,0.004404604,0.00016034726,0.000020886278,0.025752977],"genre_scores_gemma":[0.0014812172,0.9868333,0.005782584,0.000037441238,0.000080731545,0.0018549281,0.0004905438,0.00006315984,0.0033761018],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977276,0.0004139904,0.00092452427,0.000373772,0.00021240306,0.00034772695],"domain_scores_gemma":[0.9979677,0.00047730753,0.00049869344,0.00089392817,0.00008934027,0.000073032716],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010598795,0.00041145174,0.0021842706,0.000244664,0.000073588024,0.000010468733,0.0003486465,0.00013663019,0.000113701026],"category_scores_gemma":[0.000026716858,0.00024823679,0.0011948983,0.00031792466,0.00022631855,0.000027581582,0.00014496138,0.00030209686,0.00003083713],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015381309,0.0008669683,0.000011906734,0.052027747,0.0021128026,0.00042221285,0.0003633979,0.0000028183758,0.0000010708341,0.0016561351,0.00394697,0.9384342],"study_design_scores_gemma":[0.0017531287,0.0008860298,0.000103213686,0.0044205794,0.011708489,0.00011894578,0.0005671959,0.0000016976112,0.00006891748,0.0001511128,0.9799892,0.00023154807],"about_ca_topic_score_codex":0.00020740947,"about_ca_topic_score_gemma":0.000032665197,"teacher_disagreement_score":0.97604215,"about_ca_system_score_codex":0.0005490051,"about_ca_system_score_gemma":0.0002973305,"threshold_uncertainty_score":0.99999696},"labels":[],"label_agreement":null},{"id":"W2143465242","doi":"10.1016/j.humpath.2013.05.014","title":"Dysregulation of the mammalian target of rapamycin pathway in chromophobe renal cell carcinomas","year":2013,"lang":"en","type":"article","venue":"Human Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"PTEN; Chromophobe cell; PI3K/AKT/mTOR pathway; Protein kinase B; Medicine; Cancer research; Clear cell; Internal medicine; Kidney cancer; Kidney; Cancer; Oncology; Renal cell carcinoma; Pathology; Endocrinology; Biology; Apoptosis","score_opus":0.018133259746038112,"score_gpt":0.23218012039886868,"score_spread":0.21404686065283057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143465242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909968,0.00034803513,0.000008950501,0.00016058145,0.000078394754,0.00066288176,0.000007893381,0.0000104346445,0.007726051],"genre_scores_gemma":[0.99798554,0.0000029423434,0.00050588953,0.000057602545,0.000048474813,0.00004593084,0.000031836553,0.000021034944,0.001300741],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986257,0.00019163123,0.0004929654,0.00025110407,0.00020267713,0.00023592032],"domain_scores_gemma":[0.99900347,0.000033333723,0.00025038474,0.00055139855,0.00010356231,0.00005784161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019027785,0.00015686448,0.000418119,0.00016587958,0.000033799864,0.0000026197401,0.00013069794,0.0001394153,0.0005888848],"category_scores_gemma":[0.000018447812,0.00010828956,0.00013785498,0.0001789059,0.00021481708,0.000047009402,0.000068187015,0.00015998025,0.000027056445],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033475524,0.00021862952,0.22382104,0.000108075335,0.00000797678,0.000098129975,0.0008423097,0.000021514963,0.77424145,0.0002632183,0.00015579215,0.00018837216],"study_design_scores_gemma":[0.0010358335,0.00038207986,0.5938092,0.000029810266,0.000017665254,0.00005825722,0.00006558889,0.000014625339,0.40406284,0.0004181816,0.000054892247,0.000051044626],"about_ca_topic_score_codex":0.00022039808,"about_ca_topic_score_gemma":0.00006049344,"teacher_disagreement_score":0.37017864,"about_ca_system_score_codex":0.00008840405,"about_ca_system_score_gemma":0.00007266517,"threshold_uncertainty_score":0.64478755},"labels":[],"label_agreement":null},{"id":"W2143802979","doi":"10.5489/cuaj.502","title":"Cost-utility analysis of radical nephrectomy versus partial nephrectomy in the management of small renal masses: adjusting for the burden of ensuing chronic kidney disease","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Nephrectomy; Medicine; Kidney disease; Creatinine; Urology; Kidney; Surgery; Internal medicine","score_opus":0.04247325949045438,"score_gpt":0.270323288717447,"score_spread":0.2278500292269926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143802979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98551816,0.00058152905,0.00060133275,0.011318486,0.00012390829,0.0014433599,0.0000857677,0.000005607279,0.0003218457],"genre_scores_gemma":[0.99842167,0.00006552466,0.0007887575,0.00027595094,0.00022248161,0.00014208331,0.0000485291,0.000007799437,0.000027207701],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977931,0.00034336513,0.0007159903,0.00019962483,0.0005017258,0.0004462131],"domain_scores_gemma":[0.9973436,0.001042691,0.00059267745,0.0002452011,0.00027091705,0.0005049139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014415211,0.00015190733,0.00048256683,0.0002554897,0.00012662678,0.000030461097,0.00026787183,0.00011623229,0.00043740007],"category_scores_gemma":[0.0008822435,0.00008955947,0.000441458,0.0006853515,0.00012894454,0.000051476953,0.000027597422,0.00035674765,0.0000016788949],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020167811,0.00031149946,0.95055485,0.00021957747,0.007871142,0.00015188483,0.0010941268,0.01113743,0.00024143835,0.00044343426,0.002467045,0.023490781],"study_design_scores_gemma":[0.0043859193,0.00049673195,0.9336874,0.00007343678,0.0056752246,0.0000068870318,0.00093198766,0.04253705,0.00008863514,0.000110527944,0.0118967,0.000109511],"about_ca_topic_score_codex":0.0059535606,"about_ca_topic_score_gemma":0.00089971983,"teacher_disagreement_score":0.03139962,"about_ca_system_score_codex":0.00095424335,"about_ca_system_score_gemma":0.0006205642,"threshold_uncertainty_score":0.90000427},"labels":[],"label_agreement":null},{"id":"W2144502965","doi":"10.1080/00313020802197962","title":"Sporadic clear cell renal cell carcinoma with diffuse cytokeratin 7 immunoreactivity","year":2008,"lang":"en","type":"article","venue":"Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Cytokeratin; Clear cell; Pathology; Immunostaining; Immunohistochemistry; Negativity effect; Reactivity (psychology); Biology; Medicine","score_opus":0.01769684213915607,"score_gpt":0.21566792681732233,"score_spread":0.19797108467816626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144502965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762391,0.00071524567,0.00013689305,0.00014420263,0.00007420407,0.0004444932,0.000012209801,0.000088225446,0.022145469],"genre_scores_gemma":[0.9946543,0.00006917272,0.0021398682,0.00026519236,0.00014034614,0.00004511106,0.00006791254,0.00006152041,0.0025565724],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99825454,0.00015076774,0.0002844713,0.0005364169,0.00028157159,0.0004922372],"domain_scores_gemma":[0.99876493,0.00007206143,0.00013924635,0.00070878625,0.00008264848,0.00023232221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012827208,0.00032062567,0.0005468489,0.00014480672,0.00016440114,0.00000787348,0.00011246937,0.00016603663,0.0001528701],"category_scores_gemma":[0.000012959904,0.00023978755,0.0001327532,0.00017191278,0.0003004321,0.000071155904,0.00005965016,0.00042657155,0.0003166038],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002498104,0.0023067696,0.43803677,0.00010800077,0.000036403744,0.04756226,0.0019135012,0.000011420823,0.5059674,0.000024988703,0.0010367035,0.00049773033],"study_design_scores_gemma":[0.0063168085,0.003963748,0.66741043,0.000013566223,0.00016736197,0.010147692,0.000105064944,0.000050851027,0.3106105,0.000012913695,0.0009272254,0.00027385278],"about_ca_topic_score_codex":0.0001410589,"about_ca_topic_score_gemma":0.000011106583,"teacher_disagreement_score":0.22937365,"about_ca_system_score_codex":0.00017038861,"about_ca_system_score_gemma":0.00019890354,"threshold_uncertainty_score":0.9778252},"labels":[],"label_agreement":null},{"id":"W2145252635","doi":"10.1007/978-2-287-71651-5_4","title":"Peut-on surveiller les petites tumeurs rénales?","year":2008,"lang":"fr","type":"book-chapter","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine","score_opus":0.09537794341035788,"score_gpt":0.28437155389356283,"score_spread":0.18899361048320495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145252635","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033909544,0.023288693,0.000031990712,0.0016424747,0.0014807214,0.0010854664,0.00009034559,0.00018273629,0.93828803],"genre_scores_gemma":[0.31022182,0.012268199,0.00042871374,0.00048275501,0.001585978,0.000026610283,0.00032258098,0.0002287364,0.6744346],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955175,0.00012732025,0.0009376829,0.0012602911,0.0012227958,0.0009343944],"domain_scores_gemma":[0.99644166,0.00089307624,0.0003440366,0.0012597847,0.00034760011,0.00071382185],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.00027028675,0.0013911185,0.001524129,0.0004821385,0.0003318451,0.000040134106,0.0003018183,0.00084622845,0.04014222],"category_scores_gemma":[0.00011511767,0.0010985321,0.0009950195,0.000075566226,0.000853611,0.00007198645,0.0001464613,0.0010774145,0.018101986],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002520494,0.0027481539,0.111984044,0.0025943432,0.0068600657,0.039014056,0.0009996337,0.00017648752,0.002148367,0.5007069,0.11832054,0.21192689],"study_design_scores_gemma":[0.0025303364,0.003056702,0.079993695,0.0020507926,0.0008882865,0.0016646575,0.00009339663,0.00004383946,0.0028716682,0.00018425539,0.90528584,0.0013365364],"about_ca_topic_score_codex":0.0009924888,"about_ca_topic_score_gemma":0.00029404837,"teacher_disagreement_score":0.7869653,"about_ca_system_score_codex":0.00082254125,"about_ca_system_score_gemma":0.00033644645,"threshold_uncertainty_score":0.99988395},"labels":[],"label_agreement":null},{"id":"W2145856054","doi":"10.1200/jco.2012.43.7376","title":"Proof of Efficacy Is Not Enough: Contemporary Management of Patients With Metastatic Renal Cell Carcinoma With Targeted Therapy","year":2012,"lang":"en","type":"letter","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Targeted therapy; Oncology; Internal medicine; Systemic therapy; Sunitinib; Cancer","score_opus":0.13195757438961989,"score_gpt":0.3748429429331296,"score_spread":0.2428853685435097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145856054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.940627,0.0030110409,0.000072717135,0.0501543,0.0005261012,0.0021980905,0.00008700854,0.0000074100803,0.003316349],"genre_scores_gemma":[0.94315994,0.00018171158,0.008963762,0.04549473,0.0010526584,0.000020834272,0.00013684985,0.00010544305,0.0008840589],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99208945,0.00092486,0.00434171,0.00044613107,0.0017152017,0.00048266642],"domain_scores_gemma":[0.98704416,0.0016277893,0.008873876,0.0006955789,0.0013887087,0.0003698748],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0016100035,0.0005855161,0.0046598217,0.00036523954,0.000027823715,0.0000059747294,0.0004096655,0.0007502787,0.00026146008],"category_scores_gemma":[0.00008379313,0.00031685468,0.0009629965,0.00024748247,0.00046456038,0.00011974782,0.000079043784,0.0026334045,0.0000061956443],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13711879,0.03267549,0.27399102,0.004359688,0.021281267,0.02123631,0.0009886994,0.000019021256,0.00012899919,0.0000071006207,0.46711323,0.041080393],"study_design_scores_gemma":[0.06276009,0.12393426,0.5525869,0.00096667116,0.0059326566,0.00017911755,0.00007687761,0.0000025691536,0.0069258013,0.000011883238,0.24620038,0.00042280747],"about_ca_topic_score_codex":0.000027673934,"about_ca_topic_score_gemma":0.0000011148235,"teacher_disagreement_score":0.27859586,"about_ca_system_score_codex":0.00024192629,"about_ca_system_score_gemma":0.001973102,"threshold_uncertainty_score":0.99992836},"labels":[],"label_agreement":null},{"id":"W2146264931","doi":"10.5489/cuaj.169","title":"Spontaneous regression of metastatic pulmonary renal cell carcinoma in the setting of sarcomatoid differentiation of the primary tumour","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Renal cell carcinoma; Medicine; Sarcomatoid carcinoma; Pathology; Radiology; Carcinoma; Regression; Oncology; Internal medicine","score_opus":0.010786370233721277,"score_gpt":0.2023401799860404,"score_spread":0.19155380975231912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146264931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99385005,0.00037911333,0.000005588527,0.004096888,0.00006358765,0.00041320157,0.000015470232,0.0000022401996,0.0011738861],"genre_scores_gemma":[0.9993699,0.00001567451,0.00013658572,0.00033094487,0.000044148972,0.000009104697,0.000016192333,0.000008056279,0.00006935074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774283,0.0006382208,0.00065072917,0.000119113654,0.0005817656,0.00026736464],"domain_scores_gemma":[0.9981413,0.00038665114,0.0009108369,0.00016823829,0.00024743928,0.00014553758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073549605,0.00013027775,0.00038486984,0.00016205531,0.00008667922,0.000013162846,0.0002039856,0.00010005075,0.00013947766],"category_scores_gemma":[0.00032025416,0.00006396981,0.00020433024,0.000267885,0.00004129475,0.00005907206,0.00002419053,0.00042156593,0.0000026480463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005747655,0.00016774543,0.9610758,0.00005442376,0.000034607932,0.00024644154,0.0004599372,0.000060591225,0.03646981,0.000019095804,0.00040946616,0.0009446493],"study_design_scores_gemma":[0.00056730607,0.00024694804,0.9924963,0.000054822678,0.000109838424,0.0012623959,0.00023804171,0.00031632325,0.004248762,0.00038194933,0.000025874213,0.00005141311],"about_ca_topic_score_codex":0.0021900085,"about_ca_topic_score_gemma":0.00034774395,"teacher_disagreement_score":0.032221045,"about_ca_system_score_codex":0.0005867648,"about_ca_system_score_gemma":0.00035026975,"threshold_uncertainty_score":0.33106527},"labels":[],"label_agreement":null},{"id":"W2146327960","doi":"10.5489/cuaj.12057","title":"Partial nephrectomy is not the proven standard for Stage T1b renal cell carcinoma","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Nephrectomy; Renal cell carcinoma; Stage (stratigraphy); Urology; Medicine; Oncology; Internal medicine; Kidney; Biology","score_opus":0.025764590862728053,"score_gpt":0.24540886137545043,"score_spread":0.21964427051272237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146327960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9669209,0.00048434327,0.00020503416,0.02808828,0.00043941225,0.00089814875,0.0002421429,0.000019487637,0.0027022494],"genre_scores_gemma":[0.98672754,0.0000127080775,0.00041861786,0.007709451,0.0016792679,0.00009068309,0.000027868558,0.000022687158,0.0033111814],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99776626,0.00018557376,0.00038563088,0.00019450308,0.00053466344,0.0009333781],"domain_scores_gemma":[0.99781626,0.00025276997,0.00031855842,0.00018108668,0.00029685843,0.0011344488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011707337,0.00019872258,0.00032353736,0.00009986179,0.00047235936,0.00010378356,0.00014552668,0.00023422283,0.0009083776],"category_scores_gemma":[0.00036776136,0.00012346737,0.00029466438,0.0001368134,0.00004013123,0.00012452772,0.000017748665,0.00056760624,0.00006206096],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006399899,0.00009680442,0.9326827,0.000015104093,0.00015505854,0.00007111458,0.0006456091,0.000011362539,0.00096778345,0.00023893695,0.061377294,0.0030982199],"study_design_scores_gemma":[0.002123327,0.0009368464,0.3888864,0.0000042804313,0.0002305572,0.00010880003,0.00009845565,0.00008415955,0.0056758528,0.00008205185,0.6016217,0.00014756687],"about_ca_topic_score_codex":0.00055818073,"about_ca_topic_score_gemma":0.00018799487,"teacher_disagreement_score":0.5437963,"about_ca_system_score_codex":0.0020829714,"about_ca_system_score_gemma":0.00080787594,"threshold_uncertainty_score":0.9946097},"labels":[],"label_agreement":null},{"id":"W2147322143","doi":"10.5489/cuaj.499","title":"Renal cell carcinoma seeding of a percutaneous biopsy tract","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Biopsy; Nephrectomy; Renal cell carcinoma; Percutaneous; Radiology; Papillary renal cell carcinomas; Renal biopsy; Cyst; Kidney; Surgery; Pathology; Internal medicine","score_opus":0.014880872895078117,"score_gpt":0.20954102318826184,"score_spread":0.19466015029318373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147322143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831434,0.00027532375,0.000011811041,0.0059280554,0.00014115419,0.00023853539,0.0000143957905,0.000014147598,0.010233171],"genre_scores_gemma":[0.99715596,0.000015299827,0.00059947534,0.00079734524,0.00030916004,0.000006373268,0.000012031094,0.000015348278,0.0010890262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983366,0.00010694952,0.0004322238,0.00018513428,0.00042050585,0.000518596],"domain_scores_gemma":[0.9980418,0.00013626201,0.0003233544,0.00011778511,0.00040190876,0.0009788831],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031493074,0.00016243396,0.000349217,0.00023700383,0.00014716348,0.000059061695,0.00010873559,0.00025127266,0.002261979],"category_scores_gemma":[0.0002683466,0.00012353699,0.00022814565,0.00018983406,0.00003334133,0.000091880385,0.000010881801,0.0005340124,0.00016662154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003526415,0.00012753128,0.95275927,0.0000130479375,0.0000671085,0.0015153058,0.00024925405,0.000023353427,0.038212996,0.000024127776,0.005502933,0.0014698165],"study_design_scores_gemma":[0.00071126764,0.00085589767,0.9861111,0.000010708941,0.00013290279,0.008002971,0.00014797325,0.00016023354,0.0013186835,0.00018741186,0.0022293727,0.00013147273],"about_ca_topic_score_codex":0.0038039824,"about_ca_topic_score_gemma":0.00006701509,"teacher_disagreement_score":0.036894314,"about_ca_system_score_codex":0.0014874052,"about_ca_system_score_gemma":0.0004892781,"threshold_uncertainty_score":0.9986501},"labels":[],"label_agreement":null},{"id":"W2147663823","doi":"10.1093/annonc/mdq651","title":"Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings","year":2011,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"U.S. Food and Drug Administration; Onyx Pharmaceuticals; Canadian Centre for Applied Research in Cancer Control; Bayer HealthCare; Bayer","keywords":"Sorafenib; Medicine; Renal cell carcinoma; Internal medicine; Rash; Oncology; Expanded access; Population; Adverse effect; Response Evaluation Criteria in Solid Tumors; Progression-free survival; Clinical trial; Hepatocellular carcinoma; Surgery; Phases of clinical research; Chemotherapy","score_opus":0.3243979502389615,"score_gpt":0.4237045269783182,"score_spread":0.09930657673935667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147663823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95303243,0.00008229574,9.019961e-7,0.00036312308,0.000100538644,0.0025718051,0.00006924492,0.000014973962,0.043764673],"genre_scores_gemma":[0.9988343,0.00001559975,0.00017605626,0.00044995605,0.000027279955,0.00006249124,0.000021381726,0.000032474734,0.0003804458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944338,0.0033523715,0.000979247,0.00040673162,0.0003722445,0.00045561173],"domain_scores_gemma":[0.99721754,0.00027989136,0.00075659924,0.0012247603,0.00038039743,0.00014079426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034198456,0.0002823358,0.00090948323,0.000194415,0.00018019139,0.000011789118,0.0013059243,0.00008502821,0.000042147818],"category_scores_gemma":[0.00026694196,0.00020335676,0.00010552498,0.00043986275,0.00020600343,0.00019187001,0.0020872734,0.00064966886,0.00001039715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019847127,0.11155052,0.765044,0.0001883994,0.00030809417,0.0020870767,0.07452385,0.0000068730164,0.0075985733,0.00001708158,0.0033589029,0.015469529],"study_design_scores_gemma":[0.042506836,0.028066296,0.8915161,0.00008129745,0.00018169856,0.000022676419,0.020229742,0.000003461519,0.016755877,0.000039919898,0.00043952998,0.00015659178],"about_ca_topic_score_codex":0.005231015,"about_ca_topic_score_gemma":0.004246558,"teacher_disagreement_score":0.1264721,"about_ca_system_score_codex":0.000094981755,"about_ca_system_score_gemma":0.000292302,"threshold_uncertainty_score":0.8292648},"labels":[],"label_agreement":null},{"id":"W2147709388","doi":"10.1016/j.juro.2008.03.063","title":"Risk Assessment of Incidentally Detected Complex Renal Cysts in Children: Potential Role for a Modification of the Bosniak Classification","year":2008,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Malignancy; Magnetic resonance imaging; Ultrasound; Cyst; Computed tomography; Cohort; Radiology; Pathology","score_opus":0.03021716228678411,"score_gpt":0.2897719088744746,"score_spread":0.2595547465876905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147709388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996178,0.00025002146,0.0020918332,0.0007777139,0.00004820154,0.0005529232,0.000012416108,0.0000027688302,0.00008614803],"genre_scores_gemma":[0.9988623,0.00013608193,0.00085179985,0.000039581606,0.000068821275,0.0000076572205,0.000009349213,0.000010495683,0.000013859089],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984125,0.00039033112,0.00067386124,0.00008655266,0.00031015388,0.00012663005],"domain_scores_gemma":[0.9980821,0.00013009728,0.0011742929,0.0002778043,0.00029745346,0.000038221784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006333465,0.00009500924,0.00031212225,0.00014328318,0.000065932436,0.0000016616353,0.0002153718,0.00007490977,0.000015317433],"category_scores_gemma":[0.000098486315,0.00005320559,0.00015941785,0.00014887578,0.0001824846,0.000038734845,0.000032514232,0.00025302445,4.772708e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019802465,0.00030421105,0.31076202,0.000011563971,0.00022633946,0.0000042814104,0.00040742496,0.0021408712,0.6832932,0.0000506772,0.00009095957,0.0007282031],"study_design_scores_gemma":[0.0027748686,0.0015020147,0.97430146,0.000012355723,0.00039221218,0.0016343858,0.000057778467,0.0070697623,0.011963333,0.00024544512,0.00001154824,0.000034821423],"about_ca_topic_score_codex":0.00009197113,"about_ca_topic_score_gemma":0.000019709836,"teacher_disagreement_score":0.67132986,"about_ca_system_score_codex":0.000110448535,"about_ca_system_score_gemma":0.00019691503,"threshold_uncertainty_score":0.2169661},"labels":[],"label_agreement":null},{"id":"W2148456219","doi":"10.1586/14737140.8.6.907","title":"Immunotherapy for renal cell cancer in the era of targeted therapy","year":2008,"lang":"en","type":"review","venue":"Expert Review of Anticancer Therapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Immunotherapy; Debulking; Ingenuity; Adjuvant; Targeted therapy; Cancer; Oncology; Adjuvant therapy; Oncolytic virus; Immune system; Internal medicine; Kidney cancer; Nephrectomy; Intensive care medicine; Ovarian cancer; Immunology; Kidney","score_opus":0.06114772087277689,"score_gpt":0.3927190114539544,"score_spread":0.3315712905811775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148456219","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011888532,0.9901685,0.000020291583,0.00066857063,0.00024408946,0.008322605,0.00011970356,0.000017822165,0.00031953186],"genre_scores_gemma":[0.000045754576,0.99244255,0.0008661643,0.0026002638,0.00043691995,0.0032020805,0.00014327772,0.00015466183,0.0001082996],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99560636,0.0005108027,0.0019611542,0.0006397964,0.0007888201,0.000493037],"domain_scores_gemma":[0.9964338,0.0005090352,0.001288816,0.0013836017,0.00030393508,0.000080794096],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006041887,0.0008585827,0.005106657,0.00018474343,0.00006211366,0.000008732092,0.00071151933,0.00027131793,0.0006540192],"category_scores_gemma":[0.00002475952,0.0004429417,0.0023667633,0.000820107,0.00027681518,0.000056806915,0.0000201591,0.0005453758,0.0000045516895],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000371368,0.000694924,0.000014550482,0.029844824,0.0006765234,0.000019451945,0.00063362025,1.3320685e-7,0.00050412025,0.00001163979,0.00496994,0.9622589],"study_design_scores_gemma":[0.0026121924,0.0012074705,0.00007781321,0.09744259,0.00017761328,0.000059661314,0.000016723228,7.615825e-7,0.0023590247,0.000006560085,0.8956916,0.00034803903],"about_ca_topic_score_codex":0.0003008658,"about_ca_topic_score_gemma":0.0000046637347,"teacher_disagreement_score":0.96191084,"about_ca_system_score_codex":0.00025009696,"about_ca_system_score_gemma":0.0012863328,"threshold_uncertainty_score":0.99980223},"labels":[],"label_agreement":null},{"id":"W2151011925","doi":"10.1016/j.ejca.2014.09.007","title":"Assessing the impact of evolving evidence in renal cell carcinoma treatment: An update of the Renal Cell Carcinoma Appropriateness-based Treatment Toolkit (ReCATT)","year":2014,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Royal Marsden NHS Foundation Trust; European Association of Urology; Pfizer","keywords":"Renal cell carcinoma; Medicine; Sunitinib; Pazopanib; Concordance; Psychological intervention; Oncology; Intensive care medicine; Medical physics; Internal medicine","score_opus":0.1054404367989314,"score_gpt":0.37642679389260714,"score_spread":0.27098635709367574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151011925","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30110905,0.6962845,0.000034833225,0.00006593271,0.00024109124,0.001095802,0.000047293714,0.0000072746425,0.001114286],"genre_scores_gemma":[0.6545741,0.34413984,0.00028242898,0.000018238628,0.0005542881,0.000029129049,0.000019846837,0.00015462963,0.00022749204],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99078,0.0039927335,0.0027958055,0.00067741727,0.0010822231,0.0006718345],"domain_scores_gemma":[0.9916326,0.0005904818,0.005060309,0.0016635892,0.000664039,0.00038901056],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020869125,0.0011544619,0.00359251,0.0005610997,0.00015342681,0.00012060629,0.0010736745,0.00016462995,0.00020501643],"category_scores_gemma":[0.00010941096,0.0005160377,0.002879316,0.00075916987,0.00029854412,0.0003534706,0.0001228189,0.00079758576,0.000009899803],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012812057,0.0025923203,0.03881781,0.010440713,0.0013827157,0.0023116923,0.0016654205,0.0027917358,0.00398095,0.0000019692106,0.00036605817,0.9343674],"study_design_scores_gemma":[0.033820532,0.052069347,0.5515948,0.14173195,0.047610354,0.0026003348,0.0005539402,0.001601255,0.060877424,0.000015198659,0.104115196,0.0034096555],"about_ca_topic_score_codex":0.0011000254,"about_ca_topic_score_gemma":0.00005244374,"teacher_disagreement_score":0.93095773,"about_ca_system_score_codex":0.0037854288,"about_ca_system_score_gemma":0.005090978,"threshold_uncertainty_score":0.9997291},"labels":[],"label_agreement":null},{"id":"W2151406448","doi":"10.5539/gjhs.v2n2p3","title":"Standard of Care and New Operative Techniques for Small Renal Tumors: a Meta-analysis with a Special Focus on Cryoablation","year":2010,"lang":"en","type":"article","venue":"Global Journal of Health Science","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Hôpital Fleurimont; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"Cryoablation; Medicine; Meta-analysis; Nephrectomy; Percutaneous; Pathological; Checklist; Surgery; Cryosurgery; Renal tumor; Resection; Radiology; Internal medicine; Kidney","score_opus":0.05879525671211566,"score_gpt":0.36578231896090635,"score_spread":0.3069870622487907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151406448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840465,0.0013620035,0.008790057,0.0035083157,0.00006461802,0.00091471267,0.000066309214,0.000008200641,0.0012392617],"genre_scores_gemma":[0.90911174,0.000017778842,0.090570234,0.000114287184,0.00016759172,0.0000040498476,0.0000012643209,0.00000342065,0.000009661497],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99829805,0.000031781106,0.0005100145,0.00021531887,0.0007257942,0.00021905017],"domain_scores_gemma":[0.99793196,0.000036245492,0.00059462734,0.0001659229,0.0009404206,0.00033084443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009689851,0.00012701548,0.00087729964,0.00024782837,0.0001305336,0.000037166843,0.00012618488,0.000030458059,0.00001974632],"category_scores_gemma":[0.000087976885,0.000071486975,0.00024601762,0.00070808904,0.0002400603,0.00013271236,0.000019318779,0.00015044765,1.5406489e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06250447,0.0015986613,0.24363133,0.0014268351,0.049129535,0.000854331,0.013163111,0.0013495024,0.030133616,0.029580195,0.0035562133,0.5630722],"study_design_scores_gemma":[0.011519743,0.1777137,0.4030125,0.000719163,0.08957685,0.00447263,0.0032607606,0.0002314709,0.30146983,0.0052904505,0.001940277,0.00079259113],"about_ca_topic_score_codex":0.00021752239,"about_ca_topic_score_gemma":0.0006449732,"teacher_disagreement_score":0.5622796,"about_ca_system_score_codex":0.00031490135,"about_ca_system_score_gemma":0.0025139744,"threshold_uncertainty_score":0.4459683},"labels":[],"label_agreement":null},{"id":"W2151554756","doi":"10.5489/cuaj.72","title":"Renal cell carcinoma: currently the most interesting genitourinary malignancy","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Dalhousie University","funders":"","keywords":"Genitourinary system; Malignancy; Renal cell carcinoma; Carcinoma; Medicine; Oncology; Cancer research; Pathology; Internal medicine","score_opus":0.027289301448895104,"score_gpt":0.23832335563809068,"score_spread":0.21103405418919557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151554756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976141,0.0027421613,0.00002693093,0.00938943,0.0006641862,0.00022872904,0.000015656986,0.00002074113,0.010771209],"genre_scores_gemma":[0.994512,0.000027295046,0.00018141624,0.0021180103,0.001923055,0.0000130744775,0.00002057955,0.00001873369,0.0011857931],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978582,0.00028064437,0.00039127865,0.00016784688,0.0004217378,0.0008802676],"domain_scores_gemma":[0.9979386,0.00019673485,0.0003049172,0.00017230408,0.00021754851,0.0011699134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008013832,0.0001962663,0.00024655566,0.00014096797,0.00047459788,0.00008078973,0.00017269458,0.00018707973,0.0006146184],"category_scores_gemma":[0.00039883167,0.00012311521,0.00018991917,0.00023494264,0.00003782548,0.00013557733,0.000036500085,0.00089768576,0.00019248194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034098895,0.00009647302,0.9774731,0.000005934256,0.000045579596,0.0002849256,0.00023492805,0.0000071440954,0.00042272787,0.000050239065,0.019476518,0.0018683441],"study_design_scores_gemma":[0.00081809546,0.00039257377,0.96221906,0.000014672822,0.00017954213,0.0016092065,0.0001388047,0.000041348296,0.00043836838,0.000091596405,0.033914927,0.00014181009],"about_ca_topic_score_codex":0.00075691333,"about_ca_topic_score_gemma":0.00012194446,"teacher_disagreement_score":0.018371088,"about_ca_system_score_codex":0.0017364705,"about_ca_system_score_gemma":0.00044989746,"threshold_uncertainty_score":0.67296404},"labels":[],"label_agreement":null},{"id":"W2151601659","doi":"10.2214/ajr.12.9414","title":"Cystic Renal Cell Carcinomas: Do They Grow, Metastasize, or Recur?","year":2013,"lang":"en","type":"article","venue":"American Journal of Roentgenology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Women's College Hospital; Mount Sinai Hospital","funders":"","keywords":"Medicine; Renal cell carcinoma; Pathology; Cancer research","score_opus":0.016121450084525587,"score_gpt":0.25240853266420066,"score_spread":0.23628708257967507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151601659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920849,0.0019459793,0.0002693234,0.0019344178,0.00027303112,0.00038619278,0.0000058291616,0.00002228997,0.0030780362],"genre_scores_gemma":[0.98832077,0.00038057647,0.009597296,0.00061605975,0.00027730546,0.000020570487,0.0000052377773,0.000051405194,0.00073076994],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973846,0.00036821642,0.0008735599,0.00031441878,0.00045777275,0.0006014397],"domain_scores_gemma":[0.9972789,0.00027131208,0.0009751123,0.00049342756,0.00048139354,0.00049982435],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031865094,0.00032352764,0.0011096003,0.00041996688,0.0000667174,0.000027531165,0.00030464688,0.00007209757,0.0009784799],"category_scores_gemma":[0.00016442964,0.00020282282,0.00035222663,0.0003252872,0.00037781047,0.00013884874,0.000077646306,0.0005067994,0.0002654584],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016503887,0.0041456167,0.14682993,0.00040543888,0.006234176,0.024957022,0.006683912,0.0003403761,0.34061694,0.00047558855,0.032452114,0.420355],"study_design_scores_gemma":[0.030882992,0.17066881,0.4769559,0.00073273096,0.008996027,0.12012471,0.020733675,0.000121962985,0.12886557,0.0037756187,0.036002055,0.0021399523],"about_ca_topic_score_codex":0.00042384243,"about_ca_topic_score_gemma":0.000018525574,"teacher_disagreement_score":0.41821507,"about_ca_system_score_codex":0.00029380032,"about_ca_system_score_gemma":0.0004155589,"threshold_uncertainty_score":0.99993473},"labels":[],"label_agreement":null},{"id":"W2151731573","doi":"10.1111/j.1464-410x.2011.10885.x","title":"Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta‐analysis of case series studies","year":2012,"lang":"en","type":"review","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McMaster University","funders":"","keywords":"Cryoablation; Medicine; Radiofrequency ablation; Nephrectomy; Renal cell carcinoma; Laparoscopy; Cryosurgery; Surgery; Cryotherapy; Complication; Ablation; Kidney cancer; Radiology; General surgery; Kidney; Oncology; Internal medicine","score_opus":0.13696724530366494,"score_gpt":0.3506301227519809,"score_spread":0.21366287744831597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151731573","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032229053,0.9947754,0.00022834956,0.00009030481,0.00020622597,0.0012104722,0.0002213398,0.0000040740942,0.000040896597],"genre_scores_gemma":[0.06273343,0.9357207,0.0008130615,0.0000110863975,0.00029587495,0.00012377159,0.000083974424,0.00003890294,0.00017922152],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9967417,0.0005026247,0.0018986895,0.0002492513,0.000320613,0.00028712902],"domain_scores_gemma":[0.99445176,0.0013077756,0.0028991736,0.0003541695,0.0008690688,0.00011807794],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000764667,0.0003902892,0.0055978578,0.0006508653,0.00010112633,0.000010943706,0.0001304775,0.0002636709,0.000084355306],"category_scores_gemma":[0.000096295546,0.00025021587,0.0042416607,0.00051325967,0.00024108084,0.000116237454,0.000019404004,0.00021356701,7.3382466e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076651375,0.0012923923,0.00018942496,0.008868188,0.45878413,0.007359159,0.00086566695,0.00027783294,0.000014411451,0.000038145095,0.00017519628,0.5213689],"study_design_scores_gemma":[0.001217889,0.0054140054,0.00021283604,0.00017580503,0.8171815,0.07062774,0.00007871619,0.000014485959,0.000048485217,0.000023791565,0.10486927,0.00013544399],"about_ca_topic_score_codex":0.00020835825,"about_ca_topic_score_gemma":0.00014247907,"teacher_disagreement_score":0.5212335,"about_ca_system_score_codex":0.0002895497,"about_ca_system_score_gemma":0.00032393637,"threshold_uncertainty_score":0.999995},"labels":[],"label_agreement":null},{"id":"W2152996449","doi":"10.1590/s1677-55382005000500008","title":"Collecting duct carcinoma associated with oncocytoma","year":2005,"lang":"en","type":"article","venue":"International braz j urol","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Mount Sinai Hospital; St. John’s Health Sciences Centre","funders":"","keywords":"Medicine; Oncocytoma; Immunohistochemistry; Pathology; Duct (anatomy); Clear cell; Kidney; Internal medicine","score_opus":0.02499824829664417,"score_gpt":0.27778117934373703,"score_spread":0.2527829310470929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152996449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92156696,0.000108770255,0.000046236793,0.0036668202,0.00016172102,0.00026361138,0.000013122116,0.00009925526,0.07407352],"genre_scores_gemma":[0.98614657,0.0000028249158,0.00082205824,0.00093775697,0.0004823926,0.000035583125,0.00007937193,0.00003381137,0.0114596225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865514,0.00002987573,0.00023376087,0.00028704986,0.00057170365,0.00022244941],"domain_scores_gemma":[0.9991855,0.00013248473,0.00011533136,0.000181201,0.00025959985,0.00012586422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011030639,0.0001684738,0.00020781957,0.0001613949,0.00007270039,0.000036956088,0.00012518647,0.000063635576,0.00060585636],"category_scores_gemma":[0.00017962392,0.00013401381,0.00009272481,0.000185613,0.00004239439,0.000114148526,0.000036251105,0.00017652825,0.00018346623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018561331,0.0018309645,0.93948346,0.000023922223,0.001772566,0.0025753977,0.0009572548,0.00042210717,0.0194435,0.00056748214,0.013136906,0.017930273],"study_design_scores_gemma":[0.006531703,0.0010808235,0.924632,0.000117945754,0.00021015188,0.0010646872,0.00008090468,0.0037575592,0.044466466,0.000039874765,0.017730547,0.00028732175],"about_ca_topic_score_codex":0.000060881408,"about_ca_topic_score_gemma":0.00008533076,"teacher_disagreement_score":0.064579636,"about_ca_system_score_codex":0.0007909234,"about_ca_system_score_gemma":0.00016125332,"threshold_uncertainty_score":0.66337025},"labels":[],"label_agreement":null},{"id":"W2153130650","doi":"10.1093/jnci/djk181","title":"Alcohol Intake and Renal Cell Cancer in a Pooled Analysis of 12 Prospective Studies","year":2007,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Prospective cohort study; Internal medicine; Confidence interval; Relative risk; Cancer; Kidney cancer; Proportional hazards model; Incidence (geometry); Alcohol; Biology","score_opus":0.07043549340325599,"score_gpt":0.375398136096932,"score_spread":0.304962642693676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153130650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98940843,0.0075412807,0.000024209736,0.0010169953,0.00041281764,0.00024796888,0.00003721499,0.000002415585,0.0013086342],"genre_scores_gemma":[0.99787706,0.00086205266,0.00030273976,0.00028054445,0.00031751746,0.000013305802,0.0000013627979,0.0000072107587,0.00033820525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822533,0.000031673222,0.0006044729,0.0001408339,0.00085241825,0.00014529383],"domain_scores_gemma":[0.9981806,0.00009577884,0.00057020754,0.00008219969,0.0009939219,0.00007724534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068964716,0.00013231061,0.0005121274,0.0006046836,0.000052215306,0.000006953726,0.00010881964,0.000051126295,0.000032758424],"category_scores_gemma":[0.00016667061,0.000080405785,0.00022659554,0.0008601662,0.00017522203,0.00014675561,0.000046963392,0.00025926568,2.6996597e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026227576,0.0004192848,0.9061656,0.00015501594,0.010642485,0.00015119647,0.0031160077,0.016905017,0.05451431,0.00037349857,0.00079079135,0.004144022],"study_design_scores_gemma":[0.0026092501,0.00016496927,0.9404825,0.00027795686,0.0030017712,0.000051427553,0.0001751188,0.00010235101,0.05226047,0.00024321438,0.00055024336,0.000080701895],"about_ca_topic_score_codex":0.0003096433,"about_ca_topic_score_gemma":0.004026377,"teacher_disagreement_score":0.034316912,"about_ca_system_score_codex":0.0014601588,"about_ca_system_score_gemma":0.00059543294,"threshold_uncertainty_score":0.38182646},"labels":[],"label_agreement":null},{"id":"W2153705463","doi":"10.1053/j.semdp.2015.02.001","title":"Renal neoplasia: From morphologic to molecular diagnosis","year":2015,"lang":"en","type":"editorial","venue":"Seminars in Diagnostic Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Pathology; Immunohistochemistry; Renal cell carcinoma; Medicine; Molecular pathology; Phenotype; Clear cell; Biology; Gene","score_opus":0.01467685618699955,"score_gpt":0.2817730287235455,"score_spread":0.26709617253654594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153705463","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5099779,0.020706981,0.000066934634,0.0011595307,0.46239597,0.0020586755,0.0011975325,0.00014957256,0.0022869452],"genre_scores_gemma":[0.10247711,0.014442432,0.019449193,0.0030345486,0.8332774,0.00926196,0.015153618,0.0007535424,0.00215022],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942418,0.00050442386,0.001088265,0.0018110942,0.0012693519,0.0010850959],"domain_scores_gemma":[0.98512006,0.0118298335,0.00034845152,0.0015622089,0.0003918346,0.0007476292],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007881827,0.00096965,0.0020997538,0.0007282421,0.00004561857,0.000031917472,0.0005957414,0.002513825,0.00029484625],"category_scores_gemma":[0.048802137,0.0009022854,0.00031757247,0.0005720646,0.0002441608,0.000045757668,0.0005547077,0.0018821859,0.0010868764],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032574404,0.0005491877,0.010680458,0.000058881094,0.000103116145,0.15575954,0.00035083562,0.000060867682,0.00081827445,0.0000043756622,0.8280911,0.003197643],"study_design_scores_gemma":[0.0067428546,0.0071755396,0.0111169135,0.0044335388,0.0019341477,0.0011080195,0.00018795294,0.000007861509,0.009634408,0.0021694994,0.95385766,0.0016315999],"about_ca_topic_score_codex":0.00061163947,"about_ca_topic_score_gemma":0.00015761399,"teacher_disagreement_score":0.40750074,"about_ca_system_score_codex":0.0014053793,"about_ca_system_score_gemma":0.0009064653,"threshold_uncertainty_score":0.9996909},"labels":[],"label_agreement":null},{"id":"W2153867442","doi":"10.1056/nejmoa066838","title":"Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma","year":2007,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3647,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Temsirolimus; Medicine; Renal cell carcinoma; Tolerability; Interferon alfa; Oncology; Interferon; Internal medicine; Cancer research; Alpha interferon; Discovery and development of mTOR inhibitors; Pharmacology; Immunology; Adverse effect; PI3K/AKT/mTOR pathway; Apoptosis","score_opus":0.031042158008703698,"score_gpt":0.29853198989495927,"score_spread":0.2674898318862556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153867442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756311,0.0053465096,0.008414317,0.0041037183,0.0011286627,0.00061573414,0.000004748837,0.000021570344,0.0047336146],"genre_scores_gemma":[0.9806965,0.00020937482,0.004646111,0.000790067,0.0059161596,0.000003505734,0.000021580625,0.000051631832,0.007665047],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99758035,0.000048438913,0.0010319682,0.00023830633,0.0006364742,0.00046447266],"domain_scores_gemma":[0.99749416,0.00058180926,0.0005474147,0.0003078816,0.00029319953,0.0007755156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014629915,0.0003040897,0.0008849579,0.0003954857,0.00005936861,0.000008051143,0.00016907263,0.00011151912,0.0002657004],"category_scores_gemma":[0.0003504598,0.00016951819,0.00020135593,0.00020940327,0.00009653318,0.000102358776,0.000023755645,0.00040798984,0.000005341655],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08134955,0.0006639937,0.0119359335,0.0005082559,0.00036771793,0.0060350783,0.0030562207,0.000037669786,0.2867999,0.00007073287,0.049244687,0.55993026],"study_design_scores_gemma":[0.30874276,0.069144465,0.024305474,0.0014873218,0.0016716644,0.012723618,0.0011745691,0.00005059024,0.18379745,0.00035651802,0.39611387,0.00043168518],"about_ca_topic_score_codex":0.00006890434,"about_ca_topic_score_gemma":0.000073592535,"teacher_disagreement_score":0.55949855,"about_ca_system_score_codex":0.00026315398,"about_ca_system_score_gemma":0.00032667682,"threshold_uncertainty_score":0.6912751},"labels":[],"label_agreement":null},{"id":"W2154540012","doi":"10.5489/cuaj.10017","title":"Cost analysis of two follow-up strategies for localized kidney cancer: A Canadian cohort comparison","year":2010,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Cohort; Kidney cancer; Academic institution; Surgery; Internal medicine; Kidney","score_opus":0.03198317008961566,"score_gpt":0.3058959494801461,"score_spread":0.27391277939053044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154540012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831782,0.00015070851,0.00031709994,0.011713372,0.00075138034,0.00075505895,0.00065387797,0.000016940354,0.0024633503],"genre_scores_gemma":[0.9954888,0.00002564734,0.00048357807,0.0029449547,0.00026360017,0.00007995377,0.00028307096,0.00001648746,0.00041387396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978949,0.0001106129,0.0006077871,0.00026242193,0.0004158609,0.00070842134],"domain_scores_gemma":[0.9956587,0.00018645097,0.00045948595,0.00019019056,0.0007852121,0.0027199585],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008031225,0.00020367773,0.0008334578,0.0007646966,0.00028285146,0.000108544344,0.00016690297,0.00031088138,0.0015550354],"category_scores_gemma":[0.0007588053,0.00016807111,0.00048193408,0.0006913001,0.000062874555,0.00008568157,0.0000069665944,0.0006486649,0.000008851708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010258057,0.000036341073,0.98040676,0.000006313018,0.0023748262,0.000041321582,0.00015484392,0.00039081942,0.00039215095,0.0005059946,0.014564421,0.0010236001],"study_design_scores_gemma":[0.0034446216,0.0003415134,0.9065705,0.000011704112,0.004748285,0.000035409084,0.00019198147,0.005388796,0.00015038543,0.00038958888,0.07851986,0.0002073807],"about_ca_topic_score_codex":0.47242555,"about_ca_topic_score_gemma":0.90127087,"teacher_disagreement_score":0.42884532,"about_ca_system_score_codex":0.0024043235,"about_ca_system_score_gemma":0.006236061,"threshold_uncertainty_score":0.99939764},"labels":[],"label_agreement":null},{"id":"W2154661082","doi":"10.1200/jco.2014.57.4673","title":"PISCES: A Horoscope for First-Line Targeted Therapy of Metastatic Renal Cell Carcinoma","year":2014,"lang":"en","type":"letter","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Targeted therapy; Internal medicine; Cancer research; Cancer","score_opus":0.19823876607313895,"score_gpt":0.4354693582588855,"score_spread":0.23723059218574655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154661082","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39009872,0.010408154,0.0018668518,0.5889289,0.003591935,0.0024865824,0.000112482485,0.00002138874,0.0024849933],"genre_scores_gemma":[0.4892676,0.003539295,0.030513594,0.4540859,0.019016467,0.00008570923,0.00025056466,0.0002393269,0.0030015516],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9911416,0.0010511612,0.0058047986,0.00050788734,0.00092200196,0.0005725411],"domain_scores_gemma":[0.98091155,0.008772477,0.007781596,0.00065055635,0.0014582728,0.0004255273],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0038894028,0.0005710648,0.006039509,0.00040796414,0.000051829957,0.00001249882,0.000516925,0.0016218197,0.00033536137],"category_scores_gemma":[0.0021185458,0.00036182746,0.0028301985,0.00016900408,0.00040377874,0.00006465284,0.00005758795,0.0034657726,0.000020192858],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011458806,0.0025696985,0.0035297233,0.0010512441,0.002035651,0.004831364,0.000107213964,0.00002643935,0.0006498637,0.0000040928708,0.96044,0.013295947],"study_design_scores_gemma":[0.024069678,0.09472941,0.006025676,0.000309913,0.0025792622,0.0007353433,0.00001692668,0.000070776674,0.0033913574,0.00036249866,0.86742616,0.000282973],"about_ca_topic_score_codex":0.000040271174,"about_ca_topic_score_gemma":0.000015379122,"teacher_disagreement_score":0.134843,"about_ca_system_score_codex":0.00032304396,"about_ca_system_score_gemma":0.0031403818,"threshold_uncertainty_score":0.99988335},"labels":[],"label_agreement":null},{"id":"W2154752460","doi":"10.5489/cuaj.1028","title":"Follow-up guidelines after radical or partial nephrectomy for localized and locally advanced renal cell carcinoma","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; University Health Network; University of Alberta; Université Laval; McGill University; McGill University Health Centre; University of Ottawa; London Health Sciences Centre; Queen's University; Princess Margaret Cancer Centre; Centre hospitalier universitaire de Québec","funders":"","keywords":"Nephrectomy; Renal cell carcinoma; Medicine; Urology; Oncology; Internal medicine; Kidney","score_opus":0.022045840020083307,"score_gpt":0.25068781532293566,"score_spread":0.22864197530285235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154752460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776412,0.000908176,0.0008532231,0.018670082,0.00036676554,0.0011625721,0.000036730657,0.000029531664,0.00033167299],"genre_scores_gemma":[0.98261714,0.000052295793,0.005843189,0.0076811034,0.0007888768,0.00034113677,0.000038372542,0.000030612726,0.0026072715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975748,0.00015680002,0.00067977427,0.00036327456,0.0004261372,0.00079919875],"domain_scores_gemma":[0.9969475,0.00026546445,0.00026342948,0.0001508836,0.00072337646,0.0016493155],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004868117,0.0002770174,0.0005244396,0.00016594304,0.00023925328,0.0001409029,0.000109232475,0.0003599086,0.0015348503],"category_scores_gemma":[0.0010824364,0.00018623,0.00025237672,0.00015648229,0.00007264623,0.00015372598,0.000022755037,0.00043541193,0.00006495368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006395806,0.00020286237,0.8146679,0.000064589156,0.00036451448,0.0012217124,0.00023726415,0.00006897851,0.0027275244,0.000058600974,0.13177328,0.04221697],"study_design_scores_gemma":[0.023380449,0.0044521806,0.5267506,0.000056262426,0.00058859616,0.001031834,0.00012607257,0.0028535575,0.0017854122,0.00065201486,0.43772238,0.0006006064],"about_ca_topic_score_codex":0.0008685241,"about_ca_topic_score_gemma":0.0007262679,"teacher_disagreement_score":0.3059491,"about_ca_system_score_codex":0.0009809238,"about_ca_system_score_gemma":0.0009235332,"threshold_uncertainty_score":0.9993779},"labels":[],"label_agreement":null},{"id":"W2154795510","doi":"10.5489/cuaj.1963","title":"Papillary renal cell carcinoma within a renal oncocytoma: Case report of very rare coexistence","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Renal oncocytoma; Oncocytoma; Papillary renal cell carcinomas; Renal cell carcinoma; Pathology; Medicine; Papillary carcinoma; Internal medicine; Thyroid carcinoma; Thyroid","score_opus":0.019241553252627896,"score_gpt":0.22853464327627881,"score_spread":0.20929309002365093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154795510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866877,0.00033432874,0.00005419707,0.003045226,0.0002884281,0.00023090804,0.000029183902,0.00002359519,0.009306422],"genre_scores_gemma":[0.9959714,0.000010176514,0.00092071155,0.0012353867,0.0005518316,0.000008870781,0.000045923247,0.000022509466,0.0012331798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970903,0.00039160086,0.0008986072,0.00035437202,0.00068310654,0.00058204477],"domain_scores_gemma":[0.99659145,0.00026392477,0.00096465496,0.00032018166,0.00059515436,0.0012646117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014683143,0.00025088873,0.00058709626,0.0002564932,0.0002833831,0.000050832245,0.00014138017,0.00036193102,0.00028269374],"category_scores_gemma":[0.0011983226,0.00019859374,0.00030217014,0.00028123168,0.000081557904,0.00009961665,0.00002952154,0.0007845148,0.00003202733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034372607,0.00019407949,0.6146132,0.000050861756,0.00019668564,0.36441362,0.0005472724,0.00018226048,0.003443219,0.00009731548,0.014889191,0.0010285727],"study_design_scores_gemma":[0.0036776664,0.0034640585,0.56538254,0.000067241024,0.00054093957,0.40512997,0.00027344833,0.0005091111,0.006271497,0.00039394805,0.013861342,0.00042824209],"about_ca_topic_score_codex":0.0026840905,"about_ca_topic_score_gemma":0.0011385732,"teacher_disagreement_score":0.049230658,"about_ca_system_score_codex":0.0018370891,"about_ca_system_score_gemma":0.0012394721,"threshold_uncertainty_score":0.80984175},"labels":[],"label_agreement":null},{"id":"W2155012968","doi":"10.1200/jco.2008.16.9847","title":"Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":908,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"National Cancer Institute","keywords":"Medicine; Bevacizumab; Internal medicine; Renal cell carcinoma; Clinical endpoint; Hazard ratio; Gastroenterology; Proteinuria; Oncology; Surgery; Randomized controlled trial; Chemotherapy; Confidence interval; Kidney","score_opus":0.0995623420053774,"score_gpt":0.3685206473544246,"score_spread":0.2689583053490472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155012968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99555355,0.00056638505,0.0004151025,0.0010201877,0.00037771338,0.00070975034,0.000009431445,0.000013008503,0.0013348553],"genre_scores_gemma":[0.9920803,0.00012401995,0.006304625,0.000798632,0.00027779833,0.000016023205,0.000029017181,0.00006228898,0.00030733863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99454457,0.0007490009,0.0029097095,0.00046092627,0.00082257576,0.0005132266],"domain_scores_gemma":[0.99537724,0.0009734219,0.0019584228,0.00043588303,0.0006257118,0.0006293469],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010283698,0.00043398357,0.002862043,0.00036885057,0.000060031132,0.000011949888,0.0003050606,0.00026487204,0.00018846341],"category_scores_gemma":[0.00016788284,0.00025776733,0.0004058017,0.00027148915,0.00044762256,0.00019441576,0.000064677915,0.0015474814,0.000025559648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21510307,0.009415489,0.7473314,0.000098034805,0.0009463314,0.009744462,0.0014172432,0.0004485412,0.00014519315,0.0000052102005,0.0027738872,0.012571142],"study_design_scores_gemma":[0.08819126,0.1456011,0.75993973,0.0002485718,0.00070931646,0.0011146133,0.00022081105,0.00022348398,0.00074265077,0.000021944965,0.0026980764,0.0002884491],"about_ca_topic_score_codex":0.00017927427,"about_ca_topic_score_gemma":0.00028378287,"teacher_disagreement_score":0.1361856,"about_ca_system_score_codex":0.0012232348,"about_ca_system_score_gemma":0.002030297,"threshold_uncertainty_score":0.9999875},"labels":[],"label_agreement":null},{"id":"W2155344354","doi":"10.1097/01.rvi.0000236718.12560.47","title":"Reporting Standards for Percutaneous Thermal Ablation of Renal Cell Carcinoma","year":2006,"lang":"en","type":"article","venue":"Journal of Vascular and Interventional Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Incidence (geometry); Kidney cancer; Cancer; Oncology; Kidney; Internal medicine","score_opus":0.01808399051801049,"score_gpt":0.2835427926618423,"score_spread":0.2654588021438318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155344354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866378,0.005925015,0.0061894273,0.000099171986,0.0001066576,0.00015693247,0.000015929558,0.0000026472992,0.00086644205],"genre_scores_gemma":[0.9967402,0.000026694637,0.0027319845,0.000014816694,0.0003023794,0.0000024547464,0.000026412215,0.000010979169,0.00014403586],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981484,0.00006980334,0.001258742,0.000115096445,0.00028363275,0.00012434484],"domain_scores_gemma":[0.9979457,0.00007948597,0.001312956,0.000088413544,0.0005172317,0.00005621108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011037419,0.000099372366,0.00046186894,0.00013901504,0.000036435697,0.000006056665,0.000040245643,0.00007729598,0.00008130132],"category_scores_gemma":[0.00018309554,0.00007338928,0.0007214346,0.00003858766,0.00006844171,0.00005076605,0.00001267057,0.000114148526,2.0783715e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045007914,0.001436776,0.22610018,0.0013805612,0.0014750882,0.0019962585,0.0002947554,0.002013206,0.74791324,0.001994511,0.0044664233,0.006428243],"study_design_scores_gemma":[0.0055699055,0.010769417,0.8890176,0.00031356415,0.0010988916,0.0335853,0.00010679895,0.0007178605,0.0545484,0.0013614534,0.0027418765,0.00016897781],"about_ca_topic_score_codex":0.000028278813,"about_ca_topic_score_gemma":0.0000022089885,"teacher_disagreement_score":0.6933648,"about_ca_system_score_codex":0.0001362512,"about_ca_system_score_gemma":0.00014941354,"threshold_uncertainty_score":0.2992728},"labels":[],"label_agreement":null},{"id":"W2155623593","doi":"10.14740/wjon911w","title":"Periampullary and Pancreatic Metastases of Renal Cell Carcinoma: An Underdiagnosed Event","year":2015,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Melena; Renal cell carcinoma; Metastasis; Abdominal pain; Periampullary cancer; Pancreaticoduodenectomy; Pancreatic cancer; Radiology; Surgery; Internal medicine; Cancer; Pancreas","score_opus":0.048454395171652904,"score_gpt":0.31985465310546596,"score_spread":0.27140025793381306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155623593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866319,0.0077159484,0.000072453106,0.00081364304,0.0002115214,0.00019624025,0.0000043554605,0.0000051126895,0.004348848],"genre_scores_gemma":[0.99358964,0.00010892206,0.0054436317,0.00017461627,0.000245363,0.0000038748826,0.000007829026,0.000019086263,0.00040705912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830705,0.0003358372,0.00065627956,0.00015290055,0.00033971178,0.00020820223],"domain_scores_gemma":[0.9981623,0.00025522822,0.0005521587,0.0002099846,0.0003189872,0.0005012882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073641766,0.0001661367,0.00082663406,0.00034938706,0.000027614995,0.0000071775457,0.000092650575,0.000065302105,0.000089827605],"category_scores_gemma":[0.00009582269,0.000121003504,0.00014905074,0.00017449723,0.00014270187,0.000097111835,0.00004532447,0.00023683818,0.0000034059672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016166195,0.011470763,0.7114731,0.00082555815,0.001808652,0.028860126,0.007457294,0.00076582975,0.14125982,0.00058842934,0.028621018,0.050703224],"study_design_scores_gemma":[0.047489874,0.087993465,0.62189746,0.00040740333,0.0073812525,0.022450414,0.005455137,0.00020478708,0.1565791,0.0014831653,0.047998257,0.0006596902],"about_ca_topic_score_codex":0.00006394618,"about_ca_topic_score_gemma":0.000083636645,"teacher_disagreement_score":0.08957564,"about_ca_system_score_codex":0.000361124,"about_ca_system_score_gemma":0.00084333814,"threshold_uncertainty_score":0.49343795},"labels":[],"label_agreement":null},{"id":"W2156092014","doi":"10.6000/1927-7229.2012.01.01.14","title":"Saving Nephrons: Current Surgical Options in Partial Nephrectomy","year":2012,"lang":"en","type":"article","venue":"Journal of Analytical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Nephrectomy; Medicine; Kidney cancer; Surgery; Gold standard (test); Kidney; General surgery; Cancer; Internal medicine","score_opus":0.06506164736285776,"score_gpt":0.38497949015805555,"score_spread":0.3199178427951978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156092014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871249,0.0042034546,0.00009722973,0.0027050595,0.0005680017,0.0001733446,9.4533635e-7,0.000007913188,0.0051191077],"genre_scores_gemma":[0.99636424,0.0004690371,0.0013956596,0.00013282977,0.0015090341,0.000007278449,0.000002460435,0.000012350104,0.000107130916],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980145,0.0002193627,0.0008223983,0.00012079606,0.00035354355,0.00046936286],"domain_scores_gemma":[0.998473,0.0004171014,0.00023577081,0.00014372617,0.00013575488,0.0005946397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086943683,0.00014625175,0.00071640854,0.00033101783,0.00002994562,0.000009406106,0.00008578521,0.00014413605,0.00052688416],"category_scores_gemma":[0.00023359148,0.0001037843,0.00033204973,0.00029322784,0.00012203386,0.00015882145,0.000045557925,0.00071122823,0.00007377584],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004704268,0.013073769,0.82531893,0.00012422871,0.0007909883,0.010551076,0.00074940285,0.0003511585,0.0011275945,0.010825323,0.009564982,0.12281827],"study_design_scores_gemma":[0.006914475,0.0032440547,0.34930262,0.0001684394,0.00091139146,0.009750241,0.0001509574,0.0010973096,0.00020362082,0.0001631717,0.6279112,0.00018251188],"about_ca_topic_score_codex":0.00000969633,"about_ca_topic_score_gemma":0.00000678456,"teacher_disagreement_score":0.6183462,"about_ca_system_score_codex":0.0009156058,"about_ca_system_score_gemma":0.0004372308,"threshold_uncertainty_score":0.5769012},"labels":[],"label_agreement":null},{"id":"W2157071879","doi":"10.1016/j.eururo.2010.12.011","title":"Prediction of Progression-Free Survival Rates After Bevacizumab Plus Interferon Versus Interferon Alone in Patients with Metastatic Renal Cell Carcinoma: Comparison of a Nomogram to the Motzer Criteria","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Nomogram; Bevacizumab; Oncology; Proportional hazards model; Interferon; Urology; Gastroenterology; Chemotherapy; Immunology","score_opus":0.028079955276174014,"score_gpt":0.2827781620400433,"score_spread":0.2546982067638693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157071879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996802,0.00014041463,0.00010840324,0.0002530069,0.00051003596,0.0010048491,0.000060490875,0.000021510248,0.0010993269],"genre_scores_gemma":[0.99877596,9.103599e-7,0.0008634272,0.00004437326,0.00007043685,0.00004912954,0.00010130022,0.00005283892,0.000041611438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977525,0.0005339588,0.00063842797,0.00040168897,0.00035545524,0.00031797073],"domain_scores_gemma":[0.9984942,0.00015247217,0.00025258935,0.00076940097,0.00020229665,0.00012905872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004091437,0.0002691434,0.00058212015,0.00023152771,0.000028763383,0.0000110420515,0.00029115062,0.000054834392,0.0001163452],"category_scores_gemma":[0.00011086135,0.00016708986,0.00008131578,0.00021260425,0.00021231566,0.000056602414,0.00027355686,0.00042825862,0.000023916835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12787312,0.0029267068,0.8420127,0.00025310047,0.00024742767,0.00021486629,0.0065893056,0.00012839992,0.015122944,0.000008369842,0.0008813901,0.0037416301],"study_design_scores_gemma":[0.015430368,0.029187838,0.9445915,0.0000583813,0.00035121242,0.000011391508,0.00015675926,0.00037917573,0.009434415,0.0000024675214,0.000268128,0.00012835598],"about_ca_topic_score_codex":0.00006706593,"about_ca_topic_score_gemma":0.0002853854,"teacher_disagreement_score":0.11244276,"about_ca_system_score_codex":0.00006859158,"about_ca_system_score_gemma":0.00005374573,"threshold_uncertainty_score":0.6813727},"labels":[],"label_agreement":null},{"id":"W2157503425","doi":"10.1186/1471-2490-4-9","title":"Microarray gene expression profiling and analysis in renal cell carcinoma","year":2004,"lang":"en","type":"article","venue":"BMC Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"University of Akron; National Cancer Institute; Wilson Foundation; U.S. Department of Defense","keywords":"Medicine; Gene expression profiling; Renal cell carcinoma; Microarray analysis techniques; Microarray; Gene expression; Gene; Computational biology; Cancer research; Bioinformatics; Pathology; Genetics; Biology","score_opus":0.019278294766674364,"score_gpt":0.24568131100186782,"score_spread":0.22640301623519346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157503425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953258,0.0019113409,0.0014879276,0.00015813555,0.000032320466,0.00026825062,0.0000032965215,0.000020255331,0.0007926718],"genre_scores_gemma":[0.97830164,0.000007694383,0.021254942,0.00015196181,0.000052608564,0.000026824504,0.00005358358,0.000014921845,0.00013582277],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889565,0.000072901916,0.0002397896,0.00040763937,0.000110249886,0.00027377764],"domain_scores_gemma":[0.99945605,0.00004305467,0.000063997926,0.00028933477,0.000028599332,0.00011899281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012826794,0.00014952617,0.00034917973,0.00035814234,0.00003286894,0.0000058737623,0.00005074951,0.000134149,0.000041563853],"category_scores_gemma":[0.000019234301,0.0001215073,0.000096061,0.00029852975,0.00006188984,0.00002685163,0.000048931026,0.00015226312,0.000018265944],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002495413,0.000102526676,0.53338164,0.000027366264,0.00001425192,0.00024023835,0.00014816677,0.0004750121,0.46532124,0.000008619165,0.000004893829,0.000026479738],"study_design_scores_gemma":[0.002167079,0.00036079987,0.48513997,0.0000017838954,0.00039073208,0.00009556514,0.000026489965,0.00010024095,0.5115641,0.000051220282,0.000027783526,0.0000742333],"about_ca_topic_score_codex":0.00011887511,"about_ca_topic_score_gemma":0.000099335426,"teacher_disagreement_score":0.04824168,"about_ca_system_score_codex":0.00009432544,"about_ca_system_score_gemma":0.00009742823,"threshold_uncertainty_score":0.4954924},"labels":[],"label_agreement":null},{"id":"W2158082603","doi":"10.2147/ijnrd.s48496","title":"Optimal first-line and second-line treatments for metastatic renal cell carcinoma: current evidence","year":2014,"lang":"en","type":"review","venue":"International Journal of Nephrology and Renovascular Disease","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Pazopanib; Axitinib; Temsirolimus; Sunitinib; Everolimus; Medicine; Oncology; Renal cell carcinoma; Internal medicine; Bevacizumab; Sorafenib; Intensive care medicine; Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway; Chemotherapy","score_opus":0.0656559042160513,"score_gpt":0.3575867527509122,"score_spread":0.29193084853486084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158082603","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03241604,0.96431965,0.0012261452,0.00043677108,0.0004953308,0.0009410398,0.00015004154,0.000007588381,0.0000074141744],"genre_scores_gemma":[0.015507568,0.9815425,0.0012315932,0.00018182927,0.00094566913,0.000092181006,0.0002469704,0.000051707946,0.00019998138],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973855,0.00021380516,0.0011079253,0.0004898881,0.0005188265,0.0002840381],"domain_scores_gemma":[0.9971255,0.0005077255,0.0009563801,0.0002986498,0.00054655067,0.0005651858],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005046606,0.0005291376,0.0018270931,0.0004963716,0.00008829646,0.000044592085,0.0002681581,0.00015408431,0.00008579588],"category_scores_gemma":[0.00018291046,0.00035295959,0.0012049488,0.00008270861,0.00020094973,0.000134728,0.0001261781,0.0004278126,0.0000067643577],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047562444,0.002047435,0.00057949015,0.024127873,0.013847243,0.0049662963,0.00011762124,0.00008674244,0.000019662502,0.000067796995,0.0016427849,0.9477408],"study_design_scores_gemma":[0.008496751,0.0030583837,0.0024391518,0.009090849,0.03619975,0.0051562833,0.000005880789,0.00020963672,0.000023573959,0.00018709991,0.93470454,0.00042811112],"about_ca_topic_score_codex":0.0000048840257,"about_ca_topic_score_gemma":0.0000036242068,"teacher_disagreement_score":0.9473127,"about_ca_system_score_codex":0.00021059962,"about_ca_system_score_gemma":0.00057374884,"threshold_uncertainty_score":0.99989223},"labels":[],"label_agreement":null},{"id":"W2158287397","doi":"10.1111/j.1464-410x.2012.11440.x","title":"Diagnostic tests in urology: percutaneous biopsy of renal masses","year":2013,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Biopsy; Renal mass; Malignancy; Renal biopsy; Radiology; Percutaneous biopsy; Percutaneous; Urology; Medical physics; Kidney; Pathology; Internal medicine; Nephrectomy","score_opus":0.012484977766796919,"score_gpt":0.242705704378207,"score_spread":0.23022072661141008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158287397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885511,0.00856776,0.00003382953,0.0016020136,0.00016630748,0.00022950352,0.0000049628,0.0000075421012,0.0008369903],"genre_scores_gemma":[0.9973284,0.0009234978,0.0010751506,0.00040863783,0.00015259303,0.0000070900805,0.000003894013,0.000021264734,0.00007948738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984003,0.00016782783,0.0007135215,0.00017178562,0.00022891529,0.00031768525],"domain_scores_gemma":[0.9982927,0.0007690048,0.0003314424,0.00014865419,0.00028050438,0.00017772194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023020263,0.00013448378,0.00059953873,0.00027085238,0.000020947762,0.00001268144,0.00014194849,0.00017066981,0.00057339476],"category_scores_gemma":[0.0012492356,0.0001311801,0.00014686435,0.00015589238,0.00020067435,0.00008120478,0.0000391541,0.000447886,0.000042364227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008118443,0.0016342978,0.6491414,0.00012583377,0.00038369506,0.2182823,0.00023923565,0.0004075153,0.07755176,0.000042849624,0.004744805,0.046634458],"study_design_scores_gemma":[0.0013295809,0.0027524673,0.60659885,0.000070200425,0.00015753244,0.38755617,0.000027491944,0.000039957467,0.0003371837,0.0004598158,0.0005980593,0.00007271077],"about_ca_topic_score_codex":0.00038496882,"about_ca_topic_score_gemma":0.000085025735,"teacher_disagreement_score":0.16927387,"about_ca_system_score_codex":0.00006381668,"about_ca_system_score_gemma":0.00015208515,"threshold_uncertainty_score":0.62782705},"labels":[],"label_agreement":null},{"id":"W2158534987","doi":"10.1016/j.juro.2011.10.025","title":"Hospital Volume is a Determinant of Postoperative Complications, Blood Transfusion and Length of Stay After Radical or Partial Nephrectomy","year":2011,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Blood transfusion; Logistic regression; Surgery; Blood loss; Blood volume; Urology; Kidney; Internal medicine","score_opus":0.020603136333540144,"score_gpt":0.2476981254204025,"score_spread":0.22709498908686238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158534987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99610454,0.0012545908,0.00017670516,0.002051568,0.000043867178,0.00028062816,0.000008632918,0.0000019537788,0.00007749305],"genre_scores_gemma":[0.9982764,0.00047761863,0.00087460986,0.00029517125,0.000027429029,0.0000063719126,5.657764e-7,0.000008810079,0.000032990745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990542,0.000164689,0.00042811545,0.00008112502,0.00015160447,0.00012024769],"domain_scores_gemma":[0.99925834,0.00009508736,0.00024479252,0.00016305414,0.00015309054,0.000085625055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023756975,0.00009813843,0.0003652802,0.00007399845,0.000026145337,0.0000013241803,0.000085697495,0.00006515363,0.00025588612],"category_scores_gemma":[0.000028905562,0.000049987022,0.000086055625,0.00005557112,0.00032952183,0.000040569445,0.00002346271,0.0001784749,0.0000017167519],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07101289,0.006488731,0.6366219,0.00017297859,0.002599925,0.0017730086,0.07600337,0.0000033116523,0.18198518,0.00016340415,0.00084516755,0.02233016],"study_design_scores_gemma":[0.0063228626,0.03288695,0.8273493,0.000059339654,0.0021350647,0.0060983757,0.00039910048,0.000121447476,0.122953184,0.00009037374,0.0014757448,0.00010822852],"about_ca_topic_score_codex":0.000054613454,"about_ca_topic_score_gemma":0.00001033211,"teacher_disagreement_score":0.19072746,"about_ca_system_score_codex":0.000011536759,"about_ca_system_score_gemma":0.00008838644,"threshold_uncertainty_score":0.28017735},"labels":[],"label_agreement":null},{"id":"W2158757654","doi":"10.5489/cuaj.2850","title":"Renal cancer seeding metastases following retroperitoneoscopic-assisted cryoablation: A case report","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cryoablation; Laparoscopy; Cancer; Radiology; Retroperitoneal space; Renal hilum; Surgery; Kidney; Ablation; Internal medicine; Nephrectomy","score_opus":0.0557693500048723,"score_gpt":0.29283749468066034,"score_spread":0.23706814467578805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158757654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773129,0.0012885288,0.00007225154,0.015768578,0.0008462339,0.0002337312,0.000023874587,0.000045290235,0.0044085733],"genre_scores_gemma":[0.9943808,0.000015546208,0.0011626537,0.001652357,0.00096071034,0.00002333817,0.000043687163,0.00002023643,0.0017407158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977307,0.00022011824,0.0005571392,0.0002834054,0.00066507206,0.00054357597],"domain_scores_gemma":[0.99712753,0.00009333766,0.00039346205,0.0001599087,0.00053661957,0.0016891476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012200845,0.0001956353,0.00042266076,0.00022869807,0.00034814485,0.00014841961,0.00007265593,0.00022315983,0.0003997172],"category_scores_gemma":[0.0017061755,0.00015283683,0.00025700187,0.00034683742,0.000022627859,0.00017919847,0.000014209161,0.00055238605,0.0000282552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009478132,0.00005576457,0.63672245,0.0000048192924,0.0005656181,0.338479,0.00020017366,0.00014158302,0.00047109675,0.000023204804,0.021477021,0.0017644878],"study_design_scores_gemma":[0.0050699376,0.0012562543,0.4433388,0.00010860764,0.0015787521,0.40830475,0.00067309313,0.00045968845,0.00061713107,0.00022475762,0.13784193,0.00052626233],"about_ca_topic_score_codex":0.0067228507,"about_ca_topic_score_gemma":0.0025351788,"teacher_disagreement_score":0.1933836,"about_ca_system_score_codex":0.004865232,"about_ca_system_score_gemma":0.0016638264,"threshold_uncertainty_score":0.99989146},"labels":[],"label_agreement":null},{"id":"W2159905384","doi":"10.1016/j.urology.2007.09.039","title":"Treatment of a Juxtaglomerular Tumour with Radiofrequency Ablation","year":2008,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Vancouver General Hospital","funders":"","keywords":"Medicine; Radiofrequency ablation; Ablation; Juxtaglomerular apparatus; Presentation (obstetrics); Nephron; Radiology; Kidney; Pathology; Urology; Renin–angiotensin system; Internal medicine","score_opus":0.02388884302190208,"score_gpt":0.24098516646687654,"score_spread":0.21709632344497445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159905384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907365,0.0018727346,0.00021339107,0.0005455098,0.000031543306,0.0003102041,0.0000024279261,0.000028827539,0.0062588933],"genre_scores_gemma":[0.99815995,0.0002474963,0.00078685017,0.000064991305,0.000057869343,0.000029241128,0.000025889467,0.000014585826,0.00061312824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999346,0.00003290736,0.0001594312,0.00017987195,0.00012195826,0.00015984115],"domain_scores_gemma":[0.99954575,0.000030473615,0.00006968591,0.00022500161,0.00005501229,0.000074067895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000017603195,0.000117138174,0.0002961225,0.000098440054,0.00002991955,6.64049e-7,0.000024476392,0.00005813667,0.000102768616],"category_scores_gemma":[0.000007502336,0.000076987606,0.000062912586,0.00010402753,0.000115452516,0.000021597218,0.0000036932329,0.000035691533,0.000039252114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048004556,0.0028290502,0.82541424,0.00009403803,0.0009582473,0.011903937,0.0031589568,0.000557087,0.1359002,0.0012583052,0.0002809121,0.012844565],"study_design_scores_gemma":[0.015522802,0.05049067,0.7749531,0.000014466755,0.0010199625,0.020098817,0.000052048985,0.0006456093,0.121252775,0.00018472964,0.015473396,0.00029158982],"about_ca_topic_score_codex":0.000101791666,"about_ca_topic_score_gemma":0.0000041219173,"teacher_disagreement_score":0.050461102,"about_ca_system_score_codex":0.000100680874,"about_ca_system_score_gemma":0.00010361272,"threshold_uncertainty_score":0.31394634},"labels":[],"label_agreement":null},{"id":"W2160046662","doi":"10.1016/j.eururo.2011.03.030","title":"Active Surveillance of Small Renal Masses: Progression Patterns of Early Stage Kidney Cancer","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":497,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; London Health Sciences Centre; University of Manitoba; Princess Margaret Cancer Centre; St Joseph's Health Care; Vancouver General Hospital; Queen Elizabeth II Health Sciences Centre; University of Ottawa; McGill University Health Centre; Queen's University; University of Toronto; Western University; Dalhousie University; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Biopsy; Histology; Stage (stratigraphy); Renal cell carcinoma; Prospective cohort study; Cancer; Metastasis; Kidney cancer; Tumor progression; Radiology; Kidney; Pathology; Internal medicine","score_opus":0.04709776680148336,"score_gpt":0.27873696765583417,"score_spread":0.2316392008543508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160046662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97731113,0.00018511877,0.00012141012,0.000100098194,0.00011068836,0.00029006513,0.00009296393,0.000026165555,0.021762365],"genre_scores_gemma":[0.99829364,0.00007165073,0.00058689143,0.00017342898,0.000065610715,0.000010153787,0.000025449839,0.00003851156,0.00073468615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986927,0.00035762548,0.0003091763,0.000274791,0.00014381653,0.00022190793],"domain_scores_gemma":[0.9990286,0.000041792755,0.0002907703,0.0003595505,0.00012679082,0.00015245404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002008495,0.0001493246,0.0003397327,0.0000910107,0.000015718339,0.0000015576044,0.00013080305,0.00004648974,0.00053929747],"category_scores_gemma":[0.00006226337,0.00011334209,0.00008544493,0.000077084034,0.00010717236,0.000024829367,0.00009101198,0.00015222913,0.00002412525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020181823,0.00028219612,0.9680894,0.00012735087,0.00016839596,0.0005323179,0.0015610602,0.0000018190286,0.021887874,0.000046346497,0.00009957741,0.0051855016],"study_design_scores_gemma":[0.0012821985,0.002718163,0.94193786,0.0000594136,0.000067114066,0.000022010281,0.000030428622,0.000006034038,0.051022183,0.0000045535758,0.0027696972,0.000080312166],"about_ca_topic_score_codex":0.00047789438,"about_ca_topic_score_gemma":0.000046880723,"teacher_disagreement_score":0.029134309,"about_ca_system_score_codex":0.000029160565,"about_ca_system_score_gemma":0.000091724236,"threshold_uncertainty_score":0.5904929},"labels":[],"label_agreement":null},{"id":"W2160120519","doi":"10.1016/s1470-2045(09)70162-7","title":"Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial","year":2009,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":591,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Sunitinib; Medicine; Discontinuation; Renal cell carcinoma; Expanded access; Internal medicine; Adverse effect; Population; Clinical trial; Oncology","score_opus":0.12229784488383882,"score_gpt":0.39522004052956183,"score_spread":0.272922195645723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160120519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885221,0.0005971067,0.00016794394,0.0023978874,0.00012985784,0.0016577266,0.000025311763,0.00002515429,0.0064769024],"genre_scores_gemma":[0.9964422,0.00009918619,0.0016918227,0.0007691712,0.00061488035,0.000051402087,0.00006272979,0.000014626193,0.00025396212],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986795,0.0002803303,0.00036313696,0.00020801168,0.00013388,0.0003350932],"domain_scores_gemma":[0.99848366,0.000694307,0.00019892515,0.000420387,0.00007386503,0.00012886312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078766816,0.00015567646,0.0008280139,0.00006327081,0.00007116142,0.00000956851,0.00016886,0.00006995136,0.00003155884],"category_scores_gemma":[0.00012092989,0.00009560887,0.000096679505,0.00010148248,0.00012238715,0.00006671121,0.000035850182,0.0001404931,0.0000019943445],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81471705,0.008446345,0.006640718,0.00063033716,0.00049869635,0.00029850076,0.006070517,0.00006768457,0.03855073,0.005351483,0.005956104,0.11277185],"study_design_scores_gemma":[0.52715623,0.062092304,0.31971565,0.00006445928,0.0023658657,0.00053929724,0.0006510979,0.00023701007,0.058543865,0.0017462663,0.026460528,0.00042744618],"about_ca_topic_score_codex":0.00004318222,"about_ca_topic_score_gemma":0.000016216993,"teacher_disagreement_score":0.31307492,"about_ca_system_score_codex":0.000093312236,"about_ca_system_score_gemma":0.00015275672,"threshold_uncertainty_score":0.38988167},"labels":[],"label_agreement":null},{"id":"W2160257239","doi":"10.1158/1078-0432.ccr-08-0608","title":"Familial Non-VHL Clear Cell (Conventional) Renal Cell Carcinoma: Clinical Features, Segregation Analysis, and Mutation Analysis of <i>FLCN</i>","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Cancer Research UK; National Institutes of Health; Institut National Du Cancer; Ligue Contre le Cancer; National Institute for Health and Care Research","keywords":"Folliculin; Penetrance; Germline mutation; Germline; Medicine; Birt–Hogg–Dubé syndrome; Renal cell carcinoma; Mutation; Cancer; Clear cell renal cell carcinoma; Oncology; Genetics; Internal medicine; Cancer research; Biology; Phenotype; Surgery","score_opus":0.14348036675283019,"score_gpt":0.4542025237708297,"score_spread":0.31072215701799955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160257239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99407583,0.0022745498,0.00020417469,0.00046161626,0.00016206881,0.00078314444,0.0001049183,0.000024258172,0.0019094604],"genre_scores_gemma":[0.9918318,0.0027176251,0.0009309858,0.00016325153,0.00043071326,0.00007960087,0.0005136889,0.0000369673,0.003295377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935236,0.0011623317,0.0018341659,0.0011472009,0.0017511578,0.00058156997],"domain_scores_gemma":[0.9949378,0.0018272282,0.0004686852,0.0008577359,0.0012534603,0.0006551236],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037704876,0.00029063234,0.0015371139,0.0012893162,0.00026261577,0.00002885788,0.00025325865,0.00045744271,0.0003566227],"category_scores_gemma":[0.00043463113,0.0002458042,0.001445853,0.003935846,0.0011310565,0.00011913873,0.00018908754,0.0013505948,0.000036791298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003705628,0.001465285,0.9817692,0.00017449139,0.0029812362,0.00040140183,0.00020371022,0.00024855038,0.0017149681,0.000018793988,0.0042909975,0.0030257243],"study_design_scores_gemma":[0.0049034883,0.0020505025,0.9741647,0.000028307993,0.007393789,0.00001247234,0.000111590685,0.0028200597,0.00783621,0.000038149865,0.0004433489,0.00019734944],"about_ca_topic_score_codex":0.0032600032,"about_ca_topic_score_gemma":0.00082424126,"teacher_disagreement_score":0.007604482,"about_ca_system_score_codex":0.00027540076,"about_ca_system_score_gemma":0.0009778031,"threshold_uncertainty_score":0.9999994},"labels":[],"label_agreement":null},{"id":"W2160324169","doi":"10.1016/j.eururo.2009.01.018","title":"Complications of Laparoscopic Surgery for Renal Masses: Prevention, Management, and Comparison with the Open Experience","year":2009,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Surgery; Laparoscopy; Open surgery; General surgery","score_opus":0.12919350648513242,"score_gpt":0.3799376335403153,"score_spread":0.2507441270551829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160324169","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032809007,0.9712917,0.0009862409,0.00030534223,0.000040845127,0.0034966627,0.000015155708,0.000021771686,0.02351415],"genre_scores_gemma":[0.004465518,0.9887837,0.0026491927,0.0002978427,0.000070465896,0.00048587826,0.00032852212,0.000066872046,0.0028519675],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99833703,0.00043934467,0.0005144439,0.0004173862,0.00010309554,0.00018867507],"domain_scores_gemma":[0.9984305,0.00033774594,0.0004927212,0.00061894406,0.000055439068,0.00006466116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034709388,0.00024056353,0.0011877577,0.00010984544,0.0000943976,0.000027926402,0.00034296472,0.00004352741,0.000013372495],"category_scores_gemma":[0.000020311485,0.00013931787,0.00014838668,0.00016348036,0.00019151838,0.000030849176,0.00017371826,0.00013620027,0.000011392161],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026125982,0.00056501565,0.0012147871,0.00796437,0.0009948001,0.000115060924,0.00030971383,0.0000024641163,0.0000020031264,0.0017619985,0.019957142,0.9668514],"study_design_scores_gemma":[0.0005313816,0.00070714473,0.005451408,0.0013040607,0.0016209813,0.0001639984,0.000029799348,0.0000022194836,0.0000016792637,0.000016462247,0.9900623,0.00010854163],"about_ca_topic_score_codex":0.0000030972387,"about_ca_topic_score_gemma":0.00000404652,"teacher_disagreement_score":0.9701052,"about_ca_system_score_codex":0.000025932739,"about_ca_system_score_gemma":0.000071054405,"threshold_uncertainty_score":0.5681218},"labels":[],"label_agreement":null},{"id":"W2160339973","doi":"10.1586/era.10.69","title":"Potential of imaging biomarkers for characterization of renal masses","year":2010,"lang":"en","type":"editorial","venue":"Expert Review of Anticancer Therapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Medical physics","score_opus":0.012842286787909767,"score_gpt":0.3316549393470549,"score_spread":0.31881265255914515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160339973","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0106833875,0.522483,0.0019641863,0.0014797309,0.45729345,0.0050000018,0.0007845736,0.00003699661,0.00027468748],"genre_scores_gemma":[0.0031170752,0.79424226,0.0037716364,0.00019965356,0.19652477,0.00019573666,0.0017403984,0.00009933977,0.00010914154],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99762243,0.00006718594,0.0009885455,0.00035699466,0.00076372275,0.00020110985],"domain_scores_gemma":[0.99713385,0.00016991058,0.0011608507,0.0005750174,0.00089191366,0.00006846645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038794425,0.0003279821,0.0015504658,0.00014584973,0.000021676049,0.0000052866467,0.00020027425,0.00023381304,0.0002523256],"category_scores_gemma":[0.00017431336,0.00023901192,0.00062815764,0.00016031649,0.00020205893,0.00006073539,0.000023825707,0.00019287187,7.214755e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011315909,0.00023284144,0.000085893436,0.011660116,0.00060093415,0.0000056301456,0.00005750736,1.6488523e-8,0.79006255,0.000003852149,0.1489402,0.047218855],"study_design_scores_gemma":[0.001840644,0.0005365522,0.00030769015,0.015086637,0.00032709553,0.0000044655344,0.0000059316194,0.0000071421096,0.27410153,0.0000053297117,0.70761317,0.00016382856],"about_ca_topic_score_codex":0.00006989973,"about_ca_topic_score_gemma":7.666219e-7,"teacher_disagreement_score":0.55867296,"about_ca_system_score_codex":0.000063968626,"about_ca_system_score_gemma":0.00055721303,"threshold_uncertainty_score":0.9746623},"labels":[],"label_agreement":null},{"id":"W2160675768","doi":"10.5489/cuaj.11199","title":"Importance of patient compliance in small renal mass active surveillance.","year":2012,"lang":"fr","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Radiology; Surgery; Renal mass; Kidney; Internal medicine","score_opus":0.05771575149218099,"score_gpt":0.24991865877975517,"score_spread":0.19220290728757417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160675768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9428073,0.039549667,0.000026041685,0.0007598211,0.0016601769,0.0017279964,0.000086182605,0.000017250604,0.0133655425],"genre_scores_gemma":[0.99562645,0.00043593848,0.00049536524,0.00013401356,0.0004608628,0.0010046192,0.000037284964,0.000037768685,0.0017676906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997198,0.00021489055,0.000659844,0.0003532377,0.00031526186,0.0012587528],"domain_scores_gemma":[0.99831325,0.00022051706,0.00038101088,0.00049495953,0.00011666859,0.0004735683],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005688062,0.0003005707,0.0006586821,0.0001227587,0.000024519517,0.0000070079886,0.00013043822,0.00013681198,0.00012388492],"category_scores_gemma":[0.00019089664,0.00028243323,0.00015084916,0.00037655464,0.00019180872,0.00014012186,0.00006250119,0.00029911252,0.000054226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000496524,0.00071694184,0.7704649,0.00031648742,0.00013942645,0.00012784608,0.00057935895,0.000021618265,0.00025102837,0.0001913021,0.00025875054,0.22643584],"study_design_scores_gemma":[0.0016303051,0.00014573292,0.9767723,0.00020968243,0.00006870285,0.00004214875,0.00019946483,0.00003492905,0.01724259,0.00009990229,0.003333097,0.00022114045],"about_ca_topic_score_codex":0.00037120242,"about_ca_topic_score_gemma":0.00030151207,"teacher_disagreement_score":0.22621469,"about_ca_system_score_codex":0.0010398614,"about_ca_system_score_gemma":0.00007689984,"threshold_uncertainty_score":0.9999628},"labels":[],"label_agreement":null},{"id":"W2161317196","doi":"10.1093/annonc/mdq599","title":"A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors","year":2010,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Cancer Institute","keywords":"Medicine; Pharmacokinetics; Pharmacodynamics; Pharmacology; Toxicity; Phases of clinical research; Internal medicine; Oncology; Urology","score_opus":0.044384554209597936,"score_gpt":0.3921113069598411,"score_spread":0.3477267527502432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161317196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99717563,0.00008962996,0.000006569177,0.0007555606,0.00007041521,0.0017690855,0.00004187503,0.0000064727637,0.000084748746],"genre_scores_gemma":[0.99839044,0.00008023479,0.00095077336,0.0004534022,0.000025321087,0.00004273693,0.000010836542,0.000021743552,0.0000244898],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986414,0.000115723466,0.00050977105,0.0002557916,0.00023406913,0.00024326507],"domain_scores_gemma":[0.99889195,0.00027384094,0.00023304996,0.0002050596,0.00022532613,0.00017075604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003280468,0.00019072284,0.00064439786,0.00016530155,0.000029114586,0.000004089462,0.00007271259,0.000030186235,0.000021837695],"category_scores_gemma":[0.00012469526,0.00011361726,0.000030007328,0.0002194313,0.00019915999,0.00005317328,0.000108588596,0.00021417168,6.3231096e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.072251864,0.040592358,0.2188965,0.00048008515,0.0010348101,0.0017788678,0.0111077605,0.000114928975,0.12823269,0.000017415046,0.0002139664,0.52527875],"study_design_scores_gemma":[0.11694832,0.2199486,0.5791508,0.00020083632,0.0012497876,0.00037526287,0.0018836207,0.0012649719,0.07713392,0.000037855923,0.0013712558,0.00043476166],"about_ca_topic_score_codex":0.000043055938,"about_ca_topic_score_gemma":0.00026476034,"teacher_disagreement_score":0.524844,"about_ca_system_score_codex":0.000022796232,"about_ca_system_score_gemma":0.00013856622,"threshold_uncertainty_score":0.46331772},"labels":[],"label_agreement":null},{"id":"W2161609794","doi":"10.1158/1078-0432.ccr-07-4921","title":"Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":605,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institutes of Health; European Commission","keywords":"Biology; Cancer research; Carcinogenesis; Epigenetics; Clear cell; Cancer; DNA methylation; Clear cell renal cell carcinoma; CpG site; Germline mutation; Mutation; Gene; Pathology; Renal cell carcinoma; Medicine; Genetics; Gene expression; Carcinoma","score_opus":0.2289285019524419,"score_gpt":0.47762697916421604,"score_spread":0.24869847721177413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161609794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962585,0.0008726262,0.00004984414,0.0009069416,0.00012785789,0.00085026864,0.000021635318,0.000017216835,0.00089514063],"genre_scores_gemma":[0.99447554,0.0010585398,0.00027899048,0.000064089116,0.00036220733,0.00016366942,0.00004560799,0.000028962648,0.0035223665],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967041,0.00043987704,0.0011838821,0.0005171462,0.0007375986,0.00041739154],"domain_scores_gemma":[0.99791014,0.00047580138,0.00016865155,0.0006195482,0.0005623282,0.00026354424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022344189,0.00012531548,0.0004307045,0.000292792,0.00011440116,0.000013566939,0.00019035481,0.00015134696,0.00023148443],"category_scores_gemma":[0.00057341764,0.000107772765,0.00017461664,0.0006153625,0.0004676837,0.00007536227,0.000094489296,0.0008160827,0.00008978113],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058741644,0.00295025,0.21261103,0.00031706944,0.00010142082,0.0005267998,0.0011056571,0.00010109293,0.7649525,0.00007665225,0.0031847737,0.008198574],"study_design_scores_gemma":[0.0037660897,0.0018914965,0.5170361,0.0001222223,0.000036726127,0.000025157131,0.00011026082,0.0023587497,0.47391167,0.000091685244,0.00051933806,0.000130521],"about_ca_topic_score_codex":0.0011232101,"about_ca_topic_score_gemma":0.00018922192,"teacher_disagreement_score":0.30442503,"about_ca_system_score_codex":0.0003581319,"about_ca_system_score_gemma":0.0009795928,"threshold_uncertainty_score":0.4394846},"labels":[],"label_agreement":null},{"id":"W2162225483","doi":"10.1002/cncr.24864","title":"Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America","year":2010,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":253,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; McGill University Health Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Sorafenib; Renal cell carcinoma; Rash; Internal medicine; Population; Adverse effect; Expanded access; Surgery; Oncology; Bevacizumab; Kidney cancer; Hepatocellular carcinoma; Chemotherapy","score_opus":0.019037891658892192,"score_gpt":0.3025669710936259,"score_spread":0.2835290794347337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162225483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950696,0.0005522319,0.0000016135173,0.00048133873,0.00016327002,0.0010937954,0.000043143078,0.000022404807,0.0025726003],"genre_scores_gemma":[0.99875,0.00012430978,0.00031739307,0.00009404237,0.00007935379,0.00011957208,0.000027179572,0.000019266705,0.00046892007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887645,0.000035195768,0.0003204464,0.0003152187,0.00021303172,0.00023968189],"domain_scores_gemma":[0.99908864,0.00006537544,0.0001717664,0.000475074,0.00008251736,0.00011664802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059490696,0.00016093483,0.00031321682,0.000057460395,0.000043393447,0.000011813774,0.00016196036,0.00006090416,0.000035268804],"category_scores_gemma":[0.000052436666,0.0001010441,0.00007413015,0.00036041898,0.0001910822,0.00006310363,0.00009633091,0.00029709123,0.0000017664055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006913521,0.00079512806,0.55630314,0.00020994716,0.000045578097,0.000077824305,0.0019075364,0.0002258078,0.054949753,0.000004976255,0.00035389315,0.37821287],"study_design_scores_gemma":[0.0073110936,0.00031692896,0.9250233,0.000049229067,0.000061671686,0.0000063437647,0.000046030378,0.0000592509,0.059587933,0.000003083011,0.00743369,0.00010143289],"about_ca_topic_score_codex":0.00048639844,"about_ca_topic_score_gemma":0.0017880173,"teacher_disagreement_score":0.37811145,"about_ca_system_score_codex":0.00008776567,"about_ca_system_score_gemma":0.00019482644,"threshold_uncertainty_score":0.41204587},"labels":[],"label_agreement":null},{"id":"W2163760444","doi":"10.1093/annonc/mdt375","title":"Overall survival for sorafenib plus interleukin-2 compared with sorafenib alone in metastatic renal cell carcinoma (mRCC): final results of the ROSORC trial","year":2013,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Bayer HealthCare","keywords":"Sorafenib; Medicine; Renal cell carcinoma; Interquartile range; Internal medicine; Confidence interval; Oncology; Refractory (planetary science); Urology; Surgery; Gastroenterology; Hepatocellular carcinoma","score_opus":0.15243239292797406,"score_gpt":0.35343033272481045,"score_spread":0.2009979397968364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163760444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98943233,0.00024962024,0.00006479509,0.0035855295,0.0002580864,0.0031558592,0.00012691907,0.0000125969045,0.0031142368],"genre_scores_gemma":[0.99638206,0.000016733635,0.0016566399,0.00029964474,0.000119011886,0.00026756976,0.00011296894,0.000036044585,0.0011093541],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970168,0.0004019425,0.0011634916,0.00044544134,0.00044690495,0.00052540854],"domain_scores_gemma":[0.9971054,0.00079370366,0.00078498456,0.00061696925,0.00054399966,0.00015491966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070684426,0.00032019016,0.0014272041,0.00021063742,0.000044741137,0.000010377939,0.00031115353,0.00014615181,0.00006888671],"category_scores_gemma":[0.00020459082,0.00020232624,0.0003435463,0.00025486862,0.00033535695,0.000097659,0.00010491366,0.0002840145,0.0000104587325],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8520337,0.01138781,0.008608479,0.0013011547,0.0012479617,0.00059341063,0.0063550947,0.0021003105,0.0642787,0.00043652827,0.044622157,0.007034731],"study_design_scores_gemma":[0.5309058,0.06737654,0.09623475,0.00036812184,0.00087839784,0.00016799047,0.001118679,0.0015985626,0.29333025,0.0010763475,0.0063506677,0.0005939475],"about_ca_topic_score_codex":0.0024168836,"about_ca_topic_score_gemma":0.0010780698,"teacher_disagreement_score":0.32112792,"about_ca_system_score_codex":0.00019389977,"about_ca_system_score_gemma":0.00094266044,"threshold_uncertainty_score":0.8250624},"labels":[],"label_agreement":null},{"id":"W2164455762","doi":"10.1016/j.eururo.2008.09.037","title":"Re: Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma","year":2008,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Temsirolimus; Medicine; Renal cell carcinoma; Interferon alfa; Oncology; Internal medicine; Interferon; Alpha interferon; Discovery and development of mTOR inhibitors; Virology; PI3K/AKT/mTOR pathway; Apoptosis","score_opus":0.03724392434054155,"score_gpt":0.2547802718044395,"score_spread":0.21753634746389797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164455762","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11705142,0.009815884,0.00076314755,0.63722175,0.0044414336,0.0074108224,0.0005859063,0.0008526911,0.22185694],"genre_scores_gemma":[0.20951429,0.00033733333,0.0017101646,0.65988195,0.00850244,0.00019825579,0.0033763498,0.0007769558,0.11570227],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99540526,0.0006694917,0.0009049314,0.0014592316,0.00039601058,0.0011650769],"domain_scores_gemma":[0.9970257,0.00049441843,0.0004959493,0.0015921246,0.00014224926,0.00024954425],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026578104,0.0009424539,0.0013437327,0.00041224988,0.00015122292,0.000022901138,0.0005185113,0.00065342075,0.00042787794],"category_scores_gemma":[0.00013725036,0.00072705303,0.0005655261,0.00016319384,0.0002688397,0.000055226476,0.00023717435,0.0020395264,0.0007683404],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035873968,0.00015193867,0.00019713237,0.00038858398,0.00016340362,0.03047165,0.00022397238,0.00000675337,0.0014001111,0.0000011575236,0.9616856,0.0017223053],"study_design_scores_gemma":[0.006021385,0.012404888,0.0012682417,0.000054055094,0.0006784112,0.0019327968,0.000015547092,0.000017727256,0.00150467,0.000006989946,0.9755094,0.0005858764],"about_ca_topic_score_codex":0.000022192691,"about_ca_topic_score_gemma":0.000011988641,"teacher_disagreement_score":0.10615466,"about_ca_system_score_codex":0.00029769551,"about_ca_system_score_gemma":0.00024658794,"threshold_uncertainty_score":0.99951804},"labels":[],"label_agreement":null},{"id":"W2164499021","doi":"10.5489/cuaj.1381","title":"Patterns of care for renal surgery: Underutilization of nephron-sparing procedures","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Nephrectomy; Medicine; Nephron; Urology; Ablative case; Kidney; Kidney disease; Surgery; General surgery; Internal medicine; Radiation therapy","score_opus":0.021778889361140575,"score_gpt":0.2325903350485919,"score_spread":0.2108114456874513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164499021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956189,0.00035391565,0.00036884577,0.0028194415,0.000086109285,0.0004073653,0.000031708634,0.000007453425,0.00030628833],"genre_scores_gemma":[0.999038,0.000049493534,0.00023939373,0.00034490274,0.0001399645,0.000022565233,0.000060685466,0.000010300827,0.00009470319],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989046,0.000058839723,0.00039934178,0.000114992756,0.00024991596,0.00027235263],"domain_scores_gemma":[0.99827135,0.0002162768,0.0004072622,0.000074808646,0.0007200727,0.00031020975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021547191,0.00009550633,0.00033019978,0.00018366658,0.00008268588,0.000020249654,0.00005373477,0.0001488956,0.00024473155],"category_scores_gemma":[0.0006946996,0.00007506051,0.00017951195,0.000105592815,0.000013156069,0.00006868847,0.0000064623373,0.00013138301,0.0000033144636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041635587,0.000028111881,0.9943292,0.000098757315,0.00009844649,0.000005265027,0.0001869964,0.00007274442,0.0007291078,0.0000810637,0.0022809077,0.0020477718],"study_design_scores_gemma":[0.0005674322,0.00038844705,0.9948509,0.00006696232,0.00010248439,0.000037304108,0.00024322633,0.00010408555,0.0019754071,0.0002802452,0.0013156742,0.00006785083],"about_ca_topic_score_codex":0.0017453686,"about_ca_topic_score_gemma":0.0016903124,"teacher_disagreement_score":0.0034191187,"about_ca_system_score_codex":0.0007616789,"about_ca_system_score_gemma":0.00067470915,"threshold_uncertainty_score":0.30608788},"labels":[],"label_agreement":null},{"id":"W2164608774","doi":"10.1148/radiol.2015140907","title":"Accuracy of Contrast-enhanced US for Differentiating Benign from Malignant Solid Small Renal Masses","year":2015,"lang":"en","type":"article","venue":"Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Vascularity; Radiology; Mann–Whitney U test; Contrast (vision); Institutional review board; Exact test; Nuclear medicine; Surgery; Internal medicine","score_opus":0.058661484565662926,"score_gpt":0.3012779678212462,"score_spread":0.2426164832555833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164608774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98215723,0.00095124566,0.014121159,0.00014178938,0.00019398393,0.00062457635,0.00004975517,0.00003529571,0.0017249908],"genre_scores_gemma":[0.9883487,0.000028643857,0.010474367,0.00011904035,0.00027658555,0.000077366254,0.00019368983,0.00002609119,0.00045548604],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874514,0.00008656944,0.000423545,0.0003178805,0.00011164874,0.00031521093],"domain_scores_gemma":[0.9984313,0.0006482738,0.0002645278,0.00030637026,0.0001680026,0.00018147404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015014615,0.00018632587,0.0006842953,0.00006663179,0.000028982238,0.000005611053,0.000101315476,0.00013834824,0.00005940533],"category_scores_gemma":[0.0004401736,0.00014064171,0.00015062571,0.000042184427,0.00008545546,0.000028448565,0.000034268964,0.000095580435,0.0000102317335],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020168766,0.00024967574,0.04518123,0.000088691144,0.00060068414,0.00010726864,0.0007524752,0.00007349092,0.943648,0.000663635,0.0006579788,0.0059599984],"study_design_scores_gemma":[0.009725124,0.003210088,0.11995891,0.00015098606,0.00063712796,0.00018645654,0.00018726655,0.00091531273,0.86082673,0.0028571428,0.001086623,0.00025820744],"about_ca_topic_score_codex":0.00009125399,"about_ca_topic_score_gemma":0.000017772594,"teacher_disagreement_score":0.082821235,"about_ca_system_score_codex":0.0001311028,"about_ca_system_score_gemma":0.00019419128,"threshold_uncertainty_score":0.5735203},"labels":[],"label_agreement":null},{"id":"W2165152110","doi":"10.5489/cuaj.1603","title":"Collecting duct of Bellini renal carcinoma with psoas muscle recurrence: A case report and review of literature","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Nephrectomy; Medicine; Adjuvant therapy; Metastasis; Distant metastasis; Stage (stratigraphy); Carcinoma; Adjuvant chemotherapy; Surgery; Disease; Renal function; Chemotherapy; Urology; Internal medicine; Kidney; Cancer","score_opus":0.01762163460171842,"score_gpt":0.2470215700143684,"score_spread":0.22939993541264997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165152110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98250645,0.011124045,0.000022469743,0.004229335,0.00006976381,0.00026175164,0.000021414924,0.000005383637,0.0017593753],"genre_scores_gemma":[0.99702775,0.0009465767,0.00088166207,0.0007196688,0.00016485291,0.0000052939827,0.000018482846,0.000008801754,0.0002268988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983859,0.00024610577,0.0005649852,0.00020108622,0.00034243666,0.00025945128],"domain_scores_gemma":[0.997581,0.00023899293,0.0007676185,0.00015153298,0.0007532079,0.0005076724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013740791,0.00013481449,0.0004916237,0.00015078372,0.00013728219,0.000020701847,0.00004791433,0.00014741925,0.00009515873],"category_scores_gemma":[0.0022493058,0.00009138505,0.000106922475,0.00039117486,0.000049172322,0.00005126453,0.000010143022,0.00045465236,7.9118007e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015055854,0.0001019111,0.9298909,0.000963689,0.00023829055,0.053820994,0.00056528865,0.000006910634,0.0002446335,0.00008500091,0.006199548,0.0077323],"study_design_scores_gemma":[0.0018624536,0.0033453736,0.6732246,0.0041530356,0.00068402704,0.3027549,0.00009066253,0.00009924173,0.00031090534,0.0001958591,0.013038007,0.00024087579],"about_ca_topic_score_codex":0.00074136385,"about_ca_topic_score_gemma":0.00038073643,"teacher_disagreement_score":0.25666624,"about_ca_system_score_codex":0.00039117926,"about_ca_system_score_gemma":0.00058115186,"threshold_uncertainty_score":0.37265742},"labels":[],"label_agreement":null},{"id":"W2165347448","doi":"10.5489/cuaj.2072","title":"Intraperitoneal marsupialization of a giant para-pelvic renal cyst: A case report","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Marsupialization; Medicine; Asymptomatic; Cyst; Surgery; Kidney; Renal pelvis; Ureter; Radiology; Internal medicine","score_opus":0.016169531720153944,"score_gpt":0.23848818912067174,"score_spread":0.2223186574005178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165347448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869675,0.00011958654,0.0007628605,0.0077115665,0.00024410283,0.00022628944,0.000020714797,0.000020722855,0.0039266464],"genre_scores_gemma":[0.9971649,0.00001528101,0.00080109836,0.0010165166,0.0005184982,0.000008107649,0.000057511323,0.000014241575,0.00040386536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803716,0.00026575828,0.0006367821,0.00021464328,0.00043731445,0.0004083217],"domain_scores_gemma":[0.9979578,0.00012572392,0.0005323555,0.00017446512,0.00041474515,0.0007948703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010247891,0.00015247049,0.000385818,0.00022107201,0.0001737677,0.000043457374,0.000067863046,0.00025148774,0.0004603406],"category_scores_gemma":[0.0012239767,0.00012106675,0.00018270688,0.00023400008,0.000043029388,0.000068893874,0.000008621452,0.0003840592,0.00002353911],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052379264,0.00038820328,0.63425165,0.00005697774,0.00075734645,0.31849042,0.00066156103,0.000291108,0.013031203,0.0012713943,0.011764777,0.018511571],"study_design_scores_gemma":[0.002332327,0.0015275499,0.5561434,0.000037859183,0.00036009634,0.40957212,0.00006849568,0.0013335207,0.0007136206,0.00066198653,0.027018,0.00023100594],"about_ca_topic_score_codex":0.0020468954,"about_ca_topic_score_gemma":0.0012131871,"teacher_disagreement_score":0.0910817,"about_ca_system_score_codex":0.0010714857,"about_ca_system_score_gemma":0.00053383404,"threshold_uncertainty_score":0.5040407},"labels":[],"label_agreement":null},{"id":"W2166010840","doi":"10.1111/j.1464-410x.2011.10629.x","title":"Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials","year":2011,"lang":"en","type":"review","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":267,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Temsirolimus; Pazopanib; Medicine; Sunitinib; Axitinib; Oncology; Internal medicine; Bevacizumab; Sorafenib; Everolimus; Clinical trial; Renal cell carcinoma; Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway; Chemotherapy; Hepatocellular carcinoma","score_opus":0.05609752772833089,"score_gpt":0.35519857381658554,"score_spread":0.29910104608825466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166010840","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000027462274,0.98629344,0.00011666795,0.000119977274,0.0006891304,0.012301922,0.00021648864,0.000013284677,0.00022161136],"genre_scores_gemma":[0.00004550549,0.99626124,0.0007156323,0.0004667642,0.00043981138,0.0014272209,0.000173474,0.000120053286,0.00035030502],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9890037,0.0028950465,0.006630465,0.00045051076,0.0005476165,0.00047261763],"domain_scores_gemma":[0.9844978,0.0025129437,0.010456631,0.00054899603,0.0016599902,0.000323676],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0074814972,0.00061240396,0.018529622,0.0004310436,0.00004800204,0.00002916827,0.0005198362,0.0005105699,0.0009053641],"category_scores_gemma":[0.0062077004,0.00043215402,0.004594081,0.0003265407,0.000121453,0.000120532495,0.000033444405,0.00075197883,0.000004573297],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047810916,0.0003628899,3.1939885e-7,0.83453006,0.0031010865,0.00068651175,0.000017895287,3.303212e-7,0.000030710897,0.0000028495158,0.004776331,0.15170993],"study_design_scores_gemma":[0.045046616,0.0034268687,0.0000025984345,0.7789608,0.031582274,0.013853586,0.000003730292,4.990618e-7,0.00007314496,0.000029741843,0.12671867,0.00030146446],"about_ca_topic_score_codex":0.000032923697,"about_ca_topic_score_gemma":0.0000046764144,"teacher_disagreement_score":0.15140846,"about_ca_system_score_codex":0.0002092011,"about_ca_system_score_gemma":0.0017010596,"threshold_uncertainty_score":0.999813},"labels":[],"label_agreement":null},{"id":"W2166597765","doi":"10.1016/j.eururo.2011.06.021","title":"Outcomes of Small Renal Mass Needle Core Biopsy, Nondiagnostic Percutaneous Biopsy, and the Role of Repeat Biopsy","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":404,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network; Queen's University","funders":"","keywords":"Medicine; Biopsy; Radiology; Grading (engineering); Renal cell carcinoma; Percutaneous; Renal biopsy; Pathology","score_opus":0.0275736788116021,"score_gpt":0.22403570965798925,"score_spread":0.19646203084638714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166597765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95428604,0.0017132157,0.000033777796,0.00027371425,0.00011678817,0.0004008414,0.000022856171,0.0000397245,0.043113057],"genre_scores_gemma":[0.9970139,0.00009529128,0.0020371545,0.00020953527,0.000057237394,0.000005792721,0.000018654164,0.000054148633,0.00050828303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982617,0.00033069283,0.00054132903,0.00038134566,0.00017042943,0.0003145261],"domain_scores_gemma":[0.9983087,0.00044006566,0.00028520604,0.0007148411,0.00011054289,0.00014062545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039728024,0.00026739377,0.00065462483,0.00016937987,0.000050387254,0.0000047776884,0.00023334914,0.00008185141,0.00018448324],"category_scores_gemma":[0.0003047247,0.00016294194,0.00018204273,0.000146067,0.0008661475,0.000018680485,0.00016191135,0.00021205175,0.00007320363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004411801,0.00057975866,0.79576117,0.00012765947,0.0008655176,0.009346471,0.005892202,0.0000087918925,0.17655016,0.0025656028,0.000087223925,0.0038036352],"study_design_scores_gemma":[0.004068703,0.0023082334,0.9623763,0.000038336362,0.0010697206,0.019817676,0.00050243107,0.00011515326,0.008205595,0.0008042583,0.0004502331,0.00024335897],"about_ca_topic_score_codex":0.0002700143,"about_ca_topic_score_gemma":0.00000507734,"teacher_disagreement_score":0.16834457,"about_ca_system_score_codex":0.00001888147,"about_ca_system_score_gemma":0.00003438435,"threshold_uncertainty_score":0.664458},"labels":[],"label_agreement":null},{"id":"W2167127007","doi":"10.5489/cuaj.67","title":"Sunitinib therapy for metastatic renal cell carcinoma: recommendations for management of side effects","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Pfizer (Canada); Hôpital Notre-Dame; CancerCare Manitoba; BC Cancer Agency","funders":"","keywords":"Sunitinib; Medicine; Discontinuation; Renal cell carcinoma; Neutropenia; Toxicity; Side effect (computer science); Internal medicine; Tyrosine-kinase inhibitor; Oncology; Cancer; Pharmacology","score_opus":0.042427090081247926,"score_gpt":0.2796902975201788,"score_spread":0.2372632074389309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167127007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97712296,0.0014663383,0.0020616732,0.013541504,0.00048202422,0.0019871232,0.00015400376,0.000015358877,0.0031690348],"genre_scores_gemma":[0.98599064,0.00008355861,0.011093044,0.0014311348,0.00027979526,0.00018948947,0.00013797829,0.000019569847,0.0007748066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855334,0.00014401227,0.00038993752,0.00013543073,0.0002134732,0.00056380854],"domain_scores_gemma":[0.99802804,0.00061197975,0.00034711117,0.00011054363,0.0002861399,0.0006161739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088222174,0.00014967575,0.0003264524,0.00017357248,0.00020642097,0.000022846854,0.00008223507,0.00009676066,0.00010274156],"category_scores_gemma":[0.0001585349,0.00011692105,0.0002728614,0.00013028223,0.000017427794,0.000082319464,0.000007605704,0.00017682393,0.000007662414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024032579,0.0032138703,0.7106545,0.0009883647,0.0040748036,0.00022320748,0.0018582493,0.00008597378,0.00690929,0.0076887524,0.14589742,0.11600231],"study_design_scores_gemma":[0.011517811,0.0033505945,0.8265042,0.000045376717,0.0011580718,0.00012443545,0.00033878715,0.00007816139,0.009758155,0.0016952372,0.1451456,0.00028359675],"about_ca_topic_score_codex":0.00014070074,"about_ca_topic_score_gemma":0.000037000653,"teacher_disagreement_score":0.11584967,"about_ca_system_score_codex":0.0008411504,"about_ca_system_score_gemma":0.0001824175,"threshold_uncertainty_score":0.4767902},"labels":[],"label_agreement":null},{"id":"W2167290534","doi":"10.1158/1078-0432.ccr-06-1432","title":"Phase I Trial of Sorafenib in Combination with IFN α-2a in Patients with Unresectable and/or Metastatic Renal Cell Carcinoma or Malignant Melanoma","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Sorafenib; Medicine; Renal cell carcinoma; Melanoma; Internal medicine; Response Evaluation Criteria in Solid Tumors; Oncology; Pharmacokinetics; Adverse effect; Cohort; Progressive disease; Gastroenterology; Combination therapy; Chemotherapy; Hepatocellular carcinoma; Cancer research","score_opus":0.17133590328777443,"score_gpt":0.46470068394029906,"score_spread":0.29336478065252464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167290534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958482,0.00026943965,0.000023346358,0.00020784643,0.000055869317,0.0030424844,0.000022891334,0.0000081600465,0.00052181154],"genre_scores_gemma":[0.99815756,0.00007709201,0.0005237566,0.000034949637,0.0000640614,0.00019826843,0.00004065155,0.000038779584,0.00086486276],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.995727,0.0005762405,0.0010399937,0.0005950871,0.0013803421,0.0006813496],"domain_scores_gemma":[0.99689806,0.0016345287,0.00020331635,0.00042430207,0.0004967861,0.00034303562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043269093,0.00021592679,0.0008208904,0.00056704145,0.000051769897,0.000021210617,0.000165201,0.000120163575,0.00018977816],"category_scores_gemma":[0.00046060878,0.00011943347,0.000060291368,0.0011477384,0.00043007123,0.000110902496,0.00009271737,0.0007185707,0.000004367644],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58387256,0.009970871,0.3952166,0.00030233033,0.000059067177,0.0011757504,0.00022139016,0.0000043590894,0.00019030621,0.000015384052,0.000093131996,0.008878217],"study_design_scores_gemma":[0.40298346,0.0966681,0.48903078,0.0004362253,0.00010342953,0.000008561787,0.0002750634,0.00008408753,0.010093804,0.000030619995,0.0001159025,0.00016995307],"about_ca_topic_score_codex":0.00223119,"about_ca_topic_score_gemma":0.005312554,"teacher_disagreement_score":0.18088911,"about_ca_system_score_codex":0.00043994022,"about_ca_system_score_gemma":0.0012624986,"threshold_uncertainty_score":0.48703554},"labels":[],"label_agreement":null},{"id":"W2167389683","doi":"10.5489/cuaj.2932","title":"Collecting (Bellini) duct carcinoma: A clinical study of a rare tumour and review of the literature","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Surgery; Radiation therapy; Gemcitabine; Renal cell carcinoma; Chemotherapy; Kidney; Internal medicine","score_opus":0.05953665542315529,"score_gpt":0.30438789159538193,"score_spread":0.24485123617222665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167389683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97618395,0.015930193,4.5845792e-7,0.006543485,0.00019606075,0.00052086473,0.000015216986,0.0000035557937,0.0006062386],"genre_scores_gemma":[0.9973021,0.00069840945,0.000054088574,0.0014796578,0.00021047851,0.000005221992,0.0000030227282,0.00000719433,0.00023978225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977411,0.00073900365,0.0007053277,0.00016131475,0.0004402721,0.00021298353],"domain_scores_gemma":[0.9974746,0.00028674598,0.0006717444,0.00014901698,0.00084256905,0.0005753032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001968334,0.00011440428,0.00053311157,0.000084201005,0.00010378136,0.000020017464,0.00010822495,0.0001438185,0.000034074994],"category_scores_gemma":[0.005604128,0.00006604643,0.00015719533,0.00046031747,0.000036546953,0.00003593598,0.000028481849,0.00062942307,0.0000012581446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000582396,0.00016067318,0.9905053,0.000102081605,0.000099080375,0.00014545636,0.00057084014,0.0000016343046,0.000009629061,0.000005342437,0.008028186,0.00031357454],"study_design_scores_gemma":[0.0018901669,0.0019451984,0.992471,0.0006960177,0.00032521278,0.0005509392,0.0004998256,0.000013417885,0.00001430393,0.00006686669,0.0014658032,0.000061285304],"about_ca_topic_score_codex":0.0005410053,"about_ca_topic_score_gemma":0.0004036288,"teacher_disagreement_score":0.021118216,"about_ca_system_score_codex":0.000489482,"about_ca_system_score_gemma":0.0011206039,"threshold_uncertainty_score":0.67090696},"labels":[],"label_agreement":null},{"id":"W2167545922","doi":"10.1016/j.eururo.2006.11.013","title":"A Prospective Randomized EORTC Intergroup Phase 3 Study Comparing the Complications of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1044,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute; Vlaamse Liga Tegen Kanker","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Kidney cancer; Perioperative; Surgery; Asymptomatic; Kidney; Dissection (medical); Stage (stratigraphy); Kidney disease; Urology; Lymph node; Prospective cohort study; Internal medicine","score_opus":0.02324272183046309,"score_gpt":0.2679309512522843,"score_spread":0.2446882294218212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167545922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843193,0.00060157495,0.0035105157,0.00022689236,0.00006325783,0.0035340223,0.000009939841,0.000050950388,0.007683536],"genre_scores_gemma":[0.9988086,0.0000055731057,0.0003208946,0.0001382178,0.00016442106,0.00027127133,0.000047626425,0.000052666277,0.00019073121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738884,0.00092493615,0.00067933556,0.00049982744,0.00016412664,0.0003429297],"domain_scores_gemma":[0.9973733,0.0016573698,0.000325514,0.0004100482,0.0001376475,0.000096160176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010626599,0.0002635219,0.0009649751,0.00018287917,0.0001709559,0.000021434356,0.00013371318,0.000038180937,0.000013708464],"category_scores_gemma":[0.00014853242,0.00018378356,0.00024267579,0.00017677851,0.000500489,0.00004196756,0.00012113523,0.00027142165,0.000006549304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17710426,0.0074780607,0.7776612,0.00022883275,0.0010111099,0.00052925065,0.004374033,0.00021288908,0.027148964,0.0017308709,0.0014748365,0.0010456839],"study_design_scores_gemma":[0.21290879,0.0026186523,0.77163094,0.000025823969,0.0010215327,0.00017740205,0.00030010688,0.00326347,0.006706107,0.00012061981,0.0009718323,0.0002547298],"about_ca_topic_score_codex":0.00021928333,"about_ca_topic_score_gemma":0.00004768724,"teacher_disagreement_score":0.035804536,"about_ca_system_score_codex":0.00008860106,"about_ca_system_score_gemma":0.00006866168,"threshold_uncertainty_score":0.7494476},"labels":[],"label_agreement":null},{"id":"W2167593269","doi":"10.1016/j.clinthera.2013.10.004","title":"Cost-Effectiveness of Everolimus for Second-Line Treatment of Metastatic Renal Cell Carcinoma in Serbia","year":2013,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Science and Engineering Research Board","keywords":"Medicine; Everolimus; Renal cell carcinoma; Oncology; Second line; Internal medicine; Urology; First line","score_opus":0.2562351824834086,"score_gpt":0.42573841229528947,"score_spread":0.16950322981188087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167593269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993837,0.0014682906,0.00035214337,0.000092431714,0.0001379197,0.003674153,0.000056123787,0.000012067397,0.00036987627],"genre_scores_gemma":[0.9962452,0.00016033924,0.0026045246,0.00013022714,0.000061780505,0.00038188745,0.000056114746,0.00004072008,0.00031920182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976815,0.00036809396,0.0011038755,0.00034904262,0.0002000436,0.00029746763],"domain_scores_gemma":[0.99622595,0.0025124731,0.00031694345,0.00051423797,0.0002779061,0.0001524877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005899576,0.00025617424,0.0011698203,0.00010964155,0.000016938426,0.0000051625225,0.00010415956,0.00014381636,0.00014626903],"category_scores_gemma":[0.00004722644,0.00018450433,0.00047962097,0.00017511052,0.00017544893,0.000043984026,0.000022302647,0.00012480016,0.000013066383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013597802,0.023226643,0.668773,0.0036563207,0.0022665043,0.00012936171,0.0010786011,0.00042661457,0.17343657,0.00019567632,0.000078764795,0.11313413],"study_design_scores_gemma":[0.020569153,0.01870657,0.52673054,0.00013667783,0.0010139863,0.000014857552,0.000116041934,0.0020044076,0.4288399,0.0008165561,0.0008542601,0.00019707176],"about_ca_topic_score_codex":0.00008426157,"about_ca_topic_score_gemma":0.000019179344,"teacher_disagreement_score":0.25540334,"about_ca_system_score_codex":0.00018009447,"about_ca_system_score_gemma":0.00019567879,"threshold_uncertainty_score":0.7523868},"labels":[],"label_agreement":null},{"id":"W2167984747","doi":"10.1111/j.1524-4733.2010.00738.x","title":"How Do Cost-Effectiveness Analyses Inform Reimbursement Decisions for Oncology Medicines in Canada? The Example of Sunitinib for First-Line Treatment of Metastatic Renal Cell Carcinoma","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Sunitinib; Reimbursement; Medicine; Context (archaeology); Oncology; Internal medicine; Tyrosine-kinase inhibitor; Sorafenib; Renal cell carcinoma; Cabozantinib; Kidney cancer; Cancer; Hepatocellular carcinoma","score_opus":0.26172057196591403,"score_gpt":0.41423857386000407,"score_spread":0.15251800189409004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167984747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98812544,0.0014165529,0.0005599273,0.003092868,0.00022045309,0.0062988666,0.00021276104,0.0000041652725,0.00006898215],"genre_scores_gemma":[0.99490273,0.00028843712,0.0029694478,0.00010315008,0.000063733685,0.00147221,0.00014768455,0.000024044037,0.000028552855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977392,0.00022212684,0.0009232595,0.00030214337,0.00036600116,0.00044724444],"domain_scores_gemma":[0.9920471,0.0064682676,0.00049847906,0.00051596685,0.00027088783,0.00019931402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012655907,0.00023837942,0.001062585,0.00032813862,0.00007701174,0.000005070284,0.00013639606,0.000062403924,0.000013145439],"category_scores_gemma":[0.00053574116,0.00014625887,0.0001595911,0.00037318235,0.00010031268,0.000035127257,0.000023095596,0.00013845872,1.2690612e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020251457,0.01201203,0.5066874,0.013467348,0.0014088784,0.00045318744,0.01654721,0.042950682,0.025647372,0.0040938566,0.0017785031,0.3547021],"study_design_scores_gemma":[0.058788605,0.0506799,0.58970034,0.001457276,0.0014402632,0.00014319089,0.0075247814,0.013372735,0.24010259,0.0017118811,0.034523744,0.0005547058],"about_ca_topic_score_codex":0.8411701,"about_ca_topic_score_gemma":0.8282159,"teacher_disagreement_score":0.35414737,"about_ca_system_score_codex":0.0018169762,"about_ca_system_score_gemma":0.004841865,"threshold_uncertainty_score":0.8589261},"labels":[],"label_agreement":null},{"id":"W2168035711","doi":"10.1016/j.urology.2015.08.043","title":"Comparison of Postoperative Complications and Mortality Between Laparoscopic and Percutaneous Local Tumor Ablation for T1a Renal Cell Carcinoma: A Population-based Study","year":2015,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Sherbrooke; Université de Montréal","funders":"","keywords":"Medicine; Perioperative; Renal cell carcinoma; Percutaneous; Logistic regression; Surgery; Odds ratio; Internal medicine; Epidemiology; Comorbidity; Complication; Urology","score_opus":0.06687038830656941,"score_gpt":0.3476732616717809,"score_spread":0.2808028733652115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168035711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594617,0.00024290454,0.0018382441,0.00046033866,0.000023231956,0.0012699196,0.00004510832,0.00001611985,0.00015793511],"genre_scores_gemma":[0.9989642,1.6019756e-7,0.00056409894,0.00014518143,0.000019507317,0.00005385353,0.00022846743,0.000012110005,0.000012456269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990274,0.00010944157,0.00031777602,0.0002780001,0.00013149154,0.00013593932],"domain_scores_gemma":[0.99915946,0.00020860767,0.00012113989,0.00020133881,0.00017235627,0.00013708361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001251729,0.00012872224,0.00044360393,0.00008076907,0.00006809161,0.0000063216435,0.00003401122,0.000059963055,0.000003736709],"category_scores_gemma":[0.000040411895,0.00011194578,0.000028065648,0.000060409624,0.000097955635,0.000023958857,0.000021963357,0.0000870967,0.000001317394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023267444,0.0003608994,0.996804,0.0000288155,0.000034373974,0.000012479192,0.0008716116,0.00049608963,0.00095311535,0.00003887504,0.000029669363,0.000137368],"study_design_scores_gemma":[0.0027737326,0.0056260494,0.97910434,0.0000032399564,0.000385279,0.00003719361,0.00041353257,0.010154549,0.0013021061,0.00008870173,0.000033797514,0.000077456294],"about_ca_topic_score_codex":0.00054672797,"about_ca_topic_score_gemma":0.00022227911,"teacher_disagreement_score":0.017699666,"about_ca_system_score_codex":0.00007409612,"about_ca_system_score_gemma":0.00009253643,"threshold_uncertainty_score":0.45650163},"labels":[],"label_agreement":null},{"id":"W2168054139","doi":"10.1002/cncr.29773","title":"Risk factors and model for predicting toxicity‐related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor–targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium","year":2015,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; BC Cancer Agency","funders":"National Cancer Institute; Astellas Pharma; Dana-Farber/Harvard Cancer Center; Sanofi; Amgen; Pfizer; Bristol-Myers Squibb; Bayer Korea; Exelixis; GlaxoSmithKline","keywords":"Medicine; Sunitinib; Discontinuation; Mucositis; Renal cell carcinoma; Internal medicine; Oncology; Sorafenib; Targeted therapy; Vascular endothelial growth factor; Toxicity; Cancer; Hepatocellular carcinoma; VEGF receptors","score_opus":0.035541617731244576,"score_gpt":0.2494180104246402,"score_spread":0.21387639269339564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168054139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98672485,0.00089682767,0.0004741667,0.00010938068,0.00008598987,0.00287202,0.008725822,0.000042811294,0.00006811978],"genre_scores_gemma":[0.9937425,0.00009215021,0.0011837902,0.000052718395,0.000063009335,0.0004087044,0.004186858,0.00008411519,0.00018610994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99706656,0.00024283543,0.00066973764,0.0008363632,0.0007342923,0.0004502168],"domain_scores_gemma":[0.99776006,0.00048468582,0.0005565567,0.00049662625,0.0003996965,0.00030235914],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000244471,0.00058421184,0.000682069,0.00017625297,0.00013330072,0.000066919194,0.00016683487,0.00007181427,0.000025336829],"category_scores_gemma":[0.00012780674,0.0003089408,0.00013742807,0.00022931145,0.00014264496,0.00028512697,0.000042502335,0.00024207123,0.000001305197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00975802,0.0009093778,0.97575366,0.000019003528,0.0008817203,0.00004632625,0.006816187,0.0022193445,0.003091825,0.0000019457523,0.000072877374,0.00042970708],"study_design_scores_gemma":[0.069528565,0.0047184215,0.74880254,0.000119895645,0.0021324218,0.0000033625429,0.0009236028,0.051961206,0.121295154,0.000020536263,0.000025437594,0.00046886125],"about_ca_topic_score_codex":0.010479311,"about_ca_topic_score_gemma":0.0012060663,"teacher_disagreement_score":0.22695114,"about_ca_system_score_codex":0.00088470575,"about_ca_system_score_gemma":0.0005285255,"threshold_uncertainty_score":0.9999363},"labels":[],"label_agreement":null},{"id":"W2168794802","doi":"10.1016/s1470-2045(12)70285-1","title":"Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study","year":2012,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta; University of British Columbia; Health Sciences Centre; Western University; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Renal cell carcinoma; Oncology; Targeted therapy; Internal medicine; Population; Cancer","score_opus":0.04824841459005484,"score_gpt":0.2997648199313557,"score_spread":0.2515164053413008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168794802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971425,0.0001736638,0.000034569846,0.00023225987,0.000042978074,0.0015181435,0.000068977344,0.000032517382,0.0007544093],"genre_scores_gemma":[0.99813586,0.0000013884573,0.00055378675,0.00021517715,0.00011113625,0.00016141798,0.00070761313,0.00003328543,0.000080334656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821365,0.0005082127,0.00028827426,0.00020450486,0.00042569364,0.0003596453],"domain_scores_gemma":[0.99864465,0.00033244936,0.00028195736,0.0004242806,0.00020494529,0.00011170821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035841146,0.00022165311,0.0007520477,0.00009484576,0.00007523508,0.000004460891,0.000104202605,0.00004555185,0.00017853643],"category_scores_gemma":[0.000015581656,0.00010946015,0.000059727663,0.00024061895,0.00009316972,0.000050214545,0.000014844892,0.00015699395,0.000010563584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073922365,0.0037959563,0.9872893,0.00003432907,0.00033843322,0.00003613846,0.0005020988,0.00007450622,0.00028078497,0.000028675466,0.00007035564,0.00015716835],"study_design_scores_gemma":[0.02210584,0.010219232,0.96486706,0.000011431065,0.0005475517,0.0000082838815,0.00020827184,0.00002591388,0.0017431894,0.000011368632,0.00013518681,0.00011668671],"about_ca_topic_score_codex":0.00034623317,"about_ca_topic_score_gemma":0.00010989118,"teacher_disagreement_score":0.022422273,"about_ca_system_score_codex":0.00022387161,"about_ca_system_score_gemma":0.00018166049,"threshold_uncertainty_score":0.44636554},"labels":[],"label_agreement":null},{"id":"W2168878075","doi":"10.1111/iju.12502","title":"Current management and future perspectives of metastatic renal cell carcinoma","year":2014,"lang":"en","type":"review","venue":"International Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada)","funders":"","keywords":"Medicine; Renal cell carcinoma; Carcinoma; Current (fluid); Oncology; Intensive care medicine; Pathology","score_opus":0.02925511146743609,"score_gpt":0.33502030997601484,"score_spread":0.30576519850857875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168878075","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017440614,0.9953516,0.00015645943,0.00034762546,0.001019649,0.00029294103,0.00001979401,0.0000033117265,0.0010645171],"genre_scores_gemma":[0.01534027,0.9822662,0.0009821311,0.00003380709,0.0012076781,0.0000091952,0.000024673594,0.000029064613,0.000106974265],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99783325,0.00021451975,0.0009838522,0.00024762537,0.00056273944,0.00015804051],"domain_scores_gemma":[0.9976939,0.00015073095,0.0013486134,0.00018868735,0.0004835783,0.00013448474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030373942,0.00030106417,0.0015564231,0.0007639496,0.000014300142,0.000011973584,0.0003036667,0.000101697646,0.00011093951],"category_scores_gemma":[0.000023158975,0.00020468682,0.00062795094,0.000084552936,0.000115636096,0.00004186334,0.00011262825,0.00049304886,0.000009085886],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032770864,0.0005168393,0.0001715978,0.006283887,0.0025273517,0.0017543476,0.00030790627,0.0000017920784,0.000004489986,0.001216904,0.0008862017,0.98600096],"study_design_scores_gemma":[0.0015746411,0.0012771554,0.0009850087,0.0011179283,0.0049546915,0.005729473,0.00012377996,0.0000037034217,0.0000081267735,0.00013030409,0.983967,0.00012816388],"about_ca_topic_score_codex":0.000002399855,"about_ca_topic_score_gemma":5.0106604e-7,"teacher_disagreement_score":0.9858728,"about_ca_system_score_codex":0.00020504584,"about_ca_system_score_gemma":0.00018838013,"threshold_uncertainty_score":0.8346886},"labels":[],"label_agreement":null},{"id":"W2168895341","doi":"10.1016/j.hoc.2011.04.003","title":"Clinical and Molecular Prognostic Factors in Renal Cell Carcinoma: What We Know So Far","year":2011,"lang":"en","type":"review","venue":"Hematology/Oncology Clinics of North America","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Renal cell carcinoma; Medicine; VEGF receptors; Clinical trial; Oncology; Vascular endothelial growth factor; PI3K/AKT/mTOR pathway; Internal medicine; Targeted therapy; Risk stratification; Bioinformatics; Cancer; Biology; Signal transduction","score_opus":0.06897272766051099,"score_gpt":0.37041144661760067,"score_spread":0.3014387189570897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168895341","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09650537,0.89983696,0.00002226869,0.00010500361,0.0005889533,0.0025889985,0.000040215884,0.000051777184,0.00026045437],"genre_scores_gemma":[0.011271852,0.9849211,0.0025455672,0.00027464362,0.000080495956,0.0002766461,0.00039532862,0.0001558925,0.00007848025],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99125314,0.001554585,0.0042262194,0.0016733665,0.00031696292,0.0009757389],"domain_scores_gemma":[0.9911645,0.0038466349,0.0027549881,0.0013106418,0.0002501858,0.00067306357],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0006616984,0.0011808632,0.00955761,0.000759791,0.00007507513,0.000018051598,0.00053616497,0.0018632064,0.000078793884],"category_scores_gemma":[0.0007987327,0.00092476857,0.0015624847,0.00069206627,0.0026370261,0.00011694942,0.00048941723,0.0023262973,0.00012662988],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001761596,0.0017291638,0.26488012,0.009445111,0.00042523223,0.0032259882,0.0001718201,2.0476847e-7,1.7323664e-7,0.000026235328,0.00017925425,0.7197405],"study_design_scores_gemma":[0.0025746478,0.006673791,0.013339277,0.005493596,0.005762297,0.0012265925,0.0001608022,0.000007060262,0.000008033783,0.000040301926,0.9639867,0.00072690897],"about_ca_topic_score_codex":0.00007101778,"about_ca_topic_score_gemma":0.00010974034,"teacher_disagreement_score":0.96380746,"about_ca_system_score_codex":0.00020308633,"about_ca_system_score_gemma":0.002848391,"threshold_uncertainty_score":0.9999754},"labels":[],"label_agreement":null},{"id":"W2169199319","doi":"10.3747/co.v18i0.941","title":"Progression-free survival as a clinical trial endpoint in advanced renal cell carcinoma","year":2011,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University Health Network; Hôpital Charles-Le Moyne; Princess Margaret Cancer Centre; Ottawa Hospital; Montreal General Hospital; University of Ottawa","funders":"","keywords":"Medicine; Clinical endpoint; Colorectal cancer; Oncology; Renal cell carcinoma; Randomized controlled trial; Progression-free survival; Overall survival; Clinical trial; Internal medicine; Confounding; Surrogate endpoint; Intensive care medicine; Cancer","score_opus":0.26887776950400666,"score_gpt":0.4641023131056264,"score_spread":0.19522454360161973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169199319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9586223,0.0017820256,0.000024205327,0.00026874067,0.003968958,0.0018759029,0.000009650476,0.000062755855,0.03338549],"genre_scores_gemma":[0.99595064,0.00014371684,0.0023735552,0.00007355739,0.00075550325,0.00034509663,0.00006860948,0.000037999027,0.00025133608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965517,0.00059234054,0.0010924349,0.00071998005,0.0004518012,0.00059172383],"domain_scores_gemma":[0.997914,0.00036704092,0.00032527087,0.0008257166,0.00012760102,0.0004403784],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010307439,0.0003186504,0.00096830184,0.00021158913,0.00004582221,0.0000063435346,0.00028050385,0.0003029513,0.00061249355],"category_scores_gemma":[0.00056852,0.0002468668,0.0003378708,0.00022031895,0.00022880697,0.00006519298,0.00027567006,0.0008024247,0.00023232095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25274622,0.019595472,0.36850125,0.00021354393,0.00007681364,0.0038593228,0.0015825246,5.509264e-7,0.0006080545,0.00049023604,0.003054686,0.34927133],"study_design_scores_gemma":[0.2625681,0.041761436,0.63269246,0.00017025416,0.00034766097,0.00015804566,0.00036762428,0.000043190354,0.008144477,0.0011416883,0.05211531,0.000489787],"about_ca_topic_score_codex":0.000045720808,"about_ca_topic_score_gemma":0.000079772835,"teacher_disagreement_score":0.34878156,"about_ca_system_score_codex":0.00048496955,"about_ca_system_score_gemma":0.0008648422,"threshold_uncertainty_score":0.99999833},"labels":[],"label_agreement":null},{"id":"W2170584913","doi":"10.14740/wjon843w","title":"Pazopanib-Induced Regression of Brain Metastasis After Whole Brain Palliative Radiotherapy in Metastatic Renal Cell Cancer Progressing on First-Line Sunitinib: A Case Report","year":2014,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Pazopanib; Sunitinib; Brain metastasis; Renal cell carcinoma; Sorafenib; Metastasis; Oncology; Internal medicine; Cancer; Radiation therapy; Hepatocellular carcinoma","score_opus":0.05919807258595305,"score_gpt":0.38221861121686146,"score_spread":0.3230205386309084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170584913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97527105,0.002287114,0.00024594358,0.020840148,0.00023391414,0.00053443917,0.000011537899,0.000009483166,0.00056635827],"genre_scores_gemma":[0.9893732,0.00007712389,0.008303709,0.0011087357,0.00030641188,0.0000596711,0.0000088661,0.00005269041,0.00070956367],"study_design_codex":"case_report","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963358,0.0009214045,0.0014750446,0.0003364462,0.00053008844,0.00040123783],"domain_scores_gemma":[0.9957817,0.0013357733,0.0018980412,0.00035711643,0.00035188915,0.0002754638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021110165,0.00034638072,0.0014305168,0.00087411754,0.00007047734,0.000015175031,0.00012170573,0.000105150284,0.00024248584],"category_scores_gemma":[0.00045297525,0.00022973976,0.00032407846,0.0005543982,0.00013397828,0.000107644344,0.000034252673,0.00068730995,0.0000023742507],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017965317,0.005083904,0.034013446,0.0006379618,0.0013879187,0.5557215,0.0058052475,0.00081474526,0.08640215,0.00003341154,0.0053295135,0.28680485],"study_design_scores_gemma":[0.075197116,0.072653376,0.1152706,0.012619418,0.0038675386,0.17333402,0.0017842666,0.0018352913,0.35577035,0.0005879756,0.1854735,0.0016065795],"about_ca_topic_score_codex":0.00021554781,"about_ca_topic_score_gemma":0.0027839115,"teacher_disagreement_score":0.38238752,"about_ca_system_score_codex":0.000976723,"about_ca_system_score_gemma":0.00057396723,"threshold_uncertainty_score":0.9368515},"labels":[],"label_agreement":null},{"id":"W2170609256","doi":"10.18632/oncotarget.1558","title":"Common reduction of the Raf kinase inhibitory protein in clear cell renal cell carcinoma","year":2014,"lang":"en","type":"article","venue":"Oncotarget","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McMaster University","funders":"Kidney Foundation of Canada","keywords":"Clear cell renal cell carcinoma; Medicine; Carcinogenesis; Renal cell carcinoma; Internal medicine; Cancer research; Oncology; Cancer","score_opus":0.010535260758839673,"score_gpt":0.22068798520906824,"score_spread":0.21015272445022856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170609256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97830987,0.0002581487,0.0000042326783,0.00045379638,0.00018797707,0.00081892754,0.000004732944,0.000021369142,0.01994096],"genre_scores_gemma":[0.9938088,0.0000036782299,0.00057628227,0.00006668612,0.00022334106,0.00004221288,0.000016917338,0.000033560118,0.0052284966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99846005,0.00023640505,0.00038698956,0.000293865,0.00036444727,0.00025824778],"domain_scores_gemma":[0.9989927,0.000027348568,0.00019686647,0.0006102728,0.00006180911,0.000111039946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033366858,0.00018835744,0.00034598782,0.000110177156,0.000053639,0.000006903697,0.00013010106,0.00012043121,0.00008228135],"category_scores_gemma":[0.000024464285,0.0001331436,0.00015387515,0.00023090237,0.00010817165,0.000052304025,0.000073049145,0.00032730543,0.000047140897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005884588,0.0007036628,0.09106164,0.00031066002,0.000007140396,0.00004003511,0.0005136021,0.000059933387,0.90413505,0.0000511091,0.0021579617,0.00037074773],"study_design_scores_gemma":[0.0023039484,0.0010881841,0.15316863,0.000110453555,0.000042008844,0.000014447643,0.000119137236,0.00017516997,0.83782774,0.00006594395,0.0049685966,0.000115733674],"about_ca_topic_score_codex":0.0005591662,"about_ca_topic_score_gemma":0.000039055663,"teacher_disagreement_score":0.06630731,"about_ca_system_score_codex":0.00025914272,"about_ca_system_score_gemma":0.00012588184,"threshold_uncertainty_score":0.5429439},"labels":[],"label_agreement":null},{"id":"W2170805911","doi":"10.1093/annonc/mdq469","title":"Increased haematopoietic progenitor cells are associated with poor outcome in patients with metastatic renal cancer treated with sunitinib","year":2010,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Cancer Research UK","keywords":"Sunitinib; Medicine; Hazard ratio; Internal medicine; Univariate analysis; Oncology; Haematopoiesis; Progenitor cell; Growth factor; CD34; Renal cell carcinoma; Gastroenterology; Confidence interval; Multivariate analysis; Stem cell; Receptor; Biology","score_opus":0.05701477999175684,"score_gpt":0.3329043085578549,"score_spread":0.27588952856609805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170805911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703693,0.000043030883,0.0000019514448,0.00074318366,0.00003621435,0.0013952007,0.000104973165,0.000037228463,0.00060128665],"genre_scores_gemma":[0.9981496,0.000005327687,0.00064836757,0.0005035352,0.000025571086,0.00023446657,0.00015453582,0.00005673253,0.00022191755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979438,0.00020699551,0.0005113747,0.00037779112,0.00047347232,0.0004865504],"domain_scores_gemma":[0.99777246,0.00023294767,0.0006073214,0.0003317717,0.000795177,0.0002603182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002650562,0.00033472976,0.0011035285,0.00026458618,0.000043118278,0.0000089405485,0.0001159273,0.0001518439,0.00017106296],"category_scores_gemma":[0.00010530949,0.00019742287,0.000074088886,0.0004765831,0.00027880343,0.000077939454,0.000023737719,0.00039535272,0.000008298287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005985249,0.0029346019,0.9854576,0.00010326866,0.0007629209,0.0010687329,0.00016509257,0.000016050783,0.002596786,0.0000052261403,0.0001746646,0.0007298263],"study_design_scores_gemma":[0.0158633,0.014428808,0.9212464,0.00032643773,0.0007334706,0.00004967968,0.0001178804,0.000019287972,0.046770234,0.000005116786,0.0001972787,0.00024211993],"about_ca_topic_score_codex":0.001107615,"about_ca_topic_score_gemma":0.0043280353,"teacher_disagreement_score":0.06421119,"about_ca_system_score_codex":0.00013994721,"about_ca_system_score_gemma":0.0005372501,"threshold_uncertainty_score":0.80506706},"labels":[],"label_agreement":null},{"id":"W2170978237","doi":"10.5489/cuaj.2426","title":"Evaluation of second line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first line cediranib","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Alberta; University of British Columbia; Sunnybrook Health Science Centre; Alberta Cancer Foundation; Juravinski Cancer Centre; Western University; BC Cancer Agency; Princess Margaret Cancer Centre; McMaster University; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Oncology; Cancer; Second line; First line; Internal medicine; Cancer research","score_opus":0.026056997204143714,"score_gpt":0.24345007601776364,"score_spread":0.2173930788136199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170978237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99619603,0.0008030706,0.0000138487,0.0020427688,0.000045567478,0.00041138913,0.000050274295,0.0000057628145,0.00043127462],"genre_scores_gemma":[0.99903333,0.00011714185,0.0001274813,0.00040349655,0.000081854974,0.000028829809,0.000068055895,0.000012675077,0.00012714685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979753,0.00042780704,0.00041395024,0.00019327649,0.00068163744,0.00030803657],"domain_scores_gemma":[0.99813527,0.00016228786,0.00038941312,0.0000863034,0.00085274613,0.00037399845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013237512,0.00016445912,0.0003733979,0.00023476161,0.00008925394,0.00002490576,0.000049745566,0.00011137447,0.0008086257],"category_scores_gemma":[0.0004008307,0.000110486435,0.00005732235,0.00022143938,0.00003643328,0.000070152644,0.000005708849,0.00028027108,0.0000032216367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018613745,0.00016502225,0.9942421,0.00001967888,0.00020355872,0.000021608415,0.00028674796,0.000731493,0.0004958365,0.0000036488605,0.00019855428,0.0034456411],"study_design_scores_gemma":[0.0061597037,0.0018352702,0.9878062,0.00004346835,0.00048866327,0.000016708718,0.000027346468,0.0015661826,0.0010701237,0.00013339863,0.0007432397,0.00010968471],"about_ca_topic_score_codex":0.002238687,"about_ca_topic_score_gemma":0.03249111,"teacher_disagreement_score":0.030252423,"about_ca_system_score_codex":0.0015100217,"about_ca_system_score_gemma":0.0005150643,"threshold_uncertainty_score":0.9851634},"labels":[],"label_agreement":null},{"id":"W2171117253","doi":"10.1016/j.eururo.2009.06.008","title":"A Proposal for Reclassification of the Fuhrman Grading System in Patients with Clear Cell Renal Cell Carcinoma","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Grading (engineering); Kidney cancer; Clear cell renal cell carcinoma; Internal medicine; Oncology; Urology","score_opus":0.012197935261030466,"score_gpt":0.2012686175175145,"score_spread":0.18907068225648402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171117253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97950155,0.00005621273,0.000067422625,0.00039795667,0.00006614785,0.0010518093,0.000004962227,0.000023513594,0.01883042],"genre_scores_gemma":[0.99881124,5.7550767e-7,0.00067263294,0.00012647168,0.00005941363,0.000008031893,0.000025089297,0.000030203524,0.00026631536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987715,0.00027942273,0.00029871982,0.000272401,0.00015789333,0.00022009751],"domain_scores_gemma":[0.9992438,0.000034244535,0.00020105169,0.0003779607,0.000084723906,0.000058237423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002263473,0.00013617879,0.00022050277,0.00009606135,0.000046921436,0.000004913947,0.00012946078,0.000039165498,0.0000030738545],"category_scores_gemma":[0.000014528356,0.000084357,0.00006620566,0.00014200009,0.00005451975,0.000025968326,0.000023088849,0.000141517,0.000014205547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009011946,0.0018895756,0.9313913,0.0005935519,0.00004240076,0.00016893807,0.0018348665,0.00011432838,0.048717465,0.0017053836,0.0012544515,0.0032757784],"study_design_scores_gemma":[0.0041292137,0.005688144,0.9785611,0.000028699815,0.00010682947,0.00001563913,0.000048213584,0.00018673693,0.01066218,0.000010336359,0.00048149485,0.00008139189],"about_ca_topic_score_codex":0.0000060978123,"about_ca_topic_score_gemma":0.0000023186517,"teacher_disagreement_score":0.04716981,"about_ca_system_score_codex":0.00010294128,"about_ca_system_score_gemma":0.000065642416,"threshold_uncertainty_score":0.3439979},"labels":[],"label_agreement":null},{"id":"W2171150888","doi":"10.5489/cuaj.753","title":"Robot-assisted laparoscopic partial nephrectomy: Early single Canadian institution experience","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Association Française d'Urologie","keywords":"Medicine; Nephrectomy; Perioperative; Renal function; Surgery; Complication; Academic institution; Retrospective cohort study; Urology; Kidney; Internal medicine","score_opus":0.026287123621812465,"score_gpt":0.23169101447147178,"score_spread":0.20540389084965932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171150888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814553,0.00013262987,0.000027553246,0.012320433,0.0006233049,0.00043905663,0.000010366894,0.000036108642,0.0049552023],"genre_scores_gemma":[0.99443895,0.000010815768,0.000326938,0.0037671488,0.0004513841,0.00007882117,0.000024838035,0.000014289006,0.0008868008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979452,0.00015328148,0.00039135615,0.00026160476,0.00039373751,0.0008548449],"domain_scores_gemma":[0.99681306,0.000053638778,0.00019550575,0.00016039128,0.00034967947,0.0024277223],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021181589,0.00019642862,0.00031991734,0.00029471933,0.00046900232,0.00025984884,0.00013412528,0.00032068908,0.0019876105],"category_scores_gemma":[0.00048443204,0.00016290336,0.00013900668,0.00031114227,0.00006195802,0.00027446545,0.000010514582,0.0005246032,0.0005764941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022194272,0.00006557373,0.9864365,0.0000027646827,0.0000810936,0.00034043728,0.0002959536,0.000032351996,0.0026792742,0.00009754381,0.004527428,0.0054188934],"study_design_scores_gemma":[0.0009586935,0.00046213935,0.9577482,0.000015174834,0.000057950983,0.00028792178,0.00006305894,0.00007469438,0.00054055406,0.000100132966,0.039535265,0.00015623838],"about_ca_topic_score_codex":0.33690184,"about_ca_topic_score_gemma":0.1377437,"teacher_disagreement_score":0.19915815,"about_ca_system_score_codex":0.006323937,"about_ca_system_score_gemma":0.0015897577,"threshold_uncertainty_score":0.99892473},"labels":[],"label_agreement":null},{"id":"W2171174421","doi":"10.1016/j.eururo.2010.11.013","title":"Adverse Renal Outcomes in Subjects Undergoing Nephrectomy for Renal Tumors: A Population-Based Analysis","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Nephrectomy; Hazard ratio; Renal function; Kidney disease; Proteinuria; Population; Urology; Internal medicine; Proportional hazards model; Dialysis; Confidence interval; Surgery; Kidney","score_opus":0.016265435466603955,"score_gpt":0.2635935778235525,"score_spread":0.24732814235694858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171174421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941053,0.000025819543,0.000749925,0.00090729626,0.000120796045,0.0004768606,0.00000939964,0.00008119073,0.0035234469],"genre_scores_gemma":[0.99419665,8.2865586e-7,0.0038843432,0.0010668299,0.00014669105,0.000028026125,0.00023117688,0.00004925429,0.00039617493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982769,0.00024960772,0.0004442939,0.00046630568,0.0001747034,0.00038817123],"domain_scores_gemma":[0.9985812,0.00056869455,0.00015888487,0.00047223087,0.000062351464,0.00015665032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046080962,0.0002276864,0.0005249238,0.0006858512,0.00006545626,0.0000112400985,0.000121836005,0.000071097245,0.00016933914],"category_scores_gemma":[0.00050542946,0.00019101238,0.00033032196,0.00046902464,0.00005222871,0.00004517189,0.000035921566,0.00031033403,0.00006529675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006266252,0.00018312506,0.991251,0.000021437809,0.0003217147,0.0006404417,0.00008265284,0.0015140986,0.004799928,0.00013437506,0.00006686489,0.000357756],"study_design_scores_gemma":[0.0040677707,0.0006171558,0.99097383,0.000009773818,0.0007526351,0.000036029178,0.000010732517,0.0018353442,0.0005365102,0.000051725492,0.0009497363,0.00015875038],"about_ca_topic_score_codex":0.0001705907,"about_ca_topic_score_gemma":0.0022674126,"teacher_disagreement_score":0.004263418,"about_ca_system_score_codex":0.00007740255,"about_ca_system_score_gemma":0.00011851875,"threshold_uncertainty_score":0.77892584},"labels":[],"label_agreement":null},{"id":"W2171369497","doi":"10.1158/1535-7163.mct-14-0208","title":"Sunitinib Dose Escalation Overcomes Transient Resistance in Clear Cell Renal Cell Carcinoma and Is Associated with Epigenetic Modifications","year":2014,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute; Agilent Technologies","keywords":"Sunitinib; Renal cell carcinoma; Epigenetics; Clear cell renal cell carcinoma; Cancer research; Medicine; Acquired resistance; Oncology; Transient (computer programming); Internal medicine; Pharmacology; Cancer; Biology; Genetics; Gene; Computer science","score_opus":0.025707271109698168,"score_gpt":0.2549107071518875,"score_spread":0.22920343604218935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171369497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98878324,0.0046674255,0.0015543532,0.0009961008,0.000023248876,0.00052904466,0.000021870503,0.0000261953,0.003398504],"genre_scores_gemma":[0.99725825,0.0002755712,0.0007163221,0.0009675397,0.000018194913,0.00007057003,0.000038532544,0.000052889234,0.0006021394],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99859583,0.00014391218,0.00026310585,0.00036985523,0.00033796055,0.00028931786],"domain_scores_gemma":[0.999226,0.00005705039,0.00011228048,0.0003713582,0.0001157276,0.00011760783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012949681,0.00022453739,0.0002895068,0.000117496296,0.00006999812,0.000025296487,0.00007168324,0.000110942194,0.000025505318],"category_scores_gemma":[0.000004264234,0.0001958556,0.000064653716,0.00028548617,0.00008926671,0.00003279122,0.00001160286,0.00019036008,0.000003089299],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024081138,0.0017270076,0.10170598,0.00049105135,0.00039060946,0.00030797286,0.0102440575,0.0015494311,0.87280726,0.000406997,0.00011623991,0.007845264],"study_design_scores_gemma":[0.0066345963,0.0008841153,0.66057533,0.00017578549,0.00063760515,0.0000060482553,0.00013706514,0.0030550791,0.324702,0.00021442144,0.0025902695,0.00038767784],"about_ca_topic_score_codex":0.00011468629,"about_ca_topic_score_gemma":0.00027495594,"teacher_disagreement_score":0.55886936,"about_ca_system_score_codex":0.00025963606,"about_ca_system_score_gemma":0.00011595955,"threshold_uncertainty_score":0.79867595},"labels":[],"label_agreement":null},{"id":"W2171600981","doi":"10.5489/cuaj.2894","title":"Management of advanced kidney cancer: Canadian Kidney Cancer Forum consensus update","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of British Columbia; BC Cancer Agency; McMaster University; Princess Margaret Cancer Centre; University of Calgary; University Health Network; Ottawa Regional Cancer Foundation; Ottawa Hospital; University of Ottawa; Sunnybrook Health Science Centre; Western University; University of Toronto; Alberta Kidney Disease Network; University of Alberta","funders":"","keywords":"Kidney cancer; Cancer; Medicine; Kidney; Internal medicine","score_opus":0.020370645203254788,"score_gpt":0.2598577940610588,"score_spread":0.239487148857804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171600981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66502064,0.0026683668,0.000008371414,0.30874187,0.0017272797,0.00079692726,0.000970079,0.000038187438,0.020028273],"genre_scores_gemma":[0.9753683,0.00066214445,0.000577768,0.020655494,0.00025920814,0.00005285498,0.00008355196,0.000027187934,0.0023134714],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975065,0.00013862834,0.00052594015,0.0002887878,0.00058270973,0.0009574622],"domain_scores_gemma":[0.9917519,0.000033823904,0.00040356486,0.00020004017,0.00066474284,0.006945923],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005084925,0.00024005714,0.00047240712,0.00032982172,0.00019762074,0.00004366133,0.00017987272,0.0002475002,0.0010800888],"category_scores_gemma":[0.0004137419,0.00020236403,0.00017312764,0.00034630575,0.000056542045,0.00006465259,0.0000219219,0.00047685325,0.0000628337],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00025507808,0.00005198258,0.65185064,0.00003145517,0.0007878412,0.0015817567,0.00012870999,0.00036478418,0.00006845533,0.0004065271,0.3343186,0.010154148],"study_design_scores_gemma":[0.0043066717,0.0004295698,0.28436288,0.00015104463,0.00049111515,0.00022130708,0.0004164204,0.00013790843,0.00023512232,0.0006260742,0.7083228,0.0002990951],"about_ca_topic_score_codex":0.2437379,"about_ca_topic_score_gemma":0.17308624,"teacher_disagreement_score":0.3740042,"about_ca_system_score_codex":0.008312051,"about_ca_system_score_gemma":0.0073014433,"threshold_uncertainty_score":0.99983305},"labels":[],"label_agreement":null},{"id":"W2172005856","doi":"10.5430/jst.v1n2p80","title":"Sunitinib induced immune thrombocytopenia in patient with metastatic renal cell carcinoma","year":2011,"lang":"en","type":"article","venue":"Journal of Solid Tumors","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Sunitinib; Medicine; Renal cell carcinoma; Tyrosine-kinase inhibitor; Rash; Neutropenia; Internal medicine; Gastroenterology; Imatinib; Adverse effect; Oncology; Cancer; Toxicity","score_opus":0.04877248817913778,"score_gpt":0.2633846826745482,"score_spread":0.2146121944954104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172005856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932762,0.00041253987,0.000013015247,0.00008008062,0.00009456763,0.00036200028,0.0000040408277,0.000007554096,0.0057499977],"genre_scores_gemma":[0.996838,0.000014269605,0.0028516857,0.00009853991,0.000056837158,0.000009031067,0.0000036469994,0.000041904837,0.00008609805],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99780416,0.00011970225,0.00097110006,0.00018176522,0.00055827043,0.00036501128],"domain_scores_gemma":[0.9983581,0.000049585666,0.00073567155,0.00029353588,0.00028028083,0.00028283877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032338707,0.00026308408,0.0009250518,0.0004197162,0.000040443338,0.000011794073,0.00015634892,0.00004543495,0.00025642337],"category_scores_gemma":[0.000033402775,0.00017152043,0.00018351365,0.00031462687,0.00006808992,0.00018398107,0.000043411725,0.0005214392,0.000023113882],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016324393,0.008387685,0.19546641,0.00071065227,0.0010028577,0.25117108,0.03788909,0.00012344556,0.48233768,0.00013470241,0.000523772,0.005928241],"study_design_scores_gemma":[0.005326209,0.009481097,0.43916196,0.00036456937,0.00033255003,0.00921983,0.002089172,0.0000125012075,0.53373575,0.0000625485,0.000025977546,0.00018785874],"about_ca_topic_score_codex":0.0002257413,"about_ca_topic_score_gemma":0.000025215395,"teacher_disagreement_score":0.24369554,"about_ca_system_score_codex":0.00026563884,"about_ca_system_score_gemma":0.00044174772,"threshold_uncertainty_score":0.69944},"labels":[],"label_agreement":null},{"id":"W2172050766","doi":"10.1200/jco.2006.06.1218","title":"Multi-Institutional Validation of a New Renal Cancer–Specific Survival Nomogram","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":555,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nomogram; Medicine; Nephrectomy; Proportional hazards model; Oncology; Internal medicine; Cancer; Overall survival; Urology; Surgery; Kidney","score_opus":0.2880847023148972,"score_gpt":0.49738998525522954,"score_spread":0.20930528294033235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172050766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807842,0.0011942254,0.011465823,0.001886633,0.0023563064,0.00020143721,0.0000034794336,0.000008203085,0.002099694],"genre_scores_gemma":[0.9659327,0.000559734,0.030058652,0.00022373172,0.0026904515,0.0000012027883,0.0000068302265,0.000012267124,0.0005144189],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9960472,0.00019625337,0.0027397166,0.00017943743,0.00060517906,0.00023223495],"domain_scores_gemma":[0.9954309,0.0013009051,0.001868239,0.00017264164,0.0006738569,0.00055344176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041672536,0.00014684202,0.0013107331,0.00018905556,0.00003307114,0.0000048993957,0.00013770135,0.00032656817,0.00026945808],"category_scores_gemma":[0.0012299024,0.00009826566,0.0006663351,0.00019930632,0.0002448858,0.00009138475,0.000032242464,0.0006771135,0.00001639646],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019913398,0.0047200546,0.25365722,0.00005378796,0.0011108867,0.0028091113,0.00020563493,0.00064778473,0.010059434,0.00041112292,0.004420895,0.70199066],"study_design_scores_gemma":[0.01572573,0.011393795,0.8754642,0.0001574847,0.0004918913,0.0006083682,0.00007192188,0.00005706744,0.007665507,0.00015089005,0.08810083,0.00011230409],"about_ca_topic_score_codex":0.000095507494,"about_ca_topic_score_gemma":0.00010584892,"teacher_disagreement_score":0.70187837,"about_ca_system_score_codex":0.0004119914,"about_ca_system_score_gemma":0.0031744835,"threshold_uncertainty_score":0.56313974},"labels":[],"label_agreement":null},{"id":"W2172795134","doi":"10.5489/cuaj.2935","title":"Tubulocystic renal cell carcinoma: Report of a rare case","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Vimentin; Pathology; Renal cell carcinoma; Neoplasm; Kidney; Medicine; Histopathological examination; Carcinoma; Nucleolus; Clear cell carcinoma; Biology; Immunohistochemistry; Internal medicine","score_opus":0.027993173421458413,"score_gpt":0.2362663860884396,"score_spread":0.2082732126669812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172795134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98410547,0.00056287675,0.000040741725,0.00436249,0.0002502789,0.00019197183,0.000024566372,0.0000141828305,0.010447402],"genre_scores_gemma":[0.9967778,0.0000039831343,0.0005101731,0.00055906014,0.00036274985,0.0000060915763,0.000029525065,0.000014131454,0.0017365229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980894,0.00017663048,0.00056264724,0.00020674444,0.00052045996,0.00044413542],"domain_scores_gemma":[0.9967929,0.00010596717,0.00047156308,0.00019452142,0.00074323715,0.0016918059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090474024,0.00015640202,0.00038710143,0.00021932158,0.00011351093,0.00003091283,0.000079280624,0.00023532231,0.0002681089],"category_scores_gemma":[0.0012052493,0.000121571764,0.00018824439,0.0002234917,0.000035754667,0.000062173254,0.00001664184,0.00048531237,0.00004439599],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013033098,0.00011690447,0.7394915,0.000013700024,0.00008485568,0.2303475,0.0002781744,0.00007170043,0.00032540716,0.000022934986,0.028744772,0.00037221354],"study_design_scores_gemma":[0.005415981,0.0027167525,0.5348386,0.00002318772,0.0006578414,0.4201643,0.00056364667,0.00021322674,0.0017104823,0.00056561764,0.032802407,0.00032793876],"about_ca_topic_score_codex":0.0039614085,"about_ca_topic_score_gemma":0.00061889563,"teacher_disagreement_score":0.20465286,"about_ca_system_score_codex":0.0022821147,"about_ca_system_score_gemma":0.0018439302,"threshold_uncertainty_score":0.5988491},"labels":[],"label_agreement":null},{"id":"W2177170245","doi":"10.5489/cuaj.3050","title":"Chromophobe renal cell carcinoma recurrence in the ureter: A late presentation of a rare metastasis","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Chromophobe cell; Lymphovascular invasion; Presentation (obstetrics); Ureter; Metastasis; Infiltration (HVAC); Kidney; Pathology; Renal cell carcinoma; Urology; Clear cell; Radiology; Internal medicine; Cancer","score_opus":0.037835447462658434,"score_gpt":0.253449861898032,"score_spread":0.21561441443537355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2177170245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98623896,0.0007502364,0.000012560237,0.009161066,0.00011495915,0.00028337122,0.000031112617,0.0000050934063,0.003402661],"genre_scores_gemma":[0.9983948,0.000033101693,0.000252879,0.00094136863,0.00017671996,0.0000147203855,0.000030500874,0.000007261755,0.00014863901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979423,0.0005410058,0.00040575146,0.00016337179,0.0005800323,0.0003675066],"domain_scores_gemma":[0.99856424,0.00015860127,0.0003294022,0.00014882212,0.0003180767,0.00048083675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012988345,0.00012819127,0.00029969783,0.00021058456,0.000071679664,0.000044185417,0.00016701361,0.00014020572,0.00011614385],"category_scores_gemma":[0.00057996647,0.00008262213,0.00013427789,0.00037133868,0.000032176064,0.00010770027,0.000012844811,0.0005116287,0.000019285873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001447035,0.00010544846,0.986641,0.0000115206985,0.00004541655,0.00066551263,0.0017754473,0.00008715332,0.0003792335,0.000030971187,0.008938783,0.0011748096],"study_design_scores_gemma":[0.002147971,0.0009969476,0.98968434,0.00001465537,0.00014765376,0.0003437727,0.00038491812,0.00016013824,0.0008069703,0.00036728592,0.0048511727,0.00009419736],"about_ca_topic_score_codex":0.0023221157,"about_ca_topic_score_gemma":0.0007843293,"teacher_disagreement_score":0.012155869,"about_ca_system_score_codex":0.0010915556,"about_ca_system_score_gemma":0.00075932575,"threshold_uncertainty_score":0.35103598},"labels":[],"label_agreement":null},{"id":"W2178723669","doi":"10.1016/j.urolonc.2015.10.005","title":"Metastatic renal cell carcinoma: Contending with a sea change in therapy","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Renal cell carcinoma; Medicine; Oncology; Carcinoma; Internal medicine","score_opus":0.11848346988302132,"score_gpt":0.32983670514194335,"score_spread":0.21135323525892202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2178723669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98626035,0.004421563,0.000022233171,0.0046931556,0.000063883104,0.000723967,0.000010946697,0.000038247974,0.0037656745],"genre_scores_gemma":[0.96873903,0.00018761796,0.028160049,0.002126606,0.00008442398,0.00029020855,0.000063813866,0.000017472174,0.00033079542],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99868315,0.00016964528,0.00025126233,0.0003649678,0.00018734942,0.00034362785],"domain_scores_gemma":[0.9990361,0.00015468485,0.00012331735,0.00018815431,0.00008074048,0.00041703373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036154073,0.0002268086,0.00044122591,0.00022646753,0.00008192898,0.000015278009,0.00006813464,0.000115152216,0.000032123535],"category_scores_gemma":[0.00004539589,0.00015443652,0.000039399907,0.00032607163,0.00042958106,0.000117905554,0.000028339236,0.0003081632,0.000016101672],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005822471,0.000385174,0.99076635,0.000024162766,0.000036851594,0.0021925392,0.0023352546,0.000018269904,0.00076568825,0.0007190606,0.00081179664,0.0013626108],"study_design_scores_gemma":[0.024925303,0.04786714,0.22770493,0.00017240789,0.00092854997,0.0063471827,0.0026519499,0.0026911844,0.010553093,0.0041173045,0.6711773,0.0008636354],"about_ca_topic_score_codex":0.0004995802,"about_ca_topic_score_gemma":0.00015742244,"teacher_disagreement_score":0.7630614,"about_ca_system_score_codex":0.00026386534,"about_ca_system_score_gemma":0.0004456023,"threshold_uncertainty_score":0.62977386},"labels":[],"label_agreement":null},{"id":"W2181053294","doi":"10.1038/bjc.2015.368","title":"Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Pfizer","keywords":"Sunitinib; Medicine; Renal cell carcinoma; Neutropenia; Oncology; Internal medicine; Chemotherapy","score_opus":0.03413820746168045,"score_gpt":0.2742318485938646,"score_spread":0.24009364113218418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2181053294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98457617,0.013742823,7.8580246e-7,0.00022438903,0.00019030107,0.0002851802,0.000015009448,0.000005241676,0.0009601135],"genre_scores_gemma":[0.9985666,0.00065440004,0.00021673882,0.00025686118,0.000066918525,0.0000057266834,0.000014853405,0.000029664556,0.00018818394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833727,0.00016342672,0.0005292136,0.00017641278,0.00053084205,0.00026281804],"domain_scores_gemma":[0.99847704,0.00007956008,0.00033964758,0.00009189137,0.0006020924,0.00040977987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003468913,0.00015429735,0.0005079596,0.00018286292,0.00003767095,0.000044821678,0.00007470806,0.00005825109,0.00006744954],"category_scores_gemma":[0.00026134888,0.00014435984,0.00010375608,0.00022460599,0.00006375055,0.00014552451,0.000035581565,0.00026595508,0.0000067284527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005090727,0.0027749145,0.826835,0.00014295564,0.0007314865,0.029311292,0.00068689085,0.00006819391,0.008242051,0.0000030116198,0.011724657,0.11438887],"study_design_scores_gemma":[0.022440936,0.001626421,0.9675896,0.0006450898,0.0004503934,0.0022828034,0.00016928965,0.000027568374,0.003528383,0.000020920721,0.0010689292,0.00014963812],"about_ca_topic_score_codex":0.0025584432,"about_ca_topic_score_gemma":0.0004592761,"teacher_disagreement_score":0.14075467,"about_ca_system_score_codex":0.00040425922,"about_ca_system_score_gemma":0.00042207766,"threshold_uncertainty_score":0.58868235},"labels":[],"label_agreement":null},{"id":"W2181552390","doi":"10.5489/cuaj.4769","title":"Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update 2017","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; Kidney Foundation of Canada; University of British Columbia; Centre Hospitalier Universitaire de Sherbrooke; Centre Hospitalier de l’Université de Montréal; Juravinski Cancer Centre; Jewish General Hospital; Sunnybrook Health Science Centre; McMaster University; Université de Sherbrooke; University of Toronto; Dalhousie University; Alberta Kidney Disease Network; William Osler Health System; University of Alberta; University Health Network; Ottawa Hospital; Regional Municipality of Durham; McGill University; University of Ottawa","funders":"Astellas Pharma; Sanofi; Exelixis; AstraZeneca; Pfizer; Amgen","keywords":"Kidney cancer; Cancer; Medicine; Kidney; Internal medicine","score_opus":0.020481487280171913,"score_gpt":0.2754690139226694,"score_spread":0.2549875266424975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2181552390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6146962,0.0016269196,0.0000046006226,0.34981108,0.0020110246,0.000818929,0.0013908037,0.00002774758,0.029612692],"genre_scores_gemma":[0.9813008,0.0018005007,0.0003810264,0.012414466,0.00032130917,0.000055954402,0.000062096675,0.000028324499,0.0036355508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974025,0.000101849815,0.0005366569,0.00035598615,0.00051987363,0.0010831674],"domain_scores_gemma":[0.99341726,0.000035772675,0.0008662111,0.00047180013,0.0005009726,0.004707966],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004540727,0.00027943388,0.0005497032,0.0002786782,0.0009810829,0.00013713728,0.00040254326,0.00029420052,0.0016191627],"category_scores_gemma":[0.00056668447,0.00023795183,0.00024082448,0.000112919864,0.000114160735,0.00011211277,0.000042454427,0.00056716264,0.00006564664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014411313,0.000041000658,0.7740179,0.00003987748,0.0008464086,0.0019674865,0.000053320524,0.000078285826,0.00013402109,0.00040414886,0.20932908,0.0129444],"study_design_scores_gemma":[0.002475378,0.0001873732,0.6497123,0.00016456058,0.0003789901,0.00013081652,0.00008270236,0.00006942117,0.00019711144,0.0003195687,0.34605774,0.00022399896],"about_ca_topic_score_codex":0.32485855,"about_ca_topic_score_gemma":0.29168847,"teacher_disagreement_score":0.36660457,"about_ca_system_score_codex":0.00521573,"about_ca_system_score_gemma":0.004491972,"threshold_uncertainty_score":0.9992935},"labels":[],"label_agreement":null},{"id":"W2182997742","doi":"","title":"Is PazOP aNIb the Preferred fIrst-LINe treatmeNt fOr metastatIc reNaL ceLL carcINOma?","year":2013,"lang":"en","type":"article","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pazopanib; Sunitinib; Medicine; Renal cell carcinoma; Oncology; Internal medicine; Cabozantinib; Kidney cancer; Tyrosine-kinase inhibitor; Clinical trial; Cancer","score_opus":0.07935437275349255,"score_gpt":0.2916583257885231,"score_spread":0.21230395303503052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2182997742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726024,0.0011903155,0.000758644,0.008279088,0.00009884479,0.004671323,0.000044310855,0.00008029537,0.012274764],"genre_scores_gemma":[0.9508555,0.00006271348,0.004015347,0.0009804552,0.00015348573,0.0014432195,0.00010581449,0.00005001123,0.04233345],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99835145,0.000042454176,0.00039594332,0.00044657046,0.00029994702,0.00046364742],"domain_scores_gemma":[0.99845195,0.0002670335,0.00010307098,0.0007566895,0.00017212096,0.000249122],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010726655,0.00035821347,0.00045880256,0.00007495148,0.00016557284,0.000049190447,0.00013063982,0.000059777998,0.0022610086],"category_scores_gemma":[0.00002098826,0.0001746657,0.00035537797,0.0001383805,0.00006342921,0.000083662366,0.00003751142,0.000082576815,0.00048029254],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058983588,0.019445049,0.10356997,0.002938402,0.0067049004,0.00081762497,0.021867562,0.00043202372,0.11003314,0.0016701634,0.5926449,0.13397792],"study_design_scores_gemma":[0.02600232,0.017256912,0.12519507,0.00007641677,0.003925386,0.00026555586,0.001398311,0.009281342,0.75089324,0.0012734211,0.063613236,0.00081882643],"about_ca_topic_score_codex":0.0013567455,"about_ca_topic_score_gemma":0.00012298007,"teacher_disagreement_score":0.6408601,"about_ca_system_score_codex":0.00030623644,"about_ca_system_score_gemma":0.0001169942,"threshold_uncertainty_score":0.9986511},"labels":[],"label_agreement":null},{"id":"W2191416853","doi":"10.1186/s40697-015-0089-y","title":"Retrospective Analysis of the Predictive Factors of Renal Function Loss after Uninephrectomy in Patients with Chronic Kidney Disease G3 to G5","year":2015,"lang":"en","type":"article","venue":"Canadian Journal of Kidney Health and Disease","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Hôpital Saint-Luc","funders":"","keywords":"Medicine; Renal function; Kidney disease; Retrospective cohort study; Disease; Nephrectomy; Internal medicine; Kidney; Urology","score_opus":0.009483903263020973,"score_gpt":0.2284268232794498,"score_spread":0.21894292001642882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2191416853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99143225,0.0011657506,0.000039843086,0.0055903387,0.00011568315,0.00055651885,0.0010625848,0.0000019545512,0.00003505243],"genre_scores_gemma":[0.99561095,0.000013533433,0.00001729385,0.004160668,0.00005290714,0.00000910809,0.00009208996,0.000013421537,0.000030021776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845564,0.00012398051,0.0004627161,0.0001920569,0.0004646279,0.00030095683],"domain_scores_gemma":[0.9662565,0.00001508701,0.00036205698,0.00026197708,0.000526458,0.03257792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017543299,0.00016770248,0.00050468923,0.00074616825,0.0000474465,0.000008740532,0.000077879056,0.000033590844,0.0000487028],"category_scores_gemma":[0.0033032193,0.000103832994,0.00015751227,0.00092838967,0.00013761147,0.00010261453,0.000013345157,0.00016921216,3.5903102e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069496497,0.0001302759,0.98600787,0.00014872469,0.0004035887,0.00007448488,0.00072426244,0.00016436892,8.2584165e-7,0.000008041141,0.005285992,0.00010192266],"study_design_scores_gemma":[0.0036542802,0.0024187425,0.9909085,0.0005746977,0.0014370289,0.0000012999028,0.000106969295,0.000051367573,0.0000063002285,0.00003921743,0.0007216778,0.00007993134],"about_ca_topic_score_codex":0.0033210465,"about_ca_topic_score_gemma":0.002622243,"teacher_disagreement_score":0.052809328,"about_ca_system_score_codex":0.0015754306,"about_ca_system_score_gemma":0.05438476,"threshold_uncertainty_score":0.950976},"labels":[],"label_agreement":null},{"id":"W2193372308","doi":"10.5489/cuaj.3317","title":"Local tumour ablation for localized kidney cancer: Practice patterns in Canada","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Context (archaeology); Cryoablation; Kidney cancer; Academic institution; Cancer; General surgery; Family medicine; Ablation; Surgery; Internal medicine; Library science","score_opus":0.025765950862264693,"score_gpt":0.2602435728779726,"score_spread":0.23447762201570793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2193372308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8273976,0.0005874237,0.003107563,0.16474243,0.0009947874,0.0008770342,0.00022745179,0.000020070336,0.0020456424],"genre_scores_gemma":[0.9838625,0.000044593486,0.00040627495,0.015045719,0.00030757973,0.00004611617,0.00006909561,0.000014800462,0.00020328318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981414,0.00020885411,0.00040971153,0.0001958666,0.00050929695,0.0005348383],"domain_scores_gemma":[0.99690586,0.0002488507,0.00030013596,0.000080873775,0.00061091094,0.00185336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081327907,0.00014431537,0.00030845846,0.0001359187,0.00009079084,0.00004302738,0.00008263616,0.00014986769,0.00016951309],"category_scores_gemma":[0.0026696858,0.00012099291,0.000075718606,0.00017927156,0.000011363295,0.00012726139,0.000008010686,0.00043111565,0.000009243915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00036724508,0.000046219204,0.94469416,0.000009472333,0.000100293226,0.00057770545,0.00010832196,0.0014733798,0.000017960423,0.000038759234,0.048252877,0.0043136235],"study_design_scores_gemma":[0.0073695104,0.0006869173,0.72681487,0.000058286863,0.00025902578,0.0005556156,0.00095075404,0.007350015,0.00014295173,0.00031474564,0.2552192,0.0002781286],"about_ca_topic_score_codex":0.94752735,"about_ca_topic_score_gemma":0.9546637,"teacher_disagreement_score":0.21787928,"about_ca_system_score_codex":0.022952054,"about_ca_system_score_gemma":0.01590173,"threshold_uncertainty_score":0.9896772},"labels":[],"label_agreement":null},{"id":"W2196801887","doi":"10.5489/cuaj.3011","title":"Bilateral renal leiomyoma with 5 year follow-up: Case report","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Leiomyoma; Renal cell carcinoma; Leiomyosarcoma; Differential diagnosis; Radiology; Uterine leiomyoma; Kidney; Radiological weapon; Pathology; Internal medicine","score_opus":0.02985286973825963,"score_gpt":0.23903120414996837,"score_spread":0.20917833441170874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2196801887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785247,0.00008227544,0.0000297043,0.010648621,0.00032070477,0.00018378615,0.000011553703,0.000030956817,0.010167687],"genre_scores_gemma":[0.9921176,0.0000028136878,0.0005821053,0.0015672571,0.0005251505,0.000007834983,0.000034735556,0.00001834809,0.0051441668],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9982383,0.00012812432,0.0003553928,0.00023256558,0.0005365873,0.0005090295],"domain_scores_gemma":[0.9971347,0.00004622801,0.00027464607,0.00017122432,0.00052666775,0.0018465461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075198605,0.00016620921,0.00030202154,0.00018565156,0.00017047912,0.00009233517,0.00006585496,0.00017941426,0.00026963555],"category_scores_gemma":[0.000516637,0.0001106419,0.00012818922,0.00021728029,0.000032921635,0.000101821126,0.000009217903,0.0005040563,0.000107435095],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024718407,0.000032267973,0.63257045,0.0000015074523,0.00017064533,0.34094054,0.00014197966,0.000022182669,0.00003432161,0.000026276219,0.025449814,0.00036285943],"study_design_scores_gemma":[0.005573424,0.002152616,0.30116853,0.000018101668,0.00029669548,0.63232934,0.00020904954,0.000039049562,0.000101107005,0.00041992456,0.05744803,0.00024409729],"about_ca_topic_score_codex":0.0029276286,"about_ca_topic_score_gemma":0.0029595206,"teacher_disagreement_score":0.33140188,"about_ca_system_score_codex":0.0023602126,"about_ca_system_score_gemma":0.001358355,"threshold_uncertainty_score":0.6171874},"labels":[],"label_agreement":null},{"id":"W2197842858","doi":"","title":"Is laparoscopic partial nephrectomy already the gold standard for small renal masses?.","year":2013,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Nephrectomy; Medicine; Modalities; Gold standard (test); Cochrane Library; Meta-analysis; Laparoscopy; MEDLINE; Surgery; General surgery; Kidney; Radiology; Internal medicine","score_opus":0.050894579249664444,"score_gpt":0.25640758357094,"score_spread":0.20551300432127556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2197842858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97637206,0.00048747213,0.00017596812,0.008042046,0.00030243013,0.0063956426,0.00004179016,0.0000904465,0.008092144],"genre_scores_gemma":[0.96551913,0.00002471973,0.0011426036,0.0018044349,0.00053308735,0.020988112,0.00003508099,0.000041106076,0.009911725],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99844,0.000045036282,0.00027638473,0.00032805224,0.00029884613,0.0006116482],"domain_scores_gemma":[0.9988639,0.00015537642,0.00008985391,0.00048832345,0.00013538056,0.00026718326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025639398,0.0002079014,0.00033874068,0.000053062107,0.00007993905,0.00008227605,0.00014505193,0.000085073196,0.00020201475],"category_scores_gemma":[0.00009655645,0.00012405097,0.0001791883,0.00012382554,0.00007797246,0.00007295669,0.00004586893,0.000140607,0.00009470415],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027086902,0.00062039756,0.18835786,0.00043123934,0.0015110181,0.00010593218,0.0009327692,0.000009920874,0.0042705047,0.0008626225,0.39865637,0.40153268],"study_design_scores_gemma":[0.0060236,0.00047149567,0.39445326,0.000028551254,0.0004964731,0.000046082263,0.00007465353,0.00009564942,0.119928,0.00057297223,0.4775592,0.000250039],"about_ca_topic_score_codex":0.00019313654,"about_ca_topic_score_gemma":0.000025116178,"teacher_disagreement_score":0.40128264,"about_ca_system_score_codex":0.00018540613,"about_ca_system_score_gemma":0.000076361146,"threshold_uncertainty_score":0.5058652},"labels":[],"label_agreement":null},{"id":"W2207823877","doi":"10.3111/13696998.2015.1131705","title":"Real-world dosing and drug costs with everolimus or axitinib as second targeted therapies for advanced renal cell carcinoma: a retrospective chart review in the US","year":2015,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Comprehensive Cancer Network; Canadian Centre for Applied Research in Cancer Control","keywords":"Axitinib; Everolimus; Medicine; Sunitinib; Hazard ratio; Internal medicine; Renal cell carcinoma; Pazopanib; Oncology; Sorafenib; Retrospective cohort study; Dosing; Discontinuation; Confidence interval; Hepatocellular carcinoma","score_opus":0.023934877566439083,"score_gpt":0.2883542912529376,"score_spread":0.2644194136864985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2207823877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737985,0.012402569,0.000011031149,0.010881143,0.00014103614,0.0008376799,0.000012351537,0.0000057261605,0.0019099471],"genre_scores_gemma":[0.98621565,0.008591291,0.0009939955,0.003399654,0.00036854824,0.00003501349,0.000010965369,0.000032203832,0.00035270068],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981198,0.00013789914,0.0007647077,0.00024004042,0.00045054444,0.00028701755],"domain_scores_gemma":[0.9981249,0.00037731763,0.0005905625,0.00022661635,0.00021899743,0.00046162686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022319283,0.00022867306,0.0008593616,0.00014441642,0.00005078765,0.00003176047,0.00020305601,0.00008275562,0.00015543624],"category_scores_gemma":[0.00032094284,0.0001221952,0.00012962944,0.0001437961,0.00014122877,0.00016292458,0.00003193492,0.0005299489,0.0000031222216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13314392,0.0070843655,0.47686177,0.012366036,0.004187103,0.022438444,0.052496724,0.00017739981,0.0018207863,0.003754621,0.16318841,0.122480415],"study_design_scores_gemma":[0.17369263,0.0430742,0.525924,0.020246722,0.0035527758,0.024975419,0.012503121,0.0012557076,0.013096419,0.0038178917,0.17564508,0.0022160278],"about_ca_topic_score_codex":0.00008884254,"about_ca_topic_score_gemma":0.0007292544,"teacher_disagreement_score":0.12026438,"about_ca_system_score_codex":0.0007096101,"about_ca_system_score_gemma":0.0010997173,"threshold_uncertainty_score":0.4982975},"labels":[],"label_agreement":null},{"id":"W2211107270","doi":"10.1200/jco.2009.27.15_suppl.5104","title":"A phase I study of sorafenib and RAD001 for metastatic clear cell renal cell carcinoma","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Sorafenib; Medicine; Sunitinib; Renal cell carcinoma; Internal medicine; Dosing; Toxicity; Urology; Pazopanib; Progressive disease; Pharmacokinetics; Oncology; Gastroenterology; Hepatocellular carcinoma; Chemotherapy","score_opus":0.1727772208750895,"score_gpt":0.4757522930892986,"score_spread":0.3029750722142091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2211107270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99516773,0.0009699468,0.00017732359,0.0013589539,0.000243947,0.0008354436,0.000005997056,0.000004811841,0.0012358148],"genre_scores_gemma":[0.99059385,0.0001054636,0.007991769,0.00053594034,0.00040284323,0.000004616784,0.0000025140698,0.000017845221,0.0003451731],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9959507,0.00046163137,0.0027006492,0.0002492186,0.0003808321,0.0002569804],"domain_scores_gemma":[0.99490273,0.0018719841,0.0020529085,0.00024369366,0.00044811607,0.00048054734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024822787,0.00019180539,0.00209701,0.0001797213,0.00003827668,0.000006979649,0.00013423339,0.00016729708,0.000042133248],"category_scores_gemma":[0.0006924483,0.00013051102,0.0005102302,0.000116909876,0.000117501375,0.00007459383,0.000029005201,0.0005579972,0.0000033840442],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17832382,0.29906,0.04572985,0.00060756085,0.0018312455,0.013549635,0.0039154585,0.000066004766,0.04874112,0.00007672041,0.01595026,0.39214832],"study_design_scores_gemma":[0.16386744,0.6948166,0.118206315,0.00005185966,0.0044615543,0.00073366874,0.0014714182,0.00030042694,0.009262165,0.00042519427,0.006211546,0.00019180962],"about_ca_topic_score_codex":0.000013938417,"about_ca_topic_score_gemma":0.00000644139,"teacher_disagreement_score":0.3957566,"about_ca_system_score_codex":0.000094403156,"about_ca_system_score_gemma":0.00074050174,"threshold_uncertainty_score":0.5322085},"labels":[],"label_agreement":null},{"id":"W2211782816","doi":"10.5489/cuaj.536","title":"Management of Advanced Kidney Cancer – Canadian Kidney Cancer Forum Consensus Update","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Kidney cancer; Cancer; Medicine; Kidney; Internal medicine","score_opus":0.011570904202970021,"score_gpt":0.2407205130414772,"score_spread":0.22914960883850718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2211782816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.710833,0.0012432109,0.0000047170606,0.27369323,0.00092619355,0.00089902914,0.00049424206,0.000026248106,0.011880113],"genre_scores_gemma":[0.9678265,0.00078566547,0.0005267305,0.027216667,0.00020604678,0.00012996596,0.00006479259,0.000027614358,0.0032160312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755394,0.000114584516,0.00053800415,0.00029504535,0.00046914618,0.0010292741],"domain_scores_gemma":[0.994001,0.00004244813,0.00039399057,0.00020119423,0.0005871772,0.0047742086],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027016355,0.00024824406,0.00045283974,0.00032371766,0.00026067253,0.000061102124,0.00017582481,0.00025294983,0.007228073],"category_scores_gemma":[0.00023677548,0.00020318847,0.00019529727,0.0003109774,0.000057307658,0.00008721423,0.00002035906,0.0004859294,0.00016080271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008192839,0.000049585356,0.6521352,0.000042745683,0.0008806494,0.0006478412,0.00007328995,0.00015617326,0.000309079,0.0003144608,0.32847974,0.01682935],"study_design_scores_gemma":[0.0022084236,0.00021820092,0.68153375,0.00013422246,0.00032897512,0.00011082849,0.00019974398,0.00012730295,0.00025334602,0.00050262595,0.31413195,0.00025063488],"about_ca_topic_score_codex":0.38434485,"about_ca_topic_score_gemma":0.1393766,"teacher_disagreement_score":0.25699347,"about_ca_system_score_codex":0.0054220073,"about_ca_system_score_gemma":0.0034740863,"threshold_uncertainty_score":0.998396},"labels":[],"label_agreement":null},{"id":"W2212066882","doi":"10.5489/cuaj.2855","title":"Clinicohistological characteristics of renal cell carcinoma in children: A multicentre study","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Retrospective cohort study; Stage (stratigraphy); Cancer; Carcinoma; Internal medicine; Gastroenterology; Surgery; Kidney","score_opus":0.02600831574279162,"score_gpt":0.24953664946335466,"score_spread":0.22352833372056305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2212066882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964383,0.00020179297,0.000003904678,0.0014371042,0.00016169185,0.0005140425,0.000023798175,0.000010289701,0.0012090636],"genre_scores_gemma":[0.9988626,0.000009324769,0.0001264544,0.0005394353,0.00023364111,0.000008484657,0.00002728109,0.000011821614,0.00018092303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756676,0.00041850773,0.00076783594,0.00024930766,0.0005104555,0.00048713238],"domain_scores_gemma":[0.9977539,0.0001253984,0.00048700123,0.00016141203,0.00037009365,0.001102166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010814441,0.00017995591,0.000572617,0.00026771394,0.00006532929,0.000025989759,0.00014154539,0.00026293128,0.0001681426],"category_scores_gemma":[0.001077104,0.00013865421,0.00015292023,0.00024242798,0.00003772596,0.000051526917,0.000025250636,0.0007322931,0.00004293866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022881785,0.0007722558,0.9963857,0.000002305708,0.000050625233,0.0006426057,0.0003802942,0.000017549142,0.000035045687,0.0000045419843,0.000873056,0.0006071844],"study_design_scores_gemma":[0.004903151,0.002445469,0.99114734,0.000005842602,0.00014929617,0.00026654865,0.0002963949,0.00008548913,0.0000334179,0.00003330657,0.0005178337,0.00011593456],"about_ca_topic_score_codex":0.0016693171,"about_ca_topic_score_gemma":0.00057462434,"teacher_disagreement_score":0.0052384026,"about_ca_system_score_codex":0.0020355457,"about_ca_system_score_gemma":0.0008762433,"threshold_uncertainty_score":0.5654155},"labels":[],"label_agreement":null},{"id":"W2214079562","doi":"10.1016/j.urology.2015.10.035","title":"Racial Disparities in Partial Nephrectomy Persist Across Hospital Types: Results From a Population-based Cohort","year":2015,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cohort; Odds ratio; Logistic regression; Nephrectomy; Population; Internal medicine; Odds; Cancer; Demography; Kidney; Environmental health","score_opus":0.022799908539916473,"score_gpt":0.2789000668258558,"score_spread":0.2561001582859393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2214079562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99575,0.00024326849,0.00002643308,0.0020730142,0.00040629608,0.0004287938,0.00010114027,0.000047714177,0.0009233002],"genre_scores_gemma":[0.9979176,0.0000021236242,0.00016312154,0.00049356057,0.00033264313,0.00007442599,0.00084320037,0.000017150362,0.00015620902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987704,0.00008760762,0.00028781866,0.00033847688,0.00020296706,0.000312704],"domain_scores_gemma":[0.9992984,0.00014014481,0.00007255278,0.00026874253,0.000062241386,0.00015791394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017116734,0.00014485586,0.00032527142,0.000059204496,0.00003784704,0.000014820693,0.00006522179,0.00015716812,0.00004290711],"category_scores_gemma":[0.0003426967,0.00012810962,0.0000732103,0.00009925292,0.00009010308,0.000043230677,0.000030359744,0.00016695955,0.00009061296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033191228,0.0002106107,0.9936218,0.0000046682258,0.000053128777,0.0003046211,0.0010544627,0.00046574167,0.000022940669,0.000024804165,0.0005962433,0.0003218194],"study_design_scores_gemma":[0.007195199,0.0012013547,0.98543817,0.0000083122895,0.000106661246,0.000008618708,0.000108940076,0.002336144,0.00019725914,0.00011054119,0.0031569174,0.00013191416],"about_ca_topic_score_codex":0.008843193,"about_ca_topic_score_gemma":0.0016103671,"teacher_disagreement_score":0.008183698,"about_ca_system_score_codex":0.00018626062,"about_ca_system_score_gemma":0.0001354235,"threshold_uncertainty_score":0.997757},"labels":[],"label_agreement":null},{"id":"W2215901955","doi":"10.1016/j.euf.2015.11.006","title":"Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell–Cell Communication in Renal Cell Carcinoma","year":2015,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; York University; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Clear cell renal cell carcinoma; microRNA; Receiver operating characteristic; Area under the curve; Renal cell carcinoma; Exosome; Internal medicine; Oncology; Confidence interval; Biomarker; Carcinoma; Pathology; Cancer research; Microvesicles; Gene; Biology","score_opus":0.020840819773525174,"score_gpt":0.21930068189670282,"score_spread":0.19845986212317765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2215901955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94410366,0.014488728,0.0000065544305,0.0017705212,0.00011461702,0.00046497074,0.000017210032,0.000053330426,0.038980428],"genre_scores_gemma":[0.998171,0.0002131661,0.00041053296,0.0004454114,0.000094798124,0.000015661673,0.00007950985,0.00007911004,0.00049083645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973843,0.0009786204,0.0004408876,0.00051395345,0.00020979217,0.0004724388],"domain_scores_gemma":[0.99808174,0.00039189603,0.00023500288,0.00075309834,0.00008940005,0.00044888744],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056990527,0.00031844305,0.00040610603,0.00026040678,0.00006703091,0.000021658056,0.00025318452,0.000113984825,0.000026966813],"category_scores_gemma":[0.00017450686,0.0002890259,0.00007462767,0.00019738996,0.000276804,0.000050757746,0.0002641575,0.00041619968,0.00024439805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010147352,0.00077780685,0.9516297,0.000119436074,0.000053618005,0.00934535,0.0031388702,0.00003056533,0.024995554,0.000010691408,0.0074199867,0.0014636943],"study_design_scores_gemma":[0.009308957,0.0016985773,0.94625235,0.000033732547,0.0002890718,0.0004033404,0.00040962806,0.000057104287,0.037599437,0.00006847394,0.0035284336,0.00035091914],"about_ca_topic_score_codex":0.0005030958,"about_ca_topic_score_gemma":0.00037172376,"teacher_disagreement_score":0.054067332,"about_ca_system_score_codex":0.00015535274,"about_ca_system_score_gemma":0.00011768466,"threshold_uncertainty_score":0.9999562},"labels":[],"label_agreement":null},{"id":"W2216703724","doi":"10.1016/j.clgc.2015.10.011","title":"Sociodemographic Disparities in the Nonoperative Management of Small Renal Masses","year":2015,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Ethnic group; Charlson comorbidity index; Socioeconomic status; Comorbidity; Subgroup analysis; Epidemiology; Internal medicine; Surveillance, Epidemiology, and End Results; Population; African american; Cancer; Demography; Gerontology; Cancer registry; Confidence interval","score_opus":0.19242303712189826,"score_gpt":0.4041198364005924,"score_spread":0.21169679927869414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2216703724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98304224,0.00498194,0.000023053475,0.0026287723,0.0002489869,0.00058634364,0.000010985262,0.00001600535,0.008461678],"genre_scores_gemma":[0.99305844,0.0023998509,0.002035756,0.0006845202,0.00033888425,0.00021301898,0.000014170043,0.000016559907,0.0012387707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831134,0.0002558867,0.00057970727,0.000295012,0.00031955141,0.00023852476],"domain_scores_gemma":[0.9990346,0.00021070559,0.00011650489,0.0003846838,0.00011068598,0.00014286427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006941571,0.00016713154,0.00041562004,0.00007031278,0.000033888602,0.000011430881,0.00018795233,0.00009654302,0.00004016573],"category_scores_gemma":[0.000029203706,0.00010318774,0.00022235585,0.00024214403,0.0002874614,0.00004191738,0.00009294937,0.0003172051,0.000013257922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014126572,0.0013364139,0.9787948,0.00023248604,0.00047978095,0.0014689751,0.000630024,0.00012025201,0.000038984814,0.00030197276,0.00567831,0.009505309],"study_design_scores_gemma":[0.0042267228,0.0019267653,0.9831063,0.00030828558,0.0004012259,0.000037061945,0.0018642218,0.00008835087,0.00031966905,0.0006120876,0.006933963,0.00017534042],"about_ca_topic_score_codex":0.00017698103,"about_ca_topic_score_gemma":0.00006889312,"teacher_disagreement_score":0.010016235,"about_ca_system_score_codex":0.0000978124,"about_ca_system_score_gemma":0.00016644967,"threshold_uncertainty_score":0.4207874},"labels":[],"label_agreement":null},{"id":"W2217148288","doi":"10.5489/cuaj.3144","title":"Dilemmas in diagnosis and natural history of renal oncocytoma and implications for management","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Oncocytoma; Renal oncocytoma; Medicine; Nephrectomy; Renal cell carcinoma; Natural history; Radiology; Cohort; Biopsy; Retrospective cohort study; Differential diagnosis; Surgery; Kidney; Pathology; Internal medicine","score_opus":0.039675668142037795,"score_gpt":0.2553966698430428,"score_spread":0.21572100170100503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2217148288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97818273,0.0036480266,0.00001930281,0.016256845,0.000120719145,0.00033444836,0.0000167408,0.000005293032,0.0014159081],"genre_scores_gemma":[0.99772376,0.00018530096,0.0006593,0.0007783835,0.00007024054,0.000050493927,0.000011908653,0.0000053208946,0.0005152848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929076,0.00005086824,0.00022294356,0.00012238875,0.000116479365,0.00019655748],"domain_scores_gemma":[0.99910545,0.000119713186,0.00013603318,0.000056694662,0.0001390806,0.00044301047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003836747,0.00007356547,0.00018710848,0.00017510729,0.000033819357,0.000010721278,0.00003554977,0.00008179414,0.000013770542],"category_scores_gemma":[0.00025321517,0.00005987365,0.000042647855,0.000064834974,0.000032098313,0.00004449981,0.0000117376185,0.00015307736,8.0434955e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007286934,0.000040722363,0.9771278,0.000010618946,0.00006935323,0.000041414518,0.0001727043,0.000004514637,0.000037405902,0.00066422904,0.014155961,0.0076024197],"study_design_scores_gemma":[0.0016117671,0.00037246133,0.9441045,0.000012894064,0.00008218338,0.00010947402,0.000043717515,0.000052625586,0.000009945948,0.0011904379,0.052356735,0.00005324026],"about_ca_topic_score_codex":0.00045583205,"about_ca_topic_score_gemma":0.0009849258,"teacher_disagreement_score":0.038200777,"about_ca_system_score_codex":0.0031923978,"about_ca_system_score_gemma":0.00027540204,"threshold_uncertainty_score":0.8348009},"labels":[],"label_agreement":null},{"id":"W2221561002","doi":"10.15586/jkcvhl.2015.43","title":"The Role of Everolimus in Renal Cell Carcinoma","year":2015,"lang":"en","type":"review","venue":"Journal of Kidney Cancer and VHL","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Everolimus; Sunitinib; Nivolumab; Renal cell carcinoma; Medicine; Cabozantinib; Oncology; Tyrosine-kinase inhibitor; Internal medicine; Tyrosine kinase; Pharmacology; Cancer; Immunotherapy; Receptor","score_opus":0.0377718419643507,"score_gpt":0.3267254861061697,"score_spread":0.288953644141819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2221561002","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021174883,0.9935992,3.01306e-7,0.00019657332,0.00026268564,0.0003239604,0.000035232904,0.0000016000128,0.0034629868],"genre_scores_gemma":[0.004507675,0.9941956,0.000045230547,0.00007525741,0.00050441,0.000015131609,0.0000058050264,0.00003032666,0.00062059413],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99808806,0.000115251954,0.0009546582,0.00015283006,0.00046257678,0.00022661845],"domain_scores_gemma":[0.99779004,0.00010840301,0.00093946076,0.00023811085,0.00025665114,0.0006673633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005729563,0.00027094796,0.0016790574,0.0002161313,0.000030411416,0.00001548809,0.00017120807,0.00016451329,0.000026021058],"category_scores_gemma":[0.000114889976,0.00013855612,0.00042722406,0.00019724033,0.00007650744,0.000046648885,0.000049046343,0.00056579924,0.0000023285045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003239952,0.00013172429,0.002115495,0.005793798,0.00027593804,0.00030541106,0.00023105145,7.188547e-7,0.00003662363,0.000008626787,0.014810232,0.9759664],"study_design_scores_gemma":[0.0015265296,0.00066102925,0.00042682802,0.0067200954,0.0016930297,0.0006937915,0.00006201686,0.000002013382,0.00017762353,0.000053535383,0.98787045,0.0001130328],"about_ca_topic_score_codex":0.00015765973,"about_ca_topic_score_gemma":0.00001154513,"teacher_disagreement_score":0.9758533,"about_ca_system_score_codex":0.00046730397,"about_ca_system_score_gemma":0.0043745684,"threshold_uncertainty_score":0.77602965},"labels":[],"label_agreement":null},{"id":"W2222086386","doi":"10.1056/nejmoa1510665","title":"Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma","year":2015,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5890,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Everolimus; Nivolumab; Renal cell carcinoma; Medicine; Oncology; Internal medicine; Cancer research; Urology; Immunotherapy; Cancer","score_opus":0.04492848070683175,"score_gpt":0.2874955900180906,"score_spread":0.24256710931125885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2222086386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9718586,0.0072049946,0.00006960425,0.004089789,0.0011347255,0.00021223788,9.2453325e-7,0.00001191752,0.015417209],"genre_scores_gemma":[0.9941915,0.00015933417,0.0010355454,0.00023566723,0.0026513909,0.0000018999684,0.0000087548015,0.000029415825,0.0016864544],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977249,0.000117736636,0.00074787554,0.00019817596,0.00088059966,0.00033069358],"domain_scores_gemma":[0.9979177,0.00020762412,0.00035800855,0.00029609143,0.00033012754,0.000890431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008762554,0.00023860838,0.0007743814,0.0004172266,0.000020079353,0.00000581438,0.00015023473,0.00009025277,0.00011916674],"category_scores_gemma":[0.0005052601,0.0001582568,0.00010845778,0.0003210387,0.00007994611,0.00012416196,0.000028564651,0.00050733984,0.000021215315],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1355054,0.0016287017,0.1670995,0.00031403158,0.00046115715,0.040042985,0.013514568,0.0013170982,0.05526497,0.00011877138,0.076279804,0.508453],"study_design_scores_gemma":[0.7852478,0.039953798,0.07513073,0.0008263507,0.00081202533,0.006029592,0.0016094615,0.00012235997,0.017315857,0.00045151488,0.07214421,0.00035631657],"about_ca_topic_score_codex":0.0003015018,"about_ca_topic_score_gemma":0.00009064068,"teacher_disagreement_score":0.64974236,"about_ca_system_score_codex":0.00048179104,"about_ca_system_score_gemma":0.00064436044,"threshold_uncertainty_score":0.6453525},"labels":[],"label_agreement":null},{"id":"W2225073250","doi":"10.1016/j.prp.2015.12.007","title":"Clear cell papillary renal cell carcinoma as part of histologically discordant multifocal renal cell carcinoma: A case report and review of literature","year":2016,"lang":"en","type":"review","venue":"Pathology - Research and Practice","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of New Brunswick; University of Toronto; Canada Research Chairs","funders":"","keywords":"Papillary renal cell carcinomas; Pathology; Renal cell carcinoma; Medicine; Clear cell; Carcinoma","score_opus":0.09941493058591465,"score_gpt":0.40286723171654987,"score_spread":0.3034523011306352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2225073250","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016244853,0.96485484,0.000006457481,0.00063499715,0.00014060858,0.0028249202,0.00031550002,0.000019736955,0.0149580985],"genre_scores_gemma":[0.0126623465,0.9798423,0.0019116512,0.00013324861,0.00026452442,0.00025862883,0.00035385365,0.00010149815,0.004471969],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.988427,0.005489691,0.002153026,0.0017374251,0.0011507708,0.0010421282],"domain_scores_gemma":[0.988222,0.0058339103,0.0019056888,0.001746431,0.0014372225,0.0008547554],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0063987756,0.0008742787,0.003679424,0.00056090124,0.00024305245,0.000041431358,0.00033077862,0.0008221889,0.00022264646],"category_scores_gemma":[0.0046768095,0.00050113106,0.0005913524,0.00064104126,0.001419147,0.00023295537,0.000727071,0.0025805484,0.00004693845],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017213264,0.0011836998,0.00014903132,0.16850302,0.00012004045,0.7698025,0.00024487948,6.834947e-9,0.0010202434,0.000025841904,0.0036586476,0.053570732],"study_design_scores_gemma":[0.0013284121,0.0065964917,0.00006508278,0.02432585,0.0019820975,0.4592654,0.00011211088,3.7061736e-7,0.0008381009,0.000027359822,0.50507563,0.00038311095],"about_ca_topic_score_codex":0.0001931938,"about_ca_topic_score_gemma":0.0000072655916,"teacher_disagreement_score":0.501417,"about_ca_system_score_codex":0.00027184363,"about_ca_system_score_gemma":0.0016819424,"threshold_uncertainty_score":0.99974406},"labels":[],"label_agreement":null},{"id":"W2228210401","doi":"10.1200/jco.2015.33.7_suppl.471","title":"Preoperative renal parenchymal volumetrics and prediction of renal insufficiency following radical nephrectomy.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Nephrectomy; Urology; Renal cell carcinoma; Renal function; Muscle hypertrophy; Parenchyma; Kidney disease; Exact test; Creatinine; Kidney; Nuclear medicine; Surgery; Internal medicine; Pathology","score_opus":0.1793229976329214,"score_gpt":0.4263482714645569,"score_spread":0.2470252738316355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2228210401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99120593,0.0021799714,0.0013293481,0.0008188202,0.0010718277,0.00024122199,0.0000055349983,0.000010132198,0.0031372085],"genre_scores_gemma":[0.9835806,0.00025199726,0.014809353,0.00022432992,0.0009128573,0.0000033337253,0.000004658722,0.000013674749,0.00019923194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99552053,0.0006087944,0.0025646912,0.00024164445,0.0008230496,0.00024128243],"domain_scores_gemma":[0.9955789,0.0013729088,0.0013868377,0.00017820093,0.0006713832,0.0008117893],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0043899138,0.00016975462,0.0015502288,0.00030397656,0.000039083887,0.000010148089,0.00012829667,0.00041076657,0.000031421463],"category_scores_gemma":[0.008674939,0.00011513457,0.00049196766,0.00038462295,0.0003479267,0.00018128326,0.00007590083,0.0009435759,0.0000042748084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008295352,0.005935942,0.8839667,0.000044101867,0.0011645746,0.0025504807,0.0008235813,0.00012281144,0.0014107988,0.000090547845,0.010104094,0.085491024],"study_design_scores_gemma":[0.025455695,0.116105676,0.8169705,0.00026853394,0.0018338439,0.0023700972,0.0003982871,0.002233664,0.0011018355,0.0002716902,0.032820273,0.00016986797],"about_ca_topic_score_codex":0.000021261745,"about_ca_topic_score_gemma":0.0000062855406,"teacher_disagreement_score":0.11016973,"about_ca_system_score_codex":0.00027832948,"about_ca_system_score_gemma":0.0027525965,"threshold_uncertainty_score":0.9996754},"labels":[],"label_agreement":null},{"id":"W2232001085","doi":"10.1200/jco.2007.25.18_suppl.5042","title":"Use of carbonic anhydrase IX (CAIX) expression and Von Hippel Lindau (VHL) gene mutation status to predict survival in renal cell carcinoma","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Renal cell carcinoma; Medicine; Cancer research; Mutation; Clear cell renal cell carcinoma; Proportional hazards model; Oncology; Gene; Internal medicine; Pathology; Biology; Genetics","score_opus":0.11369077192466372,"score_gpt":0.4046915844846835,"score_spread":0.2910008125600198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2232001085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969789,0.00070711353,0.00028638967,0.00046736098,0.0006707763,0.00042427576,0.000012244997,0.000006511196,0.0004464299],"genre_scores_gemma":[0.9909276,0.00025531425,0.0078100613,0.00027139275,0.00059362536,0.0000028436743,0.00001192985,0.000027129066,0.00010013828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950732,0.0005811827,0.0029514814,0.00032182172,0.0006269215,0.00044539335],"domain_scores_gemma":[0.9940701,0.002799769,0.0015161284,0.00026925953,0.00045265057,0.0008920518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036439674,0.00021700532,0.0014920171,0.00044064183,0.000025899608,0.000009317038,0.0001046316,0.00045903592,0.000026204723],"category_scores_gemma":[0.0021992994,0.0001624214,0.00029426647,0.00024113884,0.00015123129,0.0001542376,0.00008956612,0.0008703966,0.0000035035748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017246494,0.0021889515,0.8667434,0.00008546541,0.00008597153,0.0062558046,0.000665031,0.00024184097,0.07342593,0.0000055550167,0.00025755644,0.032797996],"study_design_scores_gemma":[0.009956199,0.020408787,0.9106302,0.0001542896,0.00028063878,0.00030666468,0.00021213872,0.0001962213,0.056566656,0.000033565542,0.0011340186,0.00012061911],"about_ca_topic_score_codex":0.00033029405,"about_ca_topic_score_gemma":0.0003574596,"teacher_disagreement_score":0.043886803,"about_ca_system_score_codex":0.00046055403,"about_ca_system_score_gemma":0.001234743,"threshold_uncertainty_score":0.6623353},"labels":[],"label_agreement":null},{"id":"W2233483325","doi":"10.1016/s1470-2045(15)00515-x","title":"Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial","year":2016,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":424,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Cancer Research UK; North Carolina GlaxoSmithKline Foundation; Novartis; Celgene; Bayer Corporation; Bristol-Myers Squibb; AstraZeneca; F. Hoffmann-La Roche; Astellas Pharma US; Pfizer; Durham University; Abbott Laboratories","keywords":"Sunitinib; Everolimus; Renal cell carcinoma; Medicine; Oncology; Open label; Internal medicine; Phases of clinical research; Clinical trial","score_opus":0.0994465300835262,"score_gpt":0.3632002380958994,"score_spread":0.2637537080123732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2233483325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788777,0.000097670825,0.00017824392,0.0012283109,0.0005388852,0.009313815,0.00015937405,0.000037685615,0.009568274],"genre_scores_gemma":[0.99205655,0.000038764618,0.00386818,0.0005404098,0.0005466934,0.0009794561,0.00012921022,0.000072764735,0.0017679427],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99734724,0.0004915844,0.00053159264,0.00051838515,0.00034143214,0.0007697847],"domain_scores_gemma":[0.99584067,0.0024177926,0.0004390298,0.0007722495,0.0002576581,0.00027259538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070004707,0.00037270845,0.0012898508,0.0000864935,0.00017330772,0.00003348157,0.00050615304,0.0001139465,0.0003221618],"category_scores_gemma":[0.00021198238,0.0001812497,0.00012885909,0.00014671615,0.00020198232,0.00012002005,0.0001515675,0.00020989319,0.00014541521],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9768999,0.0057232287,0.0002960944,0.00009473922,0.00028285212,0.00018259189,0.000376411,0.0000012633769,0.005750544,0.000015291625,0.0049355277,0.0054415553],"study_design_scores_gemma":[0.9201706,0.054690897,0.00071592483,0.00004325932,0.0016001046,0.000010767302,0.00010907925,0.00009499256,0.011221578,0.000024448831,0.011078305,0.00024004022],"about_ca_topic_score_codex":0.000079155565,"about_ca_topic_score_gemma":0.00005600007,"teacher_disagreement_score":0.056729298,"about_ca_system_score_codex":0.00045151482,"about_ca_system_score_gemma":0.00048015456,"threshold_uncertainty_score":0.7391149},"labels":[],"label_agreement":null},{"id":"W2237254160","doi":"10.1056/nejmoa1510016","title":"Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma","year":2015,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1226,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Cabozantinib; Everolimus; Renal cell carcinoma; Axitinib; Oncology; Medicine; Internal medicine; Urology; Sunitinib","score_opus":0.05038606030181386,"score_gpt":0.29719039078006293,"score_spread":0.24680433047824907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2237254160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96924835,0.006569655,0.00005571663,0.0043525295,0.0012222179,0.00022076395,0.000001140054,0.000011787042,0.018317847],"genre_scores_gemma":[0.9942052,0.00018393325,0.0010105184,0.00026330337,0.0027829397,0.0000018596236,0.000009664823,0.000029791201,0.0015127986],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99767727,0.000120258796,0.00078752055,0.00020151032,0.0008715784,0.00034188118],"domain_scores_gemma":[0.9978449,0.00024113158,0.00038352434,0.00029115408,0.0003447635,0.00089453446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009772774,0.0002463119,0.00080431555,0.00042493592,0.000019666932,0.0000059177964,0.00014775629,0.000090807465,0.00011225886],"category_scores_gemma":[0.00057940336,0.00015979733,0.00010642532,0.000340183,0.000081198225,0.000119575,0.000028456167,0.0005148985,0.000019689955],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12924205,0.0016317088,0.2885944,0.00033011712,0.00046274468,0.046585996,0.014512691,0.0011823742,0.07044811,0.00017598369,0.06437141,0.38246244],"study_design_scores_gemma":[0.7164511,0.029872267,0.11428109,0.00082485913,0.00077182165,0.0059310766,0.0015590739,0.000074772775,0.022268943,0.00028631,0.10732954,0.00034911034],"about_ca_topic_score_codex":0.00031571076,"about_ca_topic_score_gemma":0.00008399393,"teacher_disagreement_score":0.5872091,"about_ca_system_score_codex":0.00028118942,"about_ca_system_score_gemma":0.00063206436,"threshold_uncertainty_score":0.6516346},"labels":[],"label_agreement":null},{"id":"W2237286279","doi":"10.5489/cuaj.3417","title":"The role of renal biopsy in small renal masses","year":2016,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Biopsy; Radiology; Renal biopsy; Magnetic resonance imaging; Ultrasound; Renal mass; Diagnostic accuracy; Kidney; Internal medicine; Nephrectomy","score_opus":0.03133337298970277,"score_gpt":0.263872245899657,"score_spread":0.23253887290995426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2237286279","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009022825,0.9924351,0.000003378974,0.0018074855,0.00018781012,0.00042895993,0.00007185044,0.000008827952,0.0041543203],"genre_scores_gemma":[0.002113075,0.99587774,0.000098120436,0.00011506271,0.0005907044,0.000035474717,0.000031034786,0.000029269891,0.0011095137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970125,0.00060267316,0.0010420833,0.00027105125,0.00038686252,0.00068483816],"domain_scores_gemma":[0.9969239,0.0008362137,0.00109413,0.00023861218,0.00023399654,0.00067313225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001314764,0.0003203805,0.0012544557,0.00039717715,0.00017869074,0.000065642125,0.00029983083,0.00063390925,0.00026884873],"category_scores_gemma":[0.0010728908,0.00015770091,0.00066102645,0.00033831192,0.000070123555,0.000034790857,0.000029882896,0.0010559838,0.000084659594],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004530414,0.000052691215,0.020960355,0.00016006346,0.0005448908,0.00063320517,0.000022312579,7.231735e-7,0.000009133374,0.00036884833,0.0011939466,0.97600853],"study_design_scores_gemma":[0.00043120747,0.00024555033,0.0062383404,0.0015864864,0.00041214025,0.0010216489,0.00001167906,0.0000013910071,0.0000037174173,0.0008255366,0.9890717,0.00015060177],"about_ca_topic_score_codex":0.00065981015,"about_ca_topic_score_gemma":0.0014735843,"teacher_disagreement_score":0.9878777,"about_ca_system_score_codex":0.0034300757,"about_ca_system_score_gemma":0.0024942362,"threshold_uncertainty_score":0.89695287},"labels":[],"label_agreement":null},{"id":"W2240796172","doi":"10.1200/jco.2009.27.15_suppl.e17539","title":"Sunitinib, sorafenib, temsirolimus, or bevacizumab in the treatment of metastatic renal cell carcinoma (RCC): A review of health economic evaluations","year":2009,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Temsirolimus; Medicine; Sunitinib; Sorafenib; Bevacizumab; Renal cell carcinoma; Oncology; Internal medicine; Cost effectiveness; Kidney cancer; Discovery and development of mTOR inhibitors; Hepatocellular carcinoma; Chemotherapy; PI3K/AKT/mTOR pathway","score_opus":0.4362555027478233,"score_gpt":0.5691585290781784,"score_spread":0.1329030263303551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2240796172","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039365995,0.9886979,0.0000057362604,0.0025745016,0.00038050947,0.003201559,0.000078948695,0.0000034652608,0.0011207984],"genre_scores_gemma":[0.0027230277,0.99390423,0.0016248852,0.00081342517,0.000514918,0.000082741506,0.00009242039,0.000045380195,0.0001989556],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9773835,0.00773932,0.01324454,0.0004270511,0.00075897825,0.00044663265],"domain_scores_gemma":[0.97466177,0.008756339,0.014894935,0.00086602505,0.0004566889,0.00036422798],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.011944967,0.00059728127,0.014277241,0.0005804186,0.000044057106,0.0000064968012,0.0005227773,0.00043350528,0.00030965268],"category_scores_gemma":[0.0014147985,0.0002918371,0.003732854,0.00042721556,0.00026671155,0.000064142405,0.00003231269,0.0011024656,0.000024880253],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081085786,0.006933007,0.000070423586,0.030356802,0.00077535573,0.0008380665,0.00016825052,0.0000033958777,2.0219731e-7,0.000020739384,0.0018984538,0.95812446],"study_design_scores_gemma":[0.009929973,0.09570189,0.0017596373,0.041641492,0.014731054,0.0026722506,0.000108021035,0.0000051698685,0.0000033245196,0.000056973422,0.83318764,0.00020257945],"about_ca_topic_score_codex":0.00013361938,"about_ca_topic_score_gemma":0.0001387486,"teacher_disagreement_score":0.95792186,"about_ca_system_score_codex":0.0020827146,"about_ca_system_score_gemma":0.025363082,"threshold_uncertainty_score":0.9999534},"labels":[],"label_agreement":null},{"id":"W2240827233","doi":"10.1200/jco.2007.25.18_suppl.15568","title":"Sorafenib for the treatment of metastatic renal cancer (MRC) in the real world: The Princess Margaret Hospital (PMH) experience","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Sorafenib; Rash; Internal medicine; Adverse effect; Surgery; Placebo; Common Terminology Criteria for Adverse Events; Neutropenia; Gastroenterology; Toxicity; Pathology","score_opus":0.19185557726083624,"score_gpt":0.5128229503819305,"score_spread":0.32096737312109425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2240827233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761574,0.0021072368,0.0002959121,0.018329905,0.00087569695,0.001109714,0.0000058356572,0.000003032029,0.0011152604],"genre_scores_gemma":[0.9935919,0.002929458,0.0012197698,0.0008289843,0.00093757367,0.00009894964,0.0000014993309,0.000014253053,0.00037759377],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9963309,0.00045625502,0.0021609145,0.00018882219,0.0005339143,0.00032914974],"domain_scores_gemma":[0.9869437,0.0106485505,0.001609405,0.00036818098,0.00028555744,0.00014457338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004604459,0.00018030385,0.001091666,0.00010171149,0.00008063288,0.000010966204,0.00040909648,0.0001039117,0.0000675533],"category_scores_gemma":[0.000701828,0.00006411209,0.0006566708,0.00028592124,0.00053150614,0.000060008464,0.00002653023,0.0004422359,0.0000015878435],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022047902,0.012803006,0.4627408,0.00006608938,0.0022737554,0.0025993797,0.016520713,0.0002669618,0.00023746808,0.0013597524,0.002798633,0.47628552],"study_design_scores_gemma":[0.009712955,0.027339019,0.86476594,0.00008498241,0.0012390516,0.00014942071,0.0040374147,0.00010060992,0.000841029,0.0003413946,0.09129137,0.000096798256],"about_ca_topic_score_codex":0.00043811573,"about_ca_topic_score_gemma":0.0024290052,"teacher_disagreement_score":0.47618872,"about_ca_system_score_codex":0.00041578742,"about_ca_system_score_gemma":0.0009412743,"threshold_uncertainty_score":0.26144153},"labels":[],"label_agreement":null},{"id":"W2241239684","doi":"10.1200/jco.2007.25.18_suppl.5011","title":"The Advanced Renal Cell Carcinoma Sorafenib (ARCCS) expanded access trial in North America: Safety and efficacy","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Sorafenib; Sunitinib; Renal cell carcinoma; Internal medicine; Expanded access; Chromophobe cell; Adverse effect; Surgery; Clinical trial; Urology; Oncology; Clear cell; Hepatocellular carcinoma","score_opus":0.10360630427762922,"score_gpt":0.44745187823647703,"score_spread":0.3438455739588478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2241239684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99089634,0.0011529304,0.00012358099,0.0027755965,0.0010341957,0.0006662711,0.0000019181962,0.0000072539706,0.0033418913],"genre_scores_gemma":[0.99534434,0.0013798599,0.0010336031,0.0007288531,0.0012316585,0.000004418966,0.000004407572,0.000020818352,0.00025205297],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9947987,0.00057025615,0.003370941,0.0002935394,0.00050251954,0.00046402306],"domain_scores_gemma":[0.9890922,0.007789256,0.0019513326,0.00030856827,0.00028213495,0.00057655195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041521415,0.00021845114,0.001637169,0.00017114874,0.00010041056,0.000022241686,0.0003109724,0.00027835005,0.000031101667],"category_scores_gemma":[0.0025762985,0.00012505567,0.00045912166,0.00032080698,0.00042418487,0.00014323815,0.00013026356,0.0013762012,0.000007790624],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4157186,0.00227014,0.12050636,0.000016313936,0.00012311526,0.0031486878,0.00020007647,0.000045348046,0.00018334339,0.000010314138,0.00033443666,0.45744327],"study_design_scores_gemma":[0.14315705,0.02164337,0.7992028,0.000024302593,0.00022285234,0.0002450816,0.00018816751,0.000017265009,0.00028924088,0.000034730056,0.034869026,0.00010612902],"about_ca_topic_score_codex":0.00003283299,"about_ca_topic_score_gemma":0.0004598402,"teacher_disagreement_score":0.6786964,"about_ca_system_score_codex":0.00031995843,"about_ca_system_score_gemma":0.0011569884,"threshold_uncertainty_score":0.5978986},"labels":[],"label_agreement":null},{"id":"W2242698841","doi":"10.1200/jco.2015.33.7_suppl.487","title":"cMet: Results in papillary renal cell carcinoma of a phase I study of AZD6094/volitinib leading to a phase 2 clinical trial with AZD6094/volitinib in patients with advanced papillary renal cell cancer (PRCC).","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Papillary renal cell carcinomas; Medicine; Internal medicine; Cabozantinib; Oncology; Cohort; Cancer; Renal cell carcinoma; Clear cell renal cell carcinoma; Chromosome 7 (human); Cancer research; Pathology; Chromosome; Biology","score_opus":0.16531898721272034,"score_gpt":0.4756816781265127,"score_spread":0.3103626909137923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2242698841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928543,0.00060609326,0.00001555794,0.00050189235,0.0008343841,0.003339129,0.00010522235,0.00001196618,0.0017314417],"genre_scores_gemma":[0.99511826,0.00014097031,0.0028794545,0.0004204945,0.0010702651,0.000079787904,0.000040094306,0.000088317596,0.0001623288],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9837135,0.0027188896,0.009817613,0.0010020061,0.0018430151,0.00090496935],"domain_scores_gemma":[0.9854756,0.0035595205,0.006543875,0.0008723664,0.0019088637,0.0016397972],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00813337,0.00065240683,0.0055396254,0.0008939025,0.000041709653,0.0000130758535,0.00052692386,0.0006584954,0.00005389032],"category_scores_gemma":[0.0037701805,0.00044197234,0.0006358697,0.0009940441,0.0004443854,0.00026970747,0.00019369653,0.0022197608,0.000007026949],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5964584,0.06605433,0.2907297,0.00012562831,0.00039629693,0.0042034253,0.0018142537,0.0004051867,0.00029076415,0.0000017663976,0.001099912,0.038420353],"study_design_scores_gemma":[0.41753092,0.4288896,0.14782687,0.000585551,0.00079898385,0.000048265054,0.0013289119,0.000035329842,0.0012363107,0.000011475314,0.0013983478,0.00030942872],"about_ca_topic_score_codex":0.00041747253,"about_ca_topic_score_gemma":0.0006627059,"teacher_disagreement_score":0.3628353,"about_ca_system_score_codex":0.000847958,"about_ca_system_score_gemma":0.0058539636,"threshold_uncertainty_score":0.9998032},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"nonrandomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2245384963","doi":"10.1200/jco.2007.25.18_suppl.15572","title":"A population-based study evaluating metastatic renal cell cancer (mRCC) patients treated with interferon (IFN) alone, first-line IFN then second-line sunitinib, or sunitinib alone","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Sunitinib; Medicine; Internal medicine; Population; Group B; Cancer; Renal cell carcinoma; Oncology; Gastroenterology","score_opus":0.2170691400457521,"score_gpt":0.47416104228890277,"score_spread":0.2570919022431507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2245384963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99585485,0.00018542445,0.00021794136,0.00085266045,0.00045348896,0.0015993483,0.000040009683,0.000028903454,0.0007673428],"genre_scores_gemma":[0.9923412,0.000033632456,0.004287348,0.0012410209,0.0007928439,0.00004178842,0.00012953025,0.000082329294,0.0010502969],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9915418,0.001327111,0.0047550574,0.0005158066,0.0012270313,0.0006331726],"domain_scores_gemma":[0.98610526,0.0067876643,0.0039707343,0.00045931985,0.0018880966,0.00078893744],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006258511,0.00051187316,0.0029019923,0.00047770166,0.00015094063,0.000026442034,0.00028461966,0.00029932355,0.0019136522],"category_scores_gemma":[0.0023410697,0.00030300836,0.0005021997,0.00050969166,0.00014836779,0.00017747047,0.000067256595,0.001421064,0.000022729439],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1165567,0.020505494,0.8014373,0.00016801532,0.0018660799,0.0044096615,0.0006012586,0.0010508217,0.00018418024,8.638026e-7,0.00033201178,0.052887574],"study_design_scores_gemma":[0.056126885,0.19098376,0.74565846,0.00043883122,0.0035363082,0.00015567133,0.00054274005,0.00060260063,0.001141651,0.000014503069,0.00050297554,0.00029560234],"about_ca_topic_score_codex":0.0009008279,"about_ca_topic_score_gemma":0.012405627,"teacher_disagreement_score":0.17047827,"about_ca_system_score_codex":0.0008336301,"about_ca_system_score_gemma":0.001968412,"threshold_uncertainty_score":0.9999422},"labels":[],"label_agreement":null},{"id":"W2246654777","doi":"10.1200/jco.2009.27.15_suppl.e16015","title":"Identification of factors predicting loss of renal differential function on the operated kidney after laparoscopic partial nephrectomy","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Nephrectomy; Renal function; Urology; Surgery; Kidney; Internal medicine","score_opus":0.07715690072910142,"score_gpt":0.3919120475108434,"score_spread":0.314755146781742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2246654777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99588484,0.00006865544,0.00021576685,0.0021788597,0.0010954118,0.00030458366,0.0000070499973,0.0000063925404,0.00023842459],"genre_scores_gemma":[0.9985234,0.000056916684,0.0000511786,0.00051427406,0.00073603634,0.0000054189663,0.0000075505427,0.000009272422,0.00009592156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960411,0.0005454113,0.0025926554,0.0001669975,0.00049021945,0.0001635845],"domain_scores_gemma":[0.9960185,0.00091758254,0.0021265724,0.00023666985,0.0004579464,0.00024268725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013364166,0.00014387224,0.0010438977,0.000115338466,0.000034576842,0.000008104523,0.00012586282,0.0002654058,0.00025154726],"category_scores_gemma":[0.0023833162,0.00007761363,0.000452886,0.00014837705,0.00017569598,0.00007986584,0.000019262774,0.0006282286,0.00000512752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05155927,0.0073194746,0.773709,0.00009301771,0.0016720443,0.000259973,0.0005273796,0.00015052804,0.14292872,0.00027179913,0.0023340867,0.019174693],"study_design_scores_gemma":[0.0055935406,0.019727038,0.9079032,0.0001969837,0.00093063625,0.000038170965,0.000058709727,0.00021952827,0.064227104,0.00010343105,0.00094208703,0.000059599253],"about_ca_topic_score_codex":0.000009336875,"about_ca_topic_score_gemma":0.0000031305392,"teacher_disagreement_score":0.13419417,"about_ca_system_score_codex":0.00010234475,"about_ca_system_score_gemma":0.0006221849,"threshold_uncertainty_score":0.3164992},"labels":[],"label_agreement":null},{"id":"W2246998135","doi":"","title":"AZD2171 (Cediranib) is active in first line metastatic renal cell carcinoma (RCC): Interim results of a phase II trial. A trial of the PMH Phase II Consortium.","year":2007,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Interim analysis; Internal medicine; Phases of clinical research; Renal cell carcinoma; Oncology; Gastroenterology; Neutropenia; Pharmacology; Urology; Surgery; Toxicity; Clinical trial","score_opus":0.06798462123839182,"score_gpt":0.3577161289842715,"score_spread":0.2897315077458797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2246998135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99069726,0.0026293213,0.00052116596,0.0010544333,0.0004208745,0.0033588794,0.00039467102,0.000017169388,0.0009062136],"genre_scores_gemma":[0.9979644,0.00019871694,0.00031589126,0.00076065154,0.00013721442,0.00012307758,0.00004376982,0.00006794143,0.00038838008],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965378,0.00022383942,0.001433485,0.00053118373,0.0007786946,0.00049499766],"domain_scores_gemma":[0.9976105,0.00018461658,0.00083703874,0.0009090086,0.00029732907,0.00016149026],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00066213234,0.00043722196,0.0010190917,0.00027948266,0.00010699359,0.000008735426,0.00030802377,0.00015877717,0.00009034412],"category_scores_gemma":[0.00007730072,0.00031648236,0.00054301077,0.00069064705,0.0002998187,0.000049997027,0.00014820273,0.0004206914,0.0000014222276],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.57498807,0.009970502,0.000023301147,0.00014985765,0.0006365476,0.000280615,0.0049818694,0.000030081845,0.392611,0.000012333199,0.00007405263,0.016241794],"study_design_scores_gemma":[0.39003795,0.022847785,0.00005909858,0.00014707465,0.0010766031,0.000011121463,0.00018074365,0.0001634828,0.5830034,0.000031517393,0.0022815603,0.00015965385],"about_ca_topic_score_codex":0.0006830527,"about_ca_topic_score_gemma":0.00028595945,"teacher_disagreement_score":0.19039243,"about_ca_system_score_codex":0.0004226743,"about_ca_system_score_gemma":0.0005822727,"threshold_uncertainty_score":0.9999287},"labels":[],"label_agreement":null},{"id":"W2248910050","doi":"10.1200/jco.2009.27.15_suppl.e16040","title":"Cardiovascular events (CVEs) associated with tyrosine kinase inhibitor (TKI) therapy in patients with metastatic renal cell carcinoma (mRCC) at a regional cancer center","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Medicine; Sunitinib; Heart failure; Internal medicine; Incidence (geometry); Renal cell carcinoma; Sorafenib; Cancer; Cardiology","score_opus":0.07257628835990974,"score_gpt":0.3557312884349298,"score_spread":0.28315500007502004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2248910050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947458,0.0018868948,0.0000097898155,0.0020966597,0.00024693678,0.00066894083,0.000013840047,0.000008394479,0.0003227347],"genre_scores_gemma":[0.9963912,0.00033396774,0.00075723405,0.0018240407,0.0003697601,0.00001457684,0.00003698979,0.000037928086,0.00023430662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952134,0.00083437626,0.0018462894,0.0004037597,0.001239969,0.00046221173],"domain_scores_gemma":[0.9963307,0.0004850824,0.0015385954,0.00034704575,0.0007765788,0.0005220257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015121889,0.00034484247,0.0022362852,0.00023119299,0.00005294724,0.000008212431,0.00016603443,0.00025749052,0.00008299545],"category_scores_gemma":[0.00025740356,0.00019862741,0.0007973098,0.00032077174,0.00015187732,0.0001409117,0.000031235704,0.000903201,0.0000061236683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030328197,0.009286149,0.9404518,0.00001740927,0.0015315013,0.0029510984,0.000114782735,0.00015022553,0.00009926664,0.0000019795677,0.0013280845,0.013739522],"study_design_scores_gemma":[0.06432213,0.046194363,0.884154,0.00030806678,0.000886813,0.0001295079,0.00001723136,0.000011213946,0.00041802903,0.000018584398,0.0033579345,0.00018210763],"about_ca_topic_score_codex":0.00006883166,"about_ca_topic_score_gemma":0.00012920433,"teacher_disagreement_score":0.056297764,"about_ca_system_score_codex":0.0013203841,"about_ca_system_score_gemma":0.0012753679,"threshold_uncertainty_score":0.8099791},"labels":[],"label_agreement":null},{"id":"W2251006715","doi":"10.1016/j.urology.2015.12.003","title":"Nivolumab: The New Second Line Treatment for Advanced Renal-cell Carcinoma Commentary on: Nivolumab Versus Everolimus in Advanced Renal-cell Carcinoma","year":2015,"lang":"en","type":"letter","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Nivolumab; Medicine; Everolimus; Renal cell carcinoma; Clinical endpoint; Internal medicine; Oncology; Adverse effect; Carcinoma; Urology; Progression-free survival; Immunotherapy; Randomized controlled trial; Overall survival; Cancer","score_opus":0.03346082888958314,"score_gpt":0.27254644748090484,"score_spread":0.2390856185913217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2251006715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54319334,0.012069744,0.00006128216,0.4234545,0.0030316093,0.008083417,0.00085715734,0.000184719,0.009064254],"genre_scores_gemma":[0.5940384,0.00017697865,0.0008989313,0.34632704,0.0067514866,0.0016936703,0.007805148,0.0005722524,0.041736037],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924936,0.00061382906,0.001496765,0.0023294382,0.0008993904,0.0021669192],"domain_scores_gemma":[0.9936757,0.0015572216,0.00087430555,0.0029647034,0.00031298847,0.00061509485],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.00035972113,0.0018887914,0.0026186956,0.00075679674,0.0002540155,0.000045850633,0.00086022617,0.001696334,0.0005439916],"category_scores_gemma":[0.00008319352,0.0014515325,0.0009873556,0.00043924898,0.00034054526,0.00013664033,0.00027129348,0.0026740031,0.00026880138],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025808055,0.0010061254,0.00038566612,0.00030581653,0.00036482513,0.005615518,0.0006623602,0.0007336819,0.0011554509,0.000003369747,0.9585682,0.005390907],"study_design_scores_gemma":[0.07691232,0.048566278,0.00048495736,0.00006095993,0.0016856763,0.00027182052,0.000112278634,0.00030923504,0.011801083,0.0001280041,0.8586124,0.0010549722],"about_ca_topic_score_codex":0.0010911041,"about_ca_topic_score_gemma":0.0016478562,"teacher_disagreement_score":0.09995581,"about_ca_system_score_codex":0.0037126332,"about_ca_system_score_gemma":0.0013291185,"threshold_uncertainty_score":0.9996269},"labels":[],"label_agreement":null},{"id":"W2252779129","doi":"10.5489/cuaj.2848","title":"Clinical outcomes following laparoscopic management of pT3 renal masses: A large, multi-institutional cohort","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Ottawa; McGill University; University of Calgary; University of Toronto; Dalhousie University; McMaster University; Cancer Care Ontario; Ottawa Hospital; University of Manitoba","funders":"Astellas Pharma; Canadian Urological Association; Pfizer; Amgen","keywords":"Medicine; Renal cell carcinoma; Cohort; Nephrectomy; Pathological; Stage (stratigraphy); Surgery; Progression-free survival; Retrospective cohort study; Median follow-up; Urology; Internal medicine; Kidney; Overall survival","score_opus":0.0555332816468834,"score_gpt":0.3242875494730252,"score_spread":0.26875426782614176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2252779129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99064654,0.000324393,0.000534628,0.0029484571,0.000821641,0.00038069425,0.000031192776,0.000024434035,0.0042880415],"genre_scores_gemma":[0.9908224,0.000051920964,0.006017501,0.0013890264,0.0001653822,0.000016077747,0.000046367506,0.000011979323,0.0014793492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740434,0.00023785388,0.0007845784,0.0002645243,0.00078750215,0.0005211842],"domain_scores_gemma":[0.99779177,0.00012768456,0.00036058077,0.0001712885,0.0002887121,0.001259956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020699145,0.00019305637,0.0006284381,0.00017364799,0.00017169683,0.000041873504,0.00014776735,0.0002586518,0.00015754269],"category_scores_gemma":[0.00069568836,0.00013744306,0.00049100386,0.00019828821,0.00004476969,0.00009839288,0.0000365903,0.0005133996,0.0000776859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040272877,0.00022405628,0.9941304,0.0000069775338,0.0010555102,0.0010540843,0.000026981907,0.000037641414,0.000004271246,0.0003233632,0.0027300522,0.00036642156],"study_design_scores_gemma":[0.0053138197,0.0003567617,0.969734,0.000037700465,0.00048114624,0.00007911064,0.00008917513,0.000092871785,0.000008918324,0.0001428917,0.023548773,0.000114808216],"about_ca_topic_score_codex":0.0003934884,"about_ca_topic_score_gemma":0.00035781518,"teacher_disagreement_score":0.024396343,"about_ca_system_score_codex":0.0018365289,"about_ca_system_score_gemma":0.00092683174,"threshold_uncertainty_score":0.56047654},"labels":[],"label_agreement":null},{"id":"W2252992087","doi":"10.1016/j.eururo.2013.12.042","title":"Re: Pazopanib Versus Sunitinib in Metastatic Renal-cell Carcinoma","year":2014,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Pazopanib; Sunitinib; Renal cell carcinoma; Oncology; Internal medicine; Urology","score_opus":0.057886416794818006,"score_gpt":0.2659248840158177,"score_spread":0.2080384672209997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2252992087","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17845295,0.0018325007,0.000034290642,0.39057207,0.0013398847,0.0012593913,0.000042792355,0.00019638674,0.4262697],"genre_scores_gemma":[0.580832,0.000036994763,0.00029004808,0.4075616,0.0025976566,0.000033305925,0.0012173944,0.0003061499,0.007124872],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940719,0.0024746682,0.0008530631,0.0011094474,0.00047609262,0.0010148073],"domain_scores_gemma":[0.9970093,0.0008626808,0.00038225634,0.0014382361,0.00010560838,0.00020194368],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007183524,0.00075622933,0.0012377943,0.0006368319,0.00005814301,0.000028087712,0.0004432004,0.00037411976,0.00078584603],"category_scores_gemma":[0.0002248281,0.0006720451,0.00034455804,0.0002707435,0.00022497032,0.000035087756,0.0002058171,0.0029588614,0.0032714093],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010761573,0.00014955329,0.0009454117,0.00032877224,0.00015600357,0.101277545,0.00021509052,0.000009707603,0.00029241032,0.000010647445,0.89498395,0.0005547605],"study_design_scores_gemma":[0.008571446,0.0042266417,0.00806792,0.00003986071,0.0010738445,0.0006565129,0.000026340978,0.000023890865,0.00036603076,0.000018069293,0.9763964,0.0005330719],"about_ca_topic_score_codex":0.000098943885,"about_ca_topic_score_gemma":0.0000370128,"teacher_disagreement_score":0.41914484,"about_ca_system_score_codex":0.00023286787,"about_ca_system_score_gemma":0.00016420966,"threshold_uncertainty_score":0.99957305},"labels":[],"label_agreement":null},{"id":"W2254781616","doi":"10.1016/j.mpdhp.2016.01.006","title":"Handling, sampling and stage evaluation of renal cell carcinoma: a practical guide","year":2016,"lang":"en","type":"article","venue":"Diagnostic histopathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Adipose capsule of kidney; Renal sinus; Renal vein; Nephrectomy; Renal cell carcinoma; Stage (stratigraphy); Medicine; Kidney; Pathology; Histology; Clear cell; Fascia; Anatomy; Radiology; Biology; Internal medicine","score_opus":0.0679237830608081,"score_gpt":0.3453575806162532,"score_spread":0.2774337975554451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2254781616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880501,0.0022049712,0.0037173394,0.00067549973,0.0001470144,0.00050379924,0.000018599227,0.000021303136,0.004661373],"genre_scores_gemma":[0.9943767,0.00008990303,0.0043505672,0.000087492524,0.000080451544,0.000074823016,0.000015295316,0.000021457794,0.0009032709],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983623,0.0002361262,0.0003958829,0.00037758204,0.00038078302,0.0002473078],"domain_scores_gemma":[0.99711806,0.0018693472,0.00019378122,0.0003521009,0.00031921754,0.00014751875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095345505,0.00015836094,0.00036573398,0.0001398976,0.00004762091,0.0000037713164,0.00004196991,0.00011853342,0.00027435372],"category_scores_gemma":[0.0059436313,0.00010944772,0.000065925895,0.000067612054,0.00022706286,0.000051303312,0.000051607003,0.00009929586,0.00003512914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040648898,0.0007950136,0.5670662,0.0002453176,0.000028539958,0.0019453845,0.001201999,0.000015711084,0.40360326,0.00085068046,0.0016165262,0.022224909],"study_design_scores_gemma":[0.00825196,0.0020873016,0.89955693,0.00019838996,0.0014543883,0.0013696243,0.0001409176,0.00017086507,0.079910316,0.00033892103,0.006260219,0.00026017643],"about_ca_topic_score_codex":0.00007149816,"about_ca_topic_score_gemma":0.000018589742,"teacher_disagreement_score":0.33249074,"about_ca_system_score_codex":0.00024605237,"about_ca_system_score_gemma":0.00037066353,"threshold_uncertainty_score":0.71155113},"labels":[],"label_agreement":null},{"id":"W2255703287","doi":"10.1111/hdi.12390","title":"Use of mammalian target of rapamycin inhibitors after failure of tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma undergoing hemodialysis: A single‐center experience with four cases","year":2016,"lang":"en","type":"article","venue":"Hemodialysis International","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Temsirolimus; Sunitinib; Everolimus; Sorafenib; Renal cell carcinoma; Hemodialysis; Internal medicine; Adverse effect; Oncology; Cancer; Progressive disease; Targeted therapy; Surgery; Disease; PI3K/AKT/mTOR pathway; Discovery and development of mTOR inhibitors; Hepatocellular carcinoma","score_opus":0.020166023533979262,"score_gpt":0.22291512191904678,"score_spread":0.20274909838506752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2255703287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984347,0.00007511954,0.00046084082,0.00016238754,0.000078473015,0.00050455244,0.00020561737,0.000011403154,0.0000669068],"genre_scores_gemma":[0.99092185,0.000005116808,0.008588954,0.00003558194,0.00005855163,0.00008118744,0.00012125318,0.00004904759,0.00013844635],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967437,0.00014021665,0.0010439405,0.000552593,0.0011966078,0.00032293503],"domain_scores_gemma":[0.9976721,0.00028036206,0.00067930383,0.0005028426,0.0007027728,0.00016261506],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014486862,0.0003915554,0.0008459541,0.00084715476,0.000022983886,0.000019330835,0.00017027427,0.00008104262,0.00021700443],"category_scores_gemma":[0.00016235317,0.0002465314,0.0002814848,0.0005440132,0.0003015183,0.00042243372,0.0000952969,0.000110183326,0.000002787307],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004904565,0.0018088494,0.94882,0.00017010082,0.000356564,0.0003325372,0.00092567294,0.00022676204,0.041937076,0.000004928564,0.000045629866,0.00046730452],"study_design_scores_gemma":[0.010539693,0.0018183036,0.3345715,0.001161535,0.000527671,0.00005421333,0.00031895243,0.00006541484,0.65058845,0.000007797146,0.000042241714,0.00030424283],"about_ca_topic_score_codex":0.00027726576,"about_ca_topic_score_gemma":0.00049094006,"teacher_disagreement_score":0.6142485,"about_ca_system_score_codex":0.00039191588,"about_ca_system_score_gemma":0.00018627552,"threshold_uncertainty_score":0.9999987},"labels":[],"label_agreement":null},{"id":"W2257959855","doi":"","title":"Robot-assisted versus laparoscopic partial nephrectomy for localized renal tumors: a meta-analysis.","year":2014,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Perioperative; Odds ratio; Meta-analysis; Incidence (geometry); Confidence interval; Surgery; Laparoscopy; Urology; Kidney; Internal medicine","score_opus":0.12076409942472598,"score_gpt":0.2994200182623531,"score_spread":0.1786559188376271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2257959855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92130256,0.004487798,0.029270353,0.0077807605,0.0012885545,0.01809419,0.00012584054,0.0009228873,0.016727028],"genre_scores_gemma":[0.97819453,0.0000031752586,0.003759825,0.00041188952,0.00030523023,0.014784294,0.00017079372,0.00004214224,0.0023281418],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99747324,0.00019009443,0.00054654735,0.00061197026,0.00047670727,0.0007014476],"domain_scores_gemma":[0.9980796,0.00038844586,0.00020865553,0.0007253853,0.000138519,0.0004594171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006554563,0.00033650536,0.0017126042,0.00026616434,0.00009319594,0.00005715071,0.00015006837,0.00011533443,0.00019830791],"category_scores_gemma":[0.00038045007,0.00024115627,0.0017980974,0.0006038393,0.00008436966,0.000070196926,0.000044108547,0.00013838518,0.000033027227],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031687964,0.0026415829,0.013506341,0.0005929614,0.8309364,0.00031339208,0.00026375332,0.0016847346,0.0020746992,0.002170209,0.010526876,0.10360111],"study_design_scores_gemma":[0.02751039,0.000940945,0.21140464,0.0000063121356,0.6399131,0.000028905852,0.000022096952,0.002163681,0.033121362,0.000120239,0.08419342,0.00057490886],"about_ca_topic_score_codex":0.00010965139,"about_ca_topic_score_gemma":0.00009121897,"teacher_disagreement_score":0.1978983,"about_ca_system_score_codex":0.00019505393,"about_ca_system_score_gemma":0.000062148516,"threshold_uncertainty_score":0.9834068},"labels":[],"label_agreement":null},{"id":"W2261694353","doi":"10.1002/cam4.631","title":"Micro<scp>RNA</scp>‐194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma","year":2016,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre; York University; University of Toronto; St. Michael's Hospital","funders":"Kidney Foundation of Canada; Prostate Cancer Canada; Movember Foundation","keywords":"Renal cell carcinoma; Chromophobe cell; Medicine; Oncocytoma; Kidney cancer; Nephrectomy; Oncology; Clear cell; Internal medicine; Clear cell renal cell carcinoma; Stage (stratigraphy); Cancer; Carcinoma; Pathology; Cancer research; Kidney; Biology","score_opus":0.02497069384735357,"score_gpt":0.26905973117137905,"score_spread":0.24408903732402548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2261694353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96056825,0.012090508,0.000105346066,0.0075365165,0.0004441105,0.0020246839,0.000091488735,0.000066387816,0.017072726],"genre_scores_gemma":[0.9646133,0.00085018604,0.0007709782,0.0021592632,0.0010446061,0.0008159087,0.000032304102,0.000117899945,0.029595524],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970168,0.00007387967,0.0006858581,0.0008673785,0.00048807194,0.0008680296],"domain_scores_gemma":[0.99780643,0.00047155,0.00025451812,0.0006015794,0.00025639305,0.0006095465],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040666995,0.00048846187,0.0008705634,0.00032223907,0.00007233333,0.000010079873,0.00023364264,0.0002273655,0.00075768423],"category_scores_gemma":[0.00017998446,0.00030039527,0.00022198904,0.00041465592,0.0002477413,0.00009532104,0.00007213349,0.00025598772,0.00008816696],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085683505,0.0004921843,0.24032794,0.0010642074,0.00010735788,0.00040580065,0.0019285869,6.104859e-7,0.6124184,0.000015716574,0.13025478,0.012127579],"study_design_scores_gemma":[0.019312529,0.0036400377,0.15355745,0.001264639,0.00061075244,0.000063629595,0.00047220004,0.000035429228,0.712781,0.00007196356,0.10797936,0.00021096932],"about_ca_topic_score_codex":0.00046513457,"about_ca_topic_score_gemma":0.000064387525,"teacher_disagreement_score":0.10036263,"about_ca_system_score_codex":0.0008601715,"about_ca_system_score_gemma":0.0004695131,"threshold_uncertainty_score":0.9999448},"labels":[],"label_agreement":null},{"id":"W2262066536","doi":"10.1016/j.eururo.2016.01.050","title":"Complete Responses with Targeted Therapy in Metastatic Renal Cell Carcinoma: Balancing Efficacy and Toxicity","year":2016,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Sunitinib; Pazopanib; Sorafenib; Bevacizumab; Renal cell carcinoma; Oncology; Internal medicine; Angiogenesis; Vascular endothelial growth factor; Temsirolimus; Toxicity; Surgery; Chemotherapy; VEGF receptors; Hepatocellular carcinoma","score_opus":0.03138310968950889,"score_gpt":0.24227991991917194,"score_spread":0.21089681022966306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2262066536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88109356,0.0025566574,0.000050913008,0.10868947,0.000104479084,0.0009091754,0.00008429457,0.00007346522,0.0064379913],"genre_scores_gemma":[0.8156681,0.0000944208,0.0004759633,0.18049479,0.0008577566,0.000019177436,0.00022304378,0.00017504075,0.0019917372],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99540275,0.0021092005,0.00051065255,0.00091560784,0.0003273281,0.00073444896],"domain_scores_gemma":[0.997919,0.0008689438,0.0002721984,0.0007153833,0.00007752523,0.00014695464],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005047285,0.00059903343,0.000990476,0.0004528865,0.00006831158,0.000022544762,0.00020421534,0.00017751145,0.0001602533],"category_scores_gemma":[0.00007671558,0.000377477,0.00010086374,0.00015816648,0.00031339008,0.000037273854,0.00010732757,0.0012632543,0.00014666525],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025180057,0.00064920954,0.057945244,0.0007246468,0.0009903442,0.27523023,0.0019737284,0.000014049084,0.22760534,0.000009287597,0.4042787,0.0053991703],"study_design_scores_gemma":[0.019247996,0.012563652,0.46639702,0.00014156965,0.0004966947,0.00272304,0.00001168093,0.000015550097,0.0043735923,0.000014927982,0.49323598,0.00077828777],"about_ca_topic_score_codex":0.000043862045,"about_ca_topic_score_gemma":0.000007432446,"teacher_disagreement_score":0.4084518,"about_ca_system_score_codex":0.000122059086,"about_ca_system_score_gemma":0.0001500271,"threshold_uncertainty_score":0.99986774},"labels":[],"label_agreement":null},{"id":"W2262509800","doi":"10.1200/jco.2007.25.18_suppl.5093","title":"Phase II study of the angiogenesis inhibitor AZD2171 in first line, progressive, unresectable, advanced metastatic renal cell carcinoma (RCC): A trial of the PMH Phase II Consortium","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Renal cell carcinoma; Progressive disease; Clinical endpoint; Phases of clinical research; Internal medicine; Adverse effect; Gastroenterology; Performance status; Toxicity; Response Evaluation Criteria in Solid Tumors; Surgery; Urology; Cancer; Clinical trial; Chemotherapy","score_opus":0.10328772005201765,"score_gpt":0.44693138477118566,"score_spread":0.343643664719168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2262509800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99256355,0.0014014519,0.000019122623,0.0012421815,0.0015213585,0.0027910832,0.000019891213,0.0000050008193,0.00043637067],"genre_scores_gemma":[0.9980145,0.000058646598,0.0007232591,0.00019613943,0.000669652,0.00003558667,0.0000021067342,0.00003246838,0.000267639],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9913723,0.0013012448,0.0054094377,0.0003629311,0.0010843265,0.00046979907],"domain_scores_gemma":[0.9893631,0.0033190495,0.0054412093,0.0006859986,0.0008248734,0.00036580628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050898967,0.00032626747,0.0025466543,0.00030662096,0.00016080031,0.000005225006,0.00052117114,0.0002748284,0.00007620027],"category_scores_gemma":[0.0039972547,0.00016734855,0.001210018,0.0008261062,0.0005370249,0.00010311171,0.0003169033,0.0010500667,9.838326e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.56686234,0.27569807,0.057527687,0.00023352994,0.0013219514,0.0046503497,0.0020698307,0.0002393067,0.015504838,0.0000096212225,0.0010223183,0.07486017],"study_design_scores_gemma":[0.5176642,0.37898088,0.04756337,0.000281886,0.0026099607,0.00032790535,0.0009994883,0.000066886176,0.04980574,0.00004210643,0.0014874118,0.00017017174],"about_ca_topic_score_codex":0.00006777198,"about_ca_topic_score_gemma":0.0003738741,"teacher_disagreement_score":0.10328281,"about_ca_system_score_codex":0.00028786034,"about_ca_system_score_gemma":0.0021814057,"threshold_uncertainty_score":0.6824276},"labels":[],"label_agreement":null},{"id":"W2263184680","doi":"10.1200/jco.2007.25.18_suppl.5096","title":"The Advanced Renal Cell Carcinoma Sorafenib (ARCCS) expanded access trial: Long-term outcomes in first-line patients (pts)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Sorafenib; Renal cell carcinoma; Internal medicine; Nephrectomy; Placebo; Progression-free survival; Surgery; Oncology; Urology; Overall survival; Kidney; Hepatocellular carcinoma; Pathology","score_opus":0.16033879753363142,"score_gpt":0.4765897460965622,"score_spread":0.3162509485629308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2263184680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905094,0.00056819554,0.00008127039,0.0033311131,0.0026546407,0.001039076,0.000002894314,0.000011493115,0.001801907],"genre_scores_gemma":[0.9963884,0.000535268,0.00045380177,0.0009038075,0.0009520499,0.000015335736,0.000009417129,0.000036617184,0.00070533814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99302596,0.0005078092,0.0046676113,0.00035182922,0.00083095324,0.00061583763],"domain_scores_gemma":[0.98832756,0.007119574,0.002840213,0.0004814923,0.0006063985,0.00062478293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052541313,0.00031419357,0.0021352316,0.00026301143,0.00011204369,0.00003089447,0.0005616186,0.00047185516,0.00007443845],"category_scores_gemma":[0.003598199,0.00017438471,0.0009196323,0.00026086956,0.00026173153,0.00022697417,0.00017569237,0.0014280496,0.00002166134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.106713004,0.0049939463,0.7817747,0.00002706175,0.00013600594,0.0021115001,0.000068369045,0.000016747385,0.000036203146,0.0000049715186,0.00030228705,0.1038152],"study_design_scores_gemma":[0.1493548,0.023796026,0.82283515,0.00006055443,0.00026921928,0.00006849714,0.00003341703,0.000005747074,0.00070476485,0.00009018656,0.0026498006,0.00013186043],"about_ca_topic_score_codex":0.000029139583,"about_ca_topic_score_gemma":0.0007512353,"teacher_disagreement_score":0.10368334,"about_ca_system_score_codex":0.000635883,"about_ca_system_score_gemma":0.0009756761,"threshold_uncertainty_score":0.71112025},"labels":[],"label_agreement":null},{"id":"W2263864814","doi":"10.1158/1078-0432.ccr-15-2631","title":"Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":228,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); University Hospital Foundation","funders":"National Cancer Institute","keywords":"TSC1; PI3K/AKT/mTOR pathway; TSC2; Medicine; Cancer; Cancer research; Oncology; Internal medicine; Renal cell carcinoma; Sirolimus; Biology; Genetics; Apoptosis","score_opus":0.1292294006372624,"score_gpt":0.4265416049270228,"score_spread":0.2973122042897604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2263864814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948081,0.00018806302,0.000008030824,0.0032047895,0.00002633684,0.0015192825,0.00007337772,0.000014014381,0.00015802913],"genre_scores_gemma":[0.99788713,0.000019958416,0.00020820842,0.0001647172,0.000031070358,0.00039954804,0.000017150533,0.00004081142,0.001231408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99586356,0.0013629808,0.00056033087,0.000651039,0.00093951524,0.00062258984],"domain_scores_gemma":[0.9952091,0.0032322335,0.000111311325,0.00040881045,0.0005446638,0.0004938742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026766956,0.00019277105,0.000563789,0.0005157784,0.00006618861,0.000022865446,0.00012895491,0.00010025024,0.000109784545],"category_scores_gemma":[0.0021251913,0.0001074163,0.00004835896,0.0009814914,0.00039521215,0.00008360338,0.00009187741,0.0005369278,0.000029877703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025249729,0.0009390425,0.9702409,0.000035959718,0.00004952335,0.00049653713,0.0002804055,0.0000057975317,0.00046581094,0.0000020168438,0.00031133572,0.0019229212],"study_design_scores_gemma":[0.019044887,0.006700673,0.9721551,0.0006675386,0.000052106774,0.000001930802,0.00015491614,0.000007014007,0.00091439846,0.000024862009,0.00013181138,0.00014474338],"about_ca_topic_score_codex":0.0005076406,"about_ca_topic_score_gemma":0.002692131,"teacher_disagreement_score":0.006204843,"about_ca_system_score_codex":0.00083780225,"about_ca_system_score_gemma":0.00083249854,"threshold_uncertainty_score":0.43803096},"labels":[],"label_agreement":null},{"id":"W2264210466","doi":"10.1016/j.juro.2015.09.067","title":"Active Surveillance for Renal Neoplasms with Oncocytic Features is Safe","year":2015,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Renal oncocytoma; Kidney; Pathology; Internal medicine; Oncocytoma","score_opus":0.029310623622311887,"score_gpt":0.2801409165364182,"score_spread":0.2508302929141063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2264210466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98323023,0.0019168822,0.0005682434,0.0114935115,0.00017130763,0.0002728175,0.0000066436064,0.000005934146,0.0023344352],"genre_scores_gemma":[0.9966284,0.00007272254,0.00080725533,0.0013941986,0.00031855304,0.00000345168,0.0000021185847,0.000016269034,0.0007570419],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9991229,0.00013434936,0.00021195083,0.00008439504,0.0002469387,0.00019944261],"domain_scores_gemma":[0.9985897,0.00040108946,0.00028936975,0.00019079926,0.0003707652,0.00015827359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052221515,0.00011973487,0.00035860177,0.000070963484,0.000038722697,0.0000049150394,0.00012254485,0.00006707144,0.000022671808],"category_scores_gemma":[0.00012421698,0.000056493587,0.00008549735,0.00007806049,0.00011388058,0.00003856259,0.00001786044,0.0002711768,0.000009210518],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50825006,0.0016210296,0.057653546,0.00019307363,0.008023808,0.003925044,0.024913622,0.004942686,0.027362064,0.000677527,0.3190573,0.043380238],"study_design_scores_gemma":[0.058933653,0.13262184,0.44268137,0.00014670477,0.0043752855,0.11638637,0.0023129203,0.00051795953,0.075163946,0.005239495,0.16093956,0.00068090175],"about_ca_topic_score_codex":0.000022631439,"about_ca_topic_score_gemma":0.000042796575,"teacher_disagreement_score":0.44931644,"about_ca_system_score_codex":0.00013664836,"about_ca_system_score_gemma":0.00036425347,"threshold_uncertainty_score":0.23037416},"labels":[],"label_agreement":null},{"id":"W2267025725","doi":"10.5489/cuaj.61","title":"Collaborations in renal cell carcinoma research","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Canadian Urological Association","funders":"","keywords":"Renal cell carcinoma; Medicine; Temsirolimus; Sunitinib; Sorafenib; Disease; Malignancy; Internal medicine; Biology","score_opus":0.060832613365940764,"score_gpt":0.29588494629444684,"score_spread":0.23505233292850608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2267025725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9594649,0.0008389133,0.0000039659535,0.013399585,0.00019793939,0.0002472178,0.000013560202,0.000009085121,0.025824836],"genre_scores_gemma":[0.9956134,0.000026645877,0.00024916272,0.0009637231,0.00069990463,0.000020521991,0.000020332984,0.000012263677,0.0023940348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974528,0.0004971289,0.0003330735,0.00014970997,0.00060077413,0.0009665221],"domain_scores_gemma":[0.99768925,0.00024773984,0.00010916625,0.00012858407,0.00050017587,0.0013251158],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022033968,0.00011229954,0.00021940206,0.00054281484,0.00029507643,0.00006705101,0.000094575036,0.00025182636,0.0010081407],"category_scores_gemma":[0.00076250697,0.000092345144,0.000082064704,0.00078050164,0.000035566492,0.00014426127,0.000015907806,0.0010306508,0.00029237327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034064415,0.00012421106,0.976477,0.0000026921368,0.000013066769,0.00018667751,0.00023997542,0.000011572538,0.0007275062,0.0002018443,0.021704404,0.00027697225],"study_design_scores_gemma":[0.000910368,0.0003228338,0.95030946,0.000005046102,0.000025455074,0.00017152392,0.0001780214,0.000022721804,0.00048370977,0.00016033805,0.0473285,0.00008202237],"about_ca_topic_score_codex":0.0018853203,"about_ca_topic_score_gemma":0.0018284352,"teacher_disagreement_score":0.036148515,"about_ca_system_score_codex":0.0046958015,"about_ca_system_score_gemma":0.0012285331,"threshold_uncertainty_score":0.99990505},"labels":[],"label_agreement":null},{"id":"W2267533929","doi":"10.1200/jco.2015.33.15_suppl.4508","title":"Dose analysis of ASSURE (E2805): Adjuvant sorafenib or sunitinib for unfavorable renal carcinoma, an ECOG-ACRIN-led, NCTN phase 3 trial.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Sunitinib; Rash; Renal cell carcinoma; Sorafenib; Adverse effect; Discontinuation; Placebo; Internal medicine; Clinical endpoint; Toxicity; Urology; Adjuvant; Neutropenia; Surgery; Randomized controlled trial; Hepatocellular carcinoma; Pathology","score_opus":0.38941716373687607,"score_gpt":0.5368922467804587,"score_spread":0.1474750830435826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2267533929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99232846,0.00063388934,0.00046620815,0.0019691314,0.0014334995,0.0010777195,0.00008572499,0.000017333146,0.0019880023],"genre_scores_gemma":[0.9862576,0.0001479863,0.00936885,0.0007034913,0.0020358758,0.000032481694,0.00010318009,0.000049396644,0.0013011228],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9915522,0.0013213548,0.0052009523,0.00048038567,0.0008986953,0.00054642296],"domain_scores_gemma":[0.9870572,0.0039241635,0.0042295544,0.0006982887,0.0024414463,0.0016493099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00949103,0.00037685074,0.005178286,0.00078901794,0.00006348393,0.00002180559,0.00040669774,0.0006651135,0.00055752724],"category_scores_gemma":[0.007726329,0.00024037507,0.0021036041,0.000832449,0.00031663998,0.0002605648,0.00007441494,0.0009514784,0.000013209568],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84056187,0.024945095,0.018749004,0.00012330867,0.010591934,0.005015403,0.00051975297,0.00043218327,0.0014351673,0.00009839158,0.012683799,0.084844105],"study_design_scores_gemma":[0.5278747,0.31278735,0.03730462,0.00011951876,0.03672733,0.0007524098,0.001218934,0.00313338,0.0024396537,0.00034168654,0.07685633,0.00044410265],"about_ca_topic_score_codex":0.000121576064,"about_ca_topic_score_gemma":0.00037958828,"teacher_disagreement_score":0.3126872,"about_ca_system_score_codex":0.0004323811,"about_ca_system_score_gemma":0.006534469,"threshold_uncertainty_score":0.9990976},"labels":[],"label_agreement":null},{"id":"W2272378317","doi":"10.2214/ajr.15.14932","title":"Comparison of Contrast-Enhanced Multiphase Renal Protocol CT Versus MRI for Diagnosis of Papillary Renal Cell Carcinoma","year":2016,"lang":"en","type":"article","venue":"American Journal of Roentgenology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Papillary renal cell carcinomas; Renal cell carcinoma; Contrast (vision); Radiology; Intravenous contrast; Protocol (science); Nuclear medicine; Computed tomography; Internal medicine; Pathology","score_opus":0.033807752153940517,"score_gpt":0.33924994377278633,"score_spread":0.30544219161884584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2272378317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844216,0.00029270005,0.0035220108,0.0006394277,0.00015971919,0.010719597,0.00004573581,0.000008591317,0.0001905803],"genre_scores_gemma":[0.9900319,0.000055406083,0.0063922643,0.000042906388,0.00014826332,0.0032394577,0.0000048717375,0.00003749703,0.0000474532],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972628,0.00020789666,0.0013882986,0.00027991005,0.00040814898,0.00045294012],"domain_scores_gemma":[0.9954109,0.0008117688,0.0024214904,0.00037844694,0.0006972888,0.0002801073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026450222,0.00028204668,0.0015357882,0.00032724172,0.00003970425,0.0000031883185,0.00024643616,0.00005966557,0.0001284866],"category_scores_gemma":[0.00022527098,0.00018155546,0.000482399,0.00020971867,0.000700581,0.000071595896,0.000048647416,0.00018890342,0.0000036704919],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04047693,0.0024746128,0.22378519,0.00025755697,0.00085548527,0.00029963272,0.0005127116,0.00008575083,0.6485852,0.000019217592,0.0017551078,0.08089262],"study_design_scores_gemma":[0.025151048,0.04864314,0.020309784,0.00021590778,0.00056809525,0.00019432156,0.0005193142,0.0000222807,0.9022867,0.000015344875,0.0019255299,0.00014852654],"about_ca_topic_score_codex":0.000065005814,"about_ca_topic_score_gemma":0.000013332737,"teacher_disagreement_score":0.25370154,"about_ca_system_score_codex":0.00023288856,"about_ca_system_score_gemma":0.00035255877,"threshold_uncertainty_score":0.7403617},"labels":[],"label_agreement":null},{"id":"W2273363326","doi":"10.5489/cuaj.3278","title":"A single-centre experience with tumour tract seeding associated with needle manipulation of renal cell carcinomas","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Percutaneous; Renal cell carcinoma; Biopsy; Complication; Radiology; Percutaneous biopsy; Seeding; Carcinoma; Surgery; Pathology","score_opus":0.04250938341732463,"score_gpt":0.21939489103041518,"score_spread":0.17688550761309055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2273363326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99250793,0.00010924841,0.00007281286,0.0019196933,0.00007061639,0.00026589943,0.000012133158,0.000024167317,0.00501747],"genre_scores_gemma":[0.9985153,0.0000016691408,0.00032587536,0.0002818485,0.00015331552,0.000006049401,0.00003730051,0.000022180087,0.0006564749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789834,0.00016175199,0.00039872117,0.00023378979,0.0007855497,0.0005218618],"domain_scores_gemma":[0.99732,0.000114832204,0.0006074564,0.000107611966,0.00077280996,0.0010773096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047635054,0.00020780429,0.0003956575,0.00021406946,0.00013818254,0.00006425926,0.00009708206,0.00019843069,0.0001101794],"category_scores_gemma":[0.0004225222,0.00014328702,0.00009207449,0.00038819062,0.00004898552,0.0001721287,0.00000934874,0.00043412612,0.0000081326625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002531704,0.00023340694,0.9934584,0.0000046458986,0.00008789974,0.0006018737,0.0014429834,0.0005149602,0.0026310831,0.000012274733,0.0006390487,0.00012026865],"study_design_scores_gemma":[0.0036169193,0.002965431,0.98700917,0.00007362262,0.00026546017,0.00051067903,0.0014406281,0.0004533096,0.0027768447,0.000034971352,0.00064541487,0.00020753698],"about_ca_topic_score_codex":0.00085508975,"about_ca_topic_score_gemma":0.001060054,"teacher_disagreement_score":0.006449202,"about_ca_system_score_codex":0.003154261,"about_ca_system_score_gemma":0.00083576335,"threshold_uncertainty_score":0.8248283},"labels":[],"label_agreement":null},{"id":"W2275444707","doi":"","title":"Ablation radioguidée des masses rénales","year":2015,"lang":"fr","type":"dissertation","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Humanities; Gynecology; Philosophy","score_opus":0.051788811667247185,"score_gpt":0.3208507508852508,"score_spread":0.2690619392180036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2275444707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6766174,0.04386198,0.00022114495,0.00015117163,0.0017753101,0.00078970555,0.000016582057,0.00010628221,0.2764604],"genre_scores_gemma":[0.76836365,0.0016742535,0.0077520185,0.00006842328,0.001200942,0.000086303895,0.0046542482,0.00010859733,0.21609154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997161,0.00015354968,0.00068784656,0.00059650885,0.00080918305,0.00059191923],"domain_scores_gemma":[0.9976836,0.00020511994,0.00027956595,0.00048668493,0.0008064544,0.00053859083],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00038321488,0.0006231155,0.0007708977,0.00032161697,0.00016864172,0.00007384609,0.0001505999,0.0005245539,0.0030103198],"category_scores_gemma":[0.00030086245,0.0005193714,0.00029813428,0.00033780688,0.00016514219,0.00021497378,0.000022477167,0.00030199648,0.002732662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025627692,0.0022184104,0.59993136,0.008970698,0.0034886734,0.0021708442,0.021382755,0.0006876099,0.038003232,0.0144989425,0.05570074,0.250384],"study_design_scores_gemma":[0.005519265,0.0031360097,0.799699,0.0043901782,0.005838346,0.00054162106,0.020110708,0.0024235416,0.105857536,0.007628819,0.043189853,0.0016651349],"about_ca_topic_score_codex":0.0019511987,"about_ca_topic_score_gemma":0.0014898914,"teacher_disagreement_score":0.24871886,"about_ca_system_score_codex":0.0015089003,"about_ca_system_score_gemma":0.00096363685,"threshold_uncertainty_score":0.99972576},"labels":[],"label_agreement":null},{"id":"W2278320001","doi":"10.5489/cuaj.3197","title":"Robotic partial nephrectomy for renal tumours in obese patients: Perioperative outcomes in a multi-institutional analysis","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Body mass index; Perioperative; Obesity; Internal medicine; Urology; Gastroenterology; Surgery; Kidney","score_opus":0.04085954618562309,"score_gpt":0.2784764518779703,"score_spread":0.23761690569234722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2278320001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932061,0.000114792085,0.00044216248,0.0052144052,0.00017477035,0.0005893228,0.000038290375,0.000009328493,0.00021082484],"genre_scores_gemma":[0.9968223,0.000005799569,0.0014593125,0.001120443,0.0001030953,0.00010602788,0.00014407323,0.000008681806,0.00023024499],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980091,0.00024329005,0.0005311474,0.0002576736,0.00042177786,0.0005370337],"domain_scores_gemma":[0.99828213,0.00014906186,0.00019341244,0.00008667791,0.00044306033,0.0008456366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074770156,0.00019242233,0.0005978821,0.00070160447,0.000120056335,0.00006680717,0.00009091745,0.00019209017,0.000089785535],"category_scores_gemma":[0.0022096192,0.00013830034,0.00027718002,0.0006126896,0.000039049803,0.00014478865,0.000012008218,0.0004401623,0.000015453135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000164659,0.0002981763,0.98768514,0.0000017771428,0.00025111,0.00018870585,0.00031903887,0.010642837,0.00000647134,0.000060163173,0.00017172807,0.00021021528],"study_design_scores_gemma":[0.00711369,0.0005120631,0.98379934,0.000010896438,0.00030571962,0.000020253685,0.000114494214,0.0066384776,0.000010835625,0.00007356202,0.0012657131,0.00013498316],"about_ca_topic_score_codex":0.0026153629,"about_ca_topic_score_gemma":0.026898917,"teacher_disagreement_score":0.024283554,"about_ca_system_score_codex":0.005496039,"about_ca_system_score_gemma":0.0012680035,"threshold_uncertainty_score":0.9983217},"labels":[],"label_agreement":null},{"id":"W2281042985","doi":"10.1007/s00345-016-1767-9","title":"Impact of smoking status on survival after cytoreductive nephrectomy for metastatic renal cell carcinoma","year":2016,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Proportional hazards model; Nephrectomy; Cohort; Logistic regression; Smoking cessation; Nephrology; Kidney; Pathology","score_opus":0.025706454171712394,"score_gpt":0.2970271537553575,"score_spread":0.2713206995836451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2281042985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99601287,0.0014480831,0.00047405064,0.0005686274,0.00034231512,0.00030796754,0.000046699915,0.0000050294907,0.0007943777],"genre_scores_gemma":[0.9979038,0.00004250801,0.0012012387,0.00009139882,0.00031443665,0.000014604564,0.0000028729798,0.000036517573,0.0003926034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981942,0.00019411447,0.000624138,0.00020703571,0.00032463492,0.00045586828],"domain_scores_gemma":[0.99781734,0.00068781467,0.00060788327,0.00024337544,0.00037273948,0.00027087913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037492233,0.00023441651,0.0007539107,0.0005921459,0.00002596599,0.0000053609124,0.000100196376,0.000051833867,0.00030780717],"category_scores_gemma":[0.00011762323,0.00012844137,0.0005740195,0.0001722402,0.00013593615,0.000081858,0.000024816756,0.00022284371,0.0000053653753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05649673,0.0014327322,0.79322726,0.00011956641,0.0022185394,0.0018724093,0.00076488854,0.00013987186,0.12309569,0.00016453907,0.0016451298,0.018822648],"study_design_scores_gemma":[0.012108521,0.0191528,0.9397212,0.000077201556,0.0013097058,0.0006090139,0.000040449955,0.000007294059,0.023498042,0.00051138125,0.002795167,0.00016921322],"about_ca_topic_score_codex":0.000036490197,"about_ca_topic_score_gemma":0.000019615558,"teacher_disagreement_score":0.14649396,"about_ca_system_score_codex":0.00040480559,"about_ca_system_score_gemma":0.00039945362,"threshold_uncertainty_score":0.5237687},"labels":[],"label_agreement":null},{"id":"W2281421996","doi":"10.1200/jco.2015.33.7_suppl.456","title":"Efficacy of targeted therapies after PD1/PD-L1 inhibitors in metastatic clear cell renal cell carcinoma (mRCC): A multi-institution retrospective cohort.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Renal cell carcinoma; Salvage therapy; Targeted therapy; Retrospective cohort study; Oncology; Cohort; Gastroenterology; Cancer; Chemotherapy","score_opus":0.09063368928562746,"score_gpt":0.39000812939261165,"score_spread":0.2993744401069842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2281421996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930436,0.0027775608,0.00013746531,0.0006451452,0.00097283104,0.00068720715,0.000008132836,0.000010629484,0.0017174071],"genre_scores_gemma":[0.9900825,0.00018313577,0.008640116,0.000278668,0.0005177186,0.00001449472,0.0000063767484,0.0000328129,0.00024419473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99423593,0.0010349816,0.0032170117,0.000364985,0.00077874115,0.00036832175],"domain_scores_gemma":[0.99498445,0.000961989,0.002242094,0.00033103483,0.0008815911,0.00059886393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038055799,0.0002937423,0.0023083652,0.0003764379,0.000025902003,0.000009480864,0.0001799034,0.0003858652,0.0000935827],"category_scores_gemma":[0.0020018066,0.00020554112,0.00074105186,0.00034995886,0.0004498717,0.000171656,0.00007251998,0.0012835804,0.000033258584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031642508,0.008331426,0.945794,0.000082237835,0.00041186553,0.0041731307,0.0013790153,0.00012091373,0.0041187145,0.000014195653,0.00092442444,0.0030075705],"study_design_scores_gemma":[0.029486757,0.023458105,0.93439704,0.00011119921,0.00081690814,0.00018513785,0.00040430264,0.00013532086,0.009092534,0.000093939554,0.0016561012,0.00016267026],"about_ca_topic_score_codex":0.00017857083,"about_ca_topic_score_gemma":0.00008743248,"teacher_disagreement_score":0.015126678,"about_ca_system_score_codex":0.0009860005,"about_ca_system_score_gemma":0.0022735829,"threshold_uncertainty_score":0.8381724},"labels":[],"label_agreement":null},{"id":"W2282340687","doi":"10.1200/jco.2009.27.15_suppl.5098","title":"Failure of initial VEGF-targeted therapy in metastatic renal cell carcinoma (mRCC): What next?","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Sunitinib; Sorafenib; Temsirolimus; Everolimus; Bevacizumab; Internal medicine; Targeted therapy; Renal cell carcinoma; Oncology; Axitinib; Population; Cancer; Hepatocellular carcinoma; PI3K/AKT/mTOR pathway; Chemotherapy; Discovery and development of mTOR inhibitors","score_opus":0.14372453274965388,"score_gpt":0.4492427574818181,"score_spread":0.30551822473216417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2282340687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849582,0.0058405953,0.000030142248,0.0071351253,0.00059987156,0.00034242668,0.0000015520417,0.0000059813497,0.0010861582],"genre_scores_gemma":[0.9886316,0.0019542275,0.0063924943,0.0022763878,0.0006586114,0.0000030340452,0.0000061487763,0.000019570041,0.00005793975],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.994544,0.00086001545,0.0033687064,0.00025209007,0.0006244558,0.0003506968],"domain_scores_gemma":[0.99515235,0.0015713848,0.0020672001,0.00029835277,0.00048188912,0.0004288316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025486092,0.00024369684,0.002317592,0.0003472004,0.000023636216,0.00002549046,0.00025295714,0.00035693578,0.00023596353],"category_scores_gemma":[0.000741711,0.00016614638,0.0008193887,0.00029404036,0.00018444275,0.00050153845,0.000028732658,0.0012125706,0.0000134931715],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035652675,0.016671997,0.0820158,0.00012323876,0.0007623337,0.02069533,0.0015644259,0.000107687345,0.039176833,0.00013473662,0.004005387,0.79908955],"study_design_scores_gemma":[0.035409465,0.103940494,0.8204574,0.00025473916,0.00060598744,0.0011040403,0.0013140826,0.00006462157,0.027363265,0.0014614197,0.007798836,0.00022565985],"about_ca_topic_score_codex":0.000025904048,"about_ca_topic_score_gemma":0.000029914461,"teacher_disagreement_score":0.7988639,"about_ca_system_score_codex":0.00022043698,"about_ca_system_score_gemma":0.0018556501,"threshold_uncertainty_score":0.6775253},"labels":[],"label_agreement":null},{"id":"W2282366831","doi":"10.1097/pas.0000000000000617","title":"Fumarate Hydratase–deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome","year":2016,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":252,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Calgary Laboratory Services; University of Calgary","funders":"Cancer Institute NSW; European Regional Development Fund; Calgary Laboratory Services; Univerzita Karlova v Praze","keywords":"Pathology; Renal cell carcinoma; Immunohistochemistry; Clear cell; Medicine; Fumarase; Germline mutation; Papillary renal cell carcinomas; Tissue microarray; Carcinoma; Cancer research; Biology; Mutation","score_opus":0.009590081696596519,"score_gpt":0.21767787817566436,"score_spread":0.20808779647906783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2282366831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941209,0.0026383984,0.00014732177,0.0021365418,0.00010358336,0.0003663643,0.00016724806,0.000019919598,0.00029974096],"genre_scores_gemma":[0.99868774,0.00025543448,0.00038641397,0.00022458198,0.000113953276,0.000013739383,0.000039651208,0.00005509731,0.00022337073],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99664927,0.00065797823,0.00089446496,0.00057263166,0.0005897023,0.0006359834],"domain_scores_gemma":[0.99704224,0.0004908798,0.0011116579,0.0005025585,0.00025971382,0.0005929751],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00068284845,0.0005018591,0.0011768823,0.00032436414,0.00019777534,0.000038536033,0.0002111131,0.00011717641,0.00011173854],"category_scores_gemma":[0.00001687825,0.0002551644,0.00018892466,0.0004177178,0.0015451825,0.00019954963,0.0001247592,0.00055329315,0.000032777032],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040754803,0.0022598333,0.19347936,0.00033065287,0.0007941271,0.543038,0.003928389,0.00039664857,0.18608065,0.000062748004,0.004364593,0.024510209],"study_design_scores_gemma":[0.023621636,0.046011634,0.478361,0.00036582415,0.002273986,0.39031702,0.0018938815,0.00040728686,0.054821815,0.00010381579,0.00084065704,0.0009814176],"about_ca_topic_score_codex":0.00010722183,"about_ca_topic_score_gemma":0.0000042421593,"teacher_disagreement_score":0.28488168,"about_ca_system_score_codex":0.00017544095,"about_ca_system_score_gemma":0.00023166076,"threshold_uncertainty_score":0.99999005},"labels":[],"label_agreement":null},{"id":"W2283249766","doi":"10.1016/j.urology.2015.12.081","title":"Measuring the Impact of Medical Chronic Kidney Disease and Diabetes Mellitus on Renal Functional Decline Following Surgical Management of Renal Masses","year":2016,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Diabetes mellitus; Kidney disease; Kidney; Disease; Urology; Renal mass; Intensive care medicine; Internal medicine; Endocrinology; Nephrectomy","score_opus":0.026346730449851728,"score_gpt":0.277127736211614,"score_spread":0.25078100576176227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2283249766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902243,0.0033540996,0.00014490014,0.005422882,0.000092436945,0.00023239515,0.000015150174,0.000015094603,0.0004987679],"genre_scores_gemma":[0.9990779,0.00045591866,0.000027502538,0.000107381944,0.00017854915,0.000025387048,0.000017265302,0.0000146798275,0.00009538105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828297,0.0001359702,0.00033334666,0.00027803,0.0006819212,0.00028776404],"domain_scores_gemma":[0.9987459,0.00042647833,0.0001012306,0.0003018189,0.00003882192,0.0003857194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000510682,0.00016574119,0.00035324646,0.00009559735,0.000041032443,0.0000035261742,0.000111945184,0.0000871708,0.0005449129],"category_scores_gemma":[0.00015310777,0.00007705167,0.00026798423,0.00008650663,0.00023974096,0.000026978916,0.00013665325,0.000120372846,0.000008247119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012230289,0.001738315,0.8990206,0.00065093994,0.008176991,0.004475992,0.00007538738,0.00058103417,0.019544458,0.0044933576,0.0028888923,0.046123754],"study_design_scores_gemma":[0.013308042,0.004940859,0.9657968,0.00072850846,0.0015216633,0.00013604504,0.00000866788,0.0010730157,0.00772688,0.0010619569,0.0034810062,0.0002165208],"about_ca_topic_score_codex":0.000017345454,"about_ca_topic_score_gemma":0.00000246649,"teacher_disagreement_score":0.066776246,"about_ca_system_score_codex":0.00011927871,"about_ca_system_score_gemma":0.00024483877,"threshold_uncertainty_score":0.59664136},"labels":[],"label_agreement":null},{"id":"W2284575850","doi":"10.1038/bjc.2016.21","title":"Circulating biomarkers and outcome from a randomised phase II trial of sunitinib vs everolimus for patients with metastatic renal cell carcinoma","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Novartis Pharmaceuticals Corporation","keywords":"Sunitinib; Everolimus; Medicine; Renal cell carcinoma; Internal medicine; Hazard ratio; Oncology; Biomarker; Urology; Confidence interval","score_opus":0.027802235006813142,"score_gpt":0.29442682614684274,"score_spread":0.26662459114002957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2284575850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955811,0.0022339332,0.0002867319,0.00012322699,0.0001713601,0.0012023972,0.00033618265,0.0000043088335,0.000060797753],"genre_scores_gemma":[0.9976214,0.000117256444,0.0018535397,0.00005528624,0.00019035042,0.000047951842,0.000015273728,0.000032789598,0.000066120425],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981691,0.00009373096,0.0008555976,0.00018592802,0.00046573614,0.00022989954],"domain_scores_gemma":[0.99789673,0.00040110832,0.00086749817,0.00011796312,0.00048821402,0.00022849644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003305302,0.0001691042,0.0008002458,0.00011578404,0.00007332098,0.000018712813,0.00006998037,0.000043692413,0.00011617235],"category_scores_gemma":[0.00021708866,0.00011537351,0.0002451609,0.00007974691,0.00009556541,0.00013564155,0.000019290555,0.000091768045,1.8231259e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7330748,0.0020139504,0.088757016,0.0002604354,0.0015324842,0.0010154742,0.00027124945,0.0000036796152,0.015481272,8.4124656e-7,0.00033638597,0.15725242],"study_design_scores_gemma":[0.8790612,0.011532823,0.09708143,0.0010293024,0.0019780484,0.00026839037,0.00004799679,0.000015026624,0.008584846,0.000031074098,0.00020420752,0.00016560759],"about_ca_topic_score_codex":0.0003922525,"about_ca_topic_score_gemma":0.00005682369,"teacher_disagreement_score":0.1570868,"about_ca_system_score_codex":0.00014854429,"about_ca_system_score_gemma":0.00024408668,"threshold_uncertainty_score":0.47047952},"labels":[],"label_agreement":null},{"id":"W2286190652","doi":"10.1007/s00345-016-1780-z","title":"Comparison of oncologic outcomes between sarcomatoid and clear cell renal cell carcinoma","year":2016,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Clear cell renal cell carcinoma; Renal cell carcinoma; Clear cell; Internal medicine; Stage (stratigraphy); Oncology; Poisson regression; Cohort; Disease; Population","score_opus":0.03678739638885641,"score_gpt":0.30676039742978034,"score_spread":0.2699730010409239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2286190652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882977,0.004048826,0.00009732371,0.0035425688,0.00013548633,0.00015145639,0.00000544274,0.000008428775,0.0037127715],"genre_scores_gemma":[0.99733144,0.00010354801,0.0011510734,0.00021373642,0.0001541657,0.0000014030854,0.0000012735945,0.000021252205,0.0010220954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812204,0.00020135756,0.0008856516,0.0001913017,0.00029755535,0.0003021154],"domain_scores_gemma":[0.99789596,0.0006563248,0.0007939522,0.00024066016,0.00015739727,0.00025569467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003759813,0.00020298513,0.0011025469,0.00041088706,0.000039705803,0.000004855891,0.00015696141,0.00011419754,0.00016965625],"category_scores_gemma":[0.000048975497,0.00011491306,0.00021972376,0.00012926736,0.0002285903,0.000057169156,0.0000801992,0.00031232674,0.00002077171],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007538876,0.00032170617,0.9517581,0.00004448267,0.00008279608,0.0003055074,0.00014083332,0.0000021354692,0.040256158,0.000026312411,0.0014081921,0.004899877],"study_design_scores_gemma":[0.005237715,0.0067071198,0.9315937,0.000024206565,0.00046767044,0.0002974608,0.0000494109,0.000004151436,0.04542682,0.00016286147,0.009923384,0.00010546563],"about_ca_topic_score_codex":0.000011873753,"about_ca_topic_score_gemma":0.000012221223,"teacher_disagreement_score":0.020164378,"about_ca_system_score_codex":0.00010238155,"about_ca_system_score_gemma":0.00011809622,"threshold_uncertainty_score":0.46860185},"labels":[],"label_agreement":null},{"id":"W2286854579","doi":"10.5489/cuaj.568","title":"Canadian Kidney Cancer Forum 2008","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"","keywords":"Kidney cancer; Cancer; Medicine; Genitourinary system; Human kidney; Disease; Family medicine; Pathology; Kidney; Internal medicine","score_opus":0.0123480241183318,"score_gpt":0.22184999078272738,"score_spread":0.20950196666439558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2286854579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5963293,0.00072286965,0.0000059881263,0.3800064,0.00066580524,0.00045968115,0.00008578259,0.000028442291,0.021695781],"genre_scores_gemma":[0.9483782,0.00010784598,0.00013623098,0.04425691,0.0005243598,0.000048336216,0.00003717339,0.000018644823,0.0064922813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805516,0.00009334773,0.00030501463,0.00020254255,0.00035030264,0.0009936404],"domain_scores_gemma":[0.99399835,0.000047898986,0.0001548918,0.00013078476,0.00043736017,0.0052306997],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00022822374,0.0001728259,0.00027642422,0.00031187918,0.00036018505,0.0001316538,0.0001240966,0.00029776507,0.013033244],"category_scores_gemma":[0.00053548097,0.0001342934,0.00016264364,0.00022182424,0.000022194103,0.00013371963,0.000008628925,0.0005932414,0.0010112751],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004737707,0.000011040067,0.6388768,0.0000015548084,0.000085469015,0.0001617466,0.000028085648,0.0000064643914,0.000061530845,0.000038093072,0.35838085,0.002343615],"study_design_scores_gemma":[0.0006085876,0.00016572147,0.69048226,0.000011484401,0.000066257766,0.00028304255,0.000047985963,0.00008124834,0.000037351336,0.00043737833,0.3076529,0.00012576656],"about_ca_topic_score_codex":0.73074275,"about_ca_topic_score_gemma":0.48831362,"teacher_disagreement_score":0.35204896,"about_ca_system_score_codex":0.008310415,"about_ca_system_score_gemma":0.004447681,"threshold_uncertainty_score":0.9997665},"labels":[],"label_agreement":null},{"id":"W2287073069","doi":"10.1200/jco.2015.33.7_suppl.403","title":"Initial results from ASSURE (E2805): Adjuvant sorafenib or sunitinib for unfavorable renal carcinoma, an ECOG-ACRIN-led, NCTN phase III trial.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Sunitinib; Sorafenib; Interim analysis; Discontinuation; Internal medicine; Renal cell carcinoma; Adverse effect; Rash; Clinical endpoint; Hazard ratio; Placebo; Urology; Oncology; Surgery; Randomized controlled trial; Hepatocellular carcinoma; Confidence interval; Pathology","score_opus":0.38162319503794323,"score_gpt":0.5198697579504836,"score_spread":0.1382465629125404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2287073069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821455,0.0004578465,0.00036359447,0.0048833843,0.0046176855,0.001587954,0.00032219416,0.000039085677,0.0055827927],"genre_scores_gemma":[0.9732165,0.00011998209,0.011827416,0.0017221915,0.01104474,0.000045585257,0.00034055448,0.00007998103,0.0016030896],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9898781,0.0016063987,0.006124215,0.0006872234,0.0009837182,0.0007203502],"domain_scores_gemma":[0.98422986,0.0067293327,0.0039911405,0.00075918407,0.0020093962,0.002281093],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009206544,0.00048650854,0.004014176,0.00029604606,0.000118185635,0.000050045703,0.00048268208,0.0009727174,0.0003967715],"category_scores_gemma":[0.014329897,0.00032032822,0.0011420159,0.00024930396,0.0003410603,0.00039799782,0.00010830798,0.0016363828,0.000054848755],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8727107,0.010558662,0.0005625288,0.000025309175,0.000924612,0.009062297,0.0004867174,0.000034488137,0.00046438468,0.000030940493,0.03632952,0.06880986],"study_design_scores_gemma":[0.6386263,0.18997146,0.0028636479,0.00014119262,0.0025446592,0.0010073237,0.00086413155,0.0004752879,0.002039616,0.0006623654,0.1604564,0.000347648],"about_ca_topic_score_codex":0.0003604131,"about_ca_topic_score_gemma":0.00046501687,"teacher_disagreement_score":0.23408441,"about_ca_system_score_codex":0.00057362916,"about_ca_system_score_gemma":0.009788455,"threshold_uncertainty_score":0.9999249},"labels":[],"label_agreement":null},{"id":"W2287451893","doi":"10.1177/1203475416634091","title":"First Presentation of Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Pregnancy","year":2016,"lang":"en","type":"article","venue":"Journal of Cutaneous Medicine and Surgery","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Leiomyomatosis; Presentation (obstetrics); Pregnancy; Cancer; Gynecology; Obstetrics; Pathology; Internal medicine; Leiomyoma; Genetics","score_opus":0.026113377105613997,"score_gpt":0.2605380579137506,"score_spread":0.2344246808081366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2287451893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711482,0.02335543,0.000017820166,0.0049182447,0.0001769789,0.00014021389,0.0000036231866,0.0000037901957,0.0002356981],"genre_scores_gemma":[0.98324543,0.01609564,0.000083352286,0.00006905176,0.0001430822,0.000004347655,0.0000011752265,0.000014095688,0.00034381173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985533,0.00004942429,0.0007115608,0.00013340355,0.0003874446,0.00016489904],"domain_scores_gemma":[0.99832916,0.000844574,0.00039637092,0.000109004366,0.00013545876,0.00018543008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023128887,0.00013884332,0.00069696,0.00038306683,0.00002104631,0.0000028418578,0.000033058637,0.00006710129,0.00010249918],"category_scores_gemma":[0.00013444536,0.00007549256,0.00008283888,0.00013763427,0.00014125132,0.0001032528,0.000014780174,0.00010546056,5.1042105e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013266241,0.00031519175,0.8908099,0.0015015445,0.0002685362,0.03384531,0.0010916969,0.000008181023,0.031937107,0.0000068095715,0.007940999,0.030948102],"study_design_scores_gemma":[0.009235607,0.0055798604,0.75769514,0.04678242,0.0012764245,0.14641939,0.00096901396,0.00005649338,0.028939106,0.00047093467,0.0021467004,0.00042890324],"about_ca_topic_score_codex":0.00015690403,"about_ca_topic_score_gemma":0.00002951339,"teacher_disagreement_score":0.13311476,"about_ca_system_score_codex":0.0000653888,"about_ca_system_score_gemma":0.00012708218,"threshold_uncertainty_score":0.3078497},"labels":[],"label_agreement":null},{"id":"W2288421293","doi":"10.1155/2012/734985","title":"Birt‐Hogg‐Dubé Syndrome: Report of a New Mutation","year":2012,"lang":"en","type":"article","venue":"Canadian Respiratory Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regina Qu'Appelle Health Region","funders":"","keywords":"Birt–Hogg–Dubé syndrome; Folliculin; Genodermatosis; Medicine; Germline mutation; Germline; Mutation; Genetics; Gene; Pneumothorax; Anatomy; Biology","score_opus":0.04518980549924097,"score_gpt":0.2816949119377091,"score_spread":0.23650510643846817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2288421293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886449,0.0035173353,0.000059134705,0.0003977182,0.00044994245,0.00019896986,0.0000052699907,0.000011599048,0.0067151086],"genre_scores_gemma":[0.9964691,0.000008005078,0.0004993762,0.00079660263,0.0004989055,0.0000036150059,0.000007988159,0.000030158899,0.001686258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984891,0.000057050074,0.0004985049,0.00013027707,0.0003621431,0.00046291616],"domain_scores_gemma":[0.99687505,0.000021089749,0.000265607,0.0003037112,0.0001745379,0.0023599877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050230755,0.0001468332,0.00029192754,0.00050086953,0.00010067436,0.000020404397,0.000077668206,0.00010726031,0.00071802596],"category_scores_gemma":[0.00017875178,0.00012733428,0.00015111487,0.00023660298,0.00004805664,0.00017517313,0.00000794865,0.0002887323,0.00009174859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013247263,0.00015849304,0.8396791,0.000121639045,0.0004884674,0.068955764,0.0012271302,0.000020752681,0.008133051,0.00032713925,0.051690556,0.029065438],"study_design_scores_gemma":[0.0013967078,0.00059931615,0.7244167,0.00014409686,0.00022363711,0.12844259,0.00021486764,0.0000020686948,0.006785743,0.00007766584,0.13752227,0.00017436575],"about_ca_topic_score_codex":0.0061620288,"about_ca_topic_score_gemma":0.003454299,"teacher_disagreement_score":0.11526241,"about_ca_system_score_codex":0.00083452533,"about_ca_system_score_gemma":0.003012447,"threshold_uncertainty_score":0.9315185},"labels":[],"label_agreement":null},{"id":"W2290353102","doi":"10.1186/s12931-016-0339-2","title":"Birt-Hogg-Dubé syndrome: a large single family cohort","year":2016,"lang":"en","type":"article","venue":"Respiratory Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Birt–Hogg–Dubé syndrome; Folliculin; Medicine; Pulmonary function testing; Pneumothorax; Family history; Cyst; Lung; Cohort; Internal medicine; Genetic testing; Pathology; Radiology; Genetics; Biology","score_opus":0.16739142258456205,"score_gpt":0.3839763743342898,"score_spread":0.21658495174972778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2290353102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9604904,0.0024084921,0.00006121425,0.0006259634,0.00010494296,0.0011235056,0.000028881786,0.0001403329,0.035016265],"genre_scores_gemma":[0.98748696,0.00007801519,0.000083336636,0.0004413656,0.00021397446,0.00020903187,0.0000073663114,0.00008458644,0.01139537],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.995277,0.0005060173,0.0004108066,0.00073158153,0.0018723552,0.0012022307],"domain_scores_gemma":[0.9971065,0.0004443553,0.000056246077,0.0011849942,0.00057233905,0.000635592],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002519558,0.00025236577,0.00047114934,0.0006077859,0.00023940255,0.000050958493,0.00028129984,0.00020892406,0.0008116361],"category_scores_gemma":[0.00052852277,0.00015780749,0.00018233838,0.00075576815,0.00032016728,0.00014116424,0.00025331424,0.0004479537,0.004047471],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050087407,0.00092407176,0.29419783,0.00014383468,0.00021565569,0.0035950968,0.00005856699,1.31353e-7,0.6715784,0.00048590454,0.016940884,0.011358762],"study_design_scores_gemma":[0.00408184,0.004082719,0.5836872,0.0004020405,0.000058710793,0.0002671108,0.00011071732,0.000003709855,0.09953686,0.00012727875,0.30735663,0.00028519626],"about_ca_topic_score_codex":0.000039909155,"about_ca_topic_score_gemma":0.000012421583,"teacher_disagreement_score":0.5720416,"about_ca_system_score_codex":0.0009606579,"about_ca_system_score_gemma":0.0005151867,"threshold_uncertainty_score":0.996728},"labels":[],"label_agreement":null},{"id":"W2290643538","doi":"10.1016/j.ijsu.2016.02.097","title":"The role of biopsy for small renal masses","year":2016,"lang":"en","type":"review","venue":"International Journal of Surgery","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pathological; Biopsy; Incidence (geometry); Natural history; Renal biopsy; Radiology; Intensive care medicine; Medical physics; Pathology; Internal medicine","score_opus":0.10087286523454142,"score_gpt":0.3509564116713831,"score_spread":0.25008354643684166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2290643538","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039698285,0.99684316,0.000102745624,0.00031743312,0.0014327321,0.00024030116,0.000078960315,0.000004193574,0.0005835119],"genre_scores_gemma":[0.00049186405,0.9967122,0.0005151326,0.000015290198,0.0015304178,0.000023266493,0.000022950635,0.000037880793,0.00065099617],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976388,0.000078215584,0.0013689543,0.00013306185,0.00060927396,0.00017164485],"domain_scores_gemma":[0.9933313,0.003340631,0.0019625374,0.00019275234,0.0010671625,0.00010558145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084771914,0.00022720906,0.0012726556,0.00043461815,0.000028934615,0.000030066152,0.00034536666,0.00012449185,0.000051895735],"category_scores_gemma":[0.00057382573,0.00010594698,0.001917862,0.00007592673,0.00008287509,0.00005397784,0.000047253776,0.00018754468,0.00001183952],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002788803,0.00007525911,0.0004560948,0.000717904,0.002174018,0.00024165954,0.000005847865,7.762717e-8,0.00005203157,0.00018576276,0.0011361095,0.99467635],"study_design_scores_gemma":[0.00027573327,0.0000838588,0.00011085065,0.018511355,0.0006704474,0.0033340515,0.000009112827,3.982363e-7,0.00033811817,0.00038526603,0.97619194,0.00008888499],"about_ca_topic_score_codex":0.000004418965,"about_ca_topic_score_gemma":6.124169e-7,"teacher_disagreement_score":0.9945875,"about_ca_system_score_codex":0.0002761762,"about_ca_system_score_gemma":0.0010129646,"threshold_uncertainty_score":0.43203926},"labels":[],"label_agreement":null},{"id":"W2293077587","doi":"10.1016/s0140-6736(16)00559-6","title":"Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial","year":2016,"lang":"en","type":"article","venue":"The Lancet","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":638,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute; American College of Radiology Imaging Network","keywords":"Sunitinib; Sorafenib; Medicine; Renal cell carcinoma; Placebo; Oncology; Internal medicine; Adjuvant; Clinical endpoint; Clinical trial; Pathology; Hepatocellular carcinoma","score_opus":0.07669057324285966,"score_gpt":0.33040147401918724,"score_spread":0.2537109007763276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293077587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748401,0.00053230044,0.0014955493,0.003687245,0.00062491064,0.016089056,0.00047353315,0.000121429715,0.0021358526],"genre_scores_gemma":[0.9790785,0.00020162741,0.0014330432,0.0004061429,0.002975488,0.005186258,0.00014377378,0.000120747616,0.010454442],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961059,0.00047984387,0.001100192,0.0006941905,0.0005795323,0.0010403043],"domain_scores_gemma":[0.9941736,0.0030571434,0.00068181386,0.0014915327,0.00023090454,0.0003650006],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021453942,0.0006272065,0.002619864,0.00020022178,0.00028015152,0.0000770357,0.0004976616,0.0001356846,0.00070471485],"category_scores_gemma":[0.00056935055,0.00027645522,0.00066314935,0.00023946771,0.00020091281,0.00012793714,0.000090839414,0.00035135017,0.0002738134],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97233915,0.0010210169,0.00007770782,0.00017502527,0.0005955223,0.00032531327,0.00033185715,0.0000056555905,0.0070152087,0.000062521234,0.011470204,0.006580815],"study_design_scores_gemma":[0.94156593,0.007499346,0.00010062944,0.00015154776,0.0027252212,0.000111300586,0.00013844144,0.00014680772,0.043184895,0.00023627035,0.0037559296,0.00038366966],"about_ca_topic_score_codex":0.00026336955,"about_ca_topic_score_gemma":0.00012933167,"teacher_disagreement_score":0.036169685,"about_ca_system_score_codex":0.0002112883,"about_ca_system_score_gemma":0.00046365,"threshold_uncertainty_score":0.99996877},"labels":[],"label_agreement":null},{"id":"W2294289462","doi":"10.1016/j.eururo.2015.11.035","title":"Reply from Authors re: Matthew C. Hayes, David J. Breen. Excision Versus Ablation in Renal Cancer: Optimising Outcome and Minimising Risk. Eur Urol 2016;69:683–4","year":2015,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Outcome (game theory); Ablation; Kidney cancer; General surgery; Surgery; Cancer; Internal medicine","score_opus":0.07443297247606305,"score_gpt":0.3080245612372155,"score_spread":0.23359158876115244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2294289462","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47968033,0.023726314,0.0005191449,0.46608716,0.0046348344,0.002267872,0.00045300453,0.00045932896,0.022172002],"genre_scores_gemma":[0.3550897,0.004205882,0.0127987005,0.5755748,0.021992167,0.000106130545,0.00712748,0.0018608468,0.02124424],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932731,0.0021744496,0.0013312708,0.001661557,0.00071876304,0.0008408884],"domain_scores_gemma":[0.99642664,0.0008186501,0.00094416563,0.0013066991,0.00017361662,0.00033022414],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001437663,0.00082996587,0.0013002247,0.000607906,0.00014709773,0.00009216383,0.0003597646,0.00067901704,0.00028578535],"category_scores_gemma":[0.0006463605,0.0007428166,0.00021012277,0.00025631345,0.00022769881,0.00014021168,0.00034336813,0.0029721067,0.0003087589],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050991247,0.00009240999,0.020085262,0.00012753304,0.00042867943,0.018848842,0.0010070715,0.0006661759,0.00033038517,0.0000011025337,0.93625546,0.017057931],"study_design_scores_gemma":[0.009797125,0.0019046625,0.08822193,0.00040184986,0.0016557013,0.00031369738,0.000039190163,0.001240241,0.00004791403,0.00006141685,0.8954698,0.00084646966],"about_ca_topic_score_codex":0.00209334,"about_ca_topic_score_gemma":0.00008706949,"teacher_disagreement_score":0.12459062,"about_ca_system_score_codex":0.0006222186,"about_ca_system_score_gemma":0.0002524798,"threshold_uncertainty_score":0.9995023},"labels":[],"label_agreement":null},{"id":"W2295003907","doi":"10.1148/rg.2016150186","title":"The Wheel of the Mesentery: Imaging Spectrum of Primary and Secondary Mesenteric Neoplasms—How Can Radiologists Help Plan Treatment?:<i>Resident and Fellow Education Feature</i>","year":2016,"lang":"en","type":"article","venue":"Radiographics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute","keywords":"Medicine; General surgery; Radiology; Nuclear medicine","score_opus":0.01024192936528436,"score_gpt":0.21618917225046405,"score_spread":0.20594724288517968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2295003907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9652518,0.014639041,0.000013052612,0.017747678,0.0002289547,0.00068607944,0.000046140107,0.000018771423,0.0013684848],"genre_scores_gemma":[0.9898014,0.0071643847,0.00011857582,0.00015342988,0.000083936364,0.000027093087,0.0000156658,0.000024867231,0.0026106574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988055,0.00013885973,0.0002399393,0.00030884368,0.0002534457,0.00025337664],"domain_scores_gemma":[0.9987155,0.000300825,0.00025696473,0.0005401707,0.000056926936,0.00012961969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017915413,0.00025137086,0.0004155917,0.00017380156,0.00014222311,0.000028098053,0.0001254013,0.00006884048,0.000003122119],"category_scores_gemma":[0.00002897406,0.00011310166,0.00019960434,0.00023693223,0.00073235243,0.0000667115,0.00006650083,0.00012171607,1.786443e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002983973,0.00013734236,0.95047086,0.0001484378,0.00041569336,0.00002304087,0.0004628332,1.4701564e-7,0.022654513,0.00052410364,0.0032785921,0.021586033],"study_design_scores_gemma":[0.002525621,0.00062608067,0.96896106,0.00031351144,0.00046569045,0.00107197,0.00044335632,0.000012594848,0.020564843,0.00060318044,0.0042498517,0.00016226215],"about_ca_topic_score_codex":0.00019858695,"about_ca_topic_score_gemma":0.00022062956,"teacher_disagreement_score":0.024549592,"about_ca_system_score_codex":0.0001802502,"about_ca_system_score_gemma":0.0003228345,"threshold_uncertainty_score":0.4612152},"labels":[],"label_agreement":null},{"id":"W2300252385","doi":"10.2214/ajr.15.14806","title":"Enhancement Threshold of Small (&lt; 4 cm) Solid Renal Masses on CT","year":2016,"lang":"en","type":"article","venue":"American Journal of Roentgenology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Toronto General Hospital; University Health Network","funders":"","keywords":"Medicine; Hounsfield scale; Nuclear medicine; Renal cell carcinoma; Radiology; Lesion; Renal mass; Retrospective cohort study; Kidney; Computed tomography; Pathology; Nephrectomy; Internal medicine","score_opus":0.025438743133027217,"score_gpt":0.2780495294410091,"score_spread":0.25261078630798184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300252385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924598,0.0005711905,0.001044355,0.0035504655,0.00020731866,0.00015049937,0.000004742743,0.000008361752,0.0020032774],"genre_scores_gemma":[0.99516565,0.0008296973,0.0028503942,0.00043790153,0.00017363716,0.0000054575567,0.000001426786,0.000025184876,0.0005106554],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982008,0.00009981826,0.00073508907,0.00021504782,0.00037203476,0.00037725116],"domain_scores_gemma":[0.998059,0.00014499808,0.00097127794,0.00036331822,0.0002431293,0.00021832509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022804896,0.00020818356,0.0008328638,0.000320243,0.00002663115,0.000003561563,0.0001992365,0.000029492085,0.0003345208],"category_scores_gemma":[0.0000760576,0.00011943714,0.0002664134,0.00016360967,0.00044143703,0.0000380675,0.000047723992,0.00017718012,0.000042693195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004800604,0.001310539,0.06604325,0.000045518183,0.0016587224,0.0026240572,0.00026829276,0.000048679518,0.7540588,0.00042929678,0.0020905996,0.16662167],"study_design_scores_gemma":[0.0051804995,0.04775422,0.034669746,0.00056234334,0.00056146795,0.0039609047,0.00035896775,0.000006098363,0.89440995,0.00032811242,0.011981756,0.00022592217],"about_ca_topic_score_codex":0.000019801759,"about_ca_topic_score_gemma":0.000007179187,"teacher_disagreement_score":0.16639574,"about_ca_system_score_codex":0.00024714018,"about_ca_system_score_gemma":0.00021186146,"threshold_uncertainty_score":0.48705053},"labels":[],"label_agreement":null},{"id":"W2303647913","doi":"10.1093/annonc/mdu337.32","title":"Phase Ii Study of Individualized Sunitinib As First-Line Therapy for Metastatic Clear Cell Renal Cell Cancer (Mrcc)","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Regional Municipality of Durham; BC Cancer Agency; Ottawa Hospital; Ozmosis Research (Canada); Queen Elizabeth II Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Sunitinib; Oncology; Renal cell carcinoma; Internal medicine; Cancer","score_opus":0.17602858154999643,"score_gpt":0.4470818414900797,"score_spread":0.2710532599400832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2303647913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98890907,0.0010550043,0.000048529022,0.0016446004,0.000109424946,0.0019344123,0.00008053071,0.000017450388,0.006201005],"genre_scores_gemma":[0.9955281,0.0007425093,0.00093117624,0.0011121704,0.00012360698,0.0002904595,0.00007051861,0.000040040584,0.001161389],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99796855,0.0002895208,0.0007235709,0.00033691133,0.00032536418,0.00035608638],"domain_scores_gemma":[0.99770397,0.0006446068,0.00058893056,0.00041436031,0.0004744231,0.0001736906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076348183,0.0002451087,0.0010746288,0.00021159646,0.00008841418,0.000003810356,0.00017299883,0.00010840655,0.00055794534],"category_scores_gemma":[0.00010816809,0.00019009721,0.00022799477,0.0001830461,0.00011807371,0.000042204883,0.00006055968,0.000147224,0.000011263812],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08101283,0.23679717,0.0044725337,0.0018336449,0.004503535,0.00037576133,0.03164387,0.00038834097,0.16951981,0.00027197116,0.03664425,0.4325363],"study_design_scores_gemma":[0.076099776,0.38154736,0.0013287608,0.000057476012,0.00078912935,0.000015674232,0.0010366071,0.0001330423,0.41886285,0.00032475055,0.11959335,0.00021124544],"about_ca_topic_score_codex":0.0005813858,"about_ca_topic_score_gemma":0.00015882701,"teacher_disagreement_score":0.43232504,"about_ca_system_score_codex":0.000040145,"about_ca_system_score_gemma":0.00028547092,"threshold_uncertainty_score":0.7751939},"labels":[],"label_agreement":null},{"id":"W2305470966","doi":"10.1200/jco.2013.31.6_suppl.357","title":"Prolonged survival with personalized immunotherapy (AGS-003) in combination with sunitinib in unfavorable risk metastatic RCC (mRCC).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Sunitinib; Immunotherapy; Internal medicine; Oncology; Surgery; Cancer","score_opus":0.09453903908394395,"score_gpt":0.4038148977188659,"score_spread":0.30927585863492196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2305470966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99223113,0.0005384859,0.0001326106,0.0039452235,0.00019007194,0.00095181976,0.0000017844026,0.000008760401,0.002000103],"genre_scores_gemma":[0.9897883,0.00058817706,0.00851062,0.00051865424,0.000104010345,0.000040687937,0.0000073384745,0.000034617704,0.00040760462],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950394,0.0017859522,0.0019923244,0.00024819118,0.00058483396,0.00034928552],"domain_scores_gemma":[0.9947367,0.0024359268,0.0017924038,0.00022638269,0.00054948806,0.00025915122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004429639,0.00022960073,0.0019443186,0.00033371744,0.00003365249,0.000019117875,0.00015077178,0.000203649,0.00035403937],"category_scores_gemma":[0.0009166283,0.00013321015,0.00020768319,0.00041602025,0.00030503847,0.00023588736,0.00001752563,0.001398481,0.0000231413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029242156,0.007157309,0.91932756,0.000056681823,0.0008695763,0.0028304243,0.00088507787,0.000100818586,0.0003156923,0.00013017566,0.00021021774,0.038874287],"study_design_scores_gemma":[0.062294167,0.041075524,0.89190066,0.0002238426,0.0003279842,0.00056165486,0.0010685408,0.00022246271,0.00012077002,0.00048428957,0.0015693938,0.00015072469],"about_ca_topic_score_codex":0.000739116,"about_ca_topic_score_gemma":0.0009300246,"teacher_disagreement_score":0.038723562,"about_ca_system_score_codex":0.00039585464,"about_ca_system_score_gemma":0.0016167276,"threshold_uncertainty_score":0.60757816},"labels":[],"label_agreement":null},{"id":"W2309303154","doi":"10.1093/annonc/mdu342.5","title":"Nivolumab (N) (Anti-Pd-1; Bms-936558, Ono-4538) in Combination with Sunitinib (S) or Pazopanib (P) in Patients (Pts) with Metastatic Renal Cell Carcinoma (Mrcc)","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto","funders":"","keywords":"Medicine; Tolerability; Nivolumab; Renal cell carcinoma; Pazopanib; Adverse effect; Internal medicine; Sunitinib; Peripheral edema; Nausea; Oncology; Toxicity; Urology; Gastroenterology; Immunotherapy; Cancer","score_opus":0.054480412696279776,"score_gpt":0.31141016778675606,"score_spread":0.2569297550904763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2309303154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897658,0.00007965559,0.00004770005,0.0008674225,0.00005717965,0.0011179423,0.000014277374,0.000021934653,0.008028045],"genre_scores_gemma":[0.9974732,0.000029221086,0.0012113989,0.00058125553,0.000030267704,0.00009603696,0.00016268456,0.000052434727,0.00036350818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972521,0.00046514,0.00072628795,0.0005020272,0.000484168,0.00057029654],"domain_scores_gemma":[0.9980841,0.00037112104,0.0004514926,0.00045871825,0.00043862752,0.00019592294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006066475,0.00034684438,0.0010838391,0.0005884704,0.000042192052,0.000010559948,0.00017288676,0.000150041,0.0001204761],"category_scores_gemma":[0.000119101795,0.00024079146,0.00008036538,0.0005896133,0.000204921,0.00015530737,0.000055091085,0.0003378802,0.000027615877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016219394,0.010445093,0.9268892,0.0005425724,0.0001743419,0.0012917706,0.0017136348,0.00018113306,0.0008892795,0.00037458452,0.0009015971,0.04037739],"study_design_scores_gemma":[0.03152863,0.057256237,0.8912897,0.00027555707,0.00019829848,0.000083539744,0.0004005765,0.00026636294,0.016571043,0.00008714769,0.0017313258,0.00031155162],"about_ca_topic_score_codex":0.0009781518,"about_ca_topic_score_gemma":0.0023689594,"teacher_disagreement_score":0.046811145,"about_ca_system_score_codex":0.00025709072,"about_ca_system_score_gemma":0.0005278387,"threshold_uncertainty_score":0.98191905},"labels":[],"label_agreement":null},{"id":"W2309897017","doi":"10.15586/jkcvhl.2016.45","title":"Review of the Interaction Between Body Composition and Clinical Outcomes in Metastatic Renal Cell Cancer Treated With Targeted Therapies","year":2016,"lang":"en","type":"review","venue":"Journal of Kidney Cancer and VHL","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Targeted therapy; Internal medicine; Oncology; Overweight; Sarcopenia; Clinical trial; Cancer; Obesity","score_opus":0.06691004596047723,"score_gpt":0.40405703965380424,"score_spread":0.337146993693327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2309897017","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009020075,0.98873097,0.000003684301,0.0012249957,0.00013608292,0.0006993673,0.00013325314,0.0000024439357,0.000049124203],"genre_scores_gemma":[0.0030894494,0.99603564,0.00006918199,0.00044532935,0.00017041455,0.000028818426,0.000017405731,0.00002506372,0.00011871686],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99779487,0.00037139672,0.0012453508,0.00018382042,0.00027241206,0.00013212717],"domain_scores_gemma":[0.9974797,0.00030095244,0.0016026038,0.00016602664,0.00018867373,0.00026207656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044333082,0.00028968803,0.0024643764,0.00015399279,0.000027852044,0.000010661178,0.00008322264,0.00008790952,0.00007103194],"category_scores_gemma":[0.000074388976,0.00011336705,0.00043702553,0.00016739313,0.00010934636,0.00008790651,0.0000248014,0.000452939,4.1659044e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005341403,0.00035975777,0.16964437,0.089067854,0.005549667,0.00008543892,0.000102817816,1.3875191e-7,0.0000653952,0.0000012393175,0.00431909,0.7302701],"study_design_scores_gemma":[0.0043527624,0.0014178583,0.036578063,0.5774635,0.017765237,0.00032681506,0.000019881109,6.68505e-7,0.00018203218,0.000005598833,0.36163226,0.00025534336],"about_ca_topic_score_codex":0.00016354708,"about_ca_topic_score_gemma":0.000011159949,"teacher_disagreement_score":0.73001474,"about_ca_system_score_codex":0.00026371574,"about_ca_system_score_gemma":0.00095233275,"threshold_uncertainty_score":0.4622974},"labels":[],"label_agreement":null},{"id":"W2312350801","doi":"10.1097/pgp.0000000000000091","title":"Current Morphologic Criteria Perform Poorly in Identifying Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome-associated Uterine Leiomyomas","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Wellcome Trust","keywords":"Medicine; Leiomyomatosis; Renal cell carcinoma; Pathology; Biomarker; Lynch syndrome; Cancer; Oncology; Internal medicine; Leiomyoma; Biology","score_opus":0.0289298639388062,"score_gpt":0.3071649771147999,"score_spread":0.2782351131759937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312350801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950952,0.0011017903,0.00019932108,0.0016419716,0.0012669064,0.00021362583,0.000013938325,0.000022955765,0.00044428278],"genre_scores_gemma":[0.99760854,0.00019664888,0.0013965336,0.0004382718,0.00023241168,0.000017026205,0.000037585007,0.000021888818,0.00005109942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972318,0.00035861452,0.0010554399,0.00039740297,0.0005495233,0.00040725037],"domain_scores_gemma":[0.99814373,0.00042656533,0.0005786397,0.00017540925,0.00042927274,0.00024635243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010115074,0.00030241243,0.00081121287,0.00060098217,0.000057783833,0.00004847686,0.0003553636,0.0002512404,0.000606645],"category_scores_gemma":[0.0006128864,0.00022870059,0.00024459,0.00016864332,0.0002030882,0.00020318836,0.0002296975,0.0006635287,0.000025400184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092411315,0.0020453467,0.8762615,0.00009096582,0.00016996455,0.052154522,0.00027371358,0.000022647675,0.05627316,0.00011620824,0.0006550318,0.011012828],"study_design_scores_gemma":[0.0045742905,0.003684634,0.9660781,0.000118045034,0.00010127821,0.021270629,0.00006420601,0.0002927562,0.002295406,0.0009716605,0.00035729504,0.0001917061],"about_ca_topic_score_codex":0.000026483667,"about_ca_topic_score_gemma":0.000019933395,"teacher_disagreement_score":0.08981659,"about_ca_system_score_codex":0.000501856,"about_ca_system_score_gemma":0.000090313755,"threshold_uncertainty_score":0.93261397},"labels":[],"label_agreement":null},{"id":"W2312596646","doi":"10.1016/j.juro.2012.02.1624","title":"1290 DOES SURGEON AND HOSPITAL VOLUME AFFECT OUTCOMES FOR SURGERY FOR RENAL CELL CARCINOMA WITH INFERIOR VENA CAVA INVOLVEMENT? – RESULTS OF A NATIONAL POPULATION BASED STUDY","year":2012,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Inferior vena cava; Renal cell carcinoma; Population; Kidney cancer; Surgery; Vena cava; General surgery; Kidney; Internal medicine","score_opus":0.024732964343630877,"score_gpt":0.2682871198090635,"score_spread":0.24355415546543263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312596646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968227,0.00030890288,0.00019911966,0.00131767,0.00021857413,0.0010716659,0.00004580405,0.000004440926,0.000011116438],"genre_scores_gemma":[0.9992338,0.000004266999,0.00032689795,0.00010938384,0.0001800378,0.000031297233,0.000037267164,0.000020545187,0.000056528355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853355,0.00020201123,0.000566163,0.0001115181,0.00034361353,0.00024315226],"domain_scores_gemma":[0.99702775,0.0016247483,0.0007114316,0.00014841856,0.00038434778,0.00010331233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020332807,0.00015958854,0.0005453339,0.00022233586,0.00006829058,0.000005848043,0.00006204073,0.000061117426,0.0000057849657],"category_scores_gemma":[0.0003199747,0.00008040896,0.00015698731,0.00007355419,0.000051974133,0.000101529244,0.000018185505,0.00011119766,2.8042163e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007959997,0.0007875276,0.9890462,0.000083855535,0.0001914793,0.000008946559,0.0006300901,0.00005502869,0.000678465,0.0000039826064,0.00040185847,0.00015256439],"study_design_scores_gemma":[0.0065725413,0.008387469,0.9822481,0.000016196016,0.0006532602,0.000047054313,0.00019116724,0.00010859938,0.0015438985,0.000031295705,0.00011709898,0.000083271196],"about_ca_topic_score_codex":0.0001359403,"about_ca_topic_score_gemma":0.000073829324,"teacher_disagreement_score":0.0075999415,"about_ca_system_score_codex":0.00009302002,"about_ca_system_score_gemma":0.00017000434,"threshold_uncertainty_score":0.3278982},"labels":[],"label_agreement":null},{"id":"W2315224281","doi":"10.1097/spc.0000000000000074","title":"The emerging roles of stereotactic ablative radiotherapy for metastatic renal cell carcinoma","year":2014,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"SABR volatility model; Medicine; Renal cell carcinoma; Abscopal effect; Radiation therapy; Ablative case; Oncology; Radiosurgery; Radiology; Internal medicine; Immunotherapy; Cancer","score_opus":0.12988215629703775,"score_gpt":0.42196041687660957,"score_spread":0.2920782605795718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315224281","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00071752846,0.9940143,0.00042098542,0.000026043854,0.00078702986,0.0035437061,0.00038521667,0.000009481687,0.00009569281],"genre_scores_gemma":[0.004643844,0.99292517,0.00021149383,0.0000066489797,0.00023648869,0.0008336806,0.0009969283,0.00006940433,0.00007634549],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970167,0.00044720253,0.0011506029,0.00062488666,0.0003436853,0.00041689668],"domain_scores_gemma":[0.9964261,0.0013983435,0.0011880428,0.0003845291,0.00044611198,0.00015684194],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033388397,0.0006238849,0.0021953108,0.00027494066,0.00012988067,0.000028250326,0.00016336591,0.00012606557,0.000022494796],"category_scores_gemma":[0.000115270974,0.00038175573,0.0006924934,0.0002739038,0.0002066415,0.000056347315,0.00005704174,0.00042634452,0.0000026441749],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033032507,0.00019489288,0.006714084,0.101482116,0.00086125964,0.000008294848,0.0072350623,0.0000014428454,0.0000028659574,0.00030627268,0.0006008343,0.8822625],"study_design_scores_gemma":[0.0024496454,0.0014954945,0.0022167887,0.017244125,0.001407223,0.000008003395,0.0018775468,0.00003773644,0.00006870338,0.00004949046,0.9727262,0.00041903908],"about_ca_topic_score_codex":0.000006828344,"about_ca_topic_score_gemma":0.0000058009623,"teacher_disagreement_score":0.97212535,"about_ca_system_score_codex":0.0003910238,"about_ca_system_score_gemma":0.0004764652,"threshold_uncertainty_score":0.99986345},"labels":[],"label_agreement":null},{"id":"W2317915251","doi":"10.1158/1538-7445.am2012-1278","title":"Abstract 1278: Determining the proteomic changes that define progressor and non-progressor clear cell renal cell carcinoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Clear cell renal cell carcinoma; Medicine; Kidney cancer; Cancer; Renal cell carcinoma; Clear cell; Asymptomatic; Cancer research; Oncology; Pathology; Internal medicine","score_opus":0.11574277233982827,"score_gpt":0.37027574418444736,"score_spread":0.2545329718446191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317915251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98145807,0.01030903,9.575014e-7,0.0016966892,0.00012709825,0.0028374144,0.000021490365,0.000040303283,0.0035089345],"genre_scores_gemma":[0.995185,0.00042298916,0.00031558602,0.00009929035,0.0008214994,0.0015955729,0.00002015118,0.00009634513,0.0014435432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966161,0.0001667571,0.00024802136,0.0005399609,0.0010742242,0.0013548883],"domain_scores_gemma":[0.99817187,0.00020862506,0.00013116049,0.0006779671,0.00026691667,0.0005434587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012755834,0.00032695438,0.00039377928,0.00022836294,0.00041230992,0.00011727723,0.0002917666,0.00016419642,0.00024571695],"category_scores_gemma":[0.00004836159,0.00020595401,0.00009771627,0.0003039371,0.00046007574,0.00015564857,0.00029530848,0.00088706106,0.00012023479],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015774431,0.0006638414,0.7070374,0.0014879853,0.00007764958,0.00021975805,0.0028762904,9.280582e-7,0.25765553,0.0000060234584,0.0035370581,0.024860078],"study_design_scores_gemma":[0.0018003633,0.00084948924,0.51714844,0.00015020808,0.00006987388,0.000028752534,0.00026035236,0.000015734711,0.47728282,0.000004473012,0.002222155,0.00016733377],"about_ca_topic_score_codex":0.00032273773,"about_ca_topic_score_gemma":0.00005142221,"teacher_disagreement_score":0.21962729,"about_ca_system_score_codex":0.00039687188,"about_ca_system_score_gemma":0.00027274806,"threshold_uncertainty_score":0.8398561},"labels":[],"label_agreement":null},{"id":"W2318244097","doi":"10.1097/01.cot.0000383768.74300.cb","title":"Renal Cell Cancer: Role of Cytoreductive Nephrectomy Remains Unclear in Targeted Therapy Era; Retrospective Analysis Suggests Benefit","year":2010,"lang":"en","type":"article","venue":"Oncology Times","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Bevacizumab; Sorafenib; Kidney cancer; Nephrectomy; Internal medicine; Oncology; Cancer; Targeted therapy; Surgery; Chemotherapy; Kidney","score_opus":0.008195071325351251,"score_gpt":0.27438767688366966,"score_spread":0.2661926055583184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318244097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9643228,0.0014124105,0.000001477983,0.000661477,0.00012454907,0.00052064174,0.00004903895,0.000037070702,0.032870505],"genre_scores_gemma":[0.99418813,0.00034015256,0.002267111,0.00008192292,0.0001843607,0.00010018413,0.000064580265,0.000033369157,0.0027401666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983078,0.00010985859,0.0004047551,0.00051343266,0.00028600963,0.00037811307],"domain_scores_gemma":[0.9986983,0.00013111244,0.00027831507,0.00045774167,0.00027441906,0.00016011168],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026138098,0.00026299618,0.0009791085,0.00055118767,0.000060834704,0.00000629077,0.00014473053,0.0003215683,0.0017152638],"category_scores_gemma":[0.00004225888,0.0002152796,0.00028482996,0.0010496435,0.00023751454,0.0000683076,0.0000440818,0.0006241947,0.000023864437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011921208,0.0009037731,0.5714484,0.000008911396,0.0011410858,0.00012439213,0.0014876883,0.00013222764,0.4188506,0.00030521664,0.0005451047,0.0038605211],"study_design_scores_gemma":[0.0026359535,0.001606202,0.74239033,0.000013172772,0.00061293173,0.00001805087,0.00030075485,0.00017289155,0.24922678,0.0006219695,0.0022455077,0.00015544692],"about_ca_topic_score_codex":0.0020440717,"about_ca_topic_score_gemma":0.004890279,"teacher_disagreement_score":0.17094198,"about_ca_system_score_codex":0.000708111,"about_ca_system_score_gemma":0.0004968436,"threshold_uncertainty_score":0.9991973},"labels":[],"label_agreement":null},{"id":"W2318735918","doi":"10.1016/j.juro.2016.02.1728","title":"MP75-10 HILAR LOCATION OF RENAL TUMOR PREDICTS INCIDENCE OF MAJOR COMPLICATIONS AFTER ROBOTIC PARTIAL NEPHRECTOMY: A LARGE, MULTI-INSTITUTIONAL STUDY","year":2016,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Pfizer Canada; Pfizer","keywords":"Medicine; Nephrectomy; Incidence (geometry); Demographics; Univariate analysis; Renal tumor; Multivariate analysis; Surgery; General surgery; Urology; Internal medicine; Kidney; Demography","score_opus":0.025676328464204194,"score_gpt":0.2819915650454584,"score_spread":0.2563152365812542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318735918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97514236,0.0011209865,0.021325296,0.0017359582,0.000100966114,0.0005239656,0.000010083627,0.000006225317,0.000034161265],"genre_scores_gemma":[0.9989163,0.000023919687,0.0006882186,0.0001507836,0.000115530675,0.00002762856,0.000002022527,0.000009955815,0.00006559097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833375,0.00029958668,0.0007026278,0.000117859905,0.0003658193,0.000180362],"domain_scores_gemma":[0.9979232,0.00028315428,0.0006217103,0.00032852977,0.000743472,0.000099940546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007135835,0.00012909286,0.00041107537,0.00015899284,0.000051898354,0.0000021368307,0.00019180396,0.000047565096,0.00014382356],"category_scores_gemma":[0.00033663728,0.000064002685,0.00009442141,0.00019250481,0.00028427632,0.000087690634,0.00006196509,0.0001576567,0.000020891614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021356652,0.010125491,0.7527215,0.00022089234,0.0020008606,0.00071538606,0.0028219107,0.0052750665,0.20213158,0.00053667417,0.00085575937,0.0012382208],"study_design_scores_gemma":[0.007180768,0.0046931882,0.9759676,0.00016232234,0.0012493706,0.0017251031,0.000076341246,0.00090155535,0.007536556,0.00010580273,0.0003273205,0.00007408389],"about_ca_topic_score_codex":0.000020560014,"about_ca_topic_score_gemma":0.000040630413,"teacher_disagreement_score":0.22324608,"about_ca_system_score_codex":0.00009373931,"about_ca_system_score_gemma":0.00041080124,"threshold_uncertainty_score":0.2609954},"labels":[],"label_agreement":null},{"id":"W2319136460","doi":"10.1097/pas.0000000000000354","title":"Renal Leiomyoma","year":2014,"lang":"en","type":"review","venue":"The American Journal of Surgical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Calgary Laboratory Services","funders":"","keywords":"Leiomyoma; Renal sinus; Medicine; Renal capsule; Angiomyolipoma; Pathology; Renal cell carcinoma; Differential diagnosis; Nephrectomy; Fibroma; Uterine leiomyoma; Kidney; Internal medicine","score_opus":0.04642562067792438,"score_gpt":0.3425858389394454,"score_spread":0.296160218261521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319136460","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047232956,0.99205023,0.00004654938,0.00071859534,0.00023588772,0.00029176942,0.000005332242,0.0000137998795,0.0019145231],"genre_scores_gemma":[0.0012998806,0.9963262,0.000427435,0.00018603746,0.0012790961,0.0000117121335,0.000009667287,0.00006307658,0.00039687063],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961153,0.001389742,0.001346275,0.0002736665,0.00046679913,0.00040821533],"domain_scores_gemma":[0.9952796,0.0010669172,0.002529439,0.000619682,0.00018006969,0.00032430468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012883826,0.0004469121,0.004963636,0.00031817026,0.000060097937,0.000013797846,0.00045417927,0.00014683414,0.00012975058],"category_scores_gemma":[0.00008771751,0.00020343145,0.0018424386,0.00044611518,0.0010547772,0.000022706126,0.00010311688,0.0012719469,0.00018254205],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000312885,0.000103773375,0.000017084112,0.00063687237,0.00042000614,0.02035567,0.000025178959,5.4059484e-7,0.0000030309866,0.000069641144,0.0007414121,0.97731394],"study_design_scores_gemma":[0.0005786587,0.0033932042,0.00007636494,0.002264239,0.002510315,0.18586501,0.000013268166,3.5476523e-7,0.0000017727707,0.00004229926,0.80511254,0.00014195591],"about_ca_topic_score_codex":0.0000044197964,"about_ca_topic_score_gemma":2.0706533e-7,"teacher_disagreement_score":0.97717196,"about_ca_system_score_codex":0.00019061692,"about_ca_system_score_gemma":0.00039952155,"threshold_uncertainty_score":0.8295694},"labels":[],"label_agreement":null},{"id":"W2319632502","doi":"10.1097/pai.0b013e3181ec51a9","title":"Fluorescent In-situ Hybridization Study of Non-papillary Oncocytic/Eosinophilic Renal Cell Carcinoma","year":2010,"lang":"en","type":"article","venue":"Applied immunohistochemistry & molecular morphology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Eosinophilic; In situ hybridization; Pathology; In situ; Papillary renal cell carcinomas; Medicine; Renal cell carcinoma; Cancer research; Biology; Chemistry; Gene; Biochemistry; Gene expression","score_opus":0.0060141690617407425,"score_gpt":0.24015895989010902,"score_spread":0.23414479082836828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319632502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987766,0.00044737002,0.00008824922,0.00004822715,0.00016980221,0.0014095715,0.0000045073252,0.000038177226,0.010028056],"genre_scores_gemma":[0.9981535,0.000009588075,0.001021022,0.00012151919,0.00006287894,0.00022671328,0.00020683328,0.000080197446,0.00011771446],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973776,0.000046485722,0.0008126935,0.00080163096,0.00045447075,0.00050716044],"domain_scores_gemma":[0.99787813,0.00003873429,0.00032562186,0.0014243098,0.00015081691,0.00018237821],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019687731,0.00045403876,0.0007850805,0.00021904561,0.000066321554,0.000010230866,0.00032447933,0.00031543273,0.00009783672],"category_scores_gemma":[0.000029025266,0.00047239667,0.00016678614,0.00034381376,0.00023589966,0.000026716878,0.00019074073,0.0007781565,0.000036210564],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006226387,0.0023052904,0.0035607428,0.00015424976,0.000073596944,0.002001759,0.0003800971,0.00003333489,0.990377,0.000016058808,0.000099521254,0.00037568968],"study_design_scores_gemma":[0.006081127,0.00084527675,0.060724154,0.00001979824,0.00025775988,0.0005002346,0.00024719373,0.000015587915,0.93097746,0.000017754617,0.000017244796,0.00029637924],"about_ca_topic_score_codex":0.00020230684,"about_ca_topic_score_gemma":0.0000019118281,"teacher_disagreement_score":0.05939953,"about_ca_system_score_codex":0.00039181922,"about_ca_system_score_gemma":0.00029697292,"threshold_uncertainty_score":0.9997728},"labels":[],"label_agreement":null},{"id":"W2323727418","doi":"10.1016/j.juro.2012.02.787","title":"703 THE ASSOCIATION BETWEEN RENAL TUMOR SCORING SYSTEMS AND PARTIAL NEPHRECTOMY COMPLICATIONS","year":2012,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nephrectomy; Medicine; General surgery; Surgery; Library science; Classics; Internal medicine; Kidney; History","score_opus":0.040923423951782056,"score_gpt":0.2822532911193019,"score_spread":0.24132986716751986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323727418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990305,0.0032756997,0.0002998546,0.005051338,0.00020991202,0.0002156937,0.0000017812902,0.000005852448,0.0006348509],"genre_scores_gemma":[0.99844325,0.000058939208,0.00004058965,0.00027269675,0.0011039777,0.0000071340028,0.0000012086745,0.000007737767,0.00006446854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989376,0.00033123072,0.00029389941,0.000043162785,0.00019846763,0.00019561598],"domain_scores_gemma":[0.99860173,0.0006404977,0.00041437664,0.00014695767,0.00010039567,0.00009604201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013126924,0.00007161715,0.00021660184,0.000046535635,0.000119720076,0.000010820517,0.00007297529,0.000038829174,0.000007256851],"category_scores_gemma":[0.00011059099,0.00003463007,0.000051151874,0.000067314955,0.000053932195,0.00005846094,0.000028669476,0.0002821376,0.000014228085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023565684,0.00007053586,0.9911932,0.000014071086,0.0005296582,0.00001275308,0.0007887803,0.00008662754,0.004860608,0.0005081454,0.0010970002,0.0006029678],"study_design_scores_gemma":[0.0008550113,0.00047189783,0.97633374,0.000016097692,0.001145889,0.0023957202,0.00009886546,0.00010113018,0.0006327357,0.00005683359,0.01785149,0.000040599934],"about_ca_topic_score_codex":0.00003015119,"about_ca_topic_score_gemma":0.0000013000978,"teacher_disagreement_score":0.016754491,"about_ca_system_score_codex":0.0001084184,"about_ca_system_score_gemma":0.000039893275,"threshold_uncertainty_score":0.14121732},"labels":[],"label_agreement":null},{"id":"W2323745284","doi":"10.12788/jcso.0048","title":"Practice challenges affecting optimal care as identified by US medical oncologists who treat renal cell carcinomas","year":2014,"lang":"en","type":"article","venue":"The Journal of Community and Supportive Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Axdev Group (Canada)","funders":"","keywords":"Medicine; Respondent; Family medicine; Renal cell carcinoma; Clinical Practice; Internal medicine; Intensive care medicine","score_opus":0.03839577549037486,"score_gpt":0.3437274986382539,"score_spread":0.30533172314787904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323745284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9305122,0.009081856,0.00009284242,0.009258388,0.00014370473,0.00026474838,0.000003467118,0.00001409248,0.050628707],"genre_scores_gemma":[0.9941767,0.0037201913,0.00023581393,0.001178581,0.00021590789,0.000005297974,0.00001365842,0.000023275159,0.0004306183],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9923298,0.0059038424,0.00068250205,0.0001218239,0.00060362753,0.0003584017],"domain_scores_gemma":[0.9917441,0.005896487,0.0008933572,0.00043797313,0.0005904527,0.00043761672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051464303,0.0002607717,0.0008832532,0.00012375657,0.0004699513,0.000021955391,0.00039011863,0.00032393823,0.0001378258],"category_scores_gemma":[0.0020440593,0.00016348186,0.00017330553,0.00009333377,0.00057006563,0.00017835706,0.00024294156,0.0021443497,0.000012637569],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042548347,0.012599688,0.023034481,0.0019508452,0.0031993256,0.010614503,0.38490847,0.00011876644,0.041013878,0.00063033996,0.047154024,0.43222734],"study_design_scores_gemma":[0.026503675,0.13064969,0.18436521,0.00071110507,0.006969663,0.068960644,0.37227148,0.00012776774,0.06890186,0.0004594744,0.13920726,0.000872168],"about_ca_topic_score_codex":0.00072454807,"about_ca_topic_score_gemma":0.00031466177,"teacher_disagreement_score":0.43135518,"about_ca_system_score_codex":0.00044774174,"about_ca_system_score_gemma":0.0006460971,"threshold_uncertainty_score":0.9316252},"labels":[],"label_agreement":null},{"id":"W2324184778","doi":"10.1097/spc.0b013e3283644c30","title":"Side-effects associated with targeted therapies in renal cell carcinoma","year":2013,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Toxicity; Disease; Intensive care medicine; Kidney cancer; Targeted therapy; Bioinformatics; Cancer; Oncology; Pharmacology; Internal medicine","score_opus":0.104523932245038,"score_gpt":0.36961762084934596,"score_spread":0.26509368860430793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324184778","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018599277,0.97609395,0.00000638172,0.000013869656,0.00058366643,0.0040790816,0.00020105719,0.000029099323,0.00039359007],"genre_scores_gemma":[0.040681552,0.95336074,0.000042782587,0.000011976182,0.00015825918,0.0012701694,0.004280789,0.00008766824,0.000106048064],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99659014,0.0005695519,0.0008816934,0.00092061434,0.00044862184,0.00058936584],"domain_scores_gemma":[0.9978552,0.000518377,0.00068380684,0.0003386262,0.00035575204,0.00024823428],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014880211,0.0008989238,0.0025068028,0.00056198426,0.000056670004,0.000038345253,0.00013252927,0.00037806874,0.000068645466],"category_scores_gemma":[0.000110426015,0.0006032861,0.00033801608,0.0006703378,0.0001645914,0.00010367123,0.00008645705,0.00096994994,0.000029453753],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019724295,0.0009602784,0.2469073,0.107039265,0.0005736242,0.0003745039,0.011114789,9.4466094e-7,0.000006739582,0.000048819544,0.0009570702,0.6318194],"study_design_scores_gemma":[0.008602985,0.0040433896,0.44952527,0.1482348,0.0014029354,0.000018561177,0.0024303398,0.000008899705,0.00016058516,0.000040653187,0.3836798,0.0018517781],"about_ca_topic_score_codex":0.000049473572,"about_ca_topic_score_gemma":0.000023676972,"teacher_disagreement_score":0.62996763,"about_ca_system_score_codex":0.00095566007,"about_ca_system_score_gemma":0.00066473277,"threshold_uncertainty_score":0.99964184},"labels":[],"label_agreement":null},{"id":"W2325289081","doi":"10.1097/ede.0000000000000205","title":"Chronic Kidney Disease and Risk of Renal Cell Carcinoma","year":2014,"lang":"en","type":"article","venue":"Epidemiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Institutes of Health","keywords":"Medicine; Kidney disease; Renal cell carcinoma; Odds ratio; Internal medicine; Incidence (geometry); Kidney cancer; Population; Disease; Cancer; Risk factor; Environmental health","score_opus":0.027200035176420376,"score_gpt":0.28060935872890913,"score_spread":0.25340932355248874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325289081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98799086,0.0056266626,0.00073305203,0.0019978397,0.00008981462,0.00023320538,0.000023006347,0.000021578206,0.0032839777],"genre_scores_gemma":[0.9967786,0.00036366528,0.0010987659,0.00064598146,0.00038115963,0.000018981735,0.000049524984,0.00001688614,0.0006464017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982804,0.00060757785,0.0003951439,0.00034129972,0.00007203245,0.0003035556],"domain_scores_gemma":[0.997739,0.00095874973,0.00021644666,0.00044740396,0.000041288462,0.000597089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083614705,0.00015824412,0.0006077875,0.000075420045,0.000038558286,9.117308e-7,0.00005926135,0.0000939888,0.00013407881],"category_scores_gemma":[0.002333404,0.00011603197,0.00013054139,0.000054848868,0.0002186639,0.000018271681,0.000055992707,0.00017259417,0.00003915061],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022086171,0.000054742082,0.9878471,0.00022116335,0.000062782325,0.00002673081,0.000034154324,0.000030183046,0.0028888488,0.00063407805,0.0051892768,0.0027901046],"study_design_scores_gemma":[0.0018979824,0.0012513739,0.9801128,0.000037636855,0.0005237236,0.000030821793,0.0000041538397,0.0016034093,0.004006955,0.0016933613,0.008735446,0.00010235361],"about_ca_topic_score_codex":0.00025568405,"about_ca_topic_score_gemma":0.000007481912,"teacher_disagreement_score":0.00878777,"about_ca_system_score_codex":0.00008022603,"about_ca_system_score_gemma":0.00014723264,"threshold_uncertainty_score":0.47316468},"labels":[],"label_agreement":null},{"id":"W2325579641","doi":"10.1097/mou.0b013e3283542bc5","title":"The emerging role of percutaneous biopsy in diagnosis and management of small renal masses","year":2012,"lang":"en","type":"review","venue":"Current Opinion in Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Percutaneous; Biopsy; Percutaneous biopsy; Intensive care medicine; Renal mass; Renal biopsy; Radiology; General surgery; Kidney; Internal medicine; Nephrectomy","score_opus":0.10839514134057587,"score_gpt":0.36697033467985474,"score_spread":0.25857519333927886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325579641","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028114384,0.9949259,0.0000027247443,0.00006308501,0.00090051565,0.0010730533,0.000014708553,0.000006304889,0.00020223654],"genre_scores_gemma":[0.0035083224,0.9958361,0.00013465469,0.0000016936222,0.000100181795,0.00031260776,0.00007137236,0.00002604814,0.000009034329],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99806905,0.00025014518,0.0008577774,0.00033119603,0.00016375374,0.00032806565],"domain_scores_gemma":[0.99877703,0.00036266109,0.00038629185,0.0003735642,0.000030084497,0.00007034119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032762214,0.00029204917,0.0011790452,0.0003586118,0.000021149393,0.000003916121,0.00016132943,0.00016997475,0.000022621352],"category_scores_gemma":[0.00002286718,0.0001931972,0.00018692017,0.00026495563,0.00015016741,0.000014952335,0.00018776281,0.0003275662,0.0000046003643],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054758868,0.00030002315,0.011969022,0.026863387,0.0001572099,0.000030927727,0.000115128874,0.0000018443975,0.0000010581043,0.00051083136,0.000022156204,0.95997363],"study_design_scores_gemma":[0.00041516375,0.00029992583,0.0040123304,0.008982549,0.0007298831,0.0005778375,0.000062658924,0.000011846928,0.0000023199566,0.000061583945,0.9846953,0.00014856533],"about_ca_topic_score_codex":0.00003012818,"about_ca_topic_score_gemma":0.000007580279,"teacher_disagreement_score":0.9846732,"about_ca_system_score_codex":0.0000999013,"about_ca_system_score_gemma":0.000057234323,"threshold_uncertainty_score":0.7878353},"labels":[],"label_agreement":null},{"id":"W2325752728","doi":"10.1016/j.urology.2016.03.029","title":"Pathological Upstaging of Clinical T1 to Pathological T3a Renal Cell Carcinoma: A Multi-institutional Analysis of Short-term Outcomes","year":2016,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Ottawa Hospital; McGill University; University of Ottawa; University of Alberta; Cancer Care Ontario; McMaster University; University of British Columbia; Public Health Ontario; Dalhousie University; University of Toronto; Centre hospitalier universitaire de Québec; University of Manitoba","funders":"","keywords":"Medicine; Pathological; Renal cell carcinoma; Pathology; Radiology","score_opus":0.10858941431223916,"score_gpt":0.3686177988893425,"score_spread":0.2600283845771033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325752728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98777604,0.0001496479,0.009746947,0.0009138367,0.00014930361,0.00035508917,0.000086794,0.000036072153,0.00078629615],"genre_scores_gemma":[0.99497163,0.000017130242,0.0041634734,0.00048613557,0.0000683946,0.000034026063,0.00003658139,0.00001365056,0.0002089845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99693483,0.00035570958,0.0012316372,0.00068931945,0.0003663207,0.00042216177],"domain_scores_gemma":[0.9979164,0.00072196225,0.00023596201,0.0006226718,0.00019604884,0.00030693662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007348588,0.00028678068,0.0016465761,0.0004628393,0.000042544754,0.000002803893,0.00021867367,0.0003461656,0.00034781185],"category_scores_gemma":[0.0006089262,0.00014824294,0.0008805207,0.0003851408,0.0005953513,0.000032488326,0.0002103889,0.00022841424,0.000037339403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007899699,0.0011463908,0.9496827,0.000017204873,0.00037582943,0.0013728035,0.00009558575,0.00007441958,0.043341093,0.0002272469,0.000030045154,0.0028467046],"study_design_scores_gemma":[0.002497028,0.002454331,0.98747617,0.00000795646,0.0018830779,0.00009939235,0.000015866042,0.00019357604,0.005082288,0.000024310826,0.00012444597,0.00014155792],"about_ca_topic_score_codex":0.00001770852,"about_ca_topic_score_gemma":0.000017249298,"teacher_disagreement_score":0.038258806,"about_ca_system_score_codex":0.000066552864,"about_ca_system_score_gemma":0.00012757674,"threshold_uncertainty_score":0.6045171},"labels":[],"label_agreement":null},{"id":"W2327217331","doi":"10.1097/pai.0b013e31828ef24e","title":"Diagnostic and Prognostic Role of Immunohistochemical Expression of Napsin-A Aspartic Peptidase in Clear Cell and Papillary Renal Cell Carcinoma","year":2013,"lang":"en","type":"article","venue":"Applied immunohistochemistry & molecular morphology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Immunohistochemistry; Tissue microarray; Pathology; Renal cell carcinoma; Medicine; Clear cell; Carcinoma; Papillary renal cell carcinomas; Staining","score_opus":0.0037838170764787804,"score_gpt":0.20215922827928368,"score_spread":0.19837541120280489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327217331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98128253,0.014883065,0.000016754835,0.00004333712,0.000019270652,0.001087883,0.000007833531,0.00002028404,0.002639019],"genre_scores_gemma":[0.9976391,0.00009327946,0.0016491675,0.000054667227,0.000014270815,0.0003301775,0.00009308724,0.000059323567,0.00006692015],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977852,0.00006231356,0.0007574084,0.00065687863,0.0002837435,0.00045447418],"domain_scores_gemma":[0.9983466,0.00026237906,0.00033145756,0.0007469718,0.00010372421,0.00020882086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012599648,0.00040146644,0.0007830376,0.00013449695,0.000043651762,0.00000917636,0.00019619866,0.00032472482,0.00012718703],"category_scores_gemma":[0.00011707662,0.00039574783,0.00011527843,0.00016356315,0.00062102923,0.000034931087,0.0002943469,0.00040494258,0.000012445462],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040664276,0.0005250038,0.008638928,0.00062838773,0.000024520135,0.00025106675,0.00028914752,0.000005284971,0.9888622,0.000013632983,0.00008115794,0.00027401155],"study_design_scores_gemma":[0.0027777688,0.00059316796,0.04844855,0.0001398422,0.00019482979,0.0003238347,0.00028905363,0.000023673329,0.94680065,0.00013754002,0.0000069629564,0.00026411694],"about_ca_topic_score_codex":0.00021642206,"about_ca_topic_score_gemma":5.862172e-8,"teacher_disagreement_score":0.04206156,"about_ca_system_score_codex":0.00014515768,"about_ca_system_score_gemma":0.0001150895,"threshold_uncertainty_score":0.99984944},"labels":[],"label_agreement":null},{"id":"W2327663787","doi":"10.1097/01.cot.0000482225.33164.30","title":"Pazopanib or Sunitinib in Metastatic Renal Cancer","year":2016,"lang":"en","type":"article","venue":"Oncology Times","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pazopanib; Sunitinib; Medicine; Renal cell carcinoma; Oncology; Internal medicine; Kidney cancer; Cancer; Clear cell renal cell carcinoma; Progression-free survival; Genitourinary system; Overall survival","score_opus":0.06300581660993439,"score_gpt":0.35894357801559584,"score_spread":0.29593776140566147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327663787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92780375,0.00082150503,0.000031692918,0.010275795,0.00014809395,0.00044180715,0.000018392364,0.000049676994,0.060409307],"genre_scores_gemma":[0.92179173,0.00027562317,0.0012539565,0.00070778315,0.00011285202,0.00018376466,0.000007980419,0.00002198331,0.07564434],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998999,0.00011734838,0.00023902558,0.0002295662,0.00013000787,0.00028506177],"domain_scores_gemma":[0.9991945,0.0003738606,0.000069328176,0.00019589113,0.000049181435,0.00011723352],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017821486,0.00013429332,0.00039171657,0.00012778975,0.000022904724,0.0000031211398,0.00006339173,0.000072728726,0.0078114425],"category_scores_gemma":[0.00010784875,0.00006706599,0.000057616624,0.00013671511,0.00011311313,0.00004635045,0.00003124831,0.00009562942,0.00036047393],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008023733,0.0022806074,0.13884684,0.00017932107,0.0009445978,0.017774286,0.0012955877,0.000009935601,0.12816495,0.0015050824,0.09432681,0.60664827],"study_design_scores_gemma":[0.028924786,0.009284156,0.3189061,0.0009077493,0.0011231442,0.0019724823,0.0005072416,0.00006405526,0.10914407,0.0011975213,0.5273279,0.00064080564],"about_ca_topic_score_codex":0.00017958647,"about_ca_topic_score_gemma":0.00069012487,"teacher_disagreement_score":0.60600746,"about_ca_system_score_codex":0.00048476853,"about_ca_system_score_gemma":0.0005831824,"threshold_uncertainty_score":0.9930956},"labels":[],"label_agreement":null},{"id":"W2329459859","doi":"10.1016/j.juro.2013.02.2669","title":"1315 DISPARITIES IN ACCESS TO HIGH-VOLUME SURGEONS AND HOSPITALS AMONGST NON-METASTATIC KIDNEY CANCER PATIENTS TREATED WITH PARTIAL OR RADICAL NEPHRECTOMY","year":2013,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Cancer; Renal cell carcinoma; Kidney cancer; General surgery; Surgery; Family medicine; Gerontology; Kidney; Internal medicine","score_opus":0.013532339029496413,"score_gpt":0.2602696383065501,"score_spread":0.24673729927705368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329459859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888827,0.00019745246,0.000022996515,0.0101085,0.00010417499,0.00063722325,0.000011481848,0.000005854839,0.00002957713],"genre_scores_gemma":[0.9976207,0.00019200188,0.00013606471,0.0017326162,0.00006406085,0.000057171044,0.000005708624,0.000021779939,0.00016989732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986336,0.0002014972,0.00043304556,0.00013588308,0.00025712227,0.0003388172],"domain_scores_gemma":[0.9988432,0.00021363712,0.0002282831,0.00015526221,0.00015760586,0.0004020423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002163051,0.0001825604,0.00056379184,0.00018719478,0.000048056132,0.00003328598,0.00015304258,0.000055449775,0.00039811985],"category_scores_gemma":[0.00013863397,0.00008798394,0.00004278282,0.00021209782,0.00020812986,0.00018396549,0.000061234816,0.00026918587,0.000012018791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032035522,0.00025704203,0.98855335,0.000026978341,0.00021471754,0.00024978028,0.00026589906,0.000055290922,0.00016581926,0.000002159187,0.0062316246,0.0007738158],"study_design_scores_gemma":[0.004456459,0.0047936607,0.9885025,0.000073836,0.00046181178,0.00027389574,0.0000329628,0.000102633225,0.0005083221,0.00002215545,0.00067456416,0.00009718086],"about_ca_topic_score_codex":0.00662057,"about_ca_topic_score_gemma":0.000501155,"teacher_disagreement_score":0.00873796,"about_ca_system_score_codex":0.000092181515,"about_ca_system_score_gemma":0.00019225599,"threshold_uncertainty_score":0.99999446},"labels":[],"label_agreement":null},{"id":"W2330417965","doi":"10.1016/j.juro.2016.02.1727","title":"MP75-09 THE NATURAL HISTORY OF RENAL FUNCTION AFTER SURGICAL MANAGEMENT OF RENAL CELL CARCINOMA: RESULTS FROM THE CANADIAN KIDNEY CANCER INFORMATION SYSTEM","year":2016,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Renal function; Kidney cancer; Cancer; Natural history; Kidney disease; Kidney; Internal medicine","score_opus":0.011562429970337096,"score_gpt":0.20017463744307684,"score_spread":0.18861220747273974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330417965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772718,0.0054309103,0.000045102224,0.01086626,0.0011678736,0.00034012084,0.000087124456,0.0000047282724,0.0047861002],"genre_scores_gemma":[0.9983017,0.0001382313,0.00001691916,0.00051969755,0.0002941922,0.000008460085,0.000009117356,0.000009110918,0.0007025718],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9981144,0.00037239582,0.00075438054,0.00008832773,0.0004457686,0.00022472149],"domain_scores_gemma":[0.99807936,0.0002854888,0.0008000601,0.0003993266,0.00028047283,0.00015526616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000997274,0.00014352048,0.0003071318,0.000119861805,0.00006293389,0.0000040612317,0.00025401954,0.00009426086,0.000095875235],"category_scores_gemma":[0.000034251316,0.000053011063,0.00015855956,0.00008849411,0.00023747241,0.00009343284,0.000045644538,0.0003127007,0.00001141095],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32637003,0.000692809,0.08307444,0.001430582,0.009384107,0.004249869,0.042541727,0.0020609996,0.027103564,0.0027557602,0.45727855,0.04305758],"study_design_scores_gemma":[0.01765418,0.0029908286,0.7541853,0.0006003357,0.004793753,0.0015919803,0.0011673501,0.0003078032,0.0037068564,0.00007312763,0.21268593,0.00024252906],"about_ca_topic_score_codex":0.019975733,"about_ca_topic_score_gemma":0.0048251622,"teacher_disagreement_score":0.67111087,"about_ca_system_score_codex":0.0011551656,"about_ca_system_score_gemma":0.0007396144,"threshold_uncertainty_score":0.98655033},"labels":[],"label_agreement":null},{"id":"W2330712191","doi":"10.1097/mph.0000000000000094","title":"Recurrent Ascites in a Patient With Low-grade Astrocytoma and Ventriculo-Peritoneal Shunt Treated With the Multikinase Inhibitor Sorafenib","year":2013,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Sorafenib; Ascites; Shunt (medical); Complication; Internal medicine; Astrocytoma; Ascitic fluid; Surgery; Adverse effect; Gastroenterology; Hepatocellular carcinoma; Glioma; Cancer research","score_opus":0.010388792531508317,"score_gpt":0.2516769698742681,"score_spread":0.24128817734275976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330712191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990411,0.0043210927,0.000019123472,0.003948446,0.00012418907,0.0010548536,0.0000034799366,0.00001670182,0.00010113794],"genre_scores_gemma":[0.9968885,0.00034520656,0.0020412134,0.00017456691,0.0003785192,0.00011793378,0.0000055956043,0.000030782725,0.000017644377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974991,0.00033584624,0.0008631734,0.00032694975,0.00044770245,0.0005271915],"domain_scores_gemma":[0.99760664,0.00051074073,0.0008747344,0.00023020829,0.00038765746,0.00039003306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029905213,0.00035472988,0.0010716266,0.0005233658,0.00008618937,0.000027206754,0.00013506683,0.00024035784,0.00004826672],"category_scores_gemma":[0.00009861072,0.0001752341,0.0001244803,0.0005651732,0.0002339052,0.00015315172,0.000063832,0.000753503,0.000016667585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012921458,0.009189239,0.8741071,0.0005641249,0.000801195,0.061661646,0.004581042,0.00007860766,0.0021967618,0.00005491005,0.009029176,0.024814716],"study_design_scores_gemma":[0.063203216,0.17103297,0.49796614,0.0007132187,0.0040125092,0.22193466,0.01043513,0.00069643906,0.023277784,0.00006986005,0.0053915777,0.0012664798],"about_ca_topic_score_codex":0.00007755117,"about_ca_topic_score_gemma":0.000101758174,"teacher_disagreement_score":0.37614098,"about_ca_system_score_codex":0.00056713464,"about_ca_system_score_gemma":0.0006129653,"threshold_uncertainty_score":0.71458393},"labels":[],"label_agreement":null},{"id":"W2331312640","doi":"10.1097/pai.0000000000000257","title":"Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma","year":2015,"lang":"en","type":"article","venue":"Applied immunohistochemistry & molecular morphology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Renal cell carcinoma; Chromosome; Cancer research; Biology; Comparative genomic hybridization; Genetic heterogeneity; Chromosome 3; Fluorescence in situ hybridization; Cytogenetics; Primary tumor; Pathology; Metastasis; Gene; Genetics; Cancer; Medicine; Phenotype","score_opus":0.03400165614682288,"score_gpt":0.29751508668297655,"score_spread":0.26351343053615367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331312640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99197507,0.002314879,0.00092320517,0.0001328392,0.000055410623,0.0016942238,0.000049148864,0.000048576178,0.0028066188],"genre_scores_gemma":[0.98694575,0.000005710831,0.010828015,0.00053411914,0.000040867988,0.00087441475,0.0003647844,0.000082559076,0.00032376335],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99740523,0.00006194076,0.0006476311,0.0009896399,0.0002873891,0.0006081969],"domain_scores_gemma":[0.9982439,0.000083936444,0.00019972908,0.00091655937,0.00013990777,0.00041593568],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032646797,0.00044793365,0.00074429467,0.00015439498,0.00009223266,0.0000337217,0.00020227543,0.00016223712,0.00004332278],"category_scores_gemma":[0.00009181347,0.0004733324,0.0001595936,0.00023333485,0.00016994917,0.000040263774,0.00015571309,0.00033305198,0.000044223485],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001017196,0.00034746312,0.00033531876,0.00021080393,0.000058926547,0.00085930305,0.0002721428,0.00019240822,0.99635535,0.00007531177,0.00017981825,0.0000959744],"study_design_scores_gemma":[0.0050264825,0.0014517041,0.0017376549,0.00002356819,0.00026250992,0.0010508619,0.00044475505,0.00006500538,0.9890985,0.0003571139,0.00009721173,0.00038464976],"about_ca_topic_score_codex":0.0003909266,"about_ca_topic_score_gemma":0.0000019138536,"teacher_disagreement_score":0.00990481,"about_ca_system_score_codex":0.00056383316,"about_ca_system_score_gemma":0.00044608087,"threshold_uncertainty_score":0.99977183},"labels":[],"label_agreement":null},{"id":"W2333897154","doi":"10.1016/s1040-8428(13)70021-0","title":"IIIB.1 Adjuvant chemotherapy in elderly patients: an analysis of National Cancer Institute of Canada Clinical Trials Group and Intergroup JBR.10","year":2006,"lang":"en","type":"article","venue":"Critical Reviews in Oncology/Hematology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Axitinib; Medicine; Proteinuria; Discontinuation; Internal medicine; Adverse effect; Hazard ratio; Renal cell carcinoma; Urology; Gastroenterology; Renal function; Oncology; Kidney; Confidence interval; Sunitinib","score_opus":0.10382160704737768,"score_gpt":0.46543353735548804,"score_spread":0.36161193030811034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333897154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787823,0.016672982,0.00009311953,0.0017937559,0.00035674084,0.00094889005,0.000047291134,0.0000059162526,0.0012990072],"genre_scores_gemma":[0.99487793,0.0026090208,0.0012458711,0.00083973544,0.000068626796,0.00018500422,0.00011961647,0.000013305642,0.000040868734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99421257,0.001382049,0.0032623315,0.00050272164,0.0003028896,0.00033744978],"domain_scores_gemma":[0.9963169,0.0024158994,0.0005129799,0.00028681994,0.00029523924,0.00017215013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033805252,0.00023916479,0.003850901,0.00042290692,0.000019428351,0.0000031041118,0.00014068035,0.00032665546,0.0003791791],"category_scores_gemma":[0.0060821264,0.00018321835,0.00029395535,0.0005880603,0.00059187616,0.00008165642,0.00004646697,0.00030772286,0.0000011818325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014328525,0.005041233,0.8884856,0.00069098175,0.00049144437,0.00022962505,0.00010828606,0.000010149665,0.00019038269,0.022862775,0.0034425594,0.077014074],"study_design_scores_gemma":[0.01353727,0.0049079084,0.93234694,0.0014060144,0.001862218,0.00007245468,0.000103650345,0.000913977,0.00050747173,0.0020502151,0.041886467,0.0004053939],"about_ca_topic_score_codex":0.025084851,"about_ca_topic_score_gemma":0.39102116,"teacher_disagreement_score":0.3659363,"about_ca_system_score_codex":0.0006498328,"about_ca_system_score_gemma":0.0008859017,"threshold_uncertainty_score":0.98140717},"labels":[],"label_agreement":null},{"id":"W2334242996","doi":"10.1016/j.juro.2014.02.488","title":"PD10-12 CLINICAL OUTCOMES FOLLOWING LAPAROSCOPIC MANAGEMENT OF PT3 RENAL MASSES: A MULTI-INSTITUTIONAL ANALYSIS","year":2014,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Kidney cancer; General surgery; Urology; Kidney; Oncology; Internal medicine","score_opus":0.05172970717016928,"score_gpt":0.3523635947971987,"score_spread":0.3006338876270294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334242996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98464423,0.00052596413,0.0120382225,0.0013410331,0.00036076523,0.00015400987,0.0000015392541,0.000007144256,0.00092711387],"genre_scores_gemma":[0.9921556,0.00015574286,0.0067686504,0.0004882881,0.000099846235,0.0000023640625,0.0000035290047,0.000009498747,0.00031649647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978057,0.00043153303,0.0009835911,0.00013947413,0.00042555408,0.00021416106],"domain_scores_gemma":[0.9983416,0.0004998785,0.0005618485,0.00036503142,0.000100632584,0.00013097636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019584536,0.00016054565,0.0009431992,0.0002622984,0.00006603955,0.0000052229066,0.00024118961,0.00009289656,0.00007086839],"category_scores_gemma":[0.00014874154,0.00008459301,0.0008885315,0.00022466865,0.0001836575,0.000047856603,0.00007770112,0.00030767493,0.000013817769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068506534,0.00054005627,0.9837935,0.000034478187,0.010713846,0.00035823009,0.000105679814,0.0014477698,0.00041789847,0.00038672014,0.0001335815,0.0013831691],"study_design_scores_gemma":[0.0053832405,0.0015009188,0.97704965,0.00003220099,0.013035595,0.00017357653,0.000071067894,0.00068418315,0.00019836951,0.00011461311,0.0016864096,0.00007018329],"about_ca_topic_score_codex":0.000022026205,"about_ca_topic_score_gemma":0.000023848741,"teacher_disagreement_score":0.007511377,"about_ca_system_score_codex":0.000058824826,"about_ca_system_score_gemma":0.00007580208,"threshold_uncertainty_score":0.34496027},"labels":[],"label_agreement":null},{"id":"W2334633670","doi":"10.1016/j.juro.2014.02.1923","title":"MP64-06 RECURRENCE AND SURVIVAL AFTER PARTIAL VERSUS RADICAL NEPHRECTOMY FOR T1 RENAL MASS","year":2014,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saint Paul University","funders":"","keywords":"Nephrectomy; Medicine; Premise; Urology; Surgery; Internal medicine; Kidney; Philosophy","score_opus":0.027434357927141245,"score_gpt":0.27973775270907936,"score_spread":0.2523033947819381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334633670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878349,0.0014579912,0.004058617,0.0054462,0.00063749735,0.00018939827,0.000002724337,0.0000063079383,0.00036637558],"genre_scores_gemma":[0.9972301,0.00013946214,0.0012684194,0.0003605563,0.00091143354,0.000007782572,0.000001873915,0.0000135264745,0.00006682882],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987928,0.00030908445,0.00031972365,0.00011258281,0.00021387155,0.000251881],"domain_scores_gemma":[0.9984769,0.00089160685,0.00018640318,0.00017500462,0.0000995963,0.00017048507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009953136,0.00012604921,0.0003529222,0.000065791166,0.000050428836,0.000008154913,0.0001095144,0.000090556074,0.000059507125],"category_scores_gemma":[0.00028087012,0.000072558905,0.000110710134,0.000050101993,0.00022285235,0.00003949271,0.00002912562,0.0003048616,0.000010537393],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5673514,0.0014624875,0.20556642,0.00039266367,0.0041935337,0.0019104204,0.0035454708,0.00032158458,0.07570328,0.004065763,0.022684095,0.11280289],"study_design_scores_gemma":[0.06416234,0.054443456,0.21632582,0.0001351071,0.0063411845,0.008770153,0.00016355216,0.0029808239,0.015192723,0.0053174756,0.625514,0.0006534245],"about_ca_topic_score_codex":0.000005300599,"about_ca_topic_score_gemma":0.000006513384,"teacher_disagreement_score":0.6028299,"about_ca_system_score_codex":0.000035544315,"about_ca_system_score_gemma":0.000066721324,"threshold_uncertainty_score":0.29588664},"labels":[],"label_agreement":null},{"id":"W2334823457","doi":"10.1097/pas.0000000000000247","title":"The Morphologic and Immunohistochemical Spectrum of Papillary Renal Cell Carcinoma","year":2014,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University; McGill University and Génome Québec Innovation Centre","funders":"","keywords":"Immunohistochemistry; Pathology; Papillary renal cell carcinomas; Medicine; Renal cell carcinoma; Carcinoma","score_opus":0.00881331570624683,"score_gpt":0.23295030176707016,"score_spread":0.22413698606082333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334823457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894159,0.0038035708,0.000046279572,0.004455923,0.00008095171,0.00010509611,0.0000015171967,0.0000053511117,0.0020854243],"genre_scores_gemma":[0.9982856,0.0008058993,0.0003572972,0.00020470789,0.00019036177,0.0000024915144,0.0000010919593,0.000014920594,0.00013763417],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99818355,0.0005138459,0.00057360966,0.00015786185,0.00028088037,0.00029025768],"domain_scores_gemma":[0.99769366,0.0009335214,0.0007352665,0.00038259797,0.00010283028,0.00015214721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010205526,0.00016708905,0.000702383,0.000067302484,0.000100597346,0.000007209465,0.00024218712,0.000049935254,0.000024837338],"category_scores_gemma":[0.0000777635,0.00007553453,0.00023733743,0.00016189512,0.0019941402,0.00001942647,0.00009822908,0.00047446985,0.0000056921353],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017961696,0.0009488296,0.09409532,0.000095137526,0.00039512795,0.01552085,0.0012530265,0.000039902017,0.7821927,0.0020056264,0.0020453148,0.08344645],"study_design_scores_gemma":[0.009063933,0.03816652,0.64068353,0.00010490332,0.0011104087,0.16365772,0.0011184214,0.00015608715,0.1276036,0.005761288,0.012066855,0.000506692],"about_ca_topic_score_codex":0.000015507734,"about_ca_topic_score_gemma":2.893403e-7,"teacher_disagreement_score":0.6545891,"about_ca_system_score_codex":0.000056177225,"about_ca_system_score_gemma":0.00006310104,"threshold_uncertainty_score":0.73474926},"labels":[],"label_agreement":null},{"id":"W2335012284","doi":"10.1038/nature12222","title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","year":2013,"lang":"en","type":"article","venue":"Nature","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3541,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"National Cancer Institute; National Center for Advancing Translational Sciences; National Human Genome Research Institute","keywords":"Renal cell carcinoma; Characterization (materials science); Clear cell renal cell carcinoma; Cell; Computational biology; Cancer research; Pathology; Biology; Medicine; Nanotechnology; Materials science; Genetics","score_opus":0.00759687724361141,"score_gpt":0.22064389406363497,"score_spread":0.21304701682002355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335012284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912031,0.0010032126,0.000029885528,0.00041313196,0.000101602905,0.0005919106,0.000013204981,0.000027169857,0.0066167726],"genre_scores_gemma":[0.99679226,0.000019595973,0.00066982844,0.00084821193,0.000078430996,0.000016623937,0.00021461603,0.000031254225,0.0013291833],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990039,0.000040089315,0.00020557045,0.00024274463,0.00031858828,0.00018914723],"domain_scores_gemma":[0.9990586,0.000018752975,0.00012318173,0.00034516145,0.00033112962,0.00012314263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000023582346,0.00016821854,0.00027499587,0.00009607009,0.000024685061,0.00001052154,0.000081829035,0.0005907842,0.00030733392],"category_scores_gemma":[0.00000654488,0.000136379,0.0001232576,0.00016277182,0.000037265334,0.00006414251,0.000037868438,0.00078438065,0.00014732884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088008775,0.00014501672,0.0035856045,0.00020596472,0.000016721971,0.00008943494,0.00012800246,0.0000019625818,0.99465126,0.000019553092,0.00069927,0.00036919187],"study_design_scores_gemma":[0.00094197533,0.00040151246,0.25623536,0.000022651195,0.00006945888,0.000020156262,0.000028195434,0.00008112786,0.73988366,0.000013601747,0.0022159768,0.00008629268],"about_ca_topic_score_codex":0.00003444199,"about_ca_topic_score_gemma":1.8560746e-7,"teacher_disagreement_score":0.2547676,"about_ca_system_score_codex":0.00006070152,"about_ca_system_score_gemma":0.00005123836,"threshold_uncertainty_score":0.55613744},"labels":[],"label_agreement":null},{"id":"W2335536243","doi":"10.1016/j.juro.2012.02.793","title":"709 OLDER AND SICKER RENAL CELL CARCINOMA PATIENTS ARE OPERATED AT LOW VOLUME HOSPITALS","year":2012,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Charlson comorbidity index; Renal cell carcinoma; Comorbidity; General surgery; Internal medicine; Kidney","score_opus":0.0087279408997593,"score_gpt":0.2156036837728108,"score_spread":0.2068757428730515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335536243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924482,0.005470278,0.000011365364,0.0010825952,0.0002847985,0.00022535579,0.000004267493,0.0000056617196,0.0004674556],"genre_scores_gemma":[0.99742126,0.00009407003,0.00006862329,0.0008445576,0.0002869421,0.0000020434686,0.0000055777964,0.000024865198,0.0012520305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987082,0.00021042686,0.0003733329,0.00009999355,0.00025430138,0.000353744],"domain_scores_gemma":[0.99882627,0.00008524397,0.00035773427,0.00022377411,0.00024028329,0.00026668666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036736828,0.00017442559,0.00038939525,0.00008992331,0.00008270487,0.000006741927,0.000107363216,0.00010691599,0.0002237829],"category_scores_gemma":[0.000043758624,0.000097304255,0.00008908672,0.00007623895,0.00013067298,0.000099561286,0.000089439956,0.0002918284,0.000084258216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009858445,0.0004100414,0.97871464,0.0000297312,0.00010646453,0.00014454049,0.0014906847,0.000015358553,0.010259167,0.000002175123,0.007444506,0.0003968603],"study_design_scores_gemma":[0.0032698896,0.0020430987,0.98267955,0.000014434235,0.0004821332,0.0011652026,0.000080571175,0.000027693433,0.00890336,0.0000065817485,0.0012377384,0.00008973666],"about_ca_topic_score_codex":0.000014719682,"about_ca_topic_score_gemma":0.0000020887032,"teacher_disagreement_score":0.0062067676,"about_ca_system_score_codex":0.00012390826,"about_ca_system_score_gemma":0.00003924912,"threshold_uncertainty_score":0.39679524},"labels":[],"label_agreement":null},{"id":"W2335605812","doi":"10.1016/j.juro.2012.02.1627","title":"1293 ACTIVE SURVEILLANCE MAY INCREASE THE RISK OF CANCER-SPECIFIC MORTALITY RELATIVE TO PARTIAL OR RADICAL NEPHRECTOMY: A COMPETING-RISKS ANALYSIS","year":2012,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Surveillance, Epidemiology, and End Results; Epidemiology; Population; Renal cell carcinoma; Cancer; Kidney cancer; Demography; Surgery; General surgery; Oncology; Cancer registry; Internal medicine; Environmental health; Kidney","score_opus":0.05989348520660725,"score_gpt":0.3475510802978358,"score_spread":0.28765759509122857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335605812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99197537,0.0032196303,0.0006227963,0.0033796686,0.00018044261,0.00030999168,0.00004031733,0.0000064031897,0.00026538665],"genre_scores_gemma":[0.9979824,0.0008707638,0.0002585274,0.00031903852,0.00050262414,0.000009862543,0.000002989962,0.000014617517,0.000039216986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962396,0.0021898495,0.000644754,0.00013418437,0.00043371427,0.00035790494],"domain_scores_gemma":[0.9960623,0.0020250375,0.00095021364,0.00043661325,0.00023800717,0.00028787577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023806181,0.00018751192,0.0008199548,0.00016762274,0.00011667053,0.0000050540466,0.00025157657,0.00009349127,0.00043959668],"category_scores_gemma":[0.00054134836,0.0000828479,0.00034469078,0.00063097454,0.00036851785,0.000064824395,0.000080271995,0.00067887333,0.000011554412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013776105,0.00029760235,0.9734906,0.0000068923146,0.0054513994,0.000064241416,0.0029947197,0.0011477312,0.00086755725,0.00006409602,0.00031818455,0.0015208755],"study_design_scores_gemma":[0.0014088636,0.0011457888,0.98429406,0.000009277317,0.005590254,0.00023843984,0.00031896442,0.00016815889,0.0017850827,0.000036687747,0.004926224,0.000078192956],"about_ca_topic_score_codex":0.0027155105,"about_ca_topic_score_gemma":0.00072763517,"teacher_disagreement_score":0.012367242,"about_ca_system_score_codex":0.00017401927,"about_ca_system_score_gemma":0.00018018387,"threshold_uncertainty_score":0.48132756},"labels":[],"label_agreement":null},{"id":"W2335702324","doi":"10.1158/1538-7445.am2013-4069","title":"Abstract 4069: FGFR2 expression and mutation are rare in papillary renal cell carcinoma.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Papillary renal cell carcinomas; Renal cell carcinoma; Immunohistochemistry; Medicine; Cancer research; Fibroblast growth factor receptor 2; Cancer; Mutation; Pathology; Internal medicine; Receptor; Biology; Fibroblast growth factor; Gene; Genetics","score_opus":0.06817045516972807,"score_gpt":0.3551371496249612,"score_spread":0.2869666944552331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335702324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98666644,0.0076902458,0.0000013935846,0.0009260496,0.000042464697,0.00096990145,0.00000827748,0.000019501156,0.00367575],"genre_scores_gemma":[0.99727917,0.00043033343,0.000101117424,0.00006160686,0.00015524658,0.0004562528,0.000031977102,0.000031090196,0.0014532381],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981336,0.00011988522,0.00023114086,0.00041494108,0.00063776766,0.00046263565],"domain_scores_gemma":[0.99893904,0.00013795587,0.00005592846,0.0003197178,0.00026979082,0.00027758145],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032060163,0.00014894048,0.00023576857,0.0002959043,0.000100779944,0.00005031964,0.000088877336,0.00011922176,0.0009907049],"category_scores_gemma":[0.000056970708,0.000116150055,0.000041427287,0.0002821243,0.00011341422,0.00016217447,0.000091447444,0.0005084505,0.00012606314],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028530508,0.00015573144,0.17191108,0.00062589726,0.0000109947805,0.0010930476,0.0008699969,0.000021052445,0.8057602,0.0000030843507,0.00991789,0.009345724],"study_design_scores_gemma":[0.0013592634,0.00018678213,0.6932744,0.00030496778,0.000007103627,0.000020435275,0.0006899169,0.000033102435,0.30358663,0.00007485737,0.00037245775,0.00009013817],"about_ca_topic_score_codex":0.0024374377,"about_ca_topic_score_gemma":0.00009539435,"teacher_disagreement_score":0.52136326,"about_ca_system_score_codex":0.00044548127,"about_ca_system_score_gemma":0.00022051699,"threshold_uncertainty_score":0.9999225},"labels":[],"label_agreement":null},{"id":"W2336678078","doi":"10.5489/cuaj.3351","title":"A simple prognostic model for overall survival in metastatic renal cell carcinoma","year":2016,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Moncton Hospital; Jewish General Hospital; Saint John Regional Hospital; Dalhousie University","funders":"","keywords":"Renal cell carcinoma; Simple (philosophy); Oncology; Overall survival; Medicine; Internal medicine; Cancer research; Philosophy","score_opus":0.03415205140514511,"score_gpt":0.24702867037319395,"score_spread":0.21287661896804885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336678078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862264,0.00014302631,0.0023420027,0.0095234485,0.00012997765,0.00057984615,0.00010775703,0.000014820664,0.0009327524],"genre_scores_gemma":[0.99628145,0.000014071145,0.00081379415,0.0010063383,0.00020195729,0.00005881676,0.000026398417,0.000022113793,0.0015750704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979695,0.00017159461,0.00046009297,0.00026916238,0.0003889029,0.0007407468],"domain_scores_gemma":[0.998034,0.00052581046,0.00023745027,0.00012478737,0.00025709224,0.0008208732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077320146,0.00019129667,0.00040980443,0.00023417566,0.00012479295,0.00004380812,0.000110163106,0.00015528123,0.00020780497],"category_scores_gemma":[0.0010286679,0.000121882644,0.00021163799,0.00012597516,0.000023809653,0.00009785843,0.000013141358,0.00028108506,0.000030611107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023072981,0.00013297045,0.99248254,0.000014424234,0.00006762906,0.00035972873,0.00010063768,0.0003569764,0.0014317067,0.00026911357,0.0035769457,0.0009766127],"study_design_scores_gemma":[0.0069737458,0.0010770179,0.97222173,0.000020536425,0.00022762321,0.000104186314,0.000029610906,0.009024193,0.0002149515,0.006643953,0.0032280649,0.00023438154],"about_ca_topic_score_codex":0.0005337099,"about_ca_topic_score_gemma":0.0021152368,"teacher_disagreement_score":0.020260789,"about_ca_system_score_codex":0.0025795682,"about_ca_system_score_gemma":0.0010544575,"threshold_uncertainty_score":0.6745481},"labels":[],"label_agreement":null},{"id":"W2337398034","doi":"","title":"Quality improvement of reporting standards for ablative studies: where do we stand?","year":2012,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ablative case; Health science; Family medicine; Medical education; Internal medicine; Radiation therapy","score_opus":0.1407155667891751,"score_gpt":0.38771566236961946,"score_spread":0.24700009558044436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337398034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9239285,0.0680019,0.0003108025,0.0007234489,0.00030176033,0.0032919836,0.000121396195,0.000038417544,0.0032817589],"genre_scores_gemma":[0.9947131,0.0008927204,0.0007821782,0.000021813381,0.00020587356,0.0022590486,0.000003981059,0.000022186312,0.0010990823],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99759364,0.00003867755,0.0010794578,0.00022687067,0.0005761812,0.0004851483],"domain_scores_gemma":[0.9975051,0.00021794031,0.0011235619,0.0003399459,0.00061079126,0.00020263945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034413673,0.00016239319,0.000606386,0.00005405025,0.000053178956,0.000006982851,0.0000414489,0.00005195474,0.000017567769],"category_scores_gemma":[0.0017825257,0.0001156713,0.00018517341,0.00010439662,0.0000674134,0.00009242072,0.000051286414,0.00007728412,5.98151e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020991464,0.0008253464,0.29257905,0.0063499096,0.0027063703,0.000022981087,0.007855697,0.0000021349706,0.0031895835,0.00073133985,0.0061120237,0.6775264],"study_design_scores_gemma":[0.0065059955,0.00097570976,0.7576814,0.00043301817,0.0007430522,0.000019344456,0.012380876,0.0000027400647,0.14439459,0.00069535687,0.07580515,0.00036275852],"about_ca_topic_score_codex":0.000023705757,"about_ca_topic_score_gemma":0.000008583688,"teacher_disagreement_score":0.67716366,"about_ca_system_score_codex":0.0008492728,"about_ca_system_score_gemma":0.00011710686,"threshold_uncertainty_score":0.47169384},"labels":[],"label_agreement":null},{"id":"W2337725933","doi":"10.1007/978-3-319-17238-5_10","title":"Image-Guided Tumor Ablative Therapies","year":2015,"lang":"en","type":"book-chapter","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Cryoablation; Medicine; Microwave ablation; Percutaneous; Ablation; Radiofrequency ablation; Ablative case; Malignancy; Radiology; Irreversible electroporation; Tumor ablation; Thermal ablation; Cryotherapy; Radiation therapy; Pathology; Internal medicine; Electroporation","score_opus":0.07878118817705666,"score_gpt":0.30234846823793743,"score_spread":0.22356728006088078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337725933","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004509587,0.0038922054,0.00002823951,0.00064458064,0.0001264676,0.00078109244,0.000022095923,0.00014636015,0.993908],"genre_scores_gemma":[0.005105142,0.00011115705,0.004590286,0.0005051513,0.00036114294,0.000021705953,0.00012482601,0.00011996211,0.98906064],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99847484,0.000012741712,0.00033818514,0.000418573,0.00053306477,0.00022257662],"domain_scores_gemma":[0.99852586,0.000051592386,0.00016071594,0.00057037384,0.00044229947,0.00024916037],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012465274,0.00046446008,0.00072693394,0.00015586539,0.00003122959,0.000020271405,0.00008997829,0.00017259287,0.008530888],"category_scores_gemma":[0.00002286809,0.00030951411,0.00026728565,0.00001803908,0.00015646266,0.00004748876,0.000061463914,0.00029865626,0.002586633],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089906156,0.00023286114,0.0002548294,0.0004808869,0.0044008545,0.008148067,0.0016477949,6.5772383e-7,0.0028956847,0.13949782,0.8336785,0.007862987],"study_design_scores_gemma":[0.0034679014,0.0016002085,0.0006691949,0.0004770301,0.0011775253,0.0010129067,0.00013496175,0.00002135842,0.002446336,0.03218834,0.955996,0.0008082442],"about_ca_topic_score_codex":0.00005432875,"about_ca_topic_score_gemma":0.000008169174,"teacher_disagreement_score":0.1223175,"about_ca_system_score_codex":0.00039265212,"about_ca_system_score_gemma":0.000284266,"threshold_uncertainty_score":0.9999357},"labels":[],"label_agreement":null},{"id":"W2338036249","doi":"10.1093/annonc/mdu337.28","title":"Updated Os Analysis, Multivariate and Qtwist Analysis of a Randomized Sequential Open-Label Study (Switch) to Evaluate Efficacy and Safety of Sorafenib (So) / Sunitinib (Su) Versus Su/So in the Treatment of Metastatic Renal Cell Cancer (Mrcc)","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Weyerhauser (Canada)","funders":"","keywords":"Medicine; Sorafenib; Sunitinib; Multivariate analysis; Oncology; Randomized controlled trial; Internal medicine; Hepatocellular carcinoma; Renal cell carcinoma","score_opus":0.15832574604703198,"score_gpt":0.44939084254868117,"score_spread":0.2910650965016492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338036249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941703,0.0010239981,0.00006839898,0.0007059658,0.00003916201,0.0034743135,0.00014381828,0.000004413075,0.00036964193],"genre_scores_gemma":[0.9981709,0.00064437365,0.00062379934,0.00009283757,0.000015062054,0.00020015544,0.00017833375,0.000016866206,0.00005765319],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9943049,0.0028091113,0.0015908995,0.00050528056,0.00047692034,0.00031287095],"domain_scores_gemma":[0.9947991,0.0027191988,0.001119389,0.00061559473,0.00058967597,0.00015708744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003375345,0.00033616283,0.00402537,0.0010032657,0.000060923485,0.000020469153,0.00024364352,0.0000940294,0.00015240948],"category_scores_gemma":[0.00037340858,0.00021250572,0.00036265643,0.0017223167,0.0004509883,0.000054005734,0.000117454016,0.00010599318,8.3470223e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7367189,0.03721689,0.019844195,0.0002355653,0.10601292,0.000178752,0.03351114,0.006102,0.035759863,0.00015518664,0.00008071294,0.02418389],"study_design_scores_gemma":[0.67526865,0.03857947,0.13504742,0.000076480814,0.11878897,0.0000049775485,0.002111766,0.007202983,0.022127382,0.000030909905,0.00046067033,0.00030034373],"about_ca_topic_score_codex":0.01965559,"about_ca_topic_score_gemma":0.006204968,"teacher_disagreement_score":0.115203224,"about_ca_system_score_codex":0.000108020526,"about_ca_system_score_gemma":0.00035200513,"threshold_uncertainty_score":0.9868726},"labels":[],"label_agreement":null},{"id":"W2338674808","doi":"10.5489/cuaj.1069","title":"Management of kidney cancer: Canadian Kidney Cancer Forum Consensus Update","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Kidney cancer; Cancer; Medicine; Kidney; Internal medicine","score_opus":0.013252968055618371,"score_gpt":0.23730758327531118,"score_spread":0.2240546152196928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338674808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56086445,0.001155842,0.0000049971536,0.42010036,0.00091011013,0.0008317956,0.000537449,0.000026326505,0.015568668],"genre_scores_gemma":[0.95884305,0.0007463473,0.0003279234,0.036598973,0.0002512603,0.000095688425,0.00006379794,0.000025147101,0.0030477794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759257,0.00012315859,0.0005328164,0.0002744279,0.00046996956,0.0010070788],"domain_scores_gemma":[0.9925562,0.000040918247,0.00037126723,0.00019381219,0.00054634054,0.006291435],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030881554,0.00023506387,0.00043878923,0.0003389238,0.00026747948,0.000071543924,0.00017837666,0.00026609498,0.008055249],"category_scores_gemma":[0.00030206208,0.0001918413,0.00019849336,0.0003015395,0.000058190537,0.000070188304,0.000020215031,0.000493008,0.0001972016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033401688,0.000029809049,0.5730002,0.000025397896,0.00060762867,0.00046600614,0.000042619205,0.000034420154,0.000084964006,0.0002478121,0.4195393,0.0058884593],"study_design_scores_gemma":[0.001754899,0.0002023549,0.6287675,0.000114157316,0.0003749117,0.00014804996,0.00014750057,0.00015513126,0.00017569594,0.0005514615,0.3673766,0.00023172626],"about_ca_topic_score_codex":0.56785405,"about_ca_topic_score_gemma":0.15076815,"teacher_disagreement_score":0.41708592,"about_ca_system_score_codex":0.0055716587,"about_ca_system_score_gemma":0.0047922814,"threshold_uncertainty_score":0.9982458},"labels":[],"label_agreement":null},{"id":"W2340802707","doi":"","title":"A classification tree for the prediction of benign versus malignant disease in patients with small renal masses.","year":2014,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Retrospective cohort study; Disease; Radiology; Surgery; Internal medicine","score_opus":0.050140130529991195,"score_gpt":0.21679877811321402,"score_spread":0.16665864758322282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340802707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955129,0.000054350166,0.0008426891,0.00043442502,0.000101137564,0.0024721173,0.000031922802,0.000016598793,0.0005338581],"genre_scores_gemma":[0.99670327,0.000005034483,0.00029097975,0.000020404195,0.00006211812,0.0026585122,0.00012328167,0.000014306141,0.00012212494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991928,0.000034286484,0.00018987786,0.00018677236,0.00021443701,0.00018185099],"domain_scores_gemma":[0.9992656,0.00014279202,0.00010186547,0.00029107212,0.00008861747,0.000110041976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018148565,0.00009173799,0.00013745487,0.000068018264,0.000026726984,0.000006749512,0.000056251465,0.0000306959,0.0000022683082],"category_scores_gemma":[0.00013582961,0.000052236486,0.000052913805,0.000105094936,0.000041060037,0.000033995006,0.000010071436,0.000046876718,7.296446e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010229255,0.00040636808,0.9112965,0.00007582131,0.000087365144,0.0000015755734,0.000054020733,0.00004254531,0.000035268535,0.00020196628,0.00010008207,0.07746924],"study_design_scores_gemma":[0.0077647665,0.00047767372,0.98914576,0.000024224815,0.00029156616,2.1657041e-7,0.000016648244,0.0009636543,0.00036326176,0.000026235706,0.000882494,0.00004349512],"about_ca_topic_score_codex":0.000027979637,"about_ca_topic_score_gemma":0.00004463481,"teacher_disagreement_score":0.07784927,"about_ca_system_score_codex":0.00013637399,"about_ca_system_score_gemma":0.00003458693,"threshold_uncertainty_score":0.2130142},"labels":[],"label_agreement":null},{"id":"W2343761586","doi":"10.1371/journal.pone.0154074","title":"Proteotranscriptomic Analysis Reveals Stage Specific Changes in the Molecular Landscape of Clear-Cell Renal Cell Carcinoma","year":2016,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; Medical University of South Carolina","keywords":"Clear cell renal cell carcinoma; HIF1A; Transcriptome; Biology; FOXA1; Proteome; Cancer research; Warburg effect; Proteomics; Phenotype; Renal cell carcinoma; Cancer; Bioinformatics; Gene expression; Angiogenesis; Genetics; Gene; Cancer cell; Internal medicine; Medicine","score_opus":0.03864565500396187,"score_gpt":0.22238937353195848,"score_spread":0.18374371852799662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343761586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991686,0.001805127,0.00007287761,0.0010262412,0.000008181778,0.0011528027,0.000047505615,0.000019555251,0.004181737],"genre_scores_gemma":[0.99639416,0.00021613068,0.0010070775,0.000107896754,0.0000589215,0.000109298075,0.000025609925,0.00003123091,0.0020497006],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810475,0.00019384806,0.00038344672,0.00033429806,0.0006541452,0.00032948214],"domain_scores_gemma":[0.99877805,0.00008494638,0.00016759589,0.0007735472,0.00009462777,0.000101246136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038086795,0.00021288083,0.0006117155,0.0003739161,0.000025942114,0.000011556934,0.0002100883,0.0000891253,0.0004866893],"category_scores_gemma":[0.000014321352,0.00011903129,0.00020307237,0.00064214104,0.0000682957,0.00003523968,0.00002789633,0.00015374919,0.000051614606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039295506,0.0015624706,0.10277649,0.00028697232,0.00027861324,0.00021615958,0.00061684847,0.0000018093072,0.893701,0.0000150595915,0.00006950878,0.0000821075],"study_design_scores_gemma":[0.0022304838,0.00093237904,0.121082954,0.00013631245,0.0013359011,0.0000026586652,0.00021663532,0.000023368968,0.8738302,0.000014457896,0.000066266795,0.00012835617],"about_ca_topic_score_codex":0.000052085506,"about_ca_topic_score_gemma":0.000038389786,"teacher_disagreement_score":0.019870777,"about_ca_system_score_codex":0.00009147381,"about_ca_system_score_gemma":0.000040368213,"threshold_uncertainty_score":0.5328907},"labels":[],"label_agreement":null},{"id":"W2343948657","doi":"10.1016/j.ultrasmedbio.2016.01.015","title":"Quantitative Study on the Effect of Abnormalities on Respiration-Induced Kidney Movement","year":2016,"lang":"en","type":"article","venue":"Ultrasound in Medicine & Biology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Ministry of Education - Singapore","keywords":"Medicine; Ultrasound; Kidney; Abnormality; Respiration; Anatomy; Radiology; Internal medicine","score_opus":0.050905730029794476,"score_gpt":0.3430036206963738,"score_spread":0.2920978906665793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343948657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847819,0.00009198994,0.000016306789,0.0057697264,0.00025066955,0.0015089398,0.000012182159,0.000018831222,0.007549438],"genre_scores_gemma":[0.9972333,0.000035585334,0.000013415668,0.0021022528,0.00013435986,0.00018117603,0.000019461999,0.000015612872,0.00026484707],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99772763,0.00084582774,0.0005144519,0.00034554562,0.00030157104,0.00026498485],"domain_scores_gemma":[0.9920321,0.007111104,0.0001731075,0.00050704187,0.0000742681,0.000102394675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014176404,0.00024947058,0.0006141653,0.00023603612,0.00004930846,0.000002282485,0.00013309272,0.00007723204,0.00030250993],"category_scores_gemma":[0.0053836335,0.000094632895,0.00006833338,0.00019378305,0.0003095554,0.00002391466,0.000018782535,0.0001957828,0.000048842514],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036166497,0.00050115277,0.48980525,0.000045337078,0.00026413938,0.00004383209,0.0027275756,0.0000010201338,0.48992553,0.008444721,0.0015836107,0.003041156],"study_design_scores_gemma":[0.012926759,0.21645774,0.54615134,0.00096704654,0.00021839447,0.000014639534,0.002778785,0.0000022167962,0.21798888,0.0010954182,0.0011894874,0.00020931331],"about_ca_topic_score_codex":0.0004202945,"about_ca_topic_score_gemma":0.000044376193,"teacher_disagreement_score":0.27193666,"about_ca_system_score_codex":0.00018014133,"about_ca_system_score_gemma":0.000062358326,"threshold_uncertainty_score":0.64451015},"labels":[],"label_agreement":null},{"id":"W2344125398","doi":"10.1016/j.anndiagpath.2016.04.008","title":"Solid papillary renal cell carcinoma: clinicopathologic, morphologic, and immunohistochemical analysis of 10 cases and review of the literature","year":2016,"lang":"en","type":"review","venue":"Annals of Diagnostic Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Pathology; Polysomy; Immunohistochemistry; Papillary renal cell carcinomas; Papillary tumor; Medicine; Clear cell; Carcinoma; Biology; Chromosome; Fluorescence in situ hybridization","score_opus":0.06799930014696146,"score_gpt":0.3838780523785452,"score_spread":0.3158787522315838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344125398","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06975061,0.9277441,9.273885e-7,0.0001947649,0.000074070376,0.0010954996,0.0008824716,0.000008496281,0.00024906598],"genre_scores_gemma":[0.025751358,0.97311455,0.00010406777,0.000353465,0.000052602878,0.00010726685,0.0003013209,0.000033592358,0.000181789],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.995674,0.0009529948,0.0019318925,0.000754783,0.0003148517,0.0003714508],"domain_scores_gemma":[0.9888299,0.0071428744,0.002069127,0.0012775483,0.00052600977,0.00015451032],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00093631214,0.000609717,0.005643384,0.00043568126,0.00003998184,0.0000042874476,0.00031856782,0.0006966779,0.00016915705],"category_scores_gemma":[0.0079304,0.0003166222,0.0015356257,0.00078263495,0.00110463,0.000031926622,0.00042720066,0.00044550086,0.0000040107934],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003684991,0.0018505376,0.011031514,0.44895273,0.0039798007,0.014829733,0.00038126158,2.2736982e-7,0.003267088,0.00007672398,0.008092347,0.50716954],"study_design_scores_gemma":[0.0034830326,0.013091351,0.0700812,0.6354596,0.14528377,0.024132479,0.00004976271,0.0000014026912,0.014451166,0.00036741458,0.091546215,0.002052597],"about_ca_topic_score_codex":0.000008822003,"about_ca_topic_score_gemma":6.1352836e-7,"teacher_disagreement_score":0.50511694,"about_ca_system_score_codex":0.000032992524,"about_ca_system_score_gemma":0.00026632924,"threshold_uncertainty_score":0.9999286},"labels":[],"label_agreement":null},{"id":"W2345180720","doi":"10.1016/j.clon.2016.04.002","title":"Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma in Non-surgical Candidates: Initial Clinical Experience","year":2016,"lang":"en","type":"article","venue":"Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"","keywords":"SABR volatility model; Medicine; Renal cell carcinoma; Nausea; Radiation therapy; Surgery; Stage (stratigraphy); Dialysis; Ablative case; Urology; Internal medicine","score_opus":0.08494987094081809,"score_gpt":0.4411686317747894,"score_spread":0.3562187608339713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345180720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98629534,0.00037189957,0.0004191932,0.0020273628,0.0011196655,0.0016738316,0.000024913088,0.000040568884,0.008027231],"genre_scores_gemma":[0.991576,0.00043629817,0.002492171,0.0018401726,0.0016654948,0.0003787601,0.00003297646,0.00005754228,0.0015205758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99470854,0.00085426593,0.0023238012,0.0010711529,0.0003092025,0.00073303713],"domain_scores_gemma":[0.9887078,0.009273296,0.0005304303,0.00064643926,0.00017978215,0.00066228886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017633638,0.0003758043,0.0018581802,0.00014812875,0.000065796776,0.00001235332,0.0002779675,0.0007910926,0.00037167696],"category_scores_gemma":[0.0007505259,0.00023739993,0.0006501669,0.00018070721,0.00095465645,0.0001421093,0.000113970855,0.00065331615,0.00010402604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024197174,0.0047570616,0.8823442,0.00006867829,0.00024058599,0.00479769,0.0005198637,6.277777e-7,0.0020688693,0.000048855538,0.002260759,0.07869565],"study_design_scores_gemma":[0.044761796,0.028851543,0.8736361,0.000114658425,0.0002106483,0.00030150753,0.00008748001,0.00014259484,0.0019516534,0.00008762085,0.049481466,0.00037289687],"about_ca_topic_score_codex":0.000050320723,"about_ca_topic_score_gemma":0.000033294178,"teacher_disagreement_score":0.07832275,"about_ca_system_score_codex":0.0009752898,"about_ca_system_score_gemma":0.0013061692,"threshold_uncertainty_score":0.9680888},"labels":[],"label_agreement":null},{"id":"W2346455876","doi":"10.1016/j.ijscr.2016.05.010","title":"Surgical challenges in the treatment of a giant renal cell carcinoma with atypical presentation","year":2016,"lang":"en","type":"article","venue":"International Journal of Surgery Case Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kerr Wood Leidal Associates (Canada)","funders":"","keywords":"Medicine; Presentation (obstetrics); Renal cell carcinoma; Surgery; General surgery; Pathology","score_opus":0.07583328742871602,"score_gpt":0.30275523249677844,"score_spread":0.2269219450680624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346455876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932593,0.0024841984,0.000029799368,0.003218732,0.00024484305,0.0001830607,0.000004328366,0.00000348345,0.0005722595],"genre_scores_gemma":[0.9977825,0.0016110506,0.00014950176,0.000013254202,0.00032376728,0.000012915977,0.0000047142084,0.000012712798,0.00008956819],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99774843,0.00013363973,0.0008999242,0.00017877156,0.0008887468,0.0001504596],"domain_scores_gemma":[0.9976775,0.0007786861,0.0007472827,0.00021800614,0.00046994325,0.00010855654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005521628,0.00015118926,0.00041669287,0.0003236784,0.000015193057,0.00001137267,0.000047361988,0.00005452457,0.000064827706],"category_scores_gemma":[0.00005686031,0.00006515004,0.00029537015,0.0000862651,0.000080196485,0.00012118254,0.000009726307,0.000077034856,0.0000013716431],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002798896,0.0014740122,0.14544596,0.000019203711,0.00019693664,0.8189996,0.0005568399,0.000008199626,0.0019713887,0.000023662142,0.000109683846,0.028395658],"study_design_scores_gemma":[0.002000724,0.0012961017,0.26995793,0.0002513383,0.00013398602,0.6988435,0.00029357005,0.0000039922784,0.02500458,0.000055828114,0.0020795844,0.000078895115],"about_ca_topic_score_codex":0.00006610108,"about_ca_topic_score_gemma":0.00002646236,"teacher_disagreement_score":0.124511965,"about_ca_system_score_codex":0.000319239,"about_ca_system_score_gemma":0.00029622237,"threshold_uncertainty_score":0.2656741},"labels":[],"label_agreement":null},{"id":"W2367409576","doi":"","title":"Effects of X-ray Radiation on Kidney Histological Structure and Serum Creatinine and Urea Nitrogen Contents","year":2014,"lang":"en","type":"article","venue":"Dongwuxue zazhi","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Science North","funders":"","keywords":"Creatinine; Urea; Blood urea nitrogen; Kidney; Irradiation; Chemistry; Dose; Renal function; Internal medicine; Animal science; Endocrinology; Biochemistry; Biology; Medicine","score_opus":0.008417565824860425,"score_gpt":0.2230823595503942,"score_spread":0.2146647937255338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2367409576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969673,0.0008702211,0.000026706883,0.0005019322,0.00009110594,0.00047405466,0.000021847549,0.000027575414,0.0010192147],"genre_scores_gemma":[0.9984795,0.000045991885,0.00033195273,0.0007458761,0.00008734155,0.0000117245145,0.000056252713,0.000016229777,0.00022516982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909467,0.00008942003,0.00018815087,0.00026887815,0.00019578809,0.00016310447],"domain_scores_gemma":[0.9991983,0.00020347549,0.00010813547,0.00018467053,0.000048641763,0.0002567754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007389484,0.00017946989,0.00039620616,0.000082079096,0.00004349032,0.000009665306,0.000037383354,0.00012833255,0.000035277313],"category_scores_gemma":[0.00038185806,0.00012517304,0.00004689859,0.0000619417,0.000095193005,0.000034229884,0.000026646783,0.00012633625,0.000004108534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012130438,0.000305234,0.87421644,0.0008609071,0.00030663592,0.0001216469,0.0005192191,0.0000057269904,0.09219917,0.0011009346,0.0020254175,0.027125599],"study_design_scores_gemma":[0.005324549,0.0023934937,0.8963571,0.00014375604,0.0003236735,0.000074648604,0.000014404143,0.00023891915,0.09275692,0.0002934697,0.001944358,0.00013467463],"about_ca_topic_score_codex":0.00004133625,"about_ca_topic_score_gemma":0.0000018522452,"teacher_disagreement_score":0.026990926,"about_ca_system_score_codex":0.0000510055,"about_ca_system_score_gemma":0.00001827341,"threshold_uncertainty_score":0.5104408},"labels":[],"label_agreement":null},{"id":"W2375133443","doi":"10.2147/ott.s102578","title":"Evaluation of response from axitinib per Response Evaluation Criteria in Solid Tumors versus Choi criteria in previously treated patients with metastatic renal cell carcinoma","year":2016,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"Pfizer","keywords":"Axitinib; Medicine; Internal medicine; Sunitinib; Renal cell carcinoma; Oncology; Regimen; Response Evaluation Criteria in Solid Tumors; Cancer; Progressive disease; Disease","score_opus":0.05487739526461042,"score_gpt":0.3388670856391863,"score_spread":0.2839896903745759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2375133443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99499816,0.0023322008,0.0000039482024,0.00024137182,0.00008266647,0.002105728,0.00007894555,0.000012861278,0.0001441134],"genre_scores_gemma":[0.9989553,0.00010445154,0.00041025982,0.000038028942,0.000029711371,0.00024322885,0.0001224976,0.000042583426,0.00005391948],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99483484,0.0027197166,0.0005867528,0.00050506066,0.0010367677,0.00031688545],"domain_scores_gemma":[0.9980281,0.00055850856,0.000244971,0.0004025338,0.00063319545,0.00013267405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037391197,0.00030444356,0.0005806056,0.00035070616,0.000039186187,0.000019961033,0.00007185918,0.00007757014,0.0008764357],"category_scores_gemma":[0.00035928402,0.00018675542,0.00006755467,0.00020326042,0.00009336359,0.00017511735,0.000018551273,0.00009277839,0.000007403665],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34246784,0.001619204,0.26318842,0.000033039578,0.00018780079,0.00008928571,0.0052144984,0.000012436177,0.3511095,9.0596086e-7,0.000054244465,0.03602284],"study_design_scores_gemma":[0.060258824,0.0067669996,0.8840778,0.00029882105,0.00031776962,0.0000035521039,0.00012889825,0.0006022015,0.04721195,0.000074287884,0.00006431077,0.00019460429],"about_ca_topic_score_codex":0.00051040197,"about_ca_topic_score_gemma":0.00014096205,"teacher_disagreement_score":0.62088937,"about_ca_system_score_codex":0.0006335014,"about_ca_system_score_gemma":0.0005318178,"threshold_uncertainty_score":0.9596357},"labels":[],"label_agreement":null},{"id":"W2397157640","doi":"10.1016/s0242-6498(05)80151-8","title":"Une tumeur rénale inhabituelle","year":2005,"lang":"fr","type":"article","venue":"Annales de Pathologie","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine","score_opus":0.05177326530377479,"score_gpt":0.3057626141360524,"score_spread":0.2539893488322776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397157640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7565295,0.15415527,0.00044634216,0.03453704,0.000890749,0.000435527,0.000032728563,0.00017035149,0.052802484],"genre_scores_gemma":[0.90094954,0.0074106716,0.0076932022,0.0028168904,0.0020789925,0.000055339486,0.00005653749,0.00006771352,0.07887112],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99701685,0.0002737276,0.0005132331,0.00060491986,0.00036037515,0.0012308867],"domain_scores_gemma":[0.99824625,0.00023908318,0.00014443554,0.000751375,0.00014585642,0.00047299993],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005942327,0.0004464138,0.0005664828,0.00014509379,0.00013577522,0.00004236548,0.00026589862,0.00037664833,0.0015293779],"category_scores_gemma":[0.00031442245,0.0004111166,0.00035192101,0.00038819466,0.00043795962,0.00017671194,0.00016655633,0.0005506626,0.012744093],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039308603,0.0025801011,0.11428807,0.0006802441,0.00034756478,0.0240837,0.0034368215,0.00089531875,0.02975493,0.002030215,0.11992745,0.7015825],"study_design_scores_gemma":[0.003221608,0.0023011048,0.2372839,0.00074136344,0.0008446289,0.004959244,0.0009735153,0.0013809609,0.07519215,0.0017427802,0.67052007,0.00083870295],"about_ca_topic_score_codex":0.00016875051,"about_ca_topic_score_gemma":0.00009613426,"teacher_disagreement_score":0.7007438,"about_ca_system_score_codex":0.00072531454,"about_ca_system_score_gemma":0.00036609464,"threshold_uncertainty_score":0.99983406},"labels":[],"label_agreement":null},{"id":"W2397300683","doi":"10.1097/pai.0000000000000156","title":"Cystic Renal Oncocytoma and Tubulocystic Renal Cell Carcinoma","year":2015,"lang":"en","type":"article","venue":"Applied immunohistochemistry & molecular morphology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"CD117; Oncocytoma; Pathology; Vimentin; Stroma; Renal cell carcinoma; Immunohistochemistry; Biology; Carcinoma; Medicine; CD34","score_opus":0.012628047597640621,"score_gpt":0.2447753076200948,"score_spread":0.23214726002245417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397300683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9619778,0.0054018665,0.0009416063,0.00019204183,0.00011665537,0.00058349874,0.000011892505,0.000111819834,0.030662818],"genre_scores_gemma":[0.993367,0.000010126622,0.0041728285,0.0004997549,0.000112607486,0.00020322077,0.00025109673,0.00009521334,0.0012881141],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973255,0.00006267817,0.0005581339,0.0009064765,0.00047056106,0.0006766887],"domain_scores_gemma":[0.9978697,0.00006800829,0.00020931214,0.001083431,0.00016109034,0.00060849515],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002361941,0.00054621976,0.00075260416,0.00012770381,0.00010129907,0.000027240929,0.00024407354,0.00037404124,0.00011318077],"category_scores_gemma":[0.00007565031,0.00054233085,0.00016669165,0.00020595829,0.00046434705,0.000030164856,0.00023438325,0.0005417837,0.00017279627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011279872,0.00022056515,0.00016180032,0.00011990663,0.00009366475,0.0051235603,0.00014804366,0.000020100973,0.9909607,0.000093571165,0.0014366456,0.0004934626],"study_design_scores_gemma":[0.006363667,0.0008864348,0.002084212,0.000031648073,0.0005960905,0.0077571557,0.00014288747,0.00004653707,0.98078996,0.00027921185,0.00053455797,0.00048762397],"about_ca_topic_score_codex":0.00009818329,"about_ca_topic_score_gemma":7.800153e-8,"teacher_disagreement_score":0.031389236,"about_ca_system_score_codex":0.0007151508,"about_ca_system_score_gemma":0.0005061776,"threshold_uncertainty_score":0.9997028},"labels":[],"label_agreement":null},{"id":"W2397615757","doi":"10.4329/wjr.v8.i5.484","title":"Review of renal cell carcinoma and its common subtypes in radiology","year":2016,"lang":"en","type":"review","venue":"World Journal of Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; University of Alberta","funders":"","keywords":"Medicine; Renal cell carcinoma; Chromophobe cell; Magnetic resonance imaging; Asymptomatic; Incidence (geometry); Radiology; Clear cell; Clear cell renal cell carcinoma; Pathology","score_opus":0.03916889834985309,"score_gpt":0.316504508085388,"score_spread":0.2773356097355349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397615757","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013268602,0.9954866,0.0000021223693,0.00032468524,0.00033453605,0.0007250817,0.000018819648,0.000004208906,0.0017770934],"genre_scores_gemma":[0.0031099806,0.99536705,0.00011978781,0.00025611886,0.00041946306,0.000016093993,0.00002181183,0.00004993456,0.0006397312],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99558735,0.0011781424,0.0022815408,0.00034919093,0.0001960939,0.00040767377],"domain_scores_gemma":[0.99598616,0.0009090913,0.0022544598,0.00040140588,0.0001943742,0.00025450555],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012341128,0.00049876404,0.006176264,0.0011263797,0.000020722857,0.000002679739,0.00030362108,0.0003284435,0.0002026488],"category_scores_gemma":[0.00017312037,0.00029294775,0.00077822333,0.00038878652,0.00020962619,0.00004715415,0.000082321785,0.00079583767,0.000015078244],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058341905,0.0003331394,0.0043529538,0.2738579,0.00093318825,0.006530441,0.00006160192,3.6605252e-7,0.00015875437,0.0003186406,0.02320738,0.6896622],"study_design_scores_gemma":[0.0016739739,0.0015808862,0.0010032945,0.13655935,0.0020833581,0.043467194,0.0000021742678,2.802128e-7,0.00005415405,0.000034872373,0.8133171,0.00022332557],"about_ca_topic_score_codex":0.000005506535,"about_ca_topic_score_gemma":0.00000970744,"teacher_disagreement_score":0.79010975,"about_ca_system_score_codex":0.00037259833,"about_ca_system_score_gemma":0.0006470156,"threshold_uncertainty_score":0.99995226},"labels":[],"label_agreement":null},{"id":"W2398605698","doi":"","title":"CyberKnife for inoperable renal tumors: Canadian pioneering experience.","year":2013,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Cyberknife; SABR volatility model; Renal function; Kidney; Radiosurgery; Radiation therapy; Radiology; Urology; Nuclear medicine; Internal medicine","score_opus":0.03044849177866389,"score_gpt":0.22069773110332772,"score_spread":0.1902492393246638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398605698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797236,0.00021458075,0.000034673158,0.0012852747,0.0001342092,0.0024485218,0.000005349509,0.000050884228,0.016102936],"genre_scores_gemma":[0.97858274,0.0000046594605,0.00068547163,0.0005427595,0.00019421139,0.012735605,0.000022978616,0.000025892145,0.0072056623],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987972,0.000009363809,0.00018779193,0.00023863008,0.00015282095,0.00061419804],"domain_scores_gemma":[0.9988975,0.000028005592,0.000028763045,0.00025602052,0.00009103325,0.00069870247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000093420276,0.00013363034,0.00019988931,0.00013002583,0.0000894803,0.000046779263,0.00007780696,0.00005245837,0.00023913426],"category_scores_gemma":[0.00009483432,0.00010907819,0.000073827876,0.000114689916,0.00003218649,0.0001331652,0.00001563278,0.000075800606,0.0000902907],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004732488,0.00069309835,0.28026584,0.0006216302,0.00077159185,0.00096093083,0.00745742,0.00021430916,0.021371458,0.0018625294,0.10398778,0.58132017],"study_design_scores_gemma":[0.0013763311,0.00010410598,0.93147266,0.000030726977,0.000044282184,0.00011602808,0.0002713075,0.00018001693,0.030624943,0.00008143732,0.03547795,0.00022020716],"about_ca_topic_score_codex":0.05083818,"about_ca_topic_score_gemma":0.0033510262,"teacher_disagreement_score":0.6512068,"about_ca_system_score_codex":0.0004320439,"about_ca_system_score_gemma":0.00012821592,"threshold_uncertainty_score":0.95548236},"labels":[],"label_agreement":null},{"id":"W2399071404","doi":"","title":"Perioperative outcomes for laparoscopic radical nephrectomies performed on ≥ 10 cm tumors.","year":2014,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Perioperative; Nephrectomy; Complication; Surgery; Context (archaeology); Retrospective cohort study; Demographics; Urology; Kidney; Internal medicine","score_opus":0.031021786485690248,"score_gpt":0.2611226541461296,"score_spread":0.23010086766043936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399071404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770999,0.000077423574,0.00002697982,0.003043092,0.00021253462,0.0023041617,0.000008885685,0.000091841925,0.01713521],"genre_scores_gemma":[0.9723932,0.0000062748445,0.0004975084,0.0012249365,0.00027096563,0.004906308,0.000041409457,0.000037185626,0.020622224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851274,0.000058232443,0.0002636077,0.0003584453,0.00029954966,0.0005074275],"domain_scores_gemma":[0.9989113,0.00030951743,0.00006137291,0.00034797582,0.0000748082,0.00029503138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026956617,0.00024898874,0.00057142455,0.00010855749,0.00012311383,0.000038338472,0.0000976783,0.00008372324,0.00015053991],"category_scores_gemma":[0.00068376656,0.00016598342,0.00019167036,0.00008299054,0.00012066209,0.0000584117,0.000027368065,0.00014159364,0.00010145862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008231803,0.0022915127,0.6258396,0.00090595573,0.0013253852,0.0001251788,0.002468098,0.00003646315,0.0014772374,0.007491686,0.024378868,0.32542822],"study_design_scores_gemma":[0.00657071,0.0008439227,0.933964,0.000026897025,0.00014093463,0.000019867159,0.0000613632,0.00015544394,0.024363818,0.00005711742,0.033606123,0.0001897788],"about_ca_topic_score_codex":0.000013774914,"about_ca_topic_score_gemma":0.000009158767,"teacher_disagreement_score":0.32523844,"about_ca_system_score_codex":0.00024118925,"about_ca_system_score_gemma":0.000057738063,"threshold_uncertainty_score":0.67686075},"labels":[],"label_agreement":null},{"id":"W2401517553","doi":"10.1016/j.clgc.2016.05.019","title":"Molecular Dissection of Complete Response to Receptor Tyrosine Kinase Inhibition in Type II Papillary Renal Cell Carcinoma","year":2016,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Papillary renal cell carcinomas; Leiomyomatosis; Fumarase; Germline mutation; Cancer research; Tyrosine kinase; Renal cell carcinoma; Metastasis; Pathogenesis; Tyrosine-kinase inhibitor; Germline; Pathology; Internal medicine; Carcinoma; Oncology; Cancer; Mutation; Receptor; Gene; Biology; Genetics","score_opus":0.049069436257547165,"score_gpt":0.33576451621007697,"score_spread":0.2866950799525298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401517553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939998,0.0014666916,0.000038848666,0.002906131,0.0005045535,0.0006551365,0.000059483307,0.000030796935,0.00033856975],"genre_scores_gemma":[0.9971583,0.00031822533,0.00052891375,0.00041337594,0.00038609226,0.00007432485,0.000029958137,0.00004419332,0.0010466233],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99762917,0.00038342527,0.0008187236,0.0005293044,0.00032183775,0.00031757227],"domain_scores_gemma":[0.9984631,0.00028040673,0.00017851534,0.000506805,0.00023844371,0.00033272908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005227985,0.00023137944,0.00052181416,0.00020760487,0.000050386705,0.000004327498,0.000072801944,0.00017957597,0.00040845084],"category_scores_gemma":[0.00027063102,0.00016818084,0.00021250475,0.0004307649,0.00012445716,0.00006191594,0.00014179196,0.00021007565,0.00007963231],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022463169,0.0007350491,0.041915666,0.0000744576,0.000027741278,0.0009960834,0.000072620984,0.000028106579,0.9250375,0.0000027725814,0.002481608,0.006165208],"study_design_scores_gemma":[0.0044443654,0.009373518,0.4507689,0.00046162854,0.000092432325,0.00004076281,0.000025841078,0.000010615669,0.5293796,0.00002060577,0.0051543615,0.0002273564],"about_ca_topic_score_codex":0.000074088864,"about_ca_topic_score_gemma":0.000013066731,"teacher_disagreement_score":0.40885323,"about_ca_system_score_codex":0.00041298103,"about_ca_system_score_gemma":0.0002824161,"threshold_uncertainty_score":0.68582153},"labels":[],"label_agreement":null},{"id":"W2403054743","doi":"","title":"Does every second really count when it comes to renal ischemia during nephron sparing surgery?","year":2014,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; General surgery; Renal ischemia; Center (category theory); Cancer; Nephrectomy; Urology; Ischemia; Surgery; Internal medicine; Kidney","score_opus":0.020257083165691015,"score_gpt":0.21254009239525595,"score_spread":0.19228300922956493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403054743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795519,0.000105635365,0.00002547411,0.002993094,0.0003243686,0.0008455121,0.000006865902,0.00010888581,0.016038243],"genre_scores_gemma":[0.97976696,0.000019672894,0.0003291879,0.0011378567,0.00057256024,0.0007515578,0.000028590099,0.00004841255,0.017345209],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979347,0.000052205814,0.0004053298,0.00047081226,0.00045492686,0.0006820352],"domain_scores_gemma":[0.99851984,0.00022421584,0.00011430223,0.00056251703,0.00008622307,0.0004929228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056476216,0.00026330774,0.0005280955,0.00018827949,0.000089169625,0.000060564493,0.00012000938,0.00009976801,0.00025059935],"category_scores_gemma":[0.00021665862,0.00017377564,0.00016248946,0.00012296038,0.000038984857,0.00013220843,0.00011307762,0.00018539329,0.00007974085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023387563,0.000397904,0.7640838,0.0012952257,0.001044447,0.00069536944,0.0014252207,0.00004976642,0.03869637,0.00007334446,0.09965547,0.0902443],"study_design_scores_gemma":[0.00087878876,0.000035557605,0.8336441,0.00008861628,0.00012223418,0.00006275252,0.000033063774,0.000012040222,0.11421786,0.000041202416,0.050635934,0.00022784485],"about_ca_topic_score_codex":0.00014803279,"about_ca_topic_score_gemma":0.00024018127,"teacher_disagreement_score":0.090016454,"about_ca_system_score_codex":0.00046096742,"about_ca_system_score_gemma":0.000064289045,"threshold_uncertainty_score":0.7086365},"labels":[],"label_agreement":null},{"id":"W2404352909","doi":"10.1158/1535-7163.targ-15-b109","title":"Abstract B109: AZD5363, a catalytic pan-Akt inhibitor, in <i>Akt1</i> E17K mutation positive advanced solid tumors","year":2015,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"AKT1; Cancer; Protein kinase B; Library science; Medicine; Chemistry; Phosphorylation; Biochemistry; Internal medicine; Computer science","score_opus":0.02893861731283678,"score_gpt":0.30944031885153467,"score_spread":0.2805017015386979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404352909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868372,0.007414456,0.0002707976,0.0012519419,0.0002187825,0.000927322,0.000029148103,0.00007079789,0.002979536],"genre_scores_gemma":[0.9959546,0.00011243364,0.0004518134,0.0027978371,0.00009906624,0.00015931264,0.00012503692,0.00008600881,0.0002139184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99796563,0.00006406147,0.00045349973,0.00046955765,0.0005756729,0.0004716015],"domain_scores_gemma":[0.9988716,0.00003934338,0.00017211608,0.00043483902,0.00024484104,0.00023725924],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016812602,0.00035035503,0.00047643427,0.00017874128,0.000039295406,0.000032876567,0.00011937553,0.00013541339,0.000016366574],"category_scores_gemma":[0.00002213409,0.0003222664,0.00014608113,0.00038040557,0.000091923444,0.00011851571,0.000039818628,0.0003219705,0.00004852301],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002720209,0.0013038598,0.0073371436,0.00025804344,0.0008424891,0.008944054,0.006439958,0.004145166,0.853446,0.00012690593,0.00023127241,0.114204876],"study_design_scores_gemma":[0.007296177,0.0010850065,0.03722263,0.00043216973,0.0004243899,0.0001992317,0.0006606552,0.0004666864,0.9498274,0.0005217295,0.0013366749,0.0005272976],"about_ca_topic_score_codex":0.0005985774,"about_ca_topic_score_gemma":0.00018076345,"teacher_disagreement_score":0.113677576,"about_ca_system_score_codex":0.0014507575,"about_ca_system_score_gemma":0.00077187066,"threshold_uncertainty_score":0.99992293},"labels":[],"label_agreement":null},{"id":"W2405990280","doi":"","title":"Percutaneous radiofrequency ablation of small renal tumors using CT-guidance: a review and its current role.","year":2012,"lang":"en","type":"review","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Jewish General Hospital; Montreal General Hospital","funders":"","keywords":"Medicine; Ablative case; Radiofrequency ablation; Percutaneous; Ablation; Radiology; MEDLINE; Catheter ablation; Intensive care medicine; Surgery; Radiation therapy; Internal medicine","score_opus":0.12317866584698593,"score_gpt":0.31418093399290037,"score_spread":0.19100226814591442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405990280","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005536635,0.9925462,0.000003630038,0.00001874456,0.00017758654,0.0058269505,0.000046854966,0.00003452227,0.0007918688],"genre_scores_gemma":[0.0010247761,0.9970815,0.00021243157,0.00002474607,0.00032414604,0.00091621233,0.00013700542,0.0000830372,0.00019613192],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99708915,0.00025507188,0.0011611029,0.0005248264,0.0003920291,0.00057782483],"domain_scores_gemma":[0.99795574,0.0000959464,0.00086846616,0.00050409616,0.00015453348,0.0004212163],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006257352,0.0005782669,0.002866823,0.00023986527,0.000045718258,0.000013287735,0.00014288336,0.000120713725,0.00004043291],"category_scores_gemma":[0.00017673704,0.00042760163,0.00051317463,0.0003540833,0.000060270737,0.00007605127,0.00007164116,0.00042825806,0.0000129757445],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000063268244,0.000076857694,0.000053577347,0.13399722,0.00018966617,0.00014850961,0.00001850724,1.7404857e-7,0.0000026882617,0.000013721601,0.0000182862,0.86547446],"study_design_scores_gemma":[0.00044432998,0.00009237445,0.0010564805,0.095025614,0.029444197,0.025682759,0.0000030112597,0.00001250959,0.000022571045,0.000012297992,0.8475423,0.0006615783],"about_ca_topic_score_codex":0.000024931667,"about_ca_topic_score_gemma":0.0000010716658,"teacher_disagreement_score":0.8648129,"about_ca_system_score_codex":0.00076924893,"about_ca_system_score_gemma":0.0002966631,"threshold_uncertainty_score":0.99981755},"labels":[],"label_agreement":null},{"id":"W2408888560","doi":"","title":"[International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia 2012].","year":2014,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chromophobe cell; Medicine; Pathology; Clear cell; Angiomyolipoma; Renal cell carcinoma; Oncocytoma; Renal pelvis; Kidney; Internal medicine","score_opus":0.03225838282398517,"score_gpt":0.24065370092100635,"score_spread":0.2083953180970212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408888560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9650379,0.00007226025,0.0014149749,0.001228431,0.00033504283,0.00044688076,0.00000988903,0.000024635787,0.03143],"genre_scores_gemma":[0.9966629,0.000028297894,0.0013502548,0.00016175381,0.00014974175,0.00020920877,0.000035635127,0.000008645511,0.0013935701],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990005,0.0000501351,0.0003021664,0.00020414057,0.0002639991,0.00017906829],"domain_scores_gemma":[0.9992717,0.00009093529,0.00018671124,0.00022912538,0.00013667483,0.00008488733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031193972,0.000094337214,0.0002523587,0.00004872314,0.000013763735,0.000002268448,0.00009250633,0.00011831823,0.00008900128],"category_scores_gemma":[0.00009048011,0.00007106995,0.00017009041,0.00007138924,0.00013072761,0.00004410874,0.000034992103,0.00010153715,0.0000067843384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018402067,0.0019337542,0.4885707,0.00023960808,0.0007351963,0.0000416791,0.0004415506,0.000068057125,0.08119933,0.0026137775,0.13997996,0.2823362],"study_design_scores_gemma":[0.0013167989,0.00016604953,0.96994334,0.0000047023827,0.00008514507,0.000035190853,0.000019686977,0.00048000427,0.008844037,0.00016335427,0.018889705,0.000051988707],"about_ca_topic_score_codex":0.000006383774,"about_ca_topic_score_gemma":0.000004241479,"teacher_disagreement_score":0.48137265,"about_ca_system_score_codex":0.00006968776,"about_ca_system_score_gemma":0.000023613331,"threshold_uncertainty_score":0.28981486},"labels":[],"label_agreement":null},{"id":"W2409036551","doi":"","title":"Renal tumors and the risk of malignancy based on size.","year":2009,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Malignancy; Demographics; Renal mass; Incidence (geometry); Medical record; Radiology; Statistical significance; Population; Surgery; Nephrectomy; Internal medicine; Kidney","score_opus":0.013382320689329479,"score_gpt":0.20713946671673958,"score_spread":0.1937571460274101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409036551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97578603,0.00048175265,0.00000983377,0.0027186535,0.000024232866,0.0009315891,0.0000052306877,0.000018727576,0.020023927],"genre_scores_gemma":[0.9982969,0.000035543137,0.00016039265,0.0006339767,0.000049469225,0.00018184067,0.0000021787455,0.000006752675,0.00063290435],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992313,0.000076591765,0.0001596153,0.00014462514,0.0002133585,0.00017450978],"domain_scores_gemma":[0.99927753,0.00024550955,0.000086862245,0.00026870598,0.000027595603,0.00009381688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034052445,0.00009487475,0.00022281692,0.000038329603,0.00003068081,0.000005944759,0.000043187963,0.00002736049,0.000016637317],"category_scores_gemma":[0.00028168692,0.000049705945,0.000085332,0.00008999515,0.00008477712,0.000013336119,0.0000069946013,0.00008877411,0.0000027668818],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017188238,0.0014508172,0.24929915,0.00018052435,0.0004019995,0.0006786396,0.00059676985,0.00016013072,0.0008234462,0.0034334739,0.003159907,0.7226269],"study_design_scores_gemma":[0.0047525824,0.00023695671,0.98479277,0.00003082036,0.00016882336,0.000016879902,0.0000094202605,0.00013390738,0.009180759,0.0004957756,0.00013548837,0.00004582772],"about_ca_topic_score_codex":0.000030619496,"about_ca_topic_score_gemma":0.0000014099365,"teacher_disagreement_score":0.7354936,"about_ca_system_score_codex":0.000033516146,"about_ca_system_score_gemma":0.000019062198,"threshold_uncertainty_score":0.20269497},"labels":[],"label_agreement":null},{"id":"W2409921260","doi":"10.1016/j.urology.2014.01.053","title":"Reply","year":2014,"lang":"en","type":"letter","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Nephrectomy; Perioperative; Odds; Odds ratio; Surgery; Kidney cancer; Laparoscopy; General surgery; Kidney; Cancer; Internal medicine; Logistic regression","score_opus":0.02588674745825446,"score_gpt":0.2530334391788769,"score_spread":0.22714669172062243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409921260","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009522989,0.00049391587,0.000056944715,0.9355867,0.00040294701,0.0002426364,0.0000028183338,0.00008044154,0.06218133],"genre_scores_gemma":[0.008276092,0.000013661137,0.00010646902,0.96198255,0.005484016,0.000035077584,0.00038585826,0.000056778455,0.023659512],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99878496,0.000091005226,0.00020030171,0.00041714835,0.0001759263,0.00033064358],"domain_scores_gemma":[0.9989384,0.00012264038,0.00009416975,0.00074190757,0.0000469358,0.000055971585],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006833748,0.0002193491,0.0005051241,0.00013181305,0.000019329582,0.000004500453,0.000094294,0.00071510347,0.00073887274],"category_scores_gemma":[0.00005048468,0.00017110955,0.0001654562,0.000039934443,0.00008266713,0.0000058471182,0.00003530766,0.0011871257,0.0020220492],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004850046,0.000012507505,0.00029978564,0.00006921857,0.000101213394,0.0066362973,0.000010613168,4.5937963e-7,0.000034105105,0.000010655527,0.9923995,0.00037714068],"study_design_scores_gemma":[0.0005382137,0.0011127096,0.00043001852,0.0000067542933,0.00036903302,0.0024926376,2.8459365e-7,0.00001155805,0.000086938526,0.00014584207,0.9946942,0.00011181643],"about_ca_topic_score_codex":0.000034979865,"about_ca_topic_score_gemma":6.504486e-7,"teacher_disagreement_score":0.03852182,"about_ca_system_score_codex":0.00006472636,"about_ca_system_score_gemma":0.00006568749,"threshold_uncertainty_score":0.998755},"labels":[],"label_agreement":null},{"id":"W2411826505","doi":"10.1016/j.urology.2016.05.048","title":"Differences in Overall and Cancer-specific Survival of Patients Presenting With Chromophobe Versus Clear Cell Renal Cell Carcinoma: A Propensity Score Matched Analysis","year":2016,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Propensity score matching; Chromophobe cell; Renal cell carcinoma; Oncology; Internal medicine; Kidney cancer; Urology; Clear cell","score_opus":0.041239512802963584,"score_gpt":0.23242854550157235,"score_spread":0.19118903269860876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411826505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99830806,0.0004752135,0.000018470451,0.0001230772,0.00007396756,0.00039769462,0.000020513438,0.000011674383,0.00057133875],"genre_scores_gemma":[0.99954647,0.00010810596,0.000050122813,0.000013277337,0.00003651521,0.000021160646,0.000015873591,0.000017535594,0.00019095771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849963,0.00013660859,0.00029631465,0.0004710097,0.00026705972,0.0003293589],"domain_scores_gemma":[0.9991223,0.00014178445,0.00019999825,0.00030563385,0.000117317526,0.00011294576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010040085,0.00020152755,0.0006724248,0.00022105877,0.000032737542,0.000006944223,0.000089337715,0.000100818565,0.00011923271],"category_scores_gemma":[0.000012115233,0.00011883654,0.00007705829,0.00026279263,0.00018561997,0.00004991818,0.00009600215,0.00012574975,0.000003991295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053902804,0.00031711804,0.98394644,0.00006725722,0.00014378395,0.00012265307,0.0003198489,0.0000078373205,0.009520446,0.000004489989,0.000015793257,0.00014404207],"study_design_scores_gemma":[0.008085498,0.0022894666,0.9774913,0.00001002546,0.0005394593,0.0000023127384,0.000023911402,0.00007015736,0.011331747,0.000005632048,0.000029728648,0.00012071734],"about_ca_topic_score_codex":0.00077854306,"about_ca_topic_score_gemma":0.0006683662,"teacher_disagreement_score":0.0064551057,"about_ca_system_score_codex":0.000097697506,"about_ca_system_score_gemma":0.00007384143,"threshold_uncertainty_score":0.48460138},"labels":[],"label_agreement":null},{"id":"W2411884561","doi":"10.5489/cuaj.2995","title":"What’s New in Renal Cell Cancer Research? Highlights of GU-ASCO 2015","year":2015,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Canadian Urological Association","funders":"","keywords":"Medicine; Oncology; Cancer; Internal medicine","score_opus":0.13230889768751453,"score_gpt":0.3798699033972133,"score_spread":0.2475610057096988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411884561","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000682589,0.98691523,6.202932e-7,0.008550207,0.00088175986,0.000758733,0.00005578167,0.000009169972,0.0021459165],"genre_scores_gemma":[0.00050298806,0.9869312,0.000080317885,0.00025413907,0.0014868996,0.00003899158,0.000091582624,0.0000439093,0.010569962],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99464816,0.0012512542,0.0012127172,0.00044079253,0.0014271074,0.0010199489],"domain_scores_gemma":[0.9950219,0.00039445658,0.00095147203,0.00030377254,0.000978169,0.002350249],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003100854,0.00039591955,0.0020855123,0.001249639,0.00011053513,0.00013954443,0.00037026257,0.001051907,0.0009555],"category_scores_gemma":[0.0006232464,0.0002756389,0.0005338657,0.0009201678,0.00006621475,0.00018148287,0.000050265917,0.0024525817,0.00019076015],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000108592176,0.00025428235,0.0036190187,0.0012821023,0.00062199833,0.0024675822,0.00035478198,0.000017016308,0.000005800975,0.000103831335,0.558568,0.43259698],"study_design_scores_gemma":[0.0009960869,0.00057560735,0.001644215,0.0028501486,0.0005231638,0.0001981347,0.000033131717,0.0000013341338,0.0000049309033,0.00031022428,0.9926509,0.00021208699],"about_ca_topic_score_codex":0.011412421,"about_ca_topic_score_gemma":0.00853239,"teacher_disagreement_score":0.43408293,"about_ca_system_score_codex":0.012730407,"about_ca_system_score_gemma":0.015784038,"threshold_uncertainty_score":0.9999696},"labels":[],"label_agreement":null},{"id":"W2414596842","doi":"","title":"An unusual case of pancreatitis revealing a metachronous renal cell carcinoma metastasis to the gallbladder.","year":2012,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Metastasis; Renal cell carcinoma; Gallbladder; Pancreatitis; Cholecystectomy; Asymptomatic; Carcinoma; Pathology; Radiology; General surgery; Internal medicine; Cancer","score_opus":0.037156733706925855,"score_gpt":0.2641487106519038,"score_spread":0.22699197694497797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414596842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99056894,0.0026927278,0.00019710785,0.00036147318,0.00014424321,0.001721528,0.00006358546,0.000039966264,0.0042104116],"genre_scores_gemma":[0.99525446,0.000014289872,0.0020691317,0.0002918836,0.0004646259,0.0012740167,0.000032331816,0.00004745074,0.0005517867],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979388,0.00023456383,0.0004147175,0.0003163513,0.00036081014,0.0007347512],"domain_scores_gemma":[0.9981002,0.0001224387,0.00014818799,0.00080474804,0.00012289402,0.0007015069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086764764,0.00025580847,0.0005087516,0.00015760858,0.00011238962,0.00002246695,0.00015032405,0.00006852965,0.000072070965],"category_scores_gemma":[0.00008788667,0.0001669534,0.00020450595,0.00035106856,0.00006308581,0.00015083949,0.000065730426,0.00016246615,0.000026579572],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028123169,0.005758746,0.27736804,0.0011734928,0.0027017116,0.015019649,0.015027421,0.00028833232,0.026148688,0.00063937553,0.012847503,0.64021474],"study_design_scores_gemma":[0.0018770717,0.00085562974,0.64547634,0.000015881287,0.0026120334,0.00696989,0.0009526495,0.00003940444,0.33754689,0.0000073469755,0.003316164,0.00033069562],"about_ca_topic_score_codex":0.0015499935,"about_ca_topic_score_gemma":0.000113507835,"teacher_disagreement_score":0.63988405,"about_ca_system_score_codex":0.0002065618,"about_ca_system_score_gemma":0.00006454066,"threshold_uncertainty_score":0.6808162},"labels":[],"label_agreement":null},{"id":"W2415611423","doi":"10.1016/j.urology.2016.04.055","title":"Morbidity and Mortality of Radical Nephrectomy for Patients With Disseminated Cancer: An Analysis of the National Surgical Quality Improvement Program Database","year":2016,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Perioperative; Cancer; Odds ratio; Kidney cancer; Nephrectomy; Surgery; Confidence interval; Retrospective cohort study; Internal medicine; Kidney","score_opus":0.03478004226722503,"score_gpt":0.3601116120998649,"score_spread":0.3253315698326399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415611423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981275,0.000035179786,0.00005775176,0.00028879556,0.000021910399,0.00079678063,0.0006381032,0.0000093482,0.000024637495],"genre_scores_gemma":[0.9993646,0.000010195828,0.00019372307,0.0000401891,0.000017944758,0.00015053862,0.00020266954,0.0000056739186,0.000014427108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989098,0.000102965794,0.00028404716,0.00025230623,0.00031355544,0.00013734843],"domain_scores_gemma":[0.99903184,0.00019808012,0.00018783734,0.00023981334,0.0002553741,0.000087057335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027286026,0.00009542398,0.00036090086,0.00006408856,0.000025172583,0.0000015373164,0.00006458846,0.000054915832,0.00005218283],"category_scores_gemma":[0.00009226303,0.000043907545,0.00008912942,0.00018624634,0.0003192555,0.00003335645,0.000039966977,0.000043879714,6.201061e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013351282,0.0011901855,0.9883421,0.000042441163,0.00087596173,0.0000017709959,0.000030788997,0.0000042632146,0.0024034164,0.00015652261,0.000016972326,0.0056004566],"study_design_scores_gemma":[0.003266248,0.0018118836,0.9883824,0.0000076971355,0.0014048117,0.0000012916402,0.00000421913,0.000420139,0.0043179374,0.000024426652,0.00030890087,0.000050044946],"about_ca_topic_score_codex":0.00049667,"about_ca_topic_score_gemma":0.00037185277,"teacher_disagreement_score":0.005550412,"about_ca_system_score_codex":0.000061775514,"about_ca_system_score_gemma":0.000087668355,"threshold_uncertainty_score":0.17904978},"labels":[],"label_agreement":null},{"id":"W2415950182","doi":"10.1016/s1470-2045(16)30107-3","title":"Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial","year":2016,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":939,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Exelixis; Memorial Sloan-Kettering Cancer Center","keywords":"Cabozantinib; Everolimus; Meteor (satellite); Renal cell carcinoma; Medicine; Open label; Oncology; Internal medicine; Clinical trial; Astronomy; Physics","score_opus":0.16141156173900909,"score_gpt":0.39215930367378826,"score_spread":0.23074774193477918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415950182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96240294,0.000490262,0.000021076377,0.006424485,0.0011014674,0.0029836153,0.00028199638,0.000046465462,0.02624769],"genre_scores_gemma":[0.993469,0.00019091296,0.0017008412,0.0005517947,0.0013884,0.00043924365,0.00012737034,0.000039592625,0.0020928632],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99658215,0.000859413,0.0008136334,0.00069615047,0.00031745393,0.00073117524],"domain_scores_gemma":[0.99512917,0.0031428428,0.00039942848,0.0010375987,0.000087567925,0.00020339052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013633386,0.0003413868,0.0014063779,0.00011471029,0.00009505507,0.000023920456,0.0006361691,0.00022921358,0.00024898114],"category_scores_gemma":[0.0007576591,0.00018454499,0.000116511976,0.00023857449,0.00020648532,0.0001231055,0.00025642995,0.00039533453,0.00020370547],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9172742,0.0016178791,0.00015333359,0.000009779518,0.00009035854,0.0011283142,0.0003778183,0.0000024980566,0.041119795,0.000035071793,0.0047554085,0.033435594],"study_design_scores_gemma":[0.9237135,0.015989129,0.0024718856,0.00007186712,0.00028323475,0.000042497875,0.00006830324,0.000030298892,0.02002587,0.00013278933,0.036952574,0.00021804092],"about_ca_topic_score_codex":0.0007244276,"about_ca_topic_score_gemma":0.0004970331,"teacher_disagreement_score":0.033217553,"about_ca_system_score_codex":0.00056750275,"about_ca_system_score_gemma":0.0006409242,"threshold_uncertainty_score":0.7525526},"labels":[],"label_agreement":null},{"id":"W2417541108","doi":"10.1097/pas.0000000000000583","title":"Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma","year":2016,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Papillary renal cell carcinomas; Clear cell renal cell carcinoma; Clear cell; Pathology; Renal cell carcinoma; Medicine; Renal papilla; Kidney; Internal medicine","score_opus":0.009654882337388706,"score_gpt":0.2186568492866981,"score_spread":0.2090019669493094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417541108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878297,0.0034101235,0.00009102044,0.0014037915,0.00011287443,0.0003483617,0.000029510926,0.000022004366,0.0067526326],"genre_scores_gemma":[0.9952797,0.0009493789,0.0017641418,0.00029291253,0.00044072076,0.0000064336527,0.0000055263295,0.00009677359,0.0011643542],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995563,0.00088703015,0.0011450159,0.00063107413,0.0008994443,0.0008744697],"domain_scores_gemma":[0.99543154,0.0009408721,0.0018203473,0.00076472247,0.00038050834,0.0006620208],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00091283384,0.0006120866,0.0017300452,0.0003690377,0.00017761826,0.000027379108,0.0004571908,0.00018916705,0.00014127583],"category_scores_gemma":[0.000029692199,0.0003127195,0.00049342396,0.00045073678,0.0018581355,0.00014227553,0.00022351305,0.000987788,0.000023913823],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031977363,0.0010386192,0.060843896,0.00026659953,0.00016364503,0.030476393,0.0017585303,0.000076405784,0.8629507,0.000037661404,0.0021662074,0.008244006],"study_design_scores_gemma":[0.018996531,0.054765593,0.40072918,0.00039393574,0.001438202,0.040225536,0.0021356451,0.000022615804,0.47578555,0.00011557016,0.004482621,0.00090901233],"about_ca_topic_score_codex":0.00011155786,"about_ca_topic_score_gemma":0.0000050866015,"teacher_disagreement_score":0.38716513,"about_ca_system_score_codex":0.00018543265,"about_ca_system_score_gemma":0.00037419327,"threshold_uncertainty_score":0.99993247},"labels":[],"label_agreement":null},{"id":"W2417838046","doi":"","title":"Thermal ablation of small renal masses: intermediate outcomes from a Canadian center.","year":2011,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Cryoablation; Renal cell carcinoma; Ablation; Nephrectomy; Thermal ablation; Renal mass; Surgery; Kidney cancer; Population; Single Center; Radiology; Kidney; Internal medicine","score_opus":0.05619373140904562,"score_gpt":0.219018898665104,"score_spread":0.16282516725605836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417838046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96960104,0.00007686583,0.000014966087,0.00015534187,0.00018160776,0.0006037499,0.0000494231,0.000023125498,0.029293876],"genre_scores_gemma":[0.9981875,0.000006187422,0.00070298894,0.00021097188,0.00006558963,0.00025087333,0.00008113283,0.000019017954,0.00047574763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999077,0.000036627942,0.00024626552,0.00018308192,0.00014087655,0.00031612455],"domain_scores_gemma":[0.99921024,0.00003385682,0.00009350456,0.00026907324,0.000049880327,0.00034343096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011007301,0.00012775809,0.0002508824,0.00014390098,0.000018717139,0.0000064931073,0.000090976224,0.00007178189,0.00026460417],"category_scores_gemma":[0.000052201554,0.00009672487,0.0001061346,0.00006703467,0.000043806012,0.00004971518,0.000023322304,0.00009281913,0.00002510531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015776009,0.00010365975,0.9636281,0.0000151589875,0.00019322816,0.00012069126,0.0008489909,5.621086e-7,0.00015032009,0.000017473672,0.000054311622,0.03470971],"study_design_scores_gemma":[0.0012497964,0.00005612552,0.9915519,0.000017507606,0.00011043848,0.000004292525,0.000056134115,0.000015281697,0.006425533,0.000041114283,0.0003972082,0.00007471641],"about_ca_topic_score_codex":0.08688496,"about_ca_topic_score_gemma":0.041086927,"teacher_disagreement_score":0.045798033,"about_ca_system_score_codex":0.00022122239,"about_ca_system_score_gemma":0.00008631716,"threshold_uncertainty_score":0.97641075},"labels":[],"label_agreement":null},{"id":"W2418851129","doi":"","title":"Technique of laparoscopic nephrectomy in a patient with previous urinary diversion.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Nephrectomy; Contraindication; Laparoscopy; Surgery; Hydronephrosis; Urinary diversion; Urinary system; Laparoscopic surgery; General surgery; Urology; Kidney; Internal medicine; Cystectomy; Cancer","score_opus":0.015328697457227593,"score_gpt":0.20923072906293874,"score_spread":0.19390203160571115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2418851129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98296803,0.00066320464,0.000013933337,0.00005085277,0.00002394194,0.0023865036,0.000001590989,0.000023774888,0.013868141],"genre_scores_gemma":[0.9961145,0.000031253574,0.0012504366,0.000053287167,0.0000053905783,0.0022597378,0.0000034090629,0.000012105403,0.00026987804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919456,0.000053309584,0.0001674408,0.00017524093,0.00018971685,0.00021970402],"domain_scores_gemma":[0.9995424,0.000025057047,0.00006394554,0.00023346767,0.0000355999,0.0000995416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098745724,0.00010649187,0.00024376028,0.0001260776,0.000013174914,0.0000025309414,0.000037410904,0.00004494149,0.000023093857],"category_scores_gemma":[0.000034584842,0.00007514031,0.000038886184,0.00022694028,0.00003972455,0.000032926095,0.000021466003,0.00008827417,0.0000028546774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001024948,0.002086976,0.9669494,0.00040083966,0.000119600736,0.002454972,0.00046755123,0.000011344899,0.0009305636,0.00012723057,0.00038257023,0.025043998],"study_design_scores_gemma":[0.0032693022,0.0012757501,0.8290962,0.00013731259,0.00009974881,0.0005770524,0.00008390491,0.0000010164501,0.16191559,0.000054179545,0.0033613897,0.000128549],"about_ca_topic_score_codex":0.00004786766,"about_ca_topic_score_gemma":0.000004186616,"teacher_disagreement_score":0.16098502,"about_ca_system_score_codex":0.00015774637,"about_ca_system_score_gemma":0.000046396148,"threshold_uncertainty_score":0.30641332},"labels":[],"label_agreement":null},{"id":"W2427717342","doi":"","title":"Growth characteristics of renal cortical tumors in patients managed by watchful waiting.","year":2004,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"Medicine; Watchful waiting; Renal cell carcinoma; Nephrectomy; Conservative management; Natural history; Renal tumor; Radiology; Stage (stratigraphy); Surgery; Kidney; Internal medicine; Cancer","score_opus":0.012261241198857386,"score_gpt":0.19676098145130783,"score_spread":0.18449974025245044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2427717342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970125,0.000031147552,0.000013023486,0.0003695004,0.00005768269,0.00081659603,0.000020047992,0.000024275241,0.0016552497],"genre_scores_gemma":[0.99917746,0.000009396831,0.000080799386,0.00013417126,0.00003852203,0.00024019022,0.00012155127,0.000021915901,0.0001760096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858606,0.00003639286,0.00042944212,0.000225688,0.00034458766,0.000377842],"domain_scores_gemma":[0.999388,0.000035828576,0.00011316138,0.00018985833,0.00007767237,0.00019547512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016389825,0.00014323086,0.0003557581,0.00009840129,0.000020018731,0.000006984457,0.00007162399,0.00005962265,0.00001283614],"category_scores_gemma":[0.00023604836,0.000119496864,0.000070550195,0.0001684096,0.00007094407,0.000042743137,0.000038387003,0.00018432569,0.000011036891],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000691265,0.001407375,0.9795538,0.00016314925,0.00007532611,0.0002759832,0.0001713428,0.0000010812169,0.00045234442,0.00020528735,0.00029027375,0.016712736],"study_design_scores_gemma":[0.0038484207,0.00019781476,0.98358953,0.00004802376,0.00006897789,0.000007908717,0.000016012802,0.0000056355543,0.0120057715,0.000074467695,0.00004090611,0.000096555465],"about_ca_topic_score_codex":0.00009212426,"about_ca_topic_score_gemma":0.0000032214534,"teacher_disagreement_score":0.01661618,"about_ca_system_score_codex":0.00027428468,"about_ca_system_score_gemma":0.000028039558,"threshold_uncertainty_score":0.48729408},"labels":[],"label_agreement":null},{"id":"W2429668996","doi":"10.5489/cuaj.3916","title":"What’s new renal cancer research?","year":2016,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Canadian Urological Association","funders":"","keywords":"Cancer; Medicine; Internal medicine","score_opus":0.1371578307715472,"score_gpt":0.38172949959923264,"score_spread":0.24457166882768544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2429668996","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034296045,0.97428936,0.0000027977972,0.021157837,0.0014500536,0.0006300685,0.00005772598,0.00002317396,0.0023546875],"genre_scores_gemma":[0.00003855153,0.9481163,0.000032112064,0.0009881929,0.0049510193,0.000057348323,0.00004649995,0.000054186068,0.045715764],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952682,0.0009754241,0.00082059257,0.0004808161,0.0011792197,0.0012757255],"domain_scores_gemma":[0.9946684,0.0006680967,0.0006356048,0.00030090698,0.00063821935,0.0030887485],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0018963359,0.00040727932,0.0015673786,0.00082069985,0.00037791976,0.00038844545,0.00033447472,0.0010795896,0.0069561508],"category_scores_gemma":[0.0012544931,0.00023833745,0.00084322697,0.00052980875,0.00006496176,0.00020176795,0.00004487408,0.0025126152,0.0014390699],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0000147478695,0.00001878973,0.0003603003,0.00015893055,0.000490274,0.00076385314,0.000017759692,1.9060595e-7,5.694843e-7,0.00005243283,0.21956281,0.7785593],"study_design_scores_gemma":[0.0005271899,0.00032039528,0.0007024691,0.0059975646,0.00065040763,0.00091571204,0.0000073994415,2.3670127e-7,6.145329e-7,0.00044573625,0.99020714,0.0002251579],"about_ca_topic_score_codex":0.0020836692,"about_ca_topic_score_gemma":0.0013698055,"teacher_disagreement_score":0.7783342,"about_ca_system_score_codex":0.014367699,"about_ca_system_score_gemma":0.012723762,"threshold_uncertainty_score":0.99978864},"labels":[],"label_agreement":null},{"id":"W2433976232","doi":"10.1016/j.eururo.2016.05.049","title":"Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre; University Health Network; University of Toronto; Sunnybrook Health Science Centre; Queen's University","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Carcinoma; Internal medicine; Targeted therapy; Database; Cancer","score_opus":0.04153451134003557,"score_gpt":0.25925405271735386,"score_spread":0.21771954137731828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2433976232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739584,0.0025295636,0.00039978832,0.0073353876,0.0005182772,0.00085294177,0.0011173398,0.00007955722,0.013208792],"genre_scores_gemma":[0.99081796,0.00017808311,0.0017392647,0.0030475357,0.00045330203,0.000037237183,0.0011356456,0.00011706276,0.0024738808],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.994448,0.0018336604,0.0012294846,0.0011279248,0.0006299338,0.000731011],"domain_scores_gemma":[0.9959467,0.0016603463,0.000506257,0.0013866947,0.00020136804,0.0002986534],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014383366,0.0005620149,0.000704049,0.00028985922,0.00010912473,0.00003888206,0.0007570499,0.00006342695,0.00071984757],"category_scores_gemma":[0.00048760526,0.0003167608,0.00024779706,0.00028300597,0.00036499175,0.00015129788,0.00032550207,0.00057288184,0.00080518675],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019641312,0.002588569,0.06913877,0.000050552644,0.0006618357,0.024831139,0.0031413047,0.00015243008,0.8303594,0.00015052644,0.044348277,0.004935864],"study_design_scores_gemma":[0.056999132,0.0055840313,0.6350083,0.000073543335,0.0010001307,0.00059952785,0.0003318479,0.0007234147,0.2539233,0.0002194406,0.044598795,0.0009385978],"about_ca_topic_score_codex":0.0006911764,"about_ca_topic_score_gemma":0.00014728316,"teacher_disagreement_score":0.5764361,"about_ca_system_score_codex":0.00018392847,"about_ca_system_score_gemma":0.00028284173,"threshold_uncertainty_score":0.9999728},"labels":[],"label_agreement":null},{"id":"W2434288623","doi":"10.1097/coc.0000000000000307","title":"Cost-effectiveness of Management Options for Small Renal Mass","year":2016,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Renal mass; Nephrectomy; Cost effectiveness; Surgery; Variety (cybernetics); Intensive care medicine; General surgery; Medical physics; Kidney; Risk analysis (engineering); Internal medicine","score_opus":0.3131896401851001,"score_gpt":0.5322940023700894,"score_spread":0.2191043621849893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2434288623","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003330631,0.9801159,0.011332111,0.00033214592,0.0011858835,0.0034459794,0.0000727542,0.000011201801,0.003170986],"genre_scores_gemma":[0.00022494074,0.9648971,0.03328683,0.00008848282,0.0008143553,0.00023444982,0.000023895698,0.00006338004,0.00036657284],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929162,0.002162153,0.003828032,0.00039662578,0.00033060258,0.000366343],"domain_scores_gemma":[0.98098546,0.011524256,0.005936859,0.00047306318,0.0006034704,0.00047686487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048838016,0.00039582045,0.007962124,0.0004015705,0.000029512952,0.000004944388,0.00037937338,0.00033789582,0.00005457827],"category_scores_gemma":[0.000863373,0.00022861194,0.003376266,0.0002800354,0.00080022746,0.000031266365,0.000081370184,0.0007130504,0.00002577804],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024679652,0.00085381046,0.00009111674,0.0052564307,0.0038791627,0.0005938933,0.000004419274,0.0000012853905,0.0000019614426,0.00029068504,0.00024089412,0.98631835],"study_design_scores_gemma":[0.0047647334,0.027657896,0.0007999307,0.018608844,0.009154862,0.000855311,0.000027353397,6.5533544e-7,0.000005662342,0.00017917396,0.93776155,0.0001840175],"about_ca_topic_score_codex":0.0000043882765,"about_ca_topic_score_gemma":0.0000011413217,"teacher_disagreement_score":0.98613435,"about_ca_system_score_codex":0.000694512,"about_ca_system_score_gemma":0.0018871281,"threshold_uncertainty_score":0.9322524},"labels":[],"label_agreement":null},{"id":"W2435409661","doi":"","title":"Renal medullary carcinoma as an incidental finding in a horseshoe kidney: case report and literature review.","year":2005,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Medicine; Sickle cell trait; Horseshoe kidney; Autopsy; Kidney; Renal cell carcinoma; Pathology; Medullary cavity; Disease; Cause of death; Internal medicine","score_opus":0.021794144735113506,"score_gpt":0.2750001207043268,"score_spread":0.2532059759692133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2435409661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95853007,0.033760194,6.968717e-7,0.0025543014,0.00008554901,0.0016464178,0.000013356258,0.000045380195,0.0033640065],"genre_scores_gemma":[0.9926751,0.0016243459,0.0004930952,0.0023898173,0.0003655981,0.0008133178,0.00021555794,0.000035119312,0.001388043],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99802697,0.00010376739,0.00050952623,0.00054360565,0.00035088844,0.00046524615],"domain_scores_gemma":[0.99847203,0.00003217266,0.00013768426,0.00049863063,0.00006698063,0.0007925133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006817944,0.00026056272,0.0004588847,0.00024975717,0.00006410805,0.00004824322,0.00006694377,0.00013384658,0.000043249092],"category_scores_gemma":[0.00045674838,0.00021536113,0.00009661515,0.0003682385,0.00005453376,0.00028992977,0.000077878714,0.0003504729,0.000009141982],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018662153,0.00022194219,0.1297055,0.0006001789,0.000047878173,0.82233745,0.0006492437,3.2062005e-7,0.00015032483,0.000017683557,0.0035030409,0.042579822],"study_design_scores_gemma":[0.0015528637,0.00013398261,0.36060128,0.000824476,0.00018909619,0.6296228,0.00007710996,0.000017251086,0.0017215299,0.000019027899,0.005031336,0.00020927266],"about_ca_topic_score_codex":0.00016900526,"about_ca_topic_score_gemma":0.0001353093,"teacher_disagreement_score":0.23089576,"about_ca_system_score_codex":0.00038546236,"about_ca_system_score_gemma":0.00012198794,"threshold_uncertainty_score":0.87821716},"labels":[],"label_agreement":null},{"id":"W2460173197","doi":"10.1007/s00261-016-0830-8","title":"Early-stage clear cell tubulopapillary renal cell carcinoma: imaging features and distinction from clear cell and papillary subtypes","year":2016,"lang":"en","type":"article","venue":"Abdominal Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Clear cell renal cell carcinoma; Stage (stratigraphy); Exact test; Receiver operating characteristic; Papillary renal cell carcinomas; Clear cell; Renal cell carcinoma; Nuclear medicine; Radiology; Pathology; Internal medicine","score_opus":0.007043534965496057,"score_gpt":0.2086715359479638,"score_spread":0.20162800098246775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2460173197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97906935,0.014003756,0.00008073199,0.0006481186,0.0002225016,0.0003984108,0.000047516103,0.0000665922,0.005462995],"genre_scores_gemma":[0.9939504,0.0014123239,0.0010566271,0.00028529874,0.00046302436,0.000018231849,0.000049501734,0.00007198584,0.0026925798],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976893,0.00024676215,0.00039677692,0.0008614631,0.00022680343,0.00057889725],"domain_scores_gemma":[0.99840254,0.0004769744,0.00019456225,0.0004721784,0.0000736997,0.00038005292],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002240064,0.00043527884,0.0006517236,0.00016330986,0.00018868223,0.000033191278,0.00011664793,0.00023930022,0.00021022842],"category_scores_gemma":[0.000043581596,0.0003025939,0.00012912505,0.00008913423,0.00045546208,0.00013480261,0.000153767,0.00033101282,0.000082322396],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053696427,0.00017175703,0.4330112,0.00019637577,0.0000641298,0.002565006,0.00063444144,0.0000010628404,0.54775614,0.000033581535,0.0036046032,0.006592031],"study_design_scores_gemma":[0.004957746,0.0019532838,0.8587093,0.000053127616,0.00037520553,0.0010877788,0.0003148075,0.000038511058,0.12928538,0.00011881895,0.0027334038,0.0003726821],"about_ca_topic_score_codex":0.0007707745,"about_ca_topic_score_gemma":0.000015409669,"teacher_disagreement_score":0.42569804,"about_ca_system_score_codex":0.00015482817,"about_ca_system_score_gemma":0.00007775926,"threshold_uncertainty_score":0.9999426},"labels":[],"label_agreement":null},{"id":"W2460314666","doi":"10.1158/1538-7755.disp14-b58","title":"Abstract B58: Underserved populations in kidney cancer research and treatment","year":2015,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Kidney cancer; Medicine; Cancer; Kidney; Kidney disease; Disease; Internal medicine","score_opus":0.5217126686830379,"score_gpt":0.50391905887323,"score_spread":0.01779360980980793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2460314666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.963967,0.017386073,0.000041564494,0.015962826,0.00042097134,0.0011442124,0.000019620053,0.000041597898,0.0010160828],"genre_scores_gemma":[0.9932394,0.0024369224,0.0010954413,0.0002744513,0.00016842579,0.00077913195,0.0002201702,0.000026882337,0.0017591859],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750566,0.0006207983,0.00057789066,0.0005818807,0.00017881044,0.00053497526],"domain_scores_gemma":[0.9984922,0.0002869205,0.00016477438,0.00034078673,0.0001698108,0.00054553995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020797413,0.00022250946,0.0005439949,0.000354665,0.00009053385,0.000008018701,0.00006647739,0.00024234621,0.00017111287],"category_scores_gemma":[0.00048249264,0.0001806891,0.00011450487,0.0003352889,0.00027159287,0.000112823756,0.00004418899,0.00020786547,0.00002298937],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009763534,0.00033951708,0.9729722,0.00007369526,0.00033533707,0.000043008677,0.00019235596,0.00004273595,0.0014667871,0.00033805048,0.008320042,0.014899902],"study_design_scores_gemma":[0.004039852,0.000781264,0.97990614,0.000544888,0.00015022633,0.00001802568,0.00027872314,0.0002475581,0.00044530488,0.011137211,0.0022962904,0.00015451972],"about_ca_topic_score_codex":0.0119144805,"about_ca_topic_score_gemma":0.007336862,"teacher_disagreement_score":0.029272338,"about_ca_system_score_codex":0.002388508,"about_ca_system_score_gemma":0.0007417614,"threshold_uncertainty_score":0.99466527},"labels":[],"label_agreement":null},{"id":"W2461489883","doi":"10.1016/j.ctrv.2016.07.003","title":"The prospect of precision therapy for renal cell carcinoma","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Carcinoma; Intensive care medicine; Internal medicine; Medical physics","score_opus":0.1182675649391262,"score_gpt":0.3909652420386356,"score_spread":0.2726976770995094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2461489883","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000050398325,0.97777456,0.000017240323,0.00009014544,0.00034784077,0.019643908,0.0002335449,0.000023834991,0.0018185028],"genre_scores_gemma":[0.000020861866,0.967739,0.00032156106,0.000021220245,0.0006268937,0.018030247,0.00015073763,0.00012958443,0.012959884],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964799,0.00029094153,0.001558775,0.0008261264,0.00033003392,0.0005141795],"domain_scores_gemma":[0.9960414,0.00060193735,0.0014138793,0.0015808014,0.00015818595,0.00020377302],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004429822,0.0009720427,0.004277457,0.000119239325,0.00016521465,0.000027092228,0.0003167786,0.00025021995,0.0001522577],"category_scores_gemma":[0.000034298264,0.00035148842,0.0029749905,0.00024973016,0.00012633532,0.000039075287,0.00004105584,0.00013468624,0.00009918084],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020273497,0.00027984387,0.000053547195,0.010729083,0.00040213892,0.000011325287,0.000031562286,1.6028359e-8,0.000020064621,0.000015869178,0.0039029538,0.98435086],"study_design_scores_gemma":[0.0025983416,0.003128653,0.00003252903,0.022354197,0.0033390876,0.00003143995,0.000001701456,2.1155371e-7,0.0012158742,0.000019321422,0.9669926,0.000286032],"about_ca_topic_score_codex":0.00003975857,"about_ca_topic_score_gemma":0.000010862899,"teacher_disagreement_score":0.9840648,"about_ca_system_score_codex":0.0018625106,"about_ca_system_score_gemma":0.0010771779,"threshold_uncertainty_score":0.9998937},"labels":[],"label_agreement":null},{"id":"W2463254470","doi":"10.1016/j.urolonc.2016.05.025","title":"The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System","year":2016,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Princess Margaret Cancer Centre; University of Calgary; McGill University; University Health Network; Dalhousie University; University of Toronto; McMaster University; University of Alberta; Université Laval; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Nephrectomy; Medicine; Renal cell carcinoma; Renal function; Kidney disease; Urology; Kidney cancer; Kidney; Cancer; Surgery; Internal medicine","score_opus":0.017241106684029207,"score_gpt":0.23423773477561097,"score_spread":0.21699662809158177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2463254470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97445846,0.0042916364,0.000014655761,0.010228642,0.0006249546,0.0004924049,0.00022390032,0.00001735432,0.009648007],"genre_scores_gemma":[0.9962285,0.00025222913,0.0007489859,0.0005171164,0.000105640924,0.00012571114,0.000089156936,0.0000060390184,0.0019266322],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986851,0.00015832127,0.00048560364,0.00020111156,0.00023357004,0.00023627946],"domain_scores_gemma":[0.998647,0.0003373627,0.00032423766,0.0002914779,0.00014396528,0.00025596554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040323482,0.00015371719,0.00024118058,0.000086667096,0.00017682112,0.000008048674,0.000112523194,0.000152862,0.000035931997],"category_scores_gemma":[0.000047627535,0.00007248175,0.00007540624,0.000119386335,0.0007592396,0.00010432608,0.00003939718,0.00019180743,0.000009008556],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016139135,0.00029577786,0.6718131,0.000576525,0.001259282,0.0012439775,0.0058866194,0.00014371696,0.002646421,0.027216557,0.24952509,0.023253819],"study_design_scores_gemma":[0.002540022,0.0009061844,0.077485755,0.00019919054,0.00067464524,0.000079110185,0.00029811615,0.00017464769,0.0006662274,0.00015818403,0.91671616,0.00010176155],"about_ca_topic_score_codex":0.018023562,"about_ca_topic_score_gemma":0.0069015725,"teacher_disagreement_score":0.6671911,"about_ca_system_score_codex":0.0014173624,"about_ca_system_score_gemma":0.0012451771,"threshold_uncertainty_score":0.9885155},"labels":[],"label_agreement":null},{"id":"W2464636090","doi":"","title":"Malignancy in horseshoe kidneys: review and discussion of surgical implications.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Horseshoe kidney; Nephrectomy; Malignancy; Renal cell carcinoma; Radiology; Surgery; Angiography; Kidney; Internal medicine","score_opus":0.02864598605473077,"score_gpt":0.2625332484941785,"score_spread":0.2338872624394477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2464636090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.780444,0.14044906,0.000011159594,0.02474783,0.0000719471,0.004930268,0.0000149063535,0.00003840559,0.04929237],"genre_scores_gemma":[0.98666435,0.011083015,0.000114748815,0.00019556591,0.0000089627765,0.0009325841,0.000010521113,0.000008463421,0.0009817567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992813,0.000058679645,0.00023951259,0.00016536585,0.000093431925,0.00016172373],"domain_scores_gemma":[0.9995229,0.000024394043,0.00005238363,0.00022134674,0.000027546168,0.00015139718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002361498,0.00007927211,0.00027896988,0.000055996785,0.000010727219,0.0000023559494,0.000026223754,0.000034099186,0.000037605056],"category_scores_gemma":[0.00010529813,0.00004457767,0.00004582868,0.0001915954,0.0000343887,0.000028678936,0.000013843854,0.000055159384,0.000002410879],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008767686,0.0008328439,0.73466533,0.003499338,0.00007411769,0.00018074171,0.00007538244,2.6760702e-7,0.00020774726,0.004081307,0.0064502475,0.24984498],"study_design_scores_gemma":[0.0011066404,0.000038845603,0.97167486,0.0003102872,0.00014663667,0.00019535272,0.00000911486,2.4379602e-7,0.002027826,0.00017629274,0.024246486,0.0000674202],"about_ca_topic_score_codex":0.000007860547,"about_ca_topic_score_gemma":0.0000015461491,"teacher_disagreement_score":0.24977756,"about_ca_system_score_codex":0.000048938502,"about_ca_system_score_gemma":0.000027027723,"threshold_uncertainty_score":0.18178247},"labels":[],"label_agreement":null},{"id":"W2465616243","doi":"10.4081/oncol.2016.295","title":"Contemporary treatment of metastatic renal cell carcinoma","year":2016,"lang":"en","type":"review","venue":"Oncology Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Cabozantinib; Medicine; Renal cell carcinoma; Nivolumab; Targeted therapy; Clinical trial; Sunitinib; Oncology; Axitinib; Kidney cancer; PI3K/AKT/mTOR pathway; Immunotherapy; Temsirolimus; Internal medicine; Cancer research; Discovery and development of mTOR inhibitors; Cancer; Signal transduction","score_opus":0.22731580790878012,"score_gpt":0.4127841184718036,"score_spread":0.18546831056302346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2465616243","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029790614,0.9387288,0.000009210765,0.00007242093,0.0002713798,0.006202342,0.00010775379,0.000026161837,0.054552115],"genre_scores_gemma":[0.00004589043,0.9824751,0.0013623551,0.000062972504,0.00029110446,0.0015441112,0.00034839511,0.00010952363,0.013760524],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99455243,0.0014095723,0.0025068235,0.0008165817,0.00025904638,0.00045555524],"domain_scores_gemma":[0.9954038,0.0005790717,0.002175777,0.0013662792,0.00010547239,0.00036959822],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00056127855,0.0009989465,0.011004691,0.00035296785,0.000043403605,0.0000055163805,0.0002378979,0.00043478608,0.0006684411],"category_scores_gemma":[0.00006687908,0.0004969136,0.00284206,0.00029614882,0.00022888073,0.00004332265,0.000067369576,0.00023396511,0.0016288861],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006204117,0.0010451952,0.00004354427,0.03173054,0.00048196764,0.0012272666,0.000046684345,2.3912952e-9,0.000018301822,0.000010129663,0.0129674915,0.9523668],"study_design_scores_gemma":[0.0023238882,0.007601467,0.00001167134,0.01431853,0.00838447,0.0010001061,0.0000049356977,7.10662e-8,0.000095008254,0.000005379162,0.96592855,0.00032591636],"about_ca_topic_score_codex":0.000031594733,"about_ca_topic_score_gemma":0.0000031504376,"teacher_disagreement_score":0.9529611,"about_ca_system_score_codex":0.0017359374,"about_ca_system_score_gemma":0.0027652842,"threshold_uncertainty_score":0.99974823},"labels":[],"label_agreement":null},{"id":"W2466442967","doi":"10.1007/s12094-016-1524-y","title":"FGFR2 overexpression predicts survival outcome in patients with metastatic papillary renal cell carcinoma","year":2016,"lang":"en","type":"article","venue":"Clinical & Translational Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Terry Fox Foundation","keywords":"Medicine; Immunohistochemistry; Papillary renal cell carcinomas; Internal medicine; Oncology; Pathology; Renal cell carcinoma; Cancer research","score_opus":0.07423368490809736,"score_gpt":0.361256715361705,"score_spread":0.28702303045360766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466442967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919523,0.00012022405,0.00042278468,0.002154151,0.00024639073,0.0008230404,0.000072907846,0.000033620192,0.0041745715],"genre_scores_gemma":[0.99546343,0.000016016047,0.0032394107,0.00042149427,0.00017334885,0.00004285216,0.00016486592,0.00003739084,0.00044118715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966253,0.00049949606,0.0012415788,0.0005894397,0.00064737425,0.00039677988],"domain_scores_gemma":[0.9968175,0.002052201,0.00025526085,0.00034306262,0.0001805258,0.0003514301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006325118,0.0002776632,0.000865985,0.00014110024,0.000046365134,0.000005274752,0.00012621468,0.00024868562,0.00045703884],"category_scores_gemma":[0.0001518532,0.00015607498,0.00023433728,0.00016454204,0.00026105536,0.0001267228,0.00003247007,0.00035438195,0.000095803756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047298837,0.0021790995,0.98435456,0.000048751048,0.000071515315,0.00020720618,0.000045714467,0.000012042422,0.00052995456,0.00010635302,0.00017297419,0.007541965],"study_design_scores_gemma":[0.025234435,0.0060283975,0.96524715,0.000118241944,0.00021651768,0.000010909235,0.0000063463476,0.000025082229,0.00025786486,0.00025884458,0.0024144475,0.00018177318],"about_ca_topic_score_codex":0.000015693886,"about_ca_topic_score_gemma":0.000029118844,"teacher_disagreement_score":0.020504551,"about_ca_system_score_codex":0.00022333687,"about_ca_system_score_gemma":0.00051245576,"threshold_uncertainty_score":0.6364553},"labels":[],"label_agreement":null},{"id":"W2466742901","doi":"10.1016/j.urology.2016.06.005","title":"Surveillance of Small Renal Masses","year":2016,"lang":"en","type":"review","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine","score_opus":0.06465516996510424,"score_gpt":0.320600468888084,"score_spread":0.2559452989229798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466742901","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057958918,0.99096924,0.00006319276,0.000104873674,0.00018151707,0.0004514293,0.000039742434,0.000026343057,0.008105675],"genre_scores_gemma":[0.0001590144,0.99711806,0.00020292682,0.000050451414,0.00023227195,0.000048926777,0.000076359785,0.00004306498,0.0020689066],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99859273,0.00019820966,0.000487639,0.00034990557,0.00011419848,0.00025729963],"domain_scores_gemma":[0.9985632,0.00040160975,0.00032971593,0.00054946943,0.00006486696,0.00009117079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015538663,0.00027965312,0.0019655344,0.00016914262,0.000010870899,0.000001694814,0.00013497964,0.0003421418,0.00037633014],"category_scores_gemma":[0.000100852194,0.00016018769,0.00043202264,0.00010014931,0.000118958385,0.0000062083063,0.00006407745,0.00018709889,0.00030541586],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071002105,0.000075994045,0.0003596707,0.008353535,0.00047171256,0.00044207822,0.000005684986,9.547273e-8,0.000008400137,0.00016190353,0.0008708197,0.9891791],"study_design_scores_gemma":[0.00037455568,0.00070210046,0.00012353483,0.0012562966,0.0005821961,0.0007487311,2.4510143e-7,2.6022943e-7,0.000009000951,0.000030618387,0.99606156,0.00011090387],"about_ca_topic_score_codex":0.000009845195,"about_ca_topic_score_gemma":0.000008920142,"teacher_disagreement_score":0.99519074,"about_ca_system_score_codex":0.000071186805,"about_ca_system_score_gemma":0.00029968747,"threshold_uncertainty_score":0.65322644},"labels":[],"label_agreement":null},{"id":"W2468574520","doi":"10.1186/s12885-016-2539-z","title":"Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicine","year":2016,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"Medical Research Council; Canadian Institutes of Health Research; National Health and Medical Research Council; Royal Australasian College of Physicians; Ontario Institute for Cancer Research","keywords":"Clear cell renal cell carcinoma; Cancer research; Cell culture; Cell growth; Cell; Biology; Medicine; Renal cell carcinoma; Pathology; Genetics","score_opus":0.07745662340795526,"score_gpt":0.32645967974543816,"score_spread":0.2490030563374829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468574520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890818,0.0072281375,0.0006870589,0.00031093476,0.00013845142,0.001594094,0.00026320425,0.000016537624,0.0006797822],"genre_scores_gemma":[0.99308157,0.00085662556,0.0041725896,0.00015047209,0.00030490442,0.00021469052,0.00013754299,0.000049736638,0.0010318755],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970461,0.000180047,0.0007837672,0.00072101137,0.0008247065,0.00044435175],"domain_scores_gemma":[0.99776435,0.0005017973,0.00031623794,0.00038034044,0.0007257253,0.00031155723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048833684,0.00028200605,0.0006268973,0.00013671601,0.00012863794,0.000014807847,0.00009610536,0.00017367929,0.00009897654],"category_scores_gemma":[0.00007407488,0.00016488669,0.00011318933,0.000115877505,0.0004019847,0.000065262815,0.00012096147,0.00015732211,0.0000031926365],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015122624,0.0017015348,0.06753158,0.0014423081,0.00009011805,0.000025950792,0.0070597655,0.00027510125,0.8943204,0.0000620083,0.006808908,0.005559644],"study_design_scores_gemma":[0.07824201,0.027454248,0.12875427,0.0018068781,0.0013133592,0.000012889486,0.0022128362,0.01802485,0.73819745,0.000523945,0.0023373305,0.0011199211],"about_ca_topic_score_codex":0.0007712203,"about_ca_topic_score_gemma":0.000056374152,"teacher_disagreement_score":0.156123,"about_ca_system_score_codex":0.00031529745,"about_ca_system_score_gemma":0.0002974031,"threshold_uncertainty_score":0.67238843},"labels":[],"label_agreement":null},{"id":"W2468847882","doi":"10.1016/j.prp.2016.07.004","title":"TFE3-positive renal cell carcinomas are not always Xp11 translocation carcinomas: Report of a case with a TPM3-ALK translocation","year":2016,"lang":"en","type":"article","venue":"Pathology - Research and Practice","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"TFE3; Chromosomal translocation; Fusion gene; Biology; Cancer research; Renal cell carcinoma; Pathology; Gene; Medicine; Gene expression; Genetics","score_opus":0.0874581788338933,"score_gpt":0.35905120188403267,"score_spread":0.2715930230501394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468847882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97500414,0.0024748496,0.00296731,0.011634869,0.000044277742,0.0013912973,0.00007495386,0.000035469715,0.00637284],"genre_scores_gemma":[0.99437946,0.0008537521,0.0032279189,0.000111211426,0.00011064025,0.00021781371,0.000051640043,0.000043985856,0.0010035789],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959299,0.0013053715,0.0005640726,0.0008165323,0.0007794553,0.00060468627],"domain_scores_gemma":[0.9945192,0.002463134,0.00036847158,0.0007300671,0.0015349885,0.00038415703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030837918,0.00027817575,0.0005293521,0.0003941405,0.00024697278,0.000024402743,0.000102341866,0.00023107912,0.0000508868],"category_scores_gemma":[0.0011069805,0.00016678996,0.000081510734,0.0004377917,0.0007329048,0.00041612698,0.000039352533,0.0005288919,0.000020600146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021235682,0.0018836849,0.024272194,0.000540289,0.00033581225,0.30079907,0.0077734953,0.0000022627169,0.62013686,0.0002522871,0.00029958595,0.022468772],"study_design_scores_gemma":[0.0081503,0.009235143,0.07564947,0.0005084758,0.00066453026,0.31719223,0.005288854,0.000030223731,0.5812742,0.00014607057,0.0014897741,0.00037071065],"about_ca_topic_score_codex":0.0009815198,"about_ca_topic_score_gemma":0.00038013505,"teacher_disagreement_score":0.051377278,"about_ca_system_score_codex":0.00020390408,"about_ca_system_score_gemma":0.0005847184,"threshold_uncertainty_score":0.68014973},"labels":[],"label_agreement":null},{"id":"W2469385908","doi":"10.1016/j.urolonc.2016.05.034","title":"Disease progression and kidney function after partial vs. radical nephrectomy for T1 renal cancer","year":2016,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Princess Margaret Cancer Centre; University of Calgary; McGill University; University of Ottawa; Université Laval; University of Alberta; McMaster University; University Health Network; Dalhousie University; Western University; University of Toronto; University of Manitoba; University of British Columbia","funders":"","keywords":"Renal function; Medicine; Nephrectomy; Urology; Proportional hazards model; Confounding; Hazard ratio; Cancer; Kidney cancer; Kidney disease; Population; Internal medicine; Kidney; Oncology; Confidence interval","score_opus":0.02551865439055036,"score_gpt":0.3169906949751495,"score_spread":0.29147204058459913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2469385908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9519964,0.002665743,0.0007211866,0.043299235,0.00021857185,0.0008119053,0.00006917919,0.00005939328,0.0001583692],"genre_scores_gemma":[0.94597733,0.001367087,0.036449395,0.010472093,0.000869918,0.0028858318,0.0001171877,0.000033527343,0.001827655],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99883777,0.00008543921,0.00022357405,0.00042432538,0.00013443569,0.00029447972],"domain_scores_gemma":[0.9986876,0.00019365086,0.00009447407,0.00014426342,0.000056499543,0.00082347717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016969998,0.00018830456,0.00027377607,0.00008690129,0.00018075887,0.000015492033,0.000034827735,0.00017558796,0.00018915137],"category_scores_gemma":[0.00019376261,0.00011015313,0.0000620227,0.00008616762,0.00078017276,0.000101423,0.000035830133,0.00012645635,0.000006734325],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061141835,0.00024035202,0.941238,0.000081952516,0.00010047803,0.00020539905,0.00008569242,0.0000015140525,0.0039040267,0.0017296743,0.018603083,0.027695635],"study_design_scores_gemma":[0.0027048185,0.0035469136,0.03924305,0.00017380582,0.00074640266,0.00011285382,0.000006329014,0.00022975689,0.0011916278,0.0024597433,0.9494425,0.000142183],"about_ca_topic_score_codex":0.000012984981,"about_ca_topic_score_gemma":0.000008664108,"teacher_disagreement_score":0.9308394,"about_ca_system_score_codex":0.00013531478,"about_ca_system_score_gemma":0.00043429536,"threshold_uncertainty_score":0.44919142},"labels":[],"label_agreement":null},{"id":"W2469770326","doi":"10.5489/cuaj.3798","title":"Structured assessment and followup for patients with hereditary kidney tumour syndromes","year":2016,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Manitoba; Centre Hospitalier Universitaire Sainte-Justine; Memorial University of Newfoundland; Ottawa Hospital; University Health Network; Princess Margaret Cancer Centre; Vancouver General Hospital; Mount Sinai Hospital; McGill University; University of Ottawa; Western University; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Astellas Pharma; Sanofi; Intuitive Surgical; Pfizer; Amgen","keywords":"Medicine; Tuberous sclerosis; Renal cell carcinoma; Leiomyomatosis; Kidney cancer; Von Hippel–Lindau disease; Internal medicine; Pheochromocytoma; Disease; Oncology; Gynecology; Surgery; Pathology","score_opus":0.010360168485972836,"score_gpt":0.22672717633381717,"score_spread":0.21636700784784432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2469770326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777056,0.000059302296,0.00011991692,0.020924363,0.00021792347,0.00041626242,0.00015581859,0.000014176821,0.0003866662],"genre_scores_gemma":[0.9961163,0.000013076747,0.0014103344,0.001809489,0.00021569141,0.000020167909,0.000042101234,0.000014917259,0.00035791934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878806,0.00006960678,0.00021770125,0.00019761249,0.00033173227,0.0003953099],"domain_scores_gemma":[0.9981444,0.0001554499,0.00017965167,0.00007788053,0.00028593012,0.0011566756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002225281,0.00014648125,0.0002647701,0.00011078438,0.00018517244,0.000043163483,0.000054908945,0.0001391645,0.00022262531],"category_scores_gemma":[0.00036705795,0.00007633359,0.00008300899,0.000065525935,0.000027450242,0.000092135764,0.000008528928,0.0001708329,0.0000046282876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010698661,0.000037972903,0.9879014,0.0000054205407,0.0001885405,0.00011152494,0.000014318595,4.3301773e-7,0.00007837633,0.00007141604,0.008876794,0.0026068245],"study_design_scores_gemma":[0.004369396,0.001745539,0.9841736,0.000029672878,0.00015572888,0.00020962534,0.00001213893,0.000006470794,0.000019369389,0.00054599135,0.008624262,0.00010818304],"about_ca_topic_score_codex":0.000109329405,"about_ca_topic_score_gemma":0.00015100109,"teacher_disagreement_score":0.019114872,"about_ca_system_score_codex":0.0012296304,"about_ca_system_score_gemma":0.00067585317,"threshold_uncertainty_score":0.3215441},"labels":[],"label_agreement":null},{"id":"W2471958055","doi":"10.1128/mcb.00189-16","title":"Fibroblast Growth Factor Receptor-Dependent and -Independent Paracrine Signaling by Sunitinib-Resistant Renal Cell Carcinoma","year":2016,"lang":"en","type":"article","venue":"Molecular and Cellular Biology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute; National Institutes of Health; University of Texas Southwestern Medical Center; Cancer Prevention and Research Institute of Texas; American Cancer Society","keywords":"Sunitinib; Paracrine signalling; Cancer research; MAPK/ERK pathway; Biology; Fibroblast growth factor receptor; Angiogenesis; Fibroblast growth factor; Vascular endothelial growth factor; Platelet-derived growth factor receptor; Autocrine signalling; Growth factor; Signal transduction; Internal medicine; Cell biology; Receptor; Renal cell carcinoma; Medicine; Biochemistry","score_opus":0.010645238479726215,"score_gpt":0.21638937901120056,"score_spread":0.20574414053147436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471958055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928931,0.0041001616,0.001441244,0.0004521657,0.000039905128,0.000392779,0.00007621833,0.0000263039,0.00057809864],"genre_scores_gemma":[0.9987669,0.00013388314,0.00023980263,0.00011951201,0.000041980096,0.000029481993,0.00010076013,0.00003890687,0.00052877347],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980866,0.000195951,0.0003775444,0.00065639766,0.00019111886,0.000492417],"domain_scores_gemma":[0.9991993,0.00007103056,0.00010098205,0.00027146164,0.00006504407,0.0002921991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015679383,0.00033144932,0.00045365683,0.00015322895,0.000062169114,0.000018982513,0.000087068314,0.00020697172,0.0001773622],"category_scores_gemma":[0.000028205051,0.00022432418,0.000094448,0.000090832466,0.0001529657,0.00003576849,0.000116443,0.00017107259,0.00001985947],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030418442,0.0001228668,0.022595981,0.00007818219,0.00004004496,0.00061015395,0.000065376065,1.883697e-7,0.97505665,0.0001677709,0.00003922706,0.00091934856],"study_design_scores_gemma":[0.0033730525,0.0013484509,0.008178991,0.000084489526,0.000055901426,0.000090560075,0.00006347118,0.0000037532413,0.9859481,0.00014961223,0.0004300687,0.00027355654],"about_ca_topic_score_codex":0.00019835334,"about_ca_topic_score_gemma":0.000010884191,"teacher_disagreement_score":0.014416989,"about_ca_system_score_codex":0.00010521456,"about_ca_system_score_gemma":0.000051151615,"threshold_uncertainty_score":0.91476744},"labels":[],"label_agreement":null},{"id":"W2472533180","doi":"10.1016/s1762-0953(22)45294-0","title":"10.1016/s1762-0953(22)45294-0","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Physics","score_opus":0.009682947227595905,"score_gpt":0.19467994964004431,"score_spread":0.1849970024124484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2472533180","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016064888,0.00023466615,3.1053364e-7,0.00063023757,0.000001461805,0.00042698428,0.000013781338,0.00014351911,0.98248416],"genre_scores_gemma":[0.0025317366,6.0824186e-7,0.00025042417,0.00013060919,0.00020917667,0.000038332983,0.000053628413,0.000042078085,0.9967434],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988249,0.000031423944,0.00020810666,0.0003047376,0.00029741108,0.0003334361],"domain_scores_gemma":[0.9990748,0.00003803143,0.000025419948,0.00047879486,0.00005107636,0.00033183937],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00009291035,0.00019733475,0.00029258936,0.000092406066,0.00005085624,0.000019358811,0.00010483633,0.00007414691,0.99823153],"category_scores_gemma":[0.000022409327,0.00016418588,0.00011606584,0.00019555636,0.000032763764,0.000047279926,0.000028364027,0.0001237171,0.99705344],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051051594,0.00020019575,0.0000025588822,0.000019985124,0.00007115918,0.0001962936,0.000022469172,0.000014811145,0.0004869185,4.680352e-7,0.39675874,0.60171586],"study_design_scores_gemma":[0.00092020974,0.00079585816,0.00075648434,0.00004023794,0.000119707714,0.00012943486,0.0000011361568,0.000046979,0.0020482691,0.000003887455,0.9949787,0.00015904073],"about_ca_topic_score_codex":0.000037849713,"about_ca_topic_score_gemma":1.280173e-7,"teacher_disagreement_score":0.60155684,"about_ca_system_score_codex":0.00014038921,"about_ca_system_score_gemma":0.000058803507,"threshold_uncertainty_score":0.6695306},"labels":[],"label_agreement":null},{"id":"W2474647303","doi":"10.21037/atm.2016.06.25","title":"Complete response after treatment with first-line targeted anti-vascular endothelial growth factor therapy in metastatic renal cancer: what next?","year":2016,"lang":"en","type":"letter","venue":"Annals of Translational Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Xiangya Hospital, Central South University; Central South University","keywords":"Medicine; Cohort; Vascular endothelial growth factor; Oncology; Internal medicine; Targeted therapy; Vascular access; Overall survival; Population; VEGF receptors; Cancer; Surgery; Urology; Hemodialysis","score_opus":0.1066496827814677,"score_gpt":0.3234302152026433,"score_spread":0.21678053242117562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474647303","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2101182,0.04683818,0.00015037318,0.73919755,0.00021379451,0.0020775897,0.0013343306,0.000038837738,0.000031147552],"genre_scores_gemma":[0.6977145,0.11647156,0.0006375974,0.17583615,0.0041560745,0.001126555,0.0030374771,0.00029707022,0.0007230253],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950702,0.00047468362,0.0011633718,0.0008645818,0.0017051215,0.0007220129],"domain_scores_gemma":[0.9964134,0.001660131,0.00044954458,0.00064827816,0.0005941414,0.00023450794],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040271934,0.0009433269,0.0021092726,0.00088943104,0.000060027298,0.000029789315,0.00019323325,0.0003425013,0.0019439915],"category_scores_gemma":[0.00006798479,0.00052064913,0.0005026489,0.00039115787,0.000492523,0.00042650665,0.000011248668,0.00057236454,0.000016134627],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3055792,0.0057227574,0.06263952,0.0081849275,0.048250444,0.053516235,0.01770077,0.00055376464,0.13318904,0.000055513254,0.10555147,0.2590564],"study_design_scores_gemma":[0.045387372,0.025922013,0.1110458,0.014562399,0.0018566839,0.00027171455,0.000075435084,0.00008182128,0.01915295,0.000377473,0.7799673,0.0012990446],"about_ca_topic_score_codex":0.0007642078,"about_ca_topic_score_gemma":0.00021694218,"teacher_disagreement_score":0.6744158,"about_ca_system_score_codex":0.00018689933,"about_ca_system_score_gemma":0.0007067799,"threshold_uncertainty_score":0.9997245},"labels":[],"label_agreement":null},{"id":"W2476734273","doi":"10.5489/cuaj.4228","title":"Are renal tumour scoring systems better than clinical judgement at predicting partial nephrectomy complexity?","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Nephrectomy; Medicine; Intraclass correlation; Clinical judgement; Confidence interval; Cohort; Judgement; Surgery; Kidney; Internal medicine; Intensive care medicine","score_opus":0.0966184951935314,"score_gpt":0.30499983385033164,"score_spread":0.20838133865680025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2476734273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764632,0.00018337152,0.000032756012,0.018630043,0.0015405541,0.00045638814,0.000037265363,0.00004060892,0.0026158285],"genre_scores_gemma":[0.99299943,0.000022239217,0.00016332952,0.0020400207,0.003886425,0.000033356686,0.000021914559,0.000024067507,0.00080919306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996734,0.00041940063,0.0008600158,0.000404512,0.00073473377,0.0008472881],"domain_scores_gemma":[0.9958889,0.00018464644,0.0017023481,0.00036983477,0.0003175346,0.0015367335],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0018483511,0.00025213606,0.0006367158,0.00013504611,0.0015852478,0.00044638832,0.00025478017,0.0003209411,0.00032449077],"category_scores_gemma":[0.0015750483,0.00019916668,0.0003591066,0.00005806664,0.00011366141,0.00017264669,0.00010367825,0.0010009506,0.00017555899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012174385,0.00005728333,0.9891721,0.000008982337,0.0002762888,0.0013887958,0.000030958283,0.00003199756,0.00007603497,0.00003738357,0.008344138,0.00045427255],"study_design_scores_gemma":[0.0020696216,0.0003900934,0.9571224,0.000086066466,0.00023462085,0.00059960573,0.000043309097,0.0007308805,0.000057988917,0.00008182334,0.03840987,0.00017371913],"about_ca_topic_score_codex":0.0020746118,"about_ca_topic_score_gemma":0.0024563703,"teacher_disagreement_score":0.03204972,"about_ca_system_score_codex":0.0030414301,"about_ca_system_score_gemma":0.000322744,"threshold_uncertainty_score":0.99971455},"labels":[],"label_agreement":null},{"id":"W2482095145","doi":"10.1200/jco.2015.33.7_suppl.490","title":"Can neutrophil-to-lymphocyte ratio be used to identify patients with metastatic renal cell carcinoma who may gain greater benefit from cytoreductive nephrectomy?","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Nephrectomy; Multivariate analysis; Proportional hazards model; Log-rank test; Oncology; Gastroenterology; Urology; Kidney","score_opus":0.14045060979711352,"score_gpt":0.40196436166749167,"score_spread":0.2615137518703782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2482095145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98887634,0.00014497442,0.00016030799,0.008220218,0.00101088,0.00092141674,0.00007460201,0.000013645827,0.00057763763],"genre_scores_gemma":[0.9848115,0.00000865466,0.009225133,0.0040649967,0.0011253331,0.000027585933,0.000044041903,0.00006763117,0.0006251349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945937,0.000718,0.0024074141,0.00056912674,0.0011843127,0.00052749156],"domain_scores_gemma":[0.993321,0.00095118466,0.0014962481,0.0005226693,0.0015053127,0.0022035658],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013950929,0.0004223507,0.0024340595,0.000376457,0.000058870373,0.000042957992,0.00032618505,0.00026417934,0.00012781449],"category_scores_gemma":[0.00081143144,0.0002763068,0.00047812748,0.00035116545,0.00015981763,0.00018414766,0.00013277438,0.0007506843,0.000078012636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056061998,0.003914087,0.8994305,0.000039027032,0.0018193208,0.0071549374,0.0045630247,0.0013500488,0.002085272,0.000024956507,0.013272001,0.01028483],"study_design_scores_gemma":[0.03151187,0.045837816,0.90669674,0.00011729267,0.0018916085,0.00016875907,0.00038898186,0.00003381248,0.006411305,0.00015174225,0.006481172,0.0003089104],"about_ca_topic_score_codex":0.0007793792,"about_ca_topic_score_gemma":0.00039574836,"teacher_disagreement_score":0.041923728,"about_ca_system_score_codex":0.0015353854,"about_ca_system_score_gemma":0.0028311824,"threshold_uncertainty_score":0.9999689},"labels":[],"label_agreement":null},{"id":"W2483478704","doi":"10.1200/jco.2007.25.18_suppl.15580","title":"Sunitinib-related macrocytosis in patients with advanced renal cell cancer (RCC)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Macrocytosis; Medicine; Sunitinib; Internal medicine; Gastroenterology; Mean corpuscular volume; Concomitant; Anemia; Population; Oncology; Cancer; Hematocrit","score_opus":0.059895784475185204,"score_gpt":0.41925681068623427,"score_spread":0.35936102621104904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2483478704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890475,0.0004140405,0.000024541974,0.00094999257,0.0005268831,0.00028942857,0.0000032473415,0.0000075176054,0.008736795],"genre_scores_gemma":[0.99511003,0.0002535336,0.003075656,0.0008980032,0.0002614688,0.0000033750732,0.0000067491073,0.00002521621,0.00036596012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962203,0.00021664429,0.002480609,0.00021374528,0.0005004393,0.00036825638],"domain_scores_gemma":[0.99584967,0.001237547,0.0016781008,0.00017827262,0.0005747945,0.00048161412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020721608,0.00017870356,0.0013406796,0.00023577594,0.000025354368,0.0000039270617,0.00012642413,0.0003548527,0.00028278492],"category_scores_gemma":[0.0004919212,0.000113507995,0.0002931698,0.00028443706,0.00015195063,0.000098097786,0.00003224244,0.0011888369,0.000017170367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022821562,0.00350074,0.8063686,0.000023176002,0.00023720594,0.002174071,0.00011574543,0.00007353734,0.00030840473,0.0000066748216,0.00044077085,0.16392954],"study_design_scores_gemma":[0.03051832,0.026164914,0.93258303,0.00018722132,0.0003330372,0.00007273865,0.000077302306,0.0000044331427,0.001968,0.000027142447,0.007952647,0.00011121851],"about_ca_topic_score_codex":0.000040567233,"about_ca_topic_score_gemma":0.00018129323,"teacher_disagreement_score":0.16381831,"about_ca_system_score_codex":0.0005382783,"about_ca_system_score_gemma":0.0010776522,"threshold_uncertainty_score":0.5164971},"labels":[],"label_agreement":null},{"id":"W2498473468","doi":"10.1158/1538-7445.am2016-1240","title":"Abstract 1240: Targeting epigenetic regulation in clear cell renal cell carcinoma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Clear cell renal cell carcinoma; Cancer research; Epigenetics; BAP1; Biology; Cancer; Renal cell carcinoma; Pathology; Gene; Medicine; Genetics; Melanoma","score_opus":0.06980876048259854,"score_gpt":0.353920215516742,"score_spread":0.2841114550341435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2498473468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813941,0.0031017081,0.000027016446,0.0011366878,0.000083106024,0.00068144663,0.00000956112,0.000026183758,0.013540193],"genre_scores_gemma":[0.9922656,0.00036615328,0.00020255194,0.000029161305,0.000354722,0.00014337891,0.000012540499,0.000054780034,0.006571133],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972774,0.0001740588,0.000373222,0.0005426758,0.000864587,0.0007680819],"domain_scores_gemma":[0.99865925,0.0002391738,0.00007137063,0.00047288445,0.00027411262,0.0002832021],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009493988,0.0001772685,0.00026534588,0.00037786446,0.00010460792,0.00002534894,0.00016399322,0.00013338351,0.0017458402],"category_scores_gemma":[0.00008272626,0.00012289501,0.00008978623,0.0004265223,0.00014723268,0.00009136843,0.00009137274,0.00039631475,0.00044610066],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005877175,0.00014365376,0.04626741,0.00020047704,0.000007154186,0.00023854406,0.00025082438,0.000026068885,0.9419469,0.000008676685,0.0030283243,0.007294205],"study_design_scores_gemma":[0.001707187,0.0003225367,0.3891161,0.00014621211,0.000009632524,0.0000033913923,0.000074749885,0.000018634886,0.60629904,0.00008338238,0.0021168,0.00010230985],"about_ca_topic_score_codex":0.0011380193,"about_ca_topic_score_gemma":0.00009207761,"teacher_disagreement_score":0.3428487,"about_ca_system_score_codex":0.0012221129,"about_ca_system_score_gemma":0.00048368177,"threshold_uncertainty_score":0.9991667},"labels":[],"label_agreement":null},{"id":"W2500289888","doi":"10.1200/jco.2015.33.15_suppl.4507","title":"Final clinical results of a randomized phase II international trial of everolimus vs. sunitinib in patients with metastatic non-clear cell renal cell carcinoma (ASPEN).","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Chromophobe cell; Everolimus; Sunitinib; Clinical endpoint; Internal medicine; Hazard ratio; Oncology; Renal cell carcinoma; Progression-free survival; Randomized controlled trial; Clear cell; Urology; Confidence interval; Chemotherapy","score_opus":0.16073283423972487,"score_gpt":0.4422219842839687,"score_spread":0.2814891500442438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2500289888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906524,0.00009367563,0.000070392365,0.0009623534,0.0014155217,0.0013319097,0.0000422439,0.0000038586136,0.0054276474],"genre_scores_gemma":[0.99059826,0.00009296277,0.007909242,0.00026422867,0.00067269,0.000011494001,0.00004502793,0.000030093715,0.00037598028],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9862849,0.0025613178,0.00904219,0.00037557463,0.0014067518,0.00032927378],"domain_scores_gemma":[0.9826483,0.0064493045,0.00773524,0.0003975952,0.0020703478,0.000699224],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01465829,0.0003013224,0.0051821647,0.00045474543,0.000021424928,0.000006744476,0.00038637363,0.00036560063,0.000094993185],"category_scores_gemma":[0.009972151,0.00019326709,0.0013192773,0.00024387079,0.00066447794,0.00015859806,0.00014377238,0.0013075282,0.000009450189],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9331809,0.03340162,0.024545407,0.000045348632,0.0006102312,0.00096303946,0.0002801852,0.000047793015,0.000036295798,0.0000045257593,0.0015296349,0.0053549693],"study_design_scores_gemma":[0.759748,0.19268596,0.043927733,0.00012842713,0.0015028957,0.000042050007,0.000093226474,0.00020591806,0.00051177153,0.000059900878,0.0009762098,0.00011792177],"about_ca_topic_score_codex":0.00010069706,"about_ca_topic_score_gemma":0.000026042786,"teacher_disagreement_score":0.17343296,"about_ca_system_score_codex":0.00024198933,"about_ca_system_score_gemma":0.0037985742,"threshold_uncertainty_score":0.99836725},"labels":[],"label_agreement":null},{"id":"W2501767467","doi":"10.1093/annonc/mdv341.17","title":"Prognostic role of PD-L1 expression in renal cell carcinoma. A systematic review and meta-analysis","year":2015,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Meta-analysis; Renal cell carcinoma; Cochrane Library; Internal medicine; Oncology; Population; Clear cell renal cell carcinoma; MEDLINE; Kidney cancer","score_opus":0.24433423157634268,"score_gpt":0.4282160250311953,"score_spread":0.18388179345485264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2501767467","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002148078,0.99332887,0.0000011994606,0.00012618287,0.000011545163,0.0046912227,0.00006115334,0.00001120384,0.0015538349],"genre_scores_gemma":[0.0049650655,0.993156,0.00030247722,0.00013435114,0.000015635353,0.000917839,0.00012588673,0.000050819755,0.00033188256],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9947229,0.00149257,0.002428618,0.0005630977,0.00047004342,0.00032279268],"domain_scores_gemma":[0.99539316,0.000655938,0.0022876728,0.00092162035,0.0004985781,0.00024306297],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0018629334,0.00053800544,0.018071463,0.0008004134,0.000011124386,0.0000039954452,0.00023748103,0.0004236922,0.00008727504],"category_scores_gemma":[0.0004061431,0.000316983,0.0025433414,0.00090407784,0.00011631895,0.000039832936,0.00015569839,0.0003310206,0.000010864151],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030935676,0.00056207343,0.000049572664,0.96987283,0.02613778,0.00019858942,0.00009829059,5.050105e-7,0.000008575563,0.0000043991377,0.00045842413,0.0025780303],"study_design_scores_gemma":[0.0003606809,0.0021394119,0.00004285395,0.037780218,0.92902344,0.00016276073,0.00003320523,0.0000016974544,0.00010368658,0.000019809182,0.030119322,0.00021291466],"about_ca_topic_score_codex":0.00007671061,"about_ca_topic_score_gemma":0.0000183261,"teacher_disagreement_score":0.9320926,"about_ca_system_score_codex":0.00011945549,"about_ca_system_score_gemma":0.0007406023,"threshold_uncertainty_score":0.99992824},"labels":[],"label_agreement":null},{"id":"W2505393039","doi":"10.1007/s00345-016-1903-6","title":"Second-line treatment for metastatic clear cell renal cell cancer: experts’ consensus algorithms","year":2016,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; GlaxoSmithKline Australia; Novartis; Les Laboratories Pierre Fabre; Bayer; AstraZeneca; Merck; Novartis Pharma; Roche; Astellas Pharma US; Pfizer","keywords":"Medicine; Cabozantinib; Axitinib; Nivolumab; Everolimus; Clinical trial; Sunitinib; Intensive care medicine; Oncology; Kidney cancer; Second line treatment; Internal medicine; Tyrosine-kinase inhibitor; Cancer; Renal cell carcinoma; Chemotherapy; Immunotherapy","score_opus":0.045498779414551056,"score_gpt":0.3060013331278901,"score_spread":0.260502553713339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2505393039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9514683,0.024583014,0.0015256664,0.017094126,0.0010694957,0.0009755352,0.00011776309,0.000030609564,0.0031355277],"genre_scores_gemma":[0.97014123,0.0012139917,0.0074852505,0.00089614076,0.00065816165,0.000051428447,0.000005197888,0.000054727156,0.019493882],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998123,0.00014136443,0.00075973483,0.00028086925,0.00023517263,0.0004598872],"domain_scores_gemma":[0.99790066,0.00061782106,0.0005751454,0.00027797642,0.00027827235,0.00035014504],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026153144,0.0002918707,0.00082198746,0.0003621422,0.000063133906,0.00000876479,0.00011602237,0.00006711297,0.0013254848],"category_scores_gemma":[0.000031628915,0.00016242806,0.00041962965,0.00012035825,0.00013706597,0.000038867987,0.000021910799,0.00013388584,0.000027634518],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026120378,0.0041320953,0.004210429,0.00026306356,0.002644106,0.008152621,0.0011928176,0.00021534026,0.69929165,0.00012943201,0.065443754,0.1882043],"study_design_scores_gemma":[0.0395874,0.033462636,0.0015387286,0.00010507325,0.0026741344,0.0034662187,0.00015563458,0.0002175511,0.32777643,0.00043119275,0.5901811,0.00040387944],"about_ca_topic_score_codex":0.000023912487,"about_ca_topic_score_gemma":0.00012270233,"teacher_disagreement_score":0.52473736,"about_ca_system_score_codex":0.00041644904,"about_ca_system_score_gemma":0.0003809702,"threshold_uncertainty_score":0.9995874},"labels":[],"label_agreement":null},{"id":"W2507098989","doi":"10.1016/j.ejca.2016.06.016","title":"First-line sunitinib versus pazopanib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium","year":2016,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; University of Calgary","funders":"","keywords":"Pazopanib; Sunitinib; Renal cell carcinoma; Medicine; Oncology; Internal medicine","score_opus":0.06636657144106892,"score_gpt":0.29226668905466274,"score_spread":0.22590011761359383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507098989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783051,0.0045637903,0.00028472694,0.006831165,0.00118769,0.00039012864,0.0011588322,0.000015481015,0.0072630583],"genre_scores_gemma":[0.99396473,0.0005718883,0.001693312,0.00044600587,0.001087608,0.000010850071,0.00011505089,0.00009083819,0.0020196938],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99534553,0.00084969646,0.0016299138,0.00050687336,0.0011589198,0.0005090582],"domain_scores_gemma":[0.99570876,0.0014386377,0.0011806729,0.0007136564,0.0005495153,0.0004087558],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017824266,0.00044415978,0.00067882723,0.0002843663,0.00010092326,0.00006637548,0.0006963339,0.000027464637,0.0009307486],"category_scores_gemma":[0.0005715926,0.0002480697,0.0003337076,0.00027234803,0.0002122328,0.00029298774,0.00019741108,0.0006027286,0.00011836863],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.153783,0.005337773,0.10571396,0.0005501036,0.003918174,0.13681468,0.01155808,0.0025496671,0.35992697,0.00013775607,0.16003557,0.059674278],"study_design_scores_gemma":[0.1649434,0.006962664,0.45404702,0.0021952153,0.004903525,0.0010281861,0.0015427055,0.00046667206,0.25784582,0.00009386443,0.10465123,0.0013196819],"about_ca_topic_score_codex":0.0006575331,"about_ca_topic_score_gemma":0.00053371093,"teacher_disagreement_score":0.34833306,"about_ca_system_score_codex":0.0005789714,"about_ca_system_score_gemma":0.000632924,"threshold_uncertainty_score":0.99999714},"labels":[],"label_agreement":null},{"id":"W2511487625","doi":"10.3747/co.22.2741","title":"Cost-Effectiveness of Pazopanib: An Example of Improved Transparency and Accessibility of Industry-Sponsored Economic Evaluations through Publication in Peer-Reviewed Journals","year":2016,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Sunnybrook Health Science Centre; Cancer Care Ontario","funders":"","keywords":"Pazopanib; Sunitinib; Medicine; Transparency (behavior); Renal cell carcinoma; Oncology; Library science; Computer science","score_opus":0.4291615192472224,"score_gpt":0.5110825467626819,"score_spread":0.08192102751545954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511487625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99489015,0.001976362,0.0005582725,0.00044675334,0.00015450147,0.0017217023,0.00008361518,0.000006670314,0.00016194943],"genre_scores_gemma":[0.9988528,0.00055124593,0.0002590359,0.0000042843494,0.000026300653,0.00022705561,0.00005966147,0.000009684394,0.000009945802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975325,0.00090497156,0.0008992083,0.00033615643,0.00016605739,0.0001611168],"domain_scores_gemma":[0.99760395,0.00065274164,0.0006031997,0.00041489807,0.0006290238,0.00009617744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024791486,0.00013597643,0.0007594759,0.00016599295,0.000016680691,0.0000035102073,0.00012288117,0.00018468527,0.00022946416],"category_scores_gemma":[0.00059915707,0.00009392815,0.000082070685,0.00016950142,0.00020762197,0.00025405228,0.00002906612,0.00017145164,0.0000011533425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001190544,0.0020225162,0.6158039,0.00082171866,0.00007917912,9.652696e-7,0.0008893637,0.000004204113,0.131617,0.00029841086,0.000032764903,0.24723947],"study_design_scores_gemma":[0.0052831736,0.0014473643,0.9368381,0.00046366855,0.0002048322,0.000011094179,0.00008638029,0.0000930188,0.05423563,0.0006594262,0.00060138106,0.00007591519],"about_ca_topic_score_codex":0.00028258422,"about_ca_topic_score_gemma":0.00014380658,"teacher_disagreement_score":0.32103425,"about_ca_system_score_codex":0.00049975485,"about_ca_system_score_gemma":0.0006397205,"threshold_uncertainty_score":0.38302788},"labels":[],"label_agreement":null},{"id":"W2511930612","doi":"10.1016/s0167-8140(16)33536-8","title":"137: Stereoactic Ablative Radiotherapy (SABR) for Large Renal Tumours: Outcomes, Toxicity, and Technical Considerations","year":2016,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"SABR volatility model; Ablative case; Medicine; Toxicity; Radiation therapy; Oncology; Radiology; Internal medicine","score_opus":0.0340695466399043,"score_gpt":0.3399601773333345,"score_spread":0.3058906306934302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511930612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9177576,0.00758819,0.031776723,0.038896155,0.00021554403,0.0023302801,0.00009771198,0.00013441559,0.0012033888],"genre_scores_gemma":[0.9702145,0.001959312,0.022011064,0.0041068885,0.00025912854,0.00018548395,0.000009279698,0.000044452365,0.0012099126],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985908,0.00014443784,0.00033486262,0.00042593962,0.00013044686,0.00037350945],"domain_scores_gemma":[0.9979539,0.0013837409,0.0001241558,0.0002438596,0.000070963004,0.00022338479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034573025,0.00024939116,0.00069217675,0.00013172733,0.00017118621,0.000023041102,0.000043702832,0.00023711742,0.00027270426],"category_scores_gemma":[0.00009780872,0.00015206925,0.00011730055,0.0000599318,0.0002340484,0.00010291633,0.000018003784,0.0001349261,0.0000020376394],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065175532,0.0035261663,0.3087591,0.00016392377,0.0027470468,0.0006228125,0.0025765086,0.0000015271568,0.53686476,0.04465436,0.0171795,0.07638674],"study_design_scores_gemma":[0.097254604,0.033155512,0.60795444,0.00028764686,0.0009305638,0.009726881,0.0002620416,0.0003710281,0.025639175,0.008653563,0.21452723,0.0012372882],"about_ca_topic_score_codex":0.000010937586,"about_ca_topic_score_gemma":0.000118890785,"teacher_disagreement_score":0.5112256,"about_ca_system_score_codex":0.0006813795,"about_ca_system_score_gemma":0.0002047898,"threshold_uncertainty_score":0.62012035},"labels":[],"label_agreement":null},{"id":"W2512081761","doi":"10.1096/fasebj.30.1_supplement.1040.12","title":"Laterality and Locality of Metastatic Renal Cell Carcinoma to Pancreatic Position; Right Kidney RCC Mechanism of Dissemination to Pancreatic Position","year":2016,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph's Hospital; University Hospital; Western University","funders":"","keywords":"Renal cell carcinoma; Position (finance); Medicine; Pancreatic carcinoma; Mechanism (biology); Kidney; Laterality; Oncology; Internal medicine; Pancreatic cancer; Cancer; Physics","score_opus":0.01283153824803552,"score_gpt":0.25588123462982937,"score_spread":0.24304969638179386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512081761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839783,0.00012896738,0.0111960145,0.0035466813,0.0000607792,0.00063811115,0.000113174014,0.000010322924,0.00032767316],"genre_scores_gemma":[0.9969154,0.000023833549,0.002204012,0.00029263776,0.00006758023,0.000019291705,0.00002081127,0.00001979892,0.00043660912],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998007,0.00035332696,0.0006205869,0.0002246457,0.00053200556,0.00026242353],"domain_scores_gemma":[0.99828994,0.00022563289,0.0003169575,0.0003632781,0.00029474692,0.0005094395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007957866,0.00021394687,0.0005039302,0.00018932608,0.0001239208,0.000022318905,0.00012017449,0.000046947498,0.00021187973],"category_scores_gemma":[0.00012645642,0.00011233465,0.00013978919,0.00020618674,0.00008150189,0.00012201706,0.00005242178,0.00012545878,0.000016569436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007953631,0.00022248352,0.0067386385,0.000195818,0.00013534259,0.00010755264,0.00081529905,0.000004334308,0.98948354,0.00047896025,0.00029206154,0.0007306258],"study_design_scores_gemma":[0.001450104,0.0016126597,0.118812665,0.00076899724,0.0009689156,0.00082464796,0.000115876624,0.000057196085,0.87305456,0.0022088962,0.0000056940235,0.000119811826],"about_ca_topic_score_codex":0.00013854407,"about_ca_topic_score_gemma":0.0000056109643,"teacher_disagreement_score":0.116428986,"about_ca_system_score_codex":0.0002742217,"about_ca_system_score_gemma":0.00011790497,"threshold_uncertainty_score":0.4580874},"labels":[],"label_agreement":null},{"id":"W2512806889","doi":"10.1016/j.rmcr.2016.08.006","title":"Recurrent spontaneous pneumothoraces and bullous emphysema. A novel mutation causing Birt-Hogg-Dube syndrome","year":2016,"lang":"en","type":"article","venue":"Respiratory Medicine Case Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Birt–Hogg–Dubé syndrome; Folliculin; Medicine; Pneumothorax; Dermatology; Mutation; Pathology; Surgery; Gene; Genetics","score_opus":0.04163222560048667,"score_gpt":0.30194126054055287,"score_spread":0.2603090349400662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512806889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98910683,0.007195186,0.00022403769,0.001147305,0.0005925134,0.0009935698,0.000009521154,0.0001835663,0.00054746657],"genre_scores_gemma":[0.99821055,0.0001255589,0.00019636359,0.0003956392,0.0004293645,0.00006519487,0.000013037128,0.00008621639,0.00047808737],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99656004,0.00011556431,0.0010843831,0.0009254019,0.000810954,0.0005036499],"domain_scores_gemma":[0.99729264,0.00032083003,0.0005791762,0.00083026063,0.000303544,0.00067354005],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009031823,0.00047801904,0.0008660772,0.00042566782,0.00018065478,0.00002061651,0.000029766927,0.00018132738,0.00015570124],"category_scores_gemma":[0.0008466227,0.0002936476,0.000121182966,0.0003137734,0.00033821963,0.00014635664,0.00006559495,0.00021454765,0.000016540454],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020124177,0.00015857257,0.0023406325,0.00027582012,0.00011968814,0.89245677,0.0003219052,0.0000014729178,0.08428276,0.000012960663,0.00028995186,0.01953825],"study_design_scores_gemma":[0.0019589025,0.0027774952,0.010504949,0.0017503207,0.0005434405,0.9688937,0.00026704033,0.000016817321,0.005146978,0.00003496557,0.007782508,0.00032285153],"about_ca_topic_score_codex":0.00017640897,"about_ca_topic_score_gemma":0.000058197707,"teacher_disagreement_score":0.07913578,"about_ca_system_score_codex":0.00052407896,"about_ca_system_score_gemma":0.00030340927,"threshold_uncertainty_score":0.99995154},"labels":[],"label_agreement":null},{"id":"W2513069845","doi":"10.1111/bju.13630","title":"Safety, reliability and accuracy of small renal tumour biopsies: results from a multi‐institution registry","year":2016,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; Université Laval; Public Health Ontario; McGill University Health Centre; McGill University; Centre hospitalier universitaire de Québec; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network; Université de Sherbrooke; University of Toronto; Centre Hospitalier Universitaire de Sherbrooke; McMaster University","funders":"","keywords":"Medicine; Concordance; Biopsy; Logistic regression; Retrospective cohort study; Triage; Diagnostic accuracy; Radiology; Academic institution; Surgery; Emergency medicine; Internal medicine","score_opus":0.024213582352709647,"score_gpt":0.2559638139708363,"score_spread":0.23175023161812663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513069845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914086,0.0034650995,0.0013428356,0.002911314,0.000177157,0.00016906406,0.0001845738,0.000010293745,0.00033106783],"genre_scores_gemma":[0.9920881,0.0026076385,0.0048418627,0.00010698121,0.00021035381,0.0000016010127,0.0000116857145,0.000011569339,0.000120208155],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99819815,0.0001811645,0.0009426286,0.00026659167,0.00020753167,0.00020390295],"domain_scores_gemma":[0.99780226,0.0006127026,0.00077105337,0.00024713844,0.00037240726,0.0001944147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063355884,0.00013063908,0.00051890843,0.00009140278,0.000047564707,0.000010723865,0.000121897334,0.00016401889,0.000038158432],"category_scores_gemma":[0.0038566298,0.00009980831,0.00014559674,0.00007196592,0.0003972353,0.00011379497,0.000062566534,0.00025809012,0.000004124875],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051341154,0.0025591913,0.1098911,0.0002651635,0.0011415189,0.028366454,0.00077415985,0.00016576443,0.4451166,0.000106213905,0.004235986,0.3560367],"study_design_scores_gemma":[0.018417176,0.00210858,0.93522304,0.0007930793,0.0004075515,0.028122146,0.000047875317,0.00006148379,0.01024081,0.00045247152,0.00398013,0.00014565192],"about_ca_topic_score_codex":0.0007994909,"about_ca_topic_score_gemma":0.00015009232,"teacher_disagreement_score":0.8253319,"about_ca_system_score_codex":0.000110909525,"about_ca_system_score_gemma":0.00024298504,"threshold_uncertainty_score":0.46170247},"labels":[],"label_agreement":null},{"id":"W2513374664","doi":"10.3747/co.23.2244","title":"Cost-Effectiveness of Pazopanib Compared with Sunitinib in Metastatic Renal Cell Carcinoma in Canada","year":2016,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"Novartis","keywords":"Pazopanib; Sunitinib; Medicine; Renal cell carcinoma; Oncology; Internal medicine; Cancer research","score_opus":0.15085575615755556,"score_gpt":0.36480144667373726,"score_spread":0.2139456905161817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513374664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964023,0.0007667287,0.00006320915,0.00011625439,0.0001935667,0.0012679773,0.000039528582,0.000006474914,0.0011439332],"genre_scores_gemma":[0.999521,0.000027349266,0.00010543092,0.000015748179,0.000019236,0.00023184379,0.000042210304,0.000018800774,0.00001838147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807256,0.0005464857,0.00042854802,0.0003165205,0.00025273362,0.00038313871],"domain_scores_gemma":[0.9984374,0.00085617474,0.00016192984,0.0002628936,0.00012506949,0.00015654089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000336589,0.00020527859,0.0007935922,0.00021781426,0.0000123665,0.0000016422456,0.00010276167,0.000038555565,0.0000882222],"category_scores_gemma":[0.000048455036,0.0001274292,0.000044555873,0.00028551006,0.00011005593,0.00003777324,0.000039224135,0.0001866303,0.000005655995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026725251,0.0009946611,0.9722097,0.0005089721,0.000031314477,0.0012784599,0.00019315763,0.00005146584,0.0077195987,0.000038854447,0.00010238449,0.014198937],"study_design_scores_gemma":[0.015256158,0.0015098652,0.93678784,0.0005526046,0.00011044657,0.000105839055,0.00031863534,0.000064079904,0.04376342,0.000024026554,0.0013538653,0.00015321928],"about_ca_topic_score_codex":0.20994042,"about_ca_topic_score_gemma":0.67911416,"teacher_disagreement_score":0.46917373,"about_ca_system_score_codex":0.0031830112,"about_ca_system_score_gemma":0.0033667197,"threshold_uncertainty_score":0.8323464},"labels":[],"label_agreement":null},{"id":"W2514283099","doi":"10.1177/1756287216663073","title":"Cabozantinib in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience","year":2016,"lang":"en","type":"review","venue":"Therapeutic Advances in Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"FP7 Science in Society; Bristol-Myers Squibb","keywords":"Cabozantinib; Medicine; Sunitinib; Axitinib; Oncology; Metastasis; Renal cell carcinoma; Internal medicine; Targeted therapy; Tyrosine-kinase inhibitor; Cancer research; Vascular endothelial growth factor; Angiogenesis; Tyrosine kinase; Everolimus; Receptor tyrosine kinase; Cancer; Receptor; VEGF receptors","score_opus":0.1681734959571597,"score_gpt":0.4580039289744441,"score_spread":0.2898304330172844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514283099","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06689772,0.9290515,0.000017813476,0.00008856726,0.00038481195,0.0031643726,0.00000936115,0.000010751738,0.0003750798],"genre_scores_gemma":[0.12187327,0.8766938,0.00017282527,0.00009384812,0.00021754831,0.00081340136,0.00000914208,0.000036266687,0.00008993592],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99537504,0.0013110987,0.001645037,0.0008686667,0.00029374423,0.00050644204],"domain_scores_gemma":[0.9941221,0.004137425,0.00068449875,0.0009244129,0.00004074284,0.000090856636],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006574139,0.0005713558,0.0028602988,0.00025297276,0.000033001757,0.00000607585,0.0003560336,0.00038275105,0.000037949907],"category_scores_gemma":[0.000100757716,0.00028536146,0.0004287281,0.0003248299,0.00074299704,0.00011396302,0.000048525715,0.00038253155,0.0000108314935],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009715544,0.0010292969,0.0013195266,0.000970978,0.000039661474,0.00030142243,0.00074796006,0.0000010075429,0.00000401222,0.000056790894,7.8390264e-7,0.985813],"study_design_scores_gemma":[0.035037827,0.020703854,0.0014440981,0.0021502287,0.00091985444,0.0002863952,0.00013456587,0.000003357504,0.000026683241,0.00019478449,0.93876237,0.00033600582],"about_ca_topic_score_codex":0.000016004005,"about_ca_topic_score_gemma":0.000030687548,"teacher_disagreement_score":0.98547703,"about_ca_system_score_codex":0.00016523429,"about_ca_system_score_gemma":0.0003298231,"threshold_uncertainty_score":0.9999598},"labels":[],"label_agreement":null},{"id":"W2516130739","doi":"10.1136/bcr-2016-216081","title":"Isolated brain metastasis from a small renal mass","year":2016,"lang":"en","type":"article","venue":"BMJ Case Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Renal mass; Brain metastasis; Guideline; Metastasis; Distant metastasis; Radiation therapy; Kidney; Radiology; Internal medicine; Pathology; Nephrectomy; Cancer","score_opus":0.043162460735900264,"score_gpt":0.2947471361421214,"score_spread":0.25158467540622115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2516130739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98940027,0.0004095716,0.0032490552,0.0030678858,0.00018576921,0.0007983253,0.000025919058,0.00013372682,0.0027294557],"genre_scores_gemma":[0.9899859,0.000011227691,0.0041132984,0.00029923,0.00023659517,0.00008749696,0.0000511522,0.00004542337,0.005169684],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.998048,0.000094366784,0.000648903,0.0005558127,0.00032338835,0.00032954747],"domain_scores_gemma":[0.99805945,0.00021168144,0.0003100265,0.00094616506,0.0001268741,0.0003457781],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040752438,0.000245598,0.00045755564,0.00011293555,0.000054563312,0.000018378858,0.00002543872,0.00011579844,0.0010091772],"category_scores_gemma":[0.0003755132,0.00014650414,0.0002424822,0.00014498523,0.000050683466,0.00005962985,0.000044531174,0.00009678741,0.00015361003],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002325397,0.00008911702,0.004081911,0.000016696247,0.00036147994,0.8879439,0.000057887893,4.2809182e-7,0.08098809,0.0000054858074,0.0029340244,0.023288427],"study_design_scores_gemma":[0.0016984694,0.0004644812,0.0049078977,0.00027043326,0.0006833706,0.9124724,0.000042465334,0.000035465266,0.06647891,0.0004296162,0.012233722,0.0002827376],"about_ca_topic_score_codex":0.0009119119,"about_ca_topic_score_gemma":0.000112589645,"teacher_disagreement_score":0.024528518,"about_ca_system_score_codex":0.00021808034,"about_ca_system_score_gemma":0.00019821367,"threshold_uncertainty_score":0.99990404},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"case_report","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"case_report","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"agree"},{"id":"W2516212424","doi":"10.21860/52;3_345","title":"New WHO histological classification of renal epithelial tumors","year":2016,"lang":"en","type":"article","venue":"Medicina","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pathology; Medicine","score_opus":0.04029778019048923,"score_gpt":0.2751274245845763,"score_spread":0.23482964439408704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2516212424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.967536,0.0005573726,0.0049858713,0.008776337,0.00016406665,0.0002927746,0.0000045814827,0.000051365012,0.01763165],"genre_scores_gemma":[0.98994887,0.000046549998,0.0008151621,0.00013369034,0.0003320278,0.000006127249,0.0000068605827,0.000012778621,0.008697963],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988094,0.000044126416,0.00032158985,0.00023614053,0.00039994065,0.00018882415],"domain_scores_gemma":[0.99912244,0.000107933716,0.0001326941,0.0003325501,0.00007195227,0.00023245205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001705526,0.0001255905,0.00036423374,0.00009221056,0.000021113072,0.0000014158612,0.00008339528,0.0000818597,0.00080044195],"category_scores_gemma":[0.00023667088,0.00006332027,0.000092662965,0.00010738045,0.00015620844,0.000030147577,0.00002005249,0.00008100795,0.0001109188],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096936396,0.00020142649,0.04375822,0.00007913603,0.00009189004,0.0003376126,0.00044697928,2.5018824e-7,0.7031781,0.0026008391,0.028522767,0.21981344],"study_design_scores_gemma":[0.0045908657,0.0021800348,0.8489901,0.0006312408,0.00023889486,0.00027407252,0.00007700822,0.0000230136,0.12499637,0.00072348054,0.017139861,0.00013507195],"about_ca_topic_score_codex":0.00006991205,"about_ca_topic_score_gemma":0.00000490499,"teacher_disagreement_score":0.80523187,"about_ca_system_score_codex":0.00019570925,"about_ca_system_score_gemma":0.00018776402,"threshold_uncertainty_score":0.8764278},"labels":[],"label_agreement":null},{"id":"W2519254806","doi":"10.1097/coc.0000000000000329","title":"Stereotactic Ablative Radiotherapy (SABR) for Large Renal Tumors","year":2016,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; SABR volatility model; Common Terminology Criteria for Adverse Events; Renal cell carcinoma; Nephrectomy; Response Evaluation Criteria in Solid Tumors; Ablative case; Progressive disease; Confidence interval; Radiation therapy; Nausea; Pneumonitis; Surgery; Adverse effect; Radiology; Internal medicine; Kidney; Chemotherapy; Lung","score_opus":0.07778116298228616,"score_gpt":0.4458222962025069,"score_spread":0.36804113322022075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519254806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97262746,0.00031313414,0.0098872855,0.014801751,0.0005340627,0.00038288545,0.000012583642,0.000013446811,0.0014273633],"genre_scores_gemma":[0.9760523,0.00043493084,0.018409267,0.0029289243,0.0012502979,0.000012570324,0.0000012950728,0.000035186637,0.00087521615],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99672985,0.00054299465,0.0017714016,0.00025785563,0.00030242075,0.0003954724],"domain_scores_gemma":[0.9911417,0.0054588653,0.0021606912,0.0002569663,0.00045293552,0.00052884454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020942558,0.00018919572,0.0017984231,0.00014346004,0.000040797124,0.0000056032345,0.00016697694,0.00011125021,0.0002561172],"category_scores_gemma":[0.0016972808,0.00009997426,0.00076970854,0.00014958193,0.00048478175,0.00009920816,0.000023219514,0.0003655493,0.000020955404],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024666965,0.0022272472,0.1463278,0.000014857788,0.0025698785,0.001408812,0.00028982383,0.0000011998974,0.00341022,0.0003946286,0.0049547125,0.8137339],"study_design_scores_gemma":[0.03884109,0.1787439,0.4112792,0.00033249706,0.001035764,0.0033243296,0.0004435759,0.000042129766,0.0015609062,0.00060939253,0.36346588,0.00032133987],"about_ca_topic_score_codex":0.000007495203,"about_ca_topic_score_gemma":0.0000054807138,"teacher_disagreement_score":0.81341255,"about_ca_system_score_codex":0.00040011323,"about_ca_system_score_gemma":0.0011132939,"threshold_uncertainty_score":0.40768322},"labels":[],"label_agreement":null},{"id":"W2519353447","doi":"10.1016/j.ejso.2016.08.023","title":"Mortality, morbidity and healthcare expenditures after local tumour ablation or partial nephrectomy for T1A kidney cancer","year":2016,"lang":"en","type":"article","venue":"European Journal of Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Perioperative; Nephrectomy; Propensity score matching; Mortality rate; Complication; Population; Renal cell carcinoma; Bladder cancer; Surgery; Sepsis; Cancer; Internal medicine; Kidney","score_opus":0.06972516187661218,"score_gpt":0.3610926508712469,"score_spread":0.2913674889946347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519353447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773513,0.0013091776,0.0016889869,0.017445013,0.00063026923,0.00044588748,0.00004266905,0.000017151691,0.0010695658],"genre_scores_gemma":[0.99541235,0.0011505934,0.0005800432,0.0008126235,0.0016583153,0.000026654116,0.0000047168846,0.000031680505,0.00032304766],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99799496,0.0005704321,0.0006407623,0.00022743104,0.00026978733,0.0002966273],"domain_scores_gemma":[0.99837154,0.00028952945,0.00034839948,0.00012563892,0.00018787678,0.00067701365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079515687,0.0001791179,0.0005564143,0.00009168982,0.000052276857,0.00001252741,0.00007869488,0.00007028192,0.0005302804],"category_scores_gemma":[0.00006834917,0.00009142242,0.00018212602,0.000046330646,0.00018532792,0.000104780935,0.000051864627,0.00020589205,0.000014036834],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06679084,0.0013931618,0.1959366,0.0005217077,0.0011724146,0.07999428,0.0007267305,0.000030396219,0.00747537,0.0002713004,0.03558897,0.61009824],"study_design_scores_gemma":[0.013770928,0.007674403,0.23467791,0.00041553634,0.0004035559,0.004595993,0.000059579583,0.000034495846,0.0039162864,0.00005846761,0.73419654,0.00019627374],"about_ca_topic_score_codex":0.000035232744,"about_ca_topic_score_gemma":0.000039800027,"teacher_disagreement_score":0.6986076,"about_ca_system_score_codex":0.00032768387,"about_ca_system_score_gemma":0.00044406604,"threshold_uncertainty_score":0.5806199},"labels":[],"label_agreement":null},{"id":"W2519800643","doi":"10.1097/pas.0000000000000719","title":"Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci","year":2016,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Calgary Laboratory Services; University of Calgary","funders":"National Cancer Institute","keywords":"Immunohistochemistry; Pathology; Renal cell carcinoma; Adenocarcinoma; Metastasis; Medicine; Clear cell carcinoma; Adipose capsule of kidney; Carcinoma; Kidney; Clear cell renal cell carcinoma; Biology; Internal medicine; Cancer","score_opus":0.011483313021363043,"score_gpt":0.23343093093988623,"score_spread":0.2219476179185232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519800643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98828036,0.00021831156,0.00013189783,0.010610302,0.00010830304,0.00015514568,0.000008733477,0.000006547603,0.00048040386],"genre_scores_gemma":[0.9990374,0.00007180409,0.00013363897,0.00034816057,0.000117193704,0.0000033037152,6.11355e-7,0.000021176857,0.00026673244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981934,0.0004831464,0.000490863,0.00014873971,0.00040635854,0.00027751815],"domain_scores_gemma":[0.9978276,0.00043462447,0.000811823,0.0004433542,0.00024751958,0.00023511179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032911415,0.00017794388,0.00074187294,0.000088397384,0.00005253009,0.0000040713217,0.00029316047,0.00003577331,0.00010434528],"category_scores_gemma":[0.00010909003,0.00005506266,0.00028398877,0.00029299458,0.0014253013,0.00002955138,0.00006811274,0.00026005722,0.000009301706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015032979,0.0008579385,0.80139315,0.0000547306,0.0008236684,0.01056049,0.0007854051,0.0000074590603,0.13793099,0.00044154498,0.0009425489,0.031169076],"study_design_scores_gemma":[0.004969639,0.0070552463,0.944115,0.00024089994,0.000617865,0.0281615,0.00017537709,0.0000036547422,0.013741591,0.00021170355,0.00059581216,0.00011171048],"about_ca_topic_score_codex":0.000024873443,"about_ca_topic_score_gemma":0.0000011522914,"teacher_disagreement_score":0.14272183,"about_ca_system_score_codex":0.00008700763,"about_ca_system_score_gemma":0.00021730727,"threshold_uncertainty_score":0.5251582},"labels":[],"label_agreement":null},{"id":"W2520345751","doi":"10.1007/s00428-016-2022-x","title":"Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant","year":2016,"lang":"en","type":"article","venue":"Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Royal Columbian Hospital","funders":"Lékařská Fakulta v Plzni, Univerzita Karlova; Fakultní Nemocnice Plzen","keywords":"Chromophobe cell; Immunohistochemistry; Pathology; Biology; Renal cell carcinoma; Medicine; Clear cell","score_opus":0.027785267868157673,"score_gpt":0.32347587676891204,"score_spread":0.2956906089007544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520345751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884354,0.0053822068,0.0019698443,0.0006006745,0.00014544702,0.000965122,0.00018537673,0.00021740033,0.0020985233],"genre_scores_gemma":[0.98900676,0.0011395409,0.008522987,0.00036389116,0.00025545427,0.00009758037,0.0003961146,0.000086895576,0.00013077534],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9937397,0.00079757173,0.0015088058,0.0018740199,0.0007900218,0.0012898674],"domain_scores_gemma":[0.99442667,0.0020101634,0.0007201502,0.0018059326,0.00022824628,0.0008088306],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010177755,0.0010160503,0.0024206704,0.00097642664,0.00028610654,0.000029367278,0.00073666446,0.0005237426,0.00020330866],"category_scores_gemma":[0.0009011688,0.0006002685,0.0007323518,0.0009856102,0.002608853,0.00019501122,0.0005863723,0.00093411654,0.000030229266],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016259009,0.0011585639,0.0049679647,0.00019592587,0.0016866742,0.0030702217,0.0011367308,0.00017750709,0.9788084,0.00038504793,0.000044812154,0.0067422185],"study_design_scores_gemma":[0.014199624,0.014403531,0.59453803,0.0005541414,0.015224554,0.00088386907,0.0010627441,0.007269557,0.3483106,0.0013309552,0.00029475006,0.0019276368],"about_ca_topic_score_codex":0.00024802863,"about_ca_topic_score_gemma":0.000013339035,"teacher_disagreement_score":0.6304978,"about_ca_system_score_codex":0.0001943722,"about_ca_system_score_gemma":0.0003338383,"threshold_uncertainty_score":0.9996449},"labels":[],"label_agreement":null},{"id":"W2520786257","doi":"10.5489/cuaj.3707","title":"Survival after partial and radical nephrectomy for high-risk disease: A propensity-matched comparison","year":2016,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Nephrectomy; Propensity score matching; Medicine; Urology; Surgery; Oncology; Internal medicine; Kidney","score_opus":0.021288142295258404,"score_gpt":0.23759304957571561,"score_spread":0.2163049072804572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520786257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9630922,0.00035661922,0.00052782986,0.035096586,0.0002562239,0.0004800878,0.00010936944,0.0000225301,0.00005857114],"genre_scores_gemma":[0.99723893,0.000064090724,0.00047315288,0.001119523,0.0006810954,0.000061070146,0.000016773847,0.000016330674,0.00032901252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982356,0.00026901904,0.00035254742,0.00026523357,0.00034994626,0.0005276503],"domain_scores_gemma":[0.9975063,0.00035000528,0.00022764571,0.000113922215,0.00019372247,0.0016083866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063236454,0.00016958865,0.00045049103,0.00009673943,0.00021718792,0.00007438105,0.000062966814,0.00018290657,0.00040453364],"category_scores_gemma":[0.0011098847,0.00009912543,0.0001401553,0.00007624445,0.00007100878,0.00008140095,0.000016879843,0.00029119273,0.000035392444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010255297,0.000066185006,0.9911213,0.000005907977,0.00015451665,0.00022851521,0.000033658867,0.000001022207,0.00009790496,0.00010283699,0.0030490328,0.004113584],"study_design_scores_gemma":[0.0033699744,0.00055888394,0.95653045,0.000019527663,0.0003342465,0.00006559093,0.000010561261,0.000041004703,0.00009259266,0.00078134955,0.038060598,0.00013524095],"about_ca_topic_score_codex":0.00047707665,"about_ca_topic_score_gemma":0.0006997665,"teacher_disagreement_score":0.035011567,"about_ca_system_score_codex":0.0009702693,"about_ca_system_score_gemma":0.00039034899,"threshold_uncertainty_score":0.44293597},"labels":[],"label_agreement":null},{"id":"W2521564131","doi":"10.1148/radiol.2016161477","title":"Homogeneous T1 Hyperintense Renal Lesions with Smooth Borders","year":2016,"lang":"en","type":"letter","venue":"Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital","funders":"","keywords":"Medicine; Homogeneous; Radiology; Renal cell carcinoma; Magnetic resonance imaging; Contrast (vision); Nuclear medicine; Pathology; Artificial intelligence","score_opus":0.020438831555242922,"score_gpt":0.25158503186194864,"score_spread":0.2311462003067057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521564131","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07632846,0.003258259,0.0002976718,0.8966284,0.0006801635,0.0011608048,0.00012899685,0.00023303255,0.021284234],"genre_scores_gemma":[0.042643387,0.0010641979,0.003137959,0.8754123,0.01233477,0.00035560157,0.0012320844,0.00040368742,0.06341606],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977111,0.00016275505,0.00032388148,0.0007664906,0.0002684195,0.00076731434],"domain_scores_gemma":[0.9983203,0.00023988199,0.00016646128,0.00096536125,0.00013623918,0.00017179556],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007776859,0.0005255399,0.001021734,0.0002600412,0.00007919518,0.000008670866,0.00019398797,0.0009429758,0.00061148364],"category_scores_gemma":[0.00004526016,0.0003001624,0.00025366587,0.000098918856,0.00044061843,0.000017415661,0.00005097289,0.0010939303,0.0003974981],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044046194,0.000030381867,0.000759373,0.00008267897,0.0005965321,0.03710818,0.00003154041,0.0000011878025,0.0016701302,0.000018340734,0.95311767,0.006143501],"study_design_scores_gemma":[0.00184418,0.0028642379,0.0019729554,0.00019897899,0.00056749297,0.024582038,0.000007792951,0.0000017572244,0.00046440389,0.00004690387,0.9670944,0.00035485072],"about_ca_topic_score_codex":0.00006666761,"about_ca_topic_score_gemma":0.000008992663,"teacher_disagreement_score":0.04213182,"about_ca_system_score_codex":0.00036004276,"about_ca_system_score_gemma":0.00041389227,"threshold_uncertainty_score":0.99994504},"labels":[],"label_agreement":null},{"id":"W2521607824","doi":"10.1016/j.euf.2016.09.002","title":"Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy","year":2016,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Toronto General Hospital; McGill University Health Centre; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Oncology; Internal medicine; Cancer; Bioinformatics; PTEN; Papillary renal cell carcinomas; Hedgehog; Renal cell carcinoma; Pathology; Biology; Genetics; PI3K/AKT/mTOR pathway; Gene; Signal transduction","score_opus":0.020856551882489645,"score_gpt":0.2414072111310206,"score_spread":0.22055065924853096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521607824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98938775,0.0070683695,0.0009807232,0.00075489294,0.000050528088,0.0008400039,0.00023248838,0.00004611359,0.00063910254],"genre_scores_gemma":[0.99862844,0.00060731807,0.00026348588,0.00003890477,0.000024680669,0.00006295903,0.00012928946,0.00004066631,0.00020424412],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99831676,0.00028712317,0.0006486278,0.00042530155,0.000100578436,0.00022157571],"domain_scores_gemma":[0.9982949,0.0003079695,0.00045401472,0.0005066873,0.0003376317,0.000098821416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037914398,0.00019430468,0.00045906636,0.00036053115,0.000055640674,0.000004799708,0.00013312016,0.00008419876,0.00005709127],"category_scores_gemma":[0.00009767025,0.00012957903,0.00018267987,0.00053109566,0.00019047041,0.000037412352,0.000033715412,0.00007947864,0.0000065041513],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010955151,0.00029952577,0.38297385,0.00005482797,0.001457986,0.000011098311,0.00042812907,0.000009762559,0.5724018,0.00030424385,0.00015557944,0.04080763],"study_design_scores_gemma":[0.0020155609,0.0011860842,0.94591445,0.000015105468,0.0025776895,0.00000993354,0.000019519219,0.00010470529,0.047537908,0.00017281191,0.00033504097,0.00011121273],"about_ca_topic_score_codex":0.000055760444,"about_ca_topic_score_gemma":0.00001806958,"teacher_disagreement_score":0.5629406,"about_ca_system_score_codex":0.000061954524,"about_ca_system_score_gemma":0.000114514754,"threshold_uncertainty_score":0.52840793},"labels":[],"label_agreement":null},{"id":"W2522519290","doi":"10.1016/j.ejca.2016.08.004","title":"Open-label phase 2 trial of first-line everolimus monotherapy in patients with papillary metastatic renal cell carcinoma: RAPTOR final analysis","year":2016,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novartis Pharma; Exelixis; Canadian Centre for Applied Research in Cancer Control; Novartis Pharmaceuticals Corporation; Pfizer","keywords":"Everolimus; Medicine; Oncology; Renal cell carcinoma; Internal medicine; Urology","score_opus":0.05198801059173726,"score_gpt":0.31286978979389846,"score_spread":0.2608817792021612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522519290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959416,0.0018198786,0.00045595533,0.0004467193,0.00012357741,0.0006069699,0.000051053157,0.0000037639834,0.00055048056],"genre_scores_gemma":[0.9974429,0.00040215784,0.0012097306,0.000107978194,0.00019329089,0.000008182871,0.000007969057,0.0000512576,0.00057650835],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973423,0.00041600651,0.001027695,0.00026233704,0.000689359,0.00026234146],"domain_scores_gemma":[0.99778354,0.00010376415,0.0010429439,0.0003637361,0.00046970815,0.00023628591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007589544,0.0002602713,0.0009310543,0.00047845428,0.000034679244,0.000020181924,0.0003263737,0.000020645024,0.0004025179],"category_scores_gemma":[0.000041524414,0.000140617,0.00021043612,0.00053713046,0.000080386315,0.00020272486,0.00005554113,0.00017475098,0.0000055996597],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6211934,0.010383301,0.2858931,0.00011314736,0.0038707554,0.0024838056,0.0006654763,0.00033957904,0.0054815016,0.0000020021212,0.0011978375,0.0683761],"study_design_scores_gemma":[0.6920449,0.033656634,0.25885105,0.00038463683,0.003458039,0.000017787177,0.00002285479,0.00003822896,0.009342661,0.0000049793525,0.0019269226,0.0002512972],"about_ca_topic_score_codex":0.000051968913,"about_ca_topic_score_gemma":0.00003857105,"teacher_disagreement_score":0.070851535,"about_ca_system_score_codex":0.00026163933,"about_ca_system_score_gemma":0.0002601056,"threshold_uncertainty_score":0.5734195},"labels":[],"label_agreement":null},{"id":"W2525526604","doi":"10.21037/tcr.2016.09.41","title":"Long-term safety of targeted agents used to treat metastatic renal cell carcinoma: the issue is not the rate of adverse events over time, but the expertise needed to manage them","year":2016,"lang":"en","type":"article","venue":"Translational Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Renal cell carcinoma; Adverse effect; Medicine; Term (time); Intensive care medicine; Oncology; Internal medicine","score_opus":0.11978516154847975,"score_gpt":0.37790437800663124,"score_spread":0.2581192164581515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525526604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9670744,0.00040566418,0.0001581724,0.028310765,0.00004575208,0.0026787093,0.000477756,0.00000987584,0.000838889],"genre_scores_gemma":[0.9851052,0.000062672436,0.00007803832,0.0007396295,0.000100347745,0.0003575725,0.000027617072,0.00004418141,0.013484743],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99629706,0.00065056497,0.00053732964,0.00041152188,0.0016058948,0.00049765594],"domain_scores_gemma":[0.9975433,0.00091464916,0.00011058122,0.00081272284,0.00040346917,0.0002152872],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011482264,0.00025648437,0.00039545225,0.00017907316,0.00022273957,0.000007762586,0.00051940954,0.000052984342,0.0050123385],"category_scores_gemma":[0.000049910795,0.000107039654,0.00024908155,0.0006756655,0.0002554062,0.000087769375,0.000091323614,0.00021505424,0.00023428103],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018980242,0.0006315764,0.03795652,0.00038774332,0.00071671366,0.00010741516,0.022625403,0.00051833317,0.9008572,0.000078334895,0.01051644,0.0066240514],"study_design_scores_gemma":[0.0039615934,0.00036926745,0.5012246,0.00014525617,0.00022500893,0.000005622925,0.00019953729,0.00010203303,0.49283054,0.00004876199,0.0007629485,0.0001248544],"about_ca_topic_score_codex":0.0024946933,"about_ca_topic_score_gemma":0.00016813644,"teacher_disagreement_score":0.46326804,"about_ca_system_score_codex":0.00029059898,"about_ca_system_score_gemma":0.00029095166,"threshold_uncertainty_score":0.99589723},"labels":[],"label_agreement":null},{"id":"W2526832748","doi":"10.1016/j.cjca.2016.07.485","title":"METABOLOMIC PROFILING OF SUNITINIB INDUCED CARDIOTOXICITY: A PILOT STUDY","year":2016,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Research Manitoba","funders":"","keywords":"Medicine; Sunitinib; Cardiotoxicity; Internal medicine; Oncology; Cancer; Metabolomics; Tyrosine-kinase inhibitor; Intensive care medicine; Bioinformatics; Chemotherapy","score_opus":0.07294842481783541,"score_gpt":0.281505435428501,"score_spread":0.20855701061066556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526832748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937681,0.00063044473,0.00019925367,0.00035597218,0.00044467993,0.00046389486,0.00002167621,0.0000048392803,0.004111153],"genre_scores_gemma":[0.99897885,0.000023959232,0.00020248517,0.00005136039,0.000642582,0.000008567714,0.0000013928942,0.00002459007,0.000066230656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830157,0.00034550473,0.00060353684,0.00016996897,0.00021545742,0.00036393848],"domain_scores_gemma":[0.9980614,0.00014470913,0.0002940194,0.0003314782,0.0005183017,0.0006501012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007531608,0.00017151836,0.0011223222,0.00054363615,0.000043531898,0.000005315295,0.00016095498,0.000076062,0.000024733687],"category_scores_gemma":[0.00039757436,0.000107089334,0.00026442835,0.00016230026,0.00014158365,0.000057907466,0.000015131058,0.00022274142,0.00000916539],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092442945,0.00004549215,0.61022586,0.00003491521,0.002605077,0.003087797,0.0002691482,0.000037745518,0.37575287,0.00014994475,0.00048548204,0.0063812584],"study_design_scores_gemma":[0.0086443955,0.023067057,0.82420367,0.0001764883,0.0016901125,0.0050855796,0.0010499255,6.644663e-7,0.13302465,0.00014610386,0.0026536125,0.00025771957],"about_ca_topic_score_codex":0.0010179116,"about_ca_topic_score_gemma":0.0006623667,"teacher_disagreement_score":0.24272822,"about_ca_system_score_codex":0.00032637594,"about_ca_system_score_gemma":0.0021194792,"threshold_uncertainty_score":0.43669763},"labels":[],"label_agreement":null},{"id":"W2526931774","doi":"10.1016/j.ijrobp.2016.06.1280","title":"Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: Initial Clinical Experience","year":2016,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; SABR volatility model; Renal cell carcinoma; Nausea; Radiation therapy; Stage (stratigraphy); Surgery; Dialysis; Cohort; Urology; Internal medicine; Radiology","score_opus":0.04773150629127592,"score_gpt":0.37954180086448897,"score_spread":0.33181029457321304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526931774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824185,0.00078985665,0.009469986,0.002570445,0.0031951703,0.0005810142,0.000060285853,0.00003224092,0.0008825339],"genre_scores_gemma":[0.989476,0.001045379,0.0017103992,0.0013145092,0.0060724285,0.000056402823,0.000100799676,0.000043290052,0.00018076082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99723566,0.00035858233,0.0013096242,0.0003777077,0.00040289247,0.00031553488],"domain_scores_gemma":[0.9957506,0.0011966161,0.0015693081,0.0002475584,0.0009966921,0.00023922996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007474872,0.00027563088,0.0006719538,0.00019428803,0.000080923906,0.00002787411,0.0003793399,0.0003183228,0.00011030062],"category_scores_gemma":[0.0003839247,0.00018930611,0.00052374124,0.00010975239,0.00025759847,0.00042896596,0.000051141746,0.00034013047,0.00003488651],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045606107,0.0013534139,0.6091115,0.000010902593,0.00050252076,0.00011329533,0.00036156573,0.00000612765,0.032379765,0.0007289144,0.001485124,0.34938627],"study_design_scores_gemma":[0.045398854,0.013767054,0.7980122,0.00008260831,0.00035381824,0.0006583784,0.00005922303,0.00026541497,0.07129556,0.0035233335,0.066130795,0.00045274416],"about_ca_topic_score_codex":0.000008049987,"about_ca_topic_score_gemma":6.394203e-7,"teacher_disagreement_score":0.34893355,"about_ca_system_score_codex":0.0012733635,"about_ca_system_score_gemma":0.0010857083,"threshold_uncertainty_score":0.77196795},"labels":[],"label_agreement":null},{"id":"W2527416156","doi":"10.1007/s00261-016-0914-5","title":"“Incidentalomas” on abdominal and pelvic CT in emergency radiology: literature review and current management recommendations","year":2016,"lang":"en","type":"review","venue":"Abdominal Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton General Hospital","funders":"","keywords":"Medicine; Hepatology; Radiology; Computed tomography; General surgery; Internal medicine","score_opus":0.03410645769768319,"score_gpt":0.36093434582897327,"score_spread":0.3268278881312901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2527416156","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030705478,0.992882,0.000009444938,0.0011629375,0.00067922426,0.0030580843,0.000075369804,0.00002876027,0.0017971013],"genre_scores_gemma":[0.000108034284,0.9967113,0.0003412589,0.00030087258,0.00029433065,0.0007944298,0.00053322467,0.00007231784,0.00084419275],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956988,0.00085984275,0.0013908942,0.001236436,0.00018391895,0.00063008885],"domain_scores_gemma":[0.9980179,0.00036298763,0.0005430266,0.00071476965,0.000043184948,0.00031809555],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007086841,0.0008986065,0.0035558674,0.00077312964,0.000096771655,0.000015759604,0.00022601231,0.00027064572,0.00033510276],"category_scores_gemma":[0.00010998673,0.0005888627,0.00046673676,0.00041594412,0.00021778625,0.00007531698,0.00019150217,0.000882749,0.00014105222],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011006524,0.00014338156,0.00024946962,0.04308842,0.00044374296,0.0021138284,0.00003067245,6.477614e-9,9.327039e-7,0.00037931028,0.009590222,0.9438499],"study_design_scores_gemma":[0.001706179,0.00086312636,0.0021721832,0.106558405,0.0045837266,0.028593134,0.000015105959,7.9710145e-7,4.7935157e-7,0.00018006076,0.8548104,0.00051639334],"about_ca_topic_score_codex":0.0000058065298,"about_ca_topic_score_gemma":0.000006190432,"teacher_disagreement_score":0.94333357,"about_ca_system_score_codex":0.00055267336,"about_ca_system_score_gemma":0.0000990814,"threshold_uncertainty_score":0.99965626},"labels":[],"label_agreement":null},{"id":"W2528407746","doi":"10.1200/jco.2014.32.4_suppl.417","title":"Survival outcomes associated with different sunitinib dosing regimens in metastatic renal cell carcinoma.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Dosing; Sunitinib; Renal cell carcinoma; Discontinuation; Internal medicine; Surgery","score_opus":0.14859220776025606,"score_gpt":0.4142551626451508,"score_spread":0.2656629548848947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528407746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901374,0.00012652863,0.00013958439,0.0029279313,0.00055840984,0.00023837601,0.0000024712292,0.000010679285,0.0058586253],"genre_scores_gemma":[0.99694663,0.000032107113,0.0013022146,0.00077890523,0.0002811508,0.0000044313465,0.000008929862,0.000033744975,0.0006118603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99426293,0.0018242454,0.0025446278,0.0002660296,0.0006851047,0.00041707302],"domain_scores_gemma":[0.98968214,0.0069730873,0.0021580681,0.00028356313,0.00039131343,0.00051180075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004198279,0.00027589287,0.0028574418,0.00025697352,0.00003978827,0.00001352016,0.00017118634,0.00024934637,0.00008018555],"category_scores_gemma":[0.0035020402,0.00015806929,0.0005385796,0.00018922912,0.00020136376,0.00007973246,0.00005082311,0.0012766953,0.000008359495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025283284,0.003629239,0.9854821,0.00003023824,0.0004161228,0.0024663985,0.00012665478,0.000032571534,0.00026755297,0.00006179141,0.00023999995,0.004719026],"study_design_scores_gemma":[0.022618368,0.019170698,0.95489633,0.00014377649,0.0010065488,0.00019518888,0.00014395145,0.00009407721,0.0005924472,0.00012588133,0.0008667344,0.00014600709],"about_ca_topic_score_codex":0.000051456085,"about_ca_topic_score_gemma":0.00032214803,"teacher_disagreement_score":0.030585755,"about_ca_system_score_codex":0.00046709544,"about_ca_system_score_gemma":0.000838861,"threshold_uncertainty_score":0.6445879},"labels":[],"label_agreement":null},{"id":"W2528719424","doi":"10.14740/jcgo412w","title":"Combined Surgery for Uterine and Renal Cell Cancers in Obese Patients: A Case Series","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Gynecology and Obstetrics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Series (stratigraphy); Gynecology; Surgery; General surgery; Urology; Biology","score_opus":0.05176873114438542,"score_gpt":0.34139471969805135,"score_spread":0.28962598855366595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528719424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99638253,0.0013144807,0.000033880293,0.0010193206,0.0009538777,0.0002238098,0.000012334475,0.0000033014123,0.00005643635],"genre_scores_gemma":[0.9944775,0.0039388933,0.0008085221,0.00029192638,0.000102880134,0.000006725291,0.0000016837914,0.000010608718,0.00036124143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826384,0.0001325537,0.0011176149,0.00016717901,0.00011722596,0.00020159123],"domain_scores_gemma":[0.98295265,0.01590681,0.0005009266,0.0001028772,0.00027789615,0.00025882554],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0008899469,0.00012302138,0.0007812591,0.0002270873,0.00003630609,0.0000068349077,0.000034140645,0.00019299121,0.000025950416],"category_scores_gemma":[0.01122975,0.00007193361,0.00016026465,0.00013587181,0.00017559296,0.00011448295,0.000035769957,0.00020759235,8.0346985e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002630858,0.0006241355,0.9205351,0.00013730195,0.0000828562,0.006060014,0.000048163598,6.7905296e-7,0.000042275842,0.000013107319,0.00098496,0.06884058],"study_design_scores_gemma":[0.022757964,0.014775829,0.947031,0.00019768643,0.00025886236,0.002162089,0.00010803543,0.000018001905,0.00047384293,0.00037658168,0.011676947,0.00016311386],"about_ca_topic_score_codex":0.0000067374403,"about_ca_topic_score_gemma":0.00004997941,"teacher_disagreement_score":0.06867746,"about_ca_system_score_codex":0.00012298397,"about_ca_system_score_gemma":0.00026292805,"threshold_uncertainty_score":0.9970991},"labels":[],"label_agreement":null},{"id":"W2530041904","doi":"10.1007/s00261-016-0940-3","title":"A practical imaging classification for the non-invasive differentiation of renal cell carcinoma into its main subtypes","year":2016,"lang":"en","type":"article","venue":"Abdominal Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital","funders":"","keywords":"Medicine; Chromophobe cell; Renal cell carcinoma; Receiver operating characteristic; Hepatology; Clear cell; Radiology; Vascularity; Pathology; Internal medicine","score_opus":0.030816992581127196,"score_gpt":0.2931778006365766,"score_spread":0.2623608080554494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530041904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94329435,0.00040390558,0.046495106,0.008375907,0.00015613872,0.00083886046,0.00000983739,0.000011347913,0.0004145686],"genre_scores_gemma":[0.99650407,0.000079124744,0.0025085972,0.000119301454,0.00023519584,0.00017486708,0.000023244713,0.000020136398,0.00033548902],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99883693,0.000122605,0.00033698292,0.0003038676,0.0001468307,0.00025275105],"domain_scores_gemma":[0.99724054,0.0019207869,0.00025180145,0.00031755876,0.00018618557,0.00008313647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029636887,0.00015705536,0.0003175895,0.00009432201,0.00008050887,0.0000054985544,0.00009466637,0.00008954585,0.000054539814],"category_scores_gemma":[0.0004720218,0.000082187886,0.00014553072,0.0000738914,0.0001824834,0.00006820564,0.000029227558,0.000091414586,0.000025381978],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001973772,0.00012951021,0.02752164,0.000105541905,0.000079002275,0.000042274816,0.0003034959,8.605706e-7,0.9607248,0.0013433942,0.001717773,0.006057955],"study_design_scores_gemma":[0.0031794447,0.0009368512,0.4718654,0.00004518529,0.0005172625,0.00046076885,0.00029595444,0.0016773238,0.52035224,0.00036438453,0.00019754178,0.00010763435],"about_ca_topic_score_codex":0.000028789378,"about_ca_topic_score_gemma":0.000012449812,"teacher_disagreement_score":0.44434375,"about_ca_system_score_codex":0.00021404296,"about_ca_system_score_gemma":0.0002290357,"threshold_uncertainty_score":0.33515248},"labels":[],"label_agreement":null},{"id":"W2530236800","doi":"10.1200/jco.2013.31.15_suppl.4568","title":"<i>VHL</i>-mutant renal cell carcinomas contain cancer cells with mesenchymal phenotypes.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Stromal cell; Cancer research; Biology; Mesenchymal stem cell; Cancer stem cell; Cancer; Cancer cell; Pathology; Medicine; Cell biology; Genetics","score_opus":0.07281746736423177,"score_gpt":0.38389914641678535,"score_spread":0.3110816790525536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530236800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761044,0.001591025,0.00011323865,0.006195524,0.00094571785,0.0005557044,0.000005026822,0.000015094904,0.014474318],"genre_scores_gemma":[0.9884471,0.0005129201,0.004660756,0.0028076181,0.0017321132,0.00002374371,0.0000026434182,0.00004247554,0.001770608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956296,0.00044246227,0.00237336,0.00034448394,0.0007132124,0.0004968531],"domain_scores_gemma":[0.9944192,0.0012984214,0.0019523107,0.00034986497,0.0010216993,0.0009585025],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014320742,0.00030242678,0.002062683,0.00014032907,0.000054884014,0.000021494698,0.00023992373,0.00042170737,0.001458985],"category_scores_gemma":[0.00026295718,0.00017452087,0.00057816226,0.00018072911,0.00032550155,0.00017325359,0.00006342219,0.0013360651,0.00017019626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027428849,0.011117404,0.4531108,0.0003392363,0.0035342965,0.02364078,0.0009606825,0.0005580288,0.224839,0.00019312497,0.06998391,0.18429388],"study_design_scores_gemma":[0.04451539,0.09001553,0.64247143,0.00045154674,0.003839697,0.0031178792,0.0006664861,0.00035867046,0.10849502,0.00047498537,0.104838826,0.0007545661],"about_ca_topic_score_codex":0.0005580936,"about_ca_topic_score_gemma":0.00012759247,"teacher_disagreement_score":0.18936059,"about_ca_system_score_codex":0.0004854581,"about_ca_system_score_gemma":0.0033239094,"threshold_uncertainty_score":0.99945384},"labels":[],"label_agreement":null},{"id":"W2531271615","doi":"10.1186/s40425-016-0174-5","title":"High-dose interleukin2 – a 10-year single-site experience in the treatment of metastatic renal cell carcinoma: careful selection of patients gives an excellent outcome","year":2016,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Christie (Canada)","funders":"","keywords":"Medicine; Internal medicine; Clinical trial; Oncology; Renal cell carcinoma","score_opus":0.04813171222505309,"score_gpt":0.33063154148190993,"score_spread":0.28249982925685685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531271615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961677,0.0024917193,0.000119360266,0.00011949982,0.00023085729,0.0007747999,0.000064696724,0.000003932399,0.000027416378],"genre_scores_gemma":[0.9977176,0.00066419394,0.000851591,0.000025988576,0.0000693771,0.00011946225,0.0000076047677,0.00003055001,0.00051359355],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99811727,0.00013467092,0.0008652355,0.0001988582,0.0004448201,0.00023914877],"domain_scores_gemma":[0.99843967,0.00012640357,0.0007260318,0.00028052364,0.00036300748,0.00006435773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001931228,0.00022605943,0.00061149464,0.00023241797,0.000048891707,0.0000099837625,0.00015039534,0.000047055713,0.00028111183],"category_scores_gemma":[0.000012680716,0.000113665956,0.0003272317,0.00016032677,0.00011269722,0.00014029501,0.00000690569,0.000066815104,7.402247e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013700599,0.0048270845,0.34024107,0.0001670011,0.00035877828,0.000013943569,0.02179153,0.00004326317,0.5692518,0.000007945134,0.000068608526,0.04952838],"study_design_scores_gemma":[0.020189162,0.023742946,0.3206993,0.00022016186,0.00025546507,0.000019265663,0.0011899921,0.000013216171,0.6313997,0.000038915707,0.0020793092,0.00015254195],"about_ca_topic_score_codex":0.00057102414,"about_ca_topic_score_gemma":0.000118171796,"teacher_disagreement_score":0.06214792,"about_ca_system_score_codex":0.0006856545,"about_ca_system_score_gemma":0.00012796624,"threshold_uncertainty_score":0.4635163},"labels":[],"label_agreement":null},{"id":"W2531840633","doi":"10.5489/cuaj.1234","title":"Moderated Poster Session 2: Kidney Cancer","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Session (web analytics); Kidney cancer; Psychology; Cancer; Medicine; Computer science; Internal medicine; World Wide Web","score_opus":0.018152351990600574,"score_gpt":0.24039869103951614,"score_spread":0.22224633904891555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531840633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9026133,0.0002163163,0.0000133310805,0.08973465,0.00029574698,0.00025582494,0.000017692135,0.000024704825,0.0068284594],"genre_scores_gemma":[0.97337484,0.000053412117,0.0001031321,0.022198558,0.0003839055,0.000027744805,0.0000277135,0.0000129671325,0.003817731],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986833,0.00011721686,0.00025791634,0.00016258152,0.0003162203,0.0004628108],"domain_scores_gemma":[0.99759066,0.000040283332,0.00015502695,0.00008938574,0.0004479703,0.0016766745],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018486589,0.0001324037,0.00022293729,0.0001338277,0.00020749992,0.00011795455,0.00006620803,0.00022947113,0.007849134],"category_scores_gemma":[0.0003414569,0.00009055596,0.000110875226,0.00014261725,0.000014816315,0.00013320392,0.000009946479,0.00046561807,0.00046028337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003007056,0.00004108947,0.8598066,0.0000036797494,0.000120286575,0.00011090619,0.00007101201,0.00002559323,0.0019728285,0.000014134128,0.1343693,0.0034345065],"study_design_scores_gemma":[0.0010740317,0.00024082512,0.9709411,0.0000253549,0.00008376121,0.00026466264,0.000020956228,0.000426724,0.0004149429,0.0003725633,0.026012674,0.00012239358],"about_ca_topic_score_codex":0.005889904,"about_ca_topic_score_gemma":0.00028454213,"teacher_disagreement_score":0.111134514,"about_ca_system_score_codex":0.0021297007,"about_ca_system_score_gemma":0.000858645,"threshold_uncertainty_score":0.99305785},"labels":[],"label_agreement":null},{"id":"W2532493119","doi":"10.1016/j.anndiagpath.2016.10.007","title":"Cystic and necrotic papillary renal cell carcinoma: prognosis, morphology, immunohistochemical, and molecular-genetic profile of 10 cases","year":2016,"lang":"en","type":"article","venue":"Annals of Diagnostic Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Columbian Hospital; University of British Columbia","funders":"","keywords":"Papillary renal cell carcinomas; Polysomy; Pathology; Chromosome 7 (human); Renal cell carcinoma; Immunohistochemistry; Chromosome 17 (human); Biology; Carcinoma; Clear cell; Chromosome; Medicine; Fluorescence in situ hybridization","score_opus":0.025042838610790555,"score_gpt":0.2742072153401511,"score_spread":0.24916437672936054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2532493119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9660823,0.03183938,0.00004669699,0.0008677958,0.00003981813,0.0007527534,0.000081519596,0.00001781248,0.000271962],"genre_scores_gemma":[0.9962028,0.0018075638,0.0014663994,0.0002017301,0.000025367863,0.00014860825,0.000022937098,0.000033151853,0.00009140828],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99821115,0.00017471456,0.00055276434,0.00048649346,0.00018005802,0.00039480493],"domain_scores_gemma":[0.9968473,0.0019954962,0.000271487,0.0004337618,0.00024708887,0.00020487803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017911548,0.00027671285,0.0007108004,0.00016281763,0.000034859964,0.0000036374024,0.00009721674,0.00020059332,0.0001297965],"category_scores_gemma":[0.002237028,0.00019737893,0.00010979,0.00011426362,0.0009267399,0.000034489523,0.00014808368,0.000103275255,0.000013315934],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002950896,0.0004568125,0.10393749,0.00047587644,0.000060115508,0.0055435975,0.00008980093,4.144988e-7,0.8834391,0.000027818514,0.0007692567,0.0049046283],"study_design_scores_gemma":[0.001440144,0.0034361952,0.33813065,0.00024965755,0.00029854782,0.002960934,0.000023432465,0.0000026645307,0.65310556,0.00017564456,0.000030446608,0.00014611438],"about_ca_topic_score_codex":0.00005172308,"about_ca_topic_score_gemma":0.0000010960164,"teacher_disagreement_score":0.23419316,"about_ca_system_score_codex":0.000019523131,"about_ca_system_score_gemma":0.00012577086,"threshold_uncertainty_score":0.80488795},"labels":[],"label_agreement":null},{"id":"W2532994291","doi":"10.1016/j.eururo.2016.09.047","title":"Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto; University Health Network; Princess Margaret Cancer Centre; Ottawa Regional Cancer Foundation; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Carcinoma; Oncology; Internal medicine; Baseline (sea); Urology; Database","score_opus":0.05249452266807545,"score_gpt":0.2787321393715898,"score_spread":0.22623761670351436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2532994291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906257,0.0016136217,0.0019757492,0.0014704323,0.00038817403,0.0020375869,0.0008869882,0.000047380418,0.0009544004],"genre_scores_gemma":[0.9932774,0.0000353977,0.002800432,0.0014311379,0.0005927887,0.00016126328,0.0011711374,0.00011976183,0.00041071218],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9966199,0.00067827443,0.00092487317,0.00088665925,0.00030212317,0.00058817456],"domain_scores_gemma":[0.9970961,0.0012974545,0.00036217936,0.0006890463,0.00024209425,0.000313089],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008071374,0.00042605554,0.00070133945,0.0005287187,0.0000448751,0.000012290353,0.00038609686,0.00006735863,0.0007446965],"category_scores_gemma":[0.00044266332,0.00031126774,0.0001976992,0.00022542116,0.000126532,0.000118604985,0.0002015275,0.0002332155,0.00013092582],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010194939,0.0015568872,0.14465888,0.00011736021,0.00016285386,0.002004451,0.0010423425,0.000032188105,0.8305538,0.000020356172,0.0015376089,0.008118313],"study_design_scores_gemma":[0.026614781,0.0057573556,0.61881566,0.00007230733,0.0003702069,0.00008488063,0.000117099,0.0004991844,0.34113798,0.00002466754,0.0060292133,0.00047664766],"about_ca_topic_score_codex":0.00020291863,"about_ca_topic_score_gemma":0.00007316137,"teacher_disagreement_score":0.48941582,"about_ca_system_score_codex":0.00012827842,"about_ca_system_score_gemma":0.00016061457,"threshold_uncertainty_score":0.99993396},"labels":[],"label_agreement":null},{"id":"W2534471526","doi":"10.1016/j.eururo.2016.10.007","title":"Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":203,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Sunitinib; Everolimus; BAP1; Renal cell carcinoma; Clear cell renal cell carcinoma; PTEN; Oncology; Internal medicine; Kidney cancer; Cancer research; Cancer; PI3K/AKT/mTOR pathway; Biology","score_opus":0.0220491632672999,"score_gpt":0.22366098757125152,"score_spread":0.20161182430395164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2534471526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943727,0.00028475033,0.00008969318,0.00018677146,0.00006284189,0.0013865494,0.000009760917,0.00001626744,0.0035906173],"genre_scores_gemma":[0.9993569,0.000021297472,0.00032296346,0.00008687716,0.0000404419,0.000019042925,0.000023298095,0.0000428151,0.00008633723],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99772674,0.00087898795,0.0006057893,0.00033705038,0.00016722428,0.0002842334],"domain_scores_gemma":[0.9986698,0.00057108887,0.00027473035,0.00028757818,0.00006907496,0.00012773991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007035573,0.00021728537,0.00095497305,0.00026323256,0.000026844787,0.000004700238,0.000086627144,0.000028498902,0.00005390792],"category_scores_gemma":[0.00014872318,0.00012565657,0.00010266149,0.00010209267,0.0002994134,0.000033355303,0.00008246788,0.00009824589,0.000021164244],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79155123,0.00038450016,0.20563032,0.000048006375,0.00020966947,0.00027863376,0.0002068078,0.000011120877,0.0009860083,0.000010043746,0.000024388863,0.0006592972],"study_design_scores_gemma":[0.6111659,0.0031715604,0.38468668,0.000023383374,0.0003697807,0.000020282247,0.0000054663406,0.00003604564,0.0003699979,0.000008096518,0.000055782257,0.00008707793],"about_ca_topic_score_codex":0.000057097124,"about_ca_topic_score_gemma":0.000024161047,"teacher_disagreement_score":0.18038535,"about_ca_system_score_codex":0.00005269355,"about_ca_system_score_gemma":0.000042717453,"threshold_uncertainty_score":0.5124126},"labels":[],"label_agreement":null},{"id":"W2538251152","doi":"10.1200/jco.2009.27.15_suppl.3023","title":"Phase II study of recombinant IL-21 (rIL-21) plus sorafenib as second- or third-line therapy for metastatic renal cell cancer (mRCC): Final results","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Sorafenib; Temsirolimus; Sunitinib; Internal medicine; Oncology; Bevacizumab; Everolimus; Adverse effect; Phases of clinical research; Vascular endothelial growth factor; Progression-free survival; Renal cell carcinoma; Gastroenterology; Clinical trial; Overall survival; Hepatocellular carcinoma; Chemotherapy; Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway; VEGF receptors","score_opus":0.27611046466165373,"score_gpt":0.5126640576467328,"score_spread":0.2365535929850791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538251152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864456,0.0014248085,0.00008840077,0.007603258,0.001594336,0.0017505131,0.000051960735,0.000013222698,0.0010279213],"genre_scores_gemma":[0.9809166,0.0014969759,0.0046677445,0.0021772713,0.0010929661,0.00004161856,0.000016229218,0.000036382047,0.009554217],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9921605,0.0008118642,0.0052808844,0.0004982528,0.0007433036,0.00050520664],"domain_scores_gemma":[0.99000216,0.0034130726,0.004400041,0.000489419,0.001082545,0.0006127585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004870223,0.0003966572,0.0034472786,0.00027489208,0.0001212133,0.000012335315,0.00035587212,0.00033807335,0.0004872747],"category_scores_gemma":[0.0020515807,0.00023458633,0.0009794304,0.0002772196,0.00016700459,0.00013852997,0.00005350567,0.0011577522,0.000010813013],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5177401,0.11452562,0.00031822678,0.00012115222,0.0024939291,0.01199463,0.0020513507,0.00019265506,0.0050896737,0.000027547407,0.03390909,0.31153607],"study_design_scores_gemma":[0.23995402,0.69302374,0.0068267146,0.00019649557,0.0019692993,0.0011480944,0.00065714365,0.0002418571,0.0077666882,0.0006957834,0.047265355,0.0002547917],"about_ca_topic_score_codex":0.0000670806,"about_ca_topic_score_gemma":0.00020849798,"teacher_disagreement_score":0.5784981,"about_ca_system_score_codex":0.0004293895,"about_ca_system_score_gemma":0.004678515,"threshold_uncertainty_score":0.95661527},"labels":[],"label_agreement":null},{"id":"W2541447616","doi":"10.1016/j.jval.2016.09.1541","title":"Follow-Up Imaging After Nephrectomy in Canada: Urologists’ Compliance with Guidelines and Cost of Surveillance","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Nephrectomy; Guideline; Cohort; Renal cell carcinoma; Stage (stratigraphy); Population; Kidney cancer; Surgery; General surgery; Internal medicine; Kidney","score_opus":0.07945701525497316,"score_gpt":0.304048522511601,"score_spread":0.22459150725662785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541447616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98550016,0.00507045,0.00007863768,0.008622174,0.00007593768,0.0005286107,0.000019253534,0.000007885551,0.00009689725],"genre_scores_gemma":[0.9972233,0.0004538354,0.00130567,0.0008811244,0.00002440709,0.000040476567,0.0000026032264,0.000013849657,0.000054686676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986808,0.0001077263,0.00044130237,0.0002535344,0.00021151036,0.00030517846],"domain_scores_gemma":[0.999252,0.00018030453,0.00012361798,0.00022782209,0.00009312888,0.0001231331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038083032,0.00012506054,0.0003974888,0.0000812792,0.000012504159,0.0000023431928,0.00004565675,0.000018206123,0.000009182353],"category_scores_gemma":[0.000094756484,0.00007599112,0.000015407657,0.00016139589,0.000063053056,0.000030279767,0.000021552423,0.0000752065,0.0000010426463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005308565,0.000018767107,0.9907637,0.0001696049,0.0000062360587,0.0001752029,0.00005420637,0.00006964233,0.00006434445,0.000008462662,0.00021317585,0.007925774],"study_design_scores_gemma":[0.0033741104,0.00016726031,0.99338764,0.00083631393,0.000003257942,0.000071069946,0.000036447844,0.00084979855,0.00015346428,0.00001727503,0.0010250767,0.00007827323],"about_ca_topic_score_codex":0.88748723,"about_ca_topic_score_gemma":0.7939832,"teacher_disagreement_score":0.09350405,"about_ca_system_score_codex":0.00080337876,"about_ca_system_score_gemma":0.0014554982,"threshold_uncertainty_score":0.30988282},"labels":[],"label_agreement":null},{"id":"W2541695863","doi":"10.1016/j.jval.2016.09.2177","title":"Economic Evaluation of Targeted Therapies in Metastatic Clear Renal Cell Carcinoma in Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Pazopanib; Sunitinib; Renal cell carcinoma; Cohort; Axitinib; Metastasectomy; Targeted therapy; Internal medicine; Kidney cancer; Cancer; Temsirolimus; Everolimus; Oncology; Nephrectomy; Metastasis; Kidney","score_opus":0.05884222490641769,"score_gpt":0.28982674212872045,"score_spread":0.23098451722230276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541695863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99420285,0.0031461944,0.0000017911696,0.0014398507,0.00008908744,0.0008501013,0.000018180655,0.0000035586256,0.00024840693],"genre_scores_gemma":[0.99936885,0.0001361573,0.00028390993,0.0000980392,0.000017305094,0.000044320204,0.000009316615,0.000017155791,0.000024938032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782205,0.0006078128,0.00067735784,0.0002446018,0.00034154265,0.00030663778],"domain_scores_gemma":[0.999226,0.00020165583,0.0001841853,0.00024911063,0.000039452818,0.00009959736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014774296,0.0001254815,0.00041908488,0.0002831221,0.000010548017,0.0000018363353,0.00006193284,0.000027295404,0.00015164513],"category_scores_gemma":[0.00005147569,0.000090927555,0.000033489214,0.00015805163,0.000023192742,0.000046647834,0.000013180813,0.00009947449,0.000008305945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00052064896,0.00021810873,0.96780103,0.00040019193,0.000022558695,0.000083948966,0.001798928,0.013442405,0.0031683154,0.00008407814,0.0001740164,0.012285751],"study_design_scores_gemma":[0.005764726,0.0005323779,0.9741238,0.00028843258,0.000019975389,0.000008166995,0.00046181463,0.009843065,0.008508805,0.0003053854,0.00005013649,0.00009335028],"about_ca_topic_score_codex":0.9528009,"about_ca_topic_score_gemma":0.83589697,"teacher_disagreement_score":0.11690398,"about_ca_system_score_codex":0.006554183,"about_ca_system_score_gemma":0.00699431,"threshold_uncertainty_score":0.9986351},"labels":[],"label_agreement":null},{"id":"W2549348854","doi":"10.1016/j.urology.2016.08.069","title":"Prediction of Competing Mortality for Decision-making Between Surgery or Observation in Elderly Patients With T1 Kidney Cancer","year":2016,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Hazard ratio; Kidney disease; Internal medicine; Kidney cancer; Charlson comorbidity index; Cancer; Acute kidney injury; Proportional hazards model; Comorbidity; Nephrology; Epidemiology; Kidney; Disease; Surgery; Confidence interval","score_opus":0.07339748815851287,"score_gpt":0.30597705429463734,"score_spread":0.23257956613612446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549348854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571997,0.000029976249,0.0031401543,0.00033374428,0.00011851478,0.00049997744,0.000113430266,0.000016111253,0.000028146287],"genre_scores_gemma":[0.9989622,0.000009937346,0.00064408913,0.00014045516,0.00007853711,0.00007648359,0.00006085494,0.000014120795,0.000013275279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990551,0.00004703669,0.00035367787,0.00020985906,0.00016058255,0.0001737814],"domain_scores_gemma":[0.99781823,0.0016212884,0.00018493843,0.00016230364,0.00015494498,0.000058268015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021215662,0.0000929635,0.0003170705,0.00011481639,0.00002186145,0.0000017336434,0.00003272067,0.0000828066,0.000053249503],"category_scores_gemma":[0.00090039487,0.000052448613,0.000043600154,0.000116328374,0.00004108337,0.000060549497,0.000013618694,0.000044104978,0.0000010000753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013802772,0.00007843703,0.97174525,0.00006165809,0.00006422177,0.000007559493,0.000053346776,0.000012916628,0.00020100911,0.000004949598,0.00013577718,0.026254583],"study_design_scores_gemma":[0.0017908508,0.0010382186,0.9959439,0.00037023428,0.00012827023,0.0000015056288,0.0000058123837,0.00006600589,0.00030511816,0.00008445987,0.00021974475,0.000045879493],"about_ca_topic_score_codex":0.00009729434,"about_ca_topic_score_gemma":0.00019783764,"teacher_disagreement_score":0.026208702,"about_ca_system_score_codex":0.00011305132,"about_ca_system_score_gemma":0.00019485275,"threshold_uncertainty_score":0.21387924},"labels":[],"label_agreement":null},{"id":"W2549441941","doi":"10.5489/cuaj.2645","title":"Tremendous non-progressed chromophobe renal cell carcinoma for eight years performed by laparoscope","year":2016,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Chromophobe cell; Kidney; Radiology; Computed tomography; Clear cell; Pathology; Internal medicine","score_opus":0.011800347901627222,"score_gpt":0.21884720499564125,"score_spread":0.20704685709401402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549441941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878776,0.00038973923,0.0000671424,0.00871282,0.00030886606,0.00054616114,0.00022884662,0.00001794619,0.0018508496],"genre_scores_gemma":[0.9933651,0.00006677731,0.00039362322,0.0013569238,0.00058164075,0.0000638835,0.000079951424,0.000032144166,0.0040599187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978404,0.000094682306,0.00042978761,0.00032615088,0.0004534684,0.00085551385],"domain_scores_gemma":[0.99781615,0.0001996026,0.00031980482,0.00017299774,0.00028856756,0.0012028888],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004911271,0.00023132942,0.00041115753,0.00017298105,0.00025175614,0.000070501505,0.00016296846,0.00029969806,0.0010619691],"category_scores_gemma":[0.00025273528,0.00014972976,0.0002625812,0.00015021734,0.000047114812,0.000121425175,0.000014099058,0.00030840567,0.00012675741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057979947,0.0002738876,0.6861687,0.000026087937,0.00022051913,0.0007841258,0.00016764624,0.0000020730195,0.09649566,0.0000146571765,0.205553,0.009713852],"study_design_scores_gemma":[0.012471173,0.004542732,0.7257702,0.00004081213,0.00038725894,0.00047803446,0.00003805024,0.000065408894,0.059972845,0.00016147837,0.1956061,0.0004659368],"about_ca_topic_score_codex":0.00026984015,"about_ca_topic_score_gemma":0.00014753042,"teacher_disagreement_score":0.03960147,"about_ca_system_score_codex":0.0028149514,"about_ca_system_score_gemma":0.0008133016,"threshold_uncertainty_score":0.99985117},"labels":[],"label_agreement":null},{"id":"W2558450726","doi":"10.1093/neuonc/now212.048","title":"ACTR-50. MARIZOMIB (MRZ) WITH BEVACIZUMAB (BEV) IN WHO GRADE IV MALIGNANT GLIOMA (G4 MG): FULL ENROLLMENT RESULTS FROM THE PHASE 1, MULTICENTER, OPEN-LABEL STUDY","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Glioma; Internal medicine; Population; Progressive disease; Cohort; Surgery; Tolerability; Gastroenterology; Adverse effect; Chemotherapy","score_opus":0.05990842500613037,"score_gpt":0.3412815241594815,"score_spread":0.2813730991533511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558450726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97275805,0.00027099004,0.00002133404,0.019274669,0.0005020118,0.005586625,0.00021501785,0.00007537782,0.0012958929],"genre_scores_gemma":[0.995746,0.00018499953,0.0005750466,0.0020401445,0.00026268535,0.00065516395,0.00007294428,0.000098317054,0.00036466395],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99478585,0.0011124539,0.0010915664,0.0014119676,0.00069937174,0.0008987907],"domain_scores_gemma":[0.9953581,0.0020169155,0.00048418692,0.0015964147,0.00013742603,0.0004069586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007222916,0.00061811606,0.0011969255,0.00022028157,0.0001758414,0.00007441392,0.0008629708,0.0002316631,0.00012959467],"category_scores_gemma":[0.00037750913,0.00031352346,0.00010382806,0.00038573163,0.00024864907,0.00020951683,0.0006723197,0.00052578276,0.00016571919],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09357911,0.028583907,0.01525066,0.000019605208,0.0005479517,0.020203559,0.0036836579,0.000002335652,0.78793067,0.000027177155,0.004674006,0.04549735],"study_design_scores_gemma":[0.62359804,0.09620062,0.062311284,0.0005178198,0.0014140283,0.0013230556,0.0025977592,0.00028347143,0.102813125,0.00008242613,0.10793277,0.000925615],"about_ca_topic_score_codex":0.0018486324,"about_ca_topic_score_gemma":0.002392282,"teacher_disagreement_score":0.68511754,"about_ca_system_score_codex":0.0011706572,"about_ca_system_score_gemma":0.0004932527,"threshold_uncertainty_score":0.9999317},"labels":[],"label_agreement":null},{"id":"W2559811342","doi":"10.1080/14737140.2017.1269605","title":"On-treatment biomarkers in metastatic renal cell carcinoma: towards individualization of prognosis?","year":2016,"lang":"en","type":"editorial","venue":"Expert Review of Anticancer Therapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Internal medicine; Cancer research","score_opus":0.03135229829340001,"score_gpt":0.3576693729735103,"score_spread":0.3263170746801103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559811342","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010766626,0.87495226,0.00003397962,0.00091142557,0.10541348,0.0055045313,0.00040172765,0.000031772168,0.00198422],"genre_scores_gemma":[0.028874794,0.914151,0.0012012887,0.00028874996,0.053564873,0.0008775172,0.0006920932,0.00013603769,0.00021360288],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958418,0.00033550616,0.0013187475,0.0006823426,0.0014434148,0.0003781884],"domain_scores_gemma":[0.997229,0.00048804097,0.00094190147,0.0008188521,0.00038137872,0.0001408639],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005053848,0.0006860368,0.0023841553,0.00037494447,0.0000231877,0.000008190622,0.00025187363,0.00026162976,0.00043086807],"category_scores_gemma":[0.00017972133,0.00039035932,0.00063629966,0.0004281965,0.0001891828,0.000050299033,0.000032807016,0.00018585876,0.000011096678],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026936703,0.0044994755,0.0013707468,0.019747091,0.0026150397,0.00022232428,0.0010843211,3.6381982e-7,0.0047866507,0.000030097726,0.8040939,0.15885633],"study_design_scores_gemma":[0.012184549,0.010060059,0.0012961037,0.050289247,0.0009027661,0.000007306143,0.000033119257,0.0000022821255,0.15576379,0.000039476978,0.7687753,0.0006460152],"about_ca_topic_score_codex":0.0004930727,"about_ca_topic_score_gemma":0.000008796078,"teacher_disagreement_score":0.15821032,"about_ca_system_score_codex":0.0008352011,"about_ca_system_score_gemma":0.0014435482,"threshold_uncertainty_score":0.9998548},"labels":[],"label_agreement":null},{"id":"W2560329402","doi":"10.1200/jco.2011.29.7_suppl.312","title":"Phase III, randomized, placebo-controlled study of everolimus in patients with metastatic renal cell carcinoma (mRCC): Subgroup analysis of patients intolerant of prior vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) therapy.","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Everolimus; Medicine; Sorafenib; Sunitinib; Internal medicine; Placebo; Renal cell carcinoma; Subgroup analysis; Oncology; Tyrosine-kinase inhibitor; Adverse effect; Gastroenterology; Urology; Hepatocellular carcinoma; Confidence interval; Cancer; Pathology","score_opus":0.049749145513324655,"score_gpt":0.3362646173618153,"score_spread":0.28651547184849063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560329402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99503475,0.00043005063,0.000058309764,0.000018881641,0.00034843417,0.003957404,0.00006695869,0.0000047294193,0.00008044802],"genre_scores_gemma":[0.99826807,0.00015664319,0.0012748487,0.000055546254,0.00009959093,0.00005988233,0.000028303017,0.000042871787,0.0000142680965],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9870925,0.0031333084,0.007480051,0.00045758515,0.0014506713,0.00038587285],"domain_scores_gemma":[0.98527765,0.0036397986,0.008085736,0.0005168642,0.0020579954,0.0004219675],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004198284,0.0004842862,0.009495421,0.0012331612,0.0000310139,0.0000049602836,0.00032958842,0.0002759111,0.00028850895],"category_scores_gemma":[0.0021400137,0.00028343181,0.0021379683,0.0007682065,0.00037836397,0.00016638324,0.00007216176,0.00073427154,0.0000011248195],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5507808,0.060480002,0.37572172,0.00006209521,0.0073433095,0.000119756485,0.0019072426,0.000017771004,0.0005633245,0.0000014692758,0.000008077404,0.0029944254],"study_design_scores_gemma":[0.54951614,0.0725849,0.36441004,0.00006994267,0.008691717,0.0000013584935,0.00018667668,0.00006166562,0.0043404386,0.000006174266,0.0000049175696,0.00012600415],"about_ca_topic_score_codex":0.0004984478,"about_ca_topic_score_gemma":0.00010531655,"teacher_disagreement_score":0.012104896,"about_ca_system_score_codex":0.0002611201,"about_ca_system_score_gemma":0.0008177384,"threshold_uncertainty_score":0.9999618},"labels":[],"label_agreement":null},{"id":"W2560470830","doi":"10.1200/jco.2011.29.7_suppl.387","title":"Neoadjuvant temsirolimus in high-risk renal cell carcinoma: Results from a single-center prospective study.","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Temsirolimus; Nephrectomy; Renal cell carcinoma; Surgery; Urology; Internal medicine; Kidney; Discovery and development of mTOR inhibitors","score_opus":0.1387588322372436,"score_gpt":0.3726228569516508,"score_spread":0.2338640247144072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560470830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98684824,0.0003279924,0.00001977431,0.00046968137,0.0012610374,0.00086579466,0.000034218552,0.000013298096,0.010159972],"genre_scores_gemma":[0.9931386,0.000074393494,0.00493258,0.0003031603,0.0012607112,0.000013634657,0.0000075414637,0.00003636167,0.00023301308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99297327,0.0012316464,0.004229711,0.0005384516,0.0006007237,0.0004262203],"domain_scores_gemma":[0.99339116,0.0019693382,0.0030769687,0.00049218774,0.00049192936,0.000578414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003128724,0.00030545332,0.0023147925,0.00028447295,0.00004137989,0.000010319075,0.0002712865,0.00045400762,0.000118941505],"category_scores_gemma":[0.002241612,0.00020606382,0.0005786073,0.000222091,0.00019670812,0.00013061517,0.00012764882,0.0019067308,0.00006106137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0403796,0.027733965,0.8961062,0.000007140162,0.0003459704,0.015450213,0.0024164505,0.000004635125,0.00031486858,0.0000033571948,0.00073619164,0.016501427],"study_design_scores_gemma":[0.060315505,0.07259784,0.8629647,0.000068664565,0.00075181865,0.00027084284,0.00070042704,0.000018778599,0.001129057,0.00032912064,0.0007044375,0.00014883644],"about_ca_topic_score_codex":0.0020668246,"about_ca_topic_score_gemma":0.0009464862,"teacher_disagreement_score":0.044863876,"about_ca_system_score_codex":0.0007433698,"about_ca_system_score_gemma":0.0010245325,"threshold_uncertainty_score":0.8403039},"labels":[],"label_agreement":null},{"id":"W2560526418","doi":"10.1200/jco.2011.29.7_suppl.304","title":"Everolimus in metastatic renal cell carcinoma (mRCC): Subgroup analysis of patients (pts) with one versus two prior vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) therapies enrolled in the phase III RECORD-1 study.","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Everolimus; Medicine; Hazard ratio; Sorafenib; Sunitinib; Internal medicine; Placebo; Renal cell carcinoma; Oncology; Gastroenterology; Urology; Confidence interval; Hepatocellular carcinoma; Pathology","score_opus":0.11169553886781514,"score_gpt":0.37803803422792326,"score_spread":0.2663424953601081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560526418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971215,0.0004185586,0.000028992445,0.0001795338,0.0004971464,0.0014746211,0.000036142203,0.0000065921554,0.00023687426],"genre_scores_gemma":[0.99678105,0.00019775493,0.0024356453,0.00017560877,0.0002780647,0.00004952347,0.000019217572,0.000039935123,0.000023188193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9913959,0.002620512,0.003888651,0.0004810355,0.0011533076,0.0004606194],"domain_scores_gemma":[0.9922292,0.0033206672,0.0028493172,0.00054850033,0.0007140666,0.0003382481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037179936,0.00041612604,0.0035758158,0.0009854762,0.000051179406,0.000013024392,0.00042903307,0.00021131692,0.00038404646],"category_scores_gemma":[0.0013102801,0.00023949887,0.0010299934,0.001180802,0.0002815074,0.00018723922,0.000072496216,0.0011439787,0.000006068174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14559072,0.052092914,0.7740233,0.000055858716,0.0052407836,0.001606726,0.0068775993,0.0000111758145,0.001306716,0.0000080695145,0.000038035534,0.013148128],"study_design_scores_gemma":[0.16646995,0.0868045,0.7364462,0.00006191301,0.006750053,0.000007952652,0.0014135481,0.000035648485,0.0016814402,0.00001644527,0.00012249178,0.00018986786],"about_ca_topic_score_codex":0.0009765087,"about_ca_topic_score_gemma":0.0017328816,"teacher_disagreement_score":0.037577078,"about_ca_system_score_codex":0.00047820763,"about_ca_system_score_gemma":0.00089200126,"threshold_uncertainty_score":0.97664803},"labels":[],"label_agreement":null},{"id":"W2561330387","doi":"10.4103/2156-7514.197026","title":"Multimodality Imaging Characteristics of the Common Renal Cell Carcinoma Subtypes: An Analysis of 544 Pathologically Proven Tumors","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Imaging Science","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Multimodality; Renal cell carcinoma; Pathology; Oncology; Linguistics","score_opus":0.045327545683206454,"score_gpt":0.3671275498359055,"score_spread":0.32180000415269905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561330387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973499,0.0000739999,0.00063253875,0.0012462402,0.00021574362,0.00016221663,0.000018955403,0.0000064631436,0.00029390986],"genre_scores_gemma":[0.9964974,0.000015050287,0.0031156354,0.0002209375,0.00010369446,9.625024e-7,9.4514564e-7,0.000009456615,0.000035928293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956324,0.00037330826,0.00220358,0.00035798247,0.0011198752,0.00031286778],"domain_scores_gemma":[0.9943997,0.0007129411,0.0026214449,0.00075471867,0.0011724677,0.00033868058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054527763,0.00017361558,0.001145353,0.00031221408,0.00009047869,0.000028072172,0.0007786189,0.000042555283,0.000028776347],"category_scores_gemma":[0.0023836396,0.00008057966,0.0007168409,0.00088112726,0.0020289717,0.00035395144,0.00017978356,0.0003574345,0.0000012672637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024366759,0.00052613724,0.8465264,0.000020748379,0.000039747818,0.00014054208,0.00010828838,0.0000073929414,0.13989,0.000012437009,0.0000064677197,0.012478164],"study_design_scores_gemma":[0.0011133242,0.0004968203,0.9569863,0.00018031469,0.0009462349,0.00010555114,0.00007905486,0.002484552,0.037433114,0.00007725489,0.000009459205,0.0000880118],"about_ca_topic_score_codex":0.00005886038,"about_ca_topic_score_gemma":0.0000030963765,"teacher_disagreement_score":0.110459894,"about_ca_system_score_codex":0.00012711708,"about_ca_system_score_gemma":0.0007209527,"threshold_uncertainty_score":0.74758303},"labels":[],"label_agreement":null},{"id":"W2561651629","doi":"10.1200/jco.2015.33.7_suppl.424","title":"The proportion and characterization of patients with metastatic renal cell carcinoma who are never treated or have delayed treatment with targeted therapy: Results from a large prospective cohort.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Ottawa Hospital; University Health Network; CancerCare Manitoba; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Dalhousie University; University of Toronto; Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre; University of Calgary; BC Cancer Agency","funders":"","keywords":"Medicine; Renal cell carcinoma; Cohort; Internal medicine; Hazard ratio; Population; Cancer; Proportional hazards model; Kidney cancer; Prospective cohort study; Surgery; Oncology; Gastroenterology; Confidence interval","score_opus":0.06635071013552195,"score_gpt":0.34558572398363874,"score_spread":0.2792350138481168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561651629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99719805,0.00022209749,0.00006411139,0.0007408457,0.00007851908,0.0014391507,0.00014205217,0.000006836968,0.00010832414],"genre_scores_gemma":[0.9980324,0.0003088111,0.00073705585,0.00015323845,0.0001296527,0.000031528307,0.00018640915,0.000026489173,0.00039440603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966929,0.00055033393,0.0016660036,0.00029015652,0.00058314885,0.00021744483],"domain_scores_gemma":[0.9937657,0.0006299285,0.0034795508,0.00024581162,0.0015375211,0.00034147955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009834758,0.00024052201,0.0013840428,0.000079733305,0.00006337596,0.000014087181,0.00006972017,0.00014878613,0.000011735028],"category_scores_gemma":[0.0003246312,0.00009514958,0.00013526458,0.00014317266,0.00020028581,0.00016464516,0.000017981947,0.00028893535,0.0000010930884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16648836,0.0032549722,0.8221959,0.000006337818,0.001225137,0.0005326526,0.00060374616,0.000002712123,0.00023680425,0.0000011663082,0.00007413556,0.005378101],"study_design_scores_gemma":[0.05276868,0.09345361,0.84727913,0.0000648161,0.0012668422,0.000043686498,0.0002681151,0.000083382816,0.0038150835,0.000012862067,0.000853629,0.00009013853],"about_ca_topic_score_codex":0.0001649357,"about_ca_topic_score_gemma":0.00020858116,"teacher_disagreement_score":0.113719694,"about_ca_system_score_codex":0.00040146813,"about_ca_system_score_gemma":0.0012636953,"threshold_uncertainty_score":0.38800874},"labels":[],"label_agreement":null},{"id":"W2562252195","doi":"10.1016/j.eururo.2016.12.013","title":"Reply to Roberto Iacovelli, Walter Artibani, and Giampaolo Tortora's Letter to the Editor re: Ian D. Davis, Wanling Xie, Carmel Pezaro, et al. Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category. Eur Urol 2017;71:970–8","year":2016,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Classics","score_opus":0.039492417459690815,"score_gpt":0.2783214578204729,"score_spread":0.2388290403607821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562252195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51516825,0.0018358389,0.0025518283,0.4661518,0.0036587017,0.0063119405,0.003984833,0.00007502951,0.00026177877],"genre_scores_gemma":[0.5128816,0.000035478468,0.0019435093,0.46557122,0.014233989,0.00044188992,0.0038509632,0.00029957367,0.00074176904],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9916738,0.0018327018,0.0018340102,0.002441201,0.00084811053,0.0013701281],"domain_scores_gemma":[0.99436736,0.00176665,0.00083160884,0.0019004634,0.00054074835,0.00059317384],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020102798,0.0012420273,0.0016258638,0.0010030189,0.00014352197,0.00010452284,0.0010368937,0.00024692254,0.0004224622],"category_scores_gemma":[0.0007452078,0.0009009254,0.00037712086,0.00033826346,0.00016682051,0.00019543759,0.00070175313,0.0016718847,0.00015384522],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003783718,0.00035685507,0.0045213117,0.00017999057,0.00025866352,0.003777767,0.0016330889,0.000076241035,0.052626874,7.1783705e-7,0.9318025,0.000982245],"study_design_scores_gemma":[0.008024547,0.004650066,0.017562572,0.00019990694,0.000661334,0.00013566818,0.00006569292,0.00023684846,0.019036675,0.0000042855813,0.9484496,0.000972802],"about_ca_topic_score_codex":0.0006747903,"about_ca_topic_score_gemma":0.00018694178,"teacher_disagreement_score":0.033590198,"about_ca_system_score_codex":0.0002713722,"about_ca_system_score_gemma":0.00029729964,"threshold_uncertainty_score":0.9993441},"labels":[],"label_agreement":null},{"id":"W2566958034","doi":"10.1200/jco.2005.23.16_suppl.4603","title":"Preliminary phase 2 results of ABT-751 in subjects with advanced renal cell carcinoma (RCC)","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada); BC Cancer Agency","funders":"","keywords":"Medicine; Adverse effect; Nausea; Discontinuation; Internal medicine; Renal cell carcinoma; Gastroenterology; Constipation; Ileus; Adjuvant therapy; Carcinoma; Surgery; Chemotherapy","score_opus":0.07917845952725919,"score_gpt":0.42234288424944494,"score_spread":0.3431644247221858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566958034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834849,0.0013057183,0.000024831219,0.0033102361,0.00024175529,0.00036173058,0.000007798727,0.0000065411145,0.0112564685],"genre_scores_gemma":[0.98497844,0.000252823,0.012980394,0.00047840807,0.0007175312,0.000005425802,0.000008186603,0.00002585806,0.0005529227],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9949363,0.00043494828,0.0034368325,0.00030363616,0.0005442713,0.0003440416],"domain_scores_gemma":[0.9941551,0.0019811813,0.0025544087,0.00036063156,0.00046942398,0.00047922542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002293178,0.0002238625,0.0018830149,0.0002859337,0.00001978983,0.0000033121717,0.00019446714,0.00034940572,0.000053804855],"category_scores_gemma":[0.0011822206,0.0001463004,0.00041798322,0.00024747726,0.00024363997,0.00015146624,0.00004912368,0.0010903601,0.000013131621],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42682275,0.028522683,0.080362715,0.00021220384,0.0003608247,0.020093607,0.0009839499,0.0010805699,0.012825418,0.000025476545,0.0053185965,0.42339122],"study_design_scores_gemma":[0.13495544,0.25395146,0.5449029,0.000376951,0.0006947614,0.0019274107,0.00024824918,0.00021916405,0.04079055,0.00003734832,0.021678733,0.00021700912],"about_ca_topic_score_codex":0.00002921253,"about_ca_topic_score_gemma":0.00008628466,"teacher_disagreement_score":0.4645402,"about_ca_system_score_codex":0.00035158222,"about_ca_system_score_gemma":0.001987466,"threshold_uncertainty_score":0.5965957},"labels":[],"label_agreement":null},{"id":"W2567343182","doi":"10.1093/annonc/mdv341.14","title":"Complete remission (CR) during treatment for metastatic renal cell carcinoma (mRCC) with tyrosine kinase inhibitors (TKIs)","year":2015,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Pazopanib; Sunitinib; Internal medicine; Sorafenib; Population; Renal cell carcinoma; Gastroenterology; Oncology; Surgery; Hepatocellular carcinoma","score_opus":0.167415488593777,"score_gpt":0.3621885307379039,"score_spread":0.1947730421441269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567343182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900874,0.0017063695,0.00005851266,0.0025405332,0.00010255133,0.0011865662,0.00006261694,0.000034136796,0.004221349],"genre_scores_gemma":[0.9913619,0.00006431105,0.006361549,0.00021158895,0.00017678183,0.00014428936,0.00015872833,0.000048670667,0.0014721891],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99815434,0.00011632242,0.00052144035,0.0004260239,0.0003160255,0.0004658638],"domain_scores_gemma":[0.99812686,0.00015340892,0.00033293312,0.00042590336,0.00046326843,0.0004976446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026162202,0.00031972417,0.00087338075,0.00021026768,0.00007286139,0.0000075270905,0.00008848652,0.00010495691,0.000033736174],"category_scores_gemma":[0.00006388593,0.00021583006,0.00020968053,0.00018373583,0.00014171605,0.000069408066,0.000044558798,0.00010299418,0.000016650794],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038852293,0.009757806,0.035724565,0.0014438091,0.0011062037,0.0054166764,0.0038010199,0.00045671526,0.8471696,0.00019160508,0.018804075,0.03727563],"study_design_scores_gemma":[0.02067631,0.058550894,0.01287034,0.00014880803,0.0007091046,0.00047232347,0.0004297045,0.0001309899,0.8475376,0.00010019895,0.05808918,0.00028457987],"about_ca_topic_score_codex":0.00025740766,"about_ca_topic_score_gemma":0.000040018636,"teacher_disagreement_score":0.04879309,"about_ca_system_score_codex":0.00039601556,"about_ca_system_score_gemma":0.00056012615,"threshold_uncertainty_score":0.88012946},"labels":[],"label_agreement":null},{"id":"W2567658625","doi":"10.1016/j.eururo.2016.07.010","title":"Re: Alexander Kutikov, Marc C. Smaldone, Robert G. Uzzo, Miki Haifler, Gennady Bratslavsky, Bradley C. Leibovich. Renal Mass Biopsy: Always, Sometimes, or Never? Eur Urol 2016;70:403–6","year":2016,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Renal mass; Biopsy; Radiology; Kidney; Internal medicine","score_opus":0.02930264268600588,"score_gpt":0.24451822498229445,"score_spread":0.21521558229628857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567658625","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031568706,0.012453852,0.0011729794,0.77857554,0.0041284813,0.003480611,0.00073506637,0.00123046,0.19506612],"genre_scores_gemma":[0.005072886,0.0016263375,0.00198151,0.5946691,0.01707033,0.00014082337,0.00259785,0.0014816032,0.37535957],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98567915,0.0033736678,0.002266025,0.0037228814,0.0015844207,0.0033738804],"domain_scores_gemma":[0.99198306,0.0010870043,0.0012920174,0.004133184,0.00048867706,0.0010160358],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0013632133,0.0026251753,0.0030936906,0.0014161004,0.00039950907,0.00018155853,0.0018146035,0.0020404821,0.01265485],"category_scores_gemma":[0.00038449024,0.0018653657,0.0011791015,0.00070932053,0.00097486476,0.000347697,0.0009373197,0.004548601,0.013462261],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002794406,0.0002529298,0.00090169307,0.0003161138,0.0017924254,0.07289886,0.00009083792,0.000005320341,0.0058901217,0.000023408711,0.910574,0.00445986],"study_design_scores_gemma":[0.00852924,0.0035199453,0.005231242,0.00028195418,0.0020821423,0.006329619,0.000010142899,0.000036740825,0.0005623154,0.00007997609,0.97150207,0.0018345894],"about_ca_topic_score_codex":0.0002453118,"about_ca_topic_score_gemma":0.000046726527,"teacher_disagreement_score":0.18390647,"about_ca_system_score_codex":0.00063823187,"about_ca_system_score_gemma":0.0010964426,"threshold_uncertainty_score":0.99925506},"labels":[],"label_agreement":null},{"id":"W2567749076","doi":"10.1016/j.urolonc.2016.12.001","title":"Does teaching of robotic partial nephrectomy affect renal function and perioperative outcomes?","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Nephrectomy; Affect (linguistics); Perioperative; Renal function; Urology; Surgery; Internal medicine; Kidney","score_opus":0.03543236616639452,"score_gpt":0.3281480225520905,"score_spread":0.292715656385696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567749076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904847,0.00028424818,0.0001552408,0.0058298483,0.0002318681,0.0004654525,0.0000052907094,0.000028431175,0.0025149195],"genre_scores_gemma":[0.9790055,0.00008049366,0.019246817,0.00047243867,0.00010921259,0.00008892784,0.000017474944,0.0000097017055,0.00096938945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998943,0.0001588481,0.00024378742,0.0003264142,0.00012216828,0.00020581963],"domain_scores_gemma":[0.99900013,0.00023179951,0.00023977272,0.00028110528,0.00004598962,0.00020121064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032120768,0.00018956348,0.0004708541,0.00008857951,0.00064495025,0.000042336236,0.00006963024,0.00016295866,0.000036214522],"category_scores_gemma":[0.0003699122,0.00010687606,0.000064352906,0.00003182116,0.00097640645,0.00015872244,0.00007114321,0.00032570094,0.000004431871],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019349057,0.00013692511,0.9853403,0.000032668915,0.00013142305,0.000082212595,0.00038822414,0.00002925017,0.004241732,0.006831881,0.0001440804,0.0024478058],"study_design_scores_gemma":[0.0028227998,0.007255986,0.87551564,0.00009988587,0.001255179,0.00032630374,0.0003083,0.0011233409,0.0025996123,0.003106195,0.10535368,0.00023306497],"about_ca_topic_score_codex":0.00013356314,"about_ca_topic_score_gemma":0.000039270322,"teacher_disagreement_score":0.10982466,"about_ca_system_score_codex":0.00007009759,"about_ca_system_score_gemma":0.00014810443,"threshold_uncertainty_score":0.4960501},"labels":[],"label_agreement":null},{"id":"W2568364351","doi":"10.5489/cuaj.4294","title":"The next 10 years: Challenges for the future and overcoming resistance to targeted therapies for renal cell carcinoma","year":2016,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Targeted therapy; Cabozantinib; PI3K/AKT/mTOR pathway; Oncology; Discovery and development of mTOR inhibitors; Tyrosine kinase; Adjuvant; Internal medicine; Acquired resistance; Cancer research; Intensive care medicine; Cancer; Receptor; Signal transduction; Biology","score_opus":0.04543506718884423,"score_gpt":0.2706050532972803,"score_spread":0.22516998610843608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568364351","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000268228,0.96296954,0.00002151653,0.034309015,0.00039848904,0.0016616702,0.0001776984,0.000009510779,0.00018433499],"genre_scores_gemma":[0.0017837193,0.99019897,0.00024964783,0.0007233174,0.0027569155,0.0003455834,0.000021234839,0.00004392768,0.0038766908],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980216,0.00025609724,0.0004777155,0.0003230908,0.00029206497,0.00062945025],"domain_scores_gemma":[0.99591845,0.0025017082,0.0005204672,0.0002442862,0.00028825577,0.00052681495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012119059,0.00031283914,0.00078464707,0.00011604026,0.00070713606,0.00019185494,0.00026815804,0.00042941456,0.000059576156],"category_scores_gemma":[0.00055850396,0.00013945473,0.0005152946,0.00010135151,0.000043906475,0.0000472671,0.00002244129,0.00046494292,0.000013114255],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018116596,0.000015020725,0.00013241629,0.00044251487,0.0004719898,0.00003459793,0.00023283402,1.669494e-7,0.000003084466,0.00030575972,0.04381009,0.9543704],"study_design_scores_gemma":[0.00064334995,0.00041085933,0.005316849,0.00034155932,0.0005791142,0.00005553875,0.00012109365,0.0000011264091,0.0000010044321,0.0003014815,0.99206436,0.0001636881],"about_ca_topic_score_codex":0.00002441634,"about_ca_topic_score_gemma":0.0010124095,"teacher_disagreement_score":0.95420665,"about_ca_system_score_codex":0.0014313753,"about_ca_system_score_gemma":0.00079935906,"threshold_uncertainty_score":0.5686799},"labels":[],"label_agreement":null},{"id":"W2568788055","doi":"10.5489/cuaj.4315","title":"Sunitinib side effects as surrogate biomarkers of efficacy","year":2016,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Sunitinib; Medicine; Renal cell carcinoma; Adverse effect; Neutropenia; Oncology; Intensive care medicine; Internal medicine; Chemotherapy","score_opus":0.03200430186215161,"score_gpt":0.293736270266685,"score_spread":0.2617319684045334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568788055","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003047827,0.98362947,0.000002271545,0.0015230889,0.00053042505,0.00090344256,0.00009402924,0.000026175583,0.010243247],"genre_scores_gemma":[0.0068483786,0.9906649,0.0000561904,0.00045473443,0.0005692148,0.000025650219,0.000100144025,0.00005426458,0.0012265167],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964396,0.000884839,0.0009743498,0.00034406182,0.000605825,0.00075134967],"domain_scores_gemma":[0.9945997,0.0019549883,0.0013347048,0.00026713588,0.0003609653,0.0014825045],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010159417,0.00044992517,0.002045152,0.0006193575,0.00014978903,0.00004847026,0.00023844816,0.000852478,0.00056713424],"category_scores_gemma":[0.003293483,0.00027589974,0.0011885366,0.0003748277,0.00007322512,0.00005105746,0.000027872724,0.0008576503,0.00055344723],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055569475,0.00010141579,0.0022645756,0.0014072559,0.0022495936,0.002162364,0.000021239342,1.5655674e-7,0.00000570145,0.00009131058,0.0036446555,0.98799616],"study_design_scores_gemma":[0.0014691815,0.0008298291,0.009946071,0.0043428913,0.0020088512,0.0015031961,0.0000041587014,2.2435592e-7,0.0000097367165,0.00011126865,0.97951275,0.0002618409],"about_ca_topic_score_codex":0.00055511674,"about_ca_topic_score_gemma":0.000097809316,"teacher_disagreement_score":0.9877343,"about_ca_system_score_codex":0.0034862012,"about_ca_system_score_gemma":0.0028548797,"threshold_uncertainty_score":0.9999693},"labels":[],"label_agreement":null},{"id":"W2568812071","doi":"10.5489/cuaj.4252","title":"Rethinking lymph node metastasis and cytoreductive nephrectomy","year":2016,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Nephrectomy; Lymph node metastasis; Metastasis; Medicine; Lymph node; General surgery; Internal medicine; Kidney; Cancer","score_opus":0.022696924701630494,"score_gpt":0.2317870376124912,"score_spread":0.20909011291086071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568812071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95095086,0.0004661335,0.000094407136,0.045610882,0.00017320184,0.00011498758,0.00002073077,0.000021998621,0.0025467675],"genre_scores_gemma":[0.9951187,0.00012629385,0.0010254192,0.0026955113,0.00037516357,0.0000063402713,0.0000035738165,0.00001206261,0.00063693465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986542,0.000173674,0.0002354621,0.0002046897,0.00031199623,0.00042000576],"domain_scores_gemma":[0.9984643,0.00021265748,0.00018126654,0.00009343272,0.00021508045,0.00083328906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055872847,0.00013524048,0.0002630143,0.000166807,0.00021801078,0.000056980287,0.000059739323,0.00017749112,0.00044732945],"category_scores_gemma":[0.00079431,0.00007903535,0.00011016239,0.000120349236,0.000047596724,0.00011147564,0.000014277447,0.00023905172,0.00005048408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007548859,0.000023415676,0.9822499,0.0000028342108,0.00027762807,0.00034530868,0.00021556113,0.0000013014514,0.0013068438,0.00023616855,0.0022328326,0.013032682],"study_design_scores_gemma":[0.0017096413,0.00020088673,0.9723658,0.00002854762,0.00021250865,0.0011874122,0.00004619164,0.000010023418,0.00046329453,0.004243126,0.019403253,0.00012932115],"about_ca_topic_score_codex":0.00055727124,"about_ca_topic_score_gemma":0.000101461126,"teacher_disagreement_score":0.04416781,"about_ca_system_score_codex":0.002385227,"about_ca_system_score_gemma":0.0004171716,"threshold_uncertainty_score":0.6237286},"labels":[],"label_agreement":null},{"id":"W2568964360","doi":"10.5489/cuaj.4296","title":"Sunitinib toxicity management – a practical approach","year":2016,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Sunitinib; Medicine; Adverse effect; Toxicity; Intensive care medicine; Internal medicine; Cancer","score_opus":0.0753501076526003,"score_gpt":0.318498435188088,"score_spread":0.2431483275354877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568964360","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048241724,0.9318309,0.00021839922,0.0036480373,0.00033742638,0.0010880232,0.00008907027,0.000043662807,0.06269626],"genre_scores_gemma":[0.00023741406,0.9905507,0.001439901,0.0010705342,0.001064133,0.00009138506,0.00012574819,0.000049329024,0.005370853],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961527,0.0008659513,0.00083827745,0.00046333126,0.00074819673,0.0009315551],"domain_scores_gemma":[0.9964414,0.00041234423,0.00081273005,0.0002948589,0.00023393458,0.0018047339],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014660711,0.00046362917,0.0015964571,0.00048994075,0.00025603568,0.00013828951,0.00020228993,0.00087883044,0.0011820487],"category_scores_gemma":[0.00072300556,0.00027762644,0.00091388274,0.0003143168,0.00004778291,0.00010535396,0.000048554317,0.0014472042,0.0007271331],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021602636,0.00022218659,0.0007216706,0.001127727,0.0017644353,0.003448666,0.000012494789,1.4640048e-7,8.838676e-8,0.0013048652,0.0263862,0.9649899],"study_design_scores_gemma":[0.0006002408,0.00025945014,0.0012744732,0.0009916541,0.0019391738,0.0046938695,0.000012652245,0.0000012219916,1.0859621e-7,0.00017073454,0.98978823,0.0002682014],"about_ca_topic_score_codex":0.00007723241,"about_ca_topic_score_gemma":0.00003036097,"teacher_disagreement_score":0.96472174,"about_ca_system_score_codex":0.0069161993,"about_ca_system_score_gemma":0.0016122267,"threshold_uncertainty_score":0.9999676},"labels":[],"label_agreement":null},{"id":"W2569047031","doi":"10.5489/cuaj.4293","title":"Can individualized sunitinib dose and schedule changes optimize outcomes for kidney cancer patients?","year":2016,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Sunitinib; Schedule; Medicine; Oncology; Cancer; Urology; Internal medicine; Computer science","score_opus":0.05652435596631345,"score_gpt":0.317553856221732,"score_spread":0.26102950025541855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569047031","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001990591,0.9593309,0.0000031590143,0.030977275,0.0007828871,0.002183027,0.0042001177,0.000033038814,0.00049899495],"genre_scores_gemma":[0.0005744073,0.9908355,0.00039823446,0.0048036855,0.0007024415,0.00042098403,0.000581527,0.00006322343,0.0016200229],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974512,0.00032495576,0.0006272998,0.00039073234,0.00042788484,0.00077791815],"domain_scores_gemma":[0.9958117,0.00058595365,0.00095522427,0.00015737046,0.00044927397,0.0020404756],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006091524,0.0004710935,0.0018329556,0.00043049775,0.00030507176,0.00012560161,0.00016515437,0.00073408196,0.00068942906],"category_scores_gemma":[0.0021732755,0.000279412,0.00050220604,0.00015466167,0.000050530543,0.000050064282,0.000033939672,0.00061785977,0.000016904078],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006699648,0.00014119784,0.151879,0.0013678017,0.002571734,0.00011223141,0.00010430209,1.7209082e-7,2.6668488e-7,0.00011005359,0.024179652,0.8194666],"study_design_scores_gemma":[0.0033316766,0.0005014389,0.026103398,0.0013646617,0.0018813933,0.00006678775,0.0000070330357,6.752206e-7,3.6431518e-7,0.000077607125,0.9663619,0.00030311107],"about_ca_topic_score_codex":0.0006136862,"about_ca_topic_score_gemma":0.0009925371,"teacher_disagreement_score":0.9421822,"about_ca_system_score_codex":0.0033053427,"about_ca_system_score_gemma":0.0024985871,"threshold_uncertainty_score":0.9999658},"labels":[],"label_agreement":null},{"id":"W2569254611","doi":"10.5489/cuaj.4292","title":"Treatment options in advanced renal cell carcinoma after first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitors","year":2016,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cabozantinib; Axitinib; Everolimus; Lenvatinib; Medicine; Renal cell carcinoma; Sunitinib; Nivolumab; Vascular endothelial growth factor; Pazopanib; Oncology; Targeted therapy; Tyrosine-kinase inhibitor; Tyrosine kinase; Internal medicine; Cancer research; VEGF receptors; Sorafenib; Immunotherapy; Receptor; Cancer","score_opus":0.019776472609960308,"score_gpt":0.240965493428227,"score_spread":0.2211890208182667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569254611","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06170196,0.9308769,0.000013466389,0.0021340174,0.00046784,0.002601281,0.0018059035,0.000046515575,0.0003521009],"genre_scores_gemma":[0.080291696,0.9147197,0.00034992516,0.00013162661,0.0013239747,0.0007730646,0.000456604,0.00011898272,0.001834451],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99551976,0.00054532406,0.0012019519,0.0008571288,0.0006688642,0.0012069466],"domain_scores_gemma":[0.9962352,0.0004146666,0.0008825029,0.00043002624,0.0003206966,0.0017169404],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022642905,0.0010678943,0.0023931563,0.00086243474,0.00026908002,0.00010707028,0.00018046671,0.0008335552,0.0011524884],"category_scores_gemma":[0.00017032227,0.00058451056,0.0012467889,0.00047639702,0.00007211109,0.00014239743,0.00002318861,0.00072404684,0.00025450066],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014771131,0.0028918446,0.16378534,0.0011795835,0.0022898656,0.011995212,0.0004431402,0.000021966964,0.00004592236,0.000032704942,0.00075220386,0.8150851],"study_design_scores_gemma":[0.008319731,0.009545348,0.01845719,0.0015959436,0.0018552953,0.000494632,0.000011487961,0.0000017610507,0.00006251653,0.000015150194,0.95895755,0.00068337185],"about_ca_topic_score_codex":0.0015130873,"about_ca_topic_score_gemma":0.003529773,"teacher_disagreement_score":0.95820534,"about_ca_system_score_codex":0.026426975,"about_ca_system_score_gemma":0.002819367,"threshold_uncertainty_score":0.99976057},"labels":[],"label_agreement":null},{"id":"W2569560965","doi":"10.5489/cuaj.4307","title":"First-line treatment options in metastatic renal cell cancer","year":2016,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Canadian Urological Association","funders":"","keywords":"Temsirolimus; Pazopanib; Sunitinib; Renal cell carcinoma; Medicine; Oncology; Discovery and development of mTOR inhibitors; Targeted therapy; Internal medicine; PI3K/AKT/mTOR pathway; Angiogenesis; Cancer research; Vascular endothelial growth factor; Cancer; VEGF receptors; Biology; Signal transduction","score_opus":0.0673418987590646,"score_gpt":0.31660889140795834,"score_spread":0.24926699264889374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569560965","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045841176,0.9915488,0.00001279474,0.0050873044,0.00032819377,0.0009101792,0.00037760113,0.000018309307,0.0012584073],"genre_scores_gemma":[0.0010153617,0.9919589,0.00016855064,0.00034219198,0.00071922084,0.00027852666,0.00011852561,0.00004667918,0.0053520137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968605,0.0004627685,0.000994889,0.00042887853,0.00042283032,0.0008301544],"domain_scores_gemma":[0.9971502,0.00044411974,0.00078349485,0.00023341186,0.0001776668,0.0012111051],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005176201,0.00050786114,0.0018477999,0.0006985153,0.000201732,0.00007070822,0.00016245937,0.00048152424,0.0024013522],"category_scores_gemma":[0.00023741864,0.0002932792,0.0008577383,0.00039543054,0.00003212373,0.00006467819,0.000016264376,0.0007811605,0.00037504022],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047409092,0.0005158412,0.006460023,0.00083592086,0.0015089611,0.003929139,0.00007686938,0.00007859113,0.0000011767714,0.00006207764,0.005569502,0.9809145],"study_design_scores_gemma":[0.0014941948,0.00073721964,0.0029223848,0.0018458035,0.001884242,0.0005015242,0.0000039766937,0.0000066150883,7.5469507e-7,0.00011660554,0.99022347,0.00026322587],"about_ca_topic_score_codex":0.002763075,"about_ca_topic_score_gemma":0.008410207,"teacher_disagreement_score":0.98465395,"about_ca_system_score_codex":0.019340048,"about_ca_system_score_gemma":0.0036962368,"threshold_uncertainty_score":0.99995196},"labels":[],"label_agreement":null},{"id":"W2570279348","doi":"10.14740/wjnu286w","title":"Comparative Analysis of Robotic-Assisted Partial Nephrectomy Versus Open Partial Nephrectomy During the Initial Robotic Learning Curve: Does the End Justify the Means?","year":2016,"lang":"en","type":"article","venue":"World Journal of Nephrology and Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Renal function; Perioperative; Blood loss; Urology; Surgery; Robotic surgery; Kidney; Internal medicine","score_opus":0.05317199702366841,"score_gpt":0.3301191252177121,"score_spread":0.27694712819404366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570279348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9704857,0.001387801,0.00031894256,0.025871718,0.00060371315,0.00065003376,0.0000040928485,0.000012474386,0.0006655292],"genre_scores_gemma":[0.997804,0.00018675995,0.00011482149,0.00096420496,0.0005481067,0.00005720471,0.000004391782,0.000017196578,0.0003033312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99578935,0.0020567817,0.0009367936,0.00034278113,0.00034615572,0.0005281208],"domain_scores_gemma":[0.99469817,0.0034419699,0.0009935072,0.00045355043,0.00024996145,0.00016284113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012212924,0.00032863027,0.0013064721,0.00038896216,0.00054402166,0.000049089766,0.000599744,0.0001608181,0.0006317539],"category_scores_gemma":[0.00021050475,0.00012172955,0.00040649137,0.0007394088,0.0015870843,0.00016402622,0.00029981657,0.000945596,0.0000074235754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17992759,0.0019007501,0.56536347,0.000115540104,0.079450995,0.0029085989,0.011215925,0.063320704,0.058765277,0.009906863,0.0029889343,0.024135344],"study_design_scores_gemma":[0.012043566,0.0031767697,0.9185337,0.00003689657,0.0173804,0.0013073084,0.0005083269,0.0018645425,0.0025169088,0.00013281302,0.042257797,0.00024097919],"about_ca_topic_score_codex":0.00011015847,"about_ca_topic_score_gemma":0.0014393356,"teacher_disagreement_score":0.35317022,"about_ca_system_score_codex":0.00007819963,"about_ca_system_score_gemma":0.00018493773,"threshold_uncertainty_score":0.6917262},"labels":[],"label_agreement":null},{"id":"W2570489675","doi":"10.5489/cuaj.1999","title":"Mortality trends and the impact of lymphadenectomy on survival for renal cell carcinoma patients with distant metastasis","year":2016,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Institutes of Health; National Center for Advancing Translational Sciences; Johns Hopkins University","keywords":"Renal cell carcinoma; Lymphadenectomy; Medicine; Distant metastasis; Metastasis; Oncology; Carcinoma; Internal medicine; General surgery; Cancer","score_opus":0.01777912825394114,"score_gpt":0.2458375608745496,"score_spread":0.22805843262060846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570489675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99521214,0.00007890591,0.000049572784,0.0031794505,0.00005364091,0.00025100922,0.00028577406,0.0000044380317,0.0008850719],"genre_scores_gemma":[0.99948835,0.000009118896,0.000038134494,0.00013744319,0.000093418894,0.000014980491,0.00002153664,0.000011398521,0.00018561125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985481,0.00022803237,0.00029794764,0.00018262515,0.00038906856,0.00035423436],"domain_scores_gemma":[0.998245,0.00046220544,0.00035500634,0.00014011645,0.00030389088,0.00049376773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063231285,0.00016337265,0.00039952353,0.00013374517,0.000146169,0.000027204485,0.00007559549,0.00009346362,0.00014003209],"category_scores_gemma":[0.0002752891,0.000062558836,0.00025931452,0.00013616792,0.0000915369,0.000048687612,0.000008069216,0.000118549615,0.0000014920552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013736729,0.00011327272,0.9948541,0.0000032242274,0.00031136128,0.00001898229,0.000041505566,0.000007954644,0.000056306635,0.000095059106,0.00049466663,0.0026299092],"study_design_scores_gemma":[0.010846434,0.0024145206,0.9856349,0.000008752588,0.00032515798,0.000014746872,0.000009464585,0.000012974421,0.00021118986,0.00022164521,0.00021954878,0.00008067034],"about_ca_topic_score_codex":0.0018144647,"about_ca_topic_score_gemma":0.00043527596,"teacher_disagreement_score":0.009472761,"about_ca_system_score_codex":0.0013074422,"about_ca_system_score_gemma":0.00033198166,"threshold_uncertainty_score":0.3418916},"labels":[],"label_agreement":null},{"id":"W2570623839","doi":"10.5489/cuaj.4282","title":"Kidney cancer, ESMO 2016","year":2016,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Kidney cancer; Cancer; Medicine; Kidney; Oncology; Internal medicine","score_opus":0.038634215267692174,"score_gpt":0.29792228389154707,"score_spread":0.2592880686238549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570623839","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015313146,0.9797679,0.0000047588514,0.011165126,0.0010934005,0.00050394295,0.00034213706,0.000031476753,0.0070758983],"genre_scores_gemma":[0.000044212768,0.9796662,0.000051898507,0.0032199235,0.002401076,0.000075148244,0.000093789226,0.000052285875,0.0143954875],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969857,0.00039567312,0.0007930326,0.00039273535,0.00054141844,0.0008914398],"domain_scores_gemma":[0.99518585,0.00026385864,0.00091113837,0.00024538723,0.00031778982,0.0030759799],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006324475,0.00045447124,0.0017150417,0.00043505663,0.00024665636,0.00009334643,0.00024583814,0.0010019403,0.004986254],"category_scores_gemma":[0.00111991,0.00025667343,0.0009850062,0.00025374797,0.00003961622,0.000066480614,0.000025079893,0.0012110297,0.0013735655],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000009447747,0.000028409184,0.0027233893,0.00037304976,0.0007753028,0.00067578966,0.000007000335,8.418277e-8,1.8044368e-7,0.000030745003,0.23756666,0.75780994],"study_design_scores_gemma":[0.0005766323,0.00019848898,0.0012931147,0.003967741,0.0013794814,0.000996374,0.0000012650829,3.7348417e-7,2.5162248e-7,0.000086686225,0.9912372,0.0002623503],"about_ca_topic_score_codex":0.0013208993,"about_ca_topic_score_gemma":0.00021004972,"teacher_disagreement_score":0.7575476,"about_ca_system_score_codex":0.010432487,"about_ca_system_score_gemma":0.00956018,"threshold_uncertainty_score":0.99998856},"labels":[],"label_agreement":null},{"id":"W2571191689","doi":"10.5489/cuaj.4295","title":"Practical first-line management of renal cell carcinoma in a community practice","year":2016,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"William Osler Health System","funders":"","keywords":"Sunitinib; Medicine; Dosing; Renal cell carcinoma; Toxicity; Schedule; Quality of life (healthcare); Tyrosine-kinase inhibitor; Oncology; Internal medicine; Vascular endothelial growth factor; Cancer; Intensive care medicine; VEGF receptors; Nursing","score_opus":0.06936866295086051,"score_gpt":0.3301862605164727,"score_spread":0.2608175975656122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571191689","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013470125,0.9683543,0.00005023549,0.009563185,0.00027016443,0.0012426926,0.00011339726,0.000016103219,0.019042896],"genre_scores_gemma":[0.0237498,0.9735879,0.000907343,0.0004971831,0.00028116646,0.000054434862,0.00007691752,0.000042620795,0.0008026625],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99490905,0.0020206738,0.0013338412,0.00030238685,0.00071507326,0.0007189654],"domain_scores_gemma":[0.99461335,0.0019472706,0.0016871397,0.0004225576,0.00039722823,0.0009324719],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002774192,0.00042509713,0.0017028622,0.0005469287,0.00021830478,0.000048418187,0.00027685106,0.00075837225,0.00045558112],"category_scores_gemma":[0.0014063749,0.0002845206,0.0006162512,0.00046256237,0.000059387206,0.00013844401,0.00008464896,0.0027715955,0.00014350067],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086501514,0.0045410166,0.021903051,0.018731715,0.004098182,0.036398597,0.00046227567,0.000017792403,0.0000016332184,0.001027672,0.036739945,0.8752131],"study_design_scores_gemma":[0.0016352884,0.001053825,0.0068995873,0.0030508891,0.0021917012,0.0020115569,0.000068146575,0.0000028263637,0.0000013918784,0.00009354042,0.98273736,0.00025386232],"about_ca_topic_score_codex":0.0015292424,"about_ca_topic_score_gemma":0.0006573836,"teacher_disagreement_score":0.9459974,"about_ca_system_score_codex":0.0065025724,"about_ca_system_score_gemma":0.0017843083,"threshold_uncertainty_score":0.9999607},"labels":[],"label_agreement":null},{"id":"W2572214220","doi":"10.1016/j.urology.2017.01.006","title":"Commentary on: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma After Nephrectomy","year":2017,"lang":"en","type":"letter","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Nephrectomy; Adjuvant; Placebo; Internal medicine; Oncology; Urology; Kidney disease; Clear cell renal cell carcinoma; Kidney; Pathology","score_opus":0.016268662601239242,"score_gpt":0.24161902972247537,"score_spread":0.22535036712123613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572214220","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52773744,0.001274181,0.0000028201682,0.46313864,0.00069978816,0.0008585979,0.00019345684,0.00004764206,0.006047455],"genre_scores_gemma":[0.48313493,0.000074391566,0.00008771861,0.50946313,0.0031785131,0.00025781785,0.0012749602,0.0001116703,0.002416844],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961801,0.0005873727,0.00063861406,0.0010921987,0.00047013414,0.0010315924],"domain_scores_gemma":[0.996723,0.00044348164,0.00047305026,0.002091654,0.000076861565,0.00019192888],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00023161406,0.0008155264,0.0014761242,0.00066508364,0.000109768785,0.000031159758,0.0004437599,0.0014523217,0.0011117834],"category_scores_gemma":[0.00004659479,0.0006869149,0.00036117833,0.00009028613,0.00031213288,0.00004964993,0.00022668544,0.004236632,0.00077836844],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016007555,0.00025602468,0.04828107,0.00015208326,0.00013776823,0.08004441,0.000114931485,0.0000042817865,0.000026781465,0.0000014596972,0.86836606,0.0010143602],"study_design_scores_gemma":[0.0070297,0.0040892614,0.09017265,0.00007696764,0.0009084086,0.0005475334,0.000005782325,0.000012941631,0.00058515166,0.00012896121,0.8959236,0.0005190456],"about_ca_topic_score_codex":0.0026659984,"about_ca_topic_score_gemma":0.0002881625,"teacher_disagreement_score":0.079496875,"about_ca_system_score_codex":0.0004032419,"about_ca_system_score_gemma":0.00016584362,"threshold_uncertainty_score":0.99999964},"labels":[],"label_agreement":null},{"id":"W2572922053","doi":"10.1200/jco.2016.69.9645","title":"Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":376,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; American Society of Clinical Oncology; National Cancer Coalition","keywords":"Medicine; Guideline; Nephrology; Kidney disease; Nephrectomy; Internal medicine; Intensive care medicine; Renal function; Observational study; Clinical trial; Surgery; Kidney; Pathology","score_opus":0.34390507024286443,"score_gpt":0.5798912535917476,"score_spread":0.23598618334888322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572922053","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8737334,0.0008348509,0.00284301,0.061446704,0.004360936,0.00086157327,0.000015473363,0.000020471802,0.055883553],"genre_scores_gemma":[0.46292078,0.0123011125,0.5141166,0.0061134286,0.0035959415,0.000007477962,0.000008185541,0.000049171227,0.0008873414],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97729343,0.0028262767,0.017508358,0.0006797626,0.001150396,0.0005417968],"domain_scores_gemma":[0.9506422,0.013313798,0.03042176,0.0015503641,0.0029210902,0.0011507807],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.037711363,0.00039014794,0.0068522124,0.00012879558,0.00011538664,0.000017759596,0.0011003352,0.0011289968,0.00016369675],"category_scores_gemma":[0.021977188,0.00027709611,0.004229175,0.00017420277,0.003129579,0.00023944369,0.00063741056,0.0030257662,0.000031218475],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020634707,0.014403449,0.19593,0.0001657107,0.0067656045,0.0047514047,0.0000613025,0.000019929243,0.00006371084,0.00025317835,0.04729542,0.7096556],"study_design_scores_gemma":[0.015970029,0.05112273,0.3876174,0.00024744804,0.0037964934,0.0005851174,0.0006877047,0.00019128951,0.00007120501,0.00016358148,0.5393919,0.00015511033],"about_ca_topic_score_codex":0.00019604337,"about_ca_topic_score_gemma":0.00004979422,"teacher_disagreement_score":0.7095005,"about_ca_system_score_codex":0.0003239331,"about_ca_system_score_gemma":0.0047517484,"threshold_uncertainty_score":0.9999681},"labels":[],"label_agreement":null},{"id":"W2573089847","doi":"10.1016/j.clgc.2017.01.005","title":"Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma","year":2017,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Queen Elizabeth II Health Sciences Centre; University of Alberta; University of British Columbia; BC Cancer Agency; Dalhousie University","funders":"National Cancer Institute","keywords":"Medicine; Renal cell carcinoma; Oncology; Toxicity; VEGF receptors; Internal medicine; Targeted therapy; Second-line therapy; Cancer; Chemotherapy","score_opus":0.11363597456475641,"score_gpt":0.4247044064405806,"score_spread":0.3110684318758242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573089847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98919773,0.006861031,0.000014498227,0.00076493545,0.0008815595,0.0018088188,0.00006306502,0.000026101892,0.0003822391],"genre_scores_gemma":[0.9955446,0.00046169566,0.0021778543,0.00010696675,0.00041735935,0.00039816592,0.0000311756,0.00005375511,0.00080843223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773514,0.00018736292,0.0007805831,0.00055390876,0.0003115043,0.00043151996],"domain_scores_gemma":[0.99735445,0.00081236725,0.000660364,0.00084381574,0.00013017231,0.00019884498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060458423,0.00033993088,0.0011029075,0.00010530275,0.00014830286,0.000030877298,0.00030021407,0.00014759916,0.00014198013],"category_scores_gemma":[0.00023589031,0.0002330613,0.000551932,0.00007133629,0.00026935065,0.0001475517,0.00011495439,0.00031974557,0.0000031307854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015916541,0.001992561,0.8867404,0.00035858806,0.00046599988,0.00029614833,0.00042839095,0.000010220948,0.032118827,0.000004572861,0.0003480892,0.061319645],"study_design_scores_gemma":[0.019548142,0.0066205617,0.86002743,0.00016378827,0.00020106886,0.000003277634,0.00010560859,0.00010300202,0.11251773,0.000052642623,0.00043889383,0.00021784533],"about_ca_topic_score_codex":0.00006876545,"about_ca_topic_score_gemma":0.00017862063,"teacher_disagreement_score":0.0803989,"about_ca_system_score_codex":0.00012879069,"about_ca_system_score_gemma":0.00025499123,"threshold_uncertainty_score":0.9503964},"labels":[],"label_agreement":null},{"id":"W2574286987","doi":"10.1016/j.ebiom.2017.01.012","title":"Downregulation of PDZ Domain Containing 1 (PDZK1) is a Poor Prognostic Marker for Clear Cell Renal Cell Carcinoma","year":2017,"lang":"en","type":"letter","venue":"EBioMedicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Clear cell renal cell carcinoma; PDZ domain; Renal cell carcinoma; Biomarker; Clear cell carcinoma; Oncology; Medicine; Disease; Clear cell; Internal medicine; Cancer; Kidney cancer; Bioinformatics; Cancer research; Biology; Genetics","score_opus":0.024284585829775378,"score_gpt":0.26225064729890685,"score_spread":0.23796606146913146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574286987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5452814,0.0051980163,0.0008304962,0.4141198,0.0013068793,0.009570203,0.0008543762,0.00017434063,0.022664469],"genre_scores_gemma":[0.88899386,0.000031406355,0.004937373,0.06607146,0.0072099403,0.00039811243,0.0044748145,0.00030209642,0.027580954],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953214,0.00013466082,0.0012198688,0.0011312262,0.001238402,0.00095446734],"domain_scores_gemma":[0.9956759,0.0005314119,0.0013925661,0.001545243,0.00054551713,0.0003093295],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006876844,0.00089427887,0.0019150542,0.00074127037,0.00021274098,0.000040913474,0.00043032426,0.0011053669,0.00047809188],"category_scores_gemma":[0.00015288644,0.00070260145,0.0006352744,0.00021584048,0.0005008479,0.00007649254,0.00012937088,0.0011008959,0.00006561146],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028434396,0.00029997926,0.005307116,0.0056767487,0.0003589215,0.0027926352,0.0009012938,4.3075718e-7,0.054264035,0.0000036087763,0.92580324,0.0017485336],"study_design_scores_gemma":[0.022143975,0.014788155,0.06287449,0.0026667616,0.004260634,0.0005507234,0.00025323924,0.0002749332,0.03619915,0.00021534911,0.85467505,0.0010975453],"about_ca_topic_score_codex":0.00023565118,"about_ca_topic_score_gemma":0.000004183083,"teacher_disagreement_score":0.34804833,"about_ca_system_score_codex":0.00044111037,"about_ca_system_score_gemma":0.00051354,"threshold_uncertainty_score":0.99954253},"labels":[],"label_agreement":null},{"id":"W2576883525","doi":"10.1200/jco.2014.32.4_suppl.477","title":"Neutrophil to lymphocyte ratio and response to tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Sunitinib; Internal medicine; Renal cell carcinoma; Sorafenib; Gastroenterology; Oncology; Tyrosine-kinase inhibitor; Neutrophil to lymphocyte ratio; Lymphocyte; Response Evaluation Criteria in Solid Tumors; Progressive disease; Cancer; Disease; Hepatocellular carcinoma","score_opus":0.08616720757808899,"score_gpt":0.4004625786739059,"score_spread":0.3142953710958169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576883525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98304105,0.0008030203,0.00020890262,0.014619961,0.00047838417,0.00047408507,0.0000022889303,0.000005950351,0.00036634918],"genre_scores_gemma":[0.9829329,0.00016894453,0.00907482,0.0066564265,0.00077931513,0.000013330114,0.0000012388463,0.000027248085,0.00034576564],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.995396,0.0015132313,0.0020802398,0.00031066642,0.00039050728,0.00030931432],"domain_scores_gemma":[0.99501526,0.0027516123,0.00065364526,0.0002931697,0.00032271806,0.00096360856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050864806,0.00021583209,0.0015558081,0.00040296733,0.00003324812,0.000016628235,0.00013488054,0.000177961,0.000042572392],"category_scores_gemma":[0.0028707986,0.00014839279,0.00026592438,0.00027727254,0.000097843105,0.00007538288,0.00006900889,0.00050386554,0.000036141653],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28580058,0.0056275576,0.107825324,0.00007989844,0.00024727397,0.00936178,0.001399752,0.00044736368,0.28463873,0.00006265655,0.006424944,0.29808414],"study_design_scores_gemma":[0.030137375,0.09391247,0.8008659,0.00010172662,0.0002124859,0.0005956163,0.00008726855,0.00013815357,0.026126448,0.000083602084,0.047549933,0.00018903564],"about_ca_topic_score_codex":0.00005035129,"about_ca_topic_score_gemma":0.000040182815,"teacher_disagreement_score":0.69304055,"about_ca_system_score_codex":0.00046185797,"about_ca_system_score_gemma":0.0014429789,"threshold_uncertainty_score":0.6051282},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"agree"},{"id":"W2579668215","doi":"10.1016/j.anndiagpath.2017.01.005","title":"Warthin-like papillary renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 11 cases","year":2017,"lang":"en","type":"article","venue":"Annals of Diagnostic Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Royal Columbian Hospital","funders":"","keywords":"Pathology; Immunohistochemistry; Oncocytoma; MSH6; Biology; Vimentin; CD117; MSH2; PAX8; Medicine; Cancer; DNA mismatch repair; Colorectal cancer","score_opus":0.05328180286906456,"score_gpt":0.3281681042574224,"score_spread":0.2748863013883578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579668215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797157,0.018516088,0.000077842175,0.00050612754,0.000114086186,0.00041617546,0.00008909148,0.000020743184,0.0005441548],"genre_scores_gemma":[0.99486834,0.0025123137,0.0017645622,0.00059219537,0.00003502795,0.000048493017,0.00009418169,0.000026788635,0.00005810838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99741465,0.00024817628,0.0008873973,0.0006868267,0.00030223894,0.0004606958],"domain_scores_gemma":[0.99549294,0.0015594959,0.00084032357,0.0015415441,0.0003372993,0.0002284034],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046731048,0.00035422912,0.0014599446,0.0003632468,0.00012215361,0.000012628092,0.00033528756,0.0003407475,0.00009909919],"category_scores_gemma":[0.0035157292,0.0002972984,0.0005264304,0.00017943102,0.0011383597,0.000050899183,0.00033440042,0.0002322462,0.000008638847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026772587,0.0007300209,0.7398663,0.00015929528,0.00030293525,0.029958345,0.00021367802,0.00003155831,0.22651777,0.00003588654,0.00038759923,0.0015288512],"study_design_scores_gemma":[0.0010625953,0.0021799544,0.7926784,0.00004352939,0.002723264,0.0010634013,0.000044809436,0.000033375243,0.19977257,0.00016857205,0.000035301622,0.00019423151],"about_ca_topic_score_codex":0.00033211565,"about_ca_topic_score_gemma":0.000014704087,"teacher_disagreement_score":0.052812055,"about_ca_system_score_codex":0.000021482872,"about_ca_system_score_gemma":0.00009966988,"threshold_uncertainty_score":0.9999479},"labels":[],"label_agreement":null},{"id":"W2580256720","doi":"10.4103/0974-7796.198888","title":"Feasibility of laparoscopic partial nephrectomy in the obese patient and assessment of predictors of perioperative outcomes","year":2017,"lang":"en","type":"article","venue":"Urology Annals","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Queen's University","funders":"","keywords":"Medicine; Nephrectomy; Body mass index; Renal function; Perioperative; Comorbidity; Complication; Surgery; Diabetes mellitus; Retrospective cohort study; Kidney disease; Internal medicine; Kidney","score_opus":0.07654001534883617,"score_gpt":0.38577366685292624,"score_spread":0.3092336515040901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580256720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99587125,0.00033075598,0.000001978097,0.0012671527,0.00006166745,0.00068041513,0.000020033163,0.000002427904,0.0017643492],"genre_scores_gemma":[0.99958783,0.000042052645,0.00012628603,0.00015676566,0.00001053671,0.000045141394,0.000004032085,0.0000040050877,0.000023364782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989263,0.00023510182,0.00036179344,0.00016852278,0.00018001799,0.00012829888],"domain_scores_gemma":[0.9989219,0.00016142729,0.00027656934,0.0004992493,0.000102222155,0.000038665272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038806797,0.00010325517,0.0004931954,0.000052941847,0.000043081254,0.0000037318657,0.000105713196,0.00007286447,0.000035948717],"category_scores_gemma":[0.00024899698,0.000059809096,0.000072402414,0.00003157809,0.00047124113,0.00004184234,0.00006125483,0.00012638047,3.1989643e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027136417,0.0004507284,0.9950227,0.000058906935,0.00009623458,0.00001641233,0.001790785,0.0000061478263,0.0017668769,0.00026806296,0.000014063823,0.00023771008],"study_design_scores_gemma":[0.0015962084,0.0021370964,0.9857644,0.000018859313,0.00008623434,0.0000061521528,0.00017437128,0.0000684168,0.009916428,0.00004996692,0.00014894165,0.0000329551],"about_ca_topic_score_codex":0.00016921452,"about_ca_topic_score_gemma":0.00007631423,"teacher_disagreement_score":0.009258336,"about_ca_system_score_codex":0.000012429579,"about_ca_system_score_gemma":0.00009644029,"threshold_uncertainty_score":0.24389441},"labels":[],"label_agreement":null},{"id":"W2583240333","doi":"10.1200/jco.2012.30.5_suppl.358","title":"Conditional survival (CS) for patients with metastatic renal cell carcinoma (mRCC) treated with vascular endothelial growth factor (VEGF)-targeted therapy (TT): Results from the International mRCC Database Consortium.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Surgery; Oncology; Urology","score_opus":0.10404273790826808,"score_gpt":0.3658012201547133,"score_spread":0.2617584822464452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583240333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924701,0.0003566329,0.0005019557,0.0016003943,0.00086487667,0.0010074604,0.0026519417,0.000014708533,0.00053196074],"genre_scores_gemma":[0.98919487,0.0001414028,0.0061033657,0.0009583359,0.0017521303,0.000037685597,0.0016418314,0.000053983593,0.000116372066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99487025,0.0008164778,0.0022069323,0.00040494592,0.0012310846,0.00047029147],"domain_scores_gemma":[0.98642224,0.008778714,0.002336672,0.00040386975,0.0014559164,0.00060257426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019029776,0.00038309555,0.0014816184,0.00012952046,0.00012078758,0.000028002973,0.00037130143,0.00020167316,0.0003330059],"category_scores_gemma":[0.0020544056,0.00018812793,0.00059788936,0.0001382908,0.0003912667,0.00031919297,0.000052611103,0.0007939902,0.000016038612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08289911,0.0074589276,0.8988907,0.000017756753,0.0036732291,0.0003594924,0.00024555394,0.000013194325,0.0010516708,0.00007669572,0.0030724427,0.0022412767],"study_design_scores_gemma":[0.07536749,0.01822162,0.8881908,0.000056769044,0.0013878882,0.00008517743,0.00015458441,0.000039122,0.0040361295,0.000050649338,0.012187461,0.00022231418],"about_ca_topic_score_codex":0.00020305492,"about_ca_topic_score_gemma":0.000051593164,"teacher_disagreement_score":0.010762692,"about_ca_system_score_codex":0.00029950563,"about_ca_system_score_gemma":0.0013308987,"threshold_uncertainty_score":0.76716346},"labels":[],"label_agreement":null},{"id":"W2584985761","doi":"10.1016/j.juro.2016.12.088","title":"Re: Multilocular Cystic Renal Cell Carcinoma: Pathological T Staging Makes No Difference to Favorable Outcomes and Should be Reclassified","year":2017,"lang":"en","type":"letter","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pathological; Renal cell carcinoma; Carcinoma; Pathology; Radiology; Urology; General surgery","score_opus":0.07660493105793119,"score_gpt":0.2959668792246654,"score_spread":0.2193619481667342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584985761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58395904,0.0015393725,0.00017825687,0.41225252,0.0005135227,0.0004526631,0.00002103365,0.000015140739,0.0010684212],"genre_scores_gemma":[0.81637764,0.0001630517,0.00076467893,0.17640959,0.001222876,0.000011273848,0.0000173023,0.00006163804,0.0049719433],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9966732,0.00068470166,0.0008184939,0.00043423646,0.00071741967,0.0006719397],"domain_scores_gemma":[0.9963591,0.0010308779,0.0009814596,0.0010310136,0.00033409812,0.00026342753],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0011101167,0.0005703595,0.0015721807,0.0002929354,0.0002478844,0.00005954653,0.0006580061,0.0007928723,0.000078725934],"category_scores_gemma":[0.00061707204,0.00030357068,0.00031252916,0.000059575832,0.00038141987,0.000041325075,0.00027123163,0.0034554964,0.000024372259],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007983966,0.0006358274,0.15702409,0.0009987045,0.001245433,0.13062865,0.0024328134,0.00008922775,0.038269475,0.000010147343,0.6577809,0.0029007671],"study_design_scores_gemma":[0.0119285965,0.020720202,0.65224826,0.0003865679,0.009087961,0.017029371,0.00028389264,0.00024509695,0.0033940847,0.00057417044,0.28266266,0.0014391405],"about_ca_topic_score_codex":0.00007042932,"about_ca_topic_score_gemma":0.0000075185503,"teacher_disagreement_score":0.49522418,"about_ca_system_score_codex":0.00017500148,"about_ca_system_score_gemma":0.00020931536,"threshold_uncertainty_score":0.99994165},"labels":[],"label_agreement":null},{"id":"W2585144179","doi":"10.1016/j.clgc.2017.01.016","title":"Outcomes and Drug Costs of Sunitinib Regimens for Metastatic Renal Cell Carcinoma: A Provincial Population-Based Study","year":2017,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"Saskatchewan Cancer Agency; Pfizer","keywords":"Medicine; Sunitinib; Dosing; Discontinuation; Renal cell carcinoma; Regimen; Internal medicine; Oncology; Adverse effect; Population; Renal function; Urology","score_opus":0.08856902812750578,"score_gpt":0.4031532497966694,"score_spread":0.3145842216691636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585144179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99525124,0.00041062164,0.00001778019,0.00081192685,0.00034930464,0.00264499,0.00015849939,0.000021797192,0.0003338441],"genre_scores_gemma":[0.99634105,0.000012629544,0.0011722018,0.00016414793,0.0003675677,0.00036402058,0.00005294696,0.000042802512,0.0014826424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788046,0.00017956713,0.00082509214,0.00050183554,0.00032891167,0.00028414032],"domain_scores_gemma":[0.9972524,0.0007943744,0.0006205077,0.00081944955,0.00024638238,0.00026688215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000586693,0.00026284,0.0008781948,0.00008689148,0.00026243215,0.00002959754,0.00018386803,0.000073213756,0.000037681748],"category_scores_gemma":[0.00041316226,0.00020263436,0.00031266152,0.00004242988,0.00015494057,0.00007679876,0.00010264342,0.00020670852,0.0000027256865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019449792,0.0018964766,0.99065554,0.00021635802,0.0001691375,0.00021376919,0.0001016105,0.000009245586,0.00013149172,0.0000060423104,0.00053433795,0.0041210093],"study_design_scores_gemma":[0.0125877755,0.0032640118,0.98123884,0.00006530042,0.0011152719,0.0000048127845,0.00014274445,0.00010868142,0.0011107629,0.00004127459,0.00013518006,0.00018532749],"about_ca_topic_score_codex":0.0019801657,"about_ca_topic_score_gemma":0.00062645826,"teacher_disagreement_score":0.010642796,"about_ca_system_score_codex":0.00015729299,"about_ca_system_score_gemma":0.0004493188,"threshold_uncertainty_score":0.8263189},"labels":[],"label_agreement":null},{"id":"W2585269465","doi":"10.1016/j.jvir.2016.12.673","title":"Radiofrequency ablation of renal cell carcinoma: procedural efficacy and oncologic outcomes","year":2017,"lang":"en","type":"article","venue":"Journal of Vascular and Interventional Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Radiofrequency ablation; Renal cell carcinoma; Percutaneous; Nephrectomy; Radiology; Biopsy; Retrospective cohort study; Ablation; Surgery; Internal medicine; Kidney","score_opus":0.029464276204488736,"score_gpt":0.30545572556703454,"score_spread":0.2759914493625458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585269465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98852915,0.009634437,0.00021244476,0.00061906764,0.00014554533,0.00016850198,0.0000032176795,0.0000025469044,0.00068511895],"genre_scores_gemma":[0.9982743,0.0003813688,0.0010151694,0.000042052794,0.0001257571,0.0000026966416,0.000006137333,0.000007975488,0.0001445409],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988643,0.00009249294,0.00056812924,0.00014498748,0.00020007211,0.00013005047],"domain_scores_gemma":[0.99871916,0.00008790193,0.0007020123,0.00017757658,0.00019316452,0.000120198136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004714369,0.00013190525,0.00057304883,0.0001474013,0.00009701962,0.000016759079,0.00010650252,0.00010085504,0.00005755385],"category_scores_gemma":[0.0002651375,0.00008866685,0.00040269597,0.000021478001,0.00023719964,0.00014264103,0.000043767523,0.00018675119,9.946704e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009871146,0.0009991857,0.956316,0.00048674946,0.001066563,0.0004325132,0.00022518318,0.000020558073,0.028488606,0.0011237478,0.0006857104,0.009168086],"study_design_scores_gemma":[0.005820736,0.0043518487,0.98290545,0.000113146,0.00044110857,0.0026990771,0.000027021844,0.00003816202,0.0027334297,0.00046725463,0.00033229083,0.00007047071],"about_ca_topic_score_codex":0.00002314392,"about_ca_topic_score_gemma":0.0000013778159,"teacher_disagreement_score":0.02658947,"about_ca_system_score_codex":0.000080888865,"about_ca_system_score_gemma":0.00009110098,"threshold_uncertainty_score":0.36157292},"labels":[],"label_agreement":null},{"id":"W2586881663","doi":"10.1007/s11934-017-0653-3","title":"Should Small Renal Masses Be Biopsied?","year":2017,"lang":"en","type":"review","venue":"Current Urology Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Nephrology; Pathological; Biopsy; Incidence (geometry); Renal cell carcinoma; Radiology; Renal biopsy; Internal medicine; Intensive care medicine; Pathology; Surgery","score_opus":0.39196515853238345,"score_gpt":0.441438406236293,"score_spread":0.04947324770390954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586881663","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018843227,0.98669505,0.0000134914235,0.00024473184,0.0037325192,0.0018281854,0.000029756806,0.0001602793,0.007107543],"genre_scores_gemma":[0.00015299507,0.99405175,0.00015314543,0.00008660444,0.0011383503,0.00042161762,0.0013477667,0.00013963303,0.0025081488],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99546903,0.00021255146,0.0016107564,0.0014828047,0.00045439848,0.0007704582],"domain_scores_gemma":[0.9942238,0.00016244352,0.0021362153,0.0028365161,0.00016316239,0.00047789922],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000589407,0.0009931647,0.00392217,0.0004516777,0.00019257945,0.000058003425,0.00032133705,0.0009207551,0.00028458008],"category_scores_gemma":[0.00047214454,0.00071141816,0.0014850785,0.00014096018,0.00034927027,0.000050608338,0.00032470012,0.00139761,0.00014595051],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002937454,0.0003242439,0.0015364682,0.01043422,0.0007106575,0.026687853,0.000014304437,1.1809489e-7,0.0000011835613,0.000022703287,0.00791985,0.952319],"study_design_scores_gemma":[0.00026571416,0.00037708913,0.00022367164,0.0034005372,0.0079090735,0.039021317,7.691202e-7,5.282119e-7,0.000005521228,0.000046856938,0.9482966,0.00045233755],"about_ca_topic_score_codex":0.000017647912,"about_ca_topic_score_gemma":0.000008651346,"teacher_disagreement_score":0.9518667,"about_ca_system_score_codex":0.00026357253,"about_ca_system_score_gemma":0.0013595712,"threshold_uncertainty_score":0.9995337},"labels":[],"label_agreement":null},{"id":"W2587066300","doi":"10.1002/dc.23676","title":"Fine‐needle aspiration findings of <scp>X</scp>p11 translocation renal cell carcinoma metastatic to a hilar lymph node","year":2017,"lang":"en","type":"article","venue":"Diagnostic Cytopathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"TFE3; Renal cell carcinoma; Medicine; Pathology; Nephrectomy; Lymph node; Clear cell; Fine-needle aspiration; Immunohistochemistry; Eosinophilic; Chromosomal translocation; Kidney; Biopsy; Biology; Internal medicine; Gene","score_opus":0.02766466514182987,"score_gpt":0.27016717493224496,"score_spread":0.2425025097904151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587066300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917147,0.0007557985,0.0026069314,0.00081485126,0.00024680136,0.0009443604,0.00006333389,0.000039762173,0.0028134459],"genre_scores_gemma":[0.9956507,0.000031893487,0.0029505475,0.00031911518,0.000122569,0.00018298521,0.00015207968,0.00004890375,0.0005411958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978922,0.00012355173,0.0006017732,0.0005608086,0.00035937224,0.0004623048],"domain_scores_gemma":[0.9970677,0.0011068818,0.00030975643,0.001018767,0.00023527838,0.00026160965],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003979128,0.00032223124,0.00071051903,0.00030219357,0.00019327742,0.000037267342,0.00028733542,0.00014929286,0.00006081323],"category_scores_gemma":[0.0037545445,0.00029827902,0.00019356921,0.00014922058,0.00016932708,0.00012635229,0.0000844724,0.00016347207,0.0002331142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014608118,0.0009912228,0.7360022,0.00051249366,0.00006892571,0.0024324458,0.003333951,0.00022991627,0.24937594,0.0003599439,0.001319745,0.005227125],"study_design_scores_gemma":[0.002426776,0.0011951977,0.72618973,0.00012729054,0.00042085277,0.00030964724,0.00010210804,0.0000972555,0.2686927,0.00012397485,0.00022049167,0.00009395692],"about_ca_topic_score_codex":0.00023137129,"about_ca_topic_score_gemma":0.000055816945,"teacher_disagreement_score":0.019316753,"about_ca_system_score_codex":0.00016602616,"about_ca_system_score_gemma":0.00020759,"threshold_uncertainty_score":0.99994695},"labels":[],"label_agreement":null},{"id":"W2587145330","doi":"10.1093/annonc/mdw373.44","title":"Prognostic ability of HR-QoL parameters in metastatic renal cell carcinoma (mRCC)","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Pazopanib; Internal medicine; Renal cell carcinoma; Sunitinib; Proportional hazards model; Quality of life (healthcare); Oncology; Urology","score_opus":0.11052725328309958,"score_gpt":0.3582128302810531,"score_spread":0.24768557699795352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587145330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923775,0.00051450625,0.00004138652,0.0023934788,0.00006446212,0.0007324252,0.000023021805,0.000010642753,0.0038425652],"genre_scores_gemma":[0.99748355,0.000059410453,0.0020073496,0.0001996276,0.00001701237,0.00006509196,0.000007336006,0.000016676957,0.00014394225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804103,0.0002920155,0.000720004,0.00033007015,0.00025242314,0.00036446273],"domain_scores_gemma":[0.9978389,0.0010084889,0.0003220515,0.000440242,0.00023503769,0.00015528084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058537064,0.00018144683,0.00082591793,0.00022669196,0.000011219476,0.0000013935652,0.00012372,0.000107602325,0.00011558952],"category_scores_gemma":[0.00047414776,0.000116303745,0.00020277528,0.00020910494,0.00032625228,0.00005469652,0.000053979966,0.00011309338,0.000024967263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024469001,0.0038071992,0.6915953,0.00070929225,0.00020773735,0.0008230051,0.00077349774,0.00002074215,0.23678656,0.00013208186,0.00124995,0.061447687],"study_design_scores_gemma":[0.0032761977,0.009921556,0.6112219,0.00010719662,0.00017021995,0.00005501301,0.00008939856,0.000013768124,0.3738275,0.0006664166,0.00054548,0.000105354535],"about_ca_topic_score_codex":0.00027339748,"about_ca_topic_score_gemma":0.00005463308,"teacher_disagreement_score":0.13704093,"about_ca_system_score_codex":0.00012088918,"about_ca_system_score_gemma":0.00040431033,"threshold_uncertainty_score":0.4742729},"labels":[],"label_agreement":null},{"id":"W2587781858","doi":"10.1200/jco.2012.30.15_suppl.4536","title":"An in-depth multicentered population-based analysis of outcomes of patients with metastatic renal cell carcinoma (mRCC) that do not meet eligibility criteria for clinical trials.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; BC Cancer Agency; Princess Margaret Cancer Centre; University of Toronto; Cancer Care Ontario; Sunnybrook Health Science Centre; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Renal cell carcinoma; Clinical trial; Gastroenterology; Population; Surgery; Confidence interval","score_opus":0.34731477682087525,"score_gpt":0.55479961950805,"score_spread":0.20748484268717476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587781858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973146,0.00015199526,0.0004823279,0.00031347934,0.00058467034,0.0009802761,0.00012381,0.0000041115773,0.00004473312],"genre_scores_gemma":[0.97746915,0.000018931532,0.021822356,0.00035940795,0.00018533411,0.000012883317,0.000101324775,0.00002499227,0.0000056103527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98639095,0.004306762,0.007834879,0.00035177806,0.00075902266,0.0003566234],"domain_scores_gemma":[0.9737069,0.016703837,0.0073602614,0.00058285514,0.0010067939,0.00063933857],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.020639382,0.000280504,0.006327579,0.0005921783,0.000023326087,0.000007651341,0.00023099077,0.00034297313,0.00010646515],"category_scores_gemma":[0.010284099,0.00016657854,0.002218422,0.0003520417,0.00020932472,0.00020297046,0.0000310672,0.00045751708,6.521181e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033182684,0.014916478,0.94433147,0.00012039536,0.0022967802,0.00002474866,0.00011412288,0.00010775048,0.000094245835,0.000006051683,0.000053719104,0.0047515365],"study_design_scores_gemma":[0.03272459,0.017782582,0.9342008,0.000045516506,0.013462971,0.000001990489,0.000089245164,0.000828875,0.00067109836,0.000019129446,0.000049777893,0.00012342208],"about_ca_topic_score_codex":0.00015259864,"about_ca_topic_score_gemma":0.00026773682,"teacher_disagreement_score":0.02134003,"about_ca_system_score_codex":0.00024165798,"about_ca_system_score_gemma":0.00075863174,"threshold_uncertainty_score":0.9980527},"labels":[],"label_agreement":null},{"id":"W2588076823","doi":"10.1093/annonc/mdw435.22","title":"genitourinary tumours, non prostate Phase III trial of sunitinib (SU) vs placebo (PBO) as adjuvant treatment for high-risk renal cell carcinoma (RCC) after nephrectomy (S-TRAC)","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; Eisai; GlaxoSmithKline Australia; Exelixis; Roche; Bayer; Novartis; British Microcirculation Society; Pfizer","keywords":"Medicine; Clinical endpoint; Renal cell carcinoma; Adverse effect; Urology; Placebo; Internal medicine; Sunitinib; Nephrectomy; Surgery; Randomized controlled trial; Kidney; Pathology","score_opus":0.04961390079722365,"score_gpt":0.34960734874100846,"score_spread":0.2999934479437848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588076823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98827136,0.0008724616,0.000045309247,0.0025098096,0.0003969217,0.004794587,0.00061004004,0.000036432146,0.0024630607],"genre_scores_gemma":[0.99214554,0.00072898815,0.0009716078,0.00021146219,0.00068161084,0.0012646111,0.00015778052,0.00008143535,0.0037569485],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966023,0.00034670028,0.0011919815,0.00066711765,0.00040504767,0.00078688195],"domain_scores_gemma":[0.99654263,0.0008657774,0.0009524365,0.0006992947,0.00052711775,0.0004127175],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005840652,0.0005346212,0.0016681704,0.00037003978,0.000079874735,0.00000809456,0.00018282642,0.0003206324,0.00036512152],"category_scores_gemma":[0.00011062315,0.0003483254,0.0006065718,0.00016336737,0.00031067745,0.00011852613,0.0000797725,0.00017332275,0.000045352106],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80546,0.010619251,0.00417034,0.00022040932,0.00057456875,0.0020025962,0.001248614,0.000003246749,0.054426573,0.000028512612,0.0052565737,0.11598933],"study_design_scores_gemma":[0.29177642,0.18332848,0.008462366,0.000121798024,0.001021422,0.00014913469,0.00013163875,0.000006755294,0.49952966,0.00016378133,0.015035758,0.00027277687],"about_ca_topic_score_codex":0.0009620734,"about_ca_topic_score_gemma":0.00008167719,"teacher_disagreement_score":0.51368356,"about_ca_system_score_codex":0.00030370028,"about_ca_system_score_gemma":0.0010782355,"threshold_uncertainty_score":0.9998969},"labels":[],"label_agreement":null},{"id":"W2588114211","doi":"10.1016/j.urolonc.2017.01.018","title":"Erratum to “The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System” [Urol Oncol 34(11) (2016) 486.e1–486.e7]","year":2017,"lang":"en","type":"erratum","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; McGill University; University of Ottawa; Princess Margaret Cancer Centre; University of Calgary; University Health Network; Dalhousie University; University of Toronto; McMaster University; University of Alberta; Université Laval; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Natural history; Renal cell carcinoma; Cancer; Kidney cancer; Renal function; Kidney; Function (biology); Urology; General surgery; Oncology; Internal medicine; Biology","score_opus":0.0218521363317264,"score_gpt":0.2539814095709124,"score_spread":0.23212927323918603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588114211","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3915229,0.053942822,0.000047114976,0.07145114,0.065671414,0.011419665,0.008565922,0.00020822258,0.39717078],"genre_scores_gemma":[0.7802192,0.0011848353,0.002262261,0.0052288147,0.0028906194,0.001664271,0.00586021,0.00008187932,0.20060791],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99636656,0.00041489588,0.0012106586,0.0006861312,0.0007106817,0.0006110589],"domain_scores_gemma":[0.99595314,0.00024550728,0.0013789376,0.0011578852,0.0004469051,0.00081762666],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00087903946,0.0005989244,0.0010200499,0.00039902618,0.0005129936,0.000050746003,0.0005442443,0.0009915748,0.00012020309],"category_scores_gemma":[0.00015824617,0.00037873472,0.00026750873,0.00024739074,0.0011147772,0.00020434386,0.00018352683,0.0014949696,0.000040011048],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.001720876,0.000080656195,0.006404742,0.00039546454,0.00033126425,0.00060140045,0.0013065288,0.00007413737,0.000018743165,0.00028452498,0.9882427,0.00053897453],"study_design_scores_gemma":[0.0022390946,0.0017231127,0.019189378,0.0008936952,0.0025449123,0.00015998869,0.00032285048,0.0003647705,0.000042552776,0.00005307309,0.9721526,0.0003140052],"about_ca_topic_score_codex":0.10150022,"about_ca_topic_score_gemma":0.05799206,"teacher_disagreement_score":0.38869628,"about_ca_system_score_codex":0.004329872,"about_ca_system_score_gemma":0.007895492,"threshold_uncertainty_score":0.9998665},"labels":[],"label_agreement":null},{"id":"W2588171532","doi":"10.1093/annonc/mdw373.54","title":"Clinical outcomes and dosing patterns of 2nd targeted therapy in metastatic renal carcinoma: a retrospective chart review in the EU","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novartis Pharmaceuticals Canada","keywords":"Medicine; Pazopanib; Sunitinib; Sorafenib; Renal cell carcinoma; Axitinib; Hazard ratio; Internal medicine; Oncology; Targeted therapy; Proportional hazards model; Everolimus; Dosing; Progression-free survival; Temsirolimus; Cancer; Overall survival; Confidence interval; Hepatocellular carcinoma","score_opus":0.15936970711736387,"score_gpt":0.4342919707927113,"score_spread":0.27492226367534744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588171532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96323144,0.015071047,0.000004147948,0.020549614,0.00004163496,0.00073344156,0.000015211228,0.000003378711,0.00035010974],"genre_scores_gemma":[0.9679927,0.029030519,0.0001287307,0.0027302133,0.000026962349,0.00004209056,0.000005486121,0.000009718854,0.000033546916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790365,0.0006402647,0.0007980042,0.00024673002,0.00019896828,0.0002123899],"domain_scores_gemma":[0.99837756,0.0008344944,0.00031370143,0.0002922648,0.00012673435,0.00005527029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014770824,0.0001408347,0.001091725,0.00012673433,0.000010673094,0.0000014876316,0.000090597096,0.0000716817,0.000065473054],"category_scores_gemma":[0.0003547798,0.00006725938,0.00017072378,0.00015488087,0.00015908439,0.00004185089,0.000025778185,0.00013326143,0.0000017071691],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036130246,0.0006981888,0.9612703,0.0001516622,0.000110317145,0.00023445078,0.0005012928,2.5331882e-8,0.00079519686,0.000074446616,0.0002926444,0.035510182],"study_design_scores_gemma":[0.004182826,0.0059373076,0.98611635,0.0006262126,0.00007053575,0.00005262311,0.00008819423,0.000001030469,0.0013908976,0.00016797817,0.001305719,0.00006031772],"about_ca_topic_score_codex":0.00025769006,"about_ca_topic_score_gemma":0.00015225554,"teacher_disagreement_score":0.035449866,"about_ca_system_score_codex":0.000050606366,"about_ca_system_score_gemma":0.000113751456,"threshold_uncertainty_score":0.2742758},"labels":[],"label_agreement":null},{"id":"W2588308728","doi":"10.1159/000455970","title":"Outcome of Patients with Renal Cell Carcinoma and Multiple Glandular Metastases Treated with Targeted Agents","year":2017,"lang":"en","type":"article","venue":"Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Renal cell carcinoma; Gastroenterology; Internal medicine; Carcinoma; Urology","score_opus":0.03162105037521835,"score_gpt":0.28011972940118934,"score_spread":0.248498679025971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588308728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971051,0.00012275547,0.00000894308,0.00007467617,0.000028905371,0.00059982395,0.000080784106,0.00001699867,0.0019620082],"genre_scores_gemma":[0.9976268,0.0000053802733,0.0016291298,0.000050776478,0.000020775931,0.000019339583,0.00020200486,0.000026095267,0.00041971004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892825,0.00006664161,0.0002445318,0.00030180067,0.00021834,0.00024046181],"domain_scores_gemma":[0.99878484,0.00006325778,0.00030839094,0.0005073236,0.00015972575,0.00017645978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007714921,0.00020700815,0.00059516047,0.000086575405,0.00012170796,0.000010902241,0.00009491229,0.00009110831,0.00007286806],"category_scores_gemma":[0.000044925688,0.00012262496,0.000048198515,0.000044117165,0.00023475927,0.00006435451,0.000058188598,0.00010730397,0.0000058985547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002486075,0.0008323902,0.99346405,0.00006921111,0.0001574058,0.00056587893,0.00009243875,0.0000033695876,0.0014650583,0.0000021853434,0.00010626076,0.00075565284],"study_design_scores_gemma":[0.014985413,0.009744766,0.9469773,0.000020432459,0.00059919286,0.00003302959,0.000036604757,0.000033318956,0.026537588,0.0000013471686,0.0009127278,0.0001182654],"about_ca_topic_score_codex":0.0009071024,"about_ca_topic_score_gemma":0.0001963367,"teacher_disagreement_score":0.046486758,"about_ca_system_score_codex":0.00011172874,"about_ca_system_score_gemma":0.00007860991,"threshold_uncertainty_score":0.50005007},"labels":[],"label_agreement":null},{"id":"W2588397197","doi":"10.1093/annonc/mdw370.55","title":"A phase 1 study evaluating the pharmacokinetics (PK) and safety of regorafenib (REG) in patients with advanced solid tumors with severe renal impairment (SRI)","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Juravinski Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Pharmacokinetics; Renal function; Urology; Adverse effect; Creatinine; Clinical endpoint; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Dosing; Internal medicine; Gastroenterology; Chemotherapy; Randomized controlled trial","score_opus":0.05591337534715176,"score_gpt":0.4009282352519746,"score_spread":0.34501485990482283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588397197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960588,0.00015716728,0.000010041521,0.001271511,0.000019598567,0.0019336429,0.000020854186,0.000008045286,0.00052031653],"genre_scores_gemma":[0.9991117,0.000072537005,0.00049566274,0.00015884449,0.00002031438,0.000055683104,0.0000074365175,0.000017848588,0.00005995221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821675,0.00024535906,0.0005319007,0.00029246724,0.00043324553,0.00028027885],"domain_scores_gemma":[0.99848694,0.00024844467,0.00044380457,0.000307271,0.00040968484,0.000103882376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058031763,0.00019662081,0.0006104336,0.000109668494,0.000036079677,0.0000019831202,0.0000913304,0.00004323925,0.000035691224],"category_scores_gemma":[0.00006729166,0.00008926402,0.000040192463,0.0001894699,0.00021850283,0.00006113417,0.00006481346,0.00011735368,9.297554e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11857529,0.020580087,0.4980122,0.0001744838,0.00096599077,0.00035409743,0.0052826274,0.00036834783,0.014181401,0.000015083386,0.00022543609,0.34126493],"study_design_scores_gemma":[0.09622563,0.31307942,0.56636006,0.00059340266,0.00039772168,0.000080265345,0.0010297714,0.000068184294,0.021781238,0.000024624194,0.00017092747,0.00018879233],"about_ca_topic_score_codex":0.00002593852,"about_ca_topic_score_gemma":0.000032938013,"teacher_disagreement_score":0.34107617,"about_ca_system_score_codex":0.00009384517,"about_ca_system_score_gemma":0.00025913765,"threshold_uncertainty_score":0.3640081},"labels":[],"label_agreement":null},{"id":"W2588674466","doi":"10.1136/bcr-2016-218107","title":"Tumour thrombus of the inferior vena cava extending into the right atrium in the setting of colon cancer","year":2017,"lang":"en","type":"article","venue":"BMJ Case Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Inferior vena cava; Thrombus; Radiology; Colorectal cancer; Asymptomatic; Autopsy; Lesion; Cancer; Right atrium; Surgery; Internal medicine","score_opus":0.02908941887665176,"score_gpt":0.3449043456805083,"score_spread":0.31581492680385653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588674466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919843,0.001103537,0.0000013649818,0.0021574732,0.00033017856,0.0012425672,0.0000028874372,0.0000066018238,0.0031711014],"genre_scores_gemma":[0.99945,0.000037596852,0.00005149594,0.000070874004,0.00015380495,0.00008761177,0.0000019491174,0.000016418755,0.00013023251],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839985,0.00014123852,0.00060447596,0.00021937385,0.0004343484,0.00020069728],"domain_scores_gemma":[0.9971999,0.00016627448,0.0011096267,0.0013639301,0.000119596,0.000040676015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012968355,0.00014801873,0.00035817584,0.000043298518,0.00030421713,0.00002438823,0.000142097,0.000060680497,0.000035150148],"category_scores_gemma":[0.00050902186,0.000064075815,0.00017351966,0.00011897477,0.00019016604,0.000057962803,0.0001435027,0.00021226061,9.306614e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012801487,0.00018679828,0.66392905,0.00041482766,0.0001704926,0.27372128,0.009986218,0.000068714755,0.045809265,0.000057046782,0.0008968713,0.0046314104],"study_design_scores_gemma":[0.00048846164,0.0001099398,0.80406696,0.00055677345,0.00033505054,0.11553186,0.0008583601,0.000070683265,0.077192895,0.00009710745,0.0005966123,0.00009529388],"about_ca_topic_score_codex":0.010832444,"about_ca_topic_score_gemma":0.0029067013,"teacher_disagreement_score":0.15818942,"about_ca_system_score_codex":0.00017056656,"about_ca_system_score_gemma":0.0003142348,"threshold_uncertainty_score":0.9957545},"labels":[],"label_agreement":null},{"id":"W2588980997","doi":"10.1093/annonc/mdw373.41","title":"Efficacy of cabozantinib (cabo) vs everolimus (eve) by metastatic site and tumor burden in patients (pts) with advanced renal cell carcinoma (RCC) in the phase 3 METEOR trial","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta","funders":"","keywords":"Medicine; Cabozantinib; Internal medicine; Progression-free survival; Renal cell carcinoma; Target lesion; Gastroenterology; Oncology; Everolimus; Urology; Surgery; Overall survival; Myocardial infarction","score_opus":0.04003420815654439,"score_gpt":0.3361023108916654,"score_spread":0.296068102735121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588980997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958584,0.0005162928,0.0000044362428,0.0011262451,0.000040453524,0.0016311456,0.0000800818,0.000005650725,0.0007373006],"genre_scores_gemma":[0.99906087,0.0000733445,0.00024967003,0.0003207742,0.000035599875,0.00008398212,0.000041479743,0.000022698348,0.0001115709],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99764293,0.000529415,0.000718755,0.00036815522,0.0003594438,0.0003813154],"domain_scores_gemma":[0.99788344,0.000998392,0.00045750823,0.0003651658,0.00017888044,0.000116591575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000665454,0.00024145126,0.0009432359,0.00023678722,0.000022910763,0.0000035251317,0.00014661056,0.00007172913,0.00005003846],"category_scores_gemma":[0.000259576,0.00012808772,0.00009730029,0.00027098283,0.00022473467,0.0000894867,0.000046131885,0.00017231089,0.0000060555603],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.66309845,0.017801462,0.102037184,0.0004039401,0.00036152167,0.0013651275,0.0051341397,0.000019844487,0.10230117,0.000028970328,0.0034749925,0.10397322],"study_design_scores_gemma":[0.5517499,0.100874946,0.24210908,0.00023932473,0.00042411484,0.000051554547,0.00032580268,0.000018139477,0.09960539,0.000034752484,0.0042801867,0.00028684214],"about_ca_topic_score_codex":0.00031715896,"about_ca_topic_score_gemma":0.000073959294,"teacher_disagreement_score":0.14007188,"about_ca_system_score_codex":0.000059646354,"about_ca_system_score_gemma":0.00022091377,"threshold_uncertainty_score":0.5223265},"labels":[],"label_agreement":null},{"id":"W2589024279","doi":"10.1093/annonc/mdw373.46","title":"Real world outcomes of patients with metastatic renal cell carcinoma (mRCC) using first-line sunitinib or pazopanib: the Canadian experience","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Juravinski Cancer Centre; Montreal General Hospital; Ottawa Regional Cancer Foundation; Health Sciences Centre; CancerCare Manitoba; Ottawa Hospital; BC Cancer Agency; University of Calgary; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; McGill University; University of Alberta","funders":"","keywords":"Sunitinib; Pazopanib; Medicine; Renal cell carcinoma; Hazard ratio; Mucositis; Internal medicine; Oncology; Proportional hazards model; Urology; Toxicity; Confidence interval","score_opus":0.1504262990127663,"score_gpt":0.36758658108210895,"score_spread":0.21716028206934265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589024279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99308133,0.000057055222,0.000011310739,0.0026120595,0.000070824615,0.00055818475,0.000084914675,0.0000081732105,0.00351617],"genre_scores_gemma":[0.9976347,0.000030987536,0.0008286651,0.000511267,0.00003213428,0.000032073556,0.00001699022,0.00002680196,0.0008863565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998294,0.00014156703,0.0005171648,0.0002567384,0.000349667,0.0004408501],"domain_scores_gemma":[0.99786115,0.00054084073,0.00037660977,0.00045939098,0.0004836474,0.0002783927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023582767,0.00021637732,0.0006680999,0.00024966281,0.00010722018,0.0000046778596,0.00018672377,0.00006198054,0.00032765223],"category_scores_gemma":[0.00011935266,0.000095136704,0.00011097411,0.0002860067,0.00041032545,0.00007291398,0.000046415476,0.00010150386,0.0000060719294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017650423,0.00061400695,0.9884943,0.00007660344,0.00019446423,0.0003632555,0.0014757739,0.000013299967,0.00087333366,0.00008720473,0.0003837582,0.005658971],"study_design_scores_gemma":[0.003983066,0.0062294058,0.9550154,0.000088514644,0.00026687037,0.00002362527,0.00026733542,0.000013062794,0.03055851,0.000029966366,0.0033749226,0.00014930165],"about_ca_topic_score_codex":0.0768289,"about_ca_topic_score_gemma":0.31133184,"teacher_disagreement_score":0.23450294,"about_ca_system_score_codex":0.00023709013,"about_ca_system_score_gemma":0.0011437046,"threshold_uncertainty_score":0.9293186},"labels":[],"label_agreement":null},{"id":"W2589081360","doi":"10.1093/annonc/mdw373.38","title":"Prognostic ability of early tumor shrinkage on overall survival (OS) in metastatic renal cell carcinoma (mRCC) – a validation study","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Pazopanib; Proportional hazards model; Sunitinib; Renal cell carcinoma; Internal medicine; Urology; Oncology; Survival analysis; Nuclear medicine","score_opus":0.09992246030689454,"score_gpt":0.3604701264236741,"score_spread":0.26054766611677954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589081360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941195,0.00007251698,0.000013345501,0.0006844057,0.000090839414,0.0015468186,0.000026295233,0.000013980722,0.0034323023],"genre_scores_gemma":[0.99942756,0.0000086357395,0.00017639225,0.00008127154,0.00003541971,0.00009477365,0.000009541825,0.000021476984,0.00014494671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997323,0.0006869537,0.000782653,0.0004242565,0.0004434204,0.00033971088],"domain_scores_gemma":[0.9976948,0.0010005159,0.0003886094,0.0004932468,0.00028791802,0.00013489263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011055669,0.00021856469,0.00086823426,0.00027043963,0.000017578855,0.0000033849199,0.00013481479,0.00006849447,0.00014117638],"category_scores_gemma":[0.000434581,0.0001459391,0.00016126249,0.00019473804,0.00013642211,0.000078452504,0.000063285064,0.00014149093,0.000030104424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031345529,0.008126875,0.91687614,0.00019335393,0.0001210511,0.0006930826,0.00091685343,0.000011372706,0.064754084,0.00009507758,0.00011058691,0.004966962],"study_design_scores_gemma":[0.0056647467,0.031947006,0.8646625,0.000074961674,0.00015307576,0.000013710517,0.00012690072,0.000005298782,0.0969298,0.00026096878,0.000057384772,0.00010363319],"about_ca_topic_score_codex":0.0006427651,"about_ca_topic_score_gemma":0.00010112552,"teacher_disagreement_score":0.05221364,"about_ca_system_score_codex":0.0001578062,"about_ca_system_score_gemma":0.0003456213,"threshold_uncertainty_score":0.5951224},"labels":[],"label_agreement":null},{"id":"W2589148784","doi":"10.1200/jco.2013.31.6_suppl.396","title":"Metastatic non–clear cell renal cell carcinoma (nccRCC) treated with targeted therapy agents: Applying the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) prognostic model to predict outcomes.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre; University of Toronto; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Clear cell renal cell carcinoma; Hazard ratio; Renal cell carcinoma; Internal medicine; Clear cell; Cohort; Chromophobe cell; Oncology; Targeted therapy; Urology; Cancer; Database; Confidence interval","score_opus":0.12270829399509908,"score_gpt":0.3778673700901337,"score_spread":0.25515907609503463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589148784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851765,0.0004854997,0.0024220634,0.0037723603,0.00057010824,0.0038748886,0.00008740602,0.000034504414,0.003576693],"genre_scores_gemma":[0.9698552,0.0001377775,0.022399385,0.0042435112,0.0003975024,0.0004596705,0.00010489985,0.00012113936,0.0022809415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9916714,0.0010008919,0.0038982802,0.00081594504,0.0017381407,0.0008753473],"domain_scores_gemma":[0.9904305,0.00307998,0.0028537838,0.00092204625,0.0013631667,0.0013505684],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027211031,0.0007440886,0.0026756383,0.00046990998,0.00017942429,0.0000974456,0.00095488364,0.0002434091,0.0007627529],"category_scores_gemma":[0.00084842293,0.00040635373,0.0009387606,0.00044096514,0.00040812846,0.00039315195,0.0002447411,0.0017865828,0.00018346027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026295869,0.018390488,0.8311518,0.00040538586,0.0039694686,0.0118463,0.0014270837,0.008433642,0.043808796,0.00001973142,0.042938642,0.011312826],"study_design_scores_gemma":[0.070579395,0.060439494,0.76235354,0.00027016414,0.007512446,0.0012118588,0.0017825244,0.057166725,0.029466962,0.000109841494,0.007937301,0.0011697764],"about_ca_topic_score_codex":0.00031796476,"about_ca_topic_score_gemma":0.00003523627,"teacher_disagreement_score":0.06879826,"about_ca_system_score_codex":0.0005469066,"about_ca_system_score_gemma":0.0026086003,"threshold_uncertainty_score":0.9998388},"labels":[],"label_agreement":null},{"id":"W2589230933","doi":"10.1200/jco.2016.34.2_suppl.534","title":"Change in International mRCC Database Consortium (IMDC) prognostic category and implications for efficacy of second-line targeted therapy.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre; Ottawa Regional Cancer Foundation; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Oncology; Targeted therapy; Cancer","score_opus":0.22719711655302252,"score_gpt":0.472124269521861,"score_spread":0.24492715296883846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589230933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752119,0.0012713698,0.00021128652,0.021835513,0.00054860435,0.00065974396,0.00006285457,0.000004379056,0.0001943471],"genre_scores_gemma":[0.9944965,0.0015323192,0.0022386229,0.00093039434,0.0006101765,0.00004323368,0.000020189173,0.00001299223,0.00011552688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773574,0.00015859093,0.0016412461,0.00017745476,0.00013537458,0.00015161393],"domain_scores_gemma":[0.99344873,0.0045870934,0.0011212056,0.00017194853,0.00046383333,0.0002071986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014446329,0.00010559509,0.0008096363,0.0001741857,0.000013648445,0.0000027393269,0.00012170328,0.00016095629,0.00016976114],"category_scores_gemma":[0.0032878004,0.00006036141,0.00020720321,0.00007156821,0.00017740706,0.000104016646,0.00003957445,0.00022758366,0.0000025504314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00813901,0.0035869807,0.67670715,0.000046982463,0.0004514401,0.000119361466,0.00013632703,4.8155283e-7,0.018106433,0.00034328384,0.001185137,0.29117742],"study_design_scores_gemma":[0.018132811,0.007839515,0.96005553,0.00010424786,0.00013380407,0.00020448893,0.000020877183,0.00001731986,0.001224129,0.00033399375,0.011874574,0.000058697744],"about_ca_topic_score_codex":0.000014658065,"about_ca_topic_score_gemma":0.00006021286,"teacher_disagreement_score":0.2911187,"about_ca_system_score_codex":0.00009748952,"about_ca_system_score_gemma":0.0005920511,"threshold_uncertainty_score":0.39360416},"labels":[],"label_agreement":null},{"id":"W2589234634","doi":"10.1200/jco.2016.34.2_suppl.616","title":"The impact of PBRM1 and BAP1 expression on outcomes of patients with metastatic renal cell carcinoma (mRCC) treated with VEGF-targeted therapy (TT).","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"BAP1; Medicine; Renal cell carcinoma; Internal medicine; Oncology; Immunohistochemistry; Clear cell renal cell carcinoma; Pathological; Gastroenterology; Cancer","score_opus":0.0691629640922425,"score_gpt":0.39484717094715505,"score_spread":0.32568420685491256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589234634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981879,0.00040386917,0.00002016709,0.000499763,0.00006447105,0.00039620133,0.000014570212,0.0000034894392,0.0004095758],"genre_scores_gemma":[0.998626,0.00029647167,0.00079387816,0.00006360955,0.00005698378,0.00000481834,0.0000027200256,0.000024398963,0.0001311315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99682,0.00058494176,0.0016249141,0.0001950789,0.00054036704,0.00023469905],"domain_scores_gemma":[0.9924166,0.0038305814,0.002518353,0.00031469713,0.0006133541,0.00030641875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009402815,0.00023668387,0.0016711897,0.00012900881,0.00004423428,0.000004390536,0.00013590683,0.00013649832,0.000051879964],"category_scores_gemma":[0.00049912144,0.00007204435,0.0004111966,0.00010820587,0.00038483317,0.00007779682,0.000024880317,0.00030972506,0.0000014364946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04103435,0.0025893447,0.93106645,0.000016801398,0.00080347306,0.0001635865,0.00007346739,0.00000642027,0.0046944604,0.0000029778016,0.000243099,0.019305553],"study_design_scores_gemma":[0.027548995,0.10359565,0.8520479,0.00015403572,0.00037057555,0.00003315601,0.00004243797,0.000003205537,0.016007604,0.00002714221,0.00009739343,0.000071874376],"about_ca_topic_score_codex":0.00004056532,"about_ca_topic_score_gemma":0.0000089944915,"teacher_disagreement_score":0.10100631,"about_ca_system_score_codex":0.0001429713,"about_ca_system_score_gemma":0.00080604723,"threshold_uncertainty_score":0.29378834},"labels":[],"label_agreement":null},{"id":"W2589298977","doi":"10.1200/jco.2014.32.4_suppl.396","title":"Cytoreductive nephrectomy (CN) in patients with synchronous metastases from renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Queen Elizabeth II Health Sciences Centre; Sunnybrook Health Science Centre; BC Cancer Agency; Princess Margaret Cancer Centre; University of Toronto; University Health Network; University of Calgary","funders":"","keywords":"Medicine; Pazopanib; Temsirolimus; Sunitinib; Renal cell carcinoma; Sorafenib; Nephrectomy; Bevacizumab; Internal medicine; Urology; Oncology; Surgery; Gastroenterology; Kidney; Chemotherapy; Discovery and development of mTOR inhibitors; Hepatocellular carcinoma","score_opus":0.0559746623152129,"score_gpt":0.3418407938285052,"score_spread":0.28586613151329227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589298977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917616,0.00053816615,0.00027005916,0.0025782583,0.001284032,0.0006436347,0.0008538228,0.000011820627,0.0020585952],"genre_scores_gemma":[0.98110265,0.0000439223,0.014956866,0.0014040489,0.0016184078,0.000017209104,0.00070224603,0.000051266452,0.000103412225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9919158,0.001906884,0.0036488296,0.0007566533,0.001261798,0.00051000994],"domain_scores_gemma":[0.98511726,0.00914171,0.003435614,0.0008072761,0.00086847064,0.0006297019],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030451752,0.00048122628,0.002180397,0.00024965362,0.00008842585,0.000044118187,0.0006849437,0.00024922288,0.000276433],"category_scores_gemma":[0.002875229,0.00027959817,0.00056346046,0.00024290792,0.00052667677,0.0003162712,0.00022678236,0.0017541687,0.00005023156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0779542,0.010782753,0.8738442,0.000033998233,0.0014986714,0.0041779215,0.0009120181,0.0002748823,0.0017481456,0.000022953722,0.01688456,0.011865694],"study_design_scores_gemma":[0.055438135,0.015322442,0.9081,0.00012898685,0.0023490482,0.00008867993,0.0003972389,0.00023032867,0.005852335,0.00012160295,0.011673159,0.00029804336],"about_ca_topic_score_codex":0.0022222823,"about_ca_topic_score_gemma":0.0005585886,"teacher_disagreement_score":0.034255803,"about_ca_system_score_codex":0.0006963637,"about_ca_system_score_gemma":0.0022622966,"threshold_uncertainty_score":0.9999656},"labels":[],"label_agreement":null},{"id":"W2589339251","doi":"10.1200/jco.2015.33.7_suppl.438","title":"Management and outcomes of patients with renal medullary carcinoma (RMC): A multicenter retrospective study of 39 patients.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Stage (stratigraphy); Systemic therapy; Institutional review board; Retrospective cohort study; Surgery; Internal medicine; Cancer; Kidney","score_opus":0.07012396852517819,"score_gpt":0.38628301924040775,"score_spread":0.31615905071522954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589339251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969973,0.00010696794,0.000009827886,0.00025539182,0.00033788203,0.00083986373,0.000006785295,0.0000030428293,0.0014429421],"genre_scores_gemma":[0.997192,0.000030029589,0.002405246,0.0001719991,0.00007221055,0.0000055341,0.000004245073,0.000017323688,0.000101403144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961342,0.0003795134,0.0021633462,0.00022987029,0.00091340096,0.00017967162],"domain_scores_gemma":[0.9952962,0.00037836653,0.002263058,0.00026622255,0.0013961989,0.00039994504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011355708,0.00018491688,0.0018406162,0.00019447271,0.000016647988,0.0000030416497,0.00012449831,0.00014109476,0.000018865325],"category_scores_gemma":[0.00073382776,0.00010683099,0.0002168521,0.00012088319,0.00020242327,0.000085360356,0.0001283968,0.00040322996,0.0000014464982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012798012,0.016154071,0.96121055,0.00004161051,0.0014985477,0.00043700953,0.00066428096,0.00000387377,0.0000012312069,0.000008222309,0.0002848665,0.0068977117],"study_design_scores_gemma":[0.046882473,0.08251295,0.8679981,0.000059990816,0.001345818,0.000009780149,0.00077226973,0.0000055537653,0.000018441839,0.000030019006,0.0002928901,0.00007166841],"about_ca_topic_score_codex":0.00003932784,"about_ca_topic_score_gemma":0.00003855766,"teacher_disagreement_score":0.09321242,"about_ca_system_score_codex":0.00025582412,"about_ca_system_score_gemma":0.0002545874,"threshold_uncertainty_score":0.43564412},"labels":[],"label_agreement":null},{"id":"W2589471851","doi":"10.1200/jco.2016.34.2_suppl.503","title":"Discontinuing VEGF-targeted therapy (VEGF-TT) for progression versus toxicity impacts outcomes of second-line therapies in metastatic renal cell carcinoma (mRCC).","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; BC Cancer Agency; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Discontinuation; Toxicity; Internal medicine; Renal cell carcinoma; Gastroenterology; Oncology; Urology","score_opus":0.15214884365136852,"score_gpt":0.45839115816830117,"score_spread":0.3062423145169326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589471851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908164,0.0031214808,0.00016172546,0.0039554015,0.0008471177,0.00079723384,0.000020358675,0.000009113722,0.0002711634],"genre_scores_gemma":[0.99143374,0.0004396934,0.0071673905,0.00027870346,0.00038370333,0.000023967616,0.0000045973125,0.000037809536,0.00023042277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949865,0.0006478643,0.0031252105,0.00030476224,0.00048351102,0.00045219425],"domain_scores_gemma":[0.9906492,0.0053815315,0.0028012884,0.0003161628,0.0004704288,0.0003813725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00324044,0.00030539336,0.0025635816,0.0002744325,0.000033834738,0.00000881094,0.00023378071,0.00028998544,0.00017697515],"category_scores_gemma":[0.002161137,0.00014882791,0.0010184025,0.00015036225,0.0002515248,0.00020021157,0.000051937623,0.0004964448,0.0000033260549],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059448473,0.00628141,0.5118562,0.00018047166,0.0014007926,0.00080992654,0.00096367445,0.0000041087515,0.15168017,0.00003762486,0.0005726993,0.26676443],"study_design_scores_gemma":[0.05981566,0.055222332,0.79389775,0.0002676341,0.0004095313,0.000063182684,0.00025275798,0.000019605095,0.08791102,0.0003529004,0.0016136465,0.00017399182],"about_ca_topic_score_codex":0.000015164356,"about_ca_topic_score_gemma":0.00013996741,"teacher_disagreement_score":0.28204152,"about_ca_system_score_codex":0.0003181497,"about_ca_system_score_gemma":0.0011403944,"threshold_uncertainty_score":0.6069026},"labels":[],"label_agreement":null},{"id":"W2589696161","doi":"10.1200/jco.2014.32.4_suppl.484","title":"Association of partial nephrectomy and presence of robotic surgery for kidney cancer in the United States.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Kidney cancer; Logistic regression; Odds ratio; Cohort; Surgery; Cancer; Internal medicine; Population; Urology; Kidney","score_opus":0.1208028169277016,"score_gpt":0.43629647491804563,"score_spread":0.315493657990344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589696161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854489,0.00017291092,0.00022311862,0.013442413,0.00040022662,0.00023367419,0.000004162686,0.0000010548607,0.0000735675],"genre_scores_gemma":[0.9972559,0.0007760388,0.00047118784,0.0011189267,0.0003056364,0.000010602256,0.000004234861,0.000005212459,0.000052248568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973764,0.000709335,0.0014615507,0.000076768505,0.0002516493,0.00012431346],"domain_scores_gemma":[0.9832179,0.0143454075,0.0018220627,0.00009026937,0.00039923977,0.00012513445],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0056146993,0.00006164173,0.00095730455,0.00011097079,0.000009856355,0.0000022680763,0.00006380414,0.00015271694,0.000018118504],"category_scores_gemma":[0.012394135,0.00003542633,0.00020738422,0.0001366139,0.00008903758,0.000035209967,0.000012924976,0.00027056955,2.1244662e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002718531,0.000765832,0.9676713,0.00011821057,0.0002878412,0.000023907194,0.00022040076,0.00059949805,0.0001538401,0.0000404654,0.009333711,0.018066498],"study_design_scores_gemma":[0.0061802417,0.0058341054,0.9446731,0.00022123443,0.0007155231,0.00002986205,0.00009120935,0.004119947,0.00057344587,0.00038357888,0.03712884,0.000048886475],"about_ca_topic_score_codex":0.00017934229,"about_ca_topic_score_gemma":0.00006668903,"teacher_disagreement_score":0.027795127,"about_ca_system_score_codex":0.000099483164,"about_ca_system_score_gemma":0.00072389044,"threshold_uncertainty_score":0.9959249},"labels":[],"label_agreement":null},{"id":"W2589722562","doi":"10.1093/annonc/mdx075","title":"Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Memorial Sloan-Kettering Cancer Center","keywords":"Everolimus; Sunitinib; Medicine; Hazard ratio; Internal medicine; Oncology; Confidence interval; Renal cell carcinoma; Urology; Gastroenterology","score_opus":0.26146280799231525,"score_gpt":0.44297335488792794,"score_spread":0.1815105468956127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589722562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872237,0.0008733277,0.00014069384,0.0068698525,0.0005297929,0.0026558656,0.00071030966,0.000026484306,0.0009700085],"genre_scores_gemma":[0.9962912,0.000846535,0.00021892128,0.00029525792,0.00012337186,0.00041343833,0.0005199353,0.000063423904,0.0012279213],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957264,0.00044246306,0.0015890502,0.0007280838,0.0006967683,0.0008172023],"domain_scores_gemma":[0.9923366,0.0035664684,0.0015221435,0.001561522,0.00073316233,0.00028013941],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018217983,0.0005640743,0.0024706998,0.00047404462,0.00050646113,0.00002809409,0.00076526124,0.00023588649,0.00031083822],"category_scores_gemma":[0.0016845379,0.00043612576,0.00085822167,0.00050591654,0.0003215213,0.00018542279,0.00027144182,0.0003886064,0.0000051524758],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31142488,0.14387113,0.29076487,0.0011353138,0.060202405,0.0025754673,0.011114507,0.0028797395,0.0061841765,0.00013772085,0.1025213,0.0671885],"study_design_scores_gemma":[0.39680305,0.35662824,0.109977104,0.00027310316,0.029993776,0.000047829613,0.0042712935,0.0067484314,0.011883241,0.00035733072,0.081399344,0.0016172777],"about_ca_topic_score_codex":0.00656718,"about_ca_topic_score_gemma":0.022179011,"teacher_disagreement_score":0.2127571,"about_ca_system_score_codex":0.00017687218,"about_ca_system_score_gemma":0.00028099352,"threshold_uncertainty_score":0.999809},"labels":[],"label_agreement":null},{"id":"W2589817604","doi":"10.1007/s10552-017-0857-3","title":"Antihypertensive medication use and risk of renal cell carcinoma","year":2017,"lang":"en","type":"article","venue":"Cancer Causes & Control","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Odds ratio; Renal cell carcinoma; Internal medicine; Confidence interval; Case-control study; Population; Epidemiology; Kidney cancer","score_opus":0.03269674078299544,"score_gpt":0.2755890931601261,"score_spread":0.24289235237713064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589817604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924199,0.0057250345,0.00008659043,0.00061207596,0.00016200276,0.00048672553,0.00010140561,0.000015460582,0.00039082282],"genre_scores_gemma":[0.99712294,0.0019157375,0.00008896134,0.00023883692,0.00019652155,0.000057105546,0.000008584288,0.000021529871,0.00034977205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990104,0.000047266374,0.00022973635,0.0002824167,0.00023465071,0.00019551706],"domain_scores_gemma":[0.9983136,0.00012234099,0.00038991246,0.00067699404,0.00031904457,0.0001781231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009868738,0.00016079932,0.00043673167,0.0000614606,0.00015165201,0.00003501194,0.00009380183,0.0000797478,0.000048326227],"category_scores_gemma":[0.00023595813,0.00012106335,0.000090023,0.000024461628,0.000239416,0.00014937356,0.000032592987,0.00012645409,0.0000056532394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048490064,0.000057158923,0.9293344,0.00007565841,0.00023860368,0.00011730135,0.00019105923,0.000004643853,0.06584479,0.000014802061,0.000670673,0.0029660233],"study_design_scores_gemma":[0.0059834593,0.00031457155,0.92345285,0.00007615726,0.0014952556,0.000028949355,0.000036141613,0.00028578358,0.06721052,0.00001166879,0.0010031041,0.00010156635],"about_ca_topic_score_codex":0.0035468512,"about_ca_topic_score_gemma":0.00019240254,"teacher_disagreement_score":0.005881557,"about_ca_system_score_codex":0.00008597977,"about_ca_system_score_gemma":0.00017331225,"threshold_uncertainty_score":0.53618014},"labels":[],"label_agreement":null},{"id":"W2589822434","doi":"10.14740/jocmr2839w","title":"A Three-Variable Model Predicts Short Survival in Patients With Newly Diagnosed Metastatic Renal Cell Carcinoma","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Adverse effect; Internal medicine; Overall survival; Prognostic variable; Lactate dehydrogenase; Survival analysis; Performance status; Oncology","score_opus":0.22775768338795976,"score_gpt":0.4541751376145885,"score_spread":0.22641745422662873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589822434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855003,0.00044706778,0.0010798974,0.0026128737,0.0003528452,0.0010334764,0.000008771194,0.0000069536295,0.008957845],"genre_scores_gemma":[0.9919721,0.00016320946,0.006205507,0.000102828024,0.0010072711,0.00002142401,0.000011610392,0.00005886114,0.00045720997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9914254,0.00060263986,0.0024082786,0.0005287223,0.0041685035,0.0008664549],"domain_scores_gemma":[0.99148303,0.0028322153,0.00083264365,0.001280596,0.0022951735,0.001276358],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.011939511,0.00033469376,0.0019841725,0.0006333672,0.00023586563,0.00005974793,0.0008030234,0.0002055378,0.00016343512],"category_scores_gemma":[0.008637628,0.0001928012,0.00025852246,0.0003647027,0.0009972805,0.00032679286,0.00023692571,0.0026910624,0.000016295671],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008773637,0.0023394157,0.97562724,0.00019702401,0.00021757213,0.002918856,0.00012426515,0.00020570327,0.00011921796,0.00004721191,0.0033123228,0.0061175125],"study_design_scores_gemma":[0.032929957,0.018043743,0.9421189,0.0011750123,0.00041618582,0.00004918651,0.000104671984,0.004012354,0.00019409854,0.0005939165,0.00020430498,0.00015771092],"about_ca_topic_score_codex":0.0004382963,"about_ca_topic_score_gemma":0.00016584319,"teacher_disagreement_score":0.033508405,"about_ca_system_score_codex":0.00029224326,"about_ca_system_score_gemma":0.0020321792,"threshold_uncertainty_score":0.99971306},"labels":[],"label_agreement":null},{"id":"W2589845673","doi":"10.1200/jco.2016.34.2_suppl.558","title":"Outcomes of second targeted therapy in metastatic renal carcinoma: A retrospective chart review in the EU.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Pazopanib; Sunitinib; Targeted therapy; Axitinib; Sorafenib; Renal cell carcinoma; Everolimus; Internal medicine; Oncology; Surgery; Cancer","score_opus":0.1513470616238918,"score_gpt":0.45103699635048816,"score_spread":0.29968993472659633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589845673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95487297,0.010900155,0.000005168479,0.031878475,0.0002417528,0.00056582503,0.0000059057165,0.000002081516,0.0015276603],"genre_scores_gemma":[0.9849264,0.009007471,0.0005616202,0.005122829,0.00015361734,0.000015614805,9.829423e-7,0.000012510354,0.00019895236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99459445,0.0014650706,0.0030296352,0.00019562089,0.00048061897,0.00023462002],"domain_scores_gemma":[0.9939084,0.003487567,0.0018231265,0.00031143377,0.00032639687,0.00014304725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006938403,0.00016992592,0.002626312,0.00019013004,0.000011000506,0.0000021641413,0.0002339468,0.00014145349,0.00054651423],"category_scores_gemma":[0.003734495,0.00006855239,0.0006445908,0.000273031,0.0002053861,0.00008647673,0.000026835129,0.0007082279,0.000011206884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022425272,0.0021425555,0.96249163,0.00011007853,0.0003929186,0.002130466,0.00025886888,1.7890108e-7,0.00089465146,0.000116676485,0.0030461682,0.026173279],"study_design_scores_gemma":[0.012274725,0.01266126,0.9662767,0.00059107994,0.00021114465,0.00036294726,0.00007178181,9.977272e-7,0.00031595473,0.00043229442,0.006736221,0.00006491069],"about_ca_topic_score_codex":0.000027862445,"about_ca_topic_score_gemma":0.00015013957,"teacher_disagreement_score":0.030053424,"about_ca_system_score_codex":0.0002996775,"about_ca_system_score_gemma":0.00092971965,"threshold_uncertainty_score":0.59839475},"labels":[],"label_agreement":null},{"id":"W2590029130","doi":"10.1200/jco.2016.34.2_suppl.544","title":"First-line sunitinib versus pazopanib in metastatic renal cell carcinoma (mRCC): Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Ottawa Regional Cancer Foundation; BC Cancer Agency; Princess Margaret Cancer Centre; University of Toronto; Sunnybrook Health Science Centre; University of Calgary","funders":"","keywords":"Medicine; Pazopanib; Sunitinib; Renal cell carcinoma; Hazard ratio; Internal medicine; Oncology; Population; Urology; Overall survival; Gastroenterology; Confidence interval","score_opus":0.18944983327741965,"score_gpt":0.40771099974216746,"score_spread":0.2182611664647478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590029130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9656481,0.0009193367,0.00029744612,0.024645723,0.0027272499,0.0006189961,0.0006819835,0.000016314352,0.0044448497],"genre_scores_gemma":[0.98770934,0.00058325706,0.0068901177,0.00166116,0.0018212685,0.000023534074,0.00017883895,0.00006139076,0.0010710929],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9899047,0.0017211868,0.005559574,0.00075876457,0.0013524404,0.0007033458],"domain_scores_gemma":[0.9686227,0.025120562,0.003644647,0.0009558537,0.0008300079,0.0008262439],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0061924057,0.0005280671,0.0022924608,0.00035170664,0.00010371191,0.000039879236,0.0009400246,0.00028036447,0.0008626148],"category_scores_gemma":[0.008483659,0.00028582677,0.00093714916,0.0003199888,0.0005954703,0.00032825125,0.00033215882,0.001660785,0.00016274226],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39650297,0.026112214,0.23252703,0.0003204542,0.004523762,0.10643244,0.002431018,0.0005148641,0.036575515,0.00039215657,0.12311927,0.07054829],"study_design_scores_gemma":[0.246823,0.042200062,0.55828166,0.0007478265,0.0061426503,0.0015750256,0.0011676698,0.00081740355,0.03163163,0.0009952015,0.10864657,0.0009713189],"about_ca_topic_score_codex":0.0008347789,"about_ca_topic_score_gemma":0.0014376306,"teacher_disagreement_score":0.3257546,"about_ca_system_score_codex":0.0007985365,"about_ca_system_score_gemma":0.003063268,"threshold_uncertainty_score":0.9999594},"labels":[],"label_agreement":null},{"id":"W2590047801","doi":"10.1200/jco.2014.32.4_suppl.443","title":"Dovitinib in first-line renal cell carcinoma: An investigation into tumour gene status and correlation with efficacy: A phase II clinical trial.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Renal cell carcinoma; Gastroenterology; Adverse effect; Phases of clinical research; Performance status; Progression-free survival; Surgery; Abdominal pain; Oncology; Clinical trial; Cancer; Chemotherapy","score_opus":0.12657641956834362,"score_gpt":0.434838953061354,"score_spread":0.30826253349301036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590047801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99492764,0.00030349384,0.00038461524,0.0026963016,0.00064935547,0.0007570142,0.000001892222,0.000013271078,0.00026643887],"genre_scores_gemma":[0.98682886,0.00023679835,0.00994358,0.0008135265,0.002015487,0.0000109085995,0.000035209632,0.00003245449,0.00008317287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9930558,0.0016191709,0.004022223,0.00045931427,0.00049812114,0.00034534172],"domain_scores_gemma":[0.99172693,0.0037518179,0.0026384308,0.0003094682,0.00042709857,0.0011462386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007212035,0.00026361007,0.0019604168,0.0002706692,0.000092225135,0.000017045544,0.00012550222,0.0005494978,0.000031421976],"category_scores_gemma":[0.003523295,0.00017960262,0.00029944564,0.00022729767,0.00042072844,0.00021796682,0.00006616829,0.001462303,0.0000067188116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26434708,0.0192004,0.5929346,0.000076420496,0.00018071152,0.0014218139,0.0009683713,0.0004236245,0.0012023823,0.00007306125,0.00034124436,0.118830286],"study_design_scores_gemma":[0.2970123,0.23055188,0.46552736,0.000087894645,0.0006259202,0.00025943812,0.00006390279,0.0029045702,0.0005496716,0.00029414,0.0019655786,0.0001573324],"about_ca_topic_score_codex":0.00014974724,"about_ca_topic_score_gemma":0.0004849992,"teacher_disagreement_score":0.21135148,"about_ca_system_score_codex":0.00025590503,"about_ca_system_score_gemma":0.001712436,"threshold_uncertainty_score":0.7323983},"labels":[],"label_agreement":null},{"id":"W2590055499","doi":"10.1200/jco.2011.29.7_suppl.356","title":"Effect of an individualized dose/schedule strategy for sunitinib in metastatic renal cell cancer (mRCC) on progression-free survival (PFS): Correlation with dynamic microbubble ultrasound (DCE-US) data.","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Sunitinib; Toxicity; Urology; Internal medicine; Oncology; Nuclear medicine; Cancer","score_opus":0.18349031932270524,"score_gpt":0.4801632282143826,"score_spread":0.2966729088916774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590055499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643415,0.00037275898,0.00026512967,0.00015413019,0.0004575376,0.0011709948,0.000118423166,0.000008092757,0.0010188023],"genre_scores_gemma":[0.9731032,0.00013201687,0.026120316,0.000105158884,0.00018345918,0.000038704795,0.00018934635,0.000040234132,0.0000875606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946919,0.0017408943,0.0022520823,0.00038880252,0.0005810905,0.00034522137],"domain_scores_gemma":[0.98982495,0.0062469603,0.002575229,0.0006267654,0.0003736749,0.00035240618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007099233,0.00028289406,0.001960941,0.00025308982,0.000040692878,0.000011026395,0.00046646583,0.00030456678,0.00017101444],"category_scores_gemma":[0.0017894877,0.00017114435,0.00025752385,0.00021348751,0.0002627949,0.00024362345,0.00006456613,0.0009130165,0.000004001128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29098836,0.023441741,0.4830988,0.001351959,0.0029813112,0.003254001,0.0009362953,0.0020275237,0.010257759,0.00013117539,0.0008549239,0.18067615],"study_design_scores_gemma":[0.09816814,0.27882004,0.59568435,0.0011480337,0.004360286,0.00062140956,0.00034367727,0.0017455621,0.01765805,0.00037048024,0.000691432,0.00038853186],"about_ca_topic_score_codex":0.0001928402,"about_ca_topic_score_gemma":0.00097115955,"teacher_disagreement_score":0.2553783,"about_ca_system_score_codex":0.0002212983,"about_ca_system_score_gemma":0.0017987563,"threshold_uncertainty_score":0.69790643},"labels":[],"label_agreement":null},{"id":"W2590066672","doi":"10.1200/jco.2014.32.4_suppl.425","title":"Response to systemic therapy in non-clear cell renal cell carcinomas: A systematic review and meta-analysis.","year":2014,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Sunitinib; Pazopanib; Temsirolimus; Clear cell renal cell carcinoma; Oncology; Internal medicine; Sorafenib; Renal cell carcinoma; Clinical endpoint; Progression-free survival; Everolimus; Meta-analysis; Clinical trial; Chemotherapy; Hepatocellular carcinoma; Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway","score_opus":0.2410394227245558,"score_gpt":0.48326098857595884,"score_spread":0.24222156585140303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590066672","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010817497,0.9919563,0.000031600415,0.0012116666,0.00017966237,0.005077712,0.000013157618,0.000007887919,0.00044025943],"genre_scores_gemma":[0.0035511628,0.98958707,0.0008336166,0.0034155266,0.00021955444,0.0002444623,0.0000073475812,0.000086879816,0.0020543565],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9724962,0.013042107,0.012336118,0.0007703726,0.0008693967,0.00048579817],"domain_scores_gemma":[0.9758723,0.011217458,0.00995164,0.0012477709,0.0006317904,0.0010790707],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.02844121,0.0008514551,0.048622597,0.001334015,0.000034958182,0.000027332931,0.0006071973,0.0011167146,0.00015562927],"category_scores_gemma":[0.0036978547,0.00044789477,0.011017038,0.0011167404,0.00011827272,0.00006034301,0.00014242301,0.002235588,0.00014766493],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002726434,0.0013855072,0.000045938777,0.8734879,0.1112514,0.003788928,0.000083511346,0.0000042501906,0.000005699142,0.0000011384252,0.0017335592,0.0054857363],"study_design_scores_gemma":[0.0025723043,0.01740947,0.000118207296,0.052587043,0.8277394,0.0015800917,0.000020606347,0.0000028462925,0.0000013484987,0.0000016786815,0.097639754,0.0003272181],"about_ca_topic_score_codex":0.000022493225,"about_ca_topic_score_gemma":0.000012240257,"teacher_disagreement_score":0.82090086,"about_ca_system_score_codex":0.00075273024,"about_ca_system_score_gemma":0.002604903,"threshold_uncertainty_score":0.9997973},"labels":[],"label_agreement":null},{"id":"W2590164673","doi":"10.1200/jco.2015.33.7_suppl.464","title":"Risk factors and a model to predict toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: Results from the International Metastatic RCC Database Consortium.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; BC Cancer Agency","funders":"","keywords":"Medicine; Discontinuation; Sunitinib; Mucositis; Renal cell carcinoma; Internal medicine; Adverse effect; Sorafenib; Toxicity; Oncology; Surgery; Urology; Hepatocellular carcinoma","score_opus":0.10954902848682431,"score_gpt":0.36216653307392144,"score_spread":0.25261750458709714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590164673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635756,0.00022242215,0.00015866992,0.00145563,0.00012443661,0.0010640204,0.00043695036,0.000009692378,0.00017061167],"genre_scores_gemma":[0.99386805,0.00010661587,0.005184663,0.00028366232,0.00006673282,0.000021029578,0.0003530394,0.000028670598,0.00008750849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956772,0.0008869365,0.0020382146,0.00040658106,0.0007399834,0.00025108914],"domain_scores_gemma":[0.9943281,0.002365634,0.0018660919,0.00033441462,0.0005461839,0.0005596217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001631167,0.0003213633,0.001352026,0.00019762825,0.0000435487,0.000026269408,0.00017391965,0.000103097715,0.000015325239],"category_scores_gemma":[0.0014238721,0.00014145563,0.00016934494,0.00021880181,0.0001759675,0.00020487723,0.000045218665,0.0005314176,0.000003060429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053818215,0.004653247,0.93039495,0.0000022487015,0.0014718189,0.00044622476,0.0019386112,0.001778005,0.00010571665,0.0000019754943,0.00031703518,0.0050719324],"study_design_scores_gemma":[0.071243994,0.052338134,0.8679582,0.00008618475,0.0016534358,0.000024959709,0.0005728558,0.0047100973,0.0010997175,0.00003576718,0.00012839137,0.00014825077],"about_ca_topic_score_codex":0.001127598,"about_ca_topic_score_gemma":0.00064705126,"teacher_disagreement_score":0.06243676,"about_ca_system_score_codex":0.000539192,"about_ca_system_score_gemma":0.0012644283,"threshold_uncertainty_score":0.5768393},"labels":[],"label_agreement":null},{"id":"W2590414680","doi":"10.1200/jco.2016.34.2_suppl.521","title":"Real world chart review of adverse event management in patients taking tyrosine kinase inhibitors (TKIs) for metastatic renal cell carcinoma (mRCC) by line of therapy (LoT).","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Mucositis; Sunitinib; Discontinuation; Stomatitis; Adverse effect; Internal medicine; Pazopanib; Regimen; Diarrhea; Dysgeusia; Sorafenib; Incidence (geometry); Renal cell carcinoma; Surgery; Chemotherapy","score_opus":0.09808525899197854,"score_gpt":0.41966320398896223,"score_spread":0.32157794499698367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590414680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98602617,0.008455963,0.00008702265,0.0023721377,0.00053537934,0.0014558698,0.000032734282,0.000003982118,0.0010307725],"genre_scores_gemma":[0.9707865,0.023920733,0.0037028193,0.0007506799,0.00024014789,0.000031683056,0.000016711801,0.000028716497,0.00052197656],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9936029,0.00051669544,0.0046556704,0.00028502374,0.0006299404,0.00030978848],"domain_scores_gemma":[0.9924389,0.0012966992,0.004993427,0.00032891246,0.0006446705,0.00029735384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034992495,0.00024871438,0.0022888426,0.0003298464,0.000016803575,0.0000011568754,0.00019629835,0.00012401002,0.00015659434],"category_scores_gemma":[0.0007371592,0.00014428234,0.00088362035,0.0002725127,0.00015924854,0.000093899405,0.000065510794,0.00031222234,0.000003976545],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030782335,0.023922838,0.34880444,0.0074825445,0.0014101497,0.0009083748,0.00014109166,0.000010772757,0.0075590936,0.00009790295,0.020682637,0.5581978],"study_design_scores_gemma":[0.09149499,0.07697105,0.7200506,0.0143187,0.002510323,0.000030415209,0.00007992486,0.000020266642,0.038984288,0.00014021856,0.055019192,0.00038005036],"about_ca_topic_score_codex":0.000036599202,"about_ca_topic_score_gemma":0.00001936423,"teacher_disagreement_score":0.55781776,"about_ca_system_score_codex":0.00039933593,"about_ca_system_score_gemma":0.00045456173,"threshold_uncertainty_score":0.5883663},"labels":[],"label_agreement":null},{"id":"W2590525661","doi":"10.1200/jco.2015.33.7_suppl.405","title":"The impact of BMI on outcomes of patients with metastatic renal cell carcinoma treated with targeted therapy: An external validation data set and analysis of underlying biology from The Cancer Genome Atlas.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Hazard ratio; Renal cell carcinoma; Internal medicine; Underweight; Oncology; Body mass index; Overweight; Cancer; Odds ratio; Cohort; Targeted therapy; Clear cell renal cell carcinoma; Confidence interval","score_opus":0.3065606119022541,"score_gpt":0.48059280297045665,"score_spread":0.17403219106820256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590525661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99803466,0.0008930231,0.000119045646,0.0002442262,0.00004552954,0.0002990606,0.00033776925,0.000001749042,0.00002496478],"genre_scores_gemma":[0.9983857,0.000240257,0.0010164225,0.00006241964,0.000045012464,0.0000030137778,0.00022570998,0.000014338136,0.0000071011314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99649674,0.0011117549,0.0015591219,0.00024286269,0.00042269527,0.00016683561],"domain_scores_gemma":[0.9925097,0.0028091753,0.003133918,0.00059717096,0.0007321508,0.00021784722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018483406,0.00018840384,0.0017023577,0.0001565437,0.00003517883,0.000007462908,0.00034385792,0.0001073746,0.00003439707],"category_scores_gemma":[0.00034816,0.00006825127,0.00025887182,0.00030275533,0.00038955346,0.000099852434,0.000054450542,0.00031791546,2.0406597e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016195813,0.0010663437,0.9693092,0.000004849144,0.0064219823,0.00002538885,0.00030658508,0.00074370543,0.0010326771,0.0000018446067,0.00002175116,0.004869841],"study_design_scores_gemma":[0.010205247,0.036210395,0.9473012,0.00002266481,0.004803425,0.000005568296,0.0002147691,0.00048524453,0.0006305826,0.00003995528,0.000019370307,0.000061568164],"about_ca_topic_score_codex":0.0025544825,"about_ca_topic_score_gemma":0.00033432565,"teacher_disagreement_score":0.035144053,"about_ca_system_score_codex":0.00014399315,"about_ca_system_score_gemma":0.0010105208,"threshold_uncertainty_score":0.38616306},"labels":[],"label_agreement":null},{"id":"W2590565136","doi":"10.1200/jco.2014.32.4_suppl.398","title":"The International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) model as a prognostic tool in metastatic renal cell carcinoma (mRCC) patients previously treated with first-line targeted therapy (TT).","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Queen Elizabeth II Health Sciences Centre; Sunnybrook Health Science Centre; BC Cancer Agency; Princess Margaret Cancer Centre; University of Toronto; University Health Network; University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Thrombocytosis; Neutrophilia; Gastroenterology; Anemia; Carcinoma; Concordance; Interquartile range; Oncology; Urology","score_opus":0.07833004758076212,"score_gpt":0.36076151513493276,"score_spread":0.28243146755417065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590565136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921502,0.0009852088,0.0007595327,0.002481817,0.00039333073,0.0016989058,0.00004551488,0.000019918229,0.0014655719],"genre_scores_gemma":[0.988935,0.0005744079,0.007902003,0.0012528121,0.00033283347,0.00011198178,0.00015312547,0.00008092685,0.00065694435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9915862,0.0014468477,0.0041391654,0.000675896,0.0013867908,0.0007650757],"domain_scores_gemma":[0.98798144,0.0062086163,0.0031904103,0.0007158846,0.0012808051,0.00062282727],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0040925276,0.0005937733,0.0022317946,0.00037513944,0.00016546136,0.00006189739,0.0006686382,0.00022634462,0.00014323337],"category_scores_gemma":[0.0035902949,0.00033271287,0.00065019284,0.0003684624,0.00044435303,0.00028174074,0.00014596869,0.0014925373,0.000039897615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05214289,0.017477944,0.8935593,0.00026109882,0.0014247986,0.005613524,0.0005957063,0.003882472,0.0015677217,0.00010345548,0.004944281,0.018426806],"study_design_scores_gemma":[0.115414605,0.10437143,0.7067847,0.00048005886,0.0041336403,0.0012610916,0.00026588907,0.045886748,0.010301523,0.0007060794,0.0094450675,0.0009491735],"about_ca_topic_score_codex":0.0001944635,"about_ca_topic_score_gemma":0.00035827764,"teacher_disagreement_score":0.1867746,"about_ca_system_score_codex":0.0004960871,"about_ca_system_score_gemma":0.0032026991,"threshold_uncertainty_score":0.9999125},"labels":[],"label_agreement":null},{"id":"W2590586032","doi":"10.1200/jco.2013.31.6_suppl.394","title":"Impact of bone and liver metastases (BM, LM) in patients with metastatic renal cell carcinoma (mRCC) treated with molecularly targeted agents (MTAs): Results from the International mRCC Database Consortium (IMDC).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of Toronto; Cancer Care Ontario; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Lymph node; Internal medicine; Proportional hazards model; Oncology; Urology; Surgery; Gastroenterology","score_opus":0.06672928261054789,"score_gpt":0.3562116065377301,"score_spread":0.2894823239271822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590586032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973339,0.00050928857,0.00004549631,0.0006368169,0.00009389284,0.0007020235,0.00044208713,0.000004497038,0.00023200667],"genre_scores_gemma":[0.993681,0.000111910354,0.0052917334,0.00039629295,0.00009393427,0.000010711017,0.0003323861,0.000027472752,0.00005454738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99531716,0.0008203266,0.002411738,0.0003660693,0.000794371,0.00029034837],"domain_scores_gemma":[0.9933313,0.0023774374,0.0025286963,0.0004013844,0.00093282573,0.00042832457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012818968,0.00029996797,0.0015955247,0.00022050236,0.000031591047,0.000024992474,0.00020736453,0.00012871208,0.00028255372],"category_scores_gemma":[0.0012967002,0.0001436868,0.00032184037,0.0002147439,0.00037951005,0.00027203385,0.000096690404,0.0007011877,0.000009497935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036560632,0.0044484925,0.9460631,0.000019355164,0.0019473355,0.003101154,0.00018398474,0.000062789986,0.0012956362,0.0000017465317,0.0029930833,0.003322666],"study_design_scores_gemma":[0.04010436,0.024195055,0.9319111,0.0001410426,0.0014536995,0.00013622109,0.000098125296,0.00022904537,0.0014315788,0.000009936871,0.00015984272,0.00013000962],"about_ca_topic_score_codex":0.0032368547,"about_ca_topic_score_gemma":0.00019269521,"teacher_disagreement_score":0.019746562,"about_ca_system_score_codex":0.00024663567,"about_ca_system_score_gemma":0.0009619195,"threshold_uncertainty_score":0.5859378},"labels":[],"label_agreement":null},{"id":"W2590619154","doi":"10.1200/jco.2015.33.7_suppl.412","title":"Renal nephrometry score and predictors of pathologic upstaging in patients undergoing partial and radical nephrectomies.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Nephrectomy; Malignancy; Renal sinus; Exact test; Radiology; Renal capsule; Adipose capsule of kidney; Surgery; Urology; Kidney; Internal medicine","score_opus":0.12409944290767404,"score_gpt":0.39380111749688407,"score_spread":0.26970167458921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590619154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970176,0.0010770602,0.00003192134,0.0008384283,0.00044521713,0.00017477572,0.0000015545913,0.0000049276514,0.00040851414],"genre_scores_gemma":[0.9964169,0.00044245474,0.002389646,0.000333728,0.00038786652,9.72039e-7,0.00000192263,0.000011323065,0.000015174784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968834,0.0004927764,0.0018184233,0.00019393499,0.00039970293,0.00021175397],"domain_scores_gemma":[0.9965016,0.0015914211,0.0010423567,0.00012013586,0.00021029508,0.00053417066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002764082,0.00013637175,0.0012878196,0.00024062209,0.00001671381,0.0000064627843,0.00007298955,0.00029868612,0.00001254305],"category_scores_gemma":[0.0047295103,0.00009211315,0.00018433714,0.00015234506,0.0004364956,0.00010566439,0.00009494105,0.0006801053,9.891264e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041568563,0.00069667294,0.972837,0.00003436008,0.00013329911,0.0008729316,0.00020638763,0.000012816145,0.000048479753,0.00001693753,0.00029692418,0.02068734],"study_design_scores_gemma":[0.018146686,0.021389877,0.95798784,0.0001766158,0.0002877836,0.0003890351,0.00014355667,0.00006368576,0.00009478805,0.0002906602,0.0009596016,0.000069884576],"about_ca_topic_score_codex":0.000010604666,"about_ca_topic_score_gemma":0.00001178735,"teacher_disagreement_score":0.020693203,"about_ca_system_score_codex":0.00017492086,"about_ca_system_score_gemma":0.0009343204,"threshold_uncertainty_score":0.5662007},"labels":[],"label_agreement":null},{"id":"W2590693960","doi":"10.1200/jco.2014.32.4_suppl.473","title":"Biomarker analysis from a phase III trial (GOLD) of dovitinib (Dov) versus sorafenib (Sor) in patients with metastatic renal cell carcinoma after one prior VEGF pathway–targeted therapy and one prior mTOR inhibitor therapy.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Sorafenib; Biomarker; Oncology; Hazard ratio; Internal medicine; Proportional hazards model; Renal cell carcinoma; Progression-free survival; Cohort; Overall survival; Confidence interval; Hepatocellular carcinoma","score_opus":0.09803582891267835,"score_gpt":0.3702265866734542,"score_spread":0.27219075776077584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590693960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996056,0.0013589765,0.00007766543,0.00046021916,0.00051086367,0.001347902,0.00006121606,0.000009269138,0.00011788735],"genre_scores_gemma":[0.9903281,0.00031144777,0.008231302,0.00031497385,0.00063195324,0.000041485942,0.00005973938,0.000049580565,0.000031440853],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99253523,0.0016305994,0.0037781664,0.00057267933,0.001041396,0.00044189786],"domain_scores_gemma":[0.9916303,0.003364831,0.0032322,0.0005082251,0.000656357,0.00060808525],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026755617,0.00043420948,0.0038273048,0.0006946289,0.000038619342,0.000021735194,0.00020813064,0.00041271272,0.00034120426],"category_scores_gemma":[0.00075776456,0.000284175,0.0008927089,0.00063325034,0.00032796434,0.00016824264,0.000060592403,0.00083126436,0.0000041749686],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73490006,0.020244936,0.12907387,0.000030101255,0.004285268,0.00034075894,0.00040330426,0.0000023994685,0.003613362,0.0000019009071,0.0000385375,0.10706548],"study_design_scores_gemma":[0.40188032,0.07741071,0.51462555,0.000069301626,0.002517335,0.000003931123,0.000049538547,0.00006788346,0.002644785,0.000021984128,0.0005254736,0.00018316964],"about_ca_topic_score_codex":0.00019141243,"about_ca_topic_score_gemma":0.0001759088,"teacher_disagreement_score":0.3855517,"about_ca_system_score_codex":0.00022752493,"about_ca_system_score_gemma":0.0012396149,"threshold_uncertainty_score":0.999961},"labels":[],"label_agreement":null},{"id":"W2590868182","doi":"10.1200/jco.2015.33.7_suppl.430","title":"Third-line therapy in metastatic renal cell carcinoma: Results from the International mRCC Database Consortium.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; BC Cancer Agency; University Health Network; University of Toronto; Sunnybrook Health Science Centre; University of Calgary","funders":"","keywords":"Medicine; Sunitinib; Pazopanib; Sorafenib; Internal medicine; Hazard ratio; Targeted therapy; Oncology; Renal cell carcinoma; Temsirolimus; Salvage therapy; Everolimus; Proportional hazards model; Surgery; Cancer; Chemotherapy; Confidence interval; Hepatocellular carcinoma","score_opus":0.29668788690280007,"score_gpt":0.4566390676937862,"score_spread":0.15995118079098614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590868182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96365017,0.0018471716,0.00006624396,0.025427964,0.0016710964,0.0002836466,0.00007508325,0.000006723138,0.006971924],"genre_scores_gemma":[0.9864022,0.0006904176,0.0062472117,0.0044177067,0.0016876153,0.0000052692426,0.00007459681,0.000018355577,0.00045658983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945586,0.00093122653,0.0031770938,0.00029313535,0.0007995334,0.00024045222],"domain_scores_gemma":[0.9904878,0.0060109915,0.0019223244,0.00044665407,0.0006470702,0.000485118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069734906,0.0001932053,0.0012414124,0.0001262477,0.000023923123,0.000017373126,0.00044565627,0.00017816032,0.000110946945],"category_scores_gemma":[0.006501958,0.00010355567,0.00040581074,0.00015248568,0.00023570844,0.00013869425,0.00011146374,0.0012964214,0.000055089164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15272784,0.015883084,0.48938778,0.00002086813,0.0018843198,0.0317641,0.0024627573,0.00039008827,0.005279894,0.0001581127,0.21063797,0.089403205],"study_design_scores_gemma":[0.119025946,0.030807994,0.6569199,0.00015803633,0.0008837856,0.0011628575,0.0014388125,0.0009495784,0.006197927,0.0011786569,0.180985,0.00029149262],"about_ca_topic_score_codex":0.0004478451,"about_ca_topic_score_gemma":0.00021830256,"teacher_disagreement_score":0.16753213,"about_ca_system_score_codex":0.00033325632,"about_ca_system_score_gemma":0.0029718333,"threshold_uncertainty_score":0.7783921},"labels":[],"label_agreement":null},{"id":"W2590872269","doi":"10.1200/jco.2014.32.4_suppl.420","title":"Positive surgical margins after partial nephrectomy for renal cell carcinoma: Results from Canadian Kidney Cancer Information System database.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; University of Toronto; Western University; University of British Columbia; University of Manitoba; St. Joseph's Hospital; Ottawa Hospital; University of Alberta; Dalhousie University; McMaster University; University of Calgary; Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Kidney cancer; Demographics; Pathological; Logistic regression; Surgical margin; Cancer; Multivariate analysis; Database; Internal medicine; Kidney; Surgery; Urology","score_opus":0.051584954986938075,"score_gpt":0.36107427225146294,"score_spread":0.3094893172645249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590872269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800654,0.00019283213,0.00038558335,0.007118136,0.0021527815,0.0007271225,0.0014276212,0.000010978483,0.007919529],"genre_scores_gemma":[0.9897006,0.0000396124,0.0031915687,0.0026641255,0.0038057189,0.00006452588,0.0003592979,0.00001986895,0.0001546636],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99561304,0.0005437291,0.0027147634,0.00026044578,0.00042618247,0.0004418297],"domain_scores_gemma":[0.9933265,0.002236146,0.001552472,0.00031560237,0.0007294877,0.0018397828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024912464,0.00022759064,0.0013976379,0.00021929514,0.00007187007,0.000025459576,0.0001679895,0.00045614218,0.00010731603],"category_scores_gemma":[0.0016855294,0.00016264293,0.0005727185,0.000111189205,0.00011419167,0.0002874231,0.000042524825,0.00072891184,0.00004934104],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26795173,0.0024300877,0.42622846,0.0006980545,0.0022491782,0.011848791,0.0017468891,0.00017178258,0.00048767874,0.0005385617,0.19559333,0.09005546],"study_design_scores_gemma":[0.03357686,0.008033306,0.3366353,0.0003255458,0.0012408263,0.00036306193,0.00012705551,0.0011565441,0.0016409426,0.0000121103385,0.6166763,0.00021219061],"about_ca_topic_score_codex":0.026460122,"about_ca_topic_score_gemma":0.008657959,"teacher_disagreement_score":0.42108294,"about_ca_system_score_codex":0.0011338438,"about_ca_system_score_gemma":0.0047424817,"threshold_uncertainty_score":0.9800228},"labels":[],"label_agreement":null},{"id":"W2590893780","doi":"10.1200/jco.2012.30.5_suppl.451","title":"Vascular endothelial growth factor (VEGF) therapy in metastatic renal cell carcinoma (mRCC): Differences between Asian and non-Asian patients.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Toxicity; Vascular endothelial growth factor; Gastroenterology; Oncology; VEGF receptors","score_opus":0.10394098664119455,"score_gpt":0.37933308281242534,"score_spread":0.2753920961712308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590893780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99493,0.00085300027,0.00004263852,0.0011572484,0.0005784985,0.0004389266,0.000013505421,0.000005494344,0.0019806388],"genre_scores_gemma":[0.9961418,0.0006066622,0.0016251034,0.00034808196,0.0011755326,0.000008121881,0.0000075749763,0.000030061447,0.000057096968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955659,0.00084327534,0.00222574,0.0002637497,0.00059756526,0.0005037506],"domain_scores_gemma":[0.9959022,0.0015181439,0.0012757019,0.00021524739,0.00024172498,0.00084699935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015819289,0.00029664524,0.0021131076,0.00027287533,0.000044163877,0.000014699819,0.00018923766,0.00031371485,0.00010847628],"category_scores_gemma":[0.000736794,0.00018605714,0.0005704572,0.0001476581,0.00022230184,0.00021263912,0.00005838667,0.0010211978,0.000013342379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009779774,0.0022022896,0.92625064,0.000038226528,0.0002951188,0.00021977969,0.00069924886,7.008731e-8,0.00021683864,0.0000066823945,0.000084788044,0.06900837],"study_design_scores_gemma":[0.015993683,0.019068018,0.9612323,0.000046333716,0.00043637998,0.00005246612,0.00016962364,0.0000026262862,0.0011447758,0.00010631151,0.0015943473,0.00015312512],"about_ca_topic_score_codex":0.00007064903,"about_ca_topic_score_gemma":0.000019683477,"teacher_disagreement_score":0.06885524,"about_ca_system_score_codex":0.00021101319,"about_ca_system_score_gemma":0.0005815413,"threshold_uncertainty_score":0.75871897},"labels":[],"label_agreement":null},{"id":"W2590921469","doi":"10.1200/jco.2014.32.30_suppl.265","title":"Reporting on quality indicators in renal cell carcinoma: Proportion of metastatic patients who initially commence on full-dose targeted therapy.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; Juravinski Cancer Centre; Sunnybrook Health Science Centre; BC Cancer Agency; Princess Margaret Cancer Centre; University of Toronto; University Health Network; McGill University; Centre Hospitalier de l’Université de Montréal; University of Calgary; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Sunitinib; Pazopanib; Sorafenib; Renal cell carcinoma; Temsirolimus; Everolimus; Internal medicine; Oncology; Kidney cancer; Cohort; Urology; Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway; Hepatocellular carcinoma","score_opus":0.1825192556823884,"score_gpt":0.46168308318022716,"score_spread":0.27916382749783875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590921469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99529606,0.00007033238,0.000037099016,0.0007998676,0.00035841292,0.0004941012,0.0000030855997,0.0000056876083,0.0029353802],"genre_scores_gemma":[0.9969244,0.000059198846,0.0014778426,0.001250003,0.00021487878,0.000008027068,0.000011735466,0.000020705864,0.000033179305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98883045,0.0019915008,0.007680769,0.00030030202,0.00092506787,0.0002719394],"domain_scores_gemma":[0.98165476,0.0025745488,0.014584115,0.00030168807,0.00055213895,0.00033277355],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010856363,0.00021746688,0.0021685746,0.00048228938,0.000033941524,0.000005377158,0.00016596564,0.00025568524,0.00004619314],"category_scores_gemma":[0.011862233,0.00014336464,0.0004883909,0.00033336168,0.00016768508,0.00007800562,0.000036777736,0.0011448653,0.00000659178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016041722,0.010212739,0.8964685,0.00010014438,0.00014811213,0.0008523286,0.00031348888,0.000070287046,0.0016834385,0.00007376543,0.0002315716,0.073803894],"study_design_scores_gemma":[0.013811636,0.061837886,0.91701144,0.00016493491,0.00013514943,0.000049195893,0.000059957983,0.000045139634,0.006124516,0.0001368171,0.0005180448,0.00010527466],"about_ca_topic_score_codex":0.000046041925,"about_ca_topic_score_gemma":0.00001219094,"teacher_disagreement_score":0.07369862,"about_ca_system_score_codex":0.0003259847,"about_ca_system_score_gemma":0.0010000751,"threshold_uncertainty_score":0.9964613},"labels":[],"label_agreement":null},{"id":"W2590926364","doi":"10.1200/jco.2008.26.15_suppl.5045","title":"Safety and efficacy of sorafenib in elderly patients (pts) ≥65 years: A subset analysis from the Advanced Renal Cell Carcinoma Sorafenib (ARCCS) Expanded Access Program in North America","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Sorafenib; Expanded access; Internal medicine; Renal cell carcinoma; Adverse effect; Oncology; Clinical trial; Hepatocellular carcinoma","score_opus":0.07165830181736565,"score_gpt":0.39756561600240575,"score_spread":0.3259073141850401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590926364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762547,0.00065387075,0.000022084196,0.0005829655,0.00014404571,0.00074259704,0.000028123171,0.000007091009,0.00019376825],"genre_scores_gemma":[0.9963742,0.0010156023,0.0020233623,0.00028916536,0.00016725557,0.000015373173,0.00007166529,0.000020610814,0.000022780425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99454355,0.0008914561,0.0031931591,0.00040175495,0.0006012296,0.00036884958],"domain_scores_gemma":[0.99364245,0.0030539357,0.0022121207,0.00041060182,0.00033586327,0.00034505082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008923988,0.00025163035,0.002429096,0.000389702,0.000039208753,0.000011347295,0.00038304977,0.00027765374,0.000059782637],"category_scores_gemma":[0.0011088657,0.0001642776,0.0006521042,0.0011457031,0.00046475162,0.00017280644,0.00013389431,0.0010797664,0.000003651874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011964265,0.0048731733,0.82422656,0.000012074572,0.00037769583,0.0011258995,0.00081347727,0.00026409057,0.000033571763,3.2186028e-7,0.000077327146,0.15623152],"study_design_scores_gemma":[0.027480561,0.013151396,0.9562659,0.000047022215,0.00093435345,0.000024506771,0.0001619265,0.00012722609,0.00007729157,0.000013709705,0.0015863618,0.00012972625],"about_ca_topic_score_codex":0.0006371637,"about_ca_topic_score_gemma":0.0022775608,"teacher_disagreement_score":0.1561018,"about_ca_system_score_codex":0.00024731,"about_ca_system_score_gemma":0.0008684612,"threshold_uncertainty_score":0.66990465},"labels":[],"label_agreement":null},{"id":"W2591197031","doi":"10.1200/jco.2014.32.4_suppl.434","title":"Contemporary outcomes of pT3 renal cell carcinoma: A Canadian multi-institutional experience.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; University of Alberta; University of British Columbia; Dalhousie University; University of Toronto; McMaster University; University of Calgary; McGill University; University of Manitoba","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Histopathology; Pathological; Pathological staging; Urology; Lymph; Kidney cancer; Surgery; Kidney; Internal medicine; Pathology","score_opus":0.18659174630362937,"score_gpt":0.42943832872924786,"score_spread":0.2428465824256185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591197031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9727242,0.00055279164,0.00026042777,0.0027322564,0.0010870488,0.00019641328,0.000007342139,0.0000049685436,0.022434566],"genre_scores_gemma":[0.99072653,0.000030647745,0.006478358,0.0016732629,0.0005165238,0.0000046761947,0.000005397218,0.000013647917,0.00055098475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99617964,0.0003824885,0.0024995592,0.00020956043,0.00045384344,0.0002748995],"domain_scores_gemma":[0.99548465,0.0012073856,0.0014570096,0.0002668274,0.0005397205,0.001044386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019023732,0.00019148683,0.0018317341,0.0002545868,0.000056730216,0.0000050645767,0.00021475989,0.0003571104,0.00016183691],"category_scores_gemma":[0.0022159494,0.00012035509,0.00076166604,0.000110812754,0.00045921083,0.000104155166,0.000038001686,0.00066865596,0.000025609057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010448634,0.0015464823,0.98380566,0.00003166601,0.00018844093,0.001724216,0.00023433441,0.000017247943,0.0007375355,0.0001285795,0.004365908,0.0061750547],"study_design_scores_gemma":[0.010915229,0.00806178,0.93195784,0.000039877275,0.0001972586,0.0004255484,0.00015946037,0.0001275699,0.0016599849,0.000029658397,0.04632121,0.000104581246],"about_ca_topic_score_codex":0.006548641,"about_ca_topic_score_gemma":0.0024182869,"teacher_disagreement_score":0.051847827,"about_ca_system_score_codex":0.00036333923,"about_ca_system_score_gemma":0.006879507,"threshold_uncertainty_score":0.99875057},"labels":[],"label_agreement":null},{"id":"W2591210005","doi":"10.1634/theoncologist.2016-0078","title":"Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model","year":2017,"lang":"en","type":"article","venue":"The Oncologist","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"National Cancer Institute; CRIS Cancer Foundation; Sociedad Española de Oncología Médica","keywords":"Medicine; Hazard ratio; Proportional hazards model; Concordance; Renal cell carcinoma; Oncology; Internal medicine; Clinical endpoint; Gene signature; Overall survival; Confidence interval; Gene; Gene expression; Clinical trial; Biology","score_opus":0.041624701129055905,"score_gpt":0.3126501555619361,"score_spread":0.2710254544328802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591210005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808455,0.0005285788,0.0013612554,0.0015528308,0.0002767011,0.0013311999,0.00013161333,0.000033109965,0.013939173],"genre_scores_gemma":[0.9943088,0.000027658292,0.004175527,0.00014043973,0.00008193823,0.0001554667,0.000105893254,0.000031917578,0.0009723172],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982567,0.000108976674,0.00042733998,0.00038617267,0.00050431525,0.0003165174],"domain_scores_gemma":[0.99763465,0.0002771889,0.0005161276,0.0011831103,0.0002479608,0.00014098124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047210348,0.00025004573,0.00044077056,0.00007103282,0.00019018521,0.000054433407,0.0006150612,0.00006238841,0.00004415964],"category_scores_gemma":[0.0009615907,0.00015857285,0.00017133918,0.00005020384,0.00069285877,0.00010125783,0.00031323553,0.00025081466,0.000037069516],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028590271,0.0038727906,0.33016035,0.00094688544,0.0010476528,0.0044000717,0.00066946086,0.0047343206,0.63848644,0.008472697,0.0012975578,0.0030527532],"study_design_scores_gemma":[0.0089237215,0.0041001914,0.2848784,0.00025629802,0.0043731346,0.00031987252,0.00029550507,0.1272874,0.5670239,0.0015790283,0.00036963707,0.0005929273],"about_ca_topic_score_codex":0.00032771446,"about_ca_topic_score_gemma":0.000028118333,"teacher_disagreement_score":0.12255308,"about_ca_system_score_codex":0.00017884841,"about_ca_system_score_gemma":0.00049519684,"threshold_uncertainty_score":0.64664125},"labels":[],"label_agreement":null},{"id":"W2591327090","doi":"10.1200/jco.2013.31.15_suppl.e15518","title":"First-line mTOR inhibition in metastatic renal cell carcinoma (mRCC): An updated analysis from the International mRCC Database Consortium (IMDC).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre; Baker Hughes (Canada)","funders":"","keywords":"Medicine; Temsirolimus; Everolimus; Renal cell carcinoma; Internal medicine; Refractory (planetary science); Discovery and development of mTOR inhibitors; Oncology; Clinical trial; Nephrectomy; Gastroenterology; Surgery; PI3K/AKT/mTOR pathway; Kidney","score_opus":0.11154676364097064,"score_gpt":0.401862091780227,"score_spread":0.29031532813925637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591327090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981163,0.00027161546,0.00055493176,0.016178988,0.0006503611,0.00039447102,0.00007807526,0.000009496865,0.0006990156],"genre_scores_gemma":[0.98884106,0.00015609806,0.005761681,0.003460916,0.0009970249,0.000017426759,0.0005580721,0.000020948175,0.00018674952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99455476,0.00090400985,0.0031701068,0.00038151536,0.0006976484,0.00029196026],"domain_scores_gemma":[0.9938601,0.0024708554,0.0019664548,0.00049781415,0.0007002715,0.0005044656],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002678474,0.00023927195,0.0015627426,0.00037600537,0.00005320162,0.000039663562,0.00029606547,0.00022308393,0.0034014047],"category_scores_gemma":[0.0011900939,0.00014404823,0.0006800321,0.00046774966,0.00023085033,0.0003785127,0.000119938406,0.001127964,0.0001062543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008128202,0.010439523,0.9147751,0.000027454156,0.0043967115,0.008514933,0.00049060496,0.0014186645,0.0077564013,0.000059713868,0.031654663,0.012338045],"study_design_scores_gemma":[0.013291874,0.006086932,0.9579406,0.000048817325,0.0042604585,0.00023164136,0.00036676327,0.0074333795,0.0024057378,0.00037404636,0.007385499,0.00017426597],"about_ca_topic_score_codex":0.0016706779,"about_ca_topic_score_gemma":0.002016265,"teacher_disagreement_score":0.0431655,"about_ca_system_score_codex":0.00038210137,"about_ca_system_score_gemma":0.00090938003,"threshold_uncertainty_score":0.9975096},"labels":[],"label_agreement":null},{"id":"W2591397831","doi":"10.1200/jco.2016.34.2_suppl.499","title":"Subgroup analyses of METEOR, a randomized phase 3 trial of cabozantinib versus everolimus in patients (pts) with advanced renal cell carcinoma (RCC).","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cabozantinib; Medicine; Clinical endpoint; Everolimus; Internal medicine; Interim analysis; Population; Oncology; Renal cell carcinoma; Randomized controlled trial; Pazopanib; Progression-free survival; Sunitinib; Urology; Overall survival","score_opus":0.13154582464890424,"score_gpt":0.4595782746031576,"score_spread":0.32803244995425335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591397831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958465,0.00038959362,0.00011147506,0.00034232772,0.0008312325,0.0010148005,0.000014165678,0.0000039710344,0.0014459107],"genre_scores_gemma":[0.9961562,0.0003001275,0.0030576591,0.00006119845,0.00029490024,0.000014812476,0.0000055518663,0.000024928539,0.000084635525],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9921515,0.0015666586,0.004829762,0.00030147642,0.0008263753,0.00032424208],"domain_scores_gemma":[0.9841886,0.008795603,0.0052966783,0.00037425413,0.0009673136,0.00037752086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038311088,0.00027025264,0.0048407866,0.0004260836,0.0000152083685,0.000002465104,0.00021632377,0.00032689978,0.00011982847],"category_scores_gemma":[0.0055900076,0.0001342082,0.0012064852,0.00029887535,0.00054212037,0.00014095717,0.00005065215,0.00048662277,0.0000037057232],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9286801,0.010314003,0.020267483,0.00004513429,0.0008097063,0.00046766398,0.000072237955,0.000010123332,0.0046008797,0.0000094542265,0.00008161364,0.034641586],"study_design_scores_gemma":[0.8072052,0.13747337,0.036071967,0.00016749682,0.0020898704,0.000019033481,0.00003815601,0.000009750137,0.016548721,0.000023424982,0.00024728038,0.00010571166],"about_ca_topic_score_codex":0.000077426,"about_ca_topic_score_gemma":0.000037835518,"teacher_disagreement_score":0.12715937,"about_ca_system_score_codex":0.00022185103,"about_ca_system_score_gemma":0.0014926911,"threshold_uncertainty_score":0.6692165},"labels":[],"label_agreement":null},{"id":"W2591465484","doi":"10.1200/jco.2014.32.4_suppl.512","title":"Renal nephrometry score and predictors of complications in partial nephrectomies.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Nephrectomy; Surgery; Univariate analysis; Multivariate analysis; Kidney; Internal medicine","score_opus":0.12399645738417438,"score_gpt":0.42329001034311803,"score_spread":0.29929355295894366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591465484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99307835,0.00044115577,0.00017659346,0.0030503483,0.0003182304,0.00014671405,0.0000017128515,0.0000041743333,0.0027826973],"genre_scores_gemma":[0.9955119,0.00026622196,0.0029747412,0.00054743665,0.00064740307,0.0000019658298,0.0000020857779,0.000008971666,0.000039282877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99715716,0.00035047188,0.0019502136,0.00014094375,0.00025286322,0.00014836987],"domain_scores_gemma":[0.99608016,0.002091298,0.0011264124,0.00018131488,0.0002190273,0.0003017951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020232196,0.00009718684,0.0011667788,0.00021249389,0.000016006328,0.0000032746516,0.0000943322,0.00022712526,0.000043488562],"category_scores_gemma":[0.002435756,0.00006795961,0.00029214314,0.00017210316,0.0003129327,0.00005572936,0.000043632946,0.00055803935,0.000004161433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016593576,0.0008499433,0.94885147,0.000031399835,0.00022532877,0.000091843496,0.00007066457,0.00002624165,0.0009139149,0.00022739446,0.0010219729,0.046030473],"study_design_scores_gemma":[0.0058317436,0.009140204,0.9654267,0.000105178566,0.00027853512,0.0003147723,0.000025436184,0.00017930697,0.00036605855,0.0002940952,0.017991219,0.00004674641],"about_ca_topic_score_codex":0.000020646967,"about_ca_topic_score_gemma":0.000026979747,"teacher_disagreement_score":0.045983728,"about_ca_system_score_codex":0.00008867816,"about_ca_system_score_gemma":0.00051483576,"threshold_uncertainty_score":0.29160032},"labels":[],"label_agreement":null},{"id":"W2591469525","doi":"10.1200/jco.2016.34.2_suppl.552","title":"The impact of active smoking on survival outcome in metastatic renal cell carcinoma patients treated with targeted therapy.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Targeted therapy; Oncology; Cancer; Smoking cessation; Carcinoma; Gastroenterology; Pathology","score_opus":0.1336050188865711,"score_gpt":0.43381586510572606,"score_spread":0.30021084621915495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591469525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99734086,0.00014444187,0.000007877577,0.0006045639,0.00019824287,0.0003623607,0.0000109377115,0.0000034981688,0.0013271967],"genre_scores_gemma":[0.9993473,0.00014452351,0.00013151241,0.00008320111,0.00012230832,0.0000052114074,0.0000024505525,0.000024182422,0.00013926269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99569494,0.0010906802,0.0021548623,0.00019804243,0.0005494408,0.0003120094],"domain_scores_gemma":[0.9910175,0.005594707,0.002301023,0.00026790236,0.0005471224,0.0002717133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019446678,0.00022482351,0.0016133081,0.00018155675,0.00003458393,0.000004856232,0.00017671908,0.00016151431,0.00006659577],"category_scores_gemma":[0.0012151389,0.000078834535,0.0006457854,0.00019651522,0.00020427584,0.00007981477,0.000024624336,0.0006032628,0.0000043420914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03428556,0.0027912771,0.9002421,0.00000538995,0.000613047,0.0005374763,0.0000835813,0.00001618282,0.00073787663,0.0000039235397,0.00008172176,0.060601845],"study_design_scores_gemma":[0.026336443,0.069061965,0.90017796,0.00007192417,0.00022178373,0.000034892386,0.000057038917,0.0000064751034,0.0037980394,0.000034975255,0.00012159176,0.00007689906],"about_ca_topic_score_codex":0.0001780255,"about_ca_topic_score_gemma":0.000042304266,"teacher_disagreement_score":0.06627069,"about_ca_system_score_codex":0.0006435665,"about_ca_system_score_gemma":0.0010167605,"threshold_uncertainty_score":0.32147792},"labels":[],"label_agreement":null},{"id":"W2591506614","doi":"10.1200/jco.2015.33.7_suppl.480","title":"The impact of renal cell carcinoma histopathological subtype on disease prognosis: A Canadian multi-institutional analysis.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Hôtel-Dieu de Québec; University of Calgary; University of Alberta; University of British Columbia; Dalhousie University; University of Toronto; Montreal General Hospital; Juravinski Cancer Centre; Ottawa Hospital; University of Manitoba","funders":"","keywords":"Chromophobe cell; Medicine; Histopathology; Histology; Clear cell; Renal cell carcinoma; Internal medicine; Pathological; Pathology; Stage (stratigraphy); Clear cell renal cell carcinoma; Carcinoma; Clear cell carcinoma; Kidney cancer; Kidney disease; Oncology; Gastroenterology","score_opus":0.20426369534707145,"score_gpt":0.4453578029397895,"score_spread":0.24109410759271804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591506614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99221796,0.0014012107,0.000051476494,0.002768462,0.0004075288,0.00026542746,0.000019136747,0.0000047680437,0.0028640463],"genre_scores_gemma":[0.9979508,0.000074563126,0.0008658721,0.0003571421,0.00046632622,0.000007897385,0.000011799697,0.000010228853,0.0002553919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99625903,0.0007060254,0.0018817115,0.00023565796,0.0005732267,0.00034437294],"domain_scores_gemma":[0.99403656,0.0010526315,0.0013720433,0.00032066257,0.00094342703,0.0022747086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032791414,0.00020428514,0.0014469322,0.0003256082,0.000088489905,0.000010265087,0.00025197072,0.00026678143,0.000054788372],"category_scores_gemma":[0.0043027583,0.00009517467,0.0017441709,0.0003607708,0.0005045938,0.000052371208,0.000035528516,0.0008062406,0.000023660485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010933888,0.003229213,0.9674946,0.000009068529,0.00086984417,0.0071517476,0.000069561356,0.0015017749,0.000050174545,0.00008514854,0.0040665497,0.0045384173],"study_design_scores_gemma":[0.005272431,0.018818036,0.969014,0.0000198716,0.0021995746,0.00020399202,0.000036402107,0.00076875824,0.000052841973,0.00006463914,0.00346602,0.00008343045],"about_ca_topic_score_codex":0.0037628596,"about_ca_topic_score_gemma":0.0036884213,"teacher_disagreement_score":0.015588822,"about_ca_system_score_codex":0.0015294413,"about_ca_system_score_gemma":0.014787961,"threshold_uncertainty_score":0.9907973},"labels":[],"label_agreement":null},{"id":"W2593085122","doi":"10.1111/iju.13314","title":"Patterns of care among patients receiving sequential targeted therapies for advanced renal cell carcinoma: A retrospective chart review in the <scp>USA</scp>","year":2017,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Centre for Applied Research in Cancer Control; Novartis Pharmaceuticals Corporation; Novartis; Pfizer","keywords":"Medicine; Renal cell carcinoma; Chart; Retrospective cohort study; MEDLINE; Intensive care medicine; Oncology; Internal medicine; General surgery; Statistics","score_opus":0.016799221719942786,"score_gpt":0.28870471799540626,"score_spread":0.27190549627546345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593085122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912522,0.00569984,0.000100949284,0.0009799188,0.00066860445,0.0005623491,0.00006079542,0.0000024669446,0.0006728921],"genre_scores_gemma":[0.9978037,0.0011206553,0.00020873775,0.00040374114,0.00029533906,0.000032775093,0.000048418202,0.000018330426,0.00006832005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998297,0.00014031012,0.00063136086,0.000189022,0.0005404736,0.00020183461],"domain_scores_gemma":[0.9968918,0.00021085197,0.0012676036,0.00028181024,0.0012904274,0.000057491456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039921573,0.00016607837,0.00049155054,0.00017629776,0.00006723015,0.000022575405,0.00055648544,0.00008037226,0.00003030995],"category_scores_gemma":[0.0006131746,0.000112104106,0.00029749123,0.000035863086,0.000085865795,0.00017260881,0.00006647323,0.00030777036,0.0000017331446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032312307,0.00022859116,0.99235606,0.00017346635,0.00020174422,0.00021353338,0.0019756265,0.000011064113,0.002382785,0.00002907353,0.0003632615,0.0017416473],"study_design_scores_gemma":[0.004338548,0.0022251268,0.98669994,0.00040968528,0.00018979807,0.00010721477,0.00024616343,0.000009811983,0.004767908,0.00009774567,0.0008707414,0.000037336285],"about_ca_topic_score_codex":0.00007150028,"about_ca_topic_score_gemma":0.00011704996,"teacher_disagreement_score":0.006551499,"about_ca_system_score_codex":0.00021934275,"about_ca_system_score_gemma":0.00010481912,"threshold_uncertainty_score":0.45714727},"labels":[],"label_agreement":null},{"id":"W2593824144","doi":"10.1158/1557-3265.pdx16-b09","title":"Abstract B09: Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicine","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Clear cell renal cell carcinoma; Cell culture; Cancer research; Renal cell carcinoma; Biology; Cancer; Cell; Medicine; Oncology; Pathology; Internal medicine; Genetics","score_opus":0.19953860731325393,"score_gpt":0.4357282740736187,"score_spread":0.23618966676036476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593824144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866672,0.0069608223,0.00010272541,0.0016997175,0.00019812789,0.0026594892,0.00031586466,0.000022057804,0.0013739723],"genre_scores_gemma":[0.9916228,0.004600558,0.0014130332,0.00017651821,0.0006996273,0.0003188341,0.00017652141,0.000081419545,0.00091069593],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9922747,0.0008875174,0.0020286625,0.0014449884,0.0023393375,0.0010248108],"domain_scores_gemma":[0.9903728,0.004901644,0.00044211952,0.000794125,0.0025854718,0.00090388075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052848,0.00037884238,0.0011502908,0.00030918108,0.00031572251,0.000043782402,0.0003022773,0.00045868487,0.00024185935],"category_scores_gemma":[0.000935592,0.00022562398,0.0002468683,0.0003102683,0.0020521623,0.00013678275,0.00041873727,0.0009795851,0.000015698555],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06322726,0.009559185,0.11380042,0.0032746033,0.00032452037,0.00023593781,0.005855901,0.00009074223,0.7243946,0.000167557,0.029298285,0.049770948],"study_design_scores_gemma":[0.1055464,0.08092766,0.4150512,0.0032751826,0.00086552027,0.000012931423,0.00309156,0.0051768115,0.37593383,0.0024340723,0.0061305393,0.0015542961],"about_ca_topic_score_codex":0.0011004326,"about_ca_topic_score_gemma":0.000043337004,"teacher_disagreement_score":0.3484608,"about_ca_system_score_codex":0.00044657255,"about_ca_system_score_gemma":0.0007791173,"threshold_uncertainty_score":0.9200679},"labels":[],"label_agreement":null},{"id":"W2593937186","doi":"10.1111/jsap.12645","title":"Marked serum <scp>GGT</scp> elevations in two dogs with renal carcinoma","year":2017,"lang":"en","type":"letter","venue":"Journal of Small Animal Practice","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre de Recherche en Sciences Animales de Deschambault","funders":"","keywords":"Medicine; Histopathology; Abdominal mass; Internal medicine; Alkaline phosphatase; Pathology; Urology; Gastroenterology","score_opus":0.041006301603540456,"score_gpt":0.30255640840581244,"score_spread":0.261550106802272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593937186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5749503,0.0014558946,0.000045187855,0.3830591,0.0003651225,0.0008459068,0.000030914143,0.000025556674,0.039222017],"genre_scores_gemma":[0.77078956,0.00040976214,0.021267373,0.17503808,0.013385263,0.000050024653,0.00011636698,0.00035637553,0.01858718],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953358,0.0005118994,0.0013216181,0.00057348685,0.0014666306,0.000790559],"domain_scores_gemma":[0.9913503,0.0020810724,0.003901895,0.00088130543,0.0014501897,0.00033525057],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0015511609,0.0007042488,0.0014021243,0.00081072404,0.00020165807,0.00026325282,0.00059517997,0.0005419965,0.000089978246],"category_scores_gemma":[0.0028372062,0.0005167936,0.0004367615,0.00028119472,0.00017569662,0.000992509,0.00012577347,0.00622067,0.00008039862],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044612894,0.0009755887,0.067571454,0.00070754386,0.002009963,0.23927253,0.00062128546,0.000023552235,0.0033041888,0.000030923173,0.6803102,0.0007114901],"study_design_scores_gemma":[0.007908105,0.005864513,0.25364926,0.0012181005,0.0035294879,0.050851505,0.0003040041,0.000042851872,0.0006008603,0.000038974686,0.6757237,0.00026869445],"about_ca_topic_score_codex":0.00061276095,"about_ca_topic_score_gemma":0.00015355657,"teacher_disagreement_score":0.20802103,"about_ca_system_score_codex":0.00087081036,"about_ca_system_score_gemma":0.0016261139,"threshold_uncertainty_score":0.9997284},"labels":[],"label_agreement":null},{"id":"W2596072189","doi":"10.5489/cuaj.4484","title":"CUA guideline on the management of cystic renal lesions","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital; University of British Columbia; Kingston General Hospital; Centre hospitalier universitaire de Québec; Princess Margaret Cancer Centre; Dalhousie University; University of Toronto; University Health Network; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Guideline; Medicine; Intensive care medicine; Computer science; Internal medicine; Urology; Pathology","score_opus":0.03889371342784227,"score_gpt":0.2740949782802938,"score_spread":0.23520126485245152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596072189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8275015,0.00014279496,0.000095028605,0.12629181,0.00027831347,0.00031958954,0.000026044494,0.000010476288,0.045334477],"genre_scores_gemma":[0.99462116,0.000058387766,0.00057899184,0.0025004735,0.00023424927,0.0000067831556,0.000008023603,0.0000075097673,0.0019844435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871373,0.00009837935,0.00035272812,0.00012674186,0.0004133764,0.00029502343],"domain_scores_gemma":[0.99850863,0.00011400393,0.00044151544,0.00031988038,0.00021408073,0.00040186607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008703306,0.00010472279,0.0001978266,0.00007807825,0.0006217784,0.00006679729,0.00023147283,0.000102031896,0.0006880412],"category_scores_gemma":[0.00051786663,0.00005948092,0.00015196166,0.00004954504,0.000047784346,0.00003353244,0.000026376109,0.00035129845,0.00008161903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063182577,0.00054318807,0.5999545,0.00004028372,0.0027587437,0.0049840077,0.0002278647,0.0005126219,0.0011290422,0.027623544,0.31152356,0.05007081],"study_design_scores_gemma":[0.00087437645,0.00045433207,0.9404886,0.000051182873,0.00023406601,0.00012613623,0.00004929504,0.00011195502,0.00013927901,0.0015177857,0.05588122,0.00007180626],"about_ca_topic_score_codex":0.00048784603,"about_ca_topic_score_gemma":0.00016558444,"teacher_disagreement_score":0.34053406,"about_ca_system_score_codex":0.0007632835,"about_ca_system_score_gemma":0.00018023839,"threshold_uncertainty_score":0.7533569},"labels":[],"label_agreement":null},{"id":"W2596470319","doi":"10.1089/end.2016.0639","title":"Robotic Partial Nephrectomy: Expanding Utilization, Advancing Innovation","year":2017,"lang":"en","type":"review","venue":"Journal of Endourology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Nephrectomy; Robotic surgery; Invasive surgery; Laparoscopy; Surgery; Nephrology; Warm ischemia; Urology; Kidney; General surgery; Ischemia; Internal medicine; Reperfusion injury","score_opus":0.25401826197633975,"score_gpt":0.44311814414828815,"score_spread":0.1890998821719484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596470319","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034608628,0.9954054,0.0013866697,0.00012958505,0.0013821765,0.00053547206,0.0000017360215,0.000014809285,0.000798073],"genre_scores_gemma":[0.0017094675,0.99505967,0.0010640298,0.00010219784,0.0016339952,0.000023675062,0.00004246788,0.00006196502,0.0003025541],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99733406,0.00022043851,0.0015431468,0.00023470323,0.000317091,0.00035052805],"domain_scores_gemma":[0.99551874,0.00023277299,0.0032128799,0.00041678865,0.0004781294,0.00014068025],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007161133,0.0003480609,0.0025658645,0.0009980382,0.000114425064,0.00003589646,0.00022320588,0.00034015963,0.0001374475],"category_scores_gemma":[0.0010877141,0.00024685808,0.0005304771,0.00029862343,0.000068928115,0.0001534513,0.00005841454,0.0007633427,0.000029527771],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001676443,0.00012626497,0.00036224598,0.0035195355,0.0007579054,0.0020125017,0.00003874612,0.00003058346,0.000026304377,0.00021969642,0.0012435009,0.9914951],"study_design_scores_gemma":[0.0012156203,0.0010153066,0.00007875822,0.0042709494,0.0032524315,0.010464944,0.000006089032,0.0000115074745,0.00004178548,0.000070333845,0.9794195,0.00015277212],"about_ca_topic_score_codex":0.00000270919,"about_ca_topic_score_gemma":0.0000017989152,"teacher_disagreement_score":0.9913423,"about_ca_system_score_codex":0.00036581035,"about_ca_system_score_gemma":0.0010521717,"threshold_uncertainty_score":0.9999984},"labels":[],"label_agreement":null},{"id":"W2597284738","doi":"10.1016/j.humpath.2017.03.004","title":"Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists","year":2017,"lang":"en","type":"article","venue":"Human Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Oncocytoma; Renal oncocytoma; Cytokeratin; Pathology; Medicine; Chromophobe cell; Renal cell carcinoma; Clear cell; Immunohistochemistry","score_opus":0.13060137246864204,"score_gpt":0.3811158302220721,"score_spread":0.25051445775343006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597284738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99585813,0.00033671755,0.00023646044,0.00019674783,0.00025734596,0.000814522,0.00011739314,0.000044024768,0.002138678],"genre_scores_gemma":[0.9974921,0.000030607494,0.00128491,0.0001710198,0.0001239365,0.00018849663,0.00021119436,0.00003310586,0.00046468398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822646,0.0002658952,0.00045953714,0.00049284956,0.00014458323,0.00041064995],"domain_scores_gemma":[0.9972069,0.0008402687,0.00041750234,0.0011624801,0.00024730468,0.00012552647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000846895,0.00024037599,0.0007387669,0.00011804586,0.00027467794,0.00002499129,0.00029554532,0.00023169446,0.0001615323],"category_scores_gemma":[0.004020769,0.00019411524,0.00016822622,0.000036183195,0.0006114785,0.000050527164,0.00014218995,0.00016294196,0.000041975607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011789682,0.0007552341,0.9107049,0.00032461426,0.00011348692,0.0066163694,0.00043136257,0.0000044641906,0.07468112,0.00075849105,0.0023068695,0.0021241072],"study_design_scores_gemma":[0.003069729,0.004228388,0.9843024,0.000053604956,0.00019899267,0.0008458381,0.000009755777,0.0000248201,0.0058307764,0.0010903361,0.00019214039,0.00015322205],"about_ca_topic_score_codex":0.00020946747,"about_ca_topic_score_gemma":0.00033267494,"teacher_disagreement_score":0.07359748,"about_ca_system_score_codex":0.00007855443,"about_ca_system_score_gemma":0.000100717385,"threshold_uncertainty_score":0.791579},"labels":[],"label_agreement":null},{"id":"W2597425187","doi":"10.1200/jco.2013.31.15_suppl.tps4594","title":"A phase II multicenter study of the efficacy and safety of sunitinib given on an individualized schedule as first-line therapy for metastatic renal cell cancer.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Baker Hughes (Canada); Cancer Care Ontario; Queen Elizabeth II Health Sciences Centre; Centre Hospitalier de l’Université de Montréal; Ozmosis Research (Canada); Lakeridge Health; Ottawa Hospital; Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Toxicity; Sunitinib; Internal medicine; Phases of clinical research; Urology; Oncology; Cancer; Gastroenterology; Surgery","score_opus":0.17033965749960592,"score_gpt":0.48658810486254805,"score_spread":0.3162484473629421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597425187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939562,0.0003465195,0.000016363008,0.0030908037,0.0002523954,0.0021534387,0.000026276812,0.000002774927,0.00015521196],"genre_scores_gemma":[0.99643636,0.00045643,0.0020316653,0.00066533673,0.00022758909,0.000043550837,0.0000039336132,0.000019811721,0.00011534977],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9962155,0.00080830697,0.00219333,0.00019568397,0.00040216852,0.00018497708],"domain_scores_gemma":[0.99283177,0.0036686445,0.0023326906,0.00028892362,0.00060444785,0.00027352353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019063501,0.0001740486,0.0015283764,0.00010165991,0.000076382756,0.000005253474,0.00020230439,0.00012859487,0.00023257257],"category_scores_gemma":[0.0012906053,0.00009071892,0.00035022022,0.00010319145,0.00021438736,0.0000751638,0.00006199191,0.00047488033,0.0000013054845],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22607736,0.3150481,0.06412298,0.00030857738,0.006125006,0.00023099374,0.009994343,0.00034871532,0.012373489,0.000040504354,0.0014854766,0.36384445],"study_design_scores_gemma":[0.2661724,0.45325735,0.26159212,0.00026052803,0.0018882162,0.0000419594,0.0012427464,0.00026889116,0.010578804,0.00010266203,0.004471649,0.00012267314],"about_ca_topic_score_codex":0.00012859433,"about_ca_topic_score_gemma":0.00008101331,"teacher_disagreement_score":0.3637218,"about_ca_system_score_codex":0.00007053015,"about_ca_system_score_gemma":0.0005745248,"threshold_uncertainty_score":0.369941},"labels":[],"label_agreement":null},{"id":"W2597805329","doi":"10.1200/jco.2013.31.15_suppl.4586","title":"First-, second-, third-line therapy for metastatic renal cell carcinoma (mRCC): Benchmarks for trials design from the International mRCC Database Consortium (IMDC).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of Toronto; Cancer Care Ontario; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Baker Hughes (Canada)","funders":"","keywords":"Medicine; Context (archaeology); Renal cell carcinoma; Internal medicine; Proportional hazards model; Oncology; Clinical trial; Population; Overall survival; Surgery","score_opus":0.3180546292660904,"score_gpt":0.45724678382809447,"score_spread":0.13919215456200407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597805329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9150489,0.0033038452,0.027908549,0.043307535,0.0039973278,0.005052211,0.00046141585,0.000014412114,0.0009057841],"genre_scores_gemma":[0.88022405,0.0007723996,0.104071885,0.008902572,0.004494311,0.00036365885,0.00026995645,0.000051340376,0.0008497998],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.992684,0.0013047758,0.0046062237,0.00042508473,0.00057348993,0.00040644762],"domain_scores_gemma":[0.9394904,0.054360077,0.003885246,0.00049891457,0.0012773761,0.00048799362],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.012161685,0.00033625367,0.0026222405,0.00012946692,0.00012339257,0.00005690004,0.00060286943,0.00031604286,0.0033394552],"category_scores_gemma":[0.0108052725,0.0001793883,0.0015956274,0.00008588836,0.00024753495,0.00023532314,0.00007906719,0.00080712594,0.000029377563],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06683035,0.0070180222,0.015186493,0.00012774902,0.005664642,0.0005725453,0.00049526204,0.00020950705,0.013296279,0.00020383744,0.82837677,0.062018532],"study_design_scores_gemma":[0.15056917,0.08473667,0.119242914,0.00028501937,0.006243817,0.0006382926,0.0009291276,0.008605941,0.044792566,0.010406835,0.572823,0.00072668504],"about_ca_topic_score_codex":0.0000991273,"about_ca_topic_score_gemma":0.00007075229,"teacher_disagreement_score":0.2555538,"about_ca_system_score_codex":0.00024130844,"about_ca_system_score_gemma":0.0021006109,"threshold_uncertainty_score":0.99757165},"labels":[],"label_agreement":null},{"id":"W2598071611","doi":"10.1200/jco.2017.35.6_suppl.492","title":"Real world experience of immuno-oncology agents in metastatic renal cell carcinoma: Results from the IMDC.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; University of Alberta; Université de Montréal; Queen Elizabeth II Health Sciences Centre; McMaster University; London Health Sciences Centre; University of Calgary","funders":"","keywords":"Medicine; Nivolumab; Ipilimumab; Avelumab; Pembrolizumab; Atezolizumab; Renal cell carcinoma; Internal medicine; Oncology; Population; Cancer; Immunotherapy","score_opus":0.2582689320801057,"score_gpt":0.4875456563478964,"score_spread":0.22927672426779067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598071611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97189754,0.00045492983,0.00000767137,0.0065031755,0.001341131,0.00032305068,0.000021071954,0.0000034564828,0.019447945],"genre_scores_gemma":[0.9935657,0.0005507961,0.0037776898,0.0005959725,0.0007119542,0.000009092597,0.000007867093,0.000019506771,0.0007614267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99325156,0.0011968203,0.004267268,0.00034095132,0.00058016187,0.00036325393],"domain_scores_gemma":[0.9861142,0.0064118775,0.0057490245,0.0009974599,0.00038991214,0.00033751325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004594345,0.00022588669,0.0022241161,0.0001563013,0.00013245558,0.000022854327,0.0008362674,0.0002668493,0.00014157957],"category_scores_gemma":[0.005081497,0.00013179821,0.00065516966,0.00012490423,0.0009929134,0.00016000569,0.00024283875,0.0011956829,0.00001759134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049075164,0.007262225,0.8351361,0.00004311167,0.00072061416,0.016516067,0.0059697093,0.000044756853,0.007453245,0.000068469264,0.011845617,0.06586493],"study_design_scores_gemma":[0.021418126,0.009519099,0.94585073,0.00011242343,0.00053711503,0.00015212383,0.00067153206,0.00006126935,0.0034507583,0.00023304427,0.017891346,0.000102457954],"about_ca_topic_score_codex":0.0035739192,"about_ca_topic_score_gemma":0.0020140267,"teacher_disagreement_score":0.11071461,"about_ca_system_score_codex":0.00048395598,"about_ca_system_score_gemma":0.0027149657,"threshold_uncertainty_score":0.60833937},"labels":[],"label_agreement":null},{"id":"W2598754923","doi":"10.1200/jco.2004.22.90140.1556","title":"Microvessel density predicts behavior in pediatric optic pathway/hypothalamic gliomas","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Immunostaining; Vascular endothelial growth factor; Pathology; Chemotherapy; Immunohistochemistry; Angiogenesis; Glioma; Radiation therapy; Internal medicine; VEGF receptors; Cancer research","score_opus":0.09444963013180507,"score_gpt":0.39969091682876323,"score_spread":0.30524128669695816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598754923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99453175,0.0010151973,0.000030500369,0.0017145908,0.0011697292,0.00037039616,0.0000020120212,0.000013492869,0.0011523037],"genre_scores_gemma":[0.99102247,0.0005973413,0.00637391,0.00051042816,0.0013435547,0.000007670175,0.0000027865692,0.000025418967,0.00011641953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959325,0.00028290716,0.0026753943,0.00027647926,0.0004723587,0.00036036537],"domain_scores_gemma":[0.9964833,0.0009471119,0.0013925383,0.00027240513,0.00035927058,0.00054534426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020664767,0.00020702844,0.0016127246,0.00037755538,0.000027540647,0.000008314892,0.00019082992,0.0005336138,0.000030993513],"category_scores_gemma":[0.001901276,0.00015312569,0.0006204339,0.00031474134,0.00014895195,0.000118135256,0.00006938707,0.0012662194,0.000049331495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002864775,0.008509451,0.9179663,0.000075085256,0.00014249393,0.049300686,0.000119335564,0.000045423967,0.004322365,0.0000735302,0.00027263482,0.016307905],"study_design_scores_gemma":[0.015224658,0.01516904,0.95986855,0.00006109543,0.0008349305,0.005594393,0.000040319384,0.0000050425997,0.0024092996,0.00030463366,0.00037291666,0.000115140196],"about_ca_topic_score_codex":0.000047347727,"about_ca_topic_score_gemma":0.00006936388,"teacher_disagreement_score":0.04370629,"about_ca_system_score_codex":0.000713231,"about_ca_system_score_gemma":0.0032592718,"threshold_uncertainty_score":0.62442845},"labels":[],"label_agreement":null},{"id":"W2598784832","doi":"10.1111/bju.13736","title":"Size is no barrier: robot‐assisted partial nephrectomy in patients with a high body mass index","year":2017,"lang":"en","type":"letter","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Body mass index; Nephrectomy; Cohort; Incidence (geometry); Surgery; Comorbidity; Renal function; Multivariate analysis; Prospective cohort study; Retrospective cohort study; Internal medicine; Kidney","score_opus":0.009480921733011407,"score_gpt":0.22339868481084593,"score_spread":0.21391776307783453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598784832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86094517,0.0023209474,0.00005269529,0.13052705,0.0023846147,0.0016326125,0.0002065193,0.000036313384,0.0018940822],"genre_scores_gemma":[0.8687603,0.00015705176,0.0005510641,0.12511489,0.003575162,0.000041308995,0.00013197793,0.00012879216,0.0015394991],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99644905,0.00033824376,0.0010240594,0.00052337436,0.0009295048,0.00073574187],"domain_scores_gemma":[0.9968133,0.00020591353,0.0014300584,0.0005584313,0.0007160588,0.00027625758],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00026753478,0.00047340716,0.0016727527,0.00032088693,0.00010488981,0.00010881052,0.0004393562,0.0011378948,0.0008390687],"category_scores_gemma":[0.00037163176,0.0004378754,0.00035478323,0.000100859055,0.00026581713,0.00015710025,0.00007281042,0.00354447,0.00004588704],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00425724,0.0003985437,0.3894991,0.0001421353,0.0010720788,0.15012757,0.000023479943,0.000007856775,0.00004448465,2.6374846e-7,0.44932258,0.005104639],"study_design_scores_gemma":[0.015804108,0.004676248,0.76481265,0.00048580262,0.00079701527,0.012663456,0.0000016617106,0.000007907941,0.000025791192,0.000033121432,0.20036346,0.0003287969],"about_ca_topic_score_codex":0.00040011635,"about_ca_topic_score_gemma":0.000036353005,"teacher_disagreement_score":0.37531352,"about_ca_system_score_codex":0.0003209213,"about_ca_system_score_gemma":0.0005883689,"threshold_uncertainty_score":0.9998073},"labels":[],"label_agreement":null},{"id":"W2598814209","doi":"10.1200/jco.2013.31.15_suppl.2534","title":"Phase I trial of trebananib (AMG 386) plus temsirolimus (Tr + T) in patients (pts) with advanced solid tumors (PJC-008/NCI#9041).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; University Health Network; Juravinski Cancer Centre; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Adverse effect; Mucositis; Peripheral edema; Internal medicine; Nausea; Tolerability; Rash; Temsirolimus; Gastroenterology; Pharmacology; Toxicity; PI3K/AKT/mTOR pathway","score_opus":0.08051871756361849,"score_gpt":0.4348607984110177,"score_spread":0.3543420808473992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598814209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99370676,0.00016273998,0.000022241764,0.0011572217,0.00094823196,0.0013526372,0.000005287028,0.0000098634,0.0026349912],"genre_scores_gemma":[0.9963778,0.00014705939,0.0017872372,0.00056571624,0.0007556687,0.00003099743,0.000009285712,0.000040256302,0.00028592552],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99323505,0.0007312763,0.0044019436,0.0003409263,0.00082651083,0.00046430557],"domain_scores_gemma":[0.99269956,0.0018822819,0.0035246748,0.00040366902,0.00082271,0.00066708634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019770574,0.00030917948,0.0032443793,0.00032537378,0.000034084434,0.000008866068,0.00025923716,0.00039822285,0.00023871774],"category_scores_gemma":[0.002513694,0.00019408653,0.0006103463,0.00027468143,0.00031283312,0.00023348528,0.00005897815,0.0012521321,0.000045886914],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5587406,0.04372878,0.075976156,0.0001085491,0.0008347723,0.002518749,0.00046659954,0.00017836665,0.00089703506,0.00002852219,0.0022971532,0.3142247],"study_design_scores_gemma":[0.5339956,0.24664718,0.21503764,0.0002863543,0.0005134399,0.00016770982,0.00020689749,0.00012340698,0.00064887333,0.00015442794,0.0020241577,0.0001942658],"about_ca_topic_score_codex":0.00012616404,"about_ca_topic_score_gemma":0.00007255079,"teacher_disagreement_score":0.31403044,"about_ca_system_score_codex":0.000660984,"about_ca_system_score_gemma":0.0023799532,"threshold_uncertainty_score":0.79146194},"labels":[],"label_agreement":null},{"id":"W2598832696","doi":"10.1200/jco.2017.35.6_suppl.522","title":"Analysis of overall survival (OS) based on tumor target lesion change in the phase 3 METEOR trial of cabozantinib (cabo) versus everolimus (eve) in advanced renal cell carcinoma (RCC).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Durham; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Lesion; Target lesion; Cabozantinib; Renal cell carcinoma; Urology; Internal medicine; Nuclear medicine; Surgery","score_opus":0.2587199908589407,"score_gpt":0.4938968465033816,"score_spread":0.2351768556444409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598832696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99383694,0.00017030878,0.000012240145,0.0016772053,0.0011302507,0.00073668343,0.00003507314,0.0000024949916,0.0023987836],"genre_scores_gemma":[0.99800545,0.00010311207,0.00077111245,0.00043089688,0.0006034652,0.00001843306,0.000020616491,0.000020030822,0.00002686818],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99320966,0.0017036627,0.003391696,0.00035484778,0.0009755712,0.00036455094],"domain_scores_gemma":[0.98846614,0.005328795,0.004788816,0.0008273338,0.0003414099,0.00024747243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070916764,0.0002728474,0.0032821167,0.0007411606,0.00005088786,0.000009902614,0.00056707585,0.0003226816,0.00016339176],"category_scores_gemma":[0.004384451,0.00017159298,0.0013377948,0.0003678411,0.00026484605,0.00014795233,0.00007177767,0.0010350073,0.0000025257757],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7388015,0.015790831,0.22540712,0.0000775807,0.0006609631,0.0037985449,0.00029984498,0.0005522818,0.002158913,0.000024043922,0.00012722009,0.012301147],"study_design_scores_gemma":[0.28338864,0.05163943,0.6577479,0.00009150256,0.00193159,0.000008879254,0.000083245475,0.0022562807,0.0020758705,0.000014824688,0.0006482378,0.00011356877],"about_ca_topic_score_codex":0.00046482933,"about_ca_topic_score_gemma":0.00050056604,"teacher_disagreement_score":0.45541286,"about_ca_system_score_codex":0.00024087995,"about_ca_system_score_gemma":0.0011177069,"threshold_uncertainty_score":0.6997359},"labels":[],"label_agreement":null},{"id":"W2599229094","doi":"10.1200/jco.2017.35.6_suppl.458","title":"Sunitinib dose escalation after disease progression in metastatic renal cell carcinoma.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Toxicity; Internal medicine; Progression-free survival; Tumor progression; Clear cell renal cell carcinoma; Oncology; Retrospective cohort study; Surgery; Urology; Cancer; Overall survival","score_opus":0.15509539644251874,"score_gpt":0.47761155820560264,"score_spread":0.3225161617630839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599229094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896836,0.00081010745,0.000027854874,0.004651462,0.00058169273,0.00035384388,0.0000033316367,0.0000046255363,0.0038834536],"genre_scores_gemma":[0.9946802,0.000119798555,0.0036661555,0.00042056295,0.00068598863,0.000016266744,0.0000055176733,0.000019381103,0.00038609654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99647367,0.00054787146,0.002012925,0.0002247757,0.0004800623,0.0002606721],"domain_scores_gemma":[0.9955266,0.00079434935,0.0021840853,0.00045745232,0.00031059943,0.0007269249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024725394,0.00016847128,0.0011498119,0.00017565087,0.00006800543,0.000027861619,0.00020121159,0.0001810446,0.00017615012],"category_scores_gemma":[0.002594596,0.00010971746,0.00049635646,0.00005416522,0.00024407009,0.00022876752,0.00008934687,0.0008343393,0.000033445387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017492713,0.0031931398,0.87294644,0.000082831546,0.000067744964,0.018133614,0.00008149511,0.000008899592,0.00024931724,0.000013787477,0.00038868372,0.08734133],"study_design_scores_gemma":[0.012028455,0.0069322577,0.9757997,0.00020726814,0.0005839116,0.00015483092,0.000029199893,0.00014599609,0.00034392579,0.00030597698,0.0033751454,0.00009333259],"about_ca_topic_score_codex":0.000020045942,"about_ca_topic_score_gemma":0.000034389905,"teacher_disagreement_score":0.10285326,"about_ca_system_score_codex":0.00021450648,"about_ca_system_score_gemma":0.0015000615,"threshold_uncertainty_score":0.44741482},"labels":[],"label_agreement":null},{"id":"W2599666249","doi":"10.1200/jco.2017.35.6_suppl.527","title":"CLOVIZ: Clinical outcomes visualization of IMDC criteria in metastatic renal cell carcinoma for patient-centered decision making.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Usability; Likert scale; Renal cell carcinoma; Visualization; Cohort; Medical decision making; Internal medicine; Medical physics; Oncology; Family medicine; Data mining; Computer science; Statistics","score_opus":0.23361126024498824,"score_gpt":0.5369498648941909,"score_spread":0.3033386046492027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599666249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99356264,0.00019583302,0.0019097427,0.00094708946,0.0022087113,0.00063668913,0.000012420928,0.0000060611046,0.00052079646],"genre_scores_gemma":[0.9722346,0.000109144465,0.02647173,0.00070428307,0.00037786353,0.000009123517,0.000006726641,0.000039386185,0.000047165428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9921993,0.0007800343,0.0058606896,0.00033337716,0.0005237699,0.000302842],"domain_scores_gemma":[0.98648804,0.005743672,0.0060633123,0.0005782039,0.0008050077,0.00032176424],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0050256485,0.00022732036,0.0027258948,0.0002633304,0.000059079786,0.000023669096,0.00035537605,0.0003703953,0.000070900154],"category_scores_gemma":[0.012864078,0.00015555766,0.0012930703,0.00006951906,0.00028157674,0.00018805261,0.00014271273,0.0005277923,0.000005209016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015882298,0.004427541,0.87285,0.000119420365,0.00020532617,0.00089161115,0.00011004211,0.000006356117,0.00023691216,0.000041420502,0.0015775424,0.10365153],"study_design_scores_gemma":[0.02348733,0.028160043,0.94226366,0.00023417415,0.00076820643,0.00014027288,0.00007601282,0.0004197793,0.000721126,0.0006771449,0.0029330377,0.00011921103],"about_ca_topic_score_codex":0.00002112087,"about_ca_topic_score_gemma":0.000051108836,"teacher_disagreement_score":0.10353232,"about_ca_system_score_codex":0.00019250833,"about_ca_system_score_gemma":0.0010309765,"threshold_uncertainty_score":0.995451},"labels":[],"label_agreement":null},{"id":"W2599893246","doi":"10.1200/jco.2017.35.6_suppl.436","title":"A single-arm biomarker-based phase II trial of savolitinib in patients with advanced papillary renal cell cancer (PRCC).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Oncology; Cancer; Biomarker; Clinical trial","score_opus":0.14825006570547877,"score_gpt":0.45561138248292093,"score_spread":0.30736131677744216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599893246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99312913,0.00028924085,0.0000123369155,0.0017996308,0.00097147113,0.0006886857,0.000018024595,0.0000047035414,0.0030867641],"genre_scores_gemma":[0.9963924,0.00012367043,0.0024465153,0.00039026162,0.0004976198,0.000013206783,0.000008709014,0.000026212445,0.00010138013],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957071,0.00038347061,0.002684342,0.00027409886,0.0006287294,0.00032224832],"domain_scores_gemma":[0.99256635,0.0010880708,0.004752299,0.00050159934,0.00066578476,0.0004259165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016626434,0.00022321728,0.0019905227,0.00019764985,0.00008342808,0.000009165954,0.00027465547,0.00033591426,0.00015953132],"category_scores_gemma":[0.002084764,0.00014315391,0.00050332426,0.000090410875,0.0004029895,0.00013894429,0.000070371076,0.0006684236,0.0000021624985],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5365107,0.051577047,0.11948546,0.00007352687,0.00031518308,0.0010880078,0.000050387167,0.000021208458,0.0017410559,0.000002753534,0.00044792844,0.28868675],"study_design_scores_gemma":[0.42087132,0.2802578,0.28732306,0.00040213796,0.0005113977,0.000013150432,0.000018017992,0.00003117981,0.003684981,0.00002745432,0.006731369,0.00012815715],"about_ca_topic_score_codex":0.00005340174,"about_ca_topic_score_gemma":0.000070457274,"teacher_disagreement_score":0.2885586,"about_ca_system_score_codex":0.00037006912,"about_ca_system_score_gemma":0.0024420489,"threshold_uncertainty_score":0.58376473},"labels":[],"label_agreement":null},{"id":"W2600306685","doi":"10.1200/jco.2017.35.6_suppl.498","title":"Fourth-line targeted therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Baker Hughes (Canada)","funders":"","keywords":"Medicine; Sorafenib; Sunitinib; Pazopanib; Everolimus; Targeted therapy; Axitinib; Internal medicine; Temsirolimus; Oncology; Renal cell carcinoma; Nivolumab; Cancer; Hepatocellular carcinoma; Immunotherapy; Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway","score_opus":0.2193807385605218,"score_gpt":0.4479544508668474,"score_spread":0.2285737123063256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600306685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.954026,0.0009674381,0.00008745382,0.03821578,0.0022298666,0.00037979078,0.00015899741,0.000006844522,0.003927822],"genre_scores_gemma":[0.98574984,0.0011945148,0.007112867,0.0032039015,0.0020747439,0.000007707042,0.000099577286,0.000026814292,0.00053003785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942618,0.00080728513,0.0034206735,0.0004023805,0.0007755285,0.0003323507],"domain_scores_gemma":[0.98829186,0.00578083,0.003968366,0.0009874575,0.00056335604,0.00040810663],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.005443657,0.0002614838,0.0015205746,0.00013716373,0.00012430869,0.000056474844,0.00093216816,0.00023693543,0.000346274],"category_scores_gemma":[0.008703218,0.00014821353,0.0006096422,0.00007241615,0.00043818203,0.0002390357,0.00020775551,0.0015711836,0.00004943895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10827729,0.010607247,0.6265619,0.000029575305,0.0024490994,0.037260283,0.0010144768,0.00017785966,0.017101567,0.00010239364,0.06064427,0.13577408],"study_design_scores_gemma":[0.047930878,0.009637648,0.88701767,0.000115682604,0.00048605117,0.00039521963,0.00022569786,0.00075179397,0.006271747,0.00035690353,0.046635587,0.00017512208],"about_ca_topic_score_codex":0.00081520906,"about_ca_topic_score_gemma":0.00055091263,"teacher_disagreement_score":0.26045582,"about_ca_system_score_codex":0.0002632635,"about_ca_system_score_gemma":0.0019183259,"threshold_uncertainty_score":0.9996469},"labels":[],"label_agreement":null},{"id":"W2600339273","doi":"","title":"How often are patients with diabetes or hypertension being treated with partial nephrectomy for renal cell carcinoma? A population-based analysis","year":2011,"lang":"en","type":"article","venue":"Journal of Endourology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Kidney disease; Diabetes mellitus; Renal function; Population; Disease; Cohort; Internal medicine; Nephrology; Intensive care medicine; Surgery; Kidney; Endocrinology","score_opus":0.02430044638300483,"score_gpt":0.21070687835710025,"score_spread":0.18640643197409543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600339273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984561,0.00008161547,0.000499107,0.0003236531,0.000041425483,0.00052778324,0.0000127510175,0.000015183999,0.000042385785],"genre_scores_gemma":[0.99279535,0.0000010399486,0.0065037217,0.00035927328,0.00012170309,0.000038459082,0.00007704237,0.000038856248,0.0000645304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984895,0.000111514404,0.00041650716,0.00026697546,0.00034356967,0.00037193458],"domain_scores_gemma":[0.99784386,0.00020134241,0.00080864853,0.00024943627,0.000659045,0.00023766397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013328734,0.0002648259,0.0008990106,0.00056618545,0.00008084413,0.000018332019,0.0000913222,0.00011456142,0.00005067364],"category_scores_gemma":[0.00007437215,0.00014008585,0.00028130037,0.00040299277,0.00005246025,0.0001138181,0.000011638123,0.00019425475,6.85961e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014294297,0.00057596725,0.98214436,0.00003941776,0.0010005299,0.00059675577,0.00005702052,0.0001543974,0.00079565455,0.0000011528293,0.00006112782,0.0002793065],"study_design_scores_gemma":[0.012963093,0.01419054,0.9478347,0.0000421591,0.0072829104,0.00006224261,0.000031241576,0.00064799114,0.01666795,0.0000062534855,0.000115061615,0.00015589838],"about_ca_topic_score_codex":0.0000631607,"about_ca_topic_score_gemma":0.00008058571,"teacher_disagreement_score":0.034309715,"about_ca_system_score_codex":0.00010522924,"about_ca_system_score_gemma":0.00012634051,"threshold_uncertainty_score":0.5712535},"labels":[],"label_agreement":null},{"id":"W2601754066","doi":"10.1200/jco.2017.35.6_suppl.465","title":"Eligibility criteria and endpoints in metastatic renal cell carcinoma trials.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Toronto; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Clinical trial; Clinical endpoint; Surrogate endpoint; Renal cell carcinoma; Intensive care medicine; Internal medicine; Oncology","score_opus":0.33273249674227,"score_gpt":0.5536609135203823,"score_spread":0.22092841677811226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601754066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871573,0.0010056364,0.000024162846,0.004408589,0.00086289085,0.00030368255,0.0000043980995,0.0000029443029,0.006230435],"genre_scores_gemma":[0.9923629,0.00037278188,0.005928552,0.0004682765,0.0006439843,0.000003848032,0.000001299892,0.000013008276,0.00020534823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99391043,0.0015867134,0.0036475013,0.00027469298,0.00033271973,0.0002479395],"domain_scores_gemma":[0.99181736,0.0036265189,0.0032699977,0.00050099945,0.00026459896,0.0005205124],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.015611756,0.00017255411,0.0029879222,0.00014518476,0.00006487451,0.000033275093,0.00021425608,0.0002444713,0.00018697334],"category_scores_gemma":[0.018199326,0.00011081149,0.00057712966,0.000036669888,0.00034701757,0.00016287077,0.000110739325,0.00087331823,0.000012881121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017101688,0.0036047597,0.8366215,0.00016851437,0.00031521672,0.012289517,0.00024015285,0.0000012875909,0.005423322,0.000043104545,0.003097154,0.12109375],"study_design_scores_gemma":[0.017834915,0.010817447,0.96199006,0.000069714864,0.00067086954,0.0007252826,0.000057871777,0.00004491009,0.0028214003,0.0011605327,0.003720643,0.00008636604],"about_ca_topic_score_codex":0.00009810869,"about_ca_topic_score_gemma":0.00007996899,"teacher_disagreement_score":0.12536852,"about_ca_system_score_codex":0.00018566343,"about_ca_system_score_gemma":0.0011922427,"threshold_uncertainty_score":0.9900708},"labels":[],"label_agreement":null},{"id":"W2601810960","doi":"10.1038/srep44876","title":"Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma","year":2017,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University and Génome Québec Innovation Centre","funders":"Cancer Research UK; Imperial Experimental Cancer Medicine Centre; Génome Québec; World Health Organization","keywords":"Somatic cell; Epigenetics; Autosome; Biology; DNA methylation; Genetics; X chromosome; Chromosome; Germline mutation; Gene; Mutation; Gene expression","score_opus":0.019869977412011786,"score_gpt":0.2534974730658019,"score_spread":0.2336274956537901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601810960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99340343,0.00031834038,0.000016535623,0.0001045584,0.0007021619,0.0006797959,0.0000044162084,0.000008992619,0.0047617587],"genre_scores_gemma":[0.9950437,0.000006322779,0.0005792942,0.0000063448474,0.00003733636,0.0000134311595,0.000023430546,0.000020355163,0.0042697764],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99757165,0.00004301818,0.00074157055,0.0007223967,0.00061637507,0.0003049637],"domain_scores_gemma":[0.99722683,0.000023059807,0.0006517352,0.0016533369,0.00021233957,0.00023271347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083188486,0.0001794393,0.00046051206,0.0003555074,0.00015157042,0.00006092327,0.00013406585,0.000098912526,0.00006649323],"category_scores_gemma":[0.0000924748,0.00015821577,0.000106545835,0.00022083678,0.00048805802,0.00011141952,0.0001310179,0.00010024093,0.000009238652],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000118511154,0.0001701001,0.2757523,0.00025609377,0.0000061122287,0.00061682536,0.0007192657,0.00017830604,0.7212695,0.0000056432127,0.00036408642,0.0005432516],"study_design_scores_gemma":[0.00047850062,0.00029726417,0.444136,0.000077682635,0.000043629156,0.00010867665,0.000037000802,0.00009362663,0.55428517,0.00019699548,0.00016043999,0.000085005486],"about_ca_topic_score_codex":0.00033741532,"about_ca_topic_score_gemma":0.000051103798,"teacher_disagreement_score":0.16838369,"about_ca_system_score_codex":0.00011733089,"about_ca_system_score_gemma":0.00020927239,"threshold_uncertainty_score":0.6451852},"labels":[],"label_agreement":null},{"id":"W2601946099","doi":"10.1200/jco.2014.32.15_suppl.tps5629","title":"Phase II study of XL184 (cabozantinib) in recurrent or metastatic endometrial cancer: A trial of the PMH, Chicago, and California Phase II Consortia.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Juravinski Cancer Centre; University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cabozantinib; Oncology; Internal medicine; Clinical endpoint; Endometrial cancer; Progression-free survival; Cancer; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Chemotherapy; Clinical trial","score_opus":0.2113546195443331,"score_gpt":0.511895850200911,"score_spread":0.3005412306565779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601946099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99414915,0.000624668,0.000013329101,0.0016058736,0.0017569202,0.0016274707,0.000040687304,0.0000031665902,0.00017875417],"genre_scores_gemma":[0.99795806,0.0005898128,0.0003828037,0.00019087293,0.00077240256,0.000027465596,0.0000018003557,0.000016591048,0.000060203532],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99190444,0.0020427767,0.0048182043,0.00027338185,0.000701482,0.00025969523],"domain_scores_gemma":[0.9894746,0.00530833,0.0041488144,0.00034513857,0.00038538274,0.0003377624],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.006396315,0.00022144734,0.0031870632,0.0003214852,0.000065588814,0.0000042547526,0.00023225028,0.00018690094,0.00019099482],"category_scores_gemma":[0.015403739,0.00011311355,0.0005305377,0.0004536645,0.00039895638,0.000050362138,0.00016831141,0.0009449039,9.5270883e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.56635445,0.116809465,0.0104525,0.00008994692,0.0012868098,0.00034787334,0.0007386809,0.0000096294925,0.0009685119,0.00002157095,0.00054745574,0.30237308],"study_design_scores_gemma":[0.5682879,0.41388458,0.004729067,0.00017221906,0.0022236565,0.00014107501,0.00027468035,0.00014012695,0.0006639686,0.000052218806,0.009346595,0.00008388127],"about_ca_topic_score_codex":0.0001394787,"about_ca_topic_score_gemma":0.00040394097,"teacher_disagreement_score":0.3022892,"about_ca_system_score_codex":0.00011130865,"about_ca_system_score_gemma":0.001806385,"threshold_uncertainty_score":0.99288994},"labels":[],"label_agreement":null},{"id":"W2602047891","doi":"10.1200/jco.2017.35.15_suppl.4514","title":"Phase II study of individualized sunitinib (SUN) as first-line therapy for metastatic renal cell cancer.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ozmosis Research (Canada); Queen Elizabeth II Health Sciences Centre; Juravinski Cancer Centre; McMaster University; London Health Sciences Centre; BC Cancer Agency; Princess Margaret Cancer Centre; Centre Hospitalier de l’Université de Montréal; Regional Municipality of Durham; CancerCare Manitoba; University Health Network; Ottawa Regional Cancer Foundation; Sunnybrook Hospital","funders":"","keywords":"Medicine; Toxicity; Clinical endpoint; Dosing; Internal medicine; Sunitinib; Phases of clinical research; Urology; Gastroenterology; Cancer; Surgery; Clinical trial; Oncology","score_opus":0.3432465780227212,"score_gpt":0.5581823151220743,"score_spread":0.2149357370993531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602047891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99029624,0.0009643786,0.000057940826,0.004863141,0.000882628,0.0012588568,0.000029586206,0.000005840336,0.0016413686],"genre_scores_gemma":[0.99277186,0.0017145146,0.0029679642,0.00068644236,0.0009809901,0.000054569213,0.0000072227585,0.000031700187,0.00078473735],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99533933,0.00047701862,0.0030687887,0.00025785863,0.0005668878,0.00029008908],"domain_scores_gemma":[0.9896321,0.0029365604,0.0055485116,0.0005472865,0.000896271,0.00043926397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038017556,0.00023150745,0.0026049337,0.00015966225,0.00024218966,0.000016305883,0.0004382442,0.00020734062,0.00036858555],"category_scores_gemma":[0.0031226382,0.00014921036,0.0007649578,0.00006511908,0.0002619792,0.0001218603,0.000100234545,0.00064035767,0.000004210951],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.121316165,0.16013046,0.03445559,0.00020590292,0.006375534,0.0033018528,0.0026036496,0.000057853387,0.0028858387,0.000054675907,0.0059177256,0.66269475],"study_design_scores_gemma":[0.2588041,0.609192,0.05217171,0.00016570235,0.003328853,0.000233869,0.0006166776,0.00006192561,0.0076721287,0.0005757658,0.06698743,0.00018979482],"about_ca_topic_score_codex":0.00021363102,"about_ca_topic_score_gemma":0.00021803188,"teacher_disagreement_score":0.662505,"about_ca_system_score_codex":0.00012368588,"about_ca_system_score_gemma":0.0018192002,"threshold_uncertainty_score":0.6084622},"labels":[],"label_agreement":null},{"id":"W2602358743","doi":"10.1200/jco.2017.35.6_suppl.468","title":"Individualized treatment with sunitinib versus standard dosing with sunitinib or pazopanib in patients with metastatic renal cell carcinoma (mRCC): Results from the Canadian Kidney Cancer information system (CKCis).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of Toronto; Ottawa Hospital; University Health Network; CancerCare Manitoba; McMaster University; Sunnybrook Health Science Centre; Montreal General Hospital; Juravinski Cancer Centre; University of Calgary; Princess Margaret Cancer Centre; Hôtel-Dieu de Québec; BC Cancer Agency; University of Alberta; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Pazopanib; Sunitinib; Renal cell carcinoma; Internal medicine; Dosing; Urology; Proportional hazards model; Oncology; Toxicity; Kidney cancer; Gastroenterology","score_opus":0.13482162064300587,"score_gpt":0.39222614925670485,"score_spread":0.257404528613699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602358743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98917377,0.000055772296,0.000010499621,0.003318341,0.00047893677,0.0011475171,0.0008226143,0.000009875316,0.004982645],"genre_scores_gemma":[0.9954277,0.000046408804,0.0032585817,0.0005926777,0.0003152623,0.000039474304,0.0002059325,0.000035624995,0.00007833218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99517876,0.0007256301,0.002247302,0.0002963263,0.0010297261,0.0005222425],"domain_scores_gemma":[0.99118346,0.0019957742,0.0040000575,0.000687201,0.0010385108,0.0010949945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018460376,0.00039115432,0.0017875952,0.00024821234,0.00039946058,0.00015715942,0.00036622753,0.00023650755,0.00006602369],"category_scores_gemma":[0.0011586382,0.00017157698,0.00018119106,0.00017859077,0.00039815556,0.000490081,0.000041981693,0.0008454407,0.0000071176837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37671155,0.0006885816,0.5903329,0.00006644204,0.0014223827,0.0035297468,0.0021686747,0.00008320955,0.0000016907096,0.0000134701495,0.0007078579,0.024273472],"study_design_scores_gemma":[0.16854893,0.07688274,0.73491323,0.000941234,0.0025296495,0.00011695984,0.0013517397,0.00003270366,0.0001914213,0.000002588156,0.014257013,0.0002317903],"about_ca_topic_score_codex":0.09782696,"about_ca_topic_score_gemma":0.3644581,"teacher_disagreement_score":0.26663116,"about_ca_system_score_codex":0.0029866411,"about_ca_system_score_gemma":0.015487612,"threshold_uncertainty_score":0.99009365},"labels":[],"label_agreement":null},{"id":"W2602579884","doi":"10.1200/jco.2013.31.15_suppl.tps4590","title":"ASPEN: A randomized phase II trial of everolimus versus sunitinib in patients with metastatic non-clear cell renal cell carcinoma.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Sunitinib; Everolimus; Chromophobe cell; Clinical endpoint; Internal medicine; Oncology; Renal cell carcinoma; Clear cell renal cell carcinoma; Clinical trial; Randomized controlled trial; Pathology; Clear cell","score_opus":0.08744602347207388,"score_gpt":0.3995117048112673,"score_spread":0.31206568133919343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602579884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895521,0.00013764662,0.000028999611,0.0005455254,0.0008742921,0.0021949012,0.0000056066,0.000004401433,0.006656549],"genre_scores_gemma":[0.9950519,0.00006428062,0.0039284476,0.00024500367,0.0003667096,0.000033444092,0.000012920219,0.000034799166,0.000262486],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99290305,0.0014731152,0.0041429847,0.00028403933,0.0008079864,0.00038882022],"domain_scores_gemma":[0.9892212,0.0053639896,0.0036156697,0.00034973692,0.00087951275,0.00056986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034765578,0.0002943197,0.004095801,0.00034111438,0.00003645084,0.000009074457,0.00022647735,0.00027538126,0.0005796508],"category_scores_gemma":[0.001954313,0.00017906811,0.00093116146,0.00023601753,0.00037740238,0.00017348675,0.000078962694,0.0010661626,0.000038637274],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96542144,0.022132633,0.0038169404,0.000060652197,0.00046182534,0.00064039073,0.00019624076,0.000017826469,0.00019393618,0.0000028177183,0.00073665055,0.006318628],"study_design_scores_gemma":[0.7747268,0.20248024,0.019570628,0.00006047329,0.0016902424,0.000016812104,0.000104080864,0.000097777636,0.0008231975,0.000033648914,0.00027689524,0.0001191705],"about_ca_topic_score_codex":0.00015333499,"about_ca_topic_score_gemma":0.000018174378,"teacher_disagreement_score":0.19069463,"about_ca_system_score_codex":0.00023732749,"about_ca_system_score_gemma":0.0016833103,"threshold_uncertainty_score":0.7302186},"labels":[],"label_agreement":null},{"id":"W2602842511","doi":"10.1200/jco.2017.35.6_suppl.482","title":"Clinical activity of PD1/PDL1 inhibitors in metastatic non-clear cell renal cell carcinoma (nccRCC).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Chromophobe cell; Oncology; Clear cell; Cohort; Clinical trial; Cabozantinib; Blockade; Clear cell renal cell carcinoma; Urology; Receptor","score_opus":0.15790196786822377,"score_gpt":0.4646922793092297,"score_spread":0.3067903114410059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602842511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780465,0.00035724122,0.000053424228,0.002091426,0.0018760513,0.00043260158,0.000006060466,0.00000528682,0.017131414],"genre_scores_gemma":[0.99185556,0.0004028603,0.005157986,0.00033463116,0.0012745913,0.0000046562895,0.0000017399565,0.000041507334,0.00092648616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9919175,0.0012752209,0.005088187,0.000468456,0.00076421,0.00048642443],"domain_scores_gemma":[0.9869881,0.0037955192,0.0069009517,0.00094329345,0.00053340656,0.00083867833],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008072344,0.00032823632,0.0037445102,0.00027855122,0.000090801484,0.000021383841,0.00058364804,0.00064108364,0.00015472477],"category_scores_gemma":[0.004017571,0.00023773534,0.0016410612,0.00012214266,0.0007909332,0.00026089622,0.00025627355,0.0025152455,0.000059573562],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01362176,0.010929278,0.8878405,0.00022422896,0.00029986494,0.006989076,0.00013227227,0.000018039578,0.0077355127,0.0000061018136,0.003784795,0.06841859],"study_design_scores_gemma":[0.020340882,0.03281892,0.9230026,0.00016396967,0.0009277332,0.00020208374,0.000087489316,0.00018018954,0.017603135,0.000093788214,0.0043964144,0.0001827816],"about_ca_topic_score_codex":0.00023249861,"about_ca_topic_score_gemma":0.00010858257,"teacher_disagreement_score":0.06823581,"about_ca_system_score_codex":0.00030703546,"about_ca_system_score_gemma":0.0029494881,"threshold_uncertainty_score":0.999786},"labels":[],"label_agreement":null},{"id":"W2603947135","doi":"10.1200/jco.2014.32.15_suppl.4576","title":"The impact of body mass index (BMI) on treatment outcome of targeted therapy in metastatic renal cell carcinoma (mRCC): Results from the International Metastatic Renal Cell Cancer Database Consortium.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Ottawa Regional Cancer Foundation; Queen Elizabeth II Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Underweight; Overweight; Renal cell carcinoma; Internal medicine; Body mass index; Obesity; Cancer; Gastroenterology","score_opus":0.15217479311176552,"score_gpt":0.4540940458671373,"score_spread":0.3019192527553718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603947135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99287945,0.0010588462,0.00008787436,0.0032079164,0.0006630459,0.000612896,0.00041380696,0.00000411726,0.001072051],"genre_scores_gemma":[0.996141,0.0013463602,0.001298867,0.00038883003,0.00042511022,0.000023056458,0.00007161412,0.000031147854,0.0002739954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9918057,0.0019299258,0.004585977,0.0003758715,0.00092785456,0.00037470637],"domain_scores_gemma":[0.97931665,0.01449605,0.0046204044,0.00070298027,0.00053869816,0.00032522343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00479433,0.00037944157,0.002189866,0.00020950957,0.000055636276,0.000016508151,0.0005692543,0.00015775718,0.00021730183],"category_scores_gemma":[0.0023457818,0.00016405286,0.0011484339,0.00021340996,0.00041485674,0.00009298095,0.0000668378,0.00094870804,0.0000075248513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07706127,0.008458189,0.8489589,0.00003136992,0.0037772115,0.0011429113,0.00046422434,0.003059312,0.028831491,0.000037478316,0.003913368,0.02426426],"study_design_scores_gemma":[0.040752213,0.03395914,0.89471114,0.00011738409,0.001022082,0.000049408398,0.00023479476,0.0021474508,0.024134824,0.00024438323,0.0024647545,0.00016242023],"about_ca_topic_score_codex":0.0040712105,"about_ca_topic_score_gemma":0.0005717665,"teacher_disagreement_score":0.04575223,"about_ca_system_score_codex":0.00080952985,"about_ca_system_score_gemma":0.0020752538,"threshold_uncertainty_score":0.66898817},"labels":[],"label_agreement":null},{"id":"W2603971309","doi":"10.1200/jco.2017.35.6_suppl.493","title":"Proton pump inhibitors (PPIs) and survival outcomes in patients with metastatic renal cell carcinoma (mRCC).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Sunitinib; Internal medicine; Sorafenib; Axitinib; Hazard ratio; Proportional hazards model; Oncology; Confidence interval; Renal cell carcinoma; Cohort; Adverse effect; Cancer; Hepatocellular carcinoma","score_opus":0.09226972924427522,"score_gpt":0.4067554915371706,"score_spread":0.3144857622928954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603971309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994206,0.000085312975,0.000005659942,0.0020329177,0.00056998484,0.000765321,0.0000038522126,0.000003868112,0.0023270862],"genre_scores_gemma":[0.9977148,0.00003636079,0.0015075165,0.00021776838,0.00024551328,0.000012876054,0.000002988743,0.00002319322,0.00023893932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99653196,0.00041891568,0.0019069737,0.0002637678,0.00058812223,0.0002902655],"domain_scores_gemma":[0.9955315,0.00093106256,0.0023557327,0.0003891335,0.00033132182,0.00046122578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021680195,0.00022217615,0.0019735924,0.00016665032,0.000080234444,0.00002871738,0.00019515953,0.00019925102,0.00003682635],"category_scores_gemma":[0.0015075417,0.00012740589,0.00025459248,0.00004720688,0.00033521655,0.00021069228,0.000102688646,0.0008707477,0.000008161955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051894737,0.0025298554,0.9809965,0.00006814853,0.00017845306,0.0015284714,0.000066136075,0.0000019327165,0.000033233315,0.0000064910796,0.00008260567,0.009318705],"study_design_scores_gemma":[0.027001021,0.025054606,0.94539255,0.00007634474,0.00044209944,0.000061030005,0.000048144724,0.000008026968,0.00054884376,0.000055384444,0.0011980928,0.000113829476],"about_ca_topic_score_codex":0.00010170788,"about_ca_topic_score_gemma":0.000096047115,"teacher_disagreement_score":0.035603918,"about_ca_system_score_codex":0.00019198832,"about_ca_system_score_gemma":0.0008255568,"threshold_uncertainty_score":0.5195461},"labels":[],"label_agreement":null},{"id":"W2604127247","doi":"10.1089/end.2016.0787","title":"A Multicentered, Propensity Matched Analysis Comparing Laparoscopic and Open Surgery for pT3a Renal Cell Carcinoma","year":2017,"lang":"en","type":"article","venue":"Journal of Endourology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier universitaire de Québec; Ottawa Hospital; University of Alberta; SAIT Polytechnic; University of Calgary; University of Ottawa; McGill University; Dalhousie University; University of Toronto; University of British Columbia; Public Health Ontario; McMaster University; Cancer Care Ontario; University of Manitoba","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Propensity score matching; Nephrology; Kidney cancer; Subgroup analysis; Stage (stratigraphy); Surgery; Clinical endpoint; Urology; Laparoscopy; Laparoscopic surgery; Kidney; Internal medicine; Confidence interval; Randomized controlled trial","score_opus":0.10869388072068821,"score_gpt":0.3276355282356603,"score_spread":0.21894164751497208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604127247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966187,0.00045073451,0.00022580146,0.0013435835,0.00019714837,0.000497889,0.0000056171098,0.000004401495,0.00065610965],"genre_scores_gemma":[0.99708885,0.000036086763,0.002217573,0.00020213841,0.00017125392,0.000011580272,0.000008473055,0.000017347873,0.0002466676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985995,0.00010421515,0.000579801,0.00024435215,0.0001723298,0.00029974425],"domain_scores_gemma":[0.9976551,0.00032154535,0.0010428431,0.00046434975,0.00026855298,0.00024758631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072186056,0.00017647495,0.0014924487,0.00028230084,0.00021880698,0.0001300119,0.0003212319,0.000091584385,0.00003491693],"category_scores_gemma":[0.00030741713,0.0001304219,0.00033871565,0.00006046741,0.00011753384,0.00019263825,0.00025085596,0.00023418563,0.0000026959474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035516531,0.000268947,0.9824219,0.00008179171,0.000882452,0.0007971917,0.00013200947,0.000019376514,0.010690645,0.000008452645,0.0007866681,0.00035894668],"study_design_scores_gemma":[0.007278052,0.0010466998,0.9713632,0.000039933046,0.0031286003,0.0007497314,0.000040675826,0.0006567659,0.015128193,0.00003761994,0.00042252542,0.00010800132],"about_ca_topic_score_codex":0.00021244634,"about_ca_topic_score_gemma":0.00016906235,"teacher_disagreement_score":0.011058665,"about_ca_system_score_codex":0.00007230569,"about_ca_system_score_gemma":0.00015609081,"threshold_uncertainty_score":0.5318451},"labels":[],"label_agreement":null},{"id":"W2605189400","doi":"10.1200/jco.2012.30.15_suppl.tps2614","title":"A phase I study of BMS-936558 plus sunitinib or pazopanib in patients with metastatic renal cell carcinoma.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Pazopanib; Sunitinib; Temsirolimus; Renal cell carcinoma; Tolerability; Internal medicine; Oncology; Everolimus; Bevacizumab; Pharmacology; Urology; Adverse effect; Chemotherapy; PI3K/AKT/mTOR pathway; Discovery and development of mTOR inhibitors; Apoptosis","score_opus":0.1887988785238983,"score_gpt":0.45908818947588187,"score_spread":0.2702893109519836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605189400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99724203,0.00023116307,0.00002032697,0.00016018968,0.00038903445,0.0009027669,0.0000068017966,0.000004465139,0.0010432113],"genre_scores_gemma":[0.99700546,0.000018138015,0.0021653764,0.00024882975,0.00034462212,0.000011977932,0.0000068704153,0.000031171727,0.00016753073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942855,0.0010744559,0.0032212345,0.0002122485,0.00077797176,0.00042854578],"domain_scores_gemma":[0.99386615,0.0020866417,0.0024787046,0.00032539677,0.00058771536,0.00065537007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029584814,0.00024693515,0.0024193735,0.00031915706,0.000025744004,0.0000047863973,0.00018447025,0.00016761081,0.00022251144],"category_scores_gemma":[0.0011280273,0.00013746426,0.00029151063,0.0003164431,0.00015875197,0.00017940522,0.00006401625,0.0009386273,0.000011219572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0589195,0.081382245,0.843451,0.000079826445,0.0004419048,0.0021080791,0.001368898,0.000016809,0.000057890582,0.000004074724,0.0002936941,0.011876053],"study_design_scores_gemma":[0.114052646,0.17996186,0.7020476,0.00006846504,0.0014048243,0.00015403556,0.0013485161,0.000013140248,0.00025586158,0.0000050133353,0.00058037776,0.00010768781],"about_ca_topic_score_codex":0.000077831326,"about_ca_topic_score_gemma":0.00009813234,"teacher_disagreement_score":0.14140345,"about_ca_system_score_codex":0.00035868186,"about_ca_system_score_gemma":0.0016935186,"threshold_uncertainty_score":0.56056297},"labels":[],"label_agreement":null},{"id":"W2605821659","doi":"10.3233/kca-160002","title":"Outcomes of Metastatic Chromophobe Renal Cell Carcinoma (chrRCC) in the Targeted Therapy Era: Results from the International Metastatic Renal Cell Cancer Database Consortium (IMDC)","year":2017,"lang":"en","type":"article","venue":"Kidney Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto; Sunnybrook Health Science Centre; University of Calgary","funders":"Foundation Medicine; Astellas Pharma; Eisai; National Comprehensive Cancer Network; GlaxoSmithKline; Exelixis; Genentech; AstraZeneca; Pfizer; Bristol-Myers Squibb","keywords":"Renal cell carcinoma; Medicine; Chromophobe cell; Oncology; Targeted therapy; Cancer; Internal medicine; Clear cell","score_opus":0.05602898733680911,"score_gpt":0.3205884367928813,"score_spread":0.2645594494560722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605821659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96117383,0.0062393364,0.000018989156,0.01965885,0.0008611743,0.0013503253,0.0074126325,0.000020784906,0.0032640875],"genre_scores_gemma":[0.9893741,0.0020626988,0.0008820061,0.004722827,0.00032403384,0.00046479292,0.0008150343,0.000056542674,0.0012979553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963819,0.0003312101,0.00094036775,0.00071431056,0.0011285451,0.00050365995],"domain_scores_gemma":[0.99597895,0.0006659077,0.0009195032,0.0018981616,0.00025927828,0.0002781821],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00081398984,0.00048603307,0.00081830245,0.00013092459,0.00026504858,0.00011354189,0.0011881324,0.00006842699,0.0012790097],"category_scores_gemma":[0.00044813773,0.00025992104,0.0003151698,0.0001818362,0.0003791791,0.00026912152,0.00018364885,0.0005601492,0.000025900283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007703631,0.002329659,0.44488263,0.00028583212,0.002783217,0.0017156935,0.011319158,0.0002687357,0.35014284,0.000069631176,0.17452288,0.003976133],"study_design_scores_gemma":[0.018406449,0.0003164218,0.67337406,0.00028911053,0.0009298189,0.00001819459,0.0005448525,0.00045195842,0.28850904,0.0000788471,0.01670488,0.00037634218],"about_ca_topic_score_codex":0.049679007,"about_ca_topic_score_gemma":0.0029463856,"teacher_disagreement_score":0.22849147,"about_ca_system_score_codex":0.0003870303,"about_ca_system_score_gemma":0.0015302291,"threshold_uncertainty_score":0.9999853},"labels":[],"label_agreement":null},{"id":"W2606639948","doi":"10.5489/cuaj.4398","title":"First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experience","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Juravinski Cancer Centre; Montreal General Hospital; BC Cancer Agency; University of Calgary; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Ottawa Hospital; CancerCare Manitoba; University Health Network; University of Toronto; University of Alberta; Queen Elizabeth II Health Sciences Centre; McGill University","funders":"","keywords":"Pazopanib; Sunitinib; Medicine; Hazard ratio; Renal cell carcinoma; Internal medicine; Oncology; Proportional hazards model; Confidence interval; Mucositis; Kidney cancer; Urology; Chemotherapy","score_opus":0.05555852489601952,"score_gpt":0.276163788417907,"score_spread":0.22060526352188747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606639948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94588464,0.00021889905,0.0000061417504,0.045759343,0.0002650065,0.00038181085,0.00004160655,0.000008431386,0.0074341074],"genre_scores_gemma":[0.9939374,0.000044553093,0.00013903427,0.0034650995,0.00033521967,0.000038591734,0.000017101604,0.000018556415,0.0020044737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976079,0.0002262964,0.00047311463,0.00027576962,0.0004910851,0.0009258683],"domain_scores_gemma":[0.9970698,0.00025276068,0.00042065108,0.00041590031,0.00026452073,0.0015763862],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009824865,0.00022796392,0.000379218,0.00026589664,0.001845187,0.00038108055,0.00046302134,0.00019389532,0.0012677739],"category_scores_gemma":[0.0017685633,0.00013717017,0.00015102945,0.00017171603,0.00012434977,0.00016200857,0.000030205336,0.000923758,0.00008496576],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116895,0.00006335812,0.9897432,0.000007539927,0.000045015695,0.0051502595,0.0008760517,0.00008467422,0.000035471745,0.00009389189,0.0029056226,0.0008780178],"study_design_scores_gemma":[0.0017336413,0.0004520944,0.9667368,0.00001619579,0.00009311624,0.00064734917,0.00024439467,0.00022916473,0.00012034427,0.0002419865,0.029323597,0.00016129411],"about_ca_topic_score_codex":0.44448432,"about_ca_topic_score_gemma":0.9293401,"teacher_disagreement_score":0.4848558,"about_ca_system_score_codex":0.003989333,"about_ca_system_score_gemma":0.002906082,"threshold_uncertainty_score":0.9998342},"labels":[],"label_agreement":null},{"id":"W2606890210","doi":"10.1002/cam4.1048","title":"Characterizing the outcomes of metastatic papillary renal cell carcinoma","year":2017,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Queen's University; London Health Sciences Centre; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; University of Calgary","funders":"National Center for Advancing Translational Sciences","keywords":"Renal cell carcinoma; Medicine; Papillary renal cell carcinomas; Papillary carcinoma; Clear cell renal cell carcinoma; Oncology; Carcinoma; Clear cell; Internal medicine; Urology; Pathology; Thyroid carcinoma; Thyroid","score_opus":0.05974032778386951,"score_gpt":0.32515338753635087,"score_spread":0.26541305975248136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606890210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96346515,0.0063616643,0.000013641353,0.017463595,0.00048134997,0.00048557873,0.00001513958,0.000017952409,0.011695942],"genre_scores_gemma":[0.9944782,0.00045712607,0.0001035765,0.0013126746,0.00040334417,0.00007090616,0.000017284863,0.00003024739,0.0031266164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985277,0.00004674167,0.00040565376,0.00026428705,0.00047805437,0.0002775749],"domain_scores_gemma":[0.99795175,0.00012557619,0.00044745856,0.0011669928,0.00013766551,0.00017058238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003024597,0.00023040558,0.00069818186,0.00007390974,0.00022246444,0.000011573263,0.0003049821,0.000040674975,0.00049297616],"category_scores_gemma":[0.00015052392,0.000115050556,0.00013909514,0.00006357822,0.00048221517,0.00007449302,0.00008650785,0.00019711671,0.000013837913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035648022,0.0001847423,0.61444634,0.0006258667,0.0005708976,0.00062869216,0.0026211531,0.0000016102982,0.35879648,0.0001256006,0.0040909816,0.017551167],"study_design_scores_gemma":[0.0027352048,0.0005848327,0.8797365,0.00021775252,0.00091894565,0.00004731503,0.0002877653,0.00002120463,0.11054874,0.00003576667,0.0047627967,0.00010321102],"about_ca_topic_score_codex":0.0009423358,"about_ca_topic_score_gemma":0.00002422048,"teacher_disagreement_score":0.26529014,"about_ca_system_score_codex":0.000112642316,"about_ca_system_score_gemma":0.00015828075,"threshold_uncertainty_score":0.5397743},"labels":[],"label_agreement":null},{"id":"W2606976048","doi":"10.1016/j.eururo.2017.03.037","title":"Treatment Beyond Progression in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab in CheckMate 025","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":240,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Durham; Lakeridge Health","funders":"","keywords":"Medicine; Nivolumab; Renal cell carcinoma; Internal medicine; Carcinoma; Oncology; Kidney cancer; Urology; Immunotherapy; Cancer","score_opus":0.009601757548408387,"score_gpt":0.23328043273228824,"score_spread":0.22367867518387985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606976048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9574478,0.00016783767,0.000002033373,0.00020389727,0.00003384957,0.0010977959,0.0000109787925,0.00004122451,0.040994544],"genre_scores_gemma":[0.9981943,0.00001212746,0.00048939226,0.00006275868,0.000036043955,0.000053914147,0.000139424,0.00008189665,0.0009301453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980472,0.00024036814,0.00032437936,0.0006418992,0.00022924165,0.00051694806],"domain_scores_gemma":[0.9985604,0.00002530985,0.00026952455,0.00090199756,0.00007193418,0.00017081005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102766986,0.0003730972,0.0005127859,0.0002207622,0.00011885685,0.000026097921,0.00018084949,0.00006768015,0.00003682925],"category_scores_gemma":[0.00001531243,0.00023261008,0.000049789225,0.00009575843,0.00018330355,0.000110087014,0.000079555015,0.00021202097,0.000089812784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00894799,0.0013265677,0.97007954,0.000023993696,0.00003281411,0.0049982504,0.0002996069,0.0000394977,0.00076807814,0.0000031797517,0.000016902746,0.013463591],"study_design_scores_gemma":[0.029745055,0.020703483,0.94356614,0.000050968873,0.000110145615,0.00005292867,0.000015360081,0.000034647022,0.004949009,0.0000018292163,0.0005661006,0.00020431956],"about_ca_topic_score_codex":0.000117419506,"about_ca_topic_score_gemma":0.00020475867,"teacher_disagreement_score":0.040746458,"about_ca_system_score_codex":0.00029927513,"about_ca_system_score_gemma":0.00008063563,"threshold_uncertainty_score":0.9485564},"labels":[],"label_agreement":null},{"id":"W2607289471","doi":"10.1016/b978-0-323-39242-6.00023-3","title":"10.1016/b978-0-323-39242-6.00023-3","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ablation; Medicine; Internal medicine","score_opus":0.01493163292733702,"score_gpt":0.19462428271874224,"score_spread":0.17969264979140523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607289471","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010209276,0.0013609182,2.2560475e-7,0.000342937,0.000005934663,0.0011453192,0.00010014398,0.00024916983,0.99678516],"genre_scores_gemma":[0.000009762503,0.0000035602284,0.00014656395,0.00012534778,0.00074164144,0.00005084567,0.00044854116,0.0002630575,0.99821067],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99742305,0.000020691103,0.0005447703,0.0007936106,0.00071250513,0.00050538784],"domain_scores_gemma":[0.9978655,0.00007698391,0.00015224132,0.0011620028,0.00013542232,0.00060784543],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000112515285,0.0007541646,0.0010499574,0.00039143517,0.000073764444,0.000036477068,0.00024596188,0.00051176717,0.9984231],"category_scores_gemma":[0.000019422489,0.00067214883,0.0004706063,0.000062934116,0.00009626869,0.000044105193,0.000111219655,0.0005318705,0.99827856],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007350459,0.00009890524,8.872884e-8,0.000093477865,0.00044627956,0.0010494873,0.000016734177,0.0000046587515,0.000035711866,0.000035128694,0.31155026,0.68593425],"study_design_scores_gemma":[0.0009239647,0.0012855927,0.00001430249,0.00044551806,0.00075649726,0.00031376726,2.6693817e-7,0.000005472278,0.00014559086,0.000120300436,0.995422,0.00056671724],"about_ca_topic_score_codex":0.00002841552,"about_ca_topic_score_gemma":3.33183e-7,"teacher_disagreement_score":0.6853675,"about_ca_system_score_codex":0.0004433172,"about_ca_system_score_gemma":0.00019711237,"threshold_uncertainty_score":0.999573},"labels":[],"label_agreement":null},{"id":"W2607465228","doi":"10.5489/cuaj.4107","title":"Transperitoneal laparoscopic nephrectomy: Assessing complication risk in cases of previous abdominal surgery","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Complication; Nephrectomy; Surgery; Abdominal surgery; General surgery; Laparoscopy; Surgical complication; Internal medicine; Kidney","score_opus":0.04038868700790382,"score_gpt":0.2864148107023574,"score_spread":0.2460261236944536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607465228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413335,0.00041125822,0.000024039873,0.0041702786,0.00020446166,0.00019366431,0.000020062147,0.0000084875755,0.0008343674],"genre_scores_gemma":[0.99894917,0.00018998126,0.00034712956,0.00023133321,0.00020581801,0.000009577743,0.000015630842,0.000009979892,0.00004138733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984344,0.0002457799,0.0004892871,0.00018283239,0.00028560372,0.0003620847],"domain_scores_gemma":[0.99801266,0.00041322588,0.0007596291,0.00022016036,0.00018122124,0.00041310783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008699752,0.00013019751,0.0004874224,0.00021230165,0.00037466935,0.00012992558,0.00012386152,0.0001858843,0.00012539035],"category_scores_gemma":[0.0014716497,0.0001095048,0.00017639926,0.00008603247,0.00006554019,0.00017555812,0.00000815565,0.00046419445,0.000009395358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073590294,0.00006969783,0.99168617,0.00001152494,0.000056998513,0.00037994853,0.00006628743,0.000015279518,0.0003408701,0.000009500159,0.0003633436,0.006926798],"study_design_scores_gemma":[0.0010256892,0.00016138682,0.9962448,0.000058431007,0.00012571472,0.0003987247,0.00002953258,0.000118505,0.00043647652,0.0001739824,0.0011403608,0.00008639751],"about_ca_topic_score_codex":0.009096568,"about_ca_topic_score_gemma":0.004609224,"teacher_disagreement_score":0.0068404004,"about_ca_system_score_codex":0.00120119,"about_ca_system_score_gemma":0.00070290815,"threshold_uncertainty_score":0.99750197},"labels":[],"label_agreement":null},{"id":"W2609187871","doi":"10.1016/j.anndiagpath.2017.04.007","title":"Programmed death-1 (PD-1) receptor/PD-1 ligand (PD-L1) expression in fumarate hydratase-deficient renal cell carcinoma","year":2017,"lang":"en","type":"article","venue":"Annals of Diagnostic Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of British Columbia; University of Calgary; Royal Columbian Hospital","funders":"","keywords":"Immunohistochemistry; PD-L1; Renal cell carcinoma; Pathology; Tumor-infiltrating lymphocytes; Cancer research; Receptor; Carcinoma; Medicine; Biology; Cancer; Internal medicine; Immunotherapy","score_opus":0.0697724813653984,"score_gpt":0.3273793683956772,"score_spread":0.2576068870302788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609187871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98875844,0.0045220642,0.000036127705,0.0018339229,0.00035428006,0.0012646862,0.00011394878,0.000046150737,0.00307035],"genre_scores_gemma":[0.9967942,0.00092617836,0.0008158303,0.00040520597,0.00016823437,0.00030560076,0.0002398793,0.000059962873,0.00028485633],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99657005,0.00028448744,0.00086928153,0.0008684733,0.00048177317,0.00092592963],"domain_scores_gemma":[0.9961345,0.0009307215,0.00066901156,0.0015845698,0.00027700482,0.0004041449],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007279394,0.0004774321,0.0010061126,0.00032936272,0.00022075584,0.00005009449,0.00045852576,0.00036034812,0.00010452676],"category_scores_gemma":[0.002620153,0.0003965387,0.00026677552,0.00014576894,0.00038957357,0.00016097343,0.00031048825,0.00041980468,0.00018008573],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016820291,0.0034890675,0.6421939,0.00048278522,0.000049563252,0.011506131,0.0012259973,0.00004558842,0.3204662,0.0000880849,0.0077976226,0.010973032],"study_design_scores_gemma":[0.0025960293,0.00214178,0.4386612,0.00036586903,0.0000906053,0.0001160665,0.000081987506,0.000019282446,0.554284,0.00013668061,0.0012595959,0.0002469063],"about_ca_topic_score_codex":0.00024300699,"about_ca_topic_score_gemma":0.00005906218,"teacher_disagreement_score":0.23381782,"about_ca_system_score_codex":0.00007960659,"about_ca_system_score_gemma":0.0002174964,"threshold_uncertainty_score":0.99984866},"labels":[],"label_agreement":null},{"id":"W2611163072","doi":"10.25011/cim.v40i2.28194","title":"The prognostic value of vascular endothelial growth factor in patients with renal cell carcinoma: a systematic review of the literature and meta-analysis","year":2017,"lang":"en","type":"review","venue":"Clinical and investigative medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Beijing Municipal Administration of Hospitals; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support","keywords":"Medicine; Hazard ratio; Renal cell carcinoma; Internal medicine; Meta-analysis; Confidence interval; Vascular endothelial growth factor; Oncology; Vascular endothelial growth factor A; VEGF receptors; Gastroenterology","score_opus":0.1796062793973476,"score_gpt":0.35347470777921086,"score_spread":0.17386842838186325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611163072","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0068919677,0.98668635,7.92087e-7,0.0006104762,0.000048309917,0.0055582505,0.00013745384,0.0000035510843,0.000062853884],"genre_scores_gemma":[0.04640823,0.9526678,0.000051059575,0.00020810832,0.00005970695,0.0002605277,0.0000873143,0.00003037727,0.00022690075],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9937412,0.0020442572,0.0025548663,0.0006043382,0.00083231635,0.00022303095],"domain_scores_gemma":[0.9931973,0.0020579596,0.0027104418,0.0012124121,0.0005500246,0.0002718145],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0018277497,0.0006047736,0.010066778,0.00016399896,0.00010157463,0.000014796365,0.00037576415,0.00022459765,0.000011222303],"category_scores_gemma":[0.007746534,0.00018643822,0.0017478481,0.0006517825,0.005675952,0.000051565814,0.00016170081,0.0007754456,5.573836e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027712103,0.00018721112,0.02996242,0.93607146,0.032917585,0.0000214952,0.0002439143,1.6997522e-8,2.2172273e-7,0.00012806783,0.000028687677,0.00041122854],"study_design_scores_gemma":[0.0015118273,0.0016172237,0.045209877,0.28154838,0.66901284,0.000009242968,0.000010916285,0.0000010724006,0.000005228354,0.00015752234,0.0007417878,0.0001740754],"about_ca_topic_score_codex":0.000048182494,"about_ca_topic_score_gemma":0.000007767802,"teacher_disagreement_score":0.6545231,"about_ca_system_score_codex":0.00003544472,"about_ca_system_score_gemma":0.00029976407,"threshold_uncertainty_score":0.99703},"labels":[],"label_agreement":null},{"id":"W2611277015","doi":"10.3747/co.24.3290","title":"Measuring Quality Care in Localized Renal Cell Cancer: Use of Appropriate Preoperative Investigations in a Population-Based Cohort","year":2017,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"Dalhousie University; National Comprehensive Cancer Network; Pfizer","keywords":"Medicine; Renal cell carcinoma; Cohort; Stage (stratigraphy); Radiology; Renal function; Preoperative care; Population; Creatinine; Surgery; Internal medicine","score_opus":0.24812002163871835,"score_gpt":0.42020124495126576,"score_spread":0.1720812233125474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611277015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968074,0.00097403355,0.000048188995,0.00026267162,0.00023898677,0.0012291278,0.000036527646,0.000013445919,0.00038964636],"genre_scores_gemma":[0.99833095,0.00006371125,0.0009835765,0.000025909172,0.000043484022,0.00035370837,0.00015998291,0.000013512576,0.000025148727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825484,0.00036570197,0.0005795169,0.0003397752,0.0002425245,0.00021763866],"domain_scores_gemma":[0.99866307,0.00014748136,0.00037892122,0.00047184556,0.00022145636,0.00011725459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030357385,0.00016347914,0.0005988712,0.00018579063,0.000082144616,0.000015942484,0.00011275681,0.00011898422,0.000026651673],"category_scores_gemma":[0.00043174735,0.00014376506,0.00008073347,0.00011479242,0.00014749313,0.000103081,0.00005037669,0.0002759458,0.000002751602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036370658,0.00043745333,0.9907605,0.00031106878,0.000020304606,0.00002063619,0.0011800895,0.0016121119,0.0010498068,0.000040303217,0.000011997579,0.004192022],"study_design_scores_gemma":[0.0045661274,0.00027253528,0.9834821,0.00039102914,0.00009144598,0.0000011087348,0.00009192664,0.0015025645,0.008983221,0.000041900996,0.00045716518,0.000118841264],"about_ca_topic_score_codex":0.010760086,"about_ca_topic_score_gemma":0.015100743,"teacher_disagreement_score":0.007933415,"about_ca_system_score_codex":0.0014407288,"about_ca_system_score_gemma":0.00090132543,"threshold_uncertainty_score":0.9958274},"labels":[],"label_agreement":null},{"id":"W2612317608","doi":"10.1007/s10552-017-0901-3","title":"Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PLCO cancer screening trial","year":2017,"lang":"en","type":"article","venue":"Cancer Causes & Control","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"National Institutes of Health","keywords":"Medicine; Internal medicine; Body mass index; Adiponectin; Renal cell carcinoma; Odds ratio; Oncology; Obesity; Adipokine; Endocrinology; Risk factor; Quartile; Case-control study; Insulin resistance; Gastroenterology; Confidence interval","score_opus":0.04293801997717694,"score_gpt":0.29933259262764017,"score_spread":0.2563945726504632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612317608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99061424,0.0066977,0.000046557365,0.00023317845,0.00015785653,0.0012640061,0.00014536634,0.000008178048,0.0008329394],"genre_scores_gemma":[0.99920976,0.00027429304,0.0000517028,0.00005909416,0.00015923765,0.00013070124,0.000002792053,0.000023967401,0.00008845106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982919,0.0002163876,0.00053523446,0.0003116729,0.0003562252,0.00028856206],"domain_scores_gemma":[0.998093,0.0003233563,0.0007643315,0.0005929902,0.00013638024,0.000089947054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005838347,0.00021446822,0.00067145686,0.000101808575,0.00016599002,0.000026264719,0.00019749474,0.000112994385,0.000092381466],"category_scores_gemma":[0.00019364213,0.00015013225,0.00016975401,0.00009001969,0.00023262389,0.000094761934,0.000043609336,0.0002892082,4.8667044e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009263843,0.00010210288,0.96419305,0.00016199394,0.00044221827,0.00013936339,0.0011007293,0.00044834075,0.016219236,0.000013378033,0.00004167207,0.007874087],"study_design_scores_gemma":[0.05926928,0.00047959268,0.928451,0.00032035855,0.001266125,0.000013053439,0.00025045525,0.0012659463,0.008503117,0.000020671572,0.000030631778,0.0001297811],"about_ca_topic_score_codex":0.011993485,"about_ca_topic_score_gemma":0.0010172783,"teacher_disagreement_score":0.050005436,"about_ca_system_score_codex":0.00013802406,"about_ca_system_score_gemma":0.00026126808,"threshold_uncertainty_score":0.99458575},"labels":[],"label_agreement":null},{"id":"W2612433299","doi":"10.5489/cuaj.4192","title":"Modified C index: Novel predictor of postoperative renal functional loss of laparoscopic partial nephrectomy","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Renal function; Urology; Hilum (anatomy); Renal hilum; Nuclear medicine; Kidney; Logistic regression; Surgery; Internal medicine","score_opus":0.030684858441637826,"score_gpt":0.24813240845035306,"score_spread":0.21744755000871524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612433299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99033016,0.000070309834,0.00022328153,0.006365969,0.00033506186,0.00024513836,0.00010695449,0.0000070539404,0.0023160502],"genre_scores_gemma":[0.998436,0.000011755945,0.0001670996,0.0005021928,0.0003348381,0.000013149981,0.000025306448,0.000009466409,0.0005001955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983954,0.00008515927,0.00047447818,0.00018015769,0.0005287691,0.00033607197],"domain_scores_gemma":[0.9978331,0.00009879082,0.0007400446,0.0002103611,0.0005718952,0.00054585555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040753925,0.00014569359,0.00043732423,0.00014527116,0.00030919918,0.000047856855,0.00015625743,0.00024598627,0.0004463605],"category_scores_gemma":[0.00090178894,0.000112010996,0.00018471215,0.00006843075,0.00013443215,0.00012762628,0.000024917088,0.00043355208,0.0000080065765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045089595,0.00014134614,0.99245363,0.0000063298758,0.00030220998,0.00006941135,0.000088639346,0.00031487964,0.0040157083,0.0005589498,0.0013557185,0.00024229307],"study_design_scores_gemma":[0.0038208093,0.0007466726,0.9891219,0.00002728624,0.00012310338,0.00013841683,0.000016817003,0.00038682096,0.0022314168,0.00022165428,0.00307949,0.0000855939],"about_ca_topic_score_codex":0.0014825598,"about_ca_topic_score_gemma":0.00048007164,"teacher_disagreement_score":0.008105814,"about_ca_system_score_codex":0.0007341866,"about_ca_system_score_gemma":0.001024308,"threshold_uncertainty_score":0.48873344},"labels":[],"label_agreement":null},{"id":"W2612811682","doi":"10.1016/j.eururo.2017.04.011","title":"Setting Research Priorities for Kidney Cancer","year":2017,"lang":"en","type":"editorial","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia; Princess Margaret Cancer Centre; University of Calgary; Alberta Kidney Disease Network; Memorial University of Newfoundland; University of Alberta; St. Michael's Hospital; University of Ottawa; University Health Network; Ottawa Hospital; Dalhousie University; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; General partnership; Kidney cancer; Context (archaeology); Cancer; Kidney disease; Intensive care medicine; Internal medicine","score_opus":0.07535470973050647,"score_gpt":0.3987827583344235,"score_spread":0.32342804860391705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612811682","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010641642,0.004095463,0.000011310323,0.0040418445,0.86982936,0.001376534,0.00057020737,0.00011785697,0.11889326],"genre_scores_gemma":[0.0031033684,0.0006674065,0.0002998492,0.00035442345,0.93043536,0.00018062489,0.00071855844,0.000248659,0.06399176],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964745,0.0007345104,0.00038523253,0.0008297463,0.0007362942,0.00083974056],"domain_scores_gemma":[0.99570954,0.0016679225,0.00026098732,0.0011234457,0.0008838331,0.00035428166],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021841275,0.0003576096,0.00068106386,0.0002794325,0.00044487006,0.000084417596,0.00052415335,0.00046366226,0.00013163377],"category_scores_gemma":[0.008952051,0.0003082956,0.00023009612,0.000048791724,0.00039702072,0.00003917135,0.00034332077,0.001666472,0.0003432694],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006589951,0.00003463369,0.00025409812,0.0004980862,0.00021718405,0.0008860383,0.00017542487,4.4673328e-7,0.0002110759,0.000020416794,0.99322504,0.0038185802],"study_design_scores_gemma":[0.0020854434,0.0016178057,0.0009533589,0.00018953285,0.00033839158,0.000024515026,0.000010074576,0.000006234147,0.00011313978,0.000050431754,0.9944009,0.00021013593],"about_ca_topic_score_codex":0.00014305887,"about_ca_topic_score_gemma":0.000023761128,"teacher_disagreement_score":0.060605988,"about_ca_system_score_codex":0.0002941492,"about_ca_system_score_gemma":0.001993329,"threshold_uncertainty_score":0.99993694},"labels":[],"label_agreement":null},{"id":"W2613424398","doi":"10.5489/cuaj.4137","title":"Cytoreductive nephrectomy in the modern era: Predictors of use, morbidity, and survival","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"American College of Surgeons; American Cancer Society","keywords":"Medicine; Hazard ratio; Quartile; Confidence interval; Retrospective cohort study; Renal cell carcinoma; Odds ratio; Proportional hazards model; Internal medicine; Nephrectomy; Logistic regression; Population; Surgery; Kidney","score_opus":0.036003431732580714,"score_gpt":0.255423730395201,"score_spread":0.21942029866262028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613424398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865968,0.000116510244,0.000005557021,0.010569953,0.00021991435,0.00018151094,0.000022867376,0.000003542343,0.0022833336],"genre_scores_gemma":[0.9990183,0.00006504308,0.000064842905,0.00036889332,0.00031562528,0.0000053019216,0.0000050827834,0.000006006671,0.00015087411],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988375,0.00020713266,0.00022371324,0.00013175156,0.0003351586,0.00026478534],"domain_scores_gemma":[0.9988994,0.00020098378,0.00029143467,0.00016988805,0.000152449,0.00028582072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071811106,0.000099606754,0.000245086,0.000102181715,0.00025033168,0.00011978877,0.00014822534,0.00014173382,0.00003289126],"category_scores_gemma":[0.0011017045,0.00006253782,0.000075298245,0.00005288209,0.00008362174,0.00015075684,0.00001988919,0.00048389783,0.0000021234991],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004562481,0.000034677207,0.9977952,0.0000021557796,0.00007210445,0.00014287533,0.00036141195,0.000010086201,0.000080482976,0.00008709527,0.00085630524,0.00051198207],"study_design_scores_gemma":[0.00086459145,0.00023368554,0.9958594,0.000008803446,0.000068517824,0.00015235493,0.00006816099,0.000081014165,0.00002640235,0.0012154353,0.001369796,0.000051862142],"about_ca_topic_score_codex":0.0074234563,"about_ca_topic_score_gemma":0.0047702077,"teacher_disagreement_score":0.012421519,"about_ca_system_score_codex":0.00055008574,"about_ca_system_score_gemma":0.0003116624,"threshold_uncertainty_score":0.9991862},"labels":[],"label_agreement":null},{"id":"W2614402690","doi":"10.71781/28833","title":"Le traitement non chirurgical du cancer du rein localisé : analyses populationnelles","year":2016,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.013034863547605169,"score_gpt":0.22288846474432752,"score_spread":0.20985360119672236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614402690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9107596,0.047166884,0.00096319825,0.0021761765,0.002239941,0.00097543036,0.00015788928,0.00010676461,0.03545407],"genre_scores_gemma":[0.95087,0.0039491793,0.00027859263,0.00012640523,0.0014483939,0.000119216056,0.0011764548,0.00007159137,0.041960195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99580157,0.00024944663,0.00087016495,0.0010910054,0.0012158164,0.00077200687],"domain_scores_gemma":[0.9972579,0.00017334764,0.00067053153,0.00057290983,0.00054664316,0.0007786917],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0002183024,0.0008409797,0.00097828,0.0005126083,0.0064301845,0.00006270138,0.00038127904,0.00066443026,0.00046983486],"category_scores_gemma":[0.00006801718,0.00077056297,0.0008247668,0.00042664536,0.0004093757,0.00037993098,0.0001485089,0.00042890696,0.00017762919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013485202,0.0042652884,0.39554688,0.0021100075,0.009621553,0.042771794,0.07320724,0.041117046,0.30883047,0.0714495,0.0037811329,0.0338139],"study_design_scores_gemma":[0.010515805,0.000784142,0.78210074,0.0043284,0.005429731,0.0021171868,0.03476067,0.010030393,0.10875125,0.0002667909,0.039100405,0.0018145005],"about_ca_topic_score_codex":0.16516656,"about_ca_topic_score_gemma":0.018931048,"teacher_disagreement_score":0.38655385,"about_ca_system_score_codex":0.012977327,"about_ca_system_score_gemma":0.004151733,"threshold_uncertainty_score":0.9994745},"labels":[],"label_agreement":null},{"id":"W2615856394","doi":"10.1200/jco.2012.30.15_suppl.4500","title":"Cardiac safety analysis for a phase III trial of sunitinib (SU) or sorafenib (SO) or placebo (PLC) in patients (pts) with resected renal cell carcinoma (RCC).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Ejection fraction; Sunitinib; Heart failure; Clinical endpoint; Internal medicine; Cardiology; Renal cell carcinoma; Placebo; Myocardial infarction; Population; Sorafenib; Clinical trial; Pathology","score_opus":0.1357241711022873,"score_gpt":0.4367950224942761,"score_spread":0.3010708513919888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615856394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948887,0.00020970331,0.00019977894,0.00039187577,0.0008178876,0.0023147848,0.00009166683,0.000008329033,0.0010772442],"genre_scores_gemma":[0.99345326,0.00012165262,0.0039011214,0.00020054332,0.001422213,0.000072737465,0.00009481199,0.000043867673,0.00068976096],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9919096,0.0014872616,0.0047122566,0.00035784562,0.0008732516,0.00065974134],"domain_scores_gemma":[0.98708296,0.0067301583,0.0036383017,0.00047907126,0.0012122125,0.000857291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005827327,0.00035554788,0.0043797097,0.00073609996,0.000069863454,0.0000118778935,0.00025303246,0.00058906834,0.00038958635],"category_scores_gemma":[0.0038146572,0.00019940222,0.0014318696,0.0009849755,0.00031462678,0.00018856545,0.000071708586,0.0010098165,0.0000046036507],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77984154,0.014591841,0.18734902,0.00007655052,0.002185944,0.00034645468,0.00032161965,0.000026995758,0.00015094731,0.0000059383165,0.00095505785,0.014148092],"study_design_scores_gemma":[0.56894183,0.17018805,0.2324321,0.00009305702,0.008535662,0.000046127163,0.00031760044,0.000062302664,0.0014263703,0.000005146806,0.01771949,0.000232265],"about_ca_topic_score_codex":0.000124373,"about_ca_topic_score_gemma":0.00025503206,"teacher_disagreement_score":0.21089971,"about_ca_system_score_codex":0.00059103424,"about_ca_system_score_gemma":0.0035226995,"threshold_uncertainty_score":0.8131386},"labels":[],"label_agreement":null},{"id":"W2616941176","doi":"10.21037/biotarget.2017.05.03","title":"Role of fibroblast growth factor receptor in sunitinib-resistant renal cell carcinoma","year":2017,"lang":"en","type":"article","venue":"Biotarget","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Sunitinib; Renal cell carcinoma; Medicine; Tyrosine kinase; Targeted therapy; Oncology; Internal medicine; Cancer research; Tyrosine-kinase inhibitor; Carcinoma; Nephrectomy; Kidney cancer; Cancer; Receptor; Kidney","score_opus":0.0199432086921132,"score_gpt":0.2431767317419633,"score_spread":0.2232335230498501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2616941176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98479044,0.0005572318,0.0000015351736,0.0002761932,0.0000741397,0.0003828804,0.00016198322,0.000020918807,0.013734689],"genre_scores_gemma":[0.99745315,0.000025237912,0.0012093432,0.000022426631,0.00013615743,0.000015208121,0.00006905866,0.000034722216,0.0010346766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985528,0.000051567644,0.00038298735,0.0003385093,0.00031789418,0.0003562266],"domain_scores_gemma":[0.9986388,0.00003893715,0.00026165822,0.0007401389,0.00011829885,0.00020218184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000108738896,0.00023424962,0.00044865912,0.0001582753,0.000099443576,0.000028478875,0.0002447087,0.00013798587,0.00044575703],"category_scores_gemma":[0.00010193226,0.00019267012,0.00015872589,0.000077565324,0.00013444669,0.00009256927,0.00010266808,0.00017588842,0.0000817178],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048772772,0.00028307928,0.15638149,0.00015467757,0.000021121183,0.000077323915,0.0002579141,2.543879e-7,0.8413747,0.00008167047,0.0006018419,0.00027821754],"study_design_scores_gemma":[0.0012177228,0.0006124828,0.49664894,0.00008083694,0.000017927443,0.0000042796414,0.00007864457,0.00000604536,0.5002228,0.00002872989,0.000980423,0.00010118232],"about_ca_topic_score_codex":0.0012282671,"about_ca_topic_score_gemma":0.000094438685,"teacher_disagreement_score":0.3411519,"about_ca_system_score_codex":0.00015196021,"about_ca_system_score_gemma":0.00015470485,"threshold_uncertainty_score":0.78568596},"labels":[],"label_agreement":null},{"id":"W2619763457","doi":"10.1093/neuonc/nox083.191","title":"MEDU-41. MANAGEMENT OF MEDULLOBLASTOMA PATIENTS IN PRAGUE PEDIATRIC HEMATOLOGY AND ONCOLOGY CENTER","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Medulloblastoma; Internal medicine; Hematology; Radiation therapy; Incidence (geometry); Chemotherapy; Demographics; Single Center; Oncology; Pediatrics; Pathology","score_opus":0.021463238729196456,"score_gpt":0.30004425347937996,"score_spread":0.2785810147501835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619763457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97339666,0.00024941243,0.0000041533385,0.002503437,0.00071616913,0.0010157471,0.000009307998,0.000023422894,0.022081694],"genre_scores_gemma":[0.9974455,0.00089961296,0.000802412,0.00050104555,0.00010230449,0.000113608985,0.000019878364,0.000033631874,0.00008197719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978134,0.0002424974,0.000635214,0.00056755875,0.0002561664,0.00048517025],"domain_scores_gemma":[0.9981788,0.00026120094,0.0005435322,0.0006808872,0.00010926179,0.00022635135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002306963,0.00026544614,0.0009178685,0.0003062487,0.0000952583,0.000009318274,0.00025944132,0.00030996057,0.00007073666],"category_scores_gemma":[0.0001506577,0.0002301669,0.000096584634,0.000099277495,0.00028468907,0.00008169885,0.00043428259,0.00033214776,0.000047257865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011709308,0.0022766406,0.9594898,0.00039587085,0.000109282075,0.005205392,0.00031396648,0.000001275758,0.0014357937,0.00045937105,0.0015832625,0.027558416],"study_design_scores_gemma":[0.014453033,0.0073771435,0.9533078,0.000052839994,0.00035458576,0.00077837636,0.00014537327,0.000025913263,0.0037354415,0.00011499667,0.019467847,0.00018664432],"about_ca_topic_score_codex":0.00008230559,"about_ca_topic_score_gemma":0.00020098763,"teacher_disagreement_score":0.027371773,"about_ca_system_score_codex":0.00040828422,"about_ca_system_score_gemma":0.00016907444,"threshold_uncertainty_score":0.9385934},"labels":[],"label_agreement":null},{"id":"W2619940409","doi":"10.1101/143180","title":"Clear Cell Renal Cell Carcinoma with Biallelic Inactivation of CDKN2A/B on 9p21 have Distinct Gene Expression Signature and are Associated with Poor Prognosis","year":2017,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"American Association for Cancer Research","keywords":"CDKN2A; Cancer research; Biology; Gene knockdown; Gene; Allele; Metastasis; Cancer; Molecular biology; Genetics","score_opus":0.017478311346892945,"score_gpt":0.21155958201183034,"score_spread":0.19408127066493738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619940409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963483,0.00078166823,0.00007912685,0.00016270726,0.00010293898,0.0020366735,0.00027415284,0.00013689983,0.00007751439],"genre_scores_gemma":[0.99680126,0.00006509642,0.0023235993,0.000054249016,0.00022510489,0.000261784,0.000010293762,0.00021687876,0.00004174922],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99647105,0.00019136678,0.000528492,0.0013561074,0.0009183116,0.00053465075],"domain_scores_gemma":[0.99542964,0.00011082136,0.0017709319,0.0013369446,0.0009489888,0.0004026943],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032748404,0.00087231526,0.0011688164,0.0003573485,0.0002631967,0.00013158441,0.0003122368,0.00078796135,0.000016510996],"category_scores_gemma":[0.00016171407,0.00065279263,0.00014951707,0.00021984823,0.0002372884,0.00012762741,0.00027530492,0.0011324704,0.000004332154],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018843093,0.0009304881,0.21220708,0.0010185395,0.0001947016,0.00051466655,0.000035474513,0.000030434188,0.78303653,0.000002026573,0.00014354465,0.0000022092481],"study_design_scores_gemma":[0.0021003135,0.0012724025,0.4456625,0.0018754019,0.00043380642,9.55252e-8,0.0000082776605,0.000058217087,0.54817235,1.755149e-7,0.000034481964,0.00038199103],"about_ca_topic_score_codex":0.00013459308,"about_ca_topic_score_gemma":0.000014481831,"teacher_disagreement_score":0.23486419,"about_ca_system_score_codex":0.0006205719,"about_ca_system_score_gemma":0.0006556967,"threshold_uncertainty_score":0.9995923},"labels":[],"label_agreement":null},{"id":"W2621690892","doi":"10.5167/uzh-137108","title":"Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists","year":2017,"lang":"en","type":"book-chapter","venue":"Zurich Open Repository and Archive (University of Zurich)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Oncocytoma; Renal oncocytoma; Cytokeratin; Pathology; Medicine; Chromophobe cell; Renal cell carcinoma; Nephrectomy; Clear cell; Kidney; Immunohistochemistry; Internal medicine","score_opus":0.05701765986997123,"score_gpt":0.2739001170252513,"score_spread":0.21688245715528007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621690892","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37938058,0.0029362375,0.002009795,0.0002540574,0.0004932667,0.0054615038,0.002103829,0.00006407344,0.60729665],"genre_scores_gemma":[0.7687037,0.0010575256,0.010098387,0.000046188627,0.00012389202,0.000006928648,0.0008075442,0.00007551491,0.21908031],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980933,0.00031524675,0.00035884444,0.00070687046,0.0002631756,0.00026256248],"domain_scores_gemma":[0.9950664,0.0026096383,0.0009519197,0.00083648774,0.00030333232,0.00023219158],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008116015,0.00039525304,0.0012677052,0.00021616377,0.0004092137,0.000041687144,0.00065223296,0.00028866928,0.00008316696],"category_scores_gemma":[0.00035753672,0.0003901661,0.00028081686,0.00002450667,0.00080365775,0.00014393592,0.00074737234,0.0002973107,0.00000850004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10180126,0.0069520264,0.37960133,0.022838805,0.018942663,0.09199383,0.018669507,0.000095431,0.06579092,0.033850852,0.2151277,0.044335656],"study_design_scores_gemma":[0.008963486,0.011969868,0.9235084,0.0027010026,0.004247244,0.0015188658,0.00017710781,0.0001549139,0.0011451467,0.008069096,0.036344197,0.0012006379],"about_ca_topic_score_codex":0.0013648329,"about_ca_topic_score_gemma":0.00034119736,"teacher_disagreement_score":0.5439071,"about_ca_system_score_codex":0.000086826236,"about_ca_system_score_gemma":0.00035443393,"threshold_uncertainty_score":0.99985504},"labels":[],"label_agreement":null},{"id":"W2624246814","doi":"10.1097/spc.0000000000000277","title":"Current management of metastatic renal cell carcinoma: evolving new therapies","year":2017,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Sunitinib; Everolimus; Pazopanib; Temsirolimus; Cabozantinib; Axitinib; Lenvatinib; Sorafenib; Oncology; Renal cell carcinoma; Bevacizumab; Internal medicine; Tyrosine-kinase inhibitor; Nivolumab; PI3K/AKT/mTOR pathway; Cancer; Hepatocellular carcinoma; Discovery and development of mTOR inhibitors; Immunotherapy; Chemotherapy","score_opus":0.2710818547800087,"score_gpt":0.44887000998192705,"score_spread":0.17778815520191837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624246814","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035957247,0.99418473,0.00007817586,0.000012476325,0.0016731117,0.0027160507,0.00028144894,0.000016091486,0.0006783566],"genre_scores_gemma":[0.0048434604,0.99240446,0.00031846671,0.000001870146,0.0002736194,0.00029006787,0.0016370539,0.00006678442,0.0001642111],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99658614,0.00024205136,0.0012318082,0.00090430636,0.00056277704,0.00047289877],"domain_scores_gemma":[0.99714303,0.00014854866,0.0013646126,0.000714771,0.00032173062,0.00030731622],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019739235,0.0008367125,0.002659862,0.00046099935,0.00010275126,0.00004702731,0.0002807704,0.00013531523,0.00013271417],"category_scores_gemma":[0.000031508844,0.0006259091,0.00074025005,0.00024669047,0.00018576498,0.00011484609,0.0002517416,0.0006422946,0.00002239237],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004803761,0.000236584,0.012237109,0.15919477,0.00037433725,0.000050591374,0.0023060278,1.5458632e-7,2.1689786e-7,0.00011731197,0.001045014,0.8243899],"study_design_scores_gemma":[0.0023350876,0.0005532137,0.030863484,0.0899425,0.0023813758,0.000008375012,0.0010208427,0.0000021954465,0.000014237731,0.00006291482,0.8722399,0.00057586154],"about_ca_topic_score_codex":0.000024226832,"about_ca_topic_score_gemma":0.0000023687692,"teacher_disagreement_score":0.8711949,"about_ca_system_score_codex":0.00047703227,"about_ca_system_score_gemma":0.00072402315,"threshold_uncertainty_score":0.99961925},"labels":[],"label_agreement":null},{"id":"W2624353486","doi":"","title":"LOCAL RECURRENCE OF ENDOSCOPIC ROBOTIC ASSISTED SIMPLE ENUCLEATION (ERASE) FOR RENAL CELL CARCINOMA ACCORDING TO PATHOLOGICAL CHARACTERISTICS OF PERITUMORAL PSEUDOCAPSULE: RISULTATI AT A MIDTERM FOLLOW-UP.","year":2016,"lang":"en","type":"article","venue":"Florence Research (University of Florence)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Enucleation; Medicine; Renal cell carcinoma; Pathological; Surgery; Radiology; Pathology","score_opus":0.08243372211562677,"score_gpt":0.3105050091289005,"score_spread":0.22807128701327373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624353486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739308,0.000071073526,0.023941321,0.00029102623,0.000119655604,0.0011151532,0.00029630912,0.00002134773,0.00021334627],"genre_scores_gemma":[0.99241394,0.000069795555,0.0067867455,0.000007023237,0.000049485872,0.0000108169825,0.00012847992,0.000019968771,0.0005137488],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9968284,0.0002833606,0.00050285505,0.0006635657,0.0010325293,0.0006893136],"domain_scores_gemma":[0.99666196,0.0006460889,0.00033989083,0.0005772526,0.0013490794,0.00042574297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007707638,0.00026398172,0.000851937,0.00051910576,0.00023739097,0.0000116887295,0.0005291619,0.00017478358,0.00033702186],"category_scores_gemma":[0.0006681181,0.0002221828,0.0002647634,0.00075242965,0.0009867076,0.00020884207,0.00041337643,0.00023566639,0.000022609673],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045957197,0.00060097646,0.16423896,0.0012274507,0.00007568857,0.00034724065,0.0028805055,0.0000144209935,0.76075894,0.00014432259,0.0008198398,0.06429593],"study_design_scores_gemma":[0.005755946,0.006798941,0.8135211,0.0009957958,0.00019101393,0.00003252154,0.0030272899,0.0013887322,0.16779159,0.0001103291,0.00009486825,0.00029186124],"about_ca_topic_score_codex":0.00027359638,"about_ca_topic_score_gemma":0.00005300726,"teacher_disagreement_score":0.64928216,"about_ca_system_score_codex":0.0005628371,"about_ca_system_score_gemma":0.00045996322,"threshold_uncertainty_score":0.9060352},"labels":[],"label_agreement":null},{"id":"W2624754237","doi":"","title":"Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: A populationbased assessment","year":2010,"lang":"en","type":"article","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Urology; Nephrology; Carcinoma; Kidney cancer; Surgery; Kidney; Internal medicine","score_opus":0.024410178905974977,"score_gpt":0.29981484960263216,"score_spread":0.2754046706966572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624754237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725497,0.00005913662,0.015589431,0.0017868557,0.000433965,0.0032129867,0.00001871227,0.00013769818,0.00621154],"genre_scores_gemma":[0.9527175,0.0000011891473,0.042822476,0.0017207453,0.0005221209,0.0008096969,0.0001326154,0.00007393805,0.001199746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740976,0.00008348349,0.00054860365,0.0007305032,0.00058037054,0.00064726017],"domain_scores_gemma":[0.9973914,0.00096689333,0.00013392387,0.00063476374,0.00021774121,0.0006552705],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00061029516,0.00039999845,0.00071321864,0.00034968386,0.00017377408,0.00006352021,0.0001208673,0.000206143,0.00054264534],"category_scores_gemma":[0.00013252499,0.00032495853,0.00044723344,0.00031602866,0.00005644834,0.000113530215,0.000079547775,0.00040338986,0.00008044102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021596071,0.0013084265,0.6020939,0.0004867605,0.00026435644,0.00027743963,0.00045680747,0.00005500045,0.33502075,0.0008601594,0.0335327,0.023484092],"study_design_scores_gemma":[0.0048652715,0.0012010753,0.74492013,0.000058474227,0.00038131227,0.00007817021,0.000046821937,0.002519386,0.2302408,0.00010866,0.015098052,0.00048182099],"about_ca_topic_score_codex":0.0005707658,"about_ca_topic_score_gemma":0.00014922889,"teacher_disagreement_score":0.14282627,"about_ca_system_score_codex":0.0004168596,"about_ca_system_score_gemma":0.0004856335,"threshold_uncertainty_score":0.99992025},"labels":[],"label_agreement":null},{"id":"W2625506991","doi":"10.5489/cuaj.4607","title":"New research in kidney cancer, ASCO-GU 2017","year":2017,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université Laval; University of Alberta","funders":"","keywords":"Kidney cancer; Medicine; Internal medicine; Oncology; Cancer","score_opus":0.27768398641192943,"score_gpt":0.4394116248804016,"score_spread":0.16172763846847216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625506991","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003700805,0.9685025,9.548812e-7,0.013251251,0.00079791807,0.00079974835,0.000113399554,0.000012735623,0.01648446],"genre_scores_gemma":[0.00018247041,0.9827862,0.000082607905,0.00061087165,0.0025588684,0.00006769304,0.00010160205,0.00004406284,0.013565652],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99543285,0.00091049995,0.00084953743,0.00050362654,0.0010330194,0.0012704426],"domain_scores_gemma":[0.99418896,0.00037621244,0.0008737217,0.00048994215,0.000396758,0.0036743856],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028541507,0.00039700564,0.0018812615,0.0011603114,0.0006038959,0.00031175738,0.000595364,0.0012087047,0.0011025018],"category_scores_gemma":[0.0027445082,0.00029031967,0.0006452197,0.00038020682,0.00006356732,0.000102751845,0.00005872574,0.0039367205,0.00050909293],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000018763136,0.00003733791,0.013320114,0.00057649304,0.00032403792,0.0028760105,0.000023736924,5.1411905e-7,9.6578326e-8,0.000043344287,0.22819434,0.7545852],"study_design_scores_gemma":[0.00075906084,0.00024496304,0.012641397,0.0044452366,0.0004443619,0.0007593549,0.0000042432353,0.000001324094,1.1121632e-7,0.00022672673,0.98025084,0.00022238518],"about_ca_topic_score_codex":0.033057198,"about_ca_topic_score_gemma":0.0073075807,"teacher_disagreement_score":0.7543628,"about_ca_system_score_codex":0.014595993,"about_ca_system_score_gemma":0.021905717,"threshold_uncertainty_score":0.9999549},"labels":[],"label_agreement":null},{"id":"W2626140211","doi":"10.1016/j.eururo.2017.06.006","title":"Re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol. 2017;71:606–17","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Nephrectomy; Meta-analysis; Urology; Renal cell carcinoma; Oncology; Internal medicine; Kidney","score_opus":0.41490675997856413,"score_gpt":0.4694977684829215,"score_spread":0.054591008504357386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626140211","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003331472,0.9866798,0.000033185013,0.00031145322,0.00044583983,0.009953984,0.0005506408,0.00008266716,0.0016092914],"genre_scores_gemma":[0.0011363736,0.9935179,0.0008751543,0.0005454519,0.0005122957,0.0013384027,0.0005086264,0.00018128358,0.0013845556],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9851096,0.0063617094,0.0045562363,0.0022558002,0.0007710453,0.0009455531],"domain_scores_gemma":[0.98770046,0.0039565805,0.0045205536,0.0024904588,0.00060975464,0.0007221701],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.004784347,0.0016608306,0.025384327,0.0006265743,0.00033039798,0.0000875677,0.00083427894,0.00043145014,0.00014675804],"category_scores_gemma":[0.002153057,0.0011237799,0.0045943977,0.00054722716,0.0014203504,0.00013570537,0.000615699,0.0012408482,0.000059997456],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018384375,0.000604802,0.00023158547,0.36528495,0.596541,0.003301912,0.0004023611,0.000002404768,6.302578e-7,0.000050821684,0.028834732,0.0029063383],"study_design_scores_gemma":[0.003161673,0.0021201705,0.00018855318,0.004948683,0.57343996,0.0003413048,0.000020996185,0.000019959463,5.886211e-7,0.000002986346,0.41524482,0.000510312],"about_ca_topic_score_codex":0.000030545998,"about_ca_topic_score_gemma":0.000031488482,"teacher_disagreement_score":0.3864101,"about_ca_system_score_codex":0.00016656857,"about_ca_system_score_gemma":0.00047668122,"threshold_uncertainty_score":0.9996139},"labels":[],"label_agreement":null},{"id":"W2626327171","doi":"","title":"HISTOPATHOLOGICAL ANALYSIS OF PERITUMORAL PSEUDOCAPSULE AND SURGICAL MARGIN STATUS AFTER ENDOSCOPIC ROBOT-ASSISTED SIMPLE ENUCLEATION (ERASE) FOR RENAL CELL CARCINOMA.","year":2016,"lang":"en","type":"article","venue":"Florence Research (University of Florence)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Enucleation; Renal cell carcinoma; Surgical margin; Margin (machine learning); Surgery; Radiology; Pathology; Resection","score_opus":0.05472370229425481,"score_gpt":0.2984333126573643,"score_spread":0.24370961036310948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626327171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961486,0.0004363155,0.001561837,0.00039305678,0.000028411794,0.0005970353,0.0002619506,0.000020122374,0.0005526612],"genre_scores_gemma":[0.9945882,0.0002080436,0.00415446,0.0000044750186,0.00003602983,0.000009331661,0.00013223925,0.000012168907,0.000855068],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738795,0.00028075805,0.000292348,0.0006195166,0.0007805247,0.00063891883],"domain_scores_gemma":[0.9979559,0.00042394997,0.00014370267,0.00046171976,0.0006063936,0.00040830762],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00064683426,0.0002018019,0.0007057257,0.00084999244,0.00017507507,0.000013838411,0.0002021718,0.00015130854,0.0011096377],"category_scores_gemma":[0.00012606762,0.00015953775,0.0002958548,0.0009463502,0.001064295,0.00019056219,0.0002012008,0.00019788563,0.000009565063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006460832,0.0009547108,0.7387365,0.0006822326,0.00042413897,0.0018794613,0.0025694177,0.000018888946,0.21045011,0.00043508547,0.0006985624,0.036690053],"study_design_scores_gemma":[0.003580067,0.0020683466,0.9838065,0.000092648566,0.00059311336,0.000015952268,0.0008466205,0.0010379355,0.0072682193,0.00009064563,0.0004445428,0.00015542124],"about_ca_topic_score_codex":0.000568665,"about_ca_topic_score_gemma":0.00014976406,"teacher_disagreement_score":0.24506998,"about_ca_system_score_codex":0.00037835713,"about_ca_system_score_gemma":0.00029750922,"threshold_uncertainty_score":0.9998035},"labels":[],"label_agreement":null},{"id":"W2626476465","doi":"10.5489/cuaj.4264","title":"Positive surgical margins during partial nephrectomy for renal cell carcinoma: Results from Canadian Kidney Cancer information system (CKCis) collaborative","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; University of Manitoba; SAIT Polytechnic; University of British Columbia; Université Laval; University of Alberta; Queen Elizabeth II Health Sciences Centre; University Health Network; Ottawa Hospital; University of Calgary; Princess Margaret Cancer Centre; Dalhousie University; Western University; University of Toronto; McGill University; McMaster University","funders":"","keywords":"Medicine; Hazard ratio; Renal cell carcinoma; Nephrectomy; Interquartile range; Kidney cancer; Cohort; Odds ratio; Confidence interval; Internal medicine; Surgical margin; Cancer; Incidence (geometry); Surgery; Urology; Kidney","score_opus":0.011695685624247432,"score_gpt":0.22774105593830177,"score_spread":0.21604537031405432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626476465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96203303,0.0001510381,0.000012414799,0.019218449,0.0007916341,0.0010786263,0.007302054,0.000026279518,0.00938647],"genre_scores_gemma":[0.9961123,0.000027868271,0.00020795899,0.0008613292,0.0014484277,0.0001404499,0.00067056925,0.000021524856,0.00050961267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725705,0.00021050524,0.0007191325,0.0003457141,0.00050598034,0.00096160383],"domain_scores_gemma":[0.9943704,0.00019626325,0.0009589759,0.0003084679,0.0010303964,0.0031355072],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0005981923,0.00030627978,0.0005438043,0.0003161936,0.0018409139,0.00052532944,0.00026172376,0.00047065385,0.00017470335],"category_scores_gemma":[0.0010400076,0.00026043592,0.00024362997,0.00014941697,0.000061194485,0.0005054981,0.000026759584,0.0006162208,0.00006393531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004561259,0.00007845342,0.95674264,0.00005955571,0.0006875593,0.003006311,0.0020598064,0.00023328196,0.00052194943,0.00023385891,0.030652791,0.001162523],"study_design_scores_gemma":[0.010658351,0.00043293225,0.88170266,0.00008015291,0.0003364016,0.00014590542,0.00033166067,0.00046158003,0.002992968,0.000021438234,0.10251937,0.0003165525],"about_ca_topic_score_codex":0.33577055,"about_ca_topic_score_gemma":0.1317385,"teacher_disagreement_score":0.20403206,"about_ca_system_score_codex":0.009999329,"about_ca_system_score_gemma":0.0053205304,"threshold_uncertainty_score":0.9999848},"labels":[],"label_agreement":null},{"id":"W2726299968","doi":"10.2214/ajr.17.17814","title":"Is Ultrasound Useful for Further Evaluation of Homogeneously Hyperattenuating Renal Lesions Detected on CT?","year":2017,"lang":"en","type":"article","venue":"American Journal of Roentgenology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Ultrasound; Radiology; Nuclear medicine","score_opus":0.06948710593846502,"score_gpt":0.34471750871400875,"score_spread":0.2752304027755437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2726299968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99679726,0.00030455843,0.00027992288,0.0018215416,0.0001612213,0.000376412,0.000016279322,0.000005644292,0.00023716506],"genre_scores_gemma":[0.99611306,0.00007240754,0.0032981057,0.0002247491,0.00017887891,0.000014922043,0.000004923819,0.000029310686,0.000063667],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983144,0.00017537408,0.0005467256,0.00019653088,0.000508269,0.0002587161],"domain_scores_gemma":[0.99661374,0.00026340768,0.0014877475,0.0005092555,0.0009931107,0.0001327445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061681046,0.00016395193,0.0005640947,0.00021499682,0.00016769597,0.000015528774,0.00021474341,0.000035726174,0.000116987736],"category_scores_gemma":[0.0009798888,0.00012541286,0.00026227775,0.0000722574,0.0003431334,0.000054579134,0.00002333097,0.00018434177,0.000007744128],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002980585,0.0007234879,0.17229325,0.000039101018,0.0018691424,0.0002708811,0.0017088352,0.00062858255,0.50143135,0.000021686354,0.00063659163,0.31739652],"study_design_scores_gemma":[0.008705995,0.02246912,0.6666696,0.00027921688,0.0026869194,0.0059524076,0.0018174627,0.0004043696,0.28999314,0.00031764153,0.00046289404,0.00024120044],"about_ca_topic_score_codex":0.00007412366,"about_ca_topic_score_gemma":0.000026141539,"teacher_disagreement_score":0.4943764,"about_ca_system_score_codex":0.00019720163,"about_ca_system_score_gemma":0.00032168624,"threshold_uncertainty_score":0.5114188},"labels":[],"label_agreement":null},{"id":"W2730153362","doi":"10.1007/s00247-017-3926-6","title":"Imaging of renal medullary carcinoma in children and young adults: a report from the Children’s Oncology Group","year":2017,"lang":"en","type":"article","venue":"Pediatric Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"National Cancer Institute; St. Baldrick's Foundation","keywords":"Medicine; Medullary cavity; Stage (stratigraphy); Neuroradiology; Radiology; Malignancy; Lung; Renal cell carcinoma; Pathology; Internal medicine","score_opus":0.00833781293239601,"score_gpt":0.24622454915841283,"score_spread":0.2378867362260168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2730153362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849537,0.012086473,0.000012765785,0.001035186,0.0002648348,0.0007073507,0.00004417631,0.000020186615,0.0008753191],"genre_scores_gemma":[0.9962665,0.0014438303,0.0005874888,0.00013310937,0.0012828081,0.00004843346,0.0001893866,0.000026052627,0.000022417438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980142,0.00019835663,0.00062687066,0.000589841,0.00019055278,0.00038016142],"domain_scores_gemma":[0.9979139,0.00030053395,0.0005944946,0.0009979217,0.000056675886,0.00013646611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049188465,0.00024404134,0.00070596155,0.00015838638,0.00015670231,0.000014824499,0.000314774,0.00017983968,0.000030763298],"category_scores_gemma":[0.00053974293,0.00016823862,0.00012264405,0.000086919754,0.00036932403,0.00007949201,0.00020532745,0.00038700638,0.0000046938703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034392005,0.00011347413,0.9926244,0.000009900517,0.00010355081,0.0012120424,0.00033791596,8.739444e-7,0.00012564518,0.000014275064,0.0010354994,0.004078523],"study_design_scores_gemma":[0.003903007,0.00036927807,0.9806071,0.000014839102,0.00043735464,0.014225309,0.00004312576,0.000040772375,0.00006969409,0.00012423121,0.000029769524,0.00013551775],"about_ca_topic_score_codex":0.009493583,"about_ca_topic_score_gemma":0.00022917987,"teacher_disagreement_score":0.013013267,"about_ca_system_score_codex":0.00016058788,"about_ca_system_score_gemma":0.000184397,"threshold_uncertainty_score":0.99710226},"labels":[],"label_agreement":null},{"id":"W2732772092","doi":"10.1097/pai.0000000000000490","title":"Liver Metastases From Renal Oncocytoma With Vascular Extension","year":2017,"lang":"en","type":"article","venue":"Applied immunohistochemistry & molecular morphology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"SDHB; SDHD; Medicine; Pathology; CD117; Eosinophilic; Renal oncocytoma; Metastasis; Loss of heterozygosity; Kidney; Oncocytoma; Kidney disease; Cancer; Immunohistochemistry; Biology; Internal medicine; Mutation; Germline mutation","score_opus":0.013937612523589002,"score_gpt":0.2569398417323888,"score_spread":0.24300222920879982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2732772092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837176,0.003994393,0.001365556,0.00019184662,0.000074071395,0.0005553967,0.00002825335,0.0000963074,0.009976544],"genre_scores_gemma":[0.9876122,0.000074308955,0.010567288,0.00047891273,0.0000955207,0.00018259532,0.00050802785,0.000091145674,0.00038998603],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976385,0.000039722527,0.0003664572,0.0009733863,0.00047783524,0.0005040859],"domain_scores_gemma":[0.9961694,0.00004180065,0.0003645628,0.0030384427,0.00014501283,0.00024079408],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013581352,0.0004997124,0.0007777333,0.000062372055,0.0003727114,0.000058890822,0.00046299314,0.00027356192,0.000506],"category_scores_gemma":[0.000056100085,0.00042089913,0.0002797152,0.00005860807,0.00062622706,0.00005526706,0.0002668918,0.0004314611,0.00019270512],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011793134,0.00025854193,0.000145249,0.000037166075,0.000727148,0.009681155,0.000040442825,0.000008641952,0.98523813,0.00007884703,0.00047538962,0.002129997],"study_design_scores_gemma":[0.004543732,0.0003924372,0.018411545,0.00008281122,0.0012256193,0.0014285414,0.00004025534,0.000013854564,0.97248775,0.00009965453,0.0008598373,0.00041398467],"about_ca_topic_score_codex":0.0005752684,"about_ca_topic_score_gemma":5.31047e-7,"teacher_disagreement_score":0.018266296,"about_ca_system_score_codex":0.00032233584,"about_ca_system_score_gemma":0.00018523313,"threshold_uncertainty_score":0.9998243},"labels":[],"label_agreement":null},{"id":"W2733852789","doi":"10.5539/cco.v6n2p1","title":"Mini-Review: Sarcomatoid Non-Clear Cell Renal Cancer","year":2017,"lang":"en","type":"article","venue":"Cancer and Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Renal cell carcinoma; Cancer; Medicine; Pathology; Cell; Disease; Sarcomatoid carcinoma; Clear cell; Oncology; Internal medicine; Cancer research; Carcinoma; Biology","score_opus":0.09498559816519246,"score_gpt":0.4587934273472612,"score_spread":0.3638078291820687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2733852789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84183836,0.08211169,0.000007804822,0.025070092,0.001218858,0.0007348403,0.000024294111,0.000028298597,0.048965763],"genre_scores_gemma":[0.73893434,0.23831102,0.0002819222,0.010364384,0.0011083857,0.00019023704,0.000009288007,0.00003133655,0.010769062],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983664,0.0000777015,0.000606688,0.0004690607,0.00016495009,0.00031517263],"domain_scores_gemma":[0.99822605,0.00023172346,0.0003726332,0.00063160073,0.00011147339,0.00042654134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004017453,0.0001914803,0.0009807757,0.000024132769,0.00018216952,0.000017124708,0.00019348151,0.00024580045,0.00083701836],"category_scores_gemma":[0.00015099911,0.000138203,0.00024769563,0.000031556145,0.00045107104,0.000054533684,0.0001423509,0.0003996988,0.00010108409],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012931679,0.000824087,0.38013396,0.00084218214,0.00036050924,0.00073384773,0.0000592999,4.7766395e-7,0.0010033378,0.000018030343,0.13378984,0.48094124],"study_design_scores_gemma":[0.006005769,0.0027174123,0.51512843,0.0007616922,0.0009172937,0.00004383613,0.000016509975,0.00005354961,0.00096341263,0.00002740035,0.4731744,0.00019028902],"about_ca_topic_score_codex":0.0005773496,"about_ca_topic_score_gemma":0.00033435487,"teacher_disagreement_score":0.48075095,"about_ca_system_score_codex":0.00020665194,"about_ca_system_score_gemma":0.0006799459,"threshold_uncertainty_score":0.9164764},"labels":[],"label_agreement":null},{"id":"W2734451381","doi":"10.1200/jco.2017.35.15_suppl.4507","title":"Randomized phase III trial of adjuvant pazopanib versus placebo after nephrectomy in patients with locally advanced renal cell carcinoma (RCC) (PROTECT).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Pazopanib; Clinical endpoint; Placebo; Renal cell carcinoma; Tolerability; Internal medicine; Discontinuation; Nephrectomy; Adverse effect; Surgery; Intention-to-treat analysis; Phases of clinical research; Urology; Gastroenterology; Randomized controlled trial; Clinical trial; Kidney; Pathology; Sunitinib","score_opus":0.06148641616435672,"score_gpt":0.3987801206706259,"score_spread":0.33729370450626917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734451381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922969,0.00027321032,0.00009588504,0.00057938235,0.0014213297,0.0028414698,0.0000070855026,0.0000057928987,0.0024789413],"genre_scores_gemma":[0.99580973,0.00008357841,0.0031060786,0.00014188945,0.00060858275,0.000085205014,0.0000064890937,0.00003440259,0.00012406326],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9934991,0.0010800544,0.0038379899,0.0003646324,0.0008184214,0.00039977714],"domain_scores_gemma":[0.9900231,0.0029281687,0.00518576,0.0006478507,0.0007067788,0.0005083486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004125246,0.00032940213,0.0043801456,0.0002287326,0.00005995601,0.000016195816,0.0003477819,0.00042883412,0.00014119862],"category_scores_gemma":[0.0040666074,0.00019938484,0.0009458847,0.00008585068,0.0006227121,0.00020998275,0.00010412607,0.0012046506,0.000008278472],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93085295,0.0070696264,0.018483302,0.00004313459,0.00040209154,0.0019240546,0.00009134192,0.000016982625,0.000072902,0.0000030809135,0.000072801384,0.040967707],"study_design_scores_gemma":[0.8121994,0.09222889,0.09265528,0.00018858476,0.0010682298,0.000024125522,0.000028504175,0.000043660977,0.0007363804,0.000022380324,0.0006549578,0.00014960003],"about_ca_topic_score_codex":0.00006738594,"about_ca_topic_score_gemma":0.000086617,"teacher_disagreement_score":0.118653566,"about_ca_system_score_codex":0.00031725437,"about_ca_system_score_gemma":0.0019988602,"threshold_uncertainty_score":0.8130678},"labels":[],"label_agreement":null},{"id":"W2735133783","doi":"10.17650/1726-9776-2009-5-4-25-36","title":"THE SIDE EFFECTS OF SORAFENIB, SUNITINIB, AND TEMSIROLIMUS AND THEIR THERAPY IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA","year":2014,"lang":"en","type":"article","venue":"Oncourology (Russian Society of Oncourologists)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Temsirolimus; Sunitinib; Sorafenib; Medicine; Renal cell carcinoma; Internal medicine; Oncology; Discovery and development of mTOR inhibitors; Hepatocellular carcinoma; PI3K/AKT/mTOR pathway; Chemistry","score_opus":0.009173491253687388,"score_gpt":0.22132065351147753,"score_spread":0.21214716225779015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735133783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99262977,0.002740465,0.000087670516,0.0020607552,0.000048820813,0.0009500711,0.00001062503,0.000022391057,0.0014494561],"genre_scores_gemma":[0.99718314,0.00070058374,0.0011550208,0.000746075,0.00003767507,0.000050351213,0.000016835056,0.00004581543,0.00006448558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976298,0.00046284084,0.0005554276,0.00049824745,0.00030390953,0.0005497413],"domain_scores_gemma":[0.9971827,0.0014366169,0.0005107252,0.00056637713,0.00011695316,0.00018658418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008382207,0.0004121432,0.0009821302,0.0000888396,0.00014099256,0.000012765331,0.00018036622,0.00022716269,0.0000039598535],"category_scores_gemma":[0.000075528915,0.00022734213,0.00019152784,0.00020185109,0.0015227735,0.00006151912,0.00009184516,0.0004486154,0.0000010732032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00413552,0.0014362053,0.9611035,0.0005452779,0.00049770623,0.000049988466,0.0025986168,0.000023780916,0.004512197,0.00024815035,0.00027966392,0.024569374],"study_design_scores_gemma":[0.015163261,0.015451215,0.95889103,0.00004562895,0.00020639504,0.00004483534,0.00027579744,0.00027485247,0.008200961,0.0004320393,0.00080275803,0.00021120739],"about_ca_topic_score_codex":0.0001567107,"about_ca_topic_score_gemma":0.00006293612,"teacher_disagreement_score":0.024358166,"about_ca_system_score_codex":0.000058100264,"about_ca_system_score_gemma":0.0001524724,"threshold_uncertainty_score":0.92707425},"labels":[],"label_agreement":null},{"id":"W2735381707","doi":"10.1200/jco.2007.25.18_suppl.5111","title":"Cost effectiveness of sorafenib versus best supportive care in advanced renal cell carcinoma in Canada","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bayer (Canada); Women's College Hospital; University Health Network","funders":"","keywords":"Sorafenib; Medicine; Renal cell carcinoma; Internal medicine; Incremental cost-effectiveness ratio; Oncology; Cost effectiveness; Hepatocellular carcinoma; Cost-effectiveness analysis","score_opus":0.10373986699389474,"score_gpt":0.4384161166538799,"score_spread":0.33467624965998516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735381707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917463,0.0010086948,0.00001644446,0.00013476059,0.001145463,0.00049707614,0.000008381612,0.0000014106683,0.005441467],"genre_scores_gemma":[0.9989659,0.00007398643,0.00065217,0.00008132202,0.00017500637,0.0000055190253,0.000009173802,0.000017490947,0.000019413465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955943,0.00065306405,0.0026512877,0.00023753193,0.00047516814,0.0003886462],"domain_scores_gemma":[0.991464,0.0059698545,0.0014289429,0.0001990252,0.0005355097,0.0004026191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031260878,0.00018379327,0.0018536784,0.00025525736,0.000012586592,0.0000015553046,0.00015378297,0.0002679601,0.00003748784],"category_scores_gemma":[0.0013669232,0.00014484389,0.00029866846,0.00028413758,0.00012626292,0.000068748384,0.000045341818,0.0010473969,0.0000029169203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.07224116,0.0013532961,0.8511261,0.00020185915,0.00008183867,0.016865117,0.00024210293,0.0003975499,0.001377184,0.0000062255144,0.000041990716,0.056065608],"study_design_scores_gemma":[0.03525311,0.022657821,0.91635364,0.00023376977,0.00018144639,0.00011612635,0.0022390452,0.000008346111,0.02205834,0.000010935784,0.00078423374,0.00010317031],"about_ca_topic_score_codex":0.11552531,"about_ca_topic_score_gemma":0.6955101,"teacher_disagreement_score":0.5799848,"about_ca_system_score_codex":0.003983379,"about_ca_system_score_gemma":0.011646122,"threshold_uncertainty_score":0.99984014},"labels":[],"label_agreement":null},{"id":"W2735473364","doi":"10.5489/cuaj.4166","title":"Early clamp release during laparoscopic partial nephrectomy: Implications for preservation of renal function","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Nephrectomy; Clamp; Medicine; Renal function; Urology; Surgery; Kidney; Internal medicine; Computer science; Clamping","score_opus":0.03223495337551516,"score_gpt":0.26315613867437204,"score_spread":0.23092118529885688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735473364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98459953,0.000070834736,0.00029505583,0.013631177,0.0002066696,0.0004981349,0.000046986996,0.000015883363,0.0006357395],"genre_scores_gemma":[0.99802524,0.000020506564,0.0002281817,0.00030072994,0.0005743653,0.00008704145,0.0000395587,0.0000122736865,0.0007120915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882483,0.000068098074,0.00037102195,0.00018521509,0.00020224226,0.00034859448],"domain_scores_gemma":[0.9980828,0.000088548084,0.00063273235,0.00026756397,0.00045206505,0.00047630025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003459768,0.00011322057,0.00025434414,0.00012166859,0.00074311625,0.00011075171,0.00013662319,0.00019910693,0.0000926258],"category_scores_gemma":[0.0011679169,0.000097240605,0.00016816793,0.00006359731,0.000036871934,0.00024563362,0.000014897913,0.00026514597,0.000009598593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003950462,0.000050370018,0.99135184,0.000016307751,0.0001196908,0.0000075176163,0.00003892273,0.00004469545,0.005292071,0.0005310184,0.0011520094,0.0010005024],"study_design_scores_gemma":[0.0026929278,0.0005814384,0.98750055,0.00001883825,0.00020195212,0.000028595881,0.0000056429144,0.000068137175,0.0011985814,0.0015952875,0.006030591,0.00007745742],"about_ca_topic_score_codex":0.00094337645,"about_ca_topic_score_gemma":0.0004920405,"teacher_disagreement_score":0.013425734,"about_ca_system_score_codex":0.00085778104,"about_ca_system_score_gemma":0.00043053084,"threshold_uncertainty_score":0.57155246},"labels":[],"label_agreement":null},{"id":"W2735496645","doi":"10.1016/j.urolonc.2017.06.060","title":"Metastatic renal cell carcinoma: Patterns and predictors of metastases—A contemporary population-based series","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Chromophobe cell; Oncology; Odds ratio; Epidemiology; Disease; Hazard ratio; Kidney cancer; Logistic regression; Lung cancer; Population; Performance status; Cancer; Clear cell; Confidence interval","score_opus":0.04462623261756779,"score_gpt":0.29821327858660135,"score_spread":0.2535870459690336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735496645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99358106,0.001349327,0.00005007688,0.0028314358,0.000097451,0.00047341659,0.00019562308,0.000027320699,0.0013943012],"genre_scores_gemma":[0.979809,0.00006803085,0.019092022,0.00033647756,0.00005358167,0.000063321924,0.00023894742,0.000014999863,0.00032360884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986899,0.00015380033,0.0004020817,0.00036089605,0.00017947197,0.00021385471],"domain_scores_gemma":[0.9985405,0.0002377493,0.00045001428,0.0004016339,0.00008059149,0.00028951786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029043542,0.00023315483,0.0005535576,0.00015166204,0.00038133177,0.000031849584,0.00010368302,0.000122202,0.000043872446],"category_scores_gemma":[0.00016696363,0.00018243238,0.00007708713,0.00006055216,0.00076776807,0.00018822282,0.00006321783,0.00020274191,0.000002089383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018969167,0.00017905171,0.996809,0.00015107224,0.000072885676,0.00031871887,0.00013556097,0.000022559074,0.00076377374,0.0006611189,0.00050557544,0.00019098268],"study_design_scores_gemma":[0.002779515,0.0056887916,0.9479003,0.000074426935,0.0011203988,0.00036057024,0.00022022845,0.00037202786,0.009439017,0.0013341735,0.030486757,0.00022381838],"about_ca_topic_score_codex":0.00075582194,"about_ca_topic_score_gemma":0.00010151699,"teacher_disagreement_score":0.048908733,"about_ca_system_score_codex":0.00006712682,"about_ca_system_score_gemma":0.00039304252,"threshold_uncertainty_score":0.7439377},"labels":[],"label_agreement":null},{"id":"W2735520635","doi":"10.1016/j.eururo.2017.06.040","title":"Recommendations for the Management of Rare Kidney Cancers","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Sunitinib; MEDLINE; Guideline; Druggability; Systematic review; Renal cell carcinoma; Narrative review; Intensive care medicine; Internal medicine; Bioinformatics; Oncology; Pathology","score_opus":0.1797549126628778,"score_gpt":0.382251211013476,"score_spread":0.20249629835059818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735520635","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.7110726e-7,0.9307055,0.00008912208,0.0019093562,0.00057169975,0.0017997589,0.00014123258,0.000019832665,0.064763136],"genre_scores_gemma":[0.000027480666,0.9890008,0.0006307062,0.00046947424,0.00024124849,0.00018725255,0.0004587832,0.00007664138,0.008907621],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987114,0.00022778593,0.0004391161,0.0003196628,0.00008926008,0.00021275028],"domain_scores_gemma":[0.9980994,0.00018050689,0.0004952778,0.0010675733,0.000053066353,0.00010418129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035964086,0.0002460597,0.00088287634,0.000086826614,0.00013362755,0.000009991809,0.00039901581,0.000061104714,0.00016282001],"category_scores_gemma":[0.000055352717,0.00014520502,0.00047240139,0.000051666197,0.00011505417,0.000012258893,0.00015673377,0.00019658027,0.00013550221],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002943925,0.000025825915,0.0000018638193,0.007372827,0.0013703364,0.00013184786,0.000026125606,3.7259997e-7,4.9035194e-8,0.00026170234,0.05349195,0.9372877],"study_design_scores_gemma":[0.00053151854,0.00029521043,0.00006142675,0.001959418,0.0061099115,0.000103772174,0.000008626057,0.0000017851587,3.1142395e-7,0.0000061363617,0.99082786,0.00009404883],"about_ca_topic_score_codex":0.000011305843,"about_ca_topic_score_gemma":0.000001480801,"teacher_disagreement_score":0.9373359,"about_ca_system_score_codex":0.00012717892,"about_ca_system_score_gemma":0.00018474711,"threshold_uncertainty_score":0.5921289},"labels":[],"label_agreement":null},{"id":"W2735941808","doi":"10.1200/jop.2017.023812","title":"Renal Medullary Carcinoma","year":2017,"lang":"en","type":"letter","venue":"Journal of Oncology Practice","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Renal carcinoma; Medullary cavity; MEDLINE; Oncology; Renal cell carcinoma; Internal medicine","score_opus":0.060744601644823766,"score_gpt":0.36562427299080186,"score_spread":0.3048796713459781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735941808","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0067829737,0.004647151,0.00002393248,0.873328,0.0023776023,0.0003429763,0.0000081092985,0.00001280582,0.1124765],"genre_scores_gemma":[0.01219003,0.0015700519,0.022046957,0.9045129,0.03694093,0.000017280045,0.00008050242,0.00017163235,0.022469755],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996099,0.0007661018,0.0011245076,0.00035414583,0.0011563107,0.0004999525],"domain_scores_gemma":[0.98998845,0.002072609,0.0052201524,0.00094514666,0.0014876244,0.0002860239],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0016516403,0.00044825755,0.0016530232,0.00047523534,0.00017576298,0.00006752571,0.0005562435,0.0017428192,0.00031591725],"category_scores_gemma":[0.0037079018,0.00033392975,0.00069207384,0.00007648526,0.00025441503,0.0005262646,0.0001307569,0.007343688,0.00020067193],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001364233,0.0002724782,0.0003484559,0.00011337363,0.0010891716,0.27499303,0.00009719304,6.760155e-7,0.00022134087,0.0000024331646,0.71554524,0.0059523736],"study_design_scores_gemma":[0.0029274982,0.006489909,0.0021027212,0.00019377982,0.00477463,0.20185488,0.0000565843,0.0000014824709,0.00027020392,0.000029362729,0.78111154,0.0001873779],"about_ca_topic_score_codex":0.00005027167,"about_ca_topic_score_gemma":0.0000020785515,"teacher_disagreement_score":0.09000675,"about_ca_system_score_codex":0.001580606,"about_ca_system_score_gemma":0.0041225436,"threshold_uncertainty_score":0.99991125},"labels":[],"label_agreement":null},{"id":"W2738772248","doi":"10.1111/his.13311","title":"Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading","year":2017,"lang":"en","type":"article","venue":"Histopathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Grading (engineering); Medicine; Renal cell carcinoma; Carcinoma; Clear cell; Kidney cancer; Pathology; Clear cell renal cell carcinoma; Radiology","score_opus":0.0304373933758083,"score_gpt":0.27153480031076777,"score_spread":0.24109740693495946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738772248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98807424,0.0003582329,0.0008767895,0.0024079792,0.00040642128,0.00026219318,0.000022019784,0.00002701441,0.0075651133],"genre_scores_gemma":[0.9906807,0.00006951826,0.0066061486,0.00030911848,0.00012418472,0.0000074057994,0.00013746732,0.000026311645,0.0020391257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984649,0.00012130269,0.000542316,0.00038633798,0.00023482171,0.00025034332],"domain_scores_gemma":[0.99810475,0.00006014943,0.0008423255,0.00059988524,0.00028643545,0.00010645402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037675054,0.00016884266,0.000528442,0.00015283182,0.00018861216,0.000007660955,0.0002600696,0.00014466474,0.00019881804],"category_scores_gemma":[0.00009707345,0.00015455837,0.00017154515,0.00010659232,0.0003696331,0.000063687636,0.00014168258,0.00020904008,0.000021411495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022489496,0.0006612924,0.63158876,0.00021910317,0.00000973157,0.00024095045,0.0011699646,0.000024697523,0.35998613,0.00051880983,0.0050932243,0.00026246524],"study_design_scores_gemma":[0.0021141476,0.0011625388,0.83515024,0.000016891894,0.00009028607,0.00032859307,0.000063205305,0.000069918904,0.1589927,0.00012501603,0.0017704455,0.00011601426],"about_ca_topic_score_codex":0.00006731863,"about_ca_topic_score_gemma":0.0000044251315,"teacher_disagreement_score":0.20356151,"about_ca_system_score_codex":0.0002678757,"about_ca_system_score_gemma":0.00021836438,"threshold_uncertainty_score":0.6302707},"labels":[],"label_agreement":null},{"id":"W2739628513","doi":"10.1158/1538-7445.am2017-811","title":"Abstract 811: Histological heterogeneity contributes to sunitinib resistance in clear cell renal cell carcinoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Sunitinib; Clear cell renal cell carcinoma; Cancer research; Tyrosine-kinase inhibitor; Cancer; Renal cell carcinoma; Medicine; Biology; Pathology; Internal medicine","score_opus":0.14786720823785504,"score_gpt":0.4071043491768963,"score_spread":0.25923714093904127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739628513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95336497,0.0051368093,0.0000042500856,0.0037937416,0.00012347831,0.0010669956,0.000052131327,0.000026842561,0.03643081],"genre_scores_gemma":[0.99320537,0.00018353589,0.00019944983,0.00018823109,0.00019320795,0.0003251766,0.000017781738,0.00004175685,0.005645477],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967557,0.0002032672,0.0004241903,0.00075842533,0.00082754466,0.0010308722],"domain_scores_gemma":[0.99730706,0.0002640427,0.000120456556,0.0013322463,0.00045756498,0.0005186278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012019894,0.00024953755,0.0005408711,0.0003185466,0.0004919704,0.00013402311,0.0006214281,0.00020372898,0.00036352748],"category_scores_gemma":[0.00038167072,0.00021095765,0.00013893789,0.000237739,0.0004235368,0.00009647815,0.0003151,0.0009118266,0.00026967132],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008382169,0.00093127746,0.28386855,0.0006989731,0.000049310875,0.0052878154,0.00044621612,0.000012811536,0.6717252,0.00019514817,0.026881697,0.0015208035],"study_design_scores_gemma":[0.00220206,0.00037783402,0.6124173,0.00013403488,0.000016650632,0.0000041533767,0.000060363203,0.0000021014057,0.36891866,0.000082942955,0.015645597,0.00013829616],"about_ca_topic_score_codex":0.002641287,"about_ca_topic_score_gemma":0.0038061924,"teacher_disagreement_score":0.32854873,"about_ca_system_score_codex":0.0016079098,"about_ca_system_score_gemma":0.0005986546,"threshold_uncertainty_score":0.8602603},"labels":[],"label_agreement":null},{"id":"W2740313422","doi":"10.1158/1538-7445.am2017-2464","title":"Abstract 2464: Papillary renal cell carcinoma, proposal of a new classification system based on integrated molecular, histological and clinical analysis","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; St. Michael's Hospital","funders":"","keywords":"Subtyping; Papillary renal cell carcinomas; Univariate analysis; Immunohistochemistry; Medicine; Pathology; Oncology; Internal medicine; Cohort; Multivariate analysis; Proportional hazards model; Carcinoma","score_opus":0.17082387007948965,"score_gpt":0.43255706327360416,"score_spread":0.2617331931941145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740313422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895873,0.0009242546,0.00010691535,0.0015104363,0.000059584723,0.0007245727,0.00002117381,0.000023382932,0.007042395],"genre_scores_gemma":[0.9987118,0.00007350798,0.00039994196,0.000027483138,0.000100672405,0.00006465207,0.00005348566,0.000021580767,0.0005468761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973227,0.00031794864,0.0005150731,0.0006163194,0.0008734127,0.0003545568],"domain_scores_gemma":[0.9974822,0.00021535775,0.0002729054,0.0011110784,0.00048526868,0.00043318607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012161577,0.00018396537,0.00061548763,0.00038048511,0.00019596482,0.000057422378,0.0002754348,0.0002261929,0.0001258354],"category_scores_gemma":[0.00030555303,0.00012833123,0.0002633468,0.000325708,0.0005107365,0.00004291047,0.00007722577,0.0006528578,0.000017051241],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073047513,0.0012615875,0.6629207,0.0012931197,0.0010242251,0.0018860839,0.00015713125,0.00013629257,0.29727733,0.000546137,0.0046999636,0.021492654],"study_design_scores_gemma":[0.0022331497,0.001455737,0.93119484,0.00021186894,0.00065576204,0.0000068044396,0.00015866381,0.0041994676,0.05954007,0.00001220232,0.00020686263,0.00012454216],"about_ca_topic_score_codex":0.0023963407,"about_ca_topic_score_gemma":0.00011160885,"teacher_disagreement_score":0.26827416,"about_ca_system_score_codex":0.00068107626,"about_ca_system_score_gemma":0.0015426534,"threshold_uncertainty_score":0.5233196},"labels":[],"label_agreement":null},{"id":"W2740431114","doi":"10.1053/j.ackd.2017.05.006","title":"Kidney Toxicities Associated With Novel Cancer Therapies","year":2017,"lang":"en","type":"review","venue":"Advances in Chronic Kidney Disease","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"National Cancer Institute","keywords":"Medicine; Kidney cancer; Cancer; Targeted therapy; Kidney; Internal medicine; Bioinformatics","score_opus":0.06389140552343908,"score_gpt":0.3771223493802024,"score_spread":0.3132309438567633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740431114","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003122354,0.99174845,0.000010144015,0.00034089558,0.00043560358,0.0019955898,0.0026195324,0.00010822082,0.0027103608],"genre_scores_gemma":[0.00043713016,0.99004936,0.000071270464,0.0005701681,0.00053202995,0.0017243455,0.0017528622,0.00018273683,0.004680079],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967542,0.00011486656,0.0007018863,0.00096783764,0.00066767045,0.00079349725],"domain_scores_gemma":[0.99591947,0.00018183008,0.0008258342,0.0013389417,0.00012225089,0.001611676],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017194309,0.00097486266,0.0026300615,0.00029416656,0.00018772818,0.00007792875,0.00049923896,0.00025601414,0.0004390482],"category_scores_gemma":[0.000899415,0.0006508,0.0006086762,0.00027189776,0.00049428735,0.0003977108,0.00011661138,0.00061597687,0.000030891508],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00039963305,0.00093583536,0.0018746483,0.06935482,0.0021214215,0.0015343579,0.00014033822,0.00002803581,0.0000022285683,0.00015584231,0.0031885405,0.9202643],"study_design_scores_gemma":[0.0029106128,0.00027518184,0.00034860853,0.10839586,0.0031322471,0.000019937888,0.000012418532,0.000013226199,0.0000027942497,0.00003852518,0.8842247,0.000625897],"about_ca_topic_score_codex":0.00008810938,"about_ca_topic_score_gemma":0.0001484591,"teacher_disagreement_score":0.9196384,"about_ca_system_score_codex":0.0048542344,"about_ca_system_score_gemma":0.016067777,"threshold_uncertainty_score":0.99959433},"labels":[],"label_agreement":null},{"id":"W2740892462","doi":"10.1158/1538-7445.am2017-5447","title":"Abstract 5447: A microRNA signature for the classification of renal cell carcinoma subtypes","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Toronto; University Health Network; Western University; St. Michael's Hospital; London Health Sciences Centre","funders":"","keywords":"Chromophobe cell; Oncocytoma; Renal oncocytoma; Clear cell; Renal cell carcinoma; Pathology; Papillary renal cell carcinomas; Clear cell renal cell carcinoma; Medicine; Kidney cancer; Biology","score_opus":0.1489919598155708,"score_gpt":0.4105002076269631,"score_spread":0.26150824781139226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740892462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98169357,0.007116794,0.000021793297,0.0047652987,0.000108605585,0.0011660694,0.000060653707,0.000007609842,0.0050596157],"genre_scores_gemma":[0.9942471,0.00024535807,0.000078423625,0.000026353007,0.0003375496,0.00034684237,0.00002096101,0.0000259929,0.004671465],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986341,0.000038450988,0.00018834688,0.0002924994,0.00050688226,0.0003397215],"domain_scores_gemma":[0.99781716,0.00032818655,0.00014718041,0.0009818351,0.00061536743,0.00011027226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006810606,0.00011030197,0.00019727716,0.00008880542,0.00043460814,0.00005636754,0.0003814314,0.00011091446,0.00020801192],"category_scores_gemma":[0.0001675027,0.000067794856,0.00012974802,0.00008250513,0.00036787192,0.000059061946,0.000071299124,0.00040342734,0.000022894414],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009482523,0.00009549751,0.009553444,0.00032632847,0.000051777053,0.000018860157,0.00019077904,0.0000044288895,0.9664395,0.00007893849,0.013546131,0.008746062],"study_design_scores_gemma":[0.00087546627,0.0002007889,0.48090908,0.00005666251,0.00004509576,0.000002721203,0.000104338185,0.000030710577,0.51127857,0.000053358002,0.0063993344,0.00004386488],"about_ca_topic_score_codex":0.0009690791,"about_ca_topic_score_gemma":0.00018192641,"teacher_disagreement_score":0.47135565,"about_ca_system_score_codex":0.00024498263,"about_ca_system_score_gemma":0.00053935545,"threshold_uncertainty_score":0.33426982},"labels":[],"label_agreement":null},{"id":"W2741030312","doi":"10.1200/jco.2012.30.15_suppl.4613","title":"Xp11.2 translocations in adult renal cell carcinomas with clear cell and papillary features.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; London Health Sciences Centre; University of Toronto; St. Michael's Hospital; Western University; Sunnybrook Health Science Centre","funders":"","keywords":"TFE3; Chromophobe cell; Clear cell; Pathology; Medicine; Renal cell carcinoma; Immunohistochemistry; Clear cell renal cell carcinoma; Tissue microarray; Chromosomal translocation; Papillary renal cell carcinomas; Histology; Psammoma body; Stage (stratigraphy); Biology; Gene","score_opus":0.06206653491599756,"score_gpt":0.37321706619228284,"score_spread":0.3111505312762853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741030312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760577,0.0043543624,0.000032633307,0.0041188737,0.00027172215,0.00023813854,0.0000020223413,0.0000065131517,0.014918003],"genre_scores_gemma":[0.99076015,0.0013188678,0.00547098,0.0011333429,0.00077826163,0.000004483417,0.0000032584362,0.000024482444,0.00050617463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738485,0.00037349766,0.0013736321,0.00018117938,0.0003435606,0.00034327575],"domain_scores_gemma":[0.9971695,0.0009509324,0.0007229018,0.0002012732,0.00027896254,0.00067642005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001412646,0.0001765801,0.0010877457,0.00016600238,0.00004094789,0.000006781078,0.00009501882,0.0003648586,0.00005494446],"category_scores_gemma":[0.00024359323,0.00011171978,0.00023547122,0.00015763385,0.00019369657,0.00013635111,0.00002307696,0.0011885079,0.000014244821],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010770397,0.005680447,0.9463139,0.00017229134,0.00022258484,0.0023512358,0.0013214186,0.0000336784,0.0021624162,0.00010041856,0.0040956484,0.026775565],"study_design_scores_gemma":[0.011723024,0.015956737,0.9533065,0.000094513314,0.0005854763,0.0015807821,0.00040365913,0.000013613947,0.0025698855,0.000022076552,0.01361286,0.00013090493],"about_ca_topic_score_codex":0.000054563603,"about_ca_topic_score_gemma":0.00010803927,"teacher_disagreement_score":0.02664466,"about_ca_system_score_codex":0.00016606673,"about_ca_system_score_gemma":0.00072036654,"threshold_uncertainty_score":0.51635414},"labels":[],"label_agreement":null},{"id":"W2741105765","doi":"10.1158/1538-7445.am2017-3080","title":"Abstract 3080: Y-box binding protein 1 is crucial in acquiring drug resistance in advanced renal cell carcinoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Sunitinib; Renal cell carcinoma; Cancer research; Metastasis; Cancer; Tumor microenvironment; Medicine; Cancer cell; Cell culture; Secretion; Malignancy; Drug resistance; Cell; Pharmacology; Chemistry; Internal medicine; Biology; Biochemistry","score_opus":0.08336362563502914,"score_gpt":0.3939532803539316,"score_spread":0.3105896547189025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741105765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9727197,0.0024195754,7.734589e-7,0.002217841,0.00010452669,0.001660615,0.000020765981,0.00002000866,0.020836158],"genre_scores_gemma":[0.9805986,0.00012776103,0.0004332219,0.000026206255,0.00024910757,0.0007562351,0.0000084129,0.000060825532,0.017739592],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964166,0.00012549853,0.00047603133,0.00081321754,0.0010825866,0.0010860474],"domain_scores_gemma":[0.9981081,0.00010032402,0.00016385573,0.0011311416,0.00021112025,0.0002854578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012737802,0.00026204225,0.00048166304,0.0006081409,0.0003919104,0.0001447424,0.00056143134,0.00013596816,0.00035974878],"category_scores_gemma":[0.00021977324,0.00024484604,0.00010416783,0.0003871015,0.00028773112,0.00031508226,0.00026847716,0.0010586756,0.00010400839],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002513017,0.00022511926,0.09909633,0.00076246663,0.000016046915,0.002560079,0.0017805925,0.000009296114,0.8875313,0.000036757447,0.0013707265,0.0040982957],"study_design_scores_gemma":[0.0037782,0.000093739596,0.31757122,0.0013469117,0.0000067115493,0.0000026283112,0.00022293997,0.0000050929384,0.6755707,0.0001461185,0.0010582963,0.00019744394],"about_ca_topic_score_codex":0.0025286435,"about_ca_topic_score_gemma":0.0042105266,"teacher_disagreement_score":0.21847488,"about_ca_system_score_codex":0.0020615687,"about_ca_system_score_gemma":0.00083285006,"threshold_uncertainty_score":0.9984532},"labels":[],"label_agreement":null},{"id":"W2743666174","doi":"10.5489/cuaj.4397","title":"Benchmarking quality for renal cancer surgery: Canadian Kidney Cancer information system (CKCis) perspective","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of British Columbia; University of Alberta Hospital; Université Laval; University of Alberta; University of Ottawa; McGill University; McGill University Health Centre; McMaster University; University of Toronto; Dalhousie University; University of Calgary; Princess Margaret Cancer Centre; Public Health Ontario","funders":"Astellas Pharma; Sanofi; Pfizer; Eli Lilly and Company; Amgen","keywords":"Nephrectomy; Benchmarking; Medicine; Renal cell carcinoma; Kidney cancer; Multivariate analysis; Quality management; Case mix index; Surgery; Emergency medicine; Internal medicine; Kidney; Operations management; Nursing","score_opus":0.043355820399463965,"score_gpt":0.3028352671707001,"score_spread":0.25947944677123613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743666174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83416176,0.0005862793,0.00014961846,0.14304934,0.0031444007,0.0012990078,0.0019362636,0.000058640675,0.015614679],"genre_scores_gemma":[0.99321514,0.000083077684,0.00011156277,0.004548847,0.0014689978,0.00013642,0.000088291235,0.000015479882,0.00033219586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771947,0.00015899503,0.00056930166,0.00023982051,0.00047241536,0.00083998893],"domain_scores_gemma":[0.99477655,0.00017521814,0.0009647042,0.0002541394,0.0013082173,0.0025211792],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0015062141,0.0002201469,0.00051337975,0.0003756971,0.0016809483,0.0004294173,0.00019948637,0.00034249597,0.00047619472],"category_scores_gemma":[0.0025435386,0.00018453387,0.00032594407,0.00010668257,0.000047469905,0.0004546809,0.000014333654,0.00048479557,0.000024897106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00014027221,0.000011918199,0.9477372,0.000039580675,0.00037014356,0.00007265672,0.0004189366,0.000054626795,0.000021261683,0.0009793119,0.04537304,0.004781034],"study_design_scores_gemma":[0.0011409312,0.000100654535,0.90456754,0.00011827312,0.00021663844,0.00008612351,0.00036218326,0.00041896864,0.00005010867,0.00012057161,0.09259904,0.00021897552],"about_ca_topic_score_codex":0.72319156,"about_ca_topic_score_gemma":0.49411613,"teacher_disagreement_score":0.2290754,"about_ca_system_score_codex":0.022358688,"about_ca_system_score_gemma":0.008019562,"threshold_uncertainty_score":0.9996187},"labels":[],"label_agreement":null},{"id":"W2745591830","doi":"10.21037/cco.2017.06.30","title":"Stereotactic body radiotherapy for primary renal cell carcinoma and adrenal metastases","year":2017,"lang":"en","type":"review","venue":"Chinese Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Radiation therapy; Radiosurgery; Perioperative; Population; Radiology; Oncology","score_opus":0.18763303797732872,"score_gpt":0.4855256756701115,"score_spread":0.2978926376927828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745591830","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0077051944,0.9837493,0.000032354557,0.00027661404,0.0011332199,0.0038754102,0.00021766132,0.000053221764,0.0029570519],"genre_scores_gemma":[0.00096512283,0.98711234,0.003442739,0.00056536804,0.0029236306,0.00059206266,0.0009190044,0.00018097267,0.0032987793],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99444395,0.00089771254,0.0023603365,0.0013526885,0.00030792723,0.0006373679],"domain_scores_gemma":[0.9897124,0.0059530875,0.0019096214,0.0014716999,0.00017986608,0.0007732839],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016290114,0.0010126303,0.008496616,0.0002771715,0.00020978051,0.000059570117,0.00046220233,0.0012514963,0.00012213805],"category_scores_gemma":[0.0011249693,0.00061538216,0.0024156037,0.00011522422,0.0006268215,0.000098820245,0.00023515988,0.001249455,0.0000440366],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011777367,0.0014389862,0.0026035632,0.015413497,0.0015650251,0.0016092968,0.000019946167,2.4665653e-8,0.0000052007895,0.000010146149,0.0028220497,0.97333455],"study_design_scores_gemma":[0.0075604967,0.010435482,0.011977866,0.0013793951,0.008606176,0.0018195431,0.0000017522883,0.0000060728767,0.0000016015026,0.00004398282,0.95767164,0.00049597456],"about_ca_topic_score_codex":0.000022770677,"about_ca_topic_score_gemma":0.000010699744,"teacher_disagreement_score":0.9728386,"about_ca_system_score_codex":0.0006733479,"about_ca_system_score_gemma":0.0028303477,"threshold_uncertainty_score":0.99962974},"labels":[],"label_agreement":null},{"id":"W2745799090","doi":"10.1007/s00345-017-2082-9","title":"Marital status and gender affect stage, tumor grade, treatment type and cancer specific mortality in T1–2 N0 M0 renal cell carcinoma","year":2017,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Marital status; Internal medicine; Logistic regression; Renal cell carcinoma; Epidemiology; Nephrology; Stage (stratigraphy); Cancer; Oncology; Affect (linguistics); Performance status; Demography; Population; Psychology","score_opus":0.065595657125186,"score_gpt":0.32407689218651775,"score_spread":0.25848123506133175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745799090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719537,0.024954872,0.0000015432225,0.0005216129,0.00031904678,0.00027833533,0.000016161832,0.0000046227483,0.0019500937],"genre_scores_gemma":[0.9951067,0.0032681874,0.00019652657,0.00011341434,0.0002546531,0.0000071809777,0.000004411983,0.000024807074,0.0010241095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985099,0.00013711015,0.00042040466,0.00029819153,0.00022469088,0.0004096955],"domain_scores_gemma":[0.99868387,0.00009268986,0.00042574707,0.00036222828,0.000105609906,0.00032985347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025292687,0.00025194872,0.00063534314,0.00029301472,0.000110287976,0.000043958127,0.000093737995,0.000064567634,0.00017058016],"category_scores_gemma":[0.000027232312,0.00018463352,0.00008919713,0.000089853944,0.00023292481,0.000108966466,0.00006873558,0.00033602692,0.0000031287732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013385823,0.00029195545,0.9852556,0.000053981355,0.00014650173,0.005267765,0.0002821303,0.000012972787,0.004026669,0.00004662882,0.00029024677,0.0029869792],"study_design_scores_gemma":[0.0056442157,0.0025062333,0.98252267,0.000015636464,0.00032340016,0.0006542391,0.000039266713,0.00002054187,0.0017000175,0.00011166078,0.0063319826,0.00013012694],"about_ca_topic_score_codex":0.0006711959,"about_ca_topic_score_gemma":0.0013515181,"teacher_disagreement_score":0.023152998,"about_ca_system_score_codex":0.00029884695,"about_ca_system_score_gemma":0.0002361938,"threshold_uncertainty_score":0.75291365},"labels":[],"label_agreement":null},{"id":"W2746450229","doi":"10.1016/j.prp.2017.08.004","title":"Melanotic MiT family translocation neoplasms: Expanding the clinical and molecular spectrum of this unique entity of tumors","year":2017,"lang":"en","type":"article","venue":"Pathology - Research and Practice","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; McGill University Health Centre; University of Toronto; Toronto General Hospital; Credit Valley Hospital; McMaster University","funders":"Memorial Sloan-Kettering Cancer Center","keywords":"TFE3; TFEB; Chromosomal translocation; Pathology; Kidney; Biology; Population; Renal cell carcinoma; Cancer; Cancer research; Medicine; Genetics; Transcription factor; Gene","score_opus":0.15130738001257577,"score_gpt":0.4548528533388382,"score_spread":0.3035454733262624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2746450229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824251,0.0022022137,0.00020550213,0.007936687,0.0000448492,0.0004359152,0.0000051060783,0.0000045319202,0.0067401207],"genre_scores_gemma":[0.9956004,0.0031296313,0.000991778,0.00007321669,0.000030740106,0.000015488084,0.0000035732617,0.000008713196,0.00014645724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976906,0.001246754,0.00029653386,0.0002487721,0.00030623912,0.00021105447],"domain_scores_gemma":[0.99652326,0.002417102,0.0002052684,0.0005321769,0.00021311079,0.00010908149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004898965,0.00008357404,0.00028682436,0.000090329704,0.00021821627,0.000026840004,0.00013163305,0.00010400015,0.000018135275],"category_scores_gemma":[0.0049562766,0.000051627667,0.000046885845,0.00006821164,0.0012543044,0.00014729408,0.00009596337,0.00048781568,0.0000039654033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009312478,0.0016166504,0.4979336,0.000873028,0.00073045865,0.0051300186,0.0054062284,0.0000011797632,0.4473252,0.008087369,0.00033121643,0.02325259],"study_design_scores_gemma":[0.0034913654,0.005247225,0.7789427,0.00024740264,0.0004444406,0.0019804453,0.002322843,0.000080356476,0.20147443,0.004947214,0.00068104273,0.00014055055],"about_ca_topic_score_codex":0.00046745493,"about_ca_topic_score_gemma":0.000042455897,"teacher_disagreement_score":0.2810091,"about_ca_system_score_codex":0.000016553862,"about_ca_system_score_gemma":0.00015631599,"threshold_uncertainty_score":0.5933484},"labels":[],"label_agreement":null},{"id":"W2748149325","doi":"10.1016/j.eururo.2017.07.038","title":"Intravenous Mannitol Versus Placebo During Partial Nephrectomy in Patients with Normal Kidney Function: A Double-blind, Clinically-integrated, Randomized Trial","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"Medicine; Placebo; Nephrectomy; Renal function; Randomized controlled trial; Urology; Mannitol; Double blind; Kidney; Surgery; Anesthesia; Internal medicine; Pathology","score_opus":0.03052373154215624,"score_gpt":0.2763420271572101,"score_spread":0.2458182956150539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2748149325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9653155,0.00002565316,0.000050985338,0.0004103058,0.0016462858,0.0035025347,0.0000054329266,0.00008171046,0.028961556],"genre_scores_gemma":[0.9975247,0.000012177315,0.0001529016,0.00035696218,0.0009750305,0.00019589766,0.00012098856,0.000072665665,0.0005886769],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968561,0.0008475449,0.0008196934,0.00060297834,0.00033379826,0.0005398959],"domain_scores_gemma":[0.9979217,0.0002358551,0.0004696076,0.00086049474,0.00013367785,0.00037863298],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009469522,0.00035693703,0.00095875293,0.00018379495,0.00024109535,0.00007469998,0.0002529925,0.00013588653,0.00031672925],"category_scores_gemma":[0.00058862806,0.00025483288,0.00021839318,0.00007673896,0.00037583636,0.00012634946,0.00014873194,0.00065327616,0.00039502775],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96935177,0.000751021,0.026672421,0.000016270558,0.00043432252,0.0013200366,0.00011947689,0.000021857,0.000013830755,0.00002220787,0.00011400925,0.0011627713],"study_design_scores_gemma":[0.9281849,0.00934687,0.057714943,0.000028080243,0.00063253444,0.000038801667,0.0000119780525,0.000035999874,0.000079429374,0.0000014878674,0.0037132686,0.00021168706],"about_ca_topic_score_codex":0.00008578701,"about_ca_topic_score_gemma":0.000024370393,"teacher_disagreement_score":0.041166857,"about_ca_system_score_codex":0.00009695906,"about_ca_system_score_gemma":0.00018580737,"threshold_uncertainty_score":0.9999904},"labels":[],"label_agreement":null},{"id":"W2749561870","doi":"10.1111/bju.13931","title":"The utility of micro <scp>RNA</scp> s as biomarkers in predicting progression and survival in patients with clear‐cell renal cell carcinoma","year":2017,"lang":"en","type":"letter","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Clear cell renal cell carcinoma; microRNA; Carcinogenesis; Renal cell carcinoma; Biomarker; Cancer; Kidney cancer; Tumor progression; Biology; Stage (stratigraphy); Disease; Nephrectomy; Medicine; Oncology; Pathology; Internal medicine; Gene; Kidney","score_opus":0.010833617519251475,"score_gpt":0.2315484816844063,"score_spread":0.22071486416515484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749561870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831367,0.00870113,0.0000011666123,0.0047407467,0.0003095174,0.00064955937,0.000032688662,0.000004537481,0.002423939],"genre_scores_gemma":[0.9971333,0.00039313675,0.00014921851,0.0017024099,0.00035988097,0.000008045762,0.000045117933,0.000056498928,0.00015235915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965853,0.00065243925,0.0010512633,0.00043313307,0.0006919968,0.00058588467],"domain_scores_gemma":[0.99678487,0.00061278587,0.0017059079,0.00039217164,0.00035555448,0.00014872025],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010923522,0.0003328739,0.0010021648,0.00030352536,0.00012917387,0.00006123664,0.00036166643,0.000643872,0.000010852006],"category_scores_gemma":[0.00038653865,0.0002541819,0.00016999734,0.00010965604,0.00054179993,0.00009897292,0.0001481857,0.0023945381,0.0000012153347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017527817,0.0003941603,0.94113326,0.00032670127,0.00015516179,0.016889269,0.00014553954,7.267811e-7,0.00022405921,4.9114416e-8,0.031367667,0.0076106354],"study_design_scores_gemma":[0.0086433375,0.0049969885,0.97421235,0.00065652945,0.00028844585,0.0029503363,0.000060725302,0.000016788072,0.0007738043,0.000017358638,0.007290487,0.00009287582],"about_ca_topic_score_codex":0.0005324801,"about_ca_topic_score_gemma":0.0001493482,"teacher_disagreement_score":0.033079073,"about_ca_system_score_codex":0.00011566881,"about_ca_system_score_gemma":0.0003901169,"threshold_uncertainty_score":0.99999106},"labels":[],"label_agreement":null},{"id":"W2750251971","doi":"","title":"Neklasificirani karcinomi bubrega","year":2016,"lang":"hr","type":"dissertation","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Renal cell carcinoma; Medicine; Pathology; Asymptomatic; Carcinoma; Clear cell; Population; Clear cell renal cell carcinoma","score_opus":0.026192319732012966,"score_gpt":0.27810857562192354,"score_spread":0.25191625588991057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750251971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6154897,0.0046950784,0.000057970516,0.0010577326,0.002959839,0.0016115953,0.000058338075,0.00017824919,0.3738915],"genre_scores_gemma":[0.6199264,0.0005797947,0.0001849331,0.00037600566,0.0010986464,0.0000446559,0.0010318366,0.00016967447,0.37658808],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.994915,0.00015270532,0.0012079165,0.0014741742,0.001110588,0.0011396211],"domain_scores_gemma":[0.9963509,0.0003431513,0.00052704,0.0015119753,0.00050144305,0.00076551526],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00030592733,0.001235677,0.0015324526,0.0005535855,0.0002692953,0.00009296404,0.00042140268,0.00097292266,0.016250186],"category_scores_gemma":[0.00013507192,0.00081810396,0.00082440005,0.00032734728,0.00013706584,0.00023563672,0.00006147875,0.0005960063,0.021955743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010676637,0.0036128736,0.05139343,0.0067671225,0.005727334,0.0061639706,0.007435403,0.0000045110996,0.5947773,0.018770523,0.0600029,0.234668],"study_design_scores_gemma":[0.01551398,0.0046035526,0.3160959,0.0056449235,0.006336774,0.00043193923,0.0099611115,0.000093822564,0.59098864,0.00068741175,0.046387445,0.003254485],"about_ca_topic_score_codex":0.0008499788,"about_ca_topic_score_gemma":0.00011406739,"teacher_disagreement_score":0.26470247,"about_ca_system_score_codex":0.0008849457,"about_ca_system_score_gemma":0.00090467866,"threshold_uncertainty_score":0.99942696},"labels":[],"label_agreement":null},{"id":"W2750933687","doi":"10.1007/978-3-319-67389-9_27","title":"Collage CNN for Renal Cell Carcinoma Detection from CT","year":2017,"lang":"en","type":"book-chapter","venue":"Lecture notes in computer science","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia","funders":"","keywords":"Convolutional neural network; Computer science; Renal cell carcinoma; Artificial intelligence; Malignancy; Radiology; Pattern recognition (psychology); Pathology; Medicine","score_opus":0.02559170055355358,"score_gpt":0.2526624116747015,"score_spread":0.2270707111211479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750933687","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05862701,0.0015515176,0.9199464,0.00033583038,0.002248763,0.0020732356,0.00007230273,0.00008877632,0.015056191],"genre_scores_gemma":[0.9565686,0.000015970409,0.03893635,0.00032723576,0.0011956437,0.00003238025,0.00004851381,0.000057278492,0.002818058],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99724686,0.000015281801,0.00036983233,0.0012250764,0.00066309643,0.0004798809],"domain_scores_gemma":[0.99761033,0.00034740756,0.00032501906,0.0012775272,0.00022089752,0.00021883234],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029650886,0.0004931793,0.0006615225,0.00040775273,0.00032970725,0.0001733061,0.00061776274,0.00023469065,0.000042435986],"category_scores_gemma":[0.00007504314,0.0004118621,0.00025282125,0.000073782656,0.00046819495,0.00011658094,0.0002452012,0.00047171075,0.000042104923],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005138152,0.0001367181,0.0011331398,0.00032333875,0.000073354626,0.0018792606,0.0006340104,0.0017004722,0.03583378,0.00007769048,0.00014176167,0.9575527],"study_design_scores_gemma":[0.005470155,0.0037145892,0.010548355,0.0011568298,0.0005121212,0.0004675506,6.4406817e-7,0.054759398,0.87815684,0.031262517,0.0124102775,0.001540721],"about_ca_topic_score_codex":0.00021666168,"about_ca_topic_score_gemma":0.00028011878,"teacher_disagreement_score":0.95601195,"about_ca_system_score_codex":0.0006993354,"about_ca_system_score_gemma":0.000540403,"threshold_uncertainty_score":0.99983335},"labels":[],"label_agreement":null},{"id":"W2754630413","doi":"10.1016/j.jvir.2017.07.023","title":"Radiofrequency Ablation of T1a Renal Cell Carcinomas within Renal Transplant Allografts: Oncologic Outcomes and Graft Viability","year":2017,"lang":"en","type":"article","venue":"Journal of Vascular and Interventional Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Radiofrequency ablation; Urology; Renal cell carcinoma; Transplantation; Renal transplant; Ablation; Surgery; Oncology; Internal medicine","score_opus":0.025933843807390836,"score_gpt":0.2876281042304302,"score_spread":0.2616942604230394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754630413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99084747,0.006905072,0.0008391872,0.0005669886,0.00019978908,0.00023404273,0.000016320213,0.0000046812243,0.0003864716],"genre_scores_gemma":[0.9966532,0.00064074225,0.0024413578,0.000043425847,0.0001072753,0.000005324751,0.000018115572,0.000010635984,0.00007991301],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998062,0.00025814233,0.00095339987,0.00023920127,0.00030695501,0.00018030255],"domain_scores_gemma":[0.99824953,0.00013491965,0.0009240071,0.0002857206,0.0002242401,0.00018158396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012517091,0.00020034594,0.00083047414,0.00018565806,0.00012919355,0.000021375443,0.00015552223,0.0001655257,0.00006895293],"category_scores_gemma":[0.00018488507,0.00013567426,0.0006955284,0.000031991145,0.00044205436,0.00018106608,0.00003777249,0.0003114314,7.060623e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008305161,0.00063027866,0.9661596,0.00027110588,0.0012116903,0.00047942434,0.00035851554,0.00003135998,0.027215539,0.00068403734,0.000099103905,0.0020288588],"study_design_scores_gemma":[0.0045551024,0.004442226,0.98140484,0.00020643073,0.00076597737,0.003549527,0.000046720685,0.00007876454,0.003022978,0.0015419428,0.0002734065,0.00011205622],"about_ca_topic_score_codex":0.00008893655,"about_ca_topic_score_gemma":0.0000134210295,"teacher_disagreement_score":0.02419256,"about_ca_system_score_codex":0.00011810774,"about_ca_system_score_gemma":0.000115657946,"threshold_uncertainty_score":0.55326355},"labels":[],"label_agreement":null},{"id":"W2754635348","doi":"10.1007/s11255-017-1703-y","title":"Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era","year":2017,"lang":"en","type":"article","venue":"International Urology and Nephrology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Nephrology; Oncology; Incidence (geometry); Epidemiology; Proportional hazards model","score_opus":0.013139190828764082,"score_gpt":0.2675228915549678,"score_spread":0.2543837007262037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754635348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949368,0.00022311627,0.000012007188,0.0017458642,0.0003173405,0.00036771392,0.000046424815,0.0000069811335,0.0023437503],"genre_scores_gemma":[0.9977688,0.00002452273,0.00020075,0.0012674173,0.00007716211,0.00003414828,0.00005335588,0.00001337239,0.00056047755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989188,0.00010340353,0.00030457933,0.0003060491,0.00015709529,0.00021011126],"domain_scores_gemma":[0.9991639,0.00014505451,0.00020060176,0.00026461878,0.00014376536,0.00008203678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017135766,0.00015200516,0.0003936308,0.00018898615,0.000045585428,0.0000088785655,0.0001856558,0.00010888839,0.00028095327],"category_scores_gemma":[0.00009889947,0.00012675738,0.000064457476,0.000027510945,0.0001740031,0.00006854302,0.00010703897,0.00016586813,0.000025824454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004938367,0.0004831323,0.88724256,0.0000090355825,0.00021717214,0.00015249454,0.0002558451,0.0000059131603,0.10375358,0.00021737904,0.0005841324,0.0021403902],"study_design_scores_gemma":[0.00598399,0.0023439918,0.9777065,0.0000032039597,0.000046498204,0.00001727315,0.000003566678,0.00016225425,0.011464569,0.00038661988,0.0017978941,0.00008365097],"about_ca_topic_score_codex":0.0002608426,"about_ca_topic_score_gemma":0.000070802,"teacher_disagreement_score":0.092289016,"about_ca_system_score_codex":0.00003322995,"about_ca_system_score_gemma":0.00004918891,"threshold_uncertainty_score":0.51690155},"labels":[],"label_agreement":null},{"id":"W2755425737","doi":"10.5489/cuaj.4269","title":"Accuracy of kidney cancer diagnosis and histological subtype within Canadian cancer registry data","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Medicine; Cancer registry; Chromophobe cell; Population; Not Otherwise Specified; Cohort; Cancer; Renal cell carcinoma; Pathological; Nephrectomy; Medical diagnosis; Retrospective cohort study; Surgical pathology; Kidney cancer; Pathology; Clear cell; Internal medicine; Kidney","score_opus":0.06769851991754662,"score_gpt":0.31041330792527044,"score_spread":0.24271478800772384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755425737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85253334,0.0038379203,0.0000018259259,0.13929982,0.00065715774,0.00027132512,0.0010757121,0.0000108476115,0.002312057],"genre_scores_gemma":[0.9903867,0.0023173841,0.00018085816,0.005876219,0.00043050537,0.000042105316,0.000076931385,0.000014556873,0.0006746876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982169,0.000117706055,0.00041001302,0.00035969605,0.00034730087,0.000548333],"domain_scores_gemma":[0.9947533,0.00015875579,0.0010111167,0.0006215943,0.00032534756,0.003129898],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006408055,0.00018785047,0.00045031906,0.00015478424,0.0006768523,0.0001451026,0.00052067835,0.00035618307,0.0013881247],"category_scores_gemma":[0.010128253,0.00014396297,0.00007989947,0.00007713714,0.00015849897,0.00021026588,0.00007337886,0.0006372084,0.000009782758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040624953,0.000022916338,0.9142899,0.000012224943,0.0001704528,0.00036884635,0.00006056389,0.000003670999,0.000037861373,0.00006362956,0.080253325,0.004675974],"study_design_scores_gemma":[0.0007864523,0.00014663216,0.8676913,0.000060224673,0.000261988,0.0001647746,0.000022970162,0.0001051725,0.000063354484,0.00015906473,0.13040216,0.00013589766],"about_ca_topic_score_codex":0.6785395,"about_ca_topic_score_gemma":0.6342152,"teacher_disagreement_score":0.13785341,"about_ca_system_score_codex":0.0026481166,"about_ca_system_score_gemma":0.0075552333,"threshold_uncertainty_score":0.9995247},"labels":[],"label_agreement":null},{"id":"W2755930914","doi":"10.1111/bju.14024","title":"The impact of lymph node dissection and positive lymph nodes on cancer‐specific mortality in contemporary <scp>pT</scp> <sub>2‐3</sub> non‐metastatic renal cell carcinoma treated with radical nephrectomy","year":2017,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université de Montréal","funders":"","keywords":"Medicine; Interquartile range; Nephrectomy; Renal cell carcinoma; Hazard ratio; Lymph node; Urology; Proportional hazards model; Lymph; Dissection (medical); Kidney cancer; Cancer; Internal medicine; Surgery; Oncology; Kidney; Pathology; Confidence interval","score_opus":0.023905271899995285,"score_gpt":0.2765362655244014,"score_spread":0.2526309936244061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755930914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99012005,0.008340247,0.00002451557,0.00014350914,0.000083446605,0.00037077695,0.000079462654,0.0000065361774,0.0008314793],"genre_scores_gemma":[0.99762577,0.0020509548,0.000046078712,0.00004964579,0.00013264734,0.000017058537,0.000018354543,0.000037397946,0.000022065324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784756,0.00035075843,0.00069549354,0.00032564456,0.00038319358,0.00039734005],"domain_scores_gemma":[0.99769384,0.00045688197,0.000966819,0.00033105575,0.00026661452,0.0002847776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005043204,0.00028836474,0.0008544232,0.00019634864,0.00026158904,0.000090494184,0.0001978293,0.00013201444,0.000004428549],"category_scores_gemma":[0.00013487863,0.00020185391,0.0002352303,0.000125363,0.0006712887,0.00018487673,0.000041979514,0.0004113014,0.0000012070083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030056993,0.00060413394,0.9389155,0.00004055126,0.00047695808,0.0117854355,0.00018055315,0.00015464159,0.036692083,0.0000029288087,0.00023670157,0.007904839],"study_design_scores_gemma":[0.009594999,0.00263673,0.9367391,0.00027149127,0.00027869895,0.012152224,0.00008672505,0.00017695069,0.037937775,0.000035652116,0.000009822259,0.000079846104],"about_ca_topic_score_codex":0.0045598764,"about_ca_topic_score_gemma":0.00020127656,"teacher_disagreement_score":0.007824993,"about_ca_system_score_codex":0.00034694083,"about_ca_system_score_gemma":0.00055410765,"threshold_uncertainty_score":0.8231364},"labels":[],"label_agreement":null},{"id":"W2756265351","doi":"10.1089/end.2010.1528","title":"Survey of Endourology","year":2010,"lang":"en","type":"article","venue":"Journal of Endourology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Library science","score_opus":0.034753650742917135,"score_gpt":0.29656890338699377,"score_spread":0.2618152526440766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756265351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940638,0.00058299233,0.00006927184,0.0011819699,0.001002748,0.00011064357,0.0000067306805,0.0000067178275,0.0029751537],"genre_scores_gemma":[0.9980049,0.0000497928,0.0010771469,0.00040318246,0.00029584105,0.0000015211873,0.000005256119,0.000019821257,0.00014251008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998411,0.00022676514,0.0007030767,0.00013624945,0.0002526461,0.0002702693],"domain_scores_gemma":[0.9976869,0.000564455,0.0006547026,0.00029852084,0.00058871607,0.00020665847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009899347,0.00014439992,0.00071829226,0.00030758575,0.000020365434,0.00000324504,0.00017432038,0.0002030974,0.0006025999],"category_scores_gemma":[0.0008845222,0.00010452745,0.0002092381,0.00014137868,0.00018937993,0.000044564575,0.000041829462,0.00078270485,0.000023607749],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002796244,0.00051845255,0.7195595,0.000027284437,0.00038541752,0.0017289119,0.00009961434,0.000013356031,0.2686306,0.00031053578,0.0023487832,0.0035812967],"study_design_scores_gemma":[0.0036591368,0.0048277876,0.94438815,0.000006108806,0.00021819794,0.010459811,0.0000082630595,0.00002074596,0.03212955,0.00018308742,0.0040308726,0.00006831624],"about_ca_topic_score_codex":0.00011319385,"about_ca_topic_score_gemma":0.00019132106,"teacher_disagreement_score":0.23650105,"about_ca_system_score_codex":0.000020727337,"about_ca_system_score_gemma":0.00026576413,"threshold_uncertainty_score":0.6598046},"labels":[],"label_agreement":null},{"id":"W2757591860","doi":"10.1016/j.ctrv.2017.09.004","title":"Adjuvant therapy in renal cell carcinoma","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Adjuvant; Immunotherapy; Targeted therapy; Adjuvant therapy; Clinical trial; Disease; Oncology; Kidney cancer; Internal medicine; Cancer","score_opus":0.2687763931843208,"score_gpt":0.4286284167925947,"score_spread":0.15985202360827394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757591860","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021824914,0.978457,5.057671e-7,0.000058729776,0.0003931357,0.009218228,0.000095669544,0.000040128027,0.011518385],"genre_scores_gemma":[0.00006909841,0.9774724,0.00015969825,0.000078648365,0.00066930027,0.008641526,0.0005027533,0.00017657709,0.012229948],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99549353,0.0004271612,0.0016504353,0.0013212136,0.0003489008,0.00075874705],"domain_scores_gemma":[0.99557316,0.00008291657,0.0013359457,0.002541767,0.000056773988,0.00040940646],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00031363493,0.0015442703,0.008047035,0.000397479,0.00013008274,0.000067415385,0.0004313117,0.00045188563,0.0006554312],"category_scores_gemma":[0.000017877002,0.00086801697,0.002580272,0.00027923743,0.000107833475,0.00008870819,0.00007050765,0.00045804624,0.0007753427],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050109,0.0005855649,0.0006300577,0.012895914,0.00023003522,0.0010408948,0.00007200338,8.237181e-8,0.0000024984793,0.0000017157827,0.0014890122,0.9830021],"study_design_scores_gemma":[0.0030940797,0.0015894737,0.00039410885,0.028545342,0.0033744036,0.00014693686,0.0000024425299,4.1916596e-7,0.0000711975,0.0000023304572,0.96218896,0.0005902955],"about_ca_topic_score_codex":0.00089456607,"about_ca_topic_score_gemma":0.00016198317,"teacher_disagreement_score":0.9824118,"about_ca_system_score_codex":0.004213388,"about_ca_system_score_gemma":0.0016618968,"threshold_uncertainty_score":0.9997306},"labels":[],"label_agreement":null},{"id":"W2760393940","doi":"10.1016/j.ijrobp.2017.06.355","title":"Individual Patient Data Meta-analysis of SBRT Kidney: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK)","year":2017,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Western University; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Cancer Care Ontario","funders":"","keywords":"Medicine; Renal cell carcinoma; Proportional hazards model; Radiosurgery; Exact test; Kidney cancer; Log-rank test; Urology; Hazard ratio; Survival analysis; Nuclear medicine; Internal medicine; Oncology; Radiation therapy; Confidence interval","score_opus":0.13522476241887738,"score_gpt":0.3891704515378399,"score_spread":0.25394568911896254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760393940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7764699,0.003968559,0.024058467,0.14985764,0.017754424,0.0023431594,0.021451334,0.00008348931,0.004013072],"genre_scores_gemma":[0.97629625,0.00038360787,0.008104262,0.0058613024,0.0024646802,0.00006535262,0.0066634705,0.000040632636,0.00012043796],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.99585915,0.00035406605,0.0020456817,0.00058468885,0.0008601313,0.0002963095],"domain_scores_gemma":[0.988152,0.0020838652,0.0062124645,0.0013204314,0.001874081,0.00035714873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020315975,0.00034547478,0.0018522056,0.000349528,0.00020610864,0.00009246723,0.0021906858,0.00033753505,0.00040495675],"category_scores_gemma":[0.0060372846,0.00023753208,0.0016559325,0.0001598354,0.0004956318,0.0004651044,0.0005496803,0.0005123132,0.000010455903],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022017437,0.0019063913,0.41249612,0.000012480845,0.43490282,0.00069778494,0.00096025184,0.00027454662,0.0044405116,0.0015759827,0.089153565,0.051377803],"study_design_scores_gemma":[0.011070301,0.0023472612,0.13796285,0.000053159052,0.22956173,0.0012102267,0.000290503,0.004822092,0.007869094,0.00444331,0.59985334,0.00051613775],"about_ca_topic_score_codex":0.00022050792,"about_ca_topic_score_gemma":0.000029676197,"teacher_disagreement_score":0.51069975,"about_ca_system_score_codex":0.0008287396,"about_ca_system_score_gemma":0.0027216875,"threshold_uncertainty_score":0.9686277},"labels":[],"label_agreement":null},{"id":"W2760650159","doi":"10.1016/j.urolonc.2017.09.004","title":"Sunitinib dose-escalation after disease progression in metastatic renal cell carcinoma","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Sunitinib; Medicine; Renal cell carcinoma; Toxicity; Internal medicine; Oncology; Progression-free survival; Retrospective cohort study; Urology; Progressive disease; Dosing; Surgery; Overall survival; Disease","score_opus":0.044977480753712495,"score_gpt":0.33666559523442724,"score_spread":0.29168811448071474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760650159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841428,0.0013561107,0.000011244239,0.0056263674,0.00009958419,0.00066559104,0.0000202338,0.00003049317,0.008047593],"genre_scores_gemma":[0.98029894,0.00010257286,0.01765533,0.00058647356,0.00008938426,0.00030326095,0.00009574726,0.000015995667,0.00085227576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855125,0.00016152662,0.00032973563,0.00043292664,0.00019561694,0.00032891578],"domain_scores_gemma":[0.9986531,0.00014183666,0.0002389252,0.00044589947,0.00006082414,0.00045937902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003013421,0.00022723089,0.000363943,0.00018605085,0.00034572574,0.00005373149,0.00011306908,0.00013250145,0.00010534775],"category_scores_gemma":[0.00019587616,0.0001755595,0.000071299306,0.0000968835,0.00070566527,0.00019457666,0.00008480299,0.00030875704,0.00002989053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006671897,0.0004305013,0.9921269,0.00007165276,0.000014908941,0.0025391115,0.00025322667,0.000019144329,0.0006373094,0.0004533984,0.00037098853,0.0024156917],"study_design_scores_gemma":[0.0024218198,0.0021927864,0.92862904,0.000109912355,0.00044917568,0.00015432242,0.000078920726,0.00088001264,0.0011768475,0.0025820641,0.06112379,0.00020130516],"about_ca_topic_score_codex":0.00007573103,"about_ca_topic_score_gemma":0.000057505647,"teacher_disagreement_score":0.063497834,"about_ca_system_score_codex":0.00016226666,"about_ca_system_score_gemma":0.00038916964,"threshold_uncertainty_score":0.71591085},"labels":[],"label_agreement":null},{"id":"W2760922128","doi":"10.1038/modpathol.2017.77","title":"Do significant TFE3 gene rearrangements occur in succinate dehydrogenase-deficient renal cell carcinoma? Borderline FISH results should be interpreted with caution","year":2017,"lang":"en","type":"letter","venue":"Modern Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"TFE3; SDHB; Renal cell carcinoma; Pathology; Biology; Gene mutation; Cancer research; Fluorescence in situ hybridization; Clear cell carcinoma; Gene rearrangement; Carcinoma; Chromosomal translocation; Mutation; Gene; Medicine; Genetics; Gene expression","score_opus":0.04694571135721827,"score_gpt":0.2803901673155984,"score_spread":0.23344445595838015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760922128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8967087,0.0009673365,0.0004920545,0.094626695,0.00042602842,0.0023253092,0.0013310118,0.00013899364,0.0029838702],"genre_scores_gemma":[0.9350857,0.00007257164,0.0005891542,0.05350684,0.0006787767,0.00035078175,0.00665997,0.00023820854,0.0028179549],"study_design_codex":"case_report","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99336004,0.0005490483,0.0012550231,0.0023451068,0.0010580216,0.0014327372],"domain_scores_gemma":[0.9955521,0.00012150124,0.0009591827,0.002759456,0.00034312267,0.000264601],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00071824493,0.0011591049,0.0017206924,0.00084815355,0.00020553624,0.00008900206,0.00062093226,0.0016169301,0.00006589816],"category_scores_gemma":[0.00011432914,0.0009395943,0.0003401191,0.00021950406,0.00035105788,0.0001003424,0.00028909897,0.0027308906,0.000049949613],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013121907,0.0018858569,0.009771463,0.0015436021,0.0006565642,0.43595555,0.0049081966,0.0010122532,0.14514995,0.0000030895133,0.38332927,0.0026622778],"study_design_scores_gemma":[0.10100664,0.03323661,0.098528594,0.004351821,0.008470511,0.019223154,0.00033878424,0.021116227,0.5096703,0.0003868251,0.19416495,0.009505583],"about_ca_topic_score_codex":0.00083726656,"about_ca_topic_score_gemma":0.0003921001,"teacher_disagreement_score":0.4167324,"about_ca_system_score_codex":0.0010663136,"about_ca_system_score_gemma":0.00047435332,"threshold_uncertainty_score":0.9996792},"labels":[],"label_agreement":null},{"id":"W2761073280","doi":"10.1016/j.csbj.2017.09.003","title":"A Gene Module-Based eQTL Analysis Prioritizing Disease Genes and Pathways in Kidney Cancer","year":2017,"lang":"en","type":"article","venue":"Computational and Structural Biotechnology Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; Arkansas Science and Technology Authority; National Institutes of Health; U.S. Food and Drug Administration; Hamilton Health Sciences Foundation; Arkansas Research Alliance","keywords":"Gene; Biology; BAP1; Transcriptome; Clear cell renal cell carcinoma; Computational biology; Cancer; Genetics; Disease; Cancer research; Gene expression; Renal cell carcinoma; Medicine; Oncology; Pathology","score_opus":0.024184241626916514,"score_gpt":0.27986617186480306,"score_spread":0.25568193023788655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761073280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839719,0.0038696937,0.0006983893,0.011196409,0.000074018055,0.00011965726,0.00004360572,0.00001956227,0.0000067846436],"genre_scores_gemma":[0.9925181,0.00033816166,0.0067648464,0.0002496343,0.000076627904,0.000005925008,0.00003002632,0.0000071310874,0.000009494118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913204,0.00002400467,0.00022722047,0.00025683283,0.00016924109,0.00019066544],"domain_scores_gemma":[0.999282,0.000026515161,0.00016748832,0.00015750139,0.0000843359,0.0002821301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000076627366,0.00015090231,0.00029876988,0.00038392935,0.00043341648,0.00009160998,0.00009480773,0.00011540069,0.000017392194],"category_scores_gemma":[0.00007110113,0.000113258015,0.00008459733,0.000115109164,0.00027997672,0.00008374149,0.000067222034,0.0002683496,4.5209464e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029445445,0.000023848906,0.92308486,0.0000577335,0.00043407103,0.0010492085,0.000046248573,0.0028856164,0.008032206,0.000460758,0.0000114847335,0.063619524],"study_design_scores_gemma":[0.0017364117,0.00008588274,0.9249858,0.00006642067,0.00035619512,0.0004374326,0.000013142231,0.06472025,0.0021562064,0.0053068944,0.000020604448,0.00011471765],"about_ca_topic_score_codex":0.000049949726,"about_ca_topic_score_gemma":0.000015208598,"teacher_disagreement_score":0.0635048,"about_ca_system_score_codex":0.00009543391,"about_ca_system_score_gemma":0.0002047706,"threshold_uncertainty_score":0.4618528},"labels":[],"label_agreement":null},{"id":"W2761612944","doi":"10.1093/annonc/mdx371.037","title":"Synchronous vs metachronous metastatic disease: Impact of time to metastasis on outcome in metastatic renal cell carcinoma patients treated with targeted therapy","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; BC Cancer Agency; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Metastasis; Proportional hazards model; Oncology; Nephrectomy; Disease; Performance status; Gastroenterology; Cancer; Kidney","score_opus":0.07206200555757965,"score_gpt":0.37027241758150353,"score_spread":0.2982104120239239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761612944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99462813,0.0006745974,0.000010389035,0.00053803367,0.00002776335,0.0018748138,0.00034763603,0.000019104296,0.001879527],"genre_scores_gemma":[0.9978709,0.000067236855,0.0010555016,0.00025296223,0.000018097284,0.00011999132,0.00018353135,0.000069162175,0.00036257406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99679357,0.00043683755,0.0009689784,0.0005914831,0.0005649314,0.0006441924],"domain_scores_gemma":[0.99646723,0.0002987202,0.00095554115,0.0012499721,0.00047861386,0.0005499484],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047691807,0.0005351913,0.0020845071,0.00062122,0.00010001063,0.000018387578,0.00037024618,0.00006574635,0.0005838555],"category_scores_gemma":[0.00019808163,0.0003483285,0.0005360123,0.00027970105,0.00024582373,0.00014871823,0.000064091306,0.00020986663,0.00010539773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037502926,0.014243196,0.90610564,0.00038081128,0.003653495,0.0028435222,0.0006903534,0.0013800277,0.00709912,0.000010408362,0.0011163335,0.024974165],"study_design_scores_gemma":[0.009826913,0.05645424,0.8959944,0.00007699278,0.00096364116,0.000018994017,0.000018893108,0.00011485967,0.03605485,0.0000141176615,0.0001871172,0.00027496633],"about_ca_topic_score_codex":0.0021293943,"about_ca_topic_score_gemma":0.00007411157,"teacher_disagreement_score":0.042211045,"about_ca_system_score_codex":0.00038617093,"about_ca_system_score_gemma":0.0008011233,"threshold_uncertainty_score":0.9998969},"labels":[],"label_agreement":null},{"id":"W2761728807","doi":"10.1200/jco.2017.35.15_suppl.4580","title":"Checkpoint inhibitors in metastatic renal cell carcinoma patients including elderly subgroups: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Ottawa Regional Cancer Foundation; University of Alberta; Queen Elizabeth II Health Sciences Centre; McMaster University; London Health Sciences Centre; Baker Hughes (Canada); University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Hazard ratio; Internal medicine; Oncology; Population; Proportional hazards model; Surgery; Confidence interval","score_opus":0.15717320344868443,"score_gpt":0.40647978945797664,"score_spread":0.2493065860092922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761728807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98335236,0.00059857604,0.00006818765,0.007553615,0.002774075,0.0007177814,0.00026267543,0.000010477761,0.004662237],"genre_scores_gemma":[0.99039924,0.0001611837,0.0062583,0.001095884,0.0014903005,0.00001949529,0.00020440914,0.000055822515,0.00031537967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98971194,0.0013419533,0.0060364576,0.0007611785,0.0015042461,0.00064422656],"domain_scores_gemma":[0.9840881,0.005912736,0.0071142092,0.0012469534,0.0008962648,0.00074170466],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0070326994,0.00051341025,0.0022818043,0.0003304356,0.00028303737,0.0001260603,0.00128055,0.0002872281,0.00016856968],"category_scores_gemma":[0.009403917,0.00033150963,0.0009954809,0.00015973375,0.00061124674,0.0005538113,0.0006563215,0.0023368606,0.000059033082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02445187,0.008568041,0.90307003,0.00010887867,0.00086444017,0.013776033,0.0015026672,0.000071419745,0.007965217,0.000026439848,0.018775947,0.020819023],"study_design_scores_gemma":[0.04813228,0.011729271,0.91069055,0.00030128265,0.0016657732,0.0002241559,0.00064437685,0.00037847002,0.017101415,0.0002680736,0.008499221,0.00036515974],"about_ca_topic_score_codex":0.0020799004,"about_ca_topic_score_gemma":0.0009577315,"teacher_disagreement_score":0.023680411,"about_ca_system_score_codex":0.0008563897,"about_ca_system_score_gemma":0.0023392464,"threshold_uncertainty_score":0.9999648},"labels":[],"label_agreement":null},{"id":"W2761850685","doi":"10.5489/cuaj.4519","title":"Case: Secondary polycythemia due to pazopanib in patients with metastatic renal cell carcinoma","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Pazopanib; Medicine; Renal cell carcinoma; Leukopenia; Internal medicine; Sunitinib; Anemia; Oncology; Tyrosine-kinase inhibitor; Vomiting; Adverse effect; Gastroenterology; Cancer; Chemotherapy","score_opus":0.014166143837168167,"score_gpt":0.21802540637585072,"score_spread":0.20385926253868256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761850685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901547,0.00006167663,0.000011332348,0.005816257,0.00012892156,0.00040192812,0.00006462194,0.000008499657,0.0033520511],"genre_scores_gemma":[0.99701834,0.0000015184352,0.00053246814,0.0016687057,0.00015116802,0.000014865044,0.000026208716,0.000021646187,0.0005651049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981328,0.00014145013,0.00036660867,0.0002831587,0.00043521886,0.000640744],"domain_scores_gemma":[0.9977177,0.00008072601,0.00036911634,0.00030650297,0.00024259932,0.0012833799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047163464,0.00021322728,0.0004216456,0.00026801473,0.00048443812,0.00017214648,0.00017783346,0.00013673925,0.00047633576],"category_scores_gemma":[0.0003587707,0.00015495185,0.00010190368,0.00011393189,0.000034894685,0.000146369,0.000029665698,0.00070384494,0.00006662384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024763244,0.00010034715,0.9723261,0.000006392395,0.000054602282,0.02301669,0.00014015744,0.000012400057,0.000037524147,0.0000075680446,0.0020496305,0.0020009857],"study_design_scores_gemma":[0.0039474093,0.0013633347,0.98929024,0.000013962703,0.000119632314,0.003079229,0.00004426773,0.000011532669,0.00018610168,0.00005428247,0.0017233482,0.00016666939],"about_ca_topic_score_codex":0.0048160222,"about_ca_topic_score_gemma":0.006517808,"teacher_disagreement_score":0.01993746,"about_ca_system_score_codex":0.0021899934,"about_ca_system_score_gemma":0.000862053,"threshold_uncertainty_score":0.7280417},"labels":[],"label_agreement":null},{"id":"W2762165713","doi":"10.1093/annonc/mdx440.030","title":"Immediate versus deferred cytoreductive nephrectomy (CN) in patients with synchronous metastatic renal cell carcinoma (mRCC) receiving sunitinib (EORTC 30073 SURTIME)","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Asymptomatic; Progression-free survival; Hazard ratio; Internal medicine; Urology; Adverse effect; Log-rank test; Oncology; Surgery; Chemotherapy; Survival analysis; Confidence interval","score_opus":0.07552152128933143,"score_gpt":0.34000845849170674,"score_spread":0.2644869372023753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762165713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826003,0.0003157442,0.0000052205883,0.000602866,0.0003362735,0.00093398907,0.00004271501,0.00002196665,0.015140968],"genre_scores_gemma":[0.99812555,0.00005299189,0.0011733592,0.00011029222,0.00011377783,0.00007526125,0.00012909735,0.00005629689,0.00016335117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744934,0.00027432616,0.0006231186,0.00053845375,0.00043050424,0.0006842615],"domain_scores_gemma":[0.99715126,0.00040974346,0.00078125024,0.0008402569,0.00052426406,0.00029325302],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045254946,0.0003714866,0.0010614882,0.0003206914,0.00015295371,0.000024885338,0.00030376547,0.00016379986,0.00012969892],"category_scores_gemma":[0.00033492158,0.00030462162,0.00017309493,0.00015797807,0.0004227592,0.00024180493,0.00013715086,0.00036603038,0.00004267233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03098193,0.004320628,0.9132351,0.00028153407,0.000910016,0.0020902655,0.0026394217,0.00008343969,0.0020520021,0.000036392812,0.0011796344,0.042189587],"study_design_scores_gemma":[0.019465594,0.01585963,0.94162524,0.00010855657,0.00039906253,0.000027148957,0.00031078482,0.000024783942,0.021111287,0.000039282513,0.000750942,0.0002776638],"about_ca_topic_score_codex":0.0012524145,"about_ca_topic_score_gemma":0.0004579521,"teacher_disagreement_score":0.041911922,"about_ca_system_score_codex":0.00033393878,"about_ca_system_score_gemma":0.0007456552,"threshold_uncertainty_score":0.9999406},"labels":[],"label_agreement":null},{"id":"W2762272675","doi":"10.1097/pas.0000000000000962","title":"Toward Biological Subtyping of Papillary Renal Cell Carcinoma With Clinical Implications Through Histologic, Immunohistochemical, and Molecular Analysis","year":2017,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Health Sciences Centre; McGill University Health Centre; Sunnybrook Health Science Centre; University Health Network; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Subtyping; Papillary renal cell carcinomas; Immunohistochemistry; Pathology; Medicine; Univariate analysis; Hazard ratio; Oncology; Multivariate analysis; Internal medicine; Confidence interval; Biology; Carcinoma","score_opus":0.05652743778820555,"score_gpt":0.33166028507500805,"score_spread":0.2751328472868025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762272675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893893,0.0032680985,0.0010619423,0.005206854,0.00003311074,0.00015722314,0.000007222162,0.0000077061895,0.0008685457],"genre_scores_gemma":[0.99472725,0.001465354,0.0034426828,0.0002518023,0.000074363394,0.0000063818843,0.000007191873,0.000014080015,0.000010879439],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977904,0.0004619351,0.0009046183,0.00032629326,0.00022847553,0.00028827868],"domain_scores_gemma":[0.9962072,0.0005089489,0.0019514528,0.0008409964,0.00029976288,0.00019167103],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0007640176,0.00022324309,0.0014838913,0.000114893424,0.00017357964,0.000015069949,0.0004367632,0.00010941829,0.00002334688],"category_scores_gemma":[0.00013993033,0.00011532877,0.00055908965,0.00023559523,0.0039528986,0.000053560583,0.000169331,0.00053999474,0.0000017568206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070160152,0.0008111818,0.88249093,0.00003508505,0.0015257393,0.00989598,0.00041858215,0.000018271056,0.08920287,0.0007904091,0.00013810208,0.007656822],"study_design_scores_gemma":[0.0024375974,0.0075408793,0.9675966,0.000025188196,0.002526104,0.01099689,0.00023811698,0.000009697755,0.007121684,0.0007593338,0.00055391004,0.00019400452],"about_ca_topic_score_codex":0.000060510807,"about_ca_topic_score_gemma":7.454767e-7,"teacher_disagreement_score":0.08510566,"about_ca_system_score_codex":0.000059680227,"about_ca_system_score_gemma":0.00012667182,"threshold_uncertainty_score":0.9987578},"labels":[],"label_agreement":null},{"id":"W2762408310","doi":"10.5489/cuaj.4420","title":"Ipsilateral renal function preservation following minimally invasive partial nephrectomy: The effect of tumour characteristics and warm ischemic time","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Nephrectomy; Renal function; Perioperative; Univariate analysis; Urology; Pathological; Renal hilum; Kidney; Parenchyma; Surgery; Multivariate analysis; Internal medicine; Pathology","score_opus":0.012328663620801561,"score_gpt":0.2216976771240287,"score_spread":0.20936901350322715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762408310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930243,0.00008294637,0.000005716808,0.0057174703,0.00021627996,0.00033074635,0.000013306313,0.000008932995,0.0006002883],"genre_scores_gemma":[0.998662,0.000014436563,0.000035928828,0.000370037,0.00046246938,0.000017860068,0.000032501684,0.0000105444815,0.00039422864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986932,0.00020777731,0.00032477189,0.0001618069,0.00031085694,0.0003015594],"domain_scores_gemma":[0.99851197,0.00028526929,0.00058109354,0.0001590067,0.0001362977,0.00032636194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008549084,0.00014702289,0.00033354707,0.000070032314,0.00052074715,0.00015454617,0.00012677559,0.00017262266,0.00009816244],"category_scores_gemma":[0.0018737784,0.00009208396,0.00016541616,0.000043506556,0.00004688392,0.00020573335,0.00002955757,0.00039010603,0.000017022736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004660589,0.000011444952,0.9502244,0.000009572153,0.0002442094,0.00011353665,0.0000745741,0.0000028426584,0.046057165,0.000003916827,0.0015251187,0.0012671459],"study_design_scores_gemma":[0.001568096,0.0013719349,0.9869707,0.000035907557,0.000439898,0.000100769015,0.000005254656,0.00027054266,0.0060228817,0.000041374293,0.0030889013,0.00008373229],"about_ca_topic_score_codex":0.000405005,"about_ca_topic_score_gemma":0.0001162741,"teacher_disagreement_score":0.040034283,"about_ca_system_score_codex":0.00044939402,"about_ca_system_score_gemma":0.00025779614,"threshold_uncertainty_score":0.40052187},"labels":[],"label_agreement":null},{"id":"W2762636298","doi":"10.1093/annonc/mdx440.029","title":"CheckMate 214: Efficacy and safety of nivolumab + ipilimumab (N+I) v sunitinib (S) for treatment-naïve advanced or metastatic renal cell carcinoma (mRCC), including IMDC risk and PD-L1 expression subgroups","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Renal cell carcinoma; Ipilimumab; Nivolumab; Gastroenterology; Sunitinib; Urology; Oncology; Cancer; Immunotherapy","score_opus":0.1354962718192336,"score_gpt":0.39838214762304164,"score_spread":0.26288587580380807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762636298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99347895,0.0019557127,0.00009360816,0.00055813155,0.000092598806,0.0016275297,0.00020805691,0.00002035434,0.0019650725],"genre_scores_gemma":[0.9908981,0.0028059902,0.0054009594,0.000060656334,0.00007293997,0.0001182969,0.000070787144,0.000048389073,0.000523905],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99776846,0.00021105901,0.0007663202,0.00055160624,0.00021848819,0.00048404047],"domain_scores_gemma":[0.99650204,0.0010355904,0.0011543325,0.0007198377,0.00030908716,0.00027908938],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005263275,0.00038072505,0.0013913051,0.00019602737,0.00039482326,0.000018320326,0.0001717601,0.00017497186,0.000051649873],"category_scores_gemma":[0.00045573516,0.0002745271,0.00019659268,0.00006794135,0.0004370899,0.00018752442,0.00020149208,0.00013111957,0.00000216094],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10725496,0.0044974294,0.030092407,0.0020789427,0.00106914,0.0007068038,0.0053317794,0.000041219584,0.39245537,0.00016136111,0.00072527886,0.45558533],"study_design_scores_gemma":[0.04815006,0.03733446,0.19639856,0.00035580917,0.0013027106,0.00019813127,0.00086480106,0.00022507693,0.70952606,0.00027091926,0.005025657,0.00034772966],"about_ca_topic_score_codex":0.0002994931,"about_ca_topic_score_gemma":0.00011459527,"teacher_disagreement_score":0.4552376,"about_ca_system_score_codex":0.00012393469,"about_ca_system_score_gemma":0.0002810135,"threshold_uncertainty_score":0.9999707},"labels":[],"label_agreement":null},{"id":"W2762733456","doi":"10.1093/annonc/mdx371.054","title":"Phase II study of individualized sunitinib (SUN) as first-line therapy for metastatic renal cell cancer: Pharmacokinetic data","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ozmosis Research (Canada); Queen Elizabeth II Health Sciences Centre; University of Alberta; Regional Municipality of Durham; London Health Sciences Centre; BC Cancer Agency; Hôpital Notre-Dame; CancerCare Manitoba; Ottawa Hospital; Princess Margaret Cancer Centre; Western University; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Toxicity; Pharmacokinetics; Sunitinib; Urology; Internal medicine; Nuclear medicine; Cancer","score_opus":0.3869043426930212,"score_gpt":0.5269391595123061,"score_spread":0.14003481681928487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762733456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882639,0.002226974,0.000018441566,0.0039282097,0.00017956017,0.0024170855,0.0006063742,0.000014062702,0.0023453934],"genre_scores_gemma":[0.9942651,0.0030498235,0.00070953876,0.0006026192,0.0001625961,0.00026943104,0.00032442636,0.00003561096,0.0005808849],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980152,0.00016874801,0.0007035638,0.00043626,0.00033386168,0.00034237048],"domain_scores_gemma":[0.9966259,0.00041138107,0.0009844903,0.0013725946,0.0004360797,0.00016953073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007579976,0.0002446307,0.0010697272,0.00016599744,0.00021368623,0.000009846085,0.0007031764,0.00007542414,0.0004547112],"category_scores_gemma":[0.00022522571,0.00019167113,0.00013719352,0.00008183156,0.00020424457,0.0001164642,0.00029934227,0.00014299626,0.0000040693403],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032496683,0.091691285,0.0036771188,0.0007129446,0.004996989,0.00069675676,0.005915127,0.00005806037,0.060905833,0.000042988406,0.026161477,0.77264476],"study_design_scores_gemma":[0.15646794,0.26973945,0.0056165517,0.00013527357,0.0025109404,0.000059214064,0.00068574125,0.00037327618,0.37363833,0.0002734368,0.190168,0.00033183332],"about_ca_topic_score_codex":0.0011982209,"about_ca_topic_score_gemma":0.00027715258,"teacher_disagreement_score":0.7723129,"about_ca_system_score_codex":0.000030025112,"about_ca_system_score_gemma":0.00044011846,"threshold_uncertainty_score":0.7816122},"labels":[],"label_agreement":null},{"id":"W2763170886","doi":"10.1007/s00345-017-2093-6","title":"Effect of pathological high-risk features on cancer-specific mortality in non-metastatic clear cell renal cell carcinoma: a tool for optimizing patient selection for adjuvant therapy","year":2017,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrology; Pathological; Cancer; Oncology; Internal medicine; Adjuvant; Adjuvant therapy; Kidney cancer; Carcinoma; Selection (genetic algorithm); Pathology; Cancer research","score_opus":0.021677078008657102,"score_gpt":0.29643045448453276,"score_spread":0.27475337647587567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763170886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99475193,0.002584934,0.00045684335,0.00026946556,0.0003921039,0.0014098462,0.000035569195,0.0000052225982,0.00009410837],"genre_scores_gemma":[0.995827,0.0005832041,0.0030514337,0.000100421865,0.00022170285,0.000124712,0.000007875017,0.000031780994,0.000051872925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980219,0.00033524903,0.00069660106,0.0003141106,0.00026703422,0.00036510333],"domain_scores_gemma":[0.997429,0.0006598149,0.0012696193,0.00032530178,0.00020824118,0.00010801183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009921842,0.00026712718,0.00096157263,0.00031456433,0.00015351335,0.00002001081,0.00017561244,0.000106815976,0.000024891191],"category_scores_gemma":[0.00010757199,0.0001761572,0.00039005998,0.000086908716,0.00010645721,0.00006322986,0.000027332522,0.000495647,8.319533e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13878678,0.0032656013,0.51959455,0.0007540272,0.0004983163,0.0011284665,0.0010956975,0.012585775,0.18425776,0.000053007727,0.0026755594,0.13530448],"study_design_scores_gemma":[0.020016244,0.06940088,0.7039454,0.0000770773,0.0005971459,0.00014476232,0.000022636183,0.00055511435,0.2043595,0.00012060806,0.00056910625,0.00019154137],"about_ca_topic_score_codex":0.00015221756,"about_ca_topic_score_gemma":0.00009462194,"teacher_disagreement_score":0.18435085,"about_ca_system_score_codex":0.00020518419,"about_ca_system_score_gemma":0.0000959775,"threshold_uncertainty_score":0.7183482},"labels":[],"label_agreement":null},{"id":"W2763224818","doi":"10.1093/annonc/mdx371.079","title":"A phase 2 study of investigational TORC1/2 inhibitor TAK-228 and TAK-228 plus investigational PI3Kα-selective inhibitor TAK-117 vs everolimus in adults with advanced or metastatic clear-cell renal cell carcinoma (ccRCC) that has progressed on VEGF-targeted therapy","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Everolimus; Discovery and development of mTOR inhibitors; Investigational Drugs; Phases of clinical research; Oncology; Internal medicine; Pharmacology; PI3K/AKT/mTOR pathway; Clinical trial","score_opus":0.11530180118172613,"score_gpt":0.35859554422307705,"score_spread":0.24329374304135093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763224818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99271506,0.000872722,0.0000056006616,0.0015159801,0.00013837552,0.004092,0.00010103869,0.000034273544,0.0005249389],"genre_scores_gemma":[0.99619097,0.000095080024,0.0019639947,0.0006034522,0.0001752124,0.00057844154,0.00016632746,0.00008593139,0.00014060803],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99581325,0.0005358984,0.0010384703,0.0009978651,0.00097345357,0.00064106996],"domain_scores_gemma":[0.9957618,0.00053196517,0.0015842317,0.0007520437,0.0008750981,0.00049487874],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056156446,0.0006367119,0.001549364,0.0005031045,0.000287286,0.000048064594,0.00032933854,0.00025074324,0.000060192317],"category_scores_gemma":[0.00039257965,0.00047734912,0.00014177019,0.00037778827,0.0011590858,0.00038323808,0.00012209416,0.00053641706,0.000005680792],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37247124,0.06945755,0.32025385,0.0020089431,0.00197958,0.0044555957,0.043355834,0.0010555104,0.15891337,0.00011441823,0.005229272,0.02070484],"study_design_scores_gemma":[0.10188795,0.18663402,0.27802134,0.0005816869,0.00028018877,0.00009669308,0.0018872377,0.00065749534,0.42886126,0.00021043922,0.00033263263,0.0005490621],"about_ca_topic_score_codex":0.00052204396,"about_ca_topic_score_gemma":0.00062880496,"teacher_disagreement_score":0.27058327,"about_ca_system_score_codex":0.00031299642,"about_ca_system_score_gemma":0.0021875268,"threshold_uncertainty_score":0.99976784},"labels":[],"label_agreement":null},{"id":"W2763263669","doi":"10.1200/jco.2012.30.15_suppl.tps4683","title":"Phase III trial of dovitinib (TKI258) versus sorafenib in patients with metastatic renal cell carcinoma after failure of anti-angiogenic (VEGF-targeted and mTOR inhibitor) therapies.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Sorafenib; Clinical endpoint; Renal cell carcinoma; Discontinuation; Vascular endothelial growth factor; Temsirolimus; Internal medicine; Oncology; Progressive disease; Tyrosine-kinase inhibitor; Platelet-derived growth factor receptor; PI3K/AKT/mTOR pathway; Cancer research; Clinical trial; Cancer; Hepatocellular carcinoma; Chemotherapy; Growth factor; Discovery and development of mTOR inhibitors; Receptor; Signal transduction; VEGF receptors","score_opus":0.06125033449545109,"score_gpt":0.3716325511553506,"score_spread":0.3103822166598995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763263669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964755,0.0016702696,0.000016448275,0.00025012708,0.0006830007,0.00075198896,0.000021457088,0.000003310197,0.0001278823],"genre_scores_gemma":[0.995264,0.000058323327,0.0039736917,0.00008202669,0.00055088085,0.000012217972,0.000011811897,0.000029654735,0.000017408342],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99514323,0.0006911883,0.0029477365,0.00022169929,0.00062430394,0.00037181514],"domain_scores_gemma":[0.99459237,0.0015328549,0.0027144372,0.00026123258,0.00045216212,0.00044692244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019733373,0.0002625006,0.0025068047,0.0003135147,0.000017611894,0.00000443979,0.00011703,0.00028134152,0.00011974996],"category_scores_gemma":[0.0005151888,0.00016602108,0.00058474875,0.00022431512,0.0003308807,0.00018701317,0.00005213542,0.00059021846,0.0000022663346],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.55457914,0.01860287,0.41700056,0.00011924006,0.0010090645,0.00033247063,0.0005992915,0.000001473657,0.0017741615,0.000011304953,0.00018461698,0.0057857865],"study_design_scores_gemma":[0.49699923,0.08994025,0.40559044,0.00009248669,0.0016696987,0.00003496673,0.00021997101,0.0000036786944,0.004801959,0.000016892092,0.00049498345,0.00013543914],"about_ca_topic_score_codex":0.000024916266,"about_ca_topic_score_gemma":0.000021389076,"teacher_disagreement_score":0.07133738,"about_ca_system_score_codex":0.00014763125,"about_ca_system_score_gemma":0.00078590855,"threshold_uncertainty_score":0.67701435},"labels":[],"label_agreement":null},{"id":"W2763963750","doi":"10.1200/jco.2017.35.15_suppl.tps4596","title":"A phase III randomized study comparing perioperative nivolumab vs. observation in patients with localized renal cell carcinoma undergoing nephrectomy (PROSPER RCC).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Calgary; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Nivolumab; Renal cell carcinoma; Nephrectomy; Perioperative; Stage (stratigraphy); Internal medicine; Kidney cancer; Clinical trial; Adjuvant; Surgery; Oncology; Immunotherapy; Cancer; Kidney","score_opus":0.10104672841586478,"score_gpt":0.41046365010632746,"score_spread":0.3094169216904627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763963750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944025,0.00009382284,0.00020801868,0.000554024,0.00044889504,0.0020827116,0.0000010361481,0.000008700375,0.0022002854],"genre_scores_gemma":[0.9950972,0.00002951572,0.003870259,0.0003123776,0.00033734945,0.000036123467,0.00000779612,0.00003181866,0.00027753835],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99407613,0.0012717436,0.0032290192,0.00038506172,0.0006957302,0.00034229495],"domain_scores_gemma":[0.9930648,0.001695321,0.0035744263,0.0004995186,0.00078601204,0.00037987955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039322926,0.00030811428,0.0040687947,0.00019308187,0.00020945181,0.00007060626,0.00029391234,0.0002484157,0.0000774765],"category_scores_gemma":[0.002295528,0.00019219039,0.00050464773,0.00010595159,0.00038903777,0.00037583295,0.00011228456,0.0011081953,0.000009883264],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36781868,0.010365101,0.61773413,0.000019551957,0.0003255905,0.00076278445,0.00060189806,0.00003990892,0.00003000662,0.0000069014272,0.00005078463,0.0022446492],"study_design_scores_gemma":[0.49092647,0.030357815,0.47669828,0.000106718195,0.0006321622,0.000021127797,0.00018949441,0.0006289029,0.00007811136,0.000008854898,0.00024640214,0.00010564918],"about_ca_topic_score_codex":0.00034112105,"about_ca_topic_score_gemma":0.0006383496,"teacher_disagreement_score":0.14103585,"about_ca_system_score_codex":0.000613723,"about_ca_system_score_gemma":0.0017214214,"threshold_uncertainty_score":0.7837297},"labels":[],"label_agreement":null},{"id":"W2765630339","doi":"10.1016/j.urology.2017.10.004","title":"Assessing Time of Full Renal Recovery Following Minimally Invasive Partial Nephrectomy","year":2017,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Nephrectomy; Urology; Surgery; Kidney; Internal medicine","score_opus":0.03159761589057199,"score_gpt":0.29391870761354144,"score_spread":0.26232109172296947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765630339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838535,0.00022688686,0.00009325422,0.00078770757,0.00026657752,0.00025161338,0.0000024876192,0.000025335177,0.0144925965],"genre_scores_gemma":[0.9972949,0.000008119116,0.0016102962,0.00028475717,0.00022464176,0.000022390383,0.000018732555,0.000021974958,0.00051420025],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99887174,0.00008266945,0.00028631306,0.00029170193,0.00017849001,0.00028906015],"domain_scores_gemma":[0.99876374,0.00021199047,0.00027599005,0.00058113766,0.000058802587,0.000108368746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020453632,0.00015162397,0.0004567199,0.00009250808,0.00013115822,0.000038948463,0.00015712011,0.00014711679,0.00021677012],"category_scores_gemma":[0.00047843505,0.00013111245,0.00022921238,0.000032158234,0.00012972213,0.00018911721,0.00010597963,0.00015235141,0.0001418945],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002082773,0.00023698727,0.057278495,0.00005427187,0.0006176177,0.0026096762,0.00022298483,0.00003451246,0.927976,0.000030373129,0.0010220543,0.007834233],"study_design_scores_gemma":[0.01529599,0.013488603,0.48357928,0.0002894045,0.0029548067,0.001806947,0.00011828631,0.0012188113,0.4675874,0.0009194516,0.011978246,0.00076276733],"about_ca_topic_score_codex":0.00004819319,"about_ca_topic_score_gemma":0.000018623525,"teacher_disagreement_score":0.4603886,"about_ca_system_score_codex":0.000054013664,"about_ca_system_score_gemma":0.00024638325,"threshold_uncertainty_score":0.53466105},"labels":[],"label_agreement":null},{"id":"W2767738483","doi":"10.1111/his.13432","title":"Biphasic papillary renal cell carcinoma is a rare morphological variant with frequent multifocality: a study of 28 cases","year":2017,"lang":"en","type":"article","venue":"Histopathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Calgary Laboratory Services; Rockyview General Hospital; University of Calgary","funders":"","keywords":"Cytokeratin; Papillary renal cell carcinomas; Renal cell carcinoma; Clear cell; Pathology; Renal pelvis; Medicine; Carcinoma; Chromophobe cell; Immunohistochemistry; Internal medicine; Kidney","score_opus":0.04924211297248754,"score_gpt":0.27907935782950744,"score_spread":0.2298372448570199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767738483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460167,0.001136523,0.000053675652,0.00040230018,0.00015258367,0.0010519054,0.00004452885,0.00004472602,0.0025120624],"genre_scores_gemma":[0.9974503,0.000021068043,0.0011284158,0.0002862443,0.000090471156,0.00012124936,0.000023778308,0.000039645653,0.00083886343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99769396,0.00024026447,0.0004931382,0.00076147274,0.00039165642,0.00041953844],"domain_scores_gemma":[0.9973131,0.00008854035,0.00044845938,0.001729309,0.00018693322,0.00023366716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025199165,0.00035637352,0.0009049775,0.00015770967,0.00029559873,0.000017340719,0.0002910907,0.00019077212,0.00024717444],"category_scores_gemma":[0.00010605559,0.00024504212,0.00015383393,0.00007774206,0.0005071177,0.000059747053,0.00018773261,0.00030260524,0.00003975231],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018404148,0.0029722266,0.6842352,0.0001532918,0.000038837086,0.2583346,0.0031957324,0.0000037731866,0.04780246,0.000025233683,0.0006853238,0.0007128622],"study_design_scores_gemma":[0.0069390577,0.014789335,0.94744456,0.000045765755,0.0006346034,0.018704586,0.00064286974,0.000023349545,0.010036236,0.000022194416,0.0004616261,0.0002558113],"about_ca_topic_score_codex":0.0014871397,"about_ca_topic_score_gemma":0.00016062212,"teacher_disagreement_score":0.2632093,"about_ca_system_score_codex":0.0002380866,"about_ca_system_score_gemma":0.00018255485,"threshold_uncertainty_score":0.9992528},"labels":[],"label_agreement":null},{"id":"W2767887866","doi":"10.1016/j.anndiagpath.2017.11.004","title":"Chromosomal numerical aberration pattern in papillary renal cell carcinoma: Review article","year":2017,"lang":"en","type":"review","venue":"Annals of Diagnostic Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Royal Columbian Hospital","funders":"Univerzita Karlova v Praze","keywords":"Papillary renal cell carcinomas; Biology; Genetic heterogeneity; Type (biology); Renal cell carcinoma; Pathology; Broad spectrum; Cell type; Computational biology; Gene; Cell; Genetics; Medicine; Chemistry","score_opus":0.1475999418080262,"score_gpt":0.3932420684422642,"score_spread":0.245642126634238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767887866","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053343084,0.99076635,0.000014775699,0.0006890046,0.0001787554,0.0017601461,0.000070317285,0.00002030223,0.0011660577],"genre_scores_gemma":[0.035022844,0.96311474,0.000059805425,0.0006403615,0.00021346592,0.00037408975,0.00040354973,0.000065757034,0.000105379404],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99632406,0.0006224726,0.0014190895,0.00071302126,0.00034806246,0.00057329366],"domain_scores_gemma":[0.99606115,0.0012731056,0.001025062,0.0012362644,0.0001660544,0.00023839234],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058292615,0.0005591497,0.0035775893,0.00023565235,0.00005217595,0.000011125614,0.00031097187,0.00046219557,0.00021488659],"category_scores_gemma":[0.002264172,0.00044080947,0.0007552596,0.00020438389,0.00017580482,0.00007388572,0.00015899952,0.000567415,0.00028386564],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013027471,0.0006780142,0.0029978123,0.05246464,0.00006167409,0.011677296,0.000045508834,3.086289e-7,0.000012872856,0.0000040310365,0.003777542,0.9282673],"study_design_scores_gemma":[0.002329597,0.004654103,0.06231696,0.18330362,0.005797443,0.0057113203,0.000013415762,0.000010455832,0.0009869725,0.00008127974,0.733488,0.0013068268],"about_ca_topic_score_codex":0.000075097116,"about_ca_topic_score_gemma":0.000012040288,"teacher_disagreement_score":0.92696047,"about_ca_system_score_codex":0.00008330161,"about_ca_system_score_gemma":0.00046674744,"threshold_uncertainty_score":0.9998044},"labels":[],"label_agreement":null},{"id":"W2768536352","doi":"10.1007/978-3-319-65657-1_4","title":"The Role of Renal Biopsy","year":2017,"lang":"en","type":"book-chapter","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Renal biopsy; Medicine; Biopsy; Radiology","score_opus":0.024151115141702966,"score_gpt":0.25187415330723917,"score_spread":0.2277230381655362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768536352","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002667642,0.004592737,0.000002537425,0.00024151754,0.0000754158,0.00027708468,0.000009122922,0.000017984015,0.99451685],"genre_scores_gemma":[0.042103227,0.00036765457,0.00014697689,0.000020516278,0.00019278102,0.0000053921594,0.000022986374,0.000033516593,0.95710695],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991756,0.000003834474,0.00021892057,0.00018231987,0.00029448385,0.00012481294],"domain_scores_gemma":[0.99859595,0.000051237785,0.0002212077,0.0009500951,0.00010008196,0.00008144246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008297307,0.00019046516,0.0003396527,0.000043993354,0.00008700336,0.0000132873065,0.00015206469,0.0001650365,0.0006633339],"category_scores_gemma":[0.000015295493,0.0000961516,0.00023795167,0.0000024989865,0.00018227269,0.000011180168,0.00006371543,0.00017098986,0.0002547883],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092549704,0.00010212842,0.00074466754,0.00017586697,0.0023456817,0.0008667732,0.00012784085,3.0773793e-7,0.012001537,0.7134368,0.013679783,0.25559312],"study_design_scores_gemma":[0.00051635876,0.0003719119,0.00081255496,0.0002614589,0.0004618641,0.0002387803,0.00001071081,0.000005257884,0.013848672,0.017803876,0.9655286,0.00013995665],"about_ca_topic_score_codex":0.00005556079,"about_ca_topic_score_gemma":0.000017761464,"teacher_disagreement_score":0.9518488,"about_ca_system_score_codex":0.000055684584,"about_ca_system_score_gemma":0.00010954424,"threshold_uncertainty_score":0.7263042},"labels":[],"label_agreement":null},{"id":"W2768705435","doi":"10.5489/cuaj.4644","title":"Clinical outcomes of the sequential use of pazopanib followed by everolimus for the treatment of metastatic renal cell carcinoma: A multicentre study in Korea","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pazopanib; Everolimus; Renal cell carcinoma; Medicine; Oncology; Internal medicine; Sunitinib","score_opus":0.08146545219710935,"score_gpt":0.32318664267227043,"score_spread":0.24172119047516108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768705435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951631,0.00021270398,0.0000128724905,0.0026739168,0.00025599016,0.0014538397,0.00019206858,0.0000019480242,0.000033555432],"genre_scores_gemma":[0.9992339,0.000051946507,0.00014936047,0.00013794296,0.00005857482,0.00003164159,0.000007952506,0.0000119301885,0.00031677744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975797,0.0004907373,0.0009531482,0.0001978622,0.00043946804,0.0003390797],"domain_scores_gemma":[0.99630153,0.0013189345,0.0013938755,0.00043210294,0.00029578884,0.00025774862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009063307,0.00017956081,0.0007510077,0.000080882346,0.00022709048,0.00003400365,0.00027387773,0.00012268104,0.000038883252],"category_scores_gemma":[0.0014103216,0.00008842107,0.0006215238,0.00007660389,0.000116670475,0.000064541025,0.000024106217,0.00023353973,7.9424046e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040068332,0.0013830162,0.99577,0.000007054791,0.0005341812,0.00004728312,0.00046463727,0.000052313077,0.00021791937,0.00000417832,0.00047384654,0.0006448834],"study_design_scores_gemma":[0.00885641,0.0028293116,0.9854023,0.00000803362,0.0012748246,0.000009360332,0.0002448558,0.00021766318,0.00047759264,0.000021797397,0.00059241103,0.00006544376],"about_ca_topic_score_codex":0.011138003,"about_ca_topic_score_gemma":0.011475346,"teacher_disagreement_score":0.010367707,"about_ca_system_score_codex":0.0007759866,"about_ca_system_score_gemma":0.0005285763,"threshold_uncertainty_score":0.9954469},"labels":[],"label_agreement":null},{"id":"W2769210188","doi":"10.1016/j.euf.2017.11.005","title":"Active Surveillance in Small Renal Masses in the Elderly: A Literature Review","year":2017,"lang":"en","type":"review","venue":"European Urology Focus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Context (archaeology); MEDLINE; Systematic review; Cochrane Library; Comorbidity; Population; Nephrectomy; Randomized controlled trial; Internal medicine; Epidemiology; Intensive care medicine; Surgery; Kidney","score_opus":0.08331593554711682,"score_gpt":0.34064220033857473,"score_spread":0.2573262647914579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769210188","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007339892,0.9442692,8.475553e-7,0.0011371563,0.00013560054,0.0020729552,0.00003831128,0.000028015602,0.05224454],"genre_scores_gemma":[0.0004960184,0.99732935,0.000049400514,0.00061720563,0.00032761553,0.00015069258,0.00023627661,0.00010010396,0.00069332565],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99331486,0.004306798,0.00084103376,0.00082519563,0.0001948183,0.0005173136],"domain_scores_gemma":[0.9970454,0.0005044512,0.0006300615,0.0016574684,0.00006475417,0.00009788531],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017837011,0.00065350137,0.0025472024,0.000320472,0.000065872475,0.000052490857,0.0008290253,0.00025958288,0.000047639027],"category_scores_gemma":[0.00062299444,0.00037158403,0.00056758826,0.00041674898,0.00014959658,0.000044830256,0.00017732404,0.0019224683,0.0003146196],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007140902,0.00012318733,0.00013877083,0.013129513,0.00012835677,0.025652323,0.00012883253,5.6831286e-8,1.9184644e-7,0.000021425707,0.0014293836,0.95917654],"study_design_scores_gemma":[0.00065996556,0.00079418015,0.0033264104,0.04243264,0.0005683273,0.0033756944,0.00000234004,1.1131652e-7,2.0445766e-7,0.0000138974665,0.9485718,0.00025443028],"about_ca_topic_score_codex":0.000021819336,"about_ca_topic_score_gemma":0.00019815007,"teacher_disagreement_score":0.95892215,"about_ca_system_score_codex":0.00014695755,"about_ca_system_score_gemma":0.00023753432,"threshold_uncertainty_score":0.99987364},"labels":[],"label_agreement":null},{"id":"W2772134916","doi":"10.1200/jco.2013.31.15_suppl.4582","title":"Overcoming sunitinib-induced resistance by dose escalation in renal cell carcinoma: Evidence in animal models and patients.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Sunitinib; Medicine; Renal cell carcinoma; Clear cell renal cell carcinoma; Internal medicine; Sorafenib; Oncology; Urology; Hepatocellular carcinoma","score_opus":0.17478842733452415,"score_gpt":0.4054529330704463,"score_spread":0.23066450573592212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772134916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99448377,0.001115988,0.000015124226,0.002101205,0.00013924771,0.00039729688,0.0000012331793,0.0000033013118,0.0017428271],"genre_scores_gemma":[0.99737245,0.00026061398,0.0016628477,0.00041358641,0.0001480741,0.000009616801,0.0000026076832,0.000015006821,0.00011517202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99629974,0.0005748093,0.0022259303,0.00025527427,0.00037384647,0.00027038506],"domain_scores_gemma":[0.9958618,0.0022552875,0.0010751778,0.00015965597,0.0003337699,0.0003143012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018692232,0.00015948853,0.00105913,0.00019901717,0.000022507606,0.000014004391,0.000106934196,0.00032974695,0.000038532933],"category_scores_gemma":[0.0014527108,0.00012364228,0.0001520433,0.00017234623,0.00009106797,0.0004904413,0.00005524616,0.0009391367,0.0000060331345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060037985,0.0022343136,0.96431243,0.00007647267,0.000025812571,0.0005605254,0.00033742044,0.000025586167,0.010374874,0.000028378097,0.0015009844,0.014519419],"study_design_scores_gemma":[0.010277558,0.0076586483,0.97922903,0.0002816655,0.000072897434,0.000029619961,0.00008465366,0.0007105377,0.0010074838,0.00036165505,0.00018226191,0.0001039605],"about_ca_topic_score_codex":0.00024336558,"about_ca_topic_score_gemma":0.00018099806,"teacher_disagreement_score":0.014916643,"about_ca_system_score_codex":0.0004316588,"about_ca_system_score_gemma":0.00053644186,"threshold_uncertainty_score":0.5041986},"labels":[],"label_agreement":null},{"id":"W2772242371","doi":"10.1016/j.euf.2017.11.012","title":"Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell Carcinoma Patients: A Population-based Study","year":2017,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Hazard ratio; Confidence interval; Internal medicine; Logistic regression; Cumulative incidence; Proportional hazards model; Incidence (geometry); Nephrectomy; Epidemiology; Kidney cancer; Oncology; Population; Urology; Surgery; Kidney; Cohort","score_opus":0.016065215208478513,"score_gpt":0.2484784006563874,"score_spread":0.2324131854479089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772242371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98337793,0.00013742757,0.000026164622,0.00018527,0.00031331653,0.0013747382,0.000020982754,0.000038687827,0.01452549],"genre_scores_gemma":[0.9986326,9.27803e-7,0.00034397317,0.00016040762,0.00014855099,0.00006798109,0.000052854706,0.00010851303,0.00048420255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969409,0.0008785323,0.0005287093,0.00075745606,0.00037456412,0.00051983364],"domain_scores_gemma":[0.99801266,0.00011356125,0.00033811008,0.0011768441,0.00013223507,0.00022659045],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044439168,0.00039993777,0.00059558946,0.000292162,0.00019438054,0.00005512978,0.00031801668,0.000057390975,0.0001559106],"category_scores_gemma":[0.00010812524,0.00034391804,0.00017038167,0.00011484303,0.000111466674,0.00012788585,0.00017281387,0.0004203355,0.00040860506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002671493,0.0022752439,0.9898843,0.000028838374,0.000056609668,0.0034268305,0.00073593896,0.000045390283,0.00036043135,0.0000010156217,0.000056446854,0.0004574576],"study_design_scores_gemma":[0.011551966,0.0049046217,0.9815466,0.000010165833,0.00039725145,0.000006372597,0.00011226142,0.0000808751,0.0009760944,0.00000985694,0.0001425248,0.0002614048],"about_ca_topic_score_codex":0.00089965994,"about_ca_topic_score_gemma":0.00021930847,"teacher_disagreement_score":0.015254666,"about_ca_system_score_codex":0.00019876171,"about_ca_system_score_gemma":0.00009591189,"threshold_uncertainty_score":0.9999013},"labels":[],"label_agreement":null},{"id":"W2772391813","doi":"10.9778/cmajo.20170005","title":"Follow-up imaging after nephrectomy for cancer in Canada: urologists' compliance with guidelines. An observational study","year":2017,"lang":"en","type":"article","venue":"CMAJ Open","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Observational study; Nephrectomy; Medicine; Compliance (psychology); General surgery; Kidney cancer; Medical physics; Cancer; Surgery; Internal medicine; Kidney; Psychology","score_opus":0.3056260950423676,"score_gpt":0.4203815389566324,"score_spread":0.11475544391426479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772391813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916262,0.00028537182,0.000052290216,0.0043576583,0.0001873471,0.0027647414,0.000052287178,0.000008528092,0.00066555274],"genre_scores_gemma":[0.9925841,0.000004685102,0.0029172036,0.0017421101,0.00011381357,0.0016132081,0.000037203234,0.000026971476,0.00096072006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878305,0.000025110365,0.00027337685,0.0003986423,0.00025495884,0.00026483458],"domain_scores_gemma":[0.9986767,0.00003236191,0.00014385133,0.00069913105,0.00032541176,0.00012254082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022466107,0.00017075748,0.0003592883,0.000028341583,0.00015114545,0.00011204594,0.00043367603,0.000018669107,0.00009884374],"category_scores_gemma":[0.000075667835,0.0001249597,0.000027430746,0.000047255082,0.000042260635,0.00029007322,0.00015345369,0.000088271205,0.000002644176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014181196,0.00009545197,0.9893351,0.000017739234,0.00005553315,0.00029416967,0.00011794847,0.000055501412,0.000038701277,0.0000063433613,0.0012977741,0.007267621],"study_design_scores_gemma":[0.006514058,0.0002469621,0.9864685,0.00010560122,0.00008600781,0.000012273608,0.00022662555,0.0012869096,0.0001049002,0.000018100587,0.0047811144,0.00014896905],"about_ca_topic_score_codex":0.94762504,"about_ca_topic_score_gemma":0.9897831,"teacher_disagreement_score":0.042158112,"about_ca_system_score_codex":0.0006622705,"about_ca_system_score_gemma":0.0019712544,"threshold_uncertainty_score":0.50957084},"labels":[],"label_agreement":null},{"id":"W2772581927","doi":"10.5489/cuaj.4464","title":"Epidemiology of renal cancer in developing countries: Review of the literature","year":2017,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"Pontificia Universidad Javeriana","keywords":"Epidemiology; Medicine; Intensive care medicine; Oncology; Internal medicine","score_opus":0.09748096982538917,"score_gpt":0.36907827578378205,"score_spread":0.2715973059583929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772581927","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000041718322,0.9849029,0.0000012845109,0.013553572,0.00031374398,0.0005998672,0.00019063317,0.0000020409411,0.00039424165],"genre_scores_gemma":[0.00013328588,0.99575627,0.000049330683,0.0033847769,0.00025593577,0.000034329965,0.00003105394,0.0000138908945,0.00034112638],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965195,0.0010874821,0.0014554854,0.00021894879,0.000306059,0.000412537],"domain_scores_gemma":[0.99490404,0.00078288495,0.0032157826,0.0003150891,0.00051735545,0.00026484695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025692726,0.00025923483,0.0026995994,0.00022948883,0.00011101634,0.000007168069,0.00037042517,0.0006662137,0.0002378952],"category_scores_gemma":[0.0066101863,0.00013720125,0.0007571086,0.00030878998,0.000080962396,0.00003762683,0.00003549301,0.0011936355,0.0000046764876],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048190275,0.00007006773,0.44422698,0.1305192,0.0021342596,0.00061470753,0.00019258216,0.000007601578,1.5820002e-7,0.0011781581,0.025217967,0.39579013],"study_design_scores_gemma":[0.0001507161,0.000056259807,0.036086895,0.15788563,0.0006400963,0.00028911763,7.9403696e-7,3.9561664e-7,1.9162017e-7,0.00006429001,0.8047367,0.00008892916],"about_ca_topic_score_codex":0.0006495562,"about_ca_topic_score_gemma":0.00090014894,"teacher_disagreement_score":0.7795187,"about_ca_system_score_codex":0.0034960918,"about_ca_system_score_gemma":0.0058024554,"threshold_uncertainty_score":0.9998337},"labels":[],"label_agreement":null},{"id":"W2774290406","doi":"10.1111/his.13447","title":"Low‐grade spindle cell proliferation in clear cell renal cell carcinoma is unlikely to be an initial step in sarcomatoid differentiation","year":2017,"lang":"en","type":"article","venue":"Histopathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Royal Columbian Hospital","funders":"Univerzita Karlova v Praze","keywords":"Immunohistochemistry; Renal cell carcinoma; Pathology; Sarcomatoid carcinoma; Clear cell; Biology; Spindle cell carcinoma; Mesenchymal stem cell; Cell; Medicine","score_opus":0.03480012269622346,"score_gpt":0.2846524927341265,"score_spread":0.24985237003790306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774290406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922275,0.00017535096,0.00017724118,0.0009693217,0.00033032088,0.0010974855,0.000022844604,0.000037761132,0.0049621924],"genre_scores_gemma":[0.9962923,0.000014303266,0.0011881667,0.00085399207,0.00018773625,0.00012360982,0.00015132147,0.000059306232,0.0011292859],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748915,0.0002675724,0.0006042164,0.00076160696,0.00033444498,0.0005429799],"domain_scores_gemma":[0.99831057,0.000026325723,0.00028928302,0.0010253316,0.00008462024,0.0002638836],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002897824,0.00034186698,0.0005810527,0.000543163,0.000190434,0.000052034677,0.0002836642,0.00030200105,0.00011887144],"category_scores_gemma":[0.000036044683,0.00034301786,0.000106824846,0.00013149457,0.00010805252,0.00021368716,0.0001263595,0.00041431998,0.00013033234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014902522,0.0030814542,0.4945246,0.00032076167,0.000002234851,0.0030861546,0.00809427,0.000024258601,0.48728734,0.00004171633,0.000865578,0.0011813594],"study_design_scores_gemma":[0.0043185987,0.0022534137,0.75080776,0.000033258955,0.0000442099,0.00009111772,0.00015370607,0.00052309595,0.2409033,0.000035416793,0.0005776214,0.00025851067],"about_ca_topic_score_codex":0.0006445434,"about_ca_topic_score_gemma":0.0011051461,"teacher_disagreement_score":0.25628313,"about_ca_system_score_codex":0.00065448834,"about_ca_system_score_gemma":0.00019204378,"threshold_uncertainty_score":0.9999022},"labels":[],"label_agreement":null},{"id":"W2775092792","doi":"10.1200/jco.2017.76.1759","title":"Radical Treatment of the Primary Tumor in Metastatic Bladder Cancer: Potentially Dangerous Findings From Observational Data","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Observational study; Cancer; Primary tumor; Bladder cancer; Oncology; Bladder tumor; Metastasis; Internal medicine","score_opus":0.3962684184728819,"score_gpt":0.48906602908257985,"score_spread":0.09279761060969793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775092792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819341,0.0013652438,0.00005251202,0.014742131,0.001097876,0.0003073967,0.00008310036,0.0000022290387,0.000415443],"genre_scores_gemma":[0.978571,0.0010379249,0.017837401,0.0013577145,0.0008581341,0.000008353358,0.000037260583,0.00001768423,0.00027451437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964921,0.00038603126,0.0020941198,0.0002587339,0.0005772353,0.00019180102],"domain_scores_gemma":[0.994575,0.001782095,0.0023320979,0.0009128554,0.00018441098,0.0002135441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014099354,0.00015518637,0.001580034,0.000062159306,0.000072832285,0.00001507819,0.00071988103,0.00013894791,0.00018883093],"category_scores_gemma":[0.0023268526,0.00008392572,0.00042696664,0.00005554733,0.0004456656,0.00017282802,0.00021333586,0.0004494391,0.0000045145275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036713749,0.004120348,0.851351,0.000023744406,0.0014445998,0.0024155572,0.00011138225,0.000020909185,0.0011369472,0.000031007374,0.0024741536,0.13319898],"study_design_scores_gemma":[0.010890273,0.004066034,0.96197873,0.0001251762,0.0013440314,0.00019961045,0.000023672257,0.00008447081,0.00031242313,0.00023850989,0.02067387,0.00006321003],"about_ca_topic_score_codex":0.00090280303,"about_ca_topic_score_gemma":0.0005754977,"teacher_disagreement_score":0.13313577,"about_ca_system_score_codex":0.00048733276,"about_ca_system_score_gemma":0.0037729396,"threshold_uncertainty_score":0.6693033},"labels":[],"label_agreement":null},{"id":"W2776155785","doi":"10.1007/s00345-017-2153-y","title":"Fuhrman grading is inappropriate for papillary renal cell carcinoma","year":2017,"lang":"en","type":"letter","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Nephrology; Grading (engineering); Papillary renal cell carcinomas; Renal cell carcinoma; Internal medicine; Papillary carcinoma; Oncology; Carcinoma; General surgery; Urology; Pathology; Thyroid carcinoma","score_opus":0.03241448057399519,"score_gpt":0.26985657861484913,"score_spread":0.23744209804085395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2776155785","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07290962,0.017423585,0.0001437296,0.89071214,0.0031098379,0.0011480643,0.00006666033,0.000027283082,0.01445909],"genre_scores_gemma":[0.5470084,0.00042575915,0.0022622433,0.3986154,0.019663462,0.000035636156,0.00015108912,0.00022801808,0.031610005],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996994,0.00018970172,0.0010398894,0.00047328338,0.00055623834,0.0007468552],"domain_scores_gemma":[0.99611366,0.0002895486,0.0020627428,0.0008498426,0.0004414387,0.0002427876],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005839189,0.00055516476,0.001564702,0.0009861597,0.00020249946,0.000051879833,0.00056963105,0.0007063092,0.00023656616],"category_scores_gemma":[0.000071471746,0.00043044344,0.0009837325,0.000099277764,0.00019968105,0.00009514149,0.00010602699,0.0028686118,0.000040529096],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089462614,0.00008105975,0.0025832145,0.00048305202,0.00045334583,0.018110929,0.0001587294,0.000002105575,0.0011912166,0.000008498971,0.97404957,0.001983658],"study_design_scores_gemma":[0.003896515,0.0036745553,0.0038234228,0.00012077092,0.002177806,0.006742746,0.000005680821,0.000017045613,0.0018820721,0.0006782357,0.97665393,0.000327225],"about_ca_topic_score_codex":0.000018716524,"about_ca_topic_score_gemma":0.0000051296274,"teacher_disagreement_score":0.49209675,"about_ca_system_score_codex":0.0002860691,"about_ca_system_score_gemma":0.00046737058,"threshold_uncertainty_score":0.99981475},"labels":[],"label_agreement":null},{"id":"W2779215734","doi":"10.1002/cncr.31156","title":"Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK)","year":2017,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Juravinski Cancer Centre; Sunnybrook Health Science Centre; McMaster University; Cancer Care Ontario","funders":"Accuray; Elekta; Varian Medical Systems","keywords":"SABR volatility model; Medicine; Common Terminology Criteria for Adverse Events; Renal cell carcinoma; Hazard ratio; Radiosurgery; Kidney cancer; Internal medicine; Radiation therapy; Oncology; Proportional hazards model; Cancer; Urology; Confidence interval","score_opus":0.03931370893471002,"score_gpt":0.33304249139758874,"score_spread":0.2937287824628787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2779215734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847144,0.0023814137,0.0019942494,0.005704558,0.0008095225,0.0013355066,0.00082883704,0.0000140585435,0.0022174635],"genre_scores_gemma":[0.99191964,0.0001381632,0.0019714828,0.0015373348,0.00055823126,0.0006522435,0.0005486941,0.000032015185,0.0026422143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998519,0.00004502574,0.00052281807,0.0004233809,0.00026119294,0.00022855613],"domain_scores_gemma":[0.9969132,0.0008017127,0.0009625794,0.00079338223,0.0003775806,0.00015152189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032871307,0.00019369794,0.0007918128,0.00013299413,0.00016092493,0.00003093877,0.0002638818,0.00010656927,0.00028551373],"category_scores_gemma":[0.0003207959,0.00013294937,0.00057798956,0.00008556726,0.00017556525,0.00008462468,0.000041271593,0.000109122746,7.0251093e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077339397,0.0004982326,0.7789674,0.00013481354,0.023798903,0.00035376562,0.0014026763,0.00006337936,0.13854235,0.000025044994,0.04124959,0.007229919],"study_design_scores_gemma":[0.0068266788,0.0004560875,0.8822247,0.000059865957,0.011288419,0.000039560644,0.00008529349,0.0014330779,0.047360178,0.000050251823,0.04998216,0.00019375749],"about_ca_topic_score_codex":0.00085159246,"about_ca_topic_score_gemma":0.000098405224,"teacher_disagreement_score":0.10325728,"about_ca_system_score_codex":0.00092820567,"about_ca_system_score_gemma":0.0011311522,"threshold_uncertainty_score":0.5421518},"labels":[],"label_agreement":null},{"id":"W2781495894","doi":"10.1097/pas.0000000000001000","title":"Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase–deficient Renal Cell Carcinoma","year":2018,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"National Cancer Institute","keywords":"Pathology; Medicine; Clear cell; Renal cell carcinoma; Carcinoma; Clear cell carcinoma","score_opus":0.03399041589849719,"score_gpt":0.28224343635545784,"score_spread":0.24825302045696065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781495894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99395066,0.002545736,0.000073711846,0.0010156074,0.00020348541,0.00032369827,0.000056512083,0.000016532133,0.0018140636],"genre_scores_gemma":[0.9976967,0.0001603094,0.0010406419,0.0001392716,0.00077727565,0.000008474667,0.000017189835,0.00004129847,0.00011886243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954242,0.0011903993,0.0013689796,0.0005555341,0.00072883995,0.00073202065],"domain_scores_gemma":[0.9953896,0.0012171299,0.0017990042,0.0006092972,0.0005085789,0.00047643247],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0015699201,0.00048884965,0.0019002593,0.0004269347,0.00028412105,0.000026774174,0.0004523383,0.00014271615,0.000107951266],"category_scores_gemma":[0.00014280032,0.00028939522,0.00039074535,0.0007715209,0.0035661315,0.000083228915,0.0002574871,0.00082751387,0.000012872517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005193298,0.00046311916,0.89979964,0.00007682882,0.00020765346,0.012517979,0.0018629843,0.000011411799,0.07287313,0.00005358922,0.0006809583,0.006259403],"study_design_scores_gemma":[0.0036460399,0.019525442,0.91237664,0.000079569916,0.0008453082,0.021976948,0.0012810304,0.000053684384,0.03938746,0.0000963368,0.000405786,0.00032575536],"about_ca_topic_score_codex":0.0002699563,"about_ca_topic_score_gemma":0.000006107734,"teacher_disagreement_score":0.033485673,"about_ca_system_score_codex":0.000107606276,"about_ca_system_score_gemma":0.00037279064,"threshold_uncertainty_score":0.99995583},"labels":[],"label_agreement":null},{"id":"W2782993211","doi":"10.1111/bju.14127","title":"The role of lymph node dissection in the management of renal cell carcinoma: a systematic review and meta‐analysis","year":2018,"lang":"en","type":"review","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Renal cell carcinoma; Meta-analysis; Hazard ratio; Nephrectomy; Internal medicine; Oncology; Confidence interval; Lymph node; Systematic review; MEDLINE; Kidney cancer; Dissection (medical); Surgery; Kidney","score_opus":0.027323274470860068,"score_gpt":0.28540587067161816,"score_spread":0.2580825962007581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782993211","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033701467,0.9976875,0.000014369656,0.000091862836,0.00003145439,0.0013288948,0.000017727412,0.0000014713037,0.00048968056],"genre_scores_gemma":[0.028103271,0.97151333,0.00007522824,0.00006241922,0.00003506506,0.000095142794,0.000009196194,0.000019796846,0.00008653279],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99573255,0.0013621141,0.0020433643,0.00022077921,0.00043311645,0.00020807242],"domain_scores_gemma":[0.99643034,0.00039643783,0.0024043985,0.00046795007,0.00023434042,0.00006650731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00241238,0.00026360757,0.0050864955,0.0002814662,0.000052757186,0.000017930308,0.0003675234,0.00013630817,0.00002637455],"category_scores_gemma":[0.000053909407,0.00013869,0.001897444,0.00059998134,0.00016473628,0.000030721993,0.00007080738,0.00032231162,0.0000016652651],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005145178,0.00029228252,0.00004491848,0.90189046,0.08844606,0.0017586433,0.00006117132,0.0000018467581,6.035103e-7,0.00003084658,0.00008441543,0.0073372875],"study_design_scores_gemma":[0.00042268925,0.00043286223,0.0004348744,0.025552638,0.9492728,0.019703984,0.00008240365,0.000002889783,0.0000020372304,0.00003687564,0.00396032,0.0000956445],"about_ca_topic_score_codex":0.00008024968,"about_ca_topic_score_gemma":0.000029655865,"teacher_disagreement_score":0.8763378,"about_ca_system_score_codex":0.000075454656,"about_ca_system_score_gemma":0.00009558518,"threshold_uncertainty_score":0.56556135},"labels":[],"label_agreement":null},{"id":"W2783441319","doi":"10.1200/jgo.17.00119","title":"Impact of Geographic Regions on Overall Survival in Patients With Metastatic Renal Cell Carcinoma: Results From an International Clinical Trials Database","year":2018,"lang":"en","type":"article","venue":"Journal of Global Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Dana-Farber/Harvard Cancer Center; Pfizer","keywords":"Medicine; Clinical trial; Hazard ratio; Renal cell carcinoma; Internal medicine; Adverse effect; Multivariate analysis; Proportional hazards model; Disease; Demography; Oncology; Confidence interval","score_opus":0.11148250046487754,"score_gpt":0.44103052182509184,"score_spread":0.3295480213602143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783441319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957897,0.00004517903,0.000045224187,0.00039502155,0.0007233413,0.00035539587,0.0008067447,0.000004253683,0.0018351423],"genre_scores_gemma":[0.99650073,0.000037326023,0.002488627,0.00013604808,0.00057987066,0.0000017843915,0.00023251402,0.000012961936,0.000010136763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99496865,0.0015624318,0.0021704105,0.00032188292,0.0007156508,0.00026096287],"domain_scores_gemma":[0.9952247,0.0010171044,0.002139858,0.00042404537,0.0007991324,0.00039514454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002972675,0.00022886756,0.0014448104,0.00024769834,0.000024887784,0.000011268472,0.00026423912,0.0001377,0.00008630082],"category_scores_gemma":[0.0014148444,0.00013919357,0.0004882564,0.0002155676,0.00024743206,0.00020202488,0.000054571767,0.0004139093,0.0000069061834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.075490944,0.0055340263,0.91531163,0.0000045251295,0.0006479,0.0006782843,0.000055261484,0.00002955552,0.00014046214,0.00003475773,0.0010841674,0.0009884776],"study_design_scores_gemma":[0.04043781,0.052518807,0.90569764,0.00009997757,0.0006124171,0.000070291295,0.00002750456,0.000040406772,0.00007778303,0.00011585905,0.00020608363,0.000095428775],"about_ca_topic_score_codex":0.0013683551,"about_ca_topic_score_gemma":0.0004600503,"teacher_disagreement_score":0.04698478,"about_ca_system_score_codex":0.000903846,"about_ca_system_score_gemma":0.0010482387,"threshold_uncertainty_score":0.5676149},"labels":[],"label_agreement":null},{"id":"W2785352153","doi":"10.1007/s00345-018-2176-z","title":"Magnetic resonance imaging as an adjunct diagnostic tool in computed tomography defined Bosniak IIF–III renal cysts: a multicenter study","year":2018,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Royal Columbian Hospital","funders":"","keywords":"Medicine; IIf; Magnetic resonance imaging; Computed tomography; Nephrology; Radiology; Internal medicine","score_opus":0.010883146643096657,"score_gpt":0.2595843067685963,"score_spread":0.24870116012549962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785352153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869121,0.009726517,0.00007117445,0.001434319,0.0004735406,0.0006868082,0.0000025176037,0.000022745522,0.00067027716],"genre_scores_gemma":[0.99616414,0.000060723025,0.0013566229,0.0016959017,0.0005224551,0.000019639983,0.000004725971,0.000038311362,0.00013750634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99717206,0.0004578226,0.0009892818,0.00040157454,0.00044912452,0.000530115],"domain_scores_gemma":[0.99802804,0.00055744784,0.0003694032,0.0004447316,0.00037232705,0.00022803177],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00065261184,0.00030693837,0.0007383805,0.0011142148,0.000078197154,0.000029594732,0.00026305803,0.000060048023,0.00030838698],"category_scores_gemma":[0.00033073212,0.0002453086,0.00018497564,0.0007095313,0.00024657193,0.00015517931,0.000090832145,0.0005721933,0.000045402],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062949513,0.002776564,0.9553613,0.000015200026,0.00010951708,0.011899421,0.0012381476,0.000020153411,0.0017079203,0.0000568057,0.0011438745,0.019376159],"study_design_scores_gemma":[0.015682695,0.012936295,0.9621056,0.00015279088,0.0004157071,0.0018371216,0.00015733187,0.00066075,0.00021589853,0.00019275265,0.0054441653,0.000198892],"about_ca_topic_score_codex":0.00015812271,"about_ca_topic_score_gemma":0.0009725137,"teacher_disagreement_score":0.019177267,"about_ca_system_score_codex":0.00014847213,"about_ca_system_score_gemma":0.00014218783,"threshold_uncertainty_score":0.99999994},"labels":[],"label_agreement":null},{"id":"W2786996865","doi":"10.1016/j.euf.2018.01.018","title":"Effectiveness and Harms of Using Kidneys with Small Renal Tumors from Deceased or Living Donors as a Source of Renal Transplantation: A Systematic Review","year":2018,"lang":"en","type":"review","venue":"European Urology Focus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"European Association of Urology","keywords":"Medicine; Transplantation; Context (archaeology); Kidney transplantation; Kidney; Incidence (geometry); Urology; Surgery; Internal medicine","score_opus":0.04101191615077178,"score_gpt":0.28236358563899067,"score_spread":0.2413516694882189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786996865","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014063235,0.9809071,0.0012176019,0.000007893824,0.00004088476,0.0033237978,0.00004584301,0.000035986566,0.00035769874],"genre_scores_gemma":[0.007680087,0.9908292,0.0009359317,0.00006508052,0.000118305084,0.00007681058,0.00007584254,0.00016554489,0.000053146854],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9933492,0.0039413143,0.0013894138,0.00072067947,0.00029712677,0.00030226336],"domain_scores_gemma":[0.99584675,0.0015083147,0.0015245838,0.0007054127,0.00016821547,0.00024671532],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013097561,0.00064446655,0.0042879325,0.00026611876,0.000058078156,0.000011384552,0.00024807066,0.00013872984,0.00005610447],"category_scores_gemma":[0.00047388978,0.0003787861,0.00042785096,0.00033942936,0.00034677665,0.00003550151,0.00007553001,0.00034107539,0.000026415182],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000827732,0.00012918752,0.00010600031,0.98841137,0.0018523727,0.002725613,0.00025335705,0.000002446466,0.00005111549,0.0000026810064,0.000008657969,0.005629443],"study_design_scores_gemma":[0.0015794918,0.0030704695,0.000327661,0.94075537,0.044778854,0.0075532068,0.000009780242,0.000008798187,0.00012331427,0.000001727682,0.001419193,0.0003721217],"about_ca_topic_score_codex":0.00020352378,"about_ca_topic_score_gemma":0.00001321698,"teacher_disagreement_score":0.04765601,"about_ca_system_score_codex":0.00008535673,"about_ca_system_score_gemma":0.00047257106,"threshold_uncertainty_score":0.9998664},"labels":[],"label_agreement":null},{"id":"W2787239315","doi":"10.3233/kca-170020","title":"Fourth-Line Therapy in Metastatic Renal Cell Carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)","year":2018,"lang":"en","type":"article","venue":"Kidney Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University","funders":"","keywords":"Medicine; Pazopanib; Sunitinib; Axitinib; Sorafenib; Renal cell carcinoma; Internal medicine; Oncology; Everolimus; Temsirolimus; Proportional hazards model; Targeted therapy; Retrospective cohort study; Urology; Surgery; Cancer; Hepatocellular carcinoma; Discovery and development of mTOR inhibitors","score_opus":0.05521137413412077,"score_gpt":0.3092914079217557,"score_spread":0.25408003378763494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787239315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.966716,0.0017853986,0.000084866646,0.019813305,0.0010466629,0.00076419854,0.00268761,0.000040124905,0.0070618372],"genre_scores_gemma":[0.9836946,0.00058216497,0.0015404968,0.009086844,0.0013875783,0.00013725917,0.0011064511,0.000044553803,0.0024200596],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977309,0.00012671959,0.000561236,0.0006003182,0.0006023473,0.00037847992],"domain_scores_gemma":[0.99812156,0.00028276784,0.00021329772,0.0008180108,0.00022601993,0.00033836544],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038722003,0.00029346108,0.00036651958,0.00011373089,0.00008286448,0.000042990472,0.00034078053,0.00006220709,0.0022491636],"category_scores_gemma":[0.00029687004,0.00018765115,0.00012694675,0.0002476935,0.00021763779,0.000119380085,0.00010991476,0.00030569927,0.00016451473],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01916683,0.0015805257,0.14387839,0.00007539505,0.0010674131,0.0019708122,0.0063894656,0.000054486347,0.22614685,0.000096506395,0.5788256,0.020747738],"study_design_scores_gemma":[0.035826076,0.0014773803,0.1902698,0.0005127738,0.00046569112,0.00007377914,0.0004868008,0.0029874677,0.5107567,0.00019978768,0.25634003,0.0006037156],"about_ca_topic_score_codex":0.0090276515,"about_ca_topic_score_gemma":0.00128058,"teacher_disagreement_score":0.32248554,"about_ca_system_score_codex":0.00040318814,"about_ca_system_score_gemma":0.00087831577,"threshold_uncertainty_score":0.9986629},"labels":[],"label_agreement":null},{"id":"W2787384626","doi":"10.1016/j.eururo.2018.01.019","title":"You Can Trust a Crystal Ball About as Far as You Can Throw It","year":2018,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Crystal Ball; Ball (mathematics); Geometry","score_opus":0.02177698420659383,"score_gpt":0.2484371381695119,"score_spread":0.22666015396291808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787384626","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0809287,0.0012339947,0.000006239178,0.49578932,0.0014274528,0.00088999665,0.00018761517,0.00024136448,0.41929534],"genre_scores_gemma":[0.15930471,0.00018747122,0.00009643602,0.72129935,0.011748031,0.000033058623,0.0017354878,0.00046527767,0.10513019],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99442726,0.0010960373,0.0008122685,0.0015827985,0.0007064786,0.0013751558],"domain_scores_gemma":[0.9969293,0.00013066508,0.00044686295,0.0018211037,0.000238856,0.000433203],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00040366952,0.0010468478,0.0012741361,0.00041311348,0.0001808299,0.00006712824,0.0007226962,0.00078554376,0.003815838],"category_scores_gemma":[0.00025166865,0.00089476886,0.00048774204,0.00019972505,0.0007071834,0.000033953627,0.00039050347,0.0026106797,0.0074495384],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034442183,0.000106441155,0.0014604157,0.00011952289,0.00065375573,0.059931256,0.0012497776,0.0000012167118,0.00046979415,0.000033834072,0.93483883,0.00079072465],"study_design_scores_gemma":[0.0022936065,0.0052670464,0.0073374757,0.000057890247,0.0011230181,0.0054251365,0.000045031917,0.000005293438,0.00014538442,0.000044603625,0.97761,0.0006455386],"about_ca_topic_score_codex":0.0013824983,"about_ca_topic_score_gemma":0.00026045,"teacher_disagreement_score":0.31416515,"about_ca_system_score_codex":0.00039407826,"about_ca_system_score_gemma":0.0005250576,"threshold_uncertainty_score":0.99969035},"labels":[],"label_agreement":null},{"id":"W2787593267","doi":"10.1007/s00330-017-5220-2","title":"The prognostic and predictive value of vascular response parameters measured by dynamic contrast-enhanced-CT, -MRI and -US in patients with metastatic renal cell carcinoma receiving sunitinib","year":2018,"lang":"en","type":"article","venue":"European Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University Health Network; Sunnybrook Health Science Centre; University of Toronto","funders":"Terry Fox Foundation","keywords":"Medicine; Sunitinib; Neuroradiology; Interventional radiology; Renal cell carcinoma; Dynamic contrast; Radiology; Ultrasound; Perfusion; Dynamic contrast-enhanced MRI; Magnetic resonance imaging; Nuclear medicine; Urology; Internal medicine; Oncology; Neurology","score_opus":0.008710466360610113,"score_gpt":0.2120397776120396,"score_spread":0.20332931125142947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787593267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99667263,0.0013533991,0.00029088417,0.000061015293,0.000051587318,0.0010883168,0.00003492182,0.000016056832,0.0004312119],"genre_scores_gemma":[0.9988651,0.00006986754,0.00083834335,0.000059171984,0.000013120464,0.00002444139,0.000038893257,0.000043676326,0.00004737656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963428,0.0023000208,0.00037764735,0.00042439907,0.00021118569,0.00034396694],"domain_scores_gemma":[0.998231,0.0009396231,0.00020483253,0.00033524598,0.00015075342,0.0001385513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011236717,0.00023614375,0.00044949105,0.00011291877,0.00010059516,0.000013339943,0.000097542994,0.000025109182,0.0000033542574],"category_scores_gemma":[0.00050475576,0.00015057517,0.000041802185,0.00014425072,0.0007943069,0.000045727305,0.00005060333,0.00020408967,0.0000029318428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025347902,0.00050194835,0.93158066,0.00016792023,0.00070375134,0.0005761348,0.0031936367,0.000051804593,0.03488242,0.0000116108195,0.00017273799,0.0028094666],"study_design_scores_gemma":[0.0062575866,0.008266803,0.98037165,0.000110683424,0.00035174636,0.0001182957,0.00017279426,0.00031407754,0.0038421229,0.0000096749045,0.00005116132,0.00013342072],"about_ca_topic_score_codex":0.00002437287,"about_ca_topic_score_gemma":0.000013149086,"teacher_disagreement_score":0.048790965,"about_ca_system_score_codex":0.00010175502,"about_ca_system_score_gemma":0.000065508706,"threshold_uncertainty_score":0.61402774},"labels":[],"label_agreement":null},{"id":"W2789404741","doi":"10.5489/cuaj.4781","title":"Case ‒ Laparoscopic transperitoneal partial nephrectomy of T3a renal cell carcinoma within a horseshoe kidney","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Nephrectomy; Medicine; Renal cell carcinoma; Horseshoe kidney; Renal vein; Surgery; Carcinoma; Kidney; Internal medicine","score_opus":0.01814623859323987,"score_gpt":0.23325125755199796,"score_spread":0.2151050189587581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789404741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918539,0.0001315785,0.000031975742,0.0034034706,0.0005142944,0.00033658883,0.00008574735,0.000022032424,0.003620411],"genre_scores_gemma":[0.99552435,0.0000070036504,0.0006604126,0.002072812,0.0011869641,0.000017496846,0.000026968555,0.000022291317,0.00048172343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976516,0.00026925496,0.00064827054,0.00029483432,0.00048291023,0.0006531666],"domain_scores_gemma":[0.9969944,0.00008135766,0.0004008901,0.00019601278,0.0004387439,0.0018885896],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005717861,0.00023726546,0.0005136301,0.00023847194,0.00030810837,0.000053255422,0.0001249043,0.00034216326,0.0012488428],"category_scores_gemma":[0.00033715105,0.00019040913,0.00024891712,0.0002989118,0.00014269054,0.00009291842,0.000012450878,0.0006189841,0.000066276276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006090207,0.0002719409,0.9561833,0.000036618872,0.00023628099,0.01420304,0.0014160004,0.000018581843,0.011285693,0.000100582394,0.015072114,0.00056683825],"study_design_scores_gemma":[0.020578003,0.016355934,0.6598176,0.00012358026,0.0021598744,0.04937015,0.0006636395,0.0013092125,0.15682778,0.00048269008,0.091126926,0.001184633],"about_ca_topic_score_codex":0.0036615375,"about_ca_topic_score_gemma":0.0017970974,"teacher_disagreement_score":0.2963657,"about_ca_system_score_codex":0.0011230616,"about_ca_system_score_gemma":0.0016306527,"threshold_uncertainty_score":0.9996641},"labels":[],"label_agreement":null},{"id":"W2789468111","doi":"10.1007/s11523-018-0559-0","title":"Cabozantinib Versus Standard-of-Care Comparators in the Treatment of Advanced/Metastatic Renal Cell Carcinoma in Treatment-naïve Patients: a Systematic Review and Network Meta-Analysis","year":2018,"lang":"en","type":"review","venue":"Targeted Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ipsen; Canadian Centre for Applied Research in Cancer Control","keywords":"Cabozantinib; Medicine; Sunitinib; Internal medicine; Sorafenib; Oncology; Hazard ratio; Renal cell carcinoma; Meta-analysis; Bevacizumab; Temsirolimus; Progression-free survival; Subgroup analysis; Confidence interval; Overall survival; Hepatocellular carcinoma; Chemotherapy; Discovery and development of mTOR inhibitors","score_opus":0.11091761757752623,"score_gpt":0.38345245457670035,"score_spread":0.27253483699917413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789468111","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00533972,0.9819739,0.000001477434,0.000021946065,0.000102120335,0.011596773,0.00050850527,0.000010534681,0.00044500758],"genre_scores_gemma":[0.013777847,0.9814775,0.00080162135,0.000035061585,0.000034330584,0.0025984175,0.0011602798,0.00005894893,0.000055992143],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9920517,0.0029866192,0.0030280263,0.00083838776,0.0005093332,0.0005858881],"domain_scores_gemma":[0.9939665,0.0018822433,0.0023897707,0.0012670635,0.0003358678,0.00015850973],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0006304622,0.0010301648,0.019900339,0.0007520819,0.00005067696,0.000008653652,0.0002723555,0.00028098997,0.00012183905],"category_scores_gemma":[0.00010195757,0.0005274687,0.0029321662,0.0021378598,0.00024414403,0.000043213124,0.00004319188,0.00022916244,0.000010934637],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021684892,0.0041893786,0.0009010123,0.8429807,0.13397083,0.0007869894,0.0035178394,0.000059846567,1.7582316e-7,0.000024241648,0.00018369839,0.011216793],"study_design_scores_gemma":[0.007827555,0.04039405,0.0001600012,0.01615049,0.902218,0.000028284652,0.0004979063,0.000004226001,0.000009032134,0.0000035406877,0.032332428,0.00037450512],"about_ca_topic_score_codex":0.00019703644,"about_ca_topic_score_gemma":0.00095940416,"teacher_disagreement_score":0.8268302,"about_ca_system_score_codex":0.0019558426,"about_ca_system_score_gemma":0.00078919827,"threshold_uncertainty_score":0.9997177},"labels":[],"label_agreement":null},{"id":"W2790809143","doi":"10.1200/jco.2018.36.6_suppl.tps707","title":"A phase 2 trial of lenvatinib 18 mg versus 14 mg once daily (QD) in combination with everolimus (5 mg QD) in renal cell carcinoma (RCC) after 1 prior VEGF-targeted treatment.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Everolimus; Adverse effect; Internal medicine; Clinical endpoint; Tolerability; Regimen; Renal cell carcinoma; Nivolumab; Lenvatinib; Phases of clinical research; Oncology; Urology; Surgery; Randomized controlled trial; Cancer; Clinical trial; Immunotherapy","score_opus":0.1251830929051753,"score_gpt":0.43276769499447115,"score_spread":0.30758460208929583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790809143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992905,0.00046522298,0.00002705831,0.001148288,0.0012643483,0.001112211,0.000011221613,0.00000965229,0.0030569767],"genre_scores_gemma":[0.99548864,0.00014497363,0.002609256,0.00027986267,0.0010918616,0.000051135677,0.00001655461,0.000042020045,0.0002757011],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99373144,0.0010229299,0.003527431,0.00047235723,0.00073467556,0.0005111389],"domain_scores_gemma":[0.9935189,0.0024666528,0.0024958681,0.000434774,0.00065067795,0.000433164],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022588724,0.00037779292,0.0024196706,0.0005199968,0.000039770475,0.000011836084,0.00022467192,0.0005608976,0.0002662583],"category_scores_gemma":[0.0012595861,0.0002630075,0.00051875634,0.0004653875,0.00045820844,0.00021344212,0.000057919642,0.0009162396,0.000022502194],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85575163,0.028337426,0.06557946,0.000061319275,0.00037163383,0.0048527485,0.0010511902,0.000010034908,0.002988568,0.0000104799365,0.00044886884,0.040536657],"study_design_scores_gemma":[0.504841,0.2835596,0.20396839,0.00018033384,0.0006504802,0.00012871556,0.00015856976,0.00018968202,0.0037901006,0.000044021974,0.0023134144,0.00017568625],"about_ca_topic_score_codex":0.00019100447,"about_ca_topic_score_gemma":0.0007165852,"teacher_disagreement_score":0.3509106,"about_ca_system_score_codex":0.0012020018,"about_ca_system_score_gemma":0.0028149786,"threshold_uncertainty_score":0.99998224},"labels":[],"label_agreement":null},{"id":"W2791195919","doi":"10.5489/cuaj.4960","title":"The true malignancy risk of Bosniak III cystic renal lesions: Active surveillance or surgical resection?","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Malignancy; Medicine; Radiology; Pathological; Magnetic resonance imaging; Lesion; Stage (stratigraphy); Histology; Pathology","score_opus":0.017189772076197284,"score_gpt":0.256371391320109,"score_spread":0.2391816192439117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791195919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98695356,0.0005095464,0.000042133845,0.007262326,0.00044167368,0.00030425217,0.00007262173,0.00001859326,0.004395267],"genre_scores_gemma":[0.99542457,0.00045006225,0.0000955931,0.00023621695,0.0009767924,0.000014210941,0.000010950831,0.000013540393,0.0027780896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99732333,0.0007739157,0.0005479267,0.00023534075,0.00056042185,0.00055906596],"domain_scores_gemma":[0.9964189,0.0013294951,0.0006010884,0.00021467195,0.0007706374,0.0006652336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015606721,0.00016944432,0.00037544512,0.00013985673,0.0008530792,0.000057348916,0.0001632265,0.0002534765,0.0006945992],"category_scores_gemma":[0.0030702786,0.0000921797,0.00021116612,0.00038067382,0.0001694601,0.00006426593,0.000021884685,0.00067523605,0.00005604744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00687812,0.00019660791,0.957813,0.000009465964,0.0009935626,0.0013575406,0.00043474467,0.000036369085,0.00031801537,0.00054804655,0.016411427,0.015003048],"study_design_scores_gemma":[0.0023793005,0.002491612,0.94591206,0.00003103266,0.00013677578,0.0011592727,0.000114006805,0.000105060135,0.00040205312,0.00078296324,0.046361323,0.00012454554],"about_ca_topic_score_codex":0.0019395439,"about_ca_topic_score_gemma":0.008681259,"teacher_disagreement_score":0.029949896,"about_ca_system_score_codex":0.0017885496,"about_ca_system_score_gemma":0.0012930469,"threshold_uncertainty_score":0.7605374},"labels":[],"label_agreement":null},{"id":"W2791527077","doi":"10.1007/s10689-018-0076-4","title":"A retrospective review of 48 individuals, including 12 families, molecularly diagnosed with hereditary leiomyomatosis and renal cell cancer (HLRCC)","year":2018,"lang":"en","type":"review","venue":"Familial Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Children's Hospital of Eastern Ontario","funders":"","keywords":"Leiomyomatosis; Medicine; Germline mutation; Germline; Pathology; Genetic testing; Papillary renal cell carcinomas; Renal cell carcinoma; Oncology; Internal medicine; Mutation; Leiomyoma; Genetics; Biology; Gene","score_opus":0.045365274432224365,"score_gpt":0.3220327230599673,"score_spread":0.2766674486277429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791527077","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020810717,0.9902047,0.000010961481,0.000067259876,0.00046224083,0.0036228015,0.0013548124,0.000065980224,0.0021301901],"genre_scores_gemma":[0.0005070463,0.9941182,0.0006333882,0.00047126965,0.001003725,0.0021228092,0.00039847085,0.0002153691,0.00052969425],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99528754,0.00028831614,0.0012419936,0.0012751892,0.0012495907,0.0006573989],"domain_scores_gemma":[0.9969256,0.00012655466,0.0011320179,0.00091892603,0.00050895853,0.00038792455],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004033062,0.0011230416,0.0044607758,0.0003842263,0.00013814982,0.000027556523,0.0003264283,0.00047742852,0.00034119192],"category_scores_gemma":[0.000093661634,0.00078584347,0.00067255046,0.0008701952,0.00043680615,0.00013581148,0.0002930183,0.0007364932,0.000020176089],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037658232,0.0005370368,0.011568091,0.5832333,0.005109064,0.0015697645,0.0008384065,6.7624677e-7,0.000064538624,0.000015076621,0.05300554,0.34368196],"study_design_scores_gemma":[0.001997377,0.0012557609,0.0032017394,0.35517007,0.012823184,0.00016733089,0.000054867054,0.0000014686667,0.0002161422,0.000005717454,0.6242361,0.0008702048],"about_ca_topic_score_codex":0.0056555457,"about_ca_topic_score_gemma":0.0006586231,"teacher_disagreement_score":0.5712306,"about_ca_system_score_codex":0.0017318039,"about_ca_system_score_gemma":0.002288289,"threshold_uncertainty_score":0.99945927},"labels":[],"label_agreement":null},{"id":"W2792325188","doi":"10.1200/jco.2018.36.6_suppl.667","title":"Impact of tumor size on survival outcome in metastatic renal cell carcinoma patients (mRCC) treated with targeted therapy.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Sunnybrook Health Science Centre; Ottawa Hospital; Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre; University of Alberta; Health Sciences Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Cohort; Nephrectomy; Oncology; Metastasis; Targeted therapy; Internal medicine; Proportional hazards model; Cancer; Kidney","score_opus":0.12531369407310516,"score_gpt":0.43463918543349744,"score_spread":0.3093254913603923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792325188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966413,0.0001069134,0.000004692144,0.00023163778,0.00030058922,0.00044236946,0.0000131034285,0.0000060459242,0.0022533946],"genre_scores_gemma":[0.99778306,0.000027102327,0.0013196503,0.00036045077,0.00031183666,0.0000043056834,0.000006368852,0.000035827154,0.00015141876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947697,0.00095798733,0.0029642617,0.00027685717,0.0006614607,0.00036971862],"domain_scores_gemma":[0.9929672,0.0028722656,0.0024836063,0.00032497555,0.0008953846,0.00045657673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018426179,0.00029780547,0.0025137798,0.0002660088,0.000024698295,0.000005482865,0.00018766733,0.0001765583,0.00036068194],"category_scores_gemma":[0.0016249745,0.00015702017,0.0007553138,0.00033332108,0.00028528148,0.00007853579,0.000028013843,0.0007831715,0.000020657979],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038424976,0.0075759436,0.94613475,0.000018957378,0.0004817524,0.0016165626,0.00010739634,0.000017341343,0.0009265679,0.0000017830912,0.0002544183,0.0044395276],"study_design_scores_gemma":[0.028651873,0.16987674,0.7981972,0.000052526873,0.0003087235,0.000083158295,0.000033481934,0.000021770002,0.0025252327,0.000015668296,0.00012878508,0.00010480732],"about_ca_topic_score_codex":0.0002684036,"about_ca_topic_score_gemma":0.000059317845,"teacher_disagreement_score":0.1623008,"about_ca_system_score_codex":0.00048796306,"about_ca_system_score_gemma":0.0014370668,"threshold_uncertainty_score":0.6403097},"labels":[],"label_agreement":null},{"id":"W2792325737","doi":"10.1200/jco.2018.36.6_suppl.626","title":"Genomic alterations to refine prognostication of patients with metastatic renal cell carcinoma.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"BAP1; Medicine; Clear cell renal cell carcinoma; Renal cell carcinoma; Internal medicine; Oncology; Proportional hazards model; Cancer","score_opus":0.1003443753210771,"score_gpt":0.4106007203347001,"score_spread":0.310256345013623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792325737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947481,0.00007319656,0.00071326044,0.0019043031,0.00026356895,0.00045990208,0.000008375455,0.0000037279947,0.0018255471],"genre_scores_gemma":[0.96348906,0.000009499576,0.03514072,0.0006414991,0.0004999855,0.000007347589,0.000013330724,0.0000161112,0.00018246577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971559,0.00025255606,0.0018694177,0.00017725366,0.00037282455,0.00017202467],"domain_scores_gemma":[0.9956639,0.0007667489,0.0014510993,0.00024546788,0.0014942746,0.00037850285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010122695,0.00012404074,0.0009541396,0.00017170528,0.00003328665,0.000004957238,0.000115441726,0.00009254961,0.00012006396],"category_scores_gemma":[0.0010808599,0.00007699576,0.00019368269,0.00017555164,0.00018521563,0.000064256434,0.00003499098,0.0002921728,0.000044136395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012558679,0.0063820668,0.94175243,0.00007608156,0.0004354804,0.00021858403,0.00050603383,0.00002665703,0.0045460775,0.00007774079,0.0031452451,0.030274892],"study_design_scores_gemma":[0.0067776786,0.06310488,0.91923314,0.00004614391,0.0008782186,0.000054843284,0.000023016935,0.00003264144,0.004022692,0.00004819666,0.0057120044,0.00006652151],"about_ca_topic_score_codex":0.000011732647,"about_ca_topic_score_gemma":0.00002352742,"teacher_disagreement_score":0.056722816,"about_ca_system_score_codex":0.00017189232,"about_ca_system_score_gemma":0.0011803354,"threshold_uncertainty_score":0.3139796},"labels":[],"label_agreement":null},{"id":"W2792512381","doi":"10.5489/cuaj.5187","title":"Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trials","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Dalhousie University; BC Cancer Agency; Princess Margaret Cancer Centre; Juravinski Cancer Centre; University of Manitoba; Ottawa Hospital; Université Laval; Centre Hospitalier de l’Université de Montréal; University of British Columbia; Centre Hospitalier Universitaire de Sherbrooke; McGill University; McGill University Health Centre; Jewish General Hospital; Sunnybrook Health Science Centre; McMaster University; University of Alberta; Université de Montréal","funders":"","keywords":"Medicine; Sunitinib; Pazopanib; Internal medicine; Sorafenib; Oncology; Vandetanib; Nephrectomy; Renal cell carcinoma; Hazard ratio; Kidney cancer; Adjuvant therapy; Placebo; Randomized controlled trial; Adjuvant; Cancer; Surgery; Confidence interval; Kidney; Pathology; Hepatocellular carcinoma; Alternative medicine","score_opus":0.04624415173658525,"score_gpt":0.30540919698615704,"score_spread":0.2591650452495718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792512381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799624,0.008353859,0.00001195006,0.00687805,0.00007142024,0.0025723698,0.0020997587,0.0000010520831,0.000049159986],"genre_scores_gemma":[0.99808943,0.00024685534,0.00016291215,0.0009882977,0.00008256398,0.00027024437,0.000034931636,0.000010716438,0.00011403006],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9896778,0.006452583,0.0020361945,0.00025623888,0.0010976925,0.00047952862],"domain_scores_gemma":[0.98079336,0.011728171,0.0033539936,0.00032017607,0.0034201692,0.00038413043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011394655,0.00025207966,0.006060635,0.00055742543,0.00022794727,0.000027953618,0.0001765232,0.00012799853,0.0004876854],"category_scores_gemma":[0.0043623582,0.00010543557,0.0027223623,0.0016545344,0.00027814033,0.00001586246,0.000023208182,0.00043787362,7.178757e-8],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13939492,0.0002485803,0.13460426,0.00004694751,0.70794636,0.00003013017,0.0025007965,0.005372157,0.0018390102,0.00013380924,0.0077504567,0.00013255981],"study_design_scores_gemma":[0.09484622,0.0015514392,0.2919972,0.000030521845,0.6010505,0.000002956779,0.00046609365,0.0034596517,0.0050596157,0.00083492836,0.0005287297,0.00017213257],"about_ca_topic_score_codex":0.2213386,"about_ca_topic_score_gemma":0.20844465,"teacher_disagreement_score":0.15739295,"about_ca_system_score_codex":0.0006130646,"about_ca_system_score_gemma":0.0024742037,"threshold_uncertainty_score":0.80599916},"labels":[],"label_agreement":null},{"id":"W2792750235","doi":"10.5489/cuaj.4831","title":"Evaluating the role for renal biopsy in T1 and T2 renal masses: A single-centre study","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"","keywords":"Medicine; Biopsy; Radiology; Grading (engineering); Nephrectomy; Logistic regression; Context (archaeology); Radiography; Renal biopsy; Retrospective cohort study; Renal cell carcinoma; Confounding; Surgery; Kidney; Internal medicine","score_opus":0.05384180274616324,"score_gpt":0.3027924578226856,"score_spread":0.24895065507652236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792750235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98676705,0.00023145648,0.000020819265,0.0111514125,0.000110095905,0.0007841805,0.000011932589,0.0000101777,0.00091288623],"genre_scores_gemma":[0.9971131,0.0000029392525,0.00077257963,0.0009935779,0.0006573873,0.000029568957,0.0000072658004,0.000012293295,0.0004113016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816984,0.0003426166,0.0003739076,0.0002434701,0.00038064885,0.0004895305],"domain_scores_gemma":[0.99855965,0.00034205063,0.00023736265,0.00011583027,0.00031841602,0.0004267101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017361661,0.00014378269,0.00025261997,0.00014836372,0.00036717302,0.00011874695,0.00009652171,0.00013693953,0.00021565311],"category_scores_gemma":[0.0013640068,0.00009131493,0.00008407269,0.00019337967,0.00005122398,0.0000611543,0.000019882593,0.0003666009,0.000014579776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027502302,0.00018961632,0.98801625,0.000002277277,0.00012775522,0.00011237823,0.0009922519,0.000011069365,0.0019513661,0.000031599106,0.0007605648,0.007529859],"study_design_scores_gemma":[0.004188525,0.0056669833,0.97441953,0.000030733823,0.00025275417,0.00035154214,0.0014242994,0.0014724403,0.00013460171,0.0010559186,0.01084882,0.00015384679],"about_ca_topic_score_codex":0.00068022334,"about_ca_topic_score_gemma":0.004171439,"teacher_disagreement_score":0.013596706,"about_ca_system_score_codex":0.0013891461,"about_ca_system_score_gemma":0.0004236219,"threshold_uncertainty_score":0.37237146},"labels":[],"label_agreement":null},{"id":"W2792841998","doi":"10.1200/jco.2018.36.6_suppl.615","title":"Real world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Sunnybrook Hospital; University of Manitoba; BC Cancer Agency; Princess Margaret Cancer Centre; London Health Sciences Centre; University of Calgary","funders":"","keywords":"Cabozantinib; Nivolumab; Medicine; Renal cell carcinoma; Oncology; Hazard ratio; Internal medicine; Tyrosine-kinase inhibitor; Population; Kidney cancer; Axitinib; Urology; Cancer; Immunotherapy; Sunitinib; Confidence interval","score_opus":0.1283341814706414,"score_gpt":0.41237827101512387,"score_spread":0.28404408954448246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792841998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98449934,0.00058324484,0.00004623185,0.005577533,0.0011951153,0.00046229915,0.00030533707,0.000007361537,0.0073235286],"genre_scores_gemma":[0.98422617,0.00023968221,0.01245784,0.0010080837,0.00082665426,0.000007777666,0.00008183898,0.000036001617,0.0011159254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9917959,0.0012505946,0.004956031,0.0005632597,0.0009834219,0.00045082372],"domain_scores_gemma":[0.9851017,0.009267716,0.0036965152,0.0006721262,0.0007709184,0.0004910271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00512256,0.00037641946,0.0024551707,0.0004036205,0.00007082011,0.000026119234,0.0005517639,0.00016688666,0.00025292108],"category_scores_gemma":[0.0030417945,0.00023176167,0.00057313166,0.0003220515,0.0009536183,0.00020782222,0.00028529888,0.001293321,0.000022534377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024978306,0.0043288637,0.9342106,0.0000816621,0.00094261527,0.0063059293,0.0011492705,0.0000140147,0.007101182,0.0000990281,0.015647003,0.0051415563],"study_design_scores_gemma":[0.035235286,0.007961236,0.93761146,0.0001148712,0.0018215779,0.00028066194,0.0006003478,0.00033117997,0.009615844,0.00017775198,0.0060412376,0.00020853215],"about_ca_topic_score_codex":0.0032049546,"about_ca_topic_score_gemma":0.0034617342,"teacher_disagreement_score":0.012411608,"about_ca_system_score_codex":0.00025887162,"about_ca_system_score_gemma":0.0022419712,"threshold_uncertainty_score":0.9450967},"labels":[],"label_agreement":null},{"id":"W2792860024","doi":"10.1016/j.anndiagpath.2018.01.010","title":"Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases","year":2018,"lang":"en","type":"article","venue":"Annals of Diagnostic Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of British Columbia; University of Calgary; Royal Columbian Hospital","funders":"Univerzita Karlova v Praze","keywords":"Papillary renal cell carcinomas; Oncocytoma; Pathology; CD117; PAX8; Karyotype; Clear cell; Biology; Psammoma body; Medicine; Carcinoma; Immunohistochemistry; Chromosome","score_opus":0.027653357407173524,"score_gpt":0.28180421570303416,"score_spread":0.25415085829586065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792860024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900937,0.007652685,0.00016918177,0.00027569392,0.000015790341,0.0003661492,0.000050505616,0.000020141606,0.0013561468],"genre_scores_gemma":[0.9962603,0.00036452553,0.0027266487,0.00041797926,0.00004939498,0.000032200962,0.000059825976,0.000027819146,0.00006132307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980676,0.00018780484,0.0004291755,0.000553758,0.00034792806,0.0004137393],"domain_scores_gemma":[0.9973109,0.0010572794,0.00037258162,0.0005812196,0.0004817816,0.00019623325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001662723,0.0003250228,0.0010544261,0.0005021597,0.000059596125,0.0000073840574,0.00011469822,0.0001677368,0.00010265572],"category_scores_gemma":[0.00047179652,0.00022065095,0.00016366568,0.00067615317,0.00084854296,0.00003814312,0.00007938497,0.00014394322,0.0000037912998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033407046,0.00090810313,0.76149756,0.00040460867,0.0025039294,0.05762136,0.000865486,0.00028988614,0.16904615,0.00008413892,0.00071500277,0.0027230636],"study_design_scores_gemma":[0.0012176505,0.012977076,0.75017923,0.000127831,0.003221029,0.002517142,0.000095546224,0.000030311225,0.22939777,0.000029233046,0.000028223745,0.00017895838],"about_ca_topic_score_codex":0.00017114493,"about_ca_topic_score_gemma":0.00012132915,"teacher_disagreement_score":0.060351636,"about_ca_system_score_codex":0.000021833335,"about_ca_system_score_gemma":0.00015572828,"threshold_uncertainty_score":0.8997885},"labels":[],"label_agreement":null},{"id":"W2792937256","doi":"10.1056/nejmoa1712126","title":"Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma","year":2018,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4643,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University Hospital Foundation","funders":"Foundation Medicine; Kite Pharma; Genentech; Astellas Pharma; Eisai; Jounce Therapeutics; Takeda Oncology; Mirati Therapeutics; Acceleron; Clovis Oncology; BioMarin Pharmaceutical; Mylan; Celldex Therapeutics; Taiho Pharmaceutical; Horizon Pharma; Ipsen; Array BioPharma; Bayer HealthCare; Exelixis; Sanofi; Memorial Sloan-Kettering Cancer Center; GlaxoSmithKline; Amgen; INOVIO Pharmaceuticals; Daiichi Sankyo Europe; National Cancer Institute; LEO Pharma; Intuitive Surgical; Pfizer; EUSA Pharma; AstraZeneca; Ono Pharmaceutical; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Ipilimumab; Sunitinib; Nivolumab; Renal cell carcinoma; Medicine; Internal medicine; Oncology; Cancer research; Urology; Immunotherapy; Cancer","score_opus":0.033984496364644755,"score_gpt":0.2907462659043244,"score_spread":0.25676176953967966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792937256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9656729,0.0030144078,0.00009611647,0.0031345682,0.0012835141,0.00027048547,0.0000018110893,0.000016192223,0.026509978],"genre_scores_gemma":[0.9900785,0.00020820618,0.0009980556,0.00029163642,0.0058563272,0.0000024268788,0.000013637554,0.000039566996,0.0025116205],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99748677,0.00013569264,0.0008957756,0.0002560385,0.0007959013,0.00042981742],"domain_scores_gemma":[0.9978089,0.000336862,0.00043512264,0.0003789301,0.00043845616,0.00060177903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007527765,0.00029405826,0.0008897029,0.0005284231,0.000056715646,0.000008408864,0.00019465738,0.000110714296,0.0006536747],"category_scores_gemma":[0.00041749567,0.00020051269,0.00013455034,0.00041727338,0.00023428534,0.00012911196,0.00003797627,0.00057787175,0.000036788515],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16863568,0.0012388665,0.039924607,0.00042727872,0.00052807055,0.022352044,0.014582554,0.00015423054,0.13680539,0.00023211498,0.028819622,0.58629954],"study_design_scores_gemma":[0.73836625,0.054283917,0.06520575,0.0013638489,0.00088653684,0.00514818,0.0016642627,0.00016236317,0.05151262,0.00025937113,0.080719694,0.00042719167],"about_ca_topic_score_codex":0.00031317343,"about_ca_topic_score_gemma":0.00024422866,"teacher_disagreement_score":0.58587235,"about_ca_system_score_codex":0.0005023701,"about_ca_system_score_gemma":0.0006501624,"threshold_uncertainty_score":0.817667},"labels":[],"label_agreement":null},{"id":"W2793249623","doi":"10.1016/j.clgc.2018.01.003","title":"Adjuvant Therapies in Nonmetastatic Renal-Cell Carcinoma: A Review of the Literature","year":2018,"lang":"en","type":"review","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Sunitinib; Pazopanib; Renal cell carcinoma; Sorafenib; Adjuvant therapy; Nephrectomy; Oncology; Kidney cancer; Internal medicine; Adjuvant; Bevacizumab; Placebo; Tyrosine-kinase inhibitor; Cancer; Kidney; Chemotherapy; Pathology; Hepatocellular carcinoma; Alternative medicine","score_opus":0.09971389070820243,"score_gpt":0.4146607554077169,"score_spread":0.3149468646995145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793249623","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004011459,0.99048793,2.9492432e-7,0.00032866502,0.00091799157,0.003283865,0.00017872888,0.000016686385,0.00077439495],"genre_scores_gemma":[0.00034209725,0.9935192,0.00027746428,0.00085625396,0.001199912,0.00060719345,0.000112211885,0.00011281853,0.0029728364],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940773,0.0012923097,0.0026734658,0.0009016618,0.000590045,0.00046518233],"domain_scores_gemma":[0.99572825,0.0006427013,0.001326922,0.0017939229,0.00027556694,0.00023260579],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010495795,0.00075557496,0.0045635146,0.00018149937,0.000050449245,0.000014084813,0.0006085621,0.0004996492,0.00030343985],"category_scores_gemma":[0.00024519712,0.00039112914,0.0027767566,0.0010646534,0.00040716396,0.000048575912,0.00032108714,0.0014648646,0.000063157255],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014562526,0.001000407,0.0013449491,0.40327156,0.00044555578,0.0009644825,0.00012830569,1.088278e-7,0.0000024489273,0.0000010821941,0.01891075,0.5737847],"study_design_scores_gemma":[0.0009236753,0.000794356,0.0021984084,0.31333852,0.0034412348,0.00016660508,0.000008411039,4.5975406e-7,0.0000105996105,0.0000100447205,0.67882943,0.0002782139],"about_ca_topic_score_codex":0.000032763743,"about_ca_topic_score_gemma":0.000011880544,"teacher_disagreement_score":0.6599187,"about_ca_system_score_codex":0.00036346252,"about_ca_system_score_gemma":0.0016281593,"threshold_uncertainty_score":0.9998541},"labels":[],"label_agreement":null},{"id":"W2793310654","doi":"10.1200/jco.2018.36.6_suppl.642","title":"Association of dividing pathologically upstaged T3a renal cell carcinoma with improved alignment of outcomes: A call for TMN revision.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Renal cell carcinoma; Stage (stratigraphy); Pathological; Cohort; Surgery; Internal medicine","score_opus":0.098306413637358,"score_gpt":0.41113100713151124,"score_spread":0.31282459349415326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793310654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931655,0.00016348845,0.0019108885,0.002703706,0.00036741747,0.00063520455,0.000016796152,0.000005665179,0.0010313435],"genre_scores_gemma":[0.96837825,0.000081196464,0.029680854,0.0006006489,0.00048452494,0.0000079528945,0.0000047478143,0.000020472362,0.0007413363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99512583,0.00054465886,0.0031660171,0.00025437583,0.0006130236,0.0002961184],"domain_scores_gemma":[0.98842686,0.0039462307,0.0054372507,0.00028397772,0.0016154839,0.00029021184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005936846,0.00020068034,0.0022692939,0.00012560324,0.00004197812,0.0000049571436,0.00019007157,0.00042961474,0.000057299345],"category_scores_gemma":[0.004666297,0.000112059985,0.0007965097,0.000120364355,0.00020154889,0.00006457961,0.00006565507,0.00046797906,0.0000027657263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015129117,0.004039814,0.91488284,0.00025040223,0.0009849707,0.0003378925,0.0004217531,0.0000066198604,0.044907127,0.000042631196,0.0031215593,0.0158753],"study_design_scores_gemma":[0.02444173,0.13854347,0.80161774,0.00025946178,0.0023687717,0.00012246065,0.00020439301,0.00011105589,0.025187697,0.00015030192,0.0068202033,0.00017273193],"about_ca_topic_score_codex":0.000014924916,"about_ca_topic_score_gemma":0.000017157065,"teacher_disagreement_score":0.13450366,"about_ca_system_score_codex":0.000459706,"about_ca_system_score_gemma":0.00092558406,"threshold_uncertainty_score":0.5586331},"labels":[],"label_agreement":null},{"id":"W2793539844","doi":"10.1200/jco.2018.36.6_suppl.634","title":"Comparison of tumor mutational burden (TMB) in <i>PBRM1/BAP1</i>-based subsets of advanced renal cell carcinoma (aRCC).","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"BAP1; Medicine; Clear cell renal cell carcinoma; Oncology; Internal medicine; Cancer research; Renal cell carcinoma; Cancer","score_opus":0.11680790066887438,"score_gpt":0.46359298274843447,"score_spread":0.3467850820795601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793539844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99259245,0.0005564318,0.000099965306,0.001356443,0.0005728151,0.00030253603,0.000011608808,0.0000046012133,0.0045031398],"genre_scores_gemma":[0.9863234,0.000012080217,0.012446394,0.00036548704,0.00073691795,0.0000048346556,0.000013209861,0.000022588247,0.000075078075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99386734,0.00056201435,0.0042528636,0.0002613545,0.00075361715,0.00030278656],"domain_scores_gemma":[0.9918688,0.0026357863,0.0036778296,0.00029240662,0.0011627307,0.00036245072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002124566,0.00021017125,0.0024169332,0.00034140475,0.000024459554,0.0000029479488,0.00025327594,0.00027833154,0.00026448522],"category_scores_gemma":[0.0014365738,0.00016025659,0.00059921463,0.000285184,0.00061868463,0.00008168806,0.000049096114,0.00078621047,0.00001829757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022921357,0.0066861776,0.90510756,0.00024039735,0.00019293695,0.0018151314,0.00057820627,0.0009542097,0.039850723,0.000056777557,0.0019925172,0.019604024],"study_design_scores_gemma":[0.02137298,0.038417995,0.8216796,0.00022213126,0.0003871375,0.00021044486,0.0003245592,0.0009259976,0.11312415,0.000154697,0.003044249,0.00013608324],"about_ca_topic_score_codex":0.00006491902,"about_ca_topic_score_gemma":0.00008039255,"teacher_disagreement_score":0.08342796,"about_ca_system_score_codex":0.00026127114,"about_ca_system_score_gemma":0.002772315,"threshold_uncertainty_score":0.6535074},"labels":[],"label_agreement":null},{"id":"W2793748657","doi":"10.1016/j.euo.2019.03.007","title":"Cytoreductive Nephrectomy in Metastatic Papillary Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium","year":2019,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; London Health Sciences Centre; Sunnybrook Hospital; Queen Elizabeth II Health Sciences Centre; University of Alberta; University of Calgary","funders":"Janssen Biotech; National Cancer Institute; Foundation Medicine; Pfizer Canada; Novartis Pharmaceuticals Canada; Bristol-Myers Squibb Canada; Eisai; National Comprehensive Cancer Network; Ipsen; Astellas Pharma Canada; Genentech; AstraZeneca Canada; Novartis; GlaxoSmithKline; Merck; Exelixis; Bayer; Bristol-Myers Squibb; AstraZeneca; Astellas Pharma; Celldex Therapeutics; Pfizer","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Papillary renal cell carcinomas; Carcinoma; Oncology; Internal medicine; Kidney; Database; Pathology; Urology","score_opus":0.0301147906641542,"score_gpt":0.26762377117072317,"score_spread":0.23750898050656896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793748657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92119306,0.001702936,0.0000470637,0.004102917,0.0011406839,0.0013158128,0.00054354937,0.000060812712,0.06989318],"genre_scores_gemma":[0.9887029,0.00006222421,0.0029577026,0.0037236249,0.0005255857,0.000056154207,0.0018115897,0.0001124781,0.0020477239],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9929553,0.0029772515,0.0012835204,0.0013978964,0.0005369548,0.0008490333],"domain_scores_gemma":[0.99526596,0.0021939366,0.0006658138,0.0013445533,0.00021061621,0.00031914646],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016141477,0.00060513517,0.0010484558,0.00037363105,0.00011495587,0.00003291331,0.0007991945,0.00013359517,0.00085090677],"category_scores_gemma":[0.00035741887,0.0004490617,0.00027175024,0.0003534835,0.0005307989,0.00016664872,0.0005825337,0.0012953317,0.0016659789],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040318213,0.0073595694,0.30546397,0.00021553332,0.0017619763,0.0897275,0.013694479,0.0012522583,0.45158687,0.00037382028,0.08386333,0.0043825037],"study_design_scores_gemma":[0.048465405,0.010187758,0.7596459,0.00004843934,0.0023704541,0.0025077087,0.0023034045,0.0011259696,0.03794114,0.00017527962,0.1342099,0.0010186735],"about_ca_topic_score_codex":0.0008995538,"about_ca_topic_score_gemma":0.0002058848,"teacher_disagreement_score":0.4541819,"about_ca_system_score_codex":0.00058662455,"about_ca_system_score_gemma":0.00081481814,"threshold_uncertainty_score":0.9997961},"labels":[],"label_agreement":null},{"id":"W2793901188","doi":"10.1200/jco.2018.36.6_suppl.686","title":"Characterization of the benefit-risk profile of nivolumab + ipilimumab (N+I) <i>v</i> sunitinib (S) for treatment-naïve advanced renal cell carcinoma (aRCC; CheckMate 214).","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Ipilimumab; Discontinuation; Adverse effect; Sunitinib; Renal cell carcinoma; Clinical endpoint; Nivolumab; Toxicity; Gastroenterology; Clinical trial; Cancer; Immunotherapy","score_opus":0.07046305125117139,"score_gpt":0.38233359659708543,"score_spread":0.3118705453459141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793901188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943084,0.00017679369,0.00013011023,0.00076317985,0.0010069944,0.0010965855,0.00016083465,0.000008000899,0.0023490705],"genre_scores_gemma":[0.99352354,0.000310132,0.00374967,0.00020298148,0.0011110577,0.000029649776,0.000040103278,0.000040930492,0.0009919371],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99551266,0.00039892958,0.0030240044,0.0002896557,0.000438831,0.00033589298],"domain_scores_gemma":[0.9910862,0.001208942,0.0053584864,0.0005078622,0.0015695584,0.00026896675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013575024,0.0002653661,0.0019484401,0.00014041376,0.000092238726,0.0000053462727,0.00027820154,0.00037411656,0.00014363852],"category_scores_gemma":[0.0009196091,0.00015831401,0.0010805835,0.0002243736,0.00050321524,0.00012540926,0.00007084851,0.00033976897,0.000008137322],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045452863,0.0085091,0.12654193,0.00036266563,0.0010108938,0.00010733216,0.0010069999,0.000017791612,0.533125,0.000132104,0.0005370078,0.2831963],"study_design_scores_gemma":[0.02281583,0.05784634,0.4138653,0.00014813722,0.0014438097,0.00013142066,0.00013659583,0.00015005776,0.49538502,0.00013533932,0.007816138,0.00012600387],"about_ca_topic_score_codex":0.000036618603,"about_ca_topic_score_gemma":0.000043172673,"teacher_disagreement_score":0.2873234,"about_ca_system_score_codex":0.00030052094,"about_ca_system_score_gemma":0.0015259397,"threshold_uncertainty_score":0.64558583},"labels":[],"label_agreement":null},{"id":"W2794179875","doi":"10.5489/cuaj.4854","title":"The effect of age on cancer-specific mortality in patients with small renal masses: A population-based analysis","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Cancer; Medicine; Demography; Population; Oncology; Internal medicine; Environmental health; Sociology","score_opus":0.016794163281224506,"score_gpt":0.24137283910428195,"score_spread":0.22457867582305743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794179875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981652,0.00004613025,0.000018688703,0.0010409935,0.00007362868,0.00029542984,0.000028246563,0.0000057087127,0.0003259915],"genre_scores_gemma":[0.9993907,0.000005525616,0.000058931804,0.00028499914,0.00012140255,0.000016882119,0.0000721807,0.000007680979,0.00004170159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830055,0.00036831584,0.0003513485,0.00018134643,0.00047117166,0.00032725194],"domain_scores_gemma":[0.99858946,0.0003504739,0.0003559964,0.00016939321,0.00022466181,0.00031001947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007337799,0.00013562987,0.00036119993,0.0002749196,0.00019248914,0.000042559524,0.00009438155,0.0001181023,0.00014137468],"category_scores_gemma":[0.00025482816,0.000072978226,0.0001606446,0.0006296761,0.000046622423,0.000023624058,0.000004385922,0.00030470805,0.000004008677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000540898,0.000040416926,0.997287,0.0000024473986,0.00039234268,0.00004256577,0.00001892809,0.00051108433,0.0000043245172,0.000009552548,0.00010742733,0.0010430661],"study_design_scores_gemma":[0.0019440639,0.002566989,0.99390453,0.000018163473,0.00040971953,8.649728e-7,0.00000349414,0.00011946809,0.000064942484,0.000020597708,0.0008784881,0.000068650574],"about_ca_topic_score_codex":0.0070745256,"about_ca_topic_score_gemma":0.044184085,"teacher_disagreement_score":0.037109558,"about_ca_system_score_codex":0.002046821,"about_ca_system_score_gemma":0.00020840674,"threshold_uncertainty_score":0.99953747},"labels":[],"label_agreement":null},{"id":"W2794428098","doi":"10.1002/jpen.1067","title":"Influence of Contrast Administration on Computed Tomography–Based Analysis of Visceral Adipose and Skeletal Muscle Tissue in Clear Cell Renal Cell Carcinoma","year":2018,"lang":"en","type":"article","venue":"Journal of Parenteral and Enteral Nutrition","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Cancer Institute","keywords":"Hounsfield scale; Medicine; Adipose tissue; Skeletal muscle; Renal cell carcinoma; Body mass index; Nuclear medicine; Internal medicine; Computed tomography; Radiology","score_opus":0.010425781363382739,"score_gpt":0.25222791608766526,"score_spread":0.24180213472428252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794428098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999106,0.00036065074,0.00005644157,0.00013442762,0.000039777355,0.00021063378,0.000042659936,0.0000032759147,0.000046128465],"genre_scores_gemma":[0.99928033,0.000036808284,0.0004533467,0.00007043991,0.000088450826,0.0000028926763,0.000053764335,0.0000076287965,0.000006359884],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99863493,0.00008968437,0.0006756121,0.00017184681,0.00027703145,0.00015087341],"domain_scores_gemma":[0.9990223,0.00004543735,0.00043095514,0.00010114516,0.00025784204,0.00014233256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012214387,0.00015866858,0.00052882766,0.0006859432,0.000028659771,0.000016353153,0.00005138489,0.000062799816,0.00001773838],"category_scores_gemma":[0.0000068722125,0.00012938523,0.00017743402,0.0003344617,0.00012618711,0.00013719633,0.0000141398705,0.00014392885,3.8051982e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008365933,0.004422077,0.42964038,0.00083096704,0.00032117378,0.0002894532,0.00071589736,0.0003428363,0.55311096,0.0000099647705,0.00012378763,0.0018265941],"study_design_scores_gemma":[0.005782937,0.012028564,0.8331715,0.00047929678,0.000546541,0.000044956894,0.00005608866,0.0018849024,0.14587727,0.000011602215,0.000033213997,0.00008314684],"about_ca_topic_score_codex":0.00008781535,"about_ca_topic_score_gemma":0.000052371714,"teacher_disagreement_score":0.4072337,"about_ca_system_score_codex":0.000046405068,"about_ca_system_score_gemma":0.000029409868,"threshold_uncertainty_score":0.52761763},"labels":[],"label_agreement":null},{"id":"W2794582683","doi":"10.18632/oncotarget.24675","title":"High competing risks minimize real-world utility of adjuvant targeted therapy in renal cell carcinoma: a population-based analysis","year":2018,"lang":"en","type":"article","venue":"Oncotarget","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Oncology; Renal cell carcinoma; Population; Adjuvant therapy; Cohort; Cancer; Environmental health","score_opus":0.03965010333255758,"score_gpt":0.30440349028527464,"score_spread":0.26475338695271705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794582683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99482,0.00034912172,0.00013737436,0.00018882159,0.00011010636,0.0005809606,0.00008523316,0.000051637977,0.0036767616],"genre_scores_gemma":[0.9884111,0.00001719454,0.010088419,0.00013123942,0.00015911297,0.000033842083,0.00075297,0.000037266644,0.0003688094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99718845,0.0003053887,0.0009072125,0.0006010416,0.0005544194,0.0004434794],"domain_scores_gemma":[0.99801755,0.000249448,0.00044570697,0.0007924337,0.00028727693,0.00020757878],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005661288,0.00033911245,0.0011306392,0.0007661312,0.00008361809,0.00001208079,0.00015654239,0.00012587814,0.0015053239],"category_scores_gemma":[0.00006103455,0.00028139094,0.00040937788,0.0017103144,0.00013072976,0.000054224416,0.000036612306,0.00023342777,0.000019263593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013602914,0.0007037207,0.98834,0.000059936967,0.00019346793,0.00007247272,0.00027373826,0.00027383925,0.008315878,0.000010330474,0.0001292375,0.00026705017],"study_design_scores_gemma":[0.0045418977,0.00065304246,0.9186798,0.000039485185,0.00044289412,8.2884446e-7,0.00006415123,0.012789504,0.062450353,0.000022848395,0.000112311165,0.00020292177],"about_ca_topic_score_codex":0.04724686,"about_ca_topic_score_gemma":0.0045369705,"teacher_disagreement_score":0.069660276,"about_ca_system_score_codex":0.00030321366,"about_ca_system_score_gemma":0.0002468928,"threshold_uncertainty_score":0.9999638},"labels":[],"label_agreement":null},{"id":"W2794958367","doi":"10.1016/j.diii.2018.03.004","title":"Characterization of small (&lt;4 cm) solid renal masses by computed tomography and magnetic resonance imaging: Current evidence and further development","year":2018,"lang":"en","type":"review","venue":"Diagnostic and Interventional Imaging","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Magnetic resonance imaging; Radiology; Chromophobe cell; Clear cell; Nuclear medicine; Effective diffusion coefficient; Angiomyolipoma; Diffusion MRI; Hyperintensity; Renal cell carcinoma; Pathology; Kidney","score_opus":0.04631109139257065,"score_gpt":0.3171623383224809,"score_spread":0.27085124692991025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794958367","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01290195,0.98494995,0.0010065357,0.00010135319,0.00015264556,0.0007611706,0.00008133264,0.00002316966,0.000021923075],"genre_scores_gemma":[0.00910286,0.9885907,0.0012659533,0.000040670828,0.0001144893,0.00013701728,0.0006124843,0.000044501277,0.000091325215],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997906,0.00012391226,0.00083741045,0.0006107815,0.0002692652,0.0002526102],"domain_scores_gemma":[0.99850094,0.0005199813,0.0004190049,0.00018339478,0.00020860687,0.00016807881],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002647374,0.00042599597,0.0009283722,0.00029076013,0.00007828707,0.00008261889,0.00009471182,0.000056178083,0.000058216592],"category_scores_gemma":[0.00020229568,0.00035308048,0.00020871479,0.00016955085,0.0003244533,0.00014142624,0.00019752208,0.00018540949,0.0000048301235],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023252285,0.0002507901,0.027184218,0.0112481415,0.00009400453,0.0000390151,0.00011067788,7.877588e-9,0.00008151147,0.000019166475,0.00039893886,0.96055025],"study_design_scores_gemma":[0.0010744812,0.00043835776,0.16632125,0.1964004,0.0017347841,0.0006545857,0.000019051282,0.00019013188,0.00025596775,0.00005233755,0.6322329,0.0006257443],"about_ca_topic_score_codex":0.000009924596,"about_ca_topic_score_gemma":0.0000019446397,"teacher_disagreement_score":0.9599245,"about_ca_system_score_codex":0.00006827067,"about_ca_system_score_gemma":0.000117473974,"threshold_uncertainty_score":0.9998921},"labels":[],"label_agreement":null},{"id":"W2795101229","doi":"10.5489/cuaj.5065","title":"Identifying the use and barriers to the adoption of renal tumour biopsy in the management of small renal masses","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McMaster University; Hamilton General Hospital; University of Ottawa; Ottawa Hospital; Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto; University Health Network; Centre Hospitalier Universitaire de Sherbrooke","funders":"Canadian Urological Association","keywords":"Medicine; Biopsy; Family medicine; Radiology","score_opus":0.04707237871102146,"score_gpt":0.25144350298366375,"score_spread":0.20437112427264228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795101229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980998,0.0001463062,0.00016675374,0.017953955,0.00008352287,0.0003130351,0.00001118722,0.000002610609,0.0003246524],"genre_scores_gemma":[0.9973434,0.0000620925,0.0007096299,0.0016193773,0.00015379267,0.000010413775,0.0000036535855,0.000005114588,0.00009249397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863696,0.00030765342,0.00033029888,0.00012220409,0.00035049266,0.00025241254],"domain_scores_gemma":[0.99900496,0.00017445836,0.00024584285,0.00014214686,0.00018200476,0.00025058418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014271843,0.000092931645,0.00015787536,0.00012383985,0.00022531103,0.00007258137,0.00017299579,0.00006994444,0.000072362855],"category_scores_gemma":[0.0003504476,0.00004311853,0.00007526967,0.00030143475,0.00008020868,0.00005232873,0.000026531401,0.00027247838,0.0000052048626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028698242,0.00005275481,0.98515165,0.000024516914,0.00041349287,0.00030321235,0.0032397553,0.0002093723,0.0018801454,0.0010946217,0.004324654,0.0030188267],"study_design_scores_gemma":[0.0004669,0.00034386097,0.9907916,0.00004859677,0.00015830723,0.00019262246,0.0011380925,0.00008106893,0.00016023459,0.00022933827,0.0063434844,0.000045904104],"about_ca_topic_score_codex":0.0010077001,"about_ca_topic_score_gemma":0.0022794101,"teacher_disagreement_score":0.016345454,"about_ca_system_score_codex":0.00032483978,"about_ca_system_score_gemma":0.0001351896,"threshold_uncertainty_score":0.17583226},"labels":[],"label_agreement":null},{"id":"W2795277495","doi":"10.1016/s0022-5347(18)31505-2","title":"1291: Prognostic Impact of Cytogenetic Findings in Clear Cell Renal Cell Carcinoma: Improved Survival is Seen in Patients with Loss of Chromosome 3P","year":2007,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Renal cell carcinoma; Chromosome; Oncology; Internal medicine; Biology; Genetics; Gene","score_opus":0.010230361655758151,"score_gpt":0.239227022848743,"score_spread":0.22899666119298484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795277495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986023,0.00052064453,0.000016978489,0.00008634256,0.000053138807,0.0004810356,0.000010937901,0.000002107906,0.00022656884],"genre_scores_gemma":[0.9996913,0.000026623564,0.00013747436,0.000038341084,0.000045457316,0.0000011380193,0.00000397643,0.0000306938,0.000024991868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997886,0.00021224683,0.0009077625,0.00015729737,0.00040383002,0.00043286433],"domain_scores_gemma":[0.99829185,0.00033403604,0.00068847294,0.00028548937,0.00025715274,0.00014298015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009974948,0.00022398743,0.0007390547,0.0004330536,0.000017374832,0.0000025200975,0.00022648145,0.00013751844,0.000058061018],"category_scores_gemma":[0.00005175875,0.00013064044,0.00016694418,0.00035777435,0.00019485549,0.00004872173,0.000057027624,0.00048067686,0.0000029852988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011492029,0.00094403623,0.92246926,0.0000801104,0.00007869036,0.0002604578,0.0011748696,0.00014217611,0.06326103,4.8573565e-7,0.000011898339,0.00008497025],"study_design_scores_gemma":[0.00917174,0.02242408,0.9260545,0.000040012193,0.00029962676,0.0001772992,0.00006839237,0.000052172454,0.041603997,0.000016302009,0.0000023517687,0.00008952633],"about_ca_topic_score_codex":0.0003457942,"about_ca_topic_score_gemma":0.000058928454,"teacher_disagreement_score":0.021657033,"about_ca_system_score_codex":0.00022568932,"about_ca_system_score_gemma":0.00028277098,"threshold_uncertainty_score":0.53273624},"labels":[],"label_agreement":null},{"id":"W2795608643","doi":"10.1016/j.juro.2018.02.1514","title":"MP48-15 DOES PARTIAL NEPHRECTOMY FOR BIOPSY PROVEN FUHRMAN GRADE 3/4 RENAL CELL CARCINOMA CONFER WORSE OUTCOMES COMPARED TO RADICAL NEPHRECTOMY? RESULTS FROM A CANADIAN MUTLICENTER COHORT","year":2018,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SNC-Lavalin (Canada)","funders":"","keywords":"Nephrectomy; Medicine; Renal cell carcinoma; General surgery; Cohort; Surgery; Kidney; Internal medicine","score_opus":0.023345024783250602,"score_gpt":0.271062589351983,"score_spread":0.24771756456873242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795608643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97784436,0.00017540436,0.00015126828,0.018451381,0.00094535766,0.0015928976,0.00018434839,0.000021526965,0.0006334664],"genre_scores_gemma":[0.99203193,0.000007959603,0.0016444672,0.004058415,0.0016631203,0.00004808857,0.00006254308,0.000052519244,0.0004309437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99694616,0.00039823988,0.0010361539,0.00037507038,0.00044047937,0.0008038988],"domain_scores_gemma":[0.9969577,0.0005586944,0.00047885728,0.000623629,0.00037504954,0.0010060639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087493303,0.0003802572,0.00096005626,0.00037014132,0.00020243136,0.000036730686,0.0004560787,0.00020860527,0.00026312927],"category_scores_gemma":[0.00020337963,0.00020902406,0.00032259326,0.00018149594,0.0003789486,0.00007947341,0.00007688917,0.00050310453,0.0000766756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059620727,0.0010955408,0.81460845,0.000044097676,0.0021193335,0.0020099883,0.0076621724,0.000055991844,0.04695524,0.000060096405,0.06472715,0.001041198],"study_design_scores_gemma":[0.021170069,0.0059947344,0.6998424,0.000047425816,0.0024703373,0.001498625,0.00029739694,0.00046010266,0.029211495,0.0001972714,0.23837993,0.000430248],"about_ca_topic_score_codex":0.023680737,"about_ca_topic_score_gemma":0.024548259,"teacher_disagreement_score":0.17365278,"about_ca_system_score_codex":0.0003107331,"about_ca_system_score_gemma":0.0006768747,"threshold_uncertainty_score":0.9932512},"labels":[],"label_agreement":null},{"id":"W2795723619","doi":"10.1016/j.juro.2018.02.904","title":"MP28-04 DO HIGH-VOLUME RENAL TUMOR BIOPSY CENTERS HAVE LOWER RATES OF BENIGN HISTOLOGY FOLLOWING NEPHRECTOMY FOR SMALL RENAL MASSES?","year":2018,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Brampton Civic Hospital","funders":"","keywords":"Medicine; Nephrectomy; Histology; Urology; Renal biopsy; Biopsy; Renal mass; Renal tumor; Kidney; Radiology; Pathology; Internal medicine","score_opus":0.024640042693918725,"score_gpt":0.2724459411281247,"score_spread":0.24780589843420597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795723619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900874,0.0014817519,0.0026037714,0.0037090892,0.0012556709,0.0004023173,0.000010010922,0.000012015606,0.00043801087],"genre_scores_gemma":[0.991949,0.00003271562,0.006136722,0.00069689297,0.00069605006,0.000008870498,0.000006974454,0.000044348304,0.00042841045],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99773455,0.0003353378,0.00089626905,0.00023547847,0.00028094486,0.0005174172],"domain_scores_gemma":[0.99755794,0.0005007879,0.0009097542,0.00041263297,0.00042650205,0.0001923793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010295451,0.00027790156,0.00089752965,0.00031150252,0.000116266354,0.000010162499,0.000357996,0.00015558007,0.00023242173],"category_scores_gemma":[0.00025091413,0.00017636937,0.0004884599,0.00013510478,0.0004587955,0.0000697908,0.00007644584,0.0003907982,0.000018484188],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06305537,0.0017307908,0.17182003,0.0001984854,0.0056305425,0.005668582,0.002736485,0.00025030153,0.7228641,0.0006697373,0.02270734,0.0026682517],"study_design_scores_gemma":[0.06714275,0.13522236,0.2559894,0.0007412595,0.017680524,0.07717716,0.001440871,0.0015823669,0.27198622,0.008388603,0.16100176,0.0016467148],"about_ca_topic_score_codex":0.00009242798,"about_ca_topic_score_gemma":0.00003883896,"teacher_disagreement_score":0.45087788,"about_ca_system_score_codex":0.0001875635,"about_ca_system_score_gemma":0.0002514698,"threshold_uncertainty_score":0.7192134},"labels":[],"label_agreement":null},{"id":"W2796139571","doi":"10.1016/j.juro.2018.02.643","title":"PD12-07 PREDICTORS OF PATHOLOGICALLY NODE POSITIVE DISEASE IN PATIENTS UNDERGOING RETROPERITONEAL LYMPH NODE DISSECTION (RPLND) FOR RENAL CELL CARCINOMA (RCC): RESULTS FROM THE CANADIAN KIDNEY CANCER COLLABORATION","year":2018,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Retroperitoneal lymph node dissection; Nephrectomy; Renal cell carcinoma; Lymph node; Dissection (medical); Kidney cancer; General surgery; Kidney disease; Cancer; Surgery; Kidney; Testicular cancer; Oncology; Internal medicine","score_opus":0.012045340171137944,"score_gpt":0.24215830728173535,"score_spread":0.2301129671105974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796139571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903265,0.00032223752,0.000054250264,0.0073159314,0.00053877675,0.00052722037,0.00064454094,0.000004237765,0.0002662887],"genre_scores_gemma":[0.997827,0.00006181362,0.0001394561,0.0012078438,0.00057447364,0.000011530885,0.00011914457,0.000020428193,0.000038341343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812484,0.00044070507,0.0006330862,0.0001938385,0.00031119012,0.00029633194],"domain_scores_gemma":[0.9976764,0.0004210336,0.00056524493,0.00027012662,0.0007354016,0.00033183052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005365935,0.00016998195,0.00032758762,0.00013135943,0.00019538857,0.000013583054,0.00019018375,0.00013303703,0.000026789487],"category_scores_gemma":[0.00071425556,0.000094111565,0.000097216165,0.00020035684,0.00024246996,0.000078601704,0.000032332387,0.00023371502,0.0000027003355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028335525,0.00025282145,0.9601845,0.000019062443,0.0001178437,0.0001061024,0.0028442568,0.00052616425,0.0056246533,0.000009790215,0.0018426136,0.00013668227],"study_design_scores_gemma":[0.006052135,0.0033711172,0.98625135,0.0000730942,0.0005146495,0.000020922935,0.00015820256,0.00037575644,0.0029021648,0.0000802858,0.000120412755,0.000079908634],"about_ca_topic_score_codex":0.0207069,"about_ca_topic_score_gemma":0.037217986,"teacher_disagreement_score":0.026066866,"about_ca_system_score_codex":0.00074368255,"about_ca_system_score_gemma":0.0016895164,"threshold_uncertainty_score":0.9858143},"labels":[],"label_agreement":null},{"id":"W2796207353","doi":"10.1016/j.celrep.2018.06.032","title":"The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma","year":2018,"lang":"en","type":"erratum","venue":"Cell Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":777,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"CDKN2A; Chromophobe cell; BAP1; Renal cell carcinoma; Biology; Cancer research; PTEN; Clear cell renal cell carcinoma; Clear cell; Kidney cancer; Phenotype; Cancer; Oncology; Gene; Medicine; Genetics; PI3K/AKT/mTOR pathway; Melanoma; Signal transduction","score_opus":0.015100164234557744,"score_gpt":0.24341707440698843,"score_spread":0.2283169101724307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796207353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8997041,0.016627962,0.0000406811,0.00016325747,0.010630251,0.0016665717,0.00006749725,0.000049064434,0.071050644],"genre_scores_gemma":[0.6483431,0.0023175296,0.00007128733,0.00017072166,0.0021134573,0.0001748723,0.0036589813,0.0001974106,0.34295267],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963743,0.000104835395,0.0011459097,0.0009194573,0.0009261709,0.0005293317],"domain_scores_gemma":[0.99509776,0.000042897682,0.0018361564,0.0017827704,0.0009764067,0.00026403138],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017924537,0.00059987354,0.000983486,0.00016977185,0.0001641741,0.000043068867,0.00022153866,0.00054063974,0.00026099675],"category_scores_gemma":[0.000025819054,0.00042534654,0.00046078692,0.00024969658,0.00028789282,0.000040464503,0.00018706686,0.00063434715,0.000037816764],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015444383,0.0001831885,0.0010555228,0.0011769058,0.00020632069,0.007843014,0.0002553334,0.000005201802,0.89241576,0.0000013301573,0.09645801,0.00024496115],"study_design_scores_gemma":[0.00043921283,0.0005246267,0.031692717,0.00023896767,0.00090998574,0.0004835755,0.000020770418,0.000018652745,0.43691504,0.000013371726,0.52839863,0.00034440856],"about_ca_topic_score_codex":0.0002347178,"about_ca_topic_score_gemma":0.000011285772,"teacher_disagreement_score":0.45550072,"about_ca_system_score_codex":0.00045167803,"about_ca_system_score_gemma":0.0012503592,"threshold_uncertainty_score":0.9998198},"labels":[],"label_agreement":null},{"id":"W2797282777","doi":"10.1016/j.cell.2018.03.057","title":"Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal","year":2018,"lang":"en","type":"article","venue":"Cell","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":875,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Stand Up To Cancer; National Institutes of Health; CRUK Lung Cancer Centre of Excellence; Cancer Research UK; Novo Nordisk Fonden; Breast Cancer Research Foundation; Rosetrees Trust; National Institute for Health and Care Research; Ministerio de Economía y Competitividad; Wellcome Trust; Francis Crick Institute; National Cancer Institute; University College London; Institute of Cancer Research; Medical Research Council; Celgene; Royal Marsden Cancer Charity","keywords":"Biology; Clear cell renal cell carcinoma; Metastasis; Phenotype; Renal cell carcinoma; Primary tumor; Cancer research; Tumor progression; Pathology; Cancer; Gene; Genetics","score_opus":0.03381055547696047,"score_gpt":0.2980480197035847,"score_spread":0.2642374642266242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797282777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789631,0.0014320015,0.0014630192,0.0007752427,0.00022855248,0.00063638255,0.00004671994,0.00008040326,0.016374584],"genre_scores_gemma":[0.99144363,0.000015113322,0.003492578,0.00046498538,0.00056936766,0.000058950827,0.00002484748,0.000027799619,0.0039027215],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987414,0.000053857206,0.0002680493,0.00034520554,0.00025933163,0.00033215285],"domain_scores_gemma":[0.9990952,0.00005374632,0.00007894386,0.00030700603,0.00019690876,0.00026817122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020457346,0.00018411191,0.00030507988,0.000116312985,0.00008626386,0.000023114893,0.000074950454,0.000067066074,0.0008963908],"category_scores_gemma":[0.000055912606,0.00014949351,0.00011453007,0.00023254445,0.00010137725,0.000070136186,0.000024450675,0.00010524438,0.0003508342],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044785056,0.00027734472,0.008540442,0.00013274951,0.00013787838,0.00017229309,0.0010268366,0.000025798303,0.9637964,0.000119370714,0.015546062,0.009777003],"study_design_scores_gemma":[0.002811129,0.0015995372,0.075716004,0.00031454753,0.00067071494,0.000109630826,0.00037670112,0.00012781454,0.9042565,0.00017238995,0.013511696,0.00033333272],"about_ca_topic_score_codex":0.00022895764,"about_ca_topic_score_gemma":0.00007005735,"teacher_disagreement_score":0.06717557,"about_ca_system_score_codex":0.00035737106,"about_ca_system_score_gemma":0.00015777013,"threshold_uncertainty_score":0.98148507},"labels":[],"label_agreement":null},{"id":"W2797542577","doi":"10.1016/j.cell.2018.03.043","title":"Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal","year":2018,"lang":"en","type":"article","venue":"Cell","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":671,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Biomedical Research Council; Seventh Framework Programme; CRUK Lung Cancer Centre of Excellence; Nemzeti Kutatási Fejlesztési és Innovációs Hivatal; Ministerio de Economía y Competitividad; Rosetrees Trust; National Institute for Health and Care Research; Medical Research Council; Celgene; Institute of Cancer Research; UCLH Biomedical Research Centre; Novo Nordisk Fonden; Cancer Research UK; Francis Crick Institute; Wellcome Trust; Kræftens Bekæmpelse; AstraZeneca; Royal Marsden Cancer Charity; NIHR Maudsley Biomedical Research Centre; GlaxoSmithKline; Pfizer","keywords":"Biology; Clear cell renal cell carcinoma; Somatic evolution in cancer; Evolutionary biology; Renal cell carcinoma; Evolutionary dynamics; Genetics; Bioinformatics; Gene; Oncology","score_opus":0.01420107624236307,"score_gpt":0.23755363201771462,"score_spread":0.22335255577535154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797542577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96019953,0.0006722574,0.000045046476,0.00011735649,0.00019557062,0.00029808245,0.000010496206,0.000092082286,0.038369603],"genre_scores_gemma":[0.99379057,0.000015323272,0.0020712947,0.0005073648,0.0005124248,0.000033874694,0.000029796745,0.000029690218,0.0030096848],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99874234,0.000037598886,0.00025862036,0.0003380682,0.00031266815,0.00031072774],"domain_scores_gemma":[0.9990884,0.00008818748,0.00007845474,0.0003442859,0.00019907921,0.00020158083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000078165496,0.00019950245,0.00026330896,0.00008817511,0.00011728682,0.00001550608,0.000108951026,0.00006335004,0.00022798165],"category_scores_gemma":[0.00006569878,0.00016668063,0.000101722384,0.00017460366,0.00030721098,0.00009618654,0.000041856758,0.0001459476,0.00053725345],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021398284,0.0014321805,0.108836606,0.001221383,0.00014880096,0.0039684274,0.0018675979,0.000008685136,0.8605014,0.00021033423,0.017511899,0.0021528418],"study_design_scores_gemma":[0.0015473638,0.0018585403,0.7852177,0.00010913413,0.00021150259,0.0006412929,0.00004559789,0.00006264061,0.20509148,0.000299418,0.0046618944,0.00025346107],"about_ca_topic_score_codex":0.000038191272,"about_ca_topic_score_gemma":0.0000034540171,"teacher_disagreement_score":0.67638105,"about_ca_system_score_codex":0.00025502418,"about_ca_system_score_gemma":0.0002691474,"threshold_uncertainty_score":0.69054854},"labels":[],"label_agreement":null},{"id":"W2797597061","doi":"10.1007/s00345-018-2297-4","title":"Early tumor shrinkage is independently associated with improved overall survival among patients with metastatic renal cell carcinoma: a validation study using the COMPARZ cohort","year":2018,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Pazopanib; Renal cell carcinoma; Internal medicine; Sunitinib; Proportional hazards model; Oncology; Clear cell renal cell carcinoma; Cohort; Nephrology","score_opus":0.02025568092181403,"score_gpt":0.2505573148518842,"score_spread":0.23030163393007017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797597061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99797076,0.000063215666,0.00017017809,0.000108105305,0.00018356522,0.0011424395,0.0000086747405,0.000011708953,0.00034136677],"genre_scores_gemma":[0.99908644,6.9992547e-7,0.00025090485,0.00022484917,0.00013469768,0.000009990012,0.00001169774,0.00004786277,0.00023285754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971214,0.0005736586,0.0006868138,0.00031069494,0.0008919827,0.00041547968],"domain_scores_gemma":[0.9971638,0.00018806252,0.0011860153,0.00035407516,0.00090875366,0.00019932348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007998898,0.00031246548,0.00076078065,0.000329318,0.00017943574,0.000051745516,0.00021243372,0.000041709627,0.00011106376],"category_scores_gemma":[0.000042021566,0.00017376215,0.000120265366,0.000384966,0.0002576127,0.00018221668,0.00006165719,0.0005887548,0.000004357973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031204503,0.0013711695,0.9920474,0.000007734307,0.0010158225,0.0005833654,0.0010486366,0.00005289012,0.00066707877,0.0000018205208,0.000055461165,0.000028141134],"study_design_scores_gemma":[0.012985721,0.013537233,0.96880674,0.000028936194,0.002744901,0.00013325592,0.0001542572,0.0002889117,0.0011330104,0.000010233383,0.000016764325,0.00016004308],"about_ca_topic_score_codex":0.0004037117,"about_ca_topic_score_gemma":0.00054781744,"teacher_disagreement_score":0.023240697,"about_ca_system_score_codex":0.00029054267,"about_ca_system_score_gemma":0.00024340868,"threshold_uncertainty_score":0.70858145},"labels":[],"label_agreement":null},{"id":"W2797702016","doi":"10.1016/j.cell.2018.02.020","title":"Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal","year":2018,"lang":"en","type":"article","venue":"Cell","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":560,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"European Research Council; Institute of Cancer Research; Medical Research Council; Cancer Research UK; University of Cambridge; Novo Nordisk Fonden; Breast Cancer Research Foundation; Rosetrees Trust; University College London; National Institute for Health and Care Research; Wellcome Trust; Francis Crick Institute; Prostate Cancer Foundation","keywords":"Biology; Landmark; Cell; Kidney cancer; Cancer; Kidney; Cancer research; Genetics; Cartography","score_opus":0.023522269657338335,"score_gpt":0.2636460225826683,"score_spread":0.24012375292532995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797702016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95489717,0.0019096138,0.00006151452,0.00044365518,0.00014543858,0.0005190905,0.000007930425,0.0000138253645,0.042001765],"genre_scores_gemma":[0.99538606,0.00010833967,0.00016179644,0.0001375459,0.00037030992,0.000034152963,0.000011038107,0.000023439727,0.0037672848],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853224,0.0001774191,0.0003142615,0.00026069052,0.00040563915,0.00030976918],"domain_scores_gemma":[0.99907047,0.00011878849,0.00016719865,0.0004915911,0.00008375646,0.00006821077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047774042,0.00017289273,0.00023324956,0.00008169028,0.00010385318,0.000007348161,0.00023645832,0.00008975218,0.00022372024],"category_scores_gemma":[0.000012366011,0.00009510472,0.00012697106,0.00027102893,0.00012002656,0.000042951753,0.000044608456,0.00026333373,0.00011051412],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003326619,0.0025236923,0.1314727,0.00080137595,0.00010997596,0.0001950656,0.018104358,0.00028271409,0.8092125,0.000047243233,0.030038971,0.003884757],"study_design_scores_gemma":[0.005516569,0.002356965,0.28493628,0.00031270625,0.0004920409,0.000048786103,0.0024367168,0.0014951706,0.6871619,0.00017722632,0.0147559345,0.00030966508],"about_ca_topic_score_codex":0.0014068456,"about_ca_topic_score_gemma":0.00025777475,"teacher_disagreement_score":0.15346357,"about_ca_system_score_codex":0.00031476252,"about_ca_system_score_gemma":0.00016722706,"threshold_uncertainty_score":0.3878258},"labels":[],"label_agreement":null},{"id":"W2797935388","doi":"10.1016/j.eururo.2018.03.036","title":"First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis","year":2018,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Sunnybrook Health Science Centre; Health Sciences Centre; Mount Sinai Hospital; Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Ipilimumab; Nivolumab; Cabozantinib; Meta-analysis; Internal medicine; Oncology; Renal cell carcinoma; MEDLINE; Adverse effect; Randomized controlled trial; Clinical trial; Systematic review; Intensive care medicine; Immunotherapy; Cancer","score_opus":0.139009630443,"score_gpt":0.3312376492555004,"score_spread":0.19222801881250043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797935388","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000051479933,0.98632777,0.0006596646,0.00014662913,0.00010594521,0.011827216,0.00012950027,0.00007199895,0.0007261446],"genre_scores_gemma":[0.00072545314,0.9918006,0.00074718666,0.0013745046,0.00037967335,0.0016943213,0.0005321393,0.00025767682,0.0024884588],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99082273,0.004222507,0.0025715318,0.0013430119,0.00032862733,0.00071160734],"domain_scores_gemma":[0.9940697,0.0014230423,0.0019604233,0.0019307671,0.00028365906,0.00033243964],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.003234458,0.0011894733,0.016897986,0.0004454989,0.00015794758,0.000039784583,0.0004533954,0.00016666813,0.00021311358],"category_scores_gemma":[0.00024265292,0.0006833099,0.0057856753,0.0008752364,0.0001568806,0.0000320046,0.00016385432,0.00040928298,0.00032394417],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003885814,0.00010095239,0.0000015598126,0.85931325,0.13784634,0.0004666397,0.000028779185,0.0000066765406,7.946758e-8,0.000012448285,0.0018693377,0.0003150864],"study_design_scores_gemma":[0.000703837,0.0017711645,0.0000025787936,0.0148263415,0.84052974,0.0017919787,0.0000015873069,0.000018623574,1.7143631e-7,0.000005623342,0.13996136,0.00038695923],"about_ca_topic_score_codex":0.00000758332,"about_ca_topic_score_gemma":0.0000060745488,"teacher_disagreement_score":0.8444869,"about_ca_system_score_codex":0.00012116321,"about_ca_system_score_gemma":0.00015316857,"threshold_uncertainty_score":0.9995618},"labels":[],"label_agreement":null},{"id":"W2797937732","doi":"10.1007/s00261-018-1593-1","title":"Magnetic resonance imaging (MRI) of the renal sinus","year":2018,"lang":"en","type":"review","venue":"Abdominal Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Renal sinus; Magnetic resonance imaging; Radiology; Renal cell carcinoma; Sinus (botany); Gadolinium; Kidney; Nephrectomy; Pathology; Internal medicine","score_opus":0.02811240559686773,"score_gpt":0.29947912941733856,"score_spread":0.27136672382047083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797937732","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023088638,0.9906793,0.0000094450525,0.0001185628,0.0004671546,0.00096307136,0.000020978357,0.00001735182,0.0074932175],"genre_scores_gemma":[0.00041077886,0.9952519,0.0007475236,0.0001296654,0.0006644953,0.0000925435,0.000026743464,0.00006221357,0.0026141338],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997521,0.00043990434,0.00080058497,0.00055771956,0.00024689996,0.00043391337],"domain_scores_gemma":[0.99786466,0.00036956603,0.00047273512,0.0010716779,0.0001086568,0.00011269725],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032753136,0.00045292417,0.0021847372,0.00015420106,0.00006643093,0.0000055451787,0.0004235183,0.0002670685,0.00027746378],"category_scores_gemma":[0.00017428792,0.00025329832,0.0008726551,0.0002942548,0.00082152424,0.00001734577,0.00015874633,0.00045598857,0.00016828394],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013712463,0.000059316233,0.00015998524,0.0031268115,0.00009188733,0.0006897232,0.00003933914,5.6609654e-8,0.000022695167,0.000098335746,0.008729948,0.9868448],"study_design_scores_gemma":[0.00063908374,0.0005686646,0.001361348,0.007008281,0.0024301365,0.019104041,0.0000065138543,0.0000073312845,0.000046559395,0.000051528998,0.96858126,0.00019523036],"about_ca_topic_score_codex":0.00003491232,"about_ca_topic_score_gemma":0.000003149545,"teacher_disagreement_score":0.9866496,"about_ca_system_score_codex":0.00028602424,"about_ca_system_score_gemma":0.00055436546,"threshold_uncertainty_score":0.99999195},"labels":[],"label_agreement":null},{"id":"W2799597692","doi":"10.1158/2326-6066.cir-17-0475","title":"The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non–Clear Cell Renal Cell Carcinoma","year":2018,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada)","funders":"National Cancer Institute; Dana-Farber/Harvard Cancer Center; Memorial Sloan-Kettering Cancer Center","keywords":"Renal cell carcinoma; Medicine; Immunotherapy; PD-L1; Cancer research; Internal medicine; Oncology; Cancer","score_opus":0.13248197790817184,"score_gpt":0.43656753841307966,"score_spread":0.3040855605049078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799597692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830675,0.0066154147,0.0000056710323,0.0011999762,0.0004498897,0.0009902735,0.00001086627,0.000014839419,0.007645558],"genre_scores_gemma":[0.9937583,0.0011619624,0.00011425453,0.00004378431,0.0003016882,0.00019254233,0.0000051738934,0.000045627752,0.004376626],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957057,0.0013195098,0.0007143745,0.00061673555,0.00066719076,0.00097646884],"domain_scores_gemma":[0.9965664,0.0013318132,0.0001997462,0.0010824535,0.0006412933,0.00017830457],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0028843498,0.00024101218,0.0006820242,0.00035911077,0.0002636226,0.0000213374,0.0004690892,0.00024234723,0.00024266749],"category_scores_gemma":[0.00029618372,0.00016489475,0.00022061713,0.000814574,0.0027737743,0.00007741891,0.00040087613,0.0015879573,0.00021341184],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016299348,0.0018238688,0.23445751,0.00030403858,0.00038447435,0.0004946848,0.00139376,0.0000033706824,0.70336676,0.000037081754,0.0077556614,0.033679444],"study_design_scores_gemma":[0.0036028135,0.004669319,0.42499563,0.000073947245,0.00007121671,0.000017526521,0.00044897167,0.00008491137,0.5626033,0.00005688124,0.0032547372,0.000120738274],"about_ca_topic_score_codex":0.0024121262,"about_ca_topic_score_gemma":0.00047484337,"teacher_disagreement_score":0.19053812,"about_ca_system_score_codex":0.0005762579,"about_ca_system_score_gemma":0.0014406955,"threshold_uncertainty_score":0.9999401},"labels":[],"label_agreement":null},{"id":"W2800195468","doi":"10.1016/j.csbj.2018.04.002","title":"Corrigendum to “A Gene Module-Based eQTL Analysis Prioritizing Disease Genes and Pathways in Kidney Cancer”","year":2018,"lang":"en","type":"erratum","venue":"Computational and Structural Biotechnology Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; Food and Drug Administration; Arkansas Science and Technology Authority; National Institutes of Health; U.S. Food and Drug Administration; Hamilton Health Sciences Foundation; Arkansas Research Alliance","keywords":"Gene; Computational biology; Expression quantitative trait loci; Kidney cancer; Pathway analysis; Disease; Biology; Cancer; Bioinformatics; Medicine; Genetics; Gene expression; Internal medicine; Single-nucleotide polymorphism","score_opus":0.024710009194199457,"score_gpt":0.26941176883237206,"score_spread":0.2447017596381726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800195468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9620599,0.018769452,0.0017835097,0.011383894,0.004805642,0.0005356588,0.0005498994,0.00007301005,0.00003898856],"genre_scores_gemma":[0.97742045,0.0018540309,0.014546814,0.0016293657,0.0015041968,0.000035176075,0.0012921558,0.000056439774,0.001661377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979135,0.00006364463,0.0005428144,0.00064757897,0.00041713877,0.00041532365],"domain_scores_gemma":[0.99846673,0.000028954491,0.00028279194,0.00021582136,0.00026947472,0.00073620025],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011910625,0.0004397235,0.00082576886,0.0015245778,0.00028969298,0.00008617575,0.0001634678,0.0005666003,0.00006383384],"category_scores_gemma":[0.00009376691,0.00034886826,0.00019344295,0.00067657995,0.00031657107,0.000053951913,0.00013174803,0.0009949481,0.0000027437231],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005135778,0.00037569006,0.52149844,0.00251576,0.011369875,0.017033981,0.00087537215,0.012923695,0.013078202,0.0012655505,0.1845945,0.22933318],"study_design_scores_gemma":[0.0033845895,0.00095870945,0.8842272,0.0009548856,0.0029397593,0.0019118364,0.000057916117,0.08909844,0.0010742077,0.0058057383,0.008676502,0.0009102134],"about_ca_topic_score_codex":0.000069020134,"about_ca_topic_score_gemma":0.000047757934,"teacher_disagreement_score":0.36272877,"about_ca_system_score_codex":0.00039064224,"about_ca_system_score_gemma":0.0010075809,"threshold_uncertainty_score":0.99989635},"labels":[],"label_agreement":null},{"id":"W2801330519","doi":"10.1097/mou.0000000000000506","title":"Roles for active surveillance in renal cancer","year":2018,"lang":"en","type":"review","venue":"Current Opinion in Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Intensive care medicine; Watchful waiting; Biopsy; Active monitoring; Disease; Cancer; Radiology; Internal medicine; Prostate cancer","score_opus":0.16027912350245044,"score_gpt":0.4449922531254937,"score_spread":0.28471312962304324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801330519","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012084267,0.9925609,0.000027682743,0.00015361521,0.004598789,0.0021984808,0.00018957083,0.000020506901,0.0001295618],"genre_scores_gemma":[0.00014630142,0.9952196,0.000032288473,0.00001744731,0.0014661265,0.0021893303,0.00083376694,0.000052992542,0.000042168962],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976232,0.00028618073,0.00072742865,0.00072582875,0.00015582872,0.0004815004],"domain_scores_gemma":[0.9987046,0.0003837034,0.000341814,0.00037874834,0.00009099616,0.000100106496],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028844306,0.00042741277,0.0018862244,0.0004993527,0.000022443406,0.000006184272,0.00017579993,0.00039465004,0.00007682999],"category_scores_gemma":[0.00012955832,0.00033522226,0.00034756717,0.00031451866,0.00012287607,0.000027449687,0.00007778701,0.00053318404,0.00004223278],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036685602,0.00027087188,0.0015923167,0.01616057,0.00011349068,0.0000075471944,0.0000783608,0.0000030069716,2.6561406e-7,0.00007243816,0.0042091287,0.97712517],"study_design_scores_gemma":[0.0014635668,0.0005358865,0.0018065467,0.0069081504,0.00012620738,0.000047254623,0.0000029554062,0.000026827258,0.0000012700305,0.000060612296,0.98878884,0.00023185083],"about_ca_topic_score_codex":0.000032254484,"about_ca_topic_score_gemma":0.00012712383,"teacher_disagreement_score":0.98457974,"about_ca_system_score_codex":0.0005861812,"about_ca_system_score_gemma":0.00061672716,"threshold_uncertainty_score":0.99991},"labels":[],"label_agreement":null},{"id":"W2801876087","doi":"10.1097/coc.0000000000000451","title":"Nivolumab in the Treatment of Metastatic Renal Cell Carcinoma","year":2018,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Nivolumab; Medicine; Renal cell carcinoma; Quality-adjusted life year; Willingness to pay; Cost effectiveness; Oncology; Cost–utility analysis; Everolimus; Cost–benefit analysis; Cohort; Quality of life (healthcare); Internal medicine; Cancer; Intensive care medicine; Immunotherapy; Risk analysis (engineering); Nursing","score_opus":0.10691684125219736,"score_gpt":0.4359489687321487,"score_spread":0.32903212747995136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801876087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905904,0.00051007693,0.000058139056,0.0024749949,0.00027133245,0.00025176076,0.0000025237364,0.0000025436966,0.005838212],"genre_scores_gemma":[0.9916708,0.00035115815,0.006380854,0.00076907506,0.0006605174,0.000006601187,0.0000016136012,0.000014554249,0.00014482884],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9961616,0.0010735778,0.00192896,0.00019019457,0.0003815664,0.0002641343],"domain_scores_gemma":[0.9951417,0.002254905,0.0017112922,0.00035671672,0.0003148592,0.0002205338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014876972,0.0001689498,0.0016619866,0.00017550784,0.00002585831,0.0000039292445,0.00021509956,0.00006344122,0.00011389763],"category_scores_gemma":[0.0002761897,0.00008925025,0.0005802169,0.00034487294,0.0012492024,0.00003665087,0.000015656704,0.00031036517,0.000024536565],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010060944,0.012953616,0.33873,0.00002340957,0.0005155154,0.0043147695,0.0034803622,0.0000066833654,0.0010785953,0.000041493255,0.0014045096,0.6273901],"study_design_scores_gemma":[0.011866569,0.3240867,0.6243166,0.000035232646,0.0010643895,0.0014087866,0.0021389488,0.000033443794,0.003222087,0.00011396377,0.03161018,0.00010314415],"about_ca_topic_score_codex":0.00025390022,"about_ca_topic_score_gemma":0.00008536837,"teacher_disagreement_score":0.627287,"about_ca_system_score_codex":0.0002577649,"about_ca_system_score_gemma":0.0010078615,"threshold_uncertainty_score":0.46027383},"labels":[],"label_agreement":null},{"id":"W2802331759","doi":"10.1001/jamainternmed.2018.1183","title":"Uncoupling Diagnosis and Treatment of Incidentally Imaged Renal Masses—Reply","year":2018,"lang":"en","type":"letter","venue":"JAMA Internal Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Renal mass; General surgery; Intensive care medicine; Radiology; Surgery; Kidney; Internal medicine; Nephrectomy","score_opus":0.03438894314169087,"score_gpt":0.2944106750803789,"score_spread":0.260021731938688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802331759","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5304702,0.006052369,0.00007582241,0.45361996,0.0010983802,0.001336474,0.00007197457,0.00008328436,0.007191544],"genre_scores_gemma":[0.34267434,0.008248387,0.0036926433,0.5685946,0.047430232,0.000715845,0.0013799398,0.0004518716,0.026812166],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99613076,0.00010703741,0.0011695928,0.00088893244,0.0011715016,0.00053214625],"domain_scores_gemma":[0.99694765,0.0007564237,0.0007421977,0.00084135897,0.00041082827,0.0003015748],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029727892,0.0007989101,0.0018371147,0.0005964385,0.00006260879,0.000034990095,0.00024527704,0.0005544669,0.0012284032],"category_scores_gemma":[0.00044102123,0.00052627496,0.00034000515,0.00019280122,0.0007222118,0.000102409474,0.00013025673,0.00095210253,0.00005906077],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011487643,0.00034247694,0.07325712,0.00076449057,0.0018625371,0.017281761,0.0007811814,3.763791e-7,0.0047843163,0.0000019422519,0.88188756,0.017887462],"study_design_scores_gemma":[0.010994942,0.021850977,0.03374019,0.008218745,0.0031940907,0.003159239,0.0001557459,0.000053225194,0.028797267,0.000086061315,0.88922256,0.0005269289],"about_ca_topic_score_codex":0.003688393,"about_ca_topic_score_gemma":0.000061602994,"teacher_disagreement_score":0.18779586,"about_ca_system_score_codex":0.0009394908,"about_ca_system_score_gemma":0.00016324065,"threshold_uncertainty_score":0.9997189},"labels":[],"label_agreement":null},{"id":"W2803196865","doi":"10.5489/cuaj.4924","title":"The impact of targeted therapy on healthcare resource use in patients with metastatic renal cell carcinoma: The University of Sherbrooke experience","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"Medicine; Renal cell carcinoma; Targeted therapy; Health care; Internal medicine; Population; Emergency department; Oncology; Emergency medicine; Cancer","score_opus":0.020769378884883425,"score_gpt":0.2283055653842065,"score_spread":0.20753618649932307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803196865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978694,0.00016862524,0.0000037822847,0.0014405758,0.000022237344,0.0002840394,0.000023168823,0.000002504892,0.0001856994],"genre_scores_gemma":[0.9995415,0.000020189489,0.00004373639,0.0002577323,0.000029893232,9.607077e-7,0.000007553669,0.000006574015,0.00009182647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857134,0.0004095194,0.00022361419,0.00012549631,0.00036605718,0.0003039688],"domain_scores_gemma":[0.9986124,0.00026630118,0.0003258925,0.0001722007,0.00035482514,0.00026837134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003799006,0.00010936747,0.00021527475,0.00008861585,0.0002635205,0.000017088125,0.0001478246,0.0000659037,0.0000831735],"category_scores_gemma":[0.00015146447,0.000051496576,0.0001084446,0.0002483614,0.00014531122,0.00004861952,0.000008932014,0.00031895237,0.0000025868094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012064439,0.00009216881,0.9958801,0.0000017400948,0.000054455406,0.000027581204,0.0014568282,0.00008325836,0.000056943278,0.000008066775,0.0007103064,0.00042210956],"study_design_scores_gemma":[0.0020772226,0.004464148,0.99209124,0.000012798399,0.000021400834,0.00000571511,0.00029530298,0.00004424016,0.00021481815,0.000018484025,0.0007072086,0.00004739979],"about_ca_topic_score_codex":0.012898168,"about_ca_topic_score_gemma":0.0043862155,"teacher_disagreement_score":0.008511952,"about_ca_system_score_codex":0.0013587085,"about_ca_system_score_gemma":0.00046141658,"threshold_uncertainty_score":0.99367505},"labels":[],"label_agreement":null},{"id":"W2803470609","doi":"10.5489/cuaj.5013","title":"Contemporary surgical outcomes of venous tumour thrombectomy managed with intraoperative Doppler ultrasound for kidney cancer","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Prevention and Research Institute of Texas","keywords":"Medicine; Nephrectomy; Surgery; Thrombus; Body mass index; Hazard ratio; Creatinine; Proportional hazards model; Hematocrit; Internal medicine; Kidney","score_opus":0.023769861748636965,"score_gpt":0.26525717565072837,"score_spread":0.2414873139020914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803470609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98015183,0.000219335,0.000054992357,0.014062428,0.00020839249,0.00057542196,0.00017047976,0.000017591736,0.0045395494],"genre_scores_gemma":[0.99545497,0.00002834768,0.00042963852,0.0027477322,0.00049062615,0.000028808297,0.00004580921,0.000019710638,0.00075436506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984638,0.00014692632,0.00037976698,0.00022295407,0.0003546764,0.00043188065],"domain_scores_gemma":[0.9977114,0.00032705735,0.00032213997,0.00010609306,0.00067578384,0.0008575069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044392346,0.00019110942,0.0005649096,0.00013801108,0.00023795386,0.000044908702,0.00010045579,0.0001742669,0.0007283185],"category_scores_gemma":[0.0004797969,0.00011983552,0.00016329165,0.00016920453,0.00012593974,0.00008674797,0.000007550893,0.00033749067,0.000013258826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055361586,0.00014045298,0.9706073,0.000013652299,0.000914166,0.00034677118,0.0003868584,0.000009110056,0.00043057933,0.00013219316,0.026261697,0.00020364346],"study_design_scores_gemma":[0.004788051,0.003409505,0.95949006,0.000037150523,0.00027004268,0.0006421468,0.00014619705,0.00003159333,0.0011121558,0.00016052971,0.029728727,0.00018386007],"about_ca_topic_score_codex":0.002958651,"about_ca_topic_score_gemma":0.0013914541,"teacher_disagreement_score":0.015303153,"about_ca_system_score_codex":0.0014595938,"about_ca_system_score_gemma":0.0018569852,"threshold_uncertainty_score":0.79745775},"labels":[],"label_agreement":null},{"id":"W2803584113","doi":"10.1007/s10456-018-9623-8","title":"Preclinical impact of high dose intermittent antiangiogenic tyrosine kinase inhibitor pazopanib in intrinsically resistant tumor models","year":2018,"lang":"en","type":"article","venue":"Angiogenesis","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"University of Toronto; Worldwide Cancer Research","keywords":"Pazopanib; Medicine; Tyrosine-kinase inhibitor; Context (archaeology); Angiogenesis; Pharmacology; Oncology; Cancer research; Sunitinib; Tyrosine kinase; Internal medicine; Cancer; Renal cell carcinoma; Receptor; Biology","score_opus":0.03652006156195732,"score_gpt":0.3080435976180789,"score_spread":0.2715235360561216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803584113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666256,0.0017137283,0.0000702053,0.00026533255,0.00015901362,0.0007434812,0.00007356372,0.000057829147,0.0002542592],"genre_scores_gemma":[0.99772507,0.00008364708,0.001327505,0.00014034292,0.0004340978,0.0000488083,0.00005372887,0.00006948534,0.000117285716],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972403,0.00013927728,0.00097365846,0.00063870265,0.00046352463,0.0005445604],"domain_scores_gemma":[0.9980774,0.00014303025,0.00023785932,0.00085781177,0.0003360499,0.00034786086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035398337,0.0003844735,0.0008751974,0.0004530305,0.00004568343,0.000018362109,0.00020881953,0.00015421552,0.00019283219],"category_scores_gemma":[0.00015081542,0.00029137632,0.0009302799,0.00069111254,0.00027253115,0.00012253267,0.00017660092,0.00012097855,0.00007735283],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022727916,0.005700588,0.27413785,0.00036387503,0.0018843481,0.0036025313,0.0008412415,0.00014736588,0.6605594,0.0005201042,0.0030929937,0.026421783],"study_design_scores_gemma":[0.004049555,0.0052805445,0.8339283,0.00038218236,0.00048241083,0.00012446717,0.000032233085,0.00045246753,0.1546343,0.00029232213,0.000038688973,0.00030254736],"about_ca_topic_score_codex":0.001926819,"about_ca_topic_score_gemma":0.00022861664,"teacher_disagreement_score":0.55979043,"about_ca_system_score_codex":0.0004201579,"about_ca_system_score_gemma":0.00033684692,"threshold_uncertainty_score":0.99995387},"labels":[],"label_agreement":null},{"id":"W2804558195","doi":"10.1016/j.canep.2018.04.006","title":"Effect of African-American race on cancer specific mortality differs according to clear cell vs. non-clear cell histologic subtype in metastatic renal cell carcinoma","year":2018,"lang":"en","type":"article","venue":"Cancer Epidemiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Race (biology); Cancer; Cell; Oncology; Clear cell renal cell carcinoma; Cancer research; Internal medicine; Pathology; Genetics; Biology","score_opus":0.061025611719092994,"score_gpt":0.36259536826161726,"score_spread":0.30156975654252427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804558195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98979974,0.0035806915,0.00011046484,0.0010972416,0.000733033,0.0014121289,0.00005175287,0.000043223037,0.003171701],"genre_scores_gemma":[0.995822,0.0005099846,0.00088177645,0.0013435144,0.00037079377,0.00035759195,0.000023575982,0.00008961374,0.0006011334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994574,0.0016067321,0.0011171298,0.0012563862,0.0003043239,0.0011413929],"domain_scores_gemma":[0.99546295,0.0020656486,0.00080058054,0.0010191281,0.00014849834,0.0005031648],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016700297,0.00063187856,0.0026238863,0.00042838516,0.000092327864,0.0000055360283,0.00037715337,0.000183241,0.0004240806],"category_scores_gemma":[0.00031741612,0.0004889292,0.0003595614,0.000715129,0.0007358846,0.000049098842,0.00014579977,0.0006088572,0.00019753155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009266069,0.00032909733,0.9404506,0.0006742086,0.000098806864,0.00024077206,0.0006332022,0.0006998821,0.038931068,0.000011658102,0.0056919535,0.0029726638],"study_design_scores_gemma":[0.0039321724,0.021903768,0.73964584,0.00018064941,0.00057549885,0.000010180113,0.00033077554,0.00048756562,0.22956303,0.000025914811,0.0027874557,0.00055716804],"about_ca_topic_score_codex":0.01159087,"about_ca_topic_score_gemma":0.00043588842,"teacher_disagreement_score":0.20080478,"about_ca_system_score_codex":0.0018556784,"about_ca_system_score_gemma":0.00028336293,"threshold_uncertainty_score":0.9997562},"labels":[],"label_agreement":null},{"id":"W2804649716","doi":"10.1200/edbk_201215","title":"Personalized Management of Advanced Kidney Cancer","year":2018,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Kidney cancer; Medicine; Renal cell carcinoma; Context (archaeology); Cancer; Oncology; Translational research; Targeted therapy; Clear cell renal cell carcinoma; PI3K/AKT/mTOR pathway; Intensive care medicine; Internal medicine; Bioinformatics; Pathology; Biology; Signal transduction","score_opus":0.15324590002521474,"score_gpt":0.526550103224348,"score_spread":0.37330420319913327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804649716","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020487623,0.97648305,0.000008346744,0.0064301416,0.0005863135,0.0013801622,0.00010091505,0.000015517155,0.014790698],"genre_scores_gemma":[0.000013477972,0.92051685,0.029893719,0.004034713,0.00076438277,0.00053494214,0.00029217385,0.00005113871,0.04389863],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958167,0.00032884264,0.0023437187,0.0006896172,0.00052147446,0.00029963432],"domain_scores_gemma":[0.9932971,0.0020017803,0.003155316,0.0005835826,0.00049576216,0.0004664597],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00070396735,0.00040781073,0.0046887835,0.000060560695,0.000045063516,0.0000021863316,0.0003024601,0.00035209645,0.0023293258],"category_scores_gemma":[0.00019052361,0.00031599618,0.0032537137,0.00034674729,0.0034303966,0.000036814345,0.0001224206,0.0004969021,0.00007551583],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016536588,0.0015078088,0.00032844112,0.010711746,0.0041341987,0.0000040780205,0.00012917028,1.4041268e-7,5.395468e-7,0.00030206083,0.1266279,0.8560885],"study_design_scores_gemma":[0.0014210255,0.0017828933,0.0018393568,0.007193137,0.0055433866,0.000018889428,0.0002875396,0.0000010937345,0.0000018417239,0.000037846068,0.9816621,0.00021091868],"about_ca_topic_score_codex":0.00006987966,"about_ca_topic_score_gemma":8.357122e-7,"teacher_disagreement_score":0.85587764,"about_ca_system_score_codex":0.00077524607,"about_ca_system_score_gemma":0.009876778,"threshold_uncertainty_score":0.9999292},"labels":[],"label_agreement":null},{"id":"W2805011737","doi":"10.1016/j.clgc.2018.03.003","title":"Predictors of Cancer-specific Survival After Disease Recurrence in Patients With Renal Cell Carcinoma: The Effect of Time to Recurrence","year":2018,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Nephrectomy; Interquartile range; Renal cell carcinoma; Proportional hazards model; Disease; Retrospective cohort study; Regimen; Internal medicine; Cancer; Localized disease; Surgery; Urology; Oncology; Kidney; Prostate cancer","score_opus":0.019548714726438352,"score_gpt":0.3043169565525032,"score_spread":0.2847682418260648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805011737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99409175,0.002847804,0.0000029510861,0.00018242966,0.0007253125,0.0015092635,0.00022664884,0.000013072193,0.0004007829],"genre_scores_gemma":[0.9981374,0.00018364473,0.00005471577,0.000056674515,0.00074327656,0.00034440096,0.000022431072,0.000035727866,0.00042171087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970375,0.00042616043,0.0008439958,0.0006390091,0.00065629976,0.00039704278],"domain_scores_gemma":[0.9976036,0.000504851,0.0003087533,0.0008045184,0.00034519317,0.000433106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004908815,0.00032333343,0.00075697515,0.00011261521,0.00004253334,0.000006711034,0.00029926363,0.000102931794,0.0005587773],"category_scores_gemma":[0.00011279103,0.00019005133,0.00021752571,0.00051661633,0.00059616263,0.00006160238,0.00016232306,0.00035103087,0.000058564485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0246371,0.00056690397,0.96510386,0.00018570968,0.00006558818,0.00006599963,0.00011224465,0.000023107546,0.00008981046,1.3137092e-7,0.0014098859,0.0077396496],"study_design_scores_gemma":[0.004131201,0.011768862,0.9780891,0.00055866514,0.00029837393,5.724159e-7,0.0000053856484,0.000015054565,0.0037043132,0.0000014313292,0.0012416493,0.00018536873],"about_ca_topic_score_codex":0.00014338868,"about_ca_topic_score_gemma":0.00004722821,"teacher_disagreement_score":0.020505898,"about_ca_system_score_codex":0.0002067626,"about_ca_system_score_gemma":0.00036836517,"threshold_uncertainty_score":0.77500683},"labels":[],"label_agreement":null},{"id":"W2805244703","doi":"10.1016/j.euo.2018.05.001","title":"Role of Active Surveillance for Localized Small Renal Masses","year":2018,"lang":"en","type":"review","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Interquartile range; Kidney cancer; MEDLINE; Cancer; Surgery; Internal medicine","score_opus":0.07044376850108269,"score_gpt":0.3449440507820464,"score_spread":0.2745002822809637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805244703","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038490244,0.9457628,0.00014703756,0.0001010239,0.0003757639,0.002070291,0.0001442681,0.00007303698,0.05094088],"genre_scores_gemma":[0.0003597672,0.9927661,0.0032148976,0.0002725363,0.0009881882,0.00019041168,0.000612829,0.00020388105,0.0013914043],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951686,0.0021793519,0.0010703529,0.0008732755,0.00013330822,0.0005750801],"domain_scores_gemma":[0.99625945,0.0013881571,0.0010832016,0.0007742306,0.0002924373,0.00020253648],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00089992717,0.00058764074,0.0035828797,0.00031492842,0.000060752885,0.0000046532,0.00039055315,0.00053388363,0.00016935906],"category_scores_gemma":[0.0004589252,0.00044741508,0.0008767677,0.00020158745,0.0006238113,0.00001585098,0.00021831667,0.00050382083,0.0003557517],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016331902,0.00047060396,0.00006720685,0.0039330325,0.0015139848,0.0005604905,0.000104417675,5.172501e-7,0.0000537493,0.000105009036,0.0028111169,0.9887467],"study_design_scores_gemma":[0.0022762315,0.009019594,0.00029926884,0.0004562179,0.0023963416,0.0011986356,0.000012666367,0.0000040570962,0.000040599443,0.00004631921,0.9839846,0.0002655056],"about_ca_topic_score_codex":0.000012035695,"about_ca_topic_score_gemma":0.000039102815,"teacher_disagreement_score":0.98848116,"about_ca_system_score_codex":0.00031616742,"about_ca_system_score_gemma":0.0008555841,"threshold_uncertainty_score":0.99979776},"labels":[],"label_agreement":null},{"id":"W2805463503","doi":"10.1186/s12894-018-0317-8","title":"Metastatic renal cell carcinoma initially presenting with hematochezia and subsequently with vaginal bleeding: a case report","year":2018,"lang":"en","type":"article","venue":"BMC Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"Medicine; Hematochezia; Renal cell carcinoma; Nephrectomy; Polypectomy; Vaginal bleeding; Radiology; Clear cell carcinoma; Metastasis; Biopsy; Colonoscopy; Renal vein; Clear cell renal cell carcinoma; Metastatic carcinoma; Carcinoma; Kidney; Cancer; Pathology; Colorectal cancer; Internal medicine","score_opus":0.04145312460444259,"score_gpt":0.27831257805098564,"score_spread":0.23685945344654305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805463503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860749,0.00027595327,0.0012827445,0.00018418329,0.000039428753,0.000657627,0.0000033567592,0.000059736503,0.011422038],"genre_scores_gemma":[0.98380756,6.5265044e-7,0.014885229,0.00017097467,0.00020143412,0.00007385933,0.000020193478,0.00005241367,0.0007876939],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99809325,0.00010827775,0.00036301446,0.00063234003,0.0003001714,0.000502922],"domain_scores_gemma":[0.99867064,0.00012586486,0.0002489979,0.00040316422,0.00026254394,0.0002888034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002929504,0.00030261,0.00047582813,0.00017131717,0.00013734851,0.000031474698,0.00006578288,0.000078175,0.00010025473],"category_scores_gemma":[0.000048662678,0.00020637189,0.000048031485,0.00019269183,0.000491974,0.00009180923,0.000071365415,0.00022233438,0.000017092589],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023478703,0.00022346598,0.4139926,0.00029661815,0.00012842036,0.57705367,0.0008795149,0.0000061445426,0.004807269,0.00011307459,0.00012482845,0.000026506566],"study_design_scores_gemma":[0.00489514,0.007752024,0.09210502,0.000013650519,0.0016649277,0.87209904,0.00027269172,0.00038300166,0.020227196,0.0000671856,0.00024614923,0.00027395063],"about_ca_topic_score_codex":0.0002769734,"about_ca_topic_score_gemma":0.00030104208,"teacher_disagreement_score":0.3218876,"about_ca_system_score_codex":0.00005274826,"about_ca_system_score_gemma":0.00034779968,"threshold_uncertainty_score":0.8415601},"labels":[],"label_agreement":null},{"id":"W2805746404","doi":"10.1186/s13014-018-0992-3","title":"A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma","year":2018,"lang":"en","type":"article","venue":"Radiation Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Cancer Care Ontario","funders":"Schulich School of Medicine and Dentistry","keywords":"Medicine; SABR volatility model; Renal cell carcinoma; Urology; Renal function; Nephrectomy; Radiation therapy; Surgery; Internal medicine; Oncology; Kidney","score_opus":0.024807618473196364,"score_gpt":0.3508695075288136,"score_spread":0.3260618890556172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805746404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870604,0.000038744998,0.0027652672,0.00018298558,0.0002941306,0.007991761,0.000080108395,0.000028376295,0.0015581814],"genre_scores_gemma":[0.9864885,0.000003955911,0.011425897,0.0002124919,0.00049760053,0.00086872355,0.00021271866,0.000052217816,0.00023784477],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978568,0.00033946955,0.0005113495,0.0005789572,0.00038258854,0.00033081512],"domain_scores_gemma":[0.997575,0.00030952375,0.0005416273,0.00031316435,0.0009978605,0.0002628657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027431152,0.00029474637,0.0007046069,0.00036019116,0.00012303794,0.000018899904,0.00009604083,0.00010219264,0.00013710004],"category_scores_gemma":[0.00013876637,0.00023212311,0.0001023973,0.0004004844,0.00016495622,0.00034863673,0.000014604764,0.00013847803,0.000015242497],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83895653,0.016865449,0.036112662,0.000109122586,0.0019996313,0.000050756793,0.04510044,0.00029240994,0.023076976,0.00073570706,0.00036605648,0.03633424],"study_design_scores_gemma":[0.3947627,0.30501568,0.13682026,0.00003908753,0.0009547704,0.000028758699,0.0007163599,0.0024170782,0.15652092,0.0004413443,0.0018647247,0.00041831864],"about_ca_topic_score_codex":0.000252572,"about_ca_topic_score_gemma":0.00004240887,"teacher_disagreement_score":0.44419387,"about_ca_system_score_codex":0.001840395,"about_ca_system_score_gemma":0.0007400757,"threshold_uncertainty_score":0.94657063},"labels":[],"label_agreement":null},{"id":"W2806690245","doi":"10.14740/gr981w","title":"Renal Cell Carcinoma Presenting as an Ampullary Mass: A Case Report and Review of Literature","year":2018,"lang":"en","type":"article","venue":"Gastroenterology Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Renal mass; Renal cell carcinoma; Urology; General surgery; Pathology; Internal medicine; Kidney; Nephrectomy","score_opus":0.04600490518587938,"score_gpt":0.3608880560005003,"score_spread":0.3148831508146209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806690245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854865,0.00954224,0.0000135140235,0.0009387659,0.000056532976,0.00082639477,0.000012144259,0.00002055755,0.0031033717],"genre_scores_gemma":[0.99520373,0.001019541,0.0016980596,0.00039389054,0.0003208088,0.000058092406,0.000091791,0.000031629417,0.0011824366],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99675876,0.00075078645,0.0005371737,0.00065335067,0.0005905084,0.00070940016],"domain_scores_gemma":[0.99744844,0.0000869463,0.00015877698,0.00090564915,0.0009928478,0.00040732155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018547821,0.00020569972,0.000526892,0.00033159065,0.00014837584,0.000025504101,0.00014577538,0.0001394685,0.00017161501],"category_scores_gemma":[0.00029726134,0.00016409044,0.00010870044,0.0003160201,0.00064282445,0.000108815104,0.00023944947,0.000629582,0.000019853955],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014272251,0.00035422095,0.5619114,0.005095269,0.000091653455,0.40238708,0.0006082636,4.958446e-8,0.023811068,0.000011610781,0.0039468585,0.00035528152],"study_design_scores_gemma":[0.0028873172,0.013304388,0.15096246,0.0034306725,0.00025612293,0.8020624,0.00028901204,0.000070291695,0.025626974,0.00014328574,0.0008200635,0.00014699783],"about_ca_topic_score_codex":0.0001535182,"about_ca_topic_score_gemma":0.000033492783,"teacher_disagreement_score":0.41094896,"about_ca_system_score_codex":0.00007706585,"about_ca_system_score_gemma":0.00015643223,"threshold_uncertainty_score":0.66914135},"labels":[],"label_agreement":null},{"id":"W2807175041","doi":"10.5489/cuaj.5462","title":"Canadian Urological Association guideline for followup of patients after treatment of non-metastatic renal cell carcinoma","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Toronto; Western University; Université de Sherbrooke; Queen's University; McMaster University; Dalhousie University; University of Manitoba; Université Laval; Université de Montréal; University of Alberta; University of Ottawa; McGill University Health Centre","funders":"","keywords":"Guideline; Medicine; Renal cell carcinoma; Association (psychology); Carcinoma; Internal medicine; Oncology; General surgery; Urology; Pathology; Psychology","score_opus":0.014666759312141292,"score_gpt":0.2405835720058503,"score_spread":0.225916812693709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807175041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99125445,0.00018238607,0.00011633484,0.0052795555,0.00036785714,0.00086562964,0.00059482246,0.000008417621,0.0013305534],"genre_scores_gemma":[0.99471825,0.000019638288,0.0020136032,0.0015357395,0.0004935349,0.000061380844,0.0002463193,0.000026729776,0.00088480284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99679005,0.0002182133,0.0011386835,0.00033985675,0.0006255257,0.0008876743],"domain_scores_gemma":[0.9953403,0.0002912682,0.0010086304,0.00021525001,0.001832708,0.0013118742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080365886,0.00030171123,0.00076410524,0.00046023008,0.0002036823,0.0000322031,0.00013251092,0.00039316295,0.0008172586],"category_scores_gemma":[0.0008537386,0.00022997842,0.0005025605,0.00029234713,0.000054437893,0.00007990185,0.000012074875,0.00022649324,0.00003534487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045131467,0.0003386728,0.98665744,0.000012536097,0.00024965964,0.000064254134,0.0002122195,0.000012933123,0.00024459106,0.0000063094403,0.010358625,0.0013914597],"study_design_scores_gemma":[0.0048527606,0.009078534,0.95308393,0.000010161498,0.00064200716,0.000014867851,0.00003851756,0.00027524083,0.0013459359,0.00017417697,0.030296855,0.00018699693],"about_ca_topic_score_codex":0.037447028,"about_ca_topic_score_gemma":0.03822755,"teacher_disagreement_score":0.03357348,"about_ca_system_score_codex":0.008019608,"about_ca_system_score_gemma":0.0018730598,"threshold_uncertainty_score":0.99578846},"labels":[],"label_agreement":null},{"id":"W2807230276","doi":"10.1097/pas.0000000000001087","title":"Challenges in Pathologic Staging of Renal Cell Carcinoma","year":2018,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Calgary Laboratory Services; Trillium Health Centre","funders":"","keywords":"Renal sinus; Adipose capsule of kidney; Medicine; Kidney; Renal cell carcinoma; Renal vein; Kidney cancer; Pathology; Gross examination; Clear cell; Sinus (botany); Lumen (anatomy); Radiology; Clear cell carcinoma; Stage (stratigraphy); Carcinoma; Nephrectomy; Surgery; Internal medicine; Biology","score_opus":0.053609189525890354,"score_gpt":0.29362858329537816,"score_spread":0.2400193937694878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807230276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98770195,0.0031174985,0.000026904547,0.0026019325,0.0000910064,0.00010825204,0.0000017817063,0.0000058786113,0.0063448157],"genre_scores_gemma":[0.99762636,0.0012318387,0.0006896715,0.00012894992,0.00026363344,0.0000025530146,6.4222706e-7,0.000016249003,0.000040075844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979541,0.00056609116,0.00066244527,0.00019856152,0.00029581995,0.000323002],"domain_scores_gemma":[0.99819964,0.0003413096,0.00075983483,0.00034638052,0.00022221192,0.0001305943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011709767,0.00016704248,0.000864228,0.000251481,0.00003127143,0.0000030818196,0.00022375713,0.000049905088,0.000056241985],"category_scores_gemma":[0.00005027515,0.00009338423,0.00021173042,0.0002900084,0.0012614818,0.00003590368,0.0000750558,0.00040893132,0.00001283537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01574255,0.0025433833,0.377651,0.00017767985,0.00019238892,0.13462062,0.011125885,0.00007682591,0.17571102,0.00075706653,0.00024072686,0.28116083],"study_design_scores_gemma":[0.0045870473,0.023204131,0.8984602,0.00012417343,0.00021345477,0.034950964,0.0033872102,0.00002578867,0.033154137,0.00067478605,0.0010139762,0.00020409985],"about_ca_topic_score_codex":0.000016098249,"about_ca_topic_score_gemma":0.0000032504154,"teacher_disagreement_score":0.52080923,"about_ca_system_score_codex":0.000079073274,"about_ca_system_score_gemma":0.00010100513,"threshold_uncertainty_score":0.4647982},"labels":[],"label_agreement":null},{"id":"W2808072359","doi":"10.1007/s00261-018-1663-4","title":"Society of Abdominal Radiology disease-focused panel on renal cell carcinoma: update on past, current, and future goals","year":2018,"lang":"en","type":"article","venue":"Abdominal Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute; National Institute of Biomedical Imaging and Bioengineering; Society of Gastrointestinal Radiologists","keywords":"Renal cell carcinoma; Medicine; Disease; Scope (computer science); Intensive care medicine; Premise; Internal medicine; Oncology; Radiology; Medical physics","score_opus":0.025909253777186593,"score_gpt":0.26582045102044966,"score_spread":0.23991119724326307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808072359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890072,0.004750928,0.0000986207,0.002678717,0.0007468506,0.00072968885,0.0000836148,0.000044241307,0.0018601861],"genre_scores_gemma":[0.99219954,0.0009022495,0.0012577232,0.0011159162,0.004017538,0.000064485204,0.00012652976,0.00006193058,0.00025407752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967808,0.00039649228,0.0006832831,0.0010044794,0.00033699744,0.00079790544],"domain_scores_gemma":[0.9976463,0.0003859405,0.0003784934,0.000819264,0.00018453434,0.0005854934],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040084287,0.00059577235,0.0012141807,0.0002163002,0.00017766327,0.000010141994,0.00024968263,0.00033921766,0.00027252643],"category_scores_gemma":[0.000039922743,0.00045426053,0.00045543234,0.00021089113,0.0011827871,0.000055063225,0.00009849745,0.0005797612,0.00015065057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09904885,0.0049044145,0.3146505,0.0020103166,0.0015819382,0.0029995854,0.00347705,0.000024833877,0.15272236,0.005076942,0.22623329,0.18726991],"study_design_scores_gemma":[0.017912518,0.018671107,0.870086,0.0001913223,0.0014902288,0.002032858,0.00032526642,0.0005155917,0.04214192,0.00059213006,0.04517083,0.0008701964],"about_ca_topic_score_codex":0.000022512504,"about_ca_topic_score_gemma":0.0000021792137,"teacher_disagreement_score":0.55543554,"about_ca_system_score_codex":0.00022786316,"about_ca_system_score_gemma":0.00022870481,"threshold_uncertainty_score":0.9997909},"labels":[],"label_agreement":null},{"id":"W2808615542","doi":"10.1002/cncr.31578","title":"The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing","year":2018,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Institutes of Health; Children’s Oncology Group; National Cancer Institute; St. Baldrick's Foundation","keywords":"Medicine; Renal cell carcinoma; Chromophobe cell; Oncology; Internal medicine; Clear cell; Tuberous sclerosis; TFE3; Pathology; Prospective cohort study","score_opus":0.05366787210071824,"score_gpt":0.29986499751426005,"score_spread":0.2461971254135418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808615542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97224414,0.00047198383,0.000016989485,0.00065270433,0.00009631934,0.022859039,0.000009378591,0.000020597332,0.0036288677],"genre_scores_gemma":[0.9554583,0.00003231317,0.0003620933,0.00014785133,0.0008606673,0.04281972,0.0000030480508,0.000027928056,0.00028807833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866843,0.00012858176,0.000341736,0.00034963712,0.00025391957,0.00025769856],"domain_scores_gemma":[0.9985424,0.00021149761,0.0003224357,0.00054879766,0.00028466422,0.00009014855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017111086,0.00018451313,0.00021403855,0.000057168738,0.00019246523,0.000022267863,0.0001275462,0.00009291809,0.000035727087],"category_scores_gemma":[0.00011784245,0.000097157535,0.00006048631,0.00021274366,0.0002874912,0.000024767156,0.000046749425,0.00018078349,0.000010195356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018885002,0.00019217822,0.95745736,0.00015655145,0.000083645136,0.00002545051,0.0007282693,0.0000012824136,0.011740004,0.00006377011,0.0017486579,0.025914302],"study_design_scores_gemma":[0.0019119133,0.0020477613,0.98892117,0.00006992904,0.00026298923,0.000028435037,0.000044976478,0.0001522813,0.005762194,0.000032893924,0.00066248386,0.00010298558],"about_ca_topic_score_codex":0.0002872205,"about_ca_topic_score_gemma":0.00032941726,"teacher_disagreement_score":0.03146377,"about_ca_system_score_codex":0.0002158057,"about_ca_system_score_gemma":0.00017227436,"threshold_uncertainty_score":0.39619693},"labels":[],"label_agreement":null},{"id":"W2809229376","doi":"10.1089/end.2018.0144","title":"Surgical Approach Does Not Impact Margin Status After Partial Nephrectomy for Large Renal Masses","year":2018,"lang":"en","type":"article","venue":"Journal of Endourology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Center for Advancing Translational Sciences; Weill Cornell Medical College","keywords":"Medicine; Nephrectomy; Propensity score matching; Hazard ratio; Surgical margin; Renal cell carcinoma; Confidence interval; Kidney cancer; Surgery; Stage (stratigraphy); Proportional hazards model; Retrospective cohort study; Urology; Cancer; Internal medicine; Kidney","score_opus":0.02394484126834942,"score_gpt":0.31555466441094865,"score_spread":0.2916098231425992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809229376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99515265,0.0005994433,0.0013158467,0.0009301154,0.00045364085,0.00043570568,0.00006131022,0.000015280446,0.0010359995],"genre_scores_gemma":[0.98946154,0.00005251979,0.006749545,0.00038210867,0.0029186804,0.000051716794,0.000015469037,0.000034760596,0.00033363944],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979329,0.00016639435,0.000600579,0.00024277752,0.00033358444,0.0007237659],"domain_scores_gemma":[0.99839014,0.00028058083,0.00035212366,0.00023372048,0.00032662103,0.00041682328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005796179,0.00024100865,0.0007045161,0.0002406007,0.00006092735,0.000024181174,0.0000993497,0.00017472188,0.0008862281],"category_scores_gemma":[0.00014161885,0.00013211422,0.0005224111,0.00010135423,0.00012588147,0.00010684159,0.000046462166,0.00035208408,0.000018948114],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16099425,0.0031862326,0.77581054,0.00019784227,0.00295366,0.00981338,0.000850959,0.000024489362,0.02620576,0.00074837194,0.0140938,0.005120723],"study_design_scores_gemma":[0.035801094,0.02657443,0.1898854,0.000057629328,0.0015073168,0.017535899,0.000120163844,0.0005971097,0.0571896,0.00051822094,0.66976744,0.00044571422],"about_ca_topic_score_codex":0.00001640204,"about_ca_topic_score_gemma":0.000014673729,"teacher_disagreement_score":0.6556736,"about_ca_system_score_codex":0.0001483186,"about_ca_system_score_gemma":0.00025502057,"threshold_uncertainty_score":0.97035766},"labels":[],"label_agreement":null},{"id":"W2809585483","doi":"10.1016/j.mpdhp.2018.05.003","title":"Tumour-to-tumour metastasis: a rare cause of apparent intratumoural heterogeneity in conventional clear cell renal cell carcinoma","year":2018,"lang":"en","type":"article","venue":"Diagnostic histopathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Renal cell carcinoma; Metastasis; Pathology; Vascularity; Clear cell; Cell; Medicine; Tumour heterogeneity; Carcinoma; Clear cell renal cell carcinoma; Cancer research; Cancer; Biology; Internal medicine","score_opus":0.025707539467852557,"score_gpt":0.2688056756047568,"score_spread":0.24309813613690426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809585483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480474,0.0012868927,0.0002290248,0.0003433958,0.00047758676,0.0009751787,0.0001257051,0.000043878947,0.0017136082],"genre_scores_gemma":[0.9972212,0.000025706058,0.0015181021,0.00039943523,0.00023531585,0.00018467937,0.00014588235,0.000059956776,0.00020973108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967624,0.00038342705,0.000906826,0.0008024529,0.000449894,0.0006950272],"domain_scores_gemma":[0.9979637,0.00040201598,0.0002956748,0.0005895906,0.00031011776,0.00043886036],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004178285,0.00042798708,0.000933509,0.0005323482,0.0000891943,0.000011118268,0.00025696692,0.00018319931,0.00039222924],"category_scores_gemma":[0.0004990821,0.00040372837,0.0002728774,0.00040722324,0.00041161777,0.00006412989,0.00017300715,0.00036628396,0.00040652725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021835861,0.0037023786,0.54341835,0.0005741231,0.000052493855,0.018093992,0.002827719,0.00004360246,0.4221213,0.0003661802,0.0062338603,0.00038241726],"study_design_scores_gemma":[0.0034207092,0.0039933864,0.63469505,0.00011324809,0.00037886156,0.0010094491,0.00021198201,0.00004391322,0.35535777,0.0000619649,0.0004120877,0.00030158358],"about_ca_topic_score_codex":0.00024036203,"about_ca_topic_score_gemma":0.00028059218,"teacher_disagreement_score":0.09127668,"about_ca_system_score_codex":0.00043668645,"about_ca_system_score_gemma":0.00033029818,"threshold_uncertainty_score":0.99984145},"labels":[],"label_agreement":null},{"id":"W2809772201","doi":"10.1016/j.mpdhp.2018.05.001","title":"Subtypes of renal cell carcinoma with defined genomic alterations: diagnostic and prognostic significance","year":2018,"lang":"en","type":"article","venue":"Diagnostic histopathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Renal cell carcinoma; Tuberous sclerosis; Clear cell; Pathology; Medicine; Carcinoma; Cancer; Kidney cancer; Internal medicine","score_opus":0.012387028609762941,"score_gpt":0.22428207979480835,"score_spread":0.21189505118504542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809772201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911995,0.003913581,0.0009849288,0.00028723056,0.00014949296,0.0010976937,0.00003160674,0.0000485201,0.0022874665],"genre_scores_gemma":[0.99470866,0.000115577044,0.0040863366,0.00021807411,0.0001846488,0.0002672792,0.00006744739,0.000048932317,0.0003030193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982032,0.00013963536,0.00045476475,0.0005886348,0.00021347443,0.00040026286],"domain_scores_gemma":[0.99588233,0.0028982458,0.00022068959,0.0005032344,0.00028340847,0.00021209911],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017169635,0.00030351168,0.0005713853,0.0002113097,0.0001291257,0.000011769478,0.000108891225,0.00012222563,0.00013080258],"category_scores_gemma":[0.0019013932,0.00024670654,0.00006360305,0.00021177436,0.00089114264,0.00005430242,0.0000562293,0.00016744649,0.000093698545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039878502,0.000523264,0.9276155,0.00026538273,0.00002481172,0.0021970475,0.0012892203,0.000014128201,0.065667704,0.00039355017,0.00065304537,0.0009575653],"study_design_scores_gemma":[0.0021707125,0.006342449,0.94808835,0.00014013295,0.0006200274,0.0012164302,0.000073061645,0.00004668804,0.040376723,0.00014171582,0.0005260486,0.00025769192],"about_ca_topic_score_codex":0.00012018018,"about_ca_topic_score_gemma":0.00009935021,"teacher_disagreement_score":0.025290981,"about_ca_system_score_codex":0.00012417632,"about_ca_system_score_gemma":0.00029715113,"threshold_uncertainty_score":0.9999985},"labels":[],"label_agreement":null},{"id":"W2810134512","doi":"10.1200/jco.2017.35.15_suppl.tps4594","title":"Avelumab plus axitinib vs sunitinib as first-line treatment of advanced renal cell carcinoma: Phase 3 study (JAVELIN Renal 101).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Axitinib; Medicine; Sunitinib; Avelumab; Internal medicine; Renal cell carcinoma; Tyrosine-kinase inhibitor; Oncology; Gastroenterology; Cancer; Nivolumab; Immunotherapy","score_opus":0.16769427094462616,"score_gpt":0.4735742379567842,"score_spread":0.305879967012158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810134512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824181,0.00080569607,0.000045929515,0.0033232176,0.0012668063,0.0012860248,0.000038156173,0.00001662007,0.01079942],"genre_scores_gemma":[0.9915722,0.0007820739,0.0025735688,0.0002630867,0.0022446604,0.000035200654,0.00002578743,0.00006406425,0.002439357],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99206245,0.0007204677,0.005008114,0.0006000252,0.0010026296,0.0006062855],"domain_scores_gemma":[0.98738056,0.0024320735,0.006597981,0.0012902812,0.0012242896,0.0010748147],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002581376,0.000543045,0.0042093084,0.00029994608,0.00029718364,0.000034250887,0.0006061424,0.0005329657,0.0005880217],"category_scores_gemma":[0.0030407242,0.00037652577,0.0014707025,0.00011755393,0.00058275263,0.00021977967,0.0001673696,0.0010006926,0.000084489984],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20475025,0.1355453,0.12361189,0.00024306058,0.003327383,0.05805574,0.0029237813,0.00034643937,0.0040140795,0.00005630934,0.0024867216,0.46463904],"study_design_scores_gemma":[0.2167003,0.4476574,0.26988682,0.00021408619,0.0036163619,0.001714349,0.0008921268,0.00015478687,0.015953917,0.0001420591,0.04266591,0.00040187023],"about_ca_topic_score_codex":0.00030559546,"about_ca_topic_score_gemma":0.00027690796,"teacher_disagreement_score":0.46423718,"about_ca_system_score_codex":0.00090229814,"about_ca_system_score_gemma":0.0041541816,"threshold_uncertainty_score":0.9998687},"labels":[],"label_agreement":null},{"id":"W2810152004","doi":"10.3747/co.25.3927","title":"Anastomosing Hemangioma of the Kidney: Radiologic and Pathologic Distinctions of a Kidney Cancer Mimic","year":2018,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Medicine; Nephrectomy; Hemangioma; Renal cell carcinoma; Kidney; Kidney cancer; Lymph node; Cancer; Pathology; Genitourinary system; Dissection (medical); Biopsy; Angiosarcoma; Radiology; Internal medicine","score_opus":0.09904771171121977,"score_gpt":0.3840237673854213,"score_spread":0.28497605567420153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810152004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920285,0.0028614537,0.000077575,0.002075204,0.00104856,0.00038530302,0.000050252358,0.0000178062,0.0014553822],"genre_scores_gemma":[0.99883974,0.00023368209,0.000286688,0.00029167067,0.00020166665,0.00004452478,0.00001383679,0.000008934363,0.00007923692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904394,0.00013358991,0.00028781645,0.00023257958,0.000109630586,0.00019245515],"domain_scores_gemma":[0.9990582,0.0000758668,0.00022969216,0.00027928382,0.00014600849,0.00021093973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013969613,0.00013068314,0.000402878,0.00007803918,0.00007571844,0.0000018894812,0.000089952424,0.000093713796,0.00012486437],"category_scores_gemma":[0.00046611176,0.00007735016,0.00011390038,0.0002138794,0.0008090136,0.000017783846,0.00010035929,0.0001320074,0.000003715436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036583183,0.0009836376,0.84600914,0.000470325,0.00016380454,0.00004415368,0.001148044,9.86508e-7,0.08799735,0.0003362613,0.017240258,0.0452402],"study_design_scores_gemma":[0.0046145343,0.0051830406,0.85922736,0.0007972844,0.0013164374,0.0010962355,0.00028152834,0.00031635942,0.058244746,0.00064577744,0.068023026,0.000253692],"about_ca_topic_score_codex":0.000043626307,"about_ca_topic_score_gemma":0.000014528228,"teacher_disagreement_score":0.05078277,"about_ca_system_score_codex":0.00018979104,"about_ca_system_score_gemma":0.00044310166,"threshold_uncertainty_score":0.3154248},"labels":[],"label_agreement":null},{"id":"W2883055139","doi":"10.1093/neuonc/noy099","title":"Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of Toronto; Sunnybrook Health Science Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston; National Institutes of Health; Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Renal cell carcinoma; Hazard ratio; Internal medicine; Retrospective cohort study; Oncology; Cohort; Proportional hazards model; Performance status; Nephrectomy; Overall survival; Kidney; Confidence interval","score_opus":0.026716118426693265,"score_gpt":0.30451959854374994,"score_spread":0.2778034801170567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883055139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939984,0.0000142159915,0.0013644281,0.0008362588,0.0004868708,0.002521151,0.00008699153,0.000037835296,0.00065383874],"genre_scores_gemma":[0.9727365,4.1987474e-7,0.025754038,0.000743599,0.00028415944,0.00021511964,0.00017824181,0.00005806951,0.000029898743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729764,0.00056691136,0.0005628825,0.0005678003,0.0005217091,0.0004830289],"domain_scores_gemma":[0.9974622,0.0007653705,0.0004803746,0.00066031824,0.00044905482,0.00018264478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047787314,0.00031231705,0.00063413003,0.00010554402,0.00018392997,0.00001860757,0.00025339014,0.00011413116,0.000055391374],"category_scores_gemma":[0.00033834128,0.00019168858,0.0001560732,0.0002459679,0.0003339604,0.00010109311,0.0001252129,0.00027263685,0.0000060295893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047686743,0.006123768,0.58794075,0.00048387476,0.0003587152,0.00031143337,0.0010582934,0.00022511909,0.37824658,0.0004139977,0.003625923,0.016442884],"study_design_scores_gemma":[0.022859808,0.06614085,0.6645687,0.000117743075,0.0019597576,0.00018609763,0.00016648561,0.0045866934,0.23235686,0.00022362114,0.0063218125,0.000511557],"about_ca_topic_score_codex":0.000043914715,"about_ca_topic_score_gemma":0.0000667411,"teacher_disagreement_score":0.14588971,"about_ca_system_score_codex":0.0002695634,"about_ca_system_score_gemma":0.0007578667,"threshold_uncertainty_score":0.7816833},"labels":[],"label_agreement":null},{"id":"W2883184460","doi":"10.1007/s00345-018-2373-9","title":"Renal tumor biopsy: indicators, technique, safety, accuracy results, and impact on treatment decision management","year":2018,"lang":"en","type":"review","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Nephrology; Kidney cancer; Modalities; Biopsy; Psychological intervention; Intensive care medicine; Watchful waiting; Kidney disease; Renal cell carcinoma; Prostate cancer; Surgery; Radiology; Cancer; Internal medicine","score_opus":0.03230854097456717,"score_gpt":0.35566138928876784,"score_spread":0.3233528483142007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883184460","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038961883,0.9928884,0.000076162905,0.00030380144,0.00030549045,0.0018124682,0.000081777274,0.000024851743,0.004117461],"genre_scores_gemma":[0.0015322674,0.9931541,0.0035672872,0.00012857618,0.00066216587,0.000059587517,0.00007516635,0.000088899505,0.00073195883],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958885,0.00038834402,0.0020253472,0.0006170412,0.00056784577,0.0005129738],"domain_scores_gemma":[0.9952331,0.0009794297,0.002346288,0.0008060738,0.00012026059,0.0005148588],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010270238,0.0008541361,0.0031465425,0.0032199326,0.00010480502,0.000033910375,0.0003248097,0.0002677682,0.0001589541],"category_scores_gemma":[0.00015292865,0.00044844078,0.0011575792,0.00076939247,0.00021247986,0.00006118866,0.00015978157,0.00076507346,0.000074098236],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005550165,0.00052733725,0.000054903074,0.00077833066,0.0020481432,0.007329437,0.00001903739,0.0000011012403,0.000001864733,0.00005337094,0.005888913,0.9777474],"study_design_scores_gemma":[0.003427222,0.011459494,0.0017135725,0.006831022,0.005610085,0.021405708,0.0000027305384,4.229253e-7,0.000013214877,0.00012255934,0.94914484,0.00026912274],"about_ca_topic_score_codex":0.0000090633575,"about_ca_topic_score_gemma":0.0000044389813,"teacher_disagreement_score":0.97747827,"about_ca_system_score_codex":0.0015105351,"about_ca_system_score_gemma":0.0004535403,"threshold_uncertainty_score":0.99979675},"labels":[],"label_agreement":null},{"id":"W2883344392","doi":"10.5489/cuaj.5196","title":"Classification tree for the prediction of malignant disease and the prediction of non-diagnostic biopsies in patients with small renal masses","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University; Princess Margaret Cancer Centre; University Health Network; Dalhousie University; University of Toronto; Saint John Regional Hospital; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Tree (set theory); Decision tree; Radiology; Renal mass; Disease; Computer science; Pathology; Artificial intelligence; Internal medicine; Kidney; Mathematics; Nephrectomy","score_opus":0.02026317685428557,"score_gpt":0.20682800221983458,"score_spread":0.186564825365549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883344392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929375,0.00012665048,0.0003030055,0.0054607713,0.00009882591,0.00080491044,0.00018443703,0.000004085862,0.00007982559],"genre_scores_gemma":[0.99927056,0.00008090132,0.00015704833,0.0001640944,0.00017514151,0.0000555653,0.00005481132,0.0000068512973,0.000035035904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895203,0.000119464064,0.0003550563,0.00012912067,0.00025924217,0.00018507878],"domain_scores_gemma":[0.99815387,0.0007148241,0.00038106757,0.00011183925,0.00045110213,0.00018727432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005046058,0.00009338021,0.0001931982,0.00011829221,0.00015331173,0.000020330937,0.000065512744,0.00008405974,0.000015877853],"category_scores_gemma":[0.0012868145,0.000045002544,0.00006436866,0.00015579333,0.00018993445,0.000052204505,0.000007313545,0.00014479207,5.693421e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011335062,0.00007078609,0.99674964,0.000011632519,0.00010906917,0.000002267829,0.00017115133,0.000022401086,0.000074571435,0.0000697005,0.00038579665,0.0011994981],"study_design_scores_gemma":[0.0039547156,0.0013267298,0.9918484,0.000052492505,0.0003723868,0.0000066289376,0.00009628959,0.0016132384,0.000057071666,0.00020228459,0.0004371052,0.00003267358],"about_ca_topic_score_codex":0.0004212383,"about_ca_topic_score_gemma":0.0008530679,"teacher_disagreement_score":0.0063330624,"about_ca_system_score_codex":0.0003488019,"about_ca_system_score_gemma":0.00024294859,"threshold_uncertainty_score":0.18351504},"labels":[],"label_agreement":null},{"id":"W2884540301","doi":"10.1016/j.euo.2018.06.007","title":"Systematic Review of the Management of Local Kidney Cancer Relapse","year":2018,"lang":"en","type":"review","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Kidney cancer; Renal cell carcinoma; Cancer; Radiation therapy; Meta-analysis; Surgery; Systematic review; Retrospective cohort study; CINAHL; MEDLINE; Kidney; General surgery; Oncology; Internal medicine; Psychological intervention","score_opus":0.04137451773879018,"score_gpt":0.3400570479144596,"score_spread":0.2986825301756694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884540301","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004535423,0.94659775,0.000019490986,0.00043311232,0.0007266253,0.003977784,0.000035236095,0.000021767715,0.048183672],"genre_scores_gemma":[0.00003139421,0.994056,0.0001317676,0.0022901446,0.00013342379,0.0002480117,0.0000460086,0.00009706995,0.0029661888],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930448,0.003685247,0.0020862035,0.0005383575,0.00030954942,0.00033587322],"domain_scores_gemma":[0.9955888,0.00022904958,0.0021933035,0.0016169474,0.00019611836,0.00017580467],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015186354,0.00047765492,0.0048425402,0.0001448716,0.00003802965,0.0000013738048,0.0006957985,0.0002507394,0.00031878048],"category_scores_gemma":[0.0001596289,0.00025712757,0.0010938362,0.00038206705,0.00078817597,0.000011022773,0.0005175494,0.0005009555,0.0003794113],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029482866,0.00019566747,0.0000020770879,0.9558281,0.0028119525,0.0006389198,0.000024708183,9.523061e-8,2.557566e-7,0.00015115886,0.010391381,0.029926248],"study_design_scores_gemma":[0.0003833917,0.00081285235,0.000015645093,0.45881706,0.027197827,0.0007289769,0.0000055506434,2.847774e-7,0.0000015647904,0.0000020512905,0.51193863,0.0000961361],"about_ca_topic_score_codex":0.0000080018535,"about_ca_topic_score_gemma":0.0000016723961,"teacher_disagreement_score":0.5015473,"about_ca_system_score_codex":0.00042769188,"about_ca_system_score_gemma":0.0006645537,"threshold_uncertainty_score":0.9999881},"labels":[],"label_agreement":null},{"id":"W2884569774","doi":"10.1097/spc.0000000000000363","title":"Role of immunotherapy in kidney cancer","year":2018,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Memorial Sloan-Kettering Cancer Center","keywords":"Nivolumab; Medicine; Immunotherapy; Oncology; Kidney cancer; Renal cell carcinoma; Internal medicine; Cabozantinib; Cancer; Immunology","score_opus":0.1339646977978208,"score_gpt":0.43951689809328465,"score_spread":0.3055522002954638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884569774","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007299875,0.9959855,0.0000015200911,0.000011507365,0.00083701964,0.0015555518,0.0005745047,0.000007567163,0.00029683355],"genre_scores_gemma":[0.0006569739,0.9971693,0.000022754295,0.000011660868,0.00025966333,0.00050506805,0.0013025838,0.00004085622,0.000031150965],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979445,0.00017020937,0.00083831715,0.0005250813,0.00024338266,0.00027850704],"domain_scores_gemma":[0.9987371,0.000079939935,0.00050265173,0.00026929475,0.0002574916,0.00015350747],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000108577915,0.000440741,0.0017604048,0.00039061563,0.00001923367,0.000007480252,0.0001017531,0.00021341363,0.00022397644],"category_scores_gemma":[0.000052791223,0.00033087778,0.0003215351,0.00039167327,0.00014880352,0.00004182528,0.000059341968,0.00039483295,0.000011529395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011596393,0.00020403606,0.105289556,0.05922394,0.00020697991,0.000004971781,0.004372721,5.934312e-8,0.0000027435601,0.000056251716,0.00054258265,0.8299802],"study_design_scores_gemma":[0.0012390779,0.00037731818,0.017648332,0.12095582,0.0001552109,0.0000022850988,0.00050657894,9.258821e-7,0.000031358733,0.000027078611,0.8587927,0.00026328178],"about_ca_topic_score_codex":0.00007934585,"about_ca_topic_score_gemma":0.000012804671,"teacher_disagreement_score":0.85825014,"about_ca_system_score_codex":0.00051192095,"about_ca_system_score_gemma":0.00090024737,"threshold_uncertainty_score":0.99991435},"labels":[],"label_agreement":null},{"id":"W2884654969","doi":"10.5489/cuaj.5245","title":"Images – Isolated caval recurrence of renal cell carcinoma","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Renal cell carcinoma; Medicine; Carcinoma; Urology; Radiology; Pathology","score_opus":0.014962993944264275,"score_gpt":0.22804497890954134,"score_spread":0.21308198496527705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884654969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817685,0.00037025497,0.000087275446,0.0039082766,0.0002900285,0.0001535008,0.000037570207,0.000013897252,0.013370699],"genre_scores_gemma":[0.99711293,0.00002436268,0.00035950667,0.0007694661,0.00054221816,0.0000028769691,0.000016291824,0.000011600728,0.0011607612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833393,0.0001693041,0.00041434373,0.00020431388,0.0003896451,0.0004884534],"domain_scores_gemma":[0.99790144,0.00009583146,0.00036320093,0.00014676826,0.0007154266,0.0007773417],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048369338,0.00015182004,0.00031687866,0.00020818724,0.0001856716,0.000033916902,0.0001291254,0.00022168532,0.0010477364],"category_scores_gemma":[0.00038023453,0.000118687305,0.00016283739,0.0002648871,0.00009374678,0.00007169322,0.0000163173,0.00046533011,0.00011776382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022965828,0.00010850659,0.95050454,0.0000106485995,0.000087310975,0.00040870864,0.00021965381,0.0000051981756,0.0108461715,0.000030007814,0.035169147,0.0023804684],"study_design_scores_gemma":[0.0013452665,0.002757927,0.9683523,0.00001693569,0.00015862336,0.0004958401,0.00004256198,0.00013390962,0.013785021,0.00020653926,0.012557875,0.00014720052],"about_ca_topic_score_codex":0.0013514124,"about_ca_topic_score_gemma":0.00025578096,"teacher_disagreement_score":0.022611272,"about_ca_system_score_codex":0.0010390171,"about_ca_system_score_gemma":0.0007641319,"threshold_uncertainty_score":0.9998654},"labels":[],"label_agreement":null},{"id":"W2885135931","doi":"10.1007/s00345-018-2427-z","title":"External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma","year":2018,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Alberta Kidney Disease Network; Queen Elizabeth II Health Sciences Centre; McMaster University","funders":"National Institute for Health and Care Research","keywords":"Medicine; Nomogram; Renal cell carcinoma; Nephrology; Nephrectomy; Urology; Internal medicine; Multivariate analysis; Retrospective cohort study; Surgery; Stage (stratigraphy); Oncology; Kidney","score_opus":0.029429258401866207,"score_gpt":0.27754400368930043,"score_spread":0.2481147452874342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885135931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96771675,0.0008690041,0.029712314,0.00020840055,0.00027511278,0.00039575942,0.00004585509,0.0000036394995,0.0007731366],"genre_scores_gemma":[0.9818841,0.000014205912,0.017303383,0.00006179814,0.0003833996,0.000020302397,0.000004854932,0.000025734824,0.00030221182],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982342,0.00016613651,0.0007968101,0.00018972081,0.00037208782,0.00024102496],"domain_scores_gemma":[0.99746794,0.000222447,0.0009046904,0.00020694155,0.0010574425,0.00014054666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047647933,0.00018299485,0.00072896166,0.00049865077,0.000025228277,0.0000037442944,0.00012338378,0.00005593441,0.00010047621],"category_scores_gemma":[0.000074550495,0.00014178606,0.00031493985,0.00018249071,0.00029626692,0.00010857583,0.000034782537,0.00019922835,0.000002059669],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10224561,0.002723661,0.120638564,0.0005813452,0.0020184873,0.0003889765,0.0068533733,0.005474421,0.7546846,0.0005177118,0.0008543732,0.0030188446],"study_design_scores_gemma":[0.014215468,0.02470535,0.11878772,0.00013440978,0.0043651303,0.000776168,0.0002465678,0.007997711,0.82329935,0.0048691398,0.00034925374,0.0002537591],"about_ca_topic_score_codex":0.000014824685,"about_ca_topic_score_gemma":0.000011107941,"teacher_disagreement_score":0.08803014,"about_ca_system_score_codex":0.00010936835,"about_ca_system_score_gemma":0.0003348175,"threshold_uncertainty_score":0.5781868},"labels":[],"label_agreement":null},{"id":"W2885351104","doi":"10.1158/1078-0432.ccr-18-0269","title":"Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"National Cancer Institute","keywords":"PI3K/AKT/mTOR pathway; Renal cell carcinoma; Chromosomal translocation; Cancer research; TFE3; Medicine; Targeted therapy; Pathology; Biology; Internal medicine; Cancer; Signal transduction; Cell biology; Genetics; Gene","score_opus":0.24536082572216666,"score_gpt":0.4940059777601674,"score_spread":0.24864515203800075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885351104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98737377,0.005362722,0.00004821893,0.0015668076,0.0001962622,0.000804289,0.0000091753745,0.000018352848,0.004620394],"genre_scores_gemma":[0.9969173,0.0005877783,0.0003605365,0.00014327312,0.0008307177,0.00012842231,0.000015496118,0.00003986156,0.0009766268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962936,0.0006571126,0.0009626412,0.00057733536,0.00090744975,0.000601831],"domain_scores_gemma":[0.99744874,0.0008660601,0.0001209996,0.00054671767,0.0007429208,0.0002745866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003422788,0.0001687119,0.0005409633,0.0002750664,0.000087859546,0.000014195864,0.00024855716,0.00021607288,0.0008573262],"category_scores_gemma":[0.00035566208,0.00013439238,0.00019956652,0.000744898,0.00075450924,0.00006253998,0.00006873698,0.0008181712,0.00010908216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060986257,0.0018644002,0.72414565,0.0006042584,0.0001177089,0.00015575183,0.001925823,0.000008484079,0.16200073,0.000109335815,0.0037758858,0.09919336],"study_design_scores_gemma":[0.005357897,0.0051635816,0.66325444,0.00028450717,0.00006697939,0.000005583002,0.00036966364,0.00047661568,0.3205921,0.00027555221,0.003961263,0.00019180164],"about_ca_topic_score_codex":0.0015752517,"about_ca_topic_score_gemma":0.00038633938,"teacher_disagreement_score":0.15859139,"about_ca_system_score_codex":0.00040117977,"about_ca_system_score_gemma":0.0009483241,"threshold_uncertainty_score":0.93871206},"labels":[],"label_agreement":null},{"id":"W2885449436","doi":"10.1148/rg.2018170152","title":"Successful Integration of Contrast-enhanced US into Routine Abdominal Imaging","year":2018,"lang":"en","type":"review","venue":"Radiographics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Microbubbles; Radiology; Contrast (vision); Contrast-enhanced ultrasound; Pancreas; Perfusion; Thrombus; Ultrasound; Surgery; Internal medicine","score_opus":0.029934125064487494,"score_gpt":0.3278821667137278,"score_spread":0.29794804164924027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885449436","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030244251,0.99149406,0.0019399237,0.000034335524,0.0004388476,0.0014791765,0.00003102587,0.00007194625,0.0014862315],"genre_scores_gemma":[0.033763606,0.96280193,0.002104784,0.000037475747,0.00051616266,0.000120174605,0.00045630467,0.000098356715,0.000101205034],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99707216,0.00019794588,0.0011803738,0.0006239998,0.00054071425,0.00038479874],"domain_scores_gemma":[0.99751604,0.00021825942,0.00084319536,0.0008098236,0.00038727274,0.00022540224],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046293842,0.00065583666,0.0026555676,0.0010933792,0.000079098376,0.00003469396,0.0002613388,0.00032626712,0.000060793613],"category_scores_gemma":[0.00013007919,0.0004801195,0.001450295,0.0013072339,0.0004293504,0.00009608106,0.000054507993,0.0005455449,0.000022895347],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013940078,0.00025448183,0.001455616,0.016467983,0.00092206645,0.00013481065,0.0001752682,1.122434e-7,0.00016525957,0.00014402975,0.0004125003,0.97972846],"study_design_scores_gemma":[0.006232822,0.0027251714,0.0020290385,0.10622148,0.030671306,0.002072302,0.00023678488,0.00027108766,0.0050017918,0.0003368836,0.84211487,0.0020864834],"about_ca_topic_score_codex":0.00023486324,"about_ca_topic_score_gemma":0.00005747581,"teacher_disagreement_score":0.977642,"about_ca_system_score_codex":0.00026544326,"about_ca_system_score_gemma":0.00035636418,"threshold_uncertainty_score":0.99976504},"labels":[],"label_agreement":null},{"id":"W2885763638","doi":"10.1016/j.eururo.2018.07.023","title":"Adjuvant Therapy for Resected Renal Cell Carcinoma—Still Searching","year":2018,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Adjuvant; Adjuvant therapy; Oncology; Carcinoma; Internal medicine; Cancer","score_opus":0.042511222484433224,"score_gpt":0.27189746761657263,"score_spread":0.2293862451321394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885763638","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46897417,0.0057411944,0.00046908658,0.40236214,0.0017906448,0.004459589,0.0003004121,0.00047130094,0.11543145],"genre_scores_gemma":[0.37951443,0.00013254822,0.0014272148,0.5694236,0.020181319,0.000107087566,0.0027398507,0.0006386064,0.025835326],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99525154,0.0012641788,0.0006168613,0.0012414355,0.0004822312,0.0011437853],"domain_scores_gemma":[0.99727196,0.0005369716,0.00031882976,0.0013095171,0.0003378155,0.00022493927],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000662512,0.0006923037,0.0009485382,0.00045412718,0.00014849856,0.00004121268,0.00050706626,0.00052062067,0.00045436603],"category_scores_gemma":[0.00015079373,0.0005450572,0.00047849905,0.00015879843,0.0003257762,0.00003425234,0.00020266291,0.0021696675,0.00096324785],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015686885,0.000106794105,0.0004309672,0.00019567455,0.00018755297,0.009893283,0.00036703958,0.000001588219,0.008359844,0.000002143393,0.97684604,0.0020403767],"study_design_scores_gemma":[0.004589538,0.009150726,0.011937765,0.000032189277,0.00032006804,0.00062342896,0.0000050244084,0.000047837762,0.0042380914,0.000033955737,0.9685984,0.00042296527],"about_ca_topic_score_codex":0.000037162692,"about_ca_topic_score_gemma":0.0000029149714,"teacher_disagreement_score":0.1670615,"about_ca_system_score_codex":0.00016484396,"about_ca_system_score_gemma":0.0002450074,"threshold_uncertainty_score":0.9998146},"labels":[],"label_agreement":null},{"id":"W2885983077","doi":"10.1016/j.urology.2018.07.007","title":"Has the Age of Cytoreductive Nephrectomy Come to an End?","year":2018,"lang":"en","type":"letter","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Clinical endpoint; Nephrectomy; Internal medicine; Urology; Kidney cancer; Surgery; Cancer; Clinical trial; Oncology; Kidney","score_opus":0.04621070231424455,"score_gpt":0.2804257717548365,"score_spread":0.23421506944059195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885983077","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18112245,0.00032717743,0.000060543793,0.80628467,0.00087125244,0.0011450329,0.00005751216,0.00005098848,0.0100804],"genre_scores_gemma":[0.29815662,0.000005786636,0.00036669907,0.6906709,0.0067068287,0.00011760658,0.00061387575,0.00008096766,0.003280718],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998333,0.00025285408,0.00027910163,0.00046454472,0.00028024384,0.00039027492],"domain_scores_gemma":[0.9984677,0.0001937392,0.00013639216,0.0009857123,0.00013557091,0.000080916005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013170045,0.00029414322,0.0006671693,0.00019972581,0.000062788145,0.000010485771,0.00029705247,0.00056917756,0.00062800833],"category_scores_gemma":[0.00005512823,0.0001826029,0.0001601867,0.00012695184,0.00065231003,0.000019009958,0.000100476915,0.0008688291,0.00028422454],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044538904,0.00009121772,0.0005624441,0.00005274123,0.00038452444,0.0028745502,0.0010654202,0.000002084322,0.0024065552,0.000029111554,0.9916502,0.00043573708],"study_design_scores_gemma":[0.00060438924,0.0046932697,0.0065323412,0.000010570485,0.0004934651,0.00055998546,0.000021952184,0.0000030336353,0.0014496606,0.00019269157,0.9853034,0.00013526081],"about_ca_topic_score_codex":0.00024203141,"about_ca_topic_score_gemma":0.000035736823,"teacher_disagreement_score":0.11703416,"about_ca_system_score_codex":0.000106408304,"about_ca_system_score_gemma":0.00015246533,"threshold_uncertainty_score":0.744633},"labels":[],"label_agreement":null},{"id":"W2886258832","doi":"10.1158/1538-7445.am2018-5342","title":"Abstract 5342: Somatic bi-allelic loss of TSC genes in eosinophilic solid and cystic renal cell carcinoma (ESC RCC)","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Renal cell carcinoma; Tuberous sclerosis; Somatic cell; Kidney cancer; Germline; Germline mutation; Allele; TSC1; Cancer; Cancer research; Medicine; Clear cell; Gene; Biology; Mutation; Pathology; Genetics; Internal medicine; PI3K/AKT/mTOR pathway","score_opus":0.0782673445800243,"score_gpt":0.3809542869781105,"score_spread":0.30268694239808625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886258832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861523,0.009899928,0.000003953491,0.00045444572,0.000081496815,0.0008283688,0.000018845882,0.000017966593,0.0025426897],"genre_scores_gemma":[0.99774534,0.00069931144,0.000134547,0.00003767941,0.00039238425,0.00015062619,0.0000115656985,0.000049063434,0.00077946647],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972088,0.00015650668,0.0004928707,0.00052789843,0.00086928887,0.00074468716],"domain_scores_gemma":[0.9982639,0.00026153016,0.00009660531,0.00061527395,0.00043338802,0.0003292874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007482182,0.00023427416,0.0005202482,0.00058017543,0.00011375505,0.000029691373,0.00021729615,0.00014249295,0.00047851916],"category_scores_gemma":[0.0000991541,0.00019186163,0.00008062456,0.0005840274,0.0007224123,0.00008089947,0.00016283565,0.00043330184,0.00010480171],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010024866,0.00048365473,0.14699057,0.0021432263,0.00007716984,0.0009208207,0.0017239081,0.000017925766,0.83927804,0.000041387382,0.0006413637,0.006679451],"study_design_scores_gemma":[0.0024118903,0.0012174713,0.53604186,0.00042839817,0.000048762045,0.00007031138,0.00020926671,0.00014436862,0.45874238,0.00025390726,0.00027153993,0.00015986814],"about_ca_topic_score_codex":0.002549376,"about_ca_topic_score_gemma":0.0004950632,"teacher_disagreement_score":0.3890513,"about_ca_system_score_codex":0.00047495798,"about_ca_system_score_gemma":0.0006728031,"threshold_uncertainty_score":0.78238904},"labels":[],"label_agreement":null},{"id":"W2887130112","doi":"10.1158/1538-7445.am2018-4237","title":"Abstract 4237: Differences in the frequencies of tumor <i>VHL</i> mutation and HIF-2α expression between black and white patients with clear cell renal carcinoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cancer; Renal cell carcinoma; Clear cell renal cell carcinoma; Immunohistochemistry; Kidney cancer; Internal medicine; Oncology; Kidney disease; Pathology; Cancer research","score_opus":0.06345583324635751,"score_gpt":0.3232579458300653,"score_spread":0.2598021125837078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887130112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974133,0.00039205162,0.0000018921849,0.00023669905,0.000011780343,0.0006455149,0.00002815131,0.0000053408953,0.0012653207],"genre_scores_gemma":[0.9995712,0.00006390157,0.00008198367,0.000026135123,0.000106135754,0.000046886325,0.000015472568,0.0000148468,0.00007342446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983284,0.00014212656,0.00020564883,0.00029785396,0.0007399839,0.0002859714],"domain_scores_gemma":[0.99908644,0.00019734254,0.00007926024,0.00023635995,0.00029377275,0.000106846535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004091238,0.00012653555,0.00023474688,0.00015467106,0.00010742986,0.000033579287,0.000108797,0.000048030226,0.00005715093],"category_scores_gemma":[0.000034161538,0.000069969836,0.000018308934,0.0002575466,0.00071751483,0.00009603328,0.00005636593,0.00027369944,0.00000419847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005807468,0.00007769639,0.9726228,0.00021843205,0.000011459485,0.000042211,0.003777612,3.1036242e-7,0.02168128,0.000002004767,0.00021343342,0.0007719721],"study_design_scores_gemma":[0.0015607197,0.0016871791,0.9222041,0.00028898133,0.000023398825,0.0000030346414,0.0010001886,0.000007507327,0.073080294,0.00004959403,0.00002839836,0.00006664949],"about_ca_topic_score_codex":0.0010069796,"about_ca_topic_score_gemma":0.00015060681,"teacher_disagreement_score":0.051399015,"about_ca_system_score_codex":0.00010143252,"about_ca_system_score_gemma":0.00013689071,"threshold_uncertainty_score":0.2853287},"labels":[],"label_agreement":null},{"id":"W2887719048","doi":"10.1007/s00270-018-2050-9","title":"Percutaneous Ablation Versus Nephrectomy for Small Renal Masses: Clinical Outcomes in a Single-Center Cohort","year":2018,"lang":"en","type":"article","venue":"CardioVascular and Interventional Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Columbian Hospital; McGill University; University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Medicine; Biopsy; Cohort; Nephrectomy; Renal function; Retrospective cohort study; Urology; Log-rank test; Renal cell carcinoma; Complication; Surgery; Single Center; Percutaneous; Kidney; Radiology; Survival analysis; Internal medicine","score_opus":0.07605315261112766,"score_gpt":0.3305231747281218,"score_spread":0.25447002211699415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887719048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905412,0.0019121007,0.0039904537,0.00012557537,0.00080314075,0.0008338174,0.000019823026,0.00002643675,0.0017474368],"genre_scores_gemma":[0.9950313,0.00007942519,0.003649646,0.00012222442,0.0005154344,0.00008427892,0.00018978653,0.000022391603,0.00030551804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833566,0.0002242923,0.0005325735,0.00048289157,0.000163664,0.00026094756],"domain_scores_gemma":[0.99906456,0.0002908323,0.00006811022,0.00029447424,0.00016604022,0.00011597488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007614068,0.00018364377,0.000753028,0.00014326433,0.00005047235,0.000014957648,0.00006670972,0.00018669087,0.00008622447],"category_scores_gemma":[0.00033254197,0.00015218064,0.0015889874,0.00006774763,0.0002413931,0.00004347138,0.00004403514,0.00014833931,0.000017749886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033955704,0.0005897901,0.9783942,0.00008452923,0.0066738473,0.000345199,0.000049538707,0.000010219803,0.00022337255,0.00034359965,0.0005054351,0.009384685],"study_design_scores_gemma":[0.01310522,0.0067141997,0.93064964,0.00012010948,0.0011833977,0.004770577,0.00004258614,0.00028311025,0.000121859885,0.00020442561,0.042576443,0.00022843885],"about_ca_topic_score_codex":0.000027337297,"about_ca_topic_score_gemma":0.00003932582,"teacher_disagreement_score":0.04774458,"about_ca_system_score_codex":0.00018964335,"about_ca_system_score_gemma":0.000049331164,"threshold_uncertainty_score":0.62057465},"labels":[],"label_agreement":null},{"id":"W2888229344","doi":"10.1177/1756287218794094","title":"The contemporary role of lymph node dissection in the management of renal cell carcinoma","year":2018,"lang":"en","type":"review","venue":"Therapeutic Advances in Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital","funders":"National Cancer Institute","keywords":"Medicine; Renal cell carcinoma; Lymph node; Nephrectomy; Dissection (medical); Disease; Systemic therapy; Oncology; Kidney cancer; Internal medicine; Adjuvant; Randomized controlled trial; Clinical trial; Cancer; Surgery; Kidney","score_opus":0.038821155564756724,"score_gpt":0.32760745649240836,"score_spread":0.2887863009276516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888229344","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032161213,0.9813445,0.00003134869,0.00005947422,0.00016577252,0.0013179267,0.000007440516,0.0000071276604,0.013850291],"genre_scores_gemma":[0.3026186,0.69692326,0.00004354917,0.00004921421,0.000051028277,0.00018852024,0.000021248625,0.000025156009,0.000079448306],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975315,0.0006107923,0.00092052465,0.00036553698,0.00027234742,0.00029933182],"domain_scores_gemma":[0.9980368,0.0005136209,0.0005971879,0.000782153,0.000042345073,0.000027896072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006395808,0.0003331996,0.0011891171,0.0001859589,0.00004049603,0.0000037438483,0.00044028592,0.00019023214,0.000012919641],"category_scores_gemma":[0.0000049310484,0.0001700186,0.00026739767,0.0003821398,0.00042830224,0.000040928997,0.00007685378,0.00029522946,0.000007790882],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093999243,0.0005224358,0.0020472496,0.009172286,0.0003304378,0.00018423259,0.0005399566,0.000012980825,0.000015902024,0.0011583633,0.000009495626,0.98506665],"study_design_scores_gemma":[0.0019688774,0.0013898533,0.0038194414,0.0018336546,0.0014201931,0.00023605312,0.00068516977,0.000030507294,0.00011755276,0.00224492,0.9860161,0.00023769158],"about_ca_topic_score_codex":0.000031180258,"about_ca_topic_score_gemma":0.000016905116,"teacher_disagreement_score":0.9860066,"about_ca_system_score_codex":0.00013060613,"about_ca_system_score_gemma":0.00013486734,"threshold_uncertainty_score":0.69331574},"labels":[],"label_agreement":null},{"id":"W2888435130","doi":"10.3747/co.25.3935","title":"Baseline Edmonton Symptom Assessment System and Survival in Metastatic Renal Cell Carcinoma","year":2018,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Hazard ratio; Proportional hazards model; Internal medicine; Cohort; Oncology; Cancer; Overall survival; Confidence interval","score_opus":0.08094354817400969,"score_gpt":0.38202874207720344,"score_spread":0.30108519390319377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888435130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98244107,0.0027327659,0.000558,0.00034113217,0.0011446669,0.0007447475,0.000015937505,0.000049602895,0.011972107],"genre_scores_gemma":[0.997555,0.00007009462,0.0014765225,0.00004214141,0.00047149818,0.000099595716,0.00007612154,0.000027795671,0.00018123921],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770176,0.00047718897,0.0005370808,0.0005228431,0.00031797594,0.00044315768],"domain_scores_gemma":[0.9987632,0.00026180298,0.00016296431,0.00035696875,0.00017467614,0.0002803566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082338817,0.000274291,0.00072327163,0.0002466992,0.00006455963,0.000014513296,0.00008411599,0.000093900264,0.00010440315],"category_scores_gemma":[0.000039616258,0.00022073287,0.00008518328,0.00021167706,0.00017526685,0.00005369298,0.00010312695,0.0003062777,0.000057196885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010396712,0.003382621,0.91056436,0.0019044132,0.00014805255,0.0018601678,0.001225524,0.0000055447777,0.012122867,0.0012048553,0.0028571836,0.06368473],"study_design_scores_gemma":[0.012642824,0.0071928925,0.9382115,0.00034623488,0.00077911513,0.0005379173,0.0012192401,0.007540966,0.0057129376,0.000039308074,0.02535305,0.00042400698],"about_ca_topic_score_codex":0.00014923158,"about_ca_topic_score_gemma":0.00021765768,"teacher_disagreement_score":0.06326073,"about_ca_system_score_codex":0.0012096845,"about_ca_system_score_gemma":0.00045618566,"threshold_uncertainty_score":0.9001225},"labels":[],"label_agreement":null},{"id":"W2888977263","doi":"10.1016/j.canep.2018.08.006","title":"Partial nephrectomy seems to confer a survival benefit relative to radical nephrectomy in metastatic renal cell carcinoma","year":2018,"lang":"en","type":"article","venue":"Cancer Epidemiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Propensity score matching; Hazard ratio; Odds ratio; Poisson regression; Logistic regression; Proportional hazards model; Internal medicine; Urology; Surgery; Confidence interval; Kidney; Population","score_opus":0.09312632171560364,"score_gpt":0.36885914613771487,"score_spread":0.2757328244221112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888977263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97871214,0.001478276,0.0027327905,0.0103239175,0.0009882632,0.0019005972,0.000049809627,0.00006632304,0.0037478642],"genre_scores_gemma":[0.97768503,0.000027791124,0.010399439,0.008061194,0.0011762118,0.0011775271,0.0000494167,0.00006853747,0.0013548585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954817,0.0008430917,0.0010606924,0.0011144748,0.00027660368,0.0012234278],"domain_scores_gemma":[0.9964242,0.0014502781,0.00020034664,0.0006616771,0.00022650827,0.0010370117],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011956716,0.0004940249,0.0016974631,0.00039686353,0.000091826754,0.00000885619,0.00023701608,0.00024278687,0.0012242319],"category_scores_gemma":[0.000919084,0.00040625295,0.00024405388,0.0006179524,0.00035038384,0.00008597261,0.00016521564,0.00053381885,0.00078718574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007861721,0.00040421917,0.9367566,0.00017140455,0.00048110212,0.00089350785,0.0032864949,0.0007986749,0.016420558,0.0054558213,0.019498587,0.007971313],"study_design_scores_gemma":[0.009553344,0.0063366285,0.6127183,0.0002789232,0.0006476865,0.0001415405,0.00020590774,0.0014239134,0.03425029,0.0023428004,0.3311461,0.0009545842],"about_ca_topic_score_codex":0.0042267526,"about_ca_topic_score_gemma":0.0016414862,"teacher_disagreement_score":0.32403833,"about_ca_system_score_codex":0.0009559974,"about_ca_system_score_gemma":0.00054404204,"threshold_uncertainty_score":0.9999908},"labels":[],"label_agreement":null},{"id":"W2889152069","doi":"10.1096/fj.201800596r","title":"Sunitinib induces early histomolecular changes in a subset of renal cancer cells that contribute to resistance","year":2018,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Hort Innovation; Kidney Foundation of Canada","keywords":"Sunitinib; Renal cell carcinoma; Cancer research; Medicine; Cancer; Biology; Internal medicine; Pathology","score_opus":0.03857038310055487,"score_gpt":0.27970949357066394,"score_spread":0.24113911047010905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889152069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99352074,0.0015964501,0.000050437207,0.0033621269,0.00019150182,0.00032192405,0.00004464026,0.000007931562,0.0009042722],"genre_scores_gemma":[0.9975785,0.00019078172,0.00014848674,0.00057355186,0.0003433306,0.000019193452,0.0000032409546,0.00001950237,0.0011233924],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986398,0.00015654284,0.0002570962,0.00015590483,0.00045505675,0.00033555625],"domain_scores_gemma":[0.9990043,0.00006471975,0.00021068225,0.00027950856,0.00024210292,0.00019865243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005562073,0.00015335652,0.0003319184,0.00018597947,0.00009680136,0.000023422344,0.00019567473,0.00005726065,0.0002194369],"category_scores_gemma":[0.00004351233,0.00009743969,0.000082906445,0.0002674511,0.00015005414,0.00004327676,0.000039107217,0.0002918247,0.000020888223],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001235187,0.00006961531,0.004500347,0.000021434347,0.00010129013,0.00051511475,0.0021923648,0.000004767174,0.98902005,0.000020848409,0.0017505517,0.00056842406],"study_design_scores_gemma":[0.0015105294,0.00067368994,0.043694627,0.00048429202,0.000116773095,0.00012115352,0.00017142978,0.0000026925557,0.9519131,0.00005722606,0.0011601166,0.00009437835],"about_ca_topic_score_codex":0.00029846362,"about_ca_topic_score_gemma":0.0013587989,"teacher_disagreement_score":0.03919428,"about_ca_system_score_codex":0.0002815433,"about_ca_system_score_gemma":0.00017636888,"threshold_uncertainty_score":0.3973475},"labels":[],"label_agreement":null},{"id":"W2889381133","doi":"10.5489/cuaj.5414","title":"National trends of preoperative imaging modalities before partial nephrectomy for renal masses in the U.S. from 2007–2015","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Soonchunhyang University","keywords":"Medicine; Magnetic resonance imaging; Nephrectomy; Ultrasonography; Radiology; Computed tomography; Population; Nuclear medicine; Kidney; Internal medicine","score_opus":0.023076063973646463,"score_gpt":0.2748962350047648,"score_spread":0.2518201710311183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889381133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9620092,0.00024643497,0.00010863632,0.03170421,0.00023274007,0.00028884786,0.00026466648,0.000008195028,0.0051370845],"genre_scores_gemma":[0.9947813,0.0000049346268,0.0007711253,0.002532112,0.0014627982,0.000051826893,0.00010320039,0.0000081384305,0.0002845417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844503,0.0002094166,0.00037127503,0.00016085099,0.00047597467,0.0003374666],"domain_scores_gemma":[0.9986456,0.0002822174,0.00022842834,0.00007623831,0.00056300947,0.00020452762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081366027,0.00012370561,0.00024501412,0.00021249545,0.00017431368,0.00006008842,0.00011913096,0.00010637233,0.0008390522],"category_scores_gemma":[0.000617433,0.000078893114,0.00013365033,0.00019340045,0.00008216028,0.000111397596,0.000008392761,0.000262962,0.000007793626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021118285,0.000071357616,0.9598454,0.0000024361652,0.00013664294,0.000038143608,0.0015174372,0.000035183584,0.00007822043,0.0005145923,0.03578948,0.0017598976],"study_design_scores_gemma":[0.0016674458,0.00064319116,0.95032144,0.000015748277,0.00009124127,0.00006965122,0.00037744828,0.0011392838,0.000220871,0.0036539375,0.041714206,0.00008556647],"about_ca_topic_score_codex":0.0016712119,"about_ca_topic_score_gemma":0.0037969232,"teacher_disagreement_score":0.03277214,"about_ca_system_score_codex":0.0009771454,"about_ca_system_score_gemma":0.0007001561,"threshold_uncertainty_score":0.9187033},"labels":[],"label_agreement":null},{"id":"W2889642957","doi":"10.1200/jco.2017.35.15_suppl.3070","title":"Validation of the Princess Margaret immune oncology prognostic index (PM-IPI) for patients (pts) treated in immune oncology (IO) early phase trials.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Cohort; Oncology; Progression-free survival; Gastroenterology; Surgery; Overall survival","score_opus":0.19966323785957193,"score_gpt":0.4962821865088141,"score_spread":0.2966189486492422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889642957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98679996,0.00032734306,0.00006867899,0.0054537505,0.0027869125,0.0026690098,0.000023874534,0.000008647899,0.0018618209],"genre_scores_gemma":[0.9974481,0.00032206476,0.0009299947,0.00019735115,0.000725271,0.00009849736,0.000028041215,0.000039312934,0.00021138765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9884759,0.0030328836,0.007034132,0.0003906323,0.00058755395,0.0004788519],"domain_scores_gemma":[0.9756707,0.008990955,0.012794573,0.000802299,0.001412935,0.00032856973],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01188864,0.00032916397,0.0045440025,0.0002963721,0.00016491443,0.000025431167,0.00081086386,0.0011238476,0.00010619731],"category_scores_gemma":[0.03442058,0.00019737284,0.0013879654,0.00017838838,0.0006972312,0.00023686673,0.00023556167,0.0013610182,0.000008028653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04117188,0.017247923,0.71098876,0.00009160062,0.000898555,0.0003724744,0.00026772326,0.000015232041,0.0014536724,0.00005507354,0.0002955454,0.22714157],"study_design_scores_gemma":[0.07829246,0.07045201,0.83568907,0.00027218834,0.0014103793,0.0001108779,0.000059567545,0.000085990876,0.0043475884,0.000387267,0.008751013,0.00014157034],"about_ca_topic_score_codex":0.00028835973,"about_ca_topic_score_gemma":0.000121873585,"teacher_disagreement_score":0.22700001,"about_ca_system_score_codex":0.0011571355,"about_ca_system_score_gemma":0.0031731867,"threshold_uncertainty_score":0.9737129},"labels":[],"label_agreement":null},{"id":"W2889887419","doi":"10.1200/jco.2019.37.15_suppl.tps4597","title":"PROSPER: A phase III randomized study comparing perioperative nivolumab (nivo) versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN 8143).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Calgary; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Nivolumab; Perioperative; Nephrectomy; Internal medicine; Kidney cancer; Stage (stratigraphy); Blockade; Oncology; Urology; Surgery; Cancer; Immunotherapy; Kidney","score_opus":0.09170392916847256,"score_gpt":0.39466345786887347,"score_spread":0.3029595287004009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889887419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921407,0.000121466,0.000040150368,0.0002367167,0.00090383826,0.003096144,0.000001313762,0.000012722806,0.0034469147],"genre_scores_gemma":[0.9966809,0.000026098478,0.0023846894,0.00017597216,0.00028993693,0.000039560844,0.000014301629,0.00003809691,0.0003504486],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9937522,0.0013777395,0.0032797619,0.00044816485,0.0007499204,0.00039220488],"domain_scores_gemma":[0.99334323,0.0030138344,0.002204694,0.0003386563,0.00074835634,0.00035123262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030823834,0.00033967907,0.0037756928,0.00026280346,0.00006458707,0.000030766823,0.00019687247,0.00024637085,0.00016090582],"category_scores_gemma":[0.0010687117,0.00022371726,0.00048866845,0.00029386132,0.00017210977,0.0003090089,0.00008687935,0.0012177676,0.000032907945],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42326552,0.0074593583,0.5657489,0.000029095194,0.00037642152,0.00039502897,0.0008073333,0.00011452132,0.00007039201,0.000007287224,0.000031092437,0.0016950736],"study_design_scores_gemma":[0.51223,0.052473724,0.4331261,0.00009688492,0.0005629679,0.00001807393,0.0005861209,0.0005234014,0.00008112558,0.00000314549,0.00017008123,0.00012842662],"about_ca_topic_score_codex":0.0001653372,"about_ca_topic_score_gemma":0.00043585847,"teacher_disagreement_score":0.13262278,"about_ca_system_score_codex":0.000892384,"about_ca_system_score_gemma":0.002060233,"threshold_uncertainty_score":0.9122925},"labels":[],"label_agreement":null},{"id":"W2890014497","doi":"10.1200/jco.2018.36.15_suppl.4500","title":"Pembrolizumab monotherapy as first-line therapy in advanced clear cell renal cell carcinoma (accRCC): Results from cohort A of KEYNOTE-427.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Pembrolizumab; Cohort; Clinical endpoint; Internal medicine; Renal cell carcinoma; Oncology; Response Evaluation Criteria in Solid Tumors; Progressive disease; Adverse effect; Surgery; Urology; Clinical trial; Disease; Cancer; Immunotherapy","score_opus":0.0781875072256028,"score_gpt":0.4026770833521769,"score_spread":0.3244895761265741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890014497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98260945,0.0015943499,0.000055078286,0.0031736933,0.00086551084,0.00064773386,0.000023914588,0.000013274177,0.011017009],"genre_scores_gemma":[0.9868951,0.003997032,0.0048584784,0.001713581,0.0017408768,0.000009004958,0.000017002152,0.00006067056,0.00070827606],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9928613,0.0006950569,0.0046755522,0.00056040153,0.00074004405,0.0004676823],"domain_scores_gemma":[0.99119633,0.0031376267,0.0033998862,0.0006990318,0.001019389,0.0005477612],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002581185,0.0003689034,0.0026807096,0.00031048417,0.0000511352,0.000009602676,0.00041322445,0.0006929776,0.00042861298],"category_scores_gemma":[0.0013483049,0.00026512367,0.0008577688,0.0002998265,0.00044481375,0.00013637291,0.00007328901,0.001296548,0.0000762624],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.51021034,0.013338764,0.3239089,0.00006193031,0.00073881034,0.0045979386,0.0018055922,0.00023304447,0.027178012,0.000012636515,0.004622444,0.113291614],"study_design_scores_gemma":[0.08388946,0.118388236,0.7177186,0.00015558575,0.00028467688,0.00016068993,0.00012512271,0.00021868391,0.052385904,0.0003998387,0.026035247,0.00023794535],"about_ca_topic_score_codex":0.00057607517,"about_ca_topic_score_gemma":0.00020081185,"teacher_disagreement_score":0.42632085,"about_ca_system_score_codex":0.00041212628,"about_ca_system_score_gemma":0.0017759942,"threshold_uncertainty_score":0.9999801},"labels":[],"label_agreement":null},{"id":"W2890030948","doi":"10.1200/jco.2016.34.15_suppl.e16118","title":"Baseline lactate dehydrogenase (LDH) and overall survival (OS) in metastatic renal cell carcinoma (mRCC) patients (pts) treated with everolimus (EVE) versus sunitinib (SUN): Predictive biomarker analysis from the RECORD-3 trial.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Lactate dehydrogenase; Sunitinib; Internal medicine; Temsirolimus; Renal cell carcinoma; Everolimus; Progression-free survival; Proportional hazards model; Gastroenterology; Hazard ratio; Urology; Oncology; Discovery and development of mTOR inhibitors; Overall survival; PI3K/AKT/mTOR pathway; Confidence interval; Apoptosis","score_opus":0.1092548767671688,"score_gpt":0.37358715672499254,"score_spread":0.2643322799578237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890030948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958744,0.0003122623,0.00014308188,0.0016812119,0.0004318465,0.0007390974,0.00012549046,0.000011274421,0.0006813285],"genre_scores_gemma":[0.9976972,0.00044737535,0.0007348949,0.00042547673,0.00039268777,0.000021306365,0.00006497507,0.00004063984,0.00017546378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9918746,0.0034338841,0.0029177351,0.00054330594,0.00076231285,0.00046816858],"domain_scores_gemma":[0.9805334,0.015323775,0.0023326345,0.00046989028,0.00068149297,0.00065880216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038384649,0.0004045815,0.0025340356,0.00038960663,0.0000655853,0.000019268908,0.00023877808,0.00028991385,0.00032897136],"category_scores_gemma":[0.0029809903,0.0001892756,0.0007375995,0.00055653177,0.0003695977,0.00019281714,0.000088719804,0.00069401826,0.000010992465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40137208,0.0031662416,0.5718561,0.000009411851,0.0040235803,0.0020665934,0.00010060986,0.000017738817,0.00019900672,0.0000015729994,0.00049588864,0.016691197],"study_design_scores_gemma":[0.24135421,0.030393578,0.7172589,0.00007987307,0.008748627,0.000026947571,0.000095262316,0.0004208994,0.00033543186,0.000031685217,0.0010686463,0.0001859858],"about_ca_topic_score_codex":0.0010431925,"about_ca_topic_score_gemma":0.00155357,"teacher_disagreement_score":0.16001785,"about_ca_system_score_codex":0.00049972825,"about_ca_system_score_gemma":0.0010644523,"threshold_uncertainty_score":0.7718435},"labels":[],"label_agreement":null},{"id":"W2890032742","doi":"10.1200/jco.2017.35.15_suppl.5524","title":"Phase II study of cabozantinib (cabo) in patients (pts) with recurrent/metastatic endometrial cancer (EC): A study of the Princess Margaret, Chicago, and California phase II consortia.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Cancer Care Ontario; Juravinski Cancer Centre; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Cohort; Progression-free survival; Oncology; Mucositis; Phases of clinical research; Cabozantinib; Endometrial cancer; Cancer; Chemotherapy; Surgery","score_opus":0.14368234547990025,"score_gpt":0.4800996152587704,"score_spread":0.3364172697788701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890032742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596447,0.00024315435,0.0000017268975,0.00043476807,0.0008585935,0.0022959064,0.00005778834,0.0000026171745,0.00014097927],"genre_scores_gemma":[0.99935085,0.00015093602,0.000117483316,0.00006404442,0.0002255694,0.000032281503,0.0000020480643,0.000020609836,0.000036172773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99393326,0.001101031,0.003434806,0.00034646504,0.00090942706,0.00027501237],"domain_scores_gemma":[0.9909312,0.0013148631,0.006144248,0.00061032927,0.0006880576,0.00031128386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028316176,0.00025774035,0.002624345,0.000263743,0.00019208573,0.000011762294,0.00042145833,0.00013681523,0.00007279804],"category_scores_gemma":[0.004702098,0.0001368032,0.00023531808,0.00024641494,0.00044541567,0.000111228575,0.0003296772,0.0009496849,4.6875164e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048001785,0.14476213,0.7325027,0.000051075458,0.0011027859,0.00037827878,0.0013546391,0.000004918122,0.000044329176,0.000001983415,0.000079915524,0.07171543],"study_design_scores_gemma":[0.22256504,0.28460598,0.4896545,0.00020304727,0.0015433249,0.00002789954,0.0007486075,0.000021310345,0.0000904912,0.0000064603432,0.0004522416,0.000081102764],"about_ca_topic_score_codex":0.0005392463,"about_ca_topic_score_gemma":0.0020404402,"teacher_disagreement_score":0.24284822,"about_ca_system_score_codex":0.00012918875,"about_ca_system_score_gemma":0.0012265184,"threshold_uncertainty_score":0.562919},"labels":[],"label_agreement":null},{"id":"W2890659508","doi":"10.1007/s00428-018-2456-4","title":"“High-grade oncocytic renal tumor”: morphologic, immunohistochemical, and molecular genetic study of 14 cases","year":2018,"lang":"en","type":"article","venue":"Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Calgary; McGill University; Royal Columbian Hospital; University of British Columbia; Calgary Laboratory Services","funders":"Lékařská Fakulta v Plzni, Univerzita Karlova; Fakultní Nemocnice Plzen","keywords":"Pathology; Cytokeratin; CD117; Biology; Oncocytoma; Immunohistochemistry; TFE3; Eosinophilic; Medicine; CD34; Genetics; Gene","score_opus":0.033482964498919,"score_gpt":0.3447668673627436,"score_spread":0.31128390286382457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890659508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98972845,0.0057103573,0.00022538299,0.00032634378,0.0002632185,0.0018304029,0.000041525756,0.00019543605,0.0016788789],"genre_scores_gemma":[0.98832023,0.00049029524,0.009394804,0.0009980786,0.00034890382,0.0001510602,0.00011906537,0.00009103706,0.00008651746],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99447185,0.0007907574,0.0013807077,0.0015369523,0.00079809275,0.0010216355],"domain_scores_gemma":[0.99565184,0.0011230997,0.00065141125,0.0017769823,0.0002855707,0.0005110837],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0007392851,0.0008905708,0.0018708425,0.00043160518,0.00027730662,0.000027824575,0.00064155494,0.0003178163,0.000100135774],"category_scores_gemma":[0.0013863128,0.0006350969,0.0003229323,0.00058231,0.0031930474,0.00008535646,0.00067876664,0.0010328622,0.000065083455],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021495675,0.0034615183,0.011849517,0.00019863495,0.0012179452,0.011052862,0.00163145,0.000057543468,0.9637461,0.0004374504,0.00095420214,0.003243217],"study_design_scores_gemma":[0.02052952,0.055828117,0.29409364,0.00058949325,0.0050201532,0.0023240014,0.004360266,0.0003423138,0.6087824,0.005656172,0.0007956107,0.0016782712],"about_ca_topic_score_codex":0.0006440675,"about_ca_topic_score_gemma":0.000025112253,"teacher_disagreement_score":0.35496366,"about_ca_system_score_codex":0.00015125952,"about_ca_system_score_gemma":0.00036048418,"threshold_uncertainty_score":0.99961},"labels":[],"label_agreement":null},{"id":"W2890747191","doi":"10.1016/j.clgc.2018.09.006","title":"Active Smoking Is Associated With Worse Prognosis in Metastatic Renal Cell Carcinoma Patients Treated With Targeted Therapies","year":2018,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Internal medicine; Kidney cancer; Carcinoma; Targeted therapy; Cancer","score_opus":0.05160311231907259,"score_gpt":0.32438790381401117,"score_spread":0.27278479149493856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890747191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99642897,0.00054337276,0.0000025929025,0.00025311887,0.00010876664,0.0013966588,0.00007670857,0.00007081315,0.0011189802],"genre_scores_gemma":[0.99720114,0.000073999145,0.00044209583,0.0005034698,0.00025850945,0.00038792062,0.00012494119,0.00009026031,0.0009176503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969743,0.00034688396,0.00069964613,0.00079222623,0.0005809671,0.0006060034],"domain_scores_gemma":[0.9980117,0.00030037886,0.00041614092,0.00039478624,0.0005670419,0.000309933],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023891134,0.0004560977,0.00087720813,0.00019569919,0.00012229335,0.000024322071,0.00014838549,0.00017120341,0.00045354854],"category_scores_gemma":[0.0000694334,0.00029282997,0.00018221742,0.00075637724,0.00042585548,0.00014201047,0.00005995079,0.00051681895,0.000020776273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007650085,0.0026496793,0.9803512,0.000039018134,0.00083405565,0.0010243455,0.0009952978,0.0000041974236,0.00019962912,1.8342972e-7,0.0006254781,0.0056268233],"study_design_scores_gemma":[0.011981767,0.014338944,0.95049447,0.00036275215,0.000904236,0.000013346412,0.00023015654,0.00006408035,0.021046843,0.0000060120433,0.0002050888,0.000352327],"about_ca_topic_score_codex":0.0003793227,"about_ca_topic_score_gemma":0.00025418325,"teacher_disagreement_score":0.029856762,"about_ca_system_score_codex":0.0005437219,"about_ca_system_score_gemma":0.00041426296,"threshold_uncertainty_score":0.9999524},"labels":[],"label_agreement":null},{"id":"W2891078672","doi":"10.1038/s41416-018-0164-0","title":"Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Exelixis; Memorial Sloan-Kettering Cancer Center","keywords":"Cabozantinib; Pazopanib; Sunitinib; Medicine; Everolimus; Renal cell carcinoma; Internal medicine; Oncology; Urology; Progression-free survival; Tyrosine-kinase inhibitor; Surgery; Cancer; Chemotherapy","score_opus":0.03876065357668174,"score_gpt":0.34884107414325466,"score_spread":0.3100804205665729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891078672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99327874,0.0033932198,0.000005159188,0.00049481756,0.00063898653,0.0007544935,0.000025865793,0.0000034214172,0.0014053143],"genre_scores_gemma":[0.9981695,0.0005889072,0.00030697635,0.00038578623,0.00041075388,0.00003748567,0.000003396161,0.00002433271,0.00007289983],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978261,0.00022450999,0.0007616211,0.00019376102,0.0007153061,0.00027871717],"domain_scores_gemma":[0.9986214,0.00031520435,0.00047463056,0.000242459,0.0002496854,0.00009662874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067881733,0.00017818286,0.0006453918,0.00023959887,0.0000367764,0.000020039426,0.00020934286,0.000076507924,0.00022662952],"category_scores_gemma":[0.00014896234,0.0001295377,0.00026639516,0.00029813696,0.000105839674,0.00009130653,0.000010371926,0.0003624244,0.0000023331638],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5613578,0.0047221007,0.045627847,0.000071669325,0.00015879168,0.0043535046,0.00077981554,0.00015761938,0.010411651,0.000003841135,0.00078385987,0.37157148],"study_design_scores_gemma":[0.5065209,0.023524215,0.41280046,0.0004973053,0.00014553533,0.00015873078,0.00019137084,0.000063885425,0.05259061,0.000009198165,0.0033337218,0.00016403882],"about_ca_topic_score_codex":0.00067993003,"about_ca_topic_score_gemma":0.0009188331,"teacher_disagreement_score":0.37140745,"about_ca_system_score_codex":0.00021813405,"about_ca_system_score_gemma":0.00049842766,"threshold_uncertainty_score":0.5282394},"labels":[],"label_agreement":null},{"id":"W2891539948","doi":"10.1016/j.clgc.2018.09.005","title":"Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma","year":2018,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"Kidney Cancer Association; National Cancer Institute; Conquer Cancer Foundation; National Institutes of Health; Cancer Prevention and Research Institute of Texas; Johnson Foundation","keywords":"Medicine; Sickle cell trait; Clinical trial; Renal cell carcinoma; Disease; Dosing; Internal medicine; Chemotherapy; Intensive care medicine; Oncology; Nephrectomy; Kidney","score_opus":0.13382681391219975,"score_gpt":0.4528119512202993,"score_spread":0.3189851373080996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891539948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871459,0.00017748098,0.000025276526,0.005989288,0.0014605962,0.0038026338,0.00015648082,0.00004766903,0.0011946653],"genre_scores_gemma":[0.9890189,0.00080621097,0.002461629,0.0028391255,0.0027783709,0.0011153537,0.0002663362,0.00004779757,0.00066626794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99695504,0.00046271714,0.0010642176,0.0008437905,0.0003055348,0.0003686944],"domain_scores_gemma":[0.9967461,0.0014603968,0.0002918413,0.0008309661,0.00033953082,0.00033111952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010644273,0.00029267496,0.0005796902,0.00006408162,0.00028399564,0.00003805802,0.00018868198,0.00018271356,0.0005780833],"category_scores_gemma":[0.0003419523,0.00017296146,0.00028708047,0.00017551174,0.0005844448,0.00006934868,0.00015514642,0.0003613298,0.00003093784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0951363,0.0034307183,0.71719754,0.00004640101,0.00066247076,0.000041438627,0.000027791122,1.4264498e-7,0.000001323937,0.000037036116,0.1445611,0.038857754],"study_design_scores_gemma":[0.052429616,0.022518476,0.8401195,0.00012988882,0.0009056616,0.0000038082278,0.000031692998,0.00003993117,0.000078724464,0.00015332473,0.08336587,0.00022353],"about_ca_topic_score_codex":0.000024186056,"about_ca_topic_score_gemma":0.000028860397,"teacher_disagreement_score":0.12292194,"about_ca_system_score_codex":0.00012632587,"about_ca_system_score_gemma":0.00014769501,"threshold_uncertainty_score":0.7053163},"labels":[],"label_agreement":null},{"id":"W2891773217","doi":"10.1200/jco.2017.35.15_suppl.4574","title":"Effects of pazopanib (PAZ) and sunitinib (SUN) dose modification on safety and efficacy in patients with metastatic renal cell carcinoma (mRCC) from COMPARZ.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Sunnybrook Hospital","funders":"","keywords":"Medicine; Pazopanib; Renal cell carcinoma; Adverse effect; Sunitinib; Internal medicine; Dosing; Urology","score_opus":0.09640312324605789,"score_gpt":0.39568890662049133,"score_spread":0.29928578337443346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891773217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975259,0.00028311895,0.000024875802,0.0006032218,0.00015910548,0.0005345727,0.000009981046,0.0000026490945,0.0008566278],"genre_scores_gemma":[0.99749285,0.00014411594,0.00201966,0.00015879488,0.00012623683,0.0000030376566,0.000012501995,0.000017195463,0.000025596652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970036,0.000568741,0.0016009016,0.00026090903,0.0003780908,0.00018776968],"domain_scores_gemma":[0.99260026,0.0041123643,0.0023469874,0.00033627165,0.00026173747,0.0003424043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010881037,0.00019220571,0.0016351532,0.00014025053,0.000065863045,0.000014835405,0.0001465319,0.00016346184,0.000012595762],"category_scores_gemma":[0.0013619674,0.00012374774,0.00013789814,0.000046017965,0.00036438936,0.000109082896,0.000049058857,0.0006156785,0.0000026328073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04278635,0.0071480386,0.87784576,0.0001571062,0.00029134683,0.00082587276,0.00030399888,0.000023845929,0.0007088137,0.00005049632,0.000055180706,0.06980317],"study_design_scores_gemma":[0.046536043,0.025165774,0.9251991,0.00024051234,0.00071100367,0.000022351578,0.00003559636,0.00007358261,0.0016588297,0.00005189294,0.00021271252,0.0000925993],"about_ca_topic_score_codex":0.00014915451,"about_ca_topic_score_gemma":0.000045201472,"teacher_disagreement_score":0.069710575,"about_ca_system_score_codex":0.00011281183,"about_ca_system_score_gemma":0.0003316272,"threshold_uncertainty_score":0.50462866},"labels":[],"label_agreement":null},{"id":"W2891785187","doi":"10.1200/jco.2017.35.15_suppl.e18331","title":"Nivolumab in the treatment of metastatic renal cell carcinoma: A cost-utility analysis.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Hospital; University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Nivolumab; Medicine; Everolimus; Quality-adjusted life year; Renal cell carcinoma; Oncology; Cost–utility analysis; Quality of life (healthcare); Cost effectiveness; Cohort; Internal medicine; Clinical trial; Cost–benefit analysis; Cancer; Immunotherapy; Risk analysis (engineering); Nursing","score_opus":0.23907608985782514,"score_gpt":0.4828454824997873,"score_spread":0.24376939264196218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891785187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886005,0.001094261,0.000067601926,0.002907829,0.0002671118,0.0004652682,0.000007574267,0.0000018198051,0.006588024],"genre_scores_gemma":[0.99716,0.00043639733,0.0016281878,0.00021661531,0.0002752131,0.0000118269245,0.0000041563353,0.000008890954,0.00025872228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99527055,0.0010478111,0.002673101,0.0002334934,0.0005184995,0.00025656566],"domain_scores_gemma":[0.9928182,0.0023839425,0.0033066892,0.00088534347,0.00034462544,0.00026119893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039283712,0.00018654193,0.002625138,0.0002352596,0.00007795356,0.000015831894,0.00039833406,0.0001804942,0.00012828987],"category_scores_gemma":[0.0012300615,0.00009636492,0.001600825,0.00018384944,0.0004176148,0.00008416281,0.000033621433,0.0004977302,0.000008463782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005386202,0.013391969,0.90945387,0.000035526675,0.001820403,0.004854703,0.0006286202,0.00003116899,0.00013261495,0.000018570005,0.00052865245,0.063717715],"study_design_scores_gemma":[0.013555461,0.028100464,0.9425688,0.000014965807,0.0069596996,0.00018641244,0.00023489623,0.00026725218,0.00061693246,0.00012707905,0.0073042964,0.000063741434],"about_ca_topic_score_codex":0.00046167674,"about_ca_topic_score_gemma":0.0006688666,"teacher_disagreement_score":0.06365397,"about_ca_system_score_codex":0.00032592763,"about_ca_system_score_gemma":0.0012260927,"threshold_uncertainty_score":0.39296475},"labels":[],"label_agreement":null},{"id":"W2892233176","doi":"10.1093/ajcp/aqy107","title":"Quality and Quantity in Kidney Cancer Surgery","year":2018,"lang":"en","type":"article","venue":"American Journal of Clinical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Manitoba; Dalhousie University","funders":"","keywords":"Kidney cancer; Cancer surgery; Medicine; Quality (philosophy); Cancer; Intensive care medicine; General surgery; Surgery; Internal medicine","score_opus":0.1764053064111491,"score_gpt":0.4842032471894269,"score_spread":0.3077979407782778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892233176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99363077,0.00035325624,0.00007214327,0.0049727736,0.0005308992,0.000063979984,0.000003962992,0.0000050295007,0.00036721182],"genre_scores_gemma":[0.9923696,0.00092904124,0.0013944134,0.00462971,0.0006320134,0.0000018676996,9.3030695e-7,0.000010565028,0.000031895193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711734,0.0007965096,0.0014728908,0.0002066426,0.00019304123,0.00021359822],"domain_scores_gemma":[0.9968128,0.0013595596,0.00095615286,0.00019946105,0.00024711402,0.0004248855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031808694,0.000109672554,0.0012914405,0.00014946623,0.00002005295,0.000004345241,0.0000635151,0.00007743433,0.00008777711],"category_scores_gemma":[0.0036729884,0.00007845137,0.00023489284,0.00019872165,0.0013792698,0.000047927602,0.000034865145,0.00041673263,0.000011083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012999233,0.00022873038,0.91102856,0.000014490672,0.000048958766,0.0009090793,0.000071856055,1.095081e-7,0.00033911894,0.000022924609,0.00062490685,0.08541133],"study_design_scores_gemma":[0.0012080036,0.0023626788,0.99377817,0.00009936604,0.00006357851,0.0008247216,0.00008352336,0.0000033931256,0.00014129358,0.0001503883,0.0012137442,0.00007115657],"about_ca_topic_score_codex":0.0003128184,"about_ca_topic_score_gemma":0.000090967005,"teacher_disagreement_score":0.08534018,"about_ca_system_score_codex":0.000045546887,"about_ca_system_score_gemma":0.0005165669,"threshold_uncertainty_score":0.5081977},"labels":[],"label_agreement":null},{"id":"W2892242225","doi":"10.1200/jco.2017.35.15_suppl.e16065","title":"Clinical outcomes according to ethnicity in patients with metastatic renal cell carcinoma (mRCC) treated with VEGF-targeted therapy (TT).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; McMaster University; Queen Elizabeth II Health Sciences Centre; Baker Hughes (Canada)","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Nephrectomy; Anemia; Kidney cancer; Cancer; Histology; Oncology; Gastroenterology; Kidney","score_opus":0.16145747959391302,"score_gpt":0.451637824812956,"score_spread":0.290180345219043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892242225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948349,0.0001166821,0.000057115736,0.002205364,0.00042679388,0.0008839903,0.000006362496,0.000012675924,0.0014561182],"genre_scores_gemma":[0.9895893,0.000081382546,0.008336605,0.0014016876,0.00031009637,0.000014293659,0.000007371561,0.0000543333,0.00020497425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936066,0.0010307602,0.003475947,0.00052209466,0.0008309241,0.00053363555],"domain_scores_gemma":[0.99127847,0.0024904446,0.0036167467,0.0008423832,0.0008348437,0.0009371173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037017115,0.00040808113,0.0035645524,0.0002938729,0.00014265676,0.000039722392,0.0005078949,0.0003642806,0.00006233543],"category_scores_gemma":[0.0023604988,0.00021653179,0.00070882717,0.00018018764,0.00037230502,0.0002457443,0.00011067121,0.0016324838,0.000024602621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031833615,0.0051031034,0.9227006,0.000017894161,0.00066279894,0.0019831967,0.000075817836,0.00001802511,0.0000359751,0.000002649048,0.00020109571,0.037365235],"study_design_scores_gemma":[0.046776623,0.06737823,0.8837528,0.00012020733,0.0006290253,0.00004714984,0.00010131702,0.000012272887,0.00031885135,0.0000171672,0.0006386991,0.00020760843],"about_ca_topic_score_codex":0.0002611245,"about_ca_topic_score_gemma":0.00021770154,"teacher_disagreement_score":0.06227513,"about_ca_system_score_codex":0.00035706488,"about_ca_system_score_gemma":0.0014522093,"threshold_uncertainty_score":0.882991},"labels":[],"label_agreement":null},{"id":"W2892390072","doi":"10.1016/j.eururo.2018.09.035","title":"Lessons Learned from the Global Epidemiology of Kidney Cancer: A Refresher in Epidemiology 101","year":2018,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Epidemiology; Kidney cancer; Epidemiology of cancer; Cancer; Oncology; Internal medicine; Breast cancer","score_opus":0.17016779293750467,"score_gpt":0.3698195794372992,"score_spread":0.19965178649979454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892390072","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02309278,0.009715365,0.00004744003,0.94015473,0.0012180628,0.00061768544,0.0006546107,0.0000672579,0.024432065],"genre_scores_gemma":[0.024091091,0.0014897492,0.000609233,0.96278983,0.0072876923,0.00006305666,0.001320892,0.00014475685,0.0022036778],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9824254,0.012969449,0.0016805441,0.0014637947,0.0001887842,0.0012720387],"domain_scores_gemma":[0.9909394,0.0056024976,0.0010837744,0.0019055691,0.0001482624,0.0003205013],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.003147618,0.00068182795,0.0025787395,0.0001567848,0.00006706099,0.0000024650283,0.00087862415,0.0011425876,0.0012143012],"category_scores_gemma":[0.012522108,0.0004497334,0.00048672815,0.00027974433,0.0014957347,0.00002222754,0.00047359313,0.0027339053,0.0008166199],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047047556,0.000053697557,0.27428925,0.000048560854,0.00041515715,0.0019326229,0.000087594155,0.000009384117,0.000020341471,0.000104074716,0.72064173,0.0019271398],"study_design_scores_gemma":[0.0014519966,0.00088600145,0.25059438,0.000106318745,0.0004929187,0.00020195275,0.000006345227,0.000021489333,0.0000062427616,0.0027174796,0.74329144,0.00022340742],"about_ca_topic_score_codex":0.0046079294,"about_ca_topic_score_gemma":0.0004547693,"teacher_disagreement_score":0.02369485,"about_ca_system_score_codex":0.00041921373,"about_ca_system_score_gemma":0.0005744321,"threshold_uncertainty_score":0.9999614},"labels":[],"label_agreement":null},{"id":"W2893335845","doi":"10.1007/s40261-018-0705-6","title":"Cost-utility of Sunitinib Versus Pazopanib in Metastatic Renal Cell Carcinoma in Canada using Real-world Evidence","year":2018,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier universitaire de Québec; University of Alberta; McGill University Health Centre; University of Ottawa; Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre; University of Calgary; Sunnybrook Hospital; Queen Elizabeth II Health Sciences Centre; University of British Columbia; University of Toronto; Dalhousie University; McMaster University","funders":"Fonds de Recherche du Québec - Santé; Canadian Centre for Applied Research in Cancer Control","keywords":"Pazopanib; Sunitinib; Medicine; Renal cell carcinoma; Internal medicine; Oncology; Cost effectiveness; Intensive care medicine","score_opus":0.3289610242284381,"score_gpt":0.4109753416940739,"score_spread":0.08201431746563581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893335845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971764,0.00012214176,0.000008603237,0.00035980053,0.00033335408,0.0007912986,0.000013656041,0.000010605101,0.0011841488],"genre_scores_gemma":[0.9975866,0.000026464972,0.0018934164,0.0002171054,0.000118290205,0.000021069263,0.000041922944,0.000019432726,0.00007568094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99656826,0.00074121193,0.0014191795,0.00046748333,0.0004729529,0.00033088704],"domain_scores_gemma":[0.99647826,0.0020616632,0.00039273486,0.000493187,0.0002481743,0.00032597003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016342325,0.00020061711,0.00062238483,0.00019623345,0.00003584046,0.000007857781,0.00013863736,0.00005957394,0.0001011177],"category_scores_gemma":[0.0017078167,0.00018660403,0.00009211927,0.00074606744,0.0004834304,0.00014457246,0.0000650583,0.00039537123,0.000008627946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010044444,0.0001088203,0.9954691,0.00017430025,0.00001537749,0.00013565962,0.00034760873,0.00007131818,0.0013185084,0.00002406916,0.00030445532,0.0010263603],"study_design_scores_gemma":[0.0031640164,0.00035828605,0.94053984,0.0005052699,0.00014253288,0.0000033243898,0.00027469508,0.015825637,0.03878532,0.00023360978,0.00002786585,0.00013963303],"about_ca_topic_score_codex":0.86484814,"about_ca_topic_score_gemma":0.9318499,"teacher_disagreement_score":0.06700176,"about_ca_system_score_codex":0.0013152469,"about_ca_system_score_gemma":0.0050926046,"threshold_uncertainty_score":0.90340614},"labels":[],"label_agreement":null},{"id":"W2895203332","doi":"10.1097/pas.0000000000001150","title":"VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney","year":2018,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute","keywords":"Biomarker; Biology; Cancer; Pathology; Renal cell carcinoma; In situ hybridization; Cancer research; Medicine; Gene expression; Gene; Genetics","score_opus":0.0195082039510218,"score_gpt":0.26111570858012084,"score_spread":0.24160750462909905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895203332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952163,0.00070643297,0.000057308414,0.0030076911,0.000097305005,0.00029423513,0.000024225345,0.0000031475502,0.00059336267],"genre_scores_gemma":[0.9981558,0.00021662167,0.0007056981,0.0006139239,0.00017660546,0.0000026408838,0.0000011094838,0.000018773115,0.000108872344],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986291,0.00029483146,0.0003992136,0.00020985592,0.00022578308,0.00024121335],"domain_scores_gemma":[0.9983214,0.0003140277,0.0005769043,0.00030756064,0.0002567549,0.00022332737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046661304,0.00017232746,0.0006165745,0.00008752834,0.00010805116,0.000007944038,0.000109806846,0.00005468059,0.000030874577],"category_scores_gemma":[0.00004993976,0.000082453415,0.00019126493,0.00015950642,0.0017176803,0.00003058704,0.00010710431,0.00020042181,0.0000019835898],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013841024,0.0005354993,0.06377242,0.00012656479,0.00022686791,0.0023071114,0.00486421,7.089943e-7,0.8920627,0.00010720363,0.0048889336,0.017266726],"study_design_scores_gemma":[0.0064667226,0.011522498,0.63393337,0.0002437513,0.0004400468,0.026053876,0.0014713828,0.00007963895,0.31223908,0.00033385787,0.0070097703,0.00020597834],"about_ca_topic_score_codex":0.000023839357,"about_ca_topic_score_gemma":2.8865307e-7,"teacher_disagreement_score":0.5798237,"about_ca_system_score_codex":0.000038424765,"about_ca_system_score_gemma":0.000086953674,"threshold_uncertainty_score":0.63288647},"labels":[],"label_agreement":null},{"id":"W289544031","doi":"10.1200/jco.2014.32.15_suppl.5010","title":"Nivolumab (anti-PD-1; BMS-936558, ONO-4538) in combination with sunitinib or pazopanib in patients (pts) with metastatic renal cell carcinoma (mRCC).","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":231,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary; Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto","funders":"","keywords":"Medicine; Tolerability; Nivolumab; Pazopanib; Sunitinib; Renal cell carcinoma; Internal medicine; Peripheral edema; Urology; Oncology; Gastroenterology; Surgery; Adverse effect; Immunotherapy; Cancer","score_opus":0.07842517922211807,"score_gpt":0.37313754177960434,"score_spread":0.2947123625574863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W289544031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945035,0.000070399044,0.00014105783,0.0011825635,0.00028483573,0.0006807652,0.0000037236034,0.00000971978,0.0031234578],"genre_scores_gemma":[0.99380773,0.000046278405,0.004805939,0.00075103453,0.00020594762,0.000016165654,0.00002327962,0.00004903546,0.00029459145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99415267,0.0013249608,0.0028159453,0.00040124013,0.0008172119,0.0004879972],"domain_scores_gemma":[0.9940204,0.0023359144,0.0021327843,0.00035633682,0.0006787616,0.00047578439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031141918,0.00033572732,0.002310209,0.00053139305,0.000041850348,0.00001819575,0.00023868585,0.0002826304,0.00013173596],"category_scores_gemma":[0.0012401192,0.00019741298,0.00023912798,0.00047957854,0.0002543717,0.00022114978,0.000053843713,0.0013776006,0.000024840985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02768623,0.01003029,0.9256878,0.00011705358,0.00016276288,0.0032715623,0.0002572041,0.000115231596,0.00005571321,0.000058476886,0.00036385024,0.03219383],"study_design_scores_gemma":[0.06623832,0.08890201,0.8408151,0.00031600404,0.00050040754,0.00034433333,0.00020575237,0.00026098808,0.00037623727,0.00006693967,0.0017735519,0.00020034667],"about_ca_topic_score_codex":0.00018290602,"about_ca_topic_score_gemma":0.0011383959,"teacher_disagreement_score":0.08487269,"about_ca_system_score_codex":0.0006376236,"about_ca_system_score_gemma":0.0018603029,"threshold_uncertainty_score":0.80502677},"labels":[],"label_agreement":null},{"id":"W2895870246","doi":"10.1186/s40425-018-0420-0","title":"Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study","year":2018,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta; University of Calgary; BC Cancer Agency","funders":"National Cancer Institute; Bristol-Myers Squibb","keywords":"Medicine; Pazopanib; Nivolumab; Sunitinib; Renal cell carcinoma; Tolerability; Discontinuation; Adverse effect; Internal medicine; Clinical endpoint; Oncology; Peripheral edema; Urology; Clinical trial; Cancer; Immunotherapy","score_opus":0.02981774737536692,"score_gpt":0.33283564118325626,"score_spread":0.30301789380788935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895870246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99506634,0.0025991092,0.000081102735,0.00026435588,0.00008855562,0.0017985274,0.0000124205335,0.0000037382376,0.00008581805],"genre_scores_gemma":[0.99763197,0.0007796071,0.0007122122,0.000055246335,0.000041316,0.000073612784,0.0000026314299,0.000034155804,0.00066923327],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99846697,0.00013351675,0.0006830574,0.00016689695,0.0003260175,0.00022354712],"domain_scores_gemma":[0.9986911,0.00026621285,0.0004902993,0.0002186604,0.0002876436,0.00004613096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006439441,0.00018272812,0.00057097676,0.00020316103,0.00008385169,0.000013220595,0.0001160807,0.00003162967,0.00013864627],"category_scores_gemma":[0.000035538753,0.000090260684,0.00007043352,0.0003211861,0.00015788824,0.00010578597,0.00001340064,0.00019499661,2.635915e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5002815,0.007814197,0.18787113,0.0006764894,0.0012644434,0.000280147,0.029534018,0.00029516828,0.11326576,0.00003771272,0.00009890672,0.15858051],"study_design_scores_gemma":[0.091949314,0.02702075,0.8177083,0.0005511792,0.0002654458,0.00014981402,0.0036059786,0.00013291217,0.057772294,0.00004098737,0.0006383928,0.00016461955],"about_ca_topic_score_codex":0.00044812373,"about_ca_topic_score_gemma":0.0015783393,"teacher_disagreement_score":0.6298372,"about_ca_system_score_codex":0.0002493974,"about_ca_system_score_gemma":0.00038170835,"threshold_uncertainty_score":0.3680724},"labels":[],"label_agreement":null},{"id":"W2896264511","doi":"10.1111/his.13754","title":"Data set for the reporting of carcinoma of renal tubular origin: recommendations from the International Collaboration on Cancer Reporting (<scp>ICCR</scp>)","year":2018,"lang":"en","type":"review","venue":"Histopathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Lymphovascular invasion; Penile cancer; Surgical margin; Nephrectomy; Cancer; Lymph node; Surgical pathology; Pathology; General surgery; Internal medicine; Kidney","score_opus":0.2811542948146492,"score_gpt":0.43792993242217054,"score_spread":0.15677563760752133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896264511","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009158589,0.9796099,0.00026466456,0.0014905749,0.0025888786,0.0022786744,0.0037792465,0.000025200217,0.0008042837],"genre_scores_gemma":[0.004542964,0.96814513,0.0035131462,0.00034137638,0.002581296,0.0010312308,0.01758122,0.00013307846,0.0021305252],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99405956,0.0002566253,0.00429069,0.00074762217,0.00040757062,0.00023792741],"domain_scores_gemma":[0.97962976,0.00199646,0.015530442,0.0020629312,0.000727592,0.000052843574],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0030689011,0.0003358468,0.0016395705,0.00015044303,0.00018020747,0.000016784805,0.0006877936,0.00025327445,0.0000613146],"category_scores_gemma":[0.0112186195,0.00019371723,0.0003589068,0.00029144905,0.00024066026,0.000059783786,0.00026087175,0.0003627025,0.000005924044],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033583498,0.00074451807,0.019275077,0.010072225,0.002084006,0.0013569298,0.0048292773,0.000031327163,0.0015311324,0.001123261,0.5609455,0.39767092],"study_design_scores_gemma":[0.00037211116,0.00027414144,0.0017032548,0.0028906171,0.002766082,0.00041777387,0.00022207489,0.00008757811,0.00020754771,0.00004285808,0.99093944,0.00007652758],"about_ca_topic_score_codex":0.0004654174,"about_ca_topic_score_gemma":0.0003555954,"teacher_disagreement_score":0.42999393,"about_ca_system_score_codex":0.000567798,"about_ca_system_score_gemma":0.001514962,"threshold_uncertainty_score":0.9971103},"labels":[],"label_agreement":null},{"id":"W2896783336","doi":"10.1093/annonc/mdy283.088","title":"Activity of cabozantinib (cabo) after PD-1/PD-L1 immune checkpoint blockade (ICB) in metastatic clear cell renal cell carcinoma (mccRCC)","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Cabozantinib; Renal cell carcinoma; Internal medicine; Immune checkpoint; Oncology; Surgery; Cancer; Urology; Gastroenterology; Immunotherapy","score_opus":0.06585146620734529,"score_gpt":0.33995755899635066,"score_spread":0.2741060927890054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896783336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766954,0.0015404775,0.000016563165,0.001263202,0.0001844754,0.0007439514,0.000040857933,0.000020658917,0.019494385],"genre_scores_gemma":[0.99680245,0.00017771035,0.0014112712,0.0002878323,0.00016053233,0.0000651002,0.000018190149,0.000056248376,0.0010206468],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99678713,0.00040121112,0.0010918104,0.00057363557,0.00043661092,0.0007095863],"domain_scores_gemma":[0.99753314,0.00027379263,0.00069173373,0.0008056224,0.00044951675,0.00024616538],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008416252,0.00039321894,0.0014574948,0.00043901283,0.00004084423,0.000006189882,0.00023882545,0.00026330366,0.0007363819],"category_scores_gemma":[0.00010190299,0.00033947465,0.00042863714,0.00042980874,0.00056227064,0.000104359424,0.00020096134,0.00043386375,0.00011015762],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012462599,0.004943819,0.029090328,0.0007254142,0.00021986957,0.0012698765,0.0021035173,0.000010222646,0.94071394,0.000012935768,0.00058528356,0.0078621805],"study_design_scores_gemma":[0.003667945,0.010328347,0.3113095,0.00006948774,0.00020637976,0.000070094495,0.0001508356,0.00007043489,0.6711085,0.000045838024,0.002800353,0.0001722991],"about_ca_topic_score_codex":0.0019399842,"about_ca_topic_score_gemma":0.0002616632,"teacher_disagreement_score":0.28221917,"about_ca_system_score_codex":0.0001289474,"about_ca_system_score_gemma":0.00057483686,"threshold_uncertainty_score":0.9999057},"labels":[],"label_agreement":null},{"id":"W2896809746","doi":"10.1016/j.eururo.2018.10.010","title":"Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions","year":2018,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":251,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"Eisai; Pfizer Pharmaceuticals; Ipsen Biopharmaceuticals","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Cabozantinib; Immunotherapy; Oncology; Internal medicine; Kidney cancer; Bevacizumab; Systemic therapy; Systematic review; Intensive care medicine; MEDLINE; Cancer; Chemotherapy; Breast cancer","score_opus":0.06739911552993089,"score_gpt":0.29867236533035735,"score_spread":0.23127324980042646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896809746","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035863917,0.9608501,0.0000039231404,0.00001554425,0.00044504035,0.0015139466,0.00012857566,0.000021625641,0.0011573156],"genre_scores_gemma":[0.016281592,0.9824777,0.00017740206,0.000010872423,0.000330159,0.000050511728,0.00016662522,0.00013735321,0.00036778892],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958175,0.0016800516,0.0012801572,0.00066191517,0.0001912785,0.00036910217],"domain_scores_gemma":[0.9977275,0.00027955818,0.00088093546,0.00088592886,0.00007609077,0.00015000078],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025896277,0.0006222289,0.002567063,0.0005673671,0.00003816684,0.000010071897,0.00015052724,0.00013499374,0.00005804312],"category_scores_gemma":[0.0000113024835,0.00043976182,0.0005320423,0.0002979469,0.0002361237,0.000037076104,0.00006510957,0.0002923964,0.00007349238],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001063875,0.0036483873,0.0014985815,0.031887032,0.0010935082,0.0015134003,0.0021232376,0.000003723798,0.000233789,0.000031635824,0.001152168,0.95575064],"study_design_scores_gemma":[0.0021134904,0.0061225006,0.0016214725,0.001222822,0.0029138622,0.0008744783,0.00002003409,0.0000050435433,0.00005879468,0.0000010943447,0.98480326,0.00024315873],"about_ca_topic_score_codex":0.00010762693,"about_ca_topic_score_gemma":0.000009166989,"teacher_disagreement_score":0.9836511,"about_ca_system_score_codex":0.00024949538,"about_ca_system_score_gemma":0.00022771975,"threshold_uncertainty_score":0.9998054},"labels":[],"label_agreement":null},{"id":"W2897008012","doi":"10.1093/annonc/mdy283.098","title":"Clinical outcomes of patients with metastatic renal cell carcinoma (mRCC) treated with vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKI) and mammalian target of rapamycin inhibitors (mTORI) after immuno-oncology (IO) checkpoint inhibitors","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Medicine; Axitinib; Pazopanib; Sunitinib; Temsirolimus; Sorafenib; Everolimus; Cabozantinib; Discontinuation; Internal medicine; Hazard ratio; Oncology; Renal cell carcinoma; Tyrosine-kinase inhibitor; Lenvatinib; Urology; Cancer; Hepatocellular carcinoma; PI3K/AKT/mTOR pathway; Confidence interval; Discovery and development of mTOR inhibitors","score_opus":0.03005668430230609,"score_gpt":0.3013022353966353,"score_spread":0.27124555109432924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897008012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957409,0.0007173082,0.000012665472,0.0004347445,0.00044948628,0.001741401,0.0003912172,0.00003437385,0.00047789942],"genre_scores_gemma":[0.994845,0.00013238618,0.003922252,0.00021603476,0.00033132892,0.00011219161,0.00018373365,0.00011780921,0.00013931045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941146,0.00083194184,0.0024454002,0.0009433178,0.0008661694,0.00079856964],"domain_scores_gemma":[0.9945126,0.00063955033,0.0017942002,0.00077564426,0.0017320284,0.0005459489],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008864837,0.00079361047,0.002932377,0.0006242049,0.000080900085,0.0000106755315,0.0002338314,0.00051458925,0.00030653892],"category_scores_gemma":[0.00034254327,0.0005308045,0.0006119322,0.00056152296,0.0019424295,0.00020787364,0.00018921867,0.00046070354,0.000012231693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01576863,0.0049041696,0.94998294,0.00045096866,0.0012591919,0.0002276057,0.001205636,0.0000013114264,0.022566475,0.0000089573605,0.000630004,0.0029941385],"study_design_scores_gemma":[0.013830646,0.050920814,0.50884277,0.00015729427,0.00074003654,0.000018009396,0.00021904329,0.0000022386935,0.4229226,0.000014151959,0.0020031915,0.00032917171],"about_ca_topic_score_codex":0.0007663178,"about_ca_topic_score_gemma":0.0001323548,"teacher_disagreement_score":0.44114012,"about_ca_system_score_codex":0.00025728028,"about_ca_system_score_gemma":0.0007912469,"threshold_uncertainty_score":0.9997144},"labels":[],"label_agreement":null},{"id":"W2897051754","doi":"10.1016/j.ijrobp.2018.06.275","title":"Renal SABR in Patients with a Solitary Kidney: An Individual-Patient Pooled Analysis from the International Radiosurgery Oncology Consortium for Kidney (IROCK)","year":2018,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Cancer Care Ontario","funders":"","keywords":"Medicine; SABR volatility model; Renal cell carcinoma; Cohort; Urology; Radiosurgery; Renal function; Kidney cancer; Proportional hazards model; Exact test; Kidney; Pathological; Kidney disease; Clear cell; Internal medicine; Oncology; Radiation therapy","score_opus":0.020602599885935054,"score_gpt":0.30290497292081214,"score_spread":0.2823023730348771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897051754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827115,0.00013841686,0.0042700167,0.008531586,0.002337797,0.00068955065,0.0009215946,0.000029402381,0.0003701489],"genre_scores_gemma":[0.97829485,0.000065024644,0.0062151547,0.009190083,0.0030205725,0.000064311665,0.0030853553,0.0000429606,0.000021689928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965507,0.00046367847,0.0013523237,0.0005036613,0.0007330676,0.0003965897],"domain_scores_gemma":[0.9946198,0.0009703033,0.0017222429,0.00035154895,0.0018853646,0.00045075442],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00084625464,0.0003574765,0.000930718,0.0005628017,0.00012459842,0.000053132466,0.0007074639,0.000324742,0.00022964881],"category_scores_gemma":[0.00094296504,0.00025019347,0.00045721623,0.0004449562,0.00042922515,0.00039310975,0.000120991695,0.00054320676,0.000016183652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006022296,0.0020795518,0.92538595,0.0000038947965,0.009214537,0.00007288522,0.0015080214,0.00022754975,0.0009780683,0.0004583464,0.006801806,0.04724709],"study_design_scores_gemma":[0.02420643,0.010896432,0.8957845,0.00012783142,0.00390321,0.000104734776,0.00029905225,0.0030115768,0.0031101974,0.0027807301,0.05534439,0.0004309052],"about_ca_topic_score_codex":0.00015285028,"about_ca_topic_score_gemma":0.0000740232,"teacher_disagreement_score":0.048542585,"about_ca_system_score_codex":0.0019151486,"about_ca_system_score_gemma":0.0020703792,"threshold_uncertainty_score":0.99999505},"labels":[],"label_agreement":null},{"id":"W2897161734","doi":"10.1002/cncr.31595","title":"Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium","year":2018,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; University of Ottawa; Health Sciences Centre; University of Alberta; Queen Elizabeth II Health Sciences Centre; McMaster University; London Health Sciences Centre; Princess Margaret Cancer Centre","funders":"Foundation Medicine; Novartis Pharma; Genentech; Ipsen; Celldex Therapeutics; Astellas Pharma; Eisai; National Comprehensive Cancer Network; Sanofi; Exelixis; GlaxoSmithKline; Bristol-Myers Squibb; AstraZeneca; Pfizer","keywords":"Medicine; Nivolumab; Renal cell carcinoma; Ipilimumab; Internal medicine; Oncology; Clear cell renal cell carcinoma; Retrospective cohort study; Carcinoma; Cancer; Gastroenterology; Immunotherapy","score_opus":0.027319987898225866,"score_gpt":0.2602327787762104,"score_spread":0.23291279087798455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897161734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99126375,0.0009875288,0.00004735813,0.00090621755,0.0006070431,0.0011597599,0.0016247059,0.000030954958,0.003372674],"genre_scores_gemma":[0.99435234,0.00001836183,0.0017690788,0.00067776476,0.0005499439,0.00017832614,0.0013721096,0.00007075386,0.0010113036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99646604,0.00018074225,0.0008876927,0.0008905924,0.0010118816,0.000563056],"domain_scores_gemma":[0.99756896,0.0002808377,0.0004593071,0.0009555333,0.00043757257,0.00029779057],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039566777,0.00047477407,0.0005673015,0.00019352611,0.00012283343,0.000058902082,0.00037144168,0.000060007013,0.00060314],"category_scores_gemma":[0.00011872515,0.00029813632,0.00015332158,0.00039133153,0.00036936603,0.0002100689,0.00018826594,0.00044132816,0.000114272974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014586257,0.0021909068,0.90967894,0.00019906068,0.00054288283,0.0012247267,0.005107744,0.000115803465,0.02597157,0.000019210833,0.03865595,0.0017069767],"study_design_scores_gemma":[0.024667503,0.0014599399,0.6989009,0.00028110825,0.0009595631,0.0000143888865,0.00050859596,0.0003192856,0.26837426,0.00002592783,0.004014298,0.00047426255],"about_ca_topic_score_codex":0.0062695094,"about_ca_topic_score_gemma":0.0016483878,"teacher_disagreement_score":0.24240269,"about_ca_system_score_codex":0.0008156525,"about_ca_system_score_gemma":0.00067772606,"threshold_uncertainty_score":0.9999471},"labels":[],"label_agreement":null},{"id":"W2897300072","doi":"10.1093/annonc/mdy283.080","title":"KEYNOTE-427 cohort A: Pembrolizumab monotherapy as first-line therapy in advanced clear cell renal cell carcinoma (ccRCC)","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Pembrolizumab; Cohort; Internal medicine; Clear cell renal cell carcinoma; Clinical endpoint; Oncology; Renal cell carcinoma; Progressive disease; Response Evaluation Criteria in Solid Tumors; Surgery; Urology; Chemotherapy; Cancer; Clinical trial; Immunotherapy","score_opus":0.05574008702059895,"score_gpt":0.3487237175352484,"score_spread":0.29298363051464943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897300072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9406052,0.0026671907,0.000022226344,0.0027293824,0.00021297995,0.0011154842,0.000010915687,0.000045632463,0.05259099],"genre_scores_gemma":[0.98977774,0.0040729847,0.00074466463,0.002731988,0.00036101718,0.00009597907,0.000036978694,0.000080676466,0.0020979517],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99724275,0.00019836289,0.00079168973,0.00067106466,0.00039731918,0.00069881097],"domain_scores_gemma":[0.99792427,0.00022463445,0.00037608622,0.00076040387,0.00044074646,0.00027385546],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041980957,0.00040552288,0.0010605656,0.0003462159,0.00008391607,0.000008397914,0.00026874398,0.00036819765,0.00082178705],"category_scores_gemma":[0.00004431678,0.00034495088,0.00028394331,0.000364553,0.000341667,0.000099385004,0.00006740895,0.00035746727,0.00024947393],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11449586,0.014039533,0.34781092,0.0004282317,0.00062976027,0.0033672526,0.006519396,0.00032672947,0.3028634,0.00019884403,0.017721903,0.19159816],"study_design_scores_gemma":[0.018557223,0.06740283,0.27987728,0.000054376167,0.00006527004,0.00011892223,0.000115016526,0.00013572689,0.5605758,0.0003516891,0.07240287,0.00034304644],"about_ca_topic_score_codex":0.0007122857,"about_ca_topic_score_gemma":0.00020614485,"teacher_disagreement_score":0.25771236,"about_ca_system_score_codex":0.0002225172,"about_ca_system_score_gemma":0.00048397257,"threshold_uncertainty_score":0.9999002},"labels":[],"label_agreement":null},{"id":"W2897371817","doi":"10.1016/j.ijrobp.2018.07.365","title":"Identifying Potential Predictors of Late Renal Toxicity after Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: A Prospective Cohort Study","year":2018,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Renal cell carcinoma; Toxicity; Renal function; Urology; Kidney disease; Proportional hazards model; Cohort; Prospective cohort study; Internal medicine; Oncology","score_opus":0.015720626115207775,"score_gpt":0.30502416472644694,"score_spread":0.28930353861123914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897371817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900967,0.000454763,0.0048235515,0.00024597943,0.0021459816,0.0018084036,0.000089780435,0.000027195174,0.00030764093],"genre_scores_gemma":[0.9943257,0.0001424474,0.0010313244,0.00023029803,0.0038672246,0.00012146789,0.00012796844,0.000047733283,0.00010586841],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99712116,0.00034073286,0.0011844337,0.00042889765,0.0006189628,0.00030581577],"domain_scores_gemma":[0.99568343,0.0002557669,0.0018254911,0.00025344978,0.0018202933,0.00016158643],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00087938627,0.00031679086,0.00077946484,0.0003250532,0.000103052735,0.00003707116,0.00031386735,0.00023312643,0.00007001291],"category_scores_gemma":[0.00012533172,0.00026619248,0.00042266143,0.00019584518,0.0002460371,0.00040244366,0.00007273521,0.00039736833,0.00000982542],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068691936,0.0022242668,0.934487,0.000021006443,0.0017167758,0.00009202964,0.0012808428,0.000041802075,0.04662622,0.000053650423,0.00019131514,0.0063959192],"study_design_scores_gemma":[0.013977664,0.011170272,0.92053604,0.000035933543,0.0006561807,0.0001290905,0.000058600333,0.00037174727,0.051640905,0.00084328995,0.00039649097,0.00018379185],"about_ca_topic_score_codex":0.00003332911,"about_ca_topic_score_gemma":0.000005455058,"teacher_disagreement_score":0.013950946,"about_ca_system_score_codex":0.0015543594,"about_ca_system_score_gemma":0.00078874547,"threshold_uncertainty_score":0.999979},"labels":[],"label_agreement":null},{"id":"W2897917006","doi":"10.1016/j.crad.2018.09.003","title":"Contemporary update on imaging of cystic renal masses with histopathological correlation and emphasis on patient management","year":2018,"lang":"en","type":"review","venue":"Clinical Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Radiology; Angiomyolipoma; Renal cell carcinoma; Magnetic resonance imaging; Serous fluid; Ultrasound; Kidney; Pathology; Internal medicine","score_opus":0.1057053738260107,"score_gpt":0.3828939468170462,"score_spread":0.2771885729910355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897917006","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009864525,0.97938275,0.00015384691,0.00011853419,0.00046145666,0.0016270078,0.000024916435,0.000043281343,0.008323699],"genre_scores_gemma":[0.04571523,0.95091385,0.0018643567,0.0005405979,0.00023382425,0.000118318705,0.00035376727,0.000051476654,0.00020855734],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964921,0.00082411745,0.0013541951,0.0008625608,0.00022355055,0.00024349791],"domain_scores_gemma":[0.9968894,0.0014328676,0.0008209214,0.0005972925,0.00006753186,0.00019197824],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005999098,0.00043244316,0.002455334,0.00021822863,0.000042964344,0.000005765343,0.00011195015,0.00034366897,0.00003539312],"category_scores_gemma":[0.00028899408,0.0002508464,0.00037423155,0.00011570189,0.00071915856,0.000018254937,0.00008505221,0.0005004196,0.0000756131],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023621663,0.0008174757,0.008958785,0.0031309628,0.000624792,0.0048095244,0.000016917054,0.0000019456877,1.6998324e-7,0.00046242872,0.007717787,0.97109705],"study_design_scores_gemma":[0.0024593235,0.016798386,0.01192096,0.010789479,0.0027588008,0.0014062857,0.000012698359,0.00002397037,0.0000011744211,0.000070198934,0.9534242,0.000334511],"about_ca_topic_score_codex":0.0000014720918,"about_ca_topic_score_gemma":1.3221485e-7,"teacher_disagreement_score":0.97076255,"about_ca_system_score_codex":0.00018891584,"about_ca_system_score_gemma":0.00013614427,"threshold_uncertainty_score":0.9999944},"labels":[],"label_agreement":null},{"id":"W2898472087","doi":"10.1093/annonc/mdy424.036","title":"JAVELIN renal 101: A randomized, phase III study of avelumab + axitinib vs sunitinib as first-line treatment of advanced renal cell carcinoma (aRCC)","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Pfizer","keywords":"Medicine; Internal medicine; Clinical endpoint; Axitinib; Progression-free survival; Sunitinib; Renal cell carcinoma; Oncology; Randomized controlled trial; Gastroenterology; Urology; Overall survival","score_opus":0.0815391772182499,"score_gpt":0.3859280008197945,"score_spread":0.3043888236015446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898472087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788849,0.0010327653,0.000036637768,0.0009097903,0.00017758661,0.0035010374,0.00010256605,0.000028842012,0.0153259095],"genre_scores_gemma":[0.9962881,0.00053059467,0.0008810242,0.00019177662,0.00033393293,0.0003006008,0.00014969897,0.000056995188,0.0012672332],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99543256,0.00062911655,0.0020553106,0.00065498997,0.0006193788,0.00060864416],"domain_scores_gemma":[0.99483484,0.0011110766,0.0014405857,0.0009183314,0.0013500095,0.00034517355],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00087417115,0.0005295962,0.0033100485,0.0004925927,0.000098169345,0.000004557383,0.00024602303,0.0002621888,0.00086555595],"category_scores_gemma":[0.00031012052,0.00040464278,0.00066966476,0.00039156026,0.0008667126,0.00007576272,0.00010541276,0.0001811386,0.000038804446],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81907237,0.05672358,0.0016089848,0.00031502996,0.0019490609,0.0014323856,0.01433742,0.00006342796,0.03642847,0.00011565489,0.0011040872,0.06684955],"study_design_scores_gemma":[0.4371138,0.1818352,0.0016543625,0.00010468093,0.001079264,0.00013334448,0.001265953,0.00008540728,0.3724278,0.00010121311,0.003990682,0.00020832711],"about_ca_topic_score_codex":0.0017700179,"about_ca_topic_score_gemma":0.0004933169,"teacher_disagreement_score":0.38195854,"about_ca_system_score_codex":0.00017720151,"about_ca_system_score_gemma":0.00074944925,"threshold_uncertainty_score":0.99984056},"labels":[],"label_agreement":null},{"id":"W2898786130","doi":"10.3747/co.25.3865","title":"Is There a Role for Adjuvant Therapy After Surgery in “High Risk for Recurrence” Kidney Cancer? an Update on Current Concepts","year":2018,"lang":"en","type":"review","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Pazopanib; Sunitinib; Sorafenib; Adjuvant therapy; Adjuvant; Clinical trial; Population; Internal medicine; Oncology; Renal cell carcinoma; Randomized controlled trial; Kidney cancer; Disease; Cancer; Surgery; Hepatocellular carcinoma","score_opus":0.20687280242281628,"score_gpt":0.47438939155248544,"score_spread":0.26751658912966914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898786130","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006304538,0.9728709,0.000039976163,0.00024806662,0.007190806,0.008591976,0.004635804,0.000061777006,0.000056148892],"genre_scores_gemma":[0.0011245592,0.9735159,0.00014612447,0.00028583812,0.002609175,0.018957298,0.003124073,0.00018206099,0.000054959928],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99453455,0.0007763298,0.0015367811,0.0016679257,0.0003880477,0.0010963826],"domain_scores_gemma":[0.9954755,0.0011329005,0.0012619478,0.0010581207,0.00040463946,0.00066690857],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009551463,0.0011545693,0.0045538615,0.0005911076,0.000115854804,0.000034740046,0.00039810463,0.0006922126,0.00048296005],"category_scores_gemma":[0.00026905612,0.0008078654,0.0015560845,0.00037150475,0.00026303742,0.000091920454,0.000082505685,0.0009645387,0.000117425254],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001452114,0.0018926443,0.0034821243,0.0093875015,0.00029845818,0.000023908826,0.00029521168,1.3766194e-7,1.4723153e-7,0.00003069161,0.024867505,0.95826954],"study_design_scores_gemma":[0.004055986,0.003972605,0.0006154126,0.021550732,0.0017234004,0.000022214901,0.000025766863,0.00003138387,0.00001679591,0.0003543666,0.9669319,0.0006994828],"about_ca_topic_score_codex":0.00009746767,"about_ca_topic_score_gemma":0.00013724797,"teacher_disagreement_score":0.9575701,"about_ca_system_score_codex":0.0019518259,"about_ca_system_score_gemma":0.0038098593,"threshold_uncertainty_score":0.9994372},"labels":[],"label_agreement":null},{"id":"W2898835023","doi":"10.1200/jco.2018.79.0147","title":"Prognostication in Kidney Cancer: Recent Advances and Future Directions","year":2018,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Disease; Renal cell carcinoma; Kidney cancer; Cancer; Clinical trial; Oncology; Internal medicine; Localized disease; Systemic therapy; Bioinformatics; Prostate cancer","score_opus":0.1885659619419373,"score_gpt":0.5265841929566255,"score_spread":0.3380182310146882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898835023","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000116617,0.9886004,0.0000016842339,0.005432204,0.0031583232,0.00061843323,0.000008952224,0.0000060686402,0.0020573714],"genre_scores_gemma":[0.000006114036,0.99098164,0.0013771873,0.00039829567,0.006998106,0.000050497343,0.000013354161,0.000023003731,0.00015178355],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957568,0.00065436674,0.0028843847,0.0002734058,0.0002470057,0.00018405181],"domain_scores_gemma":[0.99458486,0.0014662833,0.0028009324,0.00018297535,0.000435881,0.00052905193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017408652,0.00022702987,0.0036192145,0.00024757223,0.000028082059,0.0000071888785,0.00010777247,0.0007067031,0.00012701744],"category_scores_gemma":[0.003158704,0.00013566444,0.00053760473,0.00028522135,0.00019307606,0.00007622573,0.000037828584,0.0012585004,0.0000130219],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026588832,0.0006505863,0.0014661752,0.0028649783,0.000299442,0.00024596695,0.000020208505,2.1468313e-8,3.009729e-8,0.000008175344,0.002526742,0.9916518],"study_design_scores_gemma":[0.0015353804,0.005203827,0.003286391,0.008310962,0.0028124985,0.0009644341,0.000014130183,6.6576604e-7,2.567386e-7,0.000042592736,0.97773135,0.00009751558],"about_ca_topic_score_codex":0.000007349795,"about_ca_topic_score_gemma":0.0000522994,"teacher_disagreement_score":0.99155426,"about_ca_system_score_codex":0.0005722684,"about_ca_system_score_gemma":0.0052128853,"threshold_uncertainty_score":0.9247434},"labels":[],"label_agreement":null},{"id":"W2899562057","doi":"10.1007/s00345-018-2555-5","title":"Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma","year":2018,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Interquartile range; Renal cell carcinoma; Lymph node; Nephrectomy; Cohort; Stage (stratigraphy); Clear cell renal cell carcinoma; Nephrology; Lymphadenectomy; Pathological staging; Internal medicine; Pathological; Radiology; Oncology; Urology; Kidney","score_opus":0.0202922212998276,"score_gpt":0.23801507475573191,"score_spread":0.2177228534559043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899562057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99730945,0.00026791394,0.0015446694,0.0001310385,0.00009467755,0.000263789,0.0000032057046,0.000004047916,0.0003812232],"genre_scores_gemma":[0.9708885,0.0000063887837,0.028667983,0.00013124546,0.00015288987,0.000004293407,0.0000061321857,0.000017098135,0.00012550216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987626,0.00006260253,0.0004933023,0.00018095042,0.0002723451,0.0002281943],"domain_scores_gemma":[0.99875253,0.000080931044,0.00049519865,0.00011397993,0.00041329348,0.00014403436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027906257,0.00014797926,0.00036925412,0.00025025776,0.00006116518,0.000008222508,0.00007556929,0.00005497896,0.000050424012],"category_scores_gemma":[0.000021027729,0.00009896527,0.00006679189,0.00009494816,0.00015068174,0.00005711003,0.000039777104,0.00017394776,0.0000025993686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012105275,0.0007616574,0.9552382,0.00011981838,0.00005806566,0.0002731821,0.001031156,0.000009712849,0.02303222,0.00002881465,0.00013691327,0.007204973],"study_design_scores_gemma":[0.00878599,0.018138424,0.8636283,0.00006237668,0.00029877987,0.0002767577,0.0000543417,0.00003186415,0.10586422,0.000058255027,0.0026677446,0.00013293086],"about_ca_topic_score_codex":0.000001950767,"about_ca_topic_score_gemma":0.0000040251475,"teacher_disagreement_score":0.091609895,"about_ca_system_score_codex":0.00006831987,"about_ca_system_score_gemma":0.00013491382,"threshold_uncertainty_score":0.40356866},"labels":[],"label_agreement":null},{"id":"W2899667855","doi":"10.1016/j.jpedsurg.2018.10.095","title":"Volume and function of the operated kidney after nephron-sparing surgery for unilateral renal tumor","year":2018,"lang":"en","type":"article","venue":"Journal of Pediatric Surgery","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; SickKids Foundation","funders":"Nando and Elsa Peretti Foundation","keywords":"Medicine; Nephron; Renal function; Kidney; Urology; Surgery; Nephrectomy; Internal medicine","score_opus":0.022302247431015356,"score_gpt":0.23323902386891954,"score_spread":0.21093677643790418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899667855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965648,0.0010630284,0.00011046381,0.00051695143,0.0014913913,0.00019100624,0.000008313526,0.0000075483067,0.00004647642],"genre_scores_gemma":[0.99390143,0.00015800448,0.00018182101,0.00040178528,0.004959273,0.000008510044,0.000004422261,0.000026176926,0.00035855826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983635,0.000092738,0.0007850351,0.00015196193,0.00035423454,0.00025252948],"domain_scores_gemma":[0.9979409,0.00046358438,0.00059925084,0.00019130656,0.00056656275,0.0002383847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096159807,0.000165531,0.00056168693,0.00036764194,0.00007397974,0.000024360901,0.000052866784,0.00007088849,0.000115317634],"category_scores_gemma":[0.00053927756,0.00010214092,0.00041146344,0.0003651461,0.00008527631,0.00016788367,0.00003825048,0.00016584258,0.00000371761],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022657728,0.0000997803,0.9226542,0.00015948164,0.00014793372,0.00009304059,0.00006661896,0.0000030968329,0.0017547971,9.0848863e-7,0.07155676,0.0011975745],"study_design_scores_gemma":[0.00097104313,0.00043124356,0.9868687,0.00016495667,0.00094582886,0.00039322418,0.000024559737,0.00009746705,0.004511779,0.000023598672,0.00543499,0.00013265129],"about_ca_topic_score_codex":0.000019024688,"about_ca_topic_score_gemma":0.0000021515727,"teacher_disagreement_score":0.06612177,"about_ca_system_score_codex":0.00009938152,"about_ca_system_score_gemma":0.00071895565,"threshold_uncertainty_score":0.41651857},"labels":[],"label_agreement":null},{"id":"W2900345444","doi":"10.1016/j.euo.2018.10.003","title":"Adjuvant Radiation Therapy After Radical Nephrectomy in Patients with Localized Renal Cell Carcinoma: A Systematic Review and Meta-analysis","year":2018,"lang":"en","type":"review","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Queen's University","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Radiation therapy; Hazard ratio; Internal medicine; Oncology; Meta-analysis; Adjuvant therapy; Adjuvant; Proportional hazards model; Randomized controlled trial; Kidney cancer; Surgery; Cancer; Kidney; Confidence interval","score_opus":0.03927091721695056,"score_gpt":0.29670798988080344,"score_spread":0.25743707266385285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900345444","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011411736,0.99072134,0.000017525817,0.00019028863,0.000047952966,0.0067361,0.000042335807,0.000038802642,0.0010644696],"genre_scores_gemma":[0.0045585595,0.98976433,0.0003918109,0.00309403,0.00008249131,0.0010683419,0.0005182268,0.00015367783,0.0003685323],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98769337,0.008182068,0.0019263156,0.001245158,0.0003729577,0.00058011914],"domain_scores_gemma":[0.99658257,0.00048890966,0.0012950134,0.0011547321,0.00015637392,0.00032241357],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001578688,0.0009588179,0.012701235,0.0008803852,0.000052315812,0.000016473448,0.00028852996,0.0004121892,0.00058953575],"category_scores_gemma":[0.000108838176,0.0005324132,0.0016720439,0.00091873854,0.00043022214,0.00004812681,0.00013606827,0.0007751181,0.0002536541],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026082138,0.0030098471,0.0051527256,0.7590341,0.20620145,0.008374751,0.00037497535,0.0000011123242,1.1309658e-7,0.0000055253463,0.0015747179,0.013662449],"study_design_scores_gemma":[0.0037253862,0.0046909577,0.0020767779,0.0014748812,0.6982416,0.00024606584,0.0000010982886,0.0000015049982,1.4675906e-7,6.2342133e-7,0.28918967,0.00035131266],"about_ca_topic_score_codex":0.000015640315,"about_ca_topic_score_gemma":0.000018288918,"teacher_disagreement_score":0.75755924,"about_ca_system_score_codex":0.00041674584,"about_ca_system_score_gemma":0.00036113666,"threshold_uncertainty_score":0.99971277},"labels":[],"label_agreement":null},{"id":"W2900717648","doi":"10.1111/his.13791","title":"Reactivity of <scp>CK</scp>7 across the spectrum of renal cell carcinomas with clear cells","year":2018,"lang":"en","type":"article","venue":"Histopathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Royal Columbian Hospital","funders":"Univerzita Karlova v Praze","keywords":"Clear cell; Cytokeratin; Pathology; Renal cell carcinoma; Cell; Clear cell renal cell carcinoma; Medicine; Papillary renal cell carcinomas; Neoplasm; Immunostaining; Oncocytoma; Staining; Immunohistochemistry; Biology","score_opus":0.015155786296114722,"score_gpt":0.24158008256956104,"score_spread":0.22642429627344632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900717648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97073126,0.00046033747,0.0001260167,0.00011247815,0.00018888807,0.00036491393,0.000024270752,0.000026476266,0.027965363],"genre_scores_gemma":[0.9963045,0.000020809759,0.0006456296,0.00009648672,0.00017599613,0.00001294084,0.000007494201,0.00003712602,0.002699022],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983774,0.00016691328,0.00035086405,0.00038885395,0.0002975554,0.00041844638],"domain_scores_gemma":[0.99830234,0.0001937666,0.0003610632,0.00087112875,0.00016697955,0.00010471057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039255133,0.0002211109,0.0005673618,0.00008310529,0.00009916468,0.0000035213786,0.00018519067,0.00013896833,0.00004488037],"category_scores_gemma":[0.000048646678,0.00013947359,0.0001405407,0.00021383008,0.0012846235,0.00003719513,0.00009503553,0.0002598699,0.000066561006],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005727153,0.0004844883,0.04714242,0.00014938432,0.000019454157,0.0007117353,0.005666799,0.0000046606133,0.9434361,0.00014660861,0.001460098,0.00020554542],"study_design_scores_gemma":[0.0010824674,0.0037129363,0.3557808,0.000022063927,0.00015963001,0.00061515573,0.0003368756,0.000009562955,0.63262826,0.0000547306,0.005552876,0.00004465886],"about_ca_topic_score_codex":0.0002514667,"about_ca_topic_score_gemma":0.000110740875,"teacher_disagreement_score":0.31080785,"about_ca_system_score_codex":0.00015045957,"about_ca_system_score_gemma":0.00015011747,"threshold_uncertainty_score":0.56875676},"labels":[],"label_agreement":null},{"id":"W2900877533","doi":"10.1101/mcs.a003137","title":"Whole-genome and transcriptome profiling of a metastatic thyroid-like follicular renal cell carcinoma","year":2018,"lang":"en","type":"article","venue":"Molecular Case Studies","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre; Vancouver General Hospital; Abbotsford Veterinary Clinic","funders":"BC Cancer Foundation; University of British Columbia; Canada Research Chairs; Genome British Columbia; Michael Smith Health Research BC; Canadian Institutes of Health Research; Genome Canada","keywords":"PDGFRB; PDGFRA; Transcriptome; Cancer research; Biology; Medicine; Oncology; Genetics; Gene; Gene expression; Stromal cell","score_opus":0.03151225445667651,"score_gpt":0.28255137713825823,"score_spread":0.25103912268158174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900877533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9604615,0.037236296,0.00052892737,0.00017953616,0.000075585405,0.0007766176,0.000045337474,0.000030995045,0.00066518446],"genre_scores_gemma":[0.993069,0.00008402111,0.0062078196,0.00018601943,0.000060168517,0.00007253597,0.000024184537,0.000044441516,0.00025183335],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983189,0.00010345172,0.0004094606,0.00046369675,0.00035069638,0.00035378366],"domain_scores_gemma":[0.99893683,0.000042059208,0.000116036754,0.00042170304,0.00031945793,0.00016389946],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021750088,0.000321919,0.0006996126,0.00018455551,0.00013884902,0.000012170804,0.000056748286,0.000047722904,0.000009715339],"category_scores_gemma":[0.00004140146,0.00025102214,0.00021686616,0.00025894662,0.00041700152,0.00004667366,0.00008323851,0.00012266103,0.000012124008],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018101004,0.00015268844,0.00082411134,0.0006243646,0.0007312383,0.033877138,0.002662467,0.0000034715326,0.96069264,0.000043890963,0.000058291927,0.00014866027],"study_design_scores_gemma":[0.004491149,0.0042821467,0.0018107309,0.00010155047,0.0027426828,0.009382174,0.0038524864,0.00008208016,0.97202283,0.00011970775,0.000736178,0.00037627347],"about_ca_topic_score_codex":0.000051718573,"about_ca_topic_score_gemma":0.000011827684,"teacher_disagreement_score":0.03715227,"about_ca_system_score_codex":0.00008178816,"about_ca_system_score_gemma":0.00006423683,"threshold_uncertainty_score":0.9999942},"labels":[],"label_agreement":null},{"id":"W2901492218","doi":"10.1016/j.anndiagpath.2018.11.004","title":"Papillary pattern in clear cell renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 23 cases","year":2018,"lang":"en","type":"article","venue":"Annals of Diagnostic Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Royal Columbian Hospital","funders":"Univerzita Karlova v Praze","keywords":"Pathology; Immunohistochemistry; Clear cell; Papillary renal cell carcinomas; Papillary tumor; Renal cell carcinoma; Differential diagnosis; Clear cell renal cell carcinoma; Medicine; Metastasis; TFE3; Surgical pathology; Biology; Cancer; Internal medicine; Gene","score_opus":0.038436310060085986,"score_gpt":0.31011241572652304,"score_spread":0.2716761056664371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901492218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854547,0.013070809,0.00012885524,0.00020020969,0.00006488125,0.00042222627,0.00007908474,0.000017035856,0.0005621948],"genre_scores_gemma":[0.99646103,0.0016034452,0.0009065393,0.00079069193,0.000046007237,0.000041151558,0.00009808899,0.000029006254,0.000024032288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971995,0.00036882408,0.0009954481,0.00068602513,0.00026086185,0.0004893676],"domain_scores_gemma":[0.99672604,0.0016171548,0.00044314444,0.00074995984,0.00028855694,0.00017514922],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044823062,0.00032865407,0.0012718281,0.00060047844,0.00003192472,0.0000045128036,0.00019001802,0.00032964288,0.00014674904],"category_scores_gemma":[0.0012219427,0.00028669788,0.0003413288,0.0005692542,0.0008544639,0.000029246683,0.00020648347,0.00025108526,0.000023400815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039261414,0.001013902,0.6228667,0.0001613863,0.0001287512,0.018511772,0.00040344428,0.000021532027,0.35446602,0.0000036507008,0.00022385074,0.0018064072],"study_design_scores_gemma":[0.0010686191,0.0047849263,0.66315556,0.000040471263,0.0010228121,0.00042981247,0.00008195687,0.00006517476,0.32910687,0.00006707296,0.000010969776,0.00016577385],"about_ca_topic_score_codex":0.00024051925,"about_ca_topic_score_gemma":0.000018869297,"teacher_disagreement_score":0.040288873,"about_ca_system_score_codex":0.000033558426,"about_ca_system_score_gemma":0.000084133666,"threshold_uncertainty_score":0.9999585},"labels":[],"label_agreement":null},{"id":"W2901952796","doi":"10.1016/j.hpb.2018.07.015","title":"Renal outcomes following left renal vein harvest for venous reconstruction during pancreas and liver surgery","year":2018,"lang":"en","type":"article","venue":"HPB","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; University Health Network","funders":"","keywords":"Medicine; Renal function; Kidney disease; Creatinine; Acute kidney injury; Logistic regression; Urology; Kidney; Surgery; Internal medicine; Gastroenterology","score_opus":0.03626826919290924,"score_gpt":0.252646080285931,"score_spread":0.21637781109302176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901952796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99761146,0.00044190878,0.00022457282,0.00007963722,0.0004227354,0.00033973294,0.0000057997127,0.000051497154,0.00082266494],"genre_scores_gemma":[0.9925761,0.000040585808,0.0035216003,0.00006395842,0.00040209468,0.00002347057,0.000020721262,0.000030029061,0.003321434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990019,0.000032553173,0.00023858715,0.0002936725,0.00015711703,0.00027614174],"domain_scores_gemma":[0.9993135,0.00019305722,0.0000787709,0.000212665,0.00006152209,0.00014049733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018750962,0.00016109823,0.0003764103,0.00012013669,0.00016882524,0.000031028605,0.000029284165,0.00007679131,0.00008348827],"category_scores_gemma":[0.00015816091,0.00013331414,0.00019894127,0.000053129617,0.00008002552,0.00012991285,0.000025123198,0.00007797108,0.000059556274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007173903,0.00019368087,0.86443114,0.00023175222,0.0005770959,0.0004233956,0.00053244916,7.501648e-7,0.05715218,0.000013072269,0.001012234,0.07471485],"study_design_scores_gemma":[0.0015768923,0.00043760575,0.960441,0.0002588406,0.00028340376,0.0009265908,0.000051227827,0.0000965002,0.033993196,0.000013215275,0.0017453015,0.00017624196],"about_ca_topic_score_codex":0.00009719312,"about_ca_topic_score_gemma":0.00005686204,"teacher_disagreement_score":0.09600983,"about_ca_system_score_codex":0.00011442635,"about_ca_system_score_gemma":0.00006645462,"threshold_uncertainty_score":0.54363924},"labels":[],"label_agreement":null},{"id":"W2902071034","doi":"10.1038/s41416-018-0297-1","title":"Pre- and post-operative anti-PD-L1 plus anti-angiogenic therapies in mouse breast or renal cancer models of micro- or macro-metastatic disease","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Genentech; Cure Brain Cancer Foundation; University of Toronto","keywords":"Medicine; Breast cancer; Disease; Metastatic breast cancer; Cancer; Oncology; Kidney cancer; Internal medicine; Cancer research; Pathology","score_opus":0.02330542606875529,"score_gpt":0.3082916745140264,"score_spread":0.2849862484452711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902071034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94800097,0.050011482,0.000051811498,0.00052233035,0.00011666801,0.0004920054,0.0007634239,0.0000074991203,0.000033808952],"genre_scores_gemma":[0.9835429,0.01366823,0.00075420894,0.00036048616,0.0002828304,0.000034957797,0.000008411746,0.000048958693,0.0012989729],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980823,0.00012369026,0.00071029627,0.0002784128,0.00046208088,0.0003432133],"domain_scores_gemma":[0.9982695,0.000059557584,0.00040431388,0.00017185097,0.000768299,0.0003264614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002057258,0.00024831996,0.00080882077,0.00020719499,0.000074515025,0.00006256104,0.0001396396,0.000048713577,0.0006412799],"category_scores_gemma":[0.00003955262,0.00018249189,0.00018948462,0.00024569134,0.00032912756,0.00034131994,0.000041217067,0.00022192195,0.0000012938024],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07279356,0.0024867211,0.1713341,0.0018651604,0.0069621373,0.027019773,0.013011494,0.0039791646,0.5648485,0.000026405904,0.0029868193,0.13268618],"study_design_scores_gemma":[0.014336024,0.0018558663,0.920307,0.0048820963,0.0012550183,0.013496878,0.00069705414,0.00082619046,0.041648842,0.000059046342,0.0001978084,0.00043820063],"about_ca_topic_score_codex":0.0035985617,"about_ca_topic_score_gemma":0.003808194,"teacher_disagreement_score":0.7489729,"about_ca_system_score_codex":0.00035171214,"about_ca_system_score_gemma":0.0015042343,"threshold_uncertainty_score":0.7441803},"labels":[],"label_agreement":null},{"id":"W2902813781","doi":"10.5489/cuaj.5545","title":"Growth rates and outcomes of observed large renal masses","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Retrospective cohort study; Natural history; Metastasis; Life expectancy; Confidence interval; Internal medicine; Cancer; Surgery; Population","score_opus":0.029969340090283743,"score_gpt":0.2515012356056955,"score_spread":0.22153189551541175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902813781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838874,0.00022859874,0.000019571293,0.013886944,0.00011354679,0.00010034063,0.000024000303,0.000009808038,0.0017298139],"genre_scores_gemma":[0.99663985,0.000047059635,0.00050509744,0.001909655,0.00022722175,0.0000024373976,0.000009396815,0.0000075866856,0.00065167726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888635,0.000110167064,0.0002826986,0.00013105669,0.00024981846,0.00033993868],"domain_scores_gemma":[0.9986358,0.00014878482,0.00021519668,0.00007209301,0.0003982216,0.0005298601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048793075,0.00010874325,0.00030150687,0.0001255428,0.00015493375,0.000033458422,0.000058879254,0.00014497386,0.00049622887],"category_scores_gemma":[0.0009219314,0.000074959906,0.000095922056,0.00012293847,0.000052153202,0.00006249917,0.0000140781485,0.00022130439,0.000020862377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035500325,0.00003435388,0.99592197,0.0000036647853,0.00013918438,0.000066304754,0.00006394347,1.2494546e-7,0.00038420703,0.00028923873,0.0029014824,0.00016004754],"study_design_scores_gemma":[0.0010811177,0.0005486059,0.9874682,0.000008004417,0.000097903394,0.00011197235,0.000040043295,0.00002052643,0.00081041467,0.0008200634,0.00892657,0.0000666038],"about_ca_topic_score_codex":0.0005658308,"about_ca_topic_score_gemma":0.0011683538,"teacher_disagreement_score":0.012752492,"about_ca_system_score_codex":0.000391552,"about_ca_system_score_gemma":0.00025295303,"threshold_uncertainty_score":0.5433358},"labels":[],"label_agreement":null},{"id":"W2904100862","doi":"10.1111/his.13727","title":"New and emerging renal entities: a perspective post‐<scp>WHO</scp> 2016 classification","year":2018,"lang":"en","type":"review","venue":"Histopathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"World Health Organization","keywords":"Renal cell carcinoma; Pathology; Papillary renal cell carcinomas; Medicine; Clear cell; Kidney; Kidney cancer; Clear cell carcinoma; Carcinoma; Cancer research; Internal medicine","score_opus":0.0487537263969712,"score_gpt":0.3242985037905588,"score_spread":0.2755447773935876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904100862","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003003343,0.96885824,0.00019742166,0.00013191001,0.0005275945,0.00091480854,0.000032679345,0.00008728295,0.028949747],"genre_scores_gemma":[0.000024082996,0.936273,0.0012374531,0.000101038626,0.00092178833,0.00011056326,0.00018153056,0.00009195817,0.061058618],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974929,0.0002662149,0.00060541386,0.00095784897,0.00024306032,0.00043454496],"domain_scores_gemma":[0.9980315,0.00019830234,0.0004994004,0.00069519127,0.00028641443,0.00028918238],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024980586,0.00054270343,0.0018023921,0.00055721815,0.00013222599,0.000022082335,0.00015761865,0.0005064452,0.00013784421],"category_scores_gemma":[0.00035114383,0.00043459,0.00043516984,0.00021377145,0.00031917004,0.00006461905,0.00011072578,0.00045319082,0.0004941881],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108978114,0.0004236823,0.00022331538,0.01941369,0.0004800965,0.00460961,0.012925191,4.3751267e-8,0.0005917698,0.014850586,0.19735652,0.7490165],"study_design_scores_gemma":[0.0005235492,0.00080905313,0.0012733701,0.0036961017,0.002205619,0.0039012674,0.00040363893,0.0000011913862,0.000005387338,0.00015891428,0.98687875,0.00014317628],"about_ca_topic_score_codex":0.00016540667,"about_ca_topic_score_gemma":0.000023649196,"teacher_disagreement_score":0.78952223,"about_ca_system_score_codex":0.0013440711,"about_ca_system_score_gemma":0.0010863064,"threshold_uncertainty_score":0.9998106},"labels":[],"label_agreement":null},{"id":"W2904582373","doi":"10.14366/usg.18024","title":"Multislice computed tomography/contrast-enhanced ultrasound image fusion as a tool for evaluating unclear renal cysts","year":2018,"lang":"en","type":"article","venue":"ULTRASONOGRAPHY","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Radiology; Ultrasound; Vascularity; Magnetic resonance imaging; Image fusion; Multislice; Contrast-enhanced ultrasound; Ultrasonography; Computed tomography; Tomography; Fusion","score_opus":0.02075743154349067,"score_gpt":0.3043452054190206,"score_spread":0.2835877738755299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904582373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793575,0.0004458147,0.011138898,0.00015091964,0.00031716883,0.002915038,0.00007457328,0.00039284903,0.0052072657],"genre_scores_gemma":[0.91577077,0.000037982063,0.08222571,0.00059602334,0.0006476356,0.0002749955,0.00022414532,0.000097484,0.00012523597],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99648803,0.00017143937,0.0007026484,0.0009942758,0.0007274168,0.0009162053],"domain_scores_gemma":[0.9968784,0.0010454942,0.00030436483,0.0006703713,0.00076805445,0.00033335917],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071425707,0.0005761583,0.0007108124,0.00061030325,0.0005905783,0.0001313816,0.00024556564,0.00023640886,0.00032484645],"category_scores_gemma":[0.00047738553,0.0005035405,0.00083308277,0.0012381654,0.00054268,0.00022595136,0.00004451163,0.00029445544,0.00015105691],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021253778,0.00057938026,0.011991344,0.00016537054,0.00059219624,0.00002628005,0.00092280435,0.000009642248,0.972812,0.00013756489,0.0015147818,0.009123252],"study_design_scores_gemma":[0.014910121,0.0140888635,0.238279,0.00079661614,0.0011547458,0.0004964131,0.00047052358,0.0013739002,0.72492075,0.00058327167,0.0018928488,0.001032969],"about_ca_topic_score_codex":0.00011406241,"about_ca_topic_score_gemma":0.000027048296,"teacher_disagreement_score":0.24789128,"about_ca_system_score_codex":0.000082493796,"about_ca_system_score_gemma":0.00013465523,"threshold_uncertainty_score":0.9997416},"labels":[],"label_agreement":null},{"id":"W2904665099","doi":"10.1186/s12885-018-5157-0","title":"Axitinib, cabozantinib, or everolimus in the treatment of prior sunitinib-treated patients with metastatic renal cell carcinoma: results of matching-adjusted indirect comparison analyses","year":2018,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"TransCanada (Canada)","funders":"Pfizer","keywords":"Axitinib; Cabozantinib; Medicine; Sunitinib; Everolimus; Internal medicine; Oncology; Hazard ratio; Renal cell carcinoma; Urology; Confidence interval","score_opus":0.12047167671653994,"score_gpt":0.35850417713282823,"score_spread":0.2380325004162883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904665099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99550897,0.00083278335,0.000010332354,0.000035210527,0.000058205627,0.0016707354,0.00038572453,0.00002270971,0.0014753334],"genre_scores_gemma":[0.99784076,0.00006134301,0.0010702962,0.00003323246,0.000079284524,0.00016464881,0.00025002751,0.000043367796,0.00045702377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971411,0.00034169742,0.00096360606,0.0004618352,0.0006836786,0.00040806647],"domain_scores_gemma":[0.9975947,0.000460191,0.00072527665,0.0006601138,0.0004432403,0.00011647542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021111777,0.00039856412,0.0011408008,0.0003286076,0.00007258242,0.000013053044,0.0001714406,0.000075605254,0.00015729913],"category_scores_gemma":[0.000047071346,0.00020463555,0.00017494982,0.0008489899,0.0002530556,0.000061738494,0.00002247863,0.00012036017,0.000007360983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027047921,0.005264842,0.9508448,0.0003731225,0.0004611911,0.000116499854,0.011004626,0.000147946,0.0018113087,0.0000021050957,0.0002792544,0.0026463694],"study_design_scores_gemma":[0.021718925,0.009636366,0.82970595,0.00026283963,0.0015338028,0.000011089844,0.001185525,0.00009322249,0.13539943,0.0000015810596,0.00026749546,0.00018374747],"about_ca_topic_score_codex":0.012037626,"about_ca_topic_score_gemma":0.011144582,"teacher_disagreement_score":0.13358812,"about_ca_system_score_codex":0.00027935597,"about_ca_system_score_gemma":0.0004916852,"threshold_uncertainty_score":0.9945413},"labels":[],"label_agreement":null},{"id":"W2905004070","doi":"10.3747/co.25.4103","title":"Use of Targeted Therapy in Patients with Metastatic Renal Cell Carcinoma: Clinical and Economic Impact in a Canadian Real-Life Setting","year":2018,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Centre hospitalier universitaire de Québec; University of Alberta; Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre; University of Calgary; Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; University of British Columbia; University of Toronto; Dalhousie University; McMaster University; Sunnybrook Health Science Centre; University of Ottawa; McGill University Health Centre","funders":"Astellas Pharma; Ipsen; Pfizer","keywords":"Pazopanib; Medicine; Sunitinib; Interquartile range; Renal cell carcinoma; Hazard ratio; Discontinuation; Internal medicine; Oncology; Clinical trial; Urology; Confidence interval","score_opus":0.11155359196257655,"score_gpt":0.3902748894843991,"score_spread":0.2787212975218225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905004070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99845076,0.00035791888,0.0000010083737,0.00008627294,0.0001719116,0.0007310585,0.00004707961,0.000005182369,0.00014879357],"genre_scores_gemma":[0.9993176,0.00010654024,0.0003225466,0.000058257563,0.000066102075,0.000021341497,0.000081938706,0.000019813506,0.000005891534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982753,0.00028535453,0.0005950905,0.0003344545,0.00009366275,0.00041617386],"domain_scores_gemma":[0.998826,0.00021153531,0.00020440423,0.00022883173,0.000086518674,0.00044266405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039331213,0.0001840206,0.0006297354,0.00035835718,0.000022409706,0.000006517504,0.0000566896,0.000087798915,0.00007461751],"category_scores_gemma":[0.00008097413,0.00013340551,0.000063483305,0.00013029268,0.00023707178,0.000070626425,0.00002421492,0.00023894958,0.00000786234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013547065,0.00047979475,0.9906558,0.00002780795,0.00004351656,0.000050431972,0.00045971895,0.000013217416,0.000027809445,0.0000037598459,0.0002384645,0.006644975],"study_design_scores_gemma":[0.009218193,0.0074237026,0.98182905,0.000043006974,0.000057469402,0.000006220494,0.000039102517,0.000687803,0.0001368687,0.000004721478,0.00044625558,0.00010759811],"about_ca_topic_score_codex":0.111741476,"about_ca_topic_score_gemma":0.1787983,"teacher_disagreement_score":0.06705682,"about_ca_system_score_codex":0.0011398727,"about_ca_system_score_gemma":0.0023559178,"threshold_uncertainty_score":0.8941735},"labels":[],"label_agreement":null},{"id":"W2905342886","doi":"10.5527/wjn.v7.i8.155","title":"Clear cell papillary renal cell carcinoma: A case report and review of the literature","year":2018,"lang":"en","type":"article","venue":"World Journal of Nephrology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Papillary renal cell carcinomas; Renal cell carcinoma; Clear cell; Immunohistochemistry; Pathology; Kidney; Radiology; Internal medicine","score_opus":0.012743237186238428,"score_gpt":0.25254924716083604,"score_spread":0.2398060099745976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905342886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8699041,0.12110309,0.0000024687977,0.0038497203,0.00020250204,0.00025074976,0.0000033901988,0.0000036943593,0.0046802666],"genre_scores_gemma":[0.9879223,0.0038344222,0.0007397878,0.0049110334,0.00060596253,0.0000019826557,0.0000023831947,0.00002028999,0.0019618517],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9983013,0.0002235653,0.00078514573,0.00019121889,0.00027754833,0.00022119928],"domain_scores_gemma":[0.9978921,0.00009090957,0.00085335574,0.00047310576,0.0005127429,0.00017778648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056881545,0.00018199974,0.0006114926,0.00017774555,0.00007501038,0.000008027468,0.000117990414,0.00008995287,0.00016940337],"category_scores_gemma":[0.000060633392,0.00010401322,0.00026323288,0.0003713997,0.000283239,0.000054806336,0.00009189618,0.00048629596,0.000004766694],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002502208,0.0006655792,0.029879903,0.006943398,0.00031476724,0.69591683,0.0016358439,8.661692e-7,0.07987162,0.000053921496,0.17979217,0.0024228678],"study_design_scores_gemma":[0.0022261809,0.0034295872,0.033967737,0.0025211114,0.0010110843,0.8215109,0.000048979047,0.0000035782416,0.02248643,0.000079417616,0.11258312,0.00013187356],"about_ca_topic_score_codex":0.000018491464,"about_ca_topic_score_gemma":0.000024378378,"teacher_disagreement_score":0.12559403,"about_ca_system_score_codex":0.00006516558,"about_ca_system_score_gemma":0.00021171593,"threshold_uncertainty_score":0.4241536},"labels":[],"label_agreement":null},{"id":"W2906138948","doi":"10.5489/cuaj.5786","title":"Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of cytoreductive nephrectomy for patients with metastatic renal cell carcinoma","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Western University; University of British Columbia; McGill University; Université de Montréal; University of Alberta; Dalhousie University; University of Toronto; Université de Sherbrooke; McMaster University; University of Ottawa","funders":"","keywords":"Nephrectomy; Renal cell carcinoma; Medicine; Kidney cancer; Cancer; Kidney; Statement (logic); Urology; Oncology; Internal medicine; General surgery","score_opus":0.025336453376523776,"score_gpt":0.2630895937250606,"score_spread":0.2377531403485368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906138948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98916733,0.00013815725,0.0000041352596,0.00806289,0.00014832747,0.0008476684,0.0003489708,0.0000023025436,0.0012802144],"genre_scores_gemma":[0.99824756,0.0000052729024,0.00036718848,0.00079221406,0.0002964102,0.00005709611,0.000026454243,0.000015699437,0.00019211728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973344,0.000427287,0.0004402714,0.00019760635,0.0008878291,0.0007125644],"domain_scores_gemma":[0.9956411,0.0007030312,0.0005046649,0.00015593063,0.0022980499,0.00069718546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011928374,0.00015019912,0.00034374307,0.00009925328,0.0004000941,0.000016595566,0.00012882517,0.00006903466,0.0002576158],"category_scores_gemma":[0.0007431893,0.00008711281,0.00008122921,0.00030461143,0.00014454943,0.000019376454,0.000014738816,0.0003840294,0.0000013183192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019697696,0.00019715748,0.87757367,0.000020734056,0.0005246921,0.000032062406,0.00041030996,0.00024192702,0.0003482102,0.00030288647,0.11792652,0.0004520778],"study_design_scores_gemma":[0.0042865323,0.008195263,0.9336243,0.00008024318,0.00035867104,0.000013971795,0.00079402036,0.00015108209,0.008639384,0.0011779735,0.04249367,0.0001848371],"about_ca_topic_score_codex":0.20910008,"about_ca_topic_score_gemma":0.2029081,"teacher_disagreement_score":0.07543285,"about_ca_system_score_codex":0.0035578734,"about_ca_system_score_gemma":0.0073075406,"threshold_uncertainty_score":0.9983201},"labels":[],"label_agreement":null},{"id":"W2906780340","doi":"10.1200/jco.2014.32.15_suppl.e15571","title":"Surgical ischemia and detection of clear cell renal cell carcinoma biomarkers.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Clear cell renal cell carcinoma; Biomarker; Perioperative; Nephrectomy; Renal cell carcinoma; Ischemia; Clear cell; Cohort; Pathology; Internal medicine; Oncology; Kidney; Surgery; Biology","score_opus":0.05748911722807229,"score_gpt":0.3719757220900661,"score_spread":0.31448660486199376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906780340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98137546,0.00088226266,0.00012819793,0.0007519759,0.00042154908,0.00012551567,0.0000010197904,0.0000057110396,0.016308313],"genre_scores_gemma":[0.99621004,0.00025141262,0.0022361202,0.00017442719,0.0008217989,0.00000118118,0.0000011930582,0.000018327986,0.00028551693],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99670184,0.00051846396,0.0019796807,0.00022096219,0.00036489032,0.00021418066],"domain_scores_gemma":[0.9955326,0.0018620272,0.0015735936,0.00021333083,0.00032795983,0.00049054023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027968024,0.00015740067,0.001353703,0.00014476888,0.000030220715,0.000005198374,0.000101278274,0.00046551073,0.00007633961],"category_scores_gemma":[0.0006566749,0.0001091959,0.0005119899,0.00011451739,0.00027704122,0.00006190222,0.000059475482,0.00073323207,0.000012987783],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041702673,0.0054694875,0.2948206,0.00053181563,0.00060613756,0.003663058,0.00021035052,0.00000994054,0.34987065,0.00004476004,0.003902468,0.29916805],"study_design_scores_gemma":[0.026282992,0.06661829,0.4819127,0.000081140104,0.0012604416,0.0028335436,0.00012194671,0.00043361238,0.3343665,0.00012325349,0.0857565,0.00020906822],"about_ca_topic_score_codex":0.000026854575,"about_ca_topic_score_gemma":0.0000056389654,"teacher_disagreement_score":0.298959,"about_ca_system_score_codex":0.000106334155,"about_ca_system_score_gemma":0.00042203514,"threshold_uncertainty_score":0.44528794},"labels":[],"label_agreement":null},{"id":"W2906948676","doi":"10.1111/iju.13882","title":"Risk‐adjusted proposal for &gt;60 months follow up after surgical treatment of organ‐confined renal cell carcinoma according to life expectancy","year":2018,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Life expectancy; Renal cell carcinoma; Carcinoma; Urology; General surgery; Surgery; Oncology; Internal medicine; Environmental health","score_opus":0.020958255908447944,"score_gpt":0.28353051333874657,"score_spread":0.2625722574302986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906948676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99203545,0.00087529724,0.000961748,0.0030770511,0.0015754492,0.0005959343,0.000046878773,0.000012951552,0.000819236],"genre_scores_gemma":[0.99339247,0.000051677776,0.004028295,0.00019171908,0.001771109,0.000055862896,0.000017353095,0.000040675735,0.00045083486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977589,0.000118443284,0.0009287929,0.00030985207,0.00055288064,0.00033109353],"domain_scores_gemma":[0.99696606,0.00025794722,0.0006451896,0.00023339911,0.0015412248,0.00035618545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022195748,0.00027488352,0.0006977472,0.0004968829,0.000043026237,0.000018350347,0.00025949752,0.00015568972,0.00035765325],"category_scores_gemma":[0.00024055429,0.00020090617,0.0004682966,0.00013216847,0.000112239475,0.00008501766,0.0000572632,0.00014610293,0.000028166134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16524135,0.00423379,0.67914987,0.00007706037,0.004275502,0.011449597,0.005806572,0.0001063938,0.09738695,0.00044906512,0.0029739633,0.028849877],"study_design_scores_gemma":[0.06397756,0.08523489,0.43323374,0.0001351207,0.002720091,0.0065409443,0.00077985605,0.00080289925,0.384702,0.0007400631,0.020456428,0.0006764338],"about_ca_topic_score_codex":0.000083118655,"about_ca_topic_score_gemma":0.00007053075,"teacher_disagreement_score":0.28731504,"about_ca_system_score_codex":0.00035055843,"about_ca_system_score_gemma":0.0006115822,"threshold_uncertainty_score":0.81927156},"labels":[],"label_agreement":null},{"id":"W2907342474","doi":"10.1200/jco.2014.32.15_suppl.6594","title":"Comparison of RCC surveillance guidelines: Competing tradeoffs.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation exposure; Guideline; Renal cell carcinoma; Nephrectomy; Risk assessment; Nuclear medicine; Medical physics; Oncology; Internal medicine; Pathology; Kidney","score_opus":0.34462978616178547,"score_gpt":0.5469357402240312,"score_spread":0.20230595406224577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907342474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787804,0.0010500288,0.00088865956,0.007998595,0.0010612117,0.0001237597,0.0000011720626,0.000008893483,0.010087303],"genre_scores_gemma":[0.9791933,0.00016252494,0.018036969,0.0009920961,0.001489514,8.0104263e-7,0.0000023077137,0.000015364434,0.00010713152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937011,0.00073664624,0.004710542,0.0001640751,0.00048289722,0.0002047339],"domain_scores_gemma":[0.9906379,0.004369804,0.0033995002,0.000250106,0.0010026834,0.00034003388],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0062271967,0.00014125819,0.0026443808,0.00010163192,0.000023780181,0.0000037693403,0.0001835827,0.00028209976,0.000093856135],"category_scores_gemma":[0.009523175,0.00009418968,0.00065075944,0.00011754249,0.00020273215,0.000038882252,0.00003872192,0.0007261844,0.00001818684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019208532,0.00163104,0.83963364,0.00006891921,0.00028163544,0.0001231082,0.00009714751,0.00011406477,0.0010241133,0.00013616003,0.0068411184,0.1481282],"study_design_scores_gemma":[0.009291293,0.02314944,0.82080656,0.00021295939,0.00032196238,0.00045841341,0.00024160185,0.0020445813,0.0012563384,0.00013924783,0.14196184,0.00011576363],"about_ca_topic_score_codex":0.000016255653,"about_ca_topic_score_gemma":0.000019937906,"teacher_disagreement_score":0.14801243,"about_ca_system_score_codex":0.00009843348,"about_ca_system_score_gemma":0.00064324884,"threshold_uncertainty_score":0.99882},"labels":[],"label_agreement":null},{"id":"W2907490175","doi":"10.1371/journal.pmed.1002724","title":"The influence of obesity-related factors in the etiology of renal cell carcinoma—A mendelian randomization study","year":2019,"lang":"en","type":"article","venue":"PLoS Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University and Génome Québec Innovation Centre","funders":"National Cancer Institute; World Cancer Research Fund; Medical Research Council; Canadian Institutes of Health Research; University of Bristol; World Cancer Research Fund International; National Institutes of Health; Cancer Research UK; AstraZeneca; University Hospitals Bristol NHS Foundation Trust; Wellcome Trust; National Institute for Health and Care Research; Duncan Family Institute for Cancer Prevention and Risk Assessment; World Health Organization; University of Texas MD Anderson Cancer Center; Pfizer","keywords":"Mendelian randomization; Medicine; Internal medicine; Odds ratio; Renal cell carcinoma; Body mass index; Blood pressure; Obesity; Confidence interval; Genome-wide association study; Oncology; Confounding; Type 2 diabetes; Risk factor; Diabetes mellitus; Endocrinology; Single-nucleotide polymorphism; Genetics; Biology; Genotype; Genetic variants","score_opus":0.017250860927100896,"score_gpt":0.24777437815135978,"score_spread":0.23052351722425887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907490175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994727,0.00048530215,0.0000022253328,0.0006080739,0.000071382594,0.0021274937,0.000002036887,0.000009484829,0.0019669952],"genre_scores_gemma":[0.9995111,0.000065342334,0.0000072613157,0.000062034276,0.000025592728,0.000030073747,0.000022249511,0.000013452441,0.0002628577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782753,0.00046027233,0.0007251369,0.00022461983,0.0005594654,0.00020298485],"domain_scores_gemma":[0.99791384,0.0009610602,0.00032461734,0.0005604864,0.00018518516,0.00005481061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009301401,0.00017509174,0.0006358162,0.00017148373,0.00004260696,0.0000020246393,0.0002227429,0.00007945908,0.00007856271],"category_scores_gemma":[0.0003307749,0.000076650955,0.00006717681,0.00044156038,0.000214136,0.000034193978,0.000035578534,0.00025493116,0.000009450134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009557672,0.0008066761,0.8996186,0.000109923916,0.00011245301,0.000025389189,0.010148192,0.00035058387,0.08772605,0.00005120558,0.0000491539,0.0000459931],"study_design_scores_gemma":[0.01668121,0.00372164,0.94910216,0.00015337349,0.00043031314,0.000010352382,0.0060479906,0.00015258562,0.0235527,0.000055468263,0.00002380846,0.00006838741],"about_ca_topic_score_codex":0.000507001,"about_ca_topic_score_gemma":0.00005209266,"teacher_disagreement_score":0.06417335,"about_ca_system_score_codex":0.000064303276,"about_ca_system_score_gemma":0.00007615264,"threshold_uncertainty_score":0.31257352},"labels":[],"label_agreement":null},{"id":"W2907509786","doi":"10.1155/2018/8734823","title":"Combined Papillary Renal Cell Carcinoma with Neuroendocrine Differentiation and Mucinous Tubular and Spindle Cell Carcinoma","year":2018,"lang":"en","type":"article","venue":"Case Reports in Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North Island College; Abbotsford Veterinary Clinic","funders":"","keywords":"Papillary renal cell carcinomas; Medicine; Pathology; Neuroendocrine differentiation; Immunohistochemistry; Carcinoma; Neuroendocrine carcinoma; Cancer; Internal medicine","score_opus":0.011297220692861522,"score_gpt":0.22518973018097607,"score_spread":0.21389250948811456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907509786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955844,0.0015342557,0.00003362002,0.00014042984,0.00020728042,0.0008434237,0.0000058000983,0.000045306635,0.0016054519],"genre_scores_gemma":[0.99856126,0.00005093569,0.0005221845,0.00016226147,0.00013467645,0.00005369012,0.000062986495,0.00005804273,0.0003939628],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99764663,0.00015547483,0.00059391285,0.00088748656,0.00022216741,0.0004943352],"domain_scores_gemma":[0.99850655,0.000059565144,0.00028960893,0.00071672804,0.00014074618,0.00028681097],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017458173,0.00037769182,0.0006267767,0.00028616135,0.00013229549,0.000022725395,0.000031253992,0.000116357085,0.000044130426],"category_scores_gemma":[0.00004024218,0.00030281863,0.0000551319,0.00018513486,0.00037786414,0.0000735934,0.00013296065,0.0002918151,0.0000039449105],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026532405,0.0002132361,0.4480272,0.00015361415,0.000007672712,0.5273265,0.00030670705,7.168716e-7,0.02331927,0.000005152736,0.000045439083,0.00032914948],"study_design_scores_gemma":[0.002615993,0.00429064,0.5072554,0.000022568744,0.00019549759,0.40498477,0.00011042975,0.00008858961,0.08014011,0.00003724719,0.00006613367,0.00019262922],"about_ca_topic_score_codex":0.00022071371,"about_ca_topic_score_gemma":0.00007827107,"teacher_disagreement_score":0.12234174,"about_ca_system_score_codex":0.000105120926,"about_ca_system_score_gemma":0.00011012827,"threshold_uncertainty_score":0.9999424},"labels":[],"label_agreement":null},{"id":"W2907623918","doi":"10.21037/atm.2018.11.37","title":"Benefit of nephron sparing surgery translates into lower cancer specific mortality in patients with localized renal cell carcinoma","year":2018,"lang":"en","type":"letter","venue":"Annals of Translational Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Renal cell carcinoma; Medicine; Nephrectomy; Urology; Kidney cancer; Renal function; Cancer; Nephron; Stage (stratigraphy); Internal medicine; Oncology; Kidney; Surgery","score_opus":0.06775988018318069,"score_gpt":0.2960922416527057,"score_spread":0.228332361469525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907623918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90103376,0.006462554,0.0000610269,0.09025859,0.0002861942,0.0010179919,0.0001946331,0.000018161752,0.0006671157],"genre_scores_gemma":[0.9776974,0.00043838783,0.00048350898,0.016999578,0.0015960567,0.000057067544,0.0024421324,0.000112757065,0.00017315254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949342,0.000109218134,0.0016712251,0.00076314603,0.001963407,0.00055878324],"domain_scores_gemma":[0.997004,0.0005573408,0.0007097489,0.00065506605,0.0008953214,0.00017857642],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004725314,0.0006785967,0.002108548,0.00081462733,0.00004076015,0.000005307466,0.0002094213,0.0005655603,0.0010453052],"category_scores_gemma":[0.000023253771,0.0005025702,0.00040131522,0.00056587765,0.00069390464,0.00012525683,0.000015016651,0.000800322,0.00000459089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004692248,0.0006731381,0.9105622,0.0030295681,0.0006263345,0.00034596925,0.000761372,0.00008783705,0.00051670294,0.0000059401345,0.07586531,0.00283333],"study_design_scores_gemma":[0.007066969,0.0021428294,0.9270265,0.004228135,0.00080506416,0.0000061936125,0.000012484815,0.000026634312,0.011110348,0.00024044755,0.04681973,0.00051467813],"about_ca_topic_score_codex":0.0025163502,"about_ca_topic_score_gemma":0.00029364906,"teacher_disagreement_score":0.07666362,"about_ca_system_score_codex":0.00008635786,"about_ca_system_score_gemma":0.00037679373,"threshold_uncertainty_score":0.99986786},"labels":[],"label_agreement":null},{"id":"W2907983605","doi":"10.1016/j.eururo.2018.12.027","title":"Renal Function Outcomes Following Radical or Partial Nephrectomy for Localized Renal Cell Carcinoma: Should Urologists Rely on Preoperative Variables to Predict Renal Function in the Long Term?","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Urology; Renal function; Nephrology; Kidney; Surgery; Internal medicine","score_opus":0.04548489675109446,"score_gpt":0.27557481163972963,"score_spread":0.23008991488863517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907983605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7600403,0.0007786625,0.017319743,0.18994273,0.005141338,0.014830049,0.00021605717,0.0004543284,0.011276822],"genre_scores_gemma":[0.659514,0.000008135557,0.00041042225,0.32833385,0.004154685,0.00079110276,0.0016512786,0.00026534672,0.004871199],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99105644,0.0033438492,0.0013068974,0.0019106012,0.0010451126,0.0013370871],"domain_scores_gemma":[0.99585676,0.0019655812,0.0004621153,0.0013642198,0.00013537909,0.0002159381],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0018103091,0.001144697,0.0016166427,0.0006452836,0.00025786195,0.00011551256,0.00062740926,0.0010105622,0.0002123113],"category_scores_gemma":[0.0006129214,0.000701728,0.0007827553,0.00040359976,0.00022019309,0.00012302707,0.00021292701,0.0032324938,0.00033603067],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048666988,0.00086538144,0.10748617,0.00036970817,0.0013680586,0.019427577,0.0007695336,0.0013543667,0.001939778,0.000037578473,0.8163774,0.0013374372],"study_design_scores_gemma":[0.018186094,0.035445347,0.2600997,0.00016849671,0.004040594,0.00045077805,0.000022409911,0.00031056587,0.0007079782,0.000019744199,0.6795769,0.0009713988],"about_ca_topic_score_codex":0.00006622707,"about_ca_topic_score_gemma":0.000039607115,"teacher_disagreement_score":0.15261355,"about_ca_system_score_codex":0.0004035239,"about_ca_system_score_gemma":0.0004131352,"threshold_uncertainty_score":0.99954337},"labels":[],"label_agreement":null},{"id":"W2908005683","doi":"10.2214/ajr.18.20209","title":"Diagnostic Accuracy of MRI for Detecting Inferior Vena Cava Wall Invasion in Renal Cell Carcinoma Tumor Thrombus Using Quantitative and Subjective Analysis","year":2018,"lang":"en","type":"article","venue":"American Journal of Roentgenology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Inferior vena cava; Renal cell carcinoma; Vena cava; Radiology; Thrombus; Carcinoma; Pathology; Internal medicine","score_opus":0.031268579111050576,"score_gpt":0.3100507041745425,"score_spread":0.2787821250634919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908005683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99578065,0.0009877778,0.0026109342,0.00012321449,0.00007279306,0.0003864434,0.000008254363,0.000004078305,0.000025877502],"genre_scores_gemma":[0.98651713,0.0000892602,0.01319806,0.00007950009,0.00008029587,0.000005954076,0.0000029800278,0.000024300689,0.000002525419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998121,0.00025861038,0.0007782216,0.00027984515,0.00020752494,0.0003547766],"domain_scores_gemma":[0.99597174,0.0016777511,0.0014184028,0.00020629517,0.000575352,0.00015048942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004172772,0.00021052675,0.001113949,0.0009351793,0.00006990457,0.0000084604635,0.00011372672,0.000050910472,0.000015420504],"category_scores_gemma":[0.0013024245,0.00017300891,0.00023741437,0.0008443498,0.0005882728,0.0001081238,0.00005934363,0.00025361404,8.748765e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002269627,0.00024677961,0.85695446,0.00007207141,0.000791537,0.00042507332,0.004897436,0.00026947237,0.1316309,0.0000068091713,0.0000057561874,0.0024300623],"study_design_scores_gemma":[0.0030557523,0.020067472,0.8142668,0.00015078734,0.0023515648,0.0007503297,0.0046179933,0.0016447597,0.15284948,0.000071807335,0.000011778063,0.00016150223],"about_ca_topic_score_codex":0.0015623997,"about_ca_topic_score_gemma":0.00053538656,"teacher_disagreement_score":0.042687703,"about_ca_system_score_codex":0.00031806572,"about_ca_system_score_gemma":0.0003062385,"threshold_uncertainty_score":0.70550984},"labels":[],"label_agreement":null},{"id":"W2908462842","doi":"10.1200/jco.2014.32.15_suppl.e15544","title":"FGFR1 overexpression and anti-FGFR compound sensitivity in renal cell carcinoma.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ponatinib; Medicine; Renal cell carcinoma; Fibroblast growth factor receptor 1; Cancer; Immunohistochemistry; Cancer research; Internal medicine; Pathology; Fibroblast growth factor; Receptor; Dasatinib","score_opus":0.08799213177184954,"score_gpt":0.40445891446828625,"score_spread":0.3164667826964367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908462842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898233,0.000336258,0.00010648261,0.0018778658,0.00037917247,0.00014977217,0.000001176831,0.0000053230456,0.0073206825],"genre_scores_gemma":[0.99519897,0.00013926985,0.0027974632,0.00089675625,0.0008026931,8.6526205e-7,0.000002103421,0.000015257012,0.0001466526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99653184,0.00096125156,0.0016669194,0.00024357677,0.0003473467,0.00024905126],"domain_scores_gemma":[0.9953616,0.0026944517,0.0010780165,0.00021172357,0.0002029059,0.00045129412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040016053,0.00016557414,0.0015673457,0.00015433677,0.000033658453,0.000009516944,0.00006603662,0.00036494373,0.000036545116],"category_scores_gemma":[0.0011272755,0.00011357144,0.00028703365,0.000089265704,0.00020497703,0.00009390397,0.00008255128,0.0010309427,0.000011989876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029467046,0.002040768,0.92368364,0.0000756076,0.000058422345,0.0041653924,0.00010043947,0.000034337292,0.038138278,0.000042979143,0.00205479,0.026658626],"study_design_scores_gemma":[0.01034654,0.007530775,0.96476877,0.00015262286,0.00016474964,0.001564483,0.000039484534,0.0004303534,0.0052548656,0.00015671467,0.009489478,0.00010114873],"about_ca_topic_score_codex":0.00006553912,"about_ca_topic_score_gemma":0.00004007343,"teacher_disagreement_score":0.04108513,"about_ca_system_score_codex":0.00016163003,"about_ca_system_score_gemma":0.00048735517,"threshold_uncertainty_score":0.4631309},"labels":[],"label_agreement":null},{"id":"W2908530606","doi":"10.1016/j.eururo.2019.01.006","title":"Needle Tract Seeding Following Renal Tumor Biopsy: Scarcely a Concern or a Concern to Scare?","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Seeding; Biopsy; Urology; Renal biopsy; Radiology; Intensive care medicine; Surgery","score_opus":0.062470460440980535,"score_gpt":0.28593494384486473,"score_spread":0.2234644834038842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908530606","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5366004,0.0015384383,0.0001269534,0.35951877,0.0038095044,0.0031217462,0.00016731829,0.0006147598,0.0945021],"genre_scores_gemma":[0.47728696,0.0000093436065,0.00040636578,0.49366862,0.006885322,0.0000414893,0.00039063927,0.00045547154,0.020855771],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945994,0.0007580757,0.0009065285,0.0015991516,0.0007712837,0.0013655538],"domain_scores_gemma":[0.9972659,0.0005412151,0.0004234545,0.0012434394,0.00016000654,0.00036603367],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005702586,0.0009909701,0.001690036,0.00060746743,0.00013873448,0.00010085713,0.0006586116,0.0004653211,0.0006474688],"category_scores_gemma":[0.0003272196,0.00078119413,0.00078931305,0.00040924142,0.00017996076,0.00008510812,0.00040728558,0.0024902455,0.0059214584],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011641234,0.00011175069,0.0068921107,0.00028867947,0.0008616145,0.17398013,0.0010491265,0.0000137399475,0.012580017,0.000003099328,0.8020902,0.00096534623],"study_design_scores_gemma":[0.0041181734,0.004305421,0.011841879,0.00037428192,0.0012136569,0.00928009,0.000085840955,0.0000446765,0.00025833386,0.0000031697864,0.9675998,0.0008746731],"about_ca_topic_score_codex":0.0001040759,"about_ca_topic_score_gemma":0.0000031279096,"teacher_disagreement_score":0.16550955,"about_ca_system_score_codex":0.00044909064,"about_ca_system_score_gemma":0.00043028253,"threshold_uncertainty_score":0.99981105},"labels":[],"label_agreement":null},{"id":"W2909546373","doi":"10.2214/ajr.18.20221","title":"Diagnostic Yield and Complication Rate in Percutaneous Needle Biopsy of Renal Hilar Masses With Comparison With Renal Cortical Mass Biopsies in a Cohort of 195 Patients","year":2019,"lang":"en","type":"article","venue":"American Journal of Roentgenology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Renal mass; Cohort; Complication; Biopsy; Radiology; Percutaneous biopsy; Percutaneous; Needle biopsy; Surgery; Kidney; Internal medicine; Nephrectomy","score_opus":0.009915072731854394,"score_gpt":0.23612823842681954,"score_spread":0.22621316569496513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909546373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987516,0.0002643701,0.00016327576,0.00028818435,0.00002278262,0.00041126573,0.0000072231887,0.000003356148,0.00008796526],"genre_scores_gemma":[0.99771696,0.00013349518,0.0020581947,0.000040637613,0.000010411483,0.0000058561013,0.000010591488,0.00001726287,0.0000066100774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983599,0.00014617488,0.00075112673,0.0002091772,0.00028688338,0.00024672892],"domain_scores_gemma":[0.99807537,0.00052510924,0.00082479103,0.00020725187,0.0002548169,0.00011268407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017912612,0.00017696357,0.001014705,0.00040029062,0.000012536903,0.0000042718007,0.00009709257,0.000049189828,0.000025714902],"category_scores_gemma":[0.00013221055,0.00012127203,0.000047147412,0.00037327857,0.0005609082,0.00005143222,0.000025652542,0.00029385646,0.0000015670245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035004953,0.00053522363,0.9480266,0.00005641741,0.000203445,0.00043746893,0.0004321129,0.00062376156,0.045503046,0.000011234037,0.0000060329157,0.0006641725],"study_design_scores_gemma":[0.0023282361,0.017393392,0.96972805,0.00045084683,0.00023296497,0.0020622339,0.001135735,0.00015620288,0.0063942587,0.000010211837,0.000008481297,0.00009940669],"about_ca_topic_score_codex":0.00036632933,"about_ca_topic_score_gemma":0.00008386893,"teacher_disagreement_score":0.039108787,"about_ca_system_score_codex":0.00012390951,"about_ca_system_score_gemma":0.00013405914,"threshold_uncertainty_score":0.494533},"labels":[],"label_agreement":null},{"id":"W2910644531","doi":"10.1016/j.ejca.2018.12.006","title":"The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial","year":2019,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Ozmosis Research (Canada); Queen Elizabeth II Health Sciences Centre; Regional Municipality of Durham; Centre Hospitalier de l’Université de Montréal; London Health Sciences Centre; Ottawa Hospital; BC Cancer Agency; Princess Margaret Cancer Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"Pfizer","keywords":"Sunitinib; Medicine; Toxicity; Renal cell carcinoma; Dosing; Clinical endpoint; Internal medicine; Clinical trial; Phases of clinical research; Oncology; Adverse effect; Urology; Confidence interval; Surgery","score_opus":0.09894425372658124,"score_gpt":0.39578725060013864,"score_spread":0.2968429968735574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910644531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99293905,0.0030885378,0.000042568456,0.0010548016,0.0004053761,0.0013225905,0.00005252041,0.00000501459,0.0010895472],"genre_scores_gemma":[0.99678355,0.001037203,0.0005423787,0.00027609736,0.000813317,0.000007671115,0.000012988164,0.0000501314,0.000476638],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99725574,0.0007907554,0.0010704746,0.00021439367,0.00045159057,0.00021706568],"domain_scores_gemma":[0.9971353,0.0010361203,0.000898751,0.000331458,0.00033342149,0.00026495542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027205863,0.00019963265,0.00060518313,0.00009635857,0.00009648729,0.000030290488,0.00020202085,0.000027009504,0.00013297435],"category_scores_gemma":[0.00024792735,0.00011297093,0.00029368783,0.0000930674,0.00013057112,0.000074050826,0.00002675277,0.0003350827,0.000008084761],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8208541,0.005119008,0.0046039885,0.00014633643,0.0012281758,0.0004909902,0.0019206794,0.00017055165,0.005378675,0.00007201323,0.0016654718,0.15835],"study_design_scores_gemma":[0.68737125,0.14926334,0.06769154,0.0003761408,0.0011280846,0.00012412282,0.00033284412,0.00010029878,0.021621563,0.00003408709,0.07169078,0.0002659649],"about_ca_topic_score_codex":0.0000064240994,"about_ca_topic_score_gemma":0.000003270857,"teacher_disagreement_score":0.15808403,"about_ca_system_score_codex":0.000053844968,"about_ca_system_score_gemma":0.00031293908,"threshold_uncertainty_score":0.46068206},"labels":[],"label_agreement":null},{"id":"W2911350330","doi":"10.1136/jclinpath-2018-205655","title":"Accuracy of renal tumour biopsy for the diagnosis and subtyping of papillary renal cell carcinoma: analysis of paired biopsy and nephrectomy specimens with focus on discordant cases","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; University Health Network","funders":"","keywords":"Subtyping; Nephrectomy; Papillary renal cell carcinomas; Medicine; Renal cell carcinoma; Concordance; Biopsy; Pathology; Kidney; Internal medicine","score_opus":0.06591527922035996,"score_gpt":0.3433982524732126,"score_spread":0.27748297325285265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911350330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995063,0.003294359,0.00014533315,0.00077364966,0.000101900216,0.00048614046,0.000063265674,0.0000026188463,0.000069698675],"genre_scores_gemma":[0.99651796,0.0009810209,0.0022581764,0.000056886634,0.0001301798,0.000008582042,0.000006680174,0.000019909341,0.00002058396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99705595,0.00031639216,0.0017576873,0.00030632803,0.0003376578,0.00022597036],"domain_scores_gemma":[0.9895282,0.0072266823,0.0023209394,0.00038681758,0.00036564874,0.00017171234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013715272,0.00022666143,0.0018311549,0.00037311675,0.000036922775,0.0000063283815,0.00013287045,0.00012208437,0.000032927226],"category_scores_gemma":[0.00085713074,0.0001194335,0.0005946105,0.00034843155,0.00046441052,0.000060631788,0.00006787476,0.0003349941,3.847364e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00872877,0.0008200285,0.9364386,0.00021455703,0.0014075453,0.0016932698,0.00019976826,0.00006626227,0.047194377,0.000041393818,0.00005538216,0.0031400202],"study_design_scores_gemma":[0.005575872,0.01340864,0.93198425,0.0002535271,0.0058095343,0.0018946772,0.0003138789,0.00015018732,0.040395413,0.00006491696,0.000034845798,0.000114250244],"about_ca_topic_score_codex":0.000072042596,"about_ca_topic_score_gemma":0.000026720449,"teacher_disagreement_score":0.012588613,"about_ca_system_score_codex":0.000027087122,"about_ca_system_score_gemma":0.00018477447,"threshold_uncertainty_score":0.4870357},"labels":[],"label_agreement":null},{"id":"W2911812451","doi":"10.1056/nejmoa1816047","title":"Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma","year":2019,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2550,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; BC Cancer Agency","funders":"National Cancer Institute; Merck; Pfizer","keywords":"Axitinib; Avelumab; Sunitinib; Renal cell carcinoma; Medicine; Internal medicine; Oncology; Carcinoma; Urology; Immunotherapy; Nivolumab; Cancer","score_opus":0.03480851642747787,"score_gpt":0.2891911489677947,"score_spread":0.2543826325403168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911812451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9710927,0.002909356,0.00038017918,0.0042981924,0.0018454152,0.0007632686,0.000008214438,0.000019910312,0.01868275],"genre_scores_gemma":[0.9854944,0.000151335,0.0023183099,0.00038916423,0.004155958,0.000006831195,0.000053394717,0.000054967495,0.0073756566],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976561,0.000075800526,0.0008369176,0.0002652134,0.00074341753,0.0004225637],"domain_scores_gemma":[0.99712783,0.0007692658,0.00057348656,0.00038600815,0.0005138904,0.0006295389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007200711,0.00031254042,0.0010159165,0.00031040946,0.000053319065,0.000010120286,0.00018662376,0.00011254274,0.0006813774],"category_scores_gemma":[0.00038273327,0.0002072262,0.00025970346,0.00019353315,0.00008168158,0.0001134863,0.000027601467,0.00044142437,0.000039474646],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19368984,0.00097060896,0.014788693,0.0016898337,0.0013142888,0.0050239614,0.007492279,0.00059884856,0.28440762,0.0009207114,0.05678313,0.43232018],"study_design_scores_gemma":[0.6886995,0.043693345,0.0087972395,0.00097035296,0.0014935178,0.0032962232,0.0012928909,0.00014947832,0.05797761,0.0002603292,0.1929735,0.0003960392],"about_ca_topic_score_codex":0.000055362005,"about_ca_topic_score_gemma":0.000012120024,"teacher_disagreement_score":0.49500963,"about_ca_system_score_codex":0.00029698326,"about_ca_system_score_gemma":0.0006258367,"threshold_uncertainty_score":0.8450439},"labels":[],"label_agreement":null},{"id":"W2912199505","doi":"10.1016/j.clgc.2019.01.015","title":"COMPARZ Post Hoc Analysis: Characterizing Pazopanib Responders With Advanced Renal Cell Carcinoma","year":2019,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; University of British Columbia","funders":"Janssen Biotech; National Cancer Institute; Eisai; Ipsen Biopharmaceuticals; Prometheus; North Carolina GlaxoSmithKline Foundation; Novartis; GlaxoSmithKline Australia; Exelixis; Sanofi; GlaxoSmithKline; Merck; Astellas Pharma Global Development; Bayer Corporation; Bristol-Myers Squibb; AstraZeneca; Memorial Sloan-Kettering Cancer Center; Roche; Astellas Pharma US; Novartis Pharmaceuticals Corporation; Pfizer","keywords":"Pazopanib; Medicine; Post-hoc analysis; Oncology; Renal cell carcinoma; Internal medicine; Post hoc; Sunitinib","score_opus":0.03562386660572312,"score_gpt":0.33030507837456136,"score_spread":0.2946812117688382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912199505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913148,0.0022893199,0.000012831112,0.0009905858,0.00042824223,0.0009616609,0.00005489574,0.000098529876,0.0038491127],"genre_scores_gemma":[0.99126035,0.00024375129,0.0011144023,0.0016281983,0.00059700495,0.00009997638,0.00022260078,0.00007891658,0.004754813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965892,0.00023993659,0.0009145896,0.0010440233,0.0005965795,0.0006156891],"domain_scores_gemma":[0.9973171,0.00030321343,0.00040355677,0.001097448,0.00030487374,0.0005738197],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003644726,0.0004589839,0.001274108,0.0003056447,0.00009993524,0.000034771245,0.0002526013,0.00020560967,0.0007788789],"category_scores_gemma":[0.00002290391,0.00034472943,0.0006880552,0.00078492827,0.0001701303,0.00016798583,0.00012233206,0.0006636799,0.00032710255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026633857,0.0009459763,0.91982263,0.00020528314,0.0014879424,0.0018432711,0.00018554955,0.00030728345,0.042118367,0.0000045991223,0.00054255914,0.005902668],"study_design_scores_gemma":[0.007289181,0.009672205,0.9663489,0.00013047521,0.0025568986,0.00006698779,0.00033413016,0.00022784657,0.0075963987,0.0000022959666,0.0053011393,0.00047357086],"about_ca_topic_score_codex":0.000068897825,"about_ca_topic_score_gemma":0.0000338615,"teacher_disagreement_score":0.046526227,"about_ca_system_score_codex":0.00032019944,"about_ca_system_score_gemma":0.0005462854,"threshold_uncertainty_score":0.99990046},"labels":[],"label_agreement":null},{"id":"W2912969260","doi":"10.1101/549709","title":"Activated thiol Sepharose-based proteomic approach to globally quantify protein oxidation","year":2019,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; Princess Margaret Cancer Foundation","keywords":"PKM2; Reactive oxygen species; Chemistry; Biochemistry; Proteomics; Gene isoform; Sepharose; Cell biology; Pyruvate kinase; Biology; Metabolism; Enzyme; Glycolysis; Gene","score_opus":0.024949300492165285,"score_gpt":0.24288131038664482,"score_spread":0.21793200989447953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912969260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789478,0.00021657145,0.0050105522,0.00058990874,0.00046173122,0.013703805,0.00015504162,0.00077172683,0.00014283751],"genre_scores_gemma":[0.9594282,0.000008962258,0.03681218,0.00047714455,0.00036720233,0.0025691094,0.000008983296,0.0002826555,0.000045580902],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99475724,0.00028143305,0.00086223014,0.002040648,0.001157026,0.0009014384],"domain_scores_gemma":[0.9950298,0.000038417726,0.00064729,0.0026905679,0.0009134234,0.00068048324],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000775146,0.0010990814,0.0012833737,0.0005706617,0.00013723769,0.00028003333,0.00066817197,0.0009916907,0.00004599399],"category_scores_gemma":[0.00029911115,0.0010428448,0.00037744996,0.0008790624,0.00008271749,0.0001486846,0.00044980092,0.0012044526,0.0005926392],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007686962,0.00088569126,0.0059076524,0.0020151138,0.00035401396,0.000093684204,0.000009148863,0.00058766693,0.98895174,0.00014449602,0.00028010673,0.0000019866739],"study_design_scores_gemma":[0.0021087285,0.00038755054,0.13553207,0.0013070859,0.0003179031,8.432665e-8,0.0000018837253,0.00094444014,0.85786706,5.819874e-7,0.0006676581,0.00086494937],"about_ca_topic_score_codex":0.00012621636,"about_ca_topic_score_gemma":5.7798155e-7,"teacher_disagreement_score":0.13108468,"about_ca_system_score_codex":0.0018254917,"about_ca_system_score_gemma":0.002513189,"threshold_uncertainty_score":0.9992022},"labels":[],"label_agreement":null},{"id":"W2913818103","doi":"10.1016/j.anndiagpath.2019.02.008","title":"Fumarate hydratase deficient renal cell carcinoma: Chromosomal numerical aberration analysis of 12 cases","year":2019,"lang":"en","type":"article","venue":"Annals of Diagnostic Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Calgary Laboratory Services; Royal Columbian Hospital; University of Calgary","funders":"Univerzita Karlova v Praze","keywords":"Comparative genomic hybridization; Biology; Renal cell carcinoma; Chromosome; Loss of heterozygosity; Pathology; Molecular biology; Carcinoma; Mutation; Cancer research; Genetics; Gene; Medicine","score_opus":0.043066481732263434,"score_gpt":0.29806948613800177,"score_spread":0.2550030044057383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913818103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99509025,0.0019495878,0.00012120365,0.00026535764,0.00011775645,0.0004563646,0.0002268603,0.000016140524,0.0017564564],"genre_scores_gemma":[0.99854654,0.0001295604,0.00023137889,0.00027207637,0.000038764545,0.00003410542,0.000601417,0.000019415771,0.00012672745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791586,0.00020295376,0.00068464736,0.0004630902,0.00035808692,0.00037533272],"domain_scores_gemma":[0.9970807,0.0014281255,0.00040618714,0.0006448323,0.00026570432,0.00017446293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002643075,0.00024434074,0.0010016783,0.00048085628,0.000030515906,0.0000050436015,0.00011626124,0.00015076737,0.000508671],"category_scores_gemma":[0.00071610796,0.00020648334,0.0004047574,0.000614031,0.00014758731,0.000060812956,0.00006998424,0.0001409017,0.0000942496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007157755,0.0027260259,0.8553025,0.0003230213,0.0007615119,0.0053340467,0.0007279081,0.0031113646,0.12813208,0.00020277224,0.0014972793,0.0011657252],"study_design_scores_gemma":[0.0011411263,0.0037460788,0.73233896,0.000041937103,0.0021478692,0.0002449359,0.00008840655,0.0008537085,0.2591313,0.000020308047,0.00008005053,0.000165327],"about_ca_topic_score_codex":0.0002116052,"about_ca_topic_score_gemma":0.000022978338,"teacher_disagreement_score":0.13099924,"about_ca_system_score_codex":0.000035696758,"about_ca_system_score_gemma":0.00013870846,"threshold_uncertainty_score":0.8420146},"labels":[],"label_agreement":null},{"id":"W2915931128","doi":"10.5489/cuaj.5789","title":"Images – pT3a clear-cell renal cell carcinoma in a renal allograft managed effectively with open partial nephrectomy","year":2019,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Nephrectomy; Renal cell carcinoma; Urology; Medicine; Kidney; Internal medicine","score_opus":0.00987739854334834,"score_gpt":0.2162523479700954,"score_spread":0.20637494942674706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915931128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719896,0.00018786157,0.000023191371,0.0033306188,0.00012868896,0.0013651913,0.00002149908,0.00002282993,0.022930557],"genre_scores_gemma":[0.993917,0.000015931419,0.0007619087,0.0017702573,0.00023436632,0.000072320116,0.00003836902,0.000038286424,0.003151602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968128,0.0006230581,0.0004911382,0.00052584294,0.0005930951,0.00095403974],"domain_scores_gemma":[0.99784863,0.00024641166,0.00040322862,0.0002534044,0.00022227732,0.0010260189],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011493884,0.00033274258,0.0006539021,0.00038054702,0.00020064533,0.00026482137,0.00035832354,0.00031905176,0.0009311821],"category_scores_gemma":[0.00012792416,0.00024658715,0.00019305601,0.00044828566,0.000049867594,0.00024904727,0.00007500481,0.001231534,0.00023072255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001406919,0.00022555704,0.98365265,0.000018243369,0.00010112019,0.0023715256,0.00013171205,0.00020364842,0.004781114,0.000017564233,0.0065306644,0.0005592778],"study_design_scores_gemma":[0.008859724,0.0036022894,0.96183586,0.000035579014,0.00017467758,0.00037366126,0.000088514586,0.00016472538,0.0034954515,0.00007124288,0.020991938,0.0003063632],"about_ca_topic_score_codex":0.005606408,"about_ca_topic_score_gemma":0.0020386528,"teacher_disagreement_score":0.021927396,"about_ca_system_score_codex":0.0023779036,"about_ca_system_score_gemma":0.00089737616,"threshold_uncertainty_score":0.9999986},"labels":[],"label_agreement":null},{"id":"W2916100539","doi":"10.1016/s1470-2045(18)30907-0","title":"Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study","year":2019,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":175,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; University of Calgary","funders":"Janssen Pharmaceuticals; National Cancer Institute; Takeda Pharmaceuticals U.S.A.; Sanofi Genzyme; Genentech; National Institutes of Health; European Society for Medical Oncology; Eisai; Bayer Fund; Clovis Oncology; Active Biotech; Ipsen Biopharmaceuticals; Bavarian Nordic; Novartis; AbbVie; Exelixis; Sanofi; Merck; GlaxoSmithKline; Roche; Astellas Pharma US; Pfizer; Bristol-Myers Squibb; AstraZeneca; Boehringer Ingelheim","keywords":"Cabozantinib; Medicine; Renal cell carcinoma; Retrospective cohort study; Oncology; Cohort; Internal medicine; Urology","score_opus":0.01779356237453034,"score_gpt":0.2916839099226428,"score_spread":0.2738903475481125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916100539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8984776,0.00025255757,0.0000031879545,0.00052578043,0.00035050913,0.0037174537,0.0000075951675,0.00004901008,0.09661629],"genre_scores_gemma":[0.99179417,0.00005870477,0.00046869155,0.00044209522,0.00026971524,0.0001857945,0.000018884879,0.000049264945,0.0067126923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974395,0.00034892457,0.00045064886,0.0006625755,0.00039340835,0.0007049622],"domain_scores_gemma":[0.99824613,0.00023734478,0.00022423352,0.0010442324,0.000116769384,0.00013129356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078836776,0.0003076003,0.00124683,0.00012627062,0.000064843436,0.000012752082,0.00030205317,0.0001546063,0.00035514907],"category_scores_gemma":[0.00004574644,0.00020928727,0.00012002015,0.00034699365,0.00008802306,0.00006033683,0.00016336485,0.0007093539,0.00070410076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028779285,0.001990076,0.9735431,0.000067620975,0.0000516556,0.0007232099,0.0015376803,0.00004809671,0.018161245,0.000011600744,0.0007478812,0.00023992447],"study_design_scores_gemma":[0.023500824,0.005111143,0.96150297,0.000022388293,0.00019424019,0.000046711848,0.0012908654,0.0002922117,0.00571162,0.000011132352,0.0021208234,0.0001950834],"about_ca_topic_score_codex":0.00060593954,"about_ca_topic_score_gemma":0.00041199155,"teacher_disagreement_score":0.09331654,"about_ca_system_score_codex":0.00082841,"about_ca_system_score_gemma":0.0002359521,"threshold_uncertainty_score":0.90500253},"labels":[],"label_agreement":null},{"id":"W2916578543","doi":"10.5489/cuaj.5666","title":"Upfront cytoreductive nephrectomy vs. upfront systemic therapy in metastatic kidney cancer","year":2018,"lang":"en","type":"letter","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Systemic therapy; Kidney cancer; Urology; Nephrectomy; Internal medicine; Oncology; Cancer; Kidney","score_opus":0.0243845582196661,"score_gpt":0.2540013708276006,"score_spread":0.2296168126079345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916578543","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1517073,0.004460641,0.000011478307,0.83837676,0.0022302254,0.0013699471,0.00038818282,0.000044872057,0.0014106167],"genre_scores_gemma":[0.19845957,0.001409275,0.00026609167,0.782933,0.01102289,0.00028065435,0.0004952139,0.00011496007,0.005018361],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951896,0.0009165902,0.0009348315,0.00063793064,0.0010104069,0.0013106469],"domain_scores_gemma":[0.99655914,0.00021249056,0.00095163885,0.0003137918,0.0007105113,0.0012524128],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00089161715,0.000604964,0.0013323242,0.0007644348,0.00021713742,0.00015972606,0.00032006414,0.0012006778,0.0025835393],"category_scores_gemma":[0.00065613067,0.0004505979,0.00045967835,0.00035516635,0.00009096305,0.000121372745,0.00002164847,0.0037366478,0.00021091054],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017386996,0.000046888417,0.11568377,0.000038160888,0.000906172,0.0038216067,0.00028205375,0.000010059214,0.000035924753,0.0000019579074,0.87814385,0.0008556917],"study_design_scores_gemma":[0.003040758,0.0012452892,0.11116976,0.0003045697,0.00048188696,0.0016328314,0.000057430214,0.000038405982,0.000034184683,0.00022117153,0.881301,0.00047275217],"about_ca_topic_score_codex":0.0149920145,"about_ca_topic_score_gemma":0.002163416,"teacher_disagreement_score":0.055443745,"about_ca_system_score_codex":0.018324086,"about_ca_system_score_gemma":0.0051916125,"threshold_uncertainty_score":0.9997946},"labels":[],"label_agreement":null},{"id":"W2916949868","doi":"10.14740/gr1129","title":"Peri-Ampullary Metastasis From Endometrial Adenocarcinoma: A Rare Etiology of Obstructive Jaundice","year":2019,"lang":"en","type":"article","venue":"Gastroenterology Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Peri; Medicine; Obstructive jaundice; Etiology; Metastasis; Jaundice; Adenocarcinoma; Gastroenterology; Internal medicine; General surgery; Cancer","score_opus":0.06278451874062027,"score_gpt":0.338063781371399,"score_spread":0.27527926263077873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916949868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948535,0.001303975,0.000046960304,0.00087402336,0.00036958652,0.0012150413,0.0001620974,0.000031335214,0.0011434901],"genre_scores_gemma":[0.99693507,0.000070421636,0.0018767475,0.00012902929,0.00025137712,0.00010069942,0.00022661038,0.00004367195,0.00036635844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954449,0.0013263231,0.00057580776,0.00082192954,0.00083345256,0.0009976224],"domain_scores_gemma":[0.99732214,0.0007616743,0.00017005771,0.00091158785,0.0005328281,0.0003017143],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00093471917,0.00028068165,0.0010554302,0.000955624,0.00008063283,0.00001315993,0.00037286401,0.00025783735,0.0019427236],"category_scores_gemma":[0.00041571108,0.00023658205,0.00031980526,0.00052199146,0.00066828646,0.00008480415,0.0004224017,0.00093896873,0.0003896844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011482158,0.00034689717,0.94640774,0.00008238684,0.0009241917,0.0004204123,0.0005500469,0.000004053876,0.0386841,0.00006798405,0.00044300288,0.00058703154],"study_design_scores_gemma":[0.00959781,0.006698395,0.9719877,0.00004982507,0.00024021209,0.00053640717,0.0012966436,0.000027119404,0.0090353815,0.00021744195,0.00022131075,0.000091731985],"about_ca_topic_score_codex":0.00051379984,"about_ca_topic_score_gemma":0.000042342934,"teacher_disagreement_score":0.029648717,"about_ca_system_score_codex":0.00028784695,"about_ca_system_score_gemma":0.00020405902,"threshold_uncertainty_score":0.9989696},"labels":[],"label_agreement":null},{"id":"W2917434007","doi":"10.5489/cuaj.5750","title":"A systematic management algorithm for perioperative complications after robotic assisted partial nephrectomy","year":2019,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Nephrectomy; Renal cell carcinoma; Medicine; Perioperative; Surgery; Gold standard (test); Robotic surgery; Urology; Kidney; Radiology; Oncology; Internal medicine","score_opus":0.05193093239549119,"score_gpt":0.3001510256758816,"score_spread":0.2482200932803904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917434007","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010654932,0.98580194,0.0024444596,0.0011106855,0.00058656523,0.008400358,0.00020782382,0.000036613743,0.0014009157],"genre_scores_gemma":[0.00044787093,0.9697141,0.009592865,0.0019980662,0.0009706038,0.008023129,0.0008125441,0.00012935922,0.008311429],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996593,0.00057778286,0.0011720106,0.0004733183,0.00048123975,0.00070265785],"domain_scores_gemma":[0.99700946,0.0004449148,0.00092419994,0.00034158092,0.0004246937,0.0008551272],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006644296,0.00048758744,0.0024035638,0.00043555832,0.0002913236,0.00023658427,0.0002165201,0.00053946726,0.0002494052],"category_scores_gemma":[0.00022211717,0.0003356233,0.0011956024,0.00031804727,0.000029609459,0.00006479625,0.000028440056,0.0007230699,0.00041961286],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069320784,0.0005594312,0.0010054469,0.12226306,0.015289185,0.0015907797,0.000212084,0.000032201253,2.4116457e-7,0.0005652535,0.006876919,0.8515361],"study_design_scores_gemma":[0.0013093256,0.00050288736,0.0031814575,0.015623199,0.012905984,0.0014886676,0.000040346487,0.0005436714,6.723867e-8,0.000020977408,0.96394145,0.00044196076],"about_ca_topic_score_codex":0.00006060755,"about_ca_topic_score_gemma":0.00006239046,"teacher_disagreement_score":0.9570645,"about_ca_system_score_codex":0.006100009,"about_ca_system_score_gemma":0.001066024,"threshold_uncertainty_score":0.9999096},"labels":[],"label_agreement":null},{"id":"W2917902101","doi":"10.1016/j.euf.2019.02.008","title":"The role and timing of cytoreductive nephrectomy in the immunotherapy era","year":2019,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Immunotherapy; Nephrectomy; Clinical trial; Cytokine; Internal medicine; Oncology; Urology; Surgery; Kidney; Cancer","score_opus":0.009597925875774235,"score_gpt":0.22893376381153416,"score_spread":0.21933583793575992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917902101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9176436,0.0067538787,0.0000030174283,0.0015443744,0.000062198305,0.00034928415,8.041307e-7,0.000009447776,0.073633395],"genre_scores_gemma":[0.9991712,0.00013757288,0.00006740636,0.00027050366,0.00005746457,0.0000063077086,0.0000014108822,0.000020052912,0.0002681066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989795,0.00041787577,0.0001669261,0.00016599677,0.00010062084,0.00016904711],"domain_scores_gemma":[0.99929523,0.00024250979,0.00007009367,0.0003465391,0.000023772962,0.000021844917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046597884,0.000101035745,0.0001615199,0.000046400164,0.000052922347,0.000008730497,0.00012976781,0.00002456747,0.00002973395],"category_scores_gemma":[0.00002325122,0.000051509058,0.000047120586,0.00008455143,0.00014834903,0.000022329154,0.000038269725,0.00021480145,0.000065912536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063223657,0.00062414823,0.43605956,0.00004043794,0.00077515806,0.0009353739,0.025436217,0.000041217736,0.20236264,0.0049980814,0.00077883096,0.32162598],"study_design_scores_gemma":[0.0025873473,0.0016661187,0.95336276,0.000011504808,0.000060584633,0.00038035432,0.0009352217,0.00006574274,0.0052775824,0.00050233444,0.035060238,0.00009022551],"about_ca_topic_score_codex":0.00003883868,"about_ca_topic_score_gemma":0.0000048719803,"teacher_disagreement_score":0.51730317,"about_ca_system_score_codex":0.000017573104,"about_ca_system_score_gemma":0.000021542055,"threshold_uncertainty_score":0.21004784},"labels":[],"label_agreement":null},{"id":"W2918160387","doi":"10.5489/cuaj.2014","title":"What’s new in renal cell cancer research? Highlights of GU-ASCO 2014","year":2014,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Genitourinary system; Medicine; Renal cell carcinoma; Kidney cancer; Cancer; General surgery; Oncology; Internal medicine; Urology; Gynecology","score_opus":0.0769589164567342,"score_gpt":0.3478571495910976,"score_spread":0.2708982331343634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918160387","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00084909075,0.9893944,0.0000024369037,0.006270675,0.0008575615,0.00070342905,0.00003256333,0.0000093968765,0.0018804189],"genre_scores_gemma":[0.0012742219,0.9886089,0.0000802079,0.00040595754,0.001712121,0.000039937917,0.000072227354,0.000045484132,0.0077609587],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946502,0.0014346732,0.0012882592,0.00047141692,0.0011197486,0.0010357081],"domain_scores_gemma":[0.99563116,0.00071693957,0.0010639833,0.00032617227,0.0005398572,0.0017218968],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026484143,0.00040307964,0.0022043085,0.0012370535,0.00014573104,0.0001430919,0.00037771094,0.0010563306,0.0015508117],"category_scores_gemma":[0.00060866243,0.00028114446,0.0006824961,0.00064757856,0.0000673023,0.00013479221,0.000043412063,0.0024528448,0.00027923813],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00010166223,0.00025516903,0.0058830576,0.002747334,0.000772112,0.0015371781,0.00024163425,0.000022649669,0.000016173188,0.0002718502,0.4163773,0.5717739],"study_design_scores_gemma":[0.0008286164,0.0005317352,0.0039200983,0.0035491094,0.0005100153,0.00014781924,0.000012757189,0.0000020648197,0.00000848221,0.00023076087,0.99004245,0.00021611422],"about_ca_topic_score_codex":0.010348805,"about_ca_topic_score_gemma":0.008705595,"teacher_disagreement_score":0.5736651,"about_ca_system_score_codex":0.007450635,"about_ca_system_score_gemma":0.0072200503,"threshold_uncertainty_score":0.99996406},"labels":[],"label_agreement":null},{"id":"W2919539688","doi":"10.1136/bmjopen-2018-025662","title":"Renal hypothermia during partial nephrectomy for patients with renal tumours: a randomised controlled clinical trial protocol","year":2019,"lang":"en","type":"article","venue":"BMJ Open","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Université Laval; Ottawa Hospital; Princess Margaret Cancer Centre; McMaster University; Dalhousie University; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Nephrectomy; Renal function; Renal hilum; Creatinine; Kidney; Urology; Renal ischemia; Hypothermia; Nephrology; Surgery; Internal medicine; Ischemia; Reperfusion injury","score_opus":0.08178729043087539,"score_gpt":0.4071113829644626,"score_spread":0.3253240925335872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919539688","genre_codex":"empirical","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5222924,9.0904956e-7,0.0000150746955,0.000093004266,0.00009286164,0.47506744,0.000007167425,0.000023844852,0.0024073357],"genre_scores_gemma":[0.25240564,1.2954332e-7,0.002185715,0.00014491472,0.0007460556,0.74094874,0.00004424804,0.00006539398,0.003459153],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99673563,0.00038408465,0.0012174735,0.00062414294,0.0005835386,0.00045513627],"domain_scores_gemma":[0.99758047,0.0005631385,0.0006511763,0.00068921334,0.00022502498,0.00029095632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015779649,0.0003318389,0.0016446675,0.00007576213,0.000093641225,0.000120522025,0.00029886785,0.00013966607,0.00051823957],"category_scores_gemma":[0.00059100974,0.0001987558,0.00048093149,0.000103552426,0.000061667786,0.00017186321,0.00013610796,0.00018406058,0.0000942631],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9514264,0.0013936493,0.0446716,0.00011771642,0.0005084937,0.00005563232,0.000039338942,0.000008905288,0.00031133599,0.000007454596,0.00070304616,0.00075646583],"study_design_scores_gemma":[0.9449959,0.014452992,0.034485005,0.00041458875,0.00043440907,0.000017521761,0.000010510037,0.00019615833,0.0015514024,0.000013584049,0.0031517625,0.0002762128],"about_ca_topic_score_codex":0.000022270231,"about_ca_topic_score_gemma":0.000010620963,"teacher_disagreement_score":0.2698867,"about_ca_system_score_codex":0.00012878918,"about_ca_system_score_gemma":0.0006710393,"threshold_uncertainty_score":0.81050265},"labels":[],"label_agreement":null},{"id":"W2920206705","doi":"10.1016/j.urolonc.2019.02.006","title":"The prognostic significance of nodal disease burden in patients with lymph node metastases from renal cell carcinoma","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital; Juravinski Cancer Centre","funders":"National Cancer Institute; Sidney Kimmel Center for Prostate and Urologic Cancers","keywords":"Medicine; Interquartile range; Renal cell carcinoma; Nephrectomy; Proportional hazards model; Internal medicine; Lymph node; Clear cell; Urology; Cancer; Oncology; Carcinoma; Gastroenterology; Surgery; Kidney","score_opus":0.013544364732218329,"score_gpt":0.24231533526287527,"score_spread":0.22877097053065695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920206705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952447,0.0013049787,0.000005648599,0.0013128505,0.00006203831,0.0008879073,0.00010348595,0.000014694476,0.0010637419],"genre_scores_gemma":[0.99238527,0.000038655642,0.0066848267,0.00025167444,0.00003933108,0.000114663024,0.00017980977,0.000013321805,0.00029244125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986324,0.00017055201,0.00031133366,0.00037698084,0.00023618102,0.00027259366],"domain_scores_gemma":[0.9984655,0.0006885277,0.0002004061,0.00031254813,0.0000917222,0.00024129708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015872034,0.00019812465,0.0003692107,0.00008589061,0.00010306644,0.000013016921,0.00011286877,0.00008608866,0.00004583274],"category_scores_gemma":[0.00010598334,0.000118586424,0.000048717124,0.00020347015,0.0005857401,0.00006317775,0.00004478535,0.000178278,0.000016267128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009560476,0.00032015872,0.9970829,0.000036780657,0.000038499747,0.00011523093,0.00015624664,0.0002737495,0.0004568214,0.00018847661,0.00013230096,0.00024279646],"study_design_scores_gemma":[0.0029642642,0.0026098555,0.9781788,0.000059724844,0.00047013594,0.0000067497313,0.00013356836,0.00029020183,0.00085437833,0.00052430027,0.013771678,0.00013634504],"about_ca_topic_score_codex":0.00032603485,"about_ca_topic_score_gemma":0.000022747838,"teacher_disagreement_score":0.018904094,"about_ca_system_score_codex":0.00013200294,"about_ca_system_score_gemma":0.0005074831,"threshold_uncertainty_score":0.4835814},"labels":[],"label_agreement":null},{"id":"W2921242005","doi":"10.1200/jco.2019.37.7_suppl.568","title":"Efficacy of targeted therapy (TT) after checkpoint inhibitors (CPI) in metastatic renal cell carcinoma (mRCC): Results from the Canadian Kidney Cancer Information System (CKCis).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Ottawa Hospital; University of British Columbia; London Health Sciences Centre; McMaster University; Juravinski Cancer Centre; Dalhousie University; Hôtel-Dieu de Québec; Centre Hospitalier de l’Université de Montréal; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Nivolumab; Axitinib; Renal cell carcinoma; Hazard ratio; Internal medicine; Cancer; Kidney cancer; Ipilimumab; Oncology; Urology; Gastroenterology; Sunitinib; Immunotherapy; Confidence interval","score_opus":0.05934665579512874,"score_gpt":0.3556969391781236,"score_spread":0.29635028338299485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921242005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98830956,0.00093520386,0.0000031565116,0.005917807,0.0014091973,0.0008432881,0.00011729578,0.000005453454,0.0024590534],"genre_scores_gemma":[0.9967523,0.00014312664,0.00061740703,0.0017852412,0.00054581533,0.000017667875,0.00004129011,0.000019329269,0.00007778794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938621,0.00077697646,0.004168301,0.00021360294,0.0006292633,0.00034976652],"domain_scores_gemma":[0.9937626,0.0018504418,0.002710469,0.00042325826,0.00053856,0.000714631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034123526,0.00023361137,0.0015470757,0.00029342505,0.00003746894,0.000017942297,0.0002482336,0.00034059334,0.00019642538],"category_scores_gemma":[0.0015055123,0.00013367464,0.00058512395,0.0002818501,0.00013973219,0.00020847273,0.000037963022,0.0010675857,0.000057784768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.073265895,0.0015855045,0.8732039,0.0002560826,0.0011819619,0.0017645239,0.0051018214,0.0006223405,0.0021548409,0.000026064852,0.0112836845,0.029553402],"study_design_scores_gemma":[0.030536238,0.005392836,0.93955475,0.00040944343,0.0003337288,0.00006390549,0.0005390317,0.0002480092,0.005071652,0.000011619606,0.01770934,0.00012946717],"about_ca_topic_score_codex":0.07146903,"about_ca_topic_score_gemma":0.022398945,"teacher_disagreement_score":0.06635085,"about_ca_system_score_codex":0.0013493047,"about_ca_system_score_gemma":0.007355864,"threshold_uncertainty_score":0.9982715},"labels":[],"label_agreement":null},{"id":"W2921483392","doi":"10.1200/jco.2019.37.7_suppl.610","title":"Real-world assessment of clinical outcomes among first-line (1L) sunitinib (SUN) patients (pts) with metastatic renal cell carcinoma (mRCC) by the international mRCC database consortium (IMDC) risk group.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; University of Calgary","funders":"","keywords":"Medicine; Discontinuation; Sunitinib; Renal cell carcinoma; Internal medicine; Thrombocytosis; Clear cell renal cell carcinoma; Anemia; Database; Oncology","score_opus":0.10083678117430452,"score_gpt":0.43539819432713356,"score_spread":0.33456141315282906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921483392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98558784,0.00007449176,0.00018921486,0.0024284692,0.0020214058,0.0009775098,0.00019635422,0.000012895744,0.008511809],"genre_scores_gemma":[0.98958606,0.00064443407,0.00637848,0.0011738514,0.00055344414,0.000020624908,0.00020603115,0.000056385463,0.0013806819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98892903,0.001844934,0.0064929007,0.00058530195,0.001674804,0.0004730495],"domain_scores_gemma":[0.97616345,0.012968416,0.008032475,0.00085976697,0.0012702293,0.00070564967],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.007879884,0.00044689103,0.0033127116,0.00027542602,0.00008678548,0.000026373167,0.00072484266,0.00028180334,0.0007753756],"category_scores_gemma":[0.0025613427,0.00024242359,0.0012037695,0.00026636772,0.00072352646,0.00027261022,0.00028244412,0.0024216867,0.000031572134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056596347,0.007769487,0.9724694,0.00007531416,0.0016522341,0.00056752295,0.000046393856,0.00006821764,0.00003406965,0.000075460426,0.005848444,0.0057338607],"study_design_scores_gemma":[0.030655013,0.024126602,0.92828614,0.00014561067,0.002322979,0.000073899464,0.00015709642,0.00053595525,0.00013701743,0.000039143222,0.013309529,0.00021104567],"about_ca_topic_score_codex":0.0010275077,"about_ca_topic_score_gemma":0.0015684683,"teacher_disagreement_score":0.044183254,"about_ca_system_score_codex":0.00039996585,"about_ca_system_score_gemma":0.0016801839,"threshold_uncertainty_score":0.9998798},"labels":[],"label_agreement":null},{"id":"W2921633401","doi":"10.1200/jco.2019.37.7_suppl.543","title":"Pembrolizumab (pembro) plus axitinib (axi) versus sunitinib as first-line therapy for locally advanced or metastatic renal cell carcinoma (mRCC): phase III KEYNOTE-426 study.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Clinical endpoint; Temsirolimus; Internal medicine; Interim analysis; Oncology; Tolerability; Discontinuation; Phases of clinical research; Adverse effect; Clinical trial; Discovery and development of mTOR inhibitors","score_opus":0.18107808368130654,"score_gpt":0.4758328862607582,"score_spread":0.29475480257945164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921633401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851268,0.0012189483,0.0005174337,0.0022399013,0.0027757033,0.0040483824,0.000032148087,0.000036293823,0.0040044216],"genre_scores_gemma":[0.9875417,0.0007443691,0.005289016,0.001530843,0.0014370432,0.000116930314,0.000043263783,0.00011740878,0.0031794747],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9915118,0.00091721007,0.0048712855,0.00075317355,0.0010992417,0.0008472748],"domain_scores_gemma":[0.98258334,0.010588487,0.003500069,0.00080217986,0.0014404815,0.0010854414],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0036320197,0.00064433133,0.004251489,0.00036288076,0.00014693946,0.000034597666,0.00056835153,0.00047020148,0.0014783089],"category_scores_gemma":[0.002799318,0.00042208994,0.0015347587,0.00035094333,0.00026999385,0.0002513223,0.00012232002,0.0015561869,0.00014684061],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8223227,0.02268683,0.0026367484,0.00020816662,0.0020886862,0.008010604,0.00072427717,0.0004652753,0.0011169764,0.00005048183,0.0017833856,0.13790585],"study_design_scores_gemma":[0.4989007,0.43980372,0.010102744,0.00014698206,0.002044996,0.0010082399,0.0014127211,0.0006297932,0.0023370658,0.000115238494,0.043068238,0.00042956395],"about_ca_topic_score_codex":0.00006768928,"about_ca_topic_score_gemma":0.0001275808,"teacher_disagreement_score":0.41711688,"about_ca_system_score_codex":0.00075595506,"about_ca_system_score_gemma":0.00631843,"threshold_uncertainty_score":0.9998231},"labels":[],"label_agreement":null},{"id":"W2921697223","doi":"10.1200/jco.2019.37.7_suppl.564","title":"Treatment-free survival (TFS) after discontinuation of first-line nivolumab (NIVO) plus ipilimumab (IPI) or sunitinib (SUN) in intention-to-treat (ITT) and IMDC favorable-risk patients (pts) with advanced renal cell carcinoma (aRCC) from CheckMate 214.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Discontinuation; Nivolumab; Internal medicine; Ipilimumab; Sunitinib; Gastroenterology; Oncology; Cancer; Immunotherapy","score_opus":0.04489977160114744,"score_gpt":0.33908855315619607,"score_spread":0.29418878155504863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921697223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957492,0.00035530093,0.0000786308,0.00067813427,0.0005750011,0.0012395668,0.00012826629,0.000011629533,0.0011843173],"genre_scores_gemma":[0.9948697,0.00060131855,0.0030004745,0.000113781105,0.00025551402,0.00003915388,0.00009136193,0.00005978834,0.00096888334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945621,0.0006947924,0.0029708997,0.0005981221,0.0006976115,0.00047646937],"domain_scores_gemma":[0.99339193,0.0021934428,0.0024043955,0.00067480013,0.00078495935,0.000550481],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001024258,0.00046281476,0.0026997877,0.00037782325,0.000048394875,0.000020555406,0.00026651032,0.00039156622,0.00029007866],"category_scores_gemma":[0.0009805594,0.00028765734,0.00044407844,0.00030749998,0.00021758574,0.00030900622,0.00016040257,0.0007105575,0.000027059908],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.092349924,0.0042410595,0.85399425,0.000089481044,0.00027644594,0.0007612077,0.0006160687,0.0001238681,0.00024017264,0.0000030507938,0.000046330348,0.047258127],"study_design_scores_gemma":[0.09520158,0.07641,0.82371455,0.00039507102,0.0009608326,0.000060778053,0.0005833078,0.00021540002,0.0015137864,0.00006429318,0.00063781015,0.00024256714],"about_ca_topic_score_codex":0.0014424104,"about_ca_topic_score_gemma":0.0071626888,"teacher_disagreement_score":0.07216894,"about_ca_system_score_codex":0.0009620906,"about_ca_system_score_gemma":0.0009861541,"threshold_uncertainty_score":0.99995756},"labels":[],"label_agreement":null},{"id":"W2921712318","doi":"10.1200/jco.2019.37.7_suppl.584","title":"First-line (1L) immuno-oncology (IO) combination therapies in metastatic renal cell carcinoma (mRCC): Preliminary results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Dalhousie University; University of Manitoba; Princess Margaret Cancer Centre; Sunnybrook Hospital; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Nivolumab; Renal cell carcinoma; Hazard ratio; Internal medicine; Ipilimumab; Proportional hazards model; Oncology; Cohort; Urology; Gastroenterology; Cancer; Confidence interval; Immunotherapy","score_opus":0.0989817461027572,"score_gpt":0.381779474156885,"score_spread":0.28279772805412784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921712318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96882623,0.0034120716,0.00015315713,0.019649485,0.0027691075,0.0012159502,0.00023322455,0.000017336793,0.0037234446],"genre_scores_gemma":[0.9874669,0.000848391,0.0069088717,0.0024175004,0.0007789444,0.000039431252,0.00042112617,0.00006389843,0.0010549686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98931843,0.0023764165,0.005645642,0.0007775091,0.0012552353,0.0006267483],"domain_scores_gemma":[0.9770813,0.016058855,0.004521118,0.0009705005,0.0009126462,0.000455553],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0070510814,0.00054738513,0.0026667318,0.0004424479,0.00011373654,0.00004723971,0.0009731552,0.00040258863,0.0006943774],"category_scores_gemma":[0.002732674,0.0003569313,0.0008965581,0.00035457866,0.0004991228,0.00039359822,0.00036883538,0.0022257369,0.00014921965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3036205,0.048964534,0.44386512,0.00060423184,0.005045006,0.03786116,0.009705989,0.0028029254,0.045810986,0.00042118205,0.05286219,0.048436195],"study_design_scores_gemma":[0.10075267,0.07352669,0.7511491,0.00036903354,0.003141749,0.0015767675,0.0025730608,0.004513397,0.010982009,0.0010774136,0.049714625,0.0006234747],"about_ca_topic_score_codex":0.0008670004,"about_ca_topic_score_gemma":0.0004964535,"teacher_disagreement_score":0.307284,"about_ca_system_score_codex":0.0010776041,"about_ca_system_score_gemma":0.003198857,"threshold_uncertainty_score":0.99988824},"labels":[],"label_agreement":null},{"id":"W2921789044","doi":"10.1200/jco.2019.37.7_suppl.544","title":"Subgroup analysis from JAVELIN Renal 101: Outcomes for avelumab plus axitinib (A + Ax) versus sunitinib (S) in advanced renal cell carcinoma (aRCC).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Renal cell carcinoma; Subgroup analysis; Axitinib; Sunitinib; Clinical endpoint; Temsirolimus; Progression-free survival; Discontinuation; Gastroenterology; Randomized controlled trial; Urology; Oncology; Confidence interval; Overall survival","score_opus":0.10929191523843512,"score_gpt":0.4221614423895783,"score_spread":0.3128695271511432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921789044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98954993,0.00053650734,0.0003373502,0.0021766762,0.0018986736,0.00086835393,0.00007959809,0.000017182925,0.0045356946],"genre_scores_gemma":[0.98250264,0.0001319544,0.014189692,0.0008505139,0.00096633914,0.000029381517,0.00015482279,0.000056835324,0.0011178397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9923727,0.00076433364,0.0046231537,0.000682748,0.0008490936,0.00070797553],"domain_scores_gemma":[0.9844004,0.010531139,0.0029111838,0.00068129716,0.0007358537,0.0007401602],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032796974,0.00046199668,0.0044992347,0.0007652632,0.00005540026,0.000023196124,0.0004567778,0.0007625954,0.00091704616],"category_scores_gemma":[0.0025376547,0.00034789785,0.0025385127,0.00060548534,0.00019195718,0.00020051909,0.00012485243,0.0015780819,0.00010859966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09443502,0.0035149725,0.852489,0.000097252385,0.0040497086,0.0031221695,0.00045101563,0.0010459853,0.0024500566,0.00010255429,0.001129042,0.037113238],"study_design_scores_gemma":[0.08759815,0.023977263,0.8703052,0.00008206948,0.0045490153,0.000055057033,0.00052803487,0.0009854176,0.0017345212,0.00018687906,0.00965213,0.00034625866],"about_ca_topic_score_codex":0.00026555164,"about_ca_topic_score_gemma":0.00071347924,"teacher_disagreement_score":0.03676698,"about_ca_system_score_codex":0.0009881693,"about_ca_system_score_gemma":0.0023275383,"threshold_uncertainty_score":0.99999624},"labels":[],"label_agreement":null},{"id":"W2921852699","doi":"10.1155/2019/8071025","title":"Thoracoabdominal Approach for Large Retroperitoneal Masses: Case Series and Review","year":2019,"lang":"en","type":"article","venue":"Case Reports in Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Blood loss; Renal hilum; Perioperative; Surgery; Nephrectomy; Retroperitoneal space; Hilum (anatomy); General surgery; Concomitant; Kidney","score_opus":0.02451876483381968,"score_gpt":0.2996723812007075,"score_spread":0.27515361636688784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921852699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9676556,0.02656063,0.00014817981,0.00046101632,0.00017551707,0.0019680653,0.00001074495,0.000027448024,0.0029928288],"genre_scores_gemma":[0.99247867,0.00089685834,0.004728579,0.0006297188,0.000086826636,0.0002451168,0.000080246005,0.000031306467,0.00082270533],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99842036,0.0000934573,0.0005161996,0.00053275196,0.00010142082,0.000335796],"domain_scores_gemma":[0.99900156,0.000074465745,0.00017359071,0.0005362001,0.000081924445,0.000132232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007397691,0.00019292343,0.0006436015,0.00008994721,0.00004922723,0.000008326502,0.000017240434,0.00014700585,0.000074209645],"category_scores_gemma":[0.00019409943,0.00015100652,0.00009249262,0.00010609433,0.00006642167,0.0000702776,0.00006265223,0.00019784777,0.0000030322265],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047613707,0.00017245975,0.034017347,0.0026822966,0.000052896034,0.9605098,0.00008945524,0.0000018965211,0.00025311598,0.00013137964,0.0005145169,0.0010987333],"study_design_scores_gemma":[0.00085756095,0.0013139711,0.00044036075,0.0000885771,0.00029842707,0.9769454,0.00019813607,0.00018522958,0.0001730654,0.00003155977,0.019340307,0.00012742673],"about_ca_topic_score_codex":0.000040060364,"about_ca_topic_score_gemma":0.000025042424,"teacher_disagreement_score":0.033576984,"about_ca_system_score_codex":0.00008192383,"about_ca_system_score_gemma":0.00010668828,"threshold_uncertainty_score":0.6157867},"labels":[],"label_agreement":null},{"id":"W2921869013","doi":"10.1200/jco.2019.37.7_suppl.566","title":"Impact of body mass index (BMI) on treatment outcomes to immune checkpoint blockade (ICB) in metastatic renal cell carcinoma (mRCC).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Renal cell carcinoma; Underweight; Proportional hazards model; Overweight; Body mass index; Oncology; Gastroenterology; Confidence interval","score_opus":0.09813768646173032,"score_gpt":0.44327081788098144,"score_spread":0.3451331314192511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921869013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930885,0.00026144023,0.00001898602,0.0018980049,0.0005857174,0.00087665877,0.00001119037,0.00000641889,0.003253123],"genre_scores_gemma":[0.9963331,0.000094893534,0.0018346497,0.00022041853,0.00022617483,0.000013263458,0.0000055366418,0.000040693893,0.0012312275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99354386,0.0006492858,0.004238619,0.0003803329,0.0006891207,0.00049880147],"domain_scores_gemma":[0.9937154,0.0023839334,0.0022869436,0.0005991111,0.00031639994,0.00069823145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021903084,0.0004196439,0.0039484887,0.0005947876,0.000017450706,0.000008394685,0.00025995428,0.0003245096,0.00048498405],"category_scores_gemma":[0.00085717137,0.00023954907,0.0021120335,0.00028416078,0.00009952476,0.00007570422,0.00006490714,0.0009174505,0.00013910228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012143413,0.007387764,0.94113064,0.00004983888,0.0010220151,0.0024776724,0.00014066872,0.0007725109,0.028534314,0.0000056005065,0.00008948188,0.006246094],"study_design_scores_gemma":[0.021548467,0.106591664,0.8576982,0.00010518107,0.0006147424,0.00020751877,0.000103814426,0.00011842882,0.012354969,0.000063792795,0.00043995713,0.0001532842],"about_ca_topic_score_codex":0.0004797527,"about_ca_topic_score_gemma":0.00004026152,"teacher_disagreement_score":0.0992039,"about_ca_system_score_codex":0.0019305685,"about_ca_system_score_gemma":0.0023449955,"threshold_uncertainty_score":0.9768528},"labels":[],"label_agreement":null},{"id":"W2922056055","doi":"10.1200/jco.2019.37.7_suppl.581","title":"Outcomes in patients (pts) with advanced renal cell carcinoma (aRCC) who discontinued (DC) first-line nivolumab + ipilimumab (N+I) or sunitinib (S) due to treatment-related adverse events (TRAEs) in CheckMate 214.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Randomized controlled trial; Diarrhea; Adverse effect; Gastroenterology","score_opus":0.04543029092802406,"score_gpt":0.3627115971951943,"score_spread":0.3172813062671702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922056055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938661,0.00008218759,0.000006307005,0.0016181422,0.00071669836,0.001927472,0.000026530966,0.000017180242,0.0017393981],"genre_scores_gemma":[0.9943688,0.000114227325,0.0012469782,0.00045293226,0.00013359335,0.000043056723,0.000039728842,0.000077688535,0.0035229789],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9930681,0.0006504335,0.0041128434,0.00065335195,0.00074319285,0.0007720794],"domain_scores_gemma":[0.994624,0.0015194705,0.0020673634,0.00059248455,0.00042149288,0.0007751795],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012906365,0.00056818017,0.003826036,0.0006255265,0.000045198194,0.000007809596,0.0003317886,0.0005305851,0.0003981509],"category_scores_gemma":[0.0008433439,0.00034529323,0.0006648776,0.00055769633,0.000121226585,0.00030069868,0.00010899215,0.001131215,0.00014940153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053704336,0.010165798,0.8929677,0.00006938109,0.00032910137,0.0047303773,0.0005696846,0.00064535026,0.00008394902,0.0000035340206,0.000052488474,0.036678325],"study_design_scores_gemma":[0.10530933,0.07277044,0.81855726,0.00044213442,0.00036212313,0.00014566179,0.00024457747,0.00008269672,0.00044625718,0.000018530274,0.0013346303,0.00028634875],"about_ca_topic_score_codex":0.00022579991,"about_ca_topic_score_gemma":0.002171119,"teacher_disagreement_score":0.07441041,"about_ca_system_score_codex":0.0016611847,"about_ca_system_score_gemma":0.001461445,"threshold_uncertainty_score":0.9998999},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2922177938","doi":"10.1200/jco.2019.37.7_suppl.664","title":"Genomic and clinical determinants of recurrence in localized clear cell renal cell carcinoma (ccRCC).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Clear cell renal cell carcinoma; BAP1; Internal medicine; PTEN; Proportional hazards model; Oncology; Renal cell carcinoma; Cancer; PI3K/AKT/mTOR pathway; Biology; Genetics","score_opus":0.09942283151706245,"score_gpt":0.4268646399002469,"score_spread":0.3274418083831845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922177938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99319386,0.0014782652,0.000009928583,0.0002946464,0.0010221769,0.00040839714,0.0000034162344,0.0000036761207,0.00358562],"genre_scores_gemma":[0.9938534,0.0014742796,0.0034997845,0.00038282547,0.00038423575,0.0000016230154,0.0000013481005,0.000025650776,0.00037684743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99302745,0.0010166176,0.004810883,0.0003979766,0.00039888217,0.00034822052],"domain_scores_gemma":[0.9928191,0.003112408,0.0028298637,0.00038597372,0.00030292428,0.0005497325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004942293,0.00022609349,0.0028359445,0.00021830182,0.00001628469,0.0000060961447,0.00025146015,0.0006175408,0.00016624277],"category_scores_gemma":[0.0009972809,0.00016481528,0.0006784791,0.00014672079,0.00037040235,0.00008452315,0.00014713132,0.0014292656,0.00006564488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009703646,0.0022062038,0.94414663,0.00014073175,0.00005003935,0.0014315096,0.00007171511,0.000005395686,0.0017944144,0.000003179565,0.00032857686,0.040117934],"study_design_scores_gemma":[0.020203216,0.037585113,0.93377566,0.00016603927,0.00036068808,0.00042434369,0.00009146963,0.00042047785,0.0021090799,0.00006434701,0.0046640267,0.00013554146],"about_ca_topic_score_codex":0.000059162678,"about_ca_topic_score_gemma":0.000048525322,"teacher_disagreement_score":0.039982393,"about_ca_system_score_codex":0.00018600626,"about_ca_system_score_gemma":0.0017113243,"threshold_uncertainty_score":0.6720972},"labels":[],"label_agreement":null},{"id":"W2922202278","doi":"10.1200/jco.2019.37.7_suppl.546","title":"First-line pembrolizumab (pembro) monotherapy for advanced non-clear cell renal cell carcinoma (nccRCC): Results from KEYNOTE-427 cohort B.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Pembrolizumab; Cohort; Renal cell carcinoma; Internal medicine; Chromophobe cell; Clinical endpoint; Population; Surgery; Oncology; Gastroenterology; Clear cell; Cancer; Clinical trial; Immunotherapy","score_opus":0.059357984523098505,"score_gpt":0.38132261727029954,"score_spread":0.32196463274720105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922202278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980665,0.00095692836,0.0007710579,0.0038894264,0.002229064,0.0016208659,0.000089825044,0.00002446986,0.009753325],"genre_scores_gemma":[0.97081286,0.0010529947,0.018225744,0.0020443231,0.0022692352,0.000026270227,0.00007358045,0.00010577065,0.0053892443],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.992925,0.00036778644,0.0045046005,0.0007870186,0.0007601501,0.0006554804],"domain_scores_gemma":[0.9880801,0.005800323,0.0035262827,0.00087665097,0.0008574486,0.00085919024],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024360872,0.00048582398,0.0032046447,0.00022629643,0.000088475026,0.00002206143,0.00046927572,0.00087584904,0.0003533146],"category_scores_gemma":[0.0010163867,0.00036006086,0.001593878,0.0001804882,0.0001685838,0.00018360456,0.00009388346,0.0014550145,0.00022514109],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6010265,0.012652549,0.25688246,0.00042745317,0.0017834109,0.0034344129,0.0008781425,0.0032004218,0.042453676,0.00001789062,0.032619424,0.044623706],"study_design_scores_gemma":[0.20414239,0.116518654,0.51766944,0.0002736877,0.0017643317,0.0002429974,0.00021790815,0.0034162994,0.033960767,0.00036453758,0.12078761,0.00064135314],"about_ca_topic_score_codex":0.00020074552,"about_ca_topic_score_gemma":0.000052437324,"teacher_disagreement_score":0.39688405,"about_ca_system_score_codex":0.00059742597,"about_ca_system_score_gemma":0.0018411056,"threshold_uncertainty_score":0.99988514},"labels":[],"label_agreement":null},{"id":"W2922321113","doi":"10.1016/j.csbj.2019.03.005","title":"Risk Prediction Tool for Aggressive Tumors in Clinical T1 Stage Clear Cell Renal Cell Carcinoma Using Molecular Biomarkers","year":2019,"lang":"en","type":"article","venue":"Computational and Structural Biotechnology Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia; Korea Health Industry Development Institute; Memorial Sloan-Kettering Cancer Center","keywords":"Clear cell renal cell carcinoma; BAP1; Immunohistochemistry; Renal cell carcinoma; Stage (stratigraphy); Logistic regression; Oncology; Medicine; Internal medicine; Multivariate analysis; Univariate; Univariate analysis; Multivariate statistics; Cancer; Cancer research; Biology; Machine learning","score_opus":0.014198013367272814,"score_gpt":0.27575979054852406,"score_spread":0.26156177718125123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922321113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945384,0.00089448923,0.0031929247,0.00035776815,0.00026818473,0.0006097086,0.00007758909,0.000029715868,0.000031181025],"genre_scores_gemma":[0.9794265,0.00005275198,0.02023344,0.00008005075,0.000088691406,0.0000039955107,0.000053736032,0.000020967742,0.00003984932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820584,0.000114911534,0.0007056352,0.0004085926,0.00024925513,0.00031575997],"domain_scores_gemma":[0.9988355,0.00014757592,0.00058728585,0.00014975299,0.00014769411,0.00013220395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031500065,0.00022708984,0.00040883556,0.00035985903,0.00016119875,0.000034268345,0.00010540929,0.00034393664,0.000036196758],"category_scores_gemma":[0.00007800282,0.00018058579,0.00019395382,0.00018031121,0.00020784342,0.00009529616,0.00006703693,0.0007177361,0.000004425226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030758216,0.00013725208,0.89116085,0.0002038544,0.00025635085,0.0012574221,0.00014064026,0.017159231,0.07066029,0.00026741973,0.000114423645,0.015566463],"study_design_scores_gemma":[0.009102369,0.0028864522,0.799333,0.00011530306,0.00019594327,0.0029316922,0.00024256982,0.15384892,0.027781356,0.0032132845,0.00006640699,0.00028273585],"about_ca_topic_score_codex":0.00001570482,"about_ca_topic_score_gemma":7.836081e-7,"teacher_disagreement_score":0.1366897,"about_ca_system_score_codex":0.00018716151,"about_ca_system_score_gemma":0.00020173931,"threshold_uncertainty_score":0.7364075},"labels":[],"label_agreement":null},{"id":"W2922347809","doi":"10.1200/jco.2019.37.7_suppl.569","title":"Systematic review and REMARK scoring of renal cell carcinoma (RCC) prognostic circulating biomarker manuscripts.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Biomarker; Internal medicine; Oncology; Blinding; MEDLINE; Clear cell renal cell carcinoma; Cancer; Hazard ratio; Kidney cancer; Clinical trial; Confidence interval","score_opus":0.11932958410922478,"score_gpt":0.3960013679252129,"score_spread":0.2766717838159881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922347809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94790536,0.0445463,0.000025248199,0.000830903,0.00047614958,0.0012906858,0.0000014109127,0.0000060231314,0.0049179066],"genre_scores_gemma":[0.9951405,0.0017748959,0.0017905738,0.0007077742,0.00016228885,0.0000085944,0.0000018134099,0.000024507377,0.00038907485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99399155,0.0007793437,0.004216251,0.00026444095,0.00049397635,0.0002544206],"domain_scores_gemma":[0.9924053,0.0025690792,0.003750948,0.00038209214,0.00052705087,0.00036553745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050166007,0.00020880207,0.0035743734,0.00015834611,0.000023742616,0.0000073073566,0.00015323468,0.00024341977,0.00008273054],"category_scores_gemma":[0.004234254,0.00013554335,0.00063683157,0.000175348,0.00012263976,0.000096607975,0.00008408658,0.00061031326,0.000023301473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011663744,0.0014537445,0.6168735,0.36531222,0.0012015409,0.002835057,0.000110900866,0.000004134854,0.0071060807,0.000038532347,0.0008122158,0.0030856754],"study_design_scores_gemma":[0.0087184915,0.017545285,0.8607725,0.09284817,0.012606757,0.00584293,0.00015190107,0.0001832474,0.0007455158,0.00008380647,0.00024019131,0.00026119142],"about_ca_topic_score_codex":0.000011489169,"about_ca_topic_score_gemma":0.0000016459362,"teacher_disagreement_score":0.27246407,"about_ca_system_score_codex":0.00016776874,"about_ca_system_score_gemma":0.00066268176,"threshold_uncertainty_score":0.5527297},"labels":[],"label_agreement":null},{"id":"W2922497097","doi":"10.1200/jco.2019.37.7_suppl.605","title":"Patterns of response of organ specific metastasis in patients with metastatic renal cell cancer (mRCC) treated with an immune checkpoint inhibitor (CPI) post tyrosine kinase inhibitor (TKI).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Tyrosine-kinase inhibitor; Nivolumab; Oncology; Cohort; Renal cell carcinoma; Cancer; Immunotherapy","score_opus":0.04800085762007966,"score_gpt":0.35058926734152746,"score_spread":0.3025884097214478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922497097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976761,0.00049217866,0.000010612678,0.00055640243,0.00024714836,0.00083750265,0.000098939105,0.0000060501493,0.000075118456],"genre_scores_gemma":[0.99632,0.00014032923,0.0029834292,0.00012078158,0.0001650382,0.000009473549,0.00003808308,0.000060245424,0.00016259022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99320835,0.0013128812,0.0037884729,0.0004089991,0.0009059775,0.0003753118],"domain_scores_gemma":[0.9924478,0.0011897653,0.0038255728,0.0005548753,0.0015209458,0.0004610285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002731853,0.00037370258,0.0030356855,0.0005235294,0.000020294186,0.0000086314285,0.00021660332,0.00023118439,0.00054993614],"category_scores_gemma":[0.00042070824,0.000220411,0.00042616087,0.00046728062,0.0002262978,0.00022086992,0.00006355945,0.0008474242,0.00001039444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20060335,0.010380951,0.72025585,0.00020051505,0.0007175584,0.0010514422,0.00025800866,0.00007104591,0.062271934,0.000002166793,0.00003757386,0.004149618],"study_design_scores_gemma":[0.034749426,0.102476165,0.7124804,0.00069401786,0.0009113311,0.00006808547,0.00027542922,0.0000065083873,0.14794768,0.000002363053,0.00022792682,0.00016065821],"about_ca_topic_score_codex":0.0003593151,"about_ca_topic_score_gemma":0.00018788413,"teacher_disagreement_score":0.16585392,"about_ca_system_score_codex":0.00050181954,"about_ca_system_score_gemma":0.0017034353,"threshold_uncertainty_score":0.89881},"labels":[],"label_agreement":null},{"id":"W2924862708","doi":"10.1186/s12885-019-5375-0","title":"Prognostic value of performance status in metastatic renal cell carcinoma patients receiving tyrosine kinase inhibitors: a systematic review and meta-analysis","year":2019,"lang":"en","type":"review","venue":"BMC Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Meta-analysis; Funnel plot; Renal cell carcinoma; Hazard ratio; Publication bias; Oncology; Confidence interval; Subgroup analysis; Progression-free survival; Overall survival","score_opus":0.08705358555856,"score_gpt":0.3297282866383597,"score_spread":0.24267470107979966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924862708","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037215194,0.9854063,0.0000056558038,0.000007949112,0.00005760451,0.010406059,0.00027581377,0.00001373646,0.00010540678],"genre_scores_gemma":[0.021450596,0.9739181,0.00043641456,0.000052972693,0.00002327332,0.0029783214,0.0003123206,0.00009449034,0.0007335204],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9945441,0.00080594135,0.0024463371,0.0008671336,0.0008021355,0.0005343386],"domain_scores_gemma":[0.99596465,0.0005116674,0.0019181015,0.0010639189,0.00030275068,0.00023891742],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00075503957,0.00085850985,0.0126294745,0.00081550435,0.000031829997,0.000024546245,0.00018025418,0.00014930028,0.00016285015],"category_scores_gemma":[0.00030222215,0.00053474563,0.0022249469,0.0017275992,0.000068203866,0.00011013331,0.00012613158,0.00037507428,0.000021659976],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017350298,0.00022740907,0.007006073,0.9697691,0.02163876,0.000019946629,0.00006254779,0.000014155921,3.8030834e-7,0.0000010343895,0.000035249897,0.0012079733],"study_design_scores_gemma":[0.00070779485,0.00036297954,0.002102812,0.14961499,0.84573466,0.000013581538,0.0000076041156,0.00003856236,0.000013312973,2.7591506e-7,0.0010263041,0.00037711515],"about_ca_topic_score_codex":0.00043097755,"about_ca_topic_score_gemma":0.00012469529,"teacher_disagreement_score":0.8240959,"about_ca_system_score_codex":0.00082691776,"about_ca_system_score_gemma":0.0009413705,"threshold_uncertainty_score":0.9997104},"labels":[],"label_agreement":null},{"id":"W2924873513","doi":"10.2214/ajr.19.21093","title":"Update on Indications for Percutaneous Renal Mass Biopsy in the Era of Advanced CT and MRI","year":2019,"lang":"en","type":"review","venue":"American Journal of Roentgenology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiology; Renal mass; Percutaneous biopsy; Percutaneous; Biopsy; Kidney; Internal medicine; Nephrectomy","score_opus":0.02731396082724306,"score_gpt":0.32477730204881483,"score_spread":0.29746334122157175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924873513","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032835234,0.9641734,0.00009621866,0.0014486108,0.00012920829,0.001129125,0.000058116435,0.0000033718618,0.0001267152],"genre_scores_gemma":[0.02228148,0.973261,0.0040417057,0.00020078341,0.00007576757,0.00003093607,0.000038743925,0.000035574238,0.000034012348],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99806976,0.00028935654,0.0009027767,0.0002400034,0.00023432974,0.00026374497],"domain_scores_gemma":[0.9971613,0.0005118931,0.0017298086,0.00039739383,0.00011153838,0.0000880587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002989251,0.0002755336,0.0020746419,0.00043564176,0.000028543778,0.000005932588,0.00027914307,0.00005520367,0.000018606803],"category_scores_gemma":[0.00008645855,0.00015795714,0.00041559074,0.00031032856,0.00033194537,0.000022912092,0.00002387151,0.00065738155,0.000008017831],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039628922,0.00019193842,0.00013143788,0.0013293151,0.0006517634,0.0011354272,0.0001857819,0.000015846581,0.00007434562,0.000115886214,0.00011446746,0.9956575],"study_design_scores_gemma":[0.002679848,0.02481001,0.0008354816,0.009034345,0.0063538086,0.14142266,0.0012855988,0.00000569943,0.00004259045,0.00017896347,0.8129548,0.0003962189],"about_ca_topic_score_codex":0.000012491796,"about_ca_topic_score_gemma":0.0000025897634,"teacher_disagreement_score":0.9952613,"about_ca_system_score_codex":0.0001888204,"about_ca_system_score_gemma":0.00040950588,"threshold_uncertainty_score":0.6441305},"labels":[],"label_agreement":null},{"id":"W2925036534","doi":"10.1177/1078155219837333","title":"Survival outcomes associated with different sunitinib dosing regimens in metastatic renal cell carcinoma","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Dosing; Medicine; Sunitinib; Renal cell carcinoma; Discontinuation; Internal medicine; Surgery","score_opus":0.07079760148535519,"score_gpt":0.37716953225057115,"score_spread":0.30637193076521596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2925036534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97911274,0.00045540187,0.000020976524,0.0057619493,0.0005197248,0.0005395889,0.0000044402536,0.0000129362215,0.013572236],"genre_scores_gemma":[0.9962526,0.000105585226,0.0013251461,0.0010849173,0.00009995348,0.000007955023,0.000011009642,0.00004574042,0.0010670794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962571,0.001293698,0.00095251005,0.00026169367,0.000779047,0.00045589596],"domain_scores_gemma":[0.9932981,0.0037990264,0.001781254,0.00024721347,0.00057336624,0.0003010153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017336548,0.00032405424,0.0012492889,0.00040753995,0.000052600844,0.00002915824,0.00017062413,0.000076273296,0.00029584765],"category_scores_gemma":[0.0007455669,0.0002129606,0.0002193533,0.00030774347,0.00007360526,0.00054637605,0.000054498818,0.0012678755,0.000030507625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0102329925,0.0056600748,0.93983805,0.00009259028,0.0013151658,0.016994309,0.001075767,0.00011781168,0.022962734,0.000022868926,0.0004998531,0.0011877933],"study_design_scores_gemma":[0.07196965,0.010523339,0.86082727,0.00024918327,0.005107353,0.006871654,0.0025188706,0.00016996305,0.02726003,0.000017110347,0.014086119,0.00039948113],"about_ca_topic_score_codex":0.00009595066,"about_ca_topic_score_gemma":0.000036095145,"teacher_disagreement_score":0.07901079,"about_ca_system_score_codex":0.0013395845,"about_ca_system_score_gemma":0.0009430614,"threshold_uncertainty_score":0.8684282},"labels":[],"label_agreement":null},{"id":"W2927555818","doi":"","title":"Stereotactic radiotherapy as a treatment option for renal tumours in the solitary kidney: a multicenter analysis from the International Radiosurgery Oncology Consortium for Kidney (IROCK).","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"SABR volatility model; Medicine; Radiosurgery; Cohort; Renal function; Renal cell carcinoma; Radiation therapy; Kidney cancer; Kidney; Urology; Internal medicine; Logistic regression; Oncology; Surgery","score_opus":0.025212969983926043,"score_gpt":0.30887922504642695,"score_spread":0.2836662550625009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2927555818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.912018,0.0012344513,0.0013739896,0.08322773,0.0006346172,0.0013282717,0.0000661915,0.000005367423,0.00011135358],"genre_scores_gemma":[0.9812206,0.0005823351,0.00072863954,0.016403636,0.0006604967,0.00009226177,0.00008852365,0.00002315511,0.0002003505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784124,0.0006448993,0.00069977297,0.00020574925,0.00029553342,0.00031281676],"domain_scores_gemma":[0.99503565,0.0035953163,0.00063333206,0.0004012832,0.00018130905,0.0001531291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014487279,0.00021980799,0.000689817,0.00026564146,0.00008085821,0.000021329357,0.00038861227,0.000114680166,0.00020768364],"category_scores_gemma":[0.00036034302,0.00009694436,0.000634761,0.00016378287,0.000116067975,0.00007899092,0.000022350467,0.00028341069,0.000008960074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18321168,0.006158481,0.5944149,0.00007530789,0.04697539,0.0009549602,0.02870803,0.0036494373,0.0859388,0.0004713436,0.038670387,0.0107713],"study_design_scores_gemma":[0.083436005,0.04172635,0.5191357,0.00015873167,0.034043364,0.007662886,0.0049262773,0.037262544,0.0045279237,0.002103412,0.26438093,0.0006358766],"about_ca_topic_score_codex":0.0002522873,"about_ca_topic_score_gemma":0.00006643981,"teacher_disagreement_score":0.22571056,"about_ca_system_score_codex":0.0005835472,"about_ca_system_score_gemma":0.0005526046,"threshold_uncertainty_score":0.39532763},"labels":[],"label_agreement":null},{"id":"W2927857619","doi":"10.1016/j.tiv.2019.03.029","title":"The uremic toxin p-cresol promotes the invasion and migration on carcinoma cells via Ras and mTOR signaling","year":2019,"lang":"en","type":"article","venue":"Toxicology in Vitro","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Chung Shan Medical University Hospital; Ditmanson Medical Foundation Chia-Yi Christian Hospital; Beef Cattle Research Council","keywords":"PI3K/AKT/mTOR pathway; Protein kinase B; Cancer research; Gentamicin protection assay; Cell migration; Cancer cell; Chemistry; MTT assay; Cell; Biology; Cancer; Cell biology; Signal transduction; Medicine; Internal medicine; Metastasis; Biochemistry","score_opus":0.014905773970860198,"score_gpt":0.23712353325841107,"score_spread":0.22221775928755086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2927857619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99287665,0.0012148005,0.0000049335595,0.004212486,0.00013328441,0.0012227084,0.000001991325,0.00001662609,0.0003164969],"genre_scores_gemma":[0.99864936,0.00007008974,0.00013353412,0.000605966,0.000078013356,0.000063686275,0.0000078081275,0.000016779328,0.00037474843],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888545,0.0001944868,0.00021852678,0.0002950712,0.00015269703,0.00025375947],"domain_scores_gemma":[0.9988526,0.0006450472,0.00008216994,0.0003257688,0.00002731981,0.00006706416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038017824,0.0001644132,0.00023931127,0.00007155858,0.00012330615,0.00002412987,0.000091108115,0.00013529717,0.000017210172],"category_scores_gemma":[0.00007289771,0.000088073466,0.000037565012,0.00008670979,0.00013877747,0.000035378558,0.000072512026,0.00026961835,0.000031726064],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007428557,0.00015424874,0.018115418,0.000029029125,0.000021674296,0.00003728446,0.0005701193,0.0000033432736,0.97781366,0.00002756322,0.00015374772,0.0023310622],"study_design_scores_gemma":[0.0028396095,0.0013650318,0.065433234,0.000038510243,0.0000616886,0.0001063375,0.0002165326,0.0012167738,0.9281025,0.00021848323,0.0003039222,0.000097359305],"about_ca_topic_score_codex":0.000076398464,"about_ca_topic_score_gemma":0.000094732364,"teacher_disagreement_score":0.049711138,"about_ca_system_score_codex":0.00011592699,"about_ca_system_score_gemma":0.000047255042,"threshold_uncertainty_score":0.35915315},"labels":[],"label_agreement":null},{"id":"W2930700235","doi":"10.1016/j.carj.2019.03.002","title":"Recommendations for the Management of the Incidental Renal Mass in Adults: Endorsement and Adaptation of the 2017 ACR Incidental Findings Committee White Paper by the Canadian Association of Radiologists Incidental Findings Working Group","year":2019,"lang":"en","type":"article","venue":"Canadian Association of Radiologists Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan; University of Toronto; Western University; University of Manitoba","funders":"Siemens Healthineers","keywords":"Medicine; Association (psychology); White (mutation); Adaptation (eye); Renal mass; White paper; Family medicine; Internal medicine; Kidney; Law","score_opus":0.01972127441420527,"score_gpt":0.24211646355216287,"score_spread":0.2223951891379576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2930700235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98623294,0.00049680506,0.00003242445,0.010051224,0.00063637836,0.0017333743,0.00033935482,0.000003627565,0.0004738953],"genre_scores_gemma":[0.998044,0.00038209325,0.0003284403,0.00038179813,0.000067946916,0.00005357496,0.000111418725,0.000019527773,0.0006111766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969916,0.0004895569,0.0010907063,0.00024400215,0.0006991843,0.00048498574],"domain_scores_gemma":[0.9966603,0.0006412006,0.0019041722,0.00034546776,0.0002765861,0.00017225285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003284,0.00023251824,0.00048486207,0.00025719436,0.00049372314,0.00004819623,0.0005442949,0.00024584014,0.00006144058],"category_scores_gemma":[0.00048446632,0.00013947855,0.00029422177,0.00040406323,0.00019092966,0.00016798552,0.0000759277,0.00055511453,0.0000011429507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011197074,0.000039828694,0.9844502,0.00005565811,0.00055303925,0.000004652995,0.0024543956,0.00017907821,0.0008243126,0.00023539626,0.009708434,0.0013829914],"study_design_scores_gemma":[0.0031847672,0.00022753853,0.9870077,0.0005496236,0.0003076401,0.00007684682,0.0054426077,0.00041899423,0.0004337884,0.00012187851,0.0020981808,0.00013042889],"about_ca_topic_score_codex":0.10888788,"about_ca_topic_score_gemma":0.6520498,"teacher_disagreement_score":0.5431619,"about_ca_system_score_codex":0.00806789,"about_ca_system_score_gemma":0.00056109973,"threshold_uncertainty_score":0.99573994},"labels":[],"label_agreement":null},{"id":"W2936143333","doi":"10.1097/ju.0000000000000264","title":"The Prevalence, Clinicodemographics, and Outcomes of Incidental and Symptomatic Renal Cysts in a Pediatric Cohort Undergoing Ultrasonography","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Hydronephrosis; Cyst; Echogenicity; Cohort; Radiology; Retrospective cohort study; Presentation (obstetrics); Population; Ultrasound; Surgery; Urinary system; Pathology; Internal medicine","score_opus":0.008298326308331518,"score_gpt":0.25409796918196953,"score_spread":0.245799642873638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936143333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886466,0.01000537,0.000004465948,0.00080544135,0.00010487587,0.00030943324,0.000001038614,0.0000028394304,0.00011990848],"genre_scores_gemma":[0.98354346,0.016197689,0.000058771093,0.00012779246,0.00003626021,0.0000016235147,2.5085077e-7,0.000008476988,0.000025678351],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986211,0.00028343467,0.0005969512,0.00009351013,0.00023846459,0.00016653424],"domain_scores_gemma":[0.99698937,0.0022016377,0.00049240276,0.00018437901,0.00006440004,0.00006780858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015584705,0.000112364425,0.00041041433,0.00026116066,0.000043100445,0.000007371463,0.00012365817,0.000075874035,0.000005991403],"category_scores_gemma":[0.00016397134,0.00005469568,0.000102926846,0.00019283913,0.00022496395,0.000053732827,0.00004690179,0.00039166023,0.0000010503437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042887178,0.000059016507,0.99846554,0.0001262443,0.00022625324,0.000025477484,0.00025827513,0.000008980884,0.00019556447,0.000041398314,0.00001620998,0.00014814895],"study_design_scores_gemma":[0.0018839875,0.0017666155,0.9930928,0.000038117483,0.0007724863,0.0017351414,0.00013280234,0.0000518105,0.000032423097,0.00044453234,0.000006858775,0.00004246146],"about_ca_topic_score_codex":0.000011207626,"about_ca_topic_score_gemma":0.000038795406,"teacher_disagreement_score":0.0061923186,"about_ca_system_score_codex":0.00001616698,"about_ca_system_score_gemma":0.000072302966,"threshold_uncertainty_score":0.2230425},"labels":[],"label_agreement":null},{"id":"W2936265289","doi":"10.17709/2409-2231-2019-6-1-5","title":"ANALYSIS OF THE INTRAOPERATIVE ULTRASOUND RESULTS IN THE SURGICAL TREATMENT OF RENAL TUMORS","year":2019,"lang":"en","type":"article","venue":"Research and Practical Medicine Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Defence Medical Centre","funders":"","keywords":"Medicine; Nephrectomy; Kidney; Kidney cancer; Ultrasonography; Surgery; Ultrasound; Radiology; Lesion; Cancer; Renal tumor; Internal medicine","score_opus":0.12120770375755716,"score_gpt":0.4442267773278045,"score_spread":0.3230190735702474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936265289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9666187,0.0009319567,0.0000035179862,0.021431167,0.000033794437,0.00049740926,0.000007781321,0.0000012752392,0.010474409],"genre_scores_gemma":[0.9974531,0.001592075,0.00005302313,0.000034951412,0.00017317908,0.000006857718,0.000007540243,0.000005747242,0.00067355984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960704,0.0012928216,0.0006440018,0.00020444447,0.0014700788,0.00031827745],"domain_scores_gemma":[0.9922317,0.0066006565,0.00018772788,0.0003804789,0.00038177412,0.00021763581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038932925,0.00012687822,0.00063000387,0.00043628312,0.00009125171,0.000017889979,0.000105757106,0.00006462874,0.00046968483],"category_scores_gemma":[0.0023044837,0.000046750807,0.00015133551,0.0014655543,0.0006766832,0.00007088517,0.000028696413,0.00078101305,0.0000033811136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04014572,0.007835628,0.84906524,0.00023474505,0.0080810385,0.0062352433,0.027017407,0.00015064975,0.040525865,0.0045159934,0.005848865,0.010343629],"study_design_scores_gemma":[0.012320604,0.026334085,0.92947555,0.00052695576,0.0015417469,0.008439567,0.0076494436,0.00038972343,0.0064209886,0.0004203041,0.0063782893,0.00010272049],"about_ca_topic_score_codex":0.00025789332,"about_ca_topic_score_gemma":0.000051457955,"teacher_disagreement_score":0.080410354,"about_ca_system_score_codex":0.00016606454,"about_ca_system_score_gemma":0.00036435938,"threshold_uncertainty_score":0.514272},"labels":[],"label_agreement":null},{"id":"W2936799710","doi":"10.1089/end.2019.0179","title":"Impact of Tumor Size on Cancer-Specific Mortality Rate After Local Tumor Ablation in T1a Renal-Cell Carcinoma","year":2019,"lang":"en","type":"article","venue":"Journal of Endourology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Ablation; Cancer; Kidney cancer; Tumor ablation; Internal medicine; Oncology; Nephrology; Carcinoma; Urology; Renal tumor; Kidney; Nephrectomy","score_opus":0.01975436582329564,"score_gpt":0.28845670773445625,"score_spread":0.2687023419111606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936799710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99682057,0.0011832946,0.000019939927,0.00022264461,0.00030929636,0.00036162525,0.000014935614,0.000004897488,0.0010628022],"genre_scores_gemma":[0.99922645,0.000051320196,0.000070763774,0.00025385967,0.00022089355,0.000010757532,0.0000029864523,0.000029286006,0.00013370195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978844,0.0002614673,0.0008833714,0.00025423986,0.00035392566,0.00036261458],"domain_scores_gemma":[0.9981618,0.0003089768,0.00075025845,0.00034713498,0.00023868076,0.00019313341],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053244707,0.00024531558,0.000853676,0.00031963814,0.000012527867,0.0000068210006,0.00011723671,0.000091938,0.0011627568],"category_scores_gemma":[0.00005516191,0.00017327658,0.00039863162,0.00020600864,0.00008854278,0.00009232093,0.000028211869,0.00052946835,0.000037212612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008964304,0.0005611105,0.88578385,0.00007046722,0.00012547652,0.0034416215,0.00014280618,0.002942922,0.09736158,0.000009697494,0.00030190905,0.00029423297],"study_design_scores_gemma":[0.006144996,0.007178042,0.9539271,0.00007582134,0.0001315911,0.0005900477,0.000025839478,0.0001763157,0.03146019,0.0000566773,0.000122795,0.00011057571],"about_ca_topic_score_codex":0.00030984584,"about_ca_topic_score_gemma":0.000054833134,"teacher_disagreement_score":0.06814324,"about_ca_system_score_codex":0.0005896731,"about_ca_system_score_gemma":0.0003925883,"threshold_uncertainty_score":0.9997503},"labels":[],"label_agreement":null},{"id":"W2938542802","doi":"10.1016/j.euf.2019.04.004","title":"An Update on Predictive Biomarkers in Metastatic Renal Cell Carcinoma","year":2019,"lang":"en","type":"review","venue":"European Urology Focus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Nivolumab; Biomarker; Ipilimumab; Oncology; Internal medicine; Clinical trial; Targeted therapy; Intensive care medicine; Cancer; Immunotherapy","score_opus":0.046945970147185816,"score_gpt":0.3023948541974595,"score_spread":0.25544888405027366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2938542802","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032148534,0.9428201,0.000019310895,0.00007168875,0.00034528945,0.0022141945,0.00012852847,0.000091879076,0.051094204],"genre_scores_gemma":[0.06765412,0.9292917,0.00024964425,0.0003624034,0.00029963997,0.000096475305,0.00088923005,0.00039676213,0.0007600122],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99350494,0.0030178835,0.0010073145,0.0013748342,0.00036531975,0.0007297202],"domain_scores_gemma":[0.9972329,0.0002832387,0.0005246554,0.0015387519,0.00005655899,0.0003639072],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00079880597,0.00091698434,0.0025090368,0.00095060037,0.000048827205,0.000023795303,0.00048317443,0.00022807188,0.00019480298],"category_scores_gemma":[0.000055420616,0.00068465533,0.0006370907,0.0004367341,0.00018030305,0.00006555899,0.00014501641,0.0011062197,0.004069033],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018480812,0.0017759447,0.0006085619,0.008630942,0.0019428546,0.037199344,0.00027999026,0.000031359214,0.000030755713,0.000069702786,0.0034980443,0.9440844],"study_design_scores_gemma":[0.0040905694,0.012567746,0.0038578447,0.0015562208,0.00848416,0.0012920062,0.000018863662,0.000045652196,0.000047192276,0.000018116116,0.9672151,0.00080653257],"about_ca_topic_score_codex":0.000029410283,"about_ca_topic_score_gemma":0.0000062146964,"teacher_disagreement_score":0.96371704,"about_ca_system_score_codex":0.00037054197,"about_ca_system_score_gemma":0.0003915392,"threshold_uncertainty_score":0.9995605},"labels":[],"label_agreement":null},{"id":"W2940502605","doi":"10.1097/01.ju.0000555342.90934.fc","title":"MP16-06 EXPLOITING NOVEL THERAPEUTIC TARGETS TO BLOCK METASTASIS OF CLEAR CELL RENAL CELL CARCINOMA (RCC)","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Small hairpin RNA; Metastasis; Cancer research; Clear cell renal cell carcinoma; Cell; Cancer; Kidney cancer; Cell culture; Pathology; Internal medicine; Biology; Gene knockdown; Genetics","score_opus":0.027344893666811695,"score_gpt":0.24929919760678707,"score_spread":0.22195430393997537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940502605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99016273,0.0045814225,0.00037421274,0.0018040526,0.0001949166,0.00037388224,0.0000062011313,0.000007903962,0.0024946793],"genre_scores_gemma":[0.996576,0.00007929231,0.0012643485,0.0012315917,0.00019185468,0.0000024233075,0.0000021017122,0.000044888762,0.0006074879],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99796116,0.00025369466,0.0007351755,0.00018555863,0.00045569427,0.00040869036],"domain_scores_gemma":[0.99801135,0.0003719788,0.00064948265,0.00046698522,0.0002919989,0.000208196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090974063,0.00023794756,0.0007164272,0.00025927162,0.00005161195,0.0000065964587,0.0003272353,0.00010447766,0.0002386973],"category_scores_gemma":[0.000035265515,0.00014652034,0.00029089826,0.00019973559,0.000077206416,0.00005791249,0.000100479505,0.0004863227,0.00013126318],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032052791,0.0005708579,0.008837384,0.00009977778,0.00029573662,0.00013939771,0.0021563764,0.0012255085,0.9819872,0.00002620336,0.0008389709,0.0006173227],"study_design_scores_gemma":[0.009972274,0.023664609,0.06959431,0.000058132337,0.003184931,0.0041664103,0.0020720116,0.00038628018,0.87638956,0.0001548706,0.00998651,0.00037012168],"about_ca_topic_score_codex":0.000036067682,"about_ca_topic_score_gemma":0.0000029432738,"teacher_disagreement_score":0.105597645,"about_ca_system_score_codex":0.000085011794,"about_ca_system_score_gemma":0.0001595776,"threshold_uncertainty_score":0.5974926},"labels":[],"label_agreement":null},{"id":"W2940715321","doi":"10.1097/01.ju.0000555297.39355.67","title":"MP14-01 NATURAL HISTORY OF RENAL ANGIOMYOLIPOMA (AML) FAVORS SURVEILLANCE AS AN INITIAL APPROACH","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Natural history; Angiomyolipoma; Classics; General surgery; Internal medicine; Kidney; History","score_opus":0.02059443792543912,"score_gpt":0.25774714643264646,"score_spread":0.23715270850720732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940715321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847392,0.00566669,0.000047853293,0.00056465995,0.0007688194,0.00019328979,0.0000020135749,0.0000088003935,0.0080087],"genre_scores_gemma":[0.9974964,0.00007130314,0.0002499181,0.00051765784,0.0003713436,0.0000010507945,0.000007940331,0.00002161826,0.001262754],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982796,0.0004619177,0.00049100764,0.00013450242,0.00038138908,0.00025163256],"domain_scores_gemma":[0.9985491,0.00019805624,0.00053463,0.00038054955,0.00020727841,0.00013038753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008544237,0.00016269882,0.0005530885,0.00018644381,0.000020398851,0.0000024493677,0.00026931963,0.00011260438,0.00021565029],"category_scores_gemma":[0.00007240296,0.00009728015,0.00019698538,0.00009479526,0.00022262865,0.00008540772,0.000044552806,0.00050542224,0.000030707426],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.096746854,0.004659052,0.20011982,0.0005856928,0.0050191935,0.0037600186,0.019577574,0.0025389292,0.6190189,0.0027599777,0.027720204,0.017493764],"study_design_scores_gemma":[0.02172338,0.044685,0.80188465,0.0000915859,0.0018319061,0.074438825,0.0010918132,0.003089912,0.013375295,0.0009835344,0.036046453,0.0007576352],"about_ca_topic_score_codex":0.00008217366,"about_ca_topic_score_gemma":0.000009559058,"teacher_disagreement_score":0.60564363,"about_ca_system_score_codex":0.00024943438,"about_ca_system_score_gemma":0.00039010405,"threshold_uncertainty_score":0.39669693},"labels":[],"label_agreement":null},{"id":"W2941186281","doi":"10.1097/01.ju.0000555235.06238.11","title":"PD07-02 DIVIDING PATHOLOGICALLY UPSTAGED T3A RENAL CELL CARCINOMA BASED ON CLINICAL T STAGE AT PRESENTATION IS ASSOCIATED WITH IMPROVED ALIGNMENT OF OUTCOMES: A CALL FOR TNM REVISION","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Presentation (obstetrics); Stage (stratigraphy); Renal cell carcinoma; Carcinoma; Radiology; Pathology; Paleontology","score_opus":0.04668400726471287,"score_gpt":0.31954806703483546,"score_spread":0.27286405977012257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941186281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995174,0.00014013615,0.0010260791,0.0020380295,0.00014033553,0.0011840556,0.000030481468,0.000008662283,0.00025824143],"genre_scores_gemma":[0.99648553,0.00003605214,0.00068263896,0.0016132821,0.00005885261,0.000007870476,0.000019269206,0.000030174722,0.00106633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99696374,0.00086320116,0.0010721594,0.00024902498,0.0005363831,0.00031550616],"domain_scores_gemma":[0.9951328,0.0023995175,0.0015402287,0.000434185,0.00034480146,0.00014846477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027947584,0.000238309,0.00090975227,0.00012643916,0.00006957924,0.000007156416,0.00021406484,0.00019545043,0.00012844634],"category_scores_gemma":[0.00042842227,0.000119075914,0.00037986416,0.00009501875,0.00011032183,0.000043241784,0.0000642915,0.0004062215,0.0000075765006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033788312,0.0017013722,0.8222578,0.00016329686,0.00052764924,0.00032804132,0.0009224249,0.0010992282,0.13753901,0.000012306279,0.0010020348,0.00065852364],"study_design_scores_gemma":[0.026301486,0.079721086,0.8499256,0.00015066512,0.0019239308,0.00014136803,0.00019154028,0.005722097,0.03522119,0.00003433145,0.00043043355,0.0002363002],"about_ca_topic_score_codex":0.000013301187,"about_ca_topic_score_gemma":0.000005263294,"teacher_disagreement_score":0.102317825,"about_ca_system_score_codex":0.00024100607,"about_ca_system_score_gemma":0.00015147234,"threshold_uncertainty_score":0.48557746},"labels":[],"label_agreement":null},{"id":"W2941284207","doi":"10.1097/01.ju.0000555314.30838.23","title":"MP14-18 AN ANATOMIC CLASSIFICATION SYSTEM FOR LOCAL RECURRENCE FOLLOWING RESECTION OF INTERMEDIATE AND HIGH RISK NON-METASTATIC RENAL CELL CARCINOMA: AN ANALYSIS OF THE ASSURE (ECOG-ACRIN 2805) TRIAL","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Resection; Surgery; Internal medicine","score_opus":0.024584917708323318,"score_gpt":0.28515341798257743,"score_spread":0.2605685002742541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941284207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603635,0.00033940584,0.0021529028,0.00008486202,0.0006199839,0.00070566876,0.000026751852,0.0000035168239,0.000030554165],"genre_scores_gemma":[0.9996416,0.000039608385,0.00014495803,0.000013973443,0.00010906219,0.000008255563,0.0000135288465,0.000015456131,0.000013559836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974321,0.0010089078,0.0008522611,0.00019259079,0.00032719178,0.00018695199],"domain_scores_gemma":[0.99718916,0.0005113938,0.0014594669,0.0004769282,0.00026431013,0.000098747376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002267411,0.00015449863,0.0007827386,0.0003730449,0.00006425134,0.0000075401886,0.00024323174,0.00009919387,0.000010912071],"category_scores_gemma":[0.00011035141,0.0000860317,0.0003324844,0.00036174976,0.00014294936,0.00011305284,0.000036567686,0.00033543742,6.882288e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2498208,0.0017884615,0.50632846,0.001077183,0.0069753984,0.000076181925,0.006316464,0.012040813,0.20545658,0.00014143734,0.00013685755,0.0098413825],"study_design_scores_gemma":[0.03157433,0.02674268,0.8217876,0.0000844136,0.01949416,0.00020334625,0.0033877932,0.07694404,0.019537447,0.000097232376,0.000010937866,0.00013602027],"about_ca_topic_score_codex":0.00025285655,"about_ca_topic_score_gemma":0.00012850986,"teacher_disagreement_score":0.31545916,"about_ca_system_score_codex":0.00013785427,"about_ca_system_score_gemma":0.00016736863,"threshold_uncertainty_score":0.3508271},"labels":[],"label_agreement":null},{"id":"W2941321623","doi":"10.1097/01.ju.0000556552.01352.65","title":"PD41-08 CHRONIC KIDNEY DISEASE AND END-STAGE RENAL DISEASE AFTER RADICAL OR PARTIAL NEPHRECTOMY FOR T1A RENAL CELL CARCINOMA: A POPULATION-BASED STUDY","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nephrectomy; Medicine; Renal cell carcinoma; Kidney disease; Population; Kidney; Kidney cancer; Stage (stratigraphy); Urology; End stage renal disease; Disease; Surgery; Internal medicine","score_opus":0.015534644513722192,"score_gpt":0.26403253280751043,"score_spread":0.24849788829378824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941321623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99285525,0.0019201745,0.00023873265,0.0028888197,0.00022198378,0.0017744381,0.000071249844,0.000012623977,0.000016740103],"genre_scores_gemma":[0.9971884,0.000014608862,0.00013586899,0.0013034992,0.00069906225,0.00009380586,0.00004005553,0.000041771676,0.00048294582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997763,0.00045247038,0.00061237864,0.000286601,0.00045150312,0.0004340504],"domain_scores_gemma":[0.99759364,0.00046463026,0.00036183043,0.0004557998,0.00011915005,0.0010049336],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000600247,0.00028352407,0.00055829936,0.00018294217,0.000101049474,0.000020807127,0.00017426992,0.00007705738,0.0009887447],"category_scores_gemma":[0.00016700354,0.00016083312,0.00024447517,0.00010924875,0.0001199895,0.00008485908,0.000058875,0.00037581037,0.000017471795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11664981,0.0015058481,0.8735531,0.00027966072,0.00030597893,0.0026779892,0.00028891076,0.00077481085,0.0026697281,0.000014850062,0.0009782513,0.0003010578],"study_design_scores_gemma":[0.023052547,0.012505071,0.94929564,0.000048232563,0.0036680468,0.00020827873,0.000044900404,0.0032483467,0.00050466426,0.000051720504,0.0071363575,0.00023621043],"about_ca_topic_score_codex":0.000038810136,"about_ca_topic_score_gemma":0.00001997147,"teacher_disagreement_score":0.09359726,"about_ca_system_score_codex":0.00021493825,"about_ca_system_score_gemma":0.0012733438,"threshold_uncertainty_score":0.9999245},"labels":[],"label_agreement":null},{"id":"W2941363586","doi":"10.1097/01.ju.0000555241.27498.f6","title":"PD07-08 MACHINE LEARNING TO PREDICT RECURRENCE OF LOCALIZED RENAL CELL CARCINOMA","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nomogram; Renal cell carcinoma; Stage (stratigraphy); T-stage; Artificial intelligence; Radiology; Machine learning; Oncology; Cancer; Internal medicine","score_opus":0.014730077430566717,"score_gpt":0.24423956152768708,"score_spread":0.22950948409712035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941363586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99246746,0.002795885,0.00038385755,0.0015197686,0.00024369976,0.00027973592,0.0000031574366,0.000006776359,0.0022996336],"genre_scores_gemma":[0.9980693,0.00013569533,0.0004613294,0.00033765697,0.00013059891,0.0000013898016,0.0000027830401,0.000018920793,0.0008423338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983016,0.00038602465,0.0005595801,0.00012687939,0.0003700414,0.00025586813],"domain_scores_gemma":[0.9984993,0.00031047946,0.00048549552,0.00030771623,0.00022122376,0.00017582063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089392246,0.00015374049,0.0005435128,0.00018751406,0.00003369999,0.0000033352865,0.00025104312,0.00008303859,0.00039739397],"category_scores_gemma":[0.00013591618,0.00008997054,0.00015751844,0.00017641379,0.000084259475,0.00003805763,0.00008316568,0.0005981774,0.00010036963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02208219,0.00061192375,0.60234684,0.00024494584,0.00037039755,0.0006609067,0.0037072331,0.0077559836,0.3535818,0.00005059584,0.00282185,0.0057653305],"study_design_scores_gemma":[0.027668415,0.09676911,0.5180766,0.00034038356,0.003482534,0.01611575,0.0007778463,0.006065112,0.27024418,0.00043519368,0.059394218,0.00063063804],"about_ca_topic_score_codex":0.000050101236,"about_ca_topic_score_gemma":0.000003298278,"teacher_disagreement_score":0.096157186,"about_ca_system_score_codex":0.00006499543,"about_ca_system_score_gemma":0.00015584777,"threshold_uncertainty_score":0.43511856},"labels":[],"label_agreement":null},{"id":"W2941854700","doi":"10.1097/01.ju.0000556210.51056.a3","title":"MP42-07 ONCOLOGICAL OUTCOMES OF PATIENTS WITH SPORADIC, NON-METASTATIC RENAL CELL CARCINOMA WITH RENAL VEIN OR INFERIOR VENA CAVA TUMOR THROMBUS","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Inferior vena cava; Renal vein; Thrombus; Cancer; Kidney cancer; Kidney; General surgery; Surgery; Pathology; Internal medicine","score_opus":0.01511483253113982,"score_gpt":0.24560466655007923,"score_spread":0.2304898340189394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941854700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975789,0.00023901844,0.00007416094,0.00062807556,0.0001342906,0.00071722583,0.000013144678,0.000007742814,0.00060743594],"genre_scores_gemma":[0.9978836,0.00001537133,0.00112165,0.000547379,0.00006833522,0.0000043687205,0.000008964269,0.000039538296,0.00031079273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758166,0.00028738022,0.0007885599,0.00021606496,0.000702148,0.00042420664],"domain_scores_gemma":[0.99728304,0.00050261104,0.0011244277,0.0004707365,0.00039186387,0.00022733507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005513096,0.0003324523,0.0012576348,0.00020814936,0.00005406468,0.000007966418,0.00030668915,0.00008384756,0.000561944],"category_scores_gemma":[0.000065607914,0.00013695385,0.00016146827,0.00021234198,0.00034356557,0.000095033996,0.00006850843,0.0006094468,0.000053934527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026128761,0.0012400293,0.96551645,0.00009383489,0.00048844324,0.0020205993,0.00060271885,0.00042410425,0.00300594,0.0000063079387,0.0002714046,0.00020142228],"study_design_scores_gemma":[0.011739813,0.051223375,0.93017095,0.000051179977,0.0013571118,0.001932819,0.00015256526,0.00004186022,0.0028830965,0.000019648503,0.00027969712,0.00014788075],"about_ca_topic_score_codex":0.000060948507,"about_ca_topic_score_gemma":0.00002665047,"teacher_disagreement_score":0.049983345,"about_ca_system_score_codex":0.00015968479,"about_ca_system_score_gemma":0.0006243231,"threshold_uncertainty_score":0.6152893},"labels":[],"label_agreement":null},{"id":"W2942360226","doi":"10.1097/01.ju.0000555975.72575.3b","title":"PD27-12 TOWARDS OPTIMIZING SIMULATION-BASED TRAINING FOR PERCUTANEOUS NEPHROLITHOTOMY: A PROSPECTIVE COMPARATIVE STUDY","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Percutaneous nephrolithotomy; Training (meteorology); Simulation training; Percutaneous; Prospective cohort study; Urology; Surgery; Simulation","score_opus":0.07484182894297398,"score_gpt":0.3410778449081491,"score_spread":0.2662360159651751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942360226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928734,0.00023262542,0.0031877141,0.0007745521,0.00014884508,0.0019057627,0.0000031051409,0.000013138437,0.0008608709],"genre_scores_gemma":[0.9970625,0.0000023531347,0.0021490015,0.00047041257,0.00017242889,0.000013454734,0.0000016912992,0.000021038573,0.00010710746],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9986711,0.00025368715,0.00042472998,0.0001415744,0.0002620958,0.00024678468],"domain_scores_gemma":[0.99768776,0.0012922357,0.0003614733,0.00021569636,0.00035033375,0.00009250961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006910195,0.00017029578,0.00062820455,0.00013493792,0.000084051426,0.000010889475,0.00013339215,0.00006078091,0.00008447767],"category_scores_gemma":[0.00010785176,0.00010060267,0.00016966948,0.00008911131,0.0000708468,0.00004941211,0.000018162571,0.00031364654,0.000009947079],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03632812,0.0015401744,0.036061198,0.000056095236,0.0019300627,0.00074717513,0.07830815,0.8320738,0.011453102,0.00005441482,0.00006419273,0.0013835358],"study_design_scores_gemma":[0.037475422,0.12432608,0.2835107,0.000113283844,0.0060671195,0.010328279,0.039533418,0.4929872,0.0027852065,0.0009706515,0.0012805492,0.0006221012],"about_ca_topic_score_codex":0.000012383583,"about_ca_topic_score_gemma":0.0000073543088,"teacher_disagreement_score":0.3390866,"about_ca_system_score_codex":0.00018450787,"about_ca_system_score_gemma":0.0003296775,"threshold_uncertainty_score":0.41024578},"labels":[],"label_agreement":null},{"id":"W2942812139","doi":"10.1007/s00261-019-02018-y","title":"Can MRI be used to diagnose histologic grade in T1a (&lt; 4 cm) clear cell renal cell carcinomas?","year":2019,"lang":"en","type":"article","venue":"Abdominal Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Ottawa Hospital","funders":"","keywords":"Medicine; Nuclear medicine; Effective diffusion coefficient; Receiver operating characteristic; Confidence interval; Logistic regression; Area under the curve; Kappa; Radiology; Pathology; Internal medicine; Magnetic resonance imaging","score_opus":0.024418626379085505,"score_gpt":0.25502127918966566,"score_spread":0.23060265281058015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942812139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98337257,0.0015059784,0.000019569226,0.004661707,0.00045128592,0.0014375829,0.000016742795,0.00006084089,0.008473712],"genre_scores_gemma":[0.9919269,0.00011303507,0.0015345988,0.0019313956,0.00020376017,0.0001395848,0.000073968535,0.000066873145,0.004009864],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967477,0.00035284678,0.00063043274,0.00096799457,0.0003320333,0.0009690277],"domain_scores_gemma":[0.9978427,0.00053276133,0.00018002233,0.00087661756,0.00006513306,0.0005027214],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038609665,0.00047581256,0.0011458124,0.00046860075,0.000060178765,0.000012398474,0.00032803114,0.000362246,0.0006453818],"category_scores_gemma":[0.000079153,0.00040714207,0.0002585346,0.00036625238,0.0001685321,0.000050064737,0.00012735886,0.0005534729,0.00061564223],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038971335,0.0011999644,0.4529621,0.00024753314,0.00010751192,0.008408881,0.0034995964,0.00035525768,0.5099295,0.0002753348,0.018374251,0.0007429571],"study_design_scores_gemma":[0.01985012,0.018649835,0.7283539,0.00013629478,0.00062633015,0.0029091865,0.0012145712,0.00049485726,0.19098824,0.00026320017,0.035193488,0.001319931],"about_ca_topic_score_codex":0.0011547093,"about_ca_topic_score_gemma":0.00044347325,"teacher_disagreement_score":0.31894124,"about_ca_system_score_codex":0.00095864147,"about_ca_system_score_gemma":0.00025245085,"threshold_uncertainty_score":0.99983805},"labels":[],"label_agreement":null},{"id":"W2943049136","doi":"10.3747/co.26.4595","title":"Real-World Outcomes of Nivolumab and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium","year":2019,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; BC Cancer Foundation; Princess Margaret Cancer Centre; Spinal Cord Injury BC; London Health Sciences Centre; Queen's University; University Health Network; Alberta Cancer Foundation; Sunnybrook Health Science Centre; University of Calgary","funders":"","keywords":"Cabozantinib; Renal cell carcinoma; Medicine; Nivolumab; Oncology; Metastatic Urothelial Carcinoma; Metastatic melanoma; Internal medicine; Metastatic carcinoma; Carcinoma; Cancer research; Urothelial carcinoma; Immunotherapy; Cancer","score_opus":0.08547793021661805,"score_gpt":0.3559964659620393,"score_spread":0.2705185357454213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943049136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98594934,0.0021642838,0.000018521892,0.0011453098,0.0011513872,0.0013052473,0.001180309,0.000022511696,0.0070630684],"genre_scores_gemma":[0.9950722,0.00020786778,0.0016216345,0.00013421358,0.000119240554,0.00007044129,0.0013326311,0.00004216241,0.0013996384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99612546,0.00049684907,0.0013428195,0.00086713774,0.0006421513,0.0005256],"domain_scores_gemma":[0.9959365,0.0019410597,0.00073444366,0.000932902,0.00022050517,0.00023457337],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00082080666,0.0004473453,0.0012292712,0.00039779354,0.000057240297,0.000024615865,0.00040711203,0.000076058466,0.00032152698],"category_scores_gemma":[0.00022233104,0.00031354878,0.00021660262,0.0003331881,0.00030336462,0.00013820716,0.00034816944,0.0006237084,0.000074338874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026604752,0.0019971319,0.96782285,0.00027515975,0.00021619786,0.00067084463,0.0016928372,0.000023042629,0.01710648,0.00017501244,0.005269325,0.002090622],"study_design_scores_gemma":[0.02592538,0.0012751924,0.93396354,0.00013815699,0.0010997957,0.000071513656,0.001010752,0.0010291479,0.02501115,0.0000814344,0.010034733,0.0003592198],"about_ca_topic_score_codex":0.0047611347,"about_ca_topic_score_gemma":0.002164911,"teacher_disagreement_score":0.033859346,"about_ca_system_score_codex":0.00042824732,"about_ca_system_score_gemma":0.0007434145,"threshold_uncertainty_score":0.99993163},"labels":[],"label_agreement":null},{"id":"W2944070440","doi":"10.48083/oses5540","title":"Active Surveillance for Small Renal Masses","year":2022,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Institutes of Health","keywords":"Medicine; Watchful waiting; Intervention (counseling); Active monitoring; Intensive care medicine; Internal medicine; Cancer; Computer science","score_opus":0.07404165289032641,"score_gpt":0.3290431641089072,"score_spread":0.25500151121858083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944070440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97739434,0.0006840169,0.0018421933,0.008041557,0.0012067981,0.00051729125,0.00015804403,0.00006003373,0.010095727],"genre_scores_gemma":[0.9875806,0.00010157131,0.0033294687,0.001347059,0.00073547836,0.00021242024,0.00016439086,0.00002449865,0.006504523],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99841756,0.0001375001,0.0003478548,0.00026192036,0.0005279114,0.0003072411],"domain_scores_gemma":[0.99855536,0.000520785,0.0003080073,0.00015947373,0.00033009468,0.00012625591],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055163936,0.00016733308,0.0002845137,0.00016265282,0.00037378524,0.000040749906,0.00026462364,0.000052931777,0.0015414158],"category_scores_gemma":[0.00036390292,0.00014515675,0.00036856797,0.00010038093,0.000055778786,0.000072064555,0.00014303258,0.0005837097,0.000008265329],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022596562,0.003549679,0.666557,0.00015338088,0.006379006,0.0035382698,0.002141938,0.006003114,0.030221283,0.0049319714,0.11753254,0.13639523],"study_design_scores_gemma":[0.012468199,0.0059239445,0.41622496,0.0000297482,0.00028298039,0.008047747,0.0023575185,0.0013445298,0.008771273,0.011941726,0.53205836,0.0005490442],"about_ca_topic_score_codex":0.000009844655,"about_ca_topic_score_gemma":0.000007713797,"teacher_disagreement_score":0.4145258,"about_ca_system_score_codex":0.00085403444,"about_ca_system_score_gemma":0.0003309329,"threshold_uncertainty_score":0.9993713},"labels":[],"label_agreement":null},{"id":"W2946386938","doi":"10.1055/a-0869-6536","title":"ASCO-GU 2019: Fortgeschrittenes Nierenzellkarzinom","year":2019,"lang":"de","type":"article","venue":"Onkologische Welt","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gynecology; Medicine","score_opus":0.019812809619261115,"score_gpt":0.25925133901545183,"score_spread":0.2394385293961907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946386938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7871828,0.13387926,0.000083295454,0.005415696,0.0061184904,0.0022565601,0.00009231571,0.0002658082,0.06470574],"genre_scores_gemma":[0.9294468,0.0061880313,0.0021766447,0.0014069923,0.0021612893,0.00008666982,0.00046103715,0.0001816024,0.057890926],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946113,0.0003514047,0.0010179,0.0014936961,0.0009386734,0.0015869916],"domain_scores_gemma":[0.99593294,0.00042466182,0.0004720917,0.0022287283,0.00024380337,0.00069778576],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000750249,0.0010178987,0.0015465007,0.0003354153,0.00017884655,0.000117800664,0.0006624233,0.0009141922,0.0065126526],"category_scores_gemma":[0.00014936876,0.0008210799,0.0007240793,0.00043775045,0.00036559883,0.00023759459,0.00042896895,0.0010835992,0.07513449],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001588138,0.0018942651,0.7549346,0.0010705593,0.003735702,0.001954989,0.0006331062,0.000099462864,0.022655256,0.0035281081,0.18800563,0.01990018],"study_design_scores_gemma":[0.0076505723,0.004545572,0.19228792,0.0006883597,0.0030115766,0.00013180997,0.0004458913,0.00024104361,0.04651629,0.00029917987,0.7428027,0.0013790812],"about_ca_topic_score_codex":0.00058738596,"about_ca_topic_score_gemma":0.000021490001,"teacher_disagreement_score":0.5626467,"about_ca_system_score_codex":0.0003848357,"about_ca_system_score_gemma":0.0005137381,"threshold_uncertainty_score":0.999424},"labels":[],"label_agreement":null},{"id":"W2946444383","doi":"10.5489/cuaj.6048","title":"Is nephrectomy no longer beneficial in the management of metastatic kidney cancer?","year":2019,"lang":"en","type":"editorial","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Nephrectomy; Medicine; Kidney cancer; Cancer; Kidney; General surgery; Urology; Oncology; Internal medicine","score_opus":0.017269461855660532,"score_gpt":0.26412039585350483,"score_spread":0.2468509339978443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946444383","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.086842656,0.004157032,0.000007744085,0.03736988,0.84572285,0.002914098,0.002172109,0.000027082964,0.020786561],"genre_scores_gemma":[0.1642488,0.0053498913,0.0007546402,0.016059786,0.800094,0.00026529003,0.0011622251,0.0001461531,0.011919214],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964309,0.000330905,0.0007237293,0.00033545963,0.0015466578,0.00063236104],"domain_scores_gemma":[0.99736696,0.00049089274,0.0007584153,0.0002707835,0.00057069183,0.0005422228],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012647255,0.00032243223,0.0007883866,0.00034195968,0.000103217724,0.00008053142,0.00036990707,0.0006162114,0.0013893589],"category_scores_gemma":[0.0005676532,0.00021050176,0.00036861087,0.00034767095,0.000030068519,0.000053793192,0.000027476635,0.0017018047,0.00014974114],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001430164,0.00008956233,0.02427184,0.00016606753,0.0009205608,0.00062773033,0.00020356981,0.00001761973,0.0000026543764,0.000017779794,0.9727207,0.00081888906],"study_design_scores_gemma":[0.002098744,0.0004916219,0.05030728,0.00023457957,0.0011433776,0.000026045349,0.0000801099,0.000022335893,0.0000042409597,0.00011770946,0.9452827,0.00019127273],"about_ca_topic_score_codex":0.0052239983,"about_ca_topic_score_gemma":0.0010936628,"teacher_disagreement_score":0.07740613,"about_ca_system_score_codex":0.0038752598,"about_ca_system_score_gemma":0.0024994595,"threshold_uncertainty_score":0.9999487},"labels":[],"label_agreement":null},{"id":"W2946472581","doi":"10.1016/j.clgc.2019.05.017","title":"Real-World Evidence Data on Metastatic Renal-Cell Carcinoma Treatment in Austria: The RELACS Study","year":2019,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Astellas Pharma; Eisai; Fondazione Internazionale Menarini; British Microcirculation Society; M.S.I. Foundation; Ipsen Biopharmaceuticals; Pfizer; Intuitive Surgical; Takeda Pharmaceutical Company; Exelixis; Meso Scale Diagnostics; Ipsen; Olympus; Medtronic; Roche; Baxter International; Novartis Pharma; Novartis","keywords":"Medicine; Renal cell carcinoma; Real world evidence; Oncology; Internal medicine; Real world data; Data science","score_opus":0.27979379609309263,"score_gpt":0.45433514373646267,"score_spread":0.17454134764337004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946472581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866173,0.0024329766,3.8050717e-7,0.0021140908,0.00078364724,0.004059645,0.0000459278,0.000043319294,0.003902696],"genre_scores_gemma":[0.9715674,0.0019172439,0.0001368857,0.00038810275,0.000678716,0.00038470296,0.000052130334,0.00006222375,0.0248126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953091,0.00091724447,0.0012253905,0.0013388103,0.0006690454,0.00054037303],"domain_scores_gemma":[0.9927623,0.0029885874,0.00032383623,0.0035368155,0.000087981425,0.0003004622],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013950424,0.0004595519,0.0010288884,0.00018158913,0.000089748646,0.000033157965,0.00067273533,0.000101975354,0.00050698966],"category_scores_gemma":[0.0002343627,0.00026937327,0.00027173548,0.0005857816,0.00013115554,0.00015631763,0.00040063052,0.0007292606,0.00060212106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035366158,0.0050494606,0.9767631,0.00007255167,0.00029260296,0.0027605072,0.00025340766,0.00014853511,0.00020654607,0.0000034926509,0.0045683356,0.0063448036],"study_design_scores_gemma":[0.0086754905,0.014433868,0.9684089,0.0002912348,0.0012146406,0.00002495238,0.0005040704,0.00023362266,0.0006245245,0.000012216148,0.005286812,0.00028965922],"about_ca_topic_score_codex":0.0037142893,"about_ca_topic_score_gemma":0.0014415755,"teacher_disagreement_score":0.020909904,"about_ca_system_score_codex":0.0010298097,"about_ca_system_score_gemma":0.0008602879,"threshold_uncertainty_score":0.99997586},"labels":[],"label_agreement":null},{"id":"W2946582232","doi":"10.1097/spc.0000000000000433","title":"Cytoreductive nephrectomy in metastatic kidney cancer: what do we do now?","year":2019,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Kidney cancer; Nephrectomy; Cancer; Kidney; Internal medicine","score_opus":0.19152845839888896,"score_gpt":0.4487355910246158,"score_spread":0.2572071326257268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946582232","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035493268,0.9893991,0.0000049650002,0.00015232016,0.0044649714,0.004526286,0.0009508783,0.000021115997,0.00012547658],"genre_scores_gemma":[0.00026943948,0.99486196,0.00006016354,0.000026787879,0.0004208048,0.0016065729,0.0025640395,0.00009334215,0.00009690173],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957855,0.0004971923,0.0012080497,0.0013300076,0.0005427196,0.00063657545],"domain_scores_gemma":[0.99757296,0.00032493597,0.0007662532,0.00050107227,0.0003886263,0.0004461707],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020074548,0.0010174104,0.0033599222,0.0008170766,0.000047844667,0.000112265916,0.0001943833,0.00027725587,0.00033228696],"category_scores_gemma":[0.0001082544,0.000773299,0.00060062454,0.0008580937,0.00018105718,0.0003346388,0.00016428153,0.0011110784,0.00010543072],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001281889,0.00024461234,0.021909483,0.10234761,0.00046547074,0.00006627847,0.0067029996,9.414122e-7,2.5993967e-7,0.00009264046,0.0018437702,0.86619776],"study_design_scores_gemma":[0.0019255971,0.00037129133,0.0017545018,0.19382574,0.0009163994,0.000012980374,0.0046090586,0.0000018334791,0.0000054094235,0.00004679672,0.79595643,0.0005739324],"about_ca_topic_score_codex":0.000037628823,"about_ca_topic_score_gemma":0.00001228069,"teacher_disagreement_score":0.86562383,"about_ca_system_score_codex":0.0018296983,"about_ca_system_score_gemma":0.002126542,"threshold_uncertainty_score":0.9994718},"labels":[],"label_agreement":null},{"id":"W2946628936","doi":"10.1016/j.euo.2019.04.007","title":"Individualised Indications for Cytoreductive Nephrectomy: Which Criteria Define the Optimal Candidates?","year":2019,"lang":"en","type":"review","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"European Organisation for Research and Treatment of Cancer; Medtronic","keywords":"Medicine; Nephrectomy; Intensive care medicine; MEDLINE; Urology; Internal medicine; Kidney","score_opus":0.10100723821200605,"score_gpt":0.38861430127581376,"score_spread":0.2876070630638077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946628936","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00057550357,0.9665826,0.00012429034,0.0024804387,0.0012805074,0.005479775,0.00047100472,0.00012190957,0.022883983],"genre_scores_gemma":[0.0015677697,0.9832025,0.003014159,0.0018967547,0.0016886295,0.0012628727,0.0045294403,0.00033953405,0.0024983333],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943311,0.0025853761,0.0010378779,0.0010700114,0.00020517908,0.0007704588],"domain_scores_gemma":[0.9955974,0.0016840581,0.00095627055,0.0012450321,0.00027803914,0.00023920232],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001215403,0.0007490182,0.0027477313,0.00046194193,0.00024889858,0.000035341396,0.0007204594,0.0005883381,0.00035687364],"category_scores_gemma":[0.0006013036,0.0004782734,0.0006495064,0.0005082129,0.00045815666,0.000048303886,0.00035631767,0.0011602947,0.0016682099],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001399347,0.0014847006,0.00019341164,0.007056049,0.006856905,0.0010316663,0.0021721756,0.000007898835,0.000031958167,0.0014732258,0.10708045,0.8712122],"study_design_scores_gemma":[0.0022186674,0.0040391446,0.0007138528,0.0002801686,0.0097265225,0.0024786622,0.000033045282,0.000007656384,0.0000027323329,0.000018610948,0.980136,0.0003449312],"about_ca_topic_score_codex":0.000013671439,"about_ca_topic_score_gemma":0.000017392274,"teacher_disagreement_score":0.8730556,"about_ca_system_score_codex":0.0006058302,"about_ca_system_score_gemma":0.0021335154,"threshold_uncertainty_score":0.9997669},"labels":[],"label_agreement":null},{"id":"W2946957740","doi":"10.1016/j.clgc.2021.05.004","title":"Active Surveillance in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System","year":2021,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre; University of Calgary; University of British Columbia; McMaster University; Sunnybrook Health Science Centre; University of Manitoba; Juravinski Cancer Centre; Queen Elizabeth II Health Sciences Centre; University of Alberta; CancerCare Manitoba; Ottawa Hospital; McGill University Health Centre; University of Ottawa","funders":"Genentech; Ipsen; Amgen Astellas Biopharma; Astellas Pharma; Merck Sharp and Dohme; Bristol-Myers Squibb Canada; Eisai; AbbVie; Exelixis; Sanofi; Roche; Karyopharm Therapeutics; Novartis; MedImmune; GlaxoSmithKline; Boehringer Ingelheim; Amgen; Pfizer; Bayer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Cohort; Hazard ratio; Renal cell carcinoma; Internal medicine; Kidney cancer; Systemic therapy; Cancer; Cohort study; Confidence interval; Oncology; Breast cancer","score_opus":0.05802921157147152,"score_gpt":0.32756667941217094,"score_spread":0.26953746784069943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946957740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775002,0.0025614642,0.0000038753924,0.007502024,0.0012393811,0.0007067163,0.0023508677,0.000032865075,0.008102578],"genre_scores_gemma":[0.99394596,0.00042158726,0.00022499624,0.0028095178,0.0008748687,0.00022992962,0.0007041855,0.00002756662,0.0007613815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968696,0.00053074386,0.0011229254,0.00051766814,0.00044996894,0.0005090803],"domain_scores_gemma":[0.9971303,0.0006687613,0.00032381102,0.00074125396,0.00039835516,0.0007375275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005711153,0.00028552595,0.00063615997,0.000096248106,0.00017214303,0.000054544813,0.00020445364,0.00017963769,0.0002015597],"category_scores_gemma":[0.0005013029,0.0002071379,0.0002489141,0.00047749403,0.00012162916,0.00018031993,0.000089086476,0.0006990811,0.0001042873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005800596,0.00044203282,0.90189284,0.0004269143,0.0006267926,0.0065883594,0.0026406744,0.00096541404,0.0004072262,0.000018467008,0.058032524,0.022158137],"study_design_scores_gemma":[0.0068145613,0.00022915292,0.95876485,0.00029680456,0.00024450262,0.00004419073,0.0007705927,0.0005735082,0.0030438765,0.000008560276,0.028946798,0.00026263122],"about_ca_topic_score_codex":0.32363185,"about_ca_topic_score_gemma":0.2873658,"teacher_disagreement_score":0.056871958,"about_ca_system_score_codex":0.002035993,"about_ca_system_score_gemma":0.006457202,"threshold_uncertainty_score":0.99917525},"labels":[],"label_agreement":null},{"id":"W2947107330","doi":"10.1016/j.eururo.2019.05.033","title":"Reply to Takeshi Takahashi's Letter to the Editor re: Bimal Bhindi, Christine M. Lohse, Phillip J. Schulte, et al. Predicting functional outcomes after partial and radical nephrectomy. Eur Urol 2019;75:766–72. Partial Nephrectomy: “Geocentrism” of the 21st century in the Church of Urology?","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Calgary","funders":"","keywords":"Medicine; Nephrectomy; Internal medicine; Kidney","score_opus":0.015809895396502717,"score_gpt":0.23703209143736773,"score_spread":0.22122219604086502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947107330","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1930192,0.0020589074,0.000061848485,0.7915882,0.007805074,0.0035318334,0.00044560968,0.00007854855,0.0014107719],"genre_scores_gemma":[0.32411838,0.0001090226,0.00007244701,0.6571191,0.017466104,0.0002064276,0.0003158387,0.00017063525,0.0004220541],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98950815,0.004476111,0.0016123096,0.0015859654,0.0014607584,0.0013567101],"domain_scores_gemma":[0.99444246,0.0024361988,0.0006953905,0.001993487,0.00021273312,0.00021971196],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0029443384,0.0009746563,0.0014327898,0.0004991459,0.0001891789,0.00008465857,0.0010677679,0.00057792244,0.00043374716],"category_scores_gemma":[0.001431304,0.0005367398,0.00055123353,0.0006581138,0.0007662109,0.00011942518,0.00074476574,0.0044691865,0.00016637173],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002869276,0.00020797036,0.104417086,0.00009868791,0.0003960318,0.0010622047,0.0009766577,0.000095782154,0.0002587865,0.000008539389,0.88910776,0.00050123065],"study_design_scores_gemma":[0.002348502,0.0011611328,0.24633817,0.000071434944,0.00045497314,0.00035640717,0.000030181249,0.000039428298,0.000048269878,0.0000013550831,0.74884284,0.00030731127],"about_ca_topic_score_codex":0.00014926256,"about_ca_topic_score_gemma":0.00002285738,"teacher_disagreement_score":0.14192109,"about_ca_system_score_codex":0.00011597668,"about_ca_system_score_gemma":0.000299444,"threshold_uncertainty_score":0.9997084},"labels":[],"label_agreement":null},{"id":"W2947112139","doi":"10.1016/j.kint.2019.04.043","title":"Summary of the International Conference on Onco-Nephrology: an emerging field in medicine","year":2019,"lang":"en","type":"article","venue":"Kidney International","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health","keywords":"Medicine; Nephrology; Multidisciplinary approach; Intensive care medicine; Kidney cancer; Cancer; Cancer therapy; Internal medicine; Family medicine; Oncology; Political science","score_opus":0.04270424031258496,"score_gpt":0.32603563551717424,"score_spread":0.2833313952045893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947112139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7485864,0.000016463346,0.000011506079,0.06522368,0.0014901132,0.00022704178,0.000017986082,0.0000128451975,0.18441397],"genre_scores_gemma":[0.98721707,0.00003021368,0.00017738895,0.007997951,0.0002478865,0.000012625218,0.00011012973,0.0000099296685,0.004196827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877197,0.000038468297,0.00029823274,0.00023255576,0.0005387485,0.00012000671],"domain_scores_gemma":[0.99926484,0.000082972074,0.000119226264,0.00029484407,0.00014124111,0.000096891104],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017925263,0.00011647774,0.0002013585,0.00018685272,0.000013445578,0.000006270428,0.00036821104,0.00006924612,0.004622891],"category_scores_gemma":[0.00022079523,0.00007700533,0.000068449364,0.00008723028,0.000061405306,0.00007690242,0.000086636035,0.00021905343,0.000049866638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013846373,0.000706786,0.7768274,0.000048377336,0.00040495358,0.0000843338,0.001241859,0.000063211315,0.12164775,0.037589006,0.056016672,0.003985031],"study_design_scores_gemma":[0.013429025,0.0031848475,0.7844482,0.002131779,0.00013578852,0.00021341648,0.0010192905,0.014446044,0.067336455,0.004306718,0.108940855,0.00040758582],"about_ca_topic_score_codex":0.00024824074,"about_ca_topic_score_gemma":0.000045359644,"teacher_disagreement_score":0.23863065,"about_ca_system_score_codex":0.00017039174,"about_ca_system_score_gemma":0.00016397965,"threshold_uncertainty_score":0.99628705},"labels":[],"label_agreement":null},{"id":"W2947269143","doi":"10.1200/jco.2019.37.15_suppl.4570","title":"First-line pembrolizumab (pembro) monotherapy in advanced clear cell renal cell carcinoma (ccRCC): Updated results for KEYNOTE-427 cohort A.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Pembrolizumab; Cohort; Renal cell carcinoma; Internal medicine; Clear cell renal cell carcinoma; Clinical endpoint; Oncology; Surgery; Urology; Gastroenterology; Cancer; Clinical trial; Immunotherapy","score_opus":0.06056821045133883,"score_gpt":0.38968190688245813,"score_spread":0.3291136964311193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947269143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824113,0.00084753527,0.00018209039,0.003635481,0.0013357132,0.0016839394,0.000029145554,0.00002187069,0.009852923],"genre_scores_gemma":[0.98417354,0.000945816,0.0085142115,0.0014471032,0.0009045461,0.000025912985,0.00005602931,0.000081292674,0.0038515774],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9929217,0.00050381944,0.0046279933,0.0006669464,0.0006215458,0.00065796834],"domain_scores_gemma":[0.99221736,0.0029364747,0.0028278243,0.0006712488,0.0007113636,0.00063572405],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0034408874,0.00041705446,0.002879125,0.00036248172,0.000054265114,0.000015562284,0.00038711212,0.0008047216,0.00020793226],"category_scores_gemma":[0.0008773236,0.00031423048,0.0010631807,0.00029431822,0.00014498566,0.00017729161,0.00007552513,0.0015086236,0.00011993403],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.57503515,0.012069557,0.34149805,0.00042707106,0.00068069104,0.0037173685,0.00047256515,0.005832315,0.0137910275,0.000041173826,0.01897583,0.027459202],"study_design_scores_gemma":[0.17106311,0.09214886,0.5920263,0.00018269938,0.00063001906,0.00037595423,0.00010760208,0.002394706,0.010130731,0.00023359052,0.13027224,0.00043420837],"about_ca_topic_score_codex":0.00006788191,"about_ca_topic_score_gemma":0.00009663935,"teacher_disagreement_score":0.40397203,"about_ca_system_score_codex":0.0007231172,"about_ca_system_score_gemma":0.0016997242,"threshold_uncertainty_score":0.999931},"labels":[],"label_agreement":null},{"id":"W2947405348","doi":"10.1200/jco.2019.37.15_suppl.4578","title":"Deferred cytoreductive nephrectomy among patients with newly diagnosed metastatic renal cell carcinoma treated initially with sunitinib.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University; University of Manitoba; Princess Margaret Cancer Centre; BC Cancer Agency; Dalhousie University; University of Calgary","funders":"","keywords":"Sunitinib; Medicine; Renal cell carcinoma; Proportional hazards model; Internal medicine; Cohort; Nephrectomy; Surgery; Oncology; Expanded access; Urology; Kidney","score_opus":0.061423392041514924,"score_gpt":0.3531500393208842,"score_spread":0.29172664727936926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947405348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98764193,0.00010769925,0.000044305292,0.00026274414,0.00031884978,0.0010990027,0.000014075715,0.000019297699,0.010492101],"genre_scores_gemma":[0.9915773,0.00002598847,0.006962734,0.00050479505,0.00038466233,0.000019241566,0.000042534964,0.00006917722,0.00041352597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951296,0.00088975736,0.0021745546,0.00043773477,0.0008811494,0.00048724463],"domain_scores_gemma":[0.99214685,0.0025582404,0.00265082,0.0003559737,0.0014699203,0.00081822154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010312579,0.00041277547,0.0024720347,0.00030531656,0.000052858442,0.000023769535,0.00022540452,0.00028950666,0.0003171885],"category_scores_gemma":[0.0005674454,0.00023643722,0.0004886493,0.0003616781,0.00041195715,0.00029240444,0.000048612932,0.0012293616,0.000054381773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031130932,0.0043499367,0.9488353,0.000051915642,0.0010547815,0.007790204,0.0002691399,0.00008506976,0.00016894583,0.000007033369,0.0003783177,0.0058784015],"study_design_scores_gemma":[0.054173246,0.080341116,0.8601562,0.00016396341,0.0021372433,0.00047653556,0.00032513862,0.000019359373,0.0010372576,0.000017995688,0.0009219081,0.00023008494],"about_ca_topic_score_codex":0.00015812683,"about_ca_topic_score_gemma":0.00008358039,"teacher_disagreement_score":0.088679165,"about_ca_system_score_codex":0.0004039978,"about_ca_system_score_gemma":0.0023432632,"threshold_uncertainty_score":0.964163},"labels":[],"label_agreement":null},{"id":"W2947648853","doi":"10.1200/jco.2021.39.6_suppl.276","title":"Outcomes of first-line (1L) immuno-oncology (IO) combination therapies in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Dalhousie University; University of Ottawa; University of Calgary","funders":"","keywords":"Medicine; Axitinib; Nivolumab; Internal medicine; Ipilimumab; Oncology; Renal cell carcinoma; Hazard ratio; Population; Cancer; Sunitinib; Immunotherapy; Confidence interval","score_opus":0.14275147815557596,"score_gpt":0.4227383730812307,"score_spread":0.27998689492565476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947648853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94623965,0.0021044237,0.00009838298,0.046817943,0.0019542605,0.00030834207,0.00015332863,0.0000063171988,0.0023173317],"genre_scores_gemma":[0.99013007,0.0015373076,0.005015149,0.0022253243,0.00042252822,0.000010310855,0.00021622403,0.000023135086,0.00041995267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99261546,0.0014258536,0.0045376685,0.000371017,0.00077047275,0.00027950114],"domain_scores_gemma":[0.9792441,0.015541632,0.0033108396,0.0005670237,0.0011229119,0.00021346634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004585856,0.0002566413,0.0021040733,0.00019428198,0.000052571922,0.00001618342,0.00046304052,0.0002866525,0.00036925063],"category_scores_gemma":[0.00788332,0.00015834963,0.0006665591,0.00023569881,0.0004009573,0.00016324641,0.00021738304,0.0011418776,0.00001432112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024741037,0.015406465,0.8932505,0.0000660651,0.0027563113,0.010533386,0.0019494409,0.00014506403,0.0096395565,0.00027594613,0.008893733,0.03234248],"study_design_scores_gemma":[0.042867642,0.008408299,0.90443534,0.00013844232,0.0010184506,0.0004528612,0.001425547,0.00034421458,0.008434808,0.0008006199,0.03151593,0.00015784522],"about_ca_topic_score_codex":0.00046402213,"about_ca_topic_score_gemma":0.0013895516,"teacher_disagreement_score":0.04459262,"about_ca_system_score_codex":0.0004978556,"about_ca_system_score_gemma":0.002444544,"threshold_uncertainty_score":0.943764},"labels":[],"label_agreement":null},{"id":"W2947663188","doi":"10.1200/jco.2019.37.15_suppl.4569","title":"KEYNOTE-427 cohort B: First-line pembrolizumab (pembro) monotherapy for advanced non‒clear cell renal cell carcinoma (NCC-RCC).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Cohort; Chromophobe cell; Pembrolizumab; Renal cell carcinoma; Internal medicine; Population; Clinical endpoint; Histology; Urology; Oncology; Clear cell; Surgery; Cancer; Clinical trial; Immunotherapy","score_opus":0.05779333220240377,"score_gpt":0.39268583742607055,"score_spread":0.33489250522366676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947663188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978568,0.0013126472,0.0009365366,0.0030221706,0.0020894865,0.0017553766,0.000015198604,0.000025494926,0.012275048],"genre_scores_gemma":[0.9757169,0.0010856806,0.01145973,0.002175634,0.0018659137,0.000038118964,0.000020639409,0.000116885545,0.0075204996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938379,0.00033172604,0.0037041951,0.0006580784,0.00074722164,0.0007208867],"domain_scores_gemma":[0.9915169,0.0030576284,0.0028728137,0.00074298086,0.00092732854,0.00088233134],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023595428,0.00048503376,0.0031968488,0.00026778708,0.00009411412,0.000021092123,0.0004494961,0.00080959714,0.000582194],"category_scores_gemma":[0.000555399,0.00035828643,0.001752969,0.0002038571,0.00018134443,0.00019321806,0.000087861976,0.0014428163,0.0002431868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20835613,0.014259005,0.635801,0.0009737363,0.0014902911,0.0031482927,0.0004660214,0.0019716476,0.04588577,0.000055239158,0.021261148,0.06633172],"study_design_scores_gemma":[0.14356743,0.16307862,0.4736185,0.00022641754,0.0019046791,0.0007692149,0.00015994468,0.0022800677,0.035219062,0.00030076964,0.17817314,0.0007021342],"about_ca_topic_score_codex":0.000036953687,"about_ca_topic_score_gemma":0.000021887165,"teacher_disagreement_score":0.16218248,"about_ca_system_score_codex":0.000642211,"about_ca_system_score_gemma":0.0020243113,"threshold_uncertainty_score":0.99988693},"labels":[],"label_agreement":null},{"id":"W2947664767","doi":"10.1200/jco.2019.37.15_suppl.4500","title":"Pembrolizumab (pembro) plus axitinib (axi) versus sunitinib as first-line therapy for metastatic renal cell carcinoma (mRCC): Outcomes in the combined IMDC intermediate/poor risk and sarcomatoid subgroups of the phase 3 KEYNOTE-426 study.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Clinical endpoint; Internal medicine; Axitinib; Oncology; Everolimus; Urology; Surgery; Clinical trial","score_opus":0.10725753453450605,"score_gpt":0.42692863951810667,"score_spread":0.31967110498360063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947664767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99049425,0.0006934351,0.00002239079,0.0038658034,0.00131001,0.0030743247,0.00004847293,0.000008240547,0.0004830462],"genre_scores_gemma":[0.99744374,0.00054938253,0.00034763763,0.0010888673,0.00027660443,0.00006480582,0.000012572847,0.000047971283,0.00016843977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99274117,0.0020903493,0.0034819732,0.00040636762,0.00080496,0.00047515967],"domain_scores_gemma":[0.9793314,0.016076917,0.0031453585,0.00067656505,0.00046837554,0.00030138443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052472414,0.0004228741,0.0028766552,0.00024780058,0.000108161235,0.000025041414,0.00066271477,0.0002655042,0.00012193651],"category_scores_gemma":[0.002958346,0.0002097423,0.0010791857,0.0002672973,0.0004363542,0.000120563986,0.00015238917,0.001427798,0.000010817508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25632405,0.025036747,0.6883807,0.00023833982,0.0017963336,0.0012967983,0.003757617,0.000055794153,0.00046015956,0.00009469334,0.00075735745,0.02180138],"study_design_scores_gemma":[0.25449303,0.13413568,0.60354125,0.000077864235,0.0013126476,0.00027609608,0.0025844288,0.00032653662,0.00087240885,0.00029049203,0.001899444,0.00019013185],"about_ca_topic_score_codex":0.00020769381,"about_ca_topic_score_gemma":0.00029440052,"teacher_disagreement_score":0.109098926,"about_ca_system_score_codex":0.00024791033,"about_ca_system_score_gemma":0.0013062158,"threshold_uncertainty_score":0.85530424},"labels":[],"label_agreement":null},{"id":"W2948757664","doi":"10.21873/anticanres.13402","title":"Long-term Prognostic Impact of Chromosome Abnormalities in Clear Cell Renal Cell Carcinoma","year":2019,"lang":"en","type":"article","venue":"Anticancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Clear cell renal cell carcinoma; Renal cell carcinoma; Proportional hazards model; Chromosome abnormality; Oncology; Clear cell; Internal medicine; Chromosome; Cytogenetics; Kidney cancer; Pathology; Biology; Medicine; Chromosome 7 (human); Cancer; Karyotype; Genetics","score_opus":0.054440085918523416,"score_gpt":0.3705143278082583,"score_spread":0.31607424188973493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948757664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794087,0.0016166471,0.000001059538,0.000091845366,0.00004903438,0.00141491,0.000018333882,0.000017583028,0.017381903],"genre_scores_gemma":[0.99614346,0.00020280598,0.000049412083,0.0000144661635,0.00010494331,0.000058874302,0.0000324196,0.000051865994,0.0033417284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968025,0.00023387423,0.0004397411,0.00048230647,0.001118155,0.0009233917],"domain_scores_gemma":[0.99828225,0.0003277775,0.000082431616,0.0007211348,0.0003274869,0.00025893652],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007122651,0.00023092174,0.00055711914,0.00053697434,0.000045743047,0.00003113595,0.0002505058,0.00012126801,0.0015447956],"category_scores_gemma":[0.00005010201,0.00017811346,0.0002265556,0.00069130893,0.00028298897,0.00013442985,0.00016942834,0.0006191103,0.00046467278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009841985,0.0005657688,0.9056992,0.001043404,0.000037619182,0.0005973688,0.0005396438,0.000016308166,0.09000225,0.000017643479,0.00017271523,0.00032389682],"study_design_scores_gemma":[0.0023994592,0.0042872215,0.8398345,0.00025167235,0.000032830256,0.0000442892,0.0001257979,0.000102146696,0.15275869,0.000016396423,0.000013322402,0.00013363973],"about_ca_topic_score_codex":0.002769039,"about_ca_topic_score_gemma":0.000059744707,"teacher_disagreement_score":0.06586464,"about_ca_system_score_codex":0.00069440657,"about_ca_system_score_gemma":0.0009704748,"threshold_uncertainty_score":0.99936795},"labels":[],"label_agreement":null},{"id":"W2949246094","doi":"10.1200/jco.19.00107","title":"Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Renal cell carcinoma; Sunitinib; Nomogram; Sorafenib; TNM staging system; Stage (stratigraphy); Kidney cancer; Internal medicine; Cancer; Prospective cohort study; Cancer staging; Oncology; Clinical trial; Clear cell renal cell carcinoma; Staging system; Hepatocellular carcinoma","score_opus":0.36815285276110676,"score_gpt":0.4716899339327549,"score_spread":0.10353708117164812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949246094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883418,0.00033115927,0.0013694506,0.0007038644,0.00054527115,0.0009431108,0.0000047543263,0.000010940482,0.007749637],"genre_scores_gemma":[0.9815648,0.00009193547,0.017728254,0.000095679745,0.0003602812,0.000037714395,0.0000068922077,0.000018089133,0.00009635374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99660665,0.00037930117,0.002060606,0.00022272114,0.00053973665,0.00019096168],"domain_scores_gemma":[0.98916805,0.00606627,0.0031488072,0.00015879984,0.0012679776,0.00019012023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023905057,0.0001390328,0.0011620678,0.0001527503,0.00003926877,0.000008368582,0.000091247624,0.00019738963,0.000030504607],"category_scores_gemma":[0.0058681886,0.0000917116,0.00027888635,0.00023670934,0.00012250435,0.00016069578,0.000019053325,0.00071065343,0.000004161906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07490392,0.002002365,0.86228466,0.00010275278,0.00061625475,0.00014965402,0.00044904754,0.025893532,0.00028781593,0.00052137783,0.000058828977,0.032729775],"study_design_scores_gemma":[0.23092175,0.19661081,0.51229,0.004742548,0.004606592,0.00047146174,0.0008903982,0.04250946,0.0039768247,0.0021519628,0.0004285462,0.0003996422],"about_ca_topic_score_codex":0.000033247685,"about_ca_topic_score_gemma":0.000026783347,"teacher_disagreement_score":0.34999466,"about_ca_system_score_codex":0.00028968204,"about_ca_system_score_gemma":0.0036475698,"threshold_uncertainty_score":0.70251936},"labels":[],"label_agreement":null},{"id":"W2949754698","doi":"10.1200/jco.2012.30.15_suppl.5010","title":"Molecular determinants of outcome with mTOR inhibition in endometrial cancer (EC).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"PTEN; KRAS; Neuroblastoma RAS viral oncogene homolog; Medicine; Temsirolimus; PI3K/AKT/mTOR pathway; Cancer research; Selumetinib; PDGFRA; Oncology; Internal medicine; CDKN2A; Cancer; Discovery and development of mTOR inhibitors; Genetics; Biology; Signal transduction","score_opus":0.18033303618569202,"score_gpt":0.4885293930350842,"score_spread":0.3081963568493922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949754698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967148,0.000907388,0.000031538086,0.00061085727,0.00084406644,0.00020883132,0.0000022163988,0.000002227599,0.0006781201],"genre_scores_gemma":[0.9969619,0.0001679865,0.0016239638,0.00038676104,0.0008003915,0.000006094748,6.5185844e-7,0.000013722196,0.00003850884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966375,0.00032561438,0.0023106965,0.0001035352,0.00039007698,0.00023252537],"domain_scores_gemma":[0.99649894,0.0010795635,0.0017311358,0.00013265954,0.0002419415,0.00031573695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024561936,0.00011416655,0.0015578318,0.00026156942,0.000007758284,0.0000017994953,0.000050857892,0.00024444202,0.00009212428],"category_scores_gemma":[0.002009778,0.000069177564,0.0003214489,0.00020632034,0.00012646991,0.00010567415,0.000026200554,0.00052507344,0.0000057882653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070020314,0.0016928812,0.9643818,0.0000381663,0.00013038609,0.0016338886,0.000058511567,0.000012197128,0.0014080313,0.000012012391,0.00005385393,0.02357622],"study_design_scores_gemma":[0.01753446,0.01429393,0.9529181,0.00017013962,0.0004591033,0.0006495471,0.00003812802,0.000009187227,0.012682226,0.000018994973,0.0011581029,0.000068057016],"about_ca_topic_score_codex":0.00006676314,"about_ca_topic_score_gemma":0.000065122345,"teacher_disagreement_score":0.023508163,"about_ca_system_score_codex":0.00026218756,"about_ca_system_score_gemma":0.00063200213,"threshold_uncertainty_score":0.28209794},"labels":[],"label_agreement":null},{"id":"W2949800402","doi":"10.1038/s41431-019-0455-9","title":"Sex specific associations in genome wide association analysis of renal cell carcinoma","year":2019,"lang":"en","type":"review","venue":"European Journal of Human Genetics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre","funders":"University of Texas MD Anderson Cancer Center; Ministerstvo Zdravotnictví Ceské Republiky; Duncan Family Institute for Cancer Prevention and Risk Assessment; National Institute for Health and Care Research; National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services; Cancer Research UK; World Health Organization","keywords":"Renal cell carcinoma; Biology; Genome-wide association study; Genetics; Genetic association; Oncology; Internal medicine; Computational biology; Medicine; Single-nucleotide polymorphism; Gene; Genotype","score_opus":0.07488886047586926,"score_gpt":0.30211265410588584,"score_spread":0.22722379363001657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949800402","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.078452006,0.9137466,0.00002317104,0.000014952967,0.00014379286,0.0004333923,0.00010256472,0.0000052370997,0.0070782723],"genre_scores_gemma":[0.06723305,0.9287886,0.00042312287,0.000024915737,0.00042540385,0.0000014177899,0.00040573478,0.00011986995,0.0025778878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945012,0.0013562274,0.0025682969,0.00032534654,0.0009109485,0.0003379857],"domain_scores_gemma":[0.99396807,0.00038077583,0.00443228,0.0005886425,0.00044763932,0.00018257837],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001958684,0.00042668154,0.0032770906,0.001898874,0.00004768473,0.000039535873,0.0003948314,0.00014919582,0.0001475152],"category_scores_gemma":[0.00009472224,0.0003625904,0.0018204406,0.0010604156,0.000032386903,0.000036146186,0.00009185266,0.0008099233,0.00007105491],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017785159,0.0050406707,0.5957236,0.023675125,0.04605134,0.011281277,0.006483386,0.0037715414,0.0024731488,0.000023337536,0.011977474,0.29332122],"study_design_scores_gemma":[0.002149579,0.0020026814,0.4857096,0.0020810922,0.04380786,0.000057519756,0.000071681505,0.000009303174,0.00011873244,0.000004106701,0.46346304,0.0005248099],"about_ca_topic_score_codex":0.0000030471635,"about_ca_topic_score_gemma":0.000005235684,"teacher_disagreement_score":0.45148557,"about_ca_system_score_codex":0.0017540803,"about_ca_system_score_gemma":0.00034772832,"threshold_uncertainty_score":0.9998826},"labels":[],"label_agreement":null},{"id":"W2950537929","doi":"10.1148/radiol.2019182646","title":"Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment","year":2019,"lang":"en","type":"review","venue":"Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":511,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Medical physics; Radiology","score_opus":0.04944938553157272,"score_gpt":0.3513204766824348,"score_spread":0.3018710911508621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950537929","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027283013,0.9933614,0.00012825527,0.000108333326,0.00033891157,0.0016935832,0.0000782184,0.000033718,0.001529249],"genre_scores_gemma":[0.0022382454,0.9902703,0.003555493,0.000024343602,0.00020719098,0.00006552106,0.0029175454,0.0000549523,0.00066641223],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99781746,0.000513276,0.00065437285,0.00050983985,0.0002225632,0.00028246385],"domain_scores_gemma":[0.9983233,0.00017413417,0.0005343734,0.0007056911,0.00008496303,0.00017750548],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000383753,0.00038755286,0.0020354928,0.00041850106,0.000035991667,0.000009800901,0.00014957,0.0005072585,0.00009754662],"category_scores_gemma":[0.000029216348,0.00027346067,0.00022795156,0.00020103157,0.00015569427,0.00006097013,0.00006803994,0.0003975308,0.00009808388],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042842692,0.0006642704,0.003174505,0.039688334,0.0016296438,0.00030941237,0.00007623487,0.0000024173703,0.0013189383,0.008078196,0.008361777,0.93626785],"study_design_scores_gemma":[0.0012406078,0.0027376416,0.006545671,0.0029408673,0.0043930914,0.0021595603,0.000024013661,0.000097921285,0.000013604155,0.000042109983,0.97951037,0.00029453775],"about_ca_topic_score_codex":0.000017596722,"about_ca_topic_score_gemma":8.224494e-7,"teacher_disagreement_score":0.9711486,"about_ca_system_score_codex":0.00042966666,"about_ca_system_score_gemma":0.001032531,"threshold_uncertainty_score":0.99997175},"labels":[],"label_agreement":null},{"id":"W2951118748","doi":"10.1093/jscr/rjz177","title":"Clear cell papillary renal cell carcinoma: a case report and literature review","year":2019,"lang":"en","type":"article","venue":"Journal of Surgical Case Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Papillary renal cell carcinomas; Clear cell; Clear cell renal cell carcinoma; Pathology; Transplantation; Renal cell carcinoma; Cytokeratin; Chromophobe cell; Carcinoma; Clear cell carcinoma; Pathological; Internal medicine; Immunohistochemistry","score_opus":0.012224618450995603,"score_gpt":0.25431920089262955,"score_spread":0.24209458244163395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951118748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8036423,0.1883935,0.0000010388986,0.00045837398,0.00025740225,0.00049540965,0.0000034901198,0.000013084836,0.006735401],"genre_scores_gemma":[0.97936916,0.016225018,0.0004813896,0.00021548977,0.0003928407,0.000004334656,0.00001648536,0.00004521117,0.0032500795],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9964214,0.00015906576,0.0018104922,0.00047719054,0.0007761636,0.00035567713],"domain_scores_gemma":[0.99616766,0.00015027194,0.0015471601,0.0007089177,0.0006323135,0.0007936831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013136282,0.00035853992,0.0011839122,0.00019593046,0.00007552124,0.00005303368,0.00003416365,0.00021527825,0.00031353923],"category_scores_gemma":[0.000080902704,0.00023846513,0.0005992925,0.00032436417,0.00006120501,0.00020700281,0.00008175299,0.0008299942,0.000012028735],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003272983,0.00027891164,0.009329898,0.002999466,0.00005738512,0.98118705,0.000091070746,0.0000016834999,0.00075805816,0.0000012227624,0.0045838193,0.00038415214],"study_design_scores_gemma":[0.0016242642,0.001525004,0.00072695327,0.0022910768,0.0007233208,0.95966053,0.00008080487,0.0000044156145,0.0025497903,0.000010067479,0.030586977,0.00021680519],"about_ca_topic_score_codex":0.00003079358,"about_ca_topic_score_gemma":0.0000012458249,"teacher_disagreement_score":0.17572686,"about_ca_system_score_codex":0.00016734892,"about_ca_system_score_gemma":0.000304864,"threshold_uncertainty_score":0.9724326},"labels":[],"label_agreement":null},{"id":"W2951459521","doi":"10.1016/j.eururo.2019.06.006","title":"Surgical Safety of Cytoreductive Nephrectomy Following Sunitinib: Results from the Multicentre, Randomised Controlled Trial of Immediate Versus Deferred Nephrectomy (SURTIME)","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre","funders":"Ipsen; European Society for Medical Oncology; Astellas Pharma; Eisai; GlaxoSmithKline; Pfizer; AstraZeneca; European Organisation for Research and Treatment of Cancer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Adverse effect; Common Terminology Criteria for Adverse Events; Nephrectomy; Kidney cancer; Surgery; Randomized controlled trial; Internal medicine; Kidney","score_opus":0.021642751848621408,"score_gpt":0.25962897743649965,"score_spread":0.23798622558787824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951459521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9462288,0.00052952307,0.000005868108,0.0005507917,0.001663867,0.004498967,0.000073724244,0.00004845986,0.046399996],"genre_scores_gemma":[0.99848044,0.00006770229,0.0001881199,0.00008446662,0.00053766434,0.00003141272,0.00023517697,0.00006488959,0.0003101338],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99454486,0.0026973728,0.0013281225,0.0005435181,0.00044858587,0.00043753028],"domain_scores_gemma":[0.9897145,0.008423694,0.0007120988,0.0008059688,0.00017542375,0.0001683302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014952992,0.00035084417,0.001542039,0.00011425912,0.00006167662,0.000009145593,0.0002882538,0.00011982148,0.00021458241],"category_scores_gemma":[0.0018760643,0.00022401252,0.00085803244,0.00020795286,0.0002145243,0.000053995933,0.00012793018,0.00037909314,0.00017436214],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9898946,0.0004435242,0.0010541935,0.0000077607,0.0018644308,0.0004414722,0.0011825751,0.00006919099,0.004186624,0.000029886383,0.0001615847,0.0006641515],"study_design_scores_gemma":[0.9745874,0.0031435888,0.0121546965,0.00003014037,0.0016308869,0.000017168117,0.00031479428,0.00017857703,0.0019809583,0.000007055182,0.005784394,0.00017034097],"about_ca_topic_score_codex":0.00016376826,"about_ca_topic_score_gemma":0.000008811044,"teacher_disagreement_score":0.05225163,"about_ca_system_score_codex":0.00007697958,"about_ca_system_score_gemma":0.00018416079,"threshold_uncertainty_score":0.91349655},"labels":[],"label_agreement":null},{"id":"W2951604609","doi":"10.1016/j.urolonc.2019.05.009","title":"Morphologic subtyping as a prognostic predictor for survival in papillary renal cell carcinoma: Type 1 vs. type 2","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of British Columbia; McMaster University; Muscular Dystrophy Canada; University of Ottawa","funders":"","keywords":"Medicine; Hazard ratio; Renal cell carcinoma; Nephrectomy; Papillary renal cell carcinomas; Cohort; Internal medicine; Urology; Lymph node; Clear cell; Confidence interval; Kidney cancer; Gastroenterology; Oncology; Kidney","score_opus":0.03180586596165426,"score_gpt":0.28880818324214075,"score_spread":0.2570023172804865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951604609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98842555,0.002311558,0.0000074999944,0.0021022412,0.00048701084,0.0015517381,0.000015623415,0.00006348751,0.005035301],"genre_scores_gemma":[0.98354965,0.00022430948,0.012404067,0.0011876079,0.00014533133,0.00014318226,0.00021613546,0.000027221062,0.0021025129],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822825,0.00015396075,0.0003880705,0.0005783553,0.00017374936,0.0004775953],"domain_scores_gemma":[0.9985441,0.0005925515,0.00016098769,0.00027922262,0.00014989392,0.0002732318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040961266,0.00027877121,0.00056013156,0.00021238066,0.000116237374,0.000017682954,0.00011671993,0.0003562025,0.00017729837],"category_scores_gemma":[0.00037007895,0.00022563718,0.00007606726,0.0004150032,0.00031067786,0.00007983333,0.00006736533,0.00038492683,0.00012516507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009764526,0.00029341158,0.9882046,0.00013257728,0.00003218175,0.00046967468,0.00022795239,0.00006977254,0.006141099,0.00078808493,0.0025140122,0.0001502111],"study_design_scores_gemma":[0.0071671945,0.047351483,0.48968938,0.00017226303,0.0008895018,0.0015014025,0.0004899862,0.0022841333,0.0045343507,0.0046425527,0.44058633,0.00069142965],"about_ca_topic_score_codex":0.00008630019,"about_ca_topic_score_gemma":0.00002325284,"teacher_disagreement_score":0.4985152,"about_ca_system_score_codex":0.00024206632,"about_ca_system_score_gemma":0.0007572834,"threshold_uncertainty_score":0.9201217},"labels":[],"label_agreement":null},{"id":"W2952439923","doi":"10.1038/s41379-019-0304-y","title":"Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma","year":2019,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy; Khalifa Bin Zayed Al Nahyan Foundation","keywords":"Oncocytoma; Chromophobe cell; Renal oncocytoma; Clear cell; Pathology; Biology; Renal cell carcinoma; Medicine","score_opus":0.012396396561174809,"score_gpt":0.2240629441666687,"score_spread":0.2116665476054939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952439923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870618,0.0037837937,0.00086550676,0.00025590026,0.00027423055,0.0009351199,0.00021833487,0.00014378381,0.006461524],"genre_scores_gemma":[0.99559844,0.00005173662,0.0016818995,0.0005155313,0.00029927286,0.00007496846,0.00037034502,0.00014021585,0.0012675787],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996074,0.00028243198,0.00068080594,0.0015078378,0.000587346,0.000867546],"domain_scores_gemma":[0.9974568,0.00016016557,0.00036262377,0.0013283564,0.00015949253,0.0005325744],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023125706,0.0006868611,0.0012825596,0.0002392164,0.00013295836,0.0000534113,0.00027100777,0.00029091467,0.00035484156],"category_scores_gemma":[0.000053163945,0.00060543837,0.00030060927,0.0001434789,0.00027844202,0.00016813213,0.00031093648,0.0006358045,0.0005185817],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014884886,0.00066854316,0.1297571,0.0002471646,0.0001380496,0.067176744,0.0011484488,0.000041395888,0.7965963,0.000028436887,0.00044784037,0.0022614968],"study_design_scores_gemma":[0.010597407,0.004102815,0.5883634,0.00024708637,0.00064769125,0.008158487,0.00015205685,0.004379,0.38090727,0.0008596987,0.0006661717,0.0009189307],"about_ca_topic_score_codex":0.0003480185,"about_ca_topic_score_gemma":0.000048871094,"teacher_disagreement_score":0.45860627,"about_ca_system_score_codex":0.00056332425,"about_ca_system_score_gemma":0.0003211941,"threshold_uncertainty_score":0.9996397},"labels":[],"label_agreement":null},{"id":"W2953688847","doi":"10.1016/j.jval.2019.04.146","title":"PCN22 CLINICAL HETEROGENEITY AMONG FIRST-LINE SUNITINIB PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) CATEGORIZED AS INTERMEDIATE RISK (IR) GROUP ACCORDING TO THE INTERNATIONAL MRCC DATABASE CONSORTIUM (IMDC) RISK MODEL","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; University of Calgary","funders":"","keywords":"Sunitinib; Medicine; Discontinuation; Renal cell carcinoma; Internal medicine; Oncology; Gastroenterology","score_opus":0.05839267446960073,"score_gpt":0.31812552893717355,"score_spread":0.2597328544675728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953688847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925184,0.00017433288,0.0011724591,0.0008631888,0.0009917191,0.0033862058,0.000663856,0.00005706557,0.00017277387],"genre_scores_gemma":[0.9941095,0.00035760194,0.002981564,0.0011246293,0.00019015776,0.00018487609,0.0008336294,0.00008987819,0.00012817293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943956,0.0010663328,0.0016574606,0.001035617,0.0010430322,0.00080191524],"domain_scores_gemma":[0.99574184,0.0010627316,0.0010296473,0.0011893943,0.0002565179,0.00071988505],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028696475,0.00050270685,0.0010031917,0.00035251596,0.00020631586,0.00006173113,0.0005269125,0.00010533844,0.00007591376],"category_scores_gemma":[0.00058363966,0.00033783904,0.000253874,0.00038206764,0.00014804368,0.00023270074,0.00036863043,0.0010939557,0.00017908041],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030161832,0.0010193496,0.97298396,0.00019581789,0.0001649677,0.000094802665,0.0006505611,0.020558836,0.00002375243,0.000026964512,0.00026046354,0.0010043368],"study_design_scores_gemma":[0.018072864,0.0050663,0.83037686,0.00044511887,0.00038518832,0.00002856327,0.00048417153,0.1435731,0.0005907931,0.00008333827,0.0004226345,0.00047107687],"about_ca_topic_score_codex":0.01848553,"about_ca_topic_score_gemma":0.002144898,"teacher_disagreement_score":0.14260712,"about_ca_system_score_codex":0.000733008,"about_ca_system_score_gemma":0.0006474095,"threshold_uncertainty_score":0.9999074},"labels":[],"label_agreement":null},{"id":"W2954298172","doi":"10.1016/j.euf.2019.06.002","title":"The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis","year":2019,"lang":"en","type":"review","venue":"European Urology Focus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Cancer Care Ontario; McMaster University; University of Toronto; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"Accuray; Elekta; Varian Medical Systems","keywords":"Medicine; Ablative case; Renal cell carcinoma; Meta-analysis; Radiation therapy; Systematic review; Oncology; Stereotactic radiotherapy; MEDLINE; Radiosurgery; Internal medicine","score_opus":0.051896081552697954,"score_gpt":0.3058623813200204,"score_spread":0.25396629976732243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954298172","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011744383,0.98869455,0.0000643839,0.00018592493,0.00003400834,0.00753009,0.00007755597,0.000021015947,0.0033807303],"genre_scores_gemma":[0.0010714503,0.9947836,0.00020457164,0.00030248705,0.000044419998,0.00045230123,0.00007960066,0.00014778302,0.0029138082],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9939161,0.0029300367,0.0016882558,0.0007598414,0.00029433938,0.0004114407],"domain_scores_gemma":[0.9945189,0.0016982855,0.0019888333,0.0014864685,0.00017288119,0.00013467592],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018252005,0.0007199083,0.009892822,0.00033172473,0.00011335651,0.000023205195,0.00038056646,0.00012653267,0.00005595862],"category_scores_gemma":[0.00012523953,0.0003647761,0.003981853,0.00046327358,0.00015224937,0.000037938426,0.00012175654,0.00041374468,0.000034980407],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069978625,0.00008912299,0.0000067967094,0.7622357,0.23264776,0.00010541991,0.00015069263,7.992443e-7,0.0000042165216,0.000030001418,0.00013865135,0.0045208763],"study_design_scores_gemma":[0.00046918375,0.00085897336,0.00002465241,0.002066718,0.91721785,0.00025709768,0.000009019344,0.000005266098,0.0000030194722,0.000004620495,0.07884152,0.0002420846],"about_ca_topic_score_codex":0.000008356144,"about_ca_topic_score_gemma":0.0000017661449,"teacher_disagreement_score":0.76016897,"about_ca_system_score_codex":0.0001396928,"about_ca_system_score_gemma":0.00016208306,"threshold_uncertainty_score":0.99988043},"labels":[],"label_agreement":null},{"id":"W2954386514","doi":"10.3747/co.26.4707","title":"Renal Cell Carcinoma in the Canadian Indigenous Population","year":2019,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Calgary; McGill University; University of Manitoba; Ottawa Hospital; Université de Montréal; University of Alberta; Université Laval; Dalhousie University; University of Ottawa; McMaster University","funders":"","keywords":"Indigenous; Renal cell carcinoma; Medicine; Kidney disease; Population; Disease; Diabetes mellitus; Internal medicine; Cancer; Kidney cancer; Family history; Demography; Environmental health; Endocrinology","score_opus":0.07017532962760581,"score_gpt":0.3407539354182905,"score_spread":0.2705786057906847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954386514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97841996,0.0012013158,7.335382e-7,0.0005890383,0.00058461475,0.0009641448,0.0000048522083,0.000009831865,0.018225519],"genre_scores_gemma":[0.99912,0.000013512352,0.000033278484,0.0002515211,0.0001511345,0.000047800953,0.00017362957,0.000011984465,0.00019715143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886394,0.00013949706,0.000215399,0.00022650645,0.00019396946,0.00036071864],"domain_scores_gemma":[0.9993802,0.000061023875,0.00006477829,0.0003037601,0.00004226518,0.00014802325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024442616,0.00012428343,0.00023921269,0.00022526842,0.000065415676,0.000011123761,0.00011797951,0.00011963393,0.00017236746],"category_scores_gemma":[0.000010948497,0.000085400556,0.00006567833,0.00019154562,0.000025416572,0.000029815441,0.000016482432,0.00033090197,0.0003524654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052165407,0.0002454536,0.9817647,0.00004708072,0.0000048814222,0.00020683056,0.0022125707,0.00001252651,0.00015986999,0.00008346582,0.0005916673,0.014618839],"study_design_scores_gemma":[0.0014025734,0.0008465243,0.96335626,0.000015025734,0.000043668795,0.00012759773,0.00017666756,0.00005740939,0.00020658893,0.00007853123,0.03360675,0.00008242652],"about_ca_topic_score_codex":0.066778146,"about_ca_topic_score_gemma":0.20565373,"teacher_disagreement_score":0.13887557,"about_ca_system_score_codex":0.0016051105,"about_ca_system_score_gemma":0.0006936294,"threshold_uncertainty_score":0.93943626},"labels":[],"label_agreement":null},{"id":"W2954726203","doi":"10.1016/j.jgo.2019.06.005","title":"Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients","year":2019,"lang":"en","type":"article","venue":"Journal of Geriatric Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Logistic regression; Charlson comorbidity index; Odds ratio; Cohort; Perioperative; Comorbidity; Nephrectomy; Internal medicine; Complication; Renal cell carcinoma; Emergency medicine; Surgery; Kidney","score_opus":0.009260676476681795,"score_gpt":0.2928793948068955,"score_spread":0.28361871833021374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954726203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99546814,0.00026089695,0.0000038859025,0.0028375708,0.00024000803,0.000859234,0.000002069518,0.0000018281658,0.00032634076],"genre_scores_gemma":[0.99876463,0.000030433659,0.00065163884,0.00032028556,0.00016795551,0.000028725573,0.0000037245734,0.000008287934,0.000024340134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988412,0.00018747312,0.0004353178,0.00015860444,0.00021504996,0.00016229913],"domain_scores_gemma":[0.9992877,0.000107899556,0.00019065711,0.00016578815,0.00016349841,0.000084460706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003973115,0.00010832027,0.00037760366,0.00024318087,0.000012159875,0.000010764793,0.00008482933,0.00009417657,0.000043659104],"category_scores_gemma":[0.00005837416,0.00006739684,0.000059745584,0.00030460578,0.000026950242,0.0000942768,0.000032455348,0.00027191814,0.000016550157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009023149,0.00079373526,0.99359375,0.000022966062,0.00003809634,0.00016487887,0.001854767,0.000010194921,0.00036693228,0.000005847956,0.00070682773,0.0015396792],"study_design_scores_gemma":[0.003435519,0.003077334,0.99031705,0.00002964143,0.00007249942,0.00012846355,0.00045416932,0.00000444837,0.000095047304,0.000047566904,0.0022762744,0.00006198903],"about_ca_topic_score_codex":0.00006966426,"about_ca_topic_score_gemma":0.00009221662,"teacher_disagreement_score":0.0032964423,"about_ca_system_score_codex":0.00047507006,"about_ca_system_score_gemma":0.00016698785,"threshold_uncertainty_score":0.27483633},"labels":[],"label_agreement":null},{"id":"W2957874883","doi":"10.1097/mou.0000000000000657","title":"The evolving role of cytoreductive nephrectomy in metastatic renal cell carcinoma","year":2019,"lang":"en","type":"review","venue":"Current Opinion in Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Nephrectomy; Randomized controlled trial; Observational study; Systemic therapy; Internal medicine; Oncology; Urology; Cancer; Kidney","score_opus":0.09278036048075583,"score_gpt":0.3710455099952049,"score_spread":0.2782651495144491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2957874883","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001339689,0.99296105,0.0000041691,0.000040010713,0.002677083,0.0021575398,0.000028658153,0.000010647606,0.00078117894],"genre_scores_gemma":[0.012633972,0.9862944,0.000063366424,0.000003599987,0.00026948712,0.00039379357,0.0002351669,0.000059144157,0.000047101305],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964994,0.0007884161,0.0012154187,0.0006433981,0.00031465225,0.00053870934],"domain_scores_gemma":[0.9975288,0.00088536355,0.0006666878,0.00072047435,0.000097890355,0.000100763085],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049201,0.00050571567,0.0022235569,0.0006454211,0.000036970483,0.000010968749,0.00033194234,0.00023029541,0.00004789244],"category_scores_gemma":[0.00012998396,0.0003312517,0.0004918498,0.0005550392,0.0001828587,0.00004789564,0.00017197708,0.0010317347,0.00007330089],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034028283,0.0009848193,0.0058267126,0.03986518,0.00024974835,0.000038464088,0.0006256157,0.00002135496,0.000017065116,0.0005726647,0.0010861808,0.9503719],"study_design_scores_gemma":[0.0017049819,0.000859581,0.003014909,0.0040564574,0.00078639697,0.0001635522,0.00010768945,0.000096324926,0.0000170572,0.00016845392,0.98873615,0.0002884574],"about_ca_topic_score_codex":0.000062887055,"about_ca_topic_score_gemma":0.000006368328,"teacher_disagreement_score":0.98765,"about_ca_system_score_codex":0.00048666834,"about_ca_system_score_gemma":0.0009218898,"threshold_uncertainty_score":0.99991393},"labels":[],"label_agreement":null},{"id":"W2961056324","doi":"10.1136/jclinpath-2019-205959","title":"Dataset for the reporting of renal biopsy for tumour: recommendations from the International Collaboration on Cancer Reporting (ICCR)","year":2019,"lang":"en","type":"review","venue":"Journal of Clinical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Pathology; Core biopsy; Biopsy; Cancer; Oncocytoma; Renal cell carcinoma; Internal medicine; Breast cancer","score_opus":0.4715699771726663,"score_gpt":0.5658561958861265,"score_spread":0.09428621871346016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2961056324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026584389,0.9460232,0.0021534804,0.024017366,0.009284469,0.003811034,0.011940203,0.000007463516,0.00010431727],"genre_scores_gemma":[0.00071559526,0.98062515,0.006269371,0.00089607324,0.0050031226,0.00022157749,0.0060039028,0.00005717228,0.00020804058],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9866886,0.00037762223,0.012013619,0.00035966942,0.0003801094,0.00018036057],"domain_scores_gemma":[0.9357221,0.0126257595,0.04992921,0.0005917594,0.0010517669,0.00007940343],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010987706,0.00024798972,0.0027154414,0.00010874606,0.000099302226,0.000028727192,0.00040211616,0.0003198845,0.00006660476],"category_scores_gemma":[0.046164505,0.00011626373,0.0014354702,0.00014288291,0.00011518487,0.0000598442,0.000080345344,0.0008195233,0.0000033635267],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00125705,0.00042949777,0.0016704588,0.0013411766,0.0025327522,0.0003580232,0.0000840455,0.000034405966,0.00008010794,0.0000759484,0.1311077,0.86102885],"study_design_scores_gemma":[0.0014637422,0.0011663093,0.0013120698,0.005709361,0.00544267,0.0011929208,0.00009295873,0.00007377883,0.000028717963,0.00011635336,0.9832929,0.00010822074],"about_ca_topic_score_codex":0.00001880457,"about_ca_topic_score_gemma":0.000025963638,"teacher_disagreement_score":0.8609206,"about_ca_system_score_codex":0.00017762584,"about_ca_system_score_gemma":0.0016892279,"threshold_uncertainty_score":0.9618701},"labels":[],"label_agreement":null},{"id":"W2961998542","doi":"10.1016/j.euo.2019.05.007","title":"Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies","year":2019,"lang":"en","type":"review","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"SABR volatility model; Ablative case; Medicine; Meta-analysis; Radiation therapy; Renal cell carcinoma; Oncology; Radiosurgery; Stereotactic radiation therapy; Internal medicine; Radiology; Medical physics","score_opus":0.2666787028741161,"score_gpt":0.4176423623246922,"score_spread":0.1509636594505761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2961998542","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016338679,0.98838264,0.000084290004,0.00021457762,0.00033364922,0.0041624615,0.00025188143,0.000039054867,0.004897573],"genre_scores_gemma":[0.012422077,0.9812126,0.0007789021,0.00062204496,0.00017437979,0.0005149396,0.0008775071,0.00019553576,0.0032019946],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9909985,0.004819129,0.0019949425,0.0012342632,0.00032383614,0.0006292982],"domain_scores_gemma":[0.99099874,0.0044895452,0.002655464,0.0012051072,0.00046925468,0.00018186492],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017459274,0.0009673606,0.011955588,0.0018049917,0.00008628657,0.000010425902,0.0003894266,0.00036093176,0.00037352994],"category_scores_gemma":[0.0002981828,0.00063900335,0.0053397184,0.001085591,0.00038409134,0.000058247326,0.00015825446,0.0006175053,0.00021814258],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010445616,0.0011224073,0.00010176696,0.007926297,0.7805807,0.0009010987,0.0016363203,0.000057178113,0.000022908334,0.00007680489,0.0015848615,0.20494509],"study_design_scores_gemma":[0.0019213693,0.007820681,0.00037293564,0.000024529872,0.53049344,0.00011906606,0.000039400795,0.000016250007,0.000012854549,0.0000077457335,0.45891726,0.00025445657],"about_ca_topic_score_codex":0.000013915251,"about_ca_topic_score_gemma":0.000009114457,"teacher_disagreement_score":0.4573324,"about_ca_system_score_codex":0.00054744055,"about_ca_system_score_gemma":0.00072772073,"threshold_uncertainty_score":0.99960613},"labels":[],"label_agreement":null},{"id":"W2963065632","doi":"10.1016/j.euo.2019.06.018","title":"Metastatic Renal Cell Carcinoma Rapidly Progressive to Sunitinib: What to Do Next?","year":2019,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"Meso Scale Diagnostics; Novartis Pharma; F. Hoffmann-La Roche; Roche; GlaxoSmithKline; AstraZeneca; Ipsen; Bayer Schering; Novartis; Pfizer; Bristol-Myers Squibb","keywords":"Temsirolimus; Sunitinib; Medicine; Everolimus; Internal medicine; Renal cell carcinoma; Oncology; Discovery and development of mTOR inhibitors; Refractory (planetary science); Pazopanib; Sorafenib; Tyrosine-kinase inhibitor; Progressive disease; Cancer; Progression-free survival; Urology; PI3K/AKT/mTOR pathway; Chemotherapy","score_opus":0.030486559560012918,"score_gpt":0.29029199453445287,"score_spread":0.25980543497444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963065632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9186346,0.0020032313,0.000055831206,0.006133082,0.0008545986,0.0022148697,0.0000071214145,0.00010238934,0.069994256],"genre_scores_gemma":[0.9747337,0.00003428537,0.0033576759,0.017670123,0.00036214496,0.00010105399,0.000059679092,0.00013112421,0.0035501914],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.995728,0.0014320543,0.000615121,0.0009938384,0.00030757464,0.0009233949],"domain_scores_gemma":[0.99739325,0.00038506198,0.00021897319,0.0009542469,0.00024331312,0.0008051826],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00074551604,0.00045063687,0.0009197371,0.0004830744,0.00008912144,0.00006733123,0.00039412657,0.00012535123,0.0016858776],"category_scores_gemma":[0.00013940198,0.00038137852,0.00020178365,0.00040460963,0.00015505026,0.00018565022,0.00038804405,0.0005216371,0.015874712],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023819089,0.0056307726,0.067301854,0.00063950254,0.0015117488,0.12868789,0.025717856,0.001214084,0.340244,0.0012994433,0.06573085,0.33820292],"study_design_scores_gemma":[0.01344336,0.07593579,0.24085301,0.00009499797,0.001146782,0.00541335,0.0028697462,0.000050663366,0.021032367,0.00006521375,0.63808256,0.0010121379],"about_ca_topic_score_codex":0.00001477767,"about_ca_topic_score_gemma":0.000008092056,"teacher_disagreement_score":0.57235175,"about_ca_system_score_codex":0.00036650716,"about_ca_system_score_gemma":0.00037388032,"threshold_uncertainty_score":0.9998638},"labels":[],"label_agreement":null},{"id":"W2963861651","doi":"10.5489/cuaj.5926","title":"Review: Transplanting kidneys from donors with small renal masses — a strategy to expand the donor pool","year":2019,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Transplanting; Medicine; Biology; Agronomy","score_opus":0.0592417472447316,"score_gpt":0.2752685673032237,"score_spread":0.21602682005849208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963861651","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012497758,0.98933434,0.00003910009,0.005691985,0.00020525361,0.0018788654,0.0003424144,0.000023376488,0.0012349123],"genre_scores_gemma":[0.00038341523,0.9898352,0.00030084176,0.0073013417,0.0008651164,0.00010259693,0.0003742512,0.000056745554,0.0007804891],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964129,0.00071478676,0.00096929393,0.0005366594,0.0005351315,0.0008312406],"domain_scores_gemma":[0.99628687,0.000650648,0.0009373522,0.00037467762,0.000263968,0.001486473],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009819317,0.000578468,0.0020668157,0.00023869012,0.00028504452,0.00020999396,0.0004034691,0.0005166315,0.00068255846],"category_scores_gemma":[0.00044079145,0.00029277086,0.0007013944,0.00044196952,0.000031124415,0.00006116896,0.00002041991,0.0017182174,0.00027383532],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019116249,0.00013335732,0.020394126,0.007883912,0.004449365,0.0028904586,0.00017327162,0.000042631156,0.000003804688,0.000027142343,0.07469814,0.88911265],"study_design_scores_gemma":[0.0005643156,0.00082307373,0.0029321169,0.014149772,0.005081254,0.0011038434,0.00001960012,0.0000015884667,7.4166053e-7,0.000011876065,0.97497785,0.00033394317],"about_ca_topic_score_codex":0.0036908113,"about_ca_topic_score_gemma":0.003257362,"teacher_disagreement_score":0.9002797,"about_ca_system_score_codex":0.0020381964,"about_ca_system_score_gemma":0.0033284351,"threshold_uncertainty_score":0.99995244},"labels":[],"label_agreement":null},{"id":"W2963886807","doi":"10.1007/s00345-019-02879-4","title":"Safety of on- vs off-clamp robotic partial nephrectomy: per-protocol analysis from the data of the CLOCK randomized trial","year":2019,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Clamp; Nephrectomy; Nephrology; Randomized controlled trial; Surgery; Perioperative; Univariate analysis; Blood transfusion; Urology; Anesthesia; Internal medicine; Multivariate analysis; Kidney","score_opus":0.03250595631053722,"score_gpt":0.3027322464093869,"score_spread":0.2702262900988497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963886807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.931103,0.00090572913,0.00026809453,0.015142883,0.0011443355,0.04964189,0.000056911154,0.000008640268,0.0017284992],"genre_scores_gemma":[0.99749804,0.00003922199,0.0002601821,0.00070510176,0.0005096559,0.00057840516,0.000018006845,0.000017937957,0.00037345875],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99587023,0.0015622757,0.0014583988,0.0002609981,0.0006192804,0.00022881213],"domain_scores_gemma":[0.99379456,0.002797502,0.0016335913,0.001464133,0.00019879325,0.00011141083],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020375317,0.00020999122,0.0019803816,0.00025584002,0.00004678013,0.000008414722,0.00078893965,0.000094783536,0.0015873695],"category_scores_gemma":[0.00070488476,0.000094616684,0.0010157267,0.00052186,0.00030237148,0.00005066777,0.0002005193,0.0005649264,0.000015612806],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9716474,0.00041821404,0.016096527,0.000015056913,0.0050970493,0.00002686056,0.00016724734,0.0031606404,0.0008990652,0.00017075718,0.0009934341,0.0013077868],"study_design_scores_gemma":[0.91896844,0.0031270408,0.033620298,0.00007719785,0.013544533,0.000060260492,0.00003615804,0.0032343965,0.0012703718,0.00020792124,0.025725905,0.00012749428],"about_ca_topic_score_codex":0.00013626518,"about_ca_topic_score_gemma":0.00015044061,"teacher_disagreement_score":0.066395015,"about_ca_system_score_codex":0.000063443906,"about_ca_system_score_gemma":0.0003949772,"threshold_uncertainty_score":0.99932534},"labels":[],"label_agreement":null},{"id":"W2963960724","doi":"10.5489/cuaj.5941","title":"Outcomes and prognosticators of stage 4 renal cell carcinoma with pathological T4 primary lesion using a large Canadian multi-institutional database","year":2019,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Calgary; McMaster University; University of British Columbia; Public Health Ontario; Dalhousie University; University of Toronto; University of Alberta; Université de Montréal; University of Ottawa; University of Manitoba","funders":"","keywords":"Medicine; Interquartile range; Renal cell carcinoma; Nephrectomy; Hazard ratio; Proportional hazards model; Clear cell; Internal medicine; Pathological; Clear cell renal cell carcinoma; Cohort; Stage (stratigraphy); Log-rank test; Cancer; Kidney cancer; Surgery; Urology; Kidney; Confidence interval","score_opus":0.027772435530890666,"score_gpt":0.24091418212567386,"score_spread":0.2131417465947832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963960724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996613,0.0002938966,0.00014458937,0.001173243,0.00009322939,0.0005313385,0.00038691552,0.000011290252,0.00075246877],"genre_scores_gemma":[0.9946573,0.000014714054,0.0035379748,0.0012455127,0.000061668325,0.0000060459606,0.00014795562,0.000015696914,0.0003131683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792254,0.00017624008,0.00040591374,0.0003342094,0.00049455586,0.00066655886],"domain_scores_gemma":[0.9977021,0.00013770386,0.0003011106,0.00017401107,0.00026667144,0.0014183575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006325032,0.00024387834,0.0004990015,0.00035001413,0.00028096352,0.00004416283,0.00010401375,0.00025797193,0.0003385976],"category_scores_gemma":[0.0002650892,0.00015687455,0.00011478464,0.00019552138,0.00008309416,0.0001365109,0.000031700274,0.0005702986,0.000018098704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009796949,0.000123644,0.9965294,0.000030330588,0.000053304047,0.001201989,0.00006599412,0.00004379006,0.0015502917,0.0001141787,0.00007525837,0.00011387847],"study_design_scores_gemma":[0.003134671,0.00069820654,0.99310535,0.000030664673,0.00015169602,0.00053667085,0.000083457046,0.00043554508,0.00021522511,0.0000076037404,0.0014298426,0.00017103899],"about_ca_topic_score_codex":0.02269712,"about_ca_topic_score_gemma":0.019632265,"teacher_disagreement_score":0.003423993,"about_ca_system_score_codex":0.002129491,"about_ca_system_score_gemma":0.002699564,"threshold_uncertainty_score":0.99825686},"labels":[],"label_agreement":null},{"id":"W2964387582","doi":"10.21873/anticanres.13604","title":"Survival and Complication Rates of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma Treated Exclusively With Targeted Therapy: A Combined Population-based Analysis","year":2019,"lang":"en","type":"article","venue":"Anticancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Metastasectomy; Medicine; Renal cell carcinoma; Proportional hazards model; Hazard ratio; Perioperative; Epidemiology; Complication; Surveillance, Epidemiology, and End Results; Surgery; Population; Internal medicine; Oncology; Cancer; Metastasis; Cancer registry; Confidence interval","score_opus":0.04718862008351718,"score_gpt":0.3332828412121015,"score_spread":0.2860942211285843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964387582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99760085,0.00019925847,0.000040185063,0.00012998692,0.0000044156336,0.0017928847,0.000048910893,0.000010756967,0.0001727758],"genre_scores_gemma":[0.9984252,0.000008948583,0.0006243295,0.000016658976,0.0000041411768,0.00008539104,0.000747067,0.000029543527,0.000058710288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751604,0.00039197138,0.00032035078,0.00045921054,0.0009630582,0.00034936974],"domain_scores_gemma":[0.9982676,0.00034236474,0.00013808916,0.00044995875,0.0006740154,0.00012800469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000454613,0.0002004953,0.00068024505,0.0008347726,0.000057704437,0.000022115017,0.000090839,0.000035041983,0.00017229373],"category_scores_gemma":[0.000018712817,0.00012852765,0.00006417916,0.0022282826,0.00014313469,0.00007740735,0.000025321018,0.00019117384,0.0000045344073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007053075,0.0007519763,0.9882735,0.0001309121,0.00055411394,0.000017680004,0.00010956523,0.00027475905,0.002620765,0.000021627691,0.0000032583466,0.0001887616],"study_design_scores_gemma":[0.01314337,0.0038340653,0.95766807,0.000054222903,0.00038900157,5.958083e-7,0.00009376489,0.002187064,0.02249394,0.000008384699,0.000002228766,0.0001252928],"about_ca_topic_score_codex":0.00780671,"about_ca_topic_score_gemma":0.00053169474,"teacher_disagreement_score":0.030605437,"about_ca_system_score_codex":0.00019267968,"about_ca_system_score_gemma":0.00023416792,"threshold_uncertainty_score":0.9988004},"labels":[],"label_agreement":null},{"id":"W2964494624","doi":"10.1016/j.ajpath.2019.07.002","title":"Integrated Molecular Analysis of Papillary Renal Cell Carcinoma and Precursor Lesions Unfolds Evolutionary Process from Kidney Progenitor-Like Cells","year":2019,"lang":"en","type":"article","venue":"American Journal Of Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Health Sciences Centre; Sunnybrook Health Science Centre; McGill University Health Centre; St. Michael's Hospital; University Health Network; University of Toronto","funders":"Ontario Institute for Cancer Research; Hospital for Sick Children; Canadian Urological Oncology Group","keywords":"Progenitor cell; Pathology; Papillary renal cell carcinomas; Kidney; Progenitor; Biology; Renal stem cell; Renal cell carcinoma; Carcinoma; Kidney cancer; Stem cell; Cancer research; Medicine; Cell biology; Endocrinology","score_opus":0.007318118061585552,"score_gpt":0.24039213487936575,"score_spread":0.2330740168177802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964494624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967891,0.0019961717,0.00023971213,0.00017908531,0.00012493638,0.00028339212,0.0001031495,0.000009464909,0.0002749625],"genre_scores_gemma":[0.9941549,0.00010476624,0.0052425303,0.00024994166,0.00004799965,0.000007132912,0.00008247558,0.000027969128,0.000082298364],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979965,0.0003038942,0.000699458,0.00033567104,0.0003916536,0.0002728021],"domain_scores_gemma":[0.9977185,0.00012318589,0.00089007145,0.00035509435,0.00051692885,0.0003961812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018710039,0.00025097135,0.0011453934,0.00064668164,0.000030369534,0.0000064823007,0.00016558502,0.00010455813,0.00012973185],"category_scores_gemma":[0.000049671387,0.00019062744,0.00035949858,0.00093567534,0.00037671166,0.00006884103,0.000050674367,0.0003199579,0.000008766814],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008718826,0.0004065505,0.30272248,0.000059866317,0.0011701945,0.0025228322,0.0008189803,0.00014870893,0.68863124,0.0000050089075,0.00021312834,0.0024291407],"study_design_scores_gemma":[0.003731717,0.012527116,0.5384234,0.00020748349,0.010535993,0.0020687531,0.0030359677,0.0008898202,0.42771634,0.00009177194,0.00034388027,0.00042770943],"about_ca_topic_score_codex":0.00011097091,"about_ca_topic_score_gemma":0.0000020252542,"teacher_disagreement_score":0.26091486,"about_ca_system_score_codex":0.000119449105,"about_ca_system_score_gemma":0.00058428815,"threshold_uncertainty_score":0.77735615},"labels":[],"label_agreement":null},{"id":"W2964828849","doi":"10.1200/jco.2013.31.15_suppl.4578","title":"Treatment response and survival outcome of patients with late relapse (LR) from renal cell carcinoma (RCC) in the era of targeted therapy.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; BC Cancer Agency; Princess Margaret Cancer Centre; University of Toronto; Cancer Care Ontario; Sunnybrook Health Science Centre; Baker Hughes (Canada)","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Nephrectomy; Targeted therapy; Oncology; Disease; Demographics; Systemic therapy; Surgery; Cancer; Kidney; Breast cancer","score_opus":0.07836846042718823,"score_gpt":0.3691284710228253,"score_spread":0.29076001059563705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964828849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574804,0.0008023808,0.0000027238184,0.0024122335,0.00019848568,0.0005655156,0.000016408623,0.0000022470576,0.00025194357],"genre_scores_gemma":[0.998029,0.00026994591,0.0011869988,0.00027225085,0.00010739743,0.000009151299,0.000008169993,0.000017487591,0.000099581215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951236,0.0016682614,0.002319706,0.00020175331,0.00048435095,0.0002022947],"domain_scores_gemma":[0.9925075,0.0046981294,0.0018433966,0.00032887145,0.00041209554,0.000210015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017720355,0.00020343637,0.0016670908,0.000115850584,0.00002037784,0.0000052752002,0.00015602725,0.00024617164,0.000119438046],"category_scores_gemma":[0.00055481587,0.00009432204,0.0003191548,0.00013641226,0.00023101945,0.00008038593,0.000029870807,0.0006310515,0.0000042810584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03914465,0.003851837,0.94469565,0.000010750382,0.00024731064,0.00038383476,0.0006716405,0.000009194434,0.001393055,0.0000020817429,0.000079144185,0.009510867],"study_design_scores_gemma":[0.026360797,0.053748496,0.91768855,0.000035211375,0.00027834854,0.000020090372,0.00017883077,0.000015595391,0.0010944423,0.000049758008,0.0004588546,0.00007103867],"about_ca_topic_score_codex":0.00067023624,"about_ca_topic_score_gemma":0.000068922214,"teacher_disagreement_score":0.049896657,"about_ca_system_score_codex":0.00015266512,"about_ca_system_score_gemma":0.0005512489,"threshold_uncertainty_score":0.3846341},"labels":[],"label_agreement":null},{"id":"W2965181224","doi":"10.1259/bjr.20190507","title":"Validation of Region of Interest Measurements for the Objective Assessment of Post-Contrast Enhancement of Renal Lesions on MRI","year":2019,"lang":"en","type":"article","venue":"British Journal of Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital; McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncocytoma; Nephrectomy; Renal oncocytoma; Region of interest; Radiology; Papillary renal cell carcinomas; Nuclear medicine; Biopsy; Magnetic resonance imaging; Chromophobe cell; Kidney; Clear cell; Pathology; Internal medicine","score_opus":0.06794839065729565,"score_gpt":0.31533225735839004,"score_spread":0.2473838667010944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965181224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99300855,0.0011773546,0.0041654496,0.00021832298,0.0002659491,0.0007358019,0.000025850723,0.0000011664677,0.00040155265],"genre_scores_gemma":[0.9983426,0.00046117435,0.0010294655,0.000027984905,0.00006186139,0.000009515115,0.000013810068,0.0000107958585,0.00004284298],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983811,0.0001926188,0.0008775929,0.00012600621,0.00029265322,0.00013003057],"domain_scores_gemma":[0.99697965,0.00037108903,0.0013604789,0.00018294003,0.0010576382,0.000048224178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073223474,0.00010193707,0.0006588966,0.00014578478,0.000020378455,0.0000023565935,0.00013310637,0.000073100884,0.000042834487],"category_scores_gemma":[0.00019334987,0.00007732446,0.00026819124,0.00007621487,0.00012317003,0.000045285644,0.000019442414,0.0001555758,3.0644668e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033241892,0.0011779813,0.025441948,0.00031537298,0.0015783213,0.000054568,0.00029528447,0.00040706692,0.9560941,0.0003386072,0.00096217106,0.010010377],"study_design_scores_gemma":[0.0055365385,0.012052804,0.32747474,0.0016881356,0.0005271574,0.0033991036,0.000352403,0.000053148113,0.6487172,0.00011075863,0.000023965671,0.00006403666],"about_ca_topic_score_codex":0.00008622275,"about_ca_topic_score_gemma":0.000013925494,"teacher_disagreement_score":0.30737692,"about_ca_system_score_codex":0.00018648717,"about_ca_system_score_gemma":0.00023397355,"threshold_uncertainty_score":0.31532},"labels":[],"label_agreement":null},{"id":"W2965555268","doi":"10.1016/j.clon.2019.07.010","title":"Application of Hereditary Renal Cell Carcinoma Risk Criteria to a Large Prospective Database","year":2019,"lang":"en","type":"article","venue":"Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta; Children's Hospital of Eastern Ontario; Queen Elizabeth II Health Sciences Centre; Juravinski Cancer Centre; McMaster University; Western University; McGill University; University of Ottawa; Impact; Université Laval; Centre Hospitalier de l’Université de Montréal; Ottawa Hospital; University Health Network; University of Calgary; Princess Margaret Cancer Centre","funders":"Movember Canada; Canada Foundation for Innovation; Prostate Cancer Canada; Astellas Pharma Canada; Ipsen; Novartis; Cancer Research Society; Canadian Urological Association Scholarship Fund; Pfizer","keywords":"Medicine; Renal cell carcinoma; Genetic testing; Population; Prospective cohort study; Risk assessment; Incidence (geometry); Database; Germline mutation; Cancer; Internal medicine; Mutation; Genetics; Environmental health","score_opus":0.042525982473637876,"score_gpt":0.3926194390986155,"score_spread":0.35009345662497765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965555268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855978,0.00020060853,0.00082650786,0.0004501785,0.00046463372,0.0017498409,0.00014345557,0.000031060114,0.010535954],"genre_scores_gemma":[0.99248356,0.000020587095,0.0051940596,0.0006934372,0.00052728096,0.00012495284,0.00015051194,0.000025929989,0.00077970966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977835,0.00027797036,0.00082691724,0.00060132286,0.000213391,0.0002969102],"domain_scores_gemma":[0.9976788,0.00065357424,0.00032366355,0.000789942,0.00021581253,0.00033817618],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000920245,0.00016894937,0.00081250543,0.00008598896,0.000028347118,0.0000027624055,0.00014616988,0.00024735343,0.00034738934],"category_scores_gemma":[0.00033362443,0.0001366559,0.00021562727,0.00018542293,0.00009308388,0.000046647412,0.000177117,0.00040798617,0.0008672391],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029100897,0.0028034113,0.9675633,0.0001157316,0.0000785517,0.00020270613,0.00016685248,0.0000022738072,0.013172816,0.00012649516,0.0068104905,0.006047281],"study_design_scores_gemma":[0.006051361,0.011554383,0.9558898,0.000024123236,0.00030178894,0.00003991339,0.00011853918,0.00033037493,0.008547063,0.00011171817,0.016901178,0.00012974624],"about_ca_topic_score_codex":0.00016429041,"about_ca_topic_score_gemma":0.000038240498,"teacher_disagreement_score":0.011673489,"about_ca_system_score_codex":0.0002401681,"about_ca_system_score_gemma":0.00034424808,"threshold_uncertainty_score":0.9999107},"labels":[],"label_agreement":null},{"id":"W2966320079","doi":"10.1200/jco.2012.30.15_suppl.tps4686","title":"A phase II biomarker assessment of tivozanib in oncology (BATON) trial in patients (pts) with advanced renal cell carcinoma (RCC).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Oncology; Renal cell carcinoma; Clear cell renal cell carcinoma; Biomarker; Phases of clinical research; Clinical trial; Urology; Adverse effect","score_opus":0.11395758188849721,"score_gpt":0.47421493936191306,"score_spread":0.36025735747341586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966320079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98775196,0.00034285366,0.00002168057,0.00075484655,0.0011168636,0.00065125746,0.0000065452705,0.000004448721,0.009349554],"genre_scores_gemma":[0.99274105,0.00010599698,0.0061221854,0.00035101423,0.00045937867,0.000028951776,0.000014345122,0.000030986645,0.00014609793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931421,0.001249758,0.004039115,0.0003059289,0.00069075124,0.0005723025],"domain_scores_gemma":[0.99363476,0.0018733277,0.0031005465,0.00032144363,0.00045050945,0.0006194129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004360414,0.0002896453,0.002762687,0.000512457,0.000028690929,0.0000031082743,0.00020393917,0.0005562156,0.00017374867],"category_scores_gemma":[0.0008616283,0.0001933261,0.00046371846,0.00038427892,0.0002568932,0.0002307929,0.00010603538,0.0012911974,0.000005525741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2875815,0.07802853,0.45377442,0.000055967805,0.00018844432,0.0009867232,0.0002652113,0.000011448949,0.0009564326,0.000017536579,0.00034464864,0.17778914],"study_design_scores_gemma":[0.3143391,0.18419331,0.4940133,0.00009251005,0.00027807464,0.00008044264,0.00009603734,0.00003221916,0.0004938344,0.000008744088,0.0062613613,0.00011106594],"about_ca_topic_score_codex":0.00004241427,"about_ca_topic_score_gemma":0.0000777364,"teacher_disagreement_score":0.17767806,"about_ca_system_score_codex":0.001324412,"about_ca_system_score_gemma":0.0032493784,"threshold_uncertainty_score":0.78836095},"labels":[],"label_agreement":null},{"id":"W2966520977","doi":"10.21037/atm.2019.07.47","title":"Stereotactic body radiotherapy for oligometastatic renal cell carcinoma—are we ready to roll?","year":2019,"lang":"en","type":"letter","venue":"Annals of Translational Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Renal cell carcinoma; Medicine; Radiation therapy; Radiosurgery; Oncology; Internal medicine","score_opus":0.11941833290917853,"score_gpt":0.35485498003513305,"score_spread":0.23543664712595452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966520977","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012343888,0.011973704,0.0010077975,0.96657777,0.0005779072,0.0042046625,0.00086898106,0.000046555902,0.0023987119],"genre_scores_gemma":[0.18685684,0.0011229761,0.0054022223,0.7682826,0.009084843,0.00052175455,0.0063655623,0.00042374214,0.021939477],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99516803,0.00016329614,0.0013402232,0.00091599696,0.0016677271,0.0007447385],"domain_scores_gemma":[0.9956937,0.001468502,0.0007127165,0.0009311153,0.0008983935,0.00029558945],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005238198,0.000802109,0.0021780224,0.0010348391,0.00006800381,0.000014291129,0.00032885795,0.00056015607,0.0006270146],"category_scores_gemma":[0.000097407596,0.00060908013,0.0005869648,0.00041668527,0.00016211337,0.00010317279,0.000015516356,0.00087497814,0.00005280558],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002092457,0.00025599624,0.0014455785,0.0044246614,0.0010958217,0.00044210325,0.0007239452,0.0000591422,0.005703844,0.000027229044,0.9826247,0.0011045],"study_design_scores_gemma":[0.009276529,0.008763517,0.012529211,0.0020850045,0.0018978193,0.00018577774,0.00004935817,0.00018144661,0.0069022533,0.0003966588,0.9570509,0.00068152],"about_ca_topic_score_codex":0.000110385234,"about_ca_topic_score_gemma":0.000005331166,"teacher_disagreement_score":0.1982952,"about_ca_system_score_codex":0.000104515835,"about_ca_system_score_gemma":0.00042267083,"threshold_uncertainty_score":0.99963605},"labels":[],"label_agreement":null},{"id":"W2967350775","doi":"10.1016/s1470-2045(19)30413-9","title":"Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":780,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Calgary","funders":"Cilag; Foundation Medicine; Pharmacyclics; EMD Serono; Genentech; Astellas Pharma; Eisai; Jounce Therapeutics; Acceleron; Chugai Pharmaceutical; Horizon Pharma; National Cancer Institute; Intuitive Surgical; Gilead Sciences; Calithera Biosciences; Celldex Therapeutics; Ipsen; Array BioPharma; Center for Outcomes Research and Evaluation, Yale School of Medicine; Bayer HealthCare; Society of Memorial Sloan Kettering; Exelixis; Sanofi; Bristol-Myers Squibb; Ono Pharmaceutical; Eli Lilly and Company; EUSA Pharma; AstraZeneca; Memorial Sloan-Kettering Cancer Center; GlaxoSmithKline; Agilent Technologies; Amgen; Pfizer","keywords":"Nivolumab; Sunitinib; Ipilimumab; Medicine; Renal cell carcinoma; Internal medicine; Oncology; Carcinoma; First line; Randomized controlled trial; Clinical trial; Immunotherapy; Cancer","score_opus":0.06296786444902643,"score_gpt":0.34241897178061087,"score_spread":0.27945110733158446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967350775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801894,0.0013050522,0.000030348023,0.0014522342,0.00080712367,0.0112564135,0.00046515212,0.000031823853,0.0044624624],"genre_scores_gemma":[0.9956458,0.0004472919,0.0006269198,0.00007693384,0.00058635836,0.00077586423,0.0005426728,0.00003808766,0.0012600663],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971778,0.00044066945,0.0010393271,0.0005833267,0.00023035619,0.00052853534],"domain_scores_gemma":[0.9916437,0.0067783403,0.00053656794,0.0007737587,0.00012289101,0.0001446948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008401435,0.00037509718,0.0025836753,0.00012306713,0.00008280694,0.000008682581,0.00018028746,0.00021192098,0.000073409145],"category_scores_gemma":[0.00055631687,0.00023557091,0.00034345879,0.00013793206,0.00015265285,0.00004555048,0.000059193077,0.00022298613,0.0000118925],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9803102,0.0018927617,0.000041308987,0.000055382763,0.00036735713,0.00011223228,0.001468691,0.00017086399,0.004216969,0.000035349738,0.00013447217,0.011194413],"study_design_scores_gemma":[0.9404457,0.046234738,0.000759444,0.000062304454,0.0010507778,0.000014779998,0.00031431898,0.001095534,0.0053685657,0.00005487749,0.0044159917,0.00018297281],"about_ca_topic_score_codex":0.00053970533,"about_ca_topic_score_gemma":0.000841362,"teacher_disagreement_score":0.044341974,"about_ca_system_score_codex":0.000909349,"about_ca_system_score_gemma":0.00052537327,"threshold_uncertainty_score":0.9606303},"labels":[],"label_agreement":null},{"id":"W2967728988","doi":"10.1016/s1879-8497(19)90772-2","title":"10.1016/s1879-8497(19)90772-2","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.011655124841885143,"score_gpt":0.2011743788287167,"score_spread":0.18951925398683156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967728988","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014832868,0.00030293278,3.8927251e-7,0.00088589586,0.0000015042185,0.0004544007,0.000009242977,0.00015572224,0.9833571],"genre_scores_gemma":[0.002705844,7.354597e-7,0.00027040098,0.000158753,0.00021030071,0.000042739084,0.000045209053,0.00004124948,0.99652475],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988076,0.00003311738,0.00021154972,0.0003139672,0.00030004527,0.00033371497],"domain_scores_gemma":[0.99897057,0.000042824195,0.000026095058,0.0004930263,0.000048973587,0.00041849617],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000093522365,0.00020005862,0.00029668695,0.00009611944,0.000057044963,0.000019971008,0.00010789176,0.00007563412,0.99782753],"category_scores_gemma":[0.000031560638,0.0001664778,0.00012077489,0.00020484882,0.000035542464,0.00004610416,0.00002888535,0.00012299298,0.9974068],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005594999,0.00021216618,0.000003237768,0.000024582378,0.00007765035,0.00028231688,0.00003700169,0.000022844955,0.00041373144,5.892704e-7,0.45296484,0.5454016],"study_design_scores_gemma":[0.0009752842,0.00078402366,0.00079053233,0.000037493257,0.000117203526,0.00016896635,0.000001291931,0.000049697126,0.0012346776,0.0000043604414,0.99567467,0.00016178553],"about_ca_topic_score_codex":0.000055176777,"about_ca_topic_score_gemma":1.6974215e-7,"teacher_disagreement_score":0.54523975,"about_ca_system_score_codex":0.0001647315,"about_ca_system_score_gemma":0.0000707794,"threshold_uncertainty_score":0.67887676},"labels":[],"label_agreement":null},{"id":"W2969428138","doi":"10.5489/cuaj.6176","title":"Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of renal mass biopsy in the management of kidney cancer","year":2019,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Calgary; Impact; Université de Montréal; Université Laval; University of Manitoba; Ottawa Hospital; Western University; Université de Sherbrooke; McMaster University; Alberta Kidney Disease Network; Ontario Clinical Oncology Group; Dalhousie University; McGill University; University of Ottawa","funders":"","keywords":"Kidney cancer; Kidney; Cancer; Medicine; Renal mass; Biopsy; Statement (logic); Pathology; Urology; Internal medicine; Nephrectomy; Political science","score_opus":0.028507303369727146,"score_gpt":0.2810360067436674,"score_spread":0.2525287033739403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969428138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9244327,0.00055604754,7.1832636e-7,0.06755622,0.00021173457,0.00068351324,0.00019998265,0.0000016684575,0.0063574477],"genre_scores_gemma":[0.995939,0.00022355677,0.00005440072,0.0030557238,0.000116098796,0.00004455507,0.000011046425,0.000009687991,0.00054593745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966996,0.00064434024,0.0006160576,0.00017981486,0.0012107197,0.0006495009],"domain_scores_gemma":[0.9978014,0.00040580332,0.00049567426,0.00024133975,0.00048197227,0.00057377224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028819519,0.0001352515,0.00035011672,0.00011469674,0.0001257209,0.000013870121,0.00025937456,0.00010272181,0.00090948615],"category_scores_gemma":[0.00032618822,0.000075257194,0.0000961591,0.000504272,0.000069355825,0.0000142589715,0.000024709792,0.00061964255,0.0000026494563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045340354,0.00009964994,0.87414116,0.00006860882,0.0007863491,0.00020379294,0.00039777358,0.0035737837,0.0013895287,0.0019528088,0.11623321,0.0006999108],"study_design_scores_gemma":[0.0024406852,0.0008673444,0.9110488,0.0005669883,0.00022198769,0.000029507057,0.002081842,0.00038108436,0.001957933,0.0016912292,0.07854353,0.0001690273],"about_ca_topic_score_codex":0.423465,"about_ca_topic_score_gemma":0.16805367,"teacher_disagreement_score":0.25541136,"about_ca_system_score_codex":0.0032890087,"about_ca_system_score_gemma":0.005264013,"threshold_uncertainty_score":0.9958235},"labels":[],"label_agreement":null},{"id":"W2969581577","doi":"10.1016/j.clgc.2019.08.004","title":"Towards Comprehensive Clinical Trial Reporting: The Value of Unpublished Data to Inform Therapeutic Decision-Making in Metastatic Renal Cell Carcinoma","year":2019,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Pfizer Canada; Ipsen Biopharmaceuticals; Novartis; Pfizer","keywords":"Medicine; Renal cell carcinoma; Clinical trial; Oncology; Clinical decision making; Intensive care medicine; Genitourinary system; Kidney cancer; Internal medicine; Overall survival","score_opus":0.2945977963045506,"score_gpt":0.483884615773327,"score_spread":0.1892868194687764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969581577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889578,0.0018060273,0.000076647404,0.0014272345,0.0023847609,0.0031776323,0.000046793382,0.000028991099,0.00209411],"genre_scores_gemma":[0.99181694,0.00018016856,0.004255612,0.0022276903,0.00093688373,0.00010119059,0.000055799188,0.000056517245,0.00036920945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99121875,0.0006429857,0.0054502035,0.0011024675,0.0010263064,0.00055929756],"domain_scores_gemma":[0.9896824,0.004354527,0.0021689425,0.0029848912,0.00044611705,0.00036315207],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004504848,0.0004022381,0.0018042865,0.00021137306,0.00007413501,0.000048007452,0.0010387931,0.000240378,0.00039655963],"category_scores_gemma":[0.00291837,0.00025071646,0.00065095036,0.00078274944,0.00024315418,0.00021811416,0.0010577342,0.0010663004,0.000080525104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13035011,0.0035155283,0.5974616,0.00040109106,0.00086054293,0.0017983598,0.00059584045,0.0009342903,0.0005180047,0.00004166641,0.0076633324,0.25585967],"study_design_scores_gemma":[0.03972178,0.007750677,0.93446237,0.00041841887,0.00077919016,0.00008932226,0.0004449389,0.0017767521,0.0002884455,0.00024457806,0.013660654,0.0003628493],"about_ca_topic_score_codex":0.00021419248,"about_ca_topic_score_gemma":0.00003918679,"teacher_disagreement_score":0.33700082,"about_ca_system_score_codex":0.00022510457,"about_ca_system_score_gemma":0.001864779,"threshold_uncertainty_score":0.9999945},"labels":[],"label_agreement":null},{"id":"W2969712092","doi":"10.1016/j.eururo.2019.07.048","title":"First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Hospital; Queen Elizabeth II Health Sciences Centre; CancerCare Manitoba; University of Calgary","funders":"National Cancer Institute; Foundation Medicine; Pfizer Japan; Novartis Pharma; EMD Serono; Genentech; Ipsen; Alexion Pharmaceuticals; Eisai; National Comprehensive Cancer Network; Sanofi; Exelixis; GlaxoSmithKline; Astellas Pharma; Celldex Therapeutics; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Renal cell carcinoma; Oncology; Internal medicine; Metastasis; Carcinoma; Cancer","score_opus":0.03263677506092706,"score_gpt":0.26286220185634424,"score_spread":0.2302254267954172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969712092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96069854,0.0032947443,0.00014815934,0.008544776,0.0008177896,0.0013482947,0.0003738864,0.000065577915,0.02470824],"genre_scores_gemma":[0.9909528,0.0001987306,0.0010960199,0.0024738899,0.00018359479,0.000052341973,0.0023278943,0.00010971587,0.0026050233],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99457407,0.0018953362,0.0013021632,0.0010426297,0.00055077055,0.00063502026],"domain_scores_gemma":[0.9953083,0.0021807905,0.00066799845,0.0014292648,0.00023727851,0.00017640146],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017331628,0.00053176004,0.00084552425,0.0003597005,0.00012517394,0.000050211715,0.00071863475,0.0000857349,0.0006929453],"category_scores_gemma":[0.00037330997,0.00038773502,0.00023395865,0.0003323891,0.00029256035,0.0001723119,0.00042454287,0.00073148194,0.001125038],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044422325,0.016746003,0.2973049,0.00061731547,0.002975732,0.037891604,0.03154795,0.0047378517,0.5061282,0.0017709917,0.047770947,0.008086187],"study_design_scores_gemma":[0.081935294,0.011349012,0.7313468,0.00011100681,0.0021874823,0.0010290392,0.0018625802,0.007039044,0.035877828,0.0005740468,0.12543544,0.0012524588],"about_ca_topic_score_codex":0.0011030366,"about_ca_topic_score_gemma":0.0003859098,"teacher_disagreement_score":0.47025037,"about_ca_system_score_codex":0.00035224896,"about_ca_system_score_gemma":0.0002683061,"threshold_uncertainty_score":0.9998574},"labels":[],"label_agreement":null},{"id":"W2970444068","doi":"10.1002/ijc.32650","title":"Searching for prognostic biomarkers for small renal masses in the urinary proteome","year":2019,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Hospital for Sick Children; St. Michael's Hospital; Mount Sinai Hospital","funders":"Kidney Foundation of Canada; Canadian Institutes of Health Research; Canadian Urological Oncology Group","keywords":"Renal cell carcinoma; Oncocytoma; Clear cell renal cell carcinoma; Biomarker; Renal mass; Medicine; Clear cell; Proteome; Stage (stratigraphy); Renal oncocytoma; Urinary system; Proteomics; Chromophobe cell; Nephrectomy; Internal medicine; Pathology; Kidney; Oncology; Biology; Bioinformatics","score_opus":0.04409965204785378,"score_gpt":0.35773285514168895,"score_spread":0.3136332030938352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970444068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886127,0.0010350244,0.00085076387,0.007080646,0.00047440338,0.0014127409,0.000017290162,0.0000032027292,0.0005132052],"genre_scores_gemma":[0.99413323,0.00005283163,0.0044665453,0.00032714286,0.0005515026,0.00021304037,0.0000085680485,0.00001413806,0.00023299536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990222,0.000031597618,0.0003003982,0.00010258186,0.0004016944,0.00014155006],"domain_scores_gemma":[0.9989154,0.00036388266,0.00019896965,0.00007563396,0.00040235388,0.000043758555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047367706,0.000084915984,0.00016175983,0.0001892256,0.00001843448,0.000033512053,0.00022312006,0.000029306098,0.000054222764],"category_scores_gemma":[0.00013523398,0.000051014755,0.00017306452,0.000057720772,0.000022632,0.00008075245,0.000017664266,0.00012776339,0.0000021348533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02705696,0.0014998361,0.79537225,0.0007854954,0.004212288,0.0011140215,0.0022559937,0.0012711951,0.07987319,0.0013605123,0.0025320603,0.08266618],"study_design_scores_gemma":[0.023501394,0.008164701,0.8423244,0.0032196655,0.0006033954,0.0028699052,0.00084462954,0.0023512582,0.028540801,0.0049496163,0.08227756,0.00035272833],"about_ca_topic_score_codex":0.000032484346,"about_ca_topic_score_gemma":0.000016596252,"teacher_disagreement_score":0.082313456,"about_ca_system_score_codex":0.00026621917,"about_ca_system_score_gemma":0.00029066717,"threshold_uncertainty_score":0.20803215},"labels":[],"label_agreement":null},{"id":"W2970752549","doi":"10.1093/jscr/rjz257","title":"Very late locally recurrent chromophobe renal cell carcinoma: 15 years following radical nephrectomy for low-stage disease","year":2019,"lang":"en","type":"article","venue":"Journal of Surgical Case Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Stage (stratigraphy); Chromophobe cell; Disease; Histology; Surgery; Clear cell; Kidney; Pathology; Internal medicine","score_opus":0.015142443007074891,"score_gpt":0.261054738047779,"score_spread":0.2459122950407041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970752549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920789,0.004616109,0.000046669884,0.0002900132,0.001274747,0.0009038477,0.000014603649,0.000025989091,0.0007490988],"genre_scores_gemma":[0.99687076,0.000111669026,0.00070885743,0.000094017094,0.0006378625,0.000017353732,0.000032258704,0.00006761874,0.0014596176],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99618435,0.00011511687,0.0015116271,0.00050262053,0.0011134638,0.0005728475],"domain_scores_gemma":[0.9966426,0.00029928808,0.0009031625,0.00054448406,0.00026872085,0.0013417487],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010827458,0.00037347738,0.001067757,0.00026563538,0.00007682959,0.00005523396,0.00007842541,0.00017843492,0.00035046105],"category_scores_gemma":[0.00011636352,0.0002873395,0.0015430978,0.0002399394,0.00007386822,0.00023940175,0.00007359607,0.0005936093,0.000022958477],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035548152,0.0007779004,0.027285473,0.00039392058,0.00018950182,0.96340585,0.000081874074,0.00014820175,0.002030638,0.0000056378726,0.0010631469,0.0010630641],"study_design_scores_gemma":[0.030453516,0.0073962505,0.046885565,0.0018110059,0.0033196062,0.6970219,0.00018344061,0.0010126891,0.013662927,0.00012897664,0.19686146,0.001262682],"about_ca_topic_score_codex":0.00002409501,"about_ca_topic_score_gemma":0.0000019146987,"teacher_disagreement_score":0.26638395,"about_ca_system_score_codex":0.00052503723,"about_ca_system_score_gemma":0.0009568375,"threshold_uncertainty_score":0.99995786},"labels":[],"label_agreement":null},{"id":"W2971049787","doi":"10.1007/s11255-019-02266-3","title":"Unmarried status is a barrier for access to treatment in patients with metastatic renal cell carcinoma","year":2019,"lang":"en","type":"article","venue":"International Urology and Nephrology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Metastasectomy; Renal cell carcinoma; Nephrectomy; Nephrology; Internal medicine; Systemic therapy; Logistic regression; Marital status; Epidemiology; Performance status; Oncology; Urology; Cancer; Metastasis; Kidney; Population; Breast cancer","score_opus":0.015742779891782733,"score_gpt":0.27261017038956836,"score_spread":0.2568673904977856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971049787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943624,0.00009623314,0.00007326372,0.002665979,0.00015730142,0.0014286558,0.00010215229,0.00001063519,0.0011033888],"genre_scores_gemma":[0.9909327,0.0000076967,0.0005435405,0.0073472876,0.000038447077,0.000259632,0.00014367896,0.000020357234,0.0007066613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878913,0.000052254705,0.00023472203,0.0004450341,0.00013891768,0.00033993402],"domain_scores_gemma":[0.9992725,0.000172764,0.00007605258,0.00018821345,0.00012597218,0.00016446383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000062282794,0.00019870931,0.0003632817,0.00029363023,0.000026923173,0.000013000662,0.00009897625,0.0000910705,0.0004547035],"category_scores_gemma":[0.000016799031,0.00014502145,0.000055396908,0.000079530204,0.00006281751,0.000080252525,0.000057404228,0.000092952585,0.000039969684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013570331,0.00041079702,0.98296857,0.000015864305,0.00024564588,0.00006447961,0.00040443457,0.000048051443,0.00080349145,0.00016375688,0.00030566976,0.0009989071],"study_design_scores_gemma":[0.015232646,0.010350649,0.95374525,0.0000038692942,0.00017243534,0.000032383505,0.00001627986,0.0002525765,0.0021692833,0.0002226337,0.017672198,0.00012982033],"about_ca_topic_score_codex":0.00013592107,"about_ca_topic_score_gemma":0.00012457206,"teacher_disagreement_score":0.029223345,"about_ca_system_score_codex":0.00015916786,"about_ca_system_score_gemma":0.00012036898,"threshold_uncertainty_score":0.5913803},"labels":[],"label_agreement":null},{"id":"W2971977157","doi":"10.12998/wjcc.v7.i17.2487","title":"Systematic review of ablative therapy for the treatment of renal allograft neoplasms","year":2019,"lang":"en","type":"article","venue":"World Journal of Clinical Cases","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiofrequency ablation; Cryoablation; Nephrectomy; Asymptomatic; Irreversible electroporation; Checklist; Surgery; Radiology; General surgery; Ablation; Kidney; Internal medicine","score_opus":0.09648479395322007,"score_gpt":0.40978450591080956,"score_spread":0.3132997119575895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971977157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6539818,0.33857608,0.00007283083,0.0020345587,0.00047803632,0.0042900085,0.000026149077,0.0000058308633,0.0005346918],"genre_scores_gemma":[0.89843214,0.09820482,0.00091351866,0.0005489925,0.00023723782,0.00003935514,0.00000421031,0.000020433474,0.0015992718],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99636644,0.00030427185,0.0025918358,0.00013656932,0.00045826565,0.0001425896],"domain_scores_gemma":[0.98675275,0.009759347,0.002333682,0.0004289594,0.00059883454,0.00012644788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015455354,0.00018049324,0.0021932167,0.00010219953,0.000021673775,0.0000047161825,0.00013739917,0.00004659805,0.0001754532],"category_scores_gemma":[0.0010184712,0.00007803621,0.0015481565,0.0001860792,0.00012429933,0.000040825875,0.0000091730435,0.00013324886,0.000004808861],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052783597,0.02545381,0.17706256,0.6218118,0.04515706,0.002345714,0.0017540613,0.00019882039,0.0030979211,0.001256507,0.01592971,0.05314841],"study_design_scores_gemma":[0.046605013,0.17806706,0.06388367,0.6204439,0.027507279,0.0038920615,0.0007095336,0.00021297202,0.028849065,0.00034893057,0.028858438,0.0006221062],"about_ca_topic_score_codex":0.000012613375,"about_ca_topic_score_gemma":0.000010621151,"teacher_disagreement_score":0.24445035,"about_ca_system_score_codex":0.000059503673,"about_ca_system_score_gemma":0.0002309137,"threshold_uncertainty_score":0.31822243},"labels":[],"label_agreement":null},{"id":"W2972974117","doi":"10.1016/j.ijrobp.2020.06.014","title":"Stereotactic Ablative Radiotherapy for ≥T1b Primary Renal Cell Carcinoma: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK)","year":2020,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Cancer Care Ontario; McMaster University; University of Toronto; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Renal function; SABR volatility model; Urology; Radiosurgery; Kidney cancer; Cohort; Proportional hazards model; Internal medicine; Oncology; Nephrectomy; Radiation therapy; Kidney","score_opus":0.03780531573288261,"score_gpt":0.3224204931082309,"score_spread":0.2846151773753483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972974117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7490955,0.0027031542,0.12052252,0.112239495,0.008839712,0.002747896,0.0013362452,0.00009638975,0.0024190769],"genre_scores_gemma":[0.94736946,0.00042792555,0.019922791,0.020485867,0.009815493,0.00017395132,0.0015375862,0.00008701338,0.00017990761],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966816,0.00030645626,0.0015749102,0.00055330415,0.0005074513,0.00037633226],"domain_scores_gemma":[0.9918403,0.0032637068,0.0026493706,0.000278903,0.001562429,0.00040531452],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008760463,0.00039270986,0.0010329271,0.0001464921,0.00013679791,0.00005619043,0.0006876197,0.00035725842,0.00012985738],"category_scores_gemma":[0.001343074,0.00029884328,0.0008078219,0.00015321022,0.000265947,0.00030574508,0.00008906379,0.0006156115,0.000011209858],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026379174,0.002802746,0.4803445,0.00009127555,0.01161099,0.0017348623,0.004914775,0.00058204174,0.18988104,0.0020432104,0.18997532,0.08964004],"study_design_scores_gemma":[0.03790463,0.0081799915,0.058074385,0.00009553849,0.0015589918,0.002289605,0.00035280353,0.0065934397,0.03545487,0.0034902515,0.8453813,0.0006241999],"about_ca_topic_score_codex":0.000034826004,"about_ca_topic_score_gemma":0.0000024897367,"teacher_disagreement_score":0.655406,"about_ca_system_score_codex":0.0025611229,"about_ca_system_score_gemma":0.003048704,"threshold_uncertainty_score":0.99994636},"labels":[],"label_agreement":null},{"id":"W2973030304","doi":"10.1038/s41598-019-49250-6","title":"Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients","year":2019,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Surveillance, Epidemiology, and End Results; Renal cell carcinoma; Nephrectomy; Epidemiology; Framingham Risk Score; Clinical endpoint; Population; Clear cell renal cell carcinoma; Internal medicine; Database; Risk stratification; Oncology; Clinical trial; Cancer registry; Kidney; Disease","score_opus":0.0326014146298002,"score_gpt":0.2582809852906116,"score_spread":0.2256795706608114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973030304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961847,0.0002138719,0.000004630483,0.00033424725,0.0010136485,0.0017257942,0.00006847086,0.000016242562,0.0004383854],"genre_scores_gemma":[0.9975089,0.0000058863156,0.00021562823,0.000040860894,0.00003226849,0.000019789373,0.0003651592,0.00001747443,0.0017940671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99640566,0.00049944397,0.0011333153,0.000984123,0.00062639336,0.00035105055],"domain_scores_gemma":[0.9972208,0.00048938364,0.00064789876,0.0012633093,0.00018455723,0.00019401149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042979806,0.00024063743,0.0005786219,0.00016071253,0.00012361843,0.000049426562,0.00014152956,0.000069686466,0.00001528566],"category_scores_gemma":[0.0013456455,0.00013054415,0.000084984116,0.000627374,0.0003529972,0.00009801323,0.00019363768,0.00019176184,0.0000029297732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004396423,0.0001159847,0.9816167,0.000079810336,0.000015623309,0.00026561783,0.0004134027,0.00008396949,0.015774636,0.000010918613,0.00096629193,0.00021740714],"study_design_scores_gemma":[0.0019178485,0.00026837195,0.96505105,0.00014972572,0.00004624422,0.00018601296,0.00004471118,0.00010902602,0.03170792,0.00013110791,0.00026048193,0.00012747703],"about_ca_topic_score_codex":0.0013223875,"about_ca_topic_score_gemma":0.00044665977,"teacher_disagreement_score":0.016565623,"about_ca_system_score_codex":0.00007928771,"about_ca_system_score_gemma":0.00026516052,"threshold_uncertainty_score":0.5323436},"labels":[],"label_agreement":null},{"id":"W2973641376","doi":"10.1038/s41467-019-12095-8","title":"Publisher Correction: Shared heritability and functional enrichment across six solid cancers","year":2019,"lang":"en","type":"erratum","venue":"Nature Communications","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Memorial University of Newfoundland; University of Alberta; Sinai Health System; University of British Columbia; McGill University; Canada Research Chairs; Queen's University; BC Cancer Agency; Vancouver General Hospital; Princess Margaret Cancer Centre; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Centre hospitalier universitaire de Québec; Royal Victoria Hospital; University Health Network; University of Toronto","funders":"Medical Research Council; National Institute of Environmental Health Sciences; National Institute for Health and Care Research; National Cancer Institute; Cancer Research UK; Novo Nordisk Fonden; World Health Organization","keywords":"Heritability; Computational biology; Computer science; Biology; Genetics","score_opus":0.033129780952073355,"score_gpt":0.32491389499989026,"score_spread":0.2917841140478169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973641376","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062412457,0.2575196,0.000033081946,0.037140958,0.183776,0.0056825243,0.0008023462,0.00064088654,0.50816333],"genre_scores_gemma":[0.45519903,0.0057303,0.0009498086,0.0017902773,0.0014080323,0.0006845926,0.015361425,0.00012823296,0.5187483],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99756294,0.00017775981,0.00049435114,0.0007090716,0.0006423972,0.00041348202],"domain_scores_gemma":[0.99438816,0.0003296966,0.00030656607,0.0039051657,0.0008128841,0.00025754722],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00033310027,0.00046951135,0.00071596535,0.00013384206,0.00048282684,0.00019366697,0.00058086024,0.0015468457,0.00031469244],"category_scores_gemma":[0.0003562644,0.00041982005,0.0002690127,0.0004286296,0.00033033022,0.00022966493,0.00074332673,0.004839171,0.0000666615],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106835,0.00025821902,0.011115951,0.00015074157,0.00036658187,0.0000047358762,0.00030097505,0.0000049749833,0.000023225983,0.000048519338,0.98638356,0.001235676],"study_design_scores_gemma":[0.00081445876,0.0001682002,0.20679548,0.00021029184,0.00028350664,0.00010348359,0.0002971626,0.00018605021,0.0000069130506,0.000026279557,0.7908277,0.00028049937],"about_ca_topic_score_codex":0.00042327808,"about_ca_topic_score_gemma":0.002981438,"teacher_disagreement_score":0.44895777,"about_ca_system_score_codex":0.0022016766,"about_ca_system_score_gemma":0.0012785988,"threshold_uncertainty_score":0.99982536},"labels":[],"label_agreement":null},{"id":"W2975223270","doi":"10.1016/j.clgc.2019.09.004","title":"Impact of Patients’ Gender on Efficacy of Immunotherapy in Patients With Metastatic Kidney Cancer: A Systematic Review and Meta-analysis","year":2019,"lang":"en","type":"review","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"Medizinische Universität Wien","keywords":"Medicine; Meta-analysis; Internal medicine; Hazard ratio; Kidney cancer; Oncology; Confidence interval; Cancer; Immunotherapy; Randomized controlled trial; Cochrane Library; Systematic review; MEDLINE","score_opus":0.1967646823354452,"score_gpt":0.4571831977062537,"score_spread":0.2604185153708085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975223270","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014021599,0.9753046,7.206291e-7,0.000016916445,0.00006426387,0.009384803,0.0011611464,0.000008404706,0.000037526468],"genre_scores_gemma":[0.004398587,0.9934476,0.00007778584,0.00026271536,0.0000261614,0.0010984562,0.0003874196,0.00010395083,0.00019733142],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9929878,0.0012848724,0.0036755505,0.0008883113,0.0008015305,0.00036194135],"domain_scores_gemma":[0.9934439,0.0010655092,0.0031552264,0.0015409095,0.00046012813,0.0003343498],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00069950457,0.0008895381,0.019341,0.0005470508,0.000019171242,0.000008030211,0.00028948876,0.00022584699,0.0007031414],"category_scores_gemma":[0.00027914043,0.000446784,0.006276752,0.0011584241,0.00015086324,0.00005120386,0.000080130194,0.0005605762,0.000010597922],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006287771,0.0025663876,0.026910163,0.629107,0.33505273,0.000016959128,0.000022733351,0.0000118306325,1.25305055e-8,2.767089e-7,0.00013323198,0.0055499026],"study_design_scores_gemma":[0.0040082247,0.0042903936,0.05815204,0.07225934,0.86037713,0.0000017336504,0.0000013485511,0.0000010512922,1.5652954e-7,4.909104e-7,0.0005509709,0.00035712947],"about_ca_topic_score_codex":0.000199506,"about_ca_topic_score_gemma":0.0000045325073,"teacher_disagreement_score":0.55684763,"about_ca_system_score_codex":0.00055892154,"about_ca_system_score_gemma":0.0012089314,"threshold_uncertainty_score":0.9997984},"labels":[],"label_agreement":null},{"id":"W2975538531","doi":"10.1016/j.euo.2019.09.001","title":"Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma","year":2019,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McMaster University; Juravinski Cancer Centre","funders":"National Cancer Institute; Ipsen Biopharmaceuticals; Dana-Farber/Harvard Cancer Center; University of Rochester; Pfizer; Eisai; AbbVie; Bristol-Myers Squibb","keywords":"Medicine; Hazard ratio; Internal medicine; Cohort; Renal cell carcinoma; Oncology; Proportional hazards model; Antibiotics; Confidence interval","score_opus":0.017095364068757186,"score_gpt":0.2640910312807955,"score_spread":0.24699566721203828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975538531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98430485,0.00040422296,0.0000052626197,0.00024376117,0.00016344295,0.0011085281,0.0000046271343,0.00003412548,0.013731165],"genre_scores_gemma":[0.99829024,0.000017200673,0.00017336113,0.0004935817,0.000022838776,0.00000773497,0.000016164906,0.000063382926,0.00091552385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961078,0.0024201153,0.00044677826,0.00046331546,0.00018522129,0.0003767351],"domain_scores_gemma":[0.9976961,0.0013385229,0.00025707658,0.0005668085,0.00004777208,0.000093691284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077206397,0.00031291615,0.0011029667,0.00034998095,0.00001959374,0.000004976858,0.00014570853,0.00008096149,0.00006919644],"category_scores_gemma":[0.000067514615,0.00019060711,0.00012650911,0.00016711769,0.00018605405,0.000048880378,0.000054280346,0.0003523654,0.00043552343],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005152557,0.0004725912,0.96142155,0.00031523657,0.00019374609,0.0045978026,0.0006168051,0.00018944523,0.026004832,0.0000536974,0.00004549705,0.0009362106],"study_design_scores_gemma":[0.012274161,0.06250661,0.9118654,0.00006266115,0.00045475955,0.0010528077,0.00007750583,0.000032558954,0.011155804,0.0000012906737,0.0003566002,0.00015983146],"about_ca_topic_score_codex":0.000055655404,"about_ca_topic_score_gemma":0.000015460852,"teacher_disagreement_score":0.062034015,"about_ca_system_score_codex":0.00016027436,"about_ca_system_score_gemma":0.00010029434,"threshold_uncertainty_score":0.77727324},"labels":[],"label_agreement":null},{"id":"W2975769075","doi":"10.5489/cuaj.6010","title":"Survival outcomes for patients with surgically induced end-stage renal disease","year":2019,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary; University Health Network","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; End stage renal disease; Cumulative incidence; Hemodialysis; Proportional hazards model; Internal medicine; Cohort; Population; Incidence (geometry); Transplantation; Nephrectomy; Surgery; Urology; Kidney","score_opus":0.01702459461296271,"score_gpt":0.23114916350717912,"score_spread":0.2141245688942164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975769075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99017245,0.000018611354,0.00001826717,0.0073509156,0.00029459086,0.0006886471,0.00014904067,0.000020577465,0.001286923],"genre_scores_gemma":[0.99499494,0.0000033072968,0.00016552178,0.0017308318,0.00015554551,0.000021947877,0.00016733127,0.000021512787,0.0027390732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980899,0.00012564025,0.0003273848,0.00026091462,0.0006250798,0.0005710549],"domain_scores_gemma":[0.9973637,0.0003175414,0.0002696581,0.00015955749,0.00046681805,0.0014227591],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042846357,0.00019735267,0.00041881364,0.00014688731,0.00016239626,0.00007381958,0.00010553566,0.00016234879,0.0012500462],"category_scores_gemma":[0.0005215191,0.00012634051,0.00022453972,0.00012500564,0.000016859374,0.00009331306,0.000011689457,0.00037480783,0.000076890086],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051382213,0.0001268943,0.99797064,0.000006537902,0.0001825179,0.00010820027,0.00001829864,0.000017804248,0.000017515278,0.00017385339,0.00045369263,0.00041025152],"study_design_scores_gemma":[0.0046372875,0.001248211,0.97719604,0.000010006588,0.00013266245,0.0000073118963,0.000012598175,0.000029361863,0.0000061589985,0.0000816477,0.016487813,0.00015087616],"about_ca_topic_score_codex":0.00027373663,"about_ca_topic_score_gemma":0.00033395173,"teacher_disagreement_score":0.020774547,"about_ca_system_score_codex":0.001388265,"about_ca_system_score_gemma":0.00080784183,"threshold_uncertainty_score":0.99966294},"labels":[],"label_agreement":null},{"id":"W2977743112","doi":"10.1016/j.euo.2019.09.002","title":"First-line Treatment of Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis","year":2019,"lang":"en","type":"review","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Axitinib; Medicine; Oncology; Internal medicine; Renal cell carcinoma; Population; Clinical endpoint; Pembrolizumab; Adverse effect; Progression-free survival; Clinical trial; Meta-analysis; Atezolizumab; Avelumab; Cancer; Overall survival; Immunotherapy; Sunitinib","score_opus":0.1707180087076591,"score_gpt":0.35836265979127085,"score_spread":0.18764465108361175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977743112","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013339149,0.9872023,0.000058325877,0.00030456088,0.00011148031,0.0072573707,0.000108350985,0.00003991737,0.004904377],"genre_scores_gemma":[0.0007098474,0.99232006,0.00075286644,0.0006793602,0.00012324045,0.00062488246,0.0004892726,0.00016101972,0.004139452],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9881252,0.0065935445,0.0030237206,0.0012741225,0.00029927067,0.0006841325],"domain_scores_gemma":[0.99272436,0.0019829383,0.0028100887,0.0019648448,0.00018245047,0.00033534612],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0016119109,0.0012271189,0.027541602,0.0006291955,0.00007773948,0.0000096669,0.0003480895,0.00029256134,0.00053729763],"category_scores_gemma":[0.00013561243,0.0007177708,0.006033465,0.00096935587,0.00027868006,0.000026967042,0.00020831214,0.00043620876,0.00048530143],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005221952,0.00081096403,0.000011154315,0.76313144,0.23023571,0.0029193216,0.00006564592,0.000040978397,1.2732956e-7,0.000019662588,0.00043127564,0.0022814923],"study_design_scores_gemma":[0.00096350274,0.00749733,0.000014835711,0.0029519373,0.7591463,0.0015871543,0.0000025047632,0.000008670817,2.5954674e-7,0.0000027409271,0.22753848,0.0002863174],"about_ca_topic_score_codex":0.00002807135,"about_ca_topic_score_gemma":0.000029891471,"teacher_disagreement_score":0.7601795,"about_ca_system_score_codex":0.00043344064,"about_ca_system_score_gemma":0.00044505813,"threshold_uncertainty_score":0.99952734},"labels":[],"label_agreement":null},{"id":"W2978125439","doi":"10.1016/j.eururo.2019.09.025","title":"Effect of Renal Mass Biopsy on Subsequent Nephrectomy Outcomes: A Population-based Assessment","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Renal mass; Nephrectomy; Urology; Biopsy; Renal biopsy; Population; Nephrology; Kidney; Surgery; Internal medicine","score_opus":0.012767852949447194,"score_gpt":0.28373416983982674,"score_spread":0.27096631689037953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978125439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9705397,0.000038305963,0.00013064506,0.0005506557,0.0002504266,0.00074064336,0.0000069944826,0.000066032735,0.027676623],"genre_scores_gemma":[0.99793065,0.0000011513795,0.00055112696,0.0007539592,0.000056846944,0.000013841756,0.0001230195,0.000052666834,0.000516733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779004,0.00089084986,0.00036415568,0.00038071047,0.00030357038,0.00027068463],"domain_scores_gemma":[0.99859697,0.00045919413,0.00017799098,0.00060499774,0.000042416672,0.00011845467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005883935,0.00024612105,0.00053276616,0.0002056219,0.000024404717,0.000006468606,0.000113335875,0.000056177814,0.00039841523],"category_scores_gemma":[0.00006820175,0.00016960164,0.00021312796,0.00012486268,0.000037310485,0.00001846846,0.000028467031,0.00021831375,0.0005858977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011842275,0.00016619502,0.97242,0.000104721206,0.00014932781,0.00053866755,0.000016626325,0.0007708232,0.023409834,0.00016257662,0.00006897232,0.0010080589],"study_design_scores_gemma":[0.005063053,0.009567821,0.97777355,0.00003213495,0.00021168223,0.000048129186,0.0000018284126,0.0005076295,0.005678259,0.0000070099645,0.0009810595,0.00012785941],"about_ca_topic_score_codex":0.00003783918,"about_ca_topic_score_gemma":0.0000010136492,"teacher_disagreement_score":0.027390981,"about_ca_system_score_codex":0.00015323712,"about_ca_system_score_gemma":0.00005286716,"threshold_uncertainty_score":0.7530725},"labels":[],"label_agreement":null},{"id":"W2978186772","doi":"10.5489/cuaj.6256","title":"Management of Advanced Kidney Cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2019","year":2019,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; London Health Sciences Centre; Centre Hospitalier de l’Université de Montréal; BC Cancer Agency; Saint John Regional Hospital; Ottawa Hospital; CancerCare Manitoba; Alberta Kidney Disease Network; Foothills Medical Centre; William Osler Health System; University of Alberta; McMaster University; Jewish General Hospital; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"Ipsen; Astellas Pharma; Eisai; Sanofi; AstraZeneca; Pfizer; Amgen","keywords":"Medicine; Clinical trial; Multidisciplinary approach; Kidney cancer; Intensive care medicine; Cancer; Clinical research; Internal medicine; Political science","score_opus":0.018237148617715356,"score_gpt":0.2771556549221426,"score_spread":0.25891850630442725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978186772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9420186,0.0019217916,0.000001404657,0.048504677,0.0010022369,0.00065346464,0.0003860592,0.000008048111,0.005503679],"genre_scores_gemma":[0.989396,0.0012818616,0.00028373965,0.0036556188,0.00026197633,0.000026816571,0.00004533323,0.000021367834,0.005027283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99666256,0.00030780694,0.0006244692,0.00028809594,0.0010857118,0.0010313774],"domain_scores_gemma":[0.9962264,0.00017089426,0.00052790006,0.00025267157,0.0010250087,0.0017971309],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012603088,0.0001861602,0.000562738,0.00014573653,0.00018069214,0.000017811399,0.00021126807,0.0001837111,0.0020936942],"category_scores_gemma":[0.00032095241,0.00015354704,0.0001360694,0.0005157968,0.000058937243,0.000036762525,0.000045887926,0.00068491756,0.000017283162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0003378794,0.00004353456,0.59303343,0.00009034153,0.0007090844,0.0003397159,0.000046873633,0.0022557464,0.00038931647,0.00035297713,0.40028048,0.0021206324],"study_design_scores_gemma":[0.0033881043,0.0005105732,0.7398458,0.0004043971,0.0002540363,0.000056940895,0.00017916028,0.00012333902,0.0006650896,0.00039290424,0.25395042,0.0002292601],"about_ca_topic_score_codex":0.43992427,"about_ca_topic_score_gemma":0.2206961,"teacher_disagreement_score":0.21922818,"about_ca_system_score_codex":0.005541156,"about_ca_system_score_gemma":0.008914734,"threshold_uncertainty_score":0.9988185},"labels":[],"label_agreement":null},{"id":"W2978420585","doi":"10.1016/j.eururo.2019.08.035","title":"Response of Primary Renal Cell Carcinoma to Systemic Therapy","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; University of Ottawa","funders":"Dana-Farber/Harvard Cancer Center; Pfizer","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Response Evaluation Criteria in Solid Tumors; Systemic therapy; Primary tumor; Internal medicine; Targeted therapy; Oncology; Population; Kidney cancer; Clinical trial; Surgery; Urology; Phases of clinical research; Cancer; Kidney; Metastasis","score_opus":0.01792994027894139,"score_gpt":0.22405420465918482,"score_spread":0.20612426438024345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978420585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93708587,0.0012260121,0.000022310362,0.0004923001,0.00016653787,0.00063332636,0.000005215486,0.000040374314,0.06032808],"genre_scores_gemma":[0.99177074,0.000016040382,0.00023926723,0.0022629779,0.000080805155,0.0000060472776,0.000012889211,0.000057917296,0.005553339],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99797106,0.0008715573,0.0003342322,0.00035979334,0.00019415257,0.00026922862],"domain_scores_gemma":[0.9987777,0.00018155495,0.00011114621,0.00069029874,0.00008235732,0.00015693769],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00064387463,0.00017425246,0.00040847473,0.00018954276,0.000017337208,0.000003843173,0.00016268394,0.000048616002,0.00021149774],"category_scores_gemma":[0.000035271223,0.00013773091,0.00011565061,0.00013993806,0.000043454304,0.000018563629,0.00008825409,0.00014379238,0.0019798968],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012191878,0.00015191617,0.0626434,0.00006850017,0.00003494206,0.00066056196,0.0005850307,0.000034670713,0.9209707,0.000014431135,0.0017188312,0.0009251352],"study_design_scores_gemma":[0.0036980254,0.008621403,0.89298475,0.000021298856,0.00004928978,0.00053316454,0.00003158526,0.0000063099183,0.07702592,0.0000018786963,0.01688996,0.00013644704],"about_ca_topic_score_codex":0.000010062165,"about_ca_topic_score_gemma":1.8771263e-7,"teacher_disagreement_score":0.8439448,"about_ca_system_score_codex":0.00008750698,"about_ca_system_score_gemma":0.00010445569,"threshold_uncertainty_score":0.9987972},"labels":[],"label_agreement":null},{"id":"W2978638108","doi":"10.1093/annonc/mdz249.007","title":"Primary renal tumour shrinkage in patients (pts) who did not undergo upfront cytoreductive nephrectomy (uCN): Subgroup analysis from the phase III JAVELIN Renal 101 trial of first-line avelumab + axitinib (A + Ax) vs sunitinib (S) for advanced renal cell carcinoma (aRCC)","year":2019,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Foundation Medicine; EMD Serono; Genentech; EUSA Pharma; Ipsen; Incyte; Eisai; National Comprehensive Cancer Network; Alexion Pharmaceuticals; Sanofi; Exelixis; Genomic Health; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; American Society of Clinical Oncology; GlaxoSmithKline; Cilag; Astellas Pharma; Celldex Therapeutics; Pfizer","keywords":"Medicine; Axitinib; Subgroup analysis; Nephrectomy; Javelin; Urology; Renal cell carcinoma; Surgery; Internal medicine; Oncology; Kidney; Sunitinib; Meta-analysis","score_opus":0.042156929675297175,"score_gpt":0.3215684474265392,"score_spread":0.279411517751242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978638108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898109,0.00034790084,0.0002417426,0.0015947446,0.0003508828,0.00430199,0.0011698174,0.000028615057,0.0021534],"genre_scores_gemma":[0.99347305,0.00015513886,0.001423521,0.000678631,0.00048138262,0.00034226567,0.0029257054,0.00008231206,0.00043797158],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99416995,0.0006710072,0.0021883838,0.0011234386,0.000917402,0.0009298409],"domain_scores_gemma":[0.9938328,0.0020935654,0.0016806313,0.0010887602,0.0009791462,0.00032507553],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012077519,0.0006794952,0.002879115,0.00069754774,0.00012806531,0.000018189523,0.00056520035,0.00043505745,0.00040324123],"category_scores_gemma":[0.00036145287,0.0005323367,0.0011171574,0.0008960728,0.0003725567,0.00022555595,0.00024416563,0.0006307999,0.000016165677],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8348088,0.018825457,0.06354534,0.0004081348,0.0039179767,0.00030474126,0.0046705827,0.0010499766,0.041533783,0.00011340684,0.0036091346,0.027212668],"study_design_scores_gemma":[0.43101275,0.07023016,0.27494615,0.0003212295,0.003341274,0.00001376519,0.00077416236,0.0009475284,0.21074292,0.0002764012,0.006576539,0.00081710424],"about_ca_topic_score_codex":0.0014257766,"about_ca_topic_score_gemma":0.0010938018,"teacher_disagreement_score":0.40379605,"about_ca_system_score_codex":0.00057150633,"about_ca_system_score_gemma":0.0008905803,"threshold_uncertainty_score":0.9997128},"labels":[],"label_agreement":null},{"id":"W2979157870","doi":"10.1097/md.0000000000017263","title":"Robot-assisted retroperitoneal laparoscopic partial nephrectomy without hilar occlusion VS classic robot-assisted retroperitoneal laparoscopic partial nephrectomy","year":2019,"lang":"en","type":"article","venue":"Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Particle Physics","funders":"National Natural Science Foundation of China","keywords":"Medicine; Clamp; Nephrectomy; Surgery; Blood loss; Laparoscopy; Renal function; Urology; Kidney; Internal medicine","score_opus":0.026189743869476964,"score_gpt":0.2825845832877302,"score_spread":0.2563948394182532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979157870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749486,0.0023510682,0.00015697099,0.007087347,0.0042669526,0.0043111057,0.000029745446,0.0007586966,0.0060895225],"genre_scores_gemma":[0.98111445,0.0002510538,0.002350453,0.0021380652,0.003538376,0.00052059983,0.00076856447,0.00031274595,0.009005717],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99027824,0.0007405939,0.0021079634,0.0022375362,0.0025827405,0.0020529092],"domain_scores_gemma":[0.9945257,0.00023921064,0.0007548571,0.0024940504,0.0004972537,0.0014889812],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0009012488,0.0015387746,0.0035697094,0.0006769696,0.00052606396,0.00012939573,0.0007074071,0.00085107394,0.0033957595],"category_scores_gemma":[0.00035732146,0.0011477793,0.0005587078,0.00153518,0.0008602003,0.00041460802,0.00044418513,0.0016798923,0.0012579804],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008273115,0.0014445796,0.42943242,0.00089291256,0.00085108995,0.0022209026,0.00078686594,0.0000838442,0.534044,0.00009505157,0.011339831,0.010535373],"study_design_scores_gemma":[0.042027447,0.012199988,0.6785081,0.0029265801,0.0022736469,0.0015344239,0.00041280763,0.0028710288,0.108055025,0.000016259613,0.14758007,0.0015946266],"about_ca_topic_score_codex":0.0012726926,"about_ca_topic_score_gemma":0.00019159446,"teacher_disagreement_score":0.42598897,"about_ca_system_score_codex":0.0015284672,"about_ca_system_score_gemma":0.0007634741,"threshold_uncertainty_score":0.9997361},"labels":[],"label_agreement":null},{"id":"W2979588239","doi":"10.1007/s40520-019-01366-5","title":"Renal surgery for the older population: time for a paradigm shift? Data from the RESURGE project","year":2019,"lang":"en","type":"article","venue":"Aging Clinical and Experimental Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Nephrectomy; Renal cell carcinoma; Medicine; Kidney cancer; Kidney disease; Urology; Population; Internal medicine; Cancer; Disease; Kidney; Surgery; Oncology; Environmental health","score_opus":0.3728075189305762,"score_gpt":0.5125091408112101,"score_spread":0.13970162188063395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979588239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97893345,0.0044805286,0.000035150486,0.01291659,0.00021058341,0.0031008052,0.00012385195,0.000022816921,0.00017620955],"genre_scores_gemma":[0.9962297,0.000099100325,0.00023515918,0.00042951098,0.00079334225,0.00031615686,0.0007097491,0.000027823331,0.0011594548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977633,0.00028898512,0.00044641655,0.00060027535,0.0004991049,0.00040193653],"domain_scores_gemma":[0.98246384,0.016333869,0.00006059255,0.0009856658,0.000042111555,0.00011390226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004224293,0.00013382202,0.0003489644,0.00004218385,0.00032714152,0.000096851494,0.00030004882,0.00008079943,0.00012316648],"category_scores_gemma":[0.0006338438,0.00006606502,0.0001800905,0.00013103918,0.00023789308,0.000100578894,0.0003453078,0.00029302153,0.00006138156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0118036205,0.001373826,0.6862963,0.00018349687,0.0011254705,0.00005173071,0.001663574,0.0000016446089,0.0026784411,0.00092513754,0.27319187,0.020704893],"study_design_scores_gemma":[0.008199014,0.0017204736,0.86349154,0.00061967445,0.00023226548,0.000030405678,0.0010198217,0.010233937,0.005151036,0.0018168659,0.10709886,0.00038611423],"about_ca_topic_score_codex":0.0011777942,"about_ca_topic_score_gemma":0.000017886647,"teacher_disagreement_score":0.17719525,"about_ca_system_score_codex":0.000047694084,"about_ca_system_score_gemma":0.00016447157,"threshold_uncertainty_score":0.26940534},"labels":[],"label_agreement":null},{"id":"W2979711603","doi":"10.1186/s40880-019-0405-5","title":"Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study","year":2019,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institutes of Health Research","funders":"Renji Hospital; Science and Technology Commission of Shanghai Municipality; Pfizer","keywords":"Sunitinib; Sorafenib; Axitinib; Medicine; Renal cell carcinoma; Oncology; Targeted therapy; Internal medicine; Neoadjuvant therapy; Radiation therapy; Tyrosine-kinase inhibitor; Cancer; Breast cancer; Hepatocellular carcinoma","score_opus":0.08029438110833828,"score_gpt":0.3685204662015316,"score_spread":0.28822608509319336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979711603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91009724,0.024001794,0.000013970627,0.05445262,0.000115340394,0.0071164323,0.0005144417,0.000047712303,0.0036404599],"genre_scores_gemma":[0.9847983,0.0025938957,0.00057216536,0.008177374,0.00032763876,0.0009762883,0.0009465979,0.00010975027,0.0014979653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975689,0.0003197706,0.0007693729,0.0006184325,0.00036334284,0.00036015685],"domain_scores_gemma":[0.9952698,0.000907176,0.0006706929,0.002534794,0.0005063027,0.00011128379],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024824298,0.0004852189,0.0014041879,0.00022817994,0.0003006314,0.000040756095,0.0005145619,0.00038464458,0.00005860157],"category_scores_gemma":[0.000059580005,0.0004255182,0.0001838808,0.00020480475,0.0005753064,0.00006427999,0.00032352665,0.0013959381,0.0000043285313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025523661,0.0035166647,0.8086506,0.0010283409,0.0016391326,0.000058791153,0.01667221,0.000008909942,0.0015064985,0.00008566929,0.15705046,0.007230339],"study_design_scores_gemma":[0.018346159,0.0062135663,0.82668656,0.0005474722,0.0017338854,0.000026902102,0.0020005296,0.00014444243,0.0017656507,0.00005538919,0.14185189,0.0006275426],"about_ca_topic_score_codex":0.0013596065,"about_ca_topic_score_gemma":0.00019094849,"teacher_disagreement_score":0.07470109,"about_ca_system_score_codex":0.00034774517,"about_ca_system_score_gemma":0.00040263156,"threshold_uncertainty_score":0.99981964},"labels":[],"label_agreement":null},{"id":"W2979747184","doi":"10.1016/j.eururo.2019.08.039","title":"Re: Jack R. Andrews, Thomas Atwell, Grant Schmit, et al. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2019;76:244–51","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Percutaneous; Urology; Renal mass; Ablation; General surgery; Surgery; Kidney; Internal medicine","score_opus":0.03850725037447998,"score_gpt":0.28208693566071097,"score_spread":0.24357968528623097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979747184","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19801585,0.005028055,0.0005785415,0.76327515,0.0032956756,0.0061722137,0.00021045234,0.0004897787,0.022934262],"genre_scores_gemma":[0.13535178,0.0004062273,0.0028765758,0.84328544,0.0021447674,0.00012817288,0.0024132996,0.0004912844,0.012902432],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940418,0.0015988004,0.00099644,0.0016409726,0.00061211747,0.0011098661],"domain_scores_gemma":[0.9965746,0.0014521987,0.00057179085,0.0010546489,0.0001356788,0.00021112281],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010950953,0.001003926,0.0017026645,0.00038150305,0.00020674529,0.00010927525,0.00035682245,0.0007124003,0.00012557274],"category_scores_gemma":[0.00041529632,0.0007984968,0.00073393167,0.00015043408,0.00019714853,0.00013118803,0.00026745375,0.0021003508,0.00049891346],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009427788,0.00013114119,0.014918239,0.00016423038,0.00087434566,0.024889328,0.00019808233,0.000050661776,0.0014747037,0.00001547017,0.9555644,0.0007766466],"study_design_scores_gemma":[0.004681479,0.0042198463,0.012748507,0.0000621688,0.0016886942,0.0023118893,0.000014948716,0.00020854527,0.000058813912,0.000046314326,0.9732779,0.0006808936],"about_ca_topic_score_codex":0.000049382117,"about_ca_topic_score_gemma":0.000018378782,"teacher_disagreement_score":0.080010295,"about_ca_system_score_codex":0.00021213848,"about_ca_system_score_gemma":0.00021731661,"threshold_uncertainty_score":0.9994466},"labels":[],"label_agreement":null},{"id":"W2979935810","doi":"10.7759/cureus.5901","title":"Outcomes of Multi-disciplinary Management of Metastatic Renal Cell Carcinoma","year":2019,"lang":"en","type":"article","venue":"Cureus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Kingston Health Sciences Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Quality of life (healthcare); Disease; Intensive care medicine; Palliative care; Oncology; Cabozantinib; Radiation therapy; Internal medicine; Nursing","score_opus":0.04467630257290676,"score_gpt":0.3051092875114626,"score_spread":0.2604329849385558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979935810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837622,0.0018849189,0.000066958026,0.000067303736,0.0001267331,0.0007010983,0.00001583443,0.000014609191,0.013360356],"genre_scores_gemma":[0.982113,0.000032241922,0.010230075,0.00001904061,0.000008970831,0.000017724898,0.000024145631,0.000022630915,0.007532182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988363,0.000030341793,0.00038039737,0.00023742861,0.0003244622,0.00019107877],"domain_scores_gemma":[0.99902034,0.000042504536,0.00017483131,0.0006012511,0.00007137261,0.00008970881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011274067,0.00017035319,0.00051120896,0.00007827572,0.000013604413,0.0000022081063,0.00012226174,0.000035055968,0.00033177802],"category_scores_gemma":[0.000003915764,0.0001240041,0.00020336622,0.000115693285,0.000049038284,0.00004082407,0.00012254318,0.00007115388,0.00008807125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036989024,0.0023090262,0.9396533,0.0031817807,0.00094905205,0.00053979637,0.00093388656,0.00008562152,0.05003278,0.00044422224,0.00040698788,0.0010936777],"study_design_scores_gemma":[0.0038761809,0.0009566099,0.8989543,0.000098158336,0.00069263735,0.000017556446,0.0006679807,0.00018119087,0.09430322,0.000044648234,0.00009195437,0.00011562029],"about_ca_topic_score_codex":0.00006169455,"about_ca_topic_score_gemma":0.00000337201,"teacher_disagreement_score":0.044270437,"about_ca_system_score_codex":0.00008196351,"about_ca_system_score_gemma":0.000034700788,"threshold_uncertainty_score":0.50567406},"labels":[],"label_agreement":null},{"id":"W2980206217","doi":"10.3332/ecancer.2019.967","title":"Complete metastasectomy in renal cell carcinoma: a propensity-score matched by the International Metastatic RCC Database Consortium prognostic model","year":2019,"lang":"en","type":"article","venue":"ecancermedicalscience","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Metastasectomy; Medicine; Propensity score matching; Renal cell carcinoma; Hazard ratio; Proportional hazards model; Internal medicine; Overall survival; Database; Urology; Oncology; Surgery; Cancer; Metastasis","score_opus":0.060141613274272004,"score_gpt":0.2803254162679474,"score_spread":0.22018380299367538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980206217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989759,0.00065650267,0.0012129396,0.0027579654,0.00030664483,0.0017571625,0.00023632048,0.00003585141,0.0032775598],"genre_scores_gemma":[0.99488753,0.00003109834,0.0016669093,0.0013934677,0.000052307918,0.00021880424,0.00020895147,0.00002429035,0.0015166198],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9964756,0.00012441211,0.000547074,0.0007787653,0.0014871185,0.0005870633],"domain_scores_gemma":[0.99834335,0.00027414254,0.00020975298,0.00070594234,0.00014049036,0.00032629698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009977103,0.0002912844,0.0005477472,0.0001467864,0.00009603349,0.000061552295,0.00068202574,0.000044170527,0.0006773163],"category_scores_gemma":[0.00023594084,0.00018036281,0.000105814484,0.00053563615,0.00060426054,0.00021901068,0.00028346005,0.00046446396,0.00017361056],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010869348,0.002069273,0.43040657,0.0006842017,0.00018073339,0.0014866814,0.0017056111,0.0021186885,0.536473,0.00062968757,0.021246824,0.0019118253],"study_design_scores_gemma":[0.027021943,0.0022099505,0.26201478,0.0011776675,0.0011404407,0.0012479039,0.0010958479,0.5889091,0.10101493,0.00072590547,0.011704722,0.0017368139],"about_ca_topic_score_codex":0.00034733047,"about_ca_topic_score_gemma":0.000094950396,"teacher_disagreement_score":0.58679044,"about_ca_system_score_codex":0.00039602627,"about_ca_system_score_gemma":0.0010434409,"threshold_uncertainty_score":0.7416138},"labels":[],"label_agreement":null},{"id":"W2980514435","doi":"10.23736/s0393-2249.19.03583-5","title":"Robotic partial nephrectomy versus radical nephrectomy in elderly patients with large renal masses","year":2020,"lang":"en","type":"article","venue":"Minerva Urologica e Nefrologica","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Nephrectomy; Propensity score matching; Logistic regression; Urology; Renal mass; Internal medicine; Proportional hazards model; Renal function; Blood loss; Surgery; Kidney","score_opus":0.03253246135949481,"score_gpt":0.2441733649853707,"score_spread":0.2116409036258759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980514435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98713887,0.0005432855,0.00015675122,0.006552322,0.00013826991,0.001498163,0.000019085852,0.00030012906,0.0036531284],"genre_scores_gemma":[0.98874515,0.000037089278,0.0057105348,0.0045563495,0.00031370373,0.00030716183,0.00020981664,0.00005010036,0.00007006184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99600494,0.00031608474,0.0006520059,0.0011645197,0.00071572,0.00114674],"domain_scores_gemma":[0.9981556,0.00034689563,0.00021651085,0.00050132925,0.000115583316,0.00066409475],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002048692,0.0006287381,0.0010827942,0.00015553947,0.00013008274,0.000049053626,0.00035038847,0.00042306748,0.00123772],"category_scores_gemma":[0.00043306832,0.00039828353,0.00024206759,0.000750427,0.00025720385,0.0001459011,0.00019465703,0.0008128991,0.0002947113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03157582,0.0021263794,0.95465595,0.000052197596,0.0002830027,0.0030733899,0.00020132565,0.00063435436,0.0015388558,0.000091155474,0.0027748768,0.0029926838],"study_design_scores_gemma":[0.037058283,0.039626665,0.78627324,0.00004267473,0.0005862868,0.000069973765,0.000058067668,0.001811992,0.0006722115,0.00004150286,0.13302283,0.0007362781],"about_ca_topic_score_codex":0.00003539959,"about_ca_topic_score_gemma":0.000039967537,"teacher_disagreement_score":0.16838272,"about_ca_system_score_codex":0.00013321839,"about_ca_system_score_gemma":0.00012706505,"threshold_uncertainty_score":0.9998469},"labels":[],"label_agreement":null},{"id":"W2980921948","doi":"10.1016/j.euf.2019.09.014","title":"What Do International Guidelines Say About First-line Therapy for Clear-cell Metastatic Renal Cell Carcinoma?","year":2019,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Guideline; Renal cell carcinoma; Intensive care medicine; Clinical Practice; Targeted therapy; Oncology; Selection (genetic algorithm); MEDLINE; Internal medicine; Family medicine; Pathology; Cancer","score_opus":0.036514545266267906,"score_gpt":0.2878397407870709,"score_spread":0.251325195520803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980921948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94454205,0.017811434,0.00056174834,0.007739541,0.0016730811,0.0013963918,0.00003221326,0.00009928658,0.026144281],"genre_scores_gemma":[0.978641,0.0016987016,0.0024389636,0.0031160465,0.00072514644,0.000040747564,0.00014784413,0.00013749673,0.013054073],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99755836,0.00023946843,0.00067738054,0.00071074575,0.00033391145,0.00048012912],"domain_scores_gemma":[0.99821854,0.00025121705,0.00026488942,0.0006936661,0.00037274795,0.0001989399],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006349128,0.00038438247,0.00050217326,0.00020797199,0.000084149215,0.00007859231,0.00036478066,0.00007511067,0.0009326413],"category_scores_gemma":[0.00007603379,0.00029783344,0.00033424248,0.000113185575,0.000093106464,0.00016855408,0.0001234485,0.00027104173,0.0015124802],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053502526,0.009141731,0.17786372,0.0012071936,0.0037197713,0.0098732365,0.0074765515,0.0050233174,0.17078266,0.0015257719,0.21404932,0.3458342],"study_design_scores_gemma":[0.03210587,0.01586592,0.07147362,0.000103162194,0.0007271576,0.00060405914,0.0002795121,0.0020614923,0.04372326,0.00044576405,0.8317249,0.0008853253],"about_ca_topic_score_codex":0.000019142113,"about_ca_topic_score_gemma":0.0000061755827,"teacher_disagreement_score":0.61767554,"about_ca_system_score_codex":0.00008326775,"about_ca_system_score_gemma":0.00007925277,"threshold_uncertainty_score":0.9999806},"labels":[],"label_agreement":null},{"id":"W2981319505","doi":"10.1016/j.clinbiochem.2019.10.002","title":"Prognostic urinary miRNAs for the assessment of small renal masses","year":2019,"lang":"en","type":"article","venue":"Clinical Biochemistry","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Mount Sinai Hospital; Princess Margaret Cancer Centre; Hospital for Sick Children; St. Michael's Hospital","funders":"Kidney Foundation of Canada; Canadian Institutes of Health Research; Canadian Urological Oncology Group; Health Research","keywords":"Urinary system; Urology; microRNA; Medicine; Renal mass; Internal medicine; Kidney; Biology; Nephrectomy; Genetics","score_opus":0.07328995086198921,"score_gpt":0.38702411592704794,"score_spread":0.31373416506505875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981319505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99266475,0.0007107866,0.0001741282,0.0011118172,0.0001834204,0.00094060414,0.000019094736,0.000023748124,0.0041716415],"genre_scores_gemma":[0.98848563,0.00007102603,0.0073075364,0.00018175121,0.00027776213,0.000091636,0.00006227312,0.000019385296,0.0035030034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864596,0.000029373143,0.0005571764,0.00036307378,0.00020260694,0.00020181837],"domain_scores_gemma":[0.99713206,0.0017402527,0.000197048,0.000659341,0.00013899987,0.00013226709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046157764,0.00015088722,0.00038238257,0.000013629589,0.000029758547,0.0000086480795,0.00017378472,0.00016167124,0.00014223912],"category_scores_gemma":[0.00046338182,0.0000919262,0.00037719434,0.00006882079,0.00015831192,0.0000102910735,0.00008291696,0.00023529785,0.00001945269],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044317244,0.0013723708,0.9205399,0.00087156735,0.00039971195,0.00004248515,0.00000838937,0.0000041436115,0.07161343,0.000046933474,0.0018759579,0.002781897],"study_design_scores_gemma":[0.0042179734,0.0035995392,0.7575446,0.00041937752,0.0008476689,0.0001224833,0.000100707504,0.000755437,0.22238885,0.000104365026,0.009683069,0.00021592948],"about_ca_topic_score_codex":0.000002792307,"about_ca_topic_score_gemma":1.9262067e-7,"teacher_disagreement_score":0.16299534,"about_ca_system_score_codex":0.000052505216,"about_ca_system_score_gemma":0.00031626827,"threshold_uncertainty_score":0.3748642},"labels":[],"label_agreement":null},{"id":"W2981752967","doi":"10.1371/journal.pone.0222359","title":"Systematic review and REMARK scoring of renal cell carcinoma prognostic circulating biomarker manuscripts","year":2019,"lang":"en","type":"review","venue":"PLoS ONE","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Biomarker; Renal cell carcinoma; Medicine; Oncology; Internal medicine; MEDLINE; Clear cell renal cell carcinoma; Kidney cancer; Cancer; Meta-analysis; Biology","score_opus":0.15655119370146442,"score_gpt":0.29228368243761765,"score_spread":0.13573248873615323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981752967","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002608922,0.98349786,0.0000023630573,0.00001604844,0.00004130899,0.01179659,0.000030274945,0.000041825846,0.0019648233],"genre_scores_gemma":[0.003498423,0.99361414,0.000749525,0.000039298255,0.00006395967,0.00059750903,0.00015412546,0.00014152343,0.0011415],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9956955,0.00040492884,0.0019158158,0.0007528771,0.00080871413,0.0004222143],"domain_scores_gemma":[0.9963945,0.0004738691,0.0014308757,0.0012360598,0.00023059588,0.0002340651],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067179877,0.0007043695,0.0073597073,0.0003212173,0.000047264763,0.000024465979,0.00019841871,0.00025408686,0.000045306446],"category_scores_gemma":[0.0006052503,0.00050822145,0.0006297765,0.00042000285,0.000064515356,0.00006098359,0.0001675649,0.00039674185,0.00010831552],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000061331866,0.00048586584,0.00034746475,0.99516034,0.001675573,0.00022136985,0.00001995129,8.472119e-9,0.00017597654,0.0000024453636,0.00002590828,0.0018789326],"study_design_scores_gemma":[0.0003806203,0.00030157517,0.00020745509,0.8859784,0.11212334,0.0003706226,0.0000056016174,0.000009312469,0.00012596235,0.0000014709427,0.0001473925,0.00034825603],"about_ca_topic_score_codex":0.000015884072,"about_ca_topic_score_gemma":4.914165e-7,"teacher_disagreement_score":0.110447764,"about_ca_system_score_codex":0.00030988938,"about_ca_system_score_gemma":0.00028044498,"threshold_uncertainty_score":0.99973696},"labels":[],"label_agreement":null},{"id":"W2982989620","doi":"10.1038/s41585-019-0257-4","title":"Health technology assessment methodology in metastatic renal cell carcinoma","year":2019,"lang":"en","type":"review","venue":"Nature Reviews Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Merck Sharp and Dohme","keywords":"Medicine; Renal cell carcinoma; Oncology; Internal medicine; Kidney cancer; Intensive care medicine","score_opus":0.20009157365489302,"score_gpt":0.46920203055212006,"score_spread":0.269110456897227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982989620","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020817974,0.9857583,0.00016664674,0.0023333693,0.00084949186,0.008619054,0.00003977417,0.000076812496,0.0021357383],"genre_scores_gemma":[0.00013297446,0.97046095,0.024560275,0.0019361317,0.00020110923,0.001165118,0.00061875227,0.00017815964,0.0007465238],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98712724,0.0060640415,0.0030870538,0.0019235421,0.00042680837,0.0013713297],"domain_scores_gemma":[0.9939921,0.0011534897,0.0021791817,0.0022128231,0.00012279944,0.0003396369],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0037877182,0.0014088162,0.01446756,0.002510978,0.000062388346,0.000012629006,0.00071159785,0.0028946488,0.00023857344],"category_scores_gemma":[0.0004803717,0.00096596876,0.0016514898,0.0019580422,0.00020499722,0.000045946814,0.000339888,0.0074298,0.00064980256],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003589622,0.00035002962,0.00020798385,0.062542476,0.0002241705,0.0009708411,0.000019692854,4.4087923e-7,0.0000037582374,0.00086480356,0.002454688,0.93232524],"study_design_scores_gemma":[0.0012876026,0.002414112,0.0001528841,0.003802302,0.0039771195,0.004801054,0.000007986304,0.0000031850498,0.0000032550822,0.000113401155,0.98293203,0.00050508237],"about_ca_topic_score_codex":0.0000407531,"about_ca_topic_score_gemma":0.000053177624,"teacher_disagreement_score":0.98047733,"about_ca_system_score_codex":0.0016038491,"about_ca_system_score_gemma":0.0032489086,"threshold_uncertainty_score":0.9998662},"labels":[],"label_agreement":null},{"id":"W2985617220","doi":"10.1007/s00261-019-02282-y","title":"Imaging and implications of tumor thrombus in abdominal malignancies: reviewing the basics","year":2019,"lang":"en","type":"review","venue":"Abdominal Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Radiology; Malignancy; Hepatology; Magnetic resonance imaging; Hepatocellular carcinoma; Thrombus; Thrombosis; Cancer; Pathology; Internal medicine","score_opus":0.06665715412690215,"score_gpt":0.34305178651116397,"score_spread":0.2763946323842618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985617220","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011972005,0.9943017,0.000056494217,0.00034962516,0.00014765868,0.0019836714,0.00002399054,0.000011146688,0.0019285119],"genre_scores_gemma":[0.003856715,0.994558,0.0007781957,0.0002456646,0.00014753081,0.00020414617,0.000051083854,0.000053988988,0.000104683306],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973304,0.00040258435,0.0011092613,0.0005821918,0.00014704627,0.00042848426],"domain_scores_gemma":[0.9971702,0.0011215471,0.00064376305,0.00088025426,0.00008831397,0.000095902884],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007800881,0.00046442312,0.0031174466,0.00024913636,0.00005885413,0.000010512054,0.00028695777,0.00015668354,0.00004807774],"category_scores_gemma":[0.00024119754,0.00027933507,0.0004923688,0.0003520696,0.0004032636,0.00004299728,0.00013187084,0.0005251366,0.000041315354],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007119287,0.00008817811,0.0030389875,0.025302468,0.00027718925,0.00031348033,0.00020129752,4.939533e-7,0.00009406576,0.001641825,0.00046742175,0.9685034],"study_design_scores_gemma":[0.0017124062,0.0005860612,0.02111885,0.03083999,0.007723611,0.03497961,0.0002836272,0.000027543143,0.000030589996,0.00031882603,0.9017689,0.00060996827],"about_ca_topic_score_codex":0.000048464957,"about_ca_topic_score_gemma":0.000004690195,"teacher_disagreement_score":0.9678934,"about_ca_system_score_codex":0.00030262794,"about_ca_system_score_gemma":0.00052037154,"threshold_uncertainty_score":0.9999659},"labels":[],"label_agreement":null},{"id":"W2987577166","doi":"10.1093/jscr/rjz326","title":"Sunitinib cause delayed complete response on metastatic RCC and extensive IVC thrombus, but not to the kidney tumor: a case report and review of literature","year":2019,"lang":"en","type":"article","venue":"Journal of Surgical Case Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University","funders":"","keywords":"Medicine; Sunitinib; Thrombus; Kidney cancer; Oncology; Radiology; Internal medicine; Intensive care medicine; Cancer","score_opus":0.042072749332406,"score_gpt":0.3234307113684266,"score_spread":0.2813579620360206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987577166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758342,0.017255379,0.0000029574667,0.0055151284,0.00016549384,0.0009917789,0.000067604575,0.00000712913,0.0001603382],"genre_scores_gemma":[0.99336416,0.0031376116,0.00045428574,0.0025531221,0.000091743044,0.0000062793347,0.000016547068,0.000029370458,0.0003468637],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9964057,0.00053440605,0.0016673075,0.00036890162,0.0007718181,0.00025183862],"domain_scores_gemma":[0.9948261,0.0010275213,0.0014909762,0.00071807887,0.0011447516,0.00079261436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033645292,0.00030221688,0.0012683653,0.00020625214,0.0000824285,0.000041433163,0.000034618402,0.000060284434,0.00009486887],"category_scores_gemma":[0.0021132778,0.00016483813,0.00029504692,0.00030582392,0.000105063016,0.0001035908,0.00007487031,0.0005177442,0.0000030173644],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004378871,0.00014313369,0.00046254136,0.0012210158,0.0003614543,0.9895013,0.00035996607,0.0000024481474,0.0012245019,0.000009164072,0.002096023,0.00023960767],"study_design_scores_gemma":[0.0014372687,0.0026603034,0.0020154673,0.007334328,0.0011066388,0.9712929,0.00026098997,0.000008745815,0.0010259356,0.00001228672,0.012696884,0.00014824864],"about_ca_topic_score_codex":0.000079850775,"about_ca_topic_score_gemma":0.0000048935794,"teacher_disagreement_score":0.01820837,"about_ca_system_score_codex":0.000111554444,"about_ca_system_score_gemma":0.00039485758,"threshold_uncertainty_score":0.67219037},"labels":[],"label_agreement":null},{"id":"W2987633456","doi":"10.21037/atm.2019.09.143","title":"Immunohistochemical screening for the diagnosis of succinate dehydrogenase-deficient renal cell carcinoma and fumarate hydratase-deficient renal cell carcinoma","year":2019,"lang":"en","type":"letter","venue":"Annals of Translational Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Renal cell carcinoma; Immunohistochemistry; Pathology; Medicine; Succinate dehydrogenase; Kidney; Clear cell; Internal medicine; Biology; Enzyme; Biochemistry","score_opus":0.07164032586728993,"score_gpt":0.30108729268579104,"score_spread":0.22944696681850113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987633456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64145064,0.06932983,0.00080759573,0.28083205,0.00038350458,0.003929694,0.002060461,0.000038394894,0.0011678077],"genre_scores_gemma":[0.9613275,0.000542711,0.00078897737,0.030690037,0.0012411006,0.0003561249,0.004109351,0.00017255306,0.0007716404],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.993778,0.00020927151,0.001931243,0.00115903,0.0019902755,0.00093221746],"domain_scores_gemma":[0.99369633,0.00275264,0.00115885,0.0011712061,0.0009754701,0.00024551695],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010577037,0.000995558,0.0019778642,0.00064684247,0.00021943863,0.000018765408,0.0005235751,0.0007268642,0.00024920082],"category_scores_gemma":[0.0001228367,0.00069075415,0.0008646297,0.00045664262,0.00085160637,0.000097345175,0.00009305563,0.0013040826,0.000010005834],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005742701,0.0011599822,0.013667411,0.009768995,0.0011905764,0.0007449271,0.0020208615,0.0011437645,0.15548371,0.00008779448,0.8056174,0.0033719195],"study_design_scores_gemma":[0.017398221,0.009627381,0.027683394,0.0026084287,0.0062554576,0.00037064042,0.0002356946,0.0035317773,0.7532146,0.00021494001,0.17734233,0.0015171042],"about_ca_topic_score_codex":0.0005324282,"about_ca_topic_score_gemma":0.000006594473,"teacher_disagreement_score":0.62827504,"about_ca_system_score_codex":0.00008897195,"about_ca_system_score_gemma":0.00043311424,"threshold_uncertainty_score":0.99955434},"labels":[],"label_agreement":null},{"id":"W2988892807","doi":"10.1016/j.urolonc.2019.09.030","title":"Evaluation of individual and cumulative sites of extrarenal tumor invasion in pT3a clear cell renal cell carcinoma","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Renal cell carcinoma; Clear cell renal cell carcinoma; Cell; Cancer research; Biology; Medicine; Pathology","score_opus":0.06227888323747924,"score_gpt":0.3135551663548787,"score_spread":0.25127628311739947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988892807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98738515,0.0022315138,0.0000019806942,0.00024709568,0.000040416588,0.00075526285,0.000027614795,0.000008834639,0.0093021365],"genre_scores_gemma":[0.9910673,0.000069554815,0.008445114,0.00015374637,0.000024159219,0.000032834265,0.00007760562,0.000009695982,0.000120004835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807453,0.00035862616,0.00046935788,0.00037399956,0.00051402225,0.00020943642],"domain_scores_gemma":[0.9987392,0.00035838567,0.00033378255,0.00019184983,0.00022663902,0.00015016414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013023521,0.00018728827,0.000488322,0.00030087013,0.000048875467,0.0000068050276,0.00007504584,0.0001901851,0.00012751334],"category_scores_gemma":[0.00013653046,0.00015469956,0.00005200207,0.00026067052,0.00046619395,0.00010288658,0.00007393173,0.000274723,0.000006504475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029593534,0.00042043102,0.9415145,0.00013918466,0.000029785107,0.00005029717,0.0016651298,0.00034132507,0.054300845,0.00033460025,0.00018047758,0.0007275158],"study_design_scores_gemma":[0.00894059,0.019171631,0.78656167,0.00019134875,0.0018503742,0.00027753314,0.0019306312,0.009366818,0.16224821,0.0043104067,0.0047996147,0.00035115212],"about_ca_topic_score_codex":0.00010009402,"about_ca_topic_score_gemma":0.0000363947,"teacher_disagreement_score":0.1549528,"about_ca_system_score_codex":0.00013203463,"about_ca_system_score_gemma":0.00060674286,"threshold_uncertainty_score":0.63084656},"labels":[],"label_agreement":null},{"id":"W2989830802","doi":"10.1016/j.euo.2019.11.001","title":"Outcomes of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy After Immuno-oncology Checkpoint Inhibitors","year":2019,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; CancerCare Manitoba; Health Sciences Centre; University of Manitoba; Princess Margaret Cancer Centre; University of Calgary","funders":"Instituto de Salud Carlos III; Genentech; Eisai; American Psychosocial Oncology Society; Exelixis; North Carolina GlaxoSmithKline Foundation; EMD Serono; Novartis; Merck; F. Hoffmann-La Roche; Roche; Astellas Pharma US; Health Research Fund of Central Denmark Region; Dana-Farber Cancer Institute; Pfizer; Ipsen Biopharmaceuticals; Bayer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Renal cell carcinoma; Oncology; Internal medicine; Nivolumab; Immunotherapy; Cancer","score_opus":0.010604879800889895,"score_gpt":0.23012148977798388,"score_spread":0.219516609977094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989830802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97915393,0.00062338053,0.000014257805,0.0004547319,0.00018361246,0.001648675,0.000028148466,0.00007353591,0.0178197],"genre_scores_gemma":[0.9960174,0.000022508588,0.00132798,0.0011503407,0.000050507802,0.00007695792,0.00020437161,0.00014050568,0.0010094456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961026,0.0012709472,0.0008434643,0.00076139695,0.0003456868,0.000675907],"domain_scores_gemma":[0.9976688,0.00029059188,0.0006441572,0.0008064384,0.0003525552,0.0002374786],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041701118,0.0005655463,0.0014822468,0.0003725008,0.00005108959,0.0000062814465,0.00022465535,0.00017872418,0.00081803324],"category_scores_gemma":[0.000026582931,0.00034345288,0.00021636249,0.00030620545,0.0005252566,0.00007769604,0.0001140849,0.00047280698,0.00030327786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020972913,0.002595141,0.96029216,0.000046985795,0.0007667315,0.0022783228,0.00090083614,0.00003079675,0.010016086,0.0000050589124,0.00016064872,0.0019342913],"study_design_scores_gemma":[0.02529319,0.055461474,0.89867646,0.000010324009,0.000607483,0.00017767743,0.000106396845,0.000007658946,0.012213531,0.0000029650862,0.0071540955,0.00028875904],"about_ca_topic_score_codex":0.00007021336,"about_ca_topic_score_gemma":0.000027316853,"teacher_disagreement_score":0.06161574,"about_ca_system_score_codex":0.0003431885,"about_ca_system_score_gemma":0.00038179694,"threshold_uncertainty_score":0.9999018},"labels":[],"label_agreement":null},{"id":"W2990139923","doi":"10.1186/s12967-019-02144-7","title":"BMI, irAE, and gene expression signatures associate with resistance to immune-checkpoint inhibition and outcomes in renal cell carcinoma","year":2019,"lang":"en","type":"article","venue":"Journal of Translational Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Melanoma Research Alliance; U.S. Department of Defense","keywords":"Medicine; Clear cell renal cell carcinoma; Oncology; Renal cell carcinoma; Exact test; Internal medicine; Proportional hazards model; Nephrectomy; Kidney cancer; Clinical trial; Kidney","score_opus":0.011349107154420819,"score_gpt":0.2429298117199134,"score_spread":0.2315807045654926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990139923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98440784,0.007901348,0.00012560231,0.0063407226,0.00007999646,0.00041490607,0.000005437007,0.000004972058,0.0007191684],"genre_scores_gemma":[0.99381435,0.00013864167,0.0051166867,0.00013764296,0.00010691108,0.0000054375037,0.000011550442,0.00001909486,0.0006497073],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981284,0.00006485947,0.0006991518,0.00020366006,0.0007128166,0.00019111022],"domain_scores_gemma":[0.9988335,0.00029102684,0.00032361448,0.00011561734,0.00021120852,0.00022504834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056584174,0.00019080905,0.0005616286,0.000306181,0.00005043229,0.000011767919,0.00004033234,0.00008931386,0.000026556923],"category_scores_gemma":[0.00006573047,0.000117897944,0.0000636188,0.00014751639,0.000065319015,0.00013124253,0.000011033089,0.00030825485,0.0000013207732],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00490177,0.00011746655,0.31226188,0.00013890614,0.000055505338,0.00033101643,0.0007616438,0.00007186066,0.68076646,0.000024629475,0.00008851539,0.00048033407],"study_design_scores_gemma":[0.012659771,0.0018602556,0.86408186,0.0010021031,0.00010745269,0.00013949849,0.00013549394,0.000014857525,0.11945287,0.0002396606,0.00019102906,0.00011512975],"about_ca_topic_score_codex":0.000015757169,"about_ca_topic_score_gemma":0.00003879201,"teacher_disagreement_score":0.56131357,"about_ca_system_score_codex":0.000108145345,"about_ca_system_score_gemma":0.00009655918,"threshold_uncertainty_score":0.48077387},"labels":[],"label_agreement":null},{"id":"W2990378832","doi":"10.23736/s0393-2249.19.03496-9","title":"Assessment of local tumor ablation and non-interventional management versus partial nephrectomy in T1a renal cell carcinoma","year":2020,"lang":"en","type":"article","venue":"Minerva Urologica e Nefrologica","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Propensity score matching; Urology; Nephrectomy; Internal medicine; Incidence (geometry); Surgery; Gastroenterology; Kidney","score_opus":0.03222223105910394,"score_gpt":0.27020822593485433,"score_spread":0.2379859948757504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990378832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983181,0.00039939326,0.0011787388,0.0017988101,0.000080966136,0.0009234287,0.000013672952,0.000046111545,0.012377879],"genre_scores_gemma":[0.99384946,0.000023469975,0.004936472,0.0007261338,0.000103548795,0.0001906324,0.00007816381,0.000017140612,0.00007500617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997717,0.00014898817,0.0006352216,0.00068139186,0.0004142819,0.00040310813],"domain_scores_gemma":[0.999075,0.00012504502,0.00023407828,0.0002585833,0.00006625471,0.00024106866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024831912,0.0003164646,0.0006100594,0.00013756535,0.00004925612,0.00001533076,0.0001556264,0.00014499362,0.00044100732],"category_scores_gemma":[0.000025815296,0.00023945652,0.00020434393,0.00029351172,0.00025738115,0.00006713988,0.00022426542,0.00030308057,0.000022620656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017230455,0.0034579348,0.89822966,0.0008070858,0.0003816431,0.005605474,0.00026351277,0.0040095286,0.05925627,0.0010729351,0.0014547061,0.008230784],"study_design_scores_gemma":[0.0090063475,0.010699309,0.959553,0.000024100991,0.00025953888,0.0000374836,0.00014607029,0.015236415,0.0038347433,0.000045227007,0.00095229765,0.00020548851],"about_ca_topic_score_codex":0.00005956491,"about_ca_topic_score_gemma":0.000011288673,"teacher_disagreement_score":0.061323307,"about_ca_system_score_codex":0.00010822686,"about_ca_system_score_gemma":0.000045775734,"threshold_uncertainty_score":0.97647536},"labels":[],"label_agreement":null},{"id":"W2990722922","doi":"10.1016/j.jvir.2019.09.011","title":"Long-Term Survival after Percutaneous Radiofrequency Ablation of Pathologically Proven Renal Cell Carcinoma in 100 Patients","year":2019,"lang":"en","type":"article","venue":"Journal of Vascular and Interventional Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"David Geffen School of Medicine, University of California, Los Angeles; University of California, Los Angeles","keywords":"Medicine; Percutaneous; Ablation; Chromophobe cell; Radiofrequency ablation; Statistical significance; Urology; Renal cell carcinoma; Survival rate; Renal function; Retrospective cohort study; Surgery; Incidence (geometry); Internal medicine; Clear cell","score_opus":0.011858045586130182,"score_gpt":0.24542695853725308,"score_spread":0.2335689129511229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990722922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941122,0.0047609727,0.00009896843,0.000046767993,0.00021284717,0.00031651455,0.0000080876935,0.0000024268693,0.0004412051],"genre_scores_gemma":[0.9991796,0.0001734676,0.00038597733,0.00002950698,0.00008126794,0.0000045809234,0.000031994463,0.000012516037,0.000101114594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982428,0.00024573063,0.0008077214,0.00020230957,0.00032173604,0.0001797222],"domain_scores_gemma":[0.99904627,0.00007129661,0.0003814341,0.00015013595,0.00025026174,0.00010063238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045174264,0.00015731518,0.0005977769,0.00025789268,0.000012472621,0.000006809284,0.000088501125,0.00014144529,0.00039051232],"category_scores_gemma":[0.00005907634,0.00011449808,0.00052502006,0.000078836754,0.00008098947,0.000100903344,0.000033999248,0.00025781244,0.0000063478956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011644531,0.00079173554,0.98335236,0.00023276592,0.00015072267,0.0009746941,0.000114213406,0.00003052408,0.011809203,0.00004017503,0.00001018822,0.001328935],"study_design_scores_gemma":[0.003521317,0.00687089,0.9852847,0.00020561552,0.00016169368,0.0028991143,0.000015595262,0.000021016378,0.0007890197,0.00011328924,0.000025938356,0.000091806425],"about_ca_topic_score_codex":0.000013356529,"about_ca_topic_score_gemma":0.0000033141519,"teacher_disagreement_score":0.011020183,"about_ca_system_score_codex":0.00017689916,"about_ca_system_score_gemma":0.00007856269,"threshold_uncertainty_score":0.46690962},"labels":[],"label_agreement":null},{"id":"W2990897686","doi":"10.5489/cuaj.6103","title":"Identification of tumor size as the only factor associated with non-diagnostic biopsies in patients with small renal masses","year":2019,"lang":"en","type":"letter","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Queen's University; Dalhousie University; University of Toronto; Princess Margaret Cancer Centre; Saint John Regional Hospital; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Biopsy; Renal mass; Radiology; Confidence interval; Gold standard (test); Indeterminate; Surgery; Internal medicine; Kidney; Nephrectomy","score_opus":0.011415556822282309,"score_gpt":0.19622422402227196,"score_spread":0.18480866719998965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990897686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8550016,0.00005969564,0.0000025435163,0.14331067,0.00017418245,0.0009451265,0.00025430616,0.000011582766,0.0002402926],"genre_scores_gemma":[0.9155879,0.000013676845,0.000037124468,0.08202727,0.0004105421,0.000030157624,0.00040521604,0.000049406983,0.0014387246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965517,0.0004417901,0.00080382824,0.0004007668,0.0010976847,0.00070422015],"domain_scores_gemma":[0.99409145,0.0026598894,0.0017610278,0.00030638886,0.00092925644,0.0002520138],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00053862954,0.00040741407,0.000791188,0.00034907562,0.0001524446,0.00013249858,0.00029489925,0.0006766283,0.00025931868],"category_scores_gemma":[0.0048320284,0.00022871359,0.00018161043,0.00044309223,0.000100099656,0.00008974436,0.00001915907,0.0023614625,0.000049874077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016248968,0.00010920109,0.9654778,0.000024646444,0.0004943647,0.0007047721,0.00012337451,0.00003307677,0.000015571015,0.0000011177672,0.0327766,0.000076954944],"study_design_scores_gemma":[0.0025877345,0.0018344598,0.9814247,0.0002318123,0.00045793358,0.00009422498,0.000030690913,0.000006748059,0.000031105075,0.000031283333,0.013019598,0.00024971474],"about_ca_topic_score_codex":0.0017149583,"about_ca_topic_score_gemma":0.0028037655,"teacher_disagreement_score":0.0612834,"about_ca_system_score_codex":0.0032181602,"about_ca_system_score_gemma":0.0020947077,"threshold_uncertainty_score":0.99994016},"labels":[],"label_agreement":null},{"id":"W2992439077","doi":"10.1016/j.clgc.2019.11.010","title":"A Plea for Optimizing Selection in Current Adjuvant Immunotherapy Trials for High-risk Nonmetastatic Renal Cell Carcinoma According to Expected Cancer-specific Mortality","year":2019,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; McGill University Health Centre; Université de Montréal; Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Renal cell carcinoma; Nivolumab; Kidney cancer; Internal medicine; Oncology; Nephrectomy; Ipilimumab; Pembrolizumab; Cancer; Adjuvant therapy; Immunotherapy; Kidney","score_opus":0.18648242834762796,"score_gpt":0.4384022978983788,"score_spread":0.25191986955075085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992439077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97522175,0.010698313,0.003418551,0.000297909,0.002408403,0.00750365,0.00035711165,0.000064088934,0.000030206078],"genre_scores_gemma":[0.9783899,0.0033334529,0.010793976,0.00018901602,0.0020828166,0.0047156564,0.000109552384,0.00011816708,0.00026744886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99505407,0.0005259588,0.0021140005,0.0011540733,0.0003991889,0.00075273594],"domain_scores_gemma":[0.9962451,0.0017188387,0.0007859661,0.0005245373,0.00032102948,0.0004045274],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002008696,0.0004923323,0.0019776195,0.0002903842,0.00013321481,0.00004448198,0.0002208058,0.00020293091,0.00030787577],"category_scores_gemma":[0.0003311997,0.0004144107,0.0008360402,0.00046365752,0.000050284707,0.00012481536,0.00007030627,0.00052608666,0.000020389663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031742267,0.0023118118,0.6760288,0.00089782634,0.0007854726,0.00005433418,0.00066869403,0.0060269544,0.07418278,0.000011270249,0.0037511778,0.20353863],"study_design_scores_gemma":[0.04971531,0.012496265,0.85488534,0.00083715486,0.0015592524,0.000014492239,0.0007080357,0.0038583216,0.064663626,0.00018120746,0.00985276,0.0012282261],"about_ca_topic_score_codex":0.0009007913,"about_ca_topic_score_gemma":0.00013641719,"teacher_disagreement_score":0.2023104,"about_ca_system_score_codex":0.0011379255,"about_ca_system_score_gemma":0.0007257975,"threshold_uncertainty_score":0.9998308},"labels":[],"label_agreement":null},{"id":"W2992570001","doi":"10.1186/s40425-019-0559-3","title":"Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study","year":2019,"lang":"en","type":"erratum","venue":"Journal for ImmunoTherapy of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta; University of Calgary; BC Cancer Agency","funders":"National Cancer Institute; Bristol-Myers Squibb","keywords":"Pazopanib; Sunitinib; Nivolumab; Renal cell carcinoma; Medicine; Oncology; Internal medicine; Immunotherapy; Cancer","score_opus":0.02364807024486524,"score_gpt":0.32243165102808974,"score_spread":0.2987835807832245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992570001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816694,0.00781455,0.00007864195,0.00026471136,0.0045068962,0.0052096928,0.00005136231,0.000006535399,0.00039817917],"genre_scores_gemma":[0.9258496,0.0045498786,0.00031517827,0.00009004038,0.00016926495,0.00025719317,0.000046908688,0.00012217565,0.06859973],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9974153,0.00022527724,0.0011175041,0.00032415884,0.0005977658,0.00031999568],"domain_scores_gemma":[0.9975254,0.00047890292,0.0011317867,0.0003696313,0.00042382703,0.00007048115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007923672,0.00039483863,0.0013021734,0.0005171228,0.000083824,0.00002621539,0.00019267661,0.0001102123,0.00012657308],"category_scores_gemma":[0.00008495514,0.00020996961,0.00015969458,0.00049975706,0.00007518715,0.000110732166,0.00002388425,0.0008281327,5.598857e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69093245,0.010075144,0.04071864,0.0035234992,0.003007601,0.00044598582,0.024866214,0.002739315,0.016803604,0.0000063955763,0.033297133,0.17358404],"study_design_scores_gemma":[0.1310944,0.060341164,0.7606519,0.006615684,0.0012735791,0.00041209543,0.006436768,0.00041495616,0.008852407,0.000015356845,0.023223309,0.00066837325],"about_ca_topic_score_codex":0.0011892214,"about_ca_topic_score_gemma":0.0036656174,"teacher_disagreement_score":0.7199333,"about_ca_system_score_codex":0.00083296467,"about_ca_system_score_gemma":0.0013316629,"threshold_uncertainty_score":0.8562312},"labels":[],"label_agreement":null},{"id":"W2992618195","doi":"10.1016/j.ajur.2019.11.004","title":"Comparison of the oncological, perioperative and functional outcomes of partial nephrectomy versus radical nephrectomy for clinical T1b renal cell carcinoma: A systematic review and meta-analysis of retrospective studies","year":2019,"lang":"en","type":"review","venue":"Asian journal of urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Meta-analysis; Perioperative; Urology; Oncology; Surgery; Internal medicine; Kidney","score_opus":0.32734103527649194,"score_gpt":0.46895021818935634,"score_spread":0.1416091829128644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992618195","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0050148303,0.99060047,0.000027741527,0.0006744492,0.00022596253,0.0032972477,0.00008801601,0.0000022822026,0.00006897899],"genre_scores_gemma":[0.15617272,0.84255207,0.00071758387,0.00013905812,0.0000844208,0.00019844898,0.000016137128,0.000031178006,0.00008838041],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9924135,0.002260184,0.0040852195,0.00044788336,0.0005536232,0.00023957233],"domain_scores_gemma":[0.98918974,0.0035102258,0.005771936,0.0005037984,0.0008620672,0.00016223745],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00207171,0.00052247295,0.021282194,0.00036288679,0.000064748354,0.0000066826697,0.00023427422,0.0003675002,0.00007228095],"category_scores_gemma":[0.0018578944,0.00024008223,0.0053092544,0.0004746159,0.00097499747,0.000045407116,0.00014372997,0.00077795325,6.521562e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023627153,0.0013172426,0.023370856,0.39038786,0.580081,0.00006743254,0.00068441307,0.0000058445175,0.000003576114,0.00022373746,0.00057780754,0.00091754034],"study_design_scores_gemma":[0.0031580357,0.008636016,0.0070120767,0.0022597313,0.9736129,0.00024321064,0.00024705395,0.000007796995,0.000006957985,0.000006603308,0.0046503036,0.00015929625],"about_ca_topic_score_codex":0.0000029397324,"about_ca_topic_score_gemma":0.000006233411,"teacher_disagreement_score":0.39353195,"about_ca_system_score_codex":0.00015330753,"about_ca_system_score_gemma":0.0005890941,"threshold_uncertainty_score":0.9932479},"labels":[],"label_agreement":null},{"id":"W2994470113","doi":"10.1503/cmaj.191128","title":"Benign splenic regrowth mistaken as recurrent renal cell carcinoma","year":2019,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Renal cell carcinoma; Medicine; Carcinoma; Kidney; Resection; Nephrectomy; Pathology; General surgery; Urology; Surgery; Internal medicine","score_opus":0.009581890578174204,"score_gpt":0.2228540082123951,"score_spread":0.21327211763422088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994470113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91711664,0.0009153396,0.0000060706784,0.015079633,0.0009657538,0.00034068257,0.000019642986,0.000021914939,0.06553434],"genre_scores_gemma":[0.982594,0.00009565027,0.00014558084,0.004493644,0.0014447576,0.000008586166,0.0000545755,0.000038710947,0.011124472],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957399,0.00021159764,0.0006178634,0.00034488464,0.0022747011,0.00081105967],"domain_scores_gemma":[0.99525285,0.00014919136,0.00032334993,0.00028551294,0.0004736654,0.0035154116],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012077389,0.00024894509,0.0004589387,0.00030647748,0.00018357756,0.00008426597,0.0002373313,0.00047086205,0.015366758],"category_scores_gemma":[0.00060495065,0.00021353702,0.00030401192,0.00028666086,0.000032346325,0.00010609301,0.000020756042,0.0013964848,0.0026613383],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0002684694,0.00029322755,0.59738994,0.00012441014,0.00037948517,0.008351044,0.00093658525,0.000004230199,0.0010611359,0.00040119342,0.36561507,0.025175234],"study_design_scores_gemma":[0.009218085,0.0022659132,0.38862467,0.00035475142,0.00038093477,0.0056916582,0.0007786072,0.00023929373,0.002810618,0.00035230618,0.5886408,0.0006423312],"about_ca_topic_score_codex":0.0029167458,"about_ca_topic_score_gemma":0.003928938,"teacher_disagreement_score":0.22302577,"about_ca_system_score_codex":0.0039358945,"about_ca_system_score_gemma":0.0065888343,"threshold_uncertainty_score":0.9998878},"labels":[],"label_agreement":null},{"id":"W2995025482","doi":"10.1016/j.urology.2019.11.036","title":"Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging Criteria","year":2019,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Stage (stratigraphy); Renal cell carcinoma; Hazard ratio; Nephrectomy; Clear cell; T-stage; Odds ratio; Pathological; Oncology; Internal medicine; Cancer; Confidence interval; Kidney","score_opus":0.03770620589719608,"score_gpt":0.3389420625200428,"score_spread":0.3012358566228467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995025482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973952,0.000053183318,0.00025323493,0.00020214227,0.0005187188,0.00094138936,0.00046720338,0.000010557981,0.00015837868],"genre_scores_gemma":[0.99924606,0.000011678323,0.00012379144,0.00024239953,0.00007948812,0.00004166958,0.0002214956,0.000016089674,0.000017338194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777305,0.0005699481,0.0005836738,0.0005042176,0.00030673484,0.00026237874],"domain_scores_gemma":[0.9983555,0.00041421945,0.0003256465,0.0005960614,0.00015435275,0.0001541898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082582753,0.00018850282,0.0004458897,0.00024862814,0.0000788243,0.00001976284,0.0002332952,0.000055940607,0.00009931526],"category_scores_gemma":[0.00037306885,0.00011429446,0.00025489024,0.00031452705,0.00012662512,0.00009609927,0.00012984502,0.00025209005,0.0000016894744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060833804,0.00029710802,0.9974615,0.0000316252,0.0002091928,0.000004624308,0.0005362992,0.00024848492,0.00010923823,0.0000279006,0.000038345792,0.00042737354],"study_design_scores_gemma":[0.0014218135,0.0005142788,0.9908118,0.000010982579,0.0011398982,7.039063e-7,0.00026886567,0.0049671363,0.0005219955,0.000108464024,0.0001379731,0.000096079755],"about_ca_topic_score_codex":0.00032044316,"about_ca_topic_score_gemma":0.00009695204,"teacher_disagreement_score":0.006649661,"about_ca_system_score_codex":0.000076962504,"about_ca_system_score_gemma":0.00007340129,"threshold_uncertainty_score":0.46607926},"labels":[],"label_agreement":null},{"id":"W2995069737","doi":"10.1159/000504787","title":"Transverse Lumbotomy for Open Partial/Radical Nephrectomy: How I Do It","year":2019,"lang":"en","type":"article","venue":"Urologia Internationalis","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University","funders":"","keywords":"Medicine; Nephrectomy; Surgery; Kidney; Open surgery; Urology; Internal medicine","score_opus":0.04400930435297214,"score_gpt":0.3112755644266112,"score_spread":0.2672662600736391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995069737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94069093,0.00013406263,0.0010749823,0.031644348,0.0005723609,0.0026415258,0.00009316298,0.0000763796,0.023072213],"genre_scores_gemma":[0.98236835,0.000012103705,0.003425608,0.0030706595,0.00020921913,0.00038083806,0.00023050039,0.00002955973,0.010273175],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987109,0.000044347373,0.00022011863,0.00042637202,0.00033905837,0.00025924802],"domain_scores_gemma":[0.99910164,0.00019114518,0.000089473484,0.00033297576,0.00014536383,0.00013938069],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024651972,0.00018006546,0.00032448833,0.00009825452,0.00003767987,0.00010826448,0.00038587992,0.0001247797,0.00266312],"category_scores_gemma":[0.00012098259,0.00014531509,0.0002049208,0.00008768165,0.00006435749,0.00016918305,0.00008819423,0.00014791328,0.00029781673],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008972361,0.0020252638,0.62905705,0.00030883032,0.0025964908,0.00059169286,0.0013227465,0.00016708947,0.020610336,0.051490597,0.27085924,0.011998337],"study_design_scores_gemma":[0.009003113,0.0018194185,0.0296806,0.000054368487,0.00025526533,0.00013974804,0.00008697898,0.0018452324,0.013222247,0.0008048257,0.9428093,0.0002789372],"about_ca_topic_score_codex":0.0000989614,"about_ca_topic_score_gemma":0.000016394193,"teacher_disagreement_score":0.67195004,"about_ca_system_score_codex":0.00016481528,"about_ca_system_score_gemma":0.00011233184,"threshold_uncertainty_score":0.9982486},"labels":[],"label_agreement":null},{"id":"W2995462641","doi":"10.1097/pas.0000000000001422","title":"“Renal Cell Carcinoma With Leiomyomatous Stroma” Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity","year":2019,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Tuberous sclerosis; Renal cell carcinoma; Pathology; Biology; Stroma; TSC1; Carcinoma; Immunohistochemistry; Clear cell; Clear cell carcinoma; Cancer research; Medicine; PI3K/AKT/mTOR pathway; Genetics","score_opus":0.011012388137294465,"score_gpt":0.24748024138668123,"score_spread":0.23646785324938677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995462641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99872744,0.00027043777,0.00018212409,0.00023301215,0.000045197758,0.00041062024,0.00003176164,0.000008635744,0.000090758534],"genre_scores_gemma":[0.998877,0.000084622894,0.00086715503,0.000051052823,0.000033416047,0.000006763077,0.000023652881,0.000025885081,0.000030481131],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780893,0.0004172905,0.00090876874,0.00025196737,0.00035493815,0.0002581096],"domain_scores_gemma":[0.99726176,0.00028808552,0.0017531001,0.00031777364,0.00018286235,0.00019641742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057046127,0.00023664188,0.0011958213,0.00021395904,0.000042433207,0.000009485949,0.00012941177,0.000053812742,0.00013494758],"category_scores_gemma":[0.00003989239,0.00013229644,0.00014442675,0.00026299007,0.0010801973,0.00007762679,0.000060745566,0.00026981442,0.0000030132735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040105903,0.00068121956,0.7087911,0.00027292533,0.00010776375,0.014695113,0.0006273756,0.000009473313,0.26918426,0.00004743252,0.0000033373872,0.001569411],"study_design_scores_gemma":[0.003431786,0.011284938,0.95047957,0.00013210833,0.0005419642,0.019832833,0.00044747867,0.00006308545,0.013581775,0.000046559264,0.000014964402,0.00014291385],"about_ca_topic_score_codex":0.00001890487,"about_ca_topic_score_gemma":9.1186894e-7,"teacher_disagreement_score":0.25560248,"about_ca_system_score_codex":0.00003852281,"about_ca_system_score_gemma":0.00021834136,"threshold_uncertainty_score":0.5394892},"labels":[],"label_agreement":null},{"id":"W2995591367","doi":"10.1016/j.anndiagpath.2019.151448","title":"Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture","year":2019,"lang":"en","type":"article","venue":"Annals of Diagnostic Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of British Columbia; University of Calgary; Royal Columbian Hospital","funders":"Univerzita Karlova v Praze","keywords":"Chromophobe cell; Pathology; CD117; Clear cell; Biology; Eosinophilic; Population; Immunohistochemistry; Medicine; CD34","score_opus":0.03528966721309211,"score_gpt":0.2823150294146984,"score_spread":0.24702536220160626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995591367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99434,0.0030089668,0.0000114939485,0.00036506943,0.000067506975,0.0012689356,0.000039926497,0.000012383062,0.00088569906],"genre_scores_gemma":[0.99937326,0.0001943753,0.00010040769,0.00014318404,0.00004473626,0.000042539166,0.000018278408,0.00002603887,0.00005718314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981461,0.00026701862,0.0005163283,0.00037753562,0.00034948115,0.0003434975],"domain_scores_gemma":[0.996257,0.0022812022,0.00045802322,0.00077626976,0.00014385358,0.00008361673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003051483,0.00025813846,0.000862908,0.00019408464,0.00003372597,0.0000024489511,0.00019744657,0.00010208611,0.00012720685],"category_scores_gemma":[0.0003976888,0.00014570216,0.00015125376,0.00027754702,0.00028404954,0.000027758528,0.000111055764,0.0002315993,0.000008931691],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001288868,0.0033674894,0.85409766,0.00045994244,0.00021628676,0.013154217,0.004090618,0.0004746016,0.12221999,0.000030620122,0.00020708759,0.00039263864],"study_design_scores_gemma":[0.002358387,0.023278465,0.6194869,0.00013872395,0.0003020265,0.0022096087,0.0015385315,0.0000020519988,0.35047963,0.000085966196,0.0000054408692,0.0001142447],"about_ca_topic_score_codex":0.00030750033,"about_ca_topic_score_gemma":0.000048140126,"teacher_disagreement_score":0.23461072,"about_ca_system_score_codex":0.000016332011,"about_ca_system_score_gemma":0.0001042182,"threshold_uncertainty_score":0.59415615},"labels":[],"label_agreement":null},{"id":"W2995982924","doi":"10.1016/j.anndiagpath.2019.151441","title":"Papillary renal cell carcinoma with prominent spindle cell stroma - tumor mimicking mixed epithelial and stromal tumor of the kidney: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 6 cases","year":2019,"lang":"en","type":"article","venue":"Annals of Diagnostic Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Royal Columbian Hospital","funders":"Univerzita Karlova v Praze","keywords":"Pathology; Stroma; Vimentin; Stromal cell; Biology; CD34; Desmin; Immunohistochemistry; Papillary renal cell carcinomas; Carcinoma; Medicine; Stem cell","score_opus":0.018748671836755604,"score_gpt":0.25712777301686185,"score_spread":0.23837910118010625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995982924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931074,0.005251789,0.000018351597,0.0001755456,0.00006567734,0.0009877741,0.00027302944,0.0000107144315,0.00010971924],"genre_scores_gemma":[0.99750364,0.00018776582,0.0018110818,0.00032949136,0.000019912599,0.00004690301,0.000052765663,0.000031053347,0.000017362805],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973324,0.0003441955,0.00088325446,0.0006574813,0.0003578415,0.000424818],"domain_scores_gemma":[0.99688345,0.0009959274,0.0008637309,0.00079493807,0.00025703417,0.00020489634],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003401966,0.00037763515,0.0013919714,0.0002788402,0.00004043764,0.0000058174155,0.0002184731,0.00014952579,0.00005262751],"category_scores_gemma":[0.00083651283,0.00025108946,0.0003306851,0.00035562814,0.00077720464,0.000032472086,0.00026063784,0.0002479795,0.0000017640457],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044263146,0.00036839212,0.4537555,0.00028610838,0.00015573805,0.002950051,0.00012652519,0.000032839245,0.5417777,0.0000055258597,0.000023463257,0.000075560645],"study_design_scores_gemma":[0.0013325603,0.0045163725,0.5220351,0.00010298314,0.0015256662,0.000859275,0.00010282585,0.00004559048,0.46933293,0.000018501321,0.00000245453,0.00012570542],"about_ca_topic_score_codex":0.00012926814,"about_ca_topic_score_gemma":0.0000037521463,"teacher_disagreement_score":0.07244473,"about_ca_system_score_codex":0.000025407246,"about_ca_system_score_gemma":0.00020790128,"threshold_uncertainty_score":0.99999416},"labels":[],"label_agreement":null},{"id":"W2996164021","doi":"10.1016/j.clgc.2019.12.007","title":"Clinical Outcomes of First-line Sunitinib Followed by Immuno-oncology Checkpoint Inhibitors in Patients With Metastatic Renal Cell Carcinoma","year":2019,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; CancerCare Manitoba; Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Manitoba; University of Calgary","funders":"Mailman School of Public Health, Columbia University; Foundation Medicine; Genentech; Ipsen; Bayer; Calithera Biosciences; Bristol-Myers Squibb Canada; Eisai; Eli Lilly and Company; National Comprehensive Cancer Network; F. Hoffmann-La Roche; Pfizer Canada; Alexion Pharmaceuticals; Dana-Farber Cancer Institute; Roche; Novartis; Exelixis; Sanofi; Merck; GlaxoSmithKline; Instituto de Salud Carlos III; Amgen; Pfizer; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Sunitinib; Hazard ratio; Discontinuation; Renal cell carcinoma; Internal medicine; Odds ratio; Oncology; Confidence interval; Retrospective cohort study; Kidney cancer","score_opus":0.03917808895234826,"score_gpt":0.3492407280194261,"score_spread":0.31006263906707787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996164021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99371123,0.001148206,0.0000042738156,0.00056041725,0.0010384519,0.0018550989,0.00010021591,0.000031728083,0.0015503698],"genre_scores_gemma":[0.9960182,0.00031750268,0.0008803986,0.00043403628,0.00023568893,0.00013132878,0.00023560098,0.0000694133,0.0016778413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99458903,0.000525117,0.0027832245,0.0008645142,0.0006345614,0.0006035371],"domain_scores_gemma":[0.9960199,0.0013978772,0.0009036384,0.00091160985,0.0003384447,0.0004285046],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010461904,0.0004902597,0.002147424,0.00018725298,0.000044221462,0.000008807878,0.00027653066,0.00034232778,0.000546972],"category_scores_gemma":[0.00022435759,0.00034972056,0.00077621086,0.00035830514,0.00036338478,0.00010621283,0.0002090516,0.00085846806,0.000050569222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067443047,0.006180661,0.97998416,0.00019548468,0.00039040705,0.0002886829,0.00009146362,0.000027253547,0.00021053004,6.2819294e-7,0.0020203849,0.00386604],"study_design_scores_gemma":[0.030748023,0.017739633,0.94420445,0.0001659966,0.0006046803,0.000007145024,0.00011478042,0.000029270144,0.0020719767,0.000007024664,0.003960397,0.00034660543],"about_ca_topic_score_codex":0.00033809754,"about_ca_topic_score_gemma":0.00010994419,"teacher_disagreement_score":0.035779692,"about_ca_system_score_codex":0.00040628333,"about_ca_system_score_gemma":0.0006338574,"threshold_uncertainty_score":0.99989545},"labels":[],"label_agreement":null},{"id":"W2996329164","doi":"10.1053/j.sult.2019.12.004","title":"Imaging of Renal Cancer","year":2019,"lang":"en","type":"review","venue":"Seminars in Ultrasound CT and MRI","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University Health Network; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Radiology; Renal mass; Ultrasound; Grading (engineering); Biopsy; Kidney; Nephrectomy; Internal medicine","score_opus":0.03142675491986242,"score_gpt":0.33190173126428385,"score_spread":0.30047497634442144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996329164","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00214374,0.99154216,0.0000022104998,0.000018485447,0.00018512378,0.00071565394,0.00003643596,0.00001104592,0.0053451406],"genre_scores_gemma":[0.0009549603,0.9956915,0.0001632133,0.000023812609,0.000094304145,0.00006846041,0.00010421618,0.000044816235,0.0028547372],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99862254,0.000050391453,0.00047489707,0.00037861167,0.00021435632,0.00025918256],"domain_scores_gemma":[0.99899894,0.00030395598,0.0002268031,0.00034866025,0.000031811378,0.00008982794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001734594,0.0003363266,0.0015961917,0.00021695229,0.000017775732,0.000011067034,0.000090799374,0.0000727544,0.00012459587],"category_scores_gemma":[0.00003520386,0.00024368762,0.00027711835,0.00020931926,0.00010069345,0.00003364324,0.000037034788,0.00031485333,0.0000140105785],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025671487,0.00008161984,0.0055134776,0.02306991,0.00018884588,0.00031330812,0.00014061805,4.7460696e-7,0.00005037943,0.000025403473,0.0016646484,0.96892565],"study_design_scores_gemma":[0.0005456675,0.00011337264,0.00022323217,0.056773517,0.0019354478,0.001767988,0.00006646198,0.0000017377562,0.00011106235,0.000029132769,0.93817425,0.00025812627],"about_ca_topic_score_codex":0.00013847028,"about_ca_topic_score_gemma":0.000011274652,"teacher_disagreement_score":0.9686675,"about_ca_system_score_codex":0.00022496532,"about_ca_system_score_gemma":0.00028888913,"threshold_uncertainty_score":0.9937293},"labels":[],"label_agreement":null},{"id":"W2997000594","doi":"10.3390/cancers12010084","title":"Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors","year":2019,"lang":"en","type":"article","venue":"Cancers","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cabozantinib; Renal cell carcinoma; Medicine; Focus (optics); Oncology; Internal medicine; Cancer research; Pathology","score_opus":0.039523383185466936,"score_gpt":0.27808300558686677,"score_spread":0.23855962240139983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997000594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99266344,0.00016513796,3.168684e-7,0.000051723746,0.0000587184,0.0019246428,0.000111550864,0.000030085921,0.00499439],"genre_scores_gemma":[0.99865794,0.000044820266,0.0001065031,0.000048887767,0.000018856163,0.00005144833,0.00041095619,0.00003972719,0.000620874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821144,0.00008057181,0.00026020524,0.0006784797,0.0003918166,0.00037748678],"domain_scores_gemma":[0.9987227,0.00019105797,0.00016265566,0.0006813738,0.000053418833,0.00018883053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009822059,0.00030585894,0.0004986113,0.0002406524,0.00003436584,0.000021941858,0.00014367065,0.000031154275,0.00004152081],"category_scores_gemma":[0.000029548655,0.00019597563,0.000031403997,0.00037313954,0.00010446182,0.00010247006,0.000041712738,0.00019293519,0.000020917454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010462631,0.0001192463,0.99693644,0.00014397489,0.00005853078,0.00015751184,0.00031866517,0.00010320916,0.00013594149,0.000012058491,0.0001267409,0.0008413904],"study_design_scores_gemma":[0.0052374587,0.004966009,0.98244584,0.0004022014,0.00028160602,0.0000029643984,0.00015075135,0.0001409781,0.006059495,0.0000052337846,0.00008596487,0.00022149188],"about_ca_topic_score_codex":0.008885517,"about_ca_topic_score_gemma":0.0028505179,"teacher_disagreement_score":0.014490622,"about_ca_system_score_codex":0.00096121634,"about_ca_system_score_gemma":0.0004501144,"threshold_uncertainty_score":0.9977144},"labels":[],"label_agreement":null},{"id":"W2997361961","doi":"10.3233/kca-190077","title":"Individualization of Dose and Schedule Based On Toxicity for Oral VEGF Drugs in Kidney Cancer","year":2019,"lang":"en","type":"article","venue":"Kidney Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Dosing; Medicine; Toxicity; Vascular endothelial growth factor; Cancer; Drug; Tyrosine-kinase inhibitor; Adjuvant; Oncology; VEGF receptors; Pharmacology; Internal medicine","score_opus":0.0229485505792703,"score_gpt":0.3077115109704465,"score_spread":0.2847629603911762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997361961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99351114,0.00048944715,0.00002676606,0.002641993,0.00026402422,0.0012058964,0.0003502695,0.00001918995,0.001491267],"genre_scores_gemma":[0.9934726,0.000104403865,0.0005989817,0.0045338706,0.00007822544,0.00029713017,0.0001334393,0.000030235246,0.0007511594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989151,0.000036341466,0.00023567662,0.0003144947,0.0002727167,0.00022568618],"domain_scores_gemma":[0.9991989,0.000048743685,0.00011074237,0.00023802703,0.000095233474,0.00030834632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016633223,0.00016551651,0.00035467176,0.00016055607,0.000022045666,0.000009339079,0.00005444589,0.000100538906,0.0007680557],"category_scores_gemma":[0.00012927265,0.00013823123,0.00006413238,0.00021306197,0.00004210291,0.00006434341,0.000020596966,0.00009518905,0.0000060596285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018990635,0.0004950278,0.94997835,0.0017098972,0.0001282716,0.0000050992753,0.0010900706,0.00036721007,0.028622529,0.0001936663,0.0076760426,0.00783477],"study_design_scores_gemma":[0.030936562,0.0019081826,0.6586628,0.0038576017,0.00042938543,0.0000026165292,0.00015798988,0.015127607,0.26412526,0.00014407153,0.024114627,0.0005333173],"about_ca_topic_score_codex":0.00093019585,"about_ca_topic_score_gemma":0.000082223385,"teacher_disagreement_score":0.29131556,"about_ca_system_score_codex":0.00037371457,"about_ca_system_score_gemma":0.0009133553,"threshold_uncertainty_score":0.84096706},"labels":[],"label_agreement":null},{"id":"W2997429003","doi":"10.1016/j.jvir.2019.11.001","title":"Society of Interventional Radiology Position Statement on the Role of Percutaneous Ablation in Renal Cell Carcinoma","year":2020,"lang":"en","type":"review","venue":"Journal of Vascular and Interventional Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Regional Health Centre","funders":"Guerbet; Jounce Therapeutics; BTG; Boston Scientific Corporation","keywords":"Medicine; Renal cell carcinoma; Scopus; Kidney cancer; Incidence (geometry); Cancer; Carcinoma; Clear cell carcinoma; Radiology; Internal medicine; MEDLINE","score_opus":0.02866292779761469,"score_gpt":0.2972103605953955,"score_spread":0.2685474327977808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997429003","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05299002,0.9456106,0.00023733597,0.0002551404,0.0001332101,0.0005345337,0.00006348519,0.0000023300354,0.00017337712],"genre_scores_gemma":[0.30951723,0.689391,0.0005415551,0.00004258016,0.0002183544,0.000017340792,0.00020578368,0.000028064624,0.00003805983],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962427,0.0008134526,0.002070239,0.000273493,0.00041266292,0.00018746514],"domain_scores_gemma":[0.99741024,0.00036284194,0.0017053762,0.00019012041,0.00023064014,0.00010077125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010291556,0.0003130655,0.0019113935,0.00031347646,0.000032515127,0.000006714017,0.0001850096,0.00027553586,0.00026932984],"category_scores_gemma":[0.0000709413,0.00019888865,0.003156683,0.0001570592,0.00019658232,0.000050492927,0.00006734083,0.00065637485,0.0000032455353],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008662104,0.016702252,0.011654523,0.10011009,0.039747685,0.004273147,0.0034325,0.0006779249,0.013789534,0.021879625,0.01666087,0.76240975],"study_design_scores_gemma":[0.01398608,0.086631976,0.041018713,0.0636111,0.018147755,0.10677847,0.0014341729,0.0012983244,0.0027509064,0.0059687314,0.65691584,0.0014579196],"about_ca_topic_score_codex":0.00001985555,"about_ca_topic_score_gemma":0.0000018133975,"teacher_disagreement_score":0.7609518,"about_ca_system_score_codex":0.0004654127,"about_ca_system_score_gemma":0.00032412916,"threshold_uncertainty_score":0.8110444},"labels":[],"label_agreement":null},{"id":"W2997561837","doi":"10.1681/asn.2019070676","title":"Clinical Features and Outcomes of Immune Checkpoint Inhibitor–Associated AKI: A Multicenter Study","year":2020,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":388,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; American Society of Nephrology","keywords":"Medicine; Nivolumab; Acute kidney injury; Internal medicine; Immune checkpoint; Oncology; Immunotherapy; Cancer","score_opus":0.03302484275956778,"score_gpt":0.32948805111702345,"score_spread":0.29646320835745565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997561837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809717,0.000550642,0.000005293655,0.018066423,0.00008220289,0.00029796732,0.000004301957,0.000005142638,0.000016306534],"genre_scores_gemma":[0.9923459,0.00022057992,0.0013082966,0.0059321336,0.00014112369,0.0000014609128,5.1633936e-7,0.000015179062,0.000034781642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788624,0.00034160074,0.0011014142,0.00014846357,0.0003527804,0.0001694969],"domain_scores_gemma":[0.996858,0.00034401243,0.0021977962,0.00021430964,0.00024834907,0.00013755914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006010896,0.00015550954,0.0013378528,0.000026202242,0.000034712706,0.0000036602194,0.00018596626,0.00007096102,0.000010437012],"category_scores_gemma":[0.00031175071,0.000088757,0.0010518074,0.00019378075,0.00078053324,0.00003190946,0.00017281907,0.0005146958,5.939922e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014728048,0.0012930696,0.92920226,0.000035259767,0.0029062908,0.00002518269,0.0043685753,0.0000054778275,0.056011792,5.1175755e-7,0.0037102369,0.00096856605],"study_design_scores_gemma":[0.004968089,0.007005035,0.97985476,0.00003265871,0.00080945605,0.000056364657,0.005188917,0.00003931272,0.0017859627,0.0000061195246,0.00019681246,0.000056510682],"about_ca_topic_score_codex":0.00011464574,"about_ca_topic_score_gemma":0.0000049315536,"teacher_disagreement_score":0.05422583,"about_ca_system_score_codex":0.00005547674,"about_ca_system_score_gemma":0.00009729674,"threshold_uncertainty_score":0.36194053},"labels":[],"label_agreement":null},{"id":"W2997983547","doi":"10.3390/cancers12010085","title":"Molecular Genetics of Renal Cell Tumors: A Practical Diagnostic Approach","year":2019,"lang":"en","type":"review","venue":"Cancers","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Royal Columbian Hospital","funders":"Ministerstvo Zdravotnictví Ceské Republiky; Univerzita Karlova v Praze","keywords":"Immunohistochemistry; Pathology; Molecular genetics; Molecular pathology; Molecular diagnostics; Medicine; Biology; Bioinformatics; Gene; Genetics","score_opus":0.07758779430680746,"score_gpt":0.3469632603232937,"score_spread":0.26937546601648626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997983547","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023725993,0.98380405,0.00020160206,0.000008978974,0.00012757712,0.0019051329,0.00003942215,0.000018069819,0.013657937],"genre_scores_gemma":[0.0009360127,0.9956384,0.0022897096,0.000044084038,0.00015820707,0.00024433367,0.0002144154,0.0001023322,0.0003725561],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979623,0.00012861162,0.00058843713,0.0005300249,0.00046061652,0.0003299901],"domain_scores_gemma":[0.99802876,0.00039362998,0.00045649134,0.0007966515,0.00009426895,0.00023020672],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011470847,0.00043608167,0.0020249241,0.00014757876,0.000013678049,0.000009684021,0.0001458574,0.00027387167,0.000058156023],"category_scores_gemma":[0.00018758987,0.0003303263,0.00065292616,0.00025951111,0.000113094844,0.000017858541,0.00007082518,0.000460601,0.00009125089],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016835691,0.0006100754,0.00007273826,0.33580023,0.0026728432,0.0046362993,0.00023162144,0.0009789728,0.00015959302,0.00024554713,0.008197772,0.6462259],"study_design_scores_gemma":[0.0010705789,0.0010924734,0.000013716572,0.017926592,0.012395831,0.0007130566,0.000035422243,0.00011382114,0.00079188804,0.000007081808,0.96531975,0.00051975774],"about_ca_topic_score_codex":0.000043912554,"about_ca_topic_score_gemma":3.6200638e-7,"teacher_disagreement_score":0.957122,"about_ca_system_score_codex":0.0019306269,"about_ca_system_score_gemma":0.0048685684,"threshold_uncertainty_score":0.9999149},"labels":[],"label_agreement":null},{"id":"W2998691307","doi":"10.1002/9780471420194.tnmc42.pub2","title":"Kidney","year":2010,"lang":"en","type":"other","venue":"TNM Online","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Grading (engineering); Pathological; Distant metastasis; Lymph node metastasis; Stage (stratigraphy); Metastasis; Lymph node; Medicine; Lymph; Pathology; Cancer; Internal medicine; Biology; Paleontology","score_opus":0.02052056704804813,"score_gpt":0.2891132070631041,"score_spread":0.268592640015056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998691307","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039021223,0.00073095615,0.0000048017364,0.0011540612,0.0004562204,0.00042129756,0.0021090643,0.0003111952,0.9944222],"genre_scores_gemma":[0.00012328397,0.00012837483,0.008453374,0.0012983059,0.0021394338,0.000015858472,0.0068595195,0.00055270275,0.9804292],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991459,0.000010272901,0.00014289026,0.00027853565,0.0002273961,0.00019500779],"domain_scores_gemma":[0.998927,0.000012258166,0.000093877235,0.0006086506,0.00002510726,0.00033308263],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000024703664,0.00025172206,0.00041909117,0.00017506313,0.000010322857,0.0000051193642,0.00008345577,0.00038761046,0.08715901],"category_scores_gemma":[0.00007020726,0.0001869338,0.00013039072,0.00007340315,0.000050829076,0.0000049804353,0.000035427976,0.00042606442,0.0017572426],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021176633,0.00025990754,0.00016382549,0.00013023595,0.00010937672,0.00030424277,0.0000071836075,5.130932e-9,0.00064872444,0.000012404342,0.99339116,0.0049517746],"study_design_scores_gemma":[0.0008293111,0.0001525125,0.00076942664,0.00035038986,0.00022460271,0.00010625528,0.000002672488,0.0000034560728,0.00029569378,0.000007676423,0.99710697,0.00015105792],"about_ca_topic_score_codex":0.00015540663,"about_ca_topic_score_gemma":0.00015179501,"teacher_disagreement_score":0.085401766,"about_ca_system_score_codex":0.000045068417,"about_ca_system_score_gemma":0.00020917655,"threshold_uncertainty_score":0.99902},"labels":[],"label_agreement":null},{"id":"W2998883384","doi":"10.3390/cancers12010168","title":"ESC, ALK, HOT and LOT: Three Letter Acronyms of Emerging Renal Entities Knocking on the Door of the WHO Classification","year":2020,"lang":"en","type":"review","venue":"Cancers","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Rockyview General Hospital; University of Calgary","funders":"","keywords":"Renal cell carcinoma; Medicine; Anaplastic lymphoma kinase; Kidney; Kidney cancer; Pathology; Internal medicine","score_opus":0.08808668481726195,"score_gpt":0.3152412440554458,"score_spread":0.22715455923818384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998883384","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029727283,0.9917741,0.000013046537,0.001221784,0.00025154394,0.0010075449,0.00003430924,0.000010051316,0.0027148977],"genre_scores_gemma":[0.01832956,0.9804292,0.00002695833,0.00031651545,0.00029320974,0.000111602625,0.000019136342,0.00004392736,0.00042989838],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99872106,0.00009170542,0.00041753906,0.0002798423,0.0003334654,0.00015636755],"domain_scores_gemma":[0.9987727,0.00012977913,0.0005065949,0.0004927134,0.000051480052,0.00004672419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013827007,0.0002530778,0.0008794462,0.00006165677,0.00006686077,0.000012600752,0.00019316633,0.0000977936,0.00005972478],"category_scores_gemma":[0.00004479658,0.0001249618,0.00033766392,0.00020196363,0.00023116701,0.000023834058,0.00007006939,0.00031540956,0.0000039960223],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013929816,0.000023060276,0.00039960977,0.02089811,0.0013744796,0.000026239342,0.0017075874,0.000014835801,0.00048410476,0.0011719402,0.015826391,0.9579343],"study_design_scores_gemma":[0.00031966405,0.0001629177,0.0007977563,0.019714542,0.0016445426,0.000017018661,0.00018541567,0.000052555348,0.0007589538,0.000021969185,0.97617614,0.00014852497],"about_ca_topic_score_codex":0.00014257703,"about_ca_topic_score_gemma":0.00004133084,"teacher_disagreement_score":0.96034974,"about_ca_system_score_codex":0.00072648836,"about_ca_system_score_gemma":0.00047442075,"threshold_uncertainty_score":0.5095795},"labels":[],"label_agreement":null},{"id":"W2999289987","doi":"10.6004/jnccn.2019.7350","title":"Conditional Survival of Patients With Nonmetastatic Renal Cell Carcinoma: How Cancer-Specific Mortality Changes After Nephrectomy","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Surgical Specialties (Canada)","funders":"Università degli Studi di Brescia","keywords":"Medicine; Renal cell carcinoma; Proportional hazards model; Nephrectomy; Stage (stratigraphy); Internal medicine; Kidney cancer; Cancer; Oncology; T-stage; Surgery; Kidney","score_opus":0.057162086944132565,"score_gpt":0.27677181937038,"score_spread":0.21960973242624743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999289987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868611,0.0062739463,0.000108174216,0.0052429205,0.0005207206,0.00048527942,0.00039011042,0.000005665774,0.00011209372],"genre_scores_gemma":[0.99543166,0.00015417047,0.0005763262,0.0019023741,0.0017665937,0.00004071365,0.00004204128,0.000030411791,0.00005568104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971604,0.00017594743,0.0004431827,0.00023594887,0.0017296261,0.00025490363],"domain_scores_gemma":[0.99568874,0.00021930508,0.00093583635,0.00013473346,0.0028001734,0.00022124182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010360985,0.00026392651,0.0006278437,0.0000751846,0.00008705288,0.000021388649,0.00020586005,0.000059223472,0.00029099948],"category_scores_gemma":[0.000023917435,0.00016449566,0.00026714086,0.00044617587,0.00018134406,0.00010915757,0.00006990846,0.00039113715,0.0000017053607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056187133,0.0003255268,0.94299525,0.0003047777,0.001133247,0.000074908945,0.00035454755,0.022547415,0.0017825387,0.00005335393,0.024575472,0.00023426472],"study_design_scores_gemma":[0.0042724367,0.0007066301,0.9823908,0.00018849268,0.00050879584,0.000014774683,0.000050856754,0.00012767212,0.0019605327,0.000093839364,0.009525555,0.00015958461],"about_ca_topic_score_codex":0.000014886007,"about_ca_topic_score_gemma":0.000030889125,"teacher_disagreement_score":0.039395597,"about_ca_system_score_codex":0.00042661544,"about_ca_system_score_gemma":0.00050968525,"threshold_uncertainty_score":0.67079383},"labels":[],"label_agreement":null},{"id":"W2999407055","doi":"10.1016/s0923-7534(20)33391-3","title":"A Phase I Dose Escalation Study Investigating Dovitinib and Everolmus in Combination in Metastatic Clear Cell Renal Cancer Patients who have Previously Failed VEGF Targeted Therapy","year":2012,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Oncology; Targeted therapy; Cancer; Internal medicine","score_opus":0.10603385744006608,"score_gpt":0.39948546792198775,"score_spread":0.2934516104819217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999407055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962804,0.0012258869,0.0000020584237,0.00033602054,0.00004437091,0.0017932315,0.000006585023,0.000008883344,0.00030259517],"genre_scores_gemma":[0.998955,0.00022518322,0.00018524281,0.00032097098,0.000026252374,0.00018682105,0.000052532472,0.000019463507,0.000028511166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981121,0.0005165072,0.0005775099,0.0002351832,0.00023962601,0.0003190735],"domain_scores_gemma":[0.9990336,0.00018448684,0.00033942657,0.00013752491,0.00016053233,0.00014443792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007245396,0.00016883608,0.00054777873,0.00026194463,0.000027767368,0.0000061711266,0.000046573314,0.00008303082,0.00003528761],"category_scores_gemma":[0.00013928303,0.00014398838,0.000042999854,0.00022028777,0.000070561415,0.00018606837,0.000030367633,0.00018430926,0.0000021548994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014127776,0.01248682,0.9317,0.000070057446,0.00007327667,0.000025232988,0.012777555,0.000020685238,0.0041079386,0.0000041460908,0.00008771145,0.03723378],"study_design_scores_gemma":[0.030283365,0.018503169,0.9387101,0.000095263465,0.00006433155,0.0000021188162,0.0007375527,0.00091663806,0.010431333,0.000060459995,0.00008533002,0.00011035497],"about_ca_topic_score_codex":0.0008039457,"about_ca_topic_score_gemma":0.0004274787,"teacher_disagreement_score":0.037123423,"about_ca_system_score_codex":0.00015260556,"about_ca_system_score_gemma":0.00012553422,"threshold_uncertainty_score":0.58716756},"labels":[],"label_agreement":null},{"id":"W2999416926","doi":"10.1158/1078-0432.ccr-19-0374","title":"Deep Learning to Distinguish Benign from Malignant Renal Lesions Based on Routine MR Imaging","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Biomedical Imaging and Bioengineering; NIH Clinical Center; National Cancer Institute; National Institutes of Health; National Natural Science Foundation of China; Radiological Society of North America","keywords":"Medicine; Renal cell carcinoma; Deep learning; Radiomics; Artificial intelligence; Radiology; Pathology; Computer science","score_opus":0.2554288077278997,"score_gpt":0.48534024218560434,"score_spread":0.22991143445770462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999416926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94645005,0.00086949265,0.0009953972,0.045051366,0.00019806289,0.00095949677,0.000035841942,0.00013843249,0.0053018318],"genre_scores_gemma":[0.99154234,0.00007738011,0.0014597079,0.0041264333,0.0018878698,0.00014791387,0.00008718454,0.00006878294,0.0006023865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99533015,0.00080402975,0.0007087436,0.0010433008,0.0013532467,0.000760547],"domain_scores_gemma":[0.99512315,0.0023802554,0.00008937122,0.00054948404,0.0004639461,0.001393798],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016924394,0.00023307886,0.00059041585,0.0001387348,0.00028964097,0.00007334366,0.0003084422,0.000110487665,0.0014419896],"category_scores_gemma":[0.0073081465,0.00018359977,0.0002702985,0.0006471749,0.00020961967,0.000031963973,0.00028067708,0.0017457178,0.0005399878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009988077,0.000919411,0.794786,0.0001452253,0.000194703,0.0037328429,0.00099929,0.004047375,0.011313169,0.00007101963,0.018862745,0.15494017],"study_design_scores_gemma":[0.0110205775,0.0086816335,0.7610772,0.0019402923,0.000319153,0.000008582865,0.00091375003,0.13023736,0.015089066,0.0001427593,0.06980097,0.00076864107],"about_ca_topic_score_codex":0.0013190446,"about_ca_topic_score_gemma":0.000096346164,"teacher_disagreement_score":0.15417154,"about_ca_system_score_codex":0.00039323047,"about_ca_system_score_gemma":0.0005084666,"threshold_uncertainty_score":0.99947083},"labels":[],"label_agreement":null},{"id":"W2999435318","doi":"10.1016/s0923-7534(20)34326-x","title":"Randomized Phase IIIB Trial of Temsirolimus and Bevacizumab Versus Interferon and Bevacizumab in Metastatic Renal Cell Carcinoma: Results from Intoract","year":2012,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Temsirolimus; Bevacizumab; Renal cell carcinoma; Oncology; Internal medicine; Randomized controlled trial; Discovery and development of mTOR inhibitors; Chemotherapy; PI3K/AKT/mTOR pathway","score_opus":0.1350490563877559,"score_gpt":0.3991791572432816,"score_spread":0.2641301008555257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999435318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902982,0.0037077968,0.000008127861,0.00070435496,0.0003051294,0.0015302025,0.00011069113,0.000010323563,0.0033251343],"genre_scores_gemma":[0.9983674,0.00041789128,0.0006891662,0.00006533497,0.00017432336,0.00006780253,0.00011801828,0.00002390659,0.00007612072],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99696285,0.0007543791,0.001229675,0.0003711191,0.0002736412,0.0004083134],"domain_scores_gemma":[0.9960345,0.002508707,0.00066988077,0.00036824355,0.00014494291,0.00027370232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001569076,0.000288679,0.0018974252,0.00033755536,0.000025159532,0.000006155365,0.000090727626,0.00018468188,0.00003983666],"category_scores_gemma":[0.000860237,0.00022462159,0.00019715009,0.00014446797,0.00037444328,0.00014441482,0.00010866961,0.00025959013,0.000003970259],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97151256,0.0026679942,0.00023085742,0.0000996055,0.00031655945,0.00013570533,0.0028593196,0.0000011797092,0.006608189,0.000032070257,0.00025371092,0.015282239],"study_design_scores_gemma":[0.9227335,0.024072492,0.002068362,0.00007672775,0.0007592462,0.00003837177,0.0003968502,0.000093147304,0.0488696,0.00011649043,0.00062004424,0.00015517962],"about_ca_topic_score_codex":0.0016305639,"about_ca_topic_score_gemma":0.00009771071,"teacher_disagreement_score":0.04877908,"about_ca_system_score_codex":0.00011178563,"about_ca_system_score_gemma":0.00021551106,"threshold_uncertainty_score":0.9159803},"labels":[],"label_agreement":null},{"id":"W2999511123","doi":"10.1038/s41585-019-0271-6","title":"Evolution in upfront treatment strategies for metastatic RCC","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Axitinib; Avelumab; Sunitinib; Pembrolizumab; Oncology; Renal cell carcinoma; Internal medicine; Nivolumab; Metastatic melanoma; Targeted therapy; Immunotherapy; Bevacizumab; Chemotherapy; Cancer","score_opus":0.08315542478268387,"score_gpt":0.39120332751043413,"score_spread":0.3080479027277503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999511123","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000023717037,0.98801804,0.00020958758,0.0003953593,0.00037127806,0.010008581,0.00007410559,0.000046647947,0.00087406026],"genre_scores_gemma":[0.00007322546,0.9924085,0.0020845372,0.00030737527,0.0003826301,0.0035889957,0.00082019763,0.00009227075,0.00024223709],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962938,0.00070698815,0.0013418933,0.00094656995,0.0001897422,0.0005210249],"domain_scores_gemma":[0.9980871,0.00036414803,0.0006296367,0.0006516605,0.0000671592,0.00020030292],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039123624,0.0008947298,0.006320733,0.00037312534,0.000037254376,0.000018402483,0.00019142282,0.0009541516,0.00006829993],"category_scores_gemma":[0.00025062685,0.0005421153,0.0016424763,0.00047195095,0.00006215759,0.000055587323,0.000040490428,0.0010789394,0.00022126733],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010082833,0.00024336633,0.000005831091,0.02819882,0.00045958828,0.00042142216,0.000040335362,8.4404627e-7,0.0000010408679,0.0015256741,0.0009754587,0.9680268],"study_design_scores_gemma":[0.001223324,0.0025704275,0.00001611879,0.003071169,0.008914705,0.000757141,0.000009779635,0.000012949401,3.8387446e-7,0.0003056375,0.9828238,0.00029458513],"about_ca_topic_score_codex":0.000021597829,"about_ca_topic_score_gemma":0.00008441864,"teacher_disagreement_score":0.9818483,"about_ca_system_score_codex":0.0016261915,"about_ca_system_score_gemma":0.0013165616,"threshold_uncertainty_score":0.99970305},"labels":[],"label_agreement":null},{"id":"W2999559745","doi":"10.1016/j.urolonc.2019.12.024","title":"Upstaging to pT3a disease in patients undergoing robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from a multi-institutional dataset","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Nephrectomy; Logistic regression; Kidney cancer; Proportional hazards model; Urology; Internal medicine; Cohort; Stage (stratigraphy); Pathological; Kidney disease; Cancer; Oncology; Kidney; Surgery","score_opus":0.04937847680332095,"score_gpt":0.3190912112984793,"score_spread":0.2697127344951583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999559745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97400767,0.0003843851,0.0005996171,0.021922445,0.00014721374,0.0011438071,0.0017440267,0.00003606511,0.000014762976],"genre_scores_gemma":[0.9294206,0.00011409077,0.051409997,0.014959523,0.00013132958,0.00057410775,0.0033449214,0.000016487333,0.000028926463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875504,0.00006849957,0.00028955162,0.00048199002,0.0001342022,0.00027070186],"domain_scores_gemma":[0.9984823,0.00030372583,0.00008489577,0.00012540311,0.000034079614,0.0009696253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008426573,0.00021468657,0.00038894312,0.000097890916,0.0001800367,0.000022288856,0.00006814967,0.00009129111,0.000028968208],"category_scores_gemma":[0.0006844787,0.00016820153,0.000042115164,0.00014885057,0.000257455,0.000110532026,0.000077104996,0.00016600838,0.0000051023635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046346863,0.00020181859,0.9937142,0.000053787568,0.0000793123,0.000077159355,0.00037570955,0.0012922555,0.00004876728,0.00031554338,0.003018998,0.0003589605],"study_design_scores_gemma":[0.007797017,0.0022820353,0.72668165,0.0001447636,0.00079852884,0.000005924381,0.00008707621,0.014854236,0.00009391563,0.00048575114,0.24649155,0.0002775438],"about_ca_topic_score_codex":0.0002624751,"about_ca_topic_score_gemma":0.00012290048,"teacher_disagreement_score":0.26703256,"about_ca_system_score_codex":0.00019745198,"about_ca_system_score_gemma":0.0006689191,"threshold_uncertainty_score":0.68590593},"labels":[],"label_agreement":null},{"id":"W2999591965","doi":"10.1016/s0923-7534(20)33389-5","title":"Sunitinib Global Expanded-Access Trial in Metastatic Renal Cell Carcinoma (MRCC) – Final Results","year":2012,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University Hospital Foundation","funders":"","keywords":"Medicine; Sunitinib; Dysgeusia; Nausea; Neutropenia; Internal medicine; Adverse effect; Renal cell carcinoma; Stomatitis; Vomiting; Mucositis; Diarrhea; Tolerability; Surgery; Gastroenterology; Chemotherapy","score_opus":0.3021703911164218,"score_gpt":0.44953780598919746,"score_spread":0.14736741487277566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999591965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9352811,0.001062507,0.000010167849,0.001606109,0.00037049848,0.0008104755,0.00007835453,0.000018673853,0.060762126],"genre_scores_gemma":[0.9975305,0.000077598634,0.00072390476,0.0006386336,0.000369814,0.00007705554,0.00010947402,0.00001792755,0.00045506324],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99733275,0.00039223762,0.00088528264,0.00032179992,0.00036389046,0.000704044],"domain_scores_gemma":[0.9983372,0.00033918454,0.00038254404,0.00040857613,0.00019343689,0.00033906192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000970496,0.0002541246,0.00087079534,0.00020193533,0.000035085835,0.000009999895,0.00021132104,0.00016931351,0.00016391832],"category_scores_gemma":[0.00027631086,0.00021265616,0.00022262239,0.00037707153,0.00015420765,0.00019639694,0.000121674006,0.0002326459,0.000048290334],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5786141,0.021724766,0.24005063,0.00069130823,0.0005642734,0.0052990364,0.0031002758,0.000063218715,0.006299408,0.0010586055,0.051174257,0.091360115],"study_design_scores_gemma":[0.22351617,0.033207536,0.62134665,0.000113381146,0.00053363096,0.0007827162,0.0005554926,0.00002852901,0.088963665,0.00053214584,0.029908031,0.0005120572],"about_ca_topic_score_codex":0.000851672,"about_ca_topic_score_gemma":0.00017676016,"teacher_disagreement_score":0.38129604,"about_ca_system_score_codex":0.00020335946,"about_ca_system_score_gemma":0.0005756034,"threshold_uncertainty_score":0.86718667},"labels":[],"label_agreement":null},{"id":"W2999762293","doi":"10.1016/j.annonc.2019.11.017","title":"Flawed trials for cancer","year":2020,"lang":"en","type":"editorial","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Janssen Canada; Bayer Canada; Bristol-Myers Squibb Canada; Sanofi; Meso Scale Diagnostics; Astellas Pharma Canada; Roche","keywords":"Medicine; Cancer; Oncology; Intensive care medicine; Medical physics; Internal medicine","score_opus":0.3131264470494802,"score_gpt":0.4954558305697605,"score_spread":0.18232938352028027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999762293","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001022795,0.008631689,0.000022694208,0.019178959,0.9584988,0.0025338295,0.001452916,0.000048496295,0.008609831],"genre_scores_gemma":[0.0011721532,0.0040347236,0.00094612583,0.0011705396,0.98684716,0.00077242433,0.0012562159,0.00008312747,0.0037175284],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974266,0.000269385,0.0010393596,0.00046529906,0.000455439,0.00034391662],"domain_scores_gemma":[0.99320996,0.0041930294,0.0009619956,0.00032776076,0.0010766991,0.00023053138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011497019,0.00031615768,0.003044786,0.00013235449,0.000027728176,0.000005705455,0.00017189655,0.0012186576,0.00028785202],"category_scores_gemma":[0.0070024896,0.00024450934,0.0008504897,0.000104994644,0.000098814235,0.000020553482,0.000054564152,0.00042688398,0.000028905144],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046082963,0.00022154687,0.000014880061,0.0006928089,0.0012129195,0.00010638575,0.00009009284,9.229999e-7,0.0009279595,0.000025077341,0.9407361,0.051362995],"study_design_scores_gemma":[0.004516302,0.011532862,0.00004430927,0.00016266244,0.0013192911,0.0000031651002,0.000014187436,0.000004369776,0.010156486,0.00016439297,0.9719249,0.00015708167],"about_ca_topic_score_codex":0.00027349053,"about_ca_topic_score_gemma":0.00006187414,"teacher_disagreement_score":0.051205914,"about_ca_system_score_codex":0.00017847883,"about_ca_system_score_gemma":0.0031169124,"threshold_uncertainty_score":0.9970802},"labels":[],"label_agreement":null},{"id":"W2999930180","doi":"10.1016/s0923-7534(20)34327-1","title":"Temsirolimus vs Sorafenib As Second Line Therapy in Metastatic Renal Cell Carcinoma: Results from the Intorsect Trial","year":2012,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Temsirolimus; Sunitinib; Sorafenib; Renal cell carcinoma; Internal medicine; Clinical endpoint; Progression-free survival; Oncology; Gastroenterology; Urology; Surgery; Randomized controlled trial; Hepatocellular carcinoma; Chemotherapy; Discovery and development of mTOR inhibitors","score_opus":0.1424243456853607,"score_gpt":0.3746924568130888,"score_spread":0.23226811112772813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999930180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778946,0.004411947,0.0000020113714,0.0046218857,0.00047901593,0.001164114,0.00009075129,0.00001644087,0.011319216],"genre_scores_gemma":[0.9953068,0.0003030991,0.00023552257,0.0022408178,0.0009243822,0.0000800417,0.00014210439,0.000031889173,0.0007353466],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972678,0.00064516504,0.0008837524,0.0003390782,0.00031914058,0.0005451025],"domain_scores_gemma":[0.99712145,0.0014872975,0.00042721807,0.00059678906,0.00014870372,0.00021853468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013668083,0.0002726023,0.00087968656,0.00015699146,0.000046583533,0.000007756575,0.00020697038,0.00018809712,0.00046857924],"category_scores_gemma":[0.00031552545,0.00016983405,0.0002548726,0.00024133973,0.00016735209,0.00009598726,0.00006547264,0.00039910138,0.000092139846],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.741737,0.01507629,0.030228848,0.000119583485,0.0012218287,0.0015109037,0.025026616,0.00003431519,0.06593921,0.00019831248,0.050446305,0.068460785],"study_design_scores_gemma":[0.22999446,0.06287193,0.2215819,0.00006143476,0.00039430373,0.00015063497,0.0010751324,0.0000377444,0.36374626,0.00080847944,0.118836634,0.000441084],"about_ca_topic_score_codex":0.0020263758,"about_ca_topic_score_gemma":0.00036404052,"teacher_disagreement_score":0.51174253,"about_ca_system_score_codex":0.00011109551,"about_ca_system_score_gemma":0.0004497059,"threshold_uncertainty_score":0.6925631},"labels":[],"label_agreement":null},{"id":"W3000155556","doi":"10.1590/s1677-5538.ibju.2018.0716","title":"Computed tomography imaging characteristics of clear cell papillary renal cell carcinoma","year":2020,"lang":"en","type":"article","venue":"International braz j urol","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Clear cell; Radiology; Clear cell renal cell carcinoma; Papillary renal cell carcinomas; Computed tomography; Nuclear medicine; Pathology","score_opus":0.012305700772985644,"score_gpt":0.22229694806294695,"score_spread":0.2099912472899613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000155556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980488,0.00042033524,0.00050110987,0.0026317418,0.00028137115,0.00026872405,0.00009767328,0.0000657576,0.015245263],"genre_scores_gemma":[0.9958736,0.000013255329,0.001286785,0.0019404383,0.00042753833,0.000007329335,0.0002351693,0.000037526483,0.00017840549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845695,0.000037042104,0.00044239595,0.00033850461,0.00052844005,0.00019665028],"domain_scores_gemma":[0.9990157,0.000070775335,0.0002163294,0.00021364987,0.0002597222,0.00022383305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060855215,0.0002025115,0.00031218812,0.00016266,0.000031867636,0.000024350287,0.00022709419,0.000052181276,0.00034545443],"category_scores_gemma":[0.00002737058,0.00019121567,0.00023375654,0.00018496742,0.00007049092,0.0000775793,0.000113067465,0.00020839558,0.00010187941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012161816,0.000725476,0.65047485,0.00030468585,0.00018961221,0.0013835514,0.0006886325,0.000032033935,0.334308,0.00010385342,0.0059383353,0.004634788],"study_design_scores_gemma":[0.002645815,0.0007398475,0.7274987,0.00005143076,0.00016952814,0.00008406908,0.000062498555,0.006495634,0.25348753,0.000023279972,0.008507151,0.00023454476],"about_ca_topic_score_codex":0.000030227702,"about_ca_topic_score_gemma":2.6401614e-7,"teacher_disagreement_score":0.080820486,"about_ca_system_score_codex":0.000060632156,"about_ca_system_score_gemma":0.00007231629,"threshold_uncertainty_score":0.7797549},"labels":[],"label_agreement":null},{"id":"W3000620706","doi":"10.1101/2020.01.13.904235","title":"A multi-layered systems approach for renal cell carcinoma","year":2020,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McGill University","keywords":"Transcriptome; Renal cell carcinoma; Biology; DNA methylation; Metastasis; Biomarker; Clear cell renal cell carcinoma; Computational biology; Primary tumor; Cancer; Genomics; Cancer research; Bioinformatics; Genome; Gene; Pathology; Gene expression; Genetics; Medicine","score_opus":0.045468221693406315,"score_gpt":0.2409892299533348,"score_spread":0.1955210082599285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000620706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9257959,0.008790106,0.05171654,0.00039297596,0.0015188527,0.009679649,0.0011053857,0.0009088687,0.000091701],"genre_scores_gemma":[0.91085887,0.00005561794,0.084974386,0.0001757411,0.0012356908,0.002273584,0.000008750017,0.00036636283,0.000051025425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99502057,0.00017736279,0.0010077757,0.0021145125,0.0007219177,0.00095784705],"domain_scores_gemma":[0.99537194,0.00008913883,0.00067726383,0.0020679992,0.0008123166,0.0009813464],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047525755,0.0011343502,0.0016964013,0.00035002784,0.00017995523,0.0002308068,0.00057416654,0.0009317287,0.0000109504745],"category_scores_gemma":[0.00017030639,0.0010901315,0.000664058,0.00044076444,0.00011903719,0.000083745224,0.0005051016,0.0010961822,0.00007331168],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005417989,0.0009354616,0.008901853,0.0078071626,0.0005167404,0.0004908673,0.000027571275,0.00037131915,0.97886837,0.000098375276,0.0014397783,6.789418e-7],"study_design_scores_gemma":[0.011018494,0.0012514372,0.0966512,0.00086052215,0.002545102,5.368858e-7,0.000031006442,0.058145985,0.8229294,5.4677326e-7,0.0042133075,0.0023524612],"about_ca_topic_score_codex":0.00014284156,"about_ca_topic_score_gemma":3.8294036e-7,"teacher_disagreement_score":0.15593898,"about_ca_system_score_codex":0.00096846034,"about_ca_system_score_gemma":0.0013896141,"threshold_uncertainty_score":0.99915487},"labels":[],"label_agreement":null},{"id":"W3001231147","doi":"10.1634/theoncologist.2019-0605","title":"Real-World Assessment of Clinical Outcomes Among First-Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group","year":2020,"lang":"en","type":"article","venue":"The Oncologist","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Manitoba; University of Calgary","funders":"","keywords":"Sunitinib; Renal cell carcinoma; Medicine; Oncology; Internal medicine","score_opus":0.07169468822399246,"score_gpt":0.3543708603305172,"score_spread":0.28267617210652474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001231147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98118037,0.000049096638,0.00020348391,0.003068025,0.00021461412,0.0013885293,0.000677105,0.000046834397,0.013171925],"genre_scores_gemma":[0.9946897,0.00013164217,0.0020707774,0.001035714,0.0001498773,0.00008575516,0.0008520434,0.00004732857,0.00093713304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99641085,0.00063509296,0.0011450385,0.0005316365,0.0009261469,0.0003512606],"domain_scores_gemma":[0.9954836,0.0020649068,0.0011155307,0.0008078046,0.00024178554,0.00028638262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012031219,0.00035886542,0.0008536819,0.00006128281,0.0001947752,0.0000370646,0.00061242876,0.00006757535,0.00036604187],"category_scores_gemma":[0.00030765074,0.00017452765,0.00028806884,0.00025847467,0.00085532264,0.000094956034,0.00033412484,0.000772382,0.000028700826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015689034,0.0017972848,0.98707426,0.000076020486,0.0003244876,0.0001265781,0.00016738095,0.000076007585,0.00007476886,0.00005255148,0.008192038,0.00046972613],"study_design_scores_gemma":[0.00854943,0.0046458277,0.9787424,0.000032729185,0.0013221938,0.0000034523039,0.00041695146,0.0011682115,0.00093085784,0.000009604755,0.003987485,0.0001908189],"about_ca_topic_score_codex":0.003721129,"about_ca_topic_score_gemma":0.0015703817,"teacher_disagreement_score":0.013509342,"about_ca_system_score_codex":0.00022627237,"about_ca_system_score_gemma":0.00026076677,"threshold_uncertainty_score":0.7117031},"labels":[],"label_agreement":null},{"id":"W3001814058","doi":"10.5489/cuaj.6105","title":"Derivation and validation of text search algorithms for renal and adrenal lesion identification in radiology text reports","year":2020,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Ottawa Hospital; University of Ottawa","funders":"Canadian Urological Association Scholarship Fund; Canadian Urological Association","keywords":"Identification (biology); Computer science; Algorithm; Lesion; Radiology; Medicine; Natural language processing; Artificial intelligence; Pathology; Biology","score_opus":0.04813207185799331,"score_gpt":0.2761958608505042,"score_spread":0.22806378899251087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001814058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805184,0.00035001556,0.0012525577,0.017364424,0.000053601412,0.00038974057,0.000012135507,0.000006611015,0.00005249143],"genre_scores_gemma":[0.9981602,0.000108440276,0.00090452,0.000503477,0.0001789213,0.000012965435,0.0000861487,0.000008018836,0.00003734032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986379,0.00016046331,0.00051989884,0.00023441919,0.00022094265,0.00022638089],"domain_scores_gemma":[0.9987959,0.00016683205,0.00033331005,0.000059251277,0.0002636529,0.00038100404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000907259,0.0000957858,0.0002592034,0.00019340114,0.000102026905,0.00003634817,0.000031537576,0.00018795922,0.000038171915],"category_scores_gemma":[0.0010615648,0.00008255328,0.0000502804,0.0001752742,0.000038591003,0.00010140623,0.000010989255,0.00023839144,0.0000013342427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026574393,0.000044244116,0.94424886,0.000038876107,0.00007275847,0.00013638122,0.00059659674,0.00017838096,0.028327018,0.00010825133,0.0008229753,0.025159908],"study_design_scores_gemma":[0.0013019613,0.00071042636,0.9886236,0.000016829315,0.000065188564,0.0006414794,0.00008961316,0.0020793257,0.0051013003,0.0005205294,0.0007702055,0.000079512836],"about_ca_topic_score_codex":0.0002926228,"about_ca_topic_score_gemma":0.00007940265,"teacher_disagreement_score":0.044374764,"about_ca_system_score_codex":0.00044106742,"about_ca_system_score_gemma":0.00024246736,"threshold_uncertainty_score":0.33664247},"labels":[],"label_agreement":null},{"id":"W3004122466","doi":"10.1007/s10552-020-01270-8","title":"Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities","year":2020,"lang":"en","type":"article","venue":"Cancer Causes & Control","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Epidemiology; African american; Proportional hazards model; Nephrectomy; Surveillance, Epidemiology, and End Results; Oncology; Cancer registry; Kidney","score_opus":0.13210219011679766,"score_gpt":0.3226732045790792,"score_spread":0.19057101446228156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004122466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902083,0.006118732,0.000052183226,0.0012322712,0.00015677484,0.0016357118,0.00016897872,0.000022567567,0.00040443987],"genre_scores_gemma":[0.9980631,0.00017035597,0.000036657777,0.000856212,0.00016808732,0.0005650558,0.000024797624,0.000031053125,0.00008467659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981027,0.00022229285,0.00046691307,0.0005291114,0.00030848332,0.00037047223],"domain_scores_gemma":[0.99905217,0.00026301958,0.00012616953,0.00016002613,0.00007979105,0.00031882073],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000093264636,0.0003446067,0.00092972,0.0001863942,0.000035387468,0.000029319232,0.00008833099,0.00004994767,0.00003508225],"category_scores_gemma":[0.00006589109,0.0002683363,0.000095077914,0.00024141453,0.00006673592,0.00012689931,0.000044560027,0.00016398409,0.000005878984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002583062,0.00024038454,0.98207945,0.000103060775,0.00014621537,0.0004139537,0.008647441,0.00007292484,0.0020071485,0.000023976643,0.000021941014,0.003660434],"study_design_scores_gemma":[0.022933286,0.0035911382,0.9617794,0.00015028479,0.00025412953,0.0000021147737,0.0029724953,0.00082478556,0.007035512,0.000035373992,0.00009642492,0.00032506057],"about_ca_topic_score_codex":0.005784592,"about_ca_topic_score_gemma":0.0014696398,"teacher_disagreement_score":0.020350223,"about_ca_system_score_codex":0.000614949,"about_ca_system_score_gemma":0.00031554542,"threshold_uncertainty_score":0.9999769},"labels":[],"label_agreement":null},{"id":"W3004420993","doi":"10.1158/1078-0432.ccr-19-2427","title":"Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Sunitinib; Renal cell carcinoma; Medicine; Oncology; Internal medicine; Carcinoma; Phases of clinical research; Toxicity","score_opus":0.25170793116755175,"score_gpt":0.4626059476047845,"score_spread":0.21089801643723277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004420993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946103,0.00020118969,0.0000019843412,0.0016669275,0.00002182948,0.0031594008,0.000033239536,0.0000051329043,0.00029996943],"genre_scores_gemma":[0.99946386,0.000083584724,0.000041827974,0.0000882609,0.000029264049,0.0001676908,0.000024930336,0.000027047387,0.00007351679],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99570614,0.00095092604,0.0010032438,0.00048575463,0.0015344309,0.0003195149],"domain_scores_gemma":[0.99731135,0.00092928595,0.00029218147,0.0005198924,0.0007576413,0.0001896604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014282068,0.00017272987,0.0006412838,0.000179881,0.000045850742,0.000008322452,0.00029106182,0.00006033167,0.00005937133],"category_scores_gemma":[0.00052498997,0.000094885174,0.00006923449,0.0013861872,0.00033572412,0.00006169127,0.00009973222,0.0007990312,0.000002584222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08524453,0.015099836,0.89029914,0.00017093695,0.000089423105,0.00016092406,0.0033866656,0.0002993401,0.00015531346,0.0000043128707,0.000116088275,0.0049734702],"study_design_scores_gemma":[0.100209616,0.08773487,0.802131,0.00026124393,0.00005755644,7.2201715e-7,0.0011696956,0.00025223166,0.008024501,0.000015963695,0.00005097229,0.000091649315],"about_ca_topic_score_codex":0.0042888257,"about_ca_topic_score_gemma":0.0022712897,"teacher_disagreement_score":0.08816818,"about_ca_system_score_codex":0.00019474926,"about_ca_system_score_gemma":0.00081928907,"threshold_uncertainty_score":0.64834505},"labels":[],"label_agreement":null},{"id":"W3004436801","doi":"10.1016/j.euo.2020.01.001","title":"Synchronous Versus Metachronous Metastatic Disease: Impact of Time to Metastasis on Patient Outcome—Results from the International Metastatic Renal Cell Carcinoma Database Consortium","year":2020,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); Ottawa Hospital; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"Ipsen Biopharmaceuticals; Sanofi; Health Research Fund of Central Denmark Region; AstraZeneca; National Health and Medical Research Council; Amgen; Pfizer; Health Research Foundation; Roche","keywords":"Medicine; Renal cell carcinoma; Metastasis; Oncology; Disease; Internal medicine; Outcome (game theory); Cancer","score_opus":0.05860378922905161,"score_gpt":0.3120376677610792,"score_spread":0.2534338785320276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004436801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9717702,0.000738097,0.000256253,0.009265092,0.00040289946,0.001278509,0.003902281,0.00007235596,0.012314291],"genre_scores_gemma":[0.990572,0.000019008556,0.0023288773,0.005037199,0.00022358287,0.0000371443,0.0015558496,0.000087856046,0.00013850884],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9948356,0.0018273696,0.0012313135,0.0009873477,0.00055824436,0.000560124],"domain_scores_gemma":[0.9950344,0.0022868558,0.0006397001,0.0010174109,0.00019228124,0.000829339],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006090228,0.0005352141,0.0011172578,0.00018710976,0.00010664105,0.000021456093,0.00063428434,0.000040340106,0.0019391752],"category_scores_gemma":[0.0013184214,0.0003546763,0.0005601142,0.00027587844,0.0003084538,0.00007104636,0.00038354474,0.0005194759,0.0029311928],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42420775,0.017336937,0.02916245,0.00031968975,0.030115945,0.10159153,0.013812636,0.04852098,0.08714687,0.00021035252,0.19108856,0.056486316],"study_design_scores_gemma":[0.10752284,0.19142902,0.44787118,0.000086501124,0.036858056,0.0008323486,0.0009645729,0.010978061,0.018073944,0.000030755466,0.18284753,0.0025051956],"about_ca_topic_score_codex":0.00029711548,"about_ca_topic_score_gemma":0.000022759043,"teacher_disagreement_score":0.4187087,"about_ca_system_score_codex":0.0005104627,"about_ca_system_score_gemma":0.00069977075,"threshold_uncertainty_score":0.9998905},"labels":[],"label_agreement":null},{"id":"W3004493480","doi":"10.1038/s41598-020-58804-y","title":"Identification of gene signature for treatment response to guide precision oncology in clear-cell renal cell carcinoma","year":2020,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; BC Cancer Agency; Simon Fraser University; University of British Columbia","funders":"","keywords":"Clear cell renal cell carcinoma; Medicine; Gene signature; Oncology; Renal cell carcinoma; Stromal cell; Internal medicine; Disease; Immune system; Bioinformatics; Gene expression; Gene; Immunology; Biology","score_opus":0.03028209734085483,"score_gpt":0.3038449679197281,"score_spread":0.27356287057887324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004493480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924382,0.00054244447,0.00059125817,0.0014119368,0.0011448364,0.0026700678,0.000024464985,0.000031312913,0.0011454829],"genre_scores_gemma":[0.9779463,0.0000045569864,0.0035664667,0.00008132568,0.00008846724,0.00018743785,0.00016661777,0.000034778113,0.017924095],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963096,0.00017381116,0.0013523896,0.0012042619,0.00059616665,0.0003637769],"domain_scores_gemma":[0.9974518,0.00019022767,0.000573975,0.0009925328,0.00040353587,0.00038797173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018680831,0.00024194973,0.0005566896,0.0003716395,0.00009787159,0.00003992727,0.00012261096,0.00017614156,0.00009037779],"category_scores_gemma":[0.0004990708,0.00019941758,0.0002503812,0.00075031427,0.00009817347,0.00007658711,0.000060011324,0.00009225214,0.00004071016],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004696454,0.0006484555,0.0024797432,0.00009118138,0.000013208506,0.00093927246,0.002058401,0.0004136369,0.9720775,7.777491e-7,0.014620538,0.0019608238],"study_design_scores_gemma":[0.0017515908,0.0039479197,0.009954529,0.000028171224,0.000118392054,0.00009299661,0.00023752176,0.00028600384,0.9271266,0.00004838227,0.056264687,0.00014321583],"about_ca_topic_score_codex":0.00005416062,"about_ca_topic_score_gemma":0.000024985658,"teacher_disagreement_score":0.044950917,"about_ca_system_score_codex":0.0008966324,"about_ca_system_score_gemma":0.00092045567,"threshold_uncertainty_score":0.8132013},"labels":[],"label_agreement":null},{"id":"W3004761772","doi":"10.1016/j.clgc.2020.02.001","title":"Histologic Subtype, Tumor Grade, Tumor Size, and Race Can Accurately Predict the Probability of Synchronous Metastases in T2 Renal Cell Carcinoma","year":2020,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ottawa Hospital; University of Ottawa; Surgical Specialties (Canada); McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Chromophobe cell; Renal cell carcinoma; Logistic regression; Nephrectomy; Internal medicine; Carcinoma; Clear cell; Gastroenterology; Urology; Pathology; Oncology; Kidney","score_opus":0.09900866393972269,"score_gpt":0.3375998677825703,"score_spread":0.2385912038428476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004761772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98229915,0.011297228,0.0000027965727,0.0041034324,0.00019921157,0.0014703338,0.00012484932,0.000042374522,0.00046064038],"genre_scores_gemma":[0.9969594,0.0003900023,0.0005414152,0.0012938594,0.00040740348,0.00019806005,0.000017220724,0.0000356971,0.00015693918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966873,0.00056707044,0.0011453861,0.00079519,0.00036843447,0.00043660484],"domain_scores_gemma":[0.99722135,0.0011840782,0.00043724402,0.0005696505,0.00014854259,0.0004391532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055982545,0.00035826594,0.0010516957,0.00004638289,0.00007842052,0.000013420614,0.0002739644,0.000108107466,0.00019605471],"category_scores_gemma":[0.00081348314,0.00023246488,0.00028715012,0.00036380638,0.00066541653,0.00006420291,0.00022561521,0.00067910005,0.000007806767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038571684,0.0012971524,0.98226,0.0008109583,0.00013207634,0.0029474336,0.00038641278,0.00010787716,0.0036235163,0.0000062466556,0.0026872256,0.001883938],"study_design_scores_gemma":[0.004102013,0.0048047057,0.9767588,0.000078803016,0.0005400059,0.00017082102,0.00017328892,0.00023040596,0.0111381635,0.00007969108,0.0016658215,0.00025752292],"about_ca_topic_score_codex":0.0006292568,"about_ca_topic_score_gemma":0.00016877828,"teacher_disagreement_score":0.014660269,"about_ca_system_score_codex":0.00026336813,"about_ca_system_score_gemma":0.00092929933,"threshold_uncertainty_score":0.9479643},"labels":[],"label_agreement":null},{"id":"W3005905135","doi":"10.2214/ajr.19.22023","title":"Predictive Value of In Vivo MR Spectroscopy With Semilocalization by Adiabatic Selective Refocusing in Differentiating Clear Cell Renal Cell Carcinoma From Other Subtypes","year":2020,"lang":"en","type":"article","venue":"American Journal of Roentgenology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Mount Sinai Hospital; University Health Network; University of Toronto; Toronto General Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Renal cell carcinoma; Predictive value; In vivo; In vivo magnetic resonance spectroscopy; Clear cell renal cell carcinoma; Value (mathematics); Cell; Pathology; Cancer research; Nuclear magnetic resonance; Internal medicine; Magnetic resonance imaging; Radiology; Biochemistry; Biology; Physics","score_opus":0.006479760988315481,"score_gpt":0.21393924099469933,"score_spread":0.20745948000638384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005905135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950866,0.0007566778,0.003163624,0.0003176164,0.000028779583,0.0002544803,0.00002144805,0.000007378401,0.00036339695],"genre_scores_gemma":[0.9962494,0.00005923751,0.0033286116,0.00022552582,0.00007339029,0.000003891007,0.000007785226,0.00004322552,0.0000089551695],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980835,0.00034565595,0.0006607123,0.00029205115,0.00030077645,0.00031730655],"domain_scores_gemma":[0.9985094,0.00012573645,0.0009275471,0.00013946898,0.0001374496,0.00016039217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010983837,0.00021926724,0.0008587709,0.00026174053,0.000021522075,0.000006130463,0.00012164241,0.00006309115,0.000059410155],"category_scores_gemma":[0.0000439946,0.00017408948,0.000087912325,0.00061178755,0.00020194486,0.00007456721,0.000030626536,0.00041257797,0.000001593683],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034295798,0.00028983547,0.53735656,0.000035888952,0.00010663988,0.00017001366,0.0041377214,0.0011764144,0.45309854,0.0000018455382,0.000061447536,0.00013551375],"study_design_scores_gemma":[0.004241558,0.016797373,0.13702679,0.00018103192,0.0003050754,0.000057345103,0.003201165,0.0026942664,0.8353059,0.000028751037,0.000014132795,0.00014658284],"about_ca_topic_score_codex":0.0013263682,"about_ca_topic_score_gemma":0.000083040075,"teacher_disagreement_score":0.40032977,"about_ca_system_score_codex":0.00042676527,"about_ca_system_score_gemma":0.00022150093,"threshold_uncertainty_score":0.7099163},"labels":[],"label_agreement":null},{"id":"W3006846003","doi":"10.1200/jco.2020.38.6_suppl.639","title":"Cabozantinib real-world effectiveness in the first through fourth-line settings for the treatment of metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Sunnybrook Hospital; Princess Margaret Cancer Centre; University Health Network; University of Calgary","funders":"","keywords":"Medicine; Cabozantinib; Renal cell carcinoma; Internal medicine; Urology; Surgery","score_opus":0.20021283912474325,"score_gpt":0.4400189675659714,"score_spread":0.23980612844122817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006846003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8834663,0.0009519009,0.00046167834,0.1112262,0.00085081893,0.0015289983,0.00042736813,0.0000062565923,0.0010804634],"genre_scores_gemma":[0.9881223,0.0012569238,0.0034313207,0.005192361,0.0017357303,0.00006359385,0.000106411746,0.00002647576,0.00006491995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99445933,0.0011656936,0.003013463,0.0003990921,0.00066697464,0.00029546538],"domain_scores_gemma":[0.95016366,0.046188682,0.002519152,0.000524915,0.00044006004,0.00016354748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004612686,0.00028706648,0.0015752935,0.00006305613,0.00010686087,0.00002287982,0.00064152485,0.00012760914,0.000049317172],"category_scores_gemma":[0.0038725636,0.00012134385,0.0008568379,0.00026918948,0.00037803434,0.00010709961,0.00008586472,0.00071586354,0.0000069393154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3431828,0.02971469,0.41899127,0.0006492833,0.009809197,0.013276266,0.026309714,0.003007962,0.004839217,0.0011228479,0.082746536,0.06635024],"study_design_scores_gemma":[0.06964199,0.038522303,0.56556,0.00032147003,0.0046477006,0.00024883798,0.0023188998,0.002763446,0.010344137,0.0003109025,0.30507666,0.00024365804],"about_ca_topic_score_codex":0.0012176605,"about_ca_topic_score_gemma":0.0013000162,"teacher_disagreement_score":0.2735408,"about_ca_system_score_codex":0.00024904276,"about_ca_system_score_gemma":0.0010324792,"threshold_uncertainty_score":0.49482587},"labels":[],"label_agreement":null},{"id":"W3006882092","doi":"10.1200/jco.2020.38.6_suppl.692","title":"A comparison of combined immune checkpoint inhibitors (IO) versus vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKI) in the treatment of advanced clear cell renal cell carcinoma.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Renal cell carcinoma; Discontinuation; Internal medicine; Adverse effect; Oncology; Clinical trial","score_opus":0.09318190898553695,"score_gpt":0.3794151476500321,"score_spread":0.2862332386644951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006882092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99088985,0.0032914828,0.000009390156,0.0028265798,0.0012593834,0.0009469646,0.000029728533,0.000010646378,0.00073595205],"genre_scores_gemma":[0.9960632,0.0010718448,0.0016353016,0.00015495573,0.00096087134,0.000015704865,0.00002011067,0.00004860863,0.000029405966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99180037,0.0011328259,0.0052702064,0.0004226998,0.00094473624,0.00042913586],"domain_scores_gemma":[0.9919415,0.0027530522,0.0038147266,0.00044403793,0.0005306325,0.0005160444],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001281443,0.0004410938,0.0034670176,0.00022621333,0.000046925285,0.00000917535,0.00037135067,0.00046601205,0.00012942018],"category_scores_gemma":[0.0013528554,0.00027693296,0.0018314294,0.00044863144,0.00039299254,0.00010901112,0.00007574534,0.0010383816,0.00001701162],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15013205,0.04475233,0.1727562,0.0006522136,0.0010424801,0.0014779331,0.010552445,0.00030028,0.5973911,0.00003743814,0.0011983671,0.019707121],"study_design_scores_gemma":[0.06673408,0.18771322,0.09163335,0.00013638366,0.0009863133,0.000017097169,0.002033139,0.00008910525,0.6432959,0.000012688892,0.0071213897,0.00022736397],"about_ca_topic_score_codex":0.00013301056,"about_ca_topic_score_gemma":0.000019834988,"teacher_disagreement_score":0.14296089,"about_ca_system_score_codex":0.00057215965,"about_ca_system_score_gemma":0.0010870903,"threshold_uncertainty_score":0.9999683},"labels":[],"label_agreement":null},{"id":"W3006937281","doi":"10.1200/jgo.19.00380","title":"Outcomes in Black and White Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors: Insights From Two Large Cohorts","year":2020,"lang":"en","type":"article","venue":"JCO Global Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Centre Hospitalier de l’Université de Montréal; University of Calgary; CancerCare Manitoba; McMaster University; McGill University Health Centre; Juravinski Cancer Centre; BC Cancer Agency; Princess Margaret Cancer Centre; Ottawa Hospital; University of Ottawa","funders":"Genentech; Eisai; Ipsen; Mirati Therapeutics; U.S. Department of Defense; Exelixis; GlaxoSmithKline; Dana-Farber/Harvard Cancer Center; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Congressionally Directed Medical Research Programs; Astellas Pharma; Gateway for Cancer Research; Pfizer; Karyopharm Therapeutics","keywords":"Renal cell carcinoma; Tyrosine kinase; Medicine; Cancer research; Oncology; Internal medicine; Carcinoma","score_opus":0.014565016529868632,"score_gpt":0.2531003604163637,"score_spread":0.23853534388649505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006937281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949146,0.000400074,0.000030305653,0.0016922909,0.000047678262,0.0012927315,0.00025750857,0.000056740857,0.0013081051],"genre_scores_gemma":[0.9967316,0.000017747681,0.0013070005,0.0011514842,0.000092822316,0.000045832257,0.0005604903,0.00003821038,0.00005483808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771386,0.0001548721,0.00052491983,0.000729741,0.00040773553,0.00046888512],"domain_scores_gemma":[0.99864215,0.00012918697,0.0002437398,0.0003121873,0.00016524647,0.0005074921],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000050661612,0.00047182606,0.0011822116,0.000095277894,0.00005864896,0.000021105028,0.000089992,0.00012861981,0.00006848577],"category_scores_gemma":[0.000043765624,0.00029774947,0.00007422893,0.0004970315,0.00018001204,0.00011452597,0.000103401995,0.00023980615,0.00003396504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043764976,0.0015015386,0.988151,0.00008274646,0.0001965347,0.0042641647,0.0005949635,0.000090986425,0.00011432687,0.000012230083,0.0003508691,0.00026412448],"study_design_scores_gemma":[0.033528663,0.011458126,0.95133185,0.00008964947,0.0007724804,0.00002569645,0.00013447361,0.0002654108,0.0011695533,0.000021599262,0.0009108861,0.00029158496],"about_ca_topic_score_codex":0.0013933799,"about_ca_topic_score_gemma":0.0052373484,"teacher_disagreement_score":0.03681914,"about_ca_system_score_codex":0.0006774076,"about_ca_system_score_gemma":0.00024427372,"threshold_uncertainty_score":0.9999475},"labels":[],"label_agreement":null},{"id":"W3007266269","doi":"10.1200/jco.2020.38.6_suppl.642","title":"Sites of metastasis and survival in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Sunnybrook Hospital; University of Calgary; University Health Network; Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Medicine; Renal cell carcinoma; Hazard ratio; Oncology; Metastasis; Proportional hazards model; Internal medicine; Thyroid; Pancreas; Cancer; Confidence interval","score_opus":0.22530503151327455,"score_gpt":0.4213904511404731,"score_spread":0.19608541962719853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007266269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96670264,0.001218465,0.000060287577,0.029260924,0.0004491947,0.00021025057,0.00027171447,0.0000037129712,0.0018228084],"genre_scores_gemma":[0.98946124,0.00047715023,0.0070089456,0.002309643,0.00061619945,0.0000022770207,0.000066859575,0.000013167357,0.00004452063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948274,0.0009233045,0.0030715838,0.0003106636,0.0006742718,0.0001928144],"domain_scores_gemma":[0.9882543,0.008716671,0.0019809972,0.00026277968,0.00038638804,0.00039887137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036763556,0.00018150457,0.0015410053,0.00009716967,0.00002249238,0.0000124467215,0.00030990166,0.00013312083,0.00017014267],"category_scores_gemma":[0.007536216,0.00010825722,0.0003731518,0.0001673631,0.00031122135,0.00011823877,0.00018381822,0.0009594738,0.000009460936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05258281,0.0037742625,0.8617379,0.00011548675,0.002178084,0.009614517,0.0017368952,0.00009631463,0.025006492,0.00016247266,0.020271871,0.022722885],"study_design_scores_gemma":[0.039763834,0.013102892,0.9026698,0.0001272138,0.0024380665,0.00029516392,0.0016524337,0.0011254272,0.0135031,0.00020281503,0.024912106,0.00020716868],"about_ca_topic_score_codex":0.00030818203,"about_ca_topic_score_gemma":0.000196297,"teacher_disagreement_score":0.040931877,"about_ca_system_score_codex":0.00009015337,"about_ca_system_score_gemma":0.0010330817,"threshold_uncertainty_score":0.9022099},"labels":[],"label_agreement":null},{"id":"W3007384009","doi":"10.1186/s13046-020-1527-y","title":"Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinoma","year":2020,"lang":"en","type":"article","venue":"Journal of Experimental & Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prevention of Organ Failure; University of British Columbia","funders":"Canadian Institutes of Health Research; Cancer Research Society; Canadian Urological Oncology Group","keywords":"Sunitinib; Cancer research; Viability assay; Renal cell carcinoma; Flow cytometry; In vivo; Cell; Biology; Medicine; Pathology; Molecular biology; Biochemistry","score_opus":0.20414475947081998,"score_gpt":0.4620455632307689,"score_spread":0.25790080375994895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007384009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98547494,0.0080931485,0.00000425745,0.0036370188,0.00014729337,0.001235082,0.0000072289295,0.000008456235,0.0013925472],"genre_scores_gemma":[0.99260277,0.00018378302,0.0042252596,0.0004198856,0.0004187638,0.00013041956,0.0000040640143,0.0000636341,0.0019513958],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99301636,0.0009251019,0.0024134242,0.0006693691,0.002134405,0.0008413566],"domain_scores_gemma":[0.9975617,0.0003951228,0.00052871654,0.0003019571,0.00034855297,0.0008639417],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032646502,0.00032899107,0.0011264499,0.0005215733,0.00011866754,0.00006987169,0.00048775846,0.0001375398,0.000716393],"category_scores_gemma":[0.00028975462,0.00027350208,0.00035268738,0.00098343,0.00027662798,0.00023003986,0.00028795536,0.0015238492,0.00007954073],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023603182,0.003398324,0.04725453,0.0004482113,0.00011233546,0.006258128,0.008735798,0.000007624603,0.90374315,0.000010036712,0.0053877966,0.0010408798],"study_design_scores_gemma":[0.012170777,0.0024182058,0.009746549,0.0006849622,0.000033706554,0.00001978528,0.0027144537,0.000019199299,0.9682665,0.000013939709,0.0036564902,0.00025542034],"about_ca_topic_score_codex":0.00018154745,"about_ca_topic_score_gemma":0.00010698848,"teacher_disagreement_score":0.064523354,"about_ca_system_score_codex":0.001942125,"about_ca_system_score_gemma":0.0023313449,"threshold_uncertainty_score":0.9999717},"labels":[],"label_agreement":null},{"id":"W3007390686","doi":"10.1200/jco.2020.38.6_suppl.657","title":"Cost analysis of post-nephrectomy follow-up schedules from three North American clinical practice guidelines for localized renal cell carcinoma (RCC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; McGill University; Dalhousie University","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Schedule; Internal medicine; Kidney; Management","score_opus":0.29886250569133854,"score_gpt":0.5021983807769741,"score_spread":0.20333587508563555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007390686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9503705,0.0012168597,0.009882372,0.03638131,0.00088525185,0.00077557657,0.00015029447,0.000019374655,0.000318445],"genre_scores_gemma":[0.7683138,0.00053021254,0.21064338,0.017817494,0.0024961026,0.000016206972,0.00010557525,0.000046189303,0.000031024032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9881784,0.0011702128,0.008515051,0.00067477894,0.0010012449,0.00046034245],"domain_scores_gemma":[0.96491295,0.017110372,0.008441733,0.00058752025,0.0075390907,0.0014083579],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0043962086,0.0004114319,0.005885616,0.0003278293,0.00006160321,0.0000190861,0.0005126257,0.00044954085,0.00015223592],"category_scores_gemma":[0.05888132,0.00029129366,0.003956036,0.0011112726,0.00063423754,0.00018635241,0.0001571169,0.0013840188,0.000022084083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059750084,0.002629903,0.78312755,0.000049750153,0.00958707,0.0011049269,0.00012310292,0.00021692792,0.0002812975,0.000012589728,0.008587041,0.13452975],"study_design_scores_gemma":[0.027040817,0.04689991,0.772924,0.000041488838,0.03458537,0.000057510595,0.0006475697,0.0048565827,0.0004902737,0.000033281776,0.11214334,0.0002798236],"about_ca_topic_score_codex":0.0006098763,"about_ca_topic_score_gemma":0.0017644627,"teacher_disagreement_score":0.20076102,"about_ca_system_score_codex":0.00020211627,"about_ca_system_score_gemma":0.003372804,"threshold_uncertainty_score":0.9999539},"labels":[],"label_agreement":null},{"id":"W3007447088","doi":"10.1200/jco.2020.38.6_suppl.608","title":"Cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICI) or targeted therapy (TT): A propensity score-based analysis.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; University of Calgary; Ottawa Hospital; Dalhousie University; University of Ottawa","funders":"","keywords":"Medicine; Propensity score matching; Renal cell carcinoma; Hazard ratio; Confounding; Internal medicine; Proportional hazards model; Urology; Nephrectomy; Oncology; Gastroenterology; Confidence interval; Kidney","score_opus":0.19717752873204802,"score_gpt":0.38647551463242374,"score_spread":0.18929798590037572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007447088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98914534,0.0007982208,0.001262661,0.006424396,0.00019697429,0.0018680271,0.000022374144,0.000031133484,0.00025089085],"genre_scores_gemma":[0.98064303,0.00006669754,0.016481781,0.0016464934,0.0008348196,0.00005876184,0.000056050016,0.00006426331,0.00014809509],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9935233,0.0010018975,0.0036251529,0.00061715697,0.00071548077,0.00051700464],"domain_scores_gemma":[0.991799,0.0017599866,0.0035777502,0.0003943804,0.0014608919,0.0010080175],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022213475,0.0004986161,0.004377922,0.00038207596,0.00010865781,0.00002753564,0.00027067872,0.0003195812,0.00021310455],"category_scores_gemma":[0.0013971615,0.0002672232,0.0020697573,0.0011992701,0.00041158855,0.00015654789,0.000045242065,0.0011139427,0.000009718208],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4434209,0.0123556135,0.4353776,0.00032199957,0.018055275,0.011207432,0.00086652796,0.001397428,0.05729568,0.000008915265,0.0018710475,0.017821593],"study_design_scores_gemma":[0.06171579,0.15280068,0.54865044,0.00010157863,0.013762049,0.00033119606,0.00032388236,0.0016876231,0.21629436,0.00002086302,0.003879637,0.00043191283],"about_ca_topic_score_codex":0.00014916563,"about_ca_topic_score_gemma":0.00006900605,"teacher_disagreement_score":0.3817051,"about_ca_system_score_codex":0.0004919289,"about_ca_system_score_gemma":0.0044763465,"threshold_uncertainty_score":0.999978},"labels":[],"label_agreement":null},{"id":"W3007462644","doi":"10.5430/jst.v10n1p18","title":"Advanced and metastatic renal cell carcinoma – Ain Shams Clinical Oncology Department Experience","year":2020,"lang":"en","type":"article","venue":"Journal of Solid Tumors","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Pathological; Retrospective cohort study; Clinical Oncology; Oncology; Cancer","score_opus":0.07104858903820346,"score_gpt":0.36999763597079244,"score_spread":0.29894904693258895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007462644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941942,0.0018192648,0.00020267599,0.0024625517,0.00017118943,0.0002926196,0.0000063858665,0.000010263786,0.0008408627],"genre_scores_gemma":[0.99022883,0.00018404068,0.0076095257,0.0015066871,0.00031965473,0.000009832762,0.0000033202987,0.000023424152,0.00011470522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997663,0.00017706795,0.0011654766,0.00026699764,0.00043817316,0.00028926623],"domain_scores_gemma":[0.9979456,0.00020961527,0.00068389805,0.00016015153,0.00016282825,0.00083788054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042267633,0.00020961116,0.00094875647,0.00008219643,0.000050492494,0.00001250223,0.00012541194,0.000056231926,0.00010925323],"category_scores_gemma":[0.00023800471,0.00014997342,0.00026231914,0.0001382441,0.00015895751,0.00012894296,0.00006993136,0.00044181212,0.000025604191],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027673421,0.0073206075,0.462091,0.0012608519,0.0015938559,0.16960429,0.028002227,0.0015886085,0.170662,0.00011852289,0.018489849,0.11159478],"study_design_scores_gemma":[0.041086677,0.09126258,0.5601824,0.0004890297,0.0025204695,0.019196765,0.009297622,0.0032842522,0.23981941,0.00021660533,0.03164744,0.0009967819],"about_ca_topic_score_codex":0.0000034277325,"about_ca_topic_score_gemma":8.234685e-7,"teacher_disagreement_score":0.15040752,"about_ca_system_score_codex":0.00018000274,"about_ca_system_score_gemma":0.0004268081,"threshold_uncertainty_score":0.6115739},"labels":[],"label_agreement":null},{"id":"W3007700981","doi":"10.1200/jco.2020.38.6_suppl.701","title":"Outcomes of systemic therapy in relapsed renal cell carcinoma (RCC) treated with adjuvant sunitinib (AS).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Pfizer","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Internal medicine; Systemic therapy; Clinical endpoint; Progression-free survival; Surgery; Oncology; Adjuvant therapy; Adjuvant; Retrospective cohort study; Overall survival; Gastroenterology; Cancer; Clinical trial","score_opus":0.13011546843746613,"score_gpt":0.39773260319672904,"score_spread":0.2676171347592629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007700981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98949325,0.0013390903,0.000008744918,0.0046072444,0.00016060505,0.00047007366,0.000004582847,0.0000109720295,0.003905422],"genre_scores_gemma":[0.9963634,0.0005100701,0.0007411786,0.0018107514,0.0002952514,0.000006513826,0.000004695461,0.000034818582,0.00023334197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994902,0.0007698153,0.0032161504,0.00027474528,0.00054967974,0.00028759762],"domain_scores_gemma":[0.99442166,0.0018531084,0.0023651766,0.0002645831,0.0005158762,0.0005796006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013496105,0.00025973748,0.0030094394,0.0001949853,0.000018020797,0.0000044589847,0.0002194314,0.00037876258,0.00015451686],"category_scores_gemma":[0.000891696,0.00014842942,0.0005892274,0.0002996016,0.00020132853,0.000056716173,0.000034356224,0.0010616515,0.000022345323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026311869,0.0020611263,0.9407156,0.00009191263,0.0004054124,0.008801028,0.00055329496,0.0000457055,0.008151755,0.000016268756,0.00038721197,0.012458825],"study_design_scores_gemma":[0.040031895,0.089974895,0.85640395,0.00021327146,0.0004649931,0.0011277697,0.00061642623,0.000041588413,0.010200957,0.000015935693,0.0007690447,0.00013929784],"about_ca_topic_score_codex":0.00012576036,"about_ca_topic_score_gemma":0.000020764424,"teacher_disagreement_score":0.08791377,"about_ca_system_score_codex":0.00020474567,"about_ca_system_score_gemma":0.0018590069,"threshold_uncertainty_score":0.60527766},"labels":[],"label_agreement":null},{"id":"W3007807247","doi":"10.1200/jco.2020.38.6_suppl.tps761","title":"Phase II trial of cytoreductive stereotactic hypofractionated radiotherapy with combination ipilimumab/nivolumab for metastatic kidney cancer (CYTOSHRINK).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; Ontario Clinical Oncology Group; Health Sciences Centre; McMaster University Medical Centre; St. Joseph’s Healthcare Hamilton; McMaster University; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Ipilimumab; Kidney cancer; Renal cell carcinoma; Nivolumab; Contraindication; Internal medicine; Surgery; Sunitinib; Cancer; Oncology; Urology; Immunotherapy; Pathology","score_opus":0.18326508611878303,"score_gpt":0.48248983561421943,"score_spread":0.2992247494954364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007807247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.968408,0.0004450426,0.0013133233,0.027201965,0.0010422422,0.0013376212,0.000027204194,0.000010572449,0.0002140137],"genre_scores_gemma":[0.9888082,0.00045198225,0.0071394164,0.0022061276,0.0011588741,0.000046682082,0.000014868546,0.000033150718,0.00014070097],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99657434,0.0004194668,0.0020890739,0.00024263815,0.0004825772,0.00019188822],"domain_scores_gemma":[0.9935027,0.001667572,0.0030019537,0.00014858603,0.001095545,0.0005836869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010912215,0.00018816651,0.001899346,0.00012956504,0.000060439426,0.0000063301836,0.0001195422,0.00016981357,0.00021329893],"category_scores_gemma":[0.0023799532,0.00012553144,0.00053641055,0.000185461,0.00020351916,0.00023458539,0.00001667504,0.00057926896,0.0000017532517],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8653017,0.024816388,0.0006079901,0.00017928898,0.005006455,0.0003484311,0.00050474925,0.000061827166,0.005646134,0.00012673574,0.004463899,0.092936374],"study_design_scores_gemma":[0.55992377,0.40705594,0.0020258122,0.00011381073,0.002674205,0.0002531977,0.00022701197,0.00093776203,0.0034889956,0.00014098412,0.023031393,0.00012712719],"about_ca_topic_score_codex":0.000028957382,"about_ca_topic_score_gemma":0.000004505436,"teacher_disagreement_score":0.38223955,"about_ca_system_score_codex":0.00047321757,"about_ca_system_score_gemma":0.0038018194,"threshold_uncertainty_score":0.67442644},"labels":[],"label_agreement":null},{"id":"W3007846944","doi":"10.1200/jco.2020.38.6_suppl.729","title":"Evaluation of RNA-sequencing (RNA-seq) signatures with pembrolizumab (pembro) in patients (pts) with renal cell carcinoma (RCC) from KEYNOTE-427 cohort A.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Cohort; Oncology; Angiogenesis; Stromal cell; Proportional hazards model; RNA-Seq; Internal medicine; Renal cell carcinoma; Cancer research; Gene expression; Transcriptome; Gene; Biology; Genetics","score_opus":0.11423735359886043,"score_gpt":0.3762629841007573,"score_spread":0.26202563050189687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007846944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921269,0.0007741007,0.000104349194,0.0013091376,0.00025969747,0.00085943425,0.000012635814,0.000010031646,0.004543731],"genre_scores_gemma":[0.9942449,0.00006401126,0.003866595,0.0010955893,0.00061304256,0.000013287102,0.000028650918,0.00004769091,0.00002624815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9924043,0.0014010747,0.0029069025,0.00050476706,0.0024098605,0.000373112],"domain_scores_gemma":[0.99234635,0.0013742781,0.0030684355,0.00035276893,0.0022096755,0.000648514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034705196,0.00034894093,0.0023150886,0.00021918463,0.000036763435,0.000011719528,0.00028225407,0.00051013223,0.00022838183],"category_scores_gemma":[0.0020697808,0.00022065724,0.0003870565,0.00035776198,0.00025982302,0.00018756288,0.00006796051,0.0016363161,0.000010589813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051986936,0.0024644495,0.9093375,0.00009052814,0.00089261745,0.0016075806,0.00076665066,0.003604765,0.0040745703,0.0000062971944,0.0007751699,0.024392884],"study_design_scores_gemma":[0.05375641,0.05159306,0.8807867,0.0002760238,0.00320245,0.0000570708,0.00026403536,0.0016157381,0.00799281,0.000076548364,0.00016362088,0.00021552856],"about_ca_topic_score_codex":0.00049518823,"about_ca_topic_score_gemma":0.00019744282,"teacher_disagreement_score":0.049128614,"about_ca_system_score_codex":0.0012318107,"about_ca_system_score_gemma":0.005634105,"threshold_uncertainty_score":0.999466},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W3007944925","doi":"10.1200/jco.2020.38.6_suppl.690","title":"Depth of response (DepOR) analysis and correlation with clinical outcomes from JAVELIN Renal 101.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Renal cell carcinoma; Progression-free survival; Interim analysis; Multivariate analysis; Sunitinib; Proportional hazards model; Urology; Nuclear medicine; Oncology; Clinical trial; Overall survival","score_opus":0.1807682743590052,"score_gpt":0.4563232635441556,"score_spread":0.2755549891851504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007944925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98455906,0.0003164652,0.003181646,0.011110253,0.00021142937,0.00016506301,0.000007865476,0.000007812812,0.00044039296],"genre_scores_gemma":[0.9777624,0.00027166036,0.019368913,0.0020263733,0.00047143703,0.0000011996441,0.00000946494,0.000015330175,0.000073227675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936982,0.0014475114,0.0038549397,0.0003041203,0.0005364987,0.00015876199],"domain_scores_gemma":[0.984936,0.010478028,0.0031515767,0.0002388387,0.00048497735,0.00071055477],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0040359944,0.00017582533,0.00289103,0.00017329493,0.000023389208,0.0000067587944,0.000117571304,0.00042036988,0.00015481461],"category_scores_gemma":[0.00950267,0.00010447191,0.0009818889,0.0003544439,0.00033006267,0.000079281126,0.000055606535,0.0009766856,0.000010718436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056817617,0.00078996865,0.90755063,0.000008071289,0.004485058,0.0016072668,0.00012240138,0.000085270534,0.00015145236,0.000004433879,0.0003216908,0.028056147],"study_design_scores_gemma":[0.011013447,0.025513988,0.95276886,0.00004103601,0.007682772,0.000116505056,0.0001044531,0.0007613304,0.00012417532,0.000038616352,0.0017492189,0.00008560467],"about_ca_topic_score_codex":0.000049252118,"about_ca_topic_score_gemma":0.000101089245,"teacher_disagreement_score":0.04580417,"about_ca_system_score_codex":0.00007245523,"about_ca_system_score_gemma":0.0012133499,"threshold_uncertainty_score":0.9988407},"labels":[],"label_agreement":null},{"id":"W3007983591","doi":"10.1200/jco.2020.38.6_suppl.633","title":"Real-world utilization and safety of ipilimumab plus nivolumab (I+N) in metastatic renal cell carcinoma (mRCC) patients: Results from the Canadian Kidney Cancer Information System (CKCis).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Ottawa; Sunnybrook Hospital; University Health Network; Ottawa Hospital; University of Calgary; Princess Margaret Cancer Centre; Juravinski Cancer Centre; University of Manitoba; BC Cancer Agency; Hôtel-Dieu de Québec; Université Laval; Centre Hospitalier de l’Université de Montréal; University of Alberta; Dalhousie University","funders":"","keywords":"Medicine; Discontinuation; Ipilimumab; Tolerability; Nivolumab; Internal medicine; Renal cell carcinoma; Cohort; Hazard ratio; Adverse effect; Cancer; Surgery; Oncology; Immunotherapy; Confidence interval","score_opus":0.11803645853380589,"score_gpt":0.37106025176896706,"score_spread":0.25302379323516117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007983591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98433256,0.00026525033,0.000027896045,0.008839899,0.00047269982,0.00058491767,0.00026155027,0.000005560974,0.005209635],"genre_scores_gemma":[0.9964433,0.00036367268,0.00069439376,0.0020624707,0.0002794459,0.000005881434,0.00010765268,0.000012464304,0.000030729585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99503547,0.00065110595,0.0034232712,0.00018462962,0.00047965616,0.0002258576],"domain_scores_gemma":[0.9947178,0.0012925317,0.0023663759,0.00020522108,0.00062203384,0.0007960596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015536976,0.00016677953,0.0012218809,0.00018597335,0.00006328885,0.000014651649,0.00016274567,0.00018415287,0.000039286937],"category_scores_gemma":[0.0025115262,0.00010798516,0.00020174882,0.00033166242,0.00013801854,0.00023036123,0.000046466914,0.0006494222,0.0000062256067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05526923,0.00061072473,0.8555647,0.00053930894,0.000597411,0.00061467336,0.007375294,0.0008268706,0.00005343412,0.00015003447,0.016168755,0.062229533],"study_design_scores_gemma":[0.029305533,0.004797834,0.9451652,0.0003147032,0.0006380008,0.000015073462,0.00073688914,0.0030186097,0.00019150117,0.0000128640395,0.015704103,0.00009966829],"about_ca_topic_score_codex":0.10723529,"about_ca_topic_score_gemma":0.120644696,"teacher_disagreement_score":0.08960049,"about_ca_system_score_codex":0.0015906689,"about_ca_system_score_gemma":0.0062728147,"threshold_uncertainty_score":0.9993607},"labels":[],"label_agreement":null},{"id":"W3008055052","doi":"10.1200/jco.2020.38.6_suppl.715","title":"Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma (S/R RCC) to reveal potential determinants of poor prognosis and response to immune checkpoint inhibitors (ICI).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"CDKN2A; Cancer research; Immune checkpoint; Medicine; BAP1; Immune system; Transcriptome; Tumor microenvironment; CD8; Downregulation and upregulation; Cancer; Immunotherapy; Oncology; Internal medicine; Biology; Melanoma; Gene expression; Gene; Immunology","score_opus":0.04529062756487279,"score_gpt":0.3560150539376791,"score_spread":0.31072442637280634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008055052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99054796,0.0002573687,0.0001966958,0.008104067,0.00017813744,0.0006525336,0.000015891957,0.0000043336104,0.000043028296],"genre_scores_gemma":[0.9940554,0.000074334406,0.0048502586,0.0007478823,0.00020121182,0.00000808328,0.0000034056518,0.000023643413,0.00003577741],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9954428,0.0007443456,0.0029127053,0.0002953941,0.00039526244,0.00020951079],"domain_scores_gemma":[0.9962373,0.0004845816,0.001838413,0.00014206902,0.0005951207,0.00070254446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001817635,0.000218142,0.0018210345,0.00022773346,0.00002557619,0.000007772068,0.00012492413,0.0002533204,0.000013793392],"category_scores_gemma":[0.0022903236,0.0001571565,0.0003576297,0.00023641653,0.00018905006,0.00008234971,0.00017063649,0.00044793013,0.000002375683],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032165486,0.0006504392,0.06893553,0.00012256367,0.0001008877,0.0010668271,0.0010330079,0.0000018131748,0.8812807,0.0000012000177,0.000045146124,0.014596406],"study_design_scores_gemma":[0.0033380124,0.032048743,0.45788142,0.00018460772,0.00025741634,0.0002726906,0.0001891371,0.00004577872,0.5055474,0.000005373603,0.00015213546,0.00007726972],"about_ca_topic_score_codex":0.000025482363,"about_ca_topic_score_gemma":0.0000032941841,"teacher_disagreement_score":0.38894588,"about_ca_system_score_codex":0.000101192425,"about_ca_system_score_gemma":0.00069584016,"threshold_uncertainty_score":0.64086556},"labels":[],"label_agreement":null},{"id":"W3008234090","doi":"10.1200/jco.2020.38.6_suppl.610","title":"A novel clinical decision aid to support personalized treatment selection for patients with CT1 renal cortical masses: Results from a multi-institutional competing risks analysis including performance status and comorbidity.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cohort; Logistic regression; Nephrectomy; Comorbidity; Performance status; Internal medicine; Charlson comorbidity index; Surgery; Cancer; Kidney","score_opus":0.31356580220146196,"score_gpt":0.4835719479463956,"score_spread":0.1700061457449336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008234090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9658512,0.000040884057,0.031694658,0.0012265366,0.00026129186,0.00070760306,0.00014777028,0.00001568599,0.000054370492],"genre_scores_gemma":[0.7956091,0.00021442519,0.20256853,0.00080951455,0.00062417606,0.000013351647,0.000131565,0.00001685294,0.000012465824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946034,0.00037574928,0.0033706916,0.0005945718,0.00068295957,0.00037265196],"domain_scores_gemma":[0.9887514,0.0072226943,0.0016960377,0.00015828435,0.0008793546,0.0012922046],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0021952179,0.00029489913,0.002325385,0.00020279622,0.00019779042,0.000028152872,0.000110048,0.00032023902,0.00004416078],"category_scores_gemma":[0.008514396,0.0001827318,0.00073412195,0.00039736106,0.00026492795,0.00014558196,0.00008656002,0.00074628764,0.0000067215433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08981927,0.0037448693,0.8604917,0.000013833787,0.002541289,0.000102619495,0.00030298586,0.0007115218,0.00009899486,0.0000048906372,0.000104785584,0.04206326],"study_design_scores_gemma":[0.06697776,0.06919518,0.82883483,0.00010344038,0.0044896626,0.000050454575,0.00010355315,0.021619298,0.000041288837,0.0000026163839,0.008426424,0.00015549094],"about_ca_topic_score_codex":0.00014470806,"about_ca_topic_score_gemma":0.00023284917,"teacher_disagreement_score":0.17087387,"about_ca_system_score_codex":0.0006821454,"about_ca_system_score_gemma":0.0018821281,"threshold_uncertainty_score":0.9998373},"labels":[],"label_agreement":null},{"id":"W3008273616","doi":"10.1200/jco.2020.38.6_suppl.673","title":"Efficacy of immune checkpoint inhibitors (ICI) treatment in special populations of metastatic renal cell carcinoma (mRCC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Creatinine; Renal cell carcinoma; Renal function; Internal medicine; Urology; Oncology; Gastroenterology","score_opus":0.2037736878302232,"score_gpt":0.42828534458615936,"score_spread":0.22451165675593615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008273616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915041,0.00083790516,0.000031444015,0.0037854323,0.0005890427,0.0004894589,0.0000086641785,0.000003852017,0.0027501204],"genre_scores_gemma":[0.9925605,0.00012689015,0.0054005827,0.00013965163,0.0016522389,0.000004122374,0.000009895447,0.000022059361,0.00008402643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99291766,0.0005576973,0.005562178,0.00023500396,0.000486284,0.0002411906],"domain_scores_gemma":[0.99438316,0.0012953326,0.003325652,0.00024105699,0.0003147677,0.00044000542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012943024,0.00022491145,0.0026785422,0.00024415928,0.000018194123,0.0000030079636,0.0001524213,0.00021221547,0.00024926095],"category_scores_gemma":[0.0017275686,0.00015629409,0.0013365004,0.00033587846,0.00021979213,0.000067774585,0.0000571254,0.0005903425,0.0000124459675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0513687,0.0364591,0.7119582,0.0005531272,0.00175329,0.008640529,0.0050259484,0.0016184151,0.07835172,0.00029119707,0.0018162514,0.10216351],"study_design_scores_gemma":[0.029458752,0.049180076,0.85643715,0.000118639386,0.0014561263,0.00015655706,0.0003388546,0.0001323105,0.060468525,0.00011486946,0.0020139485,0.00012421425],"about_ca_topic_score_codex":0.0001883226,"about_ca_topic_score_gemma":0.000060684244,"teacher_disagreement_score":0.14447892,"about_ca_system_score_codex":0.00039995855,"about_ca_system_score_gemma":0.0016883663,"threshold_uncertainty_score":0.63734883},"labels":[],"label_agreement":null},{"id":"W3008324302","doi":"10.1200/jco.2020.38.6_suppl.753","title":"Impact of metastasectomy on progression free and overall survival in metastatic renal cell carcinoma: Analysis of the REMARCC registry.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Metastasectomy; Renal cell carcinoma; Internal medicine; Cohort; Metastasis; Oncology; Urology; Surgery; Gastroenterology; Cancer","score_opus":0.13093625353236332,"score_gpt":0.4454070677849111,"score_spread":0.3144708142525478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008324302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99521893,0.00058919255,0.000017892928,0.0028202198,0.00010577659,0.0002638533,0.000037624537,0.0000018946093,0.0009446157],"genre_scores_gemma":[0.99772906,0.00008473792,0.001814725,0.00020513216,0.00011847043,0.0000017759372,0.000006432401,0.000012418071,0.000027220167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952676,0.0011291062,0.0024584522,0.0002361125,0.00071588863,0.00019280124],"domain_scores_gemma":[0.99381155,0.0020427636,0.003062604,0.00041450048,0.00030813203,0.00036047216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024236594,0.00018294727,0.0025695716,0.00025097834,0.000016131504,0.000004176051,0.00026224979,0.00015585632,0.00008697522],"category_scores_gemma":[0.0034813187,0.00009254877,0.0014233008,0.00061889546,0.00025140634,0.000050543753,0.00012432637,0.0008027534,5.4828257e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012443638,0.0024635321,0.97166276,0.00012376292,0.0028555258,0.0010252647,0.00022195696,0.00044806694,0.0032041774,0.00002825585,0.000904517,0.0046185264],"study_design_scores_gemma":[0.010238642,0.02384099,0.95805514,0.000083381216,0.005245631,0.00005209871,0.000055846107,0.00044382192,0.0016786854,0.00007025178,0.00017018916,0.0000653084],"about_ca_topic_score_codex":0.00016256837,"about_ca_topic_score_gemma":0.00007328573,"teacher_disagreement_score":0.021377457,"about_ca_system_score_codex":0.00017136567,"about_ca_system_score_gemma":0.0012290514,"threshold_uncertainty_score":0.4167715},"labels":[],"label_agreement":null},{"id":"W3008502333","doi":"10.1016/j.urolonc.2020.01.013","title":"Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Surgical Specialties (Canada)","funders":"","keywords":"Nephrectomy; Renal cell carcinoma; Medicine; Lymph node; Oncology; Urology; Internal medicine; Kidney","score_opus":0.023906186737125454,"score_gpt":0.23805755520731697,"score_spread":0.2141513684701915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008502333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99151903,0.000558972,0.000013494689,0.0050327946,0.00003911573,0.00059913326,0.000024139457,0.000018557286,0.0021947613],"genre_scores_gemma":[0.9875077,0.00004711039,0.009157451,0.002914007,0.00003081441,0.0000538573,0.00010207604,0.000014947899,0.00017202052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986815,0.00021300805,0.00033867458,0.0003491758,0.0001752117,0.00024245607],"domain_scores_gemma":[0.9989643,0.0002878347,0.00021852189,0.00020931057,0.00007250674,0.00024751847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019309114,0.00020188763,0.00040951333,0.00009257118,0.0001220141,0.000005950452,0.00009976377,0.000115974115,0.000060183538],"category_scores_gemma":[0.0001008881,0.00012177845,0.00004510586,0.0003335059,0.00058173295,0.000059973976,0.00007234403,0.00022069016,0.000015099121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011075614,0.0002463584,0.99450725,0.000074567586,0.00002901636,0.0001347818,0.000840541,0.000261715,0.0014054711,0.000086278196,0.0011652868,0.00014115208],"study_design_scores_gemma":[0.006743439,0.009092561,0.9177104,0.00006338048,0.0006361974,0.00005872064,0.0001327075,0.0010110802,0.0052779936,0.0002107378,0.05886446,0.0001983],"about_ca_topic_score_codex":0.000096450436,"about_ca_topic_score_gemma":0.000026218533,"teacher_disagreement_score":0.076796845,"about_ca_system_score_codex":0.00023423841,"about_ca_system_score_gemma":0.00033325524,"threshold_uncertainty_score":0.49659812},"labels":[],"label_agreement":null},{"id":"W3008612357","doi":"10.1200/jco.2020.38.6_suppl.684","title":"Second-line VEGF TKI after IO combination therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University Health Network; Princess Margaret Cancer Centre; Ottawa Hospital; University of Ottawa; University of Calgary","funders":"","keywords":"Medicine; Hazard ratio; Nivolumab; Renal cell carcinoma; Internal medicine; Proportional hazards model; Gastroenterology; Ipilimumab; Vascular endothelial growth factor; Urology; Oncology; Surgery; Confidence interval; Cancer; VEGF receptors; Immunotherapy","score_opus":0.17863678335251573,"score_gpt":0.4062466362906625,"score_spread":0.22760985293814676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008612357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9197282,0.0010655178,0.00010407558,0.074399784,0.001258477,0.0003310316,0.00021008254,0.000010751567,0.002892041],"genre_scores_gemma":[0.9697773,0.000387766,0.002679718,0.024557836,0.002051714,0.000009601613,0.00016554378,0.000025501437,0.00034506232],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9950479,0.00076320436,0.002865671,0.00036114483,0.00073519757,0.0002268371],"domain_scores_gemma":[0.9919008,0.004577591,0.0020518887,0.0003584073,0.00061286887,0.0004984603],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024090772,0.00022706442,0.0011521451,0.00007292749,0.00004444505,0.00002888341,0.00040416568,0.00018079378,0.0014255204],"category_scores_gemma":[0.00280762,0.00013244578,0.0005698149,0.00013341945,0.00022332747,0.00016817945,0.00012732967,0.0012451907,0.0000948428],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29549447,0.017443663,0.1929199,0.00013538367,0.00622109,0.033337846,0.005021005,0.00010419674,0.029613266,0.0003294475,0.2970625,0.12231724],"study_design_scores_gemma":[0.070193104,0.02879831,0.5541196,0.00011064675,0.0014772228,0.00046238353,0.0004418196,0.0014842207,0.014497576,0.00047565947,0.32763433,0.00030515745],"about_ca_topic_score_codex":0.000048996302,"about_ca_topic_score_gemma":0.000044328783,"teacher_disagreement_score":0.36119968,"about_ca_system_score_codex":0.00018161607,"about_ca_system_score_gemma":0.0013271485,"threshold_uncertainty_score":0.99948734},"labels":[],"label_agreement":null},{"id":"W3008727692","doi":"10.1200/jco.2020.38.6_suppl.tps768","title":"UNISON: Nivolumab then ipilimumab + nivolumab in advanced nonclear cell renal cell carcinoma (ANZUP 1602).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Nivolumab; Ipilimumab; Medicine; Internal medicine; Oncology; Immune checkpoint; Renal cell carcinoma; Clear cell renal cell carcinoma; Immunotherapy; Cancer","score_opus":0.09471171853521936,"score_gpt":0.38629953340175954,"score_spread":0.2915878148665402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008727692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96095175,0.0019714164,0.00009284507,0.009511219,0.000822816,0.0005198339,0.0000063016455,0.000027005139,0.026096812],"genre_scores_gemma":[0.98634297,0.00053758675,0.006408593,0.003901461,0.001669484,0.000007702973,0.0000072731227,0.00007281511,0.0010521174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931319,0.0009278515,0.0038380106,0.00061340886,0.0008345486,0.0006543323],"domain_scores_gemma":[0.9939246,0.0015448814,0.0022725319,0.00049983826,0.00049863796,0.001259506],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0019218998,0.00041681854,0.0028539118,0.00022913335,0.00006932502,0.0000202574,0.00052481913,0.00069789856,0.0005449231],"category_scores_gemma":[0.000967627,0.0003246344,0.0010855711,0.00042717342,0.00028031433,0.00022789348,0.0002005133,0.0024695934,0.00023489744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13253981,0.019196302,0.43188944,0.0010294205,0.0010718371,0.069525614,0.005668078,0.0015413461,0.05360408,0.00012155397,0.042077273,0.24173523],"study_design_scores_gemma":[0.12466499,0.15368026,0.5329198,0.00030673784,0.0018063304,0.0014608885,0.0025418396,0.0020955552,0.01708339,0.00032856668,0.16218513,0.0009264818],"about_ca_topic_score_codex":0.00007011955,"about_ca_topic_score_gemma":0.000038543847,"teacher_disagreement_score":0.24080876,"about_ca_system_score_codex":0.00095452124,"about_ca_system_score_gemma":0.003499828,"threshold_uncertainty_score":0.99992055},"labels":[],"label_agreement":null},{"id":"W3008839696","doi":"10.1200/jco.2020.38.6_suppl.682","title":"Real-world evidence of cabozantinib in metastatic renal-cell carcinoma (mRCC): Results from the Canadian Kidney Cancer Information System (CKCis).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Manitoba; Juravinski Cancer Centre; University of Ottawa; Sunnybrook Hospital; London Health Sciences Centre; Western University; Princess Margaret Cancer Centre; University of Calgary; Hôtel-Dieu de Québec; Dalhousie University; University Health Network; Université Laval; University of Alberta","funders":"","keywords":"Cabozantinib; Medicine; Renal cell carcinoma; Oncology; Internal medicine; Kidney cancer; Tyrosine-kinase inhibitor; Cancer; Population; Clinical trial","score_opus":0.19980846179959852,"score_gpt":0.42616919855497715,"score_spread":0.22636073675537863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008839696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9453324,0.0007365053,0.000011586972,0.045434754,0.00069099,0.00051265967,0.00011834432,0.000006651945,0.00715611],"genre_scores_gemma":[0.9927373,0.00044410952,0.001354493,0.0047263415,0.0006195855,0.000009034297,0.000017604008,0.000013647102,0.000077882214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935728,0.00090764504,0.0043797544,0.0002076864,0.0006272401,0.00030488116],"domain_scores_gemma":[0.9907142,0.003896929,0.0032700205,0.00033566268,0.000655897,0.0011272954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035459204,0.00019015813,0.0016242176,0.00021932842,0.000050121533,0.000017566732,0.00033470613,0.00020043619,0.000070725655],"category_scores_gemma":[0.0070718667,0.000115716924,0.00040384973,0.00049298815,0.00016172692,0.0002752235,0.000053741365,0.0010729032,0.000030016308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037281968,0.0006401361,0.8502687,0.00091497425,0.000926577,0.0058159553,0.0069813933,0.0008789297,0.0010896798,0.0002095168,0.069430515,0.025561664],"study_design_scores_gemma":[0.015431949,0.0069485023,0.93400526,0.0015706056,0.0012459729,0.00009050911,0.00093077315,0.0013473361,0.0020286415,0.000016083835,0.03622042,0.00016394409],"about_ca_topic_score_codex":0.27817473,"about_ca_topic_score_gemma":0.19921628,"teacher_disagreement_score":0.08373657,"about_ca_system_score_codex":0.00096630014,"about_ca_system_score_gemma":0.012167609,"threshold_uncertainty_score":0.99343246},"labels":[],"label_agreement":null},{"id":"W3009293906","doi":"10.2147/rru.s212584","title":"&lt;p&gt;Temporal Trends in Selecting Patients for Partial Nephrectomy for Small Renal Cell Carcinomas in Alberta, Canada&lt;/p&gt;","year":2020,"lang":"en","type":"article","venue":"Research and Reports in Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Renal function; Urology; Dialysis; Odds ratio; Cohort; Stage (stratigraphy); Internal medicine; Guideline; Kidney; Surgery; Pathology","score_opus":0.050875485159145875,"score_gpt":0.3013483460109272,"score_spread":0.25047286085178133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009293906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99309546,0.0006425592,0.000010666379,0.0025434878,0.00011492561,0.0015809392,0.000010709737,0.000009492728,0.0019917602],"genre_scores_gemma":[0.99760324,0.000019826373,0.00033787187,0.00020221718,0.00018641194,0.00060522545,0.00023412683,0.00003993102,0.000771177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99664557,0.0002160029,0.0008165599,0.0008115635,0.00040247373,0.0011078413],"domain_scores_gemma":[0.9983475,0.0006337475,0.00015391025,0.0002527896,0.00019832327,0.00041368825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009668269,0.00023542588,0.0006108045,0.0005360342,0.00008908714,0.000017449855,0.00009167428,0.00021787995,0.00002313017],"category_scores_gemma":[0.00071487506,0.00020646764,0.0000786662,0.0006417666,0.000112296635,0.00004315203,0.000101714024,0.00049626036,5.42444e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032417711,0.0004091035,0.9826643,0.00021121727,0.00003411379,0.0028273305,0.00063670456,0.000076845696,0.0027343372,0.00003271438,0.0035796538,0.003551915],"study_design_scores_gemma":[0.016148007,0.012769831,0.8445155,0.000071322844,0.00007274802,0.00038443258,0.000102309874,0.0053497087,0.012804584,0.00035021565,0.10689673,0.0005346038],"about_ca_topic_score_codex":0.14835562,"about_ca_topic_score_gemma":0.7695502,"teacher_disagreement_score":0.6211946,"about_ca_system_score_codex":0.00043440296,"about_ca_system_score_gemma":0.0011359886,"threshold_uncertainty_score":0.85731554},"labels":[],"label_agreement":null},{"id":"W3009805001","doi":"10.1038/s41581-020-0264-y","title":"New insights into the obesity paradox in renal cell carcinoma","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Nephrology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Renal cell carcinoma; Context (archaeology); Transcriptome; Carcinoma; Obesity; Obesity paradox; Medicine; Kidney cancer; Oncology; Cancer research; Internal medicine; Pathology; Biology; Gene; Gene expression; Genetics","score_opus":0.030212030635264522,"score_gpt":0.3108805532267856,"score_spread":0.2806685225915211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009805001","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014989915,0.9898372,0.000012791822,0.0013281765,0.00041109705,0.005526044,0.0000036843255,0.00004860517,0.0026824884],"genre_scores_gemma":[0.0003092853,0.99215937,0.0009659445,0.0037683095,0.0014630363,0.00037138182,0.00023805827,0.00011384944,0.0006107956],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940695,0.0016978426,0.0017507838,0.0013451374,0.00046499103,0.0006717256],"domain_scores_gemma":[0.9964186,0.00048235324,0.00088456046,0.0016434628,0.00006882697,0.0005022243],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00050805544,0.0012223787,0.0065248893,0.00037502815,0.00010417385,0.000027199183,0.00083915796,0.0023546799,0.00030496117],"category_scores_gemma":[0.00021729888,0.0006412825,0.0017383299,0.0013766629,0.00013734169,0.000058418318,0.00032995708,0.005562633,0.0011784418],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068099616,0.00017623905,0.00008305165,0.017646518,0.00014967243,0.0021334358,0.0004002292,8.478708e-8,0.0000073644796,0.00021158431,0.03927381,0.9398499],"study_design_scores_gemma":[0.0008299284,0.0006550195,0.00028592529,0.0041476362,0.0030803347,0.0007049055,0.000005649546,0.0000015192282,0.000010437852,0.00013106878,0.98971117,0.00043640166],"about_ca_topic_score_codex":0.00013395846,"about_ca_topic_score_gemma":0.00018507427,"teacher_disagreement_score":0.95043737,"about_ca_system_score_codex":0.00075276266,"about_ca_system_score_gemma":0.0015164382,"threshold_uncertainty_score":0.99960387},"labels":[],"label_agreement":null},{"id":"W3010242400","doi":"10.1016/j.urolonc.2020.02.004","title":"Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); Université de Montréal","funders":"","keywords":"Clear cell renal cell carcinoma; Medicine; Stage (stratigraphy); Clear cell; Internal medicine; Chromophobe cell; Oncology; Renal cell carcinoma; Biology","score_opus":0.035142799633973806,"score_gpt":0.29997750649717486,"score_spread":0.26483470686320104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010242400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99548393,0.0007136406,0.000032244432,0.0021155789,0.00006098469,0.0009889159,0.000080589154,0.000024537949,0.0004995843],"genre_scores_gemma":[0.9956885,0.00006788105,0.0023478293,0.0013478323,0.00004376071,0.00009910475,0.0003155903,0.000019206936,0.00007031366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794984,0.00038407746,0.00054443144,0.0006286488,0.00022676482,0.00026622697],"domain_scores_gemma":[0.9985802,0.00040686413,0.00033821518,0.00023281007,0.00006241165,0.00037950042],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003041792,0.0002975962,0.00082418707,0.00041388907,0.000121146244,0.000014237771,0.00008688776,0.00022999315,0.0000376018],"category_scores_gemma":[0.0000610224,0.00025269855,0.00012424098,0.0007151318,0.00020969247,0.000072576455,0.00004087444,0.00034500656,0.0000053078534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016034035,0.00031399002,0.99034876,0.00020678547,0.00004619813,0.00011725926,0.0005012202,0.0020394397,0.004128846,0.000023047472,0.0005456885,0.0001253769],"study_design_scores_gemma":[0.0038673382,0.021783583,0.92946225,0.000039021965,0.0010206776,0.0000019647173,0.00017374745,0.005604749,0.030161148,0.000016054775,0.007599195,0.0002702462],"about_ca_topic_score_codex":0.0020943999,"about_ca_topic_score_gemma":0.00022058967,"teacher_disagreement_score":0.060886472,"about_ca_system_score_codex":0.00030845107,"about_ca_system_score_gemma":0.00020647682,"threshold_uncertainty_score":0.99999255},"labels":[],"label_agreement":null},{"id":"W3010644992","doi":"10.1200/jco.2013.31.15_suppl.4504","title":"Record-3: Phase II randomized trial comparing sequential first-line everolimus (EVE) and second-line sunitinib (SUN) versus first-line SUN and second-line EVE in patients with metastatic renal cell carcinoma (mRCC).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Sunitinib; Hazard ratio; Everolimus; Progression-free survival; Internal medicine; Surgery; Renal cell carcinoma; Confidence interval; Overall survival","score_opus":0.11612168074028142,"score_gpt":0.38564449081191227,"score_spread":0.2695228100716308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010644992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921651,0.0007688933,0.00009699374,0.0019059408,0.0013474333,0.002894264,0.00004148341,0.00002207621,0.00075779716],"genre_scores_gemma":[0.9943101,0.0004087738,0.0022818218,0.0007330277,0.0014575297,0.000084917345,0.0001339782,0.0000835841,0.00050626404],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99020225,0.0016077972,0.005797974,0.0007669739,0.0008237516,0.00080123456],"domain_scores_gemma":[0.9856653,0.007875098,0.0037285315,0.00049048883,0.0010254151,0.0012151464],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0045604073,0.00072951004,0.0059171356,0.0005609837,0.00019854485,0.000057390036,0.00028189822,0.00052853185,0.0017698541],"category_scores_gemma":[0.0026116285,0.00050359074,0.0007322469,0.00031667668,0.00069942675,0.00045310913,0.0002677556,0.00202356,0.000015646221],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9536473,0.008802168,0.024739085,0.0002355162,0.0012404418,0.0012848638,0.00030541178,0.000111434674,0.000065367545,0.000006890199,0.0006582452,0.00890324],"study_design_scores_gemma":[0.86269516,0.09457213,0.034551695,0.00021313653,0.002513055,0.00023781466,0.000071228045,0.0024254597,0.00029762895,0.0001396146,0.0018668002,0.0004162523],"about_ca_topic_score_codex":0.00033190113,"about_ca_topic_score_gemma":0.002017915,"teacher_disagreement_score":0.09095215,"about_ca_system_score_codex":0.0004344804,"about_ca_system_score_gemma":0.0010840412,"threshold_uncertainty_score":0.99974155},"labels":[],"label_agreement":null},{"id":"W3010746379","doi":"10.1159/000499262","title":"Comparative Study Assessing Postoperative Renal Loss Using Two Different Partial Nephrectomy Techniques: Off-Clamp versus Standard On-Clamp Surgery","year":2020,"lang":"en","type":"article","venue":"Current Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Clamp; Interquartile range; Perioperative; Renal function; Nephrectomy; Surgery; Urology; Anesthesia; Kidney; Internal medicine","score_opus":0.16446028538481536,"score_gpt":0.3983519904005662,"score_spread":0.23389170501575082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010746379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99340236,0.0009015661,0.0009988247,0.0011017366,0.0010105257,0.001975415,0.000032602402,0.0001989906,0.0003779788],"genre_scores_gemma":[0.9983966,0.000035918347,0.00020452055,0.00033915727,0.0006721614,0.00017907583,0.00011639072,0.000050575065,0.000005603279],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962796,0.00081647024,0.0007082169,0.0009245012,0.0006271755,0.00064401876],"domain_scores_gemma":[0.9979853,0.0006133766,0.0002912317,0.00043034684,0.0002487545,0.00043095992],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002559955,0.0005899379,0.001455712,0.00022628633,0.00022979104,0.0000744212,0.00015680933,0.00012516897,0.00018939577],"category_scores_gemma":[0.0001514062,0.0004627948,0.0002872671,0.0003328191,0.00027545457,0.00013825363,0.00016167645,0.0008462232,0.0000438311],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14700186,0.014609184,0.6737018,0.00037924503,0.005093618,0.0076225856,0.024891995,0.0012265554,0.041770812,0.00077669363,0.007726485,0.075199135],"study_design_scores_gemma":[0.10403444,0.14369038,0.1297112,0.0013760778,0.0104892915,0.0010067996,0.008713122,0.03277459,0.44461808,0.00021238963,0.11697305,0.006400584],"about_ca_topic_score_codex":0.000014196752,"about_ca_topic_score_gemma":0.000017283608,"teacher_disagreement_score":0.5439906,"about_ca_system_score_codex":0.00051597547,"about_ca_system_score_gemma":0.00044705445,"threshold_uncertainty_score":0.9997824},"labels":[],"label_agreement":null},{"id":"W3010762550","doi":"10.1016/j.euf.2020.02.011","title":"Synchronous Metastasis Rates in T1 Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results Database–based Study","year":2020,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ottawa Hospital; University of Ottawa; Surgical Specialties (Canada); McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Chromophobe cell; Renal cell carcinoma; Nephrectomy; Surveillance, Epidemiology, and End Results; Clear cell; Metastasis; Logistic regression; Internal medicine; Epidemiology; Stage (stratigraphy); Urology; Oncology; Database; Pathology; Cancer; Kidney; Cancer registry","score_opus":0.04867426762741568,"score_gpt":0.2822151800204414,"score_spread":0.2335409123930257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010762550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787189,0.004409163,0.00011321544,0.0055062384,0.00007238641,0.00096041703,0.00017518143,0.0000893294,0.009955165],"genre_scores_gemma":[0.9967555,0.00004040173,0.00087751745,0.0017974506,0.00017187794,0.00002463274,0.00020626052,0.00006803108,0.00005836547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99378556,0.0034285085,0.0008641856,0.0011287665,0.00016990477,0.0006230655],"domain_scores_gemma":[0.9974561,0.0011271252,0.0002516323,0.000677168,0.00006027048,0.00042770075],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021974728,0.0004089018,0.000970736,0.00021275358,0.00008313074,0.000011309501,0.00020655537,0.00007484648,0.00006099906],"category_scores_gemma":[0.0010753897,0.00033527272,0.00011107944,0.0003310579,0.00023623607,0.000051728846,0.00024765456,0.0005452329,0.00016700532],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060070246,0.0011268182,0.9649165,0.000098884535,0.00018264966,0.016235601,0.00090362073,0.00015799803,0.003815839,0.000013888333,0.0027773469,0.0037637735],"study_design_scores_gemma":[0.013430858,0.007928251,0.97238934,0.000008764845,0.00029981215,0.00012947619,0.00013848633,0.00060968543,0.0017684397,0.000007095549,0.002995678,0.000294085],"about_ca_topic_score_codex":0.00026687482,"about_ca_topic_score_gemma":0.000169303,"teacher_disagreement_score":0.01803656,"about_ca_system_score_codex":0.00006761498,"about_ca_system_score_gemma":0.000108126434,"threshold_uncertainty_score":0.99990994},"labels":[],"label_agreement":null},{"id":"W3010833822","doi":"10.1200/jco.2013.31.15_suppl.e15541","title":"A population-based analysis of overall survival associated with sunitinib given as intermittent, continuous, or nonconventional individualized dosing regimens for metastatic renal cell carcinoma.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Sunitinib; Dosing; Renal cell carcinoma; Discontinuation; Internal medicine; Hazard ratio; Regimen; Population; Adverse effect; Surgery; Urology; Oncology; Confidence interval","score_opus":0.12829375564595036,"score_gpt":0.42057264633582025,"score_spread":0.2922788906898699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010833822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957572,0.00007689937,0.0007417612,0.0015336613,0.0002587413,0.000786372,0.00007136874,0.000009790447,0.0007641895],"genre_scores_gemma":[0.9873127,0.000008648609,0.010535049,0.000638967,0.00017095616,0.000030877985,0.00034022046,0.000032492877,0.0009301054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943501,0.0010774813,0.0031895125,0.00029485393,0.0007546967,0.0003333532],"domain_scores_gemma":[0.98466355,0.007979777,0.004998433,0.00024929614,0.0016973002,0.00041163876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029726005,0.00026170094,0.003187364,0.00059768895,0.00005829648,0.000022980737,0.00018607413,0.00025738412,0.0008230006],"category_scores_gemma":[0.003384562,0.00016538208,0.0014371078,0.00046607386,0.0001761536,0.00013954258,0.00003384646,0.0005179441,0.000004682447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023299038,0.0063011143,0.9474918,0.00012913093,0.0140221175,0.00077902415,0.00019961133,0.00041212386,0.00079521356,0.000085953434,0.0015212086,0.004963623],"study_design_scores_gemma":[0.032210253,0.027040692,0.92174417,0.00019282676,0.015892755,0.000068111476,0.00019396837,0.0014620016,0.00038550765,0.00016492777,0.0004774835,0.00016729487],"about_ca_topic_score_codex":0.00048428605,"about_ca_topic_score_gemma":0.00034603587,"teacher_disagreement_score":0.025747664,"about_ca_system_score_codex":0.00037245787,"about_ca_system_score_gemma":0.001988799,"threshold_uncertainty_score":0.90112793},"labels":[],"label_agreement":null},{"id":"W3011134632","doi":"10.1016/j.urology.2020.03.001","title":"What to Do With Renal Cysts in Children?","year":2020,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Marsupialization; Pediatric Surgeon; Pediatric urology; Cyst; Pediatric Radiology; General surgery; Pediatrics; Surgery; Radiology; Pediatric surgery","score_opus":0.012954335199881076,"score_gpt":0.23812312339261946,"score_spread":0.2251687881927384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011134632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98018336,0.0005361328,0.00006610162,0.017634746,0.00003737153,0.0003659963,0.0000010104053,0.000022608281,0.0011526739],"genre_scores_gemma":[0.990406,0.000019271347,0.00023306659,0.009089367,0.00011958305,0.000022429394,0.00001251306,0.00001443803,0.00008334731],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992823,0.000032965352,0.00011118254,0.00026642575,0.00010728396,0.00019985647],"domain_scores_gemma":[0.99959,0.000018973746,0.000019831743,0.00016335836,0.0000182291,0.00018963958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035685443,0.00009912374,0.00020794867,0.000067279354,0.000010157955,0.000009713645,0.00005374256,0.000054483153,0.00013272403],"category_scores_gemma":[0.000021201082,0.00007117601,0.000025110021,0.00016754269,0.000027694488,0.00004017706,0.000033978456,0.0001330281,0.0002650032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034939963,0.00019842724,0.97918564,0.000016407266,0.00014911637,0.0020450933,0.0020441338,0.0005486554,0.0036409502,0.00018609999,0.0018972496,0.006594232],"study_design_scores_gemma":[0.003687697,0.0075616105,0.9794953,0.000021563259,0.000089667774,0.000919289,0.000070798415,0.00007039512,0.00323741,0.000035801357,0.004677073,0.00013340771],"about_ca_topic_score_codex":0.000020708854,"about_ca_topic_score_gemma":0.00002194704,"teacher_disagreement_score":0.010222623,"about_ca_system_score_codex":0.00003157538,"about_ca_system_score_gemma":0.000039116985,"threshold_uncertainty_score":0.34061685},"labels":[],"label_agreement":null},{"id":"W3011996260","doi":"10.1007/s11547-020-01169-z","title":"Noninvasive Fuhrman grading of clear cell renal cell carcinoma using computed tomography radiomic features and machine learning","year":2020,"lang":"en","type":"article","venue":"La radiologia medica","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Shahid Beheshti University of Medical Sciences; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Receiver operating characteristic; Artificial intelligence; Random forest; Univariate; Feature selection; Logistic regression; Support vector machine; Pattern recognition (psychology); Renal cell carcinoma; Mathematics; Computer science; Clear cell renal cell carcinoma; Multivariate statistics; Nuclear medicine; Radiology; Medicine; Statistics; Oncology","score_opus":0.022596755256475,"score_gpt":0.22997522153207178,"score_spread":0.20737846627559678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011996260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98889345,0.007938635,0.00040247146,0.0004082197,0.00008929736,0.00041451017,0.000014680535,0.000103383056,0.0017353385],"genre_scores_gemma":[0.9928732,0.00017001669,0.0061896406,0.00030578155,0.00024894768,0.0000056830067,0.00009054742,0.000049699993,0.00006646479],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978739,0.00034465527,0.00044160875,0.00055394176,0.0003765583,0.00040932285],"domain_scores_gemma":[0.9985334,0.00035751582,0.00028760103,0.00024687895,0.000056488112,0.0005180775],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002848442,0.00035273368,0.00084250356,0.00022295164,0.00015086016,0.000013667032,0.00017761183,0.0002450423,0.000058127313],"category_scores_gemma":[0.00009267195,0.000281737,0.00022148268,0.00034173933,0.00044657552,0.000052303156,0.00012317904,0.0007717584,0.0000040269742],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014319188,0.0002609822,0.43809885,0.00130637,0.00036792358,0.0055887355,0.0048420914,0.00038307233,0.54406756,0.000046534748,0.0023208952,0.0012850673],"study_design_scores_gemma":[0.012540106,0.007356484,0.3622918,0.00035937276,0.0014933866,0.0068579246,0.0009175781,0.02115351,0.5845696,0.000027589616,0.0015699323,0.0008627425],"about_ca_topic_score_codex":0.00014018199,"about_ca_topic_score_gemma":0.0000016028064,"teacher_disagreement_score":0.07580703,"about_ca_system_score_codex":0.00007539806,"about_ca_system_score_gemma":0.00013832207,"threshold_uncertainty_score":0.99996346},"labels":[],"label_agreement":null},{"id":"W3012505568","doi":"10.1007/s00261-020-02469-8","title":"Diagnostic accuracy of 99mTc-sestamibi SPECT/CT for detecting renal oncocytomas and other benign renal lesions: a systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Abdominal Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; University of Alberta","funders":"","keywords":"Medicine; Oncocytoma; Renal oncocytoma; Renal cell carcinoma; Chromophobe cell; Radiology; Meta-analysis; Nephrology; Nuclear medicine; Pathology; Internal medicine; Clear cell","score_opus":0.12833019649665092,"score_gpt":0.3771767071719465,"score_spread":0.2488465106752956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012505568","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008841092,0.9911827,0.00027344417,0.00019985173,0.00002584919,0.007929882,0.00018418758,0.000038274244,0.000077405646],"genre_scores_gemma":[0.0017528897,0.99354583,0.0019681505,0.0003156955,0.00009416544,0.0020241968,0.00008035067,0.00009842836,0.000120301636],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99439794,0.0013205862,0.0023837446,0.0011222183,0.00030686872,0.00046865657],"domain_scores_gemma":[0.98286027,0.013711172,0.0021139197,0.0008900376,0.0001292678,0.00029532786],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.001245185,0.0009177068,0.017308103,0.00051211676,0.000107697095,0.000022754803,0.0002571865,0.00015812954,0.00011899517],"category_scores_gemma":[0.008676393,0.00056358555,0.0035073822,0.0007156134,0.00025728773,0.000048596037,0.00013884927,0.00047023117,0.000011243744],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009292374,0.00006797463,0.000008499829,0.8160223,0.16043036,0.0016142789,0.000056562138,5.0610873e-7,0.0000055491305,0.0000831117,0.000119376855,0.021498565],"study_design_scores_gemma":[0.00066230993,0.0012116426,0.000005964157,0.04262661,0.92139953,0.019842168,0.000046369325,0.000020103975,0.000024326691,0.00003443376,0.013734814,0.00039170403],"about_ca_topic_score_codex":0.00006577214,"about_ca_topic_score_gemma":0.000022908684,"teacher_disagreement_score":0.77339566,"about_ca_system_score_codex":0.00022525465,"about_ca_system_score_gemma":0.0003378398,"threshold_uncertainty_score":0.99968153},"labels":[],"label_agreement":null},{"id":"W3012645123","doi":"10.5489/cuaj.6264","title":"Clinical predictors of a positive test result in patients undergoing genetic evaluation for a hereditary kidney cancer syndrome","year":2019,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Alberta; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; Genetic testing; Medical genetics; Cancer; Genetic counseling; Retrospective cohort study; Renal cell carcinoma; Kidney cancer; Logistic regression; Internal medicine; Cohort; Predictive testing; Oncology; Genetics","score_opus":0.02056050878491839,"score_gpt":0.27922181766556264,"score_spread":0.25866130888064426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012645123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944333,0.00015316354,0.0000035229248,0.0031157474,0.00058483495,0.0011131476,0.00023609182,0.0000053876165,0.0003548106],"genre_scores_gemma":[0.9980484,0.000033244254,0.00020620668,0.0011967104,0.00020934097,0.000037768215,0.00012873448,0.000013247894,0.00012631805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793494,0.0002628089,0.00068559527,0.00023404128,0.0005303887,0.0003522322],"domain_scores_gemma":[0.9974489,0.0007229972,0.00044580744,0.00010280217,0.00066965795,0.000609788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001117515,0.00012367872,0.0003795592,0.00020120942,0.000055390166,0.000015513622,0.000075576776,0.00025609162,0.0002314921],"category_scores_gemma":[0.0040811673,0.000102241225,0.00016835835,0.00017898533,0.000021998845,0.000066853056,0.000010236402,0.00034572263,0.000012277756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017720573,0.00016826707,0.9960672,0.000015144035,0.00014959999,0.00003550388,0.00006041913,0.00013984463,0.000014850043,0.0000019689244,0.0022879129,0.0008820372],"study_design_scores_gemma":[0.0064563896,0.0034741433,0.9884513,0.00011879769,0.00023155335,0.00004027883,0.00002581666,0.0007357327,0.000008459383,0.000117233554,0.00025411477,0.000086206725],"about_ca_topic_score_codex":0.0008568328,"about_ca_topic_score_gemma":0.001021921,"teacher_disagreement_score":0.0076159732,"about_ca_system_score_codex":0.0029316985,"about_ca_system_score_gemma":0.0021951436,"threshold_uncertainty_score":0.766629},"labels":[],"label_agreement":null},{"id":"W3013563111","doi":"10.1097/pas.0000000000001467","title":"Biphasic Hyalinizing Psammomatous Renal Cell Carcinoma (BHP RCC)","year":2020,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Pathology; Biology; Carcinoma; Clear cell; Basement membrane; Stroma; Psammoma body; Metastasis; Renal cell carcinoma; Cancer; Medicine; Immunohistochemistry","score_opus":0.0316223486006619,"score_gpt":0.26675522189835815,"score_spread":0.23513287329769625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013563111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784452,0.0015143566,0.0001688994,0.017303478,0.0001273987,0.00015346268,0.000004563236,0.000025842846,0.0022568286],"genre_scores_gemma":[0.99490994,0.00020882317,0.0012124126,0.0027867737,0.00075688626,0.0000034248649,0.0000029590155,0.000039545288,0.00007926136],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99757516,0.0004930939,0.0007705444,0.0002690529,0.00045970097,0.00043245062],"domain_scores_gemma":[0.9977042,0.00041549324,0.0008334875,0.0003189029,0.00018568155,0.0005422296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005052166,0.00026003574,0.0010599557,0.00012079692,0.00010220054,0.000016181879,0.00031973456,0.00005853865,0.00013231029],"category_scores_gemma":[0.00007229334,0.00015047536,0.00047184527,0.0004624745,0.0006701511,0.000052201136,0.00009776044,0.00071459083,0.00010007702],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02823671,0.0013610711,0.17658615,0.00024012796,0.00079515285,0.39137456,0.009084008,0.00044768676,0.2547503,0.00042608485,0.010473449,0.1262247],"study_design_scores_gemma":[0.031125126,0.08482778,0.35448602,0.0002623362,0.0034882163,0.33897457,0.00701737,0.00058888644,0.10997459,0.00066881994,0.06699772,0.0015885758],"about_ca_topic_score_codex":0.000017064493,"about_ca_topic_score_gemma":3.3124482e-7,"teacher_disagreement_score":0.17789985,"about_ca_system_score_codex":0.00008626151,"about_ca_system_score_gemma":0.00018766562,"threshold_uncertainty_score":0.61362076},"labels":[],"label_agreement":null},{"id":"W3013630847","doi":"10.1016/j.jmau.2015.01.003","title":"Immunohistochemical panel for differentiating renal cell carcinoma with clear and papillary features","year":2015,"lang":"en","type":"article","venue":"Journal of Microscopy and Ultrastructure","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunohistochemistry; Pathology; Papillary renal cell carcinomas; Papillary carcinoma; Medicine; Clear cell; Renal cell carcinoma; Internal medicine","score_opus":0.016016460089040584,"score_gpt":0.2507635199764739,"score_spread":0.2347470598874333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013630847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914829,0.0077254963,0.00016725462,0.00019013982,0.00011184221,0.00021119328,0.000014977495,0.000005654601,0.00009054075],"genre_scores_gemma":[0.9825602,0.00007721288,0.016812906,0.000112553884,0.00026434776,0.000001969673,0.000013560215,0.00002484537,0.00013240354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991123,0.000025757254,0.0002777693,0.00017308303,0.0002094899,0.00020157972],"domain_scores_gemma":[0.9990831,0.000063380605,0.00025405915,0.000110122666,0.00019891834,0.00029042078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011152743,0.00020483565,0.0004117834,0.00006934449,0.0000783594,0.00003928625,0.000056315625,0.00012593811,0.000007417839],"category_scores_gemma":[0.000035347613,0.00012429355,0.00008130151,0.000047851332,0.0001105937,0.00007001772,0.000019173309,0.00034774744,1.535374e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044455514,0.000050124207,0.040426522,0.00021033057,0.000091688715,0.00008914355,0.001192788,0.0000025866032,0.9503467,0.000004156166,0.0022320964,0.00090828695],"study_design_scores_gemma":[0.007207682,0.0046934877,0.23922376,0.00019390271,0.0005402902,0.009062764,0.00095524784,0.0000071921486,0.73725736,0.00011847577,0.0005562462,0.00018357187],"about_ca_topic_score_codex":0.000007448229,"about_ca_topic_score_gemma":8.3754645e-7,"teacher_disagreement_score":0.21308935,"about_ca_system_score_codex":0.000070964255,"about_ca_system_score_gemma":0.00012372388,"threshold_uncertainty_score":0.5068544},"labels":[],"label_agreement":null},{"id":"W3013894086","doi":"10.1002/jmri.27153","title":"Deep Learning Based on <scp>MRI</scp> for Differentiation of Low‐ and High‐Grade in Low‐Stage Renal Cell Carcinoma","year":2020,"lang":"en","type":"article","venue":"Journal of Magnetic Resonance Imaging","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Biomedical Imaging and Bioengineering","keywords":"Renal cell carcinoma; Receiver operating characteristic; Medicine; Exact test; Clear cell renal cell carcinoma; Mann–Whitney U test; Confidence interval; Nuclear medicine; Carcinoma; Radiology; Urology; Pathology; Internal medicine","score_opus":0.01119993400978385,"score_gpt":0.22629734023918227,"score_spread":0.2150974062293984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013894086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852662,0.009065825,0.0038836834,0.0011246027,0.00006780038,0.0003899438,0.0000052631067,0.000007912513,0.00018874739],"genre_scores_gemma":[0.9953655,0.000154429,0.0038061338,0.0002802924,0.00015873405,0.000009510677,0.0000073874767,0.00003591071,0.00018212856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816084,0.00010834774,0.0006914181,0.00026200488,0.00047966096,0.00029772666],"domain_scores_gemma":[0.9985206,0.00043807173,0.00052407576,0.00014333402,0.00016874004,0.00020518663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000289717,0.0002170689,0.00053224404,0.0002578933,0.00004424408,0.000030371564,0.00010721964,0.000052134143,0.000022409937],"category_scores_gemma":[0.00035214864,0.00018279423,0.00016123729,0.00020390475,0.00006397354,0.00010213119,0.000027979866,0.00040251098,0.0000013519928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015665707,0.00077128224,0.8137386,0.0023421252,0.000021100597,0.0012058357,0.0024390095,0.00993614,0.12046363,0.000022681397,0.00043020627,0.047062848],"study_design_scores_gemma":[0.00820956,0.0027221444,0.7445543,0.0006941776,0.00011709531,0.000043591113,0.00035645516,0.1812918,0.061307073,0.0000237987,0.00060031115,0.00007973865],"about_ca_topic_score_codex":0.000020664604,"about_ca_topic_score_gemma":0.00000259833,"teacher_disagreement_score":0.17135566,"about_ca_system_score_codex":0.000118860786,"about_ca_system_score_gemma":0.00009922067,"threshold_uncertainty_score":0.74541324},"labels":[],"label_agreement":null},{"id":"W3014683097","doi":"10.1016/j.urolonc.2020.02.015","title":"Psychological distress associated with active surveillance in patients younger than 70 with a small renal mass","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Malignancy; Anxiety; Biopsy; Distress; Depression (economics); Internal medicine; Psychological distress; Disease; Renal mass; Surgery; Clinical psychology; Kidney; Psychiatry; Nephrectomy","score_opus":0.03811115136379088,"score_gpt":0.2789579145751844,"score_spread":0.24084676321139348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014683097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989712,0.000103769664,0.00005537579,0.0075144162,0.000028807544,0.0005811276,0.000059970975,0.000060564053,0.0018839664],"genre_scores_gemma":[0.9878706,0.000032717442,0.009403689,0.0020707087,0.000044142296,0.00010796339,0.00032472928,0.000017287408,0.00012820146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840367,0.00022005082,0.00025365967,0.000558991,0.00020605225,0.00035756998],"domain_scores_gemma":[0.9989526,0.00022700946,0.00018872181,0.00016034237,0.00010451663,0.00036677328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013043579,0.0002655732,0.0004966854,0.00007487959,0.0001055847,0.000016471167,0.00009332251,0.00022902833,0.000035056182],"category_scores_gemma":[0.00018561867,0.00016848723,0.00003905358,0.00041775208,0.0006357755,0.00007721109,0.000029439097,0.00047984728,0.000007810548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023361356,0.0005598651,0.99442446,0.000011901035,0.000107120155,0.0007075182,0.0003573376,0.00005584488,0.00015755945,0.00015595225,0.00027823652,0.00084804604],"study_design_scores_gemma":[0.0047935667,0.018937485,0.9667196,0.000075285774,0.00017604175,0.00009022419,0.00011972854,0.00015441446,0.00021749902,0.00020531061,0.008277312,0.0002335177],"about_ca_topic_score_codex":0.000049880004,"about_ca_topic_score_gemma":0.00021088409,"teacher_disagreement_score":0.02770487,"about_ca_system_score_codex":0.00020869511,"about_ca_system_score_gemma":0.000114637754,"threshold_uncertainty_score":0.68707097},"labels":[],"label_agreement":null},{"id":"W3014794817","doi":"10.1186/s12885-020-06733-4","title":"Stem/progenitor cell marker expression in clear cell renal cell carcinoma: a potential relationship with the immune microenvironment to be explored","year":2020,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"Ontario Institute for Cancer Research; Princess Margaret Cancer Foundation","keywords":"Progenitor cell; Stem cell marker; Biology; Stem cell; Cancer stem cell; CD34; Tumor microenvironment; Cancer research; Clear cell renal cell carcinoma; Flow cytometry; Pathology; Immunology; Immune system; Renal cell carcinoma; Medicine; Cell biology","score_opus":0.03639053228415579,"score_gpt":0.22998149558637915,"score_spread":0.19359096330222336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014794817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897026,0.004385166,0.0002957423,0.0031031454,0.0000918767,0.0016064001,0.000028067054,0.00003206132,0.00075496465],"genre_scores_gemma":[0.99365234,0.000044508393,0.0018237805,0.0006760177,0.00026481447,0.00052188576,0.000029433153,0.00008004941,0.0029071493],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997908,0.00017046314,0.00037999946,0.00059130066,0.0005285418,0.00042168805],"domain_scores_gemma":[0.99890345,0.00006449015,0.00015004301,0.00052329357,0.000037208403,0.00032149715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012868884,0.00032018134,0.00035193661,0.00007904944,0.00012267308,0.0000304742,0.000190251,0.00010252636,0.00032633977],"category_scores_gemma":[0.000004254959,0.00021040844,0.00015287819,0.00027111114,0.000059164086,0.000075407595,0.00014957729,0.00034665366,0.00011645702],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007468399,0.00041759544,0.1516766,0.00033733004,0.000021808066,0.00028040694,0.0044228104,0.0016916061,0.82711935,7.409005e-7,0.0063807354,0.00018263464],"study_design_scores_gemma":[0.004804253,0.0008835446,0.3449214,0.00008222434,0.00021637659,0.000012123714,0.0020033824,0.00019207166,0.6421646,6.711197e-7,0.0044575073,0.00026187138],"about_ca_topic_score_codex":0.00020286252,"about_ca_topic_score_gemma":0.00006313172,"teacher_disagreement_score":0.19324481,"about_ca_system_score_codex":0.00044958558,"about_ca_system_score_gemma":0.0002024416,"threshold_uncertainty_score":0.8580207},"labels":[],"label_agreement":null},{"id":"W3014809017","doi":"10.1007/s00345-020-03187-y","title":"Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis","year":2020,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Clear cell renal cell carcinoma; Propensity score matching; Internal medicine; Surveillance, Epidemiology, and End Results; Context (archaeology); Renal cell carcinoma; Proportional hazards model; Papillary renal cell carcinomas; Nephrology; Oncology; Population; Nephrectomy; Lymph node; Clear cell; Urology; Epidemiology; Cancer registry; Kidney","score_opus":0.04329250071523947,"score_gpt":0.2686252822207942,"score_spread":0.22533278150555472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014809017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967651,0.00076565886,0.00009054811,0.0013829515,0.00006177783,0.00033109938,0.0000071694176,0.000005712118,0.0005900072],"genre_scores_gemma":[0.9985608,0.000011384118,0.00079908007,0.0004365075,0.000035120716,0.0000021404242,0.00001893066,0.00002643635,0.00010964208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739367,0.00035548623,0.0010606215,0.0002673525,0.0006160576,0.00030680816],"domain_scores_gemma":[0.9980068,0.00018091152,0.0009406424,0.00025535029,0.00033288507,0.0002833679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029145417,0.00025818511,0.0020215884,0.0006957602,0.000028526083,0.000008341323,0.00018201192,0.000052896252,0.00012349569],"category_scores_gemma":[0.000050491446,0.00017010479,0.0003451411,0.0009990392,0.000114652285,0.00006883127,0.00006998847,0.0005690773,0.000007143035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010683479,0.0015248648,0.98360825,0.00011396327,0.0007951357,0.0007639334,0.0006033777,0.0011190642,0.00049386313,0.000003910698,0.00016195298,0.00012821202],"study_design_scores_gemma":[0.008742993,0.011965225,0.9731926,0.0000123516365,0.0038437687,0.000015152609,0.00007019242,0.00021248386,0.0016292672,0.00000413673,0.00018407054,0.00012776924],"about_ca_topic_score_codex":0.0000518712,"about_ca_topic_score_gemma":0.00016970249,"teacher_disagreement_score":0.010440361,"about_ca_system_score_codex":0.00008718215,"about_ca_system_score_gemma":0.00016580068,"threshold_uncertainty_score":0.6936672},"labels":[],"label_agreement":null},{"id":"W3014903654","doi":"10.3233/kca-190076","title":"First-Line Immune Checkpoint Inhibitor-Based Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review","year":2020,"lang":"en","type":"review","venue":"Kidney Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Renal cell carcinoma; Medicine; Oncology; Nivolumab; Cancer research; Internal medicine; Immunotherapy; Cancer","score_opus":0.06481327969497024,"score_gpt":0.33528547229551825,"score_spread":0.270472192600548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014903654","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000024490064,0.97242695,0.00016265581,0.002248002,0.00043474056,0.023491396,0.00093698053,0.000110862165,0.0001859607],"genre_scores_gemma":[0.000079381694,0.9717251,0.0009589338,0.0030275285,0.00061707746,0.020676825,0.0014044695,0.0003298828,0.0011808012],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99426854,0.0003850195,0.0027196403,0.0011429444,0.00078955444,0.00069431274],"domain_scores_gemma":[0.9950989,0.00041995887,0.0017327132,0.0014294882,0.00034233538,0.0009766431],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00067608844,0.001374465,0.009076879,0.0002461613,0.00012771756,0.000047048943,0.0004256538,0.000263916,0.0005419656],"category_scores_gemma":[0.0005913636,0.00088332593,0.0034846575,0.0007331476,0.00008063453,0.000055216013,0.00007408667,0.00061797054,0.00017209344],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011840579,0.00029743224,7.750463e-7,0.97798026,0.0009190047,0.0002620843,0.00003655994,0.0000010230135,0.000016395723,0.0000021391577,0.007766272,0.012599672],"study_design_scores_gemma":[0.0028551484,0.0008179264,6.1165167e-7,0.49366212,0.021844106,0.000076617674,0.0000027732685,0.00003342089,0.00046336377,0.0000030655754,0.47976026,0.000480615],"about_ca_topic_score_codex":0.00014776728,"about_ca_topic_score_gemma":0.000006824075,"teacher_disagreement_score":0.48431814,"about_ca_system_score_codex":0.0016999134,"about_ca_system_score_gemma":0.0049610836,"threshold_uncertainty_score":0.9999006},"labels":[],"label_agreement":null},{"id":"W3017774855","doi":"10.1002/mp.14193","title":"Ensemble U‐net‐based method for fully automated detection and segmentation of renal masses on computed tomography images","year":2020,"lang":"en","type":"article","venue":"Medical Physics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; University of Ottawa; University of Toronto; Carleton University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Artificial intelligence; Segmentation; Computer science; Convolutional neural network; Similarity (geometry); Pattern recognition (psychology); Boundary (topology); Ground truth; Medical imaging; Image segmentation; Computed tomography; Nuclear medicine; Mathematics; Medicine; Image (mathematics); Radiology","score_opus":0.028161020290781616,"score_gpt":0.3088520088137426,"score_spread":0.280690988522961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017774855","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25117424,0.0000817503,0.7460636,0.0015700317,0.00005872301,0.000660025,0.000019771067,0.00019620758,0.00017568293],"genre_scores_gemma":[0.9706235,0.0000042678903,0.028121319,0.0009256327,0.00016790576,0.000040936146,0.000092873546,0.000018784722,0.0000047708218],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887407,0.00006865033,0.0002292453,0.00024279849,0.00044787792,0.00013738546],"domain_scores_gemma":[0.999175,0.0002954891,0.000102648286,0.00010459873,0.00010112667,0.00022110084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013887062,0.00013696072,0.00030303732,0.00004881903,0.00004022401,0.000008432132,0.00004008818,0.00007401693,0.000017596993],"category_scores_gemma":[0.00011038235,0.00010988371,0.000107584376,0.00025192407,0.000064817155,0.000032634653,0.00001537571,0.00011172392,0.0000021553917],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022264945,0.00074327906,0.0024341478,0.0012691352,0.00037715677,0.000066782646,0.00032703162,0.00041275405,0.6559778,0.000046287958,0.002123124,0.33399603],"study_design_scores_gemma":[0.0029730212,0.0023458586,0.0068779066,0.00009934667,0.00019951367,0.0000056835042,0.000021067593,0.11085749,0.8762945,0.00014277948,0.00009837734,0.00008448619],"about_ca_topic_score_codex":0.000017986202,"about_ca_topic_score_gemma":0.0000014715783,"teacher_disagreement_score":0.7194493,"about_ca_system_score_codex":0.000031374566,"about_ca_system_score_gemma":0.00007318211,"threshold_uncertainty_score":0.44809276},"labels":[],"label_agreement":null},{"id":"W3018979351","doi":"10.1016/j.annonc.2020.04.010","title":"Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":461,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Foundation Medicine; Pharmacyclics; EMD Serono; Ipsen; Eisai; Merck KGaA; Exelixis; GlaxoSmithKline; Memorial Sloan-Kettering Cancer Center; Astellas Pharma; Alexion Pharmaceuticals; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Axitinib; Sunitinib; Avelumab; Javelin; Renal cell carcinoma; Internal medicine; Oncology; Urology; Nivolumab; Immunotherapy; Cancer","score_opus":0.10304858030414081,"score_gpt":0.3299452875303705,"score_spread":0.22689670722622968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3018979351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97943854,0.00021823909,0.0000073767624,0.012788309,0.00020819942,0.0018841372,0.00041991237,0.000044829812,0.0049904506],"genre_scores_gemma":[0.99496686,0.00007177862,0.00058217085,0.0015833619,0.00034572347,0.00005378999,0.0022576982,0.0000538238,0.00008478018],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966778,0.00037375977,0.0011374461,0.000698356,0.0005520942,0.00056050543],"domain_scores_gemma":[0.99643314,0.0014705209,0.00065541355,0.0006430439,0.00046710458,0.00033078677],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036074696,0.000391749,0.0010559176,0.00011663274,0.000084678795,0.00001175106,0.00033204776,0.00025487685,0.00018788838],"category_scores_gemma":[0.00079139,0.00026578683,0.00019583876,0.00050510647,0.00022573504,0.00008150632,0.0001397065,0.0005529226,0.000059046943],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9620368,0.0025536628,0.0036095425,0.00003574623,0.00028943588,0.0007049223,0.0027278925,0.00095030724,0.0003896054,0.000013660919,0.008761759,0.017926682],"study_design_scores_gemma":[0.6196542,0.08321969,0.24452147,0.00015292258,0.0003922448,0.0000048040974,0.0003758815,0.00024508077,0.017622426,0.000015970265,0.03337848,0.00041683757],"about_ca_topic_score_codex":0.0007618727,"about_ca_topic_score_gemma":0.0004509864,"teacher_disagreement_score":0.34238258,"about_ca_system_score_codex":0.00018188248,"about_ca_system_score_gemma":0.0006547281,"threshold_uncertainty_score":0.99997944},"labels":[],"label_agreement":null},{"id":"W3020887562","doi":"10.1097/ju.0000000000000932.012","title":"PD45-12 ECONOMIC EVALUATION OF RENAL CELL CARCINOMA (RCC) IN CANADA USING REAL-WORLD EVIDENCE; A HEALTHCARE SYSTEM PERSPECTIVE","year":2020,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Kidney cancer; Health care; Epidemiology; Intensive care medicine; Oncology; Internal medicine; Kidney","score_opus":0.11175257530330941,"score_gpt":0.32317111251807634,"score_spread":0.21141853721476694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020887562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854739,0.0055668913,0.0000131788565,0.0076262,0.00017103137,0.00039913086,0.000005020425,0.000002466027,0.00074219436],"genre_scores_gemma":[0.9992499,0.00008622658,0.000058649734,0.0003320132,0.00024793867,0.000002409247,7.8642034e-7,0.0000152032235,0.0000068955937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749863,0.00096792734,0.00071734085,0.00014706604,0.0004493274,0.0002197092],"domain_scores_gemma":[0.99817216,0.00029414397,0.0007448279,0.00020100613,0.00041630343,0.00017154092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013676068,0.00013693231,0.0005591635,0.00016688023,0.000035699046,0.0000028728755,0.00015845719,0.000046847086,0.000047468835],"category_scores_gemma":[0.00009059122,0.00009534565,0.00009376372,0.00014351963,0.000050185692,0.00006103719,0.000035911788,0.0003617749,0.0000023451187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.020546816,0.00017566045,0.71192795,0.0012065995,0.0007188085,0.002236595,0.022278996,0.18942209,0.04807046,0.00062889844,0.0014981201,0.0012890045],"study_design_scores_gemma":[0.0096150935,0.0081530055,0.7939841,0.00056494115,0.0041028736,0.003612755,0.022152992,0.13907117,0.018184252,0.00018220405,0.0000587486,0.00031784558],"about_ca_topic_score_codex":0.7735658,"about_ca_topic_score_gemma":0.6337344,"teacher_disagreement_score":0.13983142,"about_ca_system_score_codex":0.008039846,"about_ca_system_score_gemma":0.008452066,"threshold_uncertainty_score":0.9971691},"labels":[],"label_agreement":null},{"id":"W3020938338","doi":"10.1016/j.urology.2008.12.006","title":"Reply by the Authors","year":2009,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine","score_opus":0.016757392337591836,"score_gpt":0.2642156452482674,"score_spread":0.24745825291067558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020938338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81110746,0.0018178471,0.000120259545,0.12635949,0.00014837427,0.00024821897,0.0000011887595,0.00006839596,0.06012875],"genre_scores_gemma":[0.9678225,0.000011269733,0.00004943015,0.024863591,0.00007617623,0.0000053509007,0.0000089940895,0.000005009679,0.0071577057],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99950224,0.000040921874,0.000090434456,0.00013724374,0.00007666859,0.00015247938],"domain_scores_gemma":[0.9995834,0.000039278533,0.000023919862,0.0002799789,0.00001613914,0.000057260102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087609966,0.000063195715,0.00010702069,0.000019680629,0.000034463974,0.000003023112,0.0000523472,0.000047703306,0.00013038274],"category_scores_gemma":[0.00004004009,0.000035369794,0.00004370929,0.00005180372,0.000044284374,0.000008200503,0.000008554857,0.00011879377,0.00013807513],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009492231,0.0004986889,0.011640622,0.000008561276,0.00014827822,0.0009429523,0.00080473226,0.00002132908,0.03504126,0.005402937,0.8710539,0.07348756],"study_design_scores_gemma":[0.0011974998,0.0036459367,0.087397516,0.0000018167763,0.00016973299,0.0011253298,0.00002305311,0.00013951772,0.0075418893,0.0017920926,0.8968809,0.00008468307],"about_ca_topic_score_codex":0.000014796229,"about_ca_topic_score_gemma":8.2743503e-7,"teacher_disagreement_score":0.15671499,"about_ca_system_score_codex":0.00002113144,"about_ca_system_score_gemma":0.000017760363,"threshold_uncertainty_score":0.17747226},"labels":[],"label_agreement":null},{"id":"W3020946474","doi":"10.1016/j.urology.2011.07.042","title":"MP-02.15 Outcomes and Tumour Growth Rate of Renal Masses Are Dependent on Size at Presentation in a Watchful Waiting Cohort","year":2011,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Watchful waiting; Medicine; Cohort; Natural history; Conservative management; Presentation (obstetrics); Renal mass; Surgery; Pediatrics; Kidney; Internal medicine; Nephrectomy; Cancer","score_opus":0.03082335499528257,"score_gpt":0.25785549550025294,"score_spread":0.22703214050497036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020946474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967612,0.00013074254,0.000007682389,0.00074215,0.000054306,0.0003791086,0.0000067530864,0.000017662609,0.001900419],"genre_scores_gemma":[0.99903613,0.000033641685,0.00014418438,0.0003190299,0.000024550285,0.00003253048,0.000014971233,0.00001586549,0.00037910347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894685,0.00014045653,0.00028720946,0.00028141256,0.00013208033,0.00021199003],"domain_scores_gemma":[0.99927247,0.00030015557,0.00015426766,0.00014456417,0.000054260257,0.00007425741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017489686,0.0001410311,0.0003686071,0.000104923,0.000023056902,0.0000026724779,0.00004755495,0.00008377352,0.00012732485],"category_scores_gemma":[0.00024438064,0.000107506676,0.000046487152,0.00005896398,0.00006441281,0.00003352975,0.00006222143,0.00012520533,0.000013918823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008758391,0.00018446642,0.98865575,0.00004857421,0.00008195069,0.0005586524,0.0004504143,0.000008238657,0.008894517,0.00009857821,0.000056119254,0.00008691841],"study_design_scores_gemma":[0.0019568235,0.0008683304,0.9466942,0.000017957205,0.00013416697,0.00010556667,0.00012976398,0.000102951795,0.049567033,0.00034069008,0.000011739578,0.00007080652],"about_ca_topic_score_codex":0.00049440603,"about_ca_topic_score_gemma":0.0004988885,"teacher_disagreement_score":0.04196156,"about_ca_system_score_codex":0.00007013676,"about_ca_system_score_gemma":0.00002310474,"threshold_uncertainty_score":0.4383995},"labels":[],"label_agreement":null},{"id":"W3020996739","doi":"10.1097/ju.0000000000000912.05","title":"MP50-05 HOW WELL DOES RENAL MASS SIZE MEASURED BY ULTRASOUND CORRELATE WITH MEASUREMENTS OBTAINED BY CT, MRI OR PATHOLOGY? ANALYSIS FROM THE CANADIAN KIDNEY CANCER INFORMATION SYSTEM","year":2020,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiology; Magnetic resonance imaging; Pathological; Ultrasound; Kidney cancer; Nuclear medicine; Cohort; Renal mass; Cancer; Kidney; Pathology; Nephrectomy; Internal medicine","score_opus":0.016578488868273147,"score_gpt":0.21345894379994895,"score_spread":0.1968804549316758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020996739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8748165,0.0021066938,0.0021887748,0.11851345,0.00045793044,0.00084615103,0.00048536411,0.00003435815,0.0005508208],"genre_scores_gemma":[0.99083054,0.00020922418,0.00013188338,0.008388017,0.0001703224,0.000013081083,0.00007243752,0.000020832087,0.0001636377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740505,0.0007505442,0.0005657584,0.00016775426,0.0007180813,0.00039282776],"domain_scores_gemma":[0.9973398,0.0004218504,0.00083102734,0.0003348878,0.0004527121,0.00061975623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009949802,0.00027431615,0.0006769814,0.00010977186,0.00024122304,0.000055811935,0.0003646018,0.00012126039,0.00021261381],"category_scores_gemma":[0.00046086792,0.00011075174,0.00016860422,0.00048771745,0.00016890072,0.00016464517,0.000017662864,0.00060366205,0.000015606582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02824558,0.00014864044,0.48276195,0.00016753208,0.02908462,0.0022483896,0.008735861,0.0057428777,0.077682935,0.0000091408965,0.36454362,0.0006288625],"study_design_scores_gemma":[0.057395376,0.019362533,0.4822391,0.0006876458,0.1398491,0.014511634,0.013745147,0.008803218,0.0373159,0.00008157267,0.22377558,0.0022332023],"about_ca_topic_score_codex":0.015458664,"about_ca_topic_score_gemma":0.025204971,"teacher_disagreement_score":0.14076804,"about_ca_system_score_codex":0.00059027073,"about_ca_system_score_gemma":0.00091632106,"threshold_uncertainty_score":0.9925825},"labels":[],"label_agreement":null},{"id":"W3022550028","doi":"10.1007/s00330-020-06787-9","title":"Automated classification of solid renal masses on contrast-enhanced computed tomography images using convolutional neural network with decision fusion","year":2020,"lang":"en","type":"article","venue":"European Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; University of Ottawa; University of Toronto; Carleton University","funders":"Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada","keywords":"Convolutional neural network; Neuroradiology; Artificial intelligence; Computer science; Renal cell carcinoma; Chromophobe cell; Radiology; Medicine; Diagnostic accuracy; Pattern recognition (psychology); Clear cell; Pathology; Neurology","score_opus":0.03599198240268956,"score_gpt":0.27399022895727565,"score_spread":0.2379982465545861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022550028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97747123,0.0003373356,0.019823782,0.00036317718,0.00013460909,0.00042051316,0.000021723932,0.00024793827,0.0011797028],"genre_scores_gemma":[0.9848766,0.000015618907,0.014074324,0.00047204935,0.00034668652,0.0000031935028,0.0001647623,0.000038399165,0.000008368439],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99817985,0.0004468232,0.0004354527,0.00042662807,0.00023242524,0.0002788142],"domain_scores_gemma":[0.9989249,0.00021601135,0.00027530344,0.00023331228,0.00017622054,0.00017426575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017050774,0.00022341713,0.00047351044,0.00011222642,0.00008976143,0.00000817929,0.000111395326,0.000058008536,0.00003915821],"category_scores_gemma":[0.000057999187,0.00016471822,0.00010641032,0.00036237383,0.00022661382,0.00004375714,0.000042711446,0.00019269026,0.00002041894],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069740294,0.00022411722,0.028749662,0.00005618721,0.00029787899,0.00055903866,0.00015321352,0.033720303,0.92134565,0.00021288522,0.004828009,0.002879026],"study_design_scores_gemma":[0.003682186,0.0035338637,0.8664514,0.00019553197,0.00016274709,0.00035490707,0.00002327326,0.108497925,0.016721742,0.000013427117,0.00019119926,0.00017180806],"about_ca_topic_score_codex":0.00000289826,"about_ca_topic_score_gemma":5.825613e-7,"teacher_disagreement_score":0.9046239,"about_ca_system_score_codex":0.000059755595,"about_ca_system_score_gemma":0.0000717944,"threshold_uncertainty_score":0.67170143},"labels":[],"label_agreement":null},{"id":"W3022776782","doi":"10.1016/j.eururo.2020.04.038","title":"Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; BC Cancer Agency; Calgary Laboratory Services; Princess Margaret Cancer Centre; CancerCare Manitoba; University of Alberta; University of Calgary","funders":"","keywords":"Sunitinib; Medicine; Renal cell carcinoma; Hazard ratio; Internal medicine; Proportional hazards model; Confidence interval; Urology; Oncology; Nephrectomy; Sunitinib malate; Surgery; Kidney","score_opus":0.019212219728380962,"score_gpt":0.2148306997747429,"score_spread":0.19561848004636193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022776782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846029,0.00022343348,0.000088553505,0.0008385014,0.000061427185,0.0007251156,0.000012522829,0.000060606275,0.013386885],"genre_scores_gemma":[0.99592006,0.0000028369502,0.0014431925,0.0022085577,0.00012025574,0.000018051513,0.000114101626,0.00008177001,0.00009115762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979236,0.0005301618,0.00032907148,0.0005618773,0.00024609666,0.0004091978],"domain_scores_gemma":[0.9990549,0.000107339714,0.00012521366,0.00031185988,0.00008282727,0.00031785952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105769905,0.00028726706,0.0004534682,0.0001368835,0.000035460107,0.000011863909,0.00014224912,0.000033129843,0.00013010038],"category_scores_gemma":[0.00009328941,0.00022113662,0.00008211073,0.00030831722,0.000112091366,0.00006254836,0.00008387928,0.00032730016,0.00036106963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006512982,0.0009242109,0.9750054,0.00006589694,0.00014774752,0.00842132,0.0031638576,0.00030004673,0.0018528242,0.000021097616,0.0018034326,0.0017812222],"study_design_scores_gemma":[0.014334971,0.0065981834,0.97455394,0.000007340518,0.0002658554,0.00003199262,0.00008216347,0.000060132912,0.0011706955,0.0000052138703,0.0026914147,0.00019810861],"about_ca_topic_score_codex":0.000036371403,"about_ca_topic_score_gemma":0.000007818482,"teacher_disagreement_score":0.013295727,"about_ca_system_score_codex":0.00008696421,"about_ca_system_score_gemma":0.000089821435,"threshold_uncertainty_score":0.901769},"labels":[],"label_agreement":null},{"id":"W3023842701","doi":"","title":"Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma","year":2018,"lang":"en","type":"article","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"PI3K/AKT/mTOR pathway; TFE3; Cancer research; Protein kinase B; Biology; TFEB; Clear cell renal cell carcinoma; Renal cell carcinoma; Cell biology; Signal transduction; Medicine; Pathology; Transcription factor; Gene; Genetics; Enhancer","score_opus":0.024384031061385567,"score_gpt":0.2600881287832605,"score_spread":0.23570409772187492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023842701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9743249,0.0011924595,0.0005860996,0.00037057934,0.00007947942,0.00043268615,0.0000021249305,0.000030760857,0.022980956],"genre_scores_gemma":[0.99610436,0.000022414108,0.0021759025,0.00015405538,0.0001561129,0.000020739773,0.000021000185,0.000025854923,0.0013195388],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987038,0.00006181466,0.00041906867,0.00028152464,0.0002706783,0.00026313087],"domain_scores_gemma":[0.9993132,0.000060314447,0.000087708475,0.00029870667,0.00014550521,0.000094609706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023713012,0.0001674531,0.00030865017,0.0001675063,0.00003277534,0.000005918796,0.00008159762,0.000089615736,0.00063747563],"category_scores_gemma":[0.000015838656,0.0001282272,0.00010154122,0.0002703099,0.00009939882,0.000058166257,0.000013556306,0.00011089796,0.00007175332],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060642423,0.0005779032,0.13456373,0.00020571881,0.000046130208,0.00004727568,0.002816978,0.000006006001,0.84830606,0.00017721792,0.0004940373,0.01215252],"study_design_scores_gemma":[0.0020404672,0.001225727,0.19280924,0.000048899125,0.00006646471,0.00001360052,0.00034941747,0.00050783524,0.8023525,0.00006516784,0.0004044779,0.00011624752],"about_ca_topic_score_codex":0.00052708253,"about_ca_topic_score_gemma":0.0001074408,"teacher_disagreement_score":0.05824551,"about_ca_system_score_codex":0.00015031162,"about_ca_system_score_gemma":0.00012667362,"threshold_uncertainty_score":0.69799113},"labels":[],"label_agreement":null},{"id":"W3024966661","doi":"10.1016/j.clgc.2020.05.006","title":"Safety and Efficacy of Nivolumab in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study","year":2020,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Genentech; Bristol-Myers Squibb Canada; Ignyta; Eli Lilly and Company; Ono Pharmaceutical; Astellas Pharma; Daiichi-Sankyo; Pfizer; Moderna; Five Prime Therapeutics; Mirati Therapeutics; Clovis Oncology; Roche; Karyopharm Therapeutics; Novartis; AbbVie; Sanofi; MedImmune; Merck; GlaxoSmithKline; British Microcirculation Society; Amgen; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Chromophobe cell; Nivolumab; Internal medicine; Renal cell carcinoma; Adverse effect; Regimen; Gastroenterology; Clinical endpoint; Phases of clinical research; Rash; Clear cell; Urology; Surgery; Oncology; Chemotherapy; Cancer; Clinical trial; Immunotherapy","score_opus":0.03434760163426389,"score_gpt":0.31876612176908636,"score_spread":0.2844185201348225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024966661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952948,0.00088877865,0.0000041273383,0.0005950772,0.0001405041,0.0021196362,0.00027607413,0.000025685169,0.0006553133],"genre_scores_gemma":[0.99836123,0.00021517224,0.00030740854,0.0003497112,0.00036418895,0.000039055223,0.00010790185,0.000056797544,0.00019855639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99671316,0.00027774464,0.0012655617,0.0008871574,0.000494686,0.00036170718],"domain_scores_gemma":[0.9976601,0.0006394422,0.00045320712,0.00070248195,0.00015525077,0.0003894974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029995784,0.0003549968,0.0009041327,0.000042367632,0.00008449611,0.000012376214,0.00023851114,0.0001271347,0.00006174479],"category_scores_gemma":[0.00013660346,0.00023022978,0.00016408424,0.0003048501,0.00021280338,0.00007828994,0.00022033087,0.00061910454,0.00001558638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14701468,0.009069576,0.8290372,0.000090018526,0.00016008323,0.00056438026,0.0024057315,0.000206674,0.00094501517,7.039892e-8,0.0006639077,0.009842693],"study_design_scores_gemma":[0.11071464,0.021517564,0.8639756,0.00009436046,0.00042142524,8.1541646e-7,0.00048647478,0.00020202532,0.0019023572,7.3633913e-7,0.00046681153,0.00021721453],"about_ca_topic_score_codex":0.00041113698,"about_ca_topic_score_gemma":0.000040607298,"teacher_disagreement_score":0.036300045,"about_ca_system_score_codex":0.00012774272,"about_ca_system_score_gemma":0.0002541585,"threshold_uncertainty_score":0.93884975},"labels":[],"label_agreement":null},{"id":"W3025451213","doi":"10.14740/wjon1279","title":"Epidemiology of Renal Cell Carcinoma","year":2020,"lang":"en","type":"review","venue":"World Journal of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1052,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Epidemiology; Renal cell carcinoma; Disease; Obesity; Cancer; Demography; Gerontology; Internal medicine","score_opus":0.12897999672465485,"score_gpt":0.3959705181071105,"score_spread":0.2669905213824556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025451213","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013334939,0.98480916,0.00003828808,0.00078726857,0.0006966531,0.0005337055,0.000014997143,0.000007421069,0.012979154],"genre_scores_gemma":[0.0019704215,0.99057895,0.0040903273,0.00030702728,0.0013021705,0.000013061334,0.000024754201,0.00007076616,0.0016425335],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943641,0.001305336,0.0032338207,0.0003543695,0.00030255772,0.0004398041],"domain_scores_gemma":[0.99184054,0.002134664,0.004741206,0.000416642,0.00032313386,0.00054382684],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012392221,0.00051611516,0.008398947,0.0009365735,0.00002810369,0.0000012622615,0.00040079557,0.0004762363,0.0003937678],"category_scores_gemma":[0.00046680396,0.00034431595,0.002207988,0.0005661697,0.0002421768,0.000034141856,0.00013023989,0.0016738813,0.000080901424],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043785942,0.0005024674,0.0014463557,0.011625551,0.00088083075,0.00897135,0.00007067627,0.0000020730042,0.000014711487,0.00014362042,0.01174834,0.96415615],"study_design_scores_gemma":[0.0016149766,0.006946926,0.0005006042,0.0035558827,0.0065197456,0.009983233,0.000012155545,0.0000011686265,0.000041702784,0.000058612466,0.9705833,0.00018169035],"about_ca_topic_score_codex":0.0000131582765,"about_ca_topic_score_gemma":0.0000100300695,"teacher_disagreement_score":0.9639745,"about_ca_system_score_codex":0.0011328901,"about_ca_system_score_gemma":0.0034701845,"threshold_uncertainty_score":0.9999009},"labels":[],"label_agreement":null},{"id":"W3025456390","doi":"10.1097/coc.0000000000000705","title":"Eligibility Criteria and Endpoints in Metastatic Renal Cell Carcinoma Trials","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Clinical trial; Clinical endpoint; Renal cell carcinoma; Intensive care medicine; Surrogate endpoint; Internal medicine; Disease; Oncology","score_opus":0.23265778802584905,"score_gpt":0.5115335604306447,"score_spread":0.27887577240479566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025456390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98536134,0.00064802036,0.00013052023,0.011953383,0.00021355433,0.0002959326,0.0000063194425,0.000005985124,0.0013849507],"genre_scores_gemma":[0.9819101,0.00029101782,0.01316406,0.0040907525,0.0005023947,0.000004216648,0.0000022363129,0.000017215785,0.00001801283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9926782,0.0028798422,0.003513538,0.0003403949,0.00031626984,0.0002717445],"domain_scores_gemma":[0.9915804,0.005054011,0.002123845,0.00020055384,0.00019900654,0.00084216514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061082398,0.00019656608,0.0035268408,0.00012531503,0.000017634835,0.000010150836,0.00013654874,0.00008687037,0.00019628006],"category_scores_gemma":[0.007418781,0.00013501692,0.0005223598,0.00025828482,0.0005709513,0.000072629016,0.000068008325,0.0007679478,0.00001490873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029355312,0.00245439,0.54095995,0.00013706503,0.00045890294,0.009924792,0.0013190915,0.000007612579,0.01014919,0.000020085758,0.0026131263,0.40260047],"study_design_scores_gemma":[0.018486755,0.06928058,0.89635986,0.00006145423,0.0011789599,0.001081241,0.0010345981,0.0001490154,0.0038425918,0.0002819114,0.008039969,0.00020305127],"about_ca_topic_score_codex":0.000064913,"about_ca_topic_score_gemma":0.000010513512,"teacher_disagreement_score":0.40239742,"about_ca_system_score_codex":0.00013195656,"about_ca_system_score_gemma":0.0010021307,"threshold_uncertainty_score":0.888151},"labels":[],"label_agreement":null},{"id":"W3025738778","doi":"10.5489/cuaj.6436","title":"Partial vs. radical nephrectomy and the risk of all-cause mortality, cardiovascular, and nephrological outcomes","year":2020,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Western University; McMaster University; Ottawa Hospital","funders":"","keywords":"Medicine; Nephrectomy; Cardiology; Internal medicine; Urology; Kidney","score_opus":0.03386486353864205,"score_gpt":0.24557112436074785,"score_spread":0.2117062608221058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025738778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9376634,0.0018017769,0.000047352987,0.05981628,0.00006413733,0.00030975207,0.000023211058,0.000015075227,0.00025902616],"genre_scores_gemma":[0.9896709,0.0010247882,0.00017245422,0.00881416,0.00027690877,0.0000097651155,0.0000063656257,0.000009194562,0.000015491361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976853,0.0007334816,0.0004263585,0.0002487696,0.00053012476,0.00037596142],"domain_scores_gemma":[0.99796814,0.0004631436,0.00024293236,0.00013978362,0.00010499755,0.0010810047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012628019,0.00017823788,0.0007150959,0.000052461233,0.00018357203,0.00006115132,0.00009820678,0.00024060707,0.0001302686],"category_scores_gemma":[0.001979912,0.00009653543,0.00040525533,0.000119414246,0.00027787886,0.000052246392,0.00004626568,0.0007191139,0.0000068540644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031167793,0.000023868244,0.9931252,0.0000057508446,0.0038509972,0.0002788489,0.0001909863,0.000028458742,0.00001178369,0.0003135429,0.001065477,0.00079340057],"study_design_scores_gemma":[0.0048573874,0.00048131598,0.9649109,0.0000029460218,0.0027611963,0.00029602216,0.000040021132,0.00040630627,0.000017779588,0.00043268292,0.025698101,0.00009534012],"about_ca_topic_score_codex":0.0014653093,"about_ca_topic_score_gemma":0.00017447102,"teacher_disagreement_score":0.052007485,"about_ca_system_score_codex":0.00019282787,"about_ca_system_score_gemma":0.00018052633,"threshold_uncertainty_score":0.39366004},"labels":[],"label_agreement":null},{"id":"W3026350312","doi":"10.1016/j.clgc.2020.05.009","title":"Contemporary Cytoreductive Nephrectomy Provides Survival Benefit in Clear-cell Metastatic Renal Cell Carcinoma","year":2020,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Université de Montréal","funders":"","keywords":"Medicine; Propensity score matching; Renal cell carcinoma; Hazard ratio; Cohort; Nephrectomy; Internal medicine; Proportional hazards model; Clinical endpoint; Urology; Oncology; Population; Surgery; Randomized controlled trial; Kidney; Confidence interval","score_opus":0.1313542326888146,"score_gpt":0.3565032904072205,"score_spread":0.2251490577184059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026350312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749737,0.00748741,0.000012166156,0.0035402228,0.00054787216,0.0014581407,0.00006943653,0.000091046015,0.011820031],"genre_scores_gemma":[0.9928206,0.0003005609,0.0013492901,0.0019465368,0.0016013436,0.00022052704,0.000067356574,0.000102312566,0.0015914434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961168,0.00038455153,0.0012825847,0.0010817666,0.0005499611,0.0005843315],"domain_scores_gemma":[0.99761105,0.00050202495,0.0003396532,0.0005166988,0.00018311903,0.00084743643],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004139731,0.000492362,0.0012327434,0.00012493017,0.00007442238,0.000031362633,0.00027599526,0.00019775322,0.00036025848],"category_scores_gemma":[0.0001284098,0.000421265,0.00053250795,0.00047788268,0.00026028926,0.00018464625,0.00020860281,0.00096529874,0.00018106372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02000561,0.0038599526,0.91144365,0.0011449725,0.00041274654,0.011570247,0.0015507693,0.0002840188,0.014793452,0.000009965127,0.027573522,0.0073510953],"study_design_scores_gemma":[0.031202428,0.01872208,0.8494801,0.00030629255,0.001117562,0.00010005644,0.0024870168,0.0011912226,0.057363186,0.0001594225,0.036368657,0.0015019616],"about_ca_topic_score_codex":0.000415713,"about_ca_topic_score_gemma":0.000024745923,"teacher_disagreement_score":0.061963536,"about_ca_system_score_codex":0.00032936202,"about_ca_system_score_gemma":0.0011165556,"threshold_uncertainty_score":0.9998239},"labels":[],"label_agreement":null},{"id":"W3026562924","doi":"10.1016/j.euf.2020.04.009","title":"Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non–clear Cell Renal Cell Carcinoma Patients","year":2020,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Surgical Specialties (Canada); Université de Montréal","funders":"","keywords":"Medicine; Chromophobe cell; Renal cell carcinoma; Proportional hazards model; Internal medicine; Hazard ratio; Clear cell; Urology; Oncology; Nephrectomy; Gastroenterology; Kidney; Confidence interval","score_opus":0.04258123928198527,"score_gpt":0.23906654312984985,"score_spread":0.19648530384786458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026562924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98992884,0.0020768868,0.000016489688,0.0007497513,0.00007914605,0.00085473707,0.00003384184,0.000040485356,0.006219829],"genre_scores_gemma":[0.99888915,0.00007776541,0.00011590194,0.00036148168,0.00016994958,0.000012118675,0.000053347285,0.0000656913,0.0002545948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974583,0.0010297658,0.0004379278,0.0005282829,0.00023832318,0.000307406],"domain_scores_gemma":[0.99895716,0.00026877946,0.0002689205,0.00017807247,0.00007956829,0.00024748285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039005245,0.00027752022,0.000596679,0.00012071003,0.00005497126,0.000020410022,0.00008999117,0.000074190786,0.000018126277],"category_scores_gemma":[0.0000759498,0.0002190411,0.00006546314,0.00017269482,0.00007139592,0.000083581755,0.00009017256,0.0003500621,0.000057376772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020973475,0.00016255263,0.9883511,0.00008900487,0.00015543596,0.00073769124,0.0024597659,0.0000018409471,0.004277275,0.0000012886194,0.00048132593,0.0011853777],"study_design_scores_gemma":[0.011140196,0.005895697,0.97767985,0.000015624611,0.0002363706,0.000019071273,0.00022656577,0.000048761704,0.003808637,0.000005269556,0.00072154525,0.00020244032],"about_ca_topic_score_codex":0.00009348701,"about_ca_topic_score_gemma":0.0000033878312,"teacher_disagreement_score":0.010671273,"about_ca_system_score_codex":0.00011946302,"about_ca_system_score_gemma":0.000082823244,"threshold_uncertainty_score":0.8932237},"labels":[],"label_agreement":null},{"id":"W3027622893","doi":"10.1016/j.euf.2020.05.003","title":"Contemporary Age-adjusted Incidence and Mortality Rates of Renal Cell Carcinoma: Analysis According to Gender, Race, Stage, Grade, and Histology","year":2020,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Incidence (geometry); Renal cell carcinoma; Epidemiology; Stage (stratigraphy); Kidney cancer; Demography; Retrospective cohort study; Carcinoma; Internal medicine; Biology","score_opus":0.08949159197980246,"score_gpt":0.29428085992449526,"score_spread":0.20478926794469282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027622893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98305154,0.0071480833,0.000532193,0.0010144134,0.00004255769,0.0004029931,0.000023725577,0.000047937556,0.007736562],"genre_scores_gemma":[0.9982051,0.000054923097,0.0004357949,0.0009678414,0.00006137813,0.0000066737334,0.000034500266,0.000037204798,0.00019658759],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976194,0.0006490156,0.00054106454,0.00070760754,0.00018616272,0.00029677124],"domain_scores_gemma":[0.99865544,0.00017291,0.00025220518,0.00039617525,0.00008955536,0.00043373948],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037699018,0.0002804168,0.00087056233,0.00028608993,0.00007112608,0.000012427242,0.0001432287,0.00008127311,0.00003258243],"category_scores_gemma":[0.00015883928,0.00024923816,0.00013064529,0.0005279074,0.00029511223,0.00006378621,0.00029420038,0.00027859004,0.000015257157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006547374,0.00008833056,0.96303153,0.00011985824,0.0004963107,0.005597643,0.0013137279,0.00005023476,0.027639378,0.000029148496,0.000674983,0.0003040944],"study_design_scores_gemma":[0.0020344104,0.0016083148,0.9846439,0.0000041089666,0.0015343998,0.00009047667,0.00027440366,0.00027419807,0.008724847,0.000011742302,0.00060713105,0.00019208116],"about_ca_topic_score_codex":0.00026599353,"about_ca_topic_score_gemma":0.000029268916,"teacher_disagreement_score":0.021612333,"about_ca_system_score_codex":0.00003372348,"about_ca_system_score_gemma":0.00006826269,"threshold_uncertainty_score":0.999996},"labels":[],"label_agreement":null},{"id":"W3027822766","doi":"10.1016/j.jval.2020.04.1799","title":"PCN341 REAL-WORLD TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION (HRU) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC)","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Statistics Canada","funders":"","keywords":"Medicine; Discontinuation; Internal medicine; Regimen; Ambulatory; Incidence (geometry); Renal cell carcinoma; Retrospective cohort study; Oncology; Emergency medicine","score_opus":0.08793599950874943,"score_gpt":0.29811222298814666,"score_spread":0.21017622347939724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027822766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99141395,0.0008243658,0.000023316177,0.005161584,0.000026191237,0.0021079055,0.000058898706,0.000039214337,0.0003445575],"genre_scores_gemma":[0.99724615,0.0002778615,0.0007108295,0.0011719781,0.000049732997,0.00007827801,0.0003155782,0.000055599958,0.00009399611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99720097,0.00048106175,0.0006947253,0.0006416643,0.00044949478,0.0005320792],"domain_scores_gemma":[0.99869996,0.000117405805,0.00022805796,0.0003369966,0.00005607046,0.0005614872],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022966437,0.00032223386,0.0006852875,0.00032485757,0.0000705513,0.000016985105,0.00006288044,0.000051960804,0.00002028552],"category_scores_gemma":[0.00001946282,0.00024896828,0.000049379665,0.0006139981,0.000037649872,0.000065355176,0.000034920013,0.00023106462,0.000006699127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010212038,0.0005290315,0.98837227,0.0011534746,0.00001728464,0.00018468253,0.0035637557,0.00048789312,0.0000050901754,0.000046188685,0.000049597747,0.0045695505],"study_design_scores_gemma":[0.00838444,0.0076029706,0.98037505,0.00041030734,0.000050391922,0.0000066403636,0.00038575285,0.001825209,0.00037521037,0.000013658597,0.0003957909,0.00017455702],"about_ca_topic_score_codex":0.056323994,"about_ca_topic_score_gemma":0.0046070884,"teacher_disagreement_score":0.051716905,"about_ca_system_score_codex":0.001363549,"about_ca_system_score_gemma":0.00047721763,"threshold_uncertainty_score":0.99999624},"labels":[],"label_agreement":null},{"id":"W3028026700","doi":"10.1016/j.jval.2020.04.1519","title":"PCN13 FACTORS THAT MODIFY THE EFFECT OF MONO- OR COMBINATION PD-1/PD-L1 INHIBITOR THERAPIES ON SURVIVAL OUTCOMES IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS","year":2020,"lang":"en","type":"review","venue":"Value in Health","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University","funders":"","keywords":"Medicine; Meta-analysis; Hazard ratio; Subgroup analysis; Internal medicine; Renal cell carcinoma; Oncology; Randomized controlled trial; Relative risk; Cochrane Library; Confidence interval","score_opus":0.12982187583047608,"score_gpt":0.3417928850839819,"score_spread":0.21197100925350584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028026700","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035381,0.9487392,0.0000037513576,0.00028402967,0.000038921247,0.015355427,0.00016759464,0.000016092592,0.000014033895],"genre_scores_gemma":[0.3761134,0.6222477,0.000053828284,0.00012050623,0.0000058968294,0.0010785259,0.0002420238,0.0000826406,0.000055470173],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9889721,0.006516071,0.0021991346,0.0007380883,0.0011707018,0.00040384845],"domain_scores_gemma":[0.99306494,0.00364572,0.0020684407,0.0009289501,0.00008196983,0.00020996373],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.002366577,0.0009603352,0.0153299915,0.0007486456,0.00006415076,0.000027728567,0.00024876985,0.00013105258,0.000021815074],"category_scores_gemma":[0.00026646498,0.00037207844,0.00152735,0.0014951525,0.00007812314,0.000064443804,0.00006434256,0.00061346625,0.000004300931],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001786107,0.00040520783,0.019936789,0.9543277,0.02422745,0.000040029576,0.00048642198,0.000019568888,1.3251901e-8,0.000010067835,0.0000054730763,0.0003626551],"study_design_scores_gemma":[0.0046911864,0.011140149,0.017982598,0.067143135,0.8980462,0.0000097962475,0.00014041032,0.00007134526,0.000009289679,0.000007118305,0.00013961118,0.00061914796],"about_ca_topic_score_codex":0.0017804626,"about_ca_topic_score_gemma":0.00007003781,"teacher_disagreement_score":0.88718456,"about_ca_system_score_codex":0.00074889575,"about_ca_system_score_gemma":0.0003859039,"threshold_uncertainty_score":0.9998731},"labels":[],"label_agreement":null},{"id":"W3028956426","doi":"10.1200/jco.2020.38.15_suppl.5063","title":"Application of IMDC criteria across first-line (1L) and second-line (2L) therapies in metastatic renal-cell carcinoma (mRCC): New and updated benchmarks of clinical outcomes.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Sunnybrook Hospital; Foothills Medical Centre; Ottawa Hospital; Princess Margaret Cancer Centre; Dalhousie University; University Health Network; Queen's University; Baker Hughes (Canada); University of Calgary","funders":"","keywords":"Medicine; Nivolumab; Axitinib; Ipilimumab; Renal cell carcinoma; Pazopanib; Sunitinib; Internal medicine; Everolimus; Oncology; Pembrolizumab; Clinical endpoint; Discontinuation; Cancer; Immunotherapy; Clinical trial","score_opus":0.14365032802286906,"score_gpt":0.4643076875995076,"score_spread":0.32065735957663855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028956426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98413956,0.0021695876,0.00036853744,0.012365246,0.00022543728,0.00047964786,0.000030653006,0.0000049417204,0.00021636485],"genre_scores_gemma":[0.9894409,0.001084561,0.007211288,0.0017554356,0.00035877514,0.0000048139377,0.000030217687,0.000024104205,0.00008987608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9928831,0.0005940237,0.005498974,0.00039550802,0.00035988988,0.00026849937],"domain_scores_gemma":[0.9920702,0.0033390967,0.003191374,0.0002990902,0.0004324587,0.0006677536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034967645,0.00026572167,0.00339719,0.000117624,0.000025862571,0.000009555771,0.00018933126,0.00038929866,0.00025623493],"category_scores_gemma":[0.0021092824,0.00018342267,0.0005047966,0.00024503138,0.00045835413,0.00012767164,0.00014055856,0.00095700775,0.00000226638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010926026,0.0023573758,0.9172587,0.0003603076,0.0006788218,0.0004866802,0.0010087256,0.000022254175,0.0024144966,0.000024672017,0.001669211,0.062792726],"study_design_scores_gemma":[0.023681186,0.019651817,0.9452549,0.00006559103,0.00068296393,0.00015177834,0.00027953685,0.0009154054,0.001322031,0.00031194955,0.007543109,0.0001397199],"about_ca_topic_score_codex":0.0001605638,"about_ca_topic_score_gemma":0.0002908426,"teacher_disagreement_score":0.062653005,"about_ca_system_score_codex":0.00005490697,"about_ca_system_score_gemma":0.00073024747,"threshold_uncertainty_score":0.74797595},"labels":[],"label_agreement":null},{"id":"W3029122368","doi":"10.1200/jco.2020.38.15_suppl.e19321","title":"MET status and treatment outcomes in papillary renal cell carcinoma (PRCC): Pooled analysis of historical data.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Sunitinib; Internal medicine; Everolimus; Oncology; Renal cell carcinoma; Papillary renal cell carcinomas","score_opus":0.20701632385355448,"score_gpt":0.4314200899178646,"score_spread":0.22440376606431015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029122368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887137,0.003305546,0.000031357147,0.0069437777,0.00021469679,0.00020646042,0.000029796656,0.000004904908,0.0005498011],"genre_scores_gemma":[0.99303705,0.0014446817,0.0041951328,0.00087376626,0.00026304592,0.000002283799,0.000033755463,0.000015639023,0.00013465603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952122,0.00061695074,0.0030368853,0.00038650748,0.00046525744,0.00028217846],"domain_scores_gemma":[0.99458724,0.0023043351,0.0016614274,0.00043001815,0.00019829955,0.00081865746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00125367,0.00022491952,0.003749929,0.00038914557,0.00001741034,0.0000051082748,0.00020362777,0.00028966521,0.00010480022],"category_scores_gemma":[0.0015151235,0.00014285768,0.0007332696,0.00050026417,0.000115498005,0.000093978066,0.00014329382,0.00053983263,0.0000033906704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003853957,0.002597188,0.95803404,0.000030372385,0.003397473,0.002896725,0.0002875915,0.000040368715,0.000612664,0.000008180499,0.0007111968,0.027530229],"study_design_scores_gemma":[0.010540339,0.033143226,0.9300703,0.000011983636,0.013068924,0.000040814793,0.00013795978,0.0004664913,0.00028223603,0.000014174426,0.012118659,0.000104922095],"about_ca_topic_score_codex":0.00031981422,"about_ca_topic_score_gemma":0.00017370822,"teacher_disagreement_score":0.030546037,"about_ca_system_score_codex":0.0009110193,"about_ca_system_score_gemma":0.0012647107,"threshold_uncertainty_score":0.58255666},"labels":[],"label_agreement":null},{"id":"W3029360037","doi":"10.1101/2020.05.28.20115931","title":"Sporadic Oncocytic Tumors with Features Intermediate between Oncocytoma and Chromophobe Renal Cell Carcinoma: Comprehensive Clinico-Pathological and Genomic Profiling","year":2020,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oncocytoma; Biology; Chromophobe cell; Pathology; Clear cell; Immunohistochemistry; Monosomy; Mucoepidermoid carcinoma; Carcinoma; Chromosome; Karyotype; Medicine; Genetics; Gene","score_opus":0.04905912646406647,"score_gpt":0.2859099547548716,"score_spread":0.23685082829080512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029360037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891505,0.0071195955,0.000023241268,0.00056407007,0.00018290205,0.0020718044,0.00011966453,0.00016840581,0.00059976394],"genre_scores_gemma":[0.99426246,0.00045511866,0.0033335087,0.00029858624,0.0008634728,0.00011625497,0.00042019397,0.00014242665,0.00010800879],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99572676,0.0002919673,0.00090096873,0.0018462266,0.00057859503,0.0006554916],"domain_scores_gemma":[0.9971598,0.00035078364,0.00060989184,0.0008170785,0.00016553572,0.0008969373],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002991441,0.0010044357,0.002213584,0.00027545085,0.00013651625,0.0000976224,0.00030489312,0.00057857326,0.000019814399],"category_scores_gemma":[0.00006932478,0.00072817225,0.0002570032,0.00017544038,0.00074324396,0.0000604668,0.0010929448,0.0022531168,0.000026829104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015866904,0.00015807488,0.9542784,0.0024449488,0.0002770243,0.017800633,0.0011603202,0.000013894749,0.021297852,0.000009556346,0.00007651372,0.00089607364],"study_design_scores_gemma":[0.0043163733,0.003771806,0.9618499,0.0006264221,0.0013822974,0.0013848325,0.00026317063,0.00010558851,0.02543357,0.00012755377,0.00009038033,0.0006480576],"about_ca_topic_score_codex":0.00008607749,"about_ca_topic_score_gemma":0.000009835001,"teacher_disagreement_score":0.0164158,"about_ca_system_score_codex":0.00043258708,"about_ca_system_score_gemma":0.00064444245,"threshold_uncertainty_score":0.99951696},"labels":[],"label_agreement":null},{"id":"W3029508605","doi":"10.1200/jco.2020.38.15_suppl.5024","title":"Association of gene expression with clinical outcomes in patients with renal cell carcinoma treated with pembrolizumab in KEYNOTE-427.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Gene signature; Oncology; Clear cell renal cell carcinoma; Cancer research; Proportional hazards model; Internal medicine; Population; Stromal cell; Gene expression; Gene; Biology; Genetics","score_opus":0.0662741098817285,"score_gpt":0.36992972036046345,"score_spread":0.30365561047873496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029508605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662566,0.0000543824,0.000041805528,0.00198582,0.000086042484,0.00050931453,0.000006492074,0.0000071026834,0.0006833815],"genre_scores_gemma":[0.9939492,0.000035643036,0.0050412863,0.0006086335,0.00019803809,0.000006278183,0.000013865528,0.000033877008,0.00011322694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942053,0.00094271573,0.0032443935,0.00037267964,0.00090862275,0.00032628502],"domain_scores_gemma":[0.99318326,0.0019472594,0.0034892275,0.00023678399,0.0006516698,0.0004918004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015412726,0.000269036,0.0027138437,0.0001977325,0.000017755377,0.0000061921783,0.00016949174,0.0004948276,0.000044428347],"category_scores_gemma":[0.0011893754,0.00014303911,0.00031838444,0.00034116613,0.00014348637,0.00013425921,0.0000390139,0.0013403911,0.0000047431113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0713876,0.004920377,0.9198414,0.00003871963,0.00026050516,0.0013800674,0.0001412403,0.00011731182,0.00014926384,5.192564e-7,0.00020188505,0.0015611354],"study_design_scores_gemma":[0.06625726,0.07380691,0.85727704,0.00015827743,0.0005093086,0.000024395793,0.000068973626,0.00003314519,0.0016154293,0.000002439632,0.00012129969,0.00012552024],"about_ca_topic_score_codex":0.000075478776,"about_ca_topic_score_gemma":0.00014187014,"teacher_disagreement_score":0.06888653,"about_ca_system_score_codex":0.0005055668,"about_ca_system_score_gemma":0.0013297895,"threshold_uncertainty_score":0.58329654},"labels":[],"label_agreement":null},{"id":"W3030218591","doi":"10.1200/jco.2020.38.15_suppl.5071","title":"Characterizing sites of metastatic involvement in metastatic clear-cell, papillary, and chromophobe renal cell carcinoma.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Sunnybrook Hospital; University Health Network; Queen's University; Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Medicine; Chromophobe cell; Papillary renal cell carcinomas; Clear cell renal cell carcinoma; Lymph node; Internal medicine; Cabozantinib; Oncology; Renal cell carcinoma; Clear cell; Metastasectomy; Pathology; Metastasis; Cancer","score_opus":0.1670620845367558,"score_gpt":0.39438467903818003,"score_spread":0.22732259450142422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030218591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98985434,0.0035092903,0.000026559077,0.005036592,0.00016227794,0.00035301605,0.0000063992707,0.000004925917,0.0010465932],"genre_scores_gemma":[0.98780096,0.0014852071,0.0077183866,0.0026505059,0.00026624353,0.0000043746477,0.0000080539385,0.000023590757,0.00004270502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950442,0.00069102296,0.003148397,0.00029470903,0.0005315494,0.0002901313],"domain_scores_gemma":[0.9953422,0.0014751178,0.0021121355,0.00018449484,0.00026486296,0.00062117813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022948254,0.00023201911,0.0022967304,0.0001811075,0.000023345588,0.000009732311,0.00015129203,0.00014682247,0.00014853556],"category_scores_gemma":[0.00085504114,0.00016800122,0.0004344746,0.00023003238,0.00020255637,0.00014428467,0.000113596936,0.00091785117,0.000012731785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016729383,0.008977517,0.46510047,0.0026718494,0.001165097,0.02052067,0.00446616,0.000055247223,0.4540164,0.00006143867,0.002039432,0.024196351],"study_design_scores_gemma":[0.035931353,0.10145968,0.7440253,0.0003293777,0.0032598188,0.0007697859,0.0022052699,0.00082009454,0.09920793,0.0001661357,0.01141503,0.00041021602],"about_ca_topic_score_codex":0.00004223155,"about_ca_topic_score_gemma":0.000016017757,"teacher_disagreement_score":0.35480845,"about_ca_system_score_codex":0.00014767835,"about_ca_system_score_gemma":0.0010158228,"threshold_uncertainty_score":0.6850891},"labels":[],"label_agreement":null},{"id":"W3030472743","doi":"10.1001/jamaoncol.2020.2218","title":"Efficacy of Savolitinib vs Sunitinib in Patients With<i>MET</i>-Driven Papillary Renal Cell Carcinoma","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Sunitinib; Tolerability; Internal medicine; Renal cell carcinoma; Population; Oncology; Clinical endpoint; Cabozantinib; Expanded access; Clinical trial; Urology; Surgery; Adverse effect","score_opus":0.023545140243513205,"score_gpt":0.25515136495276947,"score_spread":0.23160622470925626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030472743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98058134,0.00015171664,0.0000053623035,0.0020699492,0.00006636912,0.00094469334,0.000036622285,0.000035912042,0.016108008],"genre_scores_gemma":[0.99558455,0.000012905247,0.0016926625,0.0021146806,0.00020468306,0.0000347752,0.00022071581,0.000045668374,0.00008933664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978889,0.00024465966,0.0005887757,0.00045899977,0.0003781378,0.000440499],"domain_scores_gemma":[0.99845356,0.00035604747,0.00026160153,0.00035419056,0.00021857386,0.0003560233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012316574,0.0002685994,0.00084325776,0.00016516107,0.000031367246,0.000007029443,0.00016645202,0.00025002565,0.00024061895],"category_scores_gemma":[0.00015873085,0.00021679584,0.00013932651,0.0003749072,0.00017226678,0.00007014907,0.0001132275,0.000434984,0.000063514985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011037271,0.0018616013,0.9694324,0.00026395026,0.0000768705,0.0012630016,0.0015937942,0.000035647972,0.0041467426,0.00006240573,0.0018153854,0.008410908],"study_design_scores_gemma":[0.025903314,0.018469075,0.9320972,0.000068360074,0.00018099218,0.00002535037,0.00018198283,0.000033454657,0.014148635,0.0000071217273,0.00869983,0.00018469417],"about_ca_topic_score_codex":0.00011793095,"about_ca_topic_score_gemma":0.000022121447,"teacher_disagreement_score":0.037335232,"about_ca_system_score_codex":0.0003049785,"about_ca_system_score_gemma":0.0004581036,"threshold_uncertainty_score":0.8840678},"labels":[],"label_agreement":null},{"id":"W3031007885","doi":"10.1200/jco.2020.38.15_suppl.5065","title":"A phase II multicenter study of stereotactic radiotherapy (SRT) for oligoprogression in metastatic renal cell cancer (mRCC) patients receiving tyrosine kinase inhibitor (TKI) therapy.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Ozmosis Research (Canada); McMaster University; Juravinski Cancer Centre; Baker Hughes (Canada); Princess Margaret Cancer Centre; University of Calgary; McGill University Health Centre; McGill University; Sunnybrook Health Science Centre; Jewish General Hospital; Foothills Medical Centre; University of Alberta; Ottawa Hospital; CancerCare Manitoba; Health Sciences Centre; Cancer Care Ontario","funders":"Pfizer Canada","keywords":"Medicine; Sunitinib; Pazopanib; Internal medicine; Renal cell carcinoma; Oncology; Cancer; Cumulative incidence; Surgery; Cohort","score_opus":0.15425976726002352,"score_gpt":0.4720667528457671,"score_spread":0.3178069855857436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031007885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930855,0.0020511108,0.000042533688,0.0024072947,0.00061264716,0.001747454,0.000010188618,0.000005888393,0.0000373974],"genre_scores_gemma":[0.9934546,0.00092130736,0.0035815951,0.0012594624,0.00064526516,0.00005209961,0.000004885066,0.000038887232,0.000041900228],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9950786,0.00073972647,0.0030514796,0.00032758721,0.0005119272,0.00029066278],"domain_scores_gemma":[0.994881,0.0013539554,0.0025825205,0.0001985131,0.00054078613,0.0004432598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013880411,0.00024976072,0.0019921218,0.00017955655,0.00004445391,0.0000086280525,0.00016746568,0.00016252616,0.00010926716],"category_scores_gemma":[0.0010357033,0.0001623042,0.00046730705,0.00022835188,0.00007499286,0.00014085237,0.000051480845,0.0006677688,0.0000012238373],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11342315,0.12585203,0.32881275,0.00025721037,0.0013241641,0.0010196242,0.0055142585,0.00006590337,0.023290105,5.6984834e-7,0.0014128888,0.39902735],"study_design_scores_gemma":[0.3329821,0.4797274,0.15764853,0.0006368654,0.0012066839,0.000018195797,0.0007598684,0.001141924,0.01785261,0.000012044872,0.007749659,0.0002641261],"about_ca_topic_score_codex":0.000038015318,"about_ca_topic_score_gemma":0.000041137362,"teacher_disagreement_score":0.39876324,"about_ca_system_score_codex":0.0003176097,"about_ca_system_score_gemma":0.0006692546,"threshold_uncertainty_score":0.66185737},"labels":[],"label_agreement":null},{"id":"W3031211956","doi":"10.1177/2054358120923527","title":"Frequency, Timing, and Prediction of Major Bleeding Complications From Percutaneous Renal Biopsy","year":2020,"lang":"en","type":"article","venue":"Canadian Journal of Kidney Health and Disease","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Nephrology; Percutaneous; Renal biopsy; Radiology; Biopsy; Kidney disease; Intensive care medicine; Internal medicine; Surgery","score_opus":0.041006028657679994,"score_gpt":0.26458780414843447,"score_spread":0.22358177549075448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031211956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8376655,0.013755566,0.00013585981,0.14666478,0.00007926566,0.00024908374,0.00118846,0.0000066550297,0.0002548087],"genre_scores_gemma":[0.98116785,0.00019765124,0.0013704671,0.016989376,0.00016178688,0.0000014916385,0.00009178347,0.000009990435,0.000009574505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920785,0.000028511702,0.00033939185,0.00012852416,0.00012495418,0.00017075172],"domain_scores_gemma":[0.9712846,0.000025493666,0.00017565834,0.00008420556,0.00011800365,0.028311988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059799462,0.00008947103,0.00023075177,0.0001192122,0.00011419332,0.000015544038,0.000039179464,0.000029577457,0.000062726336],"category_scores_gemma":[0.0018879515,0.00007781287,0.000049719547,0.000082883365,0.00008545583,0.0000571118,0.00000511685,0.00012181277,0.0000013087398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051362725,0.00007219567,0.88909984,0.0010319728,0.00019463261,0.0022801282,0.0031704076,0.0000043510877,0.0073621753,0.00024745465,0.09316444,0.0028587545],"study_design_scores_gemma":[0.010009483,0.005613489,0.93328434,0.004237422,0.0021269007,0.009034879,0.0026784742,0.0025212287,0.00035290254,0.00270618,0.026882125,0.0005525547],"about_ca_topic_score_codex":0.004218257,"about_ca_topic_score_gemma":0.000098184304,"teacher_disagreement_score":0.14350235,"about_ca_system_score_codex":0.000128773,"about_ca_system_score_gemma":0.013651571,"threshold_uncertainty_score":0.9919401},"labels":[],"label_agreement":null},{"id":"W3031577106","doi":"10.1200/jco.2020.38.15_suppl.e17097","title":"Understanding the treatment effect modification of mono- or combination PD-1/PD-L1 inhibitor therapies on survival outcomes in patients with metastatic renal cell carcinoma: What does the literature say?","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Meta-analysis; Renal cell carcinoma; Oncology; Subgroup analysis; Clinical trial; Confidence interval","score_opus":0.16007684425755733,"score_gpt":0.38822200967647424,"score_spread":0.2281451654189169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031577106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98369163,0.0005023584,0.00007999938,0.0141868275,0.00044579446,0.0009813898,0.0000067043816,0.0000049697114,0.00010032985],"genre_scores_gemma":[0.99851286,0.00039037695,0.00016716037,0.00064688403,0.00017346282,0.000019158811,0.000013267955,0.00002013804,0.000056698973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960181,0.0015400201,0.0014204251,0.0002257235,0.0006123509,0.00018335515],"domain_scores_gemma":[0.99198425,0.0059122476,0.0014528333,0.00025029187,0.00024783134,0.00015253216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014719308,0.0002525858,0.0013826968,0.00011506537,0.00006781356,0.000041810865,0.00016404706,0.00014901815,0.000015773468],"category_scores_gemma":[0.000543141,0.00007917042,0.00038582046,0.0002611548,0.00018869323,0.0001878131,0.000020442785,0.00061236235,0.0000021119852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0631937,0.008312395,0.9004401,0.00016393822,0.0012812243,0.000367482,0.009056582,0.00024620828,0.00022474273,0.00026473313,0.00011993506,0.016328968],"study_design_scores_gemma":[0.026683385,0.09865117,0.8689067,0.00022537181,0.000936859,0.000010579601,0.0023039277,0.00014084585,0.0016178068,0.00026868287,0.00015069082,0.000104025465],"about_ca_topic_score_codex":0.00001035582,"about_ca_topic_score_gemma":0.000033129883,"teacher_disagreement_score":0.090338774,"about_ca_system_score_codex":0.00057918817,"about_ca_system_score_gemma":0.0003559636,"threshold_uncertainty_score":0.3228476},"labels":[],"label_agreement":null},{"id":"W3031930276","doi":"10.1200/jco.2020.38.15_suppl.5002","title":"SAVOIR: A phase III study of savolitinib versus sunitinib in pts with MET-driven papillary renal cell carcinoma (PRCC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Sunitinib; Medicine; Tolerability; Internal medicine; Oncology; Renal cell carcinoma; Adverse effect; Papillary renal cell carcinomas; Expanded access; Tyrosine-kinase inhibitor; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Urology; Clinical trial; Cancer","score_opus":0.23402722043556454,"score_gpt":0.4389662506684173,"score_spread":0.2049390302328528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031930276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908853,0.00043798942,0.000014564241,0.0019931204,0.00040237323,0.0007890619,0.000008392443,0.0000114495515,0.0054577114],"genre_scores_gemma":[0.99625856,0.000108435335,0.0018271281,0.00077805645,0.00091654935,0.00001047904,0.000007919424,0.00003933945,0.00005350711],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99358577,0.0011257246,0.0036600512,0.0004022642,0.0008188937,0.00040727208],"domain_scores_gemma":[0.9919657,0.0036526008,0.0025160073,0.00034784788,0.00060204684,0.00091576425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016785504,0.00031171876,0.0029635592,0.00024820308,0.000036479214,0.000007669811,0.00030249255,0.00033280588,0.00020816489],"category_scores_gemma":[0.0016872641,0.00021305187,0.00051585294,0.00041431357,0.00025280254,0.00011676872,0.00011704262,0.0015459884,0.000012890651],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3614571,0.05037604,0.46390465,0.00030410342,0.0022589976,0.062082175,0.0073196082,0.00026365207,0.005452175,0.00005154711,0.0030298813,0.04350005],"study_design_scores_gemma":[0.27676755,0.49207392,0.21180214,0.00016559742,0.0023743184,0.0004750668,0.007793589,0.00015386238,0.0026639553,0.000016220813,0.0054286527,0.00028510927],"about_ca_topic_score_codex":0.00010315113,"about_ca_topic_score_gemma":0.00016377949,"teacher_disagreement_score":0.4416979,"about_ca_system_score_codex":0.00030751224,"about_ca_system_score_gemma":0.0024538503,"threshold_uncertainty_score":0.8688003},"labels":[],"label_agreement":null},{"id":"W3031933721","doi":"10.1200/jco.2020.38.15_suppl.5007","title":"FRACTION-RCC: Innovative, high-throughput assessment of nivolumab + ipilimumab for treatment-refractory advanced renal cell carcinoma (aRCC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McMaster University; Juravinski Cancer Centre; Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Ipilimumab; Nivolumab; Internal medicine; Discontinuation; Refractory (planetary science); Oncology; Renal cell carcinoma; Cancer; Immunotherapy","score_opus":0.13842810872226372,"score_gpt":0.4579737183330004,"score_spread":0.31954560961073664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031933721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98567134,0.0005564553,0.0029110233,0.005395317,0.00088293257,0.00085615716,0.00004184154,0.000017870527,0.0036670617],"genre_scores_gemma":[0.9503072,0.00035333564,0.04603361,0.0013197281,0.0015741757,0.000031973148,0.000042675838,0.000050037277,0.00028728522],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99433076,0.0004457627,0.0037425642,0.00047005233,0.0006210095,0.000389819],"domain_scores_gemma":[0.990058,0.0031365105,0.004165977,0.000360834,0.0016699448,0.0006087409],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00107172,0.0003581686,0.0030335244,0.00018735306,0.00007157771,0.000009050572,0.00022501228,0.00047032686,0.000251085],"category_scores_gemma":[0.0013265013,0.00025852167,0.0009584203,0.00037869808,0.00025841678,0.00024670758,0.00006396309,0.00078371685,0.000012447893],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07338187,0.027699511,0.2574175,0.00076990825,0.004015252,0.0029832604,0.00069804327,0.0005032838,0.0984531,0.0006132522,0.016078245,0.5173868],"study_design_scores_gemma":[0.07283718,0.2234682,0.55828863,0.0001073973,0.0017299465,0.00017740819,0.00049794087,0.00046150252,0.02690594,0.00023763134,0.1149565,0.00033170683],"about_ca_topic_score_codex":0.000047389723,"about_ca_topic_score_gemma":0.000009685134,"teacher_disagreement_score":0.5170551,"about_ca_system_score_codex":0.0011406314,"about_ca_system_score_gemma":0.0047702887,"threshold_uncertainty_score":0.9999867},"labels":[],"label_agreement":null},{"id":"W3031942086","doi":"10.1200/jco.2020.38.15_suppl.5001","title":"Pembrolizumab plus axitinib versus sunitinib as first-line therapy for advanced renal cell carcinoma (RCC): Updated analysis of KEYNOTE-426.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Sunitinib; Interim analysis; Renal cell carcinoma; Axitinib; Clinical endpoint; Internal medicine; Discontinuation; Temsirolimus; Pazopanib; Oncology; Clinical trial","score_opus":0.1829514474236072,"score_gpt":0.44503408824110696,"score_spread":0.26208264081749977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031942086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98268306,0.0011636451,0.0004502267,0.010762118,0.0006910931,0.00070049556,0.00006588286,0.000021177048,0.0034623279],"genre_scores_gemma":[0.99141,0.00089937,0.004000463,0.0020947135,0.0011414142,0.000017426084,0.00015717742,0.000051665585,0.00022774322],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9940246,0.00046052714,0.0038912152,0.00047163214,0.0006912975,0.00046077312],"domain_scores_gemma":[0.98918605,0.0046389434,0.0034369568,0.00042091156,0.0013694161,0.0009477454],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014372501,0.00036477562,0.0037877255,0.00039321955,0.000072666604,0.000010911613,0.0003857062,0.0005395995,0.0007248172],"category_scores_gemma":[0.002794364,0.00027005983,0.0023992585,0.00084025494,0.00026937656,0.00011509285,0.00007698771,0.0009694931,0.00001969],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8286354,0.0073097986,0.023925202,0.0002805863,0.01573602,0.0042010183,0.001250341,0.0052641556,0.008219082,0.00019851455,0.008643513,0.09633638],"study_design_scores_gemma":[0.28727302,0.33037817,0.18419178,0.00010256551,0.021573236,0.00023754917,0.0007338319,0.0057450645,0.033038516,0.00016138722,0.13589086,0.00067404145],"about_ca_topic_score_codex":0.000040469225,"about_ca_topic_score_gemma":0.000037634712,"teacher_disagreement_score":0.54136235,"about_ca_system_score_codex":0.00032645368,"about_ca_system_score_gemma":0.0024789316,"threshold_uncertainty_score":0.99997514},"labels":[],"label_agreement":null},{"id":"W3032079924","doi":"10.1200/jco.2020.38.15_suppl.5070","title":"Outcomes of patients with metastatic renal cell carcinoma (mRCC) treated with first-line Immuno-oncology (IO) agents who do not meet eligibility criteria for clinical trials.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Foothills Medical Centre; Dalhousie University; Queen's University; University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Clinical trial; Internal medicine; Gastroenterology; Oncology; Urology; Surgery","score_opus":0.3327149293955883,"score_gpt":0.5213296342139913,"score_spread":0.18861470481840298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032079924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98792434,0.00035121408,0.00049625954,0.0077645564,0.0006139647,0.00216799,0.00018025533,0.000017800863,0.00048364385],"genre_scores_gemma":[0.9819571,0.00033145858,0.013876207,0.0028647543,0.00069307355,0.00004455451,0.000065945664,0.00007218714,0.00009474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9840172,0.003975829,0.009725223,0.0007637654,0.00095551077,0.00056246895],"domain_scores_gemma":[0.966742,0.02068479,0.008469657,0.00065011415,0.0021917028,0.001261748],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.011858269,0.00057314994,0.008985617,0.00019859264,0.00008146624,0.000019689498,0.00045031845,0.0006551827,0.0002871482],"category_scores_gemma":[0.01750415,0.0003133892,0.0020138852,0.00031109716,0.000682405,0.00017201442,0.00013023084,0.001054402,0.000008079789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15856728,0.009666602,0.8085906,0.00031981905,0.0029748497,0.0009280919,0.0002397016,0.00003080897,0.00009746334,0.000008172763,0.0065787346,0.011997906],"study_design_scores_gemma":[0.08057256,0.16533478,0.7363443,0.000115083254,0.0062602893,0.00006164727,0.00009336309,0.00014590839,0.00096472737,0.000042742984,0.009824433,0.00024015861],"about_ca_topic_score_codex":0.0000436492,"about_ca_topic_score_gemma":0.00007590925,"teacher_disagreement_score":0.15566818,"about_ca_system_score_codex":0.00039981733,"about_ca_system_score_gemma":0.0029552698,"threshold_uncertainty_score":0.9999318},"labels":[],"label_agreement":null},{"id":"W3032504166","doi":"10.1200/jco.2020.38.15_suppl.5034","title":"First-line pembrolizumab (pembro) monotherapy in advanced non-clear cell renal cell carcinoma (nccRCC): Updated follow-up for KEYNOTE-427 cohort B.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Université Laval","funders":"","keywords":"Medicine; Cohort; Pembrolizumab; Internal medicine; Renal cell carcinoma; Urology; Oncology; Surgery; Gastroenterology; Cancer; Immunotherapy","score_opus":0.07859138688941952,"score_gpt":0.38474361828413406,"score_spread":0.30615223139471454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032504166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98212945,0.0008731466,0.0015575626,0.00970025,0.001133561,0.0014717465,0.000019431262,0.000026342568,0.0030885262],"genre_scores_gemma":[0.98151946,0.0008343374,0.010113505,0.0047049425,0.0014660145,0.000041580362,0.000038613,0.000104546234,0.0011770065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935292,0.00040079548,0.0040944032,0.00067433005,0.00062997534,0.0006712715],"domain_scores_gemma":[0.9936271,0.0018804678,0.0022920442,0.00044505368,0.00065507763,0.0011003116],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017649612,0.0004710156,0.0032069902,0.00024430224,0.000078041354,0.000018095749,0.0004384326,0.0007478741,0.00031148433],"category_scores_gemma":[0.0010073531,0.00036698297,0.0013757136,0.00037744016,0.00016775126,0.00017640869,0.0000930918,0.0016094787,0.00006657095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3875469,0.009310754,0.48960122,0.00066494767,0.0011152363,0.008304117,0.001231571,0.0030111365,0.028300514,0.000023499977,0.032831613,0.03805848],"study_design_scores_gemma":[0.21766533,0.13909625,0.49423507,0.00018446369,0.0016345246,0.0003239019,0.0002394577,0.009024141,0.024180328,0.0001989935,0.112501346,0.00071619306],"about_ca_topic_score_codex":0.00005291122,"about_ca_topic_score_gemma":0.00007195682,"teacher_disagreement_score":0.16988157,"about_ca_system_score_codex":0.0005524228,"about_ca_system_score_gemma":0.0019418452,"threshold_uncertainty_score":0.9998782},"labels":[],"label_agreement":null},{"id":"W3032647502","doi":"10.1101/2020.05.28.121806","title":"Integrative Molecular Characterization of Sarcomatoid and Rhabdoid Renal Cell Carcinoma Reveals Determinants of Poor Prognosis and Response to Immune Checkpoint Inhibitors","year":2020,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary","funders":"Congressionally Directed Medical Research Programs; National Cancer Institute; National Institutes of Health; Fondation ARC pour la Recherche sur le Cancer; Bristol-Myers Squibb; Dana-Farber Cancer Institute; G. Harold and Leila Y. Mathers Foundation; Leukemia and Lymphoma Society; Dana-Farber/Harvard Cancer Center; U.S. Department of Defense","keywords":"CDKN2A; BAP1; Immune system; Immune checkpoint; Cancer research; Renal cell carcinoma; Biology; Cytotoxic T cell; Immunotherapy; Immunology; Medicine; Melanoma; Gene; Oncology; In vitro; Genetics","score_opus":0.012344751557721672,"score_gpt":0.22526751386587532,"score_spread":0.21292276230815366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032647502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952688,0.0013017639,0.00012390169,0.00042973482,0.00012487112,0.0023852063,0.00030078617,0.00006177422,0.000003142203],"genre_scores_gemma":[0.9950079,0.00014108907,0.0043438114,0.000073483985,0.00006435092,0.00023945076,0.0000021124908,0.00012312598,0.000004681349],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965582,0.00034717028,0.0012439806,0.0010023116,0.0004803118,0.00036802972],"domain_scores_gemma":[0.99703366,0.00008610576,0.0010027018,0.0007290324,0.00067413325,0.0004743718],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00066026056,0.0006613915,0.0014646931,0.00049025676,0.00005518682,0.000044908218,0.00020103477,0.00038429582,0.000007286555],"category_scores_gemma":[0.0004213359,0.00060873537,0.0002149042,0.0004997057,0.00020592728,0.0000877551,0.0006132273,0.0004507934,0.000003457108],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016962439,0.00021902347,0.0848535,0.0019042162,0.00011350756,0.00027619206,0.00018967885,3.8873256e-7,0.91072834,0.0000056435547,0.000004462988,0.000008799575],"study_design_scores_gemma":[0.0007261482,0.00070910505,0.43276247,0.001119925,0.0002233706,2.8589e-7,0.000010865163,0.000037699057,0.5641477,4.4933876e-7,0.000013707284,0.00024824913],"about_ca_topic_score_codex":0.00007707833,"about_ca_topic_score_gemma":7.08983e-7,"teacher_disagreement_score":0.34790897,"about_ca_system_score_codex":0.00024705488,"about_ca_system_score_gemma":0.00055728015,"threshold_uncertainty_score":0.9996364},"labels":[],"label_agreement":null},{"id":"W3034159339","doi":"10.1016/j.critrevonc.2020.102971","title":"Systemic therapy in metastatic renal cell carcinoma: Emerging challenges in therapeutic choice","year":2020,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; University Health Network; Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Canada Research Chairs","keywords":"Medicine; Systemic therapy; Intensive care medicine; Pace; Renal cell carcinoma; Cancer; Oncology; Internal medicine; Breast cancer","score_opus":0.24089697124174567,"score_gpt":0.4453458522876007,"score_spread":0.20444888104585504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034159339","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002857932,0.98736805,0.000023895638,0.0022367605,0.00044375428,0.005916349,0.000008721423,0.00004752627,0.003669168],"genre_scores_gemma":[0.017036205,0.9779093,0.0005392926,0.0005027941,0.00017052212,0.0035920036,0.000049580987,0.00016316467,0.000037085592],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98663443,0.0055049933,0.0042101536,0.0018406258,0.00039182237,0.0014179941],"domain_scores_gemma":[0.9917622,0.0059129433,0.0006537671,0.0011334878,0.00009966604,0.00043788657],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0022579478,0.0013445973,0.013150928,0.0012408353,0.00004428694,0.000016592396,0.0006838047,0.0011659908,0.0001726443],"category_scores_gemma":[0.0022635688,0.0009984665,0.0010812219,0.001291834,0.00040119115,0.00008862965,0.00021562178,0.0028622732,0.00046876434],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009282604,0.0013356926,0.00060901523,0.08154846,0.00010001206,0.013228036,0.00039793126,2.0032923e-7,0.000008381582,0.006217078,0.00008148412,0.8963809],"study_design_scores_gemma":[0.0035487355,0.0020224885,0.00017338009,0.053495575,0.0013307,0.0081426315,0.0002708876,0.000019732468,0.000012733458,0.00058623526,0.92957425,0.000822659],"about_ca_topic_score_codex":0.000059798498,"about_ca_topic_score_gemma":0.00022585559,"teacher_disagreement_score":0.9294928,"about_ca_system_score_codex":0.0027260627,"about_ca_system_score_gemma":0.0016332302,"threshold_uncertainty_score":0.9999305},"labels":[],"label_agreement":null},{"id":"W3034252649","doi":"","title":"Cytoreductive nephrectomy～ 分子標的薬時代のサマリーとIO combo時代での位置づけ～","year":2020,"lang":"ja","type":"article","venue":"Pharma Medica","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Kidney; Internal medicine","score_opus":0.05242778425005205,"score_gpt":0.305358548599772,"score_spread":0.25293076434971995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034252649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7377561,0.04122305,0.0003553728,0.12991044,0.0059692813,0.003746016,0.0002917342,0.0007699593,0.07997809],"genre_scores_gemma":[0.97543675,0.0021491637,0.00056356593,0.012511349,0.0071894815,0.00011261166,0.00019013732,0.00016800499,0.0016789424],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99437284,0.00040447025,0.00097628986,0.00126277,0.001751375,0.0012322236],"domain_scores_gemma":[0.9952273,0.00036406663,0.00036552403,0.0007001615,0.0002631418,0.003079808],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00041514583,0.00086721417,0.0013782508,0.00017610434,0.00022316296,0.00006702467,0.0005929672,0.00030550675,0.012593619],"category_scores_gemma":[0.00064707367,0.0007589453,0.0005113149,0.0008514524,0.00059400423,0.00023249493,0.00032800637,0.0013909838,0.007164101],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073343944,0.0036956235,0.0121910665,0.0031450393,0.00748558,0.017698154,0.05661321,0.000034875025,0.12385736,0.00037165638,0.6448687,0.122704394],"study_design_scores_gemma":[0.022714341,0.004176659,0.008748232,0.00085697515,0.0051537417,0.0006380356,0.004438346,0.0046441723,0.16992514,0.000076951284,0.77710944,0.0015179486],"about_ca_topic_score_codex":0.00012685428,"about_ca_topic_score_gemma":0.0000015533209,"teacher_disagreement_score":0.23768069,"about_ca_system_score_codex":0.0005596536,"about_ca_system_score_gemma":0.00088009017,"threshold_uncertainty_score":0.99948615},"labels":[],"label_agreement":null},{"id":"W3035072944","doi":"10.5489/cuaj.6579","title":"Canadian Update on Surgical Procedures (CUSP) Urology Group consensus for intraoperative hemostasis during minimally invasive partial nephrectomy","year":2020,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Kelowna General Hospital; Université de Montréal; Centre Hospitalier de l’Université de Montréal; McMaster University; Hamilton Health Sciences; Niagara Health System; University of British Columbia; Centre Hospitalier Universitaire de Sherbrooke; University of Toronto; Western University; Université de Sherbrooke; Queen's University; Memorial University of Newfoundland; University of Alberta; University of Manitoba; University of Calgary; University of Ottawa; McGill University; Windsor Regional Hospital; Emmanuel Bible College","funders":"","keywords":"Medicine; Nephrectomy; Hemostasis; Checklist; Delphi; Delphi method; Surgery; Medical physics; General surgery; Urology; Internal medicine; Computer science; Kidney; Psychology","score_opus":0.01976562456117564,"score_gpt":0.2358449250677582,"score_spread":0.21607930050658256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035072944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83311176,0.00018098463,0.000002818511,0.1647619,0.00016320415,0.0008187848,0.00016450716,0.00004174858,0.0007543118],"genre_scores_gemma":[0.97535837,0.000055607823,0.00028689863,0.022971777,0.00102649,0.00010093324,0.00008092888,0.000040138995,0.000078867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972648,0.0002975064,0.0005387917,0.00048128256,0.00035322606,0.001064366],"domain_scores_gemma":[0.99556786,0.00046271822,0.00026712933,0.00011071169,0.00039578244,0.003195797],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033724128,0.0003167021,0.0005684939,0.00024283674,0.00053764274,0.00011735897,0.00015693285,0.0004184407,0.0006088867],"category_scores_gemma":[0.0024116011,0.00026025737,0.00026129597,0.00025474362,0.00006897726,0.00005838337,0.000016411686,0.0007894693,0.00013169211],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010046548,0.00035333555,0.8738936,0.00012607867,0.0023042334,0.02400401,0.0018838597,0.00070854544,0.004088298,0.001979179,0.07765001,0.0029622952],"study_design_scores_gemma":[0.022947349,0.014981375,0.52310485,0.00007241127,0.0012033178,0.005827398,0.00073641114,0.0010255729,0.0070315795,0.0006563834,0.4209239,0.0014894871],"about_ca_topic_score_codex":0.009221157,"about_ca_topic_score_gemma":0.12507549,"teacher_disagreement_score":0.35078877,"about_ca_system_score_codex":0.0030328797,"about_ca_system_score_gemma":0.0033417717,"threshold_uncertainty_score":0.999985},"labels":[],"label_agreement":null},{"id":"W3035587281","doi":"10.1093/jncics/pkaa050","title":"Systematic Review and STARD Scoring of Renal Cell Carcinoma Circulating Diagnostic Biomarker Manuscripts","year":2020,"lang":"en","type":"review","venue":"JNCI Cancer Spectrum","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Renal cell carcinoma; Biomarker; MEDLINE; Diagnostic accuracy; Internal medicine; Diagnostic biomarker; Oncology; Medical physics","score_opus":0.05826820126116308,"score_gpt":0.31377714673260615,"score_spread":0.2555089454714431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035587281","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003955754,0.992205,0.000011991756,0.00022249404,0.00026791068,0.00577995,0.000103242215,0.00005314291,0.0009606542],"genre_scores_gemma":[0.007948316,0.9901853,0.00008962931,0.00016401311,0.00024936275,0.000851947,0.00007139571,0.00015082162,0.00028921233],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99584323,0.00027714283,0.0018338043,0.0008885171,0.00063114805,0.0005261564],"domain_scores_gemma":[0.99679923,0.00045503414,0.0013762355,0.0008959475,0.00008116508,0.0003924139],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033327917,0.0008400147,0.00646979,0.00024699912,0.00006767188,0.000032384345,0.00023929389,0.00020763036,0.00013566544],"category_scores_gemma":[0.00034289242,0.0006188657,0.00087322167,0.00060106517,0.00008231308,0.000064237756,0.00018984464,0.0004998768,0.0000408455],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000088966635,0.00004354838,0.00025268728,0.9877064,0.00070882234,0.0010987949,0.00004510419,1.3415315e-7,0.000010056838,0.000009589204,0.00028178477,0.009834142],"study_design_scores_gemma":[0.00062634266,0.00037017663,0.00047206902,0.9342569,0.04791024,0.0009014853,0.000020054213,0.000009929544,0.00012294998,0.000008923275,0.014689028,0.00061188935],"about_ca_topic_score_codex":0.00032303552,"about_ca_topic_score_gemma":0.000016148731,"teacher_disagreement_score":0.053449526,"about_ca_system_score_codex":0.0010797345,"about_ca_system_score_gemma":0.00072545867,"threshold_uncertainty_score":0.9996263},"labels":[],"label_agreement":null},{"id":"W3035979079","doi":"10.5489/cuaj.6374","title":"Surveillance post-radiofrequency ablation for small renal masses: Recurrence and followup","year":2020,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Radiofrequency ablation; Renal mass; Ablation; Radiology; Surgery; Urology; Kidney; Nephrectomy; Internal medicine","score_opus":0.029012551172468128,"score_gpt":0.23237977846342686,"score_spread":0.20336722729095874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035979079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9130151,0.0012146167,0.00083081005,0.082998015,0.00019180666,0.0005179365,0.00009940472,0.000029893286,0.0011024104],"genre_scores_gemma":[0.9910971,0.00014469888,0.002366626,0.0056547634,0.00050302764,0.000016612452,0.00006981278,0.0000125758115,0.00013478611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986931,0.00012459702,0.0003204381,0.0002519162,0.00022125164,0.0003886691],"domain_scores_gemma":[0.99807787,0.00023466631,0.00023608479,0.0000702365,0.00037527154,0.0010058935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048263243,0.00014308284,0.00028502962,0.000082575054,0.00020527617,0.00008420666,0.000076569326,0.00017988136,0.00011062718],"category_scores_gemma":[0.0019368867,0.00011762966,0.00012644172,0.00015935894,0.000022906997,0.0000812531,0.000008148929,0.00033726075,0.000014733364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020835608,0.000022743314,0.982897,0.000020723352,0.00012721824,0.00015462887,0.00021770154,0.000023480648,0.0011601778,0.00021054095,0.0042262175,0.010731217],"study_design_scores_gemma":[0.0018684654,0.0017636926,0.9234888,0.000016810753,0.00009755258,0.00028201204,0.0000506691,0.0007271966,0.00008981479,0.0006971531,0.07073407,0.00018375485],"about_ca_topic_score_codex":0.00035982934,"about_ca_topic_score_gemma":0.00044996163,"teacher_disagreement_score":0.07808199,"about_ca_system_score_codex":0.0007581994,"about_ca_system_score_gemma":0.0005050259,"threshold_uncertainty_score":0.47967982},"labels":[],"label_agreement":null},{"id":"W3036327941","doi":"10.5489/cuaj.6343","title":"Long-term outcomes after radical or partial nephrectomy for T1a renal cell carcinoma: A population-based study","year":2020,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Hazard ratio; Nephrectomy; Renal cell carcinoma; Kidney disease; Confidence interval; Internal medicine; Proportional hazards model; Urology; Creatinine; Kidney cancer; Population; Renal function; Surgery; Oncology; Kidney","score_opus":0.03460977899868055,"score_gpt":0.266032384028,"score_spread":0.23142260502931944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036327941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97803557,0.00010179772,0.00023689817,0.019851532,0.00020586379,0.0013994154,0.000064777705,0.00003839109,0.0000657644],"genre_scores_gemma":[0.9889682,0.0000011146271,0.00045108914,0.00912943,0.0008632495,0.00021075695,0.000090382135,0.000031917505,0.0002538478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974104,0.00027295086,0.00062538875,0.00039826153,0.000605079,0.00068789086],"domain_scores_gemma":[0.9971856,0.0003530455,0.00030430977,0.00015254515,0.00022508991,0.0017793966],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040787164,0.00028710105,0.0005996878,0.00016161309,0.00027129008,0.00012064708,0.00014618893,0.00026210854,0.0012877351],"category_scores_gemma":[0.00077186397,0.00019781894,0.00038273918,0.00023149332,0.000020988029,0.000083805375,0.000016386613,0.00056123175,0.000047513306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014381586,0.0002866592,0.9947995,0.000016320706,0.00012759167,0.0013493855,0.00014615296,0.000045884462,0.000026137297,0.0000023666635,0.0014211506,0.0003407042],"study_design_scores_gemma":[0.0071186703,0.0027237004,0.98667085,0.000006122527,0.0004703382,0.00004474109,0.000032701806,0.00030949284,0.000066602806,0.00001009858,0.0023399927,0.00020667489],"about_ca_topic_score_codex":0.0005784712,"about_ca_topic_score_gemma":0.0013877652,"teacher_disagreement_score":0.010932652,"about_ca_system_score_codex":0.0016113534,"about_ca_system_score_gemma":0.001006711,"threshold_uncertainty_score":0.9996252},"labels":[],"label_agreement":null},{"id":"W3036350371","doi":"10.5489/cuaj.6350","title":"An evaluation of the role of tumor load in cytoreductive nephrectomy","year":2020,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Concordance; Primary tumor; Proportional hazards model; Cohort; Log-rank test; Urology; Survival analysis; Oncology; Internal medicine; Radiology; Cancer; Metastasis; Kidney","score_opus":0.02432276689654735,"score_gpt":0.2505647882511666,"score_spread":0.22624202135461927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036350371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914562,0.00029731818,0.0000013562747,0.0060420395,0.00005349122,0.0002544474,0.000011779132,0.0000027902365,0.0018805478],"genre_scores_gemma":[0.99897325,0.0000033665262,0.000068359295,0.00080163556,0.00013406212,0.00000547498,0.0000032780194,0.0000047857925,0.000005787855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837434,0.000395419,0.0002894693,0.00010736132,0.00066404534,0.00016936999],"domain_scores_gemma":[0.99866194,0.000046882786,0.00030696433,0.000081064056,0.0005878978,0.00031524384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008558434,0.000069893606,0.00020693164,0.00006190323,0.000039347473,0.000008196102,0.00009607994,0.00007689813,0.00023964707],"category_scores_gemma":[0.0011179209,0.00004626312,0.00009403085,0.00026161908,0.000027737904,0.00005590092,0.0000069093735,0.00028112147,0.0000038257826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000875235,0.00005908419,0.9886044,0.000002417934,0.000047111593,0.000010432898,0.000738134,0.00043711552,0.0072504585,0.00005469481,0.00012739087,0.002581195],"study_design_scores_gemma":[0.0011166435,0.0004464757,0.9893449,0.000009275962,0.00012782145,0.00003299939,0.00038138087,0.0018988603,0.004942776,0.0008479939,0.0008101884,0.000040718016],"about_ca_topic_score_codex":0.0013984753,"about_ca_topic_score_gemma":0.00075977494,"teacher_disagreement_score":0.0075170193,"about_ca_system_score_codex":0.0018237616,"about_ca_system_score_gemma":0.0016283878,"threshold_uncertainty_score":0.47690734},"labels":[],"label_agreement":null},{"id":"W3036595858","doi":"10.5489/cuaj.6716","title":"Determining Generalizability of the Canadian Kidney Cancer information system (CKCis) to the Entire Canadian Kidney Cancer Population","year":2020,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Université de Montréal; University of Manitoba; University of British Columbia; Université Laval; University of Alberta; Université de Sherbrooke; Western University; University of Toronto; Dalhousie University; McGill University; University of Ottawa; University of Calgary; London Health Sciences Centre; McMaster University","funders":"Social Sciences and Humanities Research Council of Canada; Canadian Institutes of Health Research","keywords":"Medicine; Cancer registry; Kidney cancer; Cancer; Cohort; Population; Incidence (geometry); Kidney disease; Prospective cohort study; Renal cell carcinoma; Cohort study; Demography; Internal medicine; Environmental health","score_opus":0.023360580136770524,"score_gpt":0.23662201926886692,"score_spread":0.2132614391320964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036595858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7373296,0.00009036952,0.000009690578,0.25852573,0.00093887997,0.00080047373,0.00082880416,0.000017882572,0.0014585576],"genre_scores_gemma":[0.9365518,0.000012495884,0.00004749839,0.06259328,0.00055252656,0.000058352547,0.00007808068,0.00001450899,0.000091442846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975005,0.0003236934,0.00063979684,0.00021337299,0.0006100793,0.0007125688],"domain_scores_gemma":[0.99359816,0.000038596976,0.0004390917,0.00023275678,0.0005551896,0.0051362044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006642145,0.00021334676,0.00034919076,0.00023220047,0.000894124,0.00015621282,0.0003168063,0.00028171611,0.0005241527],"category_scores_gemma":[0.001685035,0.00013472371,0.00020595656,0.00061100686,0.00003149344,0.00018455675,0.000023322873,0.0005673092,0.000035798523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000019259773,0.0000033195467,0.96085095,0.000030366951,0.00010083458,0.000018791461,0.0009541029,0.0011619019,0.000027649774,0.000072323055,0.034727592,0.00203289],"study_design_scores_gemma":[0.00048242306,0.000097559554,0.8629026,0.00006781024,0.00017307399,0.00004397261,0.0001474063,0.0020418607,0.00007496368,0.000009238986,0.13382344,0.00013566478],"about_ca_topic_score_codex":0.9646286,"about_ca_topic_score_gemma":0.9778745,"teacher_disagreement_score":0.19922219,"about_ca_system_score_codex":0.013951787,"about_ca_system_score_gemma":0.010327763,"threshold_uncertainty_score":0.99528277},"labels":[],"label_agreement":null},{"id":"W3037021593","doi":"10.1016/j.ejca.2020.05.009","title":"Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinoma","year":2020,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"Genentech; Ipsen; Calithera Biosciences; Exelixis; Seattle Genetics; AbbVie; Merck; Bayer; Bristol-Myers Squibb; AstraZeneca; Xencor; Pfizer; Novartis","keywords":"Cabozantinib; Medicine; Oncology; Internal medicine; Renal cell carcinoma; Immune checkpoint; Clear cell renal cell carcinoma; Confidence interval; Blockade; Cancer; Immunotherapy; Receptor","score_opus":0.02767225652805078,"score_gpt":0.2604464641133596,"score_spread":0.2327742075853088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037021593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98349893,0.0081984345,0.000070654365,0.0015355882,0.00012018201,0.00021117477,0.000012209195,0.0000066075268,0.006346233],"genre_scores_gemma":[0.99782914,0.0002347882,0.0008988405,0.00019013295,0.00028602235,0.0000029169742,0.0000011352498,0.000061802224,0.0004952184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976945,0.00039801747,0.0008926265,0.0002217754,0.0005163446,0.0002767202],"domain_scores_gemma":[0.9984814,0.000045710614,0.0007241784,0.00023444586,0.00020926433,0.0003050008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005635677,0.00023553448,0.00069448433,0.00015507717,0.000017731125,0.000013416798,0.00017504148,0.000022514461,0.00047480746],"category_scores_gemma":[0.000050248054,0.00018149917,0.00035550026,0.000271227,0.00007627001,0.00010362585,0.000076740864,0.00055271457,0.000033388344],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075980346,0.0005800629,0.0298281,0.0005096999,0.00015362915,0.008934748,0.0027131366,0.00023081759,0.9433713,5.3276904e-7,0.00027382077,0.005806127],"study_design_scores_gemma":[0.0053533157,0.0019449814,0.374143,0.00018548012,0.0003284579,0.000102576276,0.00012691905,0.00007011019,0.6153395,9.947777e-7,0.0022779924,0.00012666942],"about_ca_topic_score_codex":0.000076749806,"about_ca_topic_score_gemma":0.0000071481345,"teacher_disagreement_score":0.3443149,"about_ca_system_score_codex":0.00012655635,"about_ca_system_score_gemma":0.0002749673,"threshold_uncertainty_score":0.74013215},"labels":[],"label_agreement":null},{"id":"W3037212071","doi":"10.1016/j.canep.2020.101762","title":"Renal cell carcinoma incidence rates and trends in young adults aged 20-39 years","year":2020,"lang":"en","type":"article","venue":"Cancer Epidemiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Incidence (geometry); Renal cell carcinoma; Demography; Epidemiology; Pacific islanders; Young adult; Carcinoma; Internal medicine; Population","score_opus":0.05872176384840227,"score_gpt":0.3303323176040161,"score_spread":0.2716105537556138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037212071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786831,0.013619763,0.000019300798,0.006382453,0.00014614456,0.00021697537,0.000019194014,0.000032366566,0.00088069815],"genre_scores_gemma":[0.9953673,0.00043054295,0.0005928009,0.0026081637,0.00029196643,0.000089439614,0.000060034286,0.000024956958,0.0005348205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804103,0.0003247416,0.0004902073,0.0006039586,0.00009336524,0.00044669537],"domain_scores_gemma":[0.99886024,0.0003807413,0.00015427974,0.00023417415,0.000036440895,0.00033412135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003633435,0.00022061277,0.0007518623,0.00014132768,0.000029521334,0.0000036792558,0.000101417136,0.000166229,0.0002718411],"category_scores_gemma":[0.00028142447,0.00019027702,0.000092273025,0.00027420363,0.00016220562,0.00005419935,0.00007947324,0.00036018278,0.00002961655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007121983,0.00002779381,0.98018974,0.000100121084,0.000021289163,0.00045316792,0.001191917,0.00005641121,0.0052628103,0.000016153565,0.005625254,0.0063431305],"study_design_scores_gemma":[0.0025047732,0.0006423582,0.9920487,0.000075896554,0.00006823843,0.000054505697,0.00010176263,0.00091859873,0.002689921,0.000059641974,0.0006757183,0.00015991191],"about_ca_topic_score_codex":0.0023436034,"about_ca_topic_score_gemma":0.00092995196,"teacher_disagreement_score":0.016684169,"about_ca_system_score_codex":0.00020324209,"about_ca_system_score_gemma":0.00008294174,"threshold_uncertainty_score":0.7759271},"labels":[],"label_agreement":null},{"id":"W3037595652","doi":"10.1016/j.ucl.2020.04.006","title":"Evolving Role of Urologists in the Management of Advanced Renal Cell Carcinoma","year":2020,"lang":"en","type":"review","venue":"Urologic Clinics of North America","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Renal cell carcinoma; Systemic therapy; Disease; Adjuvant therapy; Nephrectomy; Neoadjuvant therapy; Oncology; Intensive care medicine; Targeted therapy; Clinical trial; Adjuvant; Internal medicine; Chemotherapy; Cancer; Kidney","score_opus":0.04028839199734041,"score_gpt":0.31658298045314415,"score_spread":0.27629458845580374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037595652","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024267124,0.9696572,0.00001060937,0.000064215536,0.000061244325,0.001908388,0.0000943209,0.000016216487,0.003920672],"genre_scores_gemma":[0.1940318,0.80298746,0.0024666446,0.00012339497,0.000035548423,0.00010095166,0.00019646605,0.000033494372,0.000024221712],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99594176,0.00038360685,0.002041953,0.00065762573,0.0006030632,0.00037201078],"domain_scores_gemma":[0.9954631,0.00081011344,0.002355956,0.0011334622,0.00012916035,0.00010821798],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039374703,0.00051035255,0.0032696857,0.00022524703,0.000021749696,0.000003357696,0.00076367747,0.0002124226,0.00003797426],"category_scores_gemma":[0.00013903202,0.0003209015,0.0010207116,0.00086636073,0.0003679946,0.000025133793,0.00029807907,0.0006980298,0.000015112961],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029658095,0.00076066644,0.01240086,0.0112365605,0.0002996641,0.0005828057,0.00015081337,0.0000786786,0.0000013212782,0.000008349656,0.000058633912,0.9741251],"study_design_scores_gemma":[0.0020620243,0.011012974,0.055662964,0.0019908226,0.006205312,0.00006364574,0.00028361558,0.000101646234,0.000013566399,0.000055527064,0.9220917,0.00045618357],"about_ca_topic_score_codex":0.000046923633,"about_ca_topic_score_gemma":0.000005867652,"teacher_disagreement_score":0.9736689,"about_ca_system_score_codex":0.00006839572,"about_ca_system_score_gemma":0.00024279526,"threshold_uncertainty_score":0.9999243},"labels":[],"label_agreement":null},{"id":"W3038979955","doi":"10.1007/s00261-020-02632-1","title":"Importance of phase enhancement for machine learning classification of solid renal masses using texture analysis features at multi-phasic CT","year":2020,"lang":"en","type":"article","venue":"Abdominal Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Chromophobe cell; Medicine; Renal cell carcinoma; Receiver operating characteristic; Radiology; Nuclear medicine; Area under the curve; Clear cell; Pathology; Internal medicine","score_opus":0.06327481017198926,"score_gpt":0.3586396195654383,"score_spread":0.295364809393449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038979955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9613583,0.0026290142,0.03496947,0.00036953666,0.000032328127,0.00051930296,0.00005730875,0.000013707197,0.00005099698],"genre_scores_gemma":[0.9788346,0.00009533065,0.020270243,0.00012511155,0.00009453518,0.000035398727,0.0003461793,0.000020075555,0.0001785048],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984902,0.00010954669,0.00057676557,0.0004095111,0.00017189377,0.00024207756],"domain_scores_gemma":[0.9986838,0.0002149735,0.00059775065,0.00023819118,0.00013726547,0.0001280373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019615356,0.00020790585,0.0008978354,0.0001663708,0.000065253764,0.000002337211,0.00009772158,0.000074179254,0.00012328033],"category_scores_gemma":[0.0002618834,0.00016712285,0.0003553356,0.00034215365,0.0001414462,0.000032696866,0.00003411154,0.00016248845,0.0000015791859],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037625863,0.00030374975,0.064074636,0.00020203751,0.0014622927,0.000078216566,0.0003885965,0.0009805245,0.9251127,0.000018610534,0.00013770953,0.0034783361],"study_design_scores_gemma":[0.011599096,0.0057239286,0.08961917,0.000071432965,0.0073689925,0.0004303271,0.00036495543,0.25083044,0.63244236,0.0000111898025,0.001240418,0.00029770413],"about_ca_topic_score_codex":0.000039426646,"about_ca_topic_score_gemma":0.000033721943,"teacher_disagreement_score":0.29267034,"about_ca_system_score_codex":0.0001689646,"about_ca_system_score_gemma":0.00008090295,"threshold_uncertainty_score":0.68150723},"labels":[],"label_agreement":null},{"id":"W3039359921","doi":"10.1148/radiol.2020192070","title":"Diagnostic Performance of MRI in the Detection of Renal Lipid-Poor Angiomyolipomas: A Systematic Review and Meta-Analysis","year":2020,"lang":"en","type":"review","venue":"Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Meta-analysis; Cochrane Library; Confidence interval; Receiver operating characteristic; MEDLINE; Radiology; Systematic review; Contingency table; Biopsy; Subgroup analysis; Pathology; Internal medicine","score_opus":0.05974425556564991,"score_gpt":0.31307741861832294,"score_spread":0.25333316305267306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039359921","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008585881,0.9961298,0.000027006603,0.0001685439,0.000016408365,0.0034933833,0.000027730492,0.0000065249897,0.00004473267],"genre_scores_gemma":[0.009302534,0.9895037,0.000053178774,0.00012570599,0.000035001915,0.0008836898,0.00005225116,0.000018003873,0.000025945415],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99651825,0.0013150837,0.0014369718,0.0003559211,0.00020477145,0.00016900897],"domain_scores_gemma":[0.99656713,0.0016976097,0.0010121985,0.0006016471,0.00006276503,0.00005867643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008751571,0.00034912603,0.01041898,0.0003788067,0.000016353719,0.0000026658577,0.00019200161,0.00017994698,0.000035396733],"category_scores_gemma":[0.000583319,0.00016756434,0.0019386163,0.0011592094,0.00010809249,0.000019427698,0.00003758563,0.00026398548,0.00000761713],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000815692,0.00004090913,0.000017103088,0.92215955,0.07631594,0.000062340456,0.00006792567,0.0000016591827,0.000002200867,0.000007874431,0.000025335119,0.001291013],"study_design_scores_gemma":[0.00014419439,0.00067649165,0.00006827565,0.025254374,0.9668675,0.001283862,0.000009150248,0.000027262688,0.000006150017,8.498499e-7,0.005549827,0.00011208276],"about_ca_topic_score_codex":0.000024421997,"about_ca_topic_score_gemma":0.0000073899128,"teacher_disagreement_score":0.8969052,"about_ca_system_score_codex":0.00008676181,"about_ca_system_score_gemma":0.000094507675,"threshold_uncertainty_score":0.7122207},"labels":[],"label_agreement":null},{"id":"W3041182614","doi":"10.1016/j.euo.2020.06.002","title":"Learning from Our Past Mistakes: A Call for Randomized Controlled Trials in Localized Renal Cell Carcinoma","year":2020,"lang":"en","type":"letter","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Renal cell carcinoma; Randomized controlled trial; Carcinoma; MEDLINE; Oncology; Internal medicine","score_opus":0.05152276207536935,"score_gpt":0.29299089704263576,"score_spread":0.2414681349672664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041182614","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023273926,0.0059618154,0.002004722,0.90446925,0.0020698532,0.018334867,0.00016550468,0.00031152696,0.043408543],"genre_scores_gemma":[0.29633296,0.0001527333,0.0028843891,0.66462547,0.016453737,0.002193343,0.004870639,0.00055848743,0.011928232],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9511484,0.04073476,0.004614996,0.0018043172,0.00046674715,0.0012307891],"domain_scores_gemma":[0.9744815,0.021087589,0.0030981214,0.0007182749,0.00026310558,0.00035137284],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00871186,0.0012745599,0.019006569,0.0007177896,0.00012670623,0.000045137764,0.00052975584,0.0015483078,0.00027270507],"category_scores_gemma":[0.011485071,0.0009227068,0.0038548457,0.000197579,0.000377369,0.000030971918,0.0001400435,0.0048947106,0.00047566133],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4284807,0.00025162514,0.00031526329,0.0001729468,0.0016893077,0.044615883,0.00079488906,0.00005599034,0.0011174042,0.0000020776947,0.5220521,0.00045178024],"study_design_scores_gemma":[0.49619585,0.0049026273,0.00010366448,0.00004080073,0.006148657,0.0001718777,0.000093124625,0.00049048313,0.0000785662,0.000035385885,0.49133286,0.00040610507],"about_ca_topic_score_codex":0.00017263235,"about_ca_topic_score_gemma":0.000024668238,"teacher_disagreement_score":0.27305904,"about_ca_system_score_codex":0.0006127363,"about_ca_system_score_gemma":0.00086536456,"threshold_uncertainty_score":0.9997479},"labels":[],"label_agreement":null},{"id":"W3041497665","doi":"10.1007/s00345-020-03349-y","title":"Achieving the “trifecta” with open versus minimally invasive partial nephrectomy","year":2020,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Alberta Hospital Edmonton; University of Alberta; University of Toronto; Dalhousie University; McGill University; Hôtel-Dieu de Québec; McMaster University; University of British Columbia","funders":"","keywords":"Medicine; Nephrectomy; Renal function; Nephrology; Urology; Internal medicine; Renal mass; Confounding; Surgery; Kidney","score_opus":0.04763188458685091,"score_gpt":0.2836030025294663,"score_spread":0.23597111794261538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041497665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9335837,0.001687045,0.00003952682,0.056052517,0.0002332042,0.0005003805,0.0000010882053,0.000009671645,0.007892919],"genre_scores_gemma":[0.99277824,0.000078753685,0.0010382013,0.0053005717,0.00064079004,0.000012018947,0.0000015651008,0.000021692487,0.00012817304],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987571,0.00020116492,0.00036452018,0.00016903314,0.00026466252,0.00024347578],"domain_scores_gemma":[0.99852335,0.0005392181,0.0003623927,0.00018133422,0.00014167166,0.00025201327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026618034,0.00015635036,0.000460236,0.00009374133,0.00007762327,0.00003879476,0.0003699304,0.0000404126,0.00024374248],"category_scores_gemma":[0.00024217699,0.00008384188,0.00012891885,0.00029483924,0.00012273769,0.00010341095,0.00013786137,0.0005101181,0.000034462773],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37517345,0.0013159779,0.4166743,0.00021331084,0.007954445,0.037542414,0.0071929516,0.0013276188,0.07162449,0.0017301566,0.039920133,0.039330754],"study_design_scores_gemma":[0.054101605,0.063833006,0.24526386,0.00017555738,0.004469017,0.006887486,0.00074736855,0.0001136739,0.010358148,0.00006368065,0.6134724,0.00051421067],"about_ca_topic_score_codex":0.00001383634,"about_ca_topic_score_gemma":0.00011743648,"teacher_disagreement_score":0.57355225,"about_ca_system_score_codex":0.00006565395,"about_ca_system_score_gemma":0.00041967642,"threshold_uncertainty_score":0.34189725},"labels":[],"label_agreement":null},{"id":"W3041611630","doi":"10.1111/his.14204","title":"Carbonic anhydrase IX (CA9) expression in multiple renal epithelial tumour subtypes","year":2020,"lang":"en","type":"article","venue":"Histopathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Pathology; Clear cell; Chromophobe cell; Clear cell renal cell carcinoma; Immunostaining; Biomarker; Clear cell carcinoma; Renal cell carcinoma; Biology; Medicine; Carcinoma; Immunohistochemistry; Genetics","score_opus":0.031120700128544232,"score_gpt":0.2458325238750575,"score_spread":0.21471182374651326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041611630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947442,0.0011682835,0.00012635977,0.0013391606,0.00018665307,0.00033844405,0.000012668895,0.000082416474,0.0020018506],"genre_scores_gemma":[0.99699444,0.0000352058,0.0014337489,0.0008334855,0.000264722,0.000044779168,0.000044397653,0.000033909404,0.00031531553],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985261,0.00015297686,0.0003196323,0.0004826072,0.00018117206,0.00033752783],"domain_scores_gemma":[0.99930006,0.00006244275,0.00008847643,0.00027839077,0.000037017147,0.000233637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012063722,0.00020305387,0.0004452586,0.00012711129,0.000046899782,0.00000439813,0.00010180921,0.0001429731,0.00013562405],"category_scores_gemma":[0.00018359805,0.00017371927,0.00010915092,0.0001596121,0.00011178778,0.000040281993,0.000074438016,0.00030442624,0.00021843679],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009025066,0.00016216627,0.0830313,0.000048722413,0.0000022770525,0.007021172,0.0012285997,0.00003790112,0.9064917,0.000019074978,0.00055555126,0.0004990307],"study_design_scores_gemma":[0.006565509,0.0017366984,0.7178875,0.00010092957,0.00010706621,0.0008336645,0.00015018303,0.0012330437,0.26159588,0.000073260075,0.00938103,0.00033524528],"about_ca_topic_score_codex":0.0000980456,"about_ca_topic_score_gemma":0.000059131897,"teacher_disagreement_score":0.64489585,"about_ca_system_score_codex":0.00023843697,"about_ca_system_score_gemma":0.00012369189,"threshold_uncertainty_score":0.7084066},"labels":[],"label_agreement":null},{"id":"W3042095160","doi":"10.1136/jitc-2020-000891","title":"Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial","year":2020,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":225,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Bristol-Myers Squibb; Ono Pharmaceutical; National Cancer Institute; National Institutes of Health; Memorial Sloan-Kettering Cancer Center; University of Texas MD Anderson Cancer Center","keywords":"Nivolumab; Medicine; Sunitinib; Ipilimumab; Renal cell carcinoma; Internal medicine; Randomized controlled trial; Oncology; Clinical trial; Immunotherapy; Cancer","score_opus":0.04926157250532811,"score_gpt":0.3799343260798284,"score_spread":0.3306727535745003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042095160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934313,0.0015211764,0.00027661477,0.00046802286,0.00064600026,0.0035021168,0.00007404187,0.000009257091,0.000071421644],"genre_scores_gemma":[0.99734354,0.0003557891,0.0016870808,0.000085540574,0.000105642575,0.00017736152,0.00002132571,0.00006477988,0.00015894909],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99611056,0.00066435337,0.0015582398,0.00036548128,0.00096114137,0.00034021676],"domain_scores_gemma":[0.99636555,0.0012668543,0.001308708,0.00028445135,0.0005308514,0.00024361577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016934588,0.00036545465,0.0023661265,0.00019898431,0.000077300065,0.000024812622,0.00015719558,0.00012291035,0.00007246981],"category_scores_gemma":[0.00020035704,0.00022954271,0.0005433786,0.00019325891,0.00023883046,0.00015085882,0.000026603602,0.0004844054,1.5971634e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94228494,0.0013887497,0.04677108,0.00008493234,0.0013539308,0.000047212692,0.0008391219,0.00007328096,0.0009991027,0.000004025902,0.00001726354,0.0061363457],"study_design_scores_gemma":[0.8249253,0.051017817,0.120930225,0.00016681099,0.0006823579,0.000003937325,0.00034083895,0.00008956106,0.0014864664,0.0000040079276,0.00015643457,0.00019626338],"about_ca_topic_score_codex":0.00013828058,"about_ca_topic_score_gemma":0.000094676034,"teacher_disagreement_score":0.117359675,"about_ca_system_score_codex":0.00044962286,"about_ca_system_score_gemma":0.0014632066,"threshold_uncertainty_score":0.93604803},"labels":[],"label_agreement":null},{"id":"W3042347895","doi":"10.1002/cncr.33033","title":"Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long‐term follow‐up of the randomized, open‐label, phase 3 CheckMate 025 trial","year":2020,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":337,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Bristol-Myers Squibb","keywords":"Medicine; Nivolumab; Everolimus; Open label; Randomized controlled trial; Renal cell carcinoma; Internal medicine; Oncology; Immunotherapy; Cancer","score_opus":0.036626947874334084,"score_gpt":0.2968996984932093,"score_spread":0.2602727506188752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042347895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99159336,0.00052281824,0.000008849045,0.00041137217,0.00039545924,0.005395916,0.00018760677,0.000022972235,0.0014616683],"genre_scores_gemma":[0.998325,0.000029539813,0.0001457267,0.00019720015,0.00009796747,0.00036717532,0.00023122916,0.000054212313,0.0005519725],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976086,0.00019361438,0.0006414694,0.00058833766,0.0005836302,0.00038435022],"domain_scores_gemma":[0.99832433,0.0000959982,0.0004931639,0.0006024143,0.000255013,0.00022909004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001878095,0.00035897043,0.0011083843,0.00006627686,0.00006456853,0.00002496362,0.00035131106,0.0000915008,0.00010775345],"category_scores_gemma":[0.000082459796,0.00020026915,0.00012084689,0.00047953808,0.0001941967,0.00016109826,0.00014034055,0.00027915067,0.0000074367836],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9870676,0.0008260184,0.008377138,0.000088200104,0.00025704925,0.000089560075,0.00069666153,0.00007324234,0.0006261039,0.0000015113022,0.000514941,0.0013820233],"study_design_scores_gemma":[0.94679695,0.008959764,0.018069787,0.0002151184,0.00081566133,0.0000013652785,0.000034752324,0.00007457851,0.024696017,8.562413e-7,0.000110905865,0.00022421915],"about_ca_topic_score_codex":0.000345294,"about_ca_topic_score_gemma":0.00023184252,"teacher_disagreement_score":0.040270574,"about_ca_system_score_codex":0.00040402886,"about_ca_system_score_gemma":0.000627242,"threshold_uncertainty_score":0.8166739},"labels":[],"label_agreement":null},{"id":"W3042541691","doi":"10.1016/j.eururo.2020.06.053","title":"Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University of British Columbia; Queen Elizabeth II Health Sciences Centre; University of Ottawa; McGill University Health Centre; Queen's University; University of Toronto; Western University; University of Manitoba; Princess Margaret Cancer Centre; Dalhousie University; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Interquartile range; Biopsy; Renal cell carcinoma; Cohort; Clear cell; Histology; Doubling time; Pathology; Radiology; Urology; Internal medicine; Cell","score_opus":0.0377270233563232,"score_gpt":0.22892915566113434,"score_spread":0.19120213230481115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042541691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655065,0.0009120151,0.00021866069,0.010014444,0.00021910883,0.00045688648,0.000011630361,0.00014372566,0.022517012],"genre_scores_gemma":[0.99506664,0.00018753398,0.0007692299,0.0030639335,0.00032016594,0.000016863165,0.0001541189,0.00007132734,0.00035015595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747175,0.0007801486,0.00049182447,0.00067065016,0.0001357921,0.0004498387],"domain_scores_gemma":[0.99905396,0.00012879551,0.00014107625,0.00034261288,0.00007682267,0.00025675938],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040582885,0.00027941077,0.00062855886,0.00014967169,0.000037679576,0.000012754388,0.00018992416,0.000091073336,0.00035967832],"category_scores_gemma":[0.00016567938,0.00024429764,0.000118815464,0.0002642731,0.0001784176,0.000027133045,0.000090513364,0.0004120278,0.0010519009],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026820428,0.00013640383,0.737594,0.000041815158,0.00011784148,0.014046634,0.00034499954,0.0000033727779,0.24206075,0.00017474612,0.0023271958,0.00047019066],"study_design_scores_gemma":[0.0034291467,0.000904953,0.96479684,0.0000070692677,0.000042950258,0.0006110107,0.000011888352,0.000061590625,0.001386144,0.000024027433,0.028524214,0.00020019304],"about_ca_topic_score_codex":0.000014726993,"about_ca_topic_score_gemma":0.0000053204603,"teacher_disagreement_score":0.2406746,"about_ca_system_score_codex":0.000092179806,"about_ca_system_score_gemma":0.000049850238,"threshold_uncertainty_score":0.9997259},"labels":[],"label_agreement":null},{"id":"W3042649051","doi":"10.1016/j.urolonc.2020.06.001","title":"Does renal tumor biopsies for small renal carcinoma increase the risk of upstaging on final surgery pathology report and the risk of recurrence?","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Capital District Health Authority; Alberta Health Services; Juravinski Hospital; Centre hospitalier universitaire de Québec; Ottawa Hospital; University Health Network; St. Joseph’s Healthcare Hamilton; McGill University Health Centre; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Nephrectomy; Odds ratio; Confidence interval; Kidney cancer; Cohort; Pathological; Biopsy; Surgery; Urology; Renal cell carcinoma; Cancer; Kidney; Internal medicine","score_opus":0.04797432769682929,"score_gpt":0.2797521764391201,"score_spread":0.2317778487422908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042649051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843623,0.0014068752,0.00010119224,0.012766819,0.00011570446,0.0007990165,0.00016629088,0.000020465159,0.0002613377],"genre_scores_gemma":[0.98758465,0.00087625586,0.009858247,0.0011636597,0.00017119176,0.00018249163,0.00006024052,0.000013809334,0.00008943207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768525,0.00073504436,0.0006798281,0.000457763,0.00016715178,0.0002749753],"domain_scores_gemma":[0.99380696,0.004581531,0.0009198997,0.00033384186,0.00015362588,0.00020414274],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0017845287,0.0002487129,0.00075075706,0.00011528888,0.00033204842,0.000011683018,0.0001254746,0.00013712532,0.0000147397795],"category_scores_gemma":[0.0035139709,0.000109106506,0.00019826338,0.00023020711,0.0027718795,0.000036602592,0.00008324086,0.00046106268,8.997533e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031245255,0.00014062955,0.9876465,0.000108297485,0.00021475849,0.0009183386,0.0018314439,0.00007352107,0.00067930395,0.0022069449,0.0013852874,0.0016704308],"study_design_scores_gemma":[0.014247287,0.023958828,0.6938522,0.0005465986,0.012313861,0.013780248,0.004888179,0.00948156,0.02836067,0.051555213,0.14602081,0.0009945305],"about_ca_topic_score_codex":0.00032102125,"about_ca_topic_score_gemma":0.00004648115,"teacher_disagreement_score":0.2937943,"about_ca_system_score_codex":0.000040753537,"about_ca_system_score_gemma":0.00044973067,"threshold_uncertainty_score":0.999942},"labels":[],"label_agreement":null},{"id":"W3042986467","doi":"10.5489/cuaj.6483","title":"Peritoneal and port-site metastasis following robotic-assisted radical prostatectomy","year":2020,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Prostatectomy; Urology; Medicine; Port (circuit theory); Metastasis; Laparoscopic radical prostatectomy; Prostate cancer; General surgery; Internal medicine; Engineering; Cancer","score_opus":0.02415870021197803,"score_gpt":0.23575918524268155,"score_spread":0.21160048503070353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042986467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9383234,0.00069904805,0.00008358422,0.0594871,0.00013896287,0.00026952743,0.00001681382,0.000038258982,0.0009433434],"genre_scores_gemma":[0.9910196,0.000035220277,0.0013106778,0.007098681,0.00033446727,0.000008161955,0.0000354668,0.000018041912,0.00013964993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981693,0.0001855957,0.000380274,0.0002823476,0.00046471928,0.00051778584],"domain_scores_gemma":[0.9974826,0.00009350281,0.00018206403,0.00007743647,0.00011684697,0.0020475278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003991278,0.00018395865,0.00045194483,0.000112726295,0.00027588976,0.00012992774,0.000066803645,0.000196743,0.0003173259],"category_scores_gemma":[0.0007026782,0.00014365974,0.0002418746,0.00024234712,0.00003720915,0.000099954515,0.000020247322,0.0006423039,0.000047037673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014543298,0.000052636708,0.98508835,0.000013864131,0.0005091933,0.004087531,0.00035807892,0.000021742131,0.0010355177,0.000052071144,0.003600811,0.0050347433],"study_design_scores_gemma":[0.0022831974,0.0008318027,0.97346663,0.000013411896,0.0005104571,0.0011405454,0.000092469236,0.00040401288,0.00009989986,0.00006125221,0.020919355,0.00017698854],"about_ca_topic_score_codex":0.0003411331,"about_ca_topic_score_gemma":0.00009768834,"teacher_disagreement_score":0.052696273,"about_ca_system_score_codex":0.00088449806,"about_ca_system_score_gemma":0.00046187767,"threshold_uncertainty_score":0.5858274},"labels":[],"label_agreement":null},{"id":"W3045485519","doi":"10.1007/s40477-020-00510-6","title":"Sonography of solitary fibrofolliculoma with histologic correlation","year":2020,"lang":"en","type":"article","venue":"Journal of Ultrasound","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital","funders":"","keywords":"Medicine; Birt–Hogg–Dubé syndrome; Ultrasound; Pathology; Correlation; Radiology; Pneumothorax","score_opus":0.019696162002228797,"score_gpt":0.23294512389138677,"score_spread":0.21324896188915798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045485519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99420226,0.0021105523,0.0009972804,0.0008488774,0.00007914635,0.00012333617,0.000003472578,0.000007865722,0.0016272169],"genre_scores_gemma":[0.99419403,0.00011057755,0.0052655917,0.00021638052,0.00016096159,4.83463e-7,0.0000069932144,0.000008913654,0.000036094036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999041,0.000035572724,0.00039811805,0.00009049931,0.00032431705,0.00011045435],"domain_scores_gemma":[0.99885553,0.00014922155,0.0004349548,0.00009843355,0.00028541294,0.00017642604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009559338,0.00010824244,0.00037790113,0.000101508165,0.000022324732,0.000005067848,0.000061355386,0.00005223039,0.000110959736],"category_scores_gemma":[0.00012666691,0.000067852176,0.00019808201,0.0002133313,0.000074428426,0.0000895448,0.000004345539,0.00018454915,0.000005375494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00275304,0.0002552107,0.95207494,0.00020271921,0.0006411145,0.00058759254,0.0010542528,0.0005751296,0.035194147,0.00005511042,0.005440878,0.0011658448],"study_design_scores_gemma":[0.00323807,0.009752381,0.9696613,0.00019805114,0.0007598377,0.0031766698,0.0005986956,0.000080025195,0.01066176,0.00015527738,0.0015915483,0.00012640258],"about_ca_topic_score_codex":0.000011219456,"about_ca_topic_score_gemma":0.0000013606145,"teacher_disagreement_score":0.024532387,"about_ca_system_score_codex":0.00004958553,"about_ca_system_score_gemma":0.000099209276,"threshold_uncertainty_score":0.27669314},"labels":[],"label_agreement":null},{"id":"W3045597365","doi":"10.5489/cuaj.6477","title":"Comprehensive assessment of the morbidity of renal mass biopsy: A population-based assessment of biopsy-related complications","year":2020,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Government of Ontario; Institute for Clinical Evaluative Sciences","keywords":"Medicine; Odds ratio; Confidence interval; Logistic regression; Emergency department; Population; Retrospective cohort study; Surgery; Cohort; Biopsy; Emergency medicine; Internal medicine","score_opus":0.03984496196889409,"score_gpt":0.2906744178900867,"score_spread":0.2508294559211926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045597365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728073,0.000059156464,0.00090008276,0.02431133,0.00010589985,0.0004356266,0.00020759224,0.000010944538,0.0011620981],"genre_scores_gemma":[0.9959211,0.0000064215947,0.0030854752,0.0008199169,0.000048083246,0.000009027509,0.00008191719,0.000010771919,0.000017335571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976903,0.00036909882,0.00084149017,0.00019268786,0.00065914093,0.00024725558],"domain_scores_gemma":[0.99705446,0.00026873883,0.001232632,0.00021618708,0.0007836931,0.00044429957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032003794,0.00015417121,0.00051179336,0.00013747814,0.00013988359,0.000012908997,0.0001916929,0.0001842068,0.0002738005],"category_scores_gemma":[0.00025687373,0.00010799255,0.0003255362,0.00052186084,0.000080798316,0.000036495247,0.000020622296,0.0004897132,0.0000017310567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001993767,0.00010279832,0.9785983,0.000029350278,0.00024106484,0.00001338597,0.00003056364,0.003679441,0.01638728,0.00058453967,0.00023861749,0.00007472028],"study_design_scores_gemma":[0.0012097972,0.00037438003,0.9872536,0.000038791826,0.00023556956,0.000035685483,0.000033567532,0.009809064,0.00044462713,0.00024840372,0.0002367472,0.00007975073],"about_ca_topic_score_codex":0.0018355469,"about_ca_topic_score_gemma":0.000065624925,"teacher_disagreement_score":0.023491412,"about_ca_system_score_codex":0.0010951621,"about_ca_system_score_gemma":0.0012820052,"threshold_uncertainty_score":0.44038084},"labels":[],"label_agreement":null},{"id":"W3045735244","doi":"10.5489/cuaj.6485","title":"Predictors of long-term renal function after kidney surgery for patients with preoperative chronic kidney disease","year":2020,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Kidney disease; Dialysis; Renal function; Nephrectomy; Cumulative incidence; Kidney cancer; Proportional hazards model; Incidence (geometry); Urology; Body mass index; Surgery; Kidney transplantation; Internal medicine; Stage (stratigraphy); Kidney; Transplantation","score_opus":0.01117092313284607,"score_gpt":0.20068720880738153,"score_spread":0.18951628567453546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045735244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857211,0.00015091473,0.00026592263,0.012456041,0.00022285315,0.0006673841,0.0004319859,0.000017050332,0.00006672469],"genre_scores_gemma":[0.99264735,0.000016669806,0.000039168805,0.0059222374,0.00068432733,0.00006383188,0.0004885259,0.000019697087,0.00011819501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984199,0.00012527972,0.0003818174,0.00024654347,0.00043548836,0.0003910172],"domain_scores_gemma":[0.99584687,0.00012326337,0.00031721054,0.000092294744,0.00052723807,0.003093135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018678163,0.00017991847,0.00035272646,0.000116919226,0.00011972818,0.000037540387,0.000057116526,0.00013223232,0.0006316762],"category_scores_gemma":[0.0014621359,0.00012502946,0.00021711997,0.0001696062,0.000040898918,0.00012982974,0.000009584989,0.00027333674,0.000010779032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023310655,0.00010030129,0.9824971,0.00005048548,0.00037234483,0.0000907955,0.00007100493,0.000018635845,0.000015858392,0.0000030319527,0.014141066,0.00030832872],"study_design_scores_gemma":[0.0022644836,0.0024072218,0.9917936,0.00006950942,0.0005381648,0.0000067354604,0.0000035258677,0.00005712178,0.000037256566,0.000010288823,0.0026933404,0.00011879987],"about_ca_topic_score_codex":0.000037955306,"about_ca_topic_score_gemma":0.000057324058,"teacher_disagreement_score":0.011447725,"about_ca_system_score_codex":0.0014072385,"about_ca_system_score_gemma":0.0026752527,"threshold_uncertainty_score":0.6916411},"labels":[],"label_agreement":null},{"id":"W3046124556","doi":"10.1177/0885328220944871","title":"The feasibility of degradable glass microspheres as transient embolic medical devices","year":2020,"lang":"en","type":"article","venue":"Journal of Biomaterials Applications","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Dalhousie University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Embolization; Microsphere; Medicine; Occlusion; Blood flow; Biomedical engineering; Radiology; Surgery","score_opus":0.04352292778178158,"score_gpt":0.32331083913702857,"score_spread":0.279787911355247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046124556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789522,0.002404799,0.00054520677,0.017092168,0.00007387158,0.0005501754,0.000018734883,0.000012889929,0.00034993252],"genre_scores_gemma":[0.99783987,0.0002741429,0.0011485181,0.00041730417,0.00024080777,0.000031818727,0.000005768695,0.0000131481065,0.000028602532],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982453,0.000082243496,0.0008562575,0.00013932784,0.0005239678,0.00015292817],"domain_scores_gemma":[0.9985449,0.00011587932,0.0004933039,0.00025144825,0.00027089292,0.00032362738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047293078,0.000119997385,0.00042295217,0.000025337247,0.00010062713,0.000032531847,0.0002553507,0.00007858754,0.00020832435],"category_scores_gemma":[0.00011118667,0.000067180204,0.00018955211,0.00020232832,0.00016942502,0.000045465466,0.000029834613,0.000057464087,0.000027750082],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052478124,0.0003198816,0.002641554,0.00016949979,0.00019478796,0.0000235338,0.00021330111,0.0000011398514,0.99087024,0.00027391917,0.0018629814,0.0029044033],"study_design_scores_gemma":[0.0015822743,0.0009405933,0.042526316,0.00009733042,0.00035027837,0.0005174385,0.00033355085,0.000015880269,0.91353446,0.00027895917,0.039731473,0.00009143004],"about_ca_topic_score_codex":0.000047704838,"about_ca_topic_score_gemma":0.000010789893,"teacher_disagreement_score":0.07733574,"about_ca_system_score_codex":0.0000631686,"about_ca_system_score_gemma":0.0003639369,"threshold_uncertainty_score":0.27395293},"labels":[],"label_agreement":null},{"id":"W3047001933","doi":"10.1007/s00262-020-02684-8","title":"Systemic therapy for metastatic renal cell carcinoma in the first-line setting: a systematic review and network meta-analysis","year":2020,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"Medizinische Universität Wien; Universität Wien","keywords":"Axitinib; Nivolumab; Pembrolizumab; Medicine; Ipilimumab; Sunitinib; Internal medicine; Oncology; Avelumab; Adverse effect; Renal cell carcinoma; Tolerability; Discontinuation; Cancer; Immunotherapy","score_opus":0.10894403212116735,"score_gpt":0.35650736083602647,"score_spread":0.24756332871485912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047001933","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029289093,0.9766184,0.000116365394,0.0019045363,0.00012457492,0.020942712,0.00018504966,0.000051781983,0.000027287817],"genre_scores_gemma":[0.000447205,0.9656713,0.00020089275,0.004276118,0.00010713109,0.028535573,0.0003226807,0.00019051066,0.00024856543],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9926937,0.0020434624,0.002847175,0.0011904065,0.00040089176,0.0008243598],"domain_scores_gemma":[0.993872,0.0017219937,0.0020992267,0.0020099292,0.00020505123,0.00009182335],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0019759003,0.00141269,0.017504511,0.0004525963,0.00022177315,0.00007447682,0.0008947132,0.00038934252,0.00017732136],"category_scores_gemma":[0.00007018025,0.0007451598,0.0056220973,0.0019933216,0.00020247955,0.00006422426,0.00007220358,0.00093683903,0.000018557937],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023080819,0.0001716296,0.000011416938,0.6598939,0.32435971,0.00016942364,0.00050185376,0.000012925481,0.000004430605,0.000020152536,0.00045602763,0.014167728],"study_design_scores_gemma":[0.0024603237,0.0010765687,0.000017560906,0.04365322,0.7690897,0.0008441372,0.0000559527,0.000013687107,0.000005457647,0.000018384793,0.18213943,0.0006255819],"about_ca_topic_score_codex":0.00012391826,"about_ca_topic_score_gemma":0.00002887567,"teacher_disagreement_score":0.6162407,"about_ca_system_score_codex":0.0005756579,"about_ca_system_score_gemma":0.0006562835,"threshold_uncertainty_score":0.9998623},"labels":[],"label_agreement":null},{"id":"W3047355051","doi":"10.1158/1557-3125.hippo19-ia25","title":"Abstract IA25: Adult deletion of Lats1/2 leads to sarcomatoid renal cell carcinoma","year":2020,"lang":"en","type":"article","venue":"Molecular Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Hippo signaling pathway; Cancer research; Biology; Epithelial–mesenchymal transition; Cancer; Kidney; Pathology; Renal cell carcinoma; Metastasis; Medicine; Signal transduction; Cell biology; Endocrinology","score_opus":0.06317101739402169,"score_gpt":0.3523797304202445,"score_spread":0.2892087130262228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047355051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826358,0.001974358,0.0002290429,0.0070438245,0.000033874927,0.00094908214,0.00002913039,0.00003447099,0.007070402],"genre_scores_gemma":[0.99770856,0.00007374655,0.00068848935,0.0008774771,0.0001379911,0.00016009054,0.00003377885,0.000062616855,0.00025726837],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968825,0.00013953635,0.00037442907,0.0005520557,0.001448316,0.0006031418],"domain_scores_gemma":[0.9980005,0.00005216589,0.00006508328,0.0005004811,0.0007470968,0.0006346778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030969383,0.00020970905,0.00039512131,0.000248821,0.00007282123,0.000024368786,0.00024717208,0.000114950846,0.0004169998],"category_scores_gemma":[0.00013235277,0.000189323,0.00018578317,0.0007947237,0.00011143004,0.000043955955,0.0001602501,0.00052113464,0.000233657],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094598177,0.00015337595,0.013003342,0.00049809663,0.000041363546,0.0010837963,0.00048726544,0.00013324451,0.9772042,0.00007016994,0.0036686081,0.0027105755],"study_design_scores_gemma":[0.0014614325,0.0012508064,0.05425296,0.00011570736,0.000040141884,0.000014541525,0.00008760307,0.00009480138,0.9408338,0.000017434997,0.0016843483,0.0001464208],"about_ca_topic_score_codex":0.0013309414,"about_ca_topic_score_gemma":0.000039346265,"teacher_disagreement_score":0.041249618,"about_ca_system_score_codex":0.00036734334,"about_ca_system_score_gemma":0.0004765664,"threshold_uncertainty_score":0.77203673},"labels":[],"label_agreement":null},{"id":"W3048080988","doi":"10.1016/j.urolonc.2020.07.021","title":"Outcomes of complete metastasectomy in metastatic renal cell carcinoma patients: The Canadian Kidney Cancer information system experience","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; McMaster University; Centre hospitalier universitaire de Québec; Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto; University of Alberta; Queen Elizabeth II Health Sciences Centre; University of Calgary; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"Faculty of Medicine, McGill University","keywords":"Metastasectomy; Medicine; Hazard ratio; Renal cell carcinoma; Proportional hazards model; Cohort; Metastasis; Confidence interval; Kidney cancer; Internal medicine; Oncology; Surgery; Cancer; Urology","score_opus":0.04598665495310941,"score_gpt":0.2851413074170707,"score_spread":0.2391546524639613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048080988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871393,0.00027150338,0.000020104593,0.009753142,0.000079140176,0.00069580926,0.0002187076,0.000016523903,0.0018057651],"genre_scores_gemma":[0.9873543,0.00001699714,0.004936192,0.0073063094,0.000017413275,0.00019853558,0.0001446533,0.0000067103365,0.00001891483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986931,0.00016419467,0.00046752486,0.0002021067,0.00020776267,0.00026528627],"domain_scores_gemma":[0.9988291,0.00013675235,0.00023305466,0.00016380353,0.00011652088,0.0005207567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017251894,0.00018017406,0.00043409795,0.00016624272,0.00017377426,0.000017140714,0.000120883524,0.000079645135,0.000055406334],"category_scores_gemma":[0.00017557874,0.000116545096,0.000058756086,0.00036306473,0.00041327399,0.00015627444,0.00003520555,0.00023915542,0.000011137808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065796194,0.00004574235,0.99308145,0.000115956886,0.000039751787,0.000059520993,0.00392654,0.00011747464,0.000112486545,0.001107197,0.0011618187,0.00016627493],"study_design_scores_gemma":[0.0041735,0.003028075,0.6583086,0.000075144846,0.00076270505,0.00008127841,0.0034775336,0.0038091387,0.0019676138,0.000099852194,0.32393128,0.00028524108],"about_ca_topic_score_codex":0.03046357,"about_ca_topic_score_gemma":0.006597752,"teacher_disagreement_score":0.3347728,"about_ca_system_score_codex":0.00040616744,"about_ca_system_score_gemma":0.0010316883,"threshold_uncertainty_score":0.9759927},"labels":[],"label_agreement":null},{"id":"W3048875481","doi":"10.1097/spc.0000000000000519","title":"Second-line tyrosine kinase inhibitor-therapy after immunotherapy-failure","year":2020,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Pazopanib; Axitinib; Cabozantinib; Immunotherapy; Oncology; Internal medicine; Tyrosine-kinase inhibitor; Sunitinib; Renal cell carcinoma; Pharmacology; Cancer","score_opus":0.11142920778040186,"score_gpt":0.39300833871519053,"score_spread":0.2815791309347887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048875481","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00091697974,0.99339944,0.000012959761,0.0001102823,0.0014381385,0.0029154462,0.0010715155,0.000047044723,0.000088207606],"genre_scores_gemma":[0.0015957531,0.9914366,0.00008158393,0.0000827891,0.0011459118,0.0010153028,0.004421371,0.00012712422,0.00009353648],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99664015,0.00027696896,0.0011148483,0.0010787629,0.00041379617,0.00047547382],"domain_scores_gemma":[0.99820703,0.00013579195,0.0005296598,0.00044717203,0.00033274048,0.00034763126],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010350882,0.0010177112,0.0026345872,0.00035370004,0.0000613167,0.000050970186,0.00014304576,0.0003874482,0.0009795858],"category_scores_gemma":[0.000039027407,0.0007584398,0.00074809993,0.0005445135,0.0001646716,0.00009885959,0.000111243855,0.0010411858,0.00008618944],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005246391,0.0002908135,0.0058764894,0.039615393,0.00041536457,0.00019386309,0.0027427252,4.8876693e-8,0.000004772355,0.000028629876,0.0018353816,0.9484719],"study_design_scores_gemma":[0.0027030853,0.0012061845,0.0032545775,0.029981896,0.00022205664,0.000020201185,0.00028869312,7.243787e-7,0.000054407712,0.000010912479,0.9616368,0.00062047376],"about_ca_topic_score_codex":0.000003872529,"about_ca_topic_score_gemma":0.000005539364,"teacher_disagreement_score":0.95980144,"about_ca_system_score_codex":0.0005638239,"about_ca_system_score_gemma":0.00061345357,"threshold_uncertainty_score":0.99993366},"labels":[],"label_agreement":null},{"id":"W3071117894","doi":"10.1007/s00261-020-02644-x","title":"Lexicon for renal mass terms at CT and MRI: a consensus of the society of abdominal radiology disease-focused panel on renal cell carcinoma","year":2020,"lang":"en","type":"article","venue":"Abdominal Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute","keywords":"Medicine; Voting; Renal cell carcinoma; Radiology; Lexicon; Delphi method; Medical physics; Internal medicine; Artificial intelligence; Computer science; Law","score_opus":0.040382069810099404,"score_gpt":0.24848234513100717,"score_spread":0.20810027532090777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3071117894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98992115,0.0014904841,0.00022654401,0.0061560986,0.00014377135,0.0013243805,0.00018530597,0.000019287947,0.000532999],"genre_scores_gemma":[0.9939757,0.000076360775,0.004083958,0.0011025228,0.00028069605,0.00008542833,0.000049067305,0.00004691143,0.00029934887],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974094,0.0003300027,0.00074285606,0.00071741716,0.00026056566,0.0005397327],"domain_scores_gemma":[0.997421,0.0010057674,0.00050478487,0.0005547065,0.000107616645,0.00040610507],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003008954,0.00041793674,0.0011860715,0.00006998608,0.00012895394,0.00000423105,0.00024669326,0.00016175174,0.00006306609],"category_scores_gemma":[0.00016531708,0.00028119166,0.0007958688,0.0001435831,0.0012218994,0.000018767947,0.00012217354,0.000309525,0.0000059338195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036738116,0.00030778095,0.11139975,0.0010969912,0.0006358195,0.00067609164,0.0010858924,0.00013109829,0.8348265,0.00041188655,0.010905958,0.0017840997],"study_design_scores_gemma":[0.02728835,0.014257157,0.3903457,0.0001967046,0.002695589,0.0038940476,0.00044673093,0.0060383095,0.5515615,0.000707965,0.0019294933,0.0006385252],"about_ca_topic_score_codex":0.000040743947,"about_ca_topic_score_gemma":0.000003744909,"teacher_disagreement_score":0.28326505,"about_ca_system_score_codex":0.00019908044,"about_ca_system_score_gemma":0.00031487196,"threshold_uncertainty_score":0.999964},"labels":[],"label_agreement":null},{"id":"W3080223541","doi":"10.1002/jso.26149","title":"Assessment of other‐cause mortality in localized renal cell carcinoma patients within 15 years: A population‐based analysis","year":2020,"lang":"en","type":"article","venue":"Journal of Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Epidemiology; Cohort; Population; Demography; Internal medicine; Proportional hazards model; Carcinoma; Cancer; Surgery; Kidney","score_opus":0.051375874702769546,"score_gpt":0.3483511515045342,"score_spread":0.29697527680176466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080223541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99791807,0.000096928605,0.00019178788,0.0005590407,0.00007187604,0.00023962717,0.000013878028,0.000005659002,0.00090311555],"genre_scores_gemma":[0.9961811,0.000011767825,0.003321645,0.00032402965,0.0000962867,0.000004213171,0.000031644846,0.000015178162,0.000014157549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970448,0.00044991612,0.0013897558,0.00022144402,0.00069089606,0.00020317863],"domain_scores_gemma":[0.99791914,0.00022889451,0.0010492901,0.0001914584,0.0002598626,0.00035136176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006013807,0.00016849561,0.0012876333,0.00039665517,0.000013737723,0.000006602275,0.0001235857,0.000169741,0.00040389886],"category_scores_gemma":[0.0000525013,0.00012749102,0.00051017484,0.0008417085,0.000063431246,0.000063317675,0.00003588382,0.0004071183,0.000002993823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013486079,0.0016068431,0.98849595,0.000057442936,0.0005867715,0.0025060393,0.00017661211,0.004309576,0.00052479305,0.000018563607,0.000049137194,0.00031964548],"study_design_scores_gemma":[0.010968353,0.0041150283,0.97722435,0.000031619606,0.0019665062,0.000026621216,0.000042102398,0.003776733,0.00082430174,0.000014469656,0.00091234676,0.000097561075],"about_ca_topic_score_codex":0.0002935792,"about_ca_topic_score_gemma":0.000063934196,"teacher_disagreement_score":0.01127161,"about_ca_system_score_codex":0.00059814437,"about_ca_system_score_gemma":0.0005112301,"threshold_uncertainty_score":0.5198933},"labels":[],"label_agreement":null},{"id":"W3082708938","doi":"10.2217/fon-2020-0586","title":"Avelumab and Axitinib Combination Therapy for the Treatment of Advanced Renal Cell Carcinoma","year":2020,"lang":"en","type":"review","venue":"Future Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Pfizer","keywords":"Nivolumab; Axitinib; Avelumab; Medicine; Ipilimumab; Renal cell carcinoma; Oncology; Internal medicine; Immunotherapy; Combination therapy; Cabozantinib; Tyrosine-kinase inhibitor; Targeted therapy; Sunitinib; Cancer","score_opus":0.04777237359308242,"score_gpt":0.34571873806411063,"score_spread":0.2979463644710282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082708938","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00103666,0.9907619,0.000011374704,0.0010271049,0.0004817741,0.00517405,0.00011008786,0.000021274218,0.0013757912],"genre_scores_gemma":[0.0011077109,0.9946151,0.00067574054,0.000098123935,0.00097396097,0.0012351193,0.00052485126,0.00006468182,0.0007047179],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984397,0.00016711261,0.00053470774,0.00045836344,0.00015967769,0.00024040948],"domain_scores_gemma":[0.99816877,0.0007027911,0.0005112401,0.00038349043,0.00010980166,0.00012391506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009368095,0.00045051545,0.0021573056,0.00009607081,0.00008248715,0.000006910435,0.000115125156,0.00041103314,0.000044790177],"category_scores_gemma":[0.00001275342,0.00023793343,0.0005898584,0.0001482885,0.00010652976,0.000016707627,0.000020787165,0.00018970034,0.0000074948907],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057104515,0.00067785365,0.000007276368,0.0027770507,0.00033824646,0.000086025015,0.00043959447,7.265332e-8,0.000022176357,0.00023698414,0.000626862,0.9942168],"study_design_scores_gemma":[0.0072746966,0.02285585,0.000279578,0.00030164715,0.002332824,0.0001990838,0.00012406411,0.000004644305,0.00022815306,0.000017146895,0.96622634,0.00015597363],"about_ca_topic_score_codex":0.000011093517,"about_ca_topic_score_gemma":0.0000075867815,"teacher_disagreement_score":0.9940608,"about_ca_system_score_codex":0.000615343,"about_ca_system_score_gemma":0.0006745474,"threshold_uncertainty_score":0.9702644},"labels":[],"label_agreement":null},{"id":"W3083646126","doi":"10.1158/1538-7445.am2020-2162","title":"Abstract 2162: KIM–1 mediatesimmune evasioninrenal cell carcinoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Immune system; Cancer research; Tumor microenvironment; CD8; Immunotherapy; T cell; Biology; Cytotoxic T cell; Immunology; In vitro","score_opus":0.1489772875883832,"score_gpt":0.3872222499104864,"score_spread":0.23824496232210324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083646126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9622277,0.009423141,0.0000036788272,0.010219026,0.00012374103,0.0007407841,0.000026345097,0.000069357375,0.017166229],"genre_scores_gemma":[0.9961744,0.00053040107,0.00011568078,0.00049302547,0.00083624496,0.00019925526,0.000052621504,0.000064921354,0.0015334731],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967698,0.00011752122,0.0003329988,0.0005908919,0.001399214,0.0007895632],"domain_scores_gemma":[0.997957,0.00020910785,0.00005763515,0.00049817195,0.00042699047,0.00085110153],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00048058722,0.00022768826,0.00039191576,0.00017268871,0.00018016557,0.00004939232,0.00029795978,0.00013268518,0.0035617105],"category_scores_gemma":[0.0001667245,0.00018128101,0.00016201772,0.0006510279,0.00020613805,0.0000839378,0.00018617389,0.0009503737,0.0012686746],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016926134,0.00034073874,0.044336203,0.0009695606,0.00009707029,0.0022572624,0.0014793557,0.000030317065,0.89078194,0.000045660472,0.050301082,0.007668208],"study_design_scores_gemma":[0.0031161602,0.0010085588,0.2647296,0.00010594088,0.00006194376,0.000021648577,0.00035882564,0.00006537297,0.7125393,0.000030591167,0.017745225,0.00021681638],"about_ca_topic_score_codex":0.0007302065,"about_ca_topic_score_gemma":0.000016284634,"teacher_disagreement_score":0.2203934,"about_ca_system_score_codex":0.00051654584,"about_ca_system_score_gemma":0.0009560729,"threshold_uncertainty_score":0.999509},"labels":[],"label_agreement":null},{"id":"W3084500257","doi":"10.1002/cncr.33173","title":"A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study","year":2020,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Stage (stratigraphy); Lymph node; Prospective cohort study; Kidney cancer; Internal medicine; Surgery; Kidney","score_opus":0.030019530248195543,"score_gpt":0.2839904599761242,"score_spread":0.2539709297279287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3084500257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905431,0.004954415,0.0000041208814,0.0005065617,0.000103194085,0.0035501944,0.000028553595,0.000025534386,0.00028429905],"genre_scores_gemma":[0.99831814,0.00006484107,0.00003374369,0.00025534545,0.0009088851,0.00032518187,0.0000145434,0.000027681992,0.000051666142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827355,0.00013694703,0.00041159923,0.0006042375,0.00037418003,0.00019950987],"domain_scores_gemma":[0.99894625,0.00007292745,0.00027264413,0.00040359484,0.00011863798,0.0001859503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012434537,0.00022121028,0.0005342985,0.000039237697,0.00007022722,0.000010165479,0.000111108646,0.00005623094,0.0000570035],"category_scores_gemma":[0.000042177293,0.00014039155,0.00007501405,0.00027080174,0.00005720955,0.000029432196,0.00014220434,0.00030196685,0.0000036869428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008047986,0.0030341472,0.98203075,0.00003092176,0.0002204941,0.0011658568,0.00982825,0.0000042117267,0.00037367767,3.8453825e-7,0.0019750313,0.0005314603],"study_design_scores_gemma":[0.007636611,0.007001575,0.97820145,0.000011245419,0.0016295798,0.0000395783,0.004674582,0.000008183579,0.0006120415,0.0000041632575,0.00006340058,0.000117596144],"about_ca_topic_score_codex":0.0015197799,"about_ca_topic_score_gemma":0.0002766747,"teacher_disagreement_score":0.0077749845,"about_ca_system_score_codex":0.00027448343,"about_ca_system_score_gemma":0.00024246667,"threshold_uncertainty_score":0.57250017},"labels":[],"label_agreement":null},{"id":"W3085828932","doi":"10.1007/s00428-020-02927-0","title":"Characterization of a distinct low-grade oncocytic renal tumor (CD117-negative and cytokeratin 7-positive) based on a tertiary oncology center experience: the new evidence from China","year":2020,"lang":"en","type":"article","venue":"Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University; Queen Elizabeth II Health Sciences Centre; McMaster University","funders":"","keywords":"Cytokeratin; CD117; Pathology; Paraganglioma; Immunohistochemistry; Vimentin; Stroma; Medicine; Biology","score_opus":0.03944881138450939,"score_gpt":0.3413779303225387,"score_spread":0.3019291189380293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3085828932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98193175,0.0005466654,0.0025594977,0.012350282,0.00014391594,0.001521848,0.00019263157,0.00010609649,0.00064732734],"genre_scores_gemma":[0.9897887,0.0002865854,0.0025848649,0.0061503397,0.00051284285,0.00011719307,0.00047279993,0.00005138019,0.000035303456],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99537086,0.0012391799,0.0009814544,0.0011744254,0.0006199659,0.0006141125],"domain_scores_gemma":[0.9951139,0.0027850093,0.0006709296,0.000784503,0.000097835225,0.00054778537],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000462261,0.0006616128,0.0012192474,0.00014628665,0.00023422655,0.000035745852,0.00050615065,0.0002115666,0.000110600304],"category_scores_gemma":[0.0020970914,0.00039446988,0.0002672208,0.00040500105,0.0014947315,0.00017352181,0.000324557,0.0010684008,0.00002673864],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068102307,0.00083949446,0.027491529,0.00015786575,0.00034014977,0.0010300287,0.01238381,0.000085799045,0.942829,0.0000770631,0.00032234885,0.007632644],"study_design_scores_gemma":[0.00505032,0.0060796225,0.6976629,0.0011292706,0.00056071696,0.00003100982,0.0006171522,0.009070353,0.27888313,0.00031432102,0.00020309849,0.00039810158],"about_ca_topic_score_codex":0.00038121015,"about_ca_topic_score_gemma":0.000019432446,"teacher_disagreement_score":0.6701714,"about_ca_system_score_codex":0.00015461314,"about_ca_system_score_gemma":0.00073723117,"threshold_uncertainty_score":0.9998507},"labels":[],"label_agreement":null},{"id":"W3086493976","doi":"10.1007/s00330-020-07233-6","title":"Effect of phase of enhancement on texture analysis in renal masses evaluated with non-contrast-enhanced, corticomedullary, and nephrographic phase–enhanced CT images","year":2020,"lang":"en","type":"article","venue":"European Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Chromophobe cell; Renal cell carcinoma; Neuroradiology; Nuclear medicine; Radiology; Intraclass correlation; Renal tumor; Kidney; Clear cell; Pathology; Nephrectomy; Internal medicine","score_opus":0.013979210443779944,"score_gpt":0.29664499011274853,"score_spread":0.2826657796689686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3086493976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934957,0.0009813426,0.0025944614,0.00019199759,0.000025714824,0.00094864744,0.000023105815,0.000024484541,0.001714546],"genre_scores_gemma":[0.9989561,0.0002553795,0.00033170925,0.0001805379,0.000052507472,0.000028511431,0.00013373072,0.00003576736,0.000025743515],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973522,0.0008596624,0.00062303303,0.00057137007,0.00027491164,0.0003188231],"domain_scores_gemma":[0.99870193,0.0002790322,0.00035951537,0.0003715732,0.000091963644,0.00019601204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049859734,0.00034056033,0.0012855944,0.00039436988,0.000026949407,0.000006307191,0.0001237895,0.000039759103,0.00011426264],"category_scores_gemma":[0.000115516574,0.00023156061,0.00018272885,0.0009435129,0.00032784,0.00003709972,0.000038616472,0.0002459845,0.0000066980137],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013364196,0.00083214795,0.013665869,0.0002821538,0.0020752426,0.0010949934,0.00038279043,0.00023711208,0.9492012,0.0000027495262,0.00008375345,0.018777791],"study_design_scores_gemma":[0.028609809,0.050477203,0.06760224,0.0001862626,0.0029150916,0.00008263995,0.000045274595,0.0009973439,0.8488299,0.0000010792538,0.00005089248,0.00020226042],"about_ca_topic_score_codex":0.000015061818,"about_ca_topic_score_gemma":0.0000051064176,"teacher_disagreement_score":0.10037129,"about_ca_system_score_codex":0.00004298294,"about_ca_system_score_gemma":0.00004705562,"threshold_uncertainty_score":0.94427675},"labels":[],"label_agreement":null},{"id":"W3087058492","doi":"10.1097/ppo.0000000000000468","title":"Prognostic and Predictive Factors in Metastatic Renal Cell Carcinoma","year":2020,"lang":"en","type":"review","venue":"The Cancer Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Renal cell carcinoma; Medicine; Clinical trial; Oncology; Internal medicine; Disease","score_opus":0.07431645940845767,"score_gpt":0.32979603171685423,"score_spread":0.2554795723083966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087058492","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0105047375,0.9873692,0.000016765987,0.000193332,0.00017645452,0.0013608244,0.00008179307,0.000010429085,0.0002865049],"genre_scores_gemma":[0.027285054,0.97179455,0.000056169334,0.00005030769,0.00043322588,0.00013115,0.0000322502,0.000068328656,0.0001489653],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978168,0.00037980167,0.0006598923,0.0003605128,0.00042002433,0.00036296388],"domain_scores_gemma":[0.9985334,0.000303739,0.0004834735,0.00024991084,0.0000680595,0.00036139265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028412952,0.0004809196,0.0017081161,0.00019646467,0.0001028641,0.00005856919,0.00022446824,0.000098630786,0.0001347264],"category_scores_gemma":[0.00008104634,0.00023949117,0.00038266834,0.00032961706,0.00011133183,0.0000559307,0.00008992554,0.0014721592,0.000010772701],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041893873,0.000299025,0.020659875,0.02707483,0.0020660036,0.008517741,0.0038519548,0.000020630032,0.000016854789,0.000008599394,0.002590084,0.9344755],"study_design_scores_gemma":[0.0040509766,0.0030337372,0.030490372,0.028737944,0.032599997,0.009754999,0.00068358466,0.00008632079,0.0001245255,0.00017675204,0.8893389,0.0009218863],"about_ca_topic_score_codex":0.000050567905,"about_ca_topic_score_gemma":0.0000102549775,"teacher_disagreement_score":0.9335536,"about_ca_system_score_codex":0.0008356922,"about_ca_system_score_gemma":0.0013286865,"threshold_uncertainty_score":0.9766167},"labels":[],"label_agreement":null},{"id":"W3087397625","doi":"10.1016/j.urolonc.2020.08.013","title":"Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); Université de Montréal","funders":"","keywords":"Medicine; Hazard ratio; Renal cell carcinoma; Confidence interval; Proportional hazards model; Internal medicine; Nephrectomy; Urology; Concordance; Gastroenterology; Population; Carcinoma; Oncology; Surgery; Kidney","score_opus":0.0250208082716316,"score_gpt":0.2748793186329744,"score_spread":0.24985851036134277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087397625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99243534,0.00008014185,0.0001080575,0.0048771836,0.000014330068,0.001575381,0.00011496713,0.000025830388,0.0007687831],"genre_scores_gemma":[0.9460021,0.000013506626,0.05222943,0.00092175195,0.000027565387,0.000366613,0.0001359279,0.000015328236,0.00028774526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984914,0.0002509556,0.00035144252,0.0003980055,0.0001977478,0.000310442],"domain_scores_gemma":[0.99860865,0.00050799747,0.00030660548,0.00010065318,0.00022971323,0.00024638834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019049262,0.0002432611,0.0006947285,0.00010590506,0.00010288517,0.0000126009645,0.000060821356,0.0001605552,0.000025798285],"category_scores_gemma":[0.00022221018,0.00015915181,0.00005709919,0.00030743377,0.0003021914,0.00011167465,0.000020716132,0.0002490999,0.0000015576302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016306269,0.00069493253,0.99458027,0.000055686967,0.00017904557,0.00010819362,0.0013964466,0.00024472544,0.00045698864,0.00015907061,0.00040023535,0.000093752766],"study_design_scores_gemma":[0.010039451,0.046529233,0.9266543,0.000037146256,0.0012003375,0.000040132563,0.00055952667,0.0007200108,0.0102059515,0.00015360795,0.0036479787,0.00021235153],"about_ca_topic_score_codex":0.00008425701,"about_ca_topic_score_gemma":0.000093764735,"teacher_disagreement_score":0.06792603,"about_ca_system_score_codex":0.0005585205,"about_ca_system_score_gemma":0.00057147356,"threshold_uncertainty_score":0.64900225},"labels":[],"label_agreement":null},{"id":"W3089134390","doi":"10.1016/j.annonc.2020.08.798","title":"726P Collecting duct and renal medullary carcinoma: A population based analysis","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Surveillance, Epidemiology, and End Results; Epidemiology; Internal medicine; Lymph node; Proportional hazards model; Retrospective cohort study; Hazard ratio; Oncology; Population; Kidney disease; Cancer registry","score_opus":0.127607485889329,"score_gpt":0.3670435447146164,"score_spread":0.23943605882528743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089134390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832625,0.0007752132,0.00010828816,0.013674656,0.00002498844,0.00023809279,0.000006907143,0.00003623271,0.0018731463],"genre_scores_gemma":[0.9953035,0.00003145066,0.0020818524,0.0023438665,0.00009765632,0.000011323521,0.0000717743,0.000016641721,0.00004192054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885404,0.00013339259,0.00034759386,0.00028398752,0.00018964156,0.00019135648],"domain_scores_gemma":[0.99910086,0.00018395655,0.0001888398,0.00015649815,0.00015865338,0.00021117568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021471348,0.00012758559,0.00062189705,0.00023455461,0.000043220418,0.0000050335634,0.00004388253,0.00011129985,0.00007445443],"category_scores_gemma":[0.00021728166,0.000111267684,0.00018455472,0.00072440394,0.00004737519,0.000035154088,0.000033172833,0.00011725518,0.0000025381817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013294447,0.00027317824,0.97018456,0.00015966158,0.0010613018,0.00048907084,0.0006434753,0.00029187225,0.011690667,0.00004546819,0.0020808496,0.011750435],"study_design_scores_gemma":[0.0019601723,0.0047062533,0.9657119,0.00001614335,0.0015377947,0.000046330228,0.00012543514,0.004466199,0.018898444,0.000040131188,0.0023730344,0.00011816848],"about_ca_topic_score_codex":0.00044292602,"about_ca_topic_score_gemma":0.00007174981,"teacher_disagreement_score":0.012041039,"about_ca_system_score_codex":0.00005571891,"about_ca_system_score_gemma":0.00018855413,"threshold_uncertainty_score":0.45373645},"labels":[],"label_agreement":null},{"id":"W3089242719","doi":"10.1016/j.annonc.2020.08.783","title":"711P Nivolumab + ipilimumab (N+I) vs sunitinib (S) for first-line treatment of advanced renal cell carcinoma (aRCC) in CheckMate 214: 4-year follow-up and subgroup analysis of patients (pts) without nephrectomy","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Renal cell carcinoma; Nivolumab; Intention-to-treat analysis; Sunitinib; Nephrectomy; Post-hoc analysis; Subgroup analysis; Ipilimumab; Urology; Gastroenterology; Surgery; Adverse effect; Confidence interval; Kidney; Cancer; Immunotherapy","score_opus":0.06660639058166329,"score_gpt":0.3292410095913792,"score_spread":0.2626346190097159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089242719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959362,0.0006767696,0.00003170798,0.00080836617,0.00005825882,0.0013873925,0.00033307038,0.000015222716,0.0007530062],"genre_scores_gemma":[0.99720013,0.0005323855,0.001291016,0.0001804852,0.000044174485,0.00012520619,0.0004749268,0.000039699535,0.00011194895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975476,0.00013606566,0.001053818,0.000537349,0.0003003604,0.00042480108],"domain_scores_gemma":[0.99781215,0.00034380116,0.0006882883,0.00039714412,0.0005153573,0.00024324091],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019861679,0.00034452212,0.002019109,0.0005043068,0.000036368478,0.000003582594,0.00013157022,0.00019893597,0.00007387314],"category_scores_gemma":[0.00012643714,0.00029716635,0.00049495074,0.0007245074,0.00018787202,0.00007845516,0.000065986926,0.000100972204,0.0000021379133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045300573,0.005251898,0.8910171,0.0010628919,0.0022689695,0.00008811716,0.0058036866,0.00037924983,0.01155823,0.00004597524,0.00027105628,0.036952283],"study_design_scores_gemma":[0.058348548,0.07594237,0.6797788,0.000089871035,0.0036337913,0.0000041214316,0.0007606949,0.0016209518,0.17583321,0.000049211336,0.0035988467,0.000339568],"about_ca_topic_score_codex":0.0003655933,"about_ca_topic_score_gemma":0.00074005645,"teacher_disagreement_score":0.21123825,"about_ca_system_score_codex":0.00016180151,"about_ca_system_score_gemma":0.00022149358,"threshold_uncertainty_score":0.999948},"labels":[],"label_agreement":null},{"id":"W3089255874","doi":"10.1016/j.annonc.2020.08.790","title":"718P A phase II study of patients with advanced or metastatic renal cell carcinoma (mRCC) receiving pazopanib after previous checkpoint inhibitor treatment","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"NIH Clinical Center; Universitätsklinikum Essen; Queen Mary University of London; Novartis Pharmaceuticals Corporation; Massachusetts General Hospital","keywords":"Medicine; Pazopanib; Clinical endpoint; Internal medicine; Renal cell carcinoma; Oncology; Progression-free survival; Phases of clinical research; Tyrosine-kinase inhibitor; Toxicity; Chemotherapy; Urology; Surgery; Sunitinib; Clinical trial; Cancer","score_opus":0.07611631056768055,"score_gpt":0.34847571067251193,"score_spread":0.2723594001048314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089255874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950506,0.0007096507,0.000009539688,0.0006397286,0.000053113676,0.002976165,0.00006728079,0.000025910727,0.00046799175],"genre_scores_gemma":[0.9975487,0.00007629489,0.0012995332,0.0003833902,0.00006584867,0.00036678952,0.000051573727,0.000050274026,0.00015759298],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9974525,0.0002546476,0.00089573034,0.0005582801,0.00043869537,0.0004001754],"domain_scores_gemma":[0.99803895,0.00016099855,0.00059287413,0.0004400528,0.00042053056,0.00034660732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001523805,0.00038985402,0.0013304118,0.00014204148,0.0000520113,0.0000045368242,0.000114296585,0.00008314284,0.00023256526],"category_scores_gemma":[0.00010023443,0.00024474057,0.00019074211,0.00031757852,0.00010345192,0.000094460265,0.00010498927,0.00016063688,0.0000086426735],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23139656,0.17256013,0.215674,0.0019906524,0.0033791177,0.0069795414,0.060809135,0.00013659538,0.033113822,0.0000028558138,0.0010881994,0.27286938],"study_design_scores_gemma":[0.05648452,0.67002535,0.11808844,0.00017067126,0.0016468622,0.00002671034,0.0019254849,0.00003697268,0.14949314,0.0000041476937,0.0017889031,0.00030878352],"about_ca_topic_score_codex":0.00008156146,"about_ca_topic_score_gemma":0.00008173933,"teacher_disagreement_score":0.49746522,"about_ca_system_score_codex":0.00018673617,"about_ca_system_score_gemma":0.00043029193,"threshold_uncertainty_score":0.99802303},"labels":[],"label_agreement":null},{"id":"W3089685711","doi":"10.5489/cuaj.6736","title":"Radical nephrectomy with resection of vena cava thrombus using extracorporeal circulation and deep hypothermic circulatory arrest","year":2020,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Thrombus; Surgery; Extracorporeal circulation; Deep hypothermic circulatory arrest; Perioperative; Inferior vena cava; Extracorporeal; Kidney; Cardiology; Internal medicine; Perfusion","score_opus":0.030285956212400433,"score_gpt":0.22550972071307693,"score_spread":0.1952237645006765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089685711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957424,0.00048686872,0.00023559867,0.0028277254,0.00008441985,0.00021937693,0.0000061236306,0.000015756366,0.00038175803],"genre_scores_gemma":[0.99812317,0.00003109188,0.0005671072,0.00086354284,0.00037861615,0.0000019634033,0.000011533976,0.000017421,0.0000055504815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986471,0.0001358554,0.00032455105,0.00021302234,0.00038811076,0.00029134387],"domain_scores_gemma":[0.9985748,0.00007510313,0.0003329231,0.000075905766,0.00016247325,0.0007788092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027401582,0.00013781877,0.00030875008,0.00012580724,0.00016042669,0.000034578927,0.000047368958,0.00020287023,0.00012118519],"category_scores_gemma":[0.00020650947,0.00010897031,0.000081588885,0.00022754588,0.00007431096,0.0000948162,0.0000068850472,0.00044034602,0.0000038975395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002292009,0.000031951757,0.9878921,0.000017825754,0.00016683238,0.00025691674,0.00025665993,0.0006351142,0.009367362,0.00003377864,0.000081135026,0.0010311342],"study_design_scores_gemma":[0.0015212323,0.00075353036,0.99154174,0.00002383377,0.00021749828,0.0008512963,0.00006218958,0.0038841343,0.00018683127,0.00014999213,0.0006964244,0.00011129702],"about_ca_topic_score_codex":0.0008673122,"about_ca_topic_score_gemma":0.00042922847,"teacher_disagreement_score":0.009180531,"about_ca_system_score_codex":0.0010681076,"about_ca_system_score_gemma":0.00050422037,"threshold_uncertainty_score":0.44436803},"labels":[],"label_agreement":null},{"id":"W3090166067","doi":"10.5489/cuaj.6833","title":"Prognostic impact of paraneoplastic syndromes on patients with non-metastatic renal cell carcinoma undergoing surgery: Results from Canadian Kidney Cancer information system","year":2020,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University of British Columbia; Dalhousie University; University of Toronto; University of Calgary; McGill University; Université de Montréal; University of Alberta; Université Laval; University of Ottawa; University of Manitoba","funders":"","keywords":"Medicine; Renal cell carcinoma; Hazard ratio; Nephrectomy; Kidney cancer; Cancer; Internal medicine; Cohort; Oncology; Proportional hazards model; Confidence interval; Pathological; Gastroenterology; Carcinoma; Kidney; Surgery","score_opus":0.014959384034880304,"score_gpt":0.20564416476960415,"score_spread":0.19068478073472384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090166067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99358636,0.000036543315,0.000022225764,0.003152646,0.00015085102,0.0005216653,0.0018602009,0.00001712024,0.00065236836],"genre_scores_gemma":[0.9977469,0.000007711636,0.000073277675,0.001291554,0.00012315705,0.000016567468,0.00070729014,0.000020078869,0.00001345619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751943,0.00019193652,0.00074395654,0.0002446244,0.00065840775,0.0006416198],"domain_scores_gemma":[0.99479085,0.0008453684,0.00080029404,0.00013723165,0.0005003333,0.0029259485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026711274,0.00028099533,0.0006057547,0.00040398608,0.00020164753,0.000089545,0.00011002079,0.00016304244,0.00015315198],"category_scores_gemma":[0.0021844853,0.00019699126,0.00021811931,0.00041606397,0.00002695451,0.00019948136,0.000007888764,0.00046123526,0.00006291816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0007043356,0.000035264336,0.9904687,0.00006965709,0.0002877271,0.00034105964,0.00039489137,0.0020086865,0.000007280036,0.0000018851332,0.005514877,0.00016567009],"study_design_scores_gemma":[0.0034282014,0.0020963354,0.9923228,0.00024840183,0.00039902283,0.000042689746,0.00009650774,0.0009940328,0.0000340341,0.000003248695,0.00014882417,0.00018589012],"about_ca_topic_score_codex":0.17809649,"about_ca_topic_score_gemma":0.032037795,"teacher_disagreement_score":0.1460587,"about_ca_system_score_codex":0.005449303,"about_ca_system_score_gemma":0.0087462,"threshold_uncertainty_score":0.9983686},"labels":[],"label_agreement":null},{"id":"W3090697059","doi":"10.1007/s00270-020-02639-7","title":"Nonmalignant Enhancement Following Percutaneous Renal Ablation Mimicking Viable Malignancy","year":2020,"lang":"en","type":"article","venue":"CardioVascular and Interventional Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Percutaneous; Malignancy; Radiology; Ablation; Internal medicine","score_opus":0.02657848163621473,"score_gpt":0.24960738517671407,"score_spread":0.22302890354049934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090697059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9356984,0.04052066,0.019293133,0.000457931,0.0002816834,0.00048537747,0.0000072323296,0.00005133592,0.0032042584],"genre_scores_gemma":[0.99700093,0.000291146,0.0015704444,0.0003976507,0.00028870316,0.000036110247,0.00012899667,0.000023953142,0.00026205246],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99840343,0.00013293838,0.00037951427,0.00049820234,0.0003076268,0.000278266],"domain_scores_gemma":[0.9994116,0.00003450308,0.00006164015,0.00022573264,0.00006955296,0.00019698357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028758383,0.0002059392,0.0006059548,0.00006993693,0.00009784635,0.000019471829,0.00006669654,0.000106353415,0.00020359571],"category_scores_gemma":[0.00006652436,0.00017943076,0.0015015504,0.00009934044,0.000058212943,0.000072708004,0.00006363829,0.00014665087,0.000050139894],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031112214,0.0012260956,0.056925833,0.0026796886,0.056208454,0.030004174,0.002971,0.003237548,0.72684956,0.007965629,0.005248839,0.10357197],"study_design_scores_gemma":[0.038042817,0.030755544,0.23441559,0.0055177216,0.024343979,0.12844807,0.0015744889,0.01892062,0.23851417,0.002258837,0.27256206,0.0046460987],"about_ca_topic_score_codex":0.00001669875,"about_ca_topic_score_gemma":3.62182e-7,"teacher_disagreement_score":0.48833537,"about_ca_system_score_codex":0.00012222922,"about_ca_system_score_gemma":0.00004543291,"threshold_uncertainty_score":0.73169744},"labels":[],"label_agreement":null},{"id":"W3091562787","doi":"10.1002/jmri.27364","title":"Update on <scp>MRI</scp> of Cystic Renal Masses Including Bosniak Version 2019","year":2020,"lang":"en","type":"review","venue":"Journal of Magnetic Resonance Imaging","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Women's College Hospital; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Magnetic resonance imaging; Medicine; Homogeneous; Malignancy; Radiology; Renal parenchyma; Kidney; Pathology; Internal medicine","score_opus":0.030823657068041105,"score_gpt":0.30836807971431357,"score_spread":0.27754442264627244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091562787","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007101051,0.99555844,0.00006681898,0.0004710416,0.0005055065,0.00061457395,0.000053623604,0.000018780791,0.0020011046],"genre_scores_gemma":[0.00043963388,0.99229765,0.0053818044,0.00017556293,0.00073800154,0.000008845332,0.000029295388,0.000116544594,0.0008126463],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953019,0.00032413355,0.001977774,0.0005089235,0.0013696546,0.00051759765],"domain_scores_gemma":[0.9953977,0.0009786878,0.002315521,0.0005471389,0.00036518392,0.00039580572],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007456294,0.0006886987,0.0031929426,0.0007225739,0.000084394786,0.00006021852,0.0005047298,0.0002275351,0.00009484639],"category_scores_gemma":[0.00090686046,0.0005030069,0.0011534465,0.00059263693,0.00014409942,0.00016722627,0.0002201048,0.0016475844,0.00014937654],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013487124,0.00016458152,0.0003797057,0.0067430334,0.00013961086,0.005164041,0.000081235565,0.000007440501,0.0001550897,0.000012960614,0.034845527,0.9521719],"study_design_scores_gemma":[0.0015551074,0.0014535151,0.00069535273,0.04763336,0.0027326688,0.003569101,0.000048689588,0.000060469916,0.00019281657,0.00003172096,0.94187564,0.000151582],"about_ca_topic_score_codex":0.0000106192365,"about_ca_topic_score_gemma":3.2797647e-7,"teacher_disagreement_score":0.95202035,"about_ca_system_score_codex":0.0006420674,"about_ca_system_score_gemma":0.0009235642,"threshold_uncertainty_score":0.99974215},"labels":[],"label_agreement":null},{"id":"W3091585665","doi":"10.1097/pap.0000000000000286","title":"Comprehensive Review of Numerical Chromosomal Aberrations in Chromophobe Renal Cell Carcinoma Including Its Variant Morphologies","year":2020,"lang":"en","type":"review","venue":"Advances in Anatomic Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary; Royal Columbian Hospital","funders":"","keywords":"Biology; CDKN2A; Renal oncocytoma; Clear cell; Clear cell renal cell carcinoma; Renal cell carcinoma; Papillary renal cell carcinomas; Chromophobe cell; Oncocytoma; Pathology; Genetics; Gene; Carcinoma; Kidney; Medicine","score_opus":0.06196469451702177,"score_gpt":0.36283098147720483,"score_spread":0.300866286960183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091585665","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014270028,0.9937327,0.00003767859,0.00015101561,0.00030406273,0.002054555,0.00011598589,0.00004034316,0.0021366763],"genre_scores_gemma":[0.012750582,0.9844222,0.0015825412,0.00032125157,0.000102841375,0.00039757084,0.00032406507,0.00007475327,0.000024163272],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99525154,0.0007992261,0.0019595316,0.0010765166,0.00032646052,0.0005867273],"domain_scores_gemma":[0.9975509,0.0005117601,0.0009607275,0.0006798571,0.00012976477,0.0001670091],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025654823,0.00074424356,0.005075023,0.0005652241,0.000042110947,0.000005198537,0.00042139084,0.0004551609,0.000120116056],"category_scores_gemma":[0.00029754516,0.00061962067,0.0005719216,0.001232041,0.0002602627,0.0001685242,0.0003638942,0.0011246129,0.00008059833],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001428457,0.0010966589,0.0006519312,0.4558879,0.00018347261,0.09217315,0.0004675597,0.000035362693,0.0007758053,0.00048638537,0.00043798034,0.44766095],"study_design_scores_gemma":[0.0024901784,0.0012945319,0.0008250906,0.0882612,0.0014202023,0.011317425,0.00008666709,0.00010223726,0.00040749056,0.00008684344,0.8928012,0.0009069102],"about_ca_topic_score_codex":0.000023171997,"about_ca_topic_score_gemma":0.000008624603,"teacher_disagreement_score":0.89236325,"about_ca_system_score_codex":0.0008666519,"about_ca_system_score_gemma":0.0008486638,"threshold_uncertainty_score":0.9996255},"labels":[],"label_agreement":null},{"id":"W3092285243","doi":"10.4103/uros.uros_27_20","title":"Clear Renal Cell Carcinoma with Angioleiomyomatous Stroma in a Noninherited Renal Cancer Syndrome","year":2020,"lang":"en","type":"article","venue":"Urological Science","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Pathology; Cancer; Stroma; Clear cell; Asymptomatic; Tuberous sclerosis; Internal medicine","score_opus":0.02783813482022885,"score_gpt":0.2479026790064687,"score_spread":0.22006454418623986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092285243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944057,0.00035034964,0.000084177234,0.0023326168,0.00002525985,0.0004515884,0.0000062005024,0.00008099837,0.0022631378],"genre_scores_gemma":[0.99738663,0.0000061328083,0.001192829,0.0012508832,0.00005218397,0.000033517645,0.0000039867327,0.00001494955,0.000058903122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974536,0.000047857626,0.00028368796,0.0007843531,0.0007146923,0.0007158276],"domain_scores_gemma":[0.9988546,0.00006445397,0.000089021574,0.00026028778,0.000077684905,0.00065396324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002687592,0.00023274071,0.0003859458,0.00011653399,0.000108200016,0.000038823808,0.00032185734,0.00009357682,0.00026317532],"category_scores_gemma":[0.00007467093,0.00014556065,0.00007367244,0.0014400232,0.00060706213,0.00011471343,0.00014154073,0.00032982274,0.000052762105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022315753,0.00034016735,0.73827666,0.00003856242,0.000013233688,0.015112426,0.0004933974,0.00039470685,0.24237907,0.000046950223,0.00009747293,0.00057575083],"study_design_scores_gemma":[0.0017409314,0.007039355,0.9743214,0.000027957103,0.000042741387,0.0006113689,0.00004800102,0.0013377971,0.014339544,0.000010194042,0.00029342252,0.00018727989],"about_ca_topic_score_codex":0.00020895009,"about_ca_topic_score_gemma":0.000028070048,"teacher_disagreement_score":0.23604472,"about_ca_system_score_codex":0.00021365726,"about_ca_system_score_gemma":0.00029685372,"threshold_uncertainty_score":0.5935791},"labels":[],"label_agreement":null},{"id":"W3092544457","doi":"10.6004/jnccn.2020.7577","title":"Small Renal Masses With Tumor Size 0 to 2 cm: A SEER-Based Study and Validation of NCCN Guidelines","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université de Montréal","funders":"","keywords":"Medicine; Chromophobe cell; Nephrectomy; Clear cell; Renal cell carcinoma; Urology; Clear cell carcinoma; Internal medicine; Pathology; Kidney; Carcinoma","score_opus":0.12549440038722112,"score_gpt":0.3378301358079551,"score_spread":0.212335735420734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092544457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98305935,0.0012596882,0.00022867491,0.014648104,0.00014034445,0.00058117544,0.000011745269,0.0000061663213,0.00006477012],"genre_scores_gemma":[0.9842875,0.00001435073,0.008354582,0.006211962,0.001058461,0.000014314175,0.000001623114,0.000017651642,0.000039576193],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99822396,0.000116385854,0.00053821335,0.00016046847,0.00083533983,0.00012563771],"domain_scores_gemma":[0.99549115,0.00036814896,0.00055722945,0.00009031262,0.0033292677,0.00016389813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016365024,0.0001569901,0.00041177022,0.00005611977,0.0000651519,0.000017662562,0.00013032166,0.000023854276,0.000036622543],"category_scores_gemma":[0.00032397744,0.000091934024,0.00010970383,0.00040567695,0.000038455044,0.00004469095,0.00005120282,0.00018011281,7.675767e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009612214,0.00040530998,0.33269984,0.00020189838,0.0014015737,0.0001375316,0.0007382014,0.6042399,0.01832759,0.000026171601,0.03155434,0.0006554379],"study_design_scores_gemma":[0.013055876,0.009872116,0.92232287,0.0018591483,0.0017506719,0.0003582079,0.0007740349,0.0038196323,0.028734067,0.00026200808,0.016788727,0.000402643],"about_ca_topic_score_codex":0.000016218473,"about_ca_topic_score_gemma":0.000010963212,"teacher_disagreement_score":0.60042024,"about_ca_system_score_codex":0.00016422084,"about_ca_system_score_gemma":0.0004830712,"threshold_uncertainty_score":0.37489608},"labels":[],"label_agreement":null},{"id":"W3092827384","doi":"10.14740/wjon1325","title":"Evolving Paradigms in the Management and Outcomes of Sarcomatoid Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors","year":2020,"lang":"en","type":"review","venue":"World Journal of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Sarcomatoid carcinoma; Immune checkpoint; Internal medicine; Oncology; Nivolumab; Cancer; Carcinoma; Immunotherapy","score_opus":0.03375930688022201,"score_gpt":0.31401685777508925,"score_spread":0.28025755089486726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092827384","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035419457,0.9567455,0.0000015299025,0.001748709,0.00017137377,0.0011667795,0.0000040618465,0.0000018763419,0.00474072],"genre_scores_gemma":[0.31712934,0.68198216,0.00055399834,0.00011245135,0.000105272215,0.000029896197,0.0000052404785,0.000025676338,0.000056001794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99526006,0.0009443623,0.0027036048,0.00023343501,0.00056790595,0.0002906281],"domain_scores_gemma":[0.9962806,0.0008893847,0.0022556982,0.00041917298,0.00007179091,0.000083346466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020904632,0.00039019046,0.0032583224,0.0006864064,0.000028837529,0.000012018914,0.00052308216,0.00014692574,0.000029182895],"category_scores_gemma":[0.00005832306,0.00019119152,0.00081694766,0.0007453952,0.00018425961,0.000048322014,0.0001452819,0.0014636753,0.0000021210917],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005351072,0.0023667375,0.04168994,0.023332773,0.001371474,0.017673276,0.006426837,0.000009386411,0.00007371624,0.0003853683,0.0010989065,0.90503645],"study_design_scores_gemma":[0.0070531433,0.0045469007,0.20885369,0.014389841,0.004794294,0.0059163594,0.0019640578,0.0000077283385,0.00017438088,0.00014893604,0.7517887,0.00036198425],"about_ca_topic_score_codex":0.000079918085,"about_ca_topic_score_gemma":0.000075515425,"teacher_disagreement_score":0.9046745,"about_ca_system_score_codex":0.0005149578,"about_ca_system_score_gemma":0.00044418784,"threshold_uncertainty_score":0.77965635},"labels":[],"label_agreement":null},{"id":"W3093368837","doi":"10.48083/mqye9599","title":"Tissue-Based Immunohistochemical Markers for Diagnosis and Classification of Renal Cell Carcinoma","year":2020,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Chromophobe cell; Immunohistochemistry; Renal cell carcinoma; Clear cell; Pathology; Medicine; Biology","score_opus":0.06869820520106269,"score_gpt":0.32128268346557504,"score_spread":0.25258447826451236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093368837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827588,0.0014071285,0.002470316,0.010532255,0.00014283403,0.00046271202,0.000040847095,0.000020724785,0.002164355],"genre_scores_gemma":[0.9950733,0.00010469561,0.0034157718,0.0007947875,0.00026284848,0.00005849325,0.00008884681,0.000018006782,0.00018320643],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987241,0.000054059892,0.00045025442,0.00024085374,0.00034968645,0.00018106095],"domain_scores_gemma":[0.9985893,0.0004216182,0.0003444472,0.000119964905,0.0003371265,0.00018756768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020972507,0.00015726755,0.0002988487,0.00009135778,0.00007076518,0.000022456145,0.00014876724,0.000116912524,0.00023539654],"category_scores_gemma":[0.0003914188,0.00013608675,0.00020972671,0.00007346932,0.0001275232,0.00006598877,0.00003671879,0.00027560658,0.000004111441],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058838334,0.00068271067,0.40747994,0.0003960824,0.00039498054,0.00013573632,0.0004938689,0.00011034537,0.5389333,0.00023190292,0.025618767,0.01963858],"study_design_scores_gemma":[0.010848881,0.005481748,0.5028274,0.000080348254,0.0006303913,0.00022422755,0.0004972747,0.0051799747,0.46060163,0.0005409759,0.012761213,0.00032593636],"about_ca_topic_score_codex":0.000004598179,"about_ca_topic_score_gemma":3.121681e-7,"teacher_disagreement_score":0.09534748,"about_ca_system_score_codex":0.0002214613,"about_ca_system_score_gemma":0.00019799825,"threshold_uncertainty_score":0.55494565},"labels":[],"label_agreement":null},{"id":"W3093617047","doi":"10.1016/j.ijrobp.2020.07.2430","title":"Cost-Effectiveness of Radiofrequency Ablation (RFA) Versus Stereotactic Body Radiotherapy (SBRT) in the Treatment of Localized Renal Cell Carcinoma","year":2020,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; McMaster University; University of Toronto; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiofrequency ablation; Renal cell carcinoma; Stage (stratigraphy); Radiology; Ablation; Internal medicine","score_opus":0.05645723046192585,"score_gpt":0.3537377153359115,"score_spread":0.2972804848739856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093617047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896015,0.0025556246,0.004502783,0.001189005,0.0007520511,0.00090295874,0.000040655905,0.0000099666495,0.00044547213],"genre_scores_gemma":[0.99640083,0.0013698845,0.0011401877,0.00017303503,0.000750983,0.000034921377,0.00009925339,0.000025240219,0.000005660869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729663,0.0008932015,0.0009584745,0.00024200995,0.00041316042,0.0001964978],"domain_scores_gemma":[0.99648464,0.0013521421,0.0013140742,0.00019829244,0.0005380176,0.00011285221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005432626,0.00024814074,0.0008027444,0.00019144347,0.000030128112,0.000010862446,0.0003130728,0.0001806343,0.000045619137],"category_scores_gemma":[0.00013477431,0.00017641834,0.00037002363,0.00030715615,0.00017569045,0.00016930322,0.0000138311125,0.00026221882,0.000004752265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027685167,0.0047321036,0.7046636,0.00013465551,0.001996143,0.0004397857,0.0061543863,0.003766618,0.14921072,0.0022110653,0.0001336405,0.09887214],"study_design_scores_gemma":[0.12302751,0.06399559,0.4929266,0.00021108078,0.0014634803,0.00045176805,0.0005874381,0.010178134,0.28796527,0.0015667633,0.01709772,0.00052863744],"about_ca_topic_score_codex":0.000072018236,"about_ca_topic_score_gemma":0.0000023729147,"teacher_disagreement_score":0.21173696,"about_ca_system_score_codex":0.0018424842,"about_ca_system_score_gemma":0.00062016136,"threshold_uncertainty_score":0.71941316},"labels":[],"label_agreement":null},{"id":"W3093923068","doi":"10.1016/s1470-2045(20)30436-8","title":"Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":745,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre Hospitalier de l’Université de Montréal","funders":"Merck Sharp and Dohme","keywords":"Axitinib; Medicine; Sunitinib; Renal cell carcinoma; Pembrolizumab; Interim analysis; Internal medicine; Clinical endpoint; Oncology; Population; Kidney cancer; Clinical trial; Cancer; Immunotherapy","score_opus":0.1632971678821501,"score_gpt":0.3918027228166789,"score_spread":0.2285055549345288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093923068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97017634,0.0022543464,0.00007324859,0.008649216,0.00086133543,0.006145555,0.00031122277,0.00009974232,0.011428998],"genre_scores_gemma":[0.99121886,0.0012724878,0.0014604635,0.0013537926,0.0020770247,0.0010581814,0.0005845616,0.000097496195,0.0008771131],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99629515,0.00069085497,0.0010077322,0.00082340726,0.00045008113,0.00073276676],"domain_scores_gemma":[0.9959354,0.0017036616,0.0006712165,0.001075495,0.00017306233,0.00044117047],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003326864,0.00061336526,0.0026980573,0.00008848085,0.00019180735,0.000036223082,0.00069124135,0.0002795404,0.0010276469],"category_scores_gemma":[0.00023270636,0.0004113963,0.00037066152,0.00030227343,0.00026412852,0.000100129924,0.00016230332,0.000347735,0.000120839075],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9426142,0.0037672508,0.000022634125,0.000049367914,0.00071263337,0.0009889805,0.0037473056,0.000055145207,0.01905299,0.000079131576,0.0011800505,0.027730288],"study_design_scores_gemma":[0.8179444,0.095906876,0.00012936506,0.00003218543,0.0011856892,0.00004222886,0.0004076577,0.0004995486,0.05174773,0.00013900091,0.03167273,0.00029258803],"about_ca_topic_score_codex":0.0010680996,"about_ca_topic_score_gemma":0.00024026542,"teacher_disagreement_score":0.12466982,"about_ca_system_score_codex":0.0008797444,"about_ca_system_score_gemma":0.0011123453,"threshold_uncertainty_score":0.99988556},"labels":[],"label_agreement":null},{"id":"W3094637249","doi":"10.1016/j.ejso.2020.10.040","title":"Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma","year":2020,"lang":"en","type":"article","venue":"European Journal of Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Nephrectomy; Renal cell carcinoma; Stage (stratigraphy); Logistic regression; Medicine; Urology; Internal medicine; Biology; Kidney","score_opus":0.03353703516931606,"score_gpt":0.2593866993256844,"score_spread":0.22584966415636837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094637249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9052266,0.0011800287,0.000029228375,0.0024384584,0.00012502096,0.00019033023,0.000008779871,0.000008770942,0.0907928],"genre_scores_gemma":[0.99761957,0.00059016777,0.0005751185,0.00025672882,0.0005813382,6.908803e-7,0.0000022212473,0.00003955358,0.00033458252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99594516,0.0019399867,0.0011578046,0.00022085047,0.0004295055,0.0003067204],"domain_scores_gemma":[0.99762094,0.00060232054,0.0010023152,0.00021408816,0.00017901306,0.00038133422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018650618,0.00019479766,0.0007130304,0.00011629957,0.00005026973,0.000010189146,0.0002902878,0.00006278362,0.0002927754],"category_scores_gemma":[0.00012526961,0.000116634656,0.00035146216,0.00026954876,0.00018850793,0.00006253835,0.00013703585,0.001148592,0.000055121694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022435667,0.0028616765,0.71419615,0.0005049875,0.00036521934,0.17174052,0.0123874955,0.0027645973,0.045094777,0.00006459715,0.004982079,0.022602247],"study_design_scores_gemma":[0.02953769,0.045281842,0.5039871,0.0001896763,0.0009743624,0.0028790133,0.003419565,0.0011229711,0.036795173,0.000011673489,0.3754403,0.0003606505],"about_ca_topic_score_codex":0.000023799299,"about_ca_topic_score_gemma":0.0000024457268,"teacher_disagreement_score":0.37045822,"about_ca_system_score_codex":0.00015888424,"about_ca_system_score_gemma":0.00024999643,"threshold_uncertainty_score":0.49901244},"labels":[],"label_agreement":null},{"id":"W3094912389","doi":"10.1007/s00345-020-03504-5","title":"The impact of intraoperative bleeding on the risk of chronic kidney disease after nephron-sparing surgery","year":2020,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Kidney disease; Odds ratio; Nephrology; Renal function; Confidence interval; Internal medicine; Logistic regression; Surgery; Nephrectomy; Urology; Kidney","score_opus":0.02140078255234862,"score_gpt":0.26220884504123604,"score_spread":0.24080806248888742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094912389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97773725,0.0056708837,0.000028439845,0.015915573,0.00012908268,0.00016906636,0.000010182109,0.0000032440748,0.0003363007],"genre_scores_gemma":[0.99765843,0.0010833641,0.000013344505,0.00074844895,0.0004424455,0.0000050262506,0.0000010660052,0.00001579292,0.000032052485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985817,0.00028663254,0.0005473172,0.00011256929,0.00024707126,0.00022469458],"domain_scores_gemma":[0.997592,0.0011432803,0.0005812958,0.00020169406,0.00015585113,0.00032592457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000534724,0.00014972306,0.00047300692,0.00012556175,0.00006382237,0.000009154575,0.00013228704,0.000029603596,0.0002533537],"category_scores_gemma":[0.0006763218,0.00006618611,0.00046672748,0.00021954277,0.0002080669,0.000045308403,0.000045472956,0.0004806486,0.0000056047097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02579828,0.00047799738,0.92287904,0.00012247499,0.0037284074,0.0011371924,0.0017316354,0.0048332056,0.011392348,0.0003208381,0.019279364,0.008299227],"study_design_scores_gemma":[0.0020016963,0.005093084,0.9806354,0.00023969493,0.0012752612,0.00014815698,0.00009835906,0.001941127,0.0051789274,0.00020438201,0.0030554612,0.00012846818],"about_ca_topic_score_codex":0.000026685457,"about_ca_topic_score_gemma":0.00000979055,"teacher_disagreement_score":0.057756353,"about_ca_system_score_codex":0.00015301384,"about_ca_system_score_gemma":0.0005896883,"threshold_uncertainty_score":0.27740455},"labels":[],"label_agreement":null},{"id":"W3097061483","doi":"10.1016/j.soc.2020.08.003","title":"Surgical Management of Genitourinary Cancer Liver Metastases","year":2020,"lang":"en","type":"review","venue":"Surgical Oncology Clinics of North America","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Metastasectomy; Genitourinary system; Metastasis; Chemotherapy; Oncology; Germ cell tumors; Liver cancer; Cancer; Internal medicine","score_opus":0.09623652719128879,"score_gpt":0.414555846726673,"score_spread":0.3183193195353842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097061483","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00080283073,0.98866636,0.0000035008293,0.00015798502,0.00032691675,0.0015718146,0.00051207864,0.000043912536,0.007914624],"genre_scores_gemma":[0.0003484367,0.99544877,0.002249258,0.00006201013,0.00036963524,0.00026546224,0.0006162288,0.00008459736,0.0005556247],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99464273,0.0007375891,0.0025007643,0.0009125293,0.0006895424,0.0005168246],"domain_scores_gemma":[0.99460953,0.0018886224,0.0019433993,0.0007596883,0.00022511964,0.0005736381],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030155882,0.0007237509,0.007369509,0.0002408025,0.000040282208,0.0000035809019,0.00044165886,0.00044484244,0.00095451734],"category_scores_gemma":[0.00003551364,0.000520591,0.0026177082,0.00088786316,0.00079633127,0.000032645614,0.0005084846,0.00093285844,0.00015502992],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088026986,0.0015967685,0.0004555038,0.017380016,0.0040850644,0.049685698,0.0000148636145,0.0000040781288,6.4431025e-9,0.00002226719,0.00065700983,0.92521846],"study_design_scores_gemma":[0.0019654508,0.0045433473,0.00025993664,0.0030824225,0.013521581,0.0008752984,0.000015747311,0.000005676548,6.0746555e-7,0.0000027316823,0.9753859,0.00034129134],"about_ca_topic_score_codex":0.00008134872,"about_ca_topic_score_gemma":0.0000071926906,"teacher_disagreement_score":0.9747289,"about_ca_system_score_codex":0.00038372556,"about_ca_system_score_gemma":0.0012827766,"threshold_uncertainty_score":0.99995875},"labels":[],"label_agreement":null},{"id":"W3097074307","doi":"10.1016/j.eururo.2020.10.006","title":"The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis","year":2020,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Nivolumab; Internal medicine; Hazard ratio; Ipilimumab; Oncology; Odds ratio; Confidence interval; Response Evaluation Criteria in Solid Tumors; Meta-analysis; Cancer; Immunotherapy; Progressive disease; Disease","score_opus":0.033800532151267354,"score_gpt":0.25898902668824697,"score_spread":0.22518849453697962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097074307","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023223262,0.9871256,0.000013254268,0.000095502524,0.0000072972184,0.009935651,0.000079727055,0.000030592066,0.00039005044],"genre_scores_gemma":[0.09224271,0.90533954,0.00027810858,0.00013241435,0.00001984532,0.0011011099,0.00046777618,0.00021434062,0.00020413313],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9917574,0.0040991222,0.002229224,0.0009136379,0.00054636283,0.00045428876],"domain_scores_gemma":[0.9957482,0.00055596454,0.0020856534,0.0011043452,0.00026472047,0.0002410755],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011762492,0.0009291168,0.010039037,0.0003884892,0.000068463145,0.000029531733,0.00029992757,0.00008717502,0.000010318788],"category_scores_gemma":[0.00020517275,0.00039309353,0.0014468388,0.0013212749,0.00026267656,0.000040326846,0.0001599455,0.00060059194,0.000013737324],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008252773,0.00079516426,0.0016858502,0.730765,0.26234284,0.0021642454,0.00037175207,0.0000063170833,5.735037e-7,0.000009067394,0.000016539418,0.0010173831],"study_design_scores_gemma":[0.0018073963,0.0073191924,0.001922488,0.009288907,0.97758704,0.00017513603,0.00001832482,0.0000070789533,0.000009563108,6.47252e-7,0.0015529017,0.00031130825],"about_ca_topic_score_codex":0.000057302346,"about_ca_topic_score_gemma":0.000010399769,"teacher_disagreement_score":0.7214761,"about_ca_system_score_codex":0.00014598745,"about_ca_system_score_gemma":0.00022351321,"threshold_uncertainty_score":0.9998521},"labels":[],"label_agreement":null},{"id":"W3097111904","doi":"10.1177/2399369320965578","title":"An extra year of Onco-Nephrology fellowship training is required for the subspecialty: PRO","year":2020,"lang":"en","type":"article","venue":"Journal of Onco-Nephrology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Memorial Sloan-Kettering Cancer Center","keywords":"Subspecialty; Medicine; Nephrology; Internal medicine; Intensive care medicine; Disease; Hematology; Oncology; Cancer; Dialysis; Family medicine","score_opus":0.12430391759625582,"score_gpt":0.33746762595026675,"score_spread":0.21316370835401094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097111904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9542473,0.0016885289,0.0014494892,0.03970043,0.00044717328,0.0010285627,0.000032224696,0.000029592633,0.0013766894],"genre_scores_gemma":[0.97644114,0.00021867215,0.0060620364,0.01363931,0.0033717835,0.00002847014,0.000013052137,0.00007006098,0.00015547167],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969029,0.0002983771,0.0012799046,0.00038831352,0.0005335389,0.0005969817],"domain_scores_gemma":[0.9967359,0.000730216,0.0010946364,0.00048034755,0.00049490336,0.0004640047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010893071,0.00033911254,0.0013134832,0.00021206692,0.00012314871,0.000020615193,0.0004901892,0.00036068665,0.000465011],"category_scores_gemma":[0.00030054367,0.00022828663,0.0005907307,0.0002893016,0.0004220359,0.00017704867,0.000053071977,0.00066687126,0.000024307532],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052891467,0.0023956439,0.022294162,0.00069560896,0.0057737147,0.0036915443,0.05210886,0.0003559298,0.6453711,0.0028715532,0.12263599,0.08891447],"study_design_scores_gemma":[0.033278767,0.078953,0.101119906,0.0002032713,0.0051428457,0.0068907547,0.007829499,0.0026890573,0.04046492,0.003428086,0.71914744,0.00085247605],"about_ca_topic_score_codex":0.000023484032,"about_ca_topic_score_gemma":0.000036192934,"teacher_disagreement_score":0.60490614,"about_ca_system_score_codex":0.00018685554,"about_ca_system_score_gemma":0.0008613529,"threshold_uncertainty_score":0.93092585},"labels":[],"label_agreement":null},{"id":"W3097530602","doi":"10.1007/s00261-020-02835-6","title":"A review of clinical and MR imaging features of renal lipid-poor angiomyolipomas","year":2020,"lang":"en","type":"review","venue":"Abdominal Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Radiology; Magnetic resonance imaging; Hepatology; Lesion; Biopsy; Pathology; Internal medicine","score_opus":0.06288423016410175,"score_gpt":0.3970017106301391,"score_spread":0.3341174804660374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097530602","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051699633,0.99626535,0.000011563766,0.0005201017,0.00022132492,0.001254353,0.000042824468,0.00001689291,0.0016158725],"genre_scores_gemma":[0.00011894748,0.99629307,0.0017612532,0.00069455325,0.00077859475,0.00006201251,0.00012811836,0.000054796616,0.00010865266],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99580187,0.00078630855,0.0021771323,0.0006938153,0.00022624705,0.00031466025],"domain_scores_gemma":[0.9966427,0.0010437646,0.0013060507,0.00055451796,0.00014672008,0.00030623886],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008964635,0.00052098726,0.0073519326,0.00020326085,0.00002144891,0.0000029933205,0.00023024219,0.00034980656,0.00009453704],"category_scores_gemma":[0.0011262203,0.00035282862,0.0015549861,0.00029291253,0.0006812164,0.000024058143,0.00015812444,0.0006771164,0.00001623032],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023587522,0.00007583516,0.0002006885,0.1522486,0.0008404821,0.00072550087,0.00001599848,6.2325567e-9,0.000015490423,0.000088123656,0.012233773,0.8333196],"study_design_scores_gemma":[0.0010008545,0.0010286049,0.00055385166,0.11065202,0.008320832,0.011763639,0.0000066360953,0.0000019387303,0.000019174839,0.00001071212,0.8664301,0.00021161437],"about_ca_topic_score_codex":0.000025374738,"about_ca_topic_score_gemma":8.3278684e-7,"teacher_disagreement_score":0.85419637,"about_ca_system_score_codex":0.000057221532,"about_ca_system_score_gemma":0.00069121475,"threshold_uncertainty_score":0.99989235},"labels":[],"label_agreement":null},{"id":"W3098866882","doi":"10.1007/s10552-020-01364-3","title":"Prognostic factors in patients with small renal masses: a comparison between &lt;2 vs. 2.1–4 cm renal cell carcinomas","year":2020,"lang":"en","type":"article","venue":"Cancer Causes & Control","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Chromophobe cell; Renal cell carcinoma; Medicine; Clear cell; Nephrectomy; Proportional hazards model; Urology; Internal medicine; Surveillance, Epidemiology, and End Results; Kidney cancer; Oncology; Epidemiology; Gastroenterology; Kidney; Cancer registry","score_opus":0.03882189551354732,"score_gpt":0.2552592980580931,"score_spread":0.2164374025445458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3098866882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945176,0.0013119824,0.0003265138,0.00075571943,0.00008467426,0.0023411557,0.00017770338,0.00010200877,0.00038261563],"genre_scores_gemma":[0.998149,0.000014898043,0.00024880483,0.0006295855,0.00032092645,0.00025361282,0.00020970759,0.00008893467,0.00008456979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971599,0.0001335292,0.000647328,0.0007603746,0.0006030939,0.00069579046],"domain_scores_gemma":[0.9982071,0.0002471525,0.0002959495,0.0004050243,0.00021932198,0.0006254798],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007963641,0.0005323737,0.0011904929,0.00015711495,0.00007265873,0.000049372356,0.00021083132,0.00015456011,0.00014340691],"category_scores_gemma":[0.000079294994,0.0003942733,0.00016959297,0.000399083,0.000113060436,0.00010407011,0.00005369334,0.00048377566,0.00003277222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002427977,0.0002932343,0.9931281,0.00020310418,0.00030624546,0.00016391797,0.001162051,0.00020832346,0.0011414242,0.00000282844,0.00043383447,0.0005289337],"study_design_scores_gemma":[0.016091185,0.003615203,0.96756816,0.00025514836,0.0012273408,0.0000013317928,0.00009542046,0.00015898353,0.007504189,0.0000031577547,0.003082787,0.00039711475],"about_ca_topic_score_codex":0.00055688276,"about_ca_topic_score_gemma":0.00037836313,"teacher_disagreement_score":0.025559986,"about_ca_system_score_codex":0.00057312025,"about_ca_system_score_gemma":0.0004875109,"threshold_uncertainty_score":0.9998509},"labels":[],"label_agreement":null},{"id":"W3099411766","doi":"10.1016/s0167-8140(20)31103-8","title":"211: Outcomes of Radiotherapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma: Results from the Canadian Kidney Cancer Information System (CKCIS)","year":2020,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Renal cell carcinoma; Medicine; Immunotherapy; Kidney cancer; Oncology; Radiation therapy; Cancer; Internal medicine","score_opus":0.02756644570635962,"score_gpt":0.2789373444560475,"score_spread":0.2513708987496879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099411766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9590663,0.010844185,0.0002167563,0.026435787,0.00025518518,0.0013374633,0.0004517465,0.000033754528,0.0013588425],"genre_scores_gemma":[0.983463,0.0015216008,0.002038438,0.012520898,0.00016103963,0.00008782439,0.00010908178,0.00003161579,0.000066529145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800014,0.00029087052,0.00078245264,0.00029989885,0.00026257616,0.00036404538],"domain_scores_gemma":[0.99850464,0.00033225463,0.00033173032,0.00035071856,0.000077394616,0.00040323773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035728028,0.00028916151,0.000935654,0.00017297255,0.00011367525,0.000028685003,0.00019019387,0.00018155806,0.00011966336],"category_scores_gemma":[0.00004353432,0.00019099214,0.00014199283,0.0002935273,0.00015540558,0.00013733486,0.000011483897,0.00029878438,0.0000043784235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036974758,0.0005510712,0.59507316,0.00096766255,0.0037370927,0.0011608867,0.18388806,0.0020911125,0.046730828,0.00094675657,0.023926629,0.103951946],"study_design_scores_gemma":[0.06809367,0.004686056,0.66773754,0.0001911647,0.0003885876,0.0001356058,0.003044121,0.011197744,0.009586398,0.000018777082,0.23429653,0.0006238052],"about_ca_topic_score_codex":0.22192566,"about_ca_topic_score_gemma":0.042131,"teacher_disagreement_score":0.2103699,"about_ca_system_score_codex":0.002777772,"about_ca_system_score_gemma":0.0019903136,"threshold_uncertainty_score":0.97534764},"labels":[],"label_agreement":null},{"id":"W3100270977","doi":"10.1016/j.clgc.2020.10.008","title":"Artificial Neural Networks as a Way to Predict Future Kidney Cancer Incidence in the United States","year":2020,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Incidence (geometry); Obesity; Life expectancy; Population; Kidney cancer; Artificial neural network; Renal cell carcinoma; Demography; Environmental health; Internal medicine; Machine learning; Computer science; Mathematics","score_opus":0.07402055290459694,"score_gpt":0.373951521271211,"score_spread":0.29993096836661404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100270977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90379477,0.0018505777,0.00003299176,0.09191672,0.0010463899,0.0010564771,0.000051629457,0.00007006354,0.00018041098],"genre_scores_gemma":[0.9105896,0.0019005846,0.00008116228,0.078380935,0.008346968,0.00040123865,0.000112473186,0.000043172324,0.00014386959],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99704283,0.00039123342,0.0008421414,0.0006706208,0.0005121492,0.0005409999],"domain_scores_gemma":[0.9979223,0.00037341137,0.0001450007,0.00046567546,0.00014793065,0.00094566133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039998302,0.0003235479,0.0005637266,0.00009005287,0.00011142335,0.000041076695,0.00038484612,0.00021540908,0.00047827588],"category_scores_gemma":[0.00034625808,0.00021206259,0.0002476414,0.0010635266,0.00014272971,0.00007327595,0.00016721124,0.0010386002,0.00006702133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01289935,0.0011087684,0.633583,0.00022480248,0.0003984544,0.0071138847,0.004810655,0.048380006,0.00037258296,0.000025022453,0.2097282,0.08135529],"study_design_scores_gemma":[0.0038115524,0.008642738,0.7313279,0.00048383354,0.0007563943,0.00013873138,0.002186136,0.09693626,0.00054207747,0.00010982836,0.1542363,0.0008282641],"about_ca_topic_score_codex":0.0012529466,"about_ca_topic_score_gemma":0.00021241778,"teacher_disagreement_score":0.09774488,"about_ca_system_score_codex":0.00019412122,"about_ca_system_score_gemma":0.00035261182,"threshold_uncertainty_score":0.8647661},"labels":[],"label_agreement":null},{"id":"W3105189736","doi":"10.5489/cuaj.6708","title":"The value of 99mTc-sestamibi single-photon emission computed tomography-computed tomography in the evaluation and risk stratification of renal masses","year":2020,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Chromophobe cell; Oncocytoma; Nuclear medicine; Single-photon emission computed tomography; Radiology; Renal cell carcinoma; Emission computed tomography; Magnetic resonance imaging; Hounsfield scale; Renal oncocytoma; Positron emission tomography; Clear cell; Computed tomography; Pathology","score_opus":0.029503152168823564,"score_gpt":0.24979552948289638,"score_spread":0.2202923773140728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105189736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890013,0.0010684439,0.00022486725,0.008691965,0.00006470849,0.0005651126,0.00002264567,0.000008759605,0.00035223083],"genre_scores_gemma":[0.9988591,0.00011921954,0.0004636765,0.00039947196,0.00010152763,0.000009305104,0.000037952173,0.000007049585,0.0000026760827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99717766,0.0010341828,0.00060828304,0.0002013368,0.0007283638,0.00025015042],"domain_scores_gemma":[0.9977101,0.00062164624,0.0007376691,0.00014122431,0.0004926589,0.00029669027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019443973,0.00014026588,0.00027883207,0.00019766869,0.00022945773,0.000067454144,0.00015605157,0.00016054156,0.000023342725],"category_scores_gemma":[0.0009302432,0.00008202445,0.00015097728,0.00074436417,0.000084944586,0.00006652736,0.00001199873,0.00046386104,5.8341476e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018594092,0.00012095027,0.98062223,0.00001632947,0.0001708873,0.000018062594,0.00075019844,0.00043461978,0.0052621155,0.00020611276,0.0006979159,0.011514629],"study_design_scores_gemma":[0.0011424046,0.001005247,0.9827272,0.0000377163,0.00025515424,0.000036805173,0.0002678401,0.010782128,0.0017197566,0.0013089495,0.00064230815,0.00007443742],"about_ca_topic_score_codex":0.00072919286,"about_ca_topic_score_gemma":0.00041863488,"teacher_disagreement_score":0.011440192,"about_ca_system_score_codex":0.00027848105,"about_ca_system_score_gemma":0.00033449774,"threshold_uncertainty_score":0.334486},"labels":[],"label_agreement":null},{"id":"W3107429554","doi":"10.1080/2162402x.2020.1846901","title":"Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Canceropôle PACA","keywords":"Sunitinib; Renal cell carcinoma; Medicine; Bevacizumab; Internal medicine; Oncology; Immunotherapy; Cancer; Chemotherapy","score_opus":0.01270006059543189,"score_gpt":0.22113384894628305,"score_spread":0.20843378835085116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107429554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99510443,0.001115959,0.000008410911,0.00014135656,0.000021710199,0.0010982871,0.000026656202,0.000012253536,0.0024709287],"genre_scores_gemma":[0.9991217,0.00006021431,0.00053790834,0.000056984696,0.000006532611,0.000026229305,0.00008107149,0.00003099354,0.000078314784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863327,0.000113822556,0.00041653638,0.00033817778,0.00021230563,0.00028590907],"domain_scores_gemma":[0.9990465,0.00023320169,0.00025352187,0.00021667898,0.00012678221,0.00012328241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001056453,0.00022019962,0.00064726966,0.00015017958,0.000028460632,0.0000046199493,0.00007821057,0.00008984792,0.00004487407],"category_scores_gemma":[0.00009018474,0.00016553895,0.00004877802,0.00021272598,0.0003553324,0.00007126317,0.000106808875,0.00023209186,0.000004877457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037752297,0.0021870504,0.9377126,0.0011483895,0.00036255582,0.0002162656,0.0042128274,0.000022581244,0.014388569,0.000042539963,0.000059636266,0.0018946757],"study_design_scores_gemma":[0.014348524,0.03270212,0.9302422,0.00011393877,0.00042551468,0.000021774322,0.0010043109,0.00009298813,0.020858308,0.000018267265,0.000043753582,0.0001283209],"about_ca_topic_score_codex":0.00015687462,"about_ca_topic_score_gemma":0.000009325259,"teacher_disagreement_score":0.03051507,"about_ca_system_score_codex":0.000059134538,"about_ca_system_score_gemma":0.00015728423,"threshold_uncertainty_score":0.67504823},"labels":[],"label_agreement":null},{"id":"W3107453141","doi":"10.1136/esmoopen-2020-001079","title":"Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial","year":2020,"lang":"en","type":"article","venue":"ESMO Open","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":522,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Bristol-Myers Squibb Canada; National Institutes of Health; Memorial Sloan-Kettering Cancer Center","keywords":"Sunitinib; Medicine; Ipilimumab; Nivolumab; Renal cell carcinoma; Internal medicine; Gastroenterology; Oncology; Cancer; Immunotherapy","score_opus":0.086461553476601,"score_gpt":0.333877590462352,"score_spread":0.247416036985751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107453141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98544955,0.00023837814,0.0000418072,0.0009828021,0.0005797258,0.007018694,0.00027812962,0.00002754325,0.005383386],"genre_scores_gemma":[0.995093,0.000050626375,0.0009154804,0.000058567497,0.00027111568,0.00050031027,0.00029513965,0.00006444618,0.0027513492],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977703,0.00009710244,0.00078212365,0.00053900963,0.0004200525,0.00039140787],"domain_scores_gemma":[0.99799395,0.00023561646,0.00048826882,0.00081099436,0.00021504352,0.00025610707],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016840322,0.00037847657,0.0011420716,0.000061450126,0.00014250774,0.000021775086,0.00048619753,0.00011942033,0.0003127932],"category_scores_gemma":[0.00013934293,0.0002598503,0.0005741235,0.00028186984,0.00012744244,0.000111439316,0.00021826585,0.00011730668,0.000013303985],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9711877,0.0034426558,0.00016479501,0.00035999742,0.00063922664,0.00010585244,0.0036184513,0.00015096259,0.009708098,0.00018215063,0.0011601696,0.009279929],"study_design_scores_gemma":[0.6368122,0.031323258,0.00075485173,0.00006657904,0.001038785,0.00000555148,0.0006242759,0.00038318877,0.32340682,0.000024920822,0.005358638,0.00020092967],"about_ca_topic_score_codex":0.0007365238,"about_ca_topic_score_gemma":0.00024928953,"teacher_disagreement_score":0.3343755,"about_ca_system_score_codex":0.00039333536,"about_ca_system_score_gemma":0.0005699875,"threshold_uncertainty_score":0.9999854},"labels":[],"label_agreement":null},{"id":"W3107960522","doi":"10.1016/j.euros.2020.11.001","title":"In Situ Metabolomics Expands the Spectrum of Renal Tumours Positive on 99mTc-sestamibi Single Photon Emission Computed Tomography/Computed Tomography Examination","year":2020,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"VINNOVA","keywords":"Medicine; Metabolomics; Positron emission tomography; Single-photon emission computed tomography; Nuclear medicine; Radiology; Chromophobe cell; Renal cell carcinoma; Pathology; Clear cell; Biology; Bioinformatics","score_opus":0.027166123125013427,"score_gpt":0.2631117734450996,"score_spread":0.2359456503200862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107960522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96974665,0.00016282,0.00038848116,0.0035604623,0.0001552066,0.0009443771,0.0000083583045,0.00003966081,0.024993958],"genre_scores_gemma":[0.9963781,0.000008532686,0.00077081006,0.0026688795,0.00007473056,0.00000611073,0.00002592926,0.000026133304,0.000040735504],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99692756,0.0007691189,0.00047650904,0.0008444639,0.0005494828,0.0004328454],"domain_scores_gemma":[0.9985665,0.00021005142,0.000293646,0.0005174247,0.00015432364,0.0002580445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015912671,0.0002668943,0.0004527319,0.00049138156,0.00020079695,0.00008537395,0.0012067445,0.00004787664,0.000023485729],"category_scores_gemma":[0.00016270002,0.00018763429,0.00012091646,0.0025242092,0.00089973473,0.00026850143,0.00064213533,0.0003706189,0.000020275364],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014857469,0.0009309846,0.019780567,0.000020609068,0.000065361215,0.00090047595,0.0036770566,0.00054158206,0.9680189,0.000547783,0.00038774213,0.0036431756],"study_design_scores_gemma":[0.0016385993,0.0034194998,0.66061264,0.000051194398,0.000068978574,0.00007777049,0.000109538254,0.0016981531,0.3319864,0.000045587247,0.00014605708,0.0001455661],"about_ca_topic_score_codex":0.00003710317,"about_ca_topic_score_gemma":0.0000075697512,"teacher_disagreement_score":0.64083207,"about_ca_system_score_codex":0.000075571246,"about_ca_system_score_gemma":0.00013197894,"threshold_uncertainty_score":0.7651504},"labels":[],"label_agreement":null},{"id":"W3109073162","doi":"10.1016/j.euros.2020.11.003","title":"Treatment of Advanced Renal Cell Carcinoma: Immunotherapies Have Demonstrated Overall Survival Benefits While Targeted Therapies Have Not","year":2020,"lang":"en","type":"review","venue":"European Urology Open Science","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Jane ja Aatos Erkon Säätiö; Biomedicum Helsinki-säätiö; Finska Läkaresällskapet; Helsingin Yliopisto","keywords":"Medicine; Adverse effect; Renal cell carcinoma; Oncology; Clinical trial; Kidney cancer; Internal medicine; Immunotherapy; Drug; Targeted therapy; Intensive care medicine; Cancer; Pharmacology","score_opus":0.07445868870130055,"score_gpt":0.3136510320197584,"score_spread":0.23919234331845785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109073162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019713257,0.9496723,0.000007985832,0.00030003104,0.0003289821,0.003291326,0.0002450117,0.000073997275,0.026367145],"genre_scores_gemma":[0.15557583,0.8401051,0.0012476268,0.00017736979,0.00014632699,0.00011504402,0.00028285853,0.00018745703,0.0021623878],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938203,0.0011551545,0.0013913696,0.0019040249,0.0007975119,0.0009316571],"domain_scores_gemma":[0.9961439,0.00032192984,0.0011257245,0.0015902102,0.00036013496,0.00045815177],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000821992,0.0011277428,0.003500355,0.00045087043,0.0003560339,0.00016665086,0.0023106758,0.00019833681,0.00022175712],"category_scores_gemma":[0.000088042645,0.0007955503,0.00067290856,0.00069865293,0.0015510161,0.00029594867,0.0008046862,0.00048053887,0.00021526567],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016003498,0.0012887149,0.0007700118,0.0012638292,0.0008568684,0.002880754,0.0027413815,0.000051318417,0.0060653095,0.00017225019,0.00012285533,0.9821864],"study_design_scores_gemma":[0.0073177447,0.011765025,0.013263345,0.00087192,0.002305123,0.0007484282,0.0002687853,0.000047379133,0.004962325,0.000007974155,0.95725256,0.0011893861],"about_ca_topic_score_codex":0.00015381932,"about_ca_topic_score_gemma":0.000021216883,"teacher_disagreement_score":0.98099697,"about_ca_system_score_codex":0.0004764275,"about_ca_system_score_gemma":0.0017401058,"threshold_uncertainty_score":0.99944955},"labels":[],"label_agreement":null},{"id":"W3110496265","doi":"10.3390/cancers12113471","title":"Construction of a Novel Multigene Panel Potently Predicting Poor Prognosis in Patients with Clear Cell Renal Cell Carcinoma","year":2020,"lang":"en","type":"article","venue":"Cancers","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"Canadian Institutes of Health Research; Canadian Cancer Society","keywords":"Clear cell renal cell carcinoma; Downregulation and upregulation; Hazard ratio; Cancer research; Population; Cell growth; Biology; Oncology; Internal medicine; Medicine; Gene; Renal cell carcinoma; Genetics","score_opus":0.026515873674753748,"score_gpt":0.21297566033425344,"score_spread":0.1864597866594997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110496265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979,0.00014119306,0.00006786332,0.000109800836,0.000066515146,0.00088722754,0.00004979247,0.000029185889,0.0007484131],"genre_scores_gemma":[0.9948564,0.000007892921,0.0047572097,0.00016027217,0.000068544745,0.00004083504,0.000047364167,0.000035158184,0.000026289768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986709,0.000022746563,0.00032679376,0.00036798805,0.0003512284,0.0002603634],"domain_scores_gemma":[0.99928325,0.000019872443,0.00020966188,0.00013357679,0.00014242399,0.00021118786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004325259,0.0001883217,0.00033388828,0.0000863709,0.000032494438,0.000006471655,0.00006738777,0.00006471749,0.000028658831],"category_scores_gemma":[0.000018131774,0.00015652903,0.00007263213,0.00029267103,0.00009642994,0.000062717314,0.000029411902,0.0001774405,0.000003546089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023455215,0.00020108123,0.95421404,0.0003707018,0.000039969218,0.00003826538,0.0011763087,0.0010070889,0.039453145,7.5542687e-7,0.000055360666,0.0010977455],"study_design_scores_gemma":[0.013171111,0.0037712876,0.7099451,0.00015888092,0.00020940356,0.0000068612253,0.0009619584,0.0038946122,0.26766285,3.012944e-7,0.00004087791,0.00017678543],"about_ca_topic_score_codex":0.0006504964,"about_ca_topic_score_gemma":0.000016212236,"teacher_disagreement_score":0.244269,"about_ca_system_score_codex":0.0007492813,"about_ca_system_score_gemma":0.00041020924,"threshold_uncertainty_score":0.63830686},"labels":[],"label_agreement":null},{"id":"W3110704903","doi":"10.1139/cjpp-2021-0291","title":"Modified cancer TNM classification for localized renal cell carcinoma based on the prognostic analysis of 3748 cases from a single center","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Stage (stratigraphy); Medicine; Cancer; Cutoff; TNM staging system; Internal medicine; Renal cell carcinoma; Oncology; Cancer staging; Proportional hazards model; Staging system; Biology","score_opus":0.06492965015693443,"score_gpt":0.30200988264519546,"score_spread":0.23708023248826104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110704903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953281,0.0011962757,0.0001141945,0.0024956388,0.00023894956,0.0002461933,0.00027909357,0.0000015764905,0.00009992533],"genre_scores_gemma":[0.99768835,0.000026655538,0.00012511984,0.0017829739,0.0001609501,0.00003349629,0.00013012964,0.000010084994,0.00004221024],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989333,0.00026278204,0.00032537765,0.00019048998,0.00007202128,0.00021600217],"domain_scores_gemma":[0.998168,0.0008240549,0.00027541615,0.00012963971,0.0003352563,0.00026766222],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011334697,0.00012785057,0.0004829905,0.00024566732,0.000087166365,0.00000513079,0.000076236814,0.00009781275,0.0010630168],"category_scores_gemma":[0.000063970336,0.00008788452,0.00022065041,0.00023815256,0.00018891184,0.000019303428,0.00000604896,0.00017484256,6.215868e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014325331,0.0002684582,0.043054678,0.00008122892,0.0012492484,0.00036800693,0.00019237693,0.0016272344,0.94924974,0.000029857629,0.0020685734,0.00037808408],"study_design_scores_gemma":[0.0058867424,0.001977499,0.2467406,0.00005947157,0.008502923,0.00007771683,0.00016138572,0.020954534,0.71368957,0.00014340125,0.0016538575,0.00015233493],"about_ca_topic_score_codex":0.0012188137,"about_ca_topic_score_gemma":0.0022637649,"teacher_disagreement_score":0.23556018,"about_ca_system_score_codex":0.00014444823,"about_ca_system_score_gemma":0.0010565325,"threshold_uncertainty_score":0.99985015},"labels":[],"label_agreement":null},{"id":"W3111161573","doi":"10.1002/onco.13628","title":"A Randomized Phase II Study of AGS-16C3F Versus Axitinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma","year":2020,"lang":"en","type":"article","venue":"The Oncologist","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"Astellas Pharma","keywords":"Axitinib; Medicine; Renal cell carcinoma; Clinical endpoint; Internal medicine; Adverse effect; Population; Oncology; Phases of clinical research; Nausea; Gastroenterology; Urology; Pharmacology; Randomized controlled trial; Clinical trial; Sunitinib","score_opus":0.0631375381713145,"score_gpt":0.31530819442871005,"score_spread":0.25217065625739554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111161573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901128,0.00024541627,0.0000063479733,0.0004334597,0.00003858366,0.005866497,0.000017260238,0.000038135822,0.0032414983],"genre_scores_gemma":[0.9990435,0.000009067845,0.00018555559,0.00011727532,0.000032493925,0.00034825428,0.000069122485,0.000029617036,0.00016508071],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997507,0.00071937457,0.00064264424,0.0003719818,0.00045089447,0.00030812807],"domain_scores_gemma":[0.9982857,0.00061695796,0.00037798085,0.00041528395,0.00013384853,0.00017019158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047816618,0.00029226788,0.001257682,0.00008483262,0.00008217178,0.000009606789,0.0001913696,0.000044561482,0.00009832968],"category_scores_gemma":[0.00027815375,0.00015040365,0.00015131549,0.0004299999,0.00027927037,0.00003972429,0.00009777434,0.00023487372,0.0000130342205],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94024384,0.016732115,0.026589097,0.00013802623,0.0006099156,0.00094371877,0.012230214,0.00010499508,0.0005053818,0.000007919821,0.0002839728,0.0016107946],"study_design_scores_gemma":[0.89409196,0.08115951,0.017030671,0.000041091615,0.0025190315,0.000005652544,0.0018743585,0.00024073986,0.0028175663,0.0000038976573,0.000051957606,0.00016356193],"about_ca_topic_score_codex":0.00089550606,"about_ca_topic_score_gemma":0.00020317211,"teacher_disagreement_score":0.06442739,"about_ca_system_score_codex":0.00022579989,"about_ca_system_score_gemma":0.00017458372,"threshold_uncertainty_score":0.6133283},"labels":[],"label_agreement":null},{"id":"W3112393379","doi":"10.1016/j.urolonc.2020.08.028","title":"Creation of a primary tumor tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinoma","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Calgary","funders":"","keywords":"Medicine; Hazard ratio; Renal cell carcinoma; Biomarker; Clear cell renal cell carcinoma; Oncology; Nephrectomy; Survivin; Internal medicine; Proportional hazards model; Immunohistochemistry; Cancer; Cohort; Confidence interval; Pathology; Kidney","score_opus":0.04092772972940268,"score_gpt":0.28401058310950333,"score_spread":0.24308285338010066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112393379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991751,0.00042306527,0.0032309166,0.0014078063,0.000025420406,0.0017563795,0.00010188678,0.00003708923,0.0012664441],"genre_scores_gemma":[0.8415128,0.00001396516,0.15678851,0.0007125439,0.00002314234,0.00028684645,0.00048084994,0.000019277826,0.00016206612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986618,0.00008980076,0.0003772552,0.00041248402,0.00021976943,0.00023890218],"domain_scores_gemma":[0.99877405,0.00027897075,0.00030137855,0.00015575741,0.00017675362,0.0003130767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011783686,0.0002283208,0.00050628785,0.000106619314,0.00012368496,0.000009121421,0.00007047476,0.00008660241,0.00001915146],"category_scores_gemma":[0.00014887383,0.00016262056,0.00005422698,0.00020933516,0.0003531678,0.000091239206,0.000039643717,0.00012843842,0.0000026398125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043695234,0.0019849709,0.9212605,0.0010044253,0.00014924606,0.00017290644,0.0014446403,0.0010910543,0.06328584,0.0003382964,0.0032780424,0.0016205648],"study_design_scores_gemma":[0.047645666,0.14616482,0.28031754,0.00081274466,0.01124539,0.00030570553,0.0008531772,0.22736338,0.1736262,0.0030735822,0.106842786,0.0017490118],"about_ca_topic_score_codex":0.000009226324,"about_ca_topic_score_gemma":0.0000019039686,"teacher_disagreement_score":0.64094293,"about_ca_system_score_codex":0.00011565311,"about_ca_system_score_gemma":0.00041220733,"threshold_uncertainty_score":0.66314745},"labels":[],"label_agreement":null},{"id":"W3113266772","doi":"10.1111/iju.14461","title":"Nomogram predicting 30‐day mortality after nephrectomy in the contemporary era: Results from the SEER database","year":2020,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Nomogram; Nephrectomy; Logistic regression; Confidence interval; Odds ratio; Univariate analysis; Epidemiology; Surveillance, Epidemiology, and End Results; Stage (stratigraphy); Renal function; Surgery; Database; Internal medicine; Multivariate analysis; Cancer registry; Kidney","score_opus":0.05522972004626227,"score_gpt":0.30545192746095623,"score_spread":0.250222207414694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113266772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92965275,0.0013592398,0.00015618917,0.066639155,0.00046831075,0.00019953301,0.00017103643,0.000007895878,0.0013458845],"genre_scores_gemma":[0.98329693,0.000045309553,0.00012999667,0.014932473,0.001476069,0.000009724918,0.00008937323,0.00001062308,0.000009479817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804145,0.000361406,0.00067623466,0.0001865927,0.0005987508,0.00013554245],"domain_scores_gemma":[0.9982299,0.0008820436,0.0003565374,0.00021486991,0.0002230122,0.00009362714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008406364,0.00012861898,0.00024147339,0.000060643604,0.000022526488,0.000032148026,0.0004391644,0.000061964216,0.00013162148],"category_scores_gemma":[0.0007186858,0.000067590874,0.00014737697,0.000089789464,0.00009131154,0.00012665112,0.00009316552,0.0006686243,0.000020509557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053687356,0.00031514512,0.96549886,0.000004931797,0.00093739125,0.0111176185,0.004685608,0.000086617896,0.0008483283,0.000034450615,0.008752233,0.0023500572],"study_design_scores_gemma":[0.0045838407,0.0005661856,0.96777004,0.00003980297,0.0001511456,0.0003871918,0.00029425492,0.00071292056,0.00017439274,0.000104897656,0.025150912,0.000064425],"about_ca_topic_score_codex":0.00024529675,"about_ca_topic_score_gemma":0.000052297593,"teacher_disagreement_score":0.053644195,"about_ca_system_score_codex":0.000057926285,"about_ca_system_score_gemma":0.00018027276,"threshold_uncertainty_score":0.2904877},"labels":[],"label_agreement":null},{"id":"W3113357467","doi":"10.1016/j.suronc.2020.12.004","title":"Contemporary rates and predictors of open conversion during minimally invasive partial nephrectomy for kidney cancer","year":2020,"lang":"en","type":"article","venue":"Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Logistic regression; Obesity; Volume (thermodynamics); Body mass index; Surgery; Internal medicine; Kidney","score_opus":0.061539420443356425,"score_gpt":0.33569218036847337,"score_spread":0.27415275992511695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113357467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98539853,0.0007594264,0.0000012990581,0.00683399,0.00013327519,0.0014582494,0.000062776504,0.000018442535,0.0053340322],"genre_scores_gemma":[0.9979024,0.00026839107,0.00022307948,0.00088498613,0.00022267723,0.00023729971,0.000058561443,0.000015292548,0.00018731401],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99902385,0.000090756774,0.0003065463,0.0002965337,0.00010716064,0.0001751186],"domain_scores_gemma":[0.99885267,0.00038296837,0.00014023464,0.00008615139,0.000092929775,0.0004450639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103939245,0.00013004491,0.00060750544,0.000033093558,0.00003947511,0.000008523276,0.000095904696,0.0001225708,0.00021786966],"category_scores_gemma":[0.00014035172,0.00009945588,0.00008706275,0.00008237592,0.00015674812,0.00007547763,0.00017624338,0.000098143115,0.000003966059],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05815006,0.0007108512,0.7862753,0.0018069216,0.0011262267,0.003065683,0.0017503118,0.000007879288,0.11859833,0.00011210557,0.024646848,0.0037494556],"study_design_scores_gemma":[0.024333218,0.0076276627,0.03413323,0.00016513874,0.00032030814,0.000090592184,0.00027946796,0.00011356412,0.33234718,0.000011726349,0.60039043,0.00018746326],"about_ca_topic_score_codex":0.00015585496,"about_ca_topic_score_gemma":0.000006531983,"teacher_disagreement_score":0.7521421,"about_ca_system_score_codex":0.00010189751,"about_ca_system_score_gemma":0.00091281533,"threshold_uncertainty_score":0.40556931},"labels":[],"label_agreement":null},{"id":"W3118373616","doi":"10.5489/cuaj.6963","title":"Cytoreductive stereotactic body radiotherapy (SBRT) and combination SBRT with immune checkpoint inhibitors (ICIs) in metastatic renal cell carcinoma","year":2021,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Radiosurgery; Oncology; Kidney cancer; Radiation therapy; Internal medicine; Systemic therapy; Radiology; Medical physics; Cancer","score_opus":0.022907382220366656,"score_gpt":0.2621901295491404,"score_spread":0.23928274732877375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118373616","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06756201,0.92916983,0.000009358798,0.0012327748,0.00023966716,0.0012994009,0.000038035723,0.000014089445,0.00043482526],"genre_scores_gemma":[0.19408238,0.803833,0.00029706565,0.00026753522,0.00038292684,0.00015200327,0.00028137132,0.00008910067,0.00061461126],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99563795,0.0010822125,0.0012930651,0.00058565475,0.000672982,0.00072814064],"domain_scores_gemma":[0.9967698,0.0003638755,0.001365235,0.00024717388,0.00037340255,0.0008805421],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00114436,0.0005993349,0.0022840519,0.00082755,0.00019952841,0.00018940379,0.00014480528,0.0004746847,0.00029953048],"category_scores_gemma":[0.00029151028,0.0004273278,0.000530864,0.00070990593,0.00007647139,0.00016203619,0.000026152551,0.0017873984,0.000013690085],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010734985,0.0039531863,0.20957933,0.009213064,0.010611525,0.04907104,0.003332236,0.000048371927,0.00019875306,0.00034099905,0.004485291,0.7080927],"study_design_scores_gemma":[0.0150048565,0.007949382,0.32746473,0.005692472,0.009597161,0.019706352,0.0005741174,0.000079559824,0.00011382392,0.00017562286,0.61146265,0.0021792774],"about_ca_topic_score_codex":0.0011616261,"about_ca_topic_score_gemma":0.0003621279,"teacher_disagreement_score":0.7059134,"about_ca_system_score_codex":0.010935204,"about_ca_system_score_gemma":0.0025789952,"threshold_uncertainty_score":0.99981785},"labels":[],"label_agreement":null},{"id":"W3119708965","doi":"10.1016/j.eururo.2020.12.029","title":"Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"National Cancer Institute; Novartis Pharmaceuticals Corporation; Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Pazopanib; Nephrectomy; Renal cell carcinoma; Placebo; Adjuvant; Oncology; Urology; Internal medicine; Kidney cancer; Surgery; Kidney; Sunitinib; Pathology","score_opus":0.022189224509967465,"score_gpt":0.2557066031132377,"score_spread":0.2335173786032702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119708965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954976,0.00017785693,0.00012732882,0.00013360883,0.0002608938,0.0015349836,0.00004584966,0.000022144148,0.002199775],"genre_scores_gemma":[0.99858826,0.0000041445223,0.00039434686,0.00022695764,0.000077315315,0.0000691779,0.00013932561,0.000054317505,0.0004461246],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9963778,0.0014269756,0.0006210766,0.00063804135,0.0004925302,0.00044358007],"domain_scores_gemma":[0.99836844,0.00024197965,0.00027157622,0.0007676221,0.00020385154,0.00014654241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033576845,0.00033645518,0.00088637054,0.00023449954,0.00004349272,0.000011767487,0.00019245117,0.0000764915,0.00044405262],"category_scores_gemma":[0.00019959718,0.00020146476,0.00029991547,0.0008755999,0.00016368693,0.00004720415,0.00016620733,0.00039218218,0.000017704864],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9134257,0.0022191864,0.076501526,0.000047873837,0.0006587947,0.0033163698,0.00025043348,0.0009346304,0.0009633961,0.000003913864,0.0000411156,0.0016370796],"study_design_scores_gemma":[0.4678216,0.016170083,0.50787735,0.000028307126,0.0028373552,0.000014257163,0.000028951386,0.00031572778,0.0028496026,0.0000012616271,0.0018010485,0.0002544654],"about_ca_topic_score_codex":0.000038086277,"about_ca_topic_score_gemma":0.00028794652,"teacher_disagreement_score":0.4456041,"about_ca_system_score_codex":0.00014430136,"about_ca_system_score_gemma":0.00037671,"threshold_uncertainty_score":0.8215495},"labels":[],"label_agreement":null},{"id":"W3120052833","doi":"10.1007/s00428-020-02986-3","title":"Morphological findings in frozen non-neoplastic kidney tissues of patients with kidney cancer from large-scale multicentric studies on renal cancer","year":2021,"lang":"en","type":"article","venue":"Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre","funders":"FP7 Ideas: European Research Council; NHS Greater Glasgow and Clyde; World Health Organization","keywords":"Medicine; Cancer; Kidney cancer; Pathology; Kidney; Kidney disease; Nephrectomy; Renal cell carcinoma; Kidney stones; Parenchyma; Internal medicine","score_opus":0.030301708956857337,"score_gpt":0.3511832150785821,"score_spread":0.3208815061217247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120052833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890378,0.00568069,0.00019183152,0.0014274614,0.0005701849,0.0011063266,0.0011907197,0.00009479246,0.0007001593],"genre_scores_gemma":[0.98625094,0.003714967,0.0044366494,0.0033444853,0.00030440243,0.00028113494,0.0013584233,0.000078747966,0.00023026227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945705,0.00058057735,0.0012112965,0.0015881716,0.00092784874,0.001121584],"domain_scores_gemma":[0.9956594,0.0016470597,0.00052764115,0.0009955426,0.00041770766,0.000752654],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050014135,0.00085031195,0.0021041892,0.0003954048,0.0001708614,0.000020103118,0.00044652613,0.00039390492,0.00040613717],"category_scores_gemma":[0.002966128,0.0005418795,0.00029949096,0.00088072754,0.00095651497,0.00011621619,0.00047034668,0.0012535859,0.0000516007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00674485,0.0047906633,0.9013172,0.00056660315,0.0024539072,0.004692448,0.0052800872,0.0016126187,0.064452745,0.00010043375,0.0051478515,0.0028406235],"study_design_scores_gemma":[0.018949183,0.0037411656,0.8575115,0.0030595036,0.002087751,0.0000123572,0.0018080225,0.0013981267,0.108488135,0.0006623876,0.0013893594,0.0008924779],"about_ca_topic_score_codex":0.0006226755,"about_ca_topic_score_gemma":0.00019265566,"teacher_disagreement_score":0.04403539,"about_ca_system_score_codex":0.00031986128,"about_ca_system_score_gemma":0.0010553948,"threshold_uncertainty_score":0.9997033},"labels":[],"label_agreement":null},{"id":"W3120377060","doi":"10.1016/j.euo.2020.12.011","title":"Novel Liquid Biomarkers and Innovative Imaging for Kidney Cancer Diagnosis: What Can Be Implemented in Our Practice Today? A Systematic Review of the Literature","year":2021,"lang":"en","type":"review","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Bayer Yakuhin; Astellas Pharma; Roche Italia; GlaxoSmithKline; Novartis; Pfizer","keywords":"Medicine; Kidney cancer; Medical physics; Cancer; Intensive care medicine; Pathology; Engineering ethics; Internal medicine; Engineering","score_opus":0.04897353009965996,"score_gpt":0.38862529324275014,"score_spread":0.3396517631430902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120377060","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023784898,0.96050704,0.0000051792344,0.03125313,0.0005425589,0.006903836,0.00037844354,0.000015902195,0.00037011958],"genre_scores_gemma":[0.00007482097,0.967964,0.00030488413,0.027500652,0.00013181691,0.003317476,0.00052009773,0.00010578281,0.00008050535],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924161,0.0043315096,0.0017879168,0.00078353856,0.00021192511,0.00046901748],"domain_scores_gemma":[0.9947625,0.001446742,0.0020433539,0.00076002756,0.0008240731,0.0001633428],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024490962,0.00059825537,0.00403394,0.00034852573,0.000066454166,0.000030729523,0.00033153032,0.0002188338,0.000021561696],"category_scores_gemma":[0.0063579553,0.00037211782,0.00043465424,0.0012505936,0.00014565107,0.000117917996,0.00040162206,0.0007778262,0.0000021348487],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019988636,0.00043614852,0.000058999005,0.95794433,0.0026457885,0.0013065578,0.0009298056,4.683312e-8,0.000016520431,0.00006525346,0.01194862,0.024448067],"study_design_scores_gemma":[0.001360817,0.00065220706,0.000018339932,0.48385146,0.008322134,0.0026365004,0.00041990832,5.5627214e-7,0.000005393482,3.6219743e-7,0.5025484,0.00018392014],"about_ca_topic_score_codex":0.00004350646,"about_ca_topic_score_gemma":0.000042041313,"teacher_disagreement_score":0.49059978,"about_ca_system_score_codex":0.0006542131,"about_ca_system_score_gemma":0.0019571204,"threshold_uncertainty_score":0.9998731},"labels":[],"label_agreement":null},{"id":"W3120787452","doi":"","title":"99mTC-Sestamibi SPECT/CT Imaging for the Risk Stratification of Renal Masses","year":2020,"lang":"en","type":"article","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Oncocytoma; Chromophobe cell; Histopathology; Radiology; Nuclear medicine; Renal cell carcinoma; Renal oncocytoma; Biopsy; Clear cell; Pathology","score_opus":0.0407624955350972,"score_gpt":0.2812513260902837,"score_spread":0.2404888305551865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120787452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93822694,0.0012625867,0.030372363,0.013554313,0.00007422135,0.0015701588,0.00003580853,0.000091837916,0.014811762],"genre_scores_gemma":[0.99513257,0.00006258415,0.0040031336,0.00023856247,0.00012404851,0.000029792873,0.000021828715,0.000013208507,0.0003742578],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993134,0.00002196448,0.0002083853,0.00017867069,0.00016738009,0.00011019986],"domain_scores_gemma":[0.9993166,0.0002158985,0.00010325362,0.00023193841,0.00006481493,0.000067515306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113071976,0.00009136783,0.00015196449,0.000021084747,0.000049235066,0.000013778222,0.00006600275,0.0000050255285,0.00018419044],"category_scores_gemma":[0.00012605022,0.000051343395,0.000106952386,0.00010158487,0.000045385263,0.000039705857,0.000013832607,0.00006852543,0.00001519763],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016555194,0.0006206175,0.5103973,0.00076292607,0.0010264219,0.00030029032,0.0013553546,0.0005210789,0.29662004,0.010659641,0.032146003,0.14393482],"study_design_scores_gemma":[0.0023387864,0.0007436907,0.13145229,0.000045345583,0.00089288264,0.00013085596,0.0015726878,0.019555282,0.8344457,0.00056751753,0.008100188,0.00015474192],"about_ca_topic_score_codex":0.0001286369,"about_ca_topic_score_gemma":0.000014165825,"teacher_disagreement_score":0.5378257,"about_ca_system_score_codex":0.00003393802,"about_ca_system_score_gemma":0.00006566416,"threshold_uncertainty_score":0.20937228},"labels":[],"label_agreement":null},{"id":"W3121216880","doi":"10.1007/s10147-021-01874-3","title":"The impact of sex and age on distribution of metastases in patients with renal cell carcinoma","year":2021,"lang":"en","type":"article","venue":"International Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Surgical oncology; Concomitant; Renal cell carcinoma; Internal medicine; Oncology","score_opus":0.05111899844409203,"score_gpt":0.4109287235590495,"score_spread":0.3598097251149575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121216880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99836963,0.00018943487,0.000022196407,0.00048792642,0.00016285342,0.00008234507,0.000054342734,6.7402675e-7,0.0006306034],"genre_scores_gemma":[0.99945605,0.00009914043,0.0002062025,0.00004422698,0.00009978894,9.4261605e-7,0.000042129304,0.000005013543,0.000046517383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804753,0.00028223195,0.0010525261,0.00010221056,0.0004258793,0.0000896088],"domain_scores_gemma":[0.99667364,0.0014696637,0.0008645675,0.00010332562,0.00079365086,0.00009515762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007004617,0.000082872066,0.00055308675,0.00006283999,0.0000102954145,0.0000052037217,0.00010004011,0.0000714297,0.000024170813],"category_scores_gemma":[0.00072980986,0.000042909745,0.00023418423,0.000067152076,0.00017142242,0.000037436253,0.00003960803,0.00027712728,5.4812176e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008855167,0.0024797826,0.9649059,0.000007783628,0.00046344858,0.001105491,0.000052550597,0.00009089981,0.0003092352,0.00006519527,0.00025140558,0.021413125],"study_design_scores_gemma":[0.007980123,0.012824332,0.9740376,0.000067219,0.000111632056,0.00010095861,0.000044025583,0.000016983066,0.004271966,0.00009540025,0.0004183648,0.000031380685],"about_ca_topic_score_codex":0.00003917658,"about_ca_topic_score_gemma":0.00002378636,"teacher_disagreement_score":0.021381745,"about_ca_system_score_codex":0.00020138246,"about_ca_system_score_gemma":0.00060565374,"threshold_uncertainty_score":0.17498086},"labels":[],"label_agreement":null},{"id":"W3121334239","doi":"10.1007/s00345-020-03556-7","title":"Frailty predicts outcome of partial nephrectomy and guides treatment decision towards active surveillance and tumor ablation","year":2021,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Comorbidity; Hypoalbuminemia; Charlson comorbidity index; Nephrology; Internal medicine; Nephrectomy; Cohort; Surgery; Kidney","score_opus":0.03896811316353204,"score_gpt":0.31274642960310095,"score_spread":0.2737783164395689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121334239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926245,0.005030261,0.00017541542,0.0012852213,0.00017145208,0.00015145501,0.000008612733,0.0000047275707,0.0005483395],"genre_scores_gemma":[0.99691,0.00057560526,0.0020474233,0.00016184141,0.00013811802,0.000003967519,0.00000446568,0.000010189191,0.00014842013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882054,0.000127438,0.0005277124,0.00016600583,0.00021166528,0.00014666452],"domain_scores_gemma":[0.99881554,0.0003089927,0.00034588625,0.0001382142,0.00024386456,0.00014750565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022269091,0.00013470216,0.00056754984,0.00016977145,0.000031162104,0.000007802744,0.0000313017,0.000046119952,0.00007957117],"category_scores_gemma":[0.00023654239,0.00009459453,0.000094485,0.00013100913,0.0000927173,0.000062114246,0.00003465645,0.00012454278,9.147825e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033228404,0.00026445693,0.8721215,0.000030039768,0.00036118153,0.0013294832,0.00026661047,0.00005653993,0.0061789597,0.00005521158,0.00013766366,0.11587553],"study_design_scores_gemma":[0.004435659,0.002359147,0.96847475,0.00003168277,0.00025831652,0.0022756548,0.000036497066,0.00012694292,0.012298085,0.0002539901,0.009386269,0.0000630163],"about_ca_topic_score_codex":0.000032963642,"about_ca_topic_score_gemma":0.00012685498,"teacher_disagreement_score":0.11581251,"about_ca_system_score_codex":0.00009685143,"about_ca_system_score_gemma":0.00014586287,"threshold_uncertainty_score":0.3857453},"labels":[],"label_agreement":null},{"id":"W3121354740","doi":"10.1002/cam4.3717","title":"Cabozantinib real‐world effectiveness in the first‐through fourth‐line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium","year":2021,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; London Health Sciences Centre; McMaster University; Sunnybrook Health Science Centre; Juravinski Cancer Centre; University of Calgary","funders":"Ipsen; Eisai; Exelixis; Pfizer; Astellas Pharma; Bristol-Myers Squibb","keywords":"Cabozantinib; Medicine; Hazard ratio; Renal cell carcinoma; Dosing; Urology; Internal medicine; Oncology; Carcinoma; Confidence interval","score_opus":0.06322644100482115,"score_gpt":0.33049489161234286,"score_spread":0.2672684506075217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121354740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93684417,0.022680243,0.0007182372,0.030662326,0.0009774569,0.0036043942,0.002669902,0.00002651228,0.0018167462],"genre_scores_gemma":[0.98948085,0.0019430253,0.0012626826,0.001856409,0.0010121209,0.0011992555,0.002128911,0.00006968117,0.0010470498],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955407,0.000552758,0.0012944086,0.00094876497,0.0010745107,0.0005888853],"domain_scores_gemma":[0.98836637,0.008768126,0.00069177954,0.0015016376,0.0005251399,0.00014694777],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014448684,0.0006018203,0.0011835961,0.00014338607,0.00025138294,0.000032555705,0.0005808231,0.000060043225,0.00024200646],"category_scores_gemma":[0.00045210993,0.0002839444,0.00036087536,0.00077861635,0.00052627374,0.0001122998,0.000098933466,0.00038341258,0.000005820939],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07720267,0.019118015,0.24444285,0.00795881,0.010593662,0.020958833,0.15176052,0.0067850617,0.26828194,0.0017513076,0.16519436,0.025951969],"study_design_scores_gemma":[0.08153737,0.005543805,0.22754692,0.0019040784,0.011715876,0.00023278316,0.010489595,0.0036350656,0.53917843,0.0002984004,0.117182225,0.00073542894],"about_ca_topic_score_codex":0.018427785,"about_ca_topic_score_gemma":0.006945791,"teacher_disagreement_score":0.27089652,"about_ca_system_score_codex":0.0005974321,"about_ca_system_score_gemma":0.00080197194,"threshold_uncertainty_score":0.99996126},"labels":[],"label_agreement":null},{"id":"W3124025693","doi":"10.14740/jmc3640","title":"Renal Subcapsular Hematoma Formation Due to Hydronephrosis Caused by Recurrent Uterine Cervical Cancer","year":2021,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Hydronephrosis; Cervical cancer; Hematoma; Asymptomatic; Surgery; Radiology; Cancer; Urinary system; Internal medicine","score_opus":0.03249030442408706,"score_gpt":0.32173860623473033,"score_spread":0.28924830181064326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124025693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9607687,0.007899123,0.0014783065,0.029191297,0.00039264234,0.00016310689,0.000030472444,0.0000159566,0.000060394865],"genre_scores_gemma":[0.9945534,0.001311453,0.0006600588,0.0024222864,0.0007524979,0.000019836936,0.000039432773,0.000024779121,0.00021626458],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964376,0.00012881345,0.00084956066,0.00019303174,0.0020875575,0.0003034561],"domain_scores_gemma":[0.9978526,0.00016460652,0.00026174585,0.00022280536,0.0004107784,0.0010874327],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004737427,0.00020009752,0.00063886994,0.00013305534,0.000055985915,0.000034592565,0.00013899051,0.00015569363,0.002708354],"category_scores_gemma":[0.0007166243,0.00014358618,0.00025034364,0.00029833385,0.000039882914,0.00013724956,0.00008942009,0.0004322528,0.000029362922],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031849965,0.003792709,0.004162305,0.0016056345,0.0011385691,0.25086015,0.0013609083,0.000027640777,0.141887,0.00008631036,0.4259644,0.16592938],"study_design_scores_gemma":[0.00971942,0.0052583646,0.018852275,0.003904191,0.0009890229,0.115753375,0.00044072972,0.0007369567,0.6348331,0.00005914281,0.20897147,0.00048198167],"about_ca_topic_score_codex":0.00006234804,"about_ca_topic_score_gemma":0.00008561208,"teacher_disagreement_score":0.4929461,"about_ca_system_score_codex":0.00043309934,"about_ca_system_score_gemma":0.0005604322,"threshold_uncertainty_score":0.9982033},"labels":[],"label_agreement":null},{"id":"W3124179127","doi":"10.48083/tngm4076","title":"Promising Biomarkers in Renal Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Renal cell carcinoma; Medicine; Incidence (geometry); Oncology; Kidney cancer; Internal medicine; Carcinoma; Cancer","score_opus":0.043627439070540626,"score_gpt":0.30696360480882173,"score_spread":0.2633361657382811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124179127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9570073,0.002265704,0.00015483024,0.003982193,0.00056541804,0.00017922062,0.000006615783,0.000027480852,0.035811253],"genre_scores_gemma":[0.99231267,0.00015419169,0.0030432628,0.00076202926,0.00040818276,0.000014425465,0.00005420258,0.000021918953,0.003229135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998006,0.0001605926,0.00053898594,0.0003361131,0.0005793781,0.00037896205],"domain_scores_gemma":[0.9988053,0.00019127647,0.00022292403,0.00022020929,0.00036888092,0.00019141984],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000442566,0.0002061482,0.0003295318,0.00026247237,0.000097617456,0.000079462,0.00017154643,0.00014173698,0.0010607451],"category_scores_gemma":[0.00030994325,0.00017974322,0.00030659907,0.00023147745,0.000073118405,0.0001478149,0.000100528916,0.00064994633,0.000035762918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096553715,0.0011221372,0.84688777,0.00007856499,0.0005587555,0.018986579,0.00061936886,0.00015645241,0.111671485,0.00016179545,0.006276803,0.012514737],"study_design_scores_gemma":[0.008039823,0.0006415075,0.85307175,0.000120149605,0.00017604898,0.00794103,0.0010226597,0.0005313767,0.12072612,0.0016532331,0.005763684,0.00031258905],"about_ca_topic_score_codex":0.00001969371,"about_ca_topic_score_gemma":0.000013859382,"teacher_disagreement_score":0.035305366,"about_ca_system_score_codex":0.00078638364,"about_ca_system_score_gemma":0.00068002887,"threshold_uncertainty_score":0.9998524},"labels":[],"label_agreement":null},{"id":"W3124911266","doi":"10.48083/xlqz8269","title":"Novel Expanding Renal Cell Carcinoma Biomarkers","year":2021,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Renal cell carcinoma; Liquid biopsy; Medicine; Disease; Kidney cancer; Asymptomatic; Cancer; Biomarker; Proteomics; Bioinformatics; Intensive care medicine; Internal medicine; Biology","score_opus":0.05798884030559588,"score_gpt":0.31863088657393124,"score_spread":0.26064204626833537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124911266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9487504,0.0018904371,0.002203066,0.003170319,0.0011108059,0.00014638563,0.000019285559,0.000050353003,0.042658944],"genre_scores_gemma":[0.9837286,0.0001689919,0.00642707,0.0011140388,0.0008368453,0.000014650378,0.00009543256,0.000029142368,0.0075852135],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978695,0.000071376846,0.0005245669,0.00037410838,0.00074064743,0.00041980247],"domain_scores_gemma":[0.9983924,0.00021435414,0.00028177435,0.00026928977,0.0005554342,0.00028673242],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003642952,0.00025175873,0.0003526078,0.00021866968,0.00020340734,0.00010956232,0.0002154234,0.00015719904,0.0017690739],"category_scores_gemma":[0.00022889696,0.00021538057,0.00048048215,0.00019723034,0.00009213379,0.00016677164,0.00013866091,0.00061095593,0.000056648172],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093219744,0.0014306669,0.2971958,0.00007952316,0.0012439049,0.007445169,0.00066642236,0.00013330995,0.66323066,0.00032627568,0.018026553,0.009289516],"study_design_scores_gemma":[0.012474956,0.0011401973,0.55139124,0.00012589319,0.00058318133,0.02401332,0.002417951,0.0005450633,0.38713038,0.0010256023,0.018570919,0.0005812823],"about_ca_topic_score_codex":0.000016546479,"about_ca_topic_score_gemma":0.0000043989053,"teacher_disagreement_score":0.27610028,"about_ca_system_score_codex":0.0006706687,"about_ca_system_score_gemma":0.00056844373,"threshold_uncertainty_score":0.9991434},"labels":[],"label_agreement":null},{"id":"W3125140576","doi":"10.1001/jamanetworkopen.2020.21869","title":"Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival","year":2021,"lang":"en","type":"article","venue":"JAMA Network Open","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":299,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Sunnybrook Health Science Centre; University of Ottawa; Princess Margaret Cancer Centre; University of Calgary","funders":"Sanofi Genzyme; Ipsen; Astellas Pharma; Exelixis; Eisai; Sanofi; Genentech; AstraZeneca; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Chromophobe cell; Papillary renal cell carcinomas; Medicine; Metastasis; Papillary carcinoma; Clear cell; Oncology; Pathology; Clear cell renal cell carcinoma; Renal cell carcinoma; Internal medicine; Cancer; Thyroid carcinoma; Thyroid","score_opus":0.040384152762341204,"score_gpt":0.27623092032407753,"score_spread":0.23584676756173634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125140576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761042,0.0083648125,0.0000068823,0.00059190404,0.000047915128,0.0007286472,0.000014114754,0.000008838732,0.014132713],"genre_scores_gemma":[0.99611336,0.00054998015,0.0022016682,0.000099840116,0.00018165745,0.00003050593,0.00013797732,0.000028399243,0.00065662793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758184,0.00061896886,0.00028137813,0.0003856543,0.0008873682,0.0002447843],"domain_scores_gemma":[0.9984269,0.00022112869,0.00026867242,0.0002980759,0.00064675766,0.00013843224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024427199,0.00017909783,0.00047097856,0.000036777878,0.00009736914,0.00011137,0.00007404489,0.000114621886,0.00019802275],"category_scores_gemma":[0.000090049805,0.00014409372,0.00004829485,0.00027486114,0.000036021644,0.00019507567,0.00019700079,0.00015376364,0.0000051866928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011151914,0.00031723073,0.96402913,0.00023399177,0.0005139418,0.0002060068,0.00066002476,0.0004268688,0.019235969,0.000036000278,0.004256291,0.008969337],"study_design_scores_gemma":[0.007070446,0.0012477495,0.8861348,0.00013164557,0.0025854136,0.00005969113,0.00039567275,0.0016879544,0.09960664,0.00008200725,0.00079818285,0.00019976405],"about_ca_topic_score_codex":0.00022250434,"about_ca_topic_score_gemma":0.00015279763,"teacher_disagreement_score":0.08037067,"about_ca_system_score_codex":0.00023596155,"about_ca_system_score_gemma":0.00030943123,"threshold_uncertainty_score":0.58759713},"labels":[],"label_agreement":null},{"id":"W3125452651","doi":"10.1007/s00261-020-02906-8","title":"Bosniak classification of cystic renal masses, version 2019: interpretation pitfalls and recommendations to avoid misclassification","year":2021,"lang":"en","type":"review","venue":"Abdominal Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University Health Network; University of Toronto; Mount Sinai Hospital; Ottawa Hospital; University of Ottawa","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Interpretation (philosophy); Radiology; Renal mass; Classification scheme; Medical physics; Computer science; Internal medicine; Kidney; Data science; Nephrectomy","score_opus":0.04631843731306666,"score_gpt":0.3493860588738951,"score_spread":0.30306762156082845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125452651","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009305691,0.9916493,0.003426439,0.0010807475,0.00035416102,0.0014217286,0.000091355636,0.000028467082,0.0010171736],"genre_scores_gemma":[0.0034443724,0.98224664,0.009437436,0.00009387675,0.00016651291,0.00021964627,0.0035765762,0.000051902312,0.0007630291],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971509,0.00066664553,0.0010119969,0.0007070335,0.00020668739,0.0002567571],"domain_scores_gemma":[0.9974426,0.0008540307,0.00065453135,0.00059266534,0.00023348616,0.00022266891],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047035562,0.00038756165,0.0017540462,0.0005110532,0.00007506243,0.000018197412,0.00014544294,0.00042167114,0.00017303662],"category_scores_gemma":[0.00051573355,0.00033131364,0.0003207228,0.00037277103,0.00012354364,0.00006525492,0.00007431462,0.00036475438,0.000117674856],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032483932,0.0002001146,0.000056996592,0.005106,0.0004914253,0.000056940582,0.0001898511,0.0000018474449,0.002402836,0.00084924925,0.014792218,0.9755277],"study_design_scores_gemma":[0.0007848354,0.0010894331,0.0019746076,0.010491105,0.0035971901,0.001757829,0.00014865861,0.00016246838,0.00012362732,0.00003530795,0.9794969,0.0003380607],"about_ca_topic_score_codex":0.000030067746,"about_ca_topic_score_gemma":0.0000064695882,"teacher_disagreement_score":0.9751896,"about_ca_system_score_codex":0.00056999497,"about_ca_system_score_gemma":0.00046686066,"threshold_uncertainty_score":0.9999139},"labels":[],"label_agreement":null},{"id":"W3126650609","doi":"10.1016/j.euf.2018.01.007","title":"Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, Cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years","year":2018,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Hazard ratio; Propensity score matching; Confidence interval; Nephrectomy; Renal cell carcinoma; Odds ratio; Internal medicine; Proportional hazards model; Logistic regression; Cancer; Surgery; Urology; Kidney","score_opus":0.0728221043810258,"score_gpt":0.3535331856664727,"score_spread":0.28071108128544686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126650609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925045,0.0005795457,0.0000080161635,0.00006570913,0.0007048985,0.0008078266,0.00003668271,0.000060004615,0.005232864],"genre_scores_gemma":[0.99927354,0.00002633138,0.000011596711,0.00012443801,0.00041757408,0.00002353074,0.000028242886,0.000071702874,0.000023031575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99637353,0.001253656,0.0006480613,0.0007138892,0.00050944963,0.000501423],"domain_scores_gemma":[0.99845505,0.00022614098,0.00024655595,0.0007483781,0.00006283112,0.0002610619],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007646728,0.000363363,0.00080112775,0.00016671026,0.000058261678,0.00001673671,0.00019688178,0.00014140288,0.00029461845],"category_scores_gemma":[0.00008997293,0.0003116778,0.00013946263,0.00020566597,0.00073918834,0.000049255323,0.00016644604,0.00041041314,0.00016210883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014574436,0.0008283124,0.9902793,0.000033608358,0.00054668833,0.00031212613,0.0006071341,0.0000072332373,0.0002902532,0.00004478171,0.00040761163,0.005185471],"study_design_scores_gemma":[0.009584882,0.007536834,0.9758476,0.000045616263,0.0005298187,0.0000027761373,0.000009418418,0.00006218629,0.0044258824,0.000008778413,0.0017297844,0.00021643503],"about_ca_topic_score_codex":0.0005668761,"about_ca_topic_score_gemma":0.0003359682,"teacher_disagreement_score":0.014431749,"about_ca_system_score_codex":0.00012565329,"about_ca_system_score_gemma":0.00004222513,"threshold_uncertainty_score":0.99993354},"labels":[],"label_agreement":null},{"id":"W3126738486","doi":"10.1200/jco.20.02365","title":"Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":287,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Université Laval","funders":"National Cancer Institute","keywords":"Medicine; Pembrolizumab; Chromophobe cell; Internal medicine; Renal cell carcinoma; Response Evaluation Criteria in Solid Tumors; Gastroenterology; Clinical endpoint; Histology; Phases of clinical research; Cohort; Clear cell; Surgery; Oncology; Urology; Cancer; Chemotherapy; Immunotherapy; Clinical trial","score_opus":0.11567608040251645,"score_gpt":0.4254655043625331,"score_spread":0.30978942396001663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126738486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99414474,0.00074386236,0.000014630026,0.0008879753,0.0003628782,0.0013095023,0.0000055634323,0.000005779938,0.0025250886],"genre_scores_gemma":[0.99524915,0.00050592417,0.0024600367,0.0009520998,0.00022374136,0.000017729837,0.000011503982,0.00006325218,0.0005165641],"study_design_codex":"nonrandomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99449456,0.00068241556,0.0031452652,0.0005157971,0.0007678701,0.0003941172],"domain_scores_gemma":[0.99430716,0.0009352475,0.002564497,0.0005843351,0.0011426241,0.00046613853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011141768,0.00035345182,0.0026143591,0.00022367042,0.00007833646,0.00001836951,0.00045008265,0.0003150333,0.0003015879],"category_scores_gemma":[0.00030457863,0.00024141696,0.00026091456,0.00041156015,0.00013949457,0.00021221706,0.00018843493,0.0010552873,0.000007903601],"study_design_candidate":"nonrandomized_trial","study_design_consensus":"nonrandomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22682932,0.41646066,0.23239376,0.000058844053,0.0005273953,0.005639953,0.0012825269,0.00018184457,0.006265782,0.0000017449577,0.00035163615,0.11000652],"study_design_scores_gemma":[0.27392477,0.53669924,0.17617054,0.00009313236,0.00025830866,0.000059754562,0.00033292215,0.000038440856,0.010007698,0.00001859634,0.002232503,0.00016411075],"about_ca_topic_score_codex":0.000067420435,"about_ca_topic_score_gemma":0.00010148541,"teacher_disagreement_score":0.12023854,"about_ca_system_score_codex":0.0003759168,"about_ca_system_score_gemma":0.001927923,"threshold_uncertainty_score":0.9844698},"labels":[],"label_agreement":null},{"id":"W3127445005","doi":"10.2196/25635","title":"Machine Learning Approach to Predict the Probability of Recurrence of Renal Cell Carcinoma After Surgery: Prediction Model Development Study","year":2021,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Renal cell carcinoma; Nephrectomy; Medicine; Receiver operating characteristic; Naive Bayes classifier; Cohort; Surgery; Machine learning; Internal medicine; Database; Computer science; Kidney; Support vector machine","score_opus":0.035352677772320894,"score_gpt":0.2609526600505753,"score_spread":0.22559998227825442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127445005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902729,0.00017130344,0.00515094,0.00008712741,0.00005877843,0.0015085747,0.000022652119,0.000032093332,0.0026956291],"genre_scores_gemma":[0.99064404,0.000014199902,0.00850145,0.000093626004,0.00003441639,0.00041060196,0.00011933033,0.000014698854,0.00016765401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962003,0.00016298272,0.0014303273,0.00020412137,0.0017120773,0.00029017523],"domain_scores_gemma":[0.99823457,0.00018293387,0.00031301324,0.00053443,0.0003872218,0.00034781187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013504185,0.00022585383,0.00059617934,0.0001202302,0.00006577548,0.000011211155,0.00017391972,0.00013396844,0.000060626513],"category_scores_gemma":[0.00037965472,0.0001423846,0.00014429247,0.00046514565,0.00013308998,0.000097322336,0.00024902867,0.0005048977,0.000005776542],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011666814,0.007510903,0.88949984,0.00475775,0.00028852638,0.000062651634,0.073627755,0.003393118,0.00014395444,0.000029707517,0.0010161574,0.018502949],"study_design_scores_gemma":[0.0043602227,0.002296513,0.59761804,0.00096989906,0.00053252187,0.00021410648,0.0076735434,0.3649237,0.01970907,0.000053335803,0.0011749167,0.00047417468],"about_ca_topic_score_codex":0.000013602464,"about_ca_topic_score_gemma":0.0000060490693,"teacher_disagreement_score":0.36153057,"about_ca_system_score_codex":0.00016189505,"about_ca_system_score_gemma":0.0012626642,"threshold_uncertainty_score":0.58062756},"labels":[],"label_agreement":null},{"id":"W3127487470","doi":"10.1038/s41379-021-00737-6","title":"Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia","year":2021,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":220,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of British Columbia; Royal Columbian Hospital; University of Calgary","funders":"","keywords":"Renal cell carcinoma; Medicine; Pathology; Genitourinary system; Renal pathology; Hematopathology; Kidney; Internal medicine; Biology; Cytogenetics","score_opus":0.020441957472022782,"score_gpt":0.2586204142307641,"score_spread":0.2381784567587413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127487470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847872,0.0020715652,0.0046962937,0.006082006,0.00026754485,0.00033413034,0.00004561592,0.00006578785,0.0016498119],"genre_scores_gemma":[0.98677546,0.00036666516,0.0063502025,0.0033789207,0.0004030557,0.00008497563,0.00017118,0.000052298292,0.0024172578],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99781907,0.00019934113,0.00036519358,0.0007621797,0.00034622932,0.00050796254],"domain_scores_gemma":[0.99882925,0.00015699002,0.000121221405,0.0006121233,0.00013334019,0.00014709616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003236884,0.0003111384,0.00045024915,0.00007151987,0.00028480892,0.00002994376,0.00012380866,0.00023175708,0.00019202866],"category_scores_gemma":[0.00006176465,0.00021929468,0.00023553608,0.00012529426,0.0003255105,0.000061211365,0.0002739845,0.0005333051,0.000052139134],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014691395,0.00162485,0.010801445,0.0002389558,0.0006205438,0.040597167,0.009126546,0.0005006964,0.88906705,0.0027745788,0.008752485,0.03442656],"study_design_scores_gemma":[0.028527575,0.0099604735,0.39495564,0.00072274986,0.0025712927,0.28498858,0.0042792065,0.027256967,0.16775542,0.018096969,0.05825631,0.0026288375],"about_ca_topic_score_codex":0.0000070816986,"about_ca_topic_score_gemma":0.000013077015,"teacher_disagreement_score":0.7213116,"about_ca_system_score_codex":0.000106323096,"about_ca_system_score_gemma":0.0002381481,"threshold_uncertainty_score":0.8942577},"labels":[],"label_agreement":null},{"id":"W3128057647","doi":"10.1245/s10434-021-09653-0","title":"ASO Author Reflections: Long-Term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Surgical oncology; Medicine; Renal cell carcinoma; Surgical resection; Resection; General surgery; Pancreatic carcinoma; Carcinoma; Term (time); Oncology; Internal medicine; Radiology; Surgery; Pancreatic cancer; Cancer","score_opus":0.12658055915755456,"score_gpt":0.4064383758700922,"score_spread":0.2798578167125376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128057647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786995,0.0058936616,0.000012309889,0.0053155846,0.00026109707,0.00031772009,0.00009723545,0.000032729648,0.009370183],"genre_scores_gemma":[0.9935736,0.0018105857,0.0007619639,0.00017595754,0.00022331181,0.000069713635,0.00021446112,0.000033959022,0.0031364416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99666387,0.00075898843,0.0010207646,0.000571423,0.00054774043,0.0004372022],"domain_scores_gemma":[0.99682015,0.0013326763,0.00035138312,0.00057674636,0.00058735313,0.00033167884],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047552542,0.0003017367,0.0014829705,0.00021969425,0.00005827082,0.000011127209,0.00010642412,0.0003534744,0.0022207901],"category_scores_gemma":[0.00010188512,0.00023367416,0.00070727954,0.0004423012,0.00028972022,0.00009425928,0.00012834737,0.00037906054,0.000051637744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029799731,0.008636422,0.8674138,0.0006297717,0.0021087257,0.057723586,0.0004878587,0.000020944832,0.01793663,0.00040463786,0.0033406909,0.011497186],"study_design_scores_gemma":[0.007374475,0.0077033364,0.6899822,0.00019605682,0.0012837916,0.0012696164,0.00015947502,0.000011530879,0.23875529,0.00025402542,0.052696828,0.0003134288],"about_ca_topic_score_codex":0.0004042843,"about_ca_topic_score_gemma":0.00016335874,"teacher_disagreement_score":0.22081865,"about_ca_system_score_codex":0.00012776628,"about_ca_system_score_gemma":0.00039894204,"threshold_uncertainty_score":0.9986913},"labels":[],"label_agreement":null},{"id":"W3128189669","doi":"10.15586/jkcvhl.v8i1.151","title":"Bilateral Single-Stage Nephrectomy for Synchronous Bilateral Renal Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"Journal of Kidney Cancer and VHL","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thunder Bay Regional Health Sciences Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Stage (stratigraphy); Surgery; Concordance; Carcinoma; Kidney; Oncology; Pathology; Internal medicine","score_opus":0.02617540161255179,"score_gpt":0.2764010709656299,"score_spread":0.2502256693530781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128189669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881596,0.005946764,0.00016701828,0.003539901,0.00062522426,0.00024105365,0.000075472046,0.000010140289,0.0012348206],"genre_scores_gemma":[0.98916745,0.00029635435,0.0027973347,0.002023354,0.001039653,0.000014240892,0.000022832379,0.000036607857,0.004602178],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986092,0.00003656872,0.00050364825,0.00024085768,0.00027752595,0.00033220736],"domain_scores_gemma":[0.99827605,0.000056318757,0.00026827777,0.00018138943,0.00036972828,0.00084825966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014464509,0.00022354856,0.0005459483,0.00014123692,0.0000808481,0.00006222252,0.00006833016,0.00009607298,0.0002934548],"category_scores_gemma":[0.000076292396,0.00016263971,0.00029724385,0.00013409834,0.00005162241,0.00014201165,0.000035086818,0.00023471362,0.0000022697689],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034638618,0.00090845284,0.14456399,0.0013430435,0.0005891696,0.005343603,0.0014031762,0.000062408544,0.7850616,0.000021423373,0.04312152,0.01411775],"study_design_scores_gemma":[0.0136123095,0.00361837,0.039442256,0.0005114173,0.0010202589,0.003335513,0.00016412635,0.0002260439,0.76328135,0.000075470634,0.17434528,0.00036757733],"about_ca_topic_score_codex":0.00007028378,"about_ca_topic_score_gemma":0.000009735405,"teacher_disagreement_score":0.13122377,"about_ca_system_score_codex":0.00034483703,"about_ca_system_score_gemma":0.0014131973,"threshold_uncertainty_score":0.66322553},"labels":[],"label_agreement":null},{"id":"W3128607514","doi":"10.1038/s41467-021-21068-9","title":"Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma","year":2021,"lang":"en","type":"article","venue":"Nature Communications","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Congressionally Directed Medical Research Programs; Fondation ARC pour la Recherche sur le Cancer; Kidney Cancer Association; Dana-Farber/Harvard Cancer Center; Dana-Farber Cancer Institute; Bristol-Myers Squibb; G. Harold and Leila Y. Mathers Foundation; Leukemia and Lymphoma Society; National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services; U.S. Department of Defense","keywords":"CDKN2A; BAP1; Renal cell carcinoma; Cancer research; Immune system; Phenotype; Biology; Immune checkpoint; Downregulation and upregulation; Gene; Immunotherapy; Medicine; Immunology; Pathology; Melanoma; Genetics","score_opus":0.01322293704214814,"score_gpt":0.2688587533848333,"score_spread":0.2556358163426851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128607514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97530353,0.012075795,0.00016652864,0.0027682553,0.000030987398,0.00024528243,0.000035651134,0.000021483776,0.009352507],"genre_scores_gemma":[0.99020284,0.0007124688,0.007584664,0.00029767698,0.000012724499,0.000024834906,0.00076331425,0.000016737733,0.00038472834],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99919516,0.00014082645,0.00022486165,0.00017565116,0.00016130152,0.000102173515],"domain_scores_gemma":[0.9981008,0.00008975248,0.00011394111,0.0012130898,0.00040119397,0.00008122681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006948506,0.00012574666,0.0002403742,0.000086471504,0.00007707896,0.000011940719,0.00017170377,0.000165086,0.00002460214],"category_scores_gemma":[0.00007539011,0.00010716489,0.00008011406,0.00028952144,0.0001208921,0.00005389432,0.00020051532,0.00049473246,0.0000041344197],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002587336,0.00026275037,0.019452846,0.000043033473,0.000039922103,0.000033188255,0.00042312144,1.2623168e-7,0.97545165,0.0033126276,0.00008454792,0.0008703296],"study_design_scores_gemma":[0.00059205235,0.000102372986,0.21864307,0.00006246863,0.000121359335,0.000128945,0.00016278277,0.00009750694,0.7765822,0.000068497924,0.0033559198,0.00008284886],"about_ca_topic_score_codex":0.0000105383315,"about_ca_topic_score_gemma":0.0000215787,"teacher_disagreement_score":0.19919023,"about_ca_system_score_codex":0.00006073847,"about_ca_system_score_gemma":0.00015237965,"threshold_uncertainty_score":0.43700573},"labels":[],"label_agreement":null},{"id":"W3129047020","doi":"10.1245/s10434-021-09649-w","title":"Long-term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"National Cancer Institute; Università degli Studi di Verona","keywords":"Surgical oncology; Medicine; Renal cell carcinoma; Surgical resection; Resection; General surgery; Carcinoma; Oncology; Internal medicine; Surgery","score_opus":0.07973069874157124,"score_gpt":0.3584860936439911,"score_spread":0.27875539490241985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129047020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806713,0.0063251,0.000004800735,0.002995789,0.00014288376,0.00025678985,0.00009417145,0.0000207164,0.009488478],"genre_scores_gemma":[0.9954892,0.0020402593,0.0003364704,0.0001845085,0.00016534957,0.000037570862,0.00021043926,0.00002882589,0.0015073715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971178,0.0005581112,0.0008979117,0.00049648207,0.00052114716,0.00040855087],"domain_scores_gemma":[0.99717546,0.0012135382,0.00030166825,0.0005317238,0.0004671986,0.00031043933],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035823107,0.00027637192,0.001504589,0.00015461948,0.00003234058,0.0000076037054,0.00010424036,0.00028808697,0.0027304308],"category_scores_gemma":[0.00005730468,0.00020829776,0.000669447,0.0002830055,0.0002789528,0.00007345741,0.00013581036,0.00029094645,0.00004919632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0149158165,0.00384565,0.9181448,0.00033334133,0.0008577257,0.04856877,0.00017217577,0.000007056159,0.005504786,0.00013652233,0.0010510013,0.0064623337],"study_design_scores_gemma":[0.0066772364,0.004865334,0.7565057,0.00012261605,0.0007744133,0.0008569363,0.00007097333,0.00000756915,0.2136163,0.00010464952,0.016191827,0.00020642576],"about_ca_topic_score_codex":0.00032625414,"about_ca_topic_score_gemma":0.000078331745,"teacher_disagreement_score":0.20811151,"about_ca_system_score_codex":0.00008118797,"about_ca_system_score_gemma":0.0003143193,"threshold_uncertainty_score":0.9981812},"labels":[],"label_agreement":null},{"id":"W3129086961","doi":"10.1111/bju.15353","title":"Cost‐effectiveness analysis of multiple imaging modalities in diagnosis and follow‐up of intermediate complex cystic renal lesions","year":2021,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Medicine; Radiology; Malignancy; Gold standard (test); Magnetic resonance imaging; Modalities; Cost-effectiveness analysis; Ultrasound; Cost effectiveness; Internal medicine","score_opus":0.044485913410222094,"score_gpt":0.3009227403074441,"score_spread":0.256436826897222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129086961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907382,0.008238274,0.00053437595,0.00014664083,0.00009494942,0.00013724485,0.00006436698,0.0000026982823,0.000043232863],"genre_scores_gemma":[0.9981494,0.0013474134,0.00034675028,0.00006416883,0.00002760378,0.000011990735,0.000031042324,0.000011519164,0.0000101357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983181,0.0004531459,0.0006725126,0.00016714436,0.00020574009,0.00018338619],"domain_scores_gemma":[0.997895,0.001136224,0.00035141004,0.000121172234,0.00038644206,0.00010973746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004503986,0.000107507425,0.0009698773,0.0004889178,0.000024730232,0.000009517323,0.00006839039,0.000056349465,0.00008092636],"category_scores_gemma":[0.0008147197,0.00011336211,0.0002742641,0.00040516068,0.00021034574,0.00006459864,0.00006812797,0.00020976305,2.3842261e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007631777,0.0003946936,0.95977825,0.00013904051,0.0012855127,0.0063327444,0.00034720966,0.0008795971,0.012478346,0.00001256013,0.00004554561,0.017543312],"study_design_scores_gemma":[0.004726595,0.00042849762,0.9826638,0.00032782255,0.0020111154,0.0035828827,0.0003100128,0.00174451,0.003984688,0.000114987546,0.000037161557,0.000067923844],"about_ca_topic_score_codex":0.0005986464,"about_ca_topic_score_gemma":0.0006802713,"teacher_disagreement_score":0.022885542,"about_ca_system_score_codex":0.00007368216,"about_ca_system_score_gemma":0.00012310181,"threshold_uncertainty_score":0.46227726},"labels":[],"label_agreement":null},{"id":"W3129116146","doi":"10.1111/bju.15356","title":"Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib","year":2021,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Pfizer","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Tolerability; Interquartile range; Internal medicine; Clinical endpoint; Oncology; Adjuvant; Adjuvant therapy; Progression-free survival; Surgery; Clinical trial; Adverse effect; Overall survival; Cancer","score_opus":0.01912136553791418,"score_gpt":0.2440369738271287,"score_spread":0.2249156082892145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129116146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9615881,0.037301976,0.000016197733,0.0002743894,0.00011423831,0.00023153712,0.000020474472,0.000007272484,0.0004458478],"genre_scores_gemma":[0.99707747,0.00218345,0.0002904574,0.0001568197,0.000064261156,0.0000072016196,0.000031194042,0.000030259273,0.00015888894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978689,0.0003741534,0.00087700825,0.00022304813,0.00034865702,0.00030822444],"domain_scores_gemma":[0.9983552,0.00013870817,0.00052701234,0.00020355674,0.0006069548,0.00016856921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002802602,0.0001926439,0.001037225,0.000242822,0.000025017296,0.000011249766,0.00011283533,0.00012939457,0.00016244508],"category_scores_gemma":[0.00007324791,0.00015940389,0.00020938933,0.00028547845,0.00009591316,0.00005651532,0.000023550752,0.00044697156,0.0000026688472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003122636,0.001421881,0.8676169,0.00012018507,0.00033307233,0.06716297,0.0003310234,0.000070298935,0.04035757,0.0000064279434,0.00027907206,0.019177945],"study_design_scores_gemma":[0.011643454,0.0061851437,0.8821319,0.00029314292,0.00021565551,0.06417701,0.00025362847,0.00001312956,0.034830865,0.000011713951,0.000120816745,0.00012356517],"about_ca_topic_score_codex":0.00022843786,"about_ca_topic_score_gemma":0.00012668922,"teacher_disagreement_score":0.0354894,"about_ca_system_score_codex":0.000118091884,"about_ca_system_score_gemma":0.00044073537,"threshold_uncertainty_score":0.6500302},"labels":[],"label_agreement":null},{"id":"W3129240410","doi":"10.1016/j.urolonc.2021.01.003","title":"Comparison between small renal masses 0-2 cm vs. 2.1-4 cm in size: A population-based study","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université de Montréal","funders":"","keywords":"Chromophobe cell; Histology; Clear cell; Renal cell carcinoma; Nephrectomy; Medicine; Population; Urology; Stage (stratigraphy); Pathology; Internal medicine; Kidney; Biology","score_opus":0.06800168052362313,"score_gpt":0.3508501710381261,"score_spread":0.282848490514503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129240410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900534,0.00070383627,0.000031306285,0.0074148006,0.00008987814,0.00067699567,0.000012910724,0.00006288402,0.00095396064],"genre_scores_gemma":[0.95677155,0.000025890904,0.04103232,0.001170766,0.00012169677,0.0001295629,0.0002372024,0.00001746877,0.0004935236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787396,0.00040421833,0.000584348,0.00056651415,0.00021774638,0.00035320644],"domain_scores_gemma":[0.99800175,0.0010920482,0.00018782791,0.00032807744,0.00009832745,0.0002919892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038385787,0.00026378545,0.0007413956,0.00018578047,0.00018440472,0.000031451724,0.00009496331,0.0002456695,0.00014939262],"category_scores_gemma":[0.00048806652,0.0002300724,0.000073558884,0.0005130979,0.00018917084,0.000055470224,0.00006086182,0.00047850554,0.000019065112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013070964,0.0010100666,0.99561375,0.000030524632,0.0000744255,0.0010493546,0.00035395822,0.00031854914,0.00023277174,0.00023271164,0.0003946956,0.000558459],"study_design_scores_gemma":[0.0025373076,0.004303719,0.9341755,0.00005853259,0.0005617213,0.0001058593,0.00054246694,0.00040322368,0.001098884,0.0012881875,0.054716304,0.00020830789],"about_ca_topic_score_codex":0.00033052164,"about_ca_topic_score_gemma":0.000810641,"teacher_disagreement_score":0.06143829,"about_ca_system_score_codex":0.00033239907,"about_ca_system_score_gemma":0.0006719525,"threshold_uncertainty_score":0.938208},"labels":[],"label_agreement":null},{"id":"W3129780093","doi":"10.1016/s0140-6736(21)00152-5","title":"A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":279,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute; National Institutes of Health; Wayne State University","keywords":"Cabozantinib; Sunitinib; Medicine; Crizotinib; Renal cell carcinoma; Oncology; Internal medicine; Papillary renal cell carcinomas; Urology; Carcinoma; Foolishness; Psychology","score_opus":0.12531892265715538,"score_gpt":0.3859075263052156,"score_spread":0.2605886036480602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129780093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98585886,0.00469819,0.000039639603,0.0007035608,0.00007807369,0.004203699,0.00032078705,0.000018586037,0.0040786136],"genre_scores_gemma":[0.9931263,0.00026984533,0.004767213,0.00009259724,0.00034250083,0.00044158942,0.00025742798,0.000041523304,0.0006610182],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99805737,0.00021031637,0.0006725864,0.00039700672,0.0002794514,0.00038326374],"domain_scores_gemma":[0.9975803,0.000750354,0.00045002508,0.0007806784,0.00029385363,0.00014479799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030833928,0.00030274963,0.0019914128,0.000054768505,0.00010264748,0.000026630449,0.0001865651,0.00007268872,0.000050945382],"category_scores_gemma":[0.00010489909,0.00017786132,0.00012638664,0.0001899528,0.00020632864,0.00005818721,0.00007328448,0.000086862216,0.0000010848746],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8709374,0.008623194,0.0046044034,0.0007724501,0.00050909247,0.0002005953,0.0026070366,0.0000098825985,0.09984498,0.00029924363,0.0011979531,0.010393774],"study_design_scores_gemma":[0.625618,0.018926943,0.001077371,0.00013239442,0.0008706454,0.00007632585,0.0009167232,0.00008037825,0.34837037,0.000031684027,0.0037581702,0.00014100442],"about_ca_topic_score_codex":0.00007839991,"about_ca_topic_score_gemma":0.000034485918,"teacher_disagreement_score":0.2485254,"about_ca_system_score_codex":0.000051497067,"about_ca_system_score_gemma":0.00039448342,"threshold_uncertainty_score":0.72529745},"labels":[],"label_agreement":null},{"id":"W3130081349","doi":"10.1002/14651858.cd001425.pub3","title":"Immunotherapy for advanced renal cell cancer","year":2015,"lang":"en","type":"review","venue":"Cochrane Database of Systematic Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":true,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Renal cell carcinoma; Immunotherapy; Protocol (science); Cancer; Kidney cancer; Systematic review; Intensive care medicine; MEDLINE; Internal medicine; Oncology; Alternative medicine; Pathology","score_opus":0.1680139580465993,"score_gpt":0.42389336281608736,"score_spread":0.25587940476948806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130081349","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000019008567,0.9633032,0.00033826078,0.000010752652,0.00038897636,0.0335891,0.0017407389,0.000032458745,0.0005945863],"genre_scores_gemma":[3.9773406e-7,0.97170925,0.005411559,0.000037193084,0.00024480786,0.015988532,0.004082078,0.0001712032,0.0023550002],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9926079,0.00083505263,0.0045101796,0.00078972266,0.0008083424,0.00044883057],"domain_scores_gemma":[0.9912668,0.00072481914,0.004072623,0.0030443054,0.0005769899,0.00031447754],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0033951309,0.001049072,0.015020124,0.00029313765,0.00005004798,0.000022187449,0.00055603584,0.00025394515,0.0001910581],"category_scores_gemma":[0.00065948186,0.000601945,0.002384496,0.0004360254,0.000078564175,0.000110066605,0.000084649306,0.0002898034,0.00025570235],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054720298,0.00016297601,1.2806132e-7,0.87302727,0.0004142846,0.000028502438,0.000042298896,1.42147e-7,0.000086095984,0.000011698439,0.0067596408,0.11941226],"study_design_scores_gemma":[0.001048658,0.00023356061,3.0337965e-8,0.52753997,0.006656683,0.00012150098,0.000010795017,0.000002031177,0.000060075967,0.0000014081764,0.4640682,0.0002570962],"about_ca_topic_score_codex":0.000023990508,"about_ca_topic_score_gemma":0.0000033691526,"teacher_disagreement_score":0.45730856,"about_ca_system_score_codex":0.0005627274,"about_ca_system_score_gemma":0.00097123353,"threshold_uncertainty_score":0.9996432},"labels":[],"label_agreement":null},{"id":"W3131063362","doi":"10.1056/nejmoa2035716","title":"Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1761,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Western University; University Hospital Foundation","funders":"Merck Sharp and Dohme; National Cancer Institute; Eisai","keywords":"Lenvatinib; Pembrolizumab; Everolimus; Sunitinib; Renal cell carcinoma; Medicine; Oncology; Internal medicine; Immunotherapy; Cancer","score_opus":0.03799850471779221,"score_gpt":0.29417229443419496,"score_spread":0.25617378971640276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131063362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9740794,0.008326109,0.002306007,0.0088033425,0.0009392872,0.0004435884,0.000009655719,0.00001911651,0.0050735413],"genre_scores_gemma":[0.9761811,0.0003767253,0.005387403,0.0009862728,0.005347787,0.000007952961,0.000044888435,0.000050117782,0.011617775],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975435,0.000097549884,0.0009165579,0.00028320742,0.0007586985,0.00040045334],"domain_scores_gemma":[0.9971565,0.00055357756,0.0005003181,0.00035795264,0.00075920817,0.0006724263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050612685,0.00030138798,0.0010454941,0.00021457461,0.00007561229,0.000011580138,0.0001456185,0.00010899388,0.00065583223],"category_scores_gemma":[0.0007417765,0.0001805939,0.0002484205,0.00027084732,0.00008105271,0.00010539378,0.000032352582,0.00041258233,0.0000069448124],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10493331,0.0009879512,0.00849066,0.0014430906,0.0008852707,0.03178408,0.005729384,0.00067305553,0.35840386,0.00020234406,0.08676421,0.3997028],"study_design_scores_gemma":[0.53431475,0.025831975,0.014563404,0.0012245441,0.0020744568,0.031092552,0.0010076581,0.00019213872,0.19876611,0.00048045415,0.19004406,0.00040792115],"about_ca_topic_score_codex":0.000032904743,"about_ca_topic_score_gemma":0.00003240642,"teacher_disagreement_score":0.42938143,"about_ca_system_score_codex":0.00030013753,"about_ca_system_score_gemma":0.001711132,"threshold_uncertainty_score":0.73644054},"labels":[],"label_agreement":null},{"id":"W3132050035","doi":"10.2214/ajr.20.23458","title":"Adequacy of Unenhanced MRI for Surveillance of Small (Clinical T1a) Solid Renal Masses","year":2021,"lang":"en","type":"article","venue":"American Journal of Roentgenology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Intraclass correlation; Nuclear medicine; Radiology; Renal mass; Magnetic resonance imaging; Wilcoxon signed-rank test; Nephrectomy; Mann–Whitney U test; Kidney","score_opus":0.04391122231082975,"score_gpt":0.3523322473864711,"score_spread":0.3084210250756414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132050035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882879,0.0017298636,0.0068406663,0.0024078006,0.0002912899,0.00017608829,0.000019978057,0.0000058134938,0.00024056842],"genre_scores_gemma":[0.96429604,0.0012976395,0.033822,0.0001885604,0.00020181187,0.0000046918485,0.000011123743,0.000025147028,0.0001529928],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974443,0.00029886334,0.0014415282,0.00024122593,0.0002551831,0.0003189535],"domain_scores_gemma":[0.9958645,0.0006646793,0.0018371786,0.00037016714,0.0010727404,0.00019074841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051968725,0.00017223202,0.0015343333,0.00016749352,0.00002106582,0.0000030437282,0.00018277505,0.00007575199,0.00007847044],"category_scores_gemma":[0.0006472153,0.00013966017,0.0005586305,0.00029560702,0.00056271936,0.000030008308,0.000054916276,0.00025163274,0.0000022640186],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009859564,0.0024421157,0.60233575,0.000394065,0.004055286,0.0014129857,0.0005223959,0.000472348,0.2978264,0.00025322416,0.0018318763,0.07859398],"study_design_scores_gemma":[0.011195253,0.03804835,0.4169112,0.00040069953,0.0009977061,0.003723965,0.0017776218,0.00010742812,0.51773506,0.00046124036,0.008331069,0.00031037195],"about_ca_topic_score_codex":0.00002747134,"about_ca_topic_score_gemma":0.000033787997,"teacher_disagreement_score":0.21990865,"about_ca_system_score_codex":0.000072248244,"about_ca_system_score_gemma":0.0006676027,"threshold_uncertainty_score":0.5695177},"labels":[],"label_agreement":null},{"id":"W3132353769","doi":"10.1007/s00345-020-03578-1","title":"Natural history of untreated kidney cancer","year":2021,"lang":"en","type":"review","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Nephrology; Kidney cancer; Natural history; Internal medicine; Cancer; Oncology","score_opus":0.04618142061655717,"score_gpt":0.32318052836364425,"score_spread":0.2769991077470871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132353769","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021972073,0.99166185,0.0000010831374,0.00058464793,0.0034045444,0.0002241012,0.000013429384,0.0000065710447,0.004081816],"genre_scores_gemma":[0.00023032937,0.95598924,0.00012654811,0.0005733167,0.0005991952,0.000009429887,0.00004700746,0.000052233343,0.04237268],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975264,0.0003618826,0.0012542418,0.00024082461,0.000337631,0.00027901432],"domain_scores_gemma":[0.99700326,0.00021402052,0.0016818034,0.00034596244,0.00043879944,0.00031615232],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023423921,0.0003736618,0.0035375436,0.0008134349,0.000010294786,0.0000028528962,0.00020037587,0.00022703665,0.0013654478],"category_scores_gemma":[0.00016777054,0.0002523789,0.0012190368,0.0003289523,0.00016343912,0.000031276624,0.000055438675,0.0011460015,0.000013740053],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029021694,0.00027923702,0.00018635378,0.0074566333,0.0037149445,0.0071262466,0.00010724041,0.0000016643397,0.00004072391,0.000053851283,0.19048469,0.7902582],"study_design_scores_gemma":[0.0010244588,0.00047435405,0.00005636879,0.0060826284,0.008127529,0.0052406345,0.0000021686644,9.860778e-7,0.0000035648618,0.000003787719,0.9788477,0.00013585994],"about_ca_topic_score_codex":0.000052561532,"about_ca_topic_score_gemma":0.0000346482,"teacher_disagreement_score":0.79012233,"about_ca_system_score_codex":0.0024379152,"about_ca_system_score_gemma":0.0067937933,"threshold_uncertainty_score":0.99999285},"labels":[],"label_agreement":null},{"id":"W3132632009","doi":"10.5489/cuaj.6880","title":"Total robotic surgical volume influences outcomes of low-volume robotic-assisted partial nephrectomy over an extended duration","year":2021,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Perioperative; Nephrectomy; Blood loss; Surgery; Retrospective cohort study; Internal medicine; Kidney","score_opus":0.01759170907631715,"score_gpt":0.25268768375670786,"score_spread":0.2350959746803907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132632009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913907,0.00023733727,0.00008080343,0.0070750136,0.0004493931,0.0002376936,0.000016225764,0.000030923413,0.0004818838],"genre_scores_gemma":[0.9962676,0.000021468079,0.0005379671,0.000755158,0.00038692923,0.000015672644,0.000103647995,0.000018573044,0.0018929387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99687445,0.0005244768,0.0008517114,0.00035376375,0.0007751522,0.00062046625],"domain_scores_gemma":[0.9973419,0.00016101691,0.0005147471,0.00022493646,0.00063987233,0.001117554],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053166045,0.00024886467,0.0007153816,0.00018910794,0.0002338191,0.00013845468,0.000115928415,0.0003710551,0.00243145],"category_scores_gemma":[0.00093985203,0.0002005398,0.00035556304,0.00036864984,0.00007138555,0.000278297,0.000023691755,0.00056714966,0.000057606187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111011264,0.00029619757,0.9930258,0.0000100720345,0.00031074692,0.0017485681,0.000083775616,0.0016472724,0.0007821526,0.00009644557,0.00059817114,0.0012897946],"study_design_scores_gemma":[0.001995569,0.00063313264,0.9908683,0.000019052355,0.0002847103,0.0012822996,0.00006994675,0.0027580834,0.00021812675,0.000104700775,0.0015755862,0.00019054492],"about_ca_topic_score_codex":0.0009156205,"about_ca_topic_score_gemma":0.0009837861,"teacher_disagreement_score":0.006319856,"about_ca_system_score_codex":0.0013749081,"about_ca_system_score_gemma":0.0012034546,"threshold_uncertainty_score":0.99848044},"labels":[],"label_agreement":null},{"id":"W3133079649","doi":"10.1016/j.euf.2021.02.004","title":"Race/Ethnicity Determines Life Expectancy in Surgically Treated T1aN0M0 Renal Cell Carcinoma Patients","year":2021,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Life expectancy; Cohort; Renal cell carcinoma; Demography; Epidemiology; Nephrectomy; Ethnic group; Internal medicine; Gerontology; Kidney; Population","score_opus":0.017121079486520228,"score_gpt":0.22832923527464963,"score_spread":0.2112081557881294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133079649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9425077,0.0025510304,0.000012372305,0.0005256057,0.00016435447,0.0003551179,0.000011797186,0.000093719085,0.053778335],"genre_scores_gemma":[0.9967704,0.000059733753,0.00018272323,0.00054717204,0.00018892817,0.000017975182,0.00010724077,0.000090749505,0.002035092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965449,0.0010452876,0.0006760882,0.00081248453,0.00030534813,0.00061588734],"domain_scores_gemma":[0.9983212,0.00017821691,0.00017494978,0.0007065116,0.00022189721,0.0003972678],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002296441,0.00039194472,0.0006674076,0.0002091918,0.00007359642,0.000019147043,0.00017832995,0.0001365774,0.00042645584],"category_scores_gemma":[0.00028075828,0.00033757242,0.00023467618,0.0003978916,0.00012288203,0.00006402708,0.00019703577,0.00042998992,0.00044408458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012783866,0.001733244,0.94625396,0.000041784722,0.0000654322,0.032515526,0.00052048,0.000012674632,0.012618629,0.000011232669,0.001106629,0.0038420355],"study_design_scores_gemma":[0.007705453,0.0018402775,0.96013117,0.000018100638,0.00017331468,0.0002625885,0.00002638738,0.00004077928,0.0269153,0.0000120987215,0.0025923445,0.0002821872],"about_ca_topic_score_codex":0.000064311316,"about_ca_topic_score_gemma":0.00007321214,"teacher_disagreement_score":0.054262716,"about_ca_system_score_codex":0.00012599706,"about_ca_system_score_gemma":0.0001574706,"threshold_uncertainty_score":0.9999076},"labels":[],"label_agreement":null},{"id":"W3133576100","doi":"10.1001/jamaoncol.2021.0019","title":"Assessment of Immune Checkpoint Inhibitors and Genomic Alterations by Body Mass Index in Advanced Renal Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System; Juravinski Cancer Centre","funders":"Genentech; Ipsen; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Renal cell carcinoma; Body mass index; Clear cell renal cell carcinoma; Internal medicine; Oncology; Vascular endothelial growth factor; Immune checkpoint; Immune system; Carcinoma; Cancer research; Cancer; Immunotherapy; VEGF receptors; Immunology","score_opus":0.01056701007371909,"score_gpt":0.28577121943876493,"score_spread":0.27520420936504586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133576100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98623633,0.0017950736,0.00012337421,0.001578098,0.00014475205,0.00042291937,0.000020683266,0.000011195537,0.00966755],"genre_scores_gemma":[0.9945807,0.0001272024,0.0039941627,0.00016658807,0.00007483884,0.00008149892,0.00017072994,0.000022254702,0.00078202784],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983542,0.00017078042,0.00066506147,0.00036999176,0.00017452,0.0002654785],"domain_scores_gemma":[0.999093,0.0001294882,0.00021439663,0.0003116051,0.00012251292,0.0001289953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024380416,0.00017654592,0.0005627507,0.000145287,0.000037181573,0.000011893761,0.000055053588,0.00018793954,0.00011515861],"category_scores_gemma":[0.0000405679,0.00016688473,0.00010338976,0.00018660612,0.00008642785,0.00006862073,0.000092332106,0.00033097505,0.00000418019],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012629674,0.0004931507,0.18397936,0.00008181997,0.000031379153,0.0005459907,0.00015550952,0.00004929614,0.8123216,0.00004764144,0.00023693926,0.0019309883],"study_design_scores_gemma":[0.004965572,0.0010949797,0.6482171,0.000031254727,0.00006034257,0.00011583784,0.0002963664,0.0004687862,0.34260932,0.000041767424,0.0020032353,0.000095434734],"about_ca_topic_score_codex":0.000185459,"about_ca_topic_score_gemma":0.00008196175,"teacher_disagreement_score":0.46971232,"about_ca_system_score_codex":0.0008060309,"about_ca_system_score_gemma":0.0007217546,"threshold_uncertainty_score":0.6805362},"labels":[],"label_agreement":null},{"id":"W3133992222","doi":"10.1200/jco.2021.39.6_suppl.311","title":"Phase II trial of stereotactic ablative radiation (SAbR) for oligometastatic kidney cancer.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"University of Texas Southwestern Medical Center","keywords":"SABR volatility model; Medicine; Radiation therapy; Interquartile range; Internal medicine; Radiosurgery; Clinical endpoint; Surgery; Oncology; Randomized controlled trial","score_opus":0.19837727583993428,"score_gpt":0.5219639427385421,"score_spread":0.3235866668986078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133992222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850065,0.001078492,0.00042600077,0.0095232595,0.0023212172,0.00059749343,0.00003288793,0.000003630862,0.0010104793],"genre_scores_gemma":[0.9896666,0.0009792123,0.0055895494,0.0014849027,0.0014440521,0.000023423427,0.000016564298,0.00001717786,0.0007785356],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961715,0.0005031706,0.002614686,0.00017584144,0.00035137098,0.00018348265],"domain_scores_gemma":[0.9920685,0.0035351026,0.0027688672,0.00017994092,0.0009745431,0.00047303666],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002018212,0.00012757946,0.0017818338,0.00012114647,0.00003819743,0.0000046412542,0.00007787533,0.00020203029,0.0002709572],"category_scores_gemma":[0.011346104,0.000091801405,0.0007720324,0.00017420838,0.00010765581,0.00010028648,0.00002889165,0.00042334388,0.0000027903043],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3963087,0.034985125,0.0031979142,0.00031130863,0.0052220933,0.0014839371,0.0008136705,0.00003175523,0.0046370216,0.0002256202,0.012690053,0.5400928],"study_design_scores_gemma":[0.6090771,0.26933765,0.007903149,0.0002531002,0.00479516,0.0003619155,0.0001922989,0.00034428033,0.011773882,0.00078343874,0.095035195,0.00014285013],"about_ca_topic_score_codex":0.0000131092,"about_ca_topic_score_gemma":0.000008726925,"teacher_disagreement_score":0.53994995,"about_ca_system_score_codex":0.00030960783,"about_ca_system_score_gemma":0.0057466663,"threshold_uncertainty_score":0.99988985},"labels":[],"label_agreement":null},{"id":"W3134178812","doi":"10.1200/jco.2021.39.6_suppl.270","title":"Sunitinib versus cabozantinib, crizotinib or savolitinib in metastatic papillary renal cell carcinoma (pRCC): Results from the randomized phase II SWOG 1500 study.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Institutes of Health","keywords":"Medicine; Sunitinib; Cabozantinib; Internal medicine; Crizotinib; Renal cell carcinoma; Oncology; Pazopanib; Progression-free survival; Urology; Surgery; Chemotherapy; Lung cancer","score_opus":0.2216947371488914,"score_gpt":0.4630707397537619,"score_spread":0.2413760026048705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134178812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756728,0.002238476,0.0000144111955,0.009780387,0.00251877,0.0014738262,0.00011516249,0.000018485103,0.008167676],"genre_scores_gemma":[0.99047565,0.00086998823,0.0031022984,0.0018449775,0.0020540345,0.000036886846,0.00010628549,0.000059823058,0.0014500484],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98154825,0.00810264,0.0077442997,0.0007278112,0.0011805852,0.00069644157],"domain_scores_gemma":[0.93904907,0.054034203,0.0039543062,0.0009754789,0.0011957763,0.0007911527],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.01311347,0.0005191373,0.005368309,0.00022914578,0.00017748412,0.000042804353,0.0004995418,0.0004080692,0.00088946323],"category_scores_gemma":[0.03617648,0.0002854519,0.0016193816,0.00059941877,0.00055352855,0.00016367476,0.000310772,0.0024934406,0.000041206884],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87982446,0.022760814,0.0041238316,0.00003515869,0.0018686868,0.06201598,0.0025540418,0.000019347019,0.0004504385,0.000031468328,0.00644435,0.01987144],"study_design_scores_gemma":[0.8724425,0.059035517,0.035848454,0.00020274696,0.004945144,0.0008274608,0.005516389,0.00010640824,0.0016846338,0.00018918885,0.018891938,0.00030965233],"about_ca_topic_score_codex":0.0005293956,"about_ca_topic_score_gemma":0.0008471002,"teacher_disagreement_score":0.06118852,"about_ca_system_score_codex":0.0002869216,"about_ca_system_score_gemma":0.006651421,"threshold_uncertainty_score":0.99995977},"labels":[],"label_agreement":null},{"id":"W3134291244","doi":"10.1016/j.jgo.2021.02.022","title":"Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC) – an International mRCC Database Consortium (IMDC) analysis","year":2021,"lang":"en","type":"article","venue":"Journal of Geriatric Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System; Sunnybrook Hospital; Western University; London Health Sciences Centre; Princess Margaret Cancer Centre; Ottawa Hospital; University of Calgary; University of Ottawa","funders":"Johnson and Johnson; Ipsen; Astellas Pharma Canada; Meso Scale Diagnostics; Exelixis; Roche; Eisai; Merck; AstraZeneca; EMD Serono; Novartis; Pfizer","keywords":"Medicine; Renal cell carcinoma; Oncology; Internal medicine; Intensive care medicine","score_opus":0.020917277601729917,"score_gpt":0.29874170732942545,"score_spread":0.27782442972769555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134291244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552315,0.0024480424,0.00011323844,0.0006109594,0.00023723014,0.00047430754,0.000040141356,0.000003455257,0.00054949033],"genre_scores_gemma":[0.9942557,0.0005997719,0.0046281232,0.000043846376,0.00022094524,0.000016192687,0.00013111791,0.000020429741,0.0000838482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962456,0.0006107559,0.0018501901,0.00031905438,0.000703406,0.00027094764],"domain_scores_gemma":[0.99616927,0.0006023381,0.0017856593,0.0005739467,0.0006955333,0.00017327623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007742999,0.0002770887,0.0013788375,0.00092175626,0.000032155032,0.000012844454,0.00024692214,0.00009533504,0.00029194047],"category_scores_gemma":[0.000113631795,0.00016312189,0.0006689608,0.0011970926,0.00014213477,0.00014568483,0.000039893737,0.00026566163,0.0000021946319],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052070506,0.07983613,0.6041726,0.00082113536,0.015021016,0.044607695,0.038887497,0.0033589539,0.13467678,0.00007795161,0.00040667935,0.026063042],"study_design_scores_gemma":[0.033448443,0.020133564,0.78353894,0.00013779488,0.010931727,0.0025082566,0.0068981396,0.00026378542,0.1413061,0.000007404693,0.00061363087,0.00021221141],"about_ca_topic_score_codex":0.00044118054,"about_ca_topic_score_gemma":0.0002201909,"teacher_disagreement_score":0.17936632,"about_ca_system_score_codex":0.0006210976,"about_ca_system_score_gemma":0.0011487021,"threshold_uncertainty_score":0.66519177},"labels":[],"label_agreement":null},{"id":"W3134908202","doi":"10.1200/jco.2021.39.6_suppl.269","title":"Phase 3 trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) or everolimus (EVE) versus sunitinib (SUN) monotherapy as a first-line treatment for patients (pts) with advanced renal cell carcinoma (RCC) (CLEAR study).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Everolimus; Renal cell carcinoma; Clinical endpoint; Sunitinib; Progression-free survival; Oncology; Clinical trial; Urology; Confidence interval; Overall survival","score_opus":0.1826300684046734,"score_gpt":0.46084979122176783,"score_spread":0.2782197228170944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134908202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289274,0.00038544546,0.00006723276,0.0009182525,0.0012488754,0.0029859573,0.000053451062,0.000017823164,0.0014302478],"genre_scores_gemma":[0.9925031,0.0007533692,0.0035659168,0.00036796287,0.0012669995,0.00014849067,0.000070661255,0.00009781118,0.0012256764],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99289,0.00086606777,0.004045801,0.0006554433,0.0009582218,0.0005844752],"domain_scores_gemma":[0.9873643,0.0058086044,0.0035285975,0.0006774132,0.0018942873,0.00072679616],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011578028,0.0005572555,0.0036910353,0.0002453561,0.00012294251,0.000017428452,0.00027404408,0.00044998678,0.00040575117],"category_scores_gemma":[0.0021546239,0.00035226674,0.0011806048,0.000337086,0.00022333555,0.00017627227,0.00006768458,0.0006796954,0.000012056541],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83798623,0.06938973,0.0026853695,0.00008397218,0.0016001938,0.0029928426,0.00063813955,0.00012971257,0.00015682902,0.000007745488,0.0002628484,0.08406638],"study_design_scores_gemma":[0.52321774,0.45561087,0.004690559,0.00007666476,0.0016751115,0.00014087334,0.00043507142,0.0000729482,0.0020301098,0.000014159367,0.011852992,0.00018287513],"about_ca_topic_score_codex":0.00008372741,"about_ca_topic_score_gemma":0.0003158581,"teacher_disagreement_score":0.38622114,"about_ca_system_score_codex":0.0011451286,"about_ca_system_score_gemma":0.0065186108,"threshold_uncertainty_score":0.99989295},"labels":[],"label_agreement":null},{"id":"W3135168894","doi":"10.1200/jco.2021.39.6_suppl.tps372","title":"Phase III study evaluating efficacy and safety of MK-6482 + lenvatinib versus cabozantinib for second- or third-line therapy in patients with advanced renal cell carcinoma (RCC) who progressed after prior anti-PD-1/L1 therapy.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada)","funders":"","keywords":"Cabozantinib; Lenvatinib; Medicine; Renal cell carcinoma; Oncology; Internal medicine; Targeted therapy; Tyrosine-kinase inhibitor; Systemic therapy; Clear cell renal cell carcinoma; Kidney cancer; Cancer","score_opus":0.1325635417962137,"score_gpt":0.463206243036248,"score_spread":0.3306427012400343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135168894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994066,0.0016982207,0.000018548844,0.00041633873,0.0004216262,0.0032175004,0.000027184693,0.000008369078,0.00012623666],"genre_scores_gemma":[0.9932176,0.0003352489,0.005543493,0.00030768052,0.00032289384,0.00007385264,0.00002312219,0.000054343385,0.00012175644],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99391973,0.00091339275,0.003452203,0.00055124314,0.00073568005,0.0004277399],"domain_scores_gemma":[0.9910074,0.0040934957,0.0026403253,0.000419264,0.001507835,0.00033170547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029581694,0.00037877494,0.0027378814,0.00018488154,0.00006949326,0.000016083373,0.00017169818,0.0002981182,0.00017838106],"category_scores_gemma":[0.0013819349,0.00022750322,0.00035299824,0.00032166715,0.00019890719,0.00016173592,0.00006983978,0.00083067745,7.104942e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50787866,0.029172553,0.25466585,0.00008788645,0.0006847331,0.0015863627,0.0010288463,0.000020076204,0.0012279177,8.218606e-7,0.000032132433,0.20361415],"study_design_scores_gemma":[0.2920789,0.21391861,0.48909673,0.00015499994,0.0003017984,0.000040229446,0.00031501817,0.00004999201,0.0034784987,0.0000021985215,0.00043199793,0.00013101057],"about_ca_topic_score_codex":0.000005840805,"about_ca_topic_score_gemma":0.00006014723,"teacher_disagreement_score":0.2344309,"about_ca_system_score_codex":0.00013725806,"about_ca_system_score_gemma":0.002486207,"threshold_uncertainty_score":0.9277312},"labels":[],"label_agreement":null},{"id":"W3135266275","doi":"10.1200/jco.2021.39.6_suppl.316","title":"Effectiveness of first-line immune checkpoint inhibitors (ICI) in advanced non-clear cell renal cell carcinoma (ccRCC).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Juravinski Cancer Centre; Queen's University; Sunnybrook Hospital; University of Alberta; University of Ottawa; Dalhousie University; Ottawa Hospital; University Health Network; University of Calgary; Princess Margaret Cancer Centre; McMaster University","funders":"","keywords":"Medicine; Hazard ratio; Clear cell renal cell carcinoma; Renal cell carcinoma; Internal medicine; Oncology; Proportional hazards model; Combination therapy; Targeted therapy; Vascular endothelial growth factor; Cancer; Urology; VEGF receptors; Confidence interval","score_opus":0.04911479647460906,"score_gpt":0.37492427423794855,"score_spread":0.32580947776333946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135266275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896653,0.0025244914,0.000091745096,0.0008392455,0.0011833075,0.00042342275,0.0000038703624,0.0000062503786,0.0052623353],"genre_scores_gemma":[0.9954005,0.0006834049,0.0028814056,0.000104581784,0.0004918514,0.0000091662405,0.000009545198,0.00004384722,0.00037572955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932225,0.0010735042,0.004320977,0.00041095563,0.0005648293,0.0004072815],"domain_scores_gemma":[0.992192,0.003589673,0.0024271803,0.00046400918,0.0008820849,0.00044507012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004319091,0.00030005624,0.0029744755,0.0002574013,0.0000347613,0.000006209236,0.00021188773,0.00054691994,0.00015222459],"category_scores_gemma":[0.0018023008,0.0002322712,0.001257141,0.00041801922,0.00021579982,0.00011348183,0.00016630316,0.0015457663,0.000023104647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037173726,0.015782412,0.48027363,0.0019695833,0.0003657729,0.020393874,0.0003538218,0.0011791736,0.42786503,0.000009234773,0.00021567036,0.014418062],"study_design_scores_gemma":[0.020344418,0.020183269,0.5225447,0.00051942514,0.00031523165,0.00030484193,0.00015953029,0.00009473531,0.43439656,0.00006211466,0.0009432478,0.00013193657],"about_ca_topic_score_codex":0.000095036135,"about_ca_topic_score_gemma":0.00006203158,"teacher_disagreement_score":0.042271048,"about_ca_system_score_codex":0.00055979536,"about_ca_system_score_gemma":0.0020344097,"threshold_uncertainty_score":0.94717443},"labels":[],"label_agreement":null},{"id":"W3135371333","doi":"10.3233/kca-210110","title":"Real-Word Experience of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC): Results from the Canadian Kidney Cancer information system (CKCis)","year":2021,"lang":"en","type":"article","venue":"Kidney Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; St Joseph's Health Centre; University of Ottawa; Sunnybrook Health Science Centre; Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Toronto; Western University; Princess Margaret Cancer Centre; University of Calgary; Centre hospitalier universitaire de Québec; London Health Sciences Centre; Alberta Health Services; McMaster University; University of Manitoba; Juravinski Cancer Centre; Université Laval; University of Alberta","funders":"Genentech; Ipsen; Astellas Pharma; Eisai; Karyopharm Therapeutics; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer; Exelixis; GlaxoSmithKline","keywords":"Cabozantinib; Medicine; Renal cell carcinoma; Kidney cancer; Internal medicine; Cancer; Oncology; Tyrosine-kinase inhibitor; Population; Urology; Surgery; Gastroenterology","score_opus":0.027269369056509476,"score_gpt":0.27533422388788525,"score_spread":0.24806485483137578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135371333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9718836,0.0013516133,0.0000061191104,0.004795017,0.0007326995,0.00081057684,0.003915533,0.000031692263,0.016473142],"genre_scores_gemma":[0.9947554,0.0003810527,0.00042267525,0.0022854917,0.00019147026,0.0003684856,0.00073822535,0.000031011292,0.00082618324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99722946,0.0001790247,0.00094018836,0.0004425809,0.00065943523,0.00054934213],"domain_scores_gemma":[0.99724615,0.00012551842,0.00038181432,0.00083440635,0.000416204,0.0009958871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027927273,0.0003132404,0.00059458124,0.00018686862,0.00014408269,0.000056860015,0.00023598292,0.00012429927,0.00045761783],"category_scores_gemma":[0.00040259352,0.0002331971,0.00014498142,0.00075197907,0.000119301636,0.00026173686,0.00006387375,0.00030928457,0.000030673407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040717158,0.0003857704,0.62134296,0.0027369198,0.000819444,0.0030952636,0.11176465,0.000995275,0.04911506,0.0004606628,0.19324796,0.011964351],"study_design_scores_gemma":[0.012823508,0.00017890331,0.55111855,0.0030975677,0.00072706165,0.00007172352,0.008864079,0.0015018969,0.3296446,0.000011670358,0.09131582,0.00064465037],"about_ca_topic_score_codex":0.8798737,"about_ca_topic_score_gemma":0.4029926,"teacher_disagreement_score":0.47688112,"about_ca_system_score_codex":0.0019315255,"about_ca_system_score_gemma":0.010122112,"threshold_uncertainty_score":0.9954896},"labels":[],"label_agreement":null},{"id":"W3135425547","doi":"10.1200/jco.2021.39.6_suppl.325","title":"UNISON - nivolumab then ipilimumab + nivolumab in advanced non-clear cell renal cell carcinoma (ANZUP 1602): Part 1—Nivolumab monotherapy.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Nivolumab; Medicine; Ipilimumab; Renal cell carcinoma; Internal medicine; Discontinuation; Oncology; Chromophobe cell; Adverse effect; Cancer; Clear cell; Immunotherapy","score_opus":0.06523054393215995,"score_gpt":0.3812463822326602,"score_spread":0.3160158383005003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135425547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.970939,0.004430044,0.00010630038,0.0028678253,0.0019065384,0.0006004647,0.0000112041025,0.000029021749,0.019109637],"genre_scores_gemma":[0.978788,0.0023614787,0.006782371,0.0017401846,0.0015470036,0.000021135455,0.000022349635,0.00012684528,0.008610587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9909457,0.0013855852,0.0047351373,0.0009072304,0.0010552891,0.00097105466],"domain_scores_gemma":[0.99237865,0.0018664267,0.0027351798,0.0010527814,0.00097064313,0.0009963382],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026989977,0.00059846375,0.0035716682,0.000376686,0.00012722735,0.000043717817,0.00055076415,0.001027845,0.0012452964],"category_scores_gemma":[0.00068856776,0.00050394086,0.0015249577,0.0005470105,0.00034870906,0.00032251762,0.00020350757,0.0026755428,0.00023833619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.097127676,0.036398917,0.39064917,0.000832849,0.0018570665,0.08115211,0.0037982604,0.0014000651,0.067344226,0.00007200787,0.039288502,0.28007916],"study_design_scores_gemma":[0.1517418,0.08820469,0.5261391,0.0007597599,0.0019947677,0.0027989433,0.0034491394,0.0015268028,0.047073208,0.0005718057,0.17441034,0.0013296404],"about_ca_topic_score_codex":0.00021068199,"about_ca_topic_score_gemma":0.0002802806,"teacher_disagreement_score":0.2787495,"about_ca_system_score_codex":0.0017495668,"about_ca_system_score_gemma":0.006653997,"threshold_uncertainty_score":0.9997412},"labels":[],"label_agreement":null},{"id":"W3135441040","doi":"10.1200/jco.2021.39.6_suppl.tps190","title":"A phase III, randomized, open-label, study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy (NHT) in patients (pts) with metastatic, castration-resistant prostate cancer (mCRPC).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Exelixis","keywords":"Cabozantinib; Medicine; Atezolizumab; Prostate cancer; Oncology; Internal medicine; Cancer; Enzalutamide; Nivolumab; Immunotherapy; Androgen receptor","score_opus":0.19548848981625613,"score_gpt":0.4756110529767282,"score_spread":0.280122563160472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135441040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99279547,0.001935704,0.000021293978,0.00066137937,0.00056629267,0.0029895862,0.000053432905,0.000004322915,0.0009725265],"genre_scores_gemma":[0.99526715,0.0010486083,0.002757334,0.00029954372,0.000117418946,0.00011472522,0.000021960046,0.000035470628,0.0003377983],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9931585,0.0010987886,0.0042231414,0.00041788555,0.00074627943,0.00035541528],"domain_scores_gemma":[0.9916227,0.002683791,0.0034312534,0.0003620453,0.0015243135,0.00037590432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032475747,0.00032634137,0.004423536,0.00018127126,0.000049279344,0.000034586927,0.00025057996,0.00016757943,0.0002963349],"category_scores_gemma":[0.0011098891,0.00020300661,0.00030962395,0.00033519883,0.00021497114,0.00025979365,0.00009140671,0.00083091116,0.0000024009123],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9078396,0.057979677,0.0055392846,0.000035210836,0.0039798236,0.003817286,0.001297714,0.000029684814,0.0022770956,0.000025210978,0.00022150623,0.016957887],"study_design_scores_gemma":[0.8397111,0.109738775,0.04614086,0.00013109439,0.0013407958,0.00008371604,0.0009728385,0.00007216239,0.0007916496,0.000010631565,0.00084536604,0.00016095134],"about_ca_topic_score_codex":0.0006893925,"about_ca_topic_score_gemma":0.0031576108,"teacher_disagreement_score":0.06812847,"about_ca_system_score_codex":0.0004957822,"about_ca_system_score_gemma":0.0064485664,"threshold_uncertainty_score":0.99918395},"labels":[],"label_agreement":null},{"id":"W3135619295","doi":"10.1016/j.eururo.2021.02.025","title":"Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Canadian Cancer Society","keywords":"Medicine; Renal cell carcinoma; Disease; Surgical resection; Resection; Kidney disease; Carcinoma; Clear cell renal cell carcinoma; Surgery; Oncology; Internal medicine","score_opus":0.013090911233855031,"score_gpt":0.2559281251699412,"score_spread":0.24283721393608615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135619295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99207115,0.004209053,0.00045659085,0.00035719216,0.0004371625,0.0006310287,0.00002826471,0.00007427372,0.0017352711],"genre_scores_gemma":[0.99742764,0.00015466641,0.0013074771,0.00008546056,0.00030460925,0.00003595843,0.00013565754,0.00006001027,0.00048854563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743265,0.0007738512,0.00038017292,0.00075191475,0.0002506004,0.0004107914],"domain_scores_gemma":[0.9986157,0.0003558869,0.00014951208,0.00031256667,0.00014071191,0.0004256173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005170457,0.0002533112,0.00040969736,0.000084168765,0.0002202944,0.000039485207,0.0000606079,0.00007438448,0.000014649365],"category_scores_gemma":[0.00036593303,0.0002158206,0.0001221605,0.00012317782,0.00011871744,0.0000862228,0.00015849307,0.00030536845,0.000005574787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017123062,0.00039098688,0.943167,0.0002856452,0.00016370382,0.011862847,0.00039899902,0.000055021537,0.0031309822,0.00026790134,0.00015824096,0.022995615],"study_design_scores_gemma":[0.017477315,0.0060297293,0.96684086,0.00011169914,0.00067617296,0.00023931969,0.000044769982,0.0009533487,0.0018600903,0.00021048082,0.005250548,0.0003056855],"about_ca_topic_score_codex":0.000023381512,"about_ca_topic_score_gemma":0.000012194177,"teacher_disagreement_score":0.023673847,"about_ca_system_score_codex":0.00004240072,"about_ca_system_score_gemma":0.00011295726,"threshold_uncertainty_score":0.8800909},"labels":[],"label_agreement":null},{"id":"W3135698139","doi":"10.1038/s41379-021-00779-w","title":"New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia","year":2021,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":250,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of British Columbia; Royal Columbian Hospital; University of Calgary","funders":"","keywords":"Chromophobe cell; Clear cell; Pathology; Renal cell carcinoma; Oncocytoma; Medicine; Hematopathology; Clear cell renal cell carcinoma; Surgical pathology; Kidney cancer; Cancer; Biology; Internal medicine; Cytogenetics","score_opus":0.02497866581627378,"score_gpt":0.2804893520106929,"score_spread":0.25551068619441913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135698139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98635125,0.00522567,0.003066417,0.0011928747,0.00014111136,0.00025989473,0.000005852864,0.000037671725,0.0037192667],"genre_scores_gemma":[0.98370945,0.00029672147,0.0122583555,0.001966854,0.00009181038,0.00003992556,0.000051984123,0.000037310256,0.0015475826],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99810237,0.0002786629,0.00034943555,0.0005928714,0.00022280593,0.000453872],"domain_scores_gemma":[0.99919134,0.00012270054,0.00009882961,0.00038751413,0.00008298151,0.000116655734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002590296,0.00026021278,0.0004392409,0.000070907394,0.00013373501,0.000029617911,0.0001028414,0.00019130239,0.0000671913],"category_scores_gemma":[0.000100601574,0.0002074253,0.00011120416,0.00013554347,0.00016412261,0.000055661854,0.00023026069,0.00040166004,0.000021214117],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084950787,0.0006711866,0.24229382,0.00040245248,0.00063398515,0.18007326,0.04213548,0.0006124483,0.42856804,0.0037809836,0.0045307395,0.09544811],"study_design_scores_gemma":[0.012939496,0.0016571766,0.7998892,0.00081493903,0.0005383166,0.03397842,0.0041273073,0.0042836517,0.1253485,0.011210131,0.0040017953,0.0012110681],"about_ca_topic_score_codex":0.000021724318,"about_ca_topic_score_gemma":0.000029973638,"teacher_disagreement_score":0.5575954,"about_ca_system_score_codex":0.00017127175,"about_ca_system_score_gemma":0.0003004822,"threshold_uncertainty_score":0.84585583},"labels":[],"label_agreement":null},{"id":"W3135745963","doi":"10.1200/jco.2021.39.6_suppl.339","title":"The very favorable metastatic renal cell carcinoma (mRCC) risk group: Data from the International Metastatic RCC Database Consortium (IMDC).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Sunnybrook Hospital; University Health Network; Dalhousie University; University of Ottawa; Princess Margaret Cancer Centre; Ottawa Hospital; Queen's University; Baker Hughes (Canada)","funders":"","keywords":"Medicine; Renal cell carcinoma; Hazard ratio; Internal medicine; Systemic therapy; Oncology; Proportional hazards model; Targeted therapy; Performance status; Surgery; Database; Confidence interval; Cancer","score_opus":0.2169414105789285,"score_gpt":0.43149203378909984,"score_spread":0.21455062321017135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135745963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95977116,0.0098013375,0.0010965619,0.021481864,0.0038828983,0.0003749877,0.0005473478,0.000011994031,0.0030318787],"genre_scores_gemma":[0.9716385,0.0043396214,0.01640271,0.0042013796,0.0017993222,0.000010364643,0.0005447643,0.000039603416,0.0010237299],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921078,0.0025900744,0.00319712,0.00054310693,0.0011498677,0.00041200194],"domain_scores_gemma":[0.9717074,0.022570852,0.002854789,0.0016452267,0.0007387191,0.0004830245],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.008408845,0.0002866795,0.0014992686,0.00006745354,0.00023574193,0.0000982729,0.0013554989,0.00013260845,0.0007052923],"category_scores_gemma":[0.011751903,0.00014502986,0.0006475271,0.0002136661,0.00049950037,0.00032066507,0.0007714559,0.001981921,0.00012941338],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019834066,0.012098035,0.28496158,0.00011583618,0.013370701,0.05109219,0.00047209527,0.00015557605,0.006978236,0.0005685891,0.5100834,0.10026969],"study_design_scores_gemma":[0.024175372,0.0068100416,0.30716974,0.00017222141,0.01136045,0.0031306427,0.0024254427,0.0031128193,0.0032336614,0.0018653518,0.6361809,0.00036339174],"about_ca_topic_score_codex":0.00046941344,"about_ca_topic_score_gemma":0.00078507094,"teacher_disagreement_score":0.12609746,"about_ca_system_score_codex":0.00026489756,"about_ca_system_score_gemma":0.0036515351,"threshold_uncertainty_score":0.99657255},"labels":[],"label_agreement":null},{"id":"W3135800290","doi":"10.1016/j.euf.2021.02.009","title":"Tumor Stage and Substage Predict Cancer-specific Mortality After Nephrectomy for Nonmetastatic Renal Cancer: Histological Subtype-specific Validation","year":2021,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Chromophobe cell; Medicine; Nephrectomy; Stage (stratigraphy); Renal cell carcinoma; Clear cell; Kidney cancer; Proportional hazards model; Pathological; T-stage; Cancer; Oncology; Internal medicine; Kidney disease; Urology; Papillary renal cell carcinomas; Kidney","score_opus":0.045440889541786766,"score_gpt":0.28074029680915685,"score_spread":0.2352994072673701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135800290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96496105,0.029213507,0.0011831053,0.0011148421,0.00040258252,0.0008115949,0.00031201908,0.000105546445,0.0018957217],"genre_scores_gemma":[0.9939774,0.0017907274,0.001020804,0.00047789168,0.00038701246,0.00027720138,0.0001823669,0.00008146424,0.0018051311],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972226,0.00053926196,0.0005305553,0.0009058556,0.000280507,0.00052120123],"domain_scores_gemma":[0.9985728,0.00018945146,0.00022371465,0.00056386745,0.00017653342,0.00027363386],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043046157,0.00035474522,0.00058984256,0.00010892622,0.00012645128,0.000041773314,0.00011560765,0.00007734378,0.0013015802],"category_scores_gemma":[0.00006413693,0.00030149007,0.00017863438,0.00019739063,0.00027752848,0.00008206691,0.00010001014,0.00031532033,0.000053551725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013340531,0.0017313017,0.78373307,0.00075221254,0.0019282809,0.044415966,0.001620659,0.0003358784,0.08718648,0.0013508372,0.017819155,0.04578564],"study_design_scores_gemma":[0.004433135,0.0010286786,0.73428714,0.000037198424,0.00061703316,0.00037065544,0.00004350039,0.00010194345,0.015714223,0.00006590058,0.24295142,0.00034916733],"about_ca_topic_score_codex":0.000055114113,"about_ca_topic_score_gemma":0.00011385221,"teacher_disagreement_score":0.22513226,"about_ca_system_score_codex":0.00024220305,"about_ca_system_score_gemma":0.00016187564,"threshold_uncertainty_score":0.99994373},"labels":[],"label_agreement":null},{"id":"W3135839740","doi":"10.1200/jco.2021.39.6_suppl.314","title":"Health-related quality-of-life outcomes from a phase II open-label trial of two different starting doses of lenvatinib in combination with everolimus for treatment of renal cell carcinoma following one prior VEGF-targeted treatment.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Lenvatinib; Everolimus; Renal cell carcinoma; Clinical endpoint; Internal medicine; Quality of life (healthcare); Oncology; Kidney cancer; Clinical trial; Phases of clinical research; Cancer","score_opus":0.337874391333938,"score_gpt":0.5052543612984711,"score_spread":0.16737996996453314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135839740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934023,0.0016872815,0.00008758906,0.0021491793,0.00040996523,0.002085518,0.00010409947,0.000004432442,0.000069618014],"genre_scores_gemma":[0.99039173,0.0002023788,0.008949155,0.00009534552,0.00009526701,0.000048061826,0.00010952351,0.000032113603,0.000076423516],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9894777,0.0015664437,0.0076236315,0.00037215234,0.0006369532,0.00032314044],"domain_scores_gemma":[0.9831566,0.00688827,0.0085810935,0.00038930879,0.0006468972,0.00033780446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002085458,0.00033060557,0.0063515087,0.0002538104,0.000055164764,0.000005383147,0.00017776137,0.00026749272,0.00004172783],"category_scores_gemma":[0.00208204,0.00021736792,0.0009027803,0.0002647592,0.00014647057,0.00011458373,0.00007151498,0.00023817885,2.042419e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4376134,0.17673112,0.28517163,0.0003160115,0.0045931437,0.0003051525,0.002617607,0.000045694,0.0343715,0.000060202707,0.000018088667,0.058156453],"study_design_scores_gemma":[0.5431491,0.25077012,0.16038713,0.00034023577,0.0014997124,0.000005805371,0.00037351175,0.00011079371,0.043024708,0.00020625223,0.000020962543,0.000111644105],"about_ca_topic_score_codex":0.0017446915,"about_ca_topic_score_gemma":0.0007451174,"teacher_disagreement_score":0.12478451,"about_ca_system_score_codex":0.00077173114,"about_ca_system_score_gemma":0.0040859194,"threshold_uncertainty_score":0.88640064},"labels":[],"label_agreement":null},{"id":"W3136308078","doi":"10.5489/cuaj.6996","title":"Native kidney small renal masses in patients with kidney transplants: Does chronic immunosuppression affect tumor biology?","year":2021,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Univariate analysis; Immunosuppression; Urology; Renal function; Kidney disease; Pathological; Kidney; Stage (stratigraphy); Retrospective cohort study; Surgery; Internal medicine; Gastroenterology; Multivariate analysis","score_opus":0.007940934768594574,"score_gpt":0.21214084437361336,"score_spread":0.20419990960501877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136308078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98923326,0.00031162635,0.000024699548,0.008487191,0.0002733721,0.00032116825,0.00025209654,0.000018929719,0.0010776458],"genre_scores_gemma":[0.9950916,0.000071044786,0.0003182284,0.003574629,0.00020871007,0.000019684227,0.00045717202,0.000018673998,0.00024022601],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780875,0.00049555255,0.00038833186,0.0003444838,0.00032320086,0.00063966535],"domain_scores_gemma":[0.997829,0.0001722024,0.00026551101,0.00014410606,0.0003553448,0.0012338437],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037434426,0.00023905985,0.00044293702,0.00023899032,0.00019083693,0.00006087541,0.00011565759,0.00023995583,0.0009813468],"category_scores_gemma":[0.0011059887,0.00014309525,0.0001370277,0.00030154508,0.000049317805,0.000097429955,0.000015487638,0.0007948791,0.000018899695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003274935,0.00020195462,0.99544996,0.000018018984,0.00021105567,0.00095864147,0.00009478148,0.000010053012,0.000892267,0.000020382999,0.0012846903,0.00053067587],"study_design_scores_gemma":[0.0067268475,0.0013814338,0.97841746,0.00023168432,0.0001442302,0.00015681396,0.00003112685,0.000019151608,0.001960217,0.0001395542,0.0105983615,0.00019311711],"about_ca_topic_score_codex":0.00060434564,"about_ca_topic_score_gemma":0.0015339841,"teacher_disagreement_score":0.017032523,"about_ca_system_score_codex":0.0032281745,"about_ca_system_score_gemma":0.0027873213,"threshold_uncertainty_score":0.9999319},"labels":[],"label_agreement":null},{"id":"W3136630340","doi":"10.1200/cci.20.00107","title":"Risk Prediction Using Bayesian Networks: An Immunotherapy Case Study in Patients With Metastatic Renal Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"JCO Clinical Cancer Informatics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto","funders":"","keywords":"Medicine; Renal cell carcinoma; Adverse effect; Internal medicine; Oncology; Nivolumab; Receiver operating characteristic; Everolimus; Immunotherapy; Cancer","score_opus":0.05428316814276068,"score_gpt":0.3543036577697065,"score_spread":0.30002048962694583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136630340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951499,0.00029397113,0.0026854493,0.0000101976075,0.00026783047,0.0013519,0.000057107267,0.00003572695,0.00014792329],"genre_scores_gemma":[0.99187636,0.00009265235,0.0073459754,0.00028903643,0.00015432268,0.00006314933,0.00010319014,0.000043546657,0.000031789954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99668163,0.00035795788,0.0017381237,0.00028232642,0.00055894314,0.00038103084],"domain_scores_gemma":[0.9978574,0.00020113621,0.00059040275,0.00071155047,0.00034709426,0.0002924485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073626766,0.0003002844,0.00071336905,0.00012406286,0.00012443837,0.000059268397,0.00009161289,0.0001187562,0.00008831908],"category_scores_gemma":[0.000056754816,0.00022465295,0.00014161237,0.00047861342,0.000078439174,0.00037699784,0.00005293599,0.0006378097,0.0000032214261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001034243,0.0024506422,0.97345525,0.00007662817,0.00018091175,0.0014946222,0.0023504768,0.009588419,0.0000011668955,3.7376526e-7,0.000029801327,0.009337479],"study_design_scores_gemma":[0.019239623,0.0061733327,0.87901753,0.000105924875,0.00094594347,0.00025778345,0.005383113,0.08850387,0.000053343578,0.0000043175705,0.000057004025,0.00025824696],"about_ca_topic_score_codex":0.0011840664,"about_ca_topic_score_gemma":0.00096710376,"teacher_disagreement_score":0.09443773,"about_ca_system_score_codex":0.00042435294,"about_ca_system_score_gemma":0.00053853577,"threshold_uncertainty_score":0.91610813},"labels":[],"label_agreement":null},{"id":"W3136768966","doi":"10.1016/j.clgc.2021.03.006","title":"Clinical Effectiveness of Second-line Sunitinib Following Immuno-oncology Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-world Study","year":2021,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto; University of Calgary","funders":"Mailman School of Public Health, Columbia University; Pfizer Canada; Genentech; Astellas Pharma; Bristol-Myers Squibb Canada; Eisai; Ipsen; Astellas Pharma Canada; Roche; EMD Serono; Novartis; AstraZeneca; Amgen; Pfizer; Exelixis; Meso Scale Diagnostics; Sanofi; MedImmune; Merck; GlaxoSmithKline","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Oncology; Internal medicine; Clinical Oncology; Kidney cancer; Cancer","score_opus":0.0731584245030044,"score_gpt":0.40543841801258984,"score_spread":0.3322799935095854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136768966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933753,0.0016552829,0.000003904448,0.000054297474,0.0008046653,0.002256285,0.0000385362,0.000028650718,0.001783097],"genre_scores_gemma":[0.99736154,0.00032547372,0.0006479533,0.0001757011,0.00029693078,0.0003113688,0.00012451064,0.000082104285,0.00067440246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9924249,0.0034348562,0.0020752405,0.0009842278,0.00056332786,0.0005174535],"domain_scores_gemma":[0.9945268,0.0031823704,0.0005386118,0.00092294323,0.0005018841,0.00032741012],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024016395,0.00044031814,0.002212445,0.00021981023,0.00006766666,0.000012098252,0.00021671841,0.0001837361,0.00035575012],"category_scores_gemma":[0.000177463,0.00033334875,0.00069940824,0.0007591431,0.00022854182,0.0000959922,0.00018294241,0.0008735637,0.000009788732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017688423,0.019260626,0.9462171,0.00022153603,0.0009796487,0.005079681,0.00018435995,0.000027883167,0.00068388873,0.0000010446527,0.000053327094,0.009602474],"study_design_scores_gemma":[0.04680541,0.029225938,0.91828203,0.00024988333,0.000759115,0.000010675721,0.00028268772,0.0000075369967,0.003787118,0.000013839008,0.00029404505,0.00028172944],"about_ca_topic_score_codex":0.0003773406,"about_ca_topic_score_gemma":0.0008604332,"teacher_disagreement_score":0.029116988,"about_ca_system_score_codex":0.00043042575,"about_ca_system_score_gemma":0.0017048492,"threshold_uncertainty_score":0.99991184},"labels":[],"label_agreement":null},{"id":"W3137876535","doi":"10.5489/cuaj.7245","title":"Management of advanced kidney cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2021","year":2021,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; Juravinski Cancer Centre; Centre Hospitalier de l’Université de Montréal; BC Cancer Agency; Saint John Regional Hospital; Ottawa Hospital; CancerCare Manitoba; Jewish General Hospital; Sunnybrook Health Science Centre; William Osler Health System; University of Alberta; McMaster University; Foothills Medical Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Clinical trial; Multidisciplinary approach; Kidney cancer; Intensive care medicine; Immunotherapy; Cancer; Translational research; Clinical research; Alternative medicine; Clinical Practice; Internal medicine; Family medicine; Pathology; Political science","score_opus":0.023842856426292382,"score_gpt":0.28655888588689254,"score_spread":0.2627160294606002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137876535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8616149,0.005267706,0.0000046661426,0.12433988,0.001088872,0.0004180458,0.00052201125,0.0000068437234,0.006737093],"genre_scores_gemma":[0.98803777,0.0029947793,0.00062062533,0.0043273172,0.00043416192,0.000036294394,0.000068944566,0.000020315736,0.0034597958],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9965527,0.00044185293,0.0006410566,0.00030398043,0.0010709065,0.0009894959],"domain_scores_gemma":[0.99537003,0.00017905456,0.0004361886,0.00024093405,0.001751031,0.0020227695],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010726469,0.00017650651,0.00054421567,0.0001061178,0.00029595126,0.000023223118,0.00015765152,0.00017445994,0.003069578],"category_scores_gemma":[0.00080541114,0.00015446756,0.00014890717,0.00074198825,0.00006927683,0.00002967785,0.00005465919,0.0006941828,0.000004701589],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00032089508,0.00010279072,0.46542656,0.00013325916,0.0014979031,0.0042310217,0.000085677195,0.0024947033,0.00087340723,0.0006299618,0.5160994,0.00810445],"study_design_scores_gemma":[0.0036713397,0.00033162683,0.572803,0.000583286,0.00047867847,0.00018564041,0.00046409265,0.00011332826,0.0033286728,0.00079696893,0.41695312,0.0002901958],"about_ca_topic_score_codex":0.29956502,"about_ca_topic_score_gemma":0.42149392,"teacher_disagreement_score":0.12642288,"about_ca_system_score_codex":0.0055399514,"about_ca_system_score_gemma":0.016073951,"threshold_uncertainty_score":0.9982776},"labels":[],"label_agreement":null},{"id":"W3139198095","doi":"10.18433/jpps31816","title":"Clinical Importance of Plasma Drug Concentration of Oral Molecular Targeted Drugs for Renal Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Japan Society for the Promotion of Science","keywords":"Medicine; Sunitinib; Sorafenib; Axitinib; Discontinuation; Pazopanib; Everolimus; Adverse effect; Drug; Renal cell carcinoma; Pharmacology; Therapeutic drug monitoring; Internal medicine; Oncology; Hepatocellular carcinoma","score_opus":0.08024402216793146,"score_gpt":0.41654183661158045,"score_spread":0.336297814443649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139198095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99049103,0.005597125,0.00028667474,0.001761166,0.0004689817,0.00037802104,0.00002155224,0.0000066192692,0.0009888562],"genre_scores_gemma":[0.9887036,0.0004158298,0.010116151,0.0004795315,0.00018535335,0.0000047789404,0.000007401417,0.000014435125,0.00007292374],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99621564,0.00027862506,0.0016730143,0.00034033184,0.0010893637,0.000403016],"domain_scores_gemma":[0.99692434,0.0004745319,0.0009769629,0.00015924881,0.0009584351,0.000506485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019679489,0.00021239309,0.000774982,0.000103388564,0.00007500782,0.000021157253,0.00028782611,0.00005338879,0.00032267597],"category_scores_gemma":[0.00026978314,0.0001587875,0.00062029954,0.0005284344,0.0006549652,0.00024389788,0.000060468843,0.00036705573,0.0000020439613],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017121412,0.0010852154,0.1920851,0.00027164537,0.0001604656,0.00042978505,0.00023551765,0.00012242296,0.7915713,0.00014797671,0.0010071212,0.011171271],"study_design_scores_gemma":[0.008953341,0.00084217807,0.0057320846,0.00007384236,0.00076782994,0.00020916299,0.00021883615,0.0063216155,0.9699302,0.00009872917,0.0067171147,0.00013507513],"about_ca_topic_score_codex":0.00001079103,"about_ca_topic_score_gemma":0.0000012869223,"teacher_disagreement_score":0.18635301,"about_ca_system_score_codex":0.00009791857,"about_ca_system_score_gemma":0.0013005837,"threshold_uncertainty_score":0.64751667},"labels":[],"label_agreement":null},{"id":"W3139310351","doi":"10.48083/wqfr3235","title":"Can incomplete metastasectomy impact renal cell carcinoma outcomes? A propensity score matching analysis from a prospective multicenter collaboration","year":2021,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval; Centre Hospitalier de l’Université de Montréal; Ottawa Hospital; Health Sciences Centre; University of Calgary; Princess Margaret Cancer Centre; University of Toronto; McMaster University; Sunnybrook Health Science Centre; University of Manitoba; Juravinski Cancer Centre; Queen Elizabeth II Health Sciences Centre; University of Alberta; University of British Columbia; McGill University Health Centre; McGill University","funders":"","keywords":"Metastasectomy; Medicine; Propensity score matching; Renal cell carcinoma; Hazard ratio; Proportional hazards model; Nephrectomy; Confounding; Internal medicine; Oncology; Multivariate analysis; Kidney cancer; Lung; Urology; Metastasis; Surgery; Cancer; Kidney; Confidence interval","score_opus":0.054051272741415315,"score_gpt":0.32488997896966576,"score_spread":0.27083870622825046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139310351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930439,0.0004551836,0.0012804244,0.002604164,0.00034969853,0.0005843033,0.0004978886,0.000049750037,0.0011347122],"genre_scores_gemma":[0.9933366,0.000028581155,0.0037743961,0.00080302777,0.0003404875,0.000044150864,0.0009181508,0.000032308344,0.0007222646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967646,0.00040622105,0.0007542706,0.0006073782,0.001025279,0.00044224676],"domain_scores_gemma":[0.9967067,0.00031070728,0.0006564188,0.00042133342,0.0015709628,0.00033383965],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042226963,0.00041103413,0.0009357239,0.0004223903,0.00027881406,0.0002860972,0.00024245439,0.0001421306,0.001508642],"category_scores_gemma":[0.0003263926,0.00030584692,0.0010082461,0.000699614,0.000082080085,0.0002959207,0.00019053955,0.00082338706,0.00002218599],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007623842,0.0005614796,0.97204065,0.0000143408315,0.0049452423,0.0023776689,0.0010363333,0.00076496665,0.01687172,0.000018140465,0.00031892103,0.00028814754],"study_design_scores_gemma":[0.005170482,0.0004101943,0.9750422,0.000026798876,0.0027230694,0.00029112527,0.0005914488,0.0008024994,0.013804676,0.0008130932,0.00007285315,0.0002515215],"about_ca_topic_score_codex":0.00076971954,"about_ca_topic_score_gemma":0.0007764437,"teacher_disagreement_score":0.004408098,"about_ca_system_score_codex":0.0019362953,"about_ca_system_score_gemma":0.0009804633,"threshold_uncertainty_score":0.9999394},"labels":[],"label_agreement":null},{"id":"W3139388345","doi":"10.1038/s41379-021-00775-0","title":"Correction to: Novel, emerging and provisional renal entities: the Genitourinary Pathology Society (GUPS) update on renal neoplasia","year":2021,"lang":"en","type":"erratum","venue":"Modern Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of British Columbia; Royal Columbian Hospital; University of Calgary","funders":"","keywords":"Pathology; Genitourinary system; Renal pathology; Medicine; Kidney; Internal medicine","score_opus":0.01748611672678064,"score_gpt":0.26215517085601797,"score_spread":0.24466905412923734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139388345","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7816937,0.021810837,0.022096142,0.02216269,0.10857388,0.0052946727,0.00079465954,0.00061931345,0.036954105],"genre_scores_gemma":[0.22829495,0.0058928216,0.009975685,0.01853008,0.015988449,0.001448057,0.009138341,0.00075996143,0.70997167],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960044,0.00034012512,0.0006602461,0.0015295175,0.0006729857,0.00079273223],"domain_scores_gemma":[0.9979,0.0002339237,0.00033155398,0.0010045846,0.00026061875,0.00026928863],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00048953405,0.0007506546,0.0011091317,0.0002507984,0.00043394952,0.00006706147,0.0002529877,0.0008895535,0.00026926133],"category_scores_gemma":[0.00017419847,0.00055881083,0.00049693964,0.00023130685,0.0003310439,0.000063082836,0.0005013521,0.0023053675,0.00010055422],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081074843,0.0006283456,0.00029737112,0.00023176897,0.00040913434,0.009464577,0.0032133693,0.0001947404,0.015060472,0.000067514244,0.958057,0.011564958],"study_design_scores_gemma":[0.009789814,0.011359702,0.03918615,0.0029472313,0.0031835244,0.10237401,0.0018286577,0.018524732,0.0043470417,0.0011691314,0.8025918,0.0026981893],"about_ca_topic_score_codex":0.000034628454,"about_ca_topic_score_gemma":0.00007401408,"teacher_disagreement_score":0.67301756,"about_ca_system_score_codex":0.00040834452,"about_ca_system_score_gemma":0.0007180955,"threshold_uncertainty_score":0.99999636},"labels":[],"label_agreement":null},{"id":"W3140563178","doi":"10.6000/1929-2279.2013.02.03.8","title":"Nephron-Sparing Surgery in Renal Cell Carcinoma: Morbidity and Outcomes","year":2013,"lang":"en","type":"article","venue":"Journal of cancer research updates","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Perioperative; Adipose capsule of kidney; Pathological; Surgery; Cancer; Kidney cancer; Kidney; Urology; Internal medicine","score_opus":0.08114379280299205,"score_gpt":0.3692299366413228,"score_spread":0.28808614383833075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3140563178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855235,0.009265324,0.0000028848388,0.0040924624,0.00010174209,0.0003077877,0.0000026192454,0.0000051755087,0.0006984767],"genre_scores_gemma":[0.9969856,0.0018559225,0.0002635527,0.000102314865,0.0002346543,0.000035463112,0.0000021699339,0.000023251714,0.0004970379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997595,0.00019270166,0.0005649216,0.00020135706,0.0009272879,0.00051870174],"domain_scores_gemma":[0.99812454,0.0005662793,0.00018133882,0.00022252517,0.00053042895,0.00037489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013590091,0.00015970969,0.00059156335,0.000688292,0.00006894742,0.00008014803,0.00013042268,0.00007474346,0.000432433],"category_scores_gemma":[0.00018772991,0.00010882226,0.00014110553,0.0003212112,0.00015199956,0.0003316008,0.000110275236,0.0007486139,0.00002346188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021351049,0.00015050125,0.9666316,0.0001355868,0.000056881214,0.0005202643,0.00013923705,0.000017148948,0.016910667,0.000004866497,0.011311228,0.0039085057],"study_design_scores_gemma":[0.0013461887,0.0002641771,0.941516,0.00016073463,0.000033831802,0.00010490128,0.00017274075,0.000057387515,0.054916296,0.00017692213,0.0011611084,0.000089700174],"about_ca_topic_score_codex":0.0051954566,"about_ca_topic_score_gemma":0.00028312125,"teacher_disagreement_score":0.03800563,"about_ca_system_score_codex":0.00049049687,"about_ca_system_score_gemma":0.0005705504,"threshold_uncertainty_score":0.78540105},"labels":[],"label_agreement":null},{"id":"W3142535259","doi":"10.1111/bju.15426","title":"The role of nephrectomy in metastatic renal cell carcinoma in the immuno‐oncology era","year":2021,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Sunitinib; Nephrectomy; Renal cell carcinoma; Nivolumab; Kidney cancer; Internal medicine; Oncology; Ipilimumab; Cohort; Nephrology; Urology; Surgery; Cancer; Immunotherapy; Kidney","score_opus":0.012428319538438065,"score_gpt":0.25106017031576194,"score_spread":0.23863185077732388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3142535259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92624646,0.06731799,0.0000068372483,0.0021773388,0.00012728799,0.00017454573,0.0000031761083,0.0000015250291,0.003944841],"genre_scores_gemma":[0.9973383,0.0015374634,0.00044423435,0.000503876,0.00008347606,0.0000115651965,0.0000042552374,0.000013551676,0.00006331049],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99735713,0.0010573412,0.00084132294,0.00014595252,0.00028013377,0.00031809052],"domain_scores_gemma":[0.9983177,0.0007986764,0.00037750654,0.00022494068,0.00021712849,0.000064049156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011977308,0.000116942916,0.0005642546,0.00013691136,0.0000506815,0.000019254945,0.00024722345,0.0000882667,0.000078034995],"category_scores_gemma":[0.00024082923,0.000082146784,0.00019544823,0.0003111864,0.00016559778,0.000050160827,0.000052511354,0.00074000837,0.000003426607],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005826661,0.005048696,0.24897122,0.00015046597,0.0006416432,0.22987334,0.005647711,0.00060988433,0.11333998,0.0006148338,0.0032749576,0.3860006],"study_design_scores_gemma":[0.009091167,0.0039082514,0.7957126,0.00007629175,0.00039723422,0.13118376,0.0030071794,0.00010950341,0.015509781,0.0022350834,0.038641065,0.00012811813],"about_ca_topic_score_codex":0.00039953575,"about_ca_topic_score_gemma":0.0012047407,"teacher_disagreement_score":0.54674137,"about_ca_system_score_codex":0.00012240406,"about_ca_system_score_gemma":0.00067139603,"threshold_uncertainty_score":0.33498487},"labels":[],"label_agreement":null},{"id":"W3143000526","doi":"10.1201/9781351187435-26","title":"Birt–Hogg–Dubé Syndrome","year":2020,"lang":"en","type":"book-chapter","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Birt–Hogg–Dubé syndrome; Medicine; Anatomy","score_opus":0.03786402419279426,"score_gpt":0.23772938461162482,"score_spread":0.19986536041883057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3143000526","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004990889,0.0015020716,0.000021085129,0.001629897,0.00019084978,0.0006709595,0.000022414468,0.00024732106,0.9952163],"genre_scores_gemma":[0.07142546,0.00019076467,0.00067544956,0.0014707879,0.00025337978,0.000013710638,0.0002295608,0.00014323261,0.92559767],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983672,0.000005888096,0.00034872314,0.0005618846,0.0004959731,0.00022031312],"domain_scores_gemma":[0.99879557,0.000038561917,0.00010548236,0.0005932866,0.00006846785,0.00039861584],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000038268787,0.00046811023,0.0008261544,0.00014800316,0.000030168676,0.00001658486,0.00010983072,0.0003494016,0.0103547815],"category_scores_gemma":[0.0000116740275,0.00035162122,0.0004055685,0.000026892978,0.00006667052,0.00002404518,0.00009782869,0.00043941563,0.010201573],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083322957,0.00030269,0.00075974205,0.0026066208,0.005325062,0.08923371,0.00021051163,0.0000015103805,0.001627965,0.6938461,0.17972799,0.025524884],"study_design_scores_gemma":[0.0018296237,0.0025065227,0.0016162941,0.0006080273,0.0015157772,0.0050382763,0.000011323326,0.000010185085,0.0011286514,0.0053077014,0.9796847,0.00074288406],"about_ca_topic_score_codex":0.000022676675,"about_ca_topic_score_gemma":0.000004215973,"teacher_disagreement_score":0.79995674,"about_ca_system_score_codex":0.00023230948,"about_ca_system_score_gemma":0.00014095406,"threshold_uncertainty_score":0.9998936},"labels":[],"label_agreement":null},{"id":"W3144606368","doi":"10.1016/j.urolonc.2021.02.025","title":"Lymph node dissection during radical nephrectomy: A Canadian multi-institutional analysis","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; Université de Montréal; University of Alberta; Université Laval; Princess Margaret Cancer Centre; University of Calgary; University of Ottawa; McGill University; University of British Columbia; University of Toronto; McMaster University; University of Manitoba","funders":"","keywords":"Propensity score matching; Medicine; Nephrectomy; Renal cell carcinoma; Lymph node; Proportional hazards model; Kidney cancer; Dissection (medical); Urology; Cohort; Oncology; Internal medicine; Survival analysis; Surgery; Kidney","score_opus":0.029137943384666243,"score_gpt":0.2930300634981475,"score_spread":0.26389212011348123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3144606368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880157,0.0012934431,0.00027290158,0.007429678,0.00015018032,0.00017308013,0.000030209687,0.00005832295,0.0025764985],"genre_scores_gemma":[0.918716,0.00025757597,0.07725135,0.0017796151,0.00013994939,0.00007771716,0.0003878342,0.000011158532,0.0013787601],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859595,0.00012507408,0.00027716695,0.0004737128,0.00016146408,0.00036663172],"domain_scores_gemma":[0.99876374,0.00010317698,0.00007309318,0.00022202633,0.00010147984,0.000736495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014619494,0.00020747408,0.00042920272,0.0004081745,0.0005353449,0.000029204213,0.000054347413,0.00025699876,0.00032778893],"category_scores_gemma":[0.00019968858,0.00017302591,0.00016015512,0.0008840722,0.00054357,0.00008250324,0.00003216733,0.0002765387,0.000033611774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059876944,0.0002167195,0.9900901,0.000023876548,0.00054411497,0.0034465636,0.00017210617,0.0005193391,0.002489607,0.0018492934,0.00018521899,0.00040318308],"study_design_scores_gemma":[0.0022224777,0.00032021385,0.6809901,0.00003652607,0.0030842286,0.0055733183,0.00019587297,0.004786567,0.0030733217,0.00039346327,0.2990511,0.0002727995],"about_ca_topic_score_codex":0.005763029,"about_ca_topic_score_gemma":0.01591758,"teacher_disagreement_score":0.3091,"about_ca_system_score_codex":0.0008718174,"about_ca_system_score_gemma":0.0019591022,"threshold_uncertainty_score":0.8882384},"labels":[],"label_agreement":null},{"id":"W3146782956","doi":"10.1016/j.anndiagpath.2021.151734","title":"Renal cell carcinomas with tubulopapillary architecture and oncocytic cells: Molecular analysis of 39 difficult tumors to classify","year":2021,"lang":"en","type":"article","venue":"Annals of Diagnostic Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Royal Columbian Hospital","funders":"Lékařská Fakulta v Plzni, Univerzita Karlova; Ministerstvo Školství, Mládeže a Tělovýchovy","keywords":"Polysomy; Oncocytoma; Immunohistochemistry; Pathology; Renal oncocytoma; Chromophobe cell; Papillary renal cell carcinomas; Renal cell carcinoma; Clear cell; Biology; Medicine; Gene; Chromosome; Fluorescence in situ hybridization","score_opus":0.020782396059435274,"score_gpt":0.26880739618543353,"score_spread":0.24802500012599826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3146782956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914232,0.004937118,0.0004919339,0.0016607256,0.000029769906,0.00037019036,0.00008391772,0.000017276254,0.0009858626],"genre_scores_gemma":[0.9955452,0.0004174673,0.0025578456,0.0011595887,0.00002531738,0.000035725257,0.000112630805,0.00003142986,0.00011481446],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99787295,0.00022397203,0.0005252163,0.00059744896,0.00037370654,0.00040669623],"domain_scores_gemma":[0.9972358,0.0010516983,0.00022454478,0.0006485519,0.0004976448,0.00034175825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016737267,0.00030686427,0.0011786047,0.00050128566,0.000032463435,0.0000070256488,0.000108225584,0.00014478699,0.000059342998],"category_scores_gemma":[0.00071649137,0.00023654672,0.0002468683,0.0011520036,0.00023737278,0.0000198671,0.00012409383,0.00021562503,0.000005397627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005841008,0.0011138353,0.08824929,0.0005566396,0.0017230515,0.036939453,0.0016037927,0.0042824927,0.86208296,0.000112303635,0.00038131498,0.0023707773],"study_design_scores_gemma":[0.0008942129,0.0022331227,0.3652103,0.00016927041,0.002394615,0.00044794654,0.00019045724,0.000035123066,0.62813246,0.000043898002,0.000076057266,0.00017251704],"about_ca_topic_score_codex":0.000059532973,"about_ca_topic_score_gemma":0.000051412782,"teacher_disagreement_score":0.27696103,"about_ca_system_score_codex":0.000030875864,"about_ca_system_score_gemma":0.00026372698,"threshold_uncertainty_score":0.9646095},"labels":[],"label_agreement":null},{"id":"W3147831054","doi":"10.14740/jmc2289w","title":"Cerebrovascular Ischemic Events in Patients With Advanced Renal Cell Carcinoma Treated With Anti-Angiogenic Tyrosine Kinase Inhibitors: A Report on Two Cases With Different Outcomes","year":2015,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Axitinib; Pazopanib; Renal cell carcinoma; Angiogenesis; Vascular endothelial growth factor; Internal medicine; Aspirin; Dipyridamole; Stroke (engine); Oncology; Sunitinib; VEGF receptors","score_opus":0.01879062563561207,"score_gpt":0.2627120416394789,"score_spread":0.24392141600386685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3147831054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979742,0.0007085995,0.000016780172,0.00043371518,0.000092306436,0.00066631334,0.000014054976,0.000022664768,0.000071330345],"genre_scores_gemma":[0.99907213,0.00001975291,0.00026400888,0.0001600809,0.00017996527,0.000021528827,0.000106141735,0.00007409361,0.00010227363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99421644,0.00016261754,0.0010046101,0.00047395387,0.0036389336,0.00050342403],"domain_scores_gemma":[0.99664396,0.00024656983,0.0007875002,0.000546088,0.00058269623,0.0011932048],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042914873,0.0005727514,0.0013260086,0.00043481792,0.00004875556,0.000017048254,0.0001849998,0.00014620094,0.0000590578],"category_scores_gemma":[0.00048745683,0.00027303907,0.00027895154,0.0004179984,0.00015840953,0.00017457639,0.000054682394,0.0006053154,0.000004089857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074830935,0.0031029314,0.90387535,0.000073777606,0.00033459804,0.08398534,0.0000802663,0.00007133281,0.0001396138,4.3932886e-7,0.00047968214,0.0003735767],"study_design_scores_gemma":[0.045294195,0.024486784,0.88058764,0.001858261,0.0010541991,0.021242112,0.00018653963,0.000010096858,0.024827518,9.56235e-7,0.00009515894,0.00035653403],"about_ca_topic_score_codex":0.00038028878,"about_ca_topic_score_gemma":0.00015718838,"teacher_disagreement_score":0.06274323,"about_ca_system_score_codex":0.000650625,"about_ca_system_score_gemma":0.0007372228,"threshold_uncertainty_score":0.99997216},"labels":[],"label_agreement":null},{"id":"W3150402850","doi":"10.3390/curroncol28020133","title":"Efficacy and Safety of Nivolumab and Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nivolumab; Ipilimumab; Internal medicine; Renal cell carcinoma; Clinical endpoint; Retrospective cohort study; Oncology; Cohort; Cancer; Immunotherapy; Clinical trial","score_opus":0.05903007237537197,"score_gpt":0.37115760300476236,"score_spread":0.31212753062939036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3150402850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991268,0.004237449,0.00017987179,0.000112390015,0.0003033604,0.0035082405,0.0000524914,0.00001697472,0.00032122596],"genre_scores_gemma":[0.99683106,0.00026766764,0.0021714678,0.000020240697,0.0000577398,0.00025788374,0.00006469499,0.000026220729,0.00030300295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982282,0.00018452843,0.00048159648,0.000603561,0.00021511616,0.00028702835],"domain_scores_gemma":[0.99849755,0.0004462311,0.00020113427,0.0003168558,0.0003631592,0.00017508295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025380144,0.0002350162,0.00094168045,0.00009208595,0.0000766099,0.000007587597,0.00004940689,0.000057674482,0.00006621469],"category_scores_gemma":[0.00027029833,0.00018030312,0.00008917441,0.00014719527,0.00014915213,0.00004694893,0.00011518085,0.00019429627,0.0000019172203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018881153,0.008979007,0.9335891,0.00078808836,0.0005086967,0.00047128403,0.0026827413,0.0000035505186,0.0069544595,0.000028445951,0.00025318682,0.026860313],"study_design_scores_gemma":[0.053210046,0.011254125,0.9234096,0.000078615565,0.0017836099,0.00014937647,0.0014742254,0.0002036326,0.0066828076,0.000018291857,0.0015680437,0.00016766813],"about_ca_topic_score_codex":0.000014213039,"about_ca_topic_score_gemma":0.00008025566,"teacher_disagreement_score":0.034328893,"about_ca_system_score_codex":0.000439076,"about_ca_system_score_gemma":0.00030764338,"threshold_uncertainty_score":0.7352548},"labels":[],"label_agreement":null},{"id":"W3153668703","doi":"10.1148/rg.2021200160","title":"Bosniak Classification of Cystic Renal Masses, Version 2019: A Pictorial Guide to Clinical Use","year":2021,"lang":"en","type":"article","venue":"Radiographics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Women's College Hospital; University of Toronto; University Health Network; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Malignancy; Radiology; Clinical Practice; Renal cell carcinoma; Renal mass; Medical physics; Kidney; Pathology; Nephrectomy; Internal medicine","score_opus":0.052334931535406325,"score_gpt":0.3457991399724579,"score_spread":0.2934642084370516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153668703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936504,0.0007546177,0.0016587224,0.00095316936,0.001367002,0.00042129683,0.00005019597,0.000054631968,0.0010899783],"genre_scores_gemma":[0.97443116,0.00065936707,0.022497987,0.00022314207,0.0008667931,0.000014276359,0.00029761807,0.00003298814,0.0009766597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793196,0.00019289427,0.00067753287,0.0004269674,0.00053872116,0.00023195324],"domain_scores_gemma":[0.997915,0.0004415978,0.0001590582,0.00071986904,0.00042723966,0.00033721566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039983293,0.0001693052,0.0004454499,0.00028772303,0.00004985299,0.000024013145,0.0000969633,0.00020433798,0.000057557525],"category_scores_gemma":[0.00081557274,0.00015235716,0.0004020877,0.0009086879,0.00009256185,0.00007703378,0.00005282597,0.00023643082,0.000037768194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016766582,0.0010665429,0.7889068,0.0001231147,0.00054684357,0.0006452535,0.00011454582,0.000017541843,0.08452713,0.0015121155,0.118090115,0.0027733406],"study_design_scores_gemma":[0.0025218236,0.0009427186,0.7675522,0.00015526799,0.0005537025,0.000104934166,0.00004457669,0.000118128955,0.0054767225,0.000049220453,0.2223285,0.00015217753],"about_ca_topic_score_codex":0.00009068171,"about_ca_topic_score_gemma":0.000027556125,"teacher_disagreement_score":0.10423838,"about_ca_system_score_codex":0.00011041688,"about_ca_system_score_gemma":0.00032884392,"threshold_uncertainty_score":0.62129444},"labels":[],"label_agreement":null},{"id":"W3154127731","doi":"10.1016/j.suronc.2021.101588","title":"Partial nephrectomy in frail patients: Benefits of robot-assisted surgery","year":2021,"lang":"en","type":"article","venue":"Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Surgical Specialties (Canada); Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Poisson regression; Surgery; Logistic regression; Blood loss; Renal function; Internal medicine; Kidney; Population","score_opus":0.044939618732891574,"score_gpt":0.30032228213683443,"score_spread":0.25538266340394283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154127731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767874,0.0010830414,0.00000213084,0.00071025215,0.00032538114,0.00023740446,0.000008593612,0.000022255777,0.020823559],"genre_scores_gemma":[0.99859333,0.00020926069,0.0003605884,0.00019026022,0.000115608134,0.000062067564,0.00015006255,0.000016951462,0.0003018993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981789,0.0002763808,0.00060712046,0.00032852075,0.0002735851,0.00033551187],"domain_scores_gemma":[0.9983404,0.0008655768,0.00013585942,0.00025871018,0.00021809312,0.000181351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022043611,0.00015424968,0.0008853673,0.00013577669,0.000018807765,0.0000036829001,0.000045300734,0.00023765188,0.00083291525],"category_scores_gemma":[0.00018736666,0.00012839278,0.0002450644,0.0004383825,0.00009167359,0.00003506185,0.000066806926,0.00021166643,0.000044335702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013346734,0.0034150565,0.60944796,0.00007712614,0.00011097881,0.0046316893,0.00007757375,0.000047702393,0.00046817254,0.00025456108,0.000495117,0.3796394],"study_design_scores_gemma":[0.0040170676,0.0006805876,0.81538767,0.00008447157,0.00008594387,0.00021796468,0.000026218806,0.0000123616655,0.008082947,0.00002351766,0.17126271,0.000118535856],"about_ca_topic_score_codex":0.00008748533,"about_ca_topic_score_gemma":0.00012615921,"teacher_disagreement_score":0.37952083,"about_ca_system_score_codex":0.00031567283,"about_ca_system_score_gemma":0.00052271393,"threshold_uncertainty_score":0.9119838},"labels":[],"label_agreement":null},{"id":"W3154427458","doi":"10.2196/24423","title":"Presence of Urinary Exosomes for Liquid Biopsy of Clear Cell Renal Cell Carcinoma: Protocol for a Pilot Feasibility Study","year":2021,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Liquid biopsy; Medicine; Exosome; Biopsy; Microvesicles; Clear cell renal cell carcinoma; Renal cell carcinoma; Pathology; Urinary system; Radiology; Internal medicine; Cancer; microRNA; Biology","score_opus":0.3748884863666349,"score_gpt":0.5303978700765655,"score_spread":0.15550938370993056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154427458","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29419196,0.0000062775275,0.000038308073,0.00009388218,0.000003828971,0.70463276,0.000078637546,0.000026726764,0.00092759146],"genre_scores_gemma":[0.34325057,7.995607e-8,0.0022334324,0.000004523203,0.00008822657,0.65245676,0.000014903362,0.000056684818,0.0018948204],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99446166,0.0008595211,0.0010987311,0.0011000959,0.0015436069,0.00093641033],"domain_scores_gemma":[0.99366266,0.0009660915,0.00036312215,0.0017703199,0.0028432757,0.00039452003],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024086747,0.00036878983,0.0009442655,0.00032754193,0.00018765668,0.000039336388,0.00050964754,0.0001546853,0.00016964055],"category_scores_gemma":[0.00056051265,0.0002980439,0.00039298096,0.0007575197,0.00039128526,0.00014866839,0.00052005704,0.00047959643,0.000008805971],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13826346,0.07501387,0.051291954,0.036419477,0.000096561045,0.00039878904,0.001146349,0.000005454672,0.6929543,0.000057868485,0.0041270973,0.00022482149],"study_design_scores_gemma":[0.026201218,0.16835257,0.029576104,0.0010700196,0.00002766889,0.00003596552,0.0007636668,0.00005569775,0.76901466,0.0001235598,0.0045672506,0.00021161295],"about_ca_topic_score_codex":0.000053256626,"about_ca_topic_score_gemma":0.0000074710556,"teacher_disagreement_score":0.112062246,"about_ca_system_score_codex":0.0003114314,"about_ca_system_score_gemma":0.0018674406,"threshold_uncertainty_score":0.9999472},"labels":[],"label_agreement":null},{"id":"W3154563477","doi":"10.1158/0008-5472.can-20-3979","title":"mTOR Activation Initiates Renal Cell Carcinoma Development by Coordinating ERK and p38MAPK","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"PI3K/AKT/mTOR pathway; Cancer research; Renal cell carcinoma; TSC1; MAPK/ERK pathway; Cell growth; Biology; Clear cell; Cell biology; Kinase; Medicine; Signal transduction; Pathology","score_opus":0.09248545803040284,"score_gpt":0.36988556457392086,"score_spread":0.277400106543518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154563477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884341,0.0047464785,0.000030435438,0.0012611523,0.00004212512,0.00033127159,0.0000074875147,0.00002138833,0.005125608],"genre_scores_gemma":[0.9922516,0.0001274969,0.00076134916,0.00012337307,0.00013515941,0.00020990863,0.000094300565,0.000030020623,0.00626684],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817955,0.000113568305,0.00021057935,0.00041503567,0.0006468028,0.00043446544],"domain_scores_gemma":[0.99879473,0.00017811378,0.000041903462,0.00021772661,0.00053142663,0.00023608029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003874894,0.00013784833,0.00021095396,0.00012648734,0.00023728698,0.0000585797,0.000064175445,0.000078287114,0.00032312228],"category_scores_gemma":[0.00012763262,0.00012224217,0.000031697644,0.00037703742,0.000089042966,0.00009143911,0.00013834663,0.00037002005,0.000022887043],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016873005,0.00016532087,0.026160873,0.00037565056,0.00005635175,0.0004146727,0.0010814923,0.0000014560515,0.940752,0.000024306626,0.011102059,0.019697065],"study_design_scores_gemma":[0.0012765974,0.00018440546,0.048758905,0.00015128279,0.000016375188,0.0000348195,0.00045347877,0.000014088752,0.9337139,0.000020905614,0.015265689,0.0001095372],"about_ca_topic_score_codex":0.0002161751,"about_ca_topic_score_gemma":0.000023209363,"teacher_disagreement_score":0.022598032,"about_ca_system_score_codex":0.0007175798,"about_ca_system_score_gemma":0.0009965334,"threshold_uncertainty_score":0.4984891},"labels":[],"label_agreement":null},{"id":"W3154907435","doi":"10.31782/ijcrr.2021.13707","title":"Histomorphological Spectrum of Neoplastic Lesions of Kidney with a Brief Review of Literature","year":2021,"lang":"en","type":"review","venue":"International Journal of Current Research and Review","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pathology; Spectrum (functional analysis); Medicine; Kidney; Internal medicine; Physics","score_opus":0.1637537442374184,"score_gpt":0.47123323244985144,"score_spread":0.30747948821243304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154907435","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018143071,0.99708194,0.000018446814,0.0012717682,0.0002296755,0.0008991325,0.00015867935,0.000001616261,0.000320613],"genre_scores_gemma":[0.00004594001,0.9990387,0.00021170509,0.00008478149,0.00020205842,0.000019001416,0.00023047067,0.000020083162,0.00014727195],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99460995,0.0006484127,0.0020635256,0.00027580463,0.0021798823,0.00022244529],"domain_scores_gemma":[0.99279445,0.00057148736,0.0019132004,0.00034070978,0.0038981994,0.00048197128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001704584,0.00030966048,0.003726753,0.00055539917,0.000019511483,0.000013892638,0.00046231452,0.00011128028,0.0004321488],"category_scores_gemma":[0.002823509,0.00015954021,0.0010067675,0.00074910576,0.00036411665,0.00006331677,0.00018523622,0.0012525774,0.0000025157062],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009169404,0.0006978693,0.000035179368,0.54834,0.000869571,0.0010665084,0.000010598669,1.633493e-8,0.0000045144075,0.00040616567,0.017859086,0.43061876],"study_design_scores_gemma":[0.00030696217,0.00090371585,0.000013282775,0.51204526,0.0009778293,0.004755465,0.0000011647837,6.657176e-8,0.000011152251,0.00001422739,0.48091647,0.000054390817],"about_ca_topic_score_codex":0.000004190387,"about_ca_topic_score_gemma":4.7770163e-7,"teacher_disagreement_score":0.4630574,"about_ca_system_score_codex":0.00023703546,"about_ca_system_score_gemma":0.0033711048,"threshold_uncertainty_score":0.6505861},"labels":[],"label_agreement":null},{"id":"W3156019974","doi":"10.1101/2021.04.14.439908","title":"Integrative Clinical and Molecular Characterization of Translocation Renal Cell Carcinoma","year":2021,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; William Osler Health System","funders":"","keywords":"Renal cell carcinoma; Chromosomal translocation; Immunophenotyping; Biology; Kidney cancer; CD8; Cancer research; Somatic cell; Breakpoint; Immune system; Gene; Flow cytometry; Immunology; Pathology; Medicine; Genetics","score_opus":0.018683785280878787,"score_gpt":0.24772650383637868,"score_spread":0.2290427185554999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156019974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919567,0.0021661285,0.0040925136,0.00025442525,0.00038430627,0.0009741176,0.00009185988,0.00006808136,0.000011876342],"genre_scores_gemma":[0.99465024,0.0005356754,0.004297331,0.00012350985,0.00018324394,0.000104473635,0.000009355282,0.000089279834,0.000006866132],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972434,0.00027706806,0.00089990173,0.00092187093,0.00039029942,0.0002674838],"domain_scores_gemma":[0.99736315,0.000049077047,0.00052072323,0.00092329073,0.00085138774,0.0002923502],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042600246,0.0004779698,0.0009848282,0.00021540905,0.000044018725,0.00005984691,0.00014363865,0.0005542075,0.000029930952],"category_scores_gemma":[0.00009143273,0.00045182687,0.00027643362,0.000271643,0.00020971952,0.00008971641,0.00015244738,0.0006922877,0.000005640211],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013072451,0.0003677706,0.0366041,0.0008585528,0.00017508169,0.00024127739,0.000047104444,0.000001522224,0.96150184,0.000052578936,0.000009093753,0.000010332471],"study_design_scores_gemma":[0.0008398822,0.00020275726,0.3699666,0.00050188665,0.00035595385,5.6388938e-8,0.0000059420468,0.00013311424,0.62772024,2.8108795e-7,0.000057853464,0.00021545343],"about_ca_topic_score_codex":0.00004036961,"about_ca_topic_score_gemma":0.0000010741536,"teacher_disagreement_score":0.33378166,"about_ca_system_score_codex":0.00015315846,"about_ca_system_score_gemma":0.00092472247,"threshold_uncertainty_score":0.99979335},"labels":[],"label_agreement":null},{"id":"W3158912210","doi":"10.1007/s10552-021-01435-z","title":"Association between cytoreductive nephrectomy and survival among patients with metastatic renal cell carcinoma receiving modern therapies: a systematic review and meta-analysis examining effect modification according to systemic therapy approach","year":2021,"lang":"en","type":"review","venue":"Cancer Causes & Control","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Hazard ratio; Internal medicine; Meta-analysis; Nephrectomy; Systemic therapy; Oncology; Observational study; Surgery; Urology; Confidence interval; Kidney; Cancer","score_opus":0.08821736012559268,"score_gpt":0.32455833822248137,"score_spread":0.2363409780968887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158912210","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04011889,0.9441936,0.0011967067,0.000021025018,0.00003586217,0.01409083,0.0002797112,0.00004627297,0.000017090475],"genre_scores_gemma":[0.41111895,0.5800509,0.00013155071,0.000054558357,0.000063183164,0.008069917,0.00030323575,0.000113475384,0.00009423665],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9926443,0.0031667775,0.0014229744,0.0013404728,0.0009191604,0.0005063274],"domain_scores_gemma":[0.99414766,0.0018796285,0.0021786774,0.0008657951,0.0006174799,0.0003107542],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001694058,0.001100266,0.01358994,0.0005198788,0.00016379904,0.00019250068,0.00018653163,0.00021981965,0.000013258716],"category_scores_gemma":[0.00024109417,0.0006636539,0.0011682626,0.0011292131,0.00004778426,0.00020360974,0.000051919076,0.0004442565,0.0000013495589],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007060667,0.000086684726,0.0492636,0.53300846,0.4104111,0.000015428815,0.0008490855,0.000034829733,0.000007497453,5.9829813e-7,0.0000058296664,0.0062462618],"study_design_scores_gemma":[0.002077358,0.00045010154,0.0043127127,0.03293722,0.9593727,0.000011497976,0.00016054143,0.000044709974,0.0000060542443,3.4417002e-7,0.000039473023,0.00058725907],"about_ca_topic_score_codex":0.00023206818,"about_ca_topic_score_gemma":0.000015115255,"teacher_disagreement_score":0.54896164,"about_ca_system_score_codex":0.001624165,"about_ca_system_score_gemma":0.0003066919,"threshold_uncertainty_score":0.99958146},"labels":[],"label_agreement":null},{"id":"W3158993908","doi":"10.21203/rs.3.rs-446272/v1","title":"Differentiation of Renal Oncocytoma From Renal Cell Carcinoma Using 99mTc-Sestamibi SPECT/CT.","year":2021,"lang":"en","type":"preprint","venue":"Research Square","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"VINNOVA","keywords":"Oncocytoma; Renal oncocytoma; Renal cell carcinoma; Medicine; Radiology; Nuclear medicine; Pathology","score_opus":0.10221869993033904,"score_gpt":0.3731980911763011,"score_spread":0.27097939124596204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158993908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883246,0.0055645173,0.00045138886,0.00015163652,0.00030797682,0.0018898365,0.00039210546,0.000069785114,0.0028481702],"genre_scores_gemma":[0.9924219,0.00027236206,0.0024978444,0.00001379756,0.00086934405,0.000099185694,0.0029053388,0.00014745959,0.00077271997],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9918583,0.0011375323,0.0010614516,0.0015525066,0.0033572773,0.0010329138],"domain_scores_gemma":[0.99480647,0.00055332563,0.0004716786,0.0021830166,0.0013836771,0.0006018402],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008442096,0.0006648728,0.0014570972,0.0009543431,0.00020812807,0.00018713888,0.00048788133,0.00028251501,0.0014225541],"category_scores_gemma":[0.0003145922,0.00060716993,0.00078930706,0.00070795126,0.000291715,0.0001109225,0.001673364,0.0025412478,0.00004767468],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002223668,0.0035189972,0.19305287,0.008780532,0.0011207827,0.024925105,0.0021120538,0.0009796073,0.757092,0.0000535409,0.0012346219,0.0049062017],"study_design_scores_gemma":[0.0026841946,0.0009982233,0.2848218,0.0033379206,0.000515238,0.00020966874,0.00094238925,0.003396602,0.70231146,0.00024738602,0.000088782625,0.00044635448],"about_ca_topic_score_codex":0.00917472,"about_ca_topic_score_gemma":0.00034197458,"teacher_disagreement_score":0.09176893,"about_ca_system_score_codex":0.0025086233,"about_ca_system_score_gemma":0.0027488729,"threshold_uncertainty_score":0.9997599},"labels":[],"label_agreement":null},{"id":"W3159437833","doi":"10.3390/curroncol28040216","title":"Response to Combination of Pembrolizumab and Axitinib in Hereditary Leyomiomatosis and Renal Cell Cancer (HLRCC)","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Axitinib; Pembrolizumab; Bevacizumab; Tyrosine-kinase inhibitor; Kidney cancer; Cabozantinib; Oncology; Erlotinib; Internal medicine; Cancer; Renal cell carcinoma; Chemotherapy; Immunotherapy; Sunitinib; Epidermal growth factor receptor","score_opus":0.06816087945140936,"score_gpt":0.3757734824683018,"score_spread":0.3076126030168924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159437833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868804,0.008924693,0.000007776142,0.0029436923,0.0002748883,0.0003039632,0.000018264005,0.000009522409,0.00063678675],"genre_scores_gemma":[0.99872917,0.00064092537,0.0002176736,0.00012380499,0.0000441563,0.000069654016,0.000025456537,0.000011194883,0.00013795767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888587,0.00025808814,0.00027434467,0.00027498466,0.0001357951,0.00017090987],"domain_scores_gemma":[0.9992559,0.0002603782,0.000073003095,0.00014483383,0.00012307081,0.000142795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023906502,0.00011514933,0.00037367467,0.00017180106,0.000021659327,0.0000042474862,0.000029489313,0.000082897284,0.00006946817],"category_scores_gemma":[0.000117216296,0.00010763101,0.000033733188,0.00018554524,0.00007100737,0.000030731895,0.000080494145,0.00012669772,0.0000034926436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018262802,0.004609253,0.45536608,0.0013984392,0.00014192778,0.0022267099,0.0053510587,0.000015302685,0.31649056,0.0003662745,0.009769432,0.18600217],"study_design_scores_gemma":[0.010584588,0.0023517576,0.8875856,0.00031731205,0.00014169735,0.00034534317,0.00043959636,0.00013568306,0.08015271,0.0001102831,0.017690487,0.00014494335],"about_ca_topic_score_codex":0.000059162692,"about_ca_topic_score_gemma":0.00011760578,"teacher_disagreement_score":0.4322195,"about_ca_system_score_codex":0.00027930504,"about_ca_system_score_gemma":0.00034320125,"threshold_uncertainty_score":0.4389065},"labels":[],"label_agreement":null},{"id":"W3159921507","doi":"10.1007/s00330-021-07964-0","title":"The added value of contrast-enhanced ultrasound in evaluation of indeterminate small solid renal masses and risk stratification of cystic renal lesions","year":2021,"lang":"en","type":"article","venue":"European Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Sinai Health System; Women's College Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Neuroradiology; Contrast-enhanced ultrasound; Radiology; Ultrasound; Interventional radiology; Malignancy; Indeterminate; Nuclear medicine; Pathology; Neurology","score_opus":0.03560297354447731,"score_gpt":0.29248708451436645,"score_spread":0.25688411096988917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159921507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99494725,0.0015983762,0.00047516948,0.000036355577,0.00005016506,0.00036019777,0.00002194937,0.000005062328,0.0025054575],"genre_scores_gemma":[0.9982957,0.00063170714,0.0008944001,0.0000068160934,0.00003206327,0.000010110762,0.000058050784,0.000013009817,0.000058097565],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9968079,0.0020580373,0.00058172643,0.0002267949,0.00018765955,0.0001378861],"domain_scores_gemma":[0.9978356,0.0010511671,0.0004172995,0.0003235754,0.00032793518,0.000044453915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001593536,0.000108897344,0.0003447234,0.000078353565,0.00003812148,0.000004108597,0.00007201072,0.00004612451,0.0000226229],"category_scores_gemma":[0.0017298559,0.0000784998,0.000056267243,0.00013434612,0.00025602942,0.000020642887,0.000023037293,0.00014069765,0.0000013916207],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034695832,0.00013175672,0.013190808,0.000049294365,0.00013869841,0.00003884855,0.0006132691,0.000545708,0.97077453,0.0002796168,0.000015189471,0.01387532],"study_design_scores_gemma":[0.0018964513,0.0005531236,0.6713218,0.00010097898,0.0003595043,0.00015700377,0.00023212838,0.0007044237,0.32433638,0.000275436,0.000013572939,0.0000492208],"about_ca_topic_score_codex":0.000024473662,"about_ca_topic_score_gemma":0.00006188025,"teacher_disagreement_score":0.658131,"about_ca_system_score_codex":0.00004751379,"about_ca_system_score_gemma":0.00019937902,"threshold_uncertainty_score":0.32011288},"labels":[],"label_agreement":null},{"id":"W3161195108","doi":"10.1016/j.ejca.2021.04.004","title":"Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials","year":2021,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; Queen Elizabeth II Health Sciences Centre; University of Alberta; University of Calgary","funders":"Genentech; Eisai; U.S. Department of Defense; Exelixis; Congressionally Directed Medical Research Programs; Gateway for Cancer Research; Astellas Pharma; Ariad Pharmaceuticals; Bristol-Myers Squibb; Ipsen; Novartis; Pfizer","keywords":"Medicine; Oncology; Internal medicine; Clinical trial; Clinical Oncology; Intensive care medicine; Cancer","score_opus":0.14483004459395793,"score_gpt":0.45094211694231795,"score_spread":0.30611207234836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161195108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952988,0.0016200066,0.00016555762,0.0012585338,0.00034138883,0.00061644695,0.00016258565,0.0000091042375,0.00052756636],"genre_scores_gemma":[0.996125,0.0007816525,0.0017485984,0.00042978636,0.00032337476,0.000010340621,0.00002434996,0.00006087496,0.00049602427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995365,0.0014092781,0.0020950323,0.00031541457,0.0005365927,0.0002786614],"domain_scores_gemma":[0.99473685,0.0007752191,0.0018091135,0.00037820474,0.0020568096,0.00024378038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031998602,0.00028666604,0.0019970096,0.00010038786,0.00006887169,0.000033113643,0.00016277914,0.00005115953,0.00025777024],"category_scores_gemma":[0.0014856666,0.00015858942,0.0004940813,0.00014901267,0.00018731206,0.00009738534,0.000052394964,0.00018018918,0.0000023947357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029610569,0.0016487497,0.9476057,0.0002471215,0.0027543164,0.0014268671,0.00058579684,0.00006837221,0.0025363094,0.0000040499513,0.005541596,0.00797052],"study_design_scores_gemma":[0.024072113,0.010063345,0.9348272,0.00072696374,0.0017293947,0.0000737355,0.000101157646,0.0000067146448,0.0210089,0.000005045156,0.0072256895,0.00015973952],"about_ca_topic_score_codex":0.000012702765,"about_ca_topic_score_gemma":0.00005092154,"teacher_disagreement_score":0.018472591,"about_ca_system_score_codex":0.00023001434,"about_ca_system_score_gemma":0.00071889674,"threshold_uncertainty_score":0.64670885},"labels":[],"label_agreement":null},{"id":"W3161680677","doi":"10.3389/fonc.2021.634830","title":"Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy: The Next Step in the Treatment of Renal Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; McMaster University; University of Toronto; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"University of Texas MD Anderson Cancer Center","keywords":"Medicine; Renal cell carcinoma; Radiation therapy; Adaptation (eye); Magnetic resonance imaging; Radiology; Medical physics; Oncology; Neuroscience; Psychology","score_opus":0.03804784344890827,"score_gpt":0.2882844196801084,"score_spread":0.2502365762312001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161680677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90121317,0.08607024,0.00011195285,0.0027096444,0.00053835183,0.0012585818,0.000008935047,0.000008859874,0.008080294],"genre_scores_gemma":[0.98758066,0.0035090751,0.00568706,0.00072763616,0.00016057916,0.00026000632,0.000017525752,0.000030783263,0.0020266825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746263,0.0008876372,0.0005301101,0.00041434017,0.00028873724,0.0004165617],"domain_scores_gemma":[0.9985942,0.00039248532,0.00015668184,0.0007082096,0.000078850535,0.00006954398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002903579,0.00026017628,0.0007418617,0.00017312836,0.00005023604,0.00001235842,0.00020816141,0.00016833111,0.00011864968],"category_scores_gemma":[0.000030205363,0.00015058625,0.00018294544,0.0004760617,0.0002392533,0.00004300382,0.000025425094,0.00026011321,0.0000052020546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064994614,0.008969307,0.6216166,0.00012477548,0.0003216039,0.016308777,0.030782819,0.0000813004,0.0070693917,0.00017412832,0.043820925,0.26423094],"study_design_scores_gemma":[0.020418992,0.023821523,0.7220478,0.00008297169,0.0005241265,0.00088812853,0.012262425,0.0025593755,0.009540942,0.00020177748,0.20734507,0.00030683662],"about_ca_topic_score_codex":0.00039242432,"about_ca_topic_score_gemma":0.00032136554,"teacher_disagreement_score":0.2639241,"about_ca_system_score_codex":0.0016984178,"about_ca_system_score_gemma":0.0006349321,"threshold_uncertainty_score":0.6140729},"labels":[],"label_agreement":null},{"id":"W3162250788","doi":"10.3390/curroncol28030178","title":"Cytoreductive Nephrectomy Following Immunotherapy-Base Treatment in Metastatic Renal Cell Carcinoma: A Case Series and Review of Current Literature","year":2021,"lang":"en","type":"review","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Immunotherapy; Systemic therapy; Internal medicine; Clinical trial; Oncology; Kidney; Urology; Surgery; Cancer","score_opus":0.12916376098338503,"score_gpt":0.42644190662406456,"score_spread":0.29727814564067956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162250788","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007085647,0.98704046,0.000004149462,0.00006770151,0.0011307945,0.0042702076,0.00025149222,0.000022130655,0.00012742671],"genre_scores_gemma":[0.0003401088,0.9956381,0.0006977626,0.000020671272,0.00021641336,0.0014961683,0.0013922032,0.00009655018,0.0001020618],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99489224,0.001457106,0.0016702524,0.001077706,0.00033873753,0.00056398707],"domain_scores_gemma":[0.9973402,0.00042645962,0.0008901319,0.0008133731,0.00023736602,0.0002924658],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046720874,0.0010958518,0.0063534616,0.00060391624,0.00006897742,0.000026262633,0.00013693701,0.00026941107,0.00007432085],"category_scores_gemma":[0.00010374818,0.0007741546,0.0016366927,0.0009665711,0.0001720927,0.00011342958,0.00012591442,0.00091824273,0.000006766919],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010771914,0.0020179176,0.00012850651,0.17069495,0.00058094185,0.026326174,0.0008384224,6.376566e-8,0.000007431813,0.000018638226,0.00025514595,0.7990241],"study_design_scores_gemma":[0.003132189,0.0025407833,0.000010341865,0.1664732,0.007988623,0.02268026,0.00012745995,6.69197e-7,0.000056318193,0.000008105665,0.79654896,0.00043312204],"about_ca_topic_score_codex":0.00004104599,"about_ca_topic_score_gemma":0.000029092698,"teacher_disagreement_score":0.79859096,"about_ca_system_score_codex":0.0025354584,"about_ca_system_score_gemma":0.0032049776,"threshold_uncertainty_score":0.99947095},"labels":[],"label_agreement":null},{"id":"W3162838881","doi":"10.1007/s00330-021-08006-5","title":"Bosniak Classification version 2019: validation and comparison to original classification in pathologically confirmed cystic masses","year":2021,"lang":"en","type":"article","venue":"European Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Malignancy; Neuroradiology; Confidence interval; Radiology; Interventional radiology; Receiver operating characteristic; Nuclear medicine; Pathology; Internal medicine","score_opus":0.06012419453132461,"score_gpt":0.3102759527971385,"score_spread":0.2501517582658139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162838881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849025,0.00041770015,0.0014540667,0.0020534154,0.00016992848,0.00035361364,0.0000068953805,0.000054173517,0.010587726],"genre_scores_gemma":[0.9946093,0.00013304049,0.0036996999,0.00034648902,0.00010246763,0.000014064846,0.0005040341,0.000019709774,0.00057122705],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979726,0.0008044118,0.00038094132,0.00049037294,0.0001372687,0.00021437882],"domain_scores_gemma":[0.99915,0.00016458597,0.00011437744,0.00030778832,0.000115263,0.00014798944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043102182,0.00015270627,0.0003237907,0.00014866509,0.000054580763,0.000022715198,0.00006758274,0.000078281424,0.00010289335],"category_scores_gemma":[0.00031325224,0.00013389907,0.000037422404,0.0002165403,0.00007783065,0.000047025278,0.000044365966,0.00018264989,0.00042287534],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006532336,0.00037513603,0.4506083,0.000057556637,0.000034257828,0.0010254222,0.00041489178,0.00006312236,0.53229415,0.0017397918,0.0051965066,0.0075376346],"study_design_scores_gemma":[0.001329114,0.0006642782,0.97807825,0.00004321484,0.000062734856,0.0005546867,0.00022706234,0.00046334634,0.0044626407,0.000027501266,0.013965909,0.00012129249],"about_ca_topic_score_codex":0.000005920317,"about_ca_topic_score_gemma":0.000003056572,"teacher_disagreement_score":0.5278315,"about_ca_system_score_codex":0.00018487693,"about_ca_system_score_gemma":0.000073775256,"threshold_uncertainty_score":0.54602456},"labels":[],"label_agreement":null},{"id":"W3165091003","doi":"10.1186/s43055-020-00391-z","title":"Multimodality imaging review of focal renal lesions","year":2021,"lang":"en","type":"article","venue":"The Egyptian Journal of Radiology and Nuclear Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncocytoma; Radiology; Magnetic resonance imaging; Positron emission tomography; Angiomyolipoma; Ultrasound; Kidney; Pathology; Internal medicine","score_opus":0.024967429787124858,"score_gpt":0.2918665653583865,"score_spread":0.26689913557126166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165091003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65698576,0.23502366,0.0001221334,0.10440478,0.00027026222,0.00016204754,0.00000243507,0.000007743083,0.0030211885],"genre_scores_gemma":[0.95122755,0.041898414,0.00090507144,0.005459919,0.00038772088,5.2701887e-7,0.0000039533606,0.000013954287,0.00010291576],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986069,0.0003372976,0.0005748289,0.00011964822,0.00021279033,0.00014848674],"domain_scores_gemma":[0.99873495,0.00023251893,0.0003306298,0.0002555769,0.00027199194,0.00017431051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011155407,0.00011884575,0.0006982668,0.00006512303,0.00007183838,0.0000015408873,0.00009792218,0.00004716372,0.00058051484],"category_scores_gemma":[0.0005691837,0.00006123048,0.00014431078,0.00012640149,0.00059981254,0.00003423673,0.000038445527,0.00038689552,0.000003736197],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006034887,0.0012725516,0.06404463,0.011245703,0.003992695,0.022095347,0.009613469,0.000012010609,0.3964975,0.0049029323,0.24598436,0.23430392],"study_design_scores_gemma":[0.015552096,0.0071368236,0.53170574,0.04268548,0.005900334,0.29250607,0.003438975,0.00033176164,0.004203796,0.0015330978,0.09460682,0.000399031],"about_ca_topic_score_codex":0.00000768149,"about_ca_topic_score_gemma":6.921747e-7,"teacher_disagreement_score":0.46766108,"about_ca_system_score_codex":0.00003365683,"about_ca_system_score_gemma":0.00010822934,"threshold_uncertainty_score":0.63562304},"labels":[],"label_agreement":null},{"id":"W3165125148","doi":"","title":"Vancouver-Klassifikation von Nierentumoren: Empfehlungen der Konsenskonferenz der Internationalen Gesellschaft für Uropathologie (ISUP) 2012","year":2015,"lang":"de","type":"article","venue":"Der Pathologe","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.07209787825415677,"score_gpt":0.31601830334174763,"score_spread":0.24392042508759088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165125148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8648689,0.0953951,0.0045553027,0.002258068,0.013867633,0.002538411,0.0004364656,0.0004980901,0.015582024],"genre_scores_gemma":[0.97493863,0.0012072984,0.002752376,0.0011439738,0.002602768,0.00024608627,0.0012727878,0.0002454425,0.015590656],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99245375,0.0010972443,0.0014400241,0.0017958569,0.001684218,0.0015289097],"domain_scores_gemma":[0.99472886,0.0003684691,0.00075018674,0.0017319595,0.001292697,0.0011278143],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013865578,0.0012503393,0.0013397981,0.00070631056,0.00024188912,0.00017134902,0.00068454415,0.00085088436,0.0009860188],"category_scores_gemma":[0.0009955075,0.0010941194,0.0005240642,0.0005102002,0.0004944745,0.0005320627,0.00057350344,0.00111246,0.007952891],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026816777,0.0052407244,0.44285247,0.0007171965,0.004029996,0.029527297,0.009815495,0.00028592462,0.013310657,0.0006739914,0.4576944,0.03317016],"study_design_scores_gemma":[0.028993834,0.00792404,0.6148962,0.0016161737,0.017769638,0.0027986383,0.0040330538,0.005438896,0.05507448,0.0043846597,0.2515711,0.0054993527],"about_ca_topic_score_codex":0.00010887778,"about_ca_topic_score_gemma":0.00021518648,"teacher_disagreement_score":0.20612334,"about_ca_system_score_codex":0.0014709145,"about_ca_system_score_gemma":0.00079114555,"threshold_uncertainty_score":0.9999272},"labels":[],"label_agreement":null},{"id":"W3165426308","doi":"10.1016/j.urolonc.2021.04.007","title":"Leibovich score is the optimal clinico-pathological system associated with recurrence of non-metastatic clear cell renal cell carcinoma","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Proportional hazards model; Oncology","score_opus":0.0439392193209567,"score_gpt":0.2981296363804599,"score_spread":0.25419041705950324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165426308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98720765,0.0016939539,0.00008917066,0.0020380595,0.00010379022,0.0005465981,0.000066706256,0.000038605816,0.008215446],"genre_scores_gemma":[0.9711751,0.00013644614,0.026484676,0.0009849706,0.000055894547,0.00008199659,0.0001130685,0.0000195766,0.0009482892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758047,0.0004753725,0.00058928056,0.0006140789,0.00032818134,0.00041264374],"domain_scores_gemma":[0.9976261,0.0008744077,0.0004620796,0.0004457058,0.00030723447,0.00028442682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000642903,0.00030702908,0.0007426967,0.00009451012,0.00028693434,0.000024314944,0.00016798406,0.00026248803,0.00008068757],"category_scores_gemma":[0.00020713538,0.00018766959,0.00013968062,0.0005242315,0.0011528368,0.00006351417,0.00010144779,0.00061819673,0.000021523514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000798033,0.0016346204,0.9747746,0.00038832368,0.00019802645,0.0058358354,0.0020359557,0.00035039493,0.007938944,0.00072654546,0.0047950274,0.0005237116],"study_design_scores_gemma":[0.019364648,0.10408277,0.5524759,0.0017492514,0.011863936,0.012000762,0.014955785,0.017410683,0.16393936,0.00090585864,0.099242106,0.0020088977],"about_ca_topic_score_codex":0.000033515706,"about_ca_topic_score_gemma":0.00001424474,"teacher_disagreement_score":0.42229864,"about_ca_system_score_codex":0.00019238016,"about_ca_system_score_gemma":0.0009706441,"threshold_uncertainty_score":0.7652944},"labels":[],"label_agreement":null},{"id":"W3165474769","doi":"10.1007/s00345-021-03734-1","title":"Delayed surgery for localised and metastatic renal cell carcinoma: a systematic review and meta-analysis for the COVID-19 pandemic","year":2021,"lang":"en","type":"review","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Meta-analysis; Kidney cancer; Internal medicine; Nephrology; Observational study; Randomized controlled trial; Oncology; Surgery; Kidney","score_opus":0.20601260355000095,"score_gpt":0.37789936148530673,"score_spread":0.17188675793530578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165474769","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000038722187,0.9865715,0.0058185062,0.002576498,0.000065894455,0.0047964235,0.00015533091,0.0000063123307,0.00000567034],"genre_scores_gemma":[0.0009650848,0.9922651,0.0007123279,0.00415751,0.00007545518,0.0009897271,0.000103768376,0.000061086525,0.0006699532],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9942496,0.0017016899,0.002818119,0.0004906241,0.0003467278,0.0003932774],"domain_scores_gemma":[0.9789045,0.01642434,0.003154138,0.0006217873,0.00043571123,0.0004595666],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0050521195,0.0006267842,0.015803803,0.0009196777,0.00013350966,0.000038780126,0.00021369035,0.00014671456,0.00011319872],"category_scores_gemma":[0.0016384105,0.0003036464,0.0066777267,0.00080778584,0.00016259357,0.000039924875,0.00006525766,0.00050138135,9.2714083e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001383163,0.000082892126,0.00002829863,0.77694196,0.21782391,0.00051887555,0.000031953405,0.000008230639,2.5763487e-7,0.000021180871,0.0034771822,0.0009269438],"study_design_scores_gemma":[0.0007069241,0.0003699736,0.0000019261333,0.00197589,0.81962526,0.007820795,0.0000118018315,0.000017438155,1.5711377e-7,0.00002212085,0.16927512,0.000172624],"about_ca_topic_score_codex":0.000017531398,"about_ca_topic_score_gemma":0.00007571993,"teacher_disagreement_score":0.77496606,"about_ca_system_score_codex":0.00021495136,"about_ca_system_score_gemma":0.0011522617,"threshold_uncertainty_score":0.9999416},"labels":[],"label_agreement":null},{"id":"W3166074586","doi":"10.1016/j.currproblcancer.2021.100759","title":"High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors?","year":2021,"lang":"en","type":"review","venue":"Current Problems in Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Hazard ratio; Confidence interval; Adverse effect; Internal medicine; Adjuvant; Renal cell carcinoma; Oncology; VEGF receptors; Nephrectomy; Relative risk; Hepatocellular carcinoma; Surgery; Kidney","score_opus":0.0682694404941711,"score_gpt":0.3474321623877662,"score_spread":0.2791627218935951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166074586","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034302382,0.98734283,0.000016917642,0.00008714344,0.0016265725,0.0058974647,0.0010889157,0.00007374239,0.00043619264],"genre_scores_gemma":[0.0039979713,0.98475903,0.00024075546,0.000021438938,0.0014491986,0.0066917487,0.0014824584,0.00025431174,0.001103063],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942225,0.00040716495,0.001779947,0.0017150192,0.00081512774,0.0010602241],"domain_scores_gemma":[0.996511,0.0003701092,0.0010528464,0.0011815536,0.00047303294,0.00041145494],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00054413493,0.0011662539,0.003954929,0.00045843588,0.00012521936,0.00008185675,0.00040940495,0.00068268133,0.0005483897],"category_scores_gemma":[0.00008329758,0.00086907455,0.0015380428,0.0009563243,0.00011269233,0.000092321476,0.0002704823,0.0016983862,0.00004889934],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009801286,0.0009926641,0.0016207715,0.053120565,0.0003580224,0.0001776567,0.00035972396,0.00001863638,0.000016799127,0.000028808909,0.011472552,0.9317358],"study_design_scores_gemma":[0.003932548,0.00063327636,0.0002326394,0.05087388,0.0031118977,0.00004569862,0.000021357295,0.000019036594,0.00032803483,0.00011303686,0.9399064,0.0007821639],"about_ca_topic_score_codex":0.00088719395,"about_ca_topic_score_gemma":0.00028935706,"teacher_disagreement_score":0.9309536,"about_ca_system_score_codex":0.0021729684,"about_ca_system_score_gemma":0.0027853835,"threshold_uncertainty_score":0.999376},"labels":[],"label_agreement":null},{"id":"W3166268850","doi":"10.1200/jco.2021.39.15_suppl.e16561","title":"Real-world treatment patterns and overall survival in previously treated advanced renal cell carcinoma patients receiving nivolumab in the UK.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Nivolumab; Medicine; Pazopanib; Axitinib; Sunitinib; Renal cell carcinoma; Cabozantinib; Internal medicine; Oncology; Tyrosine-kinase inhibitor; Surgery; Cancer; Immunotherapy","score_opus":0.0763595982025691,"score_gpt":0.3890791354664847,"score_spread":0.3127195372639156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166268850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917338,0.00042825763,0.0000020496427,0.0013634254,0.0003662149,0.00047650625,0.0000056654703,0.0000045046186,0.0056196083],"genre_scores_gemma":[0.9958374,0.0022292193,0.00053467054,0.00039456438,0.00027789935,0.000016059246,0.000025166308,0.000022553419,0.0006625038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949776,0.0015237093,0.0023120418,0.00036763787,0.00043188335,0.00038713843],"domain_scores_gemma":[0.9956602,0.0024224196,0.0010353837,0.00033075464,0.00026884893,0.00028238774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016285636,0.00025552075,0.0016781882,0.0002076077,0.00003471988,0.000017358505,0.00013631773,0.00023119053,0.0000728528],"category_scores_gemma":[0.0006512775,0.00015692659,0.00037776495,0.00025796425,0.000077890625,0.00009148029,0.000058533966,0.00077041605,0.0000035355201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028531458,0.0035354896,0.94062203,0.000032640728,0.00008000848,0.0062423623,0.0005096433,0.000017337952,0.000103873586,0.0000055496766,0.00011158194,0.045886345],"study_design_scores_gemma":[0.026324008,0.016379539,0.9546782,0.00018065299,0.00028293766,0.00016716975,0.00021970016,0.000022933453,0.00046652232,0.000041496998,0.0011191978,0.00011769078],"about_ca_topic_score_codex":0.0013450625,"about_ca_topic_score_gemma":0.015078062,"teacher_disagreement_score":0.045768656,"about_ca_system_score_codex":0.0010160794,"about_ca_system_score_gemma":0.0010168178,"threshold_uncertainty_score":0.84139127},"labels":[],"label_agreement":null},{"id":"W3166432245","doi":"10.1200/jco.2021.39.15_suppl.4553","title":"Nivolumab plus cabozantinib (N+C) versus sunitinib (S) for advanced renal cell carcinoma (aRCC): Outcomes by baseline disease characteristics in the phase 3 CheckMate 9ER trial.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Internal medicine; Sunitinib; Nivolumab; Cabozantinib; Renal cell carcinoma; Post-hoc analysis; Clinical trial; Progression-free survival; Gastroenterology; Surgery; Oncology; Cancer; Overall survival; Immunotherapy","score_opus":0.15932828886876876,"score_gpt":0.4703809437933762,"score_spread":0.31105265492460743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166432245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98047304,0.0009858371,0.00022281594,0.013840678,0.0024575929,0.0010602148,0.00024845698,0.000010002471,0.00070135866],"genre_scores_gemma":[0.9920683,0.00042016528,0.0019802982,0.0027340548,0.0012129412,0.00006555474,0.00033647812,0.000045396693,0.0011368081],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99352276,0.0012598049,0.0036621285,0.00040585885,0.00064269017,0.0005067712],"domain_scores_gemma":[0.9870692,0.008735374,0.0021423912,0.0005425998,0.0008299738,0.00068045716],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004392965,0.00033216228,0.002412569,0.00013124943,0.00008353269,0.00002848153,0.00031472687,0.00031620055,0.00020019383],"category_scores_gemma":[0.010908379,0.00021269906,0.001138242,0.00022601851,0.00019738644,0.00012240792,0.00007068688,0.0011207279,0.0000137614925],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84789896,0.02056826,0.019710977,0.0002665619,0.0005180792,0.017169498,0.00029584015,0.000012847209,0.0016645914,0.00006965104,0.024460897,0.06736385],"study_design_scores_gemma":[0.68922156,0.038036287,0.06644194,0.00012150784,0.0021563645,0.00020782668,0.0006041255,0.00036251073,0.0016419416,0.000054349093,0.20082425,0.00032735715],"about_ca_topic_score_codex":0.000013596533,"about_ca_topic_score_gemma":0.00002477205,"teacher_disagreement_score":0.17636335,"about_ca_system_score_codex":0.00031135973,"about_ca_system_score_gemma":0.004052055,"threshold_uncertainty_score":0.9974232},"labels":[],"label_agreement":null},{"id":"W3166631750","doi":"10.1200/jco.2021.39.15_suppl.4554","title":"Outcomes of first-line (1L) ipilimumab and nivolumab (IPI-NIVO) and subsequent therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; London Health Sciences Centre; Western University; Dalhousie University; St. Joseph’s Healthcare Hamilton; University of Calgary","funders":"","keywords":"Medicine; Nivolumab; Renal cell carcinoma; Ipilimumab; Internal medicine; Nephrectomy; Gastroenterology; Clear cell renal cell carcinoma; Oncology; Urology; Surgery; Cancer; Kidney; Immunotherapy","score_opus":0.15046309236316988,"score_gpt":0.4077470997826623,"score_spread":0.2572840074194924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166631750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9721625,0.0041394527,0.0000304072,0.022063864,0.0006694022,0.00026880158,0.00013955205,0.0000038607373,0.0005221715],"genre_scores_gemma":[0.989228,0.005300166,0.003275115,0.0015523748,0.00033230483,0.0000050691992,0.000066525776,0.000018934827,0.00022148235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99509794,0.00068996847,0.002996279,0.00038702454,0.0005804043,0.0002484048],"domain_scores_gemma":[0.9892925,0.007740238,0.0017046788,0.00042293262,0.0005299876,0.00030965277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028704738,0.00023058338,0.0016411801,0.00012477628,0.000042430034,0.00001916899,0.00022966632,0.00017583088,0.00014200539],"category_scores_gemma":[0.0034556277,0.00013820255,0.00033272835,0.00013369687,0.00039603558,0.00011995335,0.00017636924,0.0008486666,0.000002698586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017627137,0.003432003,0.9457024,0.00004195294,0.001026507,0.0064002546,0.0006779984,0.000026624708,0.0028747634,0.000040477138,0.0018064565,0.020343477],"study_design_scores_gemma":[0.043917544,0.0058681215,0.936428,0.00012469235,0.000531007,0.00060103455,0.00057604356,0.00031153715,0.0048003616,0.0002816841,0.006432739,0.00012723208],"about_ca_topic_score_codex":0.0005260584,"about_ca_topic_score_gemma":0.0012538038,"teacher_disagreement_score":0.026290407,"about_ca_system_score_codex":0.00019495482,"about_ca_system_score_gemma":0.0012676517,"threshold_uncertainty_score":0.5635736},"labels":[],"label_agreement":null},{"id":"W3167509426","doi":"10.1200/jco.2021.39.15_suppl.4502","title":"Health-related quality-of-life (HRQoL) analysis from the phase 3 CLEAR trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) or everolimus (EVE) versus sunitinib (SUN) for patients (pts) with advanced renal cell carcinoma (aRCC).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Quality of life (healthcare); Clinical trial; Everolimus; Internal medicine; Nursing","score_opus":0.20489345872894418,"score_gpt":0.465467439747845,"score_spread":0.26057398101890084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167509426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99288386,0.000939104,0.00018864735,0.0028535838,0.001069142,0.0011923348,0.00020761513,0.000010941546,0.00065479055],"genre_scores_gemma":[0.99317557,0.000367696,0.0043878537,0.0008490705,0.00064930064,0.000026753349,0.00028370463,0.00005300515,0.0002070516],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98737764,0.002954961,0.007372707,0.00055259955,0.0012057732,0.0005363406],"domain_scores_gemma":[0.96838355,0.018963715,0.008834435,0.00079067744,0.002259345,0.00076828396],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0037412252,0.00040276637,0.0052843112,0.0002612398,0.00012391647,0.0000119231145,0.0004054206,0.0005147683,0.00041912677],"category_scores_gemma":[0.00965495,0.00023885485,0.0019296933,0.00088035275,0.00042860178,0.00014696407,0.000109917935,0.0011796198,0.000004825253],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9417692,0.010402656,0.014809391,0.00015509849,0.005022474,0.0003050505,0.00060719065,0.0002652488,0.00015986411,0.00003813347,0.0008194611,0.025646243],"study_design_scores_gemma":[0.69100434,0.16786897,0.12868042,0.00015116626,0.0062233023,0.000031360207,0.00092756056,0.00025288112,0.0007084556,0.000050050858,0.0038515334,0.00024992359],"about_ca_topic_score_codex":0.00051136204,"about_ca_topic_score_gemma":0.0006697772,"teacher_disagreement_score":0.25076482,"about_ca_system_score_codex":0.0005419521,"about_ca_system_score_gemma":0.009527881,"threshold_uncertainty_score":0.99868715},"labels":[],"label_agreement":null},{"id":"W3167858868","doi":"10.1200/jco.2021.39.15_suppl.4515","title":"Safety and efficacy outcomes with nivolumab plus ipilimumab in patients with advanced renal cell carcinoma and brain metastases: results from the CheckMate 920 trial.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Ipilimumab; Internal medicine; Nivolumab; Clinical endpoint; Renal cell carcinoma; Tolerability; Clinical trial; Brain metastasis; Oncology; Adverse effect; Surgery; Cancer; Immunotherapy; Metastasis","score_opus":0.05059253940692358,"score_gpt":0.3618151297599955,"score_spread":0.3112225903530719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167858868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898431,0.0008287188,0.000017580314,0.0077976077,0.00021441243,0.0006729131,0.000058320446,0.000005499628,0.00056185806],"genre_scores_gemma":[0.9941806,0.00021466568,0.0038604666,0.0012460889,0.00018623218,0.0000045746497,0.000047838792,0.000025204647,0.00023428714],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9954665,0.0010587353,0.0022363197,0.0004299314,0.0005259855,0.00028256117],"domain_scores_gemma":[0.9894308,0.007891745,0.0015448828,0.00039169446,0.00037106694,0.0003698299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020489662,0.00026220112,0.0020429455,0.000074397285,0.00006538319,0.00002171199,0.00012345324,0.00020315759,0.000021247699],"category_scores_gemma":[0.0029856244,0.0001278901,0.00020395781,0.00017986521,0.00029930976,0.00012033035,0.00009879895,0.0009192088,0.0000018852319],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.652082,0.002999572,0.3052832,0.000023180519,0.0006199371,0.0029491696,0.000499031,0.000064007094,0.000035518224,0.000007645287,0.0004113641,0.035025347],"study_design_scores_gemma":[0.33389258,0.024459912,0.6379709,0.00009756666,0.00056821643,0.00007583016,0.00021257096,0.000012678243,0.00011235453,0.000012141102,0.002490189,0.00009503427],"about_ca_topic_score_codex":0.00009171922,"about_ca_topic_score_gemma":0.0003507133,"teacher_disagreement_score":0.33268774,"about_ca_system_score_codex":0.00024191552,"about_ca_system_score_gemma":0.0015632511,"threshold_uncertainty_score":0.5215207},"labels":[],"label_agreement":null},{"id":"W3168083756","doi":"10.1200/jco.2021.39.15_suppl.4560","title":"Analysis of the CLEAR study in patients (pts) with advanced renal cell carcinoma (RCC): Depth of response and efficacy for selected subgroups in the lenvatinib (LEN) + pembrolizumab (PEMBRO) and sunitinib (SUN) treatment arms.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Internal medicine; Sunitinib; Pembrolizumab; Renal cell carcinoma; Oncology; Urology; Surgery; Cancer; Immunotherapy","score_opus":0.06677471698010366,"score_gpt":0.384418699788275,"score_spread":0.3176439828081713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168083756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99763215,0.00036136858,0.0000046162772,0.0007093945,0.0000548872,0.0011218789,0.000014208357,0.0000018866889,0.0000995846],"genre_scores_gemma":[0.99893636,0.000121996476,0.0006793602,0.00013439539,0.000039766823,0.00002191687,0.000010932995,0.000018314411,0.00003693743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99421394,0.0025662992,0.002184279,0.00032329475,0.0004597054,0.00025249188],"domain_scores_gemma":[0.9900276,0.0071011065,0.0016334122,0.000386068,0.0007051315,0.00014669138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023751364,0.00022360233,0.0019910866,0.00034363556,0.000040542513,0.0000072892435,0.0001582929,0.00017627556,0.000010249058],"category_scores_gemma":[0.0021608998,0.00011315139,0.00035326273,0.0010488189,0.00023539105,0.00006006158,0.000056870624,0.00048970064,1.2003333e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10266111,0.011126375,0.86684656,0.000035911566,0.0008653173,0.00031727005,0.0023892662,0.00011417645,0.0004509265,0.0000034107902,0.00000804106,0.015181642],"study_design_scores_gemma":[0.06058386,0.07974078,0.8533681,0.000060972805,0.0029264374,0.000057978228,0.0018961484,0.00008313265,0.0011052686,0.0000053977783,0.00009340981,0.00007853772],"about_ca_topic_score_codex":0.00008709637,"about_ca_topic_score_gemma":0.0017198098,"teacher_disagreement_score":0.0686144,"about_ca_system_score_codex":0.00023307765,"about_ca_system_score_gemma":0.0012352805,"threshold_uncertainty_score":0.46141797},"labels":[],"label_agreement":null},{"id":"W3169092451","doi":"10.1200/jco.2021.39.15_suppl.4565","title":"Ipilimumab + nivolumab in people with rare variant renal cell carcinoma refractory to nivolumab alone: Part 2 of UNISON (ANZUP 1602) nivolumab then ipilimumab + nivolumab in advanced non-clear cell renal cell carcinoma.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Nivolumab; Medicine; Ipilimumab; Renal cell carcinoma; Refractory (planetary science); Internal medicine; Oncology; Immunotherapy; Urology; Cancer","score_opus":0.03373645546351024,"score_gpt":0.32763049100636693,"score_spread":0.2938940355428567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169092451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800155,0.0032419658,0.00018652859,0.0017085987,0.0014240238,0.0016800568,0.000071649476,0.00004075502,0.011630882],"genre_scores_gemma":[0.98360634,0.0007521182,0.008677851,0.0008262718,0.0010401933,0.00007681448,0.00008720405,0.00026702273,0.0046661673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9836622,0.0025100664,0.0076720007,0.0019916536,0.0022257739,0.0019382949],"domain_scores_gemma":[0.98662394,0.002732147,0.004645473,0.0021603925,0.0020108086,0.0018272466],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.003948934,0.001281561,0.0066122697,0.0012737974,0.00020676237,0.0000660987,0.0012009003,0.0015747513,0.00082171545],"category_scores_gemma":[0.0010495823,0.0011087655,0.0015375804,0.0019657689,0.00055189856,0.0006292088,0.0006152378,0.004439579,0.00011832933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16690226,0.048870962,0.5579293,0.0023247767,0.0010434467,0.09145465,0.008899562,0.004323822,0.07135265,0.000028621087,0.015495158,0.031374816],"study_design_scores_gemma":[0.12253447,0.091603555,0.71264297,0.0014061816,0.0018942627,0.0026505885,0.005299132,0.0008270659,0.044865154,0.00009646557,0.014549112,0.0016310578],"about_ca_topic_score_codex":0.0016929181,"about_ca_topic_score_gemma":0.004901554,"teacher_disagreement_score":0.15471369,"about_ca_system_score_codex":0.0034976103,"about_ca_system_score_gemma":0.01226577,"threshold_uncertainty_score":0.9999936},"labels":[],"label_agreement":null},{"id":"W3169355614","doi":"10.1200/jco.2021.39.15_suppl.4557","title":"Treatment outcomes in renal cell carcinoma patients with metastases to the pancreas and other sites.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Pancreas; Internal medicine; Oncology; Systemic therapy; Nephrectomy; Cancer; Gastroenterology; Urology; Kidney","score_opus":0.10001248264545146,"score_gpt":0.3989554250508949,"score_spread":0.2989429424054434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169355614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909706,0.0007573244,0.0000086035725,0.0063341227,0.00014603527,0.00029322077,0.0000130895405,0.0000026060948,0.0014743631],"genre_scores_gemma":[0.9935197,0.00006717716,0.0028692419,0.00274941,0.00019241066,0.000008761541,0.000004159777,0.00001634683,0.0005727784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976071,0.00050034036,0.0011495006,0.00021392984,0.00032154724,0.0002075426],"domain_scores_gemma":[0.9970462,0.0015504907,0.00053440325,0.0002447959,0.00026648928,0.0003576397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066340686,0.00017006253,0.0013008126,0.00008844294,0.000028560324,0.000010910511,0.00007304467,0.00011394662,0.000095575575],"category_scores_gemma":[0.0006391943,0.00007517411,0.00026114317,0.00013715937,0.0000869581,0.000039856914,0.000045303448,0.00031631457,0.000012234465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025839352,0.0032037557,0.9744587,0.0000083236555,0.0002750779,0.0023010897,0.00015400775,0.0000106177595,0.000057589245,0.000010109321,0.0003923943,0.016544398],"study_design_scores_gemma":[0.01299854,0.022484278,0.9299228,0.000023697921,0.00065589754,0.00026404634,0.0001236319,0.0000036507693,0.0006942278,0.000013846828,0.032745074,0.000070269656],"about_ca_topic_score_codex":0.00009416916,"about_ca_topic_score_gemma":0.00045322938,"teacher_disagreement_score":0.044535864,"about_ca_system_score_codex":0.00023465097,"about_ca_system_score_gemma":0.00083506113,"threshold_uncertainty_score":0.30655113},"labels":[],"label_agreement":null},{"id":"W3169788128","doi":"10.1016/j.urology.2021.05.053","title":"Adrenalectomy During Radical Nephrectomy- Incidence and Oncologic Outcomes From the Canadian Kidney Cancer Information System (CKCis) -A Modern Era, Nationwide, Multicenter Cohort","year":2021,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; University of Alberta; Ottawa Hospital; Health Sciences Centre; University of Ottawa; McGill University Health Centre; Centre Hospitalier de l’Université de Montréal; Université Laval; Dalhousie University; Western University; University of Toronto; University of British Columbia; University of Manitoba; St. Joseph’s Healthcare Hamilton; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Adrenalectomy; Nephrectomy; Renal cell carcinoma; Interquartile range; Urology; Kidney cancer; Surgery; Nephrology; Internal medicine; Kidney","score_opus":0.013012503009604746,"score_gpt":0.24487435505839494,"score_spread":0.2318618520487902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169788128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98863864,0.00087737513,0.00008045065,0.008093557,0.00028915209,0.00052537944,0.000058947287,0.0000479787,0.0013885469],"genre_scores_gemma":[0.9915429,0.000060711194,0.00027873856,0.0076094754,0.000105841136,0.00014440135,0.0001371953,0.000011371965,0.00010936776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987056,0.00015297609,0.00031812256,0.00025707515,0.000253509,0.00031268375],"domain_scores_gemma":[0.99887043,0.00021722399,0.00010234323,0.0002806879,0.00017344936,0.00035586502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013736037,0.00016907009,0.0003319385,0.000103100116,0.00022128373,0.00004667749,0.00009489633,0.00017400335,0.00024149305],"category_scores_gemma":[0.00036343528,0.000115300856,0.00006317182,0.00012700855,0.00010263355,0.00014755287,0.000064649736,0.00030383968,0.000049288068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013243358,0.000017786253,0.9969837,0.000040884705,0.00022216026,0.0003643729,0.0006243783,0.0001094435,0.00035078276,0.0000421341,0.0003545111,0.0007574084],"study_design_scores_gemma":[0.0023657917,0.000062941275,0.98485994,0.000037342677,0.00027568228,0.00028629223,0.00006854766,0.0064865015,0.00090841815,0.000018770586,0.0045250216,0.00010476078],"about_ca_topic_score_codex":0.07708166,"about_ca_topic_score_gemma":0.14995669,"teacher_disagreement_score":0.07287504,"about_ca_system_score_codex":0.0006997535,"about_ca_system_score_gemma":0.0009853205,"threshold_uncertainty_score":0.92906415},"labels":[],"label_agreement":null},{"id":"W3170518524","doi":"10.1200/jco.2021.39.15_suppl.4500","title":"Pembrolizumab (pembro) plus axitinib (axi) versus sunitinib as first-line therapy for advanced clear cell renal cell carcinoma (ccRCC): Results from 42-month follow-up of KEYNOTE-426.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Sunitinib; Interim analysis; Clinical endpoint; Renal cell carcinoma; Discontinuation; Internal medicine; Population; Temsirolimus; Randomization; Oncology; Clinical trial","score_opus":0.13693495747674775,"score_gpt":0.4100780355737302,"score_spread":0.27314307809698246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170518524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719769,0.0036372691,0.00014534134,0.0042224554,0.0035084526,0.0008663725,0.00023465742,0.000026314765,0.015382236],"genre_scores_gemma":[0.98062015,0.0030508977,0.009897376,0.0008380481,0.0022919145,0.000023676346,0.00023871915,0.00010928172,0.0029299192],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9913373,0.00088018394,0.0052390513,0.0008192281,0.0009924518,0.00073180516],"domain_scores_gemma":[0.9790179,0.0126701975,0.0043213256,0.00094082096,0.0020929996,0.00095674815],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002194509,0.0005545973,0.003617002,0.00022970064,0.00013715202,0.00002329014,0.00049610116,0.0009391106,0.0004454437],"category_scores_gemma":[0.00566754,0.00044085752,0.0022137386,0.00032268028,0.0003355596,0.00017676623,0.00015896329,0.0015606008,0.000043128202],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90095055,0.0076807835,0.0018930846,0.00022006189,0.0013334817,0.00746959,0.0010512072,0.0005875072,0.016644739,0.00006130318,0.008190626,0.053917054],"study_design_scores_gemma":[0.5004011,0.16664787,0.042902295,0.00038059606,0.0021978659,0.0004251132,0.001165327,0.00037720436,0.14723161,0.0005229003,0.1371141,0.0006340467],"about_ca_topic_score_codex":0.00022440293,"about_ca_topic_score_gemma":0.0002557334,"teacher_disagreement_score":0.40054947,"about_ca_system_score_codex":0.0005997381,"about_ca_system_score_gemma":0.0054981066,"threshold_uncertainty_score":0.9998043},"labels":[],"label_agreement":null},{"id":"W3171766889","doi":"10.1200/jco.2021.39.15_suppl.4564","title":"Phase II trial of stereotactic ablative radiation (SAbR) for oligoprogressive kidney cancer.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"SABR volatility model; Medicine; Radiation therapy; Systemic therapy; Internal medicine; Oncology; Cancer; Surgery; Breast cancer","score_opus":0.17402539456067206,"score_gpt":0.5261665231081906,"score_spread":0.3521411285475185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171766889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98339134,0.001667692,0.0001337625,0.010377802,0.0025350444,0.0006535106,0.000028724335,0.000004097886,0.0012079937],"genre_scores_gemma":[0.99130225,0.0010365747,0.0033794018,0.0012206743,0.0023698127,0.000030974923,0.000016181422,0.00001688616,0.000627272],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99649024,0.00042507926,0.0023639202,0.00018708777,0.0003460122,0.00018768391],"domain_scores_gemma":[0.9923947,0.0024931445,0.0032148312,0.00017858457,0.001240791,0.00047798493],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.001484842,0.00013053321,0.0016589811,0.00009168181,0.000043782973,0.000004846633,0.00008264873,0.0002883353,0.00019965506],"category_scores_gemma":[0.009022164,0.00009296779,0.00078361563,0.00013879483,0.00013482808,0.00009928721,0.00003496833,0.00046333123,0.0000021018711],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38520613,0.026665902,0.0049919826,0.00014461766,0.0041785426,0.0017581023,0.00063816353,0.000012247671,0.0026858929,0.0001510611,0.011426031,0.5621413],"study_design_scores_gemma":[0.5871262,0.27261388,0.008944952,0.0003100995,0.0036211703,0.0003981036,0.00018262124,0.000198571,0.022174865,0.00052103656,0.10376596,0.00014255187],"about_ca_topic_score_codex":0.000010680969,"about_ca_topic_score_gemma":0.000007639542,"teacher_disagreement_score":0.5619988,"about_ca_system_score_codex":0.00032016827,"about_ca_system_score_gemma":0.0059355064,"threshold_uncertainty_score":0.9996999},"labels":[],"label_agreement":null},{"id":"W3172699038","doi":"10.1200/jco.2021.39.15_suppl.4549","title":"Association between neutrophil-to-eosinophil ratio (NER) and efficacy outcomes in the JAVELIN Renal 101 study.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Progression-free survival; Renal cell carcinoma; Proportional hazards model; Interim analysis; Multivariate analysis; Gastroenterology; Urology; Oncology; Surgery; Confidence interval; Clinical trial; Overall survival","score_opus":0.14057200808294745,"score_gpt":0.45513004038616495,"score_spread":0.3145580323032175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172699038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93661237,0.00021176705,0.000019394543,0.061790705,0.00038073809,0.0003879619,0.000002313308,0.0000041186768,0.0005906117],"genre_scores_gemma":[0.99406475,0.00012913569,0.0008645355,0.0031487136,0.0012605791,0.000005780213,0.000003664955,0.000012347198,0.00051048223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99501544,0.0016649215,0.0022168262,0.00023290978,0.00064217637,0.00022774152],"domain_scores_gemma":[0.9908417,0.0071359044,0.0010844343,0.00024017655,0.0004269544,0.00027084776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005346236,0.00015116701,0.0015588085,0.00013211978,0.000048942744,0.000026519832,0.00014431443,0.00026841788,0.00003946542],"category_scores_gemma":[0.007752473,0.000087352084,0.00033167162,0.00024415617,0.00004616714,0.000065240325,0.0000727719,0.0010859373,0.000020852583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075218873,0.0031117888,0.96908695,0.0000060211387,0.00068358524,0.0024533914,0.0005325046,0.000017753206,0.00016582373,0.000013277896,0.0014232588,0.021753464],"study_design_scores_gemma":[0.010764433,0.0127366,0.96891105,0.000033239514,0.000957437,0.00016378715,0.00036147432,0.000005653065,0.00007196772,0.00010108327,0.005822305,0.0000709475],"about_ca_topic_score_codex":0.000022669117,"about_ca_topic_score_gemma":0.00009595466,"teacher_disagreement_score":0.058641993,"about_ca_system_score_codex":0.00033385376,"about_ca_system_score_gemma":0.00086810737,"threshold_uncertainty_score":0.92809945},"labels":[],"label_agreement":null},{"id":"W3172937358","doi":"10.1200/jco.2021.39.15_suppl.4514","title":"Outcomes of patients who progressed while receiving avelumab + axitinib (A + Ax) and received subsequent treatment (Tx) in JAVELIN Renal 101.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Medicine; Axitinib; Cabozantinib; Internal medicine; Oncology; Renal cell carcinoma; Everolimus; Regimen; Clinical trial; Interim analysis; Neutropenia; Sunitinib; Chemotherapy","score_opus":0.13137860493998124,"score_gpt":0.4213184102139248,"score_spread":0.2899398052739436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172937358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99186146,0.0010628252,0.000008174469,0.003806718,0.0005016053,0.00043533868,0.000011676149,0.0000064417163,0.0023057559],"genre_scores_gemma":[0.9914973,0.0020422358,0.005291701,0.00037755756,0.00023852603,0.000014394088,0.000020663942,0.000026568843,0.00049106934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99441314,0.00089049985,0.003454741,0.00036371342,0.00053818047,0.00033969997],"domain_scores_gemma":[0.9941784,0.0021637196,0.0020512473,0.00030458765,0.00086905237,0.00043296872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017503193,0.00026517146,0.0026192416,0.00020318881,0.00003270515,0.000011852178,0.00011228781,0.0003923662,0.00019181384],"category_scores_gemma":[0.003342362,0.00018003098,0.000566872,0.00020163412,0.00021432276,0.0001005014,0.000078289595,0.0006251244,0.000006225962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032830941,0.00547278,0.86124694,0.000049324033,0.00060016016,0.002031431,0.00037023306,0.000009536701,0.0002650194,0.00001242608,0.0002210488,0.12643799],"study_design_scores_gemma":[0.022426141,0.017972086,0.95050234,0.00034521028,0.00048519621,0.0002005794,0.00019452587,0.000040592935,0.0024948828,0.00008154658,0.0051289177,0.00012800154],"about_ca_topic_score_codex":0.00003606961,"about_ca_topic_score_gemma":0.00019345169,"teacher_disagreement_score":0.12630999,"about_ca_system_score_codex":0.00062517606,"about_ca_system_score_gemma":0.0018300021,"threshold_uncertainty_score":0.73414505},"labels":[],"label_agreement":null},{"id":"W3173449000","doi":"10.1016/j.euros.2021.06.006","title":"Management of Favorable-risk Advanced Renal Cell Carcinoma: Is Dual Therapy the Answer?","year":2021,"lang":"en","type":"editorial","venue":"European Urology Open Science","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Renal cell carcinoma; Dual (grammatical number); Medicine; Oncology; Carcinoma; Internal medicine; Urology; Intensive care medicine; Philosophy","score_opus":0.019430013220088003,"score_gpt":0.2837884263535692,"score_spread":0.2643584131334812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173449000","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25656638,0.010486432,0.000069529335,0.0012677294,0.41531223,0.0036462608,0.00029149768,0.00006553775,0.31229442],"genre_scores_gemma":[0.80653524,0.0050862306,0.0033978538,0.0011301315,0.15328132,0.00011184095,0.00034574643,0.00024186887,0.029869767],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940337,0.0008943735,0.00074978493,0.0017474665,0.001784556,0.00079012656],"domain_scores_gemma":[0.99538416,0.0003925869,0.0007571878,0.0025331513,0.0006650577,0.00026785696],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0036212576,0.00056480616,0.00088298257,0.00021662588,0.0005183569,0.00018953986,0.0033645302,0.00018251031,0.00028268126],"category_scores_gemma":[0.00017261363,0.0003706936,0.00024516656,0.0010184923,0.001666626,0.00020587917,0.0025823128,0.0011989857,0.00018381873],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015433158,0.00063189334,0.0008885966,0.00015161204,0.00029714082,0.0063800015,0.0014902634,0.00006947252,0.004234123,0.000050588973,0.9666107,0.01765229],"study_design_scores_gemma":[0.0055162027,0.0031408903,0.018678358,0.00010057028,0.00056849804,0.000069129186,0.0003552562,0.000020800262,0.0121399565,0.000024950694,0.9589373,0.00044808697],"about_ca_topic_score_codex":0.000138223,"about_ca_topic_score_gemma":0.0000056095655,"teacher_disagreement_score":0.5499689,"about_ca_system_score_codex":0.00018827696,"about_ca_system_score_gemma":0.0011980034,"threshold_uncertainty_score":0.9998745},"labels":[],"label_agreement":null},{"id":"W3174608732","doi":"10.5489/cuaj.7369","title":"Inter-observer and intra-observer agreement of Bosniak classification of cystic renal masses: Comparison between original version to version 2019 and effect of an online support calculator","year":2021,"lang":"en","type":"letter","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Calculator; Observer (physics); Medicine; Computer science; Physics","score_opus":0.0341936559432955,"score_gpt":0.27511036695036595,"score_spread":0.24091671100707046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174608732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9570472,0.00023355921,0.000029880444,0.041365996,0.00019003122,0.00045942652,0.00063105114,0.000005313405,0.0000375152],"genre_scores_gemma":[0.99039793,0.000047266938,0.00071367895,0.0054676663,0.0006146389,0.0000046779683,0.0025299685,0.000023912282,0.0002002309],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99674803,0.0006675614,0.0009729271,0.00041483057,0.00079960853,0.00039703358],"domain_scores_gemma":[0.99706054,0.0004332551,0.0010800797,0.0002538864,0.00052934175,0.00064289675],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00094682944,0.00032401207,0.0012151576,0.00040956508,0.00007976751,0.000032531556,0.00015610283,0.0007781777,0.00033358997],"category_scores_gemma":[0.00040442118,0.00025968434,0.00020936962,0.00022629142,0.000079328405,0.00009973387,0.000056419518,0.0011475342,0.0000069584626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037375258,0.00008903639,0.89432216,0.00027481106,0.00045739292,0.00026079777,0.00009956251,0.000012729193,0.0019272092,0.0000015956595,0.10074601,0.001434957],"study_design_scores_gemma":[0.0021933406,0.0064989743,0.92328376,0.00029590187,0.001246551,0.00009150806,0.000043123586,0.00011157529,0.0010702958,0.00001018974,0.06495909,0.00019571731],"about_ca_topic_score_codex":0.0014626298,"about_ca_topic_score_gemma":0.00035808608,"teacher_disagreement_score":0.035898328,"about_ca_system_score_codex":0.0014410414,"about_ca_system_score_gemma":0.0005511934,"threshold_uncertainty_score":0.9999855},"labels":[],"label_agreement":null},{"id":"W3175561464","doi":"10.15586/jkcvhl.v8i2.179","title":"Partial Nephrectomy A Comparison between Different Modalities","year":2021,"lang":"en","type":"article","venue":"Journal of Kidney Cancer and VHL","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"King Abdullah International Medical Research Center","keywords":"Nephrectomy; Medicine; Incidence (geometry); Surgery; Body mass index; Cancer; Institutional review board; Surgical oncology; Kidney; Internal medicine","score_opus":0.0467319428548225,"score_gpt":0.32785710070213175,"score_spread":0.28112515784730924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3175561464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853546,0.006877677,0.00009328619,0.0064329524,0.0002954335,0.00008304741,0.00002072381,0.0000061855076,0.000836087],"genre_scores_gemma":[0.99643797,0.00075814425,0.00023341947,0.0007849685,0.0010407853,0.000007218412,0.000008736596,0.000011352164,0.0007174196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990174,0.000043127013,0.00037564602,0.000110045265,0.00029331847,0.00016046857],"domain_scores_gemma":[0.9988467,0.0000505164,0.00016625156,0.00010304359,0.0001621489,0.00067133154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007822679,0.00012356347,0.0005329448,0.000059079757,0.000042146097,0.000030040363,0.000036288027,0.000048829093,0.00022002387],"category_scores_gemma":[0.00008419121,0.00008310784,0.00014776131,0.00006661579,0.00003908918,0.000058611735,0.000026847412,0.0002138855,0.0000016060449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037902073,0.00019035717,0.9549855,0.00018536151,0.0006368252,0.00033119041,0.0007526854,0.0000048612364,0.0055987975,0.000049277973,0.022030018,0.014856134],"study_design_scores_gemma":[0.0074408366,0.001126905,0.6503974,0.0007850827,0.0016587165,0.000647617,0.0006373956,0.00009645488,0.19463684,0.00026873982,0.14207718,0.00022683886],"about_ca_topic_score_codex":0.000052986474,"about_ca_topic_score_gemma":0.0000059227154,"teacher_disagreement_score":0.30458808,"about_ca_system_score_codex":0.0001342796,"about_ca_system_score_gemma":0.0005787018,"threshold_uncertainty_score":0.33890396},"labels":[],"label_agreement":null},{"id":"W3176110720","doi":"10.1007/s00261-021-03180-y","title":"Evaluation of class II cystic renal masses proposed in Bosniak classification version 2019: a systematic review of supporting evidence","year":2021,"lang":"en","type":"review","venue":"Abdominal Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Homogeneous; Malignancy; Radiology; Renal parenchyma; Nuclear medicine; Kidney; Pathology; Internal medicine","score_opus":0.13130395644269008,"score_gpt":0.4143962651194153,"score_spread":0.2830923086767252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176110720","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010685861,0.99201256,0.00003712827,0.00010157456,0.0001372737,0.0063767275,0.000014388575,0.000010087829,0.00024167058],"genre_scores_gemma":[0.0065610725,0.99156076,0.00076689443,0.000027156239,0.00005946055,0.00047125743,0.0004221158,0.00003707174,0.00009423212],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9902386,0.004432451,0.0031875947,0.00065925514,0.0011563768,0.00032574078],"domain_scores_gemma":[0.99281067,0.0016484648,0.0033716867,0.0009261731,0.0011414259,0.00010160677],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008882775,0.00044084928,0.005714963,0.0004623744,0.00003705326,0.0000042076344,0.0002543538,0.00039538732,0.00019050717],"category_scores_gemma":[0.011796952,0.00031924018,0.00072349486,0.00067452306,0.00015219166,0.000076530414,0.00009639614,0.00039028644,0.000023758766],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007173506,0.00016655687,0.00003917522,0.9554179,0.0004339034,0.00011954198,0.000050561965,0.0000013359125,0.00036505924,0.000047597125,0.00025861769,0.043028023],"study_design_scores_gemma":[0.00074328546,0.00104471,0.00018878309,0.96183294,0.03198084,0.001842558,0.000063218395,0.00025457708,0.00009847862,0.000012293876,0.0017320982,0.00020620445],"about_ca_topic_score_codex":0.000033970813,"about_ca_topic_score_gemma":0.0000046767186,"teacher_disagreement_score":0.04282182,"about_ca_system_score_codex":0.0014090422,"about_ca_system_score_gemma":0.0031659945,"threshold_uncertainty_score":0.999926},"labels":[],"label_agreement":null},{"id":"W3176435071","doi":"10.1371/journal.pone.0253236","title":"Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden","year":2021,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Päivikki ja Sakari Sohlbergin Säätiö; Jane ja Aatos Erkon Säätiö; Novo Nordisk Fonden; Biomedicum Helsinki-säätiö; Helsingin ja Uudenmaan Sairaanhoitopiiri; Helsingin Yliopisto","keywords":"Relative survival; Renal cell carcinoma; Medicine; Demography; Survival rate; Survival analysis; Cancer; Cancer registry; Oncology; Internal medicine","score_opus":0.07840786297072999,"score_gpt":0.2819125518733321,"score_spread":0.2035046889026021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176435071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912892,0.0053499737,3.7231945e-7,0.00046250777,0.000021000773,0.00052551186,0.0000073350193,0.000010571219,0.0023335528],"genre_scores_gemma":[0.99779254,0.00013041773,0.00128694,0.00004718898,0.000043313106,0.00006542197,0.000058286732,0.000023779327,0.00055210176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843043,0.00017121827,0.00030493762,0.0003778047,0.00041287614,0.00030270612],"domain_scores_gemma":[0.99948657,0.000078727746,0.00004447556,0.00025440482,0.000056664117,0.00007917171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023723385,0.00015169397,0.00045733145,0.00013537756,0.000010900522,0.000016432887,0.000050262563,0.000101667116,0.00012615939],"category_scores_gemma":[0.000049478967,0.00014519937,0.000030221898,0.00038245792,0.000050680024,0.000060800805,0.00007126751,0.00026042847,0.000027103284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028263748,0.002118388,0.97778034,0.00021788645,0.000033763576,0.0032655448,0.0011692529,0.0000034654245,0.014739566,0.000005200275,0.00001822695,0.00036571853],"study_design_scores_gemma":[0.005510612,0.00030789402,0.93622535,0.00038300635,0.00008570032,0.000018594103,0.00018075238,0.00025580847,0.05682978,0.000058220434,0.000017331666,0.00012696935],"about_ca_topic_score_codex":0.00046066364,"about_ca_topic_score_gemma":0.0011088768,"teacher_disagreement_score":0.042090215,"about_ca_system_score_codex":0.00020718829,"about_ca_system_score_gemma":0.00017074478,"threshold_uncertainty_score":0.59210587},"labels":[],"label_agreement":null},{"id":"W3177107741","doi":"10.1016/j.urolonc.2021.05.026","title":"The increasing use of renal tumor biopsy amongst Canadian urologists: When is biopsy most utilized?","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of Alberta; Queen Elizabeth II Health Sciences Centre; St. Joseph’s Healthcare Hamilton; McMaster University; University of Calgary; Princess Margaret Cancer Centre; Ottawa Hospital; University of Ottawa; McGill University Health Centre; University of British Columbia; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Logistic regression; Biopsy; Surgery; General surgery; Internal medicine","score_opus":0.0469239435373554,"score_gpt":0.28924066317403635,"score_spread":0.24231671963668094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177107741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746738,0.002586196,0.000015787444,0.019704528,0.00015569887,0.00035691296,0.00009851556,0.000037207257,0.0023713724],"genre_scores_gemma":[0.93291694,0.00076726923,0.056850668,0.007406371,0.00013587011,0.00009312415,0.00019279741,0.000030497202,0.0016064672],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.998029,0.00026811348,0.00048694204,0.00048400092,0.00021994761,0.0005119871],"domain_scores_gemma":[0.9975581,0.00083879713,0.00024039244,0.0004751651,0.00027536735,0.0006121608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046267288,0.00026420815,0.00047290407,0.0001720376,0.000553061,0.00006129869,0.000135679,0.0002501166,0.00016052401],"category_scores_gemma":[0.0009568673,0.00018586368,0.000104616876,0.0004413548,0.0017238386,0.0001084394,0.00008354303,0.00041677433,0.000016766133],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038156478,0.0002232895,0.9607559,0.000035830886,0.00027573213,0.004596727,0.00071263587,0.000015941465,0.011927609,0.00605966,0.012309957,0.0027051682],"study_design_scores_gemma":[0.0010650936,0.0014842178,0.06017084,0.000070345865,0.000659503,0.010387354,0.0004680654,0.0006803136,0.0075191334,0.0048055854,0.9124425,0.00024706224],"about_ca_topic_score_codex":0.027037386,"about_ca_topic_score_gemma":0.009133241,"teacher_disagreement_score":0.90058506,"about_ca_system_score_codex":0.00030392403,"about_ca_system_score_gemma":0.0019963647,"threshold_uncertainty_score":0.97944164},"labels":[],"label_agreement":null},{"id":"W3178692749","doi":"10.1016/j.euo.2021.05.007","title":"Characterization and Management of Treatment-emergent Hepatic Toxicity in Patients with Advanced Renal Cell Carcinoma Receiving First-line Pembrolizumab plus Axitinib. Results from the KEYNOTE-426 Trial","year":2021,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Axitinib; Pembrolizumab; Discontinuation; Sunitinib; Adverse effect; Internal medicine; Renal cell carcinoma; Gastroenterology; Incidence (geometry); Cancer; Immunotherapy","score_opus":0.020506700954942267,"score_gpt":0.24325640937435572,"score_spread":0.22274970841941344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178692749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938879,0.00022949254,0.00008211104,0.0011524471,0.00025134807,0.0014465193,0.00011190698,0.000024513343,0.0028137832],"genre_scores_gemma":[0.9967519,0.0005329733,0.0005030308,0.00030266657,0.00013019728,0.000052272342,0.0013473426,0.00004539231,0.00033419236],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9970555,0.00095523044,0.0007662267,0.0006766949,0.00019363749,0.0003527438],"domain_scores_gemma":[0.9984312,0.0003370168,0.000432976,0.00056333555,0.00011793731,0.00011753047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026745992,0.0003021545,0.00065384776,0.00009137984,0.00009409739,0.000007799013,0.00011791466,0.00009843406,0.000059647755],"category_scores_gemma":[0.00008073526,0.00020995777,0.00008277511,0.00021510616,0.00015052661,0.000049170034,0.00015712774,0.00020279043,0.000012397199],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5587467,0.0072649023,0.3207658,0.00024019937,0.0009964532,0.0068478803,0.006231367,0.0010285197,0.011076924,0.000038952574,0.00011055978,0.086651795],"study_design_scores_gemma":[0.14936985,0.016985795,0.8283333,0.0000491817,0.00047620037,0.000023208091,0.00008422914,0.0001477248,0.0023083529,0.0000033971612,0.0020726342,0.00014610101],"about_ca_topic_score_codex":0.00008985626,"about_ca_topic_score_gemma":0.00031710655,"teacher_disagreement_score":0.5075675,"about_ca_system_score_codex":0.00046161102,"about_ca_system_score_gemma":0.00016282816,"threshold_uncertainty_score":0.85618293},"labels":[],"label_agreement":null},{"id":"W3178736812","doi":"10.1158/1538-7445.am2021-2974","title":"Abstract 2974: Loss of <i>TSC1</i> or <i>TSC2</i> drives lineage infidelity and hamartoma formation in a renal organoid model of angiomyolipoma","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; Ottawa Hospital","funders":"","keywords":"TSC1; Angiomyolipoma; Biology; TSC2; Organoid; mTORC1; Induced pluripotent stem cell; Lineage markers; Pathology; Cancer research; Cell biology; Kidney; Stem cell; PI3K/AKT/mTOR pathway; Progenitor cell; Genetics; Medicine; Gene; Signal transduction; Embryonic stem cell","score_opus":0.0958769667578749,"score_gpt":0.38242890406790514,"score_spread":0.28655193731003026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178736812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956688,0.0020760437,0.000102986676,0.00060149434,0.000019573583,0.00045210813,0.00007752279,0.000010979795,0.0009904797],"genre_scores_gemma":[0.9971283,0.0012142353,0.0009183136,0.000053464308,0.000056283006,0.000065975204,0.000039419876,0.000021186363,0.0005028226],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997954,0.00010831547,0.0005465368,0.0003056402,0.0007262501,0.00035925081],"domain_scores_gemma":[0.99835443,0.00018238573,0.000114221264,0.00040924578,0.000771956,0.00016775471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005917866,0.00014194331,0.00043568877,0.00027112124,0.00004422274,0.000016420743,0.0001003802,0.00009613832,0.00015885885],"category_scores_gemma":[0.00021119078,0.00011232054,0.00007780899,0.00068791857,0.00025843072,0.00018900828,0.00014326841,0.00033988358,0.000003548895],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015086139,0.00030582186,0.012778577,0.0012804692,0.000057990095,0.0005151702,0.0014626961,0.00025513605,0.97907454,0.000073521725,0.0005618312,0.0021256502],"study_design_scores_gemma":[0.0024571754,0.00028587517,0.03807253,0.0005534155,0.000029574214,0.0000964624,0.00029913036,0.0019750998,0.95588905,0.000095093754,0.0001536299,0.00009293813],"about_ca_topic_score_codex":0.00058191107,"about_ca_topic_score_gemma":0.0008441861,"teacher_disagreement_score":0.025293952,"about_ca_system_score_codex":0.00025209127,"about_ca_system_score_gemma":0.000898401,"threshold_uncertainty_score":0.45802984},"labels":[],"label_agreement":null},{"id":"W3179962123","doi":"10.1158/1538-7445.am2021-2441","title":"Abstract 2441: Polysome profiling suggests VHL-dependent translational control in clear cell renal cell carcinoma","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Polysome; Clear cell renal cell carcinoma; Cancer research; Translational regulation; PI3K/AKT/mTOR pathway; Translational efficiency; Biology; Renal cell carcinoma; Metastasis; Kidney cancer; Tumor progression; Medicine; Gene; Cancer; Bioinformatics; Oncology; Internal medicine; Messenger RNA; Translation (biology); Genetics; Signal transduction; RNA; Ribosome","score_opus":0.06386902647025752,"score_gpt":0.35858021079437696,"score_spread":0.29471118432411947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179962123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97783375,0.008865738,0.00001562365,0.0020540676,0.00012193669,0.0009831582,0.00009205578,0.000029109371,0.010004566],"genre_scores_gemma":[0.9952033,0.00022633847,0.00021665948,0.00013487296,0.00039667683,0.0002598646,0.00009895681,0.00006299375,0.0034002964],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99603355,0.0002654334,0.00049189175,0.00074257585,0.0015513854,0.00091514154],"domain_scores_gemma":[0.9981632,0.000312098,0.00006538615,0.00050553156,0.0005452981,0.00040843934],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008829689,0.00024820317,0.00044749616,0.0003688668,0.00013563216,0.00006321235,0.00018667823,0.00018849438,0.0015586778],"category_scores_gemma":[0.000051772404,0.00022721184,0.00017066457,0.0005912166,0.00012666492,0.00011371827,0.000057427256,0.0011500239,0.00019104958],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015477601,0.0006046997,0.14158158,0.00046176175,0.0000400306,0.0035715697,0.0003657535,0.00028486055,0.8498815,0.00004019229,0.00042857006,0.0011917815],"study_design_scores_gemma":[0.0066233906,0.0003072978,0.3038825,0.0001200433,0.000039741124,0.00003488945,0.0003135183,0.00018060772,0.6877741,0.00005328822,0.00048693098,0.0001836824],"about_ca_topic_score_codex":0.0010553107,"about_ca_topic_score_gemma":0.00045688017,"teacher_disagreement_score":0.16230093,"about_ca_system_score_codex":0.00085615565,"about_ca_system_score_gemma":0.0021121774,"threshold_uncertainty_score":0.999354},"labels":[],"label_agreement":null},{"id":"W3181405059","doi":"10.1158/1538-7445.am2021-2500","title":"Abstract 2500: The Forkhead-like protein Dach1 governs sensitivity to WEE1 kinase and PARP inhibitors","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Biology; Ku70; DNA repair; Genetics; Chromatin; Molecular biology; Cancer research; Gene","score_opus":0.09128255855732804,"score_gpt":0.38987828999796825,"score_spread":0.2985957314406402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181405059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778498,0.0021814404,0.000005570261,0.015654916,0.00009329405,0.0013116391,0.000041532436,0.00002361169,0.002838196],"genre_scores_gemma":[0.99336857,0.00012502729,0.00008446938,0.00032898915,0.00041324153,0.0003868383,0.000013895916,0.000032934804,0.005246045],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975839,0.00024011104,0.00018147191,0.000490354,0.0009407885,0.0005633463],"domain_scores_gemma":[0.99834836,0.00025497976,0.00002978474,0.00059362286,0.00037323625,0.00040004373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010412432,0.00015977467,0.00024681154,0.000075507465,0.00023142144,0.0000782948,0.000072473245,0.000082520026,0.00023008109],"category_scores_gemma":[0.00031014805,0.000107822736,0.000075799486,0.00045470396,0.00017765195,0.00006092469,0.00023060429,0.00060065876,0.000092808536],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070356426,0.0002838326,0.013517833,0.0004262087,0.00014095123,0.0042279838,0.0010316249,0.000012964244,0.9288289,0.0001959377,0.018821152,0.031809065],"study_design_scores_gemma":[0.001075297,0.00035665397,0.25500816,0.000461232,0.000037066147,0.000103824415,0.0008844061,0.000018273417,0.7066431,0.000068863716,0.03518067,0.00016245131],"about_ca_topic_score_codex":0.0030115247,"about_ca_topic_score_gemma":0.0014589546,"teacher_disagreement_score":0.24149033,"about_ca_system_score_codex":0.0006300365,"about_ca_system_score_gemma":0.0006001383,"threshold_uncertainty_score":0.45525447},"labels":[],"label_agreement":null},{"id":"W3182321248","doi":"10.1007/s00261-021-03178-6","title":"Imaging considerations for thermal and radiotherapy ablation of primary and metastatic renal cell carcinoma","year":2021,"lang":"en","type":"review","venue":"Abdominal Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Renal cell carcinoma; Ablative case; Radiation therapy; Percutaneous; Ablation; Nephrectomy; Radiology; Cryoablation; Disease; Primary tumor; Oncology; Internal medicine; Kidney; Metastasis; Cancer","score_opus":0.051965584012583686,"score_gpt":0.3167960993057345,"score_spread":0.2648305152931508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182321248","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0067963717,0.99047464,0.000730258,0.00010871,0.00007423494,0.001432036,0.000055529163,0.000008980411,0.00031923436],"genre_scores_gemma":[0.0070260004,0.96591496,0.026085878,0.000132921,0.00016325503,0.00019806917,0.0002761274,0.000056541594,0.0001462515],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99823576,0.0003163746,0.00064186496,0.00046537144,0.000101730235,0.00023892616],"domain_scores_gemma":[0.9975365,0.0016007407,0.0003721718,0.00027186517,0.00010618487,0.00011254388],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025732236,0.0003474678,0.0022678254,0.00020814937,0.0000737667,0.000014530512,0.00003827788,0.00013247138,0.000054955508],"category_scores_gemma":[0.00008689046,0.00026929972,0.00029948226,0.00007684435,0.0002518076,0.000041781368,0.000029208026,0.00018640701,6.106726e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024385707,0.00015436125,0.0003712501,0.022441607,0.0009208782,0.0006637775,0.0004549999,0.0000024607216,0.0044821477,0.00057747186,0.0006478459,0.9690393],"study_design_scores_gemma":[0.04130147,0.011913493,0.020374881,0.019122725,0.08061298,0.15172757,0.0006599019,0.002289171,0.0050073527,0.0011258539,0.66187054,0.003994076],"about_ca_topic_score_codex":0.000023548044,"about_ca_topic_score_gemma":0.0000013340359,"teacher_disagreement_score":0.9650453,"about_ca_system_score_codex":0.00017193829,"about_ca_system_score_gemma":0.000550393,"threshold_uncertainty_score":0.9999759},"labels":[],"label_agreement":null},{"id":"W3182367547","doi":"10.1096/fasebj.25.1_supplement.639.1","title":"Simulating vascular remodeling and transport in tumors","year":2011,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thomson Reuters (Canada)","funders":"","keywords":"Medicine","score_opus":0.04946491566482054,"score_gpt":0.25170753227175013,"score_spread":0.2022426166069296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182367547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99613315,0.00084380654,0.00036447935,0.000077074576,0.000031499232,0.00012015053,3.100931e-7,0.000008953575,0.0024205933],"genre_scores_gemma":[0.9981875,0.000078143865,0.0014949208,0.00008799491,0.00007685856,0.0000012025603,8.026267e-7,0.000013120914,0.000059486665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927855,0.000044278317,0.00023346794,0.00009242671,0.00018066187,0.0001706369],"domain_scores_gemma":[0.99965,0.000025967041,0.000056430352,0.00013129294,0.000030181252,0.00010613787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051019544,0.00008863827,0.00016626,0.00007066731,0.00008184515,0.000006935965,0.000050621118,0.000026475695,0.00007024266],"category_scores_gemma":[0.000017742455,0.000051818886,0.000077083576,0.00007070723,0.000034194167,0.000052738596,0.000008993313,0.0002906719,0.0000043819578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058591744,0.00021615525,0.8887897,0.00007172931,0.00017701778,0.003672316,0.015639711,0.0027376022,0.067843,0.00009125132,0.000007840523,0.020167751],"study_design_scores_gemma":[0.0042866296,0.000499979,0.9293651,0.0005645633,0.00036034005,0.0047973394,0.0019923376,0.015156844,0.041368462,0.0013612161,0.0000379674,0.00020920613],"about_ca_topic_score_codex":0.000085553314,"about_ca_topic_score_gemma":0.0000089722525,"teacher_disagreement_score":0.040575404,"about_ca_system_score_codex":0.00005198203,"about_ca_system_score_gemma":0.0000442648,"threshold_uncertainty_score":0.21131128},"labels":[],"label_agreement":null},{"id":"W3182408363","doi":"10.21203/rs.3.rs-618303/v1","title":"Diagnostic Performance of MRI, SPECT, and PET in Detecting Renal Cell Carcinoma: A Meta-Analysis","year":2021,"lang":"en","type":"preprint","venue":"Research Square","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Shanghai University of Medicine and Health Sciences; Shanghai Key Laboratory of Molecular Imaging; Shanghai Municipal Education Commission","keywords":"Diagnostic odds ratio; Meta-analysis; Medicine; Receiver operating characteristic; Nuclear medicine; Likelihood ratios in diagnostic testing; Positron emission tomography; Confidence interval; Renal cell carcinoma; Cochrane Library; Magnetic resonance imaging; Odds ratio; Single-photon emission computed tomography; Subgroup analysis; Spect imaging; Gold standard (test); Area under the curve; Radiology; Oncology; Internal medicine","score_opus":0.10675184235969884,"score_gpt":0.36464656622112446,"score_spread":0.25789472386142565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182408363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97104937,0.025667403,0.000019047524,0.00023472663,0.000026207668,0.001380895,0.00005197336,0.000017259237,0.0015531111],"genre_scores_gemma":[0.99635756,0.0012264325,0.0011788302,0.0000075268194,0.0000803103,0.00039216154,0.00016440671,0.000049399052,0.00054337864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99490166,0.000821703,0.00076457014,0.0011155914,0.0016689509,0.00072754634],"domain_scores_gemma":[0.99559116,0.0018450168,0.00022206343,0.0013175927,0.00070103107,0.00032315857],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021806913,0.00042011493,0.0022123859,0.001773017,0.00010066144,0.0000828335,0.00024811397,0.00017615434,0.0005422959],"category_scores_gemma":[0.00090242526,0.00033904094,0.0011766991,0.0017031254,0.00019918286,0.00006253144,0.001158337,0.0020193714,0.000009295234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006537578,0.0013366374,0.9050417,0.018361567,0.04171356,0.016693888,0.0035262643,0.0059508896,0.0059894784,0.0000075335515,0.000089397516,0.00063530373],"study_design_scores_gemma":[0.0018900704,0.0018649782,0.7620472,0.0006105231,0.08675382,0.00025032184,0.0023431801,0.0076683164,0.13598107,0.00003354031,0.000020894238,0.0005361046],"about_ca_topic_score_codex":0.00339113,"about_ca_topic_score_gemma":0.00083566504,"teacher_disagreement_score":0.14299454,"about_ca_system_score_codex":0.00053045305,"about_ca_system_score_gemma":0.0007008153,"threshold_uncertainty_score":0.9999062},"labels":[],"label_agreement":null},{"id":"W3184569377","doi":"","title":"TGF-β2-TGFBR3 signal is a key regulator of cancer-initiating cell maintenance in clear cell renal cell carcinoma","year":2015,"lang":"en","type":"article","venue":"The Japanese Biochemical Society/The Molecular Biology Society of Japan","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Regulator; Clear cell renal cell carcinoma; Cell growth; Cancer research; Cell; Cancer; Transforming growth factor; Renal cell carcinoma; Internal medicine; Medicine; Oncology; Biology; Gene; Genetics","score_opus":0.01910568772234775,"score_gpt":0.26558836863004764,"score_spread":0.2464826809076999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184569377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98597765,0.008374132,0.000059235048,0.003658776,0.00007700211,0.0008882842,0.0000712776,0.000035985773,0.00085763267],"genre_scores_gemma":[0.9940232,0.0002290636,0.0025830565,0.0022371812,0.00016817062,0.000085573294,0.000068275236,0.00007835799,0.00052709633],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99644804,0.0003156188,0.00095313694,0.00077101693,0.00061921205,0.0008930006],"domain_scores_gemma":[0.9973211,0.00028169455,0.0006680481,0.0010088611,0.0003990111,0.000321282],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010509716,0.0005670117,0.00099024,0.000035715464,0.00013576592,0.000013466285,0.00075238897,0.0006821748,0.00006224993],"category_scores_gemma":[0.00005054013,0.00036642115,0.0014145372,0.00060084934,0.001662039,0.0000376072,0.0004029459,0.0008572382,0.00001141355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036312302,0.00041986164,0.0108758705,0.00035518195,0.00021282677,0.0000050845265,0.017509054,0.000032896005,0.95826745,0.0000150464975,0.011846754,0.00009686089],"study_design_scores_gemma":[0.0040406818,0.0009186599,0.0025158867,0.0001206004,0.00041941015,0.00002435806,0.012955733,0.0012777555,0.9767359,0.00021229852,0.0004017047,0.00037704103],"about_ca_topic_score_codex":0.001907455,"about_ca_topic_score_gemma":0.0000061143833,"teacher_disagreement_score":0.01846843,"about_ca_system_score_codex":0.00047994844,"about_ca_system_score_gemma":0.00047471467,"threshold_uncertainty_score":0.99987876},"labels":[],"label_agreement":null},{"id":"W3185473984","doi":"10.1055/a-1522-8969","title":"Evaluation of Cystic and Solid Renal Lesions with Contrast-Enhanced Ultrasound: A Retrospective Study","year":2021,"lang":"en","type":"article","venue":"Ultrasound International Open","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Radiology; Ultrasound; Contrast-enhanced ultrasound; Predictive value; Retrospective cohort study; Kidney; Diagnostic accuracy; Histology; Ultrasonography; Contrast enhancement; Magnetic resonance imaging; Pathology; Internal medicine","score_opus":0.03762066363071582,"score_gpt":0.34355128944903396,"score_spread":0.30593062581831815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185473984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9650877,0.00015592773,0.0005270221,0.0001739146,0.00011493266,0.0015337552,0.00005377679,0.00001425252,0.032338686],"genre_scores_gemma":[0.9968429,0.00003571774,0.0014437138,0.00008429323,0.000078904246,0.00016675453,0.00015558029,0.000022232156,0.0011698982],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99745584,0.00021383246,0.00036552723,0.00046157208,0.0013450022,0.00015825688],"domain_scores_gemma":[0.9968992,0.0003556631,0.0001969218,0.0003124837,0.002122085,0.00011366206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008563314,0.00018423003,0.00040580714,0.000094344396,0.0000819489,0.00011627606,0.00018048921,0.000046325073,0.00084008364],"category_scores_gemma":[0.001560966,0.00014303823,0.000056746405,0.00019031923,0.00009703952,0.00019126231,0.00008404738,0.00015031447,0.000011115748],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022109465,0.004426781,0.27079377,0.000029478399,0.004254847,0.00022944478,0.0039843866,0.00032777715,0.70779026,0.0015723609,0.00025409632,0.0041258833],"study_design_scores_gemma":[0.009507217,0.0017768758,0.8947392,0.00020489673,0.0012886501,0.00084300153,0.0026686145,0.00014142558,0.08765887,0.00091269537,0.00007838913,0.0001801704],"about_ca_topic_score_codex":0.00021850644,"about_ca_topic_score_gemma":0.00052295096,"teacher_disagreement_score":0.6239454,"about_ca_system_score_codex":0.00048088093,"about_ca_system_score_gemma":0.00054556294,"threshold_uncertainty_score":0.91983265},"labels":[],"label_agreement":null},{"id":"W3186123873","doi":"10.3233/kca-210116","title":"Bim Expression in Peritumoral Lymphocytes is Associated with Survival in Patients with Metastatic Clear Cell Renal Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"Kidney Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Nephrectomy; Medicine; Renal cell carcinoma; Clear cell renal cell carcinoma; Immunohistochemistry; Oncology; Proportional hazards model; Internal medicine; Kidney cancer; Cancer; Metastasis; Clear cell; Pathology; Kidney","score_opus":0.014673006305765644,"score_gpt":0.2340668076723973,"score_spread":0.21939380136663164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186123873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99641633,0.0008912098,0.000005394983,0.00024617076,0.000093222836,0.00049532123,0.00013516955,0.000023829238,0.0016933533],"genre_scores_gemma":[0.9970073,0.000039065413,0.0006451822,0.00064110674,0.00003407997,0.00010272471,0.00027546185,0.0000678382,0.0011872603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771905,0.00018800347,0.0003432512,0.0005767332,0.0006753296,0.00049765065],"domain_scores_gemma":[0.99884033,0.000055324534,0.00015575526,0.00036490924,0.00021155427,0.0003721372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012285504,0.00032674745,0.0006125371,0.00016735587,0.000047320224,0.000028506247,0.00008702631,0.00007843861,0.0006490965],"category_scores_gemma":[0.000049399205,0.00023407253,0.000071253125,0.00061855285,0.00006436409,0.00011851027,0.000058581656,0.00024564078,0.000014374113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021079078,0.0011620119,0.9871246,0.00017327083,0.00004898091,0.0014113308,0.0009987247,0.000067252004,0.00581668,6.949562e-7,0.00095159304,0.00013692612],"study_design_scores_gemma":[0.02026195,0.0009909857,0.7908748,0.0007453487,0.0001677576,0.000006200919,0.000320225,0.00012152735,0.18597123,0.0000033893207,0.00025488593,0.00028174568],"about_ca_topic_score_codex":0.0011009622,"about_ca_topic_score_gemma":0.0005255798,"teacher_disagreement_score":0.19624987,"about_ca_system_score_codex":0.0013282002,"about_ca_system_score_gemma":0.0015382007,"threshold_uncertainty_score":0.9545201},"labels":[],"label_agreement":null},{"id":"W3186294569","doi":"10.30683/1927-7229.2020.09.03","title":"A Retrospective Survey of Patients Undergoing Maintenance Hemodialysis vis-à-vis Cancer Prevalence","year":2020,"lang":"en","type":"article","venue":"Journal of Analytical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Hemodialysis; Cancer; Colorectal cancer; Malignancy; Dialysis; Internal medicine; Disease; Population; Retrospective cohort study; Oncology; Intensive care medicine; Surgery","score_opus":0.044398338140996314,"score_gpt":0.32805124424876353,"score_spread":0.2836529061077672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186294569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929402,0.00040688785,0.00050375366,0.0040681497,0.0001317371,0.00017904433,0.000032034866,0.000005639616,0.0017325807],"genre_scores_gemma":[0.9976762,0.00060650916,0.0006775109,0.0007291246,0.00016377821,0.0000021667756,0.0000041493063,0.000016145106,0.00012444997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777156,0.00026624862,0.00089311984,0.00023817777,0.0005656064,0.00026526337],"domain_scores_gemma":[0.9967517,0.00046652835,0.00079810823,0.00015558256,0.0014227411,0.00040531327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005281662,0.00016520242,0.001118478,0.00013390399,0.000026735055,0.0000065310087,0.00015748783,0.00012837026,0.00035792327],"category_scores_gemma":[0.0025904302,0.0001184743,0.00033500354,0.0005277727,0.00016963971,0.000083171995,0.000061210965,0.00040335496,0.000010082601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029230183,0.000622248,0.9902287,0.0001746572,0.0008097053,0.00032249824,0.0002477037,0.00008074687,0.00030721194,0.00006516345,0.0023563982,0.0018619207],"study_design_scores_gemma":[0.0035728982,0.008120687,0.98460317,0.00014954155,0.0011025729,0.000038446462,0.00004705927,0.0013184998,0.00060406345,0.000036759517,0.00031230293,0.00009402223],"about_ca_topic_score_codex":0.00011288347,"about_ca_topic_score_gemma":0.000097796255,"teacher_disagreement_score":0.007498439,"about_ca_system_score_codex":0.0011379601,"about_ca_system_score_gemma":0.0008948646,"threshold_uncertainty_score":0.4831242},"labels":[],"label_agreement":null},{"id":"W3187870380","doi":"10.2196/19750","title":"Short-Term and Long-Term Renal Outcomes in Patients With Obesity After Minimally Invasive Versus Open Partial Nephrectomy for the Treatment of Renal Cancer: Retrospective Study","year":2021,"lang":"en","type":"article","venue":"JMIR Formative Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Renal function; Creatinine; Renal cell carcinoma; Retrospective cohort study; Odds ratio; Surgery; Obesity; Logistic regression; Medical record; Urology; Internal medicine; Kidney","score_opus":0.07073716626802996,"score_gpt":0.3991418092334295,"score_spread":0.32840464296539956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187870380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910501,0.00029514212,0.000003643283,0.00015988757,0.000052811247,0.008148696,0.00014186095,0.00000659184,0.00014121446],"genre_scores_gemma":[0.9933091,0.00014275781,0.000050229708,0.000008616996,0.000042897707,0.0061673787,0.00006412971,0.000024191982,0.00019070573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747336,0.0002999773,0.0003955761,0.00046498858,0.00087286375,0.0004932172],"domain_scores_gemma":[0.9978693,0.00058559823,0.00010215937,0.00047071627,0.00081002025,0.00016218812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035877412,0.00026792614,0.00068239385,0.00017269772,0.00018299425,0.00008956496,0.0001927436,0.00006564384,0.00007244385],"category_scores_gemma":[0.00005929099,0.00014841737,0.00010872957,0.00038364818,0.0002624438,0.00027248758,0.00026856718,0.00024101627,0.0000024350159],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025644913,0.005493828,0.9529438,0.00008455839,0.0010970111,0.00022055997,0.0107311485,0.0000015331736,0.00008907534,0.0000054967727,0.000029028128,0.003659034],"study_design_scores_gemma":[0.021717958,0.022778044,0.94698083,0.00018309732,0.00019354335,0.000003198611,0.001215172,0.00000824957,0.0067619653,0.000005284449,0.000018904213,0.0001337338],"about_ca_topic_score_codex":0.00020820735,"about_ca_topic_score_gemma":0.004165146,"teacher_disagreement_score":0.017284214,"about_ca_system_score_codex":0.0011780144,"about_ca_system_score_gemma":0.00048296803,"threshold_uncertainty_score":0.6052284},"labels":[],"label_agreement":null},{"id":"W3188805635","doi":"10.1007/s00261-021-03236-z","title":"Comparison of Bosniak Classification of cystic renal masses version 2019 assessed by CT and MRI","year":2021,"lang":"en","type":"article","venue":"Abdominal Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Radiology; Magnetic resonance imaging; Computed tomography; Nuclear medicine","score_opus":0.02758969797183839,"score_gpt":0.31840020757532217,"score_spread":0.29081050960348376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3188805635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923655,0.004709665,0.0007537657,0.00048091172,0.00008858427,0.00015917211,0.000020313333,0.000008413485,0.0014137154],"genre_scores_gemma":[0.99594396,0.00024062365,0.0032235966,0.000030129655,0.000032019623,0.0000063227903,0.00021343026,0.000010313006,0.00029960345],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988824,0.00016709798,0.0003837493,0.0002586487,0.00015771213,0.00015038114],"domain_scores_gemma":[0.99887997,0.00042133493,0.00022619819,0.0002555024,0.00013593206,0.000081033635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001576556,0.000121637255,0.000589118,0.00007554264,0.000026495803,0.000002950863,0.000051963772,0.00006744795,0.00010885821],"category_scores_gemma":[0.00014010408,0.00010430904,0.00007242252,0.00011775584,0.00017914388,0.000031834385,0.000030029098,0.00011471954,0.000009458543],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070280134,0.00028295297,0.17192122,0.0001369029,0.000115729265,0.00010997954,0.00006717469,0.000007869972,0.8148728,0.00016739195,0.0101930685,0.0014220794],"study_design_scores_gemma":[0.002454976,0.001472491,0.49376857,0.0000891202,0.00044530007,0.0010252973,0.0004534648,0.0009863033,0.49570847,0.000052153904,0.0034449059,0.00009894779],"about_ca_topic_score_codex":0.000047688714,"about_ca_topic_score_gemma":0.000003467841,"teacher_disagreement_score":0.32184735,"about_ca_system_score_codex":0.00007217466,"about_ca_system_score_gemma":0.00013309678,"threshold_uncertainty_score":0.4253599},"labels":[],"label_agreement":null},{"id":"W3189112222","doi":"10.1002/cncr.33679","title":"Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement","year":2021,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Genetic testing; Genetic counseling; Consensus conference; Family medicine; Delphi method; Risk assessment; Lynch syndrome; Cancer; Internal medicine; Genetics","score_opus":0.05874805789207591,"score_gpt":0.3767577924033976,"score_spread":0.31800973451132164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3189112222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98414195,0.009246932,0.0007491743,0.001302393,0.0010258905,0.0008433122,0.00025451797,0.000032634533,0.0024031843],"genre_scores_gemma":[0.96918434,0.0006647904,0.024791632,0.00062030996,0.0010162275,0.0003582877,0.00009846301,0.000044879413,0.0032210455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979651,0.00014591709,0.00064799335,0.0005526872,0.00031445958,0.0003738431],"domain_scores_gemma":[0.99839336,0.00024609163,0.00019091321,0.0004962919,0.00036365853,0.0003096729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027333625,0.00021555607,0.0004579882,0.000036837348,0.00008809794,0.000017828756,0.000062312276,0.000103425176,0.0006175329],"category_scores_gemma":[0.000052838397,0.00018201137,0.00029646492,0.00009718216,0.000084757485,0.00001618009,0.000056114142,0.00024699047,0.000024972616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073518406,0.001090047,0.82530135,0.00049499015,0.00055893825,0.0036177232,0.00013265111,0.0003296539,0.0061506685,0.000023438513,0.13399266,0.027572695],"study_design_scores_gemma":[0.008733067,0.0013618727,0.9164277,0.0000716641,0.0012468197,0.00010971938,0.00021474078,0.0009861374,0.027847981,0.00013758054,0.042591136,0.00027158487],"about_ca_topic_score_codex":0.00017724332,"about_ca_topic_score_gemma":0.000088058456,"teacher_disagreement_score":0.09140152,"about_ca_system_score_codex":0.0005378426,"about_ca_system_score_gemma":0.0014726849,"threshold_uncertainty_score":0.7422208},"labels":[],"label_agreement":null},{"id":"W3189215702","doi":"10.1097/ju.0000000000002101.08","title":"MP61-08 TOWARDS PERSONALIZED CARE OF CT1A PAPILLARY RCC DIAGNOSED ON BIOPSY","year":2021,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Concordance; Biopsy; Papillary renal cell carcinomas; Nephrectomy; Renal cell carcinoma; General surgery; Pathology; Internal medicine; Kidney","score_opus":0.0237064656095274,"score_gpt":0.27556880339236334,"score_spread":0.25186233778283595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3189215702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96929675,0.02102323,0.000020322103,0.0060826363,0.0002642664,0.00011315536,0.0000071531313,0.0000058119904,0.0031866974],"genre_scores_gemma":[0.99624956,0.0017779231,0.00021313188,0.0012102565,0.0002422293,0.0000017186715,0.0000068899576,0.000018602066,0.00027971473],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985436,0.0003604929,0.0004125348,0.00010906604,0.00037583028,0.0001984598],"domain_scores_gemma":[0.9984993,0.00032291643,0.00031701062,0.00031226853,0.0004309547,0.00011755557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003158626,0.00014409755,0.00052543357,0.00010493056,0.000041761312,0.0000034584934,0.00014151607,0.00010407408,0.00047121043],"category_scores_gemma":[0.00021157897,0.00008293388,0.00026802009,0.00014215689,0.00015996522,0.000021438142,0.000045009612,0.00034193505,0.000020707486],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041570816,0.003689676,0.09003852,0.0009815383,0.0064056967,0.073035926,0.043737825,0.00071111677,0.6495948,0.0018476982,0.016398767,0.07198766],"study_design_scores_gemma":[0.025604343,0.025110338,0.6333268,0.00035480017,0.0050642206,0.049027503,0.0097596655,0.000047605783,0.21322194,0.0007381945,0.037296213,0.0004483463],"about_ca_topic_score_codex":0.000022678705,"about_ca_topic_score_gemma":0.000004287187,"teacher_disagreement_score":0.5432883,"about_ca_system_score_codex":0.00009115604,"about_ca_system_score_gemma":0.00034312584,"threshold_uncertainty_score":0.5159424},"labels":[],"label_agreement":null},{"id":"W3190094695","doi":"10.1097/ju.0000000000002101.17","title":"MP61-17 CHARACTERIZING CHANGES IN MUSCLE MASS AFTER RADICAL NEPHRECTOMY FOR STAGE II-IV CLEAR CELL RENAL CELL CARCINOMA","year":2021,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Sarcopenia; Muscle mass; Classics; Internal medicine; Kidney; History","score_opus":0.019979522565733182,"score_gpt":0.24337730533846064,"score_spread":0.22339778277272745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190094695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985376,0.003313143,0.00014463507,0.009916425,0.00025324957,0.00031571864,0.0000134583,0.000008043464,0.0006593312],"genre_scores_gemma":[0.9933943,0.0002858516,0.0012418252,0.0027085056,0.0005957148,0.000018336605,0.00000926814,0.000041972595,0.0017042162],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818844,0.00032738852,0.00051019515,0.00021265302,0.00028199796,0.00047932417],"domain_scores_gemma":[0.99867034,0.0003078238,0.00033580698,0.00033488145,0.00015497282,0.00019615106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074915873,0.00021853932,0.0005745265,0.00019875738,0.00008101039,0.000013474173,0.00018411133,0.00016729294,0.00048106222],"category_scores_gemma":[0.00005310585,0.00014886814,0.00020943984,0.00015732179,0.000108056855,0.00006600151,0.00009422061,0.0006180792,0.000011185112],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009387687,0.0005986326,0.015955603,0.00017129276,0.00009243661,0.0053696167,0.002195822,0.00003261083,0.96349704,0.00000839691,0.0013786047,0.001312262],"study_design_scores_gemma":[0.015256716,0.012319819,0.34549797,0.00008615421,0.0010751532,0.002909329,0.0007604919,0.00044253038,0.41574368,0.00013027864,0.20538841,0.00038947025],"about_ca_topic_score_codex":0.000015170107,"about_ca_topic_score_gemma":0.00004408567,"teacher_disagreement_score":0.5477534,"about_ca_system_score_codex":0.00014103108,"about_ca_system_score_gemma":0.00022806038,"threshold_uncertainty_score":0.6070667},"labels":[],"label_agreement":null},{"id":"W3193705075","doi":"10.7244/cmj.2021.04.001.3","title":"Ablative Therapies versus Partial Nephrectomy for Small Renal Masses – A systematic review and meta-analysis of observational studies","year":2021,"lang":"en","type":"review","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Urology Foundation; University of Edinburgh; Rosetrees Trust; Astellas Pharma; Pancreatic Cancer UK; National Institute for Health and Care Research; Boston Scientific Corporation; Medical Research Council; Sanofi","keywords":"Medicine; Observational study; Nephrectomy; Internal medicine; Meta-analysis; Confounding; Randomized controlled trial; Systematic review; Renal function; MEDLINE; Surgery; Kidney","score_opus":0.602266215293873,"score_gpt":0.46436391242851927,"score_spread":0.13790230286535377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193705075","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000027943868,0.99266046,0.0000670637,0.00027854784,0.00003477587,0.0066359183,0.0001946475,0.000017992641,0.00010777148],"genre_scores_gemma":[0.0000029988505,0.98524374,0.005891189,0.0001587468,0.000034073495,0.006161619,0.0005974145,0.00003391015,0.0018762897],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9967193,0.0005323055,0.0016110905,0.00054998137,0.00039004718,0.00019726803],"domain_scores_gemma":[0.993723,0.0037818053,0.0010852118,0.00056851946,0.0007567625,0.00008470628],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0007418937,0.0005860608,0.0175091,0.00027815986,0.000050584702,0.00002041038,0.00010358067,0.00012281706,0.00030324914],"category_scores_gemma":[0.0008559363,0.00029982615,0.005077103,0.0008717142,0.00012738389,0.000042659212,0.0000730813,0.00011790265,0.0000021243977],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015386942,0.000037940372,0.0000013840794,0.50384337,0.4951943,0.000008936084,0.000040178686,2.7039647e-7,4.4151744e-8,0.000436688,0.0001108656,0.00031061855],"study_design_scores_gemma":[0.00037396728,0.0002465363,0.0000014123029,0.044099696,0.9047252,0.000014548968,0.00014127632,0.0000037366701,0.0000032716184,0.0000062997683,0.050189886,0.00019416689],"about_ca_topic_score_codex":0.000015131384,"about_ca_topic_score_gemma":0.000055933528,"teacher_disagreement_score":0.45974368,"about_ca_system_score_codex":0.00014997853,"about_ca_system_score_gemma":0.00031339587,"threshold_uncertainty_score":0.9999454},"labels":[],"label_agreement":null},{"id":"W3193767906","doi":"10.1016/j.urolonc.2021.07.022","title":"Adjuvant therapy with tyrosine kinase inhibitors for localized and locally advanced renal cell carcinoma: an updated systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Placebo; Meta-analysis; Oncology; Renal cell carcinoma; Adjuvant therapy; Adjuvant; Adverse effect; Randomized controlled trial; Clinical endpoint; Forest plot; Cochrane Library; Chemotherapy; Pathology","score_opus":0.0710168210008935,"score_gpt":0.3466635522659927,"score_spread":0.2756467312650992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193767906","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001965858,0.9904122,0.000109685,0.0010327605,0.000025854448,0.006131119,0.00021651445,0.00004835969,0.000057664132],"genre_scores_gemma":[0.00023918619,0.9653832,0.026886761,0.0017729984,0.00003787975,0.0024670153,0.002517106,0.000063140025,0.00063275127],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9958679,0.0009161392,0.0012686835,0.0012347049,0.0002688009,0.00044374602],"domain_scores_gemma":[0.9968131,0.0005300774,0.0009960216,0.0007072806,0.00030610294,0.00064740237],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00077424437,0.0009151183,0.009029772,0.000395764,0.000268085,0.000058917685,0.00013938661,0.0005040593,0.00007990221],"category_scores_gemma":[0.0001010507,0.0005213647,0.0007936648,0.0009318492,0.00076349464,0.00011966093,0.000072786504,0.0004970787,0.0000018736786],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006214262,0.0020968057,0.0008164259,0.83256936,0.13723527,0.0034908438,0.00040801824,0.00003135262,0.00004396181,0.0011782934,0.003087269,0.01842096],"study_design_scores_gemma":[0.0012904087,0.005668332,0.000003690348,0.0047157076,0.6238643,0.0010888295,0.000045961795,0.000039199786,0.000029180372,0.000038155154,0.36280352,0.00041271857],"about_ca_topic_score_codex":0.000036033933,"about_ca_topic_score_gemma":0.00003865767,"teacher_disagreement_score":0.8278537,"about_ca_system_score_codex":0.00018039715,"about_ca_system_score_gemma":0.00085580145,"threshold_uncertainty_score":0.9997238},"labels":[],"label_agreement":null},{"id":"W3194677003","doi":"10.1158/1078-0432.ccr-20-4504","title":"Angiokines Associated with Targeted Therapy Outcomes in Patients with Non–Clear Cell Renal Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Cancer Research UK; Novartis; Pfizer","keywords":"Renal cell carcinoma; Medicine; Oncology; Targeted therapy; Clear cell renal cell carcinoma; Internal medicine; Cancer","score_opus":0.1068312780066365,"score_gpt":0.4086008308021558,"score_spread":0.3017695527955193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194677003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99438226,0.0010620332,0.0000017961951,0.0008865905,0.0000886673,0.0010729231,0.000038905862,0.00003163463,0.0024351897],"genre_scores_gemma":[0.9931888,0.00019444834,0.00018362465,0.00034388542,0.00011595814,0.0001626844,0.00015568569,0.00008628613,0.005568632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953798,0.0006802933,0.00064597797,0.0008662292,0.0015620844,0.0008656345],"domain_scores_gemma":[0.99648046,0.00086599257,0.00014666803,0.0007364332,0.001329296,0.0004411613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010057492,0.00030764716,0.0008736728,0.00022194392,0.0001168545,0.00004804952,0.00022060827,0.00023842104,0.0005466747],"category_scores_gemma":[0.00028390947,0.00019255736,0.00019862167,0.0011418762,0.0003380056,0.000083048246,0.00012495877,0.0011964086,0.000047704285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053818733,0.0033370887,0.98726416,0.000049589482,0.00015323069,0.00086416834,0.00014520818,0.000012184714,0.00068265054,8.1057425e-7,0.0011347668,0.00097429164],"study_design_scores_gemma":[0.020419313,0.0067306412,0.9545641,0.00014463472,0.000059870097,0.0000011425708,0.00010245297,0.000026154616,0.017363245,0.000006237378,0.0003619751,0.00022024065],"about_ca_topic_score_codex":0.0006575006,"about_ca_topic_score_gemma":0.00054740265,"teacher_disagreement_score":0.032700043,"about_ca_system_score_codex":0.00052763545,"about_ca_system_score_gemma":0.0013440223,"threshold_uncertainty_score":0.7852261},"labels":[],"label_agreement":null},{"id":"W3194741964","doi":"10.1016/j.eururo.2021.07.026","title":"Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter Study","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ozmosis Research (Canada); McMaster University; University of Calgary; Princess Margaret Cancer Centre; Juravinski Cancer Centre; University of Manitoba; Ottawa Hospital; CancerCare Manitoba; University of Ottawa; McGill University; Sunnybrook Health Science Centre; Jewish General Hospital; University of Alberta; London Health Sciences Centre; University of Toronto; Western University","funders":"","keywords":"Medicine; Internal medicine; Renal cell carcinoma; Cumulative incidence; Oncology; Prospective cohort study; Tyrosine-kinase inhibitor; Radiation therapy; Incidence (geometry); Confidence interval; Systemic therapy; Cancer; Surgery; Cohort","score_opus":0.027230859123176722,"score_gpt":0.3187360434546051,"score_spread":0.29150518433142836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194741964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99254936,0.003502579,0.000052631935,0.00028461815,0.00031129358,0.002858434,0.00002121696,0.00004103279,0.00037884343],"genre_scores_gemma":[0.997238,0.00016271246,0.0008885211,0.00065672095,0.00020378643,0.0002927629,0.000058503414,0.00010281884,0.00039621018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974353,0.0008106002,0.0004679605,0.00065760355,0.00022124799,0.0004073275],"domain_scores_gemma":[0.99893355,0.00014902958,0.00019387055,0.0003606664,0.00022294135,0.00013992333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030554054,0.00029511764,0.00048703913,0.00016356487,0.00007211886,0.000027883007,0.00008766525,0.000034313973,0.00014025091],"category_scores_gemma":[0.0001025477,0.00022967228,0.00011645022,0.00023459402,0.00005149555,0.0000783313,0.00005680546,0.00024391191,0.000013987194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014610996,0.028166164,0.7936385,0.000118947,0.00063272077,0.004183424,0.007733049,0.000027949398,0.11081601,0.0000016013063,0.00040660234,0.03966398],"study_design_scores_gemma":[0.10146163,0.020441167,0.80647045,0.00012325401,0.00040913664,0.00003585127,0.00029730055,0.00037139282,0.06662132,0.0000055172136,0.0033916263,0.0003713239],"about_ca_topic_score_codex":0.000024281973,"about_ca_topic_score_gemma":0.000044748314,"teacher_disagreement_score":0.08685063,"about_ca_system_score_codex":0.000264556,"about_ca_system_score_gemma":0.000096064265,"threshold_uncertainty_score":0.93657637},"labels":[],"label_agreement":null},{"id":"W3194804370","doi":"10.1111/bju.15581","title":"Outcomes in robot‐assisted partial nephrectomy for imperative vs elective indications","year":2021,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Nephrectomy; Surgery; Propensity score matching; Renal function; Blood loss; Body mass index; Urology; Internal medicine; Kidney","score_opus":0.022600790919657856,"score_gpt":0.29734683086185787,"score_spread":0.27474603994220004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194804370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99053645,0.0027214992,0.001508667,0.00432743,0.00019928225,0.00036190575,0.000016477958,0.0000074299205,0.0003208448],"genre_scores_gemma":[0.99515903,0.00018662948,0.003330461,0.0008502752,0.00014627157,0.00006524246,0.00002244727,0.000015784759,0.00022383837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987798,0.00017550783,0.00048603365,0.00017079996,0.00014993969,0.00023795868],"domain_scores_gemma":[0.9988488,0.0002771859,0.00022489319,0.00009441871,0.00043242448,0.00012229943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019905792,0.00010169821,0.00052891445,0.00014949577,0.00005834698,0.000021367816,0.000062884574,0.000109109,0.000103345476],"category_scores_gemma":[0.00061054196,0.00010354992,0.00020433874,0.00019214113,0.00006416637,0.000074280375,0.000019967776,0.00032776222,0.000003913202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042076632,0.0040954673,0.8376896,0.000074366944,0.0022774788,0.0292789,0.001168887,0.0002450061,0.028738542,0.0006615742,0.004194444,0.0873681],"study_design_scores_gemma":[0.006072782,0.0016624527,0.9606523,0.000036125075,0.00025716287,0.023141477,0.00010103477,0.00004176529,0.005398776,0.0003528062,0.0021994126,0.00008391301],"about_ca_topic_score_codex":0.000043703174,"about_ca_topic_score_gemma":0.0003053449,"teacher_disagreement_score":0.12296272,"about_ca_system_score_codex":0.00015676313,"about_ca_system_score_gemma":0.00050278974,"threshold_uncertainty_score":0.42226434},"labels":[],"label_agreement":null},{"id":"W3195214939","doi":"10.1016/j.ejca.2021.07.014","title":"Median time to progression with TKI-based therapy after failure of immuno-oncology therapy in metastatic kidney cancer: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Pazopanib; Sunitinib; Cabozantinib; Axitinib; Medicine; Internal medicine; Oncology; Progression-free survival; Tyrosine-kinase inhibitor; Cancer; Overall survival","score_opus":0.0666762809095978,"score_gpt":0.38117108280769635,"score_spread":0.31449480189809853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195214939","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000050519062,0.99357235,0.00001126862,0.0029067867,0.00002977865,0.0032609922,0.00008150602,0.0000051353913,0.00008166934],"genre_scores_gemma":[0.0001610833,0.995365,0.0014273078,0.0018093016,0.000056582496,0.00065242406,0.000026863801,0.00011169319,0.00038969744],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99232316,0.0038930618,0.0022810118,0.00041598792,0.0008049614,0.00028182773],"domain_scores_gemma":[0.9952336,0.00021819794,0.002777318,0.0006395158,0.0006929634,0.0004383895],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022097838,0.0006521755,0.012239626,0.00077655923,0.000022146354,0.000029661647,0.0002894142,0.00006087197,0.0026284188],"category_scores_gemma":[0.00011211152,0.00030416195,0.0022060585,0.0013694118,0.00008464743,0.00006171796,0.00003734323,0.00047343355,0.000010108606],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006114813,0.00042043292,0.000040007042,0.5120222,0.32650554,0.005471214,0.00043193361,0.000013978712,0.000016460392,2.5769225e-7,0.0011275877,0.15333892],"study_design_scores_gemma":[0.0015814153,0.0020988632,0.000019428062,0.21467088,0.60998476,0.00032202416,0.000014768863,8.6987757e-7,0.000024065832,1.4432958e-7,0.17102697,0.0002558332],"about_ca_topic_score_codex":0.000023105298,"about_ca_topic_score_gemma":0.00003685042,"teacher_disagreement_score":0.2973513,"about_ca_system_score_codex":0.0004482907,"about_ca_system_score_gemma":0.0021423122,"threshold_uncertainty_score":0.99994105},"labels":[],"label_agreement":null},{"id":"W3196746312","doi":"10.1016/j.urology.2021.08.023","title":"A Systematic Review and Meta-analysis of Dual Therapy in Patients With Advanced Renal Cell Carcinoma of Favourable Risk","year":2021,"lang":"en","type":"review","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"Queen's University","keywords":"Medicine; Internal medicine; Sunitinib; Meta-analysis; Regimen; Renal cell carcinoma; Randomized controlled trial; Oncology; Subgroup analysis; Combination therapy; Cochrane Library; Relative risk; Confidence interval","score_opus":0.03863669276881268,"score_gpt":0.29067342262480506,"score_spread":0.25203672985599235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196746312","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005214149,0.99122494,0.0000030408826,0.0000151130935,0.000008468404,0.003276384,0.00015878503,0.0000039242123,0.00009519441],"genre_scores_gemma":[0.01278699,0.986156,0.00012231049,0.000077291894,0.0000028932773,0.00036107627,0.00033739407,0.000036397836,0.000119654025],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9962419,0.0011741933,0.0015015302,0.0005299989,0.00032340715,0.00022894559],"domain_scores_gemma":[0.9966221,0.0004130315,0.0017380492,0.00089529116,0.00024758367,0.00008397548],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00043999875,0.00045602827,0.01464611,0.00054479216,0.000013307284,0.0000026002015,0.000106277046,0.0001925484,0.00018196084],"category_scores_gemma":[0.00010189071,0.00024570146,0.0015549698,0.0010003716,0.000082846396,0.000021894803,0.000047939688,0.0002922689,0.0000019380275],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106279724,0.000573587,0.0011952962,0.81642836,0.1793267,0.00013779443,0.00006987335,0.000012526422,4.0088844e-7,0.0000053546196,0.00001379933,0.00213005],"study_design_scores_gemma":[0.0011954186,0.002543021,0.0006600658,0.0075110896,0.9870367,0.000028868822,0.000005265937,0.0000016479836,0.000005163202,8.2819037e-7,0.0008470794,0.00016482778],"about_ca_topic_score_codex":0.00006258864,"about_ca_topic_score_gemma":0.000022453067,"teacher_disagreement_score":0.8089172,"about_ca_system_score_codex":0.00006097503,"about_ca_system_score_gemma":0.00018396837,"threshold_uncertainty_score":0.9999995},"labels":[],"label_agreement":null},{"id":"W3197233605","doi":"10.5489/cuaj.7301","title":"Optimizing the management of patients with small renal masses in a Canadian context: A Markov decision-analysis model","year":2021,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto; Health Sciences Centre; University Health Network","funders":"","keywords":"Biopsy; Medicine; Context (archaeology); Nephrectomy; Gold standard (test); Urology; Surgery; Radiology; Internal medicine; Kidney","score_opus":0.016851086027602102,"score_gpt":0.21949727088474566,"score_spread":0.20264618485714356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197233605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98949015,0.00039790207,0.00065810175,0.0059990985,0.00004184747,0.00026184836,0.00005990914,0.0000041368194,0.0030869911],"genre_scores_gemma":[0.9896731,0.00005475174,0.0082014175,0.0016406634,0.000023924544,0.000013566456,0.000053454278,0.000010688534,0.0003284284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812305,0.00014997102,0.000447268,0.00023587998,0.00048450095,0.0005593097],"domain_scores_gemma":[0.9980697,0.0001500711,0.00024248647,0.00020623938,0.0004899049,0.0008415752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061065983,0.00015375011,0.00040359903,0.00043839906,0.00016883772,0.00006569075,0.00013856488,0.00013197931,0.0003490716],"category_scores_gemma":[0.00016597418,0.00009710454,0.00021290562,0.0008660332,0.000027445301,0.000047471513,0.00002001505,0.0003889693,0.0000044886615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012082796,0.00007044926,0.9818376,0.000004808255,0.0012978829,0.0009052331,0.0001508752,0.009806488,0.0000015672205,0.00011386499,0.00024248469,0.0054479213],"study_design_scores_gemma":[0.0016215075,0.00013687335,0.9897248,0.000040667164,0.00121086,0.000028005947,0.00020265269,0.0037951686,0.000009506997,0.00015873896,0.0029638992,0.000107300875],"about_ca_topic_score_codex":0.05004919,"about_ca_topic_score_gemma":0.6591599,"teacher_disagreement_score":0.6091107,"about_ca_system_score_codex":0.0027989708,"about_ca_system_score_gemma":0.0014780448,"threshold_uncertainty_score":0.9562766},"labels":[],"label_agreement":null},{"id":"W3198614198","doi":"10.1111/bju.15587","title":"Adjuvant therapy in patients with sarcomatoid renal cell carcinoma: <i>post hoc</i> analysis from Eastern Cooperative Oncology Group‐American College of Radiology Imaging Network (ECOG‐ACRIN) E2805","year":2021,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Renal cell carcinoma; Oncology; Internal medicine; Adjuvant therapy; Adjuvant; Radiology; Chemotherapy","score_opus":0.006627008089961288,"score_gpt":0.21673717236910572,"score_spread":0.21011016427914445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198614198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805874,0.017626293,0.00029947638,0.00055072363,0.000180621,0.00030542308,0.00016563262,0.0000073649917,0.00027703313],"genre_scores_gemma":[0.9944546,0.001100187,0.0026872435,0.0012454668,0.00020824828,0.000010526912,0.00022198894,0.000042170814,0.000029571866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962302,0.0011497507,0.0011867789,0.0004898964,0.00037042677,0.0005729337],"domain_scores_gemma":[0.9970099,0.00042575633,0.0010284701,0.00030923146,0.0009614264,0.0002652265],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035835666,0.00030880206,0.0020770822,0.00035733057,0.000069971014,0.000013431857,0.00021982737,0.00013730781,0.00018215095],"category_scores_gemma":[0.000056805042,0.0002837168,0.0003509783,0.0009723887,0.00045864313,0.0001111587,0.00008926754,0.00067110546,0.0000033116535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009674423,0.0017591818,0.94109756,0.000010281197,0.001379788,0.0245412,0.000296245,0.00076212053,0.0010031355,0.000005085872,0.0005193958,0.018951567],"study_design_scores_gemma":[0.019664405,0.018942397,0.9513271,0.00005829048,0.0011457808,0.006555658,0.00048044487,0.0002110125,0.00057129515,0.000029569648,0.0007843478,0.00022973362],"about_ca_topic_score_codex":0.0007191256,"about_ca_topic_score_gemma":0.0020062453,"teacher_disagreement_score":0.018721834,"about_ca_system_score_codex":0.0002511249,"about_ca_system_score_gemma":0.0006716717,"threshold_uncertainty_score":0.9999615},"labels":[],"label_agreement":null},{"id":"W3199693232","doi":"10.1177/17588359211034708","title":"New approaches to first-line treatment of advanced renal cell carcinoma","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Medical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; Exelixis","keywords":"Axitinib; Medicine; Nivolumab; Pazopanib; Pembrolizumab; Cabozantinib; Sunitinib; Ipilimumab; Renal cell carcinoma; Oncology; Tyrosine-kinase inhibitor; Internal medicine; Avelumab; Kidney cancer; Lenvatinib; Immunotherapy; Cancer","score_opus":0.16901093999069464,"score_gpt":0.39927029872998737,"score_spread":0.23025935873929274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199693232","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020100706,0.9894588,0.0010812853,0.0011269609,0.0004980275,0.0024710458,0.00001885833,0.00003634287,0.0051076747],"genre_scores_gemma":[0.0008689153,0.9870364,0.008703782,0.0002628952,0.0005951831,0.0006225984,0.00026211038,0.000111595364,0.0015365286],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950089,0.0005102787,0.00173871,0.0010889003,0.0008933981,0.0007598489],"domain_scores_gemma":[0.99618113,0.0013101501,0.0005727444,0.00095330767,0.000053696574,0.0009289998],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003545188,0.00088625273,0.005907214,0.00044222013,0.000042220232,0.000005570181,0.00042464797,0.00091815094,0.0009834861],"category_scores_gemma":[0.000100042715,0.00060691696,0.00085501437,0.00086330815,0.00023817694,0.000058878155,0.00014167311,0.00063016696,0.000062669846],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034891823,0.0018117672,0.00004509933,0.0047927056,0.0002289514,0.0019588117,0.00033095118,0.00003378631,0.0000014003155,0.00020690673,0.0000343729,0.9902063],"study_design_scores_gemma":[0.004638056,0.01034142,0.000029695319,0.0051784264,0.0018010295,0.00059201097,0.000078105906,0.000011555922,0.00014415069,0.0001265523,0.97665614,0.00040283232],"about_ca_topic_score_codex":0.000051194787,"about_ca_topic_score_gemma":0.00021129237,"teacher_disagreement_score":0.9898035,"about_ca_system_score_codex":0.0022083714,"about_ca_system_score_gemma":0.0042136554,"threshold_uncertainty_score":0.9999297},"labels":[],"label_agreement":null},{"id":"W3199946068","doi":"10.1053/j.semdp.2021.09.004","title":"Undifferentiated and dedifferentiated urological carcinomas: lessons learned from the recent developments","year":2021,"lang":"en","type":"review","venue":"Seminars in Diagnostic Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Calgary Laboratory Services","funders":"","keywords":"Pathology; Immunophenotyping; Biology; Vimentin; Carcinoma; Hematopathology; Immunohistochemistry; Medicine; Cytogenetics; Immunology; Flow cytometry","score_opus":0.13217086214280963,"score_gpt":0.355862471596946,"score_spread":0.22369160945413638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199946068","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06744966,0.92930114,0.000010619452,0.0009085358,0.000532765,0.0014080185,0.00015372482,0.00005947804,0.00017604246],"genre_scores_gemma":[0.0061971317,0.9884553,0.00039748457,0.00033151425,0.00011500039,0.00056364166,0.0036962912,0.000093177136,0.00015048738],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947541,0.0015256946,0.0011733305,0.0013991274,0.00037065646,0.0007771023],"domain_scores_gemma":[0.9905946,0.0077052056,0.00041815056,0.0009167304,0.000104227875,0.0002610595],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004254393,0.0008658382,0.0031551968,0.00024718937,0.00012767318,0.000045907273,0.00036449087,0.0010358223,0.00033088226],"category_scores_gemma":[0.0054490017,0.0005468517,0.00033153946,0.00059809414,0.00036136067,0.00002441821,0.0006329923,0.0013645303,0.000076381155],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038517926,0.00062638626,0.017987885,0.0010278288,0.00046297468,0.015521006,0.00034796903,1.8386706e-7,0.000009186582,0.000045684137,0.00082201714,0.9631104],"study_design_scores_gemma":[0.004044987,0.0008303364,0.2621889,0.03979188,0.011452072,0.005040591,0.00028490927,0.0000065776226,0.000065112254,0.0006839324,0.6742215,0.0013891661],"about_ca_topic_score_codex":0.00006675663,"about_ca_topic_score_gemma":0.00006334739,"teacher_disagreement_score":0.9617212,"about_ca_system_score_codex":0.00044984743,"about_ca_system_score_gemma":0.0005750882,"threshold_uncertainty_score":0.9996983},"labels":[],"label_agreement":null},{"id":"W3200904978","doi":"10.1016/j.urolonc.2021.08.016","title":"Prognostic significance of extent of venous tumor thrombus in patients with non-metastatic renal cell carcinoma: Results from a Canadian multi-institutional collaborative","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of Toronto; McMaster University; University of Calgary; University of Ottawa; McGill University; University of British Columbia; University of Manitoba; Ottawa Hospital; University of Alberta; Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Renal cell carcinoma; Interquartile range; Cohort; Internal medicine; Thrombus; Cancer; Statistical significance; Carcinoma; Kidney cancer; Oncology; Surgery","score_opus":0.019694132130670793,"score_gpt":0.2568181782263729,"score_spread":0.2371240460957021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200904978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99637324,0.0007912714,0.00003658613,0.0004908189,0.00005930186,0.00086099573,0.00071727065,0.0000061935916,0.00066431426],"genre_scores_gemma":[0.9246124,0.00002414543,0.07446774,0.00017763261,0.000014692279,0.00006925886,0.00057038787,0.000009217622,0.000054499218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984449,0.00015462894,0.0004942071,0.00041999618,0.00021700539,0.00026925435],"domain_scores_gemma":[0.99844396,0.00035073576,0.00029922463,0.00021493138,0.00039845533,0.00029271186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001483929,0.00020627846,0.0005670758,0.00018646977,0.00009812652,0.000006268802,0.00006780788,0.00008970667,0.000024531393],"category_scores_gemma":[0.00028740766,0.00015726528,0.000040175524,0.0005365953,0.0007566822,0.00005997534,0.000024637045,0.00022417476,0.0000030133297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066793826,0.0018245282,0.9906543,0.000074466814,0.00007785308,0.0017634546,0.0015224512,0.00071746384,0.0022967544,0.0001308327,0.00012447557,0.0001454618],"study_design_scores_gemma":[0.0076512666,0.007185063,0.96876067,0.00018787145,0.00050043827,0.00006673614,0.00064714934,0.00044774104,0.011975692,0.00020099069,0.0022014552,0.00017493915],"about_ca_topic_score_codex":0.011082569,"about_ca_topic_score_gemma":0.014950567,"teacher_disagreement_score":0.07443115,"about_ca_system_score_codex":0.00035409862,"about_ca_system_score_gemma":0.0045877863,"threshold_uncertainty_score":0.9955027},"labels":[],"label_agreement":null},{"id":"W3202383065","doi":"10.1016/j.annonc.2021.08.065","title":"669P Subsequent therapy following pembrolizumab + axitinib or sunitinib treatment for advanced renal cell carcinoma (RCC) in the phase III KEYNOTE-426 study","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval","funders":"Merck Sharp and Dohme; Genentech; Servier; Society for Immunotherapy of Cancer; Shionogi; Astellas Pharma; Eisai; Pfizer; Incyte; Ipsen; Mirati Therapeutics; Exelixis; MEI Pharma; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; PTC Therapeutics; Sanofi; Bristol-Myers Squibb; Eli Lilly and Company; EUSA Pharma; AstraZeneca; American Society of Clinical Oncology; Arrowhead Pharmaceuticals; Merck; Amgen","keywords":"Medicine; Axitinib; Sunitinib; Renal cell carcinoma; Pembrolizumab; Oncology; Internal medicine; Urology; Cancer; Immunotherapy","score_opus":0.20492641594701666,"score_gpt":0.4405689404238316,"score_spread":0.23564252447681494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202383065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98561674,0.0029090364,0.000019456469,0.0030607712,0.00021289826,0.0035453688,0.000054045482,0.000026654408,0.004555007],"genre_scores_gemma":[0.9952234,0.00053975935,0.000445078,0.0012845757,0.00017588606,0.0010476226,0.00023510105,0.00005271484,0.0009958862],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967685,0.0006028287,0.000893829,0.000631818,0.00041450167,0.0006885345],"domain_scores_gemma":[0.99738437,0.0010089519,0.00031545505,0.00077398506,0.00033708007,0.00018014204],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00066457875,0.00042262202,0.0012333402,0.00020145462,0.00013464052,0.000018326093,0.00022961885,0.00017205326,0.0001660364],"category_scores_gemma":[0.00012221419,0.00026390236,0.0005776628,0.00040415017,0.00009007198,0.00008100434,0.000047941656,0.00021562804,0.0000069515904],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14380307,0.11162754,0.026512606,0.00031640113,0.0025591215,0.046789527,0.042899475,0.00012708287,0.13449277,0.00029865064,0.002982069,0.48759168],"study_design_scores_gemma":[0.23858233,0.18673727,0.03362224,0.00011031078,0.00080991635,0.00060873746,0.020102719,0.000060767652,0.47150305,0.00016488216,0.04713616,0.00056163134],"about_ca_topic_score_codex":0.000294957,"about_ca_topic_score_gemma":0.00054061395,"teacher_disagreement_score":0.48703006,"about_ca_system_score_codex":0.00032406402,"about_ca_system_score_gemma":0.0012663834,"threshold_uncertainty_score":0.99998134},"labels":[],"label_agreement":null},{"id":"W3203041075","doi":"10.1016/j.annonc.2021.08.058","title":"662P Pembrolizumab (pembro) monotherapy as first-line therapy in advanced non–clear cell renal cell carcinoma (nccRCC): Results after a minimum of 34 months of follow-up from KEYNOTE-427 cohort B","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Université Laval","funders":"","keywords":"Medicine; Pembrolizumab; Cohort; Renal cell carcinoma; Oncology; Internal medicine; Cancer; Immunotherapy","score_opus":0.03387022440427974,"score_gpt":0.3120583596990088,"score_spread":0.2781881352947291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203041075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784103,0.0072874706,0.000015781372,0.0016389012,0.00024475393,0.0011520691,0.00023382569,0.000018349325,0.010998538],"genre_scores_gemma":[0.9905566,0.0047046263,0.0013791797,0.0008403515,0.00011814959,0.00013728398,0.0001980968,0.00008616489,0.001979534],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958818,0.00033126448,0.0016944677,0.00088657567,0.00059186877,0.00061400357],"domain_scores_gemma":[0.9962716,0.0006536066,0.0008838202,0.001176852,0.0007592699,0.00025482735],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041366412,0.00049776695,0.0019602808,0.00034801834,0.000033146407,0.0000059274157,0.00029148284,0.0004884037,0.00042054916],"category_scores_gemma":[0.00013209828,0.00044860615,0.00059624965,0.00047918098,0.0002381968,0.000101120415,0.00011519995,0.00037818038,0.00002279046],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23101103,0.008676528,0.13689905,0.0004865519,0.0008306476,0.0037272668,0.0072009824,0.00036576376,0.58814967,0.000008227061,0.0030420856,0.0196022],"study_design_scores_gemma":[0.035979483,0.018836867,0.24267577,0.00018276011,0.00014965721,0.00002352865,0.0004225925,0.00016011659,0.6978242,0.00012456893,0.003351655,0.0002688566],"about_ca_topic_score_codex":0.0033508793,"about_ca_topic_score_gemma":0.00080616033,"teacher_disagreement_score":0.19503155,"about_ca_system_score_codex":0.00018534377,"about_ca_system_score_gemma":0.0009144222,"threshold_uncertainty_score":0.99979657},"labels":[],"label_agreement":null},{"id":"W3203206766","doi":"10.1016/j.annonc.2021.08.736","title":"1848P Feasible 3D printed models of renal cell cancer with venous thrombus extension for surgical planning and simulation: Phase I NCT03738488","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ignyta; European Society for Medical Oncology; Eisai; MacroGenics; Grifols; Actuate Therapeutics; Servier; Tarveda Therapeutics; Sierra Oncology; Incyte; F. Hoffmann-La Roche; Taiho Pharmaceutical; Regeneron Pharmaceuticals; Array BioPharma; Sanofi; GlaxoSmithKline; Amgen; Pfizer; Centro de Investigación Biomédica en Red de Cáncer; Carrick Therapeutics; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Surgical planning; Renal cell carcinoma; Radiology; Thrombus; Radiological weapon; Clinical trial; Radiation treatment planning; Cancer; Surgery; Medical physics; Oncology; Internal medicine; Radiation therapy","score_opus":0.19395884662410695,"score_gpt":0.4386280661718895,"score_spread":0.24466921954778253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203206766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99023306,0.0049380222,0.0013805846,0.0006094168,0.000042803407,0.0004164261,0.00002586049,0.000011707277,0.002342133],"genre_scores_gemma":[0.99659735,0.00026765955,0.0026170164,0.00014123258,0.00006444626,0.000023764744,0.000049369202,0.000017811597,0.00022133329],"study_design_codex":"simulation_or_modeling","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899095,0.00005651336,0.00030931336,0.00027070692,0.00016846042,0.00020407187],"domain_scores_gemma":[0.99858034,0.00028683257,0.00020019889,0.00019398084,0.0006298597,0.0001088046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014777061,0.00012857419,0.0005910832,0.00007032481,0.00003792413,0.0000030387773,0.000032434073,0.00011316811,0.00005114883],"category_scores_gemma":[0.000028716722,0.00009856901,0.000075944365,0.00011780187,0.000103782724,0.000050502837,0.000034129218,0.00009097989,4.3217e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058830895,0.018248837,0.013060589,0.0027136034,0.0018611518,0.0103464965,0.0059019485,0.55911654,0.18430413,0.00047592985,0.0019006603,0.1432392],"study_design_scores_gemma":[0.04667447,0.055499393,0.010820206,0.0011387063,0.0011245168,0.0011639182,0.00052763976,0.14777362,0.71902186,0.00070092146,0.015107557,0.00044717392],"about_ca_topic_score_codex":0.00004729858,"about_ca_topic_score_gemma":0.00001210425,"teacher_disagreement_score":0.53471774,"about_ca_system_score_codex":0.000042437365,"about_ca_system_score_gemma":0.0004368816,"threshold_uncertainty_score":0.40195277},"labels":[],"label_agreement":null},{"id":"W3203275662","doi":"10.5489/cuaj.7307","title":"The impact of a multidisciplinary small renal mass clinic on patient treatment decisions","year":2021,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Multidisciplinary approach; Renal mass; Medicine; Intensive care medicine; Medical physics; Internal medicine; Kidney; Political science","score_opus":0.04596109956456989,"score_gpt":0.2983321909851309,"score_spread":0.252371091420561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203275662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885658,0.00058113184,0.000013815428,0.007195187,0.00017066489,0.00021896187,0.00005623957,0.000007789851,0.0031904164],"genre_scores_gemma":[0.99762225,0.00038809638,0.00033346313,0.00024657388,0.00016333487,0.000013964205,0.000031437634,0.000011838842,0.0011890602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981205,0.00034300864,0.00052091636,0.00020650511,0.00035523874,0.0004538311],"domain_scores_gemma":[0.9970638,0.0011109812,0.00035861146,0.00023999719,0.0004152034,0.00081136764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039371685,0.00017312226,0.00034121634,0.00010518258,0.00040170443,0.000050879356,0.000084318104,0.0001760743,0.00047219815],"category_scores_gemma":[0.001329456,0.00008943805,0.00059960136,0.00020665998,0.000036016532,0.000021903557,0.000016155807,0.00038518547,0.000074909796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008908713,0.0007676575,0.94842815,0.0000015101554,0.0012422857,0.0027877055,0.0003758955,0.0008435673,0.001407828,0.00005437483,0.0058458783,0.037354294],"study_design_scores_gemma":[0.0017938691,0.006420355,0.9856698,0.000029536439,0.00015364218,0.0004070687,0.00014802195,0.00016426454,0.0005630583,0.00072124606,0.0038328196,0.000096314565],"about_ca_topic_score_codex":0.0007230809,"about_ca_topic_score_gemma":0.0009941668,"teacher_disagreement_score":0.03725798,"about_ca_system_score_codex":0.0042183604,"about_ca_system_score_gemma":0.0018278997,"threshold_uncertainty_score":0.9996043},"labels":[],"label_agreement":null},{"id":"W3203989804","doi":"10.1016/j.annonc.2021.08.056","title":"660P Phase III CLEAR trial in advanced renal cell carcinoma (aRCC): Outcomes in subgroups and toxicity update","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"EMD Serono; Genentech; Aptitude Health; Ipsen; PharmaMar; European Society for Medical Oncology; Cilag; Astellas Pharma; Eisai; Incyte; Daiichi Sankyo Europe; Sanofi; Exelixis; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; American Society of Clinical Oncology; Amgen; Pfizer; Invitae; Chugai Pharmaceutical; EUSA Pharma; Society for Immunotherapy of Cancer","keywords":"Medicine; Internal medicine; Toxicity; Renal cell carcinoma; Oncology; Carcinoma","score_opus":0.06371294213044976,"score_gpt":0.37594488959952876,"score_spread":0.312231947469079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203989804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99036694,0.0012058257,0.0000043572704,0.003692937,0.00014462449,0.0006151997,0.000018366629,0.000011484505,0.0039402745],"genre_scores_gemma":[0.99767977,0.0003892194,0.00053129863,0.00090965844,0.000054750035,0.000041145708,0.0000553203,0.00001922258,0.0003196069],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998012,0.00025981286,0.0006923278,0.00042746513,0.00020698314,0.00040138752],"domain_scores_gemma":[0.99894375,0.00024329966,0.00019008598,0.00032799892,0.00012191406,0.0001729625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004326789,0.0002069515,0.0010390292,0.00023712996,0.000023220564,0.0000056837634,0.00008156217,0.00019493018,0.00013932913],"category_scores_gemma":[0.00014892769,0.00018387001,0.00014396153,0.00026577563,0.00011648687,0.00008567256,0.00010340508,0.00028437667,0.000009386802],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33772275,0.023234075,0.27074867,0.0005299959,0.0002760636,0.021284513,0.0029436606,0.000053744105,0.24235383,0.00049324625,0.0023609044,0.09799856],"study_design_scores_gemma":[0.30868462,0.023428345,0.23814979,0.000071165945,0.000106888954,0.00014901195,0.0005232024,0.000071185954,0.4233886,0.00037143665,0.004757249,0.0002985185],"about_ca_topic_score_codex":0.00018946925,"about_ca_topic_score_gemma":0.00043930238,"teacher_disagreement_score":0.18103476,"about_ca_system_score_codex":0.0001232991,"about_ca_system_score_gemma":0.00035021565,"threshold_uncertainty_score":0.74980015},"labels":[],"label_agreement":null},{"id":"W3204767207","doi":"10.1016/j.annonc.2021.08.057","title":"661P Conditional survival and 5-year follow-up in CheckMate 214: First-line nivolumab + ipilimumab (N+I) versus sunitinib (S) in advanced renal cell carcinoma (aRCC)","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Bristol-Myers Squibb","keywords":"Medicine; Progression-free survival; Ipilimumab; Intention-to-treat analysis; Sunitinib; Internal medicine; Clinical endpoint; Randomized controlled trial; Surgery; Oncology; Overall survival; Renal cell carcinoma; Cancer; Immunotherapy","score_opus":0.08853890813144567,"score_gpt":0.3488294023579169,"score_spread":0.2602904942264712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204767207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767714,0.0012497491,0.0000053302556,0.0025911275,0.00035730013,0.00036667773,0.00008870403,0.000017092534,0.018552609],"genre_scores_gemma":[0.9973577,0.0006009381,0.00045222483,0.00022080351,0.00010465041,0.00005348115,0.00047642578,0.00003282745,0.00070091087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977234,0.00024074924,0.00066652126,0.0005209005,0.0003307279,0.0005177163],"domain_scores_gemma":[0.99832284,0.0005884708,0.00020026404,0.00034408335,0.00033914464,0.00020516501],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040601753,0.00026823385,0.0008889627,0.00029243372,0.00004802149,0.000007980703,0.00010456963,0.00024013552,0.00044288152],"category_scores_gemma":[0.00024983363,0.00027671646,0.00015295988,0.0003748063,0.00020098126,0.00010575837,0.00012871924,0.000356829,0.00002670666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13805333,0.016130496,0.59094375,0.0029537436,0.0011843808,0.040470023,0.0066453223,0.0015010848,0.10711003,0.007587085,0.0075132726,0.079907484],"study_design_scores_gemma":[0.08417232,0.012197005,0.7700787,0.0002039132,0.00016263663,0.00023649403,0.0019830635,0.00019409928,0.1197411,0.0009017683,0.009648781,0.00048011923],"about_ca_topic_score_codex":0.0003017641,"about_ca_topic_score_gemma":0.0032740843,"teacher_disagreement_score":0.17913494,"about_ca_system_score_codex":0.0002141197,"about_ca_system_score_gemma":0.000664422,"threshold_uncertainty_score":0.9999685},"labels":[],"label_agreement":null},{"id":"W3205283790","doi":"10.7759/cureus.18878","title":"Renal and Lung Cysts in Birt-Hogg-Dubé Syndrome: A Continuum of the Same Disorder","year":2021,"lang":"en","type":"article","venue":"Cureus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Birt–Hogg–Dubé syndrome; Medicine; Pathology; Pneumothorax; Lung; Kidney; Dermatology; Internal medicine; Anatomy","score_opus":0.011409118469881728,"score_gpt":0.24851029926768048,"score_spread":0.23710118079779874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205283790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98446566,0.011880938,0.000008016479,0.00093111506,0.000116601164,0.0002665783,0.0000074613367,0.0000106811485,0.0023129405],"genre_scores_gemma":[0.9972092,0.00014507312,0.00014807284,0.00011745806,0.000025750238,0.000017018128,0.000007957325,0.000014786909,0.0023146733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991837,0.00005809235,0.00020621382,0.00020388169,0.00018411977,0.00016397165],"domain_scores_gemma":[0.99940616,0.0000567329,0.00005838243,0.0003562921,0.00005839452,0.00006404756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000085516134,0.000111041736,0.00027818198,0.000032524596,0.000023346996,0.000008156666,0.00005935653,0.00006260386,0.0001125948],"category_scores_gemma":[0.00010062151,0.000072423754,0.00007404965,0.00020711642,0.00007528011,0.000031547912,0.00009100535,0.00012913466,0.000004417516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117688374,0.00045530775,0.93997955,0.0002731217,0.0002040732,0.0012984243,0.0009998824,0.0000037398188,0.053340584,0.0003068898,0.0014640904,0.0015566532],"study_design_scores_gemma":[0.0021315077,0.00016842184,0.97231656,0.00031608445,0.00014009315,0.00094226206,0.00020134478,0.00004995033,0.022253415,0.00016822225,0.001220735,0.00009137066],"about_ca_topic_score_codex":0.00016337763,"about_ca_topic_score_gemma":0.0006409463,"teacher_disagreement_score":0.032337047,"about_ca_system_score_codex":0.00007287762,"about_ca_system_score_gemma":0.000096096046,"threshold_uncertainty_score":0.2953355},"labels":[],"label_agreement":null},{"id":"W3207058551","doi":"10.52733/kcj19n3-a1","title":"Tissue based biomarkers in non-clear cell RCC: Correlative analysis from the ASPEN clinical trial","year":2021,"lang":"en","type":"article","venue":"Kidney Cancer Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Duke Clinical Research Institute; National Cancer Institute; Cancer Research UK; National Institutes of Health; Pfizer","keywords":"Chromophobe cell; Sunitinib; Everolimus; Medicine; Renal cell carcinoma; Clinical endpoint; Biomarker; Clear cell; Oncology; Internal medicine; Clear cell renal cell carcinoma; Response Evaluation Criteria in Solid Tumors; Clinical trial; Pathology; Phases of clinical research; Biology","score_opus":0.05026666963239548,"score_gpt":0.36535789552615133,"score_spread":0.3150912258937558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207058551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97667783,0.0023834074,0.00069508626,0.012004104,0.0017417786,0.00059207756,0.000108475964,0.000013284547,0.0057839644],"genre_scores_gemma":[0.9917734,0.0004761865,0.0012564147,0.003630602,0.0013607901,0.000018732948,0.000110717425,0.00003157589,0.0013415766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99719316,0.0006401519,0.00085089216,0.00041553803,0.00056737,0.0003328954],"domain_scores_gemma":[0.9976671,0.00063417776,0.00036201347,0.00045890367,0.00020339493,0.0006744446],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00088539533,0.00022400111,0.00073680753,0.00016876958,0.00012812897,0.00008336254,0.00019034145,0.00016436643,0.007081175],"category_scores_gemma":[0.0005593568,0.00014676487,0.0006099048,0.0009799105,0.00010546826,0.000075474716,0.000053296295,0.00090103416,0.000102561484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04266882,0.0012467856,0.8317033,0.000021110975,0.0075857593,0.0051748184,0.00089208793,0.00052312337,0.002686438,0.0000016003255,0.097270325,0.010225845],"study_design_scores_gemma":[0.14406964,0.00179302,0.7976833,0.0003973027,0.009537241,0.00006871475,0.0007909429,0.0042199614,0.014914054,0.000065181586,0.02604055,0.00042009502],"about_ca_topic_score_codex":0.0012739316,"about_ca_topic_score_gemma":0.00040255615,"teacher_disagreement_score":0.10140083,"about_ca_system_score_codex":0.00053658575,"about_ca_system_score_gemma":0.002319776,"threshold_uncertainty_score":0.9938265},"labels":[],"label_agreement":null},{"id":"W3209090002","doi":"10.1111/bju.15625","title":"Cytoreductive nephrectomy and exposure to sunitinib – a <i>post hoc</i> analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial","year":2021,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Capital District Health Authority; Université de Montréal; Princess Margaret Cancer Centre","funders":"İstanbul Medipol Üniversitesi; Pfizer","keywords":"Sunitinib; Medicine; Sunitinib malate; Post-hoc analysis; Nephrectomy; Dosing; Kidney cancer; Surgery; Population; Confidence interval; Internal medicine; Urology; Cancer; Kidney","score_opus":0.017404203290313638,"score_gpt":0.2504160009173794,"score_spread":0.23301179762706578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209090002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959,0.0022161715,0.000004915602,0.0009791445,0.0002641546,0.00040431487,0.00020242814,0.000003979658,0.0000249069],"genre_scores_gemma":[0.9977296,0.0006239895,0.00022464916,0.0010960877,0.00012345715,0.000053163592,0.000055054836,0.000032536824,0.00006144469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99710053,0.000774653,0.0010330704,0.00028792582,0.0004365251,0.00036727588],"domain_scores_gemma":[0.99651784,0.001430381,0.0006938296,0.00020028566,0.000844205,0.0003134547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006339723,0.0002196844,0.0014405549,0.0006106137,0.00004943844,0.000032685854,0.00007490969,0.00008304348,0.00035833154],"category_scores_gemma":[0.0014794264,0.00015690405,0.000398392,0.0013247931,0.00014677325,0.00012794086,0.00005879618,0.00032829176,5.2932705e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09788577,0.00082819536,0.8715921,0.00011433032,0.003817828,0.012064876,0.0008129448,0.0001379938,0.0002716484,4.2289562e-7,0.0003360516,0.012137809],"study_design_scores_gemma":[0.018054977,0.0017710129,0.97229147,0.0005566932,0.004303476,0.0019281182,0.0002827383,0.0000060893562,0.00048398002,0.0000034596737,0.00015565786,0.00016230058],"about_ca_topic_score_codex":0.0004798773,"about_ca_topic_score_gemma":0.001880996,"teacher_disagreement_score":0.100699365,"about_ca_system_score_codex":0.00010387212,"about_ca_system_score_gemma":0.0013875235,"threshold_uncertainty_score":0.63983613},"labels":[],"label_agreement":null},{"id":"W3209403411","doi":"10.1016/j.euf.2021.10.004","title":"Outcomes of Cytoreductive Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Real World Data from Canadian Centers","year":2021,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier universitaire de Québec; Centre Hospitalier de l’Université de Montréal; University of Calgary; Princess Margaret Cancer Centre; Western University; University of Toronto; Ottawa Hospital; University Health Network; McMaster University; University of Alberta; Queen Elizabeth II Health Sciences Centre; McGill University Health Centre; McGill University; Sunnybrook Health Science Centre; SAIT Polytechnic; BC Cancer Agency; Juravinski Cancer Centre","funders":"EMD Serono; Roche; Eisai; Merck; GlaxoSmithKline; Ipsen; Novartis; Pfizer","keywords":"Medicine; Hazard ratio; Renal cell carcinoma; Cohort; Confidence interval; Internal medicine; Proportional hazards model; Nephrectomy; Propensity score matching; Kidney cancer; Urology; Oncology; Surgery; Kidney","score_opus":0.030966103431821997,"score_gpt":0.25301267894610585,"score_spread":0.22204657551428386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209403411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98188585,0.0002471642,0.000050944054,0.0007650439,0.00016863339,0.000572148,0.001374298,0.000020880367,0.014915059],"genre_scores_gemma":[0.9919544,0.000005213538,0.0044532786,0.00028286217,0.00007935981,0.000011053945,0.0024461974,0.00007284069,0.0006948075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803925,0.00031701438,0.00035046277,0.0006534506,0.00021086136,0.00042895743],"domain_scores_gemma":[0.9979868,0.00021803421,0.00019779896,0.0010408104,0.0002150123,0.0003415692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014184651,0.0002623839,0.0005648254,0.00020746764,0.00007079872,0.000011120661,0.00026891252,0.000023032982,0.00009005019],"category_scores_gemma":[0.000077877594,0.00020283433,0.000100080884,0.00021012021,0.00017588082,0.00007145634,0.00013782429,0.00017264325,0.0000370491],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012108132,0.00045040873,0.9919387,0.000023915854,0.00061784044,0.0014497528,0.00025326875,0.000005755197,0.00036278766,0.000030368305,0.0026981465,0.00095820695],"study_design_scores_gemma":[0.006128772,0.0012498847,0.98379457,0.000009471669,0.001120731,0.000013448038,0.00008393934,0.000017342833,0.0024431543,0.000019833113,0.0049545495,0.00016429096],"about_ca_topic_score_codex":0.025199834,"about_ca_topic_score_gemma":0.06906336,"teacher_disagreement_score":0.043863524,"about_ca_system_score_codex":0.00015360638,"about_ca_system_score_gemma":0.00040126097,"threshold_uncertainty_score":0.9812915},"labels":[],"label_agreement":null},{"id":"W3209684373","doi":"10.1186/s12301-021-00250-x","title":"Endoscopic ultrasound-guided trans-duodenal fine-needle biopsy of a small renal mass: case report and review of the literature","year":2021,"lang":"en","type":"article","venue":"African Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Biopsy; Hilum (anatomy); Radiology; Percutaneous; Duodenum; Renal hilum; Renal mass; Endoscopic ultrasound; Surgery; Kidney; Nephrectomy; Internal medicine","score_opus":0.021883432718260654,"score_gpt":0.26065056689066146,"score_spread":0.2387671341724008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209684373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9027229,0.09163777,0.000111503425,0.0043133525,0.00014262128,0.00019363145,0.0000195525,0.0000029843584,0.0008557138],"genre_scores_gemma":[0.99264616,0.0038026806,0.0027877393,0.0003933197,0.00010464448,0.000003397533,0.000006811436,0.000014819661,0.00024040633],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99800885,0.00030913064,0.0010260874,0.00018904742,0.000275829,0.00019105969],"domain_scores_gemma":[0.99767804,0.00027142838,0.0008529352,0.00040233936,0.00064459635,0.00015064572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005340935,0.00016928476,0.0008055183,0.00011665337,0.00003100293,0.000006154348,0.00011140209,0.000097463446,0.00011201744],"category_scores_gemma":[0.0006781027,0.00010262265,0.00033106955,0.00041463334,0.0002011586,0.0000342797,0.000025081019,0.0003899308,2.9233206e-7],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006168898,0.00055324525,0.042789467,0.005021273,0.0013766454,0.57417125,0.0025699812,0.000014758927,0.3698051,0.00015864728,0.0018958652,0.0010268826],"study_design_scores_gemma":[0.0016970683,0.0012507712,0.008855674,0.0023465895,0.0012013438,0.9540972,0.00013991952,0.0000021587762,0.029262628,0.00015045167,0.0009287945,0.000067412],"about_ca_topic_score_codex":0.000016675014,"about_ca_topic_score_gemma":0.000010149443,"teacher_disagreement_score":0.37992594,"about_ca_system_score_codex":0.000040131443,"about_ca_system_score_gemma":0.00045509494,"threshold_uncertainty_score":0.41848302},"labels":[],"label_agreement":null},{"id":"W3211458171","doi":"10.1158/1078-0432.ccr-21-1688","title":"Association of Neutrophil-to-Lymphocyte Ratio with Efficacy of First-Line Avelumab plus Axitinib vs. Sunitinib in Patients with Advanced Renal Cell Carcinoma Enrolled in the Phase 3 JAVELIN Renal 101 Trial","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"National Cancer Institute; Merck KGaA; Pfizer","keywords":"Medicine; Avelumab; Axitinib; Sunitinib; Internal medicine; Renal cell carcinoma; Renal carcinoma; Oncology; Lymphocyte; Gastroenterology; Urology; Nivolumab; Immunotherapy; Cancer","score_opus":0.08944128772444122,"score_gpt":0.41519119164430157,"score_spread":0.32574990391986036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211458171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993577,0.0002791127,0.00001676953,0.0017086288,0.000093159186,0.0036191936,0.00010904753,0.000009090776,0.00058802095],"genre_scores_gemma":[0.9977685,0.00017630434,0.00028792172,0.00014519368,0.00030571246,0.00045019572,0.00025305868,0.000049091715,0.0005640134],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9929807,0.0016705333,0.0016743621,0.0007593253,0.0022109053,0.0007041346],"domain_scores_gemma":[0.99312174,0.0035765425,0.0005325777,0.00081929436,0.0016685679,0.00028124824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033848258,0.00029523697,0.0012516053,0.00037924797,0.00009180331,0.00002725523,0.00033458316,0.00022712366,0.00025108084],"category_scores_gemma":[0.0021056822,0.00019297704,0.00021466146,0.0016877732,0.00025088975,0.00008448223,0.00013362287,0.0011155485,0.00001092012],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7583847,0.010353884,0.21747263,0.00028690355,0.0002122183,0.0006226594,0.0013589481,0.002078324,0.00075061416,0.000009628455,0.00043079647,0.008038707],"study_design_scores_gemma":[0.49512008,0.030021923,0.45711637,0.0005917052,0.00017224601,0.0000035624996,0.00022085688,0.00029897326,0.01565356,0.000008211687,0.00057402067,0.00021849675],"about_ca_topic_score_codex":0.000683866,"about_ca_topic_score_gemma":0.0016802668,"teacher_disagreement_score":0.26326463,"about_ca_system_score_codex":0.0012802839,"about_ca_system_score_gemma":0.0031769532,"threshold_uncertainty_score":0.78693753},"labels":[],"label_agreement":null},{"id":"W3211938324","doi":"10.1016/j.eururo.2021.10.001","title":"First-line Nivolumab plus Ipilimumab Versus Sunitinib in Patients Without Nephrectomy and With an Evaluable Primary Renal Tumor in the CheckMate 214 Trial","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"University of Texas MD Anderson Cancer Center; Bristol-Myers Squibb; Ono Pharmaceutical; National Cancer Institute; National Institutes of Health; Memorial Sloan-Kettering Cancer Center; European Society for Medical Oncology","keywords":"Medicine; Nivolumab; Sunitinib; Ipilimumab; Nephrectomy; Urology; Internal medicine; Second line; Kidney cancer; Renal cell carcinoma; Oncology; First line; Surgery; Kidney; Immunotherapy; Cancer","score_opus":0.03503532779758081,"score_gpt":0.26541876185246216,"score_spread":0.23038343405488135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211938324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980426,0.0002948946,0.0000042069173,0.00045856604,0.00015691099,0.0009246746,0.00000664322,0.000032788612,0.017695291],"genre_scores_gemma":[0.99789494,0.000029780747,0.00034138816,0.0010036625,0.00019659498,0.0000363082,0.00018478534,0.000056216548,0.00025631822],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9970987,0.0012275152,0.0004007543,0.00053022575,0.0003263353,0.00041649892],"domain_scores_gemma":[0.99892545,0.0002011477,0.000121196616,0.0005334275,0.000098064425,0.000120700985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007155209,0.00025476352,0.00047335782,0.00014339441,0.0000739442,0.000029805758,0.00014962017,0.000048627582,0.000085073305],"category_scores_gemma":[0.00017452771,0.00017592472,0.000045250064,0.0002910032,0.00014406846,0.00008714921,0.00011224843,0.0004164506,0.000033352953],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.784222,0.0036704012,0.1830577,0.00018177515,0.0002571683,0.01680667,0.004037666,0.00066228764,0.00034493196,0.00007186512,0.00032635918,0.00636118],"study_design_scores_gemma":[0.31721655,0.019443108,0.6559257,0.00005654362,0.000256594,0.0003802829,0.00016175755,0.00048387394,0.00010946123,0.000015400476,0.0056983936,0.00025234243],"about_ca_topic_score_codex":0.00008494702,"about_ca_topic_score_gemma":0.00054704264,"teacher_disagreement_score":0.472868,"about_ca_system_score_codex":0.00016272512,"about_ca_system_score_gemma":0.00023441331,"threshold_uncertainty_score":0.7174002},"labels":[],"label_agreement":null},{"id":"W3212351387","doi":"10.1001/jamaoncol.2021.4337","title":"Treatment Selection in First-line Metastatic Renal Cell Carcinoma—The Contemporary Treatment Paradigm in the Age of Combination Therapy","year":2021,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Clear cell renal cell carcinoma; Internal medicine; Targeted therapy; Immune checkpoint; Blockade; Biomarker; Immunotherapy; Cancer; Receptor","score_opus":0.14141519839767608,"score_gpt":0.3723387328481768,"score_spread":0.23092353445050073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212351387","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028264329,0.9615571,0.000006754947,0.0018115998,0.00013028391,0.005457582,0.000035701618,0.000014408388,0.0027222363],"genre_scores_gemma":[0.15859301,0.8371383,0.00007826799,0.00014363088,0.00012136236,0.002191394,0.0010943675,0.000050435832,0.0005892613],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949685,0.0023941817,0.0013226476,0.0005977512,0.0003410013,0.00037593648],"domain_scores_gemma":[0.9967977,0.001803089,0.00071101665,0.00054783304,0.000071056886,0.000069307236],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006216821,0.0006530584,0.0030992222,0.00044901835,0.00007420346,0.00002533315,0.0002142315,0.00038741663,0.000056365046],"category_scores_gemma":[0.000042051986,0.00031861893,0.0007708483,0.00086221227,0.00013837029,0.000053046013,0.000029113608,0.00046934988,0.000013770915],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059552654,0.010989787,0.0021452107,0.0023557888,0.0008520947,0.0073585487,0.0033208176,0.0000194869,0.000024286712,0.00027844426,0.00046713455,0.97159284],"study_design_scores_gemma":[0.013082867,0.018301297,0.004435483,0.0011569428,0.0016678219,0.0010034299,0.00022401825,0.00003864092,0.00019774261,0.00006155198,0.9595832,0.0002470042],"about_ca_topic_score_codex":0.0024962663,"about_ca_topic_score_gemma":0.0017158398,"teacher_disagreement_score":0.97134584,"about_ca_system_score_codex":0.004157181,"about_ca_system_score_gemma":0.0020866357,"threshold_uncertainty_score":0.99992657},"labels":[],"label_agreement":null},{"id":"W3213101372","doi":"10.1016/j.euf.2021.10.012","title":"Evidence-based Urology: Trustworthy Guidelines","year":2021,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Princess Margaret Cancer Centre; University Health Network; University of Toronto; McMaster University; Impact","funders":"","keywords":"Guideline; Medicine; Trustworthiness; Evidence-based medicine; Evidence-based practice; MEDLINE; Medical education; Alternative medicine; Psychology; Pathology; Political science; Social psychology","score_opus":0.10151176602685846,"score_gpt":0.3061484421431424,"score_spread":0.20463667611628394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213101372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7812272,0.057143968,0.0015043722,0.07730612,0.0008231232,0.0004520975,0.000008940817,0.00040397007,0.08113021],"genre_scores_gemma":[0.9785072,0.00033279555,0.0021141376,0.015617831,0.0006395259,0.0000126695295,0.00003572866,0.000077723365,0.0026623649],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997223,0.0008291093,0.00052409276,0.0006851349,0.00026063935,0.00047800175],"domain_scores_gemma":[0.9979823,0.00030349568,0.00012837638,0.0008976928,0.00043018768,0.0002579228],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005974008,0.00028832033,0.00044835886,0.00013775735,0.00009470021,0.000019279809,0.00017599355,0.000108144115,0.0010373283],"category_scores_gemma":[0.0012559308,0.00024230611,0.00025634942,0.00028053057,0.00018626152,0.00006049217,0.00013323636,0.00035472302,0.0017047848],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058696833,0.0017926906,0.29832175,0.00021310718,0.0013793609,0.18575107,0.00043943583,0.002286964,0.059459593,0.0016383048,0.14294663,0.29990143],"study_design_scores_gemma":[0.008368416,0.005974214,0.4626919,0.00015156674,0.0020115315,0.0061404174,0.000044689525,0.0014738004,0.030654866,0.00037170653,0.4813019,0.0008149947],"about_ca_topic_score_codex":0.000011634471,"about_ca_topic_score_gemma":0.0000118239095,"teacher_disagreement_score":0.33835527,"about_ca_system_score_codex":0.000056544013,"about_ca_system_score_gemma":0.00028974868,"threshold_uncertainty_score":0.99987584},"labels":[],"label_agreement":null},{"id":"W3213465860","doi":"10.1093/neuonc/noab196.468","title":"PATH-16. EVALUATION OF SEX-BASED DIFFERENCES IN CLINICAL OUTCOMES AND TUMOR GENOMICS IN PATIENTS WITH NEWLY DIAGNOSED IDH-WILDTYPE GLIOBLASTOMA RECEIVING CHEMORADIATION","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"CDKN2A; Hazard ratio; CDKN2B; Medicine; Internal medicine; Oncology; Cancer; Exome sequencing; Confidence interval; Biology; Gene; Mutation; Genetics","score_opus":0.037335554312836715,"score_gpt":0.3130729328709455,"score_spread":0.2757373785581088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213465860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99835134,0.000091517024,0.0000068642607,0.0004146071,0.00016401208,0.0008048892,0.0000056339095,0.000011550399,0.00014958504],"genre_scores_gemma":[0.99877286,0.000030492574,0.0005104496,0.00052859384,0.00003236275,0.00006374895,0.000038617247,0.000019527293,0.0000033727617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976915,0.0006880618,0.0006353517,0.00040972317,0.0003745438,0.00020082969],"domain_scores_gemma":[0.997982,0.0011672407,0.00028863142,0.00024123353,0.00022530573,0.00009556011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061894045,0.00016619946,0.00068148697,0.00016993935,0.00001957128,0.000007990659,0.000052245923,0.00012769041,0.000031575702],"category_scores_gemma":[0.0012556862,0.00013515036,0.0000563989,0.00024404716,0.00008305607,0.000050835864,0.00003581344,0.00024157055,0.0000023958378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009045382,0.0010557891,0.965107,0.00004452365,0.000024206136,0.00018768554,0.00027176389,0.0000735938,0.0017781394,0.0000016632384,0.000010403042,0.030540653],"study_design_scores_gemma":[0.01753075,0.0038349857,0.97249293,0.000055387532,0.00014383323,0.000009981958,0.00012347296,0.0020579651,0.0035998248,0.0000199433,0.000032746106,0.000098185075],"about_ca_topic_score_codex":0.00007735224,"about_ca_topic_score_gemma":0.0008838712,"teacher_disagreement_score":0.030442467,"about_ca_system_score_codex":0.0005671896,"about_ca_system_score_gemma":0.0008730799,"threshold_uncertainty_score":0.5511272},"labels":[],"label_agreement":null},{"id":"W3213661748","doi":"10.1172/jci144871","title":"Folliculin impairs breast tumor growth by repressing TFE3-dependent induction of the Warburg effect and angiogenesis","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Investigation","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Fonds de Recherche du Québec - Santé; Terry Fox Research Institute; Canadian Institutes of Health Research; McGill University Health Centre; Genome Canada; Cancer Research Society; Terry Fox Foundation; Deutsches Krebsforschungszentrum; McGill University","keywords":"Folliculin; Warburg effect; Angiogenesis; AMPK; Anaerobic glycolysis; TFE3; Cancer; Suppressor; Tumor progression","score_opus":0.03735209683478685,"score_gpt":0.32401216258102694,"score_spread":0.2866600657462401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213661748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951078,0.0012546325,0.000044304114,0.0029670754,0.00037152818,0.00016901102,0.000004635868,0.0000060106236,0.00007499892],"genre_scores_gemma":[0.99835956,0.000116246076,0.0007856761,0.0002589381,0.00036299165,0.000002428765,0.0000057070324,0.000013725338,0.00009470884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974523,0.00058541965,0.0011607612,0.00018874959,0.00050359825,0.000109137036],"domain_scores_gemma":[0.99756896,0.00045585498,0.0010873133,0.0002151238,0.00043807225,0.00023467958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015856407,0.00012439254,0.00053669896,0.000056443496,0.000055697965,0.000021283977,0.00006544388,0.00011320281,0.000015146244],"category_scores_gemma":[0.0017697959,0.00007410405,0.00037859997,0.00021455469,0.00018662412,0.00014522758,0.000046099587,0.00031450743,0.0000010492683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042134375,0.00021554662,0.8049789,0.0001498382,0.0002985268,0.00012670225,0.000107025306,0.000018900444,0.17890617,0.000013216149,0.0011133417,0.0136505095],"study_design_scores_gemma":[0.0017942227,0.00056461414,0.6315678,0.00033739224,0.00056253216,0.0018774568,0.000048198763,0.00006810282,0.36279663,0.00030409003,0.000025529464,0.000053441465],"about_ca_topic_score_codex":0.000031731557,"about_ca_topic_score_gemma":0.0000019297356,"teacher_disagreement_score":0.18389048,"about_ca_system_score_codex":0.000069737944,"about_ca_system_score_gemma":0.00027781277,"threshold_uncertainty_score":0.30218753},"labels":[],"label_agreement":null},{"id":"W3215107573","doi":"10.3390/curroncol28060421","title":"Addition of Salvage Immunotherapy to Targeted Therapy in Patients with Metastatic Renal Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Salvage therapy; Immunotherapy; Refractory (planetary science); Internal medicine; Oncology; Targeted therapy; Tyrosine-kinase inhibitor; Clinical trial; Systemic therapy; Tyrosine kinase; Surgery; Receptor; Cancer; Chemotherapy","score_opus":0.04882052765683091,"score_gpt":0.32384228268353105,"score_spread":0.2750217550267001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215107573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953174,0.002676004,0.00009393447,0.00018200172,0.00023042716,0.0008029808,0.000051616797,0.000013968539,0.0006316559],"genre_scores_gemma":[0.99729127,0.000106491934,0.001649934,0.00016391849,0.000039269373,0.00010700457,0.0005426515,0.000027499398,0.00007198968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985319,0.00020785475,0.00038258085,0.00032555868,0.00028314508,0.00026899079],"domain_scores_gemma":[0.99902594,0.00008879229,0.00014736404,0.0003270363,0.0002916983,0.00011918873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010839043,0.00019205919,0.0005366005,0.00020258063,0.000021961348,0.0000044104545,0.00006413182,0.000055598233,0.00055079674],"category_scores_gemma":[0.0000233125,0.0001456982,0.00009088701,0.00040215813,0.000051305473,0.00004115765,0.000025390284,0.00018578698,0.000022215063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00610491,0.009516053,0.79709464,0.00018271599,0.00018154898,0.0003881515,0.0019513816,0.000032660984,0.043155394,0.000029235598,0.0020607582,0.13930255],"study_design_scores_gemma":[0.013083163,0.007532787,0.89570403,0.000072390474,0.000062003615,0.000011670957,0.00010191199,0.00000961597,0.07554455,0.00002062864,0.0077222497,0.00013501714],"about_ca_topic_score_codex":0.000024666466,"about_ca_topic_score_gemma":0.000026713918,"teacher_disagreement_score":0.13916753,"about_ca_system_score_codex":0.00038125334,"about_ca_system_score_gemma":0.00038480587,"threshold_uncertainty_score":0.6030838},"labels":[],"label_agreement":null},{"id":"W3215615007","doi":"10.1016/j.anndiagpath.2021.151871","title":"Clear cell renal cell carcinoma with prominent microvascular hyperplasia: Morphologic, immunohistochemical and molecular-genetic analysis of 7 sporadic cases","year":2021,"lang":"en","type":"article","venue":"Annals of Diagnostic Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Royal Columbian Hospital","funders":"Lékařská Fakulta v Plzni, Univerzita Karlova; Fakultní Nemocnice Plzen","keywords":"Immunohistochemistry; Pathology; Clear cell renal cell carcinoma; Renal cell carcinoma; Clear cell; Hyperplasia; Microsatellite instability; Biology; Point mutation; Carcinoma; Mutation; Medicine; Gene; Microsatellite; Genetics","score_opus":0.01984326764377462,"score_gpt":0.2569648281324572,"score_spread":0.23712156048868258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215615007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97048604,0.02835504,0.00009323102,0.00030798354,0.000023530509,0.0003762915,0.000053926808,0.00001262118,0.00029133086],"genre_scores_gemma":[0.99497837,0.0010841619,0.0033651295,0.00025294878,0.00001573845,0.00004316194,0.00018520305,0.000031910327,0.000043405074],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979308,0.0001868434,0.00057739555,0.0006244067,0.0003029101,0.0003775984],"domain_scores_gemma":[0.99772435,0.00065902376,0.00029510126,0.00073455926,0.00038883154,0.0001981533],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016425591,0.00030537014,0.0011608861,0.00031560316,0.000032302607,0.000005590552,0.000111644586,0.0001881423,0.000105844796],"category_scores_gemma":[0.00046017164,0.0002512035,0.00037649562,0.00058666675,0.00037866592,0.000022632068,0.00010958741,0.00018835356,0.000005015001],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003964904,0.00087954453,0.15905142,0.00027816693,0.00066193193,0.044321653,0.00019024662,0.00008233918,0.7937436,0.000008234063,0.00010289941,0.00028348065],"study_design_scores_gemma":[0.0012350192,0.0023043368,0.30059767,0.000049068538,0.00373879,0.0031875288,0.00010859279,0.000024929333,0.68856627,0.000011986464,0.000027441225,0.00014833697],"about_ca_topic_score_codex":0.000117160875,"about_ca_topic_score_gemma":0.000009456988,"teacher_disagreement_score":0.14154626,"about_ca_system_score_codex":0.000030875002,"about_ca_system_score_gemma":0.00019274917,"threshold_uncertainty_score":0.99999404},"labels":[],"label_agreement":null},{"id":"W3215838825","doi":"10.5489/cuaj.7451","title":"Treatment on active surveillance of small renal masses: Progression vs. preference","year":2021,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Cohort; Renal cell carcinoma; Biopsy; Retrospective cohort study; Internal medicine; Surgery","score_opus":0.03998052001414359,"score_gpt":0.2603334832369994,"score_spread":0.2203529632228558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215838825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829135,0.0002562385,0.000017814442,0.00973657,0.00014384098,0.00022492904,0.0000542482,0.000013927359,0.0066389134],"genre_scores_gemma":[0.9973613,0.00018234007,0.0006743945,0.0005451773,0.0001852695,0.00001581999,0.000059621525,0.000010456371,0.0009655897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983896,0.00029056214,0.00032210763,0.0002475566,0.00037305983,0.00037710788],"domain_scores_gemma":[0.99824667,0.0002154195,0.00033024332,0.00015765184,0.00045619183,0.0005938152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002112662,0.00016473258,0.00038510654,0.00011162431,0.00012618002,0.000034153236,0.00006815319,0.000199437,0.00041218146],"category_scores_gemma":[0.00055508805,0.00011355636,0.00017869865,0.00019407683,0.000026072837,0.000035119796,0.000011046966,0.00032590196,0.000026998083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006261955,0.00040600274,0.96932125,0.000009756392,0.00033531044,0.0013520336,0.0001662685,0.000055791003,0.0016821024,0.00014095759,0.0007619257,0.025142422],"study_design_scores_gemma":[0.0017894405,0.003155868,0.96509105,0.00004595763,0.00008086484,0.00038102863,0.000049181,0.000047275167,0.009440928,0.0001772138,0.019631865,0.00010933592],"about_ca_topic_score_codex":0.00037004193,"about_ca_topic_score_gemma":0.001215769,"teacher_disagreement_score":0.025033085,"about_ca_system_score_codex":0.0026812644,"about_ca_system_score_gemma":0.0012670567,"threshold_uncertainty_score":0.7011413},"labels":[],"label_agreement":null},{"id":"W3216790136","doi":"10.1016/j.ajur.2021.11.010","title":"Chromophobe renal cell carcinoma: Novel molecular insights and clinicopathologic updates","year":2021,"lang":"en","type":"review","venue":"Asian journal of urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Royal Columbian Hospital","funders":"","keywords":"Eosinophilic; Pathology; Chromophobe cell; CD117; Oncocytoma; Renal cell carcinoma; Medicine; Clear cell; PTEN; BAP1; Renal oncocytoma; Cancer research; Biology; PI3K/AKT/mTOR pathway; Genetics; Stem cell; CD34","score_opus":0.03680892610808422,"score_gpt":0.3057312500093859,"score_spread":0.26892232390130166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216790136","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009524286,0.987077,0.00009457664,0.00034792337,0.00041957674,0.0003883619,0.000011081368,0.000009501111,0.0021276984],"genre_scores_gemma":[0.040077966,0.9569357,0.0019814721,0.0002966615,0.00044143386,0.000010839855,0.000064606415,0.0000822655,0.00010902493],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965615,0.00056065,0.0015649458,0.00055148714,0.0003399868,0.00042137835],"domain_scores_gemma":[0.9970978,0.00017880647,0.0014666013,0.0005324157,0.0002828447,0.0004415221],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044060926,0.00061282085,0.0037385414,0.00053832895,0.00005479691,0.00002746392,0.0002675828,0.00069894356,0.00010439747],"category_scores_gemma":[0.00014085672,0.0004196622,0.0010752471,0.00029144713,0.00022811927,0.0000690488,0.00016248734,0.0014198327,0.000028892666],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034293844,0.0019302444,0.00044333359,0.011953383,0.0017715327,0.2396393,0.00047256067,0.0000021635187,0.0016883544,0.00038900637,0.0012779922,0.7400892],"study_design_scores_gemma":[0.0030862791,0.006836132,0.0004954077,0.002093939,0.010021417,0.12710463,0.00006059063,0.0000015600408,0.00029681006,0.00007286652,0.84947884,0.00045153234],"about_ca_topic_score_codex":0.0000015081151,"about_ca_topic_score_gemma":7.4455284e-7,"teacher_disagreement_score":0.84820086,"about_ca_system_score_codex":0.00014202684,"about_ca_system_score_gemma":0.0010597187,"threshold_uncertainty_score":0.99982554},"labels":[],"label_agreement":null},{"id":"W3217071392","doi":"10.1148/radiol.2021204227","title":"Active Surveillance of Renal Masses: The Role of Radiology","year":2021,"lang":"en","type":"review","venue":"Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Women's College Hospital; University of Toronto; University Health Network; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Radiology; Malignancy; Percutaneous; Biopsy; Cancer; Kidney cancer; Intensive care medicine; Pathology; Internal medicine","score_opus":0.03527027507633031,"score_gpt":0.31894711088017835,"score_spread":0.28367683580384806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217071392","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007597371,0.9932473,0.0000126796385,0.000048118436,0.00020704896,0.00079296535,0.000098471726,0.000012198147,0.0048215175],"genre_scores_gemma":[0.0031745404,0.99553853,0.00021189533,0.000024858438,0.00026780827,0.000102770064,0.00038168606,0.000042269283,0.00025564648],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969637,0.0012418872,0.00084239413,0.00047196838,0.00015581642,0.00032423253],"domain_scores_gemma":[0.99667406,0.0014008404,0.00079249265,0.0009011542,0.00015322129,0.00007822174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037787357,0.000377959,0.0041478765,0.00015763051,0.000026319109,0.0000017083291,0.0002894344,0.00052526215,0.00019593051],"category_scores_gemma":[0.00026256865,0.00021499272,0.00086498866,0.0003055524,0.00046821308,0.0000115502135,0.00010150419,0.00048703066,0.000014319895],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019733649,0.00021467486,0.0015722779,0.007054063,0.0046477406,0.00043540818,0.00018636837,0.0000032212868,0.00032084156,0.0023883006,0.0015017325,0.98147804],"study_design_scores_gemma":[0.00046796704,0.0007360589,0.0008871593,0.0018383069,0.0013914356,0.007827374,0.00007029907,0.000002272048,0.00030348572,0.000071543545,0.9862426,0.00016148946],"about_ca_topic_score_codex":0.000039182418,"about_ca_topic_score_gemma":0.000005595689,"teacher_disagreement_score":0.98474085,"about_ca_system_score_codex":0.00020098682,"about_ca_system_score_gemma":0.0008066638,"threshold_uncertainty_score":0.8767149},"labels":[],"label_agreement":null},{"id":"W3217307305","doi":"10.3390/cancers13235906","title":"Mutation Profile Variability in the Primary Tumor and Multiple Pulmonary Metastases of Clear Cell Renal Cell Carcinoma. A Review of the Literature and Analysis of Four Metastatic Cases","year":2021,"lang":"en","type":"review","venue":"Cancers","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Renal cell carcinoma; Clear cell renal cell carcinoma; Primary tumor; Metastasis; Oncology; Mutation; Immunohistochemistry; Internal medicine; Cell; Pathology; Genetic heterogeneity; Cancer; Gene; Phenotype; Biology","score_opus":0.03840666203221902,"score_gpt":0.2961032580896944,"score_spread":0.25769659605747536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217307305","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036222383,0.9601746,0.0000021672327,0.000017716513,0.000023703895,0.0021448596,0.0012326661,0.0000023743708,0.00017951011],"genre_scores_gemma":[0.10211519,0.8963717,0.0005032454,0.00007031913,0.000012710036,0.00014339162,0.000730802,0.000021102336,0.000031540978],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9964256,0.0015609766,0.0009897436,0.00045316725,0.00041086384,0.00015963726],"domain_scores_gemma":[0.99657685,0.0014018638,0.0010044333,0.00073036243,0.00022401052,0.000062507665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011359209,0.0003364147,0.0027388453,0.00023774125,0.000029215042,0.000008936503,0.00015085046,0.000068376954,0.000037606715],"category_scores_gemma":[0.00042017864,0.00017643324,0.0007119742,0.0017935593,0.00020227222,0.000046348297,0.000085964915,0.00029759173,1.05093186e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016399677,0.0003210137,0.0022449472,0.8977558,0.0017536321,0.0012002676,0.0010318053,0.000026745049,0.00019666241,0.000005318915,0.00021411678,0.095085695],"study_design_scores_gemma":[0.0045871865,0.002738484,0.036457643,0.49085432,0.39974687,0.0039807977,0.0024890238,0.0009890747,0.005657235,0.000034219207,0.050839476,0.0016256736],"about_ca_topic_score_codex":0.00044563867,"about_ca_topic_score_gemma":0.000028273209,"teacher_disagreement_score":0.40690148,"about_ca_system_score_codex":0.00040217277,"about_ca_system_score_gemma":0.0012789968,"threshold_uncertainty_score":0.7194739},"labels":[],"label_agreement":null},{"id":"W3217344408","doi":"10.1016/j.eururo.2021.11.002","title":"A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Interquartile range; Logistic regression; Nephrectomy; Cohort; Body mass index; Renal function; Internal medicine; Referral; Surgery; Kidney","score_opus":0.10098861138534833,"score_gpt":0.38487766565775544,"score_spread":0.2838890542724071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217344408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711349,0.00005968703,0.025731863,0.0004925027,0.00029426083,0.0008595586,0.00037430608,0.00007944231,0.00097349845],"genre_scores_gemma":[0.8887693,0.00004186582,0.10529704,0.001162531,0.00047110493,0.00003881422,0.0035718181,0.000047283724,0.0006002201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99538684,0.001151335,0.0013535648,0.0013078606,0.0003940476,0.00040635891],"domain_scores_gemma":[0.99642426,0.001659757,0.00033432644,0.0005522546,0.00054345623,0.0004859753],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010233046,0.00035606383,0.0010439554,0.00021933256,0.00017932201,0.00003174001,0.00012333627,0.00014647508,0.0002308941],"category_scores_gemma":[0.0016841108,0.00024877005,0.00073976157,0.0004924613,0.0001821663,0.000043942473,0.000096684016,0.0002725176,0.00023093507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029520558,0.00355106,0.9439931,0.0000047281624,0.0028958058,0.0008273565,0.00020177153,0.00045830038,0.000053169475,0.000013502795,0.00071051857,0.017770126],"study_design_scores_gemma":[0.03801298,0.014033353,0.8585795,0.000023175973,0.0038941912,0.000050596693,0.000027929684,0.0018065367,0.000053738095,0.0000039183305,0.08330227,0.00021179813],"about_ca_topic_score_codex":0.00008413044,"about_ca_topic_score_gemma":0.0003732543,"teacher_disagreement_score":0.08541359,"about_ca_system_score_codex":0.00023156578,"about_ca_system_score_gemma":0.00043386247,"threshold_uncertainty_score":0.9999965},"labels":[],"label_agreement":null},{"id":"W4200056752","doi":"10.1016/j.ijsu.2021.106194","title":"Ablative therapies versus partial nephrectomy for small renal masses – A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"International Journal of Surgery","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Nephrectomy; Ablative case; Renal mass; Meta-analysis; Urology; Surgery; Internal medicine; Kidney; Radiation therapy","score_opus":0.3217989155909651,"score_gpt":0.4107811402190935,"score_spread":0.08898222462812844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200056752","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012301935,0.99726003,0.00022799743,0.0007029684,0.00038561886,0.0012410883,0.0001176579,0.0000073148335,0.000045046807],"genre_scores_gemma":[0.000050572835,0.99713635,0.0012392955,0.00022031945,0.00031030903,0.00042539102,0.00016798689,0.000040811166,0.00040896155],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99600255,0.0005173766,0.0022051965,0.00031104128,0.0007731032,0.00019075157],"domain_scores_gemma":[0.9908174,0.0045651835,0.0027469262,0.00027862252,0.0014245298,0.00016729855],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015049488,0.00046446148,0.010206196,0.00085992157,0.00003209404,0.00009956859,0.00021514783,0.0001342084,0.00034713643],"category_scores_gemma":[0.001149616,0.00027009516,0.009244626,0.00039818318,0.000071133625,0.00011095484,0.0000550375,0.00028988096,0.0000040830223],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013312191,0.00010799541,0.000010870462,0.22970118,0.76425326,0.00087772514,0.000027456796,8.5075146e-7,1.7518909e-7,0.00004695415,0.00054124475,0.004299148],"study_design_scores_gemma":[0.0003191182,0.000082673476,0.0000020143614,0.05297874,0.80447185,0.001121713,0.000024551136,0.000001209753,0.0000043395235,0.000006942472,0.1408169,0.00016994936],"about_ca_topic_score_codex":0.000010859254,"about_ca_topic_score_gemma":0.000005261502,"teacher_disagreement_score":0.17672244,"about_ca_system_score_codex":0.00028272564,"about_ca_system_score_gemma":0.0006925699,"threshold_uncertainty_score":0.99997514},"labels":[],"label_agreement":null},{"id":"W4200082979","doi":"10.1038/s41379-021-00998-1","title":"Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients","year":2021,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McGill University; Calgary Laboratory Services; McMaster University","funders":"","keywords":"Pathology; Renal cell carcinoma; SDHB; Eosinophilic; Immunohistochemistry; SDHA; Grading (engineering); Medicine; Clear cell; Biology; Succinate dehydrogenase; Germline mutation; Mutation","score_opus":0.030695010180928732,"score_gpt":0.2649943465478186,"score_spread":0.23429933636688988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200082979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969681,0.0004035067,0.0002785144,0.00025244168,0.00007525513,0.0011478855,0.00001910245,0.000026040585,0.0008291555],"genre_scores_gemma":[0.9992912,0.000011790491,0.00034757447,0.00009799009,0.000024507654,0.00007000597,0.000019301326,0.000039730516,0.00009789396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99667674,0.00059883966,0.00086665404,0.0008256154,0.00050367264,0.0005284762],"domain_scores_gemma":[0.9980885,0.00027499328,0.00041433063,0.0009647189,0.00012408663,0.00013338482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048307845,0.0003538146,0.0010028325,0.00024016146,0.000060702212,0.000008054326,0.00022509562,0.00015733796,0.00006738591],"category_scores_gemma":[0.0001501208,0.00021189798,0.00016376725,0.00043068876,0.00016663891,0.000028361977,0.00021622295,0.0004428817,0.000009512247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034835897,0.01001459,0.9025387,0.00007897995,0.000048730708,0.04235245,0.0071947523,0.0014476249,0.031618856,0.000065088825,0.000019332705,0.0011372762],"study_design_scores_gemma":[0.011003407,0.020658528,0.82659113,0.000096796175,0.00023592933,0.001157553,0.0017769098,0.00023646836,0.13755469,0.00047901538,0.000001471381,0.00020809543],"about_ca_topic_score_codex":0.0002710311,"about_ca_topic_score_gemma":0.0002406568,"teacher_disagreement_score":0.105935834,"about_ca_system_score_codex":0.00020811273,"about_ca_system_score_gemma":0.00028509,"threshold_uncertainty_score":0.86409485},"labels":[],"label_agreement":null},{"id":"W4200092447","doi":"10.3233/kca-210117","title":"Extended Disease Control with Unconventional Cabozantinib Dose Increase in Metastatic Renal Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"Kidney Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute; Exelixis; University of Texas Southwestern Medical Center; Burroughs Wellcome Fund","keywords":"Cabozantinib; Medicine; Disease; Renal cell carcinoma; Cancer research; Oncology; Internal medicine; Urology; Pharmacology","score_opus":0.015818733380308158,"score_gpt":0.2664854274567906,"score_spread":0.25066669407648245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200092447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987016,0.0051562646,0.00007175124,0.0029551755,0.00014285854,0.00069416955,0.00043004507,0.000034913573,0.0034988027],"genre_scores_gemma":[0.99089575,0.000072658906,0.00065981835,0.0027764805,0.00015309885,0.00037559576,0.0003431472,0.000045808603,0.004677621],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796414,0.00015990404,0.00035491833,0.00055540126,0.0005415254,0.00042409461],"domain_scores_gemma":[0.99801576,0.00007310572,0.00011505414,0.00044909568,0.00022981215,0.0011171693],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013670775,0.00028995983,0.00048953533,0.00013702705,0.000054640015,0.000026892232,0.00007401865,0.000041776275,0.0025778562],"category_scores_gemma":[0.00012225274,0.00022525329,0.0001695203,0.00037206567,0.00009317508,0.0000968413,0.000033764645,0.00022268742,0.000044136123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012643065,0.003373244,0.88971245,0.0012294787,0.00063175504,0.044089854,0.00034428766,0.00023453424,0.033240486,0.0003744967,0.011862108,0.002264265],"study_design_scores_gemma":[0.03000542,0.00034283087,0.9389495,0.0004601667,0.0013193998,0.00018766109,0.00009634701,0.0005268139,0.022179473,0.00013179137,0.0054346537,0.00036590293],"about_ca_topic_score_codex":0.0010379851,"about_ca_topic_score_gemma":0.00022883354,"teacher_disagreement_score":0.049237113,"about_ca_system_score_codex":0.0003592216,"about_ca_system_score_gemma":0.004082616,"threshold_uncertainty_score":0.99833393},"labels":[],"label_agreement":null},{"id":"W4200093953","doi":"10.1111/bju.15673","title":"Risk models for recurrence and survival after kidney cancer: a systematic review","year":2021,"lang":"en","type":"review","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NIHR Cambridge Biomedical Research Centre; Medical Research Council; Medical Research Council Canada; Mark Foundation For Cancer Research; National Institute for Health and Care Research; Cancer Research UK; University of Cambridge; Department of Health and Social Care","keywords":"Medicine; Statistic; Discriminative model; Oncology; Internal medicine; Logistic regression; Meta-analysis; Renal cell carcinoma; Stage (stratigraphy); Statistics; Surgery; Artificial intelligence; Computer science; Mathematics; Biology","score_opus":0.04641859183785434,"score_gpt":0.3280573704383553,"score_spread":0.28163877860050096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200093953","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011291556,0.9963645,0.00024013073,0.0001929215,0.00050566805,0.0022928854,0.00034432832,0.000005589506,0.000042684896],"genre_scores_gemma":[0.000030449193,0.99788976,0.00041858893,0.0005619445,0.0003028995,0.0005647294,0.000043635253,0.00005599702,0.00013199626],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9963766,0.0009430339,0.0016999128,0.00036109707,0.00031224103,0.00030712],"domain_scores_gemma":[0.9965064,0.0004894639,0.0017449374,0.00028212465,0.0005670268,0.00041007972],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001221152,0.00034910272,0.0062259673,0.00013171333,0.000045033285,0.00003723207,0.0001677303,0.00026970994,0.00006540228],"category_scores_gemma":[0.0015105072,0.00028763086,0.0011051529,0.00015649725,0.00007558589,0.00007003571,0.000062745996,0.0007324405,0.0000026539678],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026156586,0.0000611971,0.000008972812,0.7775481,0.0011261876,0.0035703366,0.000008517482,3.685501e-7,1.1546433e-8,0.0000057570137,0.001733155,0.21591124],"study_design_scores_gemma":[0.0006536555,0.0005048205,0.000005386485,0.73702025,0.034747865,0.075272456,0.00000305504,0.000007767979,3.8175457e-8,0.000042617994,0.15156923,0.00017282674],"about_ca_topic_score_codex":0.00005078992,"about_ca_topic_score_gemma":0.000020788126,"teacher_disagreement_score":0.21573842,"about_ca_system_score_codex":0.0001663495,"about_ca_system_score_gemma":0.0011560185,"threshold_uncertainty_score":0.99995756},"labels":[],"label_agreement":null},{"id":"W4200211852","doi":"10.1177/01455613211065512","title":"Metastatic Clear Renal-Cell Carcinoma Mimicking Anaplastic Thyroid Cancer: A Case Report","year":2021,"lang":"en","type":"article","venue":"Ear Nose & Throat Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Differential diagnosis; Nephrectomy; Thyroid; Pathology; Thyroid cancer; Thyroid carcinoma; Kidney cancer; Kidney; Internal medicine","score_opus":0.036025820343142036,"score_gpt":0.2950426458924142,"score_spread":0.25901682554927213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200211852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819561,0.0127306925,0.00029391472,0.0010264592,0.00065772264,0.00027395858,0.00001606252,0.000046399105,0.0029986838],"genre_scores_gemma":[0.99048287,0.00054354285,0.0043963594,0.00037468068,0.0007739329,0.000015263515,0.000027111233,0.000092007336,0.0032942337],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9969217,0.00024149196,0.0008330446,0.0005577264,0.0007719806,0.000674065],"domain_scores_gemma":[0.9976132,0.00014405715,0.00045808253,0.00064368686,0.00047108976,0.0006698921],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047448717,0.00039283492,0.00071915967,0.00021215761,0.00040187725,0.00014787547,0.00011656079,0.000092461574,0.0014229495],"category_scores_gemma":[0.00020453926,0.00032380302,0.0004561161,0.00042338215,0.00009664854,0.0001863246,0.00010425787,0.0008938829,0.00013967746],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037802875,0.0003892982,0.009269053,0.00012737213,0.00035596025,0.9522835,0.00087858475,0.00016605726,0.030014658,0.000008102733,0.004217956,0.0019114268],"study_design_scores_gemma":[0.0036786515,0.0012571502,0.013834127,0.0003112034,0.0014342127,0.9051417,0.0010604757,0.0002158097,0.06942172,0.000055483768,0.0032513225,0.00033813692],"about_ca_topic_score_codex":0.00029867355,"about_ca_topic_score_gemma":0.00019383125,"teacher_disagreement_score":0.047141794,"about_ca_system_score_codex":0.0006172148,"about_ca_system_score_gemma":0.0012157301,"threshold_uncertainty_score":0.9999214},"labels":[],"label_agreement":null},{"id":"W4200262376","doi":"10.1016/j.clgc.2021.12.003","title":"Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients","year":2021,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; McMaster University; University of Ottawa; Centre Hospitalier de l’Université de Montréal; CancerCare Manitoba; Ottawa Hospital; Princess Margaret Cancer Centre; BC Cancer Agency; Foothills Medical Centre; University of British Columbia; Juravinski Cancer Centre; Jewish General Hospital; Sunnybrook Health Science Centre; Alberta Cancer Foundation; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Ipilimumab; Nivolumab; Medicine; Discontinuation; Renal cell carcinoma; Internal medicine; Cohort; Oncology; Kidney cancer; Adverse effect; Expanded access; Cancer; Surgery; Immunotherapy","score_opus":0.07943066627634919,"score_gpt":0.3662064179276324,"score_spread":0.2867757516512832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200262376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921693,0.0029224486,0.000011879281,0.000077318655,0.00020022805,0.0006516254,0.0000648199,0.000010012281,0.0038923423],"genre_scores_gemma":[0.99450487,0.003027885,0.00077905314,0.00006874445,0.00008938957,0.000043431966,0.00012525487,0.000028676357,0.0013326887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973756,0.0002762082,0.0012579222,0.00047744185,0.0003782887,0.00023454452],"domain_scores_gemma":[0.99834645,0.00031294662,0.00035592282,0.00043531766,0.00036503386,0.0001843289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031657532,0.000198086,0.00089626276,0.00014568729,0.000027056476,0.000003847556,0.000073249816,0.000090828114,0.00020917755],"category_scores_gemma":[0.00012171767,0.00017897473,0.00019780498,0.00044366595,0.000183774,0.000056872068,0.00012328521,0.00023358094,0.0000026864184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027745573,0.001230599,0.98425895,0.0005076739,0.00012203287,0.0003219779,0.00013854152,0.000056111858,0.00054094644,0.000007036935,0.0002620916,0.009779453],"study_design_scores_gemma":[0.009577626,0.0012811226,0.97503996,0.00021745922,0.0004714035,0.000009515131,0.000082009516,0.0003083897,0.012554868,0.000028922996,0.0002971921,0.00013152356],"about_ca_topic_score_codex":0.0006495464,"about_ca_topic_score_gemma":0.00041483113,"teacher_disagreement_score":0.012013922,"about_ca_system_score_codex":0.0002972783,"about_ca_system_score_gemma":0.0007370424,"threshold_uncertainty_score":0.7298378},"labels":[],"label_agreement":null},{"id":"W4200437646","doi":"10.1158/1078-0432.ccr-21-3238","title":"From Basic Science to Clinical Translation in Kidney Cancer: A Report from the Second Kidney Cancer Research Summit","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Summit; Kidney cancer; Renal cell carcinoma; Translational research; Kidney; Basic research; Cancer; Kidney disease","score_opus":0.42649645808653047,"score_gpt":0.5751800096660913,"score_spread":0.1486835515795608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200437646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8901672,0.0072265337,0.000009232972,0.09449675,0.0018756512,0.0019002513,0.0008613647,0.00004058237,0.0034224761],"genre_scores_gemma":[0.96919364,0.0059070135,0.00058165507,0.0070773256,0.0060951672,0.0017178096,0.00023219705,0.000098885015,0.009096311],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9850206,0.003401425,0.0023604042,0.0028100805,0.004606107,0.0018014113],"domain_scores_gemma":[0.98017216,0.010225215,0.00022180157,0.0027360306,0.003299147,0.003345629],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.022728888,0.00036085575,0.0011855947,0.00043648685,0.0005867252,0.00027580257,0.0012123197,0.0004855701,0.012844557],"category_scores_gemma":[0.021491032,0.00026535173,0.0004410901,0.0046637547,0.0026921255,0.00025447956,0.00076919585,0.004750091,0.00041974726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028241307,0.00080155465,0.7577235,0.00009862208,0.0002462731,0.0027634788,0.000965227,0.00001168521,0.007769322,0.000014358653,0.1697275,0.057054326],"study_design_scores_gemma":[0.0053163515,0.0006216696,0.64602286,0.0018571329,0.00011299915,0.0000114053055,0.0006777828,0.0002620322,0.01840308,0.00072403695,0.3256543,0.0003363446],"about_ca_topic_score_codex":0.066711314,"about_ca_topic_score_gemma":0.043774746,"teacher_disagreement_score":0.15592678,"about_ca_system_score_codex":0.0022063237,"about_ca_system_score_gemma":0.031690277,"threshold_uncertainty_score":0.99997985},"labels":[],"label_agreement":null},{"id":"W4200481257","doi":"10.1016/j.humpath.2021.12.006","title":"ABCC2 expression in papillary renal cell carcinoma provides better prognostic stratification than WHO/ISUP nucleolar grade","year":2021,"lang":"en","type":"article","venue":"Human Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Calgary Laboratory Services; University of Calgary; Chinook Regional Hospital; St. John’s Health Sciences Centre; McGill University Health Centre; St. Michael's Hospital; University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Urological Association Scholarship Fund","keywords":"Medicine; Papillary renal cell carcinomas; Internal medicine; Univariate analysis; Pathology; Oncology; Renal cell carcinoma; Hazard ratio; Cohort; Multivariate analysis; Confidence interval","score_opus":0.03082853076250214,"score_gpt":0.26652868193806095,"score_spread":0.23570015117555881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200481257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480456,0.0014450434,0.000048278114,0.0006106957,0.000080311285,0.00070390804,0.000007983985,0.000060407456,0.0022387905],"genre_scores_gemma":[0.99643826,0.000025590734,0.0015640719,0.00030985716,0.00017697919,0.0001506803,0.00035995268,0.00004868246,0.0009259295],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99780524,0.0003536144,0.00047297694,0.00068437826,0.00026747157,0.0004163133],"domain_scores_gemma":[0.9988931,0.00007409333,0.0001386941,0.0006487159,0.00010366837,0.000141747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018272107,0.0002694359,0.00043380685,0.00018252185,0.000117312054,0.00003022249,0.0001108943,0.00022838214,0.00020335332],"category_scores_gemma":[0.00005130709,0.00023561918,0.0001196366,0.0001785313,0.00012345373,0.00009921944,0.00008421894,0.0003699976,0.00006623315],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039664217,0.00039701813,0.34709066,0.00016300095,0.0000061565906,0.0061095343,0.0008698654,0.0000019128167,0.64437944,0.00007607655,0.00040776702,0.00045890154],"study_design_scores_gemma":[0.0011710355,0.0005329529,0.6441599,0.00011127344,0.000067759574,0.0004535517,0.0001805041,0.00001756912,0.3524717,0.00045389248,0.00022694872,0.0001529194],"about_ca_topic_score_codex":0.000018910123,"about_ca_topic_score_gemma":0.00006323237,"teacher_disagreement_score":0.29706922,"about_ca_system_score_codex":0.00013374585,"about_ca_system_score_gemma":0.00013120758,"threshold_uncertainty_score":0.9608271},"labels":[],"label_agreement":null},{"id":"W4200622882","doi":"10.3390/curroncol28060455","title":"Phase Ib Study of Atezolizumab Plus Interferon-α with or without Bevacizumab in Patients with Metastatic Renal Cell Carcinoma and Other Solid Tumors","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"National Center for Advancing Translational Sciences; Foundation Medicine; Ignyta; Genentech; Servier; Moderna; F. Hoffmann-La Roche; Incyte; Boston Pharmaceuticals; Adaptive Biotechnologies; Exelixis; Regeneron Pharmaceuticals; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Atezolizumab; Bevacizumab; Medicine; Renal cell carcinoma; Cancer research; Oncology; Interferon; Internal medicine; Nivolumab; Immunotherapy; Cancer; Chemotherapy; Immunology","score_opus":0.08100800184156026,"score_gpt":0.37679205221673234,"score_spread":0.2957840503751721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200622882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99715036,0.0006094398,0.00004228982,0.000030599218,0.000104417646,0.0016134932,0.000025426025,0.00001681405,0.00040713162],"genre_scores_gemma":[0.99915624,0.0000074448676,0.00039287293,0.00003278023,0.000029668026,0.00014068458,0.000051032097,0.000049729122,0.00013957295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977892,0.0002768405,0.00057608716,0.00058347295,0.00038830237,0.00038610434],"domain_scores_gemma":[0.9987243,0.00009303246,0.00029496796,0.00042636614,0.00025227238,0.00020909595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012137401,0.00034962257,0.0011618481,0.00023399932,0.00003963905,0.00001128263,0.000094221374,0.000053766456,0.00012385259],"category_scores_gemma":[0.000025303214,0.00021524291,0.000045033765,0.00032286317,0.00016961535,0.000063323496,0.00010382808,0.00030985603,0.000005352555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037434045,0.029876461,0.9087693,0.00053391646,0.00029530955,0.0018959629,0.009188666,0.000025499035,0.0002801393,0.000004564361,0.000057761383,0.011638384],"study_design_scores_gemma":[0.31280094,0.24258181,0.4158324,0.00083661266,0.002355782,0.0007109246,0.010751906,0.0006239329,0.011993612,0.00000903056,0.0007997506,0.0007032797],"about_ca_topic_score_codex":0.00011994019,"about_ca_topic_score_gemma":0.0009909195,"teacher_disagreement_score":0.49293688,"about_ca_system_score_codex":0.00057166594,"about_ca_system_score_gemma":0.00080641586,"threshold_uncertainty_score":0.87773514},"labels":[],"label_agreement":null},{"id":"W4205304319","doi":"10.1016/j.adro.2022.100899","title":"Outcomes of Radiation Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System","year":2022,"lang":"en","type":"article","venue":"Advances in Radiation Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Ottawa Hospital; University of Ottawa; University of Toronto; Western University; Université Laval; Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre; University of Calgary; BC Cancer Agency; Sunnybrook Health Science Centre; Alberta Cancer Foundation; Dalhousie University; McMaster University","funders":"","keywords":"Medicine; Renal cell carcinoma; Immunotherapy; Cancer; Kidney cancer; Radiation therapy; Oncology; Kidney; Internal medicine; Cancer research","score_opus":0.018765164933441717,"score_gpt":0.3017539304997929,"score_spread":0.28298876556635116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205304319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97831047,0.011525571,0.000030424893,0.0039275154,0.0007773687,0.0015035322,0.00062016235,0.00001887256,0.0032861088],"genre_scores_gemma":[0.9953099,0.0014593501,0.00021306907,0.0015991848,0.000048923433,0.0005703067,0.00074047287,0.000014552353,0.000044238204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785334,0.00047770774,0.0008318462,0.0002151746,0.00035527156,0.00026664967],"domain_scores_gemma":[0.99847794,0.00047385192,0.0005595541,0.00031794442,0.00006419608,0.000106517364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006310383,0.00016911166,0.00047391411,0.00041974022,0.00014274719,0.000010433996,0.00017424543,0.00006820663,0.0000998805],"category_scores_gemma":[0.00010426345,0.00013090797,0.000076602526,0.0005199389,0.00005466514,0.0003321621,0.000019501604,0.0002885463,0.00000557085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037179908,0.00022826086,0.73706234,0.00006810761,0.00012904602,0.00009553369,0.01989888,0.05858184,0.00036844748,0.00043019574,0.0009264388,0.1784929],"study_design_scores_gemma":[0.018778674,0.0007513837,0.8718521,0.000020362211,0.000044262855,0.000012971497,0.0021506362,0.0034858692,0.0016778884,0.000054248623,0.10101816,0.00015344967],"about_ca_topic_score_codex":0.2145747,"about_ca_topic_score_gemma":0.0818416,"teacher_disagreement_score":0.17833945,"about_ca_system_score_codex":0.0065474715,"about_ca_system_score_gemma":0.002367596,"threshold_uncertainty_score":0.99726623},"labels":[],"label_agreement":null},{"id":"W4205630512","doi":"10.1016/j.ejvsvf.2022.01.001","title":"Temporary Vascular Debranching to Facilitate Retroperitoneal Tumour en bloc Resection","year":2022,"lang":"en","type":"article","venue":"EJVES Vascular Forum","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Surgery; Superior mesenteric artery; Angiography; Radiology; Renal artery; Axillary artery; Kidney; Internal medicine","score_opus":0.024381944558516295,"score_gpt":0.2407935419214793,"score_spread":0.216411597362963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205630512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893279,0.003256184,0.0006884603,0.0021981783,0.0004755583,0.0012001984,0.000026638594,0.00019828031,0.002628607],"genre_scores_gemma":[0.99482256,0.000059091715,0.0012806844,0.00068352226,0.0002104704,0.00033116605,0.00015410286,0.00008356033,0.002374833],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967351,0.00042023955,0.000417857,0.0007003939,0.0010990241,0.00062736945],"domain_scores_gemma":[0.99862933,0.000046409896,0.000069152185,0.00083672855,0.000067579065,0.00035082022],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008263376,0.00032231785,0.00050277717,0.00033616717,0.00054108154,0.00004131328,0.00023266808,0.00007549525,0.00042464345],"category_scores_gemma":[0.000103894534,0.00029547943,0.0006164467,0.0005349231,0.000035990986,0.00014495105,0.0004151633,0.00054648734,0.00017286351],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004794374,0.003208585,0.35850042,0.0013624062,0.006707222,0.0066607823,0.018778248,0.018574981,0.4679933,0.0005796271,0.077066116,0.03577395],"study_design_scores_gemma":[0.008865267,0.008656224,0.22885452,0.00024392585,0.0009045985,0.0011822026,0.008224652,0.001657953,0.058605928,0.00048206278,0.6808261,0.0014965471],"about_ca_topic_score_codex":0.0007320613,"about_ca_topic_score_gemma":0.00004531598,"teacher_disagreement_score":0.60376,"about_ca_system_score_codex":0.00067186187,"about_ca_system_score_gemma":0.00013885592,"threshold_uncertainty_score":0.99994975},"labels":[],"label_agreement":null},{"id":"W4205678797","doi":"10.1038/s41585-021-00560-3","title":"Substituting SABR for systemic therapy in oligometastatic renal cell carcinoma — buying time or time to change?","year":2022,"lang":"en","type":"review","venue":"Nature Reviews Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; SABR volatility model; Renal cell carcinoma; Systemic therapy; Oncology; Internal medicine; Expanded access; Cancer","score_opus":0.10873549143653466,"score_gpt":0.3596558151724702,"score_spread":0.25092032373593554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205678797","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002237122,0.98043233,0.000007727211,0.0002683893,0.0002887316,0.01794858,0.0000777833,0.00006502576,0.00068774755],"genre_scores_gemma":[0.000089843874,0.98427296,0.0009660109,0.002046485,0.00071638345,0.00827317,0.0008914893,0.00022533804,0.0025183326],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935928,0.0014820856,0.0019993754,0.0014339744,0.00044614618,0.0010456152],"domain_scores_gemma":[0.99601424,0.0013217282,0.001064142,0.001177879,0.00009473161,0.00032729452],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0021826136,0.001166516,0.006936889,0.0011707325,0.00013779307,0.000025376026,0.00060866325,0.0010711958,0.0021056817],"category_scores_gemma":[0.00058463094,0.0007654872,0.0013794625,0.001521983,0.000050836858,0.000058939302,0.00017826052,0.0022269918,0.0014321195],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030858535,0.00018281049,0.00000746854,0.04116287,0.00018038019,0.0012089106,0.0001550001,0.0000011218623,0.000042133415,0.000006395646,0.0029837016,0.9537606],"study_design_scores_gemma":[0.0013990462,0.0021955655,0.000008318703,0.0061918017,0.0022244428,0.0045685642,0.0000037152538,0.000017574708,0.0000075832527,0.0000025634297,0.98282284,0.0005579606],"about_ca_topic_score_codex":0.000014507165,"about_ca_topic_score_gemma":0.0000045310344,"teacher_disagreement_score":0.97983915,"about_ca_system_score_codex":0.0011178806,"about_ca_system_score_gemma":0.0006884692,"threshold_uncertainty_score":0.9994796},"labels":[],"label_agreement":null},{"id":"W4205922578","doi":"10.3390/jcm11020369","title":"The Impact of Modifying Sunitinib Treatment Scheduling on Renal Cancer Tumor Biology and Resistance","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Sunnybrook Health Science Centre; University of Toronto; St. Michael's Hospital","funders":"Kidney Foundation of Canada; Canadian Institutes of Health Research; Canadian Urological Oncology Group","keywords":"Sunitinib; Medicine; Renal cell carcinoma; In vivo; Cancer research; Clinical trial; Cancer treatment; Cancer; Oncology; Pharmacology; Internal medicine; Biology","score_opus":0.15420720039536054,"score_gpt":0.4807502263748304,"score_spread":0.3265430259794698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205922578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799957,0.010819097,0.000017600285,0.006952594,0.00038996432,0.00022597311,0.000012129858,0.000004581868,0.0015823279],"genre_scores_gemma":[0.9949275,0.003175744,0.00031982674,0.00027149738,0.00097605324,0.000014223977,0.0000029528608,0.000016277343,0.0002958901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972434,0.0004191896,0.0014945784,0.0001823112,0.00043681194,0.0002236893],"domain_scores_gemma":[0.9953785,0.0026211943,0.0012292801,0.00025673094,0.00023224772,0.00028208067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021445511,0.0001732211,0.0010251815,0.00013393465,0.00017300916,0.000004051526,0.00012728682,0.000043976917,0.00017475347],"category_scores_gemma":[0.0014070068,0.00007816402,0.00035509592,0.00017160062,0.00037683573,0.00002361903,0.000043625238,0.0006076281,5.1094764e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08094721,0.0038322152,0.65938437,0.00022500924,0.006599932,0.0037781845,0.0017929066,0.0027165737,0.02894048,0.0019983146,0.0048104166,0.20497437],"study_design_scores_gemma":[0.05057549,0.15366016,0.7569795,0.002535578,0.0024461665,0.0020707396,0.0021485793,0.0010731018,0.00333448,0.0038053144,0.02098725,0.00038362786],"about_ca_topic_score_codex":0.0001503604,"about_ca_topic_score_gemma":0.000015045059,"teacher_disagreement_score":0.20459074,"about_ca_system_score_codex":0.00033279802,"about_ca_system_score_gemma":0.00051483203,"threshold_uncertainty_score":0.31874362},"labels":[],"label_agreement":null},{"id":"W4206186024","doi":"10.1016/j.euros.2021.12.003","title":"Patient-reported Experience of Diagnosis, Management, and Burden of Renal Cell Carcinomas: Results from a Global Patient Survey in 43 Countries","year":2022,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of Calgary; Kidney Foundation of Canada","funders":"Ipsen; Novartis; Pfizer; Bristol-Myers Squibb","keywords":"Psychosocial; Medicine; Scale (ratio); Family medicine; Quality of life (healthcare); Psychosocial support; Clinical trial; Nursing; Pathology; Psychiatry; Geography","score_opus":0.03470286025194195,"score_gpt":0.27454257671620236,"score_spread":0.23983971646426042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206186024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838509,0.00066399825,0.000004462109,0.00011847089,0.00012737802,0.00088941905,0.00030627009,0.000009181047,0.014029952],"genre_scores_gemma":[0.9991539,0.0000602795,0.00038878247,0.00020395013,0.0000065533404,0.00005467216,0.000057295423,0.000011389799,0.00006316341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99661016,0.0007012176,0.0008113913,0.00083603256,0.0007023198,0.00033885404],"domain_scores_gemma":[0.9982585,0.00018522267,0.0005328806,0.00073337724,0.00014651375,0.00014356046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001495513,0.00017584526,0.00039531998,0.00017275446,0.0001565059,0.000029519751,0.0007645439,0.000018909408,0.00007560709],"category_scores_gemma":[0.0002636122,0.00015863872,0.00003394546,0.00085971615,0.0009641761,0.00015348659,0.0025765428,0.00013541197,0.0000045061934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017839385,0.00036431392,0.98323166,0.000015216556,0.000030538526,0.0016757481,0.008446802,0.0004091489,0.0019242777,0.000029118055,0.0003406176,0.001748606],"study_design_scores_gemma":[0.0026841678,0.0021141667,0.9864488,0.000023162642,0.000047542322,0.000053909007,0.0014289947,0.00007641845,0.0054811,0.000015742928,0.0014969156,0.00012903899],"about_ca_topic_score_codex":0.007067734,"about_ca_topic_score_gemma":0.000106588675,"teacher_disagreement_score":0.015303045,"about_ca_system_score_codex":0.00015187915,"about_ca_system_score_gemma":0.00017717929,"threshold_uncertainty_score":0.99954426},"labels":[],"label_agreement":null},{"id":"W4206312512","doi":"10.2139/ssrn.3974118","title":"The Genomic Landscape of Pediatric Renal Cell Carcinomas","year":2021,"lang":"en","type":"article","venue":"SSRN Electronic Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Renal cell carcinoma; Medicine; Geography; Biology; Pathology","score_opus":0.009220151331835787,"score_gpt":0.22229103175284182,"score_spread":0.21307088042100603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206312512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9231417,0.07094855,0.00010664077,0.0006524348,0.00013599597,0.00011606574,0.0000017611467,0.000010609781,0.0048862305],"genre_scores_gemma":[0.9734427,0.019088157,0.000089540765,0.00003815609,0.0007251351,0.00000405998,0.000007704156,0.00002836618,0.006576208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750054,0.00010610155,0.00038942028,0.0001954444,0.0003724189,0.001436093],"domain_scores_gemma":[0.99900806,0.00010200543,0.00021178713,0.00033270544,0.00021081987,0.00013460309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007729398,0.00016201272,0.00027273493,0.00008919697,0.0001966668,0.0000269374,0.00015698197,0.00006715218,0.00006235606],"category_scores_gemma":[0.00004294637,0.00010378383,0.0002694215,0.00025508035,0.00003719471,0.000038349266,0.00004991719,0.0011924277,0.00003626782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019773557,0.0013181993,0.75418055,0.00019641312,0.0020710572,0.001609954,0.00087727886,0.00015443076,0.18574631,0.021852722,0.004314377,0.025701331],"study_design_scores_gemma":[0.021391902,0.008804379,0.6665516,0.00009008837,0.0053694155,0.038158067,0.0082284715,0.00023074746,0.18579262,0.048805397,0.0153829735,0.0011943378],"about_ca_topic_score_codex":0.000018198602,"about_ca_topic_score_gemma":0.00011952887,"teacher_disagreement_score":0.08762898,"about_ca_system_score_codex":0.00064404035,"about_ca_system_score_gemma":0.0053732744,"threshold_uncertainty_score":0.9531958},"labels":[],"label_agreement":null},{"id":"W4206710181","doi":"10.1016/j.euo.2021.12.007","title":"Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomy","year":2022,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Pembrolizumab; Pazopanib; Internal medicine; Renal cell carcinoma; Hazard ratio; Kidney cancer; Adverse effect; Oncology; Placebo; Nephrectomy; Adjuvant; Confidence interval; Cancer; Kidney; Sunitinib; Immunotherapy; Pathology","score_opus":0.006648434148015535,"score_gpt":0.20948290704344646,"score_spread":0.20283447289543094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206710181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98611635,0.0008470181,0.0000029177927,0.00060178206,0.0004607175,0.0014420745,0.00007228114,0.00008803587,0.010368824],"genre_scores_gemma":[0.99579155,0.00002626404,0.00031003277,0.0013102056,0.00023315698,0.00038891184,0.00037349097,0.00014464904,0.0014217469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99555355,0.0014942357,0.00067678205,0.000989831,0.00042805605,0.00085755193],"domain_scores_gemma":[0.9983273,0.00013182666,0.00034636218,0.000748499,0.00009513024,0.0003508912],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036978247,0.0005703206,0.000910072,0.0005274318,0.00023079148,0.000011550796,0.00021607675,0.00012483314,0.0010951789],"category_scores_gemma":[0.000030363746,0.00042002072,0.00017940515,0.00037488714,0.0002594513,0.000071190036,0.00034396115,0.00083943014,0.0004036636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027381396,0.004583236,0.93792367,0.000018608927,0.00012992401,0.01576284,0.0012640211,0.00030762202,0.00026158543,0.000012175623,0.0005633095,0.011791638],"study_design_scores_gemma":[0.033843573,0.073071554,0.8602087,0.000005627336,0.0005124826,0.0003837405,0.00009538292,0.000018914327,0.00089638436,0.000012240588,0.03061852,0.00033287422],"about_ca_topic_score_codex":0.0007110327,"about_ca_topic_score_gemma":0.00016633014,"teacher_disagreement_score":0.07771494,"about_ca_system_score_codex":0.0018878897,"about_ca_system_score_gemma":0.00045824234,"threshold_uncertainty_score":0.9998252},"labels":[],"label_agreement":null},{"id":"W4206936353","doi":"10.1158/1055-9965.epi-21-0341","title":"Comparison of Approaches for Measuring Adherence and Persistence to Oral Oncologic Therapies in Patients Diagnosed with Metastatic Renal Cell Carcinoma","year":2022,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"North Carolina Translational and Clinical Sciences Institute, University of North Carolina at Chapel Hill; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill; Novo Nordisk; UCB US; Queen's University; Cancer Research UK; GlaxoSmithKline; AstraZeneca; Queen's University Belfast; Bristol-Myers Squibb","keywords":"Medicine; Pazopanib; Renal cell carcinoma; Persistence (discontinuity); Internal medicine; Sunitinib; Confidence interval; Cumulative incidence; Censoring (clinical trials); Incidence (geometry); Cause of death; Oncology; Epidemiology; Disease; Transplantation; Pathology","score_opus":0.2705672300839741,"score_gpt":0.3740158288427589,"score_spread":0.10344859875878482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206936353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99015385,0.006653513,0.00070241926,0.00035478512,0.000077562676,0.001980998,0.000020993597,0.000011422427,0.00004444465],"genre_scores_gemma":[0.98816997,0.000023656548,0.009843453,0.00008520382,0.00000942628,0.0017138375,0.00007689488,0.00001533455,0.000062231404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978037,0.00074295135,0.0005282128,0.00047100312,0.000154749,0.00029939922],"domain_scores_gemma":[0.9987605,0.0005095079,0.0003697709,0.00019067292,0.000070208924,0.00009932015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012048433,0.00018752427,0.0007364613,0.00017408813,0.00009934527,0.000002495303,0.000099068544,0.00004811275,0.00003366522],"category_scores_gemma":[0.00013862395,0.00014822079,0.00011189162,0.0002134404,0.00013991658,0.000047352984,0.000071494134,0.00013008018,3.5838164e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035018711,0.0005629355,0.97635025,0.00023044033,0.0001961266,0.000004901303,0.0010823745,0.0005447202,0.00064067397,0.000011934835,0.00017228501,0.016701492],"study_design_scores_gemma":[0.004436618,0.008376725,0.9821572,0.000111993744,0.00033651263,0.000003878154,0.0019560591,0.00078279,0.0014636315,0.00016399976,0.00006632906,0.00014426593],"about_ca_topic_score_codex":0.00030849117,"about_ca_topic_score_gemma":0.00034343923,"teacher_disagreement_score":0.016557226,"about_ca_system_score_codex":0.00045585132,"about_ca_system_score_gemma":0.00013109972,"threshold_uncertainty_score":0.60442686},"labels":[],"label_agreement":null},{"id":"W4206953274","doi":"10.1016/j.annonc.2021.08.062","title":"666P Pembrolizumab (pembro) monotherapy as first-line therapy in advanced clear cell renal cell carcinoma (ccRCC): Results after a minimum of 41 months of follow-up from KEYNOTE-427 cohort A","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute; Foundation Medicine; Genentech; Ipsen; Congressionally Directed Medical Research Programs; Celldex Therapeutics; Gateway for Cancer Research; Calithera Biosciences; Astellas Pharma; Eisai; U.S. Department of Defense; Exelixis; GlaxoSmithKline; AstraZeneca; Bristol-Myers Squibb; Pfizer","keywords":"Medicine; Pembrolizumab; Cohort; Clear cell renal cell carcinoma; Renal cell carcinoma; Oncology; Internal medicine; Cancer; Immunotherapy","score_opus":0.03871733226255215,"score_gpt":0.31502741374163873,"score_spread":0.2763100814790866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206953274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782099,0.009788419,0.00001228653,0.00177595,0.00021320867,0.0011027313,0.00023631814,0.00001999153,0.008641168],"genre_scores_gemma":[0.99057573,0.0052550104,0.0013564406,0.00086841604,0.00010851131,0.00013426456,0.00016495844,0.00008099023,0.0014556812],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995933,0.0003877561,0.0016611621,0.00085077446,0.00057672214,0.00059058843],"domain_scores_gemma":[0.9963602,0.0006773358,0.0008626076,0.0011171309,0.00073777663,0.00024495966],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004189327,0.0004728756,0.0018974406,0.00033752454,0.0000311861,0.000005663545,0.00027202675,0.0004694444,0.00041168902],"category_scores_gemma":[0.00015185513,0.00042477914,0.0005907805,0.00047245264,0.00023784791,0.00009563436,0.00010924996,0.0003649154,0.000019663663],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31139472,0.009767581,0.0943054,0.00051765767,0.0009186017,0.0041145966,0.00879615,0.00042057416,0.5397123,0.000013481929,0.0028308239,0.027208123],"study_design_scores_gemma":[0.0379703,0.020895433,0.25207773,0.000189043,0.00015684954,0.000031524087,0.00042225444,0.00011801357,0.68268657,0.00019058901,0.0049893335,0.000272375],"about_ca_topic_score_codex":0.0030629993,"about_ca_topic_score_gemma":0.00089136994,"teacher_disagreement_score":0.27342442,"about_ca_system_score_codex":0.0001614693,"about_ca_system_score_gemma":0.00087185396,"threshold_uncertainty_score":0.9998204},"labels":[],"label_agreement":null},{"id":"W4207018755","doi":"10.1016/j.euros.2021.12.007","title":"Efficacy and Safety of First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis","year":2022,"lang":"en","type":"review","venue":"European Urology Open Science","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Public Health Ontario; University of Toronto; Lunenfeld-Tanenbaum Research Institute; University of Calgary","funders":"","keywords":"Medicine; Axitinib; Oncology; Internal medicine; Ipilimumab; Nivolumab; Discontinuation; Population; Cabozantinib; Clinical endpoint; Pembrolizumab; Renal cell carcinoma; Adverse effect; Progression-free survival; Randomized controlled trial; Clinical trial; Meta-analysis; Immunotherapy; Cancer; Chemotherapy; Sunitinib","score_opus":0.16543024134435744,"score_gpt":0.36394016543321667,"score_spread":0.19850992408885923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4207018755","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005305184,0.9833027,0.00014000604,0.000114745235,0.000047601265,0.015219919,0.00009907899,0.000014954613,0.0010079206],"genre_scores_gemma":[0.0050446186,0.9919526,0.0008272899,0.000443136,0.000025986232,0.0009399695,0.00010437571,0.00007204537,0.0005899515],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99240655,0.0029569562,0.002105441,0.0014552602,0.00054973044,0.00052609097],"domain_scores_gemma":[0.993923,0.0019871285,0.0019352756,0.0016782881,0.0001827892,0.00029348698],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.011152318,0.00067127764,0.010755479,0.00045346102,0.0004212105,0.00008215298,0.001606855,0.00005019354,0.00018926754],"category_scores_gemma":[0.00055287994,0.00039806962,0.001354633,0.0021557056,0.0006123156,0.00010425822,0.0012201399,0.000344734,0.000009682252],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021129457,0.00024749181,0.00001757457,0.9513981,0.043703068,0.00031496183,0.00015334667,0.000057195408,0.0000016224669,0.000060973864,0.00015547598,0.0036789223],"study_design_scores_gemma":[0.0016831362,0.0021138352,0.00004976582,0.009206535,0.9358808,0.0014308391,0.000011661114,0.000042863583,7.726114e-7,0.0000039155675,0.049188826,0.0003870434],"about_ca_topic_score_codex":0.000019229867,"about_ca_topic_score_gemma":0.000003653593,"teacher_disagreement_score":0.94219154,"about_ca_system_score_codex":0.00011680107,"about_ca_system_score_gemma":0.00038690623,"threshold_uncertainty_score":0.9998471},"labels":[],"label_agreement":null},{"id":"W4207042661","doi":"10.1007/s00330-021-08449-w","title":"Malignancy risk stratification of cystic renal lesions based on a contrast-enhanced CT-based machine learning model and a clinical decision algorithm","year":2022,"lang":"en","type":"article","venue":"European Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Computer Research Institute of Montréal; McGill University Health Centre; McGill University","funders":"Fonds de Recherche du Québec - Santé; Fondation de l'Association des radiologistes du Québec","keywords":"Medicine; Malignancy; Radiology; Neuroradiology; Logistic regression; Receiver operating characteristic; Algorithm; Radiomics; Interventional radiology; Magnetic resonance imaging; Machine learning; Artificial intelligence; Internal medicine; Computer science","score_opus":0.02869189199486448,"score_gpt":0.29121232166759486,"score_spread":0.26252042967273037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4207042661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8267922,0.0004106872,0.17065148,0.00010468191,0.00008489667,0.00046066754,0.00008459491,0.00005288642,0.0013579142],"genre_scores_gemma":[0.97667336,0.000056278466,0.02258128,0.00020247439,0.000050672326,0.000024061985,0.00023158434,0.00003933291,0.00014093377],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99653393,0.0018939261,0.000628056,0.0004921081,0.00024228837,0.00020966727],"domain_scores_gemma":[0.9980724,0.0009962312,0.00033822472,0.00038227672,0.00006197358,0.00014890515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012470977,0.00018484937,0.00045866403,0.00016977209,0.00019792483,0.000005799118,0.00010659785,0.000030493291,0.000101212216],"category_scores_gemma":[0.0005071563,0.00015472858,0.00014412258,0.0001365886,0.00013949002,0.000015575119,0.00004784876,0.0005633564,0.00001274682],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007993189,0.0025306004,0.034758817,0.0000746613,0.00029098877,0.0022196013,0.00024903243,0.44755635,0.063634105,0.00025117001,0.00053399283,0.43990752],"study_design_scores_gemma":[0.006405264,0.005742515,0.1234641,0.00006634992,0.00025671767,0.00014958375,0.00002663775,0.8624638,0.00108002,0.00006244359,0.00014308687,0.00013952768],"about_ca_topic_score_codex":0.000014767934,"about_ca_topic_score_gemma":0.0000021548321,"teacher_disagreement_score":0.439768,"about_ca_system_score_codex":0.00008887099,"about_ca_system_score_gemma":0.00014112209,"threshold_uncertainty_score":0.6309648},"labels":[],"label_agreement":null},{"id":"W4210440333","doi":"10.1038/s41419-022-04576-4","title":"PGK1 contributes to tumorigenesis and sorafenib resistance of renal clear cell carcinoma via activating CXCR4/ERK signaling pathway and accelerating glycolysis","year":2022,"lang":"en","type":"article","venue":"Cell Death and Disease","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute on Alcohol Abuse and Alcoholism; Chengdu Science and Technology Program; Chengdu Science and Technology Bureau; National Natural Science Foundation of China","keywords":"Sorafenib; Glycolysis; MAPK/ERK pathway; Carcinogenesis; Cancer research; Signal transduction; Cell biology; Anaerobic glycolysis; Cell growth; Chemistry; Biology; Biochemistry; Metabolism; Gene; Hepatocellular carcinoma","score_opus":0.01722397889470673,"score_gpt":0.22243533102727656,"score_spread":0.20521135213256983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210440333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98494184,0.013420569,0.00014308683,0.00017105717,0.00003307429,0.0006349731,0.00009619993,0.000028122657,0.00053107267],"genre_scores_gemma":[0.9976249,0.000047595506,0.0011984421,0.0002714597,0.00006094091,0.00010742285,0.0000455298,0.000036619705,0.000607142],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982417,0.000118981974,0.00038703374,0.0005676262,0.00032925472,0.00035535547],"domain_scores_gemma":[0.99845064,0.00021411442,0.00017495707,0.00028114242,0.00009721714,0.00078194466],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023199288,0.00026862154,0.00046838282,0.00016582636,0.00046908492,0.000053757958,0.00007316125,0.000038147275,0.00005554961],"category_scores_gemma":[0.00010189965,0.00025222424,0.000092648654,0.00025428555,0.000059452217,0.00007592962,0.0002107127,0.00015427366,0.0000010132435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056696692,0.00046617657,0.28587678,0.0013950334,0.000081436345,0.000922572,0.0011178841,0.00018377969,0.70108676,0.000080028374,0.00019449677,0.0029254146],"study_design_scores_gemma":[0.008093222,0.0015345617,0.26573524,0.00022768808,0.0010971861,0.000032132342,0.0021206297,0.0017782554,0.7170147,0.0005482055,0.0010716921,0.00074652716],"about_ca_topic_score_codex":0.000087896784,"about_ca_topic_score_gemma":0.0000049951946,"teacher_disagreement_score":0.020141516,"about_ca_system_score_codex":0.00010435762,"about_ca_system_score_gemma":0.00019289869,"threshold_uncertainty_score":0.999993},"labels":[],"label_agreement":null},{"id":"W4210479555","doi":"10.1016/j.urolonc.2021.12.010","title":"Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Chromophobe cell; Interquartile range; Renal cell carcinoma; Clear cell renal cell carcinoma; Internal medicine; Clear cell; Oncology; Stage (stratigraphy); Nephrectomy; Radiology; Urology; Kidney","score_opus":0.06039941112047952,"score_gpt":0.3299964613434211,"score_spread":0.26959705022294156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210479555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655774,0.00030267585,0.000040940344,0.030329738,0.00009424071,0.0015782143,0.0001084406,0.00001968548,0.0019486521],"genre_scores_gemma":[0.9893893,0.000009170746,0.005251898,0.0045994804,0.00002420817,0.00028431692,0.00013977026,0.000017473962,0.0002844048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968822,0.0012272993,0.00076544774,0.00038360857,0.00039875534,0.00034268532],"domain_scores_gemma":[0.9977709,0.0009943672,0.00053427875,0.0003196293,0.0002164764,0.0001643347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013338542,0.00022943018,0.0006362213,0.00017738335,0.0002191929,0.0000073752867,0.0002678336,0.000099818266,0.000023683888],"category_scores_gemma":[0.0003850635,0.0001301244,0.00006664537,0.00043351648,0.00020619672,0.000040755738,0.000204674,0.00046887874,0.0000026971038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050472305,0.0010529023,0.9756105,0.000014470423,0.000066544926,0.000018830175,0.0012857394,0.009996009,0.0002347408,0.000087879656,0.010438982,0.0006886587],"study_design_scores_gemma":[0.003925032,0.036527023,0.8686075,0.00001767898,0.000802655,0.00003374584,0.0007334642,0.0023076213,0.00023649707,0.00067714363,0.08591659,0.00021502828],"about_ca_topic_score_codex":0.00022220801,"about_ca_topic_score_gemma":0.00020226551,"teacher_disagreement_score":0.107003,"about_ca_system_score_codex":0.0004015381,"about_ca_system_score_gemma":0.00023398703,"threshold_uncertainty_score":0.53063196},"labels":[],"label_agreement":null},{"id":"W4210567701","doi":"10.3390/cancers14030831","title":"A Comprehensive Commentary on the Multilocular Cystic Renal Neoplasm of Low Malignant Potential: A Urologist’s Perspective","year":2022,"lang":"en","type":"article","venue":"Cancers","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Royal Columbian Hospital","funders":"","keywords":"Medicine; Radiology; Magnetic resonance imaging; Ultrasonography; Nephrectomy; Laparoscopy; Kidney; Internal medicine","score_opus":0.021734620851685062,"score_gpt":0.2595107165677048,"score_spread":0.23777609571601974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210567701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874471,0.0014937619,0.000056102544,0.008683505,0.00026960394,0.0009281439,0.00010078484,0.000029832749,0.0009911625],"genre_scores_gemma":[0.9922517,0.000036200345,0.00009783,0.007138939,0.000072088464,0.00020161066,0.000031935677,0.000023518272,0.00014620734],"study_design_codex":"simulation_or_modeling","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986364,0.00019864723,0.00019536742,0.00030329538,0.0004314244,0.00023485166],"domain_scores_gemma":[0.99910784,0.00015539624,0.0001284192,0.00040851542,0.00011356366,0.000086262036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103304716,0.00017218706,0.0002973707,0.00007969569,0.00018301654,0.000005229393,0.00014327628,0.00002724907,0.00033386907],"category_scores_gemma":[0.00002562586,0.00011816955,0.00018792758,0.00016966862,0.00021385135,0.000014157536,0.000109728164,0.00029280418,0.000009046784],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02531038,0.0018077134,0.005010582,0.00069157104,0.006208274,0.014656515,0.021862237,0.45182803,0.28667367,0.0041001546,0.17843391,0.0034169727],"study_design_scores_gemma":[0.05846113,0.056310646,0.1192148,0.0015653061,0.006932771,0.004339002,0.20286754,0.10327913,0.31169486,0.0031268655,0.12900943,0.0031985398],"about_ca_topic_score_codex":0.0021253745,"about_ca_topic_score_gemma":0.000014535461,"teacher_disagreement_score":0.34854892,"about_ca_system_score_codex":0.0029949744,"about_ca_system_score_gemma":0.00029656323,"threshold_uncertainty_score":0.78317535},"labels":[],"label_agreement":null},{"id":"W4210621257","doi":"10.5489/cuaj.7760","title":"Canadian Urological Association guideline: Management of small renal masses – Summary of recommendations","year":2022,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Centre hospitalier universitaire de Québec; St. Michael's Hospital; St. Joseph’s Healthcare Hamilton; University of Calgary; Princess Margaret Cancer Centre; McMaster University; McGill University Health Centre; University of Ottawa; Western University; University of Toronto; Capital District Health Authority; University Health Network; Hamilton Health Sciences; Kidney Foundation of Canada; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Guideline; Association (psychology); Medicine; Urology; Psychology; Pathology","score_opus":0.024090199957458855,"score_gpt":0.24702747447658865,"score_spread":0.2229372745191298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210621257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8183363,0.00082348794,0.00012629402,0.15195681,0.0009104517,0.000893602,0.0008089652,0.00004157226,0.026102506],"genre_scores_gemma":[0.9888502,0.00020461672,0.0034839574,0.0036240695,0.00018727056,0.000045939345,0.00044327616,0.000021301936,0.003139419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966049,0.0005672384,0.0010555318,0.0002895184,0.0007858274,0.0006969847],"domain_scores_gemma":[0.9970191,0.00025262265,0.0009927659,0.00020773766,0.00056661514,0.0009611227],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022342752,0.000204682,0.00050530705,0.00055901386,0.00046685393,0.00003255277,0.00026645508,0.0002409451,0.003782774],"category_scores_gemma":[0.00047236664,0.00018910428,0.00031031447,0.0005619988,0.000025117195,0.00006474138,0.00006779408,0.000821834,0.000015865455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011425727,0.00018496123,0.87927073,0.000015226787,0.00072392385,0.00035647853,0.000088752546,0.0007548451,0.00013323427,0.00059338147,0.11441262,0.0033515836],"study_design_scores_gemma":[0.0015391386,0.0010335152,0.5803761,0.000020405423,0.0004720553,0.00018911764,0.00035694515,0.0002223553,0.00007509557,0.00090120203,0.41461533,0.00019877637],"about_ca_topic_score_codex":0.045258287,"about_ca_topic_score_gemma":0.02378341,"teacher_disagreement_score":0.3002027,"about_ca_system_score_codex":0.009776856,"about_ca_system_score_gemma":0.0014698429,"threshold_uncertainty_score":0.9971279},"labels":[],"label_agreement":null},{"id":"W4210654079","doi":"10.21037/tcr.2018.12.31","title":"The time has come to pull renal cancer’s sweet tooth","year":2019,"lang":"en","type":"letter","venue":"Translational Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cancer; Medicine; Internal medicine","score_opus":0.1698044794138519,"score_gpt":0.40827483185052893,"score_spread":0.23847035243667702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210654079","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052109025,0.00816721,0.000017869725,0.96896374,0.00038365784,0.0030546365,0.00083560945,0.000055641773,0.013310745],"genre_scores_gemma":[0.034664318,0.0020293163,0.00036527545,0.44233763,0.023567624,0.005484757,0.0035483048,0.00057467516,0.48742807],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928314,0.0004178086,0.0005458885,0.0009110972,0.0040303906,0.0012633827],"domain_scores_gemma":[0.99638945,0.0013809901,0.00009496711,0.0009404485,0.0009398185,0.00025433133],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010831261,0.00046726625,0.000686023,0.00046553332,0.0005816611,0.00023271976,0.0006610982,0.0005445308,0.004690368],"category_scores_gemma":[0.00005295127,0.00031806264,0.00032908708,0.00072043296,0.00041567814,0.00008112372,0.00008395775,0.003380512,0.0022076003],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010762613,0.000038017628,0.0006164842,0.00027747714,0.0004451988,0.0003107842,0.00022846552,0.00025607043,0.0017861665,0.000045027442,0.9911213,0.003798736],"study_design_scores_gemma":[0.0012987601,0.00046328348,0.0057714647,0.00046869117,0.000148073,0.00003450821,0.000005315942,0.00013093221,0.0009962447,0.00020176655,0.99016494,0.00031599717],"about_ca_topic_score_codex":0.0034526999,"about_ca_topic_score_gemma":0.0007140377,"teacher_disagreement_score":0.52662605,"about_ca_system_score_codex":0.0013695735,"about_ca_system_score_gemma":0.0039130277,"threshold_uncertainty_score":0.99992716},"labels":[],"label_agreement":null},{"id":"W4210681883","doi":"10.1016/j.ymgme.2021.11.138","title":"Long-term multisystemic efficacy with migalastat in ERT-naive and ERT-experienced patients with amenable variants","year":2022,"lang":"en","type":"article","venue":"Molecular Genetics and Metabolism","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Term (time); Medicine; Psychology; Physics","score_opus":0.006904816257055658,"score_gpt":0.21775894689394956,"score_spread":0.2108541306368939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210681883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99049836,0.007977148,0.0002194742,0.000043777218,0.000056542605,0.0010709753,0.000014347357,0.000012907412,0.0001064488],"genre_scores_gemma":[0.998061,0.00018184495,0.0012273518,0.0001625761,0.000013304202,0.00015195178,0.000047339654,0.00004312711,0.00011148037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849993,0.00008741468,0.00020966936,0.00046505802,0.00042021347,0.00031772736],"domain_scores_gemma":[0.9993253,0.000016006796,0.000085594635,0.00030235437,0.00006935604,0.00020140226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000074155956,0.00024071746,0.00038731992,0.00013761072,0.00010445456,0.000031699085,0.00006848173,0.000036376015,0.0000209493],"category_scores_gemma":[0.00000793608,0.0001769599,0.000029282162,0.00021275679,0.00008265671,0.000028446453,0.00012073974,0.00015340908,9.604468e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018915728,0.0013420457,0.9033689,0.00019099959,0.00042485053,0.0025087486,0.0058422033,0.00073704263,0.07156063,0.00009198608,0.000015184768,0.012025873],"study_design_scores_gemma":[0.010573191,0.0009975266,0.9776688,0.00006698573,0.00025714355,0.00014469722,0.00021373002,0.00015800163,0.009385231,0.0000067413084,0.0002935798,0.00023436992],"about_ca_topic_score_codex":0.000083674415,"about_ca_topic_score_gemma":0.000013148313,"teacher_disagreement_score":0.07429993,"about_ca_system_score_codex":0.00005491042,"about_ca_system_score_gemma":0.00007218973,"threshold_uncertainty_score":0.7216216},"labels":[],"label_agreement":null},{"id":"W4210712271","doi":"10.3390/biomedicines10020322","title":"TSC/mTOR Pathway Mutation Associated Eosinophilic/Oncocytic Renal Neoplasms: A Heterogeneous Group of Tumors with Distinct Morphology, Immunohistochemical Profile, and Similar Genetic Background","year":2022,"lang":"en","type":"review","venue":"Biomedicines","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Royal Columbian Hospital","funders":"Ministerstvo Zdravotnictví Ceské Republiky; Univerzita Karlova v Praze","keywords":"Eosinophilic; Pathology; Immunohistochemistry; Biology; TFE3; Renal oncocytoma; Oncocytoma; Renal cell carcinoma; Chromophobe cell; Clear cell; Medicine; Genetics; Gene; Gene expression","score_opus":0.03761504606480013,"score_gpt":0.28740434194829817,"score_spread":0.24978929588349805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210712271","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2172923,0.7797994,0.000011225239,0.000036035653,0.00017998145,0.002213968,0.00029220132,0.00007643981,0.00009843552],"genre_scores_gemma":[0.054221403,0.9361795,0.0011337048,0.000085978754,0.00038091314,0.001329893,0.0059601907,0.0003077393,0.00040063958],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99592024,0.00033727326,0.0013451695,0.0009978393,0.00085528154,0.00054420147],"domain_scores_gemma":[0.9971901,0.0005059264,0.0011377791,0.0007009399,0.00014138423,0.00032383366],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030992183,0.00091396464,0.0031940283,0.0005667069,0.0001395789,0.000018048018,0.0002430336,0.00040217856,0.0002733584],"category_scores_gemma":[0.00017335096,0.0006211094,0.0004106659,0.00083347247,0.00084366335,0.00003877368,0.00017085717,0.00053118635,0.000010289006],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027127778,0.0035775905,0.0018078039,0.08258363,0.008502057,0.035653938,0.00093729957,0.00000348108,0.011538995,0.00001494122,0.0013727633,0.8512947],"study_design_scores_gemma":[0.030681236,0.06482511,0.020678695,0.104407586,0.05494492,0.13094972,0.00087320514,0.00026030978,0.0019332058,0.00008803684,0.5845547,0.0058033336],"about_ca_topic_score_codex":0.0002234577,"about_ca_topic_score_gemma":0.000014687718,"teacher_disagreement_score":0.8454914,"about_ca_system_score_codex":0.0011028713,"about_ca_system_score_gemma":0.00070117344,"threshold_uncertainty_score":0.999624},"labels":[],"label_agreement":null},{"id":"W4210755410","doi":"10.1097/01.cdr.0000820636.38681.dc","title":"Renal Cell Carcinoma Subtypes and Associated Renal Malignancies: A Pictorial Review—Part II","year":2022,"lang":"en","type":"article","venue":"Contemporary Diagnostic Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Alberta","funders":"","keywords":"Medicine; Renal cell carcinoma; Angiomyolipoma; Malignancy; Oncocytoma; Renal oncocytoma; Kidney; Pathology; Biopsy; Internal medicine","score_opus":0.025401033115345906,"score_gpt":0.239287022618947,"score_spread":0.21388598950360108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210755410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86664975,0.12076572,0.0000053738954,0.002376878,0.0011446306,0.0015061753,0.0001560207,0.00009692745,0.007298499],"genre_scores_gemma":[0.98997056,0.0021437402,0.00004578019,0.0026438236,0.0005895121,0.00059810426,0.00080153055,0.000051254963,0.0031556818],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99686986,0.00072681974,0.0007457549,0.00074143586,0.00040408366,0.0005120687],"domain_scores_gemma":[0.99712,0.0015225669,0.0003600707,0.000554201,0.000118539385,0.00032458457],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007342602,0.0003874395,0.001094273,0.00016456418,0.00042956014,0.000011502891,0.00020702282,0.00014682589,0.000554476],"category_scores_gemma":[0.0016231985,0.0003473224,0.00021919633,0.00030491894,0.00022960648,0.00007732648,0.00032382942,0.0005072141,0.000027322469],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009228904,0.0008909569,0.22850153,0.0005301273,0.00032571278,0.010818551,0.0005950524,0.0000070031224,0.0067642312,0.0003294616,0.74990934,0.00040516505],"study_design_scores_gemma":[0.015721811,0.018168937,0.38834405,0.0011223656,0.0013954535,0.005623284,0.00025963053,0.00004383681,0.0045544184,0.00035262754,0.5632355,0.0011780816],"about_ca_topic_score_codex":0.00010807264,"about_ca_topic_score_gemma":0.000003997062,"teacher_disagreement_score":0.1866738,"about_ca_system_score_codex":0.00038803506,"about_ca_system_score_gemma":0.000724514,"threshold_uncertainty_score":0.9998979},"labels":[],"label_agreement":null},{"id":"W4210772770","doi":"10.24908/pocus.v7ikidney.14997","title":"Incidentalomas Among Healthy Nephrology Fellow Volunteers at POCUS Workshops: A Case Series","year":2022,"lang":"en","type":"article","venue":"POCUS Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrology; Incidence (geometry); Incidentaloma; Internal medicine; Radiology; General surgery","score_opus":0.01787663461150116,"score_gpt":0.2625054848208219,"score_spread":0.24462885020932076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210772770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98748475,0.004591952,0.000025624115,0.0047836965,0.00082687923,0.0004384699,0.000016101236,0.00006349284,0.001769038],"genre_scores_gemma":[0.99052763,0.00016145362,0.00047513202,0.0019307674,0.00048804635,0.00007265679,0.000025408284,0.00006454504,0.0062543843],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.997291,0.00035089572,0.0005906612,0.00036733563,0.00067769474,0.0007223841],"domain_scores_gemma":[0.9984534,0.000087157314,0.00027999273,0.00038288799,0.00010715019,0.00068940624],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00057251996,0.00030569933,0.0005216744,0.00033360042,0.0012146533,0.00005584771,0.0001674319,0.00009677534,0.0035110763],"category_scores_gemma":[0.00006202421,0.0002671536,0.0003139466,0.0003454741,0.00018900748,0.00019682807,0.00032286145,0.0011295712,0.00010509871],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007866552,0.00079635915,0.4487099,0.00008360513,0.000792254,0.47463086,0.005428937,0.0006011223,0.0033469158,0.00006411392,0.050147563,0.0075318087],"study_design_scores_gemma":[0.0044048657,0.0036705043,0.0542257,0.000034543726,0.0003702462,0.9044548,0.003926208,0.00015558567,0.00053867325,0.00019561691,0.027712751,0.0003104646],"about_ca_topic_score_codex":0.00049285474,"about_ca_topic_score_gemma":0.0007312037,"teacher_disagreement_score":0.42982396,"about_ca_system_score_codex":0.00226371,"about_ca_system_score_gemma":0.00030386372,"threshold_uncertainty_score":0.99997807},"labels":[],"label_agreement":null},{"id":"W4210806897","doi":"10.5489/cuaj.7763","title":"Canadian Urological Association guideline: Management of small renal masses – Full-text","year":2022,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Centre hospitalier universitaire de Québec; St. Michael's Hospital; St. Joseph’s Healthcare Hamilton; University of Calgary; Princess Margaret Cancer Centre; McMaster University; McGill University Health Centre; University of Ottawa; Western University; University of Toronto; Capital District Health Authority; University Health Network; Hamilton Health Sciences; Kidney Foundation of Canada; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Guideline; Association (psychology); Medicine; Urology; Psychology; Pathology","score_opus":0.01940425309248935,"score_gpt":0.23078533435659204,"score_spread":0.21138108126410268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210806897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9005774,0.0006820733,0.0000872183,0.07939463,0.00074967596,0.00066002435,0.00023583758,0.00004759177,0.017565535],"genre_scores_gemma":[0.98685634,0.00011012671,0.0019479078,0.0063266275,0.00037125335,0.00005715211,0.00020963202,0.00002839976,0.0040925345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958409,0.0005771285,0.0009783526,0.00040542375,0.0011185855,0.0010795763],"domain_scores_gemma":[0.9966273,0.00019420302,0.00082167576,0.00023898031,0.00051843585,0.0015994604],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023600033,0.0002792784,0.00055463257,0.00055105845,0.0007201949,0.0000774107,0.00032754184,0.00033281904,0.005822848],"category_scores_gemma":[0.00048025724,0.00024811501,0.00036881267,0.0005819884,0.000026478032,0.000067544504,0.00007880259,0.0011567108,0.000080350255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022396242,0.00018190363,0.90176105,0.000014460553,0.00090535503,0.00195858,0.0001051113,0.0015572541,0.00022225945,0.0006223203,0.08904358,0.0034041782],"study_design_scores_gemma":[0.0017437069,0.0013145551,0.58732015,0.000010962688,0.00044852844,0.0006190938,0.00027088018,0.00033980448,0.000032355834,0.0006869071,0.40695688,0.0002561872],"about_ca_topic_score_codex":0.040869478,"about_ca_topic_score_gemma":0.03093618,"teacher_disagreement_score":0.3179133,"about_ca_system_score_codex":0.01595614,"about_ca_system_score_gemma":0.0016760555,"threshold_uncertainty_score":0.99999714},"labels":[],"label_agreement":null},{"id":"W4210826013","doi":"10.1016/j.urolonc.2021.12.018","title":"Stereotactic ablative radiation therapy for renal cell carcinoma with inferior vena cava tumor thrombus","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"National Cancer Institute","keywords":"SABR volatility model; Medicine; Renal cell carcinoma; Inferior vena cava; Surgery; Radiation therapy; Radiology; Internal medicine","score_opus":0.030381952682203686,"score_gpt":0.28678817229217696,"score_spread":0.2564062196099733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210826013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915092,0.0019812423,0.00006845624,0.0031675098,0.00012520977,0.001393239,0.00006189011,0.000050795763,0.0016424411],"genre_scores_gemma":[0.9832536,0.00009062473,0.012422017,0.0023682537,0.00010130176,0.0007843171,0.00020314772,0.000028076196,0.00074866536],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.998523,0.00019658047,0.00027889802,0.00044921733,0.00021481191,0.00033748103],"domain_scores_gemma":[0.99882597,0.0003742221,0.00025883247,0.00022873671,0.00008546394,0.00022676321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027088445,0.00024642324,0.00041062906,0.00017170432,0.0005952484,0.000020351665,0.00008891257,0.000081153834,0.00017424644],"category_scores_gemma":[0.000040981377,0.00018997773,0.00007478648,0.00027177768,0.0003665653,0.00010019796,0.000044717337,0.00036592208,0.000005731802],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026746478,0.00088285375,0.97729266,0.00006127864,0.00022926556,0.0007925027,0.0027593777,0.00054230704,0.006455369,0.0014862298,0.004387874,0.0024356616],"study_design_scores_gemma":[0.008429158,0.05124975,0.16903435,0.000017337135,0.0007748603,0.0023093491,0.0009601903,0.0014112389,0.00998893,0.0018594895,0.7535291,0.00043626176],"about_ca_topic_score_codex":0.00009003003,"about_ca_topic_score_gemma":0.000013029596,"teacher_disagreement_score":0.8082583,"about_ca_system_score_codex":0.00044779075,"about_ca_system_score_gemma":0.00076301943,"threshold_uncertainty_score":0.77470666},"labels":[],"label_agreement":null},{"id":"W4211095769","doi":"10.1038/s41379-022-01018-6","title":"Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity","year":2022,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto","funders":"","keywords":"KRAS; Pathology; Medicine; Gastroenterology; Internal medicine; Biology; Cancer; Colorectal cancer","score_opus":0.031126326374455494,"score_gpt":0.26125692471545353,"score_spread":0.23013059834099803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211095769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976333,0.00028551245,0.00037107436,0.00064463465,0.000059293274,0.0005266026,0.000022766677,0.000013764767,0.00044306953],"genre_scores_gemma":[0.99682474,0.000004530311,0.0025068345,0.00020213622,0.000013004068,0.00019912804,0.00008838482,0.000014722207,0.00014653917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847466,0.00032929037,0.00031268463,0.00027759658,0.000386068,0.00021968577],"domain_scores_gemma":[0.9993533,0.00006112763,0.00015509817,0.00032943662,0.000052033738,0.00004904346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040447127,0.0001359549,0.00026582336,0.00013658777,0.0001437723,0.000002059226,0.00012745852,0.000045580444,0.000040542916],"category_scores_gemma":[0.0000247702,0.00009425767,0.000052597516,0.00020583984,0.000057016983,0.00002695855,0.00009630648,0.00033744593,0.000007538598],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010216724,0.0015605965,0.9408103,0.00009845225,0.0001227773,0.0028860704,0.038069114,0.00042430536,0.0065344055,0.00008543095,0.00008740826,0.00829942],"study_design_scores_gemma":[0.0016323604,0.00079489197,0.9940456,0.00004302937,0.00007831627,0.0008484212,0.0009728181,0.00008707543,0.0006641434,0.00036980485,0.00036063217,0.0001029095],"about_ca_topic_score_codex":0.000052525913,"about_ca_topic_score_gemma":0.00028600538,"teacher_disagreement_score":0.05323525,"about_ca_system_score_codex":0.000219187,"about_ca_system_score_gemma":0.00023235918,"threshold_uncertainty_score":0.38437164},"labels":[],"label_agreement":null},{"id":"W4211212023","doi":"10.23736/s2724-6051.22.04680-8","title":"Partial vs. radical nephrectomy in non-metastatic pT3a kidney cancer patients: a population-based study","year":2022,"lang":"en","type":"article","venue":"Minerva Urology and Nephrology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nephrectomy; Medicine; Propensity score matching; Urology; Urothelial cancer; Population; Incidence (geometry); Cumulative incidence; Kidney cancer; Internal medicine; Surgery; Cancer; Kidney; Bladder cancer","score_opus":0.013614072441285695,"score_gpt":0.26815003963868117,"score_spread":0.25453596719739546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211212023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922386,0.00030850564,0.000010931747,0.0059337723,0.00025123236,0.0011408619,0.000030840856,0.000029482047,0.00005577375],"genre_scores_gemma":[0.98096305,0.000006104286,0.00011269859,0.017499903,0.00007906555,0.0010133191,0.00022187173,0.000025558684,0.00007845496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978012,0.0005560366,0.0004341673,0.0005348979,0.00022299592,0.00045071787],"domain_scores_gemma":[0.99916273,0.00020765168,0.00011523973,0.00025403235,0.000035558198,0.00022477732],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002679616,0.00023821463,0.000593695,0.0003142545,0.00015793028,0.0000050767703,0.00009736602,0.00009631406,0.0010958265],"category_scores_gemma":[0.00009047329,0.00021252526,0.00007239039,0.00029519974,0.00011196197,0.000036545393,0.00011130999,0.00044630226,0.000009318674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044467864,0.0024395776,0.9888684,0.00002353988,0.00014847927,0.0006459803,0.00039520813,0.0003838898,0.0002706791,0.0000123058835,0.001308612,0.0010565415],"study_design_scores_gemma":[0.013467338,0.008397636,0.9639142,0.000003460476,0.00038803567,0.000072997,0.000049729177,0.003716012,0.000024598317,0.000037630827,0.009767668,0.0001606995],"about_ca_topic_score_codex":0.0018152553,"about_ca_topic_score_gemma":0.00060697173,"teacher_disagreement_score":0.024954205,"about_ca_system_score_codex":0.0001513746,"about_ca_system_score_gemma":0.00018804442,"threshold_uncertainty_score":0.9998173},"labels":[],"label_agreement":null},{"id":"W4212782745","doi":"10.1200/jco.2022.40.6_suppl.318","title":"CABOSEQ: The efficacy of cabozantinib post up-front immuno-oncology combinations in patients with advanced renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Calgary","funders":"Ipsen","keywords":"Medicine; Cabozantinib; Ipilimumab; Nivolumab; Internal medicine; Renal cell carcinoma; Oncology; Hazard ratio; Cohort; Clear cell renal cell carcinoma; Cancer; Immunotherapy; Confidence interval","score_opus":0.05525645971141906,"score_gpt":0.35960726905927937,"score_spread":0.3043508093478603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212782745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822687,0.00067703554,0.000023211047,0.010734656,0.0019877746,0.0010805392,0.00089224445,0.000007408909,0.002328455],"genre_scores_gemma":[0.9952316,0.00006559661,0.001774565,0.0015098952,0.00027623767,0.00004365549,0.0007022925,0.000041448813,0.00035465218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99103326,0.0023892617,0.0042050877,0.0005295101,0.0013846371,0.00045824263],"domain_scores_gemma":[0.98138726,0.011578062,0.004648447,0.00086052384,0.0012277593,0.00029793772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042374902,0.0003563049,0.0017667438,0.00026888418,0.00022561644,0.000017879194,0.001034658,0.00016447977,0.00035349125],"category_scores_gemma":[0.0028271908,0.00020214317,0.0005596388,0.00034047788,0.00062413735,0.00017096383,0.0005125566,0.0022135251,0.000010418614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23157871,0.04914625,0.6447136,0.00007751052,0.0019086449,0.0058142794,0.0067397635,0.0031632388,0.0076197656,0.0002087995,0.026835904,0.022193575],"study_design_scores_gemma":[0.088477954,0.027237933,0.86163896,0.0000507892,0.0011420054,0.00018038032,0.0020376677,0.0001530028,0.0015257077,0.000040503717,0.017319141,0.00019592611],"about_ca_topic_score_codex":0.00095920684,"about_ca_topic_score_gemma":0.00046857947,"teacher_disagreement_score":0.21692543,"about_ca_system_score_codex":0.0008309805,"about_ca_system_score_gemma":0.0043462375,"threshold_uncertainty_score":0.96167886},"labels":[],"label_agreement":null},{"id":"W4212861966","doi":"10.1200/jco.2022.40.6_suppl.tps404","title":"Phase 1b/2 umbrella study of investigational immune and targeted combination therapies for patients with advanced clear cell renal cell carcinoma (ccRCC).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lenvatinib; Clear cell renal cell carcinoma; Pembrolizumab; Internal medicine; Renal cell carcinoma; Oncology; Phases of clinical research; Clinical trial; Kidney cancer; Tolerability; Adverse effect; Cancer; Immunotherapy","score_opus":0.06351321590298831,"score_gpt":0.38292504736327515,"score_spread":0.31941183146028684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212861966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971297,0.00076019054,0.000025985833,0.0005231516,0.00029663532,0.001030767,0.000018922236,0.0000047647686,0.00020991774],"genre_scores_gemma":[0.9964026,0.00003786331,0.0030476449,0.00020770077,0.00009298975,0.00003379156,0.00003961852,0.000024924115,0.00011283209],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99670154,0.0005540768,0.0017589816,0.00022410936,0.0005927305,0.0001685434],"domain_scores_gemma":[0.9954368,0.001258501,0.0022151892,0.00016957175,0.00070464,0.0002152851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013247038,0.0001600623,0.0010781495,0.00016309286,0.000116545096,0.0000050350104,0.00012408142,0.00009508365,0.000057668592],"category_scores_gemma":[0.00029100975,0.000115264535,0.00020308323,0.0001446411,0.00016753079,0.00008374643,0.00006977509,0.0005436958,5.284718e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1185681,0.2061917,0.61280084,0.00026098196,0.0010695106,0.00038815133,0.0037762527,0.00040953248,0.01491319,0.00006904632,0.0012465857,0.040306102],"study_design_scores_gemma":[0.13249,0.3384517,0.5231581,0.000017322876,0.0005695059,0.000032163694,0.0012968703,0.00014544169,0.0019935032,0.00015285269,0.00158634,0.00010619179],"about_ca_topic_score_codex":0.000013789249,"about_ca_topic_score_gemma":0.0000037595212,"teacher_disagreement_score":0.13226001,"about_ca_system_score_codex":0.00017005793,"about_ca_system_score_gemma":0.00070278073,"threshold_uncertainty_score":0.47003514},"labels":[],"label_agreement":null},{"id":"W4212884503","doi":"10.1200/jco.2022.40.6_suppl.363","title":"A prospective randomized parallel-controlled pilot trial of stereotactic body radiation therapy versus radiofrequency ablation for the management of small renal masses.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Medicine; Radiofrequency ablation; Renal cell carcinoma; Chromophobe cell; Randomized controlled trial; Percutaneous; Radiology; Radiosurgery; Surgery; Clinical trial; Prospective cohort study; Ablation; Nuclear medicine; Radiation therapy; Clear cell; Internal medicine","score_opus":0.14709121753467136,"score_gpt":0.42575915079908083,"score_spread":0.2786679332644095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212884503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97656363,0.0034554598,0.0017097789,0.0036515933,0.0027022734,0.009615373,0.000006200258,0.000007019769,0.0022886947],"genre_scores_gemma":[0.99132806,0.0030313216,0.0041193045,0.00011657721,0.0006305502,0.0005496732,0.0000060571415,0.000017582137,0.00020089032],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.994156,0.0016329257,0.003280735,0.00018519332,0.0005759458,0.00016917883],"domain_scores_gemma":[0.9827434,0.011527846,0.004969345,0.00024866877,0.00041007236,0.00010067998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009564558,0.00015585155,0.002592674,0.00015016054,0.000075279124,0.0000056953,0.00018862919,0.00009355841,0.00012476483],"category_scores_gemma":[0.0015401221,0.00008768404,0.0013640134,0.00015242396,0.00016369109,0.00005907514,0.00003378127,0.0004812107,5.263858e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95744544,0.003531152,0.00080744695,0.000035651654,0.007751323,0.00008344547,0.0001279059,0.0003221162,0.00012348138,0.00094473583,0.00009335347,0.028733961],"study_design_scores_gemma":[0.8867202,0.09200676,0.013379603,0.000023772862,0.0036445113,0.000039735773,0.00010054554,0.00084446877,0.000076806195,0.0010149389,0.002087472,0.00006123287],"about_ca_topic_score_codex":0.000024523317,"about_ca_topic_score_gemma":0.0000028263444,"teacher_disagreement_score":0.08847561,"about_ca_system_score_codex":0.00044129175,"about_ca_system_score_gemma":0.0008549983,"threshold_uncertainty_score":0.35756513},"labels":[],"label_agreement":null},{"id":"W4212920865","doi":"10.1200/jco.2022.40.6_suppl.361","title":"Comparison of patients with high-risk nonmetastatic clear cell renal carcinoma in adjuvant therapy trials versus nonclinical trial patients.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Hospital; Princess Margaret Cancer Centre; University of Calgary; Université Laval; Centre Hospitalier de l’Université de Montréal; Juravinski Cancer Centre; Montreal General Hospital; University of Manitoba; University Health Network; Ottawa Hospital; University of Toronto; Dalhousie University; University of Ottawa; University of Alberta; Queen Elizabeth II Health Sciences Centre; McMaster University","funders":"","keywords":"Medicine; Internal medicine; Clinical trial; Renal cell carcinoma; Nephrectomy; Adjuvant therapy; Cohort; Randomized controlled trial; Surgery; Cancer; Kidney","score_opus":0.2181427939916996,"score_gpt":0.4663297890566239,"score_spread":0.2481869950649243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212920865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99455774,0.00041336886,0.000012791992,0.0003468776,0.0027324224,0.0015498373,0.000065160835,0.000005831563,0.0003159947],"genre_scores_gemma":[0.9966972,0.0001674547,0.0022118103,0.00022380943,0.00054259953,0.000031720083,0.000056788627,0.000042130265,0.00002650643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.983651,0.005964042,0.008018275,0.00040984486,0.0015695256,0.00038732402],"domain_scores_gemma":[0.9761049,0.013128089,0.009250647,0.00043627276,0.00061305607,0.00046701168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010077451,0.0003120674,0.00549615,0.0003485483,0.000080782615,0.000007504907,0.0003468289,0.00028356147,0.00056438334],"category_scores_gemma":[0.0054705953,0.00019823496,0.0011355389,0.00034625226,0.0002732945,0.000091440554,0.00014574111,0.0022867187,0.000008675493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45902318,0.01830671,0.49363804,0.00001210354,0.0004241638,0.00016836559,0.00015509575,0.00021950732,0.000006890707,0.0000029948187,0.0005982211,0.02744472],"study_design_scores_gemma":[0.3005454,0.22147448,0.47430304,0.000017316761,0.0008784366,0.0000030567883,0.00014094861,0.00004265102,0.00011125421,0.000017921402,0.0023679638,0.00009753428],"about_ca_topic_score_codex":0.00011183015,"about_ca_topic_score_gemma":0.000035438123,"teacher_disagreement_score":0.20316778,"about_ca_system_score_codex":0.00050225254,"about_ca_system_score_gemma":0.0019542102,"threshold_uncertainty_score":0.99347824},"labels":[],"label_agreement":null},{"id":"W4212945456","doi":"10.1016/j.urolonc.2022.01.005","title":"Outcomes following cytoreductive nephrectomy without immediate postoperative systemic therapy for patients with synchronous metastatic renal cell carcinoma","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Systemic therapy; Metastasectomy; Renal cell carcinoma; Nephrectomy; Surgery; Internal medicine; Metastasis; Cancer; Kidney; Breast cancer","score_opus":0.02036302867564935,"score_gpt":0.2809911818542471,"score_spread":0.2606281531785977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212945456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934167,0.0014997581,0.0000680722,0.0014142203,0.00024490446,0.0026455799,0.00013240207,0.000054876626,0.0005234842],"genre_scores_gemma":[0.96745574,0.000025087515,0.02853409,0.0012770524,0.00003996572,0.0017945135,0.000356229,0.000038655962,0.00047867038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798363,0.00030604002,0.0003753759,0.00059027073,0.00031570872,0.00042894954],"domain_scores_gemma":[0.99863726,0.00043575,0.00027213953,0.00025138728,0.00013561206,0.0002678491],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002937108,0.0003623256,0.0007535084,0.00020771449,0.0007071555,0.000022985738,0.00012076829,0.00008135233,0.000044812958],"category_scores_gemma":[0.00005843243,0.00025212124,0.00015351377,0.00025027452,0.0003302,0.00011986591,0.00006356115,0.00034952536,0.000004160772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010071674,0.0007395069,0.99372876,0.000032563574,0.00035551254,0.0002218154,0.0019011444,0.00023254643,0.0008157773,0.00017519559,0.00038586423,0.00040413666],"study_design_scores_gemma":[0.058142968,0.15800138,0.5930951,0.0001335909,0.006346394,0.0018261322,0.009445989,0.0011727405,0.0057900203,0.001718026,0.1623537,0.0019739259],"about_ca_topic_score_codex":0.00007845145,"about_ca_topic_score_gemma":0.000006807427,"teacher_disagreement_score":0.40063363,"about_ca_system_score_codex":0.000615427,"about_ca_system_score_gemma":0.00074258936,"threshold_uncertainty_score":0.9999931},"labels":[],"label_agreement":null},{"id":"W4212951999","doi":"10.1200/jco.2022.40.6_suppl.304","title":"Effectiveness of first-line therapy in patients with advanced non-clear renal cell carcinoma (nccRCC).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; Sunnybrook Health Science Centre; University of Ottawa; McGill University Health Centre; Université Laval; Centre Hospitalier de l’Université de Montréal; Dalhousie University; Health Sciences Centre; Ottawa Hospital; University Health Network; University of British Columbia; Queen Elizabeth II Health Sciences Centre; University of Alberta; University of Calgary; Princess Margaret Cancer Centre; Hôtel-Dieu de Québec; BC Cancer Agency; McMaster University","funders":"","keywords":"Medicine; Pazopanib; Temsirolimus; Sunitinib; Axitinib; Nivolumab; Everolimus; Internal medicine; Pembrolizumab; Discontinuation; Renal cell carcinoma; Oncology; Ipilimumab; Sorafenib; Clinical endpoint; Clinical trial; Cancer; PI3K/AKT/mTOR pathway; Immunotherapy; Hepatocellular carcinoma; Discovery and development of mTOR inhibitors","score_opus":0.042089863589646614,"score_gpt":0.36731685818673926,"score_spread":0.32522699459709264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212951999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729496,0.00034152815,0.00002489022,0.00029753466,0.00041709334,0.00062542147,0.0000061850237,0.0000034535499,0.0009889525],"genre_scores_gemma":[0.9985627,0.00011160889,0.0009174962,0.00017546915,0.00011751448,0.000019829884,0.00000886784,0.000028883063,0.00005761809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99617696,0.00094114064,0.0017633577,0.00024325788,0.0006344229,0.00024083875],"domain_scores_gemma":[0.99539375,0.0020880215,0.0016051049,0.0002619108,0.00042002063,0.00023116493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025459547,0.00017934576,0.0016848102,0.00021431402,0.000046501358,0.000002155367,0.00019468654,0.00014248375,0.00016490076],"category_scores_gemma":[0.0003004581,0.00011905771,0.00038350228,0.00027072636,0.00013045126,0.00006898044,0.0000861247,0.0010612914,0.00000271645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09212176,0.00746535,0.87901235,0.00009014598,0.00015236909,0.00083296164,0.000091610156,0.00088986976,0.00049696193,0.0000023307296,0.00006819736,0.018776082],"study_design_scores_gemma":[0.04218635,0.15487978,0.7990035,0.00008068718,0.00011680833,0.00004333768,0.000046378405,0.000030264158,0.0022912342,0.000025696247,0.0012122993,0.00008370821],"about_ca_topic_score_codex":0.000028996401,"about_ca_topic_score_gemma":0.000009375714,"teacher_disagreement_score":0.14741443,"about_ca_system_score_codex":0.00045237248,"about_ca_system_score_gemma":0.0008811342,"threshold_uncertainty_score":0.48550326},"labels":[],"label_agreement":null},{"id":"W4212989002","doi":"10.1200/jco.2022.40.6_suppl.310","title":"Predictors of objective response to first-line immuno-oncology combination therapies in metastatic renal cell carcinoma: Results from the international metastatic renal cell database consortium (IMDC).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; London Health Sciences Centre; Western University; Dalhousie University; University of Alberta; Queen Elizabeth II Health Sciences Centre; BC Cancer Agency; University of Calgary","funders":"Alberta Cancer Foundation","keywords":"Medicine; Nivolumab; Axitinib; Internal medicine; Ipilimumab; Renal cell carcinoma; Pembrolizumab; Oncology; Cabozantinib; Response Evaluation Criteria in Solid Tumors; Progressive disease; Expanded access; Pazopanib; Sunitinib; Cancer; Disease; Immunotherapy","score_opus":0.08989455035986191,"score_gpt":0.3886909595547798,"score_spread":0.2987964091949179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212989002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9733609,0.0010418512,0.00016950721,0.021153191,0.0018661072,0.00089758384,0.00061389076,0.000009044048,0.0008879413],"genre_scores_gemma":[0.99283946,0.00024399346,0.0042667175,0.0016618123,0.0003292605,0.00006711905,0.00018513198,0.000034233322,0.000372247],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.98817104,0.005119302,0.0046041734,0.00049543916,0.0012436047,0.00036644723],"domain_scores_gemma":[0.97159773,0.0229789,0.0037699623,0.0005688806,0.0007615181,0.00032298767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012861754,0.0003100581,0.0019201977,0.00052078266,0.00013092546,0.000014527287,0.0007135449,0.00014309249,0.0003958333],"category_scores_gemma":[0.007319883,0.00021176247,0.0005878041,0.000486306,0.00036975622,0.00015914612,0.00043525812,0.0016549987,0.000010565662],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6694174,0.03586446,0.11366957,0.00010614845,0.0046423837,0.014863055,0.020174831,0.0074477824,0.08769567,0.00009787703,0.03417538,0.011845448],"study_design_scores_gemma":[0.092232496,0.10165712,0.69659114,0.00017006334,0.0029137677,0.0008741134,0.008944487,0.000976611,0.01962306,0.0006880746,0.07490587,0.00042319746],"about_ca_topic_score_codex":0.0006196756,"about_ca_topic_score_gemma":0.000437887,"teacher_disagreement_score":0.58292156,"about_ca_system_score_codex":0.0014309154,"about_ca_system_score_gemma":0.003840828,"threshold_uncertainty_score":0.87631124},"labels":[],"label_agreement":null},{"id":"W4213010155","doi":"10.1200/jco.2022.40.6_suppl.316","title":"Association of cabozantinib dose reductions for toxicity with clinical effectiveness in metastatic renal cell carcinoma (mRCC): Results from the Canadian Kidney Cancer Information System (CKCis).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Hospital; Queen Elizabeth II Health Sciences Centre; Dalhousie University; Centre Hospitalier Universitaire de Sherbrooke; University of British Columbia; BC Cancer Agency; Hôtel-Dieu de Québec; Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre; University of Calgary; McMaster University; Juravinski Cancer Centre; University of Manitoba; University Health Network; University of Alberta","funders":"","keywords":"Medicine; Sunitinib; Cabozantinib; Pazopanib; Hazard ratio; Axitinib; Renal cell carcinoma; Discontinuation; Internal medicine; Toxicity; Tyrosine-kinase inhibitor; Cohort; Cancer; Oncology; Kidney cancer; Urology; Gastroenterology; Confidence interval","score_opus":0.09265056873236414,"score_gpt":0.4041913901613804,"score_spread":0.31154082142901623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213010155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872886,0.00011096842,0.00005208967,0.008467733,0.0015851725,0.0010770584,0.0006591828,0.0000051581715,0.00075405044],"genre_scores_gemma":[0.99715185,0.000033479588,0.0012646675,0.0007517943,0.00051746785,0.00009656559,0.00008790638,0.000014075461,0.00008221363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99275094,0.002597059,0.0035189062,0.00021190364,0.0006351854,0.00028601207],"domain_scores_gemma":[0.98603946,0.008186337,0.004178807,0.00026852006,0.00085604546,0.0004708527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012552167,0.00015694415,0.0014600029,0.00021208214,0.00017626307,0.000013467898,0.00020936017,0.00022037524,0.000033482644],"category_scores_gemma":[0.005995344,0.00009992737,0.00047361554,0.0003442321,0.000115910036,0.0001620073,0.000044548826,0.001231126,0.0000020523855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05308105,0.0019039443,0.9109364,0.00023826401,0.0015383529,0.00040045817,0.001239448,0.003002331,0.00023122595,0.000084112544,0.016751233,0.010593143],"study_design_scores_gemma":[0.026990129,0.011257075,0.9377267,0.00017265246,0.0015032218,0.000105533756,0.0010663441,0.0005197058,0.00052743097,0.000026948428,0.020000197,0.000104095336],"about_ca_topic_score_codex":0.046554502,"about_ca_topic_score_gemma":0.049975,"teacher_disagreement_score":0.02679023,"about_ca_system_score_codex":0.002858744,"about_ca_system_score_gemma":0.011315025,"threshold_uncertainty_score":0.9942899},"labels":[],"label_agreement":null},{"id":"W4213022323","doi":"10.1200/jco.2022.40.6_suppl.tps405","title":"TiNivo-2: A phase 3, randomized, controlled, multicenter, open-label study to compare tivozanib in combination with nivolumab to tivozanib monotherapy in subjects with renal cell carcinoma who have progressed following one or two lines of therapy where one line has an immune checkpoint inhibitor.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Nivolumab; Renal cell carcinoma; Internal medicine; Adverse effect; Oncology; Phases of clinical research; Randomized controlled trial; Urology; Clinical trial; Cancer; Immunotherapy","score_opus":0.14702469632031276,"score_gpt":0.4409735268817561,"score_spread":0.2939488305614434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213022323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98502636,0.0013085781,0.0001319733,0.0034611905,0.00023640908,0.009676855,0.000010474315,0.000013350326,0.00013483521],"genre_scores_gemma":[0.9909934,0.00010478037,0.0069000246,0.0005560131,0.00024126258,0.0007785915,0.000017192951,0.00009168786,0.0003170773],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98831964,0.004031619,0.0052361283,0.00067414757,0.0012203334,0.00051813445],"domain_scores_gemma":[0.99219906,0.0025278784,0.003301332,0.0005382397,0.00089432695,0.0005391394],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009664431,0.0005162811,0.007453195,0.0007577405,0.0001280584,0.00006607718,0.0005786792,0.00012145932,0.000094045026],"category_scores_gemma":[0.0007298546,0.00032789633,0.0004499741,0.000763457,0.00018894736,0.000269076,0.00019915737,0.0013569482,0.0000014726402],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7742681,0.15118201,0.050245773,0.00004970274,0.0011711575,0.0031607712,0.0049824486,0.00040941543,0.0056101913,0.0000021944616,0.000022535787,0.0088957045],"study_design_scores_gemma":[0.7567201,0.21194951,0.020136094,0.00066293974,0.0006193374,0.00008342625,0.0035230822,0.0016939744,0.0042344015,0.000006979863,0.00009737184,0.00027272987],"about_ca_topic_score_codex":0.0016846869,"about_ca_topic_score_gemma":0.009034368,"teacher_disagreement_score":0.060767498,"about_ca_system_score_codex":0.00073972787,"about_ca_system_score_gemma":0.002320004,"threshold_uncertainty_score":0.9999173},"labels":[],"label_agreement":null},{"id":"W4213033568","doi":"10.1056/nejmicm2114692","title":"Page Kidneys","year":2022,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"","score_opus":0.02694625130317587,"score_gpt":0.2697975056398666,"score_spread":0.24285125433669072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213033568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93875086,0.005922855,0.00020621109,0.036253303,0.0012699786,0.00018956192,0.00000289219,0.000017769875,0.017386574],"genre_scores_gemma":[0.9889283,0.00019735048,0.0005095483,0.0019037796,0.0037632016,0.0000021234114,0.000009470311,0.000018692748,0.004667517],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982741,0.000120810204,0.0004624391,0.00010667853,0.00086059,0.0001753704],"domain_scores_gemma":[0.998818,0.00012812269,0.00026537912,0.00018711684,0.00010438434,0.00049699197],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008795489,0.00012542125,0.00046166172,0.00023762492,0.00008027227,0.0000033625706,0.00011958463,0.000021435151,0.0034611477],"category_scores_gemma":[0.00023402415,0.000078461875,0.00011044625,0.00020721632,0.00005110938,0.000038009126,0.000042703425,0.000499627,0.000008424098],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006464473,0.00065083423,0.043279454,0.00011684952,0.00076159363,0.022425162,0.0044858134,0.00015212416,0.08767242,0.00050931924,0.45769292,0.37578905],"study_design_scores_gemma":[0.10886908,0.01420538,0.018712666,0.00018339652,0.00072904147,0.033152085,0.00079985254,0.000036247748,0.0024423474,0.0007346584,0.82000077,0.00013445174],"about_ca_topic_score_codex":0.000061322506,"about_ca_topic_score_gemma":0.0000018120589,"teacher_disagreement_score":0.37565458,"about_ca_system_score_codex":0.0001844703,"about_ca_system_score_gemma":0.00030725298,"threshold_uncertainty_score":0.9974498},"labels":[],"label_agreement":null},{"id":"W4213072631","doi":"10.1159/000521661","title":"Comparison of First-Line Anti-PD-1-Based Combination Therapies in Metastatic Renal-Cell Carcinoma: Real-World Experiences from a Retrospective, Multi-Institutional Cohort","year":2022,"lang":"en","type":"article","venue":"Urologia Internationalis","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nivolumab; Renal cell carcinoma; Ipilimumab; Internal medicine; Interquartile range; Axitinib; Pembrolizumab; Cohort; Proportional hazards model; Gastroenterology; Oncology; Urology; Cancer; Immunotherapy; Sunitinib","score_opus":0.04808602540786917,"score_gpt":0.3198333753273656,"score_spread":0.27174734991949645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213072631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955355,0.00052538374,0.00076760416,0.0007465316,0.00028108593,0.0007117719,0.00021534982,0.000044671007,0.0011721185],"genre_scores_gemma":[0.9957599,0.000013432704,0.0020558566,0.00016170084,0.00003304797,0.000574697,0.00116539,0.0000188139,0.00021716044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975303,0.00019849137,0.0006733404,0.0004779078,0.00091682794,0.00020315302],"domain_scores_gemma":[0.99875474,0.00029185027,0.0003907582,0.00028646822,0.00021344975,0.00006273987],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034890798,0.00024167357,0.0005921045,0.00053023314,0.00015158548,0.00001680833,0.000248539,0.000041397703,0.0013068693],"category_scores_gemma":[0.00010451111,0.0002075068,0.00016737293,0.0004650317,0.0002144897,0.0000978888,0.000102979364,0.00029964166,0.0000054089824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044857993,0.0025218343,0.9862811,0.000022013133,0.00013113268,0.00012367313,0.0019455341,0.0053261323,0.0023090583,0.00065839547,0.00018746252,0.000045080353],"study_design_scores_gemma":[0.004524348,0.00093400414,0.9369123,0.000020188729,0.000112983376,0.000007327825,0.00070500205,0.034241743,0.021917524,0.00018601018,0.00028218006,0.0001563754],"about_ca_topic_score_codex":0.005610293,"about_ca_topic_score_gemma":0.001116713,"teacher_disagreement_score":0.04936879,"about_ca_system_score_codex":0.00081832183,"about_ca_system_score_gemma":0.00016496994,"threshold_uncertainty_score":0.9996061},"labels":[],"label_agreement":null},{"id":"W4213180043","doi":"10.1200/jco.2022.40.6_suppl.317","title":"First-line therapy for metastatic renal cell carcinoma with pancreatic metastases: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Calgary; Queen Elizabeth II Health Sciences Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Renal cell carcinoma; Nivolumab; Internal medicine; Proportional hazards model; Gastroenterology; Carcinoma; Population; Urology; Oncology; Vascular endothelial growth factor; Clear cell renal cell carcinoma; Cancer; VEGF receptors; Immunotherapy","score_opus":0.13729454401842792,"score_gpt":0.3912992254531915,"score_spread":0.2540046814347636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213180043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.973475,0.0033509987,0.0018592482,0.01492473,0.0012589971,0.0017478268,0.0024084332,0.000019806963,0.0009549756],"genre_scores_gemma":[0.96081156,0.00044158558,0.030959146,0.004599762,0.0011741442,0.00020410377,0.0008564606,0.000087372326,0.00086586195],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9903723,0.0019704853,0.004519517,0.0008103182,0.0016937569,0.0006336081],"domain_scores_gemma":[0.97593796,0.016934438,0.004558117,0.000993456,0.0009001385,0.0006758645],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0072990186,0.00056611374,0.002654229,0.0002829648,0.00036660765,0.000055070028,0.0009935126,0.000119618235,0.00091071497],"category_scores_gemma":[0.0022713442,0.00032636456,0.0012122233,0.0003686023,0.00044075496,0.00022749309,0.00029880306,0.001802163,0.000018013949],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5399528,0.04189662,0.09798382,0.00049258507,0.01556924,0.044053815,0.0039215502,0.008525032,0.012729381,0.00029554448,0.2049043,0.029675286],"study_design_scores_gemma":[0.23554315,0.16859902,0.14276133,0.00024593924,0.020773374,0.0053581893,0.0048026335,0.00592398,0.021801244,0.0010960934,0.391811,0.0012840336],"about_ca_topic_score_codex":0.0005370807,"about_ca_topic_score_gemma":0.0002090265,"teacher_disagreement_score":0.30440968,"about_ca_system_score_codex":0.0006331386,"about_ca_system_score_gemma":0.0038974893,"threshold_uncertainty_score":0.9999188},"labels":[],"label_agreement":null},{"id":"W4213216277","doi":"10.1200/jco.2022.40.6_suppl.308","title":"Characterizing IMDC prognostic groups in contemporary first-line combination therapies for metastatic renal cell carcinoma (mRCC).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Juravinski Cancer Centre; McMaster University; London Health Sciences Centre; Western University; University of Alberta; Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Calgary","funders":"","keywords":"Medicine; Pazopanib; Axitinib; Sunitinib; Nivolumab; Internal medicine; Pembrolizumab; Oncology; Ipilimumab; Renal cell carcinoma; Interquartile range; Cabozantinib; Context (archaeology); Bevacizumab; Everolimus; Clinical endpoint; Vascular endothelial growth factor; Clinical trial; Cancer; Immunotherapy; Chemotherapy; VEGF receptors","score_opus":0.19155119367960255,"score_gpt":0.41269984314129327,"score_spread":0.22114864946169072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213216277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824665,0.0018800551,0.00019899446,0.0127987405,0.00091687735,0.0010524963,0.00001574367,0.000009609845,0.0006609564],"genre_scores_gemma":[0.99542004,0.00010170649,0.0019539895,0.00170789,0.00041111087,0.00012523495,0.00004958692,0.00003268505,0.00019774829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955004,0.0008166489,0.0026779554,0.00025479324,0.00047528176,0.00027495588],"domain_scores_gemma":[0.992988,0.004176521,0.002112467,0.00018307903,0.00030459944,0.00023532652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004393828,0.00019385201,0.0015762354,0.0003034269,0.00010595723,0.000011417646,0.0001878613,0.000118997465,0.000120440985],"category_scores_gemma":[0.0012196016,0.00014868888,0.0005728767,0.0002023602,0.00010500449,0.0001407777,0.00008632794,0.0009772481,0.000003836088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039056584,0.02602721,0.8512433,0.0006599133,0.0010916833,0.010605435,0.002892488,0.0001613168,0.0072498694,0.00042991358,0.004879515,0.055702776],"study_design_scores_gemma":[0.03975932,0.08178059,0.83873457,0.00009764742,0.00067317905,0.0009359895,0.0009642553,0.0008434274,0.001060523,0.0014012153,0.033528227,0.0002210528],"about_ca_topic_score_codex":0.000025620273,"about_ca_topic_score_gemma":0.00001848432,"teacher_disagreement_score":0.05575338,"about_ca_system_score_codex":0.0004668219,"about_ca_system_score_gemma":0.0013821014,"threshold_uncertainty_score":0.60633564},"labels":[],"label_agreement":null},{"id":"W4213230310","doi":"10.1200/jco.20.02363","title":"Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Pembrolizumab; Renal cell carcinoma; Oncology; Internal medicine; Open label; Phases of clinical research; First line therapy; Chemotherapy; Immunotherapy; Cancer; Clinical trial","score_opus":0.12702959612721465,"score_gpt":0.42852472236053935,"score_spread":0.3014951262333247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213230310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940129,0.0009870532,0.000010495296,0.0009671714,0.00035655682,0.0012084718,0.0000055065443,0.000006267256,0.0024455986],"genre_scores_gemma":[0.99545157,0.00059018104,0.0022782674,0.00096756284,0.00022475689,0.000015536634,0.000011225398,0.000059413498,0.00040147663],"study_design_codex":"nonrandomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9944775,0.0007777052,0.003116995,0.00049502525,0.0007564197,0.00037633133],"domain_scores_gemma":[0.9943461,0.0009849598,0.0025328172,0.0005601025,0.0011276451,0.00044838976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011640781,0.00033462033,0.0025124396,0.00021203491,0.00007565332,0.000017533514,0.00042794037,0.0003049503,0.00030705295],"category_scores_gemma":[0.00034277045,0.00022756071,0.0002518201,0.00039247054,0.00014033413,0.00020209272,0.0001792119,0.001031635,0.0000069264306],"study_design_candidate":"nonrandomized_trial","study_design_consensus":"nonrandomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25618365,0.43289313,0.16308396,0.000052917232,0.00050250883,0.0052442476,0.001236359,0.00018804867,0.003990695,0.0000030389542,0.0003258,0.13629563],"study_design_scores_gemma":[0.27791098,0.5611708,0.14810021,0.00008458559,0.00025264957,0.00007170391,0.00034892547,0.00002323956,0.008316784,0.000027920645,0.0035340155,0.00015817015],"about_ca_topic_score_codex":0.000058251415,"about_ca_topic_score_gemma":0.00010714867,"teacher_disagreement_score":0.13613746,"about_ca_system_score_codex":0.00037807573,"about_ca_system_score_gemma":0.0018270763,"threshold_uncertainty_score":0.92796564},"labels":[],"label_agreement":null},{"id":"W4213238101","doi":"10.1200/jco.2022.40.6_suppl.346","title":"Efficacy of tyrosine kinase inhibitors (TKI) after combination ipilimumab plus nivolumab (I/N) in metastatic clear cell renal cell carcinoma (ccmRCC) patients: Results from the Canadian Kidney Cancer Information System (CKCis).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Université Laval; McMaster University; University of Ottawa; Sunnybrook Hospital; BC Cancer Agency; Hôtel-Dieu de Québec; Princess Margaret Cancer Centre; University of Calgary; Juravinski Cancer Centre; University of Manitoba; Dalhousie University; University Health Network; University of British Columbia; University of Alberta","funders":"","keywords":"Medicine; Sunitinib; Pazopanib; Discontinuation; Nivolumab; Renal cell carcinoma; Internal medicine; Ipilimumab; Oncology; Tyrosine-kinase inhibitor; Cabozantinib; Cancer; Immunotherapy","score_opus":0.04212863513743546,"score_gpt":0.3229918578124641,"score_spread":0.2808632226750286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213238101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922152,0.00044655456,0.0000043780465,0.0029801577,0.0015749546,0.0008666735,0.00037784266,0.000006971105,0.0015272709],"genre_scores_gemma":[0.9976784,0.00003884015,0.0002921523,0.0013889364,0.00026929143,0.000044305496,0.00019054048,0.00002458591,0.000072945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99313635,0.0013250527,0.00395541,0.00024970324,0.0009775787,0.0003559149],"domain_scores_gemma":[0.9935991,0.0015362995,0.003122646,0.00038786023,0.00071520446,0.00063884654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027851523,0.00023670362,0.001286962,0.00041525427,0.00014222827,0.000021733698,0.00029542632,0.00020711987,0.00014937608],"category_scores_gemma":[0.0015876268,0.00016893096,0.0004399335,0.00043701805,0.00015285399,0.00025836483,0.000121722114,0.0013276924,0.000016175532],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.22058329,0.012582346,0.6417709,0.00082467875,0.00093541184,0.0040502814,0.013974672,0.006271216,0.0004103861,0.00008212883,0.056888875,0.0416258],"study_design_scores_gemma":[0.07926997,0.017812952,0.8805286,0.00027243842,0.00093099533,0.000044342825,0.0015110772,0.0012665249,0.0009673979,0.000017362625,0.017170481,0.0002078307],"about_ca_topic_score_codex":0.066052996,"about_ca_topic_score_gemma":0.017260415,"teacher_disagreement_score":0.23875771,"about_ca_system_score_codex":0.0045770295,"about_ca_system_score_gemma":0.0067133424,"threshold_uncertainty_score":0.9992442},"labels":[],"label_agreement":null},{"id":"W4213314922","doi":"10.1200/jco.2022.40.6_suppl.345","title":"The role of cytoreductive nephrectomy and systemic therapy in the management of tumor thrombus in patients with metastatic renal cell carcinoma.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Renal cell carcinoma; Systemic therapy; Thrombus; Nephrectomy; Internal medicine; Cancer; Urology; Oncology; Progression-free survival; Cohort; Surgery; Chemotherapy; Kidney","score_opus":0.04280343870933002,"score_gpt":0.34677186268360116,"score_spread":0.30396842397427115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213314922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950074,0.0029186052,0.0000015724295,0.00037855597,0.00011596248,0.00072206254,0.0000037139462,8.2634364e-7,0.0008513191],"genre_scores_gemma":[0.9990086,0.00026326388,0.0005399096,0.00010375518,0.00003468408,0.000023966979,0.000001394576,0.000010017114,0.000014427516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99641126,0.0011876855,0.001540959,0.00014066456,0.0005577911,0.00016166428],"domain_scores_gemma":[0.99674773,0.001275772,0.0015440515,0.00021041941,0.00015767416,0.00006432992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00294588,0.00011570219,0.00094130205,0.00011771848,0.000042702814,0.000003361381,0.00021427688,0.000032386783,0.000013778276],"category_scores_gemma":[0.0000549686,0.000053074593,0.00015384109,0.00023545965,0.00020753428,0.000037610345,0.00006692536,0.0005861918,2.4645374e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017799165,0.0040477356,0.94966966,0.000089296926,0.00057100685,0.0007894991,0.0014488546,0.00014258431,0.00021149048,0.0001536997,0.000054939774,0.025022093],"study_design_scores_gemma":[0.01437556,0.026618615,0.94962686,0.00007342134,0.00031531576,0.00019707103,0.007591892,0.000019028395,0.0002954625,0.00025809483,0.0005818332,0.00004684341],"about_ca_topic_score_codex":0.00005907139,"about_ca_topic_score_gemma":0.0000135201335,"teacher_disagreement_score":0.02497525,"about_ca_system_score_codex":0.00020591328,"about_ca_system_score_gemma":0.00040119808,"threshold_uncertainty_score":0.25467443},"labels":[],"label_agreement":null},{"id":"W4213356935","doi":"10.1200/jco.2022.40.6_suppl.338","title":"Efficacy and safety of lenvatinib (LEN) plus pembrolizumab (PEMBRO) versus sunitinib (SUN) in the East Asian subset of patients with advanced renal cell carcinoma (aRCC) from the phase 3 CLEAR trial.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Clinical endpoint; Odds ratio; Population; Clinical trial; Confidence interval; Oncology","score_opus":0.0947188487294451,"score_gpt":0.3856240920916396,"score_spread":0.29090524336219453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213356935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933017,0.0004185455,0.000006882713,0.0022703472,0.0005145151,0.0011819166,0.0001423083,0.0000034171308,0.0021603613],"genre_scores_gemma":[0.9985802,0.00008360557,0.00051235844,0.0003555909,0.00031862882,0.000019467352,0.00007845987,0.000027243525,0.00002445447],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99328655,0.0023519592,0.0028035266,0.0002933201,0.00096814655,0.00029649274],"domain_scores_gemma":[0.98954123,0.0064514675,0.0029569783,0.0004903905,0.00034125982,0.00021867831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028277305,0.00024093068,0.001736798,0.00013340876,0.0001104567,0.0000066099124,0.00044955272,0.00016489858,0.00025867767],"category_scores_gemma":[0.0014405709,0.00012943926,0.0003787539,0.00031643375,0.0004745861,0.00008708664,0.00015108322,0.0015018967,0.000001336413],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9288829,0.007609595,0.021940032,0.000029882094,0.00030253374,0.00046142007,0.00206631,0.000117676114,0.00009961994,0.000038831346,0.0003617583,0.038089424],"study_design_scores_gemma":[0.4396892,0.111494035,0.43892667,0.000050452378,0.0006371791,0.000045738423,0.002564998,0.000025506515,0.00009173695,0.000019887293,0.006360029,0.000094605144],"about_ca_topic_score_codex":0.000091899106,"about_ca_topic_score_gemma":0.000095472875,"teacher_disagreement_score":0.48919374,"about_ca_system_score_codex":0.00025887345,"about_ca_system_score_gemma":0.0015473948,"threshold_uncertainty_score":0.65250766},"labels":[],"label_agreement":null},{"id":"W4214672886","doi":"10.1148/rg.210138","title":"Renal Neoplasms in Young Adults","year":2022,"lang":"en","type":"article","venue":"Radiographics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Young adult; Malignancy; Watchful waiting; Disease; Biopsy; Epidemiology; Pediatrics; Kidney; Internal medicine; Cancer","score_opus":0.012445960454441775,"score_gpt":0.23380951173039022,"score_spread":0.22136355127594845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214672886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910193,0.0011530496,0.000011916837,0.00042514797,0.00020719571,0.0003748038,0.00001261825,0.000057611214,0.006738376],"genre_scores_gemma":[0.9985796,0.0001499831,0.00044504314,0.00017357379,0.000065695436,0.000121118064,0.000070890754,0.00002444729,0.00036964365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987347,0.00007016466,0.00021857084,0.0002719605,0.00043640367,0.00026818216],"domain_scores_gemma":[0.99945164,0.000042603067,0.000049177466,0.00031248867,0.000025038336,0.00011904435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002007513,0.0001315947,0.0002236937,0.00055726536,0.00010128956,0.00000810935,0.00009265254,0.000041363255,0.00017678742],"category_scores_gemma":[0.000015667092,0.00012542332,0.0001751872,0.0011566803,0.00004575752,0.00003209037,0.000059287577,0.0003831847,0.0000075932026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077673636,0.0004186101,0.9911907,0.0000426518,0.000086532615,0.0015352712,0.00087373686,0.00014844345,0.00087316614,0.0005571429,0.0014939791,0.0020030397],"study_design_scores_gemma":[0.00565531,0.0016011522,0.97866726,0.00006597937,0.00012316272,0.0019045881,0.00058074726,0.0011705348,0.00088841544,0.00023142107,0.008848123,0.00026331272],"about_ca_topic_score_codex":0.00041115534,"about_ca_topic_score_gemma":0.00024236499,"teacher_disagreement_score":0.012523437,"about_ca_system_score_codex":0.00017213942,"about_ca_system_score_gemma":0.000066859226,"threshold_uncertainty_score":0.51146144},"labels":[],"label_agreement":null},{"id":"W4214837478","doi":"10.5489/cuaj.367","title":"Management of Kidney Cancer: Canadian Kidney Cancer Forum","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Kidney cancer; Cancer; Kidney; Medicine; Internal medicine","score_opus":0.013025971405176615,"score_gpt":0.23567068726270893,"score_spread":0.22264471585753232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214837478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56567824,0.0014259411,0.000010745133,0.39778507,0.0011362587,0.001033105,0.0004111249,0.00003107906,0.032488436],"genre_scores_gemma":[0.9641712,0.00071854604,0.0002455167,0.029557746,0.00029978642,0.000118754215,0.000048625738,0.000023288088,0.0048165526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777365,0.00009351823,0.00046625634,0.00024860166,0.00047540475,0.0009425488],"domain_scores_gemma":[0.99270594,0.00003161333,0.0003082071,0.00017645693,0.00046848136,0.00630929],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027189564,0.00021152182,0.0003927222,0.00033471695,0.00024744042,0.00006854651,0.00018365032,0.00025536108,0.009228271],"category_scores_gemma":[0.00026230962,0.00017048727,0.00019936099,0.00030682355,0.000039215625,0.000118149284,0.0000183031,0.0004634578,0.00015690734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015032478,0.000028406777,0.6933242,0.000023466473,0.00045957326,0.0002423767,0.000053063777,0.00002376961,0.00008031902,0.00019580615,0.29813614,0.007417853],"study_design_scores_gemma":[0.0012347673,0.00020523793,0.7095469,0.00010541273,0.00027360435,0.000075223936,0.00012732287,0.00009957198,0.00014222479,0.00041114667,0.28759858,0.00018000096],"about_ca_topic_score_codex":0.6350352,"about_ca_topic_score_gemma":0.15318234,"teacher_disagreement_score":0.4818529,"about_ca_system_score_codex":0.006271818,"about_ca_system_score_gemma":0.004342683,"threshold_uncertainty_score":0.9975429},"labels":[],"label_agreement":null},{"id":"W4214919057","doi":"10.21203/rs.2.18147/v1","title":"Comparison of First-line Pazopanib and Sunitinib in Metastatic Renal Cell Carcinoma: Experiences of the Urologic Cancer Centre for Research and Innovation","year":2019,"lang":"en","type":"preprint","venue":"Research Square (Research Square)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Pazopanib; Sunitinib; Medicine; Renal cell carcinoma; Internal medicine; Oncology; Tyrosine-kinase inhibitor; Clinical endpoint; Cancer; Urology; Clinical trial","score_opus":0.3080759059611517,"score_gpt":0.4888211494196788,"score_spread":0.1807452434585271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214919057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97332513,0.0116075855,0.000029008104,0.0030910533,0.00013567127,0.010835998,0.00032596715,0.000017195538,0.0006323596],"genre_scores_gemma":[0.99424416,0.0014141113,0.00036161556,0.000010626447,0.00015785782,0.0024021107,0.00023501106,0.00009079263,0.0010837348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9855335,0.0037608796,0.001664826,0.0015969032,0.005403276,0.0020406505],"domain_scores_gemma":[0.9820277,0.007377455,0.00045797476,0.0016555702,0.008102273,0.0003790429],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.015598938,0.0005479752,0.001691124,0.0042316555,0.00054013066,0.00014212939,0.0010049556,0.00053899316,0.00018848202],"category_scores_gemma":[0.0038601728,0.0003872771,0.00021254207,0.004814368,0.003031496,0.00014090679,0.0028914995,0.0045616757,0.0000049245477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006540008,0.0042476235,0.8696322,0.036243692,0.00026256885,0.00013271102,0.055281166,0.0006755824,0.017286234,0.0013735248,0.0039527635,0.0043719476],"study_design_scores_gemma":[0.015097463,0.021868123,0.3864265,0.009610182,0.00023943975,0.000035623245,0.1643096,0.017127132,0.37342954,0.007679976,0.0030570223,0.0011193872],"about_ca_topic_score_codex":0.004632828,"about_ca_topic_score_gemma":0.0014952886,"teacher_disagreement_score":0.48320568,"about_ca_system_score_codex":0.00092893833,"about_ca_system_score_gemma":0.0027409345,"threshold_uncertainty_score":0.9998579},"labels":[],"label_agreement":null},{"id":"W4220675521","doi":"10.3390/curroncol29040192","title":"Whole-Exome Sequencing Identifies the VHL Mutation (c.262T &gt; C, p.Try88Arg) in Non-Obstructive Azoospermia-Associated Cystic Renal Cell Carcinoma","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Missense mutation; Mutation; Cancer research; Clear cell renal cell carcinoma; Medicine; Azoospermia; Pathology; Mutant; Germline mutation; Biology; Renal cell carcinoma; Gene; Genetics; Infertility","score_opus":0.0538712907039978,"score_gpt":0.326067483006306,"score_spread":0.2721961923023082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220675521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99168587,0.0024242215,0.00005400833,0.000687008,0.0018105999,0.0012247976,0.000055618322,0.00005857613,0.001999279],"genre_scores_gemma":[0.9977282,0.000024991157,0.000059510618,0.00012211008,0.00021967388,0.0005227576,0.00043731203,0.000046615267,0.00083877315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99672794,0.00067827763,0.0006925072,0.00063225394,0.00064078753,0.0006282214],"domain_scores_gemma":[0.998339,0.00044853124,0.0004197461,0.0004464629,0.00019218639,0.00015406196],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007416489,0.00034293247,0.0006518456,0.00034976398,0.00039904652,0.000032171876,0.00026906328,0.00013841006,0.00028636353],"category_scores_gemma":[0.0001954269,0.00027832953,0.00021588345,0.00071053684,0.0002007395,0.00012087923,0.00029056892,0.0010540216,0.00008984311],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036888092,0.0074568475,0.47902626,0.001143505,0.00081349333,0.01712987,0.079144105,0.0087024765,0.33574998,0.0005242543,0.017229553,0.04939083],"study_design_scores_gemma":[0.008409738,0.0028721802,0.95747715,0.00010464427,0.00071810675,0.00093515817,0.00872369,0.004819682,0.008716178,0.0008352034,0.0058654114,0.00052283215],"about_ca_topic_score_codex":0.0002617217,"about_ca_topic_score_gemma":0.00022808161,"teacher_disagreement_score":0.4784509,"about_ca_system_score_codex":0.005996078,"about_ca_system_score_gemma":0.0007364058,"threshold_uncertainty_score":0.99996686},"labels":[],"label_agreement":null},{"id":"W4220688389","doi":"10.1016/j.intimp.2022.108720","title":"The effect of immune checkpoint inhibitor combination therapies in metastatic renal cell carcinoma patients with and without previous cytoreductive nephrectomy: A systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"International Immunopharmacology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"European Association of Urology; Uehara Memorial Foundation","keywords":"Renal cell carcinoma; Medicine; Meta-analysis; Oncology; Nephrectomy; Internal medicine; Immune system; Carcinoma; Cancer research; Urology; Kidney; Immunology","score_opus":0.02827295094979325,"score_gpt":0.3258499789617365,"score_spread":0.29757702801194325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220688389","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03317437,0.9587382,0.0000014575115,0.000110018955,0.00010857862,0.0077144606,0.00009073858,0.000010921138,0.000051273353],"genre_scores_gemma":[0.0929962,0.9017178,0.000047650217,0.000043510285,0.000010733917,0.004512698,0.00033420857,0.000051834963,0.0002853755],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9948682,0.0021490229,0.0016440366,0.00052733097,0.0005766552,0.00023472389],"domain_scores_gemma":[0.99636304,0.0011626286,0.001783829,0.00040036,0.0002254063,0.00006473938],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001324037,0.00060747605,0.0060509755,0.0005944424,0.00009924197,0.00003342488,0.00029864113,0.00007969672,0.00022060794],"category_scores_gemma":[0.00014100241,0.0003087743,0.0011049637,0.00057380093,0.00023807511,0.00009190947,0.00021650389,0.0005178764,0.0000023332802],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011523785,0.00073928037,0.0012537654,0.55968374,0.4330855,0.000098154254,0.00045592163,0.0000028884124,0.000059222068,0.000015825248,0.0000180117,0.003435315],"study_design_scores_gemma":[0.0040688403,0.0025805768,0.0011515301,0.005343795,0.98364514,0.00016055792,0.000029291423,0.000011298627,0.0002054902,0.0000051125758,0.0024903994,0.000307984],"about_ca_topic_score_codex":0.000106092244,"about_ca_topic_score_gemma":0.0000053394774,"teacher_disagreement_score":0.55433995,"about_ca_system_score_codex":0.000532779,"about_ca_system_score_gemma":0.00015404374,"threshold_uncertainty_score":0.99993646},"labels":[],"label_agreement":null},{"id":"W4220767117","doi":"10.1016/j.urology.2022.02.020","title":"Ultrasound Correlates Highly With Cross Sectional Imaging for Small Renal Masses in a Contemporary Cohort","year":2022,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary; McGill University; Dalhousie University; University of Toronto; McMaster University; University of Alberta; Université Laval; University of Ottawa","funders":"","keywords":"Medicine; Cohort; Magnetic resonance imaging; Cross-sectional study; Ultrasound; Radiology; Body mass index; Nuclear medicine; Correlation; Internal medicine; Pathology","score_opus":0.02795976785362341,"score_gpt":0.2663008367267884,"score_spread":0.23834106887316497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220767117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937365,0.0008029201,0.00039779046,0.0006556497,0.00020259137,0.0007189164,0.000037873117,0.000047448182,0.0034003325],"genre_scores_gemma":[0.99698657,0.000003154615,0.0003897672,0.0008388619,0.000079335456,0.00050016877,0.00026923916,0.000027722755,0.00090518827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989231,0.00007498605,0.00023553413,0.00035515733,0.00015501575,0.0002562126],"domain_scores_gemma":[0.99923444,0.00039476788,0.00008337461,0.0001653933,0.000056856432,0.000065185704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025028636,0.00013611486,0.00024188175,0.00014734984,0.00012258258,0.000012988237,0.00006936259,0.000042332653,0.00020469604],"category_scores_gemma":[0.000044736556,0.00011524467,0.0000642087,0.00011474025,0.00011621185,0.000035335368,0.00004187624,0.0002629821,0.000005677078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030285898,0.00017240907,0.9920544,0.00001688533,0.00010593771,0.000708757,0.00010643814,0.001194029,0.0017436964,0.0001725383,0.0006665646,0.000029772349],"study_design_scores_gemma":[0.004481632,0.0018416033,0.9790504,0.000003885242,0.000066891,0.004091649,0.00006907828,0.0006806827,0.0005700324,0.00027257195,0.008749445,0.00012211327],"about_ca_topic_score_codex":0.00016309872,"about_ca_topic_score_gemma":0.000046044017,"teacher_disagreement_score":0.013003966,"about_ca_system_score_codex":0.0001806166,"about_ca_system_score_gemma":0.00022862019,"threshold_uncertainty_score":0.46995413},"labels":[],"label_agreement":null},{"id":"W4220770313","doi":"10.1016/j.esmoop.2022.100413","title":"“The first ones now, will later be last”: understanding the importance of historical context when reading ESMO-MCBS scores","year":2022,"lang":"en","type":"editorial","venue":"ESMO Open","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Genentech; Ipsen; Servier; Nordic Nanovector; Radius Health; Merck KGaA; FibroGen; Gilead Sciences; Amgen; Ariad Pharmaceuticals; Chugai Pharmaceutical; Roche; Meso Scale Diagnostics; Sanofi; Merck; Pfizer; G1 Therapeutics; Bayer; Shire; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Pazopanib; Medicine; Sunitinib; Axitinib; Cabozantinib; Renal cell carcinoma; Pembrolizumab; Internal medicine; Oncology; Nivolumab; Context (archaeology); Tyrosine-kinase inhibitor; Cancer; Immunotherapy","score_opus":0.05402991100113508,"score_gpt":0.2882864576658172,"score_spread":0.2342565466646821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220770313","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005984203,0.005250731,0.000050517425,0.028829046,0.92316014,0.0053070844,0.0002587248,0.00011801171,0.031041536],"genre_scores_gemma":[0.27852634,0.0025576735,0.00035303703,0.0015143676,0.55174327,0.0015911342,0.0016388355,0.0006480542,0.16142732],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961982,0.00019667308,0.0008557375,0.0007334955,0.00147934,0.0005365781],"domain_scores_gemma":[0.9952425,0.002371467,0.0007336396,0.001311817,0.0001842088,0.0001563813],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012183642,0.00051812385,0.0010989081,0.000114606424,0.00089747243,0.000186369,0.0013949357,0.00038164057,0.000848664],"category_scores_gemma":[0.0005426657,0.00030383506,0.00033731098,0.00021041697,0.0002693493,0.00019113785,0.001073768,0.0012770421,0.000021810161],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090102234,0.000095630756,0.01522864,0.0001354934,0.0005209949,0.00029186436,0.001391006,0.000002833044,0.00000391616,0.0005423632,0.9807992,0.00008701037],"study_design_scores_gemma":[0.0016631866,0.0006335401,0.0012857915,0.00039244967,0.00054244685,0.000027777156,0.0008403245,0.0000064646365,0.00008374057,0.00073521957,0.99348617,0.00030288676],"about_ca_topic_score_codex":0.003105898,"about_ca_topic_score_gemma":0.0087528825,"teacher_disagreement_score":0.3714169,"about_ca_system_score_codex":0.005510108,"about_ca_system_score_gemma":0.0006632327,"threshold_uncertainty_score":0.99994135},"labels":[],"label_agreement":null},{"id":"W4220834976","doi":"10.17305/bjbms.2021.6935","title":"Small cell variant of chromophobe renal cell carcinoma: Clinicopathologic, and molecular-genetic analysis of 10 cases.","year":2022,"lang":"en","type":"article","venue":"Bosnian Journal of Basic Medical Sciences","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Royal Columbian Hospital","funders":"Lékařská Fakulta v Plzni, Univerzita Karlova; Ministerstvo Zdravotnictví Ceské Republiky; Univerzita Karlova v Praze","keywords":"Medicine; Chromophobe cell; Pathology; Renal cell carcinoma; Carcinoma; Cell; Clear cell; Cancer research; Genetics; Biology","score_opus":0.045199953242759806,"score_gpt":0.2779186405384226,"score_spread":0.23271868729566278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220834976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99095535,0.0063565965,0.00019134558,0.00075582403,0.00013784676,0.00015698936,0.000020753792,0.0000035012613,0.00142179],"genre_scores_gemma":[0.9966217,0.00016959694,0.0028186985,0.00020870184,0.00005905349,0.000004366207,0.0000034026523,0.000008747168,0.00010570789],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99572337,0.0004429919,0.0012289874,0.0003552092,0.0019266186,0.00032284652],"domain_scores_gemma":[0.99748176,0.0004253607,0.0010521744,0.0002724086,0.0001693128,0.0005989739],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002995787,0.00018973899,0.000976271,0.0006306596,0.00013162292,0.000012065149,0.00046000147,0.00008309836,0.002335239],"category_scores_gemma":[0.0003855155,0.00013063227,0.0004443674,0.0013832272,0.00081912876,0.00004520423,0.0002048687,0.00038183492,0.0000013688862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018178595,0.0059528067,0.66945106,0.0008818164,0.0012928005,0.12256085,0.0031228524,0.0022659516,0.17061502,0.00015424704,0.00135164,0.020533124],"study_design_scores_gemma":[0.009937974,0.043406367,0.75448936,0.00026523965,0.01130469,0.017881017,0.0028827013,0.003940758,0.15408717,0.00026167568,0.0009187724,0.000624242],"about_ca_topic_score_codex":0.00015584771,"about_ca_topic_score_gemma":0.000014859962,"teacher_disagreement_score":0.10467984,"about_ca_system_score_codex":0.00008552422,"about_ca_system_score_gemma":0.0012863367,"threshold_uncertainty_score":0.99857676},"labels":[],"label_agreement":null},{"id":"W4220916373","doi":"10.1148/radiol.211680","title":"Multicenter Evaluation of Multiparametric MRI Clear Cell Likelihood Scores in Solid Indeterminate Small Renal Masses","year":2022,"lang":"en","type":"article","venue":"Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Cancer Institute","keywords":"Medicine; Clear cell renal cell carcinoma; Nuclear medicine; Logistic regression; Renal cell carcinoma; Radiology; Multiparametric MRI; Predictive value; Pathology; Internal medicine; Cancer","score_opus":0.03912291893974378,"score_gpt":0.3014105992337528,"score_spread":0.262287680294009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220916373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962635,0.0014555666,0.00002623908,0.00010415398,0.00019766255,0.0008800469,0.000011630097,0.00001773616,0.0010434901],"genre_scores_gemma":[0.99767977,0.00006595825,0.0017296168,0.00011481488,0.000052693118,0.00017960204,0.000060481947,0.000023525405,0.000093518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997844,0.00066066236,0.00043780293,0.00035801507,0.00037195155,0.00032756623],"domain_scores_gemma":[0.99905455,0.00022382247,0.0001967378,0.00032570327,0.00011744924,0.000081727136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095309323,0.00015723026,0.00043988592,0.00060136797,0.000044534514,0.0000035718997,0.00012882458,0.00008679623,0.00034519227],"category_scores_gemma":[0.0001770776,0.00014243933,0.00011013326,0.00038408628,0.000071890296,0.000027684497,0.00011413697,0.00030467822,0.00001772828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002859426,0.0019072522,0.8795319,0.00021180908,0.00017579249,0.00062920095,0.0016784818,0.008226214,0.084799334,0.000014732121,0.0004501369,0.019515682],"study_design_scores_gemma":[0.012603024,0.0039803064,0.8730291,0.000043901375,0.0004477344,0.0003826549,0.0004285702,0.04372544,0.064468466,0.00012304225,0.0005451659,0.00022258377],"about_ca_topic_score_codex":0.00014811163,"about_ca_topic_score_gemma":0.000031050637,"teacher_disagreement_score":0.035499226,"about_ca_system_score_codex":0.0004901058,"about_ca_system_score_gemma":0.00019031789,"threshold_uncertainty_score":0.5808507},"labels":[],"label_agreement":null},{"id":"W4220920700","doi":"10.1038/s41379-022-01057-z","title":"Do we need an updated classification of oncocytic renal tumors?","year":2022,"lang":"en","type":"review","venue":"Modern Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Oncocytoma; Tuberous sclerosis; Chromophobe cell; Pathology; Renal oncocytoma; Eosinophilic; Clear cell; Renal cell carcinoma; Medicine; Angiomyolipoma; Kidney; Internal medicine","score_opus":0.12941027906251815,"score_gpt":0.35501845851954617,"score_spread":0.22560817945702802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220920700","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040682815,0.99221003,0.0001543013,0.000086225555,0.00016064075,0.0012179186,0.00009421244,0.000083567924,0.0019247993],"genre_scores_gemma":[0.008326199,0.98652023,0.00039748434,0.00003415072,0.00012946325,0.00033082115,0.0033298638,0.00011758277,0.00081421866],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99678105,0.0007174753,0.0009592998,0.0008126227,0.00038223783,0.00034734135],"domain_scores_gemma":[0.9976517,0.000090542686,0.0007044413,0.001302934,0.00007584956,0.00017456153],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038521708,0.0004655674,0.0023859427,0.0004878437,0.00006234833,0.00000906473,0.00028466916,0.00039012136,0.00090871996],"category_scores_gemma":[0.00004028797,0.00037121534,0.0004907416,0.00034563892,0.00013600769,0.000041728126,0.00013153545,0.0006518465,0.00007407456],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010842813,0.00047138665,0.000025851627,0.003911718,0.00019312123,0.002140147,0.00031812346,0.0000043999576,0.00045754676,0.00019760516,0.0002805413,0.99189115],"study_design_scores_gemma":[0.0014918459,0.0024042635,0.00039617385,0.0024054637,0.004411799,0.0065222527,0.000093245675,0.0004250108,0.000053559328,0.00053965044,0.9807452,0.0005115142],"about_ca_topic_score_codex":0.000014131452,"about_ca_topic_score_gemma":0.000003670335,"teacher_disagreement_score":0.9913796,"about_ca_system_score_codex":0.00068917626,"about_ca_system_score_gemma":0.00071713206,"threshold_uncertainty_score":0.999874},"labels":[],"label_agreement":null},{"id":"W4220970449","doi":"10.1016/j.clgc.2022.03.011","title":"Cost Effectiveness Analysis of Radiofrequency Ablation (RFA) Versus Stereotactic Body Radiotherapy (SBRT) for Early Stage Renal Cell Carcinoma (RCC)","year":2022,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"Varian Medical Systems","keywords":"Medicine; Radiofrequency ablation; Renal cell carcinoma; Cost-effectiveness analysis; Stage (stratigraphy); Cohort; Radiology; Cost effectiveness; Ablation; Oncology; Internal medicine","score_opus":0.11082511121681382,"score_gpt":0.4046624807217256,"score_spread":0.2938373695049118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220970449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906407,0.004537087,0.00044522696,0.00011321559,0.0010975968,0.0022376475,0.00039310503,0.000042610616,0.0004928174],"genre_scores_gemma":[0.99568546,0.00043681785,0.00054634357,0.00009876181,0.00051857566,0.0010990356,0.00025312707,0.00007160258,0.0012902897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964682,0.0007322891,0.0009756205,0.00077155716,0.00060760474,0.00044474727],"domain_scores_gemma":[0.9963719,0.0017621584,0.0005623012,0.0007657027,0.00024528682,0.00029264356],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00095626997,0.0003346981,0.0011955102,0.0004234797,0.00021428324,0.000016802482,0.0002368838,0.00014063739,0.0009450604],"category_scores_gemma":[0.00008137685,0.00031631824,0.0010891041,0.001034631,0.00013992349,0.00010599629,0.000087357,0.00046627258,0.000004087333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043536015,0.0022931127,0.91173,0.00046114312,0.0059752557,0.00054167345,0.00037044514,0.005406273,0.015795143,0.00001656852,0.0004729796,0.013401373],"study_design_scores_gemma":[0.016641663,0.013177274,0.94885457,0.000023628927,0.0059048855,0.000009705927,0.00009028858,0.0031088958,0.0063483315,0.000008195487,0.0054915203,0.0003410513],"about_ca_topic_score_codex":0.0005038885,"about_ca_topic_score_gemma":0.000012688434,"teacher_disagreement_score":0.03712454,"about_ca_system_score_codex":0.001504709,"about_ca_system_score_gemma":0.0005483411,"threshold_uncertainty_score":0.99996823},"labels":[],"label_agreement":null},{"id":"W4221024007","doi":"10.1016/j.isci.2022.104167","title":"The genomic landscape of pediatric renal cell carcinomas","year":2022,"lang":"it","type":"article","venue":"iScience","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Bundesministerium für Gesundheit; Bundesministerium für Bildung und Forschung; Deutschen Konsortium für Translationale Krebsforschung; Deutsches Krebsforschungszentrum","keywords":"Computational biology; Biology; Medicine","score_opus":0.019663547904441192,"score_gpt":0.2342817634787269,"score_spread":0.2146182155742857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221024007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93194103,0.04788137,0.000011126871,0.0005936842,0.0008989033,0.00048235725,0.00004822835,0.00001596995,0.018127345],"genre_scores_gemma":[0.9871422,0.0007745061,0.00007387357,0.00008371631,0.00041093514,0.000048542694,0.0000072976577,0.000022782482,0.011436137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969716,0.00022026314,0.0004958128,0.0005376191,0.0011424202,0.0006322703],"domain_scores_gemma":[0.99818677,0.0003303449,0.00035348485,0.0008290127,0.000087383836,0.00021300741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010482832,0.00023181614,0.00031506846,0.00017584256,0.00095222367,0.00004223814,0.0008313032,0.000040077775,0.0007251796],"category_scores_gemma":[0.000050468607,0.00016072714,0.0001965442,0.0009970093,0.0002955773,0.00005786244,0.0006561569,0.00039909047,0.00013958782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008027411,0.00129169,0.7715054,0.00026618538,0.00010974004,0.0010666068,0.008213329,0.0040638624,0.1742759,0.00075490866,0.030489571,0.0071600536],"study_design_scores_gemma":[0.003415474,0.004789221,0.9142458,0.000020792197,0.0010211145,0.00029154413,0.0042288452,0.0032891328,0.030259613,0.00014928637,0.037692502,0.00059669244],"about_ca_topic_score_codex":0.00015752928,"about_ca_topic_score_gemma":0.0000075377475,"teacher_disagreement_score":0.14401628,"about_ca_system_score_codex":0.0003199163,"about_ca_system_score_gemma":0.0009121337,"threshold_uncertainty_score":0.79402083},"labels":[],"label_agreement":null},{"id":"W4223996839","doi":"10.1016/j.eucr.2022.102081","title":"A unique case of chromophobe renal cell carcinoma seeding after biopsy","year":2022,"lang":"en","type":"article","venue":"Urology Case Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Nephrectomy; Chromophobe cell; Biopsy; Renal cell carcinoma; Renal biopsy; Pathology; Radiology; Clear cell; Kidney; Internal medicine","score_opus":0.013326847851440598,"score_gpt":0.24250320094442676,"score_spread":0.22917635309298617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223996839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99331903,0.001568064,0.000019387682,0.00020567933,0.00031663824,0.0005498399,0.000027422655,0.000052978423,0.003940975],"genre_scores_gemma":[0.9981984,0.000004342032,0.00038684378,0.0002561771,0.00010428962,0.00023549313,0.000040427596,0.000048574595,0.00072548375],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9978882,0.0001747928,0.0006826205,0.00059070654,0.00026302217,0.00040067284],"domain_scores_gemma":[0.9983992,0.00008260683,0.0003962214,0.00076562905,0.00011472502,0.00024164595],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048820802,0.00025740056,0.00051282335,0.0003129694,0.00016184404,0.000005074313,0.000032771706,0.00012968903,0.0011364142],"category_scores_gemma":[0.000040707197,0.0002399234,0.00023360022,0.00030119825,0.00013664055,0.00004503457,0.00022713206,0.00043022254,0.0000050646504],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004167537,0.0003127122,0.04296363,0.00008732673,0.00006499671,0.92468196,0.00060772913,0.00003641985,0.030435612,0.000008457775,0.00024101608,0.0001434097],"study_design_scores_gemma":[0.00082738063,0.0018802373,0.0052898107,0.0000046026666,0.00047525647,0.95464694,0.00026772526,0.00007355957,0.034814257,0.000034029392,0.0015222502,0.00016396085],"about_ca_topic_score_codex":0.0011006629,"about_ca_topic_score_gemma":0.0000329559,"teacher_disagreement_score":0.037673824,"about_ca_system_score_codex":0.0002666262,"about_ca_system_score_gemma":0.00030361896,"threshold_uncertainty_score":0.99977666},"labels":[],"label_agreement":null},{"id":"W4224316699","doi":"10.14740/wjon1400","title":"Impact of the Discordance Between Scales of Memorial Sloan-Kettering Cancer Center and International Metastatic Renal Cell Carcinoma Database Consortium in Patients’ Prognosis With Metastatic Renal Cancer","year":2022,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Cancer; Oncology; Kidney cancer; Internal medicine","score_opus":0.03743148100045013,"score_gpt":0.32902679190148043,"score_spread":0.2915953109010303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224316699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970639,0.0007035849,0.000021241018,0.00078978104,0.0003836418,0.0004754298,0.0004673932,0.0000016508603,0.00009341106],"genre_scores_gemma":[0.9986016,0.00005309512,0.00094542024,0.000062010935,0.00014947935,0.000059124162,0.000025527042,0.000020916877,0.00008279377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977567,0.00034898682,0.00087111635,0.00020746075,0.0005720019,0.00024370234],"domain_scores_gemma":[0.998022,0.00021089359,0.0012448041,0.00017632394,0.00022650223,0.00011947556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039633986,0.00019713257,0.0007782178,0.00038089312,0.000053741867,0.000007369777,0.000233868,0.000015086888,0.0002580196],"category_scores_gemma":[0.000032826043,0.000117994496,0.00018760494,0.00034472774,0.00023061101,0.00012663586,0.0001964688,0.0004455315,1.1057369e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037938957,0.000858414,0.9849059,0.000102730184,0.00069722283,0.00016292407,0.0003663958,0.0007562582,0.00482442,0.0000028025704,0.0003836524,0.0031453974],"study_design_scores_gemma":[0.010509497,0.0035514222,0.9776267,0.00024148976,0.000852398,0.00014427795,0.0001118623,0.000049667524,0.0064875144,0.000009483803,0.00031156608,0.00010411498],"about_ca_topic_score_codex":0.00066357706,"about_ca_topic_score_gemma":0.00094831095,"teacher_disagreement_score":0.00727918,"about_ca_system_score_codex":0.0008479153,"about_ca_system_score_gemma":0.00071171025,"threshold_uncertainty_score":0.48116758},"labels":[],"label_agreement":null},{"id":"W4224320461","doi":"10.1097/pap.0000000000000349","title":"The Histologic Diversity of Chromophobe Renal Cell Carcinoma With Emphasis on Challenges Encountered in Daily Practice","year":2022,"lang":"en","type":"review","venue":"Advances in Anatomic Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Royal Columbian Hospital","funders":"","keywords":"Renal oncocytoma; Clear cell; Eosinophilic; Pathology; Renal cell carcinoma; Medicine; Chromophobe cell; Oncocytoma","score_opus":0.053401870143041395,"score_gpt":0.32629965292575736,"score_spread":0.272897782782716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224320461","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015138955,0.970263,0.000001197382,0.00011718439,0.00024522876,0.0009921597,0.00003121662,0.000015708696,0.013195348],"genre_scores_gemma":[0.0613201,0.9380235,0.00018416709,0.00006856666,0.000027743583,0.00020506809,0.000046905792,0.00003539126,0.000088521345],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966143,0.0010445084,0.0006992512,0.00080333604,0.0003978873,0.00044075385],"domain_scores_gemma":[0.9965186,0.0016623859,0.0008714951,0.0008291435,0.0000493818,0.00006898039],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074255635,0.000474258,0.0019050918,0.0004568755,0.00014758337,0.0000036600263,0.00049250945,0.00024547597,0.000043231525],"category_scores_gemma":[0.00021021966,0.0002998715,0.00024225854,0.00041022725,0.0003821261,0.00012651755,0.00039078444,0.0009367998,0.000010814281],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012833623,0.0008958033,0.0010797875,0.0051691164,0.00008597559,0.023440309,0.001086007,0.000011710701,0.00000470816,0.00029336498,0.00003054575,0.9666193],"study_design_scores_gemma":[0.002093794,0.0029700454,0.0009163967,0.0013498757,0.00068973465,0.002527738,0.001177485,0.0000023158173,0.000025986736,0.0000594007,0.9878769,0.00031032416],"about_ca_topic_score_codex":0.00009555841,"about_ca_topic_score_gemma":0.00037258878,"teacher_disagreement_score":0.9878464,"about_ca_system_score_codex":0.0015885538,"about_ca_system_score_gemma":0.00040184087,"threshold_uncertainty_score":0.99994534},"labels":[],"label_agreement":null},{"id":"W4224982972","doi":"10.1016/s1470-2045(22)00212-1","title":"Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study","year":2022,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute; Chugai Pharmaceutical; MSD Australia; EMD Serono; Genentech; Takeda Pharmaceuticals U.S.A.; Merck Sharp and Dohme; Astellas Pharma; Eisai; Pfizer; Incyte; Ipsen; Exelixis; Kissei; Bayer Fund; Sanofi; GlaxoSmithKline; Merck; Memorial Sloan-Kettering Cancer Center; Bristol-Myers Squibb; Eli Lilly and Company; EUSA Pharma; AstraZeneca; Amgen; Alexion Pharmaceuticals; Astellas Pharma US","keywords":"Pembrolizumab; Lenvatinib; Sunitinib; Renal cell carcinoma; Everolimus; Kidney cancer; Phases of clinical research; Carcinoma","score_opus":0.08879883769833696,"score_gpt":0.36365213383543105,"score_spread":0.2748532961370941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224982972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915819,0.00017795178,0.0000022398879,0.0013380327,0.00011723808,0.0051998147,0.000119235374,0.00007259013,0.001390954],"genre_scores_gemma":[0.99788207,0.000009417301,0.0001494427,0.0004913847,0.000037781716,0.00076597644,0.00024270841,0.000067412235,0.000353802],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9944465,0.0024335482,0.0011396405,0.0005384333,0.00074989477,0.0006919875],"domain_scores_gemma":[0.9965222,0.0013111826,0.0009393402,0.0008342042,0.0001696453,0.00022342947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011556162,0.00041266336,0.0025270842,0.00023896093,0.00024611378,0.000007657271,0.0003233255,0.000078815996,0.00031081046],"category_scores_gemma":[0.00018121411,0.000228379,0.00011693144,0.00068836374,0.0001958024,0.000060814225,0.00014531951,0.00072258007,0.000007262239],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68973106,0.0059597953,0.29739928,0.00008870813,0.00041331063,0.000377021,0.0037168546,0.00067846896,0.000031613024,0.000010268081,0.00008928929,0.0015043247],"study_design_scores_gemma":[0.5228049,0.08432051,0.38945264,0.000019260824,0.0002366823,0.000024598587,0.0027018131,0.000035829864,0.000052692754,0.000002239101,0.00016548435,0.00018335375],"about_ca_topic_score_codex":0.0019882352,"about_ca_topic_score_gemma":0.0010689984,"teacher_disagreement_score":0.16692618,"about_ca_system_score_codex":0.0013590242,"about_ca_system_score_gemma":0.001441825,"threshold_uncertainty_score":0.93130255},"labels":[],"label_agreement":null},{"id":"W4225006265","doi":"10.5489/cuaj.7862","title":"Practice-changing publications: Kidney cancer","year":2022,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Kidney cancer; Cancer; Medicine; Internal medicine","score_opus":0.02629574542340922,"score_gpt":0.2704514462035346,"score_spread":0.24415570078012538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225006265","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24409299,0.001726321,0.00006260113,0.7162211,0.0010306952,0.00050253235,0.00015065353,0.000080879145,0.036132243],"genre_scores_gemma":[0.94705194,0.00009997229,0.0003398695,0.044824187,0.0005116833,0.00013497386,0.00006426311,0.000014907908,0.0069581773],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99825186,0.00026216608,0.0002562061,0.00017486491,0.0005564358,0.0004984534],"domain_scores_gemma":[0.9979765,0.00015106396,0.00029651768,0.00011740703,0.00034799564,0.0011105489],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010189482,0.00010031429,0.00017106338,0.00040304614,0.0008628159,0.0000873636,0.000114401555,0.00007658314,0.0069976333],"category_scores_gemma":[0.0021382663,0.00008870339,0.00012084294,0.00054776407,0.000012407463,0.00014038742,0.0000351545,0.00075599964,0.000055611497],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010254306,0.00019613763,0.6859524,0.0000049155083,0.00042723017,0.00048119025,0.00057474663,0.00027290217,0.00017694228,0.0016012551,0.304444,0.005765757],"study_design_scores_gemma":[0.0006793794,0.00024988395,0.12518252,0.0000034317677,0.00014778516,0.0010914421,0.0003968444,0.000117455245,0.000013555177,0.00023768801,0.87178797,0.000092022616],"about_ca_topic_score_codex":0.0014754415,"about_ca_topic_score_gemma":0.00011558019,"teacher_disagreement_score":0.702959,"about_ca_system_score_codex":0.006050924,"about_ca_system_score_gemma":0.0018777811,"threshold_uncertainty_score":0.99776465},"labels":[],"label_agreement":null},{"id":"W4225147572","doi":"10.1053/j.seminoncol.2022.04.002","title":"Cancer-specific mortality in patients with non-metastatic renal cell carcinoma who have undergone a nephrectomy and are eligible for adjuvant pembrolizumab","year":2022,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Pembrolizumab; Renal cell carcinoma; Nephrectomy; Kidney cancer; Adjuvant; Oncology; Internal medicine; Cancer; Adjuvant therapy; Melanoma; Surgery; Immunotherapy; Kidney; Cancer research","score_opus":0.02166250864591987,"score_gpt":0.2929535457220311,"score_spread":0.27129103707611124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225147572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931666,0.0029861585,0.000024967989,0.00030151417,0.000121182544,0.0020651056,0.000121644865,0.0000130491335,0.0011997343],"genre_scores_gemma":[0.9962644,0.00023658903,0.0010211283,0.00023860678,0.000039838193,0.001371221,0.00013997096,0.00004747015,0.0006407537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978299,0.00017645425,0.00046873276,0.00062985305,0.00035484182,0.0005402148],"domain_scores_gemma":[0.99890727,0.00024140828,0.0002545502,0.0003538808,0.00008522907,0.00015766824],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029396373,0.00028907115,0.00086508295,0.00035219645,0.00011068055,0.000008949255,0.00012087833,0.000082769715,0.00010060714],"category_scores_gemma":[0.000018116458,0.00025499598,0.00006975691,0.00034021254,0.00012907041,0.000054769735,0.00014552526,0.00040633627,0.00000146059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060141054,0.0013967913,0.9826892,0.00022163564,0.000055744225,0.0010318132,0.001562369,0.00042968415,0.0003163462,0.000010927899,0.0019304805,0.0043408894],"study_design_scores_gemma":[0.023848597,0.0083404025,0.9594918,0.0001571536,0.0001807013,0.0000760721,0.0019034058,0.00066518073,0.0012985037,0.0001021169,0.0036673439,0.00026874559],"about_ca_topic_score_codex":0.00088561757,"about_ca_topic_score_gemma":0.0021302183,"teacher_disagreement_score":0.023197437,"about_ca_system_score_codex":0.002318126,"about_ca_system_score_gemma":0.0005059571,"threshold_uncertainty_score":0.9999902},"labels":[],"label_agreement":null},{"id":"W4225399775","doi":"10.5489/cuaj.7841","title":"Definitive treatment vs. active surveillance for small renal masses: Closing the preference gap","year":2022,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Closing (real estate); Preference; Medicine; Business; Mathematics; Statistics","score_opus":0.075631115928762,"score_gpt":0.25348328047978386,"score_spread":0.17785216455102187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225399775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96081316,0.00038914877,0.00014055609,0.031881914,0.00032567148,0.00096618733,0.00041403953,0.000025569607,0.0050437367],"genre_scores_gemma":[0.9951054,0.00006543851,0.00037067305,0.0028818676,0.00032005677,0.00024541374,0.00010429178,0.000016618429,0.0008902838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980539,0.00048118728,0.000296189,0.00026214364,0.00035429967,0.00055224233],"domain_scores_gemma":[0.99805844,0.0007702977,0.00034020518,0.00013882265,0.0002565685,0.00043565882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006779374,0.00018301509,0.00031373894,0.00011147415,0.0010736712,0.00007743885,0.00014555104,0.00009614379,0.00043244366],"category_scores_gemma":[0.0005168067,0.000118779826,0.00024347001,0.00018925052,0.00003470546,0.000040843202,0.000025693656,0.0005117175,0.000011455957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022225145,0.00039177263,0.96119165,0.000009162087,0.001200752,0.0005401308,0.0016711461,0.00067036354,0.0003180139,0.0013110144,0.008573369,0.02190011],"study_design_scores_gemma":[0.0030337516,0.004798457,0.80237883,0.000008354045,0.00024722225,0.00065295235,0.0006502125,0.0002449075,0.00023111317,0.001902224,0.18564087,0.00021109062],"about_ca_topic_score_codex":0.00129525,"about_ca_topic_score_gemma":0.0023485157,"teacher_disagreement_score":0.1770675,"about_ca_system_score_codex":0.0067698285,"about_ca_system_score_gemma":0.0011357678,"threshold_uncertainty_score":0.997043},"labels":[],"label_agreement":null},{"id":"W4225423587","doi":"10.1158/1078-0432.ccr-21-4115","title":"A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); Princess Margaret Cancer Centre","funders":"National Cancer Institute; Ipsen; Eisai; Rijksuniversiteit Groningen; Medical Research Council; G1 Therapeutics; Genentech; Janssen Scientific Affairs; Advanced Accelerator Applications; EMD Serono; Karyopharm Therapeutics; Merck KGaA; Daiichi Sankyo Europe; Sanofi; Exelixis; GlaxoSmithKline; Bristol-Myers Squibb; AstraZeneca; Astellas Pharma; Celldex Therapeutics; Pfizer","keywords":"Durvalumab; Nivolumab; Renal cell carcinoma; Phases of clinical research; Kidney cancer; Immunotherapy","score_opus":0.1397838591136135,"score_gpt":0.45797407594542655,"score_spread":0.31819021683181303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225423587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99136627,0.00044987962,0.0000041843455,0.00020051117,0.00010109241,0.007582348,0.000024080007,0.000014693431,0.00025691703],"genre_scores_gemma":[0.99651444,0.00009503089,0.0002332598,0.000035248664,0.000023647115,0.0024708214,0.000055371955,0.00006714176,0.0005050293],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9918564,0.003244512,0.0012354498,0.00078276964,0.0023108637,0.0005699943],"domain_scores_gemma":[0.99607605,0.0021833277,0.00035319792,0.00064625713,0.00050509215,0.00023604972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004224725,0.0002714503,0.0014622082,0.00058472226,0.00017489433,0.000013394569,0.00029778882,0.000058598584,0.0006929279],"category_scores_gemma":[0.00033982855,0.00018001937,0.00012837519,0.001407275,0.0003917965,0.00010333575,0.00020622257,0.0012806375,0.000003840961],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88473237,0.037019875,0.06892899,0.00011679848,0.00017440185,0.0004125363,0.0025793319,0.0003504665,0.00006604014,0.0000023607497,0.00006394777,0.0055529075],"study_design_scores_gemma":[0.7803021,0.16847508,0.04679135,0.00007194802,0.00017303729,0.0000012751894,0.0029242004,0.00060797326,0.00043849822,0.000010173435,0.000042226045,0.00016214469],"about_ca_topic_score_codex":0.002607287,"about_ca_topic_score_gemma":0.0018790055,"teacher_disagreement_score":0.1314552,"about_ca_system_score_codex":0.0010495712,"about_ca_system_score_gemma":0.0012351144,"threshold_uncertainty_score":0.75870746},"labels":[],"label_agreement":null},{"id":"W4225464106","doi":"10.1002/cncr.34180","title":"Conditional survival and long‐term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma","year":2022,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":263,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Cilag; University of Texas MD Anderson Cancer Center; Genentech; Ipsen; PharmaMar; European Society for Medical Oncology; Shionogi; Astellas Pharma; Eisai; Halozyme; Mirati Therapeutics; National Institutes of Health; Mylan; Arrowhead Pharmaceuticals; Les Laboratories Pierre Fabre; Incyte; Pfizer; Daiichi Sankyo Europe; National Cancer Institute; LEO Pharma; Intuitive Surgical; Merck KGaA; Taiho Pharmaceutical; Memorial Sloan-Kettering Cancer Center; Celgene; PTC Therapeutics; Exelixis; Sanofi; Amgen; EUSA Pharma; AstraZeneca; Ono Pharmaceutical; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Ipilimumab; Sunitinib; Hazard ratio; Nivolumab; Renal cell carcinoma; Internal medicine; Clinical endpoint; Oncology; Progression-free survival; Kidney cancer; Proportional hazards model; Survival analysis; Randomized controlled trial; Cancer; Overall survival; Confidence interval; Immunotherapy","score_opus":0.019106222268818703,"score_gpt":0.25439715199950924,"score_spread":0.23529092973069055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225464106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99648976,0.000615321,0.0000066312896,0.000078514786,0.00016537371,0.0007816341,0.0001752968,0.000025943946,0.0016615228],"genre_scores_gemma":[0.99822646,0.000011086715,0.00007335968,0.00006472203,0.00006641598,0.00026933133,0.00071140093,0.000045265628,0.00053192675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841183,0.00006685334,0.00018850366,0.00043113634,0.0005698396,0.00033184243],"domain_scores_gemma":[0.99927217,0.000086381784,0.000103337894,0.00025908306,0.00010703919,0.00017199377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005620663,0.00023362685,0.00034259286,0.0001241655,0.00014198519,0.000013007015,0.000078194236,0.000033960372,0.00065549574],"category_scores_gemma":[0.000006058887,0.00018842764,0.000038201088,0.00023570597,0.00012911206,0.00008065233,0.0000731205,0.00028839946,0.0000037917964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042946696,0.0006268703,0.9508183,0.00010618896,0.000108651024,0.00060510624,0.0004876368,0.0012220293,0.00015602238,0.000028551607,0.00011502608,0.0027789215],"study_design_scores_gemma":[0.06531573,0.004719818,0.9284488,0.0000497165,0.00014502491,0.000017161772,0.0001869829,0.000022334554,0.00063581025,0.0000016437242,0.00023802601,0.00021893812],"about_ca_topic_score_codex":0.00012676268,"about_ca_topic_score_gemma":0.00023619944,"teacher_disagreement_score":0.022369487,"about_ca_system_score_codex":0.0010615953,"about_ca_system_score_gemma":0.000460044,"threshold_uncertainty_score":0.76838565},"labels":[],"label_agreement":null},{"id":"W4225480841","doi":"10.1016/j.euros.2022.03.002","title":"Impact of Body Mass Index on Survival Outcomes of Patients with Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: A Systematic Review and Meta-analysis","year":2022,"lang":"en","type":"review","venue":"European Urology Open Science","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Imperial College London; University of Alabama; University of Alabama at Birmingham; Medical Research Council; Emory University","keywords":"Medicine; Meta-analysis; Hazard ratio; Renal cell carcinoma; Internal medicine; Overweight; Oncology; Body mass index; Systematic review; Confidence interval; Obesity; MEDLINE; Publication bias","score_opus":0.09956825744611529,"score_gpt":0.37552343574255137,"score_spread":0.27595517829643607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225480841","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009232195,0.9782692,0.0000044235117,0.00006936188,0.000027921214,0.0073931175,0.00015089118,0.0000045670095,0.004848318],"genre_scores_gemma":[0.52120775,0.47719854,0.00017238826,0.00045823833,0.0000043354253,0.0005344974,0.00014697007,0.00007396292,0.00020330651],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98785585,0.007851415,0.00183626,0.000937036,0.0010904565,0.00042897149],"domain_scores_gemma":[0.9939181,0.0015491481,0.0023049114,0.0019027354,0.00019262514,0.00013244594],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008839177,0.0006083397,0.0102822045,0.00094006205,0.000117105716,0.00003793268,0.0024665957,0.000046068657,0.0003272488],"category_scores_gemma":[0.00052908744,0.00026037972,0.001410833,0.002824726,0.0007545368,0.000109081375,0.0008006186,0.00059402233,0.000009314583],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000939049,0.005820899,0.091471896,0.6365485,0.25705585,0.0035771492,0.0014863422,0.00015975925,0.0000059787394,0.00012773354,0.00009866929,0.0027081622],"study_design_scores_gemma":[0.0013871047,0.0076026632,0.1426025,0.001168468,0.84596765,0.00010871978,0.000050219955,0.000005524531,4.4132696e-7,0.0000019675285,0.0007933935,0.000311355],"about_ca_topic_score_codex":0.000185053,"about_ca_topic_score_gemma":0.000014708103,"teacher_disagreement_score":0.63538,"about_ca_system_score_codex":0.0002943199,"about_ca_system_score_gemma":0.0009498437,"threshold_uncertainty_score":0.99998486},"labels":[],"label_agreement":null},{"id":"W4225993798","doi":"10.1016/j.celrep.2021.110190","title":"Integrative clinical and molecular characterization of translocation renal cell carcinoma","year":2022,"lang":"en","type":"article","venue":"Cell Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; William Osler Health System","funders":"Janssen Pharmaceuticals; National Cancer Institute; EMD Serono; Genentech; National Institutes of Health; Eisai; Ipsen Biopharmaceuticals; Damon Runyon Cancer Research Foundation; Exelixis; Bayer Fund; National Cancer Center; Takeda Pharmaceuticals U.S.A.; Harvard Medical School; Novartis; Bristol-Myers Squibb; Dana-Farber/Harvard Cancer Center; Merck; GlaxoSmithKline; Pfizer; Rally Foundation; Conquer Cancer Foundation; Doris Duke Charitable Foundation; American Association for Cancer Research; AstraZeneca; Roche; Astellas Pharma US","keywords":"Chromosomal translocation; Renal cell carcinoma; Biology; Cancer research; Kidney cancer; Somatic cell; CD8; Chromosome; Immune checkpoint; Gene; Immune system; Immunology; Pathology; Medicine; Immunotherapy; Genetics","score_opus":0.018839697568223526,"score_gpt":0.26684259126131266,"score_spread":0.24800289369308914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225993798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950933,0.00056320167,0.0005855351,0.00015723053,0.00017575617,0.00050157966,0.000006305124,0.000016694072,0.0029004018],"genre_scores_gemma":[0.9980344,0.000033995402,0.00029919116,0.00009191784,0.000034672958,0.000050374194,0.0002811252,0.000020143474,0.0011541421],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99852085,0.0001239315,0.00060683326,0.0003345484,0.00029755782,0.00011626297],"domain_scores_gemma":[0.99911594,0.000025955089,0.00033971498,0.0003112014,0.000099361445,0.000107813605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033703118,0.00012823286,0.0003111243,0.00008605181,0.00005558048,0.0000052743553,0.000030217367,0.000049515078,0.00012272847],"category_scores_gemma":[0.00001692439,0.00011176164,0.000118458636,0.00012608862,0.000075855154,0.000036125934,0.000038953876,0.00018979081,0.0000014209176],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016785284,0.00043188327,0.07596863,0.00010490828,0.000021930566,0.001899733,0.0006965034,0.0000049756313,0.9182732,0.00001363659,0.00010472547,0.0023119901],"study_design_scores_gemma":[0.0008001308,0.0010234759,0.1352473,0.00001855797,0.00016002465,0.00041945718,0.00017865855,0.00010313363,0.8603224,0.000048846527,0.0015765595,0.000101447244],"about_ca_topic_score_codex":0.000028207387,"about_ca_topic_score_gemma":6.8455216e-7,"teacher_disagreement_score":0.059278667,"about_ca_system_score_codex":0.00006089948,"about_ca_system_score_gemma":0.0001684378,"threshold_uncertainty_score":0.45575076},"labels":[],"label_agreement":null},{"id":"W4226437517","doi":"10.1200/jco.2022.40.6_suppl.tps398","title":"Phase II trial of cytoreductive stereotactic hypofractionated radiotherapy with combination ipilimumab/nivolumab for metastatic kidney cancer (CYTOSHRINK).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Population Health Research Institute; McMaster University Medical Centre; St. Joseph’s Healthcare Hamilton; Western University; Ontario Clinical Oncology Group; Health Sciences Centre; Ottawa Hospital; London Health Sciences Centre; McMaster University; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Nivolumab; Ipilimumab; Renal cell carcinoma; Sunitinib; Kidney cancer; Oncology; Internal medicine; Nephrectomy; Immunotherapy; Urology; Cancer; Kidney","score_opus":0.14227262965147133,"score_gpt":0.47897360899517044,"score_spread":0.33670097934369914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226437517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98634166,0.00051939965,0.00042790768,0.008939682,0.0020387024,0.0014394135,0.00004959122,0.000008600334,0.00023505435],"genre_scores_gemma":[0.9932945,0.00027515955,0.004082692,0.0009501654,0.00063849904,0.00016190678,0.000024984829,0.000034008724,0.0005381174],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961112,0.0007403001,0.0020492764,0.00023419688,0.00065963535,0.00020538567],"domain_scores_gemma":[0.99331886,0.0019138021,0.0033764732,0.0001973123,0.00085386523,0.00033971257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022016934,0.00017390147,0.0017033713,0.0002475206,0.00015313798,0.0000050739227,0.00014104006,0.000101688034,0.00057385536],"category_scores_gemma":[0.0011805984,0.00012400397,0.00054813747,0.00021131369,0.00018311897,0.00018803753,0.000033307628,0.0007578233,6.5153665e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8457272,0.049153484,0.00061551464,0.000092462964,0.004852296,0.0004132133,0.00037522754,0.00021540324,0.0031062616,0.00018912918,0.004739713,0.09052007],"study_design_scores_gemma":[0.5340148,0.41652036,0.0020765732,0.0000525269,0.0023051808,0.0007492797,0.0004281322,0.0005516372,0.001175391,0.0002892276,0.041714735,0.00012214626],"about_ca_topic_score_codex":0.000057757443,"about_ca_topic_score_gemma":0.0000066398115,"teacher_disagreement_score":0.36736688,"about_ca_system_score_codex":0.0011906163,"about_ca_system_score_gemma":0.0048226435,"threshold_uncertainty_score":0.85551625},"labels":[],"label_agreement":null},{"id":"W4226485592","doi":"","title":"Small cell variant of chromophobe renal cell carcinoma: Clinicopathologic, and molecular-genetic analysis of 10 cases.","year":2022,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Royal Columbian Hospital","funders":"","keywords":"Chromophobe cell; Renal cell carcinoma; Pathology; Carcinoma; Medicine; Oncology; Biology; Clear cell; Cancer research","score_opus":0.19541771006573386,"score_gpt":0.46570645638484953,"score_spread":0.2702887463191157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226485592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9472795,0.04694732,0.000085025385,0.000040427432,0.00013812419,0.0007600793,0.00021424005,0.000012760137,0.004522533],"genre_scores_gemma":[0.9951585,0.003097433,0.0009505683,0.00013105008,0.000040400057,0.00006897076,0.000069694484,0.000059954786,0.0004234154],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9953627,0.00071256317,0.0017194282,0.00074920704,0.0010202067,0.00043592032],"domain_scores_gemma":[0.9957801,0.00046812923,0.0019103403,0.0010058,0.00043859176,0.00039704505],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014471594,0.00044531035,0.0020741916,0.0017508985,0.00016841898,0.0001049305,0.0012340219,0.00012526997,0.012355801],"category_scores_gemma":[0.00014911969,0.00039434925,0.00071791484,0.0022076268,0.00023385212,0.00021641416,0.0014911734,0.0004993593,0.0000030556698],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009395264,0.0013587506,0.47111285,0.00032595705,0.00073361665,0.005156321,0.0002132903,0.0010421895,0.5173794,0.0000045546335,0.0008328171,0.0009007557],"study_design_scores_gemma":[0.0019300834,0.00044328056,0.6669268,0.000062332394,0.0050307615,0.00032401836,0.00016191062,0.00023522739,0.32425165,0.00008408638,0.00025600585,0.00029381993],"about_ca_topic_score_codex":0.0014500662,"about_ca_topic_score_gemma":0.000026439915,"teacher_disagreement_score":0.19581397,"about_ca_system_score_codex":0.0002068992,"about_ca_system_score_gemma":0.00038279567,"threshold_uncertainty_score":0.99985087},"labels":[],"label_agreement":null},{"id":"W4226516217","doi":"10.1097/cej.0000000000000689","title":"Race/ethnicity and advanced stage of renal cell carcinoma in adults: results from surveillance, epidemiology, and end results program 2007–2015","year":2021,"lang":"en","type":"article","venue":"European Journal of Cancer Prevention","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"","keywords":"Medicine; Odds ratio; Pacific islanders; Stage (stratigraphy); Confidence interval; Surveillance, Epidemiology, and End Results; Epidemiology; Renal cell carcinoma; Logistic regression; Chromophobe cell; Internal medicine; Ethnic group; Demography; Oncology; Clear cell; Cancer registry; Population","score_opus":0.03100018674769915,"score_gpt":0.3237940271310052,"score_spread":0.292793840383306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226516217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9688098,0.027484357,0.000071545015,0.00073374907,0.00018690803,0.00037084703,0.00022004067,0.0000091559405,0.002113595],"genre_scores_gemma":[0.9880363,0.0053172805,0.005223021,0.000045391127,0.00021152174,0.000004419578,0.00009632841,0.000025976948,0.0010397629],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99591655,0.0016832751,0.0014902947,0.00039804424,0.0002627817,0.00024904555],"domain_scores_gemma":[0.9974911,0.0003302524,0.0013034024,0.0002862921,0.0003752042,0.00021375406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002779495,0.00020037539,0.00070759485,0.00013276972,0.000029841694,0.000009719582,0.00008017176,0.0000549472,0.000040417548],"category_scores_gemma":[0.000741708,0.00016599863,0.00013506573,0.00018378806,0.00012862096,0.00013579214,0.000077662764,0.00037388725,0.0000012239174],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055345807,0.0018483954,0.41050214,0.0010815229,0.0004619561,0.0051896702,0.0028725294,0.0010392522,0.033923537,0.000009931917,0.0039018532,0.4838234],"study_design_scores_gemma":[0.019305546,0.0023995135,0.9612333,0.00121407,0.00010183413,0.00010071854,0.00024831275,0.000116829164,0.010481199,0.000032518325,0.0046274415,0.000138716],"about_ca_topic_score_codex":0.00019156789,"about_ca_topic_score_gemma":0.0003594633,"teacher_disagreement_score":0.5507311,"about_ca_system_score_codex":0.00012987028,"about_ca_system_score_gemma":0.00019930048,"threshold_uncertainty_score":0.6769228},"labels":[],"label_agreement":null},{"id":"W4229018456","doi":"10.1016/j.euros.2022.04.008","title":"Split Renal Function Is Fundamentally Important for Predicting Functional Recovery After Radical Nephrectomy","year":2022,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Nephrectomy; Renal function; Function (biology); Urology; Medicine; Kidney; Internal medicine; Biology; Cell biology","score_opus":0.030830072090677035,"score_gpt":0.2695158016984351,"score_spread":0.23868572960775805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229018456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9716354,0.00030169365,0.0009712395,0.0022304186,0.00097648235,0.0013390916,0.000059026795,0.000063051186,0.022423605],"genre_scores_gemma":[0.98382205,0.000005881189,0.0024011105,0.009237607,0.00027777543,0.00028067039,0.00007049029,0.000039144925,0.0038652674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970857,0.00022358491,0.00047384217,0.0009724292,0.0007133566,0.0005311079],"domain_scores_gemma":[0.9988171,0.00010898653,0.0001999724,0.00050536427,0.000099867255,0.00026872483],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00293436,0.00020028901,0.00025889554,0.0002203426,0.0008810318,0.00012844148,0.00063315884,0.00002707692,0.003225078],"category_scores_gemma":[0.00014073635,0.00017797336,0.00013593619,0.00049194635,0.00050893996,0.00033630844,0.0012683074,0.00034766615,0.00010850919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.076813035,0.0022713984,0.6369915,0.00009585444,0.000748393,0.0038616576,0.0019336574,0.00089173776,0.15800871,0.0015146438,0.07507564,0.04179377],"study_design_scores_gemma":[0.004735924,0.010061357,0.62966216,0.000014211781,0.00030421696,0.0019123856,0.00019085383,0.0015003539,0.0009780527,0.00031747748,0.34999996,0.0003230614],"about_ca_topic_score_codex":0.00002079401,"about_ca_topic_score_gemma":0.0000033189772,"teacher_disagreement_score":0.2749243,"about_ca_system_score_codex":0.00036504245,"about_ca_system_score_gemma":0.00054965634,"threshold_uncertainty_score":0.9976861},"labels":[],"label_agreement":null},{"id":"W4229524878","doi":"10.1016/j.juro.2012.02.659","title":"583 A POPULATION-BASED COMPETING-RISKS ANALYSIS OF SURVIVAL AFTER NEPHRECTOMY FOR RENAL CELL CARCINOMA","year":2012,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Population; Epidemiology; Demography; Oncology; Internal medicine; Kidney","score_opus":0.03704585229859524,"score_gpt":0.29512249164707166,"score_spread":0.2580766393484764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229524878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99533314,0.0017619014,0.0015907517,0.0006723677,0.00018059702,0.00021362763,0.000012828055,0.0000042640504,0.00023051808],"genre_scores_gemma":[0.998162,0.000007824151,0.0011604986,0.00029988817,0.00028792463,0.000006361136,0.000018401903,0.000017744833,0.000039382958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842316,0.0003339271,0.0005906211,0.00008383746,0.00028154056,0.0002869155],"domain_scores_gemma":[0.99784654,0.00086908444,0.0006141131,0.00026789255,0.00025651604,0.00014586402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011411919,0.00014465333,0.00067981565,0.00040104854,0.00004238995,0.0000033345873,0.00012436905,0.00008690365,0.00017566477],"category_scores_gemma":[0.00008261599,0.000087358785,0.00046215754,0.00031091628,0.00006494943,0.00004011912,0.000020701385,0.00020482046,0.0000028568895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050163358,0.0002831304,0.9871925,0.000035416135,0.0007698278,0.000018800165,0.00040924572,0.001627764,0.0043812627,0.000013377589,0.000051688257,0.00020065863],"study_design_scores_gemma":[0.0022819028,0.0014031694,0.9812224,0.0000061574465,0.009314456,0.00008152345,0.00006208777,0.0010975096,0.0040309783,0.000019103963,0.00041162796,0.000069075366],"about_ca_topic_score_codex":0.00018226804,"about_ca_topic_score_gemma":0.000041287967,"teacher_disagreement_score":0.0085446285,"about_ca_system_score_codex":0.00007503679,"about_ca_system_score_gemma":0.000086805456,"threshold_uncertainty_score":0.35623878},"labels":[],"label_agreement":null},{"id":"W4229622969","doi":"10.1016/s0022-5347(02)80286-5","title":"The results of radical nephrectomy for renal cell carcinoma","year":2002,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; General surgery; Urology; Kidney; Internal medicine","score_opus":0.028904942239465683,"score_gpt":0.25082488343257103,"score_spread":0.22191994119310535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229622969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97399974,0.0072785644,0.00016224672,0.014485218,0.00021450699,0.00028100956,0.0000056323115,0.0000037978903,0.0035692644],"genre_scores_gemma":[0.99743944,0.00035589054,0.00047665206,0.00035431018,0.00038161842,0.0000030099911,9.956741e-7,0.000013763269,0.00097432797],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99859333,0.00023278546,0.00059615413,0.000079989615,0.00025433747,0.00024337418],"domain_scores_gemma":[0.99759614,0.0013196256,0.00048672225,0.00030756567,0.00018428662,0.00010565685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009918455,0.000110486166,0.00032792502,0.0000709424,0.00009706764,0.000004180351,0.00024077766,0.000079453755,0.00004195373],"category_scores_gemma":[0.00023115345,0.000049216043,0.0002154603,0.00008932162,0.00027169462,0.00002231545,0.000029223871,0.0003107445,0.000008861562],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13200204,0.00296653,0.014877399,0.0002616427,0.0018195527,0.0016968986,0.008746289,0.000706923,0.27533072,0.0010357305,0.50435305,0.056203205],"study_design_scores_gemma":[0.0442866,0.042619202,0.06591848,0.000048423015,0.003618611,0.015733417,0.00042976963,0.0026700809,0.17998931,0.0018200582,0.6425639,0.000302171],"about_ca_topic_score_codex":0.000012440966,"about_ca_topic_score_gemma":0.0000045297024,"teacher_disagreement_score":0.1382108,"about_ca_system_score_codex":0.000043466192,"about_ca_system_score_gemma":0.00006374922,"threshold_uncertainty_score":0.2006972},"labels":[],"label_agreement":null},{"id":"W4229769653","doi":"10.1016/j.urolonc.2013.10.004","title":"Outcomes in patients with metastatic renal cell cancer treated with individualized sunitinib therapy: Correlation with dynamic microbubble ultrasound data and review of the literature","year":2013,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Sunitinib; Medicine; Toxicity; Internal medicine; Oncology; Cancer; Renal cell carcinoma; Urology","score_opus":0.022585551828201714,"score_gpt":0.2871025089758623,"score_spread":0.2645169571476606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229769653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865106,0.009803958,0.00000605555,0.0018266684,0.000012499685,0.0015188212,0.00014653338,0.000011150937,0.0001637133],"genre_scores_gemma":[0.9693666,0.0070580584,0.019834686,0.001924074,0.0000064304336,0.0002383869,0.0011500281,0.00002242406,0.00039929038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988397,0.00020576712,0.00026790422,0.00032679716,0.00018182109,0.0001780286],"domain_scores_gemma":[0.9988465,0.0002647223,0.00028988815,0.00035070544,0.00014958561,0.00009865337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001625622,0.00021916318,0.00047394322,0.00009426511,0.000092487186,0.00001930532,0.0001102041,0.00007930463,0.000052192318],"category_scores_gemma":[0.00004202874,0.000098676755,0.000017897739,0.0004097648,0.00052997016,0.00016153183,0.000034149212,0.00026271254,8.303942e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024325197,0.00027764143,0.9977439,0.00026993404,0.00013630294,0.000017122593,0.00034626113,0.000016261778,0.00015452574,0.00001618422,0.00024010932,0.0005384833],"study_design_scores_gemma":[0.0063983835,0.004705326,0.9787361,0.0025933145,0.000996799,0.00016898419,0.0001185543,0.00009267718,0.00026930118,0.00009737408,0.0056387936,0.00018441681],"about_ca_topic_score_codex":0.00023325477,"about_ca_topic_score_gemma":0.0001781905,"teacher_disagreement_score":0.01982863,"about_ca_system_score_codex":0.00007630355,"about_ca_system_score_gemma":0.00026296233,"threshold_uncertainty_score":0.40239215},"labels":[],"label_agreement":null},{"id":"W4229908018","doi":"10.1200/jco.2018.36.6_suppl.685","title":"Oncologic and functional outcomes of radical and partial nephrecotmy in PT3A patholigically upstaged renal cell carcinoma: A multi-instituitional analysis.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Urology; Clear cell renal cell carcinoma; Internal medicine; Kidney","score_opus":0.14072555501568418,"score_gpt":0.41401696267779275,"score_spread":0.2732914076621086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229908018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99502206,0.00046759844,0.0009340794,0.0020797234,0.00035437554,0.00022136554,0.000009995157,0.0000056410977,0.00090514007],"genre_scores_gemma":[0.98543876,0.00015360925,0.012720682,0.0009235225,0.00060525606,0.0000064947594,0.000008383943,0.000010480381,0.00013281273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995553,0.0006630351,0.0026484695,0.0003474948,0.00050589355,0.00028206763],"domain_scores_gemma":[0.995359,0.002161616,0.0013476955,0.00017446786,0.00042718052,0.00053004245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030123026,0.00021813592,0.002303163,0.00043570937,0.00005666101,0.000009641673,0.00009510973,0.00046480502,0.00026538133],"category_scores_gemma":[0.0016242529,0.00014375987,0.00059409474,0.0003088545,0.0011529933,0.00010077912,0.00009508105,0.00084790506,0.0000059471427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057943496,0.0033976848,0.9804823,0.00002701499,0.0006671215,0.0014572447,0.000129297,0.000022230515,0.0012376589,0.00015769181,0.00026004866,0.006367383],"study_design_scores_gemma":[0.016665304,0.01183012,0.9658982,0.000021156924,0.0016868054,0.00046622436,0.000064528394,0.000604015,0.00037758774,0.00015337723,0.002119706,0.00011294198],"about_ca_topic_score_codex":0.00003628413,"about_ca_topic_score_gemma":0.00014788604,"teacher_disagreement_score":0.014584042,"about_ca_system_score_codex":0.00017576355,"about_ca_system_score_gemma":0.0012124884,"threshold_uncertainty_score":0.5862357},"labels":[],"label_agreement":null},{"id":"W4230541360","doi":"10.1016/j.urpr.2016.04.011","title":"Editorial Commentary","year":2016,"lang":"en","type":"editorial","venue":"Urology Practice","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Library science; Urology","score_opus":0.011073265359903644,"score_gpt":0.3089446264222571,"score_spread":0.29787136106235346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230541360","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018138853,0.0009262144,0.000016926533,0.032690614,0.94429934,0.0004983019,0.00012222509,0.00011567858,0.021312585],"genre_scores_gemma":[0.000045651104,0.0006987549,0.00039436272,0.0045391624,0.99004966,0.00008188461,0.00079758494,0.00010144976,0.0032914614],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99667454,0.00047990173,0.0004340033,0.00071754126,0.0011852025,0.00050882],"domain_scores_gemma":[0.98941785,0.008280531,0.0004803657,0.0009072218,0.00065725436,0.0002568029],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007224452,0.00045571174,0.00074278587,0.0001633342,0.00009928676,0.00002474145,0.0002409646,0.0020551202,0.00041000327],"category_scores_gemma":[0.007122007,0.00033418476,0.00021700092,0.00007901566,0.00017836569,0.00021954122,0.00019162425,0.0019958382,0.0016608901],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049242876,0.0003584796,0.00002062007,0.000050732317,0.0007285043,0.0009041005,0.000033684824,7.673177e-8,0.000092899994,0.00001086155,0.9921805,0.00069524033],"study_design_scores_gemma":[0.003964669,0.0024438708,0.0000069544167,0.000031605843,0.002761897,0.00013898047,0.000011704275,3.4466524e-7,0.00005436876,0.000052449006,0.99027705,0.00025611673],"about_ca_topic_score_codex":0.000161458,"about_ca_topic_score_gemma":0.0000059398235,"teacher_disagreement_score":0.045750372,"about_ca_system_score_codex":0.00046358205,"about_ca_system_score_gemma":0.00062978076,"threshold_uncertainty_score":0.999911},"labels":[],"label_agreement":null},{"id":"W4230881714","doi":"10.4321/s0210-48062008001000005","title":"Características clínico-patológicas del carcinoma de células renales detectado incidentalmente mediante estudios radiológicos","year":2008,"lang":"es","type":"article","venue":"Actas Urológicas Españolas","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cytodiagnostics (Canada)","funders":"","keywords":"Medicine; Gynecology","score_opus":0.02653231196213795,"score_gpt":0.26316892347933024,"score_spread":0.23663661151719229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230881714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9620181,0.024268458,0.00022742909,0.0022616605,0.0013019787,0.003251269,0.00035251715,0.0005748714,0.0057437276],"genre_scores_gemma":[0.98216593,0.007793317,0.0023613523,0.0020637033,0.002303538,0.00047443845,0.00038649706,0.0005874959,0.0018637475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9857924,0.0014379744,0.0028534972,0.0031304832,0.0029227035,0.0038629714],"domain_scores_gemma":[0.98930067,0.001964889,0.0014136349,0.003406525,0.00075084023,0.0031634269],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0012914975,0.0027642376,0.0034447913,0.0013043694,0.0013919421,0.00035035837,0.0016178755,0.0013872001,0.0009806626],"category_scores_gemma":[0.0016710706,0.0025256027,0.001835958,0.0016826594,0.001692004,0.0008342161,0.0009934206,0.0026705079,0.0028381902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004761998,0.0030759845,0.84640986,0.00084848667,0.003018859,0.080183685,0.0051366985,0.000049952807,0.044941384,0.00049155706,0.0061406945,0.0049408465],"study_design_scores_gemma":[0.012963157,0.004679414,0.85566705,0.0010380964,0.0048802965,0.043384988,0.0005574109,0.0028191786,0.04828011,0.00014138287,0.022799475,0.0027894424],"about_ca_topic_score_codex":0.0010128258,"about_ca_topic_score_gemma":0.00008015426,"teacher_disagreement_score":0.036798693,"about_ca_system_score_codex":0.0029545936,"about_ca_system_score_gemma":0.0020447236,"threshold_uncertainty_score":0.9999326},"labels":[],"label_agreement":null},{"id":"W4231457470","doi":"10.1016/j.urology.2011.07.743","title":"UP-01.193 Oncological Outcomes of Partial Nephrectomy for Tumors Greater than 4cm: A 10-Year Systematic Review","year":2011,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Nephrectomy; Standard of care; Surgery; General surgery; Urology; Internal medicine; Kidney","score_opus":0.07723767992042974,"score_gpt":0.301046648053254,"score_spread":0.22380896813282425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231457470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97700983,0.006537755,0.0002119201,0.0013221784,0.00037400625,0.007563075,0.000021775963,0.00011487964,0.006844555],"genre_scores_gemma":[0.99532706,0.00008504076,0.00055824564,0.0013844449,0.00005238248,0.0010025251,0.000018399385,0.00002457558,0.0015473556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983649,0.00020341933,0.00063359225,0.0003026373,0.00016489795,0.00033050147],"domain_scores_gemma":[0.9988597,0.00019950049,0.00024673,0.00046537525,0.000096980155,0.00013169156],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034983334,0.0002156832,0.0014357294,0.00007877737,0.00002584497,0.000002277762,0.00013480277,0.00014093706,0.0011188266],"category_scores_gemma":[0.00036957968,0.0001278607,0.00033994927,0.00008095523,0.000113476664,0.000023321812,0.000050838124,0.00010238655,0.00020902502],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010150421,0.0027987023,0.57558346,0.38354647,0.0041897823,0.0020450612,0.002892969,0.0000021095832,0.00091880606,0.0049759727,0.012498616,0.00039761377],"study_design_scores_gemma":[0.050231893,0.11184622,0.6865284,0.040591106,0.053500235,0.0064053694,0.00080404244,0.0004897442,0.030546041,0.002962481,0.013221198,0.0028733064],"about_ca_topic_score_codex":0.000026525138,"about_ca_topic_score_gemma":0.0000051303964,"teacher_disagreement_score":0.34295538,"about_ca_system_score_codex":0.0000520646,"about_ca_system_score_gemma":0.00006191051,"threshold_uncertainty_score":0.9997943},"labels":[],"label_agreement":null},{"id":"W4231738730","doi":"10.1200/jco.2007.25.18_suppl.15514","title":"Durable complete responses and near complete responses to sunitinib in metastatic renal cell carcinoma","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Sunitinib; Medicine; Renal cell carcinoma; Bevacizumab; Tyrosine-kinase inhibitor; Internal medicine; Response Evaluation Criteria in Solid Tumors; Cancer; Surgery; Oncology; Urology; Progressive disease; Disease; Chemotherapy","score_opus":0.24304686232044342,"score_gpt":0.4546096296690946,"score_spread":0.21156276734865115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231738730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98898625,0.00079883396,0.00014484569,0.006407297,0.0003594631,0.0004419797,0.000019536601,0.000009484392,0.0028323003],"genre_scores_gemma":[0.9714587,0.00010584251,0.024073813,0.0031504384,0.00032766,0.0000040775462,0.0000043312666,0.00003075434,0.0008444289],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99365056,0.0016021903,0.0032957816,0.00033976138,0.0005588165,0.0005528856],"domain_scores_gemma":[0.9843034,0.012768149,0.001167927,0.00032021262,0.0004571429,0.0009831754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009933696,0.00025859647,0.0020671112,0.00053069595,0.00008626637,0.000025198242,0.00019785216,0.00022228052,0.00014036313],"category_scores_gemma":[0.0054568765,0.00019354631,0.00036610445,0.00035345193,0.00039120406,0.00010198616,0.00010973645,0.0011091504,0.000050459115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17438492,0.003772911,0.6900724,0.00018887088,0.00040407447,0.055615917,0.0011878435,0.000043218526,0.0460884,0.00014615241,0.0048694364,0.02322586],"study_design_scores_gemma":[0.011089903,0.02557075,0.9047748,0.00010733503,0.00034176308,0.0026899823,0.00038605527,0.00004810367,0.0015687123,0.0001284866,0.053133324,0.00016079459],"about_ca_topic_score_codex":0.0001564402,"about_ca_topic_score_gemma":0.0002070188,"teacher_disagreement_score":0.2147024,"about_ca_system_score_codex":0.00031368484,"about_ca_system_score_gemma":0.0016320553,"threshold_uncertainty_score":0.78925896},"labels":[],"label_agreement":null},{"id":"W4231751229","doi":"10.5489/cuaj.447","title":"Renal leiomyoma: Case report and literature review","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Differential diagnosis; Asymptomatic; Leiomyoma; Renal cell carcinoma; Flank pain; Radiology; Leiomyosarcoma; Abdominal pain; Abdominal mass; Gross hematuria; Pathology; Surgery","score_opus":0.013961666692834603,"score_gpt":0.2355175829502949,"score_spread":0.2215559162574603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231751229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86519766,0.04105232,0.000008216438,0.087878205,0.00016262509,0.00053772406,0.000012100337,0.000024112282,0.005127056],"genre_scores_gemma":[0.98061126,0.004082437,0.0004648529,0.011323016,0.00044389404,0.000026191738,0.000040649633,0.000012070093,0.002995619],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99868184,0.00013002376,0.000374544,0.00019690809,0.00025990943,0.00035678933],"domain_scores_gemma":[0.99801195,0.000070047,0.00024444715,0.00013205865,0.00043206508,0.0011094481],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00054481183,0.00013822701,0.00030375528,0.00011540909,0.00019501502,0.00012385895,0.000040456824,0.00019297865,0.0009498032],"category_scores_gemma":[0.0008260872,0.000094668685,0.00011829231,0.00019740297,0.000022524775,0.00012561065,0.000011580061,0.00056876236,0.00007616776],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010786345,0.0000365938,0.198965,0.000082712606,0.0001568634,0.64003193,0.00007211844,4.780873e-7,0.000100267986,0.000047727386,0.15488201,0.0056135077],"study_design_scores_gemma":[0.00046581446,0.00022994445,0.23111731,0.00024860716,0.00014981914,0.72680366,0.000013332648,0.000011148664,0.0000095164,0.00023602278,0.04061567,0.00009914869],"about_ca_topic_score_codex":0.0008618244,"about_ca_topic_score_gemma":0.00021022528,"teacher_disagreement_score":0.11541363,"about_ca_system_score_codex":0.0007387386,"about_ca_system_score_gemma":0.00026502277,"threshold_uncertainty_score":0.99996346},"labels":[],"label_agreement":null},{"id":"W4231894079","doi":"10.5489/cuaj.813","title":"Preferred management option for small renal masses: laparoscopic partial nephrectomy","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Nephrectomy; Medicine; Urology; Renal mass; General surgery; Kidney; Internal medicine","score_opus":0.02792175620838918,"score_gpt":0.23816989189162657,"score_spread":0.21024813568323739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231894079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804296,0.00015028816,0.00090213696,0.012110007,0.0003946075,0.0016008178,0.000016744229,0.00004352548,0.0043522706],"genre_scores_gemma":[0.9873626,0.000047909718,0.0057392125,0.0024521942,0.0006412051,0.00042668896,0.00007542418,0.000019368823,0.0032353762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983391,0.00011152149,0.00038775743,0.00025029026,0.00029308524,0.00061821804],"domain_scores_gemma":[0.998455,0.00009116584,0.00022699113,0.0001336178,0.00025874327,0.00083447853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003727082,0.00017493711,0.0002967184,0.00018342829,0.00023761611,0.00016097845,0.000108326436,0.00021678767,0.00077792926],"category_scores_gemma":[0.00016859754,0.00013799465,0.00019296535,0.00013521574,0.000019114932,0.00011042635,0.000014669521,0.00030873285,0.00019152684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047083493,0.00037695855,0.88465416,0.00008187034,0.00138268,0.00035258848,0.00019585542,0.00028980637,0.0016889747,0.0021410733,0.07681407,0.031551108],"study_design_scores_gemma":[0.0041987384,0.0010091548,0.7147116,0.000030536637,0.00034552655,0.00014789353,0.00007184391,0.00070536043,0.00041422455,0.0023525432,0.27580062,0.00021193834],"about_ca_topic_score_codex":0.0006261257,"about_ca_topic_score_gemma":0.00030796786,"teacher_disagreement_score":0.19898655,"about_ca_system_score_codex":0.0017829501,"about_ca_system_score_gemma":0.00022747209,"threshold_uncertainty_score":0.851778},"labels":[],"label_agreement":null},{"id":"W4232127070","doi":"10.1200/jco.2020.38.15_suppl.tps5101","title":"PROSPER: Phase III randomized study comparing perioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kidney Foundation of Canada; Princess Margaret Cancer Centre; University Health Network; University of Calgary; McMaster University; Juravinski Cancer Centre","funders":"National Institutes of Health","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Nivolumab; Perioperative; Internal medicine; Neoadjuvant therapy; Kidney cancer; Oncology; Surgery; Urology; Immunotherapy; Kidney; Cancer; Breast cancer","score_opus":0.1456851587564778,"score_gpt":0.4030842746793476,"score_spread":0.2573991159228698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232127070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99440134,0.0001305218,0.00011574137,0.000986695,0.00048807467,0.0022137621,0.0000015426084,0.0000143903235,0.0016479075],"genre_scores_gemma":[0.99576646,0.000029117049,0.0030699903,0.0004960359,0.0004887148,0.000034921184,0.0000144626,0.000034972676,0.00006529481],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9938811,0.0013596816,0.0032983476,0.00042512149,0.0006961161,0.00033963085],"domain_scores_gemma":[0.99409807,0.0024975927,0.0019977668,0.00021753939,0.00065708836,0.000531933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020843502,0.0003179608,0.0035558783,0.00015190091,0.000076172015,0.000029310668,0.00018994005,0.00020742875,0.000094736424],"category_scores_gemma":[0.002064581,0.0002121973,0.00045273534,0.0003248455,0.00019684588,0.00026307369,0.00008833618,0.0012456658,0.000014721455],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46944952,0.0057817423,0.5198093,0.000028469307,0.00037711335,0.00074697443,0.0014908799,0.00013563545,0.000054104457,0.000004946737,0.00006995033,0.002051356],"study_design_scores_gemma":[0.5498387,0.062309824,0.38502356,0.000059997597,0.00070317707,0.000011164653,0.000682943,0.0008893712,0.000114045,0.0000019245247,0.00023835599,0.00012690728],"about_ca_topic_score_codex":0.00009435661,"about_ca_topic_score_gemma":0.000251782,"teacher_disagreement_score":0.13478576,"about_ca_system_score_codex":0.00058634876,"about_ca_system_score_gemma":0.0018357418,"threshold_uncertainty_score":0.8653155},"labels":[],"label_agreement":null},{"id":"W4232266420","doi":"10.1200/jco.2019.37.15_suppl.4577","title":"First-line (1L) immuno-oncology (IO) combination therapies in metastatic renal-cell carcinoma (mRCC): Results from the international mRCC database consortium (IMDC).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Dalhousie University; Princess Margaret Cancer Centre; University of Manitoba; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Nivolumab; Hazard ratio; Internal medicine; Renal cell carcinoma; Ipilimumab; Proportional hazards model; Oncology; Cohort; Cancer; Urology; Gastroenterology; Confidence interval; Immunotherapy","score_opus":0.11860912169424005,"score_gpt":0.4072306054144365,"score_spread":0.28862148372019647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232266420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94571406,0.001722075,0.00007199548,0.043537382,0.0030222808,0.0006729254,0.000091993046,0.0000112616235,0.0051560225],"genre_scores_gemma":[0.98992276,0.0015244926,0.0030878005,0.003606991,0.00077050494,0.000015521497,0.00019045692,0.000032227825,0.00084923644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99294364,0.00130446,0.0041363263,0.00045656282,0.00079796126,0.00036101666],"domain_scores_gemma":[0.98171407,0.013483745,0.003175137,0.0006618258,0.00069960544,0.00026563986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061748186,0.00029944582,0.0018523952,0.00025053121,0.000059941787,0.000027321224,0.00062161946,0.00035008046,0.000602699],"category_scores_gemma":[0.0038963656,0.00018353945,0.00057877746,0.00022328214,0.00032329326,0.00023936201,0.00020817897,0.0015328212,0.00014667654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.120873965,0.02925737,0.6630632,0.00015843354,0.0044623283,0.013721425,0.004848697,0.0008973715,0.02118231,0.0008250113,0.045812476,0.09489736],"study_design_scores_gemma":[0.0805127,0.025170956,0.7106995,0.0002798505,0.0010791902,0.00073396857,0.0013782462,0.0017335886,0.0026006713,0.001303755,0.17419791,0.00030966278],"about_ca_topic_score_codex":0.0005967948,"about_ca_topic_score_gemma":0.00075499486,"teacher_disagreement_score":0.12838544,"about_ca_system_score_codex":0.00079156907,"about_ca_system_score_gemma":0.001977378,"threshold_uncertainty_score":0.7484522},"labels":[],"label_agreement":null},{"id":"W4232493431","doi":"10.1200/jco.2020.38.6_suppl.tps765","title":"PROSPER: Phase III randomized study comparing perioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Calgary; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Nivolumab; Perioperative; Internal medicine; Neoadjuvant therapy; Kidney cancer; Adjuvant; Oncology; Surgery; Urology; Immunotherapy; Kidney; Cancer; Breast cancer","score_opus":0.1456851587564778,"score_gpt":0.4030842746793476,"score_spread":0.2573991159228698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232493431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99440134,0.0001305218,0.00011574137,0.000986695,0.00048807467,0.0022137621,0.0000015426084,0.0000143903235,0.0016479075],"genre_scores_gemma":[0.99576646,0.000029117049,0.0030699903,0.0004960359,0.0004887148,0.000034921184,0.0000144626,0.000034972676,0.00006529481],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9938811,0.0013596816,0.0032983476,0.00042512149,0.0006961161,0.00033963085],"domain_scores_gemma":[0.99409807,0.0024975927,0.0019977668,0.00021753939,0.00065708836,0.000531933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020843502,0.0003179608,0.0035558783,0.00015190091,0.000076172015,0.000029310668,0.00018994005,0.00020742875,0.000094736424],"category_scores_gemma":[0.002064581,0.0002121973,0.00045273534,0.0003248455,0.00019684588,0.00026307369,0.00008833618,0.0012456658,0.000014721455],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46944952,0.0057817423,0.5198093,0.000028469307,0.00037711335,0.00074697443,0.0014908799,0.00013563545,0.000054104457,0.000004946737,0.00006995033,0.002051356],"study_design_scores_gemma":[0.5498387,0.062309824,0.38502356,0.000059997597,0.00070317707,0.000011164653,0.000682943,0.0008893712,0.000114045,0.0000019245247,0.00023835599,0.00012690728],"about_ca_topic_score_codex":0.00009435661,"about_ca_topic_score_gemma":0.000251782,"teacher_disagreement_score":0.13478576,"about_ca_system_score_codex":0.00058634876,"about_ca_system_score_gemma":0.0018357418,"threshold_uncertainty_score":0.8653155},"labels":[],"label_agreement":null},{"id":"W4233043602","doi":"10.1200/jco.2017.35.15_suppl.e16078","title":"Individualized treatment with sunitinib versus standard dosing with sunitinib or pazopanib in patients with metastatic renal cell carcinoma (mRCC): Results from the Canadian Kidney Cancer information system (CKCis).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre; Ottawa Hospital; University Health Network; CancerCare Manitoba; McMaster University; Sunnybrook Health Science Centre; Juravinski Cancer Centre; University of Calgary; Princess Margaret Cancer Centre; BC Cancer Agency; University of Alberta; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Sunitinib; Pazopanib; Renal cell carcinoma; Internal medicine; Toxicity; Dosing; Urology; Oncology; Proportional hazards model; Gastroenterology","score_opus":0.13482162064300587,"score_gpt":0.39222614925670485,"score_spread":0.257404528613699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233043602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98917377,0.000055772296,0.000010499621,0.003318341,0.00047893677,0.0011475171,0.0008226143,0.000009875316,0.004982645],"genre_scores_gemma":[0.9954277,0.000046408804,0.0032585817,0.0005926777,0.0003152623,0.000039474304,0.0002059325,0.000035624995,0.00007833218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99517876,0.0007256301,0.002247302,0.0002963263,0.0010297261,0.0005222425],"domain_scores_gemma":[0.99118346,0.0019957742,0.0040000575,0.000687201,0.0010385108,0.0010949945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018460376,0.00039115432,0.0017875952,0.00024821234,0.00039946058,0.00015715942,0.00036622753,0.00023650755,0.00006602369],"category_scores_gemma":[0.0011586382,0.00017157698,0.00018119106,0.00017859077,0.00039815556,0.000490081,0.000041981693,0.0008454407,0.0000071176837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37671155,0.0006885816,0.5903329,0.00006644204,0.0014223827,0.0035297468,0.0021686747,0.00008320955,0.0000016907096,0.0000134701495,0.0007078579,0.024273472],"study_design_scores_gemma":[0.16854893,0.07688274,0.73491323,0.000941234,0.0025296495,0.00011695984,0.0013517397,0.00003270366,0.0001914213,0.000002588156,0.014257013,0.0002317903],"about_ca_topic_score_codex":0.09782696,"about_ca_topic_score_gemma":0.3644581,"teacher_disagreement_score":0.26663116,"about_ca_system_score_codex":0.0029866411,"about_ca_system_score_gemma":0.015487612,"threshold_uncertainty_score":0.99009365},"labels":[],"label_agreement":null},{"id":"W4233116961","doi":"10.1200/jco.2012.30.5_suppl.387","title":"A population-based overview of sequences of targeted therapy in metastatic renal cell carcinoma (mRCC).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Temsirolimus; Sunitinib; Everolimus; Hazard ratio; Renal cell carcinoma; Internal medicine; Oncology; Targeted therapy; Population; Urology; PI3K/AKT/mTOR pathway; Cancer; Discovery and development of mTOR inhibitors; Confidence interval","score_opus":0.2574749230303926,"score_gpt":0.47014693469336427,"score_spread":0.21267201166297167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233116961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862932,0.012049322,0.000031676038,0.00063248305,0.00033556487,0.0002435791,0.0000050968747,0.0000023397627,0.00040676526],"genre_scores_gemma":[0.99067557,0.0004773334,0.008162735,0.00041844335,0.00021492755,0.0000038896146,0.0000070533456,0.00001365381,0.000026368543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951966,0.0009161874,0.003054758,0.00012187942,0.00047437052,0.00023619876],"domain_scores_gemma":[0.9941571,0.0022405002,0.0027709284,0.00020341137,0.000348869,0.00027919724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033700748,0.00014946802,0.0019497966,0.00024329641,0.000010877714,0.000001552679,0.00013299094,0.00018464598,0.00030105823],"category_scores_gemma":[0.00081994524,0.00009646284,0.0006054798,0.00023718474,0.00012421125,0.00010183243,0.000016448877,0.0004583059,0.000003660423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029376626,0.0035459963,0.9717823,0.00016096528,0.00014284962,0.00020241979,0.00016345215,0.00011443325,0.0076105916,0.000032785698,0.00010789804,0.013198627],"study_design_scores_gemma":[0.008399946,0.013598323,0.9568515,0.00012882985,0.00032703608,0.00007396956,0.000078737285,0.00007555606,0.019832795,0.00013642118,0.00042569364,0.00007122137],"about_ca_topic_score_codex":0.00027622384,"about_ca_topic_score_gemma":0.00003785522,"teacher_disagreement_score":0.014930847,"about_ca_system_score_codex":0.00017651216,"about_ca_system_score_gemma":0.0013694502,"threshold_uncertainty_score":0.39336404},"labels":[],"label_agreement":null},{"id":"W4233214932","doi":"10.1016/j.urology.2016.04.057","title":"Author Reply","year":2016,"lang":"en","type":"letter","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Perioperative; General surgery; Kidney cancer; Cancer; Clinical trial; Urology; Intensive care medicine; Oncology; Internal medicine; Surgery; Kidney","score_opus":0.03229092016695447,"score_gpt":0.27546367970667773,"score_spread":0.24317275953972325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233214932","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008396372,0.0006473716,0.00005527778,0.96121645,0.0007993651,0.00032038626,0.00001798938,0.00010104896,0.036002498],"genre_scores_gemma":[0.0027862983,0.0000118167445,0.000089618414,0.82977045,0.007643227,0.000050726703,0.00016870745,0.00006204772,0.15941712],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984709,0.00009656687,0.00024594774,0.00051255006,0.00021476722,0.0004592755],"domain_scores_gemma":[0.9987578,0.00016048751,0.00011523759,0.0008256458,0.00006221592,0.00007863544],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000086011416,0.00026003484,0.00052103197,0.00017109505,0.000024687206,0.000004658525,0.0001148746,0.00086132006,0.001776683],"category_scores_gemma":[0.000071832605,0.00016498724,0.00019489438,0.00004317744,0.00011407895,0.000011388278,0.000055266115,0.000965558,0.003080863],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008977209,0.000010604558,0.0002376459,0.00005057344,0.00014142269,0.011028426,0.00001466674,3.3833896e-8,0.00018118326,0.000016705708,0.9861451,0.002083878],"study_design_scores_gemma":[0.0006765127,0.0009942856,0.00047435248,0.000016098413,0.00035417377,0.0016605773,4.1690416e-7,0.000001438996,0.00021037669,0.00029763687,0.9951796,0.0001345248],"about_ca_topic_score_codex":0.00001559811,"about_ca_topic_score_gemma":7.105522e-7,"teacher_disagreement_score":0.131446,"about_ca_system_score_codex":0.0001165305,"about_ca_system_score_gemma":0.00012454264,"threshold_uncertainty_score":0.99913585},"labels":[],"label_agreement":null},{"id":"W4233505152","doi":"10.21203/rs.2.21790/v1","title":"Management of complex renal cysts in Canada: Results of a survey study","year":2020,"lang":"en","type":"preprint","venue":"Research Square","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Centre Hospitalier Universitaire de Sherbrooke; McGill University Health Centre; Juravinski Hospital; Ottawa Hospital","funders":"","keywords":"Survey research; Political science; Sociology; Socioeconomics","score_opus":0.27223557295871736,"score_gpt":0.41940938490152857,"score_spread":0.1471738119428112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233505152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98780626,0.00044211152,0.000003721633,0.00053864,0.000051453564,0.004651393,0.0009933824,0.000010346367,0.0055027176],"genre_scores_gemma":[0.9981384,0.00014095516,0.00026277354,0.0000059044646,0.000034333494,0.00017038788,0.0008954593,0.000037326754,0.00031440385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99305975,0.0014991864,0.0010934551,0.00080731517,0.0030079414,0.0005323378],"domain_scores_gemma":[0.99682534,0.0004996069,0.00025620533,0.0012668272,0.0008530364,0.00029899692],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028810138,0.00028373834,0.0011227381,0.00048157966,0.000029179055,0.0000107354335,0.000459881,0.0001046569,0.000061600455],"category_scores_gemma":[0.00036251303,0.00024669516,0.00012761427,0.0008737009,0.00010279977,0.000013333132,0.0015968487,0.0010890969,0.0000067691863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015507412,0.0038220994,0.92055476,0.016869603,0.002078437,0.019681847,0.0023791771,0.0007578493,0.0009806597,0.000038626084,0.012890417,0.004439119],"study_design_scores_gemma":[0.004597675,0.0016296284,0.98770195,0.0021057979,0.000068353605,0.000003963337,0.0022983484,0.00019682894,0.0010970663,0.000033355143,0.00013061053,0.00013639701],"about_ca_topic_score_codex":0.9672359,"about_ca_topic_score_gemma":0.9209653,"teacher_disagreement_score":0.067147225,"about_ca_system_score_codex":0.002417923,"about_ca_system_score_gemma":0.003875436,"threshold_uncertainty_score":0.9999985},"labels":[],"label_agreement":null},{"id":"W4233820885","doi":"10.1016/j.euf.2019.10.004","title":"Reply to Francesco Montorsi, Alessandro Larcher, and Umberto Capitanio’s Letter to the Editor re: Rohann J.M. Correa, Alexander V. Louie, Nicholas G. Zaorsky, et al. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Eur Urol Focus. 2019 Jun 24. pii: S2405-4569(19)30157-9. https://doi.org/10.1016/j.euf.2019.06.002. [Epub ahead of print]","year":2019,"lang":"en","type":"review","venue":"European Urology Focus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Cancer Care Ontario","funders":"Varian Medical Systems; AstraZeneca","keywords":"SABR volatility model; Medicine; Stereotactic radiotherapy; Ablative case; Renal cell carcinoma; Radiation therapy; Radiosurgery; Surgery; Internal medicine","score_opus":0.040322761021812474,"score_gpt":0.29629004256531094,"score_spread":0.25596728154349846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233820885","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029218788,0.9712807,0.00019761959,0.009135384,0.0003342227,0.015092471,0.00025010435,0.00004747687,0.0033698159],"genre_scores_gemma":[0.0046134815,0.8924223,0.00077971217,0.028716123,0.0017051743,0.0024270301,0.00037643465,0.00081074797,0.06814897],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98765135,0.0050531747,0.0031431585,0.0021012684,0.0010519832,0.00099904],"domain_scores_gemma":[0.99039716,0.0021338759,0.0029636603,0.003381282,0.00059324136,0.0005307599],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0051686415,0.0016438143,0.010103234,0.0006492079,0.00021628142,0.00008575921,0.0011838292,0.00032392432,0.0006035868],"category_scores_gemma":[0.0005028033,0.0009107524,0.0026405207,0.0010135997,0.00036474725,0.00019680696,0.000588605,0.001693703,0.00040322787],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012096197,0.0007105481,0.0003352082,0.16059583,0.09206458,0.0002560177,0.0034200284,0.000032853102,0.00009445597,0.000020207808,0.73922527,0.0020353498],"study_design_scores_gemma":[0.0014462929,0.0018729593,0.00038513285,0.0025998258,0.24979506,0.00014126264,0.000037116417,0.000012574012,0.000022306478,0.000003389717,0.7430495,0.0006346009],"about_ca_topic_score_codex":0.00032002537,"about_ca_topic_score_gemma":0.000038002127,"teacher_disagreement_score":0.15799601,"about_ca_system_score_codex":0.00026952042,"about_ca_system_score_gemma":0.00035430604,"threshold_uncertainty_score":0.9996309},"labels":[],"label_agreement":null},{"id":"W4234387811","doi":"10.5489/cuaj.961","title":"Tumour location as a predictor of benign disease in the management of renal masses","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Renal cell carcinoma; Odds ratio; Logistic regression; Surgical pathology; Univariate analysis; Renal sinus; Radiology; Internal medicine; Kidney; Nephrectomy; Multivariate analysis","score_opus":0.012868410388306429,"score_gpt":0.2201998422972166,"score_spread":0.20733143190891015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234387811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98534125,0.00028142272,0.000029466297,0.011652752,0.000044301138,0.00041463107,0.000009089784,0.0000037182456,0.0022233431],"genre_scores_gemma":[0.998825,0.00005335883,0.00018688277,0.0006132622,0.00007523439,0.000031038428,0.000014766866,0.000005036661,0.000195412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986908,0.00016366594,0.00036579356,0.00010684745,0.00044700614,0.00022593001],"domain_scores_gemma":[0.9989566,0.0000845839,0.00026612362,0.000112084,0.0002449773,0.00033561152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046314538,0.0000855214,0.0001794775,0.00014374372,0.00004772023,0.000021580181,0.000118815624,0.000067480934,0.00041241763],"category_scores_gemma":[0.00018175432,0.000053891425,0.00008737971,0.00024178273,0.000027326596,0.000064638436,0.000009069332,0.00020377788,0.000024930696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082691826,0.00015885259,0.9948025,0.000041444895,0.00015099031,0.00022393418,0.00019954976,0.00025327675,0.00021113607,0.00080165756,0.0022362543,0.00083772046],"study_design_scores_gemma":[0.00072367064,0.00030048506,0.9955004,0.000050122384,0.00013908444,0.000030088357,0.0001931073,0.00015026116,0.000069656,0.0019029208,0.0008974431,0.000042756456],"about_ca_topic_score_codex":0.001831005,"about_ca_topic_score_gemma":0.0001626928,"teacher_disagreement_score":0.013483732,"about_ca_system_score_codex":0.00055521633,"about_ca_system_score_gemma":0.00030176836,"threshold_uncertainty_score":0.4515684},"labels":[],"label_agreement":null},{"id":"W4234481289","doi":"10.14740/jmc1844w","title":"Contralateral Adrenal Metastasis After Renal Cell Carcinoma Treatment","year":2015,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Metastasis; Primary treatment; Primary tumor; Adrenal gland; Oncology; Internal medicine; Cancer","score_opus":0.05429012885028065,"score_gpt":0.30265064352945864,"score_spread":0.248360514679178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234481289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864657,0.008432163,0.00006172926,0.0035310076,0.0004097754,0.00020254368,0.000019773912,0.000014479858,0.0008628432],"genre_scores_gemma":[0.996312,0.00015459218,0.0009887448,0.00061385834,0.0011937423,0.00001428197,0.000012193338,0.000030011075,0.00068055355],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9961422,0.00018382909,0.0008470488,0.00021824978,0.002195663,0.00041299142],"domain_scores_gemma":[0.9968391,0.00020761754,0.0003181073,0.00026420245,0.00037961415,0.0019913574],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006937903,0.00030783948,0.00084656,0.00023277673,0.00003343487,0.00003544093,0.00016107498,0.0001794732,0.0014235849],"category_scores_gemma":[0.00035101306,0.00018055312,0.0005314736,0.00014494569,0.00014310912,0.00013510355,0.00004653035,0.00037253453,0.000058286627],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022718724,0.006391046,0.22326972,0.0002514409,0.0016536973,0.63585705,0.0023482828,0.000027250053,0.0023008974,0.000045620494,0.05324112,0.051895186],"study_design_scores_gemma":[0.08404304,0.078662656,0.25599533,0.0010743302,0.008498757,0.28792566,0.0019838468,0.000302173,0.18107802,0.00021319703,0.09903078,0.0011922246],"about_ca_topic_score_codex":0.00018404039,"about_ca_topic_score_gemma":0.000024636334,"teacher_disagreement_score":0.34793139,"about_ca_system_score_codex":0.00059263327,"about_ca_system_score_gemma":0.0013223172,"threshold_uncertainty_score":0.99948925},"labels":[],"label_agreement":null},{"id":"W4234686840","doi":"10.1016/j.urology.2009.06.016","title":"Reply","year":2010,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Angiomyolipoma; Oncocytoma; Urology; Surgery; Radiology; Kidney; Oncology; Internal medicine","score_opus":0.014407893912541098,"score_gpt":0.25668015109714964,"score_spread":0.24227225718460854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234686840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93229073,0.000062563384,0.000024961599,0.006334135,0.0002705967,0.00008359626,3.9252768e-7,0.00004154338,0.060891498],"genre_scores_gemma":[0.9919016,0.0000022225088,0.00043501263,0.0051704324,0.00016357587,0.000007937319,0.0000053534186,0.000007601127,0.0023063114],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996378,0.000008929157,0.00006653163,0.00012228699,0.00004901358,0.000115464674],"domain_scores_gemma":[0.9996101,0.000026933349,0.000015401498,0.00025906676,0.000021358828,0.00006710942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045109817,0.00004663708,0.00009315739,0.00003411392,0.000014214949,0.0000015659054,0.000028155942,0.000053300842,0.0007611098],"category_scores_gemma":[0.000051456507,0.00003519888,0.000034093315,0.000030738138,0.00004607,0.000007825433,0.000014411639,0.00016131176,0.0005403237],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094725355,0.0005221314,0.26313567,0.000032870143,0.00017349761,0.0029573082,0.00034837006,0.0000043594478,0.6483369,0.011157731,0.043938532,0.028445415],"study_design_scores_gemma":[0.0014155733,0.0013469404,0.25223932,8.1347747e-7,0.00010944459,0.0022065241,0.0000058047895,0.00009359958,0.025190296,0.0008467238,0.716466,0.000078970996],"about_ca_topic_score_codex":0.000020830847,"about_ca_topic_score_gemma":0.0000098706105,"teacher_disagreement_score":0.67252743,"about_ca_system_score_codex":0.000006069643,"about_ca_system_score_gemma":0.000025063266,"threshold_uncertainty_score":0.83336186},"labels":[],"label_agreement":null},{"id":"W4234840939","doi":"10.1634/theoncologist.2017-0283","title":"In Reply","year":2017,"lang":"en","type":"letter","venue":"The Oncologist","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine","score_opus":0.07220726066017526,"score_gpt":0.3398013643898503,"score_spread":0.26759410372967507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234840939","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004348101,0.0005135271,4.5293936e-7,0.83616406,0.00047159012,0.00057135074,0.000006867434,0.000029035202,0.15789501],"genre_scores_gemma":[0.012860586,0.000078706114,0.00009024014,0.8298744,0.004498382,0.00011508694,0.00008452562,0.000037741047,0.15236032],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987377,0.00011083131,0.000236656,0.0003280773,0.00027290167,0.00031385128],"domain_scores_gemma":[0.997937,0.00020341961,0.00022980344,0.0015610742,0.000036126115,0.000032546595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032394732,0.00022836245,0.00052519207,0.00007285279,0.000090937865,0.000032016927,0.000396509,0.00042604562,0.00025156958],"category_scores_gemma":[0.00019349068,0.00012227059,0.00015797146,0.000040805466,0.0003526056,0.00002464556,0.00010891822,0.001675972,0.0006602395],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006274914,0.000037409533,0.0005286522,0.00006088797,0.000043972017,0.024111697,0.000047413672,2.1270071e-7,0.000021677879,0.000005961585,0.9744424,0.0006369709],"study_design_scores_gemma":[0.000732515,0.00043237844,0.0077459477,0.00010199752,0.00016391063,0.0006608348,0.0000075052135,0.0000016921654,0.00013354955,0.00024504354,0.9896588,0.0001158553],"about_ca_topic_score_codex":0.0011176827,"about_ca_topic_score_gemma":0.00006101675,"teacher_disagreement_score":0.023450864,"about_ca_system_score_codex":0.00065403833,"about_ca_system_score_gemma":0.0002535084,"threshold_uncertainty_score":0.8486263},"labels":[],"label_agreement":null},{"id":"W4234863521","doi":"10.1200/jco.2019.37.7_suppl.tps684","title":"PROSPER: A phase III randomized study comparing perioperative nivolumab (nivo) versus observation in patients with localized renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN 8143).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Calgary; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Nivolumab; Renal cell carcinoma; Nephrectomy; Internal medicine; Kidney cancer; Perioperative; Oncology; Urology; Surgery; Cancer; Immunotherapy; Kidney","score_opus":0.08673618800770104,"score_gpt":0.39256042846608613,"score_spread":0.3058242404583851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234863521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923787,0.00014072066,0.00009527064,0.0002328652,0.0008869101,0.0034786905,0.0000014332433,0.000015019236,0.002770379],"genre_scores_gemma":[0.99549484,0.000030125138,0.0035763818,0.00020604274,0.00025946388,0.0000468337,0.000017185323,0.00004265099,0.00032647332],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9929635,0.0016875102,0.0036180618,0.00048694055,0.0008188121,0.00042517076],"domain_scores_gemma":[0.992907,0.0032055755,0.0023519504,0.00036683545,0.0007792897,0.0003893564],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033490392,0.00037542026,0.004296887,0.00027858053,0.000067999346,0.00003348147,0.00021194931,0.00027661354,0.00019401967],"category_scores_gemma":[0.0011853983,0.00024705153,0.0005469705,0.00033261086,0.00020862743,0.00030432848,0.00009283745,0.0012495226,0.000034016524],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45603696,0.0075969957,0.5329262,0.000032930613,0.00042077765,0.00042188662,0.00071189116,0.00015693466,0.000057695433,0.000007567931,0.000031781066,0.0015983847],"study_design_scores_gemma":[0.6071054,0.05673197,0.33286068,0.00012715999,0.000741074,0.000021186568,0.00065585785,0.0010975595,0.00010207964,0.0000043057316,0.00038960917,0.00016317605],"about_ca_topic_score_codex":0.00020310485,"about_ca_topic_score_gemma":0.00044686534,"teacher_disagreement_score":0.20006554,"about_ca_system_score_codex":0.00096487097,"about_ca_system_score_gemma":0.0022273147,"threshold_uncertainty_score":0.99999815},"labels":[],"label_agreement":null},{"id":"W4234985772","doi":"10.1016/j.jvir.2009.04.013","title":"Reporting Standards for Percutaneous Thermal Ablation of Renal Cell Carcinoma","year":2009,"lang":"en","type":"article","venue":"Journal of Vascular and Interventional Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Kidney cancer; Clear cell renal cell carcinoma; Cancer; Urology; Kidney; Pathology; Internal medicine","score_opus":0.022207851716650313,"score_gpt":0.29998298528125267,"score_spread":0.2777751335646024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234985772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98812604,0.005521486,0.0052157408,0.00021858928,0.00009068317,0.00015945244,0.000010087436,0.000002691934,0.00065520016],"genre_scores_gemma":[0.99676496,0.000054987253,0.0028230022,0.00004601871,0.00021072834,0.0000012058672,0.000014661723,0.00000732166,0.000077141456],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99824554,0.00006852083,0.0011670791,0.00011491202,0.00027968473,0.00012425554],"domain_scores_gemma":[0.9980431,0.00006424145,0.0012151952,0.00009414431,0.00050120713,0.00008207203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011583169,0.000099605226,0.00048058838,0.00013902277,0.00003491196,0.000005824779,0.000044372755,0.000077485776,0.00007134545],"category_scores_gemma":[0.00029717683,0.00007291426,0.0007223667,0.000039434017,0.000049065657,0.000056161454,0.000008280756,0.00012765,1.8294634e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069111926,0.0016620789,0.066172756,0.0008872024,0.001687553,0.0022957108,0.00081068475,0.0009986967,0.88056123,0.0016484332,0.0028764133,0.03348802],"study_design_scores_gemma":[0.005684624,0.025578318,0.87825984,0.00038323476,0.0010939505,0.03820883,0.00014231658,0.0006666014,0.046622127,0.0014538909,0.0017319267,0.00017431613],"about_ca_topic_score_codex":0.000004338567,"about_ca_topic_score_gemma":4.2218696e-7,"teacher_disagreement_score":0.83393914,"about_ca_system_score_codex":0.00012544547,"about_ca_system_score_gemma":0.00015063195,"threshold_uncertainty_score":0.29733574},"labels":[],"label_agreement":null},{"id":"W4235546774","doi":"10.1016/j.eururo.2013.07.025","title":"Reply to Hiten D. Patel and Mohamad E. Allaf's Letter to the Editor re: Maxine Sun, Andreas Becker, Zhe Tian, et al. Management of Localized Kidney Cancer: Calculating Cancer-specific Mortality and Competing Risks of Death for Surgery and Nonsurgical Management. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.03.034","year":2013,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cancer; Kidney cancer; Gerontology; Internal medicine","score_opus":0.093052254768827,"score_gpt":0.31450187273621655,"score_spread":0.22144961796738954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235546774","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41770217,0.010279807,0.0001659101,0.554465,0.0013632718,0.0075470572,0.0005320885,0.00010215755,0.007842534],"genre_scores_gemma":[0.13047495,0.015038484,0.0038086595,0.82015455,0.010969689,0.0022553569,0.0015045435,0.00086099707,0.014932743],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943126,0.0012367802,0.0014229572,0.0015397625,0.0006327449,0.0008551608],"domain_scores_gemma":[0.99692565,0.00071218,0.0007070017,0.001048121,0.00023612412,0.00037093792],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019333705,0.00078066584,0.0016000356,0.00036649813,0.00011225362,0.00006021597,0.0003232086,0.00024731245,0.00033893783],"category_scores_gemma":[0.00013246035,0.0005949146,0.0002037193,0.0002513635,0.00029363044,0.00006903207,0.000822343,0.0010467076,0.000038706115],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011109493,0.00010997102,0.028064432,0.0014339188,0.0009227389,0.0018931594,0.00027842523,0.000102721206,0.000087625995,0.000012048557,0.9627541,0.0032299145],"study_design_scores_gemma":[0.0026208118,0.00039476357,0.13202935,0.00055087043,0.0007493546,0.0000380816,0.000027832542,0.00023895924,0.00004144894,0.000003883856,0.86289686,0.00040775663],"about_ca_topic_score_codex":0.003319486,"about_ca_topic_score_gemma":0.00006271925,"teacher_disagreement_score":0.2872272,"about_ca_system_score_codex":0.00011929518,"about_ca_system_score_gemma":0.00004707565,"threshold_uncertainty_score":0.99965024},"labels":[],"label_agreement":null},{"id":"W4235903001","doi":"10.5489/cuaj.904","title":"Cost analysis of two follow-up strategies for localized kidney cancer: a Canadian cohort comparison","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Cohort; Nephrectomy; Renal cell carcinoma; Kidney cancer; Academic institution; Surgery; Urology; General surgery; Internal medicine; Kidney","score_opus":0.035413061530780526,"score_gpt":0.2975227604724673,"score_spread":0.2621096989416868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235903001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9763897,0.00037484517,0.00049547054,0.01770499,0.00040170923,0.0013102145,0.00046220337,0.000018893641,0.0028419693],"genre_scores_gemma":[0.9942501,0.000043244283,0.00036327375,0.0040886956,0.00017149017,0.00017997123,0.00026885167,0.000016185535,0.0006181527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977846,0.00014941815,0.0006468666,0.00025592864,0.00041332294,0.0007498668],"domain_scores_gemma":[0.99551743,0.00017721728,0.00045898426,0.00016751,0.00094961154,0.0027292382],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00054036087,0.00020741441,0.0008690439,0.00074756413,0.00025408872,0.00014095298,0.00015263136,0.00024462477,0.00272013],"category_scores_gemma":[0.0005074014,0.00016764931,0.0004697578,0.000705454,0.000050282568,0.00012502483,0.000007131117,0.00036278577,0.000025613424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052574305,0.000032090353,0.95619196,0.0000073431834,0.002771305,0.00002244894,0.0001582307,0.00078223745,0.000090245216,0.00021148774,0.03845498,0.00122511],"study_design_scores_gemma":[0.0030440807,0.00037672534,0.9507062,0.000017328028,0.003879037,0.00001961556,0.00032599055,0.008526356,0.000060474027,0.00047866345,0.032370426,0.00019512075],"about_ca_topic_score_codex":0.69442505,"about_ca_topic_score_gemma":0.71148795,"teacher_disagreement_score":0.017860431,"about_ca_system_score_codex":0.004333977,"about_ca_system_score_gemma":0.0047799554,"threshold_uncertainty_score":0.99948823},"labels":[],"label_agreement":null},{"id":"W4236013805","doi":"10.21203/rs.3.rs-25167/v1","title":"Morphological findings in frozen non-neoplastic kidney tissues of patients with kidney cancer from large-scale multicentric studies on genomics of renal cancer","year":2020,"lang":"en","type":"preprint","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre","funders":"European Commission; NHS Greater Glasgow and Clyde","keywords":"Kidney cancer; Cancer; Kidney; Pathology; Genomics; Biology; Medicine; Internal medicine; Oncology; Genome; Gene; Genetics","score_opus":0.03193005910380489,"score_gpt":0.29664197472745646,"score_spread":0.2647119156236516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236013805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992445,0.0011482439,0.00014229387,0.00067508884,0.0004390089,0.0016594551,0.0032452885,0.000029658366,0.00021598814],"genre_scores_gemma":[0.9930972,0.0011926035,0.0034368576,0.0007106564,0.0001478439,0.00026603782,0.0008867114,0.00006243071,0.00019965296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969146,0.00007912145,0.0009332524,0.00095602876,0.0007023651,0.00041460578],"domain_scores_gemma":[0.99786586,0.00022308722,0.00055882544,0.0004993364,0.0003571607,0.000495746],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010657575,0.00057991996,0.0018167032,0.00026188733,0.000029876139,0.000009435482,0.00024755788,0.00033021122,0.0006541689],"category_scores_gemma":[0.0003986577,0.00038642553,0.00018923884,0.00025692408,0.00016006369,0.000029490782,0.00056180765,0.00066527544,0.000014738937],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005305765,0.0017194558,0.97085905,0.0014980203,0.0019840242,0.00029639114,0.0055800616,0.004528602,0.0036665918,0.0000036240976,0.004372576,0.00018581063],"study_design_scores_gemma":[0.015981559,0.0022627949,0.87462914,0.006263923,0.0025630502,0.0000017031474,0.0006779038,0.004455318,0.09196615,0.00007513253,0.000383185,0.0007401603],"about_ca_topic_score_codex":0.0042966036,"about_ca_topic_score_gemma":0.00044931425,"teacher_disagreement_score":0.09622996,"about_ca_system_score_codex":0.0010499529,"about_ca_system_score_gemma":0.0008935037,"threshold_uncertainty_score":0.99985874},"labels":[],"label_agreement":null},{"id":"W4236139371","doi":"10.1093/annonc/mdw334.16","title":"Outcome of patients with multiple glandular metastases from renal cell carcinoma treated with targeted agents","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Temsirolimus; Sunitinib; Pazopanib; Renal cell carcinoma; Internal medicine; Sorafenib; Bevacizumab; Oncology; Population; Urology; Gastroenterology; Chemotherapy; Hepatocellular carcinoma; Discovery and development of mTOR inhibitors","score_opus":0.06123959229163349,"score_gpt":0.304829353636024,"score_spread":0.24358976134439048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236139371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99756855,0.00023016066,0.00004077951,0.00026267808,0.000028639213,0.0005572438,0.0005930731,0.000021255437,0.0006976492],"genre_scores_gemma":[0.99781275,0.000017528826,0.0013396144,0.00016318542,0.000026621863,0.000026503258,0.00034833205,0.00003300238,0.00023247077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831325,0.00014486504,0.0005089427,0.00034618622,0.0003717199,0.0003150285],"domain_scores_gemma":[0.99818194,0.00026390815,0.00042566733,0.00044057737,0.00049217406,0.00019573636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001063494,0.00025505933,0.0008790356,0.00015677584,0.000025258088,0.0000020180587,0.00011254701,0.0001186484,0.00029590933],"category_scores_gemma":[0.0000632617,0.0001265147,0.00012876971,0.00015898551,0.00019405081,0.00006847485,0.00004037594,0.00007763339,0.00001531599],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062867096,0.0015959594,0.9754721,0.00004414339,0.0004342359,0.00028160782,0.00009919527,0.0000037569328,0.012186131,0.0000020023872,0.0005979352,0.0029962235],"study_design_scores_gemma":[0.011251957,0.012554046,0.7066902,0.00004918992,0.00035118795,0.0000044426324,0.000024950523,0.0000035617193,0.2677865,0.0000051797047,0.0011722258,0.00010658102],"about_ca_topic_score_codex":0.0013542196,"about_ca_topic_score_gemma":0.0001336626,"teacher_disagreement_score":0.26878193,"about_ca_system_score_codex":0.000069016336,"about_ca_system_score_gemma":0.00012725093,"threshold_uncertainty_score":0.51591194},"labels":[],"label_agreement":null},{"id":"W4236150031","doi":"10.1016/j.urology.2018.05.003","title":"Reply by the Authors","year":2018,"lang":"en","type":"letter","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Nephrectomy; Renal function; Urology; Kidney disease; Kidney; Population; Surgery; Internal medicine","score_opus":0.023222349158240327,"score_gpt":0.260480936312228,"score_spread":0.23725858715398768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236150031","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026062534,0.0013409741,0.000022202135,0.9673401,0.0008422153,0.00039522676,0.000015023668,0.00006367798,0.027374305],"genre_scores_gemma":[0.003471881,0.00001922069,0.00003209343,0.8999978,0.0051205247,0.000055948225,0.00040680464,0.000054413915,0.09084133],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985307,0.00017393217,0.00022177037,0.00044461316,0.00023741665,0.0003916105],"domain_scores_gemma":[0.99865085,0.00017574531,0.000120455246,0.0009348969,0.00006275487,0.000055326866],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014938843,0.00024691297,0.00038735464,0.00006729176,0.00006165974,0.000009359774,0.0001995671,0.00073248893,0.0008941683],"category_scores_gemma":[0.000076323784,0.0001392883,0.00015889466,0.00006506706,0.00030702626,0.000008005091,0.00006638874,0.0014103552,0.0011660162],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005639079,0.000014944066,0.00013499329,0.000021927724,0.00014808966,0.0014476886,0.000052519183,6.017777e-8,0.000058872185,0.000005382992,0.9977125,0.00034663896],"study_design_scores_gemma":[0.00036453895,0.0011750289,0.00021593251,0.000004959649,0.00043227576,0.001338574,0.000002050384,0.0000070275078,0.00021485913,0.0001404772,0.99600196,0.00010231934],"about_ca_topic_score_codex":0.000071008944,"about_ca_topic_score_gemma":0.0000018600296,"teacher_disagreement_score":0.06734233,"about_ca_system_score_codex":0.0000761763,"about_ca_system_score_gemma":0.00007887434,"threshold_uncertainty_score":0.9996117},"labels":[],"label_agreement":null},{"id":"W4236152380","doi":"10.1200/jco.2019.37.15_suppl.4516","title":"Active surveillance in metastatic renal cell carcinoma (mRCC): Results from the Canadian Kidney Cancer information system (CKCis).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Manitoba; Juravinski Cancer Centre; St. Joseph’s Healthcare Hamilton; Ottawa Hospital; CancerCare Manitoba; Dalhousie University; McMaster University; Sunnybrook Health Science Centre; University of Alberta; Université Laval; Centre Hospitalier de l’Université de Montréal; BC Cancer Agency","funders":"","keywords":"Medicine; Cohort; Systemic therapy; Internal medicine; Cancer; Renal cell carcinoma; Metastasectomy; Kidney cancer; Surgery; Metastasis; Breast cancer","score_opus":0.07726084313189555,"score_gpt":0.37699534627771164,"score_spread":0.29973450314581607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236152380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728256,0.00026272226,0.000005184523,0.010654058,0.0015832318,0.00052769436,0.00020794307,0.000005076363,0.013928531],"genre_scores_gemma":[0.995843,0.00007686053,0.0004540236,0.0028624164,0.0005126174,0.000009173526,0.000046307407,0.000012356807,0.00018322373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99549717,0.0008601262,0.002626701,0.0001883977,0.00050068466,0.00032694987],"domain_scores_gemma":[0.99354434,0.002773493,0.0020947391,0.0003442114,0.0005134946,0.00072973355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032808022,0.00017617526,0.0012948936,0.00018550827,0.000049403632,0.000021461352,0.00024368722,0.0002661648,0.00011181223],"category_scores_gemma":[0.002188428,0.00010333708,0.00032815806,0.00022170684,0.00009099991,0.00022774028,0.000034869365,0.0011245051,0.00012840512],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019486265,0.00041904082,0.9220118,0.00013031892,0.00059584796,0.0018955634,0.0020784547,0.00048712973,0.0001769681,0.000055990433,0.020895867,0.031766787],"study_design_scores_gemma":[0.014251318,0.0030495282,0.9360116,0.00018735055,0.00021840786,0.0001293298,0.0007273699,0.00044582272,0.00036014986,0.000015790147,0.044499893,0.000103400984],"about_ca_topic_score_codex":0.13647774,"about_ca_topic_score_gemma":0.1447097,"teacher_disagreement_score":0.031663384,"about_ca_system_score_codex":0.002113145,"about_ca_system_score_gemma":0.0095851645,"threshold_uncertainty_score":0.99602956},"labels":[],"label_agreement":null},{"id":"W4236186667","doi":"10.5489/cuaj.559","title":"Associations between radiographic characteristics and change in renal function following partial nephrectomy using 24-hour creatinine clearance","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Nephrectomy; Renal function; Medicine; Creatinine; Urology; Radiography; Urine; Urine collection device; Kidney; Nuclear medicine; Surgery; Internal medicine","score_opus":0.040571276097134575,"score_gpt":0.25126956292224273,"score_spread":0.21069828682510816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236186667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994296,0.00029434208,0.000050977447,0.0043865456,0.00027599087,0.0005013575,0.000036094396,0.000024147712,0.0001345562],"genre_scores_gemma":[0.9970329,0.000059210557,0.00037160006,0.0012626731,0.0010819162,0.000041212188,0.0000774281,0.000019644922,0.000053411317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980538,0.0002510789,0.0005236236,0.00024031496,0.00036109667,0.0005700697],"domain_scores_gemma":[0.9985124,0.00016942137,0.00037962088,0.00009068141,0.00016526859,0.0006826476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064686866,0.00018644091,0.0004862653,0.00040448655,0.000299584,0.0001437042,0.000058763133,0.0002992217,0.00020595953],"category_scores_gemma":[0.00046109722,0.0001658472,0.00017391135,0.00043325257,0.000024504661,0.00027509153,0.000013483661,0.0006604302,0.000021823047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025964937,0.000028561413,0.9948737,0.0000023117793,0.00015994278,0.00007282251,0.00014338066,0.000003949406,0.00021611794,0.000009508194,0.0001935056,0.004270221],"study_design_scores_gemma":[0.0013448205,0.00032760634,0.9956002,0.0000353326,0.00026497862,0.000049235063,0.00002051866,0.0006529912,0.000012771667,0.00013137652,0.0014153721,0.00014477581],"about_ca_topic_score_codex":0.007489048,"about_ca_topic_score_gemma":0.0007618891,"teacher_disagreement_score":0.006727159,"about_ca_system_score_codex":0.0013130893,"about_ca_system_score_gemma":0.00019804187,"threshold_uncertainty_score":0.9991202},"labels":[],"label_agreement":null},{"id":"W4236427749","doi":"10.1016/j.carj.2019.03.004","title":"New Beginning","year":2019,"lang":"en","type":"editorial","venue":"Canadian Association of Radiologists Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Family medicine","score_opus":0.012630831859023698,"score_gpt":0.2578013111132204,"score_spread":0.24517047925419672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236427749","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001908301,0.0025354396,0.00009633307,0.0024145602,0.97609067,0.0004040834,0.00021227072,0.000023840295,0.016314482],"genre_scores_gemma":[0.0073135337,0.00090683287,0.0015283783,0.00016691723,0.90907264,0.0000031873933,0.00059280376,0.00007284668,0.08034286],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974057,0.00015304383,0.00063086796,0.00027494217,0.0009607306,0.00057471945],"domain_scores_gemma":[0.9958284,0.00064811454,0.0013981935,0.00029948514,0.0008010672,0.0010247254],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00096826174,0.00029735302,0.0009760157,0.0005945466,0.000096542884,0.00006121429,0.00023968125,0.0013878439,0.00038865863],"category_scores_gemma":[0.0041979034,0.0002673869,0.00041594534,0.00017247979,0.000029428325,0.000069825,0.000014721754,0.0017086507,0.00012752286],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00003981052,0.000008191859,0.014481311,0.00004817605,0.0005453393,0.00028145016,0.00007030409,0.000015543756,0.000020428864,0.000012123068,0.9829012,0.0015761085],"study_design_scores_gemma":[0.0018215398,0.00045735238,0.010558041,0.0002579787,0.00042284143,0.00018345147,0.000021714899,0.0000044525,0.000027338938,0.00005503802,0.98598707,0.00020317745],"about_ca_topic_score_codex":0.015977062,"about_ca_topic_score_gemma":0.0098767625,"teacher_disagreement_score":0.06701805,"about_ca_system_score_codex":0.012996579,"about_ca_system_score_gemma":0.016222244,"threshold_uncertainty_score":0.9999778},"labels":[],"label_agreement":null},{"id":"W4236431690","doi":"10.5489/cuaj.760","title":"How long can patients with renal cell carcinoma wait for surgery without compromising pathological outcomes?","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Pathological; Stage (stratigraphy); Renal cell carcinoma; Pathological staging; Multivariate analysis; Disease; Surgery; Kidney cancer; Internal medicine","score_opus":0.018721061636261402,"score_gpt":0.2033829719014669,"score_spread":0.1846619102652055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236431690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768821,0.00006407208,0.00020569014,0.021325465,0.00019037006,0.0009752764,0.000054947137,0.000031545904,0.00027053023],"genre_scores_gemma":[0.99451375,0.0000030891572,0.0008804586,0.0027595814,0.00025764157,0.00007455417,0.00015491626,0.00003475759,0.0013212549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740756,0.0002049773,0.00044697974,0.0003824448,0.00060790125,0.00095012656],"domain_scores_gemma":[0.99667275,0.0004174264,0.00050344877,0.00019145799,0.0008411223,0.0013737684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046412807,0.00032545242,0.00071338797,0.00024369128,0.00042877384,0.00030593362,0.00012979498,0.00032887224,0.00020927275],"category_scores_gemma":[0.00060178305,0.00020523001,0.00032555684,0.00017008308,0.000060220777,0.00016758914,0.000018087305,0.0005972117,0.000022168697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009388988,0.00013537658,0.9943476,0.000011598089,0.00008027463,0.0001704847,0.000047690635,0.000006788931,0.00004861737,0.000004995937,0.0040808055,0.0009719298],"study_design_scores_gemma":[0.0027104262,0.00092989084,0.9944776,0.00001552271,0.00017856073,0.000116773,0.00004182985,0.000055167016,0.00009825918,0.00008415927,0.0010456705,0.00024610315],"about_ca_topic_score_codex":0.0008848085,"about_ca_topic_score_gemma":0.000544128,"teacher_disagreement_score":0.018565884,"about_ca_system_score_codex":0.0019968562,"about_ca_system_score_gemma":0.00058402104,"threshold_uncertainty_score":0.8369037},"labels":[],"label_agreement":null},{"id":"W4236679728","doi":"10.1111/j.1464-410x.2011.10154.x","title":"TREATMENT OF METASTATIC RENAL CARCINOMA PATIENTS WITH THE COMBINATION OF GEMCITABINE, CAPECITABINE AND BEVACIZUMAB AT A TERTIARY CANCER CENTRE","year":2011,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Capecitabine; Bevacizumab; Gemcitabine; Oncology; Internal medicine; Citation; Library science; Cancer; Colorectal cancer; Chemotherapy","score_opus":0.014596378936287915,"score_gpt":0.2186204919164172,"score_spread":0.2040241129801293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236679728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915175,0.0074172695,0.000014490821,0.00041821407,0.000056766476,0.00036436354,0.000041439518,0.0000024944372,0.00016746714],"genre_scores_gemma":[0.99897605,0.0004664784,0.0003215102,0.00005348679,0.000024963883,0.000008619455,0.000014479632,0.00001720333,0.000117200965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880373,0.0001335581,0.0004685823,0.00013901386,0.00027650592,0.0001785912],"domain_scores_gemma":[0.9986838,0.000075762575,0.0005608383,0.00013548713,0.00043791908,0.000106162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008826866,0.00014185435,0.0005137739,0.00010894104,0.000043034182,0.000003546671,0.00006787969,0.000042963205,0.00015626496],"category_scores_gemma":[0.000021409476,0.00009152638,0.00010592304,0.00008826915,0.000212153,0.000063395244,0.000025353975,0.00009023858,5.600763e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038576992,0.0018715028,0.9677929,0.00008527321,0.000840212,0.0012490894,0.0015861898,0.0000066038197,0.0009068509,0.000022815278,0.00022353827,0.021557268],"study_design_scores_gemma":[0.012345368,0.007544521,0.9716209,0.00006114611,0.0012396384,0.0036690927,0.000082561855,0.000024155745,0.0032011,0.000028036893,0.000117736374,0.00006570024],"about_ca_topic_score_codex":0.00066251674,"about_ca_topic_score_gemma":0.00033936845,"teacher_disagreement_score":0.021491567,"about_ca_system_score_codex":0.00012638589,"about_ca_system_score_gemma":0.00009423704,"threshold_uncertainty_score":0.37323374},"labels":[],"label_agreement":null},{"id":"W4236683959","doi":"10.1097/mou.0b013e3282a4a6b7","title":"Predicting cancer-control outcomes in patients with renal cell carcinoma","year":2007,"lang":"en","type":"review","venue":"Current Opinion in Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Nomogram; Nephrectomy; Kidney cancer; Cancer; Oncology; Kidney disease; Multivariate analysis; Carcinoma; Internal medicine; Kidney","score_opus":0.06982244339476959,"score_gpt":0.3632693247633275,"score_spread":0.2934468813685579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236683959","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023882348,0.969725,0.000015051806,0.00004050948,0.0031243938,0.0028625974,0.000106464664,0.00003496595,0.000208662],"genre_scores_gemma":[0.046626776,0.95118463,0.000027674756,0.000039171744,0.0005256687,0.0007106656,0.0007351832,0.00011025304,0.00003997282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962898,0.0003074462,0.0012584486,0.0008881878,0.00046169574,0.00079440745],"domain_scores_gemma":[0.9981996,0.00034417526,0.0005913268,0.00055079156,0.00009927283,0.00021482309],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031010606,0.00072229723,0.0027234345,0.0010316062,0.000034895736,0.000010216308,0.00023144807,0.00047510682,0.00006117522],"category_scores_gemma":[0.000053079224,0.0005037572,0.00033187238,0.0004918271,0.000100047844,0.00005139778,0.00008442522,0.001311635,0.000031062806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002364039,0.0006606524,0.7554021,0.008260378,0.00006335268,0.000028372622,0.000045007942,0.00000888709,2.0503713e-8,0.000004428148,0.00007769549,0.23521273],"study_design_scores_gemma":[0.011596221,0.0019697023,0.5415772,0.0063780346,0.0008152801,0.000027577464,0.0000047095846,0.000023247065,3.9323757e-7,0.0000032793312,0.43709603,0.00050831673],"about_ca_topic_score_codex":0.00012703026,"about_ca_topic_score_gemma":0.000041518957,"teacher_disagreement_score":0.43701833,"about_ca_system_score_codex":0.0008574638,"about_ca_system_score_gemma":0.0005840582,"threshold_uncertainty_score":0.9997414},"labels":[],"label_agreement":null},{"id":"W4239500832","doi":"10.5489/cuaj.825","title":"The association between renal tumour scoring systems and ischemia time during open partial nephrectomy","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Nephrectomy; Interquartile range; Renal function; Cohort; Ischemia; Surgery; Medical record; Internal medicine; Kidney","score_opus":0.01604775576748413,"score_gpt":0.22391866428228577,"score_spread":0.20787090851480164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239500832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850904,0.00034465152,0.000003811999,0.010131154,0.00016923074,0.00070342247,0.000010672748,0.000022303127,0.0035243535],"genre_scores_gemma":[0.99367446,0.000047935187,0.00005565106,0.00029432637,0.0010966351,0.00007819478,0.000014506864,0.000016660002,0.004721651],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978517,0.00029906078,0.00046089877,0.00022881848,0.0004917487,0.0006677224],"domain_scores_gemma":[0.99778485,0.00040737056,0.0004915089,0.000120349185,0.00031268163,0.0008832599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012887863,0.0001714938,0.00036268754,0.00008904205,0.0008385047,0.0009312938,0.00017245546,0.00024679562,0.00018609125],"category_scores_gemma":[0.00087937363,0.00011493647,0.00009462528,0.00015438681,0.000022060172,0.0002708941,0.00006579258,0.0006595105,0.00023471305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027392223,0.000010724096,0.98865825,0.0000047055314,0.00030484717,0.00006173859,0.000046477977,0.0000146271595,0.0031531274,0.000025669377,0.007097732,0.0005947386],"study_design_scores_gemma":[0.0012828398,0.00016246548,0.97861236,0.000030085937,0.00017136286,0.00020631218,0.00004072728,0.0001833528,0.0006895766,0.00010065607,0.018385412,0.00013485111],"about_ca_topic_score_codex":0.0034289525,"about_ca_topic_score_gemma":0.0001416298,"teacher_disagreement_score":0.011287681,"about_ca_system_score_codex":0.003403121,"about_ca_system_score_gemma":0.00036084565,"threshold_uncertainty_score":0.89804876},"labels":[],"label_agreement":null},{"id":"W4239610241","doi":"10.1200/jco.2011.29.7_suppl.318","title":"Efficacy of targeted drug therapy for metastatic renal cell carcinoma in the elderly patient population.","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Sorafenib; Internal medicine; Population; Bevacizumab; Targeted therapy; Oncology; Surgery; Cancer; Chemotherapy","score_opus":0.16192317985578475,"score_gpt":0.41148315879596215,"score_spread":0.2495599789401774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239610241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99561375,0.0012094667,0.00005845054,0.00095344195,0.00036563844,0.0007838104,0.0000038244993,0.0000026621578,0.0010089336],"genre_scores_gemma":[0.9900589,0.0000970461,0.008988002,0.0005789328,0.00020053599,0.000015827918,0.0000073053056,0.000015426178,0.000038002607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959466,0.00077517604,0.0025479412,0.00015783805,0.0003682171,0.00020424381],"domain_scores_gemma":[0.994333,0.0030171045,0.0019102182,0.000246254,0.00033664439,0.00015675096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026126304,0.0001434396,0.0011886633,0.00015522334,0.000025468928,0.0000031386305,0.00019238156,0.00012516658,0.00008996928],"category_scores_gemma":[0.00090325146,0.00007578328,0.000667038,0.00014865123,0.00010059973,0.00005834597,0.000016011814,0.00048283266,0.0000028298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05897501,0.027596837,0.4647668,0.00015241078,0.0008535827,0.0018293608,0.0086969165,0.000099239405,0.0015926565,0.000277445,0.0060870945,0.42907265],"study_design_scores_gemma":[0.017872492,0.05193563,0.9230694,0.000034358705,0.0003905871,0.00012773054,0.0004138066,0.0000385545,0.003042143,0.0006654343,0.0023367186,0.00007312965],"about_ca_topic_score_codex":0.00014579725,"about_ca_topic_score_gemma":0.000031879612,"teacher_disagreement_score":0.45830262,"about_ca_system_score_codex":0.000095028576,"about_ca_system_score_gemma":0.0005552079,"threshold_uncertainty_score":0.30903527},"labels":[],"label_agreement":null},{"id":"W4240378342","doi":"10.5489/cuaj.149","title":"Partial Nephrectomy for T1b Renal Cell Carcinoma: A Safe and Superior Treatment Option","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Nephrectomy; Renal cell carcinoma; Medicine; Urology; Surgery; Oncology; Internal medicine; Kidney","score_opus":0.02288691590171357,"score_gpt":0.2358814768037453,"score_spread":0.21299456090203173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240378342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916978,0.0013766858,0.00009950843,0.0048173727,0.000273919,0.00062055537,0.000044327873,0.000015663003,0.0010542022],"genre_scores_gemma":[0.9955432,0.00005498343,0.0011784274,0.0008403339,0.0012939704,0.000107464184,0.000051474515,0.000017720735,0.0009124492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841183,0.00012330587,0.00031224955,0.00019524098,0.00022944152,0.00072794245],"domain_scores_gemma":[0.99806243,0.00014375658,0.00016583013,0.000096624324,0.00014332596,0.001388051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004245366,0.00019909177,0.00033398138,0.0001453467,0.00030904272,0.00006830364,0.000043253054,0.00023471712,0.000255379],"category_scores_gemma":[0.0001468315,0.00014688329,0.0001940959,0.00009114911,0.00002795848,0.00013264063,0.000008305158,0.00021946359,0.000034747383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028381922,0.00018373222,0.98993003,0.00000899281,0.00010336564,0.0000660164,0.00031597362,0.0000070340116,0.0019450118,0.00012512426,0.0019649467,0.005065933],"study_design_scores_gemma":[0.004018352,0.0020539535,0.81876016,0.0000051914553,0.0004023608,0.0005311938,0.000075286625,0.0001368719,0.0022596826,0.00007678363,0.17150895,0.00017121341],"about_ca_topic_score_codex":0.00076615775,"about_ca_topic_score_gemma":0.00021348461,"teacher_disagreement_score":0.17116989,"about_ca_system_score_codex":0.0026205722,"about_ca_system_score_gemma":0.0003998644,"threshold_uncertainty_score":0.68527055},"labels":[],"label_agreement":null},{"id":"W4241100721","doi":"10.1016/s1569-9056(15)60716-3","title":"724 Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma","year":2015,"lang":"en","type":"article","venue":"European Urology Supplements","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Pathological; Renal cell carcinoma; Clear cell renal cell carcinoma; NODAL; Pathological staging; Oncology; Urology; Internal medicine; Radiology","score_opus":0.03332514388754684,"score_gpt":0.2383548995779097,"score_spread":0.20502975569036286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241100721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963445,0.00008120634,0.0010885012,0.00005890505,0.00006999169,0.00083013216,0.00005000715,0.000021707418,0.0014550557],"genre_scores_gemma":[0.98346007,0.0000017266975,0.015619852,0.00015354934,0.000053774555,0.000023398807,0.0004296696,0.000045488596,0.00021247401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825865,0.00019505467,0.00041809966,0.00043411745,0.0003429991,0.0003510712],"domain_scores_gemma":[0.9990813,0.000040803847,0.00021396532,0.00023112289,0.00019852216,0.00023427578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003939393,0.00023062737,0.00029353425,0.00011979886,0.00006794441,0.000013169005,0.00010435961,0.00004376989,0.000054242115],"category_scores_gemma":[0.00002471319,0.00017347651,0.00004362897,0.00006383301,0.00009304367,0.000060304552,0.0001437116,0.00012619219,0.000024354149],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030283018,0.00061888655,0.991181,0.000082130944,0.000032700962,0.00022732992,0.0010677533,0.000009949726,0.0021855282,0.000005790493,0.00046220125,0.0010984387],"study_design_scores_gemma":[0.01636606,0.012156652,0.91303504,0.000023561819,0.00023318082,0.00003556141,0.00013654704,0.00003413479,0.05245418,0.00001275626,0.0052852696,0.00022703139],"about_ca_topic_score_codex":0.000005531817,"about_ca_topic_score_gemma":0.0000010812138,"teacher_disagreement_score":0.07814593,"about_ca_system_score_codex":0.00007691545,"about_ca_system_score_gemma":0.00009099269,"threshold_uncertainty_score":0.70741665},"labels":[],"label_agreement":null},{"id":"W4241249372","doi":"10.21203/rs.3.rs-728952/v1","title":"Prognostic and Therapeutic Potential of The OIP5 Network in Papillary Renal Cell Carcinoma","year":2021,"lang":"en","type":"preprint","venue":"Research Square","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Papillary renal cell carcinomas; Downregulation and upregulation; Cancer research; Biology; Clear cell renal cell carcinoma; Internal medicine; Carcinoma; Oncology; Medicine; Gene; Renal cell carcinoma","score_opus":0.047099411150061686,"score_gpt":0.32563167759886663,"score_spread":0.27853226644880497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241249372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9551376,0.040215194,0.000009661904,0.00068905385,0.00015906226,0.0023521532,0.0000168844,0.000013946901,0.0014064559],"genre_scores_gemma":[0.99771535,0.0009500592,0.00019215909,0.000037828377,0.0003196355,0.00019860678,0.00008291577,0.000055538876,0.0004478948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955264,0.0011328001,0.00047317013,0.0007077199,0.001434568,0.0007253419],"domain_scores_gemma":[0.99769175,0.00036540753,0.00013208303,0.0011123776,0.0004922205,0.00020614883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001082296,0.00031094626,0.0006390765,0.00023696298,0.00012292068,0.00006696549,0.00030466568,0.0003720178,0.000103273895],"category_scores_gemma":[0.0001437715,0.00021003457,0.00028208335,0.0005953253,0.0003364212,0.000020487863,0.0015377008,0.0019688683,0.0000046566797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006715082,0.0008272068,0.9595399,0.007884165,0.0002256351,0.002971391,0.0012769628,0.0015264503,0.018874953,0.000050436243,0.0005043861,0.0056470456],"study_design_scores_gemma":[0.0011604452,0.00066547387,0.98328114,0.0023375954,0.00017649536,0.000098258286,0.00055265235,0.0007210437,0.010317887,0.0004177713,0.000092680246,0.00017856596],"about_ca_topic_score_codex":0.00054354465,"about_ca_topic_score_gemma":0.00010484892,"teacher_disagreement_score":0.042577773,"about_ca_system_score_codex":0.0003198702,"about_ca_system_score_gemma":0.0012723294,"threshold_uncertainty_score":0.85649616},"labels":[],"label_agreement":null},{"id":"W4242046377","doi":"10.1097/ju.0000000000000158","title":"Re: Is Routine Renal Tumor Biopsy Associated with Lower Rates of Benign Histology following Nephrectomy for Small Renal Masses?","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Nephrectomy; Medicine; Histology; Renal tumor; Urology; Renal biopsy; Biopsy; General surgery; Kidney; Internal medicine","score_opus":0.02420103223376767,"score_gpt":0.26295694753594473,"score_spread":0.23875591530217705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242046377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99270135,0.0011523122,0.00041776733,0.004266531,0.0003333625,0.00046609185,0.000007358633,0.000010592496,0.0006446455],"genre_scores_gemma":[0.9964461,0.000017287444,0.0016383165,0.0008931738,0.00013771237,0.0000060525567,0.000009127857,0.000039117953,0.00081314927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981275,0.00028928343,0.0007121594,0.00018884723,0.00028487595,0.0003973253],"domain_scores_gemma":[0.9972944,0.00082481623,0.0010619493,0.0003364221,0.0003648954,0.00011751278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011723961,0.0002346895,0.00092491444,0.00020651885,0.00005628076,0.00000571141,0.00023990966,0.00014231814,0.0002256302],"category_scores_gemma":[0.000226715,0.00013246913,0.0003478775,0.00020408523,0.00013499992,0.0000540486,0.00004091577,0.0004105569,0.000009030401],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0730173,0.0017069106,0.6132659,0.00016672733,0.010075935,0.0034693626,0.0025920318,0.0006352777,0.28759655,0.00021109151,0.006692953,0.0005699905],"study_design_scores_gemma":[0.10872162,0.15700772,0.4569874,0.0012439595,0.026847402,0.029738404,0.0015047962,0.0027359577,0.18080331,0.0028028616,0.029987413,0.0016191449],"about_ca_topic_score_codex":0.000036486494,"about_ca_topic_score_gemma":0.000036939316,"teacher_disagreement_score":0.15627848,"about_ca_system_score_codex":0.00016098125,"about_ca_system_score_gemma":0.0002873181,"threshold_uncertainty_score":0.5401934},"labels":[],"label_agreement":null},{"id":"W4242883802","doi":"10.1002/9780471420194.tnmc42.pub3","title":"Kidney","year":2017,"lang":"en","type":"other","venue":"TNM Online","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Renal cell carcinoma; Medicine; Kidney; Kidney cancer; Physical examination; Pathology; Radiology; Internal medicine","score_opus":0.036236668575632264,"score_gpt":0.318445583974399,"score_spread":0.2822089153987667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242883802","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000076882105,0.0016708167,0.000004236476,0.00093838706,0.00031342637,0.0003673612,0.0022080818,0.0002107069,0.9942101],"genre_scores_gemma":[0.0001274147,0.00037646623,0.003088575,0.000716257,0.0018787746,0.0000143066145,0.00577,0.00044027215,0.9875879],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99919504,0.000010699026,0.00010573737,0.000278442,0.00021978693,0.00019032175],"domain_scores_gemma":[0.9985359,0.000008687418,0.0001602215,0.00097617024,0.000023450302,0.00029560612],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000025221827,0.00024624995,0.00045987574,0.0001382527,0.00002380908,0.0000096252925,0.0001311684,0.000240651,0.026436415],"category_scores_gemma":[0.00010425491,0.00018404458,0.00013841454,0.000024582198,0.00006167067,0.0000075911876,0.00004888186,0.00019722,0.0014854519],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023152697,0.00017747069,0.00018681458,0.00016138742,0.00015666797,0.0005408271,0.0000055085948,6.4102004e-9,0.00006589418,0.0000063096495,0.9922704,0.0064055338],"study_design_scores_gemma":[0.0009360922,0.00015869917,0.0011284235,0.001058122,0.00026055105,0.000082188184,0.0000015792843,0.0000033654205,0.00009405856,0.0000061182054,0.9961227,0.0001481014],"about_ca_topic_score_codex":0.000219536,"about_ca_topic_score_gemma":0.00008498712,"teacher_disagreement_score":0.024950963,"about_ca_system_score_codex":0.00007181057,"about_ca_system_score_gemma":0.0002277246,"threshold_uncertainty_score":0.999292},"labels":[],"label_agreement":null},{"id":"W4243356162","doi":"10.2217/ebo.11.13","title":"VEGF inhibitors","year":2011,"lang":"en","type":"other","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novelis (Canada)","funders":"","keywords":"Chemistry; VEGF receptors; Computational biology; Biology; Cancer research","score_opus":0.027676381650177665,"score_gpt":0.24729678924473353,"score_spread":0.21962040759455587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243356162","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017375241,0.0017122175,0.000006439583,0.000046333393,0.0002641986,0.00031793094,0.0000026842458,0.00024664856,0.9972298],"genre_scores_gemma":[0.0027647978,0.00009443201,0.001094154,0.00016273123,0.00054612214,0.00001559452,0.000033369277,0.00040316395,0.9948856],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99942416,0.0000073129886,0.0000944787,0.00020098466,0.0001420621,0.0001310001],"domain_scores_gemma":[0.9994827,0.0000038166268,0.000048189984,0.00034156197,0.000010486079,0.000113273774],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000017612301,0.00017554723,0.0002681238,0.00015152339,0.000005285002,0.000002716974,0.000036658326,0.00019867902,0.05393975],"category_scores_gemma":[0.0000037587313,0.000116602074,0.000105583626,0.000043829383,0.000028536724,0.0000041657363,0.000021786384,0.00009682733,0.0060069175],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011403935,0.00006550867,0.00072594144,0.00007732415,0.00010648561,0.0001870416,0.000017537788,7.1664213e-10,0.000051746232,0.00013649276,0.99662787,0.0019926229],"study_design_scores_gemma":[0.00045833513,0.00018749473,0.00072479283,0.00019729689,0.00016042592,0.000046376637,0.000008350436,9.5982294e-8,0.0027643116,0.00001390039,0.99532187,0.00011676443],"about_ca_topic_score_codex":0.0005923696,"about_ca_topic_score_gemma":0.000046002766,"teacher_disagreement_score":0.04793283,"about_ca_system_score_codex":0.00004799271,"about_ca_system_score_gemma":0.000047437825,"threshold_uncertainty_score":0.994767},"labels":[],"label_agreement":null},{"id":"W4243504517","doi":"10.1200/jco.2012.30.5_suppl.353","title":"A multicentered population-based analysis of outcomes of patients with metastatic renal cell carcinoma (mRCC) who do not meet eligibility criteria for clinical trials.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Clinical trial; Renal cell carcinoma; Population; Inclusion and exclusion criteria; Surgery; Gastroenterology; Oncology; Confidence interval; Pathology","score_opus":0.31167262159603804,"score_gpt":0.5496005379976042,"score_spread":0.2379279164015662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243504517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99648213,0.00021826493,0.000795585,0.0005421788,0.0006663739,0.0010266429,0.00019987219,0.000004483832,0.000064470834],"genre_scores_gemma":[0.97541356,0.000020999241,0.02370052,0.00045699067,0.00026539134,0.000013804656,0.00008155519,0.000025378642,0.00002180411],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98553914,0.0036511356,0.009303023,0.00033544237,0.00081350043,0.00035775002],"domain_scores_gemma":[0.96538955,0.022580558,0.009108075,0.0005575564,0.0016914336,0.00067283824],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.019816265,0.00029206145,0.0072731813,0.00048385383,0.000031561744,0.0000074016275,0.00021336848,0.00034598555,0.00016105927],"category_scores_gemma":[0.020124476,0.00017011777,0.0033469794,0.00036357518,0.00024109524,0.00014051452,0.00004260668,0.0004419595,0.0000010648961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035192385,0.010779499,0.944186,0.00016759404,0.004966788,0.000018636752,0.000088735855,0.00005678078,0.0000611311,0.000009953386,0.00027710127,0.0041953963],"study_design_scores_gemma":[0.032453302,0.017224813,0.92265725,0.000055461598,0.026036374,0.0000024035169,0.000046410256,0.0006713841,0.0005069075,0.000018515622,0.0002044861,0.00012270329],"about_ca_topic_score_codex":0.00009099645,"about_ca_topic_score_gemma":0.000058103036,"teacher_disagreement_score":0.022904934,"about_ca_system_score_codex":0.0002179026,"about_ca_system_score_gemma":0.0008727874,"threshold_uncertainty_score":0.98812944},"labels":[],"label_agreement":null},{"id":"W4244463229","doi":"10.1002/9781119129875.ch33","title":"Treatment of localized kidney cancer","year":2018,"lang":"en","type":"other","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Université Laval; University of Ottawa","funders":"","keywords":"Nephrectomy; Medicine; Renal cell carcinoma; Kidney cancer; Lymphadenectomy; Kidney; Adrenalectomy; Urology; Cancer; General surgery; Surgery; Internal medicine","score_opus":0.02967792918570631,"score_gpt":0.3073718619212468,"score_spread":0.2776939327355405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244463229","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002772515,0.003168155,0.000026328975,0.0002698005,0.00025054562,0.0007333909,0.00006132553,0.00010721803,0.995106],"genre_scores_gemma":[0.0007409224,0.0018775704,0.0014672128,0.00014737884,0.0005346194,0.00009959076,0.0001058539,0.00031353236,0.9947133],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991545,0.00001605874,0.00018330013,0.00027188854,0.00021027397,0.00016396254],"domain_scores_gemma":[0.9991129,0.00000884208,0.00012602042,0.0004785227,0.00004126615,0.00023243128],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000011019643,0.00027280315,0.0006775731,0.00015708515,0.0000067216756,0.000002296472,0.000041922172,0.0002002801,0.08888381],"category_scores_gemma":[0.0000062709023,0.00016218692,0.00019850714,0.000074773474,0.000097062315,0.0000038019723,0.000011383612,0.00002202172,0.000801565],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015945832,0.00040253805,0.0029747346,0.00022135512,0.0009158853,0.000086712666,0.00003129145,2.377266e-8,0.00024078666,0.00003989254,0.98993695,0.004990379],"study_design_scores_gemma":[0.0032768645,0.00151591,0.00017571644,0.0003365009,0.0007685777,0.000020225445,0.000006845745,0.0000054854145,0.012508121,0.0000040374744,0.98126006,0.00012167138],"about_ca_topic_score_codex":0.0054159495,"about_ca_topic_score_gemma":0.00018284636,"teacher_disagreement_score":0.08808225,"about_ca_system_score_codex":0.00028109914,"about_ca_system_score_gemma":0.0003207334,"threshold_uncertainty_score":0.9999764},"labels":[],"label_agreement":null},{"id":"W4245038343","doi":"10.1200/jco.2009.27.15_suppl.5041","title":"Prognostic factors for overall survival (OS) in patients with metastatic renal cell carcinoma (RCC) treated with vascular endothelial growth factor (VEGF)-targeted agents: Results from a large multicenter study","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Renal cell carcinoma; Sunitinib; Internal medicine; Bevacizumab; Sorafenib; Proportional hazards model; Oncology; Progression-free survival; Population; Clinical endpoint; Gastroenterology; Vascular endothelial growth factor; Hazard ratio; Surgery; Confidence interval; Hepatocellular carcinoma; Overall survival; Clinical trial; Chemotherapy; VEGF receptors","score_opus":0.07290138496579174,"score_gpt":0.3559160573981137,"score_spread":0.283014672432322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245038343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99586815,0.00006782186,0.00010902766,0.00021328738,0.00028394102,0.0029615513,0.0003732381,0.000018361914,0.00010464708],"genre_scores_gemma":[0.9967279,0.000014787364,0.002339887,0.00029335177,0.00027016056,0.000023152481,0.00021484941,0.000056539237,0.00005941214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933439,0.0011917943,0.0030878836,0.0006553948,0.0010655249,0.0006555339],"domain_scores_gemma":[0.9917254,0.0040776376,0.0021921967,0.00040144756,0.000964878,0.0006384698],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013490486,0.0005232466,0.0026975817,0.00030861603,0.00006375297,0.00002616345,0.00025763837,0.00025829446,0.00006201526],"category_scores_gemma":[0.0030518454,0.00029488417,0.0006062808,0.00022977474,0.000091549424,0.00021935439,0.000037601945,0.000924783,0.0000053461254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07367757,0.02579429,0.8960076,0.000025358962,0.0011974175,0.0016324266,0.00087433116,0.000019751382,0.00007071914,0.0000010484023,0.00008445527,0.0006150073],"study_design_scores_gemma":[0.14187835,0.094286546,0.760681,0.00010211018,0.002000344,0.000004913508,0.00030954555,0.00007105783,0.00027841658,0.000010672143,0.00015694914,0.00022008817],"about_ca_topic_score_codex":0.000289785,"about_ca_topic_score_gemma":0.0002580756,"teacher_disagreement_score":0.13532662,"about_ca_system_score_codex":0.0004971759,"about_ca_system_score_gemma":0.0007957716,"threshold_uncertainty_score":0.99995035},"labels":[],"label_agreement":null},{"id":"W4245339559","doi":"10.1200/jco.2014.32.4_suppl.438","title":"EVERSUN: A phase II trial of everolimus alternating with sunitinib as first-line therapy for advanced renal cell carcinoma (aRCC) (ANZUP trial 0901).","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Sunitinib; Everolimus; Clinical endpoint; Adverse effect; Internal medicine; Surgery; Renal cell carcinoma; Confidence interval; Clinical trial","score_opus":0.1411817375648806,"score_gpt":0.4584591712089288,"score_spread":0.31727743364404826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245339559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98931533,0.00026074477,0.0006592453,0.0027133825,0.0019447908,0.0021680696,0.000014515865,0.000013844865,0.0029100878],"genre_scores_gemma":[0.98445,0.00030105037,0.008269038,0.0008749346,0.0055000326,0.00006295891,0.000019104757,0.000057778536,0.00046512418],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99376357,0.0006888201,0.0038210303,0.00041430152,0.0008345717,0.00047772445],"domain_scores_gemma":[0.9866544,0.006488338,0.004704599,0.00045995298,0.0010698334,0.0006228599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046005957,0.00036388545,0.0029132278,0.00023823103,0.00013096508,0.000011044598,0.00034079395,0.000441243,0.00015386089],"category_scores_gemma":[0.003889548,0.00023574085,0.0012099523,0.00016687368,0.00028014643,0.00015101116,0.00006502511,0.0009597786,0.0000053645704],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87296194,0.012178071,0.00054520275,0.00005542328,0.00044978803,0.00037635554,0.00018431013,0.000086309396,0.0014057156,0.000034016724,0.00046303947,0.11125983],"study_design_scores_gemma":[0.55915946,0.40914184,0.00072660047,0.00008705152,0.0005696015,0.00018447927,0.00005274659,0.00017083253,0.006256685,0.00015675955,0.023361458,0.00013249613],"about_ca_topic_score_codex":0.000041715026,"about_ca_topic_score_gemma":0.000030652205,"teacher_disagreement_score":0.39696378,"about_ca_system_score_codex":0.00021740727,"about_ca_system_score_gemma":0.0020337186,"threshold_uncertainty_score":0.9613233},"labels":[],"label_agreement":null},{"id":"W4245419467","doi":"10.1038/s41598-020-59358-9","title":"Author Correction: Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients","year":2020,"lang":"en","type":"erratum","venue":"Scientific Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Surveillance, Epidemiology, and End Results; Epidemiology; Database; Medicine; Computer science; Internal medicine","score_opus":0.04479013781911023,"score_gpt":0.2729699492506782,"score_spread":0.22817981143156796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245419467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96447545,0.00077905814,0.000012168182,0.0012212566,0.029423043,0.0025285464,0.000247929,0.000040897954,0.0012716345],"genre_scores_gemma":[0.938442,0.000025559944,0.00017709337,0.000069875096,0.00037043696,0.00006271391,0.0038326147,0.00005111343,0.056968596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99335873,0.0010315678,0.0020749376,0.0018883704,0.0011451932,0.00050120096],"domain_scores_gemma":[0.995247,0.00062782975,0.001678463,0.0016726408,0.00037400326,0.00040007915],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0047214525,0.00054655934,0.0012835999,0.00029730442,0.0002916479,0.00011139,0.00025444286,0.00028445057,0.000018403643],"category_scores_gemma":[0.0045963386,0.0003185223,0.00019696023,0.0012334673,0.00066733116,0.000099758974,0.00035991703,0.00087606284,0.000002247959],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080059754,0.00016373284,0.5721663,0.00029033402,0.000054849657,0.0013627935,0.0006992851,0.000052958694,0.00082109624,0.0000032233818,0.4232085,0.00037631008],"study_design_scores_gemma":[0.0018318088,0.0005622078,0.97166866,0.0007200933,0.00025065188,0.00062271283,0.00007533203,0.00028511032,0.0043204,0.000090281865,0.019223286,0.00034944224],"about_ca_topic_score_codex":0.0019561546,"about_ca_topic_score_gemma":0.0013399309,"teacher_disagreement_score":0.4039852,"about_ca_system_score_codex":0.00020249994,"about_ca_system_score_gemma":0.0010612819,"threshold_uncertainty_score":0.9999267},"labels":[],"label_agreement":null},{"id":"W4245722877","doi":"10.1016/j.eururo.2010.12.013","title":"A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1047,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Hazard ratio; Kidney cancer; Urology; Confidence interval; Stage (stratigraphy); Surgery; Cancer; Kidney; Internal medicine","score_opus":0.03468517665407165,"score_gpt":0.29433749929549774,"score_spread":0.25965232264142607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245722877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99149233,0.00018433461,0.0003651603,0.00015153372,0.00026633876,0.0033005723,0.000005949225,0.000059961454,0.004173844],"genre_scores_gemma":[0.99872714,0.000004015378,0.0003071717,0.00024069192,0.00024486674,0.00016885443,0.000014754562,0.00006359179,0.0002289141],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99727416,0.0006898073,0.000761309,0.0006063073,0.00020015227,0.00046828543],"domain_scores_gemma":[0.9972916,0.0015456523,0.00036230046,0.0004962276,0.00011881766,0.00018536263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015698771,0.00033605134,0.0010161739,0.00019939862,0.00016382645,0.000024345121,0.00020199282,0.00007844544,0.00004863402],"category_scores_gemma":[0.00043955,0.00022295195,0.00025754006,0.0001677926,0.00041454536,0.000053033124,0.00019456605,0.0006899476,0.000009301226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024525559,0.0021003378,0.92902535,0.000092322225,0.00024971986,0.00065941527,0.0014312707,0.0000106902435,0.040788587,0.000053107746,0.00018241911,0.0008812134],"study_design_scores_gemma":[0.0712373,0.006468796,0.9092866,0.000010315834,0.0006249446,0.00022785952,0.00027974707,0.00078625936,0.009422524,0.000017221206,0.001394844,0.00024358074],"about_ca_topic_score_codex":0.000060846993,"about_ca_topic_score_gemma":0.000077297635,"teacher_disagreement_score":0.046711743,"about_ca_system_score_codex":0.00008110506,"about_ca_system_score_gemma":0.000088697125,"threshold_uncertainty_score":0.90917164},"labels":[],"label_agreement":null},{"id":"W4246240153","doi":"10.5489/cuaj.1280","title":"Moderated Video Session: Miscellaneous Topics","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Session (web analytics); Computer science; World Wide Web","score_opus":0.015423653233180614,"score_gpt":0.21596041632069843,"score_spread":0.2005367630875178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246240153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.916078,0.00028208696,0.00001619761,0.052692562,0.0002618735,0.00024720523,0.000004632857,0.000032176238,0.03038531],"genre_scores_gemma":[0.9781585,0.000035467638,0.00033793345,0.0060742823,0.0005461005,0.000010676141,0.000018436316,0.000010376089,0.0148082385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987417,0.000111719775,0.0002642165,0.00015665134,0.00029723736,0.00042847768],"domain_scores_gemma":[0.99835616,0.000061646504,0.00013284427,0.00010585178,0.00033640498,0.0010070939],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017569796,0.00012532972,0.00022387604,0.00009082248,0.00021078683,0.00011870971,0.00007304434,0.00023629601,0.006449239],"category_scores_gemma":[0.00029330523,0.000089051384,0.00011167901,0.00009148849,0.0000152547045,0.00003699859,0.000008967154,0.00046420158,0.0007166412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050114206,0.000112600756,0.6673223,0.000010478277,0.00022810682,0.0012575538,0.00014004145,0.00014623643,0.0009928207,0.00009151777,0.31603062,0.01361766],"study_design_scores_gemma":[0.0012097305,0.0005360704,0.79128116,0.00001511193,0.00009751147,0.001993908,0.000053249914,0.0009862052,0.00021364448,0.0014803756,0.2019454,0.00018767027],"about_ca_topic_score_codex":0.0025573992,"about_ca_topic_score_gemma":0.00025804012,"teacher_disagreement_score":0.12395888,"about_ca_system_score_codex":0.0013323333,"about_ca_system_score_gemma":0.00036480266,"threshold_uncertainty_score":0.994459},"labels":[],"label_agreement":null},{"id":"W4246365406","doi":"10.5489/cuaj.193","title":"Review of the efficacy and safety of cryoablation for the treatment of small renal masses","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Cryoablation; Medicine; Cryosurgery; Radiofrequency ablation; Cochrane Library; Kidney cancer; MEDLINE; Surgery; Radiology; Randomized controlled trial; Cancer; Ablation; Internal medicine","score_opus":0.028644146651834766,"score_gpt":0.24431741856333283,"score_spread":0.21567327191149807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246365406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94240934,0.025838621,0.00008477897,0.029445102,0.000101061,0.0015955096,0.00004164124,0.000002783678,0.00048118076],"genre_scores_gemma":[0.9876943,0.010896977,0.00035570463,0.00074824266,0.00008872032,0.000023559951,0.0000069890584,0.000005078602,0.00018039893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991198,0.000116631774,0.00039554143,0.000073978495,0.00015463466,0.00013938725],"domain_scores_gemma":[0.9982892,0.00061669236,0.0004939254,0.00011316266,0.00035444566,0.00013254532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035479444,0.00007716027,0.00027826952,0.000037198213,0.00008806399,0.0000066239154,0.00006166288,0.00006974212,0.00015417059],"category_scores_gemma":[0.0006038269,0.000034982626,0.00016556834,0.00009967028,0.000047304824,0.000020543717,0.0000049273167,0.000077635406,8.6100243e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029519104,0.00035854115,0.92771065,0.0005225259,0.00091894926,0.0000036316578,0.00037423204,0.00009808604,0.0016736949,0.0003937823,0.0065981606,0.061052576],"study_design_scores_gemma":[0.0012777053,0.0010809989,0.9680995,0.00027223912,0.0003993319,0.000028129714,0.000020475045,0.00007266479,0.0004951829,0.00018423192,0.028036665,0.000032908327],"about_ca_topic_score_codex":0.0008797361,"about_ca_topic_score_gemma":0.00021692847,"teacher_disagreement_score":0.061019666,"about_ca_system_score_codex":0.0003743164,"about_ca_system_score_gemma":0.00022687155,"threshold_uncertainty_score":0.16880599},"labels":[],"label_agreement":null},{"id":"W4246419861","doi":"10.1038/sj.labinvest.3700732","title":"Gynecologic","year":2008,"lang":"en","type":"article","venue":"Laboratory Investigation","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Gynecology","score_opus":0.03961233526456709,"score_gpt":0.2446438101218767,"score_spread":0.2050314748573096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246419861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946851,0.00022808494,0.000012040983,0.0006846458,0.00009547195,0.00020860965,0.0000035263467,0.00011980651,0.003962681],"genre_scores_gemma":[0.9952727,0.000024181216,0.002088023,0.0018099409,0.000097084536,0.000030149109,0.000041827047,0.000011662098,0.00062441843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993831,0.0000402803,0.00013408964,0.00015555066,0.0001698113,0.00011720295],"domain_scores_gemma":[0.99944395,0.000027923123,0.000048711092,0.00019481417,0.00013491517,0.00014968825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006631708,0.00008779422,0.00012411893,0.000056996436,0.00008319952,0.000004096064,0.000028309634,0.0000655357,0.000130863],"category_scores_gemma":[0.00010840759,0.000072998744,0.00002922234,0.00027197204,0.00012763527,0.000080009995,0.000008899338,0.00008412311,0.0003382195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003876102,0.0000966854,0.81133103,0.000048671296,0.000042416337,0.00056961924,0.0006347271,0.00001363548,0.17480811,0.0011135297,0.01097728,0.00032552212],"study_design_scores_gemma":[0.00064206094,0.00027531886,0.8112603,0.0000138456535,0.000037115435,0.00008332472,0.000030745032,0.000042469743,0.18226801,0.00030567206,0.0049527027,0.00008846119],"about_ca_topic_score_codex":0.0000070827327,"about_ca_topic_score_gemma":0.0000018719523,"teacher_disagreement_score":0.0074599045,"about_ca_system_score_codex":0.00012275262,"about_ca_system_score_gemma":0.00023579305,"threshold_uncertainty_score":0.43472403},"labels":[],"label_agreement":null},{"id":"W4246548682","doi":"10.5489/cuaj.642","title":"Recent developments in kidney cancer","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Kingston General Hospital; University Health Network; Queen's University","funders":"","keywords":"Medicine; Nephrectomy; Gynecology; Lymphadenectomy; Kidney cancer; Renal cell carcinoma; Urothelial cancer; General surgery; Cancer; Oncology; Internal medicine; Kidney; Bladder cancer","score_opus":0.022388847113027226,"score_gpt":0.24233450076839835,"score_spread":0.21994565365537114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246548682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9206446,0.00050386216,0.0000015853832,0.06761688,0.00030750263,0.0002804551,0.0000068270842,0.000011454411,0.010626835],"genre_scores_gemma":[0.9816356,0.000693828,0.0002529398,0.015517631,0.00017944058,0.00004784915,0.000015312358,0.0000090630565,0.001648359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871653,0.00009076135,0.00029145923,0.00014328632,0.00028652605,0.00047145213],"domain_scores_gemma":[0.9982783,0.00003732359,0.00012539743,0.000061649735,0.00025555468,0.0012417553],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027641148,0.000106949956,0.0002000424,0.00019084121,0.000090425834,0.000054458866,0.000068106565,0.0001631993,0.004782342],"category_scores_gemma":[0.0005481023,0.000081175465,0.00005432629,0.00022315755,0.000010854005,0.00008047576,0.000009003722,0.0004197459,0.0003544827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010858109,0.00003241828,0.94873047,0.0000019203612,0.00004802825,0.00011975715,0.000063474625,0.0000063361103,0.00010538891,0.000013311368,0.029575221,0.021292824],"study_design_scores_gemma":[0.00079366035,0.000071583614,0.8337684,0.000018278566,0.00001659899,0.00007207464,0.000018485374,0.000020027122,0.00005152917,0.00016385973,0.16493538,0.00007007208],"about_ca_topic_score_codex":0.0054375045,"about_ca_topic_score_gemma":0.0018680936,"teacher_disagreement_score":0.13536015,"about_ca_system_score_codex":0.0048686154,"about_ca_system_score_gemma":0.0013840343,"threshold_uncertainty_score":0.9989515},"labels":[],"label_agreement":null},{"id":"W4246615405","doi":"10.4081/oncol.2010.1","title":"Sequencing or not sequencing multikinase inhibitors in kidney cancer: this is the dilemma","year":2011,"lang":"en","type":"article","venue":"Oncology Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Temsirolimus; Sunitinib; Pazopanib; Sorafenib; Everolimus; Bevacizumab; Kidney cancer; Oncology; Renal cell carcinoma; Internal medicine; Cancer; Clinical trial; Pharmacology; Discovery and development of mTOR inhibitors; Hepatocellular carcinoma; PI3K/AKT/mTOR pathway; Chemotherapy","score_opus":0.19263544212619949,"score_gpt":0.36147633249868943,"score_spread":0.16884089037248995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246615405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9276125,0.022671098,0.00000822705,0.0050990162,0.00091029983,0.0042608385,0.000023055807,0.00008519661,0.039329793],"genre_scores_gemma":[0.9268712,0.031040592,0.005677839,0.027243296,0.0006306583,0.0017464177,0.000021476959,0.00008948889,0.0066790613],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974634,0.00046970954,0.00086606026,0.0005041038,0.00020653439,0.00049018627],"domain_scores_gemma":[0.9983955,0.00016991375,0.00036614417,0.00068478234,0.00008749649,0.00029616474],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012043962,0.00033292596,0.0010417313,0.00013328652,0.000113832386,0.0000094108045,0.00022007852,0.00021743703,0.002596169],"category_scores_gemma":[0.00061192806,0.00017493656,0.0002543732,0.00042011455,0.0001749572,0.00010294173,0.000102179896,0.0005273092,0.0004352134],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003035419,0.00092875864,0.17472434,0.0030375423,0.0004890445,0.010521987,0.060538117,0.000004440703,0.08548846,0.00030121722,0.117293485,0.5436372],"study_design_scores_gemma":[0.0031942152,0.0015359444,0.008233103,0.0028476503,0.00065391185,0.0008538514,0.0005828538,0.00013555563,0.058493525,0.000030451747,0.923016,0.00042293034],"about_ca_topic_score_codex":0.0059923986,"about_ca_topic_score_gemma":0.0015822545,"teacher_disagreement_score":0.80572253,"about_ca_system_score_codex":0.0030384136,"about_ca_system_score_gemma":0.0015937525,"threshold_uncertainty_score":0.9983156},"labels":[],"label_agreement":null},{"id":"W4246656709","doi":"10.1200/jco.2021.39.15_suppl.tps4596","title":"PROSPER: Phase III RandOmized Study Comparing PERioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kidney Foundation of Canada; Princess Margaret Cancer Centre; University Health Network; University of Calgary; McMaster University; Juravinski Cancer Centre","funders":"Bristol-Myers Squibb Canada; National Institutes of Health","keywords":"Medicine; Nivolumab; Renal cell carcinoma; Nephrectomy; Perioperative; Internal medicine; Neoadjuvant therapy; Kidney cancer; Oncology; Adjuvant; Stage (stratigraphy); Surgery; Urology; Immunotherapy; Kidney; Cancer; Breast cancer","score_opus":0.11734380422692563,"score_gpt":0.40725564893423777,"score_spread":0.2899118447073121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246656709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944063,0.0002499829,0.0000817817,0.00039615086,0.0008109617,0.0015321265,0.000001485681,0.000010371945,0.002510828],"genre_scores_gemma":[0.9948585,0.00005159981,0.004131101,0.00021392829,0.0003683188,0.000036396938,0.000023220184,0.000033152086,0.0002837711],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9934196,0.001768723,0.003302535,0.00043694724,0.0007138617,0.00035832237],"domain_scores_gemma":[0.99320513,0.003126374,0.0018412282,0.00031098817,0.0011446682,0.00037159567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026319604,0.00030703822,0.0035226434,0.00018549596,0.00008711933,0.000035322773,0.00014815081,0.00022745402,0.00013492149],"category_scores_gemma":[0.0021630283,0.0002110749,0.0004919322,0.00035069845,0.00019054975,0.00025348054,0.00009498487,0.0011881628,0.000010448983],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39728177,0.011046171,0.5852471,0.000027189139,0.0004908902,0.0020365203,0.00083305914,0.00010429047,0.000084783795,0.000008572207,0.000050894574,0.0027887507],"study_design_scores_gemma":[0.5248509,0.030227477,0.44235042,0.000091223425,0.00074022164,0.00003769213,0.00077357364,0.00029505987,0.00028357145,0.0000040033233,0.00022349134,0.00012235034],"about_ca_topic_score_codex":0.00010136573,"about_ca_topic_score_gemma":0.00078953535,"teacher_disagreement_score":0.1428967,"about_ca_system_score_codex":0.0008147281,"about_ca_system_score_gemma":0.0032031108,"threshold_uncertainty_score":0.86073846},"labels":[],"label_agreement":null},{"id":"W4246824793","doi":"10.5489/cuaj.601","title":"Determining optimal surgical care for patients with renal masses","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Intensive care medicine; Renal mass; Computer science; Internal medicine; Kidney; Nephrectomy","score_opus":0.010559749418404278,"score_gpt":0.21436814779349317,"score_spread":0.20380839837508888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246824793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946392,0.0001018527,0.000038668197,0.0025912765,0.00010117049,0.0005462154,0.000027992748,0.00001878782,0.0019347933],"genre_scores_gemma":[0.99507725,0.0000063569087,0.0034667682,0.0006177724,0.0003421065,0.000059244325,0.00008829349,0.000017836575,0.0003243701],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985596,0.000068297435,0.00026992624,0.00020083583,0.0003615704,0.0005397549],"domain_scores_gemma":[0.9979504,0.00017723706,0.00019279684,0.000087818065,0.0007141806,0.0008776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013719562,0.00015856249,0.00028544306,0.00012534251,0.0002694701,0.00011521929,0.000077923636,0.00018492718,0.00055922056],"category_scores_gemma":[0.00022848831,0.000104940336,0.00013869972,0.00009753334,0.000025092642,0.0001199442,0.000009065534,0.0003102123,0.000046144844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009541962,0.00004236231,0.99291205,0.000006200852,0.000091425725,0.00013230779,0.00009281438,0.00003235978,0.0000075696826,0.000020663998,0.0020720677,0.0044947467],"study_design_scores_gemma":[0.003376332,0.0022746287,0.925215,0.00001877197,0.00012473695,0.00018955159,0.00014286868,0.00007580347,0.00003101998,0.00003221741,0.06837357,0.00014551316],"about_ca_topic_score_codex":0.0002310645,"about_ca_topic_score_gemma":0.00017414527,"teacher_disagreement_score":0.06769708,"about_ca_system_score_codex":0.0013936732,"about_ca_system_score_gemma":0.00041833357,"threshold_uncertainty_score":0.6123073},"labels":[],"label_agreement":null},{"id":"W4246828179","doi":"10.1200/jco.2018.36.6_suppl.tps710","title":"A phase III randomized study comparing perioperative nivolumab vs. observation in patients with localized renal cell carcinoma undergoing nephrectomy (PROSPER RCC).","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Calgary; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Nivolumab; Renal cell carcinoma; Nephrectomy; Perioperative; Stage (stratigraphy); Internal medicine; Kidney cancer; Clinical trial; Oncology; Surgery; Cancer; Immunotherapy; Kidney","score_opus":0.08311602906615595,"score_gpt":0.3970990932735689,"score_spread":0.31398306420741295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246828179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947223,0.00008893653,0.00042551232,0.00033695,0.00045440684,0.0020604376,8.779105e-7,0.000011810655,0.0018987787],"genre_scores_gemma":[0.99291444,0.000017348879,0.005633099,0.0005667561,0.00057288405,0.000032134907,0.000008947811,0.00003331179,0.00022105177],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9934398,0.0016392581,0.0034664972,0.0003913667,0.0007041291,0.00035896344],"domain_scores_gemma":[0.9941129,0.0019413468,0.0021337646,0.00029198817,0.0011422796,0.00037773236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037530274,0.00030675292,0.003763759,0.00025494504,0.00009904946,0.000029012643,0.00017476045,0.0002456398,0.0001507905],"category_scores_gemma":[0.0013210902,0.00019052271,0.0004370058,0.00031255954,0.0004460884,0.00024468295,0.00007375605,0.00095816975,0.000018797424],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41327173,0.011354234,0.57163864,0.00001596951,0.00031894015,0.00040415514,0.0010529243,0.000020258272,0.000048489757,0.000006424851,0.00009221919,0.0017760193],"study_design_scores_gemma":[0.5534419,0.069334425,0.37445945,0.00010413728,0.00068559375,0.000028599046,0.00031932507,0.0008519426,0.00017723789,0.000009331768,0.00046716927,0.0001209439],"about_ca_topic_score_codex":0.00019761873,"about_ca_topic_score_gemma":0.0005777013,"teacher_disagreement_score":0.19717918,"about_ca_system_score_codex":0.0006831147,"about_ca_system_score_gemma":0.0018084671,"threshold_uncertainty_score":0.7769291},"labels":[],"label_agreement":null},{"id":"W4247090042","doi":"10.1016/j.urology.2015.12.083","title":"Author Reply","year":2016,"lang":"en","type":"letter","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Nephrectomy; Renal function; Diabetes mellitus; Urology; Surgery; Kidney; Internal medicine; Endocrinology","score_opus":0.03229092016695447,"score_gpt":0.27546367970667773,"score_spread":0.24317275953972325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247090042","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008396372,0.0006473716,0.00005527778,0.96121645,0.0007993651,0.00032038626,0.00001798938,0.00010104896,0.036002498],"genre_scores_gemma":[0.0027862983,0.0000118167445,0.000089618414,0.82977045,0.007643227,0.000050726703,0.00016870745,0.00006204772,0.15941712],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984709,0.00009656687,0.00024594774,0.00051255006,0.00021476722,0.0004592755],"domain_scores_gemma":[0.9987578,0.00016048751,0.00011523759,0.0008256458,0.00006221592,0.00007863544],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000086011416,0.00026003484,0.00052103197,0.00017109505,0.000024687206,0.000004658525,0.0001148746,0.00086132006,0.001776683],"category_scores_gemma":[0.000071832605,0.00016498724,0.00019489438,0.00004317744,0.00011407895,0.000011388278,0.000055266115,0.000965558,0.003080863],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008977209,0.000010604558,0.0002376459,0.00005057344,0.00014142269,0.011028426,0.00001466674,3.3833896e-8,0.00018118326,0.000016705708,0.9861451,0.002083878],"study_design_scores_gemma":[0.0006765127,0.0009942856,0.00047435248,0.000016098413,0.00035417377,0.0016605773,4.1690416e-7,0.000001438996,0.00021037669,0.00029763687,0.9951796,0.0001345248],"about_ca_topic_score_codex":0.00001559811,"about_ca_topic_score_gemma":7.105522e-7,"teacher_disagreement_score":0.131446,"about_ca_system_score_codex":0.0001165305,"about_ca_system_score_gemma":0.00012454264,"threshold_uncertainty_score":0.99913585},"labels":[],"label_agreement":null},{"id":"W4247147764","doi":"10.5489/cuaj.588","title":"Multivariate analysis of the factors involved in loss of renal differential function after laparoscopic partial nephrectomy: a role for warm ischemia time","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Nephrectomy; Renal function; Urology; Multivariate analysis; Surgery; Internal medicine; Kidney","score_opus":0.010734769747423992,"score_gpt":0.21476950621861665,"score_spread":0.20403473647119266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247147764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982796,0.000051668092,0.00006178575,0.00092373794,0.00010871954,0.0004636744,0.000056385466,0.0000048493157,0.000049582384],"genre_scores_gemma":[0.9993995,0.0000026011894,0.000048702917,0.00017146692,0.000089256646,0.00006439615,0.000045292705,0.0000084352205,0.00017035916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985512,0.00016351433,0.00049506733,0.00016527053,0.0002940937,0.00033084952],"domain_scores_gemma":[0.9987586,0.00016538468,0.00041767393,0.00012948042,0.00025491897,0.000273906],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002208544,0.00013967241,0.0005033844,0.00028479646,0.000063230225,0.00002341271,0.000092941336,0.00022054074,0.0011022219],"category_scores_gemma":[0.00032280627,0.00008618058,0.00039680267,0.0004327823,0.000039018683,0.00006906427,0.000016431643,0.00028100173,0.000005755848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024839622,0.0000852514,0.9800768,0.000005393062,0.0008085643,0.0000028261018,0.00016784579,0.000115422234,0.018219205,0.000005800533,0.00014340441,0.000121120196],"study_design_scores_gemma":[0.0016360369,0.00027191947,0.98758715,0.000013955771,0.001169536,0.0000013792059,0.000035087254,0.0027469206,0.0060416954,0.00013333412,0.00029135356,0.00007161631],"about_ca_topic_score_codex":0.003989647,"about_ca_topic_score_gemma":0.0019968257,"teacher_disagreement_score":0.01217751,"about_ca_system_score_codex":0.00073897245,"about_ca_system_score_gemma":0.00026092894,"threshold_uncertainty_score":0.99981093},"labels":[],"label_agreement":null},{"id":"W4247458385","doi":"10.5505/respircase.2016.76476","title":"Birt-Hogg-Dubé Syndrome: CT Findings of an Under Recognized Disease Requiring Multidisciplinary Approach","year":2016,"lang":"en","type":"article","venue":"Respiratory Case Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stantec (Canada)","funders":"","keywords":"Medicine; Multidisciplinary approach; Disease; Intensive care medicine; Internal medicine; Political science; Law","score_opus":0.05273007939580571,"score_gpt":0.3044037198402252,"score_spread":0.2516736404444195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247458385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99614567,0.0010126986,0.00015830617,0.000073838106,0.00017957525,0.0010035327,0.000021908701,0.00015750453,0.0012469746],"genre_scores_gemma":[0.99785775,0.000014990102,0.0009797674,0.000079336896,0.00010127609,0.00009190327,0.000029733306,0.000101327336,0.0007439106],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99667764,0.0001804433,0.00103883,0.00096663117,0.0006478724,0.0004885743],"domain_scores_gemma":[0.99681306,0.00012924768,0.0004567702,0.0015163299,0.00018911279,0.0008954678],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008783759,0.00039447212,0.0007140051,0.00035091263,0.00013939099,0.000019247578,0.00006561631,0.00010627856,0.00014159827],"category_scores_gemma":[0.00026863228,0.00026435943,0.00032733026,0.00030776398,0.00022455375,0.00031790766,0.00014480842,0.00016807887,0.000027360906],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073286844,0.0011952806,0.0917883,0.0005699852,0.00025271447,0.8475731,0.00008842065,0.00002173256,0.051349886,0.000028193494,0.00010335148,0.0062961807],"study_design_scores_gemma":[0.0064420206,0.0021446818,0.34600326,0.0013885444,0.0012346056,0.55443066,0.0003131213,0.00008620128,0.08550251,0.00039268017,0.001040105,0.0010215665],"about_ca_topic_score_codex":0.00004496132,"about_ca_topic_score_gemma":0.000004646937,"teacher_disagreement_score":0.2931424,"about_ca_system_score_codex":0.0004423365,"about_ca_system_score_gemma":0.00046526582,"threshold_uncertainty_score":0.99998087},"labels":[],"label_agreement":null},{"id":"W4247732446","doi":"10.1038/sj.modpathol.3801036","title":"Gynecologic","year":2008,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Pathology; Medicine","score_opus":0.04854708230432188,"score_gpt":0.2632663030839774,"score_spread":0.21471922077965555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247732446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728102,0.0006007888,0.00095570664,0.00055475597,0.000098389006,0.00017801227,0.0000015818616,0.0000888664,0.024711693],"genre_scores_gemma":[0.992722,0.00006498804,0.0019714723,0.0009213984,0.000059697504,0.000031789463,0.000014111471,0.000014294551,0.004200262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999278,0.000039507406,0.00012506053,0.00024118749,0.00009627858,0.00021995773],"domain_scores_gemma":[0.9995226,0.000034918005,0.000029051303,0.0002927151,0.000035553247,0.00008510876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053272517,0.00010097893,0.00022864358,0.000059898324,0.00005962847,0.0000012200967,0.00004466102,0.00010185844,0.00022213192],"category_scores_gemma":[0.00004215091,0.00007717118,0.0000755559,0.00005062266,0.00010839905,0.00001693164,0.000032729622,0.000109354725,0.00047000876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047999338,0.001305864,0.68630743,0.00006522782,0.00012813426,0.103828445,0.0026305637,0.00008588073,0.16735376,0.00067227706,0.005358437,0.031784017],"study_design_scores_gemma":[0.0019111084,0.0012466668,0.96017635,0.000005126541,0.000069988164,0.020052059,0.000015347881,0.0005170137,0.012108892,0.0015641289,0.0021887443,0.00014457761],"about_ca_topic_score_codex":0.000004313881,"about_ca_topic_score_gemma":0.0000020403008,"teacher_disagreement_score":0.27386895,"about_ca_system_score_codex":0.000068062065,"about_ca_system_score_gemma":0.000049723185,"threshold_uncertainty_score":0.60411686},"labels":[],"label_agreement":null},{"id":"W4248346590","doi":"10.1200/jco.2020.38.15_suppl.5069","title":"First-line pembrolizumab (pembro) monotherapy in advanced clear cell renal cell carcinoma (ccRCC): Updated follow-up for KEYNOTE-427 cohort A.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Cohort; Pembrolizumab; Renal cell carcinoma; Internal medicine; Proportional hazards model; Discontinuation; Urology; Clear cell renal cell carcinoma; Oncology; Surgery; Gastroenterology; Cancer; Nuclear medicine; Immunotherapy","score_opus":0.0919111155923545,"score_gpt":0.3896725936607971,"score_spread":0.2977614780684426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248346590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98132277,0.0012483856,0.001087422,0.011137964,0.001092571,0.0013492602,0.000019379648,0.00003033603,0.0027119133],"genre_scores_gemma":[0.9818634,0.0009993683,0.009562751,0.00498328,0.0014766941,0.000035877012,0.000038455313,0.00009877591,0.00094141753],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.993539,0.0004897597,0.0040631616,0.00064854714,0.00061737624,0.0006421927],"domain_scores_gemma":[0.99365133,0.0019696946,0.002252313,0.00042418015,0.000637549,0.0010649535],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018401161,0.00044553334,0.003061063,0.00023100521,0.00007425171,0.000017200322,0.00041451634,0.00072951213,0.00031489134],"category_scores_gemma":[0.0011901128,0.0003460405,0.001337062,0.0003619821,0.00016972172,0.00016958996,0.00008692584,0.0015790772,0.000059686936],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49782708,0.010165321,0.36659575,0.00066663773,0.0011887512,0.008645227,0.0012154473,0.0040471256,0.021074716,0.00005195067,0.03558729,0.05293471],"study_design_scores_gemma":[0.22067,0.14609385,0.4016078,0.00016660376,0.0016960298,0.00041092327,0.0002386238,0.005859682,0.018965118,0.00031680518,0.20326477,0.0007097855],"about_ca_topic_score_codex":0.000044091892,"about_ca_topic_score_gemma":0.000080067446,"teacher_disagreement_score":0.2771571,"about_ca_system_score_codex":0.0005389249,"about_ca_system_score_gemma":0.0017693359,"threshold_uncertainty_score":0.99989915},"labels":[],"label_agreement":null},{"id":"W4248494524","doi":"10.1158/1538-7445.am2019-2102","title":"Abstract 2102: Assessing glioma-protein inhibition in sunitinib-resistance using a 3-dimentional tissue-engineered renal cell carcinoma patient derived model","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Sunitinib; Cancer research; Medicine; Renal cell carcinoma; Sonic hedgehog; Tyrosine-kinase inhibitor; Cancer; Extracellular matrix; Hedgehog signaling pathway; Pathology; Internal medicine; Biology; Signal transduction; Cell biology","score_opus":0.09287254474761449,"score_gpt":0.3697786240415342,"score_spread":0.27690607929391975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248494524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99343455,0.0015729088,0.00018230708,0.00020980705,0.00006517815,0.0015597757,0.00003973009,0.00003332506,0.0029023928],"genre_scores_gemma":[0.99685824,0.000010304467,0.0019340406,0.000025155166,0.00009804635,0.00026835533,0.000091382775,0.00006613868,0.0006483417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967423,0.00015771214,0.000491532,0.00060388946,0.0012384821,0.0007660817],"domain_scores_gemma":[0.9986411,0.000092898474,0.000114008595,0.0004374722,0.0004594715,0.0002550775],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005610731,0.00025989916,0.00037467206,0.0006404731,0.00014117733,0.00009299957,0.0000966114,0.00015455075,0.0005049456],"category_scores_gemma":[0.000039994065,0.00025323572,0.000097398566,0.00069641887,0.000106010746,0.00028653024,0.0001037683,0.00067742105,0.00006429954],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047805373,0.00025847612,0.000079268844,0.00045195283,0.000019790918,0.0007031096,0.000288864,0.0036240432,0.9935954,0.000052947238,0.000095966425,0.0003521315],"study_design_scores_gemma":[0.0025724699,0.00017591631,0.010959904,0.00091230427,0.00002005106,0.00002254418,0.00026146506,0.00058239856,0.9840636,0.00015833312,0.000048677444,0.00022231897],"about_ca_topic_score_codex":0.0007473772,"about_ca_topic_score_gemma":0.000096949414,"teacher_disagreement_score":0.010880634,"about_ca_system_score_codex":0.0018731215,"about_ca_system_score_gemma":0.0010445066,"threshold_uncertainty_score":0.999992},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4248663753","doi":"10.5489/cuaj.1001","title":"Podium Session 5: Oncology/MIS","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Session (web analytics); Medicine; Oncology; Internal medicine; Medical physics; Computer science; World Wide Web","score_opus":0.017962142959409944,"score_gpt":0.2446420356844187,"score_spread":0.22667989272500874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248663753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8883552,0.00021018786,0.000016880746,0.076809585,0.00035117072,0.00026108325,0.000005285084,0.000028890097,0.03396169],"genre_scores_gemma":[0.9860124,0.00003478077,0.00049723213,0.008887583,0.00053074356,0.000017467284,0.00001739194,0.000011055983,0.003991371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853474,0.00017051867,0.00029802372,0.00016535415,0.0003266973,0.000504656],"domain_scores_gemma":[0.99794155,0.00012218156,0.0002045404,0.00010442626,0.00035171077,0.0012755692],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00037813815,0.00012854826,0.00026832832,0.00015874126,0.00022579268,0.00007615894,0.0000858297,0.00032717505,0.0050555384],"category_scores_gemma":[0.00046314456,0.00009002281,0.00014783865,0.0001446218,0.000023579452,0.000105731175,0.000009647811,0.000614759,0.001250889],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035665562,0.000112054404,0.824801,0.000003576215,0.00012913658,0.00051866024,0.0001256533,0.000008296438,0.0014304417,0.00006657301,0.14912818,0.023640707],"study_design_scores_gemma":[0.00089341175,0.0006598212,0.84678286,0.000007676048,0.0000664415,0.0006848523,0.00008824289,0.00006372278,0.000119954435,0.00052376656,0.15001835,0.0000908955],"about_ca_topic_score_codex":0.0022117645,"about_ca_topic_score_gemma":0.00026485647,"teacher_disagreement_score":0.09765715,"about_ca_system_score_codex":0.0036231568,"about_ca_system_score_gemma":0.0007709047,"threshold_uncertainty_score":0.99952674},"labels":[],"label_agreement":null},{"id":"W4248963290","doi":"10.1111/bju.13694","title":"Abstracts","year":2016,"lang":"fr","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Citation; Library science; Miami; Computer science","score_opus":0.018488764885700823,"score_gpt":0.2510259679900175,"score_spread":0.23253720310431664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248963290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6988064,0.26626197,0.00032903225,0.02041748,0.005273836,0.00011124782,0.000022797945,0.000007506409,0.00876972],"genre_scores_gemma":[0.96252406,0.020999458,0.00044141655,0.0007870958,0.003041362,0.0000012094183,8.8650796e-7,0.000031512394,0.012172982],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99788034,0.00022373603,0.0008557085,0.00017607135,0.00031158142,0.00055253366],"domain_scores_gemma":[0.9981055,0.00038493142,0.000541949,0.00015739138,0.00034587938,0.0004643443],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00067764556,0.00015833325,0.0005394041,0.00012499186,0.000043376276,0.000022641883,0.00016655134,0.00026373536,0.002874688],"category_scores_gemma":[0.00060598966,0.00013179908,0.00028629423,0.00007763902,0.0003298563,0.0001766144,0.000037662234,0.00041267206,0.0007001388],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004719408,0.0005601817,0.0060268547,0.000060375674,0.00045114016,0.10867973,0.00004873565,0.000016776356,0.00672693,0.00021684727,0.036932785,0.8398077],"study_design_scores_gemma":[0.005312345,0.0038489604,0.36410886,0.00097251486,0.00065030705,0.3536323,0.000023476672,0.0000019826148,0.0021019857,0.0010907802,0.2681142,0.00014228445],"about_ca_topic_score_codex":0.00011013443,"about_ca_topic_score_gemma":0.000038556496,"teacher_disagreement_score":0.8396654,"about_ca_system_score_codex":0.00024128411,"about_ca_system_score_gemma":0.00034740887,"threshold_uncertainty_score":0.9980368},"labels":[],"label_agreement":null},{"id":"W4249692483","doi":"10.1016/j.clgc.2020.06.002","title":"Safety and Efficacy of Nivolumab in Patients With Advanced Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study","year":2020,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Guardant Health; Janssen Pharmaceuticals; Janssen Biotech; Bristol-Myers Squibb Canada; EMD Serono; Genentech; Astellas Pharma; Eisai; Daiichi-Sankyo; Aileron Therapeutics; CTI Biopharma; ImmunoGen; Mirati Therapeutics; Bayer Fund; Five Prime Therapeutics; Acceleron; Clovis Oncology; TG Therapeutics; AstraZeneca; Novocure; Sanofi Genzyme; Takeda Pharmaceuticals U.S.A.; Immunocore; AbbVie; Karyopharm Therapeutics; Exelixis; MedImmune; Sanofi; Celgene; Novartis; Merck; GlaxoSmithKline; Roche; Foundation Medicine; Astellas Pharma US; American Society of Clinical Oncology; Ono Pharmaceutical; Eli Lilly and Company; Bristol-Myers Squibb; Boston Biomedical; Pfizer; Amgen; Boehringer Ingelheim; Calithera Biosciences; Bayer; Sarah Cannon Research Institute","keywords":"Medicine; Internal medicine; Nivolumab; Renal cell carcinoma; Rash; Clinical endpoint; Regimen; Clear cell renal cell carcinoma; Progression-free survival; Gastroenterology; Phases of clinical research; Oncology; Surgery; Cancer; Toxicity; Chemotherapy; Clinical trial; Immunotherapy","score_opus":0.038017893248143676,"score_gpt":0.32126363076328307,"score_spread":0.2832457375151394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249692483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99511844,0.0011989052,0.0000030623482,0.0006703564,0.0001353522,0.0019627435,0.00028785606,0.000028571496,0.0005947354],"genre_scores_gemma":[0.9983886,0.00024980897,0.00028656542,0.00036261015,0.00036551987,0.0000344164,0.000108368266,0.000053555377,0.00015056983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99672675,0.00033027137,0.0012499504,0.0008596306,0.00048645056,0.00034697336],"domain_scores_gemma":[0.99767435,0.0006822796,0.00044155336,0.0006757908,0.00015023927,0.0003757834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031221742,0.00033779757,0.0008637258,0.000039736526,0.00008213537,0.000011876888,0.00022638516,0.00012264974,0.00006371921],"category_scores_gemma":[0.00015481935,0.00021789107,0.00015853156,0.00029142,0.00021706682,0.00007579164,0.00020957763,0.000606196,0.0000141134715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18858816,0.0100279795,0.78322303,0.00009120591,0.00017106022,0.0005775624,0.0025544523,0.00025058846,0.0006813582,1.3553736e-7,0.0007517854,0.013082646],"study_design_scores_gemma":[0.10916356,0.021710219,0.86561316,0.00008430656,0.00040988697,9.348509e-7,0.00048808343,0.0001226974,0.0014528083,0.000001056063,0.00074521615,0.00020803852],"about_ca_topic_score_codex":0.0003599888,"about_ca_topic_score_gemma":0.00004075464,"teacher_disagreement_score":0.08239013,"about_ca_system_score_codex":0.00012432827,"about_ca_system_score_gemma":0.00023532126,"threshold_uncertainty_score":0.88853395},"labels":[],"label_agreement":null},{"id":"W4250674914","doi":"10.3410/f.727591217.793580400","title":"Faculty Opinions recommendation of Partial nephrectomy versus radical nephrectomy for clinical localised renal masses.","year":2020,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Nephrectomy; Renal mass; Urology; Medicine; Renal tumor; Kidney; Internal medicine","score_opus":0.10556677990022802,"score_gpt":0.42021980677794946,"score_spread":0.31465302687772145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250674914","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000021556698,0.0010930023,0.00013971288,0.2020387,0.0017970946,0.0043288134,0.7904799,0.000065551874,0.00005504472],"genre_scores_gemma":[0.000008614965,0.0007388338,0.0055141402,0.006630452,0.0016502735,0.0011438479,0.98385257,0.00006758761,0.00039369237],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9915596,0.0008876441,0.0034244596,0.001297016,0.0022130678,0.0006182048],"domain_scores_gemma":[0.98874855,0.00085690676,0.002309616,0.0019045118,0.0051376517,0.0010427493],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0019728718,0.00089318876,0.0024264655,0.00036900307,0.00023516837,0.0001200304,0.0013542437,0.0013577007,0.0005785862],"category_scores_gemma":[0.015761562,0.0005788956,0.0022675414,0.0020616103,0.00079044513,0.00025588868,0.00050696125,0.0018824622,0.00010667417],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010323654,0.0010677391,0.00003269725,0.008868214,0.00086502475,0.0000034546924,0.000039078568,9.6979285e-8,0.0000023971186,0.00010874513,0.9842787,0.0037015073],"study_design_scores_gemma":[0.00822323,0.0015316687,0.0009943622,0.0081230635,0.0017773652,0.00006800682,0.000017909002,0.000040506857,0.0000760593,0.000010068136,0.9786742,0.0004635667],"about_ca_topic_score_codex":0.000042625063,"about_ca_topic_score_gemma":0.0000041575736,"teacher_disagreement_score":0.19540825,"about_ca_system_score_codex":0.00032082858,"about_ca_system_score_gemma":0.0019187325,"threshold_uncertainty_score":0.9999387},"labels":[],"label_agreement":null},{"id":"W4251194873","doi":"10.21203/rs.2.21790/v2","title":"Management of complex renal cysts in Canada: Results of a survey study","year":2020,"lang":"en","type":"preprint","venue":"Research Square","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Centre Hospitalier Universitaire de Sherbrooke; McGill University Health Centre; Juravinski Hospital; Ottawa Hospital","funders":"Canadian Urological Association","keywords":"Geography; Medicine","score_opus":0.27223557295871736,"score_gpt":0.41940938490152857,"score_spread":0.1471738119428112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251194873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98780626,0.00044211152,0.000003721633,0.00053864,0.000051453564,0.004651393,0.0009933824,0.000010346367,0.0055027176],"genre_scores_gemma":[0.9981384,0.00014095516,0.00026277354,0.0000059044646,0.000034333494,0.00017038788,0.0008954593,0.000037326754,0.00031440385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99305975,0.0014991864,0.0010934551,0.00080731517,0.0030079414,0.0005323378],"domain_scores_gemma":[0.99682534,0.0004996069,0.00025620533,0.0012668272,0.0008530364,0.00029899692],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028810138,0.00028373834,0.0011227381,0.00048157966,0.000029179055,0.0000107354335,0.000459881,0.0001046569,0.000061600455],"category_scores_gemma":[0.00036251303,0.00024669516,0.00012761427,0.0008737009,0.00010279977,0.000013333132,0.0015968487,0.0010890969,0.0000067691863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015507412,0.0038220994,0.92055476,0.016869603,0.002078437,0.019681847,0.0023791771,0.0007578493,0.0009806597,0.000038626084,0.012890417,0.004439119],"study_design_scores_gemma":[0.004597675,0.0016296284,0.98770195,0.0021057979,0.000068353605,0.000003963337,0.0022983484,0.00019682894,0.0010970663,0.000033355143,0.00013061053,0.00013639701],"about_ca_topic_score_codex":0.9672359,"about_ca_topic_score_gemma":0.9209653,"teacher_disagreement_score":0.067147225,"about_ca_system_score_codex":0.002417923,"about_ca_system_score_gemma":0.003875436,"threshold_uncertainty_score":0.9999985},"labels":[],"label_agreement":null},{"id":"W4251379596","doi":"10.1200/jco.2012.30.15_suppl.4538","title":"Characteristics of long-term and short-term survivors of metastatic renal cell carcinoma (mRCC) treated with targeted therapy: Results from the International mRCC Database Consortium.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; BC Cancer Agency; Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre; University of Toronto; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Targeted therapy; Internal medicine; Thrombocytosis; Renal cell carcinoma; Oncology; Odds ratio; Systemic therapy; Confidence interval; Anemia; Cancer; Breast cancer","score_opus":0.12490358618711601,"score_gpt":0.38764103781255194,"score_spread":0.26273745162543594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251379596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99640274,0.0012467329,0.000055934335,0.0008068131,0.00045726798,0.00032211796,0.00034978183,0.0000044911008,0.00035412225],"genre_scores_gemma":[0.99614596,0.0011629232,0.0015332402,0.00028176926,0.0005444507,0.0000037509753,0.00022597775,0.000024407507,0.00007752512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955186,0.0006410451,0.0027779283,0.00022797816,0.0005843319,0.0002501064],"domain_scores_gemma":[0.9916995,0.0042127655,0.002690805,0.00039589254,0.00062433304,0.0003766927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024333913,0.00023461904,0.0015828606,0.00011600719,0.0000300339,0.0000089134155,0.00025961723,0.00016352643,0.00012873393],"category_scores_gemma":[0.000966604,0.00012362727,0.00029199393,0.00011269856,0.000513014,0.00014722845,0.000081362705,0.0006087792,0.000002154062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021116892,0.0024263777,0.951936,0.000031963795,0.0011003021,0.00082300376,0.000355234,8.63339e-7,0.01060452,0.0000049006076,0.00023214292,0.011367797],"study_design_scores_gemma":[0.010598538,0.0075241392,0.9623974,0.00012536818,0.0012600911,0.00035294847,0.00010626174,0.000019784911,0.017201534,0.0000029909927,0.00030893882,0.0001019811],"about_ca_topic_score_codex":0.00022723118,"about_ca_topic_score_gemma":0.0000811195,"teacher_disagreement_score":0.011265816,"about_ca_system_score_codex":0.00008934821,"about_ca_system_score_gemma":0.00062357314,"threshold_uncertainty_score":0.5041374},"labels":[],"label_agreement":null},{"id":"W4251905465","doi":"10.1016/j.juro.2012.02.1818","title":"1787 THE EFFECT OF NODAL CODING SCHEMES ON CANCER-SPECIFIC MORTALITY AFTER CYTOREDUCTIVE NEPHRECTOMY","year":2012,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Art history; Nephrectomy; Cancer; Gerontology; Classics; Religious studies; History; Internal medicine; Philosophy; Kidney","score_opus":0.026934806078599452,"score_gpt":0.3044171734536908,"score_spread":0.27748236737509135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251905465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888628,0.008256207,0.000026504233,0.0015561252,0.0005143369,0.00024335037,0.000003226082,0.000003993338,0.0005334389],"genre_scores_gemma":[0.9985265,0.00031025815,0.000024383542,0.00022024821,0.0008596357,0.000010953351,4.77361e-7,0.000014159206,0.000033358432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985842,0.00049420533,0.000311421,0.00007174724,0.00028966152,0.0002487428],"domain_scores_gemma":[0.9986303,0.0005756005,0.00033836142,0.00027398072,0.0000907526,0.000090997266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010975053,0.00014484301,0.00040453734,0.00006996931,0.000050834205,0.0000033102237,0.0001438185,0.00006328923,0.00017013865],"category_scores_gemma":[0.000060946946,0.00006067827,0.00017406495,0.00009544268,0.0002457563,0.00005552928,0.000034833156,0.00042565304,0.000011238223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024442146,0.00032858847,0.89150566,0.0000791954,0.0016979869,0.00014754092,0.003327069,0.0001050819,0.07114225,0.0002199021,0.0015825521,0.0054220404],"study_design_scores_gemma":[0.0020223898,0.0045058536,0.8531021,0.0000420544,0.0011279524,0.0010497167,0.00010285232,0.000008702112,0.13328893,0.00004047516,0.0046384325,0.000070514834],"about_ca_topic_score_codex":0.000033698958,"about_ca_topic_score_gemma":0.0000030113965,"teacher_disagreement_score":0.06214669,"about_ca_system_score_codex":0.000117783835,"about_ca_system_score_gemma":0.00004630715,"threshold_uncertainty_score":0.24743882},"labels":[],"label_agreement":null},{"id":"W4251975905","doi":"10.1200/jco.2013.31.6_suppl.430","title":"First-line mTOR inhibition in metastatic renal cell carcinoma (mRCC): An analysis from the International mRCC Database Consortium.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Temsirolimus; Medicine; Everolimus; Sorafenib; Sunitinib; Renal cell carcinoma; Internal medicine; Oncology; Discovery and development of mTOR inhibitors; Targeted therapy; PI3K/AKT/mTOR pathway; Cancer","score_opus":0.12595325309384883,"score_gpt":0.4106898319392137,"score_spread":0.28473657884536485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251975905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983879,0.00040673435,0.00060916826,0.013404521,0.00059255306,0.00034927108,0.00005333609,0.000006923537,0.00069849164],"genre_scores_gemma":[0.9889935,0.00022990709,0.0064293775,0.0028504452,0.0011099475,0.00001888281,0.00018382215,0.000017704924,0.00016637555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99504864,0.0007873348,0.0028982891,0.00034036554,0.0006680954,0.00025726674],"domain_scores_gemma":[0.9929849,0.0037351907,0.0017837625,0.00045391291,0.00057720847,0.00046501815],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00267784,0.00020970727,0.0014491157,0.00032447578,0.000047218702,0.000034513527,0.00026323838,0.00019175334,0.0021372046],"category_scores_gemma":[0.001796953,0.00012442515,0.00069236575,0.00034913208,0.00021338758,0.00033777507,0.00010509569,0.0010135444,0.00008962258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042608953,0.006736403,0.9566675,0.000025321777,0.0022617215,0.005516013,0.0003817792,0.0011197561,0.0034669088,0.000050313545,0.00710897,0.012404449],"study_design_scores_gemma":[0.010094266,0.0057197283,0.9683402,0.000055179815,0.0033418885,0.00020083322,0.0003880052,0.00613896,0.0014871594,0.0003752233,0.0037239476,0.00013457473],"about_ca_topic_score_codex":0.0018048129,"about_ca_topic_score_gemma":0.0022131156,"teacher_disagreement_score":0.012269874,"about_ca_system_score_codex":0.00038387108,"about_ca_system_score_gemma":0.000841032,"threshold_uncertainty_score":0.998775},"labels":[],"label_agreement":null},{"id":"W4252187823","doi":"10.4081/146","title":"Epidemiology, molecular epidemiology, and risk factors for renal cell carcinoma","year":2011,"lang":"en","type":"article","venue":"Oncology Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Epidemiology; Medicine; Renal cell carcinoma; Molecular epidemiology; Oncology; Environmental health; Internal medicine; Genetics; Gene; Genotype; Biology","score_opus":0.18747355827260395,"score_gpt":0.3753070601548235,"score_spread":0.18783350188221956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252187823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86564445,0.11966377,0.0018400869,0.00047006056,0.00022234008,0.002525716,0.000027734219,0.000041535408,0.009564315],"genre_scores_gemma":[0.85782355,0.03153874,0.10487816,0.0030332333,0.00022141416,0.00092817534,0.00015921971,0.00007820798,0.0013392813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99518216,0.0020432435,0.0012412799,0.00077252986,0.00005036614,0.0007104182],"domain_scores_gemma":[0.9955073,0.002444202,0.00081944827,0.00066857034,0.00008289931,0.0004775799],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0041118143,0.00042193456,0.002491435,0.00012337978,0.00012285556,0.0000010195008,0.00015380241,0.0004837689,0.00017072106],"category_scores_gemma":[0.0040366133,0.00028059605,0.00055835163,0.000107539425,0.00043835805,0.00004198487,0.0000941317,0.0004264362,0.000095542324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026367846,0.00025607774,0.9750011,0.00027373966,0.00011786311,0.00007737905,0.00030012705,4.4108245e-7,0.0007418582,0.0006457256,0.005911866,0.016410142],"study_design_scores_gemma":[0.0025706876,0.006265092,0.7379219,0.00007391791,0.0019692052,0.00032220889,0.000079772355,0.00004315476,0.004262084,0.0027671957,0.2433708,0.0003540057],"about_ca_topic_score_codex":0.0003789892,"about_ca_topic_score_gemma":0.00003886929,"teacher_disagreement_score":0.23745893,"about_ca_system_score_codex":0.00022292596,"about_ca_system_score_gemma":0.00012981046,"threshold_uncertainty_score":0.9999646},"labels":[],"label_agreement":null},{"id":"W4252195682","doi":"10.1200/jco.2018.36.6_suppl.581","title":"Cytoreductive nephrectomy in metastatic papillary renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; London Health Sciences Centre; Sunnybrook Hospital; Queen Elizabeth II Health Sciences Centre; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Hazard ratio; Renal cell carcinoma; Histology; Nephrectomy; Urology; Papillary renal cell carcinomas; Clear cell; Proportional hazards model; Retrospective cohort study; Internal medicine; Cohort; Gastroenterology; Oncology; Surgery; Kidney; Confidence interval","score_opus":0.12411096762540325,"score_gpt":0.4003767994809201,"score_spread":0.27626583185551684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252195682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97849005,0.001453382,0.00013969262,0.0087178955,0.002491639,0.00063651364,0.00029207655,0.000012876548,0.007765896],"genre_scores_gemma":[0.9766201,0.00021649942,0.016218742,0.0028310402,0.0033391658,0.000018048095,0.00016873851,0.000050858776,0.0005368397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99074304,0.0019666054,0.004738685,0.00073580275,0.0012153486,0.00060049206],"domain_scores_gemma":[0.9855893,0.0083754845,0.0034268438,0.00082200184,0.0010940935,0.0006922741],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0056528947,0.00046761465,0.0021675017,0.00034042608,0.00011254095,0.000042926666,0.0007955887,0.00025735234,0.0005039724],"category_scores_gemma":[0.004230695,0.0002913761,0.00081233354,0.0003896782,0.0009539888,0.00031720835,0.00030770604,0.0020227518,0.00013226051],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15879552,0.023965936,0.37678477,0.00021379678,0.004527076,0.073019944,0.007308755,0.00018146443,0.0701602,0.00019164382,0.25415513,0.030695774],"study_design_scores_gemma":[0.06829651,0.030090228,0.7556605,0.0002722138,0.004420042,0.0023291148,0.0027287053,0.00079428003,0.053054158,0.00083273987,0.08087026,0.000651282],"about_ca_topic_score_codex":0.0009840792,"about_ca_topic_score_gemma":0.00044414337,"teacher_disagreement_score":0.3788757,"about_ca_system_score_codex":0.0007339831,"about_ca_system_score_gemma":0.0040951213,"threshold_uncertainty_score":0.99995387},"labels":[],"label_agreement":null},{"id":"W4252389302","doi":"10.5489/cuaj.812","title":"Active surveillance as the preferred management option for small renal masses","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Renal mass; Computer science; Medicine; Kidney; Internal medicine","score_opus":0.02572564268887334,"score_gpt":0.23488388669536805,"score_spread":0.20915824400649471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252389302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93790513,0.00015336435,0.0002934848,0.050213035,0.00024105604,0.001255856,0.000021393884,0.000024341474,0.0098923175],"genre_scores_gemma":[0.99174994,0.00007521583,0.00087217917,0.0031900594,0.0003582268,0.00016981752,0.00004120735,0.000012431709,0.003530894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998693,0.00015364143,0.00025370638,0.00018683837,0.00027059144,0.00044221204],"domain_scores_gemma":[0.9986525,0.00022106283,0.00022364632,0.0001270269,0.00033038025,0.00044536102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045986552,0.00013515935,0.00019757242,0.00009681611,0.00030146987,0.00012278541,0.00012147809,0.00013955936,0.00047678544],"category_scores_gemma":[0.00032157009,0.00008293214,0.00015676572,0.00012004229,0.000023574228,0.00007454924,0.000013810479,0.00029674784,0.00014648533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001025902,0.00035829894,0.7817208,0.000055604494,0.002646923,0.00038374774,0.00066575827,0.00045016594,0.0012171452,0.0043721795,0.09643672,0.110666744],"study_design_scores_gemma":[0.0011110735,0.0004914586,0.9073435,0.000008724301,0.00009325732,0.00014515105,0.00012881319,0.00016212251,0.0001126852,0.0032688547,0.087037176,0.00009717595],"about_ca_topic_score_codex":0.0010404076,"about_ca_topic_score_gemma":0.00073843653,"teacher_disagreement_score":0.12562269,"about_ca_system_score_codex":0.0015580589,"about_ca_system_score_gemma":0.0001925821,"threshold_uncertainty_score":0.5220466},"labels":[],"label_agreement":null},{"id":"W4252679989","doi":"10.1159/000151877","title":"Genitourinary Cancers","year":2008,"lang":"en","type":"review","venue":"Progress in experimental tumor research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Genitourinary system; Biology; Medicine; Internal medicine","score_opus":0.2328989073490328,"score_gpt":0.5041825384272727,"score_spread":0.2712836310782399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252679989","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028400912,0.984256,2.6688735e-8,0.000025529727,0.00018594803,0.0041220635,0.000012851854,0.0000686834,0.0084887585],"genre_scores_gemma":[0.004612653,0.9876297,0.00036066264,0.000010932375,0.00046432292,0.005457315,0.00013394252,0.000187347,0.0011430975],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99457204,0.0006263317,0.00078909576,0.0010558302,0.001721184,0.0012354926],"domain_scores_gemma":[0.99817467,0.00017554211,0.00014679618,0.0009186868,0.00011898509,0.00046531705],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041948247,0.00063421123,0.0020499562,0.0011812019,0.00018630584,0.000050463303,0.0004989933,0.00022933316,0.00036929655],"category_scores_gemma":[0.000035607274,0.000494153,0.0005856303,0.0011655643,0.00090664136,0.00007756722,0.0005733653,0.0017384662,0.00051081215],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024317742,0.0014048261,0.0005088966,0.00942611,0.0002032072,0.037053723,0.00030257853,6.6454895e-8,0.000006439928,0.00002360469,0.0017427917,0.9490846],"study_design_scores_gemma":[0.0011493436,0.0017058348,0.00006137609,0.012675754,0.000070980204,0.005734606,0.00027116557,0.0000038116077,0.001469468,0.0000029134446,0.9764097,0.00044506261],"about_ca_topic_score_codex":0.00014351777,"about_ca_topic_score_gemma":0.0000033541965,"teacher_disagreement_score":0.9746669,"about_ca_system_score_codex":0.0061018714,"about_ca_system_score_gemma":0.0019254314,"threshold_uncertainty_score":0.99975103},"labels":[],"label_agreement":null},{"id":"W4252844485","doi":"10.5489/cuaj.4840","title":"New research in kidney cancer, ASCO 2017","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University; University of Alberta","funders":"","keywords":"Kidney cancer; Cancer; Medicine; Oncology; Internal medicine","score_opus":0.10213750797242352,"score_gpt":0.3610387398435946,"score_spread":0.2589012318711711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252844485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70179886,0.0009677551,0.0000063054363,0.24489449,0.0007009255,0.00031972848,0.00002680971,0.000012415941,0.051272746],"genre_scores_gemma":[0.9889443,0.00042000163,0.00017596324,0.0019304756,0.0011101161,0.000011022554,0.0000069752314,0.000010878914,0.0073902537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802583,0.00019346435,0.00025921382,0.00021421202,0.00059285935,0.00071443676],"domain_scores_gemma":[0.9969564,0.000100756384,0.00022131306,0.00028326648,0.00028486084,0.002153385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014749056,0.000110637986,0.0002569547,0.0003147403,0.00079329836,0.00025044696,0.0002889717,0.00025542482,0.0008901119],"category_scores_gemma":[0.0021088782,0.000088005094,0.00010128551,0.000112289556,0.00004953072,0.0001296911,0.000032183238,0.0011287874,0.00017226567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050771403,0.000022332048,0.8698929,0.0000033414499,0.000043717435,0.0008868184,0.00004743702,0.000004243019,0.00008443516,0.0001121579,0.12241846,0.0064333747],"study_design_scores_gemma":[0.0013447888,0.00020865997,0.8761953,0.000050685172,0.000022803437,0.0001377583,0.000015904692,0.000022775206,0.000052553685,0.0012039593,0.120672025,0.00007277323],"about_ca_topic_score_codex":0.06912235,"about_ca_topic_score_gemma":0.015761308,"teacher_disagreement_score":0.2871455,"about_ca_system_score_codex":0.004172759,"about_ca_system_score_gemma":0.0035426342,"threshold_uncertainty_score":0.99965006},"labels":[],"label_agreement":null},{"id":"W4253056746","doi":"10.5489/cuaj.150","title":"Partial nephrectomy is not the proven standard for Stage T1b renal cell carcinoma","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Nephrectomy; Renal cell carcinoma; Stage (stratigraphy); Medicine; Urology; Oncology; Internal medicine; Kidney; Biology","score_opus":0.025764590862728053,"score_gpt":0.24540886137545043,"score_spread":0.21964427051272237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253056746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9669209,0.00048434327,0.00020503416,0.02808828,0.00043941225,0.00089814875,0.0002421429,0.000019487637,0.0027022494],"genre_scores_gemma":[0.98672754,0.0000127080775,0.00041861786,0.007709451,0.0016792679,0.00009068309,0.000027868558,0.000022687158,0.0033111814],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99776626,0.00018557376,0.00038563088,0.00019450308,0.00053466344,0.0009333781],"domain_scores_gemma":[0.99781626,0.00025276997,0.00031855842,0.00018108668,0.00029685843,0.0011344488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011707337,0.00019872258,0.00032353736,0.00009986179,0.00047235936,0.00010378356,0.00014552668,0.00023422283,0.0009083776],"category_scores_gemma":[0.00036776136,0.00012346737,0.00029466438,0.0001368134,0.00004013123,0.00012452772,0.000017748665,0.00056760624,0.00006206096],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006399899,0.00009680442,0.9326827,0.000015104093,0.00015505854,0.00007111458,0.0006456091,0.000011362539,0.00096778345,0.00023893695,0.061377294,0.0030982199],"study_design_scores_gemma":[0.002123327,0.0009368464,0.3888864,0.0000042804313,0.0002305572,0.00010880003,0.00009845565,0.00008415955,0.0056758528,0.00008205185,0.6016217,0.00014756687],"about_ca_topic_score_codex":0.00055818073,"about_ca_topic_score_gemma":0.00018799487,"teacher_disagreement_score":0.5437963,"about_ca_system_score_codex":0.0020829714,"about_ca_system_score_gemma":0.00080787594,"threshold_uncertainty_score":0.9946097},"labels":[],"label_agreement":null},{"id":"W4253635231","doi":"10.1016/j.urology.2015.10.052","title":"Editorial Comment","year":2016,"lang":"es","type":"editorial","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Renal cell carcinoma; Urology; Retrospective cohort study; Renal mass; Carcinoma; Nuclear medicine; Nephrectomy; Kidney; Pathology; Internal medicine","score_opus":0.01094743688527651,"score_gpt":0.2732830707484416,"score_spread":0.2623356338631651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253635231","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021415563,0.0018304348,0.000056467263,0.00926499,0.9762109,0.0008896858,0.00033831177,0.00011262816,0.011082432],"genre_scores_gemma":[0.0044132075,0.0012072269,0.000021020836,0.0009015363,0.98735946,0.00016703336,0.0007086624,0.00015666858,0.0050651752],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99484104,0.00047466962,0.00086816266,0.001172926,0.0014552746,0.0011879317],"domain_scores_gemma":[0.9947403,0.002434646,0.0004917957,0.001306998,0.00049969275,0.0005265541],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000510066,0.0009087895,0.0015853522,0.00030885974,0.00015137332,0.000040780407,0.00051736285,0.0032316924,0.0020826065],"category_scores_gemma":[0.0009932683,0.0006416054,0.0004870351,0.00010920918,0.0004286414,0.00005351192,0.00036271726,0.0015374953,0.0074006594],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028963767,0.00038942715,0.00024181727,0.00014617697,0.0007843114,0.00041822647,0.00007701389,9.633166e-7,0.0004591067,0.00023979222,0.99271667,0.0016301284],"study_design_scores_gemma":[0.007763376,0.006477274,0.000074875905,0.0001116855,0.0015235837,0.000032326472,0.000007876077,0.0000029433415,0.00026281495,0.00025191417,0.983007,0.00048434263],"about_ca_topic_score_codex":0.0001411065,"about_ca_topic_score_gemma":0.000009143416,"teacher_disagreement_score":0.011148574,"about_ca_system_score_codex":0.00089467986,"about_ca_system_score_gemma":0.0009961044,"threshold_uncertainty_score":0.9996035},"labels":[],"label_agreement":null},{"id":"W4253848677","doi":"10.1200/jco.2020.38.15_suppl.5068","title":"Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC): An international mRCC database consortium (IMDC) analysis.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Calgary; Sunnybrook Hospital; Western University; Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network; London Health Sciences Centre; Queen's University","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Nephrectomy; Multivariate analysis; Population; Oncology; Kidney","score_opus":0.10023124549084568,"score_gpt":0.4011712840233951,"score_spread":0.3009400385325494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253848677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99443406,0.0006972829,0.00012093215,0.0033479766,0.00020219719,0.0006115877,0.00003311051,0.00000426423,0.0005486129],"genre_scores_gemma":[0.99507636,0.00035261293,0.0036440536,0.00042093056,0.0003773842,0.000011211716,0.00007480199,0.000019992836,0.000022658849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932903,0.000988868,0.0042818827,0.00036373033,0.00082760747,0.00024762863],"domain_scores_gemma":[0.99290454,0.0022309269,0.0034508482,0.00048423684,0.0005315917,0.0003978291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019158262,0.00027670377,0.002460446,0.00035638237,0.000021825997,0.000008368565,0.0003664035,0.00014835801,0.00017713563],"category_scores_gemma":[0.00074737705,0.00014749692,0.0011623615,0.00057739846,0.00035228478,0.00014866311,0.000045479053,0.0005747358,0.0000040534264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09418847,0.051486854,0.78663015,0.0002972163,0.008743845,0.010725733,0.013453515,0.0014324156,0.0067696767,0.00005460934,0.00031490278,0.025902627],"study_design_scores_gemma":[0.041111313,0.06301459,0.86697847,0.00014897468,0.006987599,0.00023901286,0.0024930837,0.00085774943,0.017148204,0.0000057803463,0.0008673191,0.00014789838],"about_ca_topic_score_codex":0.00028500723,"about_ca_topic_score_gemma":0.0001364698,"teacher_disagreement_score":0.08034834,"about_ca_system_score_codex":0.00022240955,"about_ca_system_score_gemma":0.0010768294,"threshold_uncertainty_score":0.601475},"labels":[],"label_agreement":null},{"id":"W4254347149","doi":"10.1097/01.ju.0000550099.29951.ae","title":"This Month in Adult Urology","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Natural history; Prostate cancer; Biopsy; Cancer; Surgery; Urology; Internal medicine","score_opus":0.012270658903238588,"score_gpt":0.24509771185217782,"score_spread":0.23282705294893924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254347149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9743639,0.001538235,0.0000116620195,0.011576408,0.00028066253,0.0001598588,4.0108176e-7,0.0000042030624,0.012064668],"genre_scores_gemma":[0.9954147,0.00027013393,0.00006879825,0.0031138153,0.00012359058,0.0000010813371,5.8070583e-7,0.00001165568,0.0009956654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989621,0.00023486487,0.00035042907,0.00007843229,0.00016197527,0.00021220517],"domain_scores_gemma":[0.9990997,0.00025306473,0.00021416188,0.00024521205,0.00011993582,0.00006792896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049937196,0.000095676245,0.0003529792,0.00015725732,0.000013312798,0.0000018463214,0.00015323998,0.000099719444,0.00075551454],"category_scores_gemma":[0.00009136917,0.00005216711,0.00008949011,0.000095987045,0.000068893525,0.000032881137,0.000033207743,0.0004654342,0.0003136964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031542208,0.0014760058,0.8417282,0.000099976096,0.00095809,0.005285687,0.0063386513,0.0016580047,0.07842764,0.002403526,0.018140387,0.011941636],"study_design_scores_gemma":[0.018866776,0.031980976,0.87380695,0.000039565548,0.0012337508,0.033074465,0.0003301446,0.0013850386,0.004586934,0.0019803129,0.03244053,0.0002745443],"about_ca_topic_score_codex":0.00005391993,"about_ca_topic_score_gemma":0.000021762422,"teacher_disagreement_score":0.07384071,"about_ca_system_score_codex":0.000057377823,"about_ca_system_score_gemma":0.000084598774,"threshold_uncertainty_score":0.82723546},"labels":[],"label_agreement":null},{"id":"W4254569446","doi":"10.3410/f.726885279.793578367","title":"Faculty Opinions recommendation of High-dose interleukin2 - a 10-year single-site experience in the treatment of metastatic renal cell carcinoma: careful selection of patients gives an excellent outcome.","year":2020,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Renal cell carcinoma; Selection (genetic algorithm); Outcome (game theory); Medicine; Oncology; Internal medicine; Computer science; Artificial intelligence; Mathematics","score_opus":0.06965529292356233,"score_gpt":0.3569512041911055,"score_spread":0.28729591126754317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254569446","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004617299,0.00062491617,0.000010026105,0.014188549,0.00029626538,0.002906952,0.977322,0.000014255443,0.00001976022],"genre_scores_gemma":[0.027438102,0.00018093707,0.0007566699,0.000433571,0.0000950773,0.00037734958,0.97051555,0.000028844122,0.00017390907],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99413824,0.0008736312,0.002349999,0.0007256808,0.001601515,0.00031095493],"domain_scores_gemma":[0.9928409,0.00018112833,0.0021818087,0.0012548893,0.0032836234,0.0002576852],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005418827,0.0006066352,0.0015582669,0.00048608985,0.00009219504,0.000041629963,0.00080142886,0.00031415973,0.0002643465],"category_scores_gemma":[0.0011652807,0.00033703903,0.0007066991,0.0018649234,0.0003297299,0.00023129529,0.0001648214,0.00048794004,0.000012612405],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029341996,0.0059243846,0.0008589937,0.008228957,0.00017972915,0.0000020271548,0.003749922,5.235228e-7,0.0000480717,0.000014234492,0.97922784,0.001471871],"study_design_scores_gemma":[0.0033090175,0.00460004,0.03437477,0.0030000673,0.0007358822,0.000017619559,0.00041252063,0.000010615453,0.0010012494,0.0000033379467,0.95228773,0.00024712094],"about_ca_topic_score_codex":0.00039033339,"about_ca_topic_score_gemma":0.00002897583,"teacher_disagreement_score":0.033515777,"about_ca_system_score_codex":0.00042792474,"about_ca_system_score_gemma":0.0003760939,"threshold_uncertainty_score":0.99990815},"labels":[],"label_agreement":null},{"id":"W4255163167","doi":"10.3410/f.723587806.793513230","title":"Faculty Opinions recommendation of Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients.","year":2016,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Nephrectomy; Medicine; Urology; General surgery; Internal medicine; Kidney","score_opus":0.07383834780002708,"score_gpt":0.4069753901236129,"score_spread":0.3331370423235858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255163167","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007024001,0.00046265026,0.000014198446,0.027453678,0.0004637352,0.0047447304,0.96667176,0.000010836626,0.00010815447],"genre_scores_gemma":[0.00024412732,0.00010793788,0.0006448567,0.000612733,0.00011333769,0.0010455678,0.99682534,0.000018035478,0.00038809393],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99499786,0.00048023363,0.0022240279,0.00072954106,0.0012112072,0.0003571294],"domain_scores_gemma":[0.99050176,0.000383039,0.002219199,0.0013448814,0.0052685346,0.0002825979],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010296291,0.00051747606,0.0023521746,0.00085760694,0.0000997931,0.000055001292,0.0011925391,0.00045430355,0.0004663047],"category_scores_gemma":[0.00294907,0.00030385994,0.0009406742,0.0032124831,0.00033034972,0.00027297085,0.0004548235,0.00049994927,0.00000902873],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005378361,0.0011101437,0.00026502207,0.0033183128,0.0014036456,2.803711e-7,0.00012419878,3.9364159e-7,0.000002696914,0.00011615485,0.99247974,0.0006415809],"study_design_scores_gemma":[0.0062637045,0.0008604814,0.016276166,0.009879601,0.002277747,0.0000023144332,0.000025653022,0.000015060192,0.00014391275,0.000006364192,0.96400493,0.00024407238],"about_ca_topic_score_codex":0.00015778701,"about_ca_topic_score_gemma":0.00004724588,"teacher_disagreement_score":0.030153533,"about_ca_system_score_codex":0.00031872728,"about_ca_system_score_gemma":0.0007543501,"threshold_uncertainty_score":0.99994135},"labels":[],"label_agreement":null},{"id":"W4255777318","doi":"10.1111/iju.12588","title":"<scp>IJU</scp> this issue","year":2014,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lower urinary tract symptoms; Renal cell carcinoma; Erectile dysfunction; Hyperplasia; Urology; Urinary system; Nephrectomy; Cancer; Intensive care medicine; Gynecology; Oncology; Internal medicine; Kidney; Prostate","score_opus":0.013928290973615623,"score_gpt":0.27939718887893733,"score_spread":0.2654688979053217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255777318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91306436,0.0009203749,0.0013902234,0.011707717,0.0023283854,0.00007748194,0.0000027034146,0.000016084556,0.07049265],"genre_scores_gemma":[0.98950654,0.000103222905,0.0011039879,0.0034280436,0.0017990227,0.0000016620351,0.0000054103684,0.000014959058,0.0040371325],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988001,0.00007843768,0.00039018213,0.00011540946,0.00046234648,0.00015350165],"domain_scores_gemma":[0.9985523,0.00032434735,0.00029749252,0.00012714554,0.00055811484,0.00014056583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030984054,0.00010730724,0.00026418932,0.00026016549,0.000017025832,0.0000145805725,0.00024361847,0.00009033148,0.00047411156],"category_scores_gemma":[0.00059228257,0.00008120525,0.00017078994,0.00004609362,0.00006379323,0.00007076457,0.000044955053,0.00026894207,0.00035714617],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021157064,0.0025624556,0.2744916,0.00007197589,0.0057987245,0.011345299,0.0028777989,0.0006370158,0.0833115,0.014449536,0.48274598,0.11959238],"study_design_scores_gemma":[0.0029484585,0.0023487231,0.064473785,0.00002387455,0.00019268897,0.009551659,0.00003622435,0.00029248872,0.008604656,0.001563568,0.90992546,0.000038416973],"about_ca_topic_score_codex":0.000012282455,"about_ca_topic_score_gemma":0.000001927273,"teacher_disagreement_score":0.4271795,"about_ca_system_score_codex":0.000096396776,"about_ca_system_score_gemma":0.000077377306,"threshold_uncertainty_score":0.5191189},"labels":[],"label_agreement":null},{"id":"W4256550902","doi":"10.1016/j.urology.2014.11.045","title":"Editorial Comment","year":2015,"lang":"es","type":"editorial","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; General surgery; Family medicine","score_opus":0.018826441909990794,"score_gpt":0.28329852324637217,"score_spread":0.2644720813363814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256550902","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032701966,0.0035568762,0.000015470698,0.0046880813,0.9758429,0.00094558665,0.00024204153,0.00011565733,0.014266348],"genre_scores_gemma":[0.003780951,0.000524571,0.000036135058,0.0008548645,0.9893026,0.00014088226,0.0022037316,0.00015432508,0.0030019914],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943546,0.000542075,0.0008728828,0.0011032837,0.00203086,0.0010963002],"domain_scores_gemma":[0.9951861,0.0012627552,0.00047704205,0.0012764194,0.0010068273,0.0007908537],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00088258804,0.00091250736,0.00173918,0.00031228125,0.00011781075,0.000053525928,0.0005189181,0.0034008897,0.00074608676],"category_scores_gemma":[0.0015056268,0.00078619167,0.0003875551,0.00016827337,0.00036502501,0.00005137592,0.00039950258,0.002294899,0.004916329],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003197711,0.0005635854,0.00017736453,0.0001515976,0.0007185231,0.00054369867,0.00021117702,0.000013806234,0.000070309725,0.00010250905,0.9937044,0.0005453237],"study_design_scores_gemma":[0.007837257,0.009062231,0.000033968652,0.000049433253,0.0020443106,0.000043164615,0.00003250941,0.000021341759,0.000062914696,0.0002541552,0.98007184,0.00048687865],"about_ca_topic_score_codex":0.0003978768,"about_ca_topic_score_gemma":0.000019466945,"teacher_disagreement_score":0.013632559,"about_ca_system_score_codex":0.001253874,"about_ca_system_score_gemma":0.0020769835,"threshold_uncertainty_score":0.9994589},"labels":[],"label_agreement":null},{"id":"W4280488872","doi":"10.1016/j.anndiagpath.2022.151978","title":"Histologic diversity in chromophobe renal cell carcinoma does not impact survival outcome: A comparative international multi-institutional study","year":2022,"lang":"en","type":"article","venue":"Annals of Diagnostic Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Royal Columbian Hospital","funders":"","keywords":"Eosinophilic; Pathology; Clear cell; Renal cell carcinoma; Biology; Medicine","score_opus":0.18685430936796438,"score_gpt":0.3857455035222239,"score_spread":0.19889119415425954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280488872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961022,0.00041337434,0.000035690602,0.0006588628,0.00062101387,0.00086111436,0.00042348704,0.000022516513,0.00086171424],"genre_scores_gemma":[0.9990442,0.0000323838,0.0001511816,0.00027068032,0.000049986844,0.00012876544,0.00016419971,0.000010550835,0.00014808841],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997433,0.0005307027,0.0005836095,0.0005093865,0.0005824837,0.0003607843],"domain_scores_gemma":[0.99798423,0.001081684,0.00027912282,0.00032415366,0.0001927317,0.00013809884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064344495,0.00028154792,0.0008195963,0.00039245142,0.00022662632,0.0000052905193,0.000320939,0.00007016403,0.00062473875],"category_scores_gemma":[0.000630345,0.00020624525,0.00026398167,0.00022870254,0.00025239063,0.000082270555,0.00082321744,0.0004092834,0.000020629688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008492949,0.005738404,0.97726274,0.00002085858,0.00010934575,0.00987209,0.0029958948,0.00063729944,0.0021702922,0.000051642834,0.0001674225,0.00012473585],"study_design_scores_gemma":[0.004980924,0.003474511,0.9851433,0.000009077901,0.000107867076,0.00024627167,0.0015807091,0.00010957332,0.0040680915,0.00003236081,0.00007150019,0.00017580307],"about_ca_topic_score_codex":0.001183084,"about_ca_topic_score_gemma":0.0002632584,"teacher_disagreement_score":0.009625819,"about_ca_system_score_codex":0.0004196432,"about_ca_system_score_gemma":0.00020845282,"threshold_uncertainty_score":0.8410437},"labels":[],"label_agreement":null},{"id":"W4280500632","doi":"10.1016/j.suronc.2022.101783","title":"Metastatic stage vs complications at radical nephrectomy with inferior vena cava thrombectomy","year":2022,"lang":"en","type":"article","venue":"Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Perioperative; Propensity score matching; Odds ratio; Complication; Nephrectomy; Confidence interval; Acute kidney injury; Inferior vena cava; Cohort; Surgery; Logistic regression; Internal medicine; Kidney","score_opus":0.04129918858137047,"score_gpt":0.32548900453149193,"score_spread":0.28418981595012144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280500632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92678165,0.00063521764,0.000044531454,0.0050849775,0.00012409479,0.0010187702,0.00006517614,0.00012356752,0.06612203],"genre_scores_gemma":[0.99132705,0.00005082781,0.0023862976,0.0010647407,0.00007142625,0.0006995277,0.0002773221,0.00004269218,0.0040801],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99778396,0.0004344407,0.00037496208,0.00046432475,0.00049398723,0.0004483236],"domain_scores_gemma":[0.99837875,0.00057881884,0.00014299301,0.00046522365,0.00006464703,0.00036953788],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026772975,0.0002300729,0.00074673747,0.00013053635,0.00032983941,0.0000091189795,0.00014935652,0.00006254405,0.006644639],"category_scores_gemma":[0.000021448612,0.00017028712,0.00016449679,0.00039364648,0.000351468,0.00003531145,0.00025168416,0.0004941162,0.00022056713],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060029317,0.030585218,0.5003312,0.0012841979,0.0072933976,0.18155234,0.006489194,0.0025156678,0.01421103,0.028781101,0.036782827,0.13014448],"study_design_scores_gemma":[0.0057922765,0.005119079,0.03397999,0.000008645008,0.00030349972,0.004888101,0.00011152129,0.0001126998,0.0003375721,0.000037960526,0.9491353,0.00017332901],"about_ca_topic_score_codex":0.000165714,"about_ca_topic_score_gemma":0.000094066716,"teacher_disagreement_score":0.9123525,"about_ca_system_score_codex":0.0016476645,"about_ca_system_score_gemma":0.0005998296,"threshold_uncertainty_score":0.9942634},"labels":[],"label_agreement":null},{"id":"W4281256430","doi":"10.1111/his.14700","title":"<scp>WHO</scp> 2022 landscape of papillary and chromophobe renal cell carcinoma","year":2022,"lang":"en","type":"review","venue":"Histopathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Cancer Research UK; Francis Crick Institute; World Health Organization","keywords":"Papillary renal cell carcinomas; Chromophobe cell; Pathology; Clear cell; Grading (engineering); Oncocytoma; Renal cell carcinoma; TFE3; Renal oncocytoma; Eosinophilic; Medicine; Biology","score_opus":0.032208020167503175,"score_gpt":0.2654356372430326,"score_spread":0.23322761707552941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281256430","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02157932,0.94599134,0.0000014236724,0.0000111016325,0.00042975697,0.0009265032,0.00013402435,0.00004271726,0.03088382],"genre_scores_gemma":[0.00080969016,0.9861566,0.00016325152,0.000074006726,0.000234864,0.0002513371,0.00068652467,0.00013010328,0.011493654],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967422,0.0005118815,0.000906108,0.00092333776,0.000415312,0.0005011812],"domain_scores_gemma":[0.9975718,0.00044533046,0.0006946465,0.00097597844,0.000057425972,0.00025481358],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004002925,0.00064769044,0.0032171237,0.00058715447,0.0001251478,0.0000063077487,0.00025171737,0.00047149535,0.0007455871],"category_scores_gemma":[0.000109236826,0.0005472912,0.00065314234,0.0003836407,0.00025891323,0.00003166045,0.0003907045,0.0008517864,0.00005383466],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001690388,0.0019974017,0.009349329,0.17213885,0.00030980684,0.0798664,0.0031296462,0.000001268049,0.0017364107,0.0003677499,0.10397343,0.62696064],"study_design_scores_gemma":[0.00089853496,0.0018046208,0.0029933406,0.0006329308,0.0024580758,0.0087367045,0.000057836947,0.0000011916576,0.000059256716,0.0000091337515,0.9821903,0.00015803684],"about_ca_topic_score_codex":0.00003621617,"about_ca_topic_score_gemma":0.0000037060336,"teacher_disagreement_score":0.8782169,"about_ca_system_score_codex":0.00043804487,"about_ca_system_score_gemma":0.00065403903,"threshold_uncertainty_score":0.99969786},"labels":[],"label_agreement":null},{"id":"W4281611541","doi":"10.2214/ajr.22.27378","title":"Diagnostic Performance and Interreader Agreement of the MRI Clear Cell Likelihood Score for Characterization of cT1a and cT1b Solid Renal Masses: An External Validation Study","year":2022,"lang":"en","type":"article","venue":"American Journal of Roentgenology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Chromophobe cell; Medicine; Clear cell renal cell carcinoma; Renal cell carcinoma; Clear cell; Cohen's kappa; Radiology; Renal mass; Pathology; Nephrectomy; Statistics; Internal medicine; Mathematics; Kidney","score_opus":0.015783048706687862,"score_gpt":0.2600228614612865,"score_spread":0.24423981275459863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281611541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983713,0.00012441784,0.00055536145,0.00023853903,0.000115176765,0.00057118246,0.000013378605,0.000002093408,0.000008569733],"genre_scores_gemma":[0.99901295,0.00021432812,0.00058076595,0.00006804297,0.00005418187,0.000023815379,0.000008775298,0.0000144006335,0.000022723867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998693,0.0002072029,0.00052037695,0.00015233761,0.0002733549,0.00015375875],"domain_scores_gemma":[0.99850875,0.0000838158,0.0009947664,0.00017660015,0.00015892826,0.00007711544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030713563,0.000115311464,0.00040530713,0.00015731608,0.00007698102,0.0000060802186,0.00012348716,0.000015680496,0.000034453013],"category_scores_gemma":[0.000033019664,0.000082670864,0.00006558337,0.00012442176,0.0001790296,0.000081890095,0.00010220371,0.00015901527,1.670314e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016740399,0.0010888914,0.82926506,0.00009271439,0.0002114112,0.000020634441,0.004460286,0.0001667864,0.14894302,0.0000030441986,0.000010123966,0.014063998],"study_design_scores_gemma":[0.0030298354,0.043178964,0.8937507,0.00009552897,0.0005444879,0.00060501933,0.0064345123,0.00034356522,0.051847003,0.000014803186,0.00007652799,0.00007903079],"about_ca_topic_score_codex":0.000029044886,"about_ca_topic_score_gemma":0.0000028404293,"teacher_disagreement_score":0.097096026,"about_ca_system_score_codex":0.00007754721,"about_ca_system_score_gemma":0.00008030731,"threshold_uncertainty_score":0.337122},"labels":[],"label_agreement":null},{"id":"W4281638764","doi":"10.1200/jco.2022.40.16_suppl.4537","title":"Sequential immunotherapy in rare variant renal cell carcinomafinal report of UNISoN (ANZUP 1602): Nivolumab then ipilimumab + nivolumab in advanced nonclear cell renal cell carcinoma.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Nivolumab; Medicine; Ipilimumab; Renal cell carcinoma; Internal medicine; Refractory (planetary science); Population; Immunotherapy; Pembrolizumab; Unison; Oncology; Cancer","score_opus":0.056268137551704185,"score_gpt":0.36679351873605187,"score_spread":0.3105253811843477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281638764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828427,0.0032678647,0.00009776199,0.0010945946,0.0014992623,0.00096845196,0.000034506236,0.000018123563,0.010176749],"genre_scores_gemma":[0.99152714,0.00043261223,0.004820156,0.00040942497,0.00062339555,0.000044645014,0.00004955153,0.00011233857,0.0019807168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98703223,0.002536893,0.006990123,0.00092095643,0.0015872791,0.0009325275],"domain_scores_gemma":[0.99103427,0.0013542323,0.0054349033,0.0010588672,0.0005704077,0.00054731936],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0064505935,0.00058924215,0.003670226,0.0009158416,0.00016123323,0.000019100478,0.0008258908,0.0006240403,0.0010439774],"category_scores_gemma":[0.00034000023,0.0005236538,0.0014046371,0.00079026725,0.00039572985,0.0002527526,0.0004129755,0.0037309122,0.000013631843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13222781,0.032476563,0.34157786,0.00059818506,0.00067314954,0.26085523,0.004330617,0.0068427026,0.18431455,0.000052166695,0.003984822,0.032066338],"study_design_scores_gemma":[0.14197728,0.107387386,0.65393263,0.0003383709,0.0012617203,0.01803748,0.0037000563,0.0012708105,0.03714621,0.00045862276,0.033320766,0.0011686855],"about_ca_topic_score_codex":0.0011222417,"about_ca_topic_score_gemma":0.00020437525,"teacher_disagreement_score":0.31235477,"about_ca_system_score_codex":0.0026333376,"about_ca_system_score_gemma":0.0070859315,"threshold_uncertainty_score":0.9998692},"labels":[],"label_agreement":null},{"id":"W4281656724","doi":"10.1016/j.jvir.2022.03.557","title":"Abstract No. 575 Renal tumors image-guided core needle biopsy: coaxial or non-coaxial?","year":2022,"lang":"en","type":"article","venue":"Journal of Vascular and Interventional Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Coaxial; Radiology; Biopsy; Core biopsy; Internal medicine; Cancer; Telecommunications","score_opus":0.0372550516594073,"score_gpt":0.30487169678774045,"score_spread":0.26761664512833316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281656724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99457633,0.0019309697,0.00042565766,0.00048218624,0.0007820985,0.00025319937,0.000035738834,0.0000106755015,0.0015031537],"genre_scores_gemma":[0.99585015,0.00011564552,0.0020008811,0.00026854893,0.0008159419,0.000018510073,0.00009759781,0.000029036079,0.00080371863],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99775964,0.00014003222,0.0010278891,0.00025084114,0.0005399723,0.00028163363],"domain_scores_gemma":[0.99858403,0.00009909223,0.00055092457,0.00019485148,0.00032688782,0.0002442375],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010147914,0.00022285145,0.00071956613,0.00032840672,0.0001681941,0.000021355992,0.00018210558,0.0000820872,0.004521207],"category_scores_gemma":[0.00018662367,0.000160067,0.0010175,0.00014261168,0.00017504048,0.0001180261,0.0001225295,0.00059075543,0.000028114304],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028882347,0.008034357,0.06904735,0.0014362385,0.01367629,0.041526742,0.0011000031,0.00064190035,0.4263516,0.0014676602,0.40035343,0.007482076],"study_design_scores_gemma":[0.02066932,0.020623954,0.7603018,0.00050097966,0.0011554321,0.14839396,0.00067151175,0.0004914417,0.0030285807,0.00087898015,0.04272814,0.00055585225],"about_ca_topic_score_codex":0.000053512744,"about_ca_topic_score_gemma":0.0000017851216,"teacher_disagreement_score":0.6912545,"about_ca_system_score_codex":0.00027294445,"about_ca_system_score_gemma":0.00029149005,"threshold_uncertainty_score":0.9963888},"labels":[],"label_agreement":null},{"id":"W4281706448","doi":"10.1016/j.ejca.2022.04.021","title":"Impact of MET status on treatment outcomes in papillary renal cell carcinoma: A pooled analysis of historical data","year":2022,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Sunitinib; Hazard ratio; Internal medicine; Oncology; Papillary renal cell carcinomas; Everolimus; Biomarker; Proportional hazards model; Renal cell carcinoma; Confidence interval; Clear cell renal cell carcinoma; Retrospective cohort study","score_opus":0.05651395345854476,"score_gpt":0.32688808438246064,"score_spread":0.2703741309239159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281706448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898413,0.007955734,0.0000066063367,0.00017571166,0.00012661316,0.00015437308,0.00031065647,0.0000031655288,0.0014258655],"genre_scores_gemma":[0.9985551,0.00036674298,0.00019605641,0.000037548383,0.0000658153,0.00000293818,0.00005563639,0.000032217635,0.0006879204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971627,0.00062153017,0.0009539138,0.00024615577,0.0007702613,0.0002454452],"domain_scores_gemma":[0.99794513,0.0001221329,0.00089254824,0.0006784759,0.00014502788,0.00021669686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006275739,0.00022314944,0.001162422,0.000899893,0.000030193072,0.000004492917,0.00028428933,0.000014175375,0.000603605],"category_scores_gemma":[0.000050594605,0.00014220201,0.0006859933,0.0007213991,0.00002982315,0.00005589199,0.00013457863,0.0002571054,0.0000012347907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028745208,0.0019152368,0.96154356,0.000025705896,0.0051714447,0.0029872917,0.0010133613,0.0070965877,0.008277844,0.0000011695557,0.0014999544,0.007593347],"study_design_scores_gemma":[0.004933891,0.011788103,0.97330487,0.00002618503,0.0061977366,0.000032306263,0.0001075985,0.000112706664,0.0014319179,8.0471835e-7,0.0019604599,0.000103405066],"about_ca_topic_score_codex":0.0014303261,"about_ca_topic_score_gemma":0.000050242692,"teacher_disagreement_score":0.01176135,"about_ca_system_score_codex":0.004267651,"about_ca_system_score_gemma":0.0005641299,"threshold_uncertainty_score":0.9995548},"labels":[],"label_agreement":null},{"id":"W4281719812","doi":"10.1016/j.currproblcancer.2022.100875","title":"Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence","year":2022,"lang":"en","type":"review","venue":"Current Problems in Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Ipsen; Clovis Oncology; Roche; Merck; Janssen Pharmaceuticals; Bayer; AstraZeneca","keywords":"Pembrolizumab; Medicine; Sunitinib; Lenvatinib; Internal medicine; Oncology; Axitinib; Renal cell carcinoma; Nivolumab; Immunotherapy; Cancer","score_opus":0.5262294098724305,"score_gpt":0.447444856489776,"score_spread":0.0787845533826545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281719812","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036022186,0.9927505,0.000033266424,0.000064727596,0.00046675446,0.00554494,0.00027798075,0.000049116752,0.0004524489],"genre_scores_gemma":[0.008314234,0.9722605,0.0002272686,0.000024696898,0.00013776406,0.017207375,0.0004379339,0.00014996034,0.00124031],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99246216,0.0007611913,0.0022963558,0.0021099264,0.0013167276,0.0010536484],"domain_scores_gemma":[0.9963471,0.00056168856,0.0012251679,0.0014501374,0.000119032455,0.00029682327],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001112241,0.001271114,0.007517709,0.0022233329,0.00010533564,0.00006002673,0.00070906396,0.0002865241,0.0024104002],"category_scores_gemma":[0.00012147176,0.00096904114,0.005083192,0.0043319818,0.00009007795,0.00027778512,0.00048487046,0.0022090315,0.00002897578],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001989753,0.0013875952,0.0021295876,0.09990836,0.028289499,0.00054104277,0.0007559061,0.0022868211,0.0000085457905,0.000016486805,0.00035380537,0.8641234],"study_design_scores_gemma":[0.0016553388,0.0003980019,0.00024277269,0.0071505043,0.32012603,0.000045012657,0.000023230614,0.00005811646,0.000016668342,0.000018563966,0.66934496,0.0009208122],"about_ca_topic_score_codex":0.0010604633,"about_ca_topic_score_gemma":0.0009495978,"teacher_disagreement_score":0.8632026,"about_ca_system_score_codex":0.006425527,"about_ca_system_score_gemma":0.0028226539,"threshold_uncertainty_score":0.999276},"labels":[],"label_agreement":null},{"id":"W4281727185","doi":"10.3390/curroncol29060330","title":"Sunitinib-Induced Elevation of Mean Corpuscular Volume (MCV)—Exploring Its Possible Clinical Relevance in Cancer Patients","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Ministerstvo Školství, Mládeže a Tělovýchovy","keywords":"Sunitinib; Medicine; Mean corpuscular volume; Tyrosine-kinase inhibitor; Internal medicine; Renal cell carcinoma; Oncology; Adverse effect; Gastroenterology; Cohort; Clinical significance; Cancer","score_opus":0.34897425479167193,"score_gpt":0.44659044162912526,"score_spread":0.09761618683745332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281727185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99444944,0.0015822309,0.000005218285,0.0002675082,0.0024481867,0.00078987435,0.000025778483,0.000028474667,0.0004033207],"genre_scores_gemma":[0.99813336,0.0007362712,0.00006433266,0.00006200068,0.00016509848,0.0005461783,0.0001355121,0.000026618049,0.00013065405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976288,0.000412397,0.00081019074,0.0003970734,0.00043245463,0.00031906198],"domain_scores_gemma":[0.9987468,0.00023044065,0.00037275947,0.00025930407,0.00026406292,0.00012663429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005674063,0.00016414083,0.000580841,0.00022060935,0.00007129041,0.0000030002532,0.00013972563,0.000075865915,0.00030305368],"category_scores_gemma":[0.00038496513,0.00016327514,0.00014555428,0.00042572478,0.000049633953,0.000085201915,0.0001624945,0.00058534305,0.00002014644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005929877,0.0031821032,0.85113156,0.0001530652,0.000060121183,0.00005515753,0.00075096026,0.0000775623,0.0020045792,0.000075521406,0.00035396553,0.14156243],"study_design_scores_gemma":[0.007803182,0.006033297,0.9438397,0.00016680098,0.00018134995,0.000012630193,0.00034485242,0.0008748854,0.0048003923,0.000049938757,0.035677638,0.00021527633],"about_ca_topic_score_codex":0.0000956964,"about_ca_topic_score_gemma":0.00007582296,"teacher_disagreement_score":0.14134715,"about_ca_system_score_codex":0.0012172939,"about_ca_system_score_gemma":0.00046078235,"threshold_uncertainty_score":0.66581666},"labels":[],"label_agreement":null},{"id":"W4281748547","doi":"10.5489/cuaj.7846","title":"Disparity in public funding of systemic therapy for metastatic renal cell carcinoma within Canada","year":2022,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre; University of British Columbia","funders":"","keywords":"Pazopanib; Medicine; Sunitinib; Formulary; Temsirolimus; Ipilimumab; Cabozantinib; Family medicine; Lenvatinib; Sorafenib; Expanded access; Renal cell carcinoma; Cancer; Oncology; Internal medicine","score_opus":0.037995758578081525,"score_gpt":0.23416456317206066,"score_spread":0.19616880459397915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281748547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99229765,0.00093472464,0.00002989178,0.0054620635,0.0002845406,0.0005184347,0.00014112197,0.00000494503,0.00032663278],"genre_scores_gemma":[0.99826807,0.000012434083,0.00015245602,0.0011014565,0.00007947113,0.00007992499,0.0000532422,0.000014021688,0.00023894424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977547,0.00040192952,0.00056838285,0.00019557803,0.0005578194,0.0005216056],"domain_scores_gemma":[0.99833894,0.00028088648,0.00050977216,0.00011430423,0.00020083989,0.0005552465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014081134,0.00013909176,0.00041462894,0.0002705964,0.00028377975,0.000029671344,0.00015129392,0.000060122988,0.00027854586],"category_scores_gemma":[0.00035243356,0.00011647193,0.00013491146,0.00033178894,0.000015192837,0.000051345873,0.000018588129,0.00055267726,6.244515e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016216782,0.00010303776,0.99405557,0.000023763358,0.00008740584,0.00030938434,0.00022195259,0.0006729324,0.0008330431,0.00017109924,0.0030625423,0.00029709202],"study_design_scores_gemma":[0.0048075095,0.0015005743,0.98412853,0.000013993079,0.00010851887,0.00072583114,0.0010502576,0.0009039861,0.00045430084,0.00035979028,0.0057449862,0.00020170039],"about_ca_topic_score_codex":0.2882402,"about_ca_topic_score_gemma":0.35108322,"teacher_disagreement_score":0.062843,"about_ca_system_score_codex":0.007837451,"about_ca_system_score_gemma":0.004832768,"threshold_uncertainty_score":0.99597126},"labels":[],"label_agreement":null},{"id":"W4281940442","doi":"10.1136/jitc-2022-004885","title":"Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with nivolumab within the NIVOREN GETUG-AFU 26 study","year":2022,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Université de Paris; Unicancer; Bristol-Myers Squibb; Sorbonne Université; Ligue Contre le Cancer; Institut National de la Santé et de la Recherche Médicale; Institute of Cancer Research; Institut National Du Cancer","keywords":"Nivolumab; Medicine; Renal cell carcinoma; Internal medicine; Oncology; Flow cytometry; Immune system; Clear cell renal cell carcinoma; Immunotherapy; B cell; Prospective cohort study; Immunology; Antibody","score_opus":0.013715196003064773,"score_gpt":0.23272666965966934,"score_spread":0.21901147365660456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281940442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99550813,0.0013841438,0.000013931334,0.000079428544,0.00017859065,0.002611542,0.00007210506,0.000037673934,0.00011443996],"genre_scores_gemma":[0.99766904,0.00003649103,0.00013163636,0.00007483418,0.000037254238,0.00011271717,0.00005680365,0.00021304628,0.0016682044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99616754,0.0005242184,0.0009350648,0.00054677506,0.0012546087,0.00057181314],"domain_scores_gemma":[0.99692327,0.00026559923,0.0016824782,0.00046636723,0.00049307325,0.00016920608],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010016654,0.00056906167,0.0010390665,0.0002887928,0.0005754257,0.00006519488,0.00025714058,0.00010954105,0.00016159583],"category_scores_gemma":[0.000012744181,0.0003336464,0.00017697613,0.0005533357,0.00013300832,0.00017613167,0.000051891417,0.0009876902,3.6159554e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022264415,0.0031200068,0.94439346,0.00008414173,0.00090363616,0.00014851124,0.0066475244,0.008628609,0.01355292,2.9004124e-7,0.00009163665,0.0001648675],"study_design_scores_gemma":[0.07655302,0.02178963,0.86669445,0.00026800155,0.0009037188,0.00002820056,0.008723957,0.00096241175,0.023464724,0.0000055538526,0.00004331961,0.0005630052],"about_ca_topic_score_codex":0.002393472,"about_ca_topic_score_gemma":0.00078779395,"teacher_disagreement_score":0.077698976,"about_ca_system_score_codex":0.0011145545,"about_ca_system_score_gemma":0.0005643051,"threshold_uncertainty_score":0.99991155},"labels":[],"label_agreement":null},{"id":"W4282926856","doi":"10.1097/01.cdr.0000820620.95153.1e","title":"Renal Cell Carcinoma Subtypes and Associated Renal Malignancies: A Pictorial Review—Part I","year":2022,"lang":"en","type":"article","venue":"Contemporary Diagnostic Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Alberta","funders":"","keywords":"Medicine; Renal cell carcinoma; Stage (stratigraphy); Renal pelvis; Incidence (geometry); Kidney; Oncology; Internal medicine; Pathology","score_opus":0.026222265537698033,"score_gpt":0.24088959726966863,"score_spread":0.2146673317319706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282926856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8523593,0.13404487,0.000009423702,0.0021196394,0.0011878051,0.0015950247,0.00016032218,0.00010087165,0.008422738],"genre_scores_gemma":[0.99088985,0.0022070098,0.000046096164,0.0026366974,0.0005639502,0.000584262,0.00076393323,0.000050078394,0.0022581075],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99692005,0.0007710736,0.00071386446,0.00071288453,0.00039264318,0.0004894836],"domain_scores_gemma":[0.9969158,0.001779216,0.00034173302,0.00053414376,0.000112892776,0.0003161849],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007176703,0.0003685452,0.0010478325,0.00015838597,0.0002661614,0.000013346358,0.00019547979,0.00013740672,0.0005247884],"category_scores_gemma":[0.0016096915,0.00033049678,0.00020969863,0.00029352633,0.00022015501,0.000073108946,0.00021620028,0.0004884333,0.000038082115],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008581488,0.000696714,0.30847907,0.0005692448,0.0002975871,0.01225591,0.00039951698,0.0000066463926,0.0068621333,0.0002510376,0.6689116,0.00041243917],"study_design_scores_gemma":[0.014674492,0.012369156,0.50911033,0.0010552519,0.0013123349,0.0058407905,0.00026300084,0.0000432053,0.0042607966,0.00032236797,0.4496372,0.0011110898],"about_ca_topic_score_codex":0.000104699466,"about_ca_topic_score_gemma":0.0000035597386,"teacher_disagreement_score":0.21927436,"about_ca_system_score_codex":0.00037562195,"about_ca_system_score_gemma":0.0006993759,"threshold_uncertainty_score":0.9999147},"labels":[],"label_agreement":null},{"id":"W4282930837","doi":"10.1016/j.jacr.2022.05.017","title":"Development and Pilot Evaluation of a Decision Aid for Small Kidney Masses","year":2022,"lang":"en","type":"article","venue":"Journal of the American College of Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health","funders":"National Institute of Dental and Craniofacial Research; National Institutes of Health; National Cancer Institute; Doris Duke Charitable Foundation","keywords":"Medicine; Decision aids; Preparedness; Patient satisfaction; Kidney disease; Family medicine; Physical therapy; Medical physics; Surgery; Internal medicine; Alternative medicine; Pathology","score_opus":0.05509630297033325,"score_gpt":0.30660047754848213,"score_spread":0.2515041745781489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282930837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99714446,0.00068551843,0.00024101345,0.0011645249,0.00018715637,0.00045341786,0.000029783872,0.0000013576442,0.00009274852],"genre_scores_gemma":[0.9516508,0.000042395943,0.047924586,0.0002480763,0.00004098207,0.000024332561,0.0000014991559,0.000009551279,0.000057761037],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99861926,0.00026004252,0.0005105027,0.00009717465,0.00040493318,0.0001081081],"domain_scores_gemma":[0.99805206,0.0003408488,0.0010489513,0.00015861962,0.00031545418,0.00008408494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013847996,0.000084953565,0.00052874535,0.00017301235,0.000072104485,9.402263e-7,0.00014099308,0.000012233398,0.00002859985],"category_scores_gemma":[0.00055335456,0.000054026917,0.00011966549,0.00020730343,0.00015400232,0.000014728027,0.00007919061,0.0001064379,9.519749e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0743716,0.0036996303,0.33767426,0.00054535276,0.004809681,0.00037978974,0.0024543316,0.0034270957,0.38179353,0.001143384,0.06286971,0.12683162],"study_design_scores_gemma":[0.04173709,0.064671695,0.65208524,0.00047815987,0.004331301,0.027589729,0.0062299096,0.0023859488,0.11412628,0.0027186344,0.08318876,0.00045724964],"about_ca_topic_score_codex":0.000007895396,"about_ca_topic_score_gemma":0.0000026635385,"teacher_disagreement_score":0.31441098,"about_ca_system_score_codex":0.00031376284,"about_ca_system_score_gemma":0.0010413473,"threshold_uncertainty_score":0.22031537},"labels":[],"label_agreement":null},{"id":"W4282943491","doi":"","title":"Time trends for drug specific adverse events in patients on sunitinib; implications for remote monitoring.","year":2022,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Sunitinib; Common Terminology Criteria for Adverse Events; Adverse effect; Renal cell carcinoma; Incidence (geometry); Cumulative incidence; Dosing; Internal medicine; Toxicity; Tyrosine-kinase inhibitor; Cancer; Cohort","score_opus":0.047378421275648175,"score_gpt":0.26833842640159694,"score_spread":0.22096000512594877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282943491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931329,0.000041320534,0.000007000978,0.0011601911,0.00029397573,0.0029490376,0.0002236544,0.000040562678,0.0021513568],"genre_scores_gemma":[0.9809943,0.0000044949697,0.00035357047,0.00007248362,0.00015762453,0.0074458993,0.0005858809,0.000038843173,0.010346937],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988453,0.000037124737,0.00024640549,0.00030530253,0.00020089236,0.00036501355],"domain_scores_gemma":[0.9992465,0.0001318469,0.00008887575,0.00033862458,0.000062590814,0.00013156529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022267127,0.00013414255,0.00020657633,0.000270157,0.00013237636,0.000002374515,0.00010461321,0.000025442881,0.00003304534],"category_scores_gemma":[0.00004816638,0.00013115861,0.0001443629,0.0002503974,0.000013839737,0.000033307835,0.000042497588,0.00010160928,0.000009107205],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039568553,0.002275955,0.3231252,0.000070537,0.00013909943,0.0000071474988,0.00043155628,0.00013798286,0.000090672016,0.000088568835,0.012275555,0.65740085],"study_design_scores_gemma":[0.005308206,0.00030981045,0.97250706,0.000008086321,0.000048055856,0.0000018724106,0.000043589982,0.000023590634,0.0005257312,0.00011398681,0.021005996,0.00010398978],"about_ca_topic_score_codex":0.000014066143,"about_ca_topic_score_gemma":0.0000015813334,"teacher_disagreement_score":0.6572969,"about_ca_system_score_codex":0.0007135805,"about_ca_system_score_gemma":0.000021731768,"threshold_uncertainty_score":0.5348493},"labels":[],"label_agreement":null},{"id":"W4282961412","doi":"10.5582/irdr.2022.01027","title":"A review of 99mTc-sestamibi SPECT/CT for renal oncocytomas: A modified diagnostic algorithm","year":2022,"lang":"en","type":"review","venue":"Intractable & Rare Diseases Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Technetium Tc 99m Sestamibi; Radiology; Nuclear medicine; Spect imaging; Scintigraphy","score_opus":0.16335207440540284,"score_gpt":0.44614020230389034,"score_spread":0.2827881278984875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282961412","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029445853,0.97948813,0.000032052038,0.00010465845,0.000208413,0.012987923,0.0051023723,0.00010541606,0.0019415929],"genre_scores_gemma":[0.000044599183,0.9786329,0.0004796585,0.00012824181,0.0006470574,0.011407896,0.0067996536,0.00029037823,0.0015695893],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.990573,0.0014676119,0.0019554722,0.0015586865,0.0028655324,0.0015796901],"domain_scores_gemma":[0.98363274,0.011550141,0.0007182866,0.0021724983,0.00084854057,0.0010777868],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017087817,0.0009714774,0.0048701284,0.0011194434,0.0003558336,0.00009359741,0.0009977516,0.00012076267,0.004315715],"category_scores_gemma":[0.0105015775,0.0007709195,0.00250033,0.0021512532,0.00035977355,0.00017155959,0.0006268308,0.0017601303,0.00012053648],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015932835,0.0012966002,0.000004115696,0.2861686,0.000726658,0.0063756653,0.0000091244965,6.060223e-7,6.4103364e-7,0.00003130871,0.021143986,0.68408334],"study_design_scores_gemma":[0.0011587453,0.0017289681,0.000012622944,0.17376019,0.004943958,0.0017788421,0.000045943823,0.00003386874,0.000022424963,0.000088562265,0.8159444,0.0004814745],"about_ca_topic_score_codex":0.00031895423,"about_ca_topic_score_gemma":0.000005612864,"teacher_disagreement_score":0.7948004,"about_ca_system_score_codex":0.0027077333,"about_ca_system_score_gemma":0.007004346,"threshold_uncertainty_score":0.99947417},"labels":[],"label_agreement":null},{"id":"W4282978369","doi":"10.1016/j.ejca.2022.05.002","title":"Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy","year":2022,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Sunnybrook Health Science Centre; Dalhousie University; University of Toronto; CancerCare Manitoba; University Health Network; Princess Margaret Cancer Centre; University of Calgary; University of Alberta; William Osler Health System; Queen's University; Juravinski Cancer Centre; University of Manitoba","funders":"","keywords":"Renal cell carcinoma; Medicine; Oncology; Immune checkpoint; Internal medicine; Nivolumab; Cancer research; Immunotherapy; Cancer","score_opus":0.010588852068646605,"score_gpt":0.221175130064015,"score_spread":0.21058627799536841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282978369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939991,0.0026440984,0.00002702992,0.00028183564,0.00012791573,0.00049562316,0.000038463975,0.000011837371,0.0023740523],"genre_scores_gemma":[0.9971518,0.0002356653,0.00067141716,0.00011441707,0.00011594011,0.00001292651,0.000019294952,0.00011617242,0.001562384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756,0.00019518191,0.0007933115,0.0002524106,0.0009103274,0.00028873788],"domain_scores_gemma":[0.99776167,0.000043091262,0.0011062679,0.00037179206,0.0005090748,0.00020812987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028921122,0.00032555044,0.00071055064,0.00020389247,0.00012075548,0.000011809359,0.00021540685,0.000016606891,0.0004985297],"category_scores_gemma":[0.000008124966,0.00019508299,0.0002409013,0.00029517952,0.00008155375,0.000101126316,0.0000703229,0.00042919515,0.000005372153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027527215,0.0020631184,0.92369336,0.00014268323,0.00047082966,0.0016165464,0.00130283,0.0033402708,0.03442924,2.2849261e-7,0.0003788606,0.0050347955],"study_design_scores_gemma":[0.023105606,0.020967705,0.78746396,0.00012843164,0.00025051224,0.000032842898,0.00016650277,0.0000094557445,0.165265,2.4953076e-7,0.0024214792,0.0001882724],"about_ca_topic_score_codex":0.000055662113,"about_ca_topic_score_gemma":0.000007213565,"teacher_disagreement_score":0.13622944,"about_ca_system_score_codex":0.00033124018,"about_ca_system_score_gemma":0.00024285584,"threshold_uncertainty_score":0.7955254},"labels":[],"label_agreement":null},{"id":"W4283220315","doi":"10.1200/jco.22.00868","title":"Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline","year":2022,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":333,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Internal medicine; Metastasectomy; Sunitinib; Asymptomatic; Clear cell renal cell carcinoma; Systemic therapy; Guideline; Pazopanib; Kidney cancer; Nephrectomy; Cancer; Metastasis; Pathology; Kidney","score_opus":0.2803893385683397,"score_gpt":0.4979387979693033,"score_spread":0.2175494594009636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283220315","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009925705,0.96811056,0.00006737067,0.00029165324,0.001632325,0.0011033169,0.00003055954,0.000009391664,0.027762271],"genre_scores_gemma":[0.0008556843,0.9716727,0.022694902,0.00030264942,0.0008796624,0.000029951263,0.00007398883,0.00010816046,0.0033823045],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9841761,0.0021824802,0.011272136,0.0005573867,0.0013362692,0.00047560924],"domain_scores_gemma":[0.98372614,0.0030711703,0.011241587,0.00082933134,0.00043329113,0.00069844734],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0076566143,0.00061426265,0.010220001,0.00054180424,0.000054461725,0.000008780274,0.00070746784,0.0005415886,0.0024463707],"category_scores_gemma":[0.00045533472,0.0004114847,0.0049466263,0.0004660813,0.00022319025,0.0000613441,0.00044734232,0.002893514,0.00008874333],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014118167,0.004988695,0.000046124438,0.017456032,0.0022898684,0.023336533,0.000024004148,0.000009880936,0.0000014957242,0.000026280008,0.020502355,0.9299069],"study_design_scores_gemma":[0.0063287993,0.025613844,0.00015609675,0.0018252954,0.026199019,0.0016034519,0.000118470714,0.0000062857926,0.000011345589,0.000035739406,0.93785596,0.00024569954],"about_ca_topic_score_codex":0.00001965179,"about_ca_topic_score_gemma":0.0000016564898,"teacher_disagreement_score":0.9296612,"about_ca_system_score_codex":0.00093625276,"about_ca_system_score_gemma":0.004234041,"threshold_uncertainty_score":0.9998337},"labels":[],"label_agreement":null},{"id":"W4283378574","doi":"10.2196/36632","title":"Individualizing the Oncological Treatment of Patients With Metastatic Non–Clear Cell Renal Cell Carcinoma by Using Gene Sequencing and Patient-Reported Outcomes: Protocol for the INDIGO Study","year":2022,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Region Hovedstaden; Gentofte Hospital","keywords":"Renal cell carcinoma; Medicine; Protocol (science); Internal medicine; Oncology; Bioinformatics; Biology; Pathology; Alternative medicine","score_opus":0.3216258257929524,"score_gpt":0.4877414516128956,"score_spread":0.1661156258199432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283378574","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49232736,0.000003825061,0.000008180929,0.00004389445,0.0000021119415,0.5075103,0.00005075447,0.00001087527,0.00004271599],"genre_scores_gemma":[0.42378333,5.069659e-8,0.00041806142,0.00002479936,0.0000110447845,0.57560664,0.000018541372,0.000040622206,0.000096877055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99443537,0.0011605311,0.0008128602,0.000692887,0.0021374621,0.0007609005],"domain_scores_gemma":[0.9970074,0.0008966605,0.0005640676,0.00087703246,0.0004372977,0.00021750916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013254797,0.00039480848,0.0006720114,0.0002219778,0.0012844704,0.00009476928,0.00033226883,0.000055359862,0.00008218404],"category_scores_gemma":[0.000061559214,0.00018261091,0.00015831206,0.0005976743,0.00029102113,0.00009011241,0.0004274233,0.00051217957,0.000001131394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01626596,0.020952458,0.9316577,0.00082550035,0.0006049592,0.00040499156,0.013864739,0.0001732365,0.011163585,0.0000017071009,0.00063886924,0.0034463515],"study_design_scores_gemma":[0.09851026,0.3671067,0.396149,0.00034680736,0.0006002986,0.00008634629,0.024704851,0.00095152506,0.09162728,0.0000288078,0.019144818,0.00074329803],"about_ca_topic_score_codex":0.00029221803,"about_ca_topic_score_gemma":0.000010350029,"teacher_disagreement_score":0.53550863,"about_ca_system_score_codex":0.001372635,"about_ca_system_score_gemma":0.0008529323,"threshold_uncertainty_score":0.9879238},"labels":[],"label_agreement":null},{"id":"W4283388855","doi":"10.1158/1538-7445.am2022-lb113","title":"Abstract LB113: Genomic classification to refine prognosis in clear cell renal cell carcinoma","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre","funders":"","keywords":"BAP1; Clear cell renal cell carcinoma; Renal cell carcinoma; Oncology; Medicine; Proportional hazards model; Cohort; Internal medicine; Kidney cancer; Clear cell; Survival analysis; Cancer; Bioinformatics; Biology","score_opus":0.14122640779904944,"score_gpt":0.38077072319849065,"score_spread":0.2395443153994412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283388855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978313,0.0016106127,0.0000012444286,0.0032763528,0.000092990114,0.0016186849,0.000044492648,0.000032172014,0.015010421],"genre_scores_gemma":[0.992098,0.00009976458,0.00017248032,0.00015198323,0.00019972547,0.0022541038,0.00006870609,0.00006813031,0.004887142],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967468,0.0002473549,0.00039174044,0.00071019516,0.0011547453,0.0007491837],"domain_scores_gemma":[0.99868137,0.00011046346,0.000069571804,0.0005735049,0.00020245202,0.00036264982],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011679466,0.00018541138,0.00029733867,0.00068986084,0.0002554167,0.000037430334,0.00032194334,0.000070505914,0.0023825436],"category_scores_gemma":[0.000032889027,0.00018001995,0.0000961717,0.0010884269,0.00007277013,0.000051666808,0.00031304426,0.0010303989,0.00032980173],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017858653,0.0006803935,0.07247072,0.00023790367,0.000013430979,0.0005133736,0.00089440885,0.00021602419,0.90817505,0.000019935542,0.010494407,0.0044985013],"study_design_scores_gemma":[0.0018000765,0.0016282522,0.7467031,0.00003470481,0.000021351692,0.000016486734,0.0007717176,0.00007778778,0.23142062,0.00001454775,0.017338673,0.00017267969],"about_ca_topic_score_codex":0.0025782606,"about_ca_topic_score_gemma":0.00016877122,"teacher_disagreement_score":0.6767544,"about_ca_system_score_codex":0.0035027748,"about_ca_system_score_gemma":0.0008447835,"threshold_uncertainty_score":0.99852943},"labels":[],"label_agreement":null},{"id":"W4285120711","doi":"10.2139/ssrn.4102630","title":"Succinate Dehydrogenase Deficient Renal Cell Carcinoma: Comprehensive Molecular Profiling with Diagnostic and Therapeutic Implications","year":2022,"lang":"en","type":"article","venue":"SSRN Electronic Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Profiling (computer programming); Renal cell carcinoma; Cancer research; Medicine; Computational biology; Pathology; Biology; Chemistry; Computer science","score_opus":0.01116084283540242,"score_gpt":0.23374674877810758,"score_spread":0.22258590594270516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285120711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.964626,0.032234717,0.0011541122,0.00094467803,0.000029773142,0.00070157694,0.00000886988,0.00002868564,0.00027160128],"genre_scores_gemma":[0.9985962,0.00048391777,0.00021996244,0.00027878335,0.000040724808,0.00013845324,0.00003074287,0.000053771164,0.00015743155],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99726087,0.00016272764,0.00028372576,0.0003759825,0.0004244541,0.0014922202],"domain_scores_gemma":[0.9990236,0.00013257595,0.00017641603,0.00030814655,0.00014988394,0.00020938582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000357007,0.00025597255,0.00029380948,0.00018605085,0.0005869411,0.000031086853,0.00013648314,0.00003454642,0.000024289526],"category_scores_gemma":[0.00001367511,0.00020168853,0.000116975774,0.0003054291,0.00006843079,0.000036648926,0.00008612287,0.0015009355,0.0000052792707],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002683036,0.0029252046,0.26739642,0.000254079,0.0018365395,0.0035607517,0.00166161,0.011376983,0.6331185,0.06097922,0.000048129838,0.014159521],"study_design_scores_gemma":[0.036409557,0.046891544,0.22856167,0.00015374356,0.007108556,0.18893923,0.01649592,0.002584078,0.40577722,0.06193814,0.0024535253,0.0026868295],"about_ca_topic_score_codex":0.0000472447,"about_ca_topic_score_gemma":0.000022259284,"teacher_disagreement_score":0.22734128,"about_ca_system_score_codex":0.0015807019,"about_ca_system_score_gemma":0.0018788634,"threshold_uncertainty_score":0.8224619},"labels":[],"label_agreement":null},{"id":"W4285136050","doi":"10.2139/ssrn.4124989","title":"Establishing an Effective Clinical Data Collecting Tool for Optimal Evaluation of Native and Allograft Renal Biopsies","year":2022,"lang":"en","type":"article","venue":"SSRN Electronic Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Renal transplant; Health care; Family medicine; Transplantation; Medical physics; Pathology; Internal medicine","score_opus":0.08863186287242153,"score_gpt":0.3965979462416765,"score_spread":0.30796608336925496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285136050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99311763,0.0031286539,0.0019035029,0.00021939835,0.00013895286,0.0013390096,0.000041864267,0.0000142754325,0.0000967249],"genre_scores_gemma":[0.9969962,0.0002519045,0.002044357,0.00003290015,0.00029008096,0.00011075901,0.00014850043,0.000027080745,0.000098210636],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9965417,0.0008889526,0.0005205718,0.00041304974,0.0007695458,0.0008662241],"domain_scores_gemma":[0.99794436,0.00080774736,0.00039515746,0.00031177333,0.0004480277,0.00009294295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017620616,0.00015712235,0.00040564578,0.00019508445,0.00045487756,0.00004430616,0.00022891839,0.000055398203,0.000024940604],"category_scores_gemma":[0.001804391,0.00013575802,0.000115187555,0.00025511364,0.00008416349,0.00035528728,0.00020327212,0.0013656248,1.7422589e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016334718,0.0029380142,0.12978347,0.00016186926,0.007056763,0.0000711464,0.004735834,0.0049726544,0.01814863,0.004925953,0.0007507117,0.8101202],"study_design_scores_gemma":[0.08866409,0.1308848,0.24661961,0.00045082046,0.016263217,0.019599104,0.06996123,0.3497144,0.010529199,0.062707186,0.0027086404,0.0018977111],"about_ca_topic_score_codex":0.000060221908,"about_ca_topic_score_gemma":0.000137491,"teacher_disagreement_score":0.80822253,"about_ca_system_score_codex":0.0014995812,"about_ca_system_score_gemma":0.0031140659,"threshold_uncertainty_score":0.6106989},"labels":[],"label_agreement":null},{"id":"W4285156420","doi":"10.1177/20543581221106246","title":"Targeted Cancer Therapies Causing Elevations in Serum Creatinine Through Tubular Secretion Inhibition: A Case Report and Review of the Literature","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Kidney Health and Disease","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Creatinine; Cancer; Internal medicine; Endocrinology; Intensive care medicine","score_opus":0.020251780529299133,"score_gpt":0.2919332358342871,"score_spread":0.27168145530498794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285156420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56956124,0.29178825,0.0000021006938,0.13786381,0.00008134986,0.00035877855,0.00031600453,0.0000013234791,0.000027135744],"genre_scores_gemma":[0.93547165,0.010258727,0.0000888233,0.053905465,0.000075197655,0.000024193183,0.00009714951,0.000009933523,0.00006888294],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99896777,0.00016231091,0.00043783683,0.00010811586,0.00017014473,0.00015382226],"domain_scores_gemma":[0.9954738,0.00001747205,0.00032581613,0.00013593929,0.0001639384,0.00388301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031849017,0.00008852623,0.00025205358,0.00011838113,0.00025213906,0.0000114963905,0.00001781971,0.000017480594,0.00015945501],"category_scores_gemma":[0.0018457182,0.0000628293,0.000059436847,0.0003437984,0.000055089065,0.000078375924,0.000010092522,0.0002196039,2.3836629e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006356376,0.00020233748,0.55529714,0.02315538,0.00020030494,0.2661428,0.016503949,0.00003115328,0.00016675238,0.00034329254,0.13514902,0.0021722375],"study_design_scores_gemma":[0.012182446,0.0027012932,0.24332146,0.106106594,0.0014175898,0.4531089,0.007808143,0.00016595502,0.00017514604,0.0024576476,0.16982946,0.00072534155],"about_ca_topic_score_codex":0.0051239138,"about_ca_topic_score_gemma":0.0010391185,"teacher_disagreement_score":0.36591038,"about_ca_system_score_codex":0.00034366598,"about_ca_system_score_gemma":0.02282257,"threshold_uncertainty_score":0.9827171},"labels":[],"label_agreement":null},{"id":"W4285189908","doi":"10.1177/17588359221108685","title":"Evolving landscape of first-line combination therapy in advanced renal cancer: a systematic review","year":2022,"lang":"en","type":"review","venue":"Therapeutic Advances in Medical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of Calgary; Queen Elizabeth II Health Sciences Centre; McMaster University; Juravinski Cancer Centre","funders":"Pfizer Canada; Merck Canada; Ipsen; Eisai","keywords":"Medicine; Cancer therapy; Systematic review; Cancer; Kidney cancer; Oncology; MEDLINE; Intensive care medicine; Internal medicine","score_opus":0.061614521457701237,"score_gpt":0.4158854827627571,"score_spread":0.35427096130505586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285189908","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000036601115,0.99189144,0.000039812152,0.0005987637,0.00037609262,0.0057973717,0.000013133619,0.000033691595,0.0012131003],"genre_scores_gemma":[0.00035426056,0.9934705,0.00010985735,0.0008162138,0.0000752751,0.0048105414,0.00018305022,0.00007535938,0.00010495357],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99331445,0.0015985357,0.002724215,0.00065341126,0.0012058826,0.00050349475],"domain_scores_gemma":[0.9946799,0.0028847863,0.001489329,0.0006627668,0.00009334876,0.00018984455],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023678283,0.0005885386,0.0072011906,0.00054593186,0.000045507295,0.0000034399184,0.0005509288,0.00044964207,0.0028315287],"category_scores_gemma":[0.00084085134,0.00040235274,0.0005130731,0.0012511269,0.0002001216,0.000103327904,0.0001238643,0.0013492476,0.000008019097],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109541776,0.0006387136,0.00006033639,0.38960737,0.00016488449,0.00035346343,0.00006842961,0.0000056673925,1.2994607e-7,0.000042039628,0.000008633073,0.6089408],"study_design_scores_gemma":[0.0034656853,0.0024424528,0.000013890734,0.4623671,0.0013598339,0.00031483086,0.000039548046,0.00012569965,8.540651e-7,0.00013892261,0.52946794,0.00026321833],"about_ca_topic_score_codex":0.000031748008,"about_ca_topic_score_gemma":0.00022983436,"teacher_disagreement_score":0.60867757,"about_ca_system_score_codex":0.001900806,"about_ca_system_score_gemma":0.0015178852,"threshold_uncertainty_score":0.9998428},"labels":[],"label_agreement":null},{"id":"W4285606218","doi":"10.1016/j.eururo.2022.06.009","title":"Health-related Quality of Life Analysis from KEYNOTE-426: Pembrolizumab plus Axitinib Versus Sunitinib for Advanced Renal Cell Carcinoma","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Sunitinib; Axitinib; Renal cell carcinoma; Pembrolizumab; Internal medicine; Kidney cancer; Quality of life (healthcare); Hazard ratio; Oncology; Adverse effect; Cancer; Confidence interval; Urology","score_opus":0.05936434309129127,"score_gpt":0.3011600521554575,"score_spread":0.24179570906416623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285606218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98255914,0.0023519835,0.00029071054,0.0018526262,0.0004060304,0.00082729623,0.00071273634,0.000099783916,0.0108997105],"genre_scores_gemma":[0.99453247,0.000016506647,0.000688171,0.0011584876,0.000134806,0.00006574749,0.0026396047,0.00009152717,0.0006726983],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99448246,0.0022847457,0.0013694068,0.00079689734,0.00045888455,0.00060761394],"domain_scores_gemma":[0.9965628,0.0010326992,0.00091125665,0.00092696893,0.00016596568,0.00040035765],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010235434,0.0003419431,0.0014024529,0.0004207667,0.00026338422,0.000007861802,0.00032820416,0.000069865346,0.0010665491],"category_scores_gemma":[0.0003545504,0.0003474621,0.00064055424,0.0006848658,0.00015707243,0.00003638286,0.0002823996,0.00049954647,0.00004671657],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6628939,0.007633764,0.09946676,0.0014344761,0.019667253,0.004545871,0.023024578,0.08536847,0.05311035,0.0027951847,0.019064322,0.020995097],"study_design_scores_gemma":[0.11149062,0.026923833,0.830428,0.000011074081,0.004944589,0.00007101768,0.0021582283,0.0029389758,0.0029121744,0.000118453434,0.01705087,0.00095216226],"about_ca_topic_score_codex":0.0015930594,"about_ca_topic_score_gemma":0.00010162087,"teacher_disagreement_score":0.7309612,"about_ca_system_score_codex":0.00034519265,"about_ca_system_score_gemma":0.000457494,"threshold_uncertainty_score":0.9998977},"labels":[],"label_agreement":null},{"id":"W4285678402","doi":"10.1016/j.eururo.2022.06.016","title":"The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours","year":2022,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":828,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Cancer Research UK; Francis Crick Institute; Centre International de Recherche sur le Cancer; World Health Organization","keywords":"Medicine; Sex organ; Urology; Urinary system; Testicular tumor; Pathology; Internal medicine","score_opus":0.037946935477844036,"score_gpt":0.26633342988946385,"score_spread":0.22838649441161982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285678402","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010611367,0.98470813,0.0000060546317,0.00050871517,0.00023475407,0.0013186927,0.00004683034,0.000027693684,0.0025377758],"genre_scores_gemma":[0.16188367,0.83588344,0.000034681612,0.00007207452,0.00015699661,0.000030579515,0.00022881491,0.00012997256,0.0015797737],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961691,0.0021049462,0.0007921835,0.00042353247,0.00028380615,0.00022642118],"domain_scores_gemma":[0.9976622,0.00046396453,0.0010159254,0.00065552484,0.000097792574,0.00010461244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009012676,0.00028094632,0.00093947584,0.00016115283,0.0002672095,0.000012396147,0.0002461572,0.00004823575,0.00009248241],"category_scores_gemma":[0.00027924008,0.00016810879,0.00012028059,0.00063637,0.0002996104,0.0000198199,0.00033854364,0.0004271271,0.000009767813],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001266175,0.0035398924,0.18465059,0.18494098,0.0033876356,0.006767625,0.004049344,0.00004611363,0.0011753426,0.01606435,0.061197758,0.5329142],"study_design_scores_gemma":[0.00089538016,0.0022553764,0.14162317,0.001430934,0.0035036057,0.013397244,0.00032844595,0.000020620948,0.000015713433,0.0000039785214,0.8362315,0.0002939803],"about_ca_topic_score_codex":0.000011221532,"about_ca_topic_score_gemma":0.0000045654697,"teacher_disagreement_score":0.7750338,"about_ca_system_score_codex":0.00017765127,"about_ca_system_score_gemma":0.0003469392,"threshold_uncertainty_score":0.68552774},"labels":[],"label_agreement":null},{"id":"W4285706465","doi":"10.54057/cpi.gu2020","title":"CPI Genitourinary Tract Radiology Module 2020","year":2020,"lang":"en","type":"dataset","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Genitourinary system; Medical physics; Radiology; Medicine; Computer science; Anatomy","score_opus":0.02826041342818862,"score_gpt":0.27417624294451687,"score_spread":0.24591582951632823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285706465","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009814288,0.0014225699,0.0000067821134,0.002005941,0.00051680376,0.0007150155,0.99135363,0.00008995986,0.0029078939],"genre_scores_gemma":[0.00089763006,0.0010708834,0.00047751068,0.0017409886,0.0017739222,0.000060542247,0.9911813,0.00004086751,0.0027563614],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99811786,0.0000926558,0.00040005174,0.0006853392,0.00033368586,0.00037039584],"domain_scores_gemma":[0.99846107,0.000087765686,0.00012995354,0.00083488104,0.000046380927,0.0004399469],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0000693007,0.00046163486,0.0009902396,0.000112008536,0.000043090717,0.000014206362,0.00023610413,0.00047189073,0.004146749],"category_scores_gemma":[0.00006296747,0.00034482995,0.00033428057,0.00014656458,0.00007090551,0.000030456149,0.00013443979,0.00073100784,0.0067397496],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023128897,0.00031780053,0.000087086,0.00028240474,0.000291388,0.0144968005,0.0000063652956,0.0000017417374,0.00011591756,0.0000016474622,0.98389,0.00027753867],"study_design_scores_gemma":[0.0010966987,0.00203988,0.002720292,0.00003733372,0.00078523124,0.004642294,0.000012112088,0.000015767342,0.0002928377,0.000015792612,0.9880617,0.00028004163],"about_ca_topic_score_codex":0.00021015722,"about_ca_topic_score_gemma":0.000010425213,"teacher_disagreement_score":0.009854507,"about_ca_system_score_codex":0.00019710274,"about_ca_system_score_gemma":0.00023715517,"threshold_uncertainty_score":0.9999004},"labels":[],"label_agreement":null},{"id":"W4286294477","doi":"10.1200/jco.2022.40.16_suppl.4513","title":"Pembrolizumab (pembro) plus axitinib (axi) versus sunitinib as first-line therapy for advanced clear cell renal cell carcinoma (ccRCC): Analysis of progression after first subsequent therapy in KEYNOTE-426.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval","funders":"","keywords":"Sunitinib; Medicine; Renal cell carcinoma; Clinical endpoint; Population; Internal medicine; Hazard ratio; Oncology; Pembrolizumab; Discontinuation; Cancer; Clinical trial; Confidence interval; Immunotherapy","score_opus":0.11094462871210896,"score_gpt":0.4268923143727819,"score_spread":0.31594768566067294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286294477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886141,0.004751151,0.00003886001,0.0026540593,0.0009837771,0.001548747,0.00006147536,0.000017117378,0.0013307349],"genre_scores_gemma":[0.9925219,0.0035332188,0.0019986362,0.00069452985,0.00052006304,0.00026921317,0.000085605374,0.00008198535,0.00029486994],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99243075,0.0010400885,0.0040703313,0.0006473477,0.0011398384,0.00067166303],"domain_scores_gemma":[0.9902175,0.004417338,0.003435482,0.0006469012,0.0007296681,0.0005531068],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031774936,0.00047425475,0.0032894122,0.00091142376,0.00017114785,0.000015373043,0.0004988082,0.0004480873,0.0012843761],"category_scores_gemma":[0.0006078161,0.00035802368,0.0022278312,0.00097454176,0.00028151277,0.00013320903,0.00016982785,0.0015524033,0.000006596179],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81490946,0.0148839755,0.094941854,0.00019989212,0.0020543905,0.004442783,0.0015303286,0.00917034,0.0021949033,0.000022460092,0.0006274443,0.05502216],"study_design_scores_gemma":[0.2051217,0.2750613,0.44777092,0.00014219261,0.0029205438,0.0002163509,0.0008778603,0.0019736437,0.010979792,0.00009992409,0.054253202,0.00058258156],"about_ca_topic_score_codex":0.00010439698,"about_ca_topic_score_gemma":0.00024888176,"teacher_disagreement_score":0.60978776,"about_ca_system_score_codex":0.0011649869,"about_ca_system_score_gemma":0.0022543871,"threshold_uncertainty_score":0.99988717},"labels":[],"label_agreement":null},{"id":"W4286297765","doi":"10.1200/jco.2022.40.16_suppl.tps4605","title":"TiNivo-2: A phase 3, randomized, controlled, multicenter, open-label study to compare tivozanib in combination with nivolumab to tivozanib monotherapy in subjects with renal cell carcinoma who have progressed following one or two lines of therapy where one line has an immune checkpoint inhibitor.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Nivolumab; Renal cell carcinoma; Internal medicine; Adverse effect; Oncology; Phases of clinical research; Clear cell renal cell carcinoma; Urology; Gastroenterology; Clinical trial; Cancer; Immunotherapy","score_opus":0.14702469632031276,"score_gpt":0.4409735268817561,"score_spread":0.2939488305614434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286297765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98502636,0.0013085781,0.0001319733,0.0034611905,0.00023640908,0.009676855,0.000010474315,0.000013350326,0.00013483521],"genre_scores_gemma":[0.9909934,0.00010478037,0.0069000246,0.0005560131,0.00024126258,0.0007785915,0.000017192951,0.00009168786,0.0003170773],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98831964,0.004031619,0.0052361283,0.00067414757,0.0012203334,0.00051813445],"domain_scores_gemma":[0.99219906,0.0025278784,0.003301332,0.0005382397,0.00089432695,0.0005391394],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009664431,0.0005162811,0.007453195,0.0007577405,0.0001280584,0.00006607718,0.0005786792,0.00012145932,0.000094045026],"category_scores_gemma":[0.0007298546,0.00032789633,0.0004499741,0.000763457,0.00018894736,0.000269076,0.00019915737,0.0013569482,0.0000014726402],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7742681,0.15118201,0.050245773,0.00004970274,0.0011711575,0.0031607712,0.0049824486,0.00040941543,0.0056101913,0.0000021944616,0.000022535787,0.0088957045],"study_design_scores_gemma":[0.7567201,0.21194951,0.020136094,0.00066293974,0.0006193374,0.00008342625,0.0035230822,0.0016939744,0.0042344015,0.000006979863,0.00009737184,0.00027272987],"about_ca_topic_score_codex":0.0016846869,"about_ca_topic_score_gemma":0.009034368,"teacher_disagreement_score":0.060767498,"about_ca_system_score_codex":0.00073972787,"about_ca_system_score_gemma":0.002320004,"threshold_uncertainty_score":0.9999173},"labels":[],"label_agreement":null},{"id":"W4286510751","doi":"10.1016/j.clgc.2022.07.008","title":"CABOSEQ: The Effectiveness of Cabozantinib in Patients With Treatment Refractory Advanced Renal Cell Carcinoma: Results From the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)","year":2022,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Calgary; Alberta Cancer Foundation","funders":"Ipsen; Ipsen Biopharmaceuticals","keywords":"Cabozantinib; Medicine; Renal cell carcinoma; Refractory (planetary science); Oncology; Internal medicine; Carcinoma; Clear cell; Urology","score_opus":0.040498504198724965,"score_gpt":0.3156316967992041,"score_spread":0.27513319260047914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286510751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896395,0.0019320877,0.000004898646,0.0005275503,0.0008621219,0.002202702,0.0036211545,0.000021427124,0.0011885281],"genre_scores_gemma":[0.9957039,0.00014545287,0.00029338925,0.00028580683,0.0003256053,0.000722126,0.0018590626,0.00006788635,0.0005967862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942073,0.0018744352,0.0013403792,0.0010281394,0.0010652554,0.00048447348],"domain_scores_gemma":[0.9933016,0.004069498,0.0007708913,0.0013613676,0.00027259407,0.0002241014],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013318856,0.00048434982,0.0008977653,0.00012147287,0.0002398049,0.000019640123,0.0005994361,0.00007693594,0.0002581272],"category_scores_gemma":[0.00018324854,0.00027548816,0.00035614084,0.00038343592,0.00037931994,0.00012077746,0.0004331424,0.0008572198,0.000009842386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08063659,0.0066696024,0.90015817,0.000104219194,0.0004362575,0.0013936122,0.0006124624,0.0018728988,0.0038455543,0.000004300886,0.0014488179,0.0028174843],"study_design_scores_gemma":[0.03639565,0.0072329743,0.93567365,0.00010600798,0.0007442751,0.0000137290135,0.0004621768,0.000105478815,0.014270751,0.000011584168,0.0046896175,0.00029410675],"about_ca_topic_score_codex":0.0032353846,"about_ca_topic_score_gemma":0.00022508405,"teacher_disagreement_score":0.044240944,"about_ca_system_score_codex":0.0009365807,"about_ca_system_score_gemma":0.0011148043,"threshold_uncertainty_score":0.9999697},"labels":[],"label_agreement":null},{"id":"W4286786496","doi":"10.48083/10.48083/rqbn1626","title":"CD34 and FSHR Expression to Differentiate Multiple Subtypes of Benign and Malignant Renal Neoplasms","year":2022,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"CD34; Pathology; Oncocytoma; Medicine; Renal oncocytoma; Chromophobe cell; Immunohistochemistry; Carcinoma; Clear cell; Biology; Stem cell","score_opus":0.03161790205666171,"score_gpt":0.28097713870208557,"score_spread":0.24935923664542387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286786496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99597365,0.0009420743,0.00028936722,0.001674097,0.00030660146,0.00023862824,0.000042877404,0.00001759624,0.0005150875],"genre_scores_gemma":[0.9969459,0.00020919356,0.0013341967,0.000326814,0.00012520452,0.000032620588,0.000029250039,0.000014760933,0.0009820173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998506,0.00012369837,0.00036832227,0.00025757885,0.0005377717,0.00020663897],"domain_scores_gemma":[0.9990648,0.00024968604,0.00023441133,0.00013557643,0.00013225868,0.00018326045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031937228,0.0001555185,0.0002968543,0.00020165993,0.00021064495,0.000030274316,0.00013320155,0.00004937769,0.0004940968],"category_scores_gemma":[0.00017377979,0.00012066062,0.00011388218,0.000071202114,0.00006504521,0.00007145263,0.00032280668,0.0003556589,0.0000019452561],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00281763,0.00051034207,0.6881797,0.00005423394,0.00043894915,0.0005053671,0.0015741389,0.0004257707,0.29283166,0.00021557153,0.00312678,0.0093198735],"study_design_scores_gemma":[0.0060813674,0.0032796722,0.9015806,0.00011647221,0.00022177515,0.0030516058,0.0015021447,0.0009999747,0.07639519,0.0018380295,0.004656759,0.00027646485],"about_ca_topic_score_codex":0.00002277913,"about_ca_topic_score_gemma":0.000006055716,"teacher_disagreement_score":0.21643646,"about_ca_system_score_codex":0.00013933588,"about_ca_system_score_gemma":0.000071548595,"threshold_uncertainty_score":0.5410013},"labels":[],"label_agreement":null},{"id":"W4288034414","doi":"10.1093/oncolo/oyac142","title":"Health-Related Quality of Life Outcomes With Two Different Starting Doses of Lenvatinib in Combination With Everolimus for Previously Treated Renal Cell Carcinoma","year":2022,"lang":"en","type":"article","venue":"The Oncologist","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Merck Sharp and Dohme; Eisai; Merck","keywords":"Lenvatinib; Medicine; Everolimus; Renal cell carcinoma; Quality of life (healthcare); Internal medicine; Oncology; Adverse effect; Clinical trial; Sorafenib; Hepatocellular carcinoma","score_opus":0.06752936432084708,"score_gpt":0.32773573030721215,"score_spread":0.26020636598636504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288034414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944321,0.00038966967,0.00003105416,0.0022257827,0.000025428979,0.002445656,0.000045153774,0.000028635222,0.00037651186],"genre_scores_gemma":[0.99877286,0.000005903974,0.00029129986,0.00016243155,0.000007319266,0.00034233698,0.00010968631,0.000024868143,0.00028331485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974795,0.00060009875,0.00091919454,0.00026316714,0.0004450581,0.000292975],"domain_scores_gemma":[0.9975726,0.00076286873,0.0010747695,0.00037776164,0.00012739164,0.000084628766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010143551,0.00020822842,0.0009779506,0.000111169546,0.00013675669,0.0000044342714,0.00014211205,0.000034883582,0.000031244024],"category_scores_gemma":[0.000116308256,0.00011152865,0.00010202787,0.00029450137,0.00019443229,0.00002827081,0.00006732144,0.00022199278,3.1710917e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009079765,0.0020350476,0.982149,0.0004045064,0.00012946762,0.000016282564,0.0021028789,0.0009412494,0.0021837114,0.00016222945,0.00006637048,0.0007294698],"study_design_scores_gemma":[0.020317351,0.016637363,0.95346427,0.00006557672,0.00016202468,0.00000974951,0.0014255297,0.00024330545,0.00745968,0.00008749611,0.000008834999,0.000118843614],"about_ca_topic_score_codex":0.0069106235,"about_ca_topic_score_gemma":0.0018248355,"teacher_disagreement_score":0.028684776,"about_ca_system_score_codex":0.00066173595,"about_ca_system_score_gemma":0.00040716646,"threshold_uncertainty_score":0.99970245},"labels":[],"label_agreement":null},{"id":"W4288056283","doi":"10.1016/j.urolonc.2022.06.022","title":"Other-cause mortality and access to care in metastatic renal cell carcinoma according to race/ethnicity","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Poisson regression; Logistic regression; Ethnic group; Internal medicine; Epidemiology; Incidence (geometry); Race (biology); Cancer; Demography; Oncology; Population","score_opus":0.0968063485757463,"score_gpt":0.37149616811598796,"score_spread":0.27468981954024163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288056283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99095565,0.0013173536,0.000048026213,0.004922247,0.00011910271,0.0011627456,0.00006920314,0.000036461308,0.0013692278],"genre_scores_gemma":[0.9800803,0.000035636884,0.013473296,0.0055526034,0.000053018888,0.000534006,0.000042727883,0.000019834102,0.00020857016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805754,0.0003369328,0.00036802053,0.00060533575,0.00024196335,0.00039022145],"domain_scores_gemma":[0.9987731,0.00025940622,0.00011580071,0.00029340188,0.00005611896,0.0005021627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045662807,0.00024544293,0.0005063161,0.00035492578,0.0003576459,0.000035817746,0.00016924918,0.00007896015,0.000103044105],"category_scores_gemma":[0.00012752807,0.00022060798,0.0000512351,0.0006109027,0.00019545638,0.00010867218,0.00038767527,0.00044848223,0.0000079352985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028022332,0.0002041576,0.9900668,0.00006240029,0.000044705088,0.0008626628,0.002859328,0.00090484944,0.0024799756,0.000307182,0.0009543463,0.0009733558],"study_design_scores_gemma":[0.0038356723,0.015332274,0.6784019,0.00005911197,0.0014123173,0.0010221773,0.009562631,0.00058198697,0.0069372333,0.0021396477,0.2800074,0.0007076499],"about_ca_topic_score_codex":0.0010829648,"about_ca_topic_score_gemma":0.0006883073,"teacher_disagreement_score":0.3116649,"about_ca_system_score_codex":0.00056023756,"about_ca_system_score_gemma":0.00039080047,"threshold_uncertainty_score":0.8996132},"labels":[],"label_agreement":null},{"id":"W4288796554","doi":"10.26443/msurj.v15i1.15","title":"Clinical Manifestations of Hereditary Leiomyomatosis and Renal Cell Carcinoma: a Case Report","year":2020,"lang":"en","type":"article","venue":"McGill Science Undergraduate Research Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Fumarase; Leiomyomatosis; Medicine; Pathology; Renal cell carcinoma; Missense mutation; Gene mutation; Germline mutation; Birt–Hogg–Dubé syndrome; Carcinoma; Mutation; Leiomyoma; Biology; Genetics; Gene; Radiology","score_opus":0.1518073918426576,"score_gpt":0.40835475503130786,"score_spread":0.25654736318865023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288796554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97511643,0.0003227428,0.00011559531,0.01763122,0.00010339633,0.0003848069,0.0000172201,0.000018972283,0.006289635],"genre_scores_gemma":[0.9946477,0.00024564378,0.0044829785,0.0001204411,0.00021445737,0.0000077400855,0.0000036006245,0.00002135511,0.0002560819],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9951335,0.00039659068,0.0009578319,0.0006284178,0.002149035,0.0007345905],"domain_scores_gemma":[0.9958693,0.00041919426,0.0002830932,0.00038080092,0.0012680341,0.0017796067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049873404,0.00018416536,0.00042517876,0.00050172594,0.0011737015,0.000089769776,0.00027383468,0.00007589766,0.000029771676],"category_scores_gemma":[0.0012582365,0.00014002032,0.00018249537,0.0014942897,0.00180303,0.00038196752,0.00030338299,0.0010623572,0.000018589251],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003169585,0.0005466957,0.05346763,0.0002109549,0.000069657726,0.8971663,0.00027681843,0.000018183147,0.038530547,0.0004721301,0.003806224,0.0051178816],"study_design_scores_gemma":[0.003044554,0.004307483,0.037554786,0.00012093309,0.00016714945,0.9146153,0.0017104365,0.0015080284,0.03393357,0.0015285274,0.001263287,0.00024596474],"about_ca_topic_score_codex":0.00022765092,"about_ca_topic_score_gemma":0.000015831729,"teacher_disagreement_score":0.01953129,"about_ca_system_score_codex":0.0002744035,"about_ca_system_score_gemma":0.0012296796,"threshold_uncertainty_score":0.90272814},"labels":[],"label_agreement":null},{"id":"W4288844466","doi":"10.1016/j.euf.2022.07.005","title":"Cancer-specific Mortality in T1a Renal Cell Carcinoma Treated with Local Tumor Destruction Versus Partial Nephrectomy","year":2022,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Hazard ratio; Propensity score matching; Internal medicine; Kidney cancer; Proportional hazards model; Cancer; Urology; Oncology; Relative survival; Stage (stratigraphy); Surgery; Gastroenterology; Kidney; Cancer registry; Confidence interval","score_opus":0.026760659080745805,"score_gpt":0.24210274128959108,"score_spread":0.21534208220884526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288844466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98363656,0.0011584761,0.00006508822,0.0002555921,0.00031900263,0.00060236454,0.000025330286,0.00010382982,0.013833751],"genre_scores_gemma":[0.9989877,0.000011142443,0.0000915476,0.00011953797,0.00024527538,0.00017849672,0.00007143524,0.00007810836,0.00021676214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972658,0.0008120824,0.00034938476,0.00068874663,0.00035953964,0.00052440126],"domain_scores_gemma":[0.999034,0.000057802165,0.00015923726,0.0005016889,0.00004702699,0.00020027395],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027679116,0.00030987262,0.00040827456,0.00020679037,0.00017062704,0.000012527395,0.00016164333,0.000038368187,0.00066706515],"category_scores_gemma":[0.000006813199,0.00027023428,0.00010373902,0.0004475759,0.00031163802,0.0000511273,0.00010380434,0.00060982653,0.00007220817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03129105,0.00092002674,0.9001659,0.00003486353,0.00023542857,0.03763487,0.00052828906,0.005390081,0.010282075,0.00012405808,0.0011733321,0.012219993],"study_design_scores_gemma":[0.015237269,0.0073468834,0.94689023,0.000005961646,0.00038117106,0.0009239968,0.00023931466,0.0003559345,0.0162202,0.0000059745657,0.01206497,0.00032806408],"about_ca_topic_score_codex":0.0013372494,"about_ca_topic_score_gemma":0.00029123816,"teacher_disagreement_score":0.04672432,"about_ca_system_score_codex":0.00059590803,"about_ca_system_score_gemma":0.00016015458,"threshold_uncertainty_score":0.99997497},"labels":[],"label_agreement":null},{"id":"W4289110221","doi":"10.3390/curroncol29080429","title":"Next Wave of Targets in the Treatment of Advanced Renal Cell Carcinoma","year":2022,"lang":"en","type":"review","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; McMaster University; Western University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Sunitinib; Cancer research; Renal cell carcinoma; Tumor microenvironment; Angiogenesis; Targeted therapy; Cancer; Bioinformatics; Oncology; Internal medicine; Biology","score_opus":0.24040239405199765,"score_gpt":0.41709733209923305,"score_spread":0.1766949380472354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289110221","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0076613585,0.98452264,0.0000013204083,0.00003187825,0.00074926927,0.002880587,0.000101056474,0.00000884205,0.0040430673],"genre_scores_gemma":[0.0047246055,0.99289256,0.00014284611,0.000008654465,0.0001654278,0.0010385744,0.00082036736,0.00004631072,0.00016066672],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966686,0.0007695418,0.0012167913,0.0005307989,0.00041794314,0.00039636355],"domain_scores_gemma":[0.99731445,0.00077912654,0.00092425995,0.000816857,0.00006184496,0.00010345656],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027779918,0.00052700256,0.0032397516,0.00040328814,0.000037514914,0.000002929493,0.00024219623,0.00022004888,0.0005064728],"category_scores_gemma":[0.00003493485,0.00031125953,0.0010067571,0.00046870948,0.00015522099,0.000024321473,0.00008043034,0.0004715252,0.000013181862],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015511633,0.0049970034,0.00011493058,0.009417431,0.000110491965,0.00051989476,0.0011710216,0.0000013335825,0.000010926485,0.000024504754,0.00032240886,0.98315495],"study_design_scores_gemma":[0.0026090434,0.010685787,0.00030884365,0.0009606333,0.002244509,0.0002253919,0.00028811715,0.0000031988318,0.00011524202,0.00001091442,0.982368,0.00018035586],"about_ca_topic_score_codex":0.000038831553,"about_ca_topic_score_gemma":0.000016670278,"teacher_disagreement_score":0.9829746,"about_ca_system_score_codex":0.0019278415,"about_ca_system_score_gemma":0.0011609783,"threshold_uncertainty_score":0.99993396},"labels":[],"label_agreement":null},{"id":"W4289704856","doi":"10.3390/curroncol29080433","title":"The Role of Cytoreductive Nephrectomy in Renal Cell Carcinoma with Sarcomatoid Histology: A Case Series and Review of the Literature","year":2022,"lang":"en","type":"review","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Grantová Agentura České Republiky","keywords":"Medicine; Nivolumab; Ipilimumab; Renal cell carcinoma; Nephrectomy; Regimen; Internal medicine; Oncology; Immunotherapy; Cancer; Kidney","score_opus":0.049707090219035306,"score_gpt":0.3444434004851175,"score_spread":0.2947363102660822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289704856","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0069334367,0.98888713,7.414511e-8,0.00016718866,0.00031659784,0.002482656,0.00009181333,0.0000067570604,0.0011143577],"genre_scores_gemma":[0.0017225575,0.9972688,0.000059551465,0.000018014856,0.0000689686,0.0006353425,0.00009278085,0.0000364687,0.00009753291],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969306,0.0012132148,0.0008557942,0.0004487323,0.00026171052,0.00028992613],"domain_scores_gemma":[0.9975428,0.0005105282,0.0010073183,0.0007171509,0.00013522651,0.00008699458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042890437,0.00043329725,0.0024266718,0.00016973783,0.000123062,0.000005229021,0.00025918047,0.00019217495,0.000042023126],"category_scores_gemma":[0.00010290646,0.00020305849,0.0003879679,0.0006607915,0.0006209245,0.000033803095,0.00028240733,0.0010981266,7.2211475e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036036584,0.00053764746,0.0013378635,0.12283077,0.00019175527,0.0024503414,0.0009600818,4.978021e-8,0.000005253338,0.00019925841,0.0006591024,0.8704675],"study_design_scores_gemma":[0.0006652445,0.0014544295,0.00008804088,0.03079364,0.0017541287,0.041248135,0.00028729287,2.7228495e-7,0.000031491196,0.000027907236,0.9235071,0.00014230095],"about_ca_topic_score_codex":0.000032766966,"about_ca_topic_score_gemma":0.000062235245,"teacher_disagreement_score":0.922848,"about_ca_system_score_codex":0.00083603006,"about_ca_system_score_gemma":0.0015792948,"threshold_uncertainty_score":0.82804847},"labels":[],"label_agreement":null},{"id":"W4290988449","doi":"10.3389/fonc.2022.945166","title":"Positive surgical margins may not affect the survival of patients with renal cell carcinoma after partial nephrectomy: A meta-analysis based on 39 studies","year":2022,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Meta-analysis; Cochrane Library; Odds ratio; Internal medicine; Surgical margin; Oncology; Distant metastasis; Confidence interval; Metastasis; Urology; Cancer; Surgery; Kidney","score_opus":0.03613237614078108,"score_gpt":0.2930673236624554,"score_spread":0.25693494752167434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290988449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937195,0.0012046493,0.00011267038,0.0020765222,0.00035907782,0.0013356985,0.00023824257,0.000012469174,0.0009411333],"genre_scores_gemma":[0.99646443,0.000006740907,0.001270256,0.0005251199,0.000048368307,0.0011338141,0.00013156499,0.00002851112,0.00039118767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960408,0.0017753807,0.00045704393,0.0005459285,0.00076647097,0.00041437408],"domain_scores_gemma":[0.99817806,0.0007946023,0.0002665068,0.0005159599,0.00013793392,0.00010692745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007453183,0.0003241781,0.0019363479,0.00049667706,0.00011701135,0.00000567864,0.0001758361,0.00008748174,0.00039250895],"category_scores_gemma":[0.000036472393,0.00018643808,0.00084484596,0.00083982415,0.0003047985,0.00002647203,0.00014262227,0.00045243543,0.0000025867114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030656215,0.0021624018,0.9279335,0.000038001464,0.031810895,0.00225429,0.0010185181,0.0022958007,0.0000140672255,0.000017808437,0.0015309409,0.00026756083],"study_design_scores_gemma":[0.010199829,0.013320342,0.8669078,0.000004811637,0.09995776,0.000009828942,0.0009899305,0.00070374797,0.0018221522,0.000009855803,0.0057839965,0.00028995427],"about_ca_topic_score_codex":0.00014762259,"about_ca_topic_score_gemma":0.00013642601,"teacher_disagreement_score":0.06814686,"about_ca_system_score_codex":0.0011075935,"about_ca_system_score_gemma":0.00025124886,"threshold_uncertainty_score":0.7602724},"labels":[],"label_agreement":null},{"id":"W4291285686","doi":"10.1016/j.urolonc.2022.07.005","title":"Patients’ perceptions on active surveillance for the treatment of small renal masses","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Ottawa Hospital; Université Laval; University of Ottawa; Centre Hospitalier Universitaire de Sherbrooke; McGill University Health Centre; Université de Sherbrooke","funders":"Canadian Urological Association Scholarship Fund","keywords":"Medicine; Focus group; Thematic analysis; Watchful waiting; Perception; Active monitoring; Family medicine; Qualitative research; Psychology; Internal medicine","score_opus":0.047544422483143015,"score_gpt":0.3040212992789343,"score_spread":0.2564768767957913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291285686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920674,0.00043816504,0.000048160364,0.005112002,0.00013677415,0.0010136,0.00021078705,0.000020973728,0.00095213344],"genre_scores_gemma":[0.98183215,0.00061586726,0.013645719,0.0009253179,0.00009844582,0.0013978764,0.0002939505,0.000014988504,0.0011757],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990838,0.00013486216,0.0002068943,0.00026299086,0.00012676859,0.00018469279],"domain_scores_gemma":[0.99854064,0.0009417939,0.00014458779,0.00020257708,0.000072584466,0.00009779537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012958715,0.00014762075,0.00027724725,0.000087381035,0.0005072659,0.000005191855,0.00006873384,0.00005941045,0.00013616543],"category_scores_gemma":[0.0000642835,0.00009357221,0.00010631259,0.00014912443,0.0003723014,0.000017089762,0.000024420817,0.0001300433,0.0000029150162],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015323631,0.002760155,0.96908224,0.000019784638,0.0002908607,0.000033906428,0.0018992787,0.00097265095,0.0007655732,0.0035627882,0.0030759082,0.0160045],"study_design_scores_gemma":[0.0019542351,0.032558363,0.14848551,0.000005502221,0.00032281235,0.00006170236,0.0006611561,0.0004314152,0.0005821109,0.0008573616,0.81398755,0.000092289694],"about_ca_topic_score_codex":0.00006127023,"about_ca_topic_score_gemma":0.000045374443,"teacher_disagreement_score":0.8205967,"about_ca_system_score_codex":0.00036850796,"about_ca_system_score_gemma":0.00019587872,"threshold_uncertainty_score":0.39015305},"labels":[],"label_agreement":null},{"id":"W4292002773","doi":"10.17650/1726-9776-2022-18-2-39-57","title":"Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study","year":2022,"lang":"en","type":"article","venue":"Cancer Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Lenvatinib; Medicine; Everolimus; Pembrolizumab; Sunitinib; Renal cell carcinoma; Oncology; Internal medicine; Quality of life (healthcare); Sorafenib; Cancer; Immunotherapy; Hepatocellular carcinoma","score_opus":0.05226541449896924,"score_gpt":0.333492476274445,"score_spread":0.28122706177547574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292002773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99357194,0.00063061574,0.000003304913,0.0004310713,0.00015770922,0.0046774405,0.00022966931,0.00006552919,0.00023274518],"genre_scores_gemma":[0.99750584,0.000011974558,0.00004160409,0.00043315662,0.000019525041,0.0013384282,0.00029688267,0.00009166058,0.0002609287],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99545974,0.0011545182,0.0012004978,0.0007628742,0.00072626927,0.00069613446],"domain_scores_gemma":[0.99733275,0.00061049446,0.00083539134,0.00065751915,0.00022310355,0.0003407475],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003438157,0.00048317178,0.0019441735,0.00040121537,0.00018496459,0.0000064728697,0.00021620192,0.000082568964,0.0006692375],"category_scores_gemma":[0.00012849929,0.00033585308,0.00012220589,0.0007893066,0.00017460878,0.00007615369,0.00010771601,0.0006151076,0.0000039660335],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50176275,0.0031139723,0.48977938,0.00007114648,0.00036946379,0.00028294727,0.0015262334,0.0021352165,0.000015854945,0.0000016770626,0.000029180934,0.0009121645],"study_design_scores_gemma":[0.42074358,0.06699248,0.5108223,0.000011227615,0.00028289622,0.000010209464,0.00076956674,0.00004836684,0.0000444876,5.514501e-7,0.000057779405,0.00021652631],"about_ca_topic_score_codex":0.0034840575,"about_ca_topic_score_gemma":0.0019394619,"teacher_disagreement_score":0.08101916,"about_ca_system_score_codex":0.0010904873,"about_ca_system_score_gemma":0.0016830792,"threshold_uncertainty_score":0.99990934},"labels":[],"label_agreement":null},{"id":"W4292262745","doi":"10.15586/jkcvhl.v9i3.231","title":"Successful Surgical Management of Locally Advanced Renal Cell Carcinoma Invading Spleen and Pancreas","year":2022,"lang":"en","type":"article","venue":"Journal of Kidney Cancer and VHL","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Pancreas; Spleen; Surgery; Kidney; Pathology; Internal medicine","score_opus":0.013600409203748097,"score_gpt":0.26170331815633946,"score_spread":0.24810290895259135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292262745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855401,0.009542376,0.000020612739,0.0013343683,0.00015901262,0.00020364238,0.000029208903,0.0000041625144,0.0031665114],"genre_scores_gemma":[0.99613184,0.0020814138,0.00069153105,0.0002656959,0.00012958045,0.000014399961,0.000006397038,0.000017131875,0.0006619969],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862427,0.00006295691,0.0004559213,0.00018131622,0.0004768863,0.00019866432],"domain_scores_gemma":[0.9988166,0.00004535073,0.00032215714,0.00012964448,0.000100920595,0.00058532285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003249078,0.0001511131,0.00047199547,0.000146574,0.00009185646,0.000012382318,0.00008973062,0.00002971413,0.0002508132],"category_scores_gemma":[0.000013005885,0.00011795059,0.000113228656,0.00015933735,0.00006579172,0.000088677814,0.00013496602,0.00026259365,3.0191734e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009672718,0.00071467285,0.904059,0.0023183683,0.00096701685,0.010094507,0.0011518387,0.00027146304,0.017403089,0.00029097585,0.010823097,0.042233255],"study_design_scores_gemma":[0.05549205,0.011575365,0.7182795,0.0019009562,0.0038075147,0.009758338,0.0045681433,0.00041161833,0.08366119,0.00037578715,0.109292276,0.0008772871],"about_ca_topic_score_codex":0.00011717148,"about_ca_topic_score_gemma":0.0000022051966,"teacher_disagreement_score":0.18577954,"about_ca_system_score_codex":0.00020022431,"about_ca_system_score_gemma":0.0003160819,"threshold_uncertainty_score":0.48098856},"labels":[],"label_agreement":null},{"id":"W4292395108","doi":"10.2196/41451","title":"An Evaluation of a Web-Based Decision Aid for Treatment Planning of Small Kidney Tumors: Pilot Randomized Controlled Trial","year":2022,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Randomized controlled trial; Medicine; Medical physics; Computer science; Surgery","score_opus":0.3324305931682587,"score_gpt":0.5382614503779294,"score_spread":0.2058308572096707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292395108","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34048775,0.000014842701,0.00015289424,0.00010697868,0.000010932282,0.65874034,0.000043271622,0.000022666965,0.00042031502],"genre_scores_gemma":[0.36357725,2.3699519e-7,0.0017314308,0.000014124772,0.00007603984,0.6344047,0.00007932825,0.000029121913,0.00008776157],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99010575,0.004831984,0.0012132536,0.0004922094,0.002899793,0.00045702056],"domain_scores_gemma":[0.9937867,0.0033167736,0.0005072954,0.00075341604,0.001306372,0.00032944858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017727602,0.00024497168,0.0019333251,0.0007946605,0.0002104534,0.000027213158,0.0002433421,0.000059754362,0.0005140403],"category_scores_gemma":[0.0033149333,0.00016400454,0.00062185485,0.0004292127,0.00016952795,0.000054373075,0.000065947796,0.00020077775,0.0000023972093],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96630126,0.007955987,0.00029194576,0.0003257962,0.00024590525,0.000021158701,0.00024184101,0.0008720096,0.020923713,0.00003871693,0.00034982458,0.0024318509],"study_design_scores_gemma":[0.85940254,0.07884587,0.00006619144,0.0010303077,0.00018060436,0.0000035586806,0.00009265974,0.03448638,0.024237925,0.00026782815,0.0012873176,0.00009882469],"about_ca_topic_score_codex":0.000060182218,"about_ca_topic_score_gemma":0.0000028569602,"teacher_disagreement_score":0.10689872,"about_ca_system_score_codex":0.0009875455,"about_ca_system_score_gemma":0.00411375,"threshold_uncertainty_score":0.72976154},"labels":[],"label_agreement":null},{"id":"W4292486508","doi":"10.1002/jmri.28397","title":"Diagnostic Accuracy of <scp>MRI</scp> for Solid Renal Masses: A Systematic Review and Meta‐analysis","year":2022,"lang":"en","type":"review","venue":"Journal of Magnetic Resonance Imaging","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Public Health; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Meta-analysis; Confidence interval; Renal cell carcinoma; Diagnostic accuracy; Clear cell renal cell carcinoma; Histology; Radiology; Study heterogeneity; Population; Nuclear medicine; Internal medicine","score_opus":0.05598024162506077,"score_gpt":0.3502426142818192,"score_spread":0.2942623726567584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292486508","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006398523,0.9944555,0.000212272,0.0002495121,0.000074186784,0.004724581,0.000113068905,0.000010510002,0.00015396382],"genre_scores_gemma":[0.000019382402,0.9938866,0.0039279535,0.00025882162,0.00010051578,0.00090152334,0.000032288077,0.00009529371,0.0007776156],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9933949,0.0007482497,0.0037382815,0.000534164,0.0011019649,0.00048240786],"domain_scores_gemma":[0.9814098,0.011676627,0.0052426714,0.0008782109,0.0004895512,0.00030317067],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002543403,0.00074971747,0.013241497,0.00097111444,0.00009832747,0.00006970702,0.0005207392,0.00009596215,0.0002577419],"category_scores_gemma":[0.009457781,0.00048267786,0.0052970527,0.0011693625,0.00012416202,0.00016716076,0.00017611639,0.0007000135,0.0000033013216],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000092759055,0.00015400688,0.000029726298,0.93192244,0.03377073,0.0008124287,0.00006971574,0.0000025607976,9.077035e-7,0.0000068516138,0.0015134007,0.031707983],"study_design_scores_gemma":[0.00043672734,0.00045310476,0.000022661736,0.098612495,0.61899555,0.002980694,0.000048519676,0.00002064257,0.0000021117482,0.000018006587,0.27829784,0.000111651665],"about_ca_topic_score_codex":0.000010548123,"about_ca_topic_score_gemma":0.0000012845715,"teacher_disagreement_score":0.8333099,"about_ca_system_score_codex":0.00029052768,"about_ca_system_score_gemma":0.00068500766,"threshold_uncertainty_score":0.9997625},"labels":[],"label_agreement":null},{"id":"W4292658218","doi":"10.47102/annals-acadmedsg.v44n10p406","title":"Singapore Cancer Network (SCAN) Guidelines for Systemic Therapy of Metastatic Renal Cell Carcinoma (mRCC)","year":2015,"lang":"en","type":"article","venue":"Annals of the Academy of Medicine Singapore","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Toronto; National University Health System; National Cancer Centre of Singapore","keywords":"Medicine; Workgroup; Systemic therapy; Renal cell carcinoma; Cancer; Kidney cancer; Excellence; Clinical Practice; Oncology; Internal medicine; Clinical Oncology; Medical physics; Family medicine","score_opus":0.3677585388106717,"score_gpt":0.43090100859958474,"score_spread":0.06314246978891302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292658218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86569536,0.07499147,0.0000725295,0.056726217,0.00027763488,0.0016128676,0.000048228685,0.000023004604,0.0005527093],"genre_scores_gemma":[0.9907433,0.001740278,0.001756972,0.0037364329,0.0010580872,0.000065816086,0.00003064729,0.00007124703,0.00079723523],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995811,0.00022509815,0.0018000732,0.00042152836,0.0012118611,0.0005304488],"domain_scores_gemma":[0.99526024,0.00035862174,0.0018072546,0.00057329505,0.0016824787,0.00031808272],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023214987,0.00043663327,0.0016268832,0.00020098677,0.00007463516,0.0000032814926,0.0005508505,0.00019656113,0.000039564144],"category_scores_gemma":[0.00073224335,0.0002482199,0.0004956782,0.0005773098,0.00069001893,0.00008221873,0.00009232042,0.00033553864,9.263599e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005925006,0.00061677507,0.030632157,0.003975139,0.0016081984,0.00003670405,0.0041519683,0.004249704,0.16113564,0.00056679855,0.7664752,0.020626687],"study_design_scores_gemma":[0.017827706,0.00620303,0.019653456,0.009279542,0.0021372966,0.0004845752,0.002480401,0.0011589926,0.9077299,0.0051192734,0.02734339,0.0005824407],"about_ca_topic_score_codex":0.00052156753,"about_ca_topic_score_gemma":0.0000051831516,"teacher_disagreement_score":0.74659425,"about_ca_system_score_codex":0.00007806074,"about_ca_system_score_gemma":0.00052322506,"threshold_uncertainty_score":0.999997},"labels":[],"label_agreement":null},{"id":"W4292829841","doi":"10.1016/j.urology.2022.07.037","title":"Author Reply","year":2022,"lang":"en","type":"letter","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine","score_opus":0.0351539582594333,"score_gpt":0.27507744311867144,"score_spread":0.23992348485923815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292829841","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017884929,0.0010221455,0.000008537583,0.96346354,0.0010114711,0.00038766628,0.000023352613,0.00010898299,0.032185797],"genre_scores_gemma":[0.0028485542,0.000008824775,0.00008586817,0.878853,0.0027963864,0.00014140952,0.0009737598,0.00006965428,0.11422254],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99836844,0.00016143406,0.00024653444,0.0005305654,0.00030602558,0.00038701834],"domain_scores_gemma":[0.99885386,0.00013531432,0.00011557672,0.0007990747,0.00003318838,0.00006298671],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000105041945,0.00024101954,0.0005115375,0.00020575305,0.000055370838,0.0000051096285,0.00013905583,0.00048189537,0.011324638],"category_scores_gemma":[0.00006353319,0.00020748308,0.00021307293,0.00009141384,0.00007223735,0.000008243634,0.00012449536,0.0021979434,0.0006442718],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014369264,0.000028321676,0.00020781202,0.000056598594,0.00015408955,0.024413692,0.00004032147,0.0000015539262,0.000031445074,0.0000133177555,0.97454107,0.0003680935],"study_design_scores_gemma":[0.0005010451,0.0021422068,0.00041656964,0.0000024707456,0.00046095077,0.0027212426,0.0000029556045,0.000009143334,0.00003418715,0.00012525018,0.99345106,0.0001329159],"about_ca_topic_score_codex":0.000049680406,"about_ca_topic_score_gemma":9.4024676e-7,"teacher_disagreement_score":0.08461055,"about_ca_system_score_codex":0.00019222591,"about_ca_system_score_gemma":0.00015272414,"threshold_uncertainty_score":0.98957914},"labels":[],"label_agreement":null},{"id":"W4293030580","doi":"10.1007/s00330-022-09102-w","title":"Proportion of malignancy in Bosniak classification of cystic renal masses version 2019 (v2019) classes: systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"European Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Malignancy; Medicine; IIf; Neuroradiology; Radiology; Internal medicine","score_opus":0.11929453783570622,"score_gpt":0.34003052151902446,"score_spread":0.22073598368331826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293030580","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000083717074,0.9950281,0.00003642415,0.0000423138,0.000036571233,0.0034354609,0.00010230177,0.000015780079,0.0012193678],"genre_scores_gemma":[0.0012024507,0.99621433,0.00027809743,0.000035936187,0.000015076368,0.0002030105,0.0011234683,0.000054212065,0.0008734187],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99188876,0.0044874763,0.0024199155,0.00063861755,0.00035823038,0.00020697016],"domain_scores_gemma":[0.9957641,0.00045010142,0.0026113233,0.0009900306,0.00010370032,0.000080780206],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021307156,0.00043505,0.008820146,0.00083055225,0.00002761924,0.0000044565927,0.00023563918,0.00011724758,0.000484099],"category_scores_gemma":[0.00044750952,0.00028189906,0.0016291891,0.00096654,0.00011860074,0.000040503055,0.00011342124,0.0003235715,0.00003468566],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024382996,0.0001611601,0.00007241089,0.95888996,0.039236333,0.00028890543,0.000027351432,0.0000022154522,0.000020607124,0.000092637085,0.0004140056,0.0007700486],"study_design_scores_gemma":[0.00028881765,0.00062580226,0.00061878003,0.02476607,0.93562645,0.0007053553,0.00001920647,0.0000049996092,0.0000024077262,0.0000027790768,0.037121553,0.0002177868],"about_ca_topic_score_codex":0.000011916258,"about_ca_topic_score_gemma":0.000001522569,"teacher_disagreement_score":0.9341239,"about_ca_system_score_codex":0.00024308046,"about_ca_system_score_gemma":0.00017998106,"threshold_uncertainty_score":0.99996334},"labels":[],"label_agreement":null},{"id":"W4293217252","doi":"10.1016/j.clgc.2022.08.010","title":"Mortality According to Treatment in Metastatic Collecting Duct Renal Cell Carcinoma","year":2022,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Université de Montréal","funders":"","keywords":"Medicine; Proportional hazards model; Internal medicine; Renal cell carcinoma; Concomitant; Cohort; Epidemiology; Nephrectomy; Gastroenterology; Surgery; Urology; Kidney","score_opus":0.17532934324454227,"score_gpt":0.42396707200482325,"score_spread":0.24863772876028098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293217252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920174,0.0016532803,0.000008456803,0.0007502148,0.00078095734,0.0015022951,0.00005666573,0.000050137493,0.0031806203],"genre_scores_gemma":[0.992345,0.000096453376,0.00082872336,0.00072468567,0.0005759838,0.0013437793,0.000033697983,0.000056782326,0.0039949026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966034,0.0005118299,0.0009852926,0.00082995626,0.00049965596,0.0005698482],"domain_scores_gemma":[0.9982715,0.00040934558,0.00019502398,0.0006064797,0.000065034816,0.00045256614],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007068861,0.00032903883,0.000856175,0.00024447928,0.00025823453,0.00001899245,0.00018072376,0.000053688655,0.0007433394],"category_scores_gemma":[0.00009308908,0.0002917136,0.00041840045,0.0007748546,0.000052401316,0.000052507025,0.00029662886,0.00050182804,0.000038693586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017279974,0.002338762,0.9684382,0.00007478289,0.00021303984,0.0061196918,0.00048725982,0.0020300094,0.0033170618,0.0000018752775,0.001303737,0.013947547],"study_design_scores_gemma":[0.009160028,0.009740882,0.95551574,0.000052273936,0.00087635353,0.00023770912,0.0023919363,0.0006588223,0.009919193,0.000047176003,0.0108430805,0.00055680814],"about_ca_topic_score_codex":0.0018015453,"about_ca_topic_score_gemma":0.0001690968,"teacher_disagreement_score":0.013390739,"about_ca_system_score_codex":0.0022500092,"about_ca_system_score_gemma":0.00092001876,"threshold_uncertainty_score":0.9999535},"labels":[],"label_agreement":null},{"id":"W4293428565","doi":"10.1016/j.ctrv.2022.102453","title":"Cabozantinib after prior checkpoint inhibitor therapy in patients with solid tumors: A systematic literature review","year":2022,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; CancerCare Manitoba","funders":"Ipsen","keywords":"Cabozantinib; Medicine; Renal cell carcinoma; Tolerability; Oncology; Observational study; Clinical trial; Cochrane Library; Internal medicine; Systematic review; Kidney cancer; MEDLINE; Adverse effect; Meta-analysis","score_opus":0.04775146533847868,"score_gpt":0.33780633725682585,"score_spread":0.29005487191834717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293428565","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016037044,0.9567426,1.582085e-7,0.000052503103,0.00022961476,0.042279758,0.00021908229,0.0000574591,0.0002584652],"genre_scores_gemma":[0.000009250078,0.9199754,0.00010507255,0.00048016733,0.00024336137,0.07639917,0.0013549328,0.00023782905,0.0011948228],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925458,0.0012402422,0.0031512745,0.0014941596,0.0008198466,0.000748723],"domain_scores_gemma":[0.99533373,0.00012785685,0.0020036679,0.0020415864,0.00013359773,0.0003595315],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00058379135,0.0019600776,0.012345395,0.00045360083,0.000090381065,0.000075880314,0.0003037539,0.00025277844,0.001251615],"category_scores_gemma":[0.00006648981,0.00095801725,0.0022085812,0.0015661711,0.00006115997,0.00013555586,0.00009395045,0.000707853,0.00016310289],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013427185,0.00088355737,0.0003693908,0.56798923,0.00062370807,0.0006698822,0.00013592922,3.0999896e-8,3.0676325e-8,3.6543008e-7,0.00023988534,0.4289537],"study_design_scores_gemma":[0.0019682802,0.0015821534,0.00012623925,0.4950242,0.004372627,0.00009968015,0.000002233639,6.7211516e-8,0.0000011003234,1.3620311e-7,0.49641386,0.00040941784],"about_ca_topic_score_codex":0.000033342407,"about_ca_topic_score_gemma":0.000023398325,"teacher_disagreement_score":0.49617398,"about_ca_system_score_codex":0.0043846625,"about_ca_system_score_gemma":0.0010572161,"threshold_uncertainty_score":0.9996614},"labels":[],"label_agreement":null},{"id":"W4293704394","doi":"10.1016/j.euros.2022.08.011","title":"Effect of Inferior Vena Cava Tumor Thrombus on Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Cytoreductive Nephrectomy","year":2022,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Inferior vena cava; Hazard ratio; Proportional hazards model; Nephrectomy; Thrombus; Internal medicine; Renal vein; Stage (stratigraphy); Urology; Surgery; Confidence interval; Oncology; Kidney","score_opus":0.01709186004752827,"score_gpt":0.2665270786327606,"score_spread":0.24943521858523232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293704394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764757,0.000040958974,0.0000015728006,0.000058792062,0.000121933204,0.0015718001,0.000027861603,0.00001690839,0.021684436],"genre_scores_gemma":[0.99932635,8.175729e-7,0.000120498575,0.00022517813,0.000014978186,0.000054821692,0.000032159194,0.00004038798,0.00018480919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958248,0.0017571659,0.00036955433,0.0008140893,0.00074095296,0.0004934495],"domain_scores_gemma":[0.9985773,0.00024323576,0.00026627557,0.00061403,0.000115228744,0.00018393953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018712643,0.0002917705,0.0006279959,0.00038537514,0.0002239886,0.000033643762,0.00089313416,0.000011812169,0.00013463038],"category_scores_gemma":[0.00014389996,0.00020781605,0.00006327567,0.0009306927,0.00065373164,0.00018216271,0.0007681613,0.00037679696,0.000038461214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009823616,0.0011216039,0.95809674,0.000041933534,0.000048519887,0.003151641,0.0011026034,0.0011101185,0.02469128,0.00003209535,0.00008273911,0.00069707865],"study_design_scores_gemma":[0.008473163,0.034641005,0.9182235,0.000015515026,0.00014192195,0.00011990841,0.00005434245,0.000094028685,0.037900463,0.0000026674725,0.00015556601,0.00017791637],"about_ca_topic_score_codex":0.0005153022,"about_ca_topic_score_gemma":0.000013547392,"teacher_disagreement_score":0.03987327,"about_ca_system_score_codex":0.00037664085,"about_ca_system_score_gemma":0.0003717319,"threshold_uncertainty_score":0.84744924},"labels":[],"label_agreement":null},{"id":"W4294125334","doi":"10.1007/s00330-022-09082-x","title":"CT-based Bosniak classification of cystic renal lesions: is version 2019 an improvement on version 2005?","year":2022,"lang":"en","type":"article","venue":"European Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Histopathology; Radiology; Conservative management; Neuroradiology; Interventional radiology; Surgery; Pathology","score_opus":0.028625631585660172,"score_gpt":0.2598683050130072,"score_spread":0.231242673427347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294125334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99111146,0.00036374968,0.00008212543,0.0009300989,0.00031033426,0.0004779073,0.000093029834,0.00005167279,0.0065796417],"genre_scores_gemma":[0.9961954,0.000039842176,0.00032005977,0.0010030038,0.000105720595,0.000015135833,0.00078860496,0.00003741657,0.0014948467],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979546,0.0006790546,0.00034053688,0.00044669738,0.00032392543,0.00025517878],"domain_scores_gemma":[0.998869,0.00010202051,0.00020822506,0.00062140025,0.00004935871,0.00015002169],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005501528,0.00017287051,0.00027604762,0.00023160178,0.00017054401,0.0000039142437,0.00017512025,0.000024689843,0.0011901046],"category_scores_gemma":[0.000039017115,0.00015125815,0.0001162084,0.00012885497,0.00008124358,0.0000305916,0.00008426039,0.00024759752,0.000355745],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044698804,0.0014337957,0.005289016,0.00008097749,0.00012351225,0.0009330645,0.000230354,0.0010574852,0.8248329,0.00018899095,0.15135728,0.010002762],"study_design_scores_gemma":[0.015445944,0.039417036,0.6359023,0.00017998955,0.00057007774,0.00053809705,0.0006679022,0.0052654194,0.09316119,0.000028437706,0.20825365,0.0005700002],"about_ca_topic_score_codex":0.000021130796,"about_ca_topic_score_gemma":4.947297e-7,"teacher_disagreement_score":0.7316717,"about_ca_system_score_codex":0.00046155177,"about_ca_system_score_gemma":0.00011637884,"threshold_uncertainty_score":0.99972296},"labels":[],"label_agreement":null},{"id":"W4294358748","doi":"10.1016/j.celrep.2018.03.075","title":"The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma","year":2018,"lang":"en","type":"article","venue":"Cell Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":805,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"National Institute on Deafness and Other Communication Disorders; National Human Genome Research Institute; Invitae; Astex Pharmaceuticals; Frederick National Laboratory for Cancer Research; National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services; Boston Scientific Corporation; Bristol-Myers Squibb; Array BioPharma","keywords":"CDKN2A; Chromophobe cell; Renal cell carcinoma; BAP1; Biology; Cancer research; PTEN; Clear cell renal cell carcinoma; Clear cell; Kidney cancer; Cancer; Pathology; Oncology; Medicine; PI3K/AKT/mTOR pathway; Genetics; Melanoma; Signal transduction","score_opus":0.015604040371371473,"score_gpt":0.2447626946925673,"score_spread":0.22915865432119584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294358748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98708177,0.0014775809,0.00011466191,0.00013924697,0.00031814197,0.00057141104,0.0000058731935,0.000022826724,0.010268517],"genre_scores_gemma":[0.9956357,0.00011417876,0.00010287828,0.00012457136,0.00023462075,0.000041966458,0.000092330185,0.00003606274,0.0036177158],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984371,0.000045432604,0.0004994177,0.0003746527,0.00037121124,0.00027218333],"domain_scores_gemma":[0.99813586,0.000027745764,0.00046689558,0.00074980594,0.00047789508,0.00014177784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010774182,0.000189418,0.0002956691,0.00005984195,0.00011499129,0.000016754286,0.00008020616,0.00007852706,0.0001321232],"category_scores_gemma":[0.000011942976,0.00013002037,0.00013781342,0.00016686956,0.00019049518,0.00003491973,0.000068385045,0.00010590395,0.000024427729],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009444339,0.000083057625,0.01065632,0.00008701582,0.000034010445,0.0013065216,0.00025193862,0.000005197487,0.9869718,0.0000040984564,0.000114908056,0.0003906996],"study_design_scores_gemma":[0.00033884813,0.00035552433,0.17528564,0.000023173945,0.00014941576,0.00021516059,0.000023341478,0.000027898994,0.8093882,0.000014378473,0.014080977,0.00009742063],"about_ca_topic_score_codex":0.00012291368,"about_ca_topic_score_gemma":0.0000051543366,"teacher_disagreement_score":0.17758358,"about_ca_system_score_codex":0.00013382416,"about_ca_system_score_gemma":0.0002185995,"threshold_uncertainty_score":0.5302077},"labels":[],"label_agreement":null},{"id":"W4294628947","doi":"10.3389/fonc.2022.955894","title":"Immunotherapy in advanced kidney cancer: an alternative meta-analytic method using reconstructed survival data in case of proportional hazard assumption violation","year":2022,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Hazard ratio; Medicine; Sunitinib; Proportional hazards model; Oncology; Internal medicine; Survival analysis; Meta-analysis; Kidney cancer; Clinical trial; Renal cell carcinoma; Progression-free survival; Hazard; Overall survival; Confidence interval","score_opus":0.28143201736131007,"score_gpt":0.48799196934139966,"score_spread":0.20655995198008958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294628947","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009346993,0.9821936,0.0027081135,0.00006283749,0.001727844,0.003116406,0.00069022126,0.000014451267,0.0001395218],"genre_scores_gemma":[0.0003055716,0.87590617,0.11976973,0.00003621991,0.000085768064,0.0005220561,0.0032644977,0.0000661041,0.000043903146],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99347174,0.003064563,0.0018152351,0.0009629967,0.000356375,0.00032905856],"domain_scores_gemma":[0.99712485,0.00032525908,0.0014779475,0.0008733728,0.0000848633,0.00011370957],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002524169,0.0004409579,0.004495584,0.0015028538,0.00003555315,0.0000067934106,0.00033679212,0.00035754775,0.00056357787],"category_scores_gemma":[0.00034023135,0.00038010388,0.0003504165,0.0009262933,0.000108569315,0.00023173908,0.00013847295,0.00086684193,4.838364e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005928042,0.00046350184,0.0067631295,0.0015667216,0.0032065774,0.0030581625,0.00020913397,0.0005810616,0.000018026038,0.000012489217,0.00004369008,0.9834847],"study_design_scores_gemma":[0.026895132,0.005199279,0.0044892477,0.0078710085,0.059738174,0.013617006,0.0025907522,0.0871568,0.00007793155,0.0014210588,0.78824943,0.0026941774],"about_ca_topic_score_codex":0.00375732,"about_ca_topic_score_gemma":0.0025705684,"teacher_disagreement_score":0.9807905,"about_ca_system_score_codex":0.00666237,"about_ca_system_score_gemma":0.0034077142,"threshold_uncertainty_score":0.9998651},"labels":[],"label_agreement":null},{"id":"W4294808804","doi":"10.1080/21681805.2022.2119273","title":"<sup>99m</sup> Tc-Sestamibi SPECT/CT and histopathological features of oncocytic renal neoplasia","year":2022,"lang":"en","type":"article","venue":"Scandinavian Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Oncocytoma; Technetium Tc 99m Sestamibi; Chromophobe cell; Nuclear medicine; Renal cell carcinoma; Radiology; Parenchyma; Biopsy; Kidney; Pathology; Clear cell; Scintigraphy; Internal medicine","score_opus":0.014855208504893224,"score_gpt":0.24846243225528042,"score_spread":0.2336072237503872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294808804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98875195,0.0074109323,0.000022470485,0.0013848683,0.00020510874,0.00019739014,0.000015678375,0.00001142886,0.002000197],"genre_scores_gemma":[0.9983405,0.0001744164,0.0003579785,0.0003590082,0.00018270093,0.0000062335685,0.000008334186,0.000023691444,0.0005471403],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9978958,0.0003737336,0.0006263781,0.00027802095,0.00047476785,0.00035130154],"domain_scores_gemma":[0.99867517,0.00017565195,0.00050164026,0.00026428915,0.00009472681,0.00028850566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000539777,0.00022610718,0.000805829,0.00037861976,0.00013316554,0.0000091421625,0.00019105517,0.000035942183,0.0005506448],"category_scores_gemma":[0.00013990427,0.00017215539,0.000250074,0.00021798856,0.0003270189,0.000052480038,0.00013269798,0.0008528675,0.0000038786707],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01862859,0.0021464112,0.65950567,0.00027261692,0.00092262356,0.24696584,0.0029383542,0.0026195806,0.02034531,0.0015953325,0.01620319,0.027856503],"study_design_scores_gemma":[0.007142434,0.027277412,0.45201263,0.00006399637,0.0009301509,0.5007419,0.00070347375,0.000092395516,0.001999363,0.0012970534,0.007495166,0.00024402421],"about_ca_topic_score_codex":0.000024081191,"about_ca_topic_score_gemma":0.0000035004284,"teacher_disagreement_score":0.25377607,"about_ca_system_score_codex":0.00039346638,"about_ca_system_score_gemma":0.0002334107,"threshold_uncertainty_score":0.7020293},"labels":[],"label_agreement":null},{"id":"W4295088437","doi":"10.1097/ju.0000000000002798.02","title":"Editorial Comment","year":2022,"lang":"es","type":"editorial","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Kidney cancer; Nephrectomy; Guideline; Renal mass; General surgery; Library science; Kidney; Internal medicine; Pathology","score_opus":0.01450921192961013,"score_gpt":0.2730566675079285,"score_spread":0.2585474555783184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295088437","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034481725,0.00911866,0.000014198703,0.0146191465,0.9711792,0.00042811094,0.00006508503,0.000010096009,0.0011173163],"genre_scores_gemma":[0.01638412,0.006630538,0.000019788138,0.0009560723,0.9752596,0.000011124433,0.000060623068,0.00008684895,0.00059129467],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926019,0.002291259,0.0015302828,0.00025977448,0.0026776015,0.0006392261],"domain_scores_gemma":[0.99070746,0.0050047818,0.0024123404,0.0008034094,0.0007577443,0.0003142608],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0042513255,0.0005586024,0.0015654191,0.0003554479,0.00033307535,0.000031026342,0.0012230547,0.00079512014,0.0027701422],"category_scores_gemma":[0.0011955781,0.00033449638,0.00066035235,0.00020429512,0.00035114912,0.00006168503,0.00050748663,0.005426138,0.00012958267],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011673215,0.0005208121,0.0001145068,0.00006957804,0.0016469752,0.0006569102,0.0006685754,0.0001366849,0.0003310121,0.00003517914,0.98364896,0.000497582],"study_design_scores_gemma":[0.0055341427,0.018363995,0.00015105543,0.0000441942,0.0055216607,0.0011303939,0.00027742976,0.0000051336997,0.000066218425,0.00018813228,0.96851087,0.00020679813],"about_ca_topic_score_codex":0.00013156822,"about_ca_topic_score_gemma":0.000003916544,"teacher_disagreement_score":0.017843183,"about_ca_system_score_codex":0.0010484635,"about_ca_system_score_gemma":0.0016821517,"threshold_uncertainty_score":0.9999107},"labels":[],"label_agreement":null},{"id":"W4295752719","doi":"10.1016/j.eururo.2022.08.019","title":"Epidemiology of Renal Cell Carcinoma: 2022 Update","year":2022,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":752,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; St. Thomas Hospital","funders":"Cancer Research UK; World Health Organization","keywords":"Medicine; Epidemiology; Incidence (geometry); Kidney cancer; Kidney disease; Disease; Renal cell carcinoma; Internal medicine; Cancer; Observational study; Germline mutation; Intensive care medicine; Oncology; Genetics; Mutation; Biology","score_opus":0.09248464971419333,"score_gpt":0.32054523547865904,"score_spread":0.2280605857644657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295752719","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025773345,0.9407513,0.000018722725,0.000108126085,0.0005155635,0.0008462055,0.0000969154,0.000058207195,0.057347238],"genre_scores_gemma":[0.0013539477,0.99250937,0.00024254691,0.0007111208,0.00042509782,0.00007133538,0.0012762535,0.00022437712,0.0031859365],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99060583,0.0057886243,0.0016501752,0.0010312281,0.00023773064,0.0006863922],"domain_scores_gemma":[0.995883,0.001197674,0.0011922495,0.001408912,0.00004685545,0.0002713136],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0017972087,0.0006719416,0.0039106663,0.0005153764,0.00008412928,0.0000012690314,0.0005584332,0.00023197675,0.004528758],"category_scores_gemma":[0.00036423784,0.0005340071,0.0012257572,0.00037126773,0.0002738702,0.00001788224,0.0007209363,0.001390182,0.0011165538],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045829272,0.0010087846,0.0020846354,0.02296579,0.0011647792,0.017652605,0.00013375471,0.000014755366,0.000014818591,0.0007710459,0.03073956,0.92299116],"study_design_scores_gemma":[0.00075088366,0.0021181155,0.00077517657,0.00012588098,0.003336502,0.0021536937,0.0000043681976,0.0000022446086,0.000004112392,0.000017264789,0.9904212,0.0002905578],"about_ca_topic_score_codex":0.000018560453,"about_ca_topic_score_gemma":9.515603e-7,"teacher_disagreement_score":0.95968163,"about_ca_system_score_codex":0.00021995328,"about_ca_system_score_gemma":0.00038292177,"threshold_uncertainty_score":0.99971116},"labels":[],"label_agreement":null},{"id":"W4295776547","doi":"10.1016/j.yacr.2022.04.004","title":"Advances in Imaging of Cystic Renal Masses: Appraisal of Emerging Evidence from Bosniak Version 2019 to Use of Artificial Intelligence","year":2022,"lang":"en","type":"article","venue":"Advances in Clinical Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Women's College Hospital; Mount Sinai Hospital","funders":"","keywords":"Computer science; Medical physics; Medicine","score_opus":0.08126484060409103,"score_gpt":0.43674843048599093,"score_spread":0.3554835898818999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295776547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748316,0.017024128,0.0066554374,0.0002612065,0.0007413563,0.00037544128,0.000046008478,0.000009218417,0.00005559485],"genre_scores_gemma":[0.9751127,0.0057316655,0.018939357,0.000074073185,0.000069909685,0.000030358795,0.000022268234,0.000013763641,0.0000059411036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963924,0.0006050991,0.0018162263,0.0005506226,0.00034959652,0.00028604834],"domain_scores_gemma":[0.9882977,0.010575969,0.00056403567,0.00038120142,0.00008709521,0.00009398083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011466789,0.0001687805,0.0009762596,0.0003006515,0.000023941077,0.0000018379782,0.00028388406,0.00006737701,0.000121357305],"category_scores_gemma":[0.0057596695,0.0001567192,0.00016253785,0.00053622795,0.00037725366,0.00031114987,0.0002555073,0.00043429137,0.0000043518135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051479074,0.00045954186,0.84766716,0.00010950944,0.000024280736,0.00018978372,0.00037309105,0.034574877,0.012805353,0.00024187131,0.00002987824,0.09837677],"study_design_scores_gemma":[0.0037087342,0.01423855,0.8824532,0.0039367364,0.0004318393,0.00017558146,0.0046055135,0.023732781,0.043286245,0.01048266,0.012053792,0.00089437875],"about_ca_topic_score_codex":0.00029229306,"about_ca_topic_score_gemma":0.00011262578,"teacher_disagreement_score":0.0974824,"about_ca_system_score_codex":0.00013245844,"about_ca_system_score_gemma":0.00014915086,"threshold_uncertainty_score":0.6895278},"labels":[],"label_agreement":null},{"id":"W4295836963","doi":"10.1016/j.annonc.2022.07.1567","title":"1464P The impact of impaired renal function on the effectiveness of first-line immuno-oncology combination therapies in metastatic renal cell carcinoma (mRCC): Results from the international metastatic RCC database consortium (IMDC)","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Cancer Centre; London Health Sciences Centre; BC Cancer Agency; University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Internal medicine","score_opus":0.09173054329450028,"score_gpt":0.3547854431976819,"score_spread":0.26305489990318165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295836963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987558,0.0010497321,0.00005569806,0.007397592,0.00028271505,0.0015141559,0.0009811991,0.000009396354,0.0011514996],"genre_scores_gemma":[0.99815243,0.00016052277,0.00006480251,0.00037226058,0.000043567074,0.00028726694,0.0008547164,0.000024296933,0.00004010647],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99374706,0.0038490207,0.0010961575,0.0003739308,0.0006415826,0.00029224873],"domain_scores_gemma":[0.9855269,0.012053028,0.001171894,0.0007610838,0.0004336876,0.000053374606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052639837,0.00027776917,0.0008553823,0.0002500248,0.00015977984,0.000008066864,0.00051014085,0.0000636992,0.0003249135],"category_scores_gemma":[0.00085435936,0.00014244263,0.00039340468,0.00045879473,0.00046839015,0.00008332219,0.00024038415,0.00048010715,0.000003196762],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30277574,0.025353866,0.07070663,0.00043421885,0.010739555,0.00078917545,0.017372623,0.02371011,0.50799716,0.0034100171,0.016407454,0.02030345],"study_design_scores_gemma":[0.023841938,0.050767172,0.76219827,0.00019032303,0.0010521936,0.00013826703,0.004259385,0.0031002292,0.14861545,0.0035012958,0.0020853134,0.00025017673],"about_ca_topic_score_codex":0.0056353095,"about_ca_topic_score_gemma":0.00041345033,"teacher_disagreement_score":0.6914916,"about_ca_system_score_codex":0.0004768031,"about_ca_system_score_gemma":0.00071762514,"threshold_uncertainty_score":0.851894},"labels":[],"label_agreement":null},{"id":"W4295836973","doi":"10.1016/j.annonc.2022.07.1551","title":"1448O Phase II KEYNOTE-B61 study of pembrolizumab (Pembro) + lenvatinib (Lenva) as first-line treatment for non-clear cell renal cell carcinoma (nccRCC)","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Lenvatinib; Medicine; Pembrolizumab; Renal cell carcinoma; Internal medicine; Oncology; Cancer research; Immunotherapy; Cancer","score_opus":0.10989365781455002,"score_gpt":0.38303768861397725,"score_spread":0.27314403079942723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295836973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805016,0.0008235109,0.000024185647,0.0019557462,0.00026213552,0.0038935605,0.00026011321,0.000039624774,0.01223953],"genre_scores_gemma":[0.9923924,0.00022107679,0.00048843166,0.00050475687,0.00020276877,0.00074196473,0.000255887,0.00010134008,0.0050913277],"study_design_codex":"nonrandomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99606353,0.00031234164,0.0013083332,0.00086510787,0.00069250626,0.0007581688],"domain_scores_gemma":[0.9966824,0.00056603126,0.00092957733,0.0010144319,0.00046128995,0.0003462859],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00054231146,0.0005544498,0.0017204147,0.00045885958,0.0004230264,0.0000067538326,0.0003698044,0.00019573115,0.0008693337],"category_scores_gemma":[0.000071708404,0.00049380964,0.00061693153,0.00039375632,0.00015941898,0.00007229185,0.00036102012,0.00032892538,0.000022444761],"study_design_candidate":"nonrandomized_trial","study_design_consensus":"nonrandomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19066249,0.37936202,0.022285448,0.0021956915,0.0031239467,0.004954754,0.037139833,0.0034731084,0.23265564,0.00015232776,0.04884088,0.075153835],"study_design_scores_gemma":[0.08308608,0.5664391,0.0054102656,0.00002811547,0.0011194241,0.00014157493,0.0029882744,0.00054178515,0.29240578,0.000089810026,0.047347203,0.0004025649],"about_ca_topic_score_codex":0.0011643426,"about_ca_topic_score_gemma":0.00014682194,"teacher_disagreement_score":0.18707708,"about_ca_system_score_codex":0.00052022515,"about_ca_system_score_gemma":0.0009318055,"threshold_uncertainty_score":0.9997513},"labels":[],"label_agreement":null},{"id":"W4295837212","doi":"10.1016/j.annonc.2022.07.1558","title":"1455P Characterization of patients with metastatic renal cell carcinoma achieving complete response to first-line therapies: Results from the international metastatic renal cell carcinoma database consortium (IMDC)","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; BC Cancer Agency; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Carcinoma; Internal medicine; Database","score_opus":0.07915184960623357,"score_gpt":0.308049444028462,"score_spread":0.22889759442222846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295837212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97981054,0.00019134325,0.00028339602,0.009218151,0.00021181972,0.0013892788,0.008534375,0.000018474379,0.0003426392],"genre_scores_gemma":[0.9894669,0.000029341601,0.002149415,0.002198543,0.00007610096,0.00015820182,0.0055949125,0.00005323271,0.00027332045],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99557376,0.001120721,0.0012302607,0.00064422784,0.0010100513,0.00042097346],"domain_scores_gemma":[0.99518234,0.0018868875,0.0011801646,0.0008850514,0.0006511924,0.00021434219],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001355064,0.00036831107,0.0008883452,0.00034064392,0.00021453701,0.00001748163,0.0005386033,0.00004641311,0.0004654405],"category_scores_gemma":[0.00032758873,0.00026549675,0.0001960295,0.00044068712,0.00020934906,0.00013850548,0.00040621267,0.0003663209,0.000012647382],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18238743,0.007169391,0.10240907,0.00027023294,0.0013350936,0.0010517238,0.014344086,0.001239645,0.68047976,0.000042198524,0.0055699362,0.0037014112],"study_design_scores_gemma":[0.018051507,0.022269588,0.81825304,0.000098130644,0.00084557344,0.00004489089,0.0011196737,0.0004511584,0.101535164,0.000022837648,0.03691712,0.00039134457],"about_ca_topic_score_codex":0.00069229555,"about_ca_topic_score_gemma":0.00011572392,"teacher_disagreement_score":0.7158439,"about_ca_system_score_codex":0.00023518123,"about_ca_system_score_gemma":0.0005603126,"threshold_uncertainty_score":0.99997973},"labels":[],"label_agreement":null},{"id":"W4295837241","doi":"10.1016/j.annonc.2022.07.1552","title":"1449MO Updated efficacy of lenvatinib (LEN) + pembrolizumab (PEMBRO) vs sunitinib (SUN) in patients (pts) with advanced renal cell carcinoma (aRCC) in the CLEAR study","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Clinical trial; Clinical endpoint; Internal medicine","score_opus":0.0469790489166364,"score_gpt":0.322511109249764,"score_spread":0.2755320603331276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295837241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889475,0.00014680871,4.8731863e-7,0.00074459193,0.00006886425,0.002251462,0.000042677424,0.000014923207,0.0077826926],"genre_scores_gemma":[0.99862224,0.000017062443,0.000114525596,0.0006289614,0.000026767599,0.00020927125,0.00021217245,0.000043297376,0.00012571603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960256,0.0012171686,0.00097163976,0.0005003982,0.00075782504,0.00052736484],"domain_scores_gemma":[0.9978567,0.00049006374,0.000559492,0.00070144027,0.00029011918,0.00010219678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008544777,0.00030351052,0.0010014339,0.0004969728,0.00008314071,0.0000044507005,0.00041933774,0.00009624934,0.0002850892],"category_scores_gemma":[0.00009900496,0.00022369302,0.00013338226,0.00091735646,0.00017844557,0.000081878505,0.0002102743,0.0006302554,0.000007320153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08960079,0.04018934,0.8261421,0.00018069215,0.0002146705,0.0016270704,0.014965878,0.0012571731,0.0017533808,0.00010705388,0.0016098521,0.022352055],"study_design_scores_gemma":[0.03762586,0.08872915,0.8617583,0.000032386324,0.00010666675,0.000037041627,0.004560773,0.000024198249,0.0040124264,0.000014760141,0.002923338,0.00017509684],"about_ca_topic_score_codex":0.0007467638,"about_ca_topic_score_gemma":0.00035321517,"teacher_disagreement_score":0.051974926,"about_ca_system_score_codex":0.0002194975,"about_ca_system_score_gemma":0.00048439766,"threshold_uncertainty_score":0.91219366},"labels":[],"label_agreement":null},{"id":"W4295837466","doi":"10.1016/j.annonc.2022.08.072","title":"LBA67 Phase III randomized study comparing perioperative nivolumab (nivo) versus observation in patients (Pts) with renal cell carcinoma (RCC) undergoing nephrectomy (PROSPER, ECOG-ACRIN EA8143), a National Clinical Trials Network trial","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Nivolumab; Renal cell carcinoma; Perioperative; Randomized controlled trial; Oncology; Internal medicine; Nephrectomy; Clinical trial; Kidney cancer; Cancer; Surgery; Kidney; Immunotherapy","score_opus":0.30145614907350077,"score_gpt":0.4595597350834706,"score_spread":0.15810358600996982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295837466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98728096,0.00023128251,0.00003458071,0.00035026527,0.00092035846,0.0078529585,0.000018958264,0.000030733834,0.0032799267],"genre_scores_gemma":[0.9966794,0.000039768725,0.00072643434,0.00034370925,0.0005222672,0.0011858216,0.00026790015,0.000043649266,0.00019099776],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9885847,0.0062509854,0.002834849,0.00075254485,0.0010371249,0.00053980295],"domain_scores_gemma":[0.992384,0.0048981896,0.0015071519,0.00035125387,0.0006546039,0.00020477381],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010140796,0.00039821674,0.0034615167,0.00030942672,0.00027620356,0.000026363412,0.00022405977,0.00015889536,0.00030471635],"category_scores_gemma":[0.0016786628,0.00032825876,0.0005320311,0.00058478065,0.00018128818,0.00016383707,0.00021699819,0.00070186384,0.000006821764],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8837286,0.014704409,0.0931555,0.000026564405,0.0007562206,0.00016326229,0.0015269646,0.0022459552,0.00005581464,0.00007597197,0.0009078085,0.0026529254],"study_design_scores_gemma":[0.87534153,0.08598019,0.033790324,0.000035601566,0.0005590884,0.000007699667,0.0010197107,0.0019307615,0.00015450663,0.000029123348,0.0008971677,0.00025427487],"about_ca_topic_score_codex":0.00051400694,"about_ca_topic_score_gemma":0.0007212097,"teacher_disagreement_score":0.071275786,"about_ca_system_score_codex":0.0007902656,"about_ca_system_score_gemma":0.0019497364,"threshold_uncertainty_score":0.999917},"labels":[],"label_agreement":null},{"id":"W4296637131","doi":"10.3390/curroncol29100533","title":"Rare and Insidious Toxicities from New Combination Therapies in Metastatic Renal Cell Cancer: Lessons Learned from Real-Practice","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Adverse effect; Intensive care medicine; Nivolumab; Ipilimumab; Cancer; Pembrolizumab; Bioinformatics; Immunotherapy; Internal medicine","score_opus":0.19539394528557064,"score_gpt":0.41562439640477694,"score_spread":0.2202304511192063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296637131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9412706,0.04342258,0.000025428895,0.012895319,0.0005950104,0.00043862496,0.00013723361,0.0000376338,0.0011775598],"genre_scores_gemma":[0.9863343,0.011621911,0.0005916706,0.00031203896,0.00012865057,0.00019772368,0.00044419084,0.000024743358,0.00034477276],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981482,0.00060856267,0.00031681015,0.000401664,0.00029505312,0.00022969524],"domain_scores_gemma":[0.9985679,0.0008035841,0.00021776327,0.00022546276,0.000058697573,0.0001266294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019463373,0.00018745738,0.0004955691,0.00016150289,0.00011596786,0.000018211264,0.00009392522,0.000051661766,0.0005494479],"category_scores_gemma":[0.000082989514,0.00017472838,0.00005737333,0.00017825393,0.000076266726,0.00010345448,0.00013756785,0.0004774561,0.000008364524],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051505473,0.005587443,0.08581414,0.00016827328,0.0007458366,0.0017950145,0.06142998,0.0002778616,0.0328324,0.0009317023,0.014045089,0.79122174],"study_design_scores_gemma":[0.04471481,0.0098549705,0.3926974,0.00033254686,0.0029504166,0.00019444266,0.044488776,0.0013052552,0.017875666,0.026254738,0.4582439,0.0010870729],"about_ca_topic_score_codex":0.013172317,"about_ca_topic_score_gemma":0.0013938968,"teacher_disagreement_score":0.79013467,"about_ca_system_score_codex":0.0009773088,"about_ca_system_score_gemma":0.00058762485,"threshold_uncertainty_score":0.993399},"labels":[],"label_agreement":null},{"id":"W4296797608","doi":"10.1093/oncolo/oyac192","title":"Randomized Phase II Trial of Sapanisertib ± TAK-117 vs. Everolimus in Patients With Advanced Renal Cell Carcinoma After VEGF-Targeted Therapy","year":2022,"lang":"en","type":"article","venue":"The Oncologist","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Everolimus; Medicine; Clinical endpoint; Renal cell carcinoma; Internal medicine; Adverse effect; Oncology; Randomized controlled trial; Urology; Tolerability; Phases of clinical research; Clinical trial","score_opus":0.01675006100570516,"score_gpt":0.2691139331315795,"score_spread":0.25236387212587436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296797608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921189,0.00081100815,0.000005433426,0.00042715904,0.0002146149,0.005029898,0.000050323255,0.000032315515,0.001310329],"genre_scores_gemma":[0.99711317,0.000033498603,0.00023475714,0.0003989493,0.000068058216,0.001495198,0.00013192139,0.000041413343,0.0004830333],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971914,0.00076240476,0.0006355575,0.00037966325,0.0006522958,0.00037866205],"domain_scores_gemma":[0.9984628,0.00029952574,0.00041285134,0.00061704573,0.00010598707,0.00010182244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075109716,0.00030011308,0.0010923995,0.00013711586,0.00017653304,0.0000073569768,0.0002470601,0.00006765081,0.0004611695],"category_scores_gemma":[0.000070730726,0.00016849398,0.00025886836,0.00033307527,0.00032080308,0.00005114814,0.00014653623,0.0003570974,0.000004493251],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98151004,0.0069039697,0.0058334786,0.000018905886,0.00011123984,0.00014435292,0.0011093543,0.00010179152,0.001329385,0.0000052482437,0.00014590548,0.0027863188],"study_design_scores_gemma":[0.9072779,0.049605522,0.034455575,0.000016405804,0.00024403703,0.000005549474,0.0001608992,0.000042502666,0.00740499,0.00003212995,0.0005796802,0.00017481286],"about_ca_topic_score_codex":0.00023494476,"about_ca_topic_score_gemma":0.000028312239,"teacher_disagreement_score":0.07423215,"about_ca_system_score_codex":0.00051021785,"about_ca_system_score_gemma":0.000295965,"threshold_uncertainty_score":0.6870985},"labels":[],"label_agreement":null},{"id":"W4297785758","doi":"10.23736/s2724-6051.22.04881-9","title":"Management of renal cell carcinoma in transplant kidney: a systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Minerva Urology and Nephrology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Meta-analysis; Renal cell carcinoma; Medicine; Urology; Systematic review; Oncology; Internal medicine; MEDLINE; Biology","score_opus":0.0615519053923469,"score_gpt":0.29385073724923017,"score_spread":0.23229883185688327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297785758","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002735991,0.9950962,0.0000047488893,0.0005972631,0.000016268314,0.0031779506,0.00012989389,0.000011378321,0.0006926797],"genre_scores_gemma":[0.0018278304,0.9930099,0.00007854799,0.0023286757,0.0000073119477,0.0016211531,0.00035503026,0.000035818968,0.0007357115],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99575466,0.00130999,0.0015014933,0.0008367023,0.00020083087,0.00039630695],"domain_scores_gemma":[0.9980184,0.00036905505,0.0006420826,0.00074462616,0.000023105618,0.00020274436],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008195288,0.00062129815,0.011354758,0.0007764367,0.000043529995,0.000003359018,0.00019413768,0.00036213186,0.00094241323],"category_scores_gemma":[0.000015348267,0.00041031864,0.001583303,0.0007254936,0.00019427751,0.00002011955,0.00016176431,0.00051252666,0.0000055565292],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007453753,0.00018909742,0.000032307908,0.8842978,0.11135455,0.0032455043,0.000053447,7.4810015e-7,8.138916e-7,0.00006766748,0.00010991648,0.00057361455],"study_design_scores_gemma":[0.00060259545,0.00081355276,0.000065974025,0.0021573557,0.92135215,0.0018956068,0.0000065947283,0.000006403906,5.156798e-7,0.0000074396976,0.07287281,0.00021898522],"about_ca_topic_score_codex":0.000060069942,"about_ca_topic_score_gemma":0.000023975766,"teacher_disagreement_score":0.88214046,"about_ca_system_score_codex":0.000054696033,"about_ca_system_score_gemma":0.000092186536,"threshold_uncertainty_score":0.99997085},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"meta_analysis","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"meta_analysis","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4297981989","doi":"10.1016/j.annonc.2022.08.069","title":"LBA4 Adjuvant nivolumab plus ipilimumab (NIVO+IPI) vs placebo (PBO) for localized renal cell carcinoma (RCC) at high risk of relapse after nephrectomy: Results from the randomized, phase III CheckMate 914 trial","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Bayer Fund; Ipsen Biopharmaceuticals; Janssen Pharmaceuticals; Sanofi Australia; AstraZeneca; Meso Scale Diagnostics; Merck; Astellas Pharma US; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Nivolumab; Ipilimumab; Renal cell carcinoma; Internal medicine; Oncology; Adjuvant; Nephrectomy; Placebo; Urology; Immunotherapy; Cancer; Kidney; Pathology","score_opus":0.0409074776014903,"score_gpt":0.31626374826913173,"score_spread":0.27535627066764146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297981989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97996694,0.003734162,0.000103613405,0.0033964927,0.0010102411,0.007146111,0.0028941932,0.000052754658,0.0016954908],"genre_scores_gemma":[0.9905425,0.0005717501,0.0009705414,0.0009220645,0.00055074826,0.0022569152,0.0009048276,0.00009338635,0.003187299],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9926526,0.0024348963,0.0023206403,0.00095477933,0.00084363,0.00079344923],"domain_scores_gemma":[0.9904005,0.0054901876,0.0020578317,0.0013078636,0.00044118636,0.00030244325],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0036552835,0.0005819566,0.0033458127,0.0002516575,0.00031901227,0.000012057919,0.00049502635,0.00033777193,0.0010663674],"category_scores_gemma":[0.0009591383,0.00041095522,0.0013902957,0.00032931563,0.0006361967,0.00007822811,0.0005020101,0.0006557404,0.000021676837],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96163714,0.0021784366,0.00011775733,0.00008225238,0.0010956138,0.00045239236,0.003073499,0.00023763387,0.0017015883,0.000026873126,0.025954489,0.0034423275],"study_design_scores_gemma":[0.8934855,0.02643699,0.00033611,0.000055468492,0.0027203774,0.00006218088,0.00039348588,0.0015368453,0.033223044,0.00041337725,0.04100768,0.00032892838],"about_ca_topic_score_codex":0.005831558,"about_ca_topic_score_gemma":0.0004235874,"teacher_disagreement_score":0.06815162,"about_ca_system_score_codex":0.00075674045,"about_ca_system_score_gemma":0.0012421958,"threshold_uncertainty_score":0.9998468},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4297984440","doi":"10.1016/j.pathol.2022.09.002","title":"LOT and HOT … or not. The proliferation of clinically insignificant and poorly characterised types of renal neoplasia","year":2022,"lang":"en","type":"article","venue":"Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York Central Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Chromophobe cell; Oncocytoma; Renal oncocytoma; Pathology; Immunohistochemistry; Eosinophilic; Biology; Renal cell carcinoma; Clear cell; Angiomyolipoma; Tuberous sclerosis; Cancer research; Kidney; Medicine; Genetics","score_opus":0.036241429240752125,"score_gpt":0.2843983197983013,"score_spread":0.2481568905575492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297984440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99837494,0.00016571887,0.000022439655,0.00085797964,0.00004968997,0.00036863258,0.000021991324,0.000006397001,0.0001322234],"genre_scores_gemma":[0.99902385,0.000072158444,0.0003119115,0.00035282417,0.000031743148,0.00004611044,0.000018476767,0.000007819311,0.00013508096],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991406,0.00017760036,0.00032266462,0.00015872293,0.00011672122,0.00008368639],"domain_scores_gemma":[0.99942213,0.00015963068,0.00017294273,0.00016116147,0.000048692746,0.00003546296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035398878,0.00007002939,0.00026287005,0.000047666545,0.00004515892,0.0000026272828,0.00003755217,0.000035423094,0.00006805326],"category_scores_gemma":[0.00012102427,0.00004123633,0.000027043468,0.000062641746,0.00014923794,0.0000137872275,0.000064734886,0.000118956115,9.2633223e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012256104,0.0003880854,0.15855454,0.00013996608,0.00010886212,0.00053844054,0.0050232965,0.0000055777364,0.8127479,0.00026489506,0.00009628172,0.0098760445],"study_design_scores_gemma":[0.001960773,0.006136016,0.9617454,0.000014288053,0.00017564437,0.0014131708,0.0003868857,0.00013566145,0.027654804,0.00004206161,0.00027447537,0.00006082274],"about_ca_topic_score_codex":0.000012027294,"about_ca_topic_score_gemma":0.000005420064,"teacher_disagreement_score":0.8031909,"about_ca_system_score_codex":0.000012744299,"about_ca_system_score_gemma":0.00008373212,"threshold_uncertainty_score":0.16815688},"labels":[],"label_agreement":null},{"id":"W4298519942","doi":"","title":"O Hes, E Comperat, N Rioux-Leclercq, N Kuroda. The 2012 ISUP Vancouver and 2016 WHO classification of adult tumors: changes for common renal tumors.Diagnostic Histopathology, 2016","year":2016,"lang":"en","type":"preprint","venue":"HAL (Le Centre pour la Communication Scientifique Directe)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Histopathology; Medicine; Pathology","score_opus":0.019708369028601538,"score_gpt":0.24464829753327785,"score_spread":0.2249399285046763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4298519942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79963285,0.022493057,0.027772836,0.11280206,0.0012359862,0.008170091,0.0013868394,0.00040813407,0.02609814],"genre_scores_gemma":[0.96646315,0.0032388335,0.005675436,0.00037569093,0.00014857968,0.00077203015,0.00080564857,0.00011504344,0.022405578],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99428064,0.0028218073,0.00087689573,0.0009977173,0.0004898235,0.00053314277],"domain_scores_gemma":[0.9895925,0.0037990147,0.0010700562,0.002608945,0.002645812,0.00028365105],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029701125,0.0005503571,0.0009747859,0.00026456942,0.00036089605,0.00009439236,0.00076350814,0.00036534292,0.00008922487],"category_scores_gemma":[0.0019990886,0.00038235137,0.00027880495,0.00018742785,0.000876327,0.000120388526,0.00074900803,0.00057571585,0.000022948832],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016735909,0.0056311297,0.06128209,0.005273558,0.0010872495,0.00015527765,0.027902067,0.000019216322,0.16518249,0.07312986,0.5019066,0.1567569],"study_design_scores_gemma":[0.012272888,0.00008490039,0.50270754,0.050334655,0.0021768115,0.00042416315,0.0009069863,0.005406719,0.2631187,0.013274037,0.14672625,0.0025663234],"about_ca_topic_score_codex":0.0008906062,"about_ca_topic_score_gemma":0.0051661707,"teacher_disagreement_score":0.44142544,"about_ca_system_score_codex":0.00037646038,"about_ca_system_score_gemma":0.0005488385,"threshold_uncertainty_score":0.99986285},"labels":[],"label_agreement":null},{"id":"W4300202407","doi":"","title":"Management of kidney cancer: Canadian Kidney Cancer Forum Consensus Statement.","year":2008,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Kidney cancer; Cancer; Statement (logic); Medicine; Kidney; Political science; Internal medicine; Law","score_opus":0.03736352390634067,"score_gpt":0.2584299255119089,"score_spread":0.22106640160556823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300202407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86846656,0.00341319,0.000004823778,0.048449606,0.000997296,0.0042494982,0.00090058,0.00008363635,0.07343484],"genre_scores_gemma":[0.97327596,0.0019826621,0.00023890202,0.0043426165,0.00008250711,0.003442342,0.00008467961,0.000040383606,0.016509965],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99798983,0.00003088916,0.00040698535,0.00034324703,0.00040682714,0.00082218874],"domain_scores_gemma":[0.9969826,0.000014385547,0.00013673464,0.00040391067,0.00012566577,0.0023367254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012963414,0.00022348789,0.0003784594,0.00020698192,0.00010309929,0.0000067421784,0.00011360193,0.00006472892,0.0004149024],"category_scores_gemma":[0.000045218392,0.00019589282,0.00011490675,0.00026004875,0.00012583986,0.000032193708,0.00004242382,0.000109021064,0.000017916074],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032392528,0.00019882392,0.37680826,0.0006345642,0.0015093868,0.0027134325,0.0002637365,0.000024823436,0.00009071276,0.00020567398,0.558106,0.059120663],"study_design_scores_gemma":[0.0038562508,0.000076726086,0.61723375,0.00016770058,0.00048062584,0.00007545669,0.0001865678,0.000022769187,0.008616724,0.000025905187,0.36900452,0.00025304544],"about_ca_topic_score_codex":0.2355458,"about_ca_topic_score_gemma":0.022354646,"teacher_disagreement_score":0.24042545,"about_ca_system_score_codex":0.0013641005,"about_ca_system_score_gemma":0.001319707,"threshold_uncertainty_score":0.9954848},"labels":[],"label_agreement":null},{"id":"W4300548903","doi":"10.1016/j.clon.2022.06.007","title":"Stereotactic Body Radiotherapy for Renal Cell Carcinoma: Oncological and Renal Function Outcomes","year":2022,"lang":"en","type":"article","venue":"Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Lakeridge Health; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Regional Municipality of Durham; University Health Network; University of Toronto; Health Sciences Centre","funders":"","keywords":"Medicine; Interquartile range; Renal function; Urology; Renal cell carcinoma; Cumulative incidence; Univariate analysis; Incidence (geometry); Metastasis; Hazard ratio; Radiology; Internal medicine; Nuclear medicine; Multivariate analysis; Confidence interval; Cancer; Cohort","score_opus":0.10192475055521988,"score_gpt":0.39993156084438847,"score_spread":0.2980068102891686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300548903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98777086,0.0010286577,0.00031986742,0.0052691386,0.0011499741,0.001378376,0.00001984584,0.00006622507,0.0029970307],"genre_scores_gemma":[0.9868613,0.000072181254,0.0025716193,0.005031539,0.0006483647,0.000497653,0.00007206136,0.000038256963,0.0042070486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970339,0.0006358576,0.00093152653,0.00068848947,0.0002864762,0.0004237673],"domain_scores_gemma":[0.99601704,0.0028118154,0.00034438958,0.00037283418,0.00008674845,0.00036717506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012957288,0.00025398418,0.0011243118,0.000110337285,0.00025980404,0.000012424953,0.00012781672,0.00028668245,0.00071028125],"category_scores_gemma":[0.00027412057,0.00019168212,0.00044469975,0.00012218744,0.00024892046,0.000045024597,0.00015544891,0.00074198184,0.000015127357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023870718,0.007475579,0.87673354,0.00010312288,0.000793337,0.0014978332,0.00019820087,0.000017254386,0.007764593,0.0005040792,0.025899343,0.05514242],"study_design_scores_gemma":[0.015609463,0.055957634,0.70635444,0.0000031900468,0.00068116904,0.00031699947,0.00009397355,0.00025014332,0.00016703457,0.00024082136,0.22013944,0.0001857101],"about_ca_topic_score_codex":0.000022076936,"about_ca_topic_score_gemma":0.000008295466,"teacher_disagreement_score":0.19424011,"about_ca_system_score_codex":0.00078725396,"about_ca_system_score_gemma":0.00051787583,"threshold_uncertainty_score":0.781657},"labels":[],"label_agreement":null},{"id":"W4300690741","doi":"10.1158/1078-0432.ccr-22-1389","title":"Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Cancer Institute","keywords":"Renal cell carcinoma; Blockade; Medicine; Immune checkpoint; Oncology; Internal medicine; Receptor","score_opus":0.0864684432790599,"score_gpt":0.40851093129502614,"score_spread":0.32204248801596624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300690741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945778,0.0005743329,0.000004939275,0.0007330622,0.00006337945,0.0026882982,0.0005333076,0.000059159804,0.0007657189],"genre_scores_gemma":[0.99573505,0.00010903352,0.000477906,0.00007025319,0.00014181735,0.00047459122,0.0010875001,0.000092794646,0.0018110288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99289894,0.0019458452,0.0013183266,0.0010575961,0.001989914,0.0007893826],"domain_scores_gemma":[0.99545395,0.0020421809,0.0004910456,0.0007490785,0.0005833071,0.0006804604],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022623122,0.00041046596,0.0013266912,0.00027026562,0.0007201892,0.00008072188,0.00025175166,0.00015733449,0.0002545979],"category_scores_gemma":[0.0001286592,0.0002744702,0.00036918622,0.00063841895,0.00068876764,0.00010523031,0.0003663416,0.0020602546,0.000015141797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003970794,0.003559756,0.98995364,0.00006254077,0.00092405715,0.00024795596,0.00014613668,0.000021195734,0.00011255245,0.0000016763901,0.0003820486,0.0006176385],"study_design_scores_gemma":[0.016037187,0.018993832,0.9597476,0.00005819878,0.0015340502,0.000006429148,0.0001513641,0.000035560814,0.0030675451,0.000009726651,0.00008684695,0.0002716223],"about_ca_topic_score_codex":0.0038221518,"about_ca_topic_score_gemma":0.00018685657,"teacher_disagreement_score":0.03020601,"about_ca_system_score_codex":0.0012028294,"about_ca_system_score_gemma":0.000584859,"threshold_uncertainty_score":0.99997073},"labels":[],"label_agreement":null},{"id":"W4303644501","doi":"10.1111/his.14816","title":"Low‐grade oncocytic tumour of the kidney is characterised by genetic alterations of <i>TSC1</i>, <i>TSC2</i>, <i>MTOR</i> or <i>PIK3CA</i> and consistent <scp>GATA3</scp> positivity","year":2022,"lang":"en","type":"article","venue":"Histopathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"TSC1; Chromophobe cell; Tuberous sclerosis; Oncocytoma; Immunohistochemistry; PTEN; Pathology; Biology; Renal cell carcinoma; TFE3; Cancer research; Eosinophilic; PI3K/AKT/mTOR pathway; TSC2; PAX8; Kidney cancer; Clear cell; Cancer; GATA3; Medicine; Gene; Gene expression; Genetics","score_opus":0.014011946902518006,"score_gpt":0.22825071061055427,"score_spread":0.21423876370803627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303644501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99279267,0.0018224091,0.0000495769,0.0017610982,0.0004562585,0.0009591019,0.00095732795,0.00003365523,0.0011679097],"genre_scores_gemma":[0.99077225,0.00015323366,0.00034699554,0.005570388,0.000056829118,0.00018529981,0.00012675938,0.000048792892,0.0027394565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973273,0.0005138094,0.000723139,0.00056302914,0.00047968276,0.00039301734],"domain_scores_gemma":[0.99802536,0.00026243125,0.0005270656,0.0007904915,0.00012612097,0.0002685116],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000287492,0.00032437668,0.0008153841,0.00013247873,0.0002878992,0.000009632006,0.00024338531,0.000103206345,0.00010931784],"category_scores_gemma":[0.00018948043,0.0002482549,0.00024954727,0.0003162919,0.00055451045,0.000049579878,0.00030720083,0.00038045223,0.000006644574],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001594499,0.0009256076,0.020106431,0.00027365063,0.000035939604,0.00032359667,0.0018056107,0.000005076501,0.9501086,0.00003900403,0.026056532,0.00016050923],"study_design_scores_gemma":[0.006419739,0.0038212538,0.26854542,0.00016082313,0.0012092226,0.0058272015,0.00043886848,0.00010740542,0.6561935,0.00006968873,0.056953236,0.00025363537],"about_ca_topic_score_codex":0.00010400339,"about_ca_topic_score_gemma":0.000011563732,"teacher_disagreement_score":0.2939151,"about_ca_system_score_codex":0.00033087347,"about_ca_system_score_gemma":0.0005816852,"threshold_uncertainty_score":0.99999696},"labels":[],"label_agreement":null},{"id":"W4303981463","doi":"10.3389/fonc.2022.1019057","title":"An external validation of the nocera nomogram: Predicting non-organ confined stage of ≥pT3 in cT1 clear cell renal cell carcinoma","year":2022,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nomogram; Medicine; Renal cell carcinoma; Clear cell renal cell carcinoma; Stage (stratigraphy); Renal sinus; Receiver operating characteristic; Urology; Cohort; Renal mass; Oncology; Radiology; Internal medicine; Nephrectomy; Kidney; Biology","score_opus":0.012924506742418348,"score_gpt":0.25922003978874797,"score_spread":0.24629553304632962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303981463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925517,0.00024146527,0.00033365385,0.00014451845,0.0006148322,0.00082622695,0.000043300613,0.000011056119,0.0052332394],"genre_scores_gemma":[0.9946598,0.000011179157,0.00419455,0.00008692609,0.000057381076,0.00006239127,0.00004273463,0.00003130323,0.00085377955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779886,0.00046800365,0.0006769484,0.0003520528,0.00038554805,0.00031856436],"domain_scores_gemma":[0.99883795,0.000077363584,0.0004586916,0.00046796334,0.000068502166,0.00008955514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062477944,0.00017643321,0.000579778,0.0003399704,0.000066386136,0.0000044168814,0.00030389396,0.00012786331,0.0002545791],"category_scores_gemma":[0.00002900384,0.00015386476,0.00011871862,0.00043148818,0.00014893862,0.00005448115,0.00015600133,0.00051780016,0.0000010737758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013698089,0.0011010701,0.87285864,0.00013578645,0.000017762943,0.00018435405,0.0029311427,0.001540117,0.118281975,0.0000059789995,0.00039747547,0.0011758906],"study_design_scores_gemma":[0.008754197,0.0070420117,0.5544301,0.000041160405,0.0001263421,0.000044090863,0.0060840747,0.0053404435,0.416498,0.000041746425,0.0014262332,0.00017155163],"about_ca_topic_score_codex":0.0009211754,"about_ca_topic_score_gemma":0.000067500565,"teacher_disagreement_score":0.3184285,"about_ca_system_score_codex":0.0008881889,"about_ca_system_score_gemma":0.00049141096,"threshold_uncertainty_score":0.6274423},"labels":[],"label_agreement":null},{"id":"W4304688613","doi":"10.1007/s00345-022-04183-0","title":"Contemporary vs historical survival rates in metastatic clear cell renal carcinoma according to race/ethnicity","year":2022,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Ethnic group; Poisson regression; Internal medicine; Renal cell carcinoma; Demography; Race (biology); Hazard ratio; Proportional hazards model; Incidence (geometry); Epidemiology; Oncology; Confidence interval; Population","score_opus":0.052478088575938546,"score_gpt":0.29000040473790684,"score_spread":0.23752231616196828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304688613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799071,0.005936861,0.00011170286,0.009778255,0.00086324033,0.00031414983,0.0000043163923,0.00001188817,0.0030724863],"genre_scores_gemma":[0.9957004,0.000025398074,0.0007580607,0.0014440547,0.0002085335,0.000016398715,0.0000048577353,0.000036257374,0.0018060011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970059,0.0008569169,0.00092093926,0.00028445627,0.0005419604,0.0003898661],"domain_scores_gemma":[0.9983746,0.00046983242,0.00045000025,0.00025261907,0.00012427647,0.000328678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013861059,0.00021909477,0.00097357284,0.0009849638,0.00010191803,0.000009751562,0.0002482878,0.00003678162,0.00038434722],"category_scores_gemma":[0.00013752191,0.00019110927,0.000258346,0.00067477406,0.00004320338,0.00007962734,0.00019785862,0.0010658951,0.000017022398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03289531,0.0019492595,0.8460317,0.00009626724,0.00032054094,0.03078467,0.001533369,0.0025399863,0.03572477,0.00010428708,0.045982905,0.002036928],"study_design_scores_gemma":[0.02349638,0.03395082,0.60638744,0.000058565405,0.00097390544,0.0073276507,0.0021419143,0.00066829583,0.0056229536,0.00043829659,0.3181149,0.0008188819],"about_ca_topic_score_codex":0.00027490777,"about_ca_topic_score_gemma":0.00006124482,"teacher_disagreement_score":0.272132,"about_ca_system_score_codex":0.0014222944,"about_ca_system_score_gemma":0.00044273603,"threshold_uncertainty_score":0.77932096},"labels":[],"label_agreement":null},{"id":"W4304893252","doi":"10.1016/j.path.2022.07.006","title":"Kidney Tumors","year":2022,"lang":"en","type":"review","venue":"Surgical pathology clinics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Rockyview General Hospital","funders":"","keywords":"Medicine; Renal cell carcinoma; Pathology; Immunohistochemistry; Eosinophilic; Anaplastic lymphoma kinase; TFE3; Kidney; Stroma; Internal medicine; Biology","score_opus":0.11728740694311988,"score_gpt":0.39894080137073784,"score_spread":0.28165339442761794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304893252","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008447625,0.96756446,8.3659955e-7,0.00013045846,0.0010415334,0.0010722235,0.00013870055,0.00013888115,0.0298284],"genre_scores_gemma":[0.0000051523807,0.9902981,0.00023593007,0.0005086661,0.0004954461,0.00033724838,0.0016835103,0.0001288696,0.0063071135],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955516,0.0010143465,0.0014476363,0.0009911843,0.0004340123,0.00056125975],"domain_scores_gemma":[0.996152,0.0015181734,0.0005270082,0.0011010813,0.00004005895,0.0006617086],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010603549,0.000625495,0.0041456413,0.00029920912,0.000113173024,0.0000099656545,0.00029494977,0.0008764038,0.0049601793],"category_scores_gemma":[0.0007910931,0.00045344577,0.002097626,0.0004711338,0.00024884552,0.000017412718,0.000370444,0.0023046471,0.0011906173],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073616604,0.00045517925,0.00007918654,0.0067608394,0.000248188,0.093318656,0.0000139979165,1.1109077e-7,1.4457487e-8,0.00031062338,0.0024671427,0.8962724],"study_design_scores_gemma":[0.0010349306,0.0008993687,0.0000124126655,0.0016782498,0.0023895784,0.018292768,0.0000046265095,7.2758445e-7,9.606678e-8,0.000042103406,0.9753106,0.00033450578],"about_ca_topic_score_codex":0.000002378548,"about_ca_topic_score_gemma":1.8770619e-7,"teacher_disagreement_score":0.97284347,"about_ca_system_score_codex":0.0002916068,"about_ca_system_score_gemma":0.0013014543,"threshold_uncertainty_score":0.9999971},"labels":[],"label_agreement":null},{"id":"W4306403523","doi":"10.3390/curroncol29100619","title":"Outcomes of High-Dose Stereotactic Ablative Radiotherapy to All/Multiple Sites for Oligometastatic Renal Cell Cancer Patients","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"China International Medical Foundation; Beijing Xisike Clinical Oncology Research Foundation","keywords":"SABR volatility model; Medicine; Radiation therapy; Renal cell carcinoma; Ablative case; Internal medicine; Univariate analysis; Oncology; Radiosurgery; Urology; Multivariate analysis","score_opus":0.10228559415153228,"score_gpt":0.3979293222638052,"score_spread":0.2956437281122729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306403523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939285,0.0014903202,0.00017467434,0.00076655584,0.00096065225,0.0021873568,0.00039337602,0.00002247154,0.00007607477],"genre_scores_gemma":[0.9950959,0.00008276896,0.002165207,0.00049670483,0.00006361883,0.0013641849,0.00027542145,0.000038827373,0.00041736758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982961,0.00017865337,0.00045730793,0.00037742069,0.0003365955,0.00035392086],"domain_scores_gemma":[0.99843365,0.00063076953,0.00030042115,0.0002613086,0.00018719104,0.00018665062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016069987,0.00022876853,0.0007516282,0.00024644783,0.00008402876,0.000004690345,0.00013798506,0.0000379116,0.0004999495],"category_scores_gemma":[0.00009241194,0.00018755313,0.00018368226,0.0002126472,0.000047723053,0.000040083833,0.00009635172,0.00018324809,0.0000075573075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004561212,0.007643661,0.92198,0.00040368448,0.001235528,0.00003081837,0.005536259,0.00058461167,0.013771315,0.000046682184,0.009991103,0.034215115],"study_design_scores_gemma":[0.027636446,0.021579172,0.8230787,0.000043432963,0.0011033419,0.000012024445,0.00039410053,0.00061656284,0.013159234,0.00011930234,0.11183468,0.00042298887],"about_ca_topic_score_codex":0.000116734926,"about_ca_topic_score_gemma":0.000046083467,"teacher_disagreement_score":0.10184358,"about_ca_system_score_codex":0.0012669468,"about_ca_system_score_gemma":0.0002307673,"threshold_uncertainty_score":0.76481944},"labels":[],"label_agreement":null},{"id":"W4306955734","doi":"10.1016/j.eururo.2022.10.004","title":"Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Dalhousie University; University of Calgary; William Osler Health System","funders":"Office of Research, Innovation and Commercialization, University of Agriculture Faisalabad; Genentech; Astellas Pharma; Calithera Biosciences; Bayer Fund; Ipsen Biopharmaceuticals; Exelixis; Gilead Sciences; Eisai; Merck; Bristol-Myers Squibb; AstraZeneca; Novartis; Pfizer","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Oncology; Internal medicine; Nivolumab; Observational study; Urology; Immunotherapy; Kidney; Cancer","score_opus":0.08657612802764626,"score_gpt":0.2861605605452182,"score_spread":0.19958443251757196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306955734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913342,0.0011202411,0.00026115324,0.0010692771,0.0003976977,0.0036884735,0.0014299612,0.00010095374,0.0005980622],"genre_scores_gemma":[0.9864498,0.0000073707847,0.003649261,0.0010712112,0.00041948256,0.0007751253,0.0063355686,0.00018879738,0.0011033971],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9937632,0.0023595775,0.0010990386,0.0012373792,0.0008981428,0.0006426256],"domain_scores_gemma":[0.9967865,0.00074906286,0.0006976743,0.001104299,0.0003806087,0.00028189144],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012387608,0.0006714709,0.00082593,0.00026507425,0.00053166866,0.00006933277,0.00072780566,0.00003266409,0.001601496],"category_scores_gemma":[0.000119220975,0.00042870085,0.00027178883,0.00042925595,0.00027995382,0.00021848782,0.0003766104,0.0006821338,0.00003756747],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0893683,0.01683089,0.35112673,0.00007976545,0.004431531,0.013422206,0.01756343,0.002652213,0.49466702,0.00005380254,0.008592193,0.0012119323],"study_design_scores_gemma":[0.036759954,0.033027805,0.8180726,0.000011728964,0.00282531,0.000663074,0.008504356,0.0021403087,0.0853153,0.000030685245,0.011799935,0.00084890786],"about_ca_topic_score_codex":0.0014308863,"about_ca_topic_score_gemma":0.000118508964,"teacher_disagreement_score":0.46694592,"about_ca_system_score_codex":0.00042924166,"about_ca_system_score_gemma":0.0006698561,"threshold_uncertainty_score":0.9998165},"labels":[],"label_agreement":null},{"id":"W4306960763","doi":"10.48083/wixm2804","title":"Adjuvant Systemic Treatment for Renal Cancer After Surgery: A Network Meta-Analysis","year":2022,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Pazopanib; Renal cell carcinoma; Pembrolizumab; Internal medicine; Adjuvant; Adverse effect; Kidney cancer; Oncology; Cancer; Meta-analysis; Disease; Randomized controlled trial; Surgery; Immunotherapy; Sunitinib","score_opus":0.1876516698442714,"score_gpt":0.369179730930479,"score_spread":0.18152806108620761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306960763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90905315,0.070269436,0.0028965105,0.012236016,0.0020097035,0.001666115,0.000870808,0.00011041327,0.00088785426],"genre_scores_gemma":[0.98408306,0.0006927128,0.000587555,0.0015275402,0.0010219876,0.00335037,0.00024608587,0.000034846384,0.008455841],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99698967,0.00034418958,0.00081756816,0.00045349484,0.000878027,0.0005170513],"domain_scores_gemma":[0.9976576,0.0008220604,0.00062481454,0.00032069135,0.00036184123,0.00021299196],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010239801,0.0003402352,0.001533439,0.00041154612,0.0003899619,0.00006534381,0.00021426786,0.00007795453,0.008335988],"category_scores_gemma":[0.00008374916,0.00023847225,0.004483101,0.00039719677,0.00005004941,0.00008692497,0.00010754426,0.00037914873,0.000007915669],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006319933,0.0010919168,0.20240475,0.00005569975,0.65936726,0.0022032554,0.00059905095,0.09041997,0.00027780753,0.00015620442,0.030982584,0.0061215553],"study_design_scores_gemma":[0.008397256,0.004418165,0.09128049,0.000036597055,0.7577106,0.0066042626,0.0009322745,0.0069459686,0.00058076513,0.0020733867,0.11996645,0.0010538087],"about_ca_topic_score_codex":0.000084668776,"about_ca_topic_score_gemma":0.00005353549,"teacher_disagreement_score":0.11112426,"about_ca_system_score_codex":0.0021644747,"about_ca_system_score_gemma":0.0005755421,"threshold_uncertainty_score":0.9925705},"labels":[],"label_agreement":null},{"id":"W4307160114","doi":"10.1053/j.seminoncol.2022.10.001","title":"IO-IO vs IO-TKI efficacy in metastatic kidney cancer patients: A structured systematic review over time","year":2022,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nivolumab; Internal medicine; Ipilimumab; Cabozantinib; Pembrolizumab; Axitinib; Sunitinib; Renal cell carcinoma; Oncology; Kidney cancer; Hazard ratio; Clinical trial; Progression-free survival; Cancer; Immunotherapy; Overall survival; Confidence interval","score_opus":0.03645426860760719,"score_gpt":0.3739355171632866,"score_spread":0.3374812485556794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307160114","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029538892,0.98448277,1.0980933e-7,0.00020245217,0.00070510915,0.012742806,0.00024723256,0.000040515213,0.0012836094],"genre_scores_gemma":[0.000021530137,0.98834944,0.00021086494,0.0016852514,0.000084386564,0.005911049,0.001657212,0.00016290588,0.0019173842],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99190545,0.0026433284,0.0027814335,0.0010908205,0.0007899886,0.0007889896],"domain_scores_gemma":[0.9949992,0.0017789599,0.001580819,0.0011728643,0.00008518705,0.00038298717],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012556933,0.0010034118,0.009685561,0.000821228,0.000057064393,0.000013455729,0.00055740273,0.00044463648,0.004797931],"category_scores_gemma":[0.0026878163,0.000744077,0.0008706896,0.0013807026,0.00011933694,0.00005509137,0.0003353418,0.0014223527,0.00020979703],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097112956,0.0011235297,0.00009796346,0.8730202,0.00075631926,0.0023335854,0.0002931154,0.0000013768915,4.7443075e-7,0.000008534948,0.013821148,0.10844665],"study_design_scores_gemma":[0.002032413,0.0011835764,0.000052442832,0.47653943,0.008678575,0.00034871246,0.00001353527,0.0000044011626,3.7845717e-7,0.000010036896,0.5107519,0.00038461498],"about_ca_topic_score_codex":0.00018622253,"about_ca_topic_score_gemma":0.00006889077,"teacher_disagreement_score":0.49693072,"about_ca_system_score_codex":0.009335198,"about_ca_system_score_gemma":0.0025900411,"threshold_uncertainty_score":0.99950105},"labels":[],"label_agreement":null},{"id":"W4307906450","doi":"10.1016/s1470-2045(22)00629-5","title":"Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma","year":2022,"lang":"en","type":"letter","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Renal cell carcinoma; Adjuvant therapy; Oncology; Adjuvant; Internal medicine; Immunotherapy; Cancer","score_opus":0.06916348275263576,"score_gpt":0.317035747058509,"score_spread":0.24787226430587325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307906450","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39998448,0.0028410996,0.000012919877,0.55839556,0.0006763556,0.0035372367,0.00010430405,0.00008250525,0.034365557],"genre_scores_gemma":[0.41128686,0.00093088334,0.00054678455,0.5610615,0.0070243254,0.0021648987,0.0023495853,0.00020493641,0.014430226],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99640864,0.00088616606,0.0006182923,0.00075256475,0.00046590273,0.00086844957],"domain_scores_gemma":[0.99737406,0.0006756962,0.000481861,0.0012786109,0.000107252265,0.00008254887],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008125382,0.0004932459,0.0014766712,0.00027572658,0.00016743275,0.000023340728,0.0006226389,0.00095554325,0.00093954493],"category_scores_gemma":[0.000034106415,0.00034748143,0.00035519758,0.00024935827,0.00014502734,0.000032547217,0.00011838806,0.0030399584,0.00014228611],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011751784,0.000415392,0.00042297086,0.00036220232,0.000084685555,0.0016827998,0.001298668,0.000017906912,0.0060011665,0.00003933268,0.97551215,0.0024109506],"study_design_scores_gemma":[0.014499844,0.010330768,0.0038745673,0.000020726946,0.00027286555,0.00032079668,0.00030522505,0.000078505866,0.0063456944,0.00033279022,0.9632951,0.00032311052],"about_ca_topic_score_codex":0.00080092554,"about_ca_topic_score_gemma":0.000036577436,"teacher_disagreement_score":0.019935332,"about_ca_system_score_codex":0.0015961052,"about_ca_system_score_gemma":0.0008688029,"threshold_uncertainty_score":0.9999737},"labels":[],"label_agreement":null},{"id":"W4307927336","doi":"10.1016/j.urolonc.2022.09.021","title":"Deferred cytoreductive nephrectomy in the management of metastatic renal cell carcinoma: A systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services; University of Toronto","funders":"","keywords":"Medicine; Renal cell carcinoma; Hazard ratio; Perioperative; Nephrectomy; Meta-analysis; Systemic therapy; Internal medicine; Oncology; Surgery; Cancer; Kidney; Confidence interval","score_opus":0.1376613381637201,"score_gpt":0.36722988709193227,"score_spread":0.22956854892821218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307927336","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005787977,0.9919748,0.000005853499,0.000656936,0.000020172121,0.005374561,0.000103920574,0.000012529468,0.0012724493],"genre_scores_gemma":[0.0003582695,0.9826631,0.010758429,0.0007083181,0.000009378439,0.004667178,0.0002993178,0.000023225744,0.0005127916],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9952486,0.0020309098,0.0013333546,0.00069291395,0.00038491658,0.00030929223],"domain_scores_gemma":[0.9969735,0.0010645926,0.0010700302,0.0006831284,0.00004642823,0.00016231701],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016271211,0.0005671493,0.006724734,0.0005957955,0.00015366025,0.000017820314,0.00028322442,0.00015366123,0.0002314366],"category_scores_gemma":[0.00006702049,0.00030936798,0.0011950419,0.0017277916,0.00048140858,0.000048969756,0.00015200397,0.0006449892,0.000004307288],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024515273,0.0006268091,0.00015751834,0.9008355,0.09283972,0.002009963,0.00063809886,0.00000767443,2.0801772e-7,0.0016307263,0.00048278205,0.00074648694],"study_design_scores_gemma":[0.0002329458,0.0008102465,0.000011439846,0.0018297012,0.72375584,0.00091424736,0.00032479485,0.00000430273,4.253579e-7,0.00018783311,0.271763,0.00016519784],"about_ca_topic_score_codex":0.00006350955,"about_ca_topic_score_gemma":0.000012227014,"teacher_disagreement_score":0.8990058,"about_ca_system_score_codex":0.0002851715,"about_ca_system_score_gemma":0.00033743083,"threshold_uncertainty_score":0.99993587},"labels":[],"label_agreement":null},{"id":"W4307969311","doi":"10.15586/jkcvhl.v9i4.255","title":"Partial Nephrectomy for T1b/T2 Renal Mass","year":2022,"lang":"en","type":"article","venue":"Journal of Kidney Cancer and VHL","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University","funders":"","keywords":"Nephrectomy; Medicine; Renal function; Renal cell carcinoma; Pathological; Renal mass; Urology; Kidney cancer; Kidney; Retrospective cohort study; Surgery; Internal medicine","score_opus":0.027265569951130546,"score_gpt":0.30070149955281894,"score_spread":0.2734359296016884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307969311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9604491,0.008689292,0.0007871689,0.02492785,0.0017977802,0.000791209,0.00017152943,0.000018008965,0.002368079],"genre_scores_gemma":[0.98858833,0.00046262424,0.002153353,0.0044805384,0.0016975185,0.00015559125,0.000013650017,0.000028559889,0.0024198212],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990664,0.00003072318,0.00029439913,0.00011426161,0.00031522693,0.00017896117],"domain_scores_gemma":[0.9990417,0.000041466155,0.00019534702,0.000089137626,0.000102646765,0.0005297189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024839398,0.0001028543,0.00030016017,0.00009504182,0.00012218962,0.000015062473,0.000059964128,0.000025307474,0.0005386508],"category_scores_gemma":[0.000079657184,0.0000765634,0.00017302594,0.00008789998,0.000026318836,0.000057163514,0.000026637643,0.00021898447,7.83261e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012727749,0.0005380568,0.0733139,0.00038668356,0.0014808832,0.001056067,0.0011308168,0.00025691369,0.12464064,0.00025787723,0.73895603,0.045254357],"study_design_scores_gemma":[0.007857668,0.0026887448,0.0049816733,0.00008720932,0.0006062967,0.000989879,0.00016378681,0.00020779975,0.023418149,0.0002634836,0.95860857,0.00012671521],"about_ca_topic_score_codex":0.00003108909,"about_ca_topic_score_gemma":0.0000012830692,"teacher_disagreement_score":0.21965253,"about_ca_system_score_codex":0.00024276665,"about_ca_system_score_gemma":0.0008037063,"threshold_uncertainty_score":0.5897848},"labels":[],"label_agreement":null},{"id":"W4308026783","doi":"10.1136/jitc-2022-005780","title":"FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy","year":2022,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Université Laval; Juravinski Cancer Centre; Université du Québec à Montréal","funders":"National Center for Advancing Translational Sciences; Foundation Medicine; EMD Serono; Genentech; European Society for Medical Oncology; Shionogi; Natera; Seagen; Pfizer; Incyte; Jounce Therapeutics; Astellas Pharma; Eisai; Ono Pharmaceutical; Eli Lilly and Company; National Comprehensive Cancer Network; National Cancer Institute; Gilead Sciences; Calithera Biosciences; Celldex Therapeutics; Ipsen; Array BioPharma; Karyopharm Therapeutics; Exelixis; Sanofi; Memorial Sloan-Kettering Cancer Center; Dana-Farber/Harvard Cancer Center; Bristol-Myers Squibb; AstraZeneca; American Society of Clinical Oncology; GlaxoSmithKline; Amgen; Dana-Farber Cancer Institute","keywords":"Nivolumab; Ipilimumab; Medicine; Internal medicine; Oncology; Tolerability; Renal cell carcinoma; Discontinuation; Combination therapy; Hazard ratio; Clinical endpoint; Progression-free survival; Adverse effect; Clinical trial; Cancer; Immunotherapy; Chemotherapy; Confidence interval","score_opus":0.024101134792033473,"score_gpt":0.3518191333851835,"score_spread":0.32771799859315004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308026783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.945512,0.048121214,0.00048295857,0.0011768513,0.0015273757,0.0026495766,0.00011716122,0.00002723467,0.00038564426],"genre_scores_gemma":[0.98481697,0.0029118496,0.0034219727,0.00095005444,0.0005491144,0.0037537378,0.000047043723,0.00013500602,0.003414275],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975361,0.00013216483,0.0007713675,0.00038199124,0.0006668594,0.0005114764],"domain_scores_gemma":[0.9979675,0.00023548093,0.0008340382,0.0004285444,0.00040666942,0.00012779904],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000478919,0.00035349836,0.00078560726,0.00029285438,0.00056897453,0.00002702532,0.00024024586,0.00012889525,0.0012878003],"category_scores_gemma":[0.000013285889,0.00027738622,0.0007652726,0.000182433,0.00008410978,0.000138512,0.000031374704,0.0005265323,0.0000019003578],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2146422,0.0014843974,0.0018015901,0.0001255786,0.00062670547,0.00006069792,0.0010809214,0.0006995324,0.3618798,0.000015163806,0.0034085554,0.41417485],"study_design_scores_gemma":[0.067645386,0.04545395,0.012558811,0.00018879518,0.00022368127,0.0003276401,0.00071134296,0.00022123347,0.28917286,0.00036050598,0.5826867,0.0004490933],"about_ca_topic_score_codex":0.000050343526,"about_ca_topic_score_gemma":0.000006591273,"teacher_disagreement_score":0.5792782,"about_ca_system_score_codex":0.0027760987,"about_ca_system_score_gemma":0.0010949705,"threshold_uncertainty_score":0.9999678},"labels":[],"label_agreement":null},{"id":"W4308034719","doi":"10.1016/j.euo.2022.10.004","title":"Real-world Practice Patterns and Safety of Concurrent Radiotherapy and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium","year":2022,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cabozantinib; Medicine; Radiation therapy; Discontinuation; Renal cell carcinoma; Oncology; Adverse effect; Internal medicine","score_opus":0.035861587331712935,"score_gpt":0.3030438251672152,"score_spread":0.2671822378355022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308034719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756663,0.0029769493,0.00012053867,0.0065366863,0.00049634324,0.0009687612,0.0016218822,0.000022829765,0.011589736],"genre_scores_gemma":[0.99334246,0.00071203004,0.0018694474,0.0023143413,0.00015687075,0.000051161827,0.0010412945,0.000062704596,0.00044966544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9926592,0.00430451,0.0012225851,0.0009139613,0.00043755583,0.00046215474],"domain_scores_gemma":[0.99432606,0.0037902182,0.0008990599,0.00065214257,0.00012691919,0.00020558553],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024002846,0.00038017827,0.0008450652,0.00031819366,0.00017180385,0.00001794629,0.00037723422,0.0000423974,0.00034970624],"category_scores_gemma":[0.00030575474,0.00030396413,0.00010447399,0.0002436301,0.00050199183,0.00010509545,0.0005858215,0.0009765049,0.000008200655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07308392,0.009006482,0.67569387,0.00038812545,0.0021087292,0.0630053,0.028125046,0.0009281563,0.10787737,0.0011732657,0.022354132,0.016255599],"study_design_scores_gemma":[0.041591298,0.007472772,0.8105172,0.000024634945,0.0017801388,0.0022476376,0.0024655685,0.0013024542,0.0035213102,0.000019069867,0.12860273,0.00045519642],"about_ca_topic_score_codex":0.0032964314,"about_ca_topic_score_gemma":0.0008378551,"teacher_disagreement_score":0.13482332,"about_ca_system_score_codex":0.00031901395,"about_ca_system_score_gemma":0.00043337015,"threshold_uncertainty_score":0.99994123},"labels":[],"label_agreement":null},{"id":"W4308307406","doi":"10.1016/j.path.2022.09.002","title":"Dedication","year":2022,"lang":"en","type":"editorial","venue":"Surgical pathology clinics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Rockyview General Hospital; University of Calgary","funders":"","keywords":"Humanity; Medicine; Environmental ethics; Psychoanalysis; Law; Psychology; Political science; Philosophy","score_opus":0.027733411224770483,"score_gpt":0.34567633879365994,"score_spread":0.3179429275688895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308307406","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012595488,0.0038158142,0.0000061439473,0.0006607119,0.9647981,0.00056995597,0.00022471664,0.00017299215,0.017156065],"genre_scores_gemma":[0.0024233228,0.0038052206,0.00038087522,0.00021705288,0.9649056,0.00025149077,0.008272751,0.00012238108,0.019621262],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996348,0.00048097165,0.0008296246,0.000881395,0.0010466506,0.0004133581],"domain_scores_gemma":[0.9953537,0.0028228287,0.00039284554,0.0009373529,0.00022320752,0.00027006975],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0012528414,0.00036823147,0.0010844355,0.000174606,0.0001224636,0.000010462507,0.00023832583,0.0019524186,0.0025459833],"category_scores_gemma":[0.001804849,0.0003164873,0.0005291507,0.00020257535,0.00022952343,0.000021484628,0.0002646565,0.0030947204,0.00050381897],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006060053,0.00042703692,0.0008589846,0.0001005486,0.00010685987,0.018357387,0.000030281111,0.0000012832287,0.000003447618,0.00006984736,0.9758799,0.0035584054],"study_design_scores_gemma":[0.002750465,0.0014980971,0.00056851556,0.000031165822,0.00054878177,0.0004962317,0.000015006269,0.0000063861194,0.0000069532175,0.00019273628,0.9936516,0.00023401757],"about_ca_topic_score_codex":0.0000064041087,"about_ca_topic_score_gemma":0.000001470637,"teacher_disagreement_score":0.017861156,"about_ca_system_score_codex":0.0003178586,"about_ca_system_score_gemma":0.0008549036,"threshold_uncertainty_score":0.9999287},"labels":[],"label_agreement":null},{"id":"W4308887302","doi":"10.1016/j.urolonc.2022.10.006","title":"Predicting short- and long-term renal function following partial and radical nephrectomy","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Nephrectomy; Renal function; Urology; Receiver operating characteristic; Retrospective cohort study; Cohort; Surgery; Internal medicine; Kidney","score_opus":0.03383944163855581,"score_gpt":0.29698958180393265,"score_spread":0.26315014016537686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308887302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919119,0.0039007128,0.000080215475,0.0029430033,0.00022101436,0.00040446283,0.0000081065045,0.00007201257,0.0004585711],"genre_scores_gemma":[0.9916781,0.00016925823,0.005953633,0.0014981808,0.00018521133,0.00018724836,0.00008662461,0.000014579432,0.00022712586],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99861294,0.00018820728,0.00026786383,0.00044215214,0.00020513496,0.00028367934],"domain_scores_gemma":[0.99922025,0.00022547993,0.00007654239,0.00012939161,0.000016343738,0.00033200762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038745475,0.00018398272,0.00032615225,0.00013089564,0.0006894652,0.00002619326,0.000042453576,0.00012719832,0.000109415196],"category_scores_gemma":[0.000076717995,0.00016115549,0.000057025194,0.00016700543,0.00046843762,0.00009321203,0.00013592387,0.0004735573,0.0000015096986],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027699262,0.00011417699,0.9912379,0.00002057195,0.000118193624,0.0007246937,0.0002843142,0.000021135776,0.0018534452,0.0006088388,0.0003750493,0.0043646847],"study_design_scores_gemma":[0.003986277,0.0148911495,0.44551128,0.000068198475,0.0025199163,0.008018261,0.00043868957,0.0034305335,0.0006196225,0.0019537923,0.51813096,0.00043135305],"about_ca_topic_score_codex":0.00002204477,"about_ca_topic_score_gemma":0.000012790685,"teacher_disagreement_score":0.54572666,"about_ca_system_score_codex":0.00015531045,"about_ca_system_score_gemma":0.00017371913,"threshold_uncertainty_score":0.65717304},"labels":[],"label_agreement":null},{"id":"W4308984634","doi":"10.1016/j.ijrobp.2022.03.028","title":"Oligometastases: Learning From the Past, Building for the Future","year":2022,"lang":"en","type":"editorial","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"Ontario Institute for Cancer Research","keywords":"Medicine; Medical physics","score_opus":0.020715676769526133,"score_gpt":0.32698893614944363,"score_spread":0.3062732593799175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308984634","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012901884,0.014960931,0.010117536,0.014869228,0.94471604,0.0010283554,0.001166134,0.000052491258,0.00018741234],"genre_scores_gemma":[0.02852565,0.0045541017,0.0019469555,0.0008397866,0.96126056,0.00013460695,0.0023991992,0.00009648817,0.00024263801],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967148,0.0006002657,0.0010067405,0.00039266032,0.00096556824,0.00031999065],"domain_scores_gemma":[0.98572946,0.009998371,0.0024888352,0.0003303443,0.0013388043,0.00011420695],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0013917958,0.0004048383,0.00084210455,0.00014779212,0.00039019025,0.000085447944,0.0011319654,0.0005570478,0.0002352],"category_scores_gemma":[0.0014640404,0.00024013879,0.00084431283,0.0001908134,0.00019153967,0.00013968581,0.00021568479,0.002726974,0.000012338089],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014471393,0.00028005938,0.012011496,0.00001644031,0.004457852,0.00009137385,0.0005054678,0.0019633218,0.0003155999,0.0010438496,0.8803854,0.09748199],"study_design_scores_gemma":[0.004721117,0.0017345594,0.0013379166,0.000059313563,0.0014077135,0.000084232866,0.00044290934,0.00045109374,0.000118517404,0.0021921336,0.9872591,0.00019138237],"about_ca_topic_score_codex":0.000064473206,"about_ca_topic_score_gemma":0.000007354692,"teacher_disagreement_score":0.1068737,"about_ca_system_score_codex":0.0020207297,"about_ca_system_score_gemma":0.0015331923,"threshold_uncertainty_score":0.99957377},"labels":[],"label_agreement":null},{"id":"W4309412449","doi":"10.1016/s1470-2045(22)00656-8","title":"5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney)","year":2022,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; University of Ottawa; Ottawa Hospital; Cancer Care Ontario; McMaster University; Sunnybrook Health Science Centre; McGill University Health Centre; Juravinski Cancer Centre","funders":"Cancer Council Tasmania","keywords":"SABR volatility model; Medicine; Renal cell carcinoma; Radiosurgery; Cyberknife; Radiation therapy; Clinical endpoint; Discontinuation; Urology; Internal medicine; Surgery; Clinical trial","score_opus":0.20941639527428876,"score_gpt":0.3794208878707568,"score_spread":0.17000449259646802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309412449","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0080366125,0.9696837,0.000038894497,0.0036028149,0.0008982445,0.004127415,0.012828744,0.000027241344,0.00075630995],"genre_scores_gemma":[0.040185735,0.91193885,0.0028213798,0.013468468,0.0019095272,0.0055206427,0.021956403,0.00029890746,0.0019000848],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940628,0.0024493402,0.0012741793,0.00087280234,0.0009085989,0.00043227265],"domain_scores_gemma":[0.9904325,0.0041140495,0.0018164831,0.0033879634,0.000105695275,0.00014333587],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015841776,0.0006069005,0.005557549,0.00024508807,0.00016799927,0.000038897622,0.0022437812,0.00023089448,0.0025240642],"category_scores_gemma":[0.00021022264,0.00025925983,0.0027673,0.00044726182,0.00030935553,0.00009517209,0.000913135,0.00085609726,0.00000599303],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034594112,0.002689896,0.025225118,0.0028079543,0.8681294,0.00036462853,0.0037469198,0.000021597745,0.000028251212,0.000058047517,0.030397952,0.063070826],"study_design_scores_gemma":[0.0012559368,0.00044325652,0.010663333,0.00002984187,0.29862496,0.000041662435,0.00008114325,0.000016477652,0.0000093906565,0.000016215601,0.68862367,0.00019408982],"about_ca_topic_score_codex":0.00019263585,"about_ca_topic_score_gemma":0.000042881315,"teacher_disagreement_score":0.6582257,"about_ca_system_score_codex":0.0007947569,"about_ca_system_score_gemma":0.0014467429,"threshold_uncertainty_score":0.99998593},"labels":[],"label_agreement":null},{"id":"W4309438097","doi":"10.1016/j.canep.2022.102297","title":"Cancer specific mortality in patients with collecting duct vs. clear cell renal carcinoma","year":2022,"lang":"en","type":"article","venue":"Cancer Epidemiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Université de Montréal","funders":"","keywords":"Medicine; Propensity score matching; Clear cell renal cell carcinoma; Internal medicine; Proportional hazards model; Nephrectomy; Stage (stratigraphy); Renal cell carcinoma; Oncology; Surveillance, Epidemiology, and End Results; Population; Lymph node; Epidemiology; Urology; Cancer registry; Kidney","score_opus":0.07725407609770076,"score_gpt":0.3278807040783491,"score_spread":0.25062662798064833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309438097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906007,0.0053391103,0.000009258869,0.0012613484,0.0005750255,0.00087049766,0.00008238625,0.000037259968,0.0012244319],"genre_scores_gemma":[0.9960574,0.0001622692,0.00026298413,0.0014816882,0.0002597409,0.0007278093,0.00009923518,0.000051189003,0.00089767476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99694645,0.00068487227,0.00063454534,0.0007695847,0.0002750397,0.0006895129],"domain_scores_gemma":[0.99854124,0.0003331045,0.00032244134,0.0004993269,0.000101062746,0.00020283577],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00076099596,0.0002844329,0.00094986736,0.00018294543,0.00020050826,0.0000035805047,0.00013086846,0.00008993791,0.0018656097],"category_scores_gemma":[0.00007311018,0.00023438728,0.00012314401,0.0004674083,0.00014196422,0.000042112326,0.00013730866,0.00064293307,0.0000126456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031135732,0.00024238495,0.98500496,0.00007084806,0.00008492259,0.00017138249,0.0002587344,0.0020435818,0.00013723911,0.000023486613,0.008385544,0.00046335955],"study_design_scores_gemma":[0.0042541726,0.0018735938,0.98114556,0.000037497102,0.00011186202,0.000014146206,0.00009686164,0.00015485204,0.00048956455,0.000049843118,0.011550162,0.00022185786],"about_ca_topic_score_codex":0.0056816908,"about_ca_topic_score_gemma":0.00054859946,"teacher_disagreement_score":0.005456728,"about_ca_system_score_codex":0.002354588,"about_ca_system_score_gemma":0.00044107836,"threshold_uncertainty_score":0.9990468},"labels":[],"label_agreement":null},{"id":"W4309575387","doi":"10.1016/j.urolonc.2022.09.015","title":"Nephron-sparing surgery for renal cell carcinoma in children and young adults: A systematic review","year":2022,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Meta-analysis; Confounding; Kidney cancer; MEDLINE; Systematic review; Population; Incidence (geometry); Surgery; Internal medicine; Kidney","score_opus":0.04616795877088565,"score_gpt":0.3087822264354913,"score_spread":0.26261426766460566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309575387","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010844187,0.98157424,0.0000036342174,0.0002815344,0.00012357718,0.006745044,0.00010326018,0.00004094635,0.0002835945],"genre_scores_gemma":[0.00016726746,0.99008536,0.0029864337,0.000696269,0.00010526694,0.0045407633,0.0010775813,0.00005500733,0.00028606495],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99643946,0.00061229354,0.0013496268,0.00086910283,0.00022847808,0.00050102914],"domain_scores_gemma":[0.9967848,0.0015508631,0.00083734246,0.0004547683,0.000043816057,0.00032841563],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011645266,0.0006126802,0.003966757,0.0004903383,0.00024719932,0.00002591433,0.00016232311,0.00040767662,0.000055524142],"category_scores_gemma":[0.0004951086,0.0004673908,0.00042476298,0.000488452,0.00032122305,0.00007356251,0.00014883759,0.0007552896,0.0000065065333],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067557776,0.00031973043,0.035092447,0.93797594,0.00033161716,0.0005692524,0.00016939356,0.0000010191809,3.72183e-7,0.00019948417,0.004290887,0.020982318],"study_design_scores_gemma":[0.00090531586,0.0018893825,0.00042964643,0.15404184,0.012647258,0.007844204,0.000052455907,0.00003498683,0.0000010413821,0.000099796336,0.8215158,0.0005382933],"about_ca_topic_score_codex":0.00013737105,"about_ca_topic_score_gemma":0.000027078428,"teacher_disagreement_score":0.8172249,"about_ca_system_score_codex":0.0006182053,"about_ca_system_score_gemma":0.0010442955,"threshold_uncertainty_score":0.9997778},"labels":[],"label_agreement":null},{"id":"W4309746225","doi":"10.5489/cuaj.8178","title":"2022 European Society for Medical Oncology: Meeting highlights","year":2022,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University; Princess Margaret Cancer Centre; University of British Columbia; London Health Sciences Centre; McMaster University; Juravinski Cancer Centre; University of Ottawa; Dalhousie University","funders":"","keywords":"Medicine; Political science; Engineering ethics; Medical physics; Engineering","score_opus":0.018446605412987416,"score_gpt":0.247242629844888,"score_spread":0.22879602443190059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309746225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71409994,0.00096548913,0.000111697904,0.24751487,0.0012451805,0.0006201468,0.00009586518,0.000056135166,0.03529068],"genre_scores_gemma":[0.97915334,0.00007886164,0.00092930417,0.01632795,0.0012058988,0.000046735044,0.00009337237,0.000026036225,0.0021384964],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973396,0.00052753475,0.00043445325,0.00025125805,0.00085805723,0.00058907334],"domain_scores_gemma":[0.99778825,0.0003994766,0.00031076663,0.000103035614,0.00020077484,0.0011976997],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0036224287,0.00013906515,0.0003068413,0.00010684857,0.0010773429,0.000040567425,0.00019741859,0.00015773077,0.0038453445],"category_scores_gemma":[0.0009898263,0.00011407555,0.00049268786,0.0001952241,0.000031448948,0.000037596972,0.000061068255,0.0010206726,0.000044010758],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037038277,0.0005364784,0.25432053,0.000018280936,0.0013052791,0.0038540112,0.0011602746,0.00019893693,0.00075339497,0.0009631619,0.7076411,0.028878123],"study_design_scores_gemma":[0.0022133554,0.0014455854,0.06835358,0.0000055766504,0.00017396365,0.0011133731,0.00027272262,0.0004363569,0.000025098505,0.00024427669,0.9255843,0.00013178402],"about_ca_topic_score_codex":0.0002170887,"about_ca_topic_score_gemma":0.00024358892,"teacher_disagreement_score":0.26505342,"about_ca_system_score_codex":0.0058081686,"about_ca_system_score_gemma":0.0016408457,"threshold_uncertainty_score":0.9980084},"labels":[],"label_agreement":null},{"id":"W4309833897","doi":"10.1016/j.eururo.2022.11.001","title":"European Association of Urology Guidelines Panel on Renal Cell Carcinoma Update on the New World Health Organization Classification of Kidney Tumours 2022: The Urologist’s Point of View","year":2022,"lang":"en","type":"editorial","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"Univerzita Karlova v Praze","keywords":"Medicine; Renal cell carcinoma; Urology; Genitourinary system; Kidney; Nephrology; Perspective (graphical); Kidney cancer; Gynecology; Internal medicine","score_opus":0.04158355193864763,"score_gpt":0.273579503901991,"score_spread":0.23199595196334336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309833897","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06477618,0.008210408,0.00043192605,0.46580642,0.37938997,0.0071847592,0.0020352937,0.0003550959,0.071809955],"genre_scores_gemma":[0.8662378,0.0017612489,0.00011077774,0.015547491,0.10445194,0.000025514324,0.0052905735,0.00043082985,0.0061438223],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98724085,0.007953372,0.0021200918,0.00088511914,0.0012780523,0.0005224942],"domain_scores_gemma":[0.9904879,0.0021356281,0.0044831675,0.0015943666,0.001036599,0.00026239452],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00528581,0.0005790153,0.001222852,0.000487492,0.00019506662,0.000014149091,0.00096333807,0.00023210254,0.00069079164],"category_scores_gemma":[0.0091112945,0.0003808503,0.00031933887,0.0008624848,0.00025543667,0.000030526993,0.00037696149,0.0017014595,0.00012582043],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092798506,0.00036783563,0.0016988554,0.00015391738,0.0001714773,0.0000617886,0.0003752879,0.00024840128,0.0017170855,0.0005776045,0.99293256,0.0007672147],"study_design_scores_gemma":[0.002399641,0.007561085,0.043788206,0.00006439461,0.0009320882,0.000022526221,0.00007112973,0.000045020173,0.001024008,0.00006527589,0.9437483,0.0002783362],"about_ca_topic_score_codex":0.00016636561,"about_ca_topic_score_gemma":0.00003262136,"teacher_disagreement_score":0.80146164,"about_ca_system_score_codex":0.00048987084,"about_ca_system_score_gemma":0.0015653323,"threshold_uncertainty_score":0.99986434},"labels":[],"label_agreement":null},{"id":"W4309855372","doi":"10.3390/curroncol29120715","title":"A Novel, Simple, and Low-Cost Approach for Machine Learning Screening of Kidney Cancer: An Eight-Indicator Blood Test Panel with Predictive Value for Early Diagnosis","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Sun Yat-sen University","keywords":"Medicine; Renal cell carcinoma; Receiver operating characteristic; Stage (stratigraphy); Cancer; Kidney cancer; Internal medicine; Oncology; Clear cell renal cell carcinoma","score_opus":0.09208782708092689,"score_gpt":0.34191263007893363,"score_spread":0.24982480299800675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309855372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97462934,0.0024820047,0.014562237,0.00033128913,0.00014062776,0.004662829,0.003042649,0.000058116453,0.00009088249],"genre_scores_gemma":[0.98024106,0.00016056681,0.008393757,0.00011690041,0.00021325177,0.00904785,0.0017283587,0.00006557545,0.00003266958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982307,0.00010362033,0.00035954296,0.0006003389,0.00028487222,0.0004209163],"domain_scores_gemma":[0.9981586,0.0006545169,0.00036423386,0.00022047626,0.00014382256,0.00045840375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003376192,0.00026670514,0.0006685088,0.00019856553,0.00030204342,0.0000107320275,0.00013713124,0.00008209876,0.00003480377],"category_scores_gemma":[0.00033355088,0.00021858719,0.0001095295,0.00019999142,0.00014879752,0.00006952153,0.00012199486,0.0003961203,1.624031e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027597442,0.005007637,0.9596782,0.00073413225,0.0004876991,0.000014147738,0.0014550425,0.000632906,0.0016284502,0.000052589145,0.00037253142,0.027176954],"study_design_scores_gemma":[0.08683379,0.12823616,0.52274287,0.0005594546,0.010785191,0.00072541065,0.0028866923,0.14548877,0.01644273,0.00005662582,0.083887324,0.0013549976],"about_ca_topic_score_codex":0.00023980827,"about_ca_topic_score_gemma":0.000017161588,"teacher_disagreement_score":0.4369353,"about_ca_system_score_codex":0.0002794008,"about_ca_system_score_gemma":0.0005707226,"threshold_uncertainty_score":0.8913727},"labels":[],"label_agreement":null},{"id":"W4310104772","doi":"10.1016/j.urolonc.2022.11.009","title":"Collecting duct carcinoma: Epidemiology, clinical characteristics and survival","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Université de Montréal","funders":"","keywords":"Medicine; Proportional hazards model; Hazard ratio; Epidemiology; Internal medicine; Cohort; Stage (stratigraphy); Nephrectomy; Surveillance, Epidemiology, and End Results; Survival analysis; Population; Oncology; Surgery; Cancer registry; Confidence interval; Kidney; Biology","score_opus":0.13099492023472173,"score_gpt":0.3852238586296991,"score_spread":0.2542289383949774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310104772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816213,0.0020896245,0.000020474004,0.012627116,0.00055768917,0.000419024,0.000038472124,0.000059078793,0.0025672067],"genre_scores_gemma":[0.96930355,0.00048768322,0.024175271,0.0040919282,0.0002994382,0.0001601009,0.00012909388,0.000019299563,0.0013336432],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972478,0.001010172,0.00065611757,0.000567372,0.00013377628,0.00038473305],"domain_scores_gemma":[0.9968745,0.002130834,0.00029823263,0.00023283382,0.00005681156,0.00040679236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020423678,0.0002181364,0.0007784062,0.0001396975,0.00076540955,0.000009751597,0.00008599749,0.0001899619,0.00015586293],"category_scores_gemma":[0.0012334819,0.00018971169,0.00009182067,0.00024779513,0.0010311708,0.00004153174,0.00022551777,0.00082707807,0.000007658396],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019896482,0.00021799318,0.98938364,0.000021445516,0.00006838441,0.00049989205,0.00018980788,0.000005855562,0.00010067248,0.0035839598,0.0035098682,0.0022195117],"study_design_scores_gemma":[0.0013816718,0.006023807,0.47943613,0.000008378624,0.0004349841,0.003045599,0.0005042738,0.000828267,0.00002178215,0.0028561708,0.50527495,0.00018395182],"about_ca_topic_score_codex":0.000093053124,"about_ca_topic_score_gemma":0.000011300507,"teacher_disagreement_score":0.5099475,"about_ca_system_score_codex":0.00022071881,"about_ca_system_score_gemma":0.00045930254,"threshold_uncertainty_score":0.7736218},"labels":[],"label_agreement":null},{"id":"W4310798566","doi":"10.1016/j.esmoop.2022.100634","title":"Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program","year":2022,"lang":"en","type":"article","venue":"ESMO Open","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Ministero della Salute; Amgen; Prostate Cancer Foundation","keywords":"Nivolumab; Medicine; Ipilimumab; Renal cell carcinoma; Internal medicine; Overall survival; Oncology; Progression-free survival; Expanded access; Response Evaluation Criteria in Solid Tumors; Urology; Cancer; Progressive disease; Disease; Immunotherapy","score_opus":0.0410528661734179,"score_gpt":0.2901908751238391,"score_spread":0.2491380089504212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310798566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99400187,0.00005564894,0.0000012416716,0.0005528655,0.000038914157,0.0039978805,0.000014809889,0.000007083571,0.0013296859],"genre_scores_gemma":[0.99880946,0.0000029308824,0.00020921387,0.00009301448,0.000008729562,0.0006239466,0.00009491869,0.000022182126,0.0001355994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827296,0.00035297245,0.0003391736,0.00030988792,0.00051480316,0.0002101893],"domain_scores_gemma":[0.999123,0.00009943495,0.00020280987,0.00047657714,0.00005465012,0.000043557713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005269823,0.00016380787,0.0003088483,0.00011066306,0.00015223125,0.00007793682,0.0005217305,0.000021220401,0.00007954203],"category_scores_gemma":[0.000040430717,0.000092123344,0.00004148114,0.000584678,0.000065230095,0.0002084513,0.00050071144,0.00021093615,5.7195956e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085749105,0.0011134533,0.99244523,0.00009769688,0.000028092762,0.000046289635,0.0026209708,0.00022863151,0.000025471614,0.0000074552127,0.00012893109,0.0024002765],"study_design_scores_gemma":[0.007891296,0.0018133218,0.9845666,0.00011599641,0.00011913985,0.000015220502,0.00066676695,0.00011281812,0.0044471454,0.00006145696,0.0000852159,0.000105016145],"about_ca_topic_score_codex":0.0027713599,"about_ca_topic_score_gemma":0.0018734378,"teacher_disagreement_score":0.007878634,"about_ca_system_score_codex":0.00019932092,"about_ca_system_score_gemma":0.00012571734,"threshold_uncertainty_score":0.41894856},"labels":[],"label_agreement":null},{"id":"W4311758290","doi":"10.1016/j.euros.2022.11.014","title":"A Systematic Review of Heterogeneity in Outcome Definition and Reporting in Localised Renal Cancer","year":2022,"lang":"en","type":"review","venue":"European Urology Open Science","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Observational study; Systematic review; MEDLINE; Cohort; Randomized controlled trial; Meta-analysis; Renal cell carcinoma; Study heterogeneity; Cohort study; Intensive care medicine; Family medicine; Internal medicine","score_opus":0.2776540968477715,"score_gpt":0.43622584152175337,"score_spread":0.15857174467398188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311758290","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018636211,0.9888249,0.0000018385803,0.000060961982,0.00006873,0.0035670986,0.000009155003,0.0000073566275,0.005596355],"genre_scores_gemma":[0.0028162664,0.9960433,0.000121619145,0.0005866472,0.000009251184,0.00033692553,0.000022477843,0.000028222008,0.00003529275],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9930264,0.0018688197,0.0035202606,0.00082435773,0.00044362684,0.0003165335],"domain_scores_gemma":[0.9956074,0.0002336631,0.003228031,0.0007620615,0.000056365636,0.000112527094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013361523,0.00027469886,0.003290553,0.00043237407,0.000065192595,0.000026781412,0.00081624434,0.000042431126,0.00007861054],"category_scores_gemma":[0.0041273204,0.00019583921,0.00017611592,0.0011918911,0.0003491325,0.00010090922,0.0011532805,0.00044166454,0.000010811527],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018660761,0.000095755924,0.002615278,0.9794526,0.00004346455,0.0029885725,0.000070252434,0.000001894809,0.0000058370347,0.000028880011,0.000008451405,0.01467037],"study_design_scores_gemma":[0.0010714737,0.0006412623,0.0061039245,0.9679707,0.0025971052,0.0041912976,0.000022088378,0.000022598617,0.000005089997,0.000008867812,0.016909776,0.00045577908],"about_ca_topic_score_codex":0.00014268086,"about_ca_topic_score_gemma":0.00004701721,"teacher_disagreement_score":0.016901325,"about_ca_system_score_codex":0.000394142,"about_ca_system_score_gemma":0.0006443965,"threshold_uncertainty_score":0.7986091},"labels":[],"label_agreement":null},{"id":"W4312056039","doi":"10.1016/j.euros.2022.12.001","title":"Corrigendum re “Impact of Body Mass Index on Survival Outcomes for Patients with Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: A Systematic Review and Meta-analysis” [Eur Urol Open Sci 2022;39:62–71]","year":2022,"lang":"en","type":"review","venue":"European Urology Open Science","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Renal cell carcinoma; Medicine; Meta-analysis; Oncology; Internal medicine; Index (typography); World Wide Web; Computer science","score_opus":0.15738119417354476,"score_gpt":0.39331345529401845,"score_spread":0.2359322611204737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312056039","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001623402,0.95779854,0.000017898188,0.00030803855,0.00016584482,0.031097172,0.0004958109,0.000012511644,0.008480779],"genre_scores_gemma":[0.30407062,0.67417216,0.0010634311,0.0053078495,0.0000432831,0.00940659,0.0012976323,0.00046547528,0.0041729296],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98429114,0.009323112,0.0023643894,0.0018432221,0.0013473544,0.0008307897],"domain_scores_gemma":[0.99178725,0.0019461492,0.0028393643,0.0028310018,0.00032042502,0.00027583053],"candidate_categories":["metaepi_narrow","open_science"],"consensus_categories":[],"category_scores_codex":[0.014996342,0.0010111663,0.011585751,0.0010416177,0.00042427683,0.00023918728,0.0061031235,0.00008683418,0.0005187782],"category_scores_gemma":[0.0010919283,0.0004780967,0.001669781,0.0032315713,0.00077355764,0.00029330887,0.0021652814,0.00093677326,0.000024858713],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045241937,0.010456559,0.04138059,0.66166097,0.26289204,0.00731159,0.0025826872,0.00020325872,0.00001201652,0.0004481031,0.003015236,0.0055127614],"study_design_scores_gemma":[0.0049222647,0.018578576,0.035285857,0.0023695268,0.92233527,0.0002934064,0.00016325442,0.000044186945,6.7107527e-7,0.000011725244,0.015064577,0.0009306979],"about_ca_topic_score_codex":0.00029024298,"about_ca_topic_score_gemma":0.00005762032,"teacher_disagreement_score":0.6594432,"about_ca_system_score_codex":0.0005598759,"about_ca_system_score_gemma":0.0020997138,"threshold_uncertainty_score":0.99976707},"labels":[],"label_agreement":null},{"id":"W4312112834","doi":"10.1177/10668969221145011","title":"A Sarcomatoid Renal Cell Carcinoma with Clear Cell Papillary-Like Primary Tumor and Lymph Node Metastasis: A Diagnostic Conundrum","year":2022,"lang":"en","type":"article","venue":"International Journal of Surgical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill Genome Centre; McGill University","funders":"","keywords":"Pathology; Papillary renal cell carcinomas; Clear cell; Metastasis; Renal cell carcinoma; Lymph node; Immunohistochemistry; Clear cell renal cell carcinoma; Medicine; Renal sinus; Immunophenotyping; Biology; Kidney; Cancer; Nephrectomy; Internal medicine; Antigen; Immunology","score_opus":0.010519841063858124,"score_gpt":0.22829466644019586,"score_spread":0.21777482537633774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312112834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98903805,0.0052209534,0.000061766026,0.002249574,0.0003973235,0.00020814166,0.0000613055,0.000015975049,0.0027469017],"genre_scores_gemma":[0.996293,0.00034807203,0.0014267717,0.0012926684,0.00021956943,0.000026721218,0.000042127842,0.00004025769,0.00031081025],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99725175,0.00035509403,0.00069300644,0.00033783604,0.0010402016,0.00032208985],"domain_scores_gemma":[0.9979878,0.00062886206,0.0005325153,0.00020005798,0.0003483616,0.00030240673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050565647,0.00026111765,0.0006485755,0.00035552518,0.00010813379,0.00003175985,0.0002916888,0.000055757708,0.0004423956],"category_scores_gemma":[0.000042524654,0.00019568557,0.00023595666,0.00013581914,0.00021094263,0.00010335276,0.00028777897,0.0005367297,0.000014664411],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015174036,0.0030178293,0.34674868,0.00018198651,0.0006276628,0.60967505,0.0007260029,0.00058091007,0.018688733,0.00017529915,0.002054593,0.0023492314],"study_design_scores_gemma":[0.034408417,0.009636177,0.38144147,0.00017141878,0.0010444917,0.51667064,0.0010351184,0.00012884609,0.010793691,0.00026249196,0.043758314,0.00064890634],"about_ca_topic_score_codex":0.00002167258,"about_ca_topic_score_gemma":9.2997436e-7,"teacher_disagreement_score":0.09300438,"about_ca_system_score_codex":0.0004237162,"about_ca_system_score_gemma":0.00035026702,"threshold_uncertainty_score":0.7979826},"labels":[],"label_agreement":null},{"id":"W4312221469","doi":"10.1016/j.humpath.2022.12.013","title":"Characterization of protein S-(2-succino)-cysteine (2SC) succination as a biomarker for fumarate hydratase–deficient renal cell carcinoma","year":2022,"lang":"en","type":"article","venue":"Human Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Immunohistochemistry; Biomarker; Renal cell carcinoma; Pathology; Clear cell; Staining; Differential diagnosis; Receiver operating characteristic; Biology; Medicine; Internal medicine; Biochemistry","score_opus":0.027449362448328733,"score_gpt":0.26683007617412857,"score_spread":0.23938071372579983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312221469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99428076,0.00021320322,0.00030887823,0.00028318388,0.00013636473,0.002538348,0.00028813462,0.00004861632,0.0019025123],"genre_scores_gemma":[0.9909563,0.0000018615883,0.00021304042,0.00013565096,0.00007073955,0.0011549499,0.0036896337,0.000051760915,0.0037260854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99782914,0.00027313858,0.0006056526,0.00055193965,0.0003703941,0.00036976027],"domain_scores_gemma":[0.9986946,0.00003405126,0.00043995408,0.00051805645,0.00020790259,0.00010545111],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000489117,0.0002581009,0.00049126503,0.0004131721,0.0002923394,0.000010233502,0.00014042818,0.00009998136,0.0006405743],"category_scores_gemma":[0.000030436422,0.00024782738,0.00017966064,0.00028644502,0.00008164433,0.000061098355,0.00013591911,0.00017341692,0.000025679357],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009151057,0.0007079748,0.0021551389,0.00027641762,0.000025459403,0.00046131283,0.00049059733,0.0000082774795,0.9934459,0.0007163096,0.00016507306,0.00063244224],"study_design_scores_gemma":[0.0067553055,0.009779045,0.15373045,0.000035134824,0.00024902864,0.00069221243,0.00016881271,0.0004257549,0.82413745,0.00023510391,0.00347931,0.00031239694],"about_ca_topic_score_codex":0.000049547638,"about_ca_topic_score_gemma":0.000007407681,"teacher_disagreement_score":0.16930845,"about_ca_system_score_codex":0.0002930727,"about_ca_system_score_gemma":0.00014163261,"threshold_uncertainty_score":0.9999974},"labels":[],"label_agreement":null},{"id":"W4312461154","doi":"10.48083/qode9040","title":"Systematic Review of Comparative Patient Reported Outcomes and Health-Related Quality of Life After Management of Localized Renal Masses or Renal Cell Carcinomas","year":2022,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Observational study; Randomized controlled trial; Quality of life (healthcare); Nephrectomy; CINAHL; Renal cell carcinoma; Systematic review; MEDLINE; Meta-analysis; Kidney cancer; Adverse effect; PsycINFO; Surgery; Internal medicine; Kidney; Psychological intervention","score_opus":0.12151003042288756,"score_gpt":0.3804544879154953,"score_spread":0.25894445749260775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312461154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9480943,0.0474464,0.000093975614,0.0015111557,0.00018362512,0.0015285278,0.00007014036,0.000013739967,0.0010581285],"genre_scores_gemma":[0.99379265,0.0032777544,0.0013873245,0.0006396278,0.0000113722535,0.00015902818,0.000053340722,0.000013445955,0.00066543336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939106,0.000906981,0.003384766,0.00027353334,0.0013110269,0.00021308078],"domain_scores_gemma":[0.99435264,0.00040925818,0.0042113704,0.00034660235,0.0005167503,0.00016335819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020986977,0.00024076573,0.00188607,0.00021140804,0.00008314171,0.0000075223643,0.00019428875,0.00005000051,0.0008121384],"category_scores_gemma":[0.00022732433,0.00016460172,0.00045763594,0.00022443841,0.00014499792,0.000061871855,0.00023696946,0.00037991974,7.4015526e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012445656,0.004640029,0.5000388,0.4523562,0.017437486,0.0020262029,0.0045277774,0.0004958097,0.0008941466,0.00074088835,0.003956342,0.0004406472],"study_design_scores_gemma":[0.02152179,0.011030286,0.8768356,0.06596113,0.0048494693,0.0023389792,0.011563088,0.00031139198,0.0034953924,0.000941148,0.00042689856,0.00072484417],"about_ca_topic_score_codex":0.000081883685,"about_ca_topic_score_gemma":0.000004374296,"teacher_disagreement_score":0.38639507,"about_ca_system_score_codex":0.0004185837,"about_ca_system_score_gemma":0.00038981668,"threshold_uncertainty_score":0.8892346},"labels":[],"label_agreement":null},{"id":"W4312838555","doi":"10.1097/pcr.0000000000000216","title":"The Many Faces of Renal Cell Carcinoma in End-Stage Renal Disease","year":2017,"lang":"en","type":"article","venue":"AJSP Review and Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Login; Computer science; Internet privacy; World Wide Web; Logo (programming language); Register (sociolinguistics); Computer security","score_opus":0.02504442892008098,"score_gpt":0.2877542880545451,"score_spread":0.26270985913446415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312838555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55028003,0.44006494,0.0000010521253,0.001112975,0.00006667308,0.0006220203,0.000005188774,0.0000059086615,0.0078412285],"genre_scores_gemma":[0.9725243,0.021286087,0.000033998374,0.00011675898,0.000040423412,0.000044522007,0.000014451944,0.000012487976,0.005926975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986233,0.000052900312,0.00056060206,0.0002981639,0.0002606826,0.00020432827],"domain_scores_gemma":[0.99810255,0.00003945939,0.00054797466,0.0010528172,0.000059550417,0.0001976575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005195859,0.0001642349,0.00047844363,0.00003209806,0.0001794692,0.000026480251,0.00009272257,0.00003643183,0.000069872796],"category_scores_gemma":[0.00013066253,0.00008839176,0.00014516256,0.000040223033,0.00018524402,0.000060337425,0.0000885469,0.00012468467,0.00000357004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025211468,0.00013494022,0.9791761,0.0035260082,0.00004041061,0.009836998,0.000059525555,6.8922617e-7,0.0010867662,0.000103310675,0.0015422705,0.0044677393],"study_design_scores_gemma":[0.00036042812,0.00012307147,0.973531,0.0011398519,0.000413364,0.00032652987,0.0000131272,0.000001477804,0.0035300844,0.00006428676,0.02039678,0.000100018544],"about_ca_topic_score_codex":0.00020887358,"about_ca_topic_score_gemma":0.000032722735,"teacher_disagreement_score":0.42224428,"about_ca_system_score_codex":0.000031785592,"about_ca_system_score_gemma":0.00013340873,"threshold_uncertainty_score":0.36045113},"labels":[],"label_agreement":null},{"id":"W4313119801","doi":"10.1093/bjs/znac242.082","title":"O082 Patient derived renal cell carcinoma tumouroids for personalised renal cancer medicine","year":2022,"lang":"en","type":"article","venue":"British journal of surgery","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Pazopanib; Medicine; Renal cell carcinoma; Stromal cell; Cancer research; Cabozantinib; Cancer; Kidney cancer; Pathology; Sunitinib; Internal medicine","score_opus":0.042237561484017944,"score_gpt":0.25629938068557184,"score_spread":0.2140618192015539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313119801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97152036,0.024647055,0.00009528929,0.0018207919,0.00093418383,0.00043136865,0.00016859132,0.000017582934,0.00036479335],"genre_scores_gemma":[0.9963251,0.0005695815,0.00034786237,0.00097394764,0.0010172277,0.00012346618,0.00009972689,0.00007055484,0.0004725558],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99662876,0.00022150856,0.0011163956,0.00032515317,0.00120172,0.0005064834],"domain_scores_gemma":[0.9974634,0.00048560073,0.00083262613,0.00018835571,0.00056885934,0.00046114376],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009485252,0.0002617212,0.0009817552,0.00036882504,0.00034912524,0.000030829342,0.00015444086,0.00006029181,0.0017305707],"category_scores_gemma":[0.00016676416,0.00025998717,0.0007113029,0.00031199463,0.00012949659,0.00012027871,0.000075571996,0.00056314416,0.000001703428],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007879903,0.0017508444,0.07635312,0.0006050276,0.00072306127,0.04700727,0.0020214783,0.0003947275,0.29911822,0.0000066902217,0.45873612,0.105403535],"study_design_scores_gemma":[0.025591899,0.010655351,0.5634967,0.003008212,0.003063008,0.118097045,0.005432956,0.0003517628,0.17506735,0.00018008203,0.09355046,0.0015051411],"about_ca_topic_score_codex":0.0006294825,"about_ca_topic_score_gemma":0.000015836942,"teacher_disagreement_score":0.4871436,"about_ca_system_score_codex":0.0007033842,"about_ca_system_score_gemma":0.0009146669,"threshold_uncertainty_score":0.9999852},"labels":[],"label_agreement":null},{"id":"W4313475270","doi":"10.21873/invivo.13093","title":"Gonadal Function in Male Patients With Metastatic Renal Cell Cancer Treated With Sunitinib","year":2023,"lang":"en","type":"article","venue":"In Vivo","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Sunitinib; Quality of life (healthcare); Renal cell carcinoma; Internal medicine; Cohort; Testosterone (patch); Cancer; Oncology","score_opus":0.022183211927631535,"score_gpt":0.24736486699808918,"score_spread":0.22518165507045765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313475270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949061,0.000058301604,0.000003945895,0.00007226849,0.000031951095,0.00052099844,0.00003475948,0.000038921913,0.0043327375],"genre_scores_gemma":[0.99522495,0.00001256961,0.00010676909,0.00006687356,0.000019963425,0.00016471033,0.00012289132,0.000028755943,0.004252541],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900657,0.00004424261,0.00017182397,0.0002339623,0.00028768458,0.000255726],"domain_scores_gemma":[0.9996071,0.000043832402,0.000052513886,0.00016070371,0.000060599526,0.00007528053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006704102,0.00014922528,0.00023077971,0.00024219754,0.000020258174,0.0000076129754,0.000032302636,0.000030629613,0.00045192806],"category_scores_gemma":[0.0000057081784,0.000098153774,0.000021642094,0.0006915711,0.000033424196,0.00005661033,0.000011709329,0.000120978046,0.000039297887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002037928,0.00033731552,0.9926269,0.000078563105,0.00005284449,0.00088525406,0.00023103249,0.00049426954,0.0017529927,0.0000030884387,0.00050576695,0.000994026],"study_design_scores_gemma":[0.008499237,0.0017278387,0.9791234,0.00024130553,0.00014944712,0.000013576947,0.00018608081,0.00015611561,0.0090883635,0.000006455377,0.0006697943,0.00013835257],"about_ca_topic_score_codex":0.0027842305,"about_ca_topic_score_gemma":0.0037649763,"teacher_disagreement_score":0.013503485,"about_ca_system_score_codex":0.00023904527,"about_ca_system_score_gemma":0.00010049494,"threshold_uncertainty_score":0.49482954},"labels":[],"label_agreement":null},{"id":"W4313557964","doi":"10.1016/j.urolonc.2022.11.022","title":"Comparative real-world survival outcomes of metastatic papillary and clear cell renal cell carcinoma treated with immunotherapy, targeted therapy, and combination therapy","year":2023,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Internal medicine; Oncology; Clear cell renal cell carcinoma; Proportional hazards model; Renal cell carcinoma; Exact test; Immunotherapy; Cancer","score_opus":0.05975180963272117,"score_gpt":0.3126910654585206,"score_spread":0.25293925582579946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313557964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922164,0.0032005361,0.0000050194067,0.0013600504,0.00003705579,0.0008449979,0.000030985062,0.000072862655,0.0022320724],"genre_scores_gemma":[0.9873872,0.0056379107,0.0050384705,0.00031510866,0.000015619315,0.00008760462,0.00018304185,0.000025963356,0.0013091291],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833107,0.00035086385,0.0003817545,0.00042825076,0.00021783408,0.00029019846],"domain_scores_gemma":[0.9985941,0.00059558207,0.00027472517,0.00021903543,0.000119109594,0.0001974218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033951356,0.00032577885,0.000832543,0.0003389758,0.00022012813,0.000020780171,0.00006643952,0.00011764026,0.000037525868],"category_scores_gemma":[0.000010586165,0.0002184069,0.000056887413,0.00053937745,0.0009215705,0.00009306318,0.00003290533,0.00023916883,0.000003906793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011776235,0.00054017664,0.9752934,0.000046959867,0.00024538487,0.00018201182,0.0018534489,0.000021068445,0.018767277,0.0008057567,0.00035121207,0.0007157032],"study_design_scores_gemma":[0.007716678,0.016285835,0.9372026,0.000023764342,0.0002949584,0.000084558305,0.00097030005,0.0006468731,0.024566263,0.000957774,0.010981634,0.00026879378],"about_ca_topic_score_codex":0.00050763495,"about_ca_topic_score_gemma":0.00007423371,"teacher_disagreement_score":0.03809081,"about_ca_system_score_codex":0.00006908889,"about_ca_system_score_gemma":0.00018206034,"threshold_uncertainty_score":0.8906375},"labels":[],"label_agreement":null},{"id":"W4315642820","doi":"10.1016/j.annepidem.2023.01.003","title":"Differences in overall survival between clear cell metastatic renal cell carcinoma patients versus population-based controls according to race/ethnicity in the United States","year":2023,"lang":"en","type":"article","venue":"Annals of Epidemiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université de Montréal","funders":"","keywords":"Medicine; Pacific islanders; Ethnic group; Demography; Epidemiology; Population; Proportional hazards model; Renal cell carcinoma; Hazard ratio; Surveillance, Epidemiology, and End Results; Internal medicine; Gerontology; Oncology; Confidence interval; Cancer registry; Environmental health","score_opus":0.24063269964436998,"score_gpt":0.39164607926606343,"score_spread":0.15101337962169345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315642820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99495584,0.00013465085,0.000038905582,0.003685467,0.000105994375,0.0008482428,0.00008491505,0.000022690458,0.00012329085],"genre_scores_gemma":[0.9969696,0.00005830154,0.00019551416,0.0014402163,0.000044654433,0.00005767943,0.0011895184,0.000021644762,0.000022913127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994995,0.0025167563,0.001074353,0.00043234846,0.00028753697,0.0006940112],"domain_scores_gemma":[0.98526627,0.013640266,0.00037100067,0.00040260676,0.00015100464,0.00016883256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003347852,0.00026727107,0.0012373321,0.0006612549,0.000048616683,0.000005829842,0.0002421322,0.00011564314,0.000021352316],"category_scores_gemma":[0.002921709,0.00018388784,0.00018099336,0.0008349018,0.00007083819,0.00004986045,0.000066119384,0.00031489602,0.000025637577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018298771,0.00021146335,0.99352473,0.00008363429,0.000040707302,0.00003590407,0.00034240383,0.0032111236,0.000098163924,0.00003947418,0.0003823255,0.00020019071],"study_design_scores_gemma":[0.0044158944,0.0022292992,0.98926497,0.000053028478,0.000078134006,2.0435354e-7,0.00040214075,0.0022936638,0.000655528,0.00040134494,0.000062476225,0.00014330646],"about_ca_topic_score_codex":0.013135103,"about_ca_topic_score_gemma":0.0003700973,"teacher_disagreement_score":0.012765005,"about_ca_system_score_codex":0.000079657635,"about_ca_system_score_gemma":0.00006387576,"threshold_uncertainty_score":0.9934365},"labels":[],"label_agreement":null},{"id":"W4315881691","doi":"10.1007/s00261-023-03799-z","title":"Performance of clear cell likelihood scores in characterizing solid renal masses at multiparametric MRI: an external validation study","year":2023,"lang":"en","type":"article","venue":"Abdominal Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Receiver operating characteristic; Clear cell renal cell carcinoma; Renal cell carcinoma; Logistic regression; Radiology; Nuclear medicine; Urology; Internal medicine","score_opus":0.02990037899487454,"score_gpt":0.29853844416425146,"score_spread":0.26863806516937694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315881691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987015,0.0001391384,0.000010408776,0.000044195465,0.00015847821,0.00071194035,0.0000043809646,0.00004506315,0.0001848672],"genre_scores_gemma":[0.99831814,0.00022963327,0.00094179215,0.000035515044,0.0001516337,0.00007091422,0.000060295453,0.000031530908,0.00016054307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980268,0.00024859558,0.0005615485,0.00044665168,0.00027581857,0.00044058042],"domain_scores_gemma":[0.9989664,0.00022282467,0.000230127,0.00037380413,0.00006985829,0.00013699109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059453066,0.00021613156,0.00059337646,0.00072696945,0.000063386215,0.000008737168,0.00015184673,0.00011196427,0.00008325803],"category_scores_gemma":[0.00007928219,0.0001857333,0.00008831624,0.0006062128,0.00008811786,0.00013146586,0.0000955762,0.00020918004,0.00014355169],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025533545,0.00048916205,0.69604844,0.000079170175,0.00003482493,0.00041362725,0.0007603981,0.00017780834,0.29652825,8.099432e-7,0.000024092516,0.0028900623],"study_design_scores_gemma":[0.0029058375,0.0064361645,0.8156699,0.00006269359,0.00009745356,0.0002635685,0.00031358976,0.0048355944,0.16927001,0.000004604388,0.000017761726,0.00012282579],"about_ca_topic_score_codex":0.00010976627,"about_ca_topic_score_gemma":0.000017179045,"teacher_disagreement_score":0.12725824,"about_ca_system_score_codex":0.00022348089,"about_ca_system_score_gemma":0.00007348236,"threshold_uncertainty_score":0.7573984},"labels":[],"label_agreement":null},{"id":"W4316469573","doi":"10.3390/curroncol30010092","title":"Purely Off-Clamp Laparoscopic Partial Nephrectomy Stands the Test of Time: 15 Years Functional and Oncologic Outcomes from a Single Center Experience","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Clamp; Laparoscopy; Surgery; Single Center; General surgery; Kidney; Internal medicine","score_opus":0.12656352121607892,"score_gpt":0.36032460198519894,"score_spread":0.23376108076912003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4316469573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99576867,0.0010836277,0.00000931097,0.0009185206,0.0009096524,0.00048714466,0.00006397574,0.00006434243,0.0006947417],"genre_scores_gemma":[0.99866056,0.00017723696,0.00008382025,0.00014245539,0.00020036077,0.0001785638,0.000109848836,0.000014708748,0.00043241636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873334,0.00010310119,0.00031746534,0.0003174153,0.00024962262,0.0002790247],"domain_scores_gemma":[0.99858975,0.000840279,0.00013691651,0.00025095,0.00006817318,0.00011393669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014107354,0.00016651551,0.00046020665,0.000084984575,0.00006198825,0.000012294894,0.0000981226,0.00010553917,0.0005915007],"category_scores_gemma":[0.00024861004,0.00010773626,0.00009693985,0.00021185908,0.0003121737,0.00004148462,0.00012840929,0.00019583647,0.00014140706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034212501,0.001164961,0.944617,0.000026268923,0.00009650138,0.0000808037,0.0012739501,0.0000043938117,0.0108747175,0.000015030289,0.009234518,0.03226973],"study_design_scores_gemma":[0.0048710783,0.0021592297,0.8647393,0.00005882636,0.0001677261,0.000042148597,0.0004195848,0.00026309764,0.0030956347,0.00009595612,0.12395767,0.00012976484],"about_ca_topic_score_codex":0.00001876456,"about_ca_topic_score_gemma":0.000020123905,"teacher_disagreement_score":0.11472315,"about_ca_system_score_codex":0.00022759991,"about_ca_system_score_gemma":0.000159072,"threshold_uncertainty_score":0.6476518},"labels":[],"label_agreement":null},{"id":"W4316495391","doi":"10.32074/1591-951x-818","title":"What’s new in the WHO 2022 classification of kidney tumours?","year":2023,"lang":"en","type":"review","venue":"Pathologica","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Chromophobe cell; Pathology; Immunohistochemistry; Renal cell carcinoma; Kidney; Medicine; Anaplastic lymphoma kinase; Papillary renal cell carcinomas; Clear cell; Internal medicine; Lung cancer","score_opus":0.2155067493892478,"score_gpt":0.38402471895164697,"score_spread":0.16851796956239917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4316495391","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013127668,0.9933942,0.0000028542174,0.0013764169,0.0002791625,0.0015948489,0.000023685234,0.00004306912,0.0031544704],"genre_scores_gemma":[0.00008320892,0.9942489,0.0000795558,0.0002595009,0.0001960189,0.00028731851,0.00039423874,0.000035909772,0.00441534],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978355,0.00044573806,0.0006588048,0.00044058528,0.0003779241,0.00024142202],"domain_scores_gemma":[0.99830264,0.00029138243,0.0004177829,0.0007884097,0.00003910242,0.00016065467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007311815,0.00030867572,0.0014550134,0.00023227917,0.000028873883,0.000029406612,0.00032563083,0.0002780674,0.000111047535],"category_scores_gemma":[0.0007005657,0.00015799583,0.00044923835,0.0007105031,0.000072138384,0.000046409834,0.0000734309,0.00047964047,0.0003295527],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019525854,0.00022412399,0.00018535343,0.009212838,0.000063965446,0.0013353401,0.000540024,9.6916146e-8,0.0000184914,0.000371621,0.02848007,0.95954853],"study_design_scores_gemma":[0.0003532557,0.00041752547,0.0075571192,0.0161359,0.0011196277,0.00039490254,0.00035837523,0.0000016018913,0.0000050936715,0.00023370842,0.9732351,0.0001878152],"about_ca_topic_score_codex":0.000017815451,"about_ca_topic_score_gemma":0.0000036165434,"teacher_disagreement_score":0.9593607,"about_ca_system_score_codex":0.00015614685,"about_ca_system_score_gemma":0.0005776552,"threshold_uncertainty_score":0.6442883},"labels":[],"label_agreement":null},{"id":"W4317242654","doi":"10.3390/curroncol30010070","title":"Navigating the Current Landscape of Non-Clear Cell Renal Cell Carcinoma: A Review of the Literature","year":2023,"lang":"en","type":"review","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Renal cell carcinoma; Medicine; Clear cell renal cell carcinoma; Clinical trial; Clear cell; Bioinformatics; Cell; Kidney cancer; Computational biology; Pathology; Oncology; Biology; Genetics","score_opus":0.10630631232782628,"score_gpt":0.42043941762866543,"score_spread":0.31413310530083915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317242654","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010664498,0.9913834,0.0000014831853,0.00022670077,0.0020934837,0.0036926884,0.00020236005,0.00002552655,0.0013079471],"genre_scores_gemma":[0.0006101243,0.99752945,0.000035424044,0.00004374606,0.00062593113,0.0003662884,0.00046751532,0.000101390695,0.00022012564],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99532616,0.0009304115,0.0018525763,0.00067637244,0.0006978704,0.0005166239],"domain_scores_gemma":[0.994979,0.0007279256,0.0022206847,0.0014799344,0.00042050707,0.00017191403],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0009101508,0.0007184665,0.0035992747,0.00010949998,0.000104744424,0.000012643404,0.0008219007,0.00034653657,0.000074756324],"category_scores_gemma":[0.00019482663,0.00034072556,0.0019901963,0.0013969296,0.00025127802,0.000028382003,0.0005599789,0.003270587,0.00009450671],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019086887,0.00042687153,0.0001211838,0.37317204,0.000070996415,0.000037621146,0.00029214835,1.5244852e-7,0.000005458734,0.0000029535815,0.010077686,0.6157738],"study_design_scores_gemma":[0.00064030715,0.0005833217,0.00013126843,0.29588547,0.0039376896,0.00009471669,0.000031110136,0.0000060355756,0.000056125602,0.0000045094066,0.6984327,0.00019673473],"about_ca_topic_score_codex":0.000010182635,"about_ca_topic_score_gemma":0.000003308041,"teacher_disagreement_score":0.688355,"about_ca_system_score_codex":0.00038297052,"about_ca_system_score_gemma":0.0016363476,"threshold_uncertainty_score":0.99990445},"labels":[],"label_agreement":null},{"id":"W4318046437","doi":"10.1016/j.eururo.2023.01.001","title":"Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma","year":2023,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Juravinski Cancer Centre; Ottawa Regional Cancer Foundation; McMaster University; Queen Elizabeth II Health Sciences Centre; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Internal medicine; Carcinoma","score_opus":0.07258535591265095,"score_gpt":0.29758289015672945,"score_spread":0.2249975342440785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318046437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850816,0.0010118834,0.0030042368,0.0039081206,0.0007151018,0.0035570667,0.0006215779,0.00014945859,0.0019509472],"genre_scores_gemma":[0.9893312,0.000026135967,0.0024042337,0.0009011494,0.00017133469,0.00059169653,0.0045237085,0.00015046571,0.001900095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99647605,0.0005637397,0.0010701236,0.00084449054,0.00039281193,0.0006528056],"domain_scores_gemma":[0.99647576,0.0019702886,0.00043369867,0.0005586661,0.00035038733,0.00021122617],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001283668,0.00049618044,0.0008243993,0.00073147035,0.0001422284,0.000042510554,0.00035572934,0.000058146863,0.00007792665],"category_scores_gemma":[0.0007287425,0.00042143016,0.00031577438,0.00033941955,0.00019089201,0.00017910867,0.0001777037,0.00029009627,0.00013082082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009382976,0.005441748,0.90844995,0.0025675942,0.0012053985,0.008840033,0.0046097687,0.0008661776,0.024580956,0.0018675489,0.030295594,0.0018922623],"study_design_scores_gemma":[0.04130132,0.009261309,0.90877914,0.00006387425,0.0012781267,0.00019903854,0.0005563107,0.013054565,0.0095395055,0.0009137796,0.0142381415,0.0008148605],"about_ca_topic_score_codex":0.00006332357,"about_ca_topic_score_gemma":0.000055342447,"teacher_disagreement_score":0.031918347,"about_ca_system_score_codex":0.00013815533,"about_ca_system_score_gemma":0.00019432812,"threshold_uncertainty_score":0.99982375},"labels":[],"label_agreement":null},{"id":"W4318066476","doi":"10.1007/s12022-023-09748-2","title":"FLCN-Driven Functional Adrenal Cortical Carcinoma with High Mitotic Tumor Grade: Extending the Endocrine Manifestations of Birt-Hogg-Dubé Syndrome","year":2023,"lang":"en","type":"article","venue":"Endocrine Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University Health Network; University of Toronto; Toronto General Hospital; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Folliculin; Birt–Hogg–Dubé syndrome; Loss of heterozygosity; Germline; Adrenocortical carcinoma; Medicine; Malignancy; Pathology; Multiple endocrine neoplasia; Adrenal gland; Germline mutation; Cancer research; Internal medicine; Biology; Allele; Pneumothorax; Genetics; Mutation; Gene; Anatomy","score_opus":0.029030219620424177,"score_gpt":0.2655271229726589,"score_spread":0.23649690335223472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318066476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99529475,0.0002489412,0.00024092407,0.002225611,0.00044296653,0.0007568782,0.000076168784,0.00019718682,0.0005165987],"genre_scores_gemma":[0.9961065,0.000041101885,0.0012661293,0.00016676259,0.00022069026,0.00026496037,0.00034145685,0.00007586151,0.0015165075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99716634,0.00024837293,0.00060886936,0.0006120983,0.00060015416,0.00076415634],"domain_scores_gemma":[0.9981142,0.00059192604,0.00020173143,0.0006728044,0.00018722839,0.00023206262],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015819377,0.00037738503,0.0006556231,0.00044497452,0.00022575697,0.000015027855,0.00019342506,0.000044842473,0.00056907325],"category_scores_gemma":[0.00016679424,0.0002472095,0.00019996347,0.00074626296,0.0004774825,0.00007810615,0.00016943803,0.0005075891,0.00029463682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012294847,0.0010905131,0.64096624,0.00045221162,0.00065226876,0.26302388,0.00043871728,0.0011403391,0.07396174,0.014047259,0.0022920363,0.0007053074],"study_design_scores_gemma":[0.0030019444,0.0019861076,0.865785,0.00005941063,0.0004786613,0.119690806,0.00028671997,0.00035476268,0.0077262097,0.00023083742,0.00019980794,0.00019972044],"about_ca_topic_score_codex":0.000112517315,"about_ca_topic_score_gemma":0.000035276385,"teacher_disagreement_score":0.22481878,"about_ca_system_score_codex":0.00014699613,"about_ca_system_score_gemma":0.00019298575,"threshold_uncertainty_score":0.99999803},"labels":[],"label_agreement":null},{"id":"W4318450598","doi":"10.1111/bju.15981","title":"Adjuvant immunotherapy in renal cell carcinoma: a systematic review and <scp>meta‐analysis</scp>","year":2023,"lang":"en","type":"review","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Renal cell carcinoma; Adjuvant; Oncology; Meta-analysis; Confidence interval; Immunotherapy; Adverse effect; Discontinuation; Subgroup analysis; Study heterogeneity; Nephrectomy; Adjuvant therapy; Placebo; Cancer; Pathology; Kidney","score_opus":0.05259071150105974,"score_gpt":0.3077392555226396,"score_spread":0.2551485440215798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318450598","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024262081,0.997082,0.000013463978,0.00007598493,0.000096579875,0.0022305197,0.000050934974,0.000016541906,0.00019135221],"genre_scores_gemma":[0.0006172089,0.99739677,0.00011299673,0.0004322078,0.00010825576,0.00019698773,0.00005423425,0.000114469076,0.0009668841],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9933095,0.0017193521,0.0033552723,0.0005361639,0.00053132704,0.0005484014],"domain_scores_gemma":[0.9950257,0.0011854197,0.0026661884,0.0005474416,0.00027114473,0.00030412318],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.002351663,0.00062906445,0.015528309,0.0012953234,0.000050649796,0.000052847532,0.00038903044,0.00045194488,0.00006857974],"category_scores_gemma":[0.0004649705,0.0004917924,0.0041203015,0.0013350358,0.00011779071,0.000070479044,0.00009787069,0.001382054,0.00004413721],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001100443,0.00024004842,0.000025280913,0.8960101,0.06569376,0.032113355,0.000042710733,0.0000019404076,0.000001070762,0.000002435553,0.0008987484,0.004959543],"study_design_scores_gemma":[0.0012333952,0.0010208496,0.00028428348,0.08254768,0.8142189,0.07790329,0.000015435484,0.0000019551187,6.09244e-7,0.000016942668,0.022599561,0.00015710924],"about_ca_topic_score_codex":0.00011290807,"about_ca_topic_score_gemma":0.000065845445,"teacher_disagreement_score":0.81346244,"about_ca_system_score_codex":0.00020944588,"about_ca_system_score_gemma":0.00050716504,"threshold_uncertainty_score":0.99975336},"labels":[],"label_agreement":null},{"id":"W4318754961","doi":"10.1016/j.euo.2023.01.010","title":"Survival by Depth of Response and Efficacy by International Metastatic Renal Cell Carcinoma Database Consortium Subgroup with Lenvatinib Plus Pembrolizumab Versus Sunitinib in Advanced Renal Cell Carcinoma: Analysis of the Phase 3 Randomized CLEAR Study","year":2023,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute; Eisai Incorporated; Genentech; Ipsen; Astellas Pharma; EUSA Pharma; Seagen; Sanofi; Exelixis; Memorial Sloan-Kettering Cancer Center; Merck Sharp and Dohme; Ono Pharmaceutical; Eisai; Merck KGaA; Handok; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer","keywords":"Medicine; Lenvatinib; Sunitinib; Pembrolizumab; Renal cell carcinoma; Internal medicine; Oncology; Everolimus; Subgroup analysis; Kidney cancer; Response Evaluation Criteria in Solid Tumors; Clinical trial; Cancer; Phases of clinical research; Meta-analysis; Immunotherapy","score_opus":0.03463152331413209,"score_gpt":0.3178959216777795,"score_spread":0.2832643983636474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318754961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940331,0.00039735416,0.000050212817,0.00038482336,0.00021517539,0.001725693,0.0004216084,0.00003590065,0.0027361487],"genre_scores_gemma":[0.9982636,0.000036710302,0.00017579897,0.000100909616,0.000026931402,0.000064260224,0.00084652664,0.00006951039,0.00041575573],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98924387,0.0076268655,0.0012633252,0.0008183619,0.0005333136,0.00051429064],"domain_scores_gemma":[0.9931972,0.0047113462,0.00087920827,0.00079429854,0.00021763514,0.00020033776],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031442859,0.00042991134,0.0019092908,0.0008441316,0.00008818533,0.000009467412,0.00043145873,0.000087425724,0.00010517746],"category_scores_gemma":[0.000775705,0.0003090879,0.00027466804,0.0012363855,0.0010229537,0.00007267524,0.0003514107,0.00054988015,0.000010609484],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88086575,0.0041044867,0.046024382,0.000052948395,0.0017897071,0.0028989043,0.0027735343,0.0006412493,0.059857637,0.000012071269,0.00059630483,0.00038299788],"study_design_scores_gemma":[0.65175587,0.020013914,0.3069261,0.0000118279395,0.0072571053,0.000078595425,0.0020595437,0.0016212527,0.009411206,9.911256e-7,0.0005664837,0.00029713416],"about_ca_topic_score_codex":0.00031796106,"about_ca_topic_score_gemma":0.0003542022,"teacher_disagreement_score":0.26090172,"about_ca_system_score_codex":0.00020597946,"about_ca_system_score_gemma":0.0004295357,"threshold_uncertainty_score":0.9999361},"labels":[],"label_agreement":null},{"id":"W4319073819","doi":"10.21203/rs.3.rs-2538913/v1","title":"The global, regional, and national burden and quality of care index (QCI) of kidney cancer; a Global Burden of Disease systematic analysis 1990–2019","year":2023,"lang":"en","type":"preprint","venue":"Research Square","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Burden of disease; Incidence (geometry); Disease burden; Quality of life (healthcare); Demography; Disease; Gerontology; Internal medicine","score_opus":0.12002797014842763,"score_gpt":0.4453059008788544,"score_spread":0.32527793073042677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319073819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91610587,0.065116554,0.00002663173,0.0054060495,0.00007914121,0.0038646369,0.008928863,0.000026552021,0.0004456987],"genre_scores_gemma":[0.99369633,0.004898359,0.000041726453,0.000009694773,0.00013279925,0.00032473973,0.000616477,0.000019760237,0.00026012777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993068,0.0010753896,0.0010683853,0.00067575235,0.003727931,0.00038453375],"domain_scores_gemma":[0.9932581,0.0011115588,0.0006472491,0.0010406139,0.0032465109,0.00069591915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00219711,0.00030462473,0.0014694859,0.00037993552,0.00013020543,0.000047051206,0.0003837128,0.00022513651,0.000017728376],"category_scores_gemma":[0.003659879,0.00020912936,0.00048075375,0.0013623047,0.0007454948,0.000034668363,0.0009907482,0.00038165622,0.0000019781442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00250464,0.00013429963,0.6685432,0.31309694,0.0076709734,0.000049083155,0.0015798989,0.0019052722,0.00009552393,0.002339954,0.0018993261,0.00018085544],"study_design_scores_gemma":[0.0020370297,0.0004804868,0.94938415,0.031643752,0.0031790906,0.000005685474,0.007615299,0.0024417953,0.00007327063,0.0027407405,0.00010281674,0.00029586744],"about_ca_topic_score_codex":0.037555415,"about_ca_topic_score_gemma":0.0012974568,"teacher_disagreement_score":0.2814532,"about_ca_system_score_codex":0.0013129337,"about_ca_system_score_gemma":0.0036497375,"threshold_uncertainty_score":0.9688536},"labels":[],"label_agreement":null},{"id":"W4319226694","doi":"10.1016/j.euo.2023.01.008","title":"A Matched Analysis of Active Surveillance Versus Nephrectomy for T1a Small Renal Masses","year":2023,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Nephrectomy; Hazard ratio; Confidence interval; Internal medicine; Proportional hazards model; Cohort; Renal cell carcinoma; Urology; Surgery; Kidney","score_opus":0.06771732435127352,"score_gpt":0.32778051386068147,"score_spread":0.26006318950940793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319226694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732677,0.00012972389,0.00029517023,0.0017484449,0.0003537819,0.0005099072,0.000066331704,0.00015129767,0.02347766],"genre_scores_gemma":[0.9960449,0.00006983855,0.0018563259,0.0003890107,0.0001684188,0.000059062764,0.00040746122,0.00005080293,0.0009542098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978261,0.0006681668,0.0004334147,0.000500249,0.0001216712,0.00045039956],"domain_scores_gemma":[0.99739575,0.0015782656,0.000272504,0.0004397695,0.00017782248,0.00013590141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068493065,0.00021470984,0.0009456819,0.00065925665,0.00005564489,0.0000038961107,0.00017522222,0.0001318325,0.000142273],"category_scores_gemma":[0.00038502697,0.0001887314,0.00037118082,0.0010920916,0.00022001208,0.000019495712,0.00011699005,0.00019352595,0.00016419463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14967108,0.0032814688,0.43847552,0.00044791316,0.06455434,0.013274796,0.0072286064,0.0051599257,0.14917205,0.0015241379,0.02441675,0.1427934],"study_design_scores_gemma":[0.0096760085,0.008278928,0.8660054,0.000004161643,0.0039755236,0.00006163366,0.00020956821,0.0011168591,0.0017911908,0.000037372247,0.10864443,0.00019888218],"about_ca_topic_score_codex":0.000036392878,"about_ca_topic_score_gemma":0.0002778745,"teacher_disagreement_score":0.4275299,"about_ca_system_score_codex":0.00015128966,"about_ca_system_score_gemma":0.00016301824,"threshold_uncertainty_score":0.7696243},"labels":[],"label_agreement":null},{"id":"W4319660667","doi":"10.1016/s0140-6736(22)02574-0","title":"Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial","year":2023,"lang":"en","type":"article","venue":"The Lancet","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; EMD Serono; Ono Pharmaceutical; Eisai; Incyte; Exelixis; Memorial Sloan-Kettering Cancer Center; Pfizer; Genentech; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Nivolumab; Renal cell carcinoma; Ipilimumab; Nephrectomy; Adjuvant; Placebo; Internal medicine; Urology; Clinical trial; Carcinoma; Oncology; Surgery; Gastroenterology; Immunotherapy; Kidney; Cancer; Pathology","score_opus":0.09256596557415632,"score_gpt":0.3391126640744914,"score_spread":0.24654669850033512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319660667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831378,0.0008439632,0.00017459874,0.001790482,0.0011021867,0.008636735,0.00017970793,0.00031428025,0.0038202365],"genre_scores_gemma":[0.98661894,0.0000700174,0.00035936173,0.00032628054,0.003311371,0.004074875,0.0003779585,0.000110458015,0.004750717],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969617,0.00018597861,0.00062923325,0.0006334913,0.0005978272,0.0009917633],"domain_scores_gemma":[0.9974427,0.0006739052,0.00022180579,0.0012308328,0.00013612577,0.00029462852],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00095550437,0.00048469412,0.0013609496,0.0001932165,0.00019864914,0.000086215,0.00038821704,0.00018464758,0.00029599335],"category_scores_gemma":[0.000092843096,0.00031790213,0.00055919896,0.00046974633,0.00015450067,0.00009256071,0.00012568281,0.00037226253,0.0004068715],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9714437,0.00029195176,0.00004549989,0.00023411708,0.0002615879,0.0004069942,0.0007696279,0.00005915207,0.0016874475,0.000019580513,0.023760311,0.001019996],"study_design_scores_gemma":[0.9562244,0.0035759367,0.00015535226,0.00007228278,0.001073121,0.000032946005,0.00016944592,0.0028763355,0.017425576,0.00005939824,0.017995428,0.00033978885],"about_ca_topic_score_codex":0.00012956226,"about_ca_topic_score_gemma":0.000053770407,"teacher_disagreement_score":0.015738128,"about_ca_system_score_codex":0.00041479146,"about_ca_system_score_gemma":0.00039769255,"threshold_uncertainty_score":0.9999273},"labels":[],"label_agreement":null},{"id":"W4320167692","doi":"10.1080/21645515.2023.2178217","title":"The emerging landscape of neo/adjuvant immunotherapy in renal cell carcinoma","year":2023,"lang":"en","type":"review","venue":"Human Vaccines & Immunotherapeutics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Renal cell carcinoma; Adjuvant; Oncology; Immunotherapy; Internal medicine; Disease; Adjuvant therapy; Neoadjuvant therapy; Intensive care medicine; Cancer","score_opus":0.07265809764399947,"score_gpt":0.3489568101776381,"score_spread":0.2762987125336386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320167692","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009947554,0.98615617,0.000004022118,0.00006465644,0.000376603,0.002100381,0.000027438744,0.000112196285,0.0012109783],"genre_scores_gemma":[0.005674722,0.9878577,0.000063593594,0.000060458122,0.00030424324,0.00027168778,0.00022153619,0.00043625062,0.005109791],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99497956,0.00037392884,0.0023697081,0.0007290261,0.0006423953,0.0009053879],"domain_scores_gemma":[0.99595815,0.0005863348,0.0011701235,0.001988326,0.00019130461,0.00010576289],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00077540404,0.0010758664,0.0032732994,0.0007828239,0.00031346767,0.00008056449,0.0008446075,0.00048697725,0.00017065974],"category_scores_gemma":[0.000017119497,0.0006875211,0.0013590595,0.0011413521,0.00011144941,0.000061925406,0.0001780572,0.0010212626,0.00011818841],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050899683,0.0006727787,0.0019582354,0.017901616,0.001955024,0.00041153337,0.0011633898,0.0000074316895,0.0011886815,0.00022273698,0.0006606369,0.9733489],"study_design_scores_gemma":[0.0047647683,0.001014293,0.0054232567,0.008933566,0.0021578488,0.00019462274,0.00025649415,0.000022636985,0.00039370728,0.00011027826,0.97585523,0.00087328313],"about_ca_topic_score_codex":0.00020727157,"about_ca_topic_score_gemma":0.00010245373,"teacher_disagreement_score":0.97519463,"about_ca_system_score_codex":0.00038520063,"about_ca_system_score_gemma":0.0005172148,"threshold_uncertainty_score":0.9995576},"labels":[],"label_agreement":null},{"id":"W4320476698","doi":"10.1016/j.euros.2022.12.007","title":"The Learning Curve for Radical Nephrectomy for Kidney Cancer: Implications for Surgical Training","year":2023,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Renal function; Kidney cancer; Cohort; Urology; Cancer; Kidney; Surgery; Cohort study; Internal medicine","score_opus":0.1197766298025497,"score_gpt":0.39323436633494274,"score_spread":0.273457736532393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320476698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72681797,0.0008008027,0.01227201,0.20297305,0.0015313401,0.014905774,0.0002666836,0.00048549753,0.0399469],"genre_scores_gemma":[0.98717546,0.00008868435,0.0034692935,0.0017414279,0.00041692998,0.0018865513,0.00009899893,0.000057663892,0.0050650025],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981444,0.00014239094,0.00027677958,0.0006134862,0.00014761051,0.0006753467],"domain_scores_gemma":[0.9974074,0.0015902567,0.000110822766,0.0003630534,0.00019650937,0.0003319535],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0038751704,0.00013571071,0.00024333352,0.000097998396,0.0015402603,0.00014543881,0.0009972564,0.000031755986,0.000011339313],"category_scores_gemma":[0.0022197117,0.00009140993,0.00012422868,0.00053676177,0.0007891957,0.00011043327,0.00030247023,0.00015104096,0.0000308849],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008418844,0.00040296494,0.082075134,0.00020633513,0.0005065439,0.00018862046,0.0067200325,0.0017492169,0.038651507,0.08208061,0.17376295,0.60523725],"study_design_scores_gemma":[0.0038327284,0.0011183264,0.041542698,0.000012236917,0.00008606631,0.00009935784,0.00011760406,0.004629061,0.00035488603,0.0004596772,0.9476261,0.00012123946],"about_ca_topic_score_codex":0.00001195969,"about_ca_topic_score_gemma":0.0000068092945,"teacher_disagreement_score":0.7738632,"about_ca_system_score_codex":0.00007736408,"about_ca_system_score_gemma":0.00072972587,"threshold_uncertainty_score":0.9997596},"labels":[],"label_agreement":null},{"id":"W4320712669","doi":"10.1097/ju.0000000000003366","title":"Evolution of Bosniak IIF Renal Cysts and Impact of the 2019 Bosniak Classification. Reply.","year":2023,"lang":"en","type":"letter","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"IIf; Medicine; Malignancy; Radiology; Internal medicine; General surgery; Indirect immunofluorescence","score_opus":0.02839323920496063,"score_gpt":0.2825589074412285,"score_spread":0.2541656682362679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320712669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6705987,0.005489472,0.000036755213,0.32249805,0.00051405176,0.0004222183,0.00006138954,0.000008696167,0.00037064176],"genre_scores_gemma":[0.9804679,0.0008518908,0.000045985398,0.015190325,0.0016471802,0.0000031943393,0.000021876529,0.000055483903,0.0017161373],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99736583,0.00066201296,0.0009521075,0.00017127505,0.0005764265,0.00027237344],"domain_scores_gemma":[0.996045,0.00064075924,0.0020589572,0.0007619844,0.00042723448,0.00006609613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010611585,0.0002511306,0.0008241648,0.000317323,0.000057866193,0.000004771372,0.00037010957,0.00041332465,0.000048093065],"category_scores_gemma":[0.00028777897,0.00011750721,0.0004892961,0.00025414073,0.00044235057,0.00004092505,0.0001030109,0.0015762931,0.000008928284],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001474917,0.00007764644,0.011548888,0.00011576503,0.0010923765,0.00020798332,0.0002642482,0.00010860912,0.029864324,0.000015449948,0.95501846,0.00021134315],"study_design_scores_gemma":[0.0023450735,0.0057859495,0.94602,0.00025708773,0.00335161,0.009369553,0.00004691325,0.00012440221,0.0010185533,0.00092987117,0.030590413,0.00016053958],"about_ca_topic_score_codex":0.0002422733,"about_ca_topic_score_gemma":0.0000063792077,"teacher_disagreement_score":0.93447113,"about_ca_system_score_codex":0.00031647165,"about_ca_system_score_gemma":0.00058400474,"threshold_uncertainty_score":0.6848297},"labels":[],"label_agreement":null},{"id":"W4321350071","doi":"10.1016/j.urolonc.2023.01.003","title":"Morbidity and mortality of multivisceral resection with radical nephrectomy for locally advanced renal cell carcinoma: An analysis of the National Surgical Quality Improvement Program (NSQIP) database","year":2023,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Propensity score matching; Renal cell carcinoma; Odds ratio; Confidence interval; Database; Nephrectomy; Retrospective cohort study; Surgery; Cohort; Internal medicine; Kidney","score_opus":0.067057038859862,"score_gpt":0.381023893112357,"score_spread":0.31396685425249504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321350071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974553,0.00009262193,0.00008509977,0.00069693767,0.000037420694,0.001178207,0.0002558314,0.00003531708,0.00016326297],"genre_scores_gemma":[0.9778661,0.000037519418,0.021014549,0.00010065252,0.000045499404,0.00031508814,0.000531762,0.000008636019,0.00008015565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823904,0.00023858529,0.00045881598,0.0004476849,0.0003824109,0.00023348666],"domain_scores_gemma":[0.99857646,0.00041809183,0.0003137291,0.00024077247,0.00024267891,0.00020828038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008940883,0.0001765295,0.00051457086,0.0002065218,0.00017559386,0.000008670548,0.000084273255,0.00013953059,0.000011176847],"category_scores_gemma":[0.0001442248,0.000112388174,0.000117977346,0.00077552866,0.0011046565,0.00009317569,0.000066221466,0.00021247988,1.9892367e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017921785,0.0009971278,0.98218936,0.00016332002,0.00038994598,0.000035176865,0.00024163545,0.0009620378,0.010297753,0.0010365593,0.00013639998,0.0017585162],"study_design_scores_gemma":[0.0050064786,0.014395363,0.92552084,0.00003183377,0.0025194453,0.000059932823,0.00025433197,0.023664251,0.01723741,0.00056070695,0.010561692,0.00018771322],"about_ca_topic_score_codex":0.00040764542,"about_ca_topic_score_gemma":0.0005711974,"teacher_disagreement_score":0.056668505,"about_ca_system_score_codex":0.00013442764,"about_ca_system_score_gemma":0.0004413793,"threshold_uncertainty_score":0.45830566},"labels":[],"label_agreement":null},{"id":"W4321367863","doi":"10.1016/j.ucl.2023.01.003","title":"Cystic Renal Masses","year":2023,"lang":"en","type":"review","venue":"Urologic Clinics of North America","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Princess Margaret Cancer Foundation; University Health Network","keywords":"Medicine; Natural history; Renal cell carcinoma; Renal mass; Radiology; Pathology; Kidney; Intensive care medicine; General surgery; Nephrectomy; Internal medicine","score_opus":0.12887624839372036,"score_gpt":0.38451834475932845,"score_spread":0.2556420963656081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321367863","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048106184,0.9963726,0.0000320654,0.00005777317,0.00028435723,0.001160127,0.00018093592,0.00017537514,0.0012557312],"genre_scores_gemma":[0.00006862467,0.9951679,0.0018557238,0.00021455347,0.00027152852,0.00014094681,0.0009548724,0.00009972435,0.0012261033],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964765,0.00023701698,0.0016044085,0.00073813845,0.00048119423,0.000462765],"domain_scores_gemma":[0.9950687,0.0021246301,0.0013579177,0.0010629352,0.00012874324,0.00025703476],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002712973,0.00058260735,0.0038414218,0.00033902517,0.000043716787,0.000009176456,0.0003693234,0.00032741317,0.0001435122],"category_scores_gemma":[0.0012826256,0.00039653698,0.0014174668,0.0008545381,0.0003155501,0.000018905606,0.00021879579,0.00074335316,0.0012412186],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006970456,0.0002232715,0.0016059052,0.0091077015,0.0007216487,0.00103972,0.00000835342,0.000008991454,2.1731543e-8,0.000002846353,0.0013849861,0.98582685],"study_design_scores_gemma":[0.00031404773,0.0026009222,0.00086420594,0.0021042116,0.004942728,0.0001452426,0.0000033927627,0.000012453983,6.673679e-8,0.000032770626,0.9887117,0.0002682252],"about_ca_topic_score_codex":0.000030301084,"about_ca_topic_score_gemma":0.000008341208,"teacher_disagreement_score":0.98732674,"about_ca_system_score_codex":0.00009385271,"about_ca_system_score_gemma":0.0007399006,"threshold_uncertainty_score":0.99984866},"labels":[],"label_agreement":null},{"id":"W4321611729","doi":"10.1158/1078-0432.ccr-22-1936","title":"Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre","funders":"NIHR Cambridge Biomedical Research Centre; European Commission; Fonds de Recherche du Québec - Santé; Kidney Foundation of Canada; National Institute for Health and Care Research; Cancer Research Society; Cancer Research UK; Ministère de l'Éducation et de l'Enseignement supérieur; McGill University; World Health Organization","keywords":"Medicine; Renal cell carcinoma; Cohort; Oncology; Internal medicine; Clear cell renal cell carcinoma; Adjuvant therapy; Cancer","score_opus":0.3207378210906531,"score_gpt":0.4987843110072705,"score_spread":0.17804648991661742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321611729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942805,0.00059725373,0.00013523332,0.0016408972,0.000067971516,0.0028493989,0.000039177296,0.000024306639,0.00036526468],"genre_scores_gemma":[0.99642694,0.00036541457,0.0006392801,0.00010310005,0.00018661791,0.0018382928,0.00010507861,0.000032895925,0.00030240827],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974624,0.00021073187,0.0008261009,0.0005451585,0.0005404327,0.00041515863],"domain_scores_gemma":[0.9979532,0.00065446884,0.00012021539,0.00056330056,0.00049134647,0.00021748275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021426082,0.00011916028,0.00038635425,0.000350589,0.00005705223,0.000010254224,0.00016098442,0.00011710535,0.00003715619],"category_scores_gemma":[0.00020750104,0.00009837914,0.00012723736,0.00078040117,0.00010032655,0.000029300683,0.000066920344,0.00032897812,0.00007281444],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003334555,0.00037864462,0.086666785,0.00023852907,0.000026320264,0.000023283174,0.0007397252,0.00045920123,0.69266224,0.000103020146,0.0017774864,0.21359022],"study_design_scores_gemma":[0.0031723664,0.0052936436,0.7397349,0.00008353442,0.000018110915,0.0000015801556,0.00036076375,0.0023540368,0.2457525,0.00034093086,0.0027575921,0.00013006252],"about_ca_topic_score_codex":0.0011561789,"about_ca_topic_score_gemma":0.00022914975,"teacher_disagreement_score":0.65306807,"about_ca_system_score_codex":0.00070845353,"about_ca_system_score_gemma":0.0007383213,"threshold_uncertainty_score":0.40117848},"labels":[],"label_agreement":null},{"id":"W4321781776","doi":"10.1016/j.jvir.2022.12.400","title":"Abstract No. 542 Microwave Ablation versus Cryoablation for T1a Renal Cell Carcinoma: A Systematic Literature Review and Meta-Analysis","year":2023,"lang":"en","type":"article","venue":"Journal of Vascular and Interventional Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Microwave ablation; Cryoablation; Meta-analysis; Renal cell carcinoma; Systematic review; Ablation; Surgery; MEDLINE; Radiology; Internal medicine","score_opus":0.04942925358402719,"score_gpt":0.3094758463964817,"score_spread":0.2600465928124545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321781776","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2140946,0.7806931,0.002193688,0.0011406043,0.00022217908,0.001319753,0.00006187651,0.000013848519,0.00026033385],"genre_scores_gemma":[0.9905687,0.0072939396,0.001133621,0.00012383182,0.00013755067,0.000048106216,0.00022137887,0.000014715209,0.00045815777],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99836457,0.00018519479,0.00085772603,0.00020866243,0.00023516083,0.000148664],"domain_scores_gemma":[0.9983405,0.00028554146,0.0005757848,0.0001547276,0.0005290583,0.00011438343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012862452,0.00017717681,0.0014111501,0.00043270405,0.000055769357,0.000028311819,0.00005534532,0.00010996546,0.00010175935],"category_scores_gemma":[0.00023956769,0.00011644252,0.0023008515,0.00030162866,0.000038897964,0.00012512306,0.000020167896,0.00017225406,0.0000068256104],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037498595,0.0010721764,0.0034502489,0.40070403,0.5468,0.0012453481,0.0007010109,0.00038826728,0.018739454,0.0011285789,0.02174842,0.00027262548],"study_design_scores_gemma":[0.006831143,0.004376095,0.13854873,0.002780944,0.8428178,0.0019824689,0.000064328495,0.0006589394,0.0006500855,0.00035109877,0.00063564145,0.00030274928],"about_ca_topic_score_codex":0.0000029104647,"about_ca_topic_score_gemma":0.000002327823,"teacher_disagreement_score":0.7764741,"about_ca_system_score_codex":0.00007249638,"about_ca_system_score_gemma":0.00003599652,"threshold_uncertainty_score":0.4748388},"labels":[],"label_agreement":null},{"id":"W4322422773","doi":"10.1016/s1470-2045(23)00049-9","title":"Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study","year":2023,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; University of Alberta","funders":"","keywords":"Lenvatinib; Medicine; Sunitinib; Renal cell carcinoma; Pembrolizumab; Everolimus; Internal medicine; Oncology; Clinical endpoint; Kidney cancer; Cancer; Clinical trial; Immunotherapy","score_opus":0.11808466686181321,"score_gpt":0.3742417348262079,"score_spread":0.25615706796439464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322422773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857422,0.0002954958,0.0000046251976,0.0017626196,0.00044671827,0.00650448,0.00026900682,0.000084825086,0.004890015],"genre_scores_gemma":[0.99590427,0.00019076132,0.00019348908,0.00024013988,0.00034307968,0.0010106134,0.0007510589,0.00007379396,0.0012927861],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969317,0.00067045924,0.00062914594,0.0006016468,0.0005391449,0.00062790903],"domain_scores_gemma":[0.9956392,0.00214718,0.0004747391,0.001334969,0.00023240244,0.00017150844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004562708,0.00045598834,0.0015416613,0.00008732713,0.00031066983,0.000029541136,0.0006420188,0.00011763107,0.00024425055],"category_scores_gemma":[0.00015673245,0.00022785946,0.00013888557,0.0004682135,0.00024658357,0.0000808019,0.00025103948,0.0002653673,0.00012165118],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92958057,0.015070694,0.010268904,0.00004315742,0.0013022083,0.0009142812,0.009230685,0.00010761319,0.00063297834,0.000034271972,0.0018639538,0.03095071],"study_design_scores_gemma":[0.8163802,0.09713788,0.072748296,0.00003885209,0.0015859442,0.000012173727,0.0023084753,0.00015601593,0.003036389,0.000051377363,0.006305909,0.00023849103],"about_ca_topic_score_codex":0.0012981531,"about_ca_topic_score_gemma":0.0011872755,"teacher_disagreement_score":0.113200344,"about_ca_system_score_codex":0.000656269,"about_ca_system_score_gemma":0.000547237,"threshold_uncertainty_score":0.9291839},"labels":[],"label_agreement":null},{"id":"W4322719704","doi":"10.2214/ajr.23.29040","title":"Proposed Modifications to the Multiparametric CT Score for Diagnosis of ccRCC Using Hyperattenuation, Segmental Enhancement Inversion, and ADER: A Secondary Analysis","year":2023,"lang":"en","type":"letter","venue":"American Journal of Roentgenology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Clear cell renal cell carcinoma; Radiology; Renal cell carcinoma; Diagnostic accuracy; Nuclear medicine; Pathology","score_opus":0.05205041844084039,"score_gpt":0.3004162639731957,"score_spread":0.2483658455323553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322719704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8510749,0.00096057315,0.0020831903,0.14442591,0.00018509578,0.0011363763,0.00012142577,0.0000074108425,0.000005135575],"genre_scores_gemma":[0.9344929,0.00080274977,0.010246582,0.05314642,0.0005922006,0.00015164369,0.00026646268,0.00007260743,0.0002284347],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9976585,0.00022056568,0.0009295206,0.0003747958,0.0004703338,0.00034626992],"domain_scores_gemma":[0.99691194,0.00050598034,0.0013833132,0.00042828624,0.0006319454,0.00013851166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003167369,0.00028643332,0.0011932144,0.0018065744,0.00012897322,0.000017863786,0.00024154721,0.00008997138,0.000047910355],"category_scores_gemma":[0.00022978346,0.00019885942,0.00045962568,0.001797888,0.00035567928,0.00004556638,0.00008068503,0.0005839101,0.000005347435],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018194638,0.0013829569,0.29334554,0.0009981322,0.040722467,0.001524964,0.004278855,0.004466713,0.01345672,0.0000071863647,0.5496281,0.088368915],"study_design_scores_gemma":[0.029634021,0.08283584,0.25814587,0.002568326,0.16678311,0.007578396,0.023006234,0.012226926,0.16698606,0.00017797237,0.24643157,0.0036256742],"about_ca_topic_score_codex":0.00030318185,"about_ca_topic_score_gemma":0.000027651886,"teacher_disagreement_score":0.30319652,"about_ca_system_score_codex":0.00039327412,"about_ca_system_score_gemma":0.00040845177,"threshold_uncertainty_score":0.8109252},"labels":[],"label_agreement":null},{"id":"W4322722432","doi":"10.1542/peds.147.3ma9.856","title":"Cardiac Complications in an Adolescent with Stage IV Renal Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"PEDIATRICS","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Stage (stratigraphy); Internal medicine; Oncology","score_opus":0.027919357242603512,"score_gpt":0.26175134986554677,"score_spread":0.23383199262294324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322722432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910432,0.0022212137,0.00012846082,0.00034228002,0.00006979101,0.00038886655,0.000054025382,0.00003973323,0.005712425],"genre_scores_gemma":[0.9955158,0.00014933675,0.002472483,0.00019822447,0.00027228685,0.000043693228,0.0002797525,0.000033525313,0.0010348799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986249,0.00007709521,0.00024232731,0.00040343843,0.00035589165,0.00029634577],"domain_scores_gemma":[0.9987842,0.000047002686,0.00007149062,0.0006125199,0.00021481053,0.0002699894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009549884,0.00017521642,0.00028836646,0.00014355817,0.000052810126,0.000024522507,0.00007617374,0.00007072169,0.00004116622],"category_scores_gemma":[0.000016539003,0.00015036752,0.00008050348,0.00055574643,0.00003069619,0.000062315026,0.00004602409,0.00024577274,0.000059553222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000782589,0.00070546294,0.9941668,0.0001777728,0.0000071440186,0.0006859787,0.0002476253,0.00007412703,0.0029071446,0.00004530176,0.00059182406,0.00031258672],"study_design_scores_gemma":[0.0014871961,0.00035219465,0.98773956,0.000013469588,0.00019446293,0.000028988257,0.000316215,0.000094387186,0.0074510835,0.0000058503806,0.0021468513,0.00016974982],"about_ca_topic_score_codex":0.000081292346,"about_ca_topic_score_gemma":0.00009539852,"teacher_disagreement_score":0.006427222,"about_ca_system_score_codex":0.0002669777,"about_ca_system_score_gemma":0.000442263,"threshold_uncertainty_score":0.61318094},"labels":[],"label_agreement":null},{"id":"W4322733329","doi":"10.1038/s41416-023-02166-5","title":"The role of cytoreductive nephrectomy and systemic therapy in the management of tumour thrombus in patients with metastatic renal cell carcinoma","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Renal cell carcinoma; Thrombus; Nephrectomy; Systemic therapy; Urology; Internal medicine; Progression-free survival; Oncology; Surgery; Gastroenterology; Cancer; Overall survival; Kidney","score_opus":0.010381064924269066,"score_gpt":0.24133690922868262,"score_spread":0.23095584430441354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322733329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737536,0.025304038,9.205575e-7,0.000073810515,0.00004162672,0.0005554019,0.000011580163,0.0000016141314,0.00025741433],"genre_scores_gemma":[0.9954896,0.0043213633,0.00008309385,0.000012960609,0.000024613466,0.000026623005,0.0000019934332,0.000013856914,0.000025909374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865925,0.00013470859,0.00043780025,0.0001058538,0.00049636746,0.00016599776],"domain_scores_gemma":[0.99925226,0.000073283314,0.00035333625,0.00011064278,0.00017229666,0.000038177986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004181881,0.000100571444,0.00034428368,0.00011321811,0.000032792672,0.000015779557,0.0001228806,0.000017444265,0.000006151082],"category_scores_gemma":[0.000004859784,0.000058154186,0.00006183747,0.0003531199,0.000087737215,0.00006254222,0.000019272593,0.00016432909,2.5723932e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030704571,0.00054976495,0.8959768,0.000466455,0.0006697754,0.0016126076,0.0030521723,0.00029175586,0.0035202508,0.000035268138,0.00015738774,0.0905973],"study_design_scores_gemma":[0.0056109293,0.0009185984,0.98265266,0.0011581909,0.0001563895,0.00026851,0.004219852,0.0000106328835,0.004799528,0.00008837397,0.00006388327,0.00005246666],"about_ca_topic_score_codex":0.00069423235,"about_ca_topic_score_gemma":0.00016887671,"teacher_disagreement_score":0.090544835,"about_ca_system_score_codex":0.00012395551,"about_ca_system_score_gemma":0.00010027754,"threshold_uncertainty_score":0.23714589},"labels":[],"label_agreement":null},{"id":"W4323656079","doi":"10.1016/j.euf.2023.02.010","title":"The Association Between Cytoreductive Nephrectomy and Overall Survival in Metastatic Renal Cell Carcinoma with Primary Tumor Size ≤4 cm","year":2023,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Hazard ratio; Nephrectomy; Internal medicine; Proportional hazards model; Propensity score matching; Oncology; Clear cell renal cell carcinoma; Population; Surveillance, Epidemiology, and End Results; Urology; Systemic therapy; Epidemiology; Gastroenterology; Cancer; Kidney; Cancer registry; Confidence interval; Breast cancer","score_opus":0.015027432152863746,"score_gpt":0.22456107567706032,"score_spread":0.20953364352419657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323656079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777183,0.00052898476,0.000005932091,0.0017436717,0.00008961813,0.00049405446,0.000015708993,0.00007524296,0.0193285],"genre_scores_gemma":[0.9975104,0.000032087024,0.00016974313,0.00018523955,0.00019501586,0.000021523243,0.000034862962,0.00005956749,0.0017916085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99752885,0.0009513403,0.00030541778,0.0004183165,0.00032044263,0.00047564492],"domain_scores_gemma":[0.9980099,0.0013074516,0.00018969463,0.00029601366,0.00006696463,0.00012998212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001026875,0.00023222693,0.00040545483,0.00011842222,0.00012546749,0.000028661934,0.00011704266,0.00003559586,0.000010036283],"category_scores_gemma":[0.0001962503,0.00015184925,0.00006360295,0.00029752075,0.00012710749,0.000059784674,0.00011672819,0.00038263272,0.00011872267],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001181544,0.00009226102,0.98783517,0.00003762851,0.00030023974,0.0036291897,0.00087617664,0.000019988507,0.0031875868,0.00005148972,0.0010358678,0.0017528806],"study_design_scores_gemma":[0.0036930516,0.0013329845,0.99064386,0.000007570532,0.00035613897,0.00007718293,0.00007986303,0.000012249466,0.0010102165,0.000114630326,0.0025345832,0.00013769971],"about_ca_topic_score_codex":0.00008795562,"about_ca_topic_score_gemma":0.000038786427,"teacher_disagreement_score":0.019792063,"about_ca_system_score_codex":0.00026168916,"about_ca_system_score_gemma":0.00011441541,"threshold_uncertainty_score":0.61922324},"labels":[],"label_agreement":null},{"id":"W4324136172","doi":"10.1200/jco.2023.41.6_suppl.654","title":"Characterization of clinical outcomes among patients with advanced chromophobe renal cell carcinoma (ChRCC) treated with first-line immunotherapy (IO)-based regimens.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary; BC Cancer Agency","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Clear cell; Clear cell renal cell carcinoma; Odds ratio; Proportional hazards model; Oncology; Logistic regression","score_opus":0.06000292314472487,"score_gpt":0.3742030261254033,"score_spread":0.3142001029806784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324136172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970542,0.000051161085,0.00011460994,0.001106384,0.00043658423,0.0007978112,0.00002284582,0.000037536,0.00037886304],"genre_scores_gemma":[0.9962358,0.00037994966,0.0018213021,0.0005534478,0.0003278164,0.00001919129,0.00016010371,0.00007629655,0.00042612568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99342597,0.0006090219,0.0042269905,0.00045011562,0.0008777161,0.00041016843],"domain_scores_gemma":[0.9899901,0.0025666934,0.005152155,0.0005535311,0.0012425397,0.00049496396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019135473,0.00038870279,0.0031671172,0.00033350542,0.000067090376,0.000009741938,0.00023895029,0.00050809735,0.00011570378],"category_scores_gemma":[0.0007528968,0.00022366176,0.0008009848,0.00055928744,0.00048529427,0.00020070166,0.00003851369,0.00091466255,0.00001815186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032261018,0.004309547,0.94850904,0.000080552054,0.00061791774,0.0010891656,0.00005208541,0.00014959583,0.0012653245,0.0000011787498,0.00012548568,0.01153908],"study_design_scores_gemma":[0.04689177,0.067031115,0.87976825,0.0002504288,0.00065181614,0.000026590636,0.000018177056,0.00013333895,0.0036650451,0.000003247741,0.0013712932,0.00018889812],"about_ca_topic_score_codex":0.000049086662,"about_ca_topic_score_gemma":0.00006809839,"teacher_disagreement_score":0.06874077,"about_ca_system_score_codex":0.00020687675,"about_ca_system_score_gemma":0.0016141316,"threshold_uncertainty_score":0.91206616},"labels":[],"label_agreement":null},{"id":"W4324136206","doi":"10.1200/jco.2023.41.6_suppl.636","title":"The survival outcomes of metastatic non-clear cell renal cell carcinoma in the immunotherapy era: Princess Margaret Cancer Centre (PMCC) experience.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Royal Victoria Regional Health Centre; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Renal cell carcinoma; Sunitinib; Internal medicine; Ipilimumab; Regimen; Nivolumab; Oncology; Proportional hazards model; Clear cell renal cell carcinoma; Progression-free survival; Cancer; Surgery; Immunotherapy; Chemotherapy","score_opus":0.11396875939156738,"score_gpt":0.43938296977762364,"score_spread":0.3254142103860563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324136206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837122,0.0012226879,0.00001010342,0.010820329,0.0012494245,0.0004461587,0.0000062728927,0.0000061109754,0.0025267329],"genre_scores_gemma":[0.99498713,0.0025485104,0.00031499827,0.0007485453,0.00029152498,0.000020633202,0.0000024700441,0.000027374545,0.0010588289],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946447,0.0012278613,0.0025899997,0.00024180593,0.0008528247,0.0004428325],"domain_scores_gemma":[0.99141616,0.0058769835,0.0017554502,0.00045281532,0.00031007986,0.00018853176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004492298,0.00023185351,0.0016500634,0.00014088136,0.00009218704,0.000017966431,0.00060500775,0.00017773778,0.00015543483],"category_scores_gemma":[0.00051784137,0.0001069649,0.0007058685,0.00042756693,0.0003850653,0.000078183235,0.00008548811,0.001077113,0.000020557141],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047413623,0.0017242165,0.9685785,0.00006932453,0.00034552708,0.0019166948,0.0037557643,0.00011374102,0.0014393443,0.00003677205,0.0028003466,0.014478388],"study_design_scores_gemma":[0.008077001,0.00455389,0.9686937,0.0000439237,0.00024542763,0.000042854783,0.0044890298,0.00012366023,0.0018177832,0.00007945637,0.0117298905,0.00010341897],"about_ca_topic_score_codex":0.00035203432,"about_ca_topic_score_gemma":0.00034090635,"teacher_disagreement_score":0.0143749695,"about_ca_system_score_codex":0.00021072275,"about_ca_system_score_gemma":0.0013454001,"threshold_uncertainty_score":0.46795797},"labels":[],"label_agreement":null},{"id":"W4324136257","doi":"10.1200/jco.2023.41.6_suppl.673","title":"Impact of number of treatment lines following first-line (1L) immuno-oncology (IO) combination on overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; BC Cancer Agency; University of Alberta; University of Calgary","funders":"Pfizer","keywords":"Medicine; Sunitinib; Cabozantinib; Axitinib; Pazopanib; Nivolumab; Ipilimumab; Internal medicine; Oncology; Renal cell carcinoma; Pembrolizumab; Cancer; Immunotherapy","score_opus":0.09932302570924442,"score_gpt":0.43582544593874145,"score_spread":0.33650242022949706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324136257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968469,0.000093574075,0.000009934272,0.00051501824,0.000691746,0.00059109647,0.000020011621,0.0000088723555,0.0012228289],"genre_scores_gemma":[0.998498,0.00018388868,0.0008045663,0.000056516114,0.0001609631,0.000012018069,0.00006172056,0.00003885056,0.00018344817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99455494,0.0008379384,0.003246128,0.00029861025,0.00067950954,0.00038284875],"domain_scores_gemma":[0.99194276,0.0040534344,0.002750695,0.0003360667,0.0006294564,0.00028757416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020583586,0.00032808195,0.002977992,0.0004361449,0.000032770047,0.0000046979944,0.00017164918,0.00030614948,0.00011088812],"category_scores_gemma":[0.0009631904,0.00019933592,0.0011847924,0.00043483556,0.00015369445,0.00011471437,0.00005556633,0.0005259796,0.000018077066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021411207,0.013208187,0.9513428,0.00007203495,0.0012736119,0.0012232867,0.0002830021,0.0011283504,0.00034489797,0.000015904938,0.00018844697,0.009508261],"study_design_scores_gemma":[0.04770579,0.13347605,0.81645155,0.00015539421,0.00094117236,0.000040260296,0.000055800363,0.00017638634,0.0005700185,0.00010833687,0.00020200375,0.00011722077],"about_ca_topic_score_codex":0.00045497375,"about_ca_topic_score_gemma":0.0001651908,"teacher_disagreement_score":0.13489123,"about_ca_system_score_codex":0.0016411077,"about_ca_system_score_gemma":0.0020586692,"threshold_uncertainty_score":0.8128683},"labels":[],"label_agreement":null},{"id":"W4324136259","doi":"10.1200/jco.2023.41.6_suppl.690","title":"Outcomes of partial nephrectomy for non-metastatic cT2 renal tumors: Results from a Canadian multi-institutional collaborative.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Queen Elizabeth II Health Sciences Centre; McGill University Health Centre; University of Ottawa; Université Laval; Sunnybrook Health Science Centre; St. Boniface Hospital; Ottawa Hospital; St. Joseph’s Healthcare Hamilton; University of Manitoba; Dalhousie University; University of Toronto; McMaster University; University of British Columbia","funders":"","keywords":"Medicine; Chromophobe cell; Nephrectomy; Renal cell carcinoma; Clear cell; Histology; Internal medicine; Urology; Cancer; Kidney cancer; Pathological; Gastroenterology; Surgery; Kidney","score_opus":0.17107211845663586,"score_gpt":0.45926812666341765,"score_spread":0.2881960082067818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324136259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98838645,0.000097704025,0.00031407096,0.008091008,0.0011686741,0.0007644802,0.00054547435,0.000010982069,0.00062116893],"genre_scores_gemma":[0.9685143,0.00007563734,0.029307654,0.0007860687,0.00077129586,0.000034981113,0.00011845367,0.000018811541,0.00037275057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99556184,0.00030887246,0.003079306,0.00026110234,0.00043890093,0.0003500011],"domain_scores_gemma":[0.9908441,0.005507106,0.0017130796,0.00022230815,0.00092334993,0.0007901079],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0026642343,0.00019856985,0.002019575,0.00034181835,0.00007322239,0.000008788072,0.00017162092,0.00022477661,0.00006326355],"category_scores_gemma":[0.0108388085,0.00012942177,0.0006659037,0.00038713255,0.00029408,0.000094658906,0.000032138472,0.0004833355,0.000042392934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.081516325,0.008983649,0.66909254,0.0002522075,0.012316417,0.027849847,0.0029122375,0.0022561653,0.0047705863,0.0006280086,0.09181539,0.09760664],"study_design_scores_gemma":[0.04210693,0.011100505,0.87056446,0.00021549399,0.00098034,0.00012999373,0.00037812252,0.0018665055,0.0012996474,0.0002466941,0.070954666,0.00015661864],"about_ca_topic_score_codex":0.004711219,"about_ca_topic_score_gemma":0.014223425,"teacher_disagreement_score":0.20147195,"about_ca_system_score_codex":0.00038853724,"about_ca_system_score_gemma":0.010879134,"threshold_uncertainty_score":0.9974933},"labels":[],"label_agreement":null},{"id":"W4324136271","doi":"10.1200/jco.2023.41.6_suppl.600","title":"Outcomes of patients with brain metastases from renal cell carcinoma treated with first-line therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Dalhousie University; University of Alberta; Queen Elizabeth II Health Sciences Centre; BC Cancer Agency; University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Sunitinib; Pazopanib; Cohort; Internal medicine; Brain metastasis; Oncology; Clear cell renal cell carcinoma; Cancer; Urology; Gastroenterology; Database; Metastasis","score_opus":0.09916175054994858,"score_gpt":0.36863244658691724,"score_spread":0.26947069603696866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324136271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846402,0.00037362505,0.00011216574,0.010245369,0.00041856704,0.00064953533,0.0030714073,0.00002348386,0.00046565846],"genre_scores_gemma":[0.99026924,0.00013918451,0.0053812475,0.0015040141,0.00044503107,0.000018077095,0.0017109594,0.00006118234,0.00047104948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9929111,0.0010410402,0.0035556774,0.0006117395,0.0014435669,0.00043689494],"domain_scores_gemma":[0.97554815,0.018215362,0.0038800554,0.000824114,0.0010521065,0.00048020604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002312359,0.00048762647,0.0024133655,0.00027738215,0.00009967274,0.000029095456,0.00062941236,0.00019926393,0.00034431444],"category_scores_gemma":[0.0023781369,0.0002374532,0.0006244729,0.00042355948,0.0005532313,0.00021052998,0.00017718943,0.00097320764,0.00003162035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044831157,0.0039533917,0.9254457,0.000033690558,0.0026756246,0.003430443,0.00059428497,0.00019898669,0.0007012245,0.000004811495,0.016172696,0.001958001],"study_design_scores_gemma":[0.04850193,0.018444752,0.91682535,0.00013468374,0.0029166788,0.000036542304,0.00052927574,0.00014140675,0.0056653027,0.000044214303,0.0065301214,0.0002297513],"about_ca_topic_score_codex":0.0016560033,"about_ca_topic_score_gemma":0.0010209524,"teacher_disagreement_score":0.017362924,"about_ca_system_score_codex":0.0002287472,"about_ca_system_score_gemma":0.0015760732,"threshold_uncertainty_score":0.96830606},"labels":[],"label_agreement":null},{"id":"W4324136592","doi":"10.1200/jco.2023.41.6_suppl.tps750","title":"Phase II trial of cytoreductive stereotactic hypofractionated radiotherapy with combination ipilimumab/nivolumab for metastatic kidney cancer (CYTOSHRINK).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Population Health Research Institute; McMaster University Medical Centre; St. Joseph’s Healthcare Hamilton; Ottawa Hospital; Health Sciences Centre; Ontario Clinical Oncology Group; Grand River Hospital; McMaster University; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Ipilimumab; Nivolumab; Renal cell carcinoma; Sunitinib; Kidney cancer; Internal medicine; Oncology; Nephrectomy; Immunotherapy; Urology; Cancer; Kidney","score_opus":0.1758098658183557,"score_gpt":0.49934697921114257,"score_spread":0.3235371133927869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324136592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860363,0.00024950664,0.00036176844,0.009925047,0.0018627095,0.0013020604,0.000029449233,0.000018662007,0.00021447058],"genre_scores_gemma":[0.9935693,0.0007972291,0.003281395,0.0005479093,0.0008999049,0.000083371175,0.000028783406,0.00003822786,0.0007538937],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965203,0.00042584218,0.0020556243,0.00023297875,0.00052795047,0.00023731172],"domain_scores_gemma":[0.9930402,0.0025257159,0.002727593,0.00019649668,0.0011211307,0.00038886906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020780938,0.00018340058,0.0017664698,0.00032374932,0.00007792787,0.0000064376295,0.00011539628,0.00018410594,0.0001554273],"category_scores_gemma":[0.0021207125,0.0001222362,0.0005371475,0.00032563834,0.00021552588,0.00022507168,0.000018579944,0.0005110405,0.0000039881184],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7973086,0.029597377,0.00094706274,0.00019476416,0.006285643,0.0006063334,0.00039938127,0.000110150024,0.0052819313,0.00018859739,0.009612158,0.14946797],"study_design_scores_gemma":[0.62090206,0.34059432,0.007928395,0.0001910832,0.0026260496,0.0003720226,0.00030750653,0.0010237881,0.0027204307,0.0004599434,0.022724014,0.00015037632],"about_ca_topic_score_codex":0.000043557317,"about_ca_topic_score_gemma":0.000009757301,"teacher_disagreement_score":0.31099695,"about_ca_system_score_codex":0.00059652847,"about_ca_system_score_gemma":0.003700291,"threshold_uncertainty_score":0.65641576},"labels":[],"label_agreement":null},{"id":"W4324136707","doi":"10.1200/jco.2023.41.6_suppl.646","title":"Real-world outcomes in patients with metastatic renal cell carcinoma (mRCC) receiving dual immune checkpoint inhibitor (ICI-ICI) regimens or immune checkpoint inhibitor and tyrosine kinase inhibitor (ICI-TKI) combinations as first-line therapy: A British Columbia (BC) population-based analysis.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Sunitinib; Nivolumab; Ipilimumab; Renal cell carcinoma; Internal medicine; Pembrolizumab; Axitinib; Oncology; Population; Tyrosine-kinase inhibitor; Proportional hazards model; Cancer; Immunotherapy","score_opus":0.05497399050232772,"score_gpt":0.3487207684273048,"score_spread":0.2937467779249771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324136707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929781,0.00044914256,0.000010324408,0.0038341817,0.00075396505,0.001641295,0.00007029657,0.00006883906,0.0001938721],"genre_scores_gemma":[0.9939591,0.0003861569,0.0019691482,0.00038091754,0.0004299461,0.000090406924,0.00037211718,0.00012287113,0.002289302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.989348,0.0011185838,0.006457559,0.00086868845,0.0013856125,0.0008215662],"domain_scores_gemma":[0.98973536,0.003484983,0.004112082,0.0007085509,0.0011871014,0.0007719414],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0042713736,0.0005973929,0.004450906,0.0012511546,0.00030695705,0.00015885038,0.00026264778,0.000441227,0.00032334775],"category_scores_gemma":[0.0026653518,0.0005225626,0.0012286193,0.002618485,0.00050232594,0.00033248082,0.00018104602,0.0016050815,0.000019145155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008080722,0.00927531,0.9723347,0.00018431195,0.0015385842,0.0035164366,0.00030927817,0.00043581333,0.00060787715,0.000004290717,0.0005193179,0.0031933933],"study_design_scores_gemma":[0.04595107,0.022046559,0.9259455,0.0006702663,0.0024160722,0.00008226682,0.00023085807,0.0006069014,0.0012058332,0.00008878004,0.00029114963,0.00046474728],"about_ca_topic_score_codex":0.021644656,"about_ca_topic_score_gemma":0.05183289,"teacher_disagreement_score":0.046389166,"about_ca_system_score_codex":0.0012278778,"about_ca_system_score_gemma":0.0017338296,"threshold_uncertainty_score":0.9997226},"labels":[],"label_agreement":null},{"id":"W4324136846","doi":"10.1200/jco.2023.41.6_suppl.671","title":"Adjuvant immunotherapy in renal cell carcinoma: A systematic review and meta-analysis of randomized clinical trials.","year":2023,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Adjuvant; Renal cell carcinoma; Internal medicine; Meta-analysis; Oncology; Immunotherapy; Randomized controlled trial; Adjuvant therapy; Systematic review; Clinical trial; Placebo; Kidney cancer; MEDLINE; Cancer; Pathology","score_opus":0.5534088171674288,"score_gpt":0.5817157849324555,"score_spread":0.028306967765026614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324136846","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000116505274,0.9909747,0.000024847259,0.00077010354,0.0004205952,0.007391683,0.0000470712,0.00000848048,0.00024597242],"genre_scores_gemma":[0.00032167562,0.9966449,0.00078101293,0.00077644404,0.0002987935,0.00033135278,0.000032569616,0.00008206029,0.0007311495],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.884929,0.064697765,0.04828118,0.00068491034,0.0010225354,0.00038459906],"domain_scores_gemma":[0.8276881,0.12630922,0.04339159,0.0011007199,0.0008693408,0.0006410454],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaresearch","metaepi_broad","research_integrity"],"category_scores_codex":[0.21820934,0.0008245305,0.17732733,0.0016673655,0.000022178521,0.000014821998,0.0005464868,0.0016377843,0.00033010845],"category_scores_gemma":[0.07561468,0.00038654683,0.05754172,0.0015433929,0.0005553123,0.00006123432,0.00014157084,0.003102252,0.00002487034],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013031523,0.0016776756,0.000025829677,0.48698705,0.47802094,0.0019451585,0.000024494355,7.160362e-7,1.0197435e-7,0.0000125240285,0.00041918433,0.017854817],"study_design_scores_gemma":[0.06801051,0.0039341976,0.00007034285,0.031867493,0.8860136,0.00034652694,0.000011902299,0.000010126169,1.7496231e-7,0.000025207763,0.009489621,0.00022029974],"about_ca_topic_score_codex":0.000046575482,"about_ca_topic_score_gemma":0.000025077508,"teacher_disagreement_score":0.45511955,"about_ca_system_score_codex":0.00031470408,"about_ca_system_score_gemma":0.004116096,"threshold_uncertainty_score":0.9998586},"labels":[],"label_agreement":null},{"id":"W4327601571","doi":"10.3390/cancers15061793","title":"Robotic versus Laparoscopic Partial Nephrectomy in the New Era: Systematic Review","year":2023,"lang":"en","type":"review","venue":"Cancers","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nephrectomy; Medicine; Gold standard (test); Robotic surgery; Surgery; Laparoscopy; Laparoscopic surgery; Kidney cancer; General surgery; Urology; Kidney; Renal cell carcinoma; Radiology; Internal medicine","score_opus":0.11996506391049287,"score_gpt":0.3767779057004341,"score_spread":0.25681284178994124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327601571","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002579784,0.9890631,0.0000016358939,0.00019591034,0.0009666627,0.008785668,0.000005572719,0.000064261425,0.0009146434],"genre_scores_gemma":[0.0000056861636,0.99397033,0.00002426395,0.00038606097,0.00041667445,0.0032584919,0.0001057545,0.000081937666,0.001750772],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.997143,0.0004414163,0.0010038804,0.00047424948,0.0005057999,0.00043170957],"domain_scores_gemma":[0.997801,0.00056089746,0.0004013606,0.001026963,0.000029058887,0.0001807031],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045317342,0.0005120257,0.004109676,0.0001539289,0.000040416176,0.00003090669,0.00036786677,0.00017319909,0.00008290073],"category_scores_gemma":[0.00035369123,0.00028285463,0.00070582004,0.0010117166,0.000046245463,0.000031078525,0.00004409977,0.0005729678,0.00086809736],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001531799,0.0000074601357,6.212645e-7,0.9793273,0.00045609902,0.0003782846,0.00005296376,0.000007721079,1.714109e-8,0.000027368818,0.010312798,0.0094139995],"study_design_scores_gemma":[0.0008528152,0.00016115315,0.0000010677666,0.7088164,0.012820894,0.000073378935,0.000024283232,0.000004156114,2.4121528e-7,0.000002308745,0.2770588,0.0001845217],"about_ca_topic_score_codex":0.00035344926,"about_ca_topic_score_gemma":0.00012917067,"teacher_disagreement_score":0.27051097,"about_ca_system_score_codex":0.004004613,"about_ca_system_score_gemma":0.0037551497,"threshold_uncertainty_score":0.9999624},"labels":[],"label_agreement":null},{"id":"W4327692917","doi":"10.1016/j.clgc.2023.03.005","title":"Identifying the Needs of Health Care Providers in Advanced First-Line Renal Cell Carcinoma: A Mixed-Methods Research","year":2023,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Axdev Group (Canada)","funders":"","keywords":"Medicine; Psychological intervention; Nursing; Health care; Family medicine","score_opus":0.19710779382864,"score_gpt":0.510845723783789,"score_spread":0.31373792995514904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327692917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96598166,0.024754858,0.00005573578,0.0058039157,0.00082883507,0.0016705198,0.00002190737,0.00006257065,0.00082002126],"genre_scores_gemma":[0.99175,0.0030730653,0.002120615,0.00025768072,0.0005575201,0.00047905144,0.000047121834,0.00006710492,0.0016478302],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99451023,0.0017943196,0.0015025468,0.00058117916,0.00073786627,0.0008738798],"domain_scores_gemma":[0.9959156,0.0021152773,0.00032824118,0.0009528633,0.00038584913,0.00030217454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046680286,0.00027586927,0.0008948525,0.0005729103,0.0002592467,0.000022037837,0.00037769967,0.00019670145,0.000060210594],"category_scores_gemma":[0.0005176179,0.00019694427,0.00039708536,0.0022735375,0.00042345354,0.00009380604,0.00041651845,0.0011956664,0.000043975706],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041363356,0.0014215444,0.39953285,0.0045731408,0.00021337846,0.0012646625,0.016104031,0.0018060879,0.0046614725,0.000018640792,0.024080303,0.5421876],"study_design_scores_gemma":[0.008770964,0.0063069924,0.92194253,0.00090797653,0.00015931253,0.00003548126,0.028630262,0.00038380863,0.015899286,0.00023641087,0.016327666,0.0003992833],"about_ca_topic_score_codex":0.0011171344,"about_ca_topic_score_gemma":0.00034114573,"teacher_disagreement_score":0.5417883,"about_ca_system_score_codex":0.00067953026,"about_ca_system_score_gemma":0.0013929639,"threshold_uncertainty_score":0.8031154},"labels":[],"label_agreement":null},{"id":"W4327753798","doi":"10.1111/bju.16009","title":"Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time","year":2023,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Renal function; Nephrectomy; Confidence interval; Surgery; Population; Logistic regression; Proportional hazards model; Urology; Internal medicine; Kidney","score_opus":0.03498275097233963,"score_gpt":0.25675730046870054,"score_spread":0.2217745494963609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327753798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972815,0.0016069588,0.000022867656,0.00050488405,0.00003914917,0.0002291435,0.000010325749,0.000018577048,0.00028659168],"genre_scores_gemma":[0.9977464,0.00088988146,0.00070512627,0.00013928636,0.000108067776,0.000008647794,0.000010610575,0.000028572502,0.00036342317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988504,0.00006664788,0.00036231938,0.00016120498,0.00028945168,0.0002700005],"domain_scores_gemma":[0.99901277,0.00014545812,0.00028708894,0.000111708156,0.00024457622,0.00019842987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002291673,0.00013328294,0.00054208905,0.00018530339,0.000048706028,0.000013526824,0.00006759528,0.000100717705,0.00015576594],"category_scores_gemma":[0.00008409415,0.00009310803,0.000056738554,0.00027130073,0.00018044829,0.00008157822,0.000030057761,0.00029579396,0.000014237658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059116747,0.00093101826,0.6718423,0.00037729982,0.002847575,0.061155338,0.0008972668,0.0018286931,0.0054104067,0.000022240198,0.0075629656,0.18800816],"study_design_scores_gemma":[0.010315208,0.017051414,0.8463234,0.00032886045,0.0007964673,0.11933811,0.000055631626,0.0002648889,0.0032857647,0.00001532776,0.002082183,0.00014279196],"about_ca_topic_score_codex":0.000077010955,"about_ca_topic_score_gemma":0.000042940803,"teacher_disagreement_score":0.18786536,"about_ca_system_score_codex":0.00002571379,"about_ca_system_score_gemma":0.00019021695,"threshold_uncertainty_score":0.37968352},"labels":[],"label_agreement":null},{"id":"W4327965321","doi":"10.3390/jcm12062361","title":"Small Renal Masses: The Evolving Histologic, Imaging, and Genomic Landscapes","year":2023,"lang":"en","type":"editorial","venue":"Journal of Clinical Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Kidney cancer; Cancer; Kidney; Pathology; Internal medicine","score_opus":0.07248516999374394,"score_gpt":0.37676926231754093,"score_spread":0.304284092323797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327965321","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021370478,0.042336665,0.000053687447,0.016111802,0.9167888,0.00042897364,0.000015313082,0.00004882075,0.0028454675],"genre_scores_gemma":[0.009102865,0.01981928,0.0007505089,0.0004881144,0.96685,0.000008607557,0.000051215873,0.00010592309,0.0028235104],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941108,0.00044350256,0.0031121585,0.0004762251,0.0014334553,0.00042380884],"domain_scores_gemma":[0.97934777,0.015807819,0.0027030094,0.0005766593,0.0009664898,0.000598245],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006165628,0.00047762724,0.0026346955,0.0003208361,0.00010865954,0.00003609015,0.00047196684,0.00064804696,0.00018875868],"category_scores_gemma":[0.029651541,0.00022792231,0.0006124969,0.00018783224,0.00056972995,0.000057224832,0.00018486472,0.0035013321,0.000033077667],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089109933,0.000103677456,0.011689744,0.0002321559,0.00061921275,0.0033976869,0.00012548073,0.0000010322366,0.00008394052,0.0000030504928,0.9724723,0.010380586],"study_design_scores_gemma":[0.006290673,0.0037729405,0.030595295,0.0023492072,0.0030414572,0.0006653753,0.00021708514,0.00006316947,0.000005838428,0.00023621519,0.952568,0.00019476356],"about_ca_topic_score_codex":0.00008376187,"about_ca_topic_score_gemma":0.00004328202,"teacher_disagreement_score":0.05006118,"about_ca_system_score_codex":0.00023948115,"about_ca_system_score_gemma":0.0010248754,"threshold_uncertainty_score":0.99879766},"labels":[],"label_agreement":null},{"id":"W4353015606","doi":"10.2214/ajr.23.29316","title":"Subcentimeter Echogenic Renal Lesions: Point—They Can Be Safely Ignored When Uniformly Echogenic","year":2023,"lang":"en","type":"article","venue":"American Journal of Roentgenology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Echogenicity; Medicine; Radiology; Point (geometry); Ultrasonography","score_opus":0.02664749437645843,"score_gpt":0.26866663275624,"score_spread":0.24201913837978153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4353015606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98713195,0.0006156587,0.0001641436,0.010852739,0.00034161002,0.00033227805,0.000032903867,0.00007935812,0.00044935427],"genre_scores_gemma":[0.99259216,0.0009803915,0.003535846,0.0014072949,0.00026104625,0.000013150049,0.00006172064,0.00008113436,0.0010672404],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967128,0.00032387514,0.0010696432,0.00040006012,0.00062892283,0.00086472393],"domain_scores_gemma":[0.9973074,0.00019569523,0.00094173476,0.0006134123,0.00037819627,0.00056353817],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056900084,0.00037716315,0.0011122153,0.0010329833,0.00012679273,0.000022718259,0.00041983428,0.00011821917,0.00041223085],"category_scores_gemma":[0.00018188616,0.00029465157,0.0006525099,0.0006909558,0.00040752132,0.000114979586,0.00014472044,0.00059650483,0.00019779589],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009870766,0.0015336735,0.13083935,0.00013859387,0.0090996735,0.021429343,0.007910528,0.00054692716,0.49794602,0.00025656202,0.030894326,0.28953424],"study_design_scores_gemma":[0.0340245,0.08171039,0.55359465,0.0009694828,0.00899619,0.07117911,0.022584787,0.0003544304,0.16128528,0.009794289,0.052798275,0.0027086393],"about_ca_topic_score_codex":0.00045852028,"about_ca_topic_score_gemma":0.00022162055,"teacher_disagreement_score":0.42275527,"about_ca_system_score_codex":0.0005357406,"about_ca_system_score_gemma":0.00054601487,"threshold_uncertainty_score":0.9999506},"labels":[],"label_agreement":null},{"id":"W4353017171","doi":"10.2214/ajr.23.29268","title":"Subcentimeter Echogenic Renal Lesions: Counterpoint—They Should Be Followed With Ultrasound","year":2023,"lang":"en","type":"article","venue":"American Journal of Roentgenology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Echogenicity; Counterpoint; Medicine; Radiology; Ultrasound; Ultrasonography","score_opus":0.03252433483665407,"score_gpt":0.28883839983116266,"score_spread":0.2563140649945086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4353017171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994699,0.00036858718,0.00028338225,0.0036303962,0.00021129269,0.0002363461,0.000009651199,0.00005372666,0.00050758844],"genre_scores_gemma":[0.99525785,0.00059834047,0.0020479155,0.0011157137,0.00016052721,0.0000103341,0.000024208102,0.000058844835,0.0007262559],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977433,0.00017911289,0.00062698364,0.00029540184,0.0005882937,0.000566916],"domain_scores_gemma":[0.9978705,0.00027260897,0.00082025595,0.00041675603,0.0002918983,0.00032798597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036492973,0.00027848894,0.00085376616,0.00057787,0.00008183475,0.000019501884,0.00023423204,0.00007075295,0.00022851021],"category_scores_gemma":[0.0001441314,0.00018735854,0.0003480855,0.0006044559,0.00039958637,0.00009048737,0.000048930415,0.00044224958,0.000108781576],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019810867,0.0017490262,0.49974853,0.00011580002,0.010177935,0.03655336,0.00411127,0.0006059465,0.3557707,0.00017260549,0.028161261,0.04302269],"study_design_scores_gemma":[0.023297582,0.090180054,0.66215384,0.0008225116,0.006011269,0.11972538,0.009174488,0.00012103996,0.053041354,0.000556352,0.03354082,0.001375324],"about_ca_topic_score_codex":0.00009929715,"about_ca_topic_score_gemma":0.000055683,"teacher_disagreement_score":0.30272937,"about_ca_system_score_codex":0.00026558095,"about_ca_system_score_gemma":0.0003058559,"threshold_uncertainty_score":0.764026},"labels":[],"label_agreement":null},{"id":"W4353081992","doi":"10.54057/cpi.gu2023","title":"CPI Genitourinary Tract Radiology Module 2023","year":2023,"lang":"en","type":"dataset","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Genitourinary system; Medicine; Radiology; Medical physics; Internal medicine","score_opus":0.040905121853822515,"score_gpt":0.29809317959647263,"score_spread":0.25718805774265013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4353081992","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018062238,0.0012728175,0.0000019490094,0.0005765798,0.0011036355,0.00070230203,0.99132097,0.00016003699,0.0030554722],"genre_scores_gemma":[0.00009889992,0.0011500032,0.0001559599,0.00032458222,0.0012453332,0.000115836294,0.9567957,0.000058278867,0.040055394],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979893,0.0000863941,0.0004074565,0.00065381976,0.00037595723,0.000487069],"domain_scores_gemma":[0.99822646,0.00017551528,0.00011904126,0.0011360976,0.000056827506,0.0002860542],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00016811451,0.00044520063,0.0008634213,0.00036000146,0.00005516667,0.000014219545,0.00023326463,0.0005683411,0.002049387],"category_scores_gemma":[0.00007252251,0.00033255585,0.00033369282,0.0002347579,0.000074573334,0.000028591738,0.00014480072,0.000623548,0.032797493],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011307515,0.00028706415,0.00007546344,0.00023264594,0.00029895685,0.011453178,0.000002515586,0.0000030321287,0.000038255,0.000002762879,0.9872069,0.00028615465],"study_design_scores_gemma":[0.0010443524,0.0013977382,0.009998242,0.00007890003,0.0006149641,0.0028697227,0.00001766418,0.000011181675,0.0001359696,0.000037769463,0.98349124,0.00030227678],"about_ca_topic_score_codex":0.0016729307,"about_ca_topic_score_gemma":0.00009359704,"teacher_disagreement_score":0.036999922,"about_ca_system_score_codex":0.00025842927,"about_ca_system_score_gemma":0.00020507668,"threshold_uncertainty_score":0.9999126},"labels":[],"label_agreement":null},{"id":"W4360605544","doi":"10.1097/ju.0000000000003231.10","title":"PD07-10 OUTCOMES OF PARTIAL NEPHRECTOMY FOR NON-METASTATIC cT2 RENAL TUMORS: RESULTS FROM A CANADIAN MULTI-INSTITUTIONAL COLLABORATIVE","year":2023,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nephrectomy; Medicine; Classics; Library science; Art history; Art; Internal medicine; Kidney; Computer science","score_opus":0.03868824698413809,"score_gpt":0.3046024893436517,"score_spread":0.2659142423595136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360605544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905858,0.00023054377,0.00029801932,0.0072295666,0.00028239135,0.00061830523,0.00053916493,0.000008298211,0.00020793456],"genre_scores_gemma":[0.996664,0.000035243513,0.002221789,0.00040956406,0.00020894618,0.00002198961,0.00008359669,0.000014957106,0.00033994383],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99838084,0.00019316362,0.00070987706,0.0001324303,0.0002750211,0.0003086942],"domain_scores_gemma":[0.9974397,0.0011573801,0.00048737097,0.00021298169,0.0004618215,0.00024073945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008184425,0.00016646954,0.0006111657,0.0003063326,0.00010741869,0.0000066392736,0.00017158959,0.00006382482,0.00008044905],"category_scores_gemma":[0.0009499838,0.00009380065,0.00017521749,0.00032042625,0.00021672042,0.000057486417,0.000025375854,0.00021544416,0.00003897669],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24254218,0.0045381878,0.1538763,0.00047669603,0.031254653,0.024392921,0.06296045,0.0542847,0.19438511,0.0018723919,0.21479504,0.014621368],"study_design_scores_gemma":[0.0586152,0.015019656,0.8198998,0.00025709916,0.0050759506,0.0018985443,0.0026907218,0.013781133,0.031139802,0.0014741343,0.049601875,0.0005460704],"about_ca_topic_score_codex":0.005976576,"about_ca_topic_score_gemma":0.009400268,"teacher_disagreement_score":0.6660235,"about_ca_system_score_codex":0.00015290942,"about_ca_system_score_gemma":0.0016772975,"threshold_uncertainty_score":0.9034835},"labels":[],"label_agreement":null},{"id":"W4360607439","doi":"10.1097/ju.0000000000003311.05","title":"MP58-05 THE IMPACT OF HISTOLOGY AND TYPE OF ENERGY USED ON ONCOLOGICAL OUTCOMES AFTER LOCAL TUMOR ABLATION OF SMALL RENAL MASSES","year":2023,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Humanities; Art history; Library science; Art","score_opus":0.050010306577580814,"score_gpt":0.3135328566197128,"score_spread":0.263522550042132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360607439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969925,0.00059492455,0.000117036616,0.0019297302,0.00009128668,0.0000836259,0.0000031574514,0.0000034644731,0.00018422061],"genre_scores_gemma":[0.9995047,0.00012197928,0.00005934631,0.0001887643,0.00004431799,0.0000014576394,0.0000016673591,0.000008718914,0.0000690749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987559,0.00036519513,0.0004878631,0.00007300854,0.00017291843,0.00014511833],"domain_scores_gemma":[0.9980029,0.0010715439,0.0005330424,0.0001813851,0.00015943717,0.000051705178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005561156,0.00011024293,0.0005536928,0.00016417284,0.000017364942,9.500227e-7,0.00011055379,0.00008575025,0.000078611054],"category_scores_gemma":[0.00017760004,0.00004625264,0.00016004931,0.00014427888,0.00038362874,0.0000149374,0.000043506723,0.00018812717,0.0000018294037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03944407,0.000874145,0.87764406,0.00007789296,0.0016398806,0.0011129461,0.0014884337,0.008771099,0.06303167,0.0006009583,0.0017350554,0.0035798014],"study_design_scores_gemma":[0.0015767753,0.014144111,0.9779832,0.00001714649,0.0004046487,0.0010962078,0.00006813069,0.00035367478,0.0035015445,0.00059728377,0.00021964595,0.00003766164],"about_ca_topic_score_codex":0.00011080144,"about_ca_topic_score_gemma":0.00003855647,"teacher_disagreement_score":0.10033912,"about_ca_system_score_codex":0.00007273501,"about_ca_system_score_gemma":0.00013970658,"threshold_uncertainty_score":0.18861279},"labels":[],"label_agreement":null},{"id":"W4360608651","doi":"10.37766/inplasy2023.3.0083","title":"Stereotactic Radiation therapy in early and locally advanced inoperable renal cell carcinoma: treatment outcomes, patterns of failure and risk factors","year":2023,"lang":"en","type":"report","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Distant metastasis; Disease; Radiation therapy; Oncology; Renal cell carcinoma; Internal medicine; Metastasis; Cancer","score_opus":0.041263359368785425,"score_gpt":0.2905195592113962,"score_spread":0.2492561998426108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360608651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99353784,0.0031371491,0.0000063291686,0.000057575046,0.0001894931,0.0018230098,0.0001664813,0.000048606715,0.001033531],"genre_scores_gemma":[0.96435267,0.02558587,0.00010004478,0.000010473238,0.000066675886,0.000107602864,0.00032339134,0.000101328864,0.009351974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99731225,0.0001272228,0.00077712047,0.0007357474,0.0006665472,0.00038110945],"domain_scores_gemma":[0.9983092,0.00025932898,0.00048944826,0.0005352837,0.00017719838,0.00022954382],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022529278,0.0006464977,0.0014094437,0.0004989828,0.000049514772,0.000033900604,0.0000651346,0.00036074288,0.000056334346],"category_scores_gemma":[0.00004756332,0.00042071092,0.00019466516,0.00018103767,0.00004640821,0.00011140326,0.00005019897,0.00036345783,0.0000045422144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019286427,0.00029376886,0.98747516,0.00031639473,0.0003995114,0.0003264037,0.00071750995,0.00000845988,0.00026593092,6.1011445e-7,0.000059165002,0.009944212],"study_design_scores_gemma":[0.0070738597,0.0041723973,0.98148304,0.00016132645,0.00048700513,0.000038490114,0.00024114145,0.000013809195,0.00486442,0.000003396101,0.0011504983,0.0003106205],"about_ca_topic_score_codex":0.040013973,"about_ca_topic_score_gemma":0.0027106826,"teacher_disagreement_score":0.03730329,"about_ca_system_score_codex":0.00094715285,"about_ca_system_score_gemma":0.0006080516,"threshold_uncertainty_score":0.99982446},"labels":[],"label_agreement":null},{"id":"W4360612889","doi":"10.1016/j.urolonc.2023.02.007","title":"Surgeon-level versus hospital-level quality variance in kidney cancer surgery","year":2023,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Kidney cancer; Kidney disease; Cohort; Cancer; Veterans Affairs; Cancer surgery; Variance (accounting); Analysis of variance; Surgery; Internal medicine","score_opus":0.15209557813202887,"score_gpt":0.37194008499688574,"score_spread":0.21984450686485688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360612889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9673749,0.0007806916,0.00001698738,0.027809162,0.00095993833,0.00041787728,0.00015539883,0.00012589076,0.0023591248],"genre_scores_gemma":[0.9789503,0.0030007744,0.00983856,0.0033147216,0.00026916713,0.00056102406,0.00043882147,0.00003584476,0.0035907715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979261,0.00023435043,0.0005131451,0.0005540979,0.00023911872,0.0005331541],"domain_scores_gemma":[0.9975029,0.0014208194,0.00019206844,0.00029846252,0.00008995398,0.0004957968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090979435,0.00026184882,0.00063518883,0.00033418817,0.00016955718,0.000017688133,0.00009340465,0.00030088495,0.00015005606],"category_scores_gemma":[0.0011780296,0.00022820305,0.0001095121,0.0009066919,0.00053188816,0.00011114476,0.0000714486,0.0003846801,0.00009380679],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034338428,0.00024300787,0.96390384,0.00008253758,0.0000882308,0.000817544,0.00036258553,0.000048822392,0.00021566654,0.0027252997,0.027483158,0.0036858895],"study_design_scores_gemma":[0.002058051,0.0008710845,0.6535298,0.0001382307,0.00018651952,0.00006944122,0.00021024808,0.0002871181,0.0003156475,0.0023704467,0.33965832,0.00030506327],"about_ca_topic_score_codex":0.0013097597,"about_ca_topic_score_gemma":0.00032889534,"teacher_disagreement_score":0.31217515,"about_ca_system_score_codex":0.00039391604,"about_ca_system_score_gemma":0.0013488933,"threshold_uncertainty_score":0.930585},"labels":[],"label_agreement":null},{"id":"W4360745743","doi":"10.1097/ju.0000000000003322.03","title":"MP64-03 LOW METASTATIC POTENTIAL OF COMPLEX RENAL CYSTS: THE Case FOR ACTIVE SURVEILLANCE","year":2023,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Library science","score_opus":0.04480442905848531,"score_gpt":0.30670156451042063,"score_spread":0.2618971354519353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360745743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897841,0.0004245244,0.00081326853,0.008224953,0.00019565511,0.0003679756,0.000040468625,0.000007562387,0.00014148375],"genre_scores_gemma":[0.9990286,0.00009745026,0.00020860699,0.00031511995,0.00019726224,0.000005864881,0.00000788909,0.000016431146,0.00012274091],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.99861926,0.00043023753,0.00043592733,0.000082714934,0.00020620126,0.00022568062],"domain_scores_gemma":[0.997792,0.00113273,0.0004804254,0.00024544093,0.00028167394,0.000067746485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001200952,0.00011554046,0.00042951762,0.00011243263,0.000092294125,0.000004144308,0.00017037548,0.00003597619,0.000066363275],"category_scores_gemma":[0.0002117543,0.000054258697,0.00020990985,0.0001853883,0.00021539586,0.000028398557,0.000043872977,0.00022978974,0.000013993435],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.089658484,0.0019048313,0.002849099,0.00083463243,0.013772472,0.07150647,0.010060101,0.024493331,0.6784745,0.0012415018,0.068401255,0.036803346],"study_design_scores_gemma":[0.033104997,0.035094894,0.3400013,0.00012457898,0.00869632,0.4934588,0.0074666156,0.023427049,0.038285054,0.010314363,0.009451832,0.0005741524],"about_ca_topic_score_codex":0.000046094025,"about_ca_topic_score_gemma":0.000039116894,"teacher_disagreement_score":0.6401894,"about_ca_system_score_codex":0.00004445426,"about_ca_system_score_gemma":0.00010784006,"threshold_uncertainty_score":0.22126055},"labels":[],"label_agreement":null},{"id":"W4360819509","doi":"10.1016/j.eururo.2023.03.003","title":"Corrigendum to “Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma” [Eur Urol 2023]","year":2023,"lang":"en","type":"erratum","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Toronto; McMaster University; Sunnybrook Health Science Centre; Juravinski Cancer Centre; Ottawa Regional Cancer Foundation; Queen Elizabeth II Health Sciences Centre; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Internal medicine; Carcinoma","score_opus":0.07805097212584937,"score_gpt":0.2959166596376353,"score_spread":0.21786568751178592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360819509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6387421,0.025510399,0.026795715,0.02961407,0.1332729,0.0638794,0.031335015,0.0014378042,0.049412623],"genre_scores_gemma":[0.84849215,0.000093346476,0.0021331625,0.0024363652,0.0011463172,0.0018611242,0.03010865,0.0005851021,0.113143794],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927644,0.0010635407,0.0021442089,0.0019467889,0.00086916535,0.0012119029],"domain_scores_gemma":[0.9945883,0.0017538465,0.0011489595,0.001219306,0.00082398806,0.0004656088],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0016938915,0.0013047408,0.002131275,0.0016798656,0.00022392975,0.000102639846,0.0009245227,0.00024860798,0.0001737754],"category_scores_gemma":[0.0015744985,0.0011673615,0.0007318156,0.00055523776,0.0002474632,0.00018598486,0.00046309902,0.0011744433,0.000359601],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045098686,0.002330804,0.021723174,0.0025041834,0.0010002641,0.0061475607,0.001188741,0.00012790122,0.0011973215,0.00016326216,0.9587476,0.0003593055],"study_design_scores_gemma":[0.0517731,0.027700817,0.26937026,0.00049193326,0.006251534,0.00046899865,0.0006078884,0.008278945,0.0018663055,0.0005658994,0.6295495,0.0030748025],"about_ca_topic_score_codex":0.00022887523,"about_ca_topic_score_gemma":0.00033822263,"teacher_disagreement_score":0.32919812,"about_ca_system_score_codex":0.00041020208,"about_ca_system_score_gemma":0.0008133359,"threshold_uncertainty_score":0.99997044},"labels":[],"label_agreement":null},{"id":"W4360825582","doi":"10.1200/jco.23.00280","title":"Evaluating Trials of Adjuvant Therapy: Is There Benefit for People With Resected Renal Cancer?","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cancer; Adjuvant; Oncology; Adjuvant therapy; Internal medicine; Clinical trial; Urothelial cancer; Kidney cancer; Bladder cancer","score_opus":0.5047290868562413,"score_gpt":0.5790289443396136,"score_spread":0.07429985748337231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360825582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98579997,0.002662664,0.00005149754,0.009748326,0.00050947303,0.00079797115,0.00003230419,0.000013179794,0.00038462933],"genre_scores_gemma":[0.98959935,0.003394515,0.004174906,0.0005937246,0.0014013974,0.000057107827,0.000009818032,0.000035940706,0.0007332225],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9946855,0.00069779356,0.0034582524,0.00022367774,0.0006619843,0.00027282466],"domain_scores_gemma":[0.9846011,0.009689834,0.003868272,0.0002477146,0.00133546,0.00025763063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012607828,0.00016480181,0.0031487518,0.00018032624,0.00004460229,0.0000059178305,0.00016041467,0.00028350955,0.00040291122],"category_scores_gemma":[0.00623726,0.000087618355,0.00088810665,0.00035342877,0.00010010181,0.00005074394,0.00003089805,0.00048308197,0.000005600804],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09779237,0.0017158588,0.1376179,0.00020068615,0.0043281363,0.00046027027,0.0010262543,0.0006533569,0.017629683,0.000050954244,0.012745552,0.725779],"study_design_scores_gemma":[0.049963783,0.12599248,0.7919757,0.00077163836,0.001998271,0.00021211884,0.00040617894,0.0013114852,0.013562787,0.001041205,0.012596385,0.00016799051],"about_ca_topic_score_codex":0.00009452158,"about_ca_topic_score_gemma":0.00018437009,"teacher_disagreement_score":0.725611,"about_ca_system_score_codex":0.00016802772,"about_ca_system_score_gemma":0.0025949946,"threshold_uncertainty_score":0.7467034},"labels":[],"label_agreement":null},{"id":"W4361823492","doi":"10.1158/0008-5472.c.6514059.v1","title":"Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; University of Toronto","funders":"National Cancer Institute; Canadian Institute for Advanced Research; Memorial Sloan-Kettering Cancer Center","keywords":"PI3K/AKT/mTOR pathway; Biology; RPTOR; Regulator; Cancer research; Effector; Protein kinase B; Cell growth; Cell biology; Receptor tyrosine kinase; Signal transduction; Genetics; Gene","score_opus":0.17295203868368333,"score_gpt":0.36980988124849345,"score_spread":0.19685784256481012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361823492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844673,0.00028192776,0.00035069845,0.0017763596,0.00052634976,0.0015166745,0.008172602,0.0002601401,0.0026479308],"genre_scores_gemma":[0.9386104,0.000037451013,0.004508155,0.00015555038,0.0002630476,0.00027498027,0.053937666,0.00006474669,0.002148007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977943,0.00006598279,0.0005184864,0.00093202025,0.00041015758,0.0002790558],"domain_scores_gemma":[0.9976816,0.00045567588,0.00024727362,0.0013658255,0.000075704214,0.00017388392],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012309988,0.0003078144,0.0005267511,0.00037278293,0.000079587924,0.000053367494,0.0003368766,0.00023103111,0.00093665085],"category_scores_gemma":[0.0003086263,0.00028191443,0.0001168538,0.0002885958,0.00005909975,0.00010365618,0.0012751408,0.0006509746,0.0005810365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008851072,0.007868115,0.75131726,0.0017504356,0.0050856476,0.008357334,0.0028372712,0.0010480853,0.06411871,0.00072107813,0.15399203,0.0020189383],"study_design_scores_gemma":[0.006173343,0.00017693551,0.9108243,0.0025268379,0.0008462567,0.00003553956,0.007478314,0.006867677,0.059005674,0.004036152,0.0012578976,0.0007710574],"about_ca_topic_score_codex":0.0032803444,"about_ca_topic_score_gemma":0.001003612,"teacher_disagreement_score":0.15950707,"about_ca_system_score_codex":0.00066633883,"about_ca_system_score_gemma":0.00034061048,"threshold_uncertainty_score":0.99997663},"labels":[],"label_agreement":null},{"id":"W4361823641","doi":"10.1158/0008-5472.c.6513277.v1","title":"Data from mTOR Activation Initiates Renal Cell Carcinoma Development by Coordinating ERK and p38MAPK","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"PI3K/AKT/mTOR pathway; Cancer research; MAPK/ERK pathway; Renal cell carcinoma; Cell growth; TSC1; Biology; Chemistry; Kinase; Cell biology; Signal transduction; Medicine; Internal medicine; Biochemistry","score_opus":0.11954822230718952,"score_gpt":0.30416733319435374,"score_spread":0.1846191108871642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361823641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912462,0.0009032631,0.0011216172,0.0007591089,0.0002501582,0.0009485154,0.00054797047,0.0002227699,0.0040003946],"genre_scores_gemma":[0.95395464,0.000054053333,0.015088693,0.00017923702,0.0002596269,0.00011476081,0.024843115,0.00009603755,0.005409833],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99712074,0.00006818762,0.0006247506,0.0012820612,0.0005464283,0.00035781335],"domain_scores_gemma":[0.99775153,0.00035612672,0.00030843937,0.0011977707,0.00013629491,0.00024985886],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030378043,0.00050149095,0.00064380193,0.00017833397,0.00012650352,0.00010806003,0.00034496622,0.00034154038,0.00023819713],"category_scores_gemma":[0.00013337877,0.00042742965,0.000060558035,0.0001172903,0.000053119315,0.00013273198,0.0023036082,0.0006030371,0.00010863323],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011566413,0.0018137202,0.32486528,0.004876448,0.0027653351,0.0021368456,0.0049458784,0.00004750945,0.22217785,0.00003584313,0.4007537,0.034424946],"study_design_scores_gemma":[0.003236031,0.0002725764,0.36713415,0.0009791258,0.00061019155,0.000025077963,0.000669674,0.0017649501,0.6161844,0.00024971942,0.0079482,0.00092589436],"about_ca_topic_score_codex":0.00164706,"about_ca_topic_score_gemma":0.00009943762,"teacher_disagreement_score":0.39400655,"about_ca_system_score_codex":0.0003999847,"about_ca_system_score_gemma":0.000494417,"threshold_uncertainty_score":0.9998177},"labels":[],"label_agreement":null},{"id":"W4361897345","doi":"10.1158/0008-5472.22413203.v1","title":"Supplemental Figures and Tables from Efficacy of Cotargeting Angiopoietin-2 and the VEGF Pathway in the Adjuvant Postsurgical Setting for Early Breast, Colorectal, and Renal Cancers","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Regorafenib; Sunitinib; Pazopanib; Internal medicine; Oncology; Adjuvant therapy; Colorectal cancer; Cancer","score_opus":0.020267691245486087,"score_gpt":0.2690184170487187,"score_spread":0.24875072580323263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361897345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98835856,0.004191399,0.000011326271,0.0034231008,0.000070689624,0.0024087357,0.0013280574,0.000026116213,0.00018204522],"genre_scores_gemma":[0.99724627,0.0003525723,0.0010239185,0.00009689781,0.00016331696,0.000258048,0.0007383905,0.000038103968,0.00008247754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795943,0.0002313685,0.0005306951,0.00058621244,0.00035024443,0.00034205188],"domain_scores_gemma":[0.9968751,0.0024621661,0.00023775247,0.0002610732,0.00006538022,0.000098525976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010088737,0.00034090338,0.0007357532,0.00009074186,0.00012967738,0.00008215255,0.00013508613,0.00016158556,0.000046303656],"category_scores_gemma":[0.00013309985,0.00017929346,0.00014857805,0.00008753847,0.00039023423,0.000034118464,0.00041991935,0.00032393553,4.3994748e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03128826,0.00068342197,0.8439577,0.0032984647,0.0032954148,0.0009135385,0.056153532,0.0002423492,0.031200144,0.0010066862,0.0073374333,0.020623019],"study_design_scores_gemma":[0.017141087,0.0007599514,0.9641521,0.0014075151,0.0006207405,0.00021542177,0.006089669,0.0019231271,0.006355669,0.00068837457,0.00027637766,0.0003699527],"about_ca_topic_score_codex":0.016739516,"about_ca_topic_score_gemma":0.001224841,"teacher_disagreement_score":0.120194376,"about_ca_system_score_codex":0.00010537839,"about_ca_system_score_gemma":0.0001645208,"threshold_uncertainty_score":0.9898081},"labels":[],"label_agreement":null},{"id":"W4361944114","doi":"10.1158/1078-0432.c.6519998","title":"Data from Sequential FDG-PET/CT as a Biomarker of Response to Sunitinib in Metastatic Clear Cell Renal Cancer","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Nuclear medicine; Sunitinib; Positron emission tomography; Renal cell carcinoma; Internal medicine","score_opus":0.22729277678142037,"score_gpt":0.4012130675070512,"score_spread":0.17392029072563084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361944114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874915,0.00052404916,0.000091518545,0.0019173148,0.00045535687,0.0017034491,0.0048558605,0.00009845391,0.0028625233],"genre_scores_gemma":[0.9773116,0.00020037577,0.005912177,0.00032689108,0.0001027415,0.00021629207,0.0039764442,0.00013535011,0.011818111],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957277,0.0006864302,0.0009900546,0.001307869,0.00082592655,0.00046199825],"domain_scores_gemma":[0.9957967,0.0007005423,0.0002966438,0.0026965293,0.00015640492,0.0003531794],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012624547,0.00050296425,0.0011516102,0.0007374439,0.000025634854,0.000040309737,0.00071166724,0.000055311182,0.004747242],"category_scores_gemma":[0.00044957272,0.00042191538,0.0002218678,0.00045859758,0.00009307002,0.00006056432,0.0024496648,0.0005865019,0.00067787647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13345149,0.0033721244,0.013493105,0.0035066637,0.006885799,0.14140567,0.0020171022,0.0014644631,0.5636247,0.000028010634,0.12750071,0.003250173],"study_design_scores_gemma":[0.03057206,0.0043352153,0.3781688,0.0110067725,0.0103692105,0.0011215396,0.0038131964,0.016485449,0.5060576,0.0017168504,0.032719724,0.003633562],"about_ca_topic_score_codex":0.07163904,"about_ca_topic_score_gemma":0.0069464725,"teacher_disagreement_score":0.3646757,"about_ca_system_score_codex":0.00050461676,"about_ca_system_score_gemma":0.0016965208,"threshold_uncertainty_score":0.9998233},"labels":[],"label_agreement":null},{"id":"W4361947121","doi":"10.1158/1078-0432.c.6530027","title":"Data from Angiokines Associated with Targeted Therapy Outcomes in Patients with Non–Clear Cell Renal Cell Carcinoma","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Cancer Research UK; Pfizer","keywords":"Sunitinib; Everolimus; Medicine; Internal medicine; Oncology; Renal cell carcinoma; Clear cell renal cell carcinoma; Progression-free survival; Axitinib; Clinical endpoint; Context (archaeology); Gastroenterology; Randomized controlled trial; Chemotherapy","score_opus":0.04953212371284594,"score_gpt":0.25845744894011274,"score_spread":0.2089253252272668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361947121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992506,0.00028101436,0.000031435062,0.000250899,0.00021338061,0.0025479323,0.0020714914,0.0002481447,0.0018496512],"genre_scores_gemma":[0.9626409,0.00004234064,0.0017072366,0.00020254582,0.000084620435,0.00011033373,0.028520646,0.00025502182,0.006436346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99547094,0.00016300278,0.00071601965,0.0017575792,0.0012024414,0.0006900361],"domain_scores_gemma":[0.99580115,0.0002543945,0.0005119683,0.0028340088,0.000310776,0.00028768263],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022454851,0.0009531689,0.0015704082,0.00042014336,0.00006279414,0.00007881901,0.000786345,0.0004920928,0.0003354039],"category_scores_gemma":[0.00004271721,0.0005797839,0.00017966735,0.00043273123,0.000096424556,0.000118891396,0.0009338827,0.0009412633,0.00012605969],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022329648,0.0019067528,0.9911828,0.000079339276,0.0006587887,0.0005569135,0.0002756139,0.00009995075,0.00026715087,1.4693684e-7,0.0026750646,0.0000644815],"study_design_scores_gemma":[0.0155788325,0.0021016956,0.97571355,0.00030849536,0.00050064526,5.053185e-7,0.00011139681,0.00047394304,0.0044956566,0.000012198136,0.000052765015,0.00065034354],"about_ca_topic_score_codex":0.0069999634,"about_ca_topic_score_gemma":0.0017660706,"teacher_disagreement_score":0.029865142,"about_ca_system_score_codex":0.00047512067,"about_ca_system_score_gemma":0.00047550115,"threshold_uncertainty_score":0.9996654},"labels":[],"label_agreement":null},{"id":"W4361949724","doi":"10.1158/1078-0432.c.6519998.v1","title":"Data from Sequential FDG-PET/CT as a Biomarker of Response to Sunitinib in Metastatic Clear Cell Renal Cancer","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Nuclear medicine; Sunitinib; Positron emission tomography; Renal cell carcinoma; Internal medicine","score_opus":0.22729277678142037,"score_gpt":0.4012130675070512,"score_spread":0.17392029072563084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361949724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874915,0.00052404916,0.000091518545,0.0019173148,0.00045535687,0.0017034491,0.0048558605,0.00009845391,0.0028625233],"genre_scores_gemma":[0.9773116,0.00020037577,0.005912177,0.00032689108,0.0001027415,0.00021629207,0.0039764442,0.00013535011,0.011818111],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957277,0.0006864302,0.0009900546,0.001307869,0.00082592655,0.00046199825],"domain_scores_gemma":[0.9957967,0.0007005423,0.0002966438,0.0026965293,0.00015640492,0.0003531794],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012624547,0.00050296425,0.0011516102,0.0007374439,0.000025634854,0.000040309737,0.00071166724,0.000055311182,0.004747242],"category_scores_gemma":[0.00044957272,0.00042191538,0.0002218678,0.00045859758,0.00009307002,0.00006056432,0.0024496648,0.0005865019,0.00067787647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13345149,0.0033721244,0.013493105,0.0035066637,0.006885799,0.14140567,0.0020171022,0.0014644631,0.5636247,0.000028010634,0.12750071,0.003250173],"study_design_scores_gemma":[0.03057206,0.0043352153,0.3781688,0.0110067725,0.0103692105,0.0011215396,0.0038131964,0.016485449,0.5060576,0.0017168504,0.032719724,0.003633562],"about_ca_topic_score_codex":0.07163904,"about_ca_topic_score_gemma":0.0069464725,"teacher_disagreement_score":0.3646757,"about_ca_system_score_codex":0.00050461676,"about_ca_system_score_gemma":0.0016965208,"threshold_uncertainty_score":0.9998233},"labels":[],"label_agreement":null},{"id":"W4361953673","doi":"10.1158/1078-0432.c.6530027.v1","title":"Data from Angiokines Associated with Targeted Therapy Outcomes in Patients with Non–Clear Cell Renal Cell Carcinoma","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Cancer Research UK; Pfizer","keywords":"Sunitinib; Everolimus; Medicine; Internal medicine; Oncology; Clear cell renal cell carcinoma; Renal cell carcinoma; Progression-free survival; Axitinib; Context (archaeology); Clinical endpoint; Gastroenterology; Randomized controlled trial; Chemotherapy","score_opus":0.04953212371284594,"score_gpt":0.25845744894011274,"score_spread":0.2089253252272668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361953673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992506,0.00028101436,0.000031435062,0.000250899,0.00021338061,0.0025479323,0.0020714914,0.0002481447,0.0018496512],"genre_scores_gemma":[0.9626409,0.00004234064,0.0017072366,0.00020254582,0.000084620435,0.00011033373,0.028520646,0.00025502182,0.006436346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99547094,0.00016300278,0.00071601965,0.0017575792,0.0012024414,0.0006900361],"domain_scores_gemma":[0.99580115,0.0002543945,0.0005119683,0.0028340088,0.000310776,0.00028768263],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022454851,0.0009531689,0.0015704082,0.00042014336,0.00006279414,0.00007881901,0.000786345,0.0004920928,0.0003354039],"category_scores_gemma":[0.00004271721,0.0005797839,0.00017966735,0.00043273123,0.000096424556,0.000118891396,0.0009338827,0.0009412633,0.00012605969],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022329648,0.0019067528,0.9911828,0.000079339276,0.0006587887,0.0005569135,0.0002756139,0.00009995075,0.00026715087,1.4693684e-7,0.0026750646,0.0000644815],"study_design_scores_gemma":[0.0155788325,0.0021016956,0.97571355,0.00030849536,0.00050064526,5.053185e-7,0.00011139681,0.00047394304,0.0044956566,0.000012198136,0.000052765015,0.00065034354],"about_ca_topic_score_codex":0.0069999634,"about_ca_topic_score_gemma":0.0017660706,"teacher_disagreement_score":0.029865142,"about_ca_system_score_codex":0.00047512067,"about_ca_system_score_gemma":0.00047550115,"threshold_uncertainty_score":0.9996654},"labels":[],"label_agreement":null},{"id":"W4361954042","doi":"10.1158/1078-0432.c.6532443.v1","title":"Data from A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Durvalumab; Nivolumab; Medicine; Renal cell carcinoma; Clinical endpoint; Internal medicine; Adverse effect; Oncology; Immunotherapy; Urology; Gastroenterology; Cancer; Randomized controlled trial","score_opus":0.06666745171825833,"score_gpt":0.32178438077281774,"score_spread":0.2551169290545594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361954042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858118,0.00022253052,0.00018359585,0.00006429835,0.00019981165,0.012811481,0.00039726743,0.00007465608,0.00023450494],"genre_scores_gemma":[0.98832154,0.00007327219,0.0049736206,0.000018380331,0.000020338523,0.00080098904,0.00505177,0.00016461132,0.0005754596],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99413425,0.00083844876,0.0015000079,0.0015840512,0.0014884444,0.00045482078],"domain_scores_gemma":[0.99526113,0.0009440105,0.0009650651,0.0023288066,0.00031332535,0.00018765595],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000857239,0.0007833673,0.0029876553,0.0007608453,0.00005266552,0.000029631883,0.0006114702,0.00017527468,0.0002636019],"category_scores_gemma":[0.00014608788,0.00049711973,0.00012581689,0.0005998379,0.00014750124,0.00018831657,0.00066342886,0.0007704529,0.000013654561],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.940847,0.032486107,0.01804552,0.0003723979,0.0010009242,0.00069330394,0.0044981493,0.00078276906,0.0000993026,8.744518e-7,0.000075397234,0.0010982461],"study_design_scores_gemma":[0.9049097,0.04654397,0.034984004,0.0005021804,0.0018731154,0.0000010381098,0.0031110689,0.006576946,0.0009831188,0.000025501207,0.0000036992167,0.00048567873],"about_ca_topic_score_codex":0.011051603,"about_ca_topic_score_gemma":0.011267575,"teacher_disagreement_score":0.035937328,"about_ca_system_score_codex":0.0006121779,"about_ca_system_score_gemma":0.00072338,"threshold_uncertainty_score":0.99974805},"labels":[],"label_agreement":null},{"id":"W4361954247","doi":"10.1158/1078-0432.c.6532988.v1","title":"Data from Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Confidence interval; Body mass index; Retrospective cohort study; Cohort; Clear cell renal cell carcinoma; Overweight; Oncology; Blockade; Immune checkpoint; Gastroenterology; Receptor","score_opus":0.05853575591384384,"score_gpt":0.31011665584193143,"score_spread":0.2515808999280876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361954247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862303,0.00026632333,0.00011213218,0.00028496468,0.000096908254,0.0036998745,0.008364149,0.00026974807,0.0006755654],"genre_scores_gemma":[0.90853596,0.00006821259,0.007119847,0.000030082101,0.000119888835,0.00011961895,0.0818818,0.0001815596,0.0019430444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943831,0.0004596836,0.0014484657,0.0019491551,0.001165605,0.0005939929],"domain_scores_gemma":[0.994687,0.0008719886,0.0011677452,0.0024125772,0.00032733715,0.0005333351],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040921156,0.0010489702,0.0022910638,0.0002868099,0.0002168259,0.00017707073,0.00044455088,0.00046971987,0.00007398378],"category_scores_gemma":[0.00004824755,0.0006622983,0.00035362042,0.000234984,0.00025427793,0.00015767083,0.0011117433,0.0012328642,0.000049392656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000937504,0.0020436507,0.9916627,0.00015577502,0.0042044655,0.00030194255,0.00015015379,0.000028277063,0.00009231409,3.745342e-7,0.00035488006,0.00006800625],"study_design_scores_gemma":[0.011959782,0.0034325789,0.9631724,0.00032089537,0.014564636,0.000003792872,0.00010290924,0.00023023592,0.0055741714,0.000017356408,0.000005987566,0.00061526714],"about_ca_topic_score_codex":0.014640893,"about_ca_topic_score_gemma":0.0009421204,"teacher_disagreement_score":0.07769439,"about_ca_system_score_codex":0.00067008624,"about_ca_system_score_gemma":0.0003054422,"threshold_uncertainty_score":0.9995828},"labels":[],"label_agreement":null},{"id":"W4361958987","doi":"10.1158/1078-0432.c.6532988","title":"Data from Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Confidence interval; Body mass index; Clear cell renal cell carcinoma; Cohort; Retrospective cohort study; Oncology; Overweight; Blockade; Gastroenterology; Receptor","score_opus":0.05853575591384384,"score_gpt":0.31011665584193143,"score_spread":0.2515808999280876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361958987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862303,0.00026632333,0.00011213218,0.00028496468,0.000096908254,0.0036998745,0.008364149,0.00026974807,0.0006755654],"genre_scores_gemma":[0.90853596,0.00006821259,0.007119847,0.000030082101,0.000119888835,0.00011961895,0.0818818,0.0001815596,0.0019430444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943831,0.0004596836,0.0014484657,0.0019491551,0.001165605,0.0005939929],"domain_scores_gemma":[0.994687,0.0008719886,0.0011677452,0.0024125772,0.00032733715,0.0005333351],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040921156,0.0010489702,0.0022910638,0.0002868099,0.0002168259,0.00017707073,0.00044455088,0.00046971987,0.00007398378],"category_scores_gemma":[0.00004824755,0.0006622983,0.00035362042,0.000234984,0.00025427793,0.00015767083,0.0011117433,0.0012328642,0.000049392656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000937504,0.0020436507,0.9916627,0.00015577502,0.0042044655,0.00030194255,0.00015015379,0.000028277063,0.00009231409,3.745342e-7,0.00035488006,0.00006800625],"study_design_scores_gemma":[0.011959782,0.0034325789,0.9631724,0.00032089537,0.014564636,0.000003792872,0.00010290924,0.00023023592,0.0055741714,0.000017356408,0.000005987566,0.00061526714],"about_ca_topic_score_codex":0.014640893,"about_ca_topic_score_gemma":0.0009421204,"teacher_disagreement_score":0.07769439,"about_ca_system_score_codex":0.00067008624,"about_ca_system_score_gemma":0.0003054422,"threshold_uncertainty_score":0.9995828},"labels":[],"label_agreement":null},{"id":"W4361959012","doi":"10.1158/1078-0432.c.6532443","title":"Data from A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Durvalumab; Nivolumab; Medicine; Renal cell carcinoma; Clinical endpoint; Internal medicine; Adverse effect; Oncology; Immunotherapy; Urology; Gastroenterology; Cancer; Randomized controlled trial","score_opus":0.06666745171825833,"score_gpt":0.32178438077281774,"score_spread":0.2551169290545594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361959012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858118,0.00022253052,0.00018359585,0.00006429835,0.00019981165,0.012811481,0.00039726743,0.00007465608,0.00023450494],"genre_scores_gemma":[0.98832154,0.00007327219,0.0049736206,0.000018380331,0.000020338523,0.00080098904,0.00505177,0.00016461132,0.0005754596],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99413425,0.00083844876,0.0015000079,0.0015840512,0.0014884444,0.00045482078],"domain_scores_gemma":[0.99526113,0.0009440105,0.0009650651,0.0023288066,0.00031332535,0.00018765595],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000857239,0.0007833673,0.0029876553,0.0007608453,0.00005266552,0.000029631883,0.0006114702,0.00017527468,0.0002636019],"category_scores_gemma":[0.00014608788,0.00049711973,0.00012581689,0.0005998379,0.00014750124,0.00018831657,0.00066342886,0.0007704529,0.000013654561],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.940847,0.032486107,0.01804552,0.0003723979,0.0010009242,0.00069330394,0.0044981493,0.00078276906,0.0000993026,8.744518e-7,0.000075397234,0.0010982461],"study_design_scores_gemma":[0.9049097,0.04654397,0.034984004,0.0005021804,0.0018731154,0.0000010381098,0.0031110689,0.006576946,0.0009831188,0.000025501207,0.0000036992167,0.00048567873],"about_ca_topic_score_codex":0.011051603,"about_ca_topic_score_gemma":0.011267575,"teacher_disagreement_score":0.035937328,"about_ca_system_score_codex":0.0006121779,"about_ca_system_score_gemma":0.00072338,"threshold_uncertainty_score":0.99974805},"labels":[],"label_agreement":null},{"id":"W4362329976","doi":"10.1158/0008-5472.22413203","title":"Supplemental Figures and Tables from Efficacy of Cotargeting Angiopoietin-2 and the VEGF Pathway in the Adjuvant Postsurgical Setting for Early Breast, Colorectal, and Renal Cancers","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Regorafenib; Sunitinib; Pazopanib; Internal medicine; Oncology; Adjuvant therapy; Breast cancer; Colorectal cancer; Cancer","score_opus":0.020267691245486087,"score_gpt":0.2690184170487187,"score_spread":0.24875072580323263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362329976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98835856,0.004191399,0.000011326271,0.0034231008,0.000070689624,0.0024087357,0.0013280574,0.000026116213,0.00018204522],"genre_scores_gemma":[0.99724627,0.0003525723,0.0010239185,0.00009689781,0.00016331696,0.000258048,0.0007383905,0.000038103968,0.00008247754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795943,0.0002313685,0.0005306951,0.00058621244,0.00035024443,0.00034205188],"domain_scores_gemma":[0.9968751,0.0024621661,0.00023775247,0.0002610732,0.00006538022,0.000098525976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010088737,0.00034090338,0.0007357532,0.00009074186,0.00012967738,0.00008215255,0.00013508613,0.00016158556,0.000046303656],"category_scores_gemma":[0.00013309985,0.00017929346,0.00014857805,0.00008753847,0.00039023423,0.000034118464,0.00041991935,0.00032393553,4.3994748e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03128826,0.00068342197,0.8439577,0.0032984647,0.0032954148,0.0009135385,0.056153532,0.0002423492,0.031200144,0.0010066862,0.0073374333,0.020623019],"study_design_scores_gemma":[0.017141087,0.0007599514,0.9641521,0.0014075151,0.0006207405,0.00021542177,0.006089669,0.0019231271,0.006355669,0.00068837457,0.00027637766,0.0003699527],"about_ca_topic_score_codex":0.016739516,"about_ca_topic_score_gemma":0.001224841,"teacher_disagreement_score":0.120194376,"about_ca_system_score_codex":0.00010537839,"about_ca_system_score_gemma":0.0001645208,"threshold_uncertainty_score":0.9898081},"labels":[],"label_agreement":null},{"id":"W4362521183","doi":"10.1097/mou.0000000000001095","title":"Role of lymphadenectomy during primary surgery for kidney cancer","year":2023,"lang":"en","type":"review","venue":"Current Opinion in Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Lymphadenectomy; Renal cell carcinoma; Lymph node; Pembrolizumab; Nephrectomy; Kidney cancer; Dissection (medical); Adjuvant therapy; Oncology; Disease; Cancer; Surgery; Radiology; Internal medicine; Immunotherapy; Kidney","score_opus":0.14396261402998348,"score_gpt":0.4039421135535778,"score_spread":0.25997949952359434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362521183","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032071586,0.99262214,0.0000026856792,0.00008454212,0.004814633,0.0018142392,0.00022854237,0.000053500233,0.00005901091],"genre_scores_gemma":[0.000054610933,0.99504554,0.000015013755,0.000015617336,0.00095443707,0.002228239,0.0015171996,0.00009997387,0.0000693374],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975019,0.00016287681,0.0010733085,0.0005884576,0.0002127885,0.00046068258],"domain_scores_gemma":[0.9981125,0.00067732943,0.00051972526,0.00042109462,0.00008042561,0.00018894923],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026097655,0.0004097417,0.0026874884,0.0008168269,0.000026005295,0.00000420121,0.0001491014,0.00035142072,0.00004953862],"category_scores_gemma":[0.00022482805,0.00034233026,0.0007914483,0.0004365859,0.000074161435,0.000026517531,0.000117715805,0.0002763158,0.00003282308],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021582705,0.00032653176,0.004309388,0.28312674,0.00043803427,0.0000113744245,0.000046443474,0.0000025623137,0.000008565852,0.00005003135,0.0049675964,0.7064969],"study_design_scores_gemma":[0.0009772104,0.00010954661,0.003284397,0.020059677,0.00063453167,0.00007863012,0.0000024825508,0.0000061672245,0.0000085694455,0.000037668608,0.9745717,0.00022942494],"about_ca_topic_score_codex":0.00002796146,"about_ca_topic_score_gemma":0.0000013807983,"teacher_disagreement_score":0.9696041,"about_ca_system_score_codex":0.0005081735,"about_ca_system_score_gemma":0.001631442,"threshold_uncertainty_score":0.99990284},"labels":[],"label_agreement":null},{"id":"W4362542431","doi":"10.1158/2159-8290.22531578","title":"Supplementary Figure Legends, Table Legends from Biallelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Prostate Cancer Foundation; National Institutes of Health; American Cancer Society; National Center for Advancing Translational Sciences; Howard Hughes Medical Institute","keywords":"Table (database); Art; Literature; Computer science","score_opus":0.02612052929812913,"score_gpt":0.236041248396807,"score_spread":0.20992071909867788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362542431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99306816,0.0011043978,0.000021358497,0.0019002955,0.0003669465,0.0016553801,0.0012797704,0.000013842496,0.00058985874],"genre_scores_gemma":[0.9956902,0.00009311073,0.000429304,0.00016427715,0.00012212667,0.000065485656,0.0017597544,0.00004437532,0.0016313392],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977797,0.00019190273,0.0006970896,0.00059264555,0.0004977896,0.00024083308],"domain_scores_gemma":[0.998402,0.00006982011,0.00036310236,0.00094512635,0.00010178298,0.00011819406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027495658,0.0003466942,0.0005935379,0.00016957146,0.00007308189,0.000024572602,0.00019520182,0.0002585399,0.00036207246],"category_scores_gemma":[0.000029363064,0.00021300717,0.0001508939,0.00022353252,0.00011032648,0.000047072383,0.0006543059,0.0003715632,0.0000012958138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025354812,0.0004317352,0.848284,0.0017392138,0.00023400156,0.00005913058,0.003311027,0.0006601482,0.14008516,0.00022627976,0.0036154804,0.0011002602],"study_design_scores_gemma":[0.0019412076,0.00020248203,0.5649688,0.00032869133,0.00023639739,0.000010540245,0.00033424675,0.0015012334,0.4295484,0.00040331238,0.00036090857,0.00016371049],"about_ca_topic_score_codex":0.022635229,"about_ca_topic_score_gemma":0.0018406692,"teacher_disagreement_score":0.28946328,"about_ca_system_score_codex":0.00018104649,"about_ca_system_score_gemma":0.00048353252,"threshold_uncertainty_score":0.9838731},"labels":[],"label_agreement":null},{"id":"W4362545300","doi":"10.1158/1538-7445.am2023-5071","title":"Abstract 5071: Olverembatinib (HQP1351) enhances antitumor effects of immunotherapy in renal cell carcinoma (RCC)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Axitinib; Cancer research; Immunotherapy; Lenvatinib; Medicine; Tumor microenvironment; Cancer immunotherapy; Cancer; Pharmacology; Sorafenib; Internal medicine","score_opus":0.06318448062453177,"score_gpt":0.3873964400267268,"score_spread":0.32421195940219505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362545300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98562807,0.0076008597,0.0000013264163,0.0002807758,0.00017695077,0.0011642351,0.000013942447,0.000044231816,0.0050896364],"genre_scores_gemma":[0.9941394,0.002719509,0.000063705666,0.000030910323,0.00017795601,0.0003916131,0.000026267799,0.00005254597,0.0023981018],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971011,0.00016440864,0.00042079296,0.00048488608,0.0010627975,0.0007659621],"domain_scores_gemma":[0.99831325,0.00059625093,0.00009461249,0.00056213414,0.00025691072,0.00017682908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008596955,0.00021239763,0.0005044811,0.0007216088,0.0000822837,0.000022625587,0.00026584853,0.00011309247,0.0004995598],"category_scores_gemma":[0.000108786815,0.00017423787,0.00014659755,0.0014132914,0.00023869945,0.00008193954,0.00009050015,0.00056362397,0.00021036324],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007633492,0.00024831266,0.035740852,0.0013756127,0.00004544095,0.000998148,0.0007081644,0.000016352224,0.95103836,0.00001423143,0.0021437902,0.0069073727],"study_design_scores_gemma":[0.0020893875,0.0005823757,0.38856062,0.00043870808,0.000009028768,0.0000039853685,0.00011346996,0.000011211582,0.60762227,0.000040666808,0.00043958798,0.00008870474],"about_ca_topic_score_codex":0.0024417061,"about_ca_topic_score_gemma":0.00012407734,"teacher_disagreement_score":0.35281977,"about_ca_system_score_codex":0.00044796473,"about_ca_system_score_gemma":0.00066232774,"threshold_uncertainty_score":0.7105214},"labels":[],"label_agreement":null},{"id":"W4362553912","doi":"10.1016/j.euf.2023.03.014","title":"Development and External Validation of a Novel Nomogram Predicting Cancer-specific Mortality–free Survival in Surgically Treated Papillary Renal Cell Carcinoma Patients","year":2023,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nomogram; Medicine; Stage (stratigraphy); Proportional hazards model; Population; Cohort; Surveillance, Epidemiology, and End Results; Renal cell carcinoma; Oncology; Internal medicine; Kidney cancer; Epidemiology; Surgery; Cancer registry","score_opus":0.04111438165274221,"score_gpt":0.2525512628571409,"score_spread":0.21143688120439869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362553912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99466187,0.0005050695,0.00003253452,0.00007532599,0.00014364626,0.00046283234,0.000037560898,0.000080479505,0.004000663],"genre_scores_gemma":[0.99901456,0.00008554635,0.00043734012,0.000021640042,0.00008551435,0.000025413572,0.00014062296,0.000052791507,0.0001365651],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977545,0.00027585038,0.00067290664,0.0005136846,0.0003842988,0.00039872635],"domain_scores_gemma":[0.99901545,0.00011651842,0.00022805226,0.00036415155,0.000112789785,0.00016302189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006025345,0.0002553568,0.00042016918,0.0002942447,0.00006279477,0.000012823815,0.00014929795,0.0000797824,0.000030871364],"category_scores_gemma":[0.000048508067,0.00022636281,0.000073243194,0.0003889146,0.00010487719,0.000049874703,0.00021384722,0.00021986755,0.0000191716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004246841,0.0004187288,0.97896206,0.000055582826,0.000056670506,0.0009197193,0.00072020275,0.00007803428,0.012561847,0.000009308239,0.00004677368,0.005746364],"study_design_scores_gemma":[0.006179603,0.00066466804,0.9724573,0.000042449192,0.00008451855,0.0000246463,0.00003417729,0.0001252846,0.019740859,0.00000438189,0.00048585184,0.00015624787],"about_ca_topic_score_codex":0.00020421586,"about_ca_topic_score_gemma":0.00006960048,"teacher_disagreement_score":0.007179011,"about_ca_system_score_codex":0.00011073295,"about_ca_system_score_gemma":0.00007871689,"threshold_uncertainty_score":0.92308074},"labels":[],"label_agreement":null},{"id":"W4362608854","doi":"10.3390/cancers15072155","title":"Critical Appraisal of Leibovich 2018 and GRANT Models for Prediction of Cancer-Specific Survival in Non-Metastatic Chromophobe Renal Cell Carcinoma","year":2023,"lang":"en","type":"article","venue":"Cancers","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Chromophobe cell; Renal cell carcinoma; Oncology; Medicine; Internal medicine; Pathology; Cancer research; Clear cell","score_opus":0.054543205172034114,"score_gpt":0.3160118269220283,"score_spread":0.2614686217499942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362608854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99500483,0.002067152,0.00057887926,0.00011480465,0.00058305013,0.00064800703,0.0005561104,0.000019473942,0.00042769365],"genre_scores_gemma":[0.99828595,0.0006007649,0.00057778944,0.000008410957,0.00011553863,0.00022076214,0.000088393965,0.000032921613,0.000069441594],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985448,0.00003658767,0.000443082,0.00034636582,0.00031349759,0.0003156678],"domain_scores_gemma":[0.9990159,0.00036474236,0.0000957536,0.00023028353,0.00015671283,0.00013656946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023474943,0.00017376922,0.00052190013,0.0002265066,0.000030955234,0.0000052875384,0.00006354099,0.00006684708,0.000022336777],"category_scores_gemma":[0.00004482521,0.00015716832,0.00010243978,0.00037217472,0.00021633918,0.00009286195,0.00002833027,0.00010796108,0.0000013560071],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074659134,0.0005790534,0.17164263,0.012354266,0.00041785327,0.00044156393,0.008774237,0.034155082,0.7455379,0.0011179076,0.009943933,0.007569664],"study_design_scores_gemma":[0.016954783,0.004681158,0.55394346,0.00092160614,0.00074136385,0.00003448008,0.00274326,0.17519987,0.24329676,0.00054918387,0.0004756164,0.00045848422],"about_ca_topic_score_codex":0.0017187794,"about_ca_topic_score_gemma":0.0001879347,"teacher_disagreement_score":0.50224113,"about_ca_system_score_codex":0.0005756406,"about_ca_system_score_gemma":0.00048074417,"threshold_uncertainty_score":0.6409138},"labels":[],"label_agreement":null},{"id":"W4362627027","doi":"10.1158/2159-8290.22531578.v1","title":"Supplementary Figure Legends, Table Legends from Biallelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Prostate Cancer Foundation; National Institutes of Health; American Cancer Society; National Center for Advancing Translational Sciences; Howard Hughes Medical Institute","keywords":"Hippo signaling pathway; Biology; Cancer research; Pathology; Cell biology; Medicine; Signal transduction","score_opus":0.02612052929812913,"score_gpt":0.236041248396807,"score_spread":0.20992071909867788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362627027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99306816,0.0011043978,0.000021358497,0.0019002955,0.0003669465,0.0016553801,0.0012797704,0.000013842496,0.00058985874],"genre_scores_gemma":[0.9956902,0.00009311073,0.000429304,0.00016427715,0.00012212667,0.000065485656,0.0017597544,0.00004437532,0.0016313392],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977797,0.00019190273,0.0006970896,0.00059264555,0.0004977896,0.00024083308],"domain_scores_gemma":[0.998402,0.00006982011,0.00036310236,0.00094512635,0.00010178298,0.00011819406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027495658,0.0003466942,0.0005935379,0.00016957146,0.00007308189,0.000024572602,0.00019520182,0.0002585399,0.00036207246],"category_scores_gemma":[0.000029363064,0.00021300717,0.0001508939,0.00022353252,0.00011032648,0.000047072383,0.0006543059,0.0003715632,0.0000012958138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025354812,0.0004317352,0.848284,0.0017392138,0.00023400156,0.00005913058,0.003311027,0.0006601482,0.14008516,0.00022627976,0.0036154804,0.0011002602],"study_design_scores_gemma":[0.0019412076,0.00020248203,0.5649688,0.00032869133,0.00023639739,0.000010540245,0.00033424675,0.0015012334,0.4295484,0.00040331238,0.00036090857,0.00016371049],"about_ca_topic_score_codex":0.022635229,"about_ca_topic_score_gemma":0.0018406692,"teacher_disagreement_score":0.28946328,"about_ca_system_score_codex":0.00018104649,"about_ca_system_score_gemma":0.00048353252,"threshold_uncertainty_score":0.9838731},"labels":[],"label_agreement":null},{"id":"W4362644007","doi":"10.56875/2589-0646.1027","title":"Efficacy and Safety of Checkpoint Inhibitors in Clear Cell Renal Cell Carcinoma: A Systematic Review of Clinical Trials","year":2023,"lang":"en","type":"review","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fraser Health","funders":"","keywords":"Renal cell carcinoma; Medicine; Clinical trial; Oncology; Internal medicine; Cancer research","score_opus":0.18934356529509228,"score_gpt":0.4355783261040979,"score_spread":0.24623476080900564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362644007","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015279582,0.9723057,0.000002458003,0.00007823454,0.00030194636,0.010561815,0.000038148224,0.000035445704,0.001396645],"genre_scores_gemma":[0.007975259,0.9905538,0.000136259,0.00010245481,0.00009005131,0.00047808455,0.00006884637,0.00011153185,0.00048373968],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9800885,0.008390676,0.00953887,0.0010705162,0.00037530594,0.0005361617],"domain_scores_gemma":[0.9830742,0.009826763,0.005610877,0.0009897719,0.00016928084,0.00032911816],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.013116888,0.00090613065,0.02091942,0.00055173744,0.00005889189,0.000006396214,0.00028183128,0.0017386357,0.00005102083],"category_scores_gemma":[0.00044875842,0.0005898055,0.0016810382,0.0005767987,0.0005408603,0.000034392888,0.00018054123,0.001159917,0.00003661358],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015047896,0.001196653,0.00021541619,0.9779927,0.0004628573,0.00068745174,0.00028188742,5.6165092e-8,0.000034480083,0.000043358068,0.0002748744,0.017305436],"study_design_scores_gemma":[0.027732557,0.011547389,0.00022500589,0.89620227,0.015324085,0.0020490065,0.00045890448,0.000008161736,0.0020043084,0.000033090455,0.043359622,0.0010556096],"about_ca_topic_score_codex":0.000021573458,"about_ca_topic_score_gemma":0.000005412074,"teacher_disagreement_score":0.081790484,"about_ca_system_score_codex":0.00016765571,"about_ca_system_score_gemma":0.0010866001,"threshold_uncertainty_score":0.9996553},"labels":[],"label_agreement":null},{"id":"W4362664033","doi":"10.1117/12.2653286","title":"Fully automated cascaded approach for renal mass detection on T2 weighted MRI images","year":2023,"lang":"en","type":"article","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Vale (Canada); University of Guelph","funders":"","keywords":"Magnetic resonance imaging; Renal cell carcinoma; Segmentation; Computer science; Steady-state free precession imaging; Artificial intelligence; Convolutional neural network; Chromophobe cell; Pattern recognition (psychology); Radiology; Clear cell; Medicine; Pathology","score_opus":0.028060389565312687,"score_gpt":0.2789389461225223,"score_spread":0.2508785565572096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362664033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88802266,0.00008951313,0.04149,0.0020683408,0.00035649168,0.0038316129,0.000047686764,0.005993566,0.058100123],"genre_scores_gemma":[0.9657266,0.000015685564,0.014376406,0.00015576291,0.00019615512,0.0003741824,0.00035143935,0.00005587264,0.018747853],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99861175,0.000042861597,0.00025047074,0.00041616647,0.00031500385,0.00036374855],"domain_scores_gemma":[0.9992654,0.00009585952,0.00006151956,0.0003156778,0.00010986834,0.00015168484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019480562,0.00021595637,0.0002913329,0.00028214505,0.000106504966,0.000025507248,0.00006270424,0.00013576048,0.00008280973],"category_scores_gemma":[0.00003809729,0.00015304395,0.00016563591,0.00046840042,0.000032926317,0.00004927827,0.000019177882,0.00012664955,0.00028628326],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029958694,0.00053218304,0.0007711902,0.00047163543,0.0006359207,0.00040793885,0.00021421988,0.00042922335,0.8895539,0.00019202547,0.08676375,0.01703212],"study_design_scores_gemma":[0.0033961227,0.001351801,0.013987155,0.00003116701,0.00020039914,0.00009620122,0.00012958497,0.1530269,0.8259402,0.00008873948,0.0015550575,0.00019668356],"about_ca_topic_score_codex":0.000048752714,"about_ca_topic_score_gemma":0.0000040074783,"teacher_disagreement_score":0.15259767,"about_ca_system_score_codex":0.00022184916,"about_ca_system_score_gemma":0.0000499535,"threshold_uncertainty_score":0.62409514},"labels":[],"label_agreement":null},{"id":"W4362697911","doi":"10.1016/j.eururo.2023.03.025","title":"Stereotactic Radiotherapy for Renal Cell Carcinoma: The Fallacy of (False) Positive Post-treatment Biopsy?","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Renal cell carcinoma; Radiation therapy; Biopsy; Radiology; Carcinoma; Oncology; Pathology","score_opus":0.026460812877283104,"score_gpt":0.25880557015489447,"score_spread":0.23234475727761136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362697911","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38243717,0.005859548,0.00015125958,0.59265256,0.0013466576,0.0050594658,0.0009198889,0.00021103394,0.011362379],"genre_scores_gemma":[0.5599054,0.0003726681,0.0008072258,0.38919726,0.00817615,0.00028315122,0.0034061556,0.0009446656,0.03690731],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962454,0.0010491932,0.00070073735,0.0009026061,0.0003493348,0.0007527516],"domain_scores_gemma":[0.99652994,0.0012615585,0.0005494157,0.0012364853,0.0003028642,0.000119768156],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034200205,0.0007246115,0.001085103,0.00034147728,0.00012430626,0.00002548903,0.00039779386,0.0003572793,0.00009532714],"category_scores_gemma":[0.00006344377,0.00045606634,0.0007427438,0.00019087717,0.00029530574,0.000027312524,0.00010193148,0.0008249961,0.00028421992],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00634444,0.0011295254,0.004218034,0.0010146295,0.005638609,0.04778393,0.0046086507,0.000023246937,0.039118428,0.00004983266,0.8844203,0.005650403],"study_design_scores_gemma":[0.0091413995,0.024455126,0.064615645,0.00006652589,0.003793466,0.0027912187,0.00007217965,0.000037283302,0.0064473436,0.000030409912,0.8878266,0.0007227946],"about_ca_topic_score_codex":0.00022112319,"about_ca_topic_score_gemma":0.000009814307,"teacher_disagreement_score":0.20345531,"about_ca_system_score_codex":0.00037970982,"about_ca_system_score_gemma":0.00023161244,"threshold_uncertainty_score":0.9997891},"labels":[],"label_agreement":null},{"id":"W4362735564","doi":"10.1016/j.adro.2023.101238","title":"Survival in Metastatic Renal Cell Carcinoma Treated With Immunotherapy and Stereotactic Radiation Therapy or Immunotherapy Alone: A National Cancer Database Analysis","year":2023,"lang":"en","type":"article","venue":"Advances in Radiation Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Center for Advancing Translational Sciences; National Institutes of Health; Georgia Clinical and Translational Science Alliance; Institute of Clinical and Translational Sciences","keywords":"Medicine; Renal cell carcinoma; Stereotactic radiation therapy; Clinical endpoint; Immunotherapy; Radiosurgery; Statistical significance; Cohort; Internal medicine; Lung cancer; Radiation therapy; Oncology; Cancer; Clinical trial","score_opus":0.03288396194827329,"score_gpt":0.3561541188024137,"score_spread":0.3232701568541404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362735564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817353,0.016053805,0.00009815508,0.00056398404,0.00010358457,0.00094102067,0.000072575735,0.00004795934,0.0003836401],"genre_scores_gemma":[0.95806354,0.03946235,0.0005748521,0.00030553545,0.000072405695,0.00054463104,0.00064634864,0.00003894479,0.00029139072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977137,0.00041816456,0.0005536918,0.00052368484,0.00042806723,0.00036269895],"domain_scores_gemma":[0.9984981,0.00071572396,0.00031699723,0.00026566416,0.00011684598,0.00008666752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005487458,0.00028515726,0.0007322859,0.0013092565,0.000069432026,0.000021442145,0.00009244898,0.00009185974,0.0002390585],"category_scores_gemma":[0.000039448405,0.00021240773,0.0000783642,0.0026482018,0.000099760786,0.00044199562,0.00001338453,0.00021433663,0.000008632413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00801319,0.00067112176,0.8776227,0.000050854956,0.0006648891,0.00049439253,0.0013198267,0.0054557547,0.005235712,0.000037811245,0.000038280807,0.10039542],"study_design_scores_gemma":[0.020490218,0.0020440253,0.96118045,0.00002435244,0.00021338934,0.00003759517,0.00026130147,0.0058119884,0.0032257817,0.000049131,0.006391033,0.00027072566],"about_ca_topic_score_codex":0.0011010567,"about_ca_topic_score_gemma":0.0032268807,"teacher_disagreement_score":0.10012469,"about_ca_system_score_codex":0.0011235804,"about_ca_system_score_gemma":0.00056446804,"threshold_uncertainty_score":0.86617357},"labels":[],"label_agreement":null},{"id":"W4365135708","doi":"10.1080/14737140.2023.2200939","title":"What is the role of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma?","year":2023,"lang":"en","type":"editorial","venue":"Expert Review of Anticancer Therapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Oncology; Urology; Internal medicine; Kidney","score_opus":0.013076808563556624,"score_gpt":0.3016934713059804,"score_spread":0.28861666274242376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365135708","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038175877,0.81451726,0.000001274395,0.00060834293,0.14276427,0.0035224806,0.0001214263,0.000019634794,0.00026945065],"genre_scores_gemma":[0.018692786,0.9091607,0.00045632693,0.00048391556,0.06973112,0.0005661236,0.00044193337,0.00019760772,0.00026953622],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963107,0.00025973402,0.0008801278,0.0005780316,0.0016051527,0.00036624714],"domain_scores_gemma":[0.99689287,0.00059687736,0.00074578275,0.0010046005,0.00066189404,0.00009798453],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000401986,0.00053797296,0.0019043161,0.00016869033,0.000035220903,0.000017792443,0.00035696646,0.0001554275,0.00019178538],"category_scores_gemma":[0.00007429011,0.00028375397,0.00041740038,0.000603323,0.00026475554,0.00013781102,0.000052064464,0.0004775833,0.000011599641],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048976527,0.0019636024,0.00490006,0.010654996,0.0017773267,0.00006577895,0.005656388,8.8648045e-7,0.00097408204,0.000008327658,0.9133116,0.05578928],"study_design_scores_gemma":[0.007236529,0.0040694317,0.0062087113,0.032816768,0.0006992006,0.0000016210982,0.0007693798,0.0000022533757,0.03343281,0.000036782705,0.9142217,0.00050483533],"about_ca_topic_score_codex":0.0006148644,"about_ca_topic_score_gemma":0.000009888629,"teacher_disagreement_score":0.09464342,"about_ca_system_score_codex":0.0002836395,"about_ca_system_score_gemma":0.0007695346,"threshold_uncertainty_score":0.99996144},"labels":[],"label_agreement":null},{"id":"W4366201810","doi":"10.1007/s00464-023-10073-2","title":"2023 Scientific Session of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), Montréal, Canada, 19 March–April 1 2023: Video Loop","year":2023,"lang":"en","type":"article","venue":"Surgical Endoscopy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Adrenalectomy; Nephrectomy; Renal cell carcinoma; Surgery; General surgery; Internal medicine; Kidney","score_opus":0.01790164893307699,"score_gpt":0.2598965543015895,"score_spread":0.24199490536851248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366201810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99497175,0.0011154208,0.000008387597,0.0023882727,0.0002418889,0.0004636164,0.00017884254,0.00003576986,0.00059606234],"genre_scores_gemma":[0.9927158,0.00029137474,0.00056832365,0.00006289208,0.000043225045,0.000030840347,0.000072109084,0.000027788152,0.0061876676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736255,0.00016408031,0.0005077872,0.0004935421,0.0009323515,0.00053970085],"domain_scores_gemma":[0.9979167,0.0007057461,0.000268815,0.0005953703,0.00015594678,0.00035744414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044053528,0.00025609473,0.00063814333,0.00010716489,0.00019987536,0.000019361902,0.00018446257,0.000043074735,0.00020299078],"category_scores_gemma":[0.00019652281,0.00016819751,0.0003230459,0.0013088506,0.0009505167,0.000039344006,0.0002602956,0.00029043257,0.0000114681825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009275843,0.00039779692,0.79601157,0.00088298664,0.00028235503,0.0009467606,0.00020490427,0.0001444275,0.066452436,0.00011549389,0.131104,0.0025296651],"study_design_scores_gemma":[0.009606786,0.0011049742,0.89930546,0.0014787826,0.0003821568,0.00048687638,0.0014617008,0.0016703953,0.057049528,0.000076672506,0.027008394,0.00036825205],"about_ca_topic_score_codex":0.31064853,"about_ca_topic_score_gemma":0.04404571,"teacher_disagreement_score":0.2666028,"about_ca_system_score_codex":0.00020949816,"about_ca_system_score_gemma":0.0010809059,"threshold_uncertainty_score":0.973398},"labels":[],"label_agreement":null},{"id":"W4366251172","doi":"10.1016/j.eururo.2023.03.032","title":"Reply to Binghao Zhao, Hao Xing, and Wenbin Ma’s Letter to the Editor re: Matthew S. Ernst, Vishal Navani, J. Connor Wells, et al. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma. Eur Urol. 2023;84:109–116","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Oncology; Theology; Philosophy","score_opus":0.04947360310919247,"score_gpt":0.2851655637115262,"score_spread":0.23569196060233372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366251172","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.094177365,0.0019768344,0.002811441,0.87603474,0.0073207053,0.012043296,0.0044962494,0.0002166816,0.0009226948],"genre_scores_gemma":[0.33715382,0.00005860534,0.0026502686,0.6356696,0.0050373543,0.0018130944,0.008679615,0.0005781968,0.008359455],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99168587,0.0018240002,0.0020337617,0.0022029378,0.0010055731,0.0012478377],"domain_scores_gemma":[0.9923498,0.0042643812,0.0010433008,0.0013929361,0.0005819425,0.0003676115],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0030083992,0.0013164926,0.0018061253,0.0011819027,0.00027088038,0.00024159146,0.000995129,0.00022150103,0.00013155036],"category_scores_gemma":[0.0014002573,0.0010163449,0.0005002327,0.00041835214,0.00030263086,0.0002422176,0.00066217437,0.0017596106,0.00028886052],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019045379,0.0004602547,0.0061962046,0.00084144913,0.00052738894,0.004073011,0.00095237786,0.00007846465,0.00074813975,0.000026758209,0.98409194,0.000099498415],"study_design_scores_gemma":[0.010340648,0.0050574816,0.014635361,0.000187797,0.001154104,0.00018283578,0.00013487547,0.00065215066,0.00049351243,0.000063803316,0.9661832,0.0009142459],"about_ca_topic_score_codex":0.0004363983,"about_ca_topic_score_gemma":0.00018527298,"teacher_disagreement_score":0.24297644,"about_ca_system_score_codex":0.00027578874,"about_ca_system_score_gemma":0.00033113308,"threshold_uncertainty_score":0.99995863},"labels":[],"label_agreement":null},{"id":"W4366316326","doi":"10.1177/17562872231164803","title":"Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review","year":2023,"lang":"en","type":"review","venue":"Therapeutic Advances in Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Radiomics; Renal cell carcinoma; Renal oncocytoma; Angiomyolipoma; Kidney cancer; Clear cell; Clear cell renal cell carcinoma; Oncocytoma; Pathology; Radiology; Kidney; Internal medicine","score_opus":0.20484533714913908,"score_gpt":0.4457634553013434,"score_spread":0.24091811815220435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366316326","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047097994,0.9965968,0.000049269034,0.00028833715,0.0001824432,0.0027072974,0.000020187139,0.000015525853,0.0000930417],"genre_scores_gemma":[0.00017669937,0.99833745,0.00018487849,0.0006843761,0.000054127766,0.00034835446,0.00016297623,0.000040198436,0.000010965753],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969277,0.000948355,0.0010830523,0.0004889587,0.00030153658,0.0002504365],"domain_scores_gemma":[0.9982588,0.0006666012,0.00040424446,0.00041497254,0.00016004946,0.00009529644],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00088312005,0.00035340263,0.0021965269,0.00050610234,0.000014980264,0.0000041947983,0.00013543734,0.0002974384,0.000025955469],"category_scores_gemma":[0.0004213113,0.00026534157,0.00017045862,0.0009561172,0.00019909268,0.000057364898,0.000059807422,0.00054876285,0.000014188755],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007238317,0.00007888622,0.000010076611,0.0405467,0.000080761965,0.00009251224,0.00011179303,0.000019154064,0.0000013505977,0.00044084497,0.0000050801214,0.95854044],"study_design_scores_gemma":[0.000628812,0.001080753,0.000066215354,0.20297459,0.005549009,0.0010063048,0.00005635467,0.00068305305,0.0000088271845,0.020122154,0.7673414,0.00048253025],"about_ca_topic_score_codex":0.0000033149097,"about_ca_topic_score_gemma":0.000013317146,"teacher_disagreement_score":0.95805794,"about_ca_system_score_codex":0.00020431867,"about_ca_system_score_gemma":0.00050732,"threshold_uncertainty_score":0.99997985},"labels":[],"label_agreement":null},{"id":"W4366351362","doi":"10.1007/s00330-023-09551-x","title":"Predicting the recurrence risk of renal cell carcinoma after nephrectomy: potential role of CT-radiomics for adjuvant treatment decisions","year":2023,"lang":"en","type":"article","venue":"European Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto; University Health Network","funders":"Royal College of Surgeons in Ireland; Deutsche Forschungsgemeinschaft; Ontario Institute for Cancer Research","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Hazard ratio; Stage (stratigraphy); Internal medicine; Adjuvant therapy; Proportional hazards model; Kidney cancer; Oncology; Radiomics; Neuroradiology; Radiology; Cancer; Kidney; Confidence interval","score_opus":0.019781995012657594,"score_gpt":0.24452423676842436,"score_spread":0.22474224175576676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366351362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930706,0.0032598977,0.00027653802,0.000092791044,0.0002858907,0.0009090697,0.0002736925,0.000047974576,0.0017835572],"genre_scores_gemma":[0.997115,0.00072384934,0.0012330002,0.000028166018,0.0003000667,0.00007336894,0.000115062096,0.000054538115,0.0003569176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978762,0.00052429264,0.00060954446,0.00041974394,0.00017853366,0.0003916638],"domain_scores_gemma":[0.9980633,0.0006810087,0.0003502082,0.00066146563,0.000112212474,0.0001318005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057501753,0.00024990647,0.00057255855,0.00019030606,0.00010258992,0.0000058584947,0.00021412781,0.00004373487,0.000028007558],"category_scores_gemma":[0.00021442444,0.00015576073,0.00038113605,0.00026559984,0.00021590837,0.00002687371,0.000098816075,0.0001628714,0.00003963839],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071431184,0.0009604425,0.7550439,0.00017494058,0.0011707131,0.0021183847,0.006301711,0.0023703768,0.103610404,0.00012886549,0.0036192352,0.11735788],"study_design_scores_gemma":[0.004918775,0.0048564915,0.93971956,0.00008435222,0.0012138756,0.00059227156,0.00051246904,0.0042543947,0.03888161,0.0001777354,0.004591581,0.00019687651],"about_ca_topic_score_codex":0.00007135504,"about_ca_topic_score_gemma":0.000006849584,"teacher_disagreement_score":0.18467563,"about_ca_system_score_codex":0.000113745926,"about_ca_system_score_gemma":0.00012954371,"threshold_uncertainty_score":0.63517386},"labels":[],"label_agreement":null},{"id":"W4366465782","doi":"10.1080/02648725.2023.2204692","title":"Significance of PBRM1 mutation in disease progress and drug selection in clear cell renal cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Biotechnology and Genetic Engineering Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Mutation; Clear cell renal cell carcinoma; Biology; Gene; Cancer research; Genetics; Medicine; Renal cell carcinoma; Oncology","score_opus":0.010313309736500178,"score_gpt":0.22971258741094364,"score_spread":0.21939927767444345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366465782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95334756,0.04560148,0.00006872727,0.00025028505,0.000018766843,0.0006639173,0.0000014010805,0.000040850162,0.000006985101],"genre_scores_gemma":[0.99019575,0.0077483365,0.0018721621,0.000006219186,0.000011518458,0.00010096314,0.0000056834597,0.000012443207,0.00004690864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992429,0.000028442455,0.00027271983,0.00023993195,0.00005704569,0.00015898765],"domain_scores_gemma":[0.99974,0.000022188864,0.000057573692,0.00011640044,0.000010173925,0.00005368737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013910349,0.000119568496,0.00027235295,0.0003111626,0.000011356184,0.0000028133966,0.000033309945,0.00010496821,0.0000021347596],"category_scores_gemma":[0.00003113992,0.000107018306,0.000026175348,0.0004689881,0.00005294476,0.000014893035,0.000024864034,0.00014650359,0.00000416843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027419286,0.0003108586,0.46133173,0.008944772,0.000017184462,0.0008310707,0.00077984045,0.0019150708,0.43160573,0.000064420055,0.00012359802,0.09380152],"study_design_scores_gemma":[0.00086999603,0.0003013619,0.894159,0.00028970948,0.000049712533,0.000028897097,0.000024880725,0.006591704,0.096265145,0.000018517638,0.0012754939,0.00012554466],"about_ca_topic_score_codex":0.000019111827,"about_ca_topic_score_gemma":0.000010039182,"teacher_disagreement_score":0.4328273,"about_ca_system_score_codex":0.000035352332,"about_ca_system_score_gemma":0.0000217552,"threshold_uncertainty_score":0.43640798},"labels":[],"label_agreement":null},{"id":"W4367052200","doi":"10.5489/cuaj.8381","title":"Adjuvant therapy for renal cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Dalhousie University; Université de Montréal; William Osler Health System; Centre hospitalier universitaire de Québec; McGill University; University of Ottawa; Centre Hospitalier Universitaire de Sherbrooke; University of British Columbia; Centre hospitalier de l'Université Laval; Ottawa Hospital; Health Sciences Centre; McMaster University; Hôtel-Dieu de Québec; University of Calgary; University of Alberta; University of Manitoba; Juravinski Cancer Centre; St. Joseph’s Healthcare Hamilton; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Kidney cancer; Context (archaeology); Referral; Pembrolizumab; Adjuvant; Family medicine; Internal medicine; Adjuvant therapy; Systemic therapy; Radiation oncologist; Oncology; Randomized controlled trial; Regimen; Intensive care medicine; Radiation therapy; Cancer; Breast cancer; Immunotherapy","score_opus":0.028069931231893632,"score_gpt":0.24395995243834298,"score_spread":0.21589002120644935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367052200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754029,0.0004619062,0.000033367167,0.020226516,0.00031329136,0.00042474963,0.00004953109,0.000049992486,0.003037751],"genre_scores_gemma":[0.9917627,0.000107157764,0.00020339007,0.0031700928,0.00069912244,0.000040906132,0.00008674953,0.000021590788,0.003908267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841046,0.00009320857,0.0002980687,0.00021178875,0.0003377782,0.00064869085],"domain_scores_gemma":[0.9983818,0.00020188408,0.00017533975,0.00011951597,0.00027212023,0.0008493705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006484131,0.00015082704,0.0002854854,0.00026110807,0.00028605483,0.0000594006,0.00010162393,0.00021543542,0.00037998398],"category_scores_gemma":[0.00025931714,0.0001120595,0.00026432995,0.00029031548,0.000018116072,0.00004835375,0.00000874857,0.0003460664,0.00021563222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030733208,0.00008849894,0.8194755,0.000010011012,0.00012568396,0.0007225693,0.00020728119,0.00006166142,0.0034664061,0.00009151862,0.16526988,0.010173689],"study_design_scores_gemma":[0.0026591255,0.0012775006,0.8627289,0.000003985756,0.000058059755,0.00014211448,0.000049239425,0.00020084345,0.001143221,0.0006015746,0.13101412,0.00012134663],"about_ca_topic_score_codex":0.00036126628,"about_ca_topic_score_gemma":0.00013888795,"teacher_disagreement_score":0.043253396,"about_ca_system_score_codex":0.0012555978,"about_ca_system_score_gemma":0.0006519659,"threshold_uncertainty_score":0.4569654},"labels":[],"label_agreement":null},{"id":"W4372401045","doi":"10.1007/s00345-023-04413-z","title":"Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy","year":2023,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Lymph node; Nephrectomy; Dissection (medical); Renal cell carcinoma; Lymph; Radiology; Nephrology; Cancer; Carcinoma; Surgery; Urology; Internal medicine; Kidney; Pathology","score_opus":0.01196640553734042,"score_gpt":0.25531121734704465,"score_spread":0.24334481180970424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4372401045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99687845,0.00040355002,0.000021528485,0.002186734,0.00016112807,0.00023674738,0.000012294658,0.000014285475,0.0000852986],"genre_scores_gemma":[0.99924886,0.000053131796,0.00023008558,0.00020210944,0.00011264656,0.000015119833,0.000009211103,0.00002493504,0.000103926825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984087,0.00017916124,0.0005440627,0.0001867813,0.0003646423,0.00031669118],"domain_scores_gemma":[0.99899876,0.00015552173,0.00031267115,0.00019309274,0.00019050468,0.00014942963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017343124,0.00016778249,0.0004947701,0.0007798421,0.000055153552,0.00000858744,0.00013033967,0.000045466517,0.000119970595],"category_scores_gemma":[0.000065955785,0.000100265934,0.00010570612,0.00084498216,0.00007757848,0.00006881278,0.00005109256,0.00022201333,0.0000060321486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012945106,0.00028937624,0.96649635,0.00003330724,0.0004447646,0.0006987591,0.0003719603,0.0032290805,0.011873838,0.000013538996,0.00036877932,0.0032351327],"study_design_scores_gemma":[0.005980796,0.00065699784,0.9890721,0.00010134635,0.00028152147,0.00032637265,0.000029898085,0.00007286285,0.0028809477,0.00003428958,0.00048041533,0.00008247414],"about_ca_topic_score_codex":0.00020432947,"about_ca_topic_score_gemma":0.00033171338,"teacher_disagreement_score":0.022575721,"about_ca_system_score_codex":0.0002889312,"about_ca_system_score_gemma":0.00016254219,"threshold_uncertainty_score":0.4088726},"labels":[],"label_agreement":null},{"id":"W4376107652","doi":"10.1056/nejmoa2212851","title":"Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma","year":2023,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Istituto Oncologico Veneto; Institut Gustave-Roussy; Université Paris-Saclay; National Cancer Institute; Cancer Research UK; Dana-Farber/Harvard Cancer Center; Bristol-Myers Squibb; Queen Mary University of London; Exelixis; Memorial Sloan-Kettering Cancer Center; Brigham and Women's Hospital","keywords":"Cabozantinib; Nivolumab; Ipilimumab; Renal cell carcinoma; Medicine; Oncology; Axitinib; Internal medicine; Immunotherapy; Sunitinib; Cancer","score_opus":0.02772866227719734,"score_gpt":0.2713468021366063,"score_spread":0.24361813985940894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376107652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828386,0.0048396434,0.000021944603,0.006708737,0.00037541802,0.00022581193,0.0000015406043,0.000021974758,0.004966351],"genre_scores_gemma":[0.9931451,0.0009999538,0.00028725414,0.0002443762,0.0016037173,0.0000020137434,0.000010732073,0.00003109605,0.0036757279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979731,0.00009884322,0.00072971586,0.0002204931,0.00062861334,0.00034926698],"domain_scores_gemma":[0.99858475,0.00027081426,0.00027121566,0.00023352506,0.0001421984,0.00049748813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009795463,0.000226117,0.0007996262,0.0007060808,0.000039301704,0.000009112505,0.00010456902,0.00009165334,0.00011655708],"category_scores_gemma":[0.0002244932,0.00014881494,0.00008578524,0.00055156485,0.000114841285,0.00008189511,0.00004300301,0.0004790127,0.00002014422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01571585,0.00058197527,0.379491,0.0010133003,0.00038695327,0.06421685,0.019020136,0.00029245633,0.14146844,0.00019134794,0.10944825,0.26817346],"study_design_scores_gemma":[0.38988423,0.010674487,0.5257383,0.0014689486,0.00071124133,0.0129905045,0.001658566,0.0006434262,0.01403457,0.0005154793,0.04131183,0.0003683965],"about_ca_topic_score_codex":0.00040927,"about_ca_topic_score_gemma":0.00008073697,"teacher_disagreement_score":0.3741684,"about_ca_system_score_codex":0.00015064694,"about_ca_system_score_gemma":0.0003686359,"threshold_uncertainty_score":0.60684973},"labels":[],"label_agreement":null},{"id":"W4376132127","doi":"10.1007/s00261-023-03946-6","title":"Prevalence of malignant or possibly malignant renal masses among homogeneous low-attenuation masses that are too small to characterize at computed tomography","year":2023,"lang":"en","type":"article","venue":"Abdominal Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Hounsfield scale; Radiology; Homogeneous; Cyst; Renal cell carcinoma; Malignancy; Nuclear medicine; Computed tomography; Pathology","score_opus":0.04194508563518285,"score_gpt":0.2598957906391256,"score_spread":0.21795070500394276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376132127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963157,0.000533703,0.00026355346,0.00080144615,0.0003589859,0.0012967568,0.00015918697,0.00015112551,0.000119536446],"genre_scores_gemma":[0.99354416,0.00041931553,0.002561639,0.0003747561,0.00020311112,0.0002104556,0.00020943093,0.000060619153,0.0024165285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99697894,0.00027727982,0.00072323694,0.0008462855,0.0004236238,0.0007506489],"domain_scores_gemma":[0.9977215,0.0004909413,0.00048485998,0.0007055349,0.0002317957,0.00036537784],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004234896,0.00046013706,0.0009989225,0.000670425,0.0001299435,0.000022000708,0.00032202125,0.00024678424,0.0002251467],"category_scores_gemma":[0.0001575643,0.00033896184,0.0003203018,0.0008120102,0.00028602997,0.00007882569,0.00022443358,0.00017106826,0.00012672687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039674216,0.00021078277,0.62481475,0.00096357014,0.00032857386,0.005337012,0.00043399385,0.00009207959,0.35988694,0.000016431755,0.0014588522,0.002489608],"study_design_scores_gemma":[0.0013711813,0.0021488275,0.84128344,0.0006610984,0.00038047606,0.0021647061,0.00014689156,0.00022465496,0.15107943,0.00001585915,0.00022758076,0.00029584992],"about_ca_topic_score_codex":0.00009753031,"about_ca_topic_score_gemma":0.00006421388,"teacher_disagreement_score":0.21646872,"about_ca_system_score_codex":0.000235746,"about_ca_system_score_gemma":0.00015325831,"threshold_uncertainty_score":0.99990624},"labels":[],"label_agreement":null},{"id":"W4376133456","doi":"10.1089/end.2022.0558","title":"Volumetric Analysis of Renal Masses as Predictors of Partial Nephrectomy Outcomes","year":2023,"lang":"en","type":"article","venue":"Journal of Endourology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Manitoba","funders":"","keywords":"Medicine; Nephrectomy; Perioperative; Univariate analysis; Multivariate analysis; Odds ratio; Renal function; Renal tumor; Academic institution; Surgery; Urology; Radiology; Internal medicine; Kidney","score_opus":0.027250791643349263,"score_gpt":0.3058803807032221,"score_spread":0.27862958905987284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376133456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977732,0.0004696459,0.000077334575,0.0005570379,0.0003287795,0.00013194651,0.000012642472,0.000014552155,0.00063487544],"genre_scores_gemma":[0.99885803,0.00014788978,0.00039427474,0.00008207881,0.00015275626,0.0000046301534,0.000011602178,0.000015216268,0.00033353522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978716,0.00015242351,0.0009999806,0.0001475069,0.0005699326,0.00025858651],"domain_scores_gemma":[0.9977045,0.0005941001,0.0009412434,0.0002576377,0.00032960295,0.00017293775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053971057,0.00015207224,0.0012518938,0.0027435601,0.000019029216,0.000003748156,0.0001519578,0.000117267504,0.0003940307],"category_scores_gemma":[0.0007528084,0.00010667638,0.0007903521,0.0023670744,0.00011395193,0.000056853154,0.000050484217,0.00023480777,0.000013512433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073234405,0.00022713805,0.9802142,0.000029589937,0.0072703892,0.0006416705,0.00012034419,0.0011087054,0.007853785,0.000036878126,0.0011561916,0.0006087895],"study_design_scores_gemma":[0.0025942351,0.003519339,0.9661075,0.000015420102,0.007933031,0.00027200775,0.00006910327,0.00037800695,0.015502165,0.000054827487,0.0034884461,0.00006592701],"about_ca_topic_score_codex":0.0000635679,"about_ca_topic_score_gemma":0.000011565603,"teacher_disagreement_score":0.014106684,"about_ca_system_score_codex":0.000055683016,"about_ca_system_score_gemma":0.00020218026,"threshold_uncertainty_score":0.43501365},"labels":[],"label_agreement":null},{"id":"W4376649495","doi":"10.1016/j.urolonc.2023.04.015","title":"Comparison of patients with renal cell carcinoma in adjuvant therapy trials to a real-world population","year":2023,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; Health Sciences Centre; Sunnybrook Health Science Centre; Université de Montréal; University of Manitoba; University of Ottawa; McGill University; University of Calgary; University of British Columbia; University of Toronto; Dalhousie University; University of Alberta; Université Laval; Queen Elizabeth II Health Sciences Centre; McMaster University","funders":"","keywords":"Medicine; Internal medicine; Renal cell carcinoma; Clinical trial; Adjuvant therapy; Adjuvant; Population; Gastroenterology; Cancer; Surgery","score_opus":0.08879285853470481,"score_gpt":0.37520187823230194,"score_spread":0.28640901969759713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376649495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953775,0.0001958881,0.0000053756416,0.0018410714,0.000066935805,0.0010728696,0.00002575882,0.00004060115,0.0013740391],"genre_scores_gemma":[0.99115205,0.00007773552,0.0075901183,0.00029134526,0.000041942552,0.00013366906,0.0003364941,0.0000146026,0.00036206612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982487,0.00029155798,0.0006318358,0.0003368439,0.00022807719,0.000263018],"domain_scores_gemma":[0.99876434,0.00044461372,0.00029433274,0.0002021813,0.00008264939,0.00021187023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006094107,0.0001890432,0.0008313904,0.00054721977,0.0000789976,0.0000074815757,0.00006449715,0.00012385739,0.000039385537],"category_scores_gemma":[0.00011710969,0.00013029577,0.000058133337,0.00087003445,0.00015636519,0.000050636005,0.000030498186,0.00019037892,0.000012589684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009696353,0.00041675474,0.9931636,0.000024328221,0.000021597016,0.00005285841,0.0006773769,0.00046054806,0.00074159354,0.00030044492,0.0013854952,0.0017857685],"study_design_scores_gemma":[0.0030325518,0.0070313024,0.9665792,0.00004111834,0.00012899433,0.000004395013,0.00012798929,0.00027065116,0.0028452603,0.00050634507,0.019312942,0.0001192694],"about_ca_topic_score_codex":0.0006780971,"about_ca_topic_score_gemma":0.00045066446,"teacher_disagreement_score":0.026584418,"about_ca_system_score_codex":0.00017727415,"about_ca_system_score_gemma":0.00017486025,"threshold_uncertainty_score":0.5313307},"labels":[],"label_agreement":null},{"id":"W4377826546","doi":"10.1016/j.urolonc.2023.04.008","title":"Stimulated Raman histology as a method to determine the adequacy of renal mass biopsy and identify malignant subtypes of renal cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; H&E stain; Biopsy; Renal cell carcinoma; Chromophobe cell; Histology; Oncocytoma; Pathology; Nephrectomy; Renal biopsy; Radiology; Clear cell; Kidney; Urology; Nuclear medicine; Staining; Internal medicine","score_opus":0.045302296344314964,"score_gpt":0.33872146118865754,"score_spread":0.29341916484434255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377826546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914575,0.001130866,0.00023329719,0.0051164986,0.00008800961,0.00059108884,0.00003244163,0.000039850336,0.0013104492],"genre_scores_gemma":[0.95954925,0.000106074855,0.03832946,0.00049610285,0.000046774127,0.00007426073,0.00005691935,0.000018221896,0.0013229484],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99807817,0.0003536789,0.00055847864,0.00046032105,0.0002025349,0.0003468415],"domain_scores_gemma":[0.9980945,0.0008454534,0.0003075389,0.0003340291,0.00013704583,0.000281437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070902775,0.00024147295,0.0006519405,0.0003713473,0.00015497317,0.000009199787,0.000147533,0.00024894022,0.00006414197],"category_scores_gemma":[0.00022280718,0.00016356238,0.00009044008,0.0006101051,0.0008323726,0.000044416243,0.00011717907,0.0002511463,0.0000180363],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011717221,0.00029592222,0.32331562,0.00026802538,0.00022450913,0.0020251714,0.002317733,0.000652307,0.66049093,0.002738661,0.0032738445,0.0032255214],"study_design_scores_gemma":[0.007719842,0.034731727,0.32331243,0.00033220148,0.004512175,0.006780676,0.0016895591,0.009878479,0.4269598,0.01761197,0.16555905,0.0009120532],"about_ca_topic_score_codex":0.00028198038,"about_ca_topic_score_gemma":0.000021557833,"teacher_disagreement_score":0.23353113,"about_ca_system_score_codex":0.00008458028,"about_ca_system_score_gemma":0.00031374837,"threshold_uncertainty_score":0.666988},"labels":[],"label_agreement":null},{"id":"W4377832483","doi":"10.23736/s2724-6051.23.05151-0","title":"Cancer-specific mortality free survival rates in non-metastatic non-clear cell renal carcinoma patients at intermediate/high risk of recurrence","year":2023,"lang":"en","type":"article","venue":"Minerva Urology and Nephrology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Chromophobe cell; Medicine; Internal medicine; Proportional hazards model; Stage (stratigraphy); Oncology; Clear cell; Renal cell carcinoma; Cancer; Carcinoma; Gastroenterology; Urology; Biology","score_opus":0.022744172474342288,"score_gpt":0.2647398998743191,"score_spread":0.24199572739997682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377832483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99732065,0.00087178237,0.000006355335,0.0003680128,0.00047160176,0.00054383045,0.00019240922,0.000024395644,0.00020097254],"genre_scores_gemma":[0.997721,0.0013240378,0.000067294364,0.0002539783,0.000086935295,0.000107841246,0.00022385297,0.000029943876,0.0001850967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754936,0.0003665785,0.00062175014,0.0006549396,0.00021693743,0.0005904657],"domain_scores_gemma":[0.99837214,0.00048253668,0.000296117,0.0005608088,0.000115603856,0.00017279746],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042717735,0.000320414,0.00086504495,0.00034262365,0.000072992974,0.0000041412513,0.00020711537,0.00024143302,0.00022446075],"category_scores_gemma":[0.000092660295,0.00027098108,0.000108320535,0.00042490227,0.0005493936,0.00005374932,0.0003184647,0.00040807787,0.000063706146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024351631,0.00031891774,0.9840633,0.000120024175,0.00014056543,0.0004567882,0.00049500447,0.000046628073,0.008380864,0.0000068251366,0.0022404534,0.0012954441],"study_design_scores_gemma":[0.006384212,0.0032363762,0.98463905,0.000017171102,0.00028638003,0.000018966119,0.000042684438,0.0011547103,0.0035981203,0.00017534605,0.0002727721,0.00017423119],"about_ca_topic_score_codex":0.0022907455,"about_ca_topic_score_gemma":0.0025366382,"teacher_disagreement_score":0.0047827438,"about_ca_system_score_codex":0.00008556365,"about_ca_system_score_gemma":0.000072196686,"threshold_uncertainty_score":0.99997425},"labels":[],"label_agreement":null},{"id":"W4378347388","doi":"10.3390/curroncol30050367","title":"Plasma Cabozantinib Level Measurement in Patients with Renal Cell and Hepatocellular Carcinomas Using a Simple HPLC–UV Method Suitable for Clinical Application","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Japan Society for the Promotion of Science","keywords":"Cabozantinib; High-performance liquid chromatography; Chromatography; Hepatocellular carcinoma; Therapeutic drug monitoring; Calibration curve; Plasma concentration; Acetonitrile; Ultraviolet; Medicine; Renal cell carcinoma; Chemistry; Pharmacology; Pharmacokinetics; Materials science; Detection limit; Internal medicine","score_opus":0.35826772204336704,"score_gpt":0.4434110967466819,"score_spread":0.08514337470331484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378347388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868516,0.0003896614,0.009438232,0.00008296481,0.00022148265,0.0028004432,0.000048963146,0.000048038637,0.00011861433],"genre_scores_gemma":[0.99052423,0.000052787236,0.008439256,0.000029774183,0.00014478409,0.00038269526,0.00032985536,0.000044794207,0.000051814055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748296,0.00025150971,0.0006623961,0.00066320895,0.00042279082,0.0005171217],"domain_scores_gemma":[0.9985027,0.0003408048,0.0002540341,0.00032807695,0.00035083416,0.00022357755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001567654,0.0002568982,0.0007014871,0.0002425482,0.00009045097,0.000012048906,0.00007602848,0.00018762145,0.000008051907],"category_scores_gemma":[0.00014050279,0.00020982196,0.00010427679,0.00035772484,0.000080202495,0.000055310567,0.000092004186,0.00028681298,0.0000120765235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012579483,0.0011969255,0.9654957,0.000277741,0.00006083655,0.000029931787,0.00017610386,0.00004070125,0.0012955888,0.000039468716,0.0005463572,0.029582668],"study_design_scores_gemma":[0.020301566,0.0036255422,0.9088282,0.000108973705,0.00051097554,0.000020641408,0.00012271699,0.037408587,0.0042393487,0.00010042496,0.024413003,0.00031999973],"about_ca_topic_score_codex":0.00008650051,"about_ca_topic_score_gemma":0.0000697197,"teacher_disagreement_score":0.056667507,"about_ca_system_score_codex":0.00052599027,"about_ca_system_score_gemma":0.0004365134,"threshold_uncertainty_score":0.85562915},"labels":[],"label_agreement":null},{"id":"W4378905031","doi":"10.5489/cuaj.8388","title":"Updated cystic renal lesions guideline","year":2023,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Queen's University; McGill University; University of British Columbia","funders":"","keywords":"Guideline; Medicine; Intensive care medicine; Pathology","score_opus":0.028067717040509577,"score_gpt":0.26435313598952526,"score_spread":0.23628541894901567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378905031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.912368,0.00014484076,0.00009442865,0.07986273,0.00040073736,0.00022182785,0.0000521297,0.00013502619,0.006720306],"genre_scores_gemma":[0.9886335,0.000046998495,0.00046264796,0.004974826,0.00059181073,0.000007347153,0.00029741248,0.00001693534,0.004968501],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99816406,0.00015533376,0.00045778148,0.00019049959,0.0004398737,0.0005924278],"domain_scores_gemma":[0.99808234,0.00012743777,0.00018062805,0.0001314977,0.00035577884,0.0011223087],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00087461824,0.00013774609,0.00025978163,0.00035210737,0.0003053638,0.00005842736,0.000100220124,0.00021935478,0.0019353005],"category_scores_gemma":[0.0011145313,0.00010412583,0.00016582347,0.0005814822,0.000021656751,0.000052031533,0.000017745586,0.000514661,0.0012580394],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007761529,0.00005163997,0.22046648,0.000002665764,0.00022949235,0.0030511594,0.00006210719,0.00048226418,0.0014533908,0.00020436103,0.76945305,0.0044657956],"study_design_scores_gemma":[0.0011093951,0.00036419457,0.67813855,0.0000099945755,0.00014708967,0.00072110543,0.00004219917,0.00091452047,0.00006791471,0.0008654798,0.31749323,0.00012634163],"about_ca_topic_score_codex":0.0006449468,"about_ca_topic_score_gemma":0.00039565054,"teacher_disagreement_score":0.45767206,"about_ca_system_score_codex":0.0015856293,"about_ca_system_score_gemma":0.0007095593,"threshold_uncertainty_score":0.9995196},"labels":[],"label_agreement":null},{"id":"W4378909279","doi":"10.5489/cuaj.8389","title":"2023 UPDATE – Canadian Urological Association guideline: Management of cystic renal lesions","year":2023,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Saint John Regional Hospital; Dalhousie University; Centre Hospitalier Universitaire de Sherbrooke; University of British Columbia; University of Calgary; Kingston General Hospital; Princess Margaret Cancer Centre; Université de Sherbrooke; University of Toronto; Université Laval; McGill University; University of Ottawa; Queen's University; McMaster University","funders":"","keywords":"Guideline; Medicine; Association (psychology); Urology; Intensive care medicine; Internal medicine; Pathology; Psychology","score_opus":0.022614578895605867,"score_gpt":0.25535523816563627,"score_spread":0.2327406592700304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378909279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8603848,0.00040831824,0.00009833885,0.11979683,0.00095858175,0.00076865294,0.00036467263,0.00012213494,0.017097639],"genre_scores_gemma":[0.9887592,0.00034298087,0.00080948207,0.004142892,0.0004388108,0.000028105125,0.00040253613,0.000027952186,0.0050480342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99611014,0.00035645437,0.000969097,0.00038102618,0.00097485934,0.0012084293],"domain_scores_gemma":[0.9963439,0.0002617523,0.00059669325,0.0002447078,0.0006343142,0.0019186293],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0023661393,0.0002710889,0.00054182427,0.00074391195,0.00043520393,0.00007961987,0.00025089263,0.0005409939,0.0018698781],"category_scores_gemma":[0.0011550701,0.00022592237,0.0003356376,0.0010380109,0.00003618466,0.000090699636,0.000044749642,0.00078711397,0.0010108602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011212644,0.00009336847,0.6016695,0.000021636402,0.0009800004,0.00314109,0.00006424058,0.000999986,0.0002259872,0.0009804372,0.38694,0.0047716564],"study_design_scores_gemma":[0.0012301889,0.00037235286,0.8194632,0.000029041437,0.0004022146,0.00015473836,0.00008705668,0.00053591677,0.00002975601,0.0011378267,0.17635855,0.00019914366],"about_ca_topic_score_codex":0.022744566,"about_ca_topic_score_gemma":0.018778747,"teacher_disagreement_score":0.21779375,"about_ca_system_score_codex":0.0062199263,"about_ca_system_score_gemma":0.0011642599,"threshold_uncertainty_score":0.99976695},"labels":[],"label_agreement":null},{"id":"W4378975577","doi":"10.1016/j.hoc.2023.04.016","title":"Prognostic Models in Metastatic Renal Cell Carcinoma","year":2023,"lang":"en","type":"review","venue":"Hematology/Oncology Clinics of North America","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Eisai; Merck KGaA","keywords":"Risk stratification; Renal cell carcinoma; Medicine; Systemic therapy; Intensive care medicine; Oncology; Kidney cancer; Clinical decision making; Internal medicine; Cancer","score_opus":0.1342944644882963,"score_gpt":0.39403318151861055,"score_spread":0.25973871703031426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378975577","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011840321,0.9818368,0.00007772087,0.00009268236,0.00036609365,0.0038814077,0.00015360779,0.00012227631,0.0016290819],"genre_scores_gemma":[0.0061295494,0.9862605,0.00461052,0.00016606522,0.000077587174,0.001138834,0.0009937397,0.00022203733,0.00040118056],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923407,0.001006855,0.0038005982,0.0013272284,0.00047937743,0.0010452755],"domain_scores_gemma":[0.9905977,0.004829228,0.0026100671,0.0012846175,0.0002532935,0.00042506217],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005940341,0.0010152251,0.009588779,0.0012524867,0.00005624643,0.0000063410494,0.00057097763,0.0007863956,0.000058548732],"category_scores_gemma":[0.00066489197,0.00082594005,0.0014734217,0.0016815568,0.00078734924,0.0000666398,0.00036385717,0.0016635235,0.0006225495],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046152886,0.0039934535,0.02852762,0.08558812,0.0016888446,0.023574924,0.000330612,0.0001159995,2.1288618e-7,0.000118694734,0.0021249834,0.85347503],"study_design_scores_gemma":[0.009538182,0.017361874,0.0055527077,0.019647967,0.033731334,0.00789081,0.0003186457,0.0013566185,0.0000073250126,0.0009109479,0.90105575,0.0026278542],"about_ca_topic_score_codex":0.00010110463,"about_ca_topic_score_gemma":0.0001811511,"teacher_disagreement_score":0.8989307,"about_ca_system_score_codex":0.000499463,"about_ca_system_score_gemma":0.0039990484,"threshold_uncertainty_score":0.99941915},"labels":[],"label_agreement":null},{"id":"W4379281663","doi":"10.1200/jco.2023.41.16_suppl.4538","title":"Characterizing progression to subsequent lines of therapy in metastatic renal cell carcinoma (mRCC) after nivolumab plus ipilimumab (Nivo+Ipi): Results from the International mRCC Database Consortium (IMDC).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of British Columbia; Dalhousie University; University of Toronto; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; BC Cancer Agency; University of Calgary","funders":"","keywords":"Medicine; Nivolumab; Ipilimumab; Internal medicine; Renal cell carcinoma; Oncology; Systemic therapy; Performance status; Progressive disease; Cancer; Expanded access; Disease; Immunotherapy","score_opus":0.16417140236697905,"score_gpt":0.4356573498684445,"score_spread":0.2714859475014655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379281663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97864115,0.0006497773,0.000026744987,0.017903686,0.0015409298,0.00069705,0.00016968003,0.000014471765,0.0003565208],"genre_scores_gemma":[0.9922212,0.00088878,0.0033494383,0.0019150571,0.0011852192,0.000040318013,0.00013848879,0.000034128832,0.00022738552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936977,0.00082244776,0.00374329,0.00043712722,0.00092558144,0.0003738735],"domain_scores_gemma":[0.992546,0.0038562568,0.002137724,0.0005292396,0.0005544612,0.00037627574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043009687,0.00027055515,0.0015397914,0.00033252878,0.00003873692,0.000022219161,0.00047797078,0.00020502412,0.00014598279],"category_scores_gemma":[0.0023104541,0.00015967527,0.00051413843,0.00037966284,0.00021635463,0.00016381558,0.00023453377,0.00095983566,0.000048350892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28584144,0.007384336,0.37099084,0.00014942461,0.0015344884,0.025060266,0.004993257,0.0002355089,0.13243303,0.000021366654,0.011991235,0.15936483],"study_design_scores_gemma":[0.03507785,0.011604013,0.9135584,0.0006169001,0.0003467017,0.00020572358,0.0005943017,0.00063127815,0.022436794,0.00006019356,0.014667473,0.00020032545],"about_ca_topic_score_codex":0.00026005667,"about_ca_topic_score_gemma":0.0002118017,"teacher_disagreement_score":0.5425676,"about_ca_system_score_codex":0.00043350473,"about_ca_system_score_gemma":0.0018344568,"threshold_uncertainty_score":0.6511368},"labels":[],"label_agreement":null},{"id":"W4379281722","doi":"10.1200/jco.2023.41.16_suppl.4544","title":"Global circulating free DNA methylation and fragmentome deconvolution in patients with metastatic renal cell carcinoma treated with immunotherapy (GOLDEN).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Clear cell renal cell carcinoma; Renal cell carcinoma; Oncology; DNA methylation; Internal medicine; Immunotherapy; Methylation; Biomarker; Cancer; Cancer research; Gene; Biology; Gene expression","score_opus":0.06259786080241296,"score_gpt":0.3744640109322438,"score_spread":0.3118661501298308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379281722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980229,0.0003344126,0.00012669875,0.00040629142,0.000100748606,0.0004295704,0.000006304496,0.0000143490415,0.00055873673],"genre_scores_gemma":[0.99690497,0.00006931121,0.0026991798,0.00011626837,0.00009763948,0.0000075928606,0.000021058191,0.00002098699,0.00006301736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996923,0.000477232,0.0015215668,0.0002541167,0.0005473167,0.00027673243],"domain_scores_gemma":[0.99717057,0.0007433185,0.0012734532,0.00022044507,0.00034801324,0.0002442207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015768257,0.00019514783,0.0011313998,0.00025460537,0.000040063594,0.000013157234,0.000095206226,0.00016878905,0.000034566117],"category_scores_gemma":[0.00032404021,0.000121278375,0.00014965377,0.0005554836,0.00012810099,0.00016187527,0.000032685806,0.000371866,0.0000047218546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068505662,0.0009745941,0.9678132,0.000035584195,0.00029688215,0.00070391333,0.000096007265,0.00019274886,0.00021744774,0.000008313203,0.00008473079,0.022726022],"study_design_scores_gemma":[0.032047853,0.025061792,0.9413583,0.00009743653,0.00043297853,0.00010461013,0.000091624956,0.00031103016,0.00014851174,0.00014829732,0.00008994837,0.00010760671],"about_ca_topic_score_codex":0.00009333928,"about_ca_topic_score_gemma":0.000094582516,"teacher_disagreement_score":0.026454877,"about_ca_system_score_codex":0.0005400063,"about_ca_system_score_gemma":0.00057835324,"threshold_uncertainty_score":0.49455887},"labels":[],"label_agreement":null},{"id":"W4379281748","doi":"10.1200/jco.2023.41.16_suppl.4541","title":"Core biopsy (bx) accuracy and safety of biopsy and preoperative immunotherapy in predicting histological subtype and nuclear grade in ECOG-ACRIN EA8143 perioperative nivolumab (nivo) versus observation in patients (pts) with renal cell carcinoma (RCC) undergoing nephrectomy.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; University of Saskatchewan","funders":"National Institutes of Health","keywords":"Medicine; Concordance; Perioperative; Nivolumab; Nephrectomy; Biopsy; Internal medicine; Surgery; Radiology; Kidney; Immunotherapy; Cancer","score_opus":0.1284391337867495,"score_gpt":0.374694729662386,"score_spread":0.24625559587563647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379281748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976829,0.0006268399,0.0000029853043,0.0007059458,0.00016117285,0.00055546395,0.000005684074,0.0000080476475,0.0002509032],"genre_scores_gemma":[0.99659944,0.0010222052,0.0021613515,0.00009373162,0.00005870502,0.000007356078,0.000009459852,0.0000235187,0.000024260005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99679273,0.0005564291,0.0017332502,0.00036603786,0.00027143167,0.00028011526],"domain_scores_gemma":[0.996233,0.0022389125,0.0010233527,0.00013456261,0.00020322086,0.00016694565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012216303,0.00023160384,0.0012986291,0.00033008397,0.000056168312,0.000014117673,0.0000870534,0.00031862082,0.000016648002],"category_scores_gemma":[0.0013606371,0.00016632823,0.00008400419,0.00041951195,0.00036560002,0.00023656599,0.000083279665,0.0008545004,7.7813763e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033015672,0.00077252707,0.9547639,0.00006750376,0.000084041596,0.000741257,0.00259084,0.000043697775,0.001405926,0.000041847088,0.00000968497,0.0064631],"study_design_scores_gemma":[0.040354077,0.022772199,0.93374723,0.00026237516,0.000076274606,0.00014362909,0.001459066,0.00085562305,0.00008545674,0.000022565355,0.00009065587,0.00013086735],"about_ca_topic_score_codex":0.00033681342,"about_ca_topic_score_gemma":0.0008412764,"teacher_disagreement_score":0.02199967,"about_ca_system_score_codex":0.00045910187,"about_ca_system_score_gemma":0.0006519221,"threshold_uncertainty_score":0.6782668},"labels":[],"label_agreement":null},{"id":"W4379282010","doi":"10.1200/jco.2023.41.16_suppl.4518","title":"First-line lenvatinib + pembrolizumab treatment across non-clear cell renal cell carcinomas: Results of the phase 2 KEYNOTE-B61 study.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Pembrolizumab; Medicine; Chromophobe cell; Clear cell; Lenvatinib; Renal cell carcinoma; Histology; Internal medicine; Oncology; Clinical endpoint; Cabozantinib; Cancer; Clinical trial; Immunotherapy","score_opus":0.16724848101688072,"score_gpt":0.46749150508458487,"score_spread":0.30024302406770415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379282010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98934126,0.00028176387,0.000013457076,0.0041413098,0.0012938525,0.0011432675,0.000074298536,0.0000241749,0.0036866234],"genre_scores_gemma":[0.9920943,0.0006771888,0.00039429482,0.00028379448,0.0012672292,0.000020801306,0.000014566128,0.000056354635,0.0051915166],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9922889,0.00080915,0.0047682887,0.00051948015,0.000988688,0.0006254953],"domain_scores_gemma":[0.9906635,0.003427874,0.0037126222,0.0009496033,0.0006596287,0.0005867496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00364605,0.00041418994,0.0026229357,0.00018882762,0.00017608504,0.000016466103,0.0005021055,0.00046605445,0.00007695792],"category_scores_gemma":[0.0015605206,0.00023162899,0.0015259561,0.000613749,0.00037948746,0.00009192457,0.0002502903,0.0011193841,0.00010425458],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3248878,0.14783032,0.291005,0.00065285544,0.004169731,0.028067848,0.0162672,0.0039772703,0.017721254,0.00000876761,0.039443664,0.12596828],"study_design_scores_gemma":[0.18420918,0.22848706,0.5290249,0.00019111423,0.001991068,0.00033412655,0.001933709,0.00072167674,0.02025986,0.000044090943,0.03251343,0.00028976644],"about_ca_topic_score_codex":0.0002289545,"about_ca_topic_score_gemma":0.00022788953,"teacher_disagreement_score":0.23801991,"about_ca_system_score_codex":0.00059504935,"about_ca_system_score_gemma":0.0019121873,"threshold_uncertainty_score":0.94455564},"labels":[],"label_agreement":null},{"id":"W4379283976","doi":"10.1200/jco.2023.41.16_suppl.4502","title":"Final prespecified overall survival (OS) analysis of CLEAR: 4-year follow-up of lenvatinib plus pembrolizumab (L+P) vs sunitinib (S) in patients (pts) with advanced renal cell carcinoma (aRCC).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Renal cell carcinoma; Urology; Sunitinib; Gastroenterology; Confidence interval; Everolimus; Hazard ratio; Clinical trial","score_opus":0.11529768167133961,"score_gpt":0.3854609462312064,"score_spread":0.27016326455986683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379283976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934572,0.0000776448,0.000017229679,0.00034711589,0.00049801543,0.00045829205,0.000046139274,0.000012647829,0.005085697],"genre_scores_gemma":[0.9975259,0.00016758188,0.0011911867,0.00011113308,0.00021500331,0.000008163284,0.00007903417,0.000044412496,0.0006576106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9927406,0.00092369004,0.0040875385,0.0004421571,0.001295747,0.0005102662],"domain_scores_gemma":[0.99141157,0.0030051623,0.0034560293,0.0005371188,0.0011551306,0.00043497735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024819071,0.00032986794,0.0038013766,0.0011490153,0.000034761866,0.000007389792,0.00036516873,0.00042324897,0.00031456785],"category_scores_gemma":[0.001541072,0.00024243983,0.0011933139,0.0014060907,0.00031831366,0.00015160158,0.00013813717,0.0010834046,0.000014805726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17810783,0.0030795778,0.8033289,0.00015207623,0.0018172981,0.0010579843,0.00047768423,0.0019717037,0.00046145293,0.000080925274,0.00080971606,0.008654856],"study_design_scores_gemma":[0.07014952,0.043331075,0.8812637,0.00012702431,0.0023833015,0.000016039767,0.00026401356,0.0003241684,0.00090197724,0.000033959037,0.0010338787,0.00017136439],"about_ca_topic_score_codex":0.0001308089,"about_ca_topic_score_gemma":0.0003016546,"teacher_disagreement_score":0.10795831,"about_ca_system_score_codex":0.00040943146,"about_ca_system_score_gemma":0.0019128516,"threshold_uncertainty_score":0.9886409},"labels":[],"label_agreement":null},{"id":"W4379333933","doi":"10.1200/jco.2023.41.16_suppl.4553","title":"Belzutifan plus lenvatinib for patients (pts) with advanced clear cell renal cell carcinoma (ccRCC) after progression on a PD-1/L1 and VEGF inhibitor: Preliminary results of arm B5 of the phase 1/2 KEYMAKER-U03B study.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Lenvatinib; Tolerability; Internal medicine; Clinical endpoint; Renal cell carcinoma; Oncology; Phases of clinical research; Adverse effect; Clear cell renal cell carcinoma; Urology; Cancer; Surgery; Clinical trial","score_opus":0.06792469037048972,"score_gpt":0.4135502440189556,"score_spread":0.3456255536484659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379333933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574226,0.00022658799,0.0000028760853,0.00079461717,0.00046765443,0.0020854427,0.00005260877,0.00000996247,0.00061801064],"genre_scores_gemma":[0.99776417,0.00007700629,0.0013132904,0.00016366554,0.0003104257,0.00006143309,0.000013608511,0.000043671098,0.000252748],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.995171,0.0005450564,0.002721623,0.00041918256,0.00080663554,0.00033650442],"domain_scores_gemma":[0.99312735,0.0023145995,0.0030755228,0.0004687121,0.00068911206,0.00032473044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017824592,0.0002821671,0.0015421489,0.00020110015,0.000071612114,0.0000059011863,0.00020303437,0.00028701572,0.000008978578],"category_scores_gemma":[0.0010468796,0.00015352042,0.00043204083,0.00028815423,0.00033517784,0.000082104234,0.00016437941,0.0007503807,0.0000028881118],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7059098,0.04257451,0.16135082,0.0006243383,0.00035248837,0.0010611558,0.0029121302,0.00012154301,0.0025507982,0.0000021003352,0.0035100991,0.07903023],"study_design_scores_gemma":[0.08558629,0.41630396,0.48257393,0.0005634416,0.0007536642,0.000032739816,0.0006148421,0.00009967202,0.011169552,0.00001717433,0.0021555158,0.00012921532],"about_ca_topic_score_codex":0.000009061336,"about_ca_topic_score_gemma":0.000015168921,"teacher_disagreement_score":0.6203235,"about_ca_system_score_codex":0.00018171775,"about_ca_system_score_gemma":0.0008936046,"threshold_uncertainty_score":0.6260381},"labels":[],"label_agreement":null},{"id":"W4379334637","doi":"10.1200/jco.2023.41.16_suppl.4530","title":"Real-world outcomes among patients with advanced/metastatic renal cell carcinoma (mRCC) treated with cabozantinib or other tyrosine kinase inhibitors (TKIs) after checkpoint inhibitor (CPI) therapy.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Calgary","funders":"Ipsen","keywords":"Medicine; Cabozantinib; Internal medicine; Clinical endpoint; Oncology; Renal cell carcinoma; Hazard ratio; Discontinuation; Confidence interval; Clinical trial","score_opus":0.061048986354388095,"score_gpt":0.37100721815226234,"score_spread":0.30995823179787424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379334637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99550253,0.00020150025,0.000006820998,0.0009443964,0.00049132586,0.0011034214,0.000029559234,0.00006167303,0.0016587435],"genre_scores_gemma":[0.9907884,0.0002518303,0.0025354463,0.00071556185,0.00058033376,0.00007070918,0.000029332328,0.00014340134,0.004884992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939739,0.00056580215,0.0030821837,0.0005938424,0.0010874831,0.00069679646],"domain_scores_gemma":[0.99366665,0.0014915349,0.0025776757,0.0005515537,0.00086626934,0.0008463012],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013777844,0.0006031336,0.0027376916,0.0005982933,0.00008166691,0.000030151416,0.00020968275,0.00027741323,0.00040646226],"category_scores_gemma":[0.0004098527,0.00029674303,0.0006559302,0.0009164451,0.0004536331,0.00028154897,0.000077248376,0.0011104103,0.00006585328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0442178,0.0038305516,0.9273049,0.000080582664,0.00058980583,0.008091422,0.0001514335,0.000039442362,0.00022843589,0.00000155947,0.00126936,0.01419471],"study_design_scores_gemma":[0.03936915,0.045392748,0.9040373,0.00038389637,0.00079970894,0.00007636927,0.000119273194,0.000016517748,0.004246066,0.0000073114343,0.005228691,0.0003229539],"about_ca_topic_score_codex":0.00022798819,"about_ca_topic_score_gemma":0.00054119737,"teacher_disagreement_score":0.041562196,"about_ca_system_score_codex":0.00036169178,"about_ca_system_score_gemma":0.0012806894,"threshold_uncertainty_score":0.99994844},"labels":[],"label_agreement":null},{"id":"W4379335780","doi":"10.1200/jco.2023.41.16_suppl.4519","title":"Efficacy of first-line (1L) immunotherapy (IO)-based regimens in patients with sarcomatoid and/or rhabdoid (S/R) metastatic non-clear cell renal cell carcinoma (nccRCC): Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; BC Cancer Agency; University of Calgary","funders":"","keywords":"Medicine; Pazopanib; Internal medicine; Renal cell carcinoma; Sunitinib; Oncology; Proportional hazards model; Gastroenterology","score_opus":0.07453684115200986,"score_gpt":0.3569206041753232,"score_spread":0.2823837630233133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379335780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930838,0.0005014781,0.00012946806,0.003715886,0.00054897025,0.0011208445,0.00043156042,0.000017838012,0.00045019423],"genre_scores_gemma":[0.9892245,0.0003414431,0.008298328,0.0009930532,0.0002777973,0.000020365313,0.000402027,0.00008240554,0.00036011077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99176294,0.0010850269,0.004516951,0.0007092858,0.0013363499,0.00058946037],"domain_scores_gemma":[0.98244596,0.011533501,0.0038800365,0.00091530813,0.0007171773,0.000508],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0036635841,0.0005302611,0.002393673,0.0005012346,0.00010806431,0.000032250995,0.0006781895,0.00022344495,0.0001849615],"category_scores_gemma":[0.0015030574,0.00030897505,0.00058241095,0.00058694015,0.0005769547,0.00018637012,0.00020736583,0.0014152053,0.000032145268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22525178,0.014530817,0.73071116,0.0002821643,0.0010801671,0.0075693172,0.0011599207,0.0010837278,0.005425878,0.000004157916,0.009310267,0.0035906576],"study_design_scores_gemma":[0.11261188,0.0289897,0.83974177,0.00031824363,0.0011384137,0.00007132453,0.00032972847,0.0019011912,0.011936543,0.000021411692,0.0026232773,0.00031651586],"about_ca_topic_score_codex":0.0005398436,"about_ca_topic_score_gemma":0.000283892,"teacher_disagreement_score":0.112639904,"about_ca_system_score_codex":0.00033171146,"about_ca_system_score_gemma":0.0020400141,"threshold_uncertainty_score":0.9999362},"labels":[],"label_agreement":null},{"id":"W4379337241","doi":"10.1200/jco.2023.41.16_suppl.4555","title":"Impact of smoking status (SS) on the clinical outcomes of patients with metastatic renal cell carcinoma (mRCC) treated with first line (1L) immuno-oncology (IO)-combination regimens: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; Cancer Care Ontario; Dalhousie University; Queen Elizabeth II Health Sciences Centre; University of Alberta; University of Calgary; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Renal cell carcinoma; Oncology; Proportional hazards model; Pembrolizumab; Logistic regression; Lung cancer; Cancer; Immunotherapy","score_opus":0.1260057301905067,"score_gpt":0.4047002711503722,"score_spread":0.2786945409598655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379337241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922716,0.00018589562,0.00004967993,0.003842312,0.00077666005,0.0011765211,0.000894048,0.000018900426,0.00078437175],"genre_scores_gemma":[0.9962988,0.00033354343,0.0014900845,0.00053929724,0.00025271432,0.000027764814,0.000752308,0.00006956057,0.00023592735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9883607,0.0025732475,0.0059928256,0.00067901367,0.001720154,0.0006740529],"domain_scores_gemma":[0.95557725,0.032687705,0.008295935,0.0010840748,0.0018764548,0.0004785681],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006707142,0.00057931786,0.003173568,0.00048502258,0.00015272033,0.000027398662,0.0007586982,0.00030088145,0.00017267621],"category_scores_gemma":[0.006574168,0.0002639212,0.0011866968,0.0007357392,0.0009980095,0.00021260178,0.00025025845,0.001729188,0.000015518874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061200574,0.00833865,0.91517884,0.000049234237,0.0037834353,0.0015494893,0.000516713,0.0005425266,0.00027314582,0.000020675243,0.0059746783,0.0025720329],"study_design_scores_gemma":[0.04886779,0.06304881,0.8806514,0.00021365768,0.0036927778,0.00006256916,0.0004590325,0.0003500066,0.0014237448,0.000057339847,0.00095723785,0.0002156402],"about_ca_topic_score_codex":0.0012831542,"about_ca_topic_score_gemma":0.0004752532,"teacher_disagreement_score":0.05471016,"about_ca_system_score_codex":0.0008021994,"about_ca_system_score_gemma":0.003869249,"threshold_uncertainty_score":0.9999813},"labels":[],"label_agreement":null},{"id":"W4379662222","doi":"10.1200/jco.2023.41.17_suppl.lba4501","title":"Pembrolizumab plus axitinib versus sunitinib as first-line therapy for advanced clear cell renal cell carcinoma: 5-year analysis of KEYNOTE-426.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Renal cell carcinoma; Temsirolimus; Population; Pembrolizumab; Internal medicine; Sunitinib; Interim analysis; Discontinuation; Oncology; Urology; Clinical trial; Cancer","score_opus":0.16010111005953448,"score_gpt":0.4468035488967355,"score_spread":0.28670243883720103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379662222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876574,0.0007546662,0.000095556614,0.002554492,0.0011347211,0.00066566037,0.00005198087,0.00003235754,0.007053163],"genre_scores_gemma":[0.9921916,0.0023179143,0.0024840678,0.00039364593,0.0010186955,0.000024158751,0.00009019386,0.00006736988,0.0014123518],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9942162,0.00045677906,0.0034858203,0.0004728058,0.00078542944,0.0005829513],"domain_scores_gemma":[0.9871531,0.0075679715,0.0029040494,0.00056190975,0.0011606974,0.0006522551],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026991812,0.00035474246,0.0033041763,0.0008366517,0.00009707754,0.000012093795,0.00038065304,0.0005896211,0.00045204206],"category_scores_gemma":[0.002052345,0.00026893485,0.0025528218,0.0011599105,0.0002791082,0.00010561954,0.000095051946,0.0009527904,0.000072738694],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8253824,0.012317495,0.035608303,0.0006467761,0.011911099,0.006414789,0.0016032828,0.012914785,0.010618753,0.0002797565,0.014871303,0.06743127],"study_design_scores_gemma":[0.2589084,0.26288265,0.3391598,0.00013621803,0.015532336,0.00015808796,0.0016382755,0.003067304,0.026846953,0.00034972932,0.090621635,0.0006986074],"about_ca_topic_score_codex":0.000054789074,"about_ca_topic_score_gemma":0.00004816175,"teacher_disagreement_score":0.56647396,"about_ca_system_score_codex":0.00038915811,"about_ca_system_score_gemma":0.0021474638,"threshold_uncertainty_score":0.9999763},"labels":[],"label_agreement":null},{"id":"W4379967101","doi":"10.1002/ijc.34608","title":"Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the <scp>CLEAR</scp> trial","year":2023,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Eisai Canada; Eisai","keywords":"Lenvatinib; Pembrolizumab; Sunitinib; Renal cell carcinoma; Medicine; Internal medicine; Oncology; Expanded access; Clinical trial; Immunotherapy; Cancer; Hepatocellular carcinoma; Sorafenib","score_opus":0.020268175368591233,"score_gpt":0.27893305588257006,"score_spread":0.25866488051397885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379967101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99655986,0.0004677832,0.00000840441,0.0012148826,0.00028787457,0.00050485623,0.00023049762,0.000003738824,0.0007221121],"genre_scores_gemma":[0.9991554,0.00013857083,0.00007437342,0.00012480139,0.0003307057,0.000014464528,0.00008053853,0.000019687433,0.00006143423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977715,0.0001397887,0.0006731733,0.00014701723,0.0011041973,0.00016435061],"domain_scores_gemma":[0.9979396,0.00052689377,0.0007239736,0.00018347113,0.00055702165,0.000069066205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031396604,0.00015625387,0.00038685388,0.00017260948,0.000032545733,0.000018289782,0.0003412427,0.000049940925,0.000045548688],"category_scores_gemma":[0.00017566436,0.0000838192,0.000118691096,0.00023573675,0.00011937663,0.00010363245,0.000051872757,0.00029641436,0.0000016563026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31721926,0.0013446383,0.6306599,0.000100680656,0.001390355,0.0005688164,0.019037941,0.0021749756,0.0025289839,0.00012739548,0.0027098053,0.02213727],"study_design_scores_gemma":[0.09015838,0.0019893844,0.9029139,0.0002989004,0.00016906111,0.000020339405,0.0013059037,0.000038297618,0.0017983795,0.000035547087,0.0012370698,0.000034825687],"about_ca_topic_score_codex":0.00023059033,"about_ca_topic_score_gemma":0.00013905267,"teacher_disagreement_score":0.27225405,"about_ca_system_score_codex":0.0001785429,"about_ca_system_score_gemma":0.00036455842,"threshold_uncertainty_score":0.34180477},"labels":[],"label_agreement":null},{"id":"W4379981168","doi":"10.21203/rs.3.rs-2771190/v1","title":"Expert Consensus on the Management of Advanced Clear-cell Renal Cell Carcinoma: Indian Perspective (Pearl-india)","year":2023,"lang":"en","type":"preprint","venue":"Research Square","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"Glenmark Pharmaceuticals","keywords":"Pearl; Perspective (graphical); Renal cell carcinoma; Medicine; Oncology; Geography; Computer science; Artificial intelligence; Archaeology","score_opus":0.08929414915814388,"score_gpt":0.3794538542415087,"score_spread":0.2901597050833648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379981168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8826894,0.003130093,0.000003817843,0.0051267785,0.0002651719,0.0058063404,0.00019912388,0.00012105102,0.102658235],"genre_scores_gemma":[0.97969174,0.00095518323,0.0007062573,0.00006762574,0.00026915505,0.00089475315,0.00014904588,0.00018458204,0.017081635],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.9928717,0.00088892446,0.00063343917,0.0014474805,0.0029739584,0.0011844924],"domain_scores_gemma":[0.99473,0.00095736847,0.00027660045,0.0024561265,0.0011057223,0.0004741762],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001654903,0.0006070515,0.00086114585,0.0008968148,0.00031273763,0.00007679737,0.0007188039,0.00042693235,0.00030770234],"category_scores_gemma":[0.00015010577,0.00043720598,0.00058824086,0.0008204027,0.0005567453,0.000022418151,0.0016026627,0.0028127786,0.00075007556],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056804195,0.026705071,0.018247545,0.09097122,0.011042053,0.16856384,0.19266431,0.00546147,0.09902587,0.022125682,0.2871142,0.021274554],"study_design_scores_gemma":[0.015603551,0.017254997,0.29056177,0.012350634,0.0007652584,0.00011680847,0.34403437,0.00026149105,0.30728316,0.0041366573,0.005536855,0.0020944339],"about_ca_topic_score_codex":0.0017226262,"about_ca_topic_score_gemma":0.00003511783,"teacher_disagreement_score":0.28157735,"about_ca_system_score_codex":0.00217059,"about_ca_system_score_gemma":0.00076863036,"threshold_uncertainty_score":0.99980795},"labels":[],"label_agreement":null},{"id":"W4380318667","doi":"10.1016/j.clgc.2023.06.003","title":"Differences in Survival of Clear Cell Metastatic Renal Cell Carcinoma According to Partial vs. Radical Cytoreductive Nephrectomy","year":2023,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Hazard ratio; Proportional hazards model; Propensity score matching; Confidence interval; Internal medicine; Nephrectomy; Urology; Surveillance, Epidemiology, and End Results; Oncology; Incidence (geometry); Cancer; Surgery; Cancer registry; Kidney","score_opus":0.10840050343005263,"score_gpt":0.3723783414142304,"score_spread":0.26397783798417773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380318667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955215,0.0005505076,0.000017825165,0.0008969573,0.0010637732,0.0008666394,0.00004838321,0.00006842138,0.0009660042],"genre_scores_gemma":[0.9964424,0.0002876234,0.0009278091,0.00017420725,0.0010659619,0.00019182704,0.00002860694,0.000060921666,0.0008206907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961539,0.00049682107,0.0012033253,0.00081401033,0.00064474484,0.0006872333],"domain_scores_gemma":[0.99766177,0.0008667057,0.00024579972,0.00050634186,0.00012421235,0.0005951653],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007300791,0.00036430018,0.0012656964,0.0003410055,0.00006694549,0.000017194481,0.00028184944,0.00016811013,0.00023083937],"category_scores_gemma":[0.00018876922,0.00030168128,0.00043883527,0.000954421,0.00027596072,0.000084092535,0.00026132845,0.0006073271,0.00016568972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007487479,0.0013858208,0.96887064,0.00031854238,0.00015583343,0.0021612681,0.00065841334,0.00014104044,0.012396694,0.000008602172,0.002328741,0.0040869396],"study_design_scores_gemma":[0.005723113,0.005331219,0.94108456,0.00016186768,0.00041365402,0.000018747412,0.0013807478,0.0004322006,0.043894857,0.000052028783,0.0011137384,0.0003932844],"about_ca_topic_score_codex":0.00038895686,"about_ca_topic_score_gemma":0.000031841508,"teacher_disagreement_score":0.031498164,"about_ca_system_score_codex":0.00025002143,"about_ca_system_score_gemma":0.00068988884,"threshold_uncertainty_score":0.99994355},"labels":[],"label_agreement":null},{"id":"W4380625568","doi":"10.1093/ndt/gfad063c_4281","title":"#4281 TERTIARY HOSPITAL EXPERIENCE IN AN ESSENTIAL SUBSPECIALTY: ONCONEPHROLOGY","year":2023,"lang":"en","type":"article","venue":"Nephrology Dialysis Transplantation","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Proteinuria; Kidney disease; Geriatric Depression Scale; Tertiary referral hospital; Kidney; Anxiety; Retrospective cohort study; Psychiatry","score_opus":0.018251013611958397,"score_gpt":0.2895622773570098,"score_spread":0.2713112637450514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380625568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970084,0.00005903317,0.00020799188,0.0013808813,0.0002738732,0.00050740206,0.000015130632,0.0002187626,0.00032851592],"genre_scores_gemma":[0.9965958,0.00040986025,0.0002155497,0.00094517897,0.00033530247,0.00023129131,0.0011740257,0.000031296935,0.00006166584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792624,0.0002239833,0.00047366825,0.00060430745,0.00028058895,0.0004911927],"domain_scores_gemma":[0.9992116,0.00012638934,0.00009280852,0.00035052092,0.00006225494,0.00015642363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020313135,0.00024006146,0.00047788364,0.00062646176,0.00008349203,0.00001759595,0.00012762776,0.00027683514,0.00023964413],"category_scores_gemma":[0.000014655864,0.00023032793,0.00014897902,0.00071797933,0.00019822035,0.00025535218,0.000014206791,0.00021826969,0.0002405604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022512837,0.00076662254,0.7705819,0.00009017945,0.00021507639,0.0052475524,0.019056728,0.0003320928,0.19524871,0.00018394623,0.0002121675,0.005813732],"study_design_scores_gemma":[0.0033637225,0.0007878174,0.9782089,0.0000137852585,0.00040812299,0.00012858538,0.00030664174,0.00084935187,0.01539413,0.00013756828,0.00020046801,0.00020088442],"about_ca_topic_score_codex":0.00021568325,"about_ca_topic_score_gemma":0.0011803553,"teacher_disagreement_score":0.20762701,"about_ca_system_score_codex":0.0001011827,"about_ca_system_score_gemma":0.00008879053,"threshold_uncertainty_score":0.93925005},"labels":[],"label_agreement":null},{"id":"W4380880531","doi":"10.1016/j.urology.2023.06.001","title":"A Comparison of Microwave Ablation and Cryoablation for the Treatment of Renal Cell Carcinoma: A Systematic Literature Review and Meta-analysis","year":2023,"lang":"en","type":"review","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"Ethicon; Sirtex Medical; Society of Interventional Radiology Foundation","keywords":"Cryoablation; Medicine; Microwave ablation; Meta-analysis; Confidence interval; Renal cell carcinoma; Odds ratio; Cryosurgery; Systematic review; Ablation; Radiology; Surgery; Internal medicine; MEDLINE","score_opus":0.1442354408664543,"score_gpt":0.3795629320217922,"score_spread":0.2353274911553379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380880531","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000052550244,0.9933379,0.00028144958,0.00013668335,0.00001711766,0.0059965863,0.00014495294,0.000007892652,0.000024852634],"genre_scores_gemma":[0.007216676,0.9906136,0.00017345618,0.000027815391,0.00002280033,0.0010002225,0.00045570132,0.000030207448,0.00045952573],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99767166,0.00040638656,0.0012304346,0.00039069616,0.00015046124,0.00015034254],"domain_scores_gemma":[0.9965737,0.0014079019,0.001256067,0.0005316157,0.0001760174,0.000054708184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003759571,0.00037446295,0.007364131,0.000362168,0.000038767525,0.00000902068,0.00006249019,0.00024321231,0.000012132325],"category_scores_gemma":[0.000056149325,0.00018059602,0.0016768179,0.0005754115,0.000078123805,0.00001616542,0.000021987242,0.00010294554,0.0000015520545],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044767206,0.00019121605,0.000036165467,0.9130563,0.08360863,0.000014400413,0.000477548,0.000009267102,0.0000058979385,0.00003376454,0.00008156168,0.0024404891],"study_design_scores_gemma":[0.0004005894,0.0016711788,0.00004127312,0.002892417,0.98653203,0.000080346996,0.0000116164665,0.0002646718,0.000018820083,0.000009689511,0.007977774,0.00009957667],"about_ca_topic_score_codex":0.0000146267375,"about_ca_topic_score_gemma":0.000020605186,"teacher_disagreement_score":0.9101639,"about_ca_system_score_codex":0.000063794265,"about_ca_system_score_gemma":0.000062623876,"threshold_uncertainty_score":0.7364492},"labels":[],"label_agreement":null},{"id":"W4380886773","doi":"10.1016/j.euros.2023.05.005","title":"Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell Carcinoma","year":2023,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Population; Cancer; Kidney cancer; Retrospective cohort study; Oncology; Internal medicine; Renal cell carcinoma; Surveillance, Epidemiology, and End Results; Nomogram; Nephrectomy; Epidemiology; Cancer registry; Kidney","score_opus":0.07813836843834139,"score_gpt":0.31093388142512024,"score_spread":0.23279551298677886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380886773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99522626,0.00025255812,0.0000514273,0.0002338941,0.0001272203,0.0010028529,0.00014295526,0.000009299538,0.002953505],"genre_scores_gemma":[0.99940276,0.00010236787,0.00027651762,0.00003584285,0.000016608326,0.00003695286,0.000024587769,0.000016040465,0.00008834593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811333,0.00034023507,0.0004039907,0.00043680385,0.00042723646,0.00027838786],"domain_scores_gemma":[0.99905676,0.00017328134,0.00019550085,0.00037331387,0.000114918425,0.00008620077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023076602,0.00012616519,0.0003324312,0.00019681852,0.000108298715,0.00002129194,0.0005693401,0.000025770185,0.000011502676],"category_scores_gemma":[0.00003520262,0.00008453624,0.000053306627,0.00080983667,0.00063818734,0.00011352619,0.00049566553,0.00012448266,0.0000012091001],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004983362,0.00032979166,0.8534337,0.0001243722,0.00004797492,0.0002319651,0.0014341465,0.005988459,0.1340004,0.00037376067,0.00015237917,0.003384678],"study_design_scores_gemma":[0.0022590877,0.0009438347,0.9812719,0.000028064549,0.000081544145,0.000018316829,0.00008665368,0.010064106,0.0050410884,0.00006459588,0.00008314537,0.000057652953],"about_ca_topic_score_codex":0.00013291695,"about_ca_topic_score_gemma":0.00002600178,"teacher_disagreement_score":0.12895931,"about_ca_system_score_codex":0.00005860162,"about_ca_system_score_gemma":0.00027563964,"threshold_uncertainty_score":0.34472877},"labels":[],"label_agreement":null},{"id":"W4381191604","doi":"10.7573/dic.2023-4-1","title":"Real-world experience of cabozantinib in Asian patients with advanced renal cell carcinoma following treatment with VEGFR tyrosine kinase inhibitors and/or immune checkpoint inhibitors","year":2023,"lang":"en","type":"article","venue":"Drugs in Context","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Ipsen","keywords":"Cabozantinib; Medicine; Renal cell carcinoma; Clinical endpoint; Oncology; Nivolumab; Internal medicine; Pazopanib; Adverse effect; Population; Cancer; Clinical trial; Sunitinib; Immunotherapy","score_opus":0.01315660330541851,"score_gpt":0.2568507259529053,"score_spread":0.2436941226474868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381191604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961164,0.00048040692,8.2647324e-7,0.00014955516,0.0001371234,0.0015024377,0.00001762453,0.00005482825,0.0015407879],"genre_scores_gemma":[0.9981756,0.000070521564,0.00034669417,0.00002000702,0.0000374319,0.00030899007,0.000111681074,0.00007297772,0.000856063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973313,0.00008198873,0.0008206314,0.0006768353,0.00052822265,0.0005609899],"domain_scores_gemma":[0.99878144,0.00012492068,0.00027990885,0.0005163439,0.00009208127,0.00020530069],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018447495,0.0004661689,0.0008874878,0.0006448181,0.00006491043,0.00001799869,0.00009900058,0.000086336084,0.000016220727],"category_scores_gemma":[0.000030968502,0.0003094572,0.00012836556,0.0013365461,0.00017746323,0.00018124352,0.00007859054,0.00020373335,0.0000065759314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048515336,0.0010567871,0.9276825,0.00017755001,0.00005608838,0.0013399962,0.022398619,0.000022563076,0.01607994,0.000009787173,0.000010884103,0.026313722],"study_design_scores_gemma":[0.020730061,0.0045644958,0.6704716,0.0012791377,0.0000835365,0.000006980007,0.009059512,0.000043564312,0.2932665,0.000002059965,0.00016045051,0.00033208245],"about_ca_topic_score_codex":0.00410857,"about_ca_topic_score_gemma":0.0030939567,"teacher_disagreement_score":0.27718657,"about_ca_system_score_codex":0.00054472487,"about_ca_system_score_gemma":0.00023538318,"threshold_uncertainty_score":0.99993575},"labels":[],"label_agreement":null},{"id":"W4381685495","doi":"10.1186/s12957-023-03061-2","title":"Comparison of peri- and intraoperative outcomes of open vs robotic-assisted partial nephrectomy for renal cell carcinoma: a propensity-matched analysis","year":2023,"lang":"en","type":"article","venue":"World Journal of Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Propensity score matching; Surgical oncology; Surgery; Perioperative; Urology; Nephrology; Internal medicine; Kidney","score_opus":0.09493259731041827,"score_gpt":0.38814752391413876,"score_spread":0.2932149266037205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381685495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99369395,0.00037967268,0.00009773208,0.0033677272,0.000117132484,0.0008962465,0.0000113776105,0.000007617223,0.0014285214],"genre_scores_gemma":[0.9954828,0.00006142951,0.0033405048,0.000056539022,0.00007846352,0.00003552046,0.00002448591,0.000018296028,0.0009019736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99727285,0.00036370705,0.0014253358,0.00026305031,0.00036995436,0.00030507648],"domain_scores_gemma":[0.99684227,0.0010349448,0.0010420891,0.0002129432,0.0005833256,0.0002844526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095638173,0.00022774132,0.003183903,0.00070172414,0.00006890974,0.000018535773,0.00022918622,0.00011820762,0.00014896221],"category_scores_gemma":[0.000071371185,0.00015052213,0.0005375616,0.001131382,0.00025796934,0.00010557349,0.00018934393,0.00032044714,0.0000023797159],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012226643,0.0021928076,0.96005684,0.00019400047,0.0031404668,0.001379514,0.001464082,0.0010614437,0.0128090605,0.00016669324,0.0011119384,0.004196514],"study_design_scores_gemma":[0.016039409,0.009189466,0.91203487,0.00007975097,0.006954939,0.00029769278,0.0007641626,0.0019570538,0.036794398,0.000034162967,0.015634162,0.00021995851],"about_ca_topic_score_codex":0.00009512641,"about_ca_topic_score_gemma":0.00021265486,"teacher_disagreement_score":0.04802199,"about_ca_system_score_codex":0.0001981504,"about_ca_system_score_gemma":0.0004155139,"threshold_uncertainty_score":0.61381143},"labels":[],"label_agreement":null},{"id":"W4382278483","doi":"10.20517/cdr.2023.02","title":"Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors","year":2023,"lang":"en","type":"review","venue":"Cancer Drug Resistance","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Context (archaeology); Medicine; Immune checkpoint; Clear cell renal cell carcinoma; Renal cell carcinoma; Disease; Narrative review; Immune system; Immunotherapy; Life expectancy; Oncology; Intensive care medicine; Cancer research; Immunology; Internal medicine; Biology","score_opus":0.0701794746677465,"score_gpt":0.39633057910282576,"score_spread":0.3261511044350793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382278483","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027687327,0.99222475,0.0000063144394,0.0018690492,0.00029022407,0.0036500376,0.00024194253,0.00006232561,0.0013784572],"genre_scores_gemma":[0.00014588104,0.983045,0.00087835,0.00010122533,0.00017485116,0.0017978041,0.00021521757,0.00014350718,0.01349816],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934917,0.0005184086,0.0036535119,0.0012544857,0.0005596553,0.0005222305],"domain_scores_gemma":[0.9955422,0.0005475453,0.0018634817,0.0013747285,0.0003694994,0.00030253048],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015605093,0.00074936415,0.0046836,0.00035210777,0.00010073748,0.000017016422,0.00034725427,0.0003615267,0.00005191805],"category_scores_gemma":[0.00045416577,0.00060634455,0.0011945034,0.0015218139,0.0003611617,0.00007401264,0.00018078223,0.00094101677,0.00001845536],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039361138,0.00037867646,0.00027746087,0.84884226,0.001245948,0.00045715607,0.00058216735,1.6221087e-7,0.00005683119,0.0021407546,0.023018267,0.122606695],"study_design_scores_gemma":[0.0010162366,0.0000694828,0.0024669038,0.4939533,0.0022802935,0.000020295553,0.00007399912,2.6163036e-7,0.00008669998,0.000452528,0.49907455,0.00050546014],"about_ca_topic_score_codex":0.00009783174,"about_ca_topic_score_gemma":0.0011280496,"teacher_disagreement_score":0.47605628,"about_ca_system_score_codex":0.0013175603,"about_ca_system_score_gemma":0.0018693111,"threshold_uncertainty_score":0.9996388},"labels":[],"label_agreement":null},{"id":"W4382701185","doi":"10.1053/j.ajkd.2023.06.002","title":"A Predictive Model for Kidney Failure After Nephrectomy for Localized Kidney Cancer: The Kidney Cancer Risk Equation","year":2023,"lang":"en","type":"article","venue":"American Journal of Kidney Diseases","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Manitoba; Ottawa Hospital; University of Ottawa; Manitoba Health; Seven Oaks General Hospital","funders":"","keywords":"Medicine; Nephrectomy; Renal function; Kidney transplantation; Kidney cancer; Dialysis; Urology; Kidney disease; Proportional hazards model; Nephrology; Kidney; Cancer; Population; Internal medicine; Surgery","score_opus":0.019457067848627156,"score_gpt":0.2976771108325236,"score_spread":0.2782200429838964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382701185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48528638,0.006189357,0.14129709,0.2794123,0.0029792741,0.013117294,0.07088409,0.0006055112,0.00022867846],"genre_scores_gemma":[0.94495785,0.0028863186,0.0048695966,0.03834549,0.0020737057,0.0046905302,0.0007460156,0.00022675746,0.0012037422],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9966548,0.00022089203,0.00091367716,0.0005413474,0.0008893465,0.0007799445],"domain_scores_gemma":[0.99177206,0.0005147205,0.0012516589,0.0005284866,0.0010212911,0.0049117976],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043170888,0.0005324297,0.0010941892,0.00039323585,0.00029999245,0.00008252769,0.00036124195,0.000092511924,0.00017734355],"category_scores_gemma":[0.006743643,0.00034799642,0.0010471458,0.00085476984,0.00047319414,0.00030098896,0.000073481686,0.00034791237,0.000010681734],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020439405,0.0005200324,0.091664694,0.0005916337,0.003078405,0.00008207042,0.0018687757,0.0048432136,0.0007894356,0.000028567261,0.86001027,0.01608348],"study_design_scores_gemma":[0.037959106,0.00930526,0.033125486,0.005218036,0.025384627,0.00014944209,0.0032630437,0.53684384,0.003281068,0.0032212122,0.34055734,0.0016915309],"about_ca_topic_score_codex":0.00053278776,"about_ca_topic_score_gemma":0.000016524917,"teacher_disagreement_score":0.53200066,"about_ca_system_score_codex":0.0007164503,"about_ca_system_score_gemma":0.009639844,"threshold_uncertainty_score":0.9998972},"labels":[],"label_agreement":null},{"id":"W4382986988","doi":"10.1016/j.hoc.2023.05.021","title":"Emerging Biomarkers of Response to Systemic Therapies in Metastatic Clear Cell Renal Cell Carcinoma","year":2023,"lang":"en","type":"review","venue":"Hematology/Oncology Clinics of North America","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Systemic therapy; Immunotherapy; Oncology; Biomarker; Clear cell renal cell carcinoma; Internal medicine; Intensive care medicine; Cancer","score_opus":0.06889863237091014,"score_gpt":0.3803642281189145,"score_spread":0.31146559574800436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382986988","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2509933,0.74536043,0.000021222893,0.00014007516,0.00031955194,0.0027173422,0.00013752846,0.00006019968,0.00025035933],"genre_scores_gemma":[0.070641175,0.92419755,0.0038059866,0.0001301791,0.0000402053,0.00049359223,0.00020235433,0.00021813078,0.0002708241],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99052554,0.0026769124,0.004264128,0.0011612313,0.000495349,0.00087683956],"domain_scores_gemma":[0.98812354,0.0065395664,0.0032710566,0.0013955957,0.00028835575,0.00038189747],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017028415,0.0009058138,0.008678619,0.0021011764,0.000055329154,0.0000046770597,0.0006323526,0.0006136629,0.000054012406],"category_scores_gemma":[0.0007827747,0.0007526335,0.0013701675,0.002219526,0.0006442856,0.00004475476,0.0003446867,0.00093532633,0.00031376185],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022268066,0.0052226107,0.056447662,0.2325845,0.0060387957,0.01677084,0.0053818673,0.00008557693,0.00022180918,0.000020809906,0.003605,0.65135247],"study_design_scores_gemma":[0.0130547965,0.036000513,0.010208414,0.03355097,0.019516094,0.004067605,0.005954763,0.00009546645,0.00027516313,0.00003129897,0.87456024,0.0026846582],"about_ca_topic_score_codex":0.00015437137,"about_ca_topic_score_gemma":0.00008118903,"teacher_disagreement_score":0.8709552,"about_ca_system_score_codex":0.00053679995,"about_ca_system_score_gemma":0.0027901062,"threshold_uncertainty_score":0.99949247},"labels":[],"label_agreement":null},{"id":"W4383302556","doi":"10.1111/bju.16114","title":"Estimated glomerular filtration rate from the renal hypothermia trial: clinical implications","year":2023,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Université Laval; Ottawa Hospital; Princess Margaret Cancer Centre; McMaster University; Dalhousie University; University of Toronto; University Health Network","funders":"","keywords":"Interquartile range; Renal function; Medicine; Urology; Confidence interval; Kidney disease; Creatinine; Nephrectomy; Internal medicine; Endocrinology; Kidney","score_opus":0.09173964974102551,"score_gpt":0.35310303954546324,"score_spread":0.26136338980443774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383302556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98212475,0.0018855875,0.00026965278,0.014560656,0.00044351557,0.00034515603,0.000032159416,0.000039505092,0.0002990417],"genre_scores_gemma":[0.9952782,0.0016122477,0.00050349446,0.0013630048,0.0009263328,0.000015257438,0.00007962847,0.000023707087,0.00019815727],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981505,0.0004854753,0.00081295235,0.0001758528,0.00017485852,0.00020035854],"domain_scores_gemma":[0.9980389,0.0009775338,0.00039922848,0.00023455129,0.00021063566,0.00013917705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011381846,0.00009656895,0.0003853949,0.00006464217,0.000103522994,0.00003645849,0.00016155456,0.00013620955,0.00019842156],"category_scores_gemma":[0.0010230568,0.00007602334,0.00024822605,0.00024866353,0.00013726662,0.00005997253,0.000026812091,0.00042014298,0.00010888816],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05146574,0.00187265,0.09329336,0.00002574995,0.0029099733,0.017614372,0.00029906683,0.00090074644,0.04150734,0.0003770431,0.35830694,0.431427],"study_design_scores_gemma":[0.021411525,0.0018857066,0.95919925,0.000045755834,0.00048655627,0.005411812,0.00001573767,0.00026251885,0.0002018706,0.0021693963,0.008835852,0.0000740355],"about_ca_topic_score_codex":0.00009427779,"about_ca_topic_score_gemma":0.000035554418,"teacher_disagreement_score":0.8659059,"about_ca_system_score_codex":0.00003686933,"about_ca_system_score_gemma":0.00020803674,"threshold_uncertainty_score":0.3100142},"labels":[],"label_agreement":null},{"id":"W4383711167","doi":"10.1259/bjr.20221087","title":"Utility of multiparametric renal CT for differentiation of low-grade from high-grade cT1a clear cell renal cell carcinoma","year":2023,"lang":"en","type":"article","venue":"British Journal of Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Confidence interval; Clear cell renal cell carcinoma; Nuclear medicine; Receiver operating characteristic; Renal cell carcinoma; Urology; Radiology; Pathology; Internal medicine","score_opus":0.025595890087490913,"score_gpt":0.2524168550827937,"score_spread":0.2268209649953028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383711167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932231,0.004486178,0.0007800257,0.00010967044,0.00045973086,0.00052459363,0.00030958638,0.000019733983,0.000087398745],"genre_scores_gemma":[0.9954097,0.00073941535,0.0030029542,0.00002925804,0.00036780513,0.000010300725,0.00024004672,0.00004382854,0.0001566861],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99703634,0.00033736505,0.0013539575,0.00037020785,0.00046359748,0.00043852336],"domain_scores_gemma":[0.99703294,0.00082952145,0.001188166,0.00032296756,0.00037432517,0.0002520845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054264057,0.00024568508,0.0012547898,0.0005645522,0.000063589876,0.0000130159115,0.000261723,0.00019212838,0.00012160129],"category_scores_gemma":[0.0003200486,0.00024356248,0.00061184063,0.0005234156,0.0002094991,0.000086838045,0.00005696446,0.00043472857,0.000005514259],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004894304,0.0030514435,0.3239001,0.0013083798,0.00085651857,0.0042775036,0.0004427823,0.0003361404,0.6215361,0.000028016393,0.02740371,0.011965011],"study_design_scores_gemma":[0.0077504115,0.0021121695,0.7230394,0.00017352425,0.00045268203,0.0026059058,0.00008422581,0.001040303,0.2622813,0.00025215824,0.00007364049,0.000134274],"about_ca_topic_score_codex":0.00086856884,"about_ca_topic_score_gemma":0.000031941177,"teacher_disagreement_score":0.3991393,"about_ca_system_score_codex":0.00011386239,"about_ca_system_score_gemma":0.00020417782,"threshold_uncertainty_score":0.99321896},"labels":[],"label_agreement":null},{"id":"W4383982112","doi":"10.1016/s1470-2045(23)00276-0","title":"Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial","year":2023,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"Merck Sharp and Dohme; National Cancer Institute; Eisai","keywords":"Lenvatinib; Pembrolizumab; Medicine; Renal cell carcinoma; Internal medicine; Clinical endpoint; Population; Oncology; Adverse effect; Phases of clinical research; Cancer; Clinical trial; Immunotherapy","score_opus":0.09302847659005466,"score_gpt":0.3660065527882697,"score_spread":0.27297807619821507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383982112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735692,0.00073611236,0.0001454968,0.006565378,0.0009173053,0.0054917987,0.000082812876,0.00024798678,0.012243875],"genre_scores_gemma":[0.9858722,0.0006320403,0.00124589,0.001741709,0.0024461204,0.000980743,0.00033795627,0.00012681796,0.006616541],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966723,0.000271019,0.00072700024,0.00075036654,0.00043473905,0.0011446063],"domain_scores_gemma":[0.9966104,0.0014583685,0.00043011687,0.0010196862,0.00020136204,0.00028004768],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067750347,0.0005067915,0.0013947216,0.00018601278,0.0003028919,0.00003230676,0.0004510347,0.00031181853,0.0002976515],"category_scores_gemma":[0.00021363983,0.0003485733,0.00041167517,0.00046240116,0.00020137372,0.00007708485,0.00013407745,0.0005132768,0.00047660014],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82137436,0.007817183,0.00019404027,0.0004042647,0.0002477179,0.0014396355,0.0038194326,0.0006065352,0.111434236,0.000057454152,0.018938448,0.033666708],"study_design_scores_gemma":[0.6882687,0.07865953,0.0007993548,0.000060530405,0.00044897688,0.00013157689,0.0005119597,0.0043792743,0.11563023,0.0002666065,0.110361494,0.0004817265],"about_ca_topic_score_codex":0.000120152195,"about_ca_topic_score_gemma":0.00006793884,"teacher_disagreement_score":0.1331056,"about_ca_system_score_codex":0.0007679005,"about_ca_system_score_gemma":0.00062670803,"threshold_uncertainty_score":0.99989665},"labels":[],"label_agreement":null},{"id":"W4384344146","doi":"10.1016/j.eururo.2023.06.025","title":"Optimizing Treatment Selection in Advanced Renal Cell Carcinoma via IMDC Risk Group Stratification","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Risk stratification; Renal cell carcinoma; Urology; Selection (genetic algorithm); Oncology; Internal medicine","score_opus":0.021173610162932024,"score_gpt":0.23817588954344082,"score_spread":0.2170022793805088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384344146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8341587,0.0019464646,0.0016621003,0.11419417,0.0014845838,0.0043009217,0.00012986269,0.0009260837,0.041197076],"genre_scores_gemma":[0.94894195,0.00031187257,0.0022319632,0.03446257,0.0031768193,0.00019988316,0.0033964305,0.0004346401,0.0068438626],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958075,0.0012660093,0.00072814873,0.0011845327,0.00030249,0.0007112631],"domain_scores_gemma":[0.9984976,0.00022165473,0.00047695596,0.00060892804,0.00007465566,0.00012017242],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032720342,0.00063372427,0.0007438683,0.00063428597,0.00011052878,0.000026802321,0.0001778587,0.0004383083,0.000092546914],"category_scores_gemma":[0.000035724606,0.0005674941,0.00026447268,0.00039376106,0.00007679736,0.000060988834,0.0000612815,0.0016195328,0.0009879333],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061397436,0.002858036,0.044219915,0.0012025,0.0014791421,0.10784511,0.0050923857,0.009330274,0.1475518,0.000027816217,0.5752782,0.09897508],"study_design_scores_gemma":[0.015253053,0.024204679,0.37305045,0.000108795924,0.002616744,0.0013322561,0.000079313606,0.002852951,0.00924522,0.00009677628,0.5694664,0.001693351],"about_ca_topic_score_codex":0.00027188548,"about_ca_topic_score_gemma":0.00011310816,"teacher_disagreement_score":0.32883054,"about_ca_system_score_codex":0.000835499,"about_ca_system_score_gemma":0.00010118723,"threshold_uncertainty_score":0.9997899},"labels":[],"label_agreement":null},{"id":"W4384701084","doi":"10.1016/j.euo.2023.06.006","title":"Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy","year":2023,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Shanghai Education Development Foundation; Changhai Hospital of Shanghai; Shanghai Municipal Health Bureau; Shanghai Municipal Education Commission; National Natural Science Foundation of China","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Hazard ratio; Clear cell renal cell carcinoma; Oncology; Nephrectomy; Proportional hazards model; Adjuvant therapy; Cancer; Urology; Confidence interval; Kidney","score_opus":0.038756231525032145,"score_gpt":0.2903480757409217,"score_spread":0.25159184421588954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384701084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943155,0.0013272368,0.000052935007,0.0015508501,0.000032049706,0.0011713672,0.00010151394,0.000018740457,0.0014298199],"genre_scores_gemma":[0.99854565,0.00018385786,0.0006820646,0.0001804168,0.000033700704,0.000060553175,0.00010383636,0.000036057547,0.00017386963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980006,0.00058357255,0.00055894157,0.00045551753,0.000102322694,0.00029902227],"domain_scores_gemma":[0.99799097,0.00092909054,0.00042148452,0.0005057305,0.00006791378,0.000084801984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005544457,0.00018120716,0.00081631227,0.00026300637,0.00006532062,0.0000032987755,0.00016073648,0.00006389054,0.000005688259],"category_scores_gemma":[0.0000962498,0.00012094272,0.00014173109,0.00066678243,0.0005162988,0.00002058465,0.00012108183,0.00020795754,0.0000022095865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046696095,0.0006621343,0.9338214,0.00021800137,0.00034751242,0.00013674698,0.00096773717,0.000050555238,0.060768567,0.000030107445,0.00016616346,0.0023641593],"study_design_scores_gemma":[0.0024696633,0.0035071764,0.98890775,0.000009190818,0.0018652946,0.00004517302,0.00008545998,0.00007283833,0.0023171343,0.00011279026,0.0005154293,0.000092110684],"about_ca_topic_score_codex":0.000053604646,"about_ca_topic_score_gemma":0.000039297505,"teacher_disagreement_score":0.058451433,"about_ca_system_score_codex":0.00006448237,"about_ca_system_score_gemma":0.00016556468,"threshold_uncertainty_score":0.4931901},"labels":[],"label_agreement":null},{"id":"W4384829284","doi":"10.3390/cancers15143672","title":"The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma","year":2023,"lang":"en","type":"review","venue":"Cancers","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; London Health Sciences Centre; McMaster University; University of Toronto; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"Bladder Cancer Advocacy Network; Varian Medical Systems; AstraZeneca","keywords":"SABR volatility model; Medicine; Cryoablation; Ablative case; Renal cell carcinoma; Cryosurgery; Percutaneous; Radiofrequency ablation; Radiosurgery; Radiation therapy; Radiology; Surgery; Ablation; Oncology; Internal medicine","score_opus":0.08502147381820994,"score_gpt":0.3315662657166833,"score_spread":0.24654479189847334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384829284","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002820216,0.99178106,0.000010871159,0.00004157199,0.00016724535,0.0031948707,0.000041224357,0.000013454773,0.0019295177],"genre_scores_gemma":[0.0017579426,0.99591035,0.0001618049,0.00007687795,0.000056296154,0.00040250144,0.000048064834,0.000077266224,0.0015088778],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974268,0.00041378,0.0008869265,0.00037234256,0.00057115866,0.00032900707],"domain_scores_gemma":[0.99734324,0.00085923815,0.00072141347,0.00094793923,0.000064018706,0.000064149135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045814936,0.000393989,0.0016666286,0.00019439554,0.00004984019,0.000016066693,0.0003528901,0.00013022023,0.000017829545],"category_scores_gemma":[0.000013156498,0.00019965175,0.00054038974,0.00072667346,0.0002651533,0.00003366799,0.00006008609,0.00036692724,0.0000067906058],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014507591,0.00022276383,0.00038644622,0.110215984,0.006123242,0.0026695796,0.0028431863,0.00019301273,0.000017020153,0.00020948102,0.0069925715,0.86867595],"study_design_scores_gemma":[0.0031556843,0.00094574376,0.0018609025,0.018003386,0.0048802863,0.00006853294,0.0005101547,0.000035700537,0.00004774125,0.000020329326,0.97013915,0.00033236458],"about_ca_topic_score_codex":0.0007812071,"about_ca_topic_score_gemma":0.000037824946,"teacher_disagreement_score":0.9631466,"about_ca_system_score_codex":0.0032832483,"about_ca_system_score_gemma":0.000999364,"threshold_uncertainty_score":0.858558},"labels":[],"label_agreement":null},{"id":"W4385256763","doi":"10.1016/j.eururo.2023.06.006","title":"Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study","year":2023,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval","funders":"Merck Sharp and Dohme","keywords":"Medicine; Axitinib; Sunitinib; Renal cell carcinoma; Pembrolizumab; Oncology; Internal medicine; Kidney cancer; Urology; Cancer; Immunotherapy","score_opus":0.05018944831186409,"score_gpt":0.30369932539317923,"score_spread":0.2535098770813151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385256763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96795243,0.0005744005,0.0000043068553,0.0004756309,0.00077238056,0.001702434,0.000094938965,0.00010771856,0.028315775],"genre_scores_gemma":[0.99472725,0.0000822882,0.000033398344,0.00007402389,0.00021680832,0.000059031947,0.00017854046,0.000115317176,0.004513361],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99670714,0.00073558924,0.0008252994,0.0006588068,0.00048592073,0.0005872159],"domain_scores_gemma":[0.9973627,0.0004928121,0.00044468103,0.0012807719,0.00019764529,0.00022139748],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030766937,0.00046569892,0.0009150214,0.00026131616,0.00014810459,0.00000739549,0.00035601636,0.00008180149,0.00021614425],"category_scores_gemma":[0.00021371606,0.00032398975,0.0004339028,0.00057333277,0.0002620008,0.000040580475,0.00023312138,0.0002248421,0.00026468319],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50788724,0.057751093,0.09191787,0.0012499519,0.0059947507,0.050584745,0.07281185,0.011468438,0.11677647,0.0005600887,0.007445727,0.07555175],"study_design_scores_gemma":[0.38426057,0.19814038,0.30878848,0.00005970799,0.0038047286,0.0003113974,0.0030729547,0.0004831302,0.07708897,0.00003330283,0.023228759,0.0007276182],"about_ca_topic_score_codex":0.00022689746,"about_ca_topic_score_gemma":0.00013628454,"teacher_disagreement_score":0.2168706,"about_ca_system_score_codex":0.00022096334,"about_ca_system_score_gemma":0.00024055541,"threshold_uncertainty_score":0.9999212},"labels":[],"label_agreement":null},{"id":"W4385341021","doi":"10.1080/13696998.2023.2242197","title":"Cost-effectiveness analysis of cabozantinib compared with everolimus, axitinib, and nivolumab in subsequent line advanced renal cell carcinoma in Japan","year":2023,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVRAZ (Canada)","funders":"Takeda Pharmaceutical Company","keywords":"Axitinib; Cabozantinib; Everolimus; Nivolumab; Medicine; Renal cell carcinoma; Oncology; Internal medicine; Urology; Second line; Tyrosine-kinase inhibitor; Sunitinib; Immunotherapy; First line; Cancer","score_opus":0.04274972990295816,"score_gpt":0.3051754524786486,"score_spread":0.2624257225756904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385341021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982787,0.00044093688,0.00003644805,0.00061947334,0.00007972916,0.00039593125,0.000019927378,0.000006462326,0.00012241409],"genre_scores_gemma":[0.998858,0.0006830212,0.00022986607,0.00007151546,0.000060968454,0.000014070497,0.00004302743,0.000022832002,0.000016748558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767774,0.00015690525,0.0011116284,0.0002703357,0.00044129384,0.00034207402],"domain_scores_gemma":[0.9981797,0.0004888364,0.0005536587,0.00022278648,0.00012696322,0.00042806639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017482366,0.00020638756,0.0014089415,0.0011497624,0.000018317385,0.000010928363,0.00016342613,0.00015393426,0.00006317261],"category_scores_gemma":[0.00015723659,0.00016288218,0.00019120952,0.000850311,0.00015685915,0.00009997396,0.00006185032,0.00048546016,0.0000021311353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049422206,0.0006786462,0.9588321,0.00027470017,0.00066244777,0.001755833,0.0008101003,0.024408445,0.0008083244,0.00003326584,0.000024130486,0.0067697754],"study_design_scores_gemma":[0.016300833,0.001528986,0.95190936,0.0003780338,0.00062175374,0.00022810935,0.0006690733,0.024378851,0.0037149508,0.000018480918,0.000110330555,0.00014123457],"about_ca_topic_score_codex":0.0002992681,"about_ca_topic_score_gemma":0.001097745,"teacher_disagreement_score":0.011358612,"about_ca_system_score_codex":0.00041844137,"about_ca_system_score_gemma":0.00061400107,"threshold_uncertainty_score":0.66421425},"labels":[],"label_agreement":null},{"id":"W4385421115","doi":"10.3390/jcm12154987","title":"Biomarkers for Immune Checkpoint Inhibitors in Renal Cell Carcinoma","year":2023,"lang":"en","type":"review","venue":"Journal of Clinical Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Renal cell carcinoma; Biomarker; Immunotherapy; Kidney cancer; Immune checkpoint; Immune system; Adverse effect; Carcinoma; Clear cell renal cell carcinoma; Autoimmunity; Cancer; Oncology; Bioinformatics; Cancer research; Immunology; Internal medicine","score_opus":0.21062658742894255,"score_gpt":0.46078314579979845,"score_spread":0.25015655837085593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385421115","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023647735,0.9891095,0.000022551785,0.0013917149,0.0033202642,0.002172802,0.000017531756,0.00002377114,0.0015770975],"genre_scores_gemma":[0.0010957685,0.98980325,0.0008846692,0.000111718844,0.0063780104,0.00007158015,0.000084257525,0.00018835618,0.0013823577],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9861226,0.0005596061,0.010952823,0.0006147051,0.0011251329,0.00062511134],"domain_scores_gemma":[0.98739266,0.0051170695,0.005416651,0.00071017747,0.00051402504,0.0008494353],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008990097,0.00077699526,0.009506304,0.0014399913,0.000041821047,0.000012284047,0.00046466297,0.0009340401,0.00010357137],"category_scores_gemma":[0.0062987385,0.00045425526,0.004098734,0.0010166996,0.00039004997,0.00007191425,0.00011889374,0.0021940998,0.000058430327],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015514831,0.00085961615,0.0007563973,0.038413282,0.0013583079,0.0050539575,0.00008420772,5.16094e-7,0.000042335683,0.000006064182,0.010747433,0.9411264],"study_design_scores_gemma":[0.014644814,0.012150701,0.0029107803,0.09222413,0.008815048,0.0013379836,0.00012324308,0.00000890015,0.00009077728,0.000095841366,0.8671723,0.00042550458],"about_ca_topic_score_codex":0.0000527759,"about_ca_topic_score_gemma":0.0000073932533,"teacher_disagreement_score":0.9407009,"about_ca_system_score_codex":0.0005525895,"about_ca_system_score_gemma":0.0019460941,"threshold_uncertainty_score":0.9997909},"labels":[],"label_agreement":null},{"id":"W4385838013","doi":"10.1158/1538-7445.kidney23-b011","title":"Abstract B011: An atlas of cellular heterogeneity in primary and metastatic renal cell carcinomas","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Citation; Renal cell carcinoma; Cancer; Medicine; Library science; Atlas (anatomy); Oncology; Internal medicine; Anatomy; Computer science","score_opus":0.1410458831664498,"score_gpt":0.3938010448498674,"score_spread":0.2527551616834176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385838013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99382484,0.0036418524,0.0000021766457,0.0001854017,0.000033248434,0.000645363,0.000030978317,0.000024056744,0.0016120733],"genre_scores_gemma":[0.9984108,0.0005784589,0.000108547814,0.000018661234,0.00006203949,0.00013243963,0.00007436609,0.000034397137,0.000580245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977573,0.00018967554,0.00031768295,0.00044203963,0.0007678539,0.0005254114],"domain_scores_gemma":[0.99887556,0.00017246752,0.000051968826,0.0004514105,0.0001630425,0.00028554915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011063926,0.00014983362,0.00038828552,0.0004985104,0.000057386016,0.000017272088,0.00013204936,0.000062849365,0.000120031626],"category_scores_gemma":[0.00003318147,0.00012578335,0.00006700751,0.0007021535,0.00021563421,0.00008535953,0.00012887664,0.000389964,0.000040894083],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004204733,0.00021284881,0.069066964,0.0010063899,0.00004668123,0.0011133938,0.000453851,0.00004391114,0.92510915,0.000009899588,0.0003678385,0.002148593],"study_design_scores_gemma":[0.0011865507,0.00042728492,0.48441026,0.00009159802,0.00002732986,0.000007958081,0.00013366717,0.00006279462,0.5133636,0.000040253908,0.00017464698,0.00007405907],"about_ca_topic_score_codex":0.0021190306,"about_ca_topic_score_gemma":0.00029309368,"teacher_disagreement_score":0.41534328,"about_ca_system_score_codex":0.00038149633,"about_ca_system_score_gemma":0.00045338902,"threshold_uncertainty_score":0.5129296},"labels":[],"label_agreement":null},{"id":"W4385933217","doi":"10.1016/j.asjsur.2023.08.048","title":"Perioperative and oncological outcomes of robot-assisted laparoscopic partial nephrectomy for cystic and solid renal masses: Evidence from controlled trials","year":2023,"lang":"en","type":"review","venue":"Asian Journal of Surgery","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Perioperative; Odds ratio; Cochrane Library; Renal function; Meta-analysis; Subgroup analysis; Confidence interval; Observational study; Randomized controlled trial; Urology; Surgery; Internal medicine; Kidney","score_opus":0.33980822845908054,"score_gpt":0.4460592641459492,"score_spread":0.10625103568686867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385933217","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02246624,0.9736575,0.00011674459,0.00043988426,0.0005672681,0.0026248326,0.00009027329,0.000013813609,0.000023427609],"genre_scores_gemma":[0.016583096,0.980347,0.001834616,0.000032452324,0.000618592,0.00032000587,0.00003702106,0.000058153117,0.00016911342],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99344254,0.001650973,0.0037013958,0.00038641103,0.0004971575,0.0003215308],"domain_scores_gemma":[0.97106785,0.024609966,0.0034132507,0.00023022751,0.00032029004,0.00035840098],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0042944085,0.0005483961,0.01458386,0.0004734013,0.00007492815,0.000078401186,0.00011241904,0.0003469135,0.000059303984],"category_scores_gemma":[0.0139484415,0.00029445247,0.0022481736,0.00020964147,0.00019565661,0.00013509957,0.00004457525,0.0004292347,0.000002808002],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012633715,0.0006614586,0.018709563,0.020152714,0.025671795,0.00513674,0.00057765894,0.0000032322437,0.0005559032,0.000017694605,0.0010490642,0.91483045],"study_design_scores_gemma":[0.0715384,0.013825626,0.1268341,0.44898656,0.17262633,0.0069117662,0.0016702958,0.000064239124,0.00084337924,0.0002385288,0.15392812,0.002532673],"about_ca_topic_score_codex":0.000011400436,"about_ca_topic_score_gemma":0.0000047313606,"teacher_disagreement_score":0.9122978,"about_ca_system_score_codex":0.00019019471,"about_ca_system_score_gemma":0.0015310803,"threshold_uncertainty_score":0.99995077},"labels":[],"label_agreement":null},{"id":"W4385949824","doi":"10.3389/fonc.2023.1223282","title":"Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms","year":2023,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute; Eisai; Memorial Sloan-Kettering Cancer Center","keywords":"Lenvatinib; Medicine; Sunitinib; Pembrolizumab; Renal cell carcinoma; Internal medicine; Oncology; Kidney cancer; Everolimus; Nephrectomy; Urology; Sorafenib; Cancer; Kidney; Immunotherapy; Hepatocellular carcinoma","score_opus":0.02308070190058515,"score_gpt":0.30565543670240686,"score_spread":0.2825747348018217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385949824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99462044,0.0002306121,0.000050255567,0.00056166435,0.00034415023,0.003854703,0.000026648584,0.000028962133,0.0002825723],"genre_scores_gemma":[0.9969737,0.00003058026,0.0017316717,0.00015057535,0.000031200005,0.0006835333,0.00009524673,0.000045204197,0.00025829545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980573,0.00018961773,0.0005030404,0.00047761772,0.0002426152,0.0005298117],"domain_scores_gemma":[0.99891376,0.0004448738,0.00014129648,0.00034277825,0.00006044463,0.00009685864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044258626,0.00026404342,0.0008119239,0.00052757637,0.000059405098,0.0000097039,0.00014718353,0.00012939372,0.000007670161],"category_scores_gemma":[0.00010662013,0.00017530199,0.000054928736,0.00054536195,0.00014341541,0.00007727425,0.00007807781,0.00035830616,0.000003539082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0130157545,0.0030588857,0.9628195,0.000050447554,0.000050802573,0.00040098466,0.0039762887,0.00011053687,0.00001836934,0.000004085361,0.0006792536,0.015815075],"study_design_scores_gemma":[0.09561644,0.0177962,0.8781959,0.000023269315,0.00008911172,0.0000041222934,0.0067631365,0.00067609287,0.00008537525,0.00003948184,0.0005532375,0.00015766732],"about_ca_topic_score_codex":0.00019670467,"about_ca_topic_score_gemma":0.00088718894,"teacher_disagreement_score":0.08462364,"about_ca_system_score_codex":0.0007567777,"about_ca_system_score_gemma":0.00020636161,"threshold_uncertainty_score":0.7148608},"labels":[],"label_agreement":null},{"id":"W4385990471","doi":"10.3389/fonc.2023.1195910","title":"Perioperative, functional, and oncological outcomes of robotic vs. laparoscopic partial nephrectomy for complex renal tumors (RENAL score ≥7): an evidence-based analysis","year":2023,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Perioperative; Urology; Renal function; Odds ratio; Cochrane Library; Blood transfusion; Laparoscopy; Surgery; Internal medicine; Kidney; Meta-analysis","score_opus":0.2455212339806797,"score_gpt":0.41232919138074314,"score_spread":0.16680795740006343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385990471","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015821073,0.96992445,0.0058231144,0.00044930223,0.0010369184,0.0066064717,0.00015370747,0.00010526892,0.00007968874],"genre_scores_gemma":[0.0039382116,0.936614,0.0499046,0.00047445248,0.00051871873,0.004977748,0.0025809207,0.00015279073,0.0008386001],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995471,0.0009133377,0.0015159892,0.0010726268,0.00043569328,0.00059134455],"domain_scores_gemma":[0.99680096,0.0014534702,0.00070235744,0.0005249433,0.00019106474,0.00032723256],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00075593893,0.00068432756,0.006998411,0.0013991208,0.0001192632,0.000026918755,0.00025643554,0.00067051075,0.00017064047],"category_scores_gemma":[0.0005659394,0.0004891821,0.0010764876,0.0012499938,0.00063362456,0.00010186748,0.00010397459,0.00056068803,0.0000068819722],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007498104,0.0038068797,0.45898834,0.027622031,0.019760039,0.0020771385,0.00039966128,0.005019835,0.00005614188,0.0002518015,0.012656454,0.46186358],"study_design_scores_gemma":[0.016768416,0.029559342,0.2928541,0.015013831,0.06427311,0.00020363706,0.00034087902,0.015095411,0.00003464896,0.00009414904,0.5639991,0.0017633504],"about_ca_topic_score_codex":0.000085643354,"about_ca_topic_score_gemma":0.00023079227,"teacher_disagreement_score":0.55134267,"about_ca_system_score_codex":0.0015282664,"about_ca_system_score_gemma":0.0021833302,"threshold_uncertainty_score":0.999756},"labels":[],"label_agreement":null},{"id":"W4386387581","doi":"10.1007/s11523-023-00987-1","title":"Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial","year":2023,"lang":"en","type":"article","venue":"Targeted Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; Ono Pharmaceutical; Memorial Sloan-Kettering Cancer Center; Bristol-Myers Squibb","keywords":"Nivolumab; Medicine; Ipilimumab; Renal cell carcinoma; Placebo; Nephrectomy; Internal medicine; Adjuvant; Oncology; Adjuvant therapy; Kidney cancer; Clinical trial; Cancer; Surgery; Immunotherapy; Kidney; Pathology; Alternative medicine","score_opus":0.12948190054941494,"score_gpt":0.4061370170159111,"score_spread":0.27665511646649615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386387581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9731466,0.0026867497,0.00022105932,0.00079194293,0.0016332488,0.01521273,0.00017365727,0.0002549028,0.005879077],"genre_scores_gemma":[0.98044455,0.00021410023,0.00257718,0.00009116631,0.0009080499,0.008176319,0.0010426538,0.00015398368,0.006391986],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9934477,0.0014164973,0.00155507,0.001023574,0.0010713267,0.0014858271],"domain_scores_gemma":[0.99287623,0.0043649,0.00047806144,0.00093608384,0.0007643797,0.00058037165],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0041848156,0.0005768373,0.0029277634,0.0012901889,0.0001960681,0.000026817903,0.00036194996,0.00066905253,0.0007114696],"category_scores_gemma":[0.0007241075,0.00047356545,0.0009997744,0.0012780947,0.0009073537,0.000115310024,0.00027870646,0.0008029089,0.00024680758],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9729884,0.0015404915,0.000026512476,0.0005006477,0.00064366317,0.0016942284,0.00112127,0.000039202576,0.0061148982,0.000069950445,0.013692332,0.001568364],"study_design_scores_gemma":[0.9187047,0.01941757,0.000018185838,0.000092894705,0.001304079,0.0000456092,0.0004491053,0.0029389486,0.03391765,0.00021571931,0.022540756,0.00035478646],"about_ca_topic_score_codex":0.00061140483,"about_ca_topic_score_gemma":0.0001675277,"teacher_disagreement_score":0.05428374,"about_ca_system_score_codex":0.0015589142,"about_ca_system_score_gemma":0.0025793328,"threshold_uncertainty_score":0.9997716},"labels":[],"label_agreement":null},{"id":"W4386388190","doi":"10.1016/j.eururo.2023.08.010","title":"Corrigendum to “Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study” [Eur. Urol. (2023)]","year":2023,"lang":"en","type":"erratum","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Axitinib; Sunitinib; Pembrolizumab; Renal cell carcinoma; Internal medicine; Oncology; Urology; Cancer; Immunotherapy","score_opus":0.05649958729501037,"score_gpt":0.3012588737262299,"score_spread":0.24475928643121952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386388190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8169277,0.0035278532,0.000012375653,0.00090107665,0.04299882,0.0059535853,0.0011928031,0.00022372372,0.12826209],"genre_scores_gemma":[0.7392147,0.00030115017,0.00003730994,0.00024250208,0.0015384783,0.00019579494,0.0014706563,0.0004562067,0.2565432],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921756,0.0014731493,0.0019720162,0.0018268699,0.0012420925,0.0013103045],"domain_scores_gemma":[0.9937613,0.00050336675,0.0014167662,0.0031206205,0.00060509145,0.00059283833],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0004973519,0.001482248,0.0028112484,0.0007586358,0.00027002927,0.000024244548,0.001111682,0.0004671266,0.0005130402],"category_scores_gemma":[0.00064566033,0.0011107607,0.0011763249,0.00105152,0.00040390398,0.000051651707,0.0007276578,0.0011694889,0.0008203364],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16341257,0.016481372,0.0014776845,0.0011965764,0.0040987455,0.028679403,0.010888699,0.0011829407,0.0030111526,0.00004987906,0.75803447,0.011486485],"study_design_scores_gemma":[0.15057045,0.16797413,0.022978898,0.00021179179,0.0068546017,0.00029001993,0.0009796491,0.0001146571,0.004612113,0.0000107388405,0.6441928,0.0012101276],"about_ca_topic_score_codex":0.00089480274,"about_ca_topic_score_gemma":0.0009522606,"teacher_disagreement_score":0.15149274,"about_ca_system_score_codex":0.00080383505,"about_ca_system_score_gemma":0.0012553018,"threshold_uncertainty_score":0.9999576},"labels":[],"label_agreement":null},{"id":"W4386530721","doi":"10.1111/his.15042","title":"<scp>ABCC2</scp> brush‐border expression predicts outcome in papillary renal cell carcinoma: a multi‐institutional study of 254 cases","year":2023,"lang":"en","type":"article","venue":"Histopathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; McGill University Health Centre; Sunnybrook Health Science Centre; Calgary Laboratory Services; University Health Network; University of Toronto; University of Calgary; St. Michael's Hospital","funders":"Government of Ontario; Canadian Urological Association Scholarship Fund; Ontario Institute for Cancer Research; Canadian Urological Association","keywords":"Immunohistochemistry; Brush border; Papillary renal cell carcinomas; Pathology; Medicine; Univariate analysis; Internal medicine; Multidrug resistance-associated protein 2; Carcinoma; Oncology; Multivariate analysis; Gastroenterology; Biology; Transporter; Gene; Genetics; ATP-binding cassette transporter","score_opus":0.05153077935751338,"score_gpt":0.30679209867153756,"score_spread":0.2552613193140242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386530721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948526,0.0016122033,0.000028983408,0.00005168714,0.00043560573,0.0010346655,0.000039688308,0.00012386081,0.0018206913],"genre_scores_gemma":[0.99502695,0.000033274995,0.0005332926,0.0000866367,0.0000959323,0.0001853833,0.00012602004,0.00004165959,0.0038708386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973493,0.00026555394,0.00076779904,0.00065280293,0.00047012436,0.00049441267],"domain_scores_gemma":[0.9985642,0.00029570152,0.00021782132,0.00061182654,0.00012679987,0.00018365853],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037419886,0.00033936187,0.00077367364,0.0006494199,0.00011674285,0.0000048156485,0.0001649608,0.00022368343,0.00004775186],"category_scores_gemma":[0.0004142389,0.00027472645,0.00015165492,0.0005340214,0.00022283885,0.00006955936,0.00020531146,0.00034742913,0.000108980166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013188431,0.0022523252,0.87807244,0.0002088587,0.0000073486867,0.02707697,0.003544667,0.00023661678,0.08653318,0.000010218008,0.0017811123,0.00014437737],"study_design_scores_gemma":[0.0066578616,0.002195453,0.9789237,0.000059911068,0.00013274046,0.000996299,0.0013889518,0.00015866657,0.007918036,0.0000069859207,0.0014656907,0.00009570379],"about_ca_topic_score_codex":0.00038006192,"about_ca_topic_score_gemma":0.00016092406,"teacher_disagreement_score":0.10085126,"about_ca_system_score_codex":0.00035091993,"about_ca_system_score_gemma":0.00023330397,"threshold_uncertainty_score":0.9999705},"labels":[],"label_agreement":null},{"id":"W4386591643","doi":"10.2217/imt-2023-0039","title":"Association Between Age and Efficacy of First-Line Immunotherapy-Based Combination Therapies for Mrcc: A Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Meta-analysis; Renal cell carcinoma; Sunitinib; Hazard ratio; Internal medicine; Kidney cancer; Immunotherapy; Oncology; Cancer; Confidence interval","score_opus":0.15708852634186113,"score_gpt":0.3821562660851957,"score_spread":0.22506773974333458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386591643","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011222706,0.9927563,0.0008545556,0.00044746452,0.000072667135,0.0041683856,0.00043158737,0.000120175784,0.000026570344],"genre_scores_gemma":[0.0014549167,0.9917971,0.00084499374,0.00007406967,0.000102216385,0.0011201963,0.0021843298,0.000216413,0.0022057493],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9965617,0.0003521716,0.0014582494,0.0006215803,0.000633918,0.00037238077],"domain_scores_gemma":[0.9939357,0.0031322376,0.0016618293,0.00090238557,0.00029852646,0.00006934432],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012307357,0.00073391094,0.006565322,0.0009883291,0.00013576803,0.00006731755,0.00023728002,0.00052420184,0.00011391429],"category_scores_gemma":[0.00010460149,0.0005138011,0.005555232,0.0012265814,0.00008093517,0.000056378398,0.000021582147,0.00028349794,0.000012447213],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028084728,0.00050547364,0.00033231155,0.0062386706,0.67490524,0.000013169836,0.00034933383,0.0000070660453,0.000025765907,0.00004238754,0.00007381408,0.3172259],"study_design_scores_gemma":[0.006880107,0.0015153609,0.0027412414,0.00082162383,0.5487387,0.000002363251,0.000012151319,0.00003796535,0.00008740632,0.00014676727,0.43849057,0.0005257306],"about_ca_topic_score_codex":0.00016274287,"about_ca_topic_score_gemma":0.000030538296,"teacher_disagreement_score":0.43841678,"about_ca_system_score_codex":0.0005152338,"about_ca_system_score_gemma":0.00017078956,"threshold_uncertainty_score":0.99973136},"labels":[],"label_agreement":null},{"id":"W4386629639","doi":"10.1016/j.thromres.2023.09.004","title":"Breaking down tumor thrombus: Current strategies for medical management","year":2023,"lang":"en","type":"review","venue":"Thrombosis Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Thrombus; Medicine; Inferior vena cava; Renal cell carcinoma; Hepatocellular carcinoma; Radiology; Fibrin; Renal vein; Thrombosis; Pathology; Internal medicine; Kidney; Immunology","score_opus":0.4300638415052927,"score_gpt":0.5475069466912418,"score_spread":0.11744310518594908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386629639","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007998002,0.98074114,0.00006969435,0.00026255578,0.0005200352,0.007797555,0.00011158543,0.00029478068,0.0101226615],"genre_scores_gemma":[0.00010191205,0.9930453,0.00034916875,0.000025682586,0.0009366902,0.0034839124,0.00063705666,0.00030021285,0.001120106],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99066895,0.0006470742,0.001317657,0.0014355174,0.004224146,0.0017066417],"domain_scores_gemma":[0.9954944,0.0016173348,0.00024600324,0.0014460242,0.00046420362,0.0007319838],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004049429,0.00081394525,0.0033295285,0.00139613,0.00039731438,0.00026914402,0.0010024675,0.0004323538,0.0008198741],"category_scores_gemma":[0.00034859,0.00057508826,0.0012584841,0.0017776366,0.00049528707,0.00011689135,0.0009524173,0.0019254184,0.0021417667],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000364347,0.0005119275,0.000004927529,0.1688807,0.0019298263,0.00053910987,0.00010912826,2.118371e-7,0.0000013748264,0.0049508302,0.021379016,0.8016565],"study_design_scores_gemma":[0.00097286765,0.0005796075,0.00013501605,0.070177756,0.0020952406,0.000118004624,0.0004304845,0.00001952312,0.000005414918,0.0009578068,0.92404705,0.00046124338],"about_ca_topic_score_codex":0.000112759415,"about_ca_topic_score_gemma":0.0000338026,"teacher_disagreement_score":0.902668,"about_ca_system_score_codex":0.0014237326,"about_ca_system_score_gemma":0.0025987504,"threshold_uncertainty_score":0.99967},"labels":[],"label_agreement":null},{"id":"W4386651916","doi":"10.21203/rs.3.rs-1348366/v1","title":"Whole-Exome Sequencing Identified Mutational Profiles of Urothelial Carcinoma post Kidney Transplantation","year":2022,"lang":"en","type":"preprint","venue":"Research Square","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Kaohsiung Medical University Chung-Ho Memorial Hospital; Universität zu Köln; Kaohsiung Medical University","keywords":"Exome sequencing; Transplantation; Kidney transplantation; Exome; Biology; Single-nucleotide polymorphism; GNAQ; Gene; Cancer research; Bioinformatics; Genetics; Medicine; Mutation; Internal medicine; Genotype","score_opus":0.08415819564510779,"score_gpt":0.37756425922263526,"score_spread":0.29340606357752747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386651916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861605,0.0006368492,0.00007970111,0.0014283499,0.00030840497,0.0034752733,0.003929184,0.00007207613,0.003909665],"genre_scores_gemma":[0.9828515,0.00010201952,0.00068427884,0.000062185034,0.00032595205,0.00096211757,0.012318235,0.000094373274,0.0025993122],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99362844,0.0008030715,0.0007533571,0.000903324,0.003276871,0.0006349591],"domain_scores_gemma":[0.99665636,0.00037623616,0.00024294874,0.0008342171,0.0014303178,0.00045989678],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014813658,0.00037387654,0.00067186245,0.0011601928,0.00027649754,0.00007755294,0.00038476373,0.0002862226,0.001996996],"category_scores_gemma":[0.00050747045,0.00035381096,0.00042704615,0.00051741424,0.00025913396,0.000101188925,0.0004299371,0.0017735059,0.000085007676],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074976096,0.0013810677,0.09350404,0.052543964,0.0011335869,0.012121871,0.016509052,0.0016368598,0.807182,0.0014756942,0.0033178031,0.001696456],"study_design_scores_gemma":[0.006251262,0.0032411497,0.72593147,0.0037361155,0.0006695403,0.0007283594,0.006017139,0.0010862781,0.24904114,0.0015601184,0.00094829354,0.00078912976],"about_ca_topic_score_codex":0.0020454484,"about_ca_topic_score_gemma":0.00003419072,"teacher_disagreement_score":0.63242745,"about_ca_system_score_codex":0.0017283525,"about_ca_system_score_gemma":0.005435363,"threshold_uncertainty_score":0.9998914},"labels":[],"label_agreement":null},{"id":"W4386780831","doi":"10.3390/diagnostics13182955","title":"Predicting Peri-Operative Outcomes in Patients Treated with Percutaneous Thermal Ablation for Small Renal Masses: The SuNS Nephrometry Score","year":2023,"lang":"en","type":"article","venue":"Diagnostics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Ministero della Salute","keywords":"Medicine; Ablation; Suns in alchemy; Logistic regression; Renal function; Percutaneous; Surgery; Urology; Internal medicine; Materials science","score_opus":0.028054723741263304,"score_gpt":0.26545658497846236,"score_spread":0.23740186123719906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386780831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972218,0.000065887376,0.000025695505,0.0004881403,0.00006205718,0.0017311388,0.00009197967,0.00009175623,0.00022153326],"genre_scores_gemma":[0.99824506,0.000048638398,0.000455745,0.0002115066,0.000085490945,0.00013450293,0.0005276137,0.000049252478,0.00024217123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877566,0.00005801286,0.00026910476,0.00027988869,0.0002855951,0.00033171056],"domain_scores_gemma":[0.99795353,0.0014434054,0.00008531038,0.0002569183,0.00017915739,0.00008167987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012863484,0.00022429088,0.00030780458,0.0001613498,0.00013889285,0.000039610153,0.000084399966,0.00008327318,0.00001858642],"category_scores_gemma":[0.00077407283,0.00012717524,0.00009324763,0.00042344377,0.000067280955,0.00005216636,0.000035205667,0.0001664255,0.000016005071],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029067913,0.00018096676,0.99528426,0.000037774746,0.0001608756,0.00028127845,0.0015685332,0.0010970357,0.00014785894,0.000010469077,0.00010545303,0.0008348272],"study_design_scores_gemma":[0.0020170526,0.0018688774,0.99144006,0.00015045967,0.0002707054,0.00002586034,0.0006745799,0.0026731926,0.0006567319,0.000006064831,0.00008095584,0.00013545589],"about_ca_topic_score_codex":0.0001379427,"about_ca_topic_score_gemma":0.00017353514,"teacher_disagreement_score":0.0038441846,"about_ca_system_score_codex":0.00019536143,"about_ca_system_score_gemma":0.000066043416,"threshold_uncertainty_score":0.5186056},"labels":[],"label_agreement":null},{"id":"W4386905206","doi":"10.1016/j.ijrobp.2023.03.073","title":"Radiation Therapy for Renal Cell Carcinoma","year":2023,"lang":"en","type":"letter","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; National Institutes of Health; American Cancer Society","keywords":"Medicine; Renal cell carcinoma; Radiation therapy; Stereotactic radiation therapy; Systemic therapy; Oncology; Internal medicine; Radiology; Radiosurgery; Cancer","score_opus":0.037759084886215905,"score_gpt":0.3272126400363594,"score_spread":0.2894535551501435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386905206","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28638938,0.006698683,0.010502354,0.66481054,0.023856012,0.0036053378,0.0013213377,0.00029188942,0.0025244663],"genre_scores_gemma":[0.49936277,0.006318064,0.006598648,0.3425831,0.12825446,0.00041021698,0.011055582,0.0006359707,0.0047811954],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99640125,0.00035214672,0.0014465975,0.0005573582,0.0007193828,0.00052328606],"domain_scores_gemma":[0.9938481,0.0012631798,0.0026838987,0.00037225126,0.0016577215,0.00017484342],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000706199,0.00057229,0.0012074886,0.00060214347,0.00010861317,0.000058433536,0.00066727906,0.00136095,0.00009246109],"category_scores_gemma":[0.00026629234,0.00049072574,0.001069035,0.0002464224,0.00017972359,0.00021809357,0.00006635469,0.0018210938,0.00012861703],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013322784,0.00047032884,0.029992547,0.000075946526,0.0016827865,0.00086242537,0.00033968166,0.00014550237,0.0036714305,0.0002555156,0.82698673,0.13418482],"study_design_scores_gemma":[0.014332712,0.005739454,0.012489646,0.00008826304,0.00061261037,0.0004599389,0.000023873437,0.00052729,0.011843202,0.0045343926,0.9488784,0.00047019776],"about_ca_topic_score_codex":0.000035429162,"about_ca_topic_score_gemma":0.0000014013561,"teacher_disagreement_score":0.32222745,"about_ca_system_score_codex":0.0023884203,"about_ca_system_score_gemma":0.0017193374,"threshold_uncertainty_score":0.9999355},"labels":[],"label_agreement":null},{"id":"W4387078230","doi":"10.1007/s00345-023-04589-4","title":"Regional differences in clear cell metastatic renal cell carcinoma patients across the USA","year":2023,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"Medizinische Universität Graz; Karl-Franzens-Universität Graz","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Nephrology; Proportional hazards model; Internal medicine; Epidemiology; Cancer registry; Surveillance, Epidemiology, and End Results; Hazard ratio; Oncology; Clear cell renal cell carcinoma; Cancer; Kidney; Confidence interval","score_opus":0.04261454629581528,"score_gpt":0.281305052974068,"score_spread":0.2386905066782527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387078230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99472696,0.00087010016,0.0000055402957,0.0028998957,0.00028855898,0.00020713234,0.0000058597834,0.0000075375424,0.0009884443],"genre_scores_gemma":[0.99661666,0.00014561834,0.000115467265,0.00078003784,0.00015161578,0.000007706776,0.000008425811,0.000021640295,0.002152808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978709,0.00030212323,0.000648401,0.0002080185,0.0004978839,0.0004726775],"domain_scores_gemma":[0.9985768,0.0004473212,0.00041499615,0.00024185279,0.00015299635,0.00016603881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055119884,0.00019567987,0.0005084023,0.0003753491,0.00009258624,0.000017805602,0.0002588421,0.000052725987,0.0001653407],"category_scores_gemma":[0.000048930404,0.000115998424,0.00021333824,0.00058820023,0.00018748564,0.000063195796,0.00008570494,0.00059212977,0.00013235722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001471712,0.00048399752,0.9867677,0.000042214982,0.000065998734,0.001740691,0.0012508957,0.00009525721,0.0011295694,0.000028446088,0.005584868,0.0013386495],"study_design_scores_gemma":[0.0036578316,0.002252501,0.98710316,0.000016633325,0.00015044099,0.0002229211,0.00019665856,0.0000846336,0.0006398932,0.00018289631,0.0053990027,0.00009344373],"about_ca_topic_score_codex":0.0000752383,"about_ca_topic_score_gemma":0.00033723676,"teacher_disagreement_score":0.0021861196,"about_ca_system_score_codex":0.00010017404,"about_ca_system_score_gemma":0.00012988113,"threshold_uncertainty_score":0.47302786},"labels":[],"label_agreement":null},{"id":"W4387117731","doi":"10.1016/j.urolonc.2023.08.014","title":"Survival of patients with clear cell renal carcinoma according to number and location of organ-specific metastatic sites","year":2023,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Lung; Renal cell carcinoma; Proportional hazards model; Metastatic carcinoma; Hazard ratio; Kidney; Internal medicine; Oncology; Pathology; Carcinoma; Confidence interval","score_opus":0.03733585232672881,"score_gpt":0.28734114617499185,"score_spread":0.25000529384826303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387117731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980125,0.00021981564,0.00005587246,0.0006372139,0.0000419417,0.0004258037,0.000021038648,0.00002577085,0.0005600442],"genre_scores_gemma":[0.9806969,0.00008012538,0.018781958,0.00010968225,0.000022662709,0.000027432527,0.000117003925,0.000014918973,0.00014930729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989211,0.00009572109,0.00030314035,0.00028816468,0.0001944538,0.00019745024],"domain_scores_gemma":[0.99888396,0.00030058797,0.00017357612,0.00017021415,0.0002819155,0.00018974577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022408731,0.00015426331,0.0004010897,0.00018424883,0.00008603703,0.0000071378213,0.00005242976,0.00007598275,0.000032619773],"category_scores_gemma":[0.00009732598,0.000116435614,0.000022605678,0.0008651111,0.00037170455,0.00006265705,0.000052508847,0.00012345224,0.000018069459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036451174,0.00016928316,0.9920801,0.00011689254,0.00004283197,0.000041508687,0.00057004986,0.000069283065,0.0050628227,0.00057404605,0.00053903233,0.0003696623],"study_design_scores_gemma":[0.002577016,0.008005954,0.9585188,0.00009343783,0.0005323459,0.00006346805,0.0014690425,0.00024540734,0.013460209,0.0005963401,0.014229182,0.00020882215],"about_ca_topic_score_codex":0.000040026443,"about_ca_topic_score_gemma":0.000011452825,"teacher_disagreement_score":0.0335613,"about_ca_system_score_codex":0.000060370912,"about_ca_system_score_gemma":0.00017105047,"threshold_uncertainty_score":0.47481066},"labels":[],"label_agreement":null},{"id":"W4387206894","doi":"10.1016/j.ijrobp.2023.06.1603","title":"Evaluation of Volumetric Response Assessment from Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Carcinoma (RCC)","year":2023,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"SABR volatility model; Medicine; Nuclear medicine; Ablative case; Renal cell carcinoma; Radiation therapy; Radiosurgery; Radiology; Urology; Internal medicine","score_opus":0.058576262822370266,"score_gpt":0.3905124955094151,"score_spread":0.3319362326870448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387206894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820413,0.0009679175,0.012448783,0.0015170198,0.001648734,0.0008134448,0.00019802773,0.000029410015,0.00033539234],"genre_scores_gemma":[0.98998797,0.00023993291,0.007744489,0.0002087944,0.0013074082,0.00006379112,0.00028178826,0.00004481234,0.00012103231],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961449,0.0011507018,0.0010722532,0.00032669728,0.0010421372,0.0002633453],"domain_scores_gemma":[0.99240357,0.002323942,0.0018174431,0.00024961843,0.0030571173,0.00014830948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037052333,0.00025307384,0.0006921328,0.00066044007,0.00006820314,0.000022445043,0.00031455953,0.000240396,0.00013730302],"category_scores_gemma":[0.0008623603,0.00022214536,0.00042616526,0.00050897815,0.00013060683,0.0002379199,0.000043789194,0.000350254,0.00001700745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01239269,0.001914895,0.47821003,0.000035213827,0.004762795,0.00012771501,0.0023323405,0.0053234235,0.24059531,0.0007022858,0.003510197,0.2500931],"study_design_scores_gemma":[0.028208371,0.008848387,0.8458722,0.00007471145,0.0016965807,0.000093697025,0.00028771782,0.06106798,0.041658692,0.006529079,0.0053774016,0.0002851548],"about_ca_topic_score_codex":0.000049000515,"about_ca_topic_score_gemma":0.0000030124622,"teacher_disagreement_score":0.3676622,"about_ca_system_score_codex":0.0033022987,"about_ca_system_score_gemma":0.0021948311,"threshold_uncertainty_score":0.9058825},"labels":[],"label_agreement":null},{"id":"W4387207934","doi":"10.1016/j.ijrobp.2023.06.402","title":"Final Results from a Prospective Randomized Pilot Trial of Stereotactic Body Radiation Therapy vs. Radiofrequency Ablation for the Management of Small Renal Masses (RADSTER)","year":2023,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; Juravinski Cancer Centre","funders":"Janssen Pharmaceuticals; Genentech; Foundation Medicine; MacroGenics; Puma Biotechnology; Astellas Pharma; Calithera Biosciences; Taiho Pharmaceutical; Sanofi; Exelixis; Plexxikon; RefleXion Medical; Varian Medical Systems; Boston Scientific Corporation; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer","keywords":"Medicine; Radiofrequency ablation; Randomized controlled trial; Renal cell carcinoma; Radiosurgery; Radiology; Randomization; Nuclear medicine; Surgery; Ablation; Radiation therapy; Internal medicine","score_opus":0.05752484497081614,"score_gpt":0.3417719020044442,"score_spread":0.28424705703362807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387207934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98032665,0.0009754591,0.009601509,0.0029387805,0.002268654,0.0032135567,0.00024640767,0.00003529391,0.00039370864],"genre_scores_gemma":[0.9894699,0.0045129037,0.0034920422,0.00011446458,0.0016758279,0.0001804846,0.0004271767,0.0000315033,0.00009573366],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99690104,0.00046629252,0.0016481981,0.00029730436,0.00047665843,0.00021050384],"domain_scores_gemma":[0.9927287,0.0031209767,0.0029194164,0.00026098287,0.0008983599,0.00007155391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018052802,0.00024661742,0.0009418451,0.0002798036,0.000069718546,0.000022148713,0.00034697758,0.00014811206,0.00002106774],"category_scores_gemma":[0.0004829334,0.00016946589,0.0005305019,0.000271692,0.00022166243,0.00019151175,0.000039754414,0.0002656555,0.000005705277],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8601242,0.0013157445,0.0141397435,0.00003937881,0.007607318,0.00004750319,0.0011639216,0.00094073673,0.0058589275,0.005653059,0.00035719338,0.10275232],"study_design_scores_gemma":[0.86660486,0.011067134,0.07823527,0.00019918257,0.0014322425,0.00004920661,0.00011435272,0.0067705447,0.013307721,0.018972743,0.0030373323,0.00020938221],"about_ca_topic_score_codex":0.00007918051,"about_ca_topic_score_gemma":0.0000025702884,"teacher_disagreement_score":0.10254294,"about_ca_system_score_codex":0.00065734447,"about_ca_system_score_gemma":0.0004159698,"threshold_uncertainty_score":0.69106185},"labels":[],"label_agreement":null},{"id":"W4387208066","doi":"10.1016/j.ijrobp.2023.06.405","title":"5-Year Renal Function Outcomes after SABR for Primary Renal Cell Carcinoma: A Report from the International Radiosurgery Oncology Consortium of the Kidney (IROCK)","year":2023,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Juravinski Cancer Centre; McGill University Health Centre; Ottawa Hospital; McMaster University; Cancer Care Ontario","funders":"","keywords":"SABR volatility model; Medicine; Renal cell carcinoma; Radiosurgery; Renal function; Internal medicine; Oncology; Urology; Radiation therapy","score_opus":0.02310139189914373,"score_gpt":0.29676980389416896,"score_spread":0.27366841199502523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387208066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96778977,0.0003529972,0.002613362,0.019012176,0.0077782567,0.000671127,0.0004380134,0.000042897344,0.0013014086],"genre_scores_gemma":[0.9899771,0.00015736143,0.0013927785,0.0036133686,0.0034251183,0.00009774676,0.00068998826,0.000047399837,0.0005991002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967065,0.00034299985,0.0015210102,0.00039686254,0.00071063905,0.000322015],"domain_scores_gemma":[0.99403083,0.0018413254,0.0022963623,0.00042016368,0.0012291754,0.00018213522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012015962,0.00030948792,0.0007920363,0.00022603461,0.00011490007,0.000028695833,0.000656013,0.0003362675,0.0001386118],"category_scores_gemma":[0.0010398627,0.00019508624,0.00085967407,0.0002692858,0.00034588686,0.00020401322,0.00020424818,0.00059941085,0.000028930977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034966515,0.00057602715,0.91987115,0.000017524731,0.001524162,0.00028769267,0.00040933734,0.0001733898,0.026826922,0.00043256336,0.03436852,0.012016066],"study_design_scores_gemma":[0.008508141,0.0010216031,0.8613595,0.000074376,0.0007667024,0.0005379149,0.00014707021,0.00030958993,0.010907899,0.0033716226,0.1127931,0.00020251608],"about_ca_topic_score_codex":0.00006073949,"about_ca_topic_score_gemma":0.000009805296,"teacher_disagreement_score":0.07842458,"about_ca_system_score_codex":0.0014679821,"about_ca_system_score_gemma":0.0021805998,"threshold_uncertainty_score":0.7955386},"labels":[],"label_agreement":null},{"id":"W4387247482","doi":"10.48083/imbm6087","title":"Role of Cryoablation for the Treatment of cT1b Kidney Lesions: Outcomes of a Systematic Review","year":2023,"lang":"en","type":"review","venue":"Société Internationale d’Urologie Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cryoablation; Nephrectomy; Cryosurgery; Internal medicine; General surgery; Surgery; Kidney; Ablation","score_opus":0.2087439719006484,"score_gpt":0.4362328902225536,"score_spread":0.22748891832190524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387247482","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000087259396,0.9935875,0.000071871385,0.0004755895,0.00032936703,0.0049416497,0.0002859271,0.00001627169,0.0002045787],"genre_scores_gemma":[0.00021078835,0.99663013,0.00029315887,0.00008622309,0.00014026104,0.0008019872,0.00019005354,0.000042741427,0.0016046822],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9960177,0.0002947095,0.0025182415,0.000226308,0.00074581645,0.00019722292],"domain_scores_gemma":[0.9912882,0.0035596334,0.0037663889,0.0005198757,0.0007618588,0.00010407449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000970226,0.00038284904,0.003863141,0.0003153069,0.00006381251,0.00001079626,0.0004112408,0.00019769928,0.00010553634],"category_scores_gemma":[0.0027849113,0.00018864428,0.0028637706,0.00022552145,0.00010288195,0.000046111425,0.000046851954,0.00021906472,0.000008415199],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085644155,0.00085433613,0.00037843568,0.8980129,0.012525397,0.000019634725,0.00018883416,0.000007614567,0.000008774655,0.0003738062,0.001093541,0.0864511],"study_design_scores_gemma":[0.0031012334,0.004015275,0.00091514504,0.80690557,0.06301947,0.0006676615,0.00044223008,0.0001105191,0.00008407161,0.0012812881,0.119080864,0.00037664422],"about_ca_topic_score_codex":0.000015611444,"about_ca_topic_score_gemma":0.0000017510101,"teacher_disagreement_score":0.11798733,"about_ca_system_score_codex":0.00052076275,"about_ca_system_score_gemma":0.00077676284,"threshold_uncertainty_score":0.76926905},"labels":[],"label_agreement":null},{"id":"W4387305055","doi":"10.48083/gwsk7789","title":"The LARCG Latin American Renal Cancer Group: Achievements in Support, Teaching, Research, Collaboration, and Advocacy","year":2023,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Latin Americans; Accreditation; Political science; Medicine; Public administration; Public relations; Medical education; Law","score_opus":0.07751511861963112,"score_gpt":0.43266621356222223,"score_spread":0.3551510949425911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387305055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9632995,0.00040033762,0.000019606954,0.03158478,0.00033310807,0.0003626218,0.000020476842,0.000043704997,0.003935843],"genre_scores_gemma":[0.98831713,0.0026175636,0.0002265488,0.00085428753,0.00047223354,0.00012130856,0.000072726936,0.000021771086,0.007296404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99727076,0.00048857456,0.00048067694,0.000280328,0.000990024,0.0004896455],"domain_scores_gemma":[0.9982375,0.00079260726,0.00025045595,0.0001859362,0.00036568617,0.00016779405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026122092,0.00015931558,0.00024055163,0.00038212625,0.0005524032,0.00016706857,0.00025371663,0.00006296528,0.00013953129],"category_scores_gemma":[0.0009872215,0.00010886352,0.000084940926,0.00049870746,0.0003408993,0.00015053539,0.00018058211,0.0011364553,0.000026222418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011324075,0.00027757126,0.84906906,0.000018118673,0.00041992706,0.0008074194,0.0026892747,0.00015242795,0.002280766,0.0012569014,0.07939841,0.06249769],"study_design_scores_gemma":[0.002572571,0.001132342,0.8952733,0.000052316216,0.000038829072,0.000112489906,0.0042888587,0.00054557115,0.00024172451,0.003176131,0.092434704,0.00013116373],"about_ca_topic_score_codex":0.00033651697,"about_ca_topic_score_gemma":0.0007025502,"teacher_disagreement_score":0.062366527,"about_ca_system_score_codex":0.0006101122,"about_ca_system_score_gemma":0.0004382562,"threshold_uncertainty_score":0.4937396},"labels":[],"label_agreement":null},{"id":"W4387320120","doi":"10.48083/sdmv1045","title":"Imaging of Renal Cell Carcinoma","year":2022,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Renal cell carcinoma; Magnetic resonance imaging; Medicine; Radiology; Ultrasound; Pathology","score_opus":0.03432666809185274,"score_gpt":0.2951699771672022,"score_spread":0.26084330907534947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387320120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9644112,0.0016003811,0.00026924038,0.002476311,0.00066137646,0.00016451739,0.000028680754,0.000025042702,0.030363252],"genre_scores_gemma":[0.9943568,0.000038501115,0.00074024725,0.0007556978,0.00031556532,0.000025255133,0.000044808978,0.000019007559,0.0037040901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980592,0.00013893978,0.0004805851,0.00021045447,0.00085019134,0.00026061112],"domain_scores_gemma":[0.99886024,0.00015024119,0.0004050161,0.00019858635,0.00025993728,0.00012599221],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048611028,0.00015332959,0.00028131143,0.00025808366,0.00021785857,0.000020209338,0.00028887088,0.000031632302,0.0034223385],"category_scores_gemma":[0.000085175474,0.00013631704,0.0003566182,0.00013301223,0.000081120765,0.000088198765,0.00022755278,0.0006881604,0.0000103172915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001275186,0.0011539055,0.9022561,0.00005305638,0.00034071133,0.0028210892,0.00088105764,0.0015201127,0.05593174,0.00048128312,0.024133652,0.009152161],"study_design_scores_gemma":[0.011882899,0.0035382954,0.8439688,0.000035046003,0.00057023857,0.015298644,0.004009166,0.0026268815,0.074800834,0.0043544737,0.038401578,0.0005131528],"about_ca_topic_score_codex":0.000020766674,"about_ca_topic_score_gemma":5.701475e-7,"teacher_disagreement_score":0.05828726,"about_ca_system_score_codex":0.0005791799,"about_ca_system_score_gemma":0.00032308695,"threshold_uncertainty_score":0.9974887},"labels":[],"label_agreement":null},{"id":"W4387320122","doi":"10.48083/xbcx3386","title":"Kidney Cancer Screening and Epidemiology","year":2022,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Overdiagnosis; Medicine; Intensive care medicine; Lung cancer screening; Cancer screening; Stage (stratigraphy); Cancer; Kidney disease; Kidney cancer; Disease; Epidemiology; Renal cell carcinoma; Dipstick; False positive paradox; Lung cancer; Oncology; Internal medicine; Urinary system; Computer science","score_opus":0.12066025870603114,"score_gpt":0.38406506332842016,"score_spread":0.263404804622389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387320122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94265556,0.0053208754,0.00090284174,0.04433744,0.0010182247,0.00019587553,0.000056697798,0.000045013017,0.005467493],"genre_scores_gemma":[0.9777618,0.00083503354,0.0028621145,0.013507136,0.00060276437,0.00008385125,0.000053271568,0.000016230522,0.0042777853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852246,0.00026213878,0.00037064086,0.00023150689,0.00033405496,0.000279202],"domain_scores_gemma":[0.99879515,0.00044059902,0.00026310585,0.00011365101,0.00012901436,0.00025848672],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008791805,0.0001345807,0.00030581615,0.00015452337,0.0003414111,0.000015111686,0.00015047492,0.00005327047,0.0035092458],"category_scores_gemma":[0.00082560134,0.0001127642,0.00015617129,0.000084467596,0.0000922238,0.00006917279,0.00021740305,0.0007732486,0.0000040829286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005367203,0.00013408661,0.9328854,0.000013938269,0.00062689197,0.00049904245,0.00021493282,0.00076125236,0.0008455575,0.00069892104,0.038389225,0.024394017],"study_design_scores_gemma":[0.0049559763,0.0013987208,0.75082517,0.000040730083,0.00028058057,0.009868643,0.00085485645,0.002417615,0.00027406524,0.005043985,0.22378431,0.0002553719],"about_ca_topic_score_codex":0.000055463035,"about_ca_topic_score_gemma":0.000001929295,"teacher_disagreement_score":0.18539509,"about_ca_system_score_codex":0.00038987107,"about_ca_system_score_gemma":0.0002567703,"threshold_uncertainty_score":0.99740165},"labels":[],"label_agreement":null},{"id":"W4387320129","doi":"10.48083/ueml5802","title":"Ablative Therapies for Localized Primary Renal Cell Carcinoma","year":2022,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Cancer Council Victoria; Australian Government","keywords":"Cryoablation; SABR volatility model; Medicine; Microwave ablation; Renal cell carcinoma; Ablative case; Radiofrequency ablation; Nephrectomy; Ablation; Surgery; Radiation therapy; Radiosurgery; Radiology; Kidney; Urology; Internal medicine","score_opus":0.04523251847998053,"score_gpt":0.30297306610519414,"score_spread":0.2577405476252136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387320129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96823055,0.003217875,0.0025842942,0.005045838,0.0009090808,0.00074429135,0.00010490987,0.000059701022,0.019103466],"genre_scores_gemma":[0.9818439,0.00008948298,0.0036916684,0.0027020816,0.0006061525,0.00025990262,0.00020661952,0.000035276706,0.010564898],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99782133,0.00019933643,0.00048836786,0.00031659356,0.0008034092,0.0003709397],"domain_scores_gemma":[0.99842846,0.00047381723,0.00039067454,0.0002034789,0.000352004,0.0001515774],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006380112,0.00023613153,0.0003964557,0.00022451248,0.0005006102,0.00004963705,0.00031366124,0.00007317084,0.0022138422],"category_scores_gemma":[0.00010038531,0.0001965308,0.00051669055,0.00012227314,0.000103920596,0.00011754371,0.00017271451,0.0007006772,0.00001059744],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0370259,0.0075336467,0.4585023,0.00044449835,0.006722521,0.0051949574,0.013422116,0.0059039854,0.13098256,0.004938452,0.25386068,0.0754684],"study_design_scores_gemma":[0.042551175,0.016618464,0.42148605,0.000048701397,0.0012033728,0.0073250085,0.0074722786,0.0027306268,0.028871832,0.024376098,0.4461303,0.0011860791],"about_ca_topic_score_codex":0.00001112194,"about_ca_topic_score_gemma":0.0000010123274,"teacher_disagreement_score":0.19226964,"about_ca_system_score_codex":0.0011999692,"about_ca_system_score_gemma":0.00047793705,"threshold_uncertainty_score":0.9986983},"labels":[],"label_agreement":null},{"id":"W4387320130","doi":"10.48083/syab9165","title":"Management of Toxicity and Side Effects of Systemic Therapy for Renal Cell Carcinoma","year":2022,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Pneumonitis; Cancer; Toxicity; Stomatitis; Adverse effect; Pulmonary toxicity; Sunitinib; Internal medicine; Intensive care medicine; Oncology; Lung","score_opus":0.02697694222755281,"score_gpt":0.28897241463337964,"score_spread":0.2619954724058268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387320130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903308,0.005436142,0.000527226,0.00033851303,0.00034360404,0.00073753216,0.000026892309,0.000009904501,0.0022493615],"genre_scores_gemma":[0.99701166,0.0006181873,0.0010794572,0.00013967515,0.000092675815,0.00011252707,0.000017725464,0.000014111562,0.00091397035],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986162,0.00011144552,0.00043119284,0.00018216045,0.00048849103,0.00017049411],"domain_scores_gemma":[0.9988282,0.0003355303,0.00044001278,0.00014543101,0.00018067498,0.00007016991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041429626,0.00013520132,0.0003359948,0.0001484857,0.000105985106,0.000008296156,0.0001708281,0.000040856874,0.000054383447],"category_scores_gemma":[0.000031607007,0.0001117415,0.00024322385,0.00007088806,0.000060143073,0.000040667597,0.000120215234,0.00022322696,3.59363e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013193083,0.0055283722,0.22432144,0.00493936,0.0047758617,0.0027106518,0.0034620215,0.0015363668,0.6344524,0.0030827925,0.0032710799,0.09872658],"study_design_scores_gemma":[0.03019119,0.014131991,0.5277923,0.00030538032,0.00077488227,0.0029585354,0.0031737296,0.00063359865,0.41503018,0.0033280484,0.0013274963,0.00035270577],"about_ca_topic_score_codex":0.000007923834,"about_ca_topic_score_gemma":2.2522403e-7,"teacher_disagreement_score":0.30347082,"about_ca_system_score_codex":0.00025440345,"about_ca_system_score_gemma":0.000085585554,"threshold_uncertainty_score":0.4556686},"labels":[],"label_agreement":null},{"id":"W4387320131","doi":"10.48083/egwh6536","title":"Management of Locally Advanced Renal Cell Carcinoma","year":2022,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Inferior vena cava; Thrombus; Nephrectomy; Perioperative; Deep hypothermic circulatory arrest; Surgery; Renal vein; Cardiopulmonary bypass; Radiology; Cardiology; Internal medicine; Kidney","score_opus":0.02807514032585442,"score_gpt":0.2910592605138321,"score_spread":0.2629841201879777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387320131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9484241,0.0013314814,0.000552549,0.001374258,0.0006233122,0.00032322714,0.000028228214,0.000028043043,0.047314785],"genre_scores_gemma":[0.9869761,0.00014568762,0.0034521944,0.00043353747,0.0001426531,0.00006252451,0.000063121755,0.000020807434,0.008703375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780256,0.000113006485,0.0005363795,0.00025623094,0.0010066712,0.0002851857],"domain_scores_gemma":[0.99889475,0.00008938928,0.00040960032,0.00024414377,0.00022683055,0.0001352894],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041115118,0.00017964237,0.00030303272,0.00020529785,0.00019606456,0.000016019021,0.00034804727,0.000043770066,0.0024061797],"category_scores_gemma":[0.000020537453,0.00016078773,0.0003423183,0.00015921307,0.00007174493,0.000079967576,0.00030281732,0.00058930006,0.000013439729],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02056312,0.010709906,0.44576454,0.0010140536,0.005918338,0.042043906,0.002950521,0.039085224,0.08343832,0.009532126,0.04673344,0.29224652],"study_design_scores_gemma":[0.02945122,0.012024123,0.80468774,0.00014822134,0.0011663772,0.007971693,0.008071977,0.0014113567,0.056186926,0.006095338,0.07193639,0.00084866316],"about_ca_topic_score_codex":0.0000062545523,"about_ca_topic_score_gemma":4.3941128e-7,"teacher_disagreement_score":0.35892317,"about_ca_system_score_codex":0.0006643881,"about_ca_system_score_gemma":0.00018236012,"threshold_uncertainty_score":0.9985058},"labels":[],"label_agreement":null},{"id":"W4387320133","doi":"10.48083/vsqg7437","title":"Neoadjuvant and Adjuvant Therapy for Renal Cell Carcinoma","year":2022,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Australian and New Zealand Urogenital and Prostate Cancer Trials Group; Ipsen; Eisai; University of Cambridge; American Society of Clinical Oncology; AstraZeneca; American College of Radiology Imaging Network; U.S. Department of Defense; Exelixis; Pfizer; ECOG-ACRIN Cancer Research Group; National Cancer Institute; Macmillan Cancer Support","keywords":"Medicine; Adjuvant therapy; Adjuvant; Renal cell carcinoma; Perioperative; Oncology; Kidney cancer; Neoadjuvant therapy; Targeted therapy; Internal medicine; Pazopanib; Systemic therapy; Disease; Cancer; Sunitinib; Surgery; Breast cancer","score_opus":0.0473745344043642,"score_gpt":0.30490400479293034,"score_spread":0.25752947038856616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387320133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98343575,0.0060605174,0.0003988741,0.0049306634,0.0007248108,0.000589021,0.000057367706,0.000036047764,0.0037669432],"genre_scores_gemma":[0.9909499,0.00042755425,0.0014356076,0.0019951323,0.0005557962,0.00018047595,0.00009149065,0.00002984883,0.0043341806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982093,0.000116238094,0.00041265864,0.0003185819,0.0006004274,0.0003428129],"domain_scores_gemma":[0.99884653,0.00027605458,0.00028298373,0.00018014881,0.00022679621,0.00018747001],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00054642366,0.0002140367,0.00033989016,0.00019371275,0.00045580097,0.0000528274,0.00022180195,0.00006279096,0.0010448658],"category_scores_gemma":[0.00007466045,0.00017352121,0.00031357724,0.00007984851,0.00007744541,0.000089611814,0.00015146032,0.00059313956,0.000004447018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016229065,0.0037036785,0.55486673,0.00012142864,0.0016196982,0.003800975,0.0037213282,0.0012101381,0.10319677,0.0017239806,0.097433314,0.21237291],"study_design_scores_gemma":[0.03493328,0.01795863,0.637333,0.00002924342,0.00042355817,0.012659185,0.0030617984,0.0027923135,0.027440365,0.00866276,0.25393042,0.0007754472],"about_ca_topic_score_codex":0.00001289426,"about_ca_topic_score_gemma":0.0000012922923,"teacher_disagreement_score":0.21159747,"about_ca_system_score_codex":0.00044449806,"about_ca_system_score_gemma":0.00027971188,"threshold_uncertainty_score":0.99986833},"labels":[],"label_agreement":null},{"id":"W4387320137","doi":"10.48083/kgtq6832","title":"Therapies in Refractory Metastatic Renal Cell Carcinoma","year":2022,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Refractory (planetary science); Medicine; Renal cell carcinoma; Immunotherapy; Disease; Clinical trial; Oncology; Adjuvant; Radiation therapy; Targeted therapy; Internal medicine; Cancer research; Cancer; Biology","score_opus":0.05370022399882229,"score_gpt":0.31168897031923004,"score_spread":0.25798874632040775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387320137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799428,0.0035857088,0.00006877211,0.0031174715,0.0006178456,0.00026212083,0.000022561224,0.000030550233,0.012352169],"genre_scores_gemma":[0.99215406,0.00015721032,0.0008983283,0.0013045468,0.00024451176,0.000085813546,0.000056216206,0.000025620944,0.0050737006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976071,0.00034566922,0.00053378026,0.00027947186,0.00088468485,0.00034926287],"domain_scores_gemma":[0.9988997,0.0002900124,0.00031900985,0.0002165468,0.0001427973,0.00013195211],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00074943574,0.00020840895,0.0003485744,0.0004138177,0.00022585124,0.000040071194,0.0003089009,0.00004464182,0.0041951053],"category_scores_gemma":[0.00010521089,0.00017714848,0.00029492212,0.00019122267,0.00007295591,0.00013576467,0.00016784752,0.001163262,0.000023234807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004375222,0.005151791,0.8645023,0.00010312046,0.0011322823,0.017299505,0.006689215,0.0030452155,0.046494577,0.0008372477,0.025459362,0.024910128],"study_design_scores_gemma":[0.012751719,0.005184215,0.8850479,0.000028458018,0.00030225856,0.0068384456,0.0071782875,0.00070108747,0.005619226,0.005926775,0.06990222,0.0005193818],"about_ca_topic_score_codex":0.00004125328,"about_ca_topic_score_gemma":0.000007385912,"teacher_disagreement_score":0.044442862,"about_ca_system_score_codex":0.0011891027,"about_ca_system_score_gemma":0.00039052288,"threshold_uncertainty_score":0.9967152},"labels":[],"label_agreement":null},{"id":"W4387320142","doi":"10.48083/cbto5325","title":"Hereditary Renal Cell Carcinoma Syndromes","year":2022,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Cancer; Germline; Germline mutation; Histopathology; Oncology; Kidney cancer; Intensive care medicine; Internal medicine; Pathology; Mutation; Biology; Genetics; Gene","score_opus":0.04636638363246739,"score_gpt":0.2928246264216843,"score_spread":0.24645824278921688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387320142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96052015,0.0023234705,0.00008957546,0.004598082,0.001602335,0.00024718686,0.000049361428,0.00006539964,0.03050445],"genre_scores_gemma":[0.98374665,0.00006467458,0.0007976843,0.0016012506,0.00084863923,0.00006776916,0.0001279716,0.000031574735,0.012713793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974147,0.0002016653,0.0004993558,0.00033145252,0.0011449163,0.0004078831],"domain_scores_gemma":[0.9987733,0.00020285886,0.0003046224,0.00026763903,0.00021313337,0.00023844306],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00051011203,0.00023922414,0.00034888653,0.00028574356,0.00046939094,0.000048469086,0.00039919498,0.00007556517,0.008044907],"category_scores_gemma":[0.000090615176,0.0002106435,0.00045239678,0.000165548,0.00008483033,0.00013727548,0.00030900526,0.0011783713,0.00006162473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033773528,0.0036691353,0.6014254,0.00012788211,0.001655371,0.051612396,0.001781592,0.0031565654,0.018556455,0.00079220894,0.2967912,0.017054414],"study_design_scores_gemma":[0.01208002,0.008052458,0.7518941,0.000033233424,0.0006550739,0.08519006,0.003922918,0.0009787119,0.009984515,0.005076751,0.12134278,0.0007893443],"about_ca_topic_score_codex":0.00002513546,"about_ca_topic_score_gemma":0.000001430298,"teacher_disagreement_score":0.17544843,"about_ca_system_score_codex":0.0010542712,"about_ca_system_score_gemma":0.00043654896,"threshold_uncertainty_score":0.99286187},"labels":[],"label_agreement":null},{"id":"W4387322507","doi":"10.48083/blpv3411","title":"Genetics and Tumor Microenvironment of Renal Cell Carcinoma","year":2022,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health","keywords":"Renal cell carcinoma; Clear cell renal cell carcinoma; Biology; Disease; Tumor microenvironment; Kidney cancer; Cancer; Cell; Cancer research; Pathology; Medicine; Genetics","score_opus":0.02733671963473575,"score_gpt":0.2635427494614896,"score_spread":0.23620602982675384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387322507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911505,0.0039548343,0.00008661766,0.0011378998,0.00026903054,0.0001917705,0.000036727022,0.000009132146,0.003163503],"genre_scores_gemma":[0.9958805,0.00024191113,0.001285014,0.0006258256,0.00016448557,0.000021885748,0.00002622734,0.00001611741,0.0017380236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984801,0.000106519525,0.00040220513,0.00020643341,0.0005965959,0.00020814303],"domain_scores_gemma":[0.99921507,0.00009709738,0.00032286134,0.00015994378,0.000075528194,0.00012949065],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002928921,0.00014547394,0.00025096783,0.00014395216,0.00016301118,0.000015056343,0.00017378101,0.00003123553,0.0013384429],"category_scores_gemma":[0.00002860584,0.0001296093,0.0001748351,0.00005683038,0.000110824374,0.000035575504,0.00026042125,0.00046551894,0.0000041473327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011856398,0.0012696205,0.78968817,0.00008017967,0.00040851015,0.0020048146,0.0008891013,0.0014608594,0.18964222,0.00011947937,0.0069648502,0.006286525],"study_design_scores_gemma":[0.0062047997,0.0044802614,0.86486685,0.000016084063,0.0003673387,0.008563527,0.0014892416,0.0007143663,0.088523954,0.0009627052,0.023546694,0.0002641964],"about_ca_topic_score_codex":0.00000796747,"about_ca_topic_score_gemma":5.735943e-7,"teacher_disagreement_score":0.101118274,"about_ca_system_score_codex":0.00040036676,"about_ca_system_score_gemma":0.00013983047,"threshold_uncertainty_score":0.9995745},"labels":[],"label_agreement":null},{"id":"W4387393316","doi":"10.1097/spc.0000000000000675","title":"Perioperative systemic therapy in renal cell carcinoma","year":2023,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Cancer Centre; Dalhousie University","funders":"","keywords":"Medicine; Pembrolizumab; Renal cell carcinoma; Perioperative; Nephrectomy; Oncology; Internal medicine; Adjuvant; Kidney cancer; Adjuvant therapy; Systemic therapy; Disease; Immunotherapy; Intensive care medicine; Surgery; Cancer; Kidney","score_opus":0.2226154718640314,"score_gpt":0.42616433033419276,"score_spread":0.20354885847016135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387393316","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010328448,0.9836049,0.0000034837228,0.000011866685,0.0012365103,0.0040194583,0.00040909764,0.00003696872,0.00034925208],"genre_scores_gemma":[0.0117019145,0.9835133,0.000013828175,0.000008167517,0.0003673066,0.0013576673,0.002716274,0.000104908606,0.00021662573],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99618053,0.0005114822,0.001241029,0.0010971524,0.00041929344,0.0005505104],"domain_scores_gemma":[0.9983003,0.00026752515,0.0004986,0.00039653396,0.00030094263,0.00023611046],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021483884,0.0008662483,0.0026541387,0.00076240714,0.000066097346,0.000040564635,0.00016043254,0.00036257168,0.00006963558],"category_scores_gemma":[0.00005496768,0.00063983037,0.0004943517,0.0008285819,0.00013464711,0.00007819469,0.00012180479,0.0009956878,0.00010216588],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028219135,0.00047796135,0.11122988,0.19187848,0.0002709457,0.0005275523,0.024080254,0.0000020487998,0.000005831026,0.00013997771,0.0006534712,0.6704514],"study_design_scores_gemma":[0.006831907,0.0025107907,0.04772013,0.1624454,0.00047052154,0.000070337475,0.008097406,0.000010578333,0.00005418534,0.000013123937,0.7702606,0.0015150574],"about_ca_topic_score_codex":0.00004486761,"about_ca_topic_score_gemma":0.000012546345,"teacher_disagreement_score":0.7696071,"about_ca_system_score_codex":0.0011283142,"about_ca_system_score_gemma":0.001003739,"threshold_uncertainty_score":0.9996053},"labels":[],"label_agreement":null},{"id":"W4387467433","doi":"10.1007/978-981-99-2341-0_5","title":"Adjuvant Treatment and Follow-Up of Clinically Localized Renal Cell Carcinoma","year":2023,"lang":"en","type":"book-chapter","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Nomogram; Adjuvant; Internal medicine; Systemic therapy; Adjuvant therapy; Angiogenesis inhibitor; Kidney cancer; Tyrosine-kinase inhibitor; Disease; Pazopanib; Angiogenesis; Cancer; Sunitinib","score_opus":0.053755137501732976,"score_gpt":0.28192322102772793,"score_spread":0.22816808352599496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387467433","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.078109436,0.0035812065,0.000031598494,0.00028459568,0.00043064833,0.0019336406,0.00015504472,0.00017804078,0.9152958],"genre_scores_gemma":[0.18179582,0.0016590153,0.00096532464,0.000105809406,0.00017457074,0.00003713097,0.00027927238,0.00016396608,0.8148191],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968653,0.00003322714,0.001344517,0.0008651482,0.000519969,0.00037186206],"domain_scores_gemma":[0.9976323,0.00031964938,0.00047726178,0.0009217559,0.0001924768,0.0004565152],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021576666,0.00073225517,0.0019041194,0.00028435214,0.0000446081,0.000013030836,0.000111426336,0.0005707027,0.000949754],"category_scores_gemma":[0.000029837543,0.00050634274,0.0007844219,0.000046372545,0.00023860994,0.000022876473,0.00013583786,0.0002861951,0.0003498801],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.077080384,0.007276347,0.109966256,0.014564016,0.02406752,0.051849194,0.0057876683,0.000028658624,0.035449717,0.080569096,0.10729024,0.4860709],"study_design_scores_gemma":[0.18231088,0.12753941,0.025902905,0.0051774513,0.0377367,0.0020422658,0.0005221352,0.00042935743,0.089288525,0.013245438,0.5096227,0.006182247],"about_ca_topic_score_codex":0.0002925978,"about_ca_topic_score_gemma":0.00007616123,"teacher_disagreement_score":0.47988865,"about_ca_system_score_codex":0.00030703295,"about_ca_system_score_gemma":0.0004198831,"threshold_uncertainty_score":0.9999635},"labels":[],"label_agreement":null},{"id":"W4387472933","doi":"10.1245/s10434-023-14367-6","title":"Prognostic Significance of Pathologic Lymph Node Invasion in Metastatic Renal Cell Carcinoma in the Immunotherapy Era","year":2023,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"Medizinische Universität Graz","keywords":"Medicine; Renal cell carcinoma; Proportional hazards model; Internal medicine; Lymph node; Hazard ratio; Stage (stratigraphy); Oncology; Surgical oncology; Surveillance, Epidemiology, and End Results; Cancer; Urology; Cancer registry; Confidence interval","score_opus":0.1030713992642026,"score_gpt":0.35044990493315653,"score_spread":0.24737850566895392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387472933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870898,0.0015968373,0.0000028626598,0.0057676146,0.000043148062,0.0007651542,0.000010663828,0.000014642641,0.004709244],"genre_scores_gemma":[0.99670327,0.0023322585,0.00022875734,0.0004280372,0.000023883384,0.00015654242,0.000036116773,0.00001583561,0.00007530412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744785,0.0007448675,0.00075536047,0.00030929755,0.00034746501,0.00039513546],"domain_scores_gemma":[0.9974895,0.0017425304,0.0002513576,0.0003430049,0.000109409804,0.000064172564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014947654,0.00018344367,0.00079877983,0.0003260857,0.000020384365,0.0000033563624,0.00020540819,0.00013159147,0.00006600132],"category_scores_gemma":[0.000075623335,0.00011411374,0.00018619341,0.0009170018,0.00023379698,0.000038388094,0.00004978249,0.00025311657,0.000027593003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00815231,0.0082246205,0.70765203,0.0009849118,0.00014339927,0.05294822,0.005480895,0.0012153494,0.16314769,0.0006157623,0.001346818,0.050088003],"study_design_scores_gemma":[0.0056762905,0.0036652612,0.9497056,0.00012266335,0.000053505893,0.00029267775,0.00060356513,0.00017210479,0.036023643,0.0007604847,0.002779328,0.00014486391],"about_ca_topic_score_codex":0.00028091896,"about_ca_topic_score_gemma":0.000022401986,"teacher_disagreement_score":0.2420536,"about_ca_system_score_codex":0.00007016521,"about_ca_system_score_gemma":0.00029738457,"threshold_uncertainty_score":0.4653423},"labels":[],"label_agreement":null},{"id":"W4387521049","doi":"10.1016/j.eururo.2023.09.019","title":"Reply to Qingpeng Xie and Dianqiu Shen’s Letter to the Editor re: Bhavan P. Rai, José Luis Dominguez Escrig, Luís Vale, et al. Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria. Eur Urol 2022;82:182–92","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Medicine; Incidence (geometry); Gynecology","score_opus":0.011327997176141568,"score_gpt":0.22288268496382999,"score_spread":0.2115546877876884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387521049","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79773253,0.008370127,0.000049129325,0.17673205,0.002308535,0.013596012,0.0008735472,0.00005352388,0.0002845672],"genre_scores_gemma":[0.38330185,0.0021383055,0.00025132892,0.6077491,0.0040151766,0.0006489395,0.00020232842,0.00048560314,0.0012073339],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9943808,0.0020936718,0.0011461109,0.0010830719,0.0007398398,0.00055654044],"domain_scores_gemma":[0.9954023,0.001461551,0.0011931072,0.0013711705,0.00034914206,0.00022277655],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016284548,0.0006928597,0.0016854759,0.0002434489,0.0001711286,0.00004253463,0.00049778796,0.00017751034,0.000012322214],"category_scores_gemma":[0.001934798,0.0003756774,0.00020784116,0.00028670474,0.00035819883,0.00007021607,0.0004922035,0.0011885342,0.0000071726545],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042493435,0.000026598815,0.033873167,0.03772681,0.00029982039,0.00023330629,0.0021760012,0.0000088961515,0.00014016674,4.150063e-7,0.92506504,0.000024872053],"study_design_scores_gemma":[0.009683061,0.01034075,0.5001317,0.066279136,0.015298527,0.00023083675,0.00027041306,0.000057732297,0.0012181869,0.000010719936,0.39446795,0.0020109233],"about_ca_topic_score_codex":0.0008569412,"about_ca_topic_score_gemma":0.00014759366,"teacher_disagreement_score":0.53059703,"about_ca_system_score_codex":0.0001354379,"about_ca_system_score_gemma":0.0001478161,"threshold_uncertainty_score":0.9998695},"labels":[],"label_agreement":null},{"id":"W4387538492","doi":"10.1016/j.urology.2023.10.001","title":"Percutaneous Image Guided Cryoablation of Adrenal Metastases From Renal Cell Carcinoma: A Single Institution Review","year":2023,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Mayo Foundation for Medical Education and Research; Mayo Clinic","keywords":"Medicine; Cryoablation; Renal cell carcinoma; Percutaneous; Radiology; Carcinoma; Oncology; Internal medicine","score_opus":0.038270176916549305,"score_gpt":0.277163719027648,"score_spread":0.23889354211109873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387538492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819744,0.011402098,0.00030217122,0.0010359295,0.00013680384,0.0005249672,0.000089493646,0.00009476011,0.0044393763],"genre_scores_gemma":[0.99649423,0.00059577666,0.0011838444,0.00052824523,0.000108147855,0.000018047425,0.0007913414,0.000021480597,0.00025889487],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850357,0.00016113167,0.00046859658,0.0003470106,0.00025896943,0.00026074488],"domain_scores_gemma":[0.9990248,0.00014182579,0.00017918945,0.0003932971,0.00015523344,0.00010564118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018620623,0.00018331449,0.00051551784,0.00018394865,0.000045623754,0.0000049199484,0.000082858,0.000099411656,0.0005428528],"category_scores_gemma":[0.00019511681,0.00015441413,0.00016826483,0.00033301645,0.00013524429,0.000058715534,0.000059280494,0.00013398728,0.00029353975],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054426346,0.00044904894,0.0030162113,0.00092960615,0.00014388752,0.0046143536,0.00023233051,0.00020024033,0.9697147,0.00009401962,0.017775584,0.00228574],"study_design_scores_gemma":[0.010130396,0.013238547,0.13382806,0.0010820278,0.009553605,0.011033639,0.00016839417,0.0043462184,0.76507276,0.0013799379,0.0489513,0.0012151366],"about_ca_topic_score_codex":0.00032430948,"about_ca_topic_score_gemma":0.000022220072,"teacher_disagreement_score":0.20464197,"about_ca_system_score_codex":0.00010115319,"about_ca_system_score_gemma":0.00013272229,"threshold_uncertainty_score":0.6296825},"labels":[],"label_agreement":null},{"id":"W4387541306","doi":"10.1089/end.2023.0342","title":"An Updated Systematic Review and Meta-Analysis on the Technical, Oncologic, and Safety Outcomes of Microwave Ablation in Patients with Renal Cell Carcinoma","year":2023,"lang":"en","type":"review","venue":"Journal of Endourology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Cryoablation; Confidence interval; Renal cell carcinoma; Meta-analysis; Microwave ablation; Internal medicine; Percutaneous; Kidney cancer; Oncology; Urology; Ablation","score_opus":0.07012674138840769,"score_gpt":0.3289064763406503,"score_spread":0.2587797349522426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387541306","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009045235,0.9877081,0.000008322069,0.0003762396,0.000014767904,0.0027278757,0.000039612554,0.0000057417637,0.0000741215],"genre_scores_gemma":[0.08730792,0.9117589,0.0002469591,0.0003981076,0.000013383021,0.00007136055,0.00009644919,0.000041408945,0.00006551023],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.995642,0.0013897503,0.0020809344,0.00030436003,0.0003872452,0.00019568452],"domain_scores_gemma":[0.9950953,0.000991524,0.003005143,0.0005294301,0.00026082972,0.00011775965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016629492,0.00040679588,0.008871834,0.00071322656,0.000032648448,0.000010258326,0.0001903852,0.00023643812,0.000056199224],"category_scores_gemma":[0.00019311301,0.00016331677,0.0010122235,0.00063884974,0.000113242706,0.000042273048,0.0000507666,0.00061642413,0.0000022295435],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014536497,0.0022871182,0.018201262,0.69322383,0.28121048,0.0015502225,0.000130596,0.000029125864,0.000015665688,0.000104680315,0.0005235206,0.0012698233],"study_design_scores_gemma":[0.0012803309,0.005334796,0.019183854,0.005007948,0.968281,0.00031965948,0.000010246531,0.0000014465761,0.0000042558004,0.000010075716,0.00040484173,0.00016157632],"about_ca_topic_score_codex":0.000011133476,"about_ca_topic_score_gemma":0.000030244959,"teacher_disagreement_score":0.6882159,"about_ca_system_score_codex":0.00015150508,"about_ca_system_score_gemma":0.00014605075,"threshold_uncertainty_score":0.6659864},"labels":[],"label_agreement":null},{"id":"W4387610595","doi":"10.1016/s1470-2045(23)00473-4","title":"Immunotherapy in renal cell carcinoma","year":2023,"lang":"en","type":"letter","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Nivolumab; Ipilimumab; Medicine; Renal cell carcinoma; Oncology; Internal medicine; Immunotherapy; Sunitinib; Kidney cancer; Cancer","score_opus":0.06913184320899503,"score_gpt":0.32171012868270427,"score_spread":0.25257828547370925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387610595","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1336491,0.0018258385,0.0000024474978,0.81552744,0.00080187956,0.00092617515,0.00003185524,0.00012075782,0.04711453],"genre_scores_gemma":[0.06322004,0.000848697,0.00032130058,0.87989515,0.015364982,0.00042486523,0.00055080804,0.00020922188,0.039164912],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99741095,0.0005102114,0.00044895153,0.00048229258,0.0003474954,0.0008001009],"domain_scores_gemma":[0.99797064,0.0005892063,0.00022000622,0.0011231477,0.00004998371,0.000047023776],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00059380895,0.00038341322,0.0013823741,0.00024260746,0.000053367956,0.000014102513,0.00045579328,0.0009326448,0.00030116437],"category_scores_gemma":[0.000024740051,0.00024066995,0.00023838595,0.00030022254,0.00017518747,0.000016791348,0.000106907275,0.0028863756,0.0010363264],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051452307,0.000074981916,0.0026360801,0.00018713251,0.00008560725,0.01351461,0.00038552302,0.000002932033,0.0013910059,0.000008566483,0.97921085,0.001988213],"study_design_scores_gemma":[0.004476118,0.0013095409,0.036527514,0.000065462526,0.00013216095,0.00040071373,0.000030815798,0.000010314997,0.00096464314,0.00023158592,0.9556366,0.0002145204],"about_ca_topic_score_codex":0.0005119968,"about_ca_topic_score_gemma":0.00010380907,"teacher_disagreement_score":0.07042905,"about_ca_system_score_codex":0.000978311,"about_ca_system_score_gemma":0.00047437457,"threshold_uncertainty_score":0.9997415},"labels":[],"label_agreement":null},{"id":"W4387692608","doi":"10.1007/s00428-023-03673-9","title":"Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT","year":2023,"lang":"en","type":"review","venue":"Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"TSC1; Eosinophilic; TFE3; Biology; Pathology; Cohort; Immunohistochemistry; Medicine; Internal medicine; PI3K/AKT/mTOR pathway; Gene; Genetics; Gene expression","score_opus":0.10881340301946493,"score_gpt":0.41321762063361883,"score_spread":0.3044042176141539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387692608","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13212751,0.8624825,0.000008708252,0.0002478816,0.0002727743,0.0030241495,0.00076843624,0.000022550075,0.0010455028],"genre_scores_gemma":[0.1720999,0.8260257,0.0006534831,0.00017083914,0.0001162209,0.00014540109,0.0006954325,0.000051367504,0.000041603824],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.992352,0.0023885819,0.0024408442,0.0006532251,0.0018294014,0.00033591624],"domain_scores_gemma":[0.9930824,0.0015082599,0.0030437594,0.0013981453,0.0007931163,0.00017431637],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.003928876,0.0006059036,0.003411215,0.0003159856,0.00009226379,0.0000033968104,0.00080371264,0.00027622413,0.00004920692],"category_scores_gemma":[0.006586491,0.00030490506,0.00096704805,0.0010191515,0.0031617673,0.00008813629,0.00048454443,0.00071893766,0.000002827453],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001082495,0.003994709,0.002989444,0.6930071,0.008532657,0.00015121419,0.0020156733,0.00045161817,0.010106748,0.01064854,0.0012162639,0.26580355],"study_design_scores_gemma":[0.014473292,0.009914082,0.117859684,0.7031361,0.08340526,0.00086056493,0.0016886875,0.0014246007,0.031269558,0.015885714,0.018165734,0.0019167418],"about_ca_topic_score_codex":0.000089053574,"about_ca_topic_score_gemma":0.000014885803,"teacher_disagreement_score":0.2638868,"about_ca_system_score_codex":0.00011183999,"about_ca_system_score_gemma":0.0056737037,"threshold_uncertainty_score":0.9999632},"labels":[],"label_agreement":null},{"id":"W4387809599","doi":"10.1016/j.annonc.2023.10.090","title":"LBA88 Belzutifan versus everolimus in participants (pts) with previously treated advanced clear cell renal cell carcinoma (ccRCC): Randomized open-label phase III LITESPARK-005 study","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"EMD Serono; Genentech; Ipsen; Astellas Pharma; Eisai; Jounce Therapeutics; Daiichi Sankyo Europe; Calithera Biosciences; Mylan; Arrowhead Pharmaceuticals; EUSA Pharma; AstraZeneca; Associazione Italiana di Oncologia Medica; European Association of Urology; Pfizer; Incyte; F. Hoffmann-La Roche; PTC Therapeutics; Sanofi; Exelixis; Bristol-Myers Squibb; Eli Lilly and Company; American Society of Clinical Oncology; Amgen; Seagen; Society for Immunotherapy of Cancer","keywords":"Medicine; Everolimus; Clear cell renal cell carcinoma; Renal cell carcinoma; Oncology; Internal medicine; Open label; Phases of clinical research; Randomized controlled trial; Clinical trial","score_opus":0.164115545599524,"score_gpt":0.4251918590171163,"score_spread":0.2610763134175923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387809599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816631,0.0009706943,0.0000032069406,0.0007587343,0.00015254837,0.00656708,0.000026063295,0.00009910184,0.009759443],"genre_scores_gemma":[0.99580103,0.00046625387,0.0002917929,0.000271558,0.000067929795,0.0009377863,0.00012900995,0.00009336319,0.0019412936],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99466217,0.0011914056,0.0013658045,0.0009585518,0.00055465667,0.0012674325],"domain_scores_gemma":[0.9962919,0.0012430642,0.0006825972,0.0009148545,0.000325101,0.0005425349],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019796616,0.0005649785,0.0027772887,0.00054840726,0.00011284018,0.00002883849,0.00047055352,0.00024065062,0.00015601658],"category_scores_gemma":[0.00025925972,0.0004323193,0.00020066155,0.0011549948,0.0003046892,0.00020506782,0.00031171483,0.0004308305,0.00012312958],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9276509,0.023728747,0.008967213,0.00015263166,0.00068971585,0.005946687,0.005234663,0.00020407628,0.010960822,0.000008971122,0.0017524037,0.014703145],"study_design_scores_gemma":[0.8503875,0.08857903,0.010170738,0.00013096264,0.001202949,0.0000291089,0.0016098825,0.0006355921,0.045864157,0.00001898418,0.00095606124,0.000415028],"about_ca_topic_score_codex":0.001079404,"about_ca_topic_score_gemma":0.0007650699,"teacher_disagreement_score":0.07726342,"about_ca_system_score_codex":0.00026028347,"about_ca_system_score_gemma":0.00069530687,"threshold_uncertainty_score":0.99981284},"labels":[],"label_agreement":null},{"id":"W4387826135","doi":"10.1016/j.annonc.2023.09.1123","title":"1893P Immune-related adverse events from contemporary first-line combination therapies in metastatic renal cell carcinoma: Results from the IMDC","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Juravinski Cancer Centre; University of Manitoba; BC Cancer Agency; Hamilton Health Sciences; Dalhousie University","funders":"","keywords":"Medicine; Nivolumab; Renal cell carcinoma; Ipilimumab; Internal medicine; Adverse effect; Oncology; Odds ratio; Nephrectomy; Kidney cancer; Cohort; Urology; Gastroenterology; Cancer; Immunotherapy; Kidney","score_opus":0.10846761252191099,"score_gpt":0.3395749140781999,"score_spread":0.2311073015562889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387826135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97441334,0.0031725639,0.0000033368947,0.017892264,0.0002512186,0.00079639285,0.00032573577,0.00004666193,0.0030985142],"genre_scores_gemma":[0.9961936,0.00052219414,0.000103314145,0.0005142339,0.000048810783,0.000057511126,0.0019021721,0.000030132263,0.00062802737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974094,0.0004978188,0.0010620138,0.0003897034,0.00033617424,0.00030488663],"domain_scores_gemma":[0.9969264,0.0017349313,0.000530933,0.0005344142,0.00018455363,0.000088761495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008555077,0.00023889942,0.00072197727,0.00020702917,0.00007040615,0.0000032757225,0.00021513658,0.00016512697,0.00009950007],"category_scores_gemma":[0.00024534186,0.00016752651,0.00023670505,0.00047753923,0.00014710113,0.00009448591,0.00010375801,0.00030745525,0.00014393537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052390873,0.018007293,0.5763636,0.00040530035,0.006279232,0.012866827,0.08392313,0.002246042,0.10039418,0.00048369414,0.107304245,0.039335553],"study_design_scores_gemma":[0.019637538,0.0036993905,0.94050634,0.00015039677,0.00019048665,0.0000085396605,0.0015302575,0.0006480538,0.025736164,0.0035505497,0.0041653165,0.00017694023],"about_ca_topic_score_codex":0.007803908,"about_ca_topic_score_gemma":0.00042879154,"teacher_disagreement_score":0.36414275,"about_ca_system_score_codex":0.00010560809,"about_ca_system_score_gemma":0.00030391972,"threshold_uncertainty_score":0.9988032},"labels":[],"label_agreement":null},{"id":"W4387837003","doi":"10.3390/curroncol30100670","title":"Genomic Profiling and Molecular Characterization of Clear Cell Renal Cell Carcinoma","year":2023,"lang":"en","type":"review","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Clear cell renal cell carcinoma; Renal cell carcinoma; Medicine; Immune checkpoint; Targeted therapy; Cancer research; Clear cell; Genome instability; Bioinformatics; Computational biology; Biology; Oncology; Immunotherapy; Cancer; Internal medicine; Genetics; DNA; DNA damage","score_opus":0.1367902133102293,"score_gpt":0.3836751283356767,"score_spread":0.24688491502544738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387837003","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14058174,0.8563461,0.000025966949,0.000013193533,0.0005150937,0.0017869829,0.000076395714,0.00004130462,0.00061322824],"genre_scores_gemma":[0.0036366978,0.9938556,0.00019161603,0.000009847346,0.00025607247,0.00017460337,0.0015046615,0.00011973388,0.00025116792],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99766976,0.0002649926,0.0008806862,0.00061694236,0.00021698463,0.00035061323],"domain_scores_gemma":[0.9984371,0.000104343,0.0007305875,0.00042504017,0.00010797441,0.00019496374],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022630372,0.00044688073,0.002106933,0.0003883589,0.0000371238,0.000009361134,0.00012693061,0.0003975,0.000029526924],"category_scores_gemma":[0.000022306376,0.00037283983,0.00039197554,0.00027132244,0.000104336985,0.000023964949,0.0001900194,0.00051144016,0.00012135364],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013640187,0.0008124342,0.0007769101,0.13358462,0.00019279977,0.0006660841,0.00019119501,2.440341e-7,0.03528097,0.00004114487,0.00011306203,0.82820415],"study_design_scores_gemma":[0.0017359768,0.0023846957,0.0011476022,0.0048063183,0.0049718586,0.00022784498,0.000024524938,0.000037429534,0.0072274758,0.000009042592,0.97695374,0.00047348975],"about_ca_topic_score_codex":0.0000047114004,"about_ca_topic_score_gemma":4.1228338e-7,"teacher_disagreement_score":0.9768407,"about_ca_system_score_codex":0.0005015696,"about_ca_system_score_gemma":0.0007896153,"threshold_uncertainty_score":0.9998723},"labels":[],"label_agreement":null},{"id":"W4387837059","doi":"10.1016/j.annonc.2023.09.1133","title":"1903P Tumor response by baseline metastases in patients (pts) with renal cell carcinoma (RCC) treated with lenvatinib (L) plus pembrolizumab (P) vs sunitinib (S): Post hoc analysis of the CLEAR trial","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Eisai Incorporated; Merck Sharp and Dohme","keywords":"Medicine; Lenvatinib; Sunitinib; Pembrolizumab; Renal cell carcinoma; Oncology; Post-hoc analysis; Internal medicine; Urology; Cancer; Immunotherapy","score_opus":0.045026071857746014,"score_gpt":0.31073095820562896,"score_spread":0.2657048863478829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387837059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955011,0.00013678864,0.0000014730647,0.0015230101,0.000035026147,0.0013835051,0.00079107814,0.000032269585,0.0005957503],"genre_scores_gemma":[0.99767286,0.000031083964,0.00009791939,0.0005874449,0.000028086642,0.000091845686,0.0009179118,0.000051492207,0.00052133325],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9957599,0.0014965766,0.0009602056,0.00053125067,0.0007135726,0.0005384792],"domain_scores_gemma":[0.99638575,0.0011450583,0.0007696498,0.0007597624,0.0007468605,0.00019290627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012022441,0.00037643447,0.0015782288,0.0010307984,0.00007240056,0.0000078996245,0.00025916414,0.0001416718,0.00016664216],"category_scores_gemma":[0.0003863458,0.00022525321,0.00035274104,0.0029865098,0.0003665501,0.000071025446,0.00009973237,0.0002866508,0.000010178003],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9161999,0.0027886597,0.06903173,0.00008301745,0.0013911887,0.0006517287,0.00067989144,0.00042596975,0.0031647084,0.000005511052,0.0039848494,0.0015928224],"study_design_scores_gemma":[0.15765522,0.16294701,0.6082413,0.00011944088,0.004004037,0.000032113945,0.000855433,0.00038275885,0.06255628,0.0000020799785,0.002861782,0.00034252886],"about_ca_topic_score_codex":0.001550531,"about_ca_topic_score_gemma":0.00077678513,"teacher_disagreement_score":0.7585447,"about_ca_system_score_codex":0.000206675,"about_ca_system_score_gemma":0.00097054977,"threshold_uncertainty_score":0.918556},"labels":[],"label_agreement":null},{"id":"W4387882019","doi":"10.1097/ju9.0000000000000075","title":"JU Open Plus: Section Meetings—Science, Practice Improvement, and Networking","year":2023,"lang":"en","type":"article","venue":"JU Open Plus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; General surgery; Surgery; Kidney; Internal medicine","score_opus":0.06219622735550482,"score_gpt":0.3643948948353389,"score_spread":0.30219866747983404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387882019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6303234,0.0003995167,0.00003402135,0.0045450544,0.0012989568,0.003944955,0.000004869506,0.00013673579,0.35931247],"genre_scores_gemma":[0.97489816,0.00027108236,0.0015098957,0.0015069968,0.00060715043,0.00022240773,0.00003974521,0.00004281933,0.020901747],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980311,0.000062639,0.00030847872,0.00064279337,0.000485041,0.00046996347],"domain_scores_gemma":[0.99874276,0.00016906502,0.00022167589,0.00046076317,0.00016358438,0.00024212469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018652272,0.00019402003,0.0003598698,0.0001617977,0.00045258334,0.00075275794,0.00050375075,0.000070208596,0.00006444041],"category_scores_gemma":[0.00022842422,0.00016003924,0.00003949929,0.0010225433,0.000108039385,0.0010282956,0.0017496058,0.00021594392,0.00013280098],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011869403,0.0012178284,0.033095907,0.0010810078,0.0018974716,0.005539436,0.020184148,0.0009847963,0.19646661,0.0026575753,0.2565209,0.4684849],"study_design_scores_gemma":[0.020416096,0.0043919934,0.059459526,0.00091886387,0.0012826885,0.00102814,0.009457369,0.019395977,0.022891391,0.0004111044,0.8592406,0.0011062564],"about_ca_topic_score_codex":0.0038996038,"about_ca_topic_score_gemma":0.00015463475,"teacher_disagreement_score":0.60271966,"about_ca_system_score_codex":0.0006761433,"about_ca_system_score_gemma":0.00055312394,"threshold_uncertainty_score":0.7258862},"labels":[],"label_agreement":null},{"id":"W4387904719","doi":"10.5489/cuaj.8449","title":"Predictors of disease recurrence in high-risk non-metastatic renal cell carcinoma patient’s post-surgical resection","year":2023,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Proportional hazards model; Univariate analysis; Multivariate analysis; Internal medicine; Nomogram; Disease; Retrospective cohort study; Log-rank test; Kidney cancer; Surgical margin; Surgery; Cancer; Kidney","score_opus":0.011279351525039089,"score_gpt":0.21880293968571188,"score_spread":0.2075235881606728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387904719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99560356,0.00017345423,0.0000037748173,0.002728327,0.00042513997,0.00036414101,0.00021160199,0.000020083047,0.00046993128],"genre_scores_gemma":[0.9990005,0.00011640639,0.000058039535,0.00016706176,0.0002069241,0.000023328548,0.00014630867,0.000016130129,0.00026529696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973505,0.0004503902,0.0006374856,0.00029350584,0.0006777589,0.00059034996],"domain_scores_gemma":[0.9975371,0.00031269895,0.0004661518,0.00016770085,0.00035056335,0.0011657978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007871407,0.00018595552,0.00038605044,0.0006378619,0.00015013266,0.000030929386,0.00011198453,0.00015659652,0.00022345835],"category_scores_gemma":[0.0010331458,0.00014981817,0.0001995372,0.0008042322,0.00004655644,0.000099810764,0.000025647993,0.0007455936,0.00007058782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056994683,0.00013112497,0.9930092,0.000020932448,0.000047820355,0.0018045992,0.00021178559,0.0004168956,0.00013441533,0.000009884843,0.002475809,0.0011675875],"study_design_scores_gemma":[0.0021131353,0.001950068,0.99366605,0.00003306736,0.00015453073,0.00006741399,0.0000997422,0.00036213547,0.00023565658,0.00018915391,0.0010065057,0.00012255136],"about_ca_topic_score_codex":0.0042656236,"about_ca_topic_score_gemma":0.0010223035,"teacher_disagreement_score":0.0033969572,"about_ca_system_score_codex":0.0015205813,"about_ca_system_score_gemma":0.00087838544,"threshold_uncertainty_score":0.64483756},"labels":[],"label_agreement":null},{"id":"W4387906707","doi":"10.5489/cuaj.8506","title":"The impact of robotic surgery access on the management of patients with clinical stage I kidney tumors at Canadian academic centers","year":2023,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Alberta; Université Laval; Centre hospitalier universitaire de Québec; University of British Columbia; Princess Margaret Cancer Centre; University of Calgary; McMaster University; University of Ottawa; McGill University Health Centre; Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Toronto; University Health Network; Ottawa Hospital","funders":"","keywords":"Medicine; Nephrectomy; Stage (stratigraphy); Kidney cancer; Confidence interval; Relative risk; Robotic surgery; Cohort; Logistic regression; Kidney; Surgery; Internal medicine; Cancer","score_opus":0.052033844132466193,"score_gpt":0.30632710192583484,"score_spread":0.25429325779336864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387906707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98680574,0.000024642011,6.3669853e-7,0.011361694,0.00019963905,0.0004250413,0.00012486486,0.0000080304135,0.0010497262],"genre_scores_gemma":[0.9977961,0.00021272311,0.000002573359,0.0012549331,0.00006668687,0.000009896084,0.000072003924,0.00001549568,0.00056956377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763596,0.00031680122,0.00064064335,0.00017895794,0.0005928289,0.0006348213],"domain_scores_gemma":[0.9967557,0.0008360373,0.0006203259,0.00021609782,0.0002319442,0.0013398697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016601875,0.00016195944,0.0003750623,0.00026942775,0.00033087717,0.000036133362,0.00027950056,0.00015114817,0.0002600937],"category_scores_gemma":[0.000613988,0.00007568888,0.0003212136,0.0005178045,0.00009800831,0.000051336334,0.000035262663,0.000624062,0.000029099494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020711421,0.000030796255,0.9709044,0.000007845178,0.0005480734,0.00017487872,0.000027160237,0.00045658532,7.400085e-7,0.000036516714,0.027147992,0.00045788434],"study_design_scores_gemma":[0.00063469127,0.00043771436,0.9969604,0.000066083325,0.000111681635,0.0000077178565,0.0000528124,0.00006643456,0.000005033675,0.000029407105,0.0015578036,0.00007021798],"about_ca_topic_score_codex":0.029714977,"about_ca_topic_score_gemma":0.012703114,"teacher_disagreement_score":0.026055988,"about_ca_system_score_codex":0.0030968853,"about_ca_system_score_gemma":0.0013524885,"threshold_uncertainty_score":0.97674626},"labels":[],"label_agreement":null},{"id":"W4387930863","doi":"10.1097/spc.0000000000000683","title":"Radiation therapy options in kidney cancer","year":2023,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Renal cell carcinoma; Toxicity; Radiation therapy; Radiosurgery; Renal function; Oncology; Radiology; Internal medicine","score_opus":0.2897994048249936,"score_gpt":0.4822839607402835,"score_spread":0.1924845559152899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387930863","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003458793,0.9945062,0.000002937969,0.00006818329,0.0017866336,0.0024157478,0.0007576846,0.000031132753,0.000085644315],"genre_scores_gemma":[0.00015052162,0.9920601,0.000009529644,0.0000212981,0.00040360808,0.0017805756,0.0054243607,0.000056740784,0.000093236966],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99784356,0.00022284813,0.0007261053,0.0006292246,0.00025967153,0.00031857335],"domain_scores_gemma":[0.9989175,0.00013912896,0.0003388674,0.00022681865,0.00015596581,0.00022168276],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013099826,0.00045644736,0.0013628395,0.0006011631,0.0000414716,0.000019839532,0.00007870566,0.0002260419,0.00012421806],"category_scores_gemma":[0.00009589195,0.00035407077,0.0002940227,0.00074741384,0.00006669833,0.000063954416,0.00004854269,0.00054461503,0.000048828453],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037732156,0.00012404805,0.051641732,0.034319967,0.00015160338,0.000015858212,0.0022250544,8.378032e-7,1.5371283e-7,0.00010795196,0.0014023449,0.9099727],"study_design_scores_gemma":[0.0014461122,0.00019371114,0.05430495,0.059298843,0.00015264587,0.0000020409464,0.0003131285,0.0000035064584,0.00000167139,0.000024539804,0.883947,0.0003118506],"about_ca_topic_score_codex":0.00007649416,"about_ca_topic_score_gemma":0.000017158754,"teacher_disagreement_score":0.9096609,"about_ca_system_score_codex":0.0009022875,"about_ca_system_score_gemma":0.0009691764,"threshold_uncertainty_score":0.9998911},"labels":[],"label_agreement":null},{"id":"W4387939747","doi":"10.37349/etat.2023.00175","title":"Biomarkers in renal cell carcinoma and their targeted therapies: a review","year":2023,"lang":"en","type":"review","venue":"Exploration of Targeted Anti-tumor Therapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Renal cell carcinoma; Targeted therapy; Immunotherapy; Cancer; Biomarker; Kidney cancer; Sunitinib; microRNA; Epigenetics; Bioinformatics; Oncology; Internal medicine; Biology","score_opus":0.09424957999287563,"score_gpt":0.32209218553763,"score_spread":0.22784260554475438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387939747","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036687811,0.99064356,0.000025783378,0.00031203925,0.00020923266,0.0047097434,0.00014459857,0.00013778516,0.00014850464],"genre_scores_gemma":[0.0037413165,0.9931084,0.00029343626,0.00023975622,0.00013966895,0.0007210689,0.001348451,0.0002346152,0.00017327891],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99547553,0.0006865524,0.0018529677,0.0009564883,0.00049632386,0.0005321644],"domain_scores_gemma":[0.9972105,0.0002723807,0.0011606177,0.000921292,0.00021208757,0.00022309633],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00084528147,0.0010319285,0.0039783325,0.0009827267,0.000083590494,0.00003416572,0.00029510216,0.00029222888,0.00015812738],"category_scores_gemma":[0.00007492061,0.00069757085,0.00087580836,0.0017039252,0.00017367228,0.0002901634,0.00006948232,0.00051696657,0.00006546189],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000627267,0.0016165979,0.00037947603,0.18973193,0.0037251275,0.0011708541,0.0030540216,0.0000034715997,0.006915061,0.00005923205,0.0071029156,0.7856141],"study_design_scores_gemma":[0.005716505,0.0023872873,0.0006932556,0.09551216,0.0011740639,0.00019559306,0.0006849162,0.00004700814,0.0069011785,0.00015736402,0.8849364,0.0015942483],"about_ca_topic_score_codex":0.00007082115,"about_ca_topic_score_gemma":0.0000075328844,"teacher_disagreement_score":0.8778335,"about_ca_system_score_codex":0.00021606845,"about_ca_system_score_gemma":0.0005769027,"threshold_uncertainty_score":0.99954754},"labels":[],"label_agreement":null},{"id":"W4387968735","doi":"10.1245/s10434-023-14476-2","title":"ASO Visual Abstract: Prognostic Significance of Pathological Lymph Node Invasion in Metastatic Renal Cell Carcinoma in the Immunotherapy Era","year":2023,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Surgical oncology; Renal cell carcinoma; Pathological; Lymph node; Immunotherapy; Pathology; Oncology; Internal medicine; Cancer","score_opus":0.09777556563829128,"score_gpt":0.3675868255017798,"score_spread":0.26981125986348853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387968735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898164,0.0010334319,0.0000021958854,0.00436598,0.000048060476,0.00078421884,0.0000125370425,0.000017932069,0.0039192215],"genre_scores_gemma":[0.9975642,0.0015863449,0.00017285602,0.00037157547,0.00003759252,0.00014363282,0.00005179757,0.000018786608,0.000053201802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99718493,0.0005560586,0.000943646,0.0003768097,0.00046565404,0.0004729203],"domain_scores_gemma":[0.996864,0.002323336,0.00029811874,0.00029687703,0.00012441473,0.000093230454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017121421,0.00022524549,0.0009209066,0.0003186879,0.000025943227,0.0000054192064,0.00021589163,0.00019229137,0.00015192141],"category_scores_gemma":[0.00010147841,0.00014074828,0.00022990756,0.0008134516,0.00029921596,0.00005069387,0.000058558453,0.00036841788,0.000038428658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01045777,0.013935349,0.63968945,0.0008816741,0.00015354696,0.052000567,0.0037967677,0.0009011849,0.21795115,0.0004399032,0.0011702459,0.058622364],"study_design_scores_gemma":[0.0042869346,0.0032843866,0.95926577,0.00009768241,0.000040262265,0.00020225429,0.00043761774,0.00012941433,0.030230148,0.00033538553,0.0015575247,0.00013263446],"about_ca_topic_score_codex":0.00026044072,"about_ca_topic_score_gemma":0.000019992041,"teacher_disagreement_score":0.3195763,"about_ca_system_score_codex":0.00007916201,"about_ca_system_score_gemma":0.00033167738,"threshold_uncertainty_score":0.5739548},"labels":[],"label_agreement":null},{"id":"W4388007664","doi":"10.20944/preprints202310.1757.v1","title":"Epidemiology Patterns of Renal Cell Carcinoma Worldwide: Examining Risk Factors and Contemporary Immunotherapy Approaches","year":2023,"lang":"en","type":"preprint","venue":"Preprints.org","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Ministry of Science and Higher Education of the Russian Federation","keywords":"Medicine; Epidemiology; Cancer; Renal cell carcinoma; Kidney cancer; Disease; Mortality rate; Kidney disease; Oncology; Internal medicine; Demography","score_opus":0.4068375786239176,"score_gpt":0.3565602925525077,"score_spread":0.05027728607140991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388007664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911817,0.0036937702,0.00022900496,0.00018665055,0.00038883346,0.0016675029,0.00018147271,0.00018842229,0.0022826432],"genre_scores_gemma":[0.9957715,0.00083851576,0.000392515,0.000051754938,0.00017179745,0.00025238367,0.0004428241,0.0001658896,0.0019127798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99478495,0.0009638619,0.0015369671,0.0017375544,0.00038790496,0.0005887845],"domain_scores_gemma":[0.994642,0.001390485,0.0014499278,0.0020691648,0.000121042925,0.00032734772],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019860123,0.00083143817,0.0021602423,0.00048267128,0.0000936014,0.000006960001,0.00043002475,0.0006597269,0.00019914044],"category_scores_gemma":[0.0005246115,0.00069101574,0.00049682346,0.00015004342,0.0002729049,0.000060087892,0.0015481323,0.00159135,0.00008897324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041272878,0.00024765267,0.99034095,0.0009955231,0.0006870322,0.000118413554,0.002276626,0.00015892442,0.0043503405,0.000013456195,0.000021701399,0.00037666765],"study_design_scores_gemma":[0.0016760561,0.00025977017,0.9204427,0.0003843899,0.00031523066,0.000020607435,0.0006127452,0.00012764719,0.07537194,0.00030042665,0.000068541034,0.00041993923],"about_ca_topic_score_codex":0.005354032,"about_ca_topic_score_gemma":0.00002907435,"teacher_disagreement_score":0.0710216,"about_ca_system_score_codex":0.00024948848,"about_ca_system_score_gemma":0.00033118328,"threshold_uncertainty_score":0.9995541},"labels":[],"label_agreement":null},{"id":"W4388034379","doi":"10.1002/cti2.1471","title":"Early CRP kinetics to predict long‐term efficacy of first‐line immune‐checkpoint inhibition combination therapies in metastatic renal cell carcinoma: an updated multicentre real‐world experience applying different CRP kinetics definitions","year":2023,"lang":"en","type":"article","venue":"Clinical & Translational Immunology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Renal cell carcinoma; Oncology; Kinetics; Medicine; Cancer research; Internal medicine","score_opus":0.09060007069248262,"score_gpt":0.3474536839784909,"score_spread":0.2568536132860083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388034379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99441737,0.00031822576,0.0012646077,0.001617101,0.0002342724,0.0018095304,0.00010208036,0.000113734255,0.00012306852],"genre_scores_gemma":[0.99465364,0.00021876719,0.0014255968,0.000058433452,0.00005977941,0.00024699158,0.0032062535,0.000056182977,0.00007437568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99593085,0.00043380616,0.0020256133,0.0006403488,0.00048527756,0.00048410438],"domain_scores_gemma":[0.9974515,0.0010930606,0.00037262563,0.0005574927,0.00032463344,0.00020071119],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000353696,0.0003858032,0.00085215224,0.0006344139,0.000105170904,0.000024852776,0.00019764906,0.0002126838,0.00017756023],"category_scores_gemma":[0.00013907201,0.00035163914,0.000311573,0.00087616424,0.000400779,0.00013604185,0.00007257696,0.0005038921,0.00003099354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00470289,0.012649606,0.70482284,0.00022158584,0.00040492532,0.00025551877,0.006995342,0.0014640776,0.26294637,0.0009777602,0.00001598846,0.004543102],"study_design_scores_gemma":[0.010810794,0.0032845405,0.95224845,0.00014416086,0.00030189156,0.000013534384,0.0002217881,0.0012489764,0.031022692,0.00042180193,0.00002536345,0.00025601283],"about_ca_topic_score_codex":0.00014866369,"about_ca_topic_score_gemma":0.0004890424,"teacher_disagreement_score":0.2474256,"about_ca_system_score_codex":0.00014980139,"about_ca_system_score_gemma":0.00008187026,"threshold_uncertainty_score":0.99989355},"labels":[],"label_agreement":null},{"id":"W4388039327","doi":"10.1016/j.euo.2023.10.002","title":"Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium","year":2023,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Western University; Dalhousie University; University of Alberta; Queen Elizabeth II Health Sciences Centre; BC Cancer Agency; University of Calgary","funders":"Genentech; Yasuda Memorial Medical Foundation; Bristol-Myers Squibb","keywords":"Medicine; Renal cell carcinoma; Subgroup analysis; Systemic therapy; Internal medicine; Nephrectomy; Oncology; Proportional hazards model; Immunotherapy; Urology; Cancer; Surgery; Kidney; Breast cancer; Confidence interval","score_opus":0.027935149860748514,"score_gpt":0.25839536693978665,"score_spread":0.23046021707903813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388039327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937299,0.00008902247,0.00019651132,0.0012087176,0.00032541607,0.001251654,0.0007647934,0.000027008002,0.0024070009],"genre_scores_gemma":[0.9929944,0.000048187285,0.0008015054,0.0006487526,0.000091053036,0.000054187873,0.005112125,0.000059391547,0.0001903481],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99526054,0.0023319349,0.0010027967,0.000556311,0.00048849534,0.00035994212],"domain_scores_gemma":[0.99597806,0.0019271725,0.0009971942,0.00065498287,0.00037574538,0.00006684155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011506993,0.00032396978,0.0006178692,0.00026759057,0.00009699947,0.000015901087,0.0004890702,0.00006334846,0.0001072517],"category_scores_gemma":[0.000305889,0.00019104512,0.000109619556,0.0005003499,0.00040318212,0.00014559926,0.00015098172,0.0005182077,0.00005466647],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09608049,0.008462087,0.4147387,0.00027710173,0.0016072931,0.0042875106,0.031208009,0.0004992989,0.43449497,0.00018290218,0.0035522475,0.004609352],"study_design_scores_gemma":[0.020613883,0.0069749705,0.9575561,0.000036621244,0.000565598,0.000055392837,0.00079391396,0.00043806952,0.011541892,0.000024416495,0.0012184861,0.00018063093],"about_ca_topic_score_codex":0.00030586863,"about_ca_topic_score_gemma":0.00018804203,"teacher_disagreement_score":0.5428174,"about_ca_system_score_codex":0.00021363822,"about_ca_system_score_gemma":0.0005231887,"threshold_uncertainty_score":0.7790594},"labels":[],"label_agreement":null},{"id":"W4388099416","doi":"10.1016/j.clgc.2023.10.007","title":"Prognostic Significance of Radiographic Lymph Node Invasion in Contemporary Metastatic Renal Cell Carcinoma Patients","year":2023,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Proportional hazards model; Stage (stratigraphy); Lymph node; Radiography; Internal medicine; Cohort; Nephrectomy; Oncology; Cancer; Metastasis; Histology; Clear cell; Radiology; Kidney","score_opus":0.11458592131447154,"score_gpt":0.35041434628872703,"score_spread":0.2358284249742555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388099416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934839,0.0029136685,0.0000055791133,0.00025990984,0.0004674019,0.0014754618,0.000070413116,0.00007040126,0.0012532711],"genre_scores_gemma":[0.99738723,0.0006831866,0.00038866416,0.00023102868,0.0002078813,0.00036928058,0.00017373529,0.00006121981,0.00049778423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99649125,0.000394244,0.0013751828,0.0007033934,0.000571451,0.00046450496],"domain_scores_gemma":[0.99766695,0.0008051109,0.0003972579,0.0005829911,0.00020764918,0.00034006173],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060774287,0.0003230865,0.0009304202,0.00047158505,0.000048437516,0.000008643761,0.00021135346,0.0001516472,0.00008093019],"category_scores_gemma":[0.00024347485,0.0002711111,0.0004381575,0.0012678006,0.0002679057,0.00009505596,0.00013209095,0.0003602491,0.0000689387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013193599,0.0015596852,0.9869686,0.00057078083,0.00009376559,0.0012584489,0.00009925064,0.00008963105,0.002832597,0.0000010424283,0.0027758635,0.0024309838],"study_design_scores_gemma":[0.007260995,0.0016508517,0.98451954,0.00033026966,0.00022401806,0.000007419728,0.000079053025,0.00024731865,0.005097516,0.00005352908,0.00029304533,0.00023646365],"about_ca_topic_score_codex":0.0003105963,"about_ca_topic_score_gemma":0.000009784311,"teacher_disagreement_score":0.005941635,"about_ca_system_score_codex":0.00017128456,"about_ca_system_score_gemma":0.0007220441,"threshold_uncertainty_score":0.99997413},"labels":[],"label_agreement":null},{"id":"W4388144843","doi":"10.1007/978-3-031-40901-1_10","title":"Prognostic Factors in Advanced Renal Cell Carcinoma","year":2023,"lang":"en","type":"book-chapter","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Oncology; Renal cell carcinoma; Clinical trial; Biomarker; Internal medicine; Risk stratification; Systemic therapy; Targeted therapy; Intensive care medicine; Cancer","score_opus":0.03621632473013425,"score_gpt":0.24780615643564372,"score_spread":0.21158983170550946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388144843","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23412073,0.00042728728,0.0000035367507,0.00008488503,0.00020785583,0.0013223132,0.000030925516,0.00017929147,0.7636232],"genre_scores_gemma":[0.4310929,0.000043585107,0.00015295875,0.000037962778,0.00007411729,0.000031739906,0.00035251724,0.00012485177,0.56808937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977949,0.000012774299,0.0005234094,0.0007053049,0.00053102884,0.00043254462],"domain_scores_gemma":[0.9987249,0.00018837689,0.00015064298,0.0005878215,0.00008433598,0.00026394986],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000073829855,0.0005932817,0.0008311433,0.00049778906,0.000029378569,0.000013467565,0.00012162852,0.00039934195,0.0010134064],"category_scores_gemma":[0.000034668596,0.0004543867,0.0003108399,0.00007717285,0.00006264559,0.000037923215,0.00009691235,0.0005771287,0.0011016278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035331137,0.0018627977,0.77869844,0.008106613,0.0014261638,0.08054651,0.0029381162,0.00015087426,0.017877193,0.047283754,0.030080032,0.02749636],"study_design_scores_gemma":[0.013287598,0.007857714,0.85389817,0.0031358982,0.0022980142,0.0002733923,0.0003474079,0.00007894376,0.046885055,0.0060107913,0.0625683,0.00335871],"about_ca_topic_score_codex":0.00010300781,"about_ca_topic_score_gemma":0.00014364006,"teacher_disagreement_score":0.19697216,"about_ca_system_score_codex":0.00045517535,"about_ca_system_score_gemma":0.00024710718,"threshold_uncertainty_score":0.9998998},"labels":[],"label_agreement":null},{"id":"W4388210755","doi":"10.1016/j.clgc.2023.10.011","title":"Other-Cause Mortality, According to Partial vs. Radical Nephrectomy: Age and Stage Analyses","year":2023,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nephrectomy; Medicine; Renal cell carcinoma; Stage (stratigraphy); Incidence (geometry); Surgery; Urology; Internal medicine; Kidney","score_opus":0.3514332743406447,"score_gpt":0.5119868355715679,"score_spread":0.16055356123092318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388210755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99501663,0.0006636213,0.000032575637,0.0019102877,0.0006405805,0.00062888913,0.000054272314,0.00023535592,0.0008177882],"genre_scores_gemma":[0.990205,0.00096944836,0.0005045146,0.0024267226,0.0021425737,0.00017023513,0.000030641422,0.00006805038,0.0034828112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973055,0.00020430333,0.0007394515,0.0007493294,0.0004503697,0.0005510592],"domain_scores_gemma":[0.9979724,0.0004162553,0.00011947074,0.00060121506,0.000057288078,0.0008333664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053797365,0.00029942094,0.0007970627,0.00018539767,0.000116001036,0.000049963768,0.00015623833,0.00018847191,0.00036723382],"category_scores_gemma":[0.0002712656,0.00024146067,0.00032127532,0.0005934133,0.0002297415,0.00007857737,0.00030765802,0.00039861258,0.00026050917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014462541,0.0003498047,0.96063846,0.0001284223,0.0010910948,0.009559894,0.00014069767,0.00010863006,0.0038893898,0.000016462523,0.009017475,0.013613428],"study_design_scores_gemma":[0.003430148,0.001945153,0.9103709,0.00016923905,0.0011928786,0.00004243973,0.00021539241,0.00054245366,0.0031868515,0.000069742455,0.07840471,0.00043012158],"about_ca_topic_score_codex":0.000483388,"about_ca_topic_score_gemma":0.00009492523,"teacher_disagreement_score":0.069387235,"about_ca_system_score_codex":0.0001417679,"about_ca_system_score_gemma":0.00023276955,"threshold_uncertainty_score":0.98464805},"labels":[],"label_agreement":null},{"id":"W4388341977","doi":"10.1016/j.ctrv.2023.102652","title":"Vascular endothelial growth factor-targeted therapy in patients with renal cell carcinoma pretreated with immune checkpoint inhibitors: A systematic literature review","year":2023,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Ipsen; Ipsen Fund","keywords":"Medicine; Cabozantinib; Tolerability; Pazopanib; Renal cell carcinoma; Oncology; Internal medicine; Vascular endothelial growth factor; Adverse effect; Systematic review; Regimen; Cochrane Library; Sunitinib; MEDLINE; Randomized controlled trial; VEGF receptors","score_opus":0.03545536927305138,"score_gpt":0.285767195707976,"score_spread":0.2503118264349246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388341977","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019210845,0.956133,9.907291e-7,0.000022615823,0.00015244019,0.041011278,0.0004749904,0.00015219735,0.0001314217],"genre_scores_gemma":[0.00029512853,0.9728078,0.00011194915,0.000069292364,0.00023392885,0.02198227,0.0032236925,0.00046398427,0.0008119178],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9910867,0.0014432238,0.0034519914,0.001888357,0.0011009376,0.0010287856],"domain_scores_gemma":[0.99410367,0.00019175625,0.0025127102,0.0022752143,0.0004344609,0.00048218836],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0004743125,0.0027538976,0.012618325,0.0007286567,0.0001104536,0.000104120656,0.00040818643,0.0005162502,0.0001435281],"category_scores_gemma":[0.000073428804,0.0012740119,0.0025943727,0.0028227011,0.00010174457,0.00018698614,0.0000682721,0.00078831834,0.00019464966],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031509835,0.0013329586,0.0043512504,0.9177094,0.0026805662,0.0009826593,0.00031554923,2.4443622e-7,0.000002864402,6.0487565e-7,0.000116073046,0.07219274],"study_design_scores_gemma":[0.0088801095,0.0057438016,0.00163251,0.88946354,0.013724352,0.000083019986,0.0000053116555,3.360594e-7,0.00013494701,5.9602525e-7,0.07919182,0.0011396616],"about_ca_topic_score_codex":0.00029233762,"about_ca_topic_score_gemma":0.000055984932,"teacher_disagreement_score":0.07907574,"about_ca_system_score_codex":0.0044684247,"about_ca_system_score_gemma":0.0010368223,"threshold_uncertainty_score":0.99935323},"labels":[],"label_agreement":null},{"id":"W4388498795","doi":"10.1016/j.clgc.2023.11.001","title":"Cabozantinib in the Routine Management of Renal Cell Carcinoma: A Systematic Literature Review of Real-World Evidence","year":2023,"lang":"en","type":"review","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Ipsen; Ipsen Fund","keywords":"Cabozantinib; Medicine; Tolerability; Renal cell carcinoma; Internal medicine; Randomized controlled trial; Oncology; Clinical trial; Kidney cancer; Adverse effect; Systematic review; MEDLINE","score_opus":0.2021130837119291,"score_gpt":0.46081948946590984,"score_spread":0.25870640575398074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388498795","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005534229,0.9885711,5.519489e-7,0.0001836154,0.00043840575,0.007763953,0.00010044244,0.000027540955,0.0023609484],"genre_scores_gemma":[0.0009884534,0.99077255,0.00015421797,0.00017423529,0.00054658076,0.0017543776,0.00012477404,0.00010315968,0.005381654],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99040544,0.0020287575,0.00510915,0.00091943896,0.0010607127,0.00047647502],"domain_scores_gemma":[0.99240595,0.0024484498,0.0025347546,0.0021221347,0.00030640975,0.0001822817],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0039579696,0.0007403431,0.006446837,0.00040758812,0.000035196306,0.00001556827,0.0008864031,0.00034068656,0.00006663399],"category_scores_gemma":[0.00027117328,0.0004132225,0.0022526577,0.0027233677,0.00018374436,0.00005888636,0.00035634657,0.0012001292,0.000050894705],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010755135,0.0004799258,0.00042066447,0.97584236,0.0004679729,0.004746804,0.00006144687,5.317332e-7,2.725241e-7,0.00001647321,0.0031780729,0.014677949],"study_design_scores_gemma":[0.00078426435,0.0006880632,0.0021181179,0.9575304,0.012476411,0.00013039501,0.00003604666,0.000001996378,0.0000031174004,0.000003457413,0.025937697,0.0002900795],"about_ca_topic_score_codex":0.000098597586,"about_ca_topic_score_gemma":0.00002312492,"teacher_disagreement_score":0.022759624,"about_ca_system_score_codex":0.00031278827,"about_ca_system_score_gemma":0.00071717927,"threshold_uncertainty_score":0.999832},"labels":[],"label_agreement":null},{"id":"W4388712377","doi":"10.1007/s00330-023-10434-4","title":"Evaluation of a multiparametric renal CT algorithm for diagnosis of clear-cell renal cell carcinoma among small (≤ 4 cm) solid renal masses","year":2023,"lang":"en","type":"article","venue":"European Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Clear cell renal cell carcinoma; Neuroradiology; Radiology; Renal cell carcinoma; Papillary renal cell carcinomas; Biopsy; Renal mass; Logistic regression; Area under the curve; Multidetector computed tomography; Ultrasound; Confidence interval; Predictive value of tests; Nephrology; Kidney; Nephrectomy; Internal medicine; Computed tomography","score_opus":0.06767758261849183,"score_gpt":0.29647096733604705,"score_spread":0.22879338471755523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388712377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897442,0.0013821523,0.0007997937,0.00005320926,0.00023962447,0.0015437871,0.000100146644,0.00007944732,0.006057632],"genre_scores_gemma":[0.98930705,0.00018655819,0.008743951,0.000038462094,0.00033947584,0.00016771897,0.00031949094,0.00010799455,0.00078931777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99574906,0.0013851034,0.000956305,0.00070058863,0.00062903296,0.00057989196],"domain_scores_gemma":[0.9969883,0.00089839444,0.00059927086,0.0006638145,0.0006262419,0.00022400722],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030486155,0.00035848067,0.00087064516,0.0008229894,0.00007788054,0.000010093304,0.00027573112,0.00009939215,0.00011409859],"category_scores_gemma":[0.00065549277,0.00031272304,0.00042058938,0.0008349923,0.0002788891,0.000052032745,0.00013201473,0.00026155144,0.000086479],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022792662,0.0031902597,0.4952336,0.0013644425,0.0014947765,0.0031972302,0.0022090948,0.006627944,0.21956168,0.000034887533,0.02973177,0.23507507],"study_design_scores_gemma":[0.009858308,0.005837723,0.62285477,0.00011711375,0.0018571867,0.00019455969,0.00015850828,0.0343638,0.32313883,0.000045002922,0.0012288287,0.00034538234],"about_ca_topic_score_codex":0.00012710984,"about_ca_topic_score_gemma":0.00001069121,"teacher_disagreement_score":0.23472969,"about_ca_system_score_codex":0.0002250197,"about_ca_system_score_gemma":0.00023835119,"threshold_uncertainty_score":0.99993247},"labels":[],"label_agreement":null},{"id":"W4388741007","doi":"10.1016/j.ijrobp.2023.08.040","title":"When Ice Hurts","year":2023,"lang":"en","type":"letter","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Western University","funders":"","keywords":"Medicine; Chromophobe cell; Renal cell carcinoma; Scopus; Intervention (counseling); Internal medicine; Oncology; Clear cell; MEDLINE; Psychiatry","score_opus":0.03807194015268928,"score_gpt":0.3304956374430785,"score_spread":0.29242369729038925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388741007","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028907785,0.0018753756,0.00258574,0.9401715,0.018834226,0.0008422824,0.0003467281,0.00022725228,0.00620911],"genre_scores_gemma":[0.08300707,0.0045217616,0.008330149,0.7465715,0.14127791,0.00011029497,0.0050688484,0.0005456741,0.01056678],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964738,0.00038484958,0.0013494431,0.0004796136,0.0008487628,0.0004635406],"domain_scores_gemma":[0.9946835,0.0009539357,0.0022850805,0.0003830351,0.0015131058,0.00018132813],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00047933494,0.00050520553,0.0011976914,0.00052847184,0.00007221868,0.000053887466,0.00074422214,0.0013293712,0.0002602957],"category_scores_gemma":[0.00043941996,0.00043150116,0.00079530646,0.00019614125,0.00023364587,0.00021499842,0.00014144552,0.0027290606,0.0006030299],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003072042,0.00025364247,0.018732958,0.000047713558,0.0026751554,0.0039067646,0.00032178784,0.00006070307,0.00056970614,0.000441747,0.9149868,0.05769584],"study_design_scores_gemma":[0.004538549,0.0018243528,0.0044109,0.00021292265,0.00076713937,0.0015324666,0.000026344078,0.00016231225,0.0008813922,0.011056674,0.97424173,0.00034522134],"about_ca_topic_score_codex":0.000045578785,"about_ca_topic_score_gemma":0.0000030897193,"teacher_disagreement_score":0.19359998,"about_ca_system_score_codex":0.0024774496,"about_ca_system_score_gemma":0.0013805984,"threshold_uncertainty_score":0.9999671},"labels":[],"label_agreement":null},{"id":"W4388742036","doi":"10.1016/j.ijrobp.2023.06.2295","title":"Selecting the Right Tool for the Job: Contemporary Treatment of Localized Renal Cell Carcinoma","year":2023,"lang":"en","type":"editorial","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Radiology; Renal cell carcinoma; Cirrhosis; Ureter; Transjugular intrahepatic portosystemic shunt; Esophageal varices; Ascites; Biopsy; Nephrectomy; Kidney; Portal hypertension; Pathology; Surgery; Internal medicine","score_opus":0.03057658813803946,"score_gpt":0.3305254714581095,"score_spread":0.29994888332007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388742036","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0839581,0.008609464,0.005881197,0.005764485,0.8905136,0.0028670277,0.0012184118,0.00008322541,0.0011045072],"genre_scores_gemma":[0.44538563,0.0018184485,0.00091002806,0.00018956259,0.54924816,0.00020300219,0.001007456,0.00013608251,0.0011016073],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963806,0.0004597934,0.0015988311,0.00039637598,0.00080930366,0.00035504566],"domain_scores_gemma":[0.98364216,0.010495174,0.0031304765,0.00039768743,0.0022208188,0.00011366683],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011505882,0.00049028057,0.0012568346,0.00021591311,0.00019478572,0.000043832883,0.00072324165,0.0007415186,0.0000327853],"category_scores_gemma":[0.0011252782,0.00026994836,0.0010782655,0.0002337827,0.00032997044,0.00011417349,0.00007725365,0.00082177354,0.00001876222],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051408946,0.0010795902,0.022685027,0.000096364805,0.0052439533,0.00025740894,0.0011036819,0.0005128422,0.0022502367,0.00058263924,0.92511004,0.035937317],"study_design_scores_gemma":[0.015321396,0.0075939433,0.0020035736,0.00012235748,0.0016018432,0.00009572942,0.00011292247,0.0009909982,0.010132925,0.001222795,0.96052974,0.0002718001],"about_ca_topic_score_codex":0.00014866584,"about_ca_topic_score_gemma":0.00001407675,"teacher_disagreement_score":0.36142755,"about_ca_system_score_codex":0.0022740602,"about_ca_system_score_gemma":0.003601936,"threshold_uncertainty_score":0.99997526},"labels":[],"label_agreement":null},{"id":"W4388862431","doi":"10.4081/aiua.2023.11723","title":"Endophytic to total tumour volume ratio: An added variable to patients with T1b/T2 renal tumours undergoing partial nephrectomy","year":2023,"lang":"en","type":"article","venue":"Archivio Italiano di Urologia e Andrologia","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Thunder Bay Regional Health Sciences Centre","funders":"","keywords":"Nephrectomy; Medicine; Radiological weapon; Volume (thermodynamics); Kidney; Urology; Surgery; Internal medicine","score_opus":0.014365444948202247,"score_gpt":0.23551498588799546,"score_spread":0.22114954093979322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388862431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992703,0.000019258392,0.0012005662,0.0009248346,0.0002953458,0.0022983812,0.000118182856,0.0005641313,0.0018762961],"genre_scores_gemma":[0.9916601,0.0000041316007,0.0036915957,0.0014611651,0.00026293762,0.0006412922,0.00067003217,0.00010425643,0.0015044905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956963,0.00027866758,0.000593235,0.0012469293,0.000735723,0.0014491293],"domain_scores_gemma":[0.9975165,0.00027365703,0.00015826085,0.0008667933,0.0001977544,0.0009870123],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036792894,0.00063032086,0.0008067201,0.0005077595,0.00029504186,0.00011781333,0.00035411312,0.00016403415,0.00021016803],"category_scores_gemma":[0.00042807727,0.00049324584,0.00015462637,0.0013725661,0.0001450903,0.00027439356,0.0003085984,0.0004330906,0.0011825573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006109233,0.0009109575,0.9590759,0.00007131483,0.00032128012,0.0015526135,0.0006211504,0.008372267,0.015277387,0.00038324777,0.005922029,0.0013826011],"study_design_scores_gemma":[0.004227706,0.016313354,0.9720695,0.00007819851,0.0003330683,0.00015669418,0.000064963526,0.0013652871,0.003970934,0.00020822011,0.0005981207,0.00061395305],"about_ca_topic_score_codex":0.00019172991,"about_ca_topic_score_gemma":0.00010798131,"teacher_disagreement_score":0.015402395,"about_ca_system_score_codex":0.00017146334,"about_ca_system_score_gemma":0.00040008873,"threshold_uncertainty_score":0.9997519},"labels":[],"label_agreement":null},{"id":"W4388899098","doi":"10.1200/go.23.00271","title":"Trends of Utilization of Systemic Therapies for Metastatic Renal Cell Carcinoma in the Canadian Health Care System","year":2023,"lang":"en","type":"article","venue":"JCO Global Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Ottawa; McGill University Health Centre; McGill University; Université Laval; Centre Hospitalier de l’Université de Montréal; Ottawa Hospital; University Health Network; Health Sciences Centre; CancerCare Manitoba; Juravinski Cancer Centre; University of Manitoba; Hôtel-Dieu de Québec; BC Cancer Agency; Dalhousie University; University of Alberta; McMaster University; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Systemic therapy; Renal cell carcinoma; Cohort; Internal medicine; Kidney cancer; Cancer; Oncology","score_opus":0.066056637526048,"score_gpt":0.3543859277361913,"score_spread":0.2883292902101433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388899098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856566,0.005777535,0.000018596085,0.0012259685,0.0001812324,0.0010965005,0.00037511755,0.000021296824,0.005647138],"genre_scores_gemma":[0.9991456,0.000034104236,0.00019078593,0.00013486257,0.00003439629,0.000119029784,0.00027809164,0.000011037761,0.00005205164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984348,0.0003031062,0.00051984226,0.00019431932,0.00022495189,0.0003230056],"domain_scores_gemma":[0.999061,0.00013767564,0.00026328466,0.0002646628,0.00016213929,0.00011122143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046460715,0.00013320059,0.00060285063,0.00029470044,0.000056359928,0.000003733152,0.00012451535,0.000090949005,0.0000057171587],"category_scores_gemma":[0.000021729613,0.00009019025,0.00012986719,0.000796303,0.0000621131,0.000020086405,0.000012962938,0.000064286294,0.0000040557115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00456125,0.0016338237,0.5432954,0.036348224,0.0013028774,0.002704927,0.15965365,0.0024370446,0.0046464894,0.049523573,0.038591616,0.15530115],"study_design_scores_gemma":[0.010197034,0.013138786,0.85939604,0.00066271384,0.000735688,0.00077150424,0.10597773,0.0010610691,0.0016724465,0.00006876133,0.006047918,0.00027029068],"about_ca_topic_score_codex":0.087739244,"about_ca_topic_score_gemma":0.20498264,"teacher_disagreement_score":0.3161007,"about_ca_system_score_codex":0.0026382513,"about_ca_system_score_gemma":0.0017865014,"threshold_uncertainty_score":0.91833556},"labels":[],"label_agreement":null},{"id":"W4388997518","doi":"10.1016/j.soncn.2023.151545","title":"The Role of Nurses in the Management of Adverse Events in Patients Receiving First-Line Axitinib Plus Immuno-Oncology Agents for Advanced Renal Cell Carcinoma","year":2023,"lang":"en","type":"review","venue":"Seminars in Oncology Nursing","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Pfizer","keywords":"Medicine; Axitinib; Adverse effect; Oncology nursing; Oncology; Renal cell carcinoma; Internal medicine; Intensive care medicine; Nursing; Sunitinib; Nurse education","score_opus":0.03999780463418665,"score_gpt":0.3715311122058733,"score_spread":0.33153330757168664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388997518","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20324215,0.7822927,0.0000020124833,0.00014984948,0.0014619988,0.008502465,0.00006166419,0.000016216964,0.004270924],"genre_scores_gemma":[0.113930956,0.8824302,0.0008265394,0.000017755892,0.00008213101,0.001524548,0.00046086288,0.000118189724,0.0006088461],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995298,0.0007679934,0.0020391957,0.00065260933,0.00046389303,0.0007782611],"domain_scores_gemma":[0.99553317,0.0021679457,0.0013596533,0.0007596803,0.0001104749,0.000069052694],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015256308,0.0005468318,0.0024487218,0.000655757,0.00012534975,0.0000026190853,0.0006600327,0.0005455054,0.0000063371544],"category_scores_gemma":[0.00014632646,0.00037824214,0.00049136946,0.00095145445,0.0003443149,0.000052631414,0.00015419442,0.00066268106,0.0000050792105],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016149533,0.0016942451,0.0030454055,0.0070930137,0.00017401845,0.00025605116,0.0046694614,0.0001382987,0.0000056335566,0.000026135674,0.000102954604,0.98117983],"study_design_scores_gemma":[0.030161448,0.01387824,0.036139265,0.19977456,0.0046690707,0.00013902523,0.024972364,0.0002620803,0.00020143652,0.00081145513,0.68799055,0.0010004836],"about_ca_topic_score_codex":0.00008517437,"about_ca_topic_score_gemma":0.00020835955,"teacher_disagreement_score":0.98017937,"about_ca_system_score_codex":0.00564395,"about_ca_system_score_gemma":0.0007261748,"threshold_uncertainty_score":0.99986696},"labels":[],"label_agreement":null},{"id":"W4389008629","doi":"10.1096/fasebj.30.1_supplement.1040.10","title":"Laterality of Pancreatic Metastases from Renal Cell Carcinoma: An Anatomical Perspective from the Left Kidney and Tail of the Pancreas","year":2016,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph's Hospital; University Hospital; Western University","funders":"","keywords":"Medicine; Lymphatic system; Pancreas; Pathology; Metastasis; Kidney; Renal cell carcinoma; Anatomy; Cancer; Internal medicine","score_opus":0.019674085772958476,"score_gpt":0.2462508420993336,"score_spread":0.2265767563263751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389008629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99287057,0.0020256196,0.000035214358,0.0038020036,0.00008936015,0.000286553,0.0005822609,0.000006948411,0.00030144225],"genre_scores_gemma":[0.99896085,0.00011803059,0.00022581054,0.00026547685,0.00026088185,0.0000028897514,0.000010727983,0.000019896703,0.00013542168],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997746,0.00084646983,0.00043459696,0.00024111632,0.0004934704,0.00023834562],"domain_scores_gemma":[0.997738,0.00068229466,0.0003864961,0.00071144046,0.00020816666,0.00027360514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055886555,0.00022023964,0.00049253675,0.000035822875,0.00018453429,0.00002632672,0.00033598085,0.00006226654,0.00039998928],"category_scores_gemma":[0.00024306538,0.00007429295,0.00025378377,0.00008336635,0.0005598326,0.000105546664,0.000114246315,0.00032070623,0.0000044026274],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010356016,0.00022034136,0.40621576,0.0000110191695,0.00046736313,0.00005468961,0.0028837363,0.0000011291619,0.58807,0.00012754557,0.00058006553,0.00033276336],"study_design_scores_gemma":[0.0022724853,0.00029502125,0.5579063,0.00014079707,0.0012087021,0.00018728263,0.001481306,0.000019871637,0.43420127,0.0021746927,0.00003713613,0.000075124364],"about_ca_topic_score_codex":0.0051179235,"about_ca_topic_score_gemma":0.00009372302,"teacher_disagreement_score":0.1538687,"about_ca_system_score_codex":0.00016542502,"about_ca_system_score_gemma":0.00029614684,"threshold_uncertainty_score":0.7736803},"labels":[],"label_agreement":null},{"id":"W4389070029","doi":"10.1002/ijc.34793","title":"Role of clinicopathological variables in predicting recurrence and survival outcomes after surgery for non‐metastatic renal cell carcinoma: Systematic review and meta‐analysis","year":2023,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Meta-analysis; Oncology; Carcinoma; Internal medicine; Urology; Surgery","score_opus":0.058748458777658684,"score_gpt":0.35908446184673615,"score_spread":0.3003360030690775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389070029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9005843,0.09773552,0.00012818284,0.0007801347,0.00013328344,0.0005025243,0.00010524553,0.0000042390952,0.000026589509],"genre_scores_gemma":[0.99428093,0.0048336084,0.00047989865,0.00014480205,0.000037888763,0.000138113,0.000008540129,0.000009497035,0.00006674035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797,0.00014832054,0.0011068451,0.00017385674,0.00046620873,0.00013475974],"domain_scores_gemma":[0.9972931,0.0013312988,0.00072836975,0.0001062389,0.00045724298,0.00008374341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016970556,0.0001444871,0.0017831658,0.0004495174,0.000012310785,0.000015412177,0.000095593285,0.00003559502,0.000050248073],"category_scores_gemma":[0.0004842976,0.00009075384,0.0005450851,0.0002783847,0.00004611847,0.00009160733,0.000047140107,0.00012562102,4.6712267e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003214969,0.00012258651,0.95850575,0.02483285,0.0154122505,0.00027417776,0.00019066418,0.00006006459,0.00016250907,0.000008226427,0.00003272104,0.00007668839],"study_design_scores_gemma":[0.0012639859,0.00019859364,0.79193664,0.003729412,0.20132361,0.00011637894,0.00015764401,0.00060604414,0.00036361057,0.00017650191,0.0000056995946,0.00012187511],"about_ca_topic_score_codex":0.000054327582,"about_ca_topic_score_gemma":0.000040306448,"teacher_disagreement_score":0.18591137,"about_ca_system_score_codex":0.00006897971,"about_ca_system_score_gemma":0.00012478897,"threshold_uncertainty_score":0.37008342},"labels":[],"label_agreement":null},{"id":"W4389178955","doi":"","title":"Robotic-Assisted Partial Nephrectomy for Kidney Cancer: A Health Technology Assessment.","year":2023,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nephrectomy; Medicine; Kidney cancer; Grading (engineering); Systematic review; General surgery; Robotic surgery; Surgery; Kidney; MEDLINE; Cancer; Internal medicine","score_opus":0.07151942779084877,"score_gpt":0.3426922724432355,"score_spread":0.2711728446523868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389178955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65217143,0.0021285692,0.0018023783,0.31124264,0.0027846755,0.021783676,0.00020216125,0.003004899,0.004879583],"genre_scores_gemma":[0.9512497,0.00017194315,0.0019772195,0.0017943463,0.0003026329,0.040828995,0.00020680157,0.00005524989,0.0034130786],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981725,0.00003852821,0.00032067936,0.0003979391,0.0002434765,0.00082683656],"domain_scores_gemma":[0.99886286,0.000064874075,0.0001262863,0.00036303396,0.00008311399,0.00049980904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003232026,0.00018162376,0.0004743822,0.00034436042,0.00011867289,0.000019979949,0.00010171195,0.000114248134,0.000030450756],"category_scores_gemma":[0.00015046632,0.00015379163,0.00013542455,0.00083939923,0.00006053835,0.000040172108,0.0000537817,0.00015764592,0.000024323437],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004148981,0.00042362645,0.12506756,0.0005714685,0.00063075026,0.00015707743,0.00007943863,0.000052496514,0.00064093026,0.001296849,0.105983116,0.7646818],"study_design_scores_gemma":[0.0052788723,0.00038135916,0.82776135,0.000059220314,0.00023471007,0.000058880792,0.00010596393,0.00080095505,0.0031960837,0.00018905701,0.16172978,0.00020376932],"about_ca_topic_score_codex":0.00014114885,"about_ca_topic_score_gemma":0.000039976803,"teacher_disagreement_score":0.764478,"about_ca_system_score_codex":0.0006496776,"about_ca_system_score_gemma":0.0005750742,"threshold_uncertainty_score":0.62714404},"labels":[],"label_agreement":null},{"id":"W4389237128","doi":"10.3390/curroncol30120749","title":"Incorporating Stereotactic Ablative Radiotherapy into the Multidisciplinary Management of Renal Cell Carcinoma","year":2023,"lang":"en","type":"review","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute","keywords":"SABR volatility model; Medicine; Renal cell carcinoma; Radiosurgery; Ablative case; Radiation therapy; Radiology; Medical physics; Oncology","score_opus":0.19384685365709367,"score_gpt":0.44400637314236385,"score_spread":0.25015951948527015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389237128","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027192936,0.9896018,0.000060646595,0.00009221167,0.0010980505,0.0036455449,0.00002234158,0.00006155224,0.0026985747],"genre_scores_gemma":[0.0018209339,0.994499,0.0011127345,0.0000067742008,0.00036432,0.00077935396,0.0002814084,0.00013332735,0.0010020967],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963138,0.000706342,0.0013275378,0.00074777973,0.00046514047,0.00043940177],"domain_scores_gemma":[0.9965886,0.0007327066,0.0014316785,0.0009319676,0.00013742475,0.0001776425],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006333584,0.00067481183,0.0026294084,0.00038421576,0.00015181059,0.000013941605,0.00039452466,0.00031142682,0.000055261327],"category_scores_gemma":[0.000018917448,0.00040513778,0.0008208716,0.00073538773,0.00031509026,0.000044275872,0.00044308096,0.00090448005,0.00011942562],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012504854,0.00074617,0.00030582727,0.048701297,0.0013070247,0.0009070356,0.0014225567,0.000003059126,0.000005621007,0.0001323017,0.00051480613,0.9458293],"study_design_scores_gemma":[0.003415141,0.003708038,0.0014089684,0.020475047,0.009817117,0.00029887585,0.0011411527,0.00015381107,0.000035315126,0.00016015161,0.95872855,0.0006578218],"about_ca_topic_score_codex":0.000030591964,"about_ca_topic_score_gemma":0.000010317987,"teacher_disagreement_score":0.95821375,"about_ca_system_score_codex":0.001788076,"about_ca_system_score_gemma":0.00073402433,"threshold_uncertainty_score":0.99984},"labels":[],"label_agreement":null},{"id":"W4389385327","doi":"10.21203/rs.3.rs-3675752/v1","title":"Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma","year":2023,"lang":"en","type":"preprint","venue":"Research Square","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre; Institute of Cancer Research","funders":"Medical Research Council; Rosetrees Trust; Department of Health and Social Care; Wellcome Trust; Francis Crick Institute; National Institute for Health and Care Research; Melanoma Research Alliance; Cancer Research UK; U.S. Department of Defense","keywords":"Clear cell renal cell carcinoma; Genome; Renal cell carcinoma; Biology; Drug repositioning; Epigenetics; Immunotherapy; Computational biology; Bioinformatics; Cancer; Gene; Medicine; Oncology; Genetics; Drug","score_opus":0.10060033869881385,"score_gpt":0.3377012893549824,"score_spread":0.23710095065616854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389385327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933097,0.0020587046,0.00001474443,0.00026655776,0.000035371722,0.0023366534,0.00033997156,0.000052692638,0.0015856307],"genre_scores_gemma":[0.99456453,0.0008898251,0.00073762133,0.000009470815,0.00012692633,0.00018836453,0.0016446131,0.00010897452,0.0017296604],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9962609,0.00032627152,0.0004721567,0.0008604178,0.0015475616,0.0005326829],"domain_scores_gemma":[0.9971293,0.00019388062,0.00023725229,0.0010775379,0.0010839006,0.00027809993],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074578583,0.0003459039,0.0005637009,0.000562034,0.0001425158,0.00007186011,0.0002229058,0.000281456,0.00006279205],"category_scores_gemma":[0.00003834434,0.0002577988,0.000119043805,0.0003219214,0.00023580612,0.000060709343,0.00033470136,0.0010135856,0.00006091772],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006103292,0.0017656747,0.4157742,0.013920346,0.0003226204,0.0005628515,0.005554169,0.0005647491,0.54918903,0.000030513485,0.0011072928,0.0051052645],"study_design_scores_gemma":[0.0028144743,0.0045900103,0.90895885,0.00047863694,0.00005879357,0.0000032544503,0.00071199454,0.00013318476,0.08116899,0.00013300541,0.00065973785,0.0002890998],"about_ca_topic_score_codex":0.0009785573,"about_ca_topic_score_gemma":0.000037964535,"teacher_disagreement_score":0.49318463,"about_ca_system_score_codex":0.0005048886,"about_ca_system_score_gemma":0.0008399129,"threshold_uncertainty_score":0.9999874},"labels":[],"label_agreement":null},{"id":"W4389500584","doi":"10.1016/j.eururo.2023.11.016","title":"Corrigendum to “Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study” [Eur Urol 84(5) (2023) 449–454]","year":2023,"lang":"en","type":"erratum","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Axitinib; Sunitinib; Pembrolizumab; Renal cell carcinoma; Urology; Oncology; Internal medicine; Cancer; Immunotherapy","score_opus":0.055619733899411716,"score_gpt":0.30049936676318856,"score_spread":0.24487963286377684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389500584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84254324,0.0035921829,0.00001425919,0.0008639721,0.0382189,0.00628038,0.0013061253,0.0002381375,0.106942795],"genre_scores_gemma":[0.7600651,0.00031153907,0.00004177559,0.00024992402,0.0016262421,0.0002220493,0.0016166382,0.00050462596,0.23536211],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99141294,0.0016640086,0.0021311082,0.0019916873,0.0013531253,0.001447148],"domain_scores_gemma":[0.9932116,0.00053225213,0.0015355744,0.0033470439,0.0006391681,0.0007343298],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0005473672,0.0016261612,0.0030166933,0.0008323538,0.00030085508,0.000028483824,0.0012254766,0.0005252801,0.00057247916],"category_scores_gemma":[0.0006861724,0.0012307704,0.0012763746,0.0011157489,0.0004212867,0.000060041548,0.0007822365,0.0013129262,0.000908343],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20283948,0.021664837,0.0023647738,0.0016414531,0.005701838,0.041486654,0.0153355505,0.0015079282,0.004807866,0.000073180076,0.68871194,0.013864474],"study_design_scores_gemma":[0.16871047,0.17519745,0.02678338,0.00025514673,0.008062389,0.000372645,0.0012721814,0.00015568202,0.0049966774,0.000013139894,0.6127291,0.0014517475],"about_ca_topic_score_codex":0.0009528381,"about_ca_topic_score_gemma":0.0010440933,"teacher_disagreement_score":0.15353261,"about_ca_system_score_codex":0.0008644741,"about_ca_system_score_gemma":0.0013670236,"threshold_uncertainty_score":0.9998696},"labels":[],"label_agreement":null},{"id":"W4389581239","doi":"10.1016/j.ijrobp.2023.12.005","title":"Evaluation of Volumetric Response Assessment From SABR for Renal Cell Carcinoma","year":2023,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; McMaster University; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"","keywords":"SABR volatility model; Medicine; Ablative case; Renal cell carcinoma; Radiation therapy; Radiology; Carcinoma; Medical physics; Nuclear medicine; Oncology; Internal medicine","score_opus":0.061039185278866225,"score_gpt":0.38676519536464166,"score_spread":0.32572601008577545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389581239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870858,0.00059594074,0.007529217,0.001633047,0.0017999975,0.00059917517,0.00020937783,0.000028195453,0.000519245],"genre_scores_gemma":[0.9912599,0.000121970326,0.006342282,0.00017064484,0.0015250645,0.00005264433,0.0003871649,0.000034073666,0.00010626691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99666154,0.00079739525,0.0010035641,0.00028075353,0.0010214889,0.00023527507],"domain_scores_gemma":[0.99335027,0.0016387154,0.0014517847,0.0002273701,0.003192428,0.00013940776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039174794,0.00020563745,0.00057651073,0.000585284,0.00005773416,0.000016769269,0.00030578033,0.00023006728,0.00010531807],"category_scores_gemma":[0.0011435382,0.00018202043,0.00040259538,0.0004567607,0.00010790064,0.0001668886,0.000060155948,0.0002974056,0.000029864183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006509815,0.0015010287,0.45105824,0.000030431145,0.0018302465,0.000099973004,0.00083488977,0.004462486,0.2281643,0.00092547777,0.006385875,0.29819724],"study_design_scores_gemma":[0.020605061,0.0055952147,0.8557601,0.00006065739,0.0015829522,0.00007177174,0.00020124865,0.038116094,0.06019732,0.010154055,0.0074323583,0.00022318897],"about_ca_topic_score_codex":0.000042396212,"about_ca_topic_score_gemma":0.0000029670348,"teacher_disagreement_score":0.40470186,"about_ca_system_score_codex":0.0022333476,"about_ca_system_score_gemma":0.0022129545,"threshold_uncertainty_score":0.7422578},"labels":[],"label_agreement":null},{"id":"W4389664194","doi":"10.1016/j.euo.2023.11.016","title":"Real-world Assessment of Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma with or Without Sarcomatoid Features Treated with First-line Systemic Therapies","year":2023,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; London Health Sciences Centre; Western University; Centre hospitalier universitaire de Québec; Princess Margaret Cancer Centre; University of Calgary; Université Laval; Centre Hospitalier de l’Université de Montréal; McMaster University; Alberta Health Services; Université de Montréal; Queen Elizabeth II Health Sciences Centre; Ottawa Hospital; University Health Network; Dalhousie University; University of Manitoba; Juravinski Cancer Centre; McGill University Health Centre","funders":"McGill University","keywords":"Medicine; Renal cell carcinoma; Systemic therapy; Oncology; Internal medicine; Intensive care medicine; Pathology; Cancer","score_opus":0.04354414202864189,"score_gpt":0.3461018557140005,"score_spread":0.3025577136853586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389664194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898065,0.00008350356,0.000025411946,0.0005341718,0.000078969555,0.0017316545,0.000028733824,0.00015298625,0.0075581074],"genre_scores_gemma":[0.9944144,0.00010763544,0.0025789938,0.00029311137,0.000052194227,0.0000988255,0.00020701505,0.00014585911,0.0021019832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99498653,0.0018680571,0.0011758419,0.00083491096,0.00048573216,0.0006489036],"domain_scores_gemma":[0.99671006,0.0012245295,0.0007856464,0.00078494474,0.00025294707,0.00024189406],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009550295,0.0005570758,0.0021462953,0.00066183455,0.00008480478,0.000010290867,0.00026163427,0.000119172604,0.00006411639],"category_scores_gemma":[0.0000592846,0.0002844078,0.00013627266,0.00080650183,0.0005787236,0.00007111042,0.00011097506,0.0006352663,0.000036758167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015924964,0.00192953,0.9736577,0.00021639613,0.00079686666,0.005949611,0.00048030843,0.00030226828,0.00006235211,0.000019727086,0.00016872789,0.0004915358],"study_design_scores_gemma":[0.027211092,0.04294834,0.9276683,0.0001492893,0.00085668464,0.00031147065,0.00018329911,0.00007396713,0.00006843972,0.0000017355319,0.0002621928,0.00026521317],"about_ca_topic_score_codex":0.00032662798,"about_ca_topic_score_gemma":0.0034358853,"teacher_disagreement_score":0.045989435,"about_ca_system_score_codex":0.00023787051,"about_ca_system_score_gemma":0.0006402128,"threshold_uncertainty_score":0.9999608},"labels":[],"label_agreement":null},{"id":"W4389734685","doi":"10.33590/emj/10301071","title":"Redefining Renal Cell Carcinoma: A Molecular Perspective on Classification and Clinical Implications","year":2023,"lang":"en","type":"article","venue":"European Medical Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Renal cell carcinoma; TFE3; Kidney cancer; Clear cell; Medicine; Pathology; Cancer research; Biology; Computational biology; Gene; Genetics","score_opus":0.0671334292945913,"score_gpt":0.34950210635921697,"score_spread":0.28236867706462565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389734685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8837528,0.00034311245,0.000360745,0.023217734,0.0001614682,0.00017372644,0.0000032251162,0.00008830742,0.09189888],"genre_scores_gemma":[0.99638295,0.00038130206,0.0005461203,0.0014176389,0.0006881232,0.0000043657296,0.0000205351,0.000050000046,0.00050895906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735296,0.0005870746,0.00058387284,0.00041399154,0.0007407085,0.00032137905],"domain_scores_gemma":[0.9980844,0.0002557187,0.0001843436,0.00033298205,0.00018383727,0.00095872214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018034896,0.00017795332,0.00027960955,0.00022091276,0.00021074372,0.000051982457,0.00016391846,0.00012117821,0.00011135583],"category_scores_gemma":[0.0010383112,0.00013586873,0.00019741897,0.00031298937,0.00019920236,0.00003927383,0.00009322752,0.0014139973,0.0005292664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025324775,0.0040821726,0.38594767,0.00018692561,0.001118093,0.07566674,0.004412173,0.0000284461,0.065783694,0.03691926,0.15197098,0.27135137],"study_design_scores_gemma":[0.0027537532,0.0012991783,0.98892766,0.00012516804,0.00018702017,0.0023036683,0.00056511146,0.00028929053,0.0003217055,0.00039187403,0.0026910726,0.0001444866],"about_ca_topic_score_codex":0.000004453486,"about_ca_topic_score_gemma":5.5182875e-7,"teacher_disagreement_score":0.60298,"about_ca_system_score_codex":0.00020703906,"about_ca_system_score_gemma":0.00027909194,"threshold_uncertainty_score":0.68028253},"labels":[],"label_agreement":null},{"id":"W4389817034","doi":"10.21203/rs.3.rs-2422476/v1","title":"Stereotactic Radiation therapy in early and locally advanced inoperable renal cell carcinoma: treatment outcomes, patterns of failure and risk factors","year":2023,"lang":"en","type":"preprint","venue":"Research Square","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Radiation therapy; Renal cell carcinoma; Systematic review; Radioresistance; Oncology; Kidney cancer; Cancer; Internal medicine; Intensive care medicine; MEDLINE","score_opus":0.06005112721671195,"score_gpt":0.3450267470897159,"score_spread":0.28497561987300396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389817034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99297154,0.003098785,0.000008742432,0.00024288012,0.000060795686,0.0032201898,0.00029959052,0.000037992188,0.000059478996],"genre_scores_gemma":[0.98711056,0.011127417,0.000111893125,0.0000043388313,0.00004870869,0.000340723,0.00028798924,0.00008473183,0.00088363327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963975,0.00062120275,0.000549462,0.00089497626,0.00092326954,0.0006136007],"domain_scores_gemma":[0.9977603,0.0006404284,0.0002132697,0.000783105,0.00027442156,0.000328474],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005825549,0.00047877833,0.0009653297,0.0008560008,0.0001030948,0.00007944108,0.00013728839,0.00034775128,0.000031121304],"category_scores_gemma":[0.00011826038,0.00034387485,0.00016606778,0.00028244036,0.00010662932,0.000100594705,0.00030548964,0.0010680301,0.0000076800725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005050227,0.00042310276,0.9877314,0.00089359906,0.00021670363,0.00032754987,0.002783393,0.00009365889,0.0009846127,0.000003081197,0.000012670293,0.006025206],"study_design_scores_gemma":[0.0060918983,0.004691894,0.97694594,0.00044954973,0.00008788015,0.000005246278,0.00078797503,0.00011353062,0.010464231,0.000049341976,0.00008642662,0.00022608659],"about_ca_topic_score_codex":0.0237218,"about_ca_topic_score_gemma":0.0013992978,"teacher_disagreement_score":0.022322502,"about_ca_system_score_codex":0.00091290905,"about_ca_system_score_gemma":0.0004454079,"threshold_uncertainty_score":0.99990135},"labels":[],"label_agreement":null},{"id":"W4389923062","doi":"10.3390/ijms242417582","title":"Mesenchymal–Epithelial Transition Kinase Inhibitor Therapy in Patients with Advanced Papillary Renal-Cell Carcinoma: A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"International Journal of Molecular Sciences","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Universidade Federal do Pará; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Medicine; Meta-analysis; Internal medicine; Papillary renal cell carcinomas; Renal cell carcinoma; Adverse effect; Oncology; Cohort; Carcinoma; Gastroenterology","score_opus":0.04481933226267177,"score_gpt":0.3197152490208445,"score_spread":0.27489591675817276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389923062","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014094723,0.98372656,0.00003961494,0.0002925496,0.00007116713,0.0016824885,0.000052380725,0.0000070318442,0.000033494045],"genre_scores_gemma":[0.040024705,0.95899445,0.00048384897,0.00025234596,0.00003232611,0.00009653741,0.00004667068,0.000031212174,0.00003791629],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99547917,0.00048251226,0.0014854335,0.00044048633,0.0019004588,0.00021192012],"domain_scores_gemma":[0.99731576,0.00015073664,0.0014671104,0.00025511984,0.00065694354,0.00015434794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011528541,0.00043148096,0.004069913,0.0013497297,0.00004191297,0.00007476272,0.0004373112,0.000097657976,0.000031017134],"category_scores_gemma":[0.000087236855,0.00022707776,0.0017659703,0.0012644749,0.000139685,0.00018849649,0.00004551099,0.0003027368,0.000004973516],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059598003,0.0023560417,0.00022985946,0.68416065,0.27887723,0.014071992,0.00079629925,0.00034174212,0.00011763544,0.00003877013,0.00005973106,0.018354092],"study_design_scores_gemma":[0.0032061131,0.004131711,0.00024194458,0.06941814,0.9206932,0.0006158471,0.00007416123,0.000011969574,0.00028814125,0.000031457246,0.0006331565,0.00065415615],"about_ca_topic_score_codex":0.000016499835,"about_ca_topic_score_gemma":0.000004366707,"teacher_disagreement_score":0.64181596,"about_ca_system_score_codex":0.000213274,"about_ca_system_score_gemma":0.00040021702,"threshold_uncertainty_score":0.92599624},"labels":[],"label_agreement":null},{"id":"W4390222755","doi":"10.1155/2023/6632030","title":"Migration of an Inferior Vena Cava Tumor Thrombus during Renal Cell Carcinoma Resection","year":2023,"lang":"en","type":"article","venue":"Case Reports in Anesthesiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; St Mary's Hospital Centre; Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Medicine; Inferior vena cava; Renal cell carcinoma; Nephrectomy; Thrombus; Cardiopulmonary bypass; Ventricle; Surgery; Radiology; Complication; Cardiology; Kidney; Internal medicine","score_opus":0.025218054930512795,"score_gpt":0.2750678122422933,"score_spread":0.24984975731178052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390222755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99882287,0.0002103574,7.2624533e-7,0.000054027267,0.00012729027,0.00045478556,0.0000014874546,0.000074334435,0.00025411637],"genre_scores_gemma":[0.9993154,0.000019441291,0.00013712392,0.000027433085,0.00010459215,0.000049365884,0.000081675775,0.000031267085,0.00023374095],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9982568,0.00016161762,0.00065704715,0.00044716225,0.00017314394,0.00030422182],"domain_scores_gemma":[0.998843,0.000067846006,0.00029535708,0.00057216553,0.000097097094,0.00012452302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040718875,0.00018019951,0.0004601904,0.00042324004,0.00006224015,0.0000055087985,0.000029360404,0.00014698076,0.000044103843],"category_scores_gemma":[0.00009816995,0.00015701093,0.000094288596,0.00040503708,0.00010342055,0.00007608474,0.000031115884,0.0001823028,0.00001223538],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028480546,0.0001283453,0.35093322,0.00017857339,0.000007963844,0.50351506,0.0004360933,0.00016233847,0.14411013,0.0000021987876,0.000026978378,0.00021430319],"study_design_scores_gemma":[0.0004588538,0.0010417635,0.59859264,0.000037804028,0.00003690216,0.19473423,0.0001958918,0.00014268492,0.20459698,0.000029495177,0.000049704777,0.00008305499],"about_ca_topic_score_codex":0.0016136618,"about_ca_topic_score_gemma":0.00046400333,"teacher_disagreement_score":0.30878082,"about_ca_system_score_codex":0.00019256276,"about_ca_system_score_gemma":0.00016691144,"threshold_uncertainty_score":0.64027196},"labels":[],"label_agreement":null},{"id":"W4390246136","doi":"10.1016/j.clgc.2023.12.013","title":"The Effect of Treatment Intensification on Other-Cause Mortality in Clear-Cell Metastatic Renal Cell Carcinoma Patients","year":2023,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Clear cell renal cell carcinoma; Internal medicine","score_opus":0.10167405571182835,"score_gpt":0.3936564586000451,"score_spread":0.29198240288821675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390246136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963197,0.0004547929,7.5840575e-7,0.00020812094,0.00043244148,0.0013924593,0.00004655232,0.00003976647,0.0011054215],"genre_scores_gemma":[0.9971753,0.00059200544,0.000021073283,0.00009947006,0.00018416489,0.00033070074,0.00006231215,0.000046461995,0.001488517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972232,0.00061231246,0.0009110297,0.0005106977,0.0003717155,0.00037103426],"domain_scores_gemma":[0.99726886,0.0013462193,0.00030376908,0.0007773604,0.000113580565,0.00019021948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006959034,0.00029164564,0.00064245315,0.0001209123,0.00007812253,0.000010804453,0.00014789723,0.000103329425,0.000041163614],"category_scores_gemma":[0.0001518871,0.00017035495,0.00037616104,0.00038519624,0.00017693716,0.000033165845,0.000059483616,0.0002788162,0.0001661922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041332785,0.0010781966,0.97938794,0.00014618738,0.00021357763,0.00022423407,0.00012707147,0.0001659538,0.0010078086,0.0000014825205,0.0010442646,0.01246999],"study_design_scores_gemma":[0.006924204,0.020093756,0.9369027,0.000071664595,0.0006091406,0.0000018593328,0.00006136029,0.00035297152,0.033833556,0.000012942812,0.0009946349,0.00014122401],"about_ca_topic_score_codex":0.00044467492,"about_ca_topic_score_gemma":0.000072553295,"teacher_disagreement_score":0.04248527,"about_ca_system_score_codex":0.00051698927,"about_ca_system_score_gemma":0.00017143047,"threshold_uncertainty_score":0.69468737},"labels":[],"label_agreement":null},{"id":"W4390490764","doi":"10.1016/s1470-2045(23)00513-2","title":"Stereotactic body radiotherapy for primary renal cell carcinoma: a systematic review and practice guideline from the International Society of Stereotactic Radiosurgery (ISRS)","year":2024,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Cancer Council Tasmania; Cancer Council Victoria","keywords":"Medicine; Radiosurgery; Guideline; Renal cell carcinoma; Stereotactic biopsy; Radiology; Radiation therapy; Biopsy; Oncology; Pathology","score_opus":0.08282780186880907,"score_gpt":0.38686672395237626,"score_spread":0.3040389220835672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390490764","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003706685,0.9719766,0.000062202496,0.018338379,0.0006479232,0.0074585252,0.0003364941,0.000039929237,0.0011029292],"genre_scores_gemma":[0.000041172992,0.97951764,0.0031853383,0.012615129,0.0016421254,0.0013381899,0.00051316194,0.000111192116,0.0010360348],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99498653,0.0014430662,0.0020177623,0.00065463374,0.00049011153,0.0004079197],"domain_scores_gemma":[0.9855216,0.010684166,0.0020475325,0.0013344906,0.00030515192,0.00010703442],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0043265,0.0006415885,0.005898512,0.000077911165,0.000088676206,0.000057163637,0.00068405265,0.00031970008,0.000053503783],"category_scores_gemma":[0.000745184,0.00029770823,0.0012651489,0.00024729173,0.00021098887,0.00009387101,0.00021944159,0.00086198136,0.000020768912],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036161294,0.00024476697,0.000009477623,0.78284514,0.0058853435,0.00014620354,0.00034854142,6.793385e-8,0.00003071322,0.000031487285,0.20255266,0.007543957],"study_design_scores_gemma":[0.0014751048,0.0005631119,0.000012661549,0.078391075,0.06363953,0.002975835,0.000071930175,0.00002485371,0.0000026929229,0.000019969984,0.8525925,0.00023070091],"about_ca_topic_score_codex":0.00007687556,"about_ca_topic_score_gemma":0.0000034387936,"teacher_disagreement_score":0.7044541,"about_ca_system_score_codex":0.0014119557,"about_ca_system_score_gemma":0.0014671765,"threshold_uncertainty_score":0.9999475},"labels":[],"label_agreement":null},{"id":"W4390645948","doi":"10.1136/bcr-2023-255841","title":"Chronic thrombotic microangiopathy presenting as acute nephrotic syndrome in a patient with renal cancer receiving tyrosine kinase inhibitor therapy","year":2024,"lang":"en","type":"article","venue":"BMJ Case Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Thrombotic microangiopathy; Medicine; Nephrotic syndrome; Tyrosine-kinase inhibitor; Internal medicine; Tyrosine kinase; Sunitinib; Protein-Tyrosine Kinases; Cancer; Gastroenterology; Receptor","score_opus":0.019160632158494548,"score_gpt":0.29498723322419007,"score_spread":0.2758266010656955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390645948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97576445,0.020074485,0.000013003255,0.0006711267,0.00041950966,0.0025087434,0.000005617977,0.00015311655,0.0003899254],"genre_scores_gemma":[0.99753517,0.00028005228,0.00028245067,0.0000869879,0.00035824347,0.000623074,0.00003454945,0.000109628454,0.0006898394],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9971386,0.00008266997,0.00079913717,0.00083387305,0.00056445954,0.00058125064],"domain_scores_gemma":[0.9986698,0.00006897438,0.00024535414,0.00067190477,0.00010511219,0.00023886834],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030817412,0.0004062816,0.0005916052,0.00031688056,0.00009100976,0.000104630424,0.000033276487,0.00011382099,0.00021033309],"category_scores_gemma":[0.00004126043,0.00029217493,0.0001941444,0.0006491881,0.000081894046,0.00018129038,0.00007178731,0.00034908502,0.000027869577],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015885578,0.00018315244,0.006197124,0.0003851165,0.00043405915,0.95179766,0.0007946076,0.00017537104,0.032105103,0.0000024442445,0.00023648885,0.007530013],"study_design_scores_gemma":[0.0009835819,0.0015413341,0.010293815,0.003888844,0.00043971033,0.9419283,0.00008199946,0.00038607843,0.03942347,0.000019948842,0.00067734474,0.00033555637],"about_ca_topic_score_codex":0.0016327598,"about_ca_topic_score_gemma":0.00033758485,"teacher_disagreement_score":0.021770703,"about_ca_system_score_codex":0.0011652724,"about_ca_system_score_gemma":0.0010309616,"threshold_uncertainty_score":0.99995303},"labels":[],"label_agreement":null},{"id":"W4390665472","doi":"10.1089/end.2023.0505","title":"Single-Port <i>vs</i> Multiport Robot-Assisted Partial Nephrectomy: A Meta-Analysis","year":2024,"lang":"en","type":"article","venue":"Journal of Endourology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Nephrectomy; Meta-analysis; Perioperative; Odds ratio; Renal function; Blood loss; Confidence interval; Surgery; Urology; Internal medicine; Kidney","score_opus":0.10632037793634302,"score_gpt":0.31963695710462625,"score_spread":0.21331657916828323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390665472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9428932,0.029974476,0.0051430827,0.014909272,0.0015802119,0.0007594295,0.000024424851,0.00015674972,0.004559119],"genre_scores_gemma":[0.9930358,0.00005286965,0.0039966484,0.0011646257,0.0005554438,0.00002897993,0.00001631408,0.00004061276,0.0011087264],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99734473,0.00021135103,0.0011245448,0.0003510739,0.00056770525,0.0004005747],"domain_scores_gemma":[0.9982063,0.00031759765,0.00045493979,0.00038549732,0.000286899,0.00034873272],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007512386,0.00030347024,0.0020175462,0.00087416405,0.000042939446,0.000050158254,0.00015097168,0.00017940388,0.0015249837],"category_scores_gemma":[0.00012716293,0.00019519542,0.003323406,0.00077536004,0.00009510698,0.00012737604,0.000043227355,0.0005895609,0.00005702145],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00447384,0.0020038362,0.026643485,0.0001635613,0.77852184,0.081493594,0.000454346,0.0016894545,0.0832882,0.00018754302,0.011733895,0.009346419],"study_design_scores_gemma":[0.0027170873,0.0049456246,0.02633797,0.000014246424,0.772233,0.021446696,0.000035319328,0.00083649193,0.02202988,0.00008523879,0.14903226,0.00028618122],"about_ca_topic_score_codex":0.000036512283,"about_ca_topic_score_gemma":0.00003592154,"teacher_disagreement_score":0.13729836,"about_ca_system_score_codex":0.00016703836,"about_ca_system_score_gemma":0.0003205668,"threshold_uncertainty_score":0.99938774},"labels":[],"label_agreement":null},{"id":"W4390685616","doi":"10.48083/grqw4595","title":"Liquid Biopsies in Genitourinary Malignancies","year":2023,"lang":"fr","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Veracyte","keywords":"Genitourinary system; Medicine; Oncology; Internal medicine","score_opus":0.07043880412702828,"score_gpt":0.3378980165110137,"score_spread":0.2674592123839854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390685616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9138177,0.03370485,0.000031474494,0.028807089,0.010232691,0.00032264905,0.000064937354,0.00011771207,0.012900908],"genre_scores_gemma":[0.9138355,0.0171262,0.00035253665,0.0008517083,0.0042759874,0.00005357636,0.00009323492,0.000050256025,0.063361004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962683,0.00035063387,0.00095022476,0.00043678284,0.0009385108,0.0010555802],"domain_scores_gemma":[0.99786603,0.0007805758,0.00037398163,0.00029174588,0.0003791308,0.00030850165],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012948657,0.00041380327,0.0005722836,0.00090147974,0.00020201552,0.00011831914,0.00049083005,0.0003703419,0.0023227711],"category_scores_gemma":[0.0008653,0.0003832472,0.00050525845,0.0006664593,0.0003597272,0.0003680236,0.00031911326,0.0012379092,0.0015122975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005688886,0.003022632,0.5775698,0.0008190799,0.003427048,0.116370276,0.0071149548,0.006293642,0.044815466,0.006065767,0.17329352,0.055518948],"study_design_scores_gemma":[0.0052492567,0.004081508,0.87492716,0.0010370517,0.00032806117,0.0072387257,0.005881082,0.0017306514,0.0047551966,0.0056136413,0.0885301,0.00062755315],"about_ca_topic_score_codex":0.00008615992,"about_ca_topic_score_gemma":0.000026160955,"teacher_disagreement_score":0.29735738,"about_ca_system_score_codex":0.001489629,"about_ca_system_score_gemma":0.00062864734,"threshold_uncertainty_score":0.99986196},"labels":[],"label_agreement":null},{"id":"W4390711094","doi":"10.48083/mpru1397","title":"Proceedings From the 5th B2B Uro-Oncology: GU Cancers Triad Meeting: Kidney Cancer","year":2023,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Triad (sociology); Kidney cancer; Medicine; Oncology; Cancer; Internal medicine; Psychology; Psychoanalysis","score_opus":0.09038309535823096,"score_gpt":0.38166103187680106,"score_spread":0.2912779365185701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390711094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.894902,0.001308525,0.0000132440355,0.07642362,0.002533248,0.0004913758,0.0001068286,0.00017097665,0.024050193],"genre_scores_gemma":[0.9752947,0.003435467,0.0003721651,0.010292946,0.0038443564,0.00021148451,0.00012303682,0.000047385194,0.006378446],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975165,0.00009656272,0.00058593834,0.0003950895,0.00089450815,0.0005114175],"domain_scores_gemma":[0.9977369,0.0006593461,0.00052198226,0.00018221674,0.0005546488,0.00034495138],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009176183,0.00028039495,0.00044588867,0.00017206222,0.00034071988,0.00011379455,0.0005136507,0.0002031235,0.0014214594],"category_scores_gemma":[0.001539576,0.00018009462,0.00038139737,0.00035043404,0.0001858912,0.0001616811,0.00017170091,0.0008697486,0.00010791418],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014354599,0.00015334957,0.34172747,0.000024397796,0.0018186505,0.0005749848,0.002319408,0.00023088862,0.009826354,0.0002253073,0.6272122,0.01445149],"study_design_scores_gemma":[0.010846245,0.0014035001,0.33225366,0.00035751273,0.001023822,0.00073713704,0.005323365,0.0021094922,0.0068206396,0.0046549942,0.6339774,0.0004922037],"about_ca_topic_score_codex":0.00053439045,"about_ca_topic_score_gemma":0.000063831474,"teacher_disagreement_score":0.080392726,"about_ca_system_score_codex":0.002111483,"about_ca_system_score_gemma":0.0015548395,"threshold_uncertainty_score":0.9994914},"labels":[],"label_agreement":null},{"id":"W4390902638","doi":"10.1200/jco.23.01569","title":"Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Western University; Juravinski Cancer Centre","funders":"Cilag; EMD Serono; Genentech; Eisai; Astellas Pharma; Eli Lilly and Company; Ono Pharmaceutical; Chugai Pharmaceutical; AstraZeneca; EUSA Pharma; Seagen; LG Chem; Advanced Accelerator Applications; Pfizer; Incyte; Ipsen; BeiGene; Tizona Therapeutics; Sanofi; Exelixis; Memorial Sloan-Kettering Cancer Center; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; Amgen; Bristol-Myers Squibb","keywords":"Medicine; Lenvatinib; Sunitinib; Clinical endpoint; Renal cell carcinoma; Internal medicine; Hazard ratio; Pembrolizumab; Discontinuation; Oncology; Phases of clinical research; Clinical trial; Confidence interval; Cancer; Sorafenib; Immunotherapy; Hepatocellular carcinoma","score_opus":0.24905172738378725,"score_gpt":0.4762400422636671,"score_spread":0.22718831487987987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390902638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926637,0.0020363014,0.00003865078,0.00051732705,0.0010042612,0.0008213614,0.000048695907,0.000012120495,0.0028576148],"genre_scores_gemma":[0.9974073,0.00078764075,0.0006473955,0.000026270605,0.0005062063,0.000021054017,0.000037572532,0.00003566237,0.0005308752],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99250853,0.0008384227,0.0049072015,0.000495869,0.0008570024,0.00039294877],"domain_scores_gemma":[0.9908697,0.0056649037,0.0020242382,0.0005070361,0.0005363981,0.00039773982],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019833443,0.00037391548,0.0043761823,0.0010624162,0.000032802094,0.000011347572,0.0002404536,0.00033494664,0.00038665993],"category_scores_gemma":[0.00073145126,0.00026823254,0.0016931752,0.0009692255,0.0002282133,0.00012608005,0.00007528141,0.0007490755,0.000005018711],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7115575,0.07573561,0.06760972,0.00035041588,0.014360355,0.021802017,0.0047009047,0.009288128,0.0015837207,0.0001281637,0.00034787168,0.092535555],"study_design_scores_gemma":[0.27790627,0.30486262,0.39114442,0.00016097646,0.01502938,0.00009039714,0.0013145916,0.0031044693,0.0015611466,0.00003052175,0.0045363638,0.000258863],"about_ca_topic_score_codex":0.00038645155,"about_ca_topic_score_gemma":0.0010935926,"teacher_disagreement_score":0.43365127,"about_ca_system_score_codex":0.0010007003,"about_ca_system_score_gemma":0.0023916876,"threshold_uncertainty_score":0.999977},"labels":[],"label_agreement":null},{"id":"W4391051278","doi":"10.1007/s00345-023-04731-2","title":"A review of stereotactic ablative radiotherapy for nonmetastatic renal cell carcinoma","year":2024,"lang":"en","type":"review","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Ottawa Regional Cancer Foundation; Kingston Health Sciences Centre","funders":"","keywords":"SABR volatility model; Medicine; Renal cell carcinoma; Ablative case; Cryotherapy; Radiation therapy; Cryoablation; Radiofrequency ablation; Nephrology; Malignancy; Radiosurgery; Dialysis; Urology; Radiology; Internal medicine; Oncology; Ablation","score_opus":0.05440573020573242,"score_gpt":0.3565611940718332,"score_spread":0.30215546386610076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391051278","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001605971,0.9961827,0.00015850236,0.0005113981,0.0005212934,0.0018485427,0.000052138428,0.000006515579,0.0007028987],"genre_scores_gemma":[0.0001546584,0.9938683,0.0027601998,0.0007234314,0.000427909,0.00007180602,0.000033078228,0.00011888288,0.0018417543],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961928,0.00049239455,0.0022424147,0.00035474135,0.00035309742,0.00036454506],"domain_scores_gemma":[0.9955298,0.0009183039,0.0025143935,0.0004548156,0.00035411623,0.0002285784],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00094797014,0.0005699699,0.0050638844,0.0010956372,0.000024252911,0.000009960404,0.00027193045,0.00015713755,0.0003006274],"category_scores_gemma":[0.00011478151,0.00035360592,0.0023459825,0.00058665604,0.00012593821,0.000049296897,0.000040013398,0.00092993607,0.000022909906],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005965027,0.00040088446,0.000013645307,0.5174957,0.005061928,0.0021337108,0.00012976474,7.819103e-7,0.000021523312,0.00006355388,0.027279235,0.44680277],"study_design_scores_gemma":[0.0012982514,0.0043832166,0.000008965376,0.06056711,0.030903777,0.0059847427,0.0000031722946,0.0000038724093,0.000008644974,0.00004947325,0.8966032,0.0001855429],"about_ca_topic_score_codex":0.0000032371472,"about_ca_topic_score_gemma":0.0000024554934,"teacher_disagreement_score":0.86932397,"about_ca_system_score_codex":0.00040797322,"about_ca_system_score_gemma":0.0011550549,"threshold_uncertainty_score":0.9998916},"labels":[],"label_agreement":null},{"id":"W4391302892","doi":"10.1200/jco.2024.42.4_suppl.395","title":"Real world outcomes of first line (1L) nivolumab and ipilimumab (NIVO IPI) in metastatic renal cell carcinoma (mRCC): An update from the International mRCC Database Consortium (IMDC).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Ottawa Hospital; Queen Elizabeth II Health Sciences Centre; Dalhousie University; Sunnybrook Health Science Centre","funders":"","keywords":"Nivolumab; Medicine; Ipilimumab; Renal cell carcinoma; Expanded access; Internal medicine; Oncology; Cancer; Immunotherapy","score_opus":0.11448769709135011,"score_gpt":0.4236837089006565,"score_spread":0.3091960118093064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391302892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787989,0.0016704473,0.000061631334,0.015847083,0.0016540856,0.00029455862,0.00014794874,0.0000122729725,0.0015130378],"genre_scores_gemma":[0.9918803,0.0015205899,0.00416223,0.0010132327,0.0008214653,0.000007335805,0.000084673484,0.00003272334,0.00047747567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99495935,0.0005955311,0.0030911064,0.00042186526,0.00065023033,0.00028191472],"domain_scores_gemma":[0.99147093,0.00624482,0.0011571452,0.000449337,0.00029108973,0.00038665632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002993575,0.00026935406,0.0017146231,0.00033219103,0.000041194307,0.000035879155,0.0003951439,0.00016424224,0.00045328218],"category_scores_gemma":[0.0010923246,0.00016097588,0.0004519798,0.0002372261,0.00039994196,0.00026423935,0.0001990335,0.0012716849,0.000016786727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009572946,0.003478165,0.9436425,0.00013280095,0.0013499294,0.009173701,0.0004888759,0.000052735904,0.000972797,0.00028200247,0.007198452,0.02365512],"study_design_scores_gemma":[0.017410876,0.0071177413,0.94509697,0.00032749327,0.0017645672,0.00039119384,0.00036715527,0.0026677272,0.0011042545,0.00064398133,0.022906223,0.000201817],"about_ca_topic_score_codex":0.0011292846,"about_ca_topic_score_gemma":0.006078565,"teacher_disagreement_score":0.023453303,"about_ca_system_score_codex":0.00031776697,"about_ca_system_score_gemma":0.0013292073,"threshold_uncertainty_score":0.65644056},"labels":[],"label_agreement":null},{"id":"W4391303050","doi":"10.1200/jco.2024.42.4_suppl.390","title":"Treatment-free survival after first-line therapies for metastatic renal cell carcinoma: An International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) analysis.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; BC Cancer Agency; Institute of Cancer Research; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Internal medicine; Clear cell renal cell carcinoma; Cancer research","score_opus":0.1440181782252977,"score_gpt":0.4280044634524601,"score_spread":0.2839862852271624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391303050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786434,0.0061129113,0.00413293,0.005926984,0.0023622676,0.0008909106,0.00071486813,0.000037809623,0.0011778945],"genre_scores_gemma":[0.97004694,0.0007187287,0.024317304,0.0005901911,0.0019143971,0.00011895835,0.00039986815,0.00008880925,0.0018047796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99228,0.0010689966,0.00405026,0.0008889867,0.0010536828,0.0006580659],"domain_scores_gemma":[0.98987436,0.005587361,0.0016343168,0.0010481857,0.0008702402,0.0009855235],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033627995,0.0006419595,0.0033468513,0.0009570474,0.00010526604,0.00010705635,0.000643163,0.0002667723,0.00092186395],"category_scores_gemma":[0.00096618367,0.00042444584,0.0026675835,0.00055523345,0.0003885529,0.00053410523,0.000158847,0.0009214706,0.000040208037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.100794144,0.04614445,0.6147981,0.002004305,0.050638184,0.105420806,0.003686522,0.0017391215,0.007757806,0.0007830787,0.012126302,0.05410716],"study_design_scores_gemma":[0.07971268,0.12263501,0.5429673,0.00021607048,0.099617995,0.0027749387,0.0012089345,0.015041733,0.010561765,0.0014376855,0.12243473,0.00139115],"about_ca_topic_score_codex":0.00020690866,"about_ca_topic_score_gemma":0.00084645906,"teacher_disagreement_score":0.11030842,"about_ca_system_score_codex":0.00078440947,"about_ca_system_score_gemma":0.0024782699,"threshold_uncertainty_score":0.9999914},"labels":[],"label_agreement":null},{"id":"W4391303054","doi":"10.1200/jco.2024.42.4_suppl.393","title":"Ipilimumab/nivolumab (I/N) compared to axitinib/pembrolizumab (A/P) in metastatic renal cell carcinoma (mRCC): Insights from a Canadian population.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; McMaster University; McGill University Health Centre; Health Sciences Centre; University Health Network; CancerCare Manitoba; Ottawa Hospital; Hôtel-Dieu de Québec; BC Cancer Agency; Juravinski Cancer Centre; Institute of Cancer Research; University of Manitoba; Dalhousie University; University of Alberta; Queen Elizabeth II Health Sciences Centre; Université Laval; Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Nivolumab; Axitinib; Medicine; Ipilimumab; Renal cell carcinoma; Pembrolizumab; Oncology; Internal medicine; Population; Metastatic melanoma; Immunotherapy; Cancer; Sunitinib","score_opus":0.10268332968470205,"score_gpt":0.4055934135473228,"score_spread":0.30291008386262075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391303054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98400974,0.0033729281,0.00005319678,0.0043717963,0.0016920262,0.00050793734,0.000030175042,0.000020112484,0.005942069],"genre_scores_gemma":[0.9919371,0.000060871287,0.004624992,0.001749482,0.0010678056,0.000014232103,0.000051556013,0.000049045375,0.0004449059],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99434274,0.0007093885,0.003351727,0.0004824636,0.0006112257,0.00050245353],"domain_scores_gemma":[0.9948176,0.002175793,0.00061840564,0.00036999918,0.00031016607,0.0017080118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011144868,0.00030697443,0.0021524176,0.0009708648,0.00005475319,0.00004590685,0.00027172084,0.00033851468,0.00043561205],"category_scores_gemma":[0.0009802156,0.00023398355,0.000661334,0.00055073836,0.0000992891,0.00017764268,0.000058581754,0.0013566143,0.00023394865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032751307,0.0077679115,0.4930758,0.00060910446,0.002928635,0.19559231,0.0062226304,0.0021523063,0.0036581773,0.0012070418,0.04927285,0.20476194],"study_design_scores_gemma":[0.0122335255,0.008516598,0.93485016,0.0003623354,0.0008666011,0.00066372054,0.00029564113,0.0014732259,0.00029722473,0.0012467913,0.038934957,0.00025922988],"about_ca_topic_score_codex":0.07673532,"about_ca_topic_score_gemma":0.14235382,"teacher_disagreement_score":0.44177434,"about_ca_system_score_codex":0.002091082,"about_ca_system_score_gemma":0.0056623244,"threshold_uncertainty_score":0.99997467},"labels":[],"label_agreement":null},{"id":"W4391303156","doi":"10.1200/jco.2024.42.4_suppl.382","title":"Real-world treatment outcomes in patients with advanced renal cell carcinoma who receive axitinib plus pembrolizumab in the first-line setting in Canadian cancer centers.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; McMaster University; Université Laval; Centre Hospitalier de l’Université de Montréal; Health Sciences Centre; CancerCare Manitoba; University Health Network; Dalhousie University; University of Alberta; University of Calgary; Princess Margaret Cancer Centre; Juravinski Cancer Centre; University of Manitoba; Centre hospitalier universitaire de Québec; University of Ottawa; McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Axitinib; Pembrolizumab; Renal cell carcinoma; Oncology; Internal medicine; Cancer; Kidney cancer; Renal carcinoma; Cancer treatment; Immunotherapy; Sunitinib","score_opus":0.05276805426933315,"score_gpt":0.39429339450685746,"score_spread":0.34152534023752434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391303156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976654,0.0005558669,5.773007e-7,0.017026575,0.0005450117,0.0008236754,0.000029330271,0.0000059595955,0.004359029],"genre_scores_gemma":[0.99719876,0.0005113337,0.00029841077,0.0011803329,0.00033910054,0.000054319036,0.00002014695,0.000034685203,0.0003628843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958198,0.00049306895,0.0022261073,0.00038456463,0.00045104758,0.00062541786],"domain_scores_gemma":[0.99672085,0.0017644061,0.000660815,0.00026661172,0.00015964815,0.000427669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013795025,0.00030612238,0.0016765889,0.00073407445,0.000038586873,0.000020683294,0.00020755352,0.00022634777,0.000061584324],"category_scores_gemma":[0.000282147,0.00016707099,0.00032497392,0.00051524356,0.00010697965,0.00012817925,0.000027226728,0.0011951425,0.0000065737877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005626997,0.0010412359,0.94011194,0.000056210178,0.00011993081,0.007979577,0.0012794764,0.00075326744,0.0000015019241,0.000010384333,0.00024844383,0.042771045],"study_design_scores_gemma":[0.025978109,0.013995127,0.9490392,0.00059897086,0.00021823193,0.000047167516,0.00020831321,0.00031902295,0.000024329614,0.000023842706,0.009408633,0.0001390027],"about_ca_topic_score_codex":0.15291862,"about_ca_topic_score_gemma":0.7884442,"teacher_disagreement_score":0.6355256,"about_ca_system_score_codex":0.0063428753,"about_ca_system_score_gemma":0.004788246,"threshold_uncertainty_score":0.9974716},"labels":[],"label_agreement":null},{"id":"W4391303168","doi":"10.1200/jco.2024.42.4_suppl.482","title":"Network meta-analysis (NMA) to assess comparative efficacy of lenvatinib plus pembrolizumab compared with other first-line treatments for management of advanced renal cell carcinoma (aRCC).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Lenvatinib; Medicine; Pembrolizumab; Renal cell carcinoma; Meta-analysis; Oncology; Internal medicine; Hepatocellular carcinoma; Cancer; Immunotherapy; Sorafenib","score_opus":0.40977554878475164,"score_gpt":0.49290238542084375,"score_spread":0.0831268366360921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391303168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980791,0.00390156,0.008088055,0.0015383335,0.0003028918,0.0017476274,0.00007598684,0.000013698772,0.0035409026],"genre_scores_gemma":[0.9372228,0.000075793505,0.06096521,0.00024887265,0.0002874496,0.00008083683,0.0000311537,0.000038557286,0.0010493727],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99445873,0.0004530248,0.0034728954,0.0004920054,0.0007357532,0.00038760176],"domain_scores_gemma":[0.9919709,0.004131593,0.0022316459,0.00049537513,0.0007432169,0.0004273005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016107593,0.00038957034,0.0059541278,0.00036985855,0.00004756861,0.00001226308,0.0002807106,0.00019631987,0.0002171002],"category_scores_gemma":[0.00008812248,0.0002310581,0.0028393154,0.0008298797,0.00019871435,0.00008367392,0.00007837366,0.00042078324,0.0000072753737],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13179229,0.011060128,0.01938419,0.0012363286,0.56056607,0.002249394,0.0012726834,0.25933424,0.00047188465,0.00047729237,0.004198197,0.007957296],"study_design_scores_gemma":[0.048246805,0.08019394,0.2554967,0.00033737067,0.596028,0.00012179306,0.00048010843,0.0025370715,0.0034954895,0.00014922366,0.012521079,0.0003924324],"about_ca_topic_score_codex":0.000032994547,"about_ca_topic_score_gemma":0.00009310887,"teacher_disagreement_score":0.25679716,"about_ca_system_score_codex":0.00039260427,"about_ca_system_score_gemma":0.00072542747,"threshold_uncertainty_score":0.9422276},"labels":[],"label_agreement":null},{"id":"W4391303220","doi":"10.1200/jco.2024.42.4_suppl.363","title":"Nivolumab plus ipilimumab (NIVO+IPI) vs sunitinib (SUN) for first-line treatment of advanced renal cell carcinoma (aRCC): Long-term follow-up data from the phase 3 CheckMate 214 trial.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Nivolumab; Sunitinib; Ipilimumab; Internal medicine; Renal cell carcinoma; Oncology; Immunotherapy; Cancer","score_opus":0.25596672697664336,"score_gpt":0.4770844221774215,"score_spread":0.22111769520077812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391303220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759309,0.008988561,0.00056668004,0.006033394,0.004846812,0.0022490278,0.0007276786,0.000033188084,0.0006237195],"genre_scores_gemma":[0.98652804,0.003106222,0.0020983848,0.0003826297,0.0050272136,0.00007731284,0.00071174104,0.00009369101,0.0019747475],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9927072,0.0006631071,0.0045099985,0.000792219,0.0007348376,0.0005926496],"domain_scores_gemma":[0.9843202,0.010712689,0.0022891064,0.0014698821,0.00058758544,0.0006205268],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025816802,0.000528049,0.0034088076,0.00020316264,0.00013180738,0.000044051467,0.00084580237,0.0005435362,0.00044317372],"category_scores_gemma":[0.001717989,0.0003109349,0.0017246187,0.00026519198,0.0003999549,0.00026635668,0.00021999124,0.00083332154,0.000038965227],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.65774214,0.013554334,0.0038554547,0.00042041135,0.0031337,0.0062353495,0.0007095411,0.00006728976,0.0017256488,0.000035470843,0.009337935,0.3031827],"study_design_scores_gemma":[0.63785976,0.21603154,0.0216596,0.0006751752,0.0088448385,0.0005622485,0.00024397763,0.0021963613,0.0070267604,0.0002675897,0.10421233,0.00041983387],"about_ca_topic_score_codex":0.00013087296,"about_ca_topic_score_gemma":0.00052799465,"teacher_disagreement_score":0.30276287,"about_ca_system_score_codex":0.000946557,"about_ca_system_score_gemma":0.0042059915,"threshold_uncertainty_score":0.99993426},"labels":[],"label_agreement":null},{"id":"W4391303262","doi":"10.1200/jco.2024.42.4_suppl.366","title":"Real-world practice patterns, treatment-related toxicity, and survival outcomes in older patients with metastatic renal cell carcinoma: Results from the Canadian Kidney Cancer information system (CKCis).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval; Princess Margaret Cancer Centre; University of Calgary; McMaster University; Sunnybrook Health Science Centre; University of Manitoba; Juravinski Cancer Centre; University of Ottawa; McGill University Health Centre; University of Alberta; Queen Elizabeth II Health Sciences Centre; Centre hospitalier universitaire de Québec; University Health Network; Ottawa Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Renal cell carcinoma; Toxicity; Kidney cancer; Oncology; Cancer; Internal medicine; Kidney","score_opus":0.057788766818501945,"score_gpt":0.38178262200828855,"score_spread":0.32399385518978663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391303262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794467,0.00027706724,0.000004483921,0.014158094,0.001107592,0.0006335122,0.00032518542,0.0000116907095,0.004035648],"genre_scores_gemma":[0.99774957,0.00023527621,0.00040294306,0.0010253496,0.00019111583,0.000016236061,0.000103116516,0.000020351728,0.0002560356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99569756,0.0008585619,0.0023718926,0.00023973703,0.00053733477,0.00029489698],"domain_scores_gemma":[0.9932059,0.004242749,0.0012397368,0.00024367029,0.00038436317,0.000683597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019108863,0.00024414883,0.0012391362,0.00029247053,0.00007164029,0.00006708447,0.00011730892,0.00019221738,0.000035750058],"category_scores_gemma":[0.0010961758,0.000121487596,0.00020659571,0.0002529631,0.00009501373,0.0004183766,0.000031098385,0.00078936166,0.000014036508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035231425,0.00071008253,0.98088574,0.00008001257,0.0009053023,0.0021101418,0.001267864,0.00002868344,0.0000019632778,0.00003086293,0.0011651645,0.009291009],"study_design_scores_gemma":[0.021359088,0.004927276,0.96353513,0.00042016272,0.0018263398,0.00006983272,0.0005613914,0.00020380023,0.00003202842,0.0000059909357,0.0069448617,0.000114077746],"about_ca_topic_score_codex":0.24687245,"about_ca_topic_score_gemma":0.29265276,"teacher_disagreement_score":0.045780312,"about_ca_system_score_codex":0.0022822162,"about_ca_system_score_gemma":0.004887767,"threshold_uncertainty_score":0.8670689},"labels":[],"label_agreement":null},{"id":"W4391303267","doi":"10.1200/jco.2024.42.4_suppl.389","title":"Management, outcomes and predictors of recurrence in chromophobe renal cell carcinoma: Results from the Canadian Kidney Cancer information system (CKCis).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Sunnybrook Health Science Centre; University of Calgary; McMaster University; University of British Columbia; Université de Sherbrooke; University of Toronto; University of Manitoba; Trillium Health Centre; St. Joseph’s Healthcare Hamilton; Ottawa Hospital; CancerCare Manitoba; Hotel Dieu Hospital; University of Ottawa; McGill University Health Centre; Queen Elizabeth II Health Sciences Centre; Université Laval; Dalhousie University","funders":"","keywords":"Medicine; Renal cell carcinoma; Kidney cancer; Chromophobe cell; Cancer; Oncology; Kidney; Internal medicine; Kidney disease; Pathology; Clear cell","score_opus":0.06188277802279362,"score_gpt":0.37032861790919114,"score_spread":0.3084458398863975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391303267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97883993,0.0016241692,0.000005014581,0.007109254,0.002030108,0.00033637573,0.00016375222,0.0000063266934,0.009885064],"genre_scores_gemma":[0.9978744,0.0007055305,0.0003369043,0.0005605207,0.00036731805,0.000007922378,0.000018615832,0.0000080803275,0.000120732104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99669075,0.00026963156,0.0023102062,0.00016123404,0.0003682782,0.00019990101],"domain_scores_gemma":[0.9970432,0.0012254354,0.0008667723,0.00020867202,0.00017993667,0.00047600627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022059996,0.00013748817,0.0008432845,0.00024949235,0.00003522947,0.000022210737,0.00016141674,0.00023304613,0.000021783457],"category_scores_gemma":[0.0007665934,0.00007799052,0.00021119943,0.00021278231,0.00014256542,0.00019982163,0.0000481987,0.00069750176,0.000008227637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022983302,0.0001815641,0.94017565,0.0004786443,0.00054330064,0.0027397547,0.00155479,0.000033897137,0.00002167732,0.00015155226,0.018682143,0.033138685],"study_design_scores_gemma":[0.0052308217,0.001663368,0.95189345,0.00076906604,0.0005434266,0.00008115782,0.0003732836,0.00023704907,0.00011866298,0.000020770813,0.039003756,0.0000651711],"about_ca_topic_score_codex":0.037451226,"about_ca_topic_score_gemma":0.022314532,"teacher_disagreement_score":0.03307351,"about_ca_system_score_codex":0.0008176411,"about_ca_system_score_gemma":0.0029808835,"threshold_uncertainty_score":0.99552566},"labels":[],"label_agreement":null},{"id":"W4391303281","doi":"10.1200/jco.2024.42.4_suppl.367","title":"Real-world efficacy and toxicity of ipilimumab and nivolumab as first line treatment of metastatic renal cell carcinoma (mRCC) in a subpopulation of elderly and poor performance status patients.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; McGill University Health Centre; McMaster University; Université Laval; Centre Hospitalier de l’Université de Montréal; University of Calgary; Princess Margaret Cancer Centre; University of Manitoba; Ottawa Hospital; BC Cancer Agency; University of Alberta; Queen Elizabeth II Health Sciences Centre; University of Toronto; Dalhousie University","funders":"","keywords":"Medicine; Nivolumab; Ipilimumab; Renal cell carcinoma; Toxicity; Oncology; Internal medicine; Metastatic melanoma; Performance status; Immunotherapy; Overall survival; Cancer","score_opus":0.0803915643702765,"score_gpt":0.39809327686299806,"score_spread":0.31770171249272156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391303281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99592066,0.0028025846,0.0000048831776,0.00035031946,0.00013326031,0.00042097922,0.000015730055,0.0000029742057,0.00034862504],"genre_scores_gemma":[0.99371326,0.0049959137,0.0010899031,0.000017868408,0.00006980386,0.000003590264,0.000009163851,0.000014983036,0.000085522144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99677825,0.00023652354,0.0022497827,0.00023216067,0.0003030102,0.00020028216],"domain_scores_gemma":[0.9965584,0.001681548,0.001126972,0.00013973888,0.00023504853,0.00025825395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007963622,0.00017919824,0.0015808372,0.00035184334,0.000019188978,0.000005154782,0.00004148912,0.00013012266,0.000020764986],"category_scores_gemma":[0.00034110338,0.00012338994,0.00016972894,0.00020358902,0.00025733377,0.00010404657,0.0000345076,0.00025916658,4.3808453e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009528138,0.0039430074,0.84254164,0.00079150015,0.0002648506,0.00025174604,0.00074581953,0.000039397382,0.0012810515,0.00001707456,0.000023716955,0.14057207],"study_design_scores_gemma":[0.01747461,0.08711676,0.8874668,0.0003251227,0.00085567025,0.00007392827,0.000057707934,0.00083706644,0.0054177702,0.000060043065,0.00024139605,0.00007311247],"about_ca_topic_score_codex":0.00069045776,"about_ca_topic_score_gemma":0.00066360243,"teacher_disagreement_score":0.14049897,"about_ca_system_score_codex":0.00024825401,"about_ca_system_score_gemma":0.00061098894,"threshold_uncertainty_score":0.5031696},"labels":[],"label_agreement":null},{"id":"W4391303450","doi":"10.1200/jco.2024.42.4_suppl.416","title":"Impact of timing of immunotherapy and cytoreductive nephrectomy on outcomes in metastatic renal cell carcinoma: Results from the CKCis database.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; McMaster University; Ottawa Hospital; McGill University Health Centre; McGill University; University of Ottawa; Hôtel-Dieu de Québec; BC Cancer Agency; Sunnybrook Health Science Centre; Université Laval; University of Alberta; Queen Elizabeth II Health Sciences Centre; University of Toronto; Dalhousie University; Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Immunotherapy; Nephrectomy; Internal medicine; Urology; Oncology; Database; Kidney; Cancer research; Cancer","score_opus":0.16167583484499456,"score_gpt":0.46841458877793224,"score_spread":0.3067387539329377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391303450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931545,0.003736623,0.000020182742,0.0017881412,0.00036813208,0.0002489002,0.0001278629,0.0000028910242,0.00055274996],"genre_scores_gemma":[0.99600625,0.0006283512,0.0028949487,0.0001403261,0.00023428797,0.0000023563941,0.000011806193,0.000017827924,0.00006381916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962409,0.0006413641,0.0023608918,0.00022540084,0.00036205843,0.00016935063],"domain_scores_gemma":[0.98707074,0.011127662,0.0011951241,0.0003036335,0.00016500983,0.00013783206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025542006,0.00017720302,0.0016372938,0.00019783882,0.0000153129,0.0000071913128,0.0001485516,0.00012359148,0.000058203328],"category_scores_gemma":[0.0015038926,0.00008662088,0.0006328387,0.00017857492,0.00025549298,0.00008895705,0.000044859094,0.0008387948,0.00000263018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06882569,0.006474628,0.76695913,0.00014422018,0.0050630323,0.004895347,0.0048664934,0.00016734832,0.030452896,0.000049060567,0.004902188,0.10719996],"study_design_scores_gemma":[0.011833569,0.018835098,0.9625654,0.00033721147,0.0006618947,0.00013506346,0.00028186868,0.0001669799,0.004359553,0.00018703232,0.00056376174,0.00007256644],"about_ca_topic_score_codex":0.0008250337,"about_ca_topic_score_gemma":0.000040151062,"teacher_disagreement_score":0.19560626,"about_ca_system_score_codex":0.00023957984,"about_ca_system_score_gemma":0.0012787824,"threshold_uncertainty_score":0.36441928},"labels":[],"label_agreement":null},{"id":"W4391303529","doi":"10.1200/jco.2024.42.4_suppl.400","title":"Evaluating intermediate endpoints (IE) for overall survival (OS) in metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICI): An IMDC study.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Dalhousie University; Queen Elizabeth II Health Sciences Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Internal medicine; Clinical endpoint; Cancer research; Immune checkpoint; Immunotherapy; Clinical trial; Cancer","score_opus":0.20245774741973144,"score_gpt":0.4760169792886244,"score_spread":0.27355923186889297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391303529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946704,0.00083329936,0.00009317547,0.00086614484,0.0012830334,0.001572298,0.000010988479,0.00002788604,0.0006427923],"genre_scores_gemma":[0.9937834,0.0000550565,0.004324993,0.00016114532,0.0011083521,0.00006446774,0.000024379375,0.00008402752,0.00039417672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9914635,0.0016921094,0.004771711,0.00061919,0.0008862431,0.00056728075],"domain_scores_gemma":[0.99310327,0.0036864108,0.0016488058,0.00040969744,0.00055477145,0.0005970745],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010750977,0.00043652076,0.0027683603,0.0005350949,0.000052993233,0.000049844683,0.00026222682,0.00026708425,0.00012854322],"category_scores_gemma":[0.0016205638,0.00027624748,0.00087766326,0.00033653624,0.00019978303,0.00028728956,0.000094756935,0.0015350399,0.000017799404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12037703,0.03680755,0.51307255,0.0014063086,0.005061791,0.062061343,0.0069247875,0.00087673374,0.050681304,0.000056636076,0.00075501355,0.20191896],"study_design_scores_gemma":[0.05198651,0.21578486,0.7066022,0.0006972115,0.0038145601,0.001029924,0.0019811161,0.0048306403,0.011976174,0.000255329,0.0006160544,0.00042538578],"about_ca_topic_score_codex":0.00024086332,"about_ca_topic_score_gemma":0.0003318267,"teacher_disagreement_score":0.20149358,"about_ca_system_score_codex":0.0008743214,"about_ca_system_score_gemma":0.0025283543,"threshold_uncertainty_score":0.99996895},"labels":[],"label_agreement":null},{"id":"W4391303561","doi":"10.1200/jco.2024.42.4_suppl.2","title":"First-line pembrolizumab plus lenvatinib for non–clear cell renal carcinomas (nccRCC): Extended follow-up of the phase 2 KEYNOTE-B61 study.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Lenvatinib; Pembrolizumab; Medicine; Renal cell carcinoma; Internal medicine; Oncology; Clear cell; Phases of clinical research; Cancer research; Cancer; Clinical trial; Immunotherapy","score_opus":0.1359062445362326,"score_gpt":0.4478767421619031,"score_spread":0.31197049762567053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391303561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98531705,0.0014274201,0.00054862874,0.0051281736,0.0036680335,0.001613639,0.000028570117,0.000020865387,0.002247634],"genre_scores_gemma":[0.9914349,0.00022604462,0.0016003429,0.00048509636,0.00201179,0.00003666688,0.0000063048415,0.00006872796,0.0041301264],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9938226,0.0005049829,0.0038989955,0.00047763053,0.0008425451,0.00045328835],"domain_scores_gemma":[0.99219996,0.004152087,0.0018200423,0.00063297356,0.0007204982,0.00047444546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033048105,0.00035639488,0.0024582047,0.00023544129,0.000111562375,0.000022948976,0.0004734709,0.00044948037,0.0001927229],"category_scores_gemma":[0.0022336405,0.00020541038,0.0020433478,0.0003391162,0.0003105201,0.000115201634,0.00017074782,0.0014263625,0.000021649503],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42011288,0.07020184,0.05125053,0.0036497132,0.011830853,0.01999427,0.0082177175,0.001122422,0.01822382,0.00052063435,0.08701813,0.30785722],"study_design_scores_gemma":[0.280255,0.35295904,0.19733912,0.0012441212,0.011601324,0.0018743185,0.0013656572,0.0103797335,0.011179338,0.0011520204,0.12997402,0.000676314],"about_ca_topic_score_codex":0.00004730579,"about_ca_topic_score_gemma":0.00009969868,"teacher_disagreement_score":0.30718088,"about_ca_system_score_codex":0.00051823515,"about_ca_system_score_gemma":0.0036310605,"threshold_uncertainty_score":0.8376392},"labels":[],"label_agreement":null},{"id":"W4391420404","doi":"10.5489/cuaj.8548","title":"Therapeutic outcome of combination therapy using immune-checkpoint inhibitors and tyrosine kinase inhibitors for metastatic non-clear-cell renal cell carcinoma","year":2024,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nivolumab; Renal cell carcinoma; Ipilimumab; Internal medicine; Oncology; Adverse effect; Progression-free survival; Tyrosine kinase; Combination therapy; Melanoma; Immunotherapy; Overall survival; Cancer research; Cancer; Receptor","score_opus":0.0321044886957741,"score_gpt":0.2646927584247374,"score_spread":0.2325882697289633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391420404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894417,0.0059024426,0.0002462477,0.0030749065,0.00042862847,0.00066610135,0.000038805145,0.000018640229,0.00018255283],"genre_scores_gemma":[0.9981835,0.000093869196,0.00061941944,0.00041401092,0.00020870213,0.00001668972,0.00003246908,0.00003865051,0.0003926808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997886,0.00016759789,0.0008118552,0.0002857094,0.00039606128,0.00045278997],"domain_scores_gemma":[0.99846834,0.00023950315,0.00039458612,0.00012677361,0.00030724268,0.0004635274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010047302,0.0002517015,0.0005013189,0.0004103278,0.00020617779,0.00012114077,0.0000785603,0.00019595766,0.00008401572],"category_scores_gemma":[0.00011928616,0.00019149255,0.00034408324,0.00029435713,0.000060765302,0.00013010512,0.000015782027,0.00047833793,0.0000062221443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007068769,0.00066415727,0.65413165,0.00041379806,0.0005343636,0.0005361336,0.0012290096,0.00016725306,0.33097953,0.00017672339,0.0008684685,0.009592037],"study_design_scores_gemma":[0.0106356,0.007040717,0.80721843,0.00015624426,0.0012066162,0.00041350967,0.00045697624,0.010929571,0.15607166,0.0014007206,0.0038517192,0.0006182301],"about_ca_topic_score_codex":0.0013443506,"about_ca_topic_score_gemma":0.000055881428,"teacher_disagreement_score":0.17490786,"about_ca_system_score_codex":0.0013462884,"about_ca_system_score_gemma":0.00047272045,"threshold_uncertainty_score":0.78088397},"labels":[],"label_agreement":null},{"id":"W4391446134","doi":"10.1002/cncr.35216","title":"Comparison of outcomes for Hispanic and non‐Hispanic patients with advanced renal cell carcinoma in the International Metastatic Renal Cell Carcinoma Database","year":2024,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of Calgary; Baker Hughes (Canada)","funders":"","keywords":"Medicine; Hazard ratio; Renal cell carcinoma; Confidence interval; Proportional hazards model; Internal medicine; Oncology; Urology","score_opus":0.03136497198160029,"score_gpt":0.31737661769575065,"score_spread":0.2860116457141504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391446134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99240744,0.0046398523,0.00020020104,0.0003911417,0.00026424284,0.0012611748,0.00038795834,0.000014250372,0.00043375834],"genre_scores_gemma":[0.99737155,0.000033387427,0.0012145129,0.00017688342,0.0000621114,0.0003518671,0.0003653816,0.000043502787,0.00038081215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825114,0.000044026197,0.00044362052,0.00046991973,0.00049473956,0.0002965244],"domain_scores_gemma":[0.9989606,0.00025892857,0.00015464681,0.0003829728,0.00013929771,0.00010352953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016863382,0.00027945975,0.000514939,0.00019152046,0.00004453781,0.000030977648,0.00020049032,0.00004194971,0.0000883895],"category_scores_gemma":[0.000020513271,0.00016976924,0.00011465914,0.00020891534,0.0000862796,0.00014212722,0.00006446836,0.0002265408,0.00000436907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011748583,0.0006532749,0.97475356,0.0011724876,0.00014456217,0.000108942164,0.0020844901,0.0001469141,0.014589117,0.00004824916,0.00253392,0.0025896328],"study_design_scores_gemma":[0.008501629,0.0022463466,0.93567574,0.0003116317,0.0008099993,0.000010080231,0.00057853514,0.0032879424,0.046339586,0.0000173602,0.0019514143,0.00026972004],"about_ca_topic_score_codex":0.000234232,"about_ca_topic_score_gemma":0.0002010449,"teacher_disagreement_score":0.0390778,"about_ca_system_score_codex":0.000328651,"about_ca_system_score_gemma":0.0002698533,"threshold_uncertainty_score":0.6922988},"labels":[],"label_agreement":null},{"id":"W4391467242","doi":"10.2139/ssrn.4711437","title":"Additive Toxicity From Combined Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors in Patients with Renal or Endometrial Carcinoma: Protocol for a Rapid Systematic Review","year":2024,"lang":"en","type":"preprint","venue":"SSRN Electronic Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Government of Canada; Health Canada; University of Ottawa","funders":"","keywords":"Tyrosine kinase; Toxicity; Renal carcinoma; Medicine; Cancer research; Carcinoma; Kinase; Oncology; Internal medicine; Pharmacology; Biology; Receptor","score_opus":0.014863899956848819,"score_gpt":0.26674910820529835,"score_spread":0.2518852082484495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391467242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.57270044,0.04468892,0.000058453123,0.000678466,0.00045467768,0.38091528,0.0003603455,0.00008263342,0.000060786653],"genre_scores_gemma":[0.79484683,0.0020136132,0.00029114925,0.00008745213,0.0009034829,0.20080322,0.00054111745,0.00021614254,0.0002970036],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99277025,0.0005186204,0.0025227389,0.0010709596,0.001098707,0.002018693],"domain_scores_gemma":[0.9964144,0.00040314626,0.0015920014,0.00069851294,0.0005418261,0.00035009155],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0027708034,0.0010431424,0.0031310713,0.00082260283,0.00013948014,0.0001447312,0.00029043906,0.00040753785,0.000056125064],"category_scores_gemma":[0.0010669675,0.0006398946,0.0007289188,0.0006459884,0.00013555572,0.000110775414,0.00046242436,0.004830781,0.000008289012],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.13017286,0.008623126,0.01171559,0.8205702,0.013838811,0.0016745857,0.0013885146,0.000015856216,0.0018808214,0.00056232745,0.0013961733,0.008161178],"study_design_scores_gemma":[0.11588012,0.04663973,0.0074991304,0.78234726,0.012718839,0.00093859044,0.00062264054,0.00011398153,0.020798508,0.010054091,0.00011154159,0.002275544],"about_ca_topic_score_codex":0.00025769355,"about_ca_topic_score_gemma":0.00029952562,"teacher_disagreement_score":0.22214639,"about_ca_system_score_codex":0.0059633967,"about_ca_system_score_gemma":0.0061009172,"threshold_uncertainty_score":0.99960524},"labels":[],"label_agreement":null},{"id":"W4391577093","doi":"10.1080/08923973.2024.2315462","title":"What factors may affect the effect of ICI-combined therapy in patients with metastatic renal cell carcinoma? A meta-analysis","year":2024,"lang":"en","type":"article","venue":"Immunopharmacology and Immunotoxicology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Meta-analysis; Internal medicine; Oncology; Randomized controlled trial; Clinical trial; Cancer; Kidney","score_opus":0.02534301645198,"score_gpt":0.300510361737777,"score_spread":0.275167345285797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391577093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.942814,0.05394864,0.000004877309,0.00037791472,0.00038110634,0.002352201,0.000016895236,0.00003277262,0.00007161999],"genre_scores_gemma":[0.9982038,0.00058353675,0.000024280647,0.00020371504,0.000011304089,0.00049281557,0.00008872319,0.000043475386,0.00034834252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966252,0.0014442541,0.0006096269,0.0005640117,0.0002661773,0.00049072696],"domain_scores_gemma":[0.99734247,0.0018142847,0.00019848662,0.00048527282,0.00007941845,0.00008006147],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078950915,0.0005157935,0.001989882,0.000688676,0.000109839304,0.00004893303,0.00021992989,0.000175003,0.0007740375],"category_scores_gemma":[0.000020380508,0.00025009635,0.000831202,0.0009880573,0.0004987596,0.00021472132,0.000089131834,0.0005991255,0.000011951716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026814206,0.0017007118,0.49241066,0.0005638799,0.26773757,0.00071039255,0.0024747606,0.00017020051,0.20540187,0.000040092138,0.00013687939,0.001838788],"study_design_scores_gemma":[0.010332624,0.021330036,0.60523677,0.000013030771,0.1222041,0.000023370818,0.00011298481,0.00006501014,0.24032502,0.000009370791,0.00012428338,0.0002233717],"about_ca_topic_score_codex":0.00014706008,"about_ca_topic_score_gemma":0.000016512642,"teacher_disagreement_score":0.14553347,"about_ca_system_score_codex":0.00013723897,"about_ca_system_score_gemma":0.0001201686,"threshold_uncertainty_score":0.9999951},"labels":[],"label_agreement":null},{"id":"W4391580550","doi":"","title":"Temporal Trends in Selecting Patients for Partial Nephrectomy for Small Renal Cell Carcinomas in Alberta, Canada","year":2020,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nephrectomy; Renal cell carcinoma; Medicine; Urology; General surgery; Oncology; Internal medicine; Kidney","score_opus":0.21213535343024606,"score_gpt":0.4641601014038654,"score_spread":0.2520247479736193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391580550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99320734,0.0016260318,0.00006424521,0.000578259,0.00026614653,0.0020783516,0.00008584324,0.000013358804,0.0020804529],"genre_scores_gemma":[0.9971526,0.00007281191,0.0007611959,0.00061551365,0.00026643305,0.0004510879,0.00021029598,0.000089685986,0.00038036006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965486,0.0001678589,0.0012972883,0.0006930493,0.00055885734,0.00073437963],"domain_scores_gemma":[0.9975715,0.00057026214,0.00071584154,0.0002980188,0.0002981532,0.00054620486],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005203611,0.00045190417,0.0012370663,0.00070838013,0.00012259386,0.00021188703,0.00083482394,0.00013368868,0.00060587924],"category_scores_gemma":[0.0003746916,0.00041460773,0.00028114335,0.0012103505,0.00003977567,0.00049800944,0.00025706054,0.000422903,0.0000012641844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027715082,0.00043142543,0.96139073,0.00027182774,0.00011201829,0.00008317365,0.0003721945,0.00020017634,0.007773767,0.0000034283732,0.018925551,0.007664211],"study_design_scores_gemma":[0.009891443,0.0002838167,0.8706289,0.0003223335,0.00022647867,0.000008624351,0.000106915344,0.0012342662,0.09787612,0.00007373211,0.018806748,0.00054062],"about_ca_topic_score_codex":0.44051802,"about_ca_topic_score_gemma":0.39951494,"teacher_disagreement_score":0.09076182,"about_ca_system_score_codex":0.00074692385,"about_ca_system_score_gemma":0.0009220414,"threshold_uncertainty_score":0.9998306},"labels":[],"label_agreement":null},{"id":"W4391598813","doi":"10.3390/curroncol31020069","title":"Ablative or Surgical Treatment for Small Renal Masses (T1a): A Single-Center Comparison of Perioperative Morbidity and Complications","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Ablative case; Nephrectomy; Perioperative; Microwave ablation; Logistic regression; Surgery; Radiofrequency ablation; Odds ratio; Kidney cancer; Ablation; Renal cell carcinoma; Kidney; Internal medicine; Radiation therapy","score_opus":0.408889328510072,"score_gpt":0.480904324629806,"score_spread":0.072014996119734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391598813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856382,0.0065060053,0.0010834512,0.0013350438,0.0003675341,0.0017733679,0.00021019456,0.000054480366,0.0030316988],"genre_scores_gemma":[0.9956638,0.000255979,0.0026190702,0.000013142738,0.00016621195,0.0005147488,0.000245822,0.000019372386,0.0005018406],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988057,0.00010251199,0.0003837445,0.00039145054,0.00010187983,0.00021472252],"domain_scores_gemma":[0.9987789,0.0006643082,0.00008698116,0.00016933431,0.00015625583,0.00014424355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008212212,0.0002073921,0.0006139723,0.00011198203,0.00007451681,0.000019596064,0.00004518628,0.000088260465,0.00008957865],"category_scores_gemma":[0.000038331436,0.00013288496,0.00014394528,0.00012131323,0.00023371547,0.000035505807,0.000039753475,0.00012640259,0.000009291846],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0106189,0.03423921,0.32090673,0.0024557635,0.0029091232,0.0006707258,0.028646419,0.00004677738,0.016860034,0.010012718,0.004968904,0.5676647],"study_design_scores_gemma":[0.0079741245,0.018601427,0.017388964,0.00042504564,0.00082190573,0.00059072656,0.0007364447,0.005303601,0.011108934,0.00005733567,0.9367633,0.0002282294],"about_ca_topic_score_codex":0.000022838987,"about_ca_topic_score_gemma":0.00016655911,"teacher_disagreement_score":0.93179435,"about_ca_system_score_codex":0.0006573649,"about_ca_system_score_gemma":0.00030706497,"threshold_uncertainty_score":0.54188913},"labels":[],"label_agreement":null},{"id":"W4391645268","doi":"10.1002/gcc.23221","title":"Segregation, immunohistochemical, molecular and functional analyses classify a novel missense variant in fumarate hydratase (<scp><i>FH</i></scp>) as pathogenic","year":2024,"lang":"en","type":"article","venue":"Genes Chromosomes and Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Missense mutation; Biology; Germline; Germline mutation; Genetics; Cancer research; Pathological; Gene; Cancer; Mutation; Pathology; Medicine","score_opus":0.031199098170152054,"score_gpt":0.3014080297471876,"score_spread":0.27020893157703557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391645268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8271256,0.17160591,0.00008001218,0.0003933949,0.00013602464,0.00024721798,0.00008395903,0.000035050907,0.00029281265],"genre_scores_gemma":[0.99162334,0.006210336,0.00031623058,0.00043776532,0.000137501,0.00016291291,0.00020153387,0.000037414982,0.0008729861],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862695,0.0000288425,0.00028428456,0.0005403911,0.00025224595,0.00026729744],"domain_scores_gemma":[0.99939257,0.00008102577,0.000052526477,0.00022703754,0.00006656519,0.00018025756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008851179,0.00026249135,0.00033374949,0.0001585219,0.000067180925,0.000078988356,0.0000355492,0.000114633964,0.00013549147],"category_scores_gemma":[0.000024569292,0.00020981181,0.00010216888,0.00034285855,0.000113600756,0.00008623172,0.000051723426,0.00016154019,0.0000150637225],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006735408,0.00009122778,0.0005374664,0.00026669356,0.00032703887,0.0024215323,0.00023559948,0.000076587734,0.98913336,0.00017987746,0.00072169764,0.005941579],"study_design_scores_gemma":[0.007967675,0.0009834784,0.038205713,0.0013400468,0.0025382268,0.012287126,0.00093089725,0.008124174,0.8686227,0.0010922882,0.05718673,0.00072089914],"about_ca_topic_score_codex":0.00029777805,"about_ca_topic_score_gemma":0.000026565243,"teacher_disagreement_score":0.16539557,"about_ca_system_score_codex":0.0002057169,"about_ca_system_score_gemma":0.00033244592,"threshold_uncertainty_score":0.8555877},"labels":[],"label_agreement":null},{"id":"W4391787349","doi":"10.1016/j.suronc.2024.102047","title":"Differences in other-cause mortality in metastatic renal cell carcinoma according to partial vs. radical nephrectomy and age: A propensity score matched study","year":2024,"lang":"en","type":"article","venue":"Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nephrectomy; Medicine; Renal cell carcinoma; Propensity score matching; Hazard ratio; Proportional hazards model; Surgery; Internal medicine; Urology; Kidney; Confidence interval","score_opus":0.12516643407605682,"score_gpt":0.35427113917102865,"score_spread":0.22910470509497183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391787349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99540395,0.00046037583,0.000008404358,0.0005500982,0.00015982491,0.0018978736,0.0000064194287,0.000051768264,0.0014612905],"genre_scores_gemma":[0.9990901,0.000021919608,0.00021049136,0.0001426487,0.00010885368,0.00025688397,0.000008071931,0.000026568685,0.00013446088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970221,0.00073269726,0.00062365626,0.0007527348,0.00035793093,0.0005108923],"domain_scores_gemma":[0.998793,0.00049001945,0.00005499467,0.0002702319,0.000026418673,0.0003653112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086644746,0.00029717918,0.0012320991,0.0002996161,0.000037674,0.000050581682,0.0001104675,0.00013507904,0.00012566708],"category_scores_gemma":[0.000060499053,0.00020749576,0.0000992567,0.0005512369,0.00017506896,0.00007269972,0.00018049084,0.0005605687,0.000032377375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018478932,0.0016723447,0.92227906,0.0001473368,0.00012745806,0.06601761,0.0018244709,0.0000030938209,0.0008295543,0.00005281779,0.000018680279,0.005179672],"study_design_scores_gemma":[0.0050102584,0.0043952535,0.9848724,0.00011182332,0.00039679254,0.0003812399,0.0005937903,0.00023066608,0.0010489604,0.0000706714,0.0026572046,0.00023093623],"about_ca_topic_score_codex":0.0021113106,"about_ca_topic_score_gemma":0.002054801,"teacher_disagreement_score":0.065636374,"about_ca_system_score_codex":0.00045545262,"about_ca_system_score_gemma":0.00035120445,"threshold_uncertainty_score":0.8461431},"labels":[],"label_agreement":null},{"id":"W4392010065","doi":"10.1016/j.jvir.2023.12.272","title":"Abstract No. 230 Safety and Efficacy of Percutaneous Transhepatic Ablation of Right Renal Masses","year":2024,"lang":"en","type":"article","venue":"Journal of Vascular and Interventional Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Percutaneous; Ablation; Radiology; Internal medicine","score_opus":0.013001231809200044,"score_gpt":0.2710036905050293,"score_spread":0.2580024586958293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392010065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703658,0.027667316,0.0009955644,0.00016466453,0.00015509182,0.00010715453,0.000011497576,0.0000033763224,0.0005295113],"genre_scores_gemma":[0.9967752,0.0020628562,0.00094437646,0.000008546533,0.00011891972,5.386912e-7,0.000014826923,0.000008531244,0.00006620358],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988327,0.00007388948,0.0006897959,0.000115369214,0.00020413964,0.000084100044],"domain_scores_gemma":[0.9992823,0.00022996399,0.00018520503,0.0000721113,0.00015664876,0.00007375889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041699977,0.00010102473,0.00045094147,0.00019344877,0.000018058117,0.0000064722617,0.00003811388,0.00007633124,0.0003484994],"category_scores_gemma":[0.00008718252,0.000069086454,0.00048735875,0.000053955755,0.00012480363,0.00006960344,0.000009052388,0.00016594918,0.0000019126735],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0197519,0.0048950478,0.08432767,0.01866625,0.029443352,0.010504857,0.0027784952,0.001174717,0.7255509,0.011649323,0.002780237,0.08847727],"study_design_scores_gemma":[0.0034076471,0.0066218427,0.9477525,0.0025540139,0.0014390665,0.026599446,0.000042647873,0.0007923022,0.004698781,0.0008644059,0.005095704,0.00013164058],"about_ca_topic_score_codex":0.00001498464,"about_ca_topic_score_gemma":0.0000019038456,"teacher_disagreement_score":0.86342484,"about_ca_system_score_codex":0.00005238507,"about_ca_system_score_gemma":0.000066131426,"threshold_uncertainty_score":0.38158238},"labels":[],"label_agreement":null},{"id":"W4392032909","doi":"10.1172/jci170559","title":"Comparative genomics incorporating translocation renal cell carcinoma mouse model reveals molecular mechanisms of tumorigenesis","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Investigation","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Microsemi (Canada)","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; National Institutes of Health; University of Texas Southwestern Medical Center; Cancer Prevention and Research Institute of Texas; U.S. Department of Defense","keywords":"TFEB; Biology; TFE3; Carcinogenesis; Cancer research; mTORC1; Cell biology; Cancer; Genetics; Autophagy; Signal transduction; Gene; PI3K/AKT/mTOR pathway; Gene expression; Apoptosis","score_opus":0.11307634480716948,"score_gpt":0.3587772021913969,"score_spread":0.24570085738422742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392032909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8942879,0.0007919597,0.103605926,0.00060370046,0.00017775527,0.00030407615,0.00001044842,0.000015542866,0.00020270662],"genre_scores_gemma":[0.93300784,0.00005711122,0.066356145,0.00019150926,0.00019537857,0.0000056910776,0.000024271974,0.000028551418,0.00013353578],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964348,0.00027947625,0.0023301763,0.0002458947,0.00056694495,0.00014268814],"domain_scores_gemma":[0.9974342,0.00030286983,0.0011406383,0.000221368,0.0005836075,0.00031728824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001823095,0.00019471032,0.00087161193,0.00023232722,0.00003590919,0.000028574188,0.000118582284,0.00016950448,0.000008274156],"category_scores_gemma":[0.00018103233,0.00015613488,0.00044312817,0.00026378917,0.00015126035,0.0002132457,0.000018179544,0.00045297714,0.000006988605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026037294,0.0002103978,0.0010407949,0.0002762187,0.0001419962,0.000110892,0.00066142186,0.0107547175,0.9838071,0.0018620929,0.0001497727,0.0007242319],"study_design_scores_gemma":[0.0010929469,0.0014051363,0.0026104513,0.00031872006,0.00051928754,0.000067920875,0.00012292745,0.07466387,0.8959649,0.02311035,0.0000065515014,0.00011690387],"about_ca_topic_score_codex":0.000012066367,"about_ca_topic_score_gemma":0.0000019361287,"teacher_disagreement_score":0.08784216,"about_ca_system_score_codex":0.00017748568,"about_ca_system_score_gemma":0.0010605336,"threshold_uncertainty_score":0.63669956},"labels":[],"label_agreement":null},{"id":"W4392126042","doi":"10.1016/j.clgc.2024.02.011","title":"Association of Cabozantinib Dose Reductions for Toxicity With Clinical Effectiveness in Metastatic Renal Cell Carcinoma (mRCC): Results From the Canadian Kidney Cancer Information System (CKCis)","year":2024,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Centre hospitalier universitaire de Québec; Centre Hospitalier de l’Université de Montréal; Centre hospitalier de l'Université Laval; University of Calgary; Princess Margaret Cancer Centre; University of Toronto; Health Sciences Centre; CancerCare Manitoba; University Health Network; McMaster University Medical Centre; Hôtel-Dieu de Québec; McGill University; University of Ottawa; University of Alberta; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Cabozantinib; Medicine; Renal cell carcinoma; Toxicity; Tyrosine-kinase inhibitor; Kidney cancer; Oncology; Drug; Cancer; Internal medicine; Clinical trial; Tyrosine kinase; Pharmacology; Receptor","score_opus":0.059389763356065835,"score_gpt":0.36273070475990254,"score_spread":0.3033409414038367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392126042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870321,0.0010890667,0.00004625964,0.0036868867,0.00202407,0.0022365095,0.0030771396,0.000048562426,0.00075936085],"genre_scores_gemma":[0.9961736,0.00023346725,0.00050559535,0.00033631903,0.0011732783,0.00070895476,0.00040501513,0.000037159436,0.00042660063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99613345,0.0007294559,0.0016827752,0.000549573,0.00046935922,0.0004354139],"domain_scores_gemma":[0.9950402,0.003000469,0.000517366,0.0005054671,0.00045719268,0.00047933825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00266041,0.0002830726,0.0008172408,0.00018263927,0.00015795643,0.000059480102,0.00018015392,0.0002828065,0.000034362187],"category_scores_gemma":[0.0008713373,0.00018827447,0.00039754433,0.00054262066,0.00015355089,0.0002358361,0.00004232337,0.0007009454,0.00001736485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01793658,0.00078218017,0.91600597,0.0024529346,0.0021201165,0.00046220567,0.001457764,0.0014962662,0.000617277,0.00005990203,0.04016031,0.016448488],"study_design_scores_gemma":[0.009926167,0.001650971,0.9625926,0.0016895434,0.0018599126,0.000019065326,0.00040107805,0.0023625104,0.003239389,0.0000192276,0.01595998,0.00027957757],"about_ca_topic_score_codex":0.11413131,"about_ca_topic_score_gemma":0.06529331,"teacher_disagreement_score":0.048838,"about_ca_system_score_codex":0.001991184,"about_ca_system_score_gemma":0.0049440335,"threshold_uncertainty_score":0.9517627},"labels":[],"label_agreement":null},{"id":"W4392161534","doi":"10.1503/cmaj.230356","title":"Advances in the management of renal cell carcinoma","year":2024,"lang":"en","type":"review","venue":"Canadian Medical Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Juravinski Hospital; Juravinski Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Renal cell carcinoma; Incidence (geometry); Kidney cancer; Medicine; Carcinoma; Cancer; Disease; Kidney disease; Kidney; Internal medicine; Oncology; Pathology; Mathematics","score_opus":0.020834861326360254,"score_gpt":0.2960745478438022,"score_spread":0.27523968651744196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392161534","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000092880444,0.9658779,0.0000023613043,0.0014536098,0.00050214917,0.00050525635,0.000028878907,0.0000048884685,0.03153206],"genre_scores_gemma":[0.0010934809,0.9964672,0.00005587008,0.0004412015,0.0007792747,0.000043775337,0.000041669937,0.00003226883,0.0010453094],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960816,0.0003214511,0.00098132,0.00023837326,0.0019155715,0.00046167808],"domain_scores_gemma":[0.998319,0.0001551235,0.00043175137,0.00022222887,0.00011727159,0.00075467426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018523533,0.0002839952,0.001049546,0.0004978388,0.000064610336,0.000046701753,0.00036111157,0.00046941917,0.0006297058],"category_scores_gemma":[0.00007243561,0.00016245067,0.0005758724,0.00063281995,0.000036602523,0.000051369596,0.000025421454,0.0018066758,0.00018794334],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003555146,0.000052413703,0.00017830578,0.010473117,0.00024752232,0.01278683,0.00013547746,2.1493817e-7,1.4620839e-8,0.00013342082,0.01923254,0.9567566],"study_design_scores_gemma":[0.0004286648,0.00010564392,0.00024486682,0.011255432,0.0020891905,0.0014800958,0.00020844032,0.0000025590914,2.8882468e-7,0.000044208286,0.9840194,0.00012122989],"about_ca_topic_score_codex":0.00034174384,"about_ca_topic_score_gemma":0.0020702705,"teacher_disagreement_score":0.9647868,"about_ca_system_score_codex":0.0026424963,"about_ca_system_score_gemma":0.0038273619,"threshold_uncertainty_score":0.78492075},"labels":[],"label_agreement":null},{"id":"W4392359260","doi":"10.17650/1726-9776-2023-19-4-32-43","title":"Survival by depth of response and efficacy by International Metastatic Renal Cell Carcinoma Database Consortium Subgroup with lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma: analysis of the phase 3 randomized CLEAR study","year":2023,"lang":"en","type":"article","venue":"Cancer Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Lenvatinib; Medicine; Sunitinib; Renal cell carcinoma; Pembrolizumab; Oncology; Internal medicine; Subgroup analysis; Carcinoma; Cancer; Immunotherapy; Meta-analysis","score_opus":0.03375832532127623,"score_gpt":0.3233777834645756,"score_spread":0.28961945814329937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392359260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995228,0.0011915512,0.000042561845,0.00026119006,0.00018840298,0.0017506343,0.0011303864,0.000022509039,0.00018476618],"genre_scores_gemma":[0.99853617,0.00007889875,0.00005980365,0.000055783163,0.000022389626,0.00025263132,0.00070930383,0.00004661046,0.00023838099],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9956128,0.001683111,0.00093855034,0.0006961297,0.00062511547,0.0004443114],"domain_scores_gemma":[0.9954987,0.0027754009,0.0006308339,0.0006910976,0.00022960907,0.0001743379],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010604478,0.00037735535,0.0016246889,0.0006437648,0.000064703454,0.000010129087,0.00030737548,0.000075575546,0.00013399744],"category_scores_gemma":[0.00038955992,0.00026757934,0.00023515295,0.0014043337,0.0006101284,0.00008058064,0.00017662332,0.00036596222,0.0000017388376],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83005846,0.0016093588,0.12546174,0.00008814009,0.0017291127,0.00040807432,0.001869036,0.001513804,0.03671183,0.000005492628,0.00033326817,0.00021167846],"study_design_scores_gemma":[0.6079086,0.006835522,0.34178331,0.000021786402,0.008209584,0.000014795919,0.0017152899,0.0037020987,0.029385192,0.000001174098,0.00012232934,0.0003003315],"about_ca_topic_score_codex":0.0015843906,"about_ca_topic_score_gemma":0.0015094938,"teacher_disagreement_score":0.22214986,"about_ca_system_score_codex":0.00022780914,"about_ca_system_score_gemma":0.0005249119,"threshold_uncertainty_score":0.99997765},"labels":[],"label_agreement":null},{"id":"W4392387942","doi":"10.3389/fonc.2023.1343027","title":"Corrigendum: Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms","year":2024,"lang":"en","type":"erratum","venue":"Frontiers in Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Lenvatinib; Sunitinib; Pembrolizumab; Renal cell carcinoma; Medicine; Oncology; Internal medicine; Immunotherapy; Cancer","score_opus":0.023404016234415046,"score_gpt":0.2998702179532843,"score_spread":0.2764662017188692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392387942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96749264,0.005137707,0.000049245376,0.0004776939,0.0153217,0.008384365,0.0002164762,0.000037652753,0.0028825332],"genre_scores_gemma":[0.9696844,0.00026403958,0.0018969022,0.00027805462,0.0003424781,0.0018102786,0.0011206057,0.00021606004,0.024387177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961324,0.0003253751,0.0010543054,0.001129102,0.0005010572,0.0008578014],"domain_scores_gemma":[0.99828976,0.00032601008,0.0003826632,0.0006957571,0.0001304309,0.00017537684],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052237936,0.00076273107,0.0021892884,0.0010579744,0.00007705966,0.000031495354,0.0003364299,0.0006654108,0.000023589064],"category_scores_gemma":[0.00012151703,0.0005049739,0.00016079379,0.00054767466,0.0002785228,0.000087560584,0.00017074934,0.0020931805,0.0000053490253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021332404,0.0053434167,0.76642054,0.00056791084,0.00030977197,0.002069839,0.0054704305,0.000024247154,0.0000022448814,0.000005332967,0.18430457,0.014149329],"study_design_scores_gemma":[0.10885224,0.041533757,0.77734977,0.00036512862,0.0010350964,0.00002855552,0.008377601,0.0006907092,0.000017355498,0.000084213614,0.060925443,0.0007401474],"about_ca_topic_score_codex":0.00045998758,"about_ca_topic_score_gemma":0.0029900454,"teacher_disagreement_score":0.12337911,"about_ca_system_score_codex":0.0026377568,"about_ca_system_score_gemma":0.0011795198,"threshold_uncertainty_score":0.9997402},"labels":[],"label_agreement":null},{"id":"W4392499500","doi":"10.15586/jkcvhl.v11i1.307","title":"The Survival Outcomes of the Metastatic Nonclear Cell Renal Cell Carcinoma in the Immunotherapy Era: Princess Margaret Cancer Centre Experience","year":2024,"lang":"en","type":"article","venue":"Journal of Kidney Cancer and VHL","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Royal Victoria Regional Health Centre; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Confidence interval; Immunotherapy; Oncology; Demographics; Carcinoma; Gastroenterology; Cancer","score_opus":0.020292189127843096,"score_gpt":0.3001376135071585,"score_spread":0.2798454243793154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392499500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94963306,0.031212226,0.000007920218,0.016971275,0.0008873433,0.0003349304,0.000033273995,0.0000036771382,0.00091629155],"genre_scores_gemma":[0.9927421,0.0050070584,0.000046075256,0.00095833425,0.00016571175,0.000021812355,7.960073e-7,0.000022051456,0.0010360577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981943,0.00019866861,0.00053546653,0.0001715262,0.0006380408,0.0002620436],"domain_scores_gemma":[0.9988826,0.00026444517,0.00026782134,0.0002943433,0.00012121538,0.00016960123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005245649,0.00020179502,0.00042356827,0.0000685453,0.00012529582,0.00006951667,0.00034307808,0.000038765254,0.00011514944],"category_scores_gemma":[0.00004613569,0.00007862827,0.00024794196,0.0002786964,0.00020622354,0.00009998412,0.000048053516,0.0004605016,8.604837e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013093356,0.00041569248,0.9124116,0.0007243283,0.0006004596,0.00052066194,0.033754144,0.000096530406,0.02547177,0.00017216448,0.013237703,0.011285622],"study_design_scores_gemma":[0.0043906304,0.0005033016,0.8830899,0.0006940084,0.000595689,0.00016775222,0.0069249747,0.00023175929,0.05194385,0.00011766903,0.05111242,0.0002280486],"about_ca_topic_score_codex":0.0010210546,"about_ca_topic_score_gemma":0.00018270694,"teacher_disagreement_score":0.04310904,"about_ca_system_score_codex":0.00020788175,"about_ca_system_score_gemma":0.0010516464,"threshold_uncertainty_score":0.32063678},"labels":[],"label_agreement":null},{"id":"W4392509384","doi":"10.1007/978-3-031-54806-2_14","title":"Deep Learning-Based Hierarchical Delineation of Kidneys, Tumors, and Cysts in CT Images","year":2024,"lang":"en","type":"book-chapter","venue":"Lecture notes in computer science","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Calgary","funders":"","keywords":"Computer science; Artificial intelligence; Deep learning; Computer vision; Pattern recognition (psychology)","score_opus":0.011961726882665757,"score_gpt":0.25302077844346693,"score_spread":0.24105905156080118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392509384","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04631315,0.006528232,0.9418625,0.0018055884,0.0004219212,0.0009423306,0.000008784872,0.000088854875,0.002028592],"genre_scores_gemma":[0.970116,0.00005948288,0.028959753,0.00027437278,0.00015357784,0.0000065371896,0.00003237357,0.000031088064,0.00036681147],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99801373,0.000026553917,0.0004094406,0.0007320421,0.00055345806,0.00026475612],"domain_scores_gemma":[0.9990265,0.00030238632,0.00011178115,0.00031371583,0.00010512762,0.00014050803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038207672,0.00030128963,0.00050677755,0.0008149133,0.000037420235,0.00004945361,0.00018494815,0.00011153847,0.000018084938],"category_scores_gemma":[0.00014569955,0.00023838932,0.00008241116,0.00027781958,0.0005539787,0.00005307408,0.00015892563,0.0007916554,0.000007547828],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028252217,0.00018634845,0.018238697,0.0017537929,0.000057574995,0.005084738,0.00092069706,0.120138235,0.003823679,0.001039904,0.000021728849,0.8484521],"study_design_scores_gemma":[0.00175118,0.0016954335,0.014977508,0.00474101,0.00011619021,0.00063581043,7.0764344e-7,0.941884,0.020290185,0.012735502,0.000572422,0.0006000777],"about_ca_topic_score_codex":0.00005372311,"about_ca_topic_score_gemma":0.000044085496,"teacher_disagreement_score":0.92380285,"about_ca_system_score_codex":0.0002538674,"about_ca_system_score_gemma":0.00036256475,"threshold_uncertainty_score":0.9721234},"labels":[],"label_agreement":null},{"id":"W4392509753","doi":"10.1007/978-3-031-54806-2_17","title":"A Deep Learning Approach for the Segmentation of Kidney, Tumor and Cyst in Computed Tomography Scans","year":2024,"lang":"en","type":"book-chapter","venue":"Lecture notes in computer science","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Computer science; Computed tomography; Segmentation; Artificial intelligence; Cyst; Computer vision; Tomography; Radiology; Medicine","score_opus":0.016658574136938657,"score_gpt":0.24783308433222914,"score_spread":0.23117451019529048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392509753","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002127324,0.003115334,0.99153715,0.00040316506,0.00025328988,0.0014205611,0.000008356288,0.000032022912,0.0011027857],"genre_scores_gemma":[0.83342427,0.00004697909,0.16535993,0.00062403927,0.00020781558,0.000058450165,0.0000623567,0.00004260022,0.0001735554],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99837744,0.00001625855,0.0003258815,0.00063132454,0.0004021805,0.00024689388],"domain_scores_gemma":[0.9990273,0.00035137183,0.00013209577,0.00027391565,0.0000980727,0.00011720923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004077349,0.0002677942,0.00041079748,0.00065441814,0.00007915412,0.00006808047,0.00022507568,0.00009817762,0.0000039352985],"category_scores_gemma":[0.00005264469,0.00017886661,0.0001125523,0.00042401385,0.00048126833,0.000051349576,0.00016222685,0.0004458233,7.4894103e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046065074,0.00027936365,0.0115841385,0.004425658,0.00037920044,0.00045343096,0.009584368,0.29075995,0.0050878017,0.0034164963,0.00004883646,0.6735201],"study_design_scores_gemma":[0.0010302238,0.00070953846,0.0020515316,0.0010439635,0.00014831229,0.00024948904,0.00000573406,0.9885809,0.0019730777,0.0037775838,0.00018355537,0.0002461227],"about_ca_topic_score_codex":0.0000428706,"about_ca_topic_score_gemma":0.000025534402,"teacher_disagreement_score":0.831297,"about_ca_system_score_codex":0.00016239351,"about_ca_system_score_gemma":0.00020349001,"threshold_uncertainty_score":0.7293969},"labels":[],"label_agreement":null},{"id":"W4392598511","doi":"10.1111/pin.13417","title":"Papillary renal neoplasm with reverse polarity is biologically and clinically distinct from eosinophilic papillary renal cell carcinoma","year":2024,"lang":"en","type":"article","venue":"Pathology International","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Calgary Laboratory Services; University of Toronto; University of Calgary; St. Michael's Hospital","funders":"Strong; Government of Ontario; Canadian Urological Association Scholarship Fund; Canadian Urological Association","keywords":"Pathology; Immunohistochemistry; Papillary renal cell carcinomas; Eosinophilic; Multidrug resistance-associated protein 2; Staining; In situ hybridization; Kidney; Biology; Medicine; Renal cell carcinoma; Internal medicine; Gene expression; Gene; Transporter; ATP-binding cassette transporter","score_opus":0.019060012369794956,"score_gpt":0.2669391147103283,"score_spread":0.2478791023405333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392598511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98216695,0.0025485328,0.00024266701,0.004966411,0.00050427415,0.0003196268,0.00045044246,0.00012666892,0.00867446],"genre_scores_gemma":[0.9906461,0.00031688952,0.00439533,0.0018468382,0.00060022884,0.000035453504,0.00070243905,0.00003885298,0.0014178674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975096,0.00016782759,0.00058725016,0.000967626,0.0004195074,0.0003482194],"domain_scores_gemma":[0.998594,0.00043568137,0.00014080275,0.0004001127,0.00016848503,0.00026094908],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031398475,0.00036695303,0.00048190553,0.00017360703,0.00009641008,0.00006363289,0.00020936047,0.00033531606,0.00079828757],"category_scores_gemma":[0.00011530541,0.00025631496,0.00018758693,0.00013291948,0.0004277679,0.000104611034,0.00021770784,0.0006373722,0.00018768672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016504297,0.0004185782,0.89448345,0.00009037677,0.000454269,0.024284003,0.00059159176,0.0000018503258,0.06689146,0.00030592023,0.0033014035,0.007526659],"study_design_scores_gemma":[0.0019580428,0.002137815,0.9770759,0.00017783121,0.0003872108,0.0036468832,0.00005197139,0.00031556006,0.0042357603,0.0010977943,0.008575378,0.00033985826],"about_ca_topic_score_codex":0.00013298904,"about_ca_topic_score_gemma":0.0000222913,"teacher_disagreement_score":0.082592435,"about_ca_system_score_codex":0.0001623913,"about_ca_system_score_gemma":0.00021334057,"threshold_uncertainty_score":0.9999889},"labels":[],"label_agreement":null},{"id":"W4392807792","doi":"10.1016/j.urolonc.2024.01.206","title":"ACTIVE SURVEILLANCE VERSUS PRIMARY INTERVENTION FOR CLINICAL T1A KIDNEY TUMORS: CONTEMPORARY RESULTS AFTER FOURTEN-YEAR EXPERIENCE OF THE DISSRM PROSPECTIVE COMPARATIVE STUDY","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Intervention (counseling); Medicine; Prospective cohort study; Primary (astronomy); Oncology; Internal medicine; Nursing","score_opus":0.10768055679330706,"score_gpt":0.4072498784454719,"score_spread":0.2995693216521648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392807792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99114245,0.000990114,0.000027863556,0.002201515,0.0005720524,0.0022047835,0.0001745722,0.000041919513,0.0026447256],"genre_scores_gemma":[0.9964181,0.000054327204,0.0019831415,0.00022418438,0.00012767305,0.0007196055,0.00007319971,0.000011091431,0.0003886801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998163,0.00036873366,0.00058567576,0.00052676356,0.00017489838,0.00018097069],"domain_scores_gemma":[0.9981088,0.0010700766,0.00023083453,0.00026284548,0.0001477756,0.00017964923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057533244,0.00019477592,0.00052201736,0.000080813385,0.000119057135,0.000019358988,0.0001084086,0.00012692448,0.000012199393],"category_scores_gemma":[0.0005130922,0.00012371202,0.00017975611,0.0002590111,0.0010516818,0.00011881013,0.00008802379,0.000339312,0.0000043153714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016181802,0.0015972063,0.9642513,0.00012466182,0.0005168469,0.00018981802,0.010265495,0.000003866014,0.000106147665,0.0011594914,0.004949193,0.0006542156],"study_design_scores_gemma":[0.011546468,0.03409606,0.8643525,0.00047467768,0.00058050314,0.000101584345,0.010179706,0.0003681191,0.0011333147,0.0017153397,0.075171545,0.00028017935],"about_ca_topic_score_codex":0.00005221849,"about_ca_topic_score_gemma":0.00004150574,"teacher_disagreement_score":0.099898756,"about_ca_system_score_codex":0.00022210988,"about_ca_system_score_gemma":0.00056965253,"threshold_uncertainty_score":0.5044829},"labels":[],"label_agreement":null},{"id":"W4392810267","doi":"10.53555/sfs.v10i6.2266","title":"Role Of Multidetector CT In Characterization Of Renal Mass","year":2023,"lang":"en","type":"article","venue":"Journal of Survey in Fisheries Sciences","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Renal mass; Characterization (materials science); Multidetector computed tomography; Radiology; Medicine; Internal medicine; Computed tomography; Kidney; Materials science; Nanotechnology","score_opus":0.12729209595540997,"score_gpt":0.28341488838007506,"score_spread":0.1561227924246651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392810267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99933714,0.00006819166,0.000004948438,0.00015954922,0.00011276796,0.00009428635,0.000012320866,0.000003085155,0.00020773259],"genre_scores_gemma":[0.99951345,0.00011353896,0.00027066158,0.0000073255724,0.000022615919,0.0000015817159,0.0000056290082,0.000004691628,0.000060517163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845666,0.000176914,0.0006414314,0.00010025238,0.00047886622,0.00014589452],"domain_scores_gemma":[0.999044,0.00021998507,0.00044602648,0.0000821474,0.00016093951,0.00004692413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002295745,0.00007551243,0.00036384026,0.00049114705,0.000016538721,0.000010268897,0.00013624776,0.000025551719,0.000042884396],"category_scores_gemma":[0.00047714153,0.000054403485,0.00006131727,0.0012447261,0.00022155173,0.00023361377,0.000022114415,0.00010342006,0.0000012554216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013885042,0.000040652598,0.6374186,0.000020507485,0.000006798542,0.0000371977,0.00026446048,0.000048111953,0.36116835,7.2786355e-7,0.000007770541,0.0008479585],"study_design_scores_gemma":[0.0005006581,0.0005808956,0.8493947,0.0001515137,0.000006006827,0.00002413088,0.00027528146,0.00014961681,0.1488168,0.000034437075,0.00003042481,0.000035554],"about_ca_topic_score_codex":0.0004711322,"about_ca_topic_score_gemma":0.00036181533,"teacher_disagreement_score":0.21235156,"about_ca_system_score_codex":0.00006134003,"about_ca_system_score_gemma":0.00019540536,"threshold_uncertainty_score":0.22185098},"labels":[],"label_agreement":null},{"id":"W4392820802","doi":"10.1016/j.radonc.2024.110216","title":"Dose-response of localized renal cell carcinoma after stereotactic body radiation therapy: A meta-analysis","year":2024,"lang":"en","type":"review","venue":"Radiotherapy and Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre; Western University; London Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Renal cell carcinoma; Meta-analysis; Cochrane Library; Internal medicine; Radiation therapy; Oncology; Radiosurgery; Dose fractionation; Surgery","score_opus":0.07243085669885219,"score_gpt":0.3677956231340067,"score_spread":0.2953647664351545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392820802","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0081191035,0.98937255,0.0000448126,0.00021494197,0.00014239155,0.001797627,0.00009924999,0.00003786761,0.00017145992],"genre_scores_gemma":[0.011437485,0.9843482,0.0004678974,0.00029889637,0.00019389969,0.0006626991,0.00010867288,0.00011587163,0.0023664108],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953923,0.0018388651,0.0011805532,0.00085525296,0.0003529636,0.00038001276],"domain_scores_gemma":[0.9973966,0.000856859,0.0006344769,0.0007894071,0.000077641176,0.0002450451],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00091769366,0.0007808072,0.0072423676,0.0012048921,0.000041389125,0.000033249908,0.00014984536,0.00070569344,0.0013917706],"category_scores_gemma":[0.00001730477,0.0004700737,0.0043788278,0.0009452614,0.00018655804,0.000050944727,0.000033552853,0.0005051374,0.000024507544],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016159425,0.0012554234,0.00022927254,0.01326529,0.48697025,0.0034321288,0.0014176859,0.0000015067652,0.00024702091,0.00002367858,0.00074260565,0.4762557],"study_design_scores_gemma":[0.0018033334,0.0030651642,0.0002927378,0.00008910673,0.37756345,0.0003127543,0.0000053111908,0.000021588905,0.00005450249,0.000005047292,0.6165406,0.00024641643],"about_ca_topic_score_codex":0.000085350985,"about_ca_topic_score_gemma":0.000012989272,"teacher_disagreement_score":0.615798,"about_ca_system_score_codex":0.001107534,"about_ca_system_score_gemma":0.0009679489,"threshold_uncertainty_score":0.9997751},"labels":[],"label_agreement":null},{"id":"W4392881191","doi":"10.1016/j.euros.2024.03.001","title":"Corrigendum to “RPN (Radius, Position of tumour, iNvasion of renal sinus) Classification and Nephrometry Scoring System: An Internationally Developed Clinical Classification To Describe the Surgical Difficulty for Renal Masses for Which Robotic Partial Nephrectomy Is Planned” [Eur. Urol. Open Sci. 54 (2023) 33–42]","year":2024,"lang":"en","type":"erratum","venue":"European Urology Open Science","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke; University of Calgary","funders":"","keywords":"Medicine; Nephrectomy; Euros; Position (finance); Renal sinus; Radiology; Kidney; Internal medicine; Humanities","score_opus":0.17350583556202626,"score_gpt":0.3838845478148039,"score_spread":0.21037871225277766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392881191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8791894,0.00090466934,0.02402656,0.019211154,0.023702677,0.0308444,0.0013641008,0.0001949213,0.02056213],"genre_scores_gemma":[0.9789194,0.00005964338,0.010487464,0.00072624447,0.0010499741,0.00063744845,0.0011989914,0.00011532063,0.0068055484],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9935968,0.00090504414,0.001841738,0.0020419464,0.0009945438,0.00061991694],"domain_scores_gemma":[0.99528056,0.0005353568,0.0010015597,0.0010539277,0.001572844,0.00055573037],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0069690645,0.0005150801,0.0011465892,0.0007251173,0.0004981724,0.00060763775,0.0029690869,0.00027021562,0.000022384267],"category_scores_gemma":[0.0015726079,0.00037768536,0.00017805754,0.0015456475,0.0006383599,0.00054828747,0.0017802853,0.0006816601,0.00004683686],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03407988,0.0028041983,0.012352526,0.002594622,0.0013152934,0.00066499214,0.003603919,0.0007836917,0.20720081,0.012058817,0.7079772,0.014564068],"study_design_scores_gemma":[0.0070101703,0.017625198,0.6967671,0.003267115,0.0023767187,0.001687503,0.0008713625,0.036455866,0.0057941354,0.000114344904,0.22668508,0.0013454063],"about_ca_topic_score_codex":0.00010912439,"about_ca_topic_score_gemma":0.00018979897,"teacher_disagreement_score":0.68441457,"about_ca_system_score_codex":0.00042335273,"about_ca_system_score_gemma":0.0020566375,"threshold_uncertainty_score":0.9998675},"labels":[],"label_agreement":null},{"id":"W4393057081","doi":"10.1158/1538-7445.am2024-4357","title":"Abstract 4357: Examining the role of end-stage kidney as a potential intermediate stage in the development of renal cell carcinomas; understanding the pathogenesis allowing for early detection","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Stage (stratigraphy); Pathogenesis; Kidney; Medicine; Renal cell carcinoma; Pathology; Internal medicine; Biology","score_opus":0.11662281140169924,"score_gpt":0.3597868093562705,"score_spread":0.24316399795457128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393057081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99418956,0.002318059,0.0006544064,0.00022533965,0.00013375458,0.0012786769,0.000051039384,0.000012537668,0.0011365963],"genre_scores_gemma":[0.9987929,0.00007882478,0.00006246692,0.000023110915,0.00013402032,0.0004855608,0.000013994404,0.000036593337,0.0003725511],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975731,0.0002445536,0.00044637077,0.0003296045,0.0009480444,0.00045834717],"domain_scores_gemma":[0.99861443,0.00072059844,0.00008719642,0.00035979203,0.00012353074,0.000094463474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030566715,0.00016007022,0.00022626753,0.0002828988,0.00023997166,0.00007440871,0.00031663338,0.00007436228,0.00011212468],"category_scores_gemma":[0.00011554131,0.00008340737,0.00013319378,0.00048523283,0.00020373834,0.00007637668,0.000111544265,0.0004906787,0.000004176929],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064763403,0.00006653283,0.002926377,0.000667249,0.00015950557,0.00010922394,0.025192546,0.000094623836,0.95239544,0.000089256806,0.000023707133,0.01762791],"study_design_scores_gemma":[0.0010781701,0.0006062185,0.10423119,0.00066404155,0.000110509485,0.000009989929,0.040855013,0.00066082063,0.8501955,0.00018415278,0.001275328,0.00012901369],"about_ca_topic_score_codex":0.0009261712,"about_ca_topic_score_gemma":0.0004025555,"teacher_disagreement_score":0.10219988,"about_ca_system_score_codex":0.0008430792,"about_ca_system_score_gemma":0.0011882574,"threshold_uncertainty_score":0.3401254},"labels":[],"label_agreement":null},{"id":"W4393080333","doi":"10.3390/curroncol31040129","title":"Soluble Immune Checkpoint Molecules as Predictors of Efficacy in Immuno-Oncology Combination Therapy in Advanced Renal Cell Carcinoma","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Renal cell carcinoma; Medicine; Oncology; Internal medicine; Nephrectomy; Univariate analysis; Combination therapy; Targeted therapy; Multivariate analysis; Immunohistochemistry; Biomarker; Cancer; Cancer research; Kidney; Biology","score_opus":0.043187964151565686,"score_gpt":0.3530179416413561,"score_spread":0.3098299774897904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393080333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9555296,0.03604987,0.000017377732,0.00059740193,0.0018685823,0.0012684747,0.0000055960945,0.000054831224,0.004608322],"genre_scores_gemma":[0.9970132,0.0020574676,0.00016401979,0.000023128498,0.0000842219,0.00022247907,0.0001781048,0.000042018008,0.00021532363],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997458,0.00031343702,0.00096630096,0.00052181183,0.00027976828,0.00046069224],"domain_scores_gemma":[0.9988631,0.0003315983,0.00020595203,0.00036938966,0.00011771879,0.000112257534],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005098454,0.00029868842,0.000843693,0.0006604527,0.000026112662,0.0000092402415,0.00016410982,0.00026188258,0.00013442484],"category_scores_gemma":[0.00008693465,0.00025959229,0.0002230366,0.00056599383,0.00018175395,0.00009071636,0.00009939577,0.0005769377,0.00004330425],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004514973,0.014621089,0.072060704,0.0008236874,0.00016244905,0.0014521688,0.0067415372,0.00022956835,0.60117334,0.00075557694,0.00039013784,0.29707476],"study_design_scores_gemma":[0.026646653,0.019733522,0.5135223,0.0006285637,0.00015083529,0.00017135641,0.00056514464,0.0013536693,0.39947426,0.00042751103,0.036937214,0.00038893233],"about_ca_topic_score_codex":0.00018216488,"about_ca_topic_score_gemma":0.000054640703,"teacher_disagreement_score":0.44146162,"about_ca_system_score_codex":0.0016941667,"about_ca_system_score_gemma":0.00096203096,"threshold_uncertainty_score":0.99998564},"labels":[],"label_agreement":null},{"id":"W4393155238","doi":"10.62051/4s6rzk59","title":"Hyperthermic Intravesical Chemotherapy Shed New Light on Therapy for NMIBC: A Meta-Analysis","year":2024,"lang":"en","type":"article","venue":"Transactions on Materials Biotechnology and Life Sciences","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Meta-analysis; Medicine; Chemotherapy; Oncology; Urology; Internal medicine","score_opus":0.06249209048088095,"score_gpt":0.3129011126600022,"score_spread":0.25040902217912125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393155238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8839569,0.0042086504,0.013011832,0.09728563,0.00025014541,0.0008054304,0.00004829807,0.00030890296,0.00012421403],"genre_scores_gemma":[0.99456376,0.0013942743,0.0018347269,0.0013426231,0.00006027791,0.000098263394,0.000004115602,0.000014572016,0.0006873731],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987703,0.000044633656,0.0002457178,0.0005413827,0.00016782833,0.00023013235],"domain_scores_gemma":[0.9994854,0.000117008814,0.000036740366,0.00024411583,0.000015045106,0.00010174199],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031786616,0.0002139745,0.00065625564,0.0005819691,0.00019719405,0.00006840403,0.0001192302,0.00025928172,0.0012854721],"category_scores_gemma":[0.000009797824,0.00012262368,0.00036775132,0.0006586083,0.00031026333,0.00005603639,0.0000017885629,0.00012367644,0.00003398215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017186332,0.0005341508,0.000007874324,0.00007951262,0.04390186,0.000031031406,0.00043237064,0.0000857549,0.88784194,0.0048633134,0.00039471043,0.060108863],"study_design_scores_gemma":[0.0006336806,0.00260266,0.00017576781,0.000010205246,0.0127636865,0.000030491574,0.000059180034,0.00012923012,0.97828245,0.0007630315,0.004404395,0.00014519805],"about_ca_topic_score_codex":0.00004365511,"about_ca_topic_score_gemma":0.000008216213,"teacher_disagreement_score":0.11060688,"about_ca_system_score_codex":0.00002395275,"about_ca_system_score_gemma":0.00011593472,"threshold_uncertainty_score":0.9996275},"labels":[],"label_agreement":null},{"id":"W4393201528","doi":"10.1007/s00345-024-04856-y","title":"Cancer-specific mortality in non-metastatic T1a renal cell carcinoma treated with radiotherapy versus partial nephrectomy","year":2024,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Hazard ratio; Internal medicine; Cumulative incidence; Proportional hazards model; Urology; Incidence (geometry); Nephrology; Propensity score matching; Oncology; Gastroenterology; Surgery; Confidence interval; Kidney; Cohort","score_opus":0.029362270884903948,"score_gpt":0.2948287053717502,"score_spread":0.26546643448684626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393201528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97122884,0.025223972,0.00016367389,0.0012851364,0.0005638048,0.00036337925,0.000007297984,0.00001895201,0.0011449164],"genre_scores_gemma":[0.9972975,0.0008594788,0.000677479,0.00015704926,0.0005220132,0.000035707963,0.000007341589,0.000047381902,0.00039600805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807346,0.00018276389,0.0006381292,0.00031782893,0.00036721549,0.00042060905],"domain_scores_gemma":[0.99897057,0.00021877623,0.00021601218,0.0002597744,0.000099976336,0.00023487156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003177821,0.00028067932,0.0007298749,0.00068978284,0.000032201457,0.00003007395,0.00012637557,0.00006299086,0.0005647981],"category_scores_gemma":[0.000006038055,0.00019279329,0.00020246844,0.0007196839,0.00018908222,0.00009959345,0.000014018943,0.00062830606,0.000013253842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054656863,0.0015529344,0.75953317,0.0003742244,0.0026693905,0.08736218,0.0015566516,0.0038600946,0.047477983,0.00020457951,0.006638842,0.03411308],"study_design_scores_gemma":[0.047323506,0.021299899,0.77456665,0.0003578683,0.0029119623,0.004300328,0.000181138,0.0031946374,0.025904119,0.00006727955,0.11918373,0.00070888165],"about_ca_topic_score_codex":0.00038103646,"about_ca_topic_score_gemma":0.0007917627,"teacher_disagreement_score":0.11254489,"about_ca_system_score_codex":0.000543585,"about_ca_system_score_gemma":0.00040083204,"threshold_uncertainty_score":0.78618824},"labels":[],"label_agreement":null},{"id":"W4393532116","doi":"10.1097/ju9.0000000000000127","title":"Evaluating the Prognostic Variables for Overall Survival in Patients with Metastatic Renal Cell Carcinoma: A Meta-Analysis Of 29,366 Patients","year":2024,"lang":"en","type":"article","venue":"JU Open Plus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Renal cell carcinoma; Oncology; Medicine; Internal medicine; Meta-analysis; Carcinoma; Overall survival","score_opus":0.13183825031223687,"score_gpt":0.3564406333823021,"score_spread":0.22460238307006522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393532116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992356,0.00073298917,0.00016077109,0.00013451623,0.000080223275,0.0050100298,0.0003122783,0.000013457545,0.0011997324],"genre_scores_gemma":[0.9929178,0.0000013696093,0.004324233,0.00007383393,0.000015979398,0.0007922114,0.00065306976,0.000046589554,0.0011749667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971451,0.0003205145,0.0006966852,0.00058571016,0.0008963415,0.0003556532],"domain_scores_gemma":[0.9976659,0.0010274925,0.0002512042,0.0005779273,0.00037621584,0.00010125675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011747865,0.00031475569,0.0014189234,0.00031628372,0.00007405151,0.00012101166,0.00031480665,0.00004581451,0.00023154811],"category_scores_gemma":[0.00022480292,0.00016387092,0.0005584181,0.0009628724,0.000052143296,0.0001741849,0.00018084257,0.00017361237,0.0000075675553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008553682,0.0044463645,0.762662,0.0022991942,0.19614013,0.00017747756,0.0050353482,0.016965616,0.00032264483,0.00068814785,0.0009912646,0.0017181117],"study_design_scores_gemma":[0.009722117,0.005224687,0.5871746,0.00007515959,0.37358713,0.0000013793065,0.00012436169,0.023088103,0.00048756393,0.00012387038,0.00009467335,0.00029636596],"about_ca_topic_score_codex":0.0012410886,"about_ca_topic_score_gemma":0.0002163047,"teacher_disagreement_score":0.177447,"about_ca_system_score_codex":0.00029815157,"about_ca_system_score_gemma":0.00043499246,"threshold_uncertainty_score":0.6682462},"labels":[],"label_agreement":null},{"id":"W4393570486","doi":"10.1117/12.3006838","title":"Radiomics feature based benign vs. malignant characterization of solid renal masses on MRI","year":2024,"lang":"en","type":"article","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Vale (Canada); University of Guelph","funders":"","keywords":"Chromophobe cell; Renal cell carcinoma; Radiomics; Magnetic resonance imaging; Medicine; Radiology; Clear cell; Support vector machine; Biopsy; Artificial intelligence; Computer science; Pathology","score_opus":0.015903947498748627,"score_gpt":0.2585849221245367,"score_spread":0.24268097462578808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393570486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809518,0.0002477636,0.0064665945,0.0060833716,0.00032771123,0.0006009599,0.00008644759,0.0001629323,0.005072461],"genre_scores_gemma":[0.9896166,0.00008383977,0.002706467,0.0005347153,0.00017062463,0.000018613775,0.0004384219,0.00003532526,0.0063953954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990214,0.000029945159,0.00020932654,0.0002843072,0.0002869768,0.00016803783],"domain_scores_gemma":[0.99945825,0.000052887335,0.000048149956,0.0002832987,0.000060471983,0.00009693927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000988781,0.00016917656,0.00028564298,0.00019014718,0.000022511771,0.000020491805,0.00005079016,0.00010334316,0.00031174225],"category_scores_gemma":[0.000012900415,0.00011380045,0.00013659644,0.00020518416,0.000028563309,0.00005178302,0.000012476571,0.00012504608,0.000051143583],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006676454,0.00021140362,0.0016851644,0.00043105622,0.00016017078,0.00051080313,0.00009938263,0.00003751872,0.9877735,0.0012353547,0.0045120153,0.0026760262],"study_design_scores_gemma":[0.00080455735,0.0011066997,0.020961009,0.0005414019,0.00021461154,0.00007203153,0.000011145116,0.0075900354,0.9531729,0.00002823208,0.01536808,0.00012924902],"about_ca_topic_score_codex":0.0000088208435,"about_ca_topic_score_gemma":0.0000016072421,"teacher_disagreement_score":0.03460051,"about_ca_system_score_codex":0.00013517775,"about_ca_system_score_gemma":0.00015536466,"threshold_uncertainty_score":0.46406478},"labels":[],"label_agreement":null},{"id":"W4393858869","doi":"10.5489/cuaj.8585","title":"Robotic-assisted laparoscopic partial nephrectomy vs. laparoscopic and open partial nephrectomy","year":2024,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Nephrectomy; Single Center; Urology; Surgery; Laparoscopy; Blood loss; Internal medicine; Kidney","score_opus":0.02634176963419845,"score_gpt":0.27139314751615057,"score_spread":0.2450513778819521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393858869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655044,0.0021124643,0.000047739653,0.025782913,0.0013098159,0.0010106624,0.000029707875,0.00010125773,0.004101013],"genre_scores_gemma":[0.9921579,0.00015532934,0.00052137254,0.0037289718,0.0010178093,0.00013028814,0.000049084454,0.00003536666,0.0022038997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728614,0.00033147412,0.0005606339,0.00049617887,0.00047856782,0.000847006],"domain_scores_gemma":[0.9977181,0.00024614038,0.00017716612,0.00019788972,0.00015575804,0.0015049466],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00071511976,0.0003063933,0.0007206196,0.00026013184,0.00039843982,0.0009774312,0.00024011286,0.00037215336,0.0012456101],"category_scores_gemma":[0.00041273324,0.0002402973,0.00017960898,0.00040079994,0.00007394189,0.0002914666,0.00008048516,0.0009148596,0.00021044064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043888195,0.00018708468,0.93406886,0.00006671928,0.0009573943,0.0030407684,0.00031310055,0.000075226075,0.0009034128,0.0012695041,0.04715416,0.011524896],"study_design_scores_gemma":[0.0036992612,0.0011559617,0.54820067,0.000119528995,0.00059652084,0.0011425281,0.000040547526,0.0010619367,0.0005949247,0.00049189734,0.44257092,0.00032528912],"about_ca_topic_score_codex":0.0019964632,"about_ca_topic_score_gemma":0.0012317786,"teacher_disagreement_score":0.39541677,"about_ca_system_score_codex":0.0017540881,"about_ca_system_score_gemma":0.0012881553,"threshold_uncertainty_score":0.9996674},"labels":[],"label_agreement":null},{"id":"W4394008906","doi":"10.1016/j.eururo.2024.03.015","title":"Characterization of Responses to Lenvatinib plus Pembrolizumab in Patients with Advanced Renal Cell Carcinoma at the Final Prespecified Survival Analysis of the Phase 3 CLEAR Study","year":2024,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta; McMaster University; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Western University","funders":"National Cancer Institute; Genentech; European Society for Medical Oncology; Astellas Pharma; National Comprehensive Cancer Network; Eisai; Ipsen; BeiGene; Daiichi Sankyo Europe; Exelixis; Memorial Sloan-Kettering Cancer Center; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Lenvatinib; Internal medicine; Confidence interval; Renal cell carcinoma; Pembrolizumab; Sunitinib; Response Evaluation Criteria in Solid Tumors; Gastroenterology; Oncology; Phases of clinical research; Urology; Clinical trial; Cancer; Immunotherapy","score_opus":0.027795215099658516,"score_gpt":0.27027845396427147,"score_spread":0.24248323886461295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394008906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99727255,0.00006159915,0.000018244753,0.00021819028,0.00009143006,0.0010357728,0.000080756065,0.000014558499,0.0012069248],"genre_scores_gemma":[0.99870485,0.0000022296474,0.000012460257,0.00008090581,0.000028812445,0.000014881919,0.000088497,0.00003455267,0.0010328218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753416,0.0011028412,0.0004479897,0.00037196447,0.000352451,0.00019061209],"domain_scores_gemma":[0.9988622,0.00020633258,0.0001652835,0.0006072607,0.00010608054,0.000052835258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037835975,0.00016985984,0.00040799967,0.00032568045,0.000046035166,0.0000079444635,0.0001898873,0.000024776327,0.000097555225],"category_scores_gemma":[0.00007432514,0.00009233255,0.000112073314,0.00094257336,0.00010255413,0.000032040425,0.00016641285,0.0001636837,0.000014468527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09602898,0.0020661636,0.8043084,0.00007204642,0.00077838165,0.00039160688,0.008111486,0.001232719,0.08436186,0.00001863519,0.000053231488,0.0025764666],"study_design_scores_gemma":[0.006479266,0.00828894,0.97833186,0.00001363489,0.00094261556,0.0000033754302,0.00008581274,0.00014925477,0.005132871,2.5001523e-7,0.00049891334,0.000073188094],"about_ca_topic_score_codex":0.000023968405,"about_ca_topic_score_gemma":0.00006243274,"teacher_disagreement_score":0.17402346,"about_ca_system_score_codex":0.00009939519,"about_ca_system_score_gemma":0.000081481514,"threshold_uncertainty_score":0.3765212},"labels":[],"label_agreement":null},{"id":"W4394108762","doi":"10.6084/m9.figshare.22735563","title":"Additional file 4 of Genomic and transcriptomic features between primary and paired metastatic fumarate hydratase–deficient renal cell carcinoma","year":2023,"lang":"en","type":"dataset","venue":"Open MIND","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Food Inspection Agency","funders":"","keywords":"Fumarase; Transcriptome; Renal cell carcinoma; Primary (astronomy); Cancer research; Chemistry; Computational biology; Biology; Gene; Medicine; Biochemistry; Oncology; Gene expression","score_opus":0.04209137821017212,"score_gpt":0.26643108771585844,"score_spread":0.22433970950568632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394108762","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038805075,0.00085715554,1.8643236e-7,0.000045690034,0.000043868364,0.0013200756,0.9584539,0.0000027328801,0.00047133982],"genre_scores_gemma":[0.00067318615,0.000070050046,0.0015840731,0.000047495887,0.00010184827,0.00028379756,0.99377424,0.000049925624,0.0034154102],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99758846,0.00014668237,0.0006047532,0.0008449173,0.00044799654,0.000367201],"domain_scores_gemma":[0.9977331,0.00092922716,0.00037989332,0.00059576414,0.00006367187,0.0002983379],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00020509973,0.0005110858,0.0011776193,0.00030833515,0.000109057015,0.000099467616,0.0003047253,0.00020731207,0.16185628],"category_scores_gemma":[0.000053134205,0.0004354631,0.00015431824,0.000162248,0.00023744826,0.00008575352,0.00032326847,0.00040593598,0.00088592956],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027969392,0.00014553303,0.000011912201,0.0005389236,0.00027310138,0.00054192945,0.000058857233,7.301935e-7,0.00092957326,4.0360444e-8,0.99499285,0.002226858],"study_design_scores_gemma":[0.0020340849,0.00089924707,0.049813397,0.0004924521,0.0017327452,0.0001779196,0.00007437966,0.0000037821912,0.0011417498,0.000004776705,0.943241,0.00038445863],"about_ca_topic_score_codex":0.00040403986,"about_ca_topic_score_gemma":0.00015164257,"teacher_disagreement_score":0.16097036,"about_ca_system_score_codex":0.0001733722,"about_ca_system_score_gemma":0.0006284151,"threshold_uncertainty_score":0.999892},"labels":[],"label_agreement":null},{"id":"W4394245664","doi":"10.6084/m9.figshare.22735554","title":"Additional file 2 of Genomic and transcriptomic features between primary and paired metastatic fumarate hydratase–deficient renal cell carcinoma","year":2023,"lang":"en","type":"dataset","venue":"Figshare","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Food Inspection Agency","funders":"","keywords":"Fumarase; Renal cell carcinoma; Transcriptome; Cancer research; Chemistry; Computational biology; Biology; Medicine; Gene; Oncology; Biochemistry; Gene expression","score_opus":0.03701744114251989,"score_gpt":0.23629343087299418,"score_spread":0.19927598973047428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394245664","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007342467,0.0020745383,1.3118095e-8,0.000022931828,0.000024485958,0.0008631229,0.996123,0.00003590758,0.00012170827],"genre_scores_gemma":[0.00017536848,0.000029037375,0.000115354145,0.00010110959,0.00017212082,0.0009498301,0.99743336,0.00006658602,0.00095725467],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99778134,0.00010432258,0.00050992175,0.0007172078,0.0005017156,0.0003854941],"domain_scores_gemma":[0.997392,0.0013141878,0.00036429925,0.00053223735,0.00009819219,0.000299102],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000050230556,0.00053982105,0.000992697,0.00034557594,0.00009584132,0.000042898417,0.00017676392,0.0002506478,0.74280614],"category_scores_gemma":[0.00023961117,0.00047199373,0.00021550196,0.00017162894,0.000056595694,0.000055077136,0.00018171508,0.00047369607,0.0021398452],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094157986,0.00007936599,0.000002097214,0.004081059,0.0001913477,0.00054746965,0.000021609892,7.627272e-7,0.00014603924,2.1592788e-8,0.99462193,0.00021412855],"study_design_scores_gemma":[0.0010845894,0.0005584552,0.066656545,0.0027976306,0.0007085886,0.00014130585,0.000019154546,0.0000043734103,0.00029298099,0.0000028702495,0.9273753,0.00035816766],"about_ca_topic_score_codex":0.00008361803,"about_ca_topic_score_gemma":0.00003832074,"teacher_disagreement_score":0.7406663,"about_ca_system_score_codex":0.00017834532,"about_ca_system_score_gemma":0.0004822045,"threshold_uncertainty_score":0.9997732},"labels":[],"label_agreement":null},{"id":"W4394326142","doi":"10.6084/m9.figshare.12056481","title":"Exploration of IMDC model in patients with metastatic renal cell carcinoma using targeted agents: a meta-analysis","year":2020,"lang":"en","type":"dataset","venue":"Figshare","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Renal cell carcinoma; Meta-analysis; Oncology; Internal medicine; Medicine","score_opus":0.20751302628627669,"score_gpt":0.3064898019742602,"score_spread":0.09897677568798349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394326142","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017510774,0.0004108256,0.00001541532,0.000017754328,0.0000072229363,0.001297095,0.99647224,0.000012484143,0.000015908012],"genre_scores_gemma":[0.04561762,0.0000019799818,0.0011486561,0.00013141058,0.000018206152,0.00032093347,0.95267093,0.000047711,0.000042538344],"study_design_codex":"not_applicable","study_design_gemma":"meta_analysis","domain_scores_codex":[0.997089,0.0001612336,0.0007824609,0.0006887406,0.0009772881,0.00030127206],"domain_scores_gemma":[0.9977172,0.00005840318,0.0008017685,0.00081851915,0.00039519605,0.00020888199],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000055541655,0.00055649737,0.0021787835,0.00075224927,0.000032599644,0.000024214372,0.000216804,0.0001601327,0.031125857],"category_scores_gemma":[0.00015172947,0.000405215,0.00092385197,0.0012074923,0.000010709054,0.00022633918,0.00012429233,0.0003597458,0.00019125637],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003519992,0.00048697356,0.00007025137,0.0015645926,0.024080887,0.00026741734,0.000102033744,0.015777206,0.000009375467,2.1775051e-8,0.95728576,0.0000034635195],"study_design_scores_gemma":[0.009817812,0.0026703265,0.0051182993,0.00086420856,0.8947431,0.000006120092,0.00010272522,0.038445096,0.0028910087,0.000008057908,0.043800604,0.0015326671],"about_ca_topic_score_codex":0.0002133802,"about_ca_topic_score_gemma":0.00009217821,"teacher_disagreement_score":0.91348517,"about_ca_system_score_codex":0.00028140767,"about_ca_system_score_gemma":0.00036409218,"threshold_uncertainty_score":0.99983996},"labels":[],"label_agreement":null},{"id":"W4394393546","doi":"10.6084/m9.figshare.11609715","title":"Computed tomography imaging characteristics of clear cell papillary renal cell carcinoma","year":2020,"lang":"en","type":"dataset","venue":"Figshare","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Papillary renal cell carcinomas; Renal cell carcinoma; Computed tomography; Medicine; Tomography; Pathology; Radiology","score_opus":0.022859504969221688,"score_gpt":0.22999957770474436,"score_spread":0.20714007273552268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394393546","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00062412367,0.0019878855,1.7588444e-7,0.000051958265,0.00012542513,0.00077596254,0.99578553,0.000069736496,0.0005791873],"genre_scores_gemma":[0.022629566,0.000030679184,0.00012715967,0.00049268187,0.00059062074,0.00006743477,0.9759071,0.00009044291,0.00006432868],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997316,0.00009131167,0.00073049066,0.00073013204,0.0006684557,0.0004636198],"domain_scores_gemma":[0.99739933,0.00013471667,0.0007022752,0.001007567,0.0003136694,0.00044241332],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0000380155,0.00064951647,0.0011466696,0.00034109398,0.00006750588,0.000043987195,0.0004335454,0.00032363445,0.036426064],"category_scores_gemma":[0.00010709562,0.0006106331,0.00056540396,0.00042328268,0.00002806386,0.0000510594,0.00040253246,0.00081329874,0.0030132425],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018186748,0.00024810722,0.00029817736,0.0075121657,0.00007293899,0.0031008918,0.000030266783,4.4418073e-7,0.00040489834,2.5680631e-8,0.98790693,0.00024326093],"study_design_scores_gemma":[0.001181677,0.00075990456,0.021373922,0.0026995284,0.0005332433,0.000093182025,0.000016607168,0.000043720964,0.009347883,5.3286294e-7,0.9634594,0.00049039535],"about_ca_topic_score_codex":0.00004508009,"about_ca_topic_score_gemma":0.0000013654594,"teacher_disagreement_score":0.03341282,"about_ca_system_score_codex":0.00011831777,"about_ca_system_score_gemma":0.00033223364,"threshold_uncertainty_score":0.9996345},"labels":[],"label_agreement":null},{"id":"W4394552120","doi":"10.6084/m9.figshare.12608093","title":"Supplementary Material for: Association between PD-L1 Expression and the Prognosis and Clinicopathologic Features of Renal Cell Carcinoma: A Systematic Review and Meta-Analysis","year":2020,"lang":"en","type":"review","venue":"Figshare","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Meta-analysis; Renal cell carcinoma; Association (psychology); Medicine; Oncology; Expression (computer science); Internal medicine; Psychology; Computer science; Psychotherapist","score_opus":0.12526092816233733,"score_gpt":0.34730341269012377,"score_spread":0.22204248452778644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394552120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012279733,0.675943,1.1416833e-7,0.0001691751,0.000005312741,0.0063876,0.3174611,0.000007888487,0.000013519168],"genre_scores_gemma":[0.0013102591,0.79697853,0.00017621511,0.00014122766,0.00008708992,0.0055908873,0.19551322,0.00003936132,0.00016319384],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9966632,0.0009587788,0.0012322424,0.0005771905,0.00036387754,0.00020468768],"domain_scores_gemma":[0.99613476,0.0013920844,0.0018146844,0.0003914913,0.00013964463,0.00012731118],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006790106,0.00049496,0.008045559,0.00012364612,0.000081434075,0.00005425613,0.00014148546,0.00025996356,0.0045717135],"category_scores_gemma":[0.0008428411,0.00023785233,0.0016153721,0.00024432677,0.0000212068,0.000036311914,0.00024117646,0.00023507535,0.0000032714765],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028866281,0.000022323655,0.00004448545,0.96428066,0.020350954,0.000018964733,0.000050258717,5.6408878e-9,6.259533e-7,2.7916334e-7,0.014870965,0.00033162587],"study_design_scores_gemma":[0.00078165403,0.00029399103,0.00015367247,0.04955246,0.9257749,0.000035032852,0.000013127749,4.546628e-7,0.000065116554,0.0000028771162,0.023130888,0.00019583321],"about_ca_topic_score_codex":0.000010653688,"about_ca_topic_score_gemma":0.0000030022861,"teacher_disagreement_score":0.91472816,"about_ca_system_score_codex":0.000096791366,"about_ca_system_score_gemma":0.000074193194,"threshold_uncertainty_score":0.99633825},"labels":[],"label_agreement":null},{"id":"W4394796261","doi":"10.1016/j.modpat.2024.100492","title":"Molecular Characterization of Juxtaglomerular Cell Tumors: Evidence of Alterations in MAPK–RAS Pathway","year":2024,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Pathology; Biology; Medicine","score_opus":0.02463573582629505,"score_gpt":0.2710835301232118,"score_spread":0.24644779429691674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394796261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98520684,0.003132782,0.01052765,0.00026457134,0.0000813769,0.00036384666,0.000021538768,0.000025906786,0.00037548956],"genre_scores_gemma":[0.9989453,0.000087416316,0.0005371543,0.00006866314,0.000023537148,0.00004702571,0.00007444957,0.000023454819,0.00019298538],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99883634,0.00010737442,0.0004174921,0.00030241863,0.00017464727,0.00016174454],"domain_scores_gemma":[0.99941176,0.0000488229,0.00008384699,0.0003316189,0.000077408906,0.000046514888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017811065,0.00012856282,0.00034255497,0.00026816476,0.000009907267,0.000005916499,0.00006382506,0.00008981244,0.000035776924],"category_scores_gemma":[0.000036146746,0.00011511467,0.000091776135,0.00022363149,0.00006677275,0.000083561565,0.000036439873,0.00012258848,0.000018676192],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070114416,0.00016052183,0.0033641844,0.0006080744,0.000013416768,0.0018932569,0.0012258801,0.00010496301,0.99068624,0.00028948075,0.0000017180928,0.0015821353],"study_design_scores_gemma":[0.00036961125,0.0005373068,0.030375682,0.00066534354,0.000065141525,0.00016945234,0.00002089253,0.0064279973,0.96088207,0.0003807342,0.000020882802,0.00008490017],"about_ca_topic_score_codex":0.000020054187,"about_ca_topic_score_gemma":0.0000034079596,"teacher_disagreement_score":0.029804198,"about_ca_system_score_codex":0.00006870911,"about_ca_system_score_gemma":0.00013711695,"threshold_uncertainty_score":0.469424},"labels":[],"label_agreement":null},{"id":"W4394803049","doi":"10.1097/01.ju.0001009492.49624.4b.17","title":"MP51-17 NATURAL HISTORY OF PATIENTS WITH REGIONAL LYMPH NODE POSITIVE RENAL CELL CARCINOMA: RESULTS FROM THE CANADIAN KIDNEY CANCER COLLABORATION","year":2024,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Renal cell carcinoma; Cancer; Natural history; Lymph node; Medicine; Kidney cancer; Kidney; Carcinoma; Lymph; Oncology; Internal medicine; Pathology","score_opus":0.011191325718426105,"score_gpt":0.2197091291811611,"score_spread":0.208517803462735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394803049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96073467,0.012879176,0.000004884524,0.023661977,0.0007734411,0.00021790701,0.00028943646,0.000004390945,0.0014341444],"genre_scores_gemma":[0.995263,0.000076350676,0.00006561718,0.0031685461,0.00035624797,0.000003088437,0.00010933157,0.00001889023,0.00093895395],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.998613,0.00024631154,0.0003870979,0.00014215478,0.00040794254,0.00020351911],"domain_scores_gemma":[0.99828523,0.00034813446,0.0003374714,0.00022783747,0.0005981953,0.00020312874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030099746,0.00014931503,0.0002667827,0.00013437316,0.000076347555,0.000009224432,0.00017010506,0.000088431145,0.000060809856],"category_scores_gemma":[0.00006846389,0.00007199982,0.000080293445,0.00015773572,0.00024460687,0.00007262216,0.0000180221,0.00039374715,0.0000042297424],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048901476,0.00044507274,0.13495398,0.00008376983,0.0019474727,0.0018625796,0.0307774,0.0011736373,0.012018972,0.00014982311,0.7664914,0.0011943853],"study_design_scores_gemma":[0.005818966,0.0016337889,0.95433605,0.0001394893,0.0016170416,0.00026410824,0.00019936608,0.00032610836,0.0012294471,0.000055921086,0.034244552,0.0001351686],"about_ca_topic_score_codex":0.05583582,"about_ca_topic_score_gemma":0.02910712,"teacher_disagreement_score":0.8193821,"about_ca_system_score_codex":0.0018760186,"about_ca_system_score_gemma":0.0051482082,"threshold_uncertainty_score":0.98860914},"labels":[],"label_agreement":null},{"id":"W4394809006","doi":"10.1097/01.ju.0001008868.74763.2c.06","title":"PD58-06 PATIENTS’ VALUES AND PREFERENCES FOR TREATMENT OF SMALL RENAL MASSES","year":2024,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Renal mass; Medicine; Urology; Internal medicine; Kidney","score_opus":0.04625151044244676,"score_gpt":0.2844891853943205,"score_spread":0.23823767495187373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394809006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853179,0.0127200205,0.00015872077,0.0011016858,0.00013925225,0.0002362602,0.000008174638,0.000005227802,0.00031279982],"genre_scores_gemma":[0.9971572,0.0014942182,0.00077653496,0.000049663366,0.00015186348,0.000005310791,0.0000039412575,0.000009665009,0.00035157183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993117,0.00008763332,0.00029492378,0.00007813086,0.000110599365,0.000117025134],"domain_scores_gemma":[0.9990878,0.00049789005,0.00014153017,0.00009916659,0.00011711643,0.000056475452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020480643,0.00009960886,0.00030730065,0.00010032574,0.000025554706,0.00000645391,0.000055207263,0.000046076977,0.00002342398],"category_scores_gemma":[0.00003878571,0.00004658359,0.00010564354,0.00004456998,0.00010086824,0.00002634295,0.000012980174,0.000054151416,0.0000019831193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027534762,0.0047793714,0.6251602,0.0015091427,0.009771693,0.00069664646,0.022906303,0.00035588603,0.047587823,0.0013118794,0.010539737,0.24784653],"study_design_scores_gemma":[0.013125425,0.15117343,0.7033707,0.0003215041,0.009917219,0.0033292584,0.00069923804,0.0007557643,0.050432518,0.02055344,0.04602562,0.00029588686],"about_ca_topic_score_codex":0.00001254505,"about_ca_topic_score_gemma":0.0000052699916,"teacher_disagreement_score":0.24755064,"about_ca_system_score_codex":0.000041796902,"about_ca_system_score_gemma":0.00008543809,"threshold_uncertainty_score":0.18996237},"labels":[],"label_agreement":null},{"id":"W4394832776","doi":"10.1097/01.ju.0001008912.25331.d7.05","title":"PD33-05 PROPOSAL AND INTERNAL VALIDATION OF A NOMOGRAM FOR THE PREDICTION OF LOCAL RECURRENCE-FREE SURVIVAL AFTER PERCUTANEOUS ABLATION FOR cT1 RENAL MASSES","year":2024,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nomogram; Percutaneous; Ablation; Medicine; Microwave ablation; Overall survival; Humanities; Nuclear medicine; Surgery; Art; Internal medicine","score_opus":0.022047874768388855,"score_gpt":0.274577759202666,"score_spread":0.25252988443427715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394832776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9043442,0.0026231094,0.088381305,0.0033245496,0.00058991974,0.0006325076,0.000059894093,0.000006331078,0.000038188915],"genre_scores_gemma":[0.99817055,0.00022022138,0.0011676277,0.000024159099,0.00032953807,0.000015684227,0.000007879314,0.000012771994,0.000051549232],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989927,0.000121562305,0.00045620787,0.00009252435,0.00022028052,0.00011675728],"domain_scores_gemma":[0.9985227,0.00076881197,0.00024827998,0.00014657935,0.00027616875,0.000037453567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008455412,0.000097046104,0.00024438737,0.00011097047,0.000032993583,0.000009888027,0.00010630106,0.00007164171,0.000017931892],"category_scores_gemma":[0.00015158913,0.000048871476,0.00013336347,0.00007019027,0.00020442258,0.000063584885,0.000029523531,0.00017415523,2.786673e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20047092,0.0021111115,0.056917194,0.0052464074,0.009581672,0.00081068394,0.019352214,0.009338787,0.30640438,0.0045386394,0.011051045,0.37417692],"study_design_scores_gemma":[0.022924613,0.16865613,0.21041104,0.00233036,0.028482258,0.1044178,0.0044881273,0.19579947,0.19205734,0.04622594,0.023465622,0.0007413002],"about_ca_topic_score_codex":0.000019776478,"about_ca_topic_score_gemma":0.00001676837,"teacher_disagreement_score":0.37343565,"about_ca_system_score_codex":0.000048113758,"about_ca_system_score_gemma":0.00013905765,"threshold_uncertainty_score":0.1992921},"labels":[],"label_agreement":null},{"id":"W4394832817","doi":"10.1097/01.ju.0001009496.54470.10.17","title":"MP67-17 PERIOPERATIVE AND LONG-TERM ONCOLOGICAL OUTCOMES AFTER LOCAL TUMOR ABLATION FOR COMPLEX (PADUA SCORE ≥10) RENAL TUMORS: A MULTICENTER ANALYSIS","year":2024,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Perioperative; Medicine; Cryoablation; Microwave ablation; Ablation; Surgery; Internal medicine","score_opus":0.04301825643187998,"score_gpt":0.3221897781839386,"score_spread":0.2791715217520586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394832817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822481,0.0020764743,0.010321599,0.0047116526,0.00007943238,0.00042736885,0.000014683948,0.000012962046,0.000107673346],"genre_scores_gemma":[0.99717593,0.00003474496,0.0008461296,0.0011206818,0.00020626807,0.000022592849,0.000015024505,0.000016390257,0.00056225725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985832,0.00022482633,0.0005292339,0.00019333573,0.00022837213,0.00024102585],"domain_scores_gemma":[0.9987659,0.0005520476,0.00017745014,0.00016116965,0.00020447616,0.00013894514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005209799,0.00019963144,0.00066252914,0.00026550214,0.00007405663,0.000035854886,0.00009631061,0.00007391052,0.00062672934],"category_scores_gemma":[0.00008144092,0.000099266246,0.00033617817,0.00017124497,0.0003026034,0.00008519513,0.000053245316,0.00030762018,0.000012302386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030968746,0.0008981607,0.9239851,0.0002692508,0.009010214,0.008441974,0.00447172,0.0015847149,0.01084969,0.000102272155,0.0016536213,0.0077644913],"study_design_scores_gemma":[0.0023119801,0.0040187845,0.9710646,0.00005204221,0.00515347,0.00225904,0.000094475596,0.0141452355,0.0001759212,0.000044866578,0.0005804388,0.000099114855],"about_ca_topic_score_codex":0.0000056204362,"about_ca_topic_score_gemma":0.000059966413,"teacher_disagreement_score":0.04707949,"about_ca_system_score_codex":0.0001471622,"about_ca_system_score_gemma":0.00009310617,"threshold_uncertainty_score":0.68622464},"labels":[],"label_agreement":null},{"id":"W4394835248","doi":"10.1097/01.ju.0001008604.95535.b9.10","title":"PD11-10 THE IMPACT OF HISTOLOGY AND TYPE OF ENERGY USED ON ONCOLOGICAL OUTCOMES AFTER LOCAL TUMOR ABLATION OF SMALL RENAL MASSES","year":2024,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Histology; Tumor ablation; Ablation; Medicine; Renal tumor; Pathology; Urology; Radiology; Internal medicine; Kidney; Nephrectomy","score_opus":0.03883813586940728,"score_gpt":0.3103780602774777,"score_spread":0.27153992440807045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394835248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941113,0.0032025615,0.00025452522,0.0018654006,0.00010907299,0.00007493867,0.0000033668512,0.000002965995,0.00037589835],"genre_scores_gemma":[0.9994698,0.00012497528,0.00008081953,0.000136156,0.000056381206,0.0000012656589,0.0000011136791,0.000009074837,0.00012037518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988444,0.0003211636,0.00047498225,0.00007857917,0.00015809071,0.00012278545],"domain_scores_gemma":[0.9982654,0.0010566885,0.00033010714,0.00016121015,0.00013847419,0.00004816135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047453964,0.00011356198,0.00051246915,0.00014153997,0.00001292731,0.0000017248849,0.0000970569,0.000086610475,0.00021778062],"category_scores_gemma":[0.00011851352,0.00004572947,0.00017488039,0.00009959447,0.00038250472,0.000018068999,0.000033639397,0.0002159806,0.0000017306689],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10232198,0.0023496759,0.6994149,0.0004088504,0.0060417545,0.0036423546,0.0038010657,0.010391963,0.14985855,0.0033619956,0.004285408,0.014121463],"study_design_scores_gemma":[0.0017171378,0.026877163,0.95688903,0.0000634661,0.0011248745,0.0032685613,0.00007183471,0.00089247903,0.006667819,0.0011791472,0.0011795664,0.00006893744],"about_ca_topic_score_codex":0.00008373674,"about_ca_topic_score_gemma":0.000027702225,"teacher_disagreement_score":0.25747406,"about_ca_system_score_codex":0.0000899542,"about_ca_system_score_gemma":0.00018696126,"threshold_uncertainty_score":0.2384545},"labels":[],"label_agreement":null},{"id":"W4394869936","doi":"10.1093/oncolo/oyae072","title":"Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimens","year":2024,"lang":"en","type":"article","venue":"The Oncologist","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Dalhousie University; Western University; Baker Hughes (Canada); Queen Elizabeth II Health Sciences Centre; University of Alberta; University of Calgary; BC Cancer Agency","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Confounding; Logistic regression; Proportional hazards model; Univariate analysis; Oncology; Kidney cancer; Multivariate analysis","score_opus":0.04695649256119615,"score_gpt":0.3369761675759084,"score_spread":0.29001967501471226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394869936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969228,0.00024510574,0.000016447375,0.000389765,0.00006525812,0.0012965731,0.00006502086,0.00006192617,0.00093709276],"genre_scores_gemma":[0.9990031,0.000014997449,0.0003594369,0.000052391926,0.00003679016,0.00006663607,0.00014048746,0.00005756427,0.0002685577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974853,0.00025181164,0.0008174932,0.00045729525,0.000520532,0.00046756843],"domain_scores_gemma":[0.99769115,0.0010234283,0.00031013798,0.0006794887,0.00013081337,0.00016495225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056524266,0.00039399334,0.0009523748,0.00022164201,0.00006039425,0.000024997425,0.0001299017,0.000093131646,0.000061960964],"category_scores_gemma":[0.00012276474,0.00017166199,0.0003357848,0.00046987753,0.00038757586,0.000046767185,0.00004280793,0.0005042179,0.000013541296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009168602,0.0027648525,0.98443204,0.00014818805,0.0004913061,0.0007205465,0.00017184044,0.0012772984,0.0001298516,0.0000044867015,0.00007656652,0.0006143937],"study_design_scores_gemma":[0.012980037,0.04300314,0.9377832,0.00044560272,0.00077176315,0.000008664864,0.000052487696,0.00023768202,0.0045073843,0.000005806912,0.000026273397,0.00017798651],"about_ca_topic_score_codex":0.0025498774,"about_ca_topic_score_gemma":0.00038623565,"teacher_disagreement_score":0.046648894,"about_ca_system_score_codex":0.0011718442,"about_ca_system_score_gemma":0.0007024914,"threshold_uncertainty_score":0.7000173},"labels":[],"label_agreement":null},{"id":"W4394961878","doi":"10.1002/jcph.2444","title":"Quantitative Assessment of Drug Efficacy and Emergence of Resistance in Patients with Metastatic Renal Cell Carcinoma Using a Longitudinal Exposure‐Tumor Growth Inhibition Model: Apitolisib (Dual PI3K/mTORC1/2 Inhibitor) Versus Everolimus (mTORC1 Inhibitor)","year":2024,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Everolimus; Discovery and development of mTOR inhibitors; mTORC1; Renal cell carcinoma; PI3K/AKT/mTOR pathway; Medicine; Oncology; Drug resistance; Cancer research; Drug; Sirolimus; Internal medicine; Pharmacology; Chemistry; Biology; Apoptosis","score_opus":0.07965369007208031,"score_gpt":0.4042599864395211,"score_spread":0.32460629636744076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394961878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950124,0.0025566972,0.0004717877,0.00021977755,0.000902068,0.00071184605,0.000033642373,0.000008944987,0.000082858125],"genre_scores_gemma":[0.9960168,0.00018837479,0.0033584235,0.000060970007,0.00030507657,0.000007285517,0.0000065554923,0.00004192112,0.000014568032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948799,0.0011056719,0.002364095,0.0003744156,0.0009198663,0.00035607192],"domain_scores_gemma":[0.9951316,0.0022271262,0.0014293684,0.00020493059,0.0007530947,0.0002538768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023808896,0.00034079413,0.0012804436,0.00037675502,0.000063526706,0.00001221501,0.00015209819,0.00008918605,0.00003742364],"category_scores_gemma":[0.0002139505,0.00022144074,0.00024638744,0.00048696352,0.00056631386,0.00028173914,0.000111476285,0.0009777648,9.610085e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25534824,0.013043302,0.5204486,0.0044633094,0.0039698556,0.0040518255,0.0071844696,0.022575142,0.16189142,0.00065890525,0.0059923404,0.00037258514],"study_design_scores_gemma":[0.08604929,0.041618478,0.75641304,0.0026617518,0.010037288,0.00021637717,0.0012567108,0.014421099,0.08600059,0.00057058374,0.000020662956,0.0007341336],"about_ca_topic_score_codex":0.0000465521,"about_ca_topic_score_gemma":0.000024594021,"teacher_disagreement_score":0.23596443,"about_ca_system_score_codex":0.00021831032,"about_ca_system_score_gemma":0.0009373634,"threshold_uncertainty_score":0.9030092},"labels":[],"label_agreement":null},{"id":"W4395461980","doi":"10.1111/bju.16336","title":"First‐line immunotherapy of metastatic renal cell carcinoma: an updated network meta‐analysis including triplet therapy","year":2024,"lang":"en","type":"review","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"European Association of Urology","keywords":"Nivolumab; Ipilimumab; Renal cell carcinoma; Cabozantinib; Medicine; Oncology; Immunotherapy; Internal medicine; Kidney cancer; Cancer","score_opus":0.11752114617609956,"score_gpt":0.35103049286621246,"score_spread":0.23350934669011292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395461980","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017078182,0.9962373,0.0004124447,0.00014114784,0.00035969043,0.000832444,0.00015937553,0.000023991703,0.00012583387],"genre_scores_gemma":[0.01868441,0.9776516,0.0018901583,0.0001988436,0.0006168899,0.000043510197,0.00046185718,0.00017266686,0.00028005062],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9933662,0.0014715089,0.0031759564,0.00064264645,0.0007031542,0.0006405651],"domain_scores_gemma":[0.99536425,0.00043066905,0.0026934247,0.000667706,0.0005001034,0.00034382285],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019818186,0.000802981,0.010070034,0.0012905962,0.00011716777,0.00007298312,0.00058668054,0.00044055635,0.0012132397],"category_scores_gemma":[0.000036835907,0.00061328115,0.006931183,0.0018715599,0.0001900045,0.00012705142,0.00010093621,0.0015672696,0.000013099782],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013358525,0.0017178534,0.000044023534,0.0059018503,0.6206888,0.03167551,0.00017085513,0.0011946659,0.000026269032,0.000019710937,0.004869634,0.332355],"study_design_scores_gemma":[0.0025431518,0.0045854286,0.00008098505,0.0005591747,0.59600395,0.022510786,0.000008430553,0.00006493451,0.000014599979,0.00014101667,0.37311628,0.00037126782],"about_ca_topic_score_codex":0.00022616738,"about_ca_topic_score_gemma":0.000098957586,"teacher_disagreement_score":0.36824664,"about_ca_system_score_codex":0.00022320185,"about_ca_system_score_gemma":0.00080413575,"threshold_uncertainty_score":0.9996998},"labels":[],"label_agreement":null},{"id":"W4395678417","doi":"10.1016/j.mex.2024.102730","title":"Additive toxicity arising from combined use of immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with renal or endometrial carcinoma: Protocol for a rapid systematic review","year":2024,"lang":"en","type":"article","venue":"MethodsX","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Adverse effect; Oncology; Renal cell carcinoma; Internal medicine; Randomized controlled trial; MEDLINE; Systematic review; Kidney cancer","score_opus":0.053297821867017904,"score_gpt":0.32620733635990257,"score_spread":0.27290951449288464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395678417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69847983,0.004779142,0.0010637868,0.00013132824,0.00019272753,0.2949612,0.00030325385,0.0000677822,0.000020927966],"genre_scores_gemma":[0.65385234,0.00008774397,0.10935183,0.00012944409,0.0002872781,0.23561104,0.00036242916,0.0001750198,0.00014288702],"study_design_codex":"systematic_review","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963301,0.00073869585,0.0015300099,0.0005811132,0.00051013636,0.0003099897],"domain_scores_gemma":[0.99649173,0.0021379841,0.00048525908,0.00046202753,0.00026123505,0.00016178896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014949741,0.00040896074,0.0018232103,0.00044813985,0.0000477996,0.000052113704,0.00007395609,0.00012291704,0.00004201659],"category_scores_gemma":[0.0031734686,0.0002446175,0.00027625548,0.0008830611,0.0001373074,0.00019470177,0.00008539773,0.00026054814,0.0000014186301],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053400416,0.0043355417,0.029579483,0.8486698,0.0021330742,0.00091040693,0.002627245,0.0000056725667,0.039546136,0.000048681235,0.00083851285,0.017905006],"study_design_scores_gemma":[0.039576214,0.013625751,0.046271216,0.38960138,0.0033801734,0.00003368924,0.000110571986,0.00034381705,0.5060618,0.00007138639,0.00026259624,0.00066144165],"about_ca_topic_score_codex":0.00032389752,"about_ca_topic_score_gemma":0.000013072808,"teacher_disagreement_score":0.46651563,"about_ca_system_score_codex":0.00036805365,"about_ca_system_score_gemma":0.0002124266,"threshold_uncertainty_score":0.99752116},"labels":[],"label_agreement":null},{"id":"W4395693760","doi":"10.1007/s00345-024-04976-5","title":"Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus","year":2024,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Nephrology; Thrombus; Carcinoma; Internal medicine; Renal carcinoma; Urology; Kidney cancer; Surgery; Oncology; General surgery; Kidney","score_opus":0.018377561334880794,"score_gpt":0.2570708105059321,"score_spread":0.2386932491710513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395693760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920087,0.004629152,0.00024215324,0.0018673508,0.0006433625,0.00027612582,0.0000042328243,0.000010561645,0.00031837696],"genre_scores_gemma":[0.9980153,0.000037450336,0.0006685344,0.00052791054,0.00025059978,0.000006885465,0.000011027585,0.000026508973,0.0004558167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986762,0.000068679394,0.0005101038,0.00022068256,0.00024725174,0.00027711692],"domain_scores_gemma":[0.99898154,0.000528208,0.00013734036,0.00010328427,0.000079842146,0.00016981654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022881097,0.00017548066,0.0004803557,0.0005730355,0.00003928552,0.000022829601,0.000059986003,0.00005805428,0.00011488099],"category_scores_gemma":[0.00005773105,0.0001280755,0.00018692203,0.00015909203,0.00009446488,0.00009054961,0.000034168672,0.0003804764,0.0000066789203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014692758,0.00028845677,0.9931135,0.00014684981,0.00013150506,0.0012838028,0.000069909824,0.00001661176,0.0004147052,0.00010726623,0.0010326033,0.0019254986],"study_design_scores_gemma":[0.006973351,0.0025090994,0.9870459,0.00006227446,0.00030851594,0.00083700963,0.000007267889,0.000062672814,0.00030139345,0.00023705198,0.001560819,0.00009467821],"about_ca_topic_score_codex":0.0000038177736,"about_ca_topic_score_gemma":0.000057618836,"teacher_disagreement_score":0.0060676485,"about_ca_system_score_codex":0.00018854083,"about_ca_system_score_gemma":0.00024885588,"threshold_uncertainty_score":0.5222767},"labels":[],"label_agreement":null},{"id":"W4395695140","doi":"10.5489/cuaj.8797","title":"2024 American Society of Clinical Oncology Genitourinary (ASCO-GU) Cancers Symposium","year":2024,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McMaster University; University of Ottawa; University of Alberta; Sinai Health System; University Health Network; Ottawa Hospital; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Clinical Oncology; Medicine; Genitourinary system; Oncology; Internal medicine; Cancer","score_opus":0.04527706035833857,"score_gpt":0.33862242246089225,"score_spread":0.2933453621025537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395695140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9055675,0.0017260989,0.00003960141,0.075146444,0.0019199434,0.00024624346,0.000059570815,0.000043274194,0.015251266],"genre_scores_gemma":[0.9872833,0.0012331727,0.00086704723,0.004627433,0.0019023778,0.000011304712,0.000018244866,0.00002178125,0.004035365],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975286,0.0003353706,0.0008317313,0.00031264222,0.00045740037,0.0005342522],"domain_scores_gemma":[0.9975543,0.0005255567,0.00038992093,0.00014160821,0.00026627147,0.0011223498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013901746,0.00017791522,0.00068564125,0.00016111358,0.0001255315,0.00004767457,0.00012748741,0.0003453088,0.0007966706],"category_scores_gemma":[0.00025783913,0.00013518395,0.00072845665,0.00039586786,0.00017123134,0.0000695697,0.000024308989,0.0012659422,0.00008818813],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019439176,0.00014212127,0.6467082,0.000043714324,0.001397462,0.0016656357,0.00030271555,0.00009454385,0.0005450076,0.000085353626,0.3119689,0.036851935],"study_design_scores_gemma":[0.0009105732,0.0034995768,0.48631606,0.00004128961,0.00047735553,0.0008244261,0.00026775518,0.00095161103,0.0000675378,0.0001643229,0.5063202,0.00015930083],"about_ca_topic_score_codex":0.0049599777,"about_ca_topic_score_gemma":0.0008238479,"teacher_disagreement_score":0.1943513,"about_ca_system_score_codex":0.0050831093,"about_ca_system_score_gemma":0.0048389356,"threshold_uncertainty_score":0.9987362},"labels":[],"label_agreement":null},{"id":"W4396213258","doi":"10.1016/s1470-2045(24)00023-8","title":"Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma—a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology","year":2024,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; London Health Sciences Centre","funders":"Associazione Italiana per la Ricerca sul Cancro; Cancer Council Tasmania; Ministero della Salute; National Institute for Health and Care Research; Institute of Cancer Research; Cancer Research UK; Istituto Europeo di Oncologia; Royal Marsden NHS Foundation Trust","keywords":"Ablative case; Medicine; Radiation therapy; Renal cell carcinoma; Stereotactic radiotherapy; Medical physics; Oncology; Internal medicine; Radiosurgery","score_opus":0.04174781330594428,"score_gpt":0.33545671988045817,"score_spread":0.2937089065745139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396213258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692587,0.009336532,0.00040514924,0.014549019,0.0002474953,0.003959897,0.00013329614,0.00004936914,0.0020605274],"genre_scores_gemma":[0.994333,0.00068780745,0.0016802215,0.001903514,0.00050070445,0.00024157108,0.000030910778,0.00007753745,0.0005447059],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99614817,0.0022998976,0.00046212904,0.0004733613,0.00017728812,0.00043915972],"domain_scores_gemma":[0.9931274,0.0058955722,0.000421115,0.0003367658,0.00013280837,0.000086348715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032727814,0.0002854437,0.0008701996,0.000074246534,0.00018478515,0.000030958443,0.00016187459,0.00010024928,0.000010566206],"category_scores_gemma":[0.00012559592,0.00016332134,0.00019258088,0.00013671805,0.0003558118,0.00002418791,0.00004224327,0.00035854656,0.0000017955643],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03909402,0.00731895,0.042653803,0.0021683692,0.029456599,0.0015710129,0.2252971,0.00022009628,0.18225382,0.0022825655,0.17053917,0.2971445],"study_design_scores_gemma":[0.13821629,0.20843102,0.1528115,0.00017689171,0.0112891765,0.002165876,0.015974466,0.0098207295,0.008578482,0.0013916079,0.44980657,0.0013373956],"about_ca_topic_score_codex":0.00002875827,"about_ca_topic_score_gemma":0.000024623605,"teacher_disagreement_score":0.2958071,"about_ca_system_score_codex":0.0006482008,"about_ca_system_score_gemma":0.00017382104,"threshold_uncertainty_score":0.6660051},"labels":[],"label_agreement":null},{"id":"W4396223241","doi":"10.1007/s00330-024-10769-6","title":"Automated abdominal CT contrast phase detection using an interpretable and open-source artificial intelligence algorithm","year":2024,"lang":"en","type":"article","venue":"European Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"National Institute of Biomedical Imaging and Bioengineering; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Neuroradiology; Interventional radiology; Medicine; Contrast (vision); Artificial intelligence; Radiology; Ultrasound; Algorithm; Phase contrast microscopy; Pattern recognition (psychology); Computer science; Neurology; Physics; Optics","score_opus":0.051734931650755774,"score_gpt":0.3353399726209769,"score_spread":0.28360504097022116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396223241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87065583,0.0010333962,0.12566087,0.00007457011,0.0004127967,0.0004013597,0.0000100529405,0.0003892287,0.0013619034],"genre_scores_gemma":[0.9948919,0.00002725319,0.0043297303,0.00015929442,0.0003367343,0.0000060909747,0.00003012674,0.000059851678,0.0001590379],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99833024,0.0004596695,0.00034298762,0.00050503865,0.00008127452,0.000280783],"domain_scores_gemma":[0.9993756,0.000104936065,0.000054911514,0.00023976759,0.00003750996,0.00018729146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051747856,0.00020180269,0.00034608465,0.00015926566,0.00010353996,0.0001375861,0.00013324407,0.000034434604,0.00008643623],"category_scores_gemma":[0.000057572724,0.00016895644,0.000052290776,0.00016438572,0.00017415869,0.0001680722,0.00011137434,0.00023326857,0.0000969587],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052137114,0.00026109058,0.000101738624,0.00004729607,0.0001760359,0.005391998,0.0005514578,0.00008736768,0.16078754,0.00007464918,0.000080959944,0.8319185],"study_design_scores_gemma":[0.0008482446,0.003040813,0.0015251673,0.00015133464,0.0003125747,0.017374635,0.0002883581,0.93463326,0.039322365,0.00009032104,0.0021690323,0.00024390419],"about_ca_topic_score_codex":0.00010143955,"about_ca_topic_score_gemma":0.0000055755713,"teacher_disagreement_score":0.9345459,"about_ca_system_score_codex":0.0001351572,"about_ca_system_score_gemma":0.000055361234,"threshold_uncertainty_score":0.6889844},"labels":[],"label_agreement":null},{"id":"W4396661997","doi":"10.1038/s41698-024-00588-9","title":"Author Correction: Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities","year":2024,"lang":"en","type":"erratum","venue":"npj Precision Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Proteogenomics; Computational biology; Cancer research; Biology; Genetics; Gene; Transcriptome","score_opus":0.02869716003018929,"score_gpt":0.3274967254476502,"score_spread":0.2987995654174609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396661997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7066908,0.17525978,0.00032643645,0.0033450623,0.07685149,0.009707795,0.00034916803,0.00052981114,0.026939664],"genre_scores_gemma":[0.6853576,0.0006949358,0.0003541706,0.00017394022,0.0009451063,0.0007483823,0.000503202,0.000120288045,0.3111024],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956948,0.0006758713,0.0012156864,0.0012062328,0.0007455686,0.0004618339],"domain_scores_gemma":[0.9958402,0.0019312471,0.0006486865,0.00084349397,0.000515205,0.00022119438],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009781695,0.00066792214,0.002489856,0.0018398911,0.00013112358,0.000073037816,0.00025360877,0.001101579,0.0008988911],"category_scores_gemma":[0.00092882634,0.00049366185,0.00077108335,0.001129975,0.00045871452,0.000049270835,0.00024905836,0.0017311168,0.0000640733],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038193855,0.0019405377,0.005212348,0.00435648,0.026130175,0.0017424055,0.006986026,0.0002883056,0.03269919,0.00020978371,0.8244246,0.09219073],"study_design_scores_gemma":[0.0038576454,0.020168655,0.24905567,0.002395102,0.109027006,0.001435989,0.0035061361,0.012001276,0.0098953545,0.0066812504,0.57981336,0.0021625634],"about_ca_topic_score_codex":0.00015368516,"about_ca_topic_score_gemma":0.00024921927,"teacher_disagreement_score":0.28416273,"about_ca_system_score_codex":0.00084723666,"about_ca_system_score_gemma":0.0012447496,"threshold_uncertainty_score":0.9997515},"labels":[],"label_agreement":null},{"id":"W4396664061","doi":"10.1503/cmaj.230356-f","title":"Percées dans la prise en charge de l’hypernéphrome","year":2024,"lang":"fr","type":"review","venue":"Canadian Medical Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; University of Toronto","funders":"","keywords":"Philosophy; Humanities; Political science; Gynecology; Medicine","score_opus":0.017039738157501247,"score_gpt":0.28111018300283575,"score_spread":0.2640704448453345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396664061","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003746597,0.94165593,0.00001900582,0.020112023,0.005115655,0.00061772513,0.0003076904,0.000047272864,0.028378068],"genre_scores_gemma":[0.0025298677,0.94275445,0.00013023398,0.002684272,0.01660747,0.000065693064,0.00015136729,0.00018600601,0.03489065],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99092263,0.0021077683,0.0015200907,0.0005754321,0.0030194027,0.0018546885],"domain_scores_gemma":[0.9894933,0.0010987489,0.00055360486,0.00033297486,0.0003942699,0.008127103],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0065984847,0.00077463785,0.0019367918,0.00069393485,0.00037246756,0.00042361973,0.0006237305,0.002855499,0.024181863],"category_scores_gemma":[0.004808593,0.00061997515,0.0012649621,0.00062458694,0.00016872822,0.00012949447,0.00006922958,0.0062893676,0.013037561],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000010567213,0.00021511552,0.007589773,0.0077320114,0.004500829,0.088137835,0.0041817077,6.985359e-7,0.000011818434,0.0018458692,0.30259925,0.5831745],"study_design_scores_gemma":[0.0007089091,0.00018221224,0.0029377996,0.018772347,0.0047846693,0.027156608,0.00050216226,0.000091853515,0.0000020368666,0.00007132414,0.94433546,0.00045459616],"about_ca_topic_score_codex":0.006120566,"about_ca_topic_score_gemma":0.0077362102,"teacher_disagreement_score":0.64173627,"about_ca_system_score_codex":0.03580744,"about_ca_system_score_gemma":0.042533334,"threshold_uncertainty_score":0.99962515},"labels":[],"label_agreement":null},{"id":"W4396814048","doi":"10.3233/kca-230025","title":"Patient Selection for Active Surveillance for Small Renal Masses: A Systematic Review of the Literature","year":2024,"lang":"en","type":"review","venue":"Kidney Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Concordance; Systematic review; Meta-analysis; Comorbidity; MEDLINE; Internal medicine; Cochrane Library; Oncology; Intensive care medicine","score_opus":0.03505213495838975,"score_gpt":0.3362367575413587,"score_spread":0.3011846225829689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396814048","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000014455262,0.9775949,0.0000284971,0.00037488798,0.0006937155,0.018421028,0.0027263488,0.000027293127,0.0001318521],"genre_scores_gemma":[0.000005046336,0.9791305,0.0002818234,0.0006160424,0.00030336133,0.01690332,0.0005058787,0.00009307198,0.0021609375],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99784696,0.00020090934,0.0009170836,0.0004951958,0.0002880884,0.00025177634],"domain_scores_gemma":[0.9977402,0.00024033,0.0008433203,0.0005159097,0.0005101712,0.0001500534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029701638,0.00047354415,0.0028688237,0.000104558756,0.000049418024,0.000025453352,0.0001468351,0.00022560745,0.000022919108],"category_scores_gemma":[0.0008131215,0.00022799306,0.0016709473,0.0006066574,0.000026155882,0.00002328455,0.00004239197,0.00029957775,0.0000040458103],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039756287,0.000034971577,0.000001320594,0.9548911,0.0012619705,0.0000023096943,0.00009034105,7.116903e-8,0.0000023508708,0.000016106918,0.02228711,0.021372598],"study_design_scores_gemma":[0.0001684022,0.00017551819,3.9690318e-7,0.5610767,0.009068524,0.000054472453,0.0000032100265,0.0000035075057,0.000034897555,0.000008384137,0.4292961,0.00010985761],"about_ca_topic_score_codex":0.00001996404,"about_ca_topic_score_gemma":0.000018650506,"teacher_disagreement_score":0.407009,"about_ca_system_score_codex":0.0011120172,"about_ca_system_score_gemma":0.0019865022,"threshold_uncertainty_score":0.9297287},"labels":[],"label_agreement":null},{"id":"W4396920800","doi":"10.1016/j.jvir.2024.05.008","title":"Cost-Effectiveness Analysis Comparing Biopsy in Advance of Ablation with Concurrent Biopsy and Ablation for Small Renal Masses Measuring 1–3 cm","year":2024,"lang":"en","type":"article","venue":"Journal of Vascular and Interventional Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Medicine; Ablation; Renal mass; Biopsy; Radiology; Percutaneous; Percutaneous biopsy; Kidney; Internal medicine; Nephrectomy","score_opus":0.06715043071488047,"score_gpt":0.33111091643553,"score_spread":0.2639604857206495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396920800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86022365,0.013215784,0.12615372,0.000042034055,0.00007442777,0.00026082754,0.000005695635,0.0000033650178,0.000020517651],"genre_scores_gemma":[0.99677825,0.0002123985,0.0028872814,0.0000024727337,0.000054617358,0.000018256129,0.000032788783,0.000007968649,0.000005990439],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989929,0.00012924154,0.00046213492,0.00016931651,0.00014389657,0.0001024628],"domain_scores_gemma":[0.99923706,0.00026043894,0.00020368112,0.000060663348,0.00018030575,0.000057832764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008003313,0.00010918309,0.00051932136,0.00051924447,0.000022179387,0.000014739749,0.000030372841,0.000050676113,0.000008919449],"category_scores_gemma":[0.00007591669,0.00007875316,0.0003149197,0.00022298153,0.000072906325,0.00010800887,0.000013483475,0.00012357814,1.0780966e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019083604,0.00034548301,0.949306,0.0016115804,0.0066229673,0.0001674754,0.00021624041,0.008760245,0.018662058,0.0021480394,0.0000054051907,0.010246128],"study_design_scores_gemma":[0.0028027154,0.0013648627,0.97587717,0.0016448863,0.0016247712,0.0015352091,0.00005807827,0.012195187,0.00245678,0.0002525397,0.00010792855,0.000079849575],"about_ca_topic_score_codex":0.000021603099,"about_ca_topic_score_gemma":0.00001968835,"teacher_disagreement_score":0.1365546,"about_ca_system_score_codex":0.00012731938,"about_ca_system_score_gemma":0.000046773897,"threshold_uncertainty_score":0.32114607},"labels":[],"label_agreement":null},{"id":"W4396977328","doi":"10.3390/curroncol31050209","title":"Impact of Robotic-Assisted Partial Nephrectomy with Single Layer versus Double Layer Renorrhaphy on Postoperative Renal Function","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Renal function; Nephrectomy; Urology; Kidney disease; Retrospective cohort study; Surgery; Urinary system; Creatinine; Kidney; Internal medicine","score_opus":0.17116410876012447,"score_gpt":0.40308765728155693,"score_spread":0.23192354852143246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396977328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98660505,0.0015918738,0.00031647793,0.0003776473,0.0019374137,0.00076743437,0.000012840276,0.000102034865,0.008289226],"genre_scores_gemma":[0.9988042,0.00002410216,0.00020961859,0.000027411015,0.00038404827,0.00011517296,0.00014385367,0.00003770106,0.00025387955],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9984398,0.00011687625,0.00032696273,0.00046503817,0.0003042392,0.0003471029],"domain_scores_gemma":[0.99901205,0.00018657562,0.00010595751,0.00030039035,0.00020348739,0.00019150929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011645317,0.00029128505,0.000534167,0.00025612986,0.00005646789,0.000026215326,0.000062389605,0.00014215153,0.00045242847],"category_scores_gemma":[0.000021481635,0.00018576325,0.00025753787,0.0004038155,0.000121689875,0.00009376653,0.00003244319,0.00038429376,0.00012741247],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26222482,0.016299296,0.04651407,0.00069355714,0.007420913,0.0023191469,0.0034537625,0.0051117516,0.26916265,0.002533829,0.03051446,0.35375175],"study_design_scores_gemma":[0.07096871,0.3157017,0.2743058,0.0021334568,0.0069703623,0.0011079364,0.00042321914,0.003967598,0.12587929,0.000067097426,0.19705422,0.0014206204],"about_ca_topic_score_codex":0.00006646871,"about_ca_topic_score_gemma":0.000055009914,"teacher_disagreement_score":0.35233113,"about_ca_system_score_codex":0.0011323529,"about_ca_system_score_gemma":0.00049451407,"threshold_uncertainty_score":0.7575205},"labels":[],"label_agreement":null},{"id":"W4396990587","doi":"10.1681/asn.20223311s156a","title":"Changes in Urinary Epidermal Growth Factor and CKD Progression: The ASSESS-AKI Study","year":2022,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Urology; Urinary system; Internal medicine; Oncology","score_opus":0.042808396782296,"score_gpt":0.32423333210038363,"score_spread":0.28142493531808765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396990587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96267307,0.00087177363,0.0000022880809,0.03596431,0.00007050999,0.0003850857,0.00000361419,0.0000037102527,0.000025639523],"genre_scores_gemma":[0.99436104,0.00019838326,0.00040988665,0.0048010317,0.00014955633,0.000022707904,3.2351943e-7,0.00001296409,0.00004408387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983029,0.00058421795,0.00033853832,0.00013306568,0.00043976444,0.00020153575],"domain_scores_gemma":[0.998497,0.00028030702,0.0008499474,0.00022891432,0.00008123804,0.00006260637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005799716,0.00012681921,0.00053943985,0.00005193688,0.00015079381,0.00000493682,0.00026078417,0.000022385948,0.000047281505],"category_scores_gemma":[0.000029946035,0.00006454175,0.00023852434,0.00030818704,0.00051935,0.000032820848,0.0003472371,0.0005823214,2.2107564e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012381914,0.0017018341,0.9539311,0.000037950234,0.00065161014,0.00029763478,0.0078501105,0.000014521899,0.02327005,0.0000057865063,0.0056631793,0.0053380397],"study_design_scores_gemma":[0.001421826,0.00917933,0.97097605,0.00001360632,0.00015985522,0.0022184579,0.014070879,0.000033011034,0.00031851357,0.000042270647,0.0015143396,0.000051835344],"about_ca_topic_score_codex":0.00008435239,"about_ca_topic_score_gemma":0.00000947793,"teacher_disagreement_score":0.031687994,"about_ca_system_score_codex":0.0001389931,"about_ca_system_score_gemma":0.00012460753,"threshold_uncertainty_score":0.2631936},"labels":[],"label_agreement":null},{"id":"W4396994630","doi":"10.1681/asn.20213210s1127c","title":"Urinary Epidermal Growth Factor and CKD Progression: The ASSESS-AKI Study","year":2021,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Urinary system; Medicine; Urology; Internal medicine; Intensive care medicine","score_opus":0.04054913054511187,"score_gpt":0.3297243304956659,"score_spread":0.289175199950554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396994630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700689,0.0015280854,0.00001975862,0.027991015,0.00008306884,0.00023108111,0.0000023375233,0.0000047935396,0.000070967464],"genre_scores_gemma":[0.9922479,0.00037836895,0.0019230837,0.00505668,0.0002706376,0.000004507283,3.6584373e-7,0.000014429551,0.00010403046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983688,0.00043823363,0.00042642216,0.0001522403,0.00041022815,0.00020407628],"domain_scores_gemma":[0.9980268,0.00034952592,0.00088330585,0.00032460684,0.00031350803,0.00010228184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033761188,0.00014739724,0.0006231042,0.000021791098,0.00012180501,0.000010443848,0.00019996727,0.000042443044,0.000036654248],"category_scores_gemma":[0.00007299381,0.00006998707,0.0004601627,0.0002492067,0.00075652456,0.000052086623,0.0002152327,0.00044974318,8.7492595e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009934548,0.0023887479,0.86930585,0.00008602409,0.002521065,0.00082938664,0.005019951,0.0000044797584,0.09325903,0.000016845011,0.016917503,0.008657652],"study_design_scores_gemma":[0.0013641564,0.0042369897,0.9777262,0.000033014905,0.00042845993,0.0053105834,0.0066124164,0.000017974777,0.0023712248,0.0000663625,0.0017741994,0.000058372694],"about_ca_topic_score_codex":0.000025346344,"about_ca_topic_score_gemma":0.000001597131,"teacher_disagreement_score":0.10842039,"about_ca_system_score_codex":0.00006890187,"about_ca_system_score_gemma":0.00025458142,"threshold_uncertainty_score":0.28539902},"labels":[],"label_agreement":null},{"id":"W4397024525","doi":"10.1681/asn.20223311s1645c","title":"A Predictive Model for Kidney Failure After Nephrectomy for Localized Kidney Cancer: The Kidney Cancer Risk Equation","year":2022,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Institute for Clinical Evaluative Sciences; University of Manitoba; Ottawa Hospital; Seven Oaks General Hospital","funders":"","keywords":"Kidney cancer; Nephrectomy; Medicine; Kidney; Cancer; Urology; Nephrology; Internal medicine; Oncology","score_opus":0.022171079123611277,"score_gpt":0.29008391096504427,"score_spread":0.267912831841433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397024525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7384696,0.0014575653,0.047007073,0.20683938,0.0005256086,0.00298168,0.002673668,0.000024616817,0.00002079766],"genre_scores_gemma":[0.872662,0.0010377737,0.016211513,0.106624626,0.0008746319,0.001965565,0.000030900625,0.000077679666,0.00051531184],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99772674,0.00032268773,0.0006666385,0.00027766294,0.000582254,0.00042400885],"domain_scores_gemma":[0.9962271,0.00037243203,0.002086626,0.00040971048,0.0005275134,0.0003766287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076287787,0.00026525542,0.00086227513,0.00006632342,0.0003702242,0.000010980555,0.00043429126,0.000077099015,0.00011738009],"category_scores_gemma":[0.0002951809,0.00015647276,0.0014224942,0.0003738983,0.00064627663,0.00007812778,0.00016303782,0.0006179357,3.1481122e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01791699,0.0003772948,0.013398239,0.00018203704,0.004054531,0.0000038396715,0.006151016,0.022370122,0.021081273,0.000018418581,0.9106688,0.0037774222],"study_design_scores_gemma":[0.01619611,0.006336245,0.016090762,0.00018429842,0.0066796914,0.00023739134,0.0034424928,0.45084044,0.002217999,0.002001418,0.49540395,0.00036920112],"about_ca_topic_score_codex":0.00075429835,"about_ca_topic_score_gemma":0.000025516829,"teacher_disagreement_score":0.4284703,"about_ca_system_score_codex":0.0008728709,"about_ca_system_score_gemma":0.0026913928,"threshold_uncertainty_score":0.6380774},"labels":[],"label_agreement":null},{"id":"W4397044818","doi":"10.1681/asn.20233411s1784a","title":"Renal TMA Presenting After Eight Years of Sunitinib Therapy","year":2023,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Sunitinib; Medicine; Urology; Nephrology; Internal medicine; Renal cell carcinoma","score_opus":0.030787510550332572,"score_gpt":0.2937453356119277,"score_spread":0.26295782506159515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397044818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944205,0.00039613995,0.000011178102,0.0048490353,0.00006734584,0.00012668422,0.0000054942493,0.0000067262804,0.00011686531],"genre_scores_gemma":[0.99493265,0.0009137542,0.001466348,0.0021211514,0.00025665318,0.0000032531555,0.000001280243,0.000019286705,0.00028563553],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986567,0.00015105853,0.0004790351,0.000101218844,0.00038946202,0.00022250568],"domain_scores_gemma":[0.9981724,0.00023917698,0.0010437685,0.00027858463,0.00019621017,0.000069835565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003830394,0.0001059443,0.0005794969,0.00007842934,0.000027168711,0.000003048446,0.00020944065,0.000049188333,0.00006242711],"category_scores_gemma":[0.000035332905,0.00006879516,0.00077364664,0.00048152806,0.0006650736,0.00003567386,0.000088178975,0.0002687532,0.0000043173795],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003132273,0.00042305712,0.10791866,0.00008496679,0.002598928,0.00024512378,0.0049954997,0.00009244538,0.79246163,0.0000114819595,0.06559084,0.022445088],"study_design_scores_gemma":[0.0014294272,0.0013048066,0.9679298,0.00004847999,0.00015985276,0.00036869207,0.0007163336,0.000050391867,0.01382021,0.00013070839,0.01398507,0.000056218276],"about_ca_topic_score_codex":0.00006887684,"about_ca_topic_score_gemma":0.0000013760275,"teacher_disagreement_score":0.86001116,"about_ca_system_score_codex":0.00004396588,"about_ca_system_score_gemma":0.0001287406,"threshold_uncertainty_score":0.28053853},"labels":[],"label_agreement":null},{"id":"W4397046386","doi":"10.1681/asn.20223311s1422c","title":"Utilizing a Patient-Specific iPSC Platform for the Study of Rare Genetic Kidney and Vascular Diseases","year":2022,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Kidney; Bioinformatics; Pathology; Biology; Internal medicine","score_opus":0.027589883059234783,"score_gpt":0.2628975082834191,"score_spread":0.23530762522418433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397046386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933474,0.0038839984,0.00004147302,0.0019582147,0.00007615803,0.00065992144,0.000024026125,0.000002740829,0.000006067669],"genre_scores_gemma":[0.99611706,0.000562275,0.00082927744,0.0023522673,0.00008366446,0.000028854136,0.0000011867334,0.000015990445,0.000009435748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987137,0.0001266218,0.00044130886,0.00012423145,0.00043071437,0.0001634564],"domain_scores_gemma":[0.9981541,0.00031680387,0.0009734616,0.00032282958,0.000136703,0.00009610928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000206396,0.000116500836,0.0005474049,0.000038011374,0.0001993181,0.000003920117,0.00022557488,0.000016068627,0.000027111893],"category_scores_gemma":[0.000034399214,0.00006417627,0.000579164,0.00020431424,0.00042521392,0.000023174602,0.00019379928,0.0002149241,7.013247e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012756033,0.008834177,0.48749894,0.00053218025,0.017304676,0.00012257507,0.062055532,0.0031971938,0.11162478,0.00004413141,0.17515948,0.1208703],"study_design_scores_gemma":[0.0049675647,0.016454672,0.87127835,0.00002599412,0.0017750585,0.00041809323,0.07382194,0.00047166974,0.0002763841,0.00009168299,0.030322285,0.00009632508],"about_ca_topic_score_codex":0.000054674565,"about_ca_topic_score_gemma":0.0000011350404,"teacher_disagreement_score":0.3837794,"about_ca_system_score_codex":0.000095657306,"about_ca_system_score_gemma":0.00013463818,"threshold_uncertainty_score":0.26170322},"labels":[],"label_agreement":null},{"id":"W4397048234","doi":"10.1681/asn.20233411s1211c","title":"Comparison of the Total Kidney Volumes Using the Ellipsoid Equation and Manual Segmentation in ADPKD","year":2023,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Ellipsoid; Urology; Mathematics; Medicine; Physics","score_opus":0.05163930065210585,"score_gpt":0.34703803659193183,"score_spread":0.29539873593982596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397048234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896638,0.00018422077,0.00012584256,0.009735088,0.000083495135,0.00018885013,0.0000030939236,0.0000025013228,0.000013146644],"genre_scores_gemma":[0.99745846,0.00010422633,0.0010635084,0.0012162968,0.000087051274,0.0000014829451,0.0000011748629,0.000007768406,0.000060039794],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99884015,0.0002292396,0.00042431842,0.0000749566,0.00030457127,0.00012675945],"domain_scores_gemma":[0.99852556,0.00018132529,0.0010043527,0.00016249612,0.00008827211,0.000037982816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042610112,0.00008189408,0.00036854585,0.00004000972,0.00006655723,0.0000039058846,0.00012395848,0.00003444664,0.000005982999],"category_scores_gemma":[0.000050107963,0.000040679806,0.00024842864,0.00038290172,0.00057865307,0.000039032322,0.00008233547,0.00022507162,4.5993832e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004233047,0.00015707502,0.35282838,0.000060049104,0.00036323018,0.0000027579301,0.008309293,0.004412155,0.6178771,0.000009843204,0.011204742,0.0043520257],"study_design_scores_gemma":[0.0010021033,0.00073122117,0.9537139,0.00006153296,0.0002611255,0.00015644405,0.010471305,0.020984925,0.012293336,0.00008611784,0.00019722618,0.000040763163],"about_ca_topic_score_codex":0.00019954567,"about_ca_topic_score_gemma":0.00000624398,"teacher_disagreement_score":0.6055838,"about_ca_system_score_codex":0.000109758395,"about_ca_system_score_gemma":0.00013424421,"threshold_uncertainty_score":0.21320714},"labels":[],"label_agreement":null},{"id":"W4398164253","doi":"10.1245/s10434-024-15431-5","title":"Sarcomatoid Dedifferentiation as a Predictor of Cancer-Specific Mortality in Surgically Treated Localized Renal Cell Carcinoma","year":2024,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"Universitätsklinikum Hamburg-Eppendorf","keywords":"Surgical oncology; Medicine; Renal cell carcinoma; Cancer; Oncology; Internal medicine; Carcinoma; Pathology","score_opus":0.06976175337220314,"score_gpt":0.36196600271992957,"score_spread":0.29220424934772643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398164253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742923,0.0119776735,0.000010191671,0.0017526017,0.00017350029,0.0005845111,0.00007049343,0.000053895597,0.011084849],"genre_scores_gemma":[0.9913377,0.007770875,0.00006501525,0.000055201017,0.000121336016,0.000085025866,0.00013759869,0.000030583426,0.0003966702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99707526,0.00033438829,0.0011216281,0.00051531894,0.00052737846,0.00042604358],"domain_scores_gemma":[0.9984127,0.00049670093,0.00023273779,0.0003405863,0.0002470407,0.00027020075],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046741616,0.00028255626,0.001204264,0.00036039334,0.000020311025,0.000009619471,0.00013125282,0.00034588878,0.0011584494],"category_scores_gemma":[0.000014268078,0.00021588495,0.00041580404,0.0006066124,0.00026119722,0.00007199408,0.000064905915,0.00031073438,0.000025466494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012520682,0.005435978,0.8746486,0.001693545,0.0007928113,0.017797682,0.00074930495,0.000079880556,0.049604226,0.0024529528,0.0037800947,0.030444272],"study_design_scores_gemma":[0.00861697,0.004883708,0.61247957,0.0005026982,0.00036170485,0.00026417844,0.000062420535,0.00080238644,0.259757,0.0005544161,0.11140202,0.00031294796],"about_ca_topic_score_codex":0.0017615961,"about_ca_topic_score_gemma":0.00015910443,"teacher_disagreement_score":0.26216903,"about_ca_system_score_codex":0.0002223807,"about_ca_system_score_gemma":0.000527008,"threshold_uncertainty_score":0.9997546},"labels":[],"label_agreement":null},{"id":"W4398210892","doi":"10.5489/cuaj.8730","title":"Case – Inferior vena caval thrombus associated with a left-sided renal cell carcinoma during pregnancy","year":2024,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Renal cell carcinoma; Pregnancy; Inferior vena cava; Thrombus; Renal carcinoma; Vena cava; Cardiology; Radiology; Internal medicine; Biology","score_opus":0.017004773420373154,"score_gpt":0.21771300493874676,"score_spread":0.2007082315183736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398210892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907959,0.0020215078,0.000012176101,0.0033770322,0.00030220667,0.00039419034,0.000071887465,0.00010299323,0.0029220716],"genre_scores_gemma":[0.996688,0.00003622706,0.000080093385,0.00033665652,0.00036832513,0.000014344874,0.000043012977,0.00005079476,0.002382554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972789,0.00026156887,0.00049688475,0.0004325604,0.00060914556,0.00092091964],"domain_scores_gemma":[0.9977425,0.00026122417,0.00024570504,0.00019200268,0.00032445538,0.0012341108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035642568,0.00033268583,0.0004925804,0.00036464958,0.000468902,0.00027007333,0.00011051458,0.00037495323,0.00072858424],"category_scores_gemma":[0.00042898746,0.00024448184,0.0002606072,0.0003902751,0.000055174107,0.00018806705,0.00002377856,0.0011790519,0.00008803054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013214661,0.0001457709,0.72029465,0.000060115857,0.00055513345,0.27291608,0.0008877257,0.000072705254,0.0020739804,0.000029808556,0.001959665,0.0008722284],"study_design_scores_gemma":[0.0028276832,0.0016221558,0.9262707,0.00038059618,0.0007497149,0.06448129,0.00012704781,0.00028215905,0.0016455997,0.00010652898,0.0011096,0.00039693023],"about_ca_topic_score_codex":0.0014557525,"about_ca_topic_score_gemma":0.0032429616,"teacher_disagreement_score":0.20843479,"about_ca_system_score_codex":0.004896222,"about_ca_system_score_gemma":0.0015910126,"threshold_uncertainty_score":0.9989238},"labels":[],"label_agreement":null},{"id":"W4398210918","doi":"10.5489/cuaj.8771","title":"Case – Long-term remission after repeated courses of palliative radiotherapy in a patient with metastatic MiT family translocation renal cell carcinoma","year":2024,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Renal cell carcinoma; Chromosomal translocation; Radiation therapy; Medicine; Oncology; Term (time); Internal medicine; Palliative care; Biology","score_opus":0.018022519054505717,"score_gpt":0.245969546309087,"score_spread":0.22794702725458127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398210918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99027795,0.006668906,0.00022345562,0.0020320653,0.000091154325,0.00045321637,0.00004513247,0.000015748876,0.00019235637],"genre_scores_gemma":[0.9985788,0.00016421154,0.0005103777,0.0004414199,0.00007082249,0.00003327063,0.000036425496,0.000023469747,0.00014120553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980706,0.0002847549,0.0005419281,0.00028680448,0.00043948513,0.00037644192],"domain_scores_gemma":[0.99872094,0.00015898314,0.00023190145,0.00012615911,0.00025329835,0.00050870713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038256936,0.00020854766,0.00039321886,0.0003934697,0.00006936969,0.00005427244,0.000052219802,0.00014877142,0.00022595716],"category_scores_gemma":[0.00006146141,0.0001418313,0.00014550479,0.00041586714,0.000040621755,0.00009373287,0.0000037553882,0.00048778448,0.0000047417807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001148297,0.0002587796,0.8641863,0.00010196694,0.00035376012,0.11647173,0.002792218,0.00023047249,0.004652333,0.000006585498,0.00043398904,0.0093635935],"study_design_scores_gemma":[0.002610163,0.0028044372,0.9834542,0.0002812811,0.00040860768,0.0063936263,0.00022296442,0.00069708127,0.002540849,0.000031927255,0.00034479555,0.0002100168],"about_ca_topic_score_codex":0.0013807421,"about_ca_topic_score_gemma":0.0015226115,"teacher_disagreement_score":0.11926798,"about_ca_system_score_codex":0.002276731,"about_ca_system_score_gemma":0.0009036189,"threshold_uncertainty_score":0.59535724},"labels":[],"label_agreement":null},{"id":"W4399047717","doi":"10.17650/1726-9776-2024-20-1-24-35","title":"Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms","year":2024,"lang":"en","type":"article","venue":"Cancer Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Lenvatinib; Medicine; Sunitinib; Pembrolizumab; Renal cell carcinoma; Oncology; Internal medicine; Cancer; Immunotherapy","score_opus":0.02240287845722777,"score_gpt":0.3040383810767318,"score_spread":0.28163550261950404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399047717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935652,0.0026240873,0.000019067023,0.0008205767,0.00017979377,0.002608148,0.000060227867,0.00002805782,0.00009485929],"genre_scores_gemma":[0.9984403,0.000036598052,0.00005701244,0.00032991476,0.000056823577,0.00085427193,0.00004488635,0.000047797803,0.0001323723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985462,0.00008285821,0.00032355604,0.00048564572,0.00017690028,0.00038486515],"domain_scores_gemma":[0.9991413,0.0003572748,0.000061498264,0.00029542777,0.0000600638,0.000084481944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013902535,0.00024391411,0.000472678,0.0001987061,0.00004506646,0.000016667116,0.000096646516,0.00006875647,0.000034189972],"category_scores_gemma":[0.000025093183,0.00014634371,0.000049174745,0.00024889442,0.0001123002,0.000069454174,0.000045646662,0.00031248195,0.0000031638601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011211141,0.0012667758,0.97369516,0.0001209282,0.00009527892,0.0002580994,0.0025951585,0.00015623253,0.00005923678,0.000017968348,0.00006058564,0.0104634315],"study_design_scores_gemma":[0.043720182,0.014419183,0.93970555,0.000019550313,0.0002451993,0.0000074372474,0.0004245432,0.0005521397,0.00015468658,0.000015939277,0.00059006683,0.0001455237],"about_ca_topic_score_codex":0.0002829247,"about_ca_topic_score_gemma":0.0015406234,"teacher_disagreement_score":0.033989616,"about_ca_system_score_codex":0.00024688512,"about_ca_system_score_gemma":0.0001870053,"threshold_uncertainty_score":0.5967723},"labels":[],"label_agreement":null},{"id":"W4399055397","doi":"10.3390/curroncol31060227","title":"Long-Term Oncologic Outcomes of Off-Clamp Robotic Partial Nephrectomy for Cystic Renal Tumors: A Propensity Score Matched-Pair Comparison of Cystic versus Pure Clear Cell Carcinoma","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Clear cell renal cell carcinoma; Propensity score matching; Proportional hazards model; Internal medicine; Urology; Kidney cancer; Oncology; Log-rank test; Stage (stratigraphy); T-stage; Cancer; Kidney","score_opus":0.17528361970681614,"score_gpt":0.39242069477069863,"score_spread":0.2171370750638825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399055397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98453957,0.008260878,0.0006199222,0.00031624784,0.0025316963,0.0032940204,0.00005223757,0.00012215662,0.0002632944],"genre_scores_gemma":[0.99790454,0.000029780545,0.00087275694,0.000018556066,0.00034856805,0.0003871249,0.00022519799,0.000066183435,0.00014729571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99646527,0.00031608008,0.0012513804,0.0007825051,0.0004995966,0.00068517897],"domain_scores_gemma":[0.9969907,0.0012518442,0.00051764364,0.00059547724,0.0003389629,0.00030538856],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046182604,0.0005183402,0.0021850707,0.00032194846,0.00008140285,0.000022557726,0.00027371373,0.0003146971,0.00012679452],"category_scores_gemma":[0.00031198637,0.0003942722,0.00059596734,0.00036395623,0.00041929443,0.00008464928,0.00019867845,0.0005963438,0.000061180974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012471,0.0052922107,0.92969406,0.008024578,0.00057821977,0.00096096296,0.0012895043,0.000363459,0.008345311,0.00021941602,0.0020104644,0.030750826],"study_design_scores_gemma":[0.018352598,0.036073536,0.89098203,0.001331136,0.0055571008,0.00028528622,0.00033533145,0.008288513,0.035088994,0.00008648018,0.0029102943,0.00070867594],"about_ca_topic_score_codex":0.000029388297,"about_ca_topic_score_gemma":0.00006732846,"teacher_disagreement_score":0.038711995,"about_ca_system_score_codex":0.0009986571,"about_ca_system_score_gemma":0.001148965,"threshold_uncertainty_score":0.9998509},"labels":[],"label_agreement":null},{"id":"W4399141568","doi":"10.1097/icb.0000000000001611","title":"RETINAL DYSTROPHY ASSOCIATED WITH BIRT–HOGG–DUBÉ SYNDROME","year":2024,"lang":"en","type":"article","venue":"Retinal Cases & Brief Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"","keywords":"Medicine; Birt–Hogg–Dubé syndrome; Retinal; Ophthalmology; Surgery","score_opus":0.017254141965445217,"score_gpt":0.2551508834810846,"score_spread":0.2378967415156394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399141568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97949886,0.0034989333,0.000051019408,0.00050675694,0.00031690372,0.00071103807,0.000026063686,0.00056216074,0.014828281],"genre_scores_gemma":[0.9906263,0.000048291895,0.0003787977,0.00015260074,0.00023805609,0.000076375676,0.0002729536,0.00013178767,0.008074886],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.996219,0.000107814325,0.0007721871,0.0010383261,0.0011826367,0.0006800607],"domain_scores_gemma":[0.9979185,0.00024366153,0.00029964972,0.0007908004,0.00027744236,0.0004699491],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005150121,0.00050393015,0.00075072254,0.00026270215,0.00015040791,0.00015373605,0.000075821816,0.00019101979,0.0005724827],"category_scores_gemma":[0.00041982147,0.0003756722,0.0003528652,0.0007202755,0.00022191799,0.0001488388,0.00007187897,0.0005463339,0.00009079319],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059069484,0.00028339686,0.051511098,0.00039942696,0.00053682685,0.93948346,0.00009872483,0.000006344288,0.0024742272,0.00019526482,0.003140882,0.0012796237],"study_design_scores_gemma":[0.0007763352,0.006568804,0.21351768,0.003016729,0.001634437,0.75235194,0.00008089158,0.00007527448,0.0051429053,0.00015314188,0.016099269,0.0005825821],"about_ca_topic_score_codex":0.00034021537,"about_ca_topic_score_gemma":0.000022870572,"teacher_disagreement_score":0.18713154,"about_ca_system_score_codex":0.00067840936,"about_ca_system_score_gemma":0.0005892148,"threshold_uncertainty_score":0.9998695},"labels":[],"label_agreement":null},{"id":"W4399156690","doi":"10.1080/14737140.2024.2362192","title":"Multidisciplinary systemic and local therapies for metastatic renal cell carcinoma: a narrative review","year":2024,"lang":"en","type":"review","venue":"Expert Review of Anticancer Therapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Systemic therapy; Oncology; Multidisciplinary approach; Internal medicine; Cancer research; Cancer","score_opus":0.0636607157657977,"score_gpt":0.4052155701520763,"score_spread":0.34155485438627864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399156690","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000096659305,0.98763394,0.00014184856,0.00055579725,0.00019842817,0.01089074,0.000079026795,0.000051336807,0.00043918463],"genre_scores_gemma":[0.000065282315,0.9920292,0.0018194485,0.0006721277,0.00022800178,0.0033823296,0.00014206966,0.00025847135,0.0014030567],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99616075,0.000417208,0.0016036242,0.0009332536,0.00048528617,0.000399884],"domain_scores_gemma":[0.99764663,0.0002953201,0.00076940574,0.00087632664,0.00020592782,0.00020641813],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00066099287,0.0010061663,0.00633308,0.00019551844,0.00006930702,0.00001643046,0.0002434796,0.00014250744,0.0002575425],"category_scores_gemma":[0.000033341992,0.0005562264,0.0016957049,0.00045742662,0.00031181023,0.0000531178,0.00008115492,0.00032260444,0.00003627626],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003807509,0.000120443496,6.562147e-7,0.5514247,0.00079100585,0.000067091,0.0004619598,4.067267e-9,0.000020880305,0.00002172438,0.008704125,0.43834937],"study_design_scores_gemma":[0.0005820245,0.0007699153,9.4147236e-7,0.46678066,0.0038610443,0.00043802775,0.000106462794,0.0000020716075,0.000043539974,0.0000069284806,0.52711135,0.00029705974],"about_ca_topic_score_codex":0.000022195596,"about_ca_topic_score_gemma":0.0000010784995,"teacher_disagreement_score":0.5184072,"about_ca_system_score_codex":0.00027103155,"about_ca_system_score_gemma":0.0007103795,"threshold_uncertainty_score":0.9996889},"labels":[],"label_agreement":null},{"id":"W4399369708","doi":"10.6004/jnccn.2024.7011","title":"Improved Survival in Contemporary Community-Based Patients With Metastatic Clear-Cell Renal Cell Carcinoma Undergoing Active Treatment","year":2024,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Hazard ratio; Renal cell carcinoma; Proportional hazards model; Internal medicine; Nephrectomy; Clear cell renal cell carcinoma; Surgery; Oncology; Kidney; Confidence interval","score_opus":0.07271995487144732,"score_gpt":0.30501299002645355,"score_spread":0.2322930351550062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399369708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912546,0.004987465,0.00007934906,0.0008738046,0.00063807314,0.0007427889,0.0000637285,0.0000132433015,0.0013469463],"genre_scores_gemma":[0.9979132,0.000045232933,0.0005902878,0.0007648563,0.0003589414,0.000028756847,0.000042576186,0.000047150763,0.0002090337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974774,0.00064076425,0.00056585204,0.0002013849,0.00084296754,0.0002715972],"domain_scores_gemma":[0.9967977,0.0013511486,0.0004527187,0.00019169746,0.0010638541,0.00014289677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023208329,0.00030676447,0.00056425325,0.00021156506,0.00017800635,0.000048092723,0.00019213087,0.00005937062,0.000028785164],"category_scores_gemma":[0.000023923705,0.00018030018,0.0003108209,0.0005252755,0.00010197023,0.00014739459,0.000051913536,0.00078676187,0.000002734026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06303412,0.009838995,0.4629137,0.003290384,0.0065138624,0.001602393,0.0056411806,0.40203983,0.015791917,0.00020176083,0.024740363,0.0043914993],"study_design_scores_gemma":[0.046374105,0.015495045,0.8879296,0.0037721745,0.0019025397,0.00012555413,0.0012984396,0.011084794,0.020064559,0.00066744577,0.010450754,0.000834999],"about_ca_topic_score_codex":0.00020389374,"about_ca_topic_score_gemma":0.00012356133,"teacher_disagreement_score":0.4250159,"about_ca_system_score_codex":0.0022785587,"about_ca_system_score_gemma":0.0022449815,"threshold_uncertainty_score":0.7352428},"labels":[],"label_agreement":null},{"id":"W4399381359","doi":"10.1200/jco.2024.42.16_suppl.4514","title":"Systemic treatments in favorable and very favorable risk metastatic renal cell carcinoma (mRCC): Real world evidence from the International mRCC Database Consortium (IMDC).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; McMaster University; University of Alberta; Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Oncology; Intensive care medicine","score_opus":0.14865811750976207,"score_gpt":0.42472553632350035,"score_spread":0.2760674188137383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399381359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97627676,0.015671952,0.00008325002,0.0035916115,0.0018670905,0.0004662797,0.00008741189,0.000015780635,0.0019398916],"genre_scores_gemma":[0.9851874,0.009416682,0.0024169257,0.00048106944,0.00084236,0.000020635316,0.000029652057,0.00003086641,0.0015743747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945172,0.0012429764,0.0026752024,0.00050830765,0.000710469,0.00034585755],"domain_scores_gemma":[0.98615175,0.011543912,0.001237259,0.0004279917,0.00023585936,0.0004032238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046346756,0.00029036787,0.0014976963,0.00029992766,0.000067202134,0.000078845886,0.0003528953,0.00016552096,0.00021937188],"category_scores_gemma":[0.0018535735,0.00017063634,0.00042952443,0.0003090339,0.0002613181,0.0003938128,0.00016748204,0.0014704587,0.00006714967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00564654,0.0013741445,0.94179523,0.00016528057,0.0014302426,0.016140696,0.0004712447,0.00010180643,0.0028703914,0.000046292535,0.0120577635,0.01790035],"study_design_scores_gemma":[0.015587683,0.009467956,0.94409394,0.003536208,0.0057868147,0.0021594951,0.0010420005,0.003899002,0.0022961455,0.00058078096,0.011202208,0.00034777715],"about_ca_topic_score_codex":0.0038544117,"about_ca_topic_score_gemma":0.0012111134,"teacher_disagreement_score":0.017552573,"about_ca_system_score_codex":0.00091654126,"about_ca_system_score_gemma":0.0026560957,"threshold_uncertainty_score":0.6958348},"labels":[],"label_agreement":null},{"id":"W4399381371","doi":"10.1200/jco.2024.42.16_suppl.4504","title":"Biomarker analyses in patients with advanced renal cell carcinoma (aRCC) from the phase 3 CLEAR trial.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Biomarker; Renal cell carcinoma; Internal medicine; Oncology","score_opus":0.18237941356264004,"score_gpt":0.4859540055649664,"score_spread":0.30357459200232634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399381371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991314,0.0025764192,0.00003294271,0.0026169922,0.0011160574,0.00050412933,0.000015278576,0.0000098459595,0.0018143187],"genre_scores_gemma":[0.99683344,0.00011584147,0.0013893258,0.00071259047,0.000751969,0.0000074686513,0.000021392312,0.000028571782,0.00013941045],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99599296,0.0007195761,0.0021501337,0.00030632154,0.00057416083,0.00025687256],"domain_scores_gemma":[0.99453056,0.00374785,0.0008290397,0.0003160904,0.0002641217,0.00031232432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014736924,0.00020354467,0.001348591,0.00017982523,0.000037059017,0.000022614373,0.00019765094,0.00024281167,0.00023416379],"category_scores_gemma":[0.0008616111,0.000096290605,0.0005801042,0.0003404984,0.00022517344,0.00012980486,0.000048520775,0.0010515606,0.00003320931],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5467648,0.009831218,0.14552984,0.000036534213,0.0010163261,0.0061394526,0.00023731562,0.000028041912,0.0007987127,0.000008166683,0.0065852082,0.2830244],"study_design_scores_gemma":[0.18258259,0.06571906,0.7334426,0.00017048436,0.0011835548,0.000033243843,0.00012449885,0.00011344296,0.00039511835,0.000067520814,0.016057236,0.00011066755],"about_ca_topic_score_codex":0.00007225873,"about_ca_topic_score_gemma":0.000036950678,"teacher_disagreement_score":0.58791274,"about_ca_system_score_codex":0.0002762916,"about_ca_system_score_gemma":0.0012393086,"threshold_uncertainty_score":0.4568566},"labels":[],"label_agreement":null},{"id":"W4399386009","doi":"10.1007/s00261-024-04403-8","title":"Development of a CT-assessed adiposity nomogram for predicting outcome in localized ccRCC","year":2024,"lang":"en","type":"article","venue":"Abdominal Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Nomogram; Medicine; Internal medicine; Cohort; Clear cell renal cell carcinoma; Proportional hazards model; Retrospective cohort study; Oncology; Renal cell carcinoma; Hepatology; Kidney disease; Nephrology","score_opus":0.0401192965254924,"score_gpt":0.32859895707300796,"score_spread":0.28847966054751556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399386009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99128836,0.0015237543,0.0048564766,0.00021993299,0.0002764051,0.0008728688,0.0000066827834,0.0000587811,0.00089675357],"genre_scores_gemma":[0.9661519,0.000010696614,0.033201884,0.00008396329,0.000080330465,0.00020438948,0.000043333137,0.000025025824,0.00019846867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983982,0.000060961673,0.00068960316,0.00036869728,0.00013618401,0.00034639565],"domain_scores_gemma":[0.9991202,0.0004355488,0.00008320467,0.00019976264,0.00005228814,0.000109045446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005382759,0.00018994365,0.0006596018,0.0002454095,0.00003530649,0.0000074785717,0.00009036188,0.000090098234,0.000044046985],"category_scores_gemma":[0.00013942092,0.00015208799,0.00016916038,0.00020377834,0.000089524685,0.000034330093,0.00003767523,0.0001790642,0.00001409862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053184163,0.0010705775,0.7412738,0.003409325,0.0014368007,0.003077399,0.0034481366,0.000059326383,0.100813106,0.0015914445,0.00048914837,0.13801251],"study_design_scores_gemma":[0.01995561,0.0038941125,0.7838427,0.0012417571,0.0015257535,0.0050763297,0.00097010424,0.020750925,0.1337622,0.00042800515,0.02776989,0.00078262424],"about_ca_topic_score_codex":0.000061074854,"about_ca_topic_score_gemma":0.000044593566,"teacher_disagreement_score":0.13722989,"about_ca_system_score_codex":0.00034144244,"about_ca_system_score_gemma":0.000322427,"threshold_uncertainty_score":0.6201968},"labels":[],"label_agreement":null},{"id":"W4399393998","doi":"10.1200/jco.2024.42.16_suppl.4505","title":"Biomarker analysis of the phase 3 KEYNOTE-426 study of pembrolizumab (P) plus axitinib (A) versus sunitinib (S) for advanced renal cell carcinoma (RCC).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Axitinib; Sunitinib; Renal cell carcinoma; Pembrolizumab; Biomarker; Oncology; Internal medicine; Kidney cancer; Cancer; Immunotherapy","score_opus":0.20354513893132523,"score_gpt":0.4965729459471428,"score_spread":0.29302780701581754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399393998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99227834,0.0012913211,0.00015450403,0.0010169926,0.0018960225,0.0009380955,0.00007255502,0.000010402303,0.0023417936],"genre_scores_gemma":[0.99814296,0.000083647275,0.000805591,0.00012438247,0.00042035844,0.000022443539,0.000017450793,0.000036439822,0.00034671577],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99387157,0.0007730332,0.00384714,0.0003846152,0.0007872199,0.00033639814],"domain_scores_gemma":[0.9887141,0.0069883903,0.0024174133,0.0005863904,0.0009521849,0.00034153377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002721349,0.00027912023,0.0028708535,0.00061990845,0.000057113506,0.000010790497,0.0003882167,0.00033153375,0.00018929593],"category_scores_gemma":[0.0020433709,0.00016745701,0.0024238664,0.0010507709,0.00031984973,0.00009303164,0.00011613434,0.00077304995,0.0000030289548],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50232,0.050461385,0.051747285,0.0012655599,0.04471979,0.00555782,0.0037925572,0.0018171011,0.027870221,0.0002871828,0.0074715056,0.30268958],"study_design_scores_gemma":[0.2440427,0.2361463,0.4029381,0.00033135046,0.069876954,0.00026815396,0.004242375,0.006616275,0.014450893,0.000104912746,0.020546451,0.00043554322],"about_ca_topic_score_codex":0.000047255246,"about_ca_topic_score_gemma":0.000101482954,"teacher_disagreement_score":0.3511908,"about_ca_system_score_codex":0.00037137355,"about_ca_system_score_gemma":0.0023701272,"threshold_uncertainty_score":0.68286985},"labels":[],"label_agreement":null},{"id":"W4399394190","doi":"10.1200/jco.2024.42.16_suppl.4508","title":"Avelumab + axitinib vs sunitinib in patients (pts) with advanced renal cell carcinoma (aRCC): Final overall survival (OS) analysis from the JAVELIN Renal 101 phase 3 trial.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Pfizer","keywords":"Medicine; Axitinib; Renal cell carcinoma; Sunitinib; Javelin; Internal medicine; Oncology; Avelumab; Urology; Cancer; Immunotherapy; Nivolumab","score_opus":0.10584516674255887,"score_gpt":0.41340355821170205,"score_spread":0.3075583914691432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399394190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99055713,0.0007819042,0.00020038856,0.0033502567,0.0013333212,0.0008262394,0.00011560316,0.000021763359,0.0028133977],"genre_scores_gemma":[0.99383,0.0002173992,0.002182072,0.0009352284,0.0020727096,0.000025337553,0.00020390992,0.00005694781,0.00047635107],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9912881,0.0018305241,0.0042072027,0.00070198043,0.001350242,0.00062192883],"domain_scores_gemma":[0.9889402,0.007255447,0.0018455117,0.00061868463,0.0006868312,0.00065336993],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004205124,0.00047908424,0.0030712187,0.0005300908,0.00008985809,0.00006512265,0.00046447635,0.00050334894,0.0010363165],"category_scores_gemma":[0.0016683986,0.0002752387,0.001548148,0.00091631856,0.00034520816,0.0002291016,0.00011829602,0.0025512886,0.00005633343],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6661796,0.016211083,0.18072663,0.00007415791,0.0045711976,0.013458992,0.0006766603,0.00041033333,0.00026298175,0.000068107234,0.0052918266,0.11206845],"study_design_scores_gemma":[0.30514273,0.08212438,0.58266073,0.00029321926,0.0065260096,0.00009374529,0.00020561508,0.0006769684,0.00037528586,0.00015698631,0.021391008,0.0003533042],"about_ca_topic_score_codex":0.0002795167,"about_ca_topic_score_gemma":0.00047694964,"teacher_disagreement_score":0.40193412,"about_ca_system_score_codex":0.0006519879,"about_ca_system_score_gemma":0.0031023596,"threshold_uncertainty_score":0.99996996},"labels":[],"label_agreement":null},{"id":"W4399564759","doi":"10.1136/bmjonc-2023-000181","title":"Association between neutrophil-to-eosinophil ratio and efficacy outcomes with avelumab plus axitinib or sunitinib in patients with advanced renal cell carcinoma: post hoc analyses from the JAVELIN Renal 101 trial","year":2024,"lang":"en","type":"article","venue":"BMJ Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"Genentech; Medac; Ipsen; National Institutes of Health; Shionogi; Ono Pharmaceutical; Astellas Pharma; Eisai; Chugai Pharmaceutical; Seagen; National Cancer Institute; Intuitive Surgical; Calithera Biosciences; Incyte; Pfizer; GlaxoSmithKline; Arrowhead Pharmaceuticals; PTC Therapeutics; Sanofi; Exelixis; Genomic Health; Les Laboratories Pierre Fabre; AstraZeneca; Bristol-Myers Squibb","keywords":"Avelumab; Medicine; Sunitinib; Renal cell carcinoma; Axitinib; Post-hoc analysis; Internal medicine; Eosinophil; Oncology; Nivolumab; Immunotherapy; Cancer","score_opus":0.04883230815604549,"score_gpt":0.3487168361763055,"score_spread":0.29988452802026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399564759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893504,0.00024306387,0.000039477032,0.0056630145,0.0001973657,0.0037516109,0.0002679109,0.00006160284,0.0004255892],"genre_scores_gemma":[0.99548244,0.00001357477,0.0013918704,0.00055756647,0.0006015537,0.0002683459,0.0008917655,0.00006421101,0.00072864257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99688584,0.0004876584,0.0007474512,0.000713145,0.00065706414,0.00050883915],"domain_scores_gemma":[0.9963297,0.002383846,0.00033549298,0.0004334103,0.0002805333,0.00023696384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041855668,0.00042813455,0.0010880439,0.00028586946,0.00013407625,0.00007629276,0.00015769695,0.00024892166,0.0000877245],"category_scores_gemma":[0.0003296242,0.00023049286,0.0001176397,0.00054610486,0.00010719313,0.00012253864,0.00009450434,0.0005263035,0.00003597571],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28857312,0.0015422117,0.67759836,0.00010893667,0.001736672,0.0024997017,0.004178338,0.00032303575,0.0013652488,0.00001930077,0.001761113,0.020293951],"study_design_scores_gemma":[0.09836077,0.02167963,0.8758557,0.00015352105,0.0013861895,0.00001751976,0.0002607021,0.00003856032,0.00084391213,0.00000718039,0.0011128034,0.00028354093],"about_ca_topic_score_codex":0.0006609532,"about_ca_topic_score_gemma":0.0012628346,"teacher_disagreement_score":0.19825731,"about_ca_system_score_codex":0.0012760744,"about_ca_system_score_gemma":0.0012126276,"threshold_uncertainty_score":0.93992263},"labels":[],"label_agreement":null},{"id":"W4399686013","doi":"10.1002/cam4.7196","title":"Cross‐sectional study of therapy‐related expectations/concerns of patients with metastatic renal cell carcinoma and physicians in Japan","year":2024,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada","keywords":"Medicine; Nausea; Renal cell carcinoma; Malaise; Adverse effect; Vomiting; Depression (economics); Anxiety; Diarrhea; Internal medicine; Systemic therapy; Disease; Cross-sectional study; Cancer; Psychiatry","score_opus":0.02837667264979271,"score_gpt":0.30904715101526503,"score_spread":0.2806704783654723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399686013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904964,0.007912663,0.0000050300837,0.0000801438,0.00013583826,0.00091117946,0.000027825474,0.000016016678,0.00041491343],"genre_scores_gemma":[0.9993414,0.00006494946,0.000025134625,0.000024446945,0.00006697109,0.000111796006,0.000048339527,0.00002712357,0.00028981667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998554,0.000051276435,0.00047556878,0.0003132568,0.0004580139,0.00014788417],"domain_scores_gemma":[0.999324,0.00010891674,0.00013684327,0.0001870021,0.00017644127,0.00006677378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097100885,0.00017436521,0.00045027173,0.00025431346,0.000024387544,0.000004676821,0.00004825264,0.000031727635,0.00021159524],"category_scores_gemma":[0.000010769457,0.00011302211,0.000037568403,0.00047151928,0.00022827488,0.00006401768,0.000013207973,0.00015510435,9.240946e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061382074,0.0007481402,0.9722109,0.0002622048,0.00024276704,0.00004783413,0.018928567,0.00008193594,0.0036053597,0.000009087032,0.000035400924,0.0032139742],"study_design_scores_gemma":[0.010522902,0.0055224323,0.97437745,0.00033838762,0.0002634867,0.0000047128574,0.0036710997,0.00014061414,0.0050398624,0.000013736375,0.000019805448,0.000085501466],"about_ca_topic_score_codex":0.0012669115,"about_ca_topic_score_gemma":0.0001300548,"teacher_disagreement_score":0.0152574675,"about_ca_system_score_codex":0.00014604366,"about_ca_system_score_gemma":0.00013372824,"threshold_uncertainty_score":0.4608908},"labels":[],"label_agreement":null},{"id":"W4399908300","doi":"","title":"Using YOLO v7 to Detect Kidney in Magnetic Resonance Imaging.","year":2024,"lang":"en","type":"preprint","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Magnetic resonance imaging; Medicine; Radiology","score_opus":0.044822968506438216,"score_gpt":0.2744946121540144,"score_spread":0.22967164364757617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399908300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9039728,0.06460772,0.000030427185,0.0050292094,0.0017028338,0.005471134,0.00007481549,0.00022370306,0.01888734],"genre_scores_gemma":[0.9873731,0.000096042815,0.0033949206,0.001327101,0.00039795204,0.0036688612,0.000026476302,0.00010872672,0.003606817],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974354,0.00007262913,0.00044736813,0.000933452,0.0004092976,0.000701858],"domain_scores_gemma":[0.99841917,0.000039570554,0.000064229454,0.0008214306,0.000064006534,0.0005915827],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037259547,0.0004020121,0.00059587805,0.0005698943,0.000021200869,0.000076640885,0.00020240367,0.00017662068,0.00004639341],"category_scores_gemma":[0.00032314603,0.00036431095,0.00019581732,0.00037972632,0.000050189876,0.00001855849,0.0009180047,0.0008361556,0.000114947936],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046353132,0.00012184271,0.034297194,0.0015744321,0.00006328456,0.00568625,0.00046621868,0.00009586459,0.0006530225,0.000023444069,0.006201475,0.95035344],"study_design_scores_gemma":[0.0015029673,0.00008672697,0.9563194,0.0015935269,0.00056450337,0.00033833119,0.000026624675,0.0010763728,0.005742124,0.002633836,0.0294662,0.00064939575],"about_ca_topic_score_codex":0.0007350766,"about_ca_topic_score_gemma":0.000045806326,"teacher_disagreement_score":0.94970405,"about_ca_system_score_codex":0.0013101659,"about_ca_system_score_gemma":0.00035045194,"threshold_uncertainty_score":0.9998809},"labels":[],"label_agreement":null},{"id":"W4399922004","doi":"10.1002/bco2.355","title":"Imaging modalities for characterising T1 renal tumours: A systematic review and meta‐analysis of diagnostic accuracy","year":2024,"lang":"en","type":"review","venue":"BJUI Compass","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Kidney and Urology Foundation of America","keywords":"Meta-analysis; Modalities; Medicine; Medical physics; Radiology; Diagnostic accuracy; Computer science; Pathology","score_opus":0.10926354728720247,"score_gpt":0.3814653581165889,"score_spread":0.27220181082938644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399922004","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008671675,0.99216807,0.00011003276,0.00037916467,0.00006032536,0.0066014836,0.00054313283,0.000058140293,0.00007098779],"genre_scores_gemma":[0.000562724,0.9948814,0.00025700423,0.00015915297,0.000067469606,0.0029394396,0.00060294,0.000093966104,0.00043591464],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99637717,0.0003741215,0.0018608243,0.00064356776,0.0004043666,0.00033995858],"domain_scores_gemma":[0.99364364,0.0039956737,0.0011354617,0.0008449325,0.00020924216,0.00017103493],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007969307,0.00074068975,0.013934371,0.00073794136,0.000054289543,0.00009336249,0.00020657945,0.000091471295,0.000055708235],"category_scores_gemma":[0.0010604563,0.0004472761,0.0041456036,0.00076524896,0.000075738935,0.000086891065,0.00013037796,0.00026331478,0.000017485048],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000034566872,0.000043075226,0.0000019215438,0.8473717,0.15125479,0.000096983786,0.000047855614,1.9059792e-7,3.4308206e-7,0.00006448061,0.00025851378,0.00085670536],"study_design_scores_gemma":[0.00010300719,0.000043485492,0.000007900435,0.27671096,0.7161719,0.0002606612,0.00001722622,0.000064670356,0.0000013742263,0.000013354352,0.006376046,0.00022942203],"about_ca_topic_score_codex":0.000041207295,"about_ca_topic_score_gemma":0.000003439148,"teacher_disagreement_score":0.5706607,"about_ca_system_score_codex":0.00020642983,"about_ca_system_score_gemma":0.00021758192,"threshold_uncertainty_score":0.9997979},"labels":[],"label_agreement":null},{"id":"W4399993529","doi":"10.1016/s1470-2045(24)00211-0","title":"Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study","year":2024,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Saskatchewan","funders":"National Cancer Institute; EMD Serono; Ipsen; Eisai; National Institutes of Health; ECOG-ACRIN Cancer Research Group; Canadian Cancer Society; Sanofi; Exelixis; Dana-Farber/Harvard Cancer Center; Genentech; Coherus Biosciences; Bristol-Myers Squibb; Pfizer; Dana-Farber Cancer Institute; American College of Radiology Imaging Network; Veracyte","keywords":"Medicine; Nivolumab; Renal cell carcinoma; Nephrectomy; Clinical endpoint; Perioperative; Kidney cancer; Internal medicine; Surgery; Clinical trial; Urology; Cancer; Kidney; Immunotherapy","score_opus":0.09033592788829715,"score_gpt":0.3633928836903327,"score_spread":0.27305695580203554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399993529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890164,0.00031769657,0.000017199689,0.0007790131,0.0003563117,0.004416717,0.000015894622,0.00006826124,0.005012468],"genre_scores_gemma":[0.9969372,0.000019102581,0.0010348356,0.0003114301,0.00029881162,0.0005570424,0.00013661267,0.000055054785,0.00064989494],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99761534,0.0006190166,0.0004035295,0.00060007523,0.00030694847,0.0004550847],"domain_scores_gemma":[0.99868727,0.00038379573,0.000105375344,0.00057420006,0.00012569095,0.00012367395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006563278,0.0003082501,0.0008252027,0.000116284755,0.00015391731,0.00012562884,0.00032882486,0.00009917901,0.0001524459],"category_scores_gemma":[0.00004873685,0.00018815475,0.000034934244,0.00038457193,0.00010372574,0.0003265077,0.00015109104,0.00045295383,0.000049184655],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4494388,0.019682415,0.48105887,0.00028951187,0.00075641833,0.002500726,0.021282192,0.00016279389,0.0050652768,0.00028767035,0.0012517504,0.018223584],"study_design_scores_gemma":[0.5979553,0.06754765,0.32659915,0.0001093057,0.00058626675,0.00002653305,0.0018672275,0.0012974512,0.0011154545,0.000019509856,0.0025294027,0.00034678652],"about_ca_topic_score_codex":0.0004585417,"about_ca_topic_score_gemma":0.0020255207,"teacher_disagreement_score":0.15445971,"about_ca_system_score_codex":0.0010574936,"about_ca_system_score_gemma":0.000669726,"threshold_uncertainty_score":0.76727283},"labels":[],"label_agreement":null},{"id":"W4400039539","doi":"10.21203/rs.3.rs-4510670/v1","title":"Characterizing the tumor suppressor activity of FLCN in Birt-Hogg-Dubé syndrome through transcriptiomic and proteomic analysis","year":2024,"lang":"en","type":"preprint","venue":"Research Square","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Myrovlytis Trust; Parc Geneteg Cymru; Tenovus; Health and Care Research Wales","keywords":"Folliculin; Birt–Hogg–Dubé syndrome; Suppressor; Cancer research; Biology; Medicine; Internal medicine; Cancer; Genetics; Anatomy; Gene","score_opus":0.07707159361028451,"score_gpt":0.3755650655249023,"score_spread":0.29849347191461784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400039539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887483,0.0030635372,0.000015945285,0.0028203372,0.00009532951,0.0043283924,0.0003212696,0.000051215062,0.00055565184],"genre_scores_gemma":[0.9976534,0.00050311344,0.00014085496,0.00001850358,0.00008386916,0.0010354962,0.00011041708,0.00007612873,0.00037821088],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9954882,0.00083225145,0.0005797524,0.0010594934,0.0013230272,0.0007172303],"domain_scores_gemma":[0.9978234,0.0003359901,0.00015163171,0.0012763228,0.00023705231,0.00017559694],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0017603306,0.00042880248,0.0013093206,0.0013507658,0.000107334316,0.00013804372,0.00036653978,0.00028554702,0.00014567534],"category_scores_gemma":[0.00015389793,0.00028745906,0.0005752881,0.0015408032,0.00041828016,0.0000934277,0.0008933936,0.0028137628,0.000030035799],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014981476,0.00075123133,0.023197925,0.016805694,0.003566023,0.0027117243,0.0076159467,0.000069536654,0.9426324,0.00012277515,0.00006392405,0.00096471375],"study_design_scores_gemma":[0.0011566243,0.0007960567,0.7519212,0.0033689179,0.001487877,0.00020940791,0.00065633847,0.0012495188,0.23785135,0.0009239495,0.0000635619,0.0003152167],"about_ca_topic_score_codex":0.0032312393,"about_ca_topic_score_gemma":0.00020520735,"teacher_disagreement_score":0.7287232,"about_ca_system_score_codex":0.0006876141,"about_ca_system_score_gemma":0.0005903593,"threshold_uncertainty_score":0.99995774},"labels":[],"label_agreement":null},{"id":"W4400108894","doi":"10.1200/jco.2024.42.16_suppl.4529","title":"First-line systemic therapy following adjuvant immunotherapy in renal cell carcinoma (RCC): An international multi-center study.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Systemic therapy; Immunotherapy; Adjuvant; Oncology; Internal medicine; Adjuvant therapy; Center (category theory); Cancer","score_opus":0.1452255188867837,"score_gpt":0.45703598364372494,"score_spread":0.31181046475694124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400108894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861705,0.0063073044,0.00020613529,0.0014990179,0.0046058097,0.0006501132,0.00000487504,0.000023678449,0.00053260097],"genre_scores_gemma":[0.99412197,0.001854903,0.0014902625,0.0005752908,0.0015134957,0.00002024394,0.000008886332,0.00005244047,0.00036253824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948491,0.00070024526,0.0030882456,0.00041650125,0.0006333335,0.00031257948],"domain_scores_gemma":[0.99730915,0.0010094842,0.0007685942,0.0003453156,0.0002478218,0.000319637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003624704,0.00027775503,0.0016246533,0.00042952655,0.000036705485,0.000040914183,0.0003680881,0.0003192747,0.00014024628],"category_scores_gemma":[0.00026223026,0.00018338223,0.0009550755,0.00019830976,0.00006746979,0.00027892858,0.00005525387,0.0012728627,0.00003485569],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008751938,0.020887524,0.8004879,0.000066863664,0.0011872551,0.026975837,0.0015860045,0.00013484931,0.0023967186,0.000007682084,0.00020477109,0.13731268],"study_design_scores_gemma":[0.056642614,0.043702044,0.8815725,0.0006179673,0.00026754997,0.0018276458,0.0005940909,0.0021741756,0.00033079533,0.000029017903,0.012013096,0.0002285457],"about_ca_topic_score_codex":0.00008487886,"about_ca_topic_score_gemma":0.00011041149,"teacher_disagreement_score":0.13708413,"about_ca_system_score_codex":0.00070048246,"about_ca_system_score_gemma":0.0010114918,"threshold_uncertainty_score":0.747811},"labels":[],"label_agreement":null},{"id":"W4400186989","doi":"10.1200/jco.2024.42.16_suppl.4538","title":"Efficacy of post-lenvatinib treatments in patients (pts) with advanced renal cell carcinoma (aRCC).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University","funders":"","keywords":"Lenvatinib; Medicine; Internal medicine; Cabozantinib; Renal cell carcinoma; Oncology; Pembrolizumab; Cohort; Sunitinib; Sorafenib; Discontinuation; Cancer; Hepatocellular carcinoma; Immunotherapy","score_opus":0.056500831292173245,"score_gpt":0.3979426933400041,"score_spread":0.34144186204783084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400186989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926012,0.00095591124,0.0000098756855,0.0008550615,0.00057033804,0.00050057797,0.000011800854,0.000009867364,0.004485365],"genre_scores_gemma":[0.9953885,0.00012901533,0.0035205656,0.000263389,0.00027449912,0.0000070689543,0.00002124165,0.000036199126,0.00035949322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958183,0.00034231957,0.0026042918,0.0003236747,0.0006035945,0.00030779332],"domain_scores_gemma":[0.9957721,0.0019248057,0.0011320494,0.00028022716,0.00051132735,0.00037947277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000967928,0.00024613817,0.0016996621,0.00034595648,0.000017793629,0.000007413277,0.00015860506,0.00028917688,0.00012064668],"category_scores_gemma":[0.000700909,0.00014850275,0.0005354154,0.00031190514,0.00018279742,0.00013714023,0.000047134432,0.0008643093,0.00002811102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03472701,0.011258818,0.68117344,0.00019207643,0.00060558383,0.0051471554,0.0003790597,0.00006106757,0.0012133432,0.000023016413,0.00055846194,0.26466098],"study_design_scores_gemma":[0.033381402,0.08690068,0.87339824,0.0003693564,0.00070554356,0.00014409421,0.00006333404,0.00002451246,0.0023027728,0.00002322715,0.0025786753,0.00010814793],"about_ca_topic_score_codex":0.000034072917,"about_ca_topic_score_gemma":0.000019067094,"teacher_disagreement_score":0.26455283,"about_ca_system_score_codex":0.00047306248,"about_ca_system_score_gemma":0.0017912508,"threshold_uncertainty_score":0.6055766},"labels":[],"label_agreement":null},{"id":"W4400300129","doi":"10.7748/ns.39.7.39.s14","title":"HIT lists: tackling the surgery backlog","year":2024,"lang":"en","type":"article","venue":"Nursing Standard","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Computer science","score_opus":0.028475747942360487,"score_gpt":0.3108795049149231,"score_spread":0.28240375697256265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400300129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.860089,0.026520083,0.001722047,0.02872992,0.0035367224,0.00058103714,0.000052411113,0.0005625499,0.07820623],"genre_scores_gemma":[0.996073,0.000112617054,0.00040082715,0.00023745812,0.00054800673,0.0000112713615,0.000022319151,0.000041429168,0.0025530464],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987731,0.000044688077,0.00020950833,0.00026774424,0.00042319088,0.00028176873],"domain_scores_gemma":[0.99917734,0.00030576857,0.000026081778,0.00032465777,0.00006960439,0.00009654869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032687292,0.00014996018,0.00026138904,0.00010082207,0.00012571036,0.00011576112,0.000054232398,0.0000630334,0.00023894919],"category_scores_gemma":[0.00007777142,0.00009101122,0.00020159768,0.00025587605,0.0001355625,0.00005526181,0.000009816439,0.00023662671,0.000106035935],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009897372,0.00017551104,0.0056446046,0.0005324607,0.00042887006,0.0026164383,0.004171383,0.000026922286,0.0040108557,0.0047922656,0.39814734,0.5784636],"study_design_scores_gemma":[0.0015947841,0.001105505,0.023365429,0.013279903,0.001755607,0.0025158895,0.001561,0.0011148748,0.05996826,0.006416597,0.8865285,0.00079367496],"about_ca_topic_score_codex":0.000012322396,"about_ca_topic_score_gemma":0.000001919559,"teacher_disagreement_score":0.5776699,"about_ca_system_score_codex":0.0006904377,"about_ca_system_score_gemma":0.0002868801,"threshold_uncertainty_score":0.371133},"labels":[],"label_agreement":null},{"id":"W4400382954","doi":"10.14740/wjon1866","title":"Comparison of Outcomes Between Partial and Radical Laparoscopic Nephrectomy for Localized Renal Tumors Larger Than Four Centimeters: A Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"World Journal of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Kunming Medical University; National Natural Science Foundation of China","keywords":"Medicine; Centimeter; Nephrectomy; Meta-analysis; Urology; Laparoscopy; Surgery; Kidney; Internal medicine","score_opus":0.19959865702664986,"score_gpt":0.45274502454493765,"score_spread":0.2531463675182878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400382954","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015521287,0.99553436,0.00013717638,0.000984662,0.00009816404,0.0029667036,0.000078846795,0.000009100998,0.00003574891],"genre_scores_gemma":[0.0020684013,0.9929343,0.0034621952,0.00020166172,0.00014403588,0.0002517639,0.000051719704,0.00006331699,0.0008226231],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99360037,0.00124102,0.0038663705,0.00042436822,0.00051570794,0.00035214075],"domain_scores_gemma":[0.99400383,0.0017696747,0.0032503905,0.00039434052,0.00019603375,0.0003857218],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0021453244,0.0006185039,0.026548851,0.0011737056,0.000045074263,0.000033171247,0.000215224,0.0002331972,0.00011551093],"category_scores_gemma":[0.00035002,0.00032106892,0.00515063,0.0007642887,0.00020460239,0.000050394527,0.00010038068,0.00070281944,0.0000047011395],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000700125,0.00019583249,0.0011925336,0.66654354,0.3276257,0.00031520624,0.000050827115,2.4660756e-7,3.6338082e-7,0.000020273188,0.0012825223,0.0027029554],"study_design_scores_gemma":[0.0011618491,0.0011748391,0.000040423496,0.036144417,0.83008814,0.0005628988,0.0000097396705,0.000005177207,0.0000039486576,0.000013273689,0.13062412,0.00017119145],"about_ca_topic_score_codex":0.000009666511,"about_ca_topic_score_gemma":0.000028161476,"teacher_disagreement_score":0.6303991,"about_ca_system_score_codex":0.00029759418,"about_ca_system_score_gemma":0.00049699505,"threshold_uncertainty_score":0.9999241},"labels":[],"label_agreement":null},{"id":"W4400443896","doi":"10.1016/j.euo.2024.06.012","title":"Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney: A Report from the International Radiosurgery Oncology Consortium of the Kidney","year":2024,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Juravinski Cancer Centre; McGill University Health Centre; Ottawa Hospital; McMaster University; London Health Sciences Centre","funders":"","keywords":"Medicine; Radiosurgery; Ablative case; Renal cell carcinoma; Renal function; Internal medicine; Oncology; Kidney; Kidney cancer; Radiation therapy; Clear cell renal cell carcinoma; Term (time); Radiology","score_opus":0.018680012198882545,"score_gpt":0.2707078697871421,"score_spread":0.2520278575882596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400443896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977005,0.0010214997,0.0008707291,0.010868085,0.0025929585,0.0015790577,0.00020658904,0.000071149145,0.0057849116],"genre_scores_gemma":[0.9833279,0.00003087708,0.00054704974,0.01342969,0.0006432528,0.00018057215,0.0006287449,0.00010728988,0.0011045861],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961492,0.0011690808,0.0009636595,0.0008286891,0.0004090465,0.00048033602],"domain_scores_gemma":[0.9963719,0.0017386872,0.0006228304,0.0007278001,0.00027364917,0.00026513045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009055479,0.0004276951,0.00084773626,0.0002187334,0.00015353515,0.000024658246,0.00035726195,0.00020940449,0.00029254533],"category_scores_gemma":[0.00036189667,0.00023898395,0.00040905632,0.00018739876,0.00064635795,0.00013267809,0.00026010192,0.0006728817,0.00001930395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0117006665,0.0007926191,0.95881796,0.00008336638,0.002336378,0.0045001674,0.0012012309,0.0000058148626,0.0054842373,0.000014859016,0.012832819,0.0022298773],"study_design_scores_gemma":[0.005999242,0.0040528295,0.9370706,0.00007640717,0.001470551,0.0009623631,0.00002721563,0.000053901786,0.0004065266,0.000028022705,0.049650546,0.0002018047],"about_ca_topic_score_codex":0.000050727405,"about_ca_topic_score_gemma":0.000020939238,"teacher_disagreement_score":0.036817726,"about_ca_system_score_codex":0.001031703,"about_ca_system_score_gemma":0.001623498,"threshold_uncertainty_score":0.9745482},"labels":[],"label_agreement":null},{"id":"W4400560373","doi":"10.1136/bmjonc-2024-000481","title":"Potential of neutrophil-to-eosinophil ratio as a new prognostic tool for patients with advanced renal cell carcinoma receiving first-line immuno-oncology combinations","year":2024,"lang":"en","type":"editorial","venue":"BMJ Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Eosinophil; Renal cell carcinoma; Medicine; Internal medicine; Oncology; Line (geometry); Immunology; Mathematics","score_opus":0.011302455529317438,"score_gpt":0.3010165278733161,"score_spread":0.2897140723439987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400560373","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43758094,0.0013613414,0.0010484712,0.006462087,0.5269837,0.022945618,0.0010799443,0.00021189929,0.0023260005],"genre_scores_gemma":[0.665125,0.00015172298,0.0138803935,0.00030684617,0.2967092,0.0049585486,0.009764053,0.00047949096,0.008624693],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995212,0.00023159297,0.0015072017,0.001222297,0.0010101065,0.0008167728],"domain_scores_gemma":[0.99363685,0.0022105905,0.0010088964,0.00086153095,0.0017809715,0.0005011847],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0003806435,0.0008167894,0.002100353,0.00068604347,0.00018643789,0.000039616494,0.00039164547,0.0014081362,0.000095138654],"category_scores_gemma":[0.0022605592,0.00068982254,0.00044840574,0.00051829155,0.00019238917,0.00010355786,0.000274945,0.0009814346,0.000089654386],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017340237,0.0047035445,0.0010355621,0.0020461152,0.00075765303,0.0012243453,0.0006894709,0.00050846935,0.0020406267,0.00005884643,0.9587647,0.010830449],"study_design_scores_gemma":[0.041377626,0.14043076,0.009375489,0.0012805853,0.0059656044,0.00018312091,0.000077055316,0.00014363053,0.0016001249,0.00036124073,0.7981178,0.0010869526],"about_ca_topic_score_codex":0.00021918029,"about_ca_topic_score_gemma":0.00017815192,"teacher_disagreement_score":0.23027448,"about_ca_system_score_codex":0.0020187658,"about_ca_system_score_gemma":0.00997804,"threshold_uncertainty_score":0.99988824},"labels":[],"label_agreement":null},{"id":"W4400567199","doi":"10.21037/tau-24-20","title":"Combination of PARP and DNA methylation inhibitors as a potential personalized therapy for SETD2-mutated clear-cell renal cancers","year":2024,"lang":"en","type":"letter","venue":"Translational Andrology and Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"DNA methylation; Methylation; DNA; Poly ADP ribose polymerase; Cancer research; Cell; Bioinformatics; Genetics; Computational biology; Biology; Medicine; Gene; Gene expression","score_opus":0.016136227514663478,"score_gpt":0.26148035943175096,"score_spread":0.24534413191708748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400567199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6446536,0.013135545,0.00037067343,0.33982575,0.00029858114,0.001153521,0.00018181477,0.000038924623,0.00034157565],"genre_scores_gemma":[0.94207615,0.0008884005,0.00020050579,0.052634515,0.0005366912,0.00012035745,0.0027560433,0.000048882746,0.0007384603],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984412,0.00017999565,0.00040561793,0.0005087849,0.00020918266,0.000255197],"domain_scores_gemma":[0.9992474,0.00029298125,0.00016685892,0.000096823576,0.00013554744,0.00006039225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020912764,0.00029035864,0.00058641244,0.00028370612,0.00008532459,0.000009241864,0.000040154366,0.0009163634,0.00013607407],"category_scores_gemma":[0.000009085623,0.00024520024,0.00017330935,0.00009313728,0.00042708212,0.00004285816,0.000009829434,0.00058884674,0.0000043372834],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18499051,0.0019772328,0.012148861,0.008803057,0.017088462,0.005158732,0.015361591,0.001142657,0.21870925,0.010367947,0.47136518,0.052886516],"study_design_scores_gemma":[0.06507553,0.036643114,0.035568006,0.00017592666,0.0068674176,0.0042221216,0.000067854206,0.015226011,0.015581551,0.07185763,0.7471412,0.0015736462],"about_ca_topic_score_codex":0.000059838232,"about_ca_topic_score_gemma":0.000008291213,"teacher_disagreement_score":0.29742253,"about_ca_system_score_codex":0.00003122065,"about_ca_system_score_gemma":0.00023515215,"threshold_uncertainty_score":0.9998976},"labels":[],"label_agreement":null},{"id":"W4400582339","doi":"10.1007/s00428-024-03865-x","title":"Contemporary review of papillary renal cell carcinoma—current state and future directions","year":2024,"lang":"en","type":"review","venue":"Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health; Ontario Institute for Cancer Research; Calgary Laboratory Services; University of Toronto; University of Calgary; St. Michael's Hospital","funders":"Ontario Institute for Cancer Research","keywords":"Papillary renal cell carcinomas; Renal cell carcinoma; Carcinoma; Pathology; State (computer science); Current (fluid); Medicine; Computer science; Physics","score_opus":0.06942613881034725,"score_gpt":0.38935999217518064,"score_spread":0.3199338533648334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400582339","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011632325,0.9810039,0.000017894492,0.00057680695,0.0012781889,0.0037646305,0.00079388515,0.00021660006,0.01118489],"genre_scores_gemma":[0.0019015656,0.9917964,0.00081033993,0.0005106412,0.0013736491,0.0004127584,0.0022879746,0.00022407378,0.0006826462],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99143666,0.001595879,0.0028752727,0.0021523582,0.0008987171,0.0010411163],"domain_scores_gemma":[0.9942427,0.0012312083,0.0015043312,0.0020005065,0.00025216767,0.0007690577],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0015469666,0.0018868034,0.006610203,0.0008565301,0.00020296479,0.000038050148,0.00070082064,0.00061306485,0.000094052055],"category_scores_gemma":[0.00037440422,0.0011606779,0.0019660306,0.0011801214,0.0014270827,0.00012088835,0.0008864903,0.0033939404,0.00019807188],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013346378,0.00050860055,0.000052950592,0.2257798,0.0011468402,0.0016395134,0.00022324131,1.6652471e-7,0.000111755755,0.00009252164,0.021608498,0.74870265],"study_design_scores_gemma":[0.0010549461,0.0018971447,0.00045011597,0.08155515,0.012464305,0.00031840018,0.000073971656,0.0000069145935,0.0001317884,0.00036621979,0.9007806,0.0009004122],"about_ca_topic_score_codex":0.000056814097,"about_ca_topic_score_gemma":0.0000027794806,"teacher_disagreement_score":0.87917215,"about_ca_system_score_codex":0.0002093253,"about_ca_system_score_gemma":0.0024556906,"threshold_uncertainty_score":0.9993876},"labels":[],"label_agreement":null},{"id":"W4400646099","doi":"10.1016/j.prro.2024.06.012","title":"Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: A Case-Based Radiosurgery Society Practice Guide","year":2024,"lang":"en","type":"review","venue":"Practical Radiation Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre; University of Toronto; McMaster University; London Health Sciences Centre","funders":"National Cancer Institute","keywords":"Medicine; Radiosurgery; Renal cell carcinoma; Radiation therapy; Medical physics; Primary (astronomy); Radiology; Oncology","score_opus":0.07469080989683412,"score_gpt":0.4208988676823671,"score_spread":0.346208057785533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400646099","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010089942,0.97929585,0.0010388686,0.005832444,0.0014873459,0.0066521806,0.00016424942,0.0002129372,0.005215204],"genre_scores_gemma":[0.00054117636,0.97472507,0.01223441,0.003392487,0.0022746753,0.0027539565,0.002385624,0.0003075472,0.0013850555],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.993104,0.0016762826,0.0020770512,0.001496198,0.0007603514,0.0008861228],"domain_scores_gemma":[0.9797185,0.016332932,0.0019271274,0.0009306865,0.0004905836,0.0006001732],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002647919,0.0010493377,0.0032126904,0.000533678,0.00025605602,0.00016816412,0.00016343246,0.0015016707,0.0001648361],"category_scores_gemma":[0.002712093,0.0008352056,0.002337906,0.00074431964,0.00015678255,0.00052032224,0.00006861352,0.0017634893,0.00033235786],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0012344251,0.002345248,0.000022867915,0.016248748,0.001898471,0.012414654,0.00018038586,0.0000021473643,0.000024736135,0.0001359173,0.113657184,0.8518352],"study_design_scores_gemma":[0.0041541434,0.0033607313,0.000038759983,0.0005568458,0.017567826,0.022568785,0.000038867875,0.00046891693,0.000046464367,0.000014741793,0.95056057,0.00062335876],"about_ca_topic_score_codex":0.00007352833,"about_ca_topic_score_gemma":0.0000022340491,"teacher_disagreement_score":0.85121185,"about_ca_system_score_codex":0.0077359607,"about_ca_system_score_gemma":0.013078104,"threshold_uncertainty_score":0.9997946},"labels":[],"label_agreement":null},{"id":"W4401078258","doi":"10.1158/1055-9965.epi-24-0306","title":"Radiodensities of Skeletal Muscle and Visceral Adipose Tissues Are Prognostic Factors in Clear-Cell Renal Cell Carcinoma","year":2024,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Cancer Institute; Memorial Sloan-Kettering Cancer Center","keywords":"Adipose tissue; Renal cell carcinoma; Skeletal muscle; Medicine; Carcinoma; Pathology; Cell; Clear cell renal cell carcinoma; Internal medicine; Oncology; Biology","score_opus":0.03966000105019105,"score_gpt":0.3186691509520757,"score_spread":0.27900914990188463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401078258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90617526,0.091764465,0.00008199695,0.00059256353,0.000337282,0.0006971072,0.000025778125,0.00005297184,0.0002725805],"genre_scores_gemma":[0.9969156,0.000955284,0.00061836955,0.000050304512,0.000111910194,0.00008925764,0.0001169693,0.000038310347,0.0011039888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976086,0.00054071937,0.00068611937,0.00061143463,0.00013445521,0.00041869588],"domain_scores_gemma":[0.99876016,0.00054167496,0.0002315274,0.0002472852,0.00005612925,0.00016319523],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070818176,0.00029877256,0.00075055065,0.0003133467,0.000044956174,0.00000961867,0.0000716095,0.0002446876,0.0001196181],"category_scores_gemma":[0.00012220627,0.00024787738,0.00024290603,0.00021281691,0.00031363277,0.00011637712,0.000057338206,0.00025285003,0.000008707767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003677608,0.00019975081,0.96413934,0.0016345053,0.00025263522,0.00023619241,0.00068684516,0.000017384466,0.021894218,0.00003935192,0.0018600711,0.008671924],"study_design_scores_gemma":[0.0011989722,0.0009931449,0.97955585,0.00085390883,0.0005266459,0.000039798775,0.0003772255,0.0008802942,0.01424957,0.00043145355,0.00068178144,0.00021137141],"about_ca_topic_score_codex":0.0008660104,"about_ca_topic_score_gemma":0.00021773082,"teacher_disagreement_score":0.09080918,"about_ca_system_score_codex":0.0003168161,"about_ca_system_score_gemma":0.0001596677,"threshold_uncertainty_score":0.9999973},"labels":[],"label_agreement":null},{"id":"W4401208972","doi":"10.1200/po.24.00094","title":"Germline Susceptibility to Renal Cell Carcinoma and Implications for Genetic Screening","year":2024,"lang":"en","type":"article","venue":"JCO Precision Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre; University of Ottawa; McGill University","funders":"","keywords":"Germline; Renal cell carcinoma; Medicine; Genetic predisposition; Oncology; Internal medicine; CHEK2; Odds ratio; Genetic testing; BAP1; Cancer; Kidney cancer; Germline mutation; Clear cell renal cell carcinoma; Biology; Genetics; Gene; Mutation","score_opus":0.05107389019641016,"score_gpt":0.3599442137011169,"score_spread":0.3088703235047067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401208972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95835286,0.002517122,0.029362526,0.006267223,0.0001857995,0.0015807482,0.000049831473,0.00008202485,0.0016018875],"genre_scores_gemma":[0.9054967,0.00004075597,0.09182622,0.00038596796,0.0002702252,0.00028487513,0.000045564855,0.00003092892,0.0016187313],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99849075,0.0000665521,0.0003900526,0.0006357082,0.00012628676,0.0002906783],"domain_scores_gemma":[0.9983079,0.0007400264,0.000044071352,0.00044332398,0.00014867852,0.00031602976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034313675,0.00017253,0.00035493454,0.00020472387,0.00009257344,0.000029393681,0.00008631526,0.00015973915,0.00010845666],"category_scores_gemma":[0.00013325295,0.00013755442,0.00012950202,0.00020687692,0.000056217545,0.000036974834,0.000114775976,0.00015251216,0.000052529726],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010673001,0.0003741411,0.053944204,0.00026077827,0.000060101214,0.00013190822,0.00057110115,0.000059573,0.20695151,0.00022524962,0.019211054,0.71714306],"study_design_scores_gemma":[0.001596222,0.0049481303,0.8660266,0.00006159153,0.00026203177,0.00035200123,0.000045881723,0.0011798326,0.012534795,0.0008816979,0.11193947,0.00017178159],"about_ca_topic_score_codex":0.000036449965,"about_ca_topic_score_gemma":0.000052327086,"teacher_disagreement_score":0.81208235,"about_ca_system_score_codex":0.0002989709,"about_ca_system_score_gemma":0.00022258803,"threshold_uncertainty_score":0.5609306},"labels":[],"label_agreement":null},{"id":"W4401252649","doi":"10.3233/kca-240005","title":"Real-World Outcomes in Patients with Advanced/Metastatic Renal Cell Carcinoma Receiving Cabozantinib or Other Tyrosine Kinase Inhibitors After Checkpoint Inhibitor-Based Therapy","year":2024,"lang":"en","type":"article","venue":"Kidney Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Calgary","funders":"Ipsen","keywords":"Cabozantinib; Renal cell carcinoma; Medicine; Tyrosine-kinase inhibitor; Tyrosine kinase; Oncology; Internal medicine; Cancer research; Cancer; Receptor","score_opus":0.016508258337435484,"score_gpt":0.2769879987711579,"score_spread":0.2604797404337224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401252649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99206674,0.0026723675,0.000010306395,0.0012736833,0.0006065361,0.0016086386,0.00023809112,0.00013813064,0.0013855282],"genre_scores_gemma":[0.990788,0.000136321,0.0013411208,0.0015171312,0.0002264734,0.0007616643,0.00008821243,0.00019566219,0.0049454034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99701667,0.000101435195,0.00066722045,0.0008474827,0.000709844,0.0006573636],"domain_scores_gemma":[0.99850273,0.00011639143,0.00015479591,0.0005798208,0.00015094934,0.0004953207],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001881277,0.0006039942,0.0007597705,0.00054977037,0.000055937773,0.00007376978,0.000109037224,0.00008749072,0.0014765563],"category_scores_gemma":[0.000039524977,0.00037234413,0.000209188,0.0008827968,0.00011745139,0.00021319857,0.00003978246,0.00040555917,0.00004839484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058176364,0.000909731,0.97761697,0.00070711516,0.00013617681,0.00092355907,0.00063712534,0.000063743086,0.004138113,0.0000027008077,0.0023983591,0.0066487473],"study_design_scores_gemma":[0.01459476,0.0018292969,0.8464799,0.0030405135,0.00023189788,0.0000036795477,0.000047140667,0.00010438556,0.122756526,0.000007423117,0.010306652,0.0005978385],"about_ca_topic_score_codex":0.0016628595,"about_ca_topic_score_gemma":0.00086667866,"teacher_disagreement_score":0.1311371,"about_ca_system_score_codex":0.00092937046,"about_ca_system_score_gemma":0.0012234004,"threshold_uncertainty_score":0.99987286},"labels":[],"label_agreement":null},{"id":"W4401305294","doi":"10.1016/j.annonc.2024.07.727","title":"Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trial","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Cilag; University of Texas MD Anderson Cancer Center; EMD Serono; Genentech; Astellas Pharma; Eisai; European Society for Medical Oncology; European Association of Urology; Seagen; Advanced Accelerator Applications; National Institutes of Health; CVS Health; Amgen; Deciphera Pharmaceuticals; Jounce Therapeutics; Ono Pharmaceutical; Eli Lilly and Company; National Comprehensive Cancer Network; Merck KGaA; Endocyte; Nihon Pharmaceutical; PTC Therapeutics; BioCryst; Ipsen; Array BioPharma; Daiichi Sankyo Europe; National Cancer Institute; Calithera Biosciences; Gilead Sciences; Revolution Medicines; Exelixis; Sanofi; Memorial Sloan-Kettering Cancer Center; Dana-Farber/Harvard Cancer Center; Bristol-Myers Squibb; EUSA Pharma; AstraZeneca; American Society of Clinical Oncology; Coherus Biosciences; Arrowhead Pharmaceuticals; GlaxoSmithKline; Dana-Farber Cancer Institute; Incyte; Pfizer","keywords":"Medicine; Sunitinib; Ipilimumab; Nivolumab; Renal cell carcinoma; Internal medicine; Oncology; Urology; Immunotherapy; Cancer","score_opus":0.11061446975755834,"score_gpt":0.3866629650592868,"score_spread":0.2760484953017285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401305294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98647946,0.004695525,0.00002764423,0.0019372972,0.00070883706,0.0026046133,0.0013297182,0.000028391734,0.0021884986],"genre_scores_gemma":[0.996089,0.0015483983,0.00050461135,0.00003217725,0.000335157,0.0001326543,0.0006321923,0.00003988686,0.00068594405],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975674,0.00015753508,0.001114848,0.0005146683,0.00028032513,0.0003652306],"domain_scores_gemma":[0.99571615,0.0027759983,0.00046570567,0.00057926425,0.00030788127,0.0001549708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041310946,0.00032036655,0.0012727289,0.00013511657,0.00007685626,0.0000068680856,0.0001435024,0.00020686543,0.00005317498],"category_scores_gemma":[0.0002753168,0.0002173448,0.0004340228,0.00020029623,0.00029262304,0.000055750053,0.00006138807,0.00012745538,0.000003272761],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8905522,0.003073503,0.000011354554,0.00021946488,0.0007690537,0.00015315699,0.0029947439,0.000051744777,0.010334711,0.00010847372,0.0012585954,0.09047296],"study_design_scores_gemma":[0.6892043,0.12387899,0.0010593596,0.0001698409,0.0014373744,0.000013223843,0.0006758595,0.00032793844,0.15847954,0.00010899072,0.024471045,0.00017356288],"about_ca_topic_score_codex":0.0005541436,"about_ca_topic_score_gemma":0.00025105666,"teacher_disagreement_score":0.20134798,"about_ca_system_score_codex":0.00021716836,"about_ca_system_score_gemma":0.00062948687,"threshold_uncertainty_score":0.8863064},"labels":[],"label_agreement":null},{"id":"W4401363791","doi":"10.1093/oncolo/oyae181.013","title":"20 Evaluating intermediate endpoints for overall survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors: an IMDC study","year":2024,"lang":"en","type":"article","venue":"The Oncologist","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Dalhousie University; Baker Hughes (Canada)","funders":"","keywords":"Medicine; Clinical endpoint; Renal cell carcinoma; Internal medicine; Oncology; Cohort; Proportional hazards model; Clinical trial","score_opus":0.07293113190360824,"score_gpt":0.35448449782588676,"score_spread":0.28155336592227853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401363791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930753,0.0006665397,0.00004129513,0.0005042258,0.0002481491,0.0037962054,0.000040245224,0.00011754641,0.0015105034],"genre_scores_gemma":[0.99666005,0.000007755755,0.00071168994,0.00005113462,0.00025675283,0.00072528055,0.00016159935,0.00007741835,0.0013483046],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969912,0.0005715367,0.0007658685,0.00064145843,0.0005083823,0.0005215642],"domain_scores_gemma":[0.9983247,0.0005868492,0.00018804848,0.00062193203,0.00012561765,0.00015283277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022796297,0.00040766632,0.000741885,0.00020696879,0.00011150611,0.000092632334,0.00022890982,0.00007027401,0.00007871489],"category_scores_gemma":[0.00012896811,0.00022515301,0.0001931701,0.00034173983,0.00019930153,0.00013601335,0.0001080441,0.00042193904,0.000034015553],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04563542,0.02163951,0.29069135,0.0028254616,0.0028912902,0.020320611,0.043936413,0.0017714396,0.53183943,0.0001678667,0.0013291654,0.036952037],"study_design_scores_gemma":[0.036401756,0.092972524,0.6710734,0.00080061797,0.0039977557,0.00041154397,0.014586502,0.018167041,0.15986368,0.0003915621,0.0003153632,0.0010183054],"about_ca_topic_score_codex":0.0018379778,"about_ca_topic_score_gemma":0.0014051414,"teacher_disagreement_score":0.380382,"about_ca_system_score_codex":0.00094614,"about_ca_system_score_gemma":0.00043604223,"threshold_uncertainty_score":0.9181473},"labels":[],"label_agreement":null},{"id":"W4401363835","doi":"10.1093/oncolo/oyae181.036","title":"35 Efficacy of treatments post-lenvatinib in patients with advanced renal cell carcinoma (aRCC)","year":2024,"lang":"en","type":"article","venue":"The Oncologist","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; Baker Hughes (Canada); University of Calgary","funders":"","keywords":"Lenvatinib; Medicine; Cabozantinib; Internal medicine; Renal cell carcinoma; Oncology; Cohort; Pembrolizumab; Discontinuation; Sorafenib; Cancer; Hepatocellular carcinoma; Immunotherapy","score_opus":0.015138111206525359,"score_gpt":0.2673251085670865,"score_spread":0.25218699736056116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401363835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854189,0.0007476309,0.000002846944,0.00040088512,0.000103242695,0.001212724,0.000038703667,0.000049113816,0.012025946],"genre_scores_gemma":[0.9978474,0.000017070297,0.00048387484,0.00009432295,0.000042919768,0.00007228942,0.00014404593,0.0000347483,0.0012633455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985867,0.0000752453,0.0003434871,0.000345907,0.00035134837,0.0002973006],"domain_scores_gemma":[0.9990057,0.00024687476,0.00010389244,0.00046947366,0.000085896594,0.00008818566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013860976,0.00023811175,0.00040133458,0.00012947794,0.000044301432,0.000012836931,0.00014390297,0.00007573218,0.00008181796],"category_scores_gemma":[0.000035164114,0.00012370694,0.00010975982,0.00034290622,0.00021143685,0.0000560435,0.000057661375,0.00021454596,0.00005414051],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01270551,0.006081649,0.9011425,0.00046459114,0.00037186922,0.0013443064,0.0024166794,0.00023995343,0.011016945,0.00016336139,0.0007729565,0.063279696],"study_design_scores_gemma":[0.008699314,0.00952275,0.9663452,0.00018771892,0.0002963586,0.000013080237,0.00011994529,0.00003377668,0.014228596,0.000016206868,0.00041229968,0.0001247685],"about_ca_topic_score_codex":0.00023084487,"about_ca_topic_score_gemma":0.000044459204,"teacher_disagreement_score":0.0652027,"about_ca_system_score_codex":0.0005052388,"about_ca_system_score_gemma":0.00024076301,"threshold_uncertainty_score":0.5044623},"labels":[],"label_agreement":null},{"id":"W4401364054","doi":"10.1093/oncolo/oyae181.026","title":"8 Nivolumab plus ipilimumab vs sunitinib for first-line treatment of advanced renal cell carcinoma: 8-year follow-up with analyses in favorable risk patients from the phase 3 CheckMate 214 trial","year":2024,"lang":"en","type":"article","venue":"The Oncologist","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Nivolumab; Ipilimumab; Sunitinib; Renal cell carcinoma; Medicine; Internal medicine; Oncology; Phases of clinical research; Clinical trial; Immunotherapy; Cancer","score_opus":0.07148638069975227,"score_gpt":0.3484030131394102,"score_spread":0.2769166324396579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401364054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99092555,0.002124683,0.00007939475,0.00050791557,0.00036461095,0.004034341,0.000855329,0.00005980476,0.0010483636],"genre_scores_gemma":[0.9958258,0.00031374203,0.00049937266,0.000037880018,0.0002910149,0.00070818985,0.0006637903,0.00005691838,0.0016032478],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977667,0.00023465011,0.0006359862,0.000530808,0.00039330317,0.00043857787],"domain_scores_gemma":[0.997358,0.0013097879,0.0003193891,0.0007492171,0.00015400749,0.00010960272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031530357,0.00039743088,0.000895289,0.000110962974,0.00020692506,0.00004263851,0.00024169721,0.000118131764,0.000087656976],"category_scores_gemma":[0.00013765725,0.00018739061,0.00036208017,0.00041738828,0.00027955466,0.00007504169,0.00005367382,0.00021590544,0.000019801735],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90770024,0.012118574,0.022025304,0.00040887794,0.0018465865,0.0006227963,0.008845437,0.0038267847,0.0031364711,0.00005844851,0.002369104,0.037041403],"study_design_scores_gemma":[0.78053266,0.1141077,0.022424476,0.00039200662,0.0060223304,0.000012548449,0.0030788798,0.004364056,0.05855854,0.00029379097,0.009650176,0.0005628513],"about_ca_topic_score_codex":0.004927036,"about_ca_topic_score_gemma":0.0035797236,"teacher_disagreement_score":0.12716757,"about_ca_system_score_codex":0.001192109,"about_ca_system_score_gemma":0.00054692366,"threshold_uncertainty_score":0.76415676},"labels":[],"label_agreement":null},{"id":"W4401380032","doi":"10.1093/oncolo/oyae181.027","title":"9 Delving into molecular underpinnings of sarcomatoid/rhabdoid dedifferentioation in renal cancers using spatial profiling","year":2024,"lang":"en","type":"article","venue":"The Oncologist","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Transcriptome; Phenotype; Biology; Clear cell renal cell carcinoma; Renal cell carcinoma; Computational biology; Exome; Pathology; Exome sequencing; Bioinformatics; Medicine; Gene; Genetics; Gene expression","score_opus":0.03754108721285215,"score_gpt":0.3317309242573873,"score_spread":0.29418983704453516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401380032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872805,0.0019649614,0.008416423,0.00057360565,0.00017355128,0.0004813509,0.0000016518898,0.00004933992,0.0010586183],"genre_scores_gemma":[0.9957116,0.00003219859,0.0039950297,0.00006654561,0.00008425709,0.000027368309,0.000015882557,0.000022257334,0.00004484566],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887806,0.00009582564,0.00033584618,0.00022808842,0.00026257738,0.00019961447],"domain_scores_gemma":[0.9994934,0.00011071408,0.00009398911,0.0002050348,0.000051989267,0.00004483178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033962,0.00013926072,0.00026380672,0.00015429936,0.000053589793,0.000023142893,0.0000930414,0.00007850589,0.000023655644],"category_scores_gemma":[0.00007783951,0.0000942368,0.000094833005,0.00029333046,0.00017280929,0.00004811136,0.000061709594,0.00021796006,0.000004549752],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032007406,0.00010805187,0.029414354,0.0006109015,0.000160072,0.0005864907,0.0014010795,0.0025972526,0.9511448,0.0012703283,0.00003576897,0.012350798],"study_design_scores_gemma":[0.0022092632,0.0011664685,0.04168206,0.002121956,0.00058228243,0.00030284617,0.00113554,0.13706984,0.80968064,0.0035749911,0.0001419816,0.00033210844],"about_ca_topic_score_codex":0.005258184,"about_ca_topic_score_gemma":0.00054100575,"teacher_disagreement_score":0.14146417,"about_ca_system_score_codex":0.0015622386,"about_ca_system_score_gemma":0.00046870307,"threshold_uncertainty_score":0.7948836},"labels":[],"label_agreement":null},{"id":"W4401528239","doi":"10.1101/2024.08.12.607453","title":"Urinary multi-omics reveal non-invasive diagnostic biomarkers in clear cell renal cell carcinoma","year":2024,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Clear cell renal cell carcinoma; Urinary system; Renal cell carcinoma; Medicine; Urine; Lipocalin; Urinalysis; Biomarker; Diagnostic biomarker; Metabolomics; Malignancy; Proteomics; Receiver operating characteristic; Internal medicine; Bioinformatics; Biology; Cancer; Biochemistry","score_opus":0.016328359735587154,"score_gpt":0.22590905473483647,"score_spread":0.2095806949992493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401528239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843167,0.0098049855,0.000049744882,0.00030134284,0.0015165772,0.003099689,0.00041168506,0.00034171072,0.00015758618],"genre_scores_gemma":[0.9894719,0.00079571165,0.0076695755,0.00022090589,0.0006579496,0.0006176983,0.000005928718,0.00047435673,0.00008594979],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99405724,0.00025116108,0.0012723089,0.0023978439,0.00076544477,0.0012560046],"domain_scores_gemma":[0.99539983,0.00047864698,0.0005178142,0.0023217278,0.00041612866,0.0008658701],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00068620057,0.0013768097,0.0015045457,0.0011391643,0.00012560595,0.00018644855,0.0006309019,0.0011668252,0.00005340003],"category_scores_gemma":[0.0003661816,0.0014079288,0.000617687,0.00096641376,0.00024967053,0.00009832433,0.0014765523,0.0023755957,0.00069607113],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006518419,0.0020366774,0.103216216,0.0077823773,0.00045929608,0.023820193,0.00009829904,0.00009680668,0.8598642,0.0000105675235,0.0019612247,0.0000023561818],"study_design_scores_gemma":[0.0033468655,0.0007997763,0.39453858,0.0019353649,0.000983641,8.64389e-7,0.00001996395,0.00058908266,0.5963669,0.0000017996351,0.00028099856,0.0011361646],"about_ca_topic_score_codex":0.00045441862,"about_ca_topic_score_gemma":0.0000105194595,"teacher_disagreement_score":0.29132235,"about_ca_system_score_codex":0.0022471328,"about_ca_system_score_gemma":0.00266538,"threshold_uncertainty_score":0.999926},"labels":[],"label_agreement":null},{"id":"W4401557101","doi":"10.1093/ndt/gfae184","title":"Immune checkpoint inhibitor–associated nephritis—treatment standard","year":2024,"lang":"en","type":"review","venue":"Nephrology Dialysis Transplantation","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Center for Clinical and Translational Science, Mayo Clinic","keywords":"Medicine; Acute kidney injury; Discontinuation; Lupus nephritis; Internal medicine; Adverse effect; Nephritis; Intensive care medicine; Oncology; Disease","score_opus":0.029293680966570125,"score_gpt":0.30468985845845725,"score_spread":0.2753961774918871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401557101","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032703658,0.9916225,0.000046087822,0.00018070052,0.00054057187,0.0021974922,0.00076840696,0.0003731806,0.0010007101],"genre_scores_gemma":[0.0023269926,0.9819876,0.00018536877,0.00008769666,0.00050541596,0.0008929291,0.012956301,0.00018372195,0.0008739621],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956402,0.00046638158,0.0016251819,0.0010862285,0.0005435631,0.0006384181],"domain_scores_gemma":[0.9982714,0.00023550275,0.00047541808,0.0006365597,0.00013764424,0.00024348027],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034603025,0.0010677461,0.0041779885,0.00086213596,0.00013327487,0.00007173834,0.00014792889,0.0011368751,0.00022260995],"category_scores_gemma":[0.000024796182,0.0007812019,0.0025643131,0.00083685626,0.00015865639,0.000088062334,0.000023428725,0.0006575833,0.0009822707],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007507975,0.00062986626,0.000043020616,0.023580318,0.012783781,0.0055029774,0.000874858,0.000003931207,0.000250784,0.000052027317,0.00045996223,0.9550677],"study_design_scores_gemma":[0.004070364,0.002760668,0.00030851972,0.011936863,0.13689797,0.0015149656,0.000020057469,0.000010541174,0.00041977552,0.000074127674,0.84121394,0.0007721916],"about_ca_topic_score_codex":0.00015793112,"about_ca_topic_score_gemma":0.00021717655,"teacher_disagreement_score":0.95429546,"about_ca_system_score_codex":0.0019031567,"about_ca_system_score_gemma":0.00080254214,"threshold_uncertainty_score":0.99979556},"labels":[],"label_agreement":null},{"id":"W4401623703","doi":"10.1016/j.eururo.2024.07.016","title":"First-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter Study","year":2024,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; London Health Sciences Centre; University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Pembrolizumab; Adjuvant; Oncology; Systemic therapy; Immunotherapy; Internal medicine; Adjuvant therapy; Carcinoma; Kidney cancer; Chemotherapy; Cancer","score_opus":0.025422851641305037,"score_gpt":0.28024148213253935,"score_spread":0.2548186304912343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401623703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858243,0.006423059,0.00008967194,0.0003781034,0.0011811323,0.00089736475,0.000005949231,0.00013443938,0.0050660153],"genre_scores_gemma":[0.9979899,0.0001886614,0.000099812336,0.0004546075,0.0004137071,0.00003784309,0.00005115321,0.000108066655,0.00065627677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770945,0.00054393435,0.0005110154,0.0006315645,0.00026771455,0.00033633466],"domain_scores_gemma":[0.9991783,0.00010092293,0.000064672255,0.00050676626,0.000042131946,0.00010721481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005889523,0.00028278277,0.00037430192,0.00034420082,0.00004748818,0.000049313534,0.00026566128,0.00005315174,0.00017499685],"category_scores_gemma":[0.00001729591,0.00022025747,0.0001815731,0.00016248315,0.00003452672,0.00012480108,0.0000728116,0.00036041212,0.00029535923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004186354,0.0046964535,0.83922184,0.00012256016,0.0007650251,0.054253824,0.014791033,0.00071354967,0.058284108,0.00003206778,0.00018191547,0.022751253],"study_design_scores_gemma":[0.013691542,0.006762909,0.96629494,0.00010161203,0.00013221326,0.0004122245,0.0003862535,0.003459782,0.0011579022,0.00000682693,0.007286755,0.00030706124],"about_ca_topic_score_codex":0.00009835432,"about_ca_topic_score_gemma":0.000033013086,"teacher_disagreement_score":0.12707306,"about_ca_system_score_codex":0.00018527835,"about_ca_system_score_gemma":0.00004928395,"threshold_uncertainty_score":0.8981839},"labels":[],"label_agreement":null},{"id":"W4401694632","doi":"10.3390/curroncol31080351","title":"Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McMaster University; University of Manitoba; Juravinski Cancer Centre; McGill University Health Centre; University of Ottawa; Hôtel-Dieu de Québec; BC Cancer Agency; Centre hospitalier universitaire de Québec; Princess Margaret Cancer Centre; University of Calgary; Sunnybrook Health Science Centre; Université Laval; University of Alberta; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Hazard ratio; Renal cell carcinoma; Internal medicine; Nephrectomy; Proportional hazards model; Confidence interval; Kidney cancer; Immunotherapy; Oncology; Database; Performance status; Cancer; Kidney","score_opus":0.23037976970203136,"score_gpt":0.45048827755110216,"score_spread":0.2201085078490708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401694632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885864,0.00849999,0.000026211312,0.00027722976,0.0004697669,0.0005519503,0.0010224713,0.000013831255,0.0005521049],"genre_scores_gemma":[0.9977674,0.00077099603,0.0005864588,0.00001277544,0.00010099513,0.00002324775,0.0006761933,0.000027680306,0.000034285145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817705,0.0003477095,0.0004977995,0.00047551972,0.00026061502,0.00024128852],"domain_scores_gemma":[0.9970746,0.0017324453,0.00019023765,0.0008698879,0.000053895877,0.00007894785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050947425,0.0002455702,0.00083181483,0.00026417346,0.000024356956,0.000010219588,0.00024670712,0.000034269884,0.00011545408],"category_scores_gemma":[0.000076645745,0.00014273889,0.00013814779,0.00034825737,0.0002568383,0.0000928323,0.00018179296,0.0003548343,0.0000052271084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021271799,0.0015928367,0.9114795,0.00023740035,0.0007334254,0.0002737735,0.0027246852,0.000011328799,0.01399064,0.00009303023,0.001922749,0.06481348],"study_design_scores_gemma":[0.0033622023,0.0017064923,0.9872964,0.0002683566,0.0005250811,0.000014240762,0.00036480403,0.0007545125,0.0042715706,0.00006370716,0.0012407585,0.00013189072],"about_ca_topic_score_codex":0.0065478296,"about_ca_topic_score_gemma":0.00086303044,"teacher_disagreement_score":0.075816914,"about_ca_system_score_codex":0.00042034342,"about_ca_system_score_gemma":0.00050117675,"threshold_uncertainty_score":0.9898403},"labels":[],"label_agreement":null},{"id":"W4401892126","doi":"10.1002/jso.27795","title":"Effect of race/ethnicity on survival in surgically treated intermediate/high risk non‐metastatic clear cell renal carcinoma","year":2024,"lang":"en","type":"article","venue":"Journal of Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Pacific islanders; Renal cell carcinoma; Nephrectomy; Hazard ratio; Population; Internal medicine; Confidence interval; Surgery; Oncology; Urology; Kidney","score_opus":0.016825277691853973,"score_gpt":0.3092357900646548,"score_spread":0.2924105123728008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401892126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917822,0.0010438428,0.000016527707,0.0005291186,0.0006938931,0.00045778952,0.000021449998,0.00001937346,0.0054358183],"genre_scores_gemma":[0.9976425,0.0013856078,0.00014115624,0.000026989466,0.00033785548,0.000010320183,0.00001371282,0.000046790967,0.0003950725],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99499595,0.0018438441,0.0015571543,0.00038804376,0.0007372693,0.0004777614],"domain_scores_gemma":[0.99346536,0.0049944757,0.00062985404,0.0002728716,0.00020400004,0.00043345153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003201172,0.0003875386,0.0021152664,0.0007327988,0.000030590985,0.000018368444,0.00020207436,0.00029421094,0.00042614623],"category_scores_gemma":[0.00018380737,0.00023816832,0.00075651467,0.0005983211,0.00024613223,0.00009506046,0.00007296631,0.0015273759,0.00007531968],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15497148,0.00770494,0.24335253,0.002351075,0.0019674348,0.40759316,0.0012942094,0.0011278774,0.019289482,0.00016227993,0.0023315905,0.15785395],"study_design_scores_gemma":[0.064479746,0.25872475,0.5134102,0.0021151428,0.00417246,0.009744115,0.00019681067,0.0030057523,0.11738308,0.00015755628,0.025834309,0.00077605026],"about_ca_topic_score_codex":0.00026560773,"about_ca_topic_score_gemma":0.000032005923,"teacher_disagreement_score":0.39784902,"about_ca_system_score_codex":0.0008708847,"about_ca_system_score_gemma":0.00047498627,"threshold_uncertainty_score":0.9712222},"labels":[],"label_agreement":null},{"id":"W4401894858","doi":"10.1111/bju.16520","title":"Salvage stereotactic ablative body radiotherapy after thermal ablation of primary kidney cancer","year":2024,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"Cancer Council Victoria; Australian Government","keywords":"SABR volatility model; Medicine; Interquartile range; Renal cell carcinoma; Surgery; Kidney cancer; Radiation therapy; Progression-free survival; Salvage therapy; Confidence interval; Radiosurgery; Ablative case; Radiology; Internal medicine; Chemotherapy","score_opus":0.0118199697540895,"score_gpt":0.2639415852776023,"score_spread":0.2521216155235128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401894858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9294807,0.06677318,0.00026502888,0.0014286002,0.00048059144,0.00018567067,0.000024614836,0.000012516959,0.0013491121],"genre_scores_gemma":[0.9946363,0.002834996,0.00038523518,0.0012597332,0.00043643403,0.000010141059,0.000006894301,0.00003322833,0.0003970172],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987819,0.00014319735,0.0004735654,0.00015421514,0.00025982503,0.00018726307],"domain_scores_gemma":[0.9992569,0.000112730646,0.00020915006,0.000101265534,0.00016546634,0.0001544615],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002490223,0.00012089503,0.00044457748,0.0001735947,0.000019261637,0.00002383214,0.00006546309,0.00010348637,0.0009402247],"category_scores_gemma":[0.000040153096,0.00011005957,0.00019860857,0.00012273277,0.000098475284,0.00016995585,0.000014247858,0.00035763503,0.0000052911314],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014362398,0.0014781669,0.19985981,0.0016185971,0.008993124,0.08443547,0.0041816845,0.00032809688,0.32238552,0.00010073989,0.016720243,0.34553614],"study_design_scores_gemma":[0.0027985158,0.0024099976,0.96210486,0.00057936425,0.0007320337,0.019063102,0.0000155165,0.0002580452,0.00244306,0.000089140296,0.0093767615,0.00012958286],"about_ca_topic_score_codex":0.0001068354,"about_ca_topic_score_gemma":0.000007792746,"teacher_disagreement_score":0.76224506,"about_ca_system_score_codex":0.00024889992,"about_ca_system_score_gemma":0.00041357384,"threshold_uncertainty_score":0.99997306},"labels":[],"label_agreement":null},{"id":"W4401907679","doi":"10.3390/curroncol31080359","title":"Contemporary Management of Renal Cell Carcinoma: A Review for General Practitioners in Oncology","year":2024,"lang":"en","type":"review","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Grand River Hospital; Victoria Hospital; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Renal cell carcinoma; Disease; Immunotherapy; Oncology; Internal medicine; Kidney cancer; Cancer; Tumor microenvironment; Adjuvant; Intensive care medicine; Cancer research","score_opus":0.29463321125415104,"score_gpt":0.48681108444581095,"score_spread":0.1921778731916599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401907679","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000058340716,0.96949655,0.000024003262,0.00043505273,0.0017417002,0.008077175,0.00016389311,0.00003592554,0.01996738],"genre_scores_gemma":[0.00007551188,0.99051917,0.001325861,0.00011090705,0.00038962343,0.004130972,0.0020282355,0.00010031961,0.0013194131],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99575776,0.00052253314,0.0019782211,0.0009371649,0.00031068092,0.00049364025],"domain_scores_gemma":[0.99761,0.0003235003,0.0010582318,0.0006230322,0.00016476706,0.00022049292],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00086618686,0.00068252324,0.0046678935,0.00062047254,0.000026912925,0.000006586217,0.00025994194,0.000503797,0.00008334197],"category_scores_gemma":[0.000036783156,0.00051137345,0.00130186,0.0005741844,0.00014665656,0.000047341535,0.00021757366,0.0008784567,0.00011512429],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009780391,0.0011209621,0.000008044385,0.3444657,0.0003017152,0.0012440042,0.0000322032,9.4425864e-8,9.872334e-7,0.00015639694,0.0897203,0.5628518],"study_design_scores_gemma":[0.0022056464,0.0023205501,0.000010149354,0.07502421,0.0103700925,0.00040320592,0.000040245366,0.0000053562644,0.000005173829,0.000034124805,0.909278,0.0003032811],"about_ca_topic_score_codex":0.000020294086,"about_ca_topic_score_gemma":0.0000066343255,"teacher_disagreement_score":0.81955767,"about_ca_system_score_codex":0.0029345937,"about_ca_system_score_gemma":0.0029784495,"threshold_uncertainty_score":0.9997338},"labels":[],"label_agreement":null},{"id":"W4402132051","doi":"10.4274/dir.2024.232100","title":"Quadratus lumborum block for procedural and postprocedural analgesia in renal cell carcinoma percutaneous cryoablation","year":2024,"lang":"en","type":"article","venue":"Diagnostic and Interventional Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Surrey Memorial Hospital; University of Saskatchewan","funders":"","keywords":"Medicine; Percutaneous; Cryoablation; Renal cell carcinoma; Cryosurgery; Urology; Surgery; Radiology; Internal medicine","score_opus":0.012562620720880721,"score_gpt":0.26466132711035245,"score_spread":0.25209870638947174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402132051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816311,0.014819679,0.00013438618,0.0016136339,0.00016966375,0.00064852997,0.00004455576,0.000031263666,0.0009071812],"genre_scores_gemma":[0.99772406,0.00015050227,0.00040776242,0.00020241646,0.00016449846,0.000120779296,0.00022914953,0.000022564192,0.0009782854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987738,0.000047156922,0.00035613772,0.00043356427,0.00010442767,0.0002849002],"domain_scores_gemma":[0.99898607,0.00068876636,0.00004478692,0.00008407762,0.0000686824,0.00012760841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014062242,0.0001919731,0.0003116299,0.00022057634,0.0000544686,0.00003437452,0.000038830127,0.00012880113,0.00005873269],"category_scores_gemma":[0.00030635597,0.000162591,0.00013743217,0.00010529576,0.00012267711,0.00007570277,0.000030534764,0.00016578038,0.000007630951],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039493735,0.0016693756,0.8580559,0.008421977,0.0006961209,0.008970567,0.0021781446,0.00010683421,0.036128767,0.034656186,0.02587805,0.019288704],"study_design_scores_gemma":[0.0017832796,0.004608545,0.9673957,0.00052942766,0.0002911065,0.016213698,0.00017973474,0.004980721,0.00088663993,0.0018735126,0.0010080095,0.00024959276],"about_ca_topic_score_codex":0.000038535978,"about_ca_topic_score_gemma":0.000025887728,"teacher_disagreement_score":0.10933983,"about_ca_system_score_codex":0.00012439628,"about_ca_system_score_gemma":0.000107066546,"threshold_uncertainty_score":0.6630268},"labels":[],"label_agreement":null},{"id":"W4402242437","doi":"10.3390/curroncol31090384","title":"Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nivolumab; Renal cell carcinoma; Nephrectomy; Oncology; Internal medicine; Urology; Cancer research; Kidney; Immunotherapy; Cancer","score_opus":0.04280759110159931,"score_gpt":0.33312532299900555,"score_spread":0.29031773189740623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402242437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941521,0.0021507624,0.000012417439,0.00030318668,0.0006991534,0.0015448015,0.0001074811,0.00004335814,0.0009867048],"genre_scores_gemma":[0.9984393,0.000039540555,0.00055876485,0.000018233799,0.00006896596,0.00022108977,0.00015035688,0.000046324447,0.00045743317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806327,0.00014712392,0.0004888677,0.0005573638,0.00032477034,0.00041863535],"domain_scores_gemma":[0.9990003,0.00016883019,0.000144341,0.00035731343,0.00014066327,0.00018854771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010226156,0.00035742903,0.0009139404,0.00037730573,0.000028147759,0.000011642041,0.000080333826,0.00007951314,0.00007620019],"category_scores_gemma":[0.000021473792,0.00023273246,0.0001921558,0.0003147529,0.00017023156,0.00006608121,0.000045772824,0.00026872606,0.000025944844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022107572,0.0055232807,0.9219023,0.00043661447,0.0005829989,0.00045484796,0.002728756,0.00000927491,0.00079910026,0.00008752082,0.00021689653,0.06504763],"study_design_scores_gemma":[0.01841118,0.024222005,0.9396007,0.00017703397,0.0015473927,0.0000340884,0.00051920686,0.00021542203,0.009315335,0.00008881876,0.0055383993,0.00033039617],"about_ca_topic_score_codex":0.00053637504,"about_ca_topic_score_gemma":0.00023971578,"teacher_disagreement_score":0.064717226,"about_ca_system_score_codex":0.0023888086,"about_ca_system_score_gemma":0.00091400166,"threshold_uncertainty_score":0.94905543},"labels":[],"label_agreement":null},{"id":"W4402267869","doi":"10.1158/1538-7445.pediatric24-a011","title":"Abstract A011 Molecular analysis improves the diagnosis of young people with renal tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Oncology; Pathology","score_opus":0.045835140753660554,"score_gpt":0.369894839463151,"score_spread":0.3240596987094904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98533994,0.009199011,0.000023632705,0.0018567631,0.000030643412,0.0005172614,0.000022688502,0.000025363193,0.0029846947],"genre_scores_gemma":[0.9978828,0.0005225928,0.00004779767,0.00001867194,0.00008532074,0.0006612648,0.00001637396,0.000030214493,0.00073499396],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979706,0.00007775725,0.00020469418,0.00036375053,0.0010143704,0.00036883113],"domain_scores_gemma":[0.9987804,0.0002479144,0.000032898595,0.0005187271,0.0002810583,0.00013896025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005928795,0.00013044509,0.00030667597,0.00040934127,0.00007793,0.000058604157,0.00017355332,0.000042805787,0.00053476327],"category_scores_gemma":[0.000052974203,0.00006938946,0.0002023604,0.0021041357,0.00021201695,0.000050682313,0.00006495415,0.00041938142,0.000022561811],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013044992,0.00043070232,0.38929245,0.0018142401,0.01008295,0.0029061106,0.0044743363,0.00072625076,0.56546736,0.00067552517,0.004855122,0.017970437],"study_design_scores_gemma":[0.0003893494,0.0005545164,0.55622953,0.0003767701,0.001113536,0.000026831416,0.0004741428,0.00020725372,0.44000936,0.000058248643,0.0004556096,0.000104820545],"about_ca_topic_score_codex":0.0062442785,"about_ca_topic_score_gemma":0.0014506177,"teacher_disagreement_score":0.16693711,"about_ca_system_score_codex":0.00029430143,"about_ca_system_score_gemma":0.00050068146,"threshold_uncertainty_score":0.9439523},"labels":[],"label_agreement":null},{"id":"W4402354861","doi":"10.3310/jwtr4127","title":"Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT","year":2024,"lang":"en","type":"article","venue":"Health Technology Assessment","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"Programme Grants for Applied Research; Health Technology Assessment Programme; British Society of Interventional radiology; International Network of Agencies for Health Technology Assessment; Ipsen; European School of Oncology; Department of Health and Social Care; University of Leeds; National Institute for Health and Care Research; Bowel Cancer UK; British Heart Foundation; Engineering and Physical Sciences Research Council; AstraZeneca; National Cancer Research Institute; Cancer Research UK; Boston Scientific Corporation; GlaxoSmithKline; Amgen","keywords":"Medicine; Internal medicine; Sunitinib; Randomized controlled trial; Quality of life (healthcare); Confidence interval; Pazopanib; Intention-to-treat analysis; Renal cell carcinoma; Oncology; Surgery","score_opus":0.02563838062294782,"score_gpt":0.34440841985988674,"score_spread":0.3187700392369389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402354861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96239096,0.0035830787,0.0028886998,0.026120108,0.00012784779,0.004491899,0.00010935576,0.00020658493,0.000081463484],"genre_scores_gemma":[0.9925012,0.00039820588,0.0045864508,0.00010524778,0.00007637711,0.0019387469,0.0002830243,0.00003544038,0.000075310316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998342,0.00005538743,0.00049770577,0.0004467652,0.00033388083,0.0003243108],"domain_scores_gemma":[0.9988175,0.00009958557,0.00031240835,0.0004406388,0.00023630355,0.00009357315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029014764,0.00026998328,0.0005591626,0.00028289302,0.00016837352,0.00001706271,0.000076183445,0.00012645221,0.000012146088],"category_scores_gemma":[0.0000067309747,0.00014559542,0.00006662328,0.0005289443,0.00020454919,0.000077277626,0.000021590982,0.00022314364,0.0000010712928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011999091,0.0037920058,0.70266503,0.0069127,0.0025057488,0.0004037715,0.003684781,0.0004764122,0.009934662,0.0047938162,0.0041229734,0.24870904],"study_design_scores_gemma":[0.038790297,0.08648023,0.61984885,0.012512947,0.0020295887,0.00036244743,0.0084813675,0.023235153,0.18617295,0.0004432764,0.02062779,0.0010151444],"about_ca_topic_score_codex":0.0014810659,"about_ca_topic_score_gemma":0.0011892229,"teacher_disagreement_score":0.2476939,"about_ca_system_score_codex":0.0013854984,"about_ca_system_score_gemma":0.0019084375,"threshold_uncertainty_score":0.5937209},"labels":[],"label_agreement":null},{"id":"W4402388619","doi":"10.1016/s1470-2045(24)00402-9","title":"[89Zr]Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial","year":2024,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Health and Medical Research Council; Astellas Pharma; Ipsen; National Breast Cancer Foundation; Y-mAbs Therapeutics; Exelixis; Australian and New Zealand Society of Nuclear Medicine; Actinium Pharmaceuticals; Pfizer; Intuitive Surgical; Australian Cancer Research Foundation; Regeneron Pharmaceuticals; Veracyte; Verily Life Sciences; Society of Nuclear Medicine and Molecular Imaging; National Imaging Facility; Medical Research Council; Australian Nuclear Science and Technology Organisation; U.S. Department of Justice; Bristol-Myers Squibb; Progenics Pharmaceuticals","keywords":"Open label; Renal cell carcinoma; Medicine; Nuclear medicine; Oncology; Clinical trial; Internal medicine","score_opus":0.07505544025566038,"score_gpt":0.38647430477783923,"score_spread":0.3114188645221788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402388619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95461977,0.0035988647,0.000118742035,0.0026908258,0.00087868783,0.0052684355,0.00013002726,0.000097366836,0.03259729],"genre_scores_gemma":[0.9910223,0.00009815827,0.003269926,0.00036873596,0.0010816093,0.0005556777,0.000078262354,0.00007061784,0.0034547246],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99764127,0.00026070245,0.0005690656,0.00061998167,0.0002738246,0.00063513406],"domain_scores_gemma":[0.9981365,0.00066411524,0.00023010455,0.00066373573,0.00015511023,0.00015042724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008595211,0.0003193018,0.0010967756,0.00012447932,0.00012652404,0.00006177796,0.0004732749,0.00004437837,0.0001405608],"category_scores_gemma":[0.000094404044,0.00021026173,0.0001886587,0.00026299723,0.00021815412,0.00011652281,0.00024753416,0.00044110452,0.000074881806],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6042148,0.028505497,0.0050590155,0.0040816865,0.00091591454,0.010937051,0.0043211104,0.000016388864,0.21322675,0.0029476138,0.093599625,0.03217454],"study_design_scores_gemma":[0.74894893,0.026158134,0.0012692426,0.00022849829,0.0024831994,0.0013439477,0.00075903896,0.008662222,0.115012564,0.0009934158,0.09360745,0.0005333724],"about_ca_topic_score_codex":0.00014698497,"about_ca_topic_score_gemma":0.0000286415,"teacher_disagreement_score":0.14473411,"about_ca_system_score_codex":0.0006125254,"about_ca_system_score_gemma":0.0006582807,"threshold_uncertainty_score":0.8574225},"labels":[],"label_agreement":null},{"id":"W4402389020","doi":"10.1200/jco.24.00767","title":"Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Cabozantinib; Sunitinib; Medicine; Crizotinib; Clinical endpoint; Internal medicine; Hazard ratio; Papillary renal cell carcinomas; Oncology; Renal cell carcinoma; Axitinib; Pazopanib; Clinical trial; Urology; Confidence interval; Lung cancer","score_opus":0.1291674654152644,"score_gpt":0.43763600479905596,"score_spread":0.3084685393837916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402389020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99150354,0.0027849989,0.0000761079,0.0006017657,0.00042780067,0.0009088373,0.000016182626,0.000015647183,0.0036651227],"genre_scores_gemma":[0.9972872,0.0004126339,0.0015065203,0.0001439704,0.0003524688,0.00001801887,0.000019865269,0.000037335925,0.00022198782],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9919391,0.0018034332,0.0044831918,0.0005353535,0.0007967848,0.0004421054],"domain_scores_gemma":[0.989969,0.0068736905,0.0017724091,0.0003526526,0.00052549154,0.0005067332],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007047998,0.0003834745,0.0060996274,0.0010695746,0.000061200706,0.000024849174,0.00019417981,0.00026567417,0.00012464999],"category_scores_gemma":[0.0013498568,0.0002503022,0.0010960032,0.00085242244,0.00047389342,0.00017650063,0.00014231144,0.0014318279,0.0000018093663],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44056338,0.015900979,0.49165422,0.00031971975,0.007258094,0.018717753,0.0022070718,0.00048059516,0.0007645614,0.00019133589,0.00011679336,0.021825511],"study_design_scores_gemma":[0.45989302,0.0716662,0.44634804,0.00037702755,0.015066142,0.0005160533,0.0015702952,0.0030736113,0.0003201507,0.000057143425,0.0008308991,0.00028142618],"about_ca_topic_score_codex":0.0002494999,"about_ca_topic_score_gemma":0.00038133922,"teacher_disagreement_score":0.055765223,"about_ca_system_score_codex":0.00015671,"about_ca_system_score_gemma":0.001585034,"threshold_uncertainty_score":0.99999493},"labels":[],"label_agreement":null},{"id":"W4402415790","doi":"10.3390/curroncol31090392","title":"Factors that Affect Outcome of Ultrasound-Guided Radiofrequency Ablation of Renal Masses","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Affect (linguistics); Ultrasound; Radiofrequency ablation; Ablation; Outcome (game theory); Radiology; Internal medicine; Communication","score_opus":0.2585694714067893,"score_gpt":0.4388252007477831,"score_spread":0.18025572934099376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402415790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845087,0.009695657,0.00037737886,0.00013757538,0.0014491626,0.00047756842,0.00002844564,0.00006117468,0.0032643676],"genre_scores_gemma":[0.99893194,0.00035906376,0.0002573181,0.000006953194,0.0001079689,0.000020487443,0.00012387316,0.000021358352,0.00017104927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998605,0.00012403159,0.000499897,0.00027524985,0.00028788892,0.00020794552],"domain_scores_gemma":[0.9986858,0.0006842481,0.0001770905,0.00026248881,0.00009079099,0.00009960945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024536453,0.00019533445,0.0006193076,0.00026325192,0.00001912959,0.000006188828,0.00008422148,0.00012487742,0.000278266],"category_scores_gemma":[0.00019146888,0.00013627834,0.00026670936,0.00023300595,0.00013883447,0.00007217339,0.00002278529,0.00020513566,0.000015970125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006149451,0.0003619931,0.94358253,0.0010464096,0.00021205202,0.000052443185,0.0005589308,0.000009586273,0.04047364,0.0006231975,0.0019074487,0.011110258],"study_design_scores_gemma":[0.0017871932,0.0025864472,0.7742077,0.00055750366,0.001041272,0.00030425313,0.00020653062,0.00013043745,0.18618338,0.0004589432,0.032305285,0.00023101873],"about_ca_topic_score_codex":0.000045437828,"about_ca_topic_score_gemma":0.000006925149,"teacher_disagreement_score":0.16937481,"about_ca_system_score_codex":0.0005137722,"about_ca_system_score_gemma":0.00022899121,"threshold_uncertainty_score":0.55572695},"labels":[],"label_agreement":null},{"id":"W4402456192","doi":"10.1080/14796694.2024.2389769","title":"Focal therapy for oligometastatic and oligoprogressive renal cell carcinoma: a narrative review","year":2024,"lang":"en","type":"review","venue":"Future Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Narrative review; Narrative; Oncology; Internal medicine; Intensive care medicine","score_opus":0.05149807865167884,"score_gpt":0.39485149131668174,"score_spread":0.3433534126650029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402456192","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000063087056,0.9868789,0.0000055125543,0.0016837207,0.0008566449,0.008097787,0.00013909776,0.000072833536,0.0022024713],"genre_scores_gemma":[0.000025810492,0.987889,0.0019178988,0.0009075947,0.0020434423,0.0040544393,0.00070005766,0.00015631579,0.0023054222],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99672806,0.00041022332,0.0009522297,0.0010607258,0.0002820112,0.00056675705],"domain_scores_gemma":[0.9979525,0.00040020817,0.0005543509,0.0005498559,0.0001937089,0.00034937594],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039647063,0.0009436441,0.0047546285,0.00031434782,0.00010342674,0.000026881473,0.00018450555,0.00070501526,0.000110805304],"category_scores_gemma":[0.00004586737,0.0005539803,0.0011448677,0.00044294764,0.00019671154,0.000036661506,0.00010384456,0.00090644404,0.000089084126],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014228772,0.00024092419,9.340459e-7,0.14945364,0.00084770104,0.0014626655,0.00055335625,4.1962043e-9,0.000001945153,0.00012562581,0.058712095,0.7884588],"study_design_scores_gemma":[0.0017547414,0.006445393,0.0000053096333,0.025793685,0.0124395015,0.0028836406,0.0001617782,6.75293e-7,0.000009719375,0.0000716451,0.95003724,0.00039669077],"about_ca_topic_score_codex":0.0000059213453,"about_ca_topic_score_gemma":0.0000074462,"teacher_disagreement_score":0.8913251,"about_ca_system_score_codex":0.0007186776,"about_ca_system_score_gemma":0.0018122379,"threshold_uncertainty_score":0.9996912},"labels":[],"label_agreement":null},{"id":"W4402513318","doi":"10.1097/io9.0000000000000085","title":"Pembrolizumab: a beacon of hope for clear-cell renal-cell carcinoma patients post-nephrectomy","year":2024,"lang":"en","type":"article","venue":"International Journal of Surgery Open","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Pembrolizumab; Internal medicine; Oncology; Urology; Kidney; Cancer; Immunotherapy","score_opus":0.03690953389082238,"score_gpt":0.3036748804481551,"score_spread":0.26676534655733275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402513318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902832,0.0012378228,0.000081809674,0.0014625646,0.0014982657,0.0005833401,0.000117916075,0.000010221923,0.0047248835],"genre_scores_gemma":[0.9960545,0.000104163715,0.0009884131,0.00037012895,0.00038851466,0.000020627518,0.00010968351,0.000051647126,0.0019123238],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976285,0.00006470987,0.0010042978,0.00025062409,0.00082725915,0.00022462178],"domain_scores_gemma":[0.9962682,0.0006317751,0.00051578355,0.00019265195,0.0021979995,0.00019360006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006262596,0.00021212957,0.0006070933,0.000615009,0.000030595198,0.00014333382,0.00046947398,0.00008362828,0.00029592775],"category_scores_gemma":[0.00020335564,0.00016549569,0.0006366098,0.00015657618,0.00004935654,0.00044441025,0.00016249363,0.00023197952,0.000031094965],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06206917,0.008590156,0.44311726,0.0023135042,0.0045329914,0.0081094755,0.0024654928,0.00014087617,0.14406706,0.00034663797,0.21460357,0.10964382],"study_design_scores_gemma":[0.018740637,0.006614661,0.38335437,0.0029207235,0.0013057896,0.0018481906,0.00036323362,0.0004430318,0.4650909,0.0004834958,0.1180801,0.0007548678],"about_ca_topic_score_codex":0.00016499747,"about_ca_topic_score_gemma":0.0000040543073,"teacher_disagreement_score":0.32102385,"about_ca_system_score_codex":0.0003374635,"about_ca_system_score_gemma":0.0007418108,"threshold_uncertainty_score":0.6748718},"labels":[],"label_agreement":null},{"id":"W4402540272","doi":"10.1089/end.2024.0251","title":"The Safety and Feasibility of Ambulatory Minimally Invasive Partial Nephrectomy: A Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Journal of Endourology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; University of Ottawa; McMaster University","funders":"","keywords":"Medicine; Nephrectomy; Ambulatory; Meta-analysis; Surgery; Systematic review; Urology; MEDLINE; Internal medicine; Kidney","score_opus":0.12812707086349737,"score_gpt":0.37704184965372733,"score_spread":0.24891477879022997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402540272","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013149447,0.9966807,0.0000028977079,0.0006556192,0.00006729166,0.0023588655,0.00003614867,0.000004601541,0.00006237511],"genre_scores_gemma":[0.0007792674,0.998546,0.00009239791,0.00023621292,0.000059556634,0.00007823256,0.0000054227144,0.000028486025,0.00017439688],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9945899,0.0016176137,0.0028368337,0.0003427622,0.00038583315,0.00022705871],"domain_scores_gemma":[0.9940269,0.002066731,0.0027673745,0.0006132642,0.00031058534,0.00021516069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028839211,0.00045719586,0.012669088,0.00035803756,0.000049991177,0.00002282752,0.00019743145,0.00021368559,0.00006041245],"category_scores_gemma":[0.001122024,0.00019300148,0.0040099877,0.0004201302,0.00025516626,0.000036943464,0.00012682148,0.00069366855,0.000004692847],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013735815,0.000052201704,0.00002522344,0.6992801,0.29913384,0.0005848678,0.00003321342,1.9102772e-7,8.452656e-7,0.00004481224,0.00015633593,0.0005509902],"study_design_scores_gemma":[0.00030301255,0.00085233466,0.000026606598,0.013057525,0.9601333,0.004897612,0.000009982537,8.2477953e-7,0.0000011841516,0.000026764266,0.020587172,0.00010364264],"about_ca_topic_score_codex":0.0000055881383,"about_ca_topic_score_gemma":0.000024395817,"teacher_disagreement_score":0.6862226,"about_ca_system_score_codex":0.00013634292,"about_ca_system_score_gemma":0.0006430801,"threshold_uncertainty_score":0.8660335},"labels":[],"label_agreement":null},{"id":"W4402564014","doi":"10.1016/j.euros.2024.08.019","title":"The Detrimental Effect of Metabolic Syndrome on Long-term Renal Function in Patients Undergoing Elective Partial Nephrectomy for Small Renal Masses","year":2024,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nephrectomy; Renal function; Medicine; Renal mass; Urology; Term (time); Kidney; Internal medicine","score_opus":0.022164155571224458,"score_gpt":0.2905201270216732,"score_spread":0.2683559714504487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402564014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99312335,0.00056686,0.00020331945,0.000103713115,0.00041637578,0.0017921474,0.0000041968397,0.000022557204,0.003767502],"genre_scores_gemma":[0.99938744,0.000015291382,0.000098315715,0.0001094114,0.00004988399,0.000089524605,0.00001266759,0.00002445545,0.00021300142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785936,0.0004736553,0.00031545237,0.0006197806,0.00031861293,0.0004131263],"domain_scores_gemma":[0.9986369,0.00077112066,0.000101733516,0.00032318203,0.00006532796,0.0001017412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020893486,0.00018740857,0.0003014856,0.00027448137,0.00022897805,0.00012849939,0.00051684206,0.00002982665,0.000014381243],"category_scores_gemma":[0.00034924343,0.000115607654,0.00009102112,0.00066972413,0.00039797203,0.00018715109,0.0002894013,0.00021198927,0.00005966906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013976104,0.00049796724,0.9185488,0.00010886299,0.0003781904,0.0007789768,0.00029482748,0.00019498196,0.024657434,0.0013624963,0.00013172612,0.039069604],"study_design_scores_gemma":[0.0032562055,0.014594439,0.9441847,0.0000949901,0.00021210781,0.000099190445,0.000005603576,0.0001757831,0.036506664,0.000026583102,0.0007349071,0.00010882372],"about_ca_topic_score_codex":0.000015594362,"about_ca_topic_score_gemma":0.00003226077,"teacher_disagreement_score":0.03896078,"about_ca_system_score_codex":0.00013014379,"about_ca_system_score_gemma":0.00024299824,"threshold_uncertainty_score":0.47143432},"labels":[],"label_agreement":null},{"id":"W4402565567","doi":"10.1016/j.annonc.2024.08.2317","title":"LBA74 Final analysis of the phase III LITESPARK-005 study of belzutifan versus everolimus in participants (pts) with previously treated advanced clear cell renal cell carcinoma (ccRCC)","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Merck Sharp and Dohme; EMD Serono; Genentech; Ipsen; European Association of Urology; European Society for Medical Oncology; Eisai; Astellas Pharma; Daiichi Sankyo Europe; Gilead Sciences; Calithera Biosciences; Jounce Therapeutics; Aptitude Health; Arrowhead Pharmaceuticals; Seagen; Society for Immunotherapy of Cancer; EUSA Pharma; Invitae; AstraZeneca; Associazione Italiana di Oncologia Medica; Pfizer; Incyte; F. Hoffmann-La Roche; Bristol-Myers Squibb; Eli Lilly and Company; American Society of Clinical Oncology; Exelixis; Sanofi; Amgen; Dana-Farber Cancer Institute","keywords":"Medicine; Everolimus; Renal cell carcinoma; Clear cell renal cell carcinoma; Oncology; Internal medicine; Urology","score_opus":0.11800073331204684,"score_gpt":0.3930948423803325,"score_spread":0.27509410906828563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402565567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99379873,0.0020849386,0.0000029926177,0.00024767494,0.000080416416,0.0012296394,0.000042391002,0.000019565437,0.0024936555],"genre_scores_gemma":[0.99919814,0.00013518034,0.00007365365,0.000052314805,0.000027553617,0.00007816655,0.000031116288,0.000033467433,0.00037042977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99694604,0.00043061236,0.0010286439,0.0005491322,0.00049572095,0.0005498764],"domain_scores_gemma":[0.99783176,0.00046663813,0.0004983743,0.000758281,0.00025961315,0.00018534035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005191715,0.00031732646,0.0014625007,0.0006422046,0.000038939994,0.0000061524297,0.00025182203,0.00014846101,0.0001234414],"category_scores_gemma":[0.000060573762,0.00020868564,0.00036505182,0.001928893,0.00022690858,0.00007521265,0.00010478844,0.00030091975,0.000004247702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2092859,0.06570828,0.47862652,0.0016218532,0.012973548,0.005179704,0.03907305,0.012534221,0.117444,0.000045714416,0.0011863651,0.056320846],"study_design_scores_gemma":[0.06714716,0.15539174,0.44672915,0.00036966248,0.016307523,0.000026767057,0.0036433898,0.0031905072,0.305807,0.000010903694,0.0009533528,0.00042284452],"about_ca_topic_score_codex":0.0010942513,"about_ca_topic_score_gemma":0.0018531686,"teacher_disagreement_score":0.18836299,"about_ca_system_score_codex":0.00016503698,"about_ca_system_score_gemma":0.00049644394,"threshold_uncertainty_score":0.85099536},"labels":[],"label_agreement":null},{"id":"W4402578243","doi":"10.1111/bju.16528","title":"Microwave vs radiofrequency ablation for small renal masses: perioperative and oncological outcomes","year":2024,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Microwave ablation; Perioperative; Poisson regression; Logistic regression; Propensity score matching; Radiofrequency ablation; Odds ratio; Ablation; Renal function; Proportional hazards model; Surgery; Internal medicine; Urology","score_opus":0.03013354079126892,"score_gpt":0.28702276164659746,"score_spread":0.25688922085532856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402578243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96482193,0.025416572,0.004371052,0.0037535275,0.0003263435,0.00037157573,0.000014655934,0.000017071314,0.0009072406],"genre_scores_gemma":[0.9862901,0.0011666956,0.011020838,0.00063651934,0.00030809458,0.000015385487,0.00001105714,0.000017951126,0.0005333686],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99898046,0.00010152071,0.00041783875,0.00019346361,0.000113880444,0.00019281999],"domain_scores_gemma":[0.9992041,0.00032410174,0.000103740014,0.00005752408,0.00017815246,0.00013236704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035526176,0.00011948724,0.00046094277,0.00011570425,0.00005930645,0.000068729336,0.000052014,0.00013811827,0.00008113552],"category_scores_gemma":[0.00023382349,0.000098233315,0.0001819783,0.00006073331,0.0001162453,0.0000861489,0.000017548553,0.0003034686,0.0000036984839],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062757954,0.00093800493,0.084779404,0.0006520167,0.002742492,0.07661487,0.001966404,0.00011688033,0.08210823,0.0031945694,0.009158963,0.73145235],"study_design_scores_gemma":[0.01008199,0.023122245,0.55256003,0.0004854202,0.0017650228,0.29714486,0.00024842794,0.0012970701,0.002885612,0.0033126106,0.10670014,0.0003965848],"about_ca_topic_score_codex":0.00001953068,"about_ca_topic_score_gemma":0.0000352712,"teacher_disagreement_score":0.7310558,"about_ca_system_score_codex":0.0001267497,"about_ca_system_score_gemma":0.00020279291,"threshold_uncertainty_score":0.40058383},"labels":[],"label_agreement":null},{"id":"W4402584887","doi":"10.1007/978-981-99-6794-0_35","title":"Genitourinary Malignancies in the UAE","year":2024,"lang":"en","type":"book-chapter","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Genitourinary system; Medicine; Internal medicine","score_opus":0.03850229546795236,"score_gpt":0.25797938524178765,"score_spread":0.2194770897738353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402584887","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019749012,0.010270632,8.4878724e-7,0.0025088727,0.00016690319,0.0005614064,0.000008523042,0.00005625222,0.98445165],"genre_scores_gemma":[0.04947526,0.00038503564,0.0000832991,0.0006435973,0.00038927264,0.000032331183,0.00004442568,0.00005404788,0.9488927],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989558,0.00000713365,0.00023050618,0.00029221192,0.00034734645,0.00016703125],"domain_scores_gemma":[0.9993606,0.000059807575,0.00003228792,0.00047091497,0.000027419917,0.000048944956],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00010718324,0.00027361765,0.00032237975,0.00017107678,0.00001837701,0.000021509391,0.00011031085,0.000183621,0.0016062236],"category_scores_gemma":[0.0000035609087,0.00014204982,0.00022249429,0.000027948196,0.000057787576,0.000014092295,0.000063415326,0.00040305805,0.0021530187],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023223957,0.00017801122,0.00033101032,0.0013897625,0.00064986234,0.06998812,0.0012550637,0.0000012108067,0.00041687881,0.74761003,0.1720569,0.005890909],"study_design_scores_gemma":[0.00050319335,0.0007771174,0.002049459,0.0009578057,0.0006878306,0.0023736279,0.00016437632,0.000005051117,0.00039253206,0.031185016,0.96059203,0.00031196792],"about_ca_topic_score_codex":0.000040597923,"about_ca_topic_score_gemma":0.00003628513,"teacher_disagreement_score":0.7885351,"about_ca_system_score_codex":0.00014957612,"about_ca_system_score_gemma":0.00008296684,"threshold_uncertainty_score":0.99930644},"labels":[],"label_agreement":null},{"id":"W4402603199","doi":"10.1007/s00428-024-03909-2","title":"Acceptance of emerging renal oncocytic neoplasms: a survey of urologic pathologists","year":2024,"lang":"en","type":"article","venue":"Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; University of Calgary","funders":"National Cancer Institute","keywords":"Oncocytoma; Medicine; Pathology; Eosinophilic; Surgical pathology; Genitourinary system; Renal cell carcinoma; Immunohistochemistry; Biopsy; Internal medicine","score_opus":0.05486961525267586,"score_gpt":0.3790054109593261,"score_spread":0.32413579570665024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402603199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9638405,0.023410778,0.0017979263,0.0005954894,0.0006370086,0.0010955413,0.0002571911,0.00035851388,0.008007073],"genre_scores_gemma":[0.9884007,0.0030470241,0.006867356,0.0004518595,0.00023220968,0.00008630187,0.00051728066,0.00010097713,0.0002962887],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9930919,0.0013461813,0.0019257122,0.0015713356,0.0009203872,0.0011445283],"domain_scores_gemma":[0.99332696,0.0035417045,0.00071436726,0.0016562759,0.00035474368,0.0004059276],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002916126,0.00090040814,0.002268325,0.00072680064,0.0001365788,0.000029988776,0.0008558064,0.00054017577,0.00021529708],"category_scores_gemma":[0.003165387,0.0006226551,0.0007066319,0.0014797731,0.0023105294,0.00018389153,0.00054310384,0.0014932817,0.000101764424],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00817779,0.0032589277,0.17132254,0.0042819935,0.004465214,0.012212773,0.005136057,0.0016932706,0.6663942,0.00780707,0.005171509,0.11007871],"study_design_scores_gemma":[0.0053870166,0.010816048,0.85017127,0.0018456978,0.002595544,0.00046824265,0.0008137892,0.0055371365,0.111619264,0.0068087233,0.0026490255,0.001288246],"about_ca_topic_score_codex":0.00063521176,"about_ca_topic_score_gemma":0.00008431225,"teacher_disagreement_score":0.67884874,"about_ca_system_score_codex":0.00015680562,"about_ca_system_score_gemma":0.0010072648,"threshold_uncertainty_score":0.99962246},"labels":[],"label_agreement":null},{"id":"W4402672560","doi":"10.2196/52837","title":"Personalized Prediction of Long-Term Renal Function Prognosis Following Nephrectomy Using Interpretable Machine Learning Algorithms: Case-Control Study","year":2024,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Nephrectomy; Kidney disease; Renal function; Machine learning; Medicine; Computer science; Artificial intelligence; Intensive care medicine; Acute kidney injury; Algorithm; Internal medicine; Kidney","score_opus":0.026049225132697314,"score_gpt":0.3039769308062124,"score_spread":0.2779277056735151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402672560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708526,0.0010471573,0.025193306,0.000054379285,0.0004590316,0.00178892,0.000025762003,0.0002580602,0.00032075675],"genre_scores_gemma":[0.9978421,0.000020828202,0.0013204481,0.000070074755,0.00028007923,0.0001745646,0.00007819969,0.000039927272,0.00017383399],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9969632,0.00013810719,0.0010623209,0.00021080502,0.0012777149,0.00034782555],"domain_scores_gemma":[0.99894977,0.00020403364,0.00019230989,0.00021506633,0.00011061259,0.00032820625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008919511,0.00029154983,0.00061193574,0.0003486452,0.00012863829,0.000078277335,0.00008973016,0.00020312841,0.0004643684],"category_scores_gemma":[0.0001423052,0.00021791196,0.0003391549,0.00046020158,0.00008831416,0.0004422983,0.00007266008,0.00074296055,0.000018574448],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018680169,0.001860318,0.60950935,0.0049502826,0.0076090437,0.017862273,0.040016323,0.00020598239,0.0019332708,0.000018694715,0.00022111049,0.31394532],"study_design_scores_gemma":[0.009350283,0.004490944,0.019516716,0.0030314538,0.0039272606,0.0074693095,0.0049466942,0.9458944,0.0006520893,0.000005056948,0.00042333378,0.0002924276],"about_ca_topic_score_codex":0.00006817275,"about_ca_topic_score_gemma":0.00000865258,"teacher_disagreement_score":0.9456884,"about_ca_system_score_codex":0.00031734246,"about_ca_system_score_gemma":0.00027976724,"threshold_uncertainty_score":0.8886192},"labels":[],"label_agreement":null},{"id":"W4402704826","doi":"10.1016/j.annonc.2024.08.1799","title":"1706P Efficacy, safety and PKPD of 23ME-00610, a first-in-class anti-CD200R1 antibody, in patients with advanced or metastatic clear-cell renal cell carcinoma (ccRCC): Results from a multi-center multi-country phase I/IIa expansion cohort","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Clear cell renal cell carcinoma; Antibody; Oncology; Center (category theory); Cancer research; Internal medicine; Immunology","score_opus":0.038363272036108204,"score_gpt":0.34463062368850683,"score_spread":0.3062673516523986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402704826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947452,0.0013196341,0.000076155804,0.00036552208,0.00018072904,0.0020503462,0.00084994873,0.00003117473,0.0003813184],"genre_scores_gemma":[0.9938304,0.000961869,0.0037593711,0.00016867054,0.000028656495,0.000034795554,0.0009585822,0.000071268274,0.00018638384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962008,0.00028881565,0.0014391145,0.0009669505,0.0004963825,0.0006079599],"domain_scores_gemma":[0.9976573,0.00076408824,0.0004701642,0.0005858498,0.00027080893,0.00025181507],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005310033,0.000484989,0.0015566442,0.00052159757,0.00004604749,0.000013475049,0.00017062231,0.00023649844,0.000048467442],"category_scores_gemma":[0.00016398237,0.00035117572,0.00015350521,0.00054233545,0.0002902227,0.00018182238,0.000138746,0.000437121,0.000012595129],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18520825,0.060878027,0.67975295,0.0022451,0.00079899165,0.00785011,0.005810509,0.00059921585,0.036163352,0.0000061651335,0.0009899822,0.019697323],"study_design_scores_gemma":[0.13547888,0.020144988,0.81310225,0.0011879129,0.00041851422,0.000029785831,0.00027572564,0.0043692105,0.021694457,0.0000021534718,0.00291007,0.00038603356],"about_ca_topic_score_codex":0.0012842396,"about_ca_topic_score_gemma":0.0009353158,"teacher_disagreement_score":0.13334928,"about_ca_system_score_codex":0.00020519485,"about_ca_system_score_gemma":0.00044693335,"threshold_uncertainty_score":0.999894},"labels":[],"label_agreement":null},{"id":"W4402704878","doi":"10.1016/j.annonc.2024.08.1797","title":"1704P Potential surrogate endpoints for overall survival (OS) in immunotherapy (IO)-treated metastatic renal cell carcinoma (mRCC): An International Metastatic Database Consortium (IMDC) study","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; BC Cancer Agency","funders":"","keywords":"Medicine; Renal cell carcinoma; Surrogate endpoint; Immunotherapy; Oncology; Internal medicine; Cancer","score_opus":0.11283027433729874,"score_gpt":0.4021011426745032,"score_spread":0.28927086833720445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402704878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99288887,0.0010728976,0.00026320154,0.0011135816,0.0007597,0.0020650048,0.0005802939,0.00005759407,0.0011988797],"genre_scores_gemma":[0.99554205,0.00022575415,0.0017479005,0.00032891615,0.0001337342,0.0002465006,0.0010205725,0.000075671625,0.0006788822],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9963198,0.00068060047,0.0011004853,0.0007808013,0.00054563914,0.0005727153],"domain_scores_gemma":[0.9979277,0.00058683933,0.00028371095,0.0005938869,0.00038188056,0.00022596135],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014799455,0.0004169061,0.0011020021,0.0006655344,0.000052083135,0.0000451979,0.00031099116,0.000091224356,0.00053135835],"category_scores_gemma":[0.00010680449,0.00035494898,0.00033456148,0.00028261088,0.00015630726,0.00034639132,0.00009584548,0.0003113607,0.000035405723],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06142566,0.05879145,0.14647752,0.0025711518,0.013514842,0.056793567,0.011393113,0.0010754544,0.57089555,0.0020552208,0.0075297356,0.06747675],"study_design_scores_gemma":[0.088500224,0.089901164,0.4805376,0.0005267806,0.00447082,0.0014657688,0.005424765,0.01612311,0.28918344,0.0017437997,0.020188726,0.0019338013],"about_ca_topic_score_codex":0.0012911112,"about_ca_topic_score_gemma":0.0004768519,"teacher_disagreement_score":0.33406007,"about_ca_system_score_codex":0.00022332127,"about_ca_system_score_gemma":0.000595983,"threshold_uncertainty_score":0.99989027},"labels":[],"label_agreement":null},{"id":"W4402757236","doi":"10.1016/j.ijrobp.2024.05.008","title":"FASTRACKing Our Understanding of Renal Function After Kidney Stereotactic Ablative Body Radiation Therapy","year":2024,"lang":"en","type":"editorial","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Western University; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Ablative case; Medicine; Renal function; Radiation therapy; Stereotactic radiation therapy; Kidney; Urology; Radiosurgery; Radiology; Internal medicine","score_opus":0.033458808416291605,"score_gpt":0.33924500083504905,"score_spread":0.30578619241875743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402757236","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.054250658,0.0050008846,0.015502279,0.0028169276,0.91907847,0.001056375,0.000795141,0.000101995975,0.0013972714],"genre_scores_gemma":[0.68698883,0.0021842176,0.0002848208,0.00022460631,0.3090778,0.000027755328,0.00092182664,0.0000945105,0.00019565526],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99599713,0.00042371568,0.0015933781,0.00050862425,0.0011341664,0.00034300066],"domain_scores_gemma":[0.9939849,0.00087216677,0.002983992,0.0002642556,0.0016359977,0.00025871352],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009119697,0.00053924083,0.001156287,0.0007115662,0.000069805916,0.00008435479,0.00035068812,0.0010740649,0.000095641924],"category_scores_gemma":[0.000766642,0.0004558745,0.0007321191,0.00028981944,0.000140302,0.00045664387,0.000074241034,0.001785472,0.000043328062],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02238124,0.00237118,0.053417753,0.0004332636,0.028672,0.0012469495,0.003362794,0.000553626,0.014883632,0.0037560067,0.7777096,0.09121197],"study_design_scores_gemma":[0.028893337,0.01828134,0.013458394,0.0027502857,0.005339419,0.0005343572,0.0007068592,0.001641662,0.008000393,0.027548073,0.89152807,0.0013178231],"about_ca_topic_score_codex":0.000027662127,"about_ca_topic_score_gemma":0.0000029690814,"teacher_disagreement_score":0.6327382,"about_ca_system_score_codex":0.0051364987,"about_ca_system_score_gemma":0.002860279,"threshold_uncertainty_score":0.9997893},"labels":[],"label_agreement":null},{"id":"W4402906391","doi":"10.1016/j.ijrobp.2024.07.126","title":"Renal Function after Definitive Local Therapy for Primary Renal Cell Carcinoma: A Meta-Analysis","year":2024,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Juravinski Cancer Centre; McMaster University; Sunnybrook Hospital","funders":"","keywords":"Renal cell carcinoma; Renal function; Meta-analysis; Medicine; Urology; Oncology; Function (biology); Internal medicine; Biology","score_opus":0.04342456215283681,"score_gpt":0.32016237842470546,"score_spread":0.27673781627186866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402906391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5534476,0.027891144,0.40751445,0.004577714,0.0027588143,0.0009937134,0.00046316875,0.000093854396,0.0022595339],"genre_scores_gemma":[0.9907953,0.0003917042,0.00377169,0.0017570219,0.0022795044,0.00015786411,0.0004694837,0.000049739967,0.00032765372],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9975022,0.00028288,0.0009803704,0.00045490655,0.0004803055,0.00029930682],"domain_scores_gemma":[0.9971007,0.00073647156,0.0006699635,0.00021185214,0.0010984152,0.00018259788],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007362237,0.00035047517,0.0011542223,0.0005645625,0.00006566699,0.000060256905,0.00023254938,0.00031937647,0.0003226337],"category_scores_gemma":[0.000053393127,0.00025498433,0.0024203027,0.00042145466,0.00019524114,0.0002947692,0.00004420805,0.00055118033,0.000044289092],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026534809,0.0039169835,0.08108222,0.00016493983,0.44758347,0.0019407667,0.0022150567,0.004730129,0.027518718,0.011357623,0.008490707,0.3844646],"study_design_scores_gemma":[0.033528518,0.031156145,0.21189548,0.00009289405,0.4236529,0.0017306134,0.00031663367,0.0141855525,0.062338743,0.035574567,0.18387276,0.0016552146],"about_ca_topic_score_codex":0.00002140593,"about_ca_topic_score_gemma":0.000005499636,"teacher_disagreement_score":0.4373477,"about_ca_system_score_codex":0.001456506,"about_ca_system_score_gemma":0.0009470129,"threshold_uncertainty_score":0.9999902},"labels":[],"label_agreement":null},{"id":"W4402907294","doi":"10.1016/j.ijrobp.2024.07.1329","title":"Long-Term Outcomes of SAbR for Metastatic RCC","year":2024,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"SABR volatility model; Term (time); Medicine; Economics; Physics; Astronomy; Econometrics","score_opus":0.048861609843409926,"score_gpt":0.3818560864492682,"score_spread":0.3329944766058583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402907294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95640856,0.002881513,0.031820625,0.0041664024,0.0035873642,0.0004701503,0.0001359695,0.000038919265,0.0004904906],"genre_scores_gemma":[0.99177235,0.00038393307,0.0058378936,0.00041950497,0.0011489886,0.000022781234,0.00013572577,0.00003381328,0.00024500838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983394,0.00010438296,0.00086637493,0.0002047074,0.0002989876,0.00018615095],"domain_scores_gemma":[0.9974948,0.00089036726,0.0006473941,0.00014281392,0.00071234663,0.00011228846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046837545,0.00019594589,0.00065179676,0.0002590819,0.00002845246,0.000022942091,0.000244062,0.0001226321,0.00008652857],"category_scores_gemma":[0.0002740505,0.00014636645,0.0005337628,0.00013029455,0.00013760042,0.00019145464,0.00003679492,0.00026345608,0.000025828303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008148756,0.00093496067,0.70932645,0.00015194844,0.0054502888,0.00031571067,0.0005585371,0.00020100405,0.011355662,0.019825133,0.0016521631,0.24941325],"study_design_scores_gemma":[0.023213588,0.011083424,0.8279872,0.00063778553,0.004003485,0.0022903658,0.00017280555,0.004516904,0.055435896,0.040087014,0.029941851,0.000629708],"about_ca_topic_score_codex":0.0000070035317,"about_ca_topic_score_gemma":0.000002424668,"teacher_disagreement_score":0.24878354,"about_ca_system_score_codex":0.00067435054,"about_ca_system_score_gemma":0.0006140743,"threshold_uncertainty_score":0.59686506},"labels":[],"label_agreement":null},{"id":"W4402909613","doi":"10.1016/j.ijrobp.2024.07.1160","title":"Stereotactic Ablative Radiotherapy for Renal Cell Carcinomas - An Experience from a Single Center","year":2024,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Ablative case; Radiation therapy; Medicine; Center (category theory); Renal cell carcinoma; Medical physics; Radiology; Oncology; Chemistry","score_opus":0.03936204397546359,"score_gpt":0.34769992454434645,"score_spread":0.30833788056888284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402909613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9611468,0.0025410743,0.030814698,0.0013669953,0.0028774492,0.0004180001,0.00018498754,0.00005237142,0.0005976342],"genre_scores_gemma":[0.9840946,0.00024056442,0.011017877,0.00070954545,0.0034318417,0.000036218946,0.0002664598,0.000050918487,0.00015194605],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99819976,0.00018488371,0.0006907924,0.00037047907,0.00029948953,0.0002545836],"domain_scores_gemma":[0.99795204,0.00058517564,0.0005318519,0.00019157463,0.00054204126,0.0001973255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002443941,0.00025462004,0.00048836967,0.00019919121,0.00005892561,0.00007693789,0.00029500684,0.00019620029,0.00014764362],"category_scores_gemma":[0.000073939824,0.0002074877,0.00034297802,0.00012547108,0.00014878204,0.00049591897,0.000029647941,0.00035354437,0.000017117283],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005206434,0.0037558742,0.26938775,0.00005291774,0.0045520836,0.00094676355,0.016750405,0.00042880024,0.45182884,0.0030149121,0.0027910979,0.24128413],"study_design_scores_gemma":[0.049270477,0.039471686,0.081650145,0.00077244587,0.0019157125,0.0033510793,0.0018613864,0.050081626,0.36941,0.02274622,0.3778234,0.0016457901],"about_ca_topic_score_codex":0.000039462182,"about_ca_topic_score_gemma":0.0000045415527,"teacher_disagreement_score":0.37503234,"about_ca_system_score_codex":0.0016460835,"about_ca_system_score_gemma":0.0004965597,"threshold_uncertainty_score":0.8461103},"labels":[],"label_agreement":null},{"id":"W4402980753","doi":"10.1016/j.urology.2024.09.054","title":"Reply to Editorial Comment on “Preoperative Computed Tomography Imaging Accurately Identifies Adrenal Gland Involvement In Patients With Renal Masses”","year":2024,"lang":"en","type":"letter","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University","funders":"","keywords":"Medicine; Adrenal gland; Computed tomography; Radiology; Pathology","score_opus":0.017385500748454245,"score_gpt":0.25659875677963195,"score_spread":0.2392132560311777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402980753","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1314455,0.00031906978,0.000067227586,0.8391409,0.024417667,0.0034476407,0.00024114046,0.00016181843,0.0007590755],"genre_scores_gemma":[0.08874149,0.0000053860995,0.00022155514,0.8776792,0.028909396,0.00040466784,0.0035966376,0.00013507808,0.00030653313],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960472,0.000291852,0.0006883915,0.0012293269,0.0010247756,0.0007184545],"domain_scores_gemma":[0.9984023,0.00023292034,0.00019607123,0.00069356256,0.00030125515,0.00017391438],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021396801,0.0007065268,0.0009510885,0.0011066945,0.00007720954,0.00012245082,0.00024879427,0.00039508427,0.000086406006],"category_scores_gemma":[0.000033167278,0.0005165467,0.00018764037,0.0004575053,0.00013029293,0.00007119729,0.00022689646,0.0020718344,0.00014211982],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027990218,0.0003070745,0.04759358,0.00014588618,0.0005572022,0.003242555,0.00042903103,0.00008402652,0.000014239348,0.000005104482,0.9447333,0.00008894513],"study_design_scores_gemma":[0.0056796526,0.0068632932,0.032473758,0.00046849935,0.00054614263,0.0000327462,0.000025317355,0.000041091902,0.00030851533,0.000055012002,0.9530052,0.0005007557],"about_ca_topic_score_codex":0.0004732028,"about_ca_topic_score_gemma":0.000075536875,"teacher_disagreement_score":0.042704,"about_ca_system_score_codex":0.0005082485,"about_ca_system_score_gemma":0.00019709542,"threshold_uncertainty_score":0.9997286},"labels":[],"label_agreement":null},{"id":"W4402991996","doi":"10.3390/cancers16193334","title":"Stereotactic Body Radiotherapy for Renal Cell Carcinoma—A Review of Use in the Primary, Cytoreductive and Oligometastatic Settings","year":2024,"lang":"en","type":"review","venue":"Cancers","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Radiosurgery; Radiation therapy; Stage (stratigraphy); Oncology; Toxicity; Disease; Radiology; Incidence (geometry); Internal medicine","score_opus":0.05255251614066199,"score_gpt":0.3402271889665175,"score_spread":0.2876746728258555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402991996","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010166744,0.99290633,0.000004480047,0.00014681106,0.00016017532,0.005329372,0.00019038352,0.000010857246,0.0002349001],"genre_scores_gemma":[0.00016684455,0.99668086,0.0005907666,0.00064065313,0.0001605551,0.0010398839,0.00019816327,0.000092301176,0.0004299861],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99782884,0.00023097469,0.00076609605,0.00055753504,0.00031476727,0.00030180326],"domain_scores_gemma":[0.9982786,0.0005372255,0.00045162052,0.00055109547,0.00008272806,0.00009871293],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052542007,0.00048656252,0.0023156723,0.0002580462,0.000026789292,0.000030195306,0.00016899628,0.000109933244,0.000018271188],"category_scores_gemma":[0.000071256865,0.00027775802,0.0005673247,0.00046621036,0.00013555925,0.000068933114,0.000029725166,0.00039165228,0.000002851069],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094435105,0.000044478133,0.000025409528,0.83788157,0.00065704883,0.00021394329,0.0006682405,2.1939253e-7,0.000019441439,0.000016856016,0.011888565,0.14848979],"study_design_scores_gemma":[0.00089653046,0.0007942437,0.00009690177,0.14179724,0.010436357,0.00041374317,0.00007612235,0.0000042405495,0.000018751307,0.00000817534,0.84518623,0.0002714777],"about_ca_topic_score_codex":0.00018275027,"about_ca_topic_score_gemma":0.0000049714877,"teacher_disagreement_score":0.83329767,"about_ca_system_score_codex":0.0030096949,"about_ca_system_score_gemma":0.0019732115,"threshold_uncertainty_score":0.99996746},"labels":[],"label_agreement":null},{"id":"W4403072778","doi":"10.3390/curroncol31100443","title":"A Case of Primary Ewing Sarcoma of the Kidney: Robotic-Assisted Nephron-Sparing Surgery, a Feasible Alternative in Treatment of Localized Disease","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Asymptomatic; Nephrectomy; Sarcoma; Surgery; Disease; Kidney; Biopsy; Localized disease; Radiology; Pathology; Cancer; Internal medicine","score_opus":0.16735323421859943,"score_gpt":0.38093866850364616,"score_spread":0.21358543428504673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403072778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850548,0.012119318,0.00011453539,0.0004672304,0.00078443566,0.0009208716,0.000041783274,0.000019077825,0.000477937],"genre_scores_gemma":[0.9990748,0.000431549,0.0001831168,0.000022854701,0.0000677096,0.00009631404,0.000041801395,0.000023625098,0.000058189242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981989,0.0002852515,0.000697064,0.0003269659,0.00023247788,0.00025930835],"domain_scores_gemma":[0.99844253,0.00059658295,0.00024821633,0.0004045573,0.00009735624,0.00021076479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020466813,0.00021945762,0.0009796373,0.00032057715,0.000023218514,0.000004609061,0.00008549714,0.000066177476,0.000038842787],"category_scores_gemma":[0.00014189394,0.00014334235,0.00040396716,0.00046659264,0.00022426559,0.00004359492,0.00009130293,0.00013246173,0.0000022517713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040215645,0.0120334495,0.6095125,0.007148016,0.0012518576,0.016896673,0.0045950767,0.00044436305,0.009690174,0.0005232354,0.0008830929,0.333],"study_design_scores_gemma":[0.02476235,0.006273468,0.83341265,0.012414794,0.0058585964,0.00533233,0.0008595271,0.023357943,0.072967336,0.0006328225,0.013373995,0.0007542098],"about_ca_topic_score_codex":0.0004889002,"about_ca_topic_score_gemma":0.000073287825,"teacher_disagreement_score":0.3322458,"about_ca_system_score_codex":0.0014637923,"about_ca_system_score_gemma":0.0015069244,"threshold_uncertainty_score":0.58453315},"labels":[],"label_agreement":null},{"id":"W4403233182","doi":"10.5489/cuaj.8906","title":"Length of hospital stay and procedure time after partial nephrectomy or percutaneous thermal ablation","year":2024,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University; University of Ottawa; University of Toronto; Hamilton Health Sciences; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke; McMaster University; McGill University; Impact","funders":"","keywords":"Percutaneous; Nephrectomy; Ablation; Medicine; Thermal ablation; Surgery; Internal medicine; Kidney","score_opus":0.015471265216270794,"score_gpt":0.25135317820325154,"score_spread":0.23588191298698075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403233182","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04779102,0.9490932,5.9275084e-7,0.0011057549,0.00029669038,0.0010220198,0.00016413763,0.000027148431,0.0004993927],"genre_scores_gemma":[0.06400199,0.9314644,0.00012862547,0.00028119635,0.0012768677,0.000089767374,0.0001205425,0.000071050774,0.0025656114],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99791604,0.00022339365,0.0006588856,0.00032932972,0.00042438664,0.00044796313],"domain_scores_gemma":[0.99840534,0.00016463599,0.00046317143,0.000119998804,0.00018598414,0.0006608956],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036764148,0.00036278856,0.001185627,0.00027131604,0.000087371045,0.000100674544,0.00008712569,0.0006551872,0.0011459236],"category_scores_gemma":[0.0003657822,0.0002122456,0.00041877566,0.00022730538,0.00004621818,0.0000654703,0.000023518622,0.0009710187,0.00014176939],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076191884,0.00045314612,0.032875553,0.008615279,0.0067239334,0.024269925,0.0011570515,0.0000057038906,0.000012521183,0.000044224682,0.017874788,0.90720594],"study_design_scores_gemma":[0.00040626485,0.0020339757,0.005870092,0.0016114819,0.005395409,0.0054701683,0.000018052013,0.000042294676,9.263393e-7,0.00003292567,0.9787675,0.0003509023],"about_ca_topic_score_codex":0.00011692451,"about_ca_topic_score_gemma":0.00010295672,"teacher_disagreement_score":0.96089274,"about_ca_system_score_codex":0.0016562566,"about_ca_system_score_gemma":0.001633101,"threshold_uncertainty_score":0.9997672},"labels":[],"label_agreement":null},{"id":"W4403315336","doi":"10.3389/fonc.2024.1417630","title":"Microvascular invasion is associated with poor prognosis in renal cell carcinoma: a retrospective cohort study and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Southern Medical University; Sun Yat-sen University; National Natural Science Foundation of China","keywords":"Renal cell carcinoma; Medicine; Retrospective cohort study; Oncology; Internal medicine; Cohort","score_opus":0.05300751683911128,"score_gpt":0.3206426826303565,"score_spread":0.26763516579124524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403315336","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.039927177,0.95174724,0.000009843373,0.00010967881,0.00014714467,0.007365129,0.00007940883,0.000035508725,0.0005788613],"genre_scores_gemma":[0.08678458,0.9048575,0.0018160277,0.000104143735,0.000053451968,0.003702215,0.00045093166,0.00016462493,0.0020664902],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99441266,0.0012830843,0.0012373092,0.0018197248,0.00065871835,0.000588485],"domain_scores_gemma":[0.9983117,0.00015334052,0.0005761464,0.0006046134,0.00015662922,0.00019756352],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001537721,0.0009264113,0.011873922,0.0024669822,0.00005037742,0.00003812834,0.00022337219,0.00081075577,0.000082138344],"category_scores_gemma":[0.000091727976,0.00058929063,0.0020150084,0.0032341608,0.0001804465,0.00005188955,0.00020490897,0.0013631642,0.000011479551],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016198723,0.0027564669,0.63939464,0.0028778415,0.3292392,0.012735331,0.0009815717,7.495639e-7,5.920506e-7,5.6087146e-7,0.0053588157,0.006492269],"study_design_scores_gemma":[0.002298803,0.003994432,0.046266787,0.00033089076,0.9295211,0.00014213145,0.0003351603,0.000019036834,0.000010104848,0.000010619055,0.016562993,0.0005079725],"about_ca_topic_score_codex":0.0007147121,"about_ca_topic_score_gemma":0.0011715747,"teacher_disagreement_score":0.6002819,"about_ca_system_score_codex":0.005654778,"about_ca_system_score_gemma":0.0008988782,"threshold_uncertainty_score":0.99965584},"labels":[],"label_agreement":null},{"id":"W4403499706","doi":"10.1016/j.clgc.2024.102237","title":"The Impact of Concomitant Medications on the Overall Survival of Patients Treated with Systemic Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-analysis","year":2024,"lang":"en","type":"review","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Concomitant; Renal cell carcinoma; Systemic therapy; Oncology; Meta-analysis; Internal medicine; Overall survival; Intensive care medicine; Cancer","score_opus":0.1818844136184329,"score_gpt":0.4447486379091504,"score_spread":0.26286422429071754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403499706","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0066680936,0.9775145,0.00000416351,0.00014822163,0.000057207093,0.014091303,0.0014606607,0.000013989368,0.00004183524],"genre_scores_gemma":[0.042590305,0.94975126,0.00003840948,0.000066926485,0.000047784826,0.006153571,0.0001860127,0.00008633329,0.0010794158],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99344367,0.0017334966,0.0031646618,0.00069940876,0.0006410056,0.0003177324],"domain_scores_gemma":[0.9878401,0.007219608,0.0026423403,0.0014875589,0.00059479394,0.00021560681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017035356,0.00077047595,0.010522966,0.00017399757,0.00010202426,0.000020198118,0.00040439153,0.00015377969,0.00008566467],"category_scores_gemma":[0.00035127113,0.00023017607,0.00578957,0.0008322467,0.00031782873,0.000028101926,0.00006685586,0.00046524202,0.0000037720472],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013513243,0.00077323295,0.00018616942,0.6493495,0.3461978,0.00005599433,0.00003998617,0.000006781373,5.9189676e-7,0.000009429473,0.0006807405,0.0013484075],"study_design_scores_gemma":[0.0016958587,0.0064023673,0.00019295063,0.029053478,0.9616479,0.000029338738,0.000026076692,0.000013918281,0.0000031151612,0.0000038458575,0.00068932935,0.00024181686],"about_ca_topic_score_codex":0.000067710454,"about_ca_topic_score_gemma":0.000013159319,"teacher_disagreement_score":0.62029606,"about_ca_system_score_codex":0.00032305988,"about_ca_system_score_gemma":0.0012377676,"threshold_uncertainty_score":0.93863076},"labels":[],"label_agreement":null},{"id":"W4403629419","doi":"10.1016/j.rx.2024.07.007","title":"Sistema de navegación electromagnética para la ablación percutánea de tumores abdominales guiada por TC: seguridad y efectividad","year":2024,"lang":"es","type":"article","venue":"Radiología","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine","score_opus":0.01353011109752216,"score_gpt":0.2893105534284709,"score_spread":0.2757804423309487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403629419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9074371,0.07058993,0.00036968308,0.0024888625,0.00044447262,0.0010961604,0.00009495349,0.0004544367,0.017024439],"genre_scores_gemma":[0.9860759,0.0031266299,0.0014998642,0.00037810564,0.0017574729,0.00028559472,0.00010826133,0.00022292687,0.00654527],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9937348,0.0014743714,0.0009409097,0.0013495581,0.0005847749,0.0019156238],"domain_scores_gemma":[0.99536675,0.0024627687,0.00019493069,0.0010582447,0.00011501734,0.0008023086],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020550366,0.0010284886,0.0014823849,0.00063785724,0.0002730414,0.0004288605,0.00048151537,0.00067897944,0.00035941924],"category_scores_gemma":[0.00074009964,0.000847569,0.0009047016,0.00074641197,0.00063746836,0.00020688103,0.00013828755,0.001236078,0.000946541],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00268457,0.0014693042,0.10932741,0.011143729,0.0060438258,0.06855097,0.003862427,0.00012584249,0.6822429,0.037597816,0.047378197,0.029573059],"study_design_scores_gemma":[0.005277531,0.009291653,0.5975989,0.007914112,0.009209292,0.06693752,0.0012855695,0.015276239,0.16160472,0.002988091,0.11957162,0.0030447259],"about_ca_topic_score_codex":0.00031331115,"about_ca_topic_score_gemma":0.000017468097,"teacher_disagreement_score":0.5206381,"about_ca_system_score_codex":0.0023334976,"about_ca_system_score_gemma":0.0015297814,"threshold_uncertainty_score":0.9998313},"labels":[],"label_agreement":null},{"id":"W4403701324","doi":"10.1097/coc.0000000000001150","title":"Efficacy and Safety of Lenvatinib in Combination With Other Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma","year":2024,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Lenvatinib; Medicine; Internal medicine; Renal cell carcinoma; Adverse effect; Oncology; Sorafenib; Hepatocellular carcinoma","score_opus":0.10550136030377723,"score_gpt":0.43960692323035616,"score_spread":0.33410556292657895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403701324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.071219265,0.92558783,0.00013020576,0.0006120203,0.00032742196,0.0017068923,0.000040943065,0.0000064573987,0.000368986],"genre_scores_gemma":[0.074852735,0.9114943,0.012666695,0.00018287747,0.00043292355,0.000051473697,0.0000355661,0.0001138742,0.00016952188],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944017,0.00084391417,0.003757257,0.0003858084,0.00034622865,0.0002651123],"domain_scores_gemma":[0.99050415,0.0046358695,0.0040149773,0.00025140567,0.00029787028,0.00029574498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002211246,0.00040019042,0.0059262067,0.0005180365,0.000018044679,0.000007879421,0.0001435222,0.00019930821,0.000015885167],"category_scores_gemma":[0.0006612799,0.00023368483,0.00079109543,0.0005223487,0.0007557999,0.000043901313,0.000049982515,0.0010299768,0.000003427437],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048910924,0.0018311891,0.0008096102,0.0051656095,0.0006699032,0.0006410145,0.000093804025,0.0000018154357,0.0000054869447,0.000043312797,0.00027443658,0.9855727],"study_design_scores_gemma":[0.023651741,0.12489799,0.0039633936,0.016291264,0.0176574,0.0015295101,0.00018815848,0.000012976873,0.000039780967,0.000053800293,0.81132877,0.00038520846],"about_ca_topic_score_codex":0.00004391816,"about_ca_topic_score_gemma":0.000016282887,"teacher_disagreement_score":0.98518753,"about_ca_system_score_codex":0.0003119196,"about_ca_system_score_gemma":0.002229047,"threshold_uncertainty_score":0.95293903},"labels":[],"label_agreement":null},{"id":"W4403731062","doi":"10.1016/j.euo.2024.10.008","title":"Oncological Outcomes of Active Surveillance versus Surgery or Ablation for Patients with Small Renal Masses: A Systematic Review and Quantitative Analysis","year":2024,"lang":"en","type":"review","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"Agencja Badań Medycznych; European Association of Urology","keywords":"Medicine; Ablation; Renal mass; Radiology; Medical physics; Internal medicine; Kidney; Nephrectomy","score_opus":0.13097529584533918,"score_gpt":0.3802293122406022,"score_spread":0.249254016395263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403731062","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010429651,0.9914912,0.000120276374,0.00016743972,0.00020928332,0.005942962,0.00025378336,0.000052413365,0.00071969104],"genre_scores_gemma":[0.00083541835,0.99536973,0.0015571028,0.0002066173,0.000037592854,0.0005889865,0.0010080786,0.00009452375,0.00030194988],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9935855,0.0033316128,0.0016283299,0.00087772025,0.00020760528,0.00036919667],"domain_scores_gemma":[0.9854018,0.011847211,0.0017166435,0.00051628763,0.00036749625,0.00015055419],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001467544,0.0006422167,0.008970197,0.0006699651,0.000051463136,0.000010091189,0.00016836711,0.00029991454,0.00003913208],"category_scores_gemma":[0.0030459356,0.00032969197,0.0010075571,0.0008440336,0.00030444685,0.000031881787,0.00012604444,0.00041466093,0.000038741196],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042602313,0.00081366004,0.002256381,0.9308514,0.038022976,0.0014037577,0.00012978792,0.0000013368729,6.4227045e-8,0.00008145981,0.00042282286,0.021756107],"study_design_scores_gemma":[0.006170916,0.043780006,0.026966812,0.09680327,0.65515846,0.00040385587,0.00007775606,0.000017149554,1.2315536e-7,0.000008529437,0.1695086,0.0011044915],"about_ca_topic_score_codex":0.0000065713502,"about_ca_topic_score_gemma":0.00012424447,"teacher_disagreement_score":0.83404815,"about_ca_system_score_codex":0.00041477763,"about_ca_system_score_gemma":0.0007008338,"threshold_uncertainty_score":0.99991554},"labels":[],"label_agreement":null},{"id":"W4403807851","doi":"10.1503/cmaj.241508","title":"Correction to “Advances in the management of renal cell carcinoma”","year":2024,"lang":"en","type":"erratum","venue":"Canadian Medical Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Computer science; Renal cell carcinoma; Text mining; Data science; World Wide Web; Information retrieval; Medicine; Pathology; Natural language processing","score_opus":0.008258106270176856,"score_gpt":0.2444708424512779,"score_spread":0.23621273618110103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403807851","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01428669,0.0330806,0.000057474677,0.042806417,0.097775534,0.0014690893,0.00009934722,0.00002891019,0.81039596],"genre_scores_gemma":[0.36501184,0.009543889,0.00027659562,0.012151424,0.015059252,0.00014968088,0.0003769477,0.00015080757,0.59727955],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957241,0.00019261267,0.0007157289,0.00028701458,0.0025654763,0.00051510957],"domain_scores_gemma":[0.9980952,0.000118894706,0.00029363536,0.00022461856,0.00026106485,0.001006589],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001658656,0.00025209418,0.00048479115,0.0006557192,0.000093606184,0.000065911794,0.00031529306,0.0005114164,0.00091889186],"category_scores_gemma":[0.00019842708,0.00017696743,0.00025542334,0.0006720091,0.00002717448,0.000057593308,0.00002821633,0.0029900179,0.00020642338],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019009141,0.00004838739,0.0016760438,0.00027962125,0.00011821624,0.005364858,0.0004094522,0.0000061733726,0.0000014122343,0.000024107347,0.9749616,0.017091142],"study_design_scores_gemma":[0.00059466757,0.00030699951,0.02353284,0.0016868819,0.00036988436,0.00064221135,0.0008636984,0.00006757678,0.00001904823,0.00005927187,0.9717064,0.00015052964],"about_ca_topic_score_codex":0.0024150354,"about_ca_topic_score_gemma":0.029376633,"teacher_disagreement_score":0.35072514,"about_ca_system_score_codex":0.0038766458,"about_ca_system_score_gemma":0.0035655608,"threshold_uncertainty_score":0.9999944},"labels":[],"label_agreement":null},{"id":"W4403831268","doi":"10.1681/asn.2024r801671n","title":"Diabetes-Specific Kidney Function Loci Identified in Genome-Wide Association Study of eGFR in 52,000 Individuals with Diabetes","year":2024,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Diabetes mellitus; Medicine; Genome-wide association study; Renal function; Internal medicine; Biology; Genetics; Endocrinology; Single-nucleotide polymorphism; Gene; Genotype","score_opus":0.014519876145423561,"score_gpt":0.24677035506176606,"score_spread":0.2322504789163425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403831268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939168,0.001003156,0.000011707496,0.0044655716,0.000117834454,0.0004285629,0.0000090695685,0.000007651431,0.000039663995],"genre_scores_gemma":[0.9969542,0.00017691521,0.0002519613,0.0023642578,0.00012622168,0.000012769595,0.000004991722,0.000025050193,0.00008362538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976382,0.00038216804,0.0008324364,0.0002115867,0.0006318189,0.00030378942],"domain_scores_gemma":[0.99770504,0.0005392881,0.0012304194,0.0002571269,0.00018121053,0.00008689691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012312726,0.00017827329,0.0009120167,0.00025313962,0.000029433944,0.0000151792065,0.00019522739,0.0000850761,0.00003583683],"category_scores_gemma":[0.00009062393,0.0001170702,0.0003317641,0.0010170706,0.00022933377,0.00011019509,0.00006481464,0.00055165245,0.0000021412607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024689623,0.0006754659,0.9392231,0.000084129155,0.0012639693,0.000015363006,0.0029853443,0.0001660161,0.04515528,0.0000011665358,0.009529046,0.0006542391],"study_design_scores_gemma":[0.0023916499,0.004298314,0.98573476,0.00014249676,0.00045174148,0.0000057548637,0.0031277363,0.00004911221,0.0011254603,0.00008101611,0.0025088626,0.00008306815],"about_ca_topic_score_codex":0.00009473316,"about_ca_topic_score_gemma":0.000027803388,"teacher_disagreement_score":0.046511702,"about_ca_system_score_codex":0.000744214,"about_ca_system_score_gemma":0.00019748611,"threshold_uncertainty_score":0.47739843},"labels":[],"label_agreement":null},{"id":"W4403877132","doi":"10.5489/cuaj.9041","title":"2024 CUA-KCRNC Expert Report: Management of non-clear cell renal cell carcinoma","year":2024,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Dalhousie University; Centre Hospitalier Universitaire de Sherbrooke; University of British Columbia; McMaster University; University of Manitoba; Juravinski Cancer Centre; Université de Sherbrooke; Western University; University of Toronto; BC Cancer Agency; University of Calgary; Princess Margaret Cancer Centre; University Health Network; Ottawa Hospital; McGill University; McGill University Health Centre; University of Ottawa; Université Laval; University of Alberta","funders":"","keywords":"Renal cell carcinoma; Medicine; Internal medicine; Oncology; Cancer research","score_opus":0.013584435697164424,"score_gpt":0.2344409064976307,"score_spread":0.22085647080046628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403877132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90482557,0.0036862402,0.000119853335,0.0074937413,0.0010552015,0.00037646698,0.000027979677,0.00003553303,0.0823794],"genre_scores_gemma":[0.96893615,0.0002234349,0.0008591973,0.0007170848,0.0005231528,0.00001590549,0.000034305922,0.00003160424,0.028659195],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9975549,0.00010506952,0.0006781697,0.00038821754,0.00067520124,0.00059844786],"domain_scores_gemma":[0.99826974,0.000086884385,0.00027626136,0.0002518454,0.00021075064,0.00090455014],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006646717,0.00023673903,0.00039994862,0.00033185986,0.00014402128,0.00010175612,0.00015018677,0.0002637443,0.0018503219],"category_scores_gemma":[0.00004472326,0.00018621405,0.00035798433,0.00036952653,0.000036752543,0.00008809617,0.00003639603,0.0006825281,0.00023992037],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042371405,0.00063631055,0.33715665,0.0005726352,0.0011591902,0.13616806,0.0014085724,0.00015803125,0.014731872,0.0002093289,0.49735585,0.010019785],"study_design_scores_gemma":[0.00252885,0.0023753713,0.697867,0.0002064081,0.0008699728,0.0033193813,0.00053825334,0.0009404799,0.0085119605,0.00033130927,0.28198463,0.00052641425],"about_ca_topic_score_codex":0.0010179512,"about_ca_topic_score_gemma":0.00006912087,"teacher_disagreement_score":0.36071032,"about_ca_system_score_codex":0.0020461145,"about_ca_system_score_gemma":0.00056715496,"threshold_uncertainty_score":0.9990621},"labels":[],"label_agreement":null},{"id":"W4404046917","doi":"10.21203/rs.3.rs-5313658/v1","title":"Sex-specific Body Composition Features Impacting Survival Outcomes in Surgically Managed Clear Cell Renal Cell Carcinoma","year":2024,"lang":"en","type":"preprint","venue":"Research Square","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Renal cell carcinoma; Composition (language); Cell; Carcinoma; Internal medicine; Oncology; Medicine; Biology; Genetics; Art","score_opus":0.05660129644044821,"score_gpt":0.36003519181792343,"score_spread":0.3034338953774752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404046917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9415807,0.0064870217,0.000009729856,0.0014167438,0.00046372422,0.0029524888,0.00018519582,0.00020156894,0.046702843],"genre_scores_gemma":[0.9867192,0.00058829505,0.00040182887,0.000025481202,0.0005877186,0.00023854223,0.0009498362,0.0002236401,0.010265437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99087906,0.0016762328,0.00094379694,0.0018265839,0.003062552,0.0016117654],"domain_scores_gemma":[0.99578303,0.0011987785,0.00018038032,0.001649064,0.0004945909,0.000694164],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0030332268,0.00084429124,0.0015950853,0.0017914813,0.00026622793,0.00047997638,0.00056588126,0.0008225947,0.00034440242],"category_scores_gemma":[0.00008173518,0.00069531647,0.00081193174,0.0008337463,0.00022003299,0.00007466417,0.0021549247,0.007042851,0.0004970264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012246314,0.008598338,0.49387228,0.04492263,0.0011536967,0.106780834,0.009193295,0.0013804209,0.28946063,0.000799324,0.025545081,0.006047147],"study_design_scores_gemma":[0.006085296,0.002784075,0.87012786,0.0029238905,0.00027055803,0.0001863737,0.0032672868,0.00067279476,0.10967489,0.00095975684,0.0017779235,0.0012692858],"about_ca_topic_score_codex":0.0016558896,"about_ca_topic_score_gemma":0.00011662544,"teacher_disagreement_score":0.3762556,"about_ca_system_score_codex":0.0024917335,"about_ca_system_score_gemma":0.0006906725,"threshold_uncertainty_score":0.9995498},"labels":[],"label_agreement":null},{"id":"W4404061099","doi":"10.1016/j.hoc.2024.08.003","title":"Surgical Management of Genitourinary Cancer Liver Metastases","year":2024,"lang":"en","type":"review","venue":"Hematology/Oncology Clinics of North America","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Genitourinary system; Medicine; Cancer; General surgery; Liver cancer; Radiology; Oncology; Internal medicine","score_opus":0.09690789587536382,"score_gpt":0.42681960358275606,"score_spread":0.32991170770739225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404061099","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021755255,0.99253625,0.000006765536,0.00010028096,0.00068293186,0.0017582638,0.0003887305,0.00006688605,0.0022843643],"genre_scores_gemma":[0.00054018595,0.9935252,0.0037194155,0.00006480402,0.00015001677,0.00057988905,0.00048487092,0.00011056536,0.00082502735],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99494857,0.00051025004,0.0025818145,0.0009735383,0.00042313983,0.000562719],"domain_scores_gemma":[0.995544,0.0011564427,0.0017844146,0.0010149213,0.00021578063,0.00028441753],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003057263,0.00078553305,0.007462694,0.00054352504,0.00003877585,0.0000033733106,0.00042306958,0.0006164742,0.00040590714],"category_scores_gemma":[0.000041360312,0.0005618243,0.0020917752,0.0008150865,0.0010058868,0.00002927807,0.0005508326,0.000939111,0.00032636567],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030182998,0.0013451788,0.001271322,0.08886006,0.007940504,0.0311956,0.000031565487,0.000001403901,1.5910311e-8,0.00015118651,0.0047818045,0.8641195],"study_design_scores_gemma":[0.00094989105,0.0023371873,0.00018213103,0.00905148,0.035211075,0.0043181702,0.000040817416,0.0000061971746,0.000002086903,0.000014019708,0.9475487,0.00033827964],"about_ca_topic_score_codex":0.00006290811,"about_ca_topic_score_gemma":0.00002078966,"teacher_disagreement_score":0.94276685,"about_ca_system_score_codex":0.00030428809,"about_ca_system_score_gemma":0.0012437829,"threshold_uncertainty_score":0.9996833},"labels":[],"label_agreement":null},{"id":"W4404193191","doi":"10.1186/s13244-024-01841-2","title":"Proceedings from an international consensus meeting on ablation in urogenital diseases","year":2024,"lang":"en","type":"article","venue":"Insights into Imaging","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Consensus conference; Medicine; Interventional radiology; Neuroradiology; Genitourinary system; Ablation; Medical physics; Radiology; Internal medicine","score_opus":0.01679844774651599,"score_gpt":0.2898472245887432,"score_spread":0.27304877684222717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404193191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98131186,0.0014405502,0.00001276948,0.00132126,0.0003848568,0.000203357,0.0000056784984,0.00015756697,0.015162123],"genre_scores_gemma":[0.99832296,0.000013869568,0.00079213886,0.00024379784,0.00040711192,0.000021133714,0.00009795551,0.00002963615,0.00007139902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989308,0.00001483157,0.000229756,0.00038481053,0.0003022746,0.00013749512],"domain_scores_gemma":[0.999583,0.00009322592,0.000034473287,0.0001061136,0.00007850956,0.000104663915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048828704,0.00014830846,0.00014124112,0.00031204434,0.000042380576,0.00013679964,0.000066075816,0.0000281005,0.00004926228],"category_scores_gemma":[0.000085374784,0.00012002807,0.00005780377,0.00014658095,0.000047000445,0.00025000516,0.000030971005,0.00015047398,0.00006253165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006834551,0.0006230715,0.80099094,0.00017024034,0.00029603756,0.0056961216,0.013869929,0.000108979424,0.10898807,0.004821279,0.00078768184,0.06296418],"study_design_scores_gemma":[0.003134096,0.00042016132,0.6810267,0.003047093,0.00041009692,0.00026209492,0.002280097,0.18932995,0.09333425,0.013230952,0.0128105255,0.00071400456],"about_ca_topic_score_codex":0.00037991744,"about_ca_topic_score_gemma":0.000022399201,"teacher_disagreement_score":0.18922096,"about_ca_system_score_codex":0.0003675151,"about_ca_system_score_gemma":0.000062910236,"threshold_uncertainty_score":0.48946026},"labels":[],"label_agreement":null},{"id":"W4404285065","doi":"10.1016/j.urolonc.2024.10.019","title":"Primary tumor ablation in metastatic renal cell carcinoma","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Primary tumor; Oncology; Ablation; Metastasis; Primary (astronomy); Internal medicine; Pathology; Cancer","score_opus":0.031147960956490958,"score_gpt":0.2933860459700578,"score_spread":0.2622380850135668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404285065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96302474,0.006823579,0.000049253576,0.0036170129,0.0001559382,0.0004585823,0.000014134043,0.00007831986,0.025778417],"genre_scores_gemma":[0.96143365,0.0001506863,0.034757372,0.0014867069,0.000100270576,0.00012663916,0.00012598361,0.000019458954,0.0017992215],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986031,0.00013556806,0.00035527966,0.00044502743,0.00016623612,0.00029478507],"domain_scores_gemma":[0.99917734,0.0003278986,0.00006827108,0.0001752167,0.00003291967,0.00021837809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035324466,0.00020660636,0.00037572556,0.00034202615,0.00008993948,0.000030979598,0.00005738135,0.00010803627,0.00011110929],"category_scores_gemma":[0.00005237046,0.00016409629,0.00006932858,0.00041690102,0.00032828713,0.00012885919,0.00003720172,0.00038068523,0.00006965721],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004125533,0.00088800513,0.9230106,0.00088551646,0.00013333603,0.016228126,0.0020004285,0.00043443093,0.02373497,0.011338026,0.014250581,0.006683462],"study_design_scores_gemma":[0.0022926875,0.006448069,0.124518976,0.00021419633,0.0010847361,0.003363658,0.00031064262,0.0067021544,0.007120164,0.010249095,0.83725417,0.0004414374],"about_ca_topic_score_codex":0.00008558924,"about_ca_topic_score_gemma":0.000025634437,"teacher_disagreement_score":0.8230036,"about_ca_system_score_codex":0.0003839103,"about_ca_system_score_gemma":0.0006381333,"threshold_uncertainty_score":0.66916525},"labels":[],"label_agreement":null},{"id":"W4404520549","doi":"10.1016/j.fpurol.2024.07.039","title":"Nivolumab plus ipilimumab (NIVO+IPI) vs sunitinib (SUN) dans le traitement de première ligne (1L) du carcinome rénal avancé (CCRa) : données de suivi à long terme de l’étude de phase 3 CheckMate 214","year":2024,"lang":"fr","type":"article","venue":"Progrès en Urologie - FMC","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Ipilimumab; Medicine; Cancer research; Immunotherapy; Cancer; Internal medicine","score_opus":0.032118375414773415,"score_gpt":0.2926767589863165,"score_spread":0.2605583835715431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404520549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93253386,0.045592472,0.0049862163,0.008231802,0.0012845191,0.0028819419,0.00029572687,0.001023463,0.0031700141],"genre_scores_gemma":[0.97992045,0.0036865068,0.005007488,0.00062328577,0.0027768014,0.0013017198,0.00034889206,0.00038671165,0.005948175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9892543,0.0014277932,0.0014845543,0.0019123344,0.0010059362,0.00491509],"domain_scores_gemma":[0.9953436,0.0009867497,0.00036740478,0.0013293863,0.00024735622,0.0017254689],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.003410101,0.001505004,0.0016153274,0.00055989996,0.0005355832,0.00056744803,0.0011804447,0.0010462921,0.00065583584],"category_scores_gemma":[0.00064823194,0.0014889931,0.0008664031,0.0007303755,0.0009547415,0.00060019625,0.00062679587,0.0018353313,0.00029809852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013109256,0.0137419915,0.45229995,0.015163542,0.006139045,0.078625984,0.063889034,0.0060860203,0.17234984,0.0030643542,0.0035272117,0.17200376],"study_design_scores_gemma":[0.05784694,0.030526055,0.33804503,0.004955272,0.011750509,0.020288877,0.007985355,0.14188476,0.32411325,0.002436122,0.05529931,0.0048685214],"about_ca_topic_score_codex":0.0023981167,"about_ca_topic_score_gemma":0.001548321,"teacher_disagreement_score":0.16713525,"about_ca_system_score_codex":0.008557509,"about_ca_system_score_gemma":0.005561681,"threshold_uncertainty_score":0.99976987},"labels":[],"label_agreement":null},{"id":"W4404600616","doi":"10.1016/j.ctro.2024.100891","title":"Stereotactic ablative radiotherapy for primary kidney cancer – An international patterns of practice survey","year":2024,"lang":"en","type":"article","venue":"Clinical and Translational Radiation Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Ottawa Hospital; University of Ottawa; McMaster University","funders":"","keywords":"Ablative case; Medicine; Radiation therapy; Cancer; Kidney cancer; Primary cancer; Radiosurgery; SABR volatility model; Radiology; Medical physics; Internal medicine","score_opus":0.08274728884740955,"score_gpt":0.4603409728938457,"score_spread":0.3775936840464361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404600616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9540906,0.0036878756,0.010822364,0.025019763,0.0018813481,0.0012264504,0.0013567732,0.00005011911,0.0018647383],"genre_scores_gemma":[0.9892155,0.0029009774,0.003708719,0.0020789057,0.00053683494,0.00008368551,0.0011988499,0.000019685625,0.00025684788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857986,0.00027599122,0.0005412205,0.0003106021,0.0001904908,0.00010186514],"domain_scores_gemma":[0.9958047,0.0035498664,0.00013438053,0.00009066357,0.0002465796,0.00017375888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008470939,0.00010705553,0.0003192669,0.00009826109,0.000030403902,0.000016038646,0.000047003534,0.00014506497,0.00022401677],"category_scores_gemma":[0.00034754392,0.00008859835,0.000114726245,0.00007722263,0.0000907038,0.00029182053,0.0000046535824,0.00015624786,0.000002158842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003280203,0.0007367358,0.75287235,0.00012963131,0.0014548602,0.000023380593,0.00061594276,0.000039331822,0.00018936506,0.002184625,0.0003038084,0.23816979],"study_design_scores_gemma":[0.0031175793,0.0013614321,0.9111722,0.000042721986,0.00025182523,0.000039576313,0.000013842682,0.0035540066,0.000045571218,0.00022233305,0.08010291,0.00007600287],"about_ca_topic_score_codex":0.000104426595,"about_ca_topic_score_gemma":0.000038492475,"teacher_disagreement_score":0.23809378,"about_ca_system_score_codex":0.00009216658,"about_ca_system_score_gemma":0.00076163025,"threshold_uncertainty_score":0.3612936},"labels":[],"label_agreement":null},{"id":"W4404844019","doi":"10.1016/j.urolonc.2024.11.002","title":"Exploring the effect of patient characteristics on the association between warm ischemia time and the risk of postoperative acute kidney injury after partial nephrectomy","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Warm ischemia; Acute kidney injury; Kidney; Ischemia; Kidney cancer; Surgery; Internal medicine; Kidney disease; Reperfusion injury","score_opus":0.017556215262720182,"score_gpt":0.266089648626238,"score_spread":0.24853343336351782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404844019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853073,0.000285187,0.0000019725787,0.012968335,0.00012131836,0.00079953956,0.0001887374,0.000016643799,0.00031101672],"genre_scores_gemma":[0.9977516,0.00044909044,0.00026721013,0.00081534305,0.00010127861,0.0004329702,0.00004537827,0.000009644218,0.00012751197],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99857384,0.0005974597,0.0002943195,0.00020062504,0.00017999762,0.00015374944],"domain_scores_gemma":[0.9969946,0.0024859447,0.00020288958,0.00017469101,0.000050595434,0.000091249196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008095189,0.000165338,0.0003799895,0.00005317461,0.0001680067,0.000020857187,0.00006190003,0.000099111094,0.000023426523],"category_scores_gemma":[0.0005841872,0.00006787791,0.000087617904,0.0001643945,0.00065451243,0.00005857478,0.00005588468,0.000425246,0.000009444526],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021262427,0.000065794855,0.97538024,0.00006436468,0.0015492088,0.000060968698,0.0049927454,0.0000045035645,0.0043350584,0.001608296,0.003219302,0.0065932786],"study_design_scores_gemma":[0.0033029667,0.02979575,0.12881269,0.0005963007,0.014166468,0.00015508189,0.00026713003,0.0019729296,0.29914895,0.0014676098,0.5199052,0.000408937],"about_ca_topic_score_codex":0.000036622223,"about_ca_topic_score_gemma":7.5662024e-7,"teacher_disagreement_score":0.8465676,"about_ca_system_score_codex":0.00011137816,"about_ca_system_score_gemma":0.00011005494,"threshold_uncertainty_score":0.2767981},"labels":[],"label_agreement":null},{"id":"W4404911856","doi":"10.1097/ju.0000000000004348","title":"Validation of Prognostic Models for Renal Cell Carcinoma Recurrence, Cancer-Specific Mortality, and All-Cause Mortality","year":2024,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Sunnybrook Health Science Centre; Université Laval; Manitoba Health; Centre Hospitalier Universitaire de Sherbrooke; University of British Columbia; University of Alberta; University of Manitoba; Juravinski Cancer Centre; McMaster University; Queen Elizabeth II Health Sciences Centre; University of Ottawa; McGill University; University of Calgary; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network; Ottawa Hospital; University of Toronto; Dalhousie University","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Internal medicine; Cancer; Carcinoma; Kidney cancer","score_opus":0.13021159188897574,"score_gpt":0.3472754483164106,"score_spread":0.21706385642743486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404911856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777099,0.018533979,0.0016476923,0.0009619525,0.00033485828,0.0004958006,0.000032453216,0.000008235413,0.00027513187],"genre_scores_gemma":[0.9972098,0.0021808746,0.00019436315,0.000057580048,0.0002597207,0.00001702268,0.000009971148,0.000018648318,0.000052052783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986358,0.00016339964,0.00055882486,0.00015969056,0.00028212988,0.00020015072],"domain_scores_gemma":[0.9987399,0.00039533686,0.0002937582,0.00022382016,0.0002409497,0.000106210115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000849915,0.0001478471,0.00037741684,0.00014080465,0.000035046687,0.000013288404,0.00011907023,0.00008337688,0.000028223165],"category_scores_gemma":[0.000035293637,0.00009044361,0.00013072096,0.00012490955,0.00015428789,0.000102896374,0.00003782277,0.00025617014,0.0000012064684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013183463,0.0028043648,0.49307972,0.0060404465,0.015093192,0.0027054383,0.014299537,0.020821506,0.38321266,0.009566833,0.020499147,0.018693686],"study_design_scores_gemma":[0.009760557,0.022147652,0.5898156,0.0006243508,0.04010325,0.006258437,0.00048529645,0.033468127,0.2519024,0.040431533,0.004249462,0.0007533104],"about_ca_topic_score_codex":0.000072054354,"about_ca_topic_score_gemma":0.000013142306,"teacher_disagreement_score":0.13131025,"about_ca_system_score_codex":0.000072264906,"about_ca_system_score_gemma":0.00021472412,"threshold_uncertainty_score":0.3688183},"labels":[],"label_agreement":null},{"id":"W4404969668","doi":"10.1016/j.jcpo.2024.100524","title":"Socioeconomic inequalities in kidney and renal pelvis cancer mortality in Canada: Trends over three decades","year":2024,"lang":"en","type":"article","venue":"Journal of Cancer Policy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"Dalhousie University; Canada Research Chairs","keywords":"Socioeconomic status; Cancer; Kidney cancer; Inequality; Renal pelvis; Medicine; Demography; Kidney; Environmental health; Population; Internal medicine; Sociology","score_opus":0.037613957095442914,"score_gpt":0.3531112131080964,"score_spread":0.3154972560126535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404969668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680128,0.020670556,9.3018747e-7,0.009997286,0.00025877345,0.00007295548,0.000094163035,0.0000045469865,0.0008879969],"genre_scores_gemma":[0.99436206,0.0029921914,0.000018393752,0.0011799703,0.0009569505,0.000019695817,0.000002555454,0.000022652526,0.00044555697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857944,0.00004241349,0.0006240925,0.00017400985,0.0002840329,0.00029601456],"domain_scores_gemma":[0.9993299,0.000065159584,0.00016296726,0.0001147934,0.00004297787,0.00028417452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002331913,0.00017841221,0.00051714806,0.0006099205,0.000017136572,0.000032128955,0.00007369355,0.00006247556,0.00044806374],"category_scores_gemma":[0.000031169267,0.000138458,0.00010238521,0.00025018287,0.000058030208,0.00016564815,0.000027908674,0.00037701154,7.750988e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00017226257,0.000025765095,0.97065455,0.00026660084,0.00028887848,0.0005940359,0.0009922595,0.00012888756,0.0005175575,0.00029604294,0.0045809937,0.02148219],"study_design_scores_gemma":[0.0015678162,0.00009794999,0.9913765,0.00079965737,0.0001347558,0.00008231192,0.00012935218,0.00024867203,0.00092456513,0.00046845534,0.0040470087,0.00012295236],"about_ca_topic_score_codex":0.96136993,"about_ca_topic_score_gemma":0.9715906,"teacher_disagreement_score":0.02634924,"about_ca_system_score_codex":0.006298845,"about_ca_system_score_gemma":0.011126681,"threshold_uncertainty_score":0.9975158},"labels":[],"label_agreement":null},{"id":"W4405013870","doi":"10.1111/bju.16609","title":"Is there a minimum percentage of sarcomatoid component required to affect outcomes of localised renal cell carcinoma?","year":2024,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Centre Hospitalier de l’Université de Montréal; Sunnybrook Health Science Centre; University of British Columbia; Alberta Health Services; McMaster University; Queen Elizabeth II Health Sciences Centre; Ottawa Hospital; University Health Network; Dalhousie University; University of Calgary; Princess Margaret Cancer Centre; St. Joseph’s Healthcare Hamilton; University of Manitoba; Juravinski Cancer Centre; University of Ottawa; McGill University Health Centre; McGill University","funders":"Eisai; EMD Serono; Ipsen; Pfizer","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Oncology; Pathological; Metastasis; Sarcomatoid carcinoma; Stage (stratigraphy); Adjuvant therapy; Overall survival; Cancer; Surgery; Carcinoma; Biology","score_opus":0.02064204342689723,"score_gpt":0.271204806493088,"score_spread":0.25056276306619074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405013870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745317,0.02203696,0.00018307162,0.0016460185,0.00033044815,0.00036074742,0.00006788523,0.000013844968,0.0008293367],"genre_scores_gemma":[0.99816805,0.00029488103,0.00057784835,0.0004955212,0.000109482266,0.0000047515805,0.000009123428,0.00004343401,0.00029692854],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976705,0.00022415798,0.0009944168,0.00026630552,0.0005146729,0.00032997076],"domain_scores_gemma":[0.9986804,0.00024612967,0.00031960566,0.00026829314,0.0002022339,0.00028330972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042862637,0.00021877844,0.0010739996,0.00033533885,0.00002855641,0.00001876427,0.00021923732,0.00014443812,0.00035817033],"category_scores_gemma":[0.000053049673,0.00019491366,0.00057852385,0.00017193414,0.00016061282,0.00006755201,0.000082610364,0.00034026036,0.000018942059],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004198102,0.0024673475,0.3366017,0.0020188377,0.0017087526,0.054224867,0.0025731954,0.00009935008,0.5535491,0.00006049509,0.027963534,0.014534736],"study_design_scores_gemma":[0.0056411503,0.0077526486,0.87563455,0.00066728913,0.0009811717,0.02494365,0.0002939377,0.00020630358,0.08059151,0.00008365166,0.0029668512,0.00023726367],"about_ca_topic_score_codex":0.00026472865,"about_ca_topic_score_gemma":0.00002063618,"teacher_disagreement_score":0.5390329,"about_ca_system_score_codex":0.0001222469,"about_ca_system_score_gemma":0.00021493608,"threshold_uncertainty_score":0.79483485},"labels":[],"label_agreement":null},{"id":"W4405050900","doi":"10.1016/j.esmoop.2024.104073","title":"Nivolumab plus relatlimab and nivolumab plus ipilimumab for patients with advanced renal cell carcinoma: results from the open-label, randomised, phase II FRACTION-RCC trial","year":2024,"lang":"en","type":"article","venue":"ESMO Open","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Université Laval","funders":"National Cancer Institute; Ono Pharmaceutical; Memorial Sloan-Kettering Cancer Center; Bristol-Myers Squibb","keywords":"Nivolumab; Ipilimumab; Medicine; Renal cell carcinoma; Open label; Internal medicine; Oncology; Randomized controlled trial; Immunotherapy; Cancer","score_opus":0.03543818598914407,"score_gpt":0.3104221155019698,"score_spread":0.27498392951282574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405050900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96938986,0.0014099434,0.0001533388,0.0013715178,0.0007639303,0.017138954,0.0008783841,0.00008716913,0.008806896],"genre_scores_gemma":[0.9834637,0.00007455855,0.0032534478,0.00024347419,0.00043424428,0.0016122559,0.002144851,0.00013863329,0.008634825],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962931,0.00021724809,0.0008937715,0.0013551734,0.0006243407,0.0006163531],"domain_scores_gemma":[0.9966484,0.0012630698,0.00034868182,0.0011472543,0.00024905332,0.00034357613],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007428909,0.00056630705,0.0011084473,0.00010846109,0.0007892863,0.0006235193,0.0007709864,0.00021023277,0.00015981049],"category_scores_gemma":[0.00032430023,0.0003622962,0.0001502425,0.00032207614,0.0001648659,0.0008465771,0.00076389743,0.00055851234,0.00004529036],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.959418,0.00235714,0.00014169751,0.00007753447,0.0005103807,0.00024033675,0.0015414992,0.000021921125,0.00018527229,0.000052221294,0.018447923,0.017006071],"study_design_scores_gemma":[0.9298271,0.022694865,0.0014254379,0.00040473105,0.0013708038,0.000024443778,0.0003133609,0.0016934866,0.0013273119,0.00014536736,0.040292453,0.000480642],"about_ca_topic_score_codex":0.004391379,"about_ca_topic_score_gemma":0.00041363173,"teacher_disagreement_score":0.029590907,"about_ca_system_score_codex":0.000972998,"about_ca_system_score_gemma":0.0011643778,"threshold_uncertainty_score":0.9998829},"labels":[],"label_agreement":null},{"id":"W4405128621","doi":"10.1016/j.euf.2024.11.011","title":"Efficacy of Treatments After Lenvatinib in Patients with Advanced Renal Cell Carcinoma","year":2024,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Lenvatinib; Renal cell carcinoma; Oncology; Internal medicine; Urology; Sorafenib; Hepatocellular carcinoma","score_opus":0.007302356358132815,"score_gpt":0.21352249735609957,"score_spread":0.20622014099796676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405128621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9763479,0.0018641626,0.000012730492,0.00011712091,0.00009128359,0.0005843096,0.00001876785,0.00005262372,0.020911107],"genre_scores_gemma":[0.99858695,0.000007642747,0.00041272517,0.00008189293,0.000047795304,0.000022968332,0.000059571074,0.00007574994,0.00070472824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984557,0.00018619021,0.000349224,0.00047842137,0.00021467781,0.00031579274],"domain_scores_gemma":[0.9992801,0.00008492723,0.0000700872,0.00040601913,0.000046940408,0.000111945825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010062627,0.00025397138,0.0003429127,0.00023985544,0.0000168389,0.000007350855,0.00008613414,0.0000490315,0.0001173371],"category_scores_gemma":[0.000016692773,0.00017765167,0.00009925243,0.0002404359,0.00010527392,0.00005601434,0.000056666246,0.00021635785,0.00022266553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010318697,0.0016427457,0.9449434,0.000121664176,0.00019587073,0.006402547,0.0009140676,0.00004471382,0.0016442743,0.00001802151,0.00017286466,0.03358108],"study_design_scores_gemma":[0.009756612,0.006605982,0.97752595,0.000058334932,0.00026291318,0.000024236002,0.0000060216867,0.000009397909,0.004633057,0.000005726139,0.000979442,0.00013231562],"about_ca_topic_score_codex":0.000014129308,"about_ca_topic_score_gemma":0.0000044706653,"teacher_disagreement_score":0.033448767,"about_ca_system_score_codex":0.00009265864,"about_ca_system_score_gemma":0.000057347217,"threshold_uncertainty_score":0.7244425},"labels":[],"label_agreement":null},{"id":"W4405249311","doi":"10.5489/cuaj.8970","title":"Complications and blood loss after invasive treatments for small renal masses","year":2024,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University; University of Ottawa; Centre Hospitalier Universitaire de Sherbrooke; McMaster University; Université de Sherbrooke; University of Toronto; McGill University; Impact","funders":"","keywords":"Blood loss; Medicine; Urology; Surgery","score_opus":0.058684907175188844,"score_gpt":0.2953483941576455,"score_spread":0.23666348698245668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405249311","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016915438,0.9917728,0.00001023205,0.0034041097,0.00021108885,0.0013088098,0.00069833954,0.000026175261,0.0008769497],"genre_scores_gemma":[0.0014891014,0.993521,0.0007330429,0.000883006,0.0005277131,0.0005695661,0.00041634587,0.00005402729,0.0018062136],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998025,0.00016252963,0.0006175775,0.00044109474,0.00022510359,0.00052870647],"domain_scores_gemma":[0.99773216,0.00045196127,0.00040621753,0.00017767353,0.00023422117,0.0009977928],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002761131,0.0004124041,0.0011131394,0.00038300597,0.0002092047,0.00019057185,0.00011447372,0.00055924896,0.00007667972],"category_scores_gemma":[0.0003622101,0.00027434723,0.0006595442,0.0001980472,0.00004573392,0.00003938688,0.000027582368,0.00068352517,0.00009866853],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018049023,0.0008780325,0.062519036,0.0094794575,0.028395372,0.014119256,0.0003495005,0.0000015713745,0.000004308378,0.0008257493,0.030086517,0.8531607],"study_design_scores_gemma":[0.0007509173,0.0006259896,0.010226395,0.0015376464,0.015998779,0.0039802287,0.000006715904,0.0000012800072,5.98324e-7,0.0005304765,0.9661038,0.0002371526],"about_ca_topic_score_codex":0.00018528094,"about_ca_topic_score_gemma":0.0007616786,"teacher_disagreement_score":0.9360173,"about_ca_system_score_codex":0.0021482217,"about_ca_system_score_gemma":0.0017484972,"threshold_uncertainty_score":0.99997085},"labels":[],"label_agreement":null},{"id":"W4405249317","doi":"10.5489/cuaj.8951","title":"Robotic-assisted partial nephrectomy using the HugoTM robotic-assisted surgery platform","year":2024,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Calgary; University Health Network; University of Toronto","funders":"","keywords":"Nephrectomy; Robotic surgery; Medicine; Surgery; Internal medicine; Kidney","score_opus":0.05987129351636678,"score_gpt":0.26697367202314215,"score_spread":0.20710237850677538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405249317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9612767,0.002328636,0.0011030531,0.030470697,0.0024743872,0.0005622114,0.00001705258,0.00013827656,0.0016289714],"genre_scores_gemma":[0.9950685,0.0000574007,0.000426539,0.0023329973,0.0013365777,0.000020791214,0.000041606832,0.000037581238,0.000678012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970319,0.00034937263,0.0006764074,0.00034172347,0.0006961376,0.0009044553],"domain_scores_gemma":[0.9973633,0.0008715326,0.00025995757,0.00022186908,0.00025808095,0.0010252516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014640258,0.00028890904,0.00055772084,0.00035532424,0.0005924015,0.00047197114,0.00015404107,0.00037087104,0.0008614075],"category_scores_gemma":[0.00074793445,0.00018234961,0.0005396177,0.00065790175,0.0000692004,0.00018962102,0.000024932613,0.0011019172,0.00013043293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031255343,0.00032533557,0.8666698,0.000089563866,0.0029896041,0.011125271,0.0006453636,0.005462913,0.0023457892,0.0008836809,0.061545245,0.04760488],"study_design_scores_gemma":[0.00082038506,0.00028011476,0.92038834,0.00013486679,0.0010974524,0.0057972907,0.00014446735,0.012736264,0.00016835607,0.00032560577,0.057747815,0.00035902404],"about_ca_topic_score_codex":0.0012195511,"about_ca_topic_score_gemma":0.00074903417,"teacher_disagreement_score":0.05371856,"about_ca_system_score_codex":0.004017296,"about_ca_system_score_gemma":0.0018065446,"threshold_uncertainty_score":0.9998061},"labels":[],"label_agreement":null},{"id":"W4405287327","doi":"10.1016/j.annonc.2024.12.003","title":"Biomarker analyses from the phase III randomized CLEAR trial: lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute; Eisai Incorporated; EMD Serono; Genentech; Institut Servier; Ipsen; Eisai; Incyte; Deciphera Pharmaceuticals; Harvard Medical School; Gilead Sciences; Exelixis; Servier; Memorial Sloan-Kettering Cancer Center; Dana-Farber/Harvard Cancer Center; GlaxoSmithKline; Dana-Farber Cancer Institute; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Lenvatinib; Sunitinib; Pembrolizumab; Renal cell carcinoma; Biomarker; Oncology; Internal medicine; Kidney cancer; Cancer; Immunotherapy; Sorafenib; Hepatocellular carcinoma","score_opus":0.23151620533878947,"score_gpt":0.45991423637376444,"score_spread":0.22839803103497497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405287327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96206856,0.009995644,0.000028719036,0.0037058669,0.0007534166,0.0018565534,0.00008538864,0.000051874587,0.02145398],"genre_scores_gemma":[0.99723285,0.0006369642,0.00027450826,0.00047962324,0.0002660399,0.0002235842,0.00031631463,0.000046503752,0.000523599],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965575,0.000957564,0.0011205341,0.00052765134,0.00038199153,0.00045477902],"domain_scores_gemma":[0.99398977,0.004789716,0.00031292043,0.0005630356,0.00018311979,0.00016141927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011152806,0.00033238137,0.0017171974,0.00033239834,0.00006667808,0.00002310912,0.00022653225,0.00023293376,0.0006221954],"category_scores_gemma":[0.0005321233,0.00021187593,0.00065958744,0.00054337725,0.00043525157,0.00010085415,0.00009105767,0.00038953248,0.000046461988],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9499759,0.00080606906,0.000024904464,0.00005546661,0.0006232169,0.0011980766,0.001018967,0.00002815907,0.012424167,0.0001053525,0.0042290217,0.029510705],"study_design_scores_gemma":[0.9333586,0.010272285,0.00073924084,0.000121195466,0.00095218344,0.000026067024,0.0008229437,0.0010517553,0.03915396,0.00017104899,0.01313183,0.00019890422],"about_ca_topic_score_codex":0.0024817502,"about_ca_topic_score_gemma":0.0002486132,"teacher_disagreement_score":0.035164308,"about_ca_system_score_codex":0.00019463406,"about_ca_system_score_gemma":0.0008697519,"threshold_uncertainty_score":0.86400497},"labels":[],"label_agreement":null},{"id":"W4405329435","doi":"10.3390/curroncol31120583","title":"Real-World Oncological Outcomes of Nivolumab Plus Ipilimumab in Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study in Japan","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Ipilimumab; Nivolumab; Renal cell carcinoma; Internal medicine; Oncology; Clinical endpoint; Cohort; Clinical trial; Immunotherapy; Cancer","score_opus":0.08862535279168644,"score_gpt":0.4092810337978215,"score_spread":0.32065568100613506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405329435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890347,0.0014420622,0.000007979929,0.00016961354,0.0010841519,0.004578018,0.00002982576,0.00007572903,0.0035778936],"genre_scores_gemma":[0.99713135,0.00019234967,0.0005522228,0.00002034122,0.00006548732,0.0008131805,0.00005107503,0.00004662619,0.001127387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959889,0.0005549178,0.0012517726,0.0010085453,0.00056252157,0.00063333253],"domain_scores_gemma":[0.99812925,0.00075575674,0.00024068999,0.0005204988,0.00014691042,0.00020690497],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00076742686,0.0004566415,0.0020439005,0.0009205932,0.000034852514,0.000014214922,0.00021421634,0.0001236992,0.00022738766],"category_scores_gemma":[0.00023420528,0.00032222297,0.00024815105,0.0010595607,0.00019460035,0.00010731101,0.00019255659,0.0008885696,0.000039518753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032776038,0.00930068,0.97482187,0.0003872604,0.00017506952,0.003322085,0.0025358705,0.00003338148,0.00050278945,0.0000516691,0.00017188015,0.0054198373],"study_design_scores_gemma":[0.020528851,0.01010379,0.96425873,0.00020944528,0.00062453136,0.000040372775,0.001847331,0.0011687845,0.00048949785,0.000037716287,0.0004433554,0.0002475961],"about_ca_topic_score_codex":0.001100889,"about_ca_topic_score_gemma":0.011040886,"teacher_disagreement_score":0.017251248,"about_ca_system_score_codex":0.0070458422,"about_ca_system_score_gemma":0.0010338632,"threshold_uncertainty_score":0.999923},"labels":[],"label_agreement":null},{"id":"W4405374842","doi":"10.1016/j.iotech.2024.100889","title":"5MO Novel radiologic phenotypes of chaotic tumor angiogenesis associated with poor ICI outcomes in NSCLC","year":2024,"lang":"en","type":"article","venue":"Immuno-Oncology Technology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"Syöpäsäätiö; Helsingin Yliopisto; Jane ja Aatos Erkon Säätiö; Ida Montinin Säätiö","keywords":"Angiogenesis; Phenotype; Chaotic; Medicine; Oncology; Internal medicine; Cancer research; Computer science; Biology; Genetics; Gene; Artificial intelligence","score_opus":0.018442608517930545,"score_gpt":0.27402059865668604,"score_spread":0.2555779901387555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405374842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820441,0.01034754,0.00009173504,0.004468973,0.00029784703,0.0007948118,0.000025508269,0.00047705637,0.0014524496],"genre_scores_gemma":[0.9971887,0.00008918233,0.0016520268,0.00024536724,0.000023911776,0.0002106977,0.000038859715,0.00005833579,0.0004929058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791247,0.00008839267,0.0006351176,0.0005691919,0.00019613959,0.00059871835],"domain_scores_gemma":[0.99858606,0.00048060936,0.0002036885,0.000544135,0.0001280964,0.00005743513],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003446333,0.00036879894,0.0013150524,0.001281118,0.000045658257,0.00000715046,0.00029140507,0.00061849115,0.00009912848],"category_scores_gemma":[0.00041684334,0.00025968446,0.00019599656,0.0013301502,0.000691306,0.000051847797,0.00013262419,0.00045142113,0.00005007793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001193176,0.002710015,0.53362334,0.00021394271,0.0031631019,0.005489861,0.0004465832,0.000036107027,0.43012556,0.0042784107,0.00026527446,0.01845463],"study_design_scores_gemma":[0.01602091,0.018457953,0.7769913,0.0011113223,0.0021658454,0.0045201825,0.0015369371,0.0005291282,0.17216946,0.0017032785,0.0038322893,0.00096139696],"about_ca_topic_score_codex":0.00013630872,"about_ca_topic_score_gemma":0.00017120312,"teacher_disagreement_score":0.25795612,"about_ca_system_score_codex":0.0009314618,"about_ca_system_score_gemma":0.00047497023,"threshold_uncertainty_score":0.9999855},"labels":[],"label_agreement":null},{"id":"W4405482456","doi":"10.21203/rs.3.rs-5299662/v1","title":"Endovascular Transcatheter Photodynamic Ablation to Downstage Locally Advanced Pancreatic Cancer Followed by Surgery: A Proof-of-Concept Study in a Porcine Model","year":2024,"lang":"en","type":"preprint","venue":"Research Square","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Ministero dello Sviluppo Economico; Agence Nationale de la Recherche; Princess Margaret Cancer Foundation","keywords":"Proof of concept; Medicine; Pancreatic cancer; Ablation; Surgery; Cancer; Internal medicine; Computer science","score_opus":0.04808661281235085,"score_gpt":0.3687905229495733,"score_spread":0.3207039101372225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405482456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96910655,0.013101648,0.0009336855,0.00065315276,0.00011024398,0.015279082,0.00040125713,0.00007978874,0.0003346028],"genre_scores_gemma":[0.9895567,0.00025050712,0.00034844287,0.000027074206,0.000059854377,0.007726018,0.00047297348,0.0001675602,0.0013908382],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9934947,0.00061642623,0.0010570101,0.0015065485,0.0023567558,0.0009685962],"domain_scores_gemma":[0.9970891,0.00035981447,0.00013786918,0.0013878654,0.00060819776,0.00041716106],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019471063,0.00062119367,0.0017104399,0.0015091284,0.00006042601,0.00006198932,0.00031467984,0.00032917762,0.0001393062],"category_scores_gemma":[0.00022076213,0.00051216007,0.0008709867,0.0012781774,0.00010881095,0.000064911605,0.00045226072,0.0016793016,0.000015542013],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022218138,0.021084582,0.100980245,0.05478104,0.010405487,0.007452202,0.063301824,0.41009527,0.18716878,0.000057659425,0.004647446,0.11780732],"study_design_scores_gemma":[0.03406503,0.019388651,0.057413198,0.0811929,0.006096645,0.0000909292,0.009865583,0.41877887,0.36445463,0.003205306,0.0004904403,0.0049578063],"about_ca_topic_score_codex":0.0036297678,"about_ca_topic_score_gemma":0.0013609419,"teacher_disagreement_score":0.17728585,"about_ca_system_score_codex":0.002054893,"about_ca_system_score_gemma":0.0019764553,"threshold_uncertainty_score":0.999733},"labels":[],"label_agreement":null},{"id":"W4405783144","doi":"10.3390/curroncol32010004","title":"Vulvar Metastasis in Renal Cell Carcinoma: A Case Report Highlighting the Aggressive Nature of Clear Cell Renal Cell Carcinoma","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Vulva; Metastasis; Renal cell carcinoma; Vulvar cancer; Clear cell carcinoma; Carcinoma; Cervix; Cancer; Dermatology; Lichen sclerosus; Labia; Sex organ; Pathology; Internal medicine; Surgery","score_opus":0.04774321855059826,"score_gpt":0.3457878816466864,"score_spread":0.2980446630960881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405783144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91998255,0.06743219,0.000026795142,0.00086644077,0.0017823761,0.0011360487,0.0000802978,0.00007070026,0.008622586],"genre_scores_gemma":[0.9970979,0.00025197506,0.00060125353,0.000077122386,0.0006655575,0.00015206724,0.00013847221,0.00009419084,0.000921475],"study_design_codex":"case_report","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99537116,0.00058738445,0.0013432787,0.0011748576,0.00066819106,0.0008551076],"domain_scores_gemma":[0.9966489,0.0008105344,0.0008268087,0.0010545716,0.0003170822,0.00034207196],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010115629,0.0006127991,0.0011550783,0.0005871617,0.00015835334,0.000040913586,0.00031275436,0.00053290784,0.00023124949],"category_scores_gemma":[0.00018985175,0.00041543975,0.000544886,0.0009038009,0.00031162554,0.00011447346,0.00032242038,0.0022132,0.000073854775],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013662338,0.0030972962,0.027456138,0.0033530935,0.00019492782,0.88178253,0.005612784,0.0000653403,0.042993803,0.0001915533,0.021978134,0.011908143],"study_design_scores_gemma":[0.009771313,0.008499224,0.028315209,0.0011933321,0.0046459245,0.16231805,0.0035817085,0.001830825,0.6330585,0.00015281819,0.14527288,0.0013601984],"about_ca_topic_score_codex":0.00040285903,"about_ca_topic_score_gemma":0.00014294224,"teacher_disagreement_score":0.7194645,"about_ca_system_score_codex":0.0010535297,"about_ca_system_score_gemma":0.0012054796,"threshold_uncertainty_score":0.99982977},"labels":[],"label_agreement":null},{"id":"W4405849772","doi":"10.3390/curroncol32010011","title":"Real-World Efficacy and Safety of Avelumab Plus Axitinib in Metastatic Renal Cell Carcinoma: Results from the Ambispective RAVE-Renal Study","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Axitinib; Avelumab; Medicine; Renal cell carcinoma; Oncology; Internal medicine; Immunotherapy; Nivolumab; Cancer; Sunitinib","score_opus":0.0933237813352886,"score_gpt":0.3815304798851603,"score_spread":0.2882066985498717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405849772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851074,0.0050315633,0.000026363261,0.0007756428,0.00063525536,0.0021599433,0.00024548074,0.000042726624,0.005975609],"genre_scores_gemma":[0.9985974,0.00025676747,0.00019319677,0.000021250285,0.00026699124,0.000103418955,0.00018778832,0.000034495723,0.00033870066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99680835,0.00066163205,0.00096341246,0.0007749186,0.00040049636,0.00039118316],"domain_scores_gemma":[0.9967026,0.0022817047,0.00021813315,0.00052033825,0.00011081941,0.00016637525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007973754,0.00033684942,0.00091985543,0.00029199728,0.000072495386,0.000022430719,0.00017104972,0.00007185221,0.00008008908],"category_scores_gemma":[0.00018023784,0.00022212454,0.00014097568,0.0005470244,0.0002716762,0.000050603856,0.00018500951,0.00070803793,0.000030318899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10313515,0.036759526,0.30318838,0.0019377009,0.0041793794,0.021202357,0.22865924,0.0005165105,0.016457416,0.0030193753,0.02286235,0.2580826],"study_design_scores_gemma":[0.02958948,0.004898671,0.95142066,0.00038858902,0.0013952014,0.00006461348,0.0028778545,0.0008406026,0.0025279685,0.00020455306,0.005541614,0.0002502015],"about_ca_topic_score_codex":0.002667782,"about_ca_topic_score_gemma":0.0028268665,"teacher_disagreement_score":0.6482323,"about_ca_system_score_codex":0.0010750381,"about_ca_system_score_gemma":0.00075708685,"threshold_uncertainty_score":0.9057976},"labels":[],"label_agreement":null},{"id":"W4405922753","doi":"10.1002/ijc.35288","title":"Clinical outcomes by baseline metastases in patients with renal cell carcinoma treated with lenvatinib plus pembrolizumab versus sunitinib: Post hoc analysis of the <scp>CLEAR</scp> trial","year":2024,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Eisai Canada; Eisai; Memorial Sloan-Kettering Cancer Center","keywords":"Lenvatinib; Pembrolizumab; Medicine; Sunitinib; Internal medicine; Renal cell carcinoma; Oncology; Post-hoc analysis; Cancer; Thyroid cancer; Immunotherapy","score_opus":0.02660081875484349,"score_gpt":0.32948605278711357,"score_spread":0.3028852340322701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405922753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964706,0.0011958596,0.00002489587,0.0005362651,0.0005916234,0.00035961138,0.0005277634,0.000009037374,0.00028435225],"genre_scores_gemma":[0.9987503,0.00009704756,0.00014153596,0.00017865305,0.00020661564,0.000014500569,0.00015909097,0.000034502737,0.00041775274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967362,0.00023587454,0.0010881856,0.0002700425,0.001460841,0.0002088324],"domain_scores_gemma":[0.9968488,0.0009042619,0.0006946227,0.00023203224,0.0011745254,0.0001457505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044552895,0.00025696936,0.0008225758,0.0006253298,0.000025847143,0.000048060174,0.00030808084,0.00007750135,0.00016082873],"category_scores_gemma":[0.00023088469,0.00013323083,0.0005683543,0.0006953458,0.00012825248,0.00016110876,0.00004804383,0.00043249788,0.0000020811606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13204876,0.0010081877,0.85016364,0.000028943916,0.010741464,0.00042525414,0.00022177152,0.0010681642,0.0001004534,0.000011084279,0.00157045,0.0026118362],"study_design_scores_gemma":[0.13737729,0.009151614,0.8412983,0.00031139646,0.007496374,0.000019435096,0.00020578995,0.00037157725,0.0018090608,0.0000018023084,0.0018708664,0.000086518055],"about_ca_topic_score_codex":0.00062834716,"about_ca_topic_score_gemma":0.00046676872,"teacher_disagreement_score":0.008865369,"about_ca_system_score_codex":0.00056285365,"about_ca_system_score_gemma":0.00084711856,"threshold_uncertainty_score":0.54329956},"labels":[],"label_agreement":null},{"id":"W4405945558","doi":"10.1016/j.euo.2024.12.011","title":"Treatment-free Survival After First-line Therapies for Metastatic Renal Cell Carcinoma: An International Metastatic Renal Cell Carcinoma Database Consortium Analysis","year":2024,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; University of Alberta; BC Cancer Agency; Alberta Health Services; Baker Hughes (Canada)","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Carcinoma; Internal medicine; Cancer research","score_opus":0.04675184849823367,"score_gpt":0.31053943928657235,"score_spread":0.2637875907883387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405945558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722246,0.0059926854,0.0046473923,0.003428434,0.001153155,0.0013730577,0.001567408,0.0001998734,0.0094133755],"genre_scores_gemma":[0.98280025,0.00019217194,0.008062975,0.00078088674,0.00071604544,0.00037974166,0.0029926235,0.0001841141,0.003891183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942788,0.0016148443,0.0011352763,0.0015920554,0.00045225967,0.0009267501],"domain_scores_gemma":[0.99601513,0.0012941288,0.0003234156,0.0015792901,0.0002738874,0.0005141171],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010102482,0.000802348,0.0014566414,0.0011175852,0.00018557707,0.00008725024,0.00063933077,0.00013295136,0.0013423061],"category_scores_gemma":[0.00013482409,0.00062792137,0.0008487394,0.00058837055,0.0004934331,0.00026882256,0.00029481167,0.0004692361,0.00028757998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059994094,0.029952174,0.44227734,0.0024995217,0.04491967,0.2766934,0.01981383,0.0039996686,0.07517952,0.0022971232,0.013974241,0.02839943],"study_design_scores_gemma":[0.05415397,0.07409303,0.45315418,0.000042066076,0.086684935,0.0039494913,0.0011231137,0.02218988,0.016999884,0.0004989795,0.2846675,0.002442967],"about_ca_topic_score_codex":0.00022435674,"about_ca_topic_score_gemma":0.00093232613,"teacher_disagreement_score":0.2727439,"about_ca_system_score_codex":0.00060414075,"about_ca_system_score_gemma":0.00051748863,"threshold_uncertainty_score":0.9996172},"labels":[],"label_agreement":null},{"id":"W4406092910","doi":"10.1111/bju.16627","title":"‘ <scp> <i>BJUI</i> </scp> Clinical Dilemma’: the incidental small renal mass in a solitary kidney","year":2025,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Asymptomatic; Physical examination; Overweight; General surgery; Surgery; Body mass index; Internal medicine","score_opus":0.021893694932840532,"score_gpt":0.28419574599000325,"score_spread":0.2623020510571627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406092910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786201,0.008352414,0.00026060987,0.005570511,0.00083088456,0.00029808067,0.0000134735965,0.000013502809,0.0060404027],"genre_scores_gemma":[0.9862365,0.0014020405,0.00084096467,0.010002019,0.00057023397,0.000011172836,0.000012648202,0.000022676211,0.00090174563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99709475,0.00060512824,0.00127727,0.00027667877,0.00029740424,0.0004487753],"domain_scores_gemma":[0.99792343,0.00092173606,0.00035070212,0.0002634004,0.00021166049,0.00032909148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015923997,0.0001823641,0.000717177,0.0002309373,0.000078760684,0.00003805461,0.0003551765,0.00024946596,0.000034876335],"category_scores_gemma":[0.002297146,0.00015163698,0.00043462607,0.00026734886,0.00030858436,0.00007920845,0.00013450354,0.0013691962,0.000018520132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012541964,0.0018061725,0.7223182,0.00011988399,0.001280867,0.086973086,0.00023914456,0.00007807083,0.002597476,0.0005380825,0.13957576,0.043219075],"study_design_scores_gemma":[0.008904452,0.0023246547,0.85473925,0.00040146304,0.00063256064,0.04810899,0.00015113219,0.0000893113,0.00035349312,0.0031145175,0.08110407,0.000076094155],"about_ca_topic_score_codex":0.00030715112,"about_ca_topic_score_gemma":0.00027848023,"teacher_disagreement_score":0.13242108,"about_ca_system_score_codex":0.00015144267,"about_ca_system_score_gemma":0.000705278,"threshold_uncertainty_score":0.61835766},"labels":[],"label_agreement":null},{"id":"W4406296618","doi":"10.1097/ccm.0000000000006496","title":"Critical Care Therapy After Cytoreductive Nephrectomy for Metastatic Kidney Cancer","year":2024,"lang":"en","type":"article","venue":"Critical Care Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Renal replacement therapy; Comorbidity; Odds ratio; Percutaneous endoscopic gastrostomy; Cancer; Internal medicine; Mortality rate; Kidney disease; Surgery; Kidney","score_opus":0.04708806422253163,"score_gpt":0.39249694955028114,"score_spread":0.3454088853277495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406296618","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19113368,0.660656,0.0038897449,0.11621831,0.007381471,0.0044179377,0.0012625227,0.0007292948,0.0143110575],"genre_scores_gemma":[0.987101,0.00028836448,0.0023443527,0.0050390945,0.0026417281,0.0019293556,0.00025452566,0.00010443713,0.00029710762],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99711657,0.000107340755,0.0004717262,0.00086107675,0.00071450503,0.00072878395],"domain_scores_gemma":[0.99609715,0.0011900631,0.000016032112,0.00046874836,0.0012088937,0.001019097],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001585516,0.00048087005,0.00083624996,0.00025267678,0.00011599128,0.0000591004,0.00012108032,0.00014495032,0.0017267202],"category_scores_gemma":[0.0019344813,0.00032029604,0.00033544048,0.0003514502,0.0009804626,0.00015059175,0.00003098128,0.00043322824,0.000046531623],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015207054,0.0015760475,0.010780221,0.09563222,0.0032895424,0.02560093,0.10867005,0.0000044878957,0.04434162,0.057359256,0.10380353,0.53373504],"study_design_scores_gemma":[0.026352702,0.0327281,0.02029596,0.019746937,0.020348916,0.0022615918,0.11446083,0.0006564928,0.10331575,0.010590552,0.64612937,0.0031127762],"about_ca_topic_score_codex":0.00014527107,"about_ca_topic_score_gemma":0.000012831376,"teacher_disagreement_score":0.79596734,"about_ca_system_score_codex":0.00067031884,"about_ca_system_score_gemma":0.00069826556,"threshold_uncertainty_score":0.9999249},"labels":[],"label_agreement":null},{"id":"W4406382201","doi":"10.5489/cuaj.8901","title":"Neoadjuvant systemic therapy in managing locally advanced renal cancer before surgery","year":2025,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Systemic therapy; Neoadjuvant therapy; Oncology; Internal medicine; Nephrectomy; Confidence interval; Meta-analysis; Randomized controlled trial; Population; Cohort; Cancer; Surgery; Breast cancer; Kidney","score_opus":0.02799669195020883,"score_gpt":0.28561989735681004,"score_spread":0.2576232054066012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406382201","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012307168,0.99344736,0.0000104504215,0.0026641525,0.0007402305,0.0010314744,0.00008029629,0.000029754017,0.00076558505],"genre_scores_gemma":[0.0038764218,0.99236387,0.000029866838,0.001257397,0.0005527218,0.00019634874,0.00015794055,0.000041626692,0.0015237933],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961062,0.00062336953,0.001308313,0.00048754737,0.0005459597,0.00092861307],"domain_scores_gemma":[0.9971407,0.0005784081,0.00096760504,0.00024604492,0.00027812316,0.0007891143],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011634673,0.00051519624,0.002537102,0.0011565075,0.00017191967,0.00009413727,0.00022976616,0.00077371387,0.00028603853],"category_scores_gemma":[0.00053246965,0.0003637421,0.0009451837,0.00077917514,0.000027255992,0.000077557335,0.00002484243,0.0016779781,0.000035051184],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000042089516,0.00003408826,0.018788438,0.0012500719,0.0004253064,0.0019410277,0.000029485576,0.000042708733,2.5595781e-7,0.000012935215,0.002469637,0.97496396],"study_design_scores_gemma":[0.0012506278,0.0003380702,0.013464555,0.026310176,0.0007951712,0.0014275834,0.000023268147,0.000019981533,3.7995358e-7,0.0001278767,0.95580316,0.00043916362],"about_ca_topic_score_codex":0.0016054066,"about_ca_topic_score_gemma":0.0029246889,"teacher_disagreement_score":0.9745248,"about_ca_system_score_codex":0.0114085,"about_ca_system_score_gemma":0.00695577,"threshold_uncertainty_score":0.99988145},"labels":[],"label_agreement":null},{"id":"W4406387791","doi":"10.2214/ajr.24.32619","title":"Editorial Comment: What Matters Most for Cystic Renal Masses?","year":2025,"lang":"en","type":"editorial","venue":"American Journal of Roentgenology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; Hamilton Health Sciences","funders":"","keywords":"Medicine; Renal mass; General surgery; Kidney; Internal medicine; Nephrectomy","score_opus":0.00785245759145541,"score_gpt":0.2792126295077505,"score_spread":0.2713601719162951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406387791","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006882916,0.0021515512,0.0010790103,0.013181837,0.981985,0.0006552815,0.00015709388,0.00002294179,0.00007903021],"genre_scores_gemma":[0.00039413507,0.0026865148,0.0035633028,0.0021143316,0.99000454,0.000057895788,0.00044200642,0.000095608804,0.0006416671],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99591553,0.0002891251,0.0013773825,0.00050446065,0.0011745028,0.00073896867],"domain_scores_gemma":[0.99308115,0.0021961436,0.002248937,0.0005830837,0.0015116181,0.00037907792],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005843383,0.00060221716,0.0023113035,0.0007694386,0.0001063194,0.00010048855,0.0005487955,0.00056892476,0.00006468736],"category_scores_gemma":[0.0009738978,0.0005013327,0.00072664977,0.00035273226,0.0004951927,0.00017558713,0.00013231875,0.0015626185,0.000016142854],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005417861,0.00026917437,0.000049356717,0.0002343472,0.00194772,0.00036867897,0.000092386836,0.0000185044,0.0003065936,0.0000075906323,0.9819527,0.009335044],"study_design_scores_gemma":[0.0054145176,0.01225227,0.000014473446,0.00096718763,0.0027032658,0.00028208026,0.0005503397,0.0000039253755,0.00025396346,0.00008592539,0.9772,0.00027206918],"about_ca_topic_score_codex":0.00010506546,"about_ca_topic_score_gemma":0.000009608536,"teacher_disagreement_score":0.011983096,"about_ca_system_score_codex":0.0012200391,"about_ca_system_score_gemma":0.0021861976,"threshold_uncertainty_score":0.9997438},"labels":[],"label_agreement":null},{"id":"W4406415064","doi":"10.1016/s1155-1917(06)44934-5","title":"10.1016/s1155-1917(06)44934-5","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Mathematics","score_opus":0.010651934992858759,"score_gpt":0.1977383819689914,"score_spread":0.18708644697613264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406415064","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0202191,0.00021590176,3.5572273e-7,0.00065162126,0.0000012471754,0.0004282264,0.000009672695,0.00014783729,0.978326],"genre_scores_gemma":[0.00379659,5.49002e-7,0.00028955573,0.00012475975,0.0002160512,0.000039640476,0.000056904304,0.000042365915,0.99543357],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99882734,0.00003125071,0.0002095499,0.00030674657,0.0002951346,0.00033000685],"domain_scores_gemma":[0.9990642,0.000040767605,0.000025452006,0.0004908148,0.00005079398,0.00032794464],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00009041832,0.00019725686,0.00029416976,0.00009125248,0.000053922708,0.00002069346,0.000105973064,0.00007401077,0.9975242],"category_scores_gemma":[0.000024625857,0.00016461806,0.00011943346,0.00019751702,0.00003427338,0.000047742702,0.000028834682,0.0001232891,0.9979582],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047882035,0.00023447673,0.000004529481,0.000025835609,0.00008975774,0.0002291336,0.000036876998,0.0000180514,0.00059453637,6.432316e-7,0.5317964,0.46649095],"study_design_scores_gemma":[0.00091577455,0.0006979218,0.0009654369,0.00004238602,0.00011693445,0.00013098995,0.0000012691295,0.000042486197,0.0015894003,0.0000037532966,0.9953339,0.00015972786],"about_ca_topic_score_codex":0.000036620277,"about_ca_topic_score_gemma":1.6837761e-7,"teacher_disagreement_score":0.4663312,"about_ca_system_score_codex":0.00015407619,"about_ca_system_score_gemma":0.00005659851,"threshold_uncertainty_score":0.671293},"labels":[],"label_agreement":null},{"id":"W4406450493","doi":"10.1016/s1283-0879(14)63986-x","title":"10.1016/s1283-0879(14)63986-x","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.010941153862636908,"score_gpt":0.1983901309747902,"score_spread":0.18744897711215328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406450493","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015299101,0.00023275574,3.590626e-7,0.0007221531,0.0000017338173,0.0004362143,0.000008764629,0.00014789967,0.983151],"genre_scores_gemma":[0.0030421175,6.0391403e-7,0.0002862276,0.00012497127,0.0002095219,0.00003890433,0.000043720105,0.000042375374,0.9962115],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99880844,0.000031565196,0.00020951654,0.0003089881,0.00030599404,0.0003355161],"domain_scores_gemma":[0.9990512,0.00003780513,0.000025659143,0.0004920524,0.000060910636,0.0003323404],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00009552207,0.00019907231,0.0002964847,0.00009430585,0.00005243716,0.00001941353,0.00010484263,0.00007679255,0.9977515],"category_scores_gemma":[0.000026488207,0.00016556599,0.000119218545,0.00020639131,0.00003362924,0.00004728695,0.00002903356,0.00012664274,0.9973843],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054850563,0.00020613374,0.000002783864,0.000023171777,0.00007802873,0.00022685305,0.000030969484,0.000021137765,0.00046178236,4.5509873e-7,0.40600458,0.5923956],"study_design_scores_gemma":[0.0009777542,0.0007786245,0.0008666365,0.00004309528,0.00012194176,0.00013297233,0.0000011530545,0.00004316009,0.0017123037,0.0000035145065,0.99515766,0.00016117569],"about_ca_topic_score_codex":0.00003398608,"about_ca_topic_score_gemma":1.622655e-7,"teacher_disagreement_score":0.59223443,"about_ca_system_score_codex":0.00013792866,"about_ca_system_score_gemma":0.00005768761,"threshold_uncertainty_score":0.6751585},"labels":[],"label_agreement":null},{"id":"W4406452253","doi":"10.1016/s1155-1917(02)00032-6","title":"10.1016/s1155-1917(02)00032-6","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology; Cancer; Internal medicine","score_opus":0.010102078620000465,"score_gpt":0.19561710201153013,"score_spread":0.18551502339152967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406452253","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017523292,0.00023605046,3.5641574e-7,0.00061525445,0.0000015472814,0.000453972,0.000010085537,0.00015469776,0.9810047],"genre_scores_gemma":[0.0034854368,6.39605e-7,0.00030703095,0.00012809318,0.00020987874,0.000042104846,0.00004548529,0.000043348602,0.99573797],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99881524,0.000032252836,0.00021218495,0.0003105481,0.0002922401,0.00033754797],"domain_scores_gemma":[0.9990477,0.000039219132,0.000025792833,0.0004955038,0.00005418954,0.00033757937],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00009404175,0.0002002849,0.00029864738,0.00009478995,0.000054141296,0.000019725781,0.000107717,0.00007533254,0.99792457],"category_scores_gemma":[0.00002453241,0.00016722889,0.00011880676,0.00021160279,0.000033863576,0.000047599624,0.000028270168,0.00012373981,0.9971593],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005535944,0.00022325572,0.0000029366097,0.000024113842,0.00008337176,0.00022903255,0.000036853005,0.000018032266,0.0005376968,5.3823555e-7,0.371793,0.62649757],"study_design_scores_gemma":[0.00090878946,0.0008453031,0.00080261246,0.000044019605,0.00011871485,0.00012972533,0.0000012032066,0.000044097163,0.0023561418,0.0000033411159,0.99458355,0.00016248031],"about_ca_topic_score_codex":0.000048330192,"about_ca_topic_score_gemma":1.746928e-7,"teacher_disagreement_score":0.6263351,"about_ca_system_score_codex":0.00014561051,"about_ca_system_score_gemma":0.000060756713,"threshold_uncertainty_score":0.6819396},"labels":[],"label_agreement":null},{"id":"W4406474228","doi":"10.1016/s1283-0879(24)73342-3","title":"10.1016/s1283-0879(24)73342-3","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nuclear medicine; Humanities; General surgery","score_opus":0.012118537179714403,"score_gpt":0.19783754466035952,"score_spread":0.18571900748064513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406474228","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019662881,0.0002543012,3.6567525e-7,0.00081013405,0.0000022614847,0.00043687376,0.000008136955,0.00015030574,0.97867477],"genre_scores_gemma":[0.0028556308,6.3955264e-7,0.00028288914,0.00014266203,0.00022792594,0.00003779338,0.000042185893,0.000042810007,0.99636745],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99881226,0.000031694686,0.00021122675,0.00031051028,0.00029598325,0.0003383481],"domain_scores_gemma":[0.9990517,0.000036620797,0.000025398138,0.00049505424,0.000054766788,0.00033645067],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00009184932,0.00020081204,0.00030426015,0.00009512346,0.000053767315,0.000018997296,0.000103470265,0.000073430754,0.9974421],"category_scores_gemma":[0.000023555242,0.00016625448,0.00011654969,0.00020483442,0.0000334302,0.000046334128,0.000029306166,0.00012954282,0.9972443],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056547584,0.00019411504,0.0000028450204,0.000021446405,0.00007503355,0.00023684917,0.000035980458,0.000017758144,0.0005159325,4.1015736e-7,0.45632702,0.54200715],"study_design_scores_gemma":[0.0009860301,0.00086545857,0.0007385441,0.000044494453,0.00012214817,0.00013498482,0.0000015863855,0.000049151004,0.0019868074,0.0000033315082,0.9949063,0.00016118644],"about_ca_topic_score_codex":0.000040962565,"about_ca_topic_score_gemma":1.649349e-7,"teacher_disagreement_score":0.5418459,"about_ca_system_score_codex":0.00014018727,"about_ca_system_score_gemma":0.00005387368,"threshold_uncertainty_score":0.6779661},"labels":[],"label_agreement":null},{"id":"W4406555694","doi":"10.1016/s1634-6939(22)44421-8","title":"10.1016/s1634-6939(22)44421-8","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Political science","score_opus":0.00969323890100028,"score_gpt":0.19450473546713787,"score_spread":0.1848114965661376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406555694","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01826088,0.00024412514,3.017039e-7,0.00059437455,0.0000015993393,0.00042920973,0.000009117582,0.00014925309,0.98031116],"genre_scores_gemma":[0.0029787675,6.8651184e-7,0.00025645885,0.00011915601,0.00022432575,0.00003841374,0.000043901302,0.000043254215,0.99629503],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99882036,0.000030996165,0.00020968268,0.0003073756,0.00029959733,0.00033195975],"domain_scores_gemma":[0.9990594,0.00003813679,0.000025542477,0.00048670292,0.000053902095,0.00033634208],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00008966797,0.0001988874,0.00029598348,0.00009383879,0.00005212993,0.000019437992,0.000106271305,0.00007500495,0.9983506],"category_scores_gemma":[0.000023144401,0.00016555788,0.00012000274,0.00020082046,0.000034252495,0.00004686076,0.000028862914,0.0001233602,0.9973096],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050166354,0.000203032,0.0000027161348,0.000021938587,0.00007563927,0.00022210275,0.000028563938,0.00001598797,0.00045837567,4.986569e-7,0.4081423,0.59032714],"study_design_scores_gemma":[0.000942011,0.0008283839,0.0007633406,0.00004449399,0.00012032903,0.0001318246,0.0000013133803,0.00004826793,0.0017994125,0.000003621046,0.99515635,0.00016066521],"about_ca_topic_score_codex":0.0000451043,"about_ca_topic_score_gemma":1.3926937e-7,"teacher_disagreement_score":0.5901665,"about_ca_system_score_codex":0.00014195107,"about_ca_system_score_gemma":0.000055339915,"threshold_uncertainty_score":0.6751255},"labels":[],"label_agreement":null},{"id":"W4406558178","doi":"10.1016/s1879-8543(18)79982-5","title":"10.1016/s1879-8543(18)79982-5","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology; Nuclear medicine","score_opus":0.013350257592910936,"score_gpt":0.20379421331029798,"score_spread":0.19044395571738704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406558178","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013855802,0.00024104824,3.1254595e-7,0.000572673,0.0000016117192,0.00042974306,0.0000099239005,0.00014824605,0.9847406],"genre_scores_gemma":[0.002836312,6.5460233e-7,0.00027240423,0.00012046102,0.00021429865,0.000039548057,0.00004522851,0.000042518226,0.99642855],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99882454,0.00003172221,0.00021015291,0.00030619043,0.00029615997,0.00033121702],"domain_scores_gemma":[0.9990628,0.000038445956,0.000025521402,0.00048975827,0.000051596246,0.00033187927],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000093621406,0.00019851228,0.00029540152,0.00009381624,0.000051638788,0.00001974934,0.00010596948,0.00007576946,0.9987201],"category_scores_gemma":[0.000023329196,0.00016518118,0.00012028036,0.00019762153,0.000033436547,0.00004559467,0.000029182196,0.00012486437,0.9973334],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046468453,0.00018764766,0.0000024252797,0.00001961516,0.00006844658,0.00020135095,0.000025424757,0.000015480773,0.00046502257,3.3999265e-7,0.4739,0.52464956],"study_design_scores_gemma":[0.0009408024,0.0008192861,0.0007576675,0.000042887066,0.00011996429,0.00012859581,0.0000012458183,0.00005021506,0.0018148557,0.0000035236098,0.99516106,0.00015990026],"about_ca_topic_score_codex":0.000039315164,"about_ca_topic_score_gemma":1.5516001e-7,"teacher_disagreement_score":0.5244897,"about_ca_system_score_codex":0.00013829111,"about_ca_system_score_gemma":0.00005813984,"threshold_uncertainty_score":0.6735892},"labels":[],"label_agreement":null},{"id":"W4406580696","doi":"10.1016/s1283-0879(96)41589-x","title":"10.1016/s1283-0879(96)41589-x","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.011134209604614755,"score_gpt":0.19842192354269836,"score_spread":0.1872877139380836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406580696","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017945101,0.00026735247,4.167203e-7,0.0007920903,0.00000159005,0.00043189083,0.000009069743,0.00014927855,0.9804032],"genre_scores_gemma":[0.0034713272,6.9412965e-7,0.00027061944,0.00012672972,0.0002118801,0.000039015566,0.000044495857,0.000042374875,0.99579287],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99881256,0.000032244432,0.00021045977,0.00030904112,0.00029899916,0.00033672526],"domain_scores_gemma":[0.99905425,0.000038875016,0.000025633133,0.0004907961,0.000053107127,0.0003373594],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000095513686,0.00019955629,0.00029719403,0.00009351969,0.000053646763,0.000019510328,0.00010665234,0.000074874006,0.9977906],"category_scores_gemma":[0.00002430675,0.00016593384,0.00012030834,0.00020189959,0.000033661006,0.000046794485,0.000029583633,0.00012639152,0.99742955],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005501702,0.00021099161,0.0000034102045,0.00002305576,0.000080001395,0.00023786724,0.000032909,0.000012713958,0.000535518,5.741307e-7,0.39148092,0.60683185],"study_design_scores_gemma":[0.0009445425,0.0008172648,0.0006862719,0.00004298949,0.00012104454,0.00013484889,0.0000012543196,0.000060175713,0.0018522172,0.000004460821,0.99517345,0.00016145552],"about_ca_topic_score_codex":0.000041171,"about_ca_topic_score_gemma":1.5149271e-7,"teacher_disagreement_score":0.60667044,"about_ca_system_score_codex":0.00013653071,"about_ca_system_score_gemma":0.000056440993,"threshold_uncertainty_score":0.6766586},"labels":[],"label_agreement":null},{"id":"W4406581023","doi":"10.1016/s1283-0879(24)42386-x","title":"10.1016/s1283-0879(24)42386-x","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.012124803257000405,"score_gpt":0.19788162433504264,"score_spread":0.18575682107804223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406581023","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016011292,0.00026578896,3.5437193e-7,0.0008127857,0.0000021664773,0.0004441865,0.000008961993,0.00015124676,0.9823032],"genre_scores_gemma":[0.002900898,6.711458e-7,0.00027559273,0.00013382951,0.00022312695,0.000040185678,0.00004548972,0.00004291245,0.9963373],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99880975,0.00003215634,0.00021229863,0.00031146873,0.00029801016,0.00033629153],"domain_scores_gemma":[0.99904734,0.000038535378,0.000025870708,0.00049692625,0.000052777727,0.00033854635],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00009205639,0.00020109287,0.00030184572,0.00009625754,0.000053049138,0.000018273493,0.00010720238,0.000073687086,0.9977109],"category_scores_gemma":[0.000024297982,0.00016655678,0.00011822376,0.00020674824,0.000033497636,0.000046674482,0.000028959857,0.00013145912,0.9973244],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005179265,0.00018698143,0.000002514354,0.000020940533,0.00007088573,0.00021105832,0.00003529063,0.00001707137,0.0003712708,3.1082968e-7,0.42293063,0.57563514],"study_design_scores_gemma":[0.0009918086,0.0008690365,0.0007882017,0.000045240842,0.00012355273,0.00013786166,0.0000016887662,0.000040561903,0.002189032,0.0000036222625,0.99464756,0.00016180168],"about_ca_topic_score_codex":0.00004540765,"about_ca_topic_score_gemma":1.6720904e-7,"teacher_disagreement_score":0.5754733,"about_ca_system_score_codex":0.00013949978,"about_ca_system_score_gemma":0.000056243203,"threshold_uncertainty_score":0.67919886},"labels":[],"label_agreement":null},{"id":"W4406624749","doi":"10.1089/end.2024.0730","title":"In-Hospital Outcomes after Robotic <i>Vs</i> Open Radical Nephroureterectomy","year":2025,"lang":"en","type":"article","venue":"Journal of Endourology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Urology; Surgery; General surgery","score_opus":0.012047733058080065,"score_gpt":0.2968516800992325,"score_spread":0.28480394704115247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406624749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9531121,0.0009152035,0.00012462625,0.040826783,0.0010116439,0.0003558316,8.206409e-7,0.0000057700695,0.0036472252],"genre_scores_gemma":[0.98855096,0.0000441936,0.0018055694,0.008255292,0.00015539484,0.00001660542,9.650206e-7,0.000014503601,0.001156537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985421,0.00014532825,0.0006331163,0.00018067932,0.00019930261,0.0002995182],"domain_scores_gemma":[0.99907476,0.00023681842,0.00020691035,0.00023606743,0.000098059885,0.00014736119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032054208,0.00017398763,0.00082956493,0.00035805872,0.000020003934,0.000026564696,0.00028784777,0.00013614418,0.00035976153],"category_scores_gemma":[0.00018392023,0.0001206894,0.00023519323,0.00018459378,0.00009592402,0.00015725255,0.0001619885,0.000523935,0.000025613563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055583585,0.0011493496,0.9558272,0.000047733945,0.00055582216,0.016063161,0.00020062344,0.0000430949,0.0007548136,0.0004267421,0.018360592,0.0010125241],"study_design_scores_gemma":[0.015264502,0.003974891,0.9434149,0.000105854924,0.00043879068,0.0023986509,0.000033568183,0.000021137908,0.0011727727,0.0013194403,0.031719252,0.0001362123],"about_ca_topic_score_codex":0.000031596384,"about_ca_topic_score_gemma":0.000019072708,"teacher_disagreement_score":0.035438843,"about_ca_system_score_codex":0.00016933806,"about_ca_system_score_gemma":0.00027181237,"threshold_uncertainty_score":0.4921571},"labels":[],"label_agreement":null},{"id":"W4406650732","doi":"10.1016/b978-2-294-76306-9.50851-6","title":"10.1016/b978-2-294-76306-9.50851-6","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.014861439906356562,"score_gpt":0.19434611054236547,"score_spread":0.17948467063600893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406650732","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011985254,0.0012195351,2.3571333e-7,0.00035610294,0.0000057990687,0.0011284708,0.00010007476,0.00023391732,0.9969439],"genre_scores_gemma":[0.000010709099,0.0000029867658,0.0001576972,0.00013047953,0.000825792,0.000049472783,0.00046453997,0.00024914276,0.99810916],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975267,0.000019877314,0.000517518,0.0007628221,0.0006818595,0.00049120927],"domain_scores_gemma":[0.9979536,0.000073350406,0.00014360166,0.001110206,0.00013126853,0.00058799045],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000110551424,0.0007308809,0.0010248104,0.0003750166,0.00007750933,0.0000401162,0.00023745443,0.00049399055,0.9981576],"category_scores_gemma":[0.000019079082,0.00064990006,0.0004561192,0.000059348506,0.000099611294,0.00004280021,0.00010880889,0.00052536407,0.998109],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007163261,0.00009917662,8.233484e-8,0.00009566859,0.00044716496,0.0011562546,0.000017884946,0.000004265388,0.000039564533,0.00003589728,0.37012926,0.6272585],"study_design_scores_gemma":[0.0009519516,0.0012291728,0.000012933302,0.0004431347,0.0007419639,0.00031748626,2.8616148e-7,0.0000053373064,0.00014618752,0.00011109258,0.9954918,0.0005486727],"about_ca_topic_score_codex":0.000028211249,"about_ca_topic_score_gemma":3.4961937e-7,"teacher_disagreement_score":0.6267098,"about_ca_system_score_codex":0.00044150697,"about_ca_system_score_gemma":0.00022193184,"threshold_uncertainty_score":0.9995952},"labels":[],"label_agreement":null},{"id":"W4406666048","doi":"10.1016/b978-0-323-04602-2.50082-5","title":"10.1016/b978-0-323-04602-2.50082-5","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Kidney disease; Medicine; Cystic kidney disease; Disease; Kidney; Pathology; Internal medicine","score_opus":0.014864201064844606,"score_gpt":0.19406444759668273,"score_spread":0.17920024653183814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406666048","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011214804,0.0013613951,1.9085239e-7,0.0003304488,0.0000059601903,0.0010833136,0.000100393685,0.00023019193,0.9968769],"genre_scores_gemma":[0.000010081331,0.0000034895804,0.00014562416,0.00012698436,0.0007019128,0.00004760053,0.0005042375,0.00024534896,0.9982147],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975303,0.000019599824,0.00051318883,0.00076108926,0.00068940414,0.0004864152],"domain_scores_gemma":[0.9979626,0.00007071767,0.00013873288,0.0011152413,0.00012777753,0.0005849567],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000105180654,0.000732037,0.0010267,0.00037042677,0.00007139708,0.000034703262,0.00023511366,0.0004945202,0.998104],"category_scores_gemma":[0.000017917884,0.0006398778,0.0004586104,0.000055801607,0.00008988836,0.00004235602,0.0001094189,0.00051645265,0.99798036],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007411379,0.000095977,6.749437e-8,0.000096419666,0.000439085,0.001117798,0.000017673605,0.0000043442124,0.000043010434,0.00003494972,0.30851486,0.6888947],"study_design_scores_gemma":[0.0009096004,0.0012188064,0.000010981382,0.00041716584,0.0007304631,0.0003188485,2.6799833e-7,0.000005431369,0.00015038758,0.00009489073,0.9956029,0.0005402464],"about_ca_topic_score_codex":0.000024136822,"about_ca_topic_score_gemma":3.571747e-7,"teacher_disagreement_score":0.68835443,"about_ca_system_score_codex":0.0004636062,"about_ca_system_score_gemma":0.00019026146,"threshold_uncertainty_score":0.99960524},"labels":[],"label_agreement":null},{"id":"W4406679361","doi":"10.1097/pas.0000000000002362","title":"Prospective Fumarate Hydratase Tumor Predisposition Syndrome Screening in Patients With Uterine Smooth Muscle Tumors","year":2025,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Germline; Medicine; Immunohistochemistry; Internal medicine; Prospective cohort study; Germline mutation; Pathology; Oncology; Gastroenterology; Cancer research; Biology; Genetics; Mutation","score_opus":0.006452746735586086,"score_gpt":0.2459123564206281,"score_spread":0.239459609685042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406679361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99791455,0.00009536765,0.00015405171,0.0010460677,0.00004738386,0.00036923646,0.000014048533,0.000011056463,0.0003482416],"genre_scores_gemma":[0.99896485,0.000012504842,0.0006420853,0.00025085945,0.0000408617,0.000014636076,0.000011596381,0.000015386444,0.00004723922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848104,0.00028624784,0.00047779243,0.00020931993,0.00027235626,0.00027325132],"domain_scores_gemma":[0.9988702,0.0001383642,0.0004607673,0.00023612965,0.00018032607,0.0001141965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037309036,0.00018701064,0.0007097152,0.00026189836,0.0000551764,0.000011619825,0.00013352754,0.000021749716,0.000027811342],"category_scores_gemma":[0.000029931198,0.00010080772,0.00011103418,0.00055625034,0.00046032455,0.00008568094,0.000057180026,0.00040691977,0.0000042550955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016113222,0.0010128634,0.93067455,0.000036468475,0.00017646786,0.038034096,0.00023866877,0.00027428585,0.000503155,0.00006396774,0.00004806519,0.012824195],"study_design_scores_gemma":[0.0050548967,0.0074255024,0.98333883,0.0002532855,0.000116767216,0.0031644662,0.00017739294,0.000027296675,0.00017133038,0.00008199663,0.00009916568,0.00008908798],"about_ca_topic_score_codex":0.000036876078,"about_ca_topic_score_gemma":0.0000022439694,"teacher_disagreement_score":0.052664265,"about_ca_system_score_codex":0.00015700902,"about_ca_system_score_gemma":0.000099741876,"threshold_uncertainty_score":0.41108197},"labels":[],"label_agreement":null},{"id":"W4406750804","doi":"10.1016/j.eururo.2025.01.007","title":"A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer Types","year":2025,"lang":"en","type":"editorial","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Kidney cancer; Cancer; Urothelial cancer; Neoadjuvant therapy; Oncology; Internal medicine; Breast cancer; Bladder cancer","score_opus":0.04612878046480832,"score_gpt":0.3370887271073967,"score_spread":0.29095994664258834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406750804","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021009417,0.02164938,0.00014362943,0.026425702,0.8900094,0.0019800551,0.011848397,0.0003009584,0.045541525],"genre_scores_gemma":[0.004224715,0.0042029796,0.00031757634,0.00938959,0.85550296,0.0007011244,0.0028537898,0.0004321144,0.12237514],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99683934,0.00044964842,0.000550396,0.0011638129,0.00036544938,0.0006313635],"domain_scores_gemma":[0.9971816,0.00095939275,0.00033828552,0.00079567684,0.0003682547,0.0003567965],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002739671,0.00058950786,0.0011581009,0.00019739111,0.00009758133,0.00003094934,0.00034993276,0.0005815969,0.0010448712],"category_scores_gemma":[0.0012118951,0.00049046305,0.00035282402,0.00012189399,0.00018882318,0.000021387696,0.00014227214,0.0009708783,0.00024011891],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020309892,0.0001255398,0.00032488175,0.00019347182,0.0012839759,0.0004534577,0.00019183535,0.000018770672,0.0009977873,0.000023329541,0.9873945,0.006961471],"study_design_scores_gemma":[0.0043401006,0.0006454913,0.00056176947,0.00028046026,0.0025038961,0.0000037351504,0.000005854446,0.000029413453,0.0003468909,0.000059306305,0.9908686,0.00035443084],"about_ca_topic_score_codex":0.004925813,"about_ca_topic_score_gemma":0.00085617247,"teacher_disagreement_score":0.07683361,"about_ca_system_score_codex":0.00034772267,"about_ca_system_score_gemma":0.002199819,"threshold_uncertainty_score":0.99986833},"labels":[],"label_agreement":null},{"id":"W4406863268","doi":"10.3390/curroncol32020064","title":"First Single-Centre Experience with the Novel HIF-α Inhibitor Belzutifan in Switzerland","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Tolerability; Tyrosine-kinase inhibitor; Internal medicine; Kidney cancer; Oncology; Carcinoma; Clear cell renal cell carcinoma; Pazopanib; Cancer; Cancer research; Gastroenterology; Sunitinib; Adverse effect","score_opus":0.07597485975686537,"score_gpt":0.3449078099866114,"score_spread":0.26893295022974606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406863268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98105997,0.0019733973,0.00015962197,0.010252908,0.0006635941,0.0007831485,0.000003440159,0.00003256535,0.005071361],"genre_scores_gemma":[0.9984416,0.000035239063,0.00017004846,0.00027088056,0.000135958,0.000120908044,0.000013500797,0.000011565913,0.00080035185],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884987,0.000044981487,0.00024933595,0.00034927536,0.00017899905,0.000327518],"domain_scores_gemma":[0.9992356,0.00018657758,0.00007926522,0.00033101276,0.000078320954,0.000089262285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103738916,0.00018493393,0.0003332095,0.00012566775,0.000096991105,0.00001441971,0.00012892848,0.0000869819,0.000059630598],"category_scores_gemma":[0.000057138972,0.00010749139,0.000056821824,0.00041131827,0.00021044601,0.000037632413,0.000084141895,0.0002800012,0.000021955806],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001981365,0.0074575753,0.8991522,0.0003858191,0.00014771034,0.00044954877,0.011064149,0.00004646926,0.007980973,0.0011585939,0.013607058,0.0565685],"study_design_scores_gemma":[0.011128862,0.0019770723,0.3315328,0.0008392773,0.00023471806,0.00012605388,0.002883462,0.00028694185,0.007875016,0.00003960493,0.64279383,0.00028233588],"about_ca_topic_score_codex":0.000034018758,"about_ca_topic_score_gemma":0.0011269466,"teacher_disagreement_score":0.6291868,"about_ca_system_score_codex":0.0007301489,"about_ca_system_score_gemma":0.00025331913,"threshold_uncertainty_score":0.43833718},"labels":[],"label_agreement":null},{"id":"W4406871579","doi":"10.1186/s12885-025-13547-9","title":"Diagnostic performance of artificial intelligence in detection of renal cell carcinoma: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"BMC Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Renal cell carcinoma; Surgical oncology; Meta-analysis; Medicine; Carcinoma; MEDLINE; Systematic review; Oncology; Internal medicine; Bioinformatics; Pathology; Biology","score_opus":0.09860627253806747,"score_gpt":0.3495516135067507,"score_spread":0.2509453409686832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406871579","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039836727,0.99553025,0.00017985914,0.000005614533,0.000030514018,0.003712908,0.00006996162,0.00000566441,0.00006683906],"genre_scores_gemma":[0.04178495,0.9558644,0.00009417777,0.000013475101,0.000015462289,0.0018557421,0.000021335969,0.000018181101,0.0003322502],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99689066,0.00032976977,0.0018337083,0.00043955108,0.00032788666,0.00017841555],"domain_scores_gemma":[0.99721146,0.0008794127,0.0010546903,0.00062458316,0.00016423232,0.000065625754],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005224094,0.0003918267,0.00818164,0.00068723544,0.000016950798,0.0000052379523,0.00013001224,0.00014759359,0.000110095665],"category_scores_gemma":[0.00032812136,0.00025412688,0.0017514785,0.001702806,0.000065148844,0.000030306705,0.000058889527,0.00021610886,0.0000035487494],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013319272,0.00007126655,0.00004910674,0.9850867,0.009381978,0.000008367018,0.000024498648,0.000024944333,0.0000019324389,0.00000243526,0.000002212166,0.005333268],"study_design_scores_gemma":[0.00005174231,0.00015918602,0.00005165121,0.10618896,0.8927933,0.000013569916,0.000009176971,0.00008801681,0.0004131755,0.0000015055668,0.0000738711,0.00015584622],"about_ca_topic_score_codex":0.00046427414,"about_ca_topic_score_gemma":0.00045813975,"teacher_disagreement_score":0.88341135,"about_ca_system_score_codex":0.00029254073,"about_ca_system_score_gemma":0.000517138,"threshold_uncertainty_score":0.9999911},"labels":[],"label_agreement":null},{"id":"W4406891962","doi":"10.7759/cureus.78150","title":"Renal Oncocytoma Treated With Stereotactic Body Radiation Therapy in a Patient With Prior Pancoast Tumor","year":2025,"lang":"en","type":"article","venue":"Cureus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Stereotactic radiotherapy; Renal oncocytoma; Radiology; Oncocytoma; Radiosurgery; Radiation therapy; Internal medicine; Kidney","score_opus":0.012828615907585866,"score_gpt":0.25450123743780667,"score_spread":0.24167262153022082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406891962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99247026,0.0010411093,0.000015066475,0.00026652415,0.000035510813,0.0011586067,0.0000042331812,0.000059094193,0.0049496046],"genre_scores_gemma":[0.9985876,0.00006657738,0.00020920332,0.00027685502,0.00003429937,0.0001801104,0.000036116304,0.000025622205,0.0005836094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888057,0.000063120075,0.0002352792,0.0003231307,0.00025062863,0.00024726294],"domain_scores_gemma":[0.9992984,0.00004944779,0.00010736771,0.00036390926,0.000086478976,0.000094382354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053804393,0.00022050053,0.0003328633,0.000153886,0.00004411031,0.000022557613,0.00005389023,0.00004676648,0.000058636175],"category_scores_gemma":[0.00001456009,0.00013327251,0.000042463722,0.00040709745,0.000040631967,0.00008543551,0.00001375583,0.00014841344,0.000010912273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016121356,0.0022742613,0.9067273,0.000120743236,0.0007905492,0.007145922,0.0015222018,0.000027018632,0.009047321,0.000071808056,0.0005442846,0.05560722],"study_design_scores_gemma":[0.012771089,0.010428221,0.9254627,0.0005215955,0.00020446205,0.00046879103,0.00016350322,0.00014735674,0.04709435,0.000011383227,0.0025126613,0.0002138664],"about_ca_topic_score_codex":0.0004389132,"about_ca_topic_score_gemma":0.00033595893,"teacher_disagreement_score":0.055393353,"about_ca_system_score_codex":0.0005883987,"about_ca_system_score_gemma":0.0002938078,"threshold_uncertainty_score":0.5434695},"labels":[],"label_agreement":null},{"id":"W4406925873","doi":"10.1016/j.urolonc.2025.01.003","title":"Recurrence after surgery for clear cell and papillary renal cell carcinoma: Head-to head comparison of validated risk scores","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Head (geology); Carcinoma; Clear cell renal cell carcinoma; Papillary renal cell carcinomas; Surgery; Oncology; Internal medicine","score_opus":0.04417852919462387,"score_gpt":0.33427448892369466,"score_spread":0.29009595972907076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406925873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98898023,0.0067313523,0.00020736369,0.0022057751,0.00016050179,0.00081930304,0.0000895965,0.000029812816,0.0007760791],"genre_scores_gemma":[0.9618857,0.0004472985,0.03609696,0.00079630356,0.00004812966,0.000193465,0.000088725224,0.00001332701,0.00043008488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982804,0.00020512802,0.0005372932,0.00050617044,0.00013303512,0.00033796855],"domain_scores_gemma":[0.9979978,0.0010608232,0.00023224844,0.00026762122,0.00014181178,0.0002996775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041915575,0.00025192075,0.000720137,0.0003127489,0.00019632414,0.000016660753,0.00007516355,0.00024196187,0.000021156742],"category_scores_gemma":[0.0002055297,0.00020994098,0.00010521731,0.00036172778,0.0005556516,0.000054268396,0.00007886406,0.00029248794,0.000005458265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011971504,0.0003882761,0.98459595,0.00029409636,0.000039846876,0.000072011884,0.00040266273,0.000038764003,0.0029198243,0.00013289986,0.00808006,0.0018384336],"study_design_scores_gemma":[0.0035960525,0.014951242,0.5537098,0.00043892176,0.0021165474,0.00014808949,0.0005619714,0.0018613338,0.104619324,0.0027305256,0.31469885,0.00056732533],"about_ca_topic_score_codex":0.00019668312,"about_ca_topic_score_gemma":0.00007540037,"teacher_disagreement_score":0.43088615,"about_ca_system_score_codex":0.00010329902,"about_ca_system_score_gemma":0.0004416426,"threshold_uncertainty_score":0.85611445},"labels":[],"label_agreement":null},{"id":"W4406972991","doi":"10.1097/og9.0000000000000058","title":"Hereditary Leiomyomatosis and Renal Cell Cancer in a Patient With Isolated Uterine Leiomyomas","year":2025,"lang":"en","type":"article","venue":"O&G Open","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Leiomyomatosis; Uterine leiomyoma; Medicine; Leiomyoma; Pathology","score_opus":0.012647106803366526,"score_gpt":0.27810244585428556,"score_spread":0.26545533905091906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406972991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97224283,0.0012819363,0.000021782154,0.0016149323,0.0000609477,0.001058886,0.000018027164,0.000020992047,0.023679681],"genre_scores_gemma":[0.99382865,0.00010884136,0.0008767532,0.00041481902,0.000019828867,0.00022904946,0.000022579996,0.000019337918,0.0044801296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999029,0.000035971727,0.00022261676,0.0003484344,0.00014205293,0.00022194644],"domain_scores_gemma":[0.9994818,0.000024668878,0.00005386532,0.00028644138,0.000048273265,0.00010493886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000642725,0.00017947637,0.00034596425,0.00014233305,0.0000441601,0.00004476111,0.00011421784,0.000058376347,0.00025172837],"category_scores_gemma":[0.0000030043816,0.00012874305,0.000026985133,0.00033603242,0.000042810145,0.000109415494,0.0002340181,0.0001249945,0.000008823722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013927815,0.002740129,0.7205614,0.001643597,0.0013913481,0.019273164,0.0032083234,0.0002001647,0.09299785,0.00021170132,0.021147074,0.12269743],"study_design_scores_gemma":[0.02416932,0.006292903,0.7353697,0.0035861873,0.00076888694,0.00093333836,0.0008441538,0.001477363,0.17791073,0.00013565457,0.047625296,0.0008864715],"about_ca_topic_score_codex":0.0038600187,"about_ca_topic_score_gemma":0.0009518155,"teacher_disagreement_score":0.12181096,"about_ca_system_score_codex":0.00017363881,"about_ca_system_score_gemma":0.0001948197,"threshold_uncertainty_score":0.58352196},"labels":[],"label_agreement":null},{"id":"W4407164384","doi":"10.1016/s1470-2045(24)00731-9","title":"Comparative efficacy and safety of ablative therapies in the management of primary localised renal cell carcinoma: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Western University; McMaster University; London Health Sciences Centre","funders":"","keywords":"Ablative case; Renal cell carcinoma; Meta-analysis; Medicine; Systematic review; Oncology; Internal medicine; Intensive care medicine; MEDLINE; Radiation therapy; Chemistry","score_opus":0.14908601705857505,"score_gpt":0.38820661703559206,"score_spread":0.239120599977017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407164384","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000072300674,0.98426247,0.000015749327,0.00074447616,0.000008056983,0.0077289557,0.00008072293,0.0000048042775,0.007082493],"genre_scores_gemma":[0.0071123685,0.9909108,0.00031411918,0.00041096951,0.00001173691,0.0007989087,0.000071937226,0.000010332735,0.00035880884],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99452955,0.0033251883,0.0013066548,0.00036313094,0.00027301107,0.00020247797],"domain_scores_gemma":[0.99515086,0.0026582577,0.0011575948,0.0009115604,0.00008835753,0.00003335037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022671102,0.00040953222,0.014245722,0.00021362236,0.00003871003,0.000005627639,0.00033789244,0.00012381212,0.000030057334],"category_scores_gemma":[0.000020203295,0.0001641039,0.0008715169,0.0008768202,0.0003316357,0.000015552485,0.00015949558,0.00033761584,0.0000013038075],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015465423,0.00021460801,0.000004570764,0.8996248,0.097291596,0.00006382751,0.0012612968,0.0000015802533,2.7949918e-7,0.00037163307,0.00011202829,0.0008990948],"study_design_scores_gemma":[0.0014544363,0.00047458484,0.0007349164,0.024820082,0.966928,0.00004566737,0.00033099722,0.0000017996823,0.0000019588658,0.000022920443,0.005058883,0.00012572424],"about_ca_topic_score_codex":0.000037641425,"about_ca_topic_score_gemma":0.00001885473,"teacher_disagreement_score":0.87480474,"about_ca_system_score_codex":0.00019321461,"about_ca_system_score_gemma":0.00017617579,"threshold_uncertainty_score":0.9738091},"labels":[],"label_agreement":null},{"id":"W4407176823","doi":"10.3390/cancers17030522","title":"Real-World Efficacy and Toxicity of Ipilimumab and Nivolumab as First-Line Treatment of Metastatic Renal Cell Carcinoma (mRCC) in a Subpopulation of Elderly and Poor Performance Status Patients","year":2025,"lang":"en","type":"article","venue":"Cancers","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier universitaire de Québec; Sunnybrook Health Science Centre; Centre Hospitalier de l’Université de Montréal; McMaster University; Alberta Health Services; Health Sciences Centre; Capital District Health Authority; University Health Network; CancerCare Manitoba; University of Alberta; Queen Elizabeth II Health Sciences Centre; Juravinski Cancer Centre; McGill University Health Centre; University of Ottawa","funders":"EMD Serono; Ipsen; Astellas Pharma; Eisai; Seagen; Advanced Accelerator Applications; Genentech; AstraZeneca; Pfizer; Amgen","keywords":"Medicine; Nivolumab; Ipilimumab; Renal cell carcinoma; Sunitinib; Internal medicine; Cohort; Toxicity; Oncology; Kidney cancer; Population; Performance status; Expanded access; Cancer; Immunotherapy","score_opus":0.01895800621687527,"score_gpt":0.2740941849173307,"score_spread":0.2551361787004554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407176823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662197,0.0019056669,0.0000030380536,0.00003423792,0.000031426003,0.0007874615,0.00004067245,0.00000491211,0.0005706327],"genre_scores_gemma":[0.99792343,0.0015411333,0.0002408831,0.000008425741,0.000006053359,0.000026130958,0.0000391397,0.000010857391,0.00020392066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889016,0.000038594695,0.0004418669,0.00026208608,0.00017223033,0.00019505553],"domain_scores_gemma":[0.99931055,0.00010014598,0.00021284184,0.00018452927,0.00009332072,0.00009858071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000066522494,0.0001739329,0.0005438509,0.00027369327,0.000028773376,0.0000035309192,0.00002542138,0.000037175774,0.000009477691],"category_scores_gemma":[0.00002270611,0.0001458917,0.0000387549,0.00026670637,0.00014068017,0.000057092395,0.000022746457,0.000049106533,1.1894869e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027866734,0.00035657219,0.9657336,0.0012488571,0.00009524487,0.0000092536575,0.0012924242,0.00026677668,0.00516081,0.00001277914,0.000011025455,0.023026008],"study_design_scores_gemma":[0.0126297455,0.0059720455,0.8807193,0.0002893453,0.00032663668,0.0000017225562,0.00010731237,0.0012716481,0.09856025,0.000017405242,0.00002284365,0.00008175945],"about_ca_topic_score_codex":0.010204583,"about_ca_topic_score_gemma":0.0023423787,"teacher_disagreement_score":0.09339944,"about_ca_system_score_codex":0.0008395322,"about_ca_system_score_gemma":0.00031511203,"threshold_uncertainty_score":0.9963865},"labels":[],"label_agreement":null},{"id":"W4407240463","doi":"10.3390/cancers17040569","title":"K-Means Clustering of Hyperpolarised 13C-MRI Identifies Intratumoral Perfusion/Metabolism Mismatch in Renal Cell Carcinoma as the Best Predictor of the Highest Grade","year":2025,"lang":"en","type":"article","venue":"Cancers","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NIHR Cambridge Biomedical Research Centre; Mark Foundation For Cancer Research; Lundbeckfonden; Cancer Research UK; Canadian Institute for Advanced Research","keywords":"Clear cell renal cell carcinoma; Renal cell carcinoma; Medicine; Biopsy; Perfusion; Magnetic resonance imaging; Radiology; Pathology; Nuclear medicine","score_opus":0.013837653877641156,"score_gpt":0.2442390162938114,"score_spread":0.23040136241617024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407240463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98824483,0.00437724,0.000017116463,0.001645732,0.0007954562,0.00074127613,0.00003041087,0.000013391103,0.004134555],"genre_scores_gemma":[0.99670804,0.0001707791,0.00010896461,0.00018649039,0.000110990775,0.000056906105,0.000009195539,0.000021525162,0.0026271062],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99839365,0.00011950761,0.00050258776,0.0002967198,0.0004005121,0.00028703976],"domain_scores_gemma":[0.9988651,0.000099685996,0.0001966988,0.0006533001,0.0001093157,0.00007588913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018857338,0.00022184574,0.00046351796,0.00014903818,0.00009354171,0.00001660856,0.00034539285,0.00009911252,0.00004842224],"category_scores_gemma":[0.00004860885,0.00013308066,0.00020348834,0.00052433327,0.00033806218,0.000055247867,0.00015668194,0.00033132985,0.0000035951928],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014545427,0.00037395384,0.39316866,0.0014315797,0.00024152467,0.00015318177,0.012260452,0.005150287,0.57891077,0.00035711337,0.0054859733,0.0010119487],"study_design_scores_gemma":[0.0038281707,0.00026504928,0.5129037,0.0007353469,0.0005978851,0.000029267918,0.003520997,0.0021390056,0.47354704,0.00012277038,0.0021312286,0.00017956037],"about_ca_topic_score_codex":0.0058609243,"about_ca_topic_score_gemma":0.0006664839,"teacher_disagreement_score":0.11973502,"about_ca_system_score_codex":0.0006311628,"about_ca_system_score_gemma":0.0009465832,"threshold_uncertainty_score":0.88600034},"labels":[],"label_agreement":null},{"id":"W4407404523","doi":"10.3390/curroncol32020094","title":"Immune Checkpoint Blockade Response in Mucinous Tubular and Spindle Cell Carcinoma","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Defense","keywords":"Medicine; Ipilimumab; Immune checkpoint; Nivolumab; Blockade; Renal cell carcinoma; Kidney cancer; Oncology; Immune system; Cancer; Cancer research; Internal medicine; Immunotherapy; Pathology; Immunology; Receptor","score_opus":0.046062342348630686,"score_gpt":0.3470238218852527,"score_spread":0.300961479536622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407404523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9661707,0.026111547,0.000018724664,0.00214205,0.0006334856,0.0007433524,0.000004088447,0.000036696947,0.0041393396],"genre_scores_gemma":[0.99813384,0.00026241428,0.00028520086,0.00008884273,0.00007077301,0.000098576216,0.000019406083,0.000018451938,0.0010224676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816465,0.00027702344,0.0005146948,0.000477178,0.00014737771,0.0004190794],"domain_scores_gemma":[0.9990226,0.00020650444,0.00009706095,0.00044507568,0.00007379581,0.00015494946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052543316,0.0002448089,0.000618004,0.0004338953,0.000056014997,0.000010215276,0.0000949133,0.00018566473,0.00007068101],"category_scores_gemma":[0.00014903238,0.00021759956,0.00011645251,0.00031669828,0.00014241964,0.00002998838,0.00016473143,0.0004475199,0.00004379071],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014756715,0.0055935527,0.6175084,0.0011959686,0.00010551571,0.0033298645,0.0027010797,0.000011963575,0.30277616,0.00018069708,0.0008785775,0.05096148],"study_design_scores_gemma":[0.00779766,0.0026307735,0.8500561,0.00014585127,0.0001825651,0.00019407782,0.00030355252,0.00021485108,0.10443157,0.000104678846,0.033758584,0.00017973025],"about_ca_topic_score_codex":0.00009907836,"about_ca_topic_score_gemma":0.000019434352,"teacher_disagreement_score":0.23254767,"about_ca_system_score_codex":0.00082655705,"about_ca_system_score_gemma":0.00056230754,"threshold_uncertainty_score":0.88734525},"labels":[],"label_agreement":null},{"id":"W4407408676","doi":"10.3390/siuj6010007","title":"Utility and Practicability of Nephrometry Scoring Systems in Contemporary Clinical Practice—An International Multicentre Perspective","year":2025,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Perspective (graphical); Clinical Practice; Medical physics; Medicine; Computer science; Family medicine; Artificial intelligence","score_opus":0.14527258821792882,"score_gpt":0.4691423661522586,"score_spread":0.3238697779343298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407408676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95446414,0.002599095,0.00035489068,0.00566898,0.0015910103,0.00055885245,0.000017772565,0.00002611908,0.034719117],"genre_scores_gemma":[0.9960194,0.0005935105,0.0022912738,0.00047658148,0.00027538819,0.000013766669,0.000016324551,0.000009338477,0.00030439981],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99694705,0.00063997635,0.0011653632,0.00044438112,0.0005979443,0.0002052673],"domain_scores_gemma":[0.99520075,0.002243894,0.0006959473,0.00029346748,0.0014051809,0.00016078608],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002507771,0.00018990852,0.0005282969,0.00038384937,0.00006595374,0.00007833678,0.0002099387,0.00018826718,0.00008894023],"category_scores_gemma":[0.010526934,0.00016343986,0.00020021811,0.00019352343,0.0002626945,0.0007841482,0.00016337761,0.0009993447,0.0000022751685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029056366,0.0019900405,0.98532563,0.000056317193,0.00084539736,0.0004029295,0.00045964794,0.000028707362,0.00021113535,0.0029953204,0.0002276476,0.0045515755],"study_design_scores_gemma":[0.004621796,0.0005252915,0.9751589,0.00016501924,0.00014994861,0.00060135894,0.0116403075,0.0028662384,0.0001406296,0.0010002147,0.003024142,0.000106190906],"about_ca_topic_score_codex":0.00032171636,"about_ca_topic_score_gemma":0.00001573884,"teacher_disagreement_score":0.041555256,"about_ca_system_score_codex":0.000627061,"about_ca_system_score_gemma":0.00074591086,"threshold_uncertainty_score":0.9978078},"labels":[],"label_agreement":null},{"id":"W4407584744","doi":"10.3390/siuj6010015","title":"B2B: Kidney Cancer Summary","year":2025,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University","funders":"Johnson and Johnson; Merck Sharp and Dohme; Bristol-Myers Squibb","keywords":"Kidney cancer; Cancer; Kidney; Medicine; Internal medicine","score_opus":0.03823751511521084,"score_gpt":0.3572146729291194,"score_spread":0.31897715781390856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407584744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7148026,0.0064357375,0.0007637514,0.060774755,0.004040568,0.0003968047,0.000047353176,0.00012373811,0.21261466],"genre_scores_gemma":[0.91488427,0.0020644295,0.0008180145,0.014438589,0.0008681169,0.000055712615,0.00005645227,0.00001709319,0.066797316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998578,0.00006873297,0.00039118223,0.00023471515,0.0004412144,0.0002861451],"domain_scores_gemma":[0.9988856,0.00016279751,0.00016854206,0.00019095448,0.0003734432,0.00021868748],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027622114,0.00018078432,0.00028913585,0.00025461457,0.00014557542,0.0000593822,0.00023857536,0.00012629747,0.0018582513],"category_scores_gemma":[0.00042891438,0.00014228822,0.00030626525,0.00015765296,0.000088213965,0.00011600401,0.00009922742,0.00059064163,0.000039241204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083738705,0.00046200567,0.5107461,0.000074865,0.0017334535,0.0008017062,0.00014610708,0.000088532564,0.0048379716,0.002139271,0.44085544,0.037277162],"study_design_scores_gemma":[0.006898863,0.00054968137,0.50058883,0.0004912999,0.0006320021,0.0009613251,0.00031974496,0.00047742535,0.009703689,0.009438945,0.46961513,0.00032304862],"about_ca_topic_score_codex":0.000039909057,"about_ca_topic_score_gemma":0.0000064307596,"teacher_disagreement_score":0.20008165,"about_ca_system_score_codex":0.000749461,"about_ca_system_score_gemma":0.00088335184,"threshold_uncertainty_score":0.9990542},"labels":[],"label_agreement":null},{"id":"W4407676833","doi":"10.1016/j.thorsurg.2024.12.001","title":"Pulmonary Metastasectomy in Renal Cell Carcinoma","year":2025,"lang":"en","type":"review","venue":"Thoracic surgery clinics/Thorac. surg. clin.","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Intuitive; Medtronic","keywords":"Metastasectomy; Medicine; Renal cell carcinoma; Oncology; Urology; Internal medicine; Metastasis; Cancer","score_opus":0.11549524973291167,"score_gpt":0.4038911906880287,"score_spread":0.288395940955117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407676833","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0075097396,0.9658605,0.000021770515,0.00010920685,0.0027588394,0.0043424144,0.0006189541,0.00040078713,0.01837779],"genre_scores_gemma":[0.0074810092,0.97299117,0.00079763343,0.0003074723,0.0013846464,0.0010654535,0.0046438286,0.0005631122,0.010765677],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9794396,0.0049476805,0.007896374,0.0035880967,0.0017253591,0.0024028795],"domain_scores_gemma":[0.9691936,0.021991283,0.002971092,0.004080972,0.00053866603,0.0012243824],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.01040745,0.0029574782,0.0145796,0.004416147,0.00025330877,0.00016355581,0.00097410555,0.0024478368,0.0009118242],"category_scores_gemma":[0.0022311187,0.0025390228,0.007350882,0.0047524343,0.00041470752,0.00033730874,0.00073371205,0.0041773687,0.0013125493],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010141162,0.0020343019,0.008536948,0.0589607,0.0005994747,0.021500843,0.000031021384,0.0000028537404,0.0000029929345,0.0000067170604,0.004120811,0.90318924],"study_design_scores_gemma":[0.00071324094,0.00034493266,0.00094347884,0.043514065,0.010598201,0.0012812831,0.00006987648,0.000029090565,0.00022425786,0.00009151737,0.93976957,0.002420512],"about_ca_topic_score_codex":0.00025610725,"about_ca_topic_score_gemma":0.000036732006,"teacher_disagreement_score":0.93564874,"about_ca_system_score_codex":0.0014310334,"about_ca_system_score_gemma":0.007684017,"threshold_uncertainty_score":0.99946505},"labels":[],"label_agreement":null},{"id":"W4407678084","doi":"10.1200/jco.2025.43.5_suppl.477","title":"Real-world outcomes of first-line dual immunotherapy versus combination VEGF immunotherapy in intermediate-poor risk metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Data Consortium (IMDC).","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre; Sunnybrook Hospital; University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Immunotherapy; Oncology; Internal medicine; Second line; Cancer research; First line; Cancer","score_opus":0.11760310345271452,"score_gpt":0.41627909486239073,"score_spread":0.2986759914096762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407678084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806195,0.0017191472,0.0001869973,0.009889446,0.003530834,0.00079018454,0.00058877165,0.000013827192,0.0026613057],"genre_scores_gemma":[0.99093187,0.002655916,0.0038935256,0.00087150163,0.0003865643,0.000021128559,0.0004500655,0.000048131522,0.00074127543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9895392,0.0019085172,0.00632173,0.00068968063,0.0010788947,0.00046196333],"domain_scores_gemma":[0.97338474,0.0189689,0.0053180777,0.0013095504,0.0007850488,0.00023366006],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006932816,0.00049509073,0.0028175935,0.0006467482,0.00010236453,0.000042007847,0.001350154,0.00025618434,0.00020715466],"category_scores_gemma":[0.0036979832,0.00032282772,0.0008308434,0.00052828796,0.00057744,0.00028724418,0.00036520665,0.0018740506,0.000014729927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14068593,0.013421958,0.7860361,0.0001205056,0.005351679,0.0027671286,0.0014586941,0.00031205584,0.0036628777,0.0001332982,0.014539687,0.031510107],"study_design_scores_gemma":[0.09730445,0.009513644,0.87532544,0.0001560526,0.0018988368,0.000033566084,0.0005425743,0.001636075,0.004582702,0.00050558633,0.008256028,0.0002450485],"about_ca_topic_score_codex":0.003768784,"about_ca_topic_score_gemma":0.003584291,"teacher_disagreement_score":0.08928936,"about_ca_system_score_codex":0.0007875434,"about_ca_system_score_gemma":0.0024315864,"threshold_uncertainty_score":0.9999224},"labels":[],"label_agreement":null},{"id":"W4407678310","doi":"10.1200/jco.2025.43.5_suppl.440","title":"KEYMAKER-U03 Substudy 03B: Pembrolizumab (pembro) and targeted therapy combinations for advanced clear cell renal cell carcinoma (ccRCC).","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Pembrolizumab; Renal cell carcinoma; Clear cell renal cell carcinoma; Oncology; Internal medicine; Cancer research; Cancer; Immunotherapy","score_opus":0.07810510800763588,"score_gpt":0.4207072258296449,"score_spread":0.34260211782200906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407678310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777435,0.0055245985,0.0003245868,0.004394372,0.0010529788,0.0010341138,0.000010114369,0.00002004455,0.009895672],"genre_scores_gemma":[0.9882039,0.0010115977,0.0058610784,0.0013766157,0.0003050404,0.00003803538,0.000012056631,0.000036237987,0.003155471],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995965,0.0005000998,0.0023895134,0.00039971623,0.00036135656,0.00038432537],"domain_scores_gemma":[0.99373895,0.003204142,0.0013495877,0.00036013487,0.00089784106,0.00044935042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016856381,0.00029150955,0.0018025028,0.00029965385,0.00015124508,0.000020302485,0.000222658,0.00044455956,0.00006124644],"category_scores_gemma":[0.00088430406,0.0002161425,0.0007272791,0.00025784754,0.00024612184,0.000115947216,0.00007034397,0.00094398356,0.000009125962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18993577,0.057620127,0.33255914,0.0010182038,0.003141452,0.0034126623,0.0017838723,0.00030568533,0.07857989,0.0023805355,0.06645625,0.26280642],"study_design_scores_gemma":[0.11363378,0.0708942,0.7305525,0.00009767733,0.0011953216,0.00022327952,0.00043881807,0.00029081537,0.015897926,0.0018446586,0.06463708,0.00029393923],"about_ca_topic_score_codex":0.000016921747,"about_ca_topic_score_gemma":0.000018801087,"teacher_disagreement_score":0.39799336,"about_ca_system_score_codex":0.00028872944,"about_ca_system_score_gemma":0.0017662876,"threshold_uncertainty_score":0.88140357},"labels":[],"label_agreement":null},{"id":"W4407678390","doi":"10.1200/jco.2025.43.5_suppl.479","title":"Cabozantinib real-world effectiveness in the second-line setting of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; McMaster University; University of Calgary","funders":"","keywords":"Cabozantinib; Medicine; Renal cell carcinoma; Oncology; Internal medicine; Urology; Database","score_opus":0.09868426204672401,"score_gpt":0.41827685727317526,"score_spread":0.3195925952264512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407678390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771378,0.0009350373,0.00019866598,0.007884856,0.0013318178,0.00090017467,0.00041635704,0.00000772821,0.011187566],"genre_scores_gemma":[0.9923934,0.00012244066,0.003936603,0.0019389284,0.000595679,0.000027654864,0.00017050933,0.000029406476,0.0007854135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98828757,0.0044346154,0.0052169464,0.0005876178,0.0010056628,0.0004675879],"domain_scores_gemma":[0.96020937,0.03426908,0.0036904933,0.0008349498,0.0007543321,0.00024178282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014459549,0.0004049093,0.002388131,0.00044216798,0.00009871199,0.000033916065,0.00094741455,0.00017672712,0.00018581792],"category_scores_gemma":[0.004386711,0.0002249004,0.00085124274,0.0006784514,0.0004356256,0.0001743268,0.00027294582,0.0021138191,0.000011330952],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07908481,0.0144590745,0.7891068,0.0011651447,0.003198393,0.018438092,0.002993004,0.0008140618,0.043324325,0.0006720442,0.033868246,0.012876],"study_design_scores_gemma":[0.034005735,0.0048935255,0.91082877,0.00043604212,0.0026792998,0.0002606483,0.0011232895,0.0006485241,0.036071908,0.0004161096,0.008422055,0.00021409756],"about_ca_topic_score_codex":0.0016740732,"about_ca_topic_score_gemma":0.002989986,"teacher_disagreement_score":0.12172196,"about_ca_system_score_codex":0.00035996272,"about_ca_system_score_gemma":0.0032317014,"threshold_uncertainty_score":0.918361},"labels":[],"label_agreement":null},{"id":"W4407678516","doi":"10.1200/jco.2025.43.5_suppl.471","title":"Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary renal cell carcinoma.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; London Health Sciences Centre; McGill University Health Centre; University of Ottawa; Sunnybrook Health Science Centre; Ottawa Hospital; CancerCare Manitoba; University of Manitoba; Hôtel-Dieu de Québec; BC Cancer Agency; University of Alberta; Queen Elizabeth II Health Sciences Centre; Western University; University of Toronto; Dalhousie University; University of Calgary; Université Laval; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Papillary renal cell carcinomas; Internal medicine","score_opus":0.17689721804712585,"score_gpt":0.5136408992373269,"score_spread":0.33674368119020104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407678516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757521,0.0006822805,0.00008973061,0.0041652457,0.0010693524,0.00062385993,0.000013407064,0.000006129789,0.017597862],"genre_scores_gemma":[0.98063254,0.0028089539,0.013881648,0.00040824804,0.00025383988,0.000014518288,0.000009918969,0.00002230949,0.0019680376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9878873,0.0014327089,0.009295652,0.0003885462,0.0006476999,0.00034808472],"domain_scores_gemma":[0.9831877,0.010710556,0.0044930154,0.000584919,0.00061194773,0.00041189825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00587989,0.00033403994,0.0057128463,0.00064842013,0.000026236314,0.0000042534225,0.000270765,0.00035049714,0.00015636845],"category_scores_gemma":[0.0019342949,0.00021150072,0.001980976,0.00047903927,0.00037809616,0.00007234265,0.00011452214,0.0010008719,0.0000034647637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034739529,0.013300853,0.954119,0.00021395361,0.0013785881,0.0020188338,0.00005026292,0.0001385852,0.000111140616,0.00016714392,0.0006745296,0.02435311],"study_design_scores_gemma":[0.022717152,0.031589597,0.93642616,0.00021398843,0.0023960085,0.000039799637,0.000096651835,0.000258389,0.0009666376,0.00032028958,0.004862786,0.00011254025],"about_ca_topic_score_codex":0.0006742522,"about_ca_topic_score_gemma":0.001381791,"teacher_disagreement_score":0.02424057,"about_ca_system_score_codex":0.00068946084,"about_ca_system_score_gemma":0.005139568,"threshold_uncertainty_score":0.91173726},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W4407699688","doi":"10.1200/jco.2025.43.5_suppl.505","title":"Low versus low-intermediate risk metastatic renal cell carcinoma (mRCC): Contemporary data from the International mRCC Database Consortium (IMDC).","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary; BC Cancer Agency","funders":"","keywords":"Medicine; Renal cell carcinoma; Database; Oncology; Internal medicine; Urology","score_opus":0.2089176474603002,"score_gpt":0.44566881026029537,"score_spread":0.23675116279999517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407699688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9665516,0.002591235,0.00061020383,0.011393467,0.008496558,0.00046306092,0.00080974604,0.000016550459,0.009067549],"genre_scores_gemma":[0.9890768,0.0009006904,0.0029068242,0.0039764224,0.0018888593,0.000008290009,0.00054166786,0.000026988626,0.000673477],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9935405,0.0013143206,0.0034353267,0.00057624176,0.0008015166,0.00033204883],"domain_scores_gemma":[0.98064846,0.014095236,0.0028770973,0.0013536549,0.00055867195,0.00046691016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047078906,0.00031623698,0.001721086,0.00018148698,0.00009074155,0.000045237313,0.0015015826,0.00024732325,0.00055968633],"category_scores_gemma":[0.008229922,0.0001922892,0.0006295797,0.00018245737,0.00055686897,0.0003103973,0.00080286205,0.0019820638,0.00012617986],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.072748624,0.0073815654,0.2866751,0.00012599067,0.0065096477,0.018643802,0.00021661504,0.000032625983,0.0016790272,0.000085048465,0.56475407,0.04114792],"study_design_scores_gemma":[0.096640915,0.015218807,0.63197786,0.00078874873,0.007773147,0.00037479,0.001320681,0.0036650237,0.0058011212,0.0005164704,0.23542652,0.0004959108],"about_ca_topic_score_codex":0.00035018133,"about_ca_topic_score_gemma":0.00023699613,"teacher_disagreement_score":0.3453028,"about_ca_system_score_codex":0.00033111652,"about_ca_system_score_gemma":0.005308945,"threshold_uncertainty_score":0.9852579},"labels":[],"label_agreement":null},{"id":"W4407699987","doi":"10.1200/jco.2025.43.5_suppl.459","title":"Patient-reported outcomes (PROs) for tivozanib (TIVO) + nivolumab (NIVO) vs TIVO monotherapy in patients with renal cell carcinoma (RCC) following an immune checkpoint inhibitor (ICI): Results of the phase 3 TiNivo-2 study.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Nivolumab; Medicine; Renal cell carcinoma; Internal medicine; Oncology; Immune checkpoint; PD-L1; Ipilimumab; Immunotherapy; Cancer","score_opus":0.053857476111527094,"score_gpt":0.3980470898107144,"score_spread":0.3441896136991873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407699987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99363434,0.00019737313,0.00003991781,0.0012243803,0.0013300492,0.002900951,0.000021643707,0.000012188163,0.0006391258],"genre_scores_gemma":[0.9975888,0.000007934511,0.0012495695,0.00042679562,0.00017666335,0.00005153939,0.000014035247,0.000049467828,0.000435178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9913884,0.00089128717,0.0058552492,0.0005593944,0.0008427527,0.00046292585],"domain_scores_gemma":[0.99184525,0.0016530743,0.0044631995,0.0008092783,0.0009528096,0.00027639803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032239112,0.0004186001,0.0028108985,0.000370458,0.00010228835,0.000015668586,0.00035742595,0.0003919579,0.00001409146],"category_scores_gemma":[0.0019822333,0.00024116795,0.0012350108,0.00048096527,0.00023728963,0.00018681592,0.00011460133,0.0010422764,0.0000012039724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10820893,0.0325415,0.83608264,0.00006020457,0.0009829671,0.00046955593,0.0013842931,0.000021619433,0.0018617027,0.0000037368231,0.00027430442,0.01810854],"study_design_scores_gemma":[0.15124898,0.09116299,0.7449035,0.00023374244,0.0009033184,0.000013499143,0.0008257773,0.000043380365,0.009888113,0.000036061567,0.0005736294,0.00016701844],"about_ca_topic_score_codex":0.00025201566,"about_ca_topic_score_gemma":0.00020268801,"teacher_disagreement_score":0.09117915,"about_ca_system_score_codex":0.0005834357,"about_ca_system_score_gemma":0.0020672854,"threshold_uncertainty_score":0.98345435},"labels":[],"label_agreement":null},{"id":"W4407700377","doi":"10.1200/jco.2025.43.5_suppl.552","title":"KEYMAKER-U03 Substudy 03B: Pembrolizumab (pembro) and novel immunotherapy agents for advanced clear cell renal cell carcinoma (ccRCC).","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Renal cell carcinoma; Clear cell renal cell carcinoma; Immunotherapy; Internal medicine; Oncology; Cancer research; Cancer","score_opus":0.09398857896513756,"score_gpt":0.43031866390823253,"score_spread":0.33633008494309496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407700377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98033816,0.003820934,0.0012228593,0.0022927828,0.0013693278,0.000976347,0.00001178321,0.000016630198,0.009951202],"genre_scores_gemma":[0.98085153,0.00076129334,0.010252541,0.002019814,0.0004826664,0.000028593377,0.0000067644337,0.000049420505,0.0055473936],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99548215,0.00031476872,0.0028382712,0.00047553438,0.00042009135,0.00046921018],"domain_scores_gemma":[0.9943952,0.0024168077,0.0016413534,0.00044323143,0.00064080243,0.0004626106],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001909832,0.00035120102,0.002152518,0.0002765819,0.00012593083,0.000022650227,0.00028212852,0.0005140936,0.00007344663],"category_scores_gemma":[0.0006497719,0.0002636805,0.00090929953,0.00021024022,0.00024036052,0.000120015626,0.00009822968,0.0010160416,0.000011953065],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26240507,0.035715688,0.25333965,0.0013014124,0.0032717844,0.0032373553,0.001227203,0.00023007349,0.1723397,0.0008759899,0.03516426,0.23089181],"study_design_scores_gemma":[0.11267113,0.051020946,0.6850721,0.00017037253,0.0014732003,0.0004250007,0.00035379213,0.00025622768,0.012950895,0.00052177964,0.1347507,0.0003338023],"about_ca_topic_score_codex":0.000024186815,"about_ca_topic_score_gemma":0.000017309696,"teacher_disagreement_score":0.43173248,"about_ca_system_score_codex":0.000383446,"about_ca_system_score_gemma":0.0016826304,"threshold_uncertainty_score":0.9999815},"labels":[],"label_agreement":null},{"id":"W4407700784","doi":"10.1200/jco.2025.43.5_suppl.567","title":"Association between abnormal IMDC laboratory criteria after surgery and cancer-specific and overall survival in non-metastatic renal cell carcinoma: Potential biomarkers for adjuvant therapy patient selection.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; McMaster University; McGill University Health Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre; University of Calgary; Ottawa Hospital; University of Alberta; Queen Elizabeth II Health Sciences Centre; Université Laval","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Internal medicine; Cancer; Adjuvant therapy; Kidney cancer; Overall survival; Adjuvant; Selection (genetic algorithm); Surgery","score_opus":0.04856286732297333,"score_gpt":0.37355196233724103,"score_spread":0.3249890950142677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407700784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908454,0.0047659837,0.0001331228,0.0024737387,0.0012315382,0.00044094565,0.0000441075,0.0000042054626,0.000060998602],"genre_scores_gemma":[0.9950272,0.0026963735,0.0010947592,0.00051103224,0.00054355466,0.00003588712,0.000009158221,0.000016286376,0.00006579163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966985,0.00061817653,0.0018382035,0.00026742884,0.00028617168,0.00029151613],"domain_scores_gemma":[0.9953168,0.0027704022,0.0010886687,0.00009033953,0.0005110733,0.00022274067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027365445,0.000187573,0.0014155123,0.00031193008,0.000048140137,0.000023864504,0.000046520698,0.00027206185,0.000040357765],"category_scores_gemma":[0.0003511791,0.00014482836,0.00028182997,0.0001861856,0.00008466581,0.00013003856,0.00003201897,0.00046224502,5.320712e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010224098,0.0006331331,0.9312432,0.00009197834,0.0005903366,0.0003034349,0.00009757917,0.0000047323247,0.0015656325,0.0000010599201,0.0049262634,0.050318558],"study_design_scores_gemma":[0.0103204455,0.004287543,0.97707874,0.000087656554,0.00046139373,0.000020957921,0.00006277919,0.00007592841,0.0010576753,0.00005525892,0.006381385,0.000110264016],"about_ca_topic_score_codex":0.00009984249,"about_ca_topic_score_gemma":0.000058688933,"teacher_disagreement_score":0.050208293,"about_ca_system_score_codex":0.00059073756,"about_ca_system_score_gemma":0.0013058952,"threshold_uncertainty_score":0.5905929},"labels":[],"label_agreement":null},{"id":"W4407721050","doi":"10.1200/jco.2025.43.5_suppl.494","title":"Updated outcomes of patients with metastatic non-clear cell renal cell carcinoma (mnccRCC) treated with first-line (1L) therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Renal cell carcinoma; Clear cell renal cell carcinoma; Oncology; Internal medicine; Carcinoma","score_opus":0.06005095628383615,"score_gpt":0.35232714463549947,"score_spread":0.2922761883516633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407721050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98944074,0.0004249973,0.00044885784,0.004582482,0.0004986234,0.0010457647,0.00080676016,0.000016425402,0.0027353482],"genre_scores_gemma":[0.9858907,0.00014899521,0.009829452,0.0016704585,0.00018132053,0.000020494652,0.0007101493,0.000062591105,0.0014858331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9920458,0.0009299962,0.004472923,0.0007134068,0.001319853,0.00051803066],"domain_scores_gemma":[0.98493904,0.0074170474,0.0045128665,0.0009959968,0.0016563131,0.0004787089],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020632364,0.000617593,0.0028718533,0.00037778527,0.00013122358,0.000038337996,0.0007953391,0.00022564066,0.00032749053],"category_scores_gemma":[0.0009698789,0.00031538194,0.00069281185,0.0005046892,0.0006462185,0.00022931294,0.00020406014,0.001357679,0.000021396307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09675896,0.01094232,0.86889005,0.00015927434,0.003759261,0.0027984942,0.0006086254,0.0003682556,0.0013151391,0.000008387437,0.012962695,0.0014285521],"study_design_scores_gemma":[0.07864321,0.02624361,0.8677334,0.00024573022,0.0062651103,0.000045183053,0.0005945763,0.00044938468,0.014107829,0.000032015494,0.005314338,0.00032557573],"about_ca_topic_score_codex":0.0008565583,"about_ca_topic_score_gemma":0.0004952231,"teacher_disagreement_score":0.018115751,"about_ca_system_score_codex":0.00038271656,"about_ca_system_score_gemma":0.0026613232,"threshold_uncertainty_score":0.99992985},"labels":[],"label_agreement":null},{"id":"W4407763978","doi":"10.1093/ndt/gfaf032","title":"The impact of the new WHO classification of renal cell carcinoma on the diagnosis of hereditary leiomyomatosis and renal cell carcinoma","year":2025,"lang":"en","type":"review","venue":"Nephrology Dialysis Transplantation","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"European Rare Kidney Disease Reference Network","keywords":"Medicine; Leiomyomatosis; Renal cell carcinoma; BAP1; Pathology; Kidney cancer; Germline mutation; Carcinoma; Germline; Nephrectomy; Oncology; Internal medicine; Cancer; Kidney; Leiomyoma; Mutation; Biology","score_opus":0.028882484148904413,"score_gpt":0.2864975307305508,"score_spread":0.25761504658164636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407763978","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4593634,0.53710645,0.000031266412,0.00039337145,0.00010463373,0.0017951332,0.0003416362,0.000010794921,0.0008533146],"genre_scores_gemma":[0.50271267,0.49653697,0.0000199556,0.000029289102,0.00008380244,0.00017774399,0.00025997823,0.000027422993,0.00015216759],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99595654,0.0011430195,0.0014337554,0.00056932785,0.0005551064,0.00034226157],"domain_scores_gemma":[0.9941535,0.00293954,0.0014480766,0.0011403067,0.00020517713,0.000113395276],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005274607,0.0005967687,0.0020015715,0.00039992345,0.00019470778,0.000014921828,0.00049066375,0.00052223133,0.00004068211],"category_scores_gemma":[0.000056836376,0.00028291412,0.0016094025,0.0008941833,0.0004886544,0.000053802873,0.00004471205,0.0005155174,0.0000028901245],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009081733,0.0039158766,0.19355103,0.11752235,0.0123595465,0.0002504653,0.009576503,0.00041731802,0.02171268,0.0011102766,0.03611479,0.5943874],"study_design_scores_gemma":[0.007446787,0.005568214,0.7906547,0.0116961105,0.084714204,0.00027231406,0.00028578387,0.00024840192,0.08422529,0.00023219205,0.013643596,0.0010123873],"about_ca_topic_score_codex":0.0011313738,"about_ca_topic_score_gemma":0.0001454145,"teacher_disagreement_score":0.5971037,"about_ca_system_score_codex":0.0001933695,"about_ca_system_score_gemma":0.0010536094,"threshold_uncertainty_score":0.99996233},"labels":[],"label_agreement":null},{"id":"W4407766526","doi":"10.1007/s00330-025-11446-y","title":"Node-RADS category on preoperative CT predicts prognosis in patients with papillary renal cell carcinoma","year":2025,"lang":"en","type":"article","venue":"European Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"Natural Science Foundation of Fujian Province; National Natural Science Foundation of China","keywords":"Medicine; Neuroradiology; Radiology; Renal cell carcinoma; Interventional radiology; Carcinoma; Ultrasound; Papillary renal cell carcinomas; Papillary carcinoma; Oncology; Internal medicine; Thyroid carcinoma; Neurology","score_opus":0.009748028472732602,"score_gpt":0.210829666760769,"score_spread":0.2010816382880364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407766526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8957182,0.00052089465,0.000010470088,0.0002596478,0.00013878629,0.0010548519,0.000011127477,0.000060783816,0.10222522],"genre_scores_gemma":[0.9967629,0.000019745796,0.00018217415,0.0009266261,0.000085770014,0.00005467056,0.00016118518,0.000053179305,0.0017538032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763626,0.00069310056,0.0003817756,0.0006526206,0.00020491207,0.0004313202],"domain_scores_gemma":[0.9991238,0.00008331493,0.00009728607,0.0004570982,0.00009591553,0.00014257676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021565237,0.00033647104,0.00049034413,0.00030758997,0.000072266215,0.0000123058635,0.00016383512,0.0000531825,0.000041486506],"category_scores_gemma":[0.000044734363,0.00023677434,0.00007803679,0.00029355686,0.00016076362,0.000046993246,0.00008266588,0.00039199312,0.00012607587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014433141,0.0007544796,0.9897684,0.000098157456,0.00009864721,0.0022009236,0.00041427027,0.00009192835,0.00037077814,0.00007988601,0.003989344,0.00068988715],"study_design_scores_gemma":[0.0061970274,0.005306944,0.9814549,0.00014729593,0.00012631621,0.000056021952,0.00003890717,0.000027459846,0.0058019143,0.0000050123253,0.0006544861,0.00018370451],"about_ca_topic_score_codex":0.000027091848,"about_ca_topic_score_gemma":0.000004455904,"teacher_disagreement_score":0.10104463,"about_ca_system_score_codex":0.00028339174,"about_ca_system_score_gemma":0.0001634497,"threshold_uncertainty_score":0.9655377},"labels":[],"label_agreement":null},{"id":"W4407803275","doi":"10.48095/cccu2014002","title":"Amended classification of renal tumours 2013 (International Society of Urological Pathology Vancouver Classification of Renal Neoplasia)","year":2014,"lang":"en","type":"article","venue":"Czech Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Renal pathology; Medicine; Pathology; Renal carcinoma; Internal medicine; Kidney; Carcinoma","score_opus":0.03488102365853362,"score_gpt":0.272941086315691,"score_spread":0.23806006265715735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407803275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98297817,0.00011546485,0.008874736,0.0027993978,0.00035512436,0.0003488158,0.000024066923,0.00003316658,0.0044710445],"genre_scores_gemma":[0.9961899,0.00007567201,0.0028638206,0.00023131438,0.00014407757,0.000043051972,0.00014636284,0.000019568171,0.00028623635],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978609,0.0002306349,0.0007996865,0.00045736766,0.0003822577,0.0002691513],"domain_scores_gemma":[0.9979043,0.00027137756,0.0007737386,0.00050869957,0.00043883163,0.00010305087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005158457,0.00020352863,0.00061616837,0.00016689616,0.00002943188,0.0000023779949,0.00023040744,0.00039502673,0.00018377403],"category_scores_gemma":[0.00017576916,0.0001716284,0.0002843617,0.00016873683,0.0005689549,0.000053281412,0.00006837595,0.00028802978,0.000014820023],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014952831,0.0007715848,0.065613575,0.00007844165,0.0002303036,0.000013208677,0.00026831537,0.00017546957,0.91044015,0.003392861,0.014259128,0.0032616977],"study_design_scores_gemma":[0.0039586034,0.0040058102,0.88468415,0.000022443313,0.00042362922,0.00020198055,0.00013551691,0.017370787,0.08128175,0.001776386,0.0059559625,0.00018299371],"about_ca_topic_score_codex":0.000020240126,"about_ca_topic_score_gemma":0.000022028527,"teacher_disagreement_score":0.82915837,"about_ca_system_score_codex":0.000094576055,"about_ca_system_score_gemma":0.00013762437,"threshold_uncertainty_score":0.6998803},"labels":[],"label_agreement":null},{"id":"W4407810872","doi":"10.48095/cccu2005023","title":"Radical laparoscopic nephrectomy in tumour with tumorous vascular thrombus (T3B)","year":2005,"lang":"en","type":"article","venue":"Czech Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cytodiagnostics (Canada)","funders":"","keywords":"Medicine; Nephrectomy; Thrombus; Urology; Internal medicine; Kidney","score_opus":0.01220674144159077,"score_gpt":0.24356695884546456,"score_spread":0.2313602174038738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407810872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904024,0.0025477633,0.00008925617,0.002507707,0.00007567084,0.00049620756,0.0000012245939,0.0000915401,0.0037882333],"genre_scores_gemma":[0.99537903,0.00007803841,0.0021791167,0.0017997632,0.00023546522,0.0000588447,0.000019060237,0.00003980384,0.00021088547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983883,0.000110729074,0.0002776161,0.0004505159,0.0002536562,0.0005191843],"domain_scores_gemma":[0.99921167,0.000072617244,0.00005585312,0.00041797484,0.00003872755,0.00020317225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015844147,0.00023816043,0.00056067447,0.0001805053,0.000037994716,0.000008722945,0.00012075126,0.00016311124,0.00033300722],"category_scores_gemma":[0.00003988063,0.00017868537,0.000083600404,0.00024470175,0.0001895893,0.00005440435,0.000043069573,0.00040181007,0.00030260987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039054374,0.0034758255,0.88805246,0.0002522858,0.00080485403,0.016327359,0.0019796675,0.0010489783,0.062067337,0.0012525616,0.003819878,0.017013324],"study_design_scores_gemma":[0.019331008,0.005633314,0.87547123,0.0000718192,0.00053023547,0.0040646857,0.00007409373,0.00074554444,0.03192834,0.00020855514,0.061453953,0.00048720828],"about_ca_topic_score_codex":0.00012637509,"about_ca_topic_score_gemma":0.00021083695,"teacher_disagreement_score":0.057634078,"about_ca_system_score_codex":0.00020546715,"about_ca_system_score_gemma":0.00016890402,"threshold_uncertainty_score":0.72865784},"labels":[],"label_agreement":null},{"id":"W4407834588","doi":"10.48095/cccu2012008","title":"Possibilities of interventional radiology for treatment of renal tumors","year":2012,"lang":"en","type":"article","venue":"Czech Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cytodiagnostics (Canada)","funders":"","keywords":"Interventional radiology; Medicine; Radiology; Medical physics","score_opus":0.04824114423704486,"score_gpt":0.3106151191315641,"score_spread":0.26237397489451925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407834588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99403554,0.0037539452,0.00053608295,0.00021375582,0.0001716904,0.00044071928,0.00003867571,0.000011974857,0.00079759094],"genre_scores_gemma":[0.9974558,0.000016665077,0.0012659114,0.000035334928,0.00016130028,0.000095331925,0.000075312724,0.000012342134,0.0008820485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990852,0.000066013155,0.0003739306,0.0001494754,0.000073065064,0.000252339],"domain_scores_gemma":[0.99923456,0.0002165395,0.00014891785,0.00022596022,0.00008914937,0.00008488422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013882162,0.00011828538,0.0004907489,0.000119889286,0.000014653136,5.5528415e-7,0.000044713845,0.000097823744,0.00021573524],"category_scores_gemma":[0.00006588587,0.00008700116,0.000274998,0.00004488387,0.00021867047,0.000024402183,0.000015813204,0.000026955424,0.00000570639],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012371347,0.00917926,0.7246971,0.0008712333,0.0024030316,0.000065675056,0.0042608767,0.000047019665,0.20006411,0.027688589,0.0016748132,0.01667694],"study_design_scores_gemma":[0.010734547,0.0517316,0.5474071,0.000041653377,0.0010833853,0.0015248478,0.0002744064,0.00012975928,0.37749362,0.003781112,0.0055872924,0.0002107119],"about_ca_topic_score_codex":0.000033446093,"about_ca_topic_score_gemma":0.0000040317846,"teacher_disagreement_score":0.17742951,"about_ca_system_score_codex":0.000092463975,"about_ca_system_score_gemma":0.000067566296,"threshold_uncertainty_score":0.35478044},"labels":[],"label_agreement":null},{"id":"W4408051604","doi":"10.7759/cureus.79827","title":"A Systematic Review of Surgical Outcomes: Comparing Robotic-Assisted Partial Nephrectomy and Open Partial Nephrectomy in Nephron-Sparing Surgery for Renal Tumors","year":2025,"lang":"en","type":"review","venue":"Cureus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Surgery; Urology; Open surgery; Kidney; Internal medicine","score_opus":0.10337230240873801,"score_gpt":0.37359436846832683,"score_spread":0.2702220660595888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408051604","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014952049,0.9807832,0.000049445567,0.00007577856,0.0002967309,0.017964639,0.000030524894,0.00005748517,0.00059266883],"genre_scores_gemma":[0.000447723,0.9891999,0.00066932035,0.00008331294,0.00014579014,0.008620403,0.00042588194,0.00010279991,0.00030486408],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99276495,0.0008812193,0.003930501,0.0010663733,0.0005720257,0.0007849577],"domain_scores_gemma":[0.99311846,0.0035348951,0.0015811148,0.0012246979,0.00017532104,0.00036547723],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0019048805,0.0010438863,0.014954812,0.0004542206,0.00009497222,0.00011535692,0.0005949759,0.00037998476,0.000043105938],"category_scores_gemma":[0.001133343,0.00074950047,0.0016730181,0.000821621,0.00012105476,0.00016908115,0.00060307275,0.0005488429,0.000010583749],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015170935,0.00034822273,0.0013540091,0.9857617,0.0015055009,0.0005050591,0.000027939519,0.0000019930326,2.6488394e-7,0.00009527569,0.00062442705,0.009623924],"study_design_scores_gemma":[0.0022427898,0.00015836382,0.00016133412,0.91390896,0.012085334,0.0005880943,0.000020229909,0.00008827694,0.000006569581,0.000004849866,0.070162036,0.00057317567],"about_ca_topic_score_codex":0.00024332742,"about_ca_topic_score_gemma":0.00008955742,"teacher_disagreement_score":0.07185273,"about_ca_system_score_codex":0.0007239293,"about_ca_system_score_gemma":0.0014631131,"threshold_uncertainty_score":0.9996692},"labels":[],"label_agreement":null},{"id":"W4408070247","doi":"10.1111/his.15436","title":"Diagnostic accuracy and clinical outcomes of patients diagnosed with clear cell papillary renal cell tumour at renal mass biopsy","year":2025,"lang":"en","type":"article","venue":"Histopathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Renal mass; Medicine; Papillary renal cell carcinomas; Biopsy; Pathology; Radiology; Clear cell; Kidney; Renal cell carcinoma; Internal medicine; Nephrectomy","score_opus":0.013497783493879426,"score_gpt":0.2690765506323787,"score_spread":0.25557876713849925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408070247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934431,0.0013095443,0.000059695685,0.0002555172,0.00027467145,0.00067628344,0.000035737725,0.00004272937,0.0039027599],"genre_scores_gemma":[0.9947368,0.0004309768,0.0017373303,0.0004335674,0.000041706742,0.000044734974,0.000091057795,0.00003509974,0.0024487583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977594,0.0002626247,0.00073658145,0.0006127197,0.00026409578,0.00036459218],"domain_scores_gemma":[0.99696624,0.0017790258,0.00034644076,0.0005454759,0.00015940162,0.00020341683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025032106,0.00031515575,0.00088430534,0.00021150763,0.000095419295,0.0000062214517,0.00013376233,0.00022131915,0.00008481621],"category_scores_gemma":[0.0006608652,0.0002321919,0.00018835606,0.00017164786,0.00044877664,0.000043494034,0.00016279278,0.00030095034,0.00004561012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001164498,0.0008723131,0.9843384,0.00018490886,0.000028633749,0.0027075107,0.00013847426,0.0000022325605,0.008508684,0.000017283206,0.0015512068,0.00048586092],"study_design_scores_gemma":[0.0062460327,0.002800054,0.98301584,0.00009106542,0.00061829406,0.0000783443,0.000037508176,0.0000060740817,0.0052414006,0.000029276653,0.0016515823,0.00018454286],"about_ca_topic_score_codex":0.000052107018,"about_ca_topic_score_gemma":0.00002235614,"teacher_disagreement_score":0.005081535,"about_ca_system_score_codex":0.00021955678,"about_ca_system_score_gemma":0.00015372127,"threshold_uncertainty_score":0.9468511},"labels":[],"label_agreement":null},{"id":"W4408173771","doi":"10.1016/j.urology.2025.02.053","title":"A Randomized Trial of Stereotactic Body Radiation Therapy vs Radiofrequency Ablation for the Treatment of Small Renal Masses: A Feasibility Study (RADSTER)","year":2025,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Randomized controlled trial; Radiofrequency ablation; Ablation; Radiology; Surgery; Internal medicine","score_opus":0.05117322274949182,"score_gpt":0.33266299855957876,"score_spread":0.28148977581008694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408173771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804346,0.002638955,0.0012934809,0.0008882057,0.00029414403,0.014189559,0.000008730925,0.000016645172,0.00023569021],"genre_scores_gemma":[0.99766546,0.000549885,0.00012925622,0.00007382839,0.00009265698,0.0012455912,0.000029053297,0.000011630708,0.00020262274],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99799484,0.00068892224,0.00070874527,0.00029888164,0.00014451044,0.00016411775],"domain_scores_gemma":[0.99671245,0.0022031472,0.00036745245,0.00054515264,0.0001381628,0.000033617816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078986114,0.00018201617,0.0009663401,0.00016595495,0.00004763101,0.0000059498093,0.00008202207,0.00009473636,0.000028927241],"category_scores_gemma":[0.00026628602,0.00010292278,0.00037753762,0.00015719756,0.00012141966,0.000026684023,0.0000077153745,0.000057979847,7.256265e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.963887,0.0046920213,0.01834981,0.00003804483,0.0016267337,0.000006365212,0.0013692278,0.000026600268,0.001146265,0.00014975342,0.000010596556,0.008697619],"study_design_scores_gemma":[0.93106043,0.032696746,0.029101536,0.0000066560888,0.0019781557,0.0000067855044,0.00006181312,0.0013659059,0.0025446902,0.0005539293,0.0005643114,0.000059042053],"about_ca_topic_score_codex":0.00023248041,"about_ca_topic_score_gemma":0.000028308232,"teacher_disagreement_score":0.032826535,"about_ca_system_score_codex":0.0001970252,"about_ca_system_score_gemma":0.00021531509,"threshold_uncertainty_score":0.4197069},"labels":[],"label_agreement":null},{"id":"W4408449167","doi":"10.1097/upj.0000000000000801","title":"Treatment Delays in the Hispanic Population With Renal Cell Carcinoma: An Analysis of Over 150,000 Patients Using the National Cancer Database","year":2025,"lang":"en","type":"article","venue":"Urology Practice","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Renal cell carcinoma; Cancer; National database; Population; Internal medicine; Oncology; Database; Environmental health","score_opus":0.034188941197263234,"score_gpt":0.3364579767112716,"score_spread":0.30226903551400836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408449167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99681586,0.0003591868,0.00010837461,0.0011625751,0.00004275422,0.00048907945,0.000061050756,0.0000055256196,0.0009556006],"genre_scores_gemma":[0.9976889,0.000024326087,0.00039269295,0.0013949212,0.000032280597,0.000057845216,0.0003434706,0.0000086200325,0.000056956687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998395,0.00050196383,0.00027196723,0.00029409866,0.00036789765,0.00016905821],"domain_scores_gemma":[0.9985082,0.00060847745,0.00026553456,0.00037086508,0.0002144095,0.000032492175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000333257,0.00014776047,0.00025916888,0.00031290838,0.00009610277,0.00001086091,0.000102722675,0.000065867804,0.000061785795],"category_scores_gemma":[0.00011440874,0.00007782125,0.000068411835,0.0007813599,0.000059864542,0.00020968566,0.000026471667,0.0001645208,8.4856254e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020592555,0.0014180244,0.98502696,0.000012726668,0.00074737065,0.000055234395,0.0007211595,0.0087623,0.0006864381,0.0002524751,0.00004469013,0.00021335446],"study_design_scores_gemma":[0.0024073205,0.000980885,0.96793514,0.0000049813843,0.00854439,0.000020563566,0.00018872891,0.01881172,0.00026710244,0.00000803011,0.0007668786,0.00006425339],"about_ca_topic_score_codex":0.010183668,"about_ca_topic_score_gemma":0.0017773397,"teacher_disagreement_score":0.017091824,"about_ca_system_score_codex":0.00049643737,"about_ca_system_score_gemma":0.00020965267,"threshold_uncertainty_score":0.9964076},"labels":[],"label_agreement":null},{"id":"W4408476470","doi":"10.1016/j.euo.2025.02.008","title":"Treatment of Metastatic Renal Cell Carcinoma: Lack of Consensus Urges the Need for a Well-organized Multidisciplinary Team","year":2025,"lang":"en","type":"editorial","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Multidisciplinary approach; Multidisciplinary team; Intensive care medicine; Oncology; MEDLINE; Internal medicine; Nursing","score_opus":0.035304713824297264,"score_gpt":0.32354127302980945,"score_spread":0.28823655920551217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408476470","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3394208,0.016293645,0.00013987036,0.007934172,0.49277782,0.012018364,0.0023205543,0.00020513572,0.12888962],"genre_scores_gemma":[0.7482664,0.0010571177,0.0074268156,0.00033249316,0.19875081,0.000562889,0.003290856,0.00049201335,0.039820638],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942823,0.0021886756,0.0015492819,0.0009307054,0.0003981493,0.00065086765],"domain_scores_gemma":[0.9880106,0.008506865,0.001378808,0.0011954737,0.00072235626,0.00018588558],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008359438,0.00077340205,0.002750485,0.0004455632,0.00014329386,0.000005847347,0.00044906596,0.0006096253,0.000100039535],"category_scores_gemma":[0.00088350335,0.00050581986,0.00079558924,0.00027848163,0.001052651,0.00001174596,0.00027460468,0.0006342841,0.000051897674],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0150882425,0.003999782,0.00080768263,0.0010095823,0.0020141543,0.0020087478,0.0015667203,0.00004203923,0.0087909885,0.000037913178,0.9634105,0.0012236498],"study_design_scores_gemma":[0.029852618,0.044573616,0.002083356,0.00004971441,0.010327993,0.0002490768,0.00044834433,0.00009221852,0.008414351,0.00005439075,0.9034851,0.000369183],"about_ca_topic_score_codex":0.00013530534,"about_ca_topic_score_gemma":0.000038795763,"teacher_disagreement_score":0.40884557,"about_ca_system_score_codex":0.0005411046,"about_ca_system_score_gemma":0.0024964847,"threshold_uncertainty_score":0.99973935},"labels":[],"label_agreement":null},{"id":"W4408559277","doi":"10.1007/s00428-025-04078-6","title":"Succinate dehydrogenase deficient renal cell carcinoma frequently expresses GATA3 and L1CAM","year":2025,"lang":"en","type":"article","venue":"Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"GATA3; Renal cell carcinoma; Carcinoma; Cancer research; Pathology; Internal medicine; Chemistry; Biology; Medicine; Biochemistry; Gene","score_opus":0.0236145156924148,"score_gpt":0.3290923206337665,"score_spread":0.3054778049413517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408559277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9457653,0.022465192,0.0008544556,0.0014886033,0.000398545,0.0015026462,0.00011067673,0.00031993166,0.02709463],"genre_scores_gemma":[0.9882944,0.0019958096,0.005148453,0.0023936138,0.0002424639,0.0001937309,0.0004521962,0.000086919754,0.0011923978],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9939861,0.00069049484,0.0012506383,0.0019070597,0.00069844135,0.0014672524],"domain_scores_gemma":[0.9954502,0.0013313311,0.00042915597,0.0018074979,0.0002682822,0.0007135445],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010076484,0.0010776075,0.0016236851,0.00070661947,0.0004885951,0.00007886564,0.00069790485,0.00043341803,0.00008876154],"category_scores_gemma":[0.000896004,0.00078993966,0.00044371508,0.00093320955,0.0014978411,0.00018112801,0.0008014887,0.0013602414,0.000107796586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003095893,0.002808341,0.0656361,0.0016195866,0.0010859298,0.0065135066,0.0016450756,0.00027407624,0.88124937,0.0060201823,0.010162826,0.019889135],"study_design_scores_gemma":[0.011727499,0.0046815667,0.24132809,0.0007350546,0.003024642,0.0002601889,0.0014272344,0.0013013392,0.7151699,0.0075518126,0.0113347825,0.0014578725],"about_ca_topic_score_codex":0.00035915602,"about_ca_topic_score_gemma":0.000028132938,"teacher_disagreement_score":0.17569199,"about_ca_system_score_codex":0.00020005625,"about_ca_system_score_gemma":0.0007881505,"threshold_uncertainty_score":0.99945515},"labels":[],"label_agreement":null},{"id":"W4408776865","doi":"10.1016/j.labinv.2024.103141","title":"908 Atrophic Tubules of the Kidney Have Regenerative Features and Cluster with Papillary Renal Cell Carcinoma, Indicating a Possible Cell of Origin and Implications to Early Prevention","year":2025,"lang":"en","type":"article","venue":"Laboratory Investigation","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Papillary renal cell carcinomas; Kidney; Pathology; Cell; Regeneration (biology); Medicine; Clear cell; Biology; Renal cell carcinoma; Internal medicine; Cell biology; Genetics","score_opus":0.01107813264908606,"score_gpt":0.24227930577204196,"score_spread":0.2312011731229559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408776865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99583143,0.00096731837,0.00008053968,0.0017163685,0.000020098645,0.000862771,0.00005266187,0.000011175915,0.00045765264],"genre_scores_gemma":[0.99416274,0.000015989253,0.0046513625,0.00046457018,0.000024560239,0.00007169718,0.000036098638,0.000012947739,0.0005600071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990325,0.00015034935,0.00026880435,0.00026228666,0.00017439935,0.00011163897],"domain_scores_gemma":[0.9989618,0.000049289923,0.00024526837,0.0003169623,0.00028348612,0.00014316877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014246773,0.00014425245,0.00021212175,0.00014347411,0.00011215789,0.00001844895,0.000061162275,0.00008308173,0.000002104719],"category_scores_gemma":[0.00005774848,0.00009828232,0.000028072143,0.00047567236,0.00020857673,0.00008664122,0.000051987558,0.00012854773,3.9811448e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077213976,0.000038698774,0.5557378,0.00032372767,0.000029391214,0.0000010146945,0.0017864803,0.000021224614,0.44092092,0.00042139294,0.00055538,0.00008680426],"study_design_scores_gemma":[0.00058825465,0.00031202825,0.5279464,0.00021985397,0.00014164526,0.000003297307,0.00013572475,0.000016513995,0.47026846,0.00029022637,0.000026467553,0.000051094026],"about_ca_topic_score_codex":0.00011907619,"about_ca_topic_score_gemma":0.000048015467,"teacher_disagreement_score":0.029347561,"about_ca_system_score_codex":0.00006777767,"about_ca_system_score_gemma":0.00055835064,"threshold_uncertainty_score":0.40078366},"labels":[],"label_agreement":null},{"id":"W4408776939","doi":"10.1016/j.labinv.2024.103156","title":"923 Well-defined Eosinophilic Chromophobe Renal Cell Carcinoma (chRCC) is More Aggressive Than Classic chRCC: A Comprehensive Morphologic and Genomic Analysis","year":2025,"lang":"en","type":"article","venue":"Laboratory Investigation","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; University of Calgary; St. Michael's Hospital","funders":"","keywords":"Pathology; Chromophobe cell; Clear cell; Renal cell carcinoma; Eosinophilic; Medicine; Biology","score_opus":0.016481731351860963,"score_gpt":0.24777396823863912,"score_spread":0.23129223688677816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408776939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887708,0.0067559164,0.000023668426,0.002205623,0.00014314182,0.00089624274,0.0001468835,0.0001247867,0.0009329318],"genre_scores_gemma":[0.9933368,0.00020617622,0.0009048961,0.0038315773,0.00012214226,0.0001218606,0.00051007717,0.000042821135,0.0009236757],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973016,0.00024027517,0.0006170221,0.00096396566,0.00042418943,0.00045299283],"domain_scores_gemma":[0.9975601,0.00013027225,0.0005450119,0.00082914997,0.00054683944,0.00038866163],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001382982,0.0005321817,0.0008692829,0.00078181777,0.00026024316,0.00007510206,0.00016909896,0.0003251905,0.00012945605],"category_scores_gemma":[0.00006281448,0.00047419954,0.00022438283,0.0023253858,0.0005746404,0.00018034119,0.0001247348,0.00039037364,0.00008363489],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002519569,0.00016365218,0.36743546,0.00040839298,0.0008685901,0.00066618493,0.001529645,0.00018038541,0.62461674,0.00016672633,0.003531652,0.00018063631],"study_design_scores_gemma":[0.002557382,0.00042972437,0.76126266,0.00013350377,0.0028633063,0.000032009306,0.0003337757,0.0017814592,0.22932412,0.0002856556,0.00064405194,0.0003523285],"about_ca_topic_score_codex":0.00022714512,"about_ca_topic_score_gemma":0.000035256355,"teacher_disagreement_score":0.3952926,"about_ca_system_score_codex":0.0005363355,"about_ca_system_score_gemma":0.0006201896,"threshold_uncertainty_score":0.999771},"labels":[],"label_agreement":null},{"id":"W4408777046","doi":"10.1016/j.labinv.2024.103100","title":"867 Reflex Somatic Testing for FGFR Alterations in Lower and Upper Urinary Tract Carcinomas: A Dual-Institution Experience","year":2025,"lang":"en","type":"article","venue":"Laboratory Investigation","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Somatic cell; Urinary system; Reflex; Medicine; Dual (grammatical number); Upper urinary tract; Urology; Pathology; Internal medicine; Oncology; Biology; Genetics","score_opus":0.03981019384213302,"score_gpt":0.3047070219689501,"score_spread":0.2648968281268171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408777046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963098,0.0005878641,0.00021317702,0.0008405233,0.00016744557,0.0010198387,0.000014759995,0.0000715481,0.00077503873],"genre_scores_gemma":[0.9906151,0.000005975486,0.00791079,0.0006734377,0.00007002025,0.00048030601,0.000057961053,0.000013908587,0.00017246246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988694,0.00006950055,0.0003738073,0.0003415894,0.00014940565,0.00019625691],"domain_scores_gemma":[0.9991769,0.00015717768,0.00009382652,0.00024808792,0.00021234524,0.00011162496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019238326,0.00017196212,0.00022213791,0.00023689594,0.00016408687,0.000045562654,0.000035380985,0.00009798241,0.0000064345113],"category_scores_gemma":[0.00054494344,0.00016251788,0.000030602285,0.0006185211,0.00015303772,0.00035437616,0.000020123693,0.00012440022,0.000004507936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014760841,0.0004305127,0.7401804,0.0006489084,0.000029829254,0.00013788864,0.004311137,0.00009741973,0.24924609,0.0036094596,0.00016273528,0.0009980538],"study_design_scores_gemma":[0.0019062,0.00071610865,0.9376705,0.0007868325,0.00011388361,0.000058824204,0.00079530815,0.0041312934,0.051759213,0.0014948132,0.00036456643,0.00020242283],"about_ca_topic_score_codex":0.000042548712,"about_ca_topic_score_gemma":0.00001607103,"teacher_disagreement_score":0.19749019,"about_ca_system_score_codex":0.00029193974,"about_ca_system_score_gemma":0.00046814771,"threshold_uncertainty_score":0.6627287},"labels":[],"label_agreement":null},{"id":"W4408815214","doi":"10.1038/s41388-025-03325-z","title":"Characterizing the tumor suppressor activity of FLCN in Birt-Hogg-Dubé syndrome cell models through transcriptomic and proteomic analysis","year":2025,"lang":"en","type":"article","venue":"Oncogene","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of General Medical Sciences; Tenovus; Delaware IDeA Network of Biomedical Research Excellence; Terry Fox Foundation; Parc Geneteg Cymru; Health and Care Research Wales; Kidney Foundation of Canada; Fulbright Association; National Institutes of Health; Myrovlytis Trust; U.S. Department of Health and Human Services","keywords":"Folliculin; Biology; Carcinogenesis; DNA damage; Cell cycle; Gene knockdown; Cancer research; Cell biology; Cancer; Cell culture; Genetics; DNA; Gene","score_opus":0.02272443703926167,"score_gpt":0.26254167867010825,"score_spread":0.23981724163084658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408815214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99503905,0.00089240033,0.00042674094,0.00069106166,0.000048172034,0.001016195,0.000039190414,0.000021405936,0.0018257638],"genre_scores_gemma":[0.9986574,0.000121468875,0.0004639941,0.00014775386,0.000013872255,0.00012285802,0.00001564091,0.000019551228,0.0004374607],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986893,0.000115387025,0.00034068484,0.00038323982,0.0002100856,0.00026129],"domain_scores_gemma":[0.9992252,0.00006771149,0.00012476477,0.0004850222,0.00004087551,0.000056456272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021775134,0.00021673545,0.0007000311,0.00026215627,0.000053100586,0.00001636633,0.0001260245,0.00007431182,0.000033200362],"category_scores_gemma":[0.0000097285365,0.00015099539,0.00022009398,0.00069557416,0.00009292738,0.00013367132,0.0000510609,0.00019024586,0.000002822973],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037862558,0.00030636237,0.0070424937,0.0002471499,0.00046295256,0.00010373658,0.0009146524,0.000117112366,0.9900224,0.000024083643,0.0000060014077,0.00037441184],"study_design_scores_gemma":[0.001719174,0.0002026709,0.13520336,0.00011124707,0.0013385672,0.00004284354,0.00009008515,0.0024472168,0.85858536,0.00011576841,0.000031106465,0.00011259916],"about_ca_topic_score_codex":0.00064715097,"about_ca_topic_score_gemma":0.00007610867,"teacher_disagreement_score":0.13143706,"about_ca_system_score_codex":0.00016409678,"about_ca_system_score_gemma":0.0001156551,"threshold_uncertainty_score":0.6157413},"labels":[],"label_agreement":null},{"id":"W4409197276","doi":"10.1016/j.clgc.2025.102342","title":"Optimal Timing of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Patients Considering Sarcomatoid Status: A Real-World Study","year":2025,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Sunnybrook Health Science Centre; London Health Sciences Centre; Western University; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec; McMaster University; BC Cancer Agency; Alberta Health Services; University of Calgary; Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre; Ottawa Hospital; University Health Network; Dalhousie University; University of Manitoba; Juravinski Cancer Centre; McGill University; McGill University Health Centre; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Oncology; Internal medicine; Urology; Pathology; Kidney","score_opus":0.06990687001142348,"score_gpt":0.38939416906212765,"score_spread":0.31948729905070417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409197276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912908,0.0011968365,0.000009417228,0.000094911695,0.00046190366,0.0018732388,0.00003653469,0.000036431902,0.004999892],"genre_scores_gemma":[0.99466574,0.0001915575,0.003639757,0.00010366279,0.00013684167,0.00025746977,0.000025878844,0.00004348188,0.0009356129],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963075,0.00044707212,0.001517486,0.0007383813,0.00042717904,0.0005623777],"domain_scores_gemma":[0.99782807,0.0006787102,0.0003660654,0.0005902268,0.00026571905,0.0002711975],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043955515,0.0003680244,0.0011790653,0.0005081727,0.000074510295,0.000014635025,0.00016331192,0.00008477584,0.0001410119],"category_scores_gemma":[0.00015075925,0.0003268443,0.00030534453,0.0007327737,0.00021977477,0.0001045833,0.00024928473,0.00055449596,0.000008604405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027016876,0.0047855177,0.9852021,0.00026070053,0.0003466409,0.00082114205,0.0007577702,0.00031393906,0.00062265294,0.0000035275216,0.00066084584,0.0035235311],"study_design_scores_gemma":[0.0114081865,0.0027266887,0.9753736,0.00029305537,0.00064767885,0.000004710136,0.00162874,0.00025536196,0.006993196,0.000024867988,0.0004001853,0.00024369515],"about_ca_topic_score_codex":0.0017737775,"about_ca_topic_score_gemma":0.00029933435,"teacher_disagreement_score":0.009828411,"about_ca_system_score_codex":0.00065805105,"about_ca_system_score_gemma":0.0010181343,"threshold_uncertainty_score":0.99991834},"labels":[],"label_agreement":null},{"id":"W4409695072","doi":"10.3390/curroncol32050246","title":"Use of Radiofrequency in Robot-Assisted Partial Nephrectomy for Small Tumors: A Novel Technique","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Kidney; Internal medicine","score_opus":0.22866436458033151,"score_gpt":0.4060019791176558,"score_spread":0.17733761453732427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409695072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94599617,0.0025697763,0.041461185,0.0011528415,0.0009875771,0.0063524074,0.000047907517,0.00010032736,0.0013318178],"genre_scores_gemma":[0.9657209,0.00008882522,0.03085679,0.00010830134,0.00010414472,0.0027983657,0.00009354978,0.00002248995,0.00020663906],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985851,0.00008321312,0.00057725376,0.0003431576,0.00009396916,0.00031732334],"domain_scores_gemma":[0.9989173,0.0003528324,0.00016419236,0.00031991795,0.00015843233,0.00008734521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022849445,0.0001899902,0.00067367096,0.0003751578,0.000023550721,0.0000060337284,0.000103878716,0.00016750811,0.000022128866],"category_scores_gemma":[0.00031206908,0.00016555742,0.00017888627,0.00038817906,0.000110470755,0.000041138137,0.000050823826,0.00023554951,0.0000021660776],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033197105,0.00859592,0.17824283,0.0017929771,0.0002751898,0.00018110377,0.00029863665,0.00005312164,0.36520416,0.00439034,0.0021773586,0.43546867],"study_design_scores_gemma":[0.019745123,0.0052241944,0.3077516,0.0022362364,0.0008499081,0.0003120127,0.00008702185,0.0013218214,0.27488923,0.00061171374,0.38647702,0.0004941231],"about_ca_topic_score_codex":0.00010419221,"about_ca_topic_score_gemma":0.000067981295,"teacher_disagreement_score":0.43497455,"about_ca_system_score_codex":0.0007145687,"about_ca_system_score_gemma":0.00073553016,"threshold_uncertainty_score":0.6751236},"labels":[],"label_agreement":null},{"id":"W4409743034","doi":"10.1089/end.2024.0849","title":"Evaluating Long-Term Oncologic Outcomes of Radiofrequency Ablation for T1a Renal Cell Carcinoma with Minimum 10 Years of Follow-Up","year":2025,"lang":"en","type":"article","venue":"Journal of Endourology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University","funders":"","keywords":"Medicine; Renal cell carcinoma; Radiofrequency ablation; Term (time); Ablation; Kidney cancer; Nephrology; Urology; Surgery; General surgery; Oncology; Internal medicine","score_opus":0.0502103095126143,"score_gpt":0.34580978489037234,"score_spread":0.29559947537775805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409743034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99568343,0.001573221,0.0005146032,0.00040769705,0.00030738782,0.00050835795,0.000006515969,0.0000050425656,0.0009937537],"genre_scores_gemma":[0.9929661,0.000027828897,0.0058882935,0.00010290795,0.000086320426,0.000012727091,0.0000086192085,0.000016376349,0.00089081243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818695,0.00015137653,0.00090644154,0.0001787612,0.00033817702,0.00023829847],"domain_scores_gemma":[0.9972244,0.0007311135,0.0011240764,0.00023915622,0.00059780123,0.00008344913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006729734,0.00016645325,0.00089739327,0.00041250087,0.000027892984,0.000004006928,0.00014749588,0.00014260456,0.00006885755],"category_scores_gemma":[0.00036604723,0.00012001438,0.00032952643,0.00017756427,0.000109711655,0.000060239552,0.00002637079,0.00020615746,0.0000010073802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008025148,0.00049755326,0.83414006,0.00033965413,0.00062944484,0.00042037503,0.0003112312,0.0002819509,0.14354865,0.00006822879,0.00036610945,0.011371571],"study_design_scores_gemma":[0.016902685,0.019234827,0.9045691,0.00010299168,0.0016583623,0.00039490513,0.000057782665,0.000119937526,0.056583196,0.00021102346,0.000071819835,0.00009340573],"about_ca_topic_score_codex":0.000015863661,"about_ca_topic_score_gemma":0.000013330964,"teacher_disagreement_score":0.08696546,"about_ca_system_score_codex":0.00016320462,"about_ca_system_score_gemma":0.000587894,"threshold_uncertainty_score":0.48940444},"labels":[],"label_agreement":null},{"id":"W4409883722","doi":"10.3390/curroncol32050256","title":"Minimally Invasive Surgical Techniques for Renal Cell Carcinoma with Intravenous Tumor Thrombus: A Systematic Review of Laparoscopic and Robotic-Assisted Approaches","year":2025,"lang":"en","type":"review","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Laparoscopy; Carcinoma; General surgery; Pathology","score_opus":0.13662355061258702,"score_gpt":0.3745403020199883,"score_spread":0.23791675140740126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409883722","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000265555,0.98304605,0.000037303784,0.000049505914,0.00013998282,0.01533251,0.00007871797,0.00004993012,0.0010004526],"genre_scores_gemma":[0.0002513631,0.9920728,0.0027229358,0.00003472538,0.00010853495,0.0040714964,0.00051491393,0.00006615275,0.00015706441],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9958517,0.0007026502,0.0018035237,0.0008545483,0.00033092094,0.00045667446],"domain_scores_gemma":[0.99553174,0.0016727804,0.0015245117,0.00071473373,0.00033287154,0.00022335634],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005852222,0.0007986723,0.009122559,0.00036650704,0.000059938222,0.000014863991,0.00028376398,0.00036046945,0.000012376167],"category_scores_gemma":[0.00032699163,0.0004942095,0.0006834148,0.00040741503,0.00031366202,0.000031225252,0.00015083012,0.0005248156,0.000003086982],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103855804,0.0009306991,0.000028996496,0.95662147,0.0004136901,0.00031629414,0.00004944678,1.969072e-8,0.0000017547128,0.000038178787,0.00032289667,0.041172724],"study_design_scores_gemma":[0.0016768997,0.006176444,0.00001962598,0.9282468,0.029982368,0.0022420515,0.000041403997,0.0000018074837,0.00019989262,0.0000052679156,0.031016396,0.00039102376],"about_ca_topic_score_codex":0.0000047822236,"about_ca_topic_score_gemma":0.000007336777,"teacher_disagreement_score":0.0407817,"about_ca_system_score_codex":0.0007467073,"about_ca_system_score_gemma":0.0032367266,"threshold_uncertainty_score":0.999751},"labels":[],"label_agreement":null},{"id":"W4409886694","doi":"10.1038/s41598-025-99376-z","title":"Author Correction: Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma","year":2025,"lang":"en","type":"erratum","venue":"Scientific Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Renal cell carcinoma; Immunotherapy; microRNA; Oncology; Medicine; Cancer research; First line; Line (geometry); Internal medicine; Immunology; Biology; Cancer; Gene; Genetics","score_opus":0.021688783887266805,"score_gpt":0.26179948613997894,"score_spread":0.24011070225271214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409886694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9131972,0.0012841886,0.00019568042,0.0006086389,0.07516716,0.0044296146,0.000098256576,0.00017619648,0.0048430515],"genre_scores_gemma":[0.59983015,0.0000026682144,0.00094357005,0.00009433052,0.00024337061,0.00020947818,0.0013508017,0.00010977967,0.39721584],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9920846,0.00036681394,0.0019383106,0.0025187482,0.0021092272,0.0009822563],"domain_scores_gemma":[0.99435157,0.00022300452,0.0012010391,0.0027066553,0.0010198266,0.00049788615],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026794053,0.00092155044,0.0014701199,0.0019600787,0.0005139545,0.00033957977,0.00029195636,0.0004150294,0.00021955553],"category_scores_gemma":[0.000693547,0.0007561669,0.00037178354,0.0024067906,0.00024196866,0.00016034841,0.00019100551,0.0011761102,0.000038163646],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005082389,0.0014153315,0.07004348,0.0009776758,0.00032400052,0.014593466,0.0020169322,0.00051423605,0.004440909,2.751805e-7,0.8984997,0.0020915624],"study_design_scores_gemma":[0.0059091696,0.0033366042,0.6714036,0.0053979526,0.0008879183,0.0012557184,0.00015177381,0.00026298148,0.011885924,0.000041630152,0.29817024,0.0012965102],"about_ca_topic_score_codex":0.00023873338,"about_ca_topic_score_gemma":0.00021569853,"teacher_disagreement_score":0.6013601,"about_ca_system_score_codex":0.0018386674,"about_ca_system_score_gemma":0.0034185378,"threshold_uncertainty_score":0.99948895},"labels":[],"label_agreement":null},{"id":"W4409965829","doi":"10.3390/curroncol32050260","title":"Spontaneous Dramatic Regression of Clear Cell Renal Cell Carcinoma After Pazopanib-Induced Severe Systemic Inflammatory Syndrome: A Case Report and Literature Review","year":2025,"lang":"en","type":"review","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pazopanib; Medicine; Renal cell carcinoma; Pathology; Internal medicine; Oncology; Cancer research; Sunitinib","score_opus":0.04254412201115474,"score_gpt":0.351966303607795,"score_spread":0.30942218159664026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409965829","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07234884,0.92080635,0.0000012735377,0.00002155286,0.0009355154,0.0050289473,0.00010261881,0.000053398253,0.0007014769],"genre_scores_gemma":[0.026464012,0.97058827,0.00011354599,0.00003385727,0.00016412268,0.0007553131,0.0005227177,0.00010084779,0.0012573019],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9939163,0.0011805366,0.002593899,0.0012344702,0.0005092027,0.00056560984],"domain_scores_gemma":[0.9949838,0.0005497821,0.002068546,0.0015687726,0.00038442216,0.0004446612],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007295281,0.0011509937,0.0059311297,0.00060255226,0.000081962986,0.000026947811,0.00024416228,0.0010466895,0.000083872605],"category_scores_gemma":[0.00021768671,0.00077857176,0.0010141617,0.0005738884,0.00011829911,0.00006754769,0.00035782333,0.0016098523,0.00003767891],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009757781,0.00023132023,0.000047288686,0.41101998,0.00007712321,0.499434,0.00011740728,1.203716e-8,0.000005498139,8.7689233e-7,0.00049428473,0.08847464],"study_design_scores_gemma":[0.0006953779,0.0009270594,0.000022888637,0.3233903,0.0058537023,0.5849638,0.000024517396,9.5098756e-7,0.0000063986636,0.0000017729146,0.08378863,0.00032459662],"about_ca_topic_score_codex":0.0000074169434,"about_ca_topic_score_gemma":0.000004438509,"teacher_disagreement_score":0.08815005,"about_ca_system_score_codex":0.0013837806,"about_ca_system_score_gemma":0.0024422517,"threshold_uncertainty_score":0.99946654},"labels":[],"label_agreement":null},{"id":"W4409966546","doi":"10.1093/oncolo/oyae373","title":"Examining the evolving landscape of kidney cancer mortality in the United States","year":2025,"lang":"en","type":"article","venue":"The Oncologist","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Demography; Ethnic group; Population; Medicine; Disease control; Cancer; Gerontology; Environmental health; Internal medicine","score_opus":0.07725012360541114,"score_gpt":0.35413357562602943,"score_spread":0.27688345202061826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409966546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9633212,0.0010484086,0.000010491059,0.012784139,0.00009705427,0.00046701965,0.000011149061,0.000016168191,0.022244332],"genre_scores_gemma":[0.9948327,0.0002523885,0.000024232282,0.0039693024,0.000044295022,0.000098961005,0.000030641113,0.00000544149,0.0007420624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898314,0.0003000353,0.00023346722,0.00012804219,0.00018822077,0.0001670942],"domain_scores_gemma":[0.9985082,0.00081726373,0.00010021869,0.00047592528,0.00006580425,0.000032601685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010642604,0.00010130971,0.00020836986,0.000061797975,0.00009897866,0.00001557436,0.000262521,0.000042165902,0.00008951102],"category_scores_gemma":[0.00049438275,0.000038240483,0.000045625344,0.00054178823,0.00024985493,0.00001647679,0.00007149636,0.00022041996,0.0000028805214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001511454,0.00018668472,0.9704777,0.0000918478,0.00018141243,0.000054811022,0.0034721321,0.0004995919,0.0006553911,0.00042970464,0.02248233,0.0013172609],"study_design_scores_gemma":[0.0008640557,0.00020540014,0.98412675,0.00015547739,0.0002712743,0.0000064099786,0.005995184,0.0015010382,0.0009766953,0.00025558422,0.005595413,0.000046748974],"about_ca_topic_score_codex":0.007527582,"about_ca_topic_score_gemma":0.000916311,"teacher_disagreement_score":0.031511437,"about_ca_system_score_codex":0.00015065365,"about_ca_system_score_gemma":0.00029962897,"threshold_uncertainty_score":0.9990814},"labels":[],"label_agreement":null},{"id":"W4410033298","doi":"10.1245/s10434-025-17398-3","title":"Comparison of In-Hospital Outcomes at Robot-Assisted Versus Open Partial Nephrectomy","year":2025,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Surgical oncology; Medicine; Nephrectomy; General surgery; Surgery; Internal medicine; Kidney","score_opus":0.16034380384268904,"score_gpt":0.466886943143565,"score_spread":0.30654313930087596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410033298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9151927,0.0006091693,0.000001998029,0.014712054,0.00036779867,0.00066435424,0.000005883008,0.000012189725,0.06843381],"genre_scores_gemma":[0.99812764,0.00021103221,0.0003169254,0.0001623994,0.000023486913,0.00006918559,0.00002904934,0.000009004051,0.0010512903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825567,0.00016759486,0.0007829337,0.00028444533,0.0002146254,0.00029472064],"domain_scores_gemma":[0.99831885,0.00085020415,0.000249754,0.00030270484,0.00015633873,0.00012212111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028551486,0.0001672827,0.0014252763,0.00016445687,0.000026670832,0.000005043411,0.00022149856,0.00020744604,0.00033100176],"category_scores_gemma":[0.00006755327,0.00012943608,0.0002476507,0.00031383347,0.00020221139,0.000050259085,0.0003503771,0.0001720164,0.000018971654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016926857,0.0067788446,0.91298825,0.00011931025,0.0007168411,0.0008428591,0.00023405794,0.000055159686,0.00097413186,0.0018659132,0.0117332535,0.04676452],"study_design_scores_gemma":[0.014682464,0.0064726262,0.6745687,0.00009639802,0.00016846707,0.000010445498,0.0001329871,0.000055844015,0.03219161,0.000054820488,0.27143976,0.00012586737],"about_ca_topic_score_codex":0.00033716278,"about_ca_topic_score_gemma":0.00015953119,"teacher_disagreement_score":0.25970653,"about_ca_system_score_codex":0.0001667682,"about_ca_system_score_gemma":0.0002569105,"threshold_uncertainty_score":0.527825},"labels":[],"label_agreement":null},{"id":"W4410131183","doi":"10.1177/20543581251336551","title":"Technical and Institutional Factors Affecting Specimen Adequacy and Complications in Ultrasound-guided Kidney Biopsy: A Retrospective Cohort Study","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Kidney Health and Disease","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Health Authority; University of Saskatchewan","funders":"","keywords":"Medicine; Retrospective cohort study; Biopsy; Radiology; Percutaneous; Kidney disease; Population; Cohort; Surgery; Internal medicine","score_opus":0.02388666126491563,"score_gpt":0.31034684853227107,"score_spread":0.28646018726735545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410131183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97567296,0.002397461,0.000044795874,0.020020366,0.00008299636,0.0009627602,0.00012233875,0.0000068738514,0.0006894664],"genre_scores_gemma":[0.9926659,0.00011469693,0.00018624676,0.006909605,0.00003573179,0.0000112275175,0.00003820074,0.0000074100167,0.000030982403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988222,0.00008591288,0.00041497886,0.00024719,0.00016192548,0.00026778222],"domain_scores_gemma":[0.9843625,0.00009318948,0.00013555464,0.00014780411,0.00011800151,0.015142954],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00034093452,0.00014868038,0.00038701168,0.0004942518,0.00029048318,0.000044122542,0.000046945952,0.00004192981,0.000015165676],"category_scores_gemma":[0.010448529,0.00012574975,0.000041926778,0.0002786683,0.00018825597,0.000087170294,0.000014229904,0.00026531206,3.884916e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091630245,0.00013057316,0.99005604,0.000131972,0.000047205747,0.00022399373,0.00036556026,4.8292367e-7,0.00004120436,0.00035846274,0.00842045,0.00013240181],"study_design_scores_gemma":[0.0022544859,0.00032078344,0.9948201,0.0004204141,0.000116860516,0.00039925423,0.0005762595,0.000008677491,0.0000035669423,0.0002947369,0.00070300815,0.00008182611],"about_ca_topic_score_codex":0.005986581,"about_ca_topic_score_gemma":0.0009650226,"teacher_disagreement_score":0.025625907,"about_ca_system_score_codex":0.0009420956,"about_ca_system_score_gemma":0.026568003,"threshold_uncertainty_score":0.9978869},"labels":[],"label_agreement":null},{"id":"W4410368595","doi":"10.1016/j.rcl.2025.03.016","title":"Imaging Biomarkers in Evaluation of Malignancy and Aggressiveness in Renal Masses","year":2025,"lang":"en","type":"article","venue":"Radiologic Clinics of North America","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Toronto; Toronto General Hospital","funders":"","keywords":"Medicine; Malignancy; Radiology; Pathology","score_opus":0.035369399884232156,"score_gpt":0.34463589912708803,"score_spread":0.3092664992428559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410368595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98634714,0.012163017,0.000035569952,0.00022139304,0.000059303366,0.00043000808,0.00000769125,0.000006067677,0.0007298025],"genre_scores_gemma":[0.9967861,0.0017508946,0.0013005123,0.00007811189,0.0000062487375,0.000030937965,0.00003290078,0.0000046522437,0.000009621142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859744,0.00022547854,0.0005842551,0.00025768369,0.00019020561,0.0001449078],"domain_scores_gemma":[0.998848,0.00044960342,0.00031579417,0.0002260434,0.00012692098,0.00003359007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006195268,0.00011244804,0.00050242845,0.00030507732,0.000010468919,0.0000019267814,0.00006843693,0.000042219708,0.000012579444],"category_scores_gemma":[0.00080862496,0.00009127395,0.00006632229,0.0004765614,0.00021562779,0.000030240486,0.000041202875,0.00009542638,4.5122462e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025509033,0.00012752553,0.8046591,0.00008143805,0.00005439386,0.00005036919,0.000043781518,0.00026534213,0.00028891122,0.000004271114,0.000025731917,0.19414404],"study_design_scores_gemma":[0.002251257,0.0002509012,0.9925904,0.00052903366,0.00014397506,0.000011000786,0.00010795829,0.0032696603,0.00037683515,0.0003178309,0.00008724206,0.00006385435],"about_ca_topic_score_codex":0.00014900188,"about_ca_topic_score_gemma":0.000051830943,"teacher_disagreement_score":0.19408019,"about_ca_system_score_codex":0.00010140041,"about_ca_system_score_gemma":0.00023730013,"threshold_uncertainty_score":0.37220436},"labels":[],"label_agreement":null},{"id":"W4410443794","doi":"10.1186/s12880-025-01715-z","title":"A CT-based intratumoral and peritumoral radiomics nomogram for postoperative recurrence risk stratification in localized clear cell renal cell carcinoma","year":2025,"lang":"en","type":"article","venue":"BMC Medical Imaging","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Nomogram; Radiomics; Risk stratification; Renal cell carcinoma; Medicine; Clear cell renal cell carcinoma; Radiology; Oncology; Internal medicine","score_opus":0.014802615946719501,"score_gpt":0.28158767438572313,"score_spread":0.26678505843900363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410443794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96776795,0.0021058626,0.026280176,0.0013772402,0.0001662757,0.0013019933,0.000025363259,0.000048389757,0.0009267375],"genre_scores_gemma":[0.98148507,0.00005165713,0.017357336,0.00054255006,0.00006835463,0.0001775447,0.00014455899,0.000025480027,0.00014742391],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9977128,0.00025832703,0.00057257304,0.00063319,0.00038832123,0.00043481024],"domain_scores_gemma":[0.9985897,0.00046326336,0.0001372233,0.00033085354,0.00013272952,0.0003462083],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006824143,0.0002882357,0.00050397543,0.00025466265,0.00012727632,0.00007505319,0.00014634858,0.000073939256,0.00004342708],"category_scores_gemma":[0.00048285304,0.00025072272,0.00012351108,0.00034798696,0.00033077007,0.00009866276,0.000047389294,0.0004915066,0.0000045904158],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048058834,0.0018996387,0.90349776,0.002055822,0.000038791157,0.00108266,0.0010570774,0.00011012555,0.017413959,0.00055124727,0.0029812679,0.0645058],"study_design_scores_gemma":[0.031031244,0.0013205094,0.1800148,0.0011432164,0.0005192336,0.00020925756,0.0018777768,0.6649507,0.116249815,0.00037940172,0.0015397011,0.00076430495],"about_ca_topic_score_codex":0.0003369032,"about_ca_topic_score_gemma":0.00015107376,"teacher_disagreement_score":0.7234829,"about_ca_system_score_codex":0.00027466935,"about_ca_system_score_gemma":0.0013949827,"threshold_uncertainty_score":0.9999945},"labels":[],"label_agreement":null},{"id":"W4410572321","doi":"10.1002/pbc.31774","title":"Contemporary Biology, Management, and Outcomes of Renal Medullary Carcinoma in Children and Adults: A Pediatric Surgical Oncology Research Collaborative Study","year":2025,"lang":"en","type":"article","venue":"Pediatric Blood & Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Sickle cell trait; Internal medicine; Oncology; Retrospective cohort study; Proportional hazards model; Disease; Surgery; Kidney","score_opus":0.0258816005720162,"score_gpt":0.3602014964894392,"score_spread":0.334319895917423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410572321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91514355,0.078478396,3.9835703e-7,0.00050091656,0.00008107726,0.0025970072,0.00009005635,0.000020064808,0.0030885208],"genre_scores_gemma":[0.9812484,0.017596725,0.00011937313,0.000053292588,0.00022147968,0.00046110433,0.000029632685,0.000019081099,0.00025092962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973516,0.00054471847,0.00063484214,0.0007190757,0.00033720967,0.00041254322],"domain_scores_gemma":[0.99855703,0.00052631914,0.00016523559,0.00032038928,0.0002613181,0.00016970525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008291303,0.0002728131,0.00088800496,0.0012100736,0.00008213376,0.000012759134,0.00013764358,0.0001863417,0.000022537906],"category_scores_gemma":[0.00006209975,0.00021469292,0.00006056096,0.0018457178,0.00021576369,0.000060705843,0.00034156855,0.00044389273,0.0000013476143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011868422,0.0015651319,0.99215233,0.00032011632,0.00053375115,0.00051590917,0.0006049594,6.8160284e-7,0.000005053222,0.000061250365,0.0010287658,0.002025186],"study_design_scores_gemma":[0.016610172,0.0022943541,0.9783225,0.000032160773,0.0012186888,0.000029964423,0.0010118653,0.0000034805962,0.000046046403,0.00005155234,0.00023228685,0.00014691179],"about_ca_topic_score_codex":0.0022950259,"about_ca_topic_score_gemma":0.00021640492,"teacher_disagreement_score":0.06610482,"about_ca_system_score_codex":0.00014535195,"about_ca_system_score_gemma":0.000761392,"threshold_uncertainty_score":0.87549233},"labels":[],"label_agreement":null},{"id":"W4410633736","doi":"10.1101/2025.05.22.25328092","title":"Evaluating the metabolic effects of neoadjuvant treatment in clear cell renal cell carcinoma using hyperpolarised [1- <sup>13</sup> C]pyruvate MRI","year":2025,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NIHR Cambridge Biomedical Research Centre; National Institute for Health and Care Research; Department of Health and Social Care; Cancer Research UK; Canadian Institute for Advanced Research; AstraZeneca","keywords":"Renal cell carcinoma; Oncology; Neoadjuvant therapy; Cell; Internal medicine; Medicine; Endocrinology; Cancer research; Chemistry; Cancer; Biochemistry","score_opus":0.04621124757106145,"score_gpt":0.3158502459029331,"score_spread":0.26963899833187166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410633736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96935546,0.02311154,0.00008125953,0.00021882125,0.00041686476,0.0046107564,0.00005989159,0.000069520116,0.0020759022],"genre_scores_gemma":[0.9927033,0.00070353434,0.003999454,0.000118260876,0.00028433415,0.00038686016,0.00009890636,0.000121537385,0.0015837802],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9938012,0.0012763849,0.0014445763,0.001434269,0.0011239203,0.00091970095],"domain_scores_gemma":[0.9955361,0.00084584916,0.00077286805,0.0022819936,0.00027136836,0.00029184678],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012099511,0.0011206359,0.002266253,0.0007211062,0.0001769202,0.000057812682,0.0005964672,0.0005610107,0.000062034866],"category_scores_gemma":[0.000190553,0.0007592712,0.00093953806,0.0006504247,0.00019414631,0.000058702113,0.0007641251,0.0012602455,0.000029721648],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029759188,0.0038173413,0.4115825,0.007273295,0.0012389756,0.0023497813,0.012253526,0.07912363,0.46731007,0.000036075282,0.00007790982,0.011960949],"study_design_scores_gemma":[0.01102455,0.003005005,0.16915622,0.0017320727,0.005603026,0.000043444514,0.00037598299,0.11441827,0.69333404,0.00010886448,0.00042500778,0.00077350327],"about_ca_topic_score_codex":0.004913672,"about_ca_topic_score_gemma":0.000052283045,"teacher_disagreement_score":0.24242629,"about_ca_system_score_codex":0.0009770866,"about_ca_system_score_gemma":0.0015419975,"threshold_uncertainty_score":0.99948585},"labels":[],"label_agreement":null},{"id":"W4410816765","doi":"10.1200/jco.2025.43.16_suppl.e16515","title":"Liquid-based kidney injury molecule-1 (KIM-1) as a diagnostic and prognostic indicator in renal cell carcinoma: A systematic review and meta-analysis.","year":2025,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Meta-analysis; Pathology; Kidney cancer; Oncology; Internal medicine; Kidney; Carcinoma; Acute kidney injury","score_opus":0.12507474088866435,"score_gpt":0.4597960338806852,"score_spread":0.3347212929920208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410816765","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005953114,0.99129426,0.000013584672,0.002478153,0.0001214446,0.005073284,0.00006749117,0.000009645331,0.00034684574],"genre_scores_gemma":[0.0054542357,0.9856927,0.00058590877,0.0072329007,0.00011703887,0.0005638186,0.00005062452,0.00005173738,0.00025106358],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98325926,0.0054109446,0.009298021,0.0008210856,0.00075083185,0.00045985906],"domain_scores_gemma":[0.9682874,0.020881878,0.008176653,0.00080316473,0.00041734066,0.0014335326],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00770486,0.0008552573,0.032558423,0.0015707976,0.000042967094,0.000029265339,0.00040706538,0.0011426803,0.00015782773],"category_scores_gemma":[0.043892846,0.0004935075,0.0061485944,0.0012333908,0.0003163831,0.0000660697,0.00020721646,0.002483662,0.00002198895],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038206915,0.0018086048,0.0004568718,0.92526567,0.061602943,0.0072936206,0.000015196816,2.902826e-7,2.0662016e-7,0.000008720818,0.0013793408,0.0017864866],"study_design_scores_gemma":[0.0020116968,0.01193301,0.00031022183,0.06837645,0.9014801,0.00068682706,0.0000042048136,0.0000021453775,0.0000016890189,0.000009306142,0.0148804635,0.00030391014],"about_ca_topic_score_codex":0.000022055956,"about_ca_topic_score_gemma":0.00000776752,"teacher_disagreement_score":0.8568892,"about_ca_system_score_codex":0.00045120888,"about_ca_system_score_gemma":0.011080631,"threshold_uncertainty_score":0.99981767},"labels":[],"label_agreement":null},{"id":"W4410821487","doi":"10.1200/jco.2025.43.16_suppl.4505","title":"Nivolumab plus ipilimumab vs sunitinib for first-line treatment of advanced renal cell carcinoma: Final analysis from the phase 3 CheckMate 214 trial.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Ipilimumab; Sunitinib; Nivolumab; Renal cell carcinoma; Internal medicine; Oncology; Phases of clinical research; Urology; Clinical trial; Cancer; Immunotherapy","score_opus":0.16938391920761428,"score_gpt":0.4654664655370909,"score_spread":0.2960825463294766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410821487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98532444,0.0026425344,0.0011664382,0.006985036,0.0010682886,0.0013943374,0.00014474677,0.00001091529,0.001263246],"genre_scores_gemma":[0.9912294,0.0009862506,0.003840475,0.000557561,0.0012468074,0.000074561816,0.00011434427,0.000024305844,0.0019263048],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9940251,0.0005973632,0.004101201,0.00042384438,0.0004609259,0.00039153255],"domain_scores_gemma":[0.9860746,0.009048961,0.0030219792,0.0006559987,0.00085798564,0.00034044907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018522412,0.00035214168,0.0037974552,0.00033015088,0.00012637214,0.000013945219,0.0003368468,0.00041652817,0.00021295367],"category_scores_gemma":[0.0017719191,0.00020599256,0.0028444221,0.000578885,0.00029891255,0.00007543938,0.000060385246,0.0005108378,0.000005532708],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7961435,0.0214426,0.009895711,0.00010921933,0.008176339,0.0009173082,0.00042965784,0.0011109259,0.00077559147,0.000058988742,0.0027693675,0.15817082],"study_design_scores_gemma":[0.6632989,0.16891024,0.056268144,0.00012906766,0.029156303,0.000044263666,0.0003784133,0.001901148,0.008368693,0.00042449252,0.07089283,0.0002275175],"about_ca_topic_score_codex":0.00020360852,"about_ca_topic_score_gemma":0.0003881161,"teacher_disagreement_score":0.15794331,"about_ca_system_score_codex":0.0008464261,"about_ca_system_score_gemma":0.0031768968,"threshold_uncertainty_score":0.84001327},"labels":[],"label_agreement":null},{"id":"W4410821779","doi":"10.1200/jco.2025.43.16_suppl.4528","title":"Assessment of time-to-treatment-failure (TTF) as a surrogate endpoint for overall survival (OS) to immune checkpoint inhibitor (ICI) regimens in metastatic renal cell carcinoma (mRCC): Findings from an IMDC analysis.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Clinical endpoint; Oncology; Surrogate endpoint; Internal medicine; Immune checkpoint; Nivolumab; Cancer research; Immunotherapy; Urology; Cancer; Clinical trial","score_opus":0.06574010573805124,"score_gpt":0.43149644236610235,"score_spread":0.3657563366280511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410821779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98699105,0.00020503518,0.00061708124,0.008933868,0.00047631172,0.0014171277,0.00008601669,0.000012391376,0.0012611204],"genre_scores_gemma":[0.96871716,0.000052161584,0.028044382,0.00088971155,0.00030411634,0.00006592754,0.000102874634,0.0000413747,0.0017823199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.991835,0.0011333973,0.0049936464,0.00072599604,0.0007120795,0.00059988064],"domain_scores_gemma":[0.992019,0.0036844206,0.0019404514,0.0007333548,0.0007532051,0.00086956995],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0045153666,0.0004889275,0.0048224893,0.0012213788,0.000056884553,0.000026904476,0.00037182024,0.00038129126,0.0005157907],"category_scores_gemma":[0.0013721434,0.00036524018,0.002009415,0.000853344,0.00014322925,0.00014323197,0.00016952353,0.00075878535,0.000037671853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051930096,0.03005725,0.66138446,0.00035693473,0.019608205,0.006104312,0.0021568034,0.0042457115,0.21212274,0.00028390827,0.0032059643,0.008543623],"study_design_scores_gemma":[0.026133632,0.045811504,0.8844875,0.00022157819,0.0084147705,0.000035633955,0.00042973305,0.00080729305,0.027559904,0.00029709056,0.0055056517,0.00029567897],"about_ca_topic_score_codex":0.001006878,"about_ca_topic_score_gemma":0.0010472662,"teacher_disagreement_score":0.22310308,"about_ca_system_score_codex":0.0017040214,"about_ca_system_score_gemma":0.003373912,"threshold_uncertainty_score":0.99987996},"labels":[],"label_agreement":null},{"id":"W4410821876","doi":"10.1200/jco.2025.43.16_suppl.4532","title":"International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) classification and regression tree analysis to characterize objective response rates (ORR) in metastatic renal cell carcinoma (mRCC).","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of Calgary; Dalhousie University; Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Clear cell renal cell carcinoma; Internal medicine; Carcinoma; Cancer research","score_opus":0.1195791700164084,"score_gpt":0.43186613091434717,"score_spread":0.3122869608979388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410821876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862001,0.00062370434,0.0008750653,0.0089869555,0.00064828567,0.0006659956,0.000079960344,0.000010840567,0.0019091222],"genre_scores_gemma":[0.98648304,0.0002299282,0.010221034,0.0012964201,0.00020915638,0.00004436557,0.000111881374,0.00002695425,0.0013772261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9913744,0.0029334198,0.0037782523,0.0007404675,0.000736589,0.0004369088],"domain_scores_gemma":[0.98954344,0.0059778797,0.0023996108,0.00056819787,0.00085080287,0.00066008326],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006286289,0.0004157478,0.002520756,0.0019849164,0.00008319371,0.000047827456,0.00036426593,0.0002461417,0.0001822892],"category_scores_gemma":[0.004157051,0.00030376163,0.0007169821,0.0011672673,0.0002800549,0.00028934475,0.00021107942,0.0012024809,0.00001769769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10792433,0.006280701,0.63288677,0.00021247861,0.0028359927,0.008843266,0.0010494898,0.00008640859,0.21042928,0.00006586236,0.0038542436,0.025531195],"study_design_scores_gemma":[0.012326431,0.006564023,0.9520929,0.0001501113,0.004896896,0.00021063797,0.0007879993,0.001420909,0.01741468,0.00005883211,0.0038552205,0.00022135251],"about_ca_topic_score_codex":0.00014572035,"about_ca_topic_score_gemma":0.00018443416,"teacher_disagreement_score":0.31920615,"about_ca_system_score_codex":0.00084738777,"about_ca_system_score_gemma":0.002464476,"threshold_uncertainty_score":0.99994147},"labels":[],"label_agreement":null},{"id":"W4410822468","doi":"10.1200/jco.2025.43.16_suppl.4549","title":"Clinical characteristics and determinants of primary refractory metastatic renal cell carcinoma (mRCC): An International Metastatic Database Consortium (IMDC) study.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; BC Cancer Agency; University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Refractory (planetary science); Oncology; Internal medicine; Cancer research","score_opus":0.16500516916579588,"score_gpt":0.47372204650189015,"score_spread":0.30871687733609426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410822468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951515,0.0004788598,0.00013756695,0.00043158344,0.0018892699,0.00055746513,0.000060784423,0.0000075724142,0.0012853489],"genre_scores_gemma":[0.9865726,0.00068785215,0.010763546,0.001095655,0.00042632248,0.0000082675615,0.00003379133,0.00002392604,0.00038804451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9906627,0.0018925308,0.00604106,0.000464573,0.00065944635,0.0002796917],"domain_scores_gemma":[0.9891646,0.0049550235,0.003868514,0.0005645366,0.0008678926,0.0005794704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071223374,0.0002867276,0.0032081488,0.00037194966,0.000046533245,0.000018004266,0.00037206168,0.00019831602,0.000104282684],"category_scores_gemma":[0.0042068386,0.0002086001,0.0005245227,0.00015719495,0.0005502992,0.0002925494,0.00023600135,0.0012295655,0.000006027077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008337302,0.013570182,0.8748877,0.00022206476,0.00091021514,0.0059119505,0.00010665792,6.5184713e-7,0.0007340554,0.000015278274,0.0005140078,0.09478993],"study_design_scores_gemma":[0.015016692,0.027542517,0.9481085,0.00015822584,0.0034787138,0.0005012317,0.00033136772,0.00016135136,0.0003420802,0.00005092235,0.004171684,0.00013672668],"about_ca_topic_score_codex":0.00003836454,"about_ca_topic_score_gemma":0.000036542755,"teacher_disagreement_score":0.094653204,"about_ca_system_score_codex":0.0002173237,"about_ca_system_score_gemma":0.0030971467,"threshold_uncertainty_score":0.8506465},"labels":[],"label_agreement":null},{"id":"W4410822789","doi":"10.1200/jco.2025.43.16_suppl.4555","title":"Clinical outcomes of patients with primary refractory metastatic renal cell carcinoma receiving second-line (2L) therapies: An International Metastatic Database Consortium (IMDC) study.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; University of Manitoba; Occupational Cancer Research Centre; CancerCare Manitoba; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Renal cell carcinoma; Refractory (planetary science); Oncology; Internal medicine; Second line; Metastatic Urothelial Carcinoma; First line; Cancer; Urothelial carcinoma","score_opus":0.1123336320096626,"score_gpt":0.4403739686444062,"score_spread":0.3280403366347436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410822789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99417615,0.00034737407,0.00030896315,0.00079084956,0.0016330755,0.00087971723,0.00007719198,0.000013004612,0.0017736814],"genre_scores_gemma":[0.97874284,0.00016408766,0.01794184,0.0020602103,0.00025061012,0.00001432752,0.000088143956,0.000037127684,0.00070080906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98980916,0.002315668,0.0059566908,0.00054432603,0.001040224,0.00033394626],"domain_scores_gemma":[0.9853059,0.0075194226,0.004386571,0.00075864536,0.0015217587,0.00050771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006639603,0.0003777062,0.003454656,0.00045925195,0.000056555633,0.000018968647,0.00052793993,0.00018690364,0.00051825616],"category_scores_gemma":[0.0031336497,0.00023439371,0.0007679108,0.0002526328,0.0004666363,0.00042885213,0.00017864138,0.0015238121,0.000007156347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013340589,0.02543649,0.93347573,0.00013165078,0.0038779764,0.0011045462,0.00022531736,0.000010639552,0.00008266062,0.000013639228,0.0006007723,0.021699958],"study_design_scores_gemma":[0.028930958,0.040214688,0.92259383,0.00011903058,0.0031013924,0.000040786377,0.0006033393,0.000027117361,0.00008362341,0.000048850077,0.0040720785,0.00016432551],"about_ca_topic_score_codex":0.000038389233,"about_ca_topic_score_gemma":0.00012287716,"teacher_disagreement_score":0.021535633,"about_ca_system_score_codex":0.00034787468,"about_ca_system_score_gemma":0.003170674,"threshold_uncertainty_score":0.9558298},"labels":[],"label_agreement":null},{"id":"W4410822837","doi":"10.1245/s10434-025-17525-0","title":"ASO Visual Abstract: Comparison of In-hospital Outcomes at Partial Nephrectomy—Robotic Versus Open","year":2025,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Surgical oncology; Nephrectomy; General surgery; Surgery; Internal medicine; Kidney","score_opus":0.11929644680572377,"score_gpt":0.4613584412477102,"score_spread":0.34206199444198643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410822837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9430126,0.00057366944,0.0000012505282,0.009694189,0.000459594,0.0006750284,0.0000043442546,0.000012353825,0.04556695],"genre_scores_gemma":[0.99869365,0.000241324,0.00013273103,0.00014923222,0.000035505203,0.00004999488,0.000028468381,0.000010992284,0.0006581217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981076,0.00010218751,0.00087066274,0.0003123193,0.0002584127,0.0003487924],"domain_scores_gemma":[0.9980701,0.0011016431,0.00027843652,0.00025712064,0.00014883981,0.00014381044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033225238,0.00019214094,0.0014594393,0.00017588366,0.000029483757,0.0000065791814,0.00021938224,0.00023331454,0.00050541735],"category_scores_gemma":[0.00008168713,0.00015210574,0.0002552746,0.00026137853,0.0002304774,0.00006690183,0.00033030132,0.00022386888,0.000038746308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019423021,0.011719309,0.91548514,0.0002280654,0.00092486956,0.0015586214,0.00040935524,0.00024791367,0.0010205334,0.0022052955,0.010161195,0.036616676],"study_design_scores_gemma":[0.018103542,0.011531148,0.79582644,0.00016987525,0.00026598678,0.000015173227,0.00027970326,0.00017187382,0.03865111,0.00011353501,0.13464974,0.00022189571],"about_ca_topic_score_codex":0.00036802518,"about_ca_topic_score_gemma":0.00013501362,"teacher_disagreement_score":0.12448854,"about_ca_system_score_codex":0.00016666476,"about_ca_system_score_gemma":0.0002898573,"threshold_uncertainty_score":0.6202692},"labels":[],"label_agreement":null},{"id":"W4410822960","doi":"10.1200/jco.2025.43.16_suppl.4556","title":"Refining intermediate-risk (IR) stratification in patients (Pts) with metastatic renal cell carcinoma (mRCC) receiving first-line (1L) immunotherapy (IO) within one year of diagnosis (Dx): Findings from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Immunotherapy; Metastatic Urothelial Carcinoma; Internal medicine; Oncology; Risk stratification; Cancer; Urothelial carcinoma","score_opus":0.07046330052147087,"score_gpt":0.35372767028367874,"score_spread":0.28326436976220787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410822960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99468905,0.00070629665,0.0005121232,0.0019931607,0.00081476383,0.00062036136,0.00017896897,0.000009933356,0.00047533822],"genre_scores_gemma":[0.9849458,0.0005405433,0.013205692,0.0006282675,0.0002138993,0.000054342836,0.0002018808,0.000045652654,0.00016392866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99235076,0.0011868038,0.0044801175,0.0005770458,0.0010186319,0.00038664514],"domain_scores_gemma":[0.98667145,0.0073580216,0.004231069,0.0006682255,0.0008179046,0.00025331878],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0042235055,0.0004059632,0.0019397532,0.0004690504,0.00010297093,0.00004370275,0.0006660899,0.00021486777,0.0002708434],"category_scores_gemma":[0.0028368703,0.00026919157,0.0004621973,0.00047301242,0.00041959106,0.00028237002,0.00016052945,0.0017358285,0.000012138032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012462173,0.0048598154,0.9692399,0.00011099161,0.000893802,0.0003059037,0.0009828265,0.00027428239,0.002321702,0.00002678996,0.0010670426,0.007454778],"study_design_scores_gemma":[0.025506953,0.011298448,0.9403694,0.0007170931,0.0017836036,0.000017228705,0.00061133865,0.00036038886,0.01851513,0.00013135794,0.00046830496,0.00022072408],"about_ca_topic_score_codex":0.0011378425,"about_ca_topic_score_gemma":0.0013456958,"teacher_disagreement_score":0.028870465,"about_ca_system_score_codex":0.00064296566,"about_ca_system_score_gemma":0.0018448316,"threshold_uncertainty_score":0.99997604},"labels":[],"label_agreement":null},{"id":"W4410823043","doi":"10.1200/jco.2025.43.16_suppl.4540","title":"Efficacy of second line (2L) treatment with tivozanib (Tivo) as monotherapy or with nivolumab (Nivo) in patients (pts) with metastatic renal cell carcinoma (mRCC) previously treated with an immune checkpoint inhibitor (ICI) combination of ipilimumab (Ipi)/Nivo or vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFR-TKI)/ICI in the phase 3 TiNivo-2 study.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Nivolumab; Medicine; Renal cell carcinoma; Metastatic melanoma; Oncology; Immune checkpoint; Internal medicine; Ipilimumab; Cancer research; Immunotherapy; Cancer","score_opus":0.05156941605445359,"score_gpt":0.36286318072101537,"score_spread":0.3112937646665618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410823043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939104,0.0003687476,0.000041673455,0.00027528495,0.00011740605,0.005047294,0.000056292072,0.000017612927,0.00016533275],"genre_scores_gemma":[0.9972895,0.00017209954,0.0015997726,0.000118757736,0.0001561768,0.00014543613,0.000072338575,0.00010007235,0.000345845],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9910506,0.0021850155,0.004136217,0.0007942555,0.0012374596,0.0005964802],"domain_scores_gemma":[0.9915101,0.0023067812,0.0036288665,0.0008134827,0.0013854074,0.00035538542],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019335031,0.0008239975,0.0038633214,0.0008346337,0.000086067856,0.000030104053,0.000416445,0.00030857485,0.00019799072],"category_scores_gemma":[0.00048115643,0.00037727275,0.0004326366,0.0012763842,0.00061901694,0.00032467168,0.000049327715,0.0010582526,0.0000025302018],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5496733,0.14133202,0.2751686,0.00040160224,0.002598782,0.0030132474,0.0056413636,0.0000727492,0.0052666543,0.000008888547,0.000019457368,0.016803283],"study_design_scores_gemma":[0.25762898,0.43589622,0.2562304,0.0009372147,0.001847767,0.00012887697,0.0020530287,0.000055291577,0.044800278,0.000005744767,0.00012250463,0.00029368818],"about_ca_topic_score_codex":0.0010249341,"about_ca_topic_score_gemma":0.002790321,"teacher_disagreement_score":0.2945642,"about_ca_system_score_codex":0.0011902644,"about_ca_system_score_gemma":0.0037796944,"threshold_uncertainty_score":0.9998679},"labels":[],"label_agreement":null},{"id":"W4410823148","doi":"10.1200/jco.2025.43.16_suppl.4544","title":"Baseline radiological tumor burden to sub-stratify IMDC risk groups in metastatic renal cell carcinoma treated with first-line therapy: A post hoc analysis from a randomized phase III trial.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Post-hoc analysis; Renal cell carcinoma; Oncology; Radiological weapon; Internal medicine; Surgery","score_opus":0.06575000979964242,"score_gpt":0.3984571933586429,"score_spread":0.3327071835590005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410823148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98479575,0.0023826563,0.0027895551,0.0069259084,0.00024055336,0.0025098915,0.000076226,0.000020010104,0.00025946798],"genre_scores_gemma":[0.9887177,0.0015320099,0.0069167395,0.0016779919,0.00074253173,0.00012702007,0.00011389088,0.000028592973,0.0001435445],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9873181,0.005158635,0.005710834,0.00070118037,0.00061409513,0.00049715367],"domain_scores_gemma":[0.97566086,0.019328816,0.0029442487,0.000556067,0.0007450298,0.0007649651],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009348519,0.00052552414,0.008172648,0.0010948934,0.00007731486,0.000029936986,0.00034098874,0.00037174672,0.0003921693],"category_scores_gemma":[0.00647177,0.00028682585,0.0022358447,0.0015271413,0.000341507,0.00009048308,0.000062200335,0.0015281914,0.000011131479],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95311147,0.007937701,0.009159074,0.000018280018,0.0066365977,0.009263194,0.00023098582,0.0006536195,0.00079708645,0.0000060461766,0.0003887354,0.0117972335],"study_design_scores_gemma":[0.8705031,0.083455384,0.024056705,0.00011129371,0.016967215,0.00011820268,0.0002222445,0.0025968042,0.0009249963,0.000124359,0.0006807411,0.00023894291],"about_ca_topic_score_codex":0.0011449511,"about_ca_topic_score_gemma":0.0011838125,"teacher_disagreement_score":0.082608335,"about_ca_system_score_codex":0.00045828585,"about_ca_system_score_gemma":0.0022270675,"threshold_uncertainty_score":0.9999584},"labels":[],"label_agreement":null},{"id":"W4410823609","doi":"10.1200/jco.2025.43.16_suppl.4548","title":"Second-line outcomes in metastatic renal cell carcinoma: The role of International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) prognostic factors after first-line immunotherapy.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; University of Alberta; Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Immunotherapy; Oncology; Internal medicine; Second line; Carcinoma; First line; Cancer research; Cancer","score_opus":0.06370025275547174,"score_gpt":0.3831138386709389,"score_spread":0.31941358591546715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410823609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870984,0.0052258,0.00023918584,0.0034590336,0.0011031808,0.0009070321,0.00014579248,0.000009278989,0.001812301],"genre_scores_gemma":[0.9940299,0.00029408408,0.0029569373,0.001110662,0.00021817334,0.000052062485,0.000059712474,0.000042022006,0.0012364398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9922214,0.001064136,0.00490762,0.0004783432,0.0008268816,0.0005015804],"domain_scores_gemma":[0.98835063,0.007285771,0.002682498,0.0006536629,0.00070100377,0.00032645295],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031286546,0.0004826268,0.0027252391,0.0006233754,0.00006243944,0.000024934869,0.00062633,0.00022831539,0.000967766],"category_scores_gemma":[0.0019207554,0.00028499705,0.0011249584,0.00038967308,0.00047819916,0.00020566549,0.00021710378,0.0016027461,0.000014407411],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008393501,0.0062659113,0.974253,0.00022862913,0.0009718151,0.0022904219,0.00044109832,0.00013592454,0.0034109831,0.000042869236,0.00047977004,0.0030860768],"study_design_scores_gemma":[0.019126842,0.008723281,0.93935955,0.0001705257,0.002023511,0.00021042919,0.0006059587,0.00046445697,0.019384224,0.0003845763,0.009306134,0.00024053291],"about_ca_topic_score_codex":0.00018292411,"about_ca_topic_score_gemma":0.00056761026,"teacher_disagreement_score":0.03489347,"about_ca_system_score_codex":0.00040863993,"about_ca_system_score_gemma":0.002347278,"threshold_uncertainty_score":0.99996024},"labels":[],"label_agreement":null},{"id":"W4410980008","doi":"10.1016/j.jvir.2025.05.029","title":"Ablative Yttrium-90 Radioembolization Therapy for Nonmetastatic Renal Cell Carcinoma (ARRCC) Phase II Trial","year":2025,"lang":"en","type":"letter","venue":"Journal of Vascular and Interventional Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Boston Scientific Corporation","keywords":"Medicine; Ablative case; Renal cell carcinoma; Yttrium; Oncology; Radiology; Internal medicine; Radiation therapy","score_opus":0.033294072294544716,"score_gpt":0.3169884188906179,"score_spread":0.2836943465960732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410980008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74493456,0.06905291,0.044860408,0.12842406,0.004522537,0.0064727017,0.0005665199,0.000032538843,0.001133768],"genre_scores_gemma":[0.7635747,0.006761948,0.012709151,0.16268344,0.030569434,0.00066363177,0.006074524,0.00033294773,0.01663017],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967485,0.0005224118,0.001432811,0.00043310144,0.00050064106,0.00036251597],"domain_scores_gemma":[0.9973917,0.00045193292,0.0011377371,0.00027496976,0.0006036665,0.00014000628],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00087390636,0.00046131015,0.0016254854,0.0007726114,0.00014781034,0.000031243482,0.00019978109,0.0005961346,0.00030698426],"category_scores_gemma":[0.00019143875,0.00034658585,0.0023867597,0.00015067073,0.00016435131,0.00011641554,0.000046853045,0.0011049149,0.0000019406707],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045990728,0.0028168908,0.00013864841,0.0010755996,0.006448928,0.001175128,0.00023705556,0.000031630512,0.00133442,0.00012007166,0.9358164,0.0048145056],"study_design_scores_gemma":[0.3126468,0.09749878,0.0016030819,0.00079653924,0.0049617733,0.0032888725,0.000045352474,0.00031002573,0.0028645224,0.0012850692,0.57416135,0.0005378382],"about_ca_topic_score_codex":0.000010253398,"about_ca_topic_score_gemma":5.0615637e-7,"teacher_disagreement_score":0.36165506,"about_ca_system_score_codex":0.00030661066,"about_ca_system_score_gemma":0.0005285156,"threshold_uncertainty_score":0.9998986},"labels":[],"label_agreement":null},{"id":"W4411028514","doi":"10.1245/s10434-025-17588-z","title":"ASO Author Reflections: Partial Nephrectomy: Insight from Comparisons Between Robot-Assisted and Open Approaches","year":2025,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Surgical oncology; Nephrectomy; Medicine; General surgery; Medical physics; Urology; Surgery; Internal medicine; Kidney","score_opus":0.41917568280872614,"score_gpt":0.46242936105329313,"score_spread":0.043253678244566995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411028514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77803993,0.004398058,0.0002869487,0.07988106,0.00024767537,0.0014836293,0.000053602653,0.00007943203,0.1355297],"genre_scores_gemma":[0.9934036,0.00052724197,0.0037096476,0.00046760374,0.00015613527,0.0001503456,0.00014618429,0.0000139335825,0.0014253147],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981455,0.00036791782,0.0005885722,0.00044488028,0.0001645646,0.00028856372],"domain_scores_gemma":[0.99823886,0.0009002442,0.00018199593,0.00032232632,0.0001198183,0.00023674122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003700331,0.00019985068,0.0011616747,0.0001711866,0.00011134264,0.000031342694,0.00018252172,0.00030850535,0.00012482442],"category_scores_gemma":[0.000048597143,0.00015710614,0.00015095162,0.00038547488,0.00027024935,0.00008753275,0.00030165186,0.00030638595,0.000015129457],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008871805,0.00529225,0.40117076,0.00021534768,0.004723333,0.0011963228,0.00095098536,0.000029782705,0.0029381316,0.009572206,0.06514335,0.49989572],"study_design_scores_gemma":[0.002686055,0.0011379813,0.2909575,0.0000790278,0.00036916477,0.000028176652,0.00009575864,0.00005629163,0.00813958,0.000442754,0.6958969,0.00011075624],"about_ca_topic_score_codex":0.0008492356,"about_ca_topic_score_gemma":0.00013492985,"teacher_disagreement_score":0.6307536,"about_ca_system_score_codex":0.00008460682,"about_ca_system_score_gemma":0.00036993416,"threshold_uncertainty_score":0.6406602},"labels":[],"label_agreement":null},{"id":"W4411094435","doi":"10.1016/j.euo.2025.05.012","title":"Quality Indicators for Renal Cancer Care: A Systematic Review","year":2025,"lang":"en","type":"review","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Quality (philosophy); Intensive care medicine; Kidney cancer; Cancer; Internal medicine","score_opus":0.06814733408136993,"score_gpt":0.42249111102646647,"score_spread":0.35434377694509656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411094435","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000012621753,0.95645213,0.00004482995,0.0005927234,0.00068794086,0.011266306,0.00018303936,0.00012458206,0.03064716],"genre_scores_gemma":[0.000008695383,0.9860458,0.00018091736,0.0048998436,0.00039123488,0.0038735315,0.0007271314,0.00013438433,0.003738465],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.98980653,0.00585112,0.0023576587,0.0010994311,0.00024759225,0.0006376556],"domain_scores_gemma":[0.99451756,0.0019652848,0.001718598,0.0013052046,0.00021778214,0.0002755411],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019719857,0.0008031675,0.008609042,0.00058818597,0.00011727202,0.000008985254,0.000564977,0.0005471052,0.00014213528],"category_scores_gemma":[0.0015862539,0.0005608327,0.001668034,0.00056113704,0.00023995,0.000018256147,0.0002606046,0.00087247475,0.00031526142],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000522925,0.00011327332,0.0000046969176,0.79341656,0.0012269927,0.0005390909,0.000054017597,6.49438e-8,1.4419044e-7,0.00010199011,0.0071658357,0.19732505],"study_design_scores_gemma":[0.00080288935,0.0011266099,0.000012621307,0.2412281,0.02787357,0.00043601816,0.0000058680794,7.6103106e-8,2.0191126e-7,0.0000026593184,0.7282525,0.00025891318],"about_ca_topic_score_codex":0.000011083563,"about_ca_topic_score_gemma":0.000016154732,"teacher_disagreement_score":0.7210866,"about_ca_system_score_codex":0.0013222988,"about_ca_system_score_gemma":0.0027219465,"threshold_uncertainty_score":0.99968433},"labels":[],"label_agreement":null},{"id":"W4411242053","doi":"10.3390/curroncol32060348","title":"Integrating Radiologic and Clinical Features to Predict VSX1 Expression in Clear Cell Renal Cell Carcinoma","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Renal cell carcinoma; Expression (computer science); Pathology; Cell; Clear cell renal cell carcinoma; Computational biology; Cancer research; Biology; Genetics; Computer science","score_opus":0.06952683720843468,"score_gpt":0.40036045726149494,"score_spread":0.3308336200530603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411242053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772445,0.007450776,0.0001631034,0.0007200052,0.0009788084,0.00085444114,0.000006120648,0.000043839074,0.0125384],"genre_scores_gemma":[0.9958963,0.00038066195,0.0023241546,0.00031955852,0.00025222477,0.000073412644,0.000035281784,0.000015302334,0.00070313335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977877,0.00042469363,0.0006138498,0.0006362615,0.00014926025,0.00038820456],"domain_scores_gemma":[0.9987093,0.000503078,0.00012343745,0.0003327899,0.000072123104,0.0002592722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005112783,0.00025145465,0.0006833452,0.00029044386,0.00006479776,0.000013851228,0.00013171119,0.00030183408,0.000032619995],"category_scores_gemma":[0.00027526225,0.00018337769,0.00013282413,0.00024889334,0.0001306676,0.00003449591,0.00023578978,0.00082932855,0.000020528762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016113685,0.0013485787,0.89007443,0.00025703546,0.000016525724,0.00030627634,0.0005197303,0.0000066914913,0.015165326,0.00004023753,0.024383685,0.066270135],"study_design_scores_gemma":[0.0057092034,0.005690364,0.93637013,0.00038083902,0.00016614266,0.00005805947,0.00051621895,0.00023465102,0.016733734,0.0000862162,0.03385957,0.00019485844],"about_ca_topic_score_codex":0.00002778874,"about_ca_topic_score_gemma":0.000032174168,"teacher_disagreement_score":0.06607528,"about_ca_system_score_codex":0.00041282186,"about_ca_system_score_gemma":0.0002936229,"threshold_uncertainty_score":0.7477925},"labels":[],"label_agreement":null},{"id":"W4411275540","doi":"10.1016/j.clgc.2025.102385","title":"Comorbidity Burden and Effectiveness of Immunotherapy in Metastatic Renal Cell Carcinoma","year":2025,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Dana-Farber Cancer Institute","keywords":"Medicine; Discontinuation; Comorbidity; Internal medicine; Hazard ratio; Renal cell carcinoma; Nivolumab; Adverse effect; Oncology; Confidence interval; Cancer; Immunotherapy","score_opus":0.04757200492122552,"score_gpt":0.38146650259542847,"score_spread":0.33389449767420293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411275540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98170006,0.0150217265,0.00002987092,0.00029743704,0.0002636578,0.0006885813,0.000014120217,0.0000123903055,0.0019721638],"genre_scores_gemma":[0.99721557,0.001615502,0.00035022327,0.00009038369,0.00012872169,0.00010277343,0.000010025901,0.000017350172,0.000469423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815536,0.00048899045,0.00060365815,0.0003810861,0.00016081563,0.00021007996],"domain_scores_gemma":[0.99845386,0.00088501896,0.000118173,0.00036955564,0.0000739052,0.00009948933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071030215,0.00018501173,0.0007359018,0.00014186164,0.000028944485,0.0000057222837,0.00009616391,0.00009723495,0.0000661617],"category_scores_gemma":[0.00005105315,0.00015161371,0.00018649033,0.00025333025,0.00020654488,0.000035580022,0.000081921695,0.0003042412,0.000003671361],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059583755,0.00077830005,0.9320919,0.0012893314,0.00025442548,0.00062171824,0.000094357674,0.000080946156,0.023386994,0.000029944995,0.00020525,0.03520844],"study_design_scores_gemma":[0.007098683,0.0012341742,0.9571031,0.00042284568,0.00020015679,0.000014010503,0.00004390969,0.000119280354,0.032622237,0.00021329158,0.00081341807,0.00011492778],"about_ca_topic_score_codex":0.0005477768,"about_ca_topic_score_gemma":0.000019062849,"teacher_disagreement_score":0.035093512,"about_ca_system_score_codex":0.00015448293,"about_ca_system_score_gemma":0.00034004822,"threshold_uncertainty_score":0.61826277},"labels":[],"label_agreement":null},{"id":"W4411306401","doi":"10.14740/wjon2593","title":"Differentiating Malignant and Healthy Areas in Isolated Kidney Samples Through Infrared Visualization Techniques","year":2025,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Visualization; Infrared; Kidney; Pathology; Urology; Internal medicine; Data mining; Optics","score_opus":0.030623259044726656,"score_gpt":0.35138240301250345,"score_spread":0.32075914396777677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411306401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9658571,0.0033440574,0.008869377,0.009273293,0.00037285965,0.00061948155,0.000004019312,0.000041189945,0.011618655],"genre_scores_gemma":[0.98933345,0.00078276376,0.006663142,0.0026281385,0.00007821938,0.000009538048,0.000012066894,0.000012170476,0.00048053928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998659,0.00018735061,0.0006934256,0.00013978226,0.00013028682,0.00019016319],"domain_scores_gemma":[0.999057,0.00018350566,0.00038338252,0.0001029047,0.00015716148,0.00011602493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031089038,0.00012776958,0.0005441104,0.0005500471,0.000047816884,0.000012907211,0.000056626377,0.0000936753,0.000047371177],"category_scores_gemma":[0.00021942018,0.00009802421,0.00006394735,0.00042413862,0.000054207198,0.000085105305,0.000043511263,0.0002521493,6.1311613e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044556144,0.001431686,0.9002019,0.0005565013,0.00040423576,0.0011046547,0.0020171623,0.000005615947,0.022866746,0.005617738,0.00836177,0.05297638],"study_design_scores_gemma":[0.01486383,0.011637488,0.80397946,0.0045841476,0.00077610044,0.0019621004,0.0008463035,0.0005310235,0.033155285,0.011652284,0.1156212,0.0003907567],"about_ca_topic_score_codex":0.00006722491,"about_ca_topic_score_gemma":0.00013470312,"teacher_disagreement_score":0.10725944,"about_ca_system_score_codex":0.00040549727,"about_ca_system_score_gemma":0.0005079265,"threshold_uncertainty_score":0.39973113},"labels":[],"label_agreement":null},{"id":"W4411368368","doi":"10.3390/curroncol32060358","title":"Comparison of Mortality and Morbidity of Robotic Versus Laparoscopic Radical Nephrectomy for the Treatment of Renal Cell Carcinoma—An Analysis of the National Surgery Quality Improvement Program (NSQIP) Targeted Nephrectomy Database","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Laparoscopy; Surgery; Urology; Carcinoma; General surgery; Kidney; Internal medicine","score_opus":0.26879532923115135,"score_gpt":0.4873294096605449,"score_spread":0.21853408042939354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411368368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99346566,0.0030959453,0.00021700283,0.00014510193,0.00055664685,0.002112056,0.00033389486,0.000010968757,0.00006269367],"genre_scores_gemma":[0.99847966,0.00012142242,0.00053562934,0.000010947101,0.000049387258,0.00032477148,0.00045358058,0.000008724027,0.00001588884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972021,0.00041530377,0.0012166289,0.0004009881,0.0005134854,0.00025149682],"domain_scores_gemma":[0.9959593,0.002003705,0.0008888466,0.0005980451,0.0004474453,0.000102678736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007240377,0.00024460733,0.0015624793,0.00027162067,0.00007345503,0.000004430591,0.0001779616,0.000112437396,0.00003533054],"category_scores_gemma":[0.00022231865,0.00014805605,0.0005640548,0.0007192009,0.0006231323,0.00003791848,0.00008064402,0.00013626995,1.1109658e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023076995,0.01193211,0.9560312,0.00089819846,0.002543669,9.619006e-7,0.00043035814,0.00051388814,0.011412985,0.00014899272,0.00031383353,0.013466124],"study_design_scores_gemma":[0.0060070422,0.0035177195,0.84996754,0.000047572372,0.0081625115,4.4551962e-7,0.0002327486,0.010076953,0.12019608,0.000017365397,0.0016767059,0.00009733258],"about_ca_topic_score_codex":0.001134921,"about_ca_topic_score_gemma":0.0007380973,"teacher_disagreement_score":0.1087831,"about_ca_system_score_codex":0.00050842034,"about_ca_system_score_gemma":0.0008911601,"threshold_uncertainty_score":0.60375506},"labels":[],"label_agreement":null},{"id":"W4411420246","doi":"10.3390/curroncol32060359","title":"Molecular Genetics of Renal Cell Carcinoma: A Narrative Review Focused on Clinical Relevance","year":2025,"lang":"en","type":"review","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Renal cell carcinoma; Precision medicine; Liquid biopsy; Genetic testing; Germline; Computational biology; Bioinformatics; Cancer; Biology; Oncology; Pathology; Internal medicine; Genetics; Gene","score_opus":0.21173145991366168,"score_gpt":0.49154401879906906,"score_spread":0.27981255888540735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411420246","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003079943,0.9873798,0.00003731451,0.00016591806,0.0013764797,0.0040203556,0.000066651766,0.000029156468,0.006616343],"genre_scores_gemma":[0.00013457554,0.997662,0.0004539647,0.00021678847,0.00027985813,0.000481713,0.00034225386,0.000062014384,0.00036682168],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940289,0.0015617775,0.0024127515,0.0010587329,0.0004785049,0.00045932506],"domain_scores_gemma":[0.9950899,0.0014345533,0.0014876797,0.0012928711,0.00039558636,0.000299424],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006792413,0.00076954754,0.0061112256,0.0002986787,0.00004171261,0.0000042450597,0.00040021414,0.00066534104,0.000072847535],"category_scores_gemma":[0.0007580795,0.0005698906,0.001947818,0.00057407154,0.00027733034,0.0000132253645,0.0002097176,0.0014861727,0.00008733962],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008498299,0.0014274679,0.000039813935,0.14130689,0.00023158245,0.0004073181,0.000037743674,3.2261687e-7,0.0000017113838,0.000038634524,0.012837641,0.8435859],"study_design_scores_gemma":[0.0015645609,0.005173704,0.000027099237,0.10341193,0.0075553292,0.000066796114,0.0000055556534,0.0000018487065,0.000053067786,0.00001754849,0.88182294,0.00029960254],"about_ca_topic_score_codex":0.0000021391481,"about_ca_topic_score_gemma":0.0000016649656,"teacher_disagreement_score":0.8689853,"about_ca_system_score_codex":0.0008432474,"about_ca_system_score_gemma":0.0036776257,"threshold_uncertainty_score":0.9996753},"labels":[],"label_agreement":null},{"id":"W4411443142","doi":"10.1016/j.jaad.2025.06.044","title":"Increased prevalence of renal cysts in hereditary leiomyomatosis and renal cell cancer: A cross-sectional magnetic resonance imaging-based study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Leiomyomatosis; Cross-sectional study; Pathology; Radiology; Leiomyoma","score_opus":0.011949926979883119,"score_gpt":0.30682976405469825,"score_spread":0.29487983707481513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411443142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97845984,0.017201595,0.000011688842,0.0037932706,0.00006955726,0.0003683209,0.000023564877,0.0000050409403,0.0000671016],"genre_scores_gemma":[0.9987425,0.000228897,0.0003658554,0.00053163077,0.00003598922,0.00001780694,4.1866124e-7,0.000012579746,0.00006427605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975499,0.00041604016,0.0010926842,0.0002418998,0.00045697542,0.00024249952],"domain_scores_gemma":[0.9980145,0.00035065447,0.0012050447,0.00018807796,0.00014285561,0.00009883561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031461852,0.00019604032,0.0008467626,0.0004554578,0.000047106372,0.000006288686,0.0003400064,0.000065931235,0.000021589052],"category_scores_gemma":[0.00010586236,0.0001403709,0.0001880245,0.00058386364,0.0007991402,0.00007335414,0.00010613318,0.0005325899,3.537251e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002069483,0.00053200405,0.9746385,0.00033464382,0.000068574634,0.00021722299,0.00008129876,0.000095765085,0.020729728,0.0000043141235,0.00039879023,0.00082967355],"study_design_scores_gemma":[0.0041488144,0.00053355575,0.9520404,0.00045429263,0.00027566255,0.0016587047,0.000079682264,0.0003181325,0.040246896,0.00005753951,0.00010345305,0.00008286747],"about_ca_topic_score_codex":0.00033596272,"about_ca_topic_score_gemma":0.000012351672,"teacher_disagreement_score":0.0225981,"about_ca_system_score_codex":0.00016299279,"about_ca_system_score_gemma":0.00046249217,"threshold_uncertainty_score":0.57241595},"labels":[],"label_agreement":null},{"id":"W4411643698","doi":"10.1016/j.ijrobp.2025.05.089","title":"SABR Versus Radiofrequency Ablation and Cryoablation for Primary Renal Cell Carcinoma: An Economic Evaluation of the FASTRACK II Trial","year":2025,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"Cancer Council Victoria; Merck Sharp and Dohme; Cancer Australia; MSD K.K.; Roche; Merck","keywords":"SABR volatility model; Ablative case; Cryoablation; Medicine; Ablation; Cryosurgery; Radiosurgery; Renal cell carcinoma; Radiofrequency ablation; Radiation therapy; Radiology; Oncology; Internal medicine","score_opus":0.040050720838182535,"score_gpt":0.3484044160519422,"score_spread":0.30835369521375966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411643698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98973304,0.0007123212,0.002508862,0.0011457276,0.003224848,0.0010614916,0.000052495547,0.0000099865165,0.001551226],"genre_scores_gemma":[0.9961041,0.00010319871,0.0019543017,0.00012880858,0.0014156436,0.000038693914,0.00018216569,0.000015753261,0.000057294885],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99806607,0.00034277653,0.00087245577,0.00024219407,0.0003286062,0.00014786993],"domain_scores_gemma":[0.9969934,0.00042881223,0.0012859149,0.00019903827,0.0010227963,0.00007001796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012447037,0.00017562533,0.00041780647,0.00019369015,0.00011937587,0.000018479237,0.00022552488,0.00021532192,0.000025169404],"category_scores_gemma":[0.00025536507,0.00014059705,0.00024168681,0.0001040461,0.00015101506,0.00032132037,0.000046932957,0.0002330446,0.0000013251562],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06634479,0.0022836477,0.18225165,0.000098533965,0.0016340838,0.0000063632046,0.001319992,0.014193122,0.0772959,0.018457968,0.0012365176,0.63487744],"study_design_scores_gemma":[0.31596628,0.0170769,0.514077,0.00014474234,0.0037253352,0.0000999702,0.00022674579,0.039789777,0.071012855,0.031070983,0.0063755903,0.00043380752],"about_ca_topic_score_codex":0.000026184061,"about_ca_topic_score_gemma":0.000007671944,"teacher_disagreement_score":0.63444364,"about_ca_system_score_codex":0.002024694,"about_ca_system_score_gemma":0.0018387951,"threshold_uncertainty_score":0.57333815},"labels":[],"label_agreement":null},{"id":"W4411690414","doi":"10.1016/j.ejso.2025.110283","title":"Head-to-head comparison of nephrometry scores for partial nephrectomy: implications for clinical guidelines","year":2025,"lang":"en","type":"article","venue":"European Journal of Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nephrectomy; Head (geology); Medicine; General surgery; Surgery; Kidney; Internal medicine","score_opus":0.27189626700130887,"score_gpt":0.5233173100669711,"score_spread":0.25142104306566226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411690414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93080086,0.0026781121,0.02045511,0.03848601,0.0010775941,0.0013901966,0.00003937221,0.000023702889,0.005049035],"genre_scores_gemma":[0.9416912,0.00039170898,0.05475636,0.001355691,0.0013287727,0.000035231413,0.000018835111,0.000034662433,0.00038752338],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963261,0.0004845853,0.0024615389,0.00026603384,0.00016540957,0.00029636195],"domain_scores_gemma":[0.99514675,0.0022246342,0.00073648413,0.00028932162,0.0012505447,0.0003522414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023540093,0.00018277172,0.0013173417,0.00033398744,0.00007484495,0.0000114546065,0.00025200492,0.00009369863,0.000032351047],"category_scores_gemma":[0.0010170243,0.00013304736,0.0007246066,0.00033341322,0.00016557884,0.000038434424,0.000079873935,0.00028818738,0.000010450096],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019085467,0.0033885506,0.22373514,0.00021637237,0.0010484095,0.0003470063,0.00011576382,0.00018474444,0.0043368596,0.0016509416,0.15046224,0.5954285],"study_design_scores_gemma":[0.009114307,0.011628351,0.1443738,0.00018795123,0.0005616992,0.0002557887,0.00004650956,0.00011627713,0.0010317559,0.00011604638,0.832475,0.00009248468],"about_ca_topic_score_codex":0.0000030020967,"about_ca_topic_score_gemma":0.0000051749043,"teacher_disagreement_score":0.6820128,"about_ca_system_score_codex":0.00014883249,"about_ca_system_score_gemma":0.0005399875,"threshold_uncertainty_score":0.5425514},"labels":[],"label_agreement":null},{"id":"W4411934388","doi":"10.1200/jco-25-00234","title":"Tumor-Intrinsic and Microenvironmental Determinants of Impaired Antitumor Immunity in Chromophobe Renal Cell Carcinoma","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Immune system; Clear cell; Renal cell carcinoma; Medicine; Chromophobe cell; Immune checkpoint; CD8; Cancer research; Clear cell renal cell carcinoma; Pathology; Immunotherapy; Immunology","score_opus":0.050407176237038394,"score_gpt":0.3793142436953793,"score_spread":0.3289070674583409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411934388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959375,0.0018938266,0.0000025819447,0.0003849066,0.00036471896,0.0002496562,0.000004324795,0.0000026138423,0.0011598193],"genre_scores_gemma":[0.9978104,0.00043465442,0.0011174448,0.00035576485,0.00011894092,0.0000023348746,0.0000014435446,0.000011216945,0.00014777879],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963887,0.0004552663,0.0024850955,0.00020358861,0.0002245413,0.00024282183],"domain_scores_gemma":[0.9972373,0.0008772126,0.0013110114,0.0002474014,0.00009593606,0.00023112675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016973906,0.00017367596,0.0017720714,0.00027655868,0.000029057452,0.0000043755704,0.00015419339,0.00020148925,0.000048746562],"category_scores_gemma":[0.00050342537,0.00013067566,0.00036896582,0.00015910008,0.0003996973,0.00008201569,0.00014499652,0.0007792595,0.0000041894486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041840677,0.0025418662,0.93565434,0.00013927055,0.00007601358,0.0068430416,0.00007431385,0.0000011768982,0.022452837,0.0000038328685,0.00020554775,0.027823688],"study_design_scores_gemma":[0.011509544,0.010296635,0.9269996,0.00018712274,0.00030403535,0.0014921754,0.00014725118,0.000024487485,0.048385188,0.00004491149,0.00053394696,0.00007506016],"about_ca_topic_score_codex":0.00013917971,"about_ca_topic_score_gemma":0.00006329107,"teacher_disagreement_score":0.027748628,"about_ca_system_score_codex":0.00032095716,"about_ca_system_score_gemma":0.0011029943,"threshold_uncertainty_score":0.5328799},"labels":[],"label_agreement":null},{"id":"W4412003127","doi":"10.1001/jamaoncol.2025.1891","title":"First-Line Therapy For Advanced Non–Clear Cell Renal Cell Carcinoma","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Oncology; Renal cell carcinoma; Meta-analysis; Cochrane Library; Observational study; MEDLINE; Clinical trial; Immunotherapy; Atezolizumab; Nivolumab; Cancer","score_opus":0.020000997743431965,"score_gpt":0.3031120302561916,"score_spread":0.28311103251275965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412003127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9228559,0.002056988,0.0010875176,0.008024007,0.0004886298,0.0018013229,0.000018805416,0.000066367305,0.06360047],"genre_scores_gemma":[0.9652871,0.0003304217,0.0069195917,0.0036027036,0.0003301465,0.00040900699,0.00007490622,0.00004499908,0.02300115],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99832076,0.00006442372,0.00042341268,0.00053334935,0.00016236556,0.0004956869],"domain_scores_gemma":[0.99848765,0.00044768312,0.00015042485,0.0005305171,0.00021197312,0.0001717732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020667889,0.00028515706,0.00064308586,0.00020052673,0.00013244367,0.000015369198,0.00017581489,0.00033809923,0.00018678624],"category_scores_gemma":[0.000051977306,0.0002332244,0.00027875748,0.00023957671,0.00008696377,0.000057391513,0.00006897842,0.00029553944,0.00008708402],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04245461,0.0075881053,0.03851374,0.0016866658,0.00042680214,0.0017002607,0.0016832238,0.00052734127,0.5027126,0.00053621916,0.12789764,0.27427277],"study_design_scores_gemma":[0.031439897,0.015757348,0.061163276,0.000058882517,0.00024901045,0.000037788013,0.00018818765,0.0010077786,0.39142227,0.0003277215,0.4980796,0.00026824474],"about_ca_topic_score_codex":0.000061391045,"about_ca_topic_score_gemma":0.000039256953,"teacher_disagreement_score":0.37018195,"about_ca_system_score_codex":0.0005902539,"about_ca_system_score_gemma":0.000531844,"threshold_uncertainty_score":0.9510615},"labels":[],"label_agreement":null},{"id":"W4412105869","doi":"10.3390/curroncol32070391","title":"Treatment-Induced Gene Expression Changes in Metastatic Renal Cell Carcinoma: Insights from a Syngeneic Mouse Model","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Nippon Kayaku","keywords":"Medicine; Cabozantinib; Axitinib; Renal cell carcinoma; Cancer research; Immunotherapy; Everolimus; Metastasis; Combination therapy; Sunitinib; Cancer; Oncology; Internal medicine","score_opus":0.1190689856638517,"score_gpt":0.36242731712607484,"score_spread":0.24335833146222313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412105869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98611474,0.009861642,0.0002929258,0.0004324767,0.00046737882,0.0011154192,0.00004831729,0.00006054041,0.0016065564],"genre_scores_gemma":[0.99537444,0.0005056355,0.002041139,0.00009891132,0.00012022568,0.0005486254,0.00031296842,0.00003336411,0.00096467877],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979003,0.00025063046,0.00045591596,0.000724212,0.00022509124,0.00044384564],"domain_scores_gemma":[0.99877596,0.00017937251,0.00015531982,0.00058531866,0.000084189174,0.00021981304],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000060653187,0.00041124737,0.0008889833,0.0005311293,0.00007344293,0.00001290624,0.00014912101,0.00017895,0.000044304215],"category_scores_gemma":[0.00002868443,0.00030874906,0.00015716603,0.00028544528,0.00005666264,0.000056587687,0.000115473245,0.00027849613,0.000041626303],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008130124,0.003725478,0.010110254,0.00012901376,0.000101271624,0.00050180143,0.0015300647,0.00012116751,0.963809,0.00003529734,0.00034674938,0.01877687],"study_design_scores_gemma":[0.010446432,0.0019379685,0.006576817,0.00010681299,0.00065326714,0.000013619555,0.00020974467,0.006400646,0.97143584,0.0002863378,0.0016876664,0.00024482133],"about_ca_topic_score_codex":0.00024327311,"about_ca_topic_score_gemma":0.0005750125,"teacher_disagreement_score":0.018532047,"about_ca_system_score_codex":0.0018046073,"about_ca_system_score_gemma":0.00071229046,"threshold_uncertainty_score":0.99993646},"labels":[],"label_agreement":null},{"id":"W4412365879","doi":"10.1245/s10434-025-17769-w","title":"The Effect of Valvulopathy on Adverse In-Hospital Outcomes After Partial and Radical Nephrectomy","year":2025,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Surgical oncology; Nephrectomy; Adverse effect; General surgery; Surgery; Internal medicine; Urology; Kidney","score_opus":0.015589841429579653,"score_gpt":0.33498864682432694,"score_spread":0.3193988053947473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412365879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764404,0.0010895373,5.1031515e-7,0.0154014705,0.00016388796,0.0004323427,0.0000029686337,0.000007584828,0.0064612823],"genre_scores_gemma":[0.9984974,0.0009070844,0.000019917668,0.00026790088,0.00003083689,0.000068637186,0.0000023456414,0.0000062386725,0.00019963487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869794,0.00028012425,0.0004018123,0.00020199316,0.00018251983,0.00023560446],"domain_scores_gemma":[0.99754125,0.0020322779,0.00008802026,0.00020045992,0.000042756557,0.00009525563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005146604,0.00014276495,0.0006873912,0.00010310424,0.000022687555,0.0000020453838,0.00006322606,0.00014568523,0.00003660899],"category_scores_gemma":[0.000109061904,0.00007650273,0.00021688583,0.00014371844,0.00038417688,0.0000200266,0.000063444786,0.00019225068,0.000006609234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013841475,0.0008045952,0.9262918,0.00011663981,0.00026542935,0.0018429988,0.00011954348,0.0000033761735,0.00007562653,0.0007846759,0.0011210537,0.054732785],"study_design_scores_gemma":[0.008415522,0.014685488,0.75380194,0.00014833885,0.00015668983,0.000030042642,0.000034136145,0.00001733075,0.016669422,0.00014475765,0.20579882,0.00009753423],"about_ca_topic_score_codex":0.000037394817,"about_ca_topic_score_gemma":0.000010350661,"teacher_disagreement_score":0.20467776,"about_ca_system_score_codex":0.00003753476,"about_ca_system_score_gemma":0.00006986842,"threshold_uncertainty_score":0.31196907},"labels":[],"label_agreement":null},{"id":"W4412400203","doi":"10.1200/op-25-00089","title":"Long-Term Performance of Prognostic Models for Advanced Renal Cell Carcinoma in the Era of Improved Survival With Immune Checkpoint Inhibitors","year":2025,"lang":"en","type":"article","venue":"JCO Oncology Practice","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Sunitinib; Ipilimumab; Nivolumab; Medicine; Renal cell carcinoma; Internal medicine; Oncology; Kidney cancer; Clear cell renal cell carcinoma; Cancer; Clinical endpoint; Concordance; Immunotherapy; Clinical trial","score_opus":0.019909045569363685,"score_gpt":0.30102724003190384,"score_spread":0.28111819446254016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412400203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877153,0.0008387901,0.0003647425,0.002090889,0.00015632152,0.0024924981,0.0000064973433,0.000012315352,0.006322619],"genre_scores_gemma":[0.99414337,0.00008678937,0.0049455385,0.00014850158,0.000040818933,0.00038414085,0.000031679774,0.000020597066,0.00019854712],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981574,0.000246471,0.0007154463,0.0003243106,0.0002486363,0.00030777487],"domain_scores_gemma":[0.99649346,0.0018892393,0.000658433,0.00048700126,0.00042466275,0.000047211215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010386307,0.00021910247,0.00064073934,0.00013511114,0.000056134257,0.000006148675,0.00018798087,0.00015241794,0.0000048964735],"category_scores_gemma":[0.00038327285,0.00014225644,0.00012538719,0.00037539136,0.00018020836,0.00026730448,0.000066544635,0.0005023452,0.0000010049661],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.096235715,0.0144303115,0.38476515,0.0060038255,0.00088134606,0.0006747404,0.0070246197,0.0031907384,0.43869206,0.0005738343,0.000093358714,0.04743431],"study_design_scores_gemma":[0.017811134,0.020740593,0.46907595,0.0004914823,0.0015262266,0.00021863001,0.0018186437,0.0040972815,0.48371097,0.000035891633,0.00024246408,0.00023072009],"about_ca_topic_score_codex":0.00013777702,"about_ca_topic_score_gemma":0.00007873903,"teacher_disagreement_score":0.08431083,"about_ca_system_score_codex":0.00028755807,"about_ca_system_score_gemma":0.0008913476,"threshold_uncertainty_score":0.58010495},"labels":[],"label_agreement":null},{"id":"W4412438061","doi":"10.1016/j.yacr.2025.05.003","title":"Radiotherapy of Primary Renal Cell Carcinoma","year":2025,"lang":"en","type":"article","venue":"Advances in Clinical Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre; Health Sciences Centre; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"AstraZeneca; Astellas Pharma US","keywords":"Renal cell carcinoma; Radiation therapy; Primary (astronomy); Medicine; Carcinoma; Oncology; Internal medicine; Urology; Physics","score_opus":0.030153322493130456,"score_gpt":0.37728458892866873,"score_spread":0.34713126643553827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412438061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9015894,0.049485605,0.0007052598,0.00068840856,0.0005588002,0.00037774717,0.0000037055786,0.000020035666,0.046571042],"genre_scores_gemma":[0.98148865,0.008125764,0.0076838685,0.001455624,0.00014441536,0.000026750426,0.000016969858,0.00001292881,0.0010450548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789053,0.00025842254,0.0010267786,0.00043226616,0.00011675431,0.0002752753],"domain_scores_gemma":[0.9975796,0.0016093255,0.00018629157,0.00048144473,0.000055563887,0.00008780755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000555687,0.00016385336,0.0009737746,0.00017404425,0.000016789361,0.0000015125987,0.00016686418,0.00022643196,0.00006214637],"category_scores_gemma":[0.00024269112,0.0001300741,0.00023980261,0.0002705792,0.00044244484,0.0000546771,0.000043502623,0.0003737312,0.0000063034254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001724691,0.0005979589,0.92399454,0.000214585,0.000053263797,0.00021709803,0.00003055933,0.000055436125,0.0043397173,0.0014646747,0.00053684984,0.0667706],"study_design_scores_gemma":[0.006484134,0.002288299,0.9597992,0.00008725388,0.00008130872,0.000060974176,0.000018167628,0.00006291107,0.006037632,0.0025457314,0.022415577,0.00011884352],"about_ca_topic_score_codex":0.000013169261,"about_ca_topic_score_gemma":0.000007345966,"teacher_disagreement_score":0.07989923,"about_ca_system_score_codex":0.00018096129,"about_ca_system_score_gemma":0.0002667372,"threshold_uncertainty_score":0.5304268},"labels":[],"label_agreement":null},{"id":"W4412647773","doi":"10.1016/j.eururo.2025.05.019","title":"First-line Pembrolizumab Plus Lenvatinib for Advanced Non–clear-cell Renal Cell Carcinoma: Updated Results from the Phase 2 KEYNOTE-B61 Trial","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"","keywords":"Medicine; Lenvatinib; Pembrolizumab; Renal cell carcinoma; Internal medicine; Oncology; Immunotherapy; Cancer; Sorafenib; Hepatocellular carcinoma","score_opus":0.025738486243495305,"score_gpt":0.2798555129792575,"score_spread":0.2541170267357622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412647773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94365287,0.0008218518,0.0015036927,0.0053136,0.00091287,0.0027693952,0.000403735,0.00013728853,0.044484716],"genre_scores_gemma":[0.9823817,0.000047601094,0.00085238897,0.0026698713,0.0009314245,0.00008463148,0.0016793186,0.00010959096,0.011243473],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99646306,0.00053749804,0.0010129493,0.00103986,0.00026653416,0.0006800867],"domain_scores_gemma":[0.99676836,0.00114012,0.0003801538,0.0013123621,0.00019642827,0.00020259015],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000576156,0.0004890647,0.0007421137,0.00015485846,0.00030227035,0.000036440306,0.0004923895,0.0001607042,0.00014250449],"category_scores_gemma":[0.00045576118,0.0003544277,0.00034263683,0.00031306446,0.00019963518,0.000057631405,0.00024307659,0.0005740872,0.00028655582],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8819804,0.0022501727,0.0001909338,0.00009790551,0.00028187735,0.0015247221,0.0012191009,0.0013629611,0.031639263,0.00006458748,0.07451096,0.0048770914],"study_design_scores_gemma":[0.6998912,0.019134497,0.006256038,0.00003999687,0.0012950404,0.000033051696,0.000101755606,0.0047031227,0.0315064,0.000089910056,0.23647222,0.00047674784],"about_ca_topic_score_codex":0.00013348398,"about_ca_topic_score_gemma":0.000039443792,"teacher_disagreement_score":0.18208921,"about_ca_system_score_codex":0.0001772139,"about_ca_system_score_gemma":0.0003127614,"threshold_uncertainty_score":0.99989074},"labels":[],"label_agreement":null},{"id":"W4412764958","doi":"10.1097/pas.0000000000002456","title":"Interobserver Reproducibility of Pelvicalyceal Invasion in Renal Cell Carcinoma Nephrectomies Among Genitourinary Pathologists","year":2025,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre; McGill University","funders":"","keywords":"Medicine; Renal sinus; Conventional PCI; Renal pelvis; Urothelium; Radiology; Renal cell carcinoma; Genitourinary system; Pathology; Urology; Urinary bladder; Kidney; Nephrectomy; Anatomy; Internal medicine; Ureter","score_opus":0.023554012864302833,"score_gpt":0.27874107107604784,"score_spread":0.25518705821174503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412764958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954704,0.0011108149,0.000034173354,0.0018707785,0.00016353883,0.00026446418,0.0000032613345,0.000009897911,0.0010726794],"genre_scores_gemma":[0.99858046,0.00020466247,0.00074117136,0.00016733892,0.00010600107,0.00000695483,0.0000029607788,0.000014395866,0.0001760328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963657,0.0012242993,0.0012042618,0.0005566911,0.0003071647,0.000341851],"domain_scores_gemma":[0.9968949,0.0006755312,0.0008911652,0.0011402818,0.0002663793,0.00013177001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027921568,0.00023677414,0.0012438432,0.0003667252,0.000042781645,0.000006980446,0.00034580528,0.00009326753,0.00003966718],"category_scores_gemma":[0.0003831294,0.00014057771,0.00042102957,0.0006597119,0.0016440098,0.000066844346,0.00024705796,0.00078561343,0.000003969544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008292408,0.00090988545,0.93732446,0.00008484205,0.00005795066,0.014935732,0.00071301707,0.00006798018,0.02873272,0.000021013806,0.00020261708,0.008657348],"study_design_scores_gemma":[0.0024066975,0.0038920788,0.96398246,0.000121276586,0.00016950055,0.0034543741,0.0005098056,0.000017477409,0.024898894,0.0003615781,0.00008774883,0.00009809775],"about_ca_topic_score_codex":0.00017822912,"about_ca_topic_score_gemma":0.000017626851,"teacher_disagreement_score":0.026657986,"about_ca_system_score_codex":0.00020086608,"about_ca_system_score_gemma":0.00021014137,"threshold_uncertainty_score":0.6057423},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4412819491","doi":"10.1038/s41591-025-03867-5","title":"Pembrolizumab plus axitinib versus sunitinib for advanced clear cell renal cell carcinoma: 5-year survival and biomarker analyses of the phase 3 KEYNOTE-426 trial","year":2025,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval; Centre hospitalier de l'Université Laval","funders":"National Cancer Institute; EMD Serono; Ipsen; Servier; Astellas Pharma; Eisai; EUSA Pharma; Seagen; UroGen Pharma; F. Hoffmann-La Roche; Incyte; Daiichi Sankyo Europe; Exelixis; Merck KGaA; Gilead Sciences; Pfizer; Les Laboratories Pierre Fabre; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Axitinib; Sunitinib; Medicine; Hazard ratio; Renal cell carcinoma; Internal medicine; Pembrolizumab; Oncology; Clear cell renal cell carcinoma; Kidney cancer; Confidence interval; Biomarker; Cancer; Immunotherapy; Biology","score_opus":0.05595577496506752,"score_gpt":0.38042463572422247,"score_spread":0.32446886075915493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412819491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9599468,0.008195243,0.00008697157,0.0020798284,0.002125075,0.0022456276,0.000093669696,0.000043278123,0.02518348],"genre_scores_gemma":[0.9953739,0.00010939301,0.00040106787,0.00024879305,0.0005318119,0.00007141072,0.00018275379,0.00004801047,0.00303283],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972904,0.00019515115,0.0007147082,0.00061648217,0.0007237066,0.00045956296],"domain_scores_gemma":[0.9971554,0.0010675169,0.00034169044,0.0007845241,0.0004276483,0.00022320141],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005063737,0.00044029075,0.0010851037,0.00035839804,0.00019128577,0.000011467363,0.00026575543,0.00043314425,0.00011312945],"category_scores_gemma":[0.00080003275,0.0002690469,0.000342742,0.0007408587,0.0004994945,0.000054436034,0.000119201184,0.00073943345,0.0000020194502],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6636549,0.0011778168,0.00048608132,0.0014066788,0.000539558,0.000135692,0.0004389192,0.000012190509,0.31823274,0.00055442733,0.0076849107,0.005676072],"study_design_scores_gemma":[0.6179642,0.010420758,0.0076693576,0.0003771937,0.003173612,0.000018103166,0.0013790973,0.00023430368,0.3501409,0.000084246385,0.008235993,0.0003022644],"about_ca_topic_score_codex":0.00012468049,"about_ca_topic_score_gemma":0.000025210713,"teacher_disagreement_score":0.04569072,"about_ca_system_score_codex":0.0002176293,"about_ca_system_score_gemma":0.00044607962,"threshold_uncertainty_score":0.99997616},"labels":[],"label_agreement":null},{"id":"W4412902428","doi":"10.1093/oncolo/oyaf240","title":"Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary renal cell carcinoma","year":2025,"lang":"en","type":"article","venue":"The Oncologist","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; London Health Sciences Centre; McGill University Health Centre; University of Ottawa; Western University; University of Toronto; SAIT Polytechnic; Sunnybrook Health Science Centre; McMaster University Medical Centre; Ottawa Hospital; CancerCare Manitoba; Hôtel-Dieu de Québec; BC Cancer Agency; Centre Hospitalier de l’Université de Montréal; Université Laval; University of Alberta; Queen Elizabeth II Health Sciences Centre; University of Calgary","funders":"AstraZeneca","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Clinical endpoint; Cabozantinib; Adverse effect; Gastroenterology; Oncology; Clinical trial; Urology","score_opus":0.10093807808990458,"score_gpt":0.4306932863931999,"score_spread":0.32975520830329536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412902428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9449079,0.00037934782,0.000029922612,0.0023849825,0.00016968975,0.0011239167,0.000024228792,0.000017722852,0.05096231],"genre_scores_gemma":[0.98995656,0.00054009387,0.0024801842,0.00013594097,0.000034833676,0.00011042114,0.000033362507,0.000014645065,0.006693947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973609,0.00039173433,0.001356061,0.0003254548,0.00030652946,0.00025933277],"domain_scores_gemma":[0.9967692,0.0017965209,0.00046331398,0.0007863498,0.00010173883,0.00008289706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010099992,0.00025343735,0.0013889241,0.00021864963,0.000045090157,0.00000464458,0.00019685659,0.00007810153,0.00008794915],"category_scores_gemma":[0.00012881277,0.00013690362,0.00042025422,0.00042854212,0.00036517717,0.000021682334,0.00011047938,0.0002151686,0.00000441273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048477406,0.0031648397,0.9909027,0.00018693334,0.00032688325,0.00025845837,0.00009515071,0.0001541968,0.00033443153,0.00044991562,0.00035979605,0.003281874],"study_design_scores_gemma":[0.0057316856,0.003914243,0.9814246,0.00007734055,0.000914589,0.000004426004,0.00016784103,0.00035208676,0.006203058,0.00020206197,0.0009206067,0.000087446526],"about_ca_topic_score_codex":0.005672866,"about_ca_topic_score_gemma":0.005069036,"teacher_disagreement_score":0.045048695,"about_ca_system_score_codex":0.0006683549,"about_ca_system_score_gemma":0.00075778936,"threshold_uncertainty_score":0.8575714},"labels":[],"label_agreement":null},{"id":"W4412925033","doi":"10.3389/fonc.2025.1605282","title":"Nivolumab plus cabozantinib in metastatic renal cell carcinoma: real-world evidence from the international ARON-1 study","year":2025,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Cabozantinib; Nivolumab; Medicine; Renal cell carcinoma; Oncology; Internal medicine; Performance status; Kidney cancer; Progression-free survival; Cohort; Urology; Overall survival; Cancer; Immunotherapy","score_opus":0.0394263623607299,"score_gpt":0.3353229784516191,"score_spread":0.29589661609088924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412925033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97230965,0.002777788,0.00038582264,0.0041651963,0.002284114,0.0014796378,0.000014128941,0.000024742349,0.016558897],"genre_scores_gemma":[0.98727995,0.00020191364,0.0057447683,0.00056270155,0.00013271434,0.00025168512,0.000038141567,0.000019711297,0.0057683988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744874,0.00049725303,0.0006876555,0.00060506305,0.00037360558,0.00038765144],"domain_scores_gemma":[0.99827164,0.00081804657,0.00017450213,0.0005755817,0.00008224092,0.00007800125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073732994,0.00025228356,0.00075961935,0.000548457,0.000058103244,0.0000236428,0.0005013214,0.00009203466,0.00011195316],"category_scores_gemma":[0.00025105008,0.00019100908,0.00011010898,0.000661794,0.00015381582,0.00009374585,0.00022680609,0.00056724466,0.000020103958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016772521,0.0009450679,0.9489363,0.0000218462,0.00016532285,0.001788328,0.002660381,0.00013014219,0.0003172915,0.000023996203,0.038970076,0.004364023],"study_design_scores_gemma":[0.010121001,0.0009373913,0.9727368,0.00017629756,0.00035283036,0.00001121343,0.0058642444,0.001768622,0.0009429182,0.00031817742,0.006611396,0.00015912583],"about_ca_topic_score_codex":0.016516734,"about_ca_topic_score_gemma":0.02124888,"teacher_disagreement_score":0.03235868,"about_ca_system_score_codex":0.0028953506,"about_ca_system_score_gemma":0.0012661873,"threshold_uncertainty_score":0.99661076},"labels":[],"label_agreement":null},{"id":"W4413019539","doi":"10.3390/cancers17152588","title":"Biomarkers in Renal Cell Carcinoma: A Systematic Review and Immunohistochemical Validation Study","year":2025,"lang":"en","type":"review","venue":"Cancers","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Partenariat Canadien Contre Le Cancer; Metro South Health","keywords":"Renal cell carcinoma; Immunohistochemistry; Biomarker; Medicine; Pathology; Cancer; Staining; Clear cell renal cell carcinoma; Clear cell; Carcinoma; Enolase; Tissue microarray; Oncology; Internal medicine; Biology","score_opus":0.03139504515832865,"score_gpt":0.3285298903679625,"score_spread":0.29713484520963385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413019539","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004252849,0.9866343,9.33079e-7,0.000015155363,0.00009626282,0.011402088,0.000018569957,0.000023203718,0.0013841867],"genre_scores_gemma":[0.001601551,0.99466944,0.00003291386,0.00006103523,0.000024398483,0.0025704731,0.000157235,0.00003978647,0.0008431582],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99733037,0.00037017663,0.0011195745,0.0006341818,0.00028273644,0.00026295357],"domain_scores_gemma":[0.9984502,0.00019641407,0.0004210934,0.00073779444,0.000064604785,0.0001298612],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004485417,0.0005070452,0.0039085653,0.00035740237,0.00003384095,0.000016968826,0.00015945068,0.00018128462,0.000027164908],"category_scores_gemma":[0.00015366553,0.00037523304,0.00037012686,0.00065208855,0.000055858498,0.000031578023,0.00008187585,0.00034224443,0.00001444608],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000151415325,0.00005589235,0.000028089446,0.99574345,0.00033402577,0.00017691194,0.000056845252,7.477558e-8,0.0000032354985,5.9945097e-7,0.00058517803,0.0030005414],"study_design_scores_gemma":[0.0014439027,0.00039184533,0.000023743352,0.947699,0.04428052,0.00014713744,0.000107005544,0.0000013920858,0.000020893998,9.899597e-7,0.0054649413,0.00041862563],"about_ca_topic_score_codex":0.00024923158,"about_ca_topic_score_gemma":0.000006604889,"teacher_disagreement_score":0.04804446,"about_ca_system_score_codex":0.006418545,"about_ca_system_score_gemma":0.0020148805,"threshold_uncertainty_score":0.99986994},"labels":[],"label_agreement":null},{"id":"W4413055936","doi":"10.1097/ju.0000000000004717","title":"Active Surveillance of Biopsy-Confirmed Oncocytic Renal Tumors: Growth Dynamics and Impact on Renal Function","year":2025,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Oncocytoma; Clear cell; Biopsy; Concordance; Chromophobe cell; Renal function; Renal cell carcinoma; Clear cell renal cell carcinoma; Renal oncocytoma; Renal biopsy; Kidney disease; Cohort; Kidney; Pathology; Radiology; Internal medicine","score_opus":0.010211874880977865,"score_gpt":0.26617817380155395,"score_spread":0.2559662989205761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413055936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947403,0.00059212075,0.0005005982,0.0022596326,0.00013699823,0.00015399767,0.000008220351,0.0000053614376,0.001602766],"genre_scores_gemma":[0.99936,0.00013956978,0.00003319992,0.00022950902,0.00009269523,0.0000011779501,0.000003891326,0.000009483174,0.0001304228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883544,0.0002794406,0.00040126682,0.0001066168,0.00019937576,0.00017786851],"domain_scores_gemma":[0.9985101,0.00054700027,0.00043218434,0.00018579779,0.00024463018,0.00008024688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005757619,0.00014911772,0.00048057167,0.00025767722,0.00004296747,0.000004287285,0.00009600298,0.000083494706,0.000030918094],"category_scores_gemma":[0.000168099,0.00008034979,0.00013099835,0.00019540625,0.00019374111,0.000036972877,0.000028603827,0.00037874066,0.0000021445173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.318754,0.0019143268,0.33371252,0.00045910955,0.0090009365,0.0019281254,0.0017852369,0.0023794852,0.27989337,0.006164429,0.0030692287,0.040939223],"study_design_scores_gemma":[0.0034680765,0.009903731,0.97366655,0.000091509704,0.000570825,0.0027340502,0.000092813265,0.00085435726,0.0070562796,0.0014680042,0.00002644542,0.00006733085],"about_ca_topic_score_codex":0.00008002372,"about_ca_topic_score_gemma":0.000021604908,"teacher_disagreement_score":0.63995403,"about_ca_system_score_codex":0.00026242377,"about_ca_system_score_gemma":0.00026788862,"threshold_uncertainty_score":0.32765692},"labels":[],"label_agreement":null},{"id":"W4413140924","doi":"10.1007/s00330-025-11894-6","title":"Comparison of coaxial technique with sequential (non-coaxial) technique for renal mass biopsy: evaluation of diagnostic efficacy, complication rates, seeding risk, and clinical outcomes","year":2025,"lang":"en","type":"article","venue":"European Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Toronto","funders":"","keywords":"Medicine; Interventional radiology; Coaxial; Radiology; Neuroradiology; Complication; Biopsy; Seeding; Ultrasound; Surgery; Neurology","score_opus":0.07874985137218268,"score_gpt":0.40753191878078543,"score_spread":0.3287820674086027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413140924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83297515,0.00022905973,0.16151604,0.00012003267,0.00012080583,0.0037357241,0.00003367736,0.000042365165,0.0012271461],"genre_scores_gemma":[0.98229134,0.00005508689,0.01708625,0.000027825872,0.00009524476,0.00021604261,0.00016588818,0.000032018972,0.00003031882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99709874,0.0010862293,0.0009469347,0.00044936183,0.00021472752,0.00020397389],"domain_scores_gemma":[0.9965136,0.001999227,0.00060723047,0.00039950895,0.00040178167,0.000078634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029466138,0.00022439055,0.0008892206,0.00023547058,0.00007559089,0.0000067849546,0.00013687859,0.00013918689,0.0000076136585],"category_scores_gemma":[0.0015502212,0.00017185765,0.0001520866,0.00018907906,0.00041582793,0.000028793618,0.000061717416,0.0002762435,0.0000018539281],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011994035,0.00038317335,0.8584051,0.00015171102,0.0003954631,0.000012865258,0.00009402481,0.00008871975,0.13437262,0.00020875063,0.00031637287,0.004371803],"study_design_scores_gemma":[0.005518719,0.0025013313,0.90381235,0.0002698506,0.0013335686,0.00009999725,0.00004553787,0.0009823685,0.08505803,0.0001245145,0.00011708335,0.00013665424],"about_ca_topic_score_codex":0.000043241376,"about_ca_topic_score_gemma":0.000004315087,"teacher_disagreement_score":0.14931618,"about_ca_system_score_codex":0.00012222897,"about_ca_system_score_gemma":0.00019850476,"threshold_uncertainty_score":0.7008152},"labels":[],"label_agreement":null},{"id":"W4413163260","doi":"10.3390/jcm14165725","title":"Relationship Between Simple Renal Cysts and Hypertension: A Systematic Review and Meta-Analysis","year":2025,"lang":"en","type":"review","venue":"Journal of Clinical Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Observational study; Internal medicine; Web of science; Pooled variance; Multivariate analysis","score_opus":0.4686578545331899,"score_gpt":0.5121927163309921,"score_spread":0.04353486179780214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413163260","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019187644,0.99313164,0.00005042532,0.0044006193,0.00007765888,0.0019826451,0.000022200666,0.000010022013,0.00030560928],"genre_scores_gemma":[0.0008638503,0.9953498,0.00038303246,0.0014326241,0.0005282786,0.000041092433,0.00005821425,0.000030373265,0.001312728],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98844075,0.0019770477,0.007895307,0.00049995346,0.00095720484,0.00022972327],"domain_scores_gemma":[0.97323227,0.019721275,0.004835823,0.0008138565,0.00063446077,0.0007623265],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.007974035,0.0006086296,0.031933792,0.0008547142,0.00006808978,0.000015647587,0.00021160251,0.00047319898,0.00013561948],"category_scores_gemma":[0.02449729,0.0002764855,0.004741153,0.0011773058,0.0002684167,0.00006508493,0.00010631925,0.0015122691,0.000006413249],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001980619,0.00006383102,0.00074946025,0.8263672,0.16461386,0.00067112164,0.0000072646367,2.5419302e-8,7.4048994e-9,0.000015223326,0.0018214181,0.0056707873],"study_design_scores_gemma":[0.000782002,0.00097504334,0.0013286194,0.17859863,0.7963935,0.0016846985,0.000005965178,4.0295114e-7,1.8510653e-8,0.00007067414,0.02002197,0.00013844231],"about_ca_topic_score_codex":0.0000071566096,"about_ca_topic_score_gemma":0.0000018253614,"teacher_disagreement_score":0.64776856,"about_ca_system_score_codex":0.00007605101,"about_ca_system_score_gemma":0.0004900838,"threshold_uncertainty_score":0.9999687},"labels":[],"label_agreement":null},{"id":"W4413323547","doi":"10.1016/j.euf.2025.07.008","title":"Exploring Management Preferences Among Patients with Small Renal Masses: Results from a Pilot Study","year":2025,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Intégré de Santé et Services Sociaux de Chaudière-Appalache; Université de Sherbrooke; McMaster University; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Impact; Centre Hospitalier Universitaire de Sherbrooke","funders":"Warren Y. Soper Charitable Trust; Canadian Urological Association Scholarship Fund","keywords":"Medicine; Internal medicine; Oncology","score_opus":0.08699807960217094,"score_gpt":0.2362131448520317,"score_spread":0.14921506524986078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413323547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8913228,0.00009870481,0.000105077874,0.00015542458,0.00016886357,0.0011437308,0.000016109936,0.00012643279,0.106862865],"genre_scores_gemma":[0.9972771,0.000021659542,0.000939259,0.00012552943,0.000068186324,0.00009290307,0.00007368489,0.00003929729,0.0013623954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777037,0.00044477184,0.00043216033,0.00075368944,0.00025900878,0.0003400087],"domain_scores_gemma":[0.99882853,0.00012151755,0.00013873151,0.00071188813,0.00007799944,0.000121326164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026962164,0.00028695888,0.00034173607,0.00023628096,0.000102307495,0.000031464715,0.00023357132,0.000018349301,0.000026251997],"category_scores_gemma":[0.000046064786,0.00020557267,0.000043786193,0.00024086886,0.00009778489,0.0000804576,0.00025759224,0.0002513588,0.00011606527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010389884,0.003117722,0.9606051,0.000024822708,0.001376713,0.0027928902,0.0010179675,0.000043402288,0.000041542025,0.000040296614,0.0003287772,0.020220898],"study_design_scores_gemma":[0.010714932,0.011569925,0.9745602,0.000081584374,0.00073714106,0.0000017302208,0.000266896,0.000004237964,0.00014164379,0.000037419886,0.0017296574,0.00015461633],"about_ca_topic_score_codex":0.00031977324,"about_ca_topic_score_gemma":0.00024912713,"teacher_disagreement_score":0.1059543,"about_ca_system_score_codex":0.000072114024,"about_ca_system_score_gemma":0.000025139958,"threshold_uncertainty_score":0.838301},"labels":[],"label_agreement":null},{"id":"W4413343069","doi":"10.54254/2753-8818/2025.ld26075","title":"Research Progress in the Application of Immune Checkpoint Inhibitors for Renal Cell Carcinoma","year":2025,"lang":"en","type":"article","venue":"Theoretical and Natural Science","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Renal cell carcinoma; Cancer research; Immune checkpoint; Medicine; Immune system; Oncology; Immunotherapy; Immunology","score_opus":0.013419946279821824,"score_gpt":0.32787189541000755,"score_spread":0.3144519491301857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413343069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909107,0.002230617,0.00005169359,0.0030907874,0.00002946753,0.00083024974,0.0000010647126,0.000004613287,0.0028508236],"genre_scores_gemma":[0.9993746,0.000008710989,0.00041473354,0.000037911253,0.000022745155,0.0000858433,0.0000023543262,0.0000022046324,0.000050847848],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988662,0.000059494458,0.00020376172,0.00023087839,0.00039073045,0.00024891092],"domain_scores_gemma":[0.9992741,0.00027015523,0.000028501026,0.00020719979,0.0001731578,0.0000468965],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0022328938,0.00006522611,0.0001304766,0.00015370663,0.00011798019,0.000017500537,0.00019597169,0.000035647176,0.0000028909208],"category_scores_gemma":[0.00011485658,0.000033026583,0.000043377975,0.0009106367,0.0030812493,0.000035943107,0.000090334535,0.000205594,8.9521933e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074151956,0.00024924884,0.013326406,0.00021156708,0.00000329132,0.0000064578608,0.0005649823,2.819504e-7,0.24337421,0.7108832,0.000022320275,0.030616537],"study_design_scores_gemma":[0.00081665243,0.0004913781,0.30456513,0.00006424069,0.000018938154,0.000009634397,0.00031176145,0.0015049161,0.6649017,0.027189627,0.00007809307,0.000047958103],"about_ca_topic_score_codex":0.00002725444,"about_ca_topic_score_gemma":0.0000014324067,"teacher_disagreement_score":0.6836935,"about_ca_system_score_codex":0.00006247852,"about_ca_system_score_gemma":0.00013830236,"threshold_uncertainty_score":0.9996318},"labels":[],"label_agreement":null},{"id":"W4413406549","doi":"10.1016/j.euf.2025.05.023","title":"Life Expectancy of Renal Cell Carcinoma with Variant Histology","year":2025,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Histology; Life expectancy; Renal cell carcinoma; Internal medicine; Oncology; Pathology","score_opus":0.010198649966962759,"score_gpt":0.2129679343287169,"score_spread":0.20276928436175415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413406549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6813105,0.0043876613,0.0010729798,0.001892538,0.00014821602,0.0002658248,0.0000037002196,0.000054274537,0.3108643],"genre_scores_gemma":[0.9944766,0.000014315018,0.00076782954,0.0010046334,0.00008430377,0.000011329957,0.000010743626,0.00004076861,0.003589473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828494,0.0003655513,0.00040298133,0.00045878245,0.00014469618,0.00034308233],"domain_scores_gemma":[0.9987706,0.00010558742,0.00016458613,0.0006466273,0.00010678661,0.00020584441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001777647,0.00023623319,0.00050942315,0.00025911626,0.000054769436,0.000003699628,0.0001748693,0.000079322555,0.00017923261],"category_scores_gemma":[0.0000963986,0.00017854749,0.000114216564,0.000234453,0.00025629514,0.00002188368,0.000099607496,0.00026784034,0.00011563982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028080309,0.005656653,0.52589184,0.0010565455,0.0025586048,0.10199968,0.0051748054,0.00024532533,0.20463005,0.02163917,0.085123695,0.017943332],"study_design_scores_gemma":[0.018370043,0.015347149,0.8338914,0.00008014387,0.0023774926,0.0026882975,0.00018640875,0.000102663966,0.07562758,0.00030821003,0.050406333,0.0006143064],"about_ca_topic_score_codex":0.000042515352,"about_ca_topic_score_gemma":0.000009076963,"teacher_disagreement_score":0.3131661,"about_ca_system_score_codex":0.000069504735,"about_ca_system_score_gemma":0.00032145646,"threshold_uncertainty_score":0.72809553},"labels":[],"label_agreement":null},{"id":"W4413425763","doi":"10.1097/ju.0000000000004746","title":"Incidence of Local Treatment and Metastasis During Active Surveillance for Patients With a Small Renal Mass in a National Multicenter Prospective Cohort","year":2025,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier universitaire de Québec; Sunnybrook Health Science Centre; University of Alberta; University of Calgary; Alberta University of the Arts; Queen Elizabeth II Health Sciences Centre; University of Manitoba; Juravinski Cancer Centre; University of Ottawa; McGill University Health Centre; McMaster University; Alberta Health Services; Dalhousie University; Windsor Regional Hospital; Health Sciences Centre; University Health Network; Ottawa Hospital","funders":"","keywords":"Medicine; Incidence (geometry); Prospective cohort study; Cohort; Distant metastasis; Renal mass; Metastasis; Oncology; Internal medicine; Kidney; Cancer; Nephrectomy","score_opus":0.011349612314329556,"score_gpt":0.25389565191921637,"score_spread":0.24254603960488683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413425763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973664,0.00026430542,0.0012052521,0.0003770683,0.000023282473,0.0006679425,0.000013969462,0.0000014579308,0.000080309765],"genre_scores_gemma":[0.9990197,0.000055571796,0.0008060542,0.00004420929,0.000013661183,0.000025681422,0.0000023324887,0.00000555277,0.000027245664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992492,0.00011559273,0.00027288412,0.00010108699,0.0001431638,0.000118072625],"domain_scores_gemma":[0.9988825,0.00036067152,0.00023815967,0.00007306933,0.00041238335,0.000033239397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027765598,0.00009865558,0.000334641,0.00014903433,0.000026519901,0.0000020843156,0.00004869242,0.000032551678,0.0000035393944],"category_scores_gemma":[0.000082034414,0.00005281713,0.000047748752,0.00009781594,0.0001261603,0.000033111468,0.000017567429,0.000101079226,1.3381494e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023912916,0.0003404347,0.9718385,0.00003167619,0.0007908387,0.000024661913,0.00040297155,0.0002920547,0.0014344369,0.00002553432,0.0000027996157,0.0009032107],"study_design_scores_gemma":[0.008767525,0.0036087167,0.9779058,0.00004155313,0.0003115574,0.00007532153,0.00009152553,0.000117998985,0.0089020515,0.00013172101,0.000011930082,0.000034300447],"about_ca_topic_score_codex":0.00004527166,"about_ca_topic_score_gemma":0.00017447324,"teacher_disagreement_score":0.015145391,"about_ca_system_score_codex":0.000332069,"about_ca_system_score_gemma":0.00015099147,"threshold_uncertainty_score":0.215382},"labels":[],"label_agreement":null},{"id":"W4413734039","doi":"10.1016/j.euo.2025.07.011","title":"Urine Glycosaminoglycan Scores for Surveillance of Recurrence in Intermediate- and High-risk Nonmetastatic Clear Cell Renal Cell Carcinoma—An Observational Prospective Multicentre Diagnostic Test Cohort Study","year":2025,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre","funders":"NIHR Cambridge Biomedical Research Centre; Medical Research Council; Lunds Universitet; European Commission; Horizon 2020; National Institute for Health and Care Research; Cancer Research UK; Scottish Government","keywords":"Medicine; Renal cell carcinoma; Observational study; Internal medicine; Urine; Prospective cohort study; Cohort study; Oncology; Cohort","score_opus":0.02074644367003278,"score_gpt":0.2816981245404117,"score_spread":0.26095168087037895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413734039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945066,0.00047217894,0.000110252084,0.00020907856,0.00026527117,0.0033060699,0.000121066565,0.000028763412,0.0009807391],"genre_scores_gemma":[0.9977883,0.00011074876,0.0012135293,0.000195116,0.00008183947,0.00020145763,0.00016616013,0.000040464012,0.00020237359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99665475,0.0011473185,0.0007714135,0.0008315168,0.00017221976,0.00042277752],"domain_scores_gemma":[0.99390155,0.0048664473,0.00040162104,0.0004389523,0.00024186996,0.0001495671],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010035753,0.00031716327,0.0008385177,0.00030106926,0.00008048375,0.000009265493,0.00021468374,0.00009113116,0.000026988339],"category_scores_gemma":[0.0022417593,0.000286459,0.00006773117,0.00027207955,0.0003965916,0.000060606326,0.00019061968,0.00041482828,0.000012589339],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025276297,0.003942033,0.9889541,0.00015625132,0.00008281318,0.0006268045,0.00096211856,0.00009864655,0.00079750345,0.000023025188,0.00014178647,0.0016872704],"study_design_scores_gemma":[0.012117385,0.019616874,0.965746,0.000023125105,0.00042322505,0.000025987816,0.0002751116,0.000735368,0.0006793994,0.000058385835,0.00012856643,0.00017060345],"about_ca_topic_score_codex":0.00034965502,"about_ca_topic_score_gemma":0.0012337138,"teacher_disagreement_score":0.02320815,"about_ca_system_score_codex":0.0002431852,"about_ca_system_score_gemma":0.000275708,"threshold_uncertainty_score":0.99995875},"labels":[],"label_agreement":null},{"id":"W4413825040","doi":"10.1093/oncolo/oyaf248.043","title":"IUC24358-87 Prognostic assessment of the Meet-URO score compared with the IMDC score in metastatic renal cell carcinoma (mRCC) receiving first-line systemic therapies (Meet-URO 33 study)","year":2025,"lang":"en","type":"article","venue":"The Oncologist","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Oncology; Urology","score_opus":0.05024075417160601,"score_gpt":0.3132272801309929,"score_spread":0.2629865259593869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413825040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98069954,0.0022107025,0.000106448664,0.005116547,0.00024248913,0.0066211997,0.000028414222,0.00006388053,0.0049107964],"genre_scores_gemma":[0.9973689,0.00006313172,0.00027316218,0.00034771688,0.000073838026,0.00085235504,0.00001562655,0.000052532276,0.00095273595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99560964,0.0013366032,0.000947974,0.000636638,0.0008807075,0.0005884272],"domain_scores_gemma":[0.99530864,0.0020654579,0.0006712872,0.0015935184,0.0002706083,0.00009049032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001742261,0.00055926153,0.001152583,0.00019047024,0.0004604811,0.000073461364,0.0009583023,0.00008917683,0.000034009736],"category_scores_gemma":[0.00021254916,0.00023406494,0.00023491746,0.0011814067,0.000803485,0.00007570808,0.00037618796,0.0006084073,0.000004236755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011462107,0.002442014,0.9815224,0.0009503639,0.0007163979,0.00040491208,0.004926441,0.0032604232,0.0028097723,0.0002919193,0.0010286764,0.0005004899],"study_design_scores_gemma":[0.006568653,0.003681222,0.97109866,0.0016523497,0.0019822766,0.00013161745,0.011102392,0.0010917991,0.0021417593,0.000100895435,0.00017855833,0.0002698272],"about_ca_topic_score_codex":0.0014648322,"about_ca_topic_score_gemma":0.0067655467,"teacher_disagreement_score":0.01666938,"about_ca_system_score_codex":0.00096443505,"about_ca_system_score_gemma":0.0010175654,"threshold_uncertainty_score":0.9544891},"labels":[],"label_agreement":null},{"id":"W4413877512","doi":"10.1007/s00345-025-05892-y","title":"The effect of chronic kidney disease on adverse in-hospital outcomes after partial nephrectomy","year":2025,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Nephrology; Nephrectomy; Kidney disease; Adverse effect; Internal medicine; Disease; Urology; Kidney; Intensive care medicine","score_opus":0.004048475675712733,"score_gpt":0.25335373426216046,"score_spread":0.24930525858644773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413877512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816775,0.0033000873,0.000005212934,0.012969039,0.00084277056,0.00036747236,0.000002447955,0.0000044712815,0.0008310011],"genre_scores_gemma":[0.99823976,0.00009446882,0.0000104870205,0.0007717756,0.00013443442,0.000032341788,0.0000011626009,0.000009566715,0.00070602744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987707,0.0002167691,0.00045386472,0.00012293784,0.00020222085,0.00023348676],"domain_scores_gemma":[0.99879307,0.00052306236,0.00019964715,0.00024796213,0.000047539004,0.00018871808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003153677,0.00014922986,0.00045727097,0.00030694433,0.000028329647,0.000003972313,0.000116071526,0.000033424647,0.00009193156],"category_scores_gemma":[0.00030786617,0.00007986937,0.00029856246,0.00019238664,0.0001336797,0.000031124328,0.00003820724,0.00033587392,0.000012897845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012760071,0.00029025928,0.9773047,0.0000646762,0.00031091005,0.0019042926,0.000029222772,0.00007842006,0.00009604299,0.00015063654,0.002031658,0.004979113],"study_design_scores_gemma":[0.007759974,0.005825519,0.93067706,0.00013969206,0.0006025998,0.0000308111,0.000004399958,0.000042962998,0.0010054273,0.00009534731,0.053750213,0.00006599972],"about_ca_topic_score_codex":0.0000070854558,"about_ca_topic_score_gemma":0.000036607296,"teacher_disagreement_score":0.051718555,"about_ca_system_score_codex":0.00020714113,"about_ca_system_score_gemma":0.00025436058,"threshold_uncertainty_score":0.32569787},"labels":[],"label_agreement":null},{"id":"W4413893419","doi":"10.1016/j.jaad.2025.05.198","title":"61055 False positive PET scan of hereditary leiomyomatosis and renal cell cancer suggesting cutaneous metastasis","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Leiomyomatosis; Metastasis; Cancer; Pathology; Dermatology; Oncology; Internal medicine; Leiomyoma","score_opus":0.012845449835227923,"score_gpt":0.2983851670984343,"score_spread":0.28553971726320637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413893419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97614783,0.005453605,0.000029026678,0.017574705,0.000082082624,0.00018045129,0.00003563399,0.000005638849,0.00049103657],"genre_scores_gemma":[0.99567884,0.00085971155,0.0023926578,0.0009166403,0.000044647702,0.0000037494945,8.2477e-7,0.000016342232,0.00008656541],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980884,0.00029120233,0.0008603533,0.00017416204,0.00033243583,0.0002534478],"domain_scores_gemma":[0.9974154,0.00047348771,0.0016746985,0.00014517225,0.00015989179,0.00013130107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014549604,0.00020518817,0.001195113,0.00033826838,0.00005981648,0.0000044470603,0.0002559057,0.000061240025,0.000013868965],"category_scores_gemma":[0.00010588437,0.00013569585,0.00030110165,0.0004601026,0.00075738516,0.000059112757,0.00013586508,0.0004917297,5.1220474e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003710125,0.00070445484,0.5166157,0.0011386778,0.0045756353,0.0034424146,0.0009658045,0.00023218294,0.4287508,0.00022208205,0.0110853445,0.028556772],"study_design_scores_gemma":[0.0019236634,0.0005741873,0.17019682,0.000929578,0.0028265498,0.06594602,0.00091384986,0.00011029627,0.7556455,0.00028058625,0.00048530247,0.00016765743],"about_ca_topic_score_codex":0.0002816313,"about_ca_topic_score_gemma":0.000004893392,"teacher_disagreement_score":0.3464189,"about_ca_system_score_codex":0.0001286814,"about_ca_system_score_gemma":0.00026831147,"threshold_uncertainty_score":0.55335164},"labels":[],"label_agreement":null},{"id":"W4413901981","doi":"10.1002/mp.18070","title":"Radiomics‐based kidney lesion classification: Mitigating batch effect with nested combat harmonization","year":2025,"lang":"en","type":"article","venue":"Medical Physics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Université Laval; Centre hospitalier universitaire de Québec","funders":"Natural Sciences and Engineering Research Council of Canada; National Cancer Institute; Fonds de Recherche du Québec - Santé; Institut de Valorisation des Données","keywords":"Radiomics; Harmonization; Artificial intelligence; Machine learning; Computer science; Feature selection; Feature (linguistics); Medical imaging; Medical physics; Pattern recognition (psychology); Radiology; Medicine","score_opus":0.024612140157153187,"score_gpt":0.2844214846459707,"score_spread":0.25980934448881754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413901981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8838135,0.00018548573,0.09222868,0.016378611,0.00029192062,0.0011277987,0.0000050632193,0.00023541812,0.005733539],"genre_scores_gemma":[0.9949003,0.000009901319,0.0007881678,0.003211023,0.00021307288,0.0000677054,0.000448547,0.000028529108,0.0003327882],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983467,0.00011883576,0.00026986183,0.0003421067,0.0006991087,0.00022341213],"domain_scores_gemma":[0.99871933,0.00029192082,0.00009432568,0.00038275737,0.00014037624,0.00037131427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023788182,0.00021090139,0.00037129942,0.000060231316,0.00012156846,0.000023994495,0.000107579996,0.00013764457,0.00006051473],"category_scores_gemma":[0.00036837527,0.00014955856,0.000086870816,0.00058994594,0.00016038962,0.000053715543,0.000026995973,0.0002966786,0.00003064227],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018769176,0.0019682434,0.666457,0.0028997099,0.0005875148,0.0005904305,0.00034099733,0.00012069438,0.040769015,0.0025463887,0.024429567,0.25741354],"study_design_scores_gemma":[0.020815749,0.002115947,0.24689059,0.0046904357,0.0012676697,0.00006100154,0.00005959629,0.08668447,0.63384765,0.00056839717,0.0024277994,0.0005706737],"about_ca_topic_score_codex":0.000022214546,"about_ca_topic_score_gemma":0.000001295768,"teacher_disagreement_score":0.5930787,"about_ca_system_score_codex":0.00024214681,"about_ca_system_score_gemma":0.0006747432,"threshold_uncertainty_score":0.6098821},"labels":[],"label_agreement":null},{"id":"W4413927220","doi":"10.1016/j.ijrobp.2025.08.043","title":"Efficacy of SABR in Uncommon Subtypes of Primary Kidney Cancer: An Analysis From the International Radiosurgery Oncology Consortium of the Kidney","year":2025,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Ottawa Hospital; University of Ottawa; Sunnybrook Health Science Centre; McGill University Health Centre; Juravinski Cancer Centre; McMaster University; London Health Sciences Centre","funders":"","keywords":"SABR volatility model; Ablative case; Radiosurgery; Medicine; Kidney cancer; Radiation oncology; Radiation therapy; Cancer; Radiology; Oncology; Internal medicine","score_opus":0.021364118168137766,"score_gpt":0.32634136115193035,"score_spread":0.3049772429837926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413927220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822968,0.00087173114,0.00053083524,0.012172126,0.0023468914,0.000296626,0.00035160102,0.000007728976,0.0011256181],"genre_scores_gemma":[0.9952768,0.0008626589,0.00067853776,0.0022731957,0.0005578794,0.000013077842,0.0002767404,0.000014036432,0.000047090212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969198,0.0006197282,0.0015642752,0.00025493084,0.0004676538,0.00017362254],"domain_scores_gemma":[0.99421704,0.0018192648,0.0024322846,0.00036919,0.001037406,0.0001248459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093930983,0.0002073156,0.0010747997,0.00044289432,0.00003634347,0.000008700294,0.0008674281,0.0002493656,0.00011809734],"category_scores_gemma":[0.0011302762,0.00013691482,0.00060516264,0.00065380614,0.00049640593,0.00014240076,0.00014548225,0.0004815801,0.0000011029102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002012195,0.0012590009,0.9338396,0.000017223467,0.0044989022,0.000016713642,0.0005427562,0.0017082632,0.023800636,0.0017873923,0.0015520508,0.028965222],"study_design_scores_gemma":[0.006952375,0.00056761166,0.9499726,0.00022345997,0.0015277453,0.000021860256,0.00014026741,0.0012944211,0.029703148,0.0015867722,0.007906608,0.00010307782],"about_ca_topic_score_codex":0.0010624601,"about_ca_topic_score_gemma":0.00015078062,"teacher_disagreement_score":0.028862145,"about_ca_system_score_codex":0.0015915633,"about_ca_system_score_gemma":0.0036301212,"threshold_uncertainty_score":0.6439679},"labels":[],"label_agreement":null},{"id":"W4414089879","doi":"10.1016/j.clgc.2025.102431","title":"CABOSEQ 3—Comparison of Cabozantinib versus Sunitinib Following First-Line Nivolumab- Ipilimumab for Metastatic Renal Cell Carcinoma: A Target Trial Emulation Using Real-World Data from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)","year":2025,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Therapure Biopharma (Canada); Institute of Cancer Research; Alberta Cancer Foundation; University of Calgary","funders":"Ipsen; Ipsen Biopharmaceuticals","keywords":"Cabozantinib; Sunitinib; Ipilimumab; Renal cell carcinoma; Metastatic melanoma; Emulation; Clinical trial; Expanded access","score_opus":0.282927175586458,"score_gpt":0.4596656794035395,"score_spread":0.17673850381708145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414089879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98170227,0.0029675774,0.0016088585,0.0010645774,0.004548511,0.0031633147,0.0041032447,0.000055162767,0.00078648364],"genre_scores_gemma":[0.97449976,0.00016148856,0.01580146,0.00023530787,0.0018765361,0.00025093,0.006018089,0.000097195116,0.0010592366],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99317193,0.00067999813,0.002926488,0.0014940314,0.0010031189,0.0007244122],"domain_scores_gemma":[0.9893657,0.0061974325,0.001413587,0.0021881715,0.0005005235,0.0003346063],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016750976,0.00066835905,0.0018951303,0.00034983858,0.0003859441,0.00008427022,0.001146643,0.0001428711,0.00029245802],"category_scores_gemma":[0.0009569871,0.0005459688,0.0008777134,0.00070662954,0.00038437668,0.0003440633,0.0008191393,0.0008041058,0.000010453665],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45761737,0.0118574435,0.44419536,0.0015763019,0.0062000365,0.0016225144,0.0010312065,0.007039432,0.01587902,0.00008181293,0.047375288,0.0055241887],"study_design_scores_gemma":[0.49348447,0.010871439,0.13805182,0.0013055997,0.030407295,0.000021840435,0.0026278975,0.2281887,0.06786024,0.00031210567,0.02478241,0.002086185],"about_ca_topic_score_codex":0.008154854,"about_ca_topic_score_gemma":0.0037522507,"teacher_disagreement_score":0.30614355,"about_ca_system_score_codex":0.00052238646,"about_ca_system_score_gemma":0.002219186,"threshold_uncertainty_score":0.9996992},"labels":[],"label_agreement":null},{"id":"W4414297945","doi":"10.3390/curroncol32090515","title":"Renal Cell Carcinoma: Prognosis in the Era of Targeted Therapy","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Renal cell carcinoma; Targeted therapy; Cohort; Poisson regression; Disease; Tyrosine-kinase inhibitor; Clear cell renal cell carcinoma; Temsirolimus; Drug; Nivolumab","score_opus":0.07427151692676587,"score_gpt":0.3635102164317516,"score_spread":0.2892386995049857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414297945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9710779,0.015976695,0.000016046586,0.0024523311,0.000391334,0.0009815592,0.0000048654033,0.000014354793,0.009084891],"genre_scores_gemma":[0.9987628,0.00041100464,0.00016720232,0.00021157127,0.00007340054,0.0002227094,0.000036011606,0.000008324077,0.00010700494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987307,0.0002401575,0.00035989264,0.00024540807,0.00018044327,0.00024339648],"domain_scores_gemma":[0.99926645,0.00020281674,0.000104982704,0.00028314273,0.0000994667,0.000043160202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028622992,0.00015156654,0.00039586416,0.00015001948,0.00003193939,0.0000043693817,0.00016773182,0.00010025083,0.0000739619],"category_scores_gemma":[0.000033131124,0.000092725815,0.00013321491,0.00042963756,0.000113954644,0.00002001957,0.00003802634,0.00041047172,0.000010427166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008528778,0.0048548733,0.8334362,0.00024564622,0.000059253856,0.00017069692,0.002099783,0.0000036323418,0.012896483,0.00033721083,0.009625334,0.13541803],"study_design_scores_gemma":[0.0055680443,0.0022351395,0.8788282,0.00008629945,0.00012372453,0.000026383286,0.00034261815,0.000055739325,0.07359854,0.00016379033,0.03887852,0.00009298785],"about_ca_topic_score_codex":0.000053104395,"about_ca_topic_score_gemma":0.000020036177,"teacher_disagreement_score":0.13532504,"about_ca_system_score_codex":0.00021829458,"about_ca_system_score_gemma":0.00040203362,"threshold_uncertainty_score":0.3781249},"labels":[],"label_agreement":null},{"id":"W4414399038","doi":"10.1016/j.mpsur.2025.07.013","title":"Pathology of tumours of the kidney and urinary tract","year":2025,"lang":"en","type":"article","venue":"Surgery (Oxford)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Urinary system; Kidney; Renal cell carcinoma; Kidney cancer; Carcinoma; Clear cell; Clear cell renal cell carcinoma","score_opus":0.017261877542768086,"score_gpt":0.254096290364998,"score_spread":0.2368344128222299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414399038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98633325,0.001401073,0.000003559124,0.001609086,0.00023540905,0.00019258368,0.000013497505,0.000010028909,0.010201515],"genre_scores_gemma":[0.9979328,0.00022016974,0.000043967277,0.00033573073,0.000017988186,0.00000963105,0.0000064412457,0.00000822068,0.0014250344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992438,0.00006950779,0.00027808404,0.00014637897,0.000121276884,0.00014093333],"domain_scores_gemma":[0.9991861,0.00026780006,0.00010992345,0.00031765085,0.000051134924,0.00006740712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022429669,0.000099178025,0.00037986337,0.00012233273,0.000025168,0.0000017101037,0.000049117614,0.00006040956,0.0000425152],"category_scores_gemma":[0.00021283411,0.000062954816,0.0001692729,0.00018928808,0.00015412686,0.000021550726,0.000053800417,0.00009341776,6.2739576e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015614489,0.0003488833,0.98801607,0.00029726376,0.000039785147,0.00017771167,0.00007832645,4.1480627e-7,0.005156429,0.0002130433,0.0024211039,0.003094841],"study_design_scores_gemma":[0.00035790002,0.00014793714,0.9544979,0.00022357116,0.0001354491,0.0002807648,0.000065213,0.0000034931616,0.039835528,0.00025407263,0.0041546198,0.00004356846],"about_ca_topic_score_codex":0.000020532698,"about_ca_topic_score_gemma":8.0154376e-7,"teacher_disagreement_score":0.0346791,"about_ca_system_score_codex":0.000025170137,"about_ca_system_score_gemma":0.00024913202,"threshold_uncertainty_score":0.25672227},"labels":[],"label_agreement":null},{"id":"W4414460385","doi":"10.1097/ju.0000000000004777","title":"Reply by Authors","year":2025,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Sunnybrook Health Science Centre; University of Alberta; Alberta University of the Arts; Queen Elizabeth II Health Sciences Centre; University of Manitoba; Juravinski Cancer Centre; University of Ottawa; McGill University Health Centre; McMaster University; Alberta Health Services; Dalhousie University; Windsor Regional Hospital; Health Sciences Centre; University Health Network; Ottawa Hospital","funders":"","keywords":"","score_opus":0.014070607565347054,"score_gpt":0.27861188847513835,"score_spread":0.2645412809097913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414460385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91774243,0.00613613,0.00045421926,0.0645202,0.0003627923,0.00008881227,6.2880974e-7,0.0000066829625,0.010688089],"genre_scores_gemma":[0.98802024,0.0001863701,0.00009890578,0.0067901807,0.00007393069,5.82901e-7,5.13307e-7,0.000004814192,0.004824432],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99934673,0.00013682217,0.00024850594,0.00004685591,0.00010863648,0.00011244613],"domain_scores_gemma":[0.99938124,0.00016549956,0.00013607765,0.0001815489,0.00008322653,0.00005243209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052645913,0.000059637496,0.00019669278,0.00008045824,0.000032384774,0.0000025033485,0.000105230036,0.000042554086,0.00007828746],"category_scores_gemma":[0.00011439,0.000030969517,0.00007614819,0.000093719915,0.00006979353,0.000015380545,0.00002323939,0.00026192682,0.000015446698],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057316315,0.0004188874,0.024088735,0.000041008105,0.0010528889,0.0007357661,0.00073311327,0.000064805674,0.08026912,0.0010359315,0.87100846,0.014819666],"study_design_scores_gemma":[0.00546597,0.007084944,0.11919211,0.000053516236,0.0025811684,0.009103419,0.0002559516,0.000102907565,0.03643293,0.005257882,0.81434584,0.00012337645],"about_ca_topic_score_codex":0.0000139649765,"about_ca_topic_score_gemma":7.1118194e-7,"teacher_disagreement_score":0.095103376,"about_ca_system_score_codex":0.00004349654,"about_ca_system_score_gemma":0.000090708956,"threshold_uncertainty_score":0.12629002},"labels":[],"label_agreement":null},{"id":"W4414517552","doi":"10.1016/j.euf.2025.08.007","title":"Cancer-specific Mortality After Radical Nephrectomy and Thrombectomy for Renal Cell Carcinoma with Tumor Thrombus According to Histological Subtypes","year":2025,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Renal cell carcinoma; Nephrectomy; Papillary renal cell carcinomas; Thrombus; Adjuvant therapy; Renal tumor","score_opus":0.021099865617794217,"score_gpt":0.26350516595733764,"score_spread":0.2424053003395434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414517552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97744036,0.006182793,0.00087412936,0.0018935943,0.00020516278,0.0011156424,0.000022660568,0.000108037486,0.0121576255],"genre_scores_gemma":[0.995603,0.000036044436,0.0019163213,0.0015734608,0.00021831566,0.00016170114,0.000013113892,0.000056701454,0.00042130213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773914,0.00025601932,0.00036799454,0.0008841389,0.00018602476,0.00056665915],"domain_scores_gemma":[0.9988321,0.00019099562,0.000096953525,0.0004965711,0.00009546315,0.00028788298],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028253306,0.00037351556,0.00065328984,0.00018473632,0.00014457261,0.000031585874,0.00016917258,0.00008480494,0.00011050875],"category_scores_gemma":[0.00004306227,0.000269364,0.00013034392,0.000251352,0.00036168733,0.00004872481,0.00012986852,0.00033122653,0.000036281454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064761564,0.0003196885,0.96720576,0.00013446562,0.00025518372,0.003984422,0.00028174077,0.000012010205,0.011848145,0.00027560984,0.0039002986,0.0053065326],"study_design_scores_gemma":[0.0038181453,0.002373695,0.94659567,0.000035927762,0.00056229485,0.00022008413,0.000042084543,0.000017029717,0.009615306,0.00007203404,0.03638283,0.00026490955],"about_ca_topic_score_codex":0.00009884043,"about_ca_topic_score_gemma":0.00006704019,"teacher_disagreement_score":0.032482535,"about_ca_system_score_codex":0.00018917416,"about_ca_system_score_gemma":0.00013233967,"threshold_uncertainty_score":0.99997586},"labels":[],"label_agreement":null},{"id":"W4414524711","doi":"10.1002/bco2.70080","title":"AI‐driven preoperative risk assessment in kidney cancer surgery: A comparative feasibility study of machine learning models","year":2025,"lang":"en","type":"article","venue":"BJUI Compass","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Kidney cancer; Risk assessment; Risk stratification; Kidney disease; Cancer; Renal cell carcinoma","score_opus":0.09627797162637906,"score_gpt":0.38017196455975083,"score_spread":0.28389399293337175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414524711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99269134,0.0004316202,0.00059590366,0.0007586392,0.00011127981,0.0023949516,0.00006244763,0.000044503417,0.0029092897],"genre_scores_gemma":[0.9986035,0.00004706642,0.00030049586,0.00016237365,0.000018745463,0.00038079981,0.000056048248,0.000015197502,0.00041575334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971977,0.00090243184,0.00066015177,0.0005403838,0.00041590066,0.00028343455],"domain_scores_gemma":[0.9984506,0.00038616662,0.000239038,0.00044144696,0.0003216262,0.00016115516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000495915,0.0002934665,0.0011918667,0.00030266968,0.000103795304,0.000021582464,0.00011622226,0.0000627156,0.00008780387],"category_scores_gemma":[0.00008222822,0.00023639636,0.00014662676,0.00057115086,0.00007691411,0.000121269106,0.00012945734,0.00065191,0.0000029646487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007364527,0.0038190389,0.96029115,0.00013668307,0.00047582993,0.000040338542,0.0038333596,0.029259223,0.00024204714,0.000102829734,0.00091213005,0.00015093181],"study_design_scores_gemma":[0.004214457,0.0007044091,0.82372373,0.00038775805,0.0003003124,0.0000019724735,0.0017298842,0.16764764,0.0009402955,0.00013577985,0.00006331683,0.00015041215],"about_ca_topic_score_codex":0.0089124385,"about_ca_topic_score_gemma":0.0034671857,"teacher_disagreement_score":0.13838843,"about_ca_system_score_codex":0.000841725,"about_ca_system_score_gemma":0.0008483459,"threshold_uncertainty_score":0.9976873},"labels":[],"label_agreement":null},{"id":"W4414574447","doi":"10.1016/j.ijrobp.2025.06.1177","title":"Stereotactic Body Radiation Therapy (SBRT) for Renal Tumors: A Prospective Phase II Study","year":2025,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre; BC Cancer Agency; University Health Network; University of Toronto; St. Michael's Hospital; Western University","funders":"AstraZeneca","keywords":"Clinical endpoint; Kidney disease; Kidney; Prospective cohort study; Radiation therapy; Kidney cancer; Nephrotoxicity; Nephrology; SABR volatility model","score_opus":0.026789396787346216,"score_gpt":0.3732751352888498,"score_spread":0.3464857385015036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414574447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855441,0.0009124473,0.006218823,0.0028170703,0.0017800217,0.0018684224,0.00005304812,0.000047305002,0.00075875275],"genre_scores_gemma":[0.99546146,0.00024670496,0.0008679357,0.0008116153,0.0019907246,0.00016221602,0.00011775102,0.000032123615,0.0003094897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773085,0.00026475327,0.0010114998,0.00036758182,0.00035487895,0.00027045177],"domain_scores_gemma":[0.99653125,0.00053393125,0.0012066083,0.00022673959,0.0013731564,0.00012829636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006946377,0.00029207114,0.00070329045,0.00040107392,0.0001683753,0.000042115986,0.0003239038,0.00017745793,0.000049568873],"category_scores_gemma":[0.00041401575,0.00023928015,0.00036813584,0.00029290415,0.00010922957,0.00031062323,0.000058524354,0.0004293556,0.000010854585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014028812,0.016218,0.57034445,0.000024438792,0.0069475924,0.00022148353,0.0029043374,0.00014054596,0.020379942,0.008488512,0.0031522573,0.35714963],"study_design_scores_gemma":[0.20802866,0.118450806,0.5073993,0.0003284484,0.0021348235,0.0007488914,0.0009010037,0.00509051,0.05553412,0.032691903,0.06781113,0.00088036165],"about_ca_topic_score_codex":0.000017003,"about_ca_topic_score_gemma":0.0000028401114,"teacher_disagreement_score":0.35626927,"about_ca_system_score_codex":0.0021488834,"about_ca_system_score_gemma":0.0011405871,"threshold_uncertainty_score":0.97575617},"labels":[],"label_agreement":null},{"id":"W4414789265","doi":"10.1177/10668969251379897","title":"<i>TFEB</i> -Amplified Renal Cell Carcinoma: Integrating Histopathologic and Molecular Diagnostics with Therapeutic Implications","year":2025,"lang":"en","type":"article","venue":"International Journal of Surgical Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Renal cell carcinoma; Nephrectomy; Eosinophilic; Kidney; PAX8; Immunohistochemistry; Clear cell; Histology","score_opus":0.01599051533973918,"score_gpt":0.2794654625830981,"score_spread":0.26347494724335896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414789265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692473,0.0046210326,0.010002028,0.00716425,0.00024872235,0.0001737977,0.000009486727,0.000014546263,0.008518874],"genre_scores_gemma":[0.99490213,0.00043122625,0.0032334924,0.0010975733,0.00009609416,0.000013856633,0.000014249339,0.000013456316,0.00019789429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986526,0.000117791875,0.00052247744,0.00023584529,0.00028697576,0.00018432218],"domain_scores_gemma":[0.9983529,0.0004182752,0.00029487794,0.00017695232,0.0006363423,0.00012065482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026895138,0.00018110021,0.00039201084,0.00029201354,0.00004907617,0.000027556229,0.0001968722,0.00011361509,0.000027875987],"category_scores_gemma":[0.00009187228,0.000121732184,0.00013778597,0.00014203963,0.0002194474,0.00005684402,0.00007369835,0.00040019286,0.0000033055398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003820306,0.0020050807,0.5677934,0.00010463646,0.0005802521,0.08544748,0.0005830771,0.00010880308,0.26181346,0.044218104,0.0013120859,0.032213274],"study_design_scores_gemma":[0.019460732,0.0057098763,0.7687196,0.0005134424,0.0015413252,0.09434909,0.00044899696,0.00010042685,0.06737586,0.015558641,0.025595605,0.0006264256],"about_ca_topic_score_codex":0.000007520596,"about_ca_topic_score_gemma":0.000002074477,"teacher_disagreement_score":0.20092614,"about_ca_system_score_codex":0.00019269824,"about_ca_system_score_gemma":0.0001921951,"threshold_uncertainty_score":0.49640945},"labels":[],"label_agreement":null},{"id":"W4414850590","doi":"10.1097/ju9.0000000000000358","title":"Renal Cancer in Hereditary Leiomyomatosis and Renal Cell Cancer: A Scoping Review of Epidemiology, Clinical Features, Management, and Outcomes","year":2025,"lang":"en","type":"article","venue":"JU Open Plus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Leiomyomatosis; Renal cell carcinoma; Observational study; Kidney cancer; Nephrectomy; Cancer; Hereditary Cancer; Cancer syndrome; Clear cell renal cell carcinoma","score_opus":0.07883434779249898,"score_gpt":0.4384181058966275,"score_spread":0.3595837581041285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414850590","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22118096,0.7410837,0.000017878829,0.012561651,0.00033589886,0.0046347096,0.000058427973,0.000020889709,0.020105898],"genre_scores_gemma":[0.15073635,0.8176551,0.0057238215,0.012918559,0.00013380934,0.0010538757,0.00006656952,0.00004100904,0.011670939],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979075,0.00028450455,0.00090160256,0.00051531976,0.00012592816,0.0002651192],"domain_scores_gemma":[0.99873036,0.00048152817,0.00024445236,0.00037071458,0.000044110908,0.0001288135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012557235,0.00020827111,0.0013746972,0.00012630109,0.00004267753,0.000011289445,0.00017732597,0.00011402019,0.000095050724],"category_scores_gemma":[0.00015791133,0.00015313637,0.0001049286,0.00022654142,0.00014826862,0.00007778599,0.00048165183,0.0002460913,0.0000014218859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052263413,0.00013937094,0.8838726,0.030715652,0.0004706977,0.00026122716,0.00004875764,0.000008393644,0.000032517037,0.0001744706,0.043592576,0.040161062],"study_design_scores_gemma":[0.0056917504,0.00020956373,0.85076624,0.13857251,0.00082392123,0.000031279542,0.000047264242,0.00004373371,0.0003235437,0.0001088993,0.0031914564,0.00018983049],"about_ca_topic_score_codex":0.004368991,"about_ca_topic_score_gemma":0.0016953325,"teacher_disagreement_score":0.10785687,"about_ca_system_score_codex":0.00017644095,"about_ca_system_score_gemma":0.00030843477,"threshold_uncertainty_score":0.6604637},"labels":[],"label_agreement":null},{"id":"W4414992798","doi":"10.1093/oncolo/oyaf276.051","title":"50Clinical characteristics, determinants and subsequent therapy of primary refractory metastatic renal cell carcinoma (mRCC): an international metastatic database consortium (IMDC) study","year":2025,"lang":"en","type":"article","venue":"The Oncologist","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; BC Cancer Foundation; BC Cancer Agency","funders":"","keywords":"Refractory (planetary science); Renal cell carcinoma; Logistic regression; Population; Primary tumor; Carcinoma; Overall survival","score_opus":0.0949413080994492,"score_gpt":0.3741196405361676,"score_spread":0.2791783324367184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414992798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99547786,0.0007001728,0.000046926307,0.00040581176,0.00034645604,0.0014991951,0.00014946783,0.00002820838,0.0013459019],"genre_scores_gemma":[0.9969274,0.0004502086,0.0009858485,0.0005957818,0.00006951975,0.00011222765,0.00017112067,0.000022794244,0.0006651305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99730057,0.00061730016,0.0008964645,0.00049118156,0.0004273274,0.00026713454],"domain_scores_gemma":[0.9975505,0.0007888278,0.00045078696,0.0008666112,0.00019409572,0.0001491746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00125185,0.00028771666,0.0008313714,0.00015390481,0.00010499781,0.00003370568,0.00035445404,0.000050022147,0.00009618904],"category_scores_gemma":[0.00024856618,0.00017903601,0.000117462856,0.0001393095,0.00059363036,0.00012938886,0.00020201574,0.00032426964,0.000008281137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007681035,0.013453184,0.8963082,0.0003406934,0.00095265923,0.0026614156,0.001219714,0.0000022731067,0.04036496,0.000109985434,0.00049759506,0.036408298],"study_design_scores_gemma":[0.0063898647,0.005090353,0.9765418,0.00006184399,0.00079057156,0.0000894725,0.00079321803,0.00014022933,0.008862062,0.00004396126,0.0010350579,0.00016156018],"about_ca_topic_score_codex":0.00037233633,"about_ca_topic_score_gemma":0.000090028916,"teacher_disagreement_score":0.08023361,"about_ca_system_score_codex":0.00030170675,"about_ca_system_score_gemma":0.00053628365,"threshold_uncertainty_score":0.7300877},"labels":[],"label_agreement":null},{"id":"W4414993075","doi":"10.1093/oncolo/oyaf276.038","title":"37Integrative multi-omic characterization of the immune landscape in renal cell carcinoma","year":2025,"lang":"en","type":"article","venue":"The Oncologist","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Mass cytometry; Immune system; Tumor microenvironment; Transcriptome; Cell; Renal cell carcinoma; Tumour heterogeneity","score_opus":0.020994979300086637,"score_gpt":0.2762426854285082,"score_spread":0.25524770612842157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414993075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855754,0.0003575228,0.000066960936,0.0029181764,0.00015905118,0.0007022783,0.000010814708,0.000012370138,0.010197459],"genre_scores_gemma":[0.99366146,0.000029337107,0.000079061225,0.00021885485,0.000026721276,0.000049693368,0.00002886326,0.000007548255,0.0058984705],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991281,0.00016577441,0.000291989,0.00015390503,0.000114887574,0.00014533591],"domain_scores_gemma":[0.9992607,0.00010538219,0.00015348637,0.00039786287,0.000063211766,0.000019344092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023334374,0.00012272922,0.00027766445,0.000070134105,0.00006118799,0.0000068640497,0.00018891807,0.00007335874,0.00004449163],"category_scores_gemma":[0.000060902614,0.000057708858,0.00010695993,0.00031263215,0.00018052745,0.000021271697,0.000088995024,0.00021658816,0.000011167242],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005524215,0.0005165328,0.21979505,0.00006324647,0.000035928835,0.000027326498,0.0009960849,0.000013594834,0.77592844,0.00024334039,0.00018773446,0.0016402921],"study_design_scores_gemma":[0.0014659017,0.00017313533,0.6855488,0.000056931767,0.00006538683,0.0000052495,0.00024778835,0.00028370196,0.3118446,0.000016286946,0.00025789434,0.000034386423],"about_ca_topic_score_codex":0.00044070763,"about_ca_topic_score_gemma":0.00018630402,"teacher_disagreement_score":0.4657537,"about_ca_system_score_codex":0.00023954462,"about_ca_system_score_gemma":0.00022102805,"threshold_uncertainty_score":0.2353299},"labels":[],"label_agreement":null},{"id":"W4415315490","doi":"10.15586/jkcvhl.v12i4.423","title":"Body Composition May Be a Novel Presurgical Risk Factor for Acute Kidney Injury among Clear Cell Renal Cell Cancer Patients Undergoing Radical Nephrectomy","year":2025,"lang":"en","type":"article","venue":"Journal of Kidney Cancer and VHL","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Institute on Minority Health and Health Disparities; National Cancer Institute; Memorial Sloan-Kettering Cancer Center","keywords":"Nephrectomy; Acute kidney injury; Renal cell carcinoma; Kidney cancer; Adipose tissue; Risk factor; Creatinine; Kidney disease; Sarcopenia","score_opus":0.012887172732508428,"score_gpt":0.2967755807128316,"score_spread":0.28388840798032317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415315490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910934,0.00073970726,0.0007087713,0.0033636624,0.00077736087,0.00071955635,0.0017389547,0.000018222645,0.00084036513],"genre_scores_gemma":[0.99145055,0.002707853,0.0013264209,0.0028962425,0.0004877936,0.00004840752,0.000052702268,0.000037801216,0.000992217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807495,0.00007152419,0.00067730324,0.00032531834,0.00047570103,0.00037520082],"domain_scores_gemma":[0.99759436,0.0001448524,0.0005313056,0.00016315946,0.0003085332,0.0012577934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001754029,0.0003016705,0.0006589402,0.00024338778,0.00018442838,0.000063928994,0.00012361044,0.00018720963,0.00017327601],"category_scores_gemma":[0.00011753942,0.00022621847,0.0003381429,0.00018585681,0.00011696412,0.00020249755,0.00005988187,0.0005390485,8.968159e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020455062,0.0022394073,0.6090538,0.0012917676,0.0026540777,0.00012102163,0.00079647463,0.00003421891,0.11838354,0.000023236029,0.24013746,0.0048099156],"study_design_scores_gemma":[0.053260837,0.007150975,0.48629564,0.003209363,0.00746295,0.000065760796,0.00006452391,0.0013358624,0.27439517,0.00006845715,0.16594681,0.0007436712],"about_ca_topic_score_codex":0.00019357508,"about_ca_topic_score_gemma":0.0000065146523,"teacher_disagreement_score":0.15601161,"about_ca_system_score_codex":0.00059331063,"about_ca_system_score_gemma":0.0018189299,"threshold_uncertainty_score":0.9224922},"labels":[],"label_agreement":null},{"id":"W4415322256","doi":"10.1016/j.annonc.2025.10.010","title":"Novel pembrolizumab-based treatments as first-line therapy in advanced clear-cell renal cell carcinoma: substudy 03A of the open-label, umbrella platform, phase I/II KEYMAKER-U03 trial","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Memorial Sloan-Kettering Cancer Center; Merck","keywords":"Clinical trial; Phase (matter); Phases of clinical research; Cell; Safety profile","score_opus":0.1515518232999306,"score_gpt":0.41865348601268293,"score_spread":0.2671016627127523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415322256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96426034,0.0017778714,0.000011705698,0.0022225883,0.00034572344,0.0041775494,0.00006499921,0.000018418352,0.027120817],"genre_scores_gemma":[0.9925734,0.00043567386,0.00041405013,0.0010694795,0.000056344245,0.00030055942,0.000064591084,0.000045482193,0.0050404514],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99687964,0.00020749809,0.0012268781,0.0006603138,0.00043902392,0.0005866583],"domain_scores_gemma":[0.9972603,0.00052374863,0.0006919006,0.001004545,0.00035117823,0.00016834046],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005344893,0.0004689571,0.0014397049,0.00034608535,0.00016983559,0.000012448518,0.0006452346,0.00033548998,0.00017084298],"category_scores_gemma":[0.00011812204,0.000329231,0.0003100837,0.00075831404,0.0002646943,0.00010572187,0.00027914724,0.00038679046,0.00001272269],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5967011,0.13818781,0.00651816,0.00036765495,0.00066796347,0.00043444984,0.0012369445,0.00044514108,0.2097019,0.0001852941,0.0035072097,0.042046383],"study_design_scores_gemma":[0.4687156,0.11358923,0.011273631,0.00014726396,0.00029777957,0.000017900054,0.00013237985,0.0001956857,0.39743716,0.000098728204,0.0078771785,0.00021745301],"about_ca_topic_score_codex":0.0010521604,"about_ca_topic_score_gemma":0.00028828968,"teacher_disagreement_score":0.18773526,"about_ca_system_score_codex":0.00033627005,"about_ca_system_score_gemma":0.0017022728,"threshold_uncertainty_score":0.99991596},"labels":[],"label_agreement":null},{"id":"W4415352518","doi":"10.1021/acs.jproteome.5c00414","title":"New Method Enhanced Extraction of Protein Signatures of Renal Cell Carcinoma from Proteomics Data","year":2025,"lang":"en","type":"article","venue":"Journal of Proteome Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; BC Cancer Agency; University of Texas MD Anderson Cancer Center; World Health Organization; Broad Institute; Georgetown University; Johns Hopkins University; Memorial Sloan-Kettering Cancer Center; Brown University; Buck Institute for Research on Aging; Purdue University; University of Southern California","keywords":"Proteomics; Renal cell carcinoma; Clear cell renal cell carcinoma; Cell; Proteome; Quantitative proteomics; Mass spectrometry; Clear cell","score_opus":0.09642634319599667,"score_gpt":0.4360218639703115,"score_spread":0.3395955207743148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415352518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92479175,0.0034648553,0.06605937,0.0009324068,0.00008843679,0.0029391614,0.0000421759,0.0000068211057,0.0016750036],"genre_scores_gemma":[0.75904536,0.000057092646,0.23853353,0.0000063826665,0.00025303726,0.000032680557,0.000018662933,0.000022738332,0.002030499],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955359,0.0007302805,0.0011899585,0.00039999586,0.0017518436,0.0003919949],"domain_scores_gemma":[0.99575734,0.00047563182,0.0008307066,0.0010788979,0.0015932067,0.00026421773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003597624,0.00021203741,0.0008362993,0.0009973054,0.00006552842,0.000027989097,0.0007658622,0.00024908374,0.0002080374],"category_scores_gemma":[0.00086125854,0.00015868424,0.00021904346,0.00089182594,0.00012265195,0.00027531644,0.0003434018,0.0015123952,0.0000048150323],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044907876,0.000487593,0.00037896793,0.0007333774,0.00023490124,0.00013949724,0.00017990598,0.00003269288,0.98418224,0.000040764186,0.0012270464,0.007872227],"study_design_scores_gemma":[0.0032352589,0.0023465194,0.010443905,0.0010592416,0.0001789335,0.000033181026,0.00023540329,0.00021106206,0.9803932,0.0013950678,0.00037540836,0.000092839204],"about_ca_topic_score_codex":0.00093310705,"about_ca_topic_score_gemma":0.000015408928,"teacher_disagreement_score":0.17247416,"about_ca_system_score_codex":0.00035400683,"about_ca_system_score_gemma":0.0030099817,"threshold_uncertainty_score":0.65706885},"labels":[],"label_agreement":null},{"id":"W4415496245","doi":"10.1016/j.suronc.2025.102306","title":"Sarcomatoid dedifferentiation as a predictor of overall mortality in surgically treated metastatic renal cell carcinoma","year":2025,"lang":"en","type":"article","venue":"Surgical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Renal cell carcinoma; Sarcomatoid carcinoma; Overall survival; Cancer; Kidney; Immunohistochemistry","score_opus":0.025240014184149954,"score_gpt":0.3146329484050399,"score_spread":0.28939293422088996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415496245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92381847,0.0006170991,0.000023232345,0.00028683635,0.00011837563,0.00073875196,0.000020423819,0.000040526153,0.07433631],"genre_scores_gemma":[0.9976157,0.000112062706,0.0002472062,0.000102629565,0.00003469922,0.0000884818,0.00017837928,0.000016500397,0.0016043428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99734837,0.00050112884,0.0009140683,0.0004607231,0.0003754147,0.0004003011],"domain_scores_gemma":[0.99849457,0.0005615098,0.00021878922,0.0003807205,0.00014268825,0.00020170603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037937515,0.0002675651,0.0011144378,0.00034698256,0.000030394762,0.0000073222545,0.00012131593,0.00023056482,0.00058237265],"category_scores_gemma":[0.000065558794,0.00020785558,0.00028924877,0.00044855286,0.00015867325,0.000050750765,0.000084723644,0.00030008703,0.000025019513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054024193,0.004606025,0.9590078,0.00047271,0.00037705104,0.007799695,0.0001925896,0.00003057931,0.013178135,0.0026516214,0.0002220174,0.006059374],"study_design_scores_gemma":[0.012794941,0.0023672474,0.945073,0.0000936336,0.0005808245,0.00019296189,0.00003492039,0.00039693163,0.028872814,0.000989935,0.008433574,0.0001692044],"about_ca_topic_score_codex":0.0008809978,"about_ca_topic_score_gemma":0.00016882639,"teacher_disagreement_score":0.073797256,"about_ca_system_score_codex":0.00058932626,"about_ca_system_score_gemma":0.0006343722,"threshold_uncertainty_score":0.8476105},"labels":[],"label_agreement":null},{"id":"W4415738684","doi":"10.1111/his.70030","title":"Comparison of glass‐based and whole‐slide image‐based grade assignment for clear‐cell and papillary renal cell carcinoma: a multi‐cohort, international reproducibility study","year":2025,"lang":"en","type":"article","venue":"Histopathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Interreg","keywords":"Grading (engineering); Reproducibility; Standardization; Modalities; Treatment modality; Papillary renal cell carcinomas","score_opus":0.039697319947910974,"score_gpt":0.3337575223506039,"score_spread":0.2940602024026929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415738684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914792,0.0018615494,0.0026802572,0.0008838293,0.00025238315,0.002002388,0.000046013483,0.000035038327,0.00075933983],"genre_scores_gemma":[0.98612034,0.000005854106,0.01245986,0.0001946719,0.000037931826,0.0002046908,0.000096508295,0.000023777739,0.0008563498],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973577,0.0002583387,0.00065344316,0.0012309775,0.00024369838,0.00025581516],"domain_scores_gemma":[0.99824077,0.00023348987,0.0002627423,0.0009595826,0.00018610829,0.000117301664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009408621,0.0002649073,0.0007286672,0.000256483,0.000100312005,0.00001231689,0.00011474169,0.00012068066,0.00001588695],"category_scores_gemma":[0.00021211526,0.0002409703,0.000120685116,0.00010765547,0.00029286405,0.000035566914,0.00010853436,0.00021005044,0.0000018452974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011641134,0.0031686693,0.791657,0.00036054206,0.000017654374,0.00018078795,0.0004393634,0.000020218185,0.20198725,0.000006730926,0.00067751727,0.0003201956],"study_design_scores_gemma":[0.008577284,0.002765424,0.88668996,0.000033589808,0.00051086716,0.000020255216,0.00043708872,0.0030071007,0.09679124,0.000018723893,0.0009946739,0.00015377633],"about_ca_topic_score_codex":0.00011155796,"about_ca_topic_score_gemma":0.00003575003,"teacher_disagreement_score":0.10519601,"about_ca_system_score_codex":0.0003352912,"about_ca_system_score_gemma":0.00019400868,"threshold_uncertainty_score":0.9826484},"labels":[],"label_agreement":null},{"id":"W4415901316","doi":"10.1016/j.euo.2025.09.018","title":"Genomic and Epigenomic Signatures Can Distinguish Aggressive Chromophobe Renal Cell Carcinoma from Indolent Renal Oncocytic Tumors in Clinical-grade Samples","year":2025,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"University of Texas MD Anderson Cancer Center; National Institutes of Health","keywords":"Epigenomics; Renal cell carcinoma; Chromophobe cell; Renal oncocytoma; Clear cell; Oncocytoma","score_opus":0.028362661116922934,"score_gpt":0.2982851752699084,"score_spread":0.26992251415298546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415901316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9702351,0.01232548,0.000018807532,0.0019243337,0.0005874751,0.0007967483,0.00006426547,0.00007311423,0.013974687],"genre_scores_gemma":[0.9944144,0.0005254484,0.000750249,0.0029154774,0.0006055209,0.00003564941,0.00016867979,0.00008099059,0.0005036223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940647,0.002329603,0.0013500914,0.0012941259,0.00017106713,0.0007904411],"domain_scores_gemma":[0.99669844,0.0014375079,0.00070924964,0.00071325473,0.000070963244,0.0003705628],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00082246715,0.00052887446,0.0013423034,0.00047395044,0.0001535384,0.000023111168,0.00038573274,0.00037101965,0.000120065575],"category_scores_gemma":[0.0005347848,0.00048010837,0.00023444508,0.00024484232,0.00083652994,0.00002884675,0.00050244684,0.0013917112,0.000086115695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031064416,0.0018729881,0.86178124,0.0001555849,0.00048328552,0.04655325,0.0028171549,0.00020091842,0.061254393,0.00019159596,0.0033091968,0.018273925],"study_design_scores_gemma":[0.008876971,0.0035747655,0.974434,0.000096698524,0.00050121476,0.000290895,0.00011150164,0.00014536444,0.0020479965,0.00023445593,0.009359008,0.00032709262],"about_ca_topic_score_codex":0.0008634159,"about_ca_topic_score_gemma":0.0008204546,"teacher_disagreement_score":0.11265277,"about_ca_system_score_codex":0.0008339029,"about_ca_system_score_gemma":0.0006816248,"threshold_uncertainty_score":0.99976504},"labels":[],"label_agreement":null},{"id":"W4415934991","doi":"10.58931/cot.2025.2343","title":"Current Issues in the Management of Sporadic Non-clear Cell Renal Cell Carcinoma (Non-ccRCC)","year":2025,"lang":"","type":"article","venue":"Canadian oncology today.","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Renal cell carcinoma; Kidney cancer; Cell; Clear cell renal cell carcinoma; Carcinoma; Cancer; Clear cell","score_opus":0.015709473236864595,"score_gpt":0.28532122771388924,"score_spread":0.2696117544770246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415934991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7118882,0.04306992,0.000017835748,0.0068138237,0.0020497704,0.0031320248,0.000083164436,0.000012134267,0.23293313],"genre_scores_gemma":[0.9776758,0.004465277,0.00031971952,0.0014750262,0.00032865943,0.00023679259,0.000110109024,0.00007028513,0.015318338],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.994203,0.000557687,0.0015650871,0.0012362004,0.0006027024,0.0018353753],"domain_scores_gemma":[0.99624527,0.00026879422,0.00047310683,0.0018132894,0.00020940602,0.0009901525],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012540383,0.00085508084,0.0015844244,0.0016041184,0.00029775675,0.000046932368,0.0012533492,0.00062434224,0.0010728015],"category_scores_gemma":[0.000018390363,0.00073719374,0.0004573851,0.0016581578,0.0006564268,0.00009626671,0.00022474935,0.001365393,0.00044712576],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0030822163,0.00825204,0.26498947,0.015401125,0.0015659898,0.055857968,0.02612599,0.00030773773,0.002629457,0.0025333879,0.46520826,0.15404636],"study_design_scores_gemma":[0.010687814,0.0044872076,0.5196091,0.0018423245,0.0025626498,0.00005652643,0.009123395,0.00046869984,0.0078633055,0.00022754543,0.44229925,0.00077219907],"about_ca_topic_score_codex":0.096672095,"about_ca_topic_score_gemma":0.06414606,"teacher_disagreement_score":0.2657876,"about_ca_system_score_codex":0.005518809,"about_ca_system_score_gemma":0.006746188,"threshold_uncertainty_score":0.9998404},"labels":[],"label_agreement":null},{"id":"W4415940078","doi":"10.1016/j.annonc.2025.08.3223","title":"2607P Belzutifan for advanced clear cell renal cell carcinoma (ccRCC) after a PD-(L)1 inhibitor and ≥2 VEGFR-TKIs in LITESPARK-005","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Clear cell renal cell carcinoma; Clear cell; Discovery and development of mTOR inhibitors; Kidney cancer; Phases of clinical research; Renal cell carcinoma","score_opus":0.03004724296364463,"score_gpt":0.33437555714878353,"score_spread":0.3043283141851389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415940078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759572,0.0065114354,0.000022712611,0.004092257,0.0001654953,0.0010594071,0.00003427523,0.00002024159,0.012136981],"genre_scores_gemma":[0.9928062,0.00032253884,0.0021625112,0.001687114,0.000115393086,0.00025737606,0.000029089404,0.000031893713,0.0025878919],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99809164,0.00011685553,0.00059727894,0.00051929126,0.00015783292,0.00051712495],"domain_scores_gemma":[0.9986805,0.0003734966,0.00018676829,0.0003810415,0.00019162294,0.00018661395],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003365809,0.00027073658,0.0007827529,0.00039446016,0.00004375121,0.000009153856,0.00010808678,0.00027195163,0.0000486262],"category_scores_gemma":[0.00009276368,0.0002471781,0.00019096269,0.00027715074,0.00016466074,0.000075803524,0.00011943958,0.00024398978,0.000010584375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05813488,0.008552477,0.2931383,0.00554918,0.00039721114,0.0024510515,0.0060510603,0.00008249229,0.4028245,0.00044029448,0.035341952,0.18703663],"study_design_scores_gemma":[0.015473763,0.019213485,0.2999791,0.00036082973,0.0002959573,0.000045510904,0.0004777077,0.00013408487,0.5353071,0.00064178463,0.12768178,0.00038889542],"about_ca_topic_score_codex":0.00008962049,"about_ca_topic_score_gemma":0.00012677447,"teacher_disagreement_score":0.18664773,"about_ca_system_score_codex":0.00013897644,"about_ca_system_score_gemma":0.0003645236,"threshold_uncertainty_score":0.99999803},"labels":[],"label_agreement":null},{"id":"W4415940248","doi":"10.1016/j.annonc.2025.08.3216","title":"2600MO Relevance of the CPS score and tumor nephrectomy in the SUNNIFORECAST trial comparing ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"EMD Serono; Ipsen; European Society for Medical Oncology; Astellas Pharma; Eisai; European Association of Urology; Micropalaeontological Society; National Cancer Institute; Aptitude Health; Bamfield Marine Sciences Centre; Cleveland Clinic; Daiichi Sankyo Europe; Exelixis; Eli Lilly and Company; AstraZeneca; American Society of Clinical Oncology; Institut Gustave-Roussy; Invitae; Gilead Sciences; Amgen; Dana-Farber Cancer Institute; Pfizer; Society for Immunotherapy of Cancer","keywords":"Standard of care; Nephrectomy; Renal cell carcinoma; Clinical trial; Immunotherapy; Kidney cancer; Cell; MEDLINE","score_opus":0.062029697455792454,"score_gpt":0.3550135299256223,"score_spread":0.29298383246982984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415940248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982,0.003590004,0.0000010153552,0.00077997684,0.0002501539,0.0010728311,0.00002872495,0.0000033705103,0.01227396],"genre_scores_gemma":[0.9990665,0.00049917743,0.000096515665,0.00013930388,0.000043324722,0.000049582883,0.0000048444763,0.000011334656,0.00008944314],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984008,0.00022281334,0.00059727806,0.00024962993,0.0002700023,0.00025947168],"domain_scores_gemma":[0.99855393,0.00048572643,0.00034107472,0.0003713098,0.0002098857,0.00003805022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041652247,0.00016176718,0.00081977766,0.00017167469,0.000033594566,0.000003920279,0.00022167945,0.000103268605,0.000017527373],"category_scores_gemma":[0.00009636148,0.00010545042,0.00013643867,0.00041809294,0.00028744334,0.00003546414,0.0001123243,0.0003141563,4.7147975e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7346644,0.0018798086,0.20004368,0.0029155686,0.00024578534,0.00028165258,0.012229972,0.0010857764,0.017277189,0.00018173453,0.003603011,0.025591418],"study_design_scores_gemma":[0.24723443,0.050207622,0.29539257,0.0021750277,0.000528575,0.000016523372,0.00893873,0.00041516812,0.3826169,0.00014906758,0.011990595,0.00033476192],"about_ca_topic_score_codex":0.0014498015,"about_ca_topic_score_gemma":0.006896054,"teacher_disagreement_score":0.48742998,"about_ca_system_score_codex":0.0002040624,"about_ca_system_score_gemma":0.0007185809,"threshold_uncertainty_score":0.43001434},"labels":[],"label_agreement":null},{"id":"W4415941717","doi":"10.1016/j.annonc.2025.08.499","title":"64eP Translating tumor biology into clinical practice using patient-derived organoids in renal cell carcinoma","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hôpital Maisonneuve-Rosemont; McGill University Health Centre; Occupational Cancer Research Centre; McGill Genome Centre","funders":"","keywords":"Organoid; Chromophobe cell; Renal cell carcinoma; Clinical Practice; Precision oncology; Ex vivo; Clear cell; Clear cell renal cell carcinoma","score_opus":0.11389469240157536,"score_gpt":0.4444231149248281,"score_spread":0.33052842252325276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415941717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755914,0.0018336067,0.00018138681,0.005081127,0.0002911186,0.0005058069,0.000004473006,0.000019321737,0.016491715],"genre_scores_gemma":[0.9791927,0.000071251576,0.017238472,0.0033226176,0.000087010325,0.000016715416,0.000018588842,0.000020052417,0.00003264459],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99706435,0.00071072293,0.0012116058,0.0004605106,0.0001406403,0.0004121613],"domain_scores_gemma":[0.99770415,0.001005639,0.0004339062,0.00034592117,0.00037478848,0.00013558057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008226893,0.00021577122,0.0009030309,0.00033264756,0.000052215284,0.0000047157628,0.0001271648,0.00029959538,0.000059172628],"category_scores_gemma":[0.0009196295,0.00019201479,0.0002039282,0.00043278787,0.0002508604,0.00008637741,0.00009302501,0.0004555571,0.000010070825],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039070267,0.003335888,0.22108471,0.00031000818,0.0002559313,0.0017373891,0.0025914027,0.000046513902,0.62012124,0.00031082475,0.0007353826,0.1455637],"study_design_scores_gemma":[0.014107312,0.028905248,0.13677025,0.00033611764,0.0008209716,0.00042606934,0.0033145358,0.0009797815,0.77981293,0.0013830449,0.032616608,0.0005271261],"about_ca_topic_score_codex":0.0008954797,"about_ca_topic_score_gemma":0.00011136546,"teacher_disagreement_score":0.15969172,"about_ca_system_score_codex":0.00016052103,"about_ca_system_score_gemma":0.0011076088,"threshold_uncertainty_score":0.78301364},"labels":[],"label_agreement":null},{"id":"W4415942102","doi":"10.1016/j.annonc.2025.08.3292","title":"2681eP Real-world comparison of immunotherapy (IO)-based combinations in intermediate/poor-(int/poor-) risk patients (pts) with non-clear cell Renal Cell Carcinoma (nccRCC): The ARON-1 multicenter experience","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Renal cell carcinoma; Immunotherapy; Kidney cancer; Multicenter study; Carcinoma; Kidney disease","score_opus":0.0312523321001368,"score_gpt":0.3467426834120145,"score_spread":0.3154903513118777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415942102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98419625,0.0004382504,0.000069352005,0.0009384078,0.0001912391,0.001209418,0.000032772463,0.000016347116,0.01290797],"genre_scores_gemma":[0.99780774,0.00026671932,0.0003911731,0.00073649496,0.000020481817,0.00015616148,0.000067270346,0.000031606876,0.00052234845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973544,0.00037650185,0.0009910754,0.00043705947,0.00039576416,0.00044521882],"domain_scores_gemma":[0.99739134,0.00061197137,0.00075695023,0.00064638053,0.00048418163,0.00010920222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034728748,0.00032084988,0.0009250965,0.00049919635,0.00009580852,0.00001028795,0.00037818844,0.00015771427,0.00009308686],"category_scores_gemma":[0.000052389623,0.00022270661,0.00020520348,0.00056394003,0.00053725444,0.00007355808,0.000094822215,0.0004640194,0.000013786256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050801095,0.008314348,0.96433806,0.00018544027,0.0001135859,0.000047032805,0.0048377616,0.00021658206,0.006396373,0.0000226193,0.0030186335,0.0074294745],"study_design_scores_gemma":[0.01478235,0.00911223,0.74717164,0.00022968996,0.00012799441,8.264166e-7,0.0012640939,0.001970411,0.22306186,0.000018171278,0.0020916092,0.00016912745],"about_ca_topic_score_codex":0.0028397723,"about_ca_topic_score_gemma":0.0013230976,"teacher_disagreement_score":0.2171664,"about_ca_system_score_codex":0.00025493946,"about_ca_system_score_gemma":0.00040820535,"threshold_uncertainty_score":0.90817124},"labels":[],"label_agreement":null},{"id":"W4415942490","doi":"10.1016/j.annonc.2025.08.3246","title":"2631P Unmet needs &amp; disparities in kidney cancer (KC): International kidney cancer coalition (IKCC) global patient survey (GPS)","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kidney Foundation of Canada; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Kidney cancer; Incidence (geometry); Cancer; Kidney disease; Cancer incidence; Healthcare system; Health care","score_opus":0.09275938904004867,"score_gpt":0.417859287127138,"score_spread":0.32509989808708933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415942490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9238392,0.0016831157,0.00005472398,0.046513386,0.0017695323,0.0005370086,0.0017314686,0.000028758437,0.023842799],"genre_scores_gemma":[0.97844267,0.002068442,0.00013586541,0.016082766,0.00012008836,0.00023740513,0.00079491065,0.0000131704455,0.0021046572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998054,0.00029698154,0.00061997963,0.00031284857,0.00034408865,0.00037209352],"domain_scores_gemma":[0.99852616,0.00017552073,0.00022519578,0.00026937132,0.00052171474,0.00028203934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041462164,0.00021934134,0.0006200374,0.00031461593,0.00003673973,0.000012752549,0.00016626206,0.00021249912,0.00070187723],"category_scores_gemma":[0.0006046042,0.00019953189,0.0001371821,0.00054065854,0.00017352261,0.00008888578,0.00012121226,0.00018996232,0.000014539571],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015704455,0.00079840166,0.7652626,0.00016239745,0.00043128544,0.00004410052,0.00026358303,0.0000673105,0.0003648611,0.001299042,0.2158386,0.013897386],"study_design_scores_gemma":[0.0029429677,0.0007890797,0.77562857,0.0005793723,0.00010997073,0.000013332888,0.00010784651,0.000070404465,0.0027248468,0.0006428608,0.2162184,0.00017237331],"about_ca_topic_score_codex":0.045374375,"about_ca_topic_score_gemma":0.01156871,"teacher_disagreement_score":0.054603487,"about_ca_system_score_codex":0.0009637159,"about_ca_system_score_gemma":0.0019483874,"threshold_uncertainty_score":0.96098256},"labels":[],"label_agreement":null},{"id":"W4415942529","doi":"10.1016/j.annonc.2025.08.3244","title":"2629P Durability of Complete Response (CR) to first-line (1L) in metastatic renal cell carcinoma (mRCC) in the real world","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Renal cell carcinoma; Complete response; Real world data; Carcinoma; Metastasis; Kidney cancer","score_opus":0.1380209231022706,"score_gpt":0.3995283480690519,"score_spread":0.2615074249667813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415942529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96205133,0.00035770185,0.0000116464935,0.024907097,0.00006350661,0.001033972,0.000038134654,0.0000072802804,0.011529329],"genre_scores_gemma":[0.9968027,0.000056715155,0.0006655839,0.0017082518,0.000019284593,0.000096351316,0.000018713994,0.000011055856,0.0006213611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99693483,0.0010823465,0.00097365124,0.00036151003,0.00027620184,0.00037148077],"domain_scores_gemma":[0.99642986,0.002380517,0.00021484471,0.0006712882,0.00021017004,0.000093323506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023679615,0.00020003296,0.0009371785,0.00070616155,0.0000280249,0.0000034095356,0.00026446924,0.000081485494,0.00006352511],"category_scores_gemma":[0.0005483168,0.0001441188,0.00017053571,0.0010964168,0.00020087832,0.000026629239,0.00010861571,0.00027897774,0.0000096614895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.081276745,0.010903944,0.77060497,0.0017439103,0.00031035463,0.003353537,0.009603295,0.0011739228,0.0905046,0.0017373672,0.008925655,0.019861685],"study_design_scores_gemma":[0.0034754886,0.0060607423,0.9513346,0.00012452876,0.00009875324,0.00001459444,0.0003526299,0.000079135505,0.02936434,0.0006761407,0.008323776,0.00009526012],"about_ca_topic_score_codex":0.003615636,"about_ca_topic_score_gemma":0.01613632,"teacher_disagreement_score":0.18072963,"about_ca_system_score_codex":0.00023477935,"about_ca_system_score_gemma":0.00053212827,"threshold_uncertainty_score":0.9004445},"labels":[],"label_agreement":null},{"id":"W4415942594","doi":"10.1016/j.annonc.2025.08.3234","title":"2619P How clinicians decide – analyzing real-world practice patterns in metastatic renal cell carcinoma (mRCC) with machine learning: Results from the international metastatic renal cell carcinoma database consortium (IMDC)","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Juravinski Cancer Centre; BC Cancer Agency; Ontario Institute for Cancer Research","funders":"","keywords":"Renal cell carcinoma; Carcinoma; MEDLINE; Metastasis; Kidney cancer; Clear cell renal cell carcinoma","score_opus":0.08858054876424672,"score_gpt":0.37312418436637157,"score_spread":0.28454363560212487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415942594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94386035,0.0013353422,0.0005768919,0.03440145,0.00026307008,0.0009930492,0.00085115456,0.000038219052,0.017680489],"genre_scores_gemma":[0.9853432,0.00065907266,0.0058447467,0.0033276407,0.00014905863,0.00009066414,0.001758908,0.000060039885,0.0027666478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99415535,0.0016375086,0.0015962826,0.0010778148,0.00080251775,0.0007305259],"domain_scores_gemma":[0.9890782,0.007301649,0.0015401128,0.0010960776,0.00071599893,0.00026796182],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024987743,0.0005647012,0.0013765207,0.0007618499,0.00015031855,0.00006540869,0.0006364861,0.00012428132,0.00015353937],"category_scores_gemma":[0.0014932061,0.00040243275,0.0003157981,0.0008638972,0.00031220843,0.0003143651,0.00032962652,0.0012361757,0.000019439067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030393729,0.004881166,0.89841837,0.00038743753,0.0022485158,0.014931572,0.0029640703,0.0013094,0.014222355,0.000212189,0.020269336,0.009761857],"study_design_scores_gemma":[0.03549821,0.010846019,0.7282916,0.00082141865,0.0058266697,0.00034508386,0.0072092167,0.0044415137,0.13341172,0.00015460205,0.07217773,0.0009762807],"about_ca_topic_score_codex":0.023176437,"about_ca_topic_score_gemma":0.021753779,"teacher_disagreement_score":0.17012683,"about_ca_system_score_codex":0.00037004912,"about_ca_system_score_gemma":0.001451726,"threshold_uncertainty_score":0.99984276},"labels":[],"label_agreement":null},{"id":"W4416074353","doi":"10.1136/jitc-2025-sitc2025.0107","title":"107 Multi-omic assessment of blood and tissue of renal cell carcinoma patients provides a comprehensive characterization of the systemic and local immune response","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Renal cell carcinoma; Immune system; Kidney cancer; Kidney; Cell","score_opus":0.011548335764911235,"score_gpt":0.2403977365315683,"score_spread":0.22884940076665705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416074353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98933315,0.0076814555,0.000051779836,0.00023868299,0.00027186747,0.00220485,0.00017964077,0.0000094927855,0.000029055387],"genre_scores_gemma":[0.99882865,0.00041475595,0.00027987533,0.00004207699,0.00002224203,0.00003019111,0.000055073077,0.000036877955,0.00029024438],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9963079,0.0006262178,0.0015686698,0.0006044442,0.0005489,0.00034385253],"domain_scores_gemma":[0.99688125,0.00024723247,0.0013080529,0.0006514849,0.00056332746,0.00034867265],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055863353,0.00049509504,0.0012062453,0.00027591892,0.00014168532,0.000032907225,0.00016384704,0.00030321037,0.0000028182892],"category_scores_gemma":[0.00022133368,0.00038617707,0.00013823099,0.00029872058,0.0015440072,0.00014029416,0.00026251137,0.00030164843,2.8349325e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074976694,0.000512839,0.21317354,0.006258819,0.00031157394,0.00003148227,0.0010822626,0.000026683225,0.777327,0.000032483687,0.000006060932,0.00048748162],"study_design_scores_gemma":[0.0036579708,0.00082936254,0.5344507,0.002358481,0.0011546003,0.000063774874,0.00031020126,0.0003906657,0.45662498,0.0000075952303,0.000017681112,0.00013398104],"about_ca_topic_score_codex":0.00041483654,"about_ca_topic_score_gemma":0.0000061743754,"teacher_disagreement_score":0.32127717,"about_ca_system_score_codex":0.00013602745,"about_ca_system_score_gemma":0.001115871,"threshold_uncertainty_score":0.99985904},"labels":[],"label_agreement":null},{"id":"W4416097902","doi":"10.1007/s00345-025-06080-8","title":"Robotic vs. open partial cytoreductive nephrectomy in metastatic renal cell carcinoma: adverse in-hospital outcomes","year":2025,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Adverse effect; Renal cell carcinoma; Nephrology; Nephrectomy; Kidney cancer; Kidney disease; Renal function; Retrospective cohort study","score_opus":0.016385260344135965,"score_gpt":0.28827986342816575,"score_spread":0.2718946030840298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416097902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835704,0.0014568196,0.00007032291,0.008849681,0.0007436575,0.0006594649,0.0000017709921,0.000005492396,0.004642384],"genre_scores_gemma":[0.99582607,0.000029887691,0.0017249164,0.00076327333,0.00008494874,0.000025223959,0.0000038440444,0.000019716377,0.0015221481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773306,0.0003331771,0.0009534777,0.00029889998,0.00024540798,0.00043595428],"domain_scores_gemma":[0.9987598,0.0002933767,0.00038169255,0.00027465002,0.00012647177,0.00016398895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000531249,0.0002585568,0.0011102541,0.0011691387,0.000033276236,0.0000171354,0.0003409244,0.000067243614,0.00015575335],"category_scores_gemma":[0.00013683598,0.0002019056,0.00022909163,0.00067088974,0.00013061528,0.0001924138,0.00017235307,0.0006889776,0.000018149822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004815389,0.00216197,0.97416806,0.000063044965,0.00033582316,0.0104653295,0.00084142556,0.0025430764,0.00094939093,0.0005052518,0.0019499749,0.0012012519],"study_design_scores_gemma":[0.016826408,0.0028383697,0.9727386,0.00006701232,0.00067315344,0.00033045682,0.00026945246,0.00013508844,0.0016959069,0.0007136681,0.0035361445,0.00017568587],"about_ca_topic_score_codex":0.00025291427,"about_ca_topic_score_gemma":0.00044854847,"teacher_disagreement_score":0.012255635,"about_ca_system_score_codex":0.00045677397,"about_ca_system_score_gemma":0.00062312593,"threshold_uncertainty_score":0.82334715},"labels":[],"label_agreement":null},{"id":"W4416322476","doi":"10.1159/000549603","title":"Impact of Body Mass Index on Renal Function Impairment in Patients Treated for Renal Cell Carcinoma at High Risk of Recurrence: Key Implications for Systemic Therapy Eligibility","year":2025,"lang":"en","type":"article","venue":"Urologia Internationalis","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Body mass index; Renal function; Renal cell carcinoma; Overweight; Systemic therapy; Adjuvant therapy; Adjuvant; Kidney; Kidney cancer","score_opus":0.017623281560443457,"score_gpt":0.3031146412010594,"score_spread":0.28549135964061595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416322476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945218,0.0001240196,0.0010165493,0.00016175878,0.00011152476,0.0027823471,0.0010876404,0.000019747258,0.00017463272],"genre_scores_gemma":[0.9975966,0.000033584973,0.00014926551,0.00004289376,0.000031034473,0.0007056956,0.0012599563,0.000015642929,0.00016530624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982433,0.000112817426,0.00072949927,0.00044582554,0.00024944375,0.00021912495],"domain_scores_gemma":[0.99777675,0.0004269908,0.00052585563,0.00042878086,0.0007820541,0.000059597205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034554244,0.00023080887,0.0004385356,0.0004057998,0.0000483315,0.0000068369563,0.00015585538,0.00015521664,0.00003537625],"category_scores_gemma":[0.00016734554,0.00017227468,0.00036654185,0.00024334413,0.000059646667,0.00004479619,0.000028416223,0.00011931844,0.0000014487465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013933456,0.0012646194,0.9721122,0.00009580612,0.00033558873,6.478557e-7,0.000046122772,0.00057674444,0.009847163,0.00020832427,0.0009431582,0.0006361746],"study_design_scores_gemma":[0.009071868,0.00932141,0.95698386,0.000078823155,0.00017445079,0.0000018845134,0.0000048135034,0.00066365924,0.022707097,0.00086749933,0.000028968181,0.000095632924],"about_ca_topic_score_codex":0.0010603234,"about_ca_topic_score_gemma":0.000024808432,"teacher_disagreement_score":0.015128302,"about_ca_system_score_codex":0.0012516379,"about_ca_system_score_gemma":0.00017346721,"threshold_uncertainty_score":0.7025158},"labels":[],"label_agreement":null},{"id":"W4416386130","doi":"10.1002/path.70001","title":"Papillary renal cell carcinoma with high‐ <scp>ABCC2</scp> shows an immune‐evasive profile associated with favorable response to immunotherapy","year":2025,"lang":"en","type":"article","venue":"The Journal of Pathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary; University of Toronto; University Health Network; Public Health Ontario; Ontario Institute for Cancer Research; Toronto Public Health; St. Michael's Hospital","funders":"Kidney Foundation of Canada; Ontario Institute for Cancer Research","keywords":"Immunotherapy; Immune system; Immune checkpoint; Immunohistochemistry; Tumor microenvironment; Renal cell carcinoma; Papillary renal cell carcinomas; Clear cell renal cell carcinoma; PD-L1","score_opus":0.010764040911601809,"score_gpt":0.2411945603048424,"score_spread":0.2304305193932406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416386130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935074,0.0024542937,0.00032857867,0.0012348216,0.0001431986,0.00082099874,0.000022255625,0.000029480487,0.0014589753],"genre_scores_gemma":[0.99015135,0.000077554774,0.00168122,0.0009835142,0.000085297455,0.000027357202,0.000017296363,0.00005977722,0.006916615],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965321,0.0014935373,0.00064578315,0.00028391473,0.00050149765,0.00054318435],"domain_scores_gemma":[0.99682146,0.00089296635,0.0006319124,0.0007430301,0.00069767854,0.00021296904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020625542,0.0003663633,0.0008702541,0.00041608428,0.000211562,0.000028464827,0.00040054918,0.00018400612,0.000059533926],"category_scores_gemma":[0.00025604502,0.00019653849,0.0001417154,0.00057148474,0.00022188152,0.00012036877,0.00006832742,0.00068923424,0.000018694373],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020540394,0.00080867996,0.01955112,0.000037855494,0.00053999276,0.008438856,0.004380926,0.00029787366,0.9432051,0.000024639952,0.0016184129,0.0005561456],"study_design_scores_gemma":[0.008712218,0.02932595,0.55190796,0.0003344508,0.00084273354,0.005294819,0.0027081303,0.000014087235,0.40003118,0.000102033104,0.0005883944,0.00013806671],"about_ca_topic_score_codex":0.00006373769,"about_ca_topic_score_gemma":0.000037923302,"teacher_disagreement_score":0.5431739,"about_ca_system_score_codex":0.00042960854,"about_ca_system_score_gemma":0.0009698408,"threshold_uncertainty_score":0.8014607},"labels":[],"label_agreement":null},{"id":"W4416391806","doi":"10.1016/j.annonc.2025.09.113","title":"LBA96 First-line pembrolizumab-based regimens for advanced clear cell renal cell carcinoma: KEYMAKER-U03 substudy 03A","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Genentech; European Association of Urology","keywords":"Clear cell renal cell carcinoma; Pembrolizumab; Clear cell; Renal cell carcinoma; Cell","score_opus":0.060103354560220396,"score_gpt":0.35542522841092666,"score_spread":0.2953218738507063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416391806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9361919,0.0029668375,0.00037444656,0.008588312,0.00032827738,0.0019575998,0.00006774553,0.000070376525,0.049454503],"genre_scores_gemma":[0.98422796,0.0001587416,0.0025865245,0.0019123731,0.00012288398,0.0002914781,0.0001357332,0.00005588703,0.010508452],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973249,0.00014482727,0.0008216164,0.00069111906,0.00030422656,0.0007133167],"domain_scores_gemma":[0.99709475,0.0007371069,0.00039787756,0.0008336447,0.0006821961,0.0002544203],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042226329,0.0004046586,0.0011327118,0.00037478656,0.00015226132,0.000008857208,0.00025105977,0.0003271128,0.00013578733],"category_scores_gemma":[0.0001487123,0.0003629822,0.0004968083,0.00040117427,0.00020316953,0.000057525733,0.0000882072,0.0002979814,0.00004120599],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.121210895,0.03693331,0.057374075,0.0088967,0.0015747364,0.0031819802,0.0025178648,0.006509664,0.25727654,0.0019208693,0.45570722,0.046896122],"study_design_scores_gemma":[0.032663327,0.038031325,0.032688312,0.00016408696,0.0008610215,0.000031830667,0.00027267315,0.00077326247,0.6763104,0.000346623,0.21742132,0.00043581042],"about_ca_topic_score_codex":0.0001223101,"about_ca_topic_score_gemma":0.00014717701,"teacher_disagreement_score":0.41903386,"about_ca_system_score_codex":0.00025259162,"about_ca_system_score_gemma":0.0009216245,"threshold_uncertainty_score":0.9998822},"labels":[],"label_agreement":null},{"id":"W4416406793","doi":"10.1016/j.urolonc.2025.10.017","title":"Partial vs. radical nephrectomy in pT3a renal cancer: Cancer-specific mortality according to fat invasion pattern","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nephrectomy; Pathological; Adipose capsule of kidney; Kidney; Renal cell carcinoma; Adverse effect","score_opus":0.056288072754365974,"score_gpt":0.3541041343907145,"score_spread":0.2978160616363485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416406793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.970579,0.0026125095,0.0002556376,0.024326546,0.00042807785,0.0007453657,0.000025510697,0.00006106771,0.0009662714],"genre_scores_gemma":[0.98529726,0.0020015019,0.0046252497,0.0066930805,0.000297787,0.00068768574,0.00005339397,0.0000149412435,0.00032911845],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980028,0.00019500504,0.0004873145,0.00064167107,0.00020880828,0.00046438808],"domain_scores_gemma":[0.9989255,0.000242502,0.00011562048,0.0002791168,0.0000578718,0.00037939928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031861922,0.000272644,0.00059550133,0.0003274818,0.00020762465,0.000030284618,0.00013704663,0.0002804569,0.0001559782],"category_scores_gemma":[0.00009681791,0.00022831655,0.00008027685,0.0006448375,0.00043893245,0.000088275316,0.000116368334,0.00051071285,0.000015030304],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003221085,0.00020112506,0.9667639,0.000044232198,0.00007370618,0.00042356914,0.0002662949,0.0002942581,0.0046923053,0.00081837835,0.0071105375,0.018989556],"study_design_scores_gemma":[0.002512,0.0016068612,0.15604626,0.00039841048,0.00038672308,0.00009243074,0.00021633954,0.00092648546,0.012568297,0.0013599943,0.82359326,0.00029295596],"about_ca_topic_score_codex":0.0020416724,"about_ca_topic_score_gemma":0.0013138949,"teacher_disagreement_score":0.8164827,"about_ca_system_score_codex":0.0007679533,"about_ca_system_score_gemma":0.00062929513,"threshold_uncertainty_score":0.93104786},"labels":[],"label_agreement":null},{"id":"W4416553375","doi":"10.7759/cureus.97538","title":"Off-Clamp Versus On-Clamp Robot-Assisted Partial Nephrectomy: A Meta-Analysis of Clinical Trials and Matched Cohort Studies","year":2025,"lang":"en","type":"article","venue":"Cureus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Observational study; Nephrectomy; Randomized controlled trial; Renal function; Meta-analysis; Funnel plot; Systematic review; Publication bias; Cohort study","score_opus":0.5249327088556256,"score_gpt":0.524576795395596,"score_spread":0.000355913460029611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416553375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95483655,0.036598735,0.00006743886,0.0023885046,0.00078931777,0.0016815623,0.000051011375,0.00007449673,0.0035123918],"genre_scores_gemma":[0.9949426,0.0015795932,0.0009175729,0.00032414898,0.00012593757,0.00028343828,0.000058994025,0.000019273586,0.0017484496],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9957325,0.0010364179,0.0018547914,0.0006426385,0.00046569205,0.00026796293],"domain_scores_gemma":[0.9936848,0.004411433,0.00057071995,0.0008613198,0.00028769491,0.0001839936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035906106,0.0003393544,0.0055816662,0.00029074115,0.00006532755,0.000020746871,0.00012060249,0.0002109,0.00031059206],"category_scores_gemma":[0.00414187,0.00021868416,0.0024342604,0.0007661161,0.00023970602,0.000039660415,0.000109067194,0.00023687097,0.000012469371],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007156648,0.00089105865,0.04377819,0.00011034575,0.93731105,0.00012034189,0.0002443764,0.0000550637,0.0007381902,0.00045414286,0.0030186772,0.006121935],"study_design_scores_gemma":[0.007406184,0.0011939453,0.20406403,0.000028524562,0.7792656,0.0000027493022,0.0003669054,0.00024919555,0.0040840153,0.00006327835,0.003087782,0.00018780454],"about_ca_topic_score_codex":0.00011433726,"about_ca_topic_score_gemma":0.00017359488,"teacher_disagreement_score":0.16028585,"about_ca_system_score_codex":0.0001438268,"about_ca_system_score_gemma":0.0002168309,"threshold_uncertainty_score":0.8917681},"labels":[],"label_agreement":null},{"id":"W4416556432","doi":"10.1016/j.ijrobp.2025.11.005","title":"Stereotactic Body Radiation Therapy for Renal Tumors: A Prospective Phase 2 Clinical Trial","year":2025,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; St. Michael's Hospital; University Health Network; University of Toronto; Princess Margaret Cancer Centre; BC Cancer Agency; University of British Columbia","funders":"Janssen Canada; AbbVie; Sanofi; AstraZeneca; Astellas Pharma; Astellas Pharma US; Amgen Canada; Amgen","keywords":"Clinical trial; Radiation therapy; Renal function; Phases of clinical research; Phase (matter)","score_opus":0.05178609849026143,"score_gpt":0.42886341792718197,"score_spread":0.3770773194369205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416556432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747538,0.0009421214,0.0124462,0.0040044244,0.004795778,0.0019671933,0.00006624375,0.000046092464,0.0009781242],"genre_scores_gemma":[0.9898598,0.00069313135,0.0016778046,0.0013825694,0.005819629,0.00013099787,0.00017905212,0.000030465646,0.00022653806],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99712896,0.00039678157,0.00152185,0.00037318942,0.0003181508,0.00026106453],"domain_scores_gemma":[0.9954972,0.0012286797,0.0016142747,0.00021957324,0.0012850073,0.00015525655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012117692,0.00026435277,0.0008278376,0.00030165142,0.000091945985,0.000045108627,0.00031508674,0.00030076838,0.000048784514],"category_scores_gemma":[0.0010560544,0.00021485986,0.0006562497,0.00021410636,0.00018048285,0.0002723291,0.00003782222,0.00055037224,0.000014265137],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18241489,0.0080662565,0.2330763,0.000021178603,0.005424187,0.00013851062,0.00041709843,0.000044944645,0.0055113584,0.013743628,0.0051587345,0.5459829],"study_design_scores_gemma":[0.65468353,0.053879004,0.13209073,0.00022592729,0.0011833513,0.0003743202,0.00008788391,0.003178156,0.020051705,0.03330733,0.10044954,0.0004885254],"about_ca_topic_score_codex":0.000008207623,"about_ca_topic_score_gemma":0.0000011473917,"teacher_disagreement_score":0.5454944,"about_ca_system_score_codex":0.0014105561,"about_ca_system_score_gemma":0.0017433607,"threshold_uncertainty_score":0.8761731},"labels":[],"label_agreement":null},{"id":"W4416565201","doi":"10.1007/s00261-025-05302-2","title":"Hereditary syndromes and RCC: what radiologists need to know","year":2025,"lang":"en","type":"article","venue":"Abdominal Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Renal cell carcinoma; Kidney cancer; Genetic counseling; Cancer; Chromophobe cell; Tuberous sclerosis; Hereditary Diseases; Genetic testing; Carcinoma","score_opus":0.015186119307265572,"score_gpt":0.2800548298081989,"score_spread":0.2648687105009333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416565201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9602562,0.021998692,0.0001589857,0.012062916,0.00071067497,0.0005708223,0.0000027111137,0.000060689283,0.0041783075],"genre_scores_gemma":[0.990381,0.0013191828,0.0021314616,0.0028478026,0.00018241325,0.00007897804,0.000023767016,0.000016365684,0.0030190053],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986076,0.00012631844,0.00029105952,0.00048205839,0.000096096446,0.00039690893],"domain_scores_gemma":[0.99892163,0.00035793398,0.000043581582,0.00038710315,0.00005769058,0.00023208195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021170889,0.00024207454,0.00066832884,0.0002704934,0.000072645,0.000023237342,0.00011637342,0.00019045603,0.00009298403],"category_scores_gemma":[0.00018010328,0.00019096005,0.00010322966,0.00022540879,0.00024297094,0.00008938791,0.000098144155,0.00019535497,0.0000866972],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011211031,0.00072227896,0.16963352,0.0008650673,0.0023709002,0.020361166,0.0017269346,0.00007322304,0.07077957,0.008276398,0.21633139,0.49764854],"study_design_scores_gemma":[0.007189341,0.006193189,0.88705,0.0007044156,0.0008852776,0.029431004,0.002448277,0.00020754973,0.011250206,0.001358122,0.052681368,0.0006012706],"about_ca_topic_score_codex":0.00006501233,"about_ca_topic_score_gemma":0.000008311025,"teacher_disagreement_score":0.71741647,"about_ca_system_score_codex":0.00017994439,"about_ca_system_score_gemma":0.000113034876,"threshold_uncertainty_score":0.77871245},"labels":[],"label_agreement":null},{"id":"W4416938093","doi":"10.1016/j.eucr.2025.103304","title":"Intrarenal parapelvic cysts presenting as allograft dysfunction 10 years post-renal transplantation: a case report","year":2025,"lang":"en","type":"article","venue":"Urology Case Reports","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hydronephrosis; Differential diagnosis; Kidney; Renal transplant; Kidney transplantation; Pyeloplasty","score_opus":0.010756498011249742,"score_gpt":0.27135756794571936,"score_spread":0.26060106993446963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416938093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892356,0.00071232906,0.0002674699,0.00079332484,0.0006497556,0.0007550979,0.000007187605,0.00017169054,0.007407561],"genre_scores_gemma":[0.9945509,0.000021434953,0.00036820857,0.00054314086,0.00018201329,0.0001199365,0.0003692802,0.000030486452,0.0038146437],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99735,0.00014423477,0.00094031333,0.0008036303,0.00031131075,0.00045054918],"domain_scores_gemma":[0.9982497,0.00015874597,0.00037562146,0.0007122847,0.00027552017,0.00022812141],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048285793,0.00029783256,0.00046954586,0.00040002953,0.00017305101,0.000030849784,0.000030004574,0.00029340695,0.00055125117],"category_scores_gemma":[0.0002566803,0.00027948752,0.00025234142,0.00034168616,0.00014421402,0.0001060935,0.000040861378,0.00036228393,0.00004112722],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065356283,0.00020657014,0.014414626,0.000109965935,0.00044605765,0.97890544,0.00022218833,0.000051646748,0.0018907158,0.00003027433,0.0006359086,0.0024330646],"study_design_scores_gemma":[0.0012315109,0.0006447982,0.020487152,0.000033735807,0.0014182955,0.96838576,0.000072977324,0.00006927759,0.00283096,0.00016036366,0.0044888905,0.00017630338],"about_ca_topic_score_codex":0.0009133837,"about_ca_topic_score_gemma":0.00028363423,"teacher_disagreement_score":0.010519683,"about_ca_system_score_codex":0.00012483425,"about_ca_system_score_gemma":0.00047802244,"threshold_uncertainty_score":0.9999657},"labels":[],"label_agreement":null},{"id":"W4416944346","doi":"10.3390/cancers17233832","title":"Clinical and Molecular Characterization of KRAS-Mutated Renal Cell Carcinoma","year":2025,"lang":"en","type":"article","venue":"Cancers","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Renal cell carcinoma; Nephron; Kidney cancer; Renal carcinoma; Kidney; Carcinoma","score_opus":0.016786221781638067,"score_gpt":0.29025928031047216,"score_spread":0.2734730585288341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416944346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99402523,0.0005503931,0.00025850435,0.00019482416,0.00012852013,0.00025484094,0.000008474427,0.00001453192,0.004564702],"genre_scores_gemma":[0.9985244,0.00009608421,0.00017843282,0.00035105154,0.000027436407,0.000012414373,0.000051963198,0.000009105949,0.00074911205],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993025,0.000036887737,0.00025785758,0.00019848076,0.00009723468,0.000107023756],"domain_scores_gemma":[0.99956906,0.00002149031,0.00007362222,0.00018119285,0.00007561285,0.00007901573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007710005,0.00008872238,0.00024375356,0.000074205964,0.000016677544,0.0000041383523,0.000032860466,0.00006591487,0.000028044502],"category_scores_gemma":[0.000017908584,0.00007803938,0.0000644959,0.0001548922,0.00010619586,0.000021031143,0.000021745585,0.00008342697,0.0000025288743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034467032,0.000034112152,0.18913294,0.0002166036,0.000075040174,0.00010757358,0.0000879825,0.0000074062755,0.80421764,0.00008542675,0.00021282869,0.005477751],"study_design_scores_gemma":[0.0017834333,0.00028938256,0.47262833,0.00007761981,0.0001924855,0.000005282808,0.000023655384,0.000276529,0.52379483,0.000019177807,0.0008518386,0.000057474706],"about_ca_topic_score_codex":0.000076616925,"about_ca_topic_score_gemma":0.0000018451915,"teacher_disagreement_score":0.28349537,"about_ca_system_score_codex":0.00021265277,"about_ca_system_score_gemma":0.00043730348,"threshold_uncertainty_score":0.31823537},"labels":[],"label_agreement":null},{"id":"W4417050804","doi":"10.3390/curroncol32120671","title":"Does Cardiopulmonary Bypass Affect Outcomes in Nephrectomy with Level III/IV Caval Thrombectomy for Renal Cell Carcinoma?","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Nephrectomy; Renal cell carcinoma; Perioperative; Cardiopulmonary bypass; Inferior vena cava; Complication; Retrospective cohort study; Stage (stratigraphy)","score_opus":0.07285270115247834,"score_gpt":0.3675983349129134,"score_spread":0.29474563376043506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417050804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847007,0.002608466,0.0005566027,0.001304499,0.0016832612,0.0027753226,0.00006752774,0.00008199843,0.0062216436],"genre_scores_gemma":[0.99469566,0.000056604218,0.0012565742,0.0001642188,0.00023395373,0.0009383395,0.00014723999,0.000045291694,0.0024621377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974522,0.00020508085,0.0005382802,0.00078089966,0.00030160794,0.00072191976],"domain_scores_gemma":[0.9983328,0.0005752943,0.00016292091,0.00056135183,0.00016972293,0.00019789695],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031595025,0.00048575824,0.0013957862,0.0004503604,0.000105541985,0.000017432694,0.00019064383,0.0002350581,0.00003990612],"category_scores_gemma":[0.00005500079,0.00027824639,0.00035335252,0.00038144542,0.0001888253,0.000078776924,0.00012274922,0.0004906356,0.000014162839],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026022359,0.001658898,0.9724511,0.0006701342,0.00028201268,0.00054761715,0.00038863352,0.000020091511,0.0022372708,0.00010449627,0.0040118364,0.015025654],"study_design_scores_gemma":[0.019929465,0.0029216842,0.9066856,0.00023389868,0.00094601617,0.00008883534,0.00034527734,0.00017957967,0.012665532,0.00013912152,0.05545212,0.0004129029],"about_ca_topic_score_codex":0.0003367951,"about_ca_topic_score_gemma":0.000725463,"teacher_disagreement_score":0.06576555,"about_ca_system_score_codex":0.001255923,"about_ca_system_score_gemma":0.0009940678,"threshold_uncertainty_score":0.999967},"labels":[],"label_agreement":null},{"id":"W4417065213","doi":"10.1007/s00330-025-12202-y","title":"Reply to the Letter to the Editor: Complication rates in renal mass biopsy—comparing co-axial with sequential biopsy techniques","year":2025,"lang":"en","type":"article","venue":"European Radiology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Complication; Interventional radiology; Renal mass; Neuroradiology; Biopsy; Ultrasound","score_opus":0.02518766887997437,"score_gpt":0.28709344396436115,"score_spread":0.2619057750843868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417065213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86408085,0.0001962308,0.012565198,0.0780296,0.0014383784,0.002360628,0.000012135576,0.00023077553,0.041086227],"genre_scores_gemma":[0.97986877,0.0000051830543,0.002928635,0.011568652,0.004752542,0.000109301945,0.000051462328,0.000031769767,0.0006837044],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982271,0.0005741913,0.0003227749,0.00043808614,0.00013887284,0.00029893604],"domain_scores_gemma":[0.9989823,0.000103177925,0.000074500684,0.00070321624,0.00006220614,0.000074593016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067883276,0.0001947828,0.00028986577,0.00019172434,0.000119593824,0.00003430614,0.00032842022,0.000039930175,0.000015693413],"category_scores_gemma":[0.00005514493,0.00010251917,0.000055155197,0.00034568584,0.00013144192,0.00002472491,0.00010036122,0.00030215477,0.00018295698],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018995873,0.00011561143,0.08355094,0.000035884183,0.0002109408,0.0006238481,0.0009828763,0.0002418822,0.2457448,0.00056636106,0.66338223,0.00264507],"study_design_scores_gemma":[0.0009461012,0.00071808056,0.37357005,0.0001430771,0.00008674117,0.00060752383,0.0000717067,0.00006389901,0.034403834,0.000019720212,0.5891815,0.0001877863],"about_ca_topic_score_codex":0.00010231227,"about_ca_topic_score_gemma":0.000015850052,"teacher_disagreement_score":0.29001912,"about_ca_system_score_codex":0.00017929537,"about_ca_system_score_gemma":0.000049450286,"threshold_uncertainty_score":0.41806105},"labels":[],"label_agreement":null},{"id":"W4417076267","doi":"10.1016/j.euf.2025.11.018","title":"Active Surveillance for Complex Cystic Renal Masses: Individualization over Generalization","year":2025,"lang":"en","type":"letter","venue":"European Urology Focus","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Generalization; MEDLINE; Kidney disease; Kidney","score_opus":0.03239711980349568,"score_gpt":0.2785539363303103,"score_spread":0.2461568165268146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417076267","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011049654,0.003236752,0.11493458,0.7348857,0.0032226553,0.008873129,0.0029847675,0.0009811816,0.119831584],"genre_scores_gemma":[0.10663527,0.00019081318,0.0044415584,0.8171887,0.0095401285,0.0002713898,0.041796595,0.0004828751,0.019452693],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967599,0.0009982553,0.00054221664,0.0008513475,0.00034036036,0.0005079176],"domain_scores_gemma":[0.9981983,0.0004183421,0.0004088222,0.00064193713,0.0002559326,0.00007670511],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031572842,0.00050211226,0.00071969314,0.00039832722,0.00013371244,0.00004022601,0.00023939366,0.00044909675,0.00022891987],"category_scores_gemma":[0.0002830685,0.00046051852,0.00025197465,0.000252094,0.0001256363,0.000046908983,0.0001223596,0.0007043349,0.000094425115],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004463773,0.00006362616,0.0022271886,0.00026526966,0.00056874333,0.0012403881,0.00010087533,0.00007414237,0.00050149724,0.00008234758,0.99233717,0.0020923628],"study_design_scores_gemma":[0.0025347357,0.00082347426,0.04392739,0.00004996978,0.0007018134,0.00013157568,0.0000025601537,0.00033670757,0.00019787007,0.00015906047,0.9508024,0.0003324326],"about_ca_topic_score_codex":0.000022787854,"about_ca_topic_score_gemma":0.00001192196,"teacher_disagreement_score":0.11049302,"about_ca_system_score_codex":0.00024103034,"about_ca_system_score_gemma":0.00017643356,"threshold_uncertainty_score":0.99978465},"labels":[],"label_agreement":null},{"id":"W4417112549","doi":"10.1186/s13244-025-02161-9","title":"A preoperative CT-based radiological score for predicting recurrence in papillary renal cell carcinoma: a multicenter validation study","year":2025,"lang":"en","type":"article","venue":"Insights into Imaging","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"Natural Science Foundation of Fujian Province; National Natural Science Foundation of China","keywords":"Neuroradiology; Papillary renal cell carcinomas; Radiological weapon; Renal cell carcinoma; Lymph node; Interventional radiology; Multicenter study; Renal function; Nephrology","score_opus":0.02765326350710547,"score_gpt":0.2973142196385986,"score_spread":0.26966095613149316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417112549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99097157,0.001582146,0.0023502128,0.00031421025,0.00022048866,0.003111413,0.00000321524,0.00006642271,0.001380334],"genre_scores_gemma":[0.99613184,0.000005669428,0.0027319558,0.0002888216,0.00008145438,0.00056169985,0.000068869216,0.000020097015,0.000109590765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998019,0.00023562835,0.0005257801,0.0006588841,0.00024161617,0.00031910927],"domain_scores_gemma":[0.9988811,0.00035326226,0.00011629304,0.00035025997,0.0002067848,0.00009227336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028895785,0.00028343033,0.00042255045,0.00035558938,0.00016549049,0.000055550627,0.00013187459,0.000041756488,0.000012091765],"category_scores_gemma":[0.00025427758,0.00021114679,0.000113405025,0.0003380276,0.00008772568,0.00016437315,0.00007739501,0.00029306865,0.000004402197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006203127,0.0010637961,0.9789001,0.00023425868,0.00003944606,0.0005283485,0.0046922243,0.00022049277,0.010948342,0.000019149926,0.0001437909,0.0025897727],"study_design_scores_gemma":[0.01658866,0.0017524577,0.6685557,0.0011149496,0.00045129127,0.000027352387,0.0033650585,0.06822285,0.23893137,0.00022095314,0.00032395122,0.000445453],"about_ca_topic_score_codex":0.00023745814,"about_ca_topic_score_gemma":0.00005119981,"teacher_disagreement_score":0.3103444,"about_ca_system_score_codex":0.0005402097,"about_ca_system_score_gemma":0.0002575922,"threshold_uncertainty_score":0.86103165},"labels":[],"label_agreement":null},{"id":"W4417208883","doi":"10.1200/po-25-00709","title":"Development and Validation of an Intratumor Heterogeneity–Based Prognostic Model for Clear Cell Renal Cell Carcinoma","year":2025,"lang":"en","type":"article","venue":"JCO Precision Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Clear cell renal cell carcinoma; Kidney cancer; Renal cell carcinoma; Immune system; Clear cell; Set (abstract data type); Prognostic model; Cell","score_opus":0.041305229038433956,"score_gpt":0.3198779747995676,"score_spread":0.2785727457611336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417208883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808525,0.00019933088,0.015691802,0.00017385406,0.000118984084,0.0014740648,0.00001125332,0.000027669788,0.0014505277],"genre_scores_gemma":[0.9096385,0.0000039925358,0.089351475,0.00015229206,0.000026652053,0.00020061764,0.00010721229,0.000019914525,0.0004993011],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984522,0.00010507547,0.00053721835,0.00045093964,0.00021162759,0.0002429405],"domain_scores_gemma":[0.9987921,0.0003331948,0.00018420292,0.0003111606,0.00022578095,0.00015355246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039666347,0.00019409008,0.00046482874,0.00024055317,0.0000798787,0.000012343001,0.00009870795,0.0001945916,0.0000107411915],"category_scores_gemma":[0.000084978485,0.00016373475,0.00008078161,0.00013184967,0.00006038091,0.000054988748,0.00006790109,0.000121103454,0.000004176811],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018395688,0.008051672,0.019679641,0.0021981227,0.00016984489,0.0001848415,0.0026870165,0.011488266,0.7556579,0.00025296467,0.00187601,0.17935802],"study_design_scores_gemma":[0.005605449,0.0033581038,0.013435531,0.00007097705,0.00025061888,0.000012541708,0.00007913485,0.08344715,0.8922042,0.00018333914,0.0012101115,0.00014281391],"about_ca_topic_score_codex":0.000005919162,"about_ca_topic_score_gemma":0.000016335425,"teacher_disagreement_score":0.17921521,"about_ca_system_score_codex":0.00030119217,"about_ca_system_score_gemma":0.00090879586,"threshold_uncertainty_score":0.66769093},"labels":[],"label_agreement":null},{"id":"W4417259318","doi":"10.1016/j.clgc.2025.102484","title":"Attrition Rates in Metastatic Renal Cell Carcinoma (mRCC) Following First Line Immunotherapy-Based Treatment: Results From the International mRCC Database Consortium (IMDC)","year":2025,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Dalhousie University; Sunnybrook Health Science Centre; Alberta Cancer Foundation; Queen Elizabeth II Health Sciences Centre; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Centre Intégré de Santé et Services Sociaux de Chaudière-Appalache","funders":"","keywords":"Renal cell carcinoma; First line; Attrition; First line therapy; Second line; Line (geometry); Expanded access","score_opus":0.0958034315958499,"score_gpt":0.38373461358010946,"score_spread":0.28793118198425954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417259318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974508,0.0092780655,0.00009906458,0.011495516,0.0013504539,0.0010735987,0.0009212552,0.000048454447,0.0012255869],"genre_scores_gemma":[0.98962635,0.0020238657,0.0012017033,0.0024225418,0.0007117412,0.00035679413,0.0017540314,0.000040371324,0.0018626162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966954,0.00034135027,0.0013627731,0.0008236962,0.00039435577,0.00038244986],"domain_scores_gemma":[0.9957936,0.0027512698,0.0002902633,0.00088698743,0.0001238697,0.00015405423],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006115924,0.0003926112,0.0007134501,0.00017232339,0.00016220605,0.000053966465,0.0003326648,0.00013604951,0.00025448218],"category_scores_gemma":[0.00028003938,0.00027257996,0.0005937876,0.00036910686,0.000164957,0.00011044543,0.00010094418,0.00043576953,0.000040624967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03956658,0.00841569,0.87268645,0.00016283328,0.002442894,0.0067136637,0.00054448657,0.0014994347,0.016194792,0.000012682721,0.018358676,0.033401836],"study_design_scores_gemma":[0.09182139,0.0036920775,0.74957883,0.0015320659,0.0021104976,0.000019042838,0.00042116598,0.0057818666,0.07301472,0.00019319003,0.07108224,0.0007529075],"about_ca_topic_score_codex":0.0029547263,"about_ca_topic_score_gemma":0.0009210821,"teacher_disagreement_score":0.12310759,"about_ca_system_score_codex":0.0007277769,"about_ca_system_score_gemma":0.0008468765,"threshold_uncertainty_score":0.99997264},"labels":[],"label_agreement":null},{"id":"W4417290913","doi":"10.1016/j.urolonc.2025.11.008","title":"Oncological outcomes of deferred systemic therapy for patients with metastatic renal cell carcinoma: A systematic review and quantitative analysis","year":2025,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Systemic therapy; Multidisciplinary approach; Kidney cancer; Renal cell carcinoma; MEDLINE; Risk assessment; Value (mathematics)","score_opus":0.06110670977565533,"score_gpt":0.362976739783401,"score_spread":0.3018700300077457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417290913","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014450511,0.9750132,0.00010343035,0.00017963923,0.000037447662,0.0097091235,0.00033281863,0.000027231841,0.0001465848],"genre_scores_gemma":[0.0018996571,0.9665948,0.026764037,0.00043408337,0.000008182282,0.00313403,0.0007380774,0.00002695557,0.0004001557],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9962596,0.0008936269,0.0014680077,0.0007671469,0.0002675303,0.0003440335],"domain_scores_gemma":[0.9937495,0.003660714,0.0015075655,0.0004742877,0.00034995345,0.00025799015],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067427993,0.00068545266,0.0074366643,0.00064978254,0.00015710712,0.00001781284,0.0001765429,0.00035312443,0.000013434284],"category_scores_gemma":[0.00061244733,0.00037237533,0.00066290994,0.0010178641,0.0006003616,0.00005371665,0.00006390807,0.00035696602,0.0000020548675],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001946744,0.0010563106,0.04033718,0.9488753,0.006428507,0.00010082814,0.00015692464,0.0000030056112,6.720421e-7,0.0008982479,0.00027583173,0.0016724874],"study_design_scores_gemma":[0.006982281,0.038148783,0.0020215677,0.1813303,0.67305815,0.0005568512,0.00026956684,0.00006392015,0.000004530655,0.00039582816,0.09595392,0.00121433],"about_ca_topic_score_codex":0.00002023616,"about_ca_topic_score_gemma":0.000008899782,"teacher_disagreement_score":0.76754504,"about_ca_system_score_codex":0.00029412712,"about_ca_system_score_gemma":0.0010323671,"threshold_uncertainty_score":0.9998728},"labels":[],"label_agreement":null},{"id":"W4417318237","doi":"10.1111/his.70071","title":"Diagnosing oncocytic renal tumours on renal mass biopsy; pathological concordance and the impact of evolving classification","year":2025,"lang":"en","type":"article","venue":"Histopathology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Concordance; Renal mass; Pathological; Biopsy; Nephrectomy; Kidney","score_opus":0.02856508679820213,"score_gpt":0.3085679475240208,"score_spread":0.28000286072581865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417318237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979355,0.0024655485,0.0008292987,0.0010268588,0.0001372205,0.00042964198,0.0000067775936,0.000035123554,0.01571456],"genre_scores_gemma":[0.99820745,0.000111974674,0.00083713315,0.00018706609,0.000055343906,0.00006525571,0.000011489199,0.0000120845525,0.00051218783],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99851173,0.00033049154,0.00038659957,0.0003784423,0.00015221268,0.00024053326],"domain_scores_gemma":[0.9986407,0.0005481391,0.0002135857,0.00041786785,0.0001088499,0.00007081329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000498572,0.00019580038,0.00054272293,0.00017483874,0.00011110178,0.000010313765,0.00010056712,0.00012812148,0.00004732698],"category_scores_gemma":[0.00050734106,0.00011426498,0.0001781405,0.00020539618,0.0008201432,0.000030489848,0.000041532825,0.0002827221,0.000010492176],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052541667,0.0004975719,0.37453666,0.000112041365,0.000052800773,0.0022381672,0.00071930053,0.00007105269,0.59291965,0.014311408,0.002221264,0.0070659085],"study_design_scores_gemma":[0.0033189335,0.0010708616,0.9897155,0.00020708289,0.00018236916,0.00074281567,0.00007055023,0.0011025912,0.0027660425,0.00067327335,0.00005823797,0.00009172981],"about_ca_topic_score_codex":0.000086133325,"about_ca_topic_score_gemma":0.000003921985,"teacher_disagreement_score":0.6151789,"about_ca_system_score_codex":0.0007827225,"about_ca_system_score_gemma":0.0001894713,"threshold_uncertainty_score":0.46595904},"labels":[],"label_agreement":null},{"id":"W4417321448","doi":"10.3322/caac.70052","title":"Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers","year":2025,"lang":"en","type":"article","venue":"CA A Cancer Journal for Clinicians","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Foothills Medical Centre; University of Calgary","funders":"","keywords":"Pembrolizumab; Consensus conference; Targeted therapy; Kidney cancer; Renal cell carcinoma; Delphi method; Bladder cancer; Systemic therapy","score_opus":0.07436056653310649,"score_gpt":0.37980496855853396,"score_spread":0.30544440202542744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417321448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94153917,0.028298397,0.00007759726,0.019413227,0.0014269574,0.0015312127,0.00019113565,0.000022433162,0.0074998448],"genre_scores_gemma":[0.96907204,0.019358208,0.00066484726,0.003343946,0.00018487735,0.00039096636,0.0000052169635,0.000030922045,0.0069489432],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99786574,0.00012214943,0.00078320556,0.0004503773,0.000315024,0.00046349358],"domain_scores_gemma":[0.99784267,0.0007356075,0.0004977283,0.0003799381,0.00035028238,0.00019377306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004390723,0.00033616525,0.00067834934,0.00014347481,0.00028552377,0.000028190854,0.00019386932,0.00013513214,0.00025432094],"category_scores_gemma":[0.000053176987,0.00022208993,0.0003057429,0.00021016673,0.0003631498,0.000022275772,0.00005007842,0.00053242006,0.0000024741869],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08696018,0.0067916797,0.04429308,0.006900979,0.0154118575,0.011077481,0.0067847124,0.014025928,0.044944413,0.007295197,0.36227274,0.39324176],"study_design_scores_gemma":[0.07443507,0.034664843,0.11361345,0.021514392,0.012043014,0.002378998,0.027126318,0.006043343,0.090798326,0.0061604534,0.6084371,0.0027846617],"about_ca_topic_score_codex":0.00025616898,"about_ca_topic_score_gemma":0.00008505236,"teacher_disagreement_score":0.3904571,"about_ca_system_score_codex":0.00061531656,"about_ca_system_score_gemma":0.0011230429,"threshold_uncertainty_score":0.90565646},"labels":[],"label_agreement":null},{"id":"W47662915","doi":"10.1016/s1695-3290(08)35028-9","title":"10.1016/s1695-3290(08)35028-9","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Humanities; Medicine; Philosophy","score_opus":0.014346755571160814,"score_gpt":0.1902581743636938,"score_spread":0.175911418792533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W47662915","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009681026,0.0013134122,1.8713389e-7,0.00033741147,0.000004950842,0.0010618055,0.000079972655,0.00021721299,0.99697536],"genre_scores_gemma":[0.0000094978195,0.0000066447956,0.00013192362,0.00012415236,0.0007234389,0.000044389417,0.0004949452,0.0002313841,0.9982336],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99769795,0.000018102262,0.00048228016,0.00070776686,0.0006392402,0.00045467736],"domain_scores_gemma":[0.9980721,0.00006907161,0.00013267172,0.001052227,0.00012442928,0.0005494852],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000100664794,0.00067983195,0.0009509051,0.00034985933,0.00006548953,0.00003141451,0.00021763,0.00046879202,0.998601],"category_scores_gemma":[0.000018526656,0.0006008365,0.0004244087,0.00005464375,0.00008136462,0.000038391667,0.00009559458,0.0005143466,0.9984973],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007121829,0.00009455903,4.4314916e-8,0.00009294413,0.0004187172,0.0010904284,0.000017222099,0.000004151979,0.000034877135,0.00003919963,0.5826716,0.4148241],"study_design_scores_gemma":[0.0009049322,0.0011723174,0.000011184486,0.00042034386,0.0007185669,0.00027343718,2.6818643e-7,0.000005202426,0.00013454871,0.00011472168,0.9957404,0.0005040904],"about_ca_topic_score_codex":0.000030237046,"about_ca_topic_score_gemma":3.2572248e-7,"teacher_disagreement_score":0.41432002,"about_ca_system_score_codex":0.0004110551,"about_ca_system_score_gemma":0.00019344191,"threshold_uncertainty_score":0.9996443},"labels":[],"label_agreement":null},{"id":"W54673028","doi":"","title":"Hypofractionated radiotherapy with concomitant sunitinib - is there a radiosensitizing effect?","year":2009,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Sunitinib; Concomitant; Radiation therapy; Dose fractionation; External beam radiotherapy; Nuclear medicine; Oncology; Tyrosine-kinase inhibitor; Internal medicine; Radiology; Cancer; Brachytherapy","score_opus":0.019414805133492138,"score_gpt":0.2368707081881979,"score_spread":0.21745590305470575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W54673028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769521,0.002086725,0.000036311685,0.004547524,0.00007094965,0.0017048722,0.000004566486,0.00016400249,0.014432994],"genre_scores_gemma":[0.99450433,0.000109391935,0.00041113386,0.003065441,0.0001920516,0.00029063548,0.000019979154,0.00003595278,0.001371087],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99867857,0.000086626584,0.00018864917,0.00030404588,0.00032189616,0.00042020308],"domain_scores_gemma":[0.9990881,0.00015723093,0.00008796238,0.00033412722,0.00007978163,0.00025277122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020895709,0.00023918279,0.0004135301,0.00011188811,0.00007687923,0.000033108787,0.000053088203,0.00008444624,0.00006871334],"category_scores_gemma":[0.000031342224,0.00015880144,0.000110196044,0.00023267641,0.00005300755,0.00010831037,0.0000046449877,0.00020242773,0.0000163832],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073944717,0.0007198344,0.03930854,0.00010469669,0.0013073529,0.0053818147,0.0006232026,0.000012228902,0.013596309,0.00021250873,0.00483229,0.92650676],"study_design_scores_gemma":[0.007114707,0.0013625547,0.9205424,0.000049367438,0.00023070864,0.0017186032,0.00004948181,0.00006025681,0.059186038,0.000026483145,0.009436473,0.00022291894],"about_ca_topic_score_codex":0.00003623632,"about_ca_topic_score_gemma":0.0000017823917,"teacher_disagreement_score":0.92628384,"about_ca_system_score_codex":0.0003289901,"about_ca_system_score_gemma":0.00004311093,"threshold_uncertainty_score":0.6475735},"labels":[],"label_agreement":null},{"id":"W623039274","doi":"10.1007/s10585-015-9725-2","title":"Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma","year":2015,"lang":"en","type":"article","venue":"Clinical & Experimental Metastasis","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; St. Michael's Hospital; Western University; London Health Sciences Centre; York University; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Clear cell renal cell carcinoma; Oncology; Internal medicine; Immunohistochemistry; Surgical oncology; Renal cell carcinoma; Proportional hazards model; Hazard ratio; Medicine; Stage (stratigraphy); Cancer; Survival analysis; Pathology; Biology; Confidence interval","score_opus":0.08596090491524395,"score_gpt":0.3601470454296193,"score_spread":0.27418614051437534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W623039274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98445415,0.0052595027,0.000029530105,0.0004223189,0.0005505099,0.0012481775,0.000042776515,0.00007305469,0.00791998],"genre_scores_gemma":[0.99159557,0.000040305593,0.005123887,0.0010640587,0.00033680638,0.00014785265,0.00007278342,0.000098612036,0.0015201323],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953845,0.0005212613,0.0014006293,0.0010827332,0.0008575909,0.000753281],"domain_scores_gemma":[0.99733824,0.00022262461,0.0002711427,0.0008453797,0.00013644046,0.0011861792],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00093442184,0.0005299222,0.0010616457,0.00022710385,0.0000703195,0.000058490034,0.00027235158,0.00027386958,0.0010217404],"category_scores_gemma":[0.0001859106,0.0004483133,0.0006790258,0.00037299586,0.00027785578,0.00017466635,0.0003109397,0.0006209387,0.0009876275],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02542766,0.042771276,0.6488122,0.0004198213,0.00072669773,0.021092737,0.0041149347,0.00002534129,0.18285021,0.000039459042,0.059464943,0.014254764],"study_design_scores_gemma":[0.025237659,0.013086374,0.12970015,0.000115218885,0.0010282595,0.0003173833,0.003513104,0.0006408236,0.819078,0.00005515725,0.0063478854,0.00087994314],"about_ca_topic_score_codex":0.00021119468,"about_ca_topic_score_gemma":0.0000040536856,"teacher_disagreement_score":0.63622785,"about_ca_system_score_codex":0.000398143,"about_ca_system_score_gemma":0.00034529305,"threshold_uncertainty_score":0.99989146},"labels":[],"label_agreement":null},{"id":"W631719039","doi":"10.1007/978-3-319-10470-6_84","title":"Automatic Labelling of Tumourous Frames in Free-Hand Laparoscopic Ultrasound Video","year":2014,"lang":"en","type":"article","venue":"Lecture notes in computer science","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Simon Fraser University","funders":"Qatar National Research Fund; Fonds National de la Recherche Luxembourg; Qatar Foundation","keywords":"Ultrasound; Nephrectomy; Computer science; Regularization (linguistics); Artificial intelligence; Frame (networking); Graph; Medicine; Radiology; Computer vision; Kidney; Internal medicine","score_opus":0.012001958850633047,"score_gpt":0.2535082967184224,"score_spread":0.24150633786778936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W631719039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69769883,0.00044952647,0.30107656,0.00032788786,0.00022995278,0.00016998222,5.853093e-7,0.000019501414,0.000027166636],"genre_scores_gemma":[0.903747,0.0000072324697,0.095773146,0.0003724114,0.00008284136,0.000005472482,0.0000013640089,0.000008694303,0.0000018054794],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984731,0.00006126069,0.00030706142,0.00039563232,0.00042010564,0.00034283134],"domain_scores_gemma":[0.99849194,0.00073179964,0.000083873565,0.00053762377,0.000065865184,0.00008886837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005395237,0.00015272906,0.00036219315,0.0003099845,0.000050002294,0.000051679803,0.00033419422,0.00006704667,0.0000144857295],"category_scores_gemma":[0.0005726329,0.00012132264,0.000039581348,0.00090506516,0.0004173152,0.00010281494,0.00009548913,0.00021895373,0.0000050719605],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053612053,0.00061537756,0.4511832,0.0006684348,0.000023425,0.00020487871,0.006034157,0.052831776,0.13295367,0.00011107979,0.000022788638,0.3552976],"study_design_scores_gemma":[0.0022287206,0.0008473371,0.20784731,0.00095712446,0.000025270976,0.00017378069,0.000002438102,0.32752413,0.45031235,0.009840228,0.000018228355,0.00022306608],"about_ca_topic_score_codex":0.00018972313,"about_ca_topic_score_gemma":0.000121277095,"teacher_disagreement_score":0.35507452,"about_ca_system_score_codex":0.00013433666,"about_ca_system_score_gemma":0.00013288294,"threshold_uncertainty_score":0.49473938},"labels":[],"label_agreement":null},{"id":"W64788256","doi":"","title":"Pazopanib: an orally administered multi-targeted tyrosine kinase inhibitor for locally advanced or metastatic renal cell carcinoma.","year":2011,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pazopanib; Medicine; Renal cell carcinoma; Sorafenib; Sunitinib; Tyrosine-kinase inhibitor; Oncology; Adverse effect; Kidney cancer; Internal medicine; Clinical trial; Cancer; Pharmacology","score_opus":0.09985080328074944,"score_gpt":0.27720504206705243,"score_spread":0.177354238786303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W64788256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98878324,0.0010548391,0.0015934769,0.00014504102,0.0003724143,0.0068720914,0.0001574665,0.00021856924,0.00080288725],"genre_scores_gemma":[0.9341998,0.000011618962,0.054466963,0.0004177992,0.0001726348,0.005890015,0.00030245163,0.00014029224,0.0043983995],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99682707,0.00012490513,0.00076533406,0.00084701355,0.00042133123,0.001014372],"domain_scores_gemma":[0.9974421,0.000101225894,0.00028244877,0.00083710806,0.00035408227,0.0009830137],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039546084,0.0005313425,0.0007803398,0.00022936035,0.00012052501,0.000039621387,0.00024626747,0.00012848224,0.00014315244],"category_scores_gemma":[0.00024298382,0.00039228605,0.00026568514,0.00030833783,0.0001227501,0.00027435028,0.00007423803,0.00020398156,0.00003246699],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.122329116,0.025441997,0.042296432,0.0042793388,0.0013698259,0.011379292,0.0060925726,0.00003859461,0.17819956,0.0001746541,0.0041999193,0.6041987],"study_design_scores_gemma":[0.02391902,0.0061527193,0.41224283,0.000059965023,0.0010569739,0.00017188377,0.00036386462,0.0004037337,0.5528467,0.000038827216,0.0020391895,0.00070424716],"about_ca_topic_score_codex":0.00008015904,"about_ca_topic_score_gemma":0.0001677391,"teacher_disagreement_score":0.60349447,"about_ca_system_score_codex":0.0002881397,"about_ca_system_score_gemma":0.0003138927,"threshold_uncertainty_score":0.9998529},"labels":[],"label_agreement":null},{"id":"W6891682197","doi":"10.48083/wqfr32352","title":"Can Incomplete Metastasectomy Impact Renal Cell Carcinoma Outcomes? A Propensity Score Matching Analysis from a Prospective Multicenter Collaboration","year":2021,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Université Laval; Queen Elizabeth II Health Sciences Centre; University of Manitoba; Ottawa Hospital; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Juravinski Cancer Centre; University of British Columbia; Centre Hospitalier de l’Université de Montréal; University of Calgary; McGill University","funders":"","keywords":"Metastasectomy; Propensity score matching; Renal cell carcinoma; Nephrectomy; Proportional hazards model; Confounding; Multivariate analysis; Kidney cancer; Lung","score_opus":0.054051272741415315,"score_gpt":0.32488997896966576,"score_spread":0.27083870622825046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6891682197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930439,0.0004551836,0.0012804244,0.002604164,0.00034969853,0.0005843033,0.0004978886,0.000049750037,0.0011347122],"genre_scores_gemma":[0.9933366,0.000028581155,0.0037743961,0.00080302777,0.0003404875,0.000044150864,0.0009181508,0.000032308344,0.0007222646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967646,0.00040622105,0.0007542706,0.0006073782,0.001025279,0.00044224676],"domain_scores_gemma":[0.9967067,0.00031070728,0.0006564188,0.00042133342,0.0015709628,0.00033383965],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042226963,0.00041103413,0.0009357239,0.0004223903,0.00027881406,0.0002860972,0.00024245439,0.0001421306,0.001508642],"category_scores_gemma":[0.0003263926,0.00030584692,0.0010082461,0.000699614,0.000082080085,0.0002959207,0.00019053955,0.00082338706,0.00002218599],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007623842,0.0005614796,0.97204065,0.0000143408315,0.0049452423,0.0023776689,0.0010363333,0.00076496665,0.01687172,0.000018140465,0.00031892103,0.00028814754],"study_design_scores_gemma":[0.005170482,0.0004101943,0.9750422,0.000026798876,0.0027230694,0.00029112527,0.0005914488,0.0008024994,0.013804676,0.0008130932,0.00007285315,0.0002515215],"about_ca_topic_score_codex":0.00076971954,"about_ca_topic_score_gemma":0.0007764437,"teacher_disagreement_score":0.004408098,"about_ca_system_score_codex":0.0019362953,"about_ca_system_score_gemma":0.0009804633,"threshold_uncertainty_score":0.9999394},"labels":[],"label_agreement":null},{"id":"W6892116735","doi":"10.5167/uzh-81215","title":"The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia","year":2013,"lang":"en","type":"article","venue":"Zurich Open Repository and Archive (University of Zurich)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chromophobe cell; Renal cell carcinoma; Oncocytoma; Clear cell; Renal pathology; Papillary renal cell carcinomas; Clear cell carcinoma; Kidney","score_opus":0.016930143393312145,"score_gpt":0.21480561432858097,"score_spread":0.19787547093526883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6892116735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772823,0.00009672254,0.0011296157,0.00071794534,0.00008999237,0.00041065027,0.000010257547,0.000006991862,0.020255523],"genre_scores_gemma":[0.9902233,0.00013756796,0.007003214,0.00003327291,0.000024662942,0.0000017724359,0.000016745149,0.000004781862,0.002554702],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991197,0.00016663746,0.00019243761,0.0002169815,0.00019398583,0.00011028136],"domain_scores_gemma":[0.99886256,0.00037879922,0.00028740696,0.00023500474,0.00016396736,0.00007228415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027000887,0.00009164451,0.00024862116,0.000041832856,0.00017172078,0.000011068487,0.00032137337,0.0000641472,0.00004810211],"category_scores_gemma":[0.000019803436,0.000069560694,0.00012507093,0.000078280515,0.00046637168,0.00013221381,0.00032139584,0.00012537726,0.0000031947045],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015819176,0.000776752,0.1953043,0.0001300758,0.0007169203,0.00011687758,0.0035364868,0.000020807194,0.69636625,0.0022105295,0.093096554,0.006142528],"study_design_scores_gemma":[0.0015547534,0.0008555596,0.9788033,0.000044077442,0.0001680412,0.0001173874,0.0029136743,0.001272862,0.0071670557,0.0008685654,0.0061425157,0.0000922158],"about_ca_topic_score_codex":0.00024849185,"about_ca_topic_score_gemma":0.000029945204,"teacher_disagreement_score":0.783499,"about_ca_system_score_codex":0.00003111798,"about_ca_system_score_gemma":0.000076548145,"threshold_uncertainty_score":0.28366026},"labels":[],"label_agreement":null},{"id":"W6901716441","doi":"10.60692/9bs75-5g067","title":"Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"","keywords":"Clear cell renal cell carcinoma; Genome; Whole genome sequencing; Epigenetics; ARID1A; Genomics; Germline; Somatic cell; DNA sequencing; Kidney cancer","score_opus":0.03603567508648707,"score_gpt":0.20270394042628262,"score_spread":0.16666826533979556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901716441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663055,0.000013702074,0.00012692944,0.000021710508,0.000034040506,0.0006762124,0.00012303989,0.00008926719,0.002284558],"genre_scores_gemma":[0.9991402,0.0000011616157,0.000213172,0.000026942382,0.000026979811,0.000040132625,0.0003265269,0.000016289197,0.00020861244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987895,0.00003669518,0.00048243447,0.00015515886,0.00035794513,0.00017829216],"domain_scores_gemma":[0.99901164,0.0000065072536,0.00032996724,0.00032441973,0.0002353838,0.0000921031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015965824,0.00016886342,0.0002522169,0.0002706048,0.00007366425,0.000042265732,0.000054587246,0.00007091544,0.000009317549],"category_scores_gemma":[0.0000020498903,0.00011575488,0.000042789095,0.00022210622,0.00003222309,0.00027691014,0.000020393598,0.00006519095,0.00019443847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010312583,0.000015542168,0.935332,0.0018932999,0.000055322267,0.000013708906,0.05647615,0.00019232399,0.0043913834,0.000009311194,0.00005470339,0.00053497846],"study_design_scores_gemma":[0.0031493348,0.0007398777,0.96560156,0.0000646576,0.000041041665,0.0000089994255,0.0052948147,0.00044399445,0.024381036,2.31041e-7,0.0001433357,0.00013108991],"about_ca_topic_score_codex":0.00001997625,"about_ca_topic_score_gemma":1.3143249e-7,"teacher_disagreement_score":0.051181335,"about_ca_system_score_codex":0.00012872723,"about_ca_system_score_gemma":0.00006560058,"threshold_uncertainty_score":0.47203472},"labels":[],"label_agreement":null},{"id":"W6902009445","doi":"10.6084/m9.figshare.12211265.v1","title":"Additional file 2 of Management of complex renal cysts in Canada: results of a survey study","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; McGill University; Ottawa Hospital; Princess Margaret Cancer Centre; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Cyst; Nephrectomy; MEDLINE; Kidney; Survey research","score_opus":0.12445842375933763,"score_gpt":0.26761120200133387,"score_spread":0.14315277824199624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902009445","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011908028,0.000017495164,1.0557387e-8,0.000030832343,0.0000028014315,0.0004718652,0.98317206,0.000003371413,0.004393532],"genre_scores_gemma":[0.49064538,1.3773612e-7,0.00008056748,0.000017914115,0.0000067886654,0.000086469765,0.5090793,0.000004657078,0.00007879041],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99883395,0.000064819964,0.0004124453,0.00017124876,0.00041515988,0.00010236451],"domain_scores_gemma":[0.9988748,0.0005011232,0.00020865232,0.00018117575,0.00015712704,0.00007712852],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00003084592,0.000089992915,0.0003199325,0.000042703494,0.000006139498,8.971697e-7,0.00009090488,0.000017502067,0.89062566],"category_scores_gemma":[0.00064008817,0.0000805084,0.000042319993,0.00025800747,0.000005357369,0.000013223471,0.00007976739,0.00005914492,0.000039449456],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004470678,0.00021245508,0.00068025396,0.0004211017,0.000108302425,0.0003011447,0.00008310927,0.000021940174,0.000013101654,1.0785286e-7,0.9973389,0.0003725156],"study_design_scores_gemma":[0.0018184957,0.00053644483,0.9706547,0.0019294707,0.000017550865,0.000002460403,0.00021331717,0.00008606469,0.00030712676,2.8319957e-7,0.024381569,0.000052514195],"about_ca_topic_score_codex":0.107497826,"about_ca_topic_score_gemma":0.29447332,"teacher_disagreement_score":0.9729573,"about_ca_system_score_codex":0.00014418595,"about_ca_system_score_gemma":0.00051541126,"threshold_uncertainty_score":0.8984454},"labels":[],"label_agreement":null},{"id":"W6920344604","doi":"10.60692/4ndcg-hg698","title":"Successful Surgical Management of Locally Advanced Renal Cell Carcinoma Invading Spleen and Pancreas","year":2022,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University","funders":"","keywords":"Nephrectomy; Renal cell carcinoma; Pancreas; Kidney; Spleen; Lung; Blood loss; Carcinoma","score_opus":0.020883177841183768,"score_gpt":0.20848094258896424,"score_spread":0.18759776474778048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920344604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98280483,0.000047380294,0.00042360387,0.000031585318,0.00009719867,0.0007703137,0.00006403801,0.0000622217,0.015698843],"genre_scores_gemma":[0.99880046,7.69358e-7,0.0005400567,0.000030529784,0.000024124756,0.00014947087,0.00007264636,0.000013543347,0.00036838668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828994,0.00008477044,0.000646019,0.00018733881,0.0005566266,0.00023533049],"domain_scores_gemma":[0.9991012,0.0000101202495,0.0003111036,0.000337698,0.00009197141,0.00014789944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033428392,0.0001876826,0.00037778183,0.0002448567,0.00013924575,0.000029756715,0.00010442941,0.000041866762,0.0000711526],"category_scores_gemma":[0.0000016969926,0.00015743147,0.00009082398,0.00023895937,0.000031838554,0.00022773701,0.00020810435,0.000119153556,0.000036433357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016948401,0.000020989888,0.9733783,0.0045026788,0.00017496577,0.00063542026,0.0171424,0.0004818955,0.000029941175,0.00038614133,0.000059137346,0.0014932897],"study_design_scores_gemma":[0.020315388,0.0016935193,0.88570714,0.00063707656,0.0006570691,0.0022197955,0.06892909,0.00294299,0.014690989,0.0000022273405,0.0016049235,0.00059979263],"about_ca_topic_score_codex":0.000022387847,"about_ca_topic_score_gemma":6.5332365e-8,"teacher_disagreement_score":0.08767116,"about_ca_system_score_codex":0.0002783535,"about_ca_system_score_gemma":0.00003946828,"threshold_uncertainty_score":0.64198685},"labels":[],"label_agreement":null},{"id":"W6920494280","doi":"10.60692/07qv9-1gz80","title":"Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"","keywords":"Clear cell renal cell carcinoma; Genome; Whole genome sequencing; Epigenetics; ARID1A; Genomics; Germline; Somatic cell; DNA sequencing; Kidney cancer","score_opus":0.03603567508648707,"score_gpt":0.20270394042628262,"score_spread":0.16666826533979556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920494280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663055,0.000013702074,0.00012692944,0.000021710508,0.000034040506,0.0006762124,0.00012303989,0.00008926719,0.002284558],"genre_scores_gemma":[0.9991402,0.0000011616157,0.000213172,0.000026942382,0.000026979811,0.000040132625,0.0003265269,0.000016289197,0.00020861244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987895,0.00003669518,0.00048243447,0.00015515886,0.00035794513,0.00017829216],"domain_scores_gemma":[0.99901164,0.0000065072536,0.00032996724,0.00032441973,0.0002353838,0.0000921031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015965824,0.00016886342,0.0002522169,0.0002706048,0.00007366425,0.000042265732,0.000054587246,0.00007091544,0.000009317549],"category_scores_gemma":[0.0000020498903,0.00011575488,0.000042789095,0.00022210622,0.00003222309,0.00027691014,0.000020393598,0.00006519095,0.00019443847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010312583,0.000015542168,0.935332,0.0018932999,0.000055322267,0.000013708906,0.05647615,0.00019232399,0.0043913834,0.000009311194,0.00005470339,0.00053497846],"study_design_scores_gemma":[0.0031493348,0.0007398777,0.96560156,0.0000646576,0.000041041665,0.0000089994255,0.0052948147,0.00044399445,0.024381036,2.31041e-7,0.0001433357,0.00013108991],"about_ca_topic_score_codex":0.00001997625,"about_ca_topic_score_gemma":1.3143249e-7,"teacher_disagreement_score":0.051181335,"about_ca_system_score_codex":0.00012872723,"about_ca_system_score_gemma":0.00006560058,"threshold_uncertainty_score":0.47203472},"labels":[],"label_agreement":null},{"id":"W6920512806","doi":"10.6084/m9.figshare.12211271.v1","title":"Additional file 3 of Management of complex renal cysts in Canada: results of a survey study","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; McGill University; Ottawa Hospital; Princess Margaret Cancer Centre; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Nephrectomy; Kidney; Survey research; MEDLINE; Kidney disease","score_opus":0.12666550223682926,"score_gpt":0.267790958306905,"score_spread":0.14112545607007576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920512806","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012101586,0.000017284998,1.0895669e-8,0.000030850468,0.0000028139157,0.00047286853,0.9830595,0.000003367718,0.0043116896],"genre_scores_gemma":[0.49242544,1.357596e-7,0.00008143932,0.00001787817,0.000006757142,0.00008641614,0.5072971,0.000004659295,0.000080190046],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9988337,0.000064772954,0.00041244575,0.00017130958,0.00041537674,0.000102398655],"domain_scores_gemma":[0.99886996,0.0005041604,0.00020835827,0.00018126225,0.00015913822,0.00007713467],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000031023843,0.000090011075,0.00031988052,0.000042719068,0.0000061383716,8.970695e-7,0.00009089674,0.00001750023,0.8899407],"category_scores_gemma":[0.000648854,0.00008051484,0.000042326254,0.00025812676,0.0000053578947,0.0000132248515,0.000079713565,0.00005914655,0.000040443076],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004530658,0.00021244884,0.00070704985,0.00042506662,0.00010821344,0.0002960885,0.00008304624,0.000021831174,0.000013683295,1.049687e-7,0.99731225,0.0003671372],"study_design_scores_gemma":[0.0018289557,0.0005342217,0.9711633,0.0019477236,0.000017400069,0.000002422,0.00021415424,0.00008668562,0.0003163661,2.80927e-7,0.023835983,0.000052524327],"about_ca_topic_score_codex":0.107647605,"about_ca_topic_score_gemma":0.29469532,"teacher_disagreement_score":0.9734763,"about_ca_system_score_codex":0.00014480019,"about_ca_system_score_gemma":0.0005183832,"threshold_uncertainty_score":0.8982946},"labels":[],"label_agreement":null},{"id":"W6920848034","doi":"10.6084/m9.figshare.12082173","title":"Additional file 1 of Stem/progenitor cell marker expression in clear cell renal cell carcinoma: a potential relationship with the immune microenvironment to be explored","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Immune system; Cell; Immune checkpoint; Correlation; Gene; Cell growth; Gene expression; Cell type; Predictive marker","score_opus":0.034724741806087686,"score_gpt":0.2000374365124975,"score_spread":0.1653126947064098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920848034","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11290143,0.00037073324,0.0000016665496,0.0006293065,0.000010094961,0.0011385933,0.883397,0.000023640434,0.0015275578],"genre_scores_gemma":[0.64945704,6.163009e-7,0.0008369594,0.00021442813,0.0000939063,0.0011299782,0.34686524,0.000041870477,0.0013599574],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983387,0.00011061978,0.00034528153,0.00041846343,0.0005041952,0.00028274299],"domain_scores_gemma":[0.9987348,0.00037841572,0.00020000665,0.00038672987,0.000063664746,0.00023642159],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000028178041,0.00025026294,0.00028519137,0.00007512929,0.00008535225,0.000016962485,0.00018570633,0.00010026217,0.80842465],"category_scores_gemma":[0.00006382665,0.00017487996,0.00015082538,0.00023049193,0.000018055855,0.00007055559,0.00017573385,0.00029826007,0.0013278228],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095510355,0.00024689012,0.00014826226,0.0002592728,0.00000972231,0.00020651118,0.0005982432,0.00008722273,0.03465571,2.561447e-8,0.96278566,0.000047357502],"study_design_scores_gemma":[0.0036907971,0.0021058144,0.17747095,0.0016263435,0.000109386194,0.000038072933,0.0017848852,0.00023933416,0.51003814,6.6321746e-7,0.30247697,0.00041863925],"about_ca_topic_score_codex":0.0000066383227,"about_ca_topic_score_gemma":0.0000026073678,"teacher_disagreement_score":0.80709684,"about_ca_system_score_codex":0.00013617934,"about_ca_system_score_gemma":0.00013375455,"threshold_uncertainty_score":0.99944973},"labels":[],"label_agreement":null},{"id":"W6920912511","doi":"10.6084/m9.figshare.12082179.v1","title":"Additional file 2 of Stem/progenitor cell marker expression in clear cell renal cell carcinoma: a potential relationship with the immune microenvironment to be explored","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cell; Immune system; Expression (computer science); Clear cell renal cell carcinoma; Cell growth; Gene expression; Cell type; T cell","score_opus":0.033604052517278375,"score_gpt":0.19961924825063146,"score_spread":0.16601519573335308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920912511","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1127841,0.00037797765,0.0000016407965,0.00062918005,0.000010196627,0.0011419689,0.88346416,0.000023744453,0.0015670558],"genre_scores_gemma":[0.6483984,6.319678e-7,0.0008205871,0.0002146282,0.0000952829,0.001110824,0.34795249,0.0000418529,0.0013653265],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983391,0.000110584944,0.00034542556,0.00041817196,0.00050407817,0.00028264622],"domain_scores_gemma":[0.9987403,0.00037344187,0.0002002672,0.00038604016,0.000063533196,0.00023638981],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000028034958,0.00025018895,0.0002852563,0.000075083546,0.000085358064,0.000016996719,0.00018561023,0.00010026271,0.80567],"category_scores_gemma":[0.000063109976,0.0001748268,0.00015079825,0.00023032534,0.000018055624,0.000070600545,0.00017571087,0.00029819625,0.0013146612],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095188594,0.00024723454,0.00014413027,0.00026190098,0.00000973891,0.00021212065,0.0005997296,0.0000877613,0.033632256,2.6077599e-8,0.96380454,0.00004866972],"study_design_scores_gemma":[0.0036981206,0.0020969918,0.17422025,0.0016007022,0.00010854423,0.000037985752,0.0017602675,0.00023681304,0.505325,6.652241e-7,0.3104986,0.00041600715],"about_ca_topic_score_codex":0.00000670051,"about_ca_topic_score_gemma":0.0000026217153,"teacher_disagreement_score":0.8043554,"about_ca_system_score_codex":0.0001362156,"about_ca_system_score_gemma":0.00013320099,"threshold_uncertainty_score":0.9994629},"labels":[],"label_agreement":null},{"id":"W6920955037","doi":"10.6084/m9.figshare.6885680.v1","title":"Additional file 1: of Off-clamp partial nephrectomy has a positive impact on short- and long-term renal function: a systematic review and meta-analysis","year":2018,"lang":"en","type":"article","venue":"Figshare","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nephrectomy; Table (database); Kidney; Kidney disease; Renal cell carcinoma; MEDLINE","score_opus":0.0880440629490279,"score_gpt":0.3065310349364848,"score_spread":0.21848697198745692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920955037","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045665287,0.013432227,4.5606967e-7,0.000103337145,0.0000029423907,0.0012833225,0.9842866,0.000018440027,0.000416042],"genre_scores_gemma":[0.089638196,0.0000151925005,0.000053097403,0.000810831,0.00011325347,0.0033469312,0.90499055,0.000022102946,0.0010098701],"study_design_codex":"not_applicable","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9986766,0.000111846944,0.00037717453,0.00033190133,0.00033935666,0.00016310891],"domain_scores_gemma":[0.998287,0.00069618877,0.00021078167,0.00033817487,0.00028911105,0.00017870433],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000051994215,0.0002450341,0.0014296517,0.00013730855,0.000076058255,0.00003145105,0.000046569447,0.000066137116,0.97790253],"category_scores_gemma":[0.0006120001,0.00014900668,0.0006778159,0.00031024378,0.000041493997,0.000069990296,0.000042483807,0.00009684986,0.0003663253],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013039328,0.00008278584,0.000015451895,0.021037225,0.049372353,0.00008017377,0.000032205557,2.3444747e-7,0.000005043873,3.6566024e-7,0.9292065,0.000037269223],"study_design_scores_gemma":[0.0008373387,0.0050280797,0.08218767,0.07218028,0.8255281,0.0007501497,0.000012825768,0.0001566851,0.00048467037,0.0000036657843,0.012304962,0.00052561396],"about_ca_topic_score_codex":0.000002852776,"about_ca_topic_score_gemma":0.000009549647,"teacher_disagreement_score":0.9775362,"about_ca_system_score_codex":0.00006417462,"about_ca_system_score_gemma":0.0000878528,"threshold_uncertainty_score":0.60763156},"labels":[],"label_agreement":null},{"id":"W6920987196","doi":"10.6084/m9.figshare.26598944.v1","title":"Additional file 2 of Comparison of peri- and intraoperative outcomes of open vs robotic-assisted partial nephrectomy for renal cell carcinoma: a propensity-matched analysis","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nephrectomy; Renal cell carcinoma; Propensity score matching; Perioperative; Standard of care; Kidney cancer; Kidney","score_opus":0.07915020875157817,"score_gpt":0.322172770360991,"score_spread":0.24302256160941282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920987196","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038050313,0.00024766164,0.0000044998674,0.00006699336,0.0000105393365,0.0012712731,0.9595266,0.000013796504,0.0008083084],"genre_scores_gemma":[0.5613278,2.3703134e-7,0.0018566648,0.000012600339,0.000018707477,0.0008818283,0.43525073,0.000012843562,0.000638555],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9986695,0.00006117276,0.0005157709,0.00033103913,0.00026098313,0.00016152769],"domain_scores_gemma":[0.9979689,0.0010790963,0.0002334159,0.00024684935,0.0003687752,0.00010292416],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000044613003,0.00019045068,0.0011305695,0.00019363782,0.00003851044,0.000027776807,0.00013579598,0.00008108798,0.74282867],"category_scores_gemma":[0.00051096344,0.00014139191,0.00029074415,0.0004259083,0.000038408474,0.000104135055,0.00015455233,0.00010746954,0.000026326496],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047848898,0.00045618418,0.0035930406,0.0017047247,0.0013865968,0.00003244753,0.0006400768,0.00007875903,0.0012788556,0.0000050022404,0.9898157,0.00053012994],"study_design_scores_gemma":[0.0035064602,0.003243965,0.7136991,0.003991321,0.004087605,0.00002849864,0.00061684137,0.019835288,0.12605472,0.000010248702,0.124460615,0.00046536454],"about_ca_topic_score_codex":0.000059480495,"about_ca_topic_score_gemma":0.00005921709,"teacher_disagreement_score":0.8653551,"about_ca_system_score_codex":0.00006053681,"about_ca_system_score_gemma":0.00030182535,"threshold_uncertainty_score":0.57657945},"labels":[],"label_agreement":null},{"id":"W6923831022","doi":"10.14288/cl.v0i76","title":"Canadian Literature, No 76 (1978): Sources","year":2015,"lang":"en","type":"article","venue":"Open Collections","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Government (linguistics); Work (physics); Natural (archaeology); Identification (biology)","score_opus":0.03568275568726723,"score_gpt":0.2743387452080035,"score_spread":0.23865598952073627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6923831022","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00993412,0.00042551468,0.000004256011,0.0011868003,0.00036745702,0.000740395,0.000038870352,0.000031625925,0.98727095],"genre_scores_gemma":[0.15985483,0.000015021733,0.0011479646,0.0005377051,0.00020001992,0.00013278122,0.00006993104,0.000016206997,0.8380255],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992435,0.000036269965,0.00012509814,0.00021040438,0.00015045496,0.0002342566],"domain_scores_gemma":[0.99866885,0.000020537895,0.000026555408,0.00029105737,0.00029208398,0.0007009402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011116144,0.00011366913,0.00017997017,0.00013120548,0.0007015875,0.00072487985,0.00013014676,0.00007104414,0.00082628895],"category_scores_gemma":[0.0000901994,0.00009450658,0.000055721823,0.0009194662,0.000021892776,0.00011327418,0.00004846963,0.00013801688,0.0003704812],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080612976,0.00008167744,0.0015082166,0.0000064613146,0.00007074016,0.00018775467,0.000347127,0.000007570382,0.000033718454,0.000040767754,0.99746084,0.00017448296],"study_design_scores_gemma":[0.0015484672,0.00056179275,0.0017017829,0.000066830646,0.00009280878,0.00042857844,0.00022839913,0.00006368472,0.00065595756,0.00027361754,0.99424523,0.00013286491],"about_ca_topic_score_codex":0.5490714,"about_ca_topic_score_gemma":0.3444155,"teacher_disagreement_score":0.20465587,"about_ca_system_score_codex":0.0007905245,"about_ca_system_score_gemma":0.0014232261,"threshold_uncertainty_score":0.9047285},"labels":[],"label_agreement":null},{"id":"W6925223628","doi":"10.17169/refubium-20930","title":"Knowledge transfer or social competence?","year":2014,"lang":"en","type":"other","venue":"Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"German; Sample (material); Class (philosophy); Perception; Confirmatory factor analysis; Social class","score_opus":0.03187326585202441,"score_gpt":0.2675938158742718,"score_spread":0.23572055002224737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6925223628","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00419109,0.009952843,0.0015027398,0.0008955991,0.0012179188,0.003119201,0.00033755545,0.0012744657,0.9775086],"genre_scores_gemma":[0.03494555,0.0031228107,0.0020765536,0.0019804272,0.0017719904,0.0000426952,0.0007361582,0.0018380445,0.9534858],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99415565,0.00039300614,0.00089530076,0.0018948896,0.0012023645,0.0014587933],"domain_scores_gemma":[0.9964805,0.00022724322,0.0003444304,0.0015866674,0.00048712987,0.00087397697],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.00033927325,0.001690968,0.0024373778,0.0054437476,0.0004201007,0.00017281732,0.0008392712,0.0014691814,0.037151765],"category_scores_gemma":[0.00003879547,0.0014000233,0.0012510796,0.0030180037,0.00066100963,0.00030259136,0.00034601585,0.0011510217,0.0048774322],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018637853,0.0010356414,0.00065041974,0.0016145722,0.0029249156,0.0032786177,0.000675825,0.0000021260273,0.00037867678,0.0013590499,0.9841775,0.002038899],"study_design_scores_gemma":[0.009556312,0.001087391,0.0010204392,0.0012599351,0.003275146,0.00090440677,0.00047466118,0.00016243334,0.000524839,0.000013278917,0.9801561,0.0015650106],"about_ca_topic_score_codex":0.0005543954,"about_ca_topic_score_gemma":0.00080153387,"teacher_disagreement_score":0.032274332,"about_ca_system_score_codex":0.00045233013,"about_ca_system_score_gemma":0.0007499068,"threshold_uncertainty_score":0.99982715},"labels":[],"label_agreement":null},{"id":"W6931255690","doi":"10.5281/zenodo.3671661","title":"Coronatella (Coronatella) circumfimbriata","year":2020,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Seta; Parthenogenesis; Morphology (biology); Taxonomy (biology); Adult male","score_opus":0.07969413189789605,"score_gpt":0.2586284412131675,"score_spread":0.1789343093152715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931255690","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3852779,0.0008443449,0.0018059637,0.0097029535,0.00017448957,0.0015433179,0.00022490502,0.0021923822,0.59823376],"genre_scores_gemma":[0.99436957,0.00014256706,0.0003131391,0.00094920205,0.0002445283,3.1773922e-8,0.0015594292,0.0013456371,0.0010758776],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981721,0.0001674647,0.0002659068,0.00052625115,0.00049118156,0.0003771106],"domain_scores_gemma":[0.99854064,0.000019996396,0.00008147105,0.00046150133,0.00038509865,0.0005113058],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00023847757,0.00018445612,0.00024327559,0.00010700664,0.00077705726,0.00026293172,0.00050373544,0.000071758266,0.022851294],"category_scores_gemma":[0.00038165774,0.0001809142,0.000095725445,0.00043161344,0.00012709774,0.00011454194,0.00068840216,0.0002804044,0.021760838],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015151884,0.0006403067,0.00018524223,0.00054029515,0.00042790055,0.0010559601,0.0029758052,0.0000727379,0.12941125,0.0035152961,0.4884668,0.3711932],"study_design_scores_gemma":[0.0015515485,0.0009940453,0.0054476964,0.000029918636,0.00006916859,0.000510148,0.00018045884,0.0003453519,0.00714029,0.000049708142,0.98348844,0.00019320473],"about_ca_topic_score_codex":0.000012446246,"about_ca_topic_score_gemma":7.673433e-8,"teacher_disagreement_score":0.6090917,"about_ca_system_score_codex":0.00021592181,"about_ca_system_score_gemma":0.00000868622,"threshold_uncertainty_score":0.9790008},"labels":[],"label_agreement":null},{"id":"W6939148845","doi":"10.60692/7k8tv-6ky92","title":"The effect of immune checkpoint inhibitor combination therapies in metastatic renal cell carcinoma patients with and without previous cytoreductive nephrectomy: A systematic review and meta-analysis","year":2022,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Sunitinib; Renal cell carcinoma; Nivolumab; Pembrolizumab; Cabozantinib; Regimen; Lenvatinib; Kidney cancer; Systemic therapy","score_opus":0.018522336861766686,"score_gpt":0.21958257062093062,"score_spread":0.20106023375916393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939148845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879459,0.0062727416,0.000051753177,0.000054799973,0.000017455113,0.0055187396,0.000064131025,0.000020116457,0.000054360993],"genre_scores_gemma":[0.9980499,0.0000050376952,0.00005631513,0.000026989495,0.0000021901853,0.0017448217,0.000050306277,0.000012922968,0.000051518222],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9971163,0.0008200961,0.001140517,0.00018702814,0.0005707199,0.00016529563],"domain_scores_gemma":[0.9982154,0.000059589107,0.0010483619,0.0004218052,0.00019352631,0.000061325445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001369728,0.00027522197,0.0018405879,0.00035600126,0.00016374093,0.000051781193,0.000081395316,0.00002414091,0.000008519007],"category_scores_gemma":[0.000031241194,0.00013400074,0.00028243536,0.00057356566,0.000063146275,0.00022197311,0.0000738708,0.00012992854,0.000002319725],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014558528,0.00004636095,0.6018135,0.29129505,0.04484907,0.000009034451,0.060416207,0.00006762477,0.000010258353,0.000015030363,0.0000036372708,0.000018404406],"study_design_scores_gemma":[0.011531485,0.005017286,0.3874081,0.0023800642,0.5769612,0.0001555639,0.012027681,0.0005868168,0.0034975638,9.0742725e-7,0.0000023880784,0.00043093244],"about_ca_topic_score_codex":0.000038381026,"about_ca_topic_score_gemma":7.2852276e-7,"teacher_disagreement_score":0.5321121,"about_ca_system_score_codex":0.00023332513,"about_ca_system_score_gemma":0.000033303095,"threshold_uncertainty_score":0.5464392},"labels":[],"label_agreement":null},{"id":"W6939230966","doi":"10.60692/11g77-8pp10","title":"Additional file 4 of Genomic and transcriptomic features between primary and paired metastatic fumarate hydratase–deficient renal cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Food Inspection Agency","funders":"","keywords":"Transcriptome; Renal cell carcinoma; Primary (astronomy); Kidney cancer; Fumarase; Metastatic melanoma; Mutation; Carcinoma","score_opus":0.030907144741299335,"score_gpt":0.19756683814575982,"score_spread":0.1666596934044605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939230966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.763378,0.000024718085,0.00003228597,0.000020370295,0.00002741831,0.00048250047,0.23470755,0.00007106867,0.0012560519],"genre_scores_gemma":[0.9411998,4.2711739e-7,0.00037174387,0.000049282597,0.00003649601,0.00019843588,0.057652168,0.000014670962,0.00047697342],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.998596,0.00006547879,0.00057520316,0.00019573011,0.0003345561,0.00023299629],"domain_scores_gemma":[0.99916154,0.00009340447,0.00026636515,0.00023422705,0.0000863928,0.00015808156],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001538939,0.00021865938,0.00044032338,0.00039082396,0.000094983545,0.00004757067,0.00005565168,0.000069790105,0.0041781915],"category_scores_gemma":[0.000013123167,0.00017210742,0.00008941591,0.00019531764,0.00007114389,0.00020095376,0.000044633387,0.00009572545,0.00031872484],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012195711,0.000034096545,0.05622213,0.014774398,0.00072180206,0.00024303584,0.065204486,0.00009034201,0.0014782153,0.000027988244,0.85749745,0.0024865035],"study_design_scores_gemma":[0.0019978378,0.0002877155,0.98916006,0.00028308728,0.00024857908,0.00017785549,0.0028753264,0.00039317377,0.0019567998,7.594193e-7,0.0024388442,0.00017994357],"about_ca_topic_score_codex":0.000009267492,"about_ca_topic_score_gemma":1.9463697e-7,"teacher_disagreement_score":0.9329379,"about_ca_system_score_codex":0.00013093998,"about_ca_system_score_gemma":0.00009948183,"threshold_uncertainty_score":0.9967321},"labels":[],"label_agreement":null},{"id":"W6939551028","doi":"10.6084/m9.figshare.12082185","title":"Additional file 4 of Stem/progenitor cell marker expression in clear cell renal cell carcinoma: a potential relationship with the immune microenvironment to be explored","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Immune system; Cell; Immunostaining; CD8; Immunohistochemistry; Clear cell renal cell carcinoma; Kidney; Cell growth","score_opus":0.03439345258038501,"score_gpt":0.20007648091625035,"score_spread":0.16568302833586535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939551028","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11365101,0.0003754605,0.0000016927971,0.0006282031,0.000010144319,0.0011445014,0.88262624,0.000023745986,0.0015390129],"genre_scores_gemma":[0.6527604,6.241059e-7,0.00082795764,0.00021432783,0.00009395499,0.0011094632,0.34361255,0.000041826126,0.0013388864],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983386,0.00011050629,0.00034554207,0.00041833177,0.00050426193,0.00028275285],"domain_scores_gemma":[0.9987381,0.00037595292,0.00020006805,0.0003863777,0.00006306991,0.00023641436],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000028187329,0.00025024626,0.00028528203,0.00007513861,0.00008538529,0.000017003682,0.00018572512,0.00010026214,0.80227226],"category_scores_gemma":[0.000062971485,0.00017486938,0.00015082733,0.00023038404,0.00001806011,0.00007061623,0.00017567765,0.0002981942,0.0013156917],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097360037,0.0002478485,0.00014933663,0.000262488,0.000009752361,0.00021033731,0.00060114847,0.00008643617,0.03438218,2.6436965e-8,0.96302867,0.000048161266],"study_design_scores_gemma":[0.0037452213,0.002148442,0.17825247,0.0016356799,0.00010983019,0.000038316823,0.0017917997,0.00024179409,0.5131304,6.7506824e-7,0.29848427,0.00042106677],"about_ca_topic_score_codex":0.0000066529765,"about_ca_topic_score_gemma":0.0000026341086,"teacher_disagreement_score":0.80095655,"about_ca_system_score_codex":0.00013619162,"about_ca_system_score_gemma":0.00013335235,"threshold_uncertainty_score":0.9994619},"labels":[],"label_agreement":null},{"id":"W6939673601","doi":"10.6084/m9.figshare.26598944","title":"Additional file 2 of Comparison of peri- and intraoperative outcomes of open vs robotic-assisted partial nephrectomy for renal cell carcinoma: a propensity-matched analysis","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nephrectomy; Renal cell carcinoma; Propensity score matching; Perioperative; Standard of care; Kidney cancer; Kidney","score_opus":0.07915020875157817,"score_gpt":0.322172770360991,"score_spread":0.24302256160941282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939673601","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038050313,0.00024766164,0.0000044998674,0.00006699336,0.0000105393365,0.0012712731,0.9595266,0.000013796504,0.0008083084],"genre_scores_gemma":[0.5613278,2.3703134e-7,0.0018566648,0.000012600339,0.000018707477,0.0008818283,0.43525073,0.000012843562,0.000638555],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9986695,0.00006117276,0.0005157709,0.00033103913,0.00026098313,0.00016152769],"domain_scores_gemma":[0.9979689,0.0010790963,0.0002334159,0.00024684935,0.0003687752,0.00010292416],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000044613003,0.00019045068,0.0011305695,0.00019363782,0.00003851044,0.000027776807,0.00013579598,0.00008108798,0.74282867],"category_scores_gemma":[0.00051096344,0.00014139191,0.00029074415,0.0004259083,0.000038408474,0.000104135055,0.00015455233,0.00010746954,0.000026326496],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047848898,0.00045618418,0.0035930406,0.0017047247,0.0013865968,0.00003244753,0.0006400768,0.00007875903,0.0012788556,0.0000050022404,0.9898157,0.00053012994],"study_design_scores_gemma":[0.0035064602,0.003243965,0.7136991,0.003991321,0.004087605,0.00002849864,0.00061684137,0.019835288,0.12605472,0.000010248702,0.124460615,0.00046536454],"about_ca_topic_score_codex":0.000059480495,"about_ca_topic_score_gemma":0.00005921709,"teacher_disagreement_score":0.8653551,"about_ca_system_score_codex":0.00006053681,"about_ca_system_score_gemma":0.00030182535,"threshold_uncertainty_score":0.57657945},"labels":[],"label_agreement":null},{"id":"W6939880943","doi":"10.6084/m9.figshare.26566565","title":"Additional file 1 of Oncologic and perioperative outcomes of laparoscopic versus open radical nephrectomy for the treatment of renal tumor (&gt; 7 cm): a systematic review and pooled analysis of comparative outcomes","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Perioperative; Nephrectomy; Table (database); Meta-analysis; Cohort; Kidney cancer; Cohort study; Pooled analysis; Subgroup analysis","score_opus":0.0909534712120613,"score_gpt":0.36408880445203307,"score_spread":0.27313533323997174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939880943","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009340059,0.020943582,2.829745e-7,0.00013729633,0.000009585063,0.0035291922,0.9657443,0.000006718319,0.000288958],"genre_scores_gemma":[0.37092835,0.00044454687,0.0017580157,0.00018687689,0.000026802774,0.016031219,0.6086775,0.000033845594,0.0019128284],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.99875253,0.0001103754,0.0005915052,0.00022654377,0.00021718597,0.00010188052],"domain_scores_gemma":[0.99262035,0.0065485686,0.0003369098,0.0002389208,0.00019543963,0.00005982936],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000060141123,0.0001950001,0.0021193814,0.00012403778,0.000034629076,0.00001384573,0.000109292494,0.000038345137,0.32932997],"category_scores_gemma":[0.00089984055,0.00009703757,0.0003367118,0.00032132043,0.00007732083,0.000048029673,0.00005719903,0.00004436764,0.000006116233],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012206095,0.0015797415,0.0007664831,0.22043687,0.06092829,0.00007613812,0.0031526496,0.000022538205,0.00014837683,0.00012795762,0.7112734,0.0002669979],"study_design_scores_gemma":[0.023254924,0.03077159,0.2522543,0.42952675,0.18680795,0.000094210955,0.0032533489,0.0074298508,0.0069828653,0.000026752166,0.05864401,0.00095346925],"about_ca_topic_score_codex":0.000016891381,"about_ca_topic_score_gemma":0.000039191298,"teacher_disagreement_score":0.6526293,"about_ca_system_score_codex":0.00009660038,"about_ca_system_score_gemma":0.00019781182,"threshold_uncertainty_score":0.6712831},"labels":[],"label_agreement":null},{"id":"W6949085416","doi":"10.5281/zenodo.11284372","title":"IN Rujm ash Shāmī al Gharbī/Kaposvár +2778915305 SSD Chemical Solutions activation powder Serbia","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nucleofection; Fusible alloy; Hyporeflexia; Gestational period; Diafiltration; Articular cartilage damage; Pretext","score_opus":0.045727829909912115,"score_gpt":0.275201913531349,"score_spread":0.22947408362143687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6949085416","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040575075,0.0007296572,0.00013863604,0.004623065,0.00024909963,0.0013450215,0.00029723707,0.0013763044,0.98718345],"genre_scores_gemma":[0.1401485,0.0004403531,0.00058354257,0.001281057,0.0013650522,9.775923e-7,0.008093964,0.021185225,0.8269013],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973688,0.00019626757,0.000380697,0.0008178317,0.00065821357,0.00057816575],"domain_scores_gemma":[0.9986364,0.000018224375,0.0001381804,0.0007003689,0.00022569059,0.0002810913],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00036365184,0.00036660125,0.00040709597,0.0008122256,0.00028377422,0.00032059682,0.0004725015,0.00030434897,0.055958536],"category_scores_gemma":[0.00026935755,0.00036456482,0.00014385479,0.00077178486,0.00016983006,0.00012697969,0.0008702437,0.0008153276,0.038880657],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011123047,0.0002896007,0.0000022625813,0.0003178373,0.00017645123,0.00016458407,0.00032607676,0.0000017047989,0.021349663,0.0007294557,0.9726333,0.0038978471],"study_design_scores_gemma":[0.0010024386,0.0002394309,0.00018042816,0.00053247175,0.00011046784,0.00027478882,0.000110267916,0.000049528677,0.002204508,0.00010184792,0.99489224,0.00030159918],"about_ca_topic_score_codex":0.00011947937,"about_ca_topic_score_gemma":0.0000019533272,"teacher_disagreement_score":0.16028215,"about_ca_system_score_codex":0.00081309245,"about_ca_system_score_gemma":0.00002255275,"threshold_uncertainty_score":0.9998806},"labels":[],"label_agreement":null},{"id":"W6949963464","doi":"10.5281/zenodo.3541257","title":"NPA_ref5815","year":2019,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Ganoderma lucidum; Context (archaeology); Ganoderma; Field (mathematics)","score_opus":0.034450065523049404,"score_gpt":0.2481803967315108,"score_spread":0.21373033120846138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6949963464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51112354,0.000106708176,0.00014646398,0.00075808156,0.0000769549,0.00057610247,0.000026227353,0.0005283647,0.4866576],"genre_scores_gemma":[0.98841417,0.000038209306,0.00025486256,0.00021559658,0.00010137631,1.8547965e-8,0.0008186147,0.001057076,0.0091001],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99875116,0.00010496853,0.00016800669,0.00033272748,0.0003594672,0.00028367114],"domain_scores_gemma":[0.9988977,0.000012207038,0.000051895302,0.00051705434,0.00031820167,0.00020296249],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00025666927,0.000117944175,0.00016578451,0.0001608655,0.00046520447,0.00018165052,0.00029674813,0.000051410396,0.03430338],"category_scores_gemma":[0.00013139097,0.00010576224,0.00007171107,0.00030683549,0.000060579943,0.0001019227,0.00040841347,0.00019044557,0.060142905],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010760201,0.0011384712,0.00060856296,0.0006262843,0.0004284484,0.00040304256,0.0020782514,0.000055295015,0.21105173,0.011117799,0.43778455,0.33363152],"study_design_scores_gemma":[0.001172083,0.0007104121,0.0082263,0.000037109075,0.000030280102,0.00047888435,0.00013478706,0.0000952159,0.0048715053,0.000052906413,0.9840746,0.00011590758],"about_ca_topic_score_codex":0.0000069897496,"about_ca_topic_score_gemma":3.115457e-8,"teacher_disagreement_score":0.54629004,"about_ca_system_score_codex":0.00020953614,"about_ca_system_score_gemma":0.000003907779,"threshold_uncertainty_score":0.9665794},"labels":[],"label_agreement":null},{"id":"W6950232026","doi":"10.5281/zenodo.7545441","title":"Unifying and disseminating musculoskeletal imaging software","year":2023,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University Health Network","funders":"","keywords":"Certification; Interoperability; Documentation; Dissemination; Software; Source code","score_opus":0.02556868362285171,"score_gpt":0.2727106231775066,"score_spread":0.2471419395546549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6950232026","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041921446,0.0016466214,0.0009436937,0.00054660114,0.00017258497,0.0011473799,0.00025185285,0.006678135,0.984421],"genre_scores_gemma":[0.1382439,0.0019070683,0.0041672303,0.00021349953,0.0015421779,4.0662493e-7,0.008355942,0.092705384,0.7528644],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99843216,0.00011725002,0.0001950885,0.0005139458,0.00037535734,0.00036618926],"domain_scores_gemma":[0.99903834,0.000033976274,0.0001257061,0.00041838887,0.00015775894,0.00022581572],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00029369097,0.00023702485,0.0002682215,0.0004405291,0.00068933144,0.00027188784,0.00025359294,0.000094114555,0.0087063145],"category_scores_gemma":[0.00067129015,0.0002306605,0.00007795808,0.00034515158,0.00014540815,0.00006569973,0.00078472693,0.00032303776,0.0038034369],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026872802,0.00007229294,0.00007684588,0.0007772124,0.00015107983,0.00039188517,0.00038668537,7.739581e-7,0.0007206722,0.00018639606,0.603807,0.39340234],"study_design_scores_gemma":[0.00060589984,0.00015355104,0.0016583848,0.0006498979,0.0001159513,0.0004247063,0.00029934366,0.000045726112,0.0000742079,0.000017292592,0.9957224,0.00023264145],"about_ca_topic_score_codex":0.000052092593,"about_ca_topic_score_gemma":9.19543e-7,"teacher_disagreement_score":0.3931697,"about_ca_system_score_codex":0.00019746457,"about_ca_system_score_gemma":0.0000040590367,"threshold_uncertainty_score":0.9969722},"labels":[],"label_agreement":null},{"id":"W6950633897","doi":"10.57439325/foo.bar","title":"[EPub] download Rachel's Holiday (Walsh Family, #2) by Marian Keyes eBook Download","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Download; Popularity; Plot (graphics); Performance art; Canadian literature; The Internet","score_opus":0.028041041293647775,"score_gpt":0.2502106963043095,"score_spread":0.22216965501066172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6950633897","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036878584,0.0058979536,0.000090260626,0.0010144436,0.00031735288,0.0015920787,0.0032801027,0.0026313332,0.98480767],"genre_scores_gemma":[0.008174183,0.001269317,0.00018655429,0.0005496141,0.0006743871,6.4362894e-7,0.019819189,0.011899082,0.957427],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962332,0.00036625486,0.00049417414,0.0011954283,0.00095317507,0.00075773825],"domain_scores_gemma":[0.99761426,0.000022946142,0.00023323066,0.0012560346,0.00030575352,0.0005677772],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00050608744,0.00061560347,0.00067578536,0.0008063455,0.00058580714,0.0008626001,0.00090015394,0.00041811191,0.086080775],"category_scores_gemma":[0.00021726576,0.0005573912,0.0002616207,0.0005627829,0.00030796652,0.00009088394,0.0012584649,0.00088037667,0.18923955],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001220146,0.00023237716,0.0000016914225,0.00058234175,0.0004764411,0.00038962354,0.00035533775,3.510748e-7,0.0056905337,0.00017428819,0.9577504,0.034224648],"study_design_scores_gemma":[0.0012577543,0.00057385874,0.000055042932,0.00042254542,0.00033954662,0.00037959812,0.00018446617,0.0000057777233,0.00096390327,0.00004126963,0.99529034,0.00048591624],"about_ca_topic_score_codex":0.00016934202,"about_ca_topic_score_gemma":9.732398e-7,"teacher_disagreement_score":0.103158765,"about_ca_system_score_codex":0.00053831824,"about_ca_system_score_gemma":0.00002212322,"threshold_uncertainty_score":0.99968773},"labels":[],"label_agreement":null},{"id":"W6955500517","doi":"10.58079/oko7","title":"Évènement de la Chaire d'études taïwanaises de l'Université d'Ottawa","year":2021,"lang":"fr","type":"article","venue":"OpenEdition (OpenEdition)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Context (archaeology); Term (time); Focus (optics); Perspective (graphical)","score_opus":0.015176997276954169,"score_gpt":0.24768985001090277,"score_spread":0.2325128527339486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6955500517","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24342236,0.07748887,0.006990785,0.17791833,0.0076943245,0.0025405386,0.0012846799,0.00046741837,0.4821927],"genre_scores_gemma":[0.9152369,0.00838739,0.007027858,0.024246383,0.0030011449,0.00029816432,0.0023545502,0.00013054976,0.03931706],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.995075,0.0010145811,0.0007345041,0.00097999,0.000982897,0.001213019],"domain_scores_gemma":[0.9966384,0.0005436207,0.00032758902,0.00086452253,0.0005979479,0.0010279287],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010049333,0.0006734398,0.0007665387,0.00025139409,0.00069807156,0.0003430317,0.0003906089,0.0005376207,0.032285076],"category_scores_gemma":[0.00031337384,0.00076140935,0.00047681973,0.0006527511,0.0005264641,0.0038075151,0.000309436,0.0006559533,0.0018886745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009057855,0.007825958,0.0177426,0.0024919435,0.003015515,0.039856993,0.0027763876,0.0016337495,0.033273824,0.49193984,0.325726,0.07281141],"study_design_scores_gemma":[0.005752901,0.00091171125,0.20781848,0.0021688659,0.0016733707,0.0029733442,0.0037710879,0.00028715841,0.11847691,0.0007938343,0.6544752,0.00089710567],"about_ca_topic_score_codex":0.00054546486,"about_ca_topic_score_gemma":0.0014152341,"teacher_disagreement_score":0.67181456,"about_ca_system_score_codex":0.0032819344,"about_ca_system_score_gemma":0.0022598852,"threshold_uncertainty_score":0.9994837},"labels":[],"label_agreement":null},{"id":"W6957896024","doi":"10.6084/m9.figshare.12211256","title":"Additional file 1 of Management of complex renal cysts in Canada: results of a survey study","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; McGill University; Ottawa Hospital; Princess Margaret Cancer Centre; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Survey research; Nephrectomy; MEDLINE; Kidney","score_opus":0.12927269587565113,"score_gpt":0.2682782763244111,"score_spread":0.13900558044875996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6957896024","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012000251,0.000017181019,1.0824021e-8,0.000031017717,0.0000027829758,0.00047285482,0.98319024,0.0000033725294,0.0042822734],"genre_scores_gemma":[0.49143675,1.335649e-7,0.00008257168,0.000017897006,0.000006669243,0.000088331195,0.50828457,0.000004660394,0.0000784234],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99883384,0.00006484509,0.00041223306,0.00017139583,0.00041527845,0.00010240765],"domain_scores_gemma":[0.9988661,0.000509371,0.00020832103,0.00018157784,0.00015753068,0.00007714253],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00003104011,0.00009002573,0.00031984274,0.000042735566,0.0000061389824,8.949426e-7,0.000090962916,0.00001750195,0.8927319],"category_scores_gemma":[0.0006490555,0.00008053858,0.00004232938,0.00025823756,0.000005357454,0.000013213091,0.00007978026,0.000059160535,0.000039937524],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045002392,0.00021260566,0.00070607214,0.00041690978,0.000108337525,0.00029206654,0.00008305675,0.00002182722,0.000013646336,1.0575285e-7,0.9973343,0.00036105202],"study_design_scores_gemma":[0.0018007214,0.00053526287,0.9717001,0.0019531453,0.000017588547,0.0000024492217,0.00021540615,0.000086554406,0.00030870858,2.8007202e-7,0.023327252,0.000052534913],"about_ca_topic_score_codex":0.10639995,"about_ca_topic_score_gemma":0.29306978,"teacher_disagreement_score":0.97400707,"about_ca_system_score_codex":0.00014413863,"about_ca_system_score_gemma":0.000518052,"threshold_uncertainty_score":0.8995506},"labels":[],"label_agreement":null},{"id":"W6957905704","doi":"10.6084/m9.figshare.14670254","title":"Additional file 1 of Coding practice in national and regional kidney biopsy registries","year":2021,"lang":"en","type":"article","venue":"Open MIND","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biopsy; Coding (social sciences); Renal biopsy; Kidney; Kidney cancer; Kidney disease","score_opus":0.06405906459148106,"score_gpt":0.32689540463642164,"score_spread":0.2628363400449406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6957905704","genre_codex":"other","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025460267,0.00038021422,0.000004605545,0.012323038,0.000050680945,0.00056528574,0.30483288,0.000002165941,0.6563809],"genre_scores_gemma":[0.10650876,0.00009134135,0.2972091,0.0022040827,0.00035877337,0.00039393487,0.4806612,0.000042907228,0.112529874],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99925864,0.000037128764,0.00016476715,0.00019491086,0.0002668425,0.00007769],"domain_scores_gemma":[0.998374,0.0011024118,0.000098625394,0.000094704796,0.00024601733,0.00008423371],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000095223106,0.00006465594,0.00014368905,0.00005393803,0.000027995065,0.000026363707,0.00004262137,0.00003897464,0.68458873],"category_scores_gemma":[0.0032390011,0.00006096174,0.000025182713,0.00015922237,0.000069118665,0.00015203517,0.000069762275,0.00007439873,0.000106039195],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013178684,0.000119932716,0.000086704626,0.000010625311,0.00003923107,0.0003604396,0.000111447756,3.4700156e-7,0.0006425407,0.00007448001,0.9955231,0.0028993655],"study_design_scores_gemma":[0.00077523186,0.00006148958,0.009987777,0.00036697515,0.00002401259,0.0013866479,0.00042310465,0.000020913229,0.002763755,0.000055633536,0.984075,0.000059426948],"about_ca_topic_score_codex":0.000019894387,"about_ca_topic_score_gemma":0.000010196741,"teacher_disagreement_score":0.6844827,"about_ca_system_score_codex":0.00007067609,"about_ca_system_score_gemma":0.0008409387,"threshold_uncertainty_score":0.3877621},"labels":[],"label_agreement":null},{"id":"W6957909511","doi":"10.60692/cd9mn-tth66","title":"Additional file 1 of Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"","keywords":"Clear cell renal cell carcinoma; Immune escape; Immune system; Cell; Gene; Gene signature; Tumor microenvironment","score_opus":0.017717229481522333,"score_gpt":0.18566719215403588,"score_spread":0.16794996267251355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6957909511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92687637,0.0000055931782,0.00011598682,0.000049609836,0.00011597607,0.0008169099,0.07063486,0.00005237691,0.001332306],"genre_scores_gemma":[0.9911056,8.272506e-8,0.00053120474,0.00003670339,0.00006345151,0.00020620314,0.0075459406,0.000017354036,0.0004934554],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9979515,0.000091766335,0.00091742125,0.00018436165,0.0005956714,0.00025926277],"domain_scores_gemma":[0.9985227,0.000033469292,0.0006017098,0.0005650688,0.00015094598,0.0001260925],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001652449,0.00021490849,0.00036487728,0.00027572957,0.00009098943,0.000017110762,0.00016382571,0.0001537304,0.009873033],"category_scores_gemma":[0.000025086605,0.00015738912,0.00024971677,0.0004009263,0.00006398994,0.00015317857,0.00014302818,0.00016924401,0.001272937],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032546618,0.000230895,0.309081,0.009338344,0.00038155363,0.00007263546,0.051726393,0.0035618397,0.014205683,0.00002360024,0.6073797,0.00074371026],"study_design_scores_gemma":[0.0011982005,0.0005025292,0.8676404,0.0004169427,0.000074425145,0.000041682506,0.0027362935,0.001205967,0.12362284,3.4058414e-7,0.002401101,0.00015931872],"about_ca_topic_score_codex":0.000035577472,"about_ca_topic_score_gemma":5.703465e-7,"teacher_disagreement_score":0.6049786,"about_ca_system_score_codex":0.00046940165,"about_ca_system_score_gemma":0.00012790719,"threshold_uncertainty_score":0.9995047},"labels":[],"label_agreement":null},{"id":"W6958064583","doi":"10.60692/kbdv7-ryp47","title":"Additional file 1 of Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"","keywords":"Clear cell renal cell carcinoma; Immune escape; Immune system; Cell; Gene; Gene signature; Tumor microenvironment","score_opus":0.017717229481522333,"score_gpt":0.18566719215403588,"score_spread":0.16794996267251355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958064583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92687637,0.0000055931782,0.00011598682,0.000049609836,0.00011597607,0.0008169099,0.07063486,0.00005237691,0.001332306],"genre_scores_gemma":[0.9911056,8.272506e-8,0.00053120474,0.00003670339,0.00006345151,0.00020620314,0.0075459406,0.000017354036,0.0004934554],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9979515,0.000091766335,0.00091742125,0.00018436165,0.0005956714,0.00025926277],"domain_scores_gemma":[0.9985227,0.000033469292,0.0006017098,0.0005650688,0.00015094598,0.0001260925],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001652449,0.00021490849,0.00036487728,0.00027572957,0.00009098943,0.000017110762,0.00016382571,0.0001537304,0.009873033],"category_scores_gemma":[0.000025086605,0.00015738912,0.00024971677,0.0004009263,0.00006398994,0.00015317857,0.00014302818,0.00016924401,0.001272937],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032546618,0.000230895,0.309081,0.009338344,0.00038155363,0.00007263546,0.051726393,0.0035618397,0.014205683,0.00002360024,0.6073797,0.00074371026],"study_design_scores_gemma":[0.0011982005,0.0005025292,0.8676404,0.0004169427,0.000074425145,0.000041682506,0.0027362935,0.001205967,0.12362284,3.4058414e-7,0.002401101,0.00015931872],"about_ca_topic_score_codex":0.000035577472,"about_ca_topic_score_gemma":5.703465e-7,"teacher_disagreement_score":0.6049786,"about_ca_system_score_codex":0.00046940165,"about_ca_system_score_gemma":0.00012790719,"threshold_uncertainty_score":0.9995047},"labels":[],"label_agreement":null},{"id":"W6958242999","doi":"10.6084/m9.figshare.12082182.v1","title":"Additional file 3 of Stem/progenitor cell marker expression in clear cell renal cell carcinoma: a potential relationship with the immune microenvironment to be explored","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Clear cell renal cell carcinoma; Cell; Immune system; Immunostaining; Immunohistochemistry; Tumor microenvironment; Cell growth; Kidney","score_opus":0.03414285318619164,"score_gpt":0.19975763535665794,"score_spread":0.1656147821704663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958242999","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1138531,0.00037336643,0.000001679157,0.00062792434,0.000010208183,0.0011411103,0.8824295,0.000023664717,0.0015394499],"genre_scores_gemma":[0.65192306,6.256581e-7,0.0008291764,0.0002146414,0.00009508448,0.0011121435,0.34439605,0.0000419399,0.0013872776],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833876,0.00011051987,0.00034542577,0.0004182923,0.00050429156,0.0002827226],"domain_scores_gemma":[0.99873793,0.000375274,0.00020003661,0.00038618653,0.000064191605,0.00023640318],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000028166061,0.0002502299,0.0002852187,0.00007510576,0.00008534536,0.000016995178,0.00018559674,0.00010025417,0.8047778],"category_scores_gemma":[0.00006381057,0.00017483815,0.00015081634,0.00023041172,0.00001805706,0.000070606526,0.0001756147,0.0002982029,0.0013414234],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096241594,0.0002472771,0.00014875048,0.00026395157,0.0000097343245,0.00020926773,0.0005994783,0.0000874246,0.034805156,2.5515469e-8,0.9626184,0.00004810816],"study_design_scores_gemma":[0.0036935771,0.0020776826,0.17441072,0.0016035283,0.00010715486,0.000037284106,0.0017555073,0.00023680077,0.51202506,6.570139e-7,0.3036384,0.0004136316],"about_ca_topic_score_codex":0.000006708996,"about_ca_topic_score_gemma":0.0000026239882,"teacher_disagreement_score":0.8034364,"about_ca_system_score_codex":0.00013668614,"about_ca_system_score_gemma":0.00013382394,"threshold_uncertainty_score":0.99943614},"labels":[],"label_agreement":null},{"id":"W6958343662","doi":"10.6084/m9.figshare.12211256.v1","title":"Additional file 1 of Management of complex renal cysts in Canada: results of a survey study","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; McGill University; Ottawa Hospital; Princess Margaret Cancer Centre; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Survey research; Nephrectomy; MEDLINE; Kidney","score_opus":0.12927269587565113,"score_gpt":0.2682782763244111,"score_spread":0.13900558044875996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958343662","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012000251,0.000017181019,1.0824021e-8,0.000031017717,0.0000027829758,0.00047285482,0.98319024,0.0000033725294,0.0042822734],"genre_scores_gemma":[0.49143675,1.335649e-7,0.00008257168,0.000017897006,0.000006669243,0.000088331195,0.50828457,0.000004660394,0.0000784234],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99883384,0.00006484509,0.00041223306,0.00017139583,0.00041527845,0.00010240765],"domain_scores_gemma":[0.9988661,0.000509371,0.00020832103,0.00018157784,0.00015753068,0.00007714253],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00003104011,0.00009002573,0.00031984274,0.000042735566,0.0000061389824,8.949426e-7,0.000090962916,0.00001750195,0.8927319],"category_scores_gemma":[0.0006490555,0.00008053858,0.00004232938,0.00025823756,0.000005357454,0.000013213091,0.00007978026,0.000059160535,0.000039937524],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045002392,0.00021260566,0.00070607214,0.00041690978,0.000108337525,0.00029206654,0.00008305675,0.00002182722,0.000013646336,1.0575285e-7,0.9973343,0.00036105202],"study_design_scores_gemma":[0.0018007214,0.00053526287,0.9717001,0.0019531453,0.000017588547,0.0000024492217,0.00021540615,0.000086554406,0.00030870858,2.8007202e-7,0.023327252,0.000052534913],"about_ca_topic_score_codex":0.10639995,"about_ca_topic_score_gemma":0.29306978,"teacher_disagreement_score":0.97400707,"about_ca_system_score_codex":0.00014413863,"about_ca_system_score_gemma":0.000518052,"threshold_uncertainty_score":0.8995506},"labels":[],"label_agreement":null},{"id":"W6958357942","doi":"10.6084/m9.figshare.12082185.v1","title":"Additional file 4 of Stem/progenitor cell marker expression in clear cell renal cell carcinoma: a potential relationship with the immune microenvironment to be explored","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Immune system; Cell; Immunostaining; CD8; Immunohistochemistry; Clear cell renal cell carcinoma; Kidney; Cell growth","score_opus":0.03439345258038501,"score_gpt":0.20007648091625035,"score_spread":0.16568302833586535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958357942","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11365101,0.0003754605,0.0000016927971,0.0006282031,0.000010144319,0.0011445014,0.88262624,0.000023745986,0.0015390129],"genre_scores_gemma":[0.6527604,6.241059e-7,0.00082795764,0.00021432783,0.00009395499,0.0011094632,0.34361255,0.000041826126,0.0013388864],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983386,0.00011050629,0.00034554207,0.00041833177,0.00050426193,0.00028275285],"domain_scores_gemma":[0.9987381,0.00037595292,0.00020006805,0.0003863777,0.00006306991,0.00023641436],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000028187329,0.00025024626,0.00028528203,0.00007513861,0.00008538529,0.000017003682,0.00018572512,0.00010026214,0.80227226],"category_scores_gemma":[0.000062971485,0.00017486938,0.00015082733,0.00023038404,0.00001806011,0.00007061623,0.00017567765,0.0002981942,0.0013156917],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097360037,0.0002478485,0.00014933663,0.000262488,0.000009752361,0.00021033731,0.00060114847,0.00008643617,0.03438218,2.6436965e-8,0.96302867,0.000048161266],"study_design_scores_gemma":[0.0037452213,0.002148442,0.17825247,0.0016356799,0.00010983019,0.000038316823,0.0017917997,0.00024179409,0.5131304,6.7506824e-7,0.29848427,0.00042106677],"about_ca_topic_score_codex":0.0000066529765,"about_ca_topic_score_gemma":0.0000026341086,"teacher_disagreement_score":0.80095655,"about_ca_system_score_codex":0.00013619162,"about_ca_system_score_gemma":0.00013335235,"threshold_uncertainty_score":0.9994619},"labels":[],"label_agreement":null},{"id":"W6958381269","doi":"10.6084/m9.figshare.14670254.v1","title":"Additional file 1 of Coding practice in national and regional kidney biopsy registries","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biopsy; Coding (social sciences); Renal biopsy; Kidney; Kidney cancer; Kidney disease","score_opus":0.05944906809510372,"score_gpt":0.29028406737379053,"score_spread":0.2308349992786868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958381269","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000060057588,0.00022080951,4.1238934e-8,0.0010897095,0.0000052524206,0.00007179985,0.9662736,0.000008811048,0.032269925],"genre_scores_gemma":[0.003148185,0.0000040732625,0.002047647,0.00066713785,0.000077520584,0.00019776504,0.9908588,0.0000074832296,0.0029913674],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99928105,0.000025688567,0.00013843551,0.00016457289,0.00030616068,0.000084110245],"domain_scores_gemma":[0.9976541,0.0016665189,0.0000946571,0.00008547549,0.0004124419,0.000086835105],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000019195251,0.00007008368,0.00012044287,0.00006305287,0.000024077748,0.000010078602,0.000023104105,0.000049054644,0.9804374],"category_scores_gemma":[0.018121958,0.0000681712,0.000037983475,0.00017558322,0.000013394137,0.000093126,0.000036037036,0.00008976258,0.00029176846],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034919067,0.00005401109,0.000010473242,0.000096364085,0.000023340916,0.00033163678,0.00003073832,2.8738307e-7,0.00007346432,0.00004084334,0.999128,0.00017595322],"study_design_scores_gemma":[0.0003978611,0.000037384263,0.014337422,0.0028920134,0.000008885357,0.0011619268,0.000094428746,0.00002335174,0.00063618895,0.000032864118,0.9803196,0.000058041875],"about_ca_topic_score_codex":0.0000033537392,"about_ca_topic_score_gemma":0.0000021641354,"teacher_disagreement_score":0.98014563,"about_ca_system_score_codex":0.00007401324,"about_ca_system_score_gemma":0.0007229142,"threshold_uncertainty_score":0.99014884},"labels":[],"label_agreement":null},{"id":"W6968941265","doi":"10.5683/sp3/bip8pr","title":"Acquisition of object-robbing and object/food-bartering behaviors: A culturally maintained token economy in free-ranging long-tailed macaques","year":2020,"lang":"en","type":"dataset","venue":"Borealis","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Lethbridge","funders":"University of Alberta","keywords":"Barter; Possession (linguistics); Population; Token economy; Dictator game; Prosocial behavior; Reciprocity (cultural anthropology); Cognition; Field (mathematics); Herding","score_opus":0.014325074865435973,"score_gpt":0.25060287514677076,"score_spread":0.2362778002813348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6968941265","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05514734,0.0014428975,0.000011977218,0.00056343945,0.00007148595,0.0011992437,0.941155,0.00006874188,0.00033983652],"genre_scores_gemma":[0.06658887,0.0004638849,0.00038093314,0.0002500008,0.00026872542,0.0001497832,0.9318248,0.000050216204,0.000022782619],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978476,0.00010624701,0.00073257077,0.0006078799,0.0002767961,0.00042889555],"domain_scores_gemma":[0.99860895,0.0000704913,0.00034104282,0.0006487685,0.000097420816,0.00023333264],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001948658,0.0004980487,0.0010269808,0.0004121007,0.00005214871,0.00006905106,0.00020661352,0.0003242344,0.000070113965],"category_scores_gemma":[0.000063588384,0.0004572821,0.0002096201,0.00019910271,0.00009728126,0.00018569111,0.00021653235,0.000411602,0.0000053445515],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047114617,0.00018043813,0.003757054,0.0019406059,0.00033302302,0.0019562156,0.00086558686,0.0000080082345,0.0007176364,0.000016388663,0.9888958,0.00085811265],"study_design_scores_gemma":[0.034882136,0.013007011,0.2644298,0.019918509,0.009133748,0.0033794555,0.005172706,0.00028480857,0.021693362,0.0007073383,0.62218904,0.005202066],"about_ca_topic_score_codex":0.013908806,"about_ca_topic_score_gemma":0.0072016385,"teacher_disagreement_score":0.36670673,"about_ca_system_score_codex":0.00045586293,"about_ca_system_score_gemma":0.00014754957,"threshold_uncertainty_score":0.99978787},"labels":[],"label_agreement":null},{"id":"W6976544288","doi":"10.60692/na7qs-94877","title":"Additional file 2 of Genomic and transcriptomic features between primary and paired metastatic fumarate hydratase–deficient renal cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Food Inspection Agency","funders":"","keywords":"Transcriptome; Renal cell carcinoma; Fumarase; Kidney cancer; Kidney; Carcinoma; Disease; Primary (astronomy)","score_opus":0.030265754233999607,"score_gpt":0.1971624481643936,"score_spread":0.166896693930394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976544288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7629665,0.00002486545,0.000031351203,0.000020393967,0.000027542177,0.00048136569,0.23509993,0.00007104392,0.0012770087],"genre_scores_gemma":[0.9402277,4.312698e-7,0.00036791895,0.0000492485,0.000036902995,0.00019826624,0.058620088,0.00001465042,0.00048479097],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99859643,0.00006552225,0.00057502236,0.00019566038,0.0003344424,0.00023291433],"domain_scores_gemma":[0.9991615,0.00009282216,0.00026661152,0.00023403547,0.00008698412,0.00015806574],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015311815,0.00021861268,0.00044028636,0.00039055696,0.0000949553,0.000047552505,0.000055619574,0.000069790476,0.004262676],"category_scores_gemma":[0.000013150079,0.00017206835,0.00008939984,0.00019527123,0.00007112741,0.00020091214,0.00004464126,0.00009572606,0.00031849183],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011690356,0.000033301792,0.053255852,0.014433284,0.00070570136,0.00023980142,0.06369186,0.0000897043,0.001416737,0.00002705172,0.86247957,0.0024581184],"study_design_scores_gemma":[0.0020013328,0.00028512048,0.98903024,0.00028122196,0.000249218,0.00017882869,0.0028667185,0.00039087696,0.0019536724,7.5930654e-7,0.002581679,0.00018035369],"about_ca_topic_score_codex":0.000009329218,"about_ca_topic_score_gemma":1.9378292e-7,"teacher_disagreement_score":0.9357744,"about_ca_system_score_codex":0.00013096147,"about_ca_system_score_gemma":0.00009937653,"threshold_uncertainty_score":0.99664754},"labels":[],"label_agreement":null},{"id":"W6976556051","doi":"10.60692/nhrcb-vwg86","title":"Learning curve of laparoscopic nephrectomy: a prospective pilot study","year":2020,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Learning curve; Blood loss; Incidence (geometry); Nephrectomy; Prospective cohort study; Laparoscopy; Significant difference","score_opus":0.05682690643615304,"score_gpt":0.24339662580499163,"score_spread":0.1865697193688386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976556051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921156,0.0000048812744,0.00043070782,0.000047727037,0.00007229523,0.0016384266,0.000011411361,0.00018866699,0.0054902635],"genre_scores_gemma":[0.9994948,5.259865e-8,0.00011948327,0.00007535205,0.00006308379,0.000113711256,0.000011399191,0.000012772473,0.00010933351],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986569,0.000082568455,0.0005666225,0.00015414433,0.0003756926,0.00016402912],"domain_scores_gemma":[0.9991189,0.0000073250562,0.00030502773,0.0002078261,0.00022074905,0.00014013865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015586753,0.00017146353,0.00044503447,0.00013063516,0.000059408907,0.000036188314,0.00006795904,0.0000321017,0.000026004242],"category_scores_gemma":[0.00004379431,0.0001295738,0.00006005285,0.00029637906,0.000020612446,0.00023871197,0.000047584348,0.00014203531,0.0004354873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006423822,0.00001923502,0.8765674,0.00058742234,0.00013210898,0.000013577673,0.121894605,0.000052746353,0.000022343098,0.000011863984,0.000012482418,0.000043796827],"study_design_scores_gemma":[0.007235765,0.011376727,0.9163668,0.00020092748,0.00021222515,0.00003670023,0.058123317,0.000880767,0.0053618597,1.5868262e-7,0.000053385196,0.00015133752],"about_ca_topic_score_codex":0.000022011853,"about_ca_topic_score_gemma":1.6043408e-7,"teacher_disagreement_score":0.063771285,"about_ca_system_score_codex":0.000161681,"about_ca_system_score_gemma":0.00006336903,"threshold_uncertainty_score":0.5597454},"labels":[],"label_agreement":null},{"id":"W6976746104","doi":"10.6084/m9.figshare.12211271","title":"Additional file 3 of Management of complex renal cysts in Canada: results of a survey study","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; McGill University; Ottawa Hospital; Princess Margaret Cancer Centre; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Nephrectomy; Kidney; Survey research; MEDLINE; Kidney disease","score_opus":0.12666550223682926,"score_gpt":0.267790958306905,"score_spread":0.14112545607007576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976746104","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012101586,0.000017284998,1.0895669e-8,0.000030850468,0.0000028139157,0.00047286853,0.9830595,0.000003367718,0.0043116896],"genre_scores_gemma":[0.49242544,1.357596e-7,0.00008143932,0.00001787817,0.000006757142,0.00008641614,0.5072971,0.000004659295,0.000080190046],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9988337,0.000064772954,0.00041244575,0.00017130958,0.00041537674,0.000102398655],"domain_scores_gemma":[0.99886996,0.0005041604,0.00020835827,0.00018126225,0.00015913822,0.00007713467],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000031023843,0.000090011075,0.00031988052,0.000042719068,0.0000061383716,8.970695e-7,0.00009089674,0.00001750023,0.8899407],"category_scores_gemma":[0.000648854,0.00008051484,0.000042326254,0.00025812676,0.0000053578947,0.0000132248515,0.000079713565,0.00005914655,0.000040443076],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004530658,0.00021244884,0.00070704985,0.00042506662,0.00010821344,0.0002960885,0.00008304624,0.000021831174,0.000013683295,1.049687e-7,0.99731225,0.0003671372],"study_design_scores_gemma":[0.0018289557,0.0005342217,0.9711633,0.0019477236,0.000017400069,0.000002422,0.00021415424,0.00008668562,0.0003163661,2.80927e-7,0.023835983,0.000052524327],"about_ca_topic_score_codex":0.107647605,"about_ca_topic_score_gemma":0.29469532,"teacher_disagreement_score":0.9734763,"about_ca_system_score_codex":0.00014480019,"about_ca_system_score_gemma":0.0005183832,"threshold_uncertainty_score":0.8982946},"labels":[],"label_agreement":null},{"id":"W6977136607","doi":"10.6084/m9.figshare.6885680","title":"Additional file 1: of Off-clamp partial nephrectomy has a positive impact on short- and long-term renal function: a systematic review and meta-analysis","year":2018,"lang":"en","type":"article","venue":"Figshare","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nephrectomy; Table (database); Kidney; Kidney disease; Renal cell carcinoma; MEDLINE","score_opus":0.0880440629490279,"score_gpt":0.3065310349364848,"score_spread":0.21848697198745692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977136607","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045665287,0.013432227,4.5606967e-7,0.000103337145,0.0000029423907,0.0012833225,0.9842866,0.000018440027,0.000416042],"genre_scores_gemma":[0.089638196,0.0000151925005,0.000053097403,0.000810831,0.00011325347,0.0033469312,0.90499055,0.000022102946,0.0010098701],"study_design_codex":"not_applicable","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9986766,0.000111846944,0.00037717453,0.00033190133,0.00033935666,0.00016310891],"domain_scores_gemma":[0.998287,0.00069618877,0.00021078167,0.00033817487,0.00028911105,0.00017870433],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000051994215,0.0002450341,0.0014296517,0.00013730855,0.000076058255,0.00003145105,0.000046569447,0.000066137116,0.97790253],"category_scores_gemma":[0.0006120001,0.00014900668,0.0006778159,0.00031024378,0.000041493997,0.000069990296,0.000042483807,0.00009684986,0.0003663253],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013039328,0.00008278584,0.000015451895,0.021037225,0.049372353,0.00008017377,0.000032205557,2.3444747e-7,0.000005043873,3.6566024e-7,0.9292065,0.000037269223],"study_design_scores_gemma":[0.0008373387,0.0050280797,0.08218767,0.07218028,0.8255281,0.0007501497,0.000012825768,0.0001566851,0.00048467037,0.0000036657843,0.012304962,0.00052561396],"about_ca_topic_score_codex":0.000002852776,"about_ca_topic_score_gemma":0.000009549647,"teacher_disagreement_score":0.9775362,"about_ca_system_score_codex":0.00006417462,"about_ca_system_score_gemma":0.0000878528,"threshold_uncertainty_score":0.60763156},"labels":[],"label_agreement":null},{"id":"W6977254233","doi":"10.6084/m9.figshare.12082182","title":"Additional file 3 of Stem/progenitor cell marker expression in clear cell renal cell carcinoma: a potential relationship with the immune microenvironment to be explored","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Clear cell renal cell carcinoma; Cell; Immune system; Immunostaining; Immunohistochemistry; Tumor microenvironment; Cell growth; Kidney","score_opus":0.03414285318619164,"score_gpt":0.19975763535665794,"score_spread":0.1656147821704663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977254233","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1138531,0.00037336643,0.000001679157,0.00062792434,0.000010208183,0.0011411103,0.8824295,0.000023664717,0.0015394499],"genre_scores_gemma":[0.65192306,6.256581e-7,0.0008291764,0.0002146414,0.00009508448,0.0011121435,0.34439605,0.0000419399,0.0013872776],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833876,0.00011051987,0.00034542577,0.0004182923,0.00050429156,0.0002827226],"domain_scores_gemma":[0.99873793,0.000375274,0.00020003661,0.00038618653,0.000064191605,0.00023640318],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000028166061,0.0002502299,0.0002852187,0.00007510576,0.00008534536,0.000016995178,0.00018559674,0.00010025417,0.8047778],"category_scores_gemma":[0.00006381057,0.00017483815,0.00015081634,0.00023041172,0.00001805706,0.000070606526,0.0001756147,0.0002982029,0.0013414234],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096241594,0.0002472771,0.00014875048,0.00026395157,0.0000097343245,0.00020926773,0.0005994783,0.0000874246,0.034805156,2.5515469e-8,0.9626184,0.00004810816],"study_design_scores_gemma":[0.0036935771,0.0020776826,0.17441072,0.0016035283,0.00010715486,0.000037284106,0.0017555073,0.00023680077,0.51202506,6.570139e-7,0.3036384,0.0004136316],"about_ca_topic_score_codex":0.000006708996,"about_ca_topic_score_gemma":0.0000026239882,"teacher_disagreement_score":0.8034364,"about_ca_system_score_codex":0.00013668614,"about_ca_system_score_gemma":0.00013382394,"threshold_uncertainty_score":0.99943614},"labels":[],"label_agreement":null},{"id":"W6977288849","doi":"10.6084/m9.figshare.12211265","title":"Additional file 2 of Management of complex renal cysts in Canada: results of a survey study","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; McGill University; Ottawa Hospital; Princess Margaret Cancer Centre; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Cyst; Nephrectomy; MEDLINE; Kidney; Survey research","score_opus":0.12445842375933763,"score_gpt":0.26761120200133387,"score_spread":0.14315277824199624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977288849","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011908028,0.000017495164,1.0557387e-8,0.000030832343,0.0000028014315,0.0004718652,0.98317206,0.000003371413,0.004393532],"genre_scores_gemma":[0.49064538,1.3773612e-7,0.00008056748,0.000017914115,0.0000067886654,0.000086469765,0.5090793,0.000004657078,0.00007879041],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99883395,0.000064819964,0.0004124453,0.00017124876,0.00041515988,0.00010236451],"domain_scores_gemma":[0.9988748,0.0005011232,0.00020865232,0.00018117575,0.00015712704,0.00007712852],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00003084592,0.000089992915,0.0003199325,0.000042703494,0.000006139498,8.971697e-7,0.00009090488,0.000017502067,0.89062566],"category_scores_gemma":[0.00064008817,0.0000805084,0.000042319993,0.00025800747,0.000005357369,0.000013223471,0.00007976739,0.00005914492,0.000039449456],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004470678,0.00021245508,0.00068025396,0.0004211017,0.000108302425,0.0003011447,0.00008310927,0.000021940174,0.000013101654,1.0785286e-7,0.9973389,0.0003725156],"study_design_scores_gemma":[0.0018184957,0.00053644483,0.9706547,0.0019294707,0.000017550865,0.000002460403,0.00021331717,0.00008606469,0.00030712676,2.8319957e-7,0.024381569,0.000052514195],"about_ca_topic_score_codex":0.107497826,"about_ca_topic_score_gemma":0.29447332,"teacher_disagreement_score":0.9729573,"about_ca_system_score_codex":0.00014418595,"about_ca_system_score_gemma":0.00051541126,"threshold_uncertainty_score":0.8984454},"labels":[],"label_agreement":null},{"id":"W6977484787","doi":"10.6084/m9.figshare.26598941","title":"Additional file 1 of Comparison of peri- and intraoperative outcomes of open vs robotic-assisted partial nephrectomy for renal cell carcinoma: a propensity-matched analysis","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nephrectomy; Renal cell carcinoma; Propensity score matching; Kidney cancer; Standard of care; Kidney; Matching (statistics)","score_opus":0.08159294887477639,"score_gpt":0.3227419088383357,"score_spread":0.2411489599635593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977484787","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038223017,0.00024356558,0.0000045859074,0.00006721254,0.000010464147,0.0012713234,0.9593761,0.000013776951,0.00078994024],"genre_scores_gemma":[0.5620886,2.3113634e-7,0.0018951588,0.00001259358,0.00001843952,0.00089770975,0.43443814,0.00001285439,0.00063625665],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9986693,0.00006119243,0.00051555183,0.00033127458,0.00026104506,0.00016158415],"domain_scores_gemma":[0.99795336,0.001093738,0.00023310493,0.00024729778,0.00036955156,0.0001029377],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000044845205,0.00019050812,0.0011303073,0.00019375811,0.000038507762,0.00002771976,0.00013586768,0.000081087535,0.7462596],"category_scores_gemma":[0.00051687856,0.00014143575,0.00029079747,0.0004262224,0.00003840898,0.00010406743,0.00015457295,0.00010749301,0.000026595642],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047868877,0.00045415922,0.003686662,0.0016821944,0.0013800024,0.00003147717,0.00063652935,0.00007802962,0.0013159978,0.0000048968177,0.98973733,0.00051400415],"study_design_scores_gemma":[0.003463382,0.0032243864,0.71869254,0.004014807,0.0040775724,0.00002827163,0.00061920966,0.019844018,0.12603979,0.000010112125,0.11952233,0.00046355155],"about_ca_topic_score_codex":0.00005891763,"about_ca_topic_score_gemma":0.000058886657,"teacher_disagreement_score":0.870215,"about_ca_system_score_codex":0.00006052037,"about_ca_system_score_gemma":0.00030310432,"threshold_uncertainty_score":0.57675827},"labels":[],"label_agreement":null},{"id":"W6980806063","doi":"","title":"A critical appraisal of Alvin Plantinga on justification and warrant","year":2001,"lang":"en","type":"other","venue":"Library and Archives Canada (Government of Canada)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Internalism and externalism; Externalism; Warrant; Critical appraisal; Class (philosophy); General interest","score_opus":0.007160362243877959,"score_gpt":0.19064391344070025,"score_spread":0.1834835511968223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6980806063","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018710999,0.0012428162,0.000024956853,0.0024306977,0.00020711341,0.00027447418,0.00037797863,0.000013481727,0.9767175],"genre_scores_gemma":[0.84782594,0.00063529564,0.0011112799,0.0003801561,0.00015448291,0.000010628552,0.000053066295,0.00013091776,0.14969823],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99805975,0.000039181145,0.00025224814,0.00027804333,0.0011709906,0.00019979123],"domain_scores_gemma":[0.99895906,0.00042038455,0.00015386034,0.00022328222,5.343551e-7,0.0002428691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000007413031,0.00022207874,0.00042208272,0.00005111373,0.000036485122,0.0000063458133,0.00007023863,0.000056828132,0.00020129488],"category_scores_gemma":[0.000014923885,0.00018884531,0.000029165562,0.0000405479,0.00013125583,0.000036991518,0.00004541485,0.00013996325,4.3033825e-9],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009246255,0.0012857628,0.123637296,0.0182499,0.0022653828,0.0053381664,0.00057915313,0.000017131337,0.108617365,0.2382377,0.39404324,0.09848267],"study_design_scores_gemma":[0.0037222502,0.001707944,0.16094485,0.0057853884,0.0009271381,0.00036101922,0.003540228,0.00072319666,0.19165199,0.00022633707,0.6292846,0.0011250614],"about_ca_topic_score_codex":0.0054020844,"about_ca_topic_score_gemma":0.005740975,"teacher_disagreement_score":0.829115,"about_ca_system_score_codex":0.000006226902,"about_ca_system_score_gemma":0.00072291563,"threshold_uncertainty_score":0.81663716},"labels":[],"label_agreement":null},{"id":"W6981720445","doi":"","title":"Exploring the lived experience of adults using prescriptions opioids to manage chronic non-cancer pain","year":2012,"lang":"en","type":"other","venue":"Library and Archives Canada (Government of Canada)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medical prescription; Chronic pain; Lived experience; Interpretative phenomenological analysis; Ambivalence; Qualitative research","score_opus":0.025815746033147895,"score_gpt":0.1974811898044948,"score_spread":0.1716654437713469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6981720445","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3698761,0.00756613,0.00023368179,0.0015125095,0.0007937379,0.0018863314,0.00039564373,0.00002643978,0.61770946],"genre_scores_gemma":[0.8449303,0.0011348313,0.0011993566,0.00046971996,0.00033861466,0.00015554052,0.000009879801,0.00015691384,0.15160485],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978473,0.000063589505,0.00027604742,0.00027231048,0.0012068371,0.00033391864],"domain_scores_gemma":[0.99899894,0.00009751593,0.00020190599,0.00040130015,8.049013e-7,0.0002995037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000013645941,0.00027131967,0.00040255563,0.00005430372,0.00007904971,0.000008027301,0.00020244392,0.00003016426,0.00023522327],"category_scores_gemma":[0.0000031027046,0.00020423159,0.000053003354,0.00009937832,0.00009307824,0.0001239538,0.00016223274,0.00013548645,6.7562302e-9],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007214095,0.00095159153,0.21420038,0.025937835,0.0053803492,0.0012953511,0.021366397,0.0009261086,0.413558,0.0097896755,0.0784549,0.2209253],"study_design_scores_gemma":[0.0021221587,0.0008076822,0.20524585,0.012438939,0.00068736885,0.000021781183,0.016199993,0.0029692675,0.22082332,0.000021476368,0.53749603,0.0011661234],"about_ca_topic_score_codex":0.037716806,"about_ca_topic_score_gemma":0.03671363,"teacher_disagreement_score":0.4750542,"about_ca_system_score_codex":0.00004648675,"about_ca_system_score_gemma":0.00094565505,"threshold_uncertainty_score":0.9808638},"labels":[],"label_agreement":null},{"id":"W6983296716","doi":"","title":"Management of kidney cancer: Canadian Kidney Cancer Forum Consensus Update","year":2009,"lang":"en","type":"article","venue":"PubMed Central","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Kidney cancer; Kidney; Cancer; Kidney disease","score_opus":0.015470157076899117,"score_gpt":0.24479101057906366,"score_spread":0.22932085350216455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6983296716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8112318,0.0038070465,0.000008736795,0.14180875,0.0019230519,0.0026694264,0.00088749966,0.000101419595,0.03756227],"genre_scores_gemma":[0.98344755,0.0012655932,0.00036261973,0.011602434,0.00022914061,0.0002332498,0.00013721938,0.000027817072,0.002694357],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9969453,0.000029034678,0.00034782133,0.00036852888,0.00036000932,0.0019492913],"domain_scores_gemma":[0.99483246,0.0000071121826,0.00011059778,0.00039206236,0.000068931455,0.0045888405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012525346,0.00025689928,0.00039367666,0.000158545,0.00007007608,0.000016696793,0.00014097457,0.00008802942,0.00050041225],"category_scores_gemma":[0.000042477914,0.00022682223,0.00015168417,0.0002483432,0.00007307934,0.000037751604,0.00002220979,0.00015147333,0.000016381926],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007259019,0.00038780132,0.36946937,0.0004897435,0.0014013345,0.002611918,0.0003183381,0.00013775115,0.00045239352,0.002853274,0.4375513,0.18360089],"study_design_scores_gemma":[0.0034428227,0.00011567312,0.75211877,0.0002851239,0.0006692122,0.00003753608,0.00011216971,0.00009009845,0.011216364,0.00010425633,0.2315212,0.00028679962],"about_ca_topic_score_codex":0.06729673,"about_ca_topic_score_gemma":0.014922294,"teacher_disagreement_score":0.3826494,"about_ca_system_score_codex":0.0019885465,"about_ca_system_score_gemma":0.0018356673,"threshold_uncertainty_score":0.93891424},"labels":[],"label_agreement":null},{"id":"W6990172571","doi":"","title":"Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study.","year":2014,"lang":"en","type":"article","venue":"YUHSpace (Yonsei University Medical Library)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Risk stratification; Carcinoma; Survival analysis; Overall survival; Proportional hazards model; Primary tumor; Conditional probability","score_opus":0.010124368035751705,"score_gpt":0.1947953349652822,"score_spread":0.1846709669295305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6990172571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99597484,0.000035268167,0.00048069915,0.0009056753,0.00002459129,0.0010345536,0.000087267,0.000111133755,0.0013459586],"genre_scores_gemma":[0.9954515,0.0000025271509,0.00119737,0.0001766278,0.000026702292,0.0000051221077,0.0015190181,0.00004885992,0.0015722843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99709725,0.00048260528,0.00025889996,0.0004782984,0.0013551575,0.0003277977],"domain_scores_gemma":[0.99818784,0.00038185416,0.00024477436,0.00045207294,0.00016260057,0.00057087175],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001405752,0.00033833933,0.00067517604,0.0003499422,0.00013421853,0.000013305034,0.00020598184,0.000103548475,0.0010026102],"category_scores_gemma":[0.000047589376,0.00023855112,0.00012930973,0.0006632046,0.00019956054,0.00024507224,0.00004826229,0.00025463736,0.0000108622535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005502701,0.0027597842,0.9899349,0.00007490062,0.0002931555,0.00056202937,0.00013780955,0.000043870088,0.000032514035,0.00007606658,0.00045310345,0.000129165],"study_design_scores_gemma":[0.022230903,0.0067665735,0.96800065,0.00008421766,0.0004492694,0.000004894556,0.00032598161,0.0003330646,0.0010150141,0.000007452376,0.0005350818,0.00024688453],"about_ca_topic_score_codex":0.0004902496,"about_ca_topic_score_gemma":0.000057672096,"teacher_disagreement_score":0.021934237,"about_ca_system_score_codex":0.00010922316,"about_ca_system_score_gemma":0.0006126129,"threshold_uncertainty_score":0.9999106},"labels":[],"label_agreement":null},{"id":"W6995431927","doi":"","title":"Osgoode Innocence Project students Emily Baier (2L) and Samantha Skinner (3L) win first place ($24K) and third place ($14K) respectively in national letter writing competition administered by Innocence Canada and sponsored by Kent Legal","year":2019,"lang":"en","type":"article","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Innocence; Commit; Legislation; Prison; Mandate; Conscience","score_opus":0.010297841601041063,"score_gpt":0.25574053538072994,"score_spread":0.2454426937796889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6995431927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916988,0.0005447181,0.000013599111,0.003082889,0.000074134376,0.0012815576,0.00015917441,0.000029952595,0.0031152028],"genre_scores_gemma":[0.9941167,0.000091551614,0.00043652867,0.0017665101,0.000050399405,0.00006543525,0.00013016563,0.000032056334,0.0033106576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971107,0.0001499187,0.0005090575,0.0008098862,0.0009885058,0.00043189563],"domain_scores_gemma":[0.9988825,0.0004019901,0.00016261435,0.00020723061,0.00016841423,0.00017730032],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005036354,0.00037283727,0.00047308113,0.00018764137,0.00013213001,0.00013791939,0.00012765173,0.00012113049,0.00005090629],"category_scores_gemma":[0.000127311,0.00032530908,0.000024673227,0.00028913876,0.00015019723,0.00030508076,0.00018056668,0.00034872122,0.0000038146986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020916262,0.00027776035,0.94708276,0.00030935905,0.00011463172,0.00028399032,0.00075128337,0.0000058135884,0.014136964,0.00033302282,0.03448319,0.00012962367],"study_design_scores_gemma":[0.01002213,0.0008920714,0.968468,0.0007665298,0.000069427326,0.00056941865,0.001542884,0.0009129809,0.007666549,0.00002245557,0.008392245,0.0006753264],"about_ca_topic_score_codex":0.09784516,"about_ca_topic_score_gemma":0.09534467,"teacher_disagreement_score":0.026090944,"about_ca_system_score_codex":0.0007708172,"about_ca_system_score_gemma":0.0005177084,"threshold_uncertainty_score":0.9999199},"labels":[],"label_agreement":null},{"id":"W6995505861","doi":"","title":"The ontogenesis of asymmetry in humans","year":2018,"lang":"de","type":"dissertation","venue":"Dokumentenrepositorium der RUB (Ruhr University Bochum)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; Mercator Research Center Ruhr; Ruhr-Universität Bochum; Deutsche Forschungsgemeinschaft","keywords":"Asymmetry; Variation (astronomy); Field (mathematics)","score_opus":0.011390157789435399,"score_gpt":0.23652216181536345,"score_spread":0.22513200402592806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6995505861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95493066,0.013483388,0.00003469261,0.00025086716,0.0070417495,0.0018237985,0.00007034981,0.00006844573,0.022296064],"genre_scores_gemma":[0.94405085,0.0022791673,0.00023338218,0.000047967136,0.0012457338,0.000011778549,0.00091249915,0.00011502513,0.051103584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994432,0.00041913416,0.0011907689,0.0012829687,0.0015744751,0.0011006545],"domain_scores_gemma":[0.995419,0.00032659754,0.0011809663,0.001629423,0.000990942,0.0004530696],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006193248,0.0009765007,0.0013506099,0.0008532065,0.0009485414,0.00011585143,0.0011277564,0.0008296137,0.000120658115],"category_scores_gemma":[0.000098415134,0.00086435484,0.00083122886,0.001086249,0.0005014249,0.00023417799,0.00026970878,0.00080358563,0.00029148522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018772725,0.0060271723,0.8487635,0.0037837776,0.015052692,0.010152604,0.027013775,0.00003414076,0.042358007,0.00290576,0.019858088,0.005277734],"study_design_scores_gemma":[0.012318991,0.0038281176,0.6419668,0.0030445503,0.012392927,0.00006382076,0.049410876,0.00012786429,0.17007329,0.000088020686,0.10444294,0.0022417582],"about_ca_topic_score_codex":0.0063710194,"about_ca_topic_score_gemma":0.0027995408,"teacher_disagreement_score":0.20679668,"about_ca_system_score_codex":0.0025052724,"about_ca_system_score_gemma":0.000909413,"threshold_uncertainty_score":0.9993807},"labels":[],"label_agreement":null},{"id":"W6995647304","doi":"","title":"Planting Sounds:re-framing the acoustic environment in 'Tree People' (2014), the story of the Colne Valley Tree Society","year":2023,"lang":"en","type":"book-chapter","venue":"Huddersfield Research Portal (University of Huddersfield)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Interdisciplinary Research in Music Media and Technology","funders":"","keywords":"Filmmaking; Context (archaeology); Subject (documents); Documentary film; Subject matter; Local history","score_opus":0.0654124529652422,"score_gpt":0.2591531768798965,"score_spread":0.19374072391465427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6995647304","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026464493,0.0016258908,0.00012645818,0.012594928,0.000272385,0.002139438,0.000041550233,0.000044710607,0.9805082],"genre_scores_gemma":[0.81623197,0.0030415643,0.00008697316,0.00013858122,0.00014305714,0.000006117246,0.000038332102,0.00006987549,0.18024355],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.99566436,0.00033725912,0.00047104352,0.0006925468,0.0020824247,0.0007523903],"domain_scores_gemma":[0.9950657,0.002572368,0.00047715197,0.0015247288,0.00019189555,0.00016815797],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021866634,0.00044602592,0.0008135605,0.0002945852,0.0009417147,0.000027095579,0.0011799874,0.0007054499,0.039343916],"category_scores_gemma":[0.0001915814,0.0003007077,0.0009742074,0.00023673991,0.0014531724,0.00009001521,0.0010101221,0.0035864394,0.00007601875],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025764728,0.00013385148,0.000862248,0.0005199497,0.0008520579,0.00049347046,0.0105678,0.00015525588,0.00063851924,0.0011072535,0.9822994,0.002112575],"study_design_scores_gemma":[0.0016868411,0.0005389497,0.0018447902,0.00082099595,0.0006417922,0.000058298807,0.9916221,0.00034362642,0.00015539277,0.0009887923,0.00094406505,0.0003543462],"about_ca_topic_score_codex":0.0013505177,"about_ca_topic_score_gemma":0.008834116,"teacher_disagreement_score":0.9813553,"about_ca_system_score_codex":0.0000061109454,"about_ca_system_score_gemma":0.0006166648,"threshold_uncertainty_score":0.9999445},"labels":[],"label_agreement":null},{"id":"W6995891212","doi":"","title":"293. Postpartum Problems Series - Maternal Physiology","year":2020,"lang":"en","type":"other","venue":"Internet Archive (Internet Archive)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Postpartum period; Pregnancy; Human physiology; Period (music); Disease","score_opus":0.01604558926691697,"score_gpt":0.23572540694612013,"score_spread":0.21967981767920317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6995891212","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008131564,0.0011290067,0.000759147,0.0010509765,0.0012236771,0.0022925525,0.0011042682,0.00083324785,0.98347557],"genre_scores_gemma":[0.050688554,0.0005767013,0.0033919157,0.00091954716,0.0017076513,0.00027300217,0.0025666081,0.0012227031,0.9386533],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952734,0.00035176717,0.00093214243,0.0017280593,0.00064772135,0.0010668868],"domain_scores_gemma":[0.99738413,0.00013611434,0.000639293,0.0010244889,0.000044242006,0.00077174284],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.00008628192,0.0013633749,0.0018307948,0.0006739186,0.000028763416,0.00010392266,0.00091296504,0.00032046562,0.020610176],"category_scores_gemma":[0.000054210133,0.0011227006,0.00085090444,0.00012954965,0.00075864646,0.00008347428,0.0010608323,0.0012875423,0.0072875647],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021138787,0.00029497765,0.0024098342,0.0014110082,0.001967744,0.0018263625,0.0016275581,0.0000021494816,0.011259527,0.0011072238,0.9757769,0.00020281864],"study_design_scores_gemma":[0.0021531812,0.0033618824,0.010616981,0.0033639602,0.0005377553,0.0015298292,0.00004459634,0.00028417076,0.0065409252,0.0010523705,0.9695506,0.00096372305],"about_ca_topic_score_codex":0.010415638,"about_ca_topic_score_gemma":0.004724515,"teacher_disagreement_score":0.044822246,"about_ca_system_score_codex":0.00012759242,"about_ca_system_score_gemma":0.00018669415,"threshold_uncertainty_score":0.9999117},"labels":[],"label_agreement":null},{"id":"W6996222153","doi":"","title":"Real time digital control system for power system analog simulator","year":2001,"lang":"en","type":"other","venue":"Mspace (University of Manitoba)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Real-time simulation; Digital signal processing; Real Time Digital Simulator; Software; Power system simulator for engineering; Control system; Simple (philosophy); Electric power system; Simulation software","score_opus":0.00951345353982007,"score_gpt":0.19145272570030414,"score_spread":0.18193927216048406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6996222153","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029373232,0.00040490003,0.0021205242,0.00019438902,0.0002803649,0.0029354834,0.0011198334,0.00072162575,0.9628497],"genre_scores_gemma":[0.57610327,0.000015975316,0.00049901323,0.0000067293295,0.00026359758,0.0000019470938,0.00023527215,0.00030483352,0.42256936],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998583,0.000040599978,0.00015039911,0.00047277324,0.00040573895,0.0003474845],"domain_scores_gemma":[0.9985539,0.00008542821,0.0003889214,0.00058676855,0.0001454551,0.00023955418],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000086075874,0.00037205388,0.0010602965,0.00038335045,0.000079918995,0.000020585363,0.00021908527,0.00041054137,0.0001343049],"category_scores_gemma":[0.000009573441,0.00039696525,0.00045215385,0.00014299035,0.00010692157,0.00006472293,0.00005933809,0.00013074547,0.0008278863],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031327158,0.000651497,0.0355712,0.008789463,0.005816131,0.0059319115,0.00014998486,0.00009386285,0.0008219736,0.0007907012,0.9376448,0.00060580403],"study_design_scores_gemma":[0.03486021,0.0046031857,0.028078103,0.008125422,0.007943952,0.0007332309,0.030146165,0.004907088,0.00012452682,0.000003462719,0.8785206,0.001954051],"about_ca_topic_score_codex":0.0023145394,"about_ca_topic_score_gemma":0.0033246404,"teacher_disagreement_score":0.54673004,"about_ca_system_score_codex":0.0009113979,"about_ca_system_score_gemma":0.00011155589,"threshold_uncertainty_score":0.9999501},"labels":[],"label_agreement":null},{"id":"W6996288264","doi":"","title":"The role of neighbourhood groups in municipal governance: A case study of abandoned buildings in Windsor","year":2022,"lang":"en","type":"article","venue":"Scholarship at UWindsor (University of Windsor)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Grassroots; Neighbourhood (mathematics); Windsor; Politics; Public policy; Local government; Urban planning; Government (linguistics); Urban policy; Municipal council","score_opus":0.01662493334825877,"score_gpt":0.23306039260876102,"score_spread":0.21643545926050226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6996288264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629563,0.001151416,5.713094e-7,0.0001946639,0.00006882328,0.0011990108,0.000055245797,0.000016409778,0.0010182343],"genre_scores_gemma":[0.99944824,0.000040986477,0.00009439681,0.000016911348,0.000016479995,0.0000078256,0.00001114367,0.000032375603,0.00033161184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968233,0.00055062986,0.00058940763,0.0005197861,0.0010366442,0.00048021178],"domain_scores_gemma":[0.9978827,0.00032049467,0.0006360794,0.00086421036,0.00013825415,0.0001582454],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001347981,0.00028560832,0.00083787733,0.00044522103,0.00038968713,0.000009269268,0.00064694625,0.00012662294,0.00026062882],"category_scores_gemma":[0.00011613717,0.00028814274,0.00027499016,0.0013022454,0.0002327845,0.00028616088,0.000810268,0.00089075597,0.0000033697274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044207573,0.0028894434,0.9431581,0.000075853866,0.00022085597,0.004425763,0.027392909,0.00024959614,0.015214961,0.00019627933,0.0000068466,0.0017486379],"study_design_scores_gemma":[0.013453726,0.0026353747,0.8511436,0.00010510988,0.00024424423,0.00071507314,0.1274353,0.00013585482,0.0035810163,0.00012903794,0.00019934285,0.00022234963],"about_ca_topic_score_codex":0.011223331,"about_ca_topic_score_gemma":0.008166385,"teacher_disagreement_score":0.10004239,"about_ca_system_score_codex":0.0007007017,"about_ca_system_score_gemma":0.00018857377,"threshold_uncertainty_score":0.9999571},"labels":[],"label_agreement":null},{"id":"W7002371703","doi":"","title":"\\nSummary of the first annual Genitourinary Medical Oncology Conference Renal Cell Carcinoma Forum","year":2007,"lang":"en","type":"article","venue":"PubMed Central","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Renal cell carcinoma; Genitourinary system; Kidney cancer; Carcinoma; Nephrology","score_opus":0.01866042281792476,"score_gpt":0.242243350881234,"score_spread":0.22358292806330923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7002371703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96720475,0.00061378314,0.00007203398,0.004990891,0.000891558,0.00081692496,0.000031109277,0.000032186916,0.02534675],"genre_scores_gemma":[0.9974366,0.00004367636,0.00020233108,0.0007111501,0.0006168832,0.000052533946,0.000024228999,0.00002650049,0.0008861171],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964994,0.00006740314,0.0005370683,0.00035026035,0.0008764388,0.0016694376],"domain_scores_gemma":[0.99808866,0.00015392971,0.00018733885,0.00048424158,0.000115292896,0.000970511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066160853,0.00024464735,0.00043537936,0.00009199065,0.00010407775,0.000006540085,0.00035627966,0.00028095354,0.00027210696],"category_scores_gemma":[0.00012135869,0.00016313195,0.00026397794,0.00021407232,0.0003642794,0.00006350005,0.00022855966,0.00048269107,0.000012934851],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001449685,0.001235628,0.94974357,0.00017828717,0.00010332356,0.0024269554,0.0010034641,0.000005148217,0.0006881959,0.00020224886,0.013583418,0.029380076],"study_design_scores_gemma":[0.00259987,0.00055348035,0.92262214,0.000033816785,0.0001507274,0.000495026,0.00042981625,0.000034954544,0.04227887,0.000024228053,0.030639574,0.00013746765],"about_ca_topic_score_codex":0.0001792024,"about_ca_topic_score_gemma":0.00042410832,"teacher_disagreement_score":0.041590676,"about_ca_system_score_codex":0.00070876814,"about_ca_system_score_gemma":0.00094839756,"threshold_uncertainty_score":0.6652328},"labels":[],"label_agreement":null},{"id":"W7005553709","doi":"","title":"The role(s) of hypoxia-inducible factors (HIFs) in the development of renal cysts in mice deficient in fumarate hydratase (Fh1)","year":2011,"lang":"en","type":"dissertation","venue":"Oxford University Research Archive (ORA) (University of Oxford)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Fumarase; Knockout mouse; Downregulation and upregulation; Kidney; Gene; Immunohistochemistry; Cyst; Transfection; Cell; Germline","score_opus":0.03824913512874839,"score_gpt":0.2649795756074069,"score_spread":0.22673044047865853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7005553709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9564821,0.00030174287,0.000026264803,0.00006074343,0.000039188133,0.0014509725,0.00017924588,0.000008309805,0.041451443],"genre_scores_gemma":[0.99533355,0.00091102975,0.00089721044,0.0000023031325,0.000007422603,0.0000015985788,0.0009661315,0.00002580385,0.001854953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956219,0.000900692,0.00056452915,0.0006857364,0.0013904913,0.0008366315],"domain_scores_gemma":[0.9972595,0.00079917005,0.0005383023,0.00078268145,0.00040755523,0.0002128053],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018883356,0.00040017508,0.0008727992,0.002550016,0.00039528517,0.0000132447,0.0015729512,0.0002843323,0.000056979778],"category_scores_gemma":[0.00012872816,0.00034509943,0.00029762488,0.0018920873,0.000644341,0.00022576236,0.00046176327,0.0014012855,0.0000041368417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06184183,0.009222408,0.3973576,0.0038353074,0.0016907582,0.00455781,0.36836645,0.00038405243,0.08988856,0.010739714,0.00068661553,0.051428895],"study_design_scores_gemma":[0.004543609,0.0012823754,0.67448765,0.0013948439,0.00016871863,0.000010081942,0.28740728,0.0002529999,0.017323365,0.0008632354,0.01182434,0.00044147935],"about_ca_topic_score_codex":0.006796184,"about_ca_topic_score_gemma":0.07615394,"teacher_disagreement_score":0.27713007,"about_ca_system_score_codex":0.0007830377,"about_ca_system_score_gemma":0.0018994265,"threshold_uncertainty_score":0.9999001},"labels":[],"label_agreement":null},{"id":"W7008853980","doi":"","title":"The clinical and economic burden of metastatic renal cell carcinoma in Canada in real-world setting","year":2019,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Renal cell carcinoma; Kidney cancer; Disease; Carcinoma; Kidney disease; MEDLINE","score_opus":0.02582533809507479,"score_gpt":0.28122023446215916,"score_spread":0.25539489636708435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7008853980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95482063,0.0008997986,2.217889e-9,0.0000427183,0.0006188446,0.0013315461,0.00032660915,0.000014165518,0.04194569],"genre_scores_gemma":[0.9932692,0.000586115,0.00016074284,0.00005480312,0.000040649902,0.00008707543,0.00042282007,0.00012977788,0.0052487957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949373,0.0006539176,0.0021368542,0.0009984546,0.0005749042,0.00069854374],"domain_scores_gemma":[0.9963284,0.0014165462,0.0009415888,0.00086481293,0.000133267,0.000315367],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017011487,0.0006389451,0.0015225691,0.00046643693,0.00018724345,0.00002792657,0.0003583231,0.00026896727,0.000058268848],"category_scores_gemma":[0.0002841246,0.0005308848,0.00027143458,0.00031796104,0.00008101199,0.00015606248,0.00011240839,0.0016549946,0.000029186578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008856703,0.0009072265,0.6664042,0.008072299,0.001640953,0.005723358,0.0002196573,0.0015198373,0.019826775,0.010310741,0.00010536402,0.27641287],"study_design_scores_gemma":[0.00938811,0.0008186559,0.92872876,0.0016691894,0.0010746162,0.0000790914,0.002793818,0.0005427515,0.047922485,0.0011423577,0.0046037734,0.0012363935],"about_ca_topic_score_codex":0.8055157,"about_ca_topic_score_gemma":0.97063005,"teacher_disagreement_score":0.2751765,"about_ca_system_score_codex":0.0032771414,"about_ca_system_score_gemma":0.0017219818,"threshold_uncertainty_score":0.99971426},"labels":[],"label_agreement":null},{"id":"W7027311065","doi":"","title":"Characterization of a novel role of the Birt-Hogg-Dubé tumor suppressor protein in metabolism","year":2010,"lang":"en","type":"other","venue":"Library and Archives Canada (Government of Canada)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Folliculin; Birt–Hogg–Dubé syndrome; Mitochondrion; PI3K/AKT/mTOR pathway; Mitochondrial biogenesis; AMPK; Phenotype; Suppressor; Function (biology); Mutation","score_opus":0.0032129780679737495,"score_gpt":0.14299947908116845,"score_spread":0.1397865010131947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7027311065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.616164,0.00047776345,0.0000037024745,0.00094351673,0.00016107994,0.0012627552,0.0013332403,0.0000073814517,0.37964654],"genre_scores_gemma":[0.8874712,0.00003929939,0.0005591837,0.00018780719,0.00007522723,0.000037558628,0.000034819885,0.0001232629,0.11147166],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978306,0.00004482306,0.00037698768,0.0002274528,0.0013264815,0.00019363283],"domain_scores_gemma":[0.99895245,0.000039376406,0.0005075726,0.0003741848,0.0000011121879,0.0001252872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000010135293,0.00023688877,0.00056235795,0.00006609242,0.000020996715,0.000004066757,0.00019557757,0.000062490355,0.00014186162],"category_scores_gemma":[0.0000053275326,0.00017091958,0.000058544476,0.0001009821,0.00010931332,0.00006467512,0.000117931115,0.00021387532,1.3663137e-9],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035567483,0.000117919066,0.0048682177,0.0006053871,0.00010846855,0.000022041995,0.00004640521,6.4412484e-7,0.9889262,0.0041463366,0.00017869512,0.0006240648],"study_design_scores_gemma":[0.00092469907,0.00005751649,0.11842606,0.0007424457,0.00007947213,0.000007680358,0.00014335984,0.000075253476,0.8288856,0.000034660963,0.050486237,0.0001369782],"about_ca_topic_score_codex":0.010278778,"about_ca_topic_score_gemma":0.03466019,"teacher_disagreement_score":0.27130717,"about_ca_system_score_codex":0.000007380561,"about_ca_system_score_gemma":0.0016006125,"threshold_uncertainty_score":0.99631184},"labels":[],"label_agreement":null},{"id":"W7030472525","doi":"","title":"Needle core biopsy of renal neoplasms: the Winnipeg experience and comparison with the literature","year":2017,"lang":"en","type":"dissertation","venue":"Mspace (University of Manitoba)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nucleofection; Tubulopathy; TSG101; Liquation; Diafiltration; Fusible alloy; Articular cartilage damage; Myoglobinuria","score_opus":0.022688005687477104,"score_gpt":0.24271312938518164,"score_spread":0.22002512369770452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7030472525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917616,0.0014974463,0.000008631047,0.000946751,0.00008008113,0.0004603337,0.000022272727,0.000012536726,0.005210309],"genre_scores_gemma":[0.9929985,0.00015028806,0.00021189864,0.000013155748,0.000039560215,0.0000010911951,0.00017973113,0.00001572005,0.0063900473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990788,0.000036938374,0.00008876063,0.0002581434,0.00038768857,0.00014966223],"domain_scores_gemma":[0.9985376,0.00006402141,0.00047842882,0.0006204661,0.00023181466,0.000067689914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007964957,0.00022123793,0.00044353039,0.00009453419,0.0003581394,0.000029784947,0.00033344992,0.00017077797,0.000007271209],"category_scores_gemma":[0.000013655169,0.00013536842,0.00010578408,0.00014391726,0.00042270517,0.000092782524,0.000046527784,0.00034047314,0.0000028993104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015619159,0.00085909077,0.69118905,0.0035902364,0.0023037677,0.0017874853,0.21055226,0.00005171768,0.037876707,0.000713267,0.02691477,0.008542508],"study_design_scores_gemma":[0.0011459433,0.0006339985,0.8183445,0.0011670464,0.00067582855,0.00010710509,0.17249447,0.00006917457,0.0024084866,0.000008078073,0.0027881404,0.00015723854],"about_ca_topic_score_codex":0.0013189875,"about_ca_topic_score_gemma":0.039810736,"teacher_disagreement_score":0.12715547,"about_ca_system_score_codex":0.000052118485,"about_ca_system_score_gemma":0.000097727534,"threshold_uncertainty_score":0.97771025},"labels":[],"label_agreement":null},{"id":"W7035833953","doi":"","title":"After Hiding in a Church for Months, Woman to Be Deported — Because Canadian Government Says She Lied About Being Gay","year":2018,"lang":"en","type":"article","venue":"eYLS (Yale Law School)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Government (linguistics); Agency (philosophy); Narrative; Immigration","score_opus":0.022940369143238392,"score_gpt":0.26472638278691535,"score_spread":0.24178601364367697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7035833953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9717287,0.00029886232,0.000044982782,0.0025297112,0.00024271775,0.0020565637,0.000074518095,0.00006390104,0.022960085],"genre_scores_gemma":[0.9871313,0.000009441738,0.0026043216,0.00572154,0.000496932,0.00087258546,0.000046655357,0.00009036083,0.0030268647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971504,0.00005147825,0.0005372924,0.0006754978,0.0006210419,0.00096427544],"domain_scores_gemma":[0.99774146,0.00007742785,0.000090651425,0.0007139395,0.00011781959,0.0012587046],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038224604,0.00036384247,0.0004997749,0.00016902003,0.00018902075,0.000100208345,0.00017955212,0.00017646457,0.0005386731],"category_scores_gemma":[0.00020357044,0.00033768077,0.00015188425,0.00030459705,0.000069976464,0.00014139425,0.000081183665,0.00026021176,0.00016745465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045994697,0.0008824161,0.8849012,0.00054584834,0.0008670672,0.00593424,0.0080924025,0.000035361332,0.0544573,0.0044652605,0.028674133,0.006545276],"study_design_scores_gemma":[0.0056704045,0.0017629635,0.7653093,0.0007845875,0.00034207574,0.00010218442,0.00060861063,0.00022331547,0.047535006,0.00016795022,0.17665537,0.0008382607],"about_ca_topic_score_codex":0.11414804,"about_ca_topic_score_gemma":0.573058,"teacher_disagreement_score":0.45890996,"about_ca_system_score_codex":0.0027430388,"about_ca_system_score_gemma":0.00034546704,"threshold_uncertainty_score":0.9999075},"labels":[],"label_agreement":null},{"id":"W7036811402","doi":"","title":"Characterization of epigenetic changes and their connection to gene expression abnormalities in clear cell renal cell carcinoma","year":2019,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McGill University","keywords":"Epigenome; Clear cell renal cell carcinoma; Enhancer; Epigenetics; Transcription factor; Gene; DNA methylation; Regulation of gene expression; Gene expression","score_opus":0.015926843276647142,"score_gpt":0.2205422056693558,"score_spread":0.20461536239270867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7036811402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890229,0.0006751976,6.411323e-7,0.000016031508,0.00051131245,0.0018956268,0.0006603772,0.00005757202,0.007160309],"genre_scores_gemma":[0.99022925,0.00054910185,0.00021985428,0.00010630181,0.000061737024,0.0001884081,0.002746683,0.00018280747,0.0057158624],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967453,0.00031729366,0.0008435077,0.001006885,0.0005404565,0.00054657855],"domain_scores_gemma":[0.99788135,0.00012570711,0.00063489605,0.0006883816,0.00034492233,0.00032474814],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004312326,0.00073992077,0.0010889081,0.00087849004,0.00021058289,0.000032601696,0.0001990607,0.00067236676,0.00011387243],"category_scores_gemma":[0.00007160126,0.00067500037,0.00019432652,0.00040744006,0.00003670932,0.00023295257,0.00010610406,0.0006614754,0.000054973683],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014212868,0.0002655531,0.0009892564,0.0017055774,0.000033709195,0.000047052108,0.0002015815,0.000009710939,0.9858313,0.0000639701,6.078791e-7,0.009430372],"study_design_scores_gemma":[0.0017886434,0.0016322333,0.061286308,0.0007829587,0.00016580484,0.000030059067,0.00090726063,0.000017202252,0.932039,0.00006540754,0.0007636411,0.00052143075],"about_ca_topic_score_codex":0.00038692256,"about_ca_topic_score_gemma":0.00036828982,"teacher_disagreement_score":0.06029705,"about_ca_system_score_codex":0.00054562726,"about_ca_system_score_gemma":0.000073865354,"threshold_uncertainty_score":0.99957013},"labels":[],"label_agreement":null},{"id":"W7045329186","doi":"","title":"An analysis of the tour operators' tourist satisfaction with leisure activities: the case of the dominican republic","year":2002,"lang":"pt","type":"book-chapter","venue":"Acceda (Universidad de Las Palmas de Gran Canaria)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tourism; Work (physics); Tourist industry; Quarter (Canadian coin)","score_opus":0.019819727777061705,"score_gpt":0.2514854047904141,"score_spread":0.2316656770133524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7045329186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823879,0.00036817565,0.000068798945,0.0021275475,0.00023822239,0.0015185328,0.00055708125,0.00003289746,0.012700841],"genre_scores_gemma":[0.9843266,0.00016468462,0.00007705731,0.00024985117,0.0002023337,0.000020127492,0.000046512094,0.00012013795,0.014792712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99595326,0.0007107553,0.0007462172,0.0009048118,0.0009778504,0.00070711854],"domain_scores_gemma":[0.9935265,0.000614814,0.0015285817,0.0035271798,0.00037742752,0.00042550263],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006577066,0.0008409356,0.0016041625,0.0007502284,0.00086309464,0.00010579373,0.0011410445,0.00066154194,0.0016162413],"category_scores_gemma":[0.00007406292,0.0004896522,0.0013062613,0.0014794851,0.001115387,0.0003209133,0.00023092414,0.0012756751,0.000002335099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034341803,0.00060451025,0.82463074,0.00070617005,0.05081147,0.011863012,0.02572794,0.009808782,0.0025205603,0.04723898,0.0043911985,0.018262455],"study_design_scores_gemma":[0.0053226114,0.0020560028,0.8893492,0.0008265916,0.056772117,0.0033579376,0.030355714,0.0046722796,0.0018584379,0.00013527618,0.0041185473,0.0011752512],"about_ca_topic_score_codex":0.077200904,"about_ca_topic_score_gemma":0.18212254,"teacher_disagreement_score":0.10492165,"about_ca_system_score_codex":0.001733284,"about_ca_system_score_gemma":0.001195048,"threshold_uncertainty_score":0.9997555},"labels":[],"label_agreement":null},{"id":"W7066141252","doi":"","title":"Identifying Barriers and Facilitators to the use of Renal Tumor Biopsy (RTB) in the Management of Small Renal Masses (SRMs) in Ontario and Potential Implementation Strategies to Promote its Widespread Adoption","year":2021,"lang":"","type":"dissertation","venue":"TSpace","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Delphi method; Qualitative research; Work (physics); MEDLINE; Health care; Phase (matter)","score_opus":0.05957894792916027,"score_gpt":0.33302148884106003,"score_spread":0.2734425409118998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7066141252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932841,0.0011212168,0.00048442485,0.00048252798,0.00021492525,0.0042707296,0.000048485832,0.0000073485967,0.00008625892],"genre_scores_gemma":[0.99388343,0.00051690964,0.0041268542,0.00004583245,0.000025586216,0.00031373138,0.00041296537,0.00003692839,0.00063778186],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99615574,0.00042827573,0.0011719719,0.0008515987,0.0008842138,0.0005082063],"domain_scores_gemma":[0.998297,0.00012935235,0.000544973,0.00052068767,0.00029241567,0.00021560179],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009913362,0.00057009887,0.00074919756,0.00062285276,0.00014205353,0.00024536395,0.00023424144,0.00014078376,0.00018601803],"category_scores_gemma":[0.00007709875,0.00042330017,0.00012496112,0.00084862113,0.00008585404,0.00029224658,0.0001593481,0.000442626,0.0000023336559],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0081515405,0.0005626105,0.07148838,0.007573342,0.002109907,0.0025055998,0.60356975,0.009212255,0.27038428,0.0007001788,0.00012438637,0.023617733],"study_design_scores_gemma":[0.0021386798,0.0010239086,0.5699256,0.0032307638,0.0009946062,0.00006272352,0.39669478,0.000104151215,0.025138251,0.000036490896,0.00030389393,0.00034613063],"about_ca_topic_score_codex":0.06141216,"about_ca_topic_score_gemma":0.27287942,"teacher_disagreement_score":0.49843723,"about_ca_system_score_codex":0.0005168109,"about_ca_system_score_gemma":0.0006040054,"threshold_uncertainty_score":0.9998219},"labels":[],"label_agreement":null},{"id":"W7071533867","doi":"","title":"Venous perfusion and intravenous dissection for fixation, evaluation and staging of renal tumours in nephrectomy specimens","year":2011,"lang":"en","type":"dissertation","venue":"Mspace (University of Manitoba)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Nephrectomy; Renal vein; Renal cell carcinoma; Perfusion; Vein; Pathological; Kidney","score_opus":0.022965750582447583,"score_gpt":0.2381839558650253,"score_spread":0.21521820528257773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7071533867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996983,0.000550676,0.0000933086,0.00006860501,0.00008999891,0.0011335714,0.00001380681,0.000010747766,0.0010562736],"genre_scores_gemma":[0.9979401,0.00030102473,0.00090402435,0.000002112984,0.000032038562,0.000002474088,0.00045890917,0.00001833195,0.00034097483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991306,0.0000542543,0.00014080608,0.00027934008,0.0002655441,0.00012945876],"domain_scores_gemma":[0.99914694,0.000047395857,0.00030910491,0.00013635447,0.00030096996,0.00005926171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025622608,0.00015769602,0.00037970312,0.00039561145,0.00008874656,0.000005394567,0.000043510878,0.00014803934,0.000012049622],"category_scores_gemma":[0.000034828583,0.00018702571,0.000060946688,0.0001249761,0.000051156647,0.00008740384,0.000018536162,0.0001272948,7.134776e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017715847,0.0023975854,0.634507,0.006910742,0.0006822655,0.00024044167,0.045835264,0.0001439706,0.16910946,0.0004859729,0.00047644856,0.121495016],"study_design_scores_gemma":[0.0024184803,0.001165149,0.96802884,0.0005607559,0.0007658806,0.000018749693,0.019670654,0.00074978964,0.0062754587,0.0001531991,0.0000556966,0.00013736203],"about_ca_topic_score_codex":0.0021980922,"about_ca_topic_score_gemma":0.083944835,"teacher_disagreement_score":0.33352184,"about_ca_system_score_codex":0.00022575408,"about_ca_system_score_gemma":0.00013007704,"threshold_uncertainty_score":0.9327708},"labels":[],"label_agreement":null},{"id":"W7084026232","doi":"10.64628/aam.ehdhgmwhg","title":"‘Elbows up’ in Canada means sustainable resource development","year":2025,"lang":"en","type":"article","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Carleton University","funders":"","keywords":"Sustainable development; Sustainability; Resource (disambiguation); Government (linguistics); Production (economics)","score_opus":0.00990617138183302,"score_gpt":0.22322104981276836,"score_spread":0.21331487843093533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7084026232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6559255,0.00029401953,0.00007092632,0.0017899844,0.00004614444,0.0003806171,2.650665e-7,0.000021107158,0.34147143],"genre_scores_gemma":[0.7724461,0.00000319017,0.0005997023,0.0009962786,0.0000070654505,0.00003345879,0.000009341146,0.0000065552226,0.22589828],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99898934,0.000021424104,0.00022827704,0.00020552575,0.00021293822,0.00034248157],"domain_scores_gemma":[0.9995552,0.00004436422,0.000018402807,0.00022852498,0.00005841481,0.000095144795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011776614,0.00011424065,0.00020328278,0.00013606639,0.00004418149,0.000007759155,0.0000640295,0.000029971456,0.0002184607],"category_scores_gemma":[0.0000381291,0.00009001999,0.000022871356,0.00030688776,0.000010304746,0.000019422601,0.000059120786,0.00009949082,0.000011814395],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061616517,0.0003287759,0.75068206,0.0008932636,0.0003129059,0.0057275183,0.0016160074,0.00023615516,0.00050981384,0.012767723,0.19997625,0.026333354],"study_design_scores_gemma":[0.0021994368,0.000050437804,0.3392458,0.000111053625,0.000039612543,0.000018632669,0.008003658,0.00010629721,0.035679027,0.00008231605,0.6143068,0.0001569295],"about_ca_topic_score_codex":0.88848346,"about_ca_topic_score_gemma":0.9384224,"teacher_disagreement_score":0.41433054,"about_ca_system_score_codex":0.003945156,"about_ca_system_score_gemma":0.0055480087,"threshold_uncertainty_score":0.9998785},"labels":[],"label_agreement":null},{"id":"W7084100641","doi":"10.6084/m9.figshare.29959147","title":"Strategic regional path development: industrial policy, place and the rhetoric of regionalisation","year":2025,"lang":"en","type":"article","venue":"Figshare","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Regionalisation; Rhetoric; Geopolitics; Politics; Government (linguistics); Path dependency; Path dependence; Strategic planning; Industrial policy","score_opus":0.12763025473279452,"score_gpt":0.29397386465575676,"score_spread":0.16634360992296224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7084100641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79208404,0.01005353,0.000004519583,0.027276875,0.00027281372,0.004907903,0.018178342,0.00019333903,0.14702865],"genre_scores_gemma":[0.98512036,0.000010717281,0.000051906187,0.00027092986,0.00015323775,0.00011249691,0.012486702,0.0000069699795,0.0017866993],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99930537,0.000048191472,0.00018848918,0.00014250462,0.00021247643,0.000102941274],"domain_scores_gemma":[0.9994113,0.00019976731,0.00009500307,0.00015139148,0.00009851129,0.000044049415],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007137541,0.00009742085,0.0001720804,0.00009887728,0.000059498892,0.0000122080955,0.000059484,0.00008329107,0.0017524045],"category_scores_gemma":[0.00027355607,0.00006201285,0.000045633573,0.00020441193,0.000024456036,0.000027921484,0.000043035892,0.00011013428,0.000027045227],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045770425,0.0003917229,0.0035108298,0.0015598922,0.0008414382,0.00010442247,0.003252398,0.000037571193,0.00034442957,0.05625357,0.9159693,0.013157398],"study_design_scores_gemma":[0.04905558,0.0006739774,0.21800654,0.016457152,0.00045498548,0.00037941383,0.0012078632,0.00061906,0.012029915,0.0061025675,0.69427097,0.0007420015],"about_ca_topic_score_codex":0.000028658636,"about_ca_topic_score_gemma":0.000005875747,"teacher_disagreement_score":0.22169833,"about_ca_system_score_codex":0.00013070845,"about_ca_system_score_gemma":0.0008610001,"threshold_uncertainty_score":0.9991601},"labels":[],"label_agreement":null},{"id":"W7084771225","doi":"","title":"L’InstitE","year":2019,"lang":"fr","type":"other","venue":"HAL (Le Centre pour la Communication Scientifique Directe)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Portrait; Work (physics); Face (sociological concept); Object (grammar)","score_opus":0.013544364619555356,"score_gpt":0.22520921473261904,"score_spread":0.21166485011306369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7084771225","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012659327,0.016967079,0.009703454,0.009739968,0.0011185141,0.0012986179,0.00007325402,0.00021922257,0.94822055],"genre_scores_gemma":[0.10989442,0.0023759238,0.013809908,0.00024085923,0.00018785223,0.000064881446,0.00051085814,0.00032437444,0.8725909],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99211353,0.0045473464,0.00069057645,0.0011290923,0.00072554674,0.0007939282],"domain_scores_gemma":[0.99225587,0.0016966319,0.00059431954,0.0034438556,0.0014852448,0.00052409375],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0029620016,0.00070578896,0.00088372506,0.00036707893,0.00024092011,0.00020457181,0.00089766714,0.0006016887,0.014158256],"category_scores_gemma":[0.0013076551,0.0006926728,0.0004662521,0.00053545396,0.00047507818,0.00011046386,0.00048858527,0.0007216943,0.013273417],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011702741,0.004133417,0.0226249,0.0024909044,0.0014962927,0.00038810962,0.012268258,0.000034076056,0.016214982,0.4391604,0.05948385,0.44158778],"study_design_scores_gemma":[0.0022375064,0.0000022646423,0.012094341,0.009169665,0.0004629138,0.00010873065,0.00012499596,0.0018194596,0.032738455,0.00021451287,0.94034696,0.00068021147],"about_ca_topic_score_codex":0.0017825811,"about_ca_topic_score_gemma":0.0013637677,"teacher_disagreement_score":0.8808631,"about_ca_system_score_codex":0.0006501746,"about_ca_system_score_gemma":0.0006845767,"threshold_uncertainty_score":0.9995524},"labels":[],"label_agreement":null},{"id":"W7088480098","doi":"10.5281/zenodo.17319958","title":"FIGURE 4 in Systematics and biogeography of tube-nosed bats, Murina (Mammalia, Chiroptera, Vespertilionidae), from the Philippines with descriptions of six new species","year":2025,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ontario Museum","funders":"","keywords":"Biogeography; Systematics; Taxonomy (biology); Phylogenetics; Cladistics; Tree (set theory)","score_opus":0.02917607328272171,"score_gpt":0.22191347310568327,"score_spread":0.19273739982296156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7088480098","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14349154,0.009145544,0.00035296974,0.001751503,0.00014279281,0.0035858715,0.001662118,0.0004023338,0.8394653],"genre_scores_gemma":[0.6849311,0.002245492,0.0013765428,0.00010372676,0.00033638577,4.2335745e-7,0.0039118426,0.0034536791,0.30364084],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985237,0.00020577497,0.00037420855,0.0003337484,0.00037648436,0.0001860633],"domain_scores_gemma":[0.9987671,0.000047572383,0.00023004689,0.0006249972,0.00022808103,0.0001022012],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016157802,0.00022678843,0.00046893297,0.0005249278,0.000184057,0.00008992286,0.00036804055,0.00010764193,0.0096341595],"category_scores_gemma":[0.00018117661,0.0001555229,0.00007967669,0.00065630267,0.0002723677,0.000038326958,0.00029685433,0.00020616014,0.00015066497],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009443858,0.00097514456,0.0042616385,0.0055216807,0.0016698234,0.00013626608,0.0039515146,0.000017041346,0.011627304,0.0023773103,0.9565878,0.011930125],"study_design_scores_gemma":[0.002556684,0.0009470168,0.074567534,0.0055719665,0.00046103078,0.000046178844,0.0010009365,0.00003043484,0.0018648404,0.000059955983,0.91262853,0.00026488164],"about_ca_topic_score_codex":0.0009499455,"about_ca_topic_score_gemma":0.000021265812,"teacher_disagreement_score":0.54143953,"about_ca_system_score_codex":0.00006242661,"about_ca_system_score_gemma":0.000019133447,"threshold_uncertainty_score":0.9912712},"labels":[],"label_agreement":null},{"id":"W7093914280","doi":"","title":"\\nThe International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia","year":2013,"lang":"","type":"article","venue":"Radboud Repository (Radboud University)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"MEDLINE; Renal pathology; Disease; Kidney disease; Kidney","score_opus":0.01538899510887742,"score_gpt":0.20610141295166345,"score_spread":0.19071241784278603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7093914280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94191384,0.0013118226,0.0016392614,0.00045354408,0.0035186757,0.0012705,0.000055211396,0.00007046777,0.049766693],"genre_scores_gemma":[0.97153836,0.00076901115,0.0012043552,0.000044321714,0.0005639454,0.00000784745,0.000056034172,0.000045330195,0.025770813],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9957132,0.00051027286,0.0011579642,0.0010266056,0.000956567,0.0006354054],"domain_scores_gemma":[0.9958411,0.0003646529,0.0013681902,0.00089549244,0.0011163119,0.000414249],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002722622,0.00058766035,0.0010846675,0.00050654256,0.00027768742,0.00004812612,0.00077825657,0.00083765003,0.00042731105],"category_scores_gemma":[0.000056474095,0.00056067324,0.00085958384,0.000691865,0.0014511152,0.00042072567,0.00035440957,0.00072022766,0.000050958908],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027456856,0.0047930023,0.097165674,0.0006553262,0.004103629,0.002117501,0.002956243,0.0027389547,0.80970794,0.00803273,0.061426528,0.0035567966],"study_design_scores_gemma":[0.015480176,0.00685933,0.6989659,0.00072410906,0.0046041165,0.001373988,0.013239165,0.047465578,0.07138539,0.00017384853,0.13800946,0.0017189211],"about_ca_topic_score_codex":0.00034683885,"about_ca_topic_score_gemma":0.000005439917,"teacher_disagreement_score":0.73832256,"about_ca_system_score_codex":0.0010305715,"about_ca_system_score_gemma":0.0006880483,"threshold_uncertainty_score":0.99968445},"labels":[],"label_agreement":null},{"id":"W7095966437","doi":"","title":"CUAJ • November-December 2014 • Volume 8, Issues 11-12 © 2014 Canadian Urological Association","year":2014,"lang":"en","type":"article","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Renal cell carcinoma; Kidney cancer; Disease; MEDLINE; Carcinoma; Nephrectomy","score_opus":0.014945651489007962,"score_gpt":0.24699052471258548,"score_spread":0.23204487322357753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7095966437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6904926,0.00031467105,0.00016060789,0.027694345,0.00042048015,0.00053530897,0.000012439989,0.00018541522,0.28018418],"genre_scores_gemma":[0.8567899,0.000037167145,0.0008688765,0.003587249,0.0005194092,0.000027388052,0.00009768265,0.000031965898,0.13804036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796736,0.00013167434,0.00032327915,0.00044363784,0.00048769664,0.0006463487],"domain_scores_gemma":[0.9984351,0.00012452324,0.00010943582,0.00047378617,0.00018365074,0.0006734953],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0004998597,0.00026126247,0.00044964813,0.0001493544,0.0001071134,0.000046895522,0.0001154914,0.00031711074,0.009657881],"category_scores_gemma":[0.0002836608,0.00019749648,0.0001656429,0.00009266774,0.000038489547,0.00008621836,0.000036161866,0.00022029073,0.008380998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021209828,0.00006738287,0.5285117,0.000008619947,0.000051919273,0.000023734734,0.000033947446,0.00000657544,0.0002534787,0.0003595754,0.47007766,0.00058417977],"study_design_scores_gemma":[0.0008904018,0.00037890644,0.4999474,0.000007928286,0.00012999927,0.000029970002,0.000016175862,0.000724898,0.0007759002,0.00012425153,0.49679983,0.00017434132],"about_ca_topic_score_codex":0.13612603,"about_ca_topic_score_gemma":0.16219887,"teacher_disagreement_score":0.16629733,"about_ca_system_score_codex":0.0008530451,"about_ca_system_score_gemma":0.00016558725,"threshold_uncertainty_score":0.9923911},"labels":[],"label_agreement":null},{"id":"W7099827172","doi":"","title":"Chemical Sciences, Computer and Mathematical","year":2013,"lang":"en","type":"article","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Work (physics); Mathematical model; Field (mathematics); Key (lock)","score_opus":0.02657891927704474,"score_gpt":0.2581756744518757,"score_spread":0.23159675517483097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7099827172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9549484,0.00004741145,0.00082364056,0.0013429994,0.00000948062,0.00016770877,6.4577115e-8,0.00002676316,0.042633496],"genre_scores_gemma":[0.9378371,0.0000017511567,0.06083216,0.000443594,0.000044226406,0.000008538339,7.0780015e-7,0.0000031607333,0.00082870637],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9995993,0.0000038423195,0.00007136595,0.0001160503,0.000111104775,0.00009834813],"domain_scores_gemma":[0.99976784,0.0000325159,0.0000069167168,0.000075041746,0.00001648837,0.00010118177],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000037106725,0.00004962451,0.00009727035,0.000018705612,0.000016507453,0.00001839201,0.000020971656,0.000021866477,0.0011431644],"category_scores_gemma":[0.0000058098112,0.000028466533,0.000018334655,0.000036584534,0.00011858561,0.000029899858,0.000032251617,0.000031035113,0.000482252],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083741594,0.0023076101,0.18462436,0.0009026814,0.0003090003,0.0003681089,0.0009367731,0.0000021387402,0.31421697,0.14293033,0.13503543,0.21828288],"study_design_scores_gemma":[0.007996994,0.0029589718,0.47117874,0.0003664489,0.00032980536,0.006705573,0.00026985924,0.073594876,0.40079105,0.0320814,0.0028252944,0.0009009915],"about_ca_topic_score_codex":0.000011821218,"about_ca_topic_score_gemma":5.859209e-8,"teacher_disagreement_score":0.2865544,"about_ca_system_score_codex":0.000013481067,"about_ca_system_score_gemma":0.00001132689,"threshold_uncertainty_score":0.9997699},"labels":[],"label_agreement":null},{"id":"W7100866932","doi":"","title":"CUAJ • September-October 2013 • Volume 7, Issues 9-10 © 2013 Canadian Urological Association","year":2013,"lang":"en","type":"article","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Observational study; Adverse effect; Prospective cohort study; Epidemiology; Weakness; Tertiary care","score_opus":0.01505283456389403,"score_gpt":0.2422755799857017,"score_spread":0.22722274542180768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7100866932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7480017,0.000668034,0.0000063628827,0.04831312,0.00018628487,0.0008389357,0.000008011743,0.00013598244,0.20184155],"genre_scores_gemma":[0.5829058,0.00004967866,0.0005696256,0.001579856,0.00020128349,0.0000782695,0.00007045083,0.000020579379,0.4145244],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9982158,0.00007865755,0.00029973238,0.00036610768,0.00041343123,0.0006262751],"domain_scores_gemma":[0.99845403,0.000060899212,0.000086959764,0.00037213444,0.00031701179,0.00070894795],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00017283503,0.00023956451,0.0003687451,0.00014025852,0.00009072783,0.00006919838,0.00009963499,0.00029817582,0.108145855],"category_scores_gemma":[0.000080864804,0.00017374934,0.0001513595,0.00014604704,0.00003352175,0.00017041907,0.000033369633,0.0002162802,0.058643583],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008425958,0.00006369659,0.23604518,0.00000733087,0.00008180378,0.000031764597,0.000039848932,0.0000042210236,0.00023788754,0.000028732475,0.76286066,0.00059047615],"study_design_scores_gemma":[0.0005479018,0.00030509304,0.5055259,0.000007647868,0.00009086357,0.000024519008,0.00004020764,0.0005979624,0.00039672683,0.000087025226,0.49221632,0.0001598281],"about_ca_topic_score_codex":0.43466762,"about_ca_topic_score_gemma":0.050578907,"teacher_disagreement_score":0.3840887,"about_ca_system_score_codex":0.0009078489,"about_ca_system_score_gemma":0.00015653104,"threshold_uncertainty_score":0.96674556},"labels":[],"label_agreement":null},{"id":"W7100934045","doi":"","title":"Robotic renal surgery: The future or a passing curiosity?","year":2009,"lang":"en","type":"article","venue":"PubMed Central","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Robotic surgery; Nephrectomy; Prostatectomy; Surgical robot; Critical appraisal; Health care","score_opus":0.026443207734242424,"score_gpt":0.2355778697975912,"score_spread":0.2091346620633488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7100934045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95610744,0.0023871264,0.00012704516,0.03700524,0.0011334266,0.00092612655,0.0000031559312,0.00013474729,0.0021756717],"genre_scores_gemma":[0.99372053,0.00013343297,0.00026152088,0.002187157,0.002328177,0.00004329893,0.000029213454,0.000017829614,0.001278838],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99774736,0.00007838959,0.00024088491,0.0002672669,0.0003792769,0.0012868156],"domain_scores_gemma":[0.9989062,0.00010356301,0.00007805234,0.0003724798,0.0000312089,0.0005085029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029737767,0.00020274083,0.00033252648,0.00006500807,0.00014041425,0.00006238903,0.00010039909,0.00008122158,0.00012125665],"category_scores_gemma":[0.00009384791,0.00010617073,0.00022142813,0.00026512946,0.000052095613,0.00008707599,0.00001768647,0.00025361136,0.000019634552],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002968187,0.0013487472,0.2073744,0.00012439529,0.0005360718,0.004737263,0.0014731949,0.00024414039,0.0011270054,0.00095606124,0.09306209,0.68604845],"study_design_scores_gemma":[0.0006948264,0.000104167084,0.9763881,0.000046015997,0.00023562941,0.00041589068,0.0000660255,0.00008856177,0.0020033943,0.000074030206,0.01974576,0.00013758411],"about_ca_topic_score_codex":0.000013343847,"about_ca_topic_score_gemma":0.000029511424,"teacher_disagreement_score":0.7690137,"about_ca_system_score_codex":0.00042053277,"about_ca_system_score_gemma":0.00026118843,"threshold_uncertainty_score":0.4329517},"labels":[],"label_agreement":null},{"id":"W7114910203","doi":"10.17863/cam.123922","title":"Evaluating the metabolic effects of neoadjuvant treatment in clear cell renal cell carcinoma using hyperpolarized [1-13 C]pyruvate MRI.","year":2025,"lang":"en","type":"article","venue":"Apollo (University of Cambridge)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NIHR Cambridge Biomedical Research Centre; National Institute for Health and Care Research; Department of Health and Social Care; Cancer Research UK; Canadian Institute for Advanced Research; AstraZeneca","keywords":"Olaparib; Renal cell carcinoma; Clear cell renal cell carcinoma; Biomarker; Complete response; Neoadjuvant therapy; Targeted therapy; Combination therapy","score_opus":0.023606170061797948,"score_gpt":0.26536527770364887,"score_spread":0.24175910764185093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7114910203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903176,0.0036253294,0.0002512858,0.000253133,0.00012319893,0.0011961226,0.000014858494,0.000021156202,0.004197305],"genre_scores_gemma":[0.99266505,0.00016905516,0.0028272236,0.0000527676,0.000021739528,0.0000019906788,0.000015501679,0.000021487895,0.004225188],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99815905,0.00031505307,0.00032505108,0.00041508346,0.00041293714,0.0003727947],"domain_scores_gemma":[0.99852395,0.00029054246,0.00029116528,0.0006373018,0.00014061091,0.00011645681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033429186,0.00029097547,0.00084536197,0.00040744882,0.00016852444,0.000008645313,0.00023396747,0.00012328611,0.000020714193],"category_scores_gemma":[0.000030524192,0.00024493635,0.00038857188,0.00065727666,0.0001985289,0.00009728632,0.00015270156,0.00020263225,0.000010337467],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001790676,0.000872352,0.04840182,0.0005636012,0.0003016224,0.00040266252,0.0022723859,0.00036732724,0.9392682,0.00019322766,0.00010270435,0.0054634674],"study_design_scores_gemma":[0.017219601,0.0024873212,0.41822267,0.00033703804,0.0027009896,0.000016807448,0.002118324,0.013085129,0.5430635,0.000016602457,0.00046465607,0.00026735492],"about_ca_topic_score_codex":0.01412029,"about_ca_topic_score_gemma":0.00012122008,"teacher_disagreement_score":0.39620465,"about_ca_system_score_codex":0.00039398888,"about_ca_system_score_gemma":0.00053354853,"threshold_uncertainty_score":0.99882144},"labels":[],"label_agreement":null},{"id":"W7115031843","doi":"","title":"Clinical significance of recurrently mutated genes in renal cell carcinoma: a closer look at VHL wild-type tumors","year":2025,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre","funders":"","keywords":"Clinical significance; Gene; Mutation; Cell; Renal cell carcinoma; Disease; Kidney","score_opus":0.03156258014264417,"score_gpt":0.29184515684555085,"score_spread":0.26028257670290667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7115031843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.945192,0.004484591,3.4036344e-8,0.000016890526,0.0015507147,0.0024230857,0.0006943623,0.00012735832,0.045510955],"genre_scores_gemma":[0.9668359,0.0009266873,0.00053422403,0.0001271221,0.00009647699,0.00023144251,0.0030210642,0.00022923035,0.027997855],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99125487,0.0009792444,0.0031447052,0.0021917126,0.0013495707,0.0010798717],"domain_scores_gemma":[0.9945575,0.00067261537,0.0015037413,0.0015743827,0.0010534979,0.0006382356],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0013115201,0.0013242997,0.002706195,0.0010495225,0.0003337593,0.000028222476,0.0006783016,0.0013929249,0.0003366526],"category_scores_gemma":[0.00081324234,0.0012865394,0.0010461014,0.0016010054,0.00017153745,0.0002420721,0.0002366918,0.00254054,0.00022619855],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039318413,0.011148305,0.16378544,0.01731231,0.0024595498,0.011704007,0.00014748049,0.00022947171,0.52068114,0.0027104144,0.00031981795,0.23018362],"study_design_scores_gemma":[0.009151314,0.002780357,0.19876355,0.0033795796,0.0020934164,0.00009491919,0.00031974423,0.000039086946,0.77247936,0.0007974156,0.008478168,0.001623062],"about_ca_topic_score_codex":0.000997477,"about_ca_topic_score_gemma":0.0022146478,"teacher_disagreement_score":0.2517982,"about_ca_system_score_codex":0.0021888067,"about_ca_system_score_gemma":0.000742357,"threshold_uncertainty_score":0.9999508},"labels":[],"label_agreement":null},{"id":"W7116924793","doi":"10.1016/j.annonc.2025.10.442","title":"546MO Knowledge gaps and shared decision making (SDM) disparities in kidney cancer (KC) across Asia: Results from the international kidney cancer coalition (IKCC) global patient survey (GPS)","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"AstraZeneca","keywords":"Kidney cancer; Cancer; Healthcare system; Global Positioning System; Global health; MEDLINE; Health care; Health equity","score_opus":0.09568904143616246,"score_gpt":0.4350608041268182,"score_spread":0.3393717626906557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116924793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95845675,0.0060562664,0.000027886885,0.020598842,0.0011486773,0.00050182606,0.007849622,0.000016769844,0.0053433473],"genre_scores_gemma":[0.9910005,0.00271394,0.00014886171,0.004981444,0.00013384168,0.00013338625,0.00065586285,0.000011172203,0.00022100766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979431,0.00029655223,0.00067817623,0.00045670485,0.00029076403,0.0003346717],"domain_scores_gemma":[0.9977462,0.0010265827,0.00026347797,0.00029307362,0.00050640095,0.00016426411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068881985,0.00020828006,0.0005134208,0.00007976725,0.000088528745,0.000036216865,0.00020666486,0.00020440326,0.00010971468],"category_scores_gemma":[0.001953738,0.00015446365,0.00009140442,0.00028928387,0.00018920598,0.00009437229,0.00028240692,0.00020476972,0.000004694357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076333806,0.00058206765,0.666109,0.00008493249,0.00038667605,0.00008724423,0.0016915381,0.000032495696,0.00027729766,0.00019731377,0.21101217,0.11190584],"study_design_scores_gemma":[0.004242418,0.00045197865,0.95039815,0.0019872359,0.00006587599,0.000008753146,0.00034187536,0.00028223672,0.0012242537,0.00063403486,0.04024364,0.00011954285],"about_ca_topic_score_codex":0.028923748,"about_ca_topic_score_gemma":0.039860588,"teacher_disagreement_score":0.28428912,"about_ca_system_score_codex":0.0006635283,"about_ca_system_score_gemma":0.0011000492,"threshold_uncertainty_score":0.97765946},"labels":[],"label_agreement":null},{"id":"W7117307022","doi":"10.1016/j.iotech.2025.101348","title":"351P Association of G-coupled protein receptor 65 (GPR65), a novel therapeutic target, with immune cell subsets in metastatic renal cell carcinoma (mRCC)","year":2025,"lang":"en","type":"article","venue":"Immuno-Oncology Technology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Renal cell carcinoma; Immune system; Kidney cancer; Receptor; Cell; Immunotherapy; T cell; Kidney","score_opus":0.009426331137015345,"score_gpt":0.25070166207310923,"score_spread":0.24127533093609388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117307022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822763,0.0068840124,0.00071411347,0.004093566,0.00019927109,0.0026549578,0.000019911682,0.00017039753,0.0029874519],"genre_scores_gemma":[0.98325604,0.00007307398,0.012003771,0.00015527078,0.000017452938,0.0008683223,0.000082718165,0.00006167147,0.003481657],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99668247,0.00023983247,0.0011619946,0.0007038032,0.0003740818,0.00083781616],"domain_scores_gemma":[0.99740463,0.00031640785,0.00084953156,0.0009644887,0.0003980524,0.000066902794],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007831286,0.0005029716,0.001525333,0.0014452698,0.00010116916,0.000010682267,0.00045011853,0.00082062103,0.00015464264],"category_scores_gemma":[0.00016456007,0.00042243284,0.0002033884,0.0018255957,0.00039165447,0.0000886685,0.0001847953,0.00095893606,0.00004702933],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019499284,0.0025374242,0.06888941,0.00027134383,0.00036758525,0.00017718798,0.00031376997,0.000019591762,0.92347574,0.00037658698,0.000086973894,0.001534429],"study_design_scores_gemma":[0.018540476,0.005114599,0.043474123,0.00020279465,0.0006346227,0.00009164888,0.001080181,0.00024737118,0.92684567,0.00053858606,0.002868941,0.00036100682],"about_ca_topic_score_codex":0.00041134818,"about_ca_topic_score_gemma":0.00018174843,"teacher_disagreement_score":0.02541529,"about_ca_system_score_codex":0.002278988,"about_ca_system_score_gemma":0.0013296016,"threshold_uncertainty_score":0.99982274},"labels":[],"label_agreement":null},{"id":"W7117320251","doi":"10.1016/j.jaad.2025.12.078","title":"Assessing and predicting cutaneous leiomyoma severity in hereditary leiomyomatosis and renal cell cancer syndrome: An observational study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Leiomyomatosis; Observational study; Leiomyoma; MEDLINE; Kidney cancer; Cell; Cancer","score_opus":0.05676837255858766,"score_gpt":0.3647437478334322,"score_spread":0.30797537527484453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117320251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988287,0.0013946749,0.0000103469465,0.009906691,0.00007404116,0.00026561145,0.0000045464453,0.000006702439,0.000050405382],"genre_scores_gemma":[0.9980436,0.0001505724,0.0010877964,0.0006463334,0.00003306123,0.0000067855594,6.028902e-7,0.000011628669,0.000019619185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982354,0.0003358919,0.00072763464,0.00020127122,0.00029776673,0.00020204952],"domain_scores_gemma":[0.9986005,0.0002772816,0.000836902,0.000111245085,0.00006726606,0.000106801206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021556576,0.00016615262,0.0007940925,0.00027841097,0.00008171189,0.000017528837,0.00017105424,0.00007718869,0.000005975912],"category_scores_gemma":[0.00006539428,0.00011825969,0.00007650038,0.0003858681,0.00037036306,0.000200522,0.00012759698,0.00055644027,1.1961649e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002311879,0.00032119887,0.98951197,0.00011734262,0.0002039583,0.0008209605,0.00030146106,0.000034250257,0.006043414,0.0000055954993,0.00014511644,0.0022635357],"study_design_scores_gemma":[0.0013877254,0.00033694136,0.96213204,0.0002722551,0.00035983734,0.029952636,0.0016238869,0.00035751596,0.003344232,0.00010429988,0.000051409246,0.00007723788],"about_ca_topic_score_codex":0.00024105774,"about_ca_topic_score_gemma":0.00001603738,"teacher_disagreement_score":0.029131675,"about_ca_system_score_codex":0.00012592916,"about_ca_system_score_gemma":0.00020645495,"threshold_uncertainty_score":0.48224902},"labels":[],"label_agreement":null},{"id":"W7128681525","doi":"10.1109/compas67506.2025.11381643","title":"Hybrid Vision Transformer and ResNet18 Framework for Multiclass Kidney Disease Detection from CT Scans","year":2025,"lang":"","type":"article","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Francis Xavier University","funders":"","keywords":"Encoder; Pattern recognition (psychology); Robustness (evolution); Feature extraction; Medical imaging; Convolutional neural network; Kidney disease; Architecture","score_opus":0.012900688106514778,"score_gpt":0.2897734590752012,"score_spread":0.2768727709686864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7128681525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6885291,0.005890898,0.2925562,0.005789453,0.0014384732,0.0035656788,0.0006433638,0.000102638325,0.0014842091],"genre_scores_gemma":[0.9853349,0.0011001587,0.006666851,0.001995506,0.00036691563,0.00027879368,0.00020960448,0.00006535088,0.0039819404],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996891,0.00012747763,0.0007358867,0.0011516891,0.00042775154,0.0006661984],"domain_scores_gemma":[0.9967228,0.00091466424,0.00011180376,0.0007401188,0.00018079997,0.0013298072],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002418825,0.00058668235,0.0006980597,0.0002846058,0.00038834396,0.00012035462,0.00013043421,0.00015593966,0.0003318734],"category_scores_gemma":[0.0007308087,0.00048664134,0.0003579138,0.00029291457,0.00027880762,0.00020511099,0.000042760195,0.00040095742,0.00003178845],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036631368,0.0034027628,0.028306467,0.0043391334,0.0032850064,0.0007326228,0.0016291178,0.000092290065,0.04763132,0.0028532716,0.010451999,0.86064464],"study_design_scores_gemma":[0.03181346,0.0047051366,0.18890862,0.008564841,0.0130949635,0.000029807861,0.00093931,0.11476555,0.5371825,0.044215534,0.05415009,0.001630153],"about_ca_topic_score_codex":0.00094964996,"about_ca_topic_score_gemma":0.0001156931,"teacher_disagreement_score":0.8590145,"about_ca_system_score_codex":0.00048533556,"about_ca_system_score_gemma":0.0005254327,"threshold_uncertainty_score":0.99975854},"labels":[],"label_agreement":null},{"id":"W7132949649","doi":"","title":"A Cost-Utility Analysis of First-Line Systemic Therapy for Patients with Metastatic Renal Cell Carcinoma","year":2020,"lang":"","type":"dissertation","venue":"TSpace","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Services and Policy Research","funders":"","keywords":"Systemic therapy; Pazopanib; Renal cell carcinoma; Sunitinib; Disease; Kidney cancer; Systemic disease; Overall survival; Targeted therapy","score_opus":0.04455345873122531,"score_gpt":0.320401370684977,"score_spread":0.2758479119537517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7132949649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97827196,0.006661122,0.0025325418,0.00011965026,0.00024478816,0.010813559,0.0007463568,0.000041596795,0.00056841125],"genre_scores_gemma":[0.97948897,0.00043758948,0.0011002461,0.000050366667,0.0000892385,0.0010710933,0.015677111,0.00017835392,0.0019070302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939685,0.00035528746,0.0017256206,0.0016136534,0.0015199443,0.00081699033],"domain_scores_gemma":[0.99275833,0.00084757,0.002341932,0.001407322,0.0020160305,0.0006288266],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00042099028,0.0013090485,0.0038579123,0.0009127214,0.00021844589,0.00004401921,0.0004111347,0.0003428438,0.00057401153],"category_scores_gemma":[0.00018323518,0.0009987028,0.001481665,0.0024317838,0.000147279,0.00008933624,0.000041584703,0.00049656327,0.000019352112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.088530906,0.008904547,0.75787437,0.025965244,0.040990386,0.00023622578,0.06600822,0.0019284828,0.0036589387,0.000015529658,0.00032336457,0.0055637686],"study_design_scores_gemma":[0.04391345,0.029520525,0.6728931,0.0022712012,0.13346693,0.000008435615,0.018562943,0.032988623,0.06402404,0.000009045005,0.00050788897,0.001833796],"about_ca_topic_score_codex":0.0011125371,"about_ca_topic_score_gemma":0.00049067463,"teacher_disagreement_score":0.09247654,"about_ca_system_score_codex":0.0006016293,"about_ca_system_score_gemma":0.00076016155,"threshold_uncertainty_score":0.9999661},"labels":[],"label_agreement":null},{"id":"W7135009996","doi":"10.5376/cge.2024.12.0023","title":"Application and Prospects of &lt;i&gt;VHL&lt;/i&gt; Gene in Kidney Cancer Diagnosis","year":2024,"lang":"","type":"article","venue":"Cancer Genetics and Epigenetics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Kidney cancer; Gene; Cancer; Kidney; Kidney disease; Mutation","score_opus":0.017173462409731482,"score_gpt":0.27456333341538325,"score_spread":0.25738987100565175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7135009996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5308978,0.46535316,0.00024128442,0.00085782545,0.00062079006,0.0012787626,0.0004832307,0.00001864378,0.00024848754],"genre_scores_gemma":[0.5666016,0.43053228,0.0005754413,0.000149751,0.0004886634,0.0011521921,0.0000378987,0.00008940126,0.00037282254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99606335,0.00008871556,0.0011072394,0.0013187431,0.0006094351,0.0008125167],"domain_scores_gemma":[0.9977262,0.00014446257,0.00026058714,0.0007418442,0.00028381773,0.00084305945],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029810215,0.0007035973,0.0009827922,0.00038903265,0.00011777491,0.000116738054,0.00020739842,0.00042745282,0.00021972378],"category_scores_gemma":[0.000047760444,0.0006873449,0.00015207939,0.0008136967,0.0005243963,0.00005041774,0.0002467355,0.00031880557,0.000010488659],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024449077,0.0005774297,0.42716646,0.0075485036,0.0009405123,0.0001833839,0.003615774,0.0016657508,0.2645048,0.0010458253,0.0024317927,0.29007527],"study_design_scores_gemma":[0.003243482,0.0015396796,0.45103672,0.0038445299,0.002616076,0.000035154808,0.00006398688,0.027078621,0.37635106,0.001087592,0.13198589,0.0011172151],"about_ca_topic_score_codex":0.00035946447,"about_ca_topic_score_gemma":0.0008746454,"teacher_disagreement_score":0.28895807,"about_ca_system_score_codex":0.0005888639,"about_ca_system_score_gemma":0.001172627,"threshold_uncertainty_score":0.9995578},"labels":[],"label_agreement":null},{"id":"W7147498895","doi":"10.70675/2c1a47c4z15d4z482azbae7z2e7209729463","title":"Ablation radioguidée des masses rénales","year":2015,"lang":"","type":"dissertation","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Carcinosis; Colonic disease; Decision system","score_opus":0.058553004676200504,"score_gpt":0.3288124918202758,"score_spread":0.27025948714407527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7147498895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6967999,0.024507614,0.000193219,0.000092124734,0.0011974877,0.001366179,0.000017122424,0.0001286956,0.27569768],"genre_scores_gemma":[0.85583705,0.0024807712,0.004345959,0.00007130788,0.0008536791,0.00012866854,0.005712143,0.00015734512,0.1304131],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99533236,0.00021323393,0.0012265523,0.0010222545,0.0014342879,0.0007713392],"domain_scores_gemma":[0.9959868,0.00023404186,0.0005686189,0.00084673637,0.0015603638,0.00080341747],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00058580836,0.0010303583,0.00127411,0.0006205572,0.0002790748,0.000140482,0.00024472168,0.00075999775,0.0043564136],"category_scores_gemma":[0.00041171088,0.00084980676,0.0004952345,0.0005643208,0.00021367123,0.00032482602,0.000037608108,0.00046557802,0.0022178646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0104067065,0.004801947,0.4674312,0.013736949,0.008499889,0.003216133,0.035429824,0.00053708826,0.0528263,0.0045063733,0.076526344,0.32208124],"study_design_scores_gemma":[0.012435298,0.007321968,0.7368445,0.0056063575,0.0125632845,0.00069184974,0.032798067,0.0024167362,0.1499108,0.010787247,0.025165308,0.0034586298],"about_ca_topic_score_codex":0.0010122163,"about_ca_topic_score_gemma":0.000710834,"teacher_disagreement_score":0.31862262,"about_ca_system_score_codex":0.001600575,"about_ca_system_score_gemma":0.0016471184,"threshold_uncertainty_score":0.99939525},"labels":[],"label_agreement":null},{"id":"W7161772041","doi":"10.82308/54791","title":"The clinical and economic burden of metastatic renal cell carcinoma in Canada in real-world setting","year":2019,"lang":"en","type":"dissertation","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sunitinib; Pazopanib; Renal cell carcinoma; Kidney cancer; Metastasectomy; Incidence (geometry); Cancer; Clinical trial; Indirect costs","score_opus":0.02694675204516617,"score_gpt":0.3073388822593905,"score_spread":0.2803921302142243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7161772041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95894176,0.0008292152,6.541677e-8,0.00015594701,0.000258044,0.00076345674,0.000014227019,0.0000032077803,0.039034106],"genre_scores_gemma":[0.9833066,0.00029105585,0.0001303314,0.000025537325,0.000049994884,0.000026698537,0.0002491334,0.000032482043,0.015888192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978595,0.00015485802,0.0011199688,0.00038791925,0.00020775167,0.000270018],"domain_scores_gemma":[0.9983372,0.00078950165,0.00036356368,0.00037013472,0.000038212303,0.0001013968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054541643,0.0002458164,0.00080875435,0.0001926448,0.000021109418,0.000010771163,0.00011024269,0.00008032161,0.00006359725],"category_scores_gemma":[0.000037325346,0.00016844171,0.00009576921,0.000094223964,0.000033365777,0.000025194864,0.000025686237,0.00041079972,0.000007038177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008220398,0.000051298986,0.98939204,0.00084335904,0.00011333798,0.00033664377,0.00061224925,0.00016922955,0.00019153347,0.00009505576,0.0012047705,0.0061684307],"study_design_scores_gemma":[0.0024945242,0.0002034617,0.9882599,0.0002519554,0.00022284164,0.00000786718,0.0041306075,0.0012850994,0.0027082285,0.000030094652,0.00022440338,0.00018098786],"about_ca_topic_score_codex":0.96836346,"about_ca_topic_score_gemma":0.9959828,"teacher_disagreement_score":0.027619375,"about_ca_system_score_codex":0.0008628343,"about_ca_system_score_gemma":0.0042029563,"threshold_uncertainty_score":0.7455864},"labels":[],"label_agreement":null},{"id":"W7161800700","doi":"10.82308/54297","title":"Investigating the genomic underpinnings of renal cell carcinoma, genetic predisposition, and their clinical implications","year":2024,"lang":"en","type":"dissertation","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genetic inheritance; Tumor cells; Mutation; Neoplasm staging","score_opus":0.03384623962276467,"score_gpt":0.3058662423020045,"score_spread":0.2720200026792398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7161800700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97911173,0.007711984,0.000055491993,0.0009024065,0.00016361951,0.0009348837,0.000035164576,0.000044936005,0.011039769],"genre_scores_gemma":[0.9912375,0.0002270273,0.001012837,0.0001999934,0.00023934328,0.000107434156,0.00082553615,0.00006902948,0.0060812845],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99818146,0.000083287494,0.0008422471,0.0005213579,0.00017249821,0.00019911966],"domain_scores_gemma":[0.99853516,0.00025841405,0.00031751694,0.00053912046,0.00017936282,0.00017041161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022442997,0.00032050832,0.0005013366,0.00012862896,0.00011234404,0.000037833594,0.000140027,0.0002641767,0.000039002316],"category_scores_gemma":[0.00003783046,0.00018822614,0.00025705356,0.00018328095,0.0001824085,0.000023076374,0.000052144445,0.00047679027,0.000020964564],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048142875,0.00089859613,0.30221477,0.00915765,0.0022150036,0.00007059346,0.023397336,0.000058105266,0.60725605,0.004290856,0.02279449,0.027165143],"study_design_scores_gemma":[0.0005696443,0.00052968407,0.96688133,0.00032242603,0.0012485795,0.00008987253,0.0014566212,0.00032898813,0.025553191,0.0026241634,0.00019980597,0.00019567147],"about_ca_topic_score_codex":0.00017983583,"about_ca_topic_score_gemma":0.00007827196,"teacher_disagreement_score":0.6646666,"about_ca_system_score_codex":0.000093555784,"about_ca_system_score_gemma":0.00048583897,"threshold_uncertainty_score":0.76756394},"labels":[],"label_agreement":null},{"id":"W79914550","doi":"10.1007/978-1-60327-914-7_4","title":"Adult Laparoscopic Partial Nephrectomy for Renal Cell Carcinoma","year":2010,"lang":"en","type":"book-chapter","venue":"Humana Press eBooks","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Malignancy; Kidney cancer; Urology; Incidence (geometry); Cancer; Kidney; Kidney disease; Carcinoma; Surgery; General surgery; Oncology; Internal medicine","score_opus":0.053666824818084,"score_gpt":0.26821135786357225,"score_spread":0.21454453304548826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W79914550","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01469499,0.0037534302,0.0000441283,0.00002960259,0.00073392555,0.004018765,0.00016987328,0.00018961696,0.9763657],"genre_scores_gemma":[0.081146374,0.00007889847,0.001511393,0.00033101256,0.002379045,0.0010021848,0.00040544747,0.00031737148,0.91282827],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971285,0.0000217358,0.0006812497,0.0009660148,0.0005673698,0.00063512585],"domain_scores_gemma":[0.9974851,0.00009802515,0.0003978763,0.0012599936,0.00034183005,0.00041719683],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010141587,0.0008276121,0.0011366877,0.00019522705,0.00020566271,0.00006985063,0.0002971915,0.000849819,0.0003546546],"category_scores_gemma":[0.000015567502,0.0007362463,0.0006515576,0.0000047251992,0.00025560704,0.000033512468,0.00014314332,0.0009575529,0.00008625081],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013904567,0.0013332749,0.00026410638,0.017422331,0.0046759686,0.0071244333,0.0046456056,0.000008568809,0.07572572,0.63698596,0.1138259,0.12408354],"study_design_scores_gemma":[0.0052137235,0.0011500901,0.000072663526,0.00029668622,0.0017120861,0.000059717724,0.000003460413,0.000017494214,0.17753908,0.0015701903,0.81172794,0.0006368423],"about_ca_topic_score_codex":0.00020585596,"about_ca_topic_score_gemma":0.00013183942,"teacher_disagreement_score":0.6979021,"about_ca_system_score_codex":0.00017103153,"about_ca_system_score_gemma":0.00024217095,"threshold_uncertainty_score":0.99950886},"labels":[],"label_agreement":null},{"id":"W81857156","doi":"10.1200/jco.2007.25.18_suppl.5010","title":"Sunitinib in metastatic renal cell carcinoma (mRCC): Preliminary assessment of toxicity in an expanded access trial with subpopulation analysis","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Sunitinib; Internal medicine; Renal cell carcinoma; Population; Expanded access; Tyrosine-kinase inhibitor; Concomitant; Gastroenterology; Cancer; Surgery; Oncology; Urology","score_opus":0.23060746489563758,"score_gpt":0.5225273647036596,"score_spread":0.291919899808022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W81857156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969204,0.00009795768,0.0009326247,0.00023365233,0.00020785736,0.00061937043,0.000002646031,0.0000034504017,0.0009820557],"genre_scores_gemma":[0.9924411,0.0000272463,0.007026673,0.0001393099,0.00029400064,0.000008041916,0.000023459013,0.000015457463,0.000024709621],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934832,0.0012737387,0.0039403304,0.00025878786,0.0007043045,0.00033966493],"domain_scores_gemma":[0.9936194,0.0025070335,0.0027781294,0.0002895382,0.0003897013,0.0004162048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008906723,0.00019663658,0.0024426663,0.0010948491,0.000018255892,0.0000098784185,0.00020861035,0.0002569898,0.00007307602],"category_scores_gemma":[0.00063404953,0.0001346945,0.00049368007,0.0009550076,0.0001319686,0.00033532677,0.000050642335,0.00089204445,3.7566699e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11867233,0.008512902,0.863558,0.000040591403,0.0003382869,0.0020973242,0.00016510766,0.00086900796,0.00039084902,0.000008960246,0.000010652559,0.0053360024],"study_design_scores_gemma":[0.06571853,0.05492178,0.8743245,0.00005058742,0.002052885,0.000091676666,0.00032040715,0.00065676874,0.0017152238,0.00003596388,0.00001332473,0.00009835041],"about_ca_topic_score_codex":0.00032291227,"about_ca_topic_score_gemma":0.0028845884,"teacher_disagreement_score":0.052953795,"about_ca_system_score_codex":0.00052943506,"about_ca_system_score_gemma":0.0014662023,"threshold_uncertainty_score":0.54926825},"labels":[],"label_agreement":null},{"id":"W827115667","doi":"","title":"Groupe d’intérêts spéciaux (GIS) en oncologie chirurgicale","year":2015,"lang":"fr","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"INT; Computer science; Operating system","score_opus":0.43074231850432937,"score_gpt":0.5739189991348773,"score_spread":0.14317668063054795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W827115667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61820644,0.2612956,0.00015442244,0.0023139082,0.0073510115,0.0017394233,0.00010483764,0.00009116826,0.10874323],"genre_scores_gemma":[0.9124136,0.06335952,0.0010273787,0.0009313322,0.00419328,0.00014240426,0.000071458875,0.00021276067,0.017648265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9908793,0.001537778,0.00230702,0.0012434815,0.0023748255,0.0016576092],"domain_scores_gemma":[0.9916953,0.001547916,0.0016300711,0.0015360577,0.0010383724,0.0025522807],"candidate_categories":["metaepi_narrow","scholarly_communication","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.004612673,0.0011127321,0.0028390992,0.0012113008,0.0002964174,0.0012579279,0.0040378976,0.00071125815,0.03663614],"category_scores_gemma":[0.0022310033,0.00095851795,0.00081524154,0.001827598,0.0006887445,0.0029332098,0.0027102625,0.0016400327,0.0011791638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002197282,0.0037615201,0.58301073,0.0006007913,0.0016414779,0.0058545554,0.0010090169,0.0003104399,0.018541098,0.0005691531,0.29625255,0.0862514],"study_design_scores_gemma":[0.0056993184,0.0004443464,0.68493587,0.002679809,0.0015676192,0.0006738953,0.00063274417,0.00019023832,0.028808901,0.0065688617,0.2666554,0.001143019],"about_ca_topic_score_codex":0.0028474885,"about_ca_topic_score_gemma":0.00007716749,"teacher_disagreement_score":0.2942072,"about_ca_system_score_codex":0.0030414753,"about_ca_system_score_gemma":0.0018044943,"threshold_uncertainty_score":0.99977887},"labels":[],"label_agreement":null},{"id":"W83791878","doi":"10.1016/s1695-3290(08)35058-7","title":"10.1016/s1695-3290(08)35058-7","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.014337354746152641,"score_gpt":0.19040606845737396,"score_spread":0.17606871371122132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W83791878","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009520437,0.0013557608,2.000423e-7,0.0003424372,0.0000050028175,0.0010767984,0.00007929908,0.00021596668,0.99691504],"genre_scores_gemma":[0.00000893961,0.000006479234,0.00014649426,0.00012035543,0.00074456027,0.000045079076,0.0004058518,0.0002311919,0.9982911],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997694,0.000018197923,0.00048395272,0.00071337994,0.0006353773,0.00045510006],"domain_scores_gemma":[0.99807626,0.000068464506,0.00012924695,0.0010545261,0.0001226414,0.00054883276],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00010168036,0.00067765004,0.00095439365,0.00034463103,0.00006758509,0.00003257992,0.00021494522,0.00046929423,0.99857825],"category_scores_gemma":[0.000018559602,0.0006006131,0.00041922202,0.00005229778,0.00008132141,0.00003755697,0.000097427386,0.00051410974,0.99845046],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006846759,0.00009306106,5.029519e-8,0.00009637019,0.00041107007,0.0011052171,0.000016129594,0.000003792445,0.000035749938,0.00004217031,0.5574979,0.4400138],"study_design_scores_gemma":[0.00091718463,0.0011775161,0.000011364192,0.00043488332,0.0007129906,0.00027185175,2.4878526e-7,0.0000048087263,0.00013777701,0.00011428735,0.99571615,0.00050090713],"about_ca_topic_score_codex":0.000023421873,"about_ca_topic_score_gemma":2.7474198e-7,"teacher_disagreement_score":0.43951288,"about_ca_system_score_codex":0.00040830704,"about_ca_system_score_gemma":0.00019218327,"threshold_uncertainty_score":0.9996445},"labels":[],"label_agreement":null},{"id":"W967702446","doi":"10.1016/j.jfma.2015.05.003","title":"Natural history of renal cell carcinoma: An immunohistochemical analysis of growth rate in patients with delayed treatment","year":2015,"lang":"en","type":"article","venue":"Journal of the Formosan Medical Association","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Renal cell carcinoma; Immunohistochemistry; Pathological; Clear cell; Growth rate; Natural history; Magnetic resonance imaging; Internal medicine; Pathology; Urology; Radiology","score_opus":0.009694354921280558,"score_gpt":0.2230379929145466,"score_spread":0.21334363799326603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W967702446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984517,0.00055922294,0.000013194307,0.00028224205,0.00020487752,0.0001897255,0.000008291995,0.0000026737137,0.00028808002],"genre_scores_gemma":[0.9993917,0.000009556562,0.0001593814,0.00005285669,0.000057288784,0.000002829873,0.000043745946,0.00001120799,0.00027146004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99693877,0.00023390538,0.00086274213,0.00011889752,0.0016632859,0.00018239206],"domain_scores_gemma":[0.9971485,0.0001209568,0.0014858138,0.00020167734,0.0008083745,0.00023465778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009947022,0.0001513512,0.0007294397,0.00027981488,0.000013907871,0.000002673593,0.00017686526,0.00015867382,0.000029892672],"category_scores_gemma":[0.00043134758,0.00008135936,0.0003487017,0.00043278444,0.00006818338,0.000120694116,0.0000262365,0.00033051943,5.420171e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036560139,0.0021650565,0.98429483,0.000026107316,0.0015482925,0.000033496988,0.0019597486,0.000045930447,0.0045814402,0.0000062267686,0.0012503344,0.00043252297],"study_design_scores_gemma":[0.0106753595,0.0042973375,0.9709593,0.00006152121,0.003221379,0.0000074576296,0.00010527607,0.0006581784,0.009842671,0.000018580797,0.000064229556,0.000088688],"about_ca_topic_score_codex":0.00024877122,"about_ca_topic_score_gemma":0.000067174806,"teacher_disagreement_score":0.013335508,"about_ca_system_score_codex":0.0068935663,"about_ca_system_score_gemma":0.0010311848,"threshold_uncertainty_score":0.9969188},"labels":[],"label_agreement":null}]}